id|nct_id|result_group_id|ctgov_group_code|title|period|description|count
96|NCT03163134|265|P2|NOT COMPLETED|Overall Study||0
97|NCT03163134|266|P1|NOT COMPLETED|Overall Study||0
98|NCT03163134|265|P2|COMPLETED|Overall Study||85
99|NCT03163134|266|P1|COMPLETED|Overall Study||85
100|NCT03163134|265|P2|STARTED|Overall Study||85
101|NCT03163134|266|P1|STARTED|Overall Study||85
102|NCT03159143|274|P1|NOT COMPLETED|Overall Study||0
103|NCT03159143|274|P1|COMPLETED|Overall Study||22
104|NCT03159143|274|P1|STARTED|Overall Study||22
105|NCT03157232|281|P1|NOT COMPLETED|Overall Study||0
106|NCT03157232|281|P1|COMPLETED|Overall Study||18
107|NCT03157232|281|P1|STARTED|Overall Study||18
108|NCT03134326|285|P1|NOT COMPLETED|Overall Study||0
109|NCT03134326|285|P1|COMPLETED|Overall Study||21
110|NCT03134326|285|P1|STARTED|Overall Study||21
111|NCT03134313|289|P1|NOT COMPLETED|Overall Study||0
112|NCT03134313|289|P1|COMPLETED|Overall Study||25
113|NCT03134313|289|P1|STARTED|Overall Study||25
114|NCT03125031|293|P2|NOT COMPLETED|Overall Study||0
115|NCT03125031|294|P1|NOT COMPLETED|Overall Study||0
116|NCT03125031|293|P2|COMPLETED|Overall Study||44
117|NCT03125031|294|P1|COMPLETED|Overall Study||44
118|NCT03125031|293|P2|STARTED|Overall Study||44
119|NCT03125031|294|P1|STARTED|Overall Study||44
120|NCT03125018|299|P1|NOT COMPLETED|Overall Study||0
121|NCT03125018|299|P1|COMPLETED|Overall Study||13
122|NCT03125018|299|P1|STARTED|Overall Study||13
123|NCT03125005|303|P1|NOT COMPLETED|Overall Study||0
124|NCT03125005|303|P1|COMPLETED|Overall Study||51
125|NCT03125005|303|P1|STARTED|Overall Study||51
126|NCT03124979|307|P1|NOT COMPLETED|Overall Study||0
127|NCT03124979|307|P1|COMPLETED|Overall Study||13
128|NCT03124979|307|P1|STARTED|Overall Study||13
129|NCT03124966|311|P1|NOT COMPLETED|Overall Study||0
130|NCT03124966|311|P1|COMPLETED|Overall Study||118
131|NCT03124966|311|P1|STARTED|Overall Study||118
132|NCT03124927|315|P1|NOT COMPLETED|Overall Study||0
133|NCT03124927|315|P1|COMPLETED|Overall Study||25
134|NCT03124927|315|P1|STARTED|Overall Study||25
135|NCT03124901|319|P1|NOT COMPLETED|Overall Study||0
136|NCT03124901|319|P1|COMPLETED|Overall Study||147
137|NCT03124901|319|P1|STARTED|Overall Study||147
138|NCT03124836|323|P1|NOT COMPLETED|Overall Study||0
139|NCT03124836|323|P1|COMPLETED|Overall Study||28
140|NCT03124836|323|P1|STARTED|Overall Study||28
141|NCT03124823|327|P1|NOT COMPLETED|Overall Study||0
142|NCT03124823|327|P1|COMPLETED|Overall Study||11
143|NCT03124823|327|P1|STARTED|Overall Study||11
144|NCT03124797|331|P1|NOT COMPLETED|Overall Study||0
145|NCT03124797|331|P1|COMPLETED|Overall Study||18
146|NCT03124797|331|P1|STARTED|Overall Study||18
147|NCT03124771|335|P1|NOT COMPLETED|Overall Study||0
148|NCT03124771|335|P1|COMPLETED|Overall Study||132
149|NCT03124771|335|P1|STARTED|Overall Study||132
150|NCT03124758|339|P1|NOT COMPLETED|Overall Study||0
151|NCT03124758|339|P1|COMPLETED|Overall Study||354
152|NCT03124758|339|P1|STARTED|Overall Study||354
153|NCT03124693|343|P1|NOT COMPLETED|Overall Study||0
154|NCT03124693|343|P1|COMPLETED|Overall Study||90
155|NCT03124693|343|P1|STARTED|Overall Study||90
156|NCT03119831|350|P3|NOT COMPLETED|Overall Study||0
157|NCT03119831|351|P2|NOT COMPLETED|Overall Study||0
158|NCT03119831|352|P1|NOT COMPLETED|Overall Study||0
159|NCT03119831|350|P3|COMPLETED|Overall Study||14
160|NCT03119831|351|P2|COMPLETED|Overall Study||14
161|NCT03119831|352|P1|COMPLETED|Overall Study||14
162|NCT03119831|350|P3|STARTED|Overall Study||14
163|NCT03119831|351|P2|STARTED|Overall Study||14
164|NCT03119831|352|P1|STARTED|Overall Study||14
165|NCT03115853|369|P1|NOT COMPLETED|Overall Study||0
166|NCT03115853|369|P1|COMPLETED|Overall Study||31
167|NCT03115853|369|P1|STARTED|Overall Study||31
168|NCT03106870|389|P2|NOT COMPLETED|Overall Study||0
169|NCT03106870|390|P1|NOT COMPLETED|Overall Study||0
170|NCT03106870|389|P2|COMPLETED|Overall Study||31
171|NCT03106870|390|P1|COMPLETED|Overall Study||31
172|NCT03106870|389|P2|STARTED|Overall Study||31
173|NCT03106870|390|P1|STARTED|Overall Study||31
174|NCT03106337|400|P1|NOT COMPLETED|Overall Study||0
175|NCT03106337|400|P1|COMPLETED|Overall Study||35
176|NCT03106337|400|P1|STARTED|Overall Study||35
177|NCT03091751|405|P1|NOT COMPLETED|Overall Study||0
178|NCT03091751|405|P1|COMPLETED|Overall Study||22
179|NCT03091751|405|P1|STARTED|Overall Study||22
180|NCT03073798|413|P1|NOT COMPLETED|Overall Study||2
181|NCT03073798|413|P1|COMPLETED|Overall Study||10
182|NCT03073798|413|P1|STARTED|Overall Study||12
183|NCT03072719|426|P2|NOT COMPLETED|Overall Study||1
184|NCT03072719|427|P1|NOT COMPLETED|Overall Study||1
185|NCT03072719|426|P2|COMPLETED|Overall Study||59
186|NCT03072719|427|P1|COMPLETED|Overall Study||59
187|NCT03072719|426|P2|STARTED|Overall Study||60
188|NCT03072719|427|P1|STARTED|Overall Study||60
189|NCT03070730|440|P3|NOT COMPLETED|Overall Study||0
190|NCT03070730|441|P2|NOT COMPLETED|Overall Study||0
191|NCT03070730|442|P1|NOT COMPLETED|Overall Study||0
192|NCT03070730|440|P3|COMPLETED|Overall Study||0
193|NCT03070730|441|P2|COMPLETED|Overall Study||0
194|NCT03070730|442|P1|COMPLETED|Overall Study||0
195|NCT03070730|440|P3|STARTED|Overall Study||0
196|NCT03070730|441|P2|STARTED|Overall Study||0
197|NCT03070730|442|P1|STARTED|Overall Study||0
198|NCT03065933|573|P1|NOT COMPLETED|Overall Study||5
199|NCT03065933|573|P1|COMPLETED|Overall Study||0
200|NCT03065933|573|P1|STARTED|Overall Study||5
201|NCT03061513|579|P2|NOT COMPLETED|Overall Study||1
202|NCT03061513|580|P1|NOT COMPLETED|Overall Study||0
203|NCT03061513|579|P2|COMPLETED|Overall Study||4
204|NCT03061513|580|P1|COMPLETED|Overall Study||6
205|NCT03061513|579|P2|STARTED|Overall Study||5
206|NCT03061513|580|P1|STARTED|Overall Study||6
207|NCT03055221|588|P1|NOT COMPLETED|Overall Study||16
208|NCT03055221|588|P1|COMPLETED|Overall Study||0
209|NCT03055221|588|P1|STARTED|Overall Study||16
210|NCT03048383|596|P3|NOT COMPLETED|Overall Study||12
211|NCT03048383|597|P2|NOT COMPLETED|Overall Study||8
212|NCT03048383|598|P1|NOT COMPLETED|Overall Study||13
213|NCT03048383|596|P3|COMPLETED|Overall Study||10
214|NCT03048383|597|P2|COMPLETED|Overall Study||13
215|NCT03048383|598|P1|COMPLETED|Overall Study||15
216|NCT03048383|596|P3|STARTED|Overall Study||22
217|NCT03048383|597|P2|STARTED|Overall Study||21
218|NCT03048383|598|P1|STARTED|Overall Study||28
219|NCT03048006|609|P1|NOT COMPLETED|Overall Study||0
220|NCT03048006|609|P1|COMPLETED|Overall Study||44456
221|NCT03048006|609|P1|STARTED|Overall Study||44456
222|NCT03047447|618|P3|NOT COMPLETED|Overall Study||0
223|NCT03047447|619|P2|NOT COMPLETED|Overall Study||0
224|NCT03047447|620|P1|NOT COMPLETED|Overall Study||0
225|NCT03047447|618|P3|COMPLETED|Overall Study||10
226|NCT03047447|619|P2|COMPLETED|Overall Study||10
227|NCT03047447|620|P1|COMPLETED|Overall Study||10
228|NCT03047447|618|P3|STARTED|Overall Study||10
229|NCT03047447|619|P2|STARTED|Overall Study||10
230|NCT03047447|620|P1|STARTED|Overall Study||10
231|NCT03043534|642|P2|NOT COMPLETED|Overall Study||0
232|NCT03043534|643|P1|NOT COMPLETED|Overall Study||0
233|NCT03043534|642|P2|COMPLETED|Overall Study||14
234|NCT03043534|643|P1|COMPLETED|Overall Study||15
235|NCT03043534|642|P2|STARTED|Overall Study||14
236|NCT03043534|643|P1|STARTED|Overall Study||15
237|NCT03041298|651|P1|NOT COMPLETED|Overall Study||0
238|NCT03041298|651|P1|COMPLETED|Overall Study||1537
239|NCT03041298|651|P1|STARTED|Overall Study||1537
240|NCT03039179|661|P2|NOT COMPLETED|Overall Study||0
241|NCT03039179|662|P1|NOT COMPLETED|Overall Study||0
242|NCT03039179|661|P2|COMPLETED|Overall Study||42
243|NCT03039179|662|P1|COMPLETED|Overall Study||38
244|NCT03039179|661|P2|STARTED|Overall Study||42
245|NCT03039179|662|P1|STARTED|Overall Study||38
246|NCT03037541|672|P2|NOT COMPLETED|Overall Study||0
247|NCT03037541|673|P1|NOT COMPLETED|Overall Study||0
248|NCT03037541|672|P2|COMPLETED|Overall Study||30
249|NCT03037541|673|P1|COMPLETED|Overall Study||30
250|NCT03037541|672|P2|STARTED|Overall Study||30
251|NCT03037541|673|P1|STARTED|Overall Study||30
252|NCT03035955|683|P2|NOT COMPLETED|Overall Study||1
253|NCT03035955|684|P1|NOT COMPLETED|Overall Study||1
254|NCT03035955|683|P2|COMPLETED|Overall Study||9
255|NCT03035955|684|P1|COMPLETED|Overall Study||9
256|NCT03035955|683|P2|STARTED|Overall Study||10
257|NCT03035955|684|P1|STARTED|Overall Study||10
258|NCT03026803|690|P1|NOT COMPLETED|Overall Study||0
259|NCT03026803|690|P1|COMPLETED|Overall Study||4
260|NCT03026803|690|P1|STARTED|Overall Study||4
261|NCT03023709|696|P2|NOT COMPLETED|Overall Study||0
262|NCT03023709|697|P1|NOT COMPLETED|Overall Study||0
263|NCT03023709|696|P2|COMPLETED|Overall Study||0
264|NCT03023709|697|P1|COMPLETED|Overall Study||3
265|NCT03023709|696|P2|STARTED|Overall Study||0
266|NCT03023709|697|P1|STARTED|Overall Study||3
267|NCT03023683|707|P2|NOT COMPLETED|Overall Study||1
268|NCT03023683|708|P1|NOT COMPLETED|Overall Study||0
269|NCT03023683|707|P2|COMPLETED|Overall Study||17
270|NCT03023683|708|P1|COMPLETED|Overall Study||0
271|NCT03023683|707|P2|STARTED|Overall Study||18
272|NCT03023683|708|P1|STARTED|Overall Study||0
273|NCT03023553|718|P2|NOT COMPLETED|Overall Study||1
274|NCT03023553|719|P1|NOT COMPLETED|Overall Study||0
275|NCT03023553|718|P2|COMPLETED|Overall Study||8
276|NCT03023553|719|P1|COMPLETED|Overall Study||4
277|NCT03023553|718|P2|STARTED|Overall Study||9
278|NCT03023553|719|P1|STARTED|Overall Study||4
279|NCT03023488|727|P1|NOT COMPLETED|Overall Study||0
280|NCT03023488|727|P1|COMPLETED|Overall Study||46
281|NCT03023488|727|P1|STARTED|Overall Study||46
282|NCT03023176|740|P1|NOT COMPLETED|Overall Study||0
283|NCT03023176|740|P1|COMPLETED|Overall Study||20
284|NCT03023176|740|P1|STARTED|Overall Study||20
285|NCT03023137|747|P2|NOT COMPLETED|Overall Study||9
286|NCT03023137|748|P1|NOT COMPLETED|Overall Study||4
287|NCT03023137|747|P2|COMPLETED|Overall Study||162
288|NCT03023137|748|P1|COMPLETED|Overall Study||174
289|NCT03023137|747|P2|STARTED|Overall Study||171
290|NCT03023137|748|P1|STARTED|Overall Study||178
291|NCT03022435|779|P5|NOT COMPLETED|Overall Study||0
292|NCT03022435|780|P4|NOT COMPLETED|Overall Study||0
293|NCT03022435|781|P3|NOT COMPLETED|Overall Study||0
294|NCT03022435|782|P2|NOT COMPLETED|Overall Study||0
295|NCT03022435|783|P1|NOT COMPLETED|Overall Study||0
296|NCT03022435|779|P5|COMPLETED|Overall Study||3
297|NCT03022435|780|P4|COMPLETED|Overall Study||3
298|NCT03022435|781|P3|COMPLETED|Overall Study||6
299|NCT03022435|782|P2|COMPLETED|Overall Study||5
300|NCT03022435|783|P1|COMPLETED|Overall Study||5
301|NCT03022435|779|P5|STARTED|Overall Study||3
302|NCT03022435|780|P4|STARTED|Overall Study||3
303|NCT03022435|781|P3|STARTED|Overall Study||6
304|NCT03022435|782|P2|STARTED|Overall Study||5
305|NCT03022435|783|P1|STARTED|Overall Study||5
306|NCT03022422|806|P6|NOT COMPLETED|Overall Study||0
307|NCT03022422|807|P5|NOT COMPLETED|Overall Study||0
308|NCT03022422|808|P4|NOT COMPLETED|Overall Study||0
309|NCT03022422|809|P3|NOT COMPLETED|Overall Study||3
310|NCT03022422|810|P2|NOT COMPLETED|Overall Study||0
311|NCT03022422|811|P1|NOT COMPLETED|Overall Study||0
312|NCT03022422|806|P6|COMPLETED|Overall Study||5
313|NCT03022422|807|P5|COMPLETED|Overall Study||5
314|NCT03022422|808|P4|COMPLETED|Overall Study||12
315|NCT03022422|809|P3|COMPLETED|Overall Study||20
316|NCT03022422|810|P2|COMPLETED|Overall Study||10
317|NCT03022422|811|P1|COMPLETED|Overall Study||8
318|NCT03022422|806|P6|STARTED|Overall Study||5
319|NCT03022422|807|P5|STARTED|Overall Study||5
320|NCT03022422|808|P4|STARTED|Overall Study||12
321|NCT03022422|809|P3|STARTED|Overall Study||23
322|NCT03022422|810|P2|STARTED|Overall Study||10
323|NCT03022422|811|P1|STARTED|Overall Study||8
324|NCT03022396|837|P6|NOT COMPLETED|Overall Study||0
325|NCT03022396|838|P5|NOT COMPLETED|Overall Study||0
326|NCT03022396|839|P4|NOT COMPLETED|Overall Study||0
327|NCT03022396|840|P3|NOT COMPLETED|Overall Study||0
328|NCT03022396|841|P2|NOT COMPLETED|Overall Study||0
329|NCT03022396|842|P1|NOT COMPLETED|Overall Study||0
330|NCT03022396|837|P6|COMPLETED|Overall Study||8
331|NCT03022396|838|P5|COMPLETED|Overall Study||14
332|NCT03022396|839|P4|COMPLETED|Overall Study||20
333|NCT03022396|840|P3|COMPLETED|Overall Study||10
334|NCT03022396|841|P2|COMPLETED|Overall Study||14
335|NCT03022396|842|P1|COMPLETED|Overall Study||16
336|NCT03022396|837|P6|STARTED|Overall Study||8
337|NCT03022396|838|P5|STARTED|Overall Study||14
338|NCT03022396|839|P4|STARTED|Overall Study||20
339|NCT03022396|840|P3|STARTED|Overall Study||10
340|NCT03022396|841|P2|STARTED|Overall Study||14
341|NCT03022396|842|P1|STARTED|Overall Study||16
342|NCT03020537|864|P2|NOT COMPLETED|Overall Study||0
343|NCT03020537|865|P1|NOT COMPLETED|Overall Study||0
344|NCT03020537|864|P2|COMPLETED|Overall Study||7
345|NCT03020537|865|P1|COMPLETED|Overall Study||1
346|NCT03020537|864|P2|STARTED|Overall Study||7
347|NCT03020537|865|P1|STARTED|Overall Study||1
348|NCT03020498|876|P3|NOT COMPLETED|Overall Study||0
349|NCT03020498|877|P2|NOT COMPLETED|Overall Study||3
350|NCT03020498|878|P1|NOT COMPLETED|Overall Study||0
351|NCT03020498|876|P3|COMPLETED|Overall Study||36
352|NCT03020498|877|P2|COMPLETED|Overall Study||38
353|NCT03020498|878|P1|COMPLETED|Overall Study||14
354|NCT03020498|876|P3|STARTED|Overall Study||36
355|NCT03020498|877|P2|STARTED|Overall Study||41
356|NCT03020498|878|P1|STARTED|Overall Study||14
357|NCT03020472|889|P1|NOT COMPLETED|Overall Study||0
358|NCT03020472|889|P1|COMPLETED|Overall Study||6
359|NCT03020472|889|P1|STARTED|Overall Study||6
360|NCT03019783|897|P2|NOT COMPLETED|Overall Study||0
361|NCT03019783|898|P1|NOT COMPLETED|Overall Study||0
362|NCT03019783|897|P2|COMPLETED|Overall Study||31
363|NCT03019783|898|P1|COMPLETED|Overall Study||29
364|NCT03019783|897|P2|STARTED|Overall Study||31
365|NCT03019783|898|P1|STARTED|Overall Study||29
366|NCT03001674|908|P2|NOT COMPLETED|Overall Study||0
367|NCT03001674|909|P1|NOT COMPLETED|Overall Study||0
368|NCT03001674|908|P2|COMPLETED|Overall Study||5
369|NCT03001674|909|P1|COMPLETED|Overall Study||10
370|NCT03001674|908|P2|STARTED|Overall Study||5
371|NCT03001674|909|P1|STARTED|Overall Study||10
372|NCT03001258|918|P3|NOT COMPLETED|Overall Study||0
373|NCT03001258|919|P2|NOT COMPLETED|Overall Study||0
374|NCT03001258|920|P1|NOT COMPLETED|Overall Study||0
375|NCT03001258|918|P3|COMPLETED|Overall Study||485
376|NCT03001258|919|P2|COMPLETED|Overall Study||751
377|NCT03001258|920|P1|COMPLETED|Overall Study||765
378|NCT03001258|918|P3|STARTED|Overall Study||485
379|NCT03001258|919|P2|STARTED|Overall Study||751
380|NCT03001258|920|P1|STARTED|Overall Study||765
381|NCT03000088|930|P2|NOT COMPLETED|Overall Study||0
382|NCT03000088|931|P1|NOT COMPLETED|Overall Study||0
383|NCT03000088|930|P2|COMPLETED|Overall Study||70
384|NCT03000088|931|P1|COMPLETED|Overall Study||70
385|NCT03000088|930|P2|STARTED|Overall Study||70
386|NCT03000088|931|P1|STARTED|Overall Study||70
387|NCT02997904|939|P2|NOT COMPLETED|Overall Study||0
388|NCT02997904|940|P1|NOT COMPLETED|Overall Study||0
389|NCT02997904|939|P2|COMPLETED|Overall Study||49
390|NCT02997904|940|P1|COMPLETED|Overall Study||51
391|NCT02997904|939|P2|STARTED|Overall Study||49
392|NCT02997904|940|P1|STARTED|Overall Study||51
393|NCT02990910|952|P2|NOT COMPLETED|Overall Study||10
394|NCT02990910|953|P1|NOT COMPLETED|Overall Study||6
395|NCT02990910|952|P2|COMPLETED|Overall Study||130
396|NCT02990910|953|P1|COMPLETED|Overall Study||134
397|NCT02990910|952|P2|STARTED|Overall Study||140
398|NCT02990910|953|P1|STARTED|Overall Study||140
399|NCT02988219|963|P2|NOT COMPLETED|Overall Study||3
400|NCT02988219|964|P1|NOT COMPLETED|Overall Study||1
401|NCT02988219|963|P2|COMPLETED|Overall Study||22
402|NCT02988219|964|P1|COMPLETED|Overall Study||24
403|NCT02988219|963|P2|STARTED|Overall Study||25
404|NCT02988219|964|P1|STARTED|Overall Study||25
405|NCT02987374|972|P1|NOT COMPLETED|Overall Study||0
406|NCT02987374|972|P1|COMPLETED|Overall Study||10
407|NCT02987374|972|P1|STARTED|Overall Study||10
408|NCT02986282|977|P1|NOT COMPLETED|Overall Study||16
409|NCT02986282|977|P1|COMPLETED|Overall Study||99
410|NCT02986282|977|P1|STARTED|Overall Study||115
411|NCT02977572|984|P2|NOT COMPLETED|Overall Study||2
412|NCT02977572|985|P1|NOT COMPLETED|Overall Study||2
413|NCT02977572|984|P2|COMPLETED|Overall Study||54
414|NCT02977572|985|P1|COMPLETED|Overall Study||56
415|NCT02977572|984|P2|STARTED|Overall Study||56
416|NCT02977572|985|P1|STARTED|Overall Study||58
417|NCT02974543|1009|P2|NOT COMPLETED|Overall Study||0
418|NCT02974543|1010|P1|NOT COMPLETED|Overall Study||1
419|NCT02974543|1009|P2|COMPLETED|Overall Study||10
420|NCT02974543|1010|P1|COMPLETED|Overall Study||10
421|NCT02974543|1009|P2|Began Crossover Assignment|Overall Study||10
422|NCT02974543|1010|P1|Began Crossover Assignment|Overall Study||10
423|NCT02974543|1009|P2|Began Washout Period|Overall Study||10
424|NCT02974543|1010|P1|Began Washout Period|Overall Study||10
425|NCT02974543|1009|P2|STARTED|Overall Study||10
426|NCT02974543|1010|P1|STARTED|Overall Study||11
427|NCT02971670|1034|P4|NOT COMPLETED|Overall Study||2
428|NCT02971670|1035|P3|NOT COMPLETED|Overall Study||1
429|NCT02971670|1036|P2|NOT COMPLETED|Overall Study||1
430|NCT02971670|1037|P1|NOT COMPLETED|Overall Study||4
431|NCT02971670|1034|P4|COMPLETED|Overall Study||1
432|NCT02971670|1035|P3|COMPLETED|Overall Study||4
433|NCT02971670|1036|P2|COMPLETED|Overall Study||1
434|NCT02971670|1037|P1|COMPLETED|Overall Study||9
435|NCT02971670|1034|P4|STARTED|Overall Study||3
436|NCT02971670|1035|P3|STARTED|Overall Study||5
437|NCT02971670|1036|P2|STARTED|Overall Study||2
438|NCT02971670|1037|P1|STARTED|Overall Study||13
439|NCT02964767|1057|P2|NOT COMPLETED|Overall Study||0
440|NCT02964767|1058|P1|NOT COMPLETED|Overall Study||0
441|NCT02964767|1057|P2|COMPLETED|Overall Study||48
442|NCT02964767|1058|P1|COMPLETED|Overall Study||171
443|NCT02964767|1057|P2|STARTED|Overall Study||48
444|NCT02964767|1058|P1|STARTED|Overall Study||171
445|NCT02961244|1067|P2|NOT COMPLETED|Overall Study||9
446|NCT02961244|1068|P1|NOT COMPLETED|Overall Study||1
447|NCT02961244|1067|P2|COMPLETED|Overall Study||55
448|NCT02961244|1068|P1|COMPLETED|Overall Study||63
449|NCT02961244|1067|P2|Patients Excluded During Randomization|Overall Study||1
450|NCT02961244|1068|P1|Patients Excluded During Randomization|Overall Study||0
451|NCT02961244|1067|P2|STARTED|Overall Study||64
452|NCT02961244|1068|P1|STARTED|Overall Study||64
453|NCT02959840|1079|P3|NOT COMPLETED|Overall Study||0
454|NCT02959840|1080|P2|NOT COMPLETED|Overall Study||0
455|NCT02959840|1081|P1|NOT COMPLETED|Overall Study||0
456|NCT02959840|1079|P3|COMPLETED|Overall Study||60
457|NCT02959840|1080|P2|COMPLETED|Overall Study||60
458|NCT02959840|1081|P1|COMPLETED|Overall Study||60
459|NCT02959840|1079|P3|STARTED|Overall Study||60
460|NCT02959840|1080|P2|STARTED|Overall Study||60
461|NCT02959840|1081|P1|STARTED|Overall Study||60
462|NCT02958995|1124|P2|NOT COMPLETED|Overall Study||0
463|NCT02958995|1125|P1|NOT COMPLETED|Overall Study||0
464|NCT02958995|1124|P2|COMPLETED|Overall Study||107495
465|NCT02958995|1125|P1|COMPLETED|Overall Study||2630666
466|NCT02958995|1124|P2|STARTED|Overall Study||107495
467|NCT02958995|1125|P1|STARTED|Overall Study||2630666
468|NCT02958956|1135|P2|NOT COMPLETED|Overall Study||0
469|NCT02958956|1136|P1|NOT COMPLETED|Overall Study||0
470|NCT02958956|1135|P2|COMPLETED|Overall Study||198317
471|NCT02958956|1136|P1|COMPLETED|Overall Study||38190
472|NCT02958956|1135|P2|STARTED|Overall Study||198317
473|NCT02958956|1136|P1|STARTED|Overall Study||38190
474|NCT02958345|1151|P2|NOT COMPLETED|Overall Study||1
475|NCT02958345|1152|P1|NOT COMPLETED|Overall Study||1
476|NCT02958345|1151|P2|COMPLETED|Overall Study||13
477|NCT02958345|1152|P1|COMPLETED|Overall Study||13
478|NCT02958345|1151|P2|STARTED|Overall Study||14
479|NCT02958345|1152|P1|STARTED|Overall Study||14
480|NCT02951767|1160|P1|NOT COMPLETED|Overall Study||119
481|NCT02951767|1160|P1|COMPLETED|Overall Study||0
482|NCT02951767|1160|P1|STARTED|Overall Study||119
483|NCT02949141|1177|P1|NOT COMPLETED|Overall Study||0
484|NCT02949141|1177|P1|COMPLETED|Overall Study||62
485|NCT02949141|1177|P1|STARTED|Overall Study||62
486|NCT02947984|1186|P2|NOT COMPLETED|Overall Study||0
487|NCT02947984|1187|P1|NOT COMPLETED|Overall Study||0
488|NCT02947984|1186|P2|COMPLETED|Overall Study||22
489|NCT02947984|1187|P1|COMPLETED|Overall Study||22
490|NCT02947984|1186|P2|STARTED|Overall Study||22
491|NCT02947984|1187|P1|STARTED|Overall Study||22
492|NCT02941640|1203|P4|NOT COMPLETED|Overall Study||0
493|NCT02941640|1204|P3|NOT COMPLETED|Overall Study||0
494|NCT02941640|1205|P2|NOT COMPLETED|Overall Study||0
495|NCT02941640|1206|P1|NOT COMPLETED|Overall Study||0
496|NCT02941640|1203|P4|COMPLETED|Overall Study||30
497|NCT02941640|1204|P3|COMPLETED|Overall Study||30
498|NCT02941640|1205|P2|COMPLETED|Overall Study||30
499|NCT02941640|1206|P1|COMPLETED|Overall Study||30
500|NCT02941640|1203|P4|STARTED|Overall Study||30
501|NCT02941640|1204|P3|STARTED|Overall Study||30
502|NCT02941640|1205|P2|STARTED|Overall Study||30
503|NCT02941640|1206|P1|STARTED|Overall Study||30
504|NCT02934347|1238|P2|NOT COMPLETED|Overall Study||0
505|NCT02934347|1239|P1|NOT COMPLETED|Overall Study||0
506|NCT02934347|1238|P2|COMPLETED|Overall Study||407
507|NCT02934347|1239|P1|COMPLETED|Overall Study||374
508|NCT02934347|1238|P2|STARTED|Overall Study||407
509|NCT02934347|1239|P1|STARTED|Overall Study||374
510|NCT02920749|1255|P4|NOT COMPLETED|Overall Study||0
511|NCT02920749|1256|P3|NOT COMPLETED|Overall Study||0
512|NCT02920749|1257|P2|NOT COMPLETED|Overall Study||0
513|NCT02920749|1258|P1|NOT COMPLETED|Overall Study||0
514|NCT02920749|1255|P4|COMPLETED|Overall Study||30
515|NCT02920749|1256|P3|COMPLETED|Overall Study||30
516|NCT02920749|1257|P2|COMPLETED|Overall Study||30
517|NCT02920749|1258|P1|COMPLETED|Overall Study||30
518|NCT02920749|1255|P4|STARTED|Overall Study||30
519|NCT02920749|1256|P3|STARTED|Overall Study||30
520|NCT02920749|1257|P2|STARTED|Overall Study||30
521|NCT02920749|1258|P1|STARTED|Overall Study||30
522|NCT02919657|1272|P2|NOT COMPLETED|Overall Study||0
523|NCT02919657|1273|P1|NOT COMPLETED|Overall Study||0
524|NCT02919657|1272|P2|COMPLETED|Overall Study|completed with the same initial 10 participants|10
525|NCT02919657|1273|P1|COMPLETED|Overall Study|completed with the same initial 10 participants|10
526|NCT02919657|1272|P2|STARTED|Overall Study|10 Participants|10
527|NCT02919657|1273|P1|STARTED|Overall Study|10 Participants|10
528|NCT02912650|1283|P4|NOT COMPLETED|Overall Study||5
529|NCT02912650|1284|P3|NOT COMPLETED|Overall Study||2
530|NCT02912650|1285|P2|NOT COMPLETED|Overall Study||0
531|NCT02912650|1286|P1|NOT COMPLETED|Overall Study||1
532|NCT02912650|1283|P4|COMPLETED|Overall Study||160
533|NCT02912650|1284|P3|COMPLETED|Overall Study||173
534|NCT02912650|1285|P2|COMPLETED|Overall Study||172
535|NCT02912650|1286|P1|COMPLETED|Overall Study||55
536|NCT02912650|1283|P4|STARTED|Overall Study||165
537|NCT02912650|1284|P3|STARTED|Overall Study||175
538|NCT02912650|1285|P2|STARTED|Overall Study||172
539|NCT02912650|1286|P1|STARTED|Overall Study||56
540|NCT02910362|1370|P2|NOT COMPLETED|Overall Study||0
541|NCT02910362|1371|P1|NOT COMPLETED|Overall Study||0
542|NCT02910362|1370|P2|COMPLETED|Overall Study||7
543|NCT02910362|1371|P1|COMPLETED|Overall Study||8
544|NCT02910362|1370|P2|STARTED|Overall Study||7
545|NCT02910362|1371|P1|STARTED|Overall Study||8
546|NCT02903238|1377|P1|NOT COMPLETED|Overall Study||4
547|NCT02903238|1377|P1|COMPLETED|Overall Study||17
548|NCT02903238|1377|P1|STARTED|Overall Study||21
549|NCT02895347|1388|P2|NOT COMPLETED|Overall Study||1
550|NCT02895347|1389|P1|NOT COMPLETED|Overall Study||3
551|NCT02895347|1388|P2|COMPLETED|Overall Study||19
552|NCT02895347|1389|P1|COMPLETED|Overall Study||17
553|NCT02895347|1388|P2|STARTED|Overall Study||20
554|NCT02895347|1389|P1|STARTED|Overall Study||20
555|NCT02891863|1398|P1|NOT COMPLETED|Overall Study||0
556|NCT02891863|1398|P1|COMPLETED|Overall Study||9
557|NCT02891863|1398|P1|STARTED|Overall Study||9
558|NCT02889289|1403|P1|NOT COMPLETED|Overall Study||0
559|NCT02889289|1403|P1|COMPLETED|Overall Study||1
560|NCT02889289|1403|P1|STARTED|Overall Study||1
561|NCT02886338|1412|P1|NOT COMPLETED|Overall Study||1
562|NCT02886338|1412|P1|COMPLETED|Overall Study||9
563|NCT02886338|1412|P1|STARTED|Overall Study||10
564|NCT02884427|1419|P3|NOT COMPLETED|Overall Study||0
565|NCT02884427|1420|P2|NOT COMPLETED|Overall Study||0
566|NCT02884427|1421|P1|NOT COMPLETED|Overall Study||0
567|NCT02884427|1419|P3|COMPLETED|Overall Study||50
568|NCT02884427|1420|P2|COMPLETED|Overall Study||52
569|NCT02884427|1421|P1|COMPLETED|Overall Study||48
570|NCT02884427|1419|P3|STARTED|Overall Study||50
571|NCT02884427|1420|P2|STARTED|Overall Study||52
572|NCT02884427|1421|P1|STARTED|Overall Study||48
573|NCT02882152|1437|P2|NOT COMPLETED|Overall Study||0
574|NCT02882152|1438|P1|NOT COMPLETED|Overall Study||1
575|NCT02882152|1437|P2|COMPLETED|Overall Study||20
576|NCT02882152|1438|P1|COMPLETED|Overall Study||19
577|NCT02882152|1437|P2|STARTED|Overall Study||20
578|NCT02882152|1438|P1|STARTED|Overall Study||20
579|NCT02873429|1448|P2|NOT COMPLETED|16 Weeks||2
580|NCT02873429|1449|P1|NOT COMPLETED|16 Weeks||5
581|NCT02873429|1448|P2|COMPLETED|16 Weeks||96
582|NCT02873429|1449|P1|COMPLETED|16 Weeks||100
583|NCT02873429|1448|P2|STARTED|16 Weeks|1 Conv. participant Missed 6-8 week but was eligible for 16 week|98
584|NCT02873429|1449|P1|STARTED|16 Weeks|10 CAM participants Missed 6-8 week but are eligible for 16 week|105
585|NCT02873429|1448|P2|NOT COMPLETED|6-8 Weeks||1
586|NCT02873429|1449|P1|NOT COMPLETED|6-8 Weeks||10
587|NCT02873429|1448|P2|COMPLETED|6-8 Weeks||97
588|NCT02873429|1449|P1|COMPLETED|6-8 Weeks||95
589|NCT02873429|1448|P2|STARTED|6-8 Weeks|2 Con. participants not eligible to complete follow ups because they did not continue treatment.|98
590|NCT02873429|1449|P1|STARTED|6-8 Weeks|4 CAM participants not eligible to complete follow ups because they did not continue treatment.|105
591|NCT02873429|1448|P2|NOT COMPLETED|Baseline||0
592|NCT02873429|1449|P1|NOT COMPLETED|Baseline||0
593|NCT02873429|1448|P2|COMPLETED|Baseline||100
594|NCT02873429|1449|P1|COMPLETED|Baseline||109
595|NCT02873429|1448|P2|STARTED|Baseline||100
596|NCT02873429|1449|P1|STARTED|Baseline||109
597|NCT02867150|1459|P1|NOT COMPLETED|Overall Study||0
598|NCT02867150|1459|P1|COMPLETED|Overall Study||58
599|NCT02867150|1459|P1|STARTED|Overall Study||58
600|NCT02863198|1465|P2|NOT COMPLETED|Overall Study||0
601|NCT02863198|1466|P1|NOT COMPLETED|Overall Study||0
602|NCT02863198|1465|P2|COMPLETED|Overall Study||60
603|NCT02863198|1466|P1|COMPLETED|Overall Study||60
604|NCT02863198|1465|P2|STARTED|Overall Study||60
605|NCT02863198|1466|P1|STARTED|Overall Study||60
606|NCT02862600|1482|P1|NOT COMPLETED|Period 2--Perhexiline-high Target Range||7
607|NCT02862600|1482|P1|COMPLETED|Period 2--Perhexiline-high Target Range|Study terminated on April 26, 2017 due to lack of efficacy in first 15 subjects completing Period 2.|15
608|NCT02862600|1482|P1|STARTED|Period 2--Perhexiline-high Target Range|First subject completed Period 1 and moved into Period 2 perhexiline dosing on October 17, 2016|22
609|NCT02862600|1482|P1|NOT COMPLETED|Period 1--Perhexiline-low Target Range||13
610|NCT02862600|1482|P1|COMPLETED|Period 1--Perhexiline-low Target Range|Study terminated on April 26, 2017 due to lack of efficacy.|22
611|NCT02862600|1482|P1|STARTED|Period 1--Perhexiline-low Target Range|First subject underwent baseline functional assessment and perhexiline dosing on August 22, 2016|35
612|NCT02862106|1495|P2|NOT COMPLETED|Overall Study||6
613|NCT02862106|1496|P1|NOT COMPLETED|Overall Study||38
614|NCT02862106|1495|P2|COMPLETED|Overall Study||20
615|NCT02862106|1496|P1|COMPLETED|Overall Study||145
616|NCT02862106|1495|P2|STARTED|Overall Study||26
617|NCT02862106|1496|P1|STARTED|Overall Study||183
618|NCT02856880|1554|P1|NOT COMPLETED|Overall Study||1
619|NCT02856880|1554|P1|COMPLETED|Overall Study||44
620|NCT02856880|1554|P1|Received SLS Negative Control|Overall Study||44
621|NCT02856880|1554|P1|Received Non-SLS Negative Control|Overall Study||44
622|NCT02856880|1554|P1|Received Positive Control|Overall Study||45
623|NCT02856880|1554|P1|Received Test Zinc Non-IPMP|Overall Study||44
624|NCT02856880|1554|P1|Received Test Zinc-IPMP|Overall Study||44
625|NCT02856880|1554|P1|STARTED|Overall Study||45
626|NCT02850159|1580|P2|NOT COMPLETED|Overall Study||0
627|NCT02850159|1581|P1|NOT COMPLETED|Overall Study||0
628|NCT02850159|1580|P2|COMPLETED|Overall Study||16
629|NCT02850159|1581|P1|COMPLETED|Overall Study||16
630|NCT02850159|1580|P2|STARTED|Overall Study||16
631|NCT02850159|1581|P1|STARTED|Overall Study||16
632|NCT02849678|1589|P2|NOT COMPLETED|Overall Study||6
633|NCT02849678|1590|P1|NOT COMPLETED|Overall Study||6
634|NCT02849678|1589|P2|COMPLETED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|18
635|NCT02849678|1590|P1|COMPLETED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|17
636|NCT02849678|1589|P2|STARTED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|24
637|NCT02849678|1590|P1|STARTED|Overall Study|Informed consent was obtained from 68 patients. Only 47 of these patients were randomized.|23
638|NCT02847169|1596|P2|NOT COMPLETED|Second Intervention (1 Week)||0
639|NCT02847169|1597|P1|NOT COMPLETED|Second Intervention (1 Week)||0
640|NCT02847169|1596|P2|COMPLETED|Second Intervention (1 Week)||15
641|NCT02847169|1597|P1|COMPLETED|Second Intervention (1 Week)||15
642|NCT02847169|1596|P2|STARTED|Second Intervention (1 Week)||15
643|NCT02847169|1597|P1|STARTED|Second Intervention (1 Week)||15
644|NCT02847169|1596|P2|NOT COMPLETED|First Intervention (1 Week)||0
645|NCT02847169|1597|P1|NOT COMPLETED|First Intervention (1 Week)||0
646|NCT02847169|1596|P2|COMPLETED|First Intervention (1 Week)||15
647|NCT02847169|1597|P1|COMPLETED|First Intervention (1 Week)||15
648|NCT02847169|1596|P2|STARTED|First Intervention (1 Week)||15
649|NCT02847169|1597|P1|STARTED|First Intervention (1 Week)||15
650|NCT02840916|1633|P2|NOT COMPLETED|Overall Study||3
651|NCT02840916|1634|P1|NOT COMPLETED|Overall Study||1
652|NCT02840916|1633|P2|COMPLETED|Overall Study||30
653|NCT02840916|1634|P1|COMPLETED|Overall Study||32
654|NCT02840916|1633|P2|STARTED|Overall Study||33
655|NCT02840916|1634|P1|STARTED|Overall Study||33
656|NCT02839772|1646|P2|NOT COMPLETED|Overall Study||0
657|NCT02839772|1647|P1|NOT COMPLETED|Overall Study||1
658|NCT02839772|1646|P2|COMPLETED|Overall Study||96
659|NCT02839772|1647|P1|COMPLETED|Overall Study|1 participant in Clinic B did not return for the 3 months post- intervention data collection.|96
660|NCT02839772|1646|P2|STARTED|Overall Study||96
661|NCT02839772|1647|P1|STARTED|Overall Study|Stratification was used. Clinic A enrolled 94 participants and Clinic B 99 participants|97
662|NCT02834624|1686|P2|NOT COMPLETED|Overall Study||0
663|NCT02834624|1687|P1|NOT COMPLETED|Overall Study||0
664|NCT02834624|1686|P2|COMPLETED|Overall Study||15
665|NCT02834624|1687|P1|COMPLETED|Overall Study||15
666|NCT02834624|1686|P2|STARTED|Overall Study||15
667|NCT02834624|1687|P1|STARTED|Overall Study||15
668|NCT02832375|1699|P2|NOT COMPLETED|Overall Study||0
669|NCT02832375|1700|P1|NOT COMPLETED|Overall Study||2
670|NCT02832375|1699|P2|COMPLETED|Overall Study||121
671|NCT02832375|1700|P1|COMPLETED|Overall Study||119
672|NCT02832375|1699|P2|STARTED|Overall Study||121
673|NCT02832375|1700|P1|STARTED|Overall Study||121
674|NCT02829775|1710|P1|NOT COMPLETED|Overall Study||5
675|NCT02829775|1710|P1|COMPLETED|Overall Study||4
676|NCT02829775|1710|P1|STARTED|Overall Study||9
677|NCT02829463|1717|P2|NOT COMPLETED|Overall Study||0
678|NCT02829463|1718|P1|NOT COMPLETED|Overall Study||0
679|NCT02829463|1717|P2|COMPLETED|Overall Study||62
680|NCT02829463|1718|P1|COMPLETED|Overall Study||59
681|NCT02829463|1717|P2|STARTED|Overall Study||62
682|NCT02829463|1718|P1|STARTED|Overall Study||59
683|NCT02828137|1727|P3|NOT COMPLETED|Overall Study||0
684|NCT02828137|1728|P2|NOT COMPLETED|Overall Study||0
685|NCT02828137|1729|P1|NOT COMPLETED|Overall Study||0
686|NCT02828137|1727|P3|COMPLETED|Overall Study||41
687|NCT02828137|1728|P2|COMPLETED|Overall Study||41
688|NCT02828137|1729|P1|COMPLETED|Overall Study||41
689|NCT02828137|1727|P3|STARTED|Overall Study||41
690|NCT02828137|1728|P2|STARTED|Overall Study||41
691|NCT02828137|1729|P1|STARTED|Overall Study||41
692|NCT02826421|1741|P4|NOT COMPLETED|Overall Study||2
693|NCT02826421|1742|P3|NOT COMPLETED|Overall Study||2
694|NCT02826421|1743|P2|NOT COMPLETED|Overall Study||3
695|NCT02826421|1744|P1|NOT COMPLETED|Overall Study||3
696|NCT02826421|1741|P4|COMPLETED|Overall Study||28
697|NCT02826421|1742|P3|COMPLETED|Overall Study||26
698|NCT02826421|1743|P2|COMPLETED|Overall Study||26
699|NCT02826421|1744|P1|COMPLETED|Overall Study||19
700|NCT02826421|1741|P4|Treated|Overall Study||28
701|NCT02826421|1742|P3|Treated|Overall Study||26
702|NCT02826421|1743|P2|Treated|Overall Study||26
703|NCT02826421|1744|P1|Treated|Overall Study||19
704|NCT02826421|1741|P4|STARTED|Overall Study||30
705|NCT02826421|1742|P3|STARTED|Overall Study||28
706|NCT02826421|1743|P2|STARTED|Overall Study||29
707|NCT02826421|1744|P1|STARTED|Overall Study||22
708|NCT02823080|1758|P2|NOT COMPLETED|Overall Study||0
709|NCT02823080|1759|P1|NOT COMPLETED|Overall Study||0
710|NCT02823080|1758|P2|COMPLETED|Overall Study||24
711|NCT02823080|1759|P1|COMPLETED|Overall Study||24
712|NCT02823080|1758|P2|STARTED|Overall Study||24
713|NCT02823080|1759|P1|STARTED|Overall Study||24
714|NCT02822885|1777|P1|NOT COMPLETED|Overall Study||0
715|NCT02822885|1777|P1|COMPLETED|Overall Study||70
716|NCT02822885|1777|P1|STARTED|Overall Study||70
717|NCT02822287|1785|P1|NOT COMPLETED|Overall Study||0
718|NCT02822287|1785|P1|COMPLETED|Overall Study||57
719|NCT02822287|1785|P1|STARTED|Overall Study||57
720|NCT02821403|1797|P2|NOT COMPLETED|"Third Intervention (1 Month)"||0
721|NCT02821403|1798|P1|NOT COMPLETED|"Third Intervention (1 Month)"||0
722|NCT02821403|1797|P2|COMPLETED|"Third Intervention (1 Month)"||40
723|NCT02821403|1798|P1|COMPLETED|"Third Intervention (1 Month)"||40
724|NCT02821403|1797|P2|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||14
725|NCT02821403|1798|P1|Used Blue-filtering Coated Lens|"Third Intervention (1 Month)"||13
726|NCT02821403|1797|P2|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
727|NCT02821403|1798|P1|Used Yellow Tinted Lens|"Third Intervention (1 Month)"||13
728|NCT02821403|1797|P2|Used Clear Lens|"Third Intervention (1 Month)"||13
729|NCT02821403|1798|P1|Used Clear Lens|"Third Intervention (1 Month)"||14
730|NCT02821403|1797|P2|STARTED|"Third Intervention (1 Month)"||40
731|NCT02821403|1798|P1|STARTED|"Third Intervention (1 Month)"||40
732|NCT02821403|1797|P2|NOT COMPLETED|"Second Intervention (1 Month)"||0
733|NCT02821403|1798|P1|NOT COMPLETED|"Second Intervention (1 Month)"||0
734|NCT02821403|1797|P2|COMPLETED|"Second Intervention (1 Month)"||40
735|NCT02821403|1798|P1|COMPLETED|"Second Intervention (1 Month)"||40
736|NCT02821403|1797|P2|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
737|NCT02821403|1798|P1|Used Blue-filtering Coated Lens|"Second Intervention (1 Month)"||13
738|NCT02821403|1797|P2|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||13
739|NCT02821403|1798|P1|Used Yellow Tinted Lens|"Second Intervention (1 Month)"||14
740|NCT02821403|1797|P2|Used Clear Lens|"Second Intervention (1 Month)"||14
741|NCT02821403|1798|P1|Used Clear Lens|"Second Intervention (1 Month)"||13
742|NCT02821403|1797|P2|STARTED|"Second Intervention (1 Month)"||40
743|NCT02821403|1798|P1|STARTED|"Second Intervention (1 Month)"||40
744|NCT02821403|1797|P2|NOT COMPLETED|"First Intervention (1 Month)"||0
745|NCT02821403|1798|P1|NOT COMPLETED|"First Intervention (1 Month)"||0
746|NCT02821403|1797|P2|COMPLETED|"First Intervention (1 Month)"||40
747|NCT02821403|1798|P1|COMPLETED|"First Intervention (1 Month)"||40
748|NCT02821403|1797|P2|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||13
749|NCT02821403|1798|P1|Used Blue-filtering Coated Lens|"First Intervention (1 Month)"||14
750|NCT02821403|1797|P2|Used Yellow Tinted Lens|"First Intervention (1 Month)"||14
751|NCT02821403|1798|P1|Used Yellow Tinted Lens|"First Intervention (1 Month)"||13
752|NCT02821403|1797|P2|Used Clear Lens|"First Intervention (1 Month)"||13
753|NCT02821403|1798|P1|Used Clear Lens|"First Intervention (1 Month)"||13
754|NCT02821403|1797|P2|STARTED|"First Intervention (1 Month)"||40
755|NCT02821403|1798|P1|STARTED|"First Intervention (1 Month)"||40
756|NCT02818244|1820|P4|NOT COMPLETED|Overall Study||0
757|NCT02818244|1821|P3|NOT COMPLETED|Overall Study||0
758|NCT02818244|1822|P2|NOT COMPLETED|Overall Study||0
759|NCT02818244|1823|P1|NOT COMPLETED|Overall Study||0
760|NCT02818244|1820|P4|COMPLETED|Overall Study||25
761|NCT02818244|1821|P3|COMPLETED|Overall Study||25
762|NCT02818244|1822|P2|COMPLETED|Overall Study||25
763|NCT02818244|1823|P1|COMPLETED|Overall Study||25
764|NCT02818244|1820|P4|STARTED|Overall Study||25
765|NCT02818244|1821|P3|STARTED|Overall Study||25
766|NCT02818244|1822|P2|STARTED|Overall Study||25
767|NCT02818244|1823|P1|STARTED|Overall Study||25
768|NCT02817763|1835|P2|NOT COMPLETED|Overall Study||0
769|NCT02817763|1836|P1|NOT COMPLETED|Overall Study||0
770|NCT02817763|1835|P2|COMPLETED|Overall Study||20
771|NCT02817763|1836|P1|COMPLETED|Overall Study||20
772|NCT02817763|1835|P2|STARTED|Overall Study||20
773|NCT02817763|1836|P1|STARTED|Overall Study||20
774|NCT02815735|1844|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
775|NCT02815735|1845|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
776|NCT02815735|1844|P2|COMPLETED|Second Intervention (4 Weeks)||37
777|NCT02815735|1845|P1|COMPLETED|Second Intervention (4 Weeks)||33
778|NCT02815735|1844|P2|STARTED|Second Intervention (4 Weeks)||37
779|NCT02815735|1845|P1|STARTED|Second Intervention (4 Weeks)||34
780|NCT02815735|1844|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
781|NCT02815735|1845|P1|NOT COMPLETED|First Intervention (4 Weeks)||2
782|NCT02815735|1844|P2|COMPLETED|First Intervention (4 Weeks)||37
783|NCT02815735|1845|P1|COMPLETED|First Intervention (4 Weeks)||34
784|NCT02815735|1844|P2|STARTED|First Intervention (4 Weeks)||38
785|NCT02815735|1845|P1|STARTED|First Intervention (4 Weeks)||36
786|NCT02814279|1862|P2|NOT COMPLETED|Overall Study||0
787|NCT02814279|1863|P1|NOT COMPLETED|Overall Study||0
788|NCT02814279|1862|P2|COMPLETED|Overall Study||21
789|NCT02814279|1863|P1|COMPLETED|Overall Study||21
790|NCT02814279|1862|P2|STARTED|Overall Study||21
791|NCT02814279|1863|P1|STARTED|Overall Study||21
792|NCT02814227|1871|P1|NOT COMPLETED|Overall Study||0
793|NCT02814227|1871|P1|COMPLETED|Overall Study||52
794|NCT02814227|1871|P1|STARTED|Overall Study||52
795|NCT02813070|1881|P3|NOT COMPLETED|Overall Study||11
796|NCT02813070|1882|P2|NOT COMPLETED|Overall Study||3
797|NCT02813070|1883|P1|NOT COMPLETED|Overall Study||3
798|NCT02813070|1881|P3|COMPLETED|Overall Study||25
799|NCT02813070|1882|P2|COMPLETED|Overall Study||20
800|NCT02813070|1883|P1|COMPLETED|Overall Study||25
801|NCT02813070|1881|P3|Treated (Safety Population)|Overall Study||25
802|NCT02813070|1882|P2|Treated (Safety Population)|Overall Study||20
803|NCT02813070|1883|P1|Treated (Safety Population)|Overall Study||25
804|NCT02813070|1881|P3|STARTED|Overall Study||36
805|NCT02813070|1882|P2|STARTED|Overall Study||23
806|NCT02813070|1883|P1|STARTED|Overall Study||28
807|NCT02809911|1894|P2|NOT COMPLETED|Overall Study||0
808|NCT02809911|1895|P1|NOT COMPLETED|Overall Study||0
809|NCT02809911|1894|P2|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|19
810|NCT02809911|1895|P1|COMPLETED|Overall Study|This is the Initial Treatment Population (subjects that completed the Enrollment Visit / Visit 2)|22
811|NCT02809911|1894|P2|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|19
812|NCT02809911|1895|P1|STARTED|Overall Study|This is the Initial Treatment Population (subjects that started the Enrollment Visit / Visit 2)|22
813|NCT02809833|1903|P1|NOT COMPLETED|Overall Study||300
814|NCT02809833|1903|P1|COMPLETED|Overall Study||550
815|NCT02809833|1903|P1|STARTED|Overall Study||850
816|NCT02808130|1983|P6|NOT COMPLETED|Overall Study||0
817|NCT02808130|1984|P5|NOT COMPLETED|Overall Study||0
818|NCT02808130|1985|P4|NOT COMPLETED|Overall Study||0
819|NCT02808130|1986|P3|NOT COMPLETED|Overall Study||0
820|NCT02808130|1987|P2|NOT COMPLETED|Overall Study||0
821|NCT02808130|1988|P1|NOT COMPLETED|Overall Study||0
822|NCT02808130|1983|P6|COMPLETED|Overall Study||15
823|NCT02808130|1984|P5|COMPLETED|Overall Study||15
824|NCT02808130|1985|P4|COMPLETED|Overall Study||15
825|NCT02808130|1986|P3|COMPLETED|Overall Study||15
826|NCT02808130|1987|P2|COMPLETED|Overall Study||15
827|NCT02808130|1988|P1|COMPLETED|Overall Study||15
828|NCT02808130|1983|P6|STARTED|Overall Study||15
829|NCT02808130|1984|P5|STARTED|Overall Study||15
830|NCT02808130|1985|P4|STARTED|Overall Study||15
831|NCT02808130|1986|P3|STARTED|Overall Study||15
832|NCT02808130|1987|P2|STARTED|Overall Study||15
833|NCT02808130|1988|P1|STARTED|Overall Study||15
834|NCT02806544|2014|P1|NOT COMPLETED|Overall Study||4
835|NCT02806544|2014|P1|COMPLETED|Overall Study||31
836|NCT02806544|2014|P1|STARTED|Overall Study||35
837|NCT02806505|2025|P2|NOT COMPLETED|Overall Study||11
838|NCT02806505|2026|P1|NOT COMPLETED|Overall Study||10
839|NCT02806505|2025|P2|COMPLETED|Overall Study||32
840|NCT02806505|2026|P1|COMPLETED|Overall Study||28
841|NCT02806505|2025|P2|STARTED|Overall Study||43
842|NCT02806505|2026|P1|STARTED|Overall Study||38
843|NCT02805907|2038|P2|NOT COMPLETED|Overall Study||3
844|NCT02805907|2039|P1|NOT COMPLETED|Overall Study||3
845|NCT02805907|2038|P2|COMPLETED|Overall Study||53
846|NCT02805907|2039|P1|COMPLETED|Overall Study||53
847|NCT02805907|2038|P2|STARTED|Overall Study||56
848|NCT02805907|2039|P1|STARTED|Overall Study||56
849|NCT02801396|2051|P6|NOT COMPLETED|Period 3||0
850|NCT02801396|2052|P5|NOT COMPLETED|Period 3||0
851|NCT02801396|2053|P4|NOT COMPLETED|Period 3||0
852|NCT02801396|2054|P3|NOT COMPLETED|Period 3||0
853|NCT02801396|2055|P2|NOT COMPLETED|Period 3||0
854|NCT02801396|2056|P1|NOT COMPLETED|Period 3||0
855|NCT02801396|2051|P6|COMPLETED|Period 3||17
856|NCT02801396|2052|P5|COMPLETED|Period 3||16
857|NCT02801396|2053|P4|COMPLETED|Period 3||16
858|NCT02801396|2054|P3|COMPLETED|Period 3||17
859|NCT02801396|2055|P2|COMPLETED|Period 3||17
860|NCT02801396|2056|P1|COMPLETED|Period 3||17
861|NCT02801396|2051|P6|STARTED|Period 3||17
862|NCT02801396|2052|P5|STARTED|Period 3||16
863|NCT02801396|2053|P4|STARTED|Period 3||16
864|NCT02801396|2054|P3|STARTED|Period 3||17
865|NCT02801396|2055|P2|STARTED|Period 3||17
866|NCT02801396|2056|P1|STARTED|Period 3||17
867|NCT02801396|2051|P6|NOT COMPLETED|Period 2||0
868|NCT02801396|2052|P5|NOT COMPLETED|Period 2||0
869|NCT02801396|2053|P4|NOT COMPLETED|Period 2||0
870|NCT02801396|2054|P3|NOT COMPLETED|Period 2||0
871|NCT02801396|2055|P2|NOT COMPLETED|Period 2||0
872|NCT02801396|2056|P1|NOT COMPLETED|Period 2||0
873|NCT02801396|2051|P6|COMPLETED|Period 2||17
874|NCT02801396|2052|P5|COMPLETED|Period 2||16
875|NCT02801396|2053|P4|COMPLETED|Period 2||16
876|NCT02801396|2054|P3|COMPLETED|Period 2||17
877|NCT02801396|2055|P2|COMPLETED|Period 2||17
878|NCT02801396|2056|P1|COMPLETED|Period 2||17
879|NCT02801396|2051|P6|STARTED|Period 2||17
880|NCT02801396|2052|P5|STARTED|Period 2||16
881|NCT02801396|2053|P4|STARTED|Period 2||16
882|NCT02801396|2054|P3|STARTED|Period 2||17
883|NCT02801396|2055|P2|STARTED|Period 2||17
884|NCT02801396|2056|P1|STARTED|Period 2||17
885|NCT02801396|2051|P6|NOT COMPLETED|Period 1||0
886|NCT02801396|2052|P5|NOT COMPLETED|Period 1||1
887|NCT02801396|2053|P4|NOT COMPLETED|Period 1||0
888|NCT02801396|2054|P3|NOT COMPLETED|Period 1||0
889|NCT02801396|2055|P2|NOT COMPLETED|Period 1||0
890|NCT02801396|2056|P1|NOT COMPLETED|Period 1||0
891|NCT02801396|2051|P6|COMPLETED|Period 1||17
892|NCT02801396|2052|P5|COMPLETED|Period 1||16
893|NCT02801396|2053|P4|COMPLETED|Period 1||16
894|NCT02801396|2054|P3|COMPLETED|Period 1||17
895|NCT02801396|2055|P2|COMPLETED|Period 1||17
896|NCT02801396|2056|P1|COMPLETED|Period 1||17
897|NCT02801396|2051|P6|STARTED|Period 1||17
898|NCT02801396|2052|P5|STARTED|Period 1||17
899|NCT02801396|2053|P4|STARTED|Period 1||16
900|NCT02801396|2054|P3|STARTED|Period 1||17
901|NCT02801396|2055|P2|STARTED|Period 1||17
902|NCT02801396|2056|P1|STARTED|Period 1||17
903|NCT02799082|2075|P2|NOT COMPLETED|Overall Study||4
904|NCT02799082|2076|P1|NOT COMPLETED|Overall Study||4
905|NCT02799082|2075|P2|COMPLETED|Overall Study||77
906|NCT02799082|2076|P1|COMPLETED|Overall Study||37
907|NCT02799082|2075|P2|STARTED|Overall Study||81
908|NCT02799082|2076|P1|STARTED|Overall Study||41
909|NCT02799069|2113|P3|NOT COMPLETED|Overall Study||7
910|NCT02799069|2114|P2|NOT COMPLETED|Overall Study||7
911|NCT02799069|2115|P1|NOT COMPLETED|Overall Study||8
912|NCT02799069|2113|P3|COMPLETED|Overall Study||240
913|NCT02799069|2114|P2|COMPLETED|Overall Study||241
914|NCT02799069|2115|P1|COMPLETED|Overall Study||68
915|NCT02799069|2113|P3|ITT/Safety|Overall Study|1 subject received medication without Illumination and thus was excluded from ITT/safety population|246
916|NCT02799069|2114|P2|ITT/Safety|Overall Study||248
917|NCT02799069|2115|P1|ITT/Safety|Overall Study||76
918|NCT02799069|2113|P3|STARTED|Overall Study||247
919|NCT02799069|2114|P2|STARTED|Overall Study||248
920|NCT02799069|2115|P1|STARTED|Overall Study||76
921|NCT02796092|2227|P2|NOT COMPLETED|Overall Study||0
922|NCT02796092|2228|P1|NOT COMPLETED|Overall Study||0
923|NCT02796092|2227|P2|COMPLETED|Overall Study||50
924|NCT02796092|2228|P1|COMPLETED|Overall Study||50
925|NCT02796092|2227|P2|STARTED|Overall Study||50
926|NCT02796092|2228|P1|STARTED|Overall Study||50
927|NCT02792049|2262|P2|NOT COMPLETED|Overall Study||0
928|NCT02792049|2263|P1|NOT COMPLETED|Overall Study||0
929|NCT02792049|2262|P2|COMPLETED|Overall Study||35
930|NCT02792049|2263|P1|COMPLETED|Overall Study||35
931|NCT02792049|2262|P2|STARTED|Overall Study||35
932|NCT02792049|2263|P1|STARTED|Overall Study||35
933|NCT02791659|2279|P2|NOT COMPLETED|Overall Study||1
934|NCT02791659|2280|P1|NOT COMPLETED|Overall Study||0
935|NCT02791659|2279|P2|COMPLETED|Overall Study||27
936|NCT02791659|2280|P1|COMPLETED|Overall Study||27
937|NCT02791659|2279|P2|STARTED|Overall Study||28
938|NCT02791659|2280|P1|STARTED|Overall Study||27
939|NCT02791269|2288|P2|NOT COMPLETED|Overall Study||1
940|NCT02791269|2289|P1|NOT COMPLETED|Overall Study||0
941|NCT02791269|2288|P2|COMPLETED|Overall Study||19
942|NCT02791269|2289|P1|COMPLETED|Overall Study||4
943|NCT02791269|2288|P2|STARTED|Overall Study||20
944|NCT02791269|2289|P1|STARTED|Overall Study||4
945|NCT02790281|2303|P1|NOT COMPLETED|Overall Study||0
946|NCT02790281|2303|P1|COMPLETED|Overall Study||33
947|NCT02790281|2303|P1|STARTED|Overall Study||33
948|NCT02788357|2311|P2|NOT COMPLETED|Overall Study||0
949|NCT02788357|2312|P1|NOT COMPLETED|Overall Study||3
950|NCT02788357|2311|P2|COMPLETED|Overall Study||6
951|NCT02788357|2312|P1|COMPLETED|Overall Study||3
952|NCT02788357|2311|P2|STARTED|Overall Study||6
953|NCT02788357|2312|P1|STARTED|Overall Study||6
954|NCT02788097|2326|P2|NOT COMPLETED|Overall Study||0
955|NCT02788097|2327|P1|NOT COMPLETED|Overall Study||0
956|NCT02788097|2326|P2|COMPLETED|Overall Study||69
957|NCT02788097|2327|P1|COMPLETED|Overall Study||61
958|NCT02788097|2326|P2|STARTED|Overall Study||69
959|NCT02788097|2327|P1|STARTED|Overall Study||61
960|NCT02786927|2333|P1|NOT COMPLETED|Overall Study||5
961|NCT02786927|2333|P1|COMPLETED|Overall Study||207
962|NCT02786927|2333|P1|STARTED|Overall Study||212
963|NCT02786004|2342|P2|NOT COMPLETED|Overall Study||14
964|NCT02786004|2343|P1|NOT COMPLETED|Overall Study||9
965|NCT02786004|2342|P2|COMPLETED|Overall Study||9
966|NCT02786004|2343|P1|COMPLETED|Overall Study||14
967|NCT02786004|2342|P2|STARTED|Overall Study||23
968|NCT02786004|2343|P1|STARTED|Overall Study||23
969|NCT02784925|2349|P1|NOT COMPLETED|Overall Study||0
970|NCT02784925|2349|P1|COMPLETED|Overall Study||30
971|NCT02784925|2349|P1|STARTED|Overall Study||30
972|NCT02780622|2353|P2|NOT COMPLETED|Treatment Period 2||0
973|NCT02780622|2354|P1|NOT COMPLETED|Treatment Period 2||0
974|NCT02780622|2353|P2|COMPLETED|Treatment Period 2||10
975|NCT02780622|2354|P1|COMPLETED|Treatment Period 2||10
976|NCT02780622|2353|P2|STARTED|Treatment Period 2||10
977|NCT02780622|2354|P1|STARTED|Treatment Period 2||10
978|NCT02780622|2353|P2|NOT COMPLETED|Treatment Period 1||0
979|NCT02780622|2354|P1|NOT COMPLETED|Treatment Period 1||0
980|NCT02780622|2353|P2|COMPLETED|Treatment Period 1||10
981|NCT02780622|2354|P1|COMPLETED|Treatment Period 1||10
982|NCT02780622|2353|P2|STARTED|Treatment Period 1||10
983|NCT02780622|2354|P1|STARTED|Treatment Period 1||10
984|NCT02777268|2392|P1|NOT COMPLETED|Overall Study||0
985|NCT02777268|2392|P1|COMPLETED|Overall Study||16
986|NCT02777268|2392|P1|STARTED|Overall Study||16
987|NCT02777125|2420|P2|NOT COMPLETED|Overall Study||47
988|NCT02777125|2421|P1|NOT COMPLETED|Overall Study||43
989|NCT02777125|2420|P2|COMPLETED|Overall Study||445
990|NCT02777125|2421|P1|COMPLETED|Overall Study||445
991|NCT02777125|2420|P2|STARTED|Overall Study||492
992|NCT02777125|2421|P1|STARTED|Overall Study||488
993|NCT02774278|2435|P1|NOT COMPLETED|Overall Study||264
994|NCT02774278|2435|P1|COMPLETED|Overall Study||0
995|NCT02774278|2435|P1|Safety Analysis Population (SAP)|Overall Study|SAP: all participants who received at least 1 dose of trial medication and had a safety follow-up.|261
996|NCT02774278|2435|P1|STARTED|Overall Study||264
1003|NCT02772666|2456|P1|NOT COMPLETED|SFT Then O-Glass||0
1004|NCT02772666|2456|P1|COMPLETED|SFT Then O-Glass||44
1005|NCT02772666|2456|P1|STARTED|SFT Then O-Glass||44
1006|NCT02772666|2456|P1|NOT COMPLETED|O-Glas Then SFT||0
1007|NCT02772666|2456|P1|COMPLETED|O-Glas Then SFT||44
1008|NCT02772666|2456|P1|STARTED|O-Glas Then SFT||44
1009|NCT02770625|2461|P1|NOT COMPLETED|Overall Study||0
1010|NCT02770625|2461|P1|COMPLETED|Overall Study||8
1011|NCT02770625|2461|P1|STARTED|Overall Study||8
1012|NCT02767843|2474|P1|NOT COMPLETED|Overall Study||0
1013|NCT02767843|2474|P1|COMPLETED|Overall Study||4
1014|NCT02767843|2474|P1|STARTED|Overall Study||4
1015|NCT02767765|2480|P1|NOT COMPLETED|Overall Study||11
1016|NCT02767765|2480|P1|COMPLETED|Overall Study||50
1017|NCT02767765|2480|P1|STARTED|Overall Study||61
1018|NCT02766400|2491|P2|NOT COMPLETED|Overall Study||2
1019|NCT02766400|2492|P1|NOT COMPLETED|Overall Study||2
1020|NCT02766400|2491|P2|COMPLETED|Overall Study||20
1021|NCT02766400|2492|P1|COMPLETED|Overall Study||19
1022|NCT02766400|2491|P2|STARTED|Overall Study||22
1023|NCT02766400|2492|P1|STARTED|Overall Study||21
1024|NCT02766244|2498|P1|NOT COMPLETED|Overall Study||0
1025|NCT02766244|2498|P1|COMPLETED|Overall Study||3
1026|NCT02766244|2498|P1|STARTED|Overall Study||3
1027|NCT02765269|2509|P2|NOT COMPLETED|Overall Study||0
1028|NCT02765269|2510|P1|NOT COMPLETED|Overall Study||0
1029|NCT02765269|2509|P2|COMPLETED|Overall Study||21
1030|NCT02765269|2510|P1|COMPLETED|Overall Study||25
1031|NCT02765269|2509|P2|STARTED|Overall Study||21
1032|NCT02765269|2510|P1|STARTED|Overall Study||25
1033|NCT02763189|2524|P2|NOT COMPLETED|Overall Study||2
1034|NCT02763189|2525|P1|NOT COMPLETED|Overall Study||0
1035|NCT02763189|2524|P2|COMPLETED|Overall Study||2
1036|NCT02763189|2525|P1|COMPLETED|Overall Study||4
1037|NCT02763189|2524|P2|STARTED|Overall Study||4
1038|NCT02763189|2525|P1|STARTED|Overall Study||4
1039|NCT02761733|2537|P4|NOT COMPLETED|Overall Study||15
1040|NCT02761733|2538|P3|NOT COMPLETED|Overall Study||27
1041|NCT02761733|2539|P2|NOT COMPLETED|Overall Study||21
1042|NCT02761733|2540|P1|NOT COMPLETED|Overall Study||30
1043|NCT02761733|2537|P4|COMPLETED|Overall Study||45
1044|NCT02761733|2538|P3|COMPLETED|Overall Study||33
1045|NCT02761733|2539|P2|COMPLETED|Overall Study||39
1046|NCT02761733|2540|P1|COMPLETED|Overall Study||30
1047|NCT02761733|2537|P4|9/30/2015|Overall Study||50
1048|NCT02761733|2538|P3|9/30/2015|Overall Study||33
1049|NCT02761733|2539|P2|9/30/2015|Overall Study||44
1050|NCT02761733|2540|P1|9/30/2015|Overall Study||40
1051|NCT02761733|2537|P4|3/31/2015|Overall Study||50
1052|NCT02761733|2538|P3|3/31/2015|Overall Study||43
1053|NCT02761733|2539|P2|3/31/2015|Overall Study||47
1054|NCT02761733|2540|P1|3/31/2015|Overall Study||48
1055|NCT02761733|2537|P4|9/30/2014|Overall Study||55
1056|NCT02761733|2538|P3|9/30/2014|Overall Study||48
1057|NCT02761733|2539|P2|9/30/2014|Overall Study||56
1058|NCT02761733|2540|P1|9/30/2014|Overall Study||53
1059|NCT02761733|2537|P4|STARTED|Overall Study||60
1060|NCT02761733|2538|P3|STARTED|Overall Study||60
1061|NCT02761733|2539|P2|STARTED|Overall Study||60
1062|NCT02761733|2540|P1|STARTED|Overall Study||60
1063|NCT02761629|2572|P2|NOT COMPLETED|Overall Study||32
1064|NCT02761629|2573|P1|NOT COMPLETED|Overall Study||27
1065|NCT02761629|2572|P2|COMPLETED|Overall Study||58
1066|NCT02761629|2573|P1|COMPLETED|Overall Study||63
1067|NCT02761629|2572|P2|Treated|Overall Study||86
1068|NCT02761629|2573|P1|Treated|Overall Study||82
1069|NCT02761629|2572|P2|STARTED|Overall Study||90
1070|NCT02761629|2573|P1|STARTED|Overall Study||90
1071|NCT02760810|2593|P1|NOT COMPLETED|Overall Study||1
1072|NCT02760810|2593|P1|COMPLETED|Overall Study||29
1073|NCT02760810|2593|P1|STARTED|Overall Study||30
1074|NCT02760654|2601|P2|NOT COMPLETED|Overall Study||6
1075|NCT02760654|2602|P1|NOT COMPLETED|Overall Study||7
1076|NCT02760654|2601|P2|COMPLETED|Overall Study||24
1077|NCT02760654|2602|P1|COMPLETED|Overall Study||23
1078|NCT02760654|2601|P2|STARTED|Overall Study||30
1079|NCT02760654|2602|P1|STARTED|Overall Study||30
1080|NCT02759692|2626|P2|NOT COMPLETED|Period 3||0
1081|NCT02759692|2627|P1|NOT COMPLETED|Period 3||0
1082|NCT02759692|2626|P2|COMPLETED|Period 3||139
1083|NCT02759692|2627|P1|COMPLETED|Period 3||137
1084|NCT02759692|2626|P2|STARTED|Period 3||139
1085|NCT02759692|2627|P1|STARTED|Period 3||137
1086|NCT02759692|2626|P2|NOT COMPLETED|Period 2||1
1087|NCT02759692|2627|P1|NOT COMPLETED|Period 2||1
1088|NCT02759692|2626|P2|COMPLETED|Period 2||139
1089|NCT02759692|2627|P1|COMPLETED|Period 2||137
1090|NCT02759692|2626|P2|STARTED|Period 2||140
1091|NCT02759692|2627|P1|STARTED|Period 2||138
1092|NCT02759692|2626|P2|NOT COMPLETED|Period 1||2
1093|NCT02759692|2627|P1|NOT COMPLETED|Period 1||3
1094|NCT02759692|2626|P2|COMPLETED|Period 1||140
1095|NCT02759692|2627|P1|COMPLETED|Period 1||138
1096|NCT02759692|2626|P2|STARTED|Period 1||142
1097|NCT02759692|2627|P1|STARTED|Period 1||141
1098|NCT02759471|2643|P1|NOT COMPLETED|Overall Study||2
1099|NCT02759471|2643|P1|COMPLETED|Overall Study||52
1100|NCT02759471|2643|P1|STARTED|Overall Study||54
1101|NCT02756637|2655|P2|NOT COMPLETED|Overall Study||54
1102|NCT02756637|2656|P1|NOT COMPLETED|Overall Study||87
1103|NCT02756637|2655|P2|COMPLETED|Overall Study||263
1104|NCT02756637|2656|P1|COMPLETED|Overall Study||230
1105|NCT02756637|2655|P2|Completed Curative Treatment|Overall Study||0
1106|NCT02756637|2656|P1|Completed Curative Treatment|Overall Study||230
1107|NCT02756637|2655|P2|Had NLR Value|Overall Study||263
1108|NCT02756637|2656|P1|Had NLR Value|Overall Study||263
1109|NCT02756637|2655|P2|Eligible for SWOG 8710|Overall Study||307
1110|NCT02756637|2656|P1|Eligible for SWOG 8710|Overall Study||307
1111|NCT02756637|2655|P2|STARTED|Overall Study||317
1112|NCT02756637|2656|P1|STARTED|Overall Study||317
1113|NCT02756624|2664|P2|NOT COMPLETED|Overall Study||7
1114|NCT02756624|2665|P1|NOT COMPLETED|Overall Study||16
1115|NCT02756624|2664|P2|COMPLETED|Overall Study||166
1116|NCT02756624|2665|P1|COMPLETED|Overall Study||327
1117|NCT02756624|2664|P2|STARTED|Overall Study||173
1118|NCT02756624|2665|P1|STARTED|Overall Study||343
1119|NCT02756351|2679|P2|NOT COMPLETED|Overall Study||0
1120|NCT02756351|2680|P1|NOT COMPLETED|Overall Study||0
1121|NCT02756351|2679|P2|COMPLETED|Overall Study||24
1122|NCT02756351|2680|P1|COMPLETED|Overall Study||24
1123|NCT02756351|2679|P2|STARTED|Overall Study||24
1124|NCT02756351|2680|P1|STARTED|Overall Study||24
1125|NCT02755805|2690|P2|NOT COMPLETED|Overall Study||4
1126|NCT02755805|2691|P1|NOT COMPLETED|Overall Study||2
1127|NCT02755805|2690|P2|COMPLETED|Overall Study||11
1128|NCT02755805|2691|P1|COMPLETED|Overall Study||13
1129|NCT02755805|2690|P2|STARTED|Overall Study||15
1130|NCT02755805|2691|P1|STARTED|Overall Study||15
1131|NCT02753699|2706|P3|NOT COMPLETED|Overall Study||23
1132|NCT02753699|2707|P2|NOT COMPLETED|Overall Study||43
1133|NCT02753699|2708|P1|NOT COMPLETED|Overall Study||14
1134|NCT02753699|2706|P3|COMPLETED|Overall Study||139
1135|NCT02753699|2707|P2|COMPLETED|Overall Study||354
1136|NCT02753699|2708|P1|COMPLETED|Overall Study||150
1137|NCT02753699|2706|P3|STARTED|Overall Study||162
1138|NCT02753699|2707|P2|STARTED|Overall Study||397
1139|NCT02753699|2708|P1|STARTED|Overall Study||164
1140|NCT02753413|2724|P2|NOT COMPLETED|Overall Study||0
1141|NCT02753413|2725|P1|NOT COMPLETED|Overall Study||0
1142|NCT02753413|2724|P2|COMPLETED|Overall Study||51
1143|NCT02753413|2725|P1|COMPLETED|Overall Study||49
1144|NCT02753413|2724|P2|STARTED|Overall Study||51
1145|NCT02753413|2725|P1|STARTED|Overall Study||49
1146|NCT02753075|2760|P3|NOT COMPLETED|Overall Study||3
1147|NCT02753075|2761|P2|NOT COMPLETED|Overall Study||3
1148|NCT02753075|2762|P1|NOT COMPLETED|Overall Study||8
1149|NCT02753075|2760|P3|COMPLETED|Overall Study||78
1150|NCT02753075|2761|P2|COMPLETED|Overall Study||77
1151|NCT02753075|2762|P1|COMPLETED|Overall Study||71
1152|NCT02753075|2760|P3|STARTED|Overall Study||81
1153|NCT02753075|2761|P2|STARTED|Overall Study||80
1154|NCT02753075|2762|P1|STARTED|Overall Study||79
1155|NCT02752802|2789|P2|NOT COMPLETED|Overall Study||0
1156|NCT02752802|2790|P1|NOT COMPLETED|Overall Study||1
1157|NCT02752802|2789|P2|COMPLETED|Overall Study||48
1158|NCT02752802|2790|P1|COMPLETED|Overall Study||47
1159|NCT02752802|2789|P2|STARTED|Overall Study||48
1160|NCT02752802|2790|P1|STARTED|Overall Study||48
1161|NCT02751450|2801|P2|NOT COMPLETED|Overall Study||0
1162|NCT02751450|2802|P1|NOT COMPLETED|Overall Study||1
1163|NCT02751450|2801|P2|COMPLETED|Overall Study||116
1164|NCT02751450|2802|P1|COMPLETED|Overall Study||116
1165|NCT02751450|2801|P2|STARTED|Overall Study||116
1166|NCT02751450|2802|P1|STARTED|Overall Study||117
1167|NCT02750943|2816|P2|NOT COMPLETED|Overall Study||9
1168|NCT02750943|2817|P1|NOT COMPLETED|Overall Study||6
1169|NCT02750943|2816|P2|COMPLETED|Overall Study||119
1170|NCT02750943|2817|P1|COMPLETED|Overall Study||119
1171|NCT02750943|2816|P2|STARTED|Overall Study||128
1172|NCT02750943|2817|P1|STARTED|Overall Study||125
1173|NCT02750709|2831|P6|NOT COMPLETED|Treatment Period 3||0
1174|NCT02750709|2832|P5|NOT COMPLETED|Treatment Period 3||0
1175|NCT02750709|2833|P4|NOT COMPLETED|Treatment Period 3||0
1176|NCT02750709|2834|P3|NOT COMPLETED|Treatment Period 3||0
1177|NCT02750709|2835|P2|NOT COMPLETED|Treatment Period 3||0
1178|NCT02750709|2836|P1|NOT COMPLETED|Treatment Period 3||0
1179|NCT02750709|2831|P6|COMPLETED|Treatment Period 3||3
1180|NCT02750709|2832|P5|COMPLETED|Treatment Period 3||4
1181|NCT02750709|2833|P4|COMPLETED|Treatment Period 3||4
1182|NCT02750709|2834|P3|COMPLETED|Treatment Period 3||4
1183|NCT02750709|2835|P2|COMPLETED|Treatment Period 3||4
1184|NCT02750709|2836|P1|COMPLETED|Treatment Period 3||4
1185|NCT02750709|2831|P6|STARTED|Treatment Period 3||3
1186|NCT02750709|2832|P5|STARTED|Treatment Period 3||4
1187|NCT02750709|2833|P4|STARTED|Treatment Period 3||4
1188|NCT02750709|2834|P3|STARTED|Treatment Period 3||4
1189|NCT02750709|2835|P2|STARTED|Treatment Period 3||4
1190|NCT02750709|2836|P1|STARTED|Treatment Period 3||4
1191|NCT02750709|2831|P6|NOT COMPLETED|Treatment Period 2||0
1192|NCT02750709|2832|P5|NOT COMPLETED|Treatment Period 2||0
1193|NCT02750709|2833|P4|NOT COMPLETED|Treatment Period 2||0
1194|NCT02750709|2834|P3|NOT COMPLETED|Treatment Period 2||0
1195|NCT02750709|2835|P2|NOT COMPLETED|Treatment Period 2||0
1196|NCT02750709|2836|P1|NOT COMPLETED|Treatment Period 2||0
1197|NCT02750709|2831|P6|COMPLETED|Treatment Period 2||3
1198|NCT02750709|2832|P5|COMPLETED|Treatment Period 2||4
1199|NCT02750709|2833|P4|COMPLETED|Treatment Period 2||4
1200|NCT02750709|2834|P3|COMPLETED|Treatment Period 2||4
1201|NCT02750709|2835|P2|COMPLETED|Treatment Period 2||4
1202|NCT02750709|2836|P1|COMPLETED|Treatment Period 2||4
1203|NCT02750709|2831|P6|STARTED|Treatment Period 2||3
1204|NCT02750709|2832|P5|STARTED|Treatment Period 2||4
1205|NCT02750709|2833|P4|STARTED|Treatment Period 2||4
1206|NCT02750709|2834|P3|STARTED|Treatment Period 2||4
1207|NCT02750709|2835|P2|STARTED|Treatment Period 2||4
1208|NCT02750709|2836|P1|STARTED|Treatment Period 2||4
1209|NCT02750709|2831|P6|NOT COMPLETED|Treatment Period 1||1
1210|NCT02750709|2832|P5|NOT COMPLETED|Treatment Period 1||0
1211|NCT02750709|2833|P4|NOT COMPLETED|Treatment Period 1||0
1212|NCT02750709|2834|P3|NOT COMPLETED|Treatment Period 1||0
1213|NCT02750709|2835|P2|NOT COMPLETED|Treatment Period 1||0
1214|NCT02750709|2836|P1|NOT COMPLETED|Treatment Period 1||0
1215|NCT02750709|2831|P6|COMPLETED|Treatment Period 1||3
1216|NCT02750709|2832|P5|COMPLETED|Treatment Period 1||4
1217|NCT02750709|2833|P4|COMPLETED|Treatment Period 1||4
1218|NCT02750709|2834|P3|COMPLETED|Treatment Period 1||4
1219|NCT02750709|2835|P2|COMPLETED|Treatment Period 1||4
1220|NCT02750709|2836|P1|COMPLETED|Treatment Period 1||4
1221|NCT02750709|2831|P6|STARTED|Treatment Period 1||4
1222|NCT02750709|2832|P5|STARTED|Treatment Period 1||4
1223|NCT02750709|2833|P4|STARTED|Treatment Period 1||4
1224|NCT02750709|2834|P3|STARTED|Treatment Period 1||4
1225|NCT02750709|2835|P2|STARTED|Treatment Period 1||4
1226|NCT02750709|2836|P1|STARTED|Treatment Period 1||4
1227|NCT02750345|2862|P6|NOT COMPLETED|Intervention 3||0
1228|NCT02750345|2863|P5|NOT COMPLETED|Intervention 3||0
1229|NCT02750345|2864|P4|NOT COMPLETED|Intervention 3||0
1230|NCT02750345|2865|P3|NOT COMPLETED|Intervention 3||0
1231|NCT02750345|2866|P2|NOT COMPLETED|Intervention 3||0
1232|NCT02750345|2867|P1|NOT COMPLETED|Intervention 3||0
1233|NCT02750345|2862|P6|COMPLETED|Intervention 3||4
1234|NCT02750345|2863|P5|COMPLETED|Intervention 3||3
1235|NCT02750345|2864|P4|COMPLETED|Intervention 3||4
1236|NCT02750345|2865|P3|COMPLETED|Intervention 3||4
1237|NCT02750345|2866|P2|COMPLETED|Intervention 3||4
1238|NCT02750345|2867|P1|COMPLETED|Intervention 3||4
1239|NCT02750345|2862|P6|STARTED|Intervention 3||4
1240|NCT02750345|2863|P5|STARTED|Intervention 3||3
1241|NCT02750345|2864|P4|STARTED|Intervention 3||4
1242|NCT02750345|2865|P3|STARTED|Intervention 3||4
1243|NCT02750345|2866|P2|STARTED|Intervention 3||4
1244|NCT02750345|2867|P1|STARTED|Intervention 3||4
1245|NCT02750345|2862|P6|NOT COMPLETED|Intervention 2||0
1246|NCT02750345|2863|P5|NOT COMPLETED|Intervention 2||0
1247|NCT02750345|2864|P4|NOT COMPLETED|Intervention 2||0
1248|NCT02750345|2865|P3|NOT COMPLETED|Intervention 2||0
1249|NCT02750345|2866|P2|NOT COMPLETED|Intervention 2||0
1250|NCT02750345|2867|P1|NOT COMPLETED|Intervention 2||0
1251|NCT02750345|2862|P6|COMPLETED|Intervention 2||4
1252|NCT02750345|2863|P5|COMPLETED|Intervention 2||3
1253|NCT02750345|2864|P4|COMPLETED|Intervention 2||4
1254|NCT02750345|2865|P3|COMPLETED|Intervention 2||4
1255|NCT02750345|2866|P2|COMPLETED|Intervention 2||4
1256|NCT02750345|2867|P1|COMPLETED|Intervention 2||4
1257|NCT02750345|2862|P6|STARTED|Intervention 2||4
1258|NCT02750345|2863|P5|STARTED|Intervention 2||3
1259|NCT02750345|2864|P4|STARTED|Intervention 2||4
1260|NCT02750345|2865|P3|STARTED|Intervention 2||4
1261|NCT02750345|2866|P2|STARTED|Intervention 2||4
1262|NCT02750345|2867|P1|STARTED|Intervention 2||4
1263|NCT02750345|2862|P6|NOT COMPLETED|Intervention 1||0
1264|NCT02750345|2863|P5|NOT COMPLETED|Intervention 1||1
1265|NCT02750345|2864|P4|NOT COMPLETED|Intervention 1||0
1266|NCT02750345|2865|P3|NOT COMPLETED|Intervention 1||0
1267|NCT02750345|2866|P2|NOT COMPLETED|Intervention 1||0
1268|NCT02750345|2867|P1|NOT COMPLETED|Intervention 1||0
1269|NCT02750345|2862|P6|COMPLETED|Intervention 1||4
1270|NCT02750345|2863|P5|COMPLETED|Intervention 1||3
1271|NCT02750345|2864|P4|COMPLETED|Intervention 1||4
1272|NCT02750345|2865|P3|COMPLETED|Intervention 1||4
1273|NCT02750345|2866|P2|COMPLETED|Intervention 1||4
1274|NCT02750345|2867|P1|COMPLETED|Intervention 1||4
1275|NCT02750345|2862|P6|STARTED|Intervention 1||4
1276|NCT02750345|2863|P5|STARTED|Intervention 1||4
1277|NCT02750345|2864|P4|STARTED|Intervention 1||4
1278|NCT02750345|2865|P3|STARTED|Intervention 1||4
1279|NCT02750345|2866|P2|STARTED|Intervention 1||4
1280|NCT02750345|2867|P1|STARTED|Intervention 1||4
1281|NCT02750332|2893|P2|NOT COMPLETED|Treatment Period 2||0
1282|NCT02750332|2894|P1|NOT COMPLETED|Treatment Period 2||0
1283|NCT02750332|2893|P2|COMPLETED|Treatment Period 2||9
1284|NCT02750332|2894|P1|COMPLETED|Treatment Period 2||10
1285|NCT02750332|2893|P2|STARTED|Treatment Period 2||9
1286|NCT02750332|2894|P1|STARTED|Treatment Period 2||10
1287|NCT02750332|2893|P2|NOT COMPLETED|Treatment Period 1||1
1288|NCT02750332|2894|P1|NOT COMPLETED|Treatment Period 1||0
1289|NCT02750332|2893|P2|COMPLETED|Treatment Period 1||9
1290|NCT02750332|2894|P1|COMPLETED|Treatment Period 1||10
1291|NCT02750332|2893|P2|STARTED|Treatment Period 1||10
1292|NCT02750332|2894|P1|STARTED|Treatment Period 1||10
1293|NCT02750267|2914|P2|NOT COMPLETED|Overall Study||0
1294|NCT02750267|2915|P1|NOT COMPLETED|Overall Study||0
1295|NCT02750267|2914|P2|COMPLETED|Overall Study||6
1296|NCT02750267|2915|P1|COMPLETED|Overall Study||6
1297|NCT02750267|2914|P2|STARTED|Overall Study||6
1298|NCT02750267|2915|P1|STARTED|Overall Study||6
1299|NCT02748213|2955|P2|NOT COMPLETED|Overall Study||112
1300|NCT02748213|2956|P1|NOT COMPLETED|Overall Study||113
1301|NCT02748213|2955|P2|COMPLETED|Overall Study||0
1302|NCT02748213|2956|P1|COMPLETED|Overall Study|"*The reason Refused Treatment also includes those who did not cooperate or withdrew consent."|0
1303|NCT02748213|2955|P2|Treated|Overall Study||110
1304|NCT02748213|2956|P1|Treated|Overall Study||112
1305|NCT02748213|2955|P2|STARTED|Overall Study||112
1306|NCT02748213|2956|P1|STARTED|Overall Study||113
1307|NCT02746679|2974|P2|NOT COMPLETED|Overall Study||6
1308|NCT02746679|2975|P1|NOT COMPLETED|Overall Study||4
1309|NCT02746679|2974|P2|COMPLETED|Overall Study||75
1310|NCT02746679|2975|P1|COMPLETED|Overall Study||76
1311|NCT02746679|2974|P2|STARTED|Overall Study||81
1312|NCT02746679|2975|P1|STARTED|Overall Study||80
1313|NCT02746406|3005|P1|NOT COMPLETED|Overall Study||0
1314|NCT02746406|3005|P1|COMPLETED|Overall Study||5
1315|NCT02746406|3005|P1|STARTED|Overall Study||5
1316|NCT02746107|3009|P1|NOT COMPLETED|Overall Study||0
1317|NCT02746107|3009|P1|COMPLETED|Overall Study||968
1318|NCT02746107|3009|P1|CHA2DS2-VASC Score = 5|Overall Study||192
1319|NCT02746107|3009|P1|CHA2DS2-VASC Score = 4|Overall Study||197
1320|NCT02746107|3009|P1|CHA2DS2-VASC Score = 3|Overall Study||195
1321|NCT02746107|3009|P1|CHA2DS2-VASC Score = 2|Overall Study||189
1322|NCT02746107|3009|P1|CHA2DS2-VASC Score = 1|Overall Study||195
1323|NCT02746107|3009|P1|Target=Physician|Overall Study||482
1324|NCT02746107|3009|P1|Target=Patient|Overall Study||486
1325|NCT02746107|3009|P1|5year Risk Estimate|Overall Study||485
1326|NCT02746107|3009|P1|1year Risk Estimate|Overall Study||483
1327|NCT02746107|3009|P1|1 Diagram DA|Overall Study||486
1328|NCT02746107|3009|P1|2 Diagrams DA|Overall Study||482
1329|NCT02746107|3009|P1|STARTED|Overall Study||968
1330|NCT02745626|3027|P3|NOT COMPLETED|Overall Study||3
1331|NCT02745626|3028|P2|NOT COMPLETED|Overall Study||6
1332|NCT02745626|3029|P1|NOT COMPLETED|Overall Study||3
1333|NCT02745626|3027|P3|COMPLETED|Overall Study||19
1334|NCT02745626|3028|P2|COMPLETED|Overall Study||16
1335|NCT02745626|3029|P1|COMPLETED|Overall Study||21
1336|NCT02745626|3027|P3|STARTED|Overall Study||22
1337|NCT02745626|3028|P2|STARTED|Overall Study||22
1338|NCT02745626|3029|P1|STARTED|Overall Study||24
1339|NCT02743702|3057|P2|NOT COMPLETED|Overall Study||0
1340|NCT02743702|3058|P1|NOT COMPLETED|Overall Study||0
1341|NCT02743702|3057|P2|COMPLETED|Overall Study||10
1342|NCT02743702|3058|P1|COMPLETED|Overall Study||11
1343|NCT02743702|3057|P2|STARTED|Overall Study||10
1344|NCT02743702|3058|P1|STARTED|Overall Study||11
1345|NCT02743936|3066|P2|NOT COMPLETED|Overall Study||0
1346|NCT02743936|3067|P1|NOT COMPLETED|Overall Study||0
1347|NCT02743936|3066|P2|COMPLETED|Overall Study||32
1348|NCT02743936|3067|P1|COMPLETED|Overall Study||32
1349|NCT02743936|3066|P2|STARTED|Overall Study||32
1350|NCT02743936|3067|P1|STARTED|Overall Study||32
1351|NCT02743780|3080|P5|NOT COMPLETED|Part 3 (7 Days)||0
1352|NCT02743780|3081|P4|NOT COMPLETED|Part 3 (7 Days)||0
1353|NCT02743780|3082|P3|NOT COMPLETED|Part 3 (7 Days)||1
1354|NCT02743780|3083|P2|NOT COMPLETED|Part 3 (7 Days)||0
1355|NCT02743780|3084|P1|NOT COMPLETED|Part 3 (7 Days)||0
1356|NCT02743780|3080|P5|COMPLETED|Part 3 (7 Days)||25
1357|NCT02743780|3081|P4|COMPLETED|Part 3 (7 Days)||0
1358|NCT02743780|3082|P3|COMPLETED|Part 3 (7 Days)||24
1359|NCT02743780|3083|P2|COMPLETED|Part 3 (7 Days)||0
1360|NCT02743780|3084|P1|COMPLETED|Part 3 (7 Days)||0
1361|NCT02743780|3080|P5|STARTED|Part 3 (7 Days)||25
1362|NCT02743780|3081|P4|STARTED|Part 3 (7 Days)||0
1363|NCT02743780|3082|P3|STARTED|Part 3 (7 Days)||25
1364|NCT02743780|3083|P2|STARTED|Part 3 (7 Days)||0
1365|NCT02743780|3084|P1|STARTED|Part 3 (7 Days)||0
1366|NCT02743780|3080|P5|NOT COMPLETED|Part 2 (8 Days)||0
1367|NCT02743780|3081|P4|NOT COMPLETED|Part 2 (8 Days)||0
1368|NCT02743780|3082|P3|NOT COMPLETED|Part 2 (8 Days)||0
1369|NCT02743780|3083|P2|NOT COMPLETED|Part 2 (8 Days)||0
1370|NCT02743780|3084|P1|NOT COMPLETED|Part 2 (8 Days)||0
1371|NCT02743780|3080|P5|COMPLETED|Part 2 (8 Days)||4
1372|NCT02743780|3081|P4|COMPLETED|Part 2 (8 Days)||0
1373|NCT02743780|3082|P3|COMPLETED|Part 2 (8 Days)||6
1374|NCT02743780|3083|P2|COMPLETED|Part 2 (8 Days)||6
1375|NCT02743780|3084|P1|COMPLETED|Part 2 (8 Days)||0
1376|NCT02743780|3080|P5|STARTED|Part 2 (8 Days)||4
1377|NCT02743780|3081|P4|STARTED|Part 2 (8 Days)||0
1378|NCT02743780|3082|P3|STARTED|Part 2 (8 Days)||6
1379|NCT02743780|3083|P2|STARTED|Part 2 (8 Days)||6
1380|NCT02743780|3084|P1|STARTED|Part 2 (8 Days)||0
1381|NCT02743780|3080|P5|NOT COMPLETED|Part 1 (3 Days)||0
1382|NCT02743780|3081|P4|NOT COMPLETED|Part 1 (3 Days)||0
1383|NCT02743780|3082|P3|NOT COMPLETED|Part 1 (3 Days)||0
1384|NCT02743780|3083|P2|NOT COMPLETED|Part 1 (3 Days)||0
1385|NCT02743780|3084|P1|NOT COMPLETED|Part 1 (3 Days)||0
1386|NCT02743780|3080|P5|COMPLETED|Part 1 (3 Days)||8
1387|NCT02743780|3081|P4|COMPLETED|Part 1 (3 Days)||6
1388|NCT02743780|3082|P3|COMPLETED|Part 1 (3 Days)||6
1389|NCT02743780|3083|P2|COMPLETED|Part 1 (3 Days)||6
1390|NCT02743780|3084|P1|COMPLETED|Part 1 (3 Days)||6
1391|NCT02743780|3080|P5|STARTED|Part 1 (3 Days)||8
1392|NCT02743780|3081|P4|STARTED|Part 1 (3 Days)||6
1393|NCT02743780|3082|P3|STARTED|Part 1 (3 Days)||6
1394|NCT02743780|3083|P2|STARTED|Part 1 (3 Days)||6
1395|NCT02743780|3084|P1|STARTED|Part 1 (3 Days)||6
1396|NCT02742987|3131|P2|NOT COMPLETED|Overall Study||0
1397|NCT02742987|3132|P1|NOT COMPLETED|Overall Study||0
1398|NCT02742987|3131|P2|COMPLETED|Overall Study||21
1399|NCT02742987|3132|P1|COMPLETED|Overall Study||21
1400|NCT02742987|3131|P2|STARTED|Overall Study||21
1401|NCT02742987|3132|P1|STARTED|Overall Study||21
1402|NCT02739698|3140|P2|NOT COMPLETED|Overall Study||5
1403|NCT02739698|3141|P1|NOT COMPLETED|Overall Study||6
1404|NCT02739698|3140|P2|COMPLETED|Overall Study||16
1405|NCT02739698|3141|P1|COMPLETED|Overall Study||16
1406|NCT02739698|3140|P2|STARTED|Overall Study||21
1407|NCT02739698|3141|P1|STARTED|Overall Study||22
1408|NCT02739594|3149|P2|NOT COMPLETED|Overall Study||28
1409|NCT02739594|3150|P1|NOT COMPLETED|Overall Study||25
1410|NCT02739594|3149|P2|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|15
1411|NCT02739594|3150|P1|COMPLETED|Overall Study|Includes all participants who reached the protocol-defined end of study (either Week 44 or 96).|21
1412|NCT02739594|3149|P2|Completed at Week 96|Overall Study||10
1413|NCT02739594|3150|P1|Completed at Week 96|Overall Study||10
1414|NCT02739594|3149|P2|Completed at Week 44|Overall Study||5
1415|NCT02739594|3150|P1|Completed at Week 44|Overall Study||11
1416|NCT02739594|3149|P2|STARTED|Overall Study||43
1417|NCT02739594|3150|P1|STARTED|Overall Study||46
1418|NCT02737852|3180|P1|NOT COMPLETED|Overall Study||2
1419|NCT02737852|3180|P1|COMPLETED|Overall Study||30
1420|NCT02737852|3180|P1|STARTED|Overall Study||32
1421|NCT02737592|3185|P1|NOT COMPLETED|Overall Study||1
1422|NCT02737592|3185|P1|COMPLETED|Overall Study||33
1423|NCT02737592|3185|P1|STARTED|Overall Study||34
1424|NCT02736721|3190|P1|NOT COMPLETED|Overall Study||16
1425|NCT02736721|3190|P1|COMPLETED|Overall Study||25
1426|NCT02736721|3190|P1|STARTED|Overall Study||41
1427|NCT02735200|3201|P2|NOT COMPLETED|Overall Study||5
1428|NCT02735200|3202|P1|NOT COMPLETED|Overall Study||8
1429|NCT02735200|3201|P2|COMPLETED|Overall Study||345
1430|NCT02735200|3202|P1|COMPLETED|Overall Study||192
1431|NCT02735200|3201|P2|STARTED|Overall Study||350
1432|NCT02735200|3202|P1|STARTED|Overall Study||200
1433|NCT02734355|3210|P2|NOT COMPLETED|Overall Study||0
1434|NCT02734355|3211|P1|NOT COMPLETED|Overall Study||0
1435|NCT02734355|3210|P2|COMPLETED|Overall Study||30
1436|NCT02734355|3211|P1|COMPLETED|Overall Study||34
1437|NCT02734355|3210|P2|STARTED|Overall Study||30
1438|NCT02734355|3211|P1|STARTED|Overall Study||34
1439|NCT02734212|3243|P2|NOT COMPLETED|Overall Study||10
1440|NCT02734212|3244|P1|NOT COMPLETED|Overall Study||5
1441|NCT02734212|3243|P2|COMPLETED|Overall Study||18
1442|NCT02734212|3244|P1|COMPLETED|Overall Study||24
1443|NCT02734212|3243|P2|STARTED|Overall Study||28
1444|NCT02734212|3244|P1|STARTED|Overall Study||29
1445|NCT02734056|3256|P2|NOT COMPLETED|Overall Study||1
1446|NCT02734056|3257|P1|NOT COMPLETED|Overall Study||0
1447|NCT02734056|3256|P2|COMPLETED|Overall Study||49
1448|NCT02734056|3257|P1|COMPLETED|Overall Study||50
1449|NCT02734056|3256|P2|STARTED|Overall Study||50
1450|NCT02734056|3257|P1|STARTED|Overall Study||50
1451|NCT02732639|3263|P1|NOT COMPLETED|Overall Study||1
1452|NCT02732639|3263|P1|COMPLETED|Overall Study||30
1453|NCT02732639|3263|P1|STARTED|Overall Study||31
1454|NCT02732561|3276|P2|NOT COMPLETED|Overall Study||1
1455|NCT02732561|3277|P1|NOT COMPLETED|Overall Study||2
1456|NCT02732561|3276|P2|COMPLETED|Overall Study||4
1457|NCT02732561|3277|P1|COMPLETED|Overall Study||3
1458|NCT02732561|3276|P2|STARTED|Overall Study||5
1459|NCT02732561|3277|P1|STARTED|Overall Study||5
1460|NCT02732327|3287|P2|NOT COMPLETED|Overall Study||1
1461|NCT02732327|3288|P1|NOT COMPLETED|Overall Study||0
1462|NCT02732327|3287|P2|COMPLETED|Overall Study||1
1463|NCT02732327|3288|P1|COMPLETED|Overall Study||0
1464|NCT02732327|3287|P2|STARTED|Overall Study||2
1465|NCT02732327|3288|P1|STARTED|Overall Study||0
1466|NCT02732210|3296|P2|NOT COMPLETED|Overall Study||294
1467|NCT02732210|3297|P1|NOT COMPLETED|Overall Study||85
1468|NCT02732210|3296|P2|COMPLETED|Overall Study||338
1469|NCT02732210|3297|P1|COMPLETED|Overall Study||218
1470|NCT02732210|3296|P2|STARTED|Overall Study||632
1471|NCT02732210|3297|P1|STARTED|Overall Study||303
1472|NCT02731833|3315|P2|NOT COMPLETED|Overall Study||0
1473|NCT02731833|3316|P1|NOT COMPLETED|Overall Study||0
1474|NCT02731833|3315|P2|COMPLETED|Overall Study||111
1475|NCT02731833|3316|P1|COMPLETED|Overall Study||111
1476|NCT02731833|3315|P2|STARTED|Overall Study||111
1477|NCT02731833|3316|P1|STARTED|Overall Study||111
1478|NCT02731313|3328|P1|NOT COMPLETED|Overall Study||0
1479|NCT02731313|3328|P1|COMPLETED|Overall Study||367
1480|NCT02731313|3328|P1|STARTED|Overall Study||367
1481|NCT02731300|3338|P2|NOT COMPLETED|Overall Study||0
1482|NCT02731300|3339|P1|NOT COMPLETED|Overall Study||0
1483|NCT02731300|3338|P2|COMPLETED|Overall Study||7
1484|NCT02731300|3339|P1|COMPLETED|Overall Study||15
1485|NCT02731300|3338|P2|STARTED|Overall Study||7
1486|NCT02731300|3339|P1|STARTED|Overall Study||15
1487|NCT02731131|3349|P2|NOT COMPLETED|Overall Study||2
1488|NCT02731131|3350|P1|NOT COMPLETED|Overall Study||0
1489|NCT02731131|3349|P2|COMPLETED|Overall Study||4
1490|NCT02731131|3350|P1|COMPLETED|Overall Study||6
1491|NCT02731131|3349|P2|STARTED|Overall Study||6
1492|NCT02731131|3350|P1|STARTED|Overall Study||6
1493|NCT02730260|3368|P2|NOT COMPLETED|Overall Study||75
1494|NCT02730260|3369|P1|NOT COMPLETED|Overall Study||82
1495|NCT02730260|3368|P2|COMPLETED|Overall Study||185
1496|NCT02730260|3369|P1|COMPLETED|Overall Study||176
1497|NCT02730260|3368|P2|STARTED|Overall Study||260
1498|NCT02730260|3369|P1|STARTED|Overall Study||258
1499|NCT02726971|3377|P2|NOT COMPLETED|Overall Study||9
1500|NCT02726971|3378|P1|NOT COMPLETED|Overall Study||11
1501|NCT02726971|3377|P2|COMPLETED|Overall Study||62
1502|NCT02726971|3378|P1|COMPLETED|Overall Study||59
1503|NCT02726971|3377|P2|STARTED|Overall Study||71
1504|NCT02726971|3378|P1|STARTED|Overall Study||70
1505|NCT02726178|3390|P2|NOT COMPLETED|Overall Study||0
1506|NCT02726178|3391|P1|NOT COMPLETED|Overall Study||0
1507|NCT02726178|3390|P2|COMPLETED|Overall Study||28
1508|NCT02726178|3391|P1|COMPLETED|Overall Study||28
1509|NCT02726178|3390|P2|STARTED|Overall Study||28
1510|NCT02726178|3391|P1|STARTED|Overall Study||28
1511|NCT02726022|3397|P1|NOT COMPLETED|Overall Study||36
1512|NCT02726022|3397|P1|COMPLETED|Overall Study||78
1513|NCT02726022|3397|P1|STARTED|Overall Study||114
1514|NCT02725788|3408|P2|NOT COMPLETED|Overall Study||2
1515|NCT02725788|3409|P1|NOT COMPLETED|Overall Study||1
1516|NCT02725788|3408|P2|COMPLETED|Overall Study||122
1517|NCT02725788|3409|P1|COMPLETED|Overall Study||122
1518|NCT02725788|3408|P2|STARTED|Overall Study||124
1519|NCT02725788|3409|P1|STARTED|Overall Study||123
1520|NCT02724449|3415|P1|NOT COMPLETED|Overall Study||0
1521|NCT02724449|3415|P1|COMPLETED|Overall Study||16
1522|NCT02724449|3415|P1|STARTED|Overall Study||16
1523|NCT02723188|3422|P3|NOT COMPLETED|Overall Study||0
1524|NCT02723188|3423|P2|NOT COMPLETED|Overall Study||0
1525|NCT02723188|3424|P1|NOT COMPLETED|Overall Study||1
1526|NCT02723188|3422|P3|COMPLETED|Overall Study||15
1527|NCT02723188|3423|P2|COMPLETED|Overall Study||15
1528|NCT02723188|3424|P1|COMPLETED|Overall Study||14
1529|NCT02723188|3422|P3|STARTED|Overall Study||15
1530|NCT02723188|3423|P2|STARTED|Overall Study||15
1531|NCT02723188|3424|P1|STARTED|Overall Study||15
1532|NCT02722564|3435|P1|NOT COMPLETED|Overall Study||0
1533|NCT02722564|3435|P1|COMPLETED|Overall Study||55
1534|NCT02722564|3435|P1|STARTED|Overall Study||55
1535|NCT02721641|3439|P1|NOT COMPLETED|Overall Study||0
1536|NCT02721641|3439|P1|COMPLETED|Overall Study|In this continued access study, all participants were considered to have completed per protocol.|69
1537|NCT02721641|3439|P1|STARTED|Overall Study||69
1538|NCT02721277|3445|P1|NOT COMPLETED|Overall Study||0
1539|NCT02721277|3445|P1|COMPLETED|Overall Study||2
1540|NCT02721277|3445|P1|STARTED|Overall Study||2
1541|NCT02720952|3474|P1|NOT COMPLETED|Overall Study||0
1542|NCT02720952|3474|P1|COMPLETED|Overall Study||24
1543|NCT02720952|3474|P1|STARTED|Overall Study||24
1544|NCT02717754|3489|P6|NOT COMPLETED|Overall Study||20
1545|NCT02717754|3490|P5|NOT COMPLETED|Overall Study||20
1546|NCT02717754|3491|P4|NOT COMPLETED|Overall Study||10
1547|NCT02717754|3492|P3|NOT COMPLETED|Overall Study||0
1548|NCT02717754|3493|P2|NOT COMPLETED|Overall Study||0
1549|NCT02717754|3494|P1|NOT COMPLETED|Overall Study||0
1550|NCT02717754|3489|P6|COMPLETED|Overall Study||0
1551|NCT02717754|3490|P5|COMPLETED|Overall Study||0
1552|NCT02717754|3491|P4|COMPLETED|Overall Study||0
1553|NCT02717754|3492|P3|COMPLETED|Overall Study||20
1554|NCT02717754|3493|P2|COMPLETED|Overall Study||19
1555|NCT02717754|3494|P1|COMPLETED|Overall Study||10
1556|NCT02717754|3489|P6|STARTED|Overall Study||20
1557|NCT02717754|3490|P5|STARTED|Overall Study||20
1558|NCT02717754|3491|P4|STARTED|Overall Study||10
1559|NCT02717754|3492|P3|STARTED|Overall Study||20
1560|NCT02717754|3493|P2|STARTED|Overall Study||19
1561|NCT02717754|3494|P1|STARTED|Overall Study||10
1562|NCT02716779|3525|P3|NOT COMPLETED|Combination Therapy||1
1563|NCT02716779|3526|P2|NOT COMPLETED|Combination Therapy||2
1564|NCT02716779|3527|P1|NOT COMPLETED|Combination Therapy||0
1565|NCT02716779|3525|P3|COMPLETED|Combination Therapy||25
1566|NCT02716779|3526|P2|COMPLETED|Combination Therapy||23
1567|NCT02716779|3527|P1|COMPLETED|Combination Therapy||14
1568|NCT02716779|3525|P3|STARTED|Combination Therapy||26
1569|NCT02716779|3526|P2|STARTED|Combination Therapy||25
1570|NCT02716779|3527|P1|STARTED|Combination Therapy||14
1571|NCT02716779|3525|P3|NOT COMPLETED|Monotherapy||1
1572|NCT02716779|3526|P2|NOT COMPLETED|Monotherapy||1
1573|NCT02716779|3527|P1|NOT COMPLETED|Monotherapy||0
1574|NCT02716779|3525|P3|COMPLETED|Monotherapy||26
1575|NCT02716779|3526|P2|COMPLETED|Monotherapy||25
1576|NCT02716779|3527|P1|COMPLETED|Monotherapy||14
1577|NCT02716779|3525|P3|STARTED|Monotherapy||27
1578|NCT02716779|3526|P2|STARTED|Monotherapy||26
1579|NCT02716779|3527|P1|STARTED|Monotherapy||14
1580|NCT02716298|3571|P2|NOT COMPLETED|Second Intervention (1 Month)||0
1581|NCT02716298|3572|P1|NOT COMPLETED|Second Intervention (1 Month)||0
1582|NCT02716298|3571|P2|COMPLETED|Second Intervention (1 Month)||23
1583|NCT02716298|3572|P1|COMPLETED|Second Intervention (1 Month)||24
1584|NCT02716298|3571|P2|STARTED|Second Intervention (1 Month)||23
1585|NCT02716298|3572|P1|STARTED|Second Intervention (1 Month)||24
1586|NCT02716298|3571|P2|NOT COMPLETED|First Intervention (1 Month)||1
1587|NCT02716298|3572|P1|NOT COMPLETED|First Intervention (1 Month)||1
1588|NCT02716298|3571|P2|COMPLETED|First Intervention (1 Month)||23
1589|NCT02716298|3572|P1|COMPLETED|First Intervention (1 Month)||24
1590|NCT02716298|3571|P2|STARTED|First Intervention (1 Month)||24
1591|NCT02716298|3572|P1|STARTED|First Intervention (1 Month)||25
1592|NCT02713594|3589|P2|NOT COMPLETED|Overall Study||396
1593|NCT02713594|3590|P1|NOT COMPLETED|Overall Study||390
1594|NCT02713594|3589|P2|COMPLETED|Overall Study||552
1595|NCT02713594|3590|P1|COMPLETED|Overall Study||562
1596|NCT02713594|3589|P2|STARTED|Overall Study||948
1597|NCT02713594|3590|P1|STARTED|Overall Study||952
1598|NCT02712099|3602|P2|NOT COMPLETED|Overall Study||0
1599|NCT02712099|3603|P1|NOT COMPLETED|Overall Study||0
1600|NCT02712099|3602|P2|COMPLETED|Overall Study||20
1601|NCT02712099|3603|P1|COMPLETED|Overall Study||30
1602|NCT02712099|3602|P2|STARTED|Overall Study||20
1603|NCT02712099|3603|P1|STARTED|Overall Study||30
1604|NCT02709577|3621|P4|NOT COMPLETED|Overall Study||0
1605|NCT02709577|3622|P3|NOT COMPLETED|Overall Study||2
1606|NCT02709577|3623|P2|NOT COMPLETED|Overall Study||5
1607|NCT02709577|3624|P1|NOT COMPLETED|Overall Study||2
1608|NCT02709577|3621|P4|COMPLETED|Overall Study||5
1609|NCT02709577|3622|P3|COMPLETED|Overall Study||4
1610|NCT02709577|3623|P2|COMPLETED|Overall Study||8
1611|NCT02709577|3624|P1|COMPLETED|Overall Study||10
1612|NCT02709577|3621|P4|STARTED|Overall Study||5
1613|NCT02709577|3622|P3|STARTED|Overall Study||6
1614|NCT02709577|3623|P2|STARTED|Overall Study||13
1615|NCT02709577|3624|P1|STARTED|Overall Study||12
1616|NCT02708524|3640|P4|NOT COMPLETED|Overall Study||0
1617|NCT02708524|3641|P3|NOT COMPLETED|Overall Study||3
1618|NCT02708524|3642|P2|NOT COMPLETED|Overall Study||6
1619|NCT02708524|3643|P1|NOT COMPLETED|Overall Study||4
1620|NCT02708524|3640|P4|COMPLETED|Overall Study||136
1621|NCT02708524|3641|P3|COMPLETED|Overall Study||134
1622|NCT02708524|3642|P2|COMPLETED|Overall Study||130
1623|NCT02708524|3643|P1|COMPLETED|Overall Study||135
1624|NCT02708524|3640|P4|STARTED|Overall Study||136
1625|NCT02708524|3641|P3|STARTED|Overall Study||137
1626|NCT02708524|3642|P2|STARTED|Overall Study||136
1627|NCT02708524|3643|P1|STARTED|Overall Study||139
1628|NCT02708355|3692|P3|NOT COMPLETED|Overall Study||0
1629|NCT02708355|3693|P2|NOT COMPLETED|Overall Study||0
1630|NCT02708355|3694|P1|NOT COMPLETED|Overall Study||1
1631|NCT02708355|3692|P3|COMPLETED|Overall Study||12
1632|NCT02708355|3693|P2|COMPLETED|Overall Study||22
1633|NCT02708355|3694|P1|COMPLETED|Overall Study||20
1634|NCT02708355|3692|P3|STARTED|Overall Study||12
1635|NCT02708355|3693|P2|STARTED|Overall Study||22
1636|NCT02708355|3694|P1|STARTED|Overall Study||21
1637|NCT02708277|3707|P2|NOT COMPLETED|Overall Study||4
1638|NCT02708277|3708|P1|NOT COMPLETED|Overall Study||7
1639|NCT02708277|3707|P2|COMPLETED|Overall Study||39
1640|NCT02708277|3708|P1|COMPLETED|Overall Study||43
1641|NCT02708277|3707|P2|STARTED|Overall Study||43
1642|NCT02708277|3708|P1|STARTED|Overall Study||50
1643|NCT02708238|3723|P3|NOT COMPLETED|Overall Study||3
1644|NCT02708238|3724|P2|NOT COMPLETED|Overall Study||1
1645|NCT02708238|3725|P1|NOT COMPLETED|Overall Study||0
1646|NCT02708238|3723|P3|COMPLETED|Overall Study||57
1647|NCT02708238|3724|P2|COMPLETED|Overall Study||59
1648|NCT02708238|3725|P1|COMPLETED|Overall Study||60
1649|NCT02708238|3723|P3|STARTED|Overall Study||60
1650|NCT02708238|3724|P2|STARTED|Overall Study||60
1651|NCT02708238|3725|P1|STARTED|Overall Study||60
1652|NCT02708212|3738|P2|NOT COMPLETED|Overall Study||0
1653|NCT02708212|3739|P1|NOT COMPLETED|Overall Study||0
1654|NCT02708212|3738|P2|COMPLETED|Overall Study||60
1655|NCT02708212|3739|P1|COMPLETED|Overall Study||60
1656|NCT02708212|3738|P2|STARTED|Overall Study||60
1657|NCT02708212|3739|P1|STARTED|Overall Study||60
1658|NCT02707640|3751|P2|NOT COMPLETED|Overall Study||7
1659|NCT02707640|3752|P1|NOT COMPLETED|Overall Study||9
1660|NCT02707640|3751|P2|COMPLETED|Overall Study||55
1661|NCT02707640|3752|P1|COMPLETED|Overall Study||52
1662|NCT02707640|3751|P2|STARTED|Overall Study||62
1663|NCT02707640|3752|P1|STARTED|Overall Study||61
1664|NCT02707172|3770|P1|NOT COMPLETED|2nd Set of Experiment||0
1665|NCT02707172|3770|P1|COMPLETED|2nd Set of Experiment||28
1666|NCT02707172|3770|P1|STARTED|2nd Set of Experiment||28
1667|NCT02707172|3770|P1|NOT COMPLETED|Wash Out||0
1668|NCT02707172|3770|P1|COMPLETED|Wash Out||28
1669|NCT02707172|3770|P1|STARTED|Wash Out||28
1670|NCT02707172|3770|P1|NOT COMPLETED|1st Set of Experiment||0
1671|NCT02707172|3770|P1|COMPLETED|1st Set of Experiment||28
1672|NCT02707172|3770|P1|STARTED|1st Set of Experiment||28
1673|NCT02706327|3778|P3|NOT COMPLETED|Overall Study||2
1674|NCT02706327|3779|P2|NOT COMPLETED|Overall Study||1
1675|NCT02706327|3780|P1|NOT COMPLETED|Overall Study||1
1676|NCT02706327|3778|P3|COMPLETED|Overall Study||21
1677|NCT02706327|3779|P2|COMPLETED|Overall Study||21
1678|NCT02706327|3780|P1|COMPLETED|Overall Study||21
1679|NCT02706327|3778|P3|STARTED|Overall Study||23
1680|NCT02706327|3779|P2|STARTED|Overall Study||22
1681|NCT02706327|3780|P1|STARTED|Overall Study||22
1682|NCT02705807|3800|P1|NOT COMPLETED|Overall Study||0
1683|NCT02705807|3800|P1|COMPLETED|Overall Study||10
1684|NCT02705807|3800|P1|STARTED|Overall Study||10
1685|NCT02705716|3832|P2|NOT COMPLETED|Overall Study||2
1686|NCT02705716|3833|P1|NOT COMPLETED|Overall Study||4
1687|NCT02705716|3832|P2|COMPLETED|Overall Study||68
1688|NCT02705716|3833|P1|COMPLETED|Overall Study||68
1689|NCT02705716|3832|P2|STARTED|Overall Study||70
1690|NCT02705716|3833|P1|STARTED|Overall Study||72
1691|NCT02701556|3845|P2|NOT COMPLETED|Overall Study||20
1692|NCT02701556|3846|P1|NOT COMPLETED|Overall Study||23
1693|NCT02701556|3845|P2|COMPLETED|Overall Study||178
1694|NCT02701556|3846|P1|COMPLETED|Overall Study||175
1695|NCT02701556|3845|P2|STARTED|Overall Study||198
1696|NCT02701556|3846|P1|STARTED|Overall Study||198
1697|NCT02701387|3852|P1|NOT COMPLETED|Overall Study||0
1698|NCT02701387|3852|P1|COMPLETED|Overall Study||7
1699|NCT02701387|3852|P1|STARTED|Overall Study||7
1700|NCT02701296|3859|P2|NOT COMPLETED|Overall Study||2
1701|NCT02701296|3860|P1|NOT COMPLETED|Overall Study||0
1702|NCT02701296|3859|P2|COMPLETED|Overall Study|Data was incomplete for two participants their data was not included in the overall data analysis.|36
1703|NCT02701296|3860|P1|COMPLETED|Overall Study||42
1704|NCT02701296|3859|P2|STARTED|Overall Study||38
1705|NCT02701296|3860|P1|STARTED|Overall Study||42
1706|NCT02701270|3876|P4|NOT COMPLETED|Fourth Intervention at Visit 4||0
1707|NCT02701270|3877|P3|NOT COMPLETED|Fourth Intervention at Visit 4||0
1708|NCT02701270|3878|P2|NOT COMPLETED|Fourth Intervention at Visit 4||0
1709|NCT02701270|3879|P1|NOT COMPLETED|Fourth Intervention at Visit 4||0
1710|NCT02701270|3876|P4|COMPLETED|Fourth Intervention at Visit 4||3
1711|NCT02701270|3877|P3|COMPLETED|Fourth Intervention at Visit 4||3
1712|NCT02701270|3878|P2|COMPLETED|Fourth Intervention at Visit 4||3
1713|NCT02701270|3879|P1|COMPLETED|Fourth Intervention at Visit 4||2
1714|NCT02701270|3876|P4|STARTED|Fourth Intervention at Visit 4||3
1715|NCT02701270|3877|P3|STARTED|Fourth Intervention at Visit 4||3
1716|NCT02701270|3878|P2|STARTED|Fourth Intervention at Visit 4||3
1717|NCT02701270|3879|P1|STARTED|Fourth Intervention at Visit 4||2
1718|NCT02701270|3876|P4|NOT COMPLETED|Third Intervention at Visit 3||0
1719|NCT02701270|3877|P3|NOT COMPLETED|Third Intervention at Visit 3||0
1720|NCT02701270|3878|P2|NOT COMPLETED|Third Intervention at Visit 3||0
1721|NCT02701270|3879|P1|NOT COMPLETED|Third Intervention at Visit 3||0
1722|NCT02701270|3876|P4|COMPLETED|Third Intervention at Visit 3||3
1723|NCT02701270|3877|P3|COMPLETED|Third Intervention at Visit 3||3
1724|NCT02701270|3878|P2|COMPLETED|Third Intervention at Visit 3||3
1725|NCT02701270|3879|P1|COMPLETED|Third Intervention at Visit 3||2
1726|NCT02701270|3876|P4|STARTED|Third Intervention at Visit 3||3
1727|NCT02701270|3877|P3|STARTED|Third Intervention at Visit 3||3
1728|NCT02701270|3878|P2|STARTED|Third Intervention at Visit 3||3
1729|NCT02701270|3879|P1|STARTED|Third Intervention at Visit 3||2
1730|NCT02701270|3876|P4|NOT COMPLETED|Second Intervention at Visit 2||0
1731|NCT02701270|3877|P3|NOT COMPLETED|Second Intervention at Visit 2||0
1732|NCT02701270|3878|P2|NOT COMPLETED|Second Intervention at Visit 2||0
1733|NCT02701270|3879|P1|NOT COMPLETED|Second Intervention at Visit 2||0
1734|NCT02701270|3876|P4|COMPLETED|Second Intervention at Visit 2||3
1735|NCT02701270|3877|P3|COMPLETED|Second Intervention at Visit 2||3
1736|NCT02701270|3878|P2|COMPLETED|Second Intervention at Visit 2||3
1737|NCT02701270|3879|P1|COMPLETED|Second Intervention at Visit 2||2
1738|NCT02701270|3876|P4|STARTED|Second Intervention at Visit 2||3
1739|NCT02701270|3877|P3|STARTED|Second Intervention at Visit 2||3
1740|NCT02701270|3878|P2|STARTED|Second Intervention at Visit 2||3
1741|NCT02701270|3879|P1|STARTED|Second Intervention at Visit 2||2
1742|NCT02701270|3876|P4|NOT COMPLETED|First Intervention at Visit 1||0
1743|NCT02701270|3877|P3|NOT COMPLETED|First Intervention at Visit 1||0
1744|NCT02701270|3878|P2|NOT COMPLETED|First Intervention at Visit 1||0
1745|NCT02701270|3879|P1|NOT COMPLETED|First Intervention at Visit 1||0
1746|NCT02701270|3876|P4|COMPLETED|First Intervention at Visit 1||3
1747|NCT02701270|3877|P3|COMPLETED|First Intervention at Visit 1||3
1748|NCT02701270|3878|P2|COMPLETED|First Intervention at Visit 1||3
1749|NCT02701270|3879|P1|COMPLETED|First Intervention at Visit 1||2
1750|NCT02701270|3876|P4|STARTED|First Intervention at Visit 1||3
1751|NCT02701270|3877|P3|STARTED|First Intervention at Visit 1||3
1752|NCT02701270|3878|P2|STARTED|First Intervention at Visit 1||3
1753|NCT02701270|3879|P1|STARTED|First Intervention at Visit 1||2
1754|NCT02699892|3893|P1|NOT COMPLETED|Overall Study||36
1755|NCT02699892|3893|P1|COMPLETED|Overall Study||94
1756|NCT02699892|3893|P1|STARTED|Overall Study||130
1757|NCT02699593|3898|P2|NOT COMPLETED|Period 2||2
1758|NCT02699593|3899|P1|NOT COMPLETED|Period 2||2
1759|NCT02699593|3898|P2|COMPLETED|Period 2||60
1760|NCT02699593|3899|P1|COMPLETED|Period 2||65
1761|NCT02699593|3898|P2|STARTED|Period 2||62
1762|NCT02699593|3899|P1|STARTED|Period 2||67
1763|NCT02699593|3898|P2|NOT COMPLETED|Period 1||7
1764|NCT02699593|3899|P1|NOT COMPLETED|Period 1||5
1765|NCT02699593|3898|P2|COMPLETED|Period 1||62
1766|NCT02699593|3899|P1|COMPLETED|Period 1||67
1767|NCT02699593|3898|P2|STARTED|Period 1||69
1768|NCT02699593|3899|P1|STARTED|Period 1||72
1769|NCT02698566|3907|P1|NOT COMPLETED|Overall Study (HCPs)||0
1770|NCT02698566|3907|P1|COMPLETED|Overall Study (HCPs)||3
1771|NCT02698566|3907|P1|STARTED|Overall Study (HCPs)||3
1772|NCT02698566|3907|P1|NOT COMPLETED|Overall Study (Patients)||0
1773|NCT02698566|3907|P1|COMPLETED|Overall Study (Patients)||35
1774|NCT02698566|3907|P1|STARTED|Overall Study (Patients)||35
1775|NCT02698423|3915|P2|NOT COMPLETED|Overall Study||24
1776|NCT02698423|3916|P1|NOT COMPLETED|Overall Study||19
1777|NCT02698423|3915|P2|COMPLETED|Overall Study||307
1778|NCT02698423|3916|P1|COMPLETED|Overall Study||317
1779|NCT02698423|3915|P2|STARTED|Overall Study||331
1780|NCT02698423|3916|P1|STARTED|Overall Study||336
1781|NCT02697890|3924|P2|NOT COMPLETED|Overall Study||0
1782|NCT02697890|3925|P1|NOT COMPLETED|Overall Study||0
1783|NCT02697890|3924|P2|COMPLETED|Overall Study||14
1784|NCT02697890|3925|P1|COMPLETED|Overall Study||14
1785|NCT02697890|3924|P2|STARTED|Overall Study||14
1786|NCT02697890|3925|P1|STARTED|Overall Study||14
1787|NCT02696317|3937|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
1788|NCT02696317|3938|P1|NOT COMPLETED|Period 2, 10 Days of Wear||1
1789|NCT02696317|3937|P2|COMPLETED|Period 2, 10 Days of Wear||36
1790|NCT02696317|3938|P1|COMPLETED|Period 2, 10 Days of Wear||39
1791|NCT02696317|3937|P2|STARTED|Period 2, 10 Days of Wear||36
1792|NCT02696317|3938|P1|STARTED|Period 2, 10 Days of Wear||40
1793|NCT02696317|3937|P2|NOT COMPLETED|Period 1, 10 Days of Wear||0
1794|NCT02696317|3938|P1|NOT COMPLETED|Period 1, 10 Days of Wear||0
1795|NCT02696317|3937|P2|COMPLETED|Period 1, 10 Days of Wear||36
1796|NCT02696317|3938|P1|COMPLETED|Period 1, 10 Days of Wear||40
1797|NCT02696317|3937|P2|STARTED|Period 1, 10 Days of Wear||36
1798|NCT02696317|3938|P1|STARTED|Period 1, 10 Days of Wear||40
1799|NCT02696317|3937|P2|NOT COMPLETED|Habitual, 10 Days of Wear||4
1800|NCT02696317|3938|P1|NOT COMPLETED|Habitual, 10 Days of Wear||2
1801|NCT02696317|3937|P2|COMPLETED|Habitual, 10 Days of Wear||36
1802|NCT02696317|3938|P1|COMPLETED|Habitual, 10 Days of Wear||40
1803|NCT02696317|3937|P2|STARTED|Habitual, 10 Days of Wear||40
1804|NCT02696317|3938|P1|STARTED|Habitual, 10 Days of Wear||42
1805|NCT02694718|3952|P1|NOT COMPLETED|Overall Study||2
1806|NCT02694718|3952|P1|COMPLETED|Overall Study||58
1807|NCT02694718|3952|P1|STARTED|Overall Study||60
1808|NCT02694536|3962|P1|NOT COMPLETED|Overall Study||80
1809|NCT02694536|3962|P1|COMPLETED|Overall Study||0
1810|NCT02694536|3962|P1|STARTED|Overall Study||80
1811|NCT02694315|3971|P1|NOT COMPLETED|Overall Study||0
1812|NCT02694315|3971|P1|COMPLETED|Overall Study||200
1813|NCT02694315|3971|P1|STARTED|Overall Study||200
1814|NCT02694198|3976|P1|NOT COMPLETED|Overall Study||0
1815|NCT02694198|3976|P1|COMPLETED|Overall Study||135
1816|NCT02694198|3976|P1|STARTED|Overall Study||135
1817|NCT02693704|3985|P4|NOT COMPLETED|Overall Study||0
1818|NCT02693704|3986|P3|NOT COMPLETED|Overall Study||0
1819|NCT02693704|3987|P2|NOT COMPLETED|Overall Study||0
1820|NCT02693704|3988|P1|NOT COMPLETED|Overall Study||0
1821|NCT02693704|3985|P4|COMPLETED|Overall Study||10
1822|NCT02693704|3986|P3|COMPLETED|Overall Study||10
1823|NCT02693704|3987|P2|COMPLETED|Overall Study||10
1824|NCT02693704|3988|P1|COMPLETED|Overall Study||10
1825|NCT02693704|3985|P4|STARTED|Overall Study||10
1826|NCT02693704|3986|P3|STARTED|Overall Study||10
1827|NCT02693704|3987|P2|STARTED|Overall Study||10
1828|NCT02693704|3988|P1|STARTED|Overall Study||10
1829|NCT02692859|4008|P2|NOT COMPLETED|Overall Study||95
1830|NCT02692859|4009|P1|NOT COMPLETED|Overall Study||84
1831|NCT02692859|4008|P2|COMPLETED|Overall Study||901
1832|NCT02692859|4009|P1|COMPLETED|Overall Study||912
1833|NCT02692859|4008|P2|STARTED|Overall Study||996
1834|NCT02692859|4009|P1|STARTED|Overall Study||996
1835|NCT02691507|4017|P2|NOT COMPLETED|Overall Study||1
1836|NCT02691507|4018|P1|NOT COMPLETED|Overall Study||0
1837|NCT02691507|4017|P2|COMPLETED|Overall Study||12
1838|NCT02691507|4018|P1|COMPLETED|Overall Study||40
1839|NCT02691507|4017|P2|STARTED|Overall Study||13
1840|NCT02691507|4018|P1|STARTED|Overall Study||40
1841|NCT02691416|4150|P2|NOT COMPLETED|Overall Study||0
1842|NCT02691416|4151|P1|NOT COMPLETED|Overall Study||0
1843|NCT02691416|4150|P2|COMPLETED|Overall Study||30
1844|NCT02691416|4151|P1|COMPLETED|Overall Study||30
1845|NCT02691416|4150|P2|STARTED|Overall Study||30
1846|NCT02691416|4151|P1|STARTED|Overall Study||30
1847|NCT02691143|4173|P2|NOT COMPLETED|Overall Study||0
1848|NCT02691143|4174|P1|NOT COMPLETED|Overall Study||0
1849|NCT02691143|4173|P2|COMPLETED|Overall Study||23
1850|NCT02691143|4174|P1|COMPLETED|Overall Study||27
1851|NCT02691143|4173|P2|STARTED|Overall Study||23
1852|NCT02691143|4174|P1|STARTED|Overall Study||27
1853|NCT02690727|4182|P2|NOT COMPLETED|Overall Study||2
1854|NCT02690727|4183|P1|NOT COMPLETED|Overall Study||2
1855|NCT02690727|4182|P2|COMPLETED|Overall Study|2 subjects withdrawn from the study|7
1856|NCT02690727|4183|P1|COMPLETED|Overall Study|2 subjects withdrawn from the study|7
1857|NCT02690727|4182|P2|STARTED|Overall Study||9
1858|NCT02690727|4183|P1|STARTED|Overall Study||9
1859|NCT02689804|4193|P2|NOT COMPLETED|Overall Study||0
1860|NCT02689804|4194|P1|NOT COMPLETED|Overall Study||2
1861|NCT02689804|4193|P2|COMPLETED|Overall Study||16
1862|NCT02689804|4194|P1|COMPLETED|Overall Study||16
1863|NCT02689804|4193|P2|STARTED|Overall Study||16
1864|NCT02689804|4194|P1|STARTED|Overall Study||18
1865|NCT02687217|4222|P2|NOT COMPLETED|Overall Study||0
1866|NCT02687217|4223|P1|NOT COMPLETED|Overall Study||0
1867|NCT02687217|4222|P2|COMPLETED|Overall Study||30
1868|NCT02687217|4223|P1|COMPLETED|Overall Study||30
1869|NCT02687217|4222|P2|STARTED|Overall Study||30
1870|NCT02687217|4223|P1|STARTED|Overall Study||30
1871|NCT02687126|4233|P1|NOT COMPLETED|Data Analysis||0
1872|NCT02687126|4233|P1|COMPLETED|Data Analysis||106
1873|NCT02687126|4233|P1|STARTED|Data Analysis||106
1874|NCT02687126|4233|P1|NOT COMPLETED|Data Collection||0
1875|NCT02687126|4233|P1|COMPLETED|Data Collection||106
1876|NCT02687126|4233|P1|STARTED|Data Collection||106
1877|NCT02684942|4240|P6|NOT COMPLETED|Overall Study||0
1878|NCT02684942|4241|P5|NOT COMPLETED|Overall Study||0
1879|NCT02684942|4242|P4|NOT COMPLETED|Overall Study||0
1880|NCT02684942|4243|P3|NOT COMPLETED|Overall Study||0
1881|NCT02684942|4244|P2|NOT COMPLETED|Overall Study||0
1882|NCT02684942|4245|P1|NOT COMPLETED|Overall Study||0
1883|NCT02684942|4240|P6|COMPLETED|Overall Study||6
1884|NCT02684942|4241|P5|COMPLETED|Overall Study||6
1885|NCT02684942|4242|P4|COMPLETED|Overall Study||7
1886|NCT02684942|4243|P3|COMPLETED|Overall Study||7
1887|NCT02684942|4244|P2|COMPLETED|Overall Study||7
1888|NCT02684942|4245|P1|COMPLETED|Overall Study||7
1889|NCT02684942|4240|P6|STARTED|Overall Study||6
1890|NCT02684942|4241|P5|STARTED|Overall Study||6
1891|NCT02684942|4242|P4|STARTED|Overall Study||7
1892|NCT02684942|4243|P3|STARTED|Overall Study||7
1893|NCT02684942|4244|P2|STARTED|Overall Study||7
1894|NCT02684942|4245|P1|STARTED|Overall Study||7
1895|NCT02684630|4261|P2|NOT COMPLETED|Overall Study||3
1896|NCT02684630|4262|P1|NOT COMPLETED|Overall Study||5
1897|NCT02684630|4261|P2|COMPLETED|Overall Study||60
1898|NCT02684630|4262|P1|COMPLETED|Overall Study||60
1899|NCT02684630|4261|P2|STARTED|Overall Study||63
1900|NCT02684630|4262|P1|STARTED|Overall Study||65
1901|NCT02684604|4272|P2|NOT COMPLETED|Overall Study||0
1902|NCT02684604|4273|P1|NOT COMPLETED|Overall Study||0
1903|NCT02684604|4272|P2|COMPLETED|Overall Study||44
1904|NCT02684604|4273|P1|COMPLETED|Overall Study||44
1905|NCT02684604|4272|P2|STARTED|Overall Study||44
1906|NCT02684604|4273|P1|STARTED|Overall Study||44
1907|NCT02684396|4285|P6|NOT COMPLETED|Overall Study||0
1908|NCT02684396|4286|P5|NOT COMPLETED|Overall Study||0
1909|NCT02684396|4287|P4|NOT COMPLETED|Overall Study||0
1910|NCT02684396|4288|P3|NOT COMPLETED|Overall Study||0
1911|NCT02684396|4289|P2|NOT COMPLETED|Overall Study||0
1912|NCT02684396|4290|P1|NOT COMPLETED|Overall Study||0
1913|NCT02684396|4285|P6|COMPLETED|Overall Study||10
1914|NCT02684396|4286|P5|COMPLETED|Overall Study||5
1915|NCT02684396|4287|P4|COMPLETED|Overall Study||6
1916|NCT02684396|4288|P3|COMPLETED|Overall Study||6
1917|NCT02684396|4289|P2|COMPLETED|Overall Study||6
1918|NCT02684396|4290|P1|COMPLETED|Overall Study||6
1919|NCT02684396|4285|P6|STARTED|Overall Study||10
1920|NCT02684396|4286|P5|STARTED|Overall Study||5
1921|NCT02684396|4287|P4|STARTED|Overall Study||6
1922|NCT02684396|4288|P3|STARTED|Overall Study||6
1923|NCT02684396|4289|P2|STARTED|Overall Study||6
1924|NCT02684396|4290|P1|STARTED|Overall Study||6
1925|NCT02683954|4344|P2|NOT COMPLETED|Overall Study||0
1926|NCT02683954|4345|P1|NOT COMPLETED|Overall Study||0
1927|NCT02683954|4344|P2|COMPLETED|Overall Study||30
1928|NCT02683954|4345|P1|COMPLETED|Overall Study||30
1929|NCT02683954|4344|P2|STARTED|Overall Study||30
1930|NCT02683954|4345|P1|STARTED|Overall Study||30
1931|NCT02682498|4353|P2|NOT COMPLETED|Overall Study||0
1932|NCT02682498|4354|P1|NOT COMPLETED|Overall Study||0
1933|NCT02682498|4353|P2|COMPLETED|Overall Study||20
1934|NCT02682498|4354|P1|COMPLETED|Overall Study||18
1935|NCT02682498|4353|P2|STARTED|Overall Study||20
1936|NCT02682498|4354|P1|STARTED|Overall Study||18
1937|NCT02681458|4370|P2|NOT COMPLETED|Overall Study||656
1938|NCT02681458|4371|P1|NOT COMPLETED|Overall Study||645
1939|NCT02681458|4370|P2|COMPLETED|Overall Study||62
1940|NCT02681458|4371|P1|COMPLETED|Overall Study||73
1941|NCT02681458|4370|P2|STARTED|Overall Study||718
1942|NCT02681458|4371|P1|STARTED|Overall Study||718
1943|NCT02679976|4377|P1|NOT COMPLETED|Overall Study||0
1944|NCT02679976|4377|P1|COMPLETED|Overall Study||30
1945|NCT02679976|4377|P1|Myopes|Overall Study||14
1946|NCT02679976|4377|P1|Hyperopes|Overall Study||16
1947|NCT02679976|4377|P1|STARTED|Overall Study||30
1948|NCT02679469|4386|P1|NOT COMPLETED|Overall Study||0
1949|NCT02679469|4386|P1|COMPLETED|Overall Study||7
1950|NCT02679469|4386|P1|STARTED|Overall Study||7
1951|NCT02678923|4394|P2|NOT COMPLETED|Overall Study||5
1952|NCT02678923|4395|P1|NOT COMPLETED|Overall Study||6
1953|NCT02678923|4394|P2|COMPLETED|Overall Study||62
1954|NCT02678923|4395|P1|COMPLETED|Overall Study||53
1955|NCT02678923|4394|P2|mITT Population|Overall Study||61
1956|NCT02678923|4395|P1|mITT Population|Overall Study||52
1957|NCT02678923|4394|P2|Received at Least 1 Dose of Study Drug|Overall Study||64
1958|NCT02678923|4395|P1|Received at Least 1 Dose of Study Drug|Overall Study||58
1959|NCT02678923|4394|P2|STARTED|Overall Study||67
1960|NCT02678923|4395|P1|STARTED|Overall Study||59
1961|NCT02678676|4411|P2|NOT COMPLETED|Overall Study||872
1962|NCT02678676|4412|P1|NOT COMPLETED|Overall Study||888
1963|NCT02678676|4411|P2|COMPLETED|Overall Study||907
1964|NCT02678676|4412|P1|COMPLETED|Overall Study||932
1965|NCT02678676|4411|P2|STARTED|Overall Study||1779
1966|NCT02678676|4412|P1|STARTED|Overall Study||1820
1967|NCT02677779|4422|P2|NOT COMPLETED|Overall Study||0
1968|NCT02677779|4423|P1|NOT COMPLETED|Overall Study||0
1969|NCT02677779|4422|P2|COMPLETED|Overall Study||10
1970|NCT02677779|4423|P1|COMPLETED|Overall Study||10
1971|NCT02677779|4422|P2|STARTED|Overall Study||10
1972|NCT02677779|4423|P1|STARTED|Overall Study||10
1973|NCT02677493|4440|P3|NOT COMPLETED|Overall Study||3
1974|NCT02677493|4441|P2|NOT COMPLETED|Overall Study||2
1975|NCT02677493|4442|P1|NOT COMPLETED|Overall Study||11
1976|NCT02677493|4440|P3|COMPLETED|Overall Study||296
1977|NCT02677493|4441|P2|COMPLETED|Overall Study||296
1978|NCT02677493|4442|P1|COMPLETED|Overall Study||1186
1979|NCT02677493|4440|P3|STARTED|Overall Study||299
1980|NCT02677493|4441|P2|STARTED|Overall Study||298
1981|NCT02677493|4442|P1|STARTED|Overall Study||1197
1982|NCT02675543|4455|P2|NOT COMPLETED|Overall Study||0
1983|NCT02675543|4456|P1|NOT COMPLETED|Overall Study||0
1984|NCT02675543|4455|P2|COMPLETED|Overall Study||20
1985|NCT02675543|4456|P1|COMPLETED|Overall Study||15
1986|NCT02675543|4455|P2|STARTED|Overall Study||20
1987|NCT02675543|4456|P1|STARTED|Overall Study||15
1988|NCT02673944|4462|P1|NOT COMPLETED|Overall Study||0
1989|NCT02673944|4462|P1|COMPLETED|Overall Study||10
1990|NCT02673944|4462|P1|STARTED|Overall Study||10
1991|NCT02672514|4469|P2|NOT COMPLETED|Overall Study||0
1992|NCT02672514|4470|P1|NOT COMPLETED|Overall Study||0
1993|NCT02672514|4469|P2|COMPLETED|Overall Study||51
1994|NCT02672514|4470|P1|COMPLETED|Overall Study||53
1995|NCT02672514|4469|P2|STARTED|Overall Study||51
1996|NCT02672514|4470|P1|STARTED|Overall Study||53
1997|NCT02670811|4478|P2|NOT COMPLETED|Overall Study||0
1998|NCT02670811|4479|P1|NOT COMPLETED|Overall Study||1
1999|NCT02670811|4478|P2|COMPLETED|Overall Study||18
2000|NCT02670811|4479|P1|COMPLETED|Overall Study||17
2001|NCT02670811|4478|P2|STARTED|Overall Study||18
2002|NCT02670811|4479|P1|STARTED|Overall Study||18
2003|NCT02670473|4495|P1|NOT COMPLETED|Overall Study||1
2004|NCT02670473|4495|P1|COMPLETED|Overall Study||34
2005|NCT02670473|4495|P1|STARTED|Overall Study||35
2006|NCT02669095|4550|P2|NOT COMPLETED|Overall Study||3
2007|NCT02669095|4551|P1|NOT COMPLETED|Overall Study||1
2008|NCT02669095|4550|P2|COMPLETED|Overall Study||72
2009|NCT02669095|4551|P1|COMPLETED|Overall Study||74
2010|NCT02669095|4550|P2|STARTED|Overall Study||75
2011|NCT02669095|4551|P1|STARTED|Overall Study||75
2012|NCT02669043|4559|P1|NOT COMPLETED|Overall Study||4
2013|NCT02669043|4559|P1|COMPLETED|Overall Study||4
2014|NCT02669043|4559|P1|STARTED|Overall Study||8
2015|NCT02667704|4563|P1|NOT COMPLETED|Treatment Period 2||0
2016|NCT02667704|4563|P1|COMPLETED|Treatment Period 2||13
2017|NCT02667704|4563|P1|STARTED|Treatment Period 2||13
2018|NCT02667704|4563|P1|NOT COMPLETED|Treatment Period 1||0
2019|NCT02667704|4563|P1|COMPLETED|Treatment Period 1||13
2020|NCT02667704|4563|P1|STARTED|Treatment Period 1||13
2021|NCT02666560|4574|P2|NOT COMPLETED|Condition 2 (1 Day)||0
2022|NCT02666560|4575|P1|NOT COMPLETED|Condition 2 (1 Day)||0
2023|NCT02666560|4574|P2|COMPLETED|Condition 2 (1 Day)||11
2024|NCT02666560|4575|P1|COMPLETED|Condition 2 (1 Day)||8
2025|NCT02666560|4574|P2|STARTED|Condition 2 (1 Day)||11
2026|NCT02666560|4575|P1|STARTED|Condition 2 (1 Day)||8
2027|NCT02666560|4574|P2|NOT COMPLETED|Condition 1 (1 Day)||0
2028|NCT02666560|4575|P1|NOT COMPLETED|Condition 1 (1 Day)||0
2029|NCT02666560|4574|P2|COMPLETED|Condition 1 (1 Day)||11
2030|NCT02666560|4575|P1|COMPLETED|Condition 1 (1 Day)||8
2031|NCT02666560|4574|P2|STARTED|Condition 1 (1 Day)||11
2032|NCT02666560|4575|P1|STARTED|Condition 1 (1 Day)||8
2033|NCT02666222|4591|P1|NOT COMPLETED|Overall Study||2
2034|NCT02666222|4591|P1|COMPLETED|Overall Study||49
2035|NCT02666222|4591|P1|STARTED|Overall Study||51
2036|NCT02665260|4603|P4|NOT COMPLETED|Overall Study||1
2037|NCT02665260|4604|P3|NOT COMPLETED|Overall Study||4
2038|NCT02665260|4605|P2|NOT COMPLETED|Overall Study||1
2039|NCT02665260|4606|P1|NOT COMPLETED|Overall Study||2
2040|NCT02665260|4603|P4|COMPLETED|Overall Study||21
2041|NCT02665260|4604|P3|COMPLETED|Overall Study||21
2042|NCT02665260|4605|P2|COMPLETED|Overall Study||22
2043|NCT02665260|4606|P1|COMPLETED|Overall Study||22
2044|NCT02665260|4603|P4|STARTED|Overall Study||22
2045|NCT02665260|4604|P3|STARTED|Overall Study||25
2046|NCT02665260|4605|P2|STARTED|Overall Study||23
2047|NCT02665260|4606|P1|STARTED|Overall Study||24
2048|NCT02664987|4620|P1|NOT COMPLETED|Overall Study||0
2049|NCT02664987|4620|P1|COMPLETED|Overall Study||462
2050|NCT02664987|4620|P1|STARTED|Overall Study||462
2051|NCT02664610|4631|P2|NOT COMPLETED|Overall Study||7
2052|NCT02664610|4632|P1|NOT COMPLETED|Overall Study||14
2053|NCT02664610|4631|P2|COMPLETED|Overall Study||41
2054|NCT02664610|4632|P1|COMPLETED|Overall Study||32
2055|NCT02664610|4631|P2|STARTED|Overall Study||48
2056|NCT02664610|4632|P1|STARTED|Overall Study||46
2057|NCT02664532|4642|P2|NOT COMPLETED|Overall Study||0
2058|NCT02664532|4643|P1|NOT COMPLETED|Overall Study||0
2059|NCT02664532|4642|P2|COMPLETED|Overall Study||75
2060|NCT02664532|4643|P1|COMPLETED|Overall Study||75
2061|NCT02664532|4642|P2|STARTED|Overall Study||75
2062|NCT02664532|4643|P1|STARTED|Overall Study||75
2063|NCT02664311|4657|P2|NOT COMPLETED|Overall Study||0
2064|NCT02664311|4658|P1|NOT COMPLETED|Overall Study||0
2065|NCT02664311|4657|P2|COMPLETED|Overall Study||3
2066|NCT02664311|4658|P1|COMPLETED|Overall Study||6
2067|NCT02664311|4657|P2|STARTED|Overall Study||3
2068|NCT02664311|4658|P1|STARTED|Overall Study||6
2069|NCT02663453|4670|P2|NOT COMPLETED|Overall Study||4
2070|NCT02663453|4671|P1|NOT COMPLETED|Overall Study||5
2071|NCT02663453|4670|P2|COMPLETED|Overall Study||18
2072|NCT02663453|4671|P1|COMPLETED|Overall Study||17
2073|NCT02663453|4670|P2|STARTED|Overall Study||22
2074|NCT02663453|4671|P1|STARTED|Overall Study||22
2075|NCT02663232|4693|P1|NOT COMPLETED|Overall Study||0
2076|NCT02663232|4693|P1|COMPLETED|Overall Study||264
2077|NCT02663232|4693|P1|STARTED|Overall Study||264
2078|NCT02662608|4714|P1|NOT COMPLETED|Overall Study||0
2079|NCT02662608|4714|P1|COMPLETED|Overall Study||1
2080|NCT02662608|4714|P1|STARTED|Overall Study||1
2081|NCT02662556|4718|P1|NOT COMPLETED|Overall Study||8
2082|NCT02662556|4718|P1|COMPLETED|Overall Study||132
2083|NCT02662556|4718|P1|STARTED|Overall Study||140
2084|NCT02662387|4727|P2|NOT COMPLETED|Overall Study||0
2085|NCT02662387|4728|P1|NOT COMPLETED|Overall Study||0
2086|NCT02662387|4727|P2|COMPLETED|Overall Study||28
2087|NCT02662387|4728|P1|COMPLETED|Overall Study||27
2088|NCT02662387|4727|P2|STARTED|Overall Study||28
2089|NCT02662387|4728|P1|STARTED|Overall Study||27
2090|NCT02658461|4739|P3|NOT COMPLETED|Overall Study||0
2091|NCT02658461|4740|P2|NOT COMPLETED|Overall Study||0
2092|NCT02658461|4741|P1|NOT COMPLETED|Overall Study||0
2093|NCT02658461|4739|P3|COMPLETED|Overall Study||12
2094|NCT02658461|4740|P2|COMPLETED|Overall Study||12
2095|NCT02658461|4741|P1|COMPLETED|Overall Study||12
2096|NCT02658461|4739|P3|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
2097|NCT02658461|4740|P2|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
2098|NCT02658461|4741|P1|STARTED|Overall Study|The enrollment reflects episodes of care and not number of actual participants.|12
2099|NCT02657629|4769|P2|NOT COMPLETED|Overall Study||0
2100|NCT02657629|4770|P1|NOT COMPLETED|Overall Study||2
2101|NCT02657629|4769|P2|COMPLETED|Overall Study||14
2102|NCT02657629|4770|P1|COMPLETED|Overall Study||12
2103|NCT02657629|4769|P2|STARTED|Overall Study||14
2104|NCT02657629|4770|P1|STARTED|Overall Study||14
2105|NCT02657538|4776|P1|NOT COMPLETED|Overall Study||4
2106|NCT02657538|4776|P1|COMPLETED|Overall Study||31
2107|NCT02657538|4776|P1|Received Visual Caries Detection + Bite|Overall Study||35
2108|NCT02657538|4776|P1|Received Near Infrared Transillumination|Overall Study||35
2109|NCT02657538|4776|P1|STARTED|Overall Study||35
2110|NCT02656485|4787|P4|NOT COMPLETED|Overall Study||2
2111|NCT02656485|4788|P3|NOT COMPLETED|Overall Study||2
2112|NCT02656485|4789|P2|NOT COMPLETED|Overall Study||3
2113|NCT02656485|4790|P1|NOT COMPLETED|Overall Study||2
2114|NCT02656485|4787|P4|COMPLETED|Overall Study||7
2115|NCT02656485|4788|P3|COMPLETED|Overall Study||7
2116|NCT02656485|4789|P2|COMPLETED|Overall Study||6
2117|NCT02656485|4790|P1|COMPLETED|Overall Study||7
2118|NCT02656485|4787|P4|STARTED|Overall Study||9
2119|NCT02656485|4788|P3|STARTED|Overall Study||9
2120|NCT02656485|4789|P2|STARTED|Overall Study||9
2121|NCT02656485|4790|P1|STARTED|Overall Study||9
2122|NCT02656160|4802|P2|NOT COMPLETED|Second Study Night||0
2123|NCT02656160|4803|P1|NOT COMPLETED|Second Study Night||0
2124|NCT02656160|4802|P2|COMPLETED|Second Study Night||6
2125|NCT02656160|4803|P1|COMPLETED|Second Study Night||4
2126|NCT02656160|4802|P2|STARTED|Second Study Night||6
2127|NCT02656160|4803|P1|STARTED|Second Study Night|3 subjects did not return for the second study night|4
2128|NCT02656160|4802|P2|NOT COMPLETED|First Study Night||0
2129|NCT02656160|4803|P1|NOT COMPLETED|First Study Night||0
2130|NCT02656160|4802|P2|COMPLETED|First Study Night||6
2131|NCT02656160|4803|P1|COMPLETED|First Study Night||7
2132|NCT02656160|4802|P2|STARTED|First Study Night||6
2133|NCT02656160|4803|P1|STARTED|First Study Night||7
2134|NCT02653560|4811|P4|NOT COMPLETED|Placebo Phase||0
2135|NCT02653560|4812|P3|NOT COMPLETED|Placebo Phase||0
2136|NCT02653560|4813|P2|NOT COMPLETED|Placebo Phase||0
2137|NCT02653560|4814|P1|NOT COMPLETED|Placebo Phase||0
2138|NCT02653560|4811|P4|COMPLETED|Placebo Phase||30
2139|NCT02653560|4812|P3|COMPLETED|Placebo Phase||0
2140|NCT02653560|4813|P2|COMPLETED|Placebo Phase||0
2141|NCT02653560|4814|P1|COMPLETED|Placebo Phase||0
2142|NCT02653560|4811|P4|STARTED|Placebo Phase||30
2143|NCT02653560|4812|P3|STARTED|Placebo Phase||0
2144|NCT02653560|4813|P2|STARTED|Placebo Phase||0
2145|NCT02653560|4814|P1|STARTED|Placebo Phase||0
2146|NCT02653560|4811|P4|NOT COMPLETED|KCl Phase||0
2147|NCT02653560|4812|P3|NOT COMPLETED|KCl Phase||0
2148|NCT02653560|4813|P2|NOT COMPLETED|KCl Phase||0
2149|NCT02653560|4814|P1|NOT COMPLETED|KCl Phase||0
2150|NCT02653560|4811|P4|COMPLETED|KCl Phase||0
2151|NCT02653560|4812|P3|COMPLETED|KCl Phase||30
2152|NCT02653560|4813|P2|COMPLETED|KCl Phase||0
2153|NCT02653560|4814|P1|COMPLETED|KCl Phase||0
2154|NCT02653560|4811|P4|STARTED|KCl Phase||0
2155|NCT02653560|4812|P3|STARTED|KCl Phase||30
2156|NCT02653560|4813|P2|STARTED|KCl Phase||0
2157|NCT02653560|4814|P1|STARTED|KCl Phase||0
2158|NCT02653560|4811|P4|NOT COMPLETED|K Citrate Phase||0
2159|NCT02653560|4812|P3|NOT COMPLETED|K Citrate Phase||0
2160|NCT02653560|4813|P2|NOT COMPLETED|K Citrate Phase||0
2161|NCT02653560|4814|P1|NOT COMPLETED|K Citrate Phase||0
2162|NCT02653560|4811|P4|COMPLETED|K Citrate Phase||0
2163|NCT02653560|4812|P3|COMPLETED|K Citrate Phase||0
2164|NCT02653560|4813|P2|COMPLETED|K Citrate Phase||30
2165|NCT02653560|4814|P1|COMPLETED|K Citrate Phase||0
2166|NCT02653560|4811|P4|STARTED|K Citrate Phase||0
2167|NCT02653560|4812|P3|STARTED|K Citrate Phase||0
2168|NCT02653560|4813|P2|STARTED|K Citrate Phase||30
2169|NCT02653560|4814|P1|STARTED|K Citrate Phase||0
2170|NCT02653560|4811|P4|NOT COMPLETED|KMgCit Phase||0
2171|NCT02653560|4812|P3|NOT COMPLETED|KMgCit Phase||0
2172|NCT02653560|4813|P2|NOT COMPLETED|KMgCit Phase||0
2173|NCT02653560|4814|P1|NOT COMPLETED|KMgCit Phase||0
2174|NCT02653560|4811|P4|COMPLETED|KMgCit Phase||0
2175|NCT02653560|4812|P3|COMPLETED|KMgCit Phase||0
2176|NCT02653560|4813|P2|COMPLETED|KMgCit Phase||0
2177|NCT02653560|4814|P1|COMPLETED|KMgCit Phase||30
2178|NCT02653560|4811|P4|STARTED|KMgCit Phase||0
2179|NCT02653560|4812|P3|STARTED|KMgCit Phase||0
2180|NCT02653560|4813|P2|STARTED|KMgCit Phase||0
2181|NCT02653560|4814|P1|STARTED|KMgCit Phase||30
2182|NCT02652221|4824|P1|NOT COMPLETED|Overall Study||0
2183|NCT02652221|4824|P1|COMPLETED|Overall Study||55
2184|NCT02652221|4824|P1|STARTED|Overall Study||55
2185|NCT02652208|4833|P2|NOT COMPLETED|Overall Study||2
2186|NCT02652208|4834|P1|NOT COMPLETED|Overall Study||4
2187|NCT02652208|4833|P2|COMPLETED|Overall Study||15
2188|NCT02652208|4834|P1|COMPLETED|Overall Study||13
2189|NCT02652208|4833|P2|STARTED|Overall Study||17
2190|NCT02652208|4834|P1|STARTED|Overall Study||17
2191|NCT02651922|4844|P1|NOT COMPLETED|Overall Study||2
2192|NCT02651922|4844|P1|COMPLETED|Overall Study||154
2193|NCT02651922|4844|P1|STARTED|Overall Study||156
2194|NCT02651467|4864|P3|NOT COMPLETED|Overall Study||4
2195|NCT02651467|4865|P2|NOT COMPLETED|Overall Study||0
2196|NCT02651467|4866|P1|NOT COMPLETED|Overall Study||1
2197|NCT02651467|4864|P3|COMPLETED|Overall Study||69
2198|NCT02651467|4865|P2|COMPLETED|Overall Study||74
2199|NCT02651467|4866|P1|COMPLETED|Overall Study||73
2200|NCT02651467|4864|P3|STARTED|Overall Study||73
2201|NCT02651467|4865|P2|STARTED|Overall Study||74
2202|NCT02651467|4866|P1|STARTED|Overall Study||74
2203|NCT02650219|4887|P2|NOT COMPLETED|Overall Study||0
2204|NCT02650219|4888|P1|NOT COMPLETED|Overall Study||0
2205|NCT02650219|4887|P2|COMPLETED|Overall Study||20
2206|NCT02650219|4888|P1|COMPLETED|Overall Study||40
2207|NCT02650219|4887|P2|STARTED|Overall Study||20
2208|NCT02650219|4888|P1|STARTED|Overall Study||40
2209|NCT02649634|4900|P2|NOT COMPLETED|Overall Study||6
2210|NCT02649634|4901|P1|NOT COMPLETED|Overall Study||3
2211|NCT02649634|4900|P2|COMPLETED|Overall Study||60
2212|NCT02649634|4901|P1|COMPLETED|Overall Study||66
2213|NCT02649634|4900|P2|STARTED|Overall Study||66
2214|NCT02649634|4901|P1|STARTED|Overall Study||69
2215|NCT02648438|4960|P3|NOT COMPLETED|Overall Study||0
2216|NCT02648438|4961|P2|NOT COMPLETED|Overall Study||3
2217|NCT02648438|4962|P1|NOT COMPLETED|Overall Study||3
2218|NCT02648438|4960|P3|COMPLETED|Overall Study||6
2219|NCT02648438|4961|P2|COMPLETED|Overall Study||9
2220|NCT02648438|4962|P1|COMPLETED|Overall Study||9
2221|NCT02648438|4960|P3|STARTED|Overall Study||6
2222|NCT02648438|4961|P2|STARTED|Overall Study||12
2223|NCT02648438|4962|P1|STARTED|Overall Study||12
2224|NCT02648022|5004|P2|NOT COMPLETED|Overall Study||0
2225|NCT02648022|5005|P1|NOT COMPLETED|Overall Study||0
2226|NCT02648022|5004|P2|COMPLETED|Overall Study||39
2227|NCT02648022|5005|P1|COMPLETED|Overall Study||40
2228|NCT02648022|5004|P2|STARTED|Overall Study||39
2229|NCT02648022|5005|P1|STARTED|Overall Study||40
2230|NCT02646449|5017|P2|NOT COMPLETED|Overall Study||0
2231|NCT02646449|5018|P1|NOT COMPLETED|Overall Study||0
2232|NCT02646449|5017|P2|COMPLETED|Overall Study||3
2233|NCT02646449|5018|P1|COMPLETED|Overall Study||4
2234|NCT02646449|5017|P2|STARTED|Overall Study||3
2235|NCT02646449|5018|P1|STARTED|Overall Study||4
2236|NCT02645760|5028|P2|NOT COMPLETED|Overall Study||0
2237|NCT02645760|5029|P1|NOT COMPLETED|Overall Study||0
2238|NCT02645760|5028|P2|COMPLETED|Overall Study||19
2239|NCT02645760|5029|P1|COMPLETED|Overall Study||19
2240|NCT02645760|5028|P2|STARTED|Overall Study||19
2241|NCT02645760|5029|P1|STARTED|Overall Study||19
2242|NCT02645123|5044|P3|NOT COMPLETED|Overall Study||0
2243|NCT02645123|5045|P2|NOT COMPLETED|Overall Study||0
2244|NCT02645123|5046|P1|NOT COMPLETED|Overall Study||0
2245|NCT02645123|5044|P3|COMPLETED|Overall Study||25
2246|NCT02645123|5045|P2|COMPLETED|Overall Study||25
2247|NCT02645123|5046|P1|COMPLETED|Overall Study||25
2248|NCT02645123|5044|P3|STARTED|Overall Study||25
2249|NCT02645123|5045|P2|STARTED|Overall Study||25
2250|NCT02645123|5046|P1|STARTED|Overall Study||25
2251|NCT02644356|5063|P1|NOT COMPLETED|Overall Study||2
2252|NCT02644356|5063|P1|COMPLETED|Overall Study|49 of the 51 consented subjects completed pre-post knowledge testing (96%)|49
2253|NCT02644356|5063|P1|STARTED|Overall Study||51
2254|NCT02644109|5075|P2|NOT COMPLETED|Overall Study||4
2255|NCT02644109|5076|P1|NOT COMPLETED|Overall Study||0
2256|NCT02644109|5075|P2|COMPLETED|Overall Study||24
2257|NCT02644109|5076|P1|COMPLETED|Overall Study||24
2258|NCT02644109|5075|P2|STARTED|Overall Study||28
2259|NCT02644109|5076|P1|STARTED|Overall Study||24
2260|NCT02644096|5084|P2|NOT COMPLETED|Overall Study||25
2261|NCT02644096|5085|P1|NOT COMPLETED|Overall Study||28
2262|NCT02644096|5084|P2|COMPLETED|Overall Study||57
2263|NCT02644096|5085|P1|COMPLETED|Overall Study||65
2264|NCT02644096|5084|P2|9 Month SF-36 Questionnaire|Overall Study||57
2265|NCT02644096|5085|P1|9 Month SF-36 Questionnaire|Overall Study||65
2266|NCT02644096|5084|P2|12 Week SF-36 Questionnaire|Overall Study||59
2267|NCT02644096|5085|P1|12 Week SF-36 Questionnaire|Overall Study||68
2268|NCT02644096|5084|P2|10 Week Interview|Overall Study||59
2269|NCT02644096|5085|P1|10 Week Interview|Overall Study|Not done in control group|0
2270|NCT02644096|5084|P2|2 Week Interview|Overall Study||68
2271|NCT02644096|5085|P1|2 Week Interview|Overall Study|Not done in control group|0
2272|NCT02644096|5084|P2|STARTED|Overall Study||82
2273|NCT02644096|5085|P1|STARTED|Overall Study||93
2274|NCT02643615|5093|P2|NOT COMPLETED|Overall Study||0
2275|NCT02643615|5094|P1|NOT COMPLETED|Overall Study||0
2276|NCT02643615|5093|P2|COMPLETED|Overall Study||11
2277|NCT02643615|5094|P1|COMPLETED|Overall Study||9
2278|NCT02643615|5093|P2|STARTED|Overall Study||11
2279|NCT02643615|5094|P1|STARTED|Overall Study||9
2280|NCT02643251|5108|P2|NOT COMPLETED|Overall Study||2
2281|NCT02643251|5109|P1|NOT COMPLETED|Overall Study||11
2282|NCT02643251|5108|P2|COMPLETED|Overall Study||67
2283|NCT02643251|5109|P1|COMPLETED|Overall Study||58
2284|NCT02643251|5108|P2|STARTED|Overall Study||69
2285|NCT02643251|5109|P1|STARTED|Overall Study||69
2286|NCT02643225|5119|P2|NOT COMPLETED|Overall Study||0
2287|NCT02643225|5120|P1|NOT COMPLETED|Overall Study||0
2288|NCT02643225|5119|P2|COMPLETED|Overall Study||40
2289|NCT02643225|5120|P1|COMPLETED|Overall Study||40
2290|NCT02643225|5119|P2|STARTED|Overall Study||40
2291|NCT02643225|5120|P1|STARTED|Overall Study||40
2292|NCT02643199|5132|P1|NOT COMPLETED|Overall Study||0
2293|NCT02643199|5132|P1|COMPLETED|Overall Study||90
2294|NCT02643199|5132|P1|STARTED|Overall Study||90
2295|NCT02643004|5137|P2|NOT COMPLETED|Second Intervention (One Week)||0
2296|NCT02643004|5138|P1|NOT COMPLETED|Second Intervention (One Week)||0
2297|NCT02643004|5137|P2|COMPLETED|Second Intervention (One Week)||35
2298|NCT02643004|5138|P1|COMPLETED|Second Intervention (One Week)||35
2299|NCT02643004|5137|P2|STARTED|Second Intervention (One Week)||35
2300|NCT02643004|5138|P1|STARTED|Second Intervention (One Week)||35
2301|NCT02643004|5137|P2|NOT COMPLETED|First Intervention (One Week)||0
2302|NCT02643004|5138|P1|NOT COMPLETED|First Intervention (One Week)||0
2303|NCT02643004|5137|P2|COMPLETED|First Intervention (One Week)||35
2304|NCT02643004|5138|P1|COMPLETED|First Intervention (One Week)||35
2305|NCT02643004|5137|P2|STARTED|First Intervention (One Week)||35
2306|NCT02643004|5138|P1|STARTED|First Intervention (One Week)||35
2307|NCT02642575|5178|P1|NOT COMPLETED|Overall Study||0
2308|NCT02642575|5178|P1|COMPLETED|Overall Study||67
2309|NCT02642575|5178|P1|STARTED|Overall Study||67
2310|NCT02642536|5186|P2|NOT COMPLETED|Overall Study||5
2311|NCT02642536|5187|P1|NOT COMPLETED|Overall Study||2
2312|NCT02642536|5186|P2|COMPLETED|Overall Study||18
2313|NCT02642536|5187|P1|COMPLETED|Overall Study||19
2314|NCT02642536|5186|P2|STARTED|Overall Study||23
2315|NCT02642536|5187|P1|STARTED|Overall Study||21
2316|NCT02641912|5215|P2|NOT COMPLETED|Overall Study||0
2317|NCT02641912|5216|P1|NOT COMPLETED|Overall Study||0
2318|NCT02641912|5215|P2|COMPLETED|Overall Study||47
2319|NCT02641912|5216|P1|COMPLETED|Overall Study||53
2320|NCT02641912|5215|P2|STARTED|Overall Study||47
2321|NCT02641912|5216|P1|STARTED|Overall Study||53
2322|NCT02641379|5295|P11|NOT COMPLETED|Overall Study||8
2323|NCT02641379|5296|P10|NOT COMPLETED|Overall Study||9
2324|NCT02641379|5297|P9|NOT COMPLETED|Overall Study||6
2325|NCT02641379|5298|P8|NOT COMPLETED|Overall Study||19
2326|NCT02641379|5299|P7|NOT COMPLETED|Overall Study||13
2327|NCT02641379|5300|P6|NOT COMPLETED|Overall Study||16
2328|NCT02641379|5301|P5|NOT COMPLETED|Overall Study||17
2329|NCT02641379|5302|P4|NOT COMPLETED|Overall Study||17
2330|NCT02641379|5303|P3|NOT COMPLETED|Overall Study||71
2331|NCT02641379|5304|P2|NOT COMPLETED|Overall Study||51
2332|NCT02641379|5305|P1|NOT COMPLETED|Overall Study||35
2333|NCT02641379|5295|P11|COMPLETED|Overall Study||0
2334|NCT02641379|5296|P10|COMPLETED|Overall Study||36
2335|NCT02641379|5297|P9|COMPLETED|Overall Study||36
2336|NCT02641379|5298|P8|COMPLETED|Overall Study||1
2337|NCT02641379|5299|P7|COMPLETED|Overall Study||12
2338|NCT02641379|5300|P6|COMPLETED|Overall Study||20
2339|NCT02641379|5301|P5|COMPLETED|Overall Study||0
2340|NCT02641379|5302|P4|COMPLETED|Overall Study||139
2341|NCT02641379|5303|P3|COMPLETED|Overall Study||7
2342|NCT02641379|5304|P2|COMPLETED|Overall Study||101
2343|NCT02641379|5305|P1|COMPLETED|Overall Study||107
2344|NCT02641379|5295|P11|STARTED|Overall Study||8
2345|NCT02641379|5296|P10|STARTED|Overall Study||45
2346|NCT02641379|5297|P9|STARTED|Overall Study||42
2347|NCT02641379|5298|P8|STARTED|Overall Study||20
2348|NCT02641379|5299|P7|STARTED|Overall Study||25
2349|NCT02641379|5300|P6|STARTED|Overall Study||36
2350|NCT02641379|5301|P5|STARTED|Overall Study||17
2351|NCT02641379|5302|P4|STARTED|Overall Study||156
2352|NCT02641379|5303|P3|STARTED|Overall Study||78
2353|NCT02641379|5304|P2|STARTED|Overall Study||152
2354|NCT02641379|5305|P1|STARTED|Overall Study||142
2355|NCT02641249|5370|P1|NOT COMPLETED|Overall Study||4
2356|NCT02641249|5370|P1|COMPLETED|Overall Study||15
2357|NCT02641249|5370|P1|STARTED|Overall Study||19
2358|NCT02639052|5379|P1|NOT COMPLETED|Overall Study||1
2359|NCT02639052|5379|P1|COMPLETED|Overall Study||34
2360|NCT02639052|5379|P1|Visit 4 (3-month Follow-up)|Overall Study||34
2361|NCT02639052|5379|P1|Visit 3 (1-month Follow-up)|Overall Study||35
2362|NCT02639052|5379|P1|Visit 2 (1-week Follow-up)|Overall Study||35
2363|NCT02639052|5379|P1|Visit 1 (Baseline)|Overall Study||35
2364|NCT02639052|5379|P1|STARTED|Overall Study||35
2365|NCT02638493|5396|P3|NOT COMPLETED|Overall Study||0
2366|NCT02638493|5397|P2|NOT COMPLETED|Overall Study||0
2367|NCT02638493|5398|P1|NOT COMPLETED|Overall Study||2
2368|NCT02638493|5396|P3|COMPLETED|Overall Study||8
2369|NCT02638493|5397|P2|COMPLETED|Overall Study||8
2370|NCT02638493|5398|P1|COMPLETED|Overall Study||8
2371|NCT02638493|5396|P3|STARTED|Overall Study||8
2372|NCT02638493|5397|P2|STARTED|Overall Study||8
2373|NCT02638493|5398|P1|STARTED|Overall Study|Two men were not able to provide semen samples, and thus were replaced|10
2374|NCT02638129|5429|P2|NOT COMPLETED|Overall Study||30
2375|NCT02638129|5430|P1|NOT COMPLETED|Overall Study||28
2376|NCT02638129|5429|P2|COMPLETED|Overall Study||0
2377|NCT02638129|5430|P1|COMPLETED|Overall Study||0
2378|NCT02638129|5429|P2|STARTED|Overall Study||30
2379|NCT02638129|5430|P1|STARTED|Overall Study||28
2380|NCT02638051|5444|P2|NOT COMPLETED|Overall Study||0
2381|NCT02638051|5445|P1|NOT COMPLETED|Overall Study||0
2382|NCT02638051|5444|P2|COMPLETED|Overall Study||130
2383|NCT02638051|5445|P1|COMPLETED|Overall Study||130
2384|NCT02638051|5444|P2|STARTED|Overall Study||130
2385|NCT02638051|5445|P1|STARTED|Overall Study||130
2386|NCT02637063|5458|P3|NOT COMPLETED|Overall Study||6
2387|NCT02637063|5459|P2|NOT COMPLETED|Overall Study||4
2388|NCT02637063|5460|P1|NOT COMPLETED|Overall Study||5
2389|NCT02637063|5458|P3|COMPLETED|Overall Study||62
2390|NCT02637063|5459|P2|COMPLETED|Overall Study||64
2391|NCT02637063|5460|P1|COMPLETED|Overall Study||62
2392|NCT02637063|5458|P3|STARTED|Overall Study||68
2393|NCT02637063|5459|P2|STARTED|Overall Study||68
2394|NCT02637063|5460|P1|STARTED|Overall Study||67
2395|NCT02635828|5486|P1|NOT COMPLETED|Overall Study||14
2396|NCT02635828|5486|P1|COMPLETED|Overall Study||40
2397|NCT02635828|5486|P1|STARTED|Overall Study||54
2398|NCT02635425|5493|P2|NOT COMPLETED|Overall Study||0
2399|NCT02635425|5494|P1|NOT COMPLETED|Overall Study||0
2400|NCT02635425|5493|P2|COMPLETED|Overall Study||15
2401|NCT02635425|5494|P1|COMPLETED|Overall Study||15
2402|NCT02635425|5493|P2|STARTED|Overall Study||15
2403|NCT02635425|5494|P1|STARTED|Overall Study||15
2404|NCT02634788|5504|P4|NOT COMPLETED|Overall Study||5
2405|NCT02634788|5505|P3|NOT COMPLETED|Overall Study||5
2406|NCT02634788|5506|P2|NOT COMPLETED|Overall Study||10
2407|NCT02634788|5507|P1|NOT COMPLETED|Overall Study||4
2408|NCT02634788|5504|P4|COMPLETED|Overall Study||77
2409|NCT02634788|5505|P3|COMPLETED|Overall Study||75
2410|NCT02634788|5506|P2|COMPLETED|Overall Study||71
2411|NCT02634788|5507|P1|COMPLETED|Overall Study||75
2412|NCT02634788|5504|P4|STARTED|Overall Study||82
2413|NCT02634788|5505|P3|STARTED|Overall Study||80
2414|NCT02634788|5506|P2|STARTED|Overall Study||81
2415|NCT02634788|5507|P1|STARTED|Overall Study||79
2416|NCT02634073|5573|P4|NOT COMPLETED|Overall Study||0
2417|NCT02634073|5574|P3|NOT COMPLETED|Overall Study||0
2418|NCT02634073|5575|P2|NOT COMPLETED|Overall Study||0
2419|NCT02634073|5576|P1|NOT COMPLETED|Overall Study||0
2420|NCT02634073|5573|P4|COMPLETED|Overall Study||4
2421|NCT02634073|5574|P3|COMPLETED|Overall Study||4
2422|NCT02634073|5575|P2|COMPLETED|Overall Study||4
2423|NCT02634073|5576|P1|COMPLETED|Overall Study||4
2424|NCT02634073|5573|P4|STARTED|Overall Study||4
2425|NCT02634073|5574|P3|STARTED|Overall Study||4
2426|NCT02634073|5575|P2|STARTED|Overall Study||4
2427|NCT02634073|5576|P1|STARTED|Overall Study||4
2428|NCT02633787|5662|P1|NOT COMPLETED|Overall Study||1
2429|NCT02633787|5662|P1|COMPLETED|Overall Study||109
2430|NCT02633787|5662|P1|STARTED|Overall Study||110
2431|NCT02633215|5670|P2|NOT COMPLETED|Overall Study||3
2432|NCT02633215|5671|P1|NOT COMPLETED|Overall Study||2
2433|NCT02633215|5670|P2|COMPLETED|Overall Study||15
2434|NCT02633215|5671|P1|COMPLETED|Overall Study||16
2435|NCT02633215|5670|P2|STARTED|Overall Study||18
2436|NCT02633215|5671|P1|STARTED|Overall Study||18
2437|NCT02632812|5683|P2|NOT COMPLETED|Overall Study||0
2438|NCT02632812|5684|P1|NOT COMPLETED|Overall Study||0
2439|NCT02632812|5683|P2|COMPLETED|Overall Study||12
2440|NCT02632812|5684|P1|COMPLETED|Overall Study||12
2441|NCT02632812|5683|P2|STARTED|Overall Study||12
2442|NCT02632812|5684|P1|STARTED|Overall Study||12
2443|NCT02630563|5702|P1|NOT COMPLETED|Overall Study||1
2444|NCT02630563|5702|P1|COMPLETED|Overall Study||8
2445|NCT02630563|5702|P1|STARTED|Overall Study||9
2446|NCT02629354|5713|P2|NOT COMPLETED|Follow-up||0
2447|NCT02629354|5714|P1|NOT COMPLETED|Follow-up||0
2448|NCT02629354|5713|P2|COMPLETED|Follow-up||18
2449|NCT02629354|5714|P1|COMPLETED|Follow-up||18
2450|NCT02629354|5713|P2|STARTED|Follow-up||18
2451|NCT02629354|5714|P1|STARTED|Follow-up||18
2452|NCT02629354|5713|P2|NOT COMPLETED|Period 2||0
2453|NCT02629354|5714|P1|NOT COMPLETED|Period 2||0
2454|NCT02629354|5713|P2|COMPLETED|Period 2||18
2455|NCT02629354|5714|P1|COMPLETED|Period 2||18
2456|NCT02629354|5713|P2|STARTED|Period 2||18
2457|NCT02629354|5714|P1|STARTED|Period 2||18
2458|NCT02629354|5713|P2|NOT COMPLETED|Washout Period||0
2459|NCT02629354|5714|P1|NOT COMPLETED|Washout Period||0
2460|NCT02629354|5713|P2|COMPLETED|Washout Period||18
2461|NCT02629354|5714|P1|COMPLETED|Washout Period||18
2462|NCT02629354|5713|P2|STARTED|Washout Period||18
2463|NCT02629354|5714|P1|STARTED|Washout Period||18
2464|NCT02629354|5713|P2|NOT COMPLETED|Period 1||0
2465|NCT02629354|5714|P1|NOT COMPLETED|Period 1||0
2466|NCT02629354|5713|P2|COMPLETED|Period 1||18
2467|NCT02629354|5714|P1|COMPLETED|Period 1||18
2468|NCT02629354|5713|P2|STARTED|Period 1||18
2469|NCT02629354|5714|P1|STARTED|Period 1||18
2470|NCT02628938|5739|P3|NOT COMPLETED|Overall Study||4
2471|NCT02628938|5740|P2|NOT COMPLETED|Overall Study||2
2472|NCT02628938|5741|P1|NOT COMPLETED|Overall Study||5
2473|NCT02628938|5739|P3|COMPLETED|Overall Study||11
2474|NCT02628938|5740|P2|COMPLETED|Overall Study||13
2475|NCT02628938|5741|P1|COMPLETED|Overall Study||10
2476|NCT02628938|5739|P3|STARTED|Overall Study||15
2477|NCT02628938|5740|P2|STARTED|Overall Study||15
2478|NCT02628938|5741|P1|STARTED|Overall Study||15
2479|NCT02628418|5757|P2|NOT COMPLETED|Overall Study||2
2480|NCT02628418|5758|P1|NOT COMPLETED|Overall Study||1
2481|NCT02628418|5757|P2|COMPLETED|Overall Study||13
2482|NCT02628418|5758|P1|COMPLETED|Overall Study||14
2483|NCT02628418|5757|P2|STARTED|Overall Study||15
2484|NCT02628418|5758|P1|STARTED|Overall Study||15
2485|NCT02628106|5779|P1|NOT COMPLETED|Overall Study||0
2486|NCT02628106|5779|P1|COMPLETED|Overall Study||21
2487|NCT02628106|5779|P1|STARTED|Overall Study||21
2488|NCT02627144|5783|P1|NOT COMPLETED|Overall Study||365
2489|NCT02627144|5783|P1|COMPLETED|Overall Study||0
2490|NCT02627144|5783|P1|Treated|Overall Study||359
2491|NCT02627144|5783|P1|STARTED|Overall Study||365
2492|NCT02627001|5793|P2|NOT COMPLETED|Overall Study||0
2493|NCT02627001|5794|P1|NOT COMPLETED|Overall Study||0
2494|NCT02627001|5793|P2|COMPLETED|Overall Study||14
2495|NCT02627001|5794|P1|COMPLETED|Overall Study||13
2496|NCT02627001|5793|P2|STARTED|Overall Study||14
2497|NCT02627001|5794|P1|STARTED|Overall Study||13
2498|NCT02625844|5800|P1|NOT COMPLETED|Overall Study||0
2499|NCT02625844|5800|P1|COMPLETED|Overall Study||110
2500|NCT02625844|5800|P1|STARTED|Overall Study||110
2501|NCT02625298|5806|P2|NOT COMPLETED|Overall Study||0
2502|NCT02625298|5807|P1|NOT COMPLETED|Overall Study||1
2503|NCT02625298|5806|P2|COMPLETED|Overall Study||13
2504|NCT02625298|5807|P1|COMPLETED|Overall Study||10
2505|NCT02625298|5806|P2|STARTED|Overall Study||13
2506|NCT02625298|5807|P1|STARTED|Overall Study||11
2507|NCT02625233|5817|P2|NOT COMPLETED|Overall Study||0
2508|NCT02625233|5818|P1|NOT COMPLETED|Overall Study||2
2509|NCT02625233|5817|P2|COMPLETED|Overall Study||56
2510|NCT02625233|5818|P1|COMPLETED|Overall Study||47
2511|NCT02625233|5817|P2|STARTED|Overall Study||56
2512|NCT02625233|5818|P1|STARTED|Overall Study||49
2513|NCT02625220|5826|P1|NOT COMPLETED|Overall Study||7
2514|NCT02625220|5826|P1|COMPLETED|Overall Study||163
2515|NCT02625220|5826|P1|STARTED|Overall Study||170
2516|NCT02625207|5837|P4|NOT COMPLETED|Part 2 (11 Days)||0
2517|NCT02625207|5838|P3|NOT COMPLETED|Part 2 (11 Days)||0
2518|NCT02625207|5839|P2|NOT COMPLETED|Part 2 (11 Days)||0
2519|NCT02625207|5840|P1|NOT COMPLETED|Part 2 (11 Days)||0
2520|NCT02625207|5837|P4|COMPLETED|Part 2 (11 Days)||0
2521|NCT02625207|5838|P3|COMPLETED|Part 2 (11 Days)||12
2522|NCT02625207|5839|P2|COMPLETED|Part 2 (11 Days)||0
2523|NCT02625207|5840|P1|COMPLETED|Part 2 (11 Days)||11
2524|NCT02625207|5837|P4|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
2525|NCT02625207|5838|P3|STARTED|Part 2 (11 Days)||12
2526|NCT02625207|5839|P2|STARTED|Part 2 (11 Days)|Part 2 was conducted only in Cohorts 1 and 3, as pre-specified in protocol.|0
2527|NCT02625207|5840|P1|STARTED|Part 2 (11 Days)||11
2528|NCT02625207|5837|P4|NOT COMPLETED|Part 1 (6 Days)||0
2529|NCT02625207|5838|P3|NOT COMPLETED|Part 1 (6 Days)||0
2530|NCT02625207|5839|P2|NOT COMPLETED|Part 1 (6 Days)||0
2531|NCT02625207|5840|P1|NOT COMPLETED|Part 1 (6 Days)||0
2532|NCT02625207|5837|P4|COMPLETED|Part 1 (6 Days)||12
2533|NCT02625207|5838|P3|COMPLETED|Part 1 (6 Days)||12
2534|NCT02625207|5839|P2|COMPLETED|Part 1 (6 Days)||12
2535|NCT02625207|5840|P1|COMPLETED|Part 1 (6 Days)||11
2536|NCT02625207|5837|P4|STARTED|Part 1 (6 Days)||12
2537|NCT02625207|5838|P3|STARTED|Part 1 (6 Days)||12
2538|NCT02625207|5839|P2|STARTED|Part 1 (6 Days)||12
2539|NCT02625207|5840|P1|STARTED|Part 1 (6 Days)||11
2540|NCT02624791|5926|P6|NOT COMPLETED|Overall Study||0
2541|NCT02624791|5927|P5|NOT COMPLETED|Overall Study||0
2542|NCT02624791|5928|P4|NOT COMPLETED|Overall Study||0
2543|NCT02624791|5929|P3|NOT COMPLETED|Overall Study||0
2544|NCT02624791|5930|P2|NOT COMPLETED|Overall Study||0
2545|NCT02624791|5931|P1|NOT COMPLETED|Overall Study||2
2546|NCT02624791|5926|P6|COMPLETED|Overall Study||2
2547|NCT02624791|5927|P5|COMPLETED|Overall Study||2
2548|NCT02624791|5928|P4|COMPLETED|Overall Study||2
2549|NCT02624791|5929|P3|COMPLETED|Overall Study||2
2550|NCT02624791|5930|P2|COMPLETED|Overall Study||1
2551|NCT02624791|5931|P1|COMPLETED|Overall Study||0
2552|NCT02624791|5926|P6|STARTED|Overall Study||2
2553|NCT02624791|5927|P5|STARTED|Overall Study||2
2554|NCT02624791|5928|P4|STARTED|Overall Study||2
2555|NCT02624791|5929|P3|STARTED|Overall Study||2
2556|NCT02624791|5930|P2|STARTED|Overall Study||1
2557|NCT02624791|5931|P1|STARTED|Overall Study||2
2558|NCT02621034|5939|P3|NOT COMPLETED|Overall Study||5
2559|NCT02621034|5940|P2|NOT COMPLETED|Overall Study||2
2560|NCT02621034|5941|P1|NOT COMPLETED|Overall Study||3
2561|NCT02621034|5939|P3|COMPLETED|Overall Study||50
2562|NCT02621034|5940|P2|COMPLETED|Overall Study||50
2563|NCT02621034|5941|P1|COMPLETED|Overall Study||50
2564|NCT02621034|5939|P3|STARTED|Overall Study||55
2565|NCT02621034|5940|P2|STARTED|Overall Study||52
2566|NCT02621034|5941|P1|STARTED|Overall Study||53
2567|NCT02619812|5958|P4|NOT COMPLETED|Overall Study||2
2568|NCT02619812|5959|P3|NOT COMPLETED|Overall Study||1
2569|NCT02619812|5960|P2|NOT COMPLETED|Overall Study||0
2570|NCT02619812|5961|P1|NOT COMPLETED|Overall Study||0
2571|NCT02619812|5958|P4|COMPLETED|Overall Study||0
2572|NCT02619812|5959|P3|COMPLETED|Overall Study||0
2573|NCT02619812|5960|P2|COMPLETED|Overall Study||0
2574|NCT02619812|5961|P1|COMPLETED|Overall Study||0
2575|NCT02619812|5958|P4|STARTED|Overall Study||2
2576|NCT02619812|5959|P3|STARTED|Overall Study||1
2577|NCT02619812|5960|P2|STARTED|Overall Study||0
2578|NCT02619812|5961|P1|STARTED|Overall Study||0
2579|NCT02619799|5977|P2|NOT COMPLETED|Overall Study||0
2580|NCT02619799|5978|P1|NOT COMPLETED|Overall Study||0
2581|NCT02619799|5977|P2|COMPLETED|Overall Study||25
2582|NCT02619799|5978|P1|COMPLETED|Overall Study||25
2583|NCT02619799|5977|P2|STARTED|Overall Study||25
2584|NCT02619799|5978|P1|STARTED|Overall Study||25
2585|NCT02619591|5996|P2|NOT COMPLETED|Overall Study||121
2586|NCT02619591|5997|P1|NOT COMPLETED|Overall Study||139
2587|NCT02619591|5996|P2|COMPLETED|Overall Study||0
2588|NCT02619591|5997|P1|COMPLETED|Overall Study||0
2589|NCT02619591|5996|P2|STARTED|Overall Study||121
2590|NCT02619591|5997|P1|STARTED|Overall Study||139
2591|NCT02618772|6005|P2|NOT COMPLETED|Overall Study||0
2592|NCT02618772|6006|P1|NOT COMPLETED|Overall Study||1
2593|NCT02618772|6005|P2|COMPLETED|Overall Study||40
2594|NCT02618772|6006|P1|COMPLETED|Overall Study||38
2595|NCT02618772|6005|P2|Withdrawal by Subject|Overall Study||0
2596|NCT02618772|6006|P1|Withdrawal by Subject|Overall Study|The participant's family withdrew from the study after administration of the trial intervention.|1
2597|NCT02618772|6005|P2|STARTED|Overall Study||40
2598|NCT02618772|6006|P1|STARTED|Overall Study||39
2599|NCT02617888|6041|P3|NOT COMPLETED|Overall Study||0
2600|NCT02617888|6042|P2|NOT COMPLETED|Overall Study||7
2601|NCT02617888|6043|P1|NOT COMPLETED|Overall Study||1
2602|NCT02617888|6041|P3|COMPLETED|Overall Study||127
2603|NCT02617888|6042|P2|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break samples.|44
2604|NCT02617888|6043|P1|COMPLETED|Overall Study|Incomplete due to inadequate double-strand DNA break sample.|49
2605|NCT02617888|6041|P3|STARTED|Overall Study||127
2606|NCT02617888|6042|P2|STARTED|Overall Study||51
2607|NCT02617888|6043|P1|STARTED|Overall Study||50
2608|NCT02617784|6052|P2|NOT COMPLETED|Overall Study||0
2609|NCT02617784|6053|P1|NOT COMPLETED|Overall Study||0
2610|NCT02617784|6052|P2|COMPLETED|Overall Study||12
2611|NCT02617784|6053|P1|COMPLETED|Overall Study||12
2612|NCT02617784|6052|P2|Second Dose Assessment Period|Overall Study||12
2613|NCT02617784|6053|P1|Second Dose Assessment Period|Overall Study||11
2614|NCT02617784|6052|P2|First Dose Assessment Period|Overall Study||12
2615|NCT02617784|6053|P1|First Dose Assessment Period|Overall Study||12
2616|NCT02617784|6052|P2|STARTED|Overall Study||12
2617|NCT02617784|6053|P1|STARTED|Overall Study|None were prematurely withdrawn; 1 switched to CAPD mid-study and was excluded from second analysis.|12
2618|NCT02616523|6103|P3|NOT COMPLETED|Overall Study||0
2619|NCT02616523|6104|P2|NOT COMPLETED|Overall Study||0
2620|NCT02616523|6105|P1|NOT COMPLETED|Overall Study||1
2621|NCT02616523|6103|P3|COMPLETED|Overall Study|April 2015|20
2622|NCT02616523|6104|P2|COMPLETED|Overall Study|April 2015|20
2623|NCT02616523|6105|P1|COMPLETED|Overall Study|April 2015|19
2624|NCT02616523|6103|P3|STARTED|Overall Study|June 2014|20
2625|NCT02616523|6104|P2|STARTED|Overall Study|June 2014|20
2626|NCT02616523|6105|P1|STARTED|Overall Study|June 2014|20
2627|NCT02615717|6121|P2|NOT COMPLETED|Overall Study||0
2628|NCT02615717|6122|P1|NOT COMPLETED|Overall Study||0
2629|NCT02615717|6121|P2|COMPLETED|Overall Study||3
2630|NCT02615717|6122|P1|COMPLETED|Overall Study||3
2631|NCT02615717|6121|P2|STARTED|Overall Study||3
2632|NCT02615717|6122|P1|STARTED|Overall Study||3
2633|NCT02614924|6136|P2|NOT COMPLETED|Overall Study||0
2634|NCT02614924|6137|P1|NOT COMPLETED|Overall Study||0
2635|NCT02614924|6136|P2|COMPLETED|Overall Study||20
2636|NCT02614924|6137|P1|COMPLETED|Overall Study||20
2637|NCT02614924|6136|P2|STARTED|Overall Study||20
2638|NCT02614924|6137|P1|STARTED|Overall Study||20
2639|NCT02614586|6145|P1|NOT COMPLETED|Overall Study||0
2640|NCT02614586|6145|P1|COMPLETED|Overall Study||11
2641|NCT02614586|6145|P1|STARTED|Overall Study||11
2642|NCT02614469|6152|P2|NOT COMPLETED|Period 2||0
2643|NCT02614469|6153|P1|NOT COMPLETED|Period 2||0
2644|NCT02614469|6152|P2|COMPLETED|Period 2||9
2645|NCT02614469|6153|P1|COMPLETED|Period 2||9
2646|NCT02614469|6152|P2|STARTED|Period 2||9
2647|NCT02614469|6153|P1|STARTED|Period 2||9
2648|NCT02614469|6152|P2|NOT COMPLETED|Period 1||0
2649|NCT02614469|6153|P1|NOT COMPLETED|Period 1||0
2650|NCT02614469|6152|P2|COMPLETED|Period 1||9
2651|NCT02614469|6153|P1|COMPLETED|Period 1||9
2652|NCT02614469|6152|P2|STARTED|Period 1||9
2653|NCT02614469|6153|P1|STARTED|Period 1||9
2654|NCT02614222|6183|P2|NOT COMPLETED|Overall Study||0
2655|NCT02614222|6184|P1|NOT COMPLETED|Overall Study||0
2656|NCT02614222|6183|P2|COMPLETED|Overall Study||14
2657|NCT02614222|6184|P1|COMPLETED|Overall Study||13
2658|NCT02614222|6183|P2|STARTED|Overall Study||14
2659|NCT02614222|6184|P1|STARTED|Overall Study||13
2660|NCT02613910|6204|P1|NOT COMPLETED|Overall Study||1
2661|NCT02613910|6204|P1|COMPLETED|Overall Study||0
2662|NCT02613910|6204|P1|STARTED|Overall Study||1
2663|NCT02612077|6253|P1|NOT COMPLETED|Overall Study||466
2664|NCT02612077|6253|P1|COMPLETED|Overall Study||299
2665|NCT02612077|6253|P1|Efficacy Analysis Set|Overall Study||737
2666|NCT02612077|6253|P1|Safety Analysis Set|Overall Study||760
2667|NCT02612077|6253|P1|Did Not Receive Study Product|Overall Study||5
2668|NCT02612077|6253|P1|STARTED|Overall Study||765
2669|NCT02612064|6265|P2|NOT COMPLETED|Overall Study||3
2670|NCT02612064|6266|P1|NOT COMPLETED|Overall Study||1
2671|NCT02612064|6265|P2|COMPLETED|Overall Study||112
2672|NCT02612064|6266|P1|COMPLETED|Overall Study||114
2673|NCT02612064|6265|P2|STARTED|Overall Study||115
2674|NCT02612064|6266|P1|STARTED|Overall Study||115
2675|NCT02611765|6278|P2|NOT COMPLETED|Overall Study||6
2676|NCT02611765|6279|P1|NOT COMPLETED|Overall Study||2
2677|NCT02611765|6278|P2|COMPLETED|Overall Study||29
2678|NCT02611765|6279|P1|COMPLETED|Overall Study||27
2679|NCT02611765|6278|P2|STARTED|Overall Study||35
2680|NCT02611765|6279|P1|STARTED|Overall Study||29
2681|NCT02611154|6285|P1|NOT COMPLETED|Overall Study||0
2682|NCT02611154|6285|P1|COMPLETED|Overall Study||5
2683|NCT02611154|6285|P1|STARTED|Overall Study||5
2684|NCT02610634|6306|P2|NOT COMPLETED|Overall Study||0
2685|NCT02610634|6307|P1|NOT COMPLETED|Overall Study||0
2686|NCT02610634|6306|P2|COMPLETED|Overall Study||40
2687|NCT02610634|6307|P1|COMPLETED|Overall Study||60
2688|NCT02610634|6306|P2|STARTED|Overall Study||40
2689|NCT02610634|6307|P1|STARTED|Overall Study||60
2690|NCT02609841|6315|P1|NOT COMPLETED|Overall Study||28
2691|NCT02609841|6315|P1|COMPLETED|Overall Study||212
2692|NCT02609841|6315|P1|STARTED|Overall Study||240
2693|NCT02609672|6323|P2|NOT COMPLETED|Overall Study||1
2694|NCT02609672|6324|P1|NOT COMPLETED|Overall Study||3
2695|NCT02609672|6323|P2|COMPLETED|Overall Study||11
2696|NCT02609672|6324|P1|COMPLETED|Overall Study||9
2697|NCT02609672|6323|P2|STARTED|Overall Study||12
2698|NCT02609672|6324|P1|STARTED|Overall Study||12
2699|NCT02609178|6358|P6|NOT COMPLETED|Third Crown||0
2700|NCT02609178|6359|P5|NOT COMPLETED|Third Crown||0
2701|NCT02609178|6360|P4|NOT COMPLETED|Third Crown||0
2702|NCT02609178|6361|P3|NOT COMPLETED|Third Crown||0
2703|NCT02609178|6362|P2|NOT COMPLETED|Third Crown||0
2704|NCT02609178|6363|P1|NOT COMPLETED|Third Crown||0
2705|NCT02609178|6358|P6|COMPLETED|Third Crown||2
2706|NCT02609178|6359|P5|COMPLETED|Third Crown||0
2707|NCT02609178|6360|P4|COMPLETED|Third Crown||2
2708|NCT02609178|6361|P3|COMPLETED|Third Crown||5
2709|NCT02609178|6362|P2|COMPLETED|Third Crown||1
2710|NCT02609178|6363|P1|COMPLETED|Third Crown||0
2711|NCT02609178|6358|P6|STARTED|Third Crown||2
2712|NCT02609178|6359|P5|STARTED|Third Crown||0
2713|NCT02609178|6360|P4|STARTED|Third Crown||2
2714|NCT02609178|6361|P3|STARTED|Third Crown||5
2715|NCT02609178|6362|P2|STARTED|Third Crown||1
2716|NCT02609178|6363|P1|STARTED|Third Crown||0
2717|NCT02609178|6358|P6|NOT COMPLETED|5-minute Washout Time||0
2718|NCT02609178|6359|P5|NOT COMPLETED|5-minute Washout Time||0
2719|NCT02609178|6360|P4|NOT COMPLETED|5-minute Washout Time||0
2720|NCT02609178|6361|P3|NOT COMPLETED|5-minute Washout Time||0
2721|NCT02609178|6362|P2|NOT COMPLETED|5-minute Washout Time||0
2722|NCT02609178|6363|P1|NOT COMPLETED|5-minute Washout Time||0
2723|NCT02609178|6358|P6|COMPLETED|5-minute Washout Time||2
2724|NCT02609178|6359|P5|COMPLETED|5-minute Washout Time||0
2725|NCT02609178|6360|P4|COMPLETED|5-minute Washout Time||2
2726|NCT02609178|6361|P3|COMPLETED|5-minute Washout Time||5
2727|NCT02609178|6362|P2|COMPLETED|5-minute Washout Time||1
2728|NCT02609178|6363|P1|COMPLETED|5-minute Washout Time||0
2729|NCT02609178|6358|P6|STARTED|5-minute Washout Time||2
2730|NCT02609178|6359|P5|STARTED|5-minute Washout Time||0
2731|NCT02609178|6360|P4|STARTED|5-minute Washout Time||2
2732|NCT02609178|6361|P3|STARTED|5-minute Washout Time||5
2733|NCT02609178|6362|P2|STARTED|5-minute Washout Time||1
2734|NCT02609178|6363|P1|STARTED|5-minute Washout Time||0
2735|NCT02609178|6358|P6|NOT COMPLETED|Second Crown||0
2736|NCT02609178|6359|P5|NOT COMPLETED|Second Crown||0
2737|NCT02609178|6360|P4|NOT COMPLETED|Second Crown||0
2738|NCT02609178|6361|P3|NOT COMPLETED|Second Crown||0
2739|NCT02609178|6362|P2|NOT COMPLETED|Second Crown||0
2740|NCT02609178|6363|P1|NOT COMPLETED|Second Crown||0
2741|NCT02609178|6358|P6|COMPLETED|Second Crown||2
2742|NCT02609178|6359|P5|COMPLETED|Second Crown||0
2743|NCT02609178|6360|P4|COMPLETED|Second Crown||2
2744|NCT02609178|6361|P3|COMPLETED|Second Crown||5
2745|NCT02609178|6362|P2|COMPLETED|Second Crown||1
2746|NCT02609178|6363|P1|COMPLETED|Second Crown||0
2747|NCT02609178|6358|P6|STARTED|Second Crown||2
2748|NCT02609178|6359|P5|STARTED|Second Crown||0
2749|NCT02609178|6360|P4|STARTED|Second Crown||2
2750|NCT02609178|6361|P3|STARTED|Second Crown||5
2751|NCT02609178|6362|P2|STARTED|Second Crown||1
2752|NCT02609178|6363|P1|STARTED|Second Crown||0
2753|NCT02609178|6358|P6|NOT COMPLETED|5-minute Washout Time||0
2754|NCT02609178|6359|P5|NOT COMPLETED|5-minute Washout Time||0
2755|NCT02609178|6360|P4|NOT COMPLETED|5-minute Washout Time||0
2756|NCT02609178|6361|P3|NOT COMPLETED|5-minute Washout Time||0
2757|NCT02609178|6362|P2|NOT COMPLETED|5-minute Washout Time||0
2758|NCT02609178|6363|P1|NOT COMPLETED|5-minute Washout Time||0
2759|NCT02609178|6358|P6|COMPLETED|5-minute Washout Time||2
2760|NCT02609178|6359|P5|COMPLETED|5-minute Washout Time||0
2761|NCT02609178|6360|P4|COMPLETED|5-minute Washout Time||2
2762|NCT02609178|6361|P3|COMPLETED|5-minute Washout Time||5
2763|NCT02609178|6362|P2|COMPLETED|5-minute Washout Time||1
2764|NCT02609178|6363|P1|COMPLETED|5-minute Washout Time||0
2765|NCT02609178|6358|P6|STARTED|5-minute Washout Time||2
2766|NCT02609178|6359|P5|STARTED|5-minute Washout Time||0
2767|NCT02609178|6360|P4|STARTED|5-minute Washout Time||2
2768|NCT02609178|6361|P3|STARTED|5-minute Washout Time||5
2769|NCT02609178|6362|P2|STARTED|5-minute Washout Time||1
2770|NCT02609178|6363|P1|STARTED|5-minute Washout Time||0
2771|NCT02609178|6358|P6|NOT COMPLETED|First Crown||0
2772|NCT02609178|6359|P5|NOT COMPLETED|First Crown||0
2773|NCT02609178|6360|P4|NOT COMPLETED|First Crown||1
2774|NCT02609178|6361|P3|NOT COMPLETED|First Crown||1
2775|NCT02609178|6362|P2|NOT COMPLETED|First Crown||0
2776|NCT02609178|6363|P1|NOT COMPLETED|First Crown||0
2777|NCT02609178|6358|P6|COMPLETED|First Crown||2
2778|NCT02609178|6359|P5|COMPLETED|First Crown||0
2779|NCT02609178|6360|P4|COMPLETED|First Crown||2
2780|NCT02609178|6361|P3|COMPLETED|First Crown||5
2781|NCT02609178|6362|P2|COMPLETED|First Crown||1
2782|NCT02609178|6363|P1|COMPLETED|First Crown||0
2783|NCT02609178|6358|P6|STARTED|First Crown||2
2784|NCT02609178|6359|P5|STARTED|First Crown||0
2785|NCT02609178|6360|P4|STARTED|First Crown||3
2786|NCT02609178|6361|P3|STARTED|First Crown||6
2787|NCT02609178|6362|P2|STARTED|First Crown||1
2788|NCT02609178|6363|P1|STARTED|First Crown||0
2789|NCT02608489|6380|P2|NOT COMPLETED|Overall Study||10
2790|NCT02608489|6381|P1|NOT COMPLETED|Overall Study||13
2791|NCT02608489|6380|P2|COMPLETED|Overall Study||33
2792|NCT02608489|6381|P1|COMPLETED|Overall Study||30
2793|NCT02608489|6380|P2|STARTED|Overall Study||43
2794|NCT02608489|6381|P1|STARTED|Overall Study||43
2795|NCT02606838|6401|P1|NOT COMPLETED|Overall Study||0
2796|NCT02606838|6401|P1|COMPLETED|Overall Study||119
2797|NCT02606838|6401|P1|STARTED|Overall Study||119
2798|NCT02606734|6409|P1|NOT COMPLETED|Overall Study||0
2799|NCT02606734|6409|P1|COMPLETED|Overall Study||44
2800|NCT02606734|6409|P1|STARTED|Overall Study||44
2801|NCT02605928|6413|P1|NOT COMPLETED|Overall Study||33
2802|NCT02605928|6413|P1|COMPLETED|Overall Study||46
2803|NCT02605928|6413|P1|Pivotal Phase, Statistical Phase|Overall Study||51
2804|NCT02605928|6413|P1|STARTED|Overall Study||79
2805|NCT02604589|6420|P3|NOT COMPLETED|Overall Study||1
2806|NCT02604589|6421|P2|NOT COMPLETED|Overall Study||0
2807|NCT02604589|6422|P1|NOT COMPLETED|Overall Study||0
2808|NCT02604589|6420|P3|COMPLETED|Overall Study||1
2809|NCT02604589|6421|P2|COMPLETED|Overall Study||5
2810|NCT02604589|6422|P1|COMPLETED|Overall Study||3
2811|NCT02604589|6420|P3|STARTED|Overall Study||2
2812|NCT02604589|6421|P2|STARTED|Overall Study||5
2813|NCT02604589|6422|P1|STARTED|Overall Study||3
2814|NCT02604550|6450|P2|NOT COMPLETED|Overall Study||26
2815|NCT02604550|6451|P1|NOT COMPLETED|Overall Study||25
2816|NCT02604550|6450|P2|COMPLETED|Overall Study||33
2817|NCT02604550|6451|P1|COMPLETED|Overall Study||31
2818|NCT02604550|6450|P2|STARTED|Overall Study||59
2819|NCT02604550|6451|P1|STARTED|Overall Study||56
2820|NCT02604407|6478|P3|NOT COMPLETED|Overall Study||16
2821|NCT02604407|6479|P2|NOT COMPLETED|Overall Study||12
2822|NCT02604407|6480|P1|NOT COMPLETED|Overall Study||11
2823|NCT02604407|6478|P3|COMPLETED|Overall Study||76
2824|NCT02604407|6479|P2|COMPLETED|Overall Study||80
2825|NCT02604407|6480|P1|COMPLETED|Overall Study||80
2826|NCT02604407|6478|P3|TREATED|Overall Study||90
2827|NCT02604407|6479|P2|TREATED|Overall Study||92
2828|NCT02604407|6480|P1|TREATED|Overall Study||89
2829|NCT02604407|6478|P3|STARTED|Overall Study||92
2830|NCT02604407|6479|P2|STARTED|Overall Study||92
2831|NCT02604407|6480|P1|STARTED|Overall Study||91
2832|NCT02604264|6493|P2|NOT COMPLETED|Overall Study||242
2833|NCT02604264|6494|P1|NOT COMPLETED|Overall Study||200
2834|NCT02604264|6493|P2|COMPLETED|Overall Study||1225
2835|NCT02604264|6494|P1|COMPLETED|Overall Study||1245
2836|NCT02604264|6493|P2|STARTED|Overall Study||1467
2837|NCT02604264|6494|P1|STARTED|Overall Study||1445
2838|NCT02603666|6500|P1|NOT COMPLETED|Overall Study||0
2839|NCT02603666|6500|P1|COMPLETED|Overall Study||130
2840|NCT02603666|6500|P1|STARTED|Overall Study||130
2841|NCT02602223|6504|P1|NOT COMPLETED|Overall Study||0
2842|NCT02602223|6504|P1|COMPLETED|Overall Study||9
2843|NCT02602223|6504|P1|STARTED|Overall Study||9
2844|NCT02598934|6522|P2|NOT COMPLETED|Overall Study||22
2845|NCT02598934|6523|P1|NOT COMPLETED|Overall Study||19
2846|NCT02598934|6522|P2|COMPLETED|Overall Study||132
2847|NCT02598934|6523|P1|COMPLETED|Overall Study||135
2848|NCT02598934|6522|P2|STARTED|Overall Study||154
2849|NCT02598934|6523|P1|STARTED|Overall Study||154
2850|NCT02598622|6535|P2|NOT COMPLETED|Overall Study||0
2851|NCT02598622|6536|P1|NOT COMPLETED|Overall Study||6
2852|NCT02598622|6535|P2|COMPLETED|Overall Study||0
2853|NCT02598622|6536|P1|COMPLETED|Overall Study||2
2854|NCT02598622|6535|P2|STARTED|Overall Study|Study terminated prior to randomization phase. No enrollment in this arm.|0
2855|NCT02598622|6536|P1|STARTED|Overall Study||8
2856|NCT02598128|6542|P4|NOT COMPLETED|Period C: Days 12 to 20||0
2857|NCT02598128|6543|P3|NOT COMPLETED|Period C: Days 12 to 20||0
2858|NCT02598128|6544|P2|NOT COMPLETED|Period C: Days 12 to 20||0
2859|NCT02598128|6545|P1|NOT COMPLETED|Period C: Days 12 to 20||0
2860|NCT02598128|6542|P4|COMPLETED|Period C: Days 12 to 20||33
2861|NCT02598128|6543|P3|COMPLETED|Period C: Days 12 to 20||0
2862|NCT02598128|6544|P2|COMPLETED|Period C: Days 12 to 20||0
2863|NCT02598128|6545|P1|COMPLETED|Period C: Days 12 to 20||0
2864|NCT02598128|6542|P4|STARTED|Period C: Days 12 to 20||33
2865|NCT02598128|6543|P3|STARTED|Period C: Days 12 to 20||0
2866|NCT02598128|6544|P2|STARTED|Period C: Days 12 to 20||0
2867|NCT02598128|6545|P1|STARTED|Period C: Days 12 to 20||0
2868|NCT02598128|6542|P4|NOT COMPLETED|Period B: Days 1 to 11||0
2869|NCT02598128|6543|P3|NOT COMPLETED|Period B: Days 1 to 11||0
2870|NCT02598128|6544|P2|NOT COMPLETED|Period B: Days 1 to 11||0
2871|NCT02598128|6545|P1|NOT COMPLETED|Period B: Days 1 to 11||0
2872|NCT02598128|6542|P4|COMPLETED|Period B: Days 1 to 11||0
2873|NCT02598128|6543|P3|COMPLETED|Period B: Days 1 to 11||16
2874|NCT02598128|6544|P2|COMPLETED|Period B: Days 1 to 11||17
2875|NCT02598128|6545|P1|COMPLETED|Period B: Days 1 to 11||0
2876|NCT02598128|6542|P4|STARTED|Period B: Days 1 to 11||0
2877|NCT02598128|6543|P3|STARTED|Period B: Days 1 to 11||16
2878|NCT02598128|6544|P2|STARTED|Period B: Days 1 to 11||17
2879|NCT02598128|6545|P1|STARTED|Period B: Days 1 to 11||0
2880|NCT02598128|6542|P4|NOT COMPLETED|Period A: Days -7 to -1||0
2881|NCT02598128|6543|P3|NOT COMPLETED|Period A: Days -7 to -1||0
2882|NCT02598128|6544|P2|NOT COMPLETED|Period A: Days -7 to -1||0
2883|NCT02598128|6545|P1|NOT COMPLETED|Period A: Days -7 to -1||1
2884|NCT02598128|6542|P4|COMPLETED|Period A: Days -7 to -1||0
2885|NCT02598128|6543|P3|COMPLETED|Period A: Days -7 to -1||0
2886|NCT02598128|6544|P2|COMPLETED|Period A: Days -7 to -1||0
2887|NCT02598128|6545|P1|COMPLETED|Period A: Days -7 to -1||33
2888|NCT02598128|6542|P4|STARTED|Period A: Days -7 to -1||0
2889|NCT02598128|6543|P3|STARTED|Period A: Days -7 to -1||0
2890|NCT02598128|6544|P2|STARTED|Period A: Days -7 to -1||0
2891|NCT02598128|6545|P1|STARTED|Period A: Days -7 to -1||34
2892|NCT02597907|6559|P2|NOT COMPLETED|Overall Study||0
2893|NCT02597907|6560|P1|NOT COMPLETED|Overall Study||0
2894|NCT02597907|6559|P2|COMPLETED|Overall Study||44
2895|NCT02597907|6560|P1|COMPLETED|Overall Study||44
2896|NCT02597907|6559|P2|STARTED|Overall Study||44
2897|NCT02597907|6560|P1|STARTED|Overall Study||44
2898|NCT02597855|6568|P2|NOT COMPLETED|Overall Study||1
2899|NCT02597855|6569|P1|NOT COMPLETED|Overall Study||2
2900|NCT02597855|6568|P2|COMPLETED|Overall Study||13
2901|NCT02597855|6569|P1|COMPLETED|Overall Study||16
2902|NCT02597855|6568|P2|STARTED|Overall Study||14
2903|NCT02597855|6569|P1|STARTED|Overall Study||18
2904|NCT02597582|6579|P2|NOT COMPLETED|Overall Study||0
2905|NCT02597582|6580|P1|NOT COMPLETED|Overall Study||0
2906|NCT02597582|6579|P2|COMPLETED|Overall Study||20
2907|NCT02597582|6580|P1|COMPLETED|Overall Study||21
2908|NCT02597582|6579|P2|STARTED|Overall Study||20
2909|NCT02597582|6580|P1|STARTED|Overall Study||21
2910|NCT02597543|6598|P2|NOT COMPLETED|Overall Study||0
2911|NCT02597543|6599|P1|NOT COMPLETED|Overall Study||0
2912|NCT02597543|6598|P2|COMPLETED|Overall Study||8
2913|NCT02597543|6599|P1|COMPLETED|Overall Study||6
2914|NCT02597543|6598|P2|STARTED|Overall Study||8
2915|NCT02597543|6599|P1|STARTED|Overall Study||6
2916|NCT02596958|6615|P1|NOT COMPLETED|Overall Study||996
2917|NCT02596958|6615|P1|COMPLETED|Overall Study||0
2918|NCT02596958|6615|P1|STARTED|Overall Study||996
2919|NCT02596945|6627|P1|NOT COMPLETED|Overall Study||56
2920|NCT02596945|6627|P1|COMPLETED|Overall Study||167
2921|NCT02596945|6627|P1|Treated|Overall Study||220
2922|NCT02596945|6627|P1|STARTED|Overall Study||223
2923|NCT02596620|6635|P2|NOT COMPLETED|Overall Study||1
2924|NCT02596620|6636|P1|NOT COMPLETED|Overall Study||1
2925|NCT02596620|6635|P2|COMPLETED|Overall Study|Completed on 30th September 2015|81
2926|NCT02596620|6636|P1|COMPLETED|Overall Study|Completed on 30th September 2015|81
2927|NCT02596620|6635|P2|STARTED|Overall Study|Started from 1st October 2013|82
2928|NCT02596620|6636|P1|STARTED|Overall Study|Started from 1st October 2013|82
2929|NCT02596451|6645|P3|NOT COMPLETED|Overall Study||14
2930|NCT02596451|6646|P2|NOT COMPLETED|Overall Study||18
2931|NCT02596451|6647|P1|NOT COMPLETED|Overall Study||4
2932|NCT02596451|6645|P3|COMPLETED|Overall Study||373
2933|NCT02596451|6646|P2|COMPLETED|Overall Study||374
2934|NCT02596451|6647|P1|COMPLETED|Overall Study||381
2935|NCT02596451|6645|P3|STARTED|Overall Study||387
2936|NCT02596451|6646|P2|STARTED|Overall Study||392
2937|NCT02596451|6647|P1|STARTED|Overall Study||385
2938|NCT02595502|6654|P2|NOT COMPLETED|Period 3||2
2939|NCT02595502|6655|P1|NOT COMPLETED|Period 3||1
2940|NCT02595502|6654|P2|COMPLETED|Period 3||136
2941|NCT02595502|6655|P1|COMPLETED|Period 3||140
2942|NCT02595502|6654|P2|STARTED|Period 3||138
2943|NCT02595502|6655|P1|STARTED|Period 3||141
2944|NCT02595502|6654|P2|NOT COMPLETED|Period 2||2
2945|NCT02595502|6655|P1|NOT COMPLETED|Period 2||1
2946|NCT02595502|6654|P2|COMPLETED|Period 2||138
2947|NCT02595502|6655|P1|COMPLETED|Period 2||141
2948|NCT02595502|6654|P2|STARTED|Period 2||140
2949|NCT02595502|6655|P1|STARTED|Period 2||142
2950|NCT02595502|6654|P2|NOT COMPLETED|Period 1||2
2951|NCT02595502|6655|P1|NOT COMPLETED|Period 1||1
2952|NCT02595502|6654|P2|COMPLETED|Period 1||140
2953|NCT02595502|6655|P1|COMPLETED|Period 1||142
2954|NCT02595502|6654|P2|STARTED|Period 1||142
2955|NCT02595502|6655|P1|STARTED|Period 1||143
2956|NCT02595450|6661|P1|NOT COMPLETED|Overall Study||81
2957|NCT02595450|6661|P1|COMPLETED|Overall Study||218
2958|NCT02595450|6661|P1|Treated|Overall Study||291
2959|NCT02595450|6661|P1|STARTED|Overall Study||299
2960|NCT02594826|6669|P2|NOT COMPLETED|Overall Study||60
2961|NCT02594826|6670|P1|NOT COMPLETED|Overall Study||57
2962|NCT02594826|6669|P2|COMPLETED|Overall Study||298
2963|NCT02594826|6670|P1|COMPLETED|Overall Study||290
2964|NCT02594826|6669|P2|STARTED|Overall Study||358
2965|NCT02594826|6670|P1|STARTED|Overall Study||347
2966|NCT02592655|6678|P1|NOT COMPLETED|Fourth Tourniquet Right Thigh.||0
2967|NCT02592655|6678|P1|COMPLETED|Fourth Tourniquet Right Thigh.||4
2968|NCT02592655|6678|P1|Tourniquet Tape 5 cm Width|Fourth Tourniquet Right Thigh.||0
2969|NCT02592655|6678|P1|Tourniquet Tape 10 cm Width|Fourth Tourniquet Right Thigh.||3
2970|NCT02592655|6678|P1|Windlass Tourniquet|Fourth Tourniquet Right Thigh.||0
2971|NCT02592655|6678|P1|ATS (Pneumatic)|Fourth Tourniquet Right Thigh.||1
2972|NCT02592655|6678|P1|STARTED|Fourth Tourniquet Right Thigh.|Only the first 4 participants received all four interventions.|4
2973|NCT02592655|6678|P1|NOT COMPLETED|Third Tourniquet, Left Thigh.||0
2974|NCT02592655|6678|P1|COMPLETED|Third Tourniquet, Left Thigh.||19
2975|NCT02592655|6678|P1|Tourniquet Tape 5 cm Width|Third Tourniquet, Left Thigh.||1
2976|NCT02592655|6678|P1|Tourniquet Tape 10 cm Width|Third Tourniquet, Left Thigh.||6
2977|NCT02592655|6678|P1|Windlass Tourniquet|Third Tourniquet, Left Thigh.||4
2978|NCT02592655|6678|P1|ATS (Pneumatic)|Third Tourniquet, Left Thigh.||8
2979|NCT02592655|6678|P1|STARTED|Third Tourniquet, Left Thigh.||19
2980|NCT02592655|6678|P1|NOT COMPLETED|Second Tourniquet Right Thigh.||0
2981|NCT02592655|6678|P1|COMPLETED|Second Tourniquet Right Thigh.||19
2982|NCT02592655|6678|P1|Tourniquet Tape 5 cm Width|Second Tourniquet Right Thigh.||1
2983|NCT02592655|6678|P1|Tourniquet Tape 10 cm Width|Second Tourniquet Right Thigh.||5
2984|NCT02592655|6678|P1|Windlass Tourniquet|Second Tourniquet Right Thigh.||8
2985|NCT02592655|6678|P1|ATS (Pneumatic)|Second Tourniquet Right Thigh.||5
2986|NCT02592655|6678|P1|STARTED|Second Tourniquet Right Thigh.||19
2987|NCT02592655|6678|P1|NOT COMPLETED|First Tourniquet, Left Thigh.||0
2988|NCT02592655|6678|P1|COMPLETED|First Tourniquet, Left Thigh.||19
2989|NCT02592655|6678|P1|Tourniquet Tape 5 cm Width|First Tourniquet, Left Thigh.||2
2990|NCT02592655|6678|P1|Tourniquet Tape 10 cm Width|First Tourniquet, Left Thigh.||5
2991|NCT02592655|6678|P1|Windlass Tourniquet|First Tourniquet, Left Thigh.||7
2992|NCT02592655|6678|P1|ATS (Pneumatic)|First Tourniquet, Left Thigh.||5
2993|NCT02592655|6678|P1|STARTED|First Tourniquet, Left Thigh.||19
2994|NCT02591238|6697|P4|NOT COMPLETED|Overall Study||3
2995|NCT02591238|6698|P3|NOT COMPLETED|Overall Study||0
2996|NCT02591238|6699|P2|NOT COMPLETED|Overall Study||1
2997|NCT02591238|6700|P1|NOT COMPLETED|Overall Study||1
2998|NCT02591238|6697|P4|COMPLETED|Overall Study||15
2999|NCT02591238|6698|P3|COMPLETED|Overall Study||17
3000|NCT02591238|6699|P2|COMPLETED|Overall Study||16
3001|NCT02591238|6700|P1|COMPLETED|Overall Study||15
3002|NCT02591238|6697|P4|STARTED|Overall Study||18
3003|NCT02591238|6698|P3|STARTED|Overall Study||17
3004|NCT02591238|6699|P2|STARTED|Overall Study||17
3005|NCT02591238|6700|P1|STARTED|Overall Study||16
3006|NCT02591056|6730|P1|NOT COMPLETED|Overall Study||0
3007|NCT02591056|6730|P1|COMPLETED|Overall Study||27
3008|NCT02591056|6730|P1|STARTED|Overall Study||27
3009|NCT02590588|6734|P1|NOT COMPLETED|Overall Study||1
3010|NCT02590588|6734|P1|COMPLETED|Overall Study||0
3011|NCT02590588|6734|P1|STARTED|Overall Study||1
3012|NCT02590562|6742|P1|NOT COMPLETED|Overall Study||6
3013|NCT02590562|6742|P1|COMPLETED|Overall Study||802
3014|NCT02590562|6742|P1|STARTED|Overall Study||808
3015|NCT02588872|6801|P2|NOT COMPLETED|Overall Study||0
3016|NCT02588872|6802|P1|NOT COMPLETED|Overall Study||0
3017|NCT02588872|6801|P2|COMPLETED|Overall Study||52
3018|NCT02588872|6802|P1|COMPLETED|Overall Study||59
3019|NCT02588872|6801|P2|STARTED|Overall Study||52
3020|NCT02588872|6802|P1|STARTED|Overall Study||59
3021|NCT02588599|6816|P1|NOT COMPLETED|Overall Study||0
3022|NCT02588599|6816|P1|COMPLETED|Overall Study||54
3023|NCT02588599|6816|P1|STARTED|Overall Study||54
3024|NCT02587819|6821|P1|NOT COMPLETED|Overall Study||2
3025|NCT02587819|6821|P1|COMPLETED|Overall Study||19
3026|NCT02587819|6821|P1|Exposed|Overall Study||21
3027|NCT02587819|6821|P1|STARTED|Overall Study||21
3028|NCT02587234|6830|P2|NOT COMPLETED|Overall Study||3
3029|NCT02587234|6831|P1|NOT COMPLETED|Overall Study||1
3030|NCT02587234|6830|P2|COMPLETED|Overall Study||7
3031|NCT02587234|6831|P1|COMPLETED|Overall Study||10
3032|NCT02587234|6830|P2|STARTED|Overall Study||10
3033|NCT02587234|6831|P1|STARTED|Overall Study||11
3034|NCT02587117|6843|P2|NOT COMPLETED|Overall Study||0
3035|NCT02587117|6844|P1|NOT COMPLETED|Overall Study||0
3036|NCT02587117|6843|P2|COMPLETED|Overall Study||15
3037|NCT02587117|6844|P1|COMPLETED|Overall Study||13
3038|NCT02587117|6843|P2|STARTED|Overall Study||15
3039|NCT02587117|6844|P1|STARTED|Overall Study||13
3040|NCT02586506|6852|P1|NOT COMPLETED|Overall Study||9
3041|NCT02586506|6852|P1|COMPLETED|Overall Study||250
3042|NCT02586506|6852|P1|STARTED|Overall Study||259
3043|NCT02586493|6858|P1|NOT COMPLETED|Overall Study||12
3044|NCT02586493|6858|P1|COMPLETED|Overall Study||266
3045|NCT02586493|6858|P1|STARTED|Overall Study||278
3046|NCT02585999|6864|P1|NOT COMPLETED|Overall Study||2
3047|NCT02585999|6864|P1|COMPLETED|Overall Study|28 participants enrolled; 2 withdrew prior to starting, leaving 26 to complete study activity.|26
3048|NCT02585999|6864|P1|STARTED|Overall Study||28
3049|NCT02584686|6871|P2|NOT COMPLETED|Overall Study||0
3050|NCT02584686|6872|P1|NOT COMPLETED|Overall Study||0
3051|NCT02584686|6871|P2|COMPLETED|Overall Study||12
3052|NCT02584686|6872|P1|COMPLETED|Overall Study||12
3053|NCT02584686|6871|P2|STARTED|Overall Study||12
3054|NCT02584686|6872|P1|STARTED|Overall Study||12
3055|NCT02584673|6900|P2|NOT COMPLETED|Overall Study||0
3056|NCT02584673|6901|P1|NOT COMPLETED|Overall Study||0
3057|NCT02584673|6900|P2|COMPLETED|Overall Study||15
3058|NCT02584673|6901|P1|COMPLETED|Overall Study||15
3059|NCT02584673|6900|P2|STARTED|Overall Study||15
3060|NCT02584673|6901|P1|STARTED|Overall Study||15
3061|NCT02582983|6913|P1|NOT COMPLETED|Overall Study||6
3062|NCT02582983|6913|P1|COMPLETED|Overall Study||17
3063|NCT02582983|6913|P1|STARTED|Overall Study||23
3064|NCT02582970|6918|P1|NOT COMPLETED|Overall Study||0
3065|NCT02582970|6918|P1|COMPLETED|Overall Study||40
3066|NCT02582970|6918|P1|STARTED|Overall Study||40
3067|NCT02581475|6930|P2|NOT COMPLETED|Overall Study||15
3068|NCT02581475|6931|P1|NOT COMPLETED|Overall Study||11
3069|NCT02581475|6930|P2|COMPLETED|Overall Study||178
3070|NCT02581475|6931|P1|COMPLETED|Overall Study||182
3071|NCT02581475|6930|P2|STARTED|Overall Study||193
3072|NCT02581475|6931|P1|STARTED|Overall Study||193
3073|NCT02580799|6943|P1|NOT COMPLETED|Overall Study||0
3074|NCT02580799|6943|P1|COMPLETED|Overall Study||30
3075|NCT02580799|6943|P1|STARTED|Overall Study||30
3076|NCT02580357|6968|P3|NOT COMPLETED|Overall Study||0
3077|NCT02580357|6969|P2|NOT COMPLETED|Overall Study||0
3078|NCT02580357|6970|P1|NOT COMPLETED|Overall Study||3
3079|NCT02580357|6968|P3|COMPLETED|Overall Study||18
3080|NCT02580357|6969|P2|COMPLETED|Overall Study||18
3081|NCT02580357|6970|P1|COMPLETED|Overall Study||15
3082|NCT02580357|6968|P3|STARTED|Overall Study||18
3083|NCT02580357|6969|P2|STARTED|Overall Study||18
3084|NCT02580357|6970|P1|STARTED|Overall Study||18
3085|NCT02580240|6983|P2|NOT COMPLETED|Overall Study||0
3086|NCT02580240|6984|P1|NOT COMPLETED|Overall Study||2
3087|NCT02580240|6983|P2|COMPLETED|Overall Study||58
3088|NCT02580240|6984|P1|COMPLETED|Overall Study||60
3089|NCT02580240|6983|P2|STARTED|Overall Study||58
3090|NCT02580240|6984|P1|STARTED|Overall Study||62
3091|NCT02578992|6994|P2|NOT COMPLETED|Overall Study||3
3092|NCT02578992|6995|P1|NOT COMPLETED|Overall Study||3
3093|NCT02578992|6994|P2|COMPLETED|Overall Study|October 2015|62
3094|NCT02578992|6995|P1|COMPLETED|Overall Study|October 2015|62
3095|NCT02578992|6994|P2|STARTED|Overall Study|November 2014|65
3096|NCT02578992|6995|P1|STARTED|Overall Study|November 2014|65
3097|NCT02578316|7007|P1|NOT COMPLETED|Extension Phase||6
3098|NCT02578316|7007|P1|COMPLETED|Extension Phase||0
3099|NCT02578316|7007|P1|STARTED|Extension Phase||6
3100|NCT02578316|7007|P1|NOT COMPLETED|Study Phase||0
3101|NCT02578316|7007|P1|COMPLETED|Study Phase||6
3102|NCT02578316|7007|P1|STARTED|Study Phase||6
3103|NCT02578199|7031|P1|NOT COMPLETED|Overall Study||4
3104|NCT02578199|7031|P1|COMPLETED|Overall Study||27
3105|NCT02578199|7031|P1|STARTED|Overall Study||31
3106|NCT02578186|7036|P2|NOT COMPLETED|Period 2 (Second of Crossover)||0
3107|NCT02578186|7037|P1|NOT COMPLETED|Period 2 (Second of Crossover)||0
3108|NCT02578186|7036|P2|COMPLETED|Period 2 (Second of Crossover)||13
3109|NCT02578186|7037|P1|COMPLETED|Period 2 (Second of Crossover)||12
3110|NCT02578186|7036|P2|STARTED|Period 2 (Second of Crossover)||13
3111|NCT02578186|7037|P1|STARTED|Period 2 (Second of Crossover)||12
3112|NCT02578186|7036|P2|NOT COMPLETED|Period 1 (First of Crossover)||5
3113|NCT02578186|7037|P1|NOT COMPLETED|Period 1 (First of Crossover)||5
3114|NCT02578186|7036|P2|COMPLETED|Period 1 (First of Crossover)||13
3115|NCT02578186|7037|P1|COMPLETED|Period 1 (First of Crossover)||12
3116|NCT02578186|7036|P2|STARTED|Period 1 (First of Crossover)||18
3117|NCT02578186|7037|P1|STARTED|Period 1 (First of Crossover)||17
3118|NCT02577445|7045|P2|NOT COMPLETED|Overall Study||17
3119|NCT02577445|7046|P1|NOT COMPLETED|Overall Study||14
3120|NCT02577445|7045|P2|COMPLETED|Overall Study|study terminated prematurely|0
3121|NCT02577445|7046|P1|COMPLETED|Overall Study|study terminated prematurely|0
3122|NCT02577445|7045|P2|STARTED|Overall Study||17
3123|NCT02577445|7046|P1|STARTED|Overall Study||14
3124|NCT02577315|7059|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3125|NCT02577315|7060|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
3126|NCT02577315|7059|P2|COMPLETED|Treatment Period 2 (4 Days)||12
3127|NCT02577315|7060|P1|COMPLETED|Treatment Period 2 (4 Days)||12
3128|NCT02577315|7059|P2|STARTED|Treatment Period 2 (4 Days)||12
3129|NCT02577315|7060|P1|STARTED|Treatment Period 2 (4 Days)||12
3130|NCT02577315|7059|P2|NOT COMPLETED|Washout Period (5 Days)||0
3131|NCT02577315|7060|P1|NOT COMPLETED|Washout Period (5 Days)||0
3132|NCT02577315|7059|P2|COMPLETED|Washout Period (5 Days)||12
3133|NCT02577315|7060|P1|COMPLETED|Washout Period (5 Days)||12
3134|NCT02577315|7059|P2|STARTED|Washout Period (5 Days)||12
3135|NCT02577315|7060|P1|STARTED|Washout Period (5 Days)||12
3136|NCT02577315|7059|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||1
3137|NCT02577315|7060|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
3138|NCT02577315|7059|P2|COMPLETED|Treatment Period 1 (4 Days)||12
3139|NCT02577315|7060|P1|COMPLETED|Treatment Period 1 (4 Days)||12
3140|NCT02577315|7059|P2|STARTED|Treatment Period 1 (4 Days)||13
3141|NCT02577315|7060|P1|STARTED|Treatment Period 1 (4 Days)||12
3142|NCT02576639|7081|P5|NOT COMPLETED|Overall Study||4
3143|NCT02576639|7082|P4|NOT COMPLETED|Overall Study||1
3144|NCT02576639|7083|P3|NOT COMPLETED|Overall Study||2
3145|NCT02576639|7084|P2|NOT COMPLETED|Overall Study||2
3146|NCT02576639|7085|P1|NOT COMPLETED|Overall Study||2
3147|NCT02576639|7081|P5|COMPLETED|Overall Study||20
3148|NCT02576639|7082|P4|COMPLETED|Overall Study||25
3149|NCT02576639|7083|P3|COMPLETED|Overall Study||23
3150|NCT02576639|7084|P2|COMPLETED|Overall Study||23
3151|NCT02576639|7085|P1|COMPLETED|Overall Study||22
3152|NCT02576639|7081|P5|Safety Analysis Set|Overall Study||24
3153|NCT02576639|7082|P4|Safety Analysis Set|Overall Study||26
3154|NCT02576639|7083|P3|Safety Analysis Set|Overall Study||25
3155|NCT02576639|7084|P2|Safety Analysis Set|Overall Study||25
3156|NCT02576639|7085|P1|Safety Analysis Set|Overall Study||24
3157|NCT02576639|7081|P5|Pharmacokinetic Analysis Set|Overall Study||24
3158|NCT02576639|7082|P4|Pharmacokinetic Analysis Set|Overall Study||26
3159|NCT02576639|7083|P3|Pharmacokinetic Analysis Set|Overall Study||25
3160|NCT02576639|7084|P2|Pharmacokinetic Analysis Set|Overall Study||25
3161|NCT02576639|7085|P1|Pharmacokinetic Analysis Set|Overall Study||0
3162|NCT02576639|7081|P5|Pharmacodynamic Analysis Set|Overall Study||25
3163|NCT02576639|7082|P4|Pharmacodynamic Analysis Set|Overall Study||25
3164|NCT02576639|7083|P3|Pharmacodynamic Analysis Set|Overall Study||25
3165|NCT02576639|7084|P2|Pharmacodynamic Analysis Set|Overall Study||24
3166|NCT02576639|7085|P1|Pharmacodynamic Analysis Set|Overall Study||24
3167|NCT02576639|7081|P5|STARTED|Overall Study||24
3168|NCT02576639|7082|P4|STARTED|Overall Study||26
3169|NCT02576639|7083|P3|STARTED|Overall Study||25
3170|NCT02576639|7084|P2|STARTED|Overall Study||25
3171|NCT02576639|7085|P1|STARTED|Overall Study||24
3172|NCT02576535|7142|P1|NOT COMPLETED|Overall Study||2
3173|NCT02576535|7142|P1|COMPLETED|Overall Study||16
3174|NCT02576535|7142|P1|STARTED|Overall Study||18
3175|NCT02576249|7153|P2|NOT COMPLETED|Overall Study||0
3176|NCT02576249|7154|P1|NOT COMPLETED|Overall Study||0
3177|NCT02576249|7153|P2|COMPLETED|Overall Study||14
3178|NCT02576249|7154|P1|COMPLETED|Overall Study||15
3179|NCT02576249|7153|P2|STARTED|Overall Study||14
3180|NCT02576249|7154|P1|STARTED|Overall Study||15
3181|NCT02576145|7166|P2|NOT COMPLETED|Overall Study||1
3182|NCT02576145|7167|P1|NOT COMPLETED|Overall Study||3
3183|NCT02576145|7166|P2|COMPLETED|Overall Study||4
3184|NCT02576145|7167|P1|COMPLETED|Overall Study||3
3185|NCT02576145|7166|P2|STARTED|Overall Study||5
3186|NCT02576145|7167|P1|STARTED|Overall Study||6
3187|NCT02576041|7203|P1|NOT COMPLETED|Bilastine (Active Treatement)||0
3188|NCT02576041|7203|P1|COMPLETED|Bilastine (Active Treatement)||18
3189|NCT02576041|7203|P1|STARTED|Bilastine (Active Treatement)||18
3190|NCT02576041|7203|P1|NOT COMPLETED|Placebo (run-in)||0
3191|NCT02576041|7203|P1|COMPLETED|Placebo (run-in)||18
3192|NCT02576041|7203|P1|STARTED|Placebo (run-in)||18
3193|NCT02575911|7209|P1|NOT COMPLETED|Overall Study||1
3194|NCT02575911|7209|P1|COMPLETED|Overall Study||29
3195|NCT02575911|7209|P1|STARTED|Overall Study||30
3196|NCT02574845|7233|P6|NOT COMPLETED|Overall Study||1
3197|NCT02574845|7234|P5|NOT COMPLETED|Overall Study||1
3198|NCT02574845|7235|P4|NOT COMPLETED|Overall Study||0
3199|NCT02574845|7236|P3|NOT COMPLETED|Overall Study||0
3200|NCT02574845|7237|P2|NOT COMPLETED|Overall Study||1
3201|NCT02574845|7238|P1|NOT COMPLETED|Overall Study||0
3202|NCT02574845|7233|P6|COMPLETED|Overall Study||2
3203|NCT02574845|7234|P5|COMPLETED|Overall Study||2
3204|NCT02574845|7235|P4|COMPLETED|Overall Study||3
3205|NCT02574845|7236|P3|COMPLETED|Overall Study||3
3206|NCT02574845|7237|P2|COMPLETED|Overall Study||2
3207|NCT02574845|7238|P1|COMPLETED|Overall Study||3
3208|NCT02574845|7233|P6|Received R|Overall Study||3
3209|NCT02574845|7234|P5|Received R|Overall Study||2
3210|NCT02574845|7235|P4|Received R|Overall Study||3
3211|NCT02574845|7236|P3|Received R|Overall Study||3
3212|NCT02574845|7237|P2|Received R|Overall Study||2
3213|NCT02574845|7238|P1|Received R|Overall Study||3
3214|NCT02574845|7233|P6|Received T5|Overall Study||2
3215|NCT02574845|7234|P5|Received T5|Overall Study||3
3216|NCT02574845|7235|P4|Received T5|Overall Study||3
3217|NCT02574845|7236|P3|Received T5|Overall Study||3
3218|NCT02574845|7237|P2|Received T5|Overall Study||2
3219|NCT02574845|7238|P1|Received T5|Overall Study||3
3220|NCT02574845|7233|P6|Received T4|Overall Study||2
3221|NCT02574845|7234|P5|Received T4|Overall Study||2
3222|NCT02574845|7235|P4|Received T4|Overall Study||3
3223|NCT02574845|7236|P3|Received T4|Overall Study||3
3224|NCT02574845|7237|P2|Received T4|Overall Study||2
3225|NCT02574845|7238|P1|Received T4|Overall Study||3
3226|NCT02574845|7233|P6|Received T3|Overall Study||3
3227|NCT02574845|7234|P5|Received T3|Overall Study||2
3228|NCT02574845|7235|P4|Received T3|Overall Study||3
3229|NCT02574845|7236|P3|Received T3|Overall Study||3
3230|NCT02574845|7237|P2|Received T3|Overall Study||2
3231|NCT02574845|7238|P1|Received T3|Overall Study|one subject missed treatment period 2|2
3232|NCT02574845|7233|P6|Received T2|Overall Study||3
3233|NCT02574845|7234|P5|Received T2|Overall Study||2
3234|NCT02574845|7235|P4|Received T2|Overall Study||3
3235|NCT02574845|7236|P3|Received T2|Overall Study||3
3236|NCT02574845|7237|P2|Received T2|Overall Study||3
3237|NCT02574845|7238|P1|Received T2|Overall Study||3
3238|NCT02574845|7233|P6|Received T1|Overall Study|one subject missed treatment period 2|2
3239|NCT02574845|7234|P5|Received T1|Overall Study||2
3240|NCT02574845|7235|P4|Received T1|Overall Study||3
3241|NCT02574845|7236|P3|Received T1|Overall Study||3
3242|NCT02574845|7237|P2|Received T1|Overall Study||2
3243|NCT02574845|7238|P1|Received T1|Overall Study||3
3244|NCT02574845|7233|P6|STARTED|Overall Study||3
3245|NCT02574845|7234|P5|STARTED|Overall Study||3
3246|NCT02574845|7235|P4|STARTED|Overall Study||3
3247|NCT02574845|7236|P3|STARTED|Overall Study||3
3248|NCT02574845|7237|P2|STARTED|Overall Study||3
3249|NCT02574845|7238|P1|STARTED|Overall Study||3
3250|NCT02574260|7264|P1|NOT COMPLETED|Overall Study||1
3251|NCT02574260|7264|P1|COMPLETED|Overall Study||2
3252|NCT02574260|7264|P1|STARTED|Overall Study||3
3253|NCT02573870|7272|P2|NOT COMPLETED|Overall Study||7
3254|NCT02573870|7273|P1|NOT COMPLETED|Overall Study||0
3255|NCT02573870|7272|P2|COMPLETED|Overall Study||35
3256|NCT02573870|7273|P1|COMPLETED|Overall Study||20
3257|NCT02573870|7272|P2|STARTED|Overall Study||42
3258|NCT02573870|7273|P1|STARTED|Overall Study||20
3259|NCT02572752|7282|P3|NOT COMPLETED|Period 3 Including Washout||0
3260|NCT02572752|7283|P2|NOT COMPLETED|Period 3 Including Washout||0
3261|NCT02572752|7284|P1|NOT COMPLETED|Period 3 Including Washout||0
3262|NCT02572752|7282|P3|COMPLETED|Period 3 Including Washout||24
3263|NCT02572752|7283|P2|COMPLETED|Period 3 Including Washout||23
3264|NCT02572752|7284|P1|COMPLETED|Period 3 Including Washout||23
3265|NCT02572752|7282|P3|STARTED|Period 3 Including Washout||24
3266|NCT02572752|7283|P2|STARTED|Period 3 Including Washout||23
3267|NCT02572752|7284|P1|STARTED|Period 3 Including Washout||23
3268|NCT02572752|7282|P3|NOT COMPLETED|Period 2 Including Washout||0
3269|NCT02572752|7283|P2|NOT COMPLETED|Period 2 Including Washout||0
3270|NCT02572752|7284|P1|NOT COMPLETED|Period 2 Including Washout||0
3271|NCT02572752|7282|P3|COMPLETED|Period 2 Including Washout||24
3272|NCT02572752|7283|P2|COMPLETED|Period 2 Including Washout||23
3273|NCT02572752|7284|P1|COMPLETED|Period 2 Including Washout||23
3274|NCT02572752|7282|P3|STARTED|Period 2 Including Washout||24
3275|NCT02572752|7283|P2|STARTED|Period 2 Including Washout||23
3276|NCT02572752|7284|P1|STARTED|Period 2 Including Washout||23
3277|NCT02572752|7282|P3|NOT COMPLETED|Period 1 Including Washout||0
3278|NCT02572752|7283|P2|NOT COMPLETED|Period 1 Including Washout||0
3279|NCT02572752|7284|P1|NOT COMPLETED|Period 1 Including Washout||0
3280|NCT02572752|7282|P3|COMPLETED|Period 1 Including Washout||24
3281|NCT02572752|7283|P2|COMPLETED|Period 1 Including Washout||23
3282|NCT02572752|7284|P1|COMPLETED|Period 1 Including Washout||23
3283|NCT02572752|7282|P3|STARTED|Period 1 Including Washout||24
3284|NCT02572752|7283|P2|STARTED|Period 1 Including Washout||23
3285|NCT02572752|7284|P1|STARTED|Period 1 Including Washout||23
3286|NCT02572609|7299|P2|NOT COMPLETED|Period 2: Treatment Period 2||0
3287|NCT02572609|7300|P1|NOT COMPLETED|Period 2: Treatment Period 2||0
3288|NCT02572609|7299|P2|COMPLETED|Period 2: Treatment Period 2||18
3289|NCT02572609|7300|P1|COMPLETED|Period 2: Treatment Period 2||18
3290|NCT02572609|7299|P2|STARTED|Period 2: Treatment Period 2||18
3291|NCT02572609|7300|P1|STARTED|Period 2: Treatment Period 2||18
3292|NCT02572609|7299|P2|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
3293|NCT02572609|7300|P1|NOT COMPLETED|Period 1: Treatment Period 1 + Washout||0
3294|NCT02572609|7299|P2|COMPLETED|Period 1: Treatment Period 1 + Washout||18
3295|NCT02572609|7300|P1|COMPLETED|Period 1: Treatment Period 1 + Washout||18
3296|NCT02572609|7299|P2|STARTED|Period 1: Treatment Period 1 + Washout||18
3297|NCT02572609|7300|P1|STARTED|Period 1: Treatment Period 1 + Washout||18
3298|NCT02572427|7310|P2|NOT COMPLETED|Overall Study||9
3299|NCT02572427|7311|P1|NOT COMPLETED|Overall Study||6
3300|NCT02572427|7310|P2|COMPLETED|Overall Study||36
3301|NCT02572427|7311|P1|COMPLETED|Overall Study||31
3302|NCT02572427|7310|P2|STARTED|Overall Study||45
3303|NCT02572427|7311|P1|STARTED|Overall Study||37
3304|NCT02571634|7319|P1|NOT COMPLETED|Overall Study||0
3305|NCT02571634|7319|P1|COMPLETED|Overall Study|The final subject was enrolled on this date.|23
3306|NCT02571634|7319|P1|STARTED|Overall Study|First subject wasn't enrolled until July related to receipt of medications from sponsor.|23
3307|NCT02571153|7330|P3|NOT COMPLETED|Overall Study||2
3308|NCT02571153|7331|P2|NOT COMPLETED|Overall Study||8
3309|NCT02571153|7332|P1|NOT COMPLETED|Overall Study||6
3310|NCT02571153|7330|P3|COMPLETED|Overall Study||43
3311|NCT02571153|7331|P2|COMPLETED|Overall Study||37
3312|NCT02571153|7332|P1|COMPLETED|Overall Study||39
3313|NCT02571153|7330|P3|STARTED|Overall Study||45
3314|NCT02571153|7331|P2|STARTED|Overall Study||45
3315|NCT02571153|7332|P1|STARTED|Overall Study||45
3316|NCT02570425|7360|P2|NOT COMPLETED|Visit 3||0
3317|NCT02570425|7361|P1|NOT COMPLETED|Visit 3||0
3318|NCT02570425|7360|P2|COMPLETED|Visit 3||231
3319|NCT02570425|7361|P1|COMPLETED|Visit 3||229
3320|NCT02570425|7360|P2|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|231
3321|NCT02570425|7361|P1|STARTED|Visit 3|In total 38 patients who completed Visit 2, did not attend Visit 3.|229
3322|NCT02570425|7360|P2|NOT COMPLETED|Visit 2||0
3323|NCT02570425|7361|P1|NOT COMPLETED|Visit 2||0
3324|NCT02570425|7360|P2|COMPLETED|Visit 2||247
3325|NCT02570425|7361|P1|COMPLETED|Visit 2||251
3326|NCT02570425|7360|P2|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|247
3327|NCT02570425|7361|P1|STARTED|Visit 2|In total 18 patients who completed Visit 1, did not attend Visit 2.|251
3328|NCT02570425|7360|P2|NOT COMPLETED|Visit 1||0
3329|NCT02570425|7361|P1|NOT COMPLETED|Visit 1||0
3330|NCT02570425|7360|P2|COMPLETED|Visit 1||242
3331|NCT02570425|7361|P1|COMPLETED|Visit 1||274
3332|NCT02570425|7360|P2|STARTED|Visit 1||242
3333|NCT02570425|7361|P1|STARTED|Visit 1||274
3334|NCT02570295|7410|P2|NOT COMPLETED|Overall Study||58
3335|NCT02570295|7411|P1|NOT COMPLETED|Overall Study||11
3336|NCT02570295|7410|P2|COMPLETED|Overall Study||289
3337|NCT02570295|7411|P1|COMPLETED|Overall Study||364
3338|NCT02570295|7410|P2|STARTED|Overall Study||347
3339|NCT02570295|7411|P1|STARTED|Overall Study||375
3340|NCT02570165|7440|P7|NOT COMPLETED|Overall Study||0
3341|NCT02570165|7441|P6|NOT COMPLETED|Overall Study||2
3342|NCT02570165|7442|P5|NOT COMPLETED|Overall Study||6
3343|NCT02570165|7443|P4|NOT COMPLETED|Overall Study||5
3344|NCT02570165|7444|P3|NOT COMPLETED|Overall Study||5
3345|NCT02570165|7445|P2|NOT COMPLETED|Overall Study||3
3346|NCT02570165|7446|P1|NOT COMPLETED|Overall Study||2
3347|NCT02570165|7440|P7|COMPLETED|Overall Study||47
3348|NCT02570165|7441|P6|COMPLETED|Overall Study||44
3349|NCT02570165|7442|P5|COMPLETED|Overall Study||41
3350|NCT02570165|7443|P4|COMPLETED|Overall Study||40
3351|NCT02570165|7444|P3|COMPLETED|Overall Study||41
3352|NCT02570165|7445|P2|COMPLETED|Overall Study||43
3353|NCT02570165|7446|P1|COMPLETED|Overall Study||44
3354|NCT02570165|7440|P7|STARTED|Overall Study||47
3355|NCT02570165|7441|P6|STARTED|Overall Study||46
3356|NCT02570165|7442|P5|STARTED|Overall Study||47
3357|NCT02570165|7443|P4|STARTED|Overall Study||45
3358|NCT02570165|7444|P3|STARTED|Overall Study||46
3359|NCT02570165|7445|P2|STARTED|Overall Study||46
3360|NCT02570165|7446|P1|STARTED|Overall Study||46
3361|NCT02570022|7471|P2|NOT COMPLETED|Overall Study||0
3362|NCT02570022|7472|P1|NOT COMPLETED|Overall Study||0
3363|NCT02570022|7471|P2|COMPLETED|Overall Study||31
3364|NCT02570022|7472|P1|COMPLETED|Overall Study||26
3365|NCT02570022|7471|P2|STARTED|Overall Study||31
3366|NCT02570022|7472|P1|STARTED|Overall Study||26
3367|NCT02569996|7480|P1|NOT COMPLETED|Overall Study||55
3368|NCT02569996|7480|P1|COMPLETED|Overall Study||69
3369|NCT02569996|7480|P1|STARTED|Overall Study||124
3370|NCT02569658|7492|P2|NOT COMPLETED|Overall Study||1
3371|NCT02569658|7493|P1|NOT COMPLETED|Overall Study||1
3372|NCT02569658|7492|P2|COMPLETED|Overall Study||56
3373|NCT02569658|7493|P1|COMPLETED|Overall Study||52
3374|NCT02569658|7492|P2|STARTED|Overall Study||57
3375|NCT02569658|7493|P1|STARTED|Overall Study||53
3376|NCT02568852|7511|P2|NOT COMPLETED|Overall Study||0
3377|NCT02568852|7512|P1|NOT COMPLETED|Overall Study||0
3378|NCT02568852|7511|P2|COMPLETED|Overall Study||25
3379|NCT02568852|7512|P1|COMPLETED|Overall Study||25
3380|NCT02568852|7511|P2|STARTED|Overall Study||25
3381|NCT02568852|7512|P1|STARTED|Overall Study||25
3382|NCT02568384|7548|P1|NOT COMPLETED|Overall Study||2
3383|NCT02568384|7548|P1|COMPLETED|Overall Study||43
3384|NCT02568384|7548|P1|STARTED|Overall Study||45
3385|NCT02568345|7558|P1|NOT COMPLETED|Overall Study||0
3386|NCT02568345|7558|P1|COMPLETED|Overall Study||31
3387|NCT02568345|7558|P1|Treated at 2.6 mg/kg|Overall Study|Patients: 8th-10th|3
3388|NCT02568345|7558|P1|Treated at 2.4 mg/kg|Overall Study|Patients: 1st-5th; 7th; 11th-15th; 21st-25th; 27th-31st|25
3389|NCT02568345|7558|P1|Treated at 2.2 mg/kg|Overall Study|patients: 6th, 20th, 26th|3
3390|NCT02568345|7558|P1|STARTED|Overall Study||31
3391|NCT02568254|7562|P6|NOT COMPLETED|Period 3||0
3392|NCT02568254|7563|P5|NOT COMPLETED|Period 3||1
3393|NCT02568254|7564|P4|NOT COMPLETED|Period 3||0
3394|NCT02568254|7565|P3|NOT COMPLETED|Period 3||0
3395|NCT02568254|7566|P2|NOT COMPLETED|Period 3||0
3396|NCT02568254|7567|P1|NOT COMPLETED|Period 3||0
3397|NCT02568254|7562|P6|COMPLETED|Period 3||12
3398|NCT02568254|7563|P5|COMPLETED|Period 3||11
3399|NCT02568254|7564|P4|COMPLETED|Period 3||12
3400|NCT02568254|7565|P3|COMPLETED|Period 3||12
3401|NCT02568254|7566|P2|COMPLETED|Period 3||12
3402|NCT02568254|7567|P1|COMPLETED|Period 3||13
3403|NCT02568254|7562|P6|STARTED|Period 3||12
3404|NCT02568254|7563|P5|STARTED|Period 3||12
3405|NCT02568254|7564|P4|STARTED|Period 3||12
3406|NCT02568254|7565|P3|STARTED|Period 3||12
3407|NCT02568254|7566|P2|STARTED|Period 3||12
3408|NCT02568254|7567|P1|STARTED|Period 3||13
3409|NCT02568254|7562|P6|NOT COMPLETED|Period 2||0
3410|NCT02568254|7563|P5|NOT COMPLETED|Period 2||0
3411|NCT02568254|7564|P4|NOT COMPLETED|Period 2||0
3412|NCT02568254|7565|P3|NOT COMPLETED|Period 2||1
3413|NCT02568254|7566|P2|NOT COMPLETED|Period 2||0
3414|NCT02568254|7567|P1|NOT COMPLETED|Period 2||0
3415|NCT02568254|7562|P6|COMPLETED|Period 2||12
3416|NCT02568254|7563|P5|COMPLETED|Period 2||12
3417|NCT02568254|7564|P4|COMPLETED|Period 2||12
3418|NCT02568254|7565|P3|COMPLETED|Period 2||12
3419|NCT02568254|7566|P2|COMPLETED|Period 2||12
3420|NCT02568254|7567|P1|COMPLETED|Period 2||13
3421|NCT02568254|7562|P6|STARTED|Period 2||12
3422|NCT02568254|7563|P5|STARTED|Period 2||12
3423|NCT02568254|7564|P4|STARTED|Period 2||12
3424|NCT02568254|7565|P3|STARTED|Period 2||13
3425|NCT02568254|7566|P2|STARTED|Period 2||12
3426|NCT02568254|7567|P1|STARTED|Period 2||13
3427|NCT02568254|7562|P6|NOT COMPLETED|Period 1||0
3428|NCT02568254|7563|P5|NOT COMPLETED|Period 1||0
3429|NCT02568254|7564|P4|NOT COMPLETED|Period 1||0
3430|NCT02568254|7565|P3|NOT COMPLETED|Period 1||0
3431|NCT02568254|7566|P2|NOT COMPLETED|Period 1||0
3432|NCT02568254|7567|P1|NOT COMPLETED|Period 1||0
3433|NCT02568254|7562|P6|COMPLETED|Period 1||12
3434|NCT02568254|7563|P5|COMPLETED|Period 1||12
3435|NCT02568254|7564|P4|COMPLETED|Period 1||12
3436|NCT02568254|7565|P3|COMPLETED|Period 1||13
3437|NCT02568254|7566|P2|COMPLETED|Period 1||12
3438|NCT02568254|7567|P1|COMPLETED|Period 1||13
3439|NCT02568254|7562|P6|STARTED|Period 1||12
3440|NCT02568254|7563|P5|STARTED|Period 1||12
3441|NCT02568254|7564|P4|STARTED|Period 1||12
3442|NCT02568254|7565|P3|STARTED|Period 1||13
3443|NCT02568254|7566|P2|STARTED|Period 1||12
3444|NCT02568254|7567|P1|STARTED|Period 1||13
3445|NCT02567188|7575|P1|NOT COMPLETED|Overall Study||35
3446|NCT02567188|7575|P1|COMPLETED|Overall Study||109
3447|NCT02567188|7575|P1|STARTED|Overall Study||144
3448|NCT02565628|7606|P2|NOT COMPLETED|Overall Study||0
3449|NCT02565628|7607|P1|NOT COMPLETED|Overall Study||0
3450|NCT02565628|7606|P2|COMPLETED|Overall Study||9
3451|NCT02565628|7607|P1|COMPLETED|Overall Study||10
3452|NCT02565628|7606|P2|Received Treatment|Overall Study||9
3453|NCT02565628|7607|P1|Received Treatment|Overall Study||10
3454|NCT02565628|7606|P2|STARTED|Overall Study||9
3455|NCT02565628|7607|P1|STARTED|Overall Study||10
3456|NCT02565381|7638|P3|NOT COMPLETED|Overall Study||1
3457|NCT02565381|7639|P2|NOT COMPLETED|Overall Study||0
3458|NCT02565381|7640|P1|NOT COMPLETED|Overall Study||1
3459|NCT02565381|7638|P3|COMPLETED|Overall Study||24
3460|NCT02565381|7639|P2|COMPLETED|Overall Study||25
3461|NCT02565381|7640|P1|COMPLETED|Overall Study||24
3462|NCT02565381|7638|P3|STARTED|Overall Study||25
3463|NCT02565381|7639|P2|STARTED|Overall Study||25
3464|NCT02565381|7640|P1|STARTED|Overall Study||25
3465|NCT02563834|7680|P2|NOT COMPLETED|Insulin Infusion (*Day 2)||0
3466|NCT02563834|7681|P1|NOT COMPLETED|Insulin Infusion (*Day 2)||0
3467|NCT02563834|7680|P2|COMPLETED|Insulin Infusion (*Day 2)||8
3468|NCT02563834|7681|P1|COMPLETED|Insulin Infusion (*Day 2)||10
3469|NCT02563834|7680|P2|STARTED|Insulin Infusion (*Day 2)||8
3470|NCT02563834|7681|P1|STARTED|Insulin Infusion (*Day 2)||10
3471|NCT02563834|7680|P2|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
3472|NCT02563834|7681|P1|NOT COMPLETED|Control (Saline) Infusion (*Day 1)||0
3473|NCT02563834|7680|P2|COMPLETED|Control (Saline) Infusion (*Day 1)||8
3474|NCT02563834|7681|P1|COMPLETED|Control (Saline) Infusion (*Day 1)||10
3475|NCT02563834|7680|P2|STARTED|Control (Saline) Infusion (*Day 1)||8
3476|NCT02563834|7681|P1|STARTED|Control (Saline) Infusion (*Day 1)||10
3477|NCT02563093|7701|P4|NOT COMPLETED|Overall Study||0
3478|NCT02563093|7702|P3|NOT COMPLETED|Overall Study||0
3479|NCT02563093|7703|P2|NOT COMPLETED|Overall Study||0
3480|NCT02563093|7704|P1|NOT COMPLETED|Overall Study||0
3481|NCT02563093|7701|P4|COMPLETED|Overall Study||51
3482|NCT02563093|7702|P3|COMPLETED|Overall Study||53
3483|NCT02563093|7703|P2|COMPLETED|Overall Study||52
3484|NCT02563093|7704|P1|COMPLETED|Overall Study||52
3485|NCT02563093|7701|P4|STARTED|Overall Study||51
3486|NCT02563093|7702|P3|STARTED|Overall Study||53
3487|NCT02563093|7703|P2|STARTED|Overall Study||52
3488|NCT02563093|7704|P1|STARTED|Overall Study||52
3489|NCT02561572|7732|P2|NOT COMPLETED|Overall Study||2
3490|NCT02561572|7733|P1|NOT COMPLETED|Overall Study||2
3491|NCT02561572|7732|P2|COMPLETED|Overall Study||62
3492|NCT02561572|7733|P1|COMPLETED|Overall Study||62
3493|NCT02561572|7732|P2|STARTED|Overall Study||64
3494|NCT02561572|7733|P1|STARTED|Overall Study||64
3495|NCT02559622|7753|P4|NOT COMPLETED|Overall Study||3
3496|NCT02559622|7754|P3|NOT COMPLETED|Overall Study||2
3497|NCT02559622|7755|P2|NOT COMPLETED|Overall Study||5
3498|NCT02559622|7756|P1|NOT COMPLETED|Overall Study||1
3499|NCT02559622|7753|P4|COMPLETED|Overall Study||20
3500|NCT02559622|7754|P3|COMPLETED|Overall Study||24
3501|NCT02559622|7755|P2|COMPLETED|Overall Study||49
3502|NCT02559622|7756|P1|COMPLETED|Overall Study||47
3503|NCT02559622|7753|P4|STARTED|Overall Study||23
3504|NCT02559622|7754|P3|STARTED|Overall Study||26
3505|NCT02559622|7755|P2|STARTED|Overall Study||54
3506|NCT02559622|7756|P1|STARTED|Overall Study||48
3507|NCT02557698|7837|P2|NOT COMPLETED|Overall Study||0
3508|NCT02557698|7838|P1|NOT COMPLETED|Overall Study||0
3509|NCT02557698|7837|P2|COMPLETED|Overall Study||30
3510|NCT02557698|7838|P1|COMPLETED|Overall Study||30
3511|NCT02557698|7837|P2|STARTED|Overall Study||30
3512|NCT02557698|7838|P1|STARTED|Overall Study||30
3513|NCT02557646|7902|P1|NOT COMPLETED|Overall Study||276
3514|NCT02557646|7902|P1|COMPLETED|Overall Study||417
3515|NCT02557646|7902|P1|STARTED|Overall Study||693
3516|NCT02557555|7920|P1|NOT COMPLETED|Overall Study||0
3517|NCT02557555|7920|P1|COMPLETED|Overall Study||100
3518|NCT02557555|7920|P1|STARTED|Overall Study||100
3519|NCT02556307|7925|P1|NOT COMPLETED|Overall Study||53
3520|NCT02556307|7925|P1|COMPLETED|Overall Study||217
3521|NCT02556307|7925|P1|Treated|Overall Study||268
3522|NCT02556307|7925|P1|STARTED|Overall Study||270
3523|NCT02555722|7937|P2|NOT COMPLETED|Month 3||0
3524|NCT02555722|7938|P1|NOT COMPLETED|Month 3||0
3525|NCT02555722|7937|P2|COMPLETED|Month 3||29
3526|NCT02555722|7938|P1|COMPLETED|Month 3||53
3527|NCT02555722|7937|P2|STARTED|Month 3||29
3528|NCT02555722|7938|P1|STARTED|Month 3||53
3529|NCT02555722|7937|P2|NOT COMPLETED|Month 2||0
3530|NCT02555722|7938|P1|NOT COMPLETED|Month 2||3
3531|NCT02555722|7937|P2|COMPLETED|Month 2||29
3532|NCT02555722|7938|P1|COMPLETED|Month 2||53
3533|NCT02555722|7937|P2|STARTED|Month 2||29
3534|NCT02555722|7938|P1|STARTED|Month 2||56
3535|NCT02555722|7937|P2|NOT COMPLETED|Month 1||0
3536|NCT02555722|7938|P1|NOT COMPLETED|Month 1||2
3537|NCT02555722|7937|P2|COMPLETED|Month 1||29
3538|NCT02555722|7938|P1|COMPLETED|Month 1||56
3539|NCT02555722|7937|P2|STARTED|Month 1||29
3540|NCT02555722|7938|P1|STARTED|Month 1||58
3541|NCT02555722|7937|P2|NOT COMPLETED|Week 2||1
3542|NCT02555722|7938|P1|NOT COMPLETED|Week 2||0
3543|NCT02555722|7937|P2|COMPLETED|Week 2||29
3544|NCT02555722|7938|P1|COMPLETED|Week 2||58
3545|NCT02555722|7937|P2|STARTED|Week 2||30
3546|NCT02555722|7938|P1|STARTED|Week 2||58
3547|NCT02555722|7937|P2|NOT COMPLETED|Week 1||0
3548|NCT02555722|7938|P1|NOT COMPLETED|Week 1||1
3549|NCT02555722|7937|P2|COMPLETED|Week 1||30
3550|NCT02555722|7938|P1|COMPLETED|Week 1||58
3551|NCT02555722|7937|P2|STARTED|Week 1||30
3552|NCT02555722|7938|P1|STARTED|Week 1||59
3553|NCT02555722|7937|P2|NOT COMPLETED|Lens Dispensed||0
3554|NCT02555722|7938|P1|NOT COMPLETED|Lens Dispensed||0
3555|NCT02555722|7937|P2|COMPLETED|Lens Dispensed||30
3556|NCT02555722|7938|P1|COMPLETED|Lens Dispensed||59
3557|NCT02555722|7937|P2|STARTED|Lens Dispensed||30
3558|NCT02555722|7938|P1|STARTED|Lens Dispensed||59
3559|NCT02555618|8098|P2|NOT COMPLETED|Overall Study||0
3560|NCT02555618|8099|P1|NOT COMPLETED|Overall Study||1
3561|NCT02555618|8098|P2|COMPLETED|Overall Study||200
3562|NCT02555618|8099|P1|COMPLETED|Overall Study||199
3563|NCT02555618|8098|P2|STARTED|Overall Study||200
3564|NCT02555618|8099|P1|STARTED|Overall Study||200
3565|NCT02555228|8143|P2|NOT COMPLETED|Overall Study||0
3566|NCT02555228|8144|P1|NOT COMPLETED|Overall Study||0
3567|NCT02555228|8143|P2|COMPLETED|Overall Study|29th October 2015|27
3568|NCT02555228|8144|P1|COMPLETED|Overall Study|19th November 2015|27
3569|NCT02555228|8143|P2|STARTED|Overall Study|14th August 2015|27
3570|NCT02555228|8144|P1|STARTED|Overall Study|20th August 2015|27
3571|NCT02554981|8156|P1|NOT COMPLETED|Overall Study||5
3572|NCT02554981|8156|P1|COMPLETED|Overall Study||46
3573|NCT02554981|8156|P1|STARTED|Overall Study||51
3574|NCT02554877|8184|P4|NOT COMPLETED|Overall Study||7
3575|NCT02554877|8185|P3|NOT COMPLETED|Overall Study||6
3576|NCT02554877|8186|P2|NOT COMPLETED|Overall Study||7
3577|NCT02554877|8187|P1|NOT COMPLETED|Overall Study||12
3578|NCT02554877|8184|P4|COMPLETED|Overall Study||45
3579|NCT02554877|8185|P3|COMPLETED|Overall Study||46
3580|NCT02554877|8186|P2|COMPLETED|Overall Study||44
3581|NCT02554877|8187|P1|COMPLETED|Overall Study||39
3582|NCT02554877|8184|P4|STARTED|Overall Study||52
3583|NCT02554877|8185|P3|STARTED|Overall Study||52
3584|NCT02554877|8186|P2|STARTED|Overall Study||51
3585|NCT02554877|8187|P1|STARTED|Overall Study||51
3586|NCT02553629|8251|P2|NOT COMPLETED|Overall Study||6
3587|NCT02553629|8252|P1|NOT COMPLETED|Overall Study||3
3588|NCT02553629|8251|P2|COMPLETED|Overall Study||50
3589|NCT02553629|8252|P1|COMPLETED|Overall Study||50
3590|NCT02553629|8251|P2|STARTED|Overall Study||56
3591|NCT02553629|8252|P1|STARTED|Overall Study||53
3592|NCT02553512|8266|P1|NOT COMPLETED|Overall Study||23
3593|NCT02553512|8266|P1|COMPLETED|Overall Study||144
3594|NCT02553512|8266|P1|STARTED|Overall Study||167
3595|NCT02553421|8276|P2|NOT COMPLETED|Overall Study||1
3596|NCT02553421|8277|P1|NOT COMPLETED|Overall Study||29
3597|NCT02553421|8276|P2|COMPLETED|Overall Study||57
3598|NCT02553421|8277|P1|COMPLETED|Overall Study||156
3599|NCT02553421|8276|P2|STARTED|Overall Study||58
3600|NCT02553421|8277|P1|STARTED|Overall Study||185
3601|NCT02552810|8287|P2|NOT COMPLETED|Overall Study||0
3602|NCT02552810|8288|P1|NOT COMPLETED|Overall Study||0
3603|NCT02552810|8287|P2|COMPLETED|Overall Study||15
3604|NCT02552810|8288|P1|COMPLETED|Overall Study||15
3605|NCT02552810|8287|P2|STARTED|Overall Study||15
3606|NCT02552810|8288|P1|STARTED|Overall Study||15
3607|NCT02552303|8308|P4|NOT COMPLETED|Follow-Up||0
3608|NCT02552303|8309|P3|NOT COMPLETED|Follow-Up||1
3609|NCT02552303|8310|P2|NOT COMPLETED|Follow-Up||2
3610|NCT02552303|8311|P1|NOT COMPLETED|Follow-Up||0
3611|NCT02552303|8308|P4|COMPLETED|Follow-Up||10
3612|NCT02552303|8309|P3|COMPLETED|Follow-Up||6
3613|NCT02552303|8310|P2|COMPLETED|Follow-Up||6
3614|NCT02552303|8311|P1|COMPLETED|Follow-Up||7
3615|NCT02552303|8308|P4|STARTED|Follow-Up||10
3616|NCT02552303|8309|P3|STARTED|Follow-Up||7
3617|NCT02552303|8310|P2|STARTED|Follow-Up||8
3618|NCT02552303|8311|P1|STARTED|Follow-Up||7
3619|NCT02552303|8308|P4|NOT COMPLETED|Allocation||1
3620|NCT02552303|8309|P3|NOT COMPLETED|Allocation||1
3621|NCT02552303|8310|P2|NOT COMPLETED|Allocation||2
3622|NCT02552303|8311|P1|NOT COMPLETED|Allocation||3
3623|NCT02552303|8308|P4|COMPLETED|Allocation||10
3624|NCT02552303|8309|P3|COMPLETED|Allocation||7
3625|NCT02552303|8310|P2|COMPLETED|Allocation||8
3626|NCT02552303|8311|P1|COMPLETED|Allocation||7
3627|NCT02552303|8308|P4|STARTED|Allocation||11
3628|NCT02552303|8309|P3|STARTED|Allocation||8
3629|NCT02552303|8310|P2|STARTED|Allocation||10
3630|NCT02552303|8311|P1|STARTED|Allocation||10
3631|NCT02551887|8328|P3|NOT COMPLETED|Overall Study||0
3632|NCT02551887|8329|P2|NOT COMPLETED|Overall Study||0
3633|NCT02551887|8330|P1|NOT COMPLETED|Overall Study||0
3634|NCT02551887|8328|P3|COMPLETED|Overall Study||222
3635|NCT02551887|8329|P2|COMPLETED|Overall Study||124
3636|NCT02551887|8330|P1|COMPLETED|Overall Study||301
3637|NCT02551887|8328|P3|STARTED|Overall Study||222
3638|NCT02551887|8329|P2|STARTED|Overall Study||124
3639|NCT02551887|8330|P1|STARTED|Overall Study||301
3640|NCT02550288|8346|P5|NOT COMPLETED|Overall Study||3
3641|NCT02550288|8347|P4|NOT COMPLETED|Overall Study||3
3642|NCT02550288|8348|P3|NOT COMPLETED|Overall Study||1
3643|NCT02550288|8349|P2|NOT COMPLETED|Overall Study||3
3644|NCT02550288|8350|P1|NOT COMPLETED|Overall Study||2
3645|NCT02550288|8346|P5|COMPLETED|Overall Study||66
3646|NCT02550288|8347|P4|COMPLETED|Overall Study||65
3647|NCT02550288|8348|P3|COMPLETED|Overall Study||68
3648|NCT02550288|8349|P2|COMPLETED|Overall Study||65
3649|NCT02550288|8350|P1|COMPLETED|Overall Study||33
3650|NCT02550288|8346|P5|STARTED|Overall Study||69
3651|NCT02550288|8347|P4|STARTED|Overall Study||68
3652|NCT02550288|8348|P3|STARTED|Overall Study||69
3653|NCT02550288|8349|P2|STARTED|Overall Study||68
3654|NCT02550288|8350|P1|STARTED|Overall Study||35
3655|NCT02550197|8449|P2|NOT COMPLETED|Overall Study||0
3656|NCT02550197|8450|P1|NOT COMPLETED|Overall Study||0
3657|NCT02550197|8449|P2|COMPLETED|Overall Study||100
3658|NCT02550197|8450|P1|COMPLETED|Overall Study||200
3659|NCT02550197|8449|P2|STARTED|Overall Study||100
3660|NCT02550197|8450|P1|STARTED|Overall Study||200
3661|NCT02550132|8468|P1|NOT COMPLETED|Overall Study||0
3662|NCT02550132|8468|P1|COMPLETED|Overall Study||25
3663|NCT02550132|8468|P1|STARTED|Overall Study||25
3664|NCT02549027|8499|P6|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3665|NCT02549027|8500|P5|NOT COMPLETED|Period 5 - MK-6096 or Placebo||2
3666|NCT02549027|8501|P4|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3667|NCT02549027|8502|P3|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3668|NCT02549027|8503|P2|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3669|NCT02549027|8504|P1|NOT COMPLETED|Period 5 - MK-6096 or Placebo||0
3670|NCT02549027|8499|P6|COMPLETED|Period 5 - MK-6096 or Placebo||1
3671|NCT02549027|8500|P5|COMPLETED|Period 5 - MK-6096 or Placebo|The 2 participants who did not complete Period 5 did not receive study drug in Period 5|14
3672|NCT02549027|8501|P4|COMPLETED|Period 5 - MK-6096 or Placebo||0
3673|NCT02549027|8502|P3|COMPLETED|Period 5 - MK-6096 or Placebo||0
3674|NCT02549027|8503|P2|COMPLETED|Period 5 - MK-6096 or Placebo||0
3675|NCT02549027|8504|P1|COMPLETED|Period 5 - MK-6096 or Placebo||0
3676|NCT02549027|8499|P6|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|1
3677|NCT02549027|8500|P5|STARTED|Period 5 - MK-6096 or Placebo|Participants entering Period 5 were previously in MK-1064/Placebo (Period 1-4) arms|16
3678|NCT02549027|8501|P4|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
3679|NCT02549027|8502|P3|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
3680|NCT02549027|8503|P2|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg (Period 5) arm|0
3681|NCT02549027|8504|P1|STARTED|Period 5 - MK-6096 or Placebo|In Period 5, participants previously in this arm appear in MK-6096 20 mg/Placebo (Period 5) arms|0
3682|NCT02549027|8499|P6|NOT COMPLETED|Washout After Period 4||0
3683|NCT02549027|8500|P5|NOT COMPLETED|Washout After Period 4||0
3684|NCT02549027|8501|P4|NOT COMPLETED|Washout After Period 4||1
3685|NCT02549027|8502|P3|NOT COMPLETED|Washout After Period 4||1
3686|NCT02549027|8503|P2|NOT COMPLETED|Washout After Period 4||1
3687|NCT02549027|8504|P1|NOT COMPLETED|Washout After Period 4||0
3688|NCT02549027|8499|P6|COMPLETED|Washout After Period 4||0
3689|NCT02549027|8500|P5|COMPLETED|Washout After Period 4||0
3690|NCT02549027|8501|P4|COMPLETED|Washout After Period 4||4
3691|NCT02549027|8502|P3|COMPLETED|Washout After Period 4||4
3692|NCT02549027|8503|P2|COMPLETED|Washout After Period 4||4
3693|NCT02549027|8504|P1|COMPLETED|Washout After Period 4||5
3694|NCT02549027|8499|P6|STARTED|Washout After Period 4||0
3695|NCT02549027|8500|P5|STARTED|Washout After Period 4||0
3696|NCT02549027|8501|P4|STARTED|Washout After Period 4||5
3697|NCT02549027|8502|P3|STARTED|Washout After Period 4||5
3698|NCT02549027|8503|P2|STARTED|Washout After Period 4||5
3699|NCT02549027|8504|P1|STARTED|Washout After Period 4||5
3700|NCT02549027|8499|P6|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3701|NCT02549027|8500|P5|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3702|NCT02549027|8501|P4|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3703|NCT02549027|8502|P3|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3704|NCT02549027|8503|P2|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3705|NCT02549027|8504|P1|NOT COMPLETED|Period 4 - MK-1064 or Placebo||0
3706|NCT02549027|8499|P6|COMPLETED|Period 4 - MK-1064 or Placebo||0
3707|NCT02549027|8500|P5|COMPLETED|Period 4 - MK-1064 or Placebo||0
3708|NCT02549027|8501|P4|COMPLETED|Period 4 - MK-1064 or Placebo||5
3709|NCT02549027|8502|P3|COMPLETED|Period 4 - MK-1064 or Placebo||5
3710|NCT02549027|8503|P2|COMPLETED|Period 4 - MK-1064 or Placebo||5
3711|NCT02549027|8504|P1|COMPLETED|Period 4 - MK-1064 or Placebo||5
3712|NCT02549027|8499|P6|STARTED|Period 4 - MK-1064 or Placebo||0
3713|NCT02549027|8500|P5|STARTED|Period 4 - MK-1064 or Placebo||0
3714|NCT02549027|8501|P4|STARTED|Period 4 - MK-1064 or Placebo||5
3715|NCT02549027|8502|P3|STARTED|Period 4 - MK-1064 or Placebo||5
3716|NCT02549027|8503|P2|STARTED|Period 4 - MK-1064 or Placebo||5
3717|NCT02549027|8504|P1|STARTED|Period 4 - MK-1064 or Placebo||5
3718|NCT02549027|8499|P6|NOT COMPLETED|Washout After Period 3||0
3719|NCT02549027|8500|P5|NOT COMPLETED|Washout After Period 3||0
3720|NCT02549027|8501|P4|NOT COMPLETED|Washout After Period 3||0
3721|NCT02549027|8502|P3|NOT COMPLETED|Washout After Period 3||0
3722|NCT02549027|8503|P2|NOT COMPLETED|Washout After Period 3||0
3723|NCT02549027|8504|P1|NOT COMPLETED|Washout After Period 3||0
3724|NCT02549027|8499|P6|COMPLETED|Washout After Period 3||0
3725|NCT02549027|8500|P5|COMPLETED|Washout After Period 3||0
3726|NCT02549027|8501|P4|COMPLETED|Washout After Period 3||5
3727|NCT02549027|8502|P3|COMPLETED|Washout After Period 3||5
3728|NCT02549027|8503|P2|COMPLETED|Washout After Period 3||5
3729|NCT02549027|8504|P1|COMPLETED|Washout After Period 3||5
3730|NCT02549027|8499|P6|STARTED|Washout After Period 3||0
3731|NCT02549027|8500|P5|STARTED|Washout After Period 3||0
3732|NCT02549027|8501|P4|STARTED|Washout After Period 3||5
3733|NCT02549027|8502|P3|STARTED|Washout After Period 3||5
3734|NCT02549027|8503|P2|STARTED|Washout After Period 3||5
3735|NCT02549027|8504|P1|STARTED|Washout After Period 3||5
3736|NCT02549027|8499|P6|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3737|NCT02549027|8500|P5|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3738|NCT02549027|8501|P4|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3739|NCT02549027|8502|P3|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3740|NCT02549027|8503|P2|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3741|NCT02549027|8504|P1|NOT COMPLETED|Period 3 - MK-1064 or Placebo||0
3742|NCT02549027|8499|P6|COMPLETED|Period 3 - MK-1064 or Placebo||0
3743|NCT02549027|8500|P5|COMPLETED|Period 3 - MK-1064 or Placebo||0
3744|NCT02549027|8501|P4|COMPLETED|Period 3 - MK-1064 or Placebo||5
3745|NCT02549027|8502|P3|COMPLETED|Period 3 - MK-1064 or Placebo||5
3746|NCT02549027|8503|P2|COMPLETED|Period 3 - MK-1064 or Placebo||5
3747|NCT02549027|8504|P1|COMPLETED|Period 3 - MK-1064 or Placebo||5
3748|NCT02549027|8499|P6|STARTED|Period 3 - MK-1064 or Placebo||0
3749|NCT02549027|8500|P5|STARTED|Period 3 - MK-1064 or Placebo||0
3750|NCT02549027|8501|P4|STARTED|Period 3 - MK-1064 or Placebo||5
3751|NCT02549027|8502|P3|STARTED|Period 3 - MK-1064 or Placebo||5
3752|NCT02549027|8503|P2|STARTED|Period 3 - MK-1064 or Placebo||5
3753|NCT02549027|8504|P1|STARTED|Period 3 - MK-1064 or Placebo||5
3754|NCT02549027|8499|P6|NOT COMPLETED|Washout After Period 2||0
3755|NCT02549027|8500|P5|NOT COMPLETED|Washout After Period 2||0
3756|NCT02549027|8501|P4|NOT COMPLETED|Washout After Period 2||0
3757|NCT02549027|8502|P3|NOT COMPLETED|Washout After Period 2||0
3758|NCT02549027|8503|P2|NOT COMPLETED|Washout After Period 2||0
3759|NCT02549027|8504|P1|NOT COMPLETED|Washout After Period 2||0
3760|NCT02549027|8499|P6|COMPLETED|Washout After Period 2||0
3761|NCT02549027|8500|P5|COMPLETED|Washout After Period 2||0
3762|NCT02549027|8501|P4|COMPLETED|Washout After Period 2||5
3763|NCT02549027|8502|P3|COMPLETED|Washout After Period 2||5
3764|NCT02549027|8503|P2|COMPLETED|Washout After Period 2||5
3765|NCT02549027|8504|P1|COMPLETED|Washout After Period 2||5
3766|NCT02549027|8499|P6|STARTED|Washout After Period 2||0
3767|NCT02549027|8500|P5|STARTED|Washout After Period 2||0
3768|NCT02549027|8501|P4|STARTED|Washout After Period 2||5
3769|NCT02549027|8502|P3|STARTED|Washout After Period 2||5
3770|NCT02549027|8503|P2|STARTED|Washout After Period 2||5
3771|NCT02549027|8504|P1|STARTED|Washout After Period 2||5
3772|NCT02549027|8499|P6|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3773|NCT02549027|8500|P5|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3774|NCT02549027|8501|P4|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3775|NCT02549027|8502|P3|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3776|NCT02549027|8503|P2|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3777|NCT02549027|8504|P1|NOT COMPLETED|Period 2 - MK-1064 or Placebo||0
3778|NCT02549027|8499|P6|COMPLETED|Period 2 - MK-1064 or Placebo||0
3779|NCT02549027|8500|P5|COMPLETED|Period 2 - MK-1064 or Placebo||0
3780|NCT02549027|8501|P4|COMPLETED|Period 2 - MK-1064 or Placebo||5
3781|NCT02549027|8502|P3|COMPLETED|Period 2 - MK-1064 or Placebo||5
3782|NCT02549027|8503|P2|COMPLETED|Period 2 - MK-1064 or Placebo||5
3783|NCT02549027|8504|P1|COMPLETED|Period 2 - MK-1064 or Placebo||5
3784|NCT02549027|8499|P6|STARTED|Period 2 - MK-1064 or Placebo||0
3785|NCT02549027|8500|P5|STARTED|Period 2 - MK-1064 or Placebo||0
3786|NCT02549027|8501|P4|STARTED|Period 2 - MK-1064 or Placebo||5
3787|NCT02549027|8502|P3|STARTED|Period 2 - MK-1064 or Placebo||5
3788|NCT02549027|8503|P2|STARTED|Period 2 - MK-1064 or Placebo||5
3789|NCT02549027|8504|P1|STARTED|Period 2 - MK-1064 or Placebo||5
3790|NCT02549027|8499|P6|NOT COMPLETED|Washout After Period 1||0
3791|NCT02549027|8500|P5|NOT COMPLETED|Washout After Period 1||0
3792|NCT02549027|8501|P4|NOT COMPLETED|Washout After Period 1||0
3793|NCT02549027|8502|P3|NOT COMPLETED|Washout After Period 1||0
3794|NCT02549027|8503|P2|NOT COMPLETED|Washout After Period 1||0
3795|NCT02549027|8504|P1|NOT COMPLETED|Washout After Period 1||0
3796|NCT02549027|8499|P6|COMPLETED|Washout After Period 1||0
3797|NCT02549027|8500|P5|COMPLETED|Washout After Period 1||0
3798|NCT02549027|8501|P4|COMPLETED|Washout After Period 1||5
3799|NCT02549027|8502|P3|COMPLETED|Washout After Period 1||5
3800|NCT02549027|8503|P2|COMPLETED|Washout After Period 1||5
3801|NCT02549027|8504|P1|COMPLETED|Washout After Period 1||5
3802|NCT02549027|8499|P6|STARTED|Washout After Period 1||0
3803|NCT02549027|8500|P5|STARTED|Washout After Period 1||0
3804|NCT02549027|8501|P4|STARTED|Washout After Period 1||5
3805|NCT02549027|8502|P3|STARTED|Washout After Period 1||5
3806|NCT02549027|8503|P2|STARTED|Washout After Period 1||5
3807|NCT02549027|8504|P1|STARTED|Washout After Period 1||5
3808|NCT02549027|8499|P6|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3809|NCT02549027|8500|P5|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3810|NCT02549027|8501|P4|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3811|NCT02549027|8502|P3|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3812|NCT02549027|8503|P2|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3813|NCT02549027|8504|P1|NOT COMPLETED|Period 1 - MK-1064 or Placebo||0
3814|NCT02549027|8499|P6|COMPLETED|Period 1 - MK-1064 or Placebo||0
3815|NCT02549027|8500|P5|COMPLETED|Period 1 - MK-1064 or Placebo||0
3816|NCT02549027|8501|P4|COMPLETED|Period 1 - MK-1064 or Placebo||5
3817|NCT02549027|8502|P3|COMPLETED|Period 1 - MK-1064 or Placebo||5
3818|NCT02549027|8503|P2|COMPLETED|Period 1 - MK-1064 or Placebo||5
3819|NCT02549027|8504|P1|COMPLETED|Period 1 - MK-1064 or Placebo||5
3820|NCT02549027|8499|P6|STARTED|Period 1 - MK-1064 or Placebo||0
3821|NCT02549027|8500|P5|STARTED|Period 1 - MK-1064 or Placebo||0
3822|NCT02549027|8501|P4|STARTED|Period 1 - MK-1064 or Placebo||5
3823|NCT02549027|8502|P3|STARTED|Period 1 - MK-1064 or Placebo||5
3824|NCT02549027|8503|P2|STARTED|Period 1 - MK-1064 or Placebo||5
3825|NCT02549027|8504|P1|STARTED|Period 1 - MK-1064 or Placebo||5
3826|NCT02549014|8541|P2|NOT COMPLETED|Overall Study||0
3827|NCT02549014|8542|P1|NOT COMPLETED|Overall Study||0
3828|NCT02549014|8541|P2|COMPLETED|Overall Study||8
3829|NCT02549014|8542|P1|COMPLETED|Overall Study||8
3830|NCT02549014|8541|P2|STARTED|Overall Study||8
3831|NCT02549014|8542|P1|STARTED|Overall Study||8
3832|NCT02548156|8632|P6|NOT COMPLETED|Period 3||0
3833|NCT02548156|8633|P5|NOT COMPLETED|Period 3||0
3834|NCT02548156|8634|P4|NOT COMPLETED|Period 3||0
3835|NCT02548156|8635|P3|NOT COMPLETED|Period 3||0
3836|NCT02548156|8636|P2|NOT COMPLETED|Period 3||0
3837|NCT02548156|8637|P1|NOT COMPLETED|Period 3||0
3838|NCT02548156|8632|P6|COMPLETED|Period 3||5
3839|NCT02548156|8633|P5|COMPLETED|Period 3||4
3840|NCT02548156|8634|P4|COMPLETED|Period 3||5
3841|NCT02548156|8635|P3|COMPLETED|Period 3||4
3842|NCT02548156|8636|P2|COMPLETED|Period 3||5
3843|NCT02548156|8637|P1|COMPLETED|Period 3||5
3844|NCT02548156|8632|P6|STARTED|Period 3||5
3845|NCT02548156|8633|P5|STARTED|Period 3||4
3846|NCT02548156|8634|P4|STARTED|Period 3||5
3847|NCT02548156|8635|P3|STARTED|Period 3||4
3848|NCT02548156|8636|P2|STARTED|Period 3||5
3849|NCT02548156|8637|P1|STARTED|Period 3||5
3850|NCT02548156|8632|P6|NOT COMPLETED|Washout Period 2||0
3851|NCT02548156|8633|P5|NOT COMPLETED|Washout Period 2||0
3852|NCT02548156|8634|P4|NOT COMPLETED|Washout Period 2||0
3853|NCT02548156|8635|P3|NOT COMPLETED|Washout Period 2||0
3854|NCT02548156|8636|P2|NOT COMPLETED|Washout Period 2||0
3855|NCT02548156|8637|P1|NOT COMPLETED|Washout Period 2||0
3856|NCT02548156|8632|P6|COMPLETED|Washout Period 2||5
3857|NCT02548156|8633|P5|COMPLETED|Washout Period 2||4
3858|NCT02548156|8634|P4|COMPLETED|Washout Period 2||5
3859|NCT02548156|8635|P3|COMPLETED|Washout Period 2||4
3860|NCT02548156|8636|P2|COMPLETED|Washout Period 2||5
3861|NCT02548156|8637|P1|COMPLETED|Washout Period 2||5
3862|NCT02548156|8632|P6|STARTED|Washout Period 2||5
3863|NCT02548156|8633|P5|STARTED|Washout Period 2||4
3864|NCT02548156|8634|P4|STARTED|Washout Period 2||5
3865|NCT02548156|8635|P3|STARTED|Washout Period 2||4
3866|NCT02548156|8636|P2|STARTED|Washout Period 2||5
3867|NCT02548156|8637|P1|STARTED|Washout Period 2||5
3868|NCT02548156|8632|P6|NOT COMPLETED|Period 2||0
3869|NCT02548156|8633|P5|NOT COMPLETED|Period 2||0
3870|NCT02548156|8634|P4|NOT COMPLETED|Period 2||0
3871|NCT02548156|8635|P3|NOT COMPLETED|Period 2||0
3872|NCT02548156|8636|P2|NOT COMPLETED|Period 2||0
3873|NCT02548156|8637|P1|NOT COMPLETED|Period 2||0
3874|NCT02548156|8632|P6|COMPLETED|Period 2||5
3875|NCT02548156|8633|P5|COMPLETED|Period 2||4
3876|NCT02548156|8634|P4|COMPLETED|Period 2||5
3877|NCT02548156|8635|P3|COMPLETED|Period 2||4
3878|NCT02548156|8636|P2|COMPLETED|Period 2||5
3879|NCT02548156|8637|P1|COMPLETED|Period 2||5
3880|NCT02548156|8632|P6|STARTED|Period 2||5
3881|NCT02548156|8633|P5|STARTED|Period 2||4
3882|NCT02548156|8634|P4|STARTED|Period 2||5
3883|NCT02548156|8635|P3|STARTED|Period 2||4
3884|NCT02548156|8636|P2|STARTED|Period 2||5
3885|NCT02548156|8637|P1|STARTED|Period 2||5
3886|NCT02548156|8632|P6|NOT COMPLETED|Washout Period 1||0
3887|NCT02548156|8633|P5|NOT COMPLETED|Washout Period 1||1
3888|NCT02548156|8634|P4|NOT COMPLETED|Washout Period 1||0
3889|NCT02548156|8635|P3|NOT COMPLETED|Washout Period 1||0
3890|NCT02548156|8636|P2|NOT COMPLETED|Washout Period 1||0
3891|NCT02548156|8637|P1|NOT COMPLETED|Washout Period 1||0
3892|NCT02548156|8632|P6|COMPLETED|Washout Period 1||5
3893|NCT02548156|8633|P5|COMPLETED|Washout Period 1||4
3894|NCT02548156|8634|P4|COMPLETED|Washout Period 1||5
3895|NCT02548156|8635|P3|COMPLETED|Washout Period 1||4
3896|NCT02548156|8636|P2|COMPLETED|Washout Period 1||5
3897|NCT02548156|8637|P1|COMPLETED|Washout Period 1||5
3898|NCT02548156|8632|P6|STARTED|Washout Period 1||5
3899|NCT02548156|8633|P5|STARTED|Washout Period 1||5
3900|NCT02548156|8634|P4|STARTED|Washout Period 1||5
3901|NCT02548156|8635|P3|STARTED|Washout Period 1||4
3902|NCT02548156|8636|P2|STARTED|Washout Period 1||5
3903|NCT02548156|8637|P1|STARTED|Washout Period 1||5
3904|NCT02548156|8632|P6|NOT COMPLETED|Period 1||0
3905|NCT02548156|8633|P5|NOT COMPLETED|Period 1||0
3906|NCT02548156|8634|P4|NOT COMPLETED|Period 1||0
3907|NCT02548156|8635|P3|NOT COMPLETED|Period 1||0
3908|NCT02548156|8636|P2|NOT COMPLETED|Period 1||0
3909|NCT02548156|8637|P1|NOT COMPLETED|Period 1||0
3910|NCT02548156|8632|P6|COMPLETED|Period 1||5
3911|NCT02548156|8633|P5|COMPLETED|Period 1||5
3912|NCT02548156|8634|P4|COMPLETED|Period 1||5
3913|NCT02548156|8635|P3|COMPLETED|Period 1||4
3914|NCT02548156|8636|P2|COMPLETED|Period 1||5
3915|NCT02548156|8637|P1|COMPLETED|Period 1||5
3916|NCT02548156|8632|P6|STARTED|Period 1||5
3917|NCT02548156|8633|P5|STARTED|Period 1||5
3918|NCT02548156|8634|P4|STARTED|Period 1||5
3919|NCT02548156|8635|P3|STARTED|Period 1||4
3920|NCT02548156|8636|P2|STARTED|Period 1||5
3921|NCT02548156|8637|P1|STARTED|Period 1||5
3922|NCT02547714|8654|P1|NOT COMPLETED|Overall Study||0
3923|NCT02547714|8654|P1|COMPLETED|Overall Study||34
3924|NCT02547714|8654|P1|STARTED|Overall Study||34
3925|NCT02547454|8664|P1|NOT COMPLETED|Overall Study||172
3926|NCT02547454|8664|P1|COMPLETED|Overall Study||221
3927|NCT02547454|8664|P1|STARTED|Overall Study||393
3928|NCT02547064|8694|P2|NOT COMPLETED|Overall Study||2
3929|NCT02547064|8695|P1|NOT COMPLETED|Overall Study||3
3930|NCT02547064|8694|P2|COMPLETED|Overall Study||79
3931|NCT02547064|8695|P1|COMPLETED|Overall Study||78
3932|NCT02547064|8694|P2|STARTED|Overall Study||81
3933|NCT02547064|8695|P1|STARTED|Overall Study||81
3934|NCT02545543|8723|P2|NOT COMPLETED|Overall Study||34
3935|NCT02545543|8724|P1|NOT COMPLETED|Overall Study||81
3936|NCT02545543|8723|P2|COMPLETED|Overall Study||535
3937|NCT02545543|8724|P1|COMPLETED|Overall Study||1628
3938|NCT02545543|8723|P2|STARTED|Overall Study||569
3939|NCT02545543|8724|P1|STARTED|Overall Study||1709
3940|NCT02545322|8748|P1|NOT COMPLETED|Overall Study||3
3941|NCT02545322|8748|P1|COMPLETED|Overall Study||15
3942|NCT02545322|8748|P1|STARTED|Overall Study||18
3943|NCT02543918|8755|P2|NOT COMPLETED|Overall Study||4
3944|NCT02543918|8756|P1|NOT COMPLETED|Overall Study||3
3945|NCT02543918|8755|P2|COMPLETED|Overall Study||39
3946|NCT02543918|8756|P1|COMPLETED|Overall Study||38
3947|NCT02543918|8755|P2|Received at Least 1 Dose of Study Drug|Overall Study||42
3948|NCT02543918|8756|P1|Received at Least 1 Dose of Study Drug|Overall Study||41
3949|NCT02543918|8755|P2|STARTED|Overall Study||43
3950|NCT02543918|8756|P1|STARTED|Overall Study||41
3951|NCT02543437|8762|P1|NOT COMPLETED|Overall Study||0
3952|NCT02543437|8762|P1|COMPLETED|Overall Study||117
3953|NCT02543437|8762|P1|STARTED|Overall Study||117
3954|NCT02542943|8770|P3|NOT COMPLETED|Overall Study||0
3955|NCT02542943|8771|P2|NOT COMPLETED|Overall Study||1
3956|NCT02542943|8772|P1|NOT COMPLETED|Overall Study||1
3957|NCT02542943|8770|P3|COMPLETED|Overall Study||81
3958|NCT02542943|8771|P2|COMPLETED|Overall Study||79
3959|NCT02542943|8772|P1|COMPLETED|Overall Study||78
3960|NCT02542943|8770|P3|STARTED|Overall Study||81
3961|NCT02542943|8771|P2|STARTED|Overall Study||80
3962|NCT02542943|8772|P1|STARTED|Overall Study||79
3963|NCT02542280|8799|P2|NOT COMPLETED|Overall Study||8
3964|NCT02542280|8800|P1|NOT COMPLETED|Overall Study||12
3965|NCT02542280|8799|P2|COMPLETED|Overall Study||167
3966|NCT02542280|8800|P1|COMPLETED|Overall Study||162
3967|NCT02542280|8799|P2|STARTED|Overall Study||175
3968|NCT02542280|8800|P1|STARTED|Overall Study||174
3969|NCT02542072|8808|P2|NOT COMPLETED|Second Intervention (1 Month)||0
3970|NCT02542072|8809|P1|NOT COMPLETED|Second Intervention (1 Month)||2
3971|NCT02542072|8808|P2|COMPLETED|Second Intervention (1 Month)||43
3972|NCT02542072|8809|P1|COMPLETED|Second Intervention (1 Month)||37
3973|NCT02542072|8808|P2|STARTED|Second Intervention (1 Month)||43
3974|NCT02542072|8809|P1|STARTED|Second Intervention (1 Month)||39
3975|NCT02542072|8808|P2|NOT COMPLETED|First Intervention (1 Month)||3
3976|NCT02542072|8809|P1|NOT COMPLETED|First Intervention (1 Month)||5
3977|NCT02542072|8808|P2|COMPLETED|First Intervention (1 Month)||43
3978|NCT02542072|8809|P1|COMPLETED|First Intervention (1 Month)||39
3979|NCT02542072|8808|P2|STARTED|First Intervention (1 Month)||46
3980|NCT02542072|8809|P1|STARTED|First Intervention (1 Month)||44
3981|NCT02541864|8911|P2|NOT COMPLETED|Overall Study||0
3982|NCT02541864|8912|P1|NOT COMPLETED|Overall Study||0
3983|NCT02541864|8911|P2|COMPLETED|Overall Study||166
3984|NCT02541864|8912|P1|COMPLETED|Overall Study||164
3985|NCT02541864|8911|P2|STARTED|Overall Study||166
3986|NCT02541864|8912|P1|STARTED|Overall Study||164
3987|NCT02540850|8921|P3|NOT COMPLETED|Overall Study||34
3988|NCT02540850|8922|P2|NOT COMPLETED|Overall Study||66
3989|NCT02540850|8923|P1|NOT COMPLETED|Overall Study||69
3990|NCT02540850|8921|P3|COMPLETED|Overall Study||410
3991|NCT02540850|8922|P2|COMPLETED|Overall Study||330
3992|NCT02540850|8923|P1|COMPLETED|Overall Study||291
3993|NCT02540850|8921|P3|STARTED|Overall Study||444
3994|NCT02540850|8922|P2|STARTED|Overall Study||396
3995|NCT02540850|8923|P1|STARTED|Overall Study||360
3996|NCT02540772|8951|P2|NOT COMPLETED|Overall Study||0
3997|NCT02540772|8952|P1|NOT COMPLETED|Overall Study||0
3998|NCT02540772|8951|P2|COMPLETED|Overall Study||10
3999|NCT02540772|8952|P1|COMPLETED|Overall Study||10
4000|NCT02540772|8951|P2|STARTED|Overall Study||10
4001|NCT02540772|8952|P1|STARTED|Overall Study||10
4002|NCT02540447|8966|P2|NOT COMPLETED|Overall Study||0
4003|NCT02540447|8967|P1|NOT COMPLETED|Overall Study||0
4004|NCT02540447|8966|P2|COMPLETED|Overall Study||40
4005|NCT02540447|8967|P1|COMPLETED|Overall Study||40
4006|NCT02540447|8966|P2|STARTED|Overall Study||40
4007|NCT02540447|8967|P1|STARTED|Overall Study||40
4008|NCT02540434|8983|P2|NOT COMPLETED|Overall Study||0
4009|NCT02540434|8984|P1|NOT COMPLETED|Overall Study||0
4010|NCT02540434|8983|P2|COMPLETED|Overall Study||1
4011|NCT02540434|8984|P1|COMPLETED|Overall Study||0
4012|NCT02540434|8983|P2|STARTED|Overall Study||1
4013|NCT02540434|8984|P1|STARTED|Overall Study||0
4014|NCT02540356|8994|P2|NOT COMPLETED|Overall Study||0
4015|NCT02540356|8995|P1|NOT COMPLETED|Overall Study||1
4016|NCT02540356|8994|P2|COMPLETED|Overall Study||0
4017|NCT02540356|8995|P1|COMPLETED|Overall Study||0
4018|NCT02540356|8994|P2|STARTED|Overall Study||0
4019|NCT02540356|8995|P1|STARTED|Overall Study||1
4020|NCT02540265|9029|P3|NOT COMPLETED|Overall Study||1
4021|NCT02540265|9030|P2|NOT COMPLETED|Overall Study||0
4022|NCT02540265|9031|P1|NOT COMPLETED|Overall Study||0
4023|NCT02540265|9029|P3|COMPLETED|Overall Study||18
4024|NCT02540265|9030|P2|COMPLETED|Overall Study||20
4025|NCT02540265|9031|P1|COMPLETED|Overall Study||20
4026|NCT02540265|9029|P3|Treatment Completion|Overall Study||18
4027|NCT02540265|9030|P2|Treatment Completion|Overall Study||19
4028|NCT02540265|9031|P1|Treatment Completion|Overall Study||20
4029|NCT02540265|9029|P3|STARTED|Overall Study||19
4030|NCT02540265|9030|P2|STARTED|Overall Study||20
4031|NCT02540265|9031|P1|STARTED|Overall Study||20
4032|NCT02540213|9051|P1|NOT COMPLETED|Overall Study||39
4033|NCT02540213|9051|P1|COMPLETED|Overall Study||201
4034|NCT02540213|9051|P1|STARTED|Overall Study||240
4035|NCT02539992|9075|P3|NOT COMPLETED|Overall Study||4
4036|NCT02539992|9076|P2|NOT COMPLETED|Overall Study||4
4037|NCT02539992|9077|P1|NOT COMPLETED|Overall Study||0
4038|NCT02539992|9075|P3|COMPLETED|Overall Study||14
4039|NCT02539992|9076|P2|COMPLETED|Overall Study||7
4040|NCT02539992|9077|P1|COMPLETED|Overall Study||15
4041|NCT02539992|9075|P3|STARTED|Overall Study||18
4042|NCT02539992|9076|P2|STARTED|Overall Study||11
4043|NCT02539992|9077|P1|STARTED|Overall Study||15
4044|NCT02539134|9109|P6|NOT COMPLETED|Overall Study||0
4045|NCT02539134|9110|P5|NOT COMPLETED|Overall Study||0
4046|NCT02539134|9111|P4|NOT COMPLETED|Overall Study||0
4047|NCT02539134|9112|P3|NOT COMPLETED|Overall Study||0
4048|NCT02539134|9113|P2|NOT COMPLETED|Overall Study||0
4049|NCT02539134|9114|P1|NOT COMPLETED|Overall Study||1
4050|NCT02539134|9109|P6|COMPLETED|Overall Study||6
4051|NCT02539134|9110|P5|COMPLETED|Overall Study||6
4052|NCT02539134|9111|P4|COMPLETED|Overall Study||6
4053|NCT02539134|9112|P3|COMPLETED|Overall Study||6
4054|NCT02539134|9113|P2|COMPLETED|Overall Study||6
4055|NCT02539134|9114|P1|COMPLETED|Overall Study||9
4056|NCT02539134|9109|P6|STARTED|Overall Study||6
4057|NCT02539134|9110|P5|STARTED|Overall Study||6
4058|NCT02539134|9111|P4|STARTED|Overall Study||6
4059|NCT02539134|9112|P3|STARTED|Overall Study||6
4060|NCT02539134|9113|P2|STARTED|Overall Study||6
4061|NCT02539134|9114|P1|STARTED|Overall Study||10
4062|NCT02539108|9168|P2|NOT COMPLETED|Overall Study||0
4063|NCT02539108|9169|P1|NOT COMPLETED|Overall Study||0
4064|NCT02539108|9168|P2|COMPLETED|Overall Study||30
4065|NCT02539108|9169|P1|COMPLETED|Overall Study||30
4066|NCT02539108|9168|P2|STARTED|Overall Study||30
4067|NCT02539108|9169|P1|STARTED|Overall Study||30
4068|NCT02538107|9183|P1|NOT COMPLETED|Overall Study||110
4069|NCT02538107|9183|P1|COMPLETED|Overall Study||180
4070|NCT02538107|9183|P1|STARTED|Overall Study||290
4071|NCT02537730|9203|P2|NOT COMPLETED|Second Intervention (7 Days)||0
4072|NCT02537730|9204|P1|NOT COMPLETED|Second Intervention (7 Days)||0
4073|NCT02537730|9203|P2|COMPLETED|Second Intervention (7 Days)||16
4074|NCT02537730|9204|P1|COMPLETED|Second Intervention (7 Days)||17
4075|NCT02537730|9203|P2|STARTED|Second Intervention (7 Days)||16
4076|NCT02537730|9204|P1|STARTED|Second Intervention (7 Days)||17
4077|NCT02537730|9203|P2|NOT COMPLETED|First Intervention (7 Days)||0
4078|NCT02537730|9204|P1|NOT COMPLETED|First Intervention (7 Days)||0
4079|NCT02537730|9203|P2|COMPLETED|First Intervention (7 Days)||16
4080|NCT02537730|9204|P1|COMPLETED|First Intervention (7 Days)||17
4081|NCT02537730|9203|P2|STARTED|First Intervention (7 Days)||16
4082|NCT02537730|9204|P1|STARTED|First Intervention (7 Days)||17
4083|NCT02537522|9216|P4|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4084|NCT02537522|9217|P3|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4085|NCT02537522|9218|P2|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4086|NCT02537522|9219|P1|NOT COMPLETED|Phase II - Period 2 Bilateral||0
4087|NCT02537522|9216|P4|COMPLETED|Phase II - Period 2 Bilateral||22
4088|NCT02537522|9217|P3|COMPLETED|Phase II - Period 2 Bilateral||23
4089|NCT02537522|9218|P2|COMPLETED|Phase II - Period 2 Bilateral||0
4090|NCT02537522|9219|P1|COMPLETED|Phase II - Period 2 Bilateral||0
4091|NCT02537522|9216|P4|STARTED|Phase II - Period 2 Bilateral||22
4092|NCT02537522|9217|P3|STARTED|Phase II - Period 2 Bilateral||23
4093|NCT02537522|9218|P2|STARTED|Phase II - Period 2 Bilateral||0
4094|NCT02537522|9219|P1|STARTED|Phase II - Period 2 Bilateral||0
4095|NCT02537522|9216|P4|NOT COMPLETED|Phase II - Period 1 Bilateral||1
4096|NCT02537522|9217|P3|NOT COMPLETED|Phase II - Period 1 Bilateral||0
4097|NCT02537522|9218|P2|NOT COMPLETED|Phase II - Period 1 Bilateral||0
4098|NCT02537522|9219|P1|NOT COMPLETED|Phase II - Period 1 Bilateral||0
4099|NCT02537522|9216|P4|COMPLETED|Phase II - Period 1 Bilateral||22
4100|NCT02537522|9217|P3|COMPLETED|Phase II - Period 1 Bilateral||23
4101|NCT02537522|9218|P2|COMPLETED|Phase II - Period 1 Bilateral||0
4102|NCT02537522|9219|P1|COMPLETED|Phase II - Period 1 Bilateral||0
4103|NCT02537522|9216|P4|STARTED|Phase II - Period 1 Bilateral||23
4104|NCT02537522|9217|P3|STARTED|Phase II - Period 1 Bilateral||23
4105|NCT02537522|9218|P2|STARTED|Phase II - Period 1 Bilateral||0
4106|NCT02537522|9219|P1|STARTED|Phase II - Period 1 Bilateral||0
4107|NCT02537522|9216|P4|NOT COMPLETED|Phase I - Contralateral||0
4108|NCT02537522|9217|P3|NOT COMPLETED|Phase I - Contralateral||0
4109|NCT02537522|9218|P2|NOT COMPLETED|Phase I - Contralateral||10
4110|NCT02537522|9219|P1|NOT COMPLETED|Phase I - Contralateral||15
4111|NCT02537522|9216|P4|COMPLETED|Phase I - Contralateral||0
4112|NCT02537522|9217|P3|COMPLETED|Phase I - Contralateral||0
4113|NCT02537522|9218|P2|COMPLETED|Phase I - Contralateral||27
4114|NCT02537522|9219|P1|COMPLETED|Phase I - Contralateral||19
4115|NCT02537522|9216|P4|STARTED|Phase I - Contralateral||0
4116|NCT02537522|9217|P3|STARTED|Phase I - Contralateral||0
4117|NCT02537522|9218|P2|STARTED|Phase I - Contralateral||37
4118|NCT02537522|9219|P1|STARTED|Phase I - Contralateral||34
4119|NCT02536781|9229|P2|NOT COMPLETED|Overall Study||0
4120|NCT02536781|9230|P1|NOT COMPLETED|Overall Study||2
4121|NCT02536781|9229|P2|COMPLETED|Overall Study||34
4122|NCT02536781|9230|P1|COMPLETED|Overall Study||34
4123|NCT02536781|9229|P2|STARTED|Overall Study||34
4124|NCT02536781|9230|P1|STARTED|Overall Study||36
4125|NCT02536664|9240|P2|NOT COMPLETED|Overall Study||80
4126|NCT02536664|9241|P1|NOT COMPLETED|Overall Study||107
4127|NCT02536664|9240|P2|COMPLETED|Overall Study||97
4128|NCT02536664|9241|P1|COMPLETED|Overall Study||205
4129|NCT02536664|9240|P2|STARTED|Overall Study||177
4130|NCT02536664|9241|P1|STARTED|Overall Study||312
4131|NCT02535741|9259|P1|NOT COMPLETED|Overall Study||32
4132|NCT02535741|9259|P1|COMPLETED|Overall Study|Completed cases at 2 years follow-up|136
4133|NCT02535741|9259|P1|STARTED|Overall Study||168
4134|NCT02535026|9263|P1|NOT COMPLETED|Overall Study||0
4135|NCT02535026|9263|P1|COMPLETED|Overall Study||580
4136|NCT02535026|9263|P1|STARTED|Overall Study||580
4137|NCT02534324|9317|P2|NOT COMPLETED|Overall Study||8
4138|NCT02534324|9318|P1|NOT COMPLETED|Overall Study||25
4139|NCT02534324|9317|P2|COMPLETED|Overall Study||40
4140|NCT02534324|9318|P1|COMPLETED|Overall Study||73
4141|NCT02534324|9317|P2|STARTED|Overall Study||48
4142|NCT02534324|9318|P1|STARTED|Overall Study||98
4143|NCT02533466|9330|P2|NOT COMPLETED|Overall Study||0
4144|NCT02533466|9331|P1|NOT COMPLETED|Overall Study||0
4145|NCT02533466|9330|P2|COMPLETED|Overall Study||14
4146|NCT02533466|9331|P1|COMPLETED|Overall Study||16
4147|NCT02533466|9330|P2|STARTED|Overall Study||14
4148|NCT02533466|9331|P1|STARTED|Overall Study||16
4149|NCT02533401|9355|P1|NOT COMPLETED|Overall Study||11
4150|NCT02533401|9355|P1|COMPLETED|Overall Study||23
4151|NCT02533401|9355|P1|STARTED|Overall Study||34
4152|NCT02532998|9363|P1|NOT COMPLETED|Overall Study||0
4153|NCT02532998|9363|P1|COMPLETED|Overall Study||23
4154|NCT02532998|9363|P1|STARTED|Overall Study||23
4155|NCT02532374|9445|P1|NOT COMPLETED|Overall Study||2
4156|NCT02532374|9445|P1|COMPLETED|Overall Study||14
4157|NCT02532374|9445|P1|STARTED|Overall Study||16
4158|NCT02531867|9469|P1|NOT COMPLETED|Overall Study||0
4159|NCT02531867|9469|P1|COMPLETED|Overall Study||13
4160|NCT02531867|9469|P1|STARTED|Overall Study||13
4161|NCT02531646|9476|P3|NOT COMPLETED|Overall Study||0
4162|NCT02531646|9477|P2|NOT COMPLETED|Overall Study||1
4163|NCT02531646|9478|P1|NOT COMPLETED|Overall Study||5
4164|NCT02531646|9476|P3|COMPLETED|Overall Study||11
4165|NCT02531646|9477|P2|COMPLETED|Overall Study||17
4166|NCT02531646|9478|P1|COMPLETED|Overall Study||32
4167|NCT02531646|9476|P3|STARTED|Overall Study||11
4168|NCT02531646|9477|P2|STARTED|Overall Study||18
4169|NCT02531646|9478|P1|STARTED|Overall Study||37
4170|NCT02531308|9492|P1|NOT COMPLETED|Overall Study||3
4171|NCT02531308|9492|P1|COMPLETED|Overall Study||2
4172|NCT02531308|9492|P1|STARTED|Overall Study||5
4173|NCT02530671|9498|P2|NOT COMPLETED|Overall Study||0
4174|NCT02530671|9499|P1|NOT COMPLETED|Overall Study||3
4175|NCT02530671|9498|P2|COMPLETED|Overall Study||55
4176|NCT02530671|9499|P1|COMPLETED|Overall Study||52
4177|NCT02530671|9498|P2|STARTED|Overall Study||55
4178|NCT02530671|9499|P1|STARTED|Overall Study||55
4179|NCT02530450|9517|P2|NOT COMPLETED|Overall Study||5
4180|NCT02530450|9518|P1|NOT COMPLETED|Overall Study||6
4181|NCT02530450|9517|P2|COMPLETED|Overall Study||9
4182|NCT02530450|9518|P1|COMPLETED|Overall Study||10
4183|NCT02530450|9517|P2|STARTED|Overall Study||14
4184|NCT02530450|9518|P1|STARTED|Overall Study||16
4185|NCT02529995|9526|P2|NOT COMPLETED|Part B||0
4186|NCT02529995|9527|P1|NOT COMPLETED|Part B||0
4187|NCT02529995|9526|P2|COMPLETED|Part B||0
4188|NCT02529995|9527|P1|COMPLETED|Part B||0
4189|NCT02529995|9526|P2|STARTED|Part B||0
4190|NCT02529995|9527|P1|STARTED|Part B||0
4191|NCT02529995|9526|P2|NOT COMPLETED|Part A||16
4192|NCT02529995|9527|P1|NOT COMPLETED|Part A||15
4193|NCT02529995|9526|P2|COMPLETED|Part A||0
4194|NCT02529995|9527|P1|COMPLETED|Part A||0
4195|NCT02529995|9526|P2|STARTED|Part A||16
4196|NCT02529995|9527|P1|STARTED|Part A||15
4197|NCT02528721|9563|P2|NOT COMPLETED|Overall Study||3
4198|NCT02528721|9564|P1|NOT COMPLETED|Overall Study||7
4199|NCT02528721|9563|P2|COMPLETED|Overall Study||76
4200|NCT02528721|9564|P1|COMPLETED|Overall Study||196
4201|NCT02528721|9563|P2|STARTED|Overall Study||79
4202|NCT02528721|9564|P1|STARTED|Overall Study||203
4203|NCT02528331|9574|P1|NOT COMPLETED|Overall Study||2
4204|NCT02528331|9574|P1|COMPLETED|Overall Study||0
4205|NCT02528331|9574|P1|STARTED|Overall Study||2
4206|NCT02528097|9583|P2|NOT COMPLETED|Overall Study||0
4207|NCT02528097|9584|P1|NOT COMPLETED|Overall Study||0
4208|NCT02528097|9583|P2|COMPLETED|Overall Study||1
4209|NCT02528097|9584|P1|COMPLETED|Overall Study||1
4210|NCT02528097|9583|P2|STARTED|Overall Study||1
4211|NCT02528097|9584|P1|STARTED|Overall Study||1
4212|NCT02527161|9592|P1|NOT COMPLETED|Overall Study||62
4213|NCT02527161|9592|P1|COMPLETED|Overall Study|Completed/Not completed counts are for knees at the 6 mo primary outcome interval.|96
4214|NCT02527161|9592|P1|STARTED|Overall Study|All results are reported by knee throughout record. Participant=knee.|158
4215|NCT02527148|9611|P2|NOT COMPLETED|Overall Study||0
4216|NCT02527148|9612|P1|NOT COMPLETED|Overall Study||1
4217|NCT02527148|9611|P2|COMPLETED|Overall Study||50
4218|NCT02527148|9612|P1|COMPLETED|Overall Study||49
4219|NCT02527148|9611|P2|STARTED|Overall Study||50
4220|NCT02527148|9612|P1|STARTED|Overall Study||50
4221|NCT02526550|9630|P1|NOT COMPLETED|Overall Study||1
4222|NCT02526550|9630|P1|COMPLETED|Overall Study||49
4223|NCT02526550|9630|P1|STARTED|Overall Study||50
4224|NCT02525536|9639|P3|NOT COMPLETED|Overall Study||0
4225|NCT02525536|9640|P2|NOT COMPLETED|Overall Study||0
4226|NCT02525536|9641|P1|NOT COMPLETED|Overall Study||0
4227|NCT02525536|9639|P3|COMPLETED|Overall Study||6
4228|NCT02525536|9640|P2|COMPLETED|Overall Study||6
4229|NCT02525536|9641|P1|COMPLETED|Overall Study||6
4230|NCT02525536|9639|P3|STARTED|Overall Study||6
4231|NCT02525536|9640|P2|STARTED|Overall Study||6
4232|NCT02525536|9641|P1|STARTED|Overall Study||6
4233|NCT02524665|9712|P1|NOT COMPLETED|Overall Study||1
4234|NCT02524665|9712|P1|COMPLETED|Overall Study||19
4235|NCT02524665|9712|P1|STARTED|Overall Study||20
4236|NCT02524561|9730|P3|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
4237|NCT02524561|9731|P2|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
4238|NCT02524561|9732|P1|NOT COMPLETED|Final: Year 3 or 4 Post-randomization||0
4239|NCT02524561|9730|P3|COMPLETED|Final: Year 3 or 4 Post-randomization||187
4240|NCT02524561|9731|P2|COMPLETED|Final: Year 3 or 4 Post-randomization||162
4241|NCT02524561|9732|P1|COMPLETED|Final: Year 3 or 4 Post-randomization||168
4242|NCT02524561|9730|P3|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||151
4243|NCT02524561|9731|P2|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||139
4244|NCT02524561|9732|P1|Obtained Year 3 or 4 Mammogram|Final: Year 3 or 4 Post-randomization||143
4245|NCT02524561|9730|P3|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|187
4246|NCT02524561|9731|P2|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|162
4247|NCT02524561|9732|P1|STARTED|Final: Year 3 or 4 Post-randomization|Consented to MDBHAS|168
4248|NCT02524561|9730|P3|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
4249|NCT02524561|9731|P2|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
4250|NCT02524561|9732|P1|NOT COMPLETED|Year 1: Post Randomization Mammograms||0
4251|NCT02524561|9730|P3|COMPLETED|Year 1: Post Randomization Mammograms||187
4252|NCT02524561|9731|P2|COMPLETED|Year 1: Post Randomization Mammograms||162
4253|NCT02524561|9732|P1|COMPLETED|Year 1: Post Randomization Mammograms||168
4254|NCT02524561|9730|P3|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|148
4255|NCT02524561|9731|P2|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post randomization mammogram|123
4256|NCT02524561|9732|P1|Obtained Mammogam|Year 1: Post Randomization Mammograms|Obtained post-randomization mammogram|136
4257|NCT02524561|9730|P3|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|187
4258|NCT02524561|9731|P2|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|162
4259|NCT02524561|9732|P1|STARTED|Year 1: Post Randomization Mammograms|Consented to MDBHAS|168
4260|NCT02524561|9730|P3|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
4261|NCT02524561|9731|P2|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
4262|NCT02524561|9732|P1|NOT COMPLETED|Baseline: Pre-randomization Mammogram||0
4263|NCT02524561|9730|P3|COMPLETED|Baseline: Pre-randomization Mammogram||187
4264|NCT02524561|9731|P2|COMPLETED|Baseline: Pre-randomization Mammogram||162
4265|NCT02524561|9732|P1|COMPLETED|Baseline: Pre-randomization Mammogram||168
4266|NCT02524561|9730|P3|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||151
4267|NCT02524561|9731|P2|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||133
4268|NCT02524561|9732|P1|Obtained Baseline Mammogram|Baseline: Pre-randomization Mammogram||137
4269|NCT02524561|9730|P3|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS.|187
4270|NCT02524561|9731|P2|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|162
4271|NCT02524561|9732|P1|STARTED|Baseline: Pre-randomization Mammogram|Consented to MDBHAS|168
4272|NCT02524418|9749|P1|NOT COMPLETED|Overall Study||13
4273|NCT02524418|9749|P1|COMPLETED|Overall Study||75
4274|NCT02524418|9749|P1|STARTED|Overall Study||88
4275|NCT02522624|9765|P2|NOT COMPLETED|Overall Study||0
4276|NCT02522624|9766|P1|NOT COMPLETED|Overall Study||1
4277|NCT02522624|9765|P2|COMPLETED|Overall Study||163
4278|NCT02522624|9766|P1|COMPLETED|Overall Study|Discontinued intervention due to technical failure (n=1)|164
4279|NCT02522624|9765|P2|STARTED|Overall Study||163
4280|NCT02522624|9766|P1|STARTED|Overall Study||165
4281|NCT02520414|9782|P1|NOT COMPLETED|Overall Study||0
4282|NCT02520414|9782|P1|COMPLETED|Overall Study||10
4283|NCT02520414|9782|P1|STARTED|Overall Study||10
4284|NCT02519855|9788|P2|NOT COMPLETED|Overall Study||4
4285|NCT02519855|9789|P1|NOT COMPLETED|Overall Study||3
4286|NCT02519855|9788|P2|COMPLETED|Overall Study||437
4287|NCT02519855|9789|P1|COMPLETED|Overall Study||438
4288|NCT02519855|9788|P2|Vaccinated at Week 4|Overall Study||424
4289|NCT02519855|9789|P1|Vaccinated at Week 4|Overall Study||432
4290|NCT02519855|9788|P2|Vaccinated on Day 1|Overall Study||441
4291|NCT02519855|9789|P1|Vaccinated on Day 1|Overall Study||440
4292|NCT02519855|9788|P2|STARTED|Overall Study|Participants are included as treated|441
4293|NCT02519855|9789|P1|STARTED|Overall Study|Participants are included as treated|441
4294|NCT02519595|9808|P3|NOT COMPLETED|Overall Study||16
4295|NCT02519595|9809|P2|NOT COMPLETED|Overall Study||22
4296|NCT02519595|9810|P1|NOT COMPLETED|Overall Study||8
4297|NCT02519595|9808|P3|COMPLETED|Overall Study||40
4298|NCT02519595|9809|P2|COMPLETED|Overall Study||35
4299|NCT02519595|9810|P1|COMPLETED|Overall Study||50
4300|NCT02519595|9808|P3|STARTED|Overall Study||56
4301|NCT02519595|9809|P2|STARTED|Overall Study||57
4302|NCT02519595|9810|P1|STARTED|Overall Study||58
4303|NCT02519387|9833|P1|NOT COMPLETED|Overall Study||22
4304|NCT02519387|9833|P1|COMPLETED|Overall Study||56
4305|NCT02519387|9833|P1|STARTED|Overall Study||78
4306|NCT02518048|9841|P1|NOT COMPLETED|Overall Study||1
4307|NCT02518048|9841|P1|COMPLETED|Overall Study||34
4308|NCT02518048|9841|P1|STARTED|Overall Study||35
4309|NCT02516306|9854|P2|NOT COMPLETED|Period 2: Day 8 - 91||2
4310|NCT02516306|9855|P1|NOT COMPLETED|Period 2: Day 8 - 91||1
4311|NCT02516306|9854|P2|COMPLETED|Period 2: Day 8 - 91||23
4312|NCT02516306|9855|P1|COMPLETED|Period 2: Day 8 - 91||49
4313|NCT02516306|9854|P2|STARTED|Period 2: Day 8 - 91||25
4314|NCT02516306|9855|P1|STARTED|Period 2: Day 8 - 91||50
4315|NCT02516306|9854|P2|NOT COMPLETED|Period 1: Day 1 - 7||0
4316|NCT02516306|9855|P1|NOT COMPLETED|Period 1: Day 1 - 7||0
4317|NCT02516306|9854|P2|COMPLETED|Period 1: Day 1 - 7||25
4318|NCT02516306|9855|P1|COMPLETED|Period 1: Day 1 - 7||50
4319|NCT02516306|9854|P2|STARTED|Period 1: Day 1 - 7||25
4320|NCT02516306|9855|P1|STARTED|Period 1: Day 1 - 7||50
4321|NCT02516163|9861|P1|NOT COMPLETED|Overall Study||28
4322|NCT02516163|9861|P1|COMPLETED|Overall Study||24
4323|NCT02516163|9861|P1|STARTED|Overall Study||52
4324|NCT02516150|9865|P1|NOT COMPLETED|Overall Study||0
4325|NCT02516150|9865|P1|COMPLETED|Overall Study||15
4326|NCT02516150|9865|P1|STARTED|Overall Study||15
4327|NCT02516098|9875|P2|NOT COMPLETED|Washout After Period 2||0
4328|NCT02516098|9876|P1|NOT COMPLETED|Washout After Period 2||0
4329|NCT02516098|9875|P2|COMPLETED|Washout After Period 2||26
4330|NCT02516098|9876|P1|COMPLETED|Washout After Period 2||27
4331|NCT02516098|9875|P2|STARTED|Washout After Period 2||26
4332|NCT02516098|9876|P1|STARTED|Washout After Period 2||27
4333|NCT02516098|9875|P2|NOT COMPLETED|Period 2||1
4334|NCT02516098|9876|P1|NOT COMPLETED|Period 2||0
4335|NCT02516098|9875|P2|COMPLETED|Period 2||26
4336|NCT02516098|9876|P1|COMPLETED|Period 2||27
4337|NCT02516098|9875|P2|STARTED|Period 2||27
4338|NCT02516098|9876|P1|STARTED|Period 2||27
4339|NCT02516098|9875|P2|NOT COMPLETED|Washout After Period 1||1
4340|NCT02516098|9876|P1|NOT COMPLETED|Washout After Period 1||0
4341|NCT02516098|9875|P2|COMPLETED|Washout After Period 1||27
4342|NCT02516098|9876|P1|COMPLETED|Washout After Period 1||27
4343|NCT02516098|9875|P2|STARTED|Washout After Period 1||28
4344|NCT02516098|9876|P1|STARTED|Washout After Period 1||27
4345|NCT02516098|9875|P2|NOT COMPLETED|Period 1||0
4346|NCT02516098|9876|P1|NOT COMPLETED|Period 1||1
4347|NCT02516098|9875|P2|COMPLETED|Period 1||28
4348|NCT02516098|9876|P1|COMPLETED|Period 1||27
4349|NCT02516098|9875|P2|STARTED|Period 1||28
4350|NCT02516098|9876|P1|STARTED|Period 1||28
4351|NCT02515994|9890|P2|NOT COMPLETED|Overall Study||7
4352|NCT02515994|9891|P1|NOT COMPLETED|Overall Study||10
4353|NCT02515994|9890|P2|COMPLETED|Overall Study||105
4354|NCT02515994|9891|P1|COMPLETED|Overall Study||99
4355|NCT02515994|9890|P2|STARTED|Overall Study||112
4356|NCT02515994|9891|P1|STARTED|Overall Study||109
4357|NCT02515279|9903|P1|NOT COMPLETED|Overall Study||104
4358|NCT02515279|9903|P1|COMPLETED|Overall Study||359
4359|NCT02515279|9903|P1|STARTED|Overall Study||463
4360|NCT02515045|9911|P3|NOT COMPLETED|Overall Study||4
4361|NCT02515045|9912|P2|NOT COMPLETED|Overall Study||4
4362|NCT02515045|9913|P1|NOT COMPLETED|Overall Study||0
4363|NCT02515045|9911|P3|COMPLETED|Overall Study||55
4364|NCT02515045|9912|P2|COMPLETED|Overall Study||26
4365|NCT02515045|9913|P1|COMPLETED|Overall Study||29
4366|NCT02515045|9911|P3|STARTED|Overall Study||59
4367|NCT02515045|9912|P2|STARTED|Overall Study||30
4368|NCT02515045|9913|P1|STARTED|Overall Study||29
4369|NCT02513095|9929|P2|NOT COMPLETED|Overall Study||16
4370|NCT02513095|9930|P1|NOT COMPLETED|Overall Study||14
4371|NCT02513095|9929|P2|COMPLETED|Overall Study||1
4372|NCT02513095|9930|P1|COMPLETED|Overall Study||3
4373|NCT02513095|9929|P2|STARTED|Overall Study||17
4374|NCT02513095|9930|P1|STARTED|Overall Study||17
4375|NCT02512900|9938|P2|NOT COMPLETED|Overall Study||0
4376|NCT02512900|9939|P1|NOT COMPLETED|Overall Study||0
4377|NCT02512900|9938|P2|COMPLETED|Overall Study||10
4378|NCT02512900|9939|P1|COMPLETED|Overall Study||11
4379|NCT02512900|9938|P2|STARTED|Overall Study||10
4380|NCT02512900|9939|P1|STARTED|Overall Study||11
4381|NCT02512783|9972|P2|NOT COMPLETED|Overall Study||0
4382|NCT02512783|9973|P1|NOT COMPLETED|Overall Study||0
4383|NCT02512783|9972|P2|COMPLETED|Overall Study||75
4384|NCT02512783|9973|P1|COMPLETED|Overall Study||96
4385|NCT02512783|9972|P2|STARTED|Overall Study||75
4386|NCT02512783|9973|P1|STARTED|Overall Study||96
4387|NCT02512679|9981|P2|NOT COMPLETED|Overall Study||0
4388|NCT02512679|9982|P1|NOT COMPLETED|Overall Study||0
4389|NCT02512679|9981|P2|COMPLETED|Overall Study||0
4390|NCT02512679|9982|P1|COMPLETED|Overall Study||20
4391|NCT02512679|9981|P2|STARTED|Overall Study||0
4392|NCT02512679|9982|P1|STARTED|Overall Study||20
4393|NCT02512393|9992|P2|NOT COMPLETED|Overall Study||0
4394|NCT02512393|9993|P1|NOT COMPLETED|Overall Study||1
4395|NCT02512393|9992|P2|COMPLETED|Overall Study||20
4396|NCT02512393|9993|P1|COMPLETED|Overall Study||20
4397|NCT02512393|9992|P2|STARTED|Overall Study||20
4398|NCT02512393|9993|P1|STARTED|Overall Study||21
4399|NCT02512224|10075|P2|NOT COMPLETED|Overall Study||0
4400|NCT02512224|10076|P1|NOT COMPLETED|Overall Study||0
4401|NCT02512224|10075|P2|COMPLETED|Overall Study||2912
4402|NCT02512224|10076|P1|COMPLETED|Overall Study||2912
4403|NCT02512224|10075|P2|STARTED|Overall Study||2912
4404|NCT02512224|10076|P1|STARTED|Overall Study||2912
4405|NCT02511782|10095|P3|NOT COMPLETED|Overall Study||0
4406|NCT02511782|10096|P2|NOT COMPLETED|Overall Study||0
4407|NCT02511782|10097|P1|NOT COMPLETED|Overall Study||1
4408|NCT02511782|10095|P3|COMPLETED|Overall Study||10
4409|NCT02511782|10096|P2|COMPLETED|Overall Study||2
4410|NCT02511782|10097|P1|COMPLETED|Overall Study||50
4411|NCT02511782|10095|P3|STARTED|Overall Study||10
4412|NCT02511782|10096|P2|STARTED|Overall Study||2
4413|NCT02511782|10097|P1|STARTED|Overall Study||51
4414|NCT02510820|10107|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
4415|NCT02510820|10108|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
4416|NCT02510820|10107|P2|COMPLETED|Second Intervention (4 Weeks)||26
4417|NCT02510820|10108|P1|COMPLETED|Second Intervention (4 Weeks)||20
4418|NCT02510820|10107|P2|STARTED|Second Intervention (4 Weeks)||26
4419|NCT02510820|10108|P1|STARTED|Second Intervention (4 Weeks)||21
4420|NCT02510820|10107|P2|NOT COMPLETED|Washout (1 Week)||0
4421|NCT02510820|10108|P1|NOT COMPLETED|Washout (1 Week)||0
4422|NCT02510820|10107|P2|COMPLETED|Washout (1 Week)||26
4423|NCT02510820|10108|P1|COMPLETED|Washout (1 Week)||21
4424|NCT02510820|10107|P2|STARTED|Washout (1 Week)||26
4425|NCT02510820|10108|P1|STARTED|Washout (1 Week)||21
4426|NCT02510820|10107|P2|NOT COMPLETED|First Intervention (4 Weeks)||1
4427|NCT02510820|10108|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
4428|NCT02510820|10107|P2|COMPLETED|First Intervention (4 Weeks)||26
4429|NCT02510820|10108|P1|COMPLETED|First Intervention (4 Weeks)||21
4430|NCT02510820|10107|P2|STARTED|First Intervention (4 Weeks)||27
4431|NCT02510820|10108|P1|STARTED|First Intervention (4 Weeks)||21
4432|NCT02508103|10148|P2|NOT COMPLETED|Overall Study||0
4433|NCT02508103|10149|P1|NOT COMPLETED|Overall Study||0
4434|NCT02508103|10148|P2|COMPLETED|Overall Study||5
4435|NCT02508103|10149|P1|COMPLETED|Overall Study||5
4436|NCT02508103|10148|P2|STARTED|Overall Study||5
4437|NCT02508103|10149|P1|STARTED|Overall Study||5
4438|NCT02507752|10157|P1|NOT COMPLETED|Overall Study||17
4439|NCT02507752|10157|P1|COMPLETED|Overall Study||55
4440|NCT02507752|10157|P1|STARTED|Overall Study||72
4441|NCT02507375|10177|P2|NOT COMPLETED|Overall Study||8
4442|NCT02507375|10178|P1|NOT COMPLETED|Overall Study||4
4443|NCT02507375|10177|P2|COMPLETED|Overall Study||1
4444|NCT02507375|10178|P1|COMPLETED|Overall Study||2
4445|NCT02507375|10177|P2|Extension Period|Overall Study||1
4446|NCT02507375|10178|P1|Extension Period|Overall Study||2
4447|NCT02507375|10177|P2|Cycle 6|Overall Study||1
4448|NCT02507375|10178|P1|Cycle 6|Overall Study||3
4449|NCT02507375|10177|P2|Cycle 5|Overall Study||1
4450|NCT02507375|10178|P1|Cycle 5|Overall Study||3
4451|NCT02507375|10177|P2|Cycle 4|Overall Study||2
4452|NCT02507375|10178|P1|Cycle 4|Overall Study||4
4453|NCT02507375|10177|P2|Cycle 3|Overall Study||5
4454|NCT02507375|10178|P1|Cycle 3|Overall Study||4
4455|NCT02507375|10177|P2|Cycle 2|Overall Study||5
4456|NCT02507375|10178|P1|Cycle 2|Overall Study||5
4457|NCT02507375|10177|P2|Received Pertuzumab|Overall Study||6
4458|NCT02507375|10178|P1|Received Pertuzumab|Overall Study||6
4459|NCT02507375|10177|P2|Cycle 1|Overall Study||9
4460|NCT02507375|10178|P1|Cycle 1|Overall Study||6
4461|NCT02507375|10177|P2|STARTED|Overall Study|Two patients in cohort 2 did not begin treatment in Cycle 1 so were not included in the analysis set|9
4462|NCT02507375|10178|P1|STARTED|Overall Study||6
4463|NCT02506881|10199|P4|NOT COMPLETED|Second Intervention (Day 1)||0
4464|NCT02506881|10200|P3|NOT COMPLETED|Second Intervention (Day 1)||0
4465|NCT02506881|10201|P2|NOT COMPLETED|Second Intervention (Day 1)||0
4466|NCT02506881|10202|P1|NOT COMPLETED|Second Intervention (Day 1)||0
4467|NCT02506881|10199|P4|COMPLETED|Second Intervention (Day 1)||12
4468|NCT02506881|10200|P3|COMPLETED|Second Intervention (Day 1)||12
4469|NCT02506881|10201|P2|COMPLETED|Second Intervention (Day 1)||12
4470|NCT02506881|10202|P1|COMPLETED|Second Intervention (Day 1)||12
4471|NCT02506881|10199|P4|STARTED|Second Intervention (Day 1)||12
4472|NCT02506881|10200|P3|STARTED|Second Intervention (Day 1)||12
4473|NCT02506881|10201|P2|STARTED|Second Intervention (Day 1)||12
4474|NCT02506881|10202|P1|STARTED|Second Intervention (Day 1)||12
4475|NCT02506881|10199|P4|NOT COMPLETED|Washout (at Least 25 Days)||0
4476|NCT02506881|10200|P3|NOT COMPLETED|Washout (at Least 25 Days)||0
4477|NCT02506881|10201|P2|NOT COMPLETED|Washout (at Least 25 Days)||0
4478|NCT02506881|10202|P1|NOT COMPLETED|Washout (at Least 25 Days)||0
4479|NCT02506881|10199|P4|COMPLETED|Washout (at Least 25 Days)||12
4480|NCT02506881|10200|P3|COMPLETED|Washout (at Least 25 Days)||12
4481|NCT02506881|10201|P2|COMPLETED|Washout (at Least 25 Days)||12
4482|NCT02506881|10202|P1|COMPLETED|Washout (at Least 25 Days)||12
4483|NCT02506881|10199|P4|STARTED|Washout (at Least 25 Days)||12
4484|NCT02506881|10200|P3|STARTED|Washout (at Least 25 Days)||12
4485|NCT02506881|10201|P2|STARTED|Washout (at Least 25 Days)||12
4486|NCT02506881|10202|P1|STARTED|Washout (at Least 25 Days)||12
4487|NCT02506881|10199|P4|NOT COMPLETED|First Intervention (Day 1)||12
4488|NCT02506881|10200|P3|NOT COMPLETED|First Intervention (Day 1)||13
4489|NCT02506881|10201|P2|NOT COMPLETED|First Intervention (Day 1)||0
4490|NCT02506881|10202|P1|NOT COMPLETED|First Intervention (Day 1)||1
4491|NCT02506881|10199|P4|COMPLETED|First Intervention (Day 1)||12
4492|NCT02506881|10200|P3|COMPLETED|First Intervention (Day 1)||12
4493|NCT02506881|10201|P2|COMPLETED|First Intervention (Day 1)||12
4494|NCT02506881|10202|P1|COMPLETED|First Intervention (Day 1)||12
4495|NCT02506881|10199|P4|STARTED|First Intervention (Day 1)||24
4496|NCT02506881|10200|P3|STARTED|First Intervention (Day 1)||25
4497|NCT02506881|10201|P2|STARTED|First Intervention (Day 1)||12
4498|NCT02506881|10202|P1|STARTED|First Intervention (Day 1)||13
4499|NCT02506309|10238|P2|NOT COMPLETED|Overall Study||1
4500|NCT02506309|10239|P1|NOT COMPLETED|Overall Study||2
4501|NCT02506309|10238|P2|COMPLETED|Overall Study||44
4502|NCT02506309|10239|P1|COMPLETED|Overall Study||46
4503|NCT02506309|10238|P2|STARTED|Overall Study||45
4504|NCT02506309|10239|P1|STARTED|Overall Study||48
4505|NCT02506257|10255|P4|NOT COMPLETED|Overall Study||0
4506|NCT02506257|10256|P3|NOT COMPLETED|Overall Study||4
4507|NCT02506257|10257|P2|NOT COMPLETED|Overall Study||2
4508|NCT02506257|10258|P1|NOT COMPLETED|Overall Study||0
4509|NCT02506257|10255|P4|COMPLETED|Overall Study||9
4510|NCT02506257|10256|P3|COMPLETED|Overall Study||23
4511|NCT02506257|10257|P2|COMPLETED|Overall Study||26
4512|NCT02506257|10258|P1|COMPLETED|Overall Study||26
4513|NCT02506257|10255|P4|STARTED|Overall Study||9
4514|NCT02506257|10256|P3|STARTED|Overall Study||27
4515|NCT02506257|10257|P2|STARTED|Overall Study||28
4516|NCT02506257|10258|P1|STARTED|Overall Study||26
4517|NCT02504775|10288|P2|NOT COMPLETED|Period 2||0
4518|NCT02504775|10289|P1|NOT COMPLETED|Period 2||0
4519|NCT02504775|10288|P2|COMPLETED|Period 2||14
4520|NCT02504775|10289|P1|COMPLETED|Period 2||14
4521|NCT02504775|10288|P2|STARTED|Period 2||14
4522|NCT02504775|10289|P1|STARTED|Period 2||14
4523|NCT02504775|10288|P2|NOT COMPLETED|Washout||0
4524|NCT02504775|10289|P1|NOT COMPLETED|Washout||0
4525|NCT02504775|10288|P2|COMPLETED|Washout||14
4526|NCT02504775|10289|P1|COMPLETED|Washout||14
4527|NCT02504775|10288|P2|STARTED|Washout||14
4528|NCT02504775|10289|P1|STARTED|Washout||14
4529|NCT02504775|10288|P2|NOT COMPLETED|Period 1||0
4530|NCT02504775|10289|P1|NOT COMPLETED|Period 1||0
4531|NCT02504775|10288|P2|COMPLETED|Period 1||14
4532|NCT02504775|10289|P1|COMPLETED|Period 1||14
4533|NCT02504775|10288|P2|STARTED|Period 1||14
4534|NCT02504775|10289|P1|STARTED|Period 1||14
4535|NCT02504723|10303|P2|NOT COMPLETED|Overall Study||0
4536|NCT02504723|10304|P1|NOT COMPLETED|Overall Study||0
4537|NCT02504723|10303|P2|COMPLETED|Overall Study||61
4538|NCT02504723|10304|P1|COMPLETED|Overall Study||60
4539|NCT02504723|10303|P2|STARTED|Overall Study||61
4540|NCT02504723|10304|P1|STARTED|Overall Study||60
4541|NCT02504502|10318|P2|NOT COMPLETED|Crossover to Enhanced Report||0
4542|NCT02504502|10319|P1|NOT COMPLETED|Crossover to Enhanced Report||5
4543|NCT02504502|10318|P2|COMPLETED|Crossover to Enhanced Report|the enhanced report arm was completed in first period and does not carry forward to period 2|0
4544|NCT02504502|10319|P1|COMPLETED|Crossover to Enhanced Report||15
4545|NCT02504502|10318|P2|STARTED|Crossover to Enhanced Report|The enhanced report arm was completed in first period and does not carry forward to period 2.|0
4546|NCT02504502|10319|P1|STARTED|Crossover to Enhanced Report||20
4547|NCT02504502|10318|P2|NOT COMPLETED|Routine Care vs. Enhanced Report||7
4548|NCT02504502|10319|P1|NOT COMPLETED|Routine Care vs. Enhanced Report||4
4549|NCT02504502|10318|P2|COMPLETED|Routine Care vs. Enhanced Report||21
4550|NCT02504502|10319|P1|COMPLETED|Routine Care vs. Enhanced Report||20
4551|NCT02504502|10318|P2|STARTED|Routine Care vs. Enhanced Report||28
4552|NCT02504502|10319|P1|STARTED|Routine Care vs. Enhanced Report||24
4553|NCT02504320|10329|P4|NOT COMPLETED|Treatment Period 4||0
4554|NCT02504320|10330|P3|NOT COMPLETED|Treatment Period 4||0
4555|NCT02504320|10331|P2|NOT COMPLETED|Treatment Period 4||0
4556|NCT02504320|10332|P1|NOT COMPLETED|Treatment Period 4||0
4557|NCT02504320|10329|P4|COMPLETED|Treatment Period 4||19
4558|NCT02504320|10330|P3|COMPLETED|Treatment Period 4||18
4559|NCT02504320|10331|P2|COMPLETED|Treatment Period 4||18
4560|NCT02504320|10332|P1|COMPLETED|Treatment Period 4||19
4561|NCT02504320|10329|P4|STARTED|Treatment Period 4||19
4562|NCT02504320|10330|P3|STARTED|Treatment Period 4||18
4563|NCT02504320|10331|P2|STARTED|Treatment Period 4||18
4564|NCT02504320|10332|P1|STARTED|Treatment Period 4||19
4565|NCT02504320|10329|P4|NOT COMPLETED|Treatment Period 3||1
4566|NCT02504320|10330|P3|NOT COMPLETED|Treatment Period 3||1
4567|NCT02504320|10331|P2|NOT COMPLETED|Treatment Period 3||0
4568|NCT02504320|10332|P1|NOT COMPLETED|Treatment Period 3||0
4569|NCT02504320|10329|P4|COMPLETED|Treatment Period 3||19
4570|NCT02504320|10330|P3|COMPLETED|Treatment Period 3||18
4571|NCT02504320|10331|P2|COMPLETED|Treatment Period 3||18
4572|NCT02504320|10332|P1|COMPLETED|Treatment Period 3||19
4573|NCT02504320|10329|P4|STARTED|Treatment Period 3||20
4574|NCT02504320|10330|P3|STARTED|Treatment Period 3||19
4575|NCT02504320|10331|P2|STARTED|Treatment Period 3||18
4576|NCT02504320|10332|P1|STARTED|Treatment Period 3||19
4577|NCT02504320|10329|P4|NOT COMPLETED|Treatment Period 2||0
4578|NCT02504320|10330|P3|NOT COMPLETED|Treatment Period 2||0
4579|NCT02504320|10331|P2|NOT COMPLETED|Treatment Period 2||1
4580|NCT02504320|10332|P1|NOT COMPLETED|Treatment Period 2||0
4581|NCT02504320|10329|P4|COMPLETED|Treatment Period 2||20
4582|NCT02504320|10330|P3|COMPLETED|Treatment Period 2||19
4583|NCT02504320|10331|P2|COMPLETED|Treatment Period 2||18
4584|NCT02504320|10332|P1|COMPLETED|Treatment Period 2||19
4585|NCT02504320|10329|P4|STARTED|Treatment Period 2||20
4586|NCT02504320|10330|P3|STARTED|Treatment Period 2||19
4587|NCT02504320|10331|P2|STARTED|Treatment Period 2||19
4588|NCT02504320|10332|P1|STARTED|Treatment Period 2||19
4589|NCT02504320|10329|P4|NOT COMPLETED|Treatment Period 1||0
4590|NCT02504320|10330|P3|NOT COMPLETED|Treatment Period 1||1
4591|NCT02504320|10331|P2|NOT COMPLETED|Treatment Period 1||0
4592|NCT02504320|10332|P1|NOT COMPLETED|Treatment Period 1||0
4593|NCT02504320|10329|P4|COMPLETED|Treatment Period 1||20
4594|NCT02504320|10330|P3|COMPLETED|Treatment Period 1||19
4595|NCT02504320|10331|P2|COMPLETED|Treatment Period 1||19
4596|NCT02504320|10332|P1|COMPLETED|Treatment Period 1||19
4597|NCT02504320|10329|P4|STARTED|Treatment Period 1||20
4598|NCT02504320|10330|P3|STARTED|Treatment Period 1||20
4599|NCT02504320|10331|P2|STARTED|Treatment Period 1||19
4600|NCT02504320|10332|P1|STARTED|Treatment Period 1||19
4601|NCT02504073|10350|P1|NOT COMPLETED|Overall Study||0
4602|NCT02504073|10350|P1|COMPLETED|Overall Study||54
4603|NCT02504073|10350|P1|STARTED|Overall Study||54
4604|NCT02503982|10356|P1|NOT COMPLETED|Overall Study||0
4605|NCT02503982|10356|P1|COMPLETED|Overall Study||13
4606|NCT02503982|10356|P1|STARTED|Overall Study||13
4607|NCT02503865|10363|P3|NOT COMPLETED|Overall Study||2
4608|NCT02503865|10364|P2|NOT COMPLETED|Overall Study||47
4609|NCT02503865|10365|P1|NOT COMPLETED|Overall Study||5
4610|NCT02503865|10363|P3|COMPLETED|Overall Study||64
4611|NCT02503865|10364|P2|COMPLETED|Overall Study||222
4612|NCT02503865|10365|P1|COMPLETED|Overall Study||65
4613|NCT02503865|10363|P3|STARTED|Overall Study||66
4614|NCT02503865|10364|P2|STARTED|Overall Study||269
4615|NCT02503865|10365|P1|STARTED|Overall Study||70
4616|NCT02503254|10387|P2|NOT COMPLETED|Overall Study||0
4617|NCT02503254|10388|P1|NOT COMPLETED|Overall Study||0
4618|NCT02503254|10387|P2|COMPLETED|Overall Study||39
4619|NCT02503254|10388|P1|COMPLETED|Overall Study||41
4620|NCT02503254|10387|P2|STARTED|Overall Study||39
4621|NCT02503254|10388|P1|STARTED|Overall Study||41
4622|NCT02503215|10401|P1|NOT COMPLETED|Overall Study||3
4623|NCT02503215|10401|P1|COMPLETED|Overall Study||14
4624|NCT02503215|10401|P1|STARTED|Overall Study||17
4625|NCT02502734|10407|P2|NOT COMPLETED|Double-blind Treatment Period 2||0
4626|NCT02502734|10408|P1|NOT COMPLETED|Double-blind Treatment Period 2||0
4627|NCT02502734|10407|P2|COMPLETED|Double-blind Treatment Period 2||30
4628|NCT02502734|10408|P1|COMPLETED|Double-blind Treatment Period 2||28
4629|NCT02502734|10407|P2|STARTED|Double-blind Treatment Period 2||30
4630|NCT02502734|10408|P1|STARTED|Double-blind Treatment Period 2||28
4631|NCT02502734|10407|P2|NOT COMPLETED|Washout Period||0
4632|NCT02502734|10408|P1|NOT COMPLETED|Washout Period||1
4633|NCT02502734|10407|P2|COMPLETED|Washout Period||30
4634|NCT02502734|10408|P1|COMPLETED|Washout Period||28
4635|NCT02502734|10407|P2|STARTED|Washout Period||30
4636|NCT02502734|10408|P1|STARTED|Washout Period||29
4637|NCT02502734|10407|P2|NOT COMPLETED|Double-blind Treatment Period 1||0
4638|NCT02502734|10408|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
4639|NCT02502734|10407|P2|COMPLETED|Double-blind Treatment Period 1||30
4640|NCT02502734|10408|P1|COMPLETED|Double-blind Treatment Period 1||29
4641|NCT02502734|10407|P2|STARTED|Double-blind Treatment Period 1||30
4642|NCT02502734|10408|P1|STARTED|Double-blind Treatment Period 1||30
4643|NCT02502487|10419|P3|NOT COMPLETED|Overall Study||0
4644|NCT02502487|10420|P2|NOT COMPLETED|Overall Study||0
4645|NCT02502487|10421|P1|NOT COMPLETED|Overall Study||0
4646|NCT02502487|10419|P3|COMPLETED|Overall Study||86
4647|NCT02502487|10420|P2|COMPLETED|Overall Study||86
4648|NCT02502487|10421|P1|COMPLETED|Overall Study||86
4649|NCT02502487|10419|P3|STARTED|Overall Study||86
4650|NCT02502487|10420|P2|STARTED|Overall Study||86
4651|NCT02502487|10421|P1|STARTED|Overall Study||86
4652|NCT02501590|10491|P2|NOT COMPLETED|Overall Study||0
4653|NCT02501590|10492|P1|NOT COMPLETED|Overall Study||0
4654|NCT02501590|10491|P2|COMPLETED|Overall Study||35
4655|NCT02501590|10492|P1|COMPLETED|Overall Study||13
4656|NCT02501590|10491|P2|STARTED|Overall Study||35
4657|NCT02501590|10492|P1|STARTED|Overall Study||13
4658|NCT02500836|10501|P3|NOT COMPLETED|Overall Study||1
4659|NCT02500836|10502|P2|NOT COMPLETED|Overall Study||5
4660|NCT02500836|10503|P1|NOT COMPLETED|Overall Study||3
4661|NCT02500836|10501|P3|COMPLETED|Overall Study||127
4662|NCT02500836|10502|P2|COMPLETED|Overall Study||254
4663|NCT02500836|10503|P1|COMPLETED|Overall Study||256
4664|NCT02500836|10501|P3|STARTED|Overall Study||128
4665|NCT02500836|10502|P2|STARTED|Overall Study||259
4666|NCT02500836|10503|P1|STARTED|Overall Study||259
4667|NCT02500758|10514|P2|NOT COMPLETED|Second Intervention (2 Minutes)||2
4668|NCT02500758|10515|P1|NOT COMPLETED|Second Intervention (2 Minutes)||3
4669|NCT02500758|10514|P2|COMPLETED|Second Intervention (2 Minutes)||10
4670|NCT02500758|10515|P1|COMPLETED|Second Intervention (2 Minutes)||10
4671|NCT02500758|10514|P2|STARTED|Second Intervention (2 Minutes)||12
4672|NCT02500758|10515|P1|STARTED|Second Intervention (2 Minutes)||13
4673|NCT02500758|10514|P2|NOT COMPLETED|Washout (1 Week)||2
4674|NCT02500758|10515|P1|NOT COMPLETED|Washout (1 Week)||2
4675|NCT02500758|10514|P2|COMPLETED|Washout (1 Week)||12
4676|NCT02500758|10515|P1|COMPLETED|Washout (1 Week)||13
4677|NCT02500758|10514|P2|STARTED|Washout (1 Week)||14
4678|NCT02500758|10515|P1|STARTED|Washout (1 Week)||15
4679|NCT02500758|10514|P2|NOT COMPLETED|First Intervention (2 Minutes)||1
4680|NCT02500758|10515|P1|NOT COMPLETED|First Intervention (2 Minutes)||0
4681|NCT02500758|10514|P2|COMPLETED|First Intervention (2 Minutes)||14
4682|NCT02500758|10515|P1|COMPLETED|First Intervention (2 Minutes)||15
4683|NCT02500758|10514|P2|STARTED|First Intervention (2 Minutes)||15
4684|NCT02500758|10515|P1|STARTED|First Intervention (2 Minutes)||15
4685|NCT02500537|10525|P2|NOT COMPLETED|Overall Study||1
4686|NCT02500537|10526|P1|NOT COMPLETED|Overall Study||3
4687|NCT02500537|10525|P2|COMPLETED|Overall Study||39
4688|NCT02500537|10526|P1|COMPLETED|Overall Study||57
4689|NCT02500537|10525|P2|STARTED|Overall Study||40
4690|NCT02500537|10526|P1|STARTED|Overall Study||60
4691|NCT02500368|10544|P2|NOT COMPLETED|Second Intervention (1 Week)||0
4692|NCT02500368|10545|P1|NOT COMPLETED|Second Intervention (1 Week)||0
4693|NCT02500368|10544|P2|COMPLETED|Second Intervention (1 Week)||20
4694|NCT02500368|10545|P1|COMPLETED|Second Intervention (1 Week)||20
4695|NCT02500368|10544|P2|STARTED|Second Intervention (1 Week)||20
4696|NCT02500368|10545|P1|STARTED|Second Intervention (1 Week)||20
4697|NCT02500368|10544|P2|NOT COMPLETED|First Intervention (1 Week)||0
4698|NCT02500368|10545|P1|NOT COMPLETED|First Intervention (1 Week)||0
4699|NCT02500368|10544|P2|COMPLETED|First Intervention (1 Week)||20
4700|NCT02500368|10545|P1|COMPLETED|First Intervention (1 Week)||20
4701|NCT02500368|10544|P2|STARTED|First Intervention (1 Week)||20
4702|NCT02500368|10545|P1|STARTED|First Intervention (1 Week)||20
4703|NCT02500056|10595|P2|NOT COMPLETED|Overall Study||8
4704|NCT02500056|10596|P1|NOT COMPLETED|Overall Study||7
4705|NCT02500056|10595|P2|COMPLETED|Overall Study||65
4706|NCT02500056|10596|P1|COMPLETED|Overall Study||63
4707|NCT02500056|10595|P2|STARTED|Overall Study||73
4708|NCT02500056|10596|P1|STARTED|Overall Study||70
4709|NCT02499692|10606|P1|NOT COMPLETED|Overall Study||0
4710|NCT02499692|10606|P1|COMPLETED|Overall Study||103
4711|NCT02499692|10606|P1|STARTED|Overall Study||103
4712|NCT02499575|10617|P2|NOT COMPLETED|Overall Study||1
4713|NCT02499575|10618|P1|NOT COMPLETED|Overall Study||0
4714|NCT02499575|10617|P2|COMPLETED|Overall Study||0
4715|NCT02499575|10618|P1|COMPLETED|Overall Study||1
4716|NCT02499575|10617|P2|STARTED|Overall Study||1
4717|NCT02499575|10618|P1|STARTED|Overall Study||1
4718|NCT02498821|10630|P2|NOT COMPLETED|Overall Study||5
4719|NCT02498821|10631|P1|NOT COMPLETED|Overall Study||3
4720|NCT02498821|10630|P2|COMPLETED|Overall Study||60
4721|NCT02498821|10631|P1|COMPLETED|Overall Study||60
4722|NCT02498821|10630|P2|STARTED|Overall Study||65
4723|NCT02498821|10631|P1|STARTED|Overall Study||63
4724|NCT02498678|10660|P2|NOT COMPLETED|Overall Study||2
4725|NCT02498678|10661|P1|NOT COMPLETED|Overall Study||0
4726|NCT02498678|10660|P2|COMPLETED|Overall Study||23
4727|NCT02498678|10661|P1|COMPLETED|Overall Study||25
4728|NCT02498678|10660|P2|STARTED|Overall Study||25
4729|NCT02498678|10661|P1|STARTED|Overall Study||25
4730|NCT02498522|10677|P2|NOT COMPLETED|Overall Study||2
4731|NCT02498522|10678|P1|NOT COMPLETED|Overall Study||2
4732|NCT02498522|10677|P2|COMPLETED|Overall Study||83
4733|NCT02498522|10678|P1|COMPLETED|Overall Study||83
4734|NCT02498522|10677|P2|STARTED|Overall Study||85
4735|NCT02498522|10678|P1|STARTED|Overall Study||85
4736|NCT02497235|10689|P5|NOT COMPLETED|Overall Study||0
4737|NCT02497235|10690|P4|NOT COMPLETED|Overall Study||0
4738|NCT02497235|10691|P3|NOT COMPLETED|Overall Study||0
4739|NCT02497235|10692|P2|NOT COMPLETED|Overall Study||0
4740|NCT02497235|10693|P1|NOT COMPLETED|Overall Study||0
4741|NCT02497235|10689|P5|COMPLETED|Overall Study||3
4742|NCT02497235|10690|P4|COMPLETED|Overall Study||2
4743|NCT02497235|10691|P3|COMPLETED|Overall Study||2
4744|NCT02497235|10692|P2|COMPLETED|Overall Study||2
4745|NCT02497235|10693|P1|COMPLETED|Overall Study||2
4746|NCT02497235|10689|P5|STARTED|Overall Study||3
4747|NCT02497235|10690|P4|STARTED|Overall Study||2
4748|NCT02497235|10691|P3|STARTED|Overall Study||2
4749|NCT02497235|10692|P2|STARTED|Overall Study||2
4750|NCT02497235|10693|P1|STARTED|Overall Study||2
4751|NCT02496533|10725|P2|NOT COMPLETED|Overall Study||6
4752|NCT02496533|10726|P1|NOT COMPLETED|Overall Study||3
4753|NCT02496533|10725|P2|COMPLETED|Overall Study||106
4754|NCT02496533|10726|P1|COMPLETED|Overall Study||102
4755|NCT02496533|10725|P2|STARTED|Overall Study||112
4756|NCT02496533|10726|P1|STARTED|Overall Study||105
4757|NCT02496221|10738|P2|NOT COMPLETED|Treatment Period 2 - 4 Days||1
4758|NCT02496221|10739|P1|NOT COMPLETED|Treatment Period 2 - 4 Days||2
4759|NCT02496221|10738|P2|COMPLETED|Treatment Period 2 - 4 Days||9
4760|NCT02496221|10739|P1|COMPLETED|Treatment Period 2 - 4 Days||8
4761|NCT02496221|10738|P2|STARTED|Treatment Period 2 - 4 Days||10
4762|NCT02496221|10739|P1|STARTED|Treatment Period 2 - 4 Days||10
4763|NCT02496221|10738|P2|NOT COMPLETED|Treatment Period 1 - 4 Days||0
4764|NCT02496221|10739|P1|NOT COMPLETED|Treatment Period 1 - 4 Days||0
4765|NCT02496221|10738|P2|COMPLETED|Treatment Period 1 - 4 Days||10
4766|NCT02496221|10739|P1|COMPLETED|Treatment Period 1 - 4 Days||10
4767|NCT02496221|10738|P2|STARTED|Treatment Period 1 - 4 Days||10
4768|NCT02496221|10739|P1|STARTED|Treatment Period 1 - 4 Days||10
4769|NCT02496039|10773|P1|NOT COMPLETED|Overall Study||4
4770|NCT02496039|10773|P1|COMPLETED|Overall Study||1
4771|NCT02496039|10773|P1|STARTED|Overall Study||5
4772|NCT02496000|10788|P3|NOT COMPLETED|Overall Study||2
4773|NCT02496000|10789|P2|NOT COMPLETED|Overall Study||5
4774|NCT02496000|10790|P1|NOT COMPLETED|Overall Study||2
4775|NCT02496000|10788|P3|COMPLETED|Overall Study||61
4776|NCT02496000|10789|P2|COMPLETED|Overall Study||56
4777|NCT02496000|10790|P1|COMPLETED|Overall Study||62
4778|NCT02496000|10788|P3|STARTED|Overall Study||63
4779|NCT02496000|10789|P2|STARTED|Overall Study||61
4780|NCT02496000|10790|P1|STARTED|Overall Study||64
4781|NCT02495948|10799|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
4782|NCT02495948|10800|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
4783|NCT02495948|10799|P2|COMPLETED|Period 2, Second 30 Days of Wear||82
4784|NCT02495948|10800|P1|COMPLETED|Period 2, Second 30 Days of Wear||82
4785|NCT02495948|10799|P2|STARTED|Period 2, Second 30 Days of Wear||83
4786|NCT02495948|10800|P1|STARTED|Period 2, Second 30 Days of Wear||83
4787|NCT02495948|10799|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
4788|NCT02495948|10800|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
4789|NCT02495948|10799|P2|COMPLETED|Period 1, First 30 Days of Wear||83
4790|NCT02495948|10800|P1|COMPLETED|Period 1, First 30 Days of Wear||83
4791|NCT02495948|10799|P2|STARTED|Period 1, First 30 Days of Wear||84
4792|NCT02495948|10800|P1|STARTED|Period 1, First 30 Days of Wear||83
4793|NCT02495831|10807|P2|NOT COMPLETED|Second Intervention||0
4794|NCT02495831|10808|P1|NOT COMPLETED|Second Intervention||0
4795|NCT02495831|10807|P2|COMPLETED|Second Intervention||10
4796|NCT02495831|10808|P1|COMPLETED|Second Intervention||12
4797|NCT02495831|10807|P2|STARTED|Second Intervention||10
4798|NCT02495831|10808|P1|STARTED|Second Intervention|One participant withdrew at the end of period 1|12
4799|NCT02495831|10807|P2|NOT COMPLETED|First Intervention||0
4800|NCT02495831|10808|P1|NOT COMPLETED|First Intervention||0
4801|NCT02495831|10807|P2|COMPLETED|First Intervention||10
4802|NCT02495831|10808|P1|COMPLETED|First Intervention||13
4803|NCT02495831|10807|P2|STARTED|First Intervention||10
4804|NCT02495831|10808|P1|STARTED|First Intervention||13
4805|NCT02495623|10825|P3|NOT COMPLETED|Overall Study||8
4806|NCT02495623|10826|P2|NOT COMPLETED|Overall Study||9
4807|NCT02495623|10827|P1|NOT COMPLETED|Overall Study||5
4808|NCT02495623|10825|P3|COMPLETED|Overall Study||20
4809|NCT02495623|10826|P2|COMPLETED|Overall Study||17
4810|NCT02495623|10827|P1|COMPLETED|Overall Study||20
4811|NCT02495623|10825|P3|Dosed|Overall Study||22
4812|NCT02495623|10826|P2|Dosed|Overall Study||19
4813|NCT02495623|10827|P1|Dosed|Overall Study||22
4814|NCT02495623|10825|P3|STARTED|Overall Study||28
4815|NCT02495623|10826|P2|STARTED|Overall Study||26
4816|NCT02495623|10827|P1|STARTED|Overall Study||25
4817|NCT02493855|10838|P3|NOT COMPLETED|Overall Study||0
4818|NCT02493855|10839|P2|NOT COMPLETED|Overall Study||1
4819|NCT02493855|10840|P1|NOT COMPLETED|Overall Study||2
4820|NCT02493855|10838|P3|COMPLETED|Overall Study||6
4821|NCT02493855|10839|P2|COMPLETED|Overall Study||18
4822|NCT02493855|10840|P1|COMPLETED|Overall Study||19
4823|NCT02493855|10838|P3|STARTED|Overall Study||6
4824|NCT02493855|10839|P2|STARTED|Overall Study||19
4825|NCT02493855|10840|P1|STARTED|Overall Study||21
4826|NCT02494596|10848|P3|NOT COMPLETED|Overall Study||1
4827|NCT02494596|10849|P2|NOT COMPLETED|Overall Study||5
4828|NCT02494596|10850|P1|NOT COMPLETED|Overall Study||3
4829|NCT02494596|10848|P3|COMPLETED|Overall Study||6
4830|NCT02494596|10849|P2|COMPLETED|Overall Study||2
4831|NCT02494596|10850|P1|COMPLETED|Overall Study||2
4832|NCT02494596|10848|P3|STARTED|Overall Study||7
4833|NCT02494596|10849|P2|STARTED|Overall Study||7
4834|NCT02494596|10850|P1|STARTED|Overall Study||5
4835|NCT02494440|10875|P1|NOT COMPLETED|Overall Study||0
4836|NCT02494440|10875|P1|COMPLETED|Overall Study||90
4837|NCT02494440|10875|P1|STARTED|Overall Study||90
4838|NCT02494323|10881|P1|NOT COMPLETED|Overall Study||0
4839|NCT02494323|10881|P1|COMPLETED|Overall Study||70
4840|NCT02494323|10881|P1|STARTED|Overall Study||70
4841|NCT02493127|10888|P2|NOT COMPLETED|Overall Study||1
4842|NCT02493127|10889|P1|NOT COMPLETED|Overall Study||1
4843|NCT02493127|10888|P2|COMPLETED|Overall Study||60
4844|NCT02493127|10889|P1|COMPLETED|Overall Study||60
4845|NCT02493127|10888|P2|STARTED|Overall Study||61
4846|NCT02493127|10889|P1|STARTED|Overall Study||61
4847|NCT02493088|10901|P1|NOT COMPLETED|Overall Study||0
4848|NCT02493088|10901|P1|COMPLETED|Overall Study||11
4849|NCT02493088|10901|P1|STARTED|Overall Study||11
4850|NCT02493036|10910|P3|NOT COMPLETED|Overall Study||2
4851|NCT02493036|10911|P2|NOT COMPLETED|Overall Study||2
4852|NCT02493036|10912|P1|NOT COMPLETED|Overall Study||1
4853|NCT02493036|10910|P3|COMPLETED|Overall Study||15
4854|NCT02493036|10911|P2|COMPLETED|Overall Study||18
4855|NCT02493036|10912|P1|COMPLETED|Overall Study||16
4856|NCT02493036|10910|P3|STARTED|Overall Study||17
4857|NCT02493036|10911|P2|STARTED|Overall Study||20
4858|NCT02493036|10912|P1|STARTED|Overall Study||17
4859|NCT02492984|10922|P2|NOT COMPLETED|Overall Study||0
4860|NCT02492984|10923|P1|NOT COMPLETED|Overall Study||3
4861|NCT02492984|10922|P2|COMPLETED|Overall Study||14
4862|NCT02492984|10923|P1|COMPLETED|Overall Study||70
4863|NCT02492984|10922|P2|STARTED|Overall Study||14
4864|NCT02492984|10923|P1|STARTED|Overall Study||73
4865|NCT02492841|10946|P3|NOT COMPLETED|Overall Study||35
4866|NCT02492841|10947|P2|NOT COMPLETED|Overall Study||31
4867|NCT02492841|10948|P1|NOT COMPLETED|Overall Study||34
4868|NCT02492841|10946|P3|COMPLETED|Overall Study||25
4869|NCT02492841|10947|P2|COMPLETED|Overall Study||22
4870|NCT02492841|10948|P1|COMPLETED|Overall Study||22
4871|NCT02492841|10946|P3|STARTED|Overall Study||60
4872|NCT02492841|10947|P2|STARTED|Overall Study||53
4873|NCT02492841|10948|P1|STARTED|Overall Study||56
4874|NCT02492451|10962|P3|NOT COMPLETED|Overall Study||0
4875|NCT02492451|10963|P2|NOT COMPLETED|Overall Study||0
4876|NCT02492451|10964|P1|NOT COMPLETED|Overall Study||0
4877|NCT02492451|10962|P3|COMPLETED|Overall Study||39
4878|NCT02492451|10963|P2|COMPLETED|Overall Study||39
4879|NCT02492451|10964|P1|COMPLETED|Overall Study||40
4880|NCT02492451|10962|P3|STARTED|Overall Study||39
4881|NCT02492451|10963|P2|STARTED|Overall Study||39
4882|NCT02492451|10964|P1|STARTED|Overall Study||40
4883|NCT02492165|10976|P4|NOT COMPLETED|Overall Study||0
4884|NCT02492165|10977|P3|NOT COMPLETED|Overall Study||0
4885|NCT02492165|10978|P2|NOT COMPLETED|Overall Study||1
4886|NCT02492165|10979|P1|NOT COMPLETED|Overall Study||0
4887|NCT02492165|10976|P4|COMPLETED|Overall Study||30
4888|NCT02492165|10977|P3|COMPLETED|Overall Study||60
4889|NCT02492165|10978|P2|COMPLETED|Overall Study||59
4890|NCT02492165|10979|P1|COMPLETED|Overall Study||100
4891|NCT02492165|10976|P4|STARTED|Overall Study||30
4892|NCT02492165|10977|P3|STARTED|Overall Study||60
4893|NCT02492165|10978|P2|STARTED|Overall Study||60
4894|NCT02492165|10979|P1|STARTED|Overall Study||100
4895|NCT02491944|11001|P1|NOT COMPLETED|Overall Study||0
4896|NCT02491944|11001|P1|COMPLETED|Overall Study||10
4897|NCT02491944|11001|P1|STARTED|Overall Study||10
4898|NCT02491892|11023|P2|NOT COMPLETED|Overall Study||38
4899|NCT02491892|11024|P1|NOT COMPLETED|Overall Study||41
4900|NCT02491892|11023|P2|COMPLETED|Overall Study||0
4901|NCT02491892|11024|P1|COMPLETED|Overall Study||0
4902|NCT02491892|11023|P2|Treated|Overall Study|One participant was randomized but died before receiving study medication.|37
4903|NCT02491892|11024|P1|Treated|Overall Study||41
4904|NCT02491892|11023|P2|STARTED|Overall Study||38
4905|NCT02491892|11024|P1|STARTED|Overall Study||41
4906|NCT02490670|11070|P2|NOT COMPLETED|Period 2 (19 Days)||0
4907|NCT02490670|11071|P1|NOT COMPLETED|Period 2 (19 Days)||0
4908|NCT02490670|11070|P2|COMPLETED|Period 2 (19 Days)||14
4909|NCT02490670|11071|P1|COMPLETED|Period 2 (19 Days)||14
4910|NCT02490670|11070|P2|STARTED|Period 2 (19 Days)||14
4911|NCT02490670|11071|P1|STARTED|Period 2 (19 Days)||14
4912|NCT02490670|11070|P2|NOT COMPLETED|Washout Period (7 Days)||0
4913|NCT02490670|11071|P1|NOT COMPLETED|Washout Period (7 Days)||0
4914|NCT02490670|11070|P2|COMPLETED|Washout Period (7 Days)||14
4915|NCT02490670|11071|P1|COMPLETED|Washout Period (7 Days)||14
4916|NCT02490670|11070|P2|STARTED|Washout Period (7 Days)||14
4917|NCT02490670|11071|P1|STARTED|Washout Period (7 Days)||14
4918|NCT02490670|11070|P2|NOT COMPLETED|Period 1 (19 Days)||0
4919|NCT02490670|11071|P1|NOT COMPLETED|Period 1 (19 Days)||0
4920|NCT02490670|11070|P2|COMPLETED|Period 1 (19 Days)||14
4921|NCT02490670|11071|P1|COMPLETED|Period 1 (19 Days)||14
4922|NCT02490670|11070|P2|STARTED|Period 1 (19 Days)||14
4923|NCT02490670|11071|P1|STARTED|Period 1 (19 Days)||14
4924|NCT02490475|11083|P4|NOT COMPLETED|Period 2: Extension Phase||1
4925|NCT02490475|11084|P3|NOT COMPLETED|Period 2: Extension Phase||3
4926|NCT02490475|11085|P2|NOT COMPLETED|Period 2: Extension Phase||0
4927|NCT02490475|11086|P1|NOT COMPLETED|Period 2: Extension Phase||1
4928|NCT02490475|11083|P4|COMPLETED|Period 2: Extension Phase||0
4929|NCT02490475|11084|P3|COMPLETED|Period 2: Extension Phase||0
4930|NCT02490475|11085|P2|COMPLETED|Period 2: Extension Phase||0
4931|NCT02490475|11086|P1|COMPLETED|Period 2: Extension Phase||0
4932|NCT02490475|11083|P4|STARTED|Period 2: Extension Phase||1
4933|NCT02490475|11084|P3|STARTED|Period 2: Extension Phase||3
4934|NCT02490475|11085|P2|STARTED|Period 2: Extension Phase||0
4935|NCT02490475|11086|P1|STARTED|Period 2: Extension Phase||1
4936|NCT02490475|11083|P4|NOT COMPLETED|Period 1: First 6 Cycles||5
4937|NCT02490475|11084|P3|NOT COMPLETED|Period 1: First 6 Cycles||6
4938|NCT02490475|11085|P2|NOT COMPLETED|Period 1: First 6 Cycles||2
4939|NCT02490475|11086|P1|NOT COMPLETED|Period 1: First 6 Cycles||6
4940|NCT02490475|11083|P4|COMPLETED|Period 1: First 6 Cycles||0
4941|NCT02490475|11084|P3|COMPLETED|Period 1: First 6 Cycles||0
4942|NCT02490475|11085|P2|COMPLETED|Period 1: First 6 Cycles||0
4943|NCT02490475|11086|P1|COMPLETED|Period 1: First 6 Cycles||0
4944|NCT02490475|11083|P4|STARTED|Period 1: First 6 Cycles||5
4945|NCT02490475|11084|P3|STARTED|Period 1: First 6 Cycles||6
4946|NCT02490475|11085|P2|STARTED|Period 1: First 6 Cycles||2
4947|NCT02490475|11086|P1|STARTED|Period 1: First 6 Cycles||6
4948|NCT02490293|11164|P2|NOT COMPLETED|Overall Study||3
4949|NCT02490293|11165|P1|NOT COMPLETED|Overall Study||2
4950|NCT02490293|11164|P2|COMPLETED|Overall Study||99
4951|NCT02490293|11165|P1|COMPLETED|Overall Study||94
4952|NCT02490293|11164|P2|STARTED|Overall Study||102
4953|NCT02490293|11165|P1|STARTED|Overall Study||96
4954|NCT02489799|11175|P2|NOT COMPLETED|Overall Study||9
4955|NCT02489799|11176|P1|NOT COMPLETED|Overall Study||9
4956|NCT02489799|11175|P2|COMPLETED|Overall Study||38
4957|NCT02489799|11176|P1|COMPLETED|Overall Study||36
4958|NCT02489799|11175|P2|Postsurgical One Week Visit (V3)|Overall Study||39
4959|NCT02489799|11176|P1|Postsurgical One Week Visit (V3)|Overall Study||40
4960|NCT02489799|11175|P2|Presurgical Consent Visit (V2)|Overall Study||39
4961|NCT02489799|11176|P1|Presurgical Consent Visit (V2)|Overall Study||40
4962|NCT02489799|11175|P2|STARTED|Overall Study||47
4963|NCT02489799|11176|P1|STARTED|Overall Study||45
4964|NCT02488980|11203|P3|NOT COMPLETED|Overall Study||2
4965|NCT02488980|11204|P2|NOT COMPLETED|Overall Study||2
4966|NCT02488980|11205|P1|NOT COMPLETED|Overall Study||2
4967|NCT02488980|11203|P3|COMPLETED|Overall Study||99
4968|NCT02488980|11204|P2|COMPLETED|Overall Study||99
4969|NCT02488980|11205|P1|COMPLETED|Overall Study||102
4970|NCT02488980|11203|P3|STARTED|Overall Study||101
4971|NCT02488980|11204|P2|STARTED|Overall Study||101
4972|NCT02488980|11205|P1|STARTED|Overall Study||104
4973|NCT02488317|11224|P2|NOT COMPLETED|Overall Study||47
4974|NCT02488317|11225|P1|NOT COMPLETED|Overall Study||54
4975|NCT02488317|11224|P2|COMPLETED|Overall Study||70
4976|NCT02488317|11225|P1|COMPLETED|Overall Study||63
4977|NCT02488317|11224|P2|STARTED|Overall Study||117
4978|NCT02488317|11225|P1|STARTED|Overall Study||117
4979|NCT02488070|11239|P1|NOT COMPLETED|Overall Study||0
4980|NCT02488070|11239|P1|COMPLETED|Overall Study||10
4981|NCT02488070|11239|P1|STARTED|Overall Study||10
4982|NCT02488018|11247|P1|NOT COMPLETED|Overall Study||0
4983|NCT02488018|11247|P1|COMPLETED|Overall Study||10
4984|NCT02488018|11247|P1|STARTED|Overall Study||10
4985|NCT02486952|11251|P1|NOT COMPLETED|Overall Study||50
4986|NCT02486952|11251|P1|COMPLETED|Overall Study||104
4987|NCT02486952|11251|P1|Started Induction Therapy|Overall Study||151
4988|NCT02486952|11251|P1|STARTED|Overall Study||154
4989|NCT02485483|11258|P2|NOT COMPLETED|Overall Study||0
4990|NCT02485483|11259|P1|NOT COMPLETED|Overall Study||54
4991|NCT02485483|11258|P2|COMPLETED|Overall Study||1015
4992|NCT02485483|11259|P1|COMPLETED|Overall Study||223
4993|NCT02485483|11258|P2|STARTED|Overall Study||1015
4994|NCT02485483|11259|P1|STARTED|Overall Study||277
4995|NCT02485158|11274|P1|NOT COMPLETED|Overall Study||4
4996|NCT02485158|11274|P1|COMPLETED|Overall Study||24
4997|NCT02485158|11274|P1|STARTED|Overall Study||28
4998|NCT02484911|11363|P2|NOT COMPLETED|Overall Study||2
4999|NCT02484911|11364|P1|NOT COMPLETED|Overall Study||4
5000|NCT02484911|11363|P2|COMPLETED|Overall Study||58
5001|NCT02484911|11364|P1|COMPLETED|Overall Study||56
5002|NCT02484911|11363|P2|STARTED|Overall Study||60
5003|NCT02484911|11364|P1|STARTED|Overall Study||60
5004|NCT02484898|11392|P1|NOT COMPLETED|Overall Study||18
5005|NCT02484898|11392|P1|COMPLETED|Overall Study||182
5006|NCT02484898|11392|P1|STARTED|Overall Study||200
5007|NCT02484729|11406|P10|NOT COMPLETED|Overall Study||1
5008|NCT02484729|11407|P9|NOT COMPLETED|Overall Study||0
5009|NCT02484729|11408|P8|NOT COMPLETED|Overall Study||0
5010|NCT02484729|11409|P7|NOT COMPLETED|Overall Study||0
5011|NCT02484729|11410|P6|NOT COMPLETED|Overall Study||0
5012|NCT02484729|11411|P5|NOT COMPLETED|Overall Study||0
5013|NCT02484729|11412|P4|NOT COMPLETED|Overall Study||0
5014|NCT02484729|11413|P3|NOT COMPLETED|Overall Study||0
5015|NCT02484729|11414|P2|NOT COMPLETED|Overall Study||0
5016|NCT02484729|11415|P1|NOT COMPLETED|Overall Study||0
5017|NCT02484729|11406|P10|COMPLETED|Overall Study||7
5018|NCT02484729|11407|P9|COMPLETED|Overall Study||6
5019|NCT02484729|11408|P8|COMPLETED|Overall Study||6
5020|NCT02484729|11409|P7|COMPLETED|Overall Study||5
5021|NCT02484729|11410|P6|COMPLETED|Overall Study||6
5022|NCT02484729|11411|P5|COMPLETED|Overall Study||5
5023|NCT02484729|11412|P4|COMPLETED|Overall Study||6
5024|NCT02484729|11413|P3|COMPLETED|Overall Study||6
5025|NCT02484729|11414|P2|COMPLETED|Overall Study||6
5026|NCT02484729|11415|P1|COMPLETED|Overall Study||16
5027|NCT02484729|11406|P10|STARTED|Overall Study||8
5028|NCT02484729|11407|P9|STARTED|Overall Study||6
5029|NCT02484729|11408|P8|STARTED|Overall Study||6
5030|NCT02484729|11409|P7|STARTED|Overall Study||5
5031|NCT02484729|11410|P6|STARTED|Overall Study||6
5032|NCT02484729|11411|P5|STARTED|Overall Study||5
5033|NCT02484729|11412|P4|STARTED|Overall Study||6
5034|NCT02484729|11413|P3|STARTED|Overall Study||6
5035|NCT02484729|11414|P2|STARTED|Overall Study||6
5036|NCT02484729|11415|P1|STARTED|Overall Study||16
5037|NCT02483975|11613|P2|NOT COMPLETED|Overall Study||2
5038|NCT02483975|11614|P1|NOT COMPLETED|Overall Study||2
5039|NCT02483975|11613|P2|COMPLETED|Overall Study|Subject reported as not completed due to AE was discontinued due to exacerbation, was not an AE/SAE|53
5040|NCT02483975|11614|P1|COMPLETED|Overall Study||54
5041|NCT02483975|11613|P2|STARTED|Overall Study||55
5042|NCT02483975|11614|P1|STARTED|Overall Study||56
5043|NCT02483611|11631|P3|NOT COMPLETED|Overall Study||1
5044|NCT02483611|11632|P2|NOT COMPLETED|Overall Study||0
5045|NCT02483611|11633|P1|NOT COMPLETED|Overall Study||0
5046|NCT02483611|11631|P3|COMPLETED|Overall Study|One patient required decurarization|15
5047|NCT02483611|11632|P2|COMPLETED|Overall Study||16
5048|NCT02483611|11633|P1|COMPLETED|Overall Study||16
5049|NCT02483611|11631|P3|STARTED|Overall Study||16
5050|NCT02483611|11632|P2|STARTED|Overall Study||16
5051|NCT02483611|11633|P1|STARTED|Overall Study||16
5052|NCT02482428|11733|P5|NOT COMPLETED|Overall Study||7
5053|NCT02482428|11734|P4|NOT COMPLETED|Overall Study||2
5054|NCT02482428|11735|P3|NOT COMPLETED|Overall Study||1
5055|NCT02482428|11736|P2|NOT COMPLETED|Overall Study||12
5056|NCT02482428|11737|P1|NOT COMPLETED|Overall Study||9
5057|NCT02482428|11733|P5|COMPLETED|Overall Study||15
5058|NCT02482428|11734|P4|COMPLETED|Overall Study||8
5059|NCT02482428|11735|P3|COMPLETED|Overall Study||9
5060|NCT02482428|11736|P2|COMPLETED|Overall Study||10
5061|NCT02482428|11737|P1|COMPLETED|Overall Study||15
5062|NCT02482428|11733|P5|STARTED|Overall Study||22
5063|NCT02482428|11734|P4|STARTED|Overall Study||10
5064|NCT02482428|11735|P3|STARTED|Overall Study||10
5065|NCT02482428|11736|P2|STARTED|Overall Study||22
5066|NCT02482428|11737|P1|STARTED|Overall Study||24
5067|NCT02482129|11759|P2|NOT COMPLETED|Overall Study||2
5068|NCT02482129|11760|P1|NOT COMPLETED|Overall Study||6
5069|NCT02482129|11759|P2|COMPLETED|Overall Study||9
5070|NCT02482129|11760|P1|COMPLETED|Overall Study||26
5071|NCT02482129|11759|P2|Treated, as Randomized|Overall Study||9
5072|NCT02482129|11760|P1|Treated, as Randomized|Overall Study||30
5073|NCT02482129|11759|P2|STARTED|Overall Study||11
5074|NCT02482129|11760|P1|STARTED|Overall Study||32
5075|NCT02481934|11787|P1|NOT COMPLETED|Overall Study||2
5076|NCT02481934|11787|P1|COMPLETED|Overall Study||3
5077|NCT02481934|11787|P1|STARTED|Overall Study||5
5078|NCT02481219|11794|P2|NOT COMPLETED|Overall Study||1
5079|NCT02481219|11795|P1|NOT COMPLETED|Overall Study||2
5080|NCT02481219|11794|P2|COMPLETED|Overall Study||61
5081|NCT02481219|11795|P1|COMPLETED|Overall Study||58
5082|NCT02481219|11794|P2|STARTED|Overall Study||62
5083|NCT02481219|11795|P1|STARTED|Overall Study||60
5084|NCT02480712|11811|P1|NOT COMPLETED|Overall Study||11
5085|NCT02480712|11811|P1|COMPLETED|Overall Study||96
5086|NCT02480712|11811|P1|STARTED|Overall Study||107
5087|NCT02480582|11828|P6|NOT COMPLETED|Overall Study||0
5088|NCT02480582|11829|P5|NOT COMPLETED|Overall Study||0
5089|NCT02480582|11830|P4|NOT COMPLETED|Overall Study||0
5090|NCT02480582|11831|P3|NOT COMPLETED|Overall Study||0
5091|NCT02480582|11832|P2|NOT COMPLETED|Overall Study||0
5092|NCT02480582|11833|P1|NOT COMPLETED|Overall Study||0
5093|NCT02480582|11828|P6|COMPLETED|Overall Study||7
5094|NCT02480582|11829|P5|COMPLETED|Overall Study||7
5095|NCT02480582|11830|P4|COMPLETED|Overall Study||7
5096|NCT02480582|11831|P3|COMPLETED|Overall Study||7
5097|NCT02480582|11832|P2|COMPLETED|Overall Study||7
5098|NCT02480582|11833|P1|COMPLETED|Overall Study||7
5099|NCT02480582|11828|P6|STARTED|Overall Study||7
5100|NCT02480582|11829|P5|STARTED|Overall Study||7
5101|NCT02480582|11830|P4|STARTED|Overall Study||7
5102|NCT02480582|11831|P3|STARTED|Overall Study||7
5103|NCT02480582|11832|P2|STARTED|Overall Study||7
5104|NCT02480582|11833|P1|STARTED|Overall Study||7
5105|NCT02480439|11856|P3|NOT COMPLETED|Treatment Period 3||0
5106|NCT02480439|11857|P2|NOT COMPLETED|Treatment Period 3||0
5107|NCT02480439|11858|P1|NOT COMPLETED|Treatment Period 3||0
5108|NCT02480439|11856|P3|COMPLETED|Treatment Period 3||7
5109|NCT02480439|11857|P2|COMPLETED|Treatment Period 3||7
5110|NCT02480439|11858|P1|COMPLETED|Treatment Period 3||8
5111|NCT02480439|11856|P3|STARTED|Treatment Period 3|1 Participant was withdrawn due to an Adverse Event after completing Period 2.|7
5112|NCT02480439|11857|P2|STARTED|Treatment Period 3||7
5113|NCT02480439|11858|P1|STARTED|Treatment Period 3||8
5114|NCT02480439|11856|P3|NOT COMPLETED|Treatment Period 2||0
5115|NCT02480439|11857|P2|NOT COMPLETED|Treatment Period 2||0
5116|NCT02480439|11858|P1|NOT COMPLETED|Treatment Period 2||0
5117|NCT02480439|11856|P3|COMPLETED|Treatment Period 2||8
5118|NCT02480439|11857|P2|COMPLETED|Treatment Period 2||7
5119|NCT02480439|11858|P1|COMPLETED|Treatment Period 2||8
5120|NCT02480439|11856|P3|STARTED|Treatment Period 2||8
5121|NCT02480439|11857|P2|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|7
5122|NCT02480439|11858|P1|STARTED|Treatment Period 2||8
5123|NCT02480439|11856|P3|NOT COMPLETED|Treatment Period 1||0
5124|NCT02480439|11857|P2|NOT COMPLETED|Treatment Period 1||0
5125|NCT02480439|11858|P1|NOT COMPLETED|Treatment Period 1||0
5126|NCT02480439|11856|P3|COMPLETED|Treatment Period 1||8
5127|NCT02480439|11857|P2|COMPLETED|Treatment Period 1||8
5128|NCT02480439|11858|P1|COMPLETED|Treatment Period 1||8
5129|NCT02480439|11856|P3|STARTED|Treatment Period 1||8
5130|NCT02480439|11857|P2|STARTED|Treatment Period 1||8
5131|NCT02480439|11858|P1|STARTED|Treatment Period 1||8
5132|NCT02480010|11883|P2|NOT COMPLETED|Overall Study||33
5133|NCT02480010|11884|P1|NOT COMPLETED|Overall Study||35
5134|NCT02480010|11883|P2|COMPLETED|Overall Study||0
5135|NCT02480010|11884|P1|COMPLETED|Overall Study||0
5136|NCT02480010|11883|P2|STARTED|Overall Study||33
5137|NCT02480010|11884|P1|STARTED|Overall Study||35
5138|NCT02479763|11930|P2|NOT COMPLETED|Overall Study||3
5139|NCT02479763|11931|P1|NOT COMPLETED|Overall Study||3
5140|NCT02479763|11930|P2|COMPLETED|Overall Study||50
5141|NCT02479763|11931|P1|COMPLETED|Overall Study||50
5142|NCT02479763|11930|P2|STARTED|Overall Study||53
5143|NCT02479763|11931|P1|STARTED|Overall Study||53
5144|NCT02479412|11946|P9|NOT COMPLETED|Overall Study||1
5145|NCT02479412|11947|P8|NOT COMPLETED|Overall Study||1
5146|NCT02479412|11948|P7|NOT COMPLETED|Overall Study||0
5147|NCT02479412|11949|P6|NOT COMPLETED|Overall Study||0
5148|NCT02479412|11950|P5|NOT COMPLETED|Overall Study||1
5149|NCT02479412|11951|P4|NOT COMPLETED|Overall Study||1
5150|NCT02479412|11952|P3|NOT COMPLETED|Overall Study||2
5151|NCT02479412|11953|P2|NOT COMPLETED|Overall Study||0
5152|NCT02479412|11954|P1|NOT COMPLETED|Overall Study||0
5153|NCT02479412|11946|P9|COMPLETED|Overall Study||6
5154|NCT02479412|11947|P8|COMPLETED|Overall Study||4
5155|NCT02479412|11948|P7|COMPLETED|Overall Study||6
5156|NCT02479412|11949|P6|COMPLETED|Overall Study||5
5157|NCT02479412|11950|P5|COMPLETED|Overall Study||5
5158|NCT02479412|11951|P4|COMPLETED|Overall Study||6
5159|NCT02479412|11952|P3|COMPLETED|Overall Study||4
5160|NCT02479412|11953|P2|COMPLETED|Overall Study||6
5161|NCT02479412|11954|P1|COMPLETED|Overall Study||6
5162|NCT02479412|11946|P9|STARTED|Overall Study||7
5163|NCT02479412|11947|P8|STARTED|Overall Study||5
5164|NCT02479412|11948|P7|STARTED|Overall Study||6
5165|NCT02479412|11949|P6|STARTED|Overall Study||5
5166|NCT02479412|11950|P5|STARTED|Overall Study||6
5167|NCT02479412|11951|P4|STARTED|Overall Study||7
5168|NCT02479412|11952|P3|STARTED|Overall Study||6
5169|NCT02479412|11953|P2|STARTED|Overall Study||6
5170|NCT02479412|11954|P1|STARTED|Overall Study||6
5171|NCT02478671|12025|P1|NOT COMPLETED|Overall Study||0
5172|NCT02478671|12025|P1|COMPLETED|Overall Study||4
5173|NCT02478671|12025|P1|STARTED|Overall Study||4
5174|NCT02478580|12032|P2|NOT COMPLETED|Overall Study||0
5175|NCT02478580|12033|P1|NOT COMPLETED|Overall Study||0
5176|NCT02478580|12032|P2|COMPLETED|Overall Study||33
5177|NCT02478580|12033|P1|COMPLETED|Overall Study||34
5178|NCT02478580|12032|P2|STARTED|Overall Study||33
5179|NCT02478580|12033|P1|STARTED|Overall Study||34
5180|NCT02478372|12041|P2|NOT COMPLETED|Overall Study||14
5181|NCT02478372|12042|P1|NOT COMPLETED|Overall Study||13
5182|NCT02478372|12041|P2|COMPLETED|Overall Study||107
5183|NCT02478372|12042|P1|COMPLETED|Overall Study||108
5184|NCT02478372|12041|P2|Reviewed at One Year|Overall Study|Routine folow up at one year - four patients did not attend, two patients died|107
5185|NCT02478372|12042|P1|Reviewed at One Year|Overall Study|Routine follow up at one year|108
5186|NCT02478372|12041|P2|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks|113
5187|NCT02478372|12042|P1|Reviewed at Six Weeks|Overall Study|Routine follow up at six weeks - one patient refused to attend|108
5188|NCT02478372|12041|P2|Recieved Allocation Intervention|Overall Study||113
5189|NCT02478372|12042|P1|Recieved Allocation Intervention|Overall Study||109
5190|NCT02478372|12041|P2|STARTED|Overall Study||121
5191|NCT02478372|12042|P1|STARTED|Overall Study||121
5192|NCT02477709|12064|P1|NOT COMPLETED|Overall Study||0
5193|NCT02477709|12064|P1|COMPLETED|Overall Study||6
5194|NCT02477709|12064|P1|STARTED|Overall Study||6
5195|NCT02477605|12070|P2|NOT COMPLETED|Overall Study||4
5196|NCT02477605|12071|P1|NOT COMPLETED|Overall Study||1
5197|NCT02477605|12070|P2|COMPLETED|Overall Study||64
5198|NCT02477605|12071|P1|COMPLETED|Overall Study||67
5199|NCT02477605|12070|P2|Randomized and Treated|Overall Study||68
5200|NCT02477605|12071|P1|Randomized and Treated|Overall Study||67
5201|NCT02477605|12070|P2|STARTED|Overall Study||68
5202|NCT02477605|12071|P1|STARTED|Overall Study||68
5203|NCT02477527|12085|P1|NOT COMPLETED|Overall Study||6
5204|NCT02477527|12085|P1|COMPLETED|Overall Study||21
5205|NCT02477527|12085|P1|STARTED|Overall Study||27
5206|NCT02476422|12095|P2|NOT COMPLETED|Overall Study||1
5207|NCT02476422|12096|P1|NOT COMPLETED|Overall Study||0
5208|NCT02476422|12095|P2|COMPLETED|Overall Study||161
5209|NCT02476422|12096|P1|COMPLETED|Overall Study||166
5210|NCT02476422|12095|P2|STARTED|Overall Study||162
5211|NCT02476422|12096|P1|STARTED|Overall Study|"started = Randomized Set/Full analysis set/Safety set"|166
5212|NCT02475980|12126|P1|NOT COMPLETED|Overall Study||5
5213|NCT02475980|12126|P1|COMPLETED|Overall Study||8
5214|NCT02475980|12126|P1|STARTED|Overall Study||13
5215|NCT02475564|12137|P2|NOT COMPLETED|Overall Study||1
5216|NCT02475564|12138|P1|NOT COMPLETED|Overall Study||4
5217|NCT02475564|12137|P2|COMPLETED|Overall Study||21
5218|NCT02475564|12138|P1|COMPLETED|Overall Study||18
5219|NCT02475564|12137|P2|STARTED|Overall Study||22
5220|NCT02475564|12138|P1|STARTED|Overall Study||22
5221|NCT02475395|12150|P2|NOT COMPLETED|Overall Study||3
5222|NCT02475395|12151|P1|NOT COMPLETED|Overall Study||30
5223|NCT02475395|12150|P2|COMPLETED|Overall Study||11
5224|NCT02475395|12151|P1|COMPLETED|Overall Study||228
5225|NCT02475395|12150|P2|STARTED|Overall Study||14
5226|NCT02475395|12151|P1|STARTED|Overall Study||258
5227|NCT02475278|12161|P1|NOT COMPLETED|Overall Study||2
5228|NCT02475278|12161|P1|COMPLETED|Overall Study||48
5229|NCT02475278|12161|P1|STARTED|Overall Study||50
5230|NCT02475031|12174|P2|NOT COMPLETED|Overall Study||0
5231|NCT02475031|12175|P1|NOT COMPLETED|Overall Study||0
5232|NCT02475031|12174|P2|COMPLETED|Overall Study||35
5233|NCT02475031|12175|P1|COMPLETED|Overall Study||35
5234|NCT02475031|12174|P2|STARTED|Overall Study||35
5235|NCT02475031|12175|P1|STARTED|Overall Study||35
5236|NCT02474498|12192|P3|NOT COMPLETED|Overall Study||0
5237|NCT02474498|12193|P2|NOT COMPLETED|Overall Study||0
5238|NCT02474498|12194|P1|NOT COMPLETED|Overall Study||0
5239|NCT02474498|12192|P3|COMPLETED|Overall Study||14
5240|NCT02474498|12193|P2|COMPLETED|Overall Study||14
5241|NCT02474498|12194|P1|COMPLETED|Overall Study||13
5242|NCT02474498|12192|P3|STARTED|Overall Study||14
5243|NCT02474498|12193|P2|STARTED|Overall Study||14
5244|NCT02474498|12194|P1|STARTED|Overall Study||13
5245|NCT02473991|12211|P1|NOT COMPLETED|Overall Study||0
5246|NCT02473991|12211|P1|COMPLETED|Overall Study||395
5247|NCT02473991|12211|P1|STARTED|Overall Study||395
5248|NCT02473523|12217|P1|NOT COMPLETED|Overall Study||2
5249|NCT02473523|12217|P1|COMPLETED|Overall Study||0
5250|NCT02473523|12217|P1|STARTED|Overall Study||2
5251|NCT02473510|12238|P2|NOT COMPLETED|Overall Study||2
5252|NCT02473510|12239|P1|NOT COMPLETED|Overall Study||1
5253|NCT02473510|12238|P2|COMPLETED|Overall Study||238
5254|NCT02473510|12239|P1|COMPLETED|Overall Study||59
5255|NCT02473510|12238|P2|STARTED|Overall Study||240
5256|NCT02473510|12239|P1|STARTED|Overall Study||60
5257|NCT02473367|12253|P1|NOT COMPLETED|Period 4||1
5258|NCT02473367|12253|P1|COMPLETED|Period 4||18
5259|NCT02473367|12253|P1|STARTED|Period 4||19
5260|NCT02473367|12253|P1|NOT COMPLETED|Wait 3||0
5261|NCT02473367|12253|P1|COMPLETED|Wait 3||19
5262|NCT02473367|12253|P1|STARTED|Wait 3||19
5263|NCT02473367|12253|P1|NOT COMPLETED|Period 3||0
5264|NCT02473367|12253|P1|COMPLETED|Period 3||19
5265|NCT02473367|12253|P1|STARTED|Period 3||19
5266|NCT02473367|12253|P1|NOT COMPLETED|Wait 2||0
5267|NCT02473367|12253|P1|COMPLETED|Wait 2||19
5268|NCT02473367|12253|P1|STARTED|Wait 2||19
5269|NCT02473367|12253|P1|NOT COMPLETED|Period 2||0
5270|NCT02473367|12253|P1|COMPLETED|Period 2||19
5271|NCT02473367|12253|P1|STARTED|Period 2||19
5272|NCT02473367|12253|P1|NOT COMPLETED|Wait 1||1
5273|NCT02473367|12253|P1|COMPLETED|Wait 1||19
5274|NCT02473367|12253|P1|STARTED|Wait 1||20
5275|NCT02473367|12253|P1|NOT COMPLETED|Period 1||0
5276|NCT02473367|12253|P1|COMPLETED|Period 1||20
5277|NCT02473367|12253|P1|STARTED|Period 1||20
5278|NCT02472886|12274|P3|NOT COMPLETED|Overall Study||1
5279|NCT02472886|12275|P2|NOT COMPLETED|Overall Study||2
5280|NCT02472886|12276|P1|NOT COMPLETED|Overall Study||0
5281|NCT02472886|12274|P3|COMPLETED|Overall Study||26
5282|NCT02472886|12275|P2|COMPLETED|Overall Study||57
5283|NCT02472886|12276|P1|COMPLETED|Overall Study||67
5284|NCT02472886|12274|P3|STARTED|Overall Study||27
5285|NCT02472886|12275|P2|STARTED|Overall Study||59
5286|NCT02472886|12276|P1|STARTED|Overall Study||67
5287|NCT02472847|12304|P2|NOT COMPLETED|Overall Study||5
5288|NCT02472847|12305|P1|NOT COMPLETED|Overall Study||1
5289|NCT02472847|12304|P2|COMPLETED|Overall Study||21
5290|NCT02472847|12305|P1|COMPLETED|Overall Study||23
5291|NCT02472847|12304|P2|STARTED|Overall Study||26
5292|NCT02472847|12305|P1|STARTED|Overall Study||24
5293|NCT02472756|12311|P1|NOT COMPLETED|Maintenance (Approximately 2 Years)||10
5294|NCT02472756|12311|P1|COMPLETED|Maintenance (Approximately 2 Years)||10
5295|NCT02472756|12311|P1|STARTED|Maintenance (Approximately 2 Years)|Out of 39 participants who completed induction period, 19 did not continue in maintenance period.|20
5296|NCT02472756|12311|P1|NOT COMPLETED|Induction (Approximately 6 Months)||2
5297|NCT02472756|12311|P1|COMPLETED|Induction (Approximately 6 Months)||39
5298|NCT02472756|12311|P1|Treated|Induction (Approximately 6 Months)||40
5299|NCT02472756|12311|P1|STARTED|Induction (Approximately 6 Months)||41
5300|NCT02472522|12319|P2|NOT COMPLETED|Overall Study||0
5301|NCT02472522|12320|P1|NOT COMPLETED|Overall Study||0
5302|NCT02472522|12319|P2|COMPLETED|Overall Study||50
5303|NCT02472522|12320|P1|COMPLETED|Overall Study||50
5304|NCT02472522|12319|P2|STARTED|Overall Study||50
5305|NCT02472522|12320|P1|STARTED|Overall Study||50
5306|NCT02472366|12352|P2|NOT COMPLETED|Overall Study||0
5307|NCT02472366|12353|P1|NOT COMPLETED|Overall Study||1
5308|NCT02472366|12352|P2|COMPLETED|Overall Study||10
5309|NCT02472366|12353|P1|COMPLETED|Overall Study||5
5310|NCT02472366|12352|P2|STARTED|Overall Study||10
5311|NCT02472366|12353|P1|STARTED|Overall Study|6 subjects receiving ILUVIEN, 7 eyes receiving ILUVIEN|6
5312|NCT02471755|12369|P2|NOT COMPLETED|Overall Study||1
5313|NCT02471755|12370|P1|NOT COMPLETED|Overall Study||1
5314|NCT02471755|12369|P2|COMPLETED|Overall Study||44
5315|NCT02471755|12370|P1|COMPLETED|Overall Study||44
5316|NCT02471755|12369|P2|STARTED|Overall Study||45
5317|NCT02471755|12370|P1|STARTED|Overall Study||45
5318|NCT02471612|12386|P1|NOT COMPLETED|Overall Study||2
5319|NCT02471612|12386|P1|COMPLETED|Overall Study||157
5320|NCT02471612|12386|P1|STARTED|Overall Study||159
5321|NCT02470949|12403|P2|NOT COMPLETED|Second Intervention||0
5322|NCT02470949|12404|P1|NOT COMPLETED|Second Intervention||0
5323|NCT02470949|12403|P2|COMPLETED|Second Intervention||2
5324|NCT02470949|12404|P1|COMPLETED|Second Intervention||4
5325|NCT02470949|12403|P2|STARTED|Second Intervention||2
5326|NCT02470949|12404|P1|STARTED|Second Intervention||4
5327|NCT02470949|12403|P2|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
5328|NCT02470949|12404|P1|NOT COMPLETED|Washout Period for a Minimum of 4 Weeks||0
5329|NCT02470949|12403|P2|COMPLETED|Washout Period for a Minimum of 4 Weeks||5
5330|NCT02470949|12404|P1|COMPLETED|Washout Period for a Minimum of 4 Weeks||4
5331|NCT02470949|12403|P2|STARTED|Washout Period for a Minimum of 4 Weeks||5
5332|NCT02470949|12404|P1|STARTED|Washout Period for a Minimum of 4 Weeks||4
5333|NCT02470949|12403|P2|NOT COMPLETED|First Intervention||0
5334|NCT02470949|12404|P1|NOT COMPLETED|First Intervention||0
5335|NCT02470949|12403|P2|COMPLETED|First Intervention||5
5336|NCT02470949|12404|P1|COMPLETED|First Intervention||4
5337|NCT02470949|12403|P2|STARTED|First Intervention||5
5338|NCT02470949|12404|P1|STARTED|First Intervention||4
5339|NCT02470494|12414|P1|NOT COMPLETED|Overall Study||5
5340|NCT02470494|12414|P1|COMPLETED|Overall Study||41
5341|NCT02470494|12414|P1|STARTED|Overall Study||46
5342|NCT02470429|12424|P2|NOT COMPLETED|Overall Study||0
5343|NCT02470429|12425|P1|NOT COMPLETED|Overall Study||2
5344|NCT02470429|12424|P2|COMPLETED|Overall Study||49
5345|NCT02470429|12425|P1|COMPLETED|Overall Study||48
5346|NCT02470429|12424|P2|STARTED|Overall Study||49
5347|NCT02470429|12425|P1|STARTED|Overall Study||50
5348|NCT02470403|12443|P5|NOT COMPLETED|Overall Study||0
5349|NCT02470403|12444|P4|NOT COMPLETED|Overall Study||4
5350|NCT02470403|12445|P3|NOT COMPLETED|Overall Study||0
5351|NCT02470403|12446|P2|NOT COMPLETED|Overall Study||1
5352|NCT02470403|12447|P1|NOT COMPLETED|Overall Study||2
5353|NCT02470403|12443|P5|COMPLETED|Overall Study||10
5354|NCT02470403|12444|P4|COMPLETED|Overall Study||39
5355|NCT02470403|12445|P3|COMPLETED|Overall Study||40
5356|NCT02470403|12446|P2|COMPLETED|Overall Study||43
5357|NCT02470403|12447|P1|COMPLETED|Overall Study||42
5358|NCT02470403|12443|P5|Normoglycemic|Overall Study||5
5359|NCT02470403|12444|P4|Normoglycemic|Overall Study||23
5360|NCT02470403|12445|P3|Normoglycemic|Overall Study||20
5361|NCT02470403|12446|P2|Normoglycemic|Overall Study||20
5362|NCT02470403|12447|P1|Normoglycemic|Overall Study||20
5363|NCT02470403|12443|P5|Dysglycemic|Overall Study||5
5364|NCT02470403|12444|P4|Dysglycemic|Overall Study||20
5365|NCT02470403|12445|P3|Dysglycemic|Overall Study||20
5366|NCT02470403|12446|P2|Dysglycemic|Overall Study||24
5367|NCT02470403|12447|P1|Dysglycemic|Overall Study||24
5368|NCT02470403|12443|P5|STARTED|Overall Study||10
5369|NCT02470403|12444|P4|STARTED|Overall Study||43
5370|NCT02470403|12445|P3|STARTED|Overall Study||40
5371|NCT02470403|12446|P2|STARTED|Overall Study||44
5372|NCT02470403|12447|P1|STARTED|Overall Study||44
5373|NCT02469961|12487|P2|NOT COMPLETED|Overall Study||1
5374|NCT02469961|12488|P1|NOT COMPLETED|Overall Study||4
5375|NCT02469961|12487|P2|COMPLETED|Overall Study||24
5376|NCT02469961|12488|P1|COMPLETED|Overall Study||21
5377|NCT02469961|12487|P2|STARTED|Overall Study||25
5378|NCT02469961|12488|P1|STARTED|Overall Study||25
5379|NCT02469597|12502|P2|NOT COMPLETED|Overall Study||0
5380|NCT02469597|12503|P1|NOT COMPLETED|Overall Study||0
5381|NCT02469597|12502|P2|COMPLETED|Overall Study||24
5382|NCT02469597|12503|P1|COMPLETED|Overall Study||22
5383|NCT02469597|12502|P2|STARTED|Overall Study||24
5384|NCT02469597|12503|P1|STARTED|Overall Study||22
5385|NCT02469298|12523|P4|NOT COMPLETED|Overall Study||2
5386|NCT02469298|12524|P3|NOT COMPLETED|Overall Study||2
5387|NCT02469298|12525|P2|NOT COMPLETED|Overall Study||1
5388|NCT02469298|12526|P1|NOT COMPLETED|Overall Study||1
5389|NCT02469298|12523|P4|COMPLETED|Overall Study||5
5390|NCT02469298|12524|P3|COMPLETED|Overall Study||14
5391|NCT02469298|12525|P2|COMPLETED|Overall Study||6
5392|NCT02469298|12526|P1|COMPLETED|Overall Study||14
5393|NCT02469298|12523|P4|STARTED|Overall Study||7
5394|NCT02469298|12524|P3|STARTED|Overall Study||16
5395|NCT02469298|12525|P2|STARTED|Overall Study||7
5396|NCT02469298|12526|P1|STARTED|Overall Study||15
5397|NCT02469116|12664|P1|NOT COMPLETED|Overall Study||0
5398|NCT02469116|12664|P1|COMPLETED|Overall Study||18
5399|NCT02469116|12664|P1|STARTED|Overall Study||18
5400|NCT02468414|12676|P2|NOT COMPLETED|Overall Study||0
5401|NCT02468414|12677|P1|NOT COMPLETED|Overall Study||3
5402|NCT02468414|12676|P2|COMPLETED|Overall Study||0
5403|NCT02468414|12677|P1|COMPLETED|Overall Study||0
5404|NCT02468414|12676|P2|Safety Follow-up|Overall Study||0
5405|NCT02468414|12677|P1|Safety Follow-up|Overall Study||0
5406|NCT02468414|12676|P2|Implantation|Overall Study||0
5407|NCT02468414|12677|P1|Implantation|Overall Study||1
5408|NCT02468414|12676|P2|Harvesting|Overall Study||0
5409|NCT02468414|12677|P1|Harvesting|Overall Study||1
5410|NCT02468414|12676|P2|Successfully Screened|Overall Study||0
5411|NCT02468414|12677|P1|Successfully Screened|Overall Study||2
5412|NCT02468414|12676|P2|STARTED|Overall Study||0
5413|NCT02468414|12677|P1|STARTED|Overall Study||3
5414|NCT02468154|12685|P2|NOT COMPLETED|Overall Study||0
5415|NCT02468154|12686|P1|NOT COMPLETED|Overall Study||0
5416|NCT02468154|12685|P2|COMPLETED|Overall Study||28
5417|NCT02468154|12686|P1|COMPLETED|Overall Study||29
5418|NCT02468154|12685|P2|STARTED|Overall Study||28
5419|NCT02468154|12686|P1|STARTED|Overall Study||29
5420|NCT02467777|12700|P2|NOT COMPLETED|Overall Study||0
5421|NCT02467777|12701|P1|NOT COMPLETED|Overall Study||0
5422|NCT02467777|12700|P2|COMPLETED|Overall Study||27
5423|NCT02467777|12701|P1|COMPLETED|Overall Study||23
5424|NCT02467777|12700|P2|STARTED|Overall Study||27
5425|NCT02467777|12701|P1|STARTED|Overall Study||23
5426|NCT02467491|12707|P1|NOT COMPLETED|Overall Study||0
5427|NCT02467491|12707|P1|COMPLETED|Overall Study||12
5428|NCT02467491|12707|P1|STARTED|Overall Study||12
5429|NCT02467075|12718|P2|NOT COMPLETED|30 Day Follow-up||0
5430|NCT02467075|12719|P1|NOT COMPLETED|30 Day Follow-up||0
5431|NCT02467075|12718|P2|COMPLETED|30 Day Follow-up||1
5432|NCT02467075|12719|P1|COMPLETED|30 Day Follow-up||0
5433|NCT02467075|12718|P2|STARTED|30 Day Follow-up||1
5434|NCT02467075|12719|P1|STARTED|30 Day Follow-up||0
5435|NCT02467075|12718|P2|NOT COMPLETED|72 Hour Follow-up||0
5436|NCT02467075|12719|P1|NOT COMPLETED|72 Hour Follow-up||0
5437|NCT02467075|12718|P2|COMPLETED|72 Hour Follow-up||1
5438|NCT02467075|12719|P1|COMPLETED|72 Hour Follow-up||0
5439|NCT02467075|12718|P2|STARTED|72 Hour Follow-up||1
5440|NCT02467075|12719|P1|STARTED|72 Hour Follow-up||0
5441|NCT02467075|12718|P2|NOT COMPLETED|48 Hour Follow-up||0
5442|NCT02467075|12719|P1|NOT COMPLETED|48 Hour Follow-up||0
5443|NCT02467075|12718|P2|COMPLETED|48 Hour Follow-up||1
5444|NCT02467075|12719|P1|COMPLETED|48 Hour Follow-up||0
5445|NCT02467075|12718|P2|STARTED|48 Hour Follow-up||1
5446|NCT02467075|12719|P1|STARTED|48 Hour Follow-up||0
5447|NCT02467075|12718|P2|NOT COMPLETED|Initial CT Scan||0
5448|NCT02467075|12719|P1|NOT COMPLETED|Initial CT Scan||0
5449|NCT02467075|12718|P2|COMPLETED|Initial CT Scan||1
5450|NCT02467075|12719|P1|COMPLETED|Initial CT Scan||0
5451|NCT02467075|12718|P2|STARTED|Initial CT Scan||1
5452|NCT02467075|12719|P1|STARTED|Initial CT Scan||0
5453|NCT02466425|12737|P2|NOT COMPLETED|Overall Study||16
5454|NCT02466425|12738|P1|NOT COMPLETED|Overall Study||14
5455|NCT02466425|12737|P2|COMPLETED|Overall Study||116
5456|NCT02466425|12738|P1|COMPLETED|Overall Study||118
5457|NCT02466425|12737|P2|Treated|Overall Study||132
5458|NCT02466425|12738|P1|Treated|Overall Study||131
5459|NCT02466425|12737|P2|STARTED|Overall Study||132
5460|NCT02466425|12738|P1|STARTED|Overall Study||132
5461|NCT02466412|12748|P2|NOT COMPLETED|Second Intervention (Day 3)||0
5462|NCT02466412|12749|P1|NOT COMPLETED|Second Intervention (Day 3)||0
5463|NCT02466412|12748|P2|COMPLETED|Second Intervention (Day 3)||24
5464|NCT02466412|12749|P1|COMPLETED|Second Intervention (Day 3)||24
5465|NCT02466412|12748|P2|STARTED|Second Intervention (Day 3)||24
5466|NCT02466412|12749|P1|STARTED|Second Intervention (Day 3)||24
5467|NCT02466412|12748|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5468|NCT02466412|12749|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
5469|NCT02466412|12748|P2|COMPLETED|Washout Period of 1 Day (Day 2)||24
5470|NCT02466412|12749|P1|COMPLETED|Washout Period of 1 Day (Day 2)||24
5471|NCT02466412|12748|P2|STARTED|Washout Period of 1 Day (Day 2)||24
5472|NCT02466412|12749|P1|STARTED|Washout Period of 1 Day (Day 2)||24
5473|NCT02466412|12748|P2|NOT COMPLETED|First Intervention (Day 1)||0
5474|NCT02466412|12749|P1|NOT COMPLETED|First Intervention (Day 1)||0
5475|NCT02466412|12748|P2|COMPLETED|First Intervention (Day 1)||24
5476|NCT02466412|12749|P1|COMPLETED|First Intervention (Day 1)||24
5477|NCT02466412|12748|P2|STARTED|First Intervention (Day 1)||24
5478|NCT02466412|12749|P1|STARTED|First Intervention (Day 1)||24
5479|NCT02466412|12748|P2|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
5480|NCT02466412|12749|P1|NOT COMPLETED|Washout Period of 1 Day (Day -1)||0
5481|NCT02466412|12748|P2|COMPLETED|Washout Period of 1 Day (Day -1)||24
5482|NCT02466412|12749|P1|COMPLETED|Washout Period of 1 Day (Day -1)||24
5483|NCT02466412|12748|P2|STARTED|Washout Period of 1 Day (Day -1)||24
5484|NCT02466412|12749|P1|STARTED|Washout Period of 1 Day (Day -1)||24
5485|NCT02465866|12758|P4|NOT COMPLETED|Period 4: Washout (14 Days)||0
5486|NCT02465866|12759|P3|NOT COMPLETED|Period 4: Washout (14 Days)||0
5487|NCT02465866|12760|P2|NOT COMPLETED|Period 4: Washout (14 Days)||0
5488|NCT02465866|12761|P1|NOT COMPLETED|Period 4: Washout (14 Days)||0
5489|NCT02465866|12758|P4|COMPLETED|Period 4: Washout (14 Days)||5
5490|NCT02465866|12759|P3|COMPLETED|Period 4: Washout (14 Days)||5
5491|NCT02465866|12760|P2|COMPLETED|Period 4: Washout (14 Days)||4
5492|NCT02465866|12761|P1|COMPLETED|Period 4: Washout (14 Days)||5
5493|NCT02465866|12758|P4|STARTED|Period 4: Washout (14 Days)||5
5494|NCT02465866|12759|P3|STARTED|Period 4: Washout (14 Days)||5
5495|NCT02465866|12760|P2|STARTED|Period 4: Washout (14 Days)||4
5496|NCT02465866|12761|P1|STARTED|Period 4: Washout (14 Days)||5
5497|NCT02465866|12758|P4|NOT COMPLETED|Period 4||0
5498|NCT02465866|12759|P3|NOT COMPLETED|Period 4||0
5499|NCT02465866|12760|P2|NOT COMPLETED|Period 4||0
5500|NCT02465866|12761|P1|NOT COMPLETED|Period 4||0
5501|NCT02465866|12758|P4|COMPLETED|Period 4||5
5502|NCT02465866|12759|P3|COMPLETED|Period 4||5
5503|NCT02465866|12760|P2|COMPLETED|Period 4||4
5504|NCT02465866|12761|P1|COMPLETED|Period 4||5
5505|NCT02465866|12758|P4|STARTED|Period 4||5
5506|NCT02465866|12759|P3|STARTED|Period 4||5
5507|NCT02465866|12760|P2|STARTED|Period 4||4
5508|NCT02465866|12761|P1|STARTED|Period 4||5
5509|NCT02465866|12758|P4|NOT COMPLETED|Period 3: Washout (14 Days)||0
5510|NCT02465866|12759|P3|NOT COMPLETED|Period 3: Washout (14 Days)||0
5511|NCT02465866|12760|P2|NOT COMPLETED|Period 3: Washout (14 Days)||0
5512|NCT02465866|12761|P1|NOT COMPLETED|Period 3: Washout (14 Days)||0
5513|NCT02465866|12758|P4|COMPLETED|Period 3: Washout (14 Days)||5
5514|NCT02465866|12759|P3|COMPLETED|Period 3: Washout (14 Days)||5
5515|NCT02465866|12760|P2|COMPLETED|Period 3: Washout (14 Days)||4
5516|NCT02465866|12761|P1|COMPLETED|Period 3: Washout (14 Days)||5
5517|NCT02465866|12758|P4|STARTED|Period 3: Washout (14 Days)||5
5518|NCT02465866|12759|P3|STARTED|Period 3: Washout (14 Days)||5
5519|NCT02465866|12760|P2|STARTED|Period 3: Washout (14 Days)||4
5520|NCT02465866|12761|P1|STARTED|Period 3: Washout (14 Days)||5
5521|NCT02465866|12758|P4|NOT COMPLETED|Period 3||0
5522|NCT02465866|12759|P3|NOT COMPLETED|Period 3||0
5523|NCT02465866|12760|P2|NOT COMPLETED|Period 3||1
5524|NCT02465866|12761|P1|NOT COMPLETED|Period 3||0
5525|NCT02465866|12758|P4|COMPLETED|Period 3||5
5526|NCT02465866|12759|P3|COMPLETED|Period 3||5
5527|NCT02465866|12760|P2|COMPLETED|Period 3||4
5528|NCT02465866|12761|P1|COMPLETED|Period 3||5
5529|NCT02465866|12758|P4|STARTED|Period 3||5
5530|NCT02465866|12759|P3|STARTED|Period 3||5
5531|NCT02465866|12760|P2|STARTED|Period 3||5
5532|NCT02465866|12761|P1|STARTED|Period 3||5
5533|NCT02465866|12758|P4|NOT COMPLETED|Period 2: Washout (14 Days)||0
5534|NCT02465866|12759|P3|NOT COMPLETED|Period 2: Washout (14 Days)||0
5535|NCT02465866|12760|P2|NOT COMPLETED|Period 2: Washout (14 Days)||0
5536|NCT02465866|12761|P1|NOT COMPLETED|Period 2: Washout (14 Days)||0
5537|NCT02465866|12758|P4|COMPLETED|Period 2: Washout (14 Days)||5
5538|NCT02465866|12759|P3|COMPLETED|Period 2: Washout (14 Days)||5
5539|NCT02465866|12760|P2|COMPLETED|Period 2: Washout (14 Days)||5
5540|NCT02465866|12761|P1|COMPLETED|Period 2: Washout (14 Days)||5
5541|NCT02465866|12758|P4|STARTED|Period 2: Washout (14 Days)||5
5542|NCT02465866|12759|P3|STARTED|Period 2: Washout (14 Days)||5
5543|NCT02465866|12760|P2|STARTED|Period 2: Washout (14 Days)||5
5544|NCT02465866|12761|P1|STARTED|Period 2: Washout (14 Days)||5
5545|NCT02465866|12758|P4|NOT COMPLETED|Period 2||0
5546|NCT02465866|12759|P3|NOT COMPLETED|Period 2||0
5547|NCT02465866|12760|P2|NOT COMPLETED|Period 2||0
5548|NCT02465866|12761|P1|NOT COMPLETED|Period 2||0
5549|NCT02465866|12758|P4|COMPLETED|Period 2||5
5550|NCT02465866|12759|P3|COMPLETED|Period 2||5
5551|NCT02465866|12760|P2|COMPLETED|Period 2||5
5552|NCT02465866|12761|P1|COMPLETED|Period 2||5
5553|NCT02465866|12758|P4|STARTED|Period 2||5
5554|NCT02465866|12759|P3|STARTED|Period 2||5
5555|NCT02465866|12760|P2|STARTED|Period 2||5
5556|NCT02465866|12761|P1|STARTED|Period 2||5
5557|NCT02465866|12758|P4|NOT COMPLETED|Period 1: Washout (14 Days)||0
5558|NCT02465866|12759|P3|NOT COMPLETED|Period 1: Washout (14 Days)||0
5559|NCT02465866|12760|P2|NOT COMPLETED|Period 1: Washout (14 Days)||0
5560|NCT02465866|12761|P1|NOT COMPLETED|Period 1: Washout (14 Days)||0
5561|NCT02465866|12758|P4|COMPLETED|Period 1: Washout (14 Days)||5
5562|NCT02465866|12759|P3|COMPLETED|Period 1: Washout (14 Days)||5
5563|NCT02465866|12760|P2|COMPLETED|Period 1: Washout (14 Days)||5
5564|NCT02465866|12761|P1|COMPLETED|Period 1: Washout (14 Days)||5
5565|NCT02465866|12758|P4|STARTED|Period 1: Washout (14 Days)||5
5566|NCT02465866|12759|P3|STARTED|Period 1: Washout (14 Days)||5
5567|NCT02465866|12760|P2|STARTED|Period 1: Washout (14 Days)||5
5568|NCT02465866|12761|P1|STARTED|Period 1: Washout (14 Days)||5
5569|NCT02465866|12758|P4|NOT COMPLETED|Period 1||0
5570|NCT02465866|12759|P3|NOT COMPLETED|Period 1||0
5571|NCT02465866|12760|P2|NOT COMPLETED|Period 1||0
5572|NCT02465866|12761|P1|NOT COMPLETED|Period 1||0
5573|NCT02465866|12758|P4|COMPLETED|Period 1||5
5574|NCT02465866|12759|P3|COMPLETED|Period 1||5
5575|NCT02465866|12760|P2|COMPLETED|Period 1||5
5576|NCT02465866|12761|P1|COMPLETED|Period 1||5
5577|NCT02465866|12758|P4|STARTED|Period 1||5
5578|NCT02465866|12759|P3|STARTED|Period 1||5
5579|NCT02465866|12760|P2|STARTED|Period 1||5
5580|NCT02465866|12761|P1|STARTED|Period 1||5
5581|NCT02465632|12834|P3|NOT COMPLETED|Overall Study||17
5582|NCT02465632|12835|P2|NOT COMPLETED|Overall Study||23
5583|NCT02465632|12836|P1|NOT COMPLETED|Overall Study||31
5584|NCT02465632|12834|P3|COMPLETED|Overall Study||203
5585|NCT02465632|12835|P2|COMPLETED|Overall Study||417
5586|NCT02465632|12836|P1|COMPLETED|Overall Study||409
5587|NCT02465632|12834|P3|STARTED|Overall Study||220
5588|NCT02465632|12835|P2|STARTED|Overall Study||440
5589|NCT02465632|12836|P1|STARTED|Overall Study||440
5590|NCT02465489|12847|P1|NOT COMPLETED|Overall Study||5
5591|NCT02465489|12847|P1|COMPLETED|Overall Study||15
5592|NCT02465489|12847|P1|STARTED|Overall Study||20
5593|NCT02465073|12877|P3|NOT COMPLETED|Overall Study||1
5594|NCT02465073|12878|P2|NOT COMPLETED|Overall Study||1
5595|NCT02465073|12879|P1|NOT COMPLETED|Overall Study||2
5596|NCT02465073|12877|P3|COMPLETED|Overall Study||15
5597|NCT02465073|12878|P2|COMPLETED|Overall Study||15
5598|NCT02465073|12879|P1|COMPLETED|Overall Study||15
5599|NCT02465073|12877|P3|STARTED|Overall Study||16
5600|NCT02465073|12878|P2|STARTED|Overall Study||16
5601|NCT02465073|12879|P1|STARTED|Overall Study||17
5602|NCT02463409|12887|P1|NOT COMPLETED|Overall Study||2
5603|NCT02463409|12887|P1|COMPLETED|Overall Study||4
5604|NCT02463409|12887|P1|STARTED|Overall Study||6
5605|NCT02463331|12895|P2|NOT COMPLETED|Overall Study||6
5606|NCT02463331|12896|P1|NOT COMPLETED|Overall Study||16
5607|NCT02463331|12895|P2|COMPLETED|Overall Study||25
5608|NCT02463331|12896|P1|COMPLETED|Overall Study||10
5609|NCT02463331|12895|P2|STARTED|Overall Study||31
5610|NCT02463331|12896|P1|STARTED|Overall Study||26
5611|NCT02463227|12904|P1|NOT COMPLETED|Overall Study||0
5612|NCT02463227|12904|P1|COMPLETED|Overall Study||14
5613|NCT02463227|12904|P1|STARTED|Overall Study||14
5614|NCT02463097|12912|P1|NOT COMPLETED|Overall Study||1
5615|NCT02463097|12912|P1|COMPLETED|Overall Study||123
5616|NCT02463097|12912|P1|STARTED|Overall Study||124
5617|NCT02462473|12918|P1|NOT COMPLETED|Overall Study||4
5618|NCT02462473|12918|P1|COMPLETED|Overall Study||5
5619|NCT02462473|12918|P1|STARTED|Overall Study||9
5620|NCT02462291|12931|P2|NOT COMPLETED|Overall Study||6
5621|NCT02462291|12932|P1|NOT COMPLETED|Overall Study||5
5622|NCT02462291|12931|P2|COMPLETED|Overall Study||75
5623|NCT02462291|12932|P1|COMPLETED|Overall Study||77
5624|NCT02462291|12931|P2|STARTED|Overall Study||81
5625|NCT02462291|12932|P1|STARTED|Overall Study||82
5626|NCT02461992|12970|P1|NOT COMPLETED|Overall Study||0
5627|NCT02461992|12970|P1|COMPLETED|Overall Study||13
5628|NCT02461992|12970|P1|STARTED|Overall Study||13
5629|NCT02461693|12989|P2|NOT COMPLETED|Overall Study||0
5630|NCT02461693|12990|P1|NOT COMPLETED|Overall Study||0
5631|NCT02461693|12989|P2|COMPLETED|Overall Study||102
5632|NCT02461693|12990|P1|COMPLETED|Overall Study||103
5633|NCT02461693|12989|P2|STARTED|Overall Study||102
5634|NCT02461693|12990|P1|STARTED|Overall Study||103
5635|NCT02461290|13002|P1|NOT COMPLETED|Overall Study||10
5636|NCT02461290|13002|P1|COMPLETED|Overall Study||89
5637|NCT02461290|13002|P1|STARTED|Overall Study||99
5638|NCT02460822|13009|P1|NOT COMPLETED|Overall Study||1
5639|NCT02460822|13009|P1|COMPLETED|Overall Study||15
5640|NCT02460822|13009|P1|STARTED|Overall Study||16
5641|NCT02460458|13018|P1|NOT COMPLETED|Prospective Phase||0
5642|NCT02460458|13018|P1|COMPLETED|Prospective Phase|Information not yet available.|0
5643|NCT02460458|13018|P1|STARTED|Prospective Phase|Information not yet available.|0
5644|NCT02460458|13018|P1|NOT COMPLETED|Confirmatory Phase||266
5645|NCT02460458|13018|P1|COMPLETED|Confirmatory Phase|Information not yet available.|0
5646|NCT02460458|13018|P1|STARTED|Confirmatory Phase||266
5647|NCT02460458|13018|P1|NOT COMPLETED|Retrospective Phase||0
5648|NCT02460458|13018|P1|COMPLETED|Retrospective Phase||266
5649|NCT02460458|13018|P1|STARTED|Retrospective Phase||266
5650|NCT02458768|13026|P2|NOT COMPLETED|Overall Study||5
5651|NCT02458768|13027|P1|NOT COMPLETED|Overall Study||7
5652|NCT02458768|13026|P2|COMPLETED|Overall Study||50
5653|NCT02458768|13027|P1|COMPLETED|Overall Study||50
5654|NCT02458768|13026|P2|STARTED|Overall Study||55
5655|NCT02458768|13027|P1|STARTED|Overall Study||57
5656|NCT02458365|13035|P2|NOT COMPLETED|Overall Study||294
5657|NCT02458365|13036|P1|NOT COMPLETED|Overall Study||277
5658|NCT02458365|13035|P2|COMPLETED|Overall Study||1607
5659|NCT02458365|13036|P1|COMPLETED|Overall Study||1723
5660|NCT02458365|13035|P2|STARTED|Overall Study||1901
5661|NCT02458365|13036|P1|STARTED|Overall Study||2000
5662|NCT02457728|13056|P1|NOT COMPLETED|Overall Study||0
5663|NCT02457728|13056|P1|COMPLETED|Overall Study||34
5664|NCT02457728|13056|P1|STARTED|Overall Study||34
5665|NCT02457611|13060|P1|NOT COMPLETED|Overall Study||3
5666|NCT02457611|13060|P1|COMPLETED|Overall Study||23
5667|NCT02457611|13060|P1|STARTED|Overall Study||26
5668|NCT02457247|13076|P4|NOT COMPLETED|Period 2||0
5669|NCT02457247|13077|P3|NOT COMPLETED|Period 2||0
5670|NCT02457247|13078|P2|NOT COMPLETED|Period 2||3
5671|NCT02457247|13079|P1|NOT COMPLETED|Period 2||2
5672|NCT02457247|13076|P4|COMPLETED|Period 2||70
5673|NCT02457247|13077|P3|COMPLETED|Period 2||68
5674|NCT02457247|13078|P2|COMPLETED|Period 2||65
5675|NCT02457247|13079|P1|COMPLETED|Period 2||64
5676|NCT02457247|13076|P4|STARTED|Period 2||70
5677|NCT02457247|13077|P3|STARTED|Period 2||68
5678|NCT02457247|13078|P2|STARTED|Period 2||68
5679|NCT02457247|13079|P1|STARTED|Period 2||66
5680|NCT02457247|13076|P4|NOT COMPLETED|Period 1||0
5681|NCT02457247|13077|P3|NOT COMPLETED|Period 1||0
5682|NCT02457247|13078|P2|NOT COMPLETED|Period 1||2
5683|NCT02457247|13079|P1|NOT COMPLETED|Period 1||2
5684|NCT02457247|13076|P4|COMPLETED|Period 1||70
5685|NCT02457247|13077|P3|COMPLETED|Period 1||68
5686|NCT02457247|13078|P2|COMPLETED|Period 1||68
5687|NCT02457247|13079|P1|COMPLETED|Period 1||66
5688|NCT02457247|13076|P4|STARTED|Period 1||70
5689|NCT02457247|13077|P3|STARTED|Period 1||68
5690|NCT02457247|13078|P2|STARTED|Period 1||70
5691|NCT02457247|13079|P1|STARTED|Period 1||68
5692|NCT02455050|13103|P4|NOT COMPLETED|Treatment Period 2||1
5693|NCT02455050|13104|P3|NOT COMPLETED|Treatment Period 2||2
5694|NCT02455050|13105|P2|NOT COMPLETED|Treatment Period 2||0
5695|NCT02455050|13106|P1|NOT COMPLETED|Treatment Period 2||1
5696|NCT02455050|13103|P4|COMPLETED|Treatment Period 2||17
5697|NCT02455050|13104|P3|COMPLETED|Treatment Period 2||17
5698|NCT02455050|13105|P2|COMPLETED|Treatment Period 2||18
5699|NCT02455050|13106|P1|COMPLETED|Treatment Period 2||18
5700|NCT02455050|13103|P4|STARTED|Treatment Period 2||18
5701|NCT02455050|13104|P3|STARTED|Treatment Period 2||19
5702|NCT02455050|13105|P2|STARTED|Treatment Period 2||18
5703|NCT02455050|13106|P1|STARTED|Treatment Period 2||19
5704|NCT02455050|13103|P4|NOT COMPLETED|Treatment Period 1||2
5705|NCT02455050|13104|P3|NOT COMPLETED|Treatment Period 1||1
5706|NCT02455050|13105|P2|NOT COMPLETED|Treatment Period 1||1
5707|NCT02455050|13106|P1|NOT COMPLETED|Treatment Period 1||1
5708|NCT02455050|13103|P4|COMPLETED|Treatment Period 1||18
5709|NCT02455050|13104|P3|COMPLETED|Treatment Period 1||19
5710|NCT02455050|13105|P2|COMPLETED|Treatment Period 1||18
5711|NCT02455050|13106|P1|COMPLETED|Treatment Period 1||19
5712|NCT02455050|13103|P4|STARTED|Treatment Period 1||20
5713|NCT02455050|13104|P3|STARTED|Treatment Period 1||20
5714|NCT02455050|13105|P2|STARTED|Treatment Period 1||19
5715|NCT02455050|13106|P1|STARTED|Treatment Period 1||20
5716|NCT02454959|13170|P1|NOT COMPLETED|Overall Study||9
5717|NCT02454959|13170|P1|COMPLETED|Overall Study||70
5718|NCT02454959|13170|P1|GFF MDI (PT003) Without Aerochamber|Overall Study||77
5719|NCT02454959|13170|P1|GFF MDI (PT003) With Aerochamber|Overall Study||73
5720|NCT02454959|13170|P1|STARTED|Overall Study||79
5721|NCT02454608|13190|P2|NOT COMPLETED|Overall Study||2
5722|NCT02454608|13191|P1|NOT COMPLETED|Overall Study||0
5723|NCT02454608|13190|P2|COMPLETED|Overall Study||8
5724|NCT02454608|13191|P1|COMPLETED|Overall Study||10
5725|NCT02454608|13190|P2|STARTED|Overall Study||10
5726|NCT02454608|13191|P1|STARTED|Overall Study||10
5727|NCT02454296|13211|P2|NOT COMPLETED|Overall Study||0
5728|NCT02454296|13212|P1|NOT COMPLETED|Overall Study||0
5729|NCT02454296|13211|P2|COMPLETED|Overall Study||21
5730|NCT02454296|13212|P1|COMPLETED|Overall Study||20
5731|NCT02454296|13211|P2|STARTED|Overall Study||21
5732|NCT02454296|13212|P1|STARTED|Overall Study||20
5733|NCT02454283|13224|P2|NOT COMPLETED|Overall Study||0
5734|NCT02454283|13225|P1|NOT COMPLETED|Overall Study||0
5735|NCT02454283|13224|P2|COMPLETED|Overall Study||15
5736|NCT02454283|13225|P1|COMPLETED|Overall Study||26
5737|NCT02454283|13224|P2|STARTED|Overall Study||15
5738|NCT02454283|13225|P1|STARTED|Overall Study||26
5739|NCT02454127|13237|P4|NOT COMPLETED|Overall Study||20
5740|NCT02454127|13238|P3|NOT COMPLETED|Overall Study||14
5741|NCT02454127|13239|P2|NOT COMPLETED|Overall Study||14
5742|NCT02454127|13240|P1|NOT COMPLETED|Overall Study||19
5743|NCT02454127|13237|P4|COMPLETED|Overall Study||20
5744|NCT02454127|13238|P3|COMPLETED|Overall Study||26
5745|NCT02454127|13239|P2|COMPLETED|Overall Study||26
5746|NCT02454127|13240|P1|COMPLETED|Overall Study||21
5747|NCT02454127|13237|P4|STARTED|Overall Study||40
5748|NCT02454127|13238|P3|STARTED|Overall Study||40
5749|NCT02454127|13239|P2|STARTED|Overall Study||40
5750|NCT02454127|13240|P1|STARTED|Overall Study||40
5751|NCT02454101|13280|P2|NOT COMPLETED|Overall Study||7
5752|NCT02454101|13281|P1|NOT COMPLETED|Overall Study||5
5753|NCT02454101|13280|P2|COMPLETED|Overall Study||143
5754|NCT02454101|13281|P1|COMPLETED|Overall Study||145
5755|NCT02454101|13280|P2|STARTED|Overall Study||150
5756|NCT02454101|13281|P1|STARTED|Overall Study||150
5757|NCT02453581|13303|P3|NOT COMPLETED|Overall Study||0
5758|NCT02453581|13304|P2|NOT COMPLETED|Overall Study||0
5759|NCT02453581|13305|P1|NOT COMPLETED|Overall Study||0
5760|NCT02453581|13303|P3|COMPLETED|Overall Study||8
5761|NCT02453581|13304|P2|COMPLETED|Overall Study||8
5762|NCT02453581|13305|P1|COMPLETED|Overall Study||8
5763|NCT02453581|13303|P3|STARTED|Overall Study||8
5764|NCT02453581|13304|P2|STARTED|Overall Study||8
5765|NCT02453581|13305|P1|STARTED|Overall Study||8
5766|NCT02452944|13327|P2|NOT COMPLETED|Overall Study||0
5767|NCT02452944|13328|P1|NOT COMPLETED|Overall Study||0
5768|NCT02452944|13327|P2|COMPLETED|Overall Study||31
5769|NCT02452944|13328|P1|COMPLETED|Overall Study||31
5770|NCT02452944|13327|P2|STARTED|Overall Study||31
5771|NCT02452944|13328|P1|STARTED|Overall Study||31
5772|NCT02451150|13338|P2|NOT COMPLETED|Overall Study||0
5773|NCT02451150|13339|P1|NOT COMPLETED|Overall Study||0
5774|NCT02451150|13338|P2|COMPLETED|Overall Study||3
5775|NCT02451150|13339|P1|COMPLETED|Overall Study||3
5776|NCT02451150|13338|P2|STARTED|Overall Study||3
5777|NCT02451150|13339|P1|STARTED|Overall Study||3
5778|NCT02450799|13392|P3|NOT COMPLETED|Overall Study||0
5779|NCT02450799|13393|P2|NOT COMPLETED|Overall Study||0
5780|NCT02450799|13394|P1|NOT COMPLETED|Overall Study||0
5781|NCT02450799|13392|P3|COMPLETED|Overall Study||30
5782|NCT02450799|13393|P2|COMPLETED|Overall Study||37
5783|NCT02450799|13394|P1|COMPLETED|Overall Study||31
5784|NCT02450799|13392|P3|STARTED|Overall Study||30
5785|NCT02450799|13393|P2|STARTED|Overall Study||37
5786|NCT02450799|13394|P1|STARTED|Overall Study||31
5787|NCT02450747|13405|P1|NOT COMPLETED|Overall Study||0
5788|NCT02450747|13405|P1|COMPLETED|Overall Study||39
5789|NCT02450747|13405|P1|STARTED|Overall Study||39
5790|NCT02449902|13416|P2|NOT COMPLETED|Overall Study||2
5791|NCT02449902|13417|P1|NOT COMPLETED|Overall Study||0
5792|NCT02449902|13416|P2|COMPLETED|Overall Study||24
5793|NCT02449902|13417|P1|COMPLETED|Overall Study||24
5794|NCT02449902|13416|P2|STARTED|Overall Study||26
5795|NCT02449902|13417|P1|STARTED|Overall Study||24
5796|NCT02449798|13441|P1|NOT COMPLETED|Overall Study||0
5797|NCT02449798|13441|P1|COMPLETED|Overall Study||120
5798|NCT02449798|13441|P1|STARTED|Overall Study||120
5799|NCT02449356|13455|P2|NOT COMPLETED|Overall Study||0
5800|NCT02449356|13456|P1|NOT COMPLETED|Overall Study||0
5801|NCT02449356|13455|P2|COMPLETED|Overall Study||30
5802|NCT02449356|13456|P1|COMPLETED|Overall Study||30
5803|NCT02449356|13455|P2|STARTED|Overall Study||30
5804|NCT02449356|13456|P1|STARTED|Overall Study||30
5805|NCT02449044|13472|P1|NOT COMPLETED|Overall Study||64
5806|NCT02449044|13472|P1|COMPLETED|Overall Study|Participants who completed Weeks 58, 106 and 216 visit.|47
5807|NCT02449044|13472|P1|STARTED|Overall Study||111
5808|NCT02448914|13491|P2|NOT COMPLETED|Second Intervention (1 Day)||0
5809|NCT02448914|13492|P1|NOT COMPLETED|Second Intervention (1 Day)||0
5810|NCT02448914|13491|P2|COMPLETED|Second Intervention (1 Day)||5
5811|NCT02448914|13492|P1|COMPLETED|Second Intervention (1 Day)||6
5812|NCT02448914|13491|P2|STARTED|Second Intervention (1 Day)||5
5813|NCT02448914|13492|P1|STARTED|Second Intervention (1 Day)||6
5814|NCT02448914|13491|P2|NOT COMPLETED|First Intervention (1 Day)||0
5815|NCT02448914|13492|P1|NOT COMPLETED|First Intervention (1 Day)||0
5816|NCT02448914|13491|P2|COMPLETED|First Intervention (1 Day)||5
5817|NCT02448914|13492|P1|COMPLETED|First Intervention (1 Day)||6
5818|NCT02448914|13491|P2|STARTED|First Intervention (1 Day)||5
5819|NCT02448914|13492|P1|STARTED|First Intervention (1 Day)||6
5820|NCT02448862|13510|P2|NOT COMPLETED|Overall Study||0
5821|NCT02448862|13511|P1|NOT COMPLETED|Overall Study||0
5822|NCT02448862|13510|P2|COMPLETED|Overall Study||6050
5823|NCT02448862|13511|P1|COMPLETED|Overall Study||4525
5824|NCT02448862|13510|P2|STARTED|Overall Study||6050
5825|NCT02448862|13511|P1|STARTED|Overall Study||4525
5826|NCT02448563|13529|P2|NOT COMPLETED|Overall Study||11
5827|NCT02448563|13530|P1|NOT COMPLETED|Overall Study||16
5828|NCT02448563|13529|P2|COMPLETED|Overall Study||19
5829|NCT02448563|13530|P1|COMPLETED|Overall Study||16
5830|NCT02448563|13529|P2|STARTED|Overall Study|Randomized after completing Visit 2|30
5831|NCT02448563|13530|P1|STARTED|Overall Study|Randomized after completing Visit 2|32
5832|NCT02447458|13555|P6|NOT COMPLETED|Overall Study||0
5833|NCT02447458|13556|P5|NOT COMPLETED|Overall Study||0
5834|NCT02447458|13557|P4|NOT COMPLETED|Overall Study||0
5835|NCT02447458|13558|P3|NOT COMPLETED|Overall Study||1
5836|NCT02447458|13559|P2|NOT COMPLETED|Overall Study||0
5837|NCT02447458|13560|P1|NOT COMPLETED|Overall Study||0
5838|NCT02447458|13555|P6|COMPLETED|Overall Study||10
5839|NCT02447458|13556|P5|COMPLETED|Overall Study||6
5840|NCT02447458|13557|P4|COMPLETED|Overall Study||6
5841|NCT02447458|13558|P3|COMPLETED|Overall Study||5
5842|NCT02447458|13559|P2|COMPLETED|Overall Study||6
5843|NCT02447458|13560|P1|COMPLETED|Overall Study||5
5844|NCT02447458|13555|P6|STARTED|Overall Study||10
5845|NCT02447458|13556|P5|STARTED|Overall Study||6
5846|NCT02447458|13557|P4|STARTED|Overall Study||6
5847|NCT02447458|13558|P3|STARTED|Overall Study||6
5848|NCT02447458|13559|P2|STARTED|Overall Study||6
5849|NCT02447458|13560|P1|STARTED|Overall Study||5
5850|NCT02447432|13658|P2|NOT COMPLETED|Epoch 002||0
5851|NCT02447432|13659|P1|NOT COMPLETED|Epoch 002||0
5852|NCT02447432|13658|P2|COMPLETED|Epoch 002||145
5853|NCT02447432|13659|P1|COMPLETED|Epoch 002||152
5854|NCT02447432|13658|P2|STARTED|Epoch 002||145
5855|NCT02447432|13659|P1|STARTED|Epoch 002||152
5856|NCT02447432|13658|P2|NOT COMPLETED|Epoch 001||13
5857|NCT02447432|13659|P1|NOT COMPLETED|Epoch 001||5
5858|NCT02447432|13658|P2|COMPLETED|Epoch 001||147
5859|NCT02447432|13659|P1|COMPLETED|Epoch 001||155
5860|NCT02447432|13658|P2|STARTED|Epoch 001||160
5861|NCT02447432|13659|P1|STARTED|Epoch 001||160
5862|NCT02447133|13691|P1|NOT COMPLETED|Overall Study||0
5863|NCT02447133|13691|P1|COMPLETED|Overall Study||12
5864|NCT02447133|13691|P1|STARTED|Overall Study||12
5865|NCT02447029|13699|P2|NOT COMPLETED|Overall Study||2
5866|NCT02447029|13700|P1|NOT COMPLETED|Overall Study||3
5867|NCT02447029|13699|P2|COMPLETED|Overall Study||68
5868|NCT02447029|13700|P1|COMPLETED|Overall Study||69
5869|NCT02447029|13699|P2|Treated|Overall Study||68
5870|NCT02447029|13700|P1|Treated|Overall Study||69
5871|NCT02447029|13699|P2|STARTED|Overall Study||70
5872|NCT02447029|13700|P1|STARTED|Overall Study||72
5873|NCT02446990|13720|P2|NOT COMPLETED|Overall Study||658
5874|NCT02446990|13721|P1|NOT COMPLETED|Overall Study||720
5875|NCT02446990|13720|P2|COMPLETED|Overall Study||8894
5876|NCT02446990|13721|P1|COMPLETED|Overall Study||8830
5877|NCT02446990|13720|P2|STARTED|Overall Study||9552
5878|NCT02446990|13721|P1|STARTED|Overall Study||9550
5879|NCT02446613|13755|P2|NOT COMPLETED|Overall Study||0
5880|NCT02446613|13756|P1|NOT COMPLETED|Overall Study||0
5881|NCT02446613|13755|P2|COMPLETED|Overall Study||10
5882|NCT02446613|13756|P1|COMPLETED|Overall Study||6
5883|NCT02446613|13755|P2|STARTED|Overall Study||10
5884|NCT02446613|13756|P1|STARTED|Overall Study||6
5885|NCT02446496|13778|P1|NOT COMPLETED|Overall Study||0
5886|NCT02446496|13778|P1|COMPLETED|Overall Study||24
5887|NCT02446496|13778|P1|STARTED|Overall Study||24
5888|NCT02446483|13790|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
5889|NCT02446483|13791|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
5890|NCT02446483|13790|P2|COMPLETED|Period 3: Intervention Period 2||30
5891|NCT02446483|13791|P1|COMPLETED|Period 3: Intervention Period 2||30
5892|NCT02446483|13790|P2|STARTED|Period 3: Intervention Period 2||30
5893|NCT02446483|13791|P1|STARTED|Period 3: Intervention Period 2||30
5894|NCT02446483|13790|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
5895|NCT02446483|13791|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
5896|NCT02446483|13790|P2|COMPLETED|Period 2: Washout Period (7 Days)||30
5897|NCT02446483|13791|P1|COMPLETED|Period 2: Washout Period (7 Days)||30
5898|NCT02446483|13790|P2|STARTED|Period 2: Washout Period (7 Days)||30
5899|NCT02446483|13791|P1|STARTED|Period 2: Washout Period (7 Days)||30
5900|NCT02446483|13790|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
5901|NCT02446483|13791|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
5902|NCT02446483|13790|P2|COMPLETED|Period 1: Intervention Period 1||30
5903|NCT02446483|13791|P1|COMPLETED|Period 1: Intervention Period 1||30
5904|NCT02446483|13790|P2|STARTED|Period 1: Intervention Period 1||30
5905|NCT02446483|13791|P1|STARTED|Period 1: Intervention Period 1||30
5906|NCT02446171|13807|P4|NOT COMPLETED|Overall Study||0
5907|NCT02446171|13808|P3|NOT COMPLETED|Overall Study||2
5908|NCT02446171|13809|P2|NOT COMPLETED|Overall Study||0
5909|NCT02446171|13810|P1|NOT COMPLETED|Overall Study||0
5910|NCT02446171|13807|P4|COMPLETED|Overall Study||11
5911|NCT02446171|13808|P3|COMPLETED|Overall Study||9
5912|NCT02446171|13809|P2|COMPLETED|Overall Study||11
5913|NCT02446171|13810|P1|COMPLETED|Overall Study||11
5914|NCT02446171|13807|P4|STARTED|Overall Study||11
5915|NCT02446171|13808|P3|STARTED|Overall Study||11
5916|NCT02446171|13809|P2|STARTED|Overall Study||11
5917|NCT02446171|13810|P1|STARTED|Overall Study||11
5918|NCT02446015|13881|P2|NOT COMPLETED|Overall Study||1
5919|NCT02446015|13882|P1|NOT COMPLETED|Overall Study||1
5920|NCT02446015|13881|P2|COMPLETED|Overall Study||62
5921|NCT02446015|13882|P1|COMPLETED|Overall Study||33
5922|NCT02446015|13881|P2|STARTED|Overall Study||63
5923|NCT02446015|13882|P1|STARTED|Overall Study||34
5924|NCT02445755|13893|P1|NOT COMPLETED|Overall Study||13
5925|NCT02445755|13893|P1|COMPLETED|Overall Study||100
5926|NCT02445755|13893|P1|STARTED|Overall Study|Neonates will be tested with 3 transcutaneous (TcB) devices +/-30 minutes of routine bilirubin labs|113
5927|NCT02445573|13902|P2|NOT COMPLETED|Overall Study||2
5928|NCT02445573|13903|P1|NOT COMPLETED|Overall Study||1
5929|NCT02445573|13902|P2|COMPLETED|Overall Study||38
5930|NCT02445573|13903|P1|COMPLETED|Overall Study||39
5931|NCT02445573|13902|P2|STARTED|Overall Study||40
5932|NCT02445573|13903|P1|STARTED|Overall Study||40
5933|NCT02445287|13919|P2|NOT COMPLETED|Overall Study||0
5934|NCT02445287|13920|P1|NOT COMPLETED|Overall Study||0
5935|NCT02445287|13919|P2|COMPLETED|Overall Study||13
5936|NCT02445287|13920|P1|COMPLETED|Overall Study||35
5937|NCT02445287|13919|P2|STARTED|Overall Study||13
5938|NCT02445287|13920|P1|STARTED|Overall Study||35
5939|NCT02445196|13935|P2|NOT COMPLETED|Overall Study||6
5940|NCT02445196|13936|P1|NOT COMPLETED|Overall Study||11
5941|NCT02445196|13935|P2|COMPLETED|Overall Study||52
5942|NCT02445196|13936|P1|COMPLETED|Overall Study||51
5943|NCT02445196|13935|P2|STARTED|Overall Study||58
5944|NCT02445196|13936|P1|STARTED|Overall Study||62
5945|NCT02444715|13951|P2|NOT COMPLETED|Overall Study||16
5946|NCT02444715|13952|P1|NOT COMPLETED|Overall Study||10
5947|NCT02444715|13951|P2|COMPLETED|Overall Study||32
5948|NCT02444715|13952|P1|COMPLETED|Overall Study||36
5949|NCT02444715|13951|P2|STARTED|Overall Study||48
5950|NCT02444715|13952|P1|STARTED|Overall Study||46
5951|NCT02444533|13983|P2|NOT COMPLETED|Overall Study||4
5952|NCT02444533|13984|P1|NOT COMPLETED|Overall Study||2
5953|NCT02444533|13983|P2|COMPLETED|Overall Study||18
5954|NCT02444533|13984|P1|COMPLETED|Overall Study||15
5955|NCT02444533|13983|P2|STARTED|Overall Study||22
5956|NCT02444533|13984|P1|STARTED|Overall Study||17
5957|NCT02444182|14000|P2|NOT COMPLETED|Overall Study||5
5958|NCT02444182|14001|P1|NOT COMPLETED|Overall Study||2
5959|NCT02444182|14000|P2|COMPLETED|Overall Study||49
5960|NCT02444182|14001|P1|COMPLETED|Overall Study||52
5961|NCT02444182|14000|P2|STARTED|Overall Study||54
5962|NCT02444182|14001|P1|STARTED|Overall Study||54
5963|NCT02443792|14011|P2|NOT COMPLETED|Overall Study||2
5964|NCT02443792|14012|P1|NOT COMPLETED|Overall Study||7
5965|NCT02443792|14011|P2|COMPLETED|Overall Study||23
5966|NCT02443792|14012|P1|COMPLETED|Overall Study||43
5967|NCT02443792|14011|P2|STARTED|Overall Study||25
5968|NCT02443792|14012|P1|STARTED|Overall Study||50
5969|NCT02442804|14028|P2|NOT COMPLETED|Overall Study||1
5970|NCT02442804|14029|P1|NOT COMPLETED|Overall Study||1
5971|NCT02442804|14028|P2|COMPLETED|Overall Study||7
5972|NCT02442804|14029|P1|COMPLETED|Overall Study||7
5973|NCT02442804|14028|P2|STARTED|Overall Study||8
5974|NCT02442804|14029|P1|STARTED|Overall Study||8
5975|NCT02442700|14059|P2|NOT COMPLETED|Later 12 Weeks||0
5976|NCT02442700|14060|P1|NOT COMPLETED|Later 12 Weeks||0
5977|NCT02442700|14059|P2|COMPLETED|Later 12 Weeks||12
5978|NCT02442700|14060|P1|COMPLETED|Later 12 Weeks||12
5979|NCT02442700|14059|P2|STARTED|Later 12 Weeks||12
5980|NCT02442700|14060|P1|STARTED|Later 12 Weeks||12
5981|NCT02442700|14059|P2|NOT COMPLETED|First 12 Weeks||0
5982|NCT02442700|14060|P1|NOT COMPLETED|First 12 Weeks||0
5983|NCT02442700|14059|P2|COMPLETED|First 12 Weeks||12
5984|NCT02442700|14060|P1|COMPLETED|First 12 Weeks||12
5985|NCT02442700|14059|P2|STARTED|First 12 Weeks||12
5986|NCT02442700|14060|P1|STARTED|First 12 Weeks||12
5987|NCT02442349|14068|P1|NOT COMPLETED|Overall Study||171
5988|NCT02442349|14068|P1|COMPLETED|Overall Study||0
5989|NCT02442349|14068|P1|STARTED|Overall Study||171
5990|NCT02442310|14073|P1|NOT COMPLETED|Overall Study||3
5991|NCT02442310|14073|P1|COMPLETED|Overall Study||17
5992|NCT02442310|14073|P1|STARTED|Overall Study||20
5993|NCT02442284|14095|P1|NOT COMPLETED|Overall Study||7
5994|NCT02442284|14095|P1|COMPLETED|Overall Study||92
5995|NCT02442284|14095|P1|STARTED|Overall Study||99
5996|NCT02442271|14102|P1|NOT COMPLETED|Overall Study||4
5997|NCT02442271|14102|P1|COMPLETED|Overall Study||218
5998|NCT02442271|14102|P1|STARTED|Overall Study||222
5999|NCT02441218|14128|P2|NOT COMPLETED|Overall Study||612
6000|NCT02441218|14129|P1|NOT COMPLETED|Overall Study||578
6001|NCT02441218|14128|P2|COMPLETED|Overall Study||2652
6002|NCT02441218|14129|P1|COMPLETED|Overall Study||2663
6003|NCT02441218|14128|P2|STARTED|Overall Study||3264
6004|NCT02441218|14129|P1|STARTED|Overall Study||3241
6005|NCT02441179|14155|P2|NOT COMPLETED|Overall Study||1
6006|NCT02441179|14156|P1|NOT COMPLETED|Overall Study||1
6007|NCT02441179|14155|P2|COMPLETED|Overall Study||16
6008|NCT02441179|14156|P1|COMPLETED|Overall Study||17
6009|NCT02441179|14155|P2|STARTED|Overall Study||17
6010|NCT02441179|14156|P1|STARTED|Overall Study||18
6011|NCT02441114|14174|P1|NOT COMPLETED|Period3||0
6012|NCT02441114|14174|P1|COMPLETED|Period3||6
6013|NCT02441114|14174|P1|STARTED|Period3||6
6014|NCT02441114|14174|P1|NOT COMPLETED|Washout2||4
6015|NCT02441114|14174|P1|COMPLETED|Washout2||6
6016|NCT02441114|14174|P1|STARTED|Washout2||10
6017|NCT02441114|14174|P1|NOT COMPLETED|Period2||0
6018|NCT02441114|14174|P1|COMPLETED|Period2||10
6019|NCT02441114|14174|P1|STARTED|Period2||10
6020|NCT02441114|14174|P1|NOT COMPLETED|Washout1||0
6021|NCT02441114|14174|P1|COMPLETED|Washout1||10
6022|NCT02441114|14174|P1|STARTED|Washout1||10
6023|NCT02441114|14174|P1|NOT COMPLETED|Period1||0
6024|NCT02441114|14174|P1|COMPLETED|Period1||10
6025|NCT02441114|14174|P1|STARTED|Period1||10
6026|NCT02440659|14182|P2|NOT COMPLETED|Overall Study||335
6027|NCT02440659|14183|P1|NOT COMPLETED|Overall Study||651
6028|NCT02440659|14182|P2|COMPLETED|Overall Study||614
6029|NCT02440659|14183|P1|COMPLETED|Overall Study||1346
6030|NCT02440659|14182|P2|STARTED|Overall Study||949
6031|NCT02440659|14183|P1|STARTED|Overall Study||1997
6032|NCT02440633|14189|P1|NOT COMPLETED|Overall Study||0
6033|NCT02440633|14189|P1|COMPLETED|Overall Study||8
6034|NCT02440633|14189|P1|STARTED|Overall Study||8
6035|NCT02440308|14198|P1|NOT COMPLETED|Overall Study||0
6036|NCT02440308|14198|P1|COMPLETED|Overall Study||10
6037|NCT02440308|14198|P1|STARTED|Overall Study||10
6038|NCT02439879|14205|P2|NOT COMPLETED|Overall Study||0
6039|NCT02439879|14206|P1|NOT COMPLETED|Overall Study||0
6040|NCT02439879|14205|P2|COMPLETED|Overall Study||17
6041|NCT02439879|14206|P1|COMPLETED|Overall Study||16
6042|NCT02439879|14205|P2|STARTED|Overall Study||17
6043|NCT02439879|14206|P1|STARTED|Overall Study||16
6044|NCT02439164|14214|P2|NOT COMPLETED|Overall Study||0
6045|NCT02439164|14215|P1|NOT COMPLETED|Overall Study||0
6046|NCT02439164|14214|P2|COMPLETED|Overall Study||18
6047|NCT02439164|14215|P1|COMPLETED|Overall Study||18
6048|NCT02439164|14214|P2|STARTED|Overall Study||18
6049|NCT02439164|14215|P1|STARTED|Overall Study||18
6050|NCT02439138|14228|P1|NOT COMPLETED|Overall Study||3
6051|NCT02439138|14228|P1|COMPLETED|Overall Study||2
6052|NCT02439138|14228|P1|STARTED|Overall Study||5
6053|NCT02438540|14241|P2|NOT COMPLETED|Overall Study||0
6054|NCT02438540|14242|P1|NOT COMPLETED|Overall Study||0
6055|NCT02438540|14241|P2|COMPLETED|Overall Study||20
6056|NCT02438540|14242|P1|COMPLETED|Overall Study||19
6057|NCT02438540|14241|P2|STARTED|Overall Study||20
6058|NCT02438540|14242|P1|STARTED|Overall Study||19
6059|NCT02438137|14284|P2|NOT COMPLETED|Overall Study||6
6060|NCT02438137|14285|P1|NOT COMPLETED|Overall Study||8
6061|NCT02438137|14284|P2|COMPLETED|Overall Study||15
6062|NCT02438137|14285|P1|COMPLETED|Overall Study||36
6063|NCT02438137|14284|P2|STARTED|Overall Study||21
6064|NCT02438137|14285|P1|STARTED|Overall Study||44
6065|NCT02437903|14293|P1|NOT COMPLETED|Overall Study||5
6066|NCT02437903|14293|P1|COMPLETED|Overall Study||25
6067|NCT02437903|14293|P1|STARTED|Overall Study||30
6068|NCT02437513|14301|P1|NOT COMPLETED|Overall Study||2
6069|NCT02437513|14301|P1|COMPLETED|Overall Study||0
6070|NCT02437513|14301|P1|STARTED|Overall Study||2
6071|NCT02437409|14309|P1|NOT COMPLETED|Overall Study||15
6072|NCT02437409|14309|P1|COMPLETED|Overall Study|In total 100 patients fulfilled the in-and exclusion criteria,15 patients were excluded/discontinued|100
6073|NCT02437409|14309|P1|STARTED|Overall Study|Eventually 100 evaluable patients, attrition rate of 15%|115
6074|NCT02437305|14320|P2|NOT COMPLETED|Overall Study||12
6075|NCT02437305|14321|P1|NOT COMPLETED|Overall Study||18
6076|NCT02437305|14320|P2|COMPLETED|Overall Study||38
6077|NCT02437305|14321|P1|COMPLETED|Overall Study||32
6078|NCT02437305|14320|P2|STARTED|Overall Study||50
6079|NCT02437305|14321|P1|STARTED|Overall Study||50
6080|NCT02436811|14332|P3|NOT COMPLETED|Overall Study||7
6081|NCT02436811|14333|P2|NOT COMPLETED|Overall Study||9
6082|NCT02436811|14334|P1|NOT COMPLETED|Overall Study||2
6083|NCT02436811|14332|P3|COMPLETED|Overall Study||53
6084|NCT02436811|14333|P2|COMPLETED|Overall Study||51
6085|NCT02436811|14334|P1|COMPLETED|Overall Study||58
6086|NCT02436811|14332|P3|STARTED|Overall Study||60
6087|NCT02436811|14333|P2|STARTED|Overall Study||60
6088|NCT02436811|14334|P1|STARTED|Overall Study||60
6089|NCT02436577|14348|P6|NOT COMPLETED|Overall Study||0
6090|NCT02436577|14349|P5|NOT COMPLETED|Overall Study||0
6091|NCT02436577|14350|P4|NOT COMPLETED|Overall Study||0
6092|NCT02436577|14351|P3|NOT COMPLETED|Overall Study||0
6093|NCT02436577|14352|P2|NOT COMPLETED|Overall Study||1
6094|NCT02436577|14353|P1|NOT COMPLETED|Overall Study||0
6095|NCT02436577|14348|P6|COMPLETED|Overall Study||7
6096|NCT02436577|14349|P5|COMPLETED|Overall Study||7
6097|NCT02436577|14350|P4|COMPLETED|Overall Study||7
6098|NCT02436577|14351|P3|COMPLETED|Overall Study||7
6099|NCT02436577|14352|P2|COMPLETED|Overall Study||6
6100|NCT02436577|14353|P1|COMPLETED|Overall Study||7
6101|NCT02436577|14348|P6|STARTED|Overall Study||7
6102|NCT02436577|14349|P5|STARTED|Overall Study||7
6103|NCT02436577|14350|P4|STARTED|Overall Study||7
6104|NCT02436577|14351|P3|STARTED|Overall Study||7
6105|NCT02436577|14352|P2|STARTED|Overall Study||7
6106|NCT02436577|14353|P1|STARTED|Overall Study||7
6107|NCT02436330|14408|P2|NOT COMPLETED|Cohort 6||1
6108|NCT02436330|14409|P1|NOT COMPLETED|Cohort 6||3
6109|NCT02436330|14408|P2|COMPLETED|Cohort 6||4
6110|NCT02436330|14409|P1|COMPLETED|Cohort 6||1
6111|NCT02436330|14408|P2|STARTED|Cohort 6||5
6112|NCT02436330|14409|P1|STARTED|Cohort 6||4
6113|NCT02436330|14408|P2|NOT COMPLETED|Cohort 5||4
6114|NCT02436330|14409|P1|NOT COMPLETED|Cohort 5||6
6115|NCT02436330|14408|P2|COMPLETED|Cohort 5||1
6116|NCT02436330|14409|P1|COMPLETED|Cohort 5||4
6117|NCT02436330|14408|P2|STARTED|Cohort 5||5
6118|NCT02436330|14409|P1|STARTED|Cohort 5||10
6119|NCT02436330|14408|P2|NOT COMPLETED|Cohort 4||0
6120|NCT02436330|14409|P1|NOT COMPLETED|Cohort 4||2
6121|NCT02436330|14408|P2|COMPLETED|Cohort 4||0
6122|NCT02436330|14409|P1|COMPLETED|Cohort 4||4
6215|NCT02433366|14614|P1|STARTED|Overall Study||411
6123|NCT02436330|14408|P2|STARTED|Cohort 4|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
6124|NCT02436330|14409|P1|STARTED|Cohort 4||6
6125|NCT02436330|14408|P2|NOT COMPLETED|Cohort 3||0
6126|NCT02436330|14409|P1|NOT COMPLETED|Cohort 3||5
6127|NCT02436330|14408|P2|COMPLETED|Cohort 3||0
6128|NCT02436330|14409|P1|COMPLETED|Cohort 3||7
6129|NCT02436330|14408|P2|STARTED|Cohort 3|Enrollment too low to have control group. All subjects in this cohort received intervention.|0
6130|NCT02436330|14409|P1|STARTED|Cohort 3||12
6131|NCT02436330|14408|P2|NOT COMPLETED|Cohort 2||3
6132|NCT02436330|14409|P1|NOT COMPLETED|Cohort 2||4
6133|NCT02436330|14408|P2|COMPLETED|Cohort 2||7
6134|NCT02436330|14409|P1|COMPLETED|Cohort 2||10
6135|NCT02436330|14408|P2|STARTED|Cohort 2||10
6136|NCT02436330|14409|P1|STARTED|Cohort 2||14
6137|NCT02436330|14408|P2|NOT COMPLETED|Cohort 1||3
6138|NCT02436330|14409|P1|NOT COMPLETED|Cohort 1||5
6139|NCT02436330|14408|P2|COMPLETED|Cohort 1||1
6140|NCT02436330|14409|P1|COMPLETED|Cohort 1||9
6141|NCT02436330|14408|P2|STARTED|Cohort 1||4
6142|NCT02436330|14409|P1|STARTED|Cohort 1||14
6143|NCT02436304|14454|P3|NOT COMPLETED|Overall Study||1
6144|NCT02436304|14455|P2|NOT COMPLETED|Overall Study||2
6145|NCT02436304|14456|P1|NOT COMPLETED|Overall Study||0
6146|NCT02436304|14454|P3|COMPLETED|Overall Study||100
6147|NCT02436304|14455|P2|COMPLETED|Overall Study||100
6148|NCT02436304|14456|P1|COMPLETED|Overall Study||153
6149|NCT02436304|14454|P3|STARTED|Overall Study||101
6150|NCT02436304|14455|P2|STARTED|Overall Study||102
6151|NCT02436304|14456|P1|STARTED|Overall Study||153
6152|NCT02436031|14471|P2|NOT COMPLETED|Second Study Night||0
6153|NCT02436031|14472|P1|NOT COMPLETED|Second Study Night||0
6154|NCT02436031|14471|P2|COMPLETED|Second Study Night||8
6155|NCT02436031|14472|P1|COMPLETED|Second Study Night||7
6156|NCT02436031|14471|P2|STARTED|Second Study Night||8
6157|NCT02436031|14472|P1|STARTED|Second Study Night|1 participant did not tolerate the study setup so did not participate in the second study night|7
6158|NCT02436031|14471|P2|NOT COMPLETED|First Study Night||0
6159|NCT02436031|14472|P1|NOT COMPLETED|First Study Night||0
6160|NCT02436031|14471|P2|COMPLETED|First Study Night||8
6161|NCT02436031|14472|P1|COMPLETED|First Study Night||8
6162|NCT02436031|14471|P2|STARTED|First Study Night||8
6163|NCT02436031|14472|P1|STARTED|First Study Night||8
6164|NCT02434939|14484|P2|NOT COMPLETED|Overall Study||49
6165|NCT02434939|14485|P1|NOT COMPLETED|Overall Study||37
6166|NCT02434939|14484|P2|COMPLETED|Overall Study||71
6167|NCT02434939|14485|P1|COMPLETED|Overall Study||83
6168|NCT02434939|14484|P2|STARTED|Overall Study||120
6169|NCT02434939|14485|P1|STARTED|Overall Study||120
6170|NCT02435966|14500|P3|NOT COMPLETED|Overall Study||0
6171|NCT02435966|14501|P2|NOT COMPLETED|Overall Study||1
6172|NCT02435966|14502|P1|NOT COMPLETED|Overall Study||0
6173|NCT02435966|14500|P3|COMPLETED|Overall Study||30
6174|NCT02435966|14501|P2|COMPLETED|Overall Study||53
6175|NCT02435966|14502|P1|COMPLETED|Overall Study||47
6176|NCT02435966|14500|P3|Follow-up|Overall Study||30
6177|NCT02435966|14501|P2|Follow-up|Overall Study||53
6178|NCT02435966|14502|P1|Follow-up|Overall Study||47
6179|NCT02435966|14500|P3|Second Intervention|Overall Study||30
6180|NCT02435966|14501|P2|Second Intervention|Overall Study||53
6181|NCT02435966|14502|P1|Second Intervention|Overall Study||47
6182|NCT02435966|14500|P3|First Intervention|Overall Study||30
6183|NCT02435966|14501|P2|First Intervention|Overall Study||54
6184|NCT02435966|14502|P1|First Intervention|Overall Study||47
6185|NCT02435966|14500|P3|STARTED|Overall Study||30
6186|NCT02435966|14501|P2|STARTED|Overall Study||54
6187|NCT02435966|14502|P1|STARTED|Overall Study||47
6188|NCT02435836|14510|P1|NOT COMPLETED|Overall Study||631
6189|NCT02435836|14510|P1|COMPLETED|Overall Study||0
6190|NCT02435836|14510|P1|STARTED|Overall Study||631
6191|NCT02434523|14528|P2|NOT COMPLETED|Overall Study||6
6192|NCT02434523|14529|P1|NOT COMPLETED|Overall Study||5
6193|NCT02434523|14528|P2|COMPLETED|Overall Study||9
6194|NCT02434523|14529|P1|COMPLETED|Overall Study||10
6195|NCT02434523|14528|P2|STARTED|Overall Study||15
6196|NCT02434523|14529|P1|STARTED|Overall Study||15
6197|NCT02434146|14541|P1|NOT COMPLETED|Overall Study||0
6198|NCT02434146|14541|P1|COMPLETED|Overall Study||3
6199|NCT02434146|14541|P1|STARTED|Overall Study||3
6200|NCT02433834|14553|P1|NOT COMPLETED|Overall Study||37
6201|NCT02433834|14553|P1|COMPLETED|Overall Study|Subject PT001101-040014 did not complete Period 4 but completed the study. CSR states 210 completed.|211
6202|NCT02433834|14553|P1|SAL 50 µg|Overall Study||167
6203|NCT02433834|14553|P1|Placebo MDI|Overall Study||174
6204|NCT02433834|14553|P1|GP MDI 1.9 µg|Overall Study||107
6205|NCT02433834|14553|P1|GP MDI 3.6 µg|Overall Study||118
6206|NCT02433834|14553|P1|GP MDI 7.2 µg|Overall Study||228
6207|NCT02433834|14553|P1|GP MDI 14.4 µg|Overall Study||230
6208|NCT02433834|14553|P1|GP MDI 28.8 µg|Overall Study||112
6209|NCT02433834|14553|P1|STARTED|Overall Study||248
6210|NCT02433366|14613|P2|NOT COMPLETED|Overall Study||0
6211|NCT02433366|14614|P1|NOT COMPLETED|Overall Study||0
6212|NCT02433366|14613|P2|COMPLETED|Overall Study||802
6213|NCT02433366|14614|P1|COMPLETED|Overall Study||411
6214|NCT02433366|14613|P2|STARTED|Overall Study||802
6216|NCT02433340|14626|P4|NOT COMPLETED|Overall Study||2
6217|NCT02433340|14627|P3|NOT COMPLETED|Overall Study||2
6218|NCT02433340|14628|P2|NOT COMPLETED|Overall Study||2
6219|NCT02433340|14629|P1|NOT COMPLETED|Overall Study||2
6220|NCT02433340|14626|P4|COMPLETED|Overall Study||38
6221|NCT02433340|14627|P3|COMPLETED|Overall Study||37
6222|NCT02433340|14628|P2|COMPLETED|Overall Study||35
6223|NCT02433340|14629|P1|COMPLETED|Overall Study||40
6224|NCT02433340|14626|P4|STARTED|Overall Study||40
6225|NCT02433340|14627|P3|STARTED|Overall Study||39
6226|NCT02433340|14628|P2|STARTED|Overall Study||37
6227|NCT02433340|14629|P1|STARTED|Overall Study||42
6228|NCT02432105|15524|P3|NOT COMPLETED|Overall Study||3
6229|NCT02432105|15525|P2|NOT COMPLETED|Overall Study||2
6230|NCT02432105|15526|P1|NOT COMPLETED|Overall Study||2
6231|NCT02432105|15524|P3|COMPLETED|Overall Study||108
6232|NCT02432105|15525|P2|COMPLETED|Overall Study||108
6233|NCT02432105|15526|P1|COMPLETED|Overall Study||162
6234|NCT02432105|15524|P3|STARTED|Overall Study||111
6235|NCT02432105|15525|P2|STARTED|Overall Study||110
6236|NCT02432105|15526|P1|STARTED|Overall Study||164
6237|NCT02432040|15543|P2|NOT COMPLETED|Overall Study||6
6238|NCT02432040|15544|P1|NOT COMPLETED|Overall Study||8
6239|NCT02432040|15543|P2|COMPLETED|Overall Study||8
6240|NCT02432040|15544|P1|COMPLETED|Overall Study||6
6241|NCT02432040|15543|P2|STARTED|Overall Study||14
6242|NCT02432040|15544|P1|STARTED|Overall Study||14
6243|NCT02431754|15566|P2|NOT COMPLETED|Period 2 (8 Weeks)||4
6244|NCT02431754|15567|P1|NOT COMPLETED|Period 2 (8 Weeks)||1
6245|NCT02431754|15566|P2|COMPLETED|Period 2 (8 Weeks)||78
6246|NCT02431754|15567|P1|COMPLETED|Period 2 (8 Weeks)||74
6247|NCT02431754|15566|P2|STARTED|Period 2 (8 Weeks)||82
6248|NCT02431754|15567|P1|STARTED|Period 2 (8 Weeks)||75
6249|NCT02431754|15566|P2|NOT COMPLETED|Wash-out Period (4 Weeks)||0
6250|NCT02431754|15567|P1|NOT COMPLETED|Wash-out Period (4 Weeks)||4
6251|NCT02431754|15566|P2|COMPLETED|Wash-out Period (4 Weeks)||82
6252|NCT02431754|15567|P1|COMPLETED|Wash-out Period (4 Weeks)||75
6253|NCT02431754|15566|P2|STARTED|Wash-out Period (4 Weeks)||82
6254|NCT02431754|15567|P1|STARTED|Wash-out Period (4 Weeks)||79
6255|NCT02431754|15566|P2|NOT COMPLETED|Period 1 (8 Weeks)||4
6256|NCT02431754|15567|P1|NOT COMPLETED|Period 1 (8 Weeks)||6
6257|NCT02431754|15566|P2|COMPLETED|Period 1 (8 Weeks)||82
6258|NCT02431754|15567|P1|COMPLETED|Period 1 (8 Weeks)||79
6259|NCT02431754|15566|P2|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||86
6260|NCT02431754|15567|P1|Received at Least One Dose of Study Drug|Period 1 (8 Weeks)||85
6261|NCT02431754|15566|P2|STARTED|Period 1 (8 Weeks)||86
6262|NCT02431754|15567|P1|STARTED|Period 1 (8 Weeks)||85
6263|NCT02431741|15585|P1|NOT COMPLETED|Overall Study||0
6264|NCT02431741|15585|P1|COMPLETED|Overall Study||14
6265|NCT02431741|15585|P1|STARTED|Overall Study||14
6266|NCT02431598|15589|P6|NOT COMPLETED|Overall Study||0
6267|NCT02431598|15590|P5|NOT COMPLETED|Overall Study||0
6268|NCT02431598|15591|P4|NOT COMPLETED|Overall Study||0
6269|NCT02431598|15592|P3|NOT COMPLETED|Overall Study||0
6270|NCT02431598|15593|P2|NOT COMPLETED|Overall Study||0
6271|NCT02431598|15594|P1|NOT COMPLETED|Overall Study||0
6272|NCT02431598|15589|P6|COMPLETED|Overall Study||6
6273|NCT02431598|15590|P5|COMPLETED|Overall Study||7
6274|NCT02431598|15591|P4|COMPLETED|Overall Study||7
6275|NCT02431598|15592|P3|COMPLETED|Overall Study||9
6276|NCT02431598|15593|P2|COMPLETED|Overall Study||9
6277|NCT02431598|15594|P1|COMPLETED|Overall Study||6
6278|NCT02431598|15589|P6|STARTED|Overall Study||6
6279|NCT02431598|15590|P5|STARTED|Overall Study||7
6280|NCT02431598|15591|P4|STARTED|Overall Study||7
6281|NCT02431598|15592|P3|STARTED|Overall Study||9
6282|NCT02431598|15593|P2|STARTED|Overall Study||9
6283|NCT02431598|15594|P1|STARTED|Overall Study||6
6284|NCT02431455|15620|P2|NOT COMPLETED|Overall Study||0
6285|NCT02431455|15621|P1|NOT COMPLETED|Overall Study||0
6286|NCT02431455|15620|P2|COMPLETED|Overall Study||112
6287|NCT02431455|15621|P1|COMPLETED|Overall Study||112
6288|NCT02431455|15620|P2|STARTED|Overall Study||112
6289|NCT02431455|15621|P1|STARTED|Overall Study||112
6290|NCT02431299|15635|P2|NOT COMPLETED|Overall Study||1
6291|NCT02431299|15636|P1|NOT COMPLETED|Overall Study||53
6292|NCT02431299|15635|P2|COMPLETED|Overall Study||62
6293|NCT02431299|15636|P1|COMPLETED|Overall Study||183
6294|NCT02431299|15635|P2|STARTED|Overall Study||63
6295|NCT02431299|15636|P1|STARTED|Overall Study||236
6296|NCT02430870|15657|P8|NOT COMPLETED|Part 2||1
6297|NCT02430870|15658|P7|NOT COMPLETED|Part 2||1
6298|NCT02430870|15659|P6|NOT COMPLETED|Part 2||0
6299|NCT02430870|15660|P5|NOT COMPLETED|Part 2||0
6300|NCT02430870|15661|P4|NOT COMPLETED|Part 2||0
6301|NCT02430870|15662|P3|NOT COMPLETED|Part 2||0
6302|NCT02430870|15663|P2|NOT COMPLETED|Part 2||0
6303|NCT02430870|15664|P1|NOT COMPLETED|Part 2||0
6304|NCT02430870|15657|P8|COMPLETED|Part 2||7
6305|NCT02430870|15658|P7|COMPLETED|Part 2||5
6306|NCT02430870|15659|P6|COMPLETED|Part 2||6
6307|NCT02430870|15660|P5|COMPLETED|Part 2||6
6308|NCT02430870|15661|P4|COMPLETED|Part 2||6
6309|NCT02430870|15662|P3|COMPLETED|Part 2||0
6310|NCT02430870|15663|P2|COMPLETED|Part 2||0
6311|NCT02430870|15664|P1|COMPLETED|Part 2||0
6312|NCT02430870|15657|P8|STARTED|Part 2||8
6313|NCT02430870|15658|P7|STARTED|Part 2||6
6314|NCT02430870|15659|P6|STARTED|Part 2||6
6315|NCT02430870|15660|P5|STARTED|Part 2||6
6316|NCT02430870|15661|P4|STARTED|Part 2||6
6317|NCT02430870|15662|P3|STARTED|Part 2||0
6318|NCT02430870|15663|P2|STARTED|Part 2||0
6319|NCT02430870|15664|P1|STARTED|Part 2||0
6320|NCT02430870|15657|P8|NOT COMPLETED|Part 1||0
6321|NCT02430870|15658|P7|NOT COMPLETED|Part 1||0
6322|NCT02430870|15659|P6|NOT COMPLETED|Part 1||0
6323|NCT02430870|15660|P5|NOT COMPLETED|Part 1||0
6324|NCT02430870|15661|P4|NOT COMPLETED|Part 1||0
6325|NCT02430870|15662|P3|NOT COMPLETED|Part 1||0
6326|NCT02430870|15663|P2|NOT COMPLETED|Part 1||0
6327|NCT02430870|15664|P1|NOT COMPLETED|Part 1||0
6328|NCT02430870|15657|P8|COMPLETED|Part 1||0
6329|NCT02430870|15658|P7|COMPLETED|Part 1||0
6330|NCT02430870|15659|P6|COMPLETED|Part 1||0
6331|NCT02430870|15660|P5|COMPLETED|Part 1||0
6332|NCT02430870|15661|P4|COMPLETED|Part 1||0
6333|NCT02430870|15662|P3|COMPLETED|Part 1||4
6334|NCT02430870|15663|P2|COMPLETED|Part 1||6
6335|NCT02430870|15664|P1|COMPLETED|Part 1||6
6336|NCT02430870|15657|P8|STARTED|Part 1||0
6337|NCT02430870|15658|P7|STARTED|Part 1||0
6338|NCT02430870|15659|P6|STARTED|Part 1||0
6339|NCT02430870|15660|P5|STARTED|Part 1||0
6340|NCT02430870|15661|P4|STARTED|Part 1||0
6341|NCT02430870|15662|P3|STARTED|Part 1||4
6342|NCT02430870|15663|P2|STARTED|Part 1||6
6343|NCT02430870|15664|P1|STARTED|Part 1||6
6344|NCT02430532|15738|P2|NOT COMPLETED|Overall Study||28
6345|NCT02430532|15739|P1|NOT COMPLETED|Overall Study||30
6346|NCT02430532|15738|P2|COMPLETED|Overall Study||0
6347|NCT02430532|15739|P1|COMPLETED|Overall Study||0
6348|NCT02430532|15738|P2|STARTED|Overall Study||28
6349|NCT02430532|15739|P1|STARTED|Overall Study||30
6350|NCT02430389|15755|P2|NOT COMPLETED|Overall Study||0
6351|NCT02430389|15756|P1|NOT COMPLETED|Overall Study||0
6352|NCT02430389|15755|P2|COMPLETED|Overall Study||10
6353|NCT02430389|15756|P1|COMPLETED|Overall Study||10
6354|NCT02430389|15755|P2|STARTED|Overall Study||10
6355|NCT02430389|15756|P1|STARTED|Overall Study||10
6356|NCT02430090|15767|P3|NOT COMPLETED|Overall Study||0
6357|NCT02430090|15768|P2|NOT COMPLETED|Overall Study||0
6358|NCT02430090|15769|P1|NOT COMPLETED|Overall Study||0
6359|NCT02430090|15767|P3|COMPLETED|Overall Study||15
6360|NCT02430090|15768|P2|COMPLETED|Overall Study||15
6361|NCT02430090|15769|P1|COMPLETED|Overall Study||15
6362|NCT02430090|15767|P3|STARTED|Overall Study||15
6363|NCT02430090|15768|P2|STARTED|Overall Study||15
6364|NCT02430090|15769|P1|STARTED|Overall Study||15
6365|NCT02429258|15779|P2|NOT COMPLETED|Overall Study||1
6366|NCT02429258|15780|P1|NOT COMPLETED|Overall Study||2
6367|NCT02429258|15779|P2|COMPLETED|Overall Study||49
6368|NCT02429258|15780|P1|COMPLETED|Overall Study||48
6369|NCT02429258|15779|P2|STARTED|Overall Study||50
6370|NCT02429258|15780|P1|STARTED|Overall Study||50
6371|NCT02428478|15806|P2|NOT COMPLETED|Second Study Night||0
6372|NCT02428478|15807|P1|NOT COMPLETED|Second Study Night||0
6373|NCT02428478|15806|P2|COMPLETED|Second Study Night||6
6374|NCT02428478|15807|P1|COMPLETED|Second Study Night||8
6375|NCT02428478|15806|P2|STARTED|Second Study Night|2 participants did not return for the second study night|6
6376|NCT02428478|15807|P1|STARTED|Second Study Night|1 participant did not return for the second study night|8
6377|NCT02428478|15806|P2|NOT COMPLETED|First Study Night||0
6378|NCT02428478|15807|P1|NOT COMPLETED|First Study Night||0
6379|NCT02428478|15806|P2|COMPLETED|First Study Night||8
6380|NCT02428478|15807|P1|COMPLETED|First Study Night||9
6381|NCT02428478|15806|P2|STARTED|First Study Night||8
6382|NCT02428478|15807|P1|STARTED|First Study Night||9
6383|NCT02428413|15817|P2|NOT COMPLETED|Overall Study||9
6384|NCT02428413|15818|P1|NOT COMPLETED|Overall Study||8
6385|NCT02428413|15817|P2|COMPLETED|Overall Study||52
6386|NCT02428413|15818|P1|COMPLETED|Overall Study||56
6387|NCT02428413|15817|P2|STARTED|Overall Study||61
6388|NCT02428413|15818|P1|STARTED|Overall Study||64
6389|NCT02428231|15832|P2|NOT COMPLETED|Overall Study||17
6390|NCT02428231|15833|P1|NOT COMPLETED|Overall Study||13
6391|NCT02428231|15832|P2|COMPLETED|Overall Study||15
6392|NCT02428231|15833|P1|COMPLETED|Overall Study||17
6393|NCT02428231|15832|P2|STARTED|Overall Study||32
6394|NCT02428231|15833|P1|STARTED|Overall Study||30
6395|NCT02427984|15850|P3|NOT COMPLETED|Overall Study||18
6396|NCT02427984|15851|P2|NOT COMPLETED|Overall Study||5
6397|NCT02427984|15852|P1|NOT COMPLETED|Overall Study||13
6398|NCT02427984|15850|P3|COMPLETED|Overall Study||32
6399|NCT02427984|15851|P2|COMPLETED|Overall Study||40
6400|NCT02427984|15852|P1|COMPLETED|Overall Study||40
6401|NCT02427984|15850|P3|STARTED|Overall Study||50
6402|NCT02427984|15851|P2|STARTED|Overall Study||45
6403|NCT02427984|15852|P1|STARTED|Overall Study||53
6404|NCT02427750|15868|P2|NOT COMPLETED|Overall Study||0
6405|NCT02427750|15869|P1|NOT COMPLETED|Overall Study||0
6406|NCT02427750|15868|P2|COMPLETED|Overall Study||63
6407|NCT02427750|15869|P1|COMPLETED|Overall Study||63
6408|NCT02427750|15868|P2|STARTED|Overall Study||63
6409|NCT02427750|15869|P1|STARTED|Overall Study||63
6410|NCT02427477|15894|P2|NOT COMPLETED|Period 3||0
6411|NCT02427477|15895|P1|NOT COMPLETED|Period 3||0
6412|NCT02427477|15894|P2|COMPLETED|Period 3||60
6413|NCT02427477|15895|P1|COMPLETED|Period 3||59
6414|NCT02427477|15894|P2|STARTED|Period 3||60
6415|NCT02427477|15895|P1|STARTED|Period 3||59
6416|NCT02427477|15894|P2|NOT COMPLETED|Period 2||0
6417|NCT02427477|15895|P1|NOT COMPLETED|Period 2||0
6418|NCT02427477|15894|P2|COMPLETED|Period 2||60
6419|NCT02427477|15895|P1|COMPLETED|Period 2||59
6420|NCT02427477|15894|P2|STARTED|Period 2||60
6421|NCT02427477|15895|P1|STARTED|Period 2||59
6422|NCT02427477|15894|P2|NOT COMPLETED|Period 1||0
6423|NCT02427477|15895|P1|NOT COMPLETED|Period 1||1
6424|NCT02427477|15894|P2|COMPLETED|Period 1||60
6425|NCT02427477|15895|P1|COMPLETED|Period 1||59
6426|NCT02427477|15894|P2|STARTED|Period 1||60
6427|NCT02427477|15895|P1|STARTED|Period 1||60
6428|NCT02427399|15908|P5|NOT COMPLETED|Overall Study||15
6429|NCT02427399|15909|P4|NOT COMPLETED|Overall Study||18
6430|NCT02427399|15910|P3|NOT COMPLETED|Overall Study||12
6431|NCT02427399|15911|P2|NOT COMPLETED|Overall Study||16
6432|NCT02427399|15912|P1|NOT COMPLETED|Overall Study||14
6433|NCT02427399|15908|P5|COMPLETED|Overall Study||205
6434|NCT02427399|15909|P4|COMPLETED|Overall Study||202
6435|NCT02427399|15910|P3|COMPLETED|Overall Study||208
6436|NCT02427399|15911|P2|COMPLETED|Overall Study||204
6437|NCT02427399|15912|P1|COMPLETED|Overall Study||206
6438|NCT02427399|15908|P5|STARTED|Overall Study||220
6439|NCT02427399|15909|P4|STARTED|Overall Study||220
6440|NCT02427399|15910|P3|STARTED|Overall Study||220
6441|NCT02427399|15911|P2|STARTED|Overall Study||220
6442|NCT02427399|15912|P1|STARTED|Overall Study||220
6443|NCT02425956|15934|P1|NOT COMPLETED|Overall Study||0
6444|NCT02425956|15934|P1|COMPLETED|Overall Study||21
6445|NCT02425956|15934|P1|STARTED|Overall Study||21
6446|NCT02425826|15941|P2|NOT COMPLETED|Overall Study||27
6447|NCT02425826|15942|P1|NOT COMPLETED|Overall Study||9
6448|NCT02425826|15941|P2|COMPLETED|Overall Study|Completed = participants who completed Week 16|121
6449|NCT02425826|15942|P1|COMPLETED|Overall Study||64
6450|NCT02425826|15941|P2|Received Treatment|Overall Study|Received treatment includes participants who received at least one dose of study drug.|147
6451|NCT02425826|15942|P1|Received Treatment|Overall Study|Received treatment includes participants who received at least one dose of study drug.|73
6452|NCT02425826|15941|P2|STARTED|Overall Study||148
6453|NCT02425826|15942|P1|STARTED|Overall Study||73
6454|NCT02424591|15971|P2|NOT COMPLETED|Overall Study||3
6455|NCT02424591|15972|P1|NOT COMPLETED|Overall Study||2
6456|NCT02424591|15971|P2|COMPLETED|Overall Study||20
6457|NCT02424591|15972|P1|COMPLETED|Overall Study||20
6458|NCT02424591|15971|P2|STARTED|Overall Study||23
6459|NCT02424591|15972|P1|STARTED|Overall Study||22
6460|NCT02424578|15984|P2|NOT COMPLETED|Overall Study||1
6461|NCT02424578|15985|P1|NOT COMPLETED|Overall Study||0
6462|NCT02424578|15984|P2|COMPLETED|Overall Study||14
6463|NCT02424578|15985|P1|COMPLETED|Overall Study||15
6464|NCT02424578|15984|P2|STARTED|Overall Study||15
6465|NCT02424578|15985|P1|STARTED|Overall Study||15
6466|NCT02424565|15991|P2|NOT COMPLETED|Period 2 (D3)||0
6467|NCT02424565|15992|P1|NOT COMPLETED|Period 2 (D3)||0
6468|NCT02424565|15991|P2|COMPLETED|Period 2 (D3)||6
6469|NCT02424565|15992|P1|COMPLETED|Period 2 (D3)||8
6470|NCT02424565|15991|P2|STARTED|Period 2 (D3)||6
6471|NCT02424565|15992|P1|STARTED|Period 2 (D3)||8
6472|NCT02424565|15991|P2|NOT COMPLETED|Washout Period||0
6473|NCT02424565|15992|P1|NOT COMPLETED|Washout Period||0
6474|NCT02424565|15991|P2|COMPLETED|Washout Period||6
6475|NCT02424565|15992|P1|COMPLETED|Washout Period||8
6476|NCT02424565|15991|P2|STARTED|Washout Period||6
6477|NCT02424565|15992|P1|STARTED|Washout Period||8
6478|NCT02424565|15991|P2|NOT COMPLETED|Period 1 (D0)||1
6479|NCT02424565|15992|P1|NOT COMPLETED|Period 1 (D0)||0
6480|NCT02424565|15991|P2|COMPLETED|Period 1 (D0)||6
6481|NCT02424565|15992|P1|COMPLETED|Period 1 (D0)||8
6482|NCT02424565|15991|P2|STARTED|Period 1 (D0)||7
6483|NCT02424565|15992|P1|STARTED|Period 1 (D0)||8
6484|NCT02424149|16000|P2|NOT COMPLETED|Overall Study||1
6485|NCT02424149|16001|P1|NOT COMPLETED|Overall Study||2
6486|NCT02424149|16000|P2|COMPLETED|Overall Study||52
6487|NCT02424149|16001|P1|COMPLETED|Overall Study||52
6488|NCT02424149|16000|P2|STARTED|Overall Study||53
6489|NCT02424149|16001|P1|STARTED|Overall Study||54
6490|NCT02423993|16019|P4|NOT COMPLETED|Overall Study||0
6491|NCT02423993|16020|P3|NOT COMPLETED|Overall Study||0
6492|NCT02423993|16021|P2|NOT COMPLETED|Overall Study||0
6493|NCT02423993|16022|P1|NOT COMPLETED|Overall Study||0
6494|NCT02423993|16019|P4|COMPLETED|Overall Study||19
6495|NCT02423993|16020|P3|COMPLETED|Overall Study||23
6496|NCT02423993|16021|P2|COMPLETED|Overall Study||16
6497|NCT02423993|16022|P1|COMPLETED|Overall Study||19
6498|NCT02423993|16019|P4|STARTED|Overall Study||19
6499|NCT02423993|16020|P3|STARTED|Overall Study||23
6500|NCT02423993|16021|P2|STARTED|Overall Study||16
6501|NCT02423993|16022|P1|STARTED|Overall Study||19
6502|NCT02423980|16052|P1|NOT COMPLETED|Overall Study||0
6503|NCT02423980|16052|P1|COMPLETED|Overall Study||7
6504|NCT02423980|16052|P1|STARTED|Overall Study||7
6505|NCT02423577|16064|P2|NOT COMPLETED|Overall Study||0
6506|NCT02423577|16065|P1|NOT COMPLETED|Overall Study||0
6507|NCT02423577|16064|P2|COMPLETED|Overall Study||26
6508|NCT02423577|16065|P1|COMPLETED|Overall Study||53
6509|NCT02423577|16064|P2|STARTED|Overall Study||26
6510|NCT02423577|16065|P1|STARTED|Overall Study||53
6511|NCT02423447|16071|P2|NOT COMPLETED|Overall Study||0
6512|NCT02423447|16072|P1|NOT COMPLETED|Overall Study||0
6513|NCT02423447|16071|P2|COMPLETED|Overall Study||12
6514|NCT02423447|16072|P1|COMPLETED|Overall Study||13
6515|NCT02423447|16071|P2|STARTED|Overall Study||12
6516|NCT02423447|16072|P1|STARTED|Overall Study||13
6517|NCT02423408|16088|P2|NOT COMPLETED|Overall Study||2
6518|NCT02423408|16089|P1|NOT COMPLETED|Overall Study||1
6519|NCT02423408|16088|P2|COMPLETED|Overall Study||80
6520|NCT02423408|16089|P1|COMPLETED|Overall Study||82
6521|NCT02423408|16088|P2|STARTED|Overall Study||82
6522|NCT02423408|16089|P1|STARTED|Overall Study||83
6523|NCT02423317|16103|P2|NOT COMPLETED|Overall Study||0
6524|NCT02423317|16104|P1|NOT COMPLETED|Overall Study||0
6525|NCT02423317|16103|P2|COMPLETED|Overall Study||30
6526|NCT02423317|16104|P1|COMPLETED|Overall Study||30
6527|NCT02423317|16103|P2|STARTED|Overall Study||30
6528|NCT02423317|16104|P1|STARTED|Overall Study||30
6529|NCT02423291|16122|P1|NOT COMPLETED|Overall Study||15
6530|NCT02423291|16122|P1|COMPLETED|Overall Study|Patients that have completed therapy|0
6531|NCT02423291|16122|P1|STARTED|Overall Study|Patients enrolled|15
6532|NCT02421211|16128|P2|NOT COMPLETED|Overall Study||0
6533|NCT02421211|16129|P1|NOT COMPLETED|Overall Study||0
6534|NCT02421211|16128|P2|COMPLETED|Overall Study||20
6535|NCT02421211|16129|P1|COMPLETED|Overall Study||20
6536|NCT02421211|16128|P2|STARTED|Overall Study||20
6537|NCT02421211|16129|P1|STARTED|Overall Study||20
6538|NCT02421120|16173|P1|NOT COMPLETED|Overall Study||1
6539|NCT02421120|16173|P1|COMPLETED|Overall Study||20
6540|NCT02421120|16173|P1|STARTED|Overall Study||21
6541|NCT02420951|16183|P2|NOT COMPLETED|Overall Study||0
6542|NCT02420951|16184|P1|NOT COMPLETED|Overall Study||0
6543|NCT02420951|16183|P2|COMPLETED|Overall Study||25
6544|NCT02420951|16184|P1|COMPLETED|Overall Study||25
6545|NCT02420951|16183|P2|STARTED|Overall Study||25
6546|NCT02420951|16184|P1|STARTED|Overall Study||25
6547|NCT02420093|16196|P2|NOT COMPLETED|Overall Study||1
6548|NCT02420093|16197|P1|NOT COMPLETED|Overall Study||1
6549|NCT02420093|16196|P2|COMPLETED|Overall Study||7
6550|NCT02420093|16197|P1|COMPLETED|Overall Study||8
6551|NCT02420093|16196|P2|STARTED|Overall Study||8
6552|NCT02420093|16197|P1|STARTED|Overall Study||9
6553|NCT02420041|16213|P2|NOT COMPLETED|Overall Study||0
6554|NCT02420041|16214|P1|NOT COMPLETED|Overall Study||0
6555|NCT02420041|16213|P2|COMPLETED|Overall Study||14
6556|NCT02420041|16214|P1|COMPLETED|Overall Study||14
6557|NCT02420041|16213|P2|STARTED|Overall Study||14
6558|NCT02420041|16214|P1|STARTED|Overall Study||14
6559|NCT02419521|16238|P1|NOT COMPLETED|Overall Study||1
6560|NCT02419521|16238|P1|COMPLETED|Overall Study||74
6561|NCT02419521|16238|P1|STARTED|Overall Study||75
6562|NCT02419313|16250|P2|NOT COMPLETED|Second Intervention||0
6563|NCT02419313|16251|P1|NOT COMPLETED|Second Intervention||1
6564|NCT02419313|16250|P2|COMPLETED|Second Intervention||15
6565|NCT02419313|16251|P1|COMPLETED|Second Intervention||15
6566|NCT02419313|16250|P2|STARTED|Second Intervention||15
6567|NCT02419313|16251|P1|STARTED|Second Intervention||16
6568|NCT02419313|16250|P2|NOT COMPLETED|First Intervention||0
6569|NCT02419313|16251|P1|NOT COMPLETED|First Intervention||2
6570|NCT02419313|16250|P2|COMPLETED|First Intervention||15
6571|NCT02419313|16251|P1|COMPLETED|First Intervention||16
6572|NCT02419313|16250|P2|STARTED|First Intervention||15
6573|NCT02419313|16251|P1|STARTED|First Intervention||18
6574|NCT02419001|16263|P2|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
6575|NCT02419001|16264|P1|NOT COMPLETED|Period 2- Ceftriaxone With SYN-004||0
6576|NCT02419001|16263|P2|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
6577|NCT02419001|16264|P1|COMPLETED|Period 2- Ceftriaxone With SYN-004||5
6578|NCT02419001|16263|P2|STARTED|Period 2- Ceftriaxone With SYN-004||5
6579|NCT02419001|16264|P1|STARTED|Period 2- Ceftriaxone With SYN-004||5
6580|NCT02419001|16263|P2|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||0
6581|NCT02419001|16264|P1|NOT COMPLETED|Period 1- Ceftriaxone Without SYN-004||1
6582|NCT02419001|16263|P2|COMPLETED|Period 1- Ceftriaxone Without SYN-004||5
6583|NCT02419001|16264|P1|COMPLETED|Period 1- Ceftriaxone Without SYN-004|The Adverse Event (AE) was with ceftriaxone, not with Investigational Product (IP)|5
6584|NCT02419001|16263|P2|STARTED|Period 1- Ceftriaxone Without SYN-004||5
6585|NCT02419001|16264|P1|STARTED|Period 1- Ceftriaxone Without SYN-004||6
6586|NCT02418676|16277|P3|NOT COMPLETED|Overall Study||0
6587|NCT02418676|16278|P2|NOT COMPLETED|Overall Study||0
6588|NCT02418676|16279|P1|NOT COMPLETED|Overall Study||0
6589|NCT02418676|16277|P3|COMPLETED|Overall Study||5
6590|NCT02418676|16278|P2|COMPLETED|Overall Study||5
6591|NCT02418676|16279|P1|COMPLETED|Overall Study||5
6592|NCT02418676|16277|P3|STARTED|Overall Study||5
6593|NCT02418676|16278|P2|STARTED|Overall Study||5
6594|NCT02418676|16279|P1|STARTED|Overall Study||5
6595|NCT02418468|16292|P2|NOT COMPLETED|Overall Study||1
6596|NCT02418468|16293|P1|NOT COMPLETED|Overall Study||2
6597|NCT02418468|16292|P2|COMPLETED|Overall Study||10
6598|NCT02418468|16293|P1|COMPLETED|Overall Study||11
6599|NCT02418468|16292|P2|STARTED|Overall Study||11
6600|NCT02418468|16293|P1|STARTED|Overall Study||13
6601|NCT02418234|16299|P1|NOT COMPLETED|Overall Study||0
6602|NCT02418234|16299|P1|COMPLETED|Overall Study||314
6603|NCT02418234|16299|P1|STARTED|Overall Study||314
6604|NCT02418026|16312|P2|NOT COMPLETED|Overall Study||0
6605|NCT02418026|16313|P1|NOT COMPLETED|Overall Study||0
6606|NCT02418026|16312|P2|COMPLETED|Overall Study||35
6607|NCT02418026|16313|P1|COMPLETED|Overall Study||44
6608|NCT02418026|16312|P2|STARTED|Overall Study||35
6609|NCT02418026|16313|P1|STARTED|Overall Study||44
6610|NCT02417961|16343|P1|NOT COMPLETED|Overall Study||4
6611|NCT02417961|16343|P1|COMPLETED|Overall Study||112
6612|NCT02417961|16343|P1|STARTED|Overall Study||116
6613|NCT02417753|16353|P1|NOT COMPLETED|Overall Study||1
6614|NCT02417753|16353|P1|COMPLETED|Overall Study||0
6615|NCT02417753|16353|P1|STARTED|Overall Study||1
6616|NCT02417532|16363|P1|NOT COMPLETED|Overall Study||4
6617|NCT02417532|16363|P1|COMPLETED|Overall Study||52
6618|NCT02417532|16363|P1|STARTED|Overall Study||56
6619|NCT02417376|16376|P2|NOT COMPLETED|Overall Study||10
6620|NCT02417376|16377|P1|NOT COMPLETED|Overall Study||5
6621|NCT02417376|16376|P2|COMPLETED|Overall Study||25
6622|NCT02417376|16377|P1|COMPLETED|Overall Study||30
6623|NCT02417376|16376|P2|STARTED|Overall Study||35
6624|NCT02417376|16377|P1|STARTED|Overall Study||35
6625|NCT02417129|16421|P2|NOT COMPLETED|Overall Study||0
6626|NCT02417129|16422|P1|NOT COMPLETED|Overall Study||0
6627|NCT02417129|16421|P2|COMPLETED|Overall Study||0
6628|NCT02417129|16422|P1|COMPLETED|Overall Study||2
6629|NCT02417129|16421|P2|STARTED|Overall Study||0
6630|NCT02417129|16422|P1|STARTED|Overall Study||2
6631|NCT02416973|16435|P3|NOT COMPLETED|Overall Study||1
6632|NCT02416973|16436|P2|NOT COMPLETED|Overall Study||3
6633|NCT02416973|16437|P1|NOT COMPLETED|Overall Study||1
6634|NCT02416973|16435|P3|COMPLETED|Overall Study||13
6635|NCT02416973|16436|P2|COMPLETED|Overall Study||10
6636|NCT02416973|16437|P1|COMPLETED|Overall Study||13
6637|NCT02416973|16435|P3|STARTED|Overall Study||14
6638|NCT02416973|16436|P2|STARTED|Overall Study||13
6639|NCT02416973|16437|P1|STARTED|Overall Study||14
6640|NCT02416180|16445|P1|NOT COMPLETED|Overall Study||1
6641|NCT02416180|16445|P1|COMPLETED|Overall Study||110
6642|NCT02416180|16445|P1|STARTED|Overall Study||111
6643|NCT02415959|16457|P5|NOT COMPLETED|Overall Study||0
6644|NCT02415959|16458|P4|NOT COMPLETED|Overall Study||1
6645|NCT02415959|16459|P3|NOT COMPLETED|Overall Study||0
6646|NCT02415959|16460|P2|NOT COMPLETED|Overall Study||1
6647|NCT02415959|16461|P1|NOT COMPLETED|Overall Study||0
6648|NCT02415959|16457|P5|COMPLETED|Overall Study||14
6649|NCT02415959|16458|P4|COMPLETED|Overall Study||13
6650|NCT02415959|16459|P3|COMPLETED|Overall Study||14
6651|NCT02415959|16460|P2|COMPLETED|Overall Study||13
6652|NCT02415959|16461|P1|COMPLETED|Overall Study||14
6653|NCT02415959|16457|P5|STARTED|Overall Study||14
6654|NCT02415959|16458|P4|STARTED|Overall Study||14
6655|NCT02415959|16459|P3|STARTED|Overall Study||14
6656|NCT02415959|16460|P2|STARTED|Overall Study||14
6657|NCT02415959|16461|P1|STARTED|Overall Study||14
6658|NCT02415439|16506|P13|NOT COMPLETED|Overall Study||0
6659|NCT02415439|16507|P12|NOT COMPLETED|Overall Study||0
6660|NCT02415439|16508|P11|NOT COMPLETED|Overall Study||0
6661|NCT02415439|16509|P10|NOT COMPLETED|Overall Study||0
6662|NCT02415439|16510|P9|NOT COMPLETED|Overall Study||1
6663|NCT02415439|16511|P8|NOT COMPLETED|Overall Study||0
6664|NCT02415439|16512|P7|NOT COMPLETED|Overall Study||0
6665|NCT02415439|16513|P6|NOT COMPLETED|Overall Study||0
6666|NCT02415439|16514|P5|NOT COMPLETED|Overall Study||0
6667|NCT02415439|16515|P4|NOT COMPLETED|Overall Study||0
6668|NCT02415439|16516|P3|NOT COMPLETED|Overall Study||0
6669|NCT02415439|16517|P2|NOT COMPLETED|Overall Study||0
6670|NCT02415439|16518|P1|NOT COMPLETED|Overall Study||0
6671|NCT02415439|16506|P13|COMPLETED|Overall Study||8
6672|NCT02415439|16507|P12|COMPLETED|Overall Study||6
6673|NCT02415439|16508|P11|COMPLETED|Overall Study||6
6674|NCT02415439|16509|P10|COMPLETED|Overall Study||6
6675|NCT02415439|16510|P9|COMPLETED|Overall Study||5
6676|NCT02415439|16511|P8|COMPLETED|Overall Study||12
6677|NCT02415439|16512|P7|COMPLETED|Overall Study||6
6678|NCT02415439|16513|P6|COMPLETED|Overall Study||6
6679|NCT02415439|16514|P5|COMPLETED|Overall Study||6
6680|NCT02415439|16515|P4|COMPLETED|Overall Study||6
6681|NCT02415439|16516|P3|COMPLETED|Overall Study||6
6682|NCT02415439|16517|P2|COMPLETED|Overall Study||6
6683|NCT02415439|16518|P1|COMPLETED|Overall Study||6
6684|NCT02415439|16506|P13|STARTED|Overall Study||8
6685|NCT02415439|16507|P12|STARTED|Overall Study||6
6686|NCT02415439|16508|P11|STARTED|Overall Study||6
6687|NCT02415439|16509|P10|STARTED|Overall Study||6
6688|NCT02415439|16510|P9|STARTED|Overall Study||6
6689|NCT02415439|16511|P8|STARTED|Overall Study||12
6690|NCT02415439|16512|P7|STARTED|Overall Study||6
6691|NCT02415439|16513|P6|STARTED|Overall Study||6
6692|NCT02415439|16514|P5|STARTED|Overall Study||6
6693|NCT02415439|16515|P4|STARTED|Overall Study||6
6694|NCT02415439|16516|P3|STARTED|Overall Study||6
6695|NCT02415439|16517|P2|STARTED|Overall Study||6
6696|NCT02415439|16518|P1|STARTED|Overall Study||6
6697|NCT02414828|16576|P4|NOT COMPLETED|Overall Study||2
6698|NCT02414828|16577|P3|NOT COMPLETED|Overall Study||1
6699|NCT02414828|16578|P2|NOT COMPLETED|Overall Study||1
6700|NCT02414828|16579|P1|NOT COMPLETED|Overall Study||0
6701|NCT02414828|16576|P4|COMPLETED|Overall Study||29
6702|NCT02414828|16577|P3|COMPLETED|Overall Study||19
6703|NCT02414828|16578|P2|COMPLETED|Overall Study||9
6704|NCT02414828|16579|P1|COMPLETED|Overall Study||11
6705|NCT02414828|16576|P4|STARTED|Overall Study||31
6706|NCT02414828|16577|P3|STARTED|Overall Study||20
6707|NCT02414828|16578|P2|STARTED|Overall Study||10
6708|NCT02414828|16579|P1|STARTED|Overall Study||11
6709|NCT02414152|16617|P1|NOT COMPLETED|Overall Study||2
6710|NCT02414152|16617|P1|COMPLETED|Overall Study|Both subjects completed 56 days of anakinra but did not complete all visits in observational period|0
6711|NCT02414152|16617|P1|STARTED|Overall Study||2
6712|NCT02413879|16621|P1|NOT COMPLETED|Overall Study||0
6713|NCT02413879|16621|P1|COMPLETED|Overall Study||86
6714|NCT02413879|16621|P1|STARTED|Overall Study||86
6715|NCT02413593|16627|P1|NOT COMPLETED|Overall Study||4
6716|NCT02413593|16627|P1|COMPLETED|Overall Study||107
6717|NCT02413593|16627|P1|STARTED|Overall Study||111
6718|NCT02413333|16640|P2|NOT COMPLETED|Period 2||0
6719|NCT02413333|16641|P1|NOT COMPLETED|Period 2||1
6720|NCT02413333|16640|P2|COMPLETED|Period 2||65
6721|NCT02413333|16641|P1|COMPLETED|Period 2||64
6722|NCT02413333|16640|P2|STARTED|Period 2||65
6723|NCT02413333|16641|P1|STARTED|Period 2||65
6724|NCT02413333|16640|P2|NOT COMPLETED|Period 1||1
6725|NCT02413333|16641|P1|NOT COMPLETED|Period 1||1
6726|NCT02413333|16640|P2|COMPLETED|Period 1||65
6727|NCT02413333|16641|P1|COMPLETED|Period 1||65
6728|NCT02413333|16640|P2|Randomized and Treated|Period 1||66
6729|NCT02413333|16641|P1|Randomized and Treated|Period 1||66
6730|NCT02413333|16640|P2|STARTED|Period 1||66
6731|NCT02413333|16641|P1|STARTED|Period 1||66
6732|NCT02413294|16649|P1|NOT COMPLETED|Overall Study||1
6733|NCT02413294|16649|P1|COMPLETED|Overall Study||11
6734|NCT02413294|16649|P1|STARTED|Overall Study||12
6735|NCT02413203|16669|P2|NOT COMPLETED|Overall Study||0
6736|NCT02413203|16670|P1|NOT COMPLETED|Overall Study||0
6737|NCT02413203|16669|P2|COMPLETED|Overall Study||10
6738|NCT02413203|16670|P1|COMPLETED|Overall Study||10
6739|NCT02413203|16669|P2|STARTED|Overall Study||10
6740|NCT02413203|16670|P1|STARTED|Overall Study||10
6741|NCT02413034|16692|P2|NOT COMPLETED|Overall Study||0
6742|NCT02413034|16693|P1|NOT COMPLETED|Overall Study||0
6743|NCT02413034|16692|P2|COMPLETED|Overall Study||14
6744|NCT02413034|16693|P1|COMPLETED|Overall Study||14
6745|NCT02413034|16692|P2|STARTED|Overall Study||14
6746|NCT02413034|16693|P1|STARTED|Overall Study||14
6747|NCT02412657|16704|P3|NOT COMPLETED|Overall Study||3
6748|NCT02412657|16705|P2|NOT COMPLETED|Overall Study||2
6749|NCT02412657|16706|P1|NOT COMPLETED|Overall Study||1
6750|NCT02412657|16704|P3|COMPLETED|Overall Study||22
6751|NCT02412657|16705|P2|COMPLETED|Overall Study||23
6752|NCT02412657|16706|P1|COMPLETED|Overall Study||24
6753|NCT02412657|16704|P3|STARTED|Overall Study||25
6754|NCT02412657|16705|P2|STARTED|Overall Study||25
6755|NCT02412657|16706|P1|STARTED|Overall Study||25
6756|NCT02411929|16714|P1|NOT COMPLETED|Period 2||0
6757|NCT02411929|16714|P1|COMPLETED|Period 2||8
6758|NCT02411929|16714|P1|STARTED|Period 2||8
6759|NCT02411929|16714|P1|NOT COMPLETED|Washout Period||0
6760|NCT02411929|16714|P1|COMPLETED|Washout Period||8
6761|NCT02411929|16714|P1|STARTED|Washout Period||8
6762|NCT02411929|16714|P1|NOT COMPLETED|Period 1||0
6763|NCT02411929|16714|P1|COMPLETED|Period 1||8
6764|NCT02411929|16714|P1|STARTED|Period 1||8
6765|NCT02411747|16746|P2|NOT COMPLETED|Overall Study||4
6766|NCT02411747|16747|P1|NOT COMPLETED|Overall Study||3
6767|NCT02411747|16746|P2|COMPLETED|Overall Study||12
6768|NCT02411747|16747|P1|COMPLETED|Overall Study||13
6769|NCT02411747|16746|P2|Simulation Training Completed|Overall Study||16
6770|NCT02411747|16747|P1|Simulation Training Completed|Overall Study||16
6771|NCT02411747|16746|P2|STARTED|Overall Study||16
6772|NCT02411747|16747|P1|STARTED|Overall Study||16
6773|NCT02411539|16755|P2|NOT COMPLETED|Overall Study||1
6774|NCT02411539|16756|P1|NOT COMPLETED|Overall Study||2
6775|NCT02411539|16755|P2|COMPLETED|Overall Study||19
6776|NCT02411539|16756|P1|COMPLETED|Overall Study||18
6777|NCT02411539|16755|P2|STARTED|Overall Study||20
6778|NCT02411539|16756|P1|STARTED|Overall Study||20
6779|NCT02411201|16825|P1|NOT COMPLETED|Overall Study||6
6780|NCT02411201|16825|P1|COMPLETED|Overall Study||45
6781|NCT02411201|16825|P1|STARTED|Overall Study||51
6782|NCT02410824|16836|P2|NOT COMPLETED|Second Intervention (One Week)||0
6783|NCT02410824|16837|P1|NOT COMPLETED|Second Intervention (One Week)||0
6784|NCT02410824|16836|P2|COMPLETED|Second Intervention (One Week)||22
6785|NCT02410824|16837|P1|COMPLETED|Second Intervention (One Week)||22
6786|NCT02410824|16836|P2|STARTED|Second Intervention (One Week)||22
6787|NCT02410824|16837|P1|STARTED|Second Intervention (One Week)||22
6788|NCT02410824|16836|P2|NOT COMPLETED|First Intervention (One Week)||1
6789|NCT02410824|16837|P1|NOT COMPLETED|First Intervention (One Week)||0
6790|NCT02410824|16836|P2|COMPLETED|First Intervention (One Week)||22
6791|NCT02410824|16837|P1|COMPLETED|First Intervention (One Week)||22
6792|NCT02410824|16836|P2|STARTED|First Intervention (One Week)||23
6793|NCT02410824|16837|P1|STARTED|First Intervention (One Week)||22
6794|NCT02410291|16871|P2|NOT COMPLETED|Overall Study||0
6795|NCT02410291|16872|P1|NOT COMPLETED|Overall Study||0
6796|NCT02410291|16871|P2|COMPLETED|Overall Study||29
6797|NCT02410291|16872|P1|COMPLETED|Overall Study||29
6798|NCT02410291|16871|P2|STARTED|Overall Study||29
6799|NCT02410291|16872|P1|STARTED|Overall Study||29
6800|NCT02410200|16878|P1|NOT COMPLETED|Overall Study||2
6801|NCT02410200|16878|P1|COMPLETED|Overall Study||20
6802|NCT02410200|16878|P1|STARTED|Overall Study||22
6803|NCT02408692|16892|P3|NOT COMPLETED|Overall Study||0
6804|NCT02408692|16893|P2|NOT COMPLETED|Overall Study||0
6805|NCT02408692|16894|P1|NOT COMPLETED|Overall Study||0
6806|NCT02408692|16892|P3|COMPLETED|Overall Study||5
6807|NCT02408692|16893|P2|COMPLETED|Overall Study||5
6808|NCT02408692|16894|P1|COMPLETED|Overall Study||5
6809|NCT02408692|16892|P3|STARTED|Overall Study||5
6810|NCT02408692|16893|P2|STARTED|Overall Study||5
6811|NCT02408692|16894|P1|STARTED|Overall Study||5
6812|NCT02406937|16908|P3|NOT COMPLETED|Overall Study||2
6813|NCT02406937|16909|P2|NOT COMPLETED|Overall Study||1
6814|NCT02406937|16910|P1|NOT COMPLETED|Overall Study||1
6815|NCT02406937|16908|P3|COMPLETED|Overall Study||58
6816|NCT02406937|16909|P2|COMPLETED|Overall Study||59
6817|NCT02406937|16910|P1|COMPLETED|Overall Study||59
6818|NCT02406937|16908|P3|STARTED|Overall Study||60
6819|NCT02406937|16909|P2|STARTED|Overall Study||60
6820|NCT02406937|16910|P1|STARTED|Overall Study||60
6821|NCT02406586|16969|P3|NOT COMPLETED|Overall Study||2
6822|NCT02406586|16970|P2|NOT COMPLETED|Overall Study||4
6823|NCT02406586|16971|P1|NOT COMPLETED|Overall Study||1
6824|NCT02406586|16969|P3|COMPLETED|Overall Study||10
6825|NCT02406586|16970|P2|COMPLETED|Overall Study||8
6826|NCT02406586|16971|P1|COMPLETED|Overall Study||11
6827|NCT02406586|16969|P3|STARTED|Overall Study||12
6828|NCT02406586|16970|P2|STARTED|Overall Study||12
6829|NCT02406586|16971|P1|STARTED|Overall Study||12
6830|NCT02406495|17024|P1|NOT COMPLETED|Overall Study||0
6831|NCT02406495|17024|P1|COMPLETED|Overall Study||40
6832|NCT02406495|17024|P1|STARTED|Overall Study||40
6833|NCT02405429|17063|P1|NOT COMPLETED|Overall Study||0
6834|NCT02405429|17063|P1|COMPLETED|Overall Study||49
6835|NCT02405429|17063|P1|STARTED|Overall Study||49
6836|NCT02405390|17073|P2|NOT COMPLETED|Overall Study||0
6837|NCT02405390|17074|P1|NOT COMPLETED|Overall Study||0
6838|NCT02405390|17073|P2|COMPLETED|Overall Study||46
6839|NCT02405390|17074|P1|COMPLETED|Overall Study||46
6840|NCT02405390|17073|P2|STARTED|Overall Study||46
6841|NCT02405390|17074|P1|STARTED|Overall Study||46
6842|NCT02404649|17084|P2|NOT COMPLETED|Overall Study||2
6843|NCT02404649|17085|P1|NOT COMPLETED|Overall Study||1
6844|NCT02404649|17084|P2|COMPLETED|Overall Study||14
6845|NCT02404649|17085|P1|COMPLETED|Overall Study||16
6846|NCT02404649|17084|P2|STARTED|Overall Study||16
6847|NCT02404649|17085|P1|STARTED|Overall Study||17
6848|NCT02404545|17093|P2|NOT COMPLETED|Overall Study||6
6849|NCT02404545|17094|P1|NOT COMPLETED|Overall Study||6
6850|NCT02404545|17093|P2|COMPLETED|Overall Study||0
6851|NCT02404545|17094|P1|COMPLETED|Overall Study||0
6852|NCT02404545|17093|P2|STARTED|Overall Study||6
6853|NCT02404545|17094|P1|STARTED|Overall Study||6
6854|NCT02404493|17103|P2|NOT COMPLETED|Overall Study||1
6855|NCT02404493|17104|P1|NOT COMPLETED|Overall Study||1
6856|NCT02404493|17103|P2|COMPLETED|Overall Study||5
6857|NCT02404493|17104|P1|COMPLETED|Overall Study||16
6858|NCT02404493|17103|P2|STARTED|Overall Study||6
6859|NCT02404493|17104|P1|STARTED|Overall Study||17
6860|NCT02403830|17344|P2|NOT COMPLETED|Visit 2||0
6861|NCT02403830|17345|P1|NOT COMPLETED|Visit 2||0
6862|NCT02403830|17344|P2|COMPLETED|Visit 2||15
6863|NCT02403830|17345|P1|COMPLETED|Visit 2||14
6864|NCT02403830|17344|P2|STARTED|Visit 2||15
6865|NCT02403830|17345|P1|STARTED|Visit 2|One subject completed visit 1 and then withdrew from the study for an adverse event (nausea).|14
6866|NCT02403830|17344|P2|NOT COMPLETED|Visit 1||0
6867|NCT02403830|17345|P1|NOT COMPLETED|Visit 1||0
6868|NCT02403830|17344|P2|COMPLETED|Visit 1||15
6869|NCT02403830|17345|P1|COMPLETED|Visit 1||15
6870|NCT02403830|17344|P2|STARTED|Visit 1||15
6871|NCT02403830|17345|P1|STARTED|Visit 1||15
6872|NCT02403206|17357|P2|NOT COMPLETED|Overall Study||10
6873|NCT02403206|17358|P1|NOT COMPLETED|Overall Study||11
6874|NCT02403206|17357|P2|COMPLETED|Overall Study||186
6875|NCT02403206|17358|P1|COMPLETED|Overall Study||183
6876|NCT02403206|17357|P2|Randomized and Treated|Overall Study||190
6877|NCT02403206|17358|P1|Randomized and Treated|Overall Study||188
6878|NCT02403206|17357|P2|Treated Prior to Randomization|Overall Study||1
6879|NCT02403206|17358|P1|Treated Prior to Randomization|Overall Study||0
6880|NCT02403206|17357|P2|STARTED|Overall Study||196
6881|NCT02403206|17358|P1|STARTED|Overall Study||194
6882|NCT02403180|17369|P2|NOT COMPLETED|Period 2 (5 Days)||1
6883|NCT02403180|17370|P1|NOT COMPLETED|Period 2 (5 Days)||0
6884|NCT02403180|17369|P2|COMPLETED|Period 2 (5 Days)||32
6885|NCT02403180|17370|P1|COMPLETED|Period 2 (5 Days)||36
6886|NCT02403180|17369|P2|STARTED|Period 2 (5 Days)||33
6887|NCT02403180|17370|P1|STARTED|Period 2 (5 Days)||36
6888|NCT02403180|17369|P2|NOT COMPLETED|Period 1 (5 Days)||0
6889|NCT02403180|17370|P1|NOT COMPLETED|Period 1 (5 Days)||0
6890|NCT02403180|17369|P2|COMPLETED|Period 1 (5 Days)||33
6891|NCT02403180|17370|P1|COMPLETED|Period 1 (5 Days)||36
6892|NCT02403180|17369|P2|Randomized|Period 1 (5 Days)||33
6893|NCT02403180|17370|P1|Randomized|Period 1 (5 Days)||36
6894|NCT02403180|17369|P2|STARTED|Period 1 (5 Days)||33
6895|NCT02403180|17370|P1|STARTED|Period 1 (5 Days)||36
6896|NCT02403180|17369|P2|NOT COMPLETED|Pre-Treatment Period||1
6897|NCT02403180|17370|P1|NOT COMPLETED|Pre-Treatment Period||0
6898|NCT02403180|17369|P2|COMPLETED|Pre-Treatment Period||33
6899|NCT02403180|17370|P1|COMPLETED|Pre-Treatment Period||36
6900|NCT02403180|17369|P2|STARTED|Pre-Treatment Period||34
6901|NCT02403180|17370|P1|STARTED|Pre-Treatment Period||36
6902|NCT02402933|17378|P1|NOT COMPLETED|Overall Study||14
6903|NCT02402933|17378|P1|COMPLETED|Overall Study||12
6904|NCT02402933|17378|P1|Received at Least One Dose of Study Drug|Overall Study||22
6905|NCT02402933|17378|P1|STARTED|Overall Study||26
6906|NCT02402764|17385|P1|NOT COMPLETED|Overall Study||0
6907|NCT02402764|17385|P1|COMPLETED|Overall Study||10
6908|NCT02402764|17385|P1|STARTED|Overall Study||10
6909|NCT02402322|17396|P3|NOT COMPLETED|Follow-up||24
6910|NCT02402322|17397|P2|NOT COMPLETED|Follow-up||3
6911|NCT02402322|17398|P1|NOT COMPLETED|Follow-up||6
6912|NCT02402322|17396|P3|COMPLETED|Follow-up||0
6913|NCT02402322|17397|P2|COMPLETED|Follow-up||21
6914|NCT02402322|17398|P1|COMPLETED|Follow-up||18
6915|NCT02402322|17396|P3|STARTED|Follow-up|These individuals were not evaluated at this follow-up as they started an alternative treatment.|24
6916|NCT02402322|17397|P2|STARTED|Follow-up||24
6917|NCT02402322|17398|P1|STARTED|Follow-up||24
6918|NCT02402322|17396|P3|NOT COMPLETED|Pretreatment||1
6919|NCT02402322|17397|P2|NOT COMPLETED|Pretreatment||1
6920|NCT02402322|17398|P1|NOT COMPLETED|Pretreatment||3
6921|NCT02402322|17396|P3|COMPLETED|Pretreatment||24
6922|NCT02402322|17397|P2|COMPLETED|Pretreatment||24
6923|NCT02402322|17398|P1|COMPLETED|Pretreatment||24
6924|NCT02402322|17396|P3|Posttreatment Measures|Pretreatment||24
6925|NCT02402322|17397|P2|Posttreatment Measures|Pretreatment||24
6926|NCT02402322|17398|P1|Posttreatment Measures|Pretreatment||24
6927|NCT02402322|17396|P3|STARTED|Pretreatment||25
6928|NCT02402322|17397|P2|STARTED|Pretreatment||25
6929|NCT02402322|17398|P1|STARTED|Pretreatment||27
6930|NCT02402296|17432|P2|NOT COMPLETED|Overall Study||0
6931|NCT02402296|17433|P1|NOT COMPLETED|Overall Study||0
6932|NCT02402296|17432|P2|COMPLETED|Overall Study||15
6933|NCT02402296|17433|P1|COMPLETED|Overall Study||15
6934|NCT02402296|17432|P2|STARTED|Overall Study||15
6935|NCT02402296|17433|P1|STARTED|Overall Study||15
6936|NCT02402127|17451|P6|NOT COMPLETED|Third Wear Period (1 Day)||0
6937|NCT02402127|17452|P5|NOT COMPLETED|Third Wear Period (1 Day)||0
6938|NCT02402127|17453|P4|NOT COMPLETED|Third Wear Period (1 Day)||0
6939|NCT02402127|17454|P3|NOT COMPLETED|Third Wear Period (1 Day)||0
6940|NCT02402127|17455|P2|NOT COMPLETED|Third Wear Period (1 Day)||0
6941|NCT02402127|17456|P1|NOT COMPLETED|Third Wear Period (1 Day)||0
6942|NCT02402127|17451|P6|COMPLETED|Third Wear Period (1 Day)||4
6943|NCT02402127|17452|P5|COMPLETED|Third Wear Period (1 Day)||4
6944|NCT02402127|17453|P4|COMPLETED|Third Wear Period (1 Day)||4
6945|NCT02402127|17454|P3|COMPLETED|Third Wear Period (1 Day)||4
6946|NCT02402127|17455|P2|COMPLETED|Third Wear Period (1 Day)||4
6947|NCT02402127|17456|P1|COMPLETED|Third Wear Period (1 Day)||4
6948|NCT02402127|17451|P6|STARTED|Third Wear Period (1 Day)||4
6949|NCT02402127|17452|P5|STARTED|Third Wear Period (1 Day)||4
6950|NCT02402127|17453|P4|STARTED|Third Wear Period (1 Day)||4
6951|NCT02402127|17454|P3|STARTED|Third Wear Period (1 Day)||4
6952|NCT02402127|17455|P2|STARTED|Third Wear Period (1 Day)||4
6953|NCT02402127|17456|P1|STARTED|Third Wear Period (1 Day)||4
6954|NCT02402127|17451|P6|NOT COMPLETED|Second Wear Period (1 Day)||0
6955|NCT02402127|17452|P5|NOT COMPLETED|Second Wear Period (1 Day)||0
6956|NCT02402127|17453|P4|NOT COMPLETED|Second Wear Period (1 Day)||0
6957|NCT02402127|17454|P3|NOT COMPLETED|Second Wear Period (1 Day)||0
6958|NCT02402127|17455|P2|NOT COMPLETED|Second Wear Period (1 Day)||0
6959|NCT02402127|17456|P1|NOT COMPLETED|Second Wear Period (1 Day)||0
6960|NCT02402127|17451|P6|COMPLETED|Second Wear Period (1 Day)||4
6961|NCT02402127|17452|P5|COMPLETED|Second Wear Period (1 Day)||4
6962|NCT02402127|17453|P4|COMPLETED|Second Wear Period (1 Day)||4
6963|NCT02402127|17454|P3|COMPLETED|Second Wear Period (1 Day)||4
6964|NCT02402127|17455|P2|COMPLETED|Second Wear Period (1 Day)||4
6965|NCT02402127|17456|P1|COMPLETED|Second Wear Period (1 Day)||4
6966|NCT02402127|17451|P6|STARTED|Second Wear Period (1 Day)||4
6967|NCT02402127|17452|P5|STARTED|Second Wear Period (1 Day)||4
6968|NCT02402127|17453|P4|STARTED|Second Wear Period (1 Day)||4
6969|NCT02402127|17454|P3|STARTED|Second Wear Period (1 Day)||4
6970|NCT02402127|17455|P2|STARTED|Second Wear Period (1 Day)||4
6971|NCT02402127|17456|P1|STARTED|Second Wear Period (1 Day)||4
6972|NCT02402127|17451|P6|NOT COMPLETED|First Wear Period (1 Day)||0
6973|NCT02402127|17452|P5|NOT COMPLETED|First Wear Period (1 Day)||0
6974|NCT02402127|17453|P4|NOT COMPLETED|First Wear Period (1 Day)||0
6975|NCT02402127|17454|P3|NOT COMPLETED|First Wear Period (1 Day)||0
6976|NCT02402127|17455|P2|NOT COMPLETED|First Wear Period (1 Day)||0
6977|NCT02402127|17456|P1|NOT COMPLETED|First Wear Period (1 Day)||0
6978|NCT02402127|17451|P6|COMPLETED|First Wear Period (1 Day)||4
6979|NCT02402127|17452|P5|COMPLETED|First Wear Period (1 Day)||4
6980|NCT02402127|17453|P4|COMPLETED|First Wear Period (1 Day)||4
6981|NCT02402127|17454|P3|COMPLETED|First Wear Period (1 Day)||4
6982|NCT02402127|17455|P2|COMPLETED|First Wear Period (1 Day)||4
6983|NCT02402127|17456|P1|COMPLETED|First Wear Period (1 Day)||4
6984|NCT02402127|17451|P6|Randomized and Treated|First Wear Period (1 Day)||4
6985|NCT02402127|17452|P5|Randomized and Treated|First Wear Period (1 Day)||4
6986|NCT02402127|17453|P4|Randomized and Treated|First Wear Period (1 Day)||4
6987|NCT02402127|17454|P3|Randomized and Treated|First Wear Period (1 Day)||4
6988|NCT02402127|17455|P2|Randomized and Treated|First Wear Period (1 Day)||4
6989|NCT02402127|17456|P1|Randomized and Treated|First Wear Period (1 Day)||4
6990|NCT02402127|17451|P6|STARTED|First Wear Period (1 Day)||4
6991|NCT02402127|17452|P5|STARTED|First Wear Period (1 Day)||4
6992|NCT02402127|17453|P4|STARTED|First Wear Period (1 Day)||4
6993|NCT02402127|17454|P3|STARTED|First Wear Period (1 Day)||4
6994|NCT02402127|17455|P2|STARTED|First Wear Period (1 Day)||4
6995|NCT02402127|17456|P1|STARTED|First Wear Period (1 Day)||4
6996|NCT02401867|17467|P1|NOT COMPLETED|Analysis||9
6997|NCT02401867|17467|P1|COMPLETED|Analysis|Comparative analysis of vaginal HPV DNA results and cervical HPV DNA results|131
6998|NCT02401867|17467|P1|STARTED|Analysis||140
6999|NCT02401867|17467|P1|NOT COMPLETED|Specimen Collection||10
7000|NCT02401867|17467|P1|COMPLETED|Specimen Collection|Completed both vaginal self-swab and provider-collected cervical swab|140
7001|NCT02401867|17467|P1|STARTED|Specimen Collection||150
7002|NCT02401867|17467|P1|NOT COMPLETED|Enrolled||0
7003|NCT02401867|17467|P1|COMPLETED|Enrolled||150
7004|NCT02401867|17467|P1|STARTED|Enrolled||150
7005|NCT02401555|17475|P3|NOT COMPLETED|Overall Study||0
7006|NCT02401555|17476|P2|NOT COMPLETED|Overall Study||0
7007|NCT02401555|17477|P1|NOT COMPLETED|Overall Study||0
7008|NCT02401555|17475|P3|COMPLETED|Overall Study||120
7009|NCT02401555|17476|P2|COMPLETED|Overall Study||212
7010|NCT02401555|17477|P1|COMPLETED|Overall Study||87
7011|NCT02401555|17475|P3|STARTED|Overall Study||120
7012|NCT02401555|17476|P2|STARTED|Overall Study||212
7013|NCT02401555|17477|P1|STARTED|Overall Study||87
7014|NCT02401529|17487|P2|NOT COMPLETED|Overall Study||7
7015|NCT02401529|17488|P1|NOT COMPLETED|Overall Study||9
7016|NCT02401529|17487|P2|COMPLETED|Overall Study||50
7017|NCT02401529|17488|P1|COMPLETED|Overall Study||50
7018|NCT02401529|17487|P2|STARTED|Overall Study||57
7019|NCT02401529|17488|P1|STARTED|Overall Study||59
7020|NCT02401464|17516|P4|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7021|NCT02401464|17517|P3|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7022|NCT02401464|17518|P2|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7023|NCT02401464|17519|P1|NOT COMPLETED|Intervention Period 2 (6 Days)||0
7024|NCT02401464|17516|P4|COMPLETED|Intervention Period 2 (6 Days)||13
7025|NCT02401464|17517|P3|COMPLETED|Intervention Period 2 (6 Days)||13
7026|NCT02401464|17518|P2|COMPLETED|Intervention Period 2 (6 Days)||13
7027|NCT02401464|17519|P1|COMPLETED|Intervention Period 2 (6 Days)||13
7028|NCT02401464|17516|P4|STARTED|Intervention Period 2 (6 Days)||13
7029|NCT02401464|17517|P3|STARTED|Intervention Period 2 (6 Days)||13
7030|NCT02401464|17518|P2|STARTED|Intervention Period 2 (6 Days)||13
7031|NCT02401464|17519|P1|STARTED|Intervention Period 2 (6 Days)||13
7032|NCT02401464|17516|P4|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7033|NCT02401464|17517|P3|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7034|NCT02401464|17518|P2|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7035|NCT02401464|17519|P1|NOT COMPLETED|Washout Period (At Least 6 Days)||0
7036|NCT02401464|17516|P4|COMPLETED|Washout Period (At Least 6 Days)||13
7037|NCT02401464|17517|P3|COMPLETED|Washout Period (At Least 6 Days)||13
7038|NCT02401464|17518|P2|COMPLETED|Washout Period (At Least 6 Days)||13
7039|NCT02401464|17519|P1|COMPLETED|Washout Period (At Least 6 Days)||13
7040|NCT02401464|17516|P4|STARTED|Washout Period (At Least 6 Days)||13
7041|NCT02401464|17517|P3|STARTED|Washout Period (At Least 6 Days)||13
7042|NCT02401464|17518|P2|STARTED|Washout Period (At Least 6 Days)||13
7043|NCT02401464|17519|P1|STARTED|Washout Period (At Least 6 Days)||13
7044|NCT02401464|17516|P4|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7045|NCT02401464|17517|P3|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7046|NCT02401464|17518|P2|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7047|NCT02401464|17519|P1|NOT COMPLETED|Intervention Period 1 (6 Days)||0
7048|NCT02401464|17516|P4|COMPLETED|Intervention Period 1 (6 Days)||13
7049|NCT02401464|17517|P3|COMPLETED|Intervention Period 1 (6 Days)||13
7050|NCT02401464|17518|P2|COMPLETED|Intervention Period 1 (6 Days)||13
7051|NCT02401464|17519|P1|COMPLETED|Intervention Period 1 (6 Days)||13
7052|NCT02401464|17516|P4|STARTED|Intervention Period 1 (6 Days)||13
7053|NCT02401464|17517|P3|STARTED|Intervention Period 1 (6 Days)||13
7054|NCT02401464|17518|P2|STARTED|Intervention Period 1 (6 Days)||13
7055|NCT02401464|17519|P1|STARTED|Intervention Period 1 (6 Days)||13
7056|NCT02400996|17553|P1|NOT COMPLETED|Overall Study||0
7057|NCT02400996|17553|P1|COMPLETED|Overall Study||40
7058|NCT02400996|17553|P1|STARTED|Overall Study||40
7059|NCT02400710|17559|P2|NOT COMPLETED|Overall Study||0
7060|NCT02400710|17560|P1|NOT COMPLETED|Overall Study||0
7061|NCT02400710|17559|P2|COMPLETED|Overall Study||10
7062|NCT02400710|17560|P1|COMPLETED|Overall Study||10
7063|NCT02400710|17559|P2|STARTED|Overall Study||10
7064|NCT02400710|17560|P1|STARTED|Overall Study||10
7065|NCT02400346|17568|P1|NOT COMPLETED|Overall Study||44
7066|NCT02400346|17568|P1|COMPLETED|Overall Study||88
7067|NCT02400346|17568|P1|STARTED|Overall Study||132
7068|NCT02400333|17576|P4|NOT COMPLETED|Overall Study||2
7069|NCT02400333|17577|P3|NOT COMPLETED|Overall Study||2
7070|NCT02400333|17578|P2|NOT COMPLETED|Overall Study||1
7071|NCT02400333|17579|P1|NOT COMPLETED|Overall Study||1
7072|NCT02400333|17576|P4|COMPLETED|Overall Study||7
7073|NCT02400333|17577|P3|COMPLETED|Overall Study||7
7074|NCT02400333|17578|P2|COMPLETED|Overall Study||8
7075|NCT02400333|17579|P1|COMPLETED|Overall Study||8
7076|NCT02400333|17576|P4|STARTED|Overall Study||9
7077|NCT02400333|17577|P3|STARTED|Overall Study||9
7078|NCT02400333|17578|P2|STARTED|Overall Study||9
7079|NCT02400333|17579|P1|STARTED|Overall Study||9
7080|NCT02399345|17637|P1|NOT COMPLETED|Overall Study||0
7081|NCT02399345|17637|P1|COMPLETED|Overall Study||10
7082|NCT02399345|17637|P1|STARTED|Overall Study||10
7083|NCT02399163|17643|P1|NOT COMPLETED|Overall Study||9
7084|NCT02399163|17643|P1|COMPLETED|Overall Study||53
7085|NCT02399163|17643|P1|STARTED|Overall Study||62
7086|NCT02399111|17671|P4|NOT COMPLETED|Overall Study||0
7087|NCT02399111|17672|P3|NOT COMPLETED|Overall Study||0
7088|NCT02399111|17673|P2|NOT COMPLETED|Overall Study||0
7089|NCT02399111|17674|P1|NOT COMPLETED|Overall Study||0
7090|NCT02399111|17671|P4|COMPLETED|Overall Study||0
7091|NCT02399111|17672|P3|COMPLETED|Overall Study||4
7092|NCT02399111|17673|P2|COMPLETED|Overall Study||1
7093|NCT02399111|17674|P1|COMPLETED|Overall Study||4
7094|NCT02399111|17671|P4|STARTED|Overall Study||0
7095|NCT02399111|17672|P3|STARTED|Overall Study||4
7096|NCT02399111|17673|P2|STARTED|Overall Study||1
7097|NCT02399111|17674|P1|STARTED|Overall Study||4
7098|NCT02397915|17688|P4|NOT COMPLETED|Period 2||0
7099|NCT02397915|17689|P3|NOT COMPLETED|Period 2||0
7100|NCT02397915|17690|P2|NOT COMPLETED|Period 2||0
7101|NCT02397915|17691|P1|NOT COMPLETED|Period 2||0
7102|NCT02397915|17688|P4|COMPLETED|Period 2||149
7103|NCT02397915|17689|P3|COMPLETED|Period 2||149
7104|NCT02397915|17690|P2|COMPLETED|Period 2||0
7105|NCT02397915|17691|P1|COMPLETED|Period 2||0
7106|NCT02397915|17688|P4|STARTED|Period 2||149
7107|NCT02397915|17689|P3|STARTED|Period 2||149
7108|NCT02397915|17690|P2|STARTED|Period 2||0
7109|NCT02397915|17691|P1|STARTED|Period 2||0
7110|NCT02397915|17688|P4|NOT COMPLETED|Period 1||0
7111|NCT02397915|17689|P3|NOT COMPLETED|Period 1||0
7112|NCT02397915|17690|P2|NOT COMPLETED|Period 1||1
7113|NCT02397915|17691|P1|NOT COMPLETED|Period 1||1
7114|NCT02397915|17688|P4|COMPLETED|Period 1||0
7115|NCT02397915|17689|P3|COMPLETED|Period 1||0
7116|NCT02397915|17690|P2|COMPLETED|Period 1||149
7117|NCT02397915|17691|P1|COMPLETED|Period 1||149
7118|NCT02397915|17688|P4|STARTED|Period 1||0
7119|NCT02397915|17689|P3|STARTED|Period 1||0
7120|NCT02397915|17690|P2|STARTED|Period 1||150
7121|NCT02397915|17691|P1|STARTED|Period 1||150
7122|NCT02397655|17741|P1|NOT COMPLETED|Overall Study||1301
7123|NCT02397655|17741|P1|COMPLETED|Overall Study||10711
7124|NCT02397655|17741|P1|STARTED|Overall Study||12012
7125|NCT02397564|17745|P1|NOT COMPLETED|Overall Study||4
7126|NCT02397564|17745|P1|COMPLETED|Overall Study||16
7127|NCT02397564|17745|P1|STARTED|Overall Study||20
7128|NCT02396537|17752|P2|NOT COMPLETED|Overall Study||1
7129|NCT02396537|17753|P1|NOT COMPLETED|Overall Study||0
7130|NCT02396537|17752|P2|COMPLETED|Overall Study||36
7131|NCT02396537|17753|P1|COMPLETED|Overall Study||40
7132|NCT02396537|17752|P2|STARTED|Overall Study||37
7133|NCT02396537|17753|P1|STARTED|Overall Study||40
7134|NCT02396316|17761|P2|NOT COMPLETED|Overall Study||5
7135|NCT02396316|17762|P1|NOT COMPLETED|Overall Study||7
7136|NCT02396316|17761|P2|COMPLETED|Overall Study||22
7137|NCT02396316|17762|P1|COMPLETED|Overall Study||20
7138|NCT02396316|17761|P2|Treated|Overall Study||27
7139|NCT02396316|17762|P1|Treated|Overall Study||27
7140|NCT02396316|17761|P2|STARTED|Overall Study||27
7141|NCT02396316|17762|P1|STARTED|Overall Study||27
7142|NCT02396160|17772|P2|NOT COMPLETED|Overall Study||2
7143|NCT02396160|17773|P1|NOT COMPLETED|Overall Study||6
7144|NCT02396160|17772|P2|COMPLETED|Overall Study||73
7145|NCT02396160|17773|P1|COMPLETED|Overall Study||69
7146|NCT02396160|17772|P2|STARTED|Overall Study||75
7147|NCT02396160|17773|P1|STARTED|Overall Study||75
7148|NCT02396147|17789|P2|NOT COMPLETED|Period 3||0
7149|NCT02396147|17790|P1|NOT COMPLETED|Period 3||0
7150|NCT02396147|17789|P2|COMPLETED|Period 3||27
7151|NCT02396147|17790|P1|COMPLETED|Period 3||27
7152|NCT02396147|17789|P2|STARTED|Period 3||27
7153|NCT02396147|17790|P1|STARTED|Period 3||27
7154|NCT02396147|17789|P2|NOT COMPLETED|Period 2||0
7155|NCT02396147|17790|P1|NOT COMPLETED|Period 2||0
7156|NCT02396147|17789|P2|COMPLETED|Period 2||27
7157|NCT02396147|17790|P1|COMPLETED|Period 2||27
7158|NCT02396147|17789|P2|STARTED|Period 2||27
7159|NCT02396147|17790|P1|STARTED|Period 2||27
7160|NCT02396147|17789|P2|NOT COMPLETED|Period 1||0
7161|NCT02396147|17790|P1|NOT COMPLETED|Period 1||0
7162|NCT02396147|17789|P2|COMPLETED|Period 1||27
7163|NCT02396147|17790|P1|COMPLETED|Period 1||27
7164|NCT02396147|17789|P2|STARTED|Period 1||27
7165|NCT02396147|17790|P1|STARTED|Period 1||27
7166|NCT02395302|17858|P1|NOT COMPLETED|Overall Study||14
7167|NCT02395302|17858|P1|COMPLETED|Overall Study||14
7168|NCT02395302|17858|P1|STARTED|Overall Study||28
7169|NCT02395055|17864|P2|NOT COMPLETED|Overall Study||3
7170|NCT02395055|17865|P1|NOT COMPLETED|Overall Study||7
7171|NCT02395055|17864|P2|COMPLETED|Overall Study||44
7172|NCT02395055|17865|P1|COMPLETED|Overall Study||40
7173|NCT02395055|17864|P2|STARTED|Overall Study||47
7174|NCT02395055|17865|P1|STARTED|Overall Study||47
7175|NCT02394925|17875|P1|NOT COMPLETED|Overall Study||29
7176|NCT02394925|17875|P1|COMPLETED|Overall Study||79
7177|NCT02394925|17875|P1|STARTED|Overall Study||108
7178|NCT02394808|17879|P2|NOT COMPLETED|Period 2||0
7179|NCT02394808|17880|P1|NOT COMPLETED|Period 2||1
7180|NCT02394808|17879|P2|COMPLETED|Period 2||28
7181|NCT02394808|17880|P1|COMPLETED|Period 2||24
7182|NCT02394808|17879|P2|STARTED|Period 2||28
7183|NCT02394808|17880|P1|STARTED|Period 2||25
7184|NCT02394808|17879|P2|NOT COMPLETED|Period 1||1
7185|NCT02394808|17880|P1|NOT COMPLETED|Period 1||0
7186|NCT02394808|17879|P2|COMPLETED|Period 1||28
7187|NCT02394808|17880|P1|COMPLETED|Period 1||25
7188|NCT02394808|17879|P2|STARTED|Period 1||29
7189|NCT02394808|17880|P1|STARTED|Period 1||25
7190|NCT02394756|17888|P6|NOT COMPLETED|Period 3||0
7191|NCT02394756|17889|P5|NOT COMPLETED|Period 3||0
7192|NCT02394756|17890|P4|NOT COMPLETED|Period 3||0
7193|NCT02394756|17891|P3|NOT COMPLETED|Period 3||0
7194|NCT02394756|17892|P2|NOT COMPLETED|Period 3||0
7195|NCT02394756|17893|P1|NOT COMPLETED|Period 3||0
7196|NCT02394756|17888|P6|COMPLETED|Period 3||6
7197|NCT02394756|17889|P5|COMPLETED|Period 3||6
7198|NCT02394756|17890|P4|COMPLETED|Period 3||6
7199|NCT02394756|17891|P3|COMPLETED|Period 3||6
7200|NCT02394756|17892|P2|COMPLETED|Period 3||6
7201|NCT02394756|17893|P1|COMPLETED|Period 3||7
7202|NCT02394756|17888|P6|STARTED|Period 3||6
7203|NCT02394756|17889|P5|STARTED|Period 3||6
7204|NCT02394756|17890|P4|STARTED|Period 3||6
7205|NCT02394756|17891|P3|STARTED|Period 3||6
7206|NCT02394756|17892|P2|STARTED|Period 3||6
7207|NCT02394756|17893|P1|STARTED|Period 3||7
7208|NCT02394756|17888|P6|NOT COMPLETED|Period 2||0
7209|NCT02394756|17889|P5|NOT COMPLETED|Period 2||1
7210|NCT02394756|17890|P4|NOT COMPLETED|Period 2||0
7211|NCT02394756|17891|P3|NOT COMPLETED|Period 2||0
7212|NCT02394756|17892|P2|NOT COMPLETED|Period 2||0
7213|NCT02394756|17893|P1|NOT COMPLETED|Period 2||0
7214|NCT02394756|17888|P6|COMPLETED|Period 2||6
7215|NCT02394756|17889|P5|COMPLETED|Period 2||6
7216|NCT02394756|17890|P4|COMPLETED|Period 2||6
7217|NCT02394756|17891|P3|COMPLETED|Period 2||6
7218|NCT02394756|17892|P2|COMPLETED|Period 2||6
7219|NCT02394756|17893|P1|COMPLETED|Period 2||7
7220|NCT02394756|17888|P6|STARTED|Period 2||6
7221|NCT02394756|17889|P5|STARTED|Period 2||7
7222|NCT02394756|17890|P4|STARTED|Period 2||6
7223|NCT02394756|17891|P3|STARTED|Period 2||6
7224|NCT02394756|17892|P2|STARTED|Period 2||6
7225|NCT02394756|17893|P1|STARTED|Period 2||7
7226|NCT02394756|17888|P6|NOT COMPLETED|Period 1||1
7227|NCT02394756|17889|P5|NOT COMPLETED|Period 1||0
7228|NCT02394756|17890|P4|NOT COMPLETED|Period 1||1
7229|NCT02394756|17891|P3|NOT COMPLETED|Period 1||1
7230|NCT02394756|17892|P2|NOT COMPLETED|Period 1||1
7231|NCT02394756|17893|P1|NOT COMPLETED|Period 1||0
7232|NCT02394756|17888|P6|COMPLETED|Period 1||6
7233|NCT02394756|17889|P5|COMPLETED|Period 1||7
7234|NCT02394756|17890|P4|COMPLETED|Period 1||6
7235|NCT02394756|17891|P3|COMPLETED|Period 1||6
7236|NCT02394756|17892|P2|COMPLETED|Period 1||6
7237|NCT02394756|17893|P1|COMPLETED|Period 1||7
7238|NCT02394756|17888|P6|STARTED|Period 1||7
7239|NCT02394756|17889|P5|STARTED|Period 1||7
7240|NCT02394756|17890|P4|STARTED|Period 1||7
7241|NCT02394756|17891|P3|STARTED|Period 1||7
7242|NCT02394756|17892|P2|STARTED|Period 1||7
7243|NCT02394756|17893|P1|STARTED|Period 1||7
7244|NCT02394665|17907|P3|NOT COMPLETED|Overall Study||0
7245|NCT02394665|17908|P2|NOT COMPLETED|Overall Study||0
7246|NCT02394665|17909|P1|NOT COMPLETED|Overall Study||1
7247|NCT02394665|17907|P3|COMPLETED|Overall Study||0
7248|NCT02394665|17908|P2|COMPLETED|Overall Study||0
7249|NCT02394665|17909|P1|COMPLETED|Overall Study||0
7250|NCT02394665|17907|P3|STARTED|Overall Study||0
7251|NCT02394665|17908|P2|STARTED|Overall Study||0
7252|NCT02394665|17909|P1|STARTED|Overall Study||1
7253|NCT02394457|17931|P2|NOT COMPLETED|Overall Study||0
7254|NCT02394457|17932|P1|NOT COMPLETED|Overall Study||0
7255|NCT02394457|17931|P2|COMPLETED|Overall Study||13
7256|NCT02394457|17932|P1|COMPLETED|Overall Study||15
7257|NCT02394457|17931|P2|STARTED|Overall Study||13
7258|NCT02394457|17932|P1|STARTED|Overall Study||15
7259|NCT02393950|17950|P2|NOT COMPLETED|Overall Study||1
7260|NCT02393950|17951|P1|NOT COMPLETED|Overall Study||1
7261|NCT02393950|17950|P2|COMPLETED|Overall Study||8
7262|NCT02393950|17951|P1|COMPLETED|Overall Study||8
7263|NCT02393950|17950|P2|Period 4|Overall Study|6 subjects ODM-106 Capsule A 100 mg (10 x 10mg) and 2 subjects on placebo|8
7264|NCT02393950|17951|P1|Period 4|Overall Study|6 subjects ODM-106 Capsule B 50 mg and 2 subjects on placebo|8
7265|NCT02393950|17950|P2|Period 3|Overall Study|6 subjects ODM-106 Capsule B 200 mg (20 x 10mg) and 2 subjects on placebo|8
7266|NCT02393950|17951|P1|Period 3|Overall Study|6 subjects ODM-106 Capsule B 25 mg and 2 subjects on placebo|8
7267|NCT02393950|17950|P2|Period 2|Overall Study|6 subjects ODM-106 Capsule B 100 mg (10 x 10mg) and 2 subjects on placebo|8
7268|NCT02393950|17951|P1|Period 2|Overall Study|6 subjects ODM-106 Capsule B 10 mg and 2 subjects on placebo|8
7269|NCT02393950|17950|P2|Period 1|Overall Study|6 subjects ODM-106 Capsule B 100 mg (1 x 100mg) and 2 subjects on placebo|8
7270|NCT02393950|17951|P1|Period 1|Overall Study|6 subjects ODM-106 Capsule B 2 mg and 2 subjects on placebo|8
7271|NCT02393950|17950|P2|STARTED|Overall Study||9
7272|NCT02393950|17951|P1|STARTED|Overall Study||9
7273|NCT02393677|18018|P2|NOT COMPLETED|Overall Study||0
7274|NCT02393677|18019|P1|NOT COMPLETED|Overall Study||0
7275|NCT02393677|18018|P2|COMPLETED|Overall Study||40
7276|NCT02393677|18019|P1|COMPLETED|Overall Study||40
7277|NCT02393677|18018|P2|STARTED|Overall Study||40
7278|NCT02393677|18019|P1|STARTED|Overall Study||40
7279|NCT02393547|18025|P1|NOT COMPLETED|Overall Study||6
7280|NCT02393547|18025|P1|COMPLETED|Overall Study||14
7281|NCT02393547|18025|P1|STARTED|Overall Study||20
7282|NCT02392767|18034|P2|NOT COMPLETED|Overall Study||0
7283|NCT02392767|18035|P1|NOT COMPLETED|Overall Study||0
7284|NCT02392767|18034|P2|COMPLETED|Overall Study||13
7285|NCT02392767|18035|P1|COMPLETED|Overall Study||12
7286|NCT02392767|18034|P2|STARTED|Overall Study||13
7287|NCT02392767|18035|P1|STARTED|Overall Study||12
7288|NCT02392247|18051|P1|NOT COMPLETED|Overall Study||2
7289|NCT02392247|18051|P1|COMPLETED|Overall Study||50
7290|NCT02392247|18051|P1|STARTED|Overall Study||52
7291|NCT02392208|18056|P1|NOT COMPLETED|Telavancin After Hemodialysis||0
7292|NCT02392208|18056|P1|COMPLETED|Telavancin After Hemodialysis||8
7293|NCT02392208|18056|P1|STARTED|Telavancin After Hemodialysis||8
7294|NCT02392208|18056|P1|NOT COMPLETED|Telavancin Before Hemodialysis||0
7295|NCT02392208|18056|P1|COMPLETED|Telavancin Before Hemodialysis||8
7296|NCT02392208|18056|P1|STARTED|Telavancin Before Hemodialysis||8
7297|NCT02391714|18068|P2|NOT COMPLETED|Overall Study||0
7298|NCT02391714|18069|P1|NOT COMPLETED|Overall Study||0
7299|NCT02391714|18068|P2|COMPLETED|Overall Study||40
7300|NCT02391714|18069|P1|COMPLETED|Overall Study||40
7301|NCT02391714|18068|P2|STARTED|Overall Study||40
7302|NCT02391714|18069|P1|STARTED|Overall Study||40
7303|NCT02391311|18081|P2|NOT COMPLETED|Overall Study||2
7304|NCT02391311|18082|P1|NOT COMPLETED|Overall Study||3
7305|NCT02391311|18081|P2|COMPLETED|Overall Study||19
7306|NCT02391311|18082|P1|COMPLETED|Overall Study||18
7307|NCT02391311|18081|P2|STARTED|Overall Study||21
7308|NCT02391311|18082|P1|STARTED|Overall Study||21
7309|NCT02391038|18090|P3|NOT COMPLETED|Overall Study||6
7310|NCT02391038|18091|P2|NOT COMPLETED|Overall Study||3
7311|NCT02391038|18092|P1|NOT COMPLETED|Overall Study||3
7312|NCT02391038|18090|P3|COMPLETED|Overall Study||0
7313|NCT02391038|18091|P2|COMPLETED|Overall Study||0
7314|NCT02391038|18092|P1|COMPLETED|Overall Study||0
7315|NCT02391038|18090|P3|STARTED|Overall Study||6
7316|NCT02391038|18091|P2|STARTED|Overall Study||3
7317|NCT02391038|18092|P1|STARTED|Overall Study||3
7318|NCT02390167|18206|P1|NOT COMPLETED|Overall Study||1
7319|NCT02390167|18206|P1|COMPLETED|Overall Study||375
7320|NCT02390167|18206|P1|Without Diabetes|Overall Study||43
7321|NCT02390167|18206|P1|With Diabetes|Overall Study||333
7322|NCT02390167|18206|P1|STARTED|Overall Study||376
7323|NCT02389881|18232|P7|NOT COMPLETED|Overall Study||0
7324|NCT02389881|18233|P6|NOT COMPLETED|Overall Study||0
7325|NCT02389881|18234|P5|NOT COMPLETED|Overall Study||0
7326|NCT02389881|18235|P4|NOT COMPLETED|Overall Study||0
7327|NCT02389881|18236|P3|NOT COMPLETED|Overall Study||0
7328|NCT02389881|18237|P2|NOT COMPLETED|Overall Study||0
7329|NCT02389881|18238|P1|NOT COMPLETED|Overall Study||0
7330|NCT02389881|18232|P7|COMPLETED|Overall Study||2
7331|NCT02389881|18233|P6|COMPLETED|Overall Study||8
7332|NCT02389881|18234|P5|COMPLETED|Overall Study||6
7333|NCT02389881|18235|P4|COMPLETED|Overall Study||6
7334|NCT02389881|18236|P3|COMPLETED|Overall Study||6
7335|NCT02389881|18237|P2|COMPLETED|Overall Study||6
7336|NCT02389881|18238|P1|COMPLETED|Overall Study||6
7337|NCT02389881|18232|P7|STARTED|Overall Study||2
7338|NCT02389881|18233|P6|STARTED|Overall Study||8
7339|NCT02389881|18234|P5|STARTED|Overall Study||6
7340|NCT02389881|18235|P4|STARTED|Overall Study||6
7341|NCT02389881|18236|P3|STARTED|Overall Study||6
7342|NCT02389881|18237|P2|STARTED|Overall Study||6
7343|NCT02389881|18238|P1|STARTED|Overall Study||6
7344|NCT02389452|18287|P1|NOT COMPLETED|Overall Study||25
7345|NCT02389452|18287|P1|COMPLETED|Overall Study||369
7346|NCT02389452|18287|P1|Participants Received Repeat Injection|Overall Study|Repeat injection based on physician's assessment of efficacy and safety at Week 26, 39 or 52.|11
7347|NCT02389452|18287|P1|STARTED|Overall Study||394
7348|NCT02389374|18308|P3|NOT COMPLETED|Overall Study||1
7349|NCT02389374|18309|P2|NOT COMPLETED|Overall Study||28
7350|NCT02389374|18310|P1|NOT COMPLETED|Overall Study||9
7351|NCT02389374|18308|P3|COMPLETED|Overall Study||10
7352|NCT02389374|18309|P2|COMPLETED|Overall Study||87
7353|NCT02389374|18310|P1|COMPLETED|Overall Study||46
7354|NCT02389374|18308|P3|STARTED|Overall Study||11
7355|NCT02389374|18309|P2|STARTED|Overall Study||115
7356|NCT02389374|18310|P1|STARTED|Overall Study||55
7357|NCT02389361|18342|P2|NOT COMPLETED|Overall Study||0
7358|NCT02389361|18343|P1|NOT COMPLETED|Overall Study||0
7359|NCT02389361|18342|P2|COMPLETED|Overall Study||27
7360|NCT02389361|18343|P1|COMPLETED|Overall Study||24
7361|NCT02389361|18342|P2|STARTED|Overall Study||27
7362|NCT02389361|18343|P1|STARTED|Overall Study||24
7363|NCT02389088|18349|P1|NOT COMPLETED|Phase II - All Study Participants||0
7364|NCT02389088|18349|P1|COMPLETED|Phase II - All Study Participants||9
7365|NCT02389088|18349|P1|STARTED|Phase II - All Study Participants||9
7366|NCT02389088|18349|P1|NOT COMPLETED|Overall Study - Phase I||0
7367|NCT02389088|18349|P1|COMPLETED|Overall Study - Phase I||9
7368|NCT02389088|18349|P1|STARTED|Overall Study - Phase I||9
7369|NCT02388815|18393|P1|NOT COMPLETED|Overall Study||4
7370|NCT02388815|18393|P1|COMPLETED|Overall Study||85
7371|NCT02388815|18393|P1|STARTED|Overall Study||89
7372|NCT02388763|18397|P2|NOT COMPLETED|Period 2, 10 Days of Wear||0
7373|NCT02388763|18398|P1|NOT COMPLETED|Period 2, 10 Days of Wear||0
7374|NCT02388763|18397|P2|COMPLETED|Period 2, 10 Days of Wear||30
7375|NCT02388763|18398|P1|COMPLETED|Period 2, 10 Days of Wear||30
7376|NCT02388763|18397|P2|STARTED|Period 2, 10 Days of Wear||30
7377|NCT02388763|18398|P1|STARTED|Period 2, 10 Days of Wear||30
7378|NCT02388763|18397|P2|NOT COMPLETED|Period 1, 10 Days of Wear||1
7379|NCT02388763|18398|P1|NOT COMPLETED|Period 1, 10 Days of Wear||1
7380|NCT02388763|18397|P2|COMPLETED|Period 1, 10 Days of Wear||30
7381|NCT02388763|18398|P1|COMPLETED|Period 1, 10 Days of Wear||30
7382|NCT02388763|18397|P2|STARTED|Period 1, 10 Days of Wear||31
7383|NCT02388763|18398|P1|STARTED|Period 1, 10 Days of Wear||31
7384|NCT02388763|18397|P2|NOT COMPLETED|Habitual, 10 Days of Wear||1
7385|NCT02388763|18398|P1|NOT COMPLETED|Habitual, 10 Days of Wear||1
7386|NCT02388763|18397|P2|COMPLETED|Habitual, 10 Days of Wear||31
7387|NCT02388763|18398|P1|COMPLETED|Habitual, 10 Days of Wear||31
7388|NCT02388763|18397|P2|STARTED|Habitual, 10 Days of Wear||32
7389|NCT02388763|18398|P1|STARTED|Habitual, 10 Days of Wear||32
7390|NCT02387268|18409|P1|NOT COMPLETED|Overall Study||1
7391|NCT02387268|18409|P1|COMPLETED|Overall Study||9
7392|NCT02387268|18409|P1|STARTED|Overall Study||10
7393|NCT02388347|18419|P5|NOT COMPLETED|Overall Study||0
7394|NCT02388347|18420|P4|NOT COMPLETED|Overall Study||0
7395|NCT02388347|18421|P3|NOT COMPLETED|Overall Study||1
7396|NCT02388347|18422|P2|NOT COMPLETED|Overall Study||0
7397|NCT02388347|18423|P1|NOT COMPLETED|Overall Study||0
7398|NCT02388347|18419|P5|COMPLETED|Overall Study||6
7399|NCT02388347|18420|P4|COMPLETED|Overall Study||6
7400|NCT02388347|18421|P3|COMPLETED|Overall Study||5
7401|NCT02388347|18422|P2|COMPLETED|Overall Study||6
7402|NCT02388347|18423|P1|COMPLETED|Overall Study||8
7403|NCT02388347|18419|P5|STARTED|Overall Study||6
7404|NCT02388347|18420|P4|STARTED|Overall Study||6
7405|NCT02388347|18421|P3|STARTED|Overall Study||6
7406|NCT02388347|18422|P2|STARTED|Overall Study||6
7407|NCT02388347|18423|P1|STARTED|Overall Study||8
7408|NCT02388191|18490|P2|NOT COMPLETED|Overall Study||0
7409|NCT02388191|18491|P1|NOT COMPLETED|Overall Study||1
7410|NCT02388191|18490|P2|COMPLETED|Overall Study||60
7411|NCT02388191|18491|P1|COMPLETED|Overall Study||58
7412|NCT02388191|18490|P2|STARTED|Overall Study||60
7413|NCT02388191|18491|P1|STARTED|Overall Study||59
7414|NCT02388074|18505|P1|NOT COMPLETED|Overall Study||3
7415|NCT02388074|18505|P1|COMPLETED|Overall Study||22
7416|NCT02388074|18505|P1|STARTED|Overall Study||25
7417|NCT02387996|18509|P1|NOT COMPLETED|Overall Study||204
7418|NCT02387996|18509|P1|COMPLETED|Overall Study|Completed equals continuing in the Treatment Period|66
7419|NCT02387996|18509|P1|STARTED|Overall Study||270
7420|NCT02387983|18520|P1|NOT COMPLETED|Overall Study||7
7421|NCT02387983|18520|P1|COMPLETED|Overall Study||58
7422|NCT02387983|18520|P1|STARTED|Overall Study||65
7423|NCT02387801|18534|P2|NOT COMPLETED|Post-Treatment Follow-up||0
7424|NCT02387801|18535|P1|NOT COMPLETED|Post-Treatment Follow-up||0
7425|NCT02387801|18534|P2|COMPLETED|Post-Treatment Follow-up||12
7426|NCT02387801|18535|P1|COMPLETED|Post-Treatment Follow-up||0
7427|NCT02387801|18534|P2|STARTED|Post-Treatment Follow-up||12
7428|NCT02387801|18535|P1|STARTED|Post-Treatment Follow-up||0
7429|NCT02387801|18534|P2|NOT COMPLETED|Maintenance Dosing Period||0
7430|NCT02387801|18535|P1|NOT COMPLETED|Maintenance Dosing Period||0
7431|NCT02387801|18534|P2|COMPLETED|Maintenance Dosing Period||12
7432|NCT02387801|18535|P1|COMPLETED|Maintenance Dosing Period||0
7433|NCT02387801|18534|P2|STARTED|Maintenance Dosing Period||12
7434|NCT02387801|18535|P1|STARTED|Maintenance Dosing Period|All participants from Induction Dosing Period went to ixe Q4W arm during Maintenance Dosing Period.|0
7435|NCT02387801|18534|P2|NOT COMPLETED|Induction Dosing Period||0
7436|NCT02387801|18535|P1|NOT COMPLETED|Induction Dosing Period||0
7437|NCT02387801|18534|P2|COMPLETED|Induction Dosing Period||6
7438|NCT02387801|18535|P1|COMPLETED|Induction Dosing Period||6
7439|NCT02387801|18534|P2|STARTED|Induction Dosing Period||6
7440|NCT02387801|18535|P1|STARTED|Induction Dosing Period||6
7441|NCT02387710|18553|P2|NOT COMPLETED|Second Study Night||0
7442|NCT02387710|18554|P1|NOT COMPLETED|Second Study Night||0
7443|NCT02387710|18553|P2|COMPLETED|Second Study Night||7
7444|NCT02387710|18554|P1|COMPLETED|Second Study Night||9
7445|NCT02387710|18553|P2|STARTED|Second Study Night|2 patients did not come back for excessive sleep disruption due to the equipment|7
7446|NCT02387710|18554|P1|STARTED|Second Study Night||9
7447|NCT02387710|18553|P2|NOT COMPLETED|First Study Night||0
7448|NCT02387710|18554|P1|NOT COMPLETED|First Study Night||0
7449|NCT02387710|18553|P2|COMPLETED|First Study Night||9
7450|NCT02387710|18554|P1|COMPLETED|First Study Night||9
7451|NCT02387710|18553|P2|STARTED|First Study Night||9
7452|NCT02387710|18554|P1|STARTED|First Study Night||9
7453|NCT02387580|18570|P6|NOT COMPLETED|Overall Study||0
7454|NCT02387580|18571|P5|NOT COMPLETED|Overall Study||0
7455|NCT02387580|18572|P4|NOT COMPLETED|Overall Study||1
7456|NCT02387580|18573|P3|NOT COMPLETED|Overall Study||0
7457|NCT02387580|18574|P2|NOT COMPLETED|Overall Study||0
7458|NCT02387580|18575|P1|NOT COMPLETED|Overall Study||0
7459|NCT02387580|18570|P6|COMPLETED|Overall Study||8
7460|NCT02387580|18571|P5|COMPLETED|Overall Study||8
7461|NCT02387580|18572|P4|COMPLETED|Overall Study||7
7462|NCT02387580|18573|P3|COMPLETED|Overall Study||8
7463|NCT02387580|18574|P2|COMPLETED|Overall Study||8
7464|NCT02387580|18575|P1|COMPLETED|Overall Study||8
7465|NCT02387580|18570|P6|STARTED|Overall Study||8
7466|NCT02387580|18571|P5|STARTED|Overall Study||8
7467|NCT02387580|18572|P4|STARTED|Overall Study||8
7468|NCT02387580|18573|P3|STARTED|Overall Study||8
7469|NCT02387580|18574|P2|STARTED|Overall Study||8
7470|NCT02387580|18575|P1|STARTED|Overall Study||8
7471|NCT02387554|18611|P4|NOT COMPLETED|Overall Study||2
7472|NCT02387554|18612|P3|NOT COMPLETED|Overall Study||2
7473|NCT02387554|18613|P2|NOT COMPLETED|Overall Study||0
7474|NCT02387554|18614|P1|NOT COMPLETED|Overall Study||3
7475|NCT02387554|18611|P4|COMPLETED|Overall Study||6
7476|NCT02387554|18612|P3|COMPLETED|Overall Study||6
7477|NCT02387554|18613|P2|COMPLETED|Overall Study||7
7478|NCT02387554|18614|P1|COMPLETED|Overall Study||7
7479|NCT02387554|18611|P4|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
7480|NCT02387554|18612|P3|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|8
7481|NCT02387554|18613|P2|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|7
7482|NCT02387554|18614|P1|STARTED|Overall Study|A,C,ALC: intervention (8 days), L: intervention (4 days), Each period washout (14days)|10
7483|NCT02387502|18627|P3|NOT COMPLETED|Overall Study||0
7484|NCT02387502|18628|P2|NOT COMPLETED|Overall Study||0
7485|NCT02387502|18629|P1|NOT COMPLETED|Overall Study||0
7486|NCT02387502|18627|P3|COMPLETED|Overall Study||40
7487|NCT02387502|18628|P2|COMPLETED|Overall Study||40
7488|NCT02387502|18629|P1|COMPLETED|Overall Study||40
7489|NCT02387502|18627|P3|STARTED|Overall Study||40
7490|NCT02387502|18628|P2|STARTED|Overall Study||40
7491|NCT02387502|18629|P1|STARTED|Overall Study||40
7492|NCT02384538|18639|P2|NOT COMPLETED|Overall Study||15
7493|NCT02384538|18640|P1|NOT COMPLETED|Overall Study||6
7494|NCT02384538|18639|P2|COMPLETED|Overall Study||49
7495|NCT02384538|18640|P1|COMPLETED|Overall Study||61
7496|NCT02384538|18639|P2|STARTED|Overall Study||64
7497|NCT02384538|18640|P1|STARTED|Overall Study||67
7498|NCT02384070|18661|P3|NOT COMPLETED|Overall Study||0
7499|NCT02384070|18662|P2|NOT COMPLETED|Overall Study||0
7500|NCT02384070|18663|P1|NOT COMPLETED|Overall Study||0
7501|NCT02384070|18661|P3|COMPLETED|Overall Study||100
7502|NCT02384070|18662|P2|COMPLETED|Overall Study||100
7503|NCT02384070|18663|P1|COMPLETED|Overall Study||100
7504|NCT02384070|18661|P3|STARTED|Overall Study||100
7505|NCT02384070|18662|P2|STARTED|Overall Study||100
7506|NCT02384070|18663|P1|STARTED|Overall Study||100
7507|NCT02383862|18679|P2|NOT COMPLETED|3 Month Follow up||21
7508|NCT02383862|18680|P1|NOT COMPLETED|3 Month Follow up||23
7509|NCT02383862|18679|P2|COMPLETED|3 Month Follow up||128
7510|NCT02383862|18680|P1|COMPLETED|3 Month Follow up||128
7511|NCT02383862|18679|P2|STARTED|3 Month Follow up||149
7512|NCT02383862|18680|P1|STARTED|3 Month Follow up||151
7513|NCT02383862|18679|P2|NOT COMPLETED|Baseline||0
7514|NCT02383862|18680|P1|NOT COMPLETED|Baseline||0
7515|NCT02383862|18679|P2|COMPLETED|Baseline||149
7516|NCT02383862|18680|P1|COMPLETED|Baseline||151
7517|NCT02383862|18679|P2|STARTED|Baseline||149
7518|NCT02383862|18680|P1|STARTED|Baseline||151
7519|NCT02383719|18711|P1|NOT COMPLETED|Overall Study||0
7520|NCT02383719|18711|P1|COMPLETED|Overall Study||18
7521|NCT02383719|18711|P1|STARTED|Overall Study||18
7522|NCT02383420|18718|P3|NOT COMPLETED|Overall Study||0
7523|NCT02383420|18719|P2|NOT COMPLETED|Overall Study||0
7524|NCT02383420|18720|P1|NOT COMPLETED|Overall Study||2
7525|NCT02383420|18718|P3|COMPLETED|Overall Study||3
7526|NCT02383420|18719|P2|COMPLETED|Overall Study||10
7527|NCT02383420|18720|P1|COMPLETED|Overall Study||8
7528|NCT02383420|18718|P3|STARTED|Overall Study||3
7529|NCT02383420|18719|P2|STARTED|Overall Study||10
7530|NCT02383420|18720|P1|STARTED|Overall Study||10
7531|NCT02382913|18738|P10|NOT COMPLETED|Overall Study||0
7532|NCT02382913|18739|P9|NOT COMPLETED|Overall Study||0
7533|NCT02382913|18740|P8|NOT COMPLETED|Overall Study||0
7534|NCT02382913|18741|P7|NOT COMPLETED|Overall Study||0
7535|NCT02382913|18742|P6|NOT COMPLETED|Overall Study||0
7536|NCT02382913|18743|P5|NOT COMPLETED|Overall Study||0
7537|NCT02382913|18744|P4|NOT COMPLETED|Overall Study||0
7538|NCT02382913|18745|P3|NOT COMPLETED|Overall Study||0
7539|NCT02382913|18746|P2|NOT COMPLETED|Overall Study||0
7540|NCT02382913|18747|P1|NOT COMPLETED|Overall Study||0
7541|NCT02382913|18738|P10|COMPLETED|Overall Study||33
7542|NCT02382913|18739|P9|COMPLETED|Overall Study||30
7543|NCT02382913|18740|P8|COMPLETED|Overall Study||30
7544|NCT02382913|18741|P7|COMPLETED|Overall Study||37
7545|NCT02382913|18742|P6|COMPLETED|Overall Study||30
7546|NCT02382913|18743|P5|COMPLETED|Overall Study||33
7547|NCT02382913|18744|P4|COMPLETED|Overall Study||27
7548|NCT02382913|18745|P3|COMPLETED|Overall Study||32
7549|NCT02382913|18746|P2|COMPLETED|Overall Study||36
7550|NCT02382913|18747|P1|COMPLETED|Overall Study||27
7551|NCT02382913|18738|P10|STARTED|Overall Study||33
7552|NCT02382913|18739|P9|STARTED|Overall Study||30
7553|NCT02382913|18740|P8|STARTED|Overall Study||30
7554|NCT02382913|18741|P7|STARTED|Overall Study||37
7555|NCT02382913|18742|P6|STARTED|Overall Study||30
7556|NCT02382913|18743|P5|STARTED|Overall Study||33
7557|NCT02382913|18744|P4|STARTED|Overall Study||27
7558|NCT02382913|18745|P3|STARTED|Overall Study||32
7559|NCT02382913|18746|P2|STARTED|Overall Study||36
7560|NCT02382913|18747|P1|STARTED|Overall Study||27
7561|NCT02382640|18787|P4|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7562|NCT02382640|18788|P3|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7563|NCT02382640|18789|P2|NOT COMPLETED|Intervention Period 4 (3 Days)||0
7564|NCT02382640|18790|P1|NOT COMPLETED|Intervention Period 4 (3 Days)||1
7565|NCT02382640|18787|P4|COMPLETED|Intervention Period 4 (3 Days)||9
7566|NCT02382640|18788|P3|COMPLETED|Intervention Period 4 (3 Days)||9
7567|NCT02382640|18789|P2|COMPLETED|Intervention Period 4 (3 Days)||9
7568|NCT02382640|18790|P1|COMPLETED|Intervention Period 4 (3 Days)||8
7569|NCT02382640|18787|P4|STARTED|Intervention Period 4 (3 Days)||9
7570|NCT02382640|18788|P3|STARTED|Intervention Period 4 (3 Days)||9
7571|NCT02382640|18789|P2|STARTED|Intervention Period 4 (3 Days)||9
7572|NCT02382640|18790|P1|STARTED|Intervention Period 4 (3 Days)||9
7573|NCT02382640|18787|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
7574|NCT02382640|18788|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
7575|NCT02382640|18789|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
7576|NCT02382640|18790|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
7577|NCT02382640|18787|P4|COMPLETED|Washout Period 3 (7 Days)||9
7578|NCT02382640|18788|P3|COMPLETED|Washout Period 3 (7 Days)||9
7579|NCT02382640|18789|P2|COMPLETED|Washout Period 3 (7 Days)||9
7580|NCT02382640|18790|P1|COMPLETED|Washout Period 3 (7 Days)||9
7581|NCT02382640|18787|P4|STARTED|Washout Period 3 (7 Days)||9
7582|NCT02382640|18788|P3|STARTED|Washout Period 3 (7 Days)||9
7583|NCT02382640|18789|P2|STARTED|Washout Period 3 (7 Days)||9
7584|NCT02382640|18790|P1|STARTED|Washout Period 3 (7 Days)||9
7585|NCT02382640|18787|P4|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7586|NCT02382640|18788|P3|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7587|NCT02382640|18789|P2|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7588|NCT02382640|18790|P1|NOT COMPLETED|Intervention Period 3 (3 Days)||0
7589|NCT02382640|18787|P4|COMPLETED|Intervention Period 3 (3 Days)||9
7590|NCT02382640|18788|P3|COMPLETED|Intervention Period 3 (3 Days)||9
7591|NCT02382640|18789|P2|COMPLETED|Intervention Period 3 (3 Days)||9
7592|NCT02382640|18790|P1|COMPLETED|Intervention Period 3 (3 Days)||9
7593|NCT02382640|18787|P4|STARTED|Intervention Period 3 (3 Days)||9
7594|NCT02382640|18788|P3|STARTED|Intervention Period 3 (3 Days)||9
7595|NCT02382640|18789|P2|STARTED|Intervention Period 3 (3 Days)||9
7596|NCT02382640|18790|P1|STARTED|Intervention Period 3 (3 Days)||9
7597|NCT02382640|18787|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
7598|NCT02382640|18788|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
7599|NCT02382640|18789|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
7600|NCT02382640|18790|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
7601|NCT02382640|18787|P4|COMPLETED|Washout Period 2 (7 Days)||9
7602|NCT02382640|18788|P3|COMPLETED|Washout Period 2 (7 Days)||9
7603|NCT02382640|18789|P2|COMPLETED|Washout Period 2 (7 Days)||9
7604|NCT02382640|18790|P1|COMPLETED|Washout Period 2 (7 Days)||9
7605|NCT02382640|18787|P4|STARTED|Washout Period 2 (7 Days)||9
7606|NCT02382640|18788|P3|STARTED|Washout Period 2 (7 Days)||9
7607|NCT02382640|18789|P2|STARTED|Washout Period 2 (7 Days)||9
7608|NCT02382640|18790|P1|STARTED|Washout Period 2 (7 Days)||9
7609|NCT02382640|18787|P4|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7610|NCT02382640|18788|P3|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7611|NCT02382640|18789|P2|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7612|NCT02382640|18790|P1|NOT COMPLETED|Intervention Period 2 (3 Days)||0
7613|NCT02382640|18787|P4|COMPLETED|Intervention Period 2 (3 Days)||9
7614|NCT02382640|18788|P3|COMPLETED|Intervention Period 2 (3 Days)||9
7615|NCT02382640|18789|P2|COMPLETED|Intervention Period 2 (3 Days)||9
7616|NCT02382640|18790|P1|COMPLETED|Intervention Period 2 (3 Days)||9
7617|NCT02382640|18787|P4|STARTED|Intervention Period 2 (3 Days)||9
7618|NCT02382640|18788|P3|STARTED|Intervention Period 2 (3 Days)||9
7619|NCT02382640|18789|P2|STARTED|Intervention Period 2 (3 Days)||9
7620|NCT02382640|18790|P1|STARTED|Intervention Period 2 (3 Days)||9
7621|NCT02382640|18787|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
7622|NCT02382640|18788|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
7623|NCT02382640|18789|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
7624|NCT02382640|18790|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
7625|NCT02382640|18787|P4|COMPLETED|Washout Period 1 (7 Days)||9
7626|NCT02382640|18788|P3|COMPLETED|Washout Period 1 (7 Days)||9
7627|NCT02382640|18789|P2|COMPLETED|Washout Period 1 (7 Days)||9
7628|NCT02382640|18790|P1|COMPLETED|Washout Period 1 (7 Days)||9
7629|NCT02382640|18787|P4|STARTED|Washout Period 1 (7 Days)||9
7630|NCT02382640|18788|P3|STARTED|Washout Period 1 (7 Days)||9
7631|NCT02382640|18789|P2|STARTED|Washout Period 1 (7 Days)||9
7632|NCT02382640|18790|P1|STARTED|Washout Period 1 (7 Days)||9
7633|NCT02382640|18787|P4|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7634|NCT02382640|18788|P3|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7635|NCT02382640|18789|P2|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7636|NCT02382640|18790|P1|NOT COMPLETED|Intervention Period 1 (3 Days)||0
7637|NCT02382640|18787|P4|COMPLETED|Intervention Period 1 (3 Days)||9
7638|NCT02382640|18788|P3|COMPLETED|Intervention Period 1 (3 Days)||9
7639|NCT02382640|18789|P2|COMPLETED|Intervention Period 1 (3 Days)||9
7640|NCT02382640|18790|P1|COMPLETED|Intervention Period 1 (3 Days)||9
7641|NCT02382640|18787|P4|STARTED|Intervention Period 1 (3 Days)||9
7642|NCT02382640|18788|P3|STARTED|Intervention Period 1 (3 Days)||9
7643|NCT02382640|18789|P2|STARTED|Intervention Period 1 (3 Days)||9
7644|NCT02382640|18790|P1|STARTED|Intervention Period 1 (3 Days)||9
7645|NCT02382133|18828|P1|NOT COMPLETED|Overall Study||33
7646|NCT02382133|18828|P1|COMPLETED|Overall Study||10
7647|NCT02382133|18828|P1|STARTED|Overall Study||43
7648|NCT02381678|18833|P3|NOT COMPLETED|Overall Study||0
7649|NCT02381678|18834|P2|NOT COMPLETED|Overall Study||0
7650|NCT02381678|18835|P1|NOT COMPLETED|Overall Study||0
7651|NCT02381678|18833|P3|COMPLETED|Overall Study||32
7652|NCT02381678|18834|P2|COMPLETED|Overall Study||139
7653|NCT02381678|18835|P1|COMPLETED|Overall Study||54
7654|NCT02381678|18833|P3|STARTED|Overall Study||32
7655|NCT02381678|18834|P2|STARTED|Overall Study||139
7656|NCT02381678|18835|P1|STARTED|Overall Study||54
7657|NCT02381418|18841|P1|NOT COMPLETED|Overall Study||0
7658|NCT02381418|18841|P1|COMPLETED|Overall Study||120
7659|NCT02381418|18841|P1|STARTED|Overall Study||120
7660|NCT02381288|18851|P4|NOT COMPLETED|Overall Study||0
7661|NCT02381288|18852|P3|NOT COMPLETED|Overall Study||0
7662|NCT02381288|18853|P2|NOT COMPLETED|Overall Study||0
7663|NCT02381288|18854|P1|NOT COMPLETED|Overall Study||0
7664|NCT02381288|18851|P4|COMPLETED|Overall Study||5
7665|NCT02381288|18852|P3|COMPLETED|Overall Study||5
7666|NCT02381288|18853|P2|COMPLETED|Overall Study||2
7667|NCT02381288|18854|P1|COMPLETED|Overall Study||5
7668|NCT02381288|18851|P4|STARTED|Overall Study||5
7669|NCT02381288|18852|P3|STARTED|Overall Study||5
7670|NCT02381288|18853|P2|STARTED|Overall Study||2
7671|NCT02381288|18854|P1|STARTED|Overall Study||5
7672|NCT02380742|18883|P2|NOT COMPLETED|Overall Study||0
7673|NCT02380742|18884|P1|NOT COMPLETED|Overall Study||1
7674|NCT02380742|18883|P2|COMPLETED|Overall Study||26
7675|NCT02380742|18884|P1|COMPLETED|Overall Study||27
7676|NCT02380742|18883|P2|STARTED|Overall Study||26
7677|NCT02380742|18884|P1|STARTED|Overall Study||28
7678|NCT02380287|18904|P8|NOT COMPLETED|Overall Study||0
7679|NCT02380287|18905|P7|NOT COMPLETED|Overall Study||0
7680|NCT02380287|18906|P6|NOT COMPLETED|Overall Study||0
7681|NCT02380287|18907|P5|NOT COMPLETED|Overall Study||0
7682|NCT02380287|18908|P4|NOT COMPLETED|Overall Study||0
7683|NCT02380287|18909|P3|NOT COMPLETED|Overall Study||1
7684|NCT02380287|18910|P2|NOT COMPLETED|Overall Study||0
7685|NCT02380287|18911|P1|NOT COMPLETED|Overall Study||0
7686|NCT02380287|18904|P8|COMPLETED|Overall Study||3
7687|NCT02380287|18905|P7|COMPLETED|Overall Study||3
7688|NCT02380287|18906|P6|COMPLETED|Overall Study||3
7689|NCT02380287|18907|P5|COMPLETED|Overall Study||3
7690|NCT02380287|18908|P4|COMPLETED|Overall Study||3
7691|NCT02380287|18909|P3|COMPLETED|Overall Study||2
7692|NCT02380287|18910|P2|COMPLETED|Overall Study||3
7693|NCT02380287|18911|P1|COMPLETED|Overall Study||1
7694|NCT02380287|18904|P8|STARTED|Overall Study||3
7695|NCT02380287|18905|P7|STARTED|Overall Study||3
7696|NCT02380287|18906|P6|STARTED|Overall Study||3
7697|NCT02380287|18907|P5|STARTED|Overall Study||3
7698|NCT02380287|18908|P4|STARTED|Overall Study||3
7699|NCT02380287|18909|P3|STARTED|Overall Study||3
7700|NCT02380287|18910|P2|STARTED|Overall Study||3
7701|NCT02380287|18911|P1|STARTED|Overall Study||1
7702|NCT02380261|18922|P1|NOT COMPLETED|Overall Study||0
7703|NCT02380261|18922|P1|COMPLETED|Overall Study||35
7704|NCT02380261|18922|P1|STARTED|Overall Study||35
7705|NCT02380248|18927|P1|NOT COMPLETED|Overall Study||14
7706|NCT02380248|18927|P1|COMPLETED|Overall Study||186
7707|NCT02380248|18927|P1|STARTED|Overall Study||200
7708|NCT02379637|18934|P2|NOT COMPLETED|Overall Study||1
7709|NCT02379637|18935|P1|NOT COMPLETED|Overall Study||2
7710|NCT02379637|18934|P2|COMPLETED|Overall Study||34
7711|NCT02379637|18935|P1|COMPLETED|Overall Study||33
7712|NCT02379637|18934|P2|STARTED|Overall Study||35
7713|NCT02379637|18935|P1|STARTED|Overall Study||35
7714|NCT02378506|18943|P1|NOT COMPLETED|Overall Study||25
7715|NCT02378506|18943|P1|COMPLETED|Overall Study||163
7716|NCT02378506|18943|P1|Treated|Overall Study||187
7717|NCT02378506|18943|P1|STARTED|Overall Study||188
7718|NCT02376998|18960|P1|NOT COMPLETED|Overall Study||9
7719|NCT02376998|18960|P1|COMPLETED|Overall Study||11
7720|NCT02376998|18960|P1|STARTED|Overall Study||20
7721|NCT02376530|18968|P4|NOT COMPLETED|Overall Study||0
7722|NCT02376530|18969|P3|NOT COMPLETED|Overall Study||0
7723|NCT02376530|18970|P2|NOT COMPLETED|Overall Study||0
7724|NCT02376530|18971|P1|NOT COMPLETED|Overall Study||0
7725|NCT02376530|18968|P4|COMPLETED|Overall Study||197
7726|NCT02376530|18969|P3|COMPLETED|Overall Study||197
7727|NCT02376530|18970|P2|COMPLETED|Overall Study||198
7728|NCT02376530|18971|P1|COMPLETED|Overall Study||196
7729|NCT02376530|18968|P4|STARTED|Overall Study||197
7730|NCT02376530|18969|P3|STARTED|Overall Study||197
7731|NCT02376530|18970|P2|STARTED|Overall Study||198
7732|NCT02376530|18971|P1|STARTED|Overall Study||196
7733|NCT02375724|18983|P2|NOT COMPLETED|Overall Study||6
7734|NCT02375724|18984|P1|NOT COMPLETED|Overall Study||6
7735|NCT02375724|18983|P2|COMPLETED|Overall Study||128
7736|NCT02375724|18984|P1|COMPLETED|Overall Study||129
7737|NCT02375724|18983|P2|STARTED|Overall Study||134
7738|NCT02375724|18984|P1|STARTED|Overall Study||135
7739|NCT02375373|18994|P1|NOT COMPLETED|Overall Study||11
7740|NCT02375373|18994|P1|COMPLETED|Overall Study||1
7741|NCT02375373|18994|P1|STARTED|Overall Study||12
7742|NCT02375347|18998|P1|NOT COMPLETED|Overall Study||1
7743|NCT02375347|18998|P1|COMPLETED|Overall Study||12
7744|NCT02375347|18998|P1|STARTED|Overall Study||13
7745|NCT02374398|19006|P4|NOT COMPLETED|Overall Study||0
7746|NCT02374398|19007|P3|NOT COMPLETED|Overall Study||3
7747|NCT02374398|19008|P2|NOT COMPLETED|Overall Study||1
7748|NCT02374398|19009|P1|NOT COMPLETED|Overall Study||2
7749|NCT02374398|19006|P4|COMPLETED|Overall Study||32
7750|NCT02374398|19007|P3|COMPLETED|Overall Study||29
7751|NCT02374398|19008|P2|COMPLETED|Overall Study||31
7752|NCT02374398|19009|P1|COMPLETED|Overall Study||29
7753|NCT02374398|19006|P4|STARTED|Overall Study||32
7754|NCT02374398|19007|P3|STARTED|Overall Study||32
7755|NCT02374398|19008|P2|STARTED|Overall Study||32
7756|NCT02374398|19009|P1|STARTED|Overall Study||31
7757|NCT02374346|19035|P1|NOT COMPLETED|Overall Study||48
7758|NCT02374346|19035|P1|COMPLETED|Overall Study||446
7759|NCT02374346|19035|P1|STARTED|Overall Study||494
7760|NCT02374164|19044|P3|NOT COMPLETED|Treatment Period 3||0
7761|NCT02374164|19045|P2|NOT COMPLETED|Treatment Period 3||0
7762|NCT02374164|19046|P1|NOT COMPLETED|Treatment Period 3||0
7763|NCT02374164|19044|P3|COMPLETED|Treatment Period 3||12
7764|NCT02374164|19045|P2|COMPLETED|Treatment Period 3||11
7765|NCT02374164|19046|P1|COMPLETED|Treatment Period 3||12
7766|NCT02374164|19044|P3|STARTED|Treatment Period 3||12
7767|NCT02374164|19045|P2|STARTED|Treatment Period 3|One participant was Lost-to-Follow-Up prior to treatment A.|11
7768|NCT02374164|19046|P1|STARTED|Treatment Period 3||12
7769|NCT02374164|19044|P3|NOT COMPLETED|Treatment Period 2||0
7770|NCT02374164|19045|P2|NOT COMPLETED|Treatment Period 2||0
7771|NCT02374164|19046|P1|NOT COMPLETED|Treatment Period 2||0
7772|NCT02374164|19044|P3|COMPLETED|Treatment Period 2||12
7773|NCT02374164|19045|P2|COMPLETED|Treatment Period 2||12
7774|NCT02374164|19046|P1|COMPLETED|Treatment Period 2||12
7775|NCT02374164|19044|P3|STARTED|Treatment Period 2||12
7776|NCT02374164|19045|P2|STARTED|Treatment Period 2||12
7777|NCT02374164|19046|P1|STARTED|Treatment Period 2||12
7778|NCT02374164|19044|P3|NOT COMPLETED|Treatment Period 1||0
7779|NCT02374164|19045|P2|NOT COMPLETED|Treatment Period 1||0
7780|NCT02374164|19046|P1|NOT COMPLETED|Treatment Period 1||0
7781|NCT02374164|19044|P3|COMPLETED|Treatment Period 1||12
7782|NCT02374164|19045|P2|COMPLETED|Treatment Period 1||12
7783|NCT02374164|19046|P1|COMPLETED|Treatment Period 1||12
7784|NCT02374164|19044|P3|STARTED|Treatment Period 1||12
7785|NCT02374164|19045|P2|STARTED|Treatment Period 1||12
7786|NCT02374164|19046|P1|STARTED|Treatment Period 1||12
7787|NCT02372344|19063|P3|NOT COMPLETED|Period 3 (Visit 4)||0
7788|NCT02372344|19064|P2|NOT COMPLETED|Period 3 (Visit 4)||0
7789|NCT02372344|19065|P1|NOT COMPLETED|Period 3 (Visit 4)||0
7790|NCT02372344|19063|P3|COMPLETED|Period 3 (Visit 4)||14
7791|NCT02372344|19064|P2|COMPLETED|Period 3 (Visit 4)||14
7792|NCT02372344|19065|P1|COMPLETED|Period 3 (Visit 4)||14
7793|NCT02372344|19063|P3|STARTED|Period 3 (Visit 4)||14
7794|NCT02372344|19064|P2|STARTED|Period 3 (Visit 4)||14
7795|NCT02372344|19065|P1|STARTED|Period 3 (Visit 4)||14
7796|NCT02372344|19063|P3|NOT COMPLETED|Period 2 (Visit 3)||0
7797|NCT02372344|19064|P2|NOT COMPLETED|Period 2 (Visit 3)||0
7798|NCT02372344|19065|P1|NOT COMPLETED|Period 2 (Visit 3)||0
7799|NCT02372344|19063|P3|COMPLETED|Period 2 (Visit 3)||14
7800|NCT02372344|19064|P2|COMPLETED|Period 2 (Visit 3)||14
7801|NCT02372344|19065|P1|COMPLETED|Period 2 (Visit 3)||14
7802|NCT02372344|19063|P3|STARTED|Period 2 (Visit 3)||14
7803|NCT02372344|19064|P2|STARTED|Period 2 (Visit 3)||14
7804|NCT02372344|19065|P1|STARTED|Period 2 (Visit 3)||14
7805|NCT02372344|19063|P3|NOT COMPLETED|Period 1 (Visit 2)||0
7806|NCT02372344|19064|P2|NOT COMPLETED|Period 1 (Visit 2)||0
7807|NCT02372344|19065|P1|NOT COMPLETED|Period 1 (Visit 2)||0
7808|NCT02372344|19063|P3|COMPLETED|Period 1 (Visit 2)||14
7809|NCT02372344|19064|P2|COMPLETED|Period 1 (Visit 2)||14
7810|NCT02372344|19065|P1|COMPLETED|Period 1 (Visit 2)||14
7811|NCT02372344|19063|P3|STARTED|Period 1 (Visit 2)||14
7812|NCT02372344|19064|P2|STARTED|Period 1 (Visit 2)||14
7813|NCT02372344|19065|P1|STARTED|Period 1 (Visit 2)||14
7814|NCT02372097|19081|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
7815|NCT02372097|19082|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
7816|NCT02372097|19081|P2|COMPLETED|Second Intervention Period (8 Days)||12
7817|NCT02372097|19082|P1|COMPLETED|Second Intervention Period (8 Days)||12
7818|NCT02372097|19081|P2|STARTED|Second Intervention Period (8 Days)||12
7819|NCT02372097|19082|P1|STARTED|Second Intervention Period (8 Days)||12
7820|NCT02372097|19081|P2|NOT COMPLETED|Wash Out Period (13 Days)||0
7821|NCT02372097|19082|P1|NOT COMPLETED|Wash Out Period (13 Days)||0
7822|NCT02372097|19081|P2|COMPLETED|Wash Out Period (13 Days)||12
7823|NCT02372097|19082|P1|COMPLETED|Wash Out Period (13 Days)||12
7824|NCT02372097|19081|P2|STARTED|Wash Out Period (13 Days)||12
7825|NCT02372097|19082|P1|STARTED|Wash Out Period (13 Days)||12
7826|NCT02372097|19081|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
7827|NCT02372097|19082|P1|NOT COMPLETED|First Intervention Period (8 Days)||0
7828|NCT02372097|19081|P2|COMPLETED|First Intervention Period (8 Days)||12
7829|NCT02372097|19082|P1|COMPLETED|First Intervention Period (8 Days)||12
7830|NCT02372097|19081|P2|STARTED|First Intervention Period (8 Days)||12
7831|NCT02372097|19082|P1|STARTED|First Intervention Period (8 Days)||12
7832|NCT02372071|19108|P1|NOT COMPLETED|Overall Study||18
7833|NCT02372071|19108|P1|COMPLETED|Overall Study||93
7834|NCT02372071|19108|P1|STARTED|Overall Study||111
7835|NCT02372058|19113|P1|NOT COMPLETED|Overall Study||3
7836|NCT02372058|19113|P1|COMPLETED|Overall Study||100
7837|NCT02372058|19113|P1|STARTED|Overall Study||103
7838|NCT02371876|19119|P1|NOT COMPLETED|Overall Study||0
7839|NCT02371876|19119|P1|COMPLETED|Overall Study||134
7840|NCT02371876|19119|P1|STARTED|Overall Study||134
7841|NCT02371850|19129|P1|NOT COMPLETED|Overall Study||0
7842|NCT02371850|19129|P1|COMPLETED|Overall Study||10
7843|NCT02371850|19129|P1|STARTED|Overall Study||10
7844|NCT02371759|19142|P8|NOT COMPLETED|Overall Study||4
7845|NCT02371759|19143|P7|NOT COMPLETED|Overall Study||0
7846|NCT02371759|19144|P6|NOT COMPLETED|Overall Study||1
7847|NCT02371759|19145|P5|NOT COMPLETED|Overall Study||3
7848|NCT02371759|19146|P4|NOT COMPLETED|Overall Study||0
7849|NCT02371759|19147|P3|NOT COMPLETED|Overall Study||1
7850|NCT02371759|19148|P2|NOT COMPLETED|Overall Study||1
7851|NCT02371759|19149|P1|NOT COMPLETED|Overall Study||3
7852|NCT02371759|19142|P8|COMPLETED|Overall Study||24
7853|NCT02371759|19143|P7|COMPLETED|Overall Study||25
7854|NCT02371759|19144|P6|COMPLETED|Overall Study||25
7855|NCT02371759|19145|P5|COMPLETED|Overall Study||24
7856|NCT02371759|19146|P4|COMPLETED|Overall Study||31
7857|NCT02371759|19147|P3|COMPLETED|Overall Study||32
7858|NCT02371759|19148|P2|COMPLETED|Overall Study||30
7859|NCT02371759|19149|P1|COMPLETED|Overall Study||29
7860|NCT02371759|19142|P8|STARTED|Overall Study||28
7861|NCT02371759|19143|P7|STARTED|Overall Study||25
7862|NCT02371759|19144|P6|STARTED|Overall Study||26
7863|NCT02371759|19145|P5|STARTED|Overall Study||27
7864|NCT02371759|19146|P4|STARTED|Overall Study||31
7865|NCT02371759|19147|P3|STARTED|Overall Study||33
7866|NCT02371759|19148|P2|STARTED|Overall Study||31
7867|NCT02371759|19149|P1|STARTED|Overall Study||32
7868|NCT02370914|19359|P1|NOT COMPLETED|Overall Study||2
7869|NCT02370914|19359|P1|COMPLETED|Overall Study||82
7870|NCT02370914|19359|P1|STARTED|Overall Study||84
7871|NCT02370667|19366|P3|NOT COMPLETED|Overall Study||0
7872|NCT02370667|19367|P2|NOT COMPLETED|Overall Study||1
7873|NCT02370667|19368|P1|NOT COMPLETED|Overall Study||0
7874|NCT02370667|19366|P3|COMPLETED|Overall Study||10
7875|NCT02370667|19367|P2|COMPLETED|Overall Study||10
7876|NCT02370667|19368|P1|COMPLETED|Overall Study||10
7877|NCT02370667|19366|P3|STARTED|Overall Study||10
7878|NCT02370667|19367|P2|STARTED|Overall Study||11
7879|NCT02370667|19368|P1|STARTED|Overall Study||10
7880|NCT02370615|19432|P2|NOT COMPLETED|Overall Study||0
7881|NCT02370615|19433|P1|NOT COMPLETED|Overall Study||1
7882|NCT02370615|19432|P2|COMPLETED|Overall Study||18
7883|NCT02370615|19433|P1|COMPLETED|Overall Study||15
7884|NCT02370615|19432|P2|STARTED|Overall Study||18
7885|NCT02370615|19433|P1|STARTED|Overall Study||16
7886|NCT02370602|19476|P6|NOT COMPLETED|Overall Study||0
7887|NCT02370602|19477|P5|NOT COMPLETED|Overall Study||0
7888|NCT02370602|19478|P4|NOT COMPLETED|Overall Study||0
7889|NCT02370602|19479|P3|NOT COMPLETED|Overall Study||0
7890|NCT02370602|19480|P2|NOT COMPLETED|Overall Study||0
7891|NCT02370602|19481|P1|NOT COMPLETED|Overall Study||1
7892|NCT02370602|19476|P6|COMPLETED|Overall Study||2
7893|NCT02370602|19477|P5|COMPLETED|Overall Study||3
7894|NCT02370602|19478|P4|COMPLETED|Overall Study||3
7895|NCT02370602|19479|P3|COMPLETED|Overall Study||2
7896|NCT02370602|19480|P2|COMPLETED|Overall Study||2
7897|NCT02370602|19481|P1|COMPLETED|Overall Study||0
7898|NCT02370602|19476|P6|STARTED|Overall Study||2
7899|NCT02370602|19477|P5|STARTED|Overall Study||3
7900|NCT02370602|19478|P4|STARTED|Overall Study||3
7901|NCT02370602|19479|P3|STARTED|Overall Study||2
7902|NCT02370602|19480|P2|STARTED|Overall Study||2
7903|NCT02370602|19481|P1|STARTED|Overall Study||1
7904|NCT02370537|19575|P3|NOT COMPLETED|Part B||259
7905|NCT02370537|19576|P2|NOT COMPLETED|Part B||3
7906|NCT02370537|19577|P1|NOT COMPLETED|Part B||1
7907|NCT02370537|19575|P3|COMPLETED|Part B||23
7908|NCT02370537|19576|P2|COMPLETED|Part B||12
7909|NCT02370537|19577|P1|COMPLETED|Part B||15
7910|NCT02370537|19575|P3|Period 2 Sequence BA|Part B||12
7911|NCT02370537|19576|P2|Period 2 Sequence BA|Part B||7
7912|NCT02370537|19577|P1|Period 2 Sequence BA|Part B||7
7913|NCT02370537|19575|P3|Period 2 Sequence AB|Part B||11
7914|NCT02370537|19576|P2|Period 2 Sequence AB|Part B||5
7915|NCT02370537|19577|P1|Period 2 Sequence AB|Part B||8
7916|NCT02370537|19575|P3|Period 1 Sequence BA|Part B||12
7917|NCT02370537|19576|P2|Period 1 Sequence BA|Part B||7
7918|NCT02370537|19577|P1|Period 1 Sequence BA|Part B||7
7919|NCT02370537|19575|P3|Period 1 Sequence AB|Part B||11
7920|NCT02370537|19576|P2|Period 1 Sequence AB|Part B||6
7921|NCT02370537|19577|P1|Period 1 Sequence AB|Part B||8
7922|NCT02370537|19575|P3|Eligible for Randomisation|Part B||23
7923|NCT02370537|19576|P2|Eligible for Randomisation|Part B||13
7924|NCT02370537|19577|P1|Eligible for Randomisation|Part B||15
7925|NCT02370537|19575|P3|STARTED|Part B||282
7926|NCT02370537|19576|P2|STARTED|Part B||15
7927|NCT02370537|19577|P1|STARTED|Part B||16
7928|NCT02370537|19575|P3|NOT COMPLETED|Part A (Open-label Recruitment)||1
7929|NCT02370537|19576|P2|NOT COMPLETED|Part A (Open-label Recruitment)||1
7930|NCT02370537|19577|P1|NOT COMPLETED|Part A (Open-label Recruitment)||0
7931|NCT02370537|19575|P3|COMPLETED|Part A (Open-label Recruitment)||282
7932|NCT02370537|19576|P2|COMPLETED|Part A (Open-label Recruitment)||15
7933|NCT02370537|19577|P1|COMPLETED|Part A (Open-label Recruitment)||16
7934|NCT02370537|19575|P3|STARTED|Part A (Open-label Recruitment)||283
7935|NCT02370537|19576|P2|STARTED|Part A (Open-label Recruitment)||16
7936|NCT02370537|19577|P1|STARTED|Part A (Open-label Recruitment)||16
7937|NCT02370407|19626|P2|NOT COMPLETED|Overall Study||0
7938|NCT02370407|19627|P1|NOT COMPLETED|Overall Study||0
7939|NCT02370407|19626|P2|COMPLETED|Overall Study||20
7940|NCT02370407|19627|P1|COMPLETED|Overall Study||20
7941|NCT02370407|19626|P2|STARTED|Overall Study||20
7942|NCT02370407|19627|P1|STARTED|Overall Study||20
7943|NCT02370121|19651|P2|NOT COMPLETED|Overall Study||1
7944|NCT02370121|19652|P1|NOT COMPLETED|Overall Study||1
7945|NCT02370121|19651|P2|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
7946|NCT02370121|19652|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
7947|NCT02370121|19651|P2|STARTED|Overall Study||12
7948|NCT02370121|19652|P1|STARTED|Overall Study||12
7949|NCT02369796|19695|P5|NOT COMPLETED|Overall Study||0
7950|NCT02369796|19696|P4|NOT COMPLETED|Overall Study||0
7951|NCT02369796|19697|P3|NOT COMPLETED|Overall Study||0
7952|NCT02369796|19698|P2|NOT COMPLETED|Overall Study||0
7953|NCT02369796|19699|P1|NOT COMPLETED|Overall Study||0
7954|NCT02369796|19695|P5|COMPLETED|Overall Study||3
7955|NCT02369796|19696|P4|COMPLETED|Overall Study||3
7956|NCT02369796|19697|P3|COMPLETED|Overall Study||3
7957|NCT02369796|19698|P2|COMPLETED|Overall Study||3
7958|NCT02369796|19699|P1|COMPLETED|Overall Study||3
7959|NCT02369796|19695|P5|STARTED|Overall Study||3
7960|NCT02369796|19696|P4|STARTED|Overall Study||3
7961|NCT02369796|19697|P3|STARTED|Overall Study||3
7962|NCT02369796|19698|P2|STARTED|Overall Study||3
7963|NCT02369796|19699|P1|STARTED|Overall Study||3
7964|NCT02369510|19741|P3|NOT COMPLETED|Overall Study||6
7965|NCT02369510|19742|P2|NOT COMPLETED|Overall Study||3
7966|NCT02369510|19743|P1|NOT COMPLETED|Overall Study||2
7967|NCT02369510|19741|P3|COMPLETED|Overall Study||17
7968|NCT02369510|19742|P2|COMPLETED|Overall Study||19
7969|NCT02369510|19743|P1|COMPLETED|Overall Study||21
7970|NCT02369510|19741|P3|STARTED|Overall Study||23
7971|NCT02369510|19742|P2|STARTED|Overall Study||22
7972|NCT02369510|19743|P1|STARTED|Overall Study||23
7973|NCT02369341|19774|P2|NOT COMPLETED|Overall Study||0
7974|NCT02369341|19775|P1|NOT COMPLETED|Overall Study||1
7975|NCT02369341|19774|P2|COMPLETED|Overall Study||57
7976|NCT02369341|19775|P1|COMPLETED|Overall Study||62
7977|NCT02369341|19774|P2|STARTED|Overall Study||57
7978|NCT02369341|19775|P1|STARTED|Overall Study||63
7979|NCT02368457|19831|P2|NOT COMPLETED|Overall Study||0
7980|NCT02368457|19832|P1|NOT COMPLETED|Overall Study||0
7981|NCT02368457|19831|P2|COMPLETED|Overall Study||12
7982|NCT02368457|19832|P1|COMPLETED|Overall Study||12
7983|NCT02368457|19831|P2|STARTED|Overall Study||12
7984|NCT02368457|19832|P1|STARTED|Overall Study||12
7985|NCT02368314|19842|P2|NOT COMPLETED|Overall Study||3
7986|NCT02368314|19843|P1|NOT COMPLETED|Overall Study||3
7987|NCT02368314|19842|P2|COMPLETED|Overall Study||57
7988|NCT02368314|19843|P1|COMPLETED|Overall Study||61
7989|NCT02368314|19842|P2|STARTED|Overall Study||60
7990|NCT02368314|19843|P1|STARTED|Overall Study||64
7991|NCT02368093|19855|P2|NOT COMPLETED|Overall Study||0
7992|NCT02368093|19856|P1|NOT COMPLETED|Overall Study||0
7993|NCT02368093|19855|P2|COMPLETED|Overall Study||24
7994|NCT02368093|19856|P1|COMPLETED|Overall Study||24
7995|NCT02368093|19855|P2|STARTED|Overall Study||24
7996|NCT02368093|19856|P1|STARTED|Overall Study||24
7997|NCT02367885|19865|P3|NOT COMPLETED|Overall Study||0
7998|NCT02367885|19866|P2|NOT COMPLETED|Overall Study||0
7999|NCT02367885|19867|P1|NOT COMPLETED|Overall Study||2
8000|NCT02367885|19865|P3|COMPLETED|Overall Study||33
8001|NCT02367885|19866|P2|COMPLETED|Overall Study||33
8002|NCT02367885|19867|P1|COMPLETED|Overall Study||31
8003|NCT02367885|19865|P3|STARTED|Overall Study||33
8004|NCT02367885|19866|P2|STARTED|Overall Study||33
8005|NCT02367885|19867|P1|STARTED|Overall Study||33
8006|NCT02367872|19940|P8|NOT COMPLETED|Overall Study||0
8007|NCT02367872|19941|P7|NOT COMPLETED|Overall Study||0
8008|NCT02367872|19942|P6|NOT COMPLETED|Overall Study||0
8009|NCT02367872|19943|P5|NOT COMPLETED|Overall Study||0
8010|NCT02367872|19944|P4|NOT COMPLETED|Overall Study||0
8011|NCT02367872|19945|P3|NOT COMPLETED|Overall Study||0
8012|NCT02367872|19946|P2|NOT COMPLETED|Overall Study||0
8013|NCT02367872|19947|P1|NOT COMPLETED|Overall Study||0
8014|NCT02367872|19940|P8|COMPLETED|Overall Study||6
8015|NCT02367872|19941|P7|COMPLETED|Overall Study||6
8016|NCT02367872|19942|P6|COMPLETED|Overall Study||6
8017|NCT02367872|19943|P5|COMPLETED|Overall Study||6
8018|NCT02367872|19944|P4|COMPLETED|Overall Study||6
8019|NCT02367872|19945|P3|COMPLETED|Overall Study||6
8020|NCT02367872|19946|P2|COMPLETED|Overall Study||6
8021|NCT02367872|19947|P1|COMPLETED|Overall Study||6
8022|NCT02367872|19940|P8|STARTED|Overall Study||6
8023|NCT02367872|19941|P7|STARTED|Overall Study||6
8024|NCT02367872|19942|P6|STARTED|Overall Study||6
8025|NCT02367872|19943|P5|STARTED|Overall Study||6
8026|NCT02367872|19944|P4|STARTED|Overall Study||6
8027|NCT02367872|19945|P3|STARTED|Overall Study||6
8028|NCT02367872|19946|P2|STARTED|Overall Study||6
8029|NCT02367872|19947|P1|STARTED|Overall Study||6
8030|NCT02367391|20102|P2|NOT COMPLETED|Overall Study||0
8031|NCT02367391|20103|P1|NOT COMPLETED|Overall Study||2
8032|NCT02367391|20102|P2|COMPLETED|Overall Study||76
8033|NCT02367391|20103|P1|COMPLETED|Overall Study||74
8034|NCT02367391|20102|P2|STARTED|Overall Study||76
8035|NCT02367391|20103|P1|STARTED|Overall Study||76
8036|NCT02367170|20123|P2|NOT COMPLETED|Overall Study||0
8037|NCT02367170|20124|P1|NOT COMPLETED|Overall Study||0
8038|NCT02367170|20123|P2|COMPLETED|Overall Study||0
8039|NCT02367170|20124|P1|COMPLETED|Overall Study||1
8040|NCT02367170|20123|P2|STARTED|Overall Study||0
8041|NCT02367170|20124|P1|STARTED|Overall Study||1
8042|NCT02367066|20136|P2|NOT COMPLETED|Overall Study||0
8043|NCT02367066|20137|P1|NOT COMPLETED|Overall Study||0
8044|NCT02367066|20136|P2|COMPLETED|Overall Study||10
8045|NCT02367066|20137|P1|COMPLETED|Overall Study||10
8046|NCT02367066|20136|P2|STARTED|Overall Study||10
8047|NCT02367066|20137|P1|STARTED|Overall Study||10
8048|NCT02366936|20195|P1|NOT COMPLETED|Overall Study||8
8049|NCT02366936|20195|P1|COMPLETED|Overall Study||24
8050|NCT02366936|20195|P1|STARTED|Overall Study||32
8051|NCT02366923|20200|P1|NOT COMPLETED|Overall Study||6
8052|NCT02366923|20200|P1|COMPLETED|Overall Study||22
8053|NCT02366923|20200|P1|STARTED|Overall Study||28
8054|NCT02366910|20213|P1|NOT COMPLETED|Overall Study||5
8055|NCT02366910|20213|P1|COMPLETED|Overall Study||21
8056|NCT02366910|20213|P1|STARTED|Overall Study||26
8057|NCT02366767|20227|P2|NOT COMPLETED|Overall Study||0
8058|NCT02366767|20228|P1|NOT COMPLETED|Overall Study||1
8059|NCT02366767|20227|P2|COMPLETED|Overall Study||10
8060|NCT02366767|20228|P1|COMPLETED|Overall Study||10
8061|NCT02366767|20227|P2|STARTED|Overall Study||10
8062|NCT02366767|20228|P1|STARTED|Overall Study||11
8063|NCT02366689|20241|P3|NOT COMPLETED|Overall Study||2
8064|NCT02366689|20242|P2|NOT COMPLETED|Overall Study||3
8065|NCT02366689|20243|P1|NOT COMPLETED|Overall Study||4
8066|NCT02366689|20241|P3|COMPLETED|Overall Study||59
8067|NCT02366689|20242|P2|COMPLETED|Overall Study||55
8068|NCT02366689|20243|P1|COMPLETED|Overall Study||56
8069|NCT02366689|20241|P3|STARTED|Overall Study||61
8070|NCT02366689|20242|P2|STARTED|Overall Study||58
8071|NCT02366689|20243|P1|STARTED|Overall Study||60
8072|NCT02366637|20266|P2|NOT COMPLETED|Second Intervention Period||1
8073|NCT02366637|20267|P1|NOT COMPLETED|Second Intervention Period||1
8074|NCT02366637|20266|P2|COMPLETED|Second Intervention Period||0
8075|NCT02366637|20267|P1|COMPLETED|Second Intervention Period||0
8076|NCT02366637|20266|P2|STARTED|Second Intervention Period||1
8077|NCT02366637|20267|P1|STARTED|Second Intervention Period||1
8078|NCT02366637|20266|P2|NOT COMPLETED|Washout Period 28 to 49 Days||0
8079|NCT02366637|20267|P1|NOT COMPLETED|Washout Period 28 to 49 Days||0
8080|NCT02366637|20266|P2|COMPLETED|Washout Period 28 to 49 Days||1
8081|NCT02366637|20267|P1|COMPLETED|Washout Period 28 to 49 Days||1
8082|NCT02366637|20266|P2|STARTED|Washout Period 28 to 49 Days||1
8083|NCT02366637|20267|P1|STARTED|Washout Period 28 to 49 Days||1
8084|NCT02366637|20266|P2|NOT COMPLETED|First Intervention Period||5
8085|NCT02366637|20267|P1|NOT COMPLETED|First Intervention Period||6
8086|NCT02366637|20266|P2|COMPLETED|First Intervention Period||1
8087|NCT02366637|20267|P1|COMPLETED|First Intervention Period||1
8088|NCT02366637|20266|P2|STARTED|First Intervention Period||6
8089|NCT02366637|20267|P1|STARTED|First Intervention Period||7
8090|NCT02366338|20294|P3|NOT COMPLETED|Overall Study||0
8091|NCT02366338|20295|P2|NOT COMPLETED|Overall Study||0
8092|NCT02366338|20296|P1|NOT COMPLETED|Overall Study||0
8093|NCT02366338|20294|P3|COMPLETED|Overall Study||36
8094|NCT02366338|20295|P2|COMPLETED|Overall Study||39
8095|NCT02366338|20296|P1|COMPLETED|Overall Study||73
8096|NCT02366338|20294|P3|STARTED|Overall Study||36
8097|NCT02366338|20295|P2|STARTED|Overall Study||39
8098|NCT02366338|20296|P1|STARTED|Overall Study||73
8099|NCT02365688|20304|P1|NOT COMPLETED|Overall Study||0
8100|NCT02365688|20304|P1|COMPLETED|Overall Study|All subjects consented to an change in standard infusion volume pre-incision|18
8101|NCT02365688|20304|P1|STARTED|Overall Study|All subjects received a bolus of 500cc before first incision|18
8102|NCT02365298|20308|P2|NOT COMPLETED|Period 2||2
8103|NCT02365298|20309|P1|NOT COMPLETED|Period 2||2
8104|NCT02365298|20308|P2|COMPLETED|Period 2||12
8105|NCT02365298|20309|P1|COMPLETED|Period 2||12
8106|NCT02365298|20308|P2|STARTED|Period 2||14
8107|NCT02365298|20309|P1|STARTED|Period 2||14
8108|NCT02365298|20308|P2|NOT COMPLETED|Period 1||0
8109|NCT02365298|20309|P1|NOT COMPLETED|Period 1||0
8110|NCT02365298|20308|P2|COMPLETED|Period 1||14
8111|NCT02365298|20309|P1|COMPLETED|Period 1||14
8112|NCT02365298|20308|P2|STARTED|Period 1||14
8113|NCT02365298|20309|P1|STARTED|Period 1||14
8114|NCT02364778|20327|P1|NOT COMPLETED|Overall Study||0
8115|NCT02364778|20327|P1|COMPLETED|Overall Study||30
8116|NCT02364778|20327|P1|STARTED|Overall Study||30
8117|NCT02364700|20339|P1|NOT COMPLETED|Overall Study||0
8118|NCT02364700|20339|P1|COMPLETED|Overall Study||12
8119|NCT02364700|20339|P1|STARTED|Overall Study||12
8120|NCT02364180|20348|P1|NOT COMPLETED|Overall Study||1
8121|NCT02364180|20348|P1|COMPLETED|Overall Study||10
8122|NCT02364180|20348|P1|STARTED|Overall Study||11
8123|NCT02363907|20352|P1|NOT COMPLETED|Overall Study||0
8124|NCT02363907|20352|P1|COMPLETED|Overall Study||30
8125|NCT02363907|20352|P1|STARTED|Overall Study||30
8126|NCT02363478|20356|P1|NOT COMPLETED|Overall Study||8
8127|NCT02363478|20356|P1|COMPLETED|Overall Study||22
8128|NCT02363478|20356|P1|STARTED|Overall Study||30
8129|NCT02362412|20363|P2|NOT COMPLETED|Treatment Period III||1
8130|NCT02362412|20364|P1|NOT COMPLETED|Treatment Period III||0
8131|NCT02362412|20363|P2|COMPLETED|Treatment Period III||10
8132|NCT02362412|20364|P1|COMPLETED|Treatment Period III||9
8133|NCT02362412|20363|P2|TREATED|Treatment Period III||11
8134|NCT02362412|20364|P1|TREATED|Treatment Period III||9
8135|NCT02362412|20363|P2|STARTED|Treatment Period III||11
8136|NCT02362412|20364|P1|STARTED|Treatment Period III||9
8137|NCT02362412|20363|P2|NOT COMPLETED|Treatment Period II||0
8138|NCT02362412|20364|P1|NOT COMPLETED|Treatment Period II||0
8139|NCT02362412|20363|P2|COMPLETED|Treatment Period II||11
8140|NCT02362412|20364|P1|COMPLETED|Treatment Period II||9
8141|NCT02362412|20363|P2|TREATED|Treatment Period II||11
8142|NCT02362412|20364|P1|TREATED|Treatment Period II||9
8143|NCT02362412|20363|P2|STARTED|Treatment Period II||11
8144|NCT02362412|20364|P1|STARTED|Treatment Period II||9
8145|NCT02362373|20390|P1|NOT COMPLETED|Overall Study||0
8146|NCT02362373|20390|P1|COMPLETED|Overall Study||20
8147|NCT02362373|20390|P1|STARTED|Overall Study||20
8148|NCT02362360|20398|P2|NOT COMPLETED|Period 2||0
8149|NCT02362360|20399|P1|NOT COMPLETED|Period 2||0
8150|NCT02362360|20398|P2|COMPLETED|Period 2||25
8151|NCT02362360|20399|P1|COMPLETED|Period 2||23
8152|NCT02362360|20398|P2|STARTED|Period 2||25
8153|NCT02362360|20399|P1|STARTED|Period 2||23
8154|NCT02362360|20398|P2|NOT COMPLETED|Period 1||1
8155|NCT02362360|20399|P1|NOT COMPLETED|Period 1||3
8156|NCT02362360|20398|P2|COMPLETED|Period 1||25
8157|NCT02362360|20399|P1|COMPLETED|Period 1||23
8158|NCT02362360|20398|P2|STARTED|Period 1||26
8159|NCT02362360|20399|P1|STARTED|Period 1||26
8160|NCT02362321|20407|P2|NOT COMPLETED|Overall Study||0
8161|NCT02362321|20408|P1|NOT COMPLETED|Overall Study||4
8162|NCT02362321|20407|P2|COMPLETED|Overall Study||10
8163|NCT02362321|20408|P1|COMPLETED|Overall Study||6
8164|NCT02362321|20407|P2|STARTED|Overall Study||10
8165|NCT02362321|20408|P1|STARTED|Overall Study||10
8166|NCT02361736|20416|P2|NOT COMPLETED|Overall Study||1
8167|NCT02361736|20417|P1|NOT COMPLETED|Overall Study||1
8168|NCT02361736|20416|P2|COMPLETED|Overall Study||59
8169|NCT02361736|20417|P1|COMPLETED|Overall Study||59
8170|NCT02361736|20416|P2|STARTED|Overall Study||60
8171|NCT02361736|20417|P1|STARTED|Overall Study||60
8172|NCT02361580|20437|P2|NOT COMPLETED|Overall Study||3
8173|NCT02361580|20438|P1|NOT COMPLETED|Overall Study||6
8174|NCT02361580|20437|P2|COMPLETED|Overall Study||0
8175|NCT02361580|20438|P1|COMPLETED|Overall Study||0
8176|NCT02361580|20437|P2|STARTED|Overall Study||3
8177|NCT02361580|20438|P1|STARTED|Overall Study||6
8178|NCT02360995|20451|P3|NOT COMPLETED|Overall Study||2
8179|NCT02360995|20452|P2|NOT COMPLETED|Overall Study||1
8180|NCT02360995|20453|P1|NOT COMPLETED|Overall Study||2
8181|NCT02360995|20451|P3|COMPLETED|Overall Study||41
8182|NCT02360995|20452|P2|COMPLETED|Overall Study||42
8183|NCT02360995|20453|P1|COMPLETED|Overall Study||41
8184|NCT02360995|20451|P3|STARTED|Overall Study||43
8185|NCT02360995|20452|P2|STARTED|Overall Study||43
8186|NCT02360995|20453|P1|STARTED|Overall Study||43
8187|NCT02360475|20480|P4|NOT COMPLETED|Overall Study||5
8188|NCT02360475|20481|P3|NOT COMPLETED|Overall Study||8
8189|NCT02360475|20482|P2|NOT COMPLETED|Overall Study||13
8190|NCT02360475|20483|P1|NOT COMPLETED|Overall Study||4
8191|NCT02360475|20480|P4|COMPLETED|Overall Study||120
8192|NCT02360475|20481|P3|COMPLETED|Overall Study||117
8193|NCT02360475|20482|P2|COMPLETED|Overall Study||111
8194|NCT02360475|20483|P1|COMPLETED|Overall Study||122
8195|NCT02360475|20480|P4|STARTED|Overall Study||125
8196|NCT02360475|20481|P3|STARTED|Overall Study||125
8197|NCT02360475|20482|P2|STARTED|Overall Study||124
8198|NCT02360475|20483|P1|STARTED|Overall Study||126
8199|NCT02360124|20544|P3|NOT COMPLETED|Overall Study||26
8200|NCT02360124|20545|P2|NOT COMPLETED|Overall Study||12
8201|NCT02360124|20546|P1|NOT COMPLETED|Overall Study||28
8202|NCT02360124|20544|P3|COMPLETED|Overall Study||82
8203|NCT02360124|20545|P2|COMPLETED|Overall Study||95
8204|NCT02360124|20546|P1|COMPLETED|Overall Study||80
8205|NCT02360124|20544|P3|STARTED|Overall Study||108
8206|NCT02360124|20545|P2|STARTED|Overall Study||107
8207|NCT02360124|20546|P1|STARTED|Overall Study||108
8208|NCT02360059|20559|P2|NOT COMPLETED|Overall Study||0
8209|NCT02360059|20560|P1|NOT COMPLETED|Overall Study||0
8210|NCT02360059|20559|P2|COMPLETED|Overall Study||0
8211|NCT02360059|20560|P1|COMPLETED|Overall Study||1
8212|NCT02360059|20559|P2|STARTED|Overall Study||0
8213|NCT02360059|20560|P1|STARTED|Overall Study||1
8214|NCT02359955|20568|P2|NOT COMPLETED|Overall Study||0
8215|NCT02359955|20569|P1|NOT COMPLETED|Overall Study||0
8216|NCT02359955|20568|P2|COMPLETED|Overall Study||10
8217|NCT02359955|20569|P1|COMPLETED|Overall Study||10
8218|NCT02359955|20568|P2|STARTED|Overall Study||10
8219|NCT02359955|20569|P1|STARTED|Overall Study||10
8220|NCT02359903|20587|P2|NOT COMPLETED|Overall Study||2
8221|NCT02359903|20588|P1|NOT COMPLETED|Overall Study||0
8222|NCT02359903|20587|P2|COMPLETED|Overall Study||43
8223|NCT02359903|20588|P1|COMPLETED|Overall Study||45
8224|NCT02359903|20587|P2|STARTED|Overall Study||45
8225|NCT02359903|20588|P1|STARTED|Overall Study||45
8226|NCT02359877|20600|P4|NOT COMPLETED|Overall Study||3
8227|NCT02359877|20601|P3|NOT COMPLETED|Overall Study||0
8228|NCT02359877|20602|P2|NOT COMPLETED|Overall Study||0
8229|NCT02359877|20603|P1|NOT COMPLETED|Overall Study||1
8230|NCT02359877|20600|P4|COMPLETED|Overall Study||11
8231|NCT02359877|20601|P3|COMPLETED|Overall Study||6
8232|NCT02359877|20602|P2|COMPLETED|Overall Study||6
8233|NCT02359877|20603|P1|COMPLETED|Overall Study||33
8234|NCT02359877|20600|P4|STARTED|Overall Study||14
8235|NCT02359877|20601|P3|STARTED|Overall Study||6
8236|NCT02359877|20602|P2|STARTED|Overall Study||6
8237|NCT02359877|20603|P1|STARTED|Overall Study||34
8238|NCT02359435|20655|P2|NOT COMPLETED|Overall Study||4
8239|NCT02359435|20656|P1|NOT COMPLETED|Overall Study||4
8240|NCT02359435|20655|P2|COMPLETED|Overall Study||216
8241|NCT02359435|20656|P1|COMPLETED|Overall Study||216
8242|NCT02359435|20655|P2|STARTED|Overall Study||220
8243|NCT02359435|20656|P1|STARTED|Overall Study||220
8244|NCT02359045|20664|P2|NOT COMPLETED|Overall Study||3
8245|NCT02359045|20665|P1|NOT COMPLETED|Overall Study||4
8246|NCT02359045|20664|P2|COMPLETED|Overall Study||39
8247|NCT02359045|20665|P1|COMPLETED|Overall Study||36
8248|NCT02359045|20664|P2|STARTED|Overall Study||42
8249|NCT02359045|20665|P1|STARTED|Overall Study||40
8250|NCT02358876|20898|P1|NOT COMPLETED|Overall Study||2
8251|NCT02358876|20898|P1|COMPLETED|Overall Study|All 32 participants completed the in-clinic portion and 30 out of the 32 completed the home portion.|30
8252|NCT02358876|20898|P1|STARTED|Overall Study||32
8253|NCT02358668|20905|P3|NOT COMPLETED|Overall Study||0
8254|NCT02358668|20906|P2|NOT COMPLETED|Overall Study||1
8255|NCT02358668|20907|P1|NOT COMPLETED|Overall Study||2
8256|NCT02358668|20905|P3|COMPLETED|Overall Study||12
8257|NCT02358668|20906|P2|COMPLETED|Overall Study||23
8258|NCT02358668|20907|P1|COMPLETED|Overall Study||22
8259|NCT02358668|20905|P3|STARTED|Overall Study||12
8260|NCT02358668|20906|P2|STARTED|Overall Study||24
8261|NCT02358668|20907|P1|STARTED|Overall Study||24
8262|NCT02358044|21049|P2|NOT COMPLETED|Overall Study||7
8263|NCT02358044|21050|P1|NOT COMPLETED|Overall Study||2
8264|NCT02358044|21049|P2|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|121
8265|NCT02358044|21050|P1|COMPLETED|Overall Study|Completed = Completed Follow-up Week 24 (end of study)|127
8266|NCT02358044|21049|P2|Treated|Overall Study||126
8267|NCT02358044|21050|P1|Treated|Overall Study||129
8268|NCT02358044|21049|P2|STARTED|Overall Study||128
8269|NCT02358044|21050|P1|STARTED|Overall Study||129
8270|NCT02357940|21068|P2|NOT COMPLETED|Overall Study||2
8271|NCT02357940|21069|P1|NOT COMPLETED|Overall Study||0
8272|NCT02357940|21068|P2|COMPLETED|Overall Study||30
8273|NCT02357940|21069|P1|COMPLETED|Overall Study||9
8274|NCT02357940|21068|P2|STARTED|Overall Study||32
8275|NCT02357940|21069|P1|STARTED|Overall Study||9
8276|NCT02357485|21193|P1|NOT COMPLETED|Overall Study||0
8277|NCT02357485|21193|P1|COMPLETED|Overall Study||6
8278|NCT02357485|21193|P1|STARTED|Overall Study|6 subjects, 8 knees ( 2 bilateral & 4 unilateral)|6
8279|NCT02357342|21203|P2|NOT COMPLETED|Extension Study||0
8280|NCT02357342|21204|P1|NOT COMPLETED|Extension Study||0
8281|NCT02357342|21203|P2|COMPLETED|Extension Study||9
8282|NCT02357342|21204|P1|COMPLETED|Extension Study||4
8283|NCT02357342|21203|P2|STARTED|Extension Study||9
8284|NCT02357342|21204|P1|STARTED|Extension Study||4
8285|NCT02357342|21203|P2|NOT COMPLETED|First 6 Months||0
8286|NCT02357342|21204|P1|NOT COMPLETED|First 6 Months||2
8287|NCT02357342|21203|P2|COMPLETED|First 6 Months||20
8288|NCT02357342|21204|P1|COMPLETED|First 6 Months|2 patients died. Neither deaths were study drug related.|18
8289|NCT02357342|21203|P2|STARTED|First 6 Months||20
8290|NCT02357342|21204|P1|STARTED|First 6 Months||20
8291|NCT02357264|21216|P2|NOT COMPLETED|Overall Study||0
8292|NCT02357264|21217|P1|NOT COMPLETED|Overall Study||0
8293|NCT02357264|21216|P2|COMPLETED|Overall Study||130
8294|NCT02357264|21217|P1|COMPLETED|Overall Study||56
8295|NCT02357264|21216|P2|STARTED|Overall Study||130
8296|NCT02357264|21217|P1|STARTED|Overall Study||56
8297|NCT02356900|21225|P2|NOT COMPLETED|Overall Study||0
8298|NCT02356900|21226|P1|NOT COMPLETED|Overall Study||0
8299|NCT02356900|21225|P2|COMPLETED|Overall Study||10
8300|NCT02356900|21226|P1|COMPLETED|Overall Study||11
8301|NCT02356900|21225|P2|STARTED|Overall Study||10
8302|NCT02356900|21226|P1|STARTED|Overall Study||11
8303|NCT02356588|21246|P2|NOT COMPLETED|Overall Study||13
8304|NCT02356588|21247|P1|NOT COMPLETED|Overall Study||5
8305|NCT02356588|21246|P2|COMPLETED|Overall Study||41
8306|NCT02356588|21247|P1|COMPLETED|Overall Study||102
8307|NCT02356588|21246|P2|STARTED|Overall Study||54
8308|NCT02356588|21247|P1|STARTED|Overall Study||107
8309|NCT02355977|21282|P3|NOT COMPLETED|Overall Study||0
8310|NCT02355977|21283|P2|NOT COMPLETED|Overall Study||0
8311|NCT02355977|21284|P1|NOT COMPLETED|Overall Study||0
8312|NCT02355977|21282|P3|COMPLETED|Overall Study||23
8313|NCT02355977|21283|P2|COMPLETED|Overall Study||26
8314|NCT02355977|21284|P1|COMPLETED|Overall Study||21
8315|NCT02355977|21282|P3|STARTED|Overall Study||23
8316|NCT02355977|21283|P2|STARTED|Overall Study||26
8317|NCT02355977|21284|P1|STARTED|Overall Study||21
8318|NCT02355275|21298|P1|NOT COMPLETED|Overall Study||8
8319|NCT02355275|21298|P1|COMPLETED|Overall Study||14
8320|NCT02355275|21298|P1|STARTED|Overall Study||22
8321|NCT02355158|21303|P1|NOT COMPLETED|Overall Study||150
8322|NCT02355158|21303|P1|COMPLETED|Overall Study||47
8323|NCT02355158|21303|P1|STARTED|Overall Study||197
8324|NCT02354924|21309|P2|NOT COMPLETED|Overall Study||0
8325|NCT02354924|21310|P1|NOT COMPLETED|Overall Study||0
8326|NCT02354924|21309|P2|COMPLETED|Overall Study||20
8327|NCT02354924|21310|P1|COMPLETED|Overall Study||40
8328|NCT02354924|21309|P2|STARTED|Overall Study||20
8329|NCT02354924|21310|P1|STARTED|Overall Study||40
8330|NCT02354833|21322|P2|NOT COMPLETED|Overall Study||0
8331|NCT02354833|21323|P1|NOT COMPLETED|Overall Study||0
8332|NCT02354833|21322|P2|COMPLETED|Overall Study||43
8333|NCT02354833|21323|P1|COMPLETED|Overall Study||38
8334|NCT02354833|21322|P2|STARTED|Overall Study||43
8335|NCT02354833|21323|P1|STARTED|Overall Study||38
8336|NCT02354599|21341|P6|NOT COMPLETED|Overall Study||1
8337|NCT02354599|21342|P5|NOT COMPLETED|Overall Study||0
8338|NCT02354599|21343|P4|NOT COMPLETED|Overall Study||0
8339|NCT02354599|21344|P3|NOT COMPLETED|Overall Study||0
8340|NCT02354599|21345|P2|NOT COMPLETED|Overall Study||1
8341|NCT02354599|21346|P1|NOT COMPLETED|Overall Study||1
8342|NCT02354599|21341|P6|COMPLETED|Overall Study||5
8343|NCT02354599|21342|P5|COMPLETED|Overall Study||2
8344|NCT02354599|21343|P4|COMPLETED|Overall Study||6
8345|NCT02354599|21344|P3|COMPLETED|Overall Study||6
8346|NCT02354599|21345|P2|COMPLETED|Overall Study||5
8347|NCT02354599|21346|P1|COMPLETED|Overall Study||5
8348|NCT02354599|21341|P6|STARTED|Overall Study||6
8349|NCT02354599|21342|P5|STARTED|Overall Study||2
8350|NCT02354599|21343|P4|STARTED|Overall Study||6
8351|NCT02354599|21344|P3|STARTED|Overall Study||6
8352|NCT02354599|21345|P2|STARTED|Overall Study||6
8353|NCT02354599|21346|P1|STARTED|Overall Study||6
8354|NCT02353754|21418|P2|NOT COMPLETED|Overall Study||0
8355|NCT02353754|21419|P1|NOT COMPLETED|Overall Study||2
8356|NCT02353754|21418|P2|COMPLETED|Overall Study||0
8357|NCT02353754|21419|P1|COMPLETED|Overall Study||10
8358|NCT02353754|21418|P2|STARTED|Overall Study||0
8359|NCT02353754|21419|P1|STARTED|Overall Study||12
8360|NCT02353572|21429|P1|NOT COMPLETED|Overall Study||3
8361|NCT02353572|21429|P1|COMPLETED|Overall Study||0
8362|NCT02353572|21429|P1|STARTED|Overall Study||3
8363|NCT02353468|21433|P1|NOT COMPLETED|Overall Study||3
8364|NCT02353468|21433|P1|COMPLETED|Overall Study||0
8365|NCT02353468|21433|P1|STARTED|Overall Study||3
8366|NCT02353442|21439|P2|NOT COMPLETED|Overall Study||4
8367|NCT02353442|21440|P1|NOT COMPLETED|Overall Study||3
8368|NCT02353442|21439|P2|COMPLETED|Overall Study||27
8369|NCT02353442|21440|P1|COMPLETED|Overall Study||25
8370|NCT02353442|21439|P2|STARTED|Overall Study||31
8371|NCT02353442|21440|P1|STARTED|Overall Study||28
8372|NCT02352779|21457|P3|NOT COMPLETED|Overall Study||2
8373|NCT02352779|21458|P2|NOT COMPLETED|Overall Study||1
8374|NCT02352779|21459|P1|NOT COMPLETED|Overall Study||8
8375|NCT02352779|21457|P3|COMPLETED|Overall Study||33
8376|NCT02352779|21458|P2|COMPLETED|Overall Study||35
8377|NCT02352779|21459|P1|COMPLETED|Overall Study||29
8378|NCT02352779|21457|P3|STARTED|Overall Study||35
8379|NCT02352779|21458|P2|STARTED|Overall Study||36
8380|NCT02352779|21459|P1|STARTED|Overall Study||37
8381|NCT02352298|21467|P1|NOT COMPLETED|Overall Study||0
8382|NCT02352298|21467|P1|COMPLETED|Overall Study||52
8383|NCT02352298|21467|P1|STARTED|Overall Study||52
8384|NCT02351934|21474|P2|NOT COMPLETED|Follow-Up||10
8385|NCT02351934|21475|P1|NOT COMPLETED|Follow-Up||7
8386|NCT02351934|21474|P2|COMPLETED|Follow-Up||51
8387|NCT02351934|21475|P1|COMPLETED|Follow-Up||44
8388|NCT02351934|21474|P2|STARTED|Follow-Up||61
8389|NCT02351934|21475|P1|STARTED|Follow-Up||51
8390|NCT02351934|21474|P2|NOT COMPLETED|Allocation||0
8391|NCT02351934|21475|P1|NOT COMPLETED|Allocation||11
8392|NCT02351934|21474|P2|COMPLETED|Allocation||61
8393|NCT02351934|21475|P1|COMPLETED|Allocation||51
8394|NCT02351934|21474|P2|Received Allocation|Allocation||61
8395|NCT02351934|21475|P1|Received Allocation|Allocation||51
8396|NCT02351934|21474|P2|STARTED|Allocation||61
8397|NCT02351934|21475|P1|STARTED|Allocation||62
8398|NCT02351817|21491|P2|NOT COMPLETED|Period 2||2
8399|NCT02351817|21492|P1|NOT COMPLETED|Period 2||1
8400|NCT02351817|21491|P2|COMPLETED|Period 2||3
8401|NCT02351817|21492|P1|COMPLETED|Period 2||4
8402|NCT02351817|21491|P2|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8403|NCT02351817|21492|P1|STARTED|Period 2|Subjects who did not complete Period 1 as planned were allowed to continue to Period 2|5
8404|NCT02351817|21491|P2|NOT COMPLETED|Period 1||3
8405|NCT02351817|21492|P1|NOT COMPLETED|Period 1||1
8406|NCT02351817|21491|P2|COMPLETED|Period 1||2
8407|NCT02351817|21492|P1|COMPLETED|Period 1||4
8408|NCT02351817|21491|P2|STARTED|Period 1||5
8409|NCT02351817|21492|P1|STARTED|Period 1||5
8410|NCT02351817|21491|P2|NOT COMPLETED|Baseline Period||0
8411|NCT02351817|21492|P1|NOT COMPLETED|Baseline Period||0
8412|NCT02351817|21491|P2|COMPLETED|Baseline Period||5
8413|NCT02351817|21492|P1|COMPLETED|Baseline Period||5
8414|NCT02351817|21491|P2|STARTED|Baseline Period||5
8415|NCT02351817|21492|P1|STARTED|Baseline Period||5
8416|NCT02351505|21499|P1|NOT COMPLETED|Overall Study||0
8417|NCT02351505|21499|P1|COMPLETED|Overall Study||1
8418|NCT02351505|21499|P1|STARTED|Overall Study||1
8419|NCT02350881|21510|P1|NOT COMPLETED|Overall Study||0
8420|NCT02350881|21510|P1|COMPLETED|Overall Study|64 patients were completed (6 bilateral)|64
8421|NCT02350881|21510|P1|STARTED|Overall Study|64 patients were included (6 bilateral)|64
8422|NCT02350569|21538|P1|NOT COMPLETED|Retreatment (LDV/SOF 12 Weeks)||0
8423|NCT02350569|21538|P1|COMPLETED|Retreatment (LDV/SOF 12 Weeks)||1
8424|NCT02350569|21538|P1|STARTED|Retreatment (LDV/SOF 12 Weeks)|1 completed treatment (Main Study), experienced virologic failure, and entered Retreatment Phase|1
8425|NCT02350569|21538|P1|NOT COMPLETED|Main Study (LDV/SOF 4 Weeks)||0
8426|NCT02350569|21538|P1|COMPLETED|Main Study (LDV/SOF 4 Weeks)|1 participant discontinued treatment, but completed follow-up visits and study.|16
8427|NCT02350569|21538|P1|STARTED|Main Study (LDV/SOF 4 Weeks)||16
8428|NCT02349711|21550|P2|NOT COMPLETED|Overall Study||2
8429|NCT02349711|21551|P1|NOT COMPLETED|Overall Study||3
8430|NCT02349711|21550|P2|COMPLETED|Overall Study||84
8431|NCT02349711|21551|P1|COMPLETED|Overall Study||84
8432|NCT02349711|21550|P2|STARTED|Overall Study||86
8433|NCT02349711|21551|P1|STARTED|Overall Study||87
8434|NCT02349685|21566|P3|NOT COMPLETED|Overall Study||4
8435|NCT02349685|21567|P2|NOT COMPLETED|Overall Study||2
8436|NCT02349685|21568|P1|NOT COMPLETED|Overall Study||5
8437|NCT02349685|21566|P3|COMPLETED|Overall Study||37
8438|NCT02349685|21567|P2|COMPLETED|Overall Study||87
8439|NCT02349685|21568|P1|COMPLETED|Overall Study||84
8440|NCT02349685|21566|P3|STARTED|Overall Study||41
8441|NCT02349685|21567|P2|STARTED|Overall Study||89
8442|NCT02349685|21568|P1|STARTED|Overall Study||89
8443|NCT02349542|21579|P1|NOT COMPLETED|Overall Study||5
8444|NCT02349542|21579|P1|COMPLETED|Overall Study||15
8445|NCT02349542|21579|P1|STARTED|Overall Study||20
8446|NCT02349451|21588|P4|NOT COMPLETED|Overall Study||1
8447|NCT02349451|21589|P3|NOT COMPLETED|Overall Study||2
8448|NCT02349451|21590|P2|NOT COMPLETED|Overall Study||1
8449|NCT02349451|21591|P1|NOT COMPLETED|Overall Study||0
8450|NCT02349451|21588|P4|COMPLETED|Overall Study||72
8451|NCT02349451|21589|P3|COMPLETED|Overall Study||69
8452|NCT02349451|21590|P2|COMPLETED|Overall Study||71
8453|NCT02349451|21591|P1|COMPLETED|Overall Study||24
8454|NCT02349451|21588|P4|STARTED|Overall Study||73
8455|NCT02349451|21589|P3|STARTED|Overall Study||71
8456|NCT02349451|21590|P2|STARTED|Overall Study||72
8457|NCT02349451|21591|P1|STARTED|Overall Study||24
8458|NCT02349438|21627|P2|NOT COMPLETED|Period 2||0
8459|NCT02349438|21628|P1|NOT COMPLETED|Period 2||0
8460|NCT02349438|21627|P2|COMPLETED|Period 2||10
8461|NCT02349438|21628|P1|COMPLETED|Period 2||11
8462|NCT02349438|21627|P2|STARTED|Period 2||10
8463|NCT02349438|21628|P1|STARTED|Period 2||11
8464|NCT02349438|21627|P2|NOT COMPLETED|Period 1||0
8465|NCT02349438|21628|P1|NOT COMPLETED|Period 1||0
8466|NCT02349438|21627|P2|COMPLETED|Period 1||10
8467|NCT02349438|21628|P1|COMPLETED|Period 1||11
8468|NCT02349438|21627|P2|STARTED|Period 1||10
8469|NCT02349438|21628|P1|STARTED|Period 1||11
8470|NCT02349048|21640|P2|NOT COMPLETED|Overall Study||0
8471|NCT02349048|21641|P1|NOT COMPLETED|Overall Study||5
8472|NCT02349048|21640|P2|COMPLETED|Overall Study||9
8473|NCT02349048|21641|P1|COMPLETED|Overall Study||54
8474|NCT02349048|21640|P2|STARTED|Overall Study||9
8475|NCT02349048|21641|P1|STARTED|Overall Study||59
8476|NCT02348658|21661|P2|NOT COMPLETED|Period 2 (7 Days)||0
8477|NCT02348658|21662|P1|NOT COMPLETED|Period 2 (7 Days)||0
8478|NCT02348658|21661|P2|COMPLETED|Period 2 (7 Days)||6
8479|NCT02348658|21662|P1|COMPLETED|Period 2 (7 Days)||6
8480|NCT02348658|21661|P2|STARTED|Period 2 (7 Days)||6
8481|NCT02348658|21662|P1|STARTED|Period 2 (7 Days)||6
8482|NCT02348658|21661|P2|NOT COMPLETED|Washout Period (22 Days)||0
8483|NCT02348658|21662|P1|NOT COMPLETED|Washout Period (22 Days)||0
8484|NCT02348658|21661|P2|COMPLETED|Washout Period (22 Days)||6
8485|NCT02348658|21662|P1|COMPLETED|Washout Period (22 Days)||6
8486|NCT02348658|21661|P2|STARTED|Washout Period (22 Days)||6
8487|NCT02348658|21662|P1|STARTED|Washout Period (22 Days)||6
8488|NCT02348658|21661|P2|NOT COMPLETED|Period 1 (7 Days)||0
8489|NCT02348658|21662|P1|NOT COMPLETED|Period 1 (7 Days)||0
8490|NCT02348658|21661|P2|COMPLETED|Period 1 (7 Days)||6
8491|NCT02348658|21662|P1|COMPLETED|Period 1 (7 Days)||6
8492|NCT02348658|21661|P2|STARTED|Period 1 (7 Days)||6
8493|NCT02348658|21662|P1|STARTED|Period 1 (7 Days)||6
8494|NCT02347488|21696|P1|NOT COMPLETED|Overall Study||0
8495|NCT02347488|21696|P1|COMPLETED|Overall Study||30
8496|NCT02347488|21696|P1|STARTED|Overall Study||30
8497|NCT02347176|21710|P4|NOT COMPLETED|Overall Study||4
8498|NCT02347176|21711|P3|NOT COMPLETED|Overall Study||8
8499|NCT02347176|21712|P2|NOT COMPLETED|Overall Study||10
8500|NCT02347176|21713|P1|NOT COMPLETED|Overall Study||12
8501|NCT02347176|21710|P4|COMPLETED|Overall Study||48
8502|NCT02347176|21711|P3|COMPLETED|Overall Study||43
8503|NCT02347176|21712|P2|COMPLETED|Overall Study||40
8504|NCT02347176|21713|P1|COMPLETED|Overall Study||39
8505|NCT02347176|21710|P4|STARTED|Overall Study||52
8506|NCT02347176|21711|P3|STARTED|Overall Study||51
8507|NCT02347176|21712|P2|STARTED|Overall Study||50
8508|NCT02347176|21713|P1|STARTED|Overall Study||51
8509|NCT02347085|21759|P1|NOT COMPLETED|Overall Study||10
8510|NCT02347085|21759|P1|COMPLETED|Overall Study||33
8511|NCT02347085|21759|P1|Placebo MDI|Overall Study||40
8512|NCT02347085|21759|P1|GFF MDI 14.4/9.6 µg|Overall Study||40
8513|NCT02347085|21759|P1|STARTED|Overall Study||43
8514|NCT02347072|21781|P1|NOT COMPLETED|Overall Study||18
8515|NCT02347072|21781|P1|COMPLETED|Overall Study||62
8516|NCT02347072|21781|P1|Spiriva Respimat 5 µg|Overall Study||73
8517|NCT02347072|21781|P1|Placebo MDI|Overall Study||72
8518|NCT02347072|21781|P1|GFF MDI 14.4/9.6 µg|Overall Study||75
8519|NCT02347072|21781|P1|STARTED|Overall Study||80
8520|NCT02346877|21815|P2|NOT COMPLETED|Overall Study||0
8521|NCT02346877|21816|P1|NOT COMPLETED|Overall Study||19
8522|NCT02346877|21815|P2|COMPLETED|Overall Study||0
8523|NCT02346877|21816|P1|COMPLETED|Overall Study||0
8524|NCT02346877|21815|P2|STARTED|Overall Study||0
8525|NCT02346877|21816|P1|STARTED|Overall Study||19
8526|NCT02346721|21826|P1|NOT COMPLETED|Overall Study||4
8527|NCT02346721|21826|P1|COMPLETED|Overall Study||107
8528|NCT02346721|21826|P1|STARTED|Overall Study||111
8529|NCT02345720|21835|P1|NOT COMPLETED|Overall Study||0
8530|NCT02345720|21835|P1|COMPLETED|Overall Study||20
8531|NCT02345720|21835|P1|STARTED|Overall Study||20
8532|NCT02344745|21843|P2|NOT COMPLETED|Overall Study||0
8533|NCT02344745|21844|P1|NOT COMPLETED|Overall Study||2
8534|NCT02344745|21843|P2|COMPLETED|Overall Study||40
8535|NCT02344745|21844|P1|COMPLETED|Overall Study||38
8536|NCT02344745|21843|P2|STARTED|Overall Study||40
8537|NCT02344745|21844|P1|STARTED|Overall Study||40
8538|NCT02344407|21859|P3|NOT COMPLETED|Overall Study||6
8539|NCT02344407|21860|P2|NOT COMPLETED|Overall Study||9
8540|NCT02344407|21861|P1|NOT COMPLETED|Overall Study||8
8541|NCT02344407|21859|P3|COMPLETED|Overall Study||494
8542|NCT02344407|21860|P2|COMPLETED|Overall Study||491
8543|NCT02344407|21861|P1|COMPLETED|Overall Study||492
8544|NCT02344407|21859|P3|STARTED|Overall Study||500
8545|NCT02344407|21860|P2|STARTED|Overall Study||500
8546|NCT02344407|21861|P1|STARTED|Overall Study||500
8547|NCT02344342|21876|P4|NOT COMPLETED|Overall Study||10
8548|NCT02344342|21877|P3|NOT COMPLETED|Overall Study||14
8549|NCT02344342|21878|P2|NOT COMPLETED|Overall Study||9
8550|NCT02344342|21879|P1|NOT COMPLETED|Overall Study||11
8551|NCT02344342|21876|P4|COMPLETED|Overall Study||3
8552|NCT02344342|21877|P3|COMPLETED|Overall Study||0
8553|NCT02344342|21878|P2|COMPLETED|Overall Study||2
8554|NCT02344342|21879|P1|COMPLETED|Overall Study||2
8555|NCT02344342|21876|P4|STARTED|Overall Study||13
8556|NCT02344342|21877|P3|STARTED|Overall Study||14
8557|NCT02344342|21878|P2|STARTED|Overall Study||11
8558|NCT02344342|21879|P1|STARTED|Overall Study||13
8559|NCT02343380|21903|P2|NOT COMPLETED|Overall Study||0
8560|NCT02343380|21904|P1|NOT COMPLETED|Overall Study||0
8561|NCT02343380|21903|P2|COMPLETED|Overall Study|Morning test (second week)|10
8562|NCT02343380|21904|P1|COMPLETED|Overall Study|Evening test (second week)|10
8563|NCT02343380|21903|P2|STARTED|Overall Study|Evening test (first week)|10
8564|NCT02343380|21904|P1|STARTED|Overall Study|Morning test (first week)|10
8565|NCT02343159|21917|P3|NOT COMPLETED|Overall Study||30
8566|NCT02343159|21918|P2|NOT COMPLETED|Overall Study||26
8567|NCT02343159|21919|P1|NOT COMPLETED|Overall Study||26
8568|NCT02343159|21917|P3|COMPLETED|Overall Study||0
8569|NCT02343159|21918|P2|COMPLETED|Overall Study||1
8570|NCT02343159|21919|P1|COMPLETED|Overall Study||1
8571|NCT02343159|21917|P3|STARTED|Overall Study||30
8572|NCT02343159|21918|P2|STARTED|Overall Study||27
8573|NCT02343159|21919|P1|STARTED|Overall Study||27
8574|NCT02343081|21946|P2|NOT COMPLETED|Second Intervention (Day 4)||0
8575|NCT02343081|21947|P1|NOT COMPLETED|Second Intervention (Day 4)||0
8576|NCT02343081|21946|P2|COMPLETED|Second Intervention (Day 4)||8
8577|NCT02343081|21947|P1|COMPLETED|Second Intervention (Day 4)||8
8578|NCT02343081|21946|P2|Received Intervention|Second Intervention (Day 4)||8
8579|NCT02343081|21947|P1|Received Intervention|Second Intervention (Day 4)||8
8580|NCT02343081|21946|P2|STARTED|Second Intervention (Day 4)||8
8581|NCT02343081|21947|P1|STARTED|Second Intervention (Day 4)||8
8582|NCT02343081|21946|P2|NOT COMPLETED|Washout (10 Hours)||0
8583|NCT02343081|21947|P1|NOT COMPLETED|Washout (10 Hours)||0
8584|NCT02343081|21946|P2|COMPLETED|Washout (10 Hours)||8
8585|NCT02343081|21947|P1|COMPLETED|Washout (10 Hours)||8
8586|NCT02343081|21946|P2|STARTED|Washout (10 Hours)||8
8587|NCT02343081|21947|P1|STARTED|Washout (10 Hours)||8
8588|NCT02343081|21946|P2|NOT COMPLETED|First Intervention (Day 3)||0
8589|NCT02343081|21947|P1|NOT COMPLETED|First Intervention (Day 3)||0
8590|NCT02343081|21946|P2|COMPLETED|First Intervention (Day 3)||8
8591|NCT02343081|21947|P1|COMPLETED|First Intervention (Day 3)||8
8592|NCT02343081|21946|P2|Received Intervention|First Intervention (Day 3)||8
8593|NCT02343081|21947|P1|Received Intervention|First Intervention (Day 3)||8
8594|NCT02343081|21946|P2|STARTED|First Intervention (Day 3)||8
8595|NCT02343081|21947|P1|STARTED|First Intervention (Day 3)||8
8596|NCT02341859|21961|P2|NOT COMPLETED|Second Intervention (1 Day)||0
8597|NCT02341859|21962|P1|NOT COMPLETED|Second Intervention (1 Day)||0
8598|NCT02341859|21961|P2|COMPLETED|Second Intervention (1 Day)||9
8599|NCT02341859|21962|P1|COMPLETED|Second Intervention (1 Day)||10
8600|NCT02341859|21961|P2|STARTED|Second Intervention (1 Day)||9
8601|NCT02341859|21962|P1|STARTED|Second Intervention (1 Day)||10
8602|NCT02341859|21961|P2|NOT COMPLETED|First Intervention (1 Day)||0
8603|NCT02341859|21962|P1|NOT COMPLETED|First Intervention (1 Day)||0
8604|NCT02341859|21961|P2|COMPLETED|First Intervention (1 Day)||9
8605|NCT02341859|21962|P1|COMPLETED|First Intervention (1 Day)||10
8606|NCT02341859|21961|P2|STARTED|First Intervention (1 Day)||9
8607|NCT02341859|21962|P1|STARTED|First Intervention (1 Day)||10
8608|NCT02342704|22117|P2|NOT COMPLETED|Overall Study||51
8609|NCT02342704|22118|P1|NOT COMPLETED|Overall Study||53
8610|NCT02342704|22117|P2|COMPLETED|Overall Study||3
8611|NCT02342704|22118|P1|COMPLETED|Overall Study||1
8612|NCT02342704|22117|P2|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8613|NCT02342704|22118|P1|STARTED|Overall Study|Safety Population: randomized participants who received at least 1 dose of study treatment.|54
8614|NCT02342561|22144|P1|NOT COMPLETED|Overall Study||0
8615|NCT02342561|22144|P1|COMPLETED|Overall Study||20
8616|NCT02342561|22144|P1|STARTED|Overall Study||20
8617|NCT02342535|22152|P1|NOT COMPLETED|Overall Study||0
8618|NCT02342535|22152|P1|COMPLETED|Overall Study|30 women in aerobic class and 38 kids in kids exercise class|68
8619|NCT02342535|22152|P1|STARTED|Overall Study|30 women who participated in the aerobic exercise class and 38 children.|68
8620|NCT02342418|22158|P2|NOT COMPLETED|Overall Study||1
8621|NCT02342418|22159|P1|NOT COMPLETED|Overall Study||0
8622|NCT02342418|22158|P2|COMPLETED|Overall Study||9
8623|NCT02342418|22159|P1|COMPLETED|Overall Study||9
8624|NCT02342418|22158|P2|STARTED|Overall Study||10
8625|NCT02342418|22159|P1|STARTED|Overall Study||9
8626|NCT02342288|22169|P2|NOT COMPLETED|Overall Study||6
8627|NCT02342288|22170|P1|NOT COMPLETED|Overall Study||5
8628|NCT02342288|22169|P2|COMPLETED|Overall Study||27
8629|NCT02342288|22170|P1|COMPLETED|Overall Study||25
8630|NCT02342288|22169|P2|STARTED|Overall Study|various issues listed below caused removal of subjects|33
8631|NCT02342288|22170|P1|STARTED|Overall Study|16 patients were not randomized to either arm.|30
8632|NCT02342223|22176|P1|NOT COMPLETED|Overall Study||1
8633|NCT02342223|22176|P1|COMPLETED|Overall Study||19
8634|NCT02342223|22176|P1|STARTED|Overall Study||20
8635|NCT02342197|22187|P2|NOT COMPLETED|Overall Study||2
8636|NCT02342197|22188|P1|NOT COMPLETED|Overall Study||3
8637|NCT02342197|22187|P2|COMPLETED|Overall Study||28
8638|NCT02342197|22188|P1|COMPLETED|Overall Study||27
8639|NCT02342197|22187|P2|STARTED|Overall Study||30
8640|NCT02342197|22188|P1|STARTED|Overall Study||30
8641|NCT02341482|22194|P1|NOT COMPLETED|Overall Study||1
8642|NCT02341482|22194|P1|COMPLETED|Overall Study||12
8643|NCT02341482|22194|P1|STARTED|Overall Study||13
8644|NCT02341144|22222|P2|NOT COMPLETED|Overall Study||1
8645|NCT02341144|22223|P1|NOT COMPLETED|Overall Study||2
8646|NCT02341144|22222|P2|COMPLETED|Overall Study||30
8647|NCT02341144|22223|P1|COMPLETED|Overall Study||28
8648|NCT02341144|22222|P2|STARTED|Overall Study||31
8649|NCT02341144|22223|P1|STARTED|Overall Study||30
8650|NCT02340338|22244|P7|NOT COMPLETED|Overall Study||0
8651|NCT02340338|22245|P6|NOT COMPLETED|Overall Study||0
8652|NCT02340338|22246|P5|NOT COMPLETED|Overall Study||0
8653|NCT02340338|22247|P4|NOT COMPLETED|Overall Study||0
8654|NCT02340338|22248|P3|NOT COMPLETED|Overall Study||0
8655|NCT02340338|22249|P2|NOT COMPLETED|Overall Study||0
8656|NCT02340338|22250|P1|NOT COMPLETED|Overall Study||0
8657|NCT02340338|22244|P7|COMPLETED|Overall Study||12
8658|NCT02340338|22245|P6|COMPLETED|Overall Study|1 withdrew voluntarily after the first immunization; safety and serum assessment completed.|9
8659|NCT02340338|22246|P5|COMPLETED|Overall Study||9
8660|NCT02340338|22247|P4|COMPLETED|Overall Study||9
8661|NCT02340338|22248|P3|COMPLETED|Overall Study||3
8662|NCT02340338|22249|P2|COMPLETED|Overall Study||2
8663|NCT02340338|22250|P1|COMPLETED|Overall Study||2
8664|NCT02340338|22244|P7|STARTED|Overall Study|Placebos were randomly assigned to dose groups 1-6, included in the 46 participants.|12
8665|NCT02340338|22245|P6|STARTED|Overall Study|9 vaccine + 3 placebo|9
8666|NCT02340338|22246|P5|STARTED|Overall Study|9 vaccine + 3 placebo|9
8667|NCT02340338|22247|P4|STARTED|Overall Study|9 vaccine + 3 placebo|9
8668|NCT02340338|22248|P3|STARTED|Overall Study|3 vaccine + 1 placebo|3
8669|NCT02340338|22249|P2|STARTED|Overall Study|2 vaccine + 1 placebo|2
8670|NCT02340338|22250|P1|STARTED|Overall Study|2 vaccine + 1 placebo|2
8671|NCT02340104|22273|P1|NOT COMPLETED|Overall Study||0
8672|NCT02340104|22273|P1|COMPLETED|Overall Study||8
8673|NCT02340104|22273|P1|STARTED|Overall Study||8
8674|NCT02340000|22280|P2|NOT COMPLETED|Time Period 2||15
8675|NCT02340000|22281|P1|NOT COMPLETED|Time Period 2||19
8676|NCT02340000|22280|P2|COMPLETED|Time Period 2||52
8677|NCT02340000|22281|P1|COMPLETED|Time Period 2||50
8678|NCT02340000|22280|P2|STARTED|Time Period 2||67
8679|NCT02340000|22281|P1|STARTED|Time Period 2||69
8680|NCT02340000|22280|P2|NOT COMPLETED|Time Period 1||15
8681|NCT02340000|22281|P1|NOT COMPLETED|Time Period 1||12
8682|NCT02340000|22280|P2|COMPLETED|Time Period 1||74
8683|NCT02340000|22281|P1|COMPLETED|Time Period 1||78
8684|NCT02340000|22280|P2|STARTED|Time Period 1||89
8685|NCT02340000|22281|P1|STARTED|Time Period 1||90
8686|NCT02339831|22310|P2|NOT COMPLETED|Overall Study||7
8687|NCT02339831|22311|P1|NOT COMPLETED|Overall Study||20
8688|NCT02339831|22310|P2|COMPLETED|Overall Study||45
8689|NCT02339831|22311|P1|COMPLETED|Overall Study||38
8690|NCT02339831|22310|P2|Lost to Follow Up|Overall Study||7
8691|NCT02339831|22311|P1|Lost to Follow Up|Overall Study||20
8692|NCT02339831|22310|P2|STARTED|Overall Study||52
8693|NCT02339831|22311|P1|STARTED|Overall Study||58
8694|NCT02339246|22335|P3|NOT COMPLETED|Third Period (7 Days)||0
8695|NCT02339246|22336|P2|NOT COMPLETED|Third Period (7 Days)||0
8696|NCT02339246|22337|P1|NOT COMPLETED|Third Period (7 Days)||0
8697|NCT02339246|22335|P3|COMPLETED|Third Period (7 Days)||0
8698|NCT02339246|22336|P2|COMPLETED|Third Period (7 Days)||16
8699|NCT02339246|22337|P1|COMPLETED|Third Period (7 Days)||15
8700|NCT02339246|22335|P3|STARTED|Third Period (7 Days)||0
8701|NCT02339246|22336|P2|STARTED|Third Period (7 Days)||16
8702|NCT02339246|22337|P1|STARTED|Third Period (7 Days)||15
8703|NCT02339246|22335|P3|NOT COMPLETED|Second Intervention (7 Days)||0
8704|NCT02339246|22336|P2|NOT COMPLETED|Second Intervention (7 Days)||0
8705|NCT02339246|22337|P1|NOT COMPLETED|Second Intervention (7 Days)||0
8706|NCT02339246|22335|P3|COMPLETED|Second Intervention (7 Days)||0
8707|NCT02339246|22336|P2|COMPLETED|Second Intervention (7 Days)||15
8708|NCT02339246|22337|P1|COMPLETED|Second Intervention (7 Days)||16
8709|NCT02339246|22335|P3|STARTED|Second Intervention (7 Days)||0
8710|NCT02339246|22336|P2|STARTED|Second Intervention (7 Days)||15
8711|NCT02339246|22337|P1|STARTED|Second Intervention (7 Days)||16
8712|NCT02339246|22335|P3|NOT COMPLETED|First Intervention (7 Days)||0
8713|NCT02339246|22336|P2|NOT COMPLETED|First Intervention (7 Days)||0
8714|NCT02339246|22337|P1|NOT COMPLETED|First Intervention (7 Days)||0
8715|NCT02339246|22335|P3|COMPLETED|First Intervention (7 Days)||31
8716|NCT02339246|22336|P2|COMPLETED|First Intervention (7 Days)||0
8717|NCT02339246|22337|P1|COMPLETED|First Intervention (7 Days)||0
8718|NCT02339246|22335|P3|STARTED|First Intervention (7 Days)||31
8719|NCT02339246|22336|P2|STARTED|First Intervention (7 Days)||0
8720|NCT02339246|22337|P1|STARTED|First Intervention (7 Days)||0
8721|NCT02339038|22351|P1|NOT COMPLETED|Overall Study||600
8722|NCT02339038|22351|P1|COMPLETED|Overall Study||0
8723|NCT02339038|22351|P1|STARTED|Overall Study||600
8724|NCT02338713|22355|P1|NOT COMPLETED|Overall Study||0
8725|NCT02338713|22355|P1|COMPLETED|Overall Study||27
8726|NCT02338713|22355|P1|STARTED|Overall Study||27
8727|NCT02338336|22379|P4|NOT COMPLETED|Overall Study||0
8728|NCT02338336|22380|P3|NOT COMPLETED|Overall Study||0
8729|NCT02338336|22381|P2|NOT COMPLETED|Overall Study||0
8730|NCT02338336|22382|P1|NOT COMPLETED|Overall Study||2
8731|NCT02338336|22379|P4|COMPLETED|Overall Study||4
8732|NCT02338336|22380|P3|COMPLETED|Overall Study||7
8733|NCT02338336|22381|P2|COMPLETED|Overall Study||17
8734|NCT02338336|22382|P1|COMPLETED|Overall Study||24
8735|NCT02338336|22379|P4|STARTED|Overall Study||4
8736|NCT02338336|22380|P3|STARTED|Overall Study||7
8737|NCT02338336|22381|P2|STARTED|Overall Study||17
8738|NCT02338336|22382|P1|STARTED|Overall Study||26
8739|NCT02338076|22390|P1|NOT COMPLETED|Overall Study||0
8740|NCT02338076|22390|P1|COMPLETED|Overall Study||20
8741|NCT02338076|22390|P1|STARTED|Overall Study||20
8742|NCT02337959|22408|P3|NOT COMPLETED|Overall Study||0
8743|NCT02337959|22409|P2|NOT COMPLETED|Overall Study||3
8744|NCT02337959|22410|P1|NOT COMPLETED|Overall Study||0
8745|NCT02337959|22408|P3|COMPLETED|Overall Study||7
8746|NCT02337959|22409|P2|COMPLETED|Overall Study||7
8747|NCT02337959|22410|P1|COMPLETED|Overall Study||10
8748|NCT02337959|22408|P3|STARTED|Overall Study||7
8749|NCT02337959|22409|P2|STARTED|Overall Study||10
8750|NCT02337959|22410|P1|STARTED|Overall Study||10
8751|NCT02337062|22420|P2|NOT COMPLETED|Overall Study||19
8752|NCT02337062|22421|P1|NOT COMPLETED|Overall Study||17
8753|NCT02337062|22420|P2|COMPLETED|Overall Study||556
8754|NCT02337062|22421|P1|COMPLETED|Overall Study||555
8755|NCT02337062|22420|P2|STARTED|Overall Study||575
8756|NCT02337062|22421|P1|STARTED|Overall Study||572
8757|NCT02336958|22429|P2|NOT COMPLETED|Overall Study||0
8758|NCT02336958|22430|P1|NOT COMPLETED|Overall Study||0
8759|NCT02336958|22429|P2|COMPLETED|Overall Study||20
8760|NCT02336958|22430|P1|COMPLETED|Overall Study||20
8761|NCT02336958|22429|P2|STARTED|Overall Study||20
8762|NCT02336958|22430|P1|STARTED|Overall Study||20
8763|NCT02336763|22438|P1|NOT COMPLETED|Overall Study||0
8764|NCT02336763|22438|P1|COMPLETED|Overall Study||2
8765|NCT02336763|22438|P1|STARTED|Overall Study||2
8766|NCT02336607|22452|P4|NOT COMPLETED|Overall Study||87
8767|NCT02336607|22453|P3|NOT COMPLETED|Overall Study||6
8768|NCT02336607|22454|P2|NOT COMPLETED|Overall Study||10
8769|NCT02336607|22455|P1|NOT COMPLETED|Overall Study||4
8770|NCT02336607|22452|P4|COMPLETED|Overall Study||180
8771|NCT02336607|22453|P3|COMPLETED|Overall Study||86
8772|NCT02336607|22454|P2|COMPLETED|Overall Study||75
8773|NCT02336607|22455|P1|COMPLETED|Overall Study||81
8774|NCT02336607|22452|P4|Patients Included in Safety Population|Overall Study||260
8775|NCT02336607|22453|P3|Patients Included in Safety Population|Overall Study||92
8776|NCT02336607|22454|P2|Patients Included in Safety Population|Overall Study||85
8777|NCT02336607|22455|P1|Patients Included in Safety Population|Overall Study||85
8778|NCT02336607|22452|P4|Patients Included in PP Population|Overall Study||162
8779|NCT02336607|22453|P3|Patients Included in PP Population|Overall Study||75
8780|NCT02336607|22454|P2|Patients Included in PP Population|Overall Study||75
8781|NCT02336607|22455|P1|Patients Included in PP Population|Overall Study||78
8782|NCT02336607|22452|P4|Patients Included in ITT Population|Overall Study||222
8783|NCT02336607|22453|P3|Patients Included in ITT Population|Overall Study||91
8784|NCT02336607|22454|P2|Patients Included in ITT Population|Overall Study||84
8785|NCT02336607|22455|P1|Patients Included in ITT Population|Overall Study||84
8786|NCT02336607|22452|P4|STARTED|Overall Study||267
8787|NCT02336607|22453|P3|STARTED|Overall Study||92
8788|NCT02336607|22454|P2|STARTED|Overall Study||85
8789|NCT02336607|22455|P1|STARTED|Overall Study||85
8790|NCT02336438|22509|P1|NOT COMPLETED|Overall Study||1
8791|NCT02336438|22509|P1|COMPLETED|Overall Study||10
8792|NCT02336438|22509|P1|STARTED|Overall Study||11
8793|NCT02336425|22522|P4|NOT COMPLETED|Overall Study||3
8794|NCT02336425|22523|P3|NOT COMPLETED|Overall Study||3
8795|NCT02336425|22524|P2|NOT COMPLETED|Overall Study||2
8796|NCT02336425|22525|P1|NOT COMPLETED|Overall Study||2
8797|NCT02336425|22522|P4|COMPLETED|Overall Study||0
8798|NCT02336425|22523|P3|COMPLETED|Overall Study||0
8799|NCT02336425|22524|P2|COMPLETED|Overall Study||0
8800|NCT02336425|22525|P1|COMPLETED|Overall Study||0
8801|NCT02336425|22522|P4|STARTED|Overall Study||3
8802|NCT02336425|22523|P3|STARTED|Overall Study||3
8803|NCT02336425|22524|P2|STARTED|Overall Study||2
8804|NCT02336425|22525|P1|STARTED|Overall Study||2
8805|NCT02336178|22575|P1|NOT COMPLETED|Overall Study||4
8806|NCT02336178|22575|P1|COMPLETED|Overall Study||66
8807|NCT02336178|22575|P1|STARTED|Overall Study||70
8808|NCT02335710|22663|P2|NOT COMPLETED|Overall Study||0
8809|NCT02335710|22664|P1|NOT COMPLETED|Overall Study||0
8810|NCT02335710|22663|P2|COMPLETED|Overall Study||10
8811|NCT02335710|22664|P1|COMPLETED|Overall Study||40
8812|NCT02335710|22663|P2|STARTED|Overall Study||10
8813|NCT02335710|22664|P1|STARTED|Overall Study||40
8814|NCT02335502|22684|P1|NOT COMPLETED|Overall Study||17
8815|NCT02335502|22684|P1|COMPLETED|Overall Study||49
8816|NCT02335502|22684|P1|Receiving Permanent System|Overall Study||56
8817|NCT02335502|22684|P1|Received Trial System|Overall Study||65
8818|NCT02335502|22684|P1|STARTED|Overall Study||66
8819|NCT02335489|22689|P1|NOT COMPLETED|Overall Study||10
8820|NCT02335489|22689|P1|COMPLETED|Overall Study||0
8821|NCT02335489|22689|P1|Receiving Permanent System|Overall Study||8
8822|NCT02335489|22689|P1|Received Trial System|Overall Study||9
8823|NCT02335489|22689|P1|STARTED|Overall Study||10
8824|NCT02334982|22700|P7|NOT COMPLETED|Overall Study||0
8825|NCT02334982|22701|P6|NOT COMPLETED|Overall Study||0
8826|NCT02334982|22702|P5|NOT COMPLETED|Overall Study||0
8827|NCT02334982|22703|P4|NOT COMPLETED|Overall Study||0
8828|NCT02334982|22704|P3|NOT COMPLETED|Overall Study||0
8829|NCT02334982|22705|P2|NOT COMPLETED|Overall Study||0
8830|NCT02334982|22706|P1|NOT COMPLETED|Overall Study||0
8831|NCT02334982|22700|P7|COMPLETED|Overall Study||12
8832|NCT02334982|22701|P6|COMPLETED|Overall Study||6
8833|NCT02334982|22702|P5|COMPLETED|Overall Study||6
8834|NCT02334982|22703|P4|COMPLETED|Overall Study||6
8835|NCT02334982|22704|P3|COMPLETED|Overall Study||6
8836|NCT02334982|22705|P2|COMPLETED|Overall Study||5
8837|NCT02334982|22706|P1|COMPLETED|Overall Study||6
8838|NCT02334982|22700|P7|STARTED|Overall Study||12
8839|NCT02334982|22701|P6|STARTED|Overall Study||6
8840|NCT02334982|22702|P5|STARTED|Overall Study||6
8841|NCT02334982|22703|P4|STARTED|Overall Study||6
8842|NCT02334982|22704|P3|STARTED|Overall Study||6
8843|NCT02334982|22705|P2|STARTED|Overall Study||5
8844|NCT02334982|22706|P1|STARTED|Overall Study||6
8845|NCT02334813|22812|P2|NOT COMPLETED|Overall Study||1
8846|NCT02334813|22813|P1|NOT COMPLETED|Overall Study||3
8847|NCT02334813|22812|P2|COMPLETED|Overall Study||13
8848|NCT02334813|22813|P1|COMPLETED|Overall Study||9
8849|NCT02334813|22812|P2|STARTED|Overall Study||14
8850|NCT02334813|22813|P1|STARTED|Overall Study||12
8851|NCT02334787|22823|P4|NOT COMPLETED|Overall Study||0
8852|NCT02334787|22824|P3|NOT COMPLETED|Overall Study||0
8853|NCT02334787|22825|P2|NOT COMPLETED|Overall Study||0
8854|NCT02334787|22826|P1|NOT COMPLETED|Overall Study||0
8855|NCT02334787|22823|P4|COMPLETED|Overall Study||8
8856|NCT02334787|22824|P3|COMPLETED|Overall Study||8
8857|NCT02334787|22825|P2|COMPLETED|Overall Study||8
8858|NCT02334787|22826|P1|COMPLETED|Overall Study||8
8859|NCT02334787|22823|P4|STARTED|Overall Study||8
8860|NCT02334787|22824|P3|STARTED|Overall Study||8
8861|NCT02334787|22825|P2|STARTED|Overall Study||8
8862|NCT02334787|22826|P1|STARTED|Overall Study||8
8863|NCT02334267|22850|P2|NOT COMPLETED|Overall Study||0
8864|NCT02334267|22851|P1|NOT COMPLETED|Overall Study||1
8865|NCT02334267|22850|P2|COMPLETED|Overall Study||5
8866|NCT02334267|22851|P1|COMPLETED|Overall Study||5
8867|NCT02334267|22850|P2|STARTED|Overall Study||5
8868|NCT02334267|22851|P1|STARTED|Overall Study||6
8869|NCT02332902|22863|P1|NOT COMPLETED|Overall Study||7
8870|NCT02332902|22863|P1|COMPLETED|Overall Study||17
8871|NCT02332902|22863|P1|STARTED|Overall Study||24
8872|NCT02332798|22871|P3|NOT COMPLETED|Overall Study||1
8873|NCT02332798|22872|P2|NOT COMPLETED|Overall Study||2
8874|NCT02332798|22873|P1|NOT COMPLETED|Overall Study||1
8875|NCT02332798|22871|P3|COMPLETED|Overall Study||11
8876|NCT02332798|22872|P2|COMPLETED|Overall Study||12
8877|NCT02332798|22873|P1|COMPLETED|Overall Study||12
8878|NCT02332798|22871|P3|STARTED|Overall Study||12
8879|NCT02332798|22872|P2|STARTED|Overall Study||14
8880|NCT02332798|22873|P1|STARTED|Overall Study||13
8881|NCT02332590|22925|P2|NOT COMPLETED|Overall Study||19
8882|NCT02332590|22926|P1|NOT COMPLETED|Overall Study||29
8883|NCT02332590|22925|P2|COMPLETED|Overall Study|All 165 participants entered open-label treatment period.|165
8884|NCT02332590|22926|P1|COMPLETED|Overall Study|155 participants entered open-label treatment period and 1 did not enroll.|156
8885|NCT02332590|22925|P2|Treated|Overall Study||184
8886|NCT02332590|22926|P1|Treated|Overall Study||184
8887|NCT02332590|22925|P2|STARTED|Overall Study||184
8888|NCT02332590|22926|P1|STARTED|Overall Study||185
8889|NCT02331940|22990|P2|NOT COMPLETED|Overall Study||5
8890|NCT02331940|22991|P1|NOT COMPLETED|Overall Study||7
8891|NCT02331940|22990|P2|COMPLETED|Overall Study||95
8892|NCT02331940|22991|P1|COMPLETED|Overall Study||93
8893|NCT02331940|22990|P2|STARTED|Overall Study||100
8894|NCT02331940|22991|P1|STARTED|Overall Study||100
8895|NCT02331589|23005|P2|NOT COMPLETED|Overall Study||5
8896|NCT02331589|23006|P1|NOT COMPLETED|Overall Study||5
8897|NCT02331589|23005|P2|COMPLETED|Overall Study||31
8898|NCT02331589|23006|P1|COMPLETED|Overall Study||34
8899|NCT02331589|23005|P2|STARTED|Overall Study||36
8900|NCT02331589|23006|P1|STARTED|Overall Study||39
8901|NCT02331446|23022|P4|NOT COMPLETED|Overall Study||3
8902|NCT02331446|23023|P3|NOT COMPLETED|Overall Study||3
8903|NCT02331446|23024|P2|NOT COMPLETED|Overall Study||5
8904|NCT02331446|23025|P1|NOT COMPLETED|Overall Study||4
8905|NCT02331446|23022|P4|COMPLETED|Overall Study||8
8906|NCT02331446|23023|P3|COMPLETED|Overall Study||8
8907|NCT02331446|23024|P2|COMPLETED|Overall Study||6
8908|NCT02331446|23025|P1|COMPLETED|Overall Study||5
8909|NCT02331446|23022|P4|STARTED|Overall Study||11
8910|NCT02331446|23023|P3|STARTED|Overall Study||11
8911|NCT02331446|23024|P2|STARTED|Overall Study||11
8912|NCT02331446|23025|P1|STARTED|Overall Study||9
8913|NCT02331108|23101|P6|NOT COMPLETED|Overall Study||2
8914|NCT02331108|23102|P5|NOT COMPLETED|Overall Study||2
8915|NCT02331108|23103|P4|NOT COMPLETED|Overall Study||1
8916|NCT02331108|23104|P3|NOT COMPLETED|Overall Study||1
8917|NCT02331108|23105|P2|NOT COMPLETED|Overall Study||2
8918|NCT02331108|23106|P1|NOT COMPLETED|Overall Study||1
8919|NCT02331108|23101|P6|COMPLETED|Overall Study||50
8920|NCT02331108|23102|P5|COMPLETED|Overall Study||50
8921|NCT02331108|23103|P4|COMPLETED|Overall Study||50
8922|NCT02331108|23104|P3|COMPLETED|Overall Study||50
8923|NCT02331108|23105|P2|COMPLETED|Overall Study||50
8924|NCT02331108|23106|P1|COMPLETED|Overall Study||50
8925|NCT02331108|23101|P6|STARTED|Overall Study||52
8926|NCT02331108|23102|P5|STARTED|Overall Study||52
8927|NCT02331108|23103|P4|STARTED|Overall Study||51
8928|NCT02331108|23104|P3|STARTED|Overall Study||51
8929|NCT02331108|23105|P2|STARTED|Overall Study||52
8930|NCT02331108|23106|P1|STARTED|Overall Study||51
8931|NCT02330588|23133|P5|NOT COMPLETED|Overall Study||19
8932|NCT02330588|23134|P4|NOT COMPLETED|Overall Study||22
8933|NCT02330588|23135|P3|NOT COMPLETED|Overall Study||15
8934|NCT02330588|23136|P2|NOT COMPLETED|Overall Study||18
8935|NCT02330588|23137|P1|NOT COMPLETED|Overall Study||16
8936|NCT02330588|23133|P5|COMPLETED|Overall Study||28
8937|NCT02330588|23134|P4|COMPLETED|Overall Study||24
8938|NCT02330588|23135|P3|COMPLETED|Overall Study||31
8939|NCT02330588|23136|P2|COMPLETED|Overall Study||25
8940|NCT02330588|23137|P1|COMPLETED|Overall Study||28
8941|NCT02330588|23133|P5|STARTED|Overall Study||47
8942|NCT02330588|23134|P4|STARTED|Overall Study||46
8943|NCT02330588|23135|P3|STARTED|Overall Study||46
8944|NCT02330588|23136|P2|STARTED|Overall Study||43
8945|NCT02330588|23137|P1|STARTED|Overall Study||44
8946|NCT02330523|23164|P2|NOT COMPLETED|Overall Study||0
8947|NCT02330523|23165|P1|NOT COMPLETED|Overall Study||0
8948|NCT02330523|23164|P2|COMPLETED|Overall Study||19
8949|NCT02330523|23165|P1|COMPLETED|Overall Study||21
8950|NCT02330523|23164|P2|STARTED|Overall Study||19
8951|NCT02330523|23165|P1|STARTED|Overall Study||21
8952|NCT02330276|23178|P3|NOT COMPLETED|Overall Study||0
8953|NCT02330276|23179|P2|NOT COMPLETED|Overall Study||0
8954|NCT02330276|23180|P1|NOT COMPLETED|Overall Study||0
8955|NCT02330276|23178|P3|COMPLETED|Overall Study||4
8956|NCT02330276|23179|P2|COMPLETED|Overall Study||4
8957|NCT02330276|23180|P1|COMPLETED|Overall Study||4
8958|NCT02330276|23178|P3|STARTED|Overall Study||4
8959|NCT02330276|23179|P2|STARTED|Overall Study||4
8960|NCT02330276|23180|P1|STARTED|Overall Study||4
8961|NCT02330172|23202|P2|NOT COMPLETED|Overall Study||1
8962|NCT02330172|23203|P1|NOT COMPLETED|Overall Study||3
8963|NCT02330172|23202|P2|COMPLETED|Overall Study||21
8964|NCT02330172|23203|P1|COMPLETED|Overall Study||19
8965|NCT02330172|23202|P2|STARTED|Overall Study||22
8966|NCT02330172|23203|P1|STARTED|Overall Study||22
8967|NCT02329964|23213|P2|NOT COMPLETED|Overall Study||0
8968|NCT02329964|23214|P1|NOT COMPLETED|Overall Study||0
8969|NCT02329964|23213|P2|COMPLETED|Overall Study||40
8970|NCT02329964|23214|P1|COMPLETED|Overall Study||40
8971|NCT02329964|23213|P2|STARTED|Overall Study||40
8972|NCT02329964|23214|P1|STARTED|Overall Study||40
8973|NCT02329730|23240|P12|NOT COMPLETED|Overall Study||0
8974|NCT02329730|23241|P11|NOT COMPLETED|Overall Study||0
8975|NCT02329730|23242|P10|NOT COMPLETED|Overall Study||1
8976|NCT02329730|23243|P9|NOT COMPLETED|Overall Study||1
8977|NCT02329730|23244|P8|NOT COMPLETED|Overall Study||1
8978|NCT02329730|23245|P7|NOT COMPLETED|Overall Study||1
8979|NCT02329730|23246|P6|NOT COMPLETED|Overall Study||2
8980|NCT02329730|23247|P5|NOT COMPLETED|Overall Study||3
8981|NCT02329730|23248|P4|NOT COMPLETED|Overall Study||0
8982|NCT02329730|23249|P3|NOT COMPLETED|Overall Study||0
8983|NCT02329730|23250|P2|NOT COMPLETED|Overall Study||0
8984|NCT02329730|23251|P1|NOT COMPLETED|Overall Study||0
8985|NCT02329730|23240|P12|COMPLETED|Overall Study||8
8986|NCT02329730|23241|P11|COMPLETED|Overall Study||8
8987|NCT02329730|23242|P10|COMPLETED|Overall Study||7
8988|NCT02329730|23243|P9|COMPLETED|Overall Study||7
8989|NCT02329730|23244|P8|COMPLETED|Overall Study||13
8990|NCT02329730|23245|P7|COMPLETED|Overall Study||13
8991|NCT02329730|23246|P6|COMPLETED|Overall Study||12
8992|NCT02329730|23247|P5|COMPLETED|Overall Study||11
8993|NCT02329730|23248|P4|COMPLETED|Overall Study||14
8994|NCT02329730|23249|P3|COMPLETED|Overall Study||14
8995|NCT02329730|23250|P2|COMPLETED|Overall Study||14
8996|NCT02329730|23251|P1|COMPLETED|Overall Study||14
8997|NCT02329730|23240|P12|STARTED|Overall Study||8
8998|NCT02329730|23241|P11|STARTED|Overall Study||8
8999|NCT02329730|23242|P10|STARTED|Overall Study||8
9000|NCT02329730|23243|P9|STARTED|Overall Study||8
9001|NCT02329730|23244|P8|STARTED|Overall Study||14
9002|NCT02329730|23245|P7|STARTED|Overall Study||14
9003|NCT02329730|23246|P6|STARTED|Overall Study||14
9004|NCT02329730|23247|P5|STARTED|Overall Study||14
9005|NCT02329730|23248|P4|STARTED|Overall Study||14
9006|NCT02329730|23249|P3|STARTED|Overall Study||14
9007|NCT02329730|23250|P2|STARTED|Overall Study||14
9008|NCT02329730|23251|P1|STARTED|Overall Study||14
9009|NCT02329600|23328|P3|NOT COMPLETED|Overall Study||0
9010|NCT02329600|23329|P2|NOT COMPLETED|Overall Study||0
9011|NCT02329600|23330|P1|NOT COMPLETED|Overall Study||0
9012|NCT02329600|23328|P3|COMPLETED|Overall Study||15
9013|NCT02329600|23329|P2|COMPLETED|Overall Study||15
9014|NCT02329600|23330|P1|COMPLETED|Overall Study||10
9015|NCT02329600|23328|P3|STARTED|Overall Study||15
9016|NCT02329600|23329|P2|STARTED|Overall Study||15
9017|NCT02329600|23330|P1|STARTED|Overall Study||10
9018|NCT02329431|23343|P2|NOT COMPLETED|Overall Study||13
9019|NCT02329431|23344|P1|NOT COMPLETED|Overall Study||20
9020|NCT02329431|23343|P2|COMPLETED|Overall Study||76
9021|NCT02329431|23344|P1|COMPLETED|Overall Study||72
9022|NCT02329431|23343|P2|Baseline Interview|Overall Study||85
9023|NCT02329431|23344|P1|Baseline Interview|Overall Study||87
9024|NCT02329431|23343|P2|STARTED|Overall Study||89
9025|NCT02329431|23344|P1|STARTED|Overall Study||92
9026|NCT02329223|23363|P3|NOT COMPLETED|Overall Study||6
9027|NCT02329223|23364|P2|NOT COMPLETED|Overall Study||3
9028|NCT02329223|23365|P1|NOT COMPLETED|Overall Study||1
9029|NCT02329223|23363|P3|COMPLETED|Overall Study||68
9030|NCT02329223|23364|P2|COMPLETED|Overall Study||68
9031|NCT02329223|23365|P1|COMPLETED|Overall Study||72
9032|NCT02329223|23363|P3|Safety Set|Overall Study||74
9033|NCT02329223|23364|P2|Safety Set|Overall Study||71
9034|NCT02329223|23365|P1|Safety Set|Overall Study||73
9035|NCT02329223|23363|P3|Full Analysis Set|Overall Study||74
9036|NCT02329223|23364|P2|Full Analysis Set|Overall Study||70
9037|NCT02329223|23365|P1|Full Analysis Set|Overall Study||73
9038|NCT02329223|23363|P3|STARTED|Overall Study||74
9039|NCT02329223|23364|P2|STARTED|Overall Study||71
9040|NCT02329223|23365|P1|STARTED|Overall Study||73
9041|NCT02329015|23398|P2|NOT COMPLETED|Overall Study||0
9042|NCT02329015|23399|P1|NOT COMPLETED|Overall Study||0
9043|NCT02329015|23398|P2|COMPLETED|Overall Study||64
9044|NCT02329015|23399|P1|COMPLETED|Overall Study||48
9045|NCT02329015|23398|P2|STARTED|Overall Study||64
9046|NCT02329015|23399|P1|STARTED|Overall Study||48
9047|NCT02328937|23415|P6|NOT COMPLETED|Period 3||0
9048|NCT02328937|23416|P5|NOT COMPLETED|Period 3||0
9049|NCT02328937|23417|P4|NOT COMPLETED|Period 3||0
9050|NCT02328937|23418|P3|NOT COMPLETED|Period 3||0
9051|NCT02328937|23419|P2|NOT COMPLETED|Period 3||0
9052|NCT02328937|23420|P1|NOT COMPLETED|Period 3||0
9053|NCT02328937|23415|P6|COMPLETED|Period 3||6
9054|NCT02328937|23416|P5|COMPLETED|Period 3||6
9055|NCT02328937|23417|P4|COMPLETED|Period 3||5
9056|NCT02328937|23418|P3|COMPLETED|Period 3||6
9057|NCT02328937|23419|P2|COMPLETED|Period 3||6
9058|NCT02328937|23420|P1|COMPLETED|Period 3||7
9059|NCT02328937|23415|P6|STARTED|Period 3||6
9060|NCT02328937|23416|P5|STARTED|Period 3||6
9061|NCT02328937|23417|P4|STARTED|Period 3||5
9062|NCT02328937|23418|P3|STARTED|Period 3||6
9063|NCT02328937|23419|P2|STARTED|Period 3||6
9064|NCT02328937|23420|P1|STARTED|Period 3||7
9065|NCT02328937|23415|P6|NOT COMPLETED|Period 2||0
9066|NCT02328937|23416|P5|NOT COMPLETED|Period 2||0
9067|NCT02328937|23417|P4|NOT COMPLETED|Period 2||0
9068|NCT02328937|23418|P3|NOT COMPLETED|Period 2||1
9069|NCT02328937|23419|P2|NOT COMPLETED|Period 2||0
9070|NCT02328937|23420|P1|NOT COMPLETED|Period 2||0
9071|NCT02328937|23415|P6|COMPLETED|Period 2||6
9072|NCT02328937|23416|P5|COMPLETED|Period 2||6
9073|NCT02328937|23417|P4|COMPLETED|Period 2||5
9074|NCT02328937|23418|P3|COMPLETED|Period 2||6
9075|NCT02328937|23419|P2|COMPLETED|Period 2||6
9076|NCT02328937|23420|P1|COMPLETED|Period 2||7
9077|NCT02328937|23415|P6|STARTED|Period 2||6
9078|NCT02328937|23416|P5|STARTED|Period 2||6
9079|NCT02328937|23417|P4|STARTED|Period 2||5
9080|NCT02328937|23418|P3|STARTED|Period 2||7
9081|NCT02328937|23419|P2|STARTED|Period 2||6
9082|NCT02328937|23420|P1|STARTED|Period 2||7
9083|NCT02328937|23415|P6|NOT COMPLETED|Period 1||0
9084|NCT02328937|23416|P5|NOT COMPLETED|Period 1||0
9085|NCT02328937|23417|P4|NOT COMPLETED|Period 1||1
9086|NCT02328937|23418|P3|NOT COMPLETED|Period 1||0
9087|NCT02328937|23419|P2|NOT COMPLETED|Period 1||0
9088|NCT02328937|23420|P1|NOT COMPLETED|Period 1||0
9089|NCT02328937|23415|P6|COMPLETED|Period 1||6
9090|NCT02328937|23416|P5|COMPLETED|Period 1||6
9091|NCT02328937|23417|P4|COMPLETED|Period 1||5
9092|NCT02328937|23418|P3|COMPLETED|Period 1||7
9093|NCT02328937|23419|P2|COMPLETED|Period 1||6
9094|NCT02328937|23420|P1|COMPLETED|Period 1||7
9095|NCT02328937|23415|P6|STARTED|Period 1||6
9096|NCT02328937|23416|P5|STARTED|Period 1||6
9097|NCT02328937|23417|P4|STARTED|Period 1||6
9098|NCT02328937|23418|P3|STARTED|Period 1||7
9099|NCT02328937|23419|P2|STARTED|Period 1||6
9100|NCT02328937|23420|P1|STARTED|Period 1||7
9101|NCT02328404|23433|P2|NOT COMPLETED|Overall Study||1
9102|NCT02328404|23434|P1|NOT COMPLETED|Overall Study||1
9103|NCT02328404|23433|P2|COMPLETED|Overall Study||29
9104|NCT02328404|23434|P1|COMPLETED|Overall Study||29
9105|NCT02328404|23433|P2|STARTED|Overall Study||30
9106|NCT02328404|23434|P1|STARTED|Overall Study||30
9107|NCT02327429|23468|P1|NOT COMPLETED|Overall Study||2
9108|NCT02327429|23468|P1|COMPLETED|Overall Study||17
9109|NCT02327429|23468|P1|STARTED|Overall Study||19
9110|NCT02327117|23490|P2|NOT COMPLETED|Overall Study||0
9111|NCT02327117|23491|P1|NOT COMPLETED|Overall Study||0
9112|NCT02327117|23490|P2|COMPLETED|Overall Study||45
9113|NCT02327117|23491|P1|COMPLETED|Overall Study||45
9114|NCT02327117|23490|P2|STARTED|Overall Study||45
9115|NCT02327117|23491|P1|STARTED|Overall Study||45
9116|NCT02326844|23497|P1|NOT COMPLETED|Overall Study||0
9117|NCT02326844|23497|P1|COMPLETED|Overall Study||3
9118|NCT02326844|23497|P1|STARTED|Overall Study||3
9119|NCT02326649|23504|P1|NOT COMPLETED|Overall Study||12
9120|NCT02326649|23504|P1|COMPLETED|Overall Study||21
9121|NCT02326649|23504|P1|STARTED|Overall Study||33
9122|NCT02325856|23510|P2|NOT COMPLETED|Overall Study||27
9123|NCT02325856|23511|P1|NOT COMPLETED|Overall Study||20
9124|NCT02325856|23510|P2|COMPLETED|Overall Study||123
9125|NCT02325856|23511|P1|COMPLETED|Overall Study||128
9126|NCT02325856|23510|P2|STARTED|Overall Study||150
9127|NCT02325856|23511|P1|STARTED|Overall Study||148
9128|NCT02325713|23535|P16|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9129|NCT02325713|23536|P15|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9130|NCT02325713|23537|P14|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9131|NCT02325713|23538|P13|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9132|NCT02325713|23539|P12|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9133|NCT02325713|23540|P11|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9134|NCT02325713|23541|P10|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9135|NCT02325713|23542|P9|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9136|NCT02325713|23543|P8|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9137|NCT02325713|23544|P7|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9138|NCT02325713|23545|P6|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9139|NCT02325713|23546|P5|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9140|NCT02325713|23547|P4|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9141|NCT02325713|23548|P3|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9142|NCT02325713|23549|P2|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9143|NCT02325713|23550|P1|NOT COMPLETED|Intervention Period 4 (2 Days)||0
9144|NCT02325713|23535|P16|COMPLETED|Intervention Period 4 (2 Days)||2
9145|NCT02325713|23536|P15|COMPLETED|Intervention Period 4 (2 Days)||2
9146|NCT02325713|23537|P14|COMPLETED|Intervention Period 4 (2 Days)||2
9147|NCT02325713|23538|P13|COMPLETED|Intervention Period 4 (2 Days)||2
9148|NCT02325713|23539|P12|COMPLETED|Intervention Period 4 (2 Days)||2
9149|NCT02325713|23540|P11|COMPLETED|Intervention Period 4 (2 Days)||1
9150|NCT02325713|23541|P10|COMPLETED|Intervention Period 4 (2 Days)||1
9151|NCT02325713|23542|P9|COMPLETED|Intervention Period 4 (2 Days)||2
9152|NCT02325713|23543|P8|COMPLETED|Intervention Period 4 (2 Days)||2
9153|NCT02325713|23544|P7|COMPLETED|Intervention Period 4 (2 Days)||2
9154|NCT02325713|23545|P6|COMPLETED|Intervention Period 4 (2 Days)||2
9155|NCT02325713|23546|P5|COMPLETED|Intervention Period 4 (2 Days)||2
9156|NCT02325713|23547|P4|COMPLETED|Intervention Period 4 (2 Days)||2
9157|NCT02325713|23548|P3|COMPLETED|Intervention Period 4 (2 Days)||2
9158|NCT02325713|23549|P2|COMPLETED|Intervention Period 4 (2 Days)||2
9159|NCT02325713|23550|P1|COMPLETED|Intervention Period 4 (2 Days)||1
9160|NCT02325713|23535|P16|STARTED|Intervention Period 4 (2 Days)||2
9161|NCT02325713|23536|P15|STARTED|Intervention Period 4 (2 Days)||2
9162|NCT02325713|23537|P14|STARTED|Intervention Period 4 (2 Days)||2
9163|NCT02325713|23538|P13|STARTED|Intervention Period 4 (2 Days)||2
9164|NCT02325713|23539|P12|STARTED|Intervention Period 4 (2 Days)||2
9165|NCT02325713|23540|P11|STARTED|Intervention Period 4 (2 Days)||1
9166|NCT02325713|23541|P10|STARTED|Intervention Period 4 (2 Days)||1
9167|NCT02325713|23542|P9|STARTED|Intervention Period 4 (2 Days)||2
9168|NCT02325713|23543|P8|STARTED|Intervention Period 4 (2 Days)||2
9169|NCT02325713|23544|P7|STARTED|Intervention Period 4 (2 Days)||2
9170|NCT02325713|23545|P6|STARTED|Intervention Period 4 (2 Days)||2
9171|NCT02325713|23546|P5|STARTED|Intervention Period 4 (2 Days)||2
9172|NCT02325713|23547|P4|STARTED|Intervention Period 4 (2 Days)||2
9173|NCT02325713|23548|P3|STARTED|Intervention Period 4 (2 Days)||2
9174|NCT02325713|23549|P2|STARTED|Intervention Period 4 (2 Days)||2
9175|NCT02325713|23550|P1|STARTED|Intervention Period 4 (2 Days)||1
9176|NCT02325713|23535|P16|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9177|NCT02325713|23536|P15|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9178|NCT02325713|23537|P14|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9179|NCT02325713|23538|P13|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9180|NCT02325713|23539|P12|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9181|NCT02325713|23540|P11|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9182|NCT02325713|23541|P10|NOT COMPLETED|Intervention Period 3 (2 Days)||1
9183|NCT02325713|23542|P9|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9184|NCT02325713|23543|P8|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9185|NCT02325713|23544|P7|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9186|NCT02325713|23545|P6|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9187|NCT02325713|23546|P5|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9188|NCT02325713|23547|P4|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9189|NCT02325713|23548|P3|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9190|NCT02325713|23549|P2|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9191|NCT02325713|23550|P1|NOT COMPLETED|Intervention Period 3 (2 Days)||0
9192|NCT02325713|23535|P16|COMPLETED|Intervention Period 3 (2 Days)||2
9193|NCT02325713|23536|P15|COMPLETED|Intervention Period 3 (2 Days)||2
9194|NCT02325713|23537|P14|COMPLETED|Intervention Period 3 (2 Days)||2
9195|NCT02325713|23538|P13|COMPLETED|Intervention Period 3 (2 Days)||2
9196|NCT02325713|23539|P12|COMPLETED|Intervention Period 3 (2 Days)||2
9197|NCT02325713|23540|P11|COMPLETED|Intervention Period 3 (2 Days)||1
9198|NCT02325713|23541|P10|COMPLETED|Intervention Period 3 (2 Days)||1
9199|NCT02325713|23542|P9|COMPLETED|Intervention Period 3 (2 Days)||2
9200|NCT02325713|23543|P8|COMPLETED|Intervention Period 3 (2 Days)||2
9201|NCT02325713|23544|P7|COMPLETED|Intervention Period 3 (2 Days)||2
9202|NCT02325713|23545|P6|COMPLETED|Intervention Period 3 (2 Days)||2
9203|NCT02325713|23546|P5|COMPLETED|Intervention Period 3 (2 Days)||2
9204|NCT02325713|23547|P4|COMPLETED|Intervention Period 3 (2 Days)||2
9205|NCT02325713|23548|P3|COMPLETED|Intervention Period 3 (2 Days)||2
9206|NCT02325713|23549|P2|COMPLETED|Intervention Period 3 (2 Days)||2
9207|NCT02325713|23550|P1|COMPLETED|Intervention Period 3 (2 Days)||1
9208|NCT02325713|23535|P16|STARTED|Intervention Period 3 (2 Days)||2
9209|NCT02325713|23536|P15|STARTED|Intervention Period 3 (2 Days)||2
9210|NCT02325713|23537|P14|STARTED|Intervention Period 3 (2 Days)||2
9211|NCT02325713|23538|P13|STARTED|Intervention Period 3 (2 Days)||2
9212|NCT02325713|23539|P12|STARTED|Intervention Period 3 (2 Days)||2
9213|NCT02325713|23540|P11|STARTED|Intervention Period 3 (2 Days)||1
9214|NCT02325713|23541|P10|STARTED|Intervention Period 3 (2 Days)||2
9215|NCT02325713|23542|P9|STARTED|Intervention Period 3 (2 Days)||2
9216|NCT02325713|23543|P8|STARTED|Intervention Period 3 (2 Days)||2
9217|NCT02325713|23544|P7|STARTED|Intervention Period 3 (2 Days)||2
9218|NCT02325713|23545|P6|STARTED|Intervention Period 3 (2 Days)||2
9219|NCT02325713|23546|P5|STARTED|Intervention Period 3 (2 Days)||2
9220|NCT02325713|23547|P4|STARTED|Intervention Period 3 (2 Days)||2
9221|NCT02325713|23548|P3|STARTED|Intervention Period 3 (2 Days)||2
9222|NCT02325713|23549|P2|STARTED|Intervention Period 3 (2 Days)||2
9223|NCT02325713|23550|P1|STARTED|Intervention Period 3 (2 Days)||1
9224|NCT02325713|23535|P16|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9225|NCT02325713|23536|P15|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9226|NCT02325713|23537|P14|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9227|NCT02325713|23538|P13|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9228|NCT02325713|23539|P12|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9229|NCT02325713|23540|P11|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9230|NCT02325713|23541|P10|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9231|NCT02325713|23542|P9|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9232|NCT02325713|23543|P8|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9233|NCT02325713|23544|P7|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9234|NCT02325713|23545|P6|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9235|NCT02325713|23546|P5|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9236|NCT02325713|23547|P4|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9237|NCT02325713|23548|P3|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9238|NCT02325713|23549|P2|NOT COMPLETED|Intervention Period 2 (2 Days)||0
9239|NCT02325713|23550|P1|NOT COMPLETED|Intervention Period 2 (2 Days)||1
9240|NCT02325713|23535|P16|COMPLETED|Intervention Period 2 (2 Days)||2
9241|NCT02325713|23536|P15|COMPLETED|Intervention Period 2 (2 Days)||2
9242|NCT02325713|23537|P14|COMPLETED|Intervention Period 2 (2 Days)||2
9243|NCT02325713|23538|P13|COMPLETED|Intervention Period 2 (2 Days)||2
9244|NCT02325713|23539|P12|COMPLETED|Intervention Period 2 (2 Days)||2
9245|NCT02325713|23540|P11|COMPLETED|Intervention Period 2 (2 Days)||1
9246|NCT02325713|23541|P10|COMPLETED|Intervention Period 2 (2 Days)||2
9247|NCT02325713|23542|P9|COMPLETED|Intervention Period 2 (2 Days)||2
9248|NCT02325713|23543|P8|COMPLETED|Intervention Period 2 (2 Days)||2
9249|NCT02325713|23544|P7|COMPLETED|Intervention Period 2 (2 Days)||2
9250|NCT02325713|23545|P6|COMPLETED|Intervention Period 2 (2 Days)||2
9251|NCT02325713|23546|P5|COMPLETED|Intervention Period 2 (2 Days)||2
9252|NCT02325713|23547|P4|COMPLETED|Intervention Period 2 (2 Days)||2
9253|NCT02325713|23548|P3|COMPLETED|Intervention Period 2 (2 Days)||2
9254|NCT02325713|23549|P2|COMPLETED|Intervention Period 2 (2 Days)||2
9255|NCT02325713|23550|P1|COMPLETED|Intervention Period 2 (2 Days)||1
9256|NCT02325713|23535|P16|STARTED|Intervention Period 2 (2 Days)||2
9257|NCT02325713|23536|P15|STARTED|Intervention Period 2 (2 Days)||2
9258|NCT02325713|23537|P14|STARTED|Intervention Period 2 (2 Days)||2
9259|NCT02325713|23538|P13|STARTED|Intervention Period 2 (2 Days)||2
9260|NCT02325713|23539|P12|STARTED|Intervention Period 2 (2 Days)||2
9261|NCT02325713|23540|P11|STARTED|Intervention Period 2 (2 Days)||1
9262|NCT02325713|23541|P10|STARTED|Intervention Period 2 (2 Days)||2
9263|NCT02325713|23542|P9|STARTED|Intervention Period 2 (2 Days)||2
9264|NCT02325713|23543|P8|STARTED|Intervention Period 2 (2 Days)||2
9265|NCT02325713|23544|P7|STARTED|Intervention Period 2 (2 Days)||2
9266|NCT02325713|23545|P6|STARTED|Intervention Period 2 (2 Days)||2
9267|NCT02325713|23546|P5|STARTED|Intervention Period 2 (2 Days)||2
9268|NCT02325713|23547|P4|STARTED|Intervention Period 2 (2 Days)||2
9269|NCT02325713|23548|P3|STARTED|Intervention Period 2 (2 Days)||2
9270|NCT02325713|23549|P2|STARTED|Intervention Period 2 (2 Days)||2
9271|NCT02325713|23550|P1|STARTED|Intervention Period 2 (2 Days)||2
9272|NCT02325713|23535|P16|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9273|NCT02325713|23536|P15|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9274|NCT02325713|23537|P14|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9275|NCT02325713|23538|P13|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9276|NCT02325713|23539|P12|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9277|NCT02325713|23540|P11|NOT COMPLETED|Intervention Period 1 (2 Days)||1
9278|NCT02325713|23541|P10|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9279|NCT02325713|23542|P9|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9280|NCT02325713|23543|P8|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9281|NCT02325713|23544|P7|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9282|NCT02325713|23545|P6|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9283|NCT02325713|23546|P5|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9284|NCT02325713|23547|P4|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9285|NCT02325713|23548|P3|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9286|NCT02325713|23549|P2|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9287|NCT02325713|23550|P1|NOT COMPLETED|Intervention Period 1 (2 Days)||0
9288|NCT02325713|23535|P16|COMPLETED|Intervention Period 1 (2 Days)||2
9289|NCT02325713|23536|P15|COMPLETED|Intervention Period 1 (2 Days)||2
9290|NCT02325713|23537|P14|COMPLETED|Intervention Period 1 (2 Days)||2
9291|NCT02325713|23538|P13|COMPLETED|Intervention Period 1 (2 Days)||2
9292|NCT02325713|23539|P12|COMPLETED|Intervention Period 1 (2 Days)||2
9293|NCT02325713|23540|P11|COMPLETED|Intervention Period 1 (2 Days)||1
9294|NCT02325713|23541|P10|COMPLETED|Intervention Period 1 (2 Days)||2
9295|NCT02325713|23542|P9|COMPLETED|Intervention Period 1 (2 Days)||2
9296|NCT02325713|23543|P8|COMPLETED|Intervention Period 1 (2 Days)||2
9297|NCT02325713|23544|P7|COMPLETED|Intervention Period 1 (2 Days)||2
9298|NCT02325713|23545|P6|COMPLETED|Intervention Period 1 (2 Days)||2
9299|NCT02325713|23546|P5|COMPLETED|Intervention Period 1 (2 Days)||2
9300|NCT02325713|23547|P4|COMPLETED|Intervention Period 1 (2 Days)||2
9301|NCT02325713|23548|P3|COMPLETED|Intervention Period 1 (2 Days)||2
9302|NCT02325713|23549|P2|COMPLETED|Intervention Period 1 (2 Days)||2
9303|NCT02325713|23550|P1|COMPLETED|Intervention Period 1 (2 Days)||2
9304|NCT02325713|23535|P16|STARTED|Intervention Period 1 (2 Days)||2
9305|NCT02325713|23536|P15|STARTED|Intervention Period 1 (2 Days)||2
9306|NCT02325713|23537|P14|STARTED|Intervention Period 1 (2 Days)||2
9307|NCT02325713|23538|P13|STARTED|Intervention Period 1 (2 Days)||2
9308|NCT02325713|23539|P12|STARTED|Intervention Period 1 (2 Days)||2
9309|NCT02325713|23540|P11|STARTED|Intervention Period 1 (2 Days)||2
9310|NCT02325713|23541|P10|STARTED|Intervention Period 1 (2 Days)||2
9311|NCT02325713|23542|P9|STARTED|Intervention Period 1 (2 Days)||2
9312|NCT02325713|23543|P8|STARTED|Intervention Period 1 (2 Days)||2
9313|NCT02325713|23544|P7|STARTED|Intervention Period 1 (2 Days)||2
9314|NCT02325713|23545|P6|STARTED|Intervention Period 1 (2 Days)||2
9315|NCT02325713|23546|P5|STARTED|Intervention Period 1 (2 Days)||2
9316|NCT02325713|23547|P4|STARTED|Intervention Period 1 (2 Days)||2
9317|NCT02325713|23548|P3|STARTED|Intervention Period 1 (2 Days)||2
9318|NCT02325713|23549|P2|STARTED|Intervention Period 1 (2 Days)||2
9319|NCT02325713|23550|P1|STARTED|Intervention Period 1 (2 Days)||2
9320|NCT02325518|23645|P2|NOT COMPLETED|Overall Study||3
9321|NCT02325518|23646|P1|NOT COMPLETED|Overall Study||4
9322|NCT02325518|23645|P2|COMPLETED|Overall Study||100
9323|NCT02325518|23646|P1|COMPLETED|Overall Study||94
9324|NCT02325518|23645|P2|Per Protocol Set (PPS)|Overall Study||97
9325|NCT02325518|23646|P1|Per Protocol Set (PPS)|Overall Study||92
9326|NCT02325518|23645|P2|Full Analysis Set (FAS)|Overall Study||101
9327|NCT02325518|23646|P1|Full Analysis Set (FAS)|Overall Study||98
9328|NCT02325518|23645|P2|Safety Set|Overall Study||103
9329|NCT02325518|23646|P1|Safety Set|Overall Study||98
9330|NCT02325518|23645|P2|STARTED|Overall Study||103
9331|NCT02325518|23646|P1|STARTED|Overall Study||98
9332|NCT02324673|23658|P3|NOT COMPLETED|Overall Study||0
9333|NCT02324673|23659|P2|NOT COMPLETED|Overall Study||0
9334|NCT02324673|23660|P1|NOT COMPLETED|Overall Study||0
9335|NCT02324673|23658|P3|COMPLETED|Overall Study||21
9336|NCT02324673|23659|P2|COMPLETED|Overall Study||20
9337|NCT02324673|23660|P1|COMPLETED|Overall Study||20
9338|NCT02324673|23658|P3|STARTED|Overall Study||21
9339|NCT02324673|23659|P2|STARTED|Overall Study||20
9340|NCT02324673|23660|P1|STARTED|Overall Study||20
9341|NCT02324660|23761|P1|NOT COMPLETED|Overall Study||32
9342|NCT02324660|23761|P1|COMPLETED|Overall Study||137
9343|NCT02324660|23761|P1|STARTED|Overall Study||169
9344|NCT02322892|23768|P2|NOT COMPLETED|Overall Study||3
9345|NCT02322892|23769|P1|NOT COMPLETED|Overall Study||2
9346|NCT02322892|23768|P2|COMPLETED|Overall Study|Received thiamine|31
9347|NCT02322892|23769|P1|COMPLETED|Overall Study|Received placebo|33
9348|NCT02322892|23768|P2|STARTED|Overall Study|Number randomized|34
9349|NCT02322892|23769|P1|STARTED|Overall Study|Number randomized|35
9350|NCT02322788|23783|P4|NOT COMPLETED|Visit 6||0
9351|NCT02322788|23784|P3|NOT COMPLETED|Visit 6||0
9352|NCT02322788|23785|P2|NOT COMPLETED|Visit 6||0
9353|NCT02322788|23786|P1|NOT COMPLETED|Visit 6||0
9354|NCT02322788|23783|P4|COMPLETED|Visit 6||15
9355|NCT02322788|23784|P3|COMPLETED|Visit 6||15
9356|NCT02322788|23785|P2|COMPLETED|Visit 6||16
9357|NCT02322788|23786|P1|COMPLETED|Visit 6||14
9358|NCT02322788|23783|P4|STARTED|Visit 6||15
9359|NCT02322788|23784|P3|STARTED|Visit 6||15
9360|NCT02322788|23785|P2|STARTED|Visit 6||16
9361|NCT02322788|23786|P1|STARTED|Visit 6||14
9362|NCT02322788|23783|P4|NOT COMPLETED|Visit 5||0
9363|NCT02322788|23784|P3|NOT COMPLETED|Visit 5||0
9364|NCT02322788|23785|P2|NOT COMPLETED|Visit 5||0
9365|NCT02322788|23786|P1|NOT COMPLETED|Visit 5||0
9366|NCT02322788|23783|P4|COMPLETED|Visit 5||14
9367|NCT02322788|23784|P3|COMPLETED|Visit 5||15
9368|NCT02322788|23785|P2|COMPLETED|Visit 5||15
9369|NCT02322788|23786|P1|COMPLETED|Visit 5||16
9370|NCT02322788|23783|P4|STARTED|Visit 5||14
9371|NCT02322788|23784|P3|STARTED|Visit 5||15
9372|NCT02322788|23785|P2|STARTED|Visit 5||15
9373|NCT02322788|23786|P1|STARTED|Visit 5||16
9374|NCT02322788|23783|P4|NOT COMPLETED|Visit 4||0
9375|NCT02322788|23784|P3|NOT COMPLETED|Visit 4||0
9376|NCT02322788|23785|P2|NOT COMPLETED|Visit 4||0
9377|NCT02322788|23786|P1|NOT COMPLETED|Visit 4||0
9378|NCT02322788|23783|P4|COMPLETED|Visit 4||15
9379|NCT02322788|23784|P3|COMPLETED|Visit 4||16
9380|NCT02322788|23785|P2|COMPLETED|Visit 4||14
9381|NCT02322788|23786|P1|COMPLETED|Visit 4||15
9382|NCT02322788|23783|P4|STARTED|Visit 4||15
9383|NCT02322788|23784|P3|STARTED|Visit 4||16
9384|NCT02322788|23785|P2|STARTED|Visit 4||14
9385|NCT02322788|23786|P1|STARTED|Visit 4||15
9386|NCT02322788|23783|P4|NOT COMPLETED|Visit 3||0
9387|NCT02322788|23784|P3|NOT COMPLETED|Visit 3||0
9388|NCT02322788|23785|P2|NOT COMPLETED|Visit 3||0
9389|NCT02322788|23786|P1|NOT COMPLETED|Visit 3||0
9390|NCT02322788|23783|P4|COMPLETED|Visit 3||16
9391|NCT02322788|23784|P3|COMPLETED|Visit 3||14
9392|NCT02322788|23785|P2|COMPLETED|Visit 3||15
9393|NCT02322788|23786|P1|COMPLETED|Visit 3||15
9394|NCT02322788|23783|P4|STARTED|Visit 3||16
9395|NCT02322788|23784|P3|STARTED|Visit 3||14
9396|NCT02322788|23785|P2|STARTED|Visit 3||15
9397|NCT02322788|23786|P1|STARTED|Visit 3||15
9398|NCT02322775|23798|P2|NOT COMPLETED|Overall Study||6
9399|NCT02322775|23799|P1|NOT COMPLETED|Overall Study||5
9400|NCT02322775|23798|P2|COMPLETED|Overall Study||99
9401|NCT02322775|23799|P1|COMPLETED|Overall Study||101
9402|NCT02322775|23798|P2|STARTED|Overall Study||105
9403|NCT02322775|23799|P1|STARTED|Overall Study||106
9404|NCT02322749|23825|P6|NOT COMPLETED|Period 3||0
9405|NCT02322749|23826|P5|NOT COMPLETED|Period 3||0
9406|NCT02322749|23827|P4|NOT COMPLETED|Period 3||0
9407|NCT02322749|23828|P3|NOT COMPLETED|Period 3||1
9408|NCT02322749|23829|P2|NOT COMPLETED|Period 3||0
9409|NCT02322749|23830|P1|NOT COMPLETED|Period 3||0
9410|NCT02322749|23825|P6|COMPLETED|Period 3||8
9411|NCT02322749|23826|P5|COMPLETED|Period 3||8
9412|NCT02322749|23827|P4|COMPLETED|Period 3||6
9413|NCT02322749|23828|P3|COMPLETED|Period 3||7
9414|NCT02322749|23829|P2|COMPLETED|Period 3||8
9415|NCT02322749|23830|P1|COMPLETED|Period 3||8
9416|NCT02322749|23825|P6|STARTED|Period 3||8
9417|NCT02322749|23826|P5|STARTED|Period 3||8
9418|NCT02322749|23827|P4|STARTED|Period 3||6
9419|NCT02322749|23828|P3|STARTED|Period 3||8
9420|NCT02322749|23829|P2|STARTED|Period 3||8
9421|NCT02322749|23830|P1|STARTED|Period 3||8
9422|NCT02322749|23825|P6|NOT COMPLETED|Period 2||0
9423|NCT02322749|23826|P5|NOT COMPLETED|Period 2||0
9424|NCT02322749|23827|P4|NOT COMPLETED|Period 2||2
9425|NCT02322749|23828|P3|NOT COMPLETED|Period 2||0
9426|NCT02322749|23829|P2|NOT COMPLETED|Period 2||0
9427|NCT02322749|23830|P1|NOT COMPLETED|Period 2||0
9428|NCT02322749|23825|P6|COMPLETED|Period 2||8
9429|NCT02322749|23826|P5|COMPLETED|Period 2||8
9430|NCT02322749|23827|P4|COMPLETED|Period 2||6
9431|NCT02322749|23828|P3|COMPLETED|Period 2||8
9432|NCT02322749|23829|P2|COMPLETED|Period 2||8
9433|NCT02322749|23830|P1|COMPLETED|Period 2||8
9434|NCT02322749|23825|P6|STARTED|Period 2||8
9435|NCT02322749|23826|P5|STARTED|Period 2||8
9436|NCT02322749|23827|P4|STARTED|Period 2||8
9437|NCT02322749|23828|P3|STARTED|Period 2||8
9438|NCT02322749|23829|P2|STARTED|Period 2||8
9439|NCT02322749|23830|P1|STARTED|Period 2||8
9440|NCT02322749|23825|P6|NOT COMPLETED|Period 1||0
9441|NCT02322749|23826|P5|NOT COMPLETED|Period 1||0
9442|NCT02322749|23827|P4|NOT COMPLETED|Period 1||0
9443|NCT02322749|23828|P3|NOT COMPLETED|Period 1||0
9444|NCT02322749|23829|P2|NOT COMPLETED|Period 1||0
9445|NCT02322749|23830|P1|NOT COMPLETED|Period 1||0
9446|NCT02322749|23825|P6|COMPLETED|Period 1||8
9447|NCT02322749|23826|P5|COMPLETED|Period 1||8
9448|NCT02322749|23827|P4|COMPLETED|Period 1||8
9449|NCT02322749|23828|P3|COMPLETED|Period 1||8
9450|NCT02322749|23829|P2|COMPLETED|Period 1||8
9451|NCT02322749|23830|P1|COMPLETED|Period 1||8
9452|NCT02322749|23825|P6|STARTED|Period 1||8
9453|NCT02322749|23826|P5|STARTED|Period 1||8
9454|NCT02322749|23827|P4|STARTED|Period 1||8
9455|NCT02322749|23828|P3|STARTED|Period 1||8
9456|NCT02322749|23829|P2|STARTED|Period 1||8
9457|NCT02322749|23830|P1|STARTED|Period 1||8
9458|NCT02322528|23853|P1|NOT COMPLETED|Overall Study||0
9459|NCT02322528|23853|P1|COMPLETED|Overall Study||10
9460|NCT02322528|23853|P1|STARTED|Overall Study||10
9461|NCT02322216|23860|P2|NOT COMPLETED|Overall Study||4
9462|NCT02322216|23861|P1|NOT COMPLETED|Overall Study||2
9463|NCT02322216|23860|P2|COMPLETED|Overall Study||123
9464|NCT02322216|23861|P1|COMPLETED|Overall Study||124
9465|NCT02322216|23860|P2|Per Protocol Set (PPS)|Overall Study||122
9466|NCT02322216|23861|P1|Per Protocol Set (PPS)|Overall Study||123
9467|NCT02322216|23860|P2|Treated (Safety Set)|Overall Study||126
9468|NCT02322216|23861|P1|Treated (Safety Set)|Overall Study||126
9469|NCT02322216|23860|P2|STARTED|Overall Study||127
9470|NCT02322216|23861|P1|STARTED|Overall Study||126
9471|NCT02321527|23868|P1|NOT COMPLETED|Overall Study||1
9472|NCT02321527|23868|P1|COMPLETED|Overall Study||20
9473|NCT02321527|23868|P1|STARTED|Overall Study||21
9474|NCT02321436|23874|P2|NOT COMPLETED|Overall Study||1
9475|NCT02321436|23875|P1|NOT COMPLETED|Overall Study||1
9476|NCT02321436|23874|P2|COMPLETED|Overall Study||13
9477|NCT02321436|23875|P1|COMPLETED|Overall Study||27
9478|NCT02321436|23874|P2|STARTED|Overall Study||14
9479|NCT02321436|23875|P1|STARTED|Overall Study||28
9480|NCT02320838|23891|P5|NOT COMPLETED|Third Intervention (1 Day)||0
9481|NCT02320838|23892|P4|NOT COMPLETED|Third Intervention (1 Day)||0
9482|NCT02320838|23893|P3|NOT COMPLETED|Third Intervention (1 Day)||0
9483|NCT02320838|23894|P2|NOT COMPLETED|Third Intervention (1 Day)||0
9484|NCT02320838|23895|P1|NOT COMPLETED|Third Intervention (1 Day)||0
9485|NCT02320838|23891|P5|COMPLETED|Third Intervention (1 Day)||7
9486|NCT02320838|23892|P4|COMPLETED|Third Intervention (1 Day)||7
9487|NCT02320838|23893|P3|COMPLETED|Third Intervention (1 Day)||8
9488|NCT02320838|23894|P2|COMPLETED|Third Intervention (1 Day)||8
9489|NCT02320838|23895|P1|COMPLETED|Third Intervention (1 Day)||8
9490|NCT02320838|23891|P5|STARTED|Third Intervention (1 Day)||7
9491|NCT02320838|23892|P4|STARTED|Third Intervention (1 Day)||7
9492|NCT02320838|23893|P3|STARTED|Third Intervention (1 Day)||8
9493|NCT02320838|23894|P2|STARTED|Third Intervention (1 Day)||8
9494|NCT02320838|23895|P1|STARTED|Third Intervention (1 Day)||8
9495|NCT02320838|23891|P5|NOT COMPLETED|Washout (1 Day)||0
9496|NCT02320838|23892|P4|NOT COMPLETED|Washout (1 Day)||0
9497|NCT02320838|23893|P3|NOT COMPLETED|Washout (1 Day)||0
9498|NCT02320838|23894|P2|NOT COMPLETED|Washout (1 Day)||0
9499|NCT02320838|23895|P1|NOT COMPLETED|Washout (1 Day)||0
9500|NCT02320838|23891|P5|COMPLETED|Washout (1 Day)||7
9501|NCT02320838|23892|P4|COMPLETED|Washout (1 Day)||7
9502|NCT02320838|23893|P3|COMPLETED|Washout (1 Day)||8
9503|NCT02320838|23894|P2|COMPLETED|Washout (1 Day)||8
9504|NCT02320838|23895|P1|COMPLETED|Washout (1 Day)||8
9505|NCT02320838|23891|P5|STARTED|Washout (1 Day)||7
9506|NCT02320838|23892|P4|STARTED|Washout (1 Day)||7
9507|NCT02320838|23893|P3|STARTED|Washout (1 Day)||8
9508|NCT02320838|23894|P2|STARTED|Washout (1 Day)||8
9509|NCT02320838|23895|P1|STARTED|Washout (1 Day)||8
9510|NCT02320838|23891|P5|NOT COMPLETED|Second Intervention (1 Day)||0
9511|NCT02320838|23892|P4|NOT COMPLETED|Second Intervention (1 Day)||0
9512|NCT02320838|23893|P3|NOT COMPLETED|Second Intervention (1 Day)||0
9513|NCT02320838|23894|P2|NOT COMPLETED|Second Intervention (1 Day)||0
9514|NCT02320838|23895|P1|NOT COMPLETED|Second Intervention (1 Day)||0
9515|NCT02320838|23891|P5|COMPLETED|Second Intervention (1 Day)||7
9516|NCT02320838|23892|P4|COMPLETED|Second Intervention (1 Day)||7
9517|NCT02320838|23893|P3|COMPLETED|Second Intervention (1 Day)||8
9518|NCT02320838|23894|P2|COMPLETED|Second Intervention (1 Day)||8
9519|NCT02320838|23895|P1|COMPLETED|Second Intervention (1 Day)||8
9520|NCT02320838|23891|P5|STARTED|Second Intervention (1 Day)||7
9521|NCT02320838|23892|P4|STARTED|Second Intervention (1 Day)||7
9522|NCT02320838|23893|P3|STARTED|Second Intervention (1 Day)||8
9523|NCT02320838|23894|P2|STARTED|Second Intervention (1 Day)||8
9524|NCT02320838|23895|P1|STARTED|Second Intervention (1 Day)||8
9525|NCT02320838|23891|P5|NOT COMPLETED|Washout (1 Day)||0
9526|NCT02320838|23892|P4|NOT COMPLETED|Washout (1 Day)||0
9527|NCT02320838|23893|P3|NOT COMPLETED|Washout (1 Day)||0
9528|NCT02320838|23894|P2|NOT COMPLETED|Washout (1 Day)||0
9529|NCT02320838|23895|P1|NOT COMPLETED|Washout (1 Day)||0
9530|NCT02320838|23891|P5|COMPLETED|Washout (1 Day)||7
9531|NCT02320838|23892|P4|COMPLETED|Washout (1 Day)||7
9532|NCT02320838|23893|P3|COMPLETED|Washout (1 Day)||8
9533|NCT02320838|23894|P2|COMPLETED|Washout (1 Day)||8
9534|NCT02320838|23895|P1|COMPLETED|Washout (1 Day)||8
9535|NCT02320838|23891|P5|STARTED|Washout (1 Day)||7
9536|NCT02320838|23892|P4|STARTED|Washout (1 Day)||7
9537|NCT02320838|23893|P3|STARTED|Washout (1 Day)||8
9538|NCT02320838|23894|P2|STARTED|Washout (1 Day)||8
9539|NCT02320838|23895|P1|STARTED|Washout (1 Day)||8
9540|NCT02320838|23891|P5|NOT COMPLETED|First Intervention (1 Day)||0
9541|NCT02320838|23892|P4|NOT COMPLETED|First Intervention (1 Day)||0
9542|NCT02320838|23893|P3|NOT COMPLETED|First Intervention (1 Day)||0
9543|NCT02320838|23894|P2|NOT COMPLETED|First Intervention (1 Day)||0
9544|NCT02320838|23895|P1|NOT COMPLETED|First Intervention (1 Day)||0
9545|NCT02320838|23891|P5|COMPLETED|First Intervention (1 Day)||7
9546|NCT02320838|23892|P4|COMPLETED|First Intervention (1 Day)||7
9547|NCT02320838|23893|P3|COMPLETED|First Intervention (1 Day)||8
9548|NCT02320838|23894|P2|COMPLETED|First Intervention (1 Day)||8
9549|NCT02320838|23895|P1|COMPLETED|First Intervention (1 Day)||8
9550|NCT02320838|23891|P5|STARTED|First Intervention (1 Day)||7
9551|NCT02320838|23892|P4|STARTED|First Intervention (1 Day)||7
9552|NCT02320838|23893|P3|STARTED|First Intervention (1 Day)||8
9553|NCT02320838|23894|P2|STARTED|First Intervention (1 Day)||8
9554|NCT02320838|23895|P1|STARTED|First Intervention (1 Day)||8
9555|NCT02320721|23962|P2|NOT COMPLETED|Overall Study||34
9556|NCT02320721|23963|P1|NOT COMPLETED|Overall Study||27
9557|NCT02320721|23962|P2|COMPLETED|Overall Study||472
9558|NCT02320721|23963|P1|COMPLETED|Overall Study||481
9559|NCT02320721|23962|P2|Treated (Safety Population)|Overall Study||505
9560|NCT02320721|23963|P1|Treated (Safety Population)|Overall Study||508
9561|NCT02320721|23962|P2|STARTED|Overall Study||506
9562|NCT02320721|23963|P1|STARTED|Overall Study||508
9563|NCT02320695|23991|P1|NOT COMPLETED|Overall Study||0
9564|NCT02320695|23991|P1|COMPLETED|Overall Study||60
9565|NCT02320695|23991|P1|Pain Relief Ointment|Overall Study||60
9566|NCT02320695|23991|P1|Original Ointment|Overall Study||60
9567|NCT02320695|23991|P1|Antibiotic/Pain Relieving Ointment|Overall Study||60
9568|NCT02320695|23991|P1|Pain Relieving Cream|Overall Study||59
9569|NCT02320695|23991|P1|Alcohol|Overall Study||60
9570|NCT02320695|23991|P1|Saline|Overall Study||60
9571|NCT02320695|23991|P1|STARTED|Overall Study||60
9572|NCT02320396|24020|P2|NOT COMPLETED|Overall Study||4
9573|NCT02320396|24021|P1|NOT COMPLETED|Overall Study||4
9574|NCT02320396|24020|P2|COMPLETED|Overall Study||221
9575|NCT02320396|24021|P1|COMPLETED|Overall Study||220
9576|NCT02320396|24020|P2|Treated (Full Analysis Set)|Overall Study||225
9577|NCT02320396|24021|P1|Treated (Full Analysis Set)|Overall Study||223
9578|NCT02320396|24020|P2|STARTED|Overall Study||225
9579|NCT02320396|24021|P1|STARTED|Overall Study||224
9580|NCT02320227|24051|P1|NOT COMPLETED|Overall Study||0
9581|NCT02320227|24051|P1|COMPLETED|Overall Study||30
9582|NCT02320227|24051|P1|STARTED|Overall Study||30
9583|NCT02320214|24056|P1|NOT COMPLETED|Overall Study||0
9584|NCT02320214|24056|P1|COMPLETED|Overall Study||30
9585|NCT02320214|24056|P1|STARTED|Overall Study||30
9586|NCT02319824|24061|P1|NOT COMPLETED|Overall Study||0
9587|NCT02319824|24061|P1|COMPLETED|Overall Study||2
9588|NCT02319824|24061|P1|STARTED|Overall Study||2
9589|NCT02319668|24069|P2|NOT COMPLETED|Overall Study||2
9590|NCT02319668|24070|P1|NOT COMPLETED|Overall Study||0
9591|NCT02319668|24069|P2|COMPLETED|Overall Study||17
9592|NCT02319668|24070|P1|COMPLETED|Overall Study||19
9593|NCT02319668|24069|P2|STARTED|Overall Study||19
9594|NCT02319668|24070|P1|STARTED|Overall Study||19
9595|NCT02319525|24084|P2|NOT COMPLETED|Overall Study||1
9596|NCT02319525|24085|P1|NOT COMPLETED|Overall Study||2
9597|NCT02319525|24084|P2|COMPLETED|Overall Study||147
9598|NCT02319525|24085|P1|COMPLETED|Overall Study||151
9599|NCT02319525|24084|P2|Primary Research Completion|Overall Study||147
9600|NCT02319525|24085|P1|Primary Research Completion|Overall Study||151
9601|NCT02319525|24084|P2|STARTED|Overall Study||148
9602|NCT02319525|24085|P1|STARTED|Overall Study||153
9603|NCT02319486|24103|P1|NOT COMPLETED|Overall Study||0
9604|NCT02319486|24103|P1|COMPLETED|Overall Study||26
9605|NCT02319486|24103|P1|STARTED|Overall Study||26
9606|NCT02319148|24112|P4|NOT COMPLETED|Second Intervention Period||2
9607|NCT02319148|24113|P3|NOT COMPLETED|Second Intervention Period||1
9608|NCT02319148|24114|P2|NOT COMPLETED|Second Intervention Period||1
9609|NCT02319148|24115|P1|NOT COMPLETED|Second Intervention Period||0
9610|NCT02319148|24112|P4|COMPLETED|Second Intervention Period||6
9611|NCT02319148|24113|P3|COMPLETED|Second Intervention Period||6
9612|NCT02319148|24114|P2|COMPLETED|Second Intervention Period||6
9613|NCT02319148|24115|P1|COMPLETED|Second Intervention Period||0
9614|NCT02319148|24112|P4|STARTED|Second Intervention Period||8
9615|NCT02319148|24113|P3|STARTED|Second Intervention Period||7
9616|NCT02319148|24114|P2|STARTED|Second Intervention Period||7
9617|NCT02319148|24115|P1|STARTED|Second Intervention Period||0
9618|NCT02319148|24112|P4|NOT COMPLETED|Washout Period 4 Days||0
9619|NCT02319148|24113|P3|NOT COMPLETED|Washout Period 4 Days||0
9620|NCT02319148|24114|P2|NOT COMPLETED|Washout Period 4 Days||0
9621|NCT02319148|24115|P1|NOT COMPLETED|Washout Period 4 Days||0
9622|NCT02319148|24112|P4|COMPLETED|Washout Period 4 Days||0
9623|NCT02319148|24113|P3|COMPLETED|Washout Period 4 Days||0
9624|NCT02319148|24114|P2|COMPLETED|Washout Period 4 Days||0
9625|NCT02319148|24115|P1|COMPLETED|Washout Period 4 Days||22
9626|NCT02319148|24112|P4|STARTED|Washout Period 4 Days||0
9627|NCT02319148|24113|P3|STARTED|Washout Period 4 Days||0
9628|NCT02319148|24114|P2|STARTED|Washout Period 4 Days||0
9629|NCT02319148|24115|P1|STARTED|Washout Period 4 Days||22
9630|NCT02319148|24112|P4|NOT COMPLETED|First Intervention Period||0
9631|NCT02319148|24113|P3|NOT COMPLETED|First Intervention Period||0
9632|NCT02319148|24114|P2|NOT COMPLETED|First Intervention Period||0
9633|NCT02319148|24115|P1|NOT COMPLETED|First Intervention Period||0
9634|NCT02319148|24112|P4|COMPLETED|First Intervention Period||0
9635|NCT02319148|24113|P3|COMPLETED|First Intervention Period||0
9636|NCT02319148|24114|P2|COMPLETED|First Intervention Period||0
9637|NCT02319148|24115|P1|COMPLETED|First Intervention Period||22
9638|NCT02319148|24112|P4|STARTED|First Intervention Period||0
9639|NCT02319148|24113|P3|STARTED|First Intervention Period||0
9640|NCT02319148|24114|P2|STARTED|First Intervention Period||0
9641|NCT02319148|24115|P1|STARTED|First Intervention Period||22
9642|NCT02319031|24177|P2|NOT COMPLETED|Follow-Up Period||0
9643|NCT02319031|24178|P1|NOT COMPLETED|Follow-Up Period||0
9644|NCT02319031|24177|P2|COMPLETED|Follow-Up Period||26
9645|NCT02319031|24178|P1|COMPLETED|Follow-Up Period||23
9646|NCT02319031|24177|P2|STARTED|Follow-Up Period||26
9647|NCT02319031|24178|P1|STARTED|Follow-Up Period||23
9648|NCT02319031|24177|P2|NOT COMPLETED|Treatment Period||0
9649|NCT02319031|24178|P1|NOT COMPLETED|Treatment Period||1
9650|NCT02319031|24177|P2|COMPLETED|Treatment Period||26
9651|NCT02319031|24178|P1|COMPLETED|Treatment Period||23
9652|NCT02319031|24177|P2|STARTED|Treatment Period||26
9653|NCT02319031|24178|P1|STARTED|Treatment Period||24
9654|NCT02318940|24190|P2|NOT COMPLETED|Overall Study||0
9655|NCT02318940|24191|P1|NOT COMPLETED|Overall Study||1
9656|NCT02318940|24190|P2|COMPLETED|Overall Study||50
9657|NCT02318940|24191|P1|COMPLETED|Overall Study||49
9658|NCT02318940|24190|P2|STARTED|Overall Study||50
9659|NCT02318940|24191|P1|STARTED|Overall Study|in the last patient we lost the record.|50
9660|NCT02318693|24205|P2|NOT COMPLETED|Overall Study||1
9661|NCT02318693|24206|P1|NOT COMPLETED|Overall Study||0
9662|NCT02318693|24205|P2|COMPLETED|Overall Study||26
9663|NCT02318693|24206|P1|COMPLETED|Overall Study||26
9664|NCT02318693|24205|P2|Treated|Overall Study|1 randomized participant did not receive treatment.|26
9665|NCT02318693|24206|P1|Treated|Overall Study||26
9666|NCT02318693|24205|P2|STARTED|Overall Study||27
9667|NCT02318693|24206|P1|STARTED|Overall Study||26
9668|NCT02318303|24227|P7|NOT COMPLETED|Overall Study||2
9669|NCT02318303|24228|P6|NOT COMPLETED|Overall Study||6
9670|NCT02318303|24229|P5|NOT COMPLETED|Overall Study||5
9671|NCT02318303|24230|P4|NOT COMPLETED|Overall Study||3
9672|NCT02318303|24231|P3|NOT COMPLETED|Overall Study||3
9673|NCT02318303|24232|P2|NOT COMPLETED|Overall Study||3
9674|NCT02318303|24233|P1|NOT COMPLETED|Overall Study||4
9675|NCT02318303|24227|P7|COMPLETED|Overall Study||158
9676|NCT02318303|24228|P6|COMPLETED|Overall Study||153
9677|NCT02318303|24229|P5|COMPLETED|Overall Study||152
9678|NCT02318303|24230|P4|COMPLETED|Overall Study||155
9679|NCT02318303|24231|P3|COMPLETED|Overall Study||157
9680|NCT02318303|24232|P2|COMPLETED|Overall Study||155
9681|NCT02318303|24233|P1|COMPLETED|Overall Study||155
9682|NCT02318303|24227|P7|STARTED|Overall Study||160
9683|NCT02318303|24228|P6|STARTED|Overall Study||159
9684|NCT02318303|24229|P5|STARTED|Overall Study||157
9685|NCT02318303|24230|P4|STARTED|Overall Study||158
9686|NCT02318303|24231|P3|STARTED|Overall Study||160
9687|NCT02318303|24232|P2|STARTED|Overall Study||158
9688|NCT02318303|24233|P1|STARTED|Overall Study||159
9689|NCT02317809|24249|P2|NOT COMPLETED|Second Intervention Period (8 Days)||0
9690|NCT02317809|24250|P1|NOT COMPLETED|Second Intervention Period (8 Days)||0
9691|NCT02317809|24249|P2|COMPLETED|Second Intervention Period (8 Days)||17
9692|NCT02317809|24250|P1|COMPLETED|Second Intervention Period (8 Days)||14
9693|NCT02317809|24249|P2|STARTED|Second Intervention Period (8 Days)||17
9694|NCT02317809|24250|P1|STARTED|Second Intervention Period (8 Days)||14
9695|NCT02317809|24249|P2|NOT COMPLETED|First Intervention Period (8 Days)||0
9696|NCT02317809|24250|P1|NOT COMPLETED|First Intervention Period (8 Days)||3
9697|NCT02317809|24249|P2|COMPLETED|First Intervention Period (8 Days)||17
9698|NCT02317809|24250|P1|COMPLETED|First Intervention Period (8 Days)||14
9699|NCT02317809|24249|P2|STARTED|First Intervention Period (8 Days)||17
9700|NCT02317809|24250|P1|STARTED|First Intervention Period (8 Days)||17
9701|NCT02317510|24294|P2|NOT COMPLETED|Overall Study||1
9702|NCT02317510|24295|P1|NOT COMPLETED|Overall Study||0
9703|NCT02317510|24294|P2|COMPLETED|Overall Study||24
9704|NCT02317510|24295|P1|COMPLETED|Overall Study||25
9705|NCT02317510|24294|P2|STARTED|Overall Study||25
9706|NCT02317510|24295|P1|STARTED|Overall Study||25
9707|NCT02317016|24323|P1|NOT COMPLETED|Part B: Day 35 to End Part B (AZD9291)||31
9708|NCT02317016|24323|P1|COMPLETED|Part B: Day 35 to End Part B (AZD9291)||11
9709|NCT02317016|24323|P1|STARTED|Part B: Day 35 to End Part B (AZD9291)|41 completed Part A + 1 entered Part B without completing Part A (due to AE) = 42 started Part B|42
9710|NCT02317016|24323|P1|NOT COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||2
9711|NCT02317016|24323|P1|COMPLETED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||41
9712|NCT02317016|24323|P1|STARTED|Part A: Day 32-34 (Rosuvastatin+AZD9291)||43
9713|NCT02317016|24323|P1|NOT COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||1
9714|NCT02317016|24323|P1|COMPLETED|Part A: Day 4-31 (AZD9291 Alone)||43
9715|NCT02317016|24323|P1|STARTED|Part A: Day 4-31 (AZD9291 Alone)||44
9716|NCT02317016|24323|P1|NOT COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||0
9717|NCT02317016|24323|P1|COMPLETED|Part A: Day 1-3 (Rosuvastatin Alone)||44
9718|NCT02317016|24323|P1|STARTED|Part A: Day 1-3 (Rosuvastatin Alone)||44
9719|NCT02316769|24351|P2|NOT COMPLETED|Overall Study||0
9720|NCT02316769|24352|P1|NOT COMPLETED|Overall Study||2
9721|NCT02316769|24351|P2|COMPLETED|Overall Study||33
9722|NCT02316769|24352|P1|COMPLETED|Overall Study||31
9723|NCT02316769|24351|P2|STARTED|Overall Study||33
9724|NCT02316769|24352|P1|STARTED|Overall Study||33
9725|NCT02316678|24362|P2|NOT COMPLETED|Overall Study||0
9726|NCT02316678|24363|P1|NOT COMPLETED|Overall Study||0
9727|NCT02316678|24362|P2|COMPLETED|Overall Study||7694
9728|NCT02316678|24363|P1|COMPLETED|Overall Study||1879
9729|NCT02316678|24362|P2|STARTED|Overall Study||7694
9730|NCT02316678|24363|P1|STARTED|Overall Study||1879
9731|NCT02316613|24369|P1|NOT COMPLETED|Overall Study||104
9732|NCT02316613|24369|P1|COMPLETED|Overall Study||156
9733|NCT02316613|24369|P1|Overall Population|Overall Study||241
9734|NCT02316613|24369|P1|Safety Population|Overall Study||255
9735|NCT02316613|24369|P1|STARTED|Overall Study||260
9736|NCT02316470|24410|P4|NOT COMPLETED|Overall Study||2
9737|NCT02316470|24411|P3|NOT COMPLETED|Overall Study||5
9738|NCT02316470|24412|P2|NOT COMPLETED|Overall Study||6
9739|NCT02316470|24413|P1|NOT COMPLETED|Overall Study||5
9740|NCT02316470|24410|P4|COMPLETED|Overall Study||46
9741|NCT02316470|24411|P3|COMPLETED|Overall Study||147
9742|NCT02316470|24412|P2|COMPLETED|Overall Study||146
9743|NCT02316470|24413|P1|COMPLETED|Overall Study||143
9744|NCT02316470|24410|P4|STARTED|Overall Study||48
9745|NCT02316470|24411|P3|STARTED|Overall Study||152
9746|NCT02316470|24412|P2|STARTED|Overall Study||152
9747|NCT02316470|24413|P1|STARTED|Overall Study||148
9748|NCT02316366|24509|P2|NOT COMPLETED|Overall Study||0
9749|NCT02316366|24510|P1|NOT COMPLETED|Overall Study||0
9750|NCT02316366|24509|P2|COMPLETED|Overall Study||40
9751|NCT02316366|24510|P1|COMPLETED|Overall Study||40
9752|NCT02316366|24509|P2|STARTED|Overall Study||40
9753|NCT02316366|24510|P1|STARTED|Overall Study||40
9754|NCT02315989|24520|P1|NOT COMPLETED|Overall Study||0
9755|NCT02315989|24520|P1|COMPLETED|Overall Study||6
9756|NCT02315989|24520|P1|STARTED|Overall Study||6
9757|NCT02315352|24530|P8|NOT COMPLETED|Fifth Intervention (Day 2)||0
9758|NCT02315352|24531|P7|NOT COMPLETED|Fifth Intervention (Day 2)||0
9759|NCT02315352|24532|P6|NOT COMPLETED|Fifth Intervention (Day 2)||0
9760|NCT02315352|24533|P5|NOT COMPLETED|Fifth Intervention (Day 2)||0
9761|NCT02315352|24534|P4|NOT COMPLETED|Fifth Intervention (Day 2)||0
9762|NCT02315352|24535|P3|NOT COMPLETED|Fifth Intervention (Day 2)||0
9763|NCT02315352|24536|P2|NOT COMPLETED|Fifth Intervention (Day 2)||0
9764|NCT02315352|24537|P1|NOT COMPLETED|Fifth Intervention (Day 2)||0
9765|NCT02315352|24530|P8|COMPLETED|Fifth Intervention (Day 2)||8
9766|NCT02315352|24531|P7|COMPLETED|Fifth Intervention (Day 2)||9
9767|NCT02315352|24532|P6|COMPLETED|Fifth Intervention (Day 2)||7
9768|NCT02315352|24533|P5|COMPLETED|Fifth Intervention (Day 2)||8
9769|NCT02315352|24534|P4|COMPLETED|Fifth Intervention (Day 2)||8
9770|NCT02315352|24535|P3|COMPLETED|Fifth Intervention (Day 2)||7
9771|NCT02315352|24536|P2|COMPLETED|Fifth Intervention (Day 2)||0
9772|NCT02315352|24537|P1|COMPLETED|Fifth Intervention (Day 2)||0
9773|NCT02315352|24530|P8|STARTED|Fifth Intervention (Day 2)||8
9774|NCT02315352|24531|P7|STARTED|Fifth Intervention (Day 2)||9
9775|NCT02315352|24532|P6|STARTED|Fifth Intervention (Day 2)||7
9776|NCT02315352|24533|P5|STARTED|Fifth Intervention (Day 2)||8
9777|NCT02315352|24534|P4|STARTED|Fifth Intervention (Day 2)||8
9778|NCT02315352|24535|P3|STARTED|Fifth Intervention (Day 2)||7
9779|NCT02315352|24536|P2|STARTED|Fifth Intervention (Day 2)||0
9780|NCT02315352|24537|P1|STARTED|Fifth Intervention (Day 2)||0
9781|NCT02315352|24530|P8|NOT COMPLETED|Fourth Intervention (Day 2)||0
9782|NCT02315352|24531|P7|NOT COMPLETED|Fourth Intervention (Day 2)||0
9783|NCT02315352|24532|P6|NOT COMPLETED|Fourth Intervention (Day 2)||0
9784|NCT02315352|24533|P5|NOT COMPLETED|Fourth Intervention (Day 2)||0
9785|NCT02315352|24534|P4|NOT COMPLETED|Fourth Intervention (Day 2)||0
9786|NCT02315352|24535|P3|NOT COMPLETED|Fourth Intervention (Day 2)||0
9787|NCT02315352|24536|P2|NOT COMPLETED|Fourth Intervention (Day 2)||0
9788|NCT02315352|24537|P1|NOT COMPLETED|Fourth Intervention (Day 2)||0
9789|NCT02315352|24530|P8|COMPLETED|Fourth Intervention (Day 2)||8
9790|NCT02315352|24531|P7|COMPLETED|Fourth Intervention (Day 2)||9
9791|NCT02315352|24532|P6|COMPLETED|Fourth Intervention (Day 2)||7
9792|NCT02315352|24533|P5|COMPLETED|Fourth Intervention (Day 2)||8
9793|NCT02315352|24534|P4|COMPLETED|Fourth Intervention (Day 2)||8
9794|NCT02315352|24535|P3|COMPLETED|Fourth Intervention (Day 2)||7
9795|NCT02315352|24536|P2|COMPLETED|Fourth Intervention (Day 2)||0
9796|NCT02315352|24537|P1|COMPLETED|Fourth Intervention (Day 2)||0
9797|NCT02315352|24530|P8|STARTED|Fourth Intervention (Day 2)||8
9798|NCT02315352|24531|P7|STARTED|Fourth Intervention (Day 2)||9
9799|NCT02315352|24532|P6|STARTED|Fourth Intervention (Day 2)||7
9800|NCT02315352|24533|P5|STARTED|Fourth Intervention (Day 2)||8
9801|NCT02315352|24534|P4|STARTED|Fourth Intervention (Day 2)||8
9802|NCT02315352|24535|P3|STARTED|Fourth Intervention (Day 2)||7
9803|NCT02315352|24536|P2|STARTED|Fourth Intervention (Day 2)||0
9804|NCT02315352|24537|P1|STARTED|Fourth Intervention (Day 2)||0
9805|NCT02315352|24530|P8|NOT COMPLETED|Third Intervention (Day 2)||0
9806|NCT02315352|24531|P7|NOT COMPLETED|Third Intervention (Day 2)||0
9807|NCT02315352|24532|P6|NOT COMPLETED|Third Intervention (Day 2)||0
9808|NCT02315352|24533|P5|NOT COMPLETED|Third Intervention (Day 2)||0
9809|NCT02315352|24534|P4|NOT COMPLETED|Third Intervention (Day 2)||0
9810|NCT02315352|24535|P3|NOT COMPLETED|Third Intervention (Day 2)||0
9811|NCT02315352|24536|P2|NOT COMPLETED|Third Intervention (Day 2)||0
9812|NCT02315352|24537|P1|NOT COMPLETED|Third Intervention (Day 2)||0
9813|NCT02315352|24530|P8|COMPLETED|Third Intervention (Day 2)||8
9814|NCT02315352|24531|P7|COMPLETED|Third Intervention (Day 2)||9
9815|NCT02315352|24532|P6|COMPLETED|Third Intervention (Day 2)||7
9816|NCT02315352|24533|P5|COMPLETED|Third Intervention (Day 2)||8
9817|NCT02315352|24534|P4|COMPLETED|Third Intervention (Day 2)||8
9818|NCT02315352|24535|P3|COMPLETED|Third Intervention (Day 2)||7
9819|NCT02315352|24536|P2|COMPLETED|Third Intervention (Day 2)||0
9820|NCT02315352|24537|P1|COMPLETED|Third Intervention (Day 2)||0
9821|NCT02315352|24530|P8|STARTED|Third Intervention (Day 2)||8
9822|NCT02315352|24531|P7|STARTED|Third Intervention (Day 2)||9
9823|NCT02315352|24532|P6|STARTED|Third Intervention (Day 2)||7
9824|NCT02315352|24533|P5|STARTED|Third Intervention (Day 2)||8
9825|NCT02315352|24534|P4|STARTED|Third Intervention (Day 2)||8
9826|NCT02315352|24535|P3|STARTED|Third Intervention (Day 2)||7
9827|NCT02315352|24536|P2|STARTED|Third Intervention (Day 2)||0
9828|NCT02315352|24537|P1|STARTED|Third Intervention (Day 2)||0
9829|NCT02315352|24530|P8|NOT COMPLETED|Second Intervention (Day 1)||0
9830|NCT02315352|24531|P7|NOT COMPLETED|Second Intervention (Day 1)||0
9831|NCT02315352|24532|P6|NOT COMPLETED|Second Intervention (Day 1)||0
9832|NCT02315352|24533|P5|NOT COMPLETED|Second Intervention (Day 1)||0
9833|NCT02315352|24534|P4|NOT COMPLETED|Second Intervention (Day 1)||0
9834|NCT02315352|24535|P3|NOT COMPLETED|Second Intervention (Day 1)||0
9835|NCT02315352|24536|P2|NOT COMPLETED|Second Intervention (Day 1)||0
9836|NCT02315352|24537|P1|NOT COMPLETED|Second Intervention (Day 1)||0
9837|NCT02315352|24530|P8|COMPLETED|Second Intervention (Day 1)||0
9838|NCT02315352|24531|P7|COMPLETED|Second Intervention (Day 1)||0
9839|NCT02315352|24532|P6|COMPLETED|Second Intervention (Day 1)||0
9840|NCT02315352|24533|P5|COMPLETED|Second Intervention (Day 1)||0
9841|NCT02315352|24534|P4|COMPLETED|Second Intervention (Day 1)||0
9842|NCT02315352|24535|P3|COMPLETED|Second Intervention (Day 1)||0
9843|NCT02315352|24536|P2|COMPLETED|Second Intervention (Day 1)||24
9844|NCT02315352|24537|P1|COMPLETED|Second Intervention (Day 1)|Out of 24 subjects completing this period, 1 discontinued before assignment to any sequence on Day 2|24
9845|NCT02315352|24530|P8|STARTED|Second Intervention (Day 1)||0
9846|NCT02315352|24531|P7|STARTED|Second Intervention (Day 1)||0
9847|NCT02315352|24532|P6|STARTED|Second Intervention (Day 1)||0
9848|NCT02315352|24533|P5|STARTED|Second Intervention (Day 1)||0
9849|NCT02315352|24534|P4|STARTED|Second Intervention (Day 1)||0
9850|NCT02315352|24535|P3|STARTED|Second Intervention (Day 1)||0
9851|NCT02315352|24536|P2|STARTED|Second Intervention (Day 1)||24
9852|NCT02315352|24537|P1|STARTED|Second Intervention (Day 1)||24
9853|NCT02315352|24530|P8|NOT COMPLETED|First Intervention (Day 1)||0
9854|NCT02315352|24531|P7|NOT COMPLETED|First Intervention (Day 1)||0
9855|NCT02315352|24532|P6|NOT COMPLETED|First Intervention (Day 1)||0
9856|NCT02315352|24533|P5|NOT COMPLETED|First Intervention (Day 1)||0
9857|NCT02315352|24534|P4|NOT COMPLETED|First Intervention (Day 1)||0
9858|NCT02315352|24535|P3|NOT COMPLETED|First Intervention (Day 1)||0
9859|NCT02315352|24536|P2|NOT COMPLETED|First Intervention (Day 1)||0
9860|NCT02315352|24537|P1|NOT COMPLETED|First Intervention (Day 1)||0
9861|NCT02315352|24530|P8|COMPLETED|First Intervention (Day 1)||0
9862|NCT02315352|24531|P7|COMPLETED|First Intervention (Day 1)||0
9863|NCT02315352|24532|P6|COMPLETED|First Intervention (Day 1)||0
9864|NCT02315352|24533|P5|COMPLETED|First Intervention (Day 1)||0
9865|NCT02315352|24534|P4|COMPLETED|First Intervention (Day 1)||0
9866|NCT02315352|24535|P3|COMPLETED|First Intervention (Day 1)||0
9867|NCT02315352|24536|P2|COMPLETED|First Intervention (Day 1)||24
9868|NCT02315352|24537|P1|COMPLETED|First Intervention (Day 1)||24
9869|NCT02315352|24530|P8|STARTED|First Intervention (Day 1)||0
9870|NCT02315352|24531|P7|STARTED|First Intervention (Day 1)||0
9871|NCT02315352|24532|P6|STARTED|First Intervention (Day 1)||0
9872|NCT02315352|24533|P5|STARTED|First Intervention (Day 1)||0
9873|NCT02315352|24534|P4|STARTED|First Intervention (Day 1)||0
9874|NCT02315352|24535|P3|STARTED|First Intervention (Day 1)||0
9875|NCT02315352|24536|P2|STARTED|First Intervention (Day 1)||24
9876|NCT02315352|24537|P1|STARTED|First Intervention (Day 1)||24
9877|NCT02314689|24564|P1|NOT COMPLETED|Overall Study||0
9878|NCT02314689|24564|P1|COMPLETED|Overall Study|Target citrulline level reached with first 4 subjects enrolled at initial IV citrulline of 20 mg/kg|4
9879|NCT02314689|24564|P1|STARTED|Overall Study||4
9880|NCT02314637|24570|P2|NOT COMPLETED|Overall Study||14
9881|NCT02314637|24571|P1|NOT COMPLETED|Overall Study||16
9882|NCT02314637|24570|P2|COMPLETED|Overall Study||75
9883|NCT02314637|24571|P1|COMPLETED|Overall Study||135
9884|NCT02314637|24570|P2|STARTED|Overall Study||89
9885|NCT02314637|24571|P1|STARTED|Overall Study||151
9886|NCT02314546|24584|P3|NOT COMPLETED|Overall Study||0
9887|NCT02314546|24585|P2|NOT COMPLETED|Overall Study||0
9888|NCT02314546|24586|P1|NOT COMPLETED|Overall Study||0
9889|NCT02314546|24584|P3|COMPLETED|Overall Study||5
9890|NCT02314546|24585|P2|COMPLETED|Overall Study||5
9891|NCT02314546|24586|P1|COMPLETED|Overall Study||5
9892|NCT02314546|24584|P3|STARTED|Overall Study||5
9893|NCT02314546|24585|P2|STARTED|Overall Study||5
9894|NCT02314546|24586|P1|STARTED|Overall Study||5
9895|NCT02314520|24614|P2|NOT COMPLETED|Overall Study||0
9896|NCT02314520|24615|P1|NOT COMPLETED|Overall Study||0
9897|NCT02314520|24614|P2|COMPLETED|Overall Study||80
9898|NCT02314520|24615|P1|COMPLETED|Overall Study||72
9899|NCT02314520|24614|P2|STARTED|Overall Study||80
9900|NCT02314520|24615|P1|STARTED|Overall Study||72
9901|NCT02314260|24627|P1|NOT COMPLETED|Overall Study||0
9902|NCT02314260|24627|P1|COMPLETED|Overall Study||80
9903|NCT02314260|24627|P1|STARTED|Overall Study||80
9904|NCT02314104|24637|P3|NOT COMPLETED|Overall Study||18
9905|NCT02314104|24638|P2|NOT COMPLETED|Overall Study||20
9906|NCT02314104|24639|P1|NOT COMPLETED|Overall Study||14
9907|NCT02314104|24637|P3|COMPLETED|Overall Study||53
9908|NCT02314104|24638|P2|COMPLETED|Overall Study||58
9909|NCT02314104|24639|P1|COMPLETED|Overall Study||57
9910|NCT02314104|24637|P3|STARTED|Overall Study||71
9911|NCT02314104|24638|P2|STARTED|Overall Study||78
9912|NCT02314104|24639|P1|STARTED|Overall Study||71
9913|NCT02313766|24662|P3|NOT COMPLETED|Overall Study||0
9914|NCT02313766|24663|P2|NOT COMPLETED|Overall Study||3
9915|NCT02313766|24664|P1|NOT COMPLETED|Overall Study||1
9916|NCT02313766|24662|P3|COMPLETED|Overall Study||50
9917|NCT02313766|24663|P2|COMPLETED|Overall Study||47
9918|NCT02313766|24664|P1|COMPLETED|Overall Study||49
9919|NCT02313766|24662|P3|STARTED|Overall Study||50
9920|NCT02313766|24663|P2|STARTED|Overall Study||50
9921|NCT02313766|24664|P1|STARTED|Overall Study||50
9922|NCT02313558|24680|P2|NOT COMPLETED|Overall Study||4
9923|NCT02313558|24681|P1|NOT COMPLETED|Overall Study||6
9924|NCT02313558|24680|P2|COMPLETED|Overall Study||46
9925|NCT02313558|24681|P1|COMPLETED|Overall Study||44
9926|NCT02313558|24680|P2|STARTED|Overall Study||50
9927|NCT02313558|24681|P1|STARTED|Overall Study||50
9928|NCT02313233|24695|P2|NOT COMPLETED|Overall Study||3
9929|NCT02313233|24696|P1|NOT COMPLETED|Overall Study||2
9930|NCT02313233|24695|P2|COMPLETED|Overall Study||18
9931|NCT02313233|24696|P1|COMPLETED|Overall Study||18
9932|NCT02313233|24695|P2|STARTED|Overall Study||21
9933|NCT02313233|24696|P1|STARTED|Overall Study||20
9934|NCT02313155|24718|P2|NOT COMPLETED|Overall Study||1
9935|NCT02313155|24719|P1|NOT COMPLETED|Overall Study||0
9936|NCT02313155|24718|P2|COMPLETED|Overall Study||54
9937|NCT02313155|24719|P1|COMPLETED|Overall Study||55
9938|NCT02313155|24718|P2|STARTED|Overall Study||55
9939|NCT02313155|24719|P1|STARTED|Overall Study||55
9940|NCT02312739|24769|P2|NOT COMPLETED|Overall Study||2
9941|NCT02312739|24770|P1|NOT COMPLETED|Overall Study||6
9942|NCT02312739|24769|P2|COMPLETED|Overall Study||34
9943|NCT02312739|24770|P1|COMPLETED|Overall Study||30
9944|NCT02312739|24769|P2|Withdrawn Prior to Procedure|Overall Study||2
9945|NCT02312739|24770|P1|Withdrawn Prior to Procedure|Overall Study||6
9946|NCT02312739|24769|P2|STARTED|Overall Study||36
9947|NCT02312739|24770|P1|STARTED|Overall Study||36
9948|NCT02312726|24784|P3|NOT COMPLETED|Overall Study||67
9949|NCT02312726|24785|P2|NOT COMPLETED|Overall Study||0
9950|NCT02312726|24786|P1|NOT COMPLETED|Overall Study||0
9951|NCT02312726|24784|P3|COMPLETED|Overall Study||0
9952|NCT02312726|24785|P2|COMPLETED|Overall Study||30
9953|NCT02312726|24786|P1|COMPLETED|Overall Study||38
9954|NCT02312726|24784|P3|STARTED|Overall Study||67
9955|NCT02312726|24785|P2|STARTED|Overall Study||30
9956|NCT02312726|24786|P1|STARTED|Overall Study||38
9957|NCT02312154|24798|P1|NOT COMPLETED|Overall Study||1
9958|NCT02312154|24798|P1|COMPLETED|Overall Study||24
9959|NCT02312154|24798|P1|STARTED|Overall Study||25
9960|NCT02311972|24815|P2|NOT COMPLETED|Overall Study||0
9961|NCT02311972|24816|P1|NOT COMPLETED|Overall Study||0
9962|NCT02311972|24815|P2|COMPLETED|Overall Study||8
9963|NCT02311972|24816|P1|COMPLETED|Overall Study||12
9964|NCT02311972|24815|P2|STARTED|Overall Study||8
9965|NCT02311972|24816|P1|STARTED|Overall Study||12
9966|NCT02311907|24835|P2|NOT COMPLETED|Overall Study||0
9967|NCT02311907|24836|P1|NOT COMPLETED|Overall Study||0
9968|NCT02311907|24835|P2|COMPLETED|Overall Study||91
9969|NCT02311907|24836|P1|COMPLETED|Overall Study||94
9970|NCT02311907|24835|P2|STARTED|Overall Study||91
9971|NCT02311907|24836|P1|STARTED|Overall Study||94
9972|NCT02311881|24861|P3|NOT COMPLETED|Overall Study||41
9973|NCT02311881|24862|P2|NOT COMPLETED|Overall Study||43
9974|NCT02311881|24863|P1|NOT COMPLETED|Overall Study||35
9975|NCT02311881|24861|P3|COMPLETED|Overall Study||196
9976|NCT02311881|24862|P2|COMPLETED|Overall Study||193
9977|NCT02311881|24863|P1|COMPLETED|Overall Study||200
9978|NCT02311881|24861|P3|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|237
9979|NCT02311881|24862|P2|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|236
9980|NCT02311881|24863|P1|Safety Population|Overall Study|All treated participants: One participant was randomized but did not receive any treatment.|234
10069|NCT02310750|24938|P7|COMPLETED|HP Washout 2||2
9981|NCT02311881|24861|P3|STARTED|Overall Study|Started refers to all randomized participants.|237
9982|NCT02311881|24862|P2|STARTED|Overall Study|Started refers to all randomized participants.|236
9983|NCT02311881|24863|P1|STARTED|Overall Study|Started refers to all randomized participants.|235
9984|NCT02311309|24901|P3|NOT COMPLETED|Overall Study||0
9985|NCT02311309|24902|P2|NOT COMPLETED|Overall Study||0
9986|NCT02311309|24903|P1|NOT COMPLETED|Overall Study||0
9987|NCT02311309|24901|P3|COMPLETED|Overall Study||863
9988|NCT02311309|24902|P2|COMPLETED|Overall Study||35
9989|NCT02311309|24903|P1|COMPLETED|Overall Study||541
9990|NCT02311309|24901|P3|STARTED|Overall Study||863
9991|NCT02311309|24902|P2|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|35
9992|NCT02311309|24903|P1|STARTED|Overall Study|There were 863 patients with no peroperative bleeding in the 1439 patients studied|541
9993|NCT02310776|24914|P1|NOT COMPLETED|Overall Study||0
9994|NCT02310776|24914|P1|COMPLETED|Overall Study||501
9995|NCT02310776|24914|P1|STARTED|Overall Study||501
9996|NCT02310750|24929|P16|NOT COMPLETED|HP MAD and Fasted/Fed||0
9997|NCT02310750|24930|P15|NOT COMPLETED|HP MAD and Fasted/Fed||0
9998|NCT02310750|24931|P14|NOT COMPLETED|HP MAD and Fasted/Fed||0
9999|NCT02310750|24932|P13|NOT COMPLETED|HP MAD and Fasted/Fed||0
10000|NCT02310750|24933|P12|NOT COMPLETED|HP MAD and Fasted/Fed||0
10001|NCT02310750|24934|P11|NOT COMPLETED|HP MAD and Fasted/Fed||0
10002|NCT02310750|24935|P10|NOT COMPLETED|HP MAD and Fasted/Fed||0
10003|NCT02310750|24936|P9|NOT COMPLETED|HP MAD and Fasted/Fed||0
10004|NCT02310750|24937|P8|NOT COMPLETED|HP MAD and Fasted/Fed||0
10005|NCT02310750|24938|P7|NOT COMPLETED|HP MAD and Fasted/Fed||0
10006|NCT02310750|24939|P6|NOT COMPLETED|HP MAD and Fasted/Fed||0
10007|NCT02310750|24940|P5|NOT COMPLETED|HP MAD and Fasted/Fed||1
10008|NCT02310750|24941|P4|NOT COMPLETED|HP MAD and Fasted/Fed||0
10009|NCT02310750|24942|P3|NOT COMPLETED|HP MAD and Fasted/Fed||0
10010|NCT02310750|24943|P2|NOT COMPLETED|HP MAD and Fasted/Fed||0
10011|NCT02310750|24944|P1|NOT COMPLETED|HP MAD and Fasted/Fed||0
10012|NCT02310750|24929|P16|COMPLETED|HP MAD and Fasted/Fed||2
10013|NCT02310750|24930|P15|COMPLETED|HP MAD and Fasted/Fed||2
10014|NCT02310750|24931|P14|COMPLETED|HP MAD and Fasted/Fed||2
10015|NCT02310750|24932|P13|COMPLETED|HP MAD and Fasted/Fed||2
10016|NCT02310750|24933|P12|COMPLETED|HP MAD and Fasted/Fed||2
10017|NCT02310750|24934|P11|COMPLETED|HP MAD and Fasted/Fed||2
10018|NCT02310750|24935|P10|COMPLETED|HP MAD and Fasted/Fed||0
10019|NCT02310750|24936|P9|COMPLETED|HP MAD and Fasted/Fed||0
10020|NCT02310750|24937|P8|COMPLETED|HP MAD and Fasted/Fed||0
10021|NCT02310750|24938|P7|COMPLETED|HP MAD and Fasted/Fed||2
10022|NCT02310750|24939|P6|COMPLETED|HP MAD and Fasted/Fed||0
10023|NCT02310750|24940|P5|COMPLETED|HP MAD and Fasted/Fed||4
10024|NCT02310750|24941|P4|COMPLETED|HP MAD and Fasted/Fed||0
10025|NCT02310750|24942|P3|COMPLETED|HP MAD and Fasted/Fed||0
10026|NCT02310750|24943|P2|COMPLETED|HP MAD and Fasted/Fed||0
10027|NCT02310750|24944|P1|COMPLETED|HP MAD and Fasted/Fed||0
10028|NCT02310750|24929|P16|STARTED|HP MAD and Fasted/Fed||2
10029|NCT02310750|24930|P15|STARTED|HP MAD and Fasted/Fed||2
10030|NCT02310750|24931|P14|STARTED|HP MAD and Fasted/Fed||2
10031|NCT02310750|24932|P13|STARTED|HP MAD and Fasted/Fed||2
10032|NCT02310750|24933|P12|STARTED|HP MAD and Fasted/Fed||2
10033|NCT02310750|24934|P11|STARTED|HP MAD and Fasted/Fed||2
10034|NCT02310750|24935|P10|STARTED|HP MAD and Fasted/Fed||0
10035|NCT02310750|24936|P9|STARTED|HP MAD and Fasted/Fed||0
10036|NCT02310750|24937|P8|STARTED|HP MAD and Fasted/Fed||0
10037|NCT02310750|24938|P7|STARTED|HP MAD and Fasted/Fed||2
10038|NCT02310750|24939|P6|STARTED|HP MAD and Fasted/Fed||0
10039|NCT02310750|24940|P5|STARTED|HP MAD and Fasted/Fed||5
10040|NCT02310750|24941|P4|STARTED|HP MAD and Fasted/Fed||0
10041|NCT02310750|24942|P3|STARTED|HP MAD and Fasted/Fed||0
10042|NCT02310750|24943|P2|STARTED|HP MAD and Fasted/Fed||0
10043|NCT02310750|24944|P1|STARTED|HP MAD and Fasted/Fed||0
10044|NCT02310750|24929|P16|NOT COMPLETED|HP Washout 2||0
10045|NCT02310750|24930|P15|NOT COMPLETED|HP Washout 2||0
10046|NCT02310750|24931|P14|NOT COMPLETED|HP Washout 2||0
10047|NCT02310750|24932|P13|NOT COMPLETED|HP Washout 2||0
10048|NCT02310750|24933|P12|NOT COMPLETED|HP Washout 2||0
10049|NCT02310750|24934|P11|NOT COMPLETED|HP Washout 2||0
10050|NCT02310750|24935|P10|NOT COMPLETED|HP Washout 2||0
10051|NCT02310750|24936|P9|NOT COMPLETED|HP Washout 2||0
10052|NCT02310750|24937|P8|NOT COMPLETED|HP Washout 2||0
10053|NCT02310750|24938|P7|NOT COMPLETED|HP Washout 2||7
10054|NCT02310750|24939|P6|NOT COMPLETED|HP Washout 2||0
10055|NCT02310750|24940|P5|NOT COMPLETED|HP Washout 2||1
10056|NCT02310750|24941|P4|NOT COMPLETED|HP Washout 2||0
10057|NCT02310750|24942|P3|NOT COMPLETED|HP Washout 2||0
10058|NCT02310750|24943|P2|NOT COMPLETED|HP Washout 2||0
10059|NCT02310750|24944|P1|NOT COMPLETED|HP Washout 2||0
10060|NCT02310750|24929|P16|COMPLETED|HP Washout 2||2
10061|NCT02310750|24930|P15|COMPLETED|HP Washout 2||2
10062|NCT02310750|24931|P14|COMPLETED|HP Washout 2||2
10063|NCT02310750|24932|P13|COMPLETED|HP Washout 2||2
10064|NCT02310750|24933|P12|COMPLETED|HP Washout 2||2
10065|NCT02310750|24934|P11|COMPLETED|HP Washout 2||2
10066|NCT02310750|24935|P10|COMPLETED|HP Washout 2||0
10067|NCT02310750|24936|P9|COMPLETED|HP Washout 2||0
10068|NCT02310750|24937|P8|COMPLETED|HP Washout 2||0
10070|NCT02310750|24939|P6|COMPLETED|HP Washout 2||0
10071|NCT02310750|24940|P5|COMPLETED|HP Washout 2||5
10072|NCT02310750|24941|P4|COMPLETED|HP Washout 2||0
10073|NCT02310750|24942|P3|COMPLETED|HP Washout 2||0
10074|NCT02310750|24943|P2|COMPLETED|HP Washout 2||0
10075|NCT02310750|24944|P1|COMPLETED|HP Washout 2||0
10076|NCT02310750|24929|P16|STARTED|HP Washout 2||2
10077|NCT02310750|24930|P15|STARTED|HP Washout 2||2
10078|NCT02310750|24931|P14|STARTED|HP Washout 2||2
10079|NCT02310750|24932|P13|STARTED|HP Washout 2||2
10080|NCT02310750|24933|P12|STARTED|HP Washout 2||2
10081|NCT02310750|24934|P11|STARTED|HP Washout 2||2
10082|NCT02310750|24935|P10|STARTED|HP Washout 2||0
10083|NCT02310750|24936|P9|STARTED|HP Washout 2||0
10084|NCT02310750|24937|P8|STARTED|HP Washout 2||0
10085|NCT02310750|24938|P7|STARTED|HP Washout 2||9
10086|NCT02310750|24939|P6|STARTED|HP Washout 2||0
10087|NCT02310750|24940|P5|STARTED|HP Washout 2||6
10088|NCT02310750|24941|P4|STARTED|HP Washout 2||0
10089|NCT02310750|24942|P3|STARTED|HP Washout 2||0
10090|NCT02310750|24943|P2|STARTED|HP Washout 2||0
10091|NCT02310750|24944|P1|STARTED|HP Washout 2||0
10092|NCT02310750|24929|P16|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10093|NCT02310750|24930|P15|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10094|NCT02310750|24931|P14|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10095|NCT02310750|24932|P13|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10096|NCT02310750|24933|P12|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10097|NCT02310750|24934|P11|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10098|NCT02310750|24935|P10|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
10099|NCT02310750|24936|P9|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||8
10100|NCT02310750|24937|P8|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10101|NCT02310750|24938|P7|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10102|NCT02310750|24939|P6|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10103|NCT02310750|24940|P5|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10104|NCT02310750|24941|P4|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||1
10105|NCT02310750|24942|P3|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10106|NCT02310750|24943|P2|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10107|NCT02310750|24944|P1|NOT COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10108|NCT02310750|24929|P16|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10109|NCT02310750|24930|P15|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10110|NCT02310750|24931|P14|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10111|NCT02310750|24932|P13|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10112|NCT02310750|24933|P12|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10113|NCT02310750|24934|P11|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10114|NCT02310750|24935|P10|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10115|NCT02310750|24936|P9|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10116|NCT02310750|24937|P8|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
10117|NCT02310750|24938|P7|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10118|NCT02310750|24939|P6|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10119|NCT02310750|24940|P5|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10120|NCT02310750|24941|P4|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||3
10121|NCT02310750|24942|P3|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
10122|NCT02310750|24943|P2|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10123|NCT02310750|24944|P1|COMPLETED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10124|NCT02310750|24929|P16|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10125|NCT02310750|24930|P15|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10126|NCT02310750|24931|P14|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10127|NCT02310750|24932|P13|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10128|NCT02310750|24933|P12|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10129|NCT02310750|24934|P11|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||2
10130|NCT02310750|24935|P10|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||7
10131|NCT02310750|24936|P9|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||14
10132|NCT02310750|24937|P8|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10133|NCT02310750|24938|P7|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||9
10134|NCT02310750|24939|P6|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10135|NCT02310750|24940|P5|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||6
10136|NCT02310750|24941|P4|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||4
10137|NCT02310750|24942|P3|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||5
10138|NCT02310750|24943|P2|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10139|NCT02310750|24944|P1|STARTED|HP MAD, Psoriasis MD, HP Fasted/Fed||0
10140|NCT02310750|24929|P16|NOT COMPLETED|HP Washout 1||0
10141|NCT02310750|24930|P15|NOT COMPLETED|HP Washout 1||0
10142|NCT02310750|24931|P14|NOT COMPLETED|HP Washout 1||0
10143|NCT02310750|24932|P13|NOT COMPLETED|HP Washout 1||0
10144|NCT02310750|24933|P12|NOT COMPLETED|HP Washout 1||0
10145|NCT02310750|24934|P11|NOT COMPLETED|HP Washout 1||0
10146|NCT02310750|24935|P10|NOT COMPLETED|HP Washout 1||0
10147|NCT02310750|24936|P9|NOT COMPLETED|HP Washout 1||0
10148|NCT02310750|24937|P8|NOT COMPLETED|HP Washout 1||0
10149|NCT02310750|24938|P7|NOT COMPLETED|HP Washout 1||3
10150|NCT02310750|24939|P6|NOT COMPLETED|HP Washout 1||2
10151|NCT02310750|24940|P5|NOT COMPLETED|HP Washout 1||2
10152|NCT02310750|24941|P4|NOT COMPLETED|HP Washout 1||1
10153|NCT02310750|24942|P3|NOT COMPLETED|HP Washout 1||1
10154|NCT02310750|24943|P2|NOT COMPLETED|HP Washout 1||0
10155|NCT02310750|24944|P1|NOT COMPLETED|HP Washout 1||0
10156|NCT02310750|24929|P16|COMPLETED|HP Washout 1||2
10157|NCT02310750|24930|P15|COMPLETED|HP Washout 1||2
10158|NCT02310750|24931|P14|COMPLETED|HP Washout 1||2
10159|NCT02310750|24932|P13|COMPLETED|HP Washout 1||2
10160|NCT02310750|24933|P12|COMPLETED|HP Washout 1||2
10161|NCT02310750|24934|P11|COMPLETED|HP Washout 1||2
10162|NCT02310750|24935|P10|COMPLETED|HP Washout 1||0
10163|NCT02310750|24936|P9|COMPLETED|HP Washout 1||0
10164|NCT02310750|24937|P8|COMPLETED|HP Washout 1||0
10165|NCT02310750|24938|P7|COMPLETED|HP Washout 1||9
10166|NCT02310750|24939|P6|COMPLETED|HP Washout 1||6
10167|NCT02310750|24940|P5|COMPLETED|HP Washout 1||6
10168|NCT02310750|24941|P4|COMPLETED|HP Washout 1||4
10169|NCT02310750|24942|P3|COMPLETED|HP Washout 1||5
10170|NCT02310750|24943|P2|COMPLETED|HP Washout 1||0
10171|NCT02310750|24944|P1|COMPLETED|HP Washout 1||0
10172|NCT02310750|24929|P16|STARTED|HP Washout 1||2
10173|NCT02310750|24930|P15|STARTED|HP Washout 1||2
10174|NCT02310750|24931|P14|STARTED|HP Washout 1||2
10175|NCT02310750|24932|P13|STARTED|HP Washout 1||2
10176|NCT02310750|24933|P12|STARTED|HP Washout 1||2
10177|NCT02310750|24934|P11|STARTED|HP Washout 1||2
10178|NCT02310750|24935|P10|STARTED|HP Washout 1||0
10179|NCT02310750|24936|P9|STARTED|HP Washout 1||0
10180|NCT02310750|24937|P8|STARTED|HP Washout 1||0
10181|NCT02310750|24938|P7|STARTED|HP Washout 1||12
10182|NCT02310750|24939|P6|STARTED|HP Washout 1||8
10183|NCT02310750|24940|P5|STARTED|HP Washout 1||8
10184|NCT02310750|24941|P4|STARTED|HP Washout 1||5
10185|NCT02310750|24942|P3|STARTED|HP Washout 1||6
10186|NCT02310750|24943|P2|STARTED|HP Washout 1||0
10187|NCT02310750|24944|P1|STARTED|HP Washout 1||0
10188|NCT02310750|24929|P16|NOT COMPLETED|HP Period 1||0
10189|NCT02310750|24930|P15|NOT COMPLETED|HP Period 1||0
10190|NCT02310750|24931|P14|NOT COMPLETED|HP Period 1||0
10191|NCT02310750|24932|P13|NOT COMPLETED|HP Period 1||0
10192|NCT02310750|24933|P12|NOT COMPLETED|HP Period 1||0
10193|NCT02310750|24934|P11|NOT COMPLETED|HP Period 1||0
10194|NCT02310750|24935|P10|NOT COMPLETED|HP Period 1||0
10195|NCT02310750|24936|P9|NOT COMPLETED|HP Period 1||0
10196|NCT02310750|24937|P8|NOT COMPLETED|HP Period 1||0
10197|NCT02310750|24938|P7|NOT COMPLETED|HP Period 1||1
10198|NCT02310750|24939|P6|NOT COMPLETED|HP Period 1||0
10199|NCT02310750|24940|P5|NOT COMPLETED|HP Period 1||0
10200|NCT02310750|24941|P4|NOT COMPLETED|HP Period 1||1
10201|NCT02310750|24942|P3|NOT COMPLETED|HP Period 1||0
10202|NCT02310750|24943|P2|NOT COMPLETED|HP Period 1||0
10203|NCT02310750|24944|P1|NOT COMPLETED|HP Period 1||1
10204|NCT02310750|24929|P16|COMPLETED|HP Period 1||2
10205|NCT02310750|24930|P15|COMPLETED|HP Period 1||2
10206|NCT02310750|24931|P14|COMPLETED|HP Period 1||2
10207|NCT02310750|24932|P13|COMPLETED|HP Period 1||2
10208|NCT02310750|24933|P12|COMPLETED|HP Period 1||2
10209|NCT02310750|24934|P11|COMPLETED|HP Period 1||2
10210|NCT02310750|24935|P10|COMPLETED|HP Period 1||0
10211|NCT02310750|24936|P9|COMPLETED|HP Period 1||0
10212|NCT02310750|24937|P8|COMPLETED|HP Period 1||0
10213|NCT02310750|24938|P7|COMPLETED|HP Period 1||12
10214|NCT02310750|24939|P6|COMPLETED|HP Period 1||8
10215|NCT02310750|24940|P5|COMPLETED|HP Period 1||8
10216|NCT02310750|24941|P4|COMPLETED|HP Period 1||5
10217|NCT02310750|24942|P3|COMPLETED|HP Period 1||6
10218|NCT02310750|24943|P2|COMPLETED|HP Period 1||6
10219|NCT02310750|24944|P1|COMPLETED|HP Period 1||6
10220|NCT02310750|24929|P16|STARTED|HP Period 1||2
10221|NCT02310750|24930|P15|STARTED|HP Period 1||2
10222|NCT02310750|24931|P14|STARTED|HP Period 1||2
10223|NCT02310750|24932|P13|STARTED|HP Period 1||2
10224|NCT02310750|24933|P12|STARTED|HP Period 1||2
10225|NCT02310750|24934|P11|STARTED|HP Period 1||2
10226|NCT02310750|24935|P10|STARTED|HP Period 1||0
10227|NCT02310750|24936|P9|STARTED|HP Period 1||0
10228|NCT02310750|24937|P8|STARTED|HP Period 1||0
10229|NCT02310750|24938|P7|STARTED|HP Period 1||13
10230|NCT02310750|24939|P6|STARTED|HP Period 1||8
10231|NCT02310750|24940|P5|STARTED|HP Period 1||8
10232|NCT02310750|24941|P4|STARTED|HP Period 1||6
10233|NCT02310750|24942|P3|STARTED|HP Period 1||6
10234|NCT02310750|24943|P2|STARTED|HP Period 1||6
10235|NCT02310750|24944|P1|STARTED|HP Period 1||7
10236|NCT02310646|25385|P2|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
10237|NCT02310646|25386|P1|NOT COMPLETED|Second Intervention (Day 8 - Day 14)||0
10238|NCT02310646|25385|P2|COMPLETED|Second Intervention (Day 8 - Day 14)||104
10239|NCT02310646|25386|P1|COMPLETED|Second Intervention (Day 8 - Day 14)||107
10240|NCT02310646|25385|P2|STARTED|Second Intervention (Day 8 - Day 14)||104
10241|NCT02310646|25386|P1|STARTED|Second Intervention (Day 8 - Day 14)||107
10242|NCT02310646|25385|P2|NOT COMPLETED|First Intervention (Day 1 - Day 7)||0
10243|NCT02310646|25386|P1|NOT COMPLETED|First Intervention (Day 1 - Day 7)||2
10244|NCT02310646|25385|P2|COMPLETED|First Intervention (Day 1 - Day 7)||104
10245|NCT02310646|25386|P1|COMPLETED|First Intervention (Day 1 - Day 7)||107
10246|NCT02310646|25385|P2|STARTED|First Intervention (Day 1 - Day 7)||104
10247|NCT02310646|25386|P1|STARTED|First Intervention (Day 1 - Day 7)||109
10248|NCT02310581|25414|P4|NOT COMPLETED|Overall Study||1
10249|NCT02310581|25415|P3|NOT COMPLETED|Overall Study||1
10250|NCT02310581|25416|P2|NOT COMPLETED|Overall Study||2
10251|NCT02310581|25417|P1|NOT COMPLETED|Overall Study||3
10252|NCT02310581|25414|P4|COMPLETED|Overall Study||9
10253|NCT02310581|25415|P3|COMPLETED|Overall Study||9
10254|NCT02310581|25416|P2|COMPLETED|Overall Study||9
10255|NCT02310581|25417|P1|COMPLETED|Overall Study||6
10256|NCT02310581|25414|P4|STARTED|Overall Study||10
10257|NCT02310581|25415|P3|STARTED|Overall Study||10
10258|NCT02310581|25416|P2|STARTED|Overall Study||11
10259|NCT02310581|25417|P1|STARTED|Overall Study||9
10260|NCT02310568|25456|P5|NOT COMPLETED|Stage 2 (4 Weeks)||1
10261|NCT02310568|25457|P4|NOT COMPLETED|Stage 2 (4 Weeks)||5
10262|NCT02310568|25458|P3|NOT COMPLETED|Stage 2 (4 Weeks)||1
10263|NCT02310568|25459|P2|NOT COMPLETED|Stage 2 (4 Weeks)||1
10264|NCT02310568|25460|P1|NOT COMPLETED|Stage 2 (4 Weeks)||1
10265|NCT02310568|25456|P5|COMPLETED|Stage 2 (4 Weeks)||19
10266|NCT02310568|25457|P4|COMPLETED|Stage 2 (4 Weeks)||17
10267|NCT02310568|25458|P3|COMPLETED|Stage 2 (4 Weeks)||13
10268|NCT02310568|25459|P2|COMPLETED|Stage 2 (4 Weeks)||12
10269|NCT02310568|25460|P1|COMPLETED|Stage 2 (4 Weeks)||11
10270|NCT02310568|25456|P5|STARTED|Stage 2 (4 Weeks)||20
10271|NCT02310568|25457|P4|STARTED|Stage 2 (4 Weeks)||22
10272|NCT02310568|25458|P3|STARTED|Stage 2 (4 Weeks)||14
10273|NCT02310568|25459|P2|STARTED|Stage 2 (4 Weeks)||13
10274|NCT02310568|25460|P1|STARTED|Stage 2 (4 Weeks)||12
10275|NCT02310568|25456|P5|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
10276|NCT02310568|25457|P4|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
10277|NCT02310568|25458|P3|NOT COMPLETED|Stage 1 ( 4 Weeks)||1
10278|NCT02310568|25459|P2|NOT COMPLETED|Stage 1 ( 4 Weeks)||2
10279|NCT02310568|25460|P1|NOT COMPLETED|Stage 1 ( 4 Weeks)||3
10280|NCT02310568|25456|P5|COMPLETED|Stage 1 ( 4 Weeks)||20
10281|NCT02310568|25457|P4|COMPLETED|Stage 1 ( 4 Weeks)||22
10282|NCT02310568|25458|P3|COMPLETED|Stage 1 ( 4 Weeks)||14
10283|NCT02310568|25459|P2|COMPLETED|Stage 1 ( 4 Weeks)||13
10284|NCT02310568|25460|P1|COMPLETED|Stage 1 ( 4 Weeks)||12
10285|NCT02310568|25456|P5|STARTED|Stage 1 ( 4 Weeks)||21
10286|NCT02310568|25457|P4|STARTED|Stage 1 ( 4 Weeks)||24
10287|NCT02310568|25458|P3|STARTED|Stage 1 ( 4 Weeks)||15
10288|NCT02310568|25459|P2|STARTED|Stage 1 ( 4 Weeks)||15
10289|NCT02310568|25460|P1|STARTED|Stage 1 ( 4 Weeks)||15
10290|NCT02310126|25540|P2|NOT COMPLETED|Period 2 (15 Minutes)||0
10291|NCT02310126|25541|P1|NOT COMPLETED|Period 2 (15 Minutes)||0
10292|NCT02310126|25540|P2|COMPLETED|Period 2 (15 Minutes)||95
10293|NCT02310126|25541|P1|COMPLETED|Period 2 (15 Minutes)||94
10294|NCT02310126|25540|P2|Myopes|Period 2 (15 Minutes)||63
10295|NCT02310126|25541|P1|Myopes|Period 2 (15 Minutes)||56
10296|NCT02310126|25540|P2|Hyperopes|Period 2 (15 Minutes)||32
10297|NCT02310126|25541|P1|Hyperopes|Period 2 (15 Minutes)||38
10298|NCT02310126|25540|P2|STARTED|Period 2 (15 Minutes)||95
10299|NCT02310126|25541|P1|STARTED|Period 2 (15 Minutes)||94
10300|NCT02310126|25540|P2|NOT COMPLETED|Period 1 (15 Minutes)||2
10301|NCT02310126|25541|P1|NOT COMPLETED|Period 1 (15 Minutes)||0
10302|NCT02310126|25540|P2|COMPLETED|Period 1 (15 Minutes)||95
10303|NCT02310126|25541|P1|COMPLETED|Period 1 (15 Minutes)||94
10304|NCT02310126|25540|P2|Myopes|Period 1 (15 Minutes)||64
10305|NCT02310126|25541|P1|Myopes|Period 1 (15 Minutes)||56
10306|NCT02310126|25540|P2|Hyperopes|Period 1 (15 Minutes)||33
10307|NCT02310126|25541|P1|Hyperopes|Period 1 (15 Minutes)||38
10308|NCT02310126|25540|P2|STARTED|Period 1 (15 Minutes)||97
10309|NCT02310126|25541|P1|STARTED|Period 1 (15 Minutes)||94
10310|NCT02309723|25550|P3|NOT COMPLETED|Overall Study||24
10311|NCT02309723|25551|P2|NOT COMPLETED|Overall Study||23
10312|NCT02309723|25552|P1|NOT COMPLETED|Overall Study||24
10313|NCT02309723|25550|P3|COMPLETED|Overall Study||105
10314|NCT02309723|25551|P2|COMPLETED|Overall Study||105
10315|NCT02309723|25552|P1|COMPLETED|Overall Study||105
10316|NCT02309723|25550|P3|STARTED|Overall Study||129
10317|NCT02309723|25551|P2|STARTED|Overall Study||128
10318|NCT02309723|25552|P1|STARTED|Overall Study||129
10319|NCT02309294|25566|P1|NOT COMPLETED|Overall Study||2
10320|NCT02309294|25566|P1|COMPLETED|Overall Study||41
10321|NCT02309294|25566|P1|STARTED|Overall Study||43
10322|NCT02309112|25573|P3|NOT COMPLETED|Overall Study||1
10323|NCT02309112|25574|P2|NOT COMPLETED|Overall Study||1
10324|NCT02309112|25575|P1|NOT COMPLETED|Overall Study||1
10325|NCT02309112|25573|P3|COMPLETED|Overall Study||4
10326|NCT02309112|25574|P2|COMPLETED|Overall Study||4
10327|NCT02309112|25575|P1|COMPLETED|Overall Study||4
10328|NCT02309112|25573|P3|Completed Yoga Intervention|Overall Study||4
10329|NCT02309112|25574|P2|Completed Yoga Intervention|Overall Study||5
10330|NCT02309112|25575|P1|Completed Yoga Intervention|Overall Study||4
10331|NCT02309112|25573|P3|STARTED|Overall Study||5
10332|NCT02309112|25574|P2|STARTED|Overall Study||5
10333|NCT02309112|25575|P1|STARTED|Overall Study||5
10334|NCT02308787|25596|P1|NOT COMPLETED|Overall Study||0
10335|NCT02308787|25596|P1|COMPLETED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
10336|NCT02308787|25596|P1|STARTED|Overall Study|Data were collected from 20 PLTD procedures performed in 12 subjects|12
10337|NCT02308748|25611|P10|NOT COMPLETED|Period 5||0
10338|NCT02308748|25612|P9|NOT COMPLETED|Period 5||1
10339|NCT02308748|25613|P8|NOT COMPLETED|Period 5||0
10340|NCT02308748|25614|P7|NOT COMPLETED|Period 5||0
10341|NCT02308748|25615|P6|NOT COMPLETED|Period 5||0
10342|NCT02308748|25616|P5|NOT COMPLETED|Period 5||0
10343|NCT02308748|25617|P4|NOT COMPLETED|Period 5||0
10344|NCT02308748|25618|P3|NOT COMPLETED|Period 5||0
10345|NCT02308748|25619|P2|NOT COMPLETED|Period 5||0
10346|NCT02308748|25620|P1|NOT COMPLETED|Period 5||1
10347|NCT02308748|25611|P10|COMPLETED|Period 5||2
10348|NCT02308748|25612|P9|COMPLETED|Period 5||1
10349|NCT02308748|25613|P8|COMPLETED|Period 5||1
10350|NCT02308748|25614|P7|COMPLETED|Period 5||2
10351|NCT02308748|25615|P6|COMPLETED|Period 5||3
10352|NCT02308748|25616|P5|COMPLETED|Period 5||2
10353|NCT02308748|25617|P4|COMPLETED|Period 5||2
10354|NCT02308748|25618|P3|COMPLETED|Period 5||1
10355|NCT02308748|25619|P2|COMPLETED|Period 5||2
10356|NCT02308748|25620|P1|COMPLETED|Period 5||1
10357|NCT02308748|25611|P10|STARTED|Period 5||2
10358|NCT02308748|25612|P9|STARTED|Period 5||2
10359|NCT02308748|25613|P8|STARTED|Period 5||1
10360|NCT02308748|25614|P7|STARTED|Period 5||2
10361|NCT02308748|25615|P6|STARTED|Period 5||3
10362|NCT02308748|25616|P5|STARTED|Period 5||2
10363|NCT02308748|25617|P4|STARTED|Period 5||2
10364|NCT02308748|25618|P3|STARTED|Period 5||1
10365|NCT02308748|25619|P2|STARTED|Period 5||2
10366|NCT02308748|25620|P1|STARTED|Period 5||2
10367|NCT02308748|25611|P10|NOT COMPLETED|Period 4||0
10368|NCT02308748|25612|P9|NOT COMPLETED|Period 4||0
10369|NCT02308748|25613|P8|NOT COMPLETED|Period 4||0
10370|NCT02308748|25614|P7|NOT COMPLETED|Period 4||0
10371|NCT02308748|25615|P6|NOT COMPLETED|Period 4||0
10372|NCT02308748|25616|P5|NOT COMPLETED|Period 4||0
10373|NCT02308748|25617|P4|NOT COMPLETED|Period 4||0
10374|NCT02308748|25618|P3|NOT COMPLETED|Period 4||0
10375|NCT02308748|25619|P2|NOT COMPLETED|Period 4||0
10376|NCT02308748|25620|P1|NOT COMPLETED|Period 4||0
10377|NCT02308748|25611|P10|COMPLETED|Period 4||2
10378|NCT02308748|25612|P9|COMPLETED|Period 4||2
10379|NCT02308748|25613|P8|COMPLETED|Period 4||1
10380|NCT02308748|25614|P7|COMPLETED|Period 4||2
10381|NCT02308748|25615|P6|COMPLETED|Period 4||3
10382|NCT02308748|25616|P5|COMPLETED|Period 4||2
10383|NCT02308748|25617|P4|COMPLETED|Period 4||2
10384|NCT02308748|25618|P3|COMPLETED|Period 4||1
10385|NCT02308748|25619|P2|COMPLETED|Period 4||2
10386|NCT02308748|25620|P1|COMPLETED|Period 4||2
10387|NCT02308748|25611|P10|STARTED|Period 4||2
10388|NCT02308748|25612|P9|STARTED|Period 4||2
10389|NCT02308748|25613|P8|STARTED|Period 4||1
10390|NCT02308748|25614|P7|STARTED|Period 4||2
10391|NCT02308748|25615|P6|STARTED|Period 4||3
10392|NCT02308748|25616|P5|STARTED|Period 4||2
10393|NCT02308748|25617|P4|STARTED|Period 4||2
10394|NCT02308748|25618|P3|STARTED|Period 4||1
10395|NCT02308748|25619|P2|STARTED|Period 4||2
10396|NCT02308748|25620|P1|STARTED|Period 4||2
10397|NCT02308748|25611|P10|NOT COMPLETED|Period 3||1
10398|NCT02308748|25612|P9|NOT COMPLETED|Period 3||0
10399|NCT02308748|25613|P8|NOT COMPLETED|Period 3||0
10400|NCT02308748|25614|P7|NOT COMPLETED|Period 3||0
10401|NCT02308748|25615|P6|NOT COMPLETED|Period 3||0
10402|NCT02308748|25616|P5|NOT COMPLETED|Period 3||0
10403|NCT02308748|25617|P4|NOT COMPLETED|Period 3||0
10404|NCT02308748|25618|P3|NOT COMPLETED|Period 3||0
10405|NCT02308748|25619|P2|NOT COMPLETED|Period 3||0
10406|NCT02308748|25620|P1|NOT COMPLETED|Period 3||0
10407|NCT02308748|25611|P10|COMPLETED|Period 3||2
10408|NCT02308748|25612|P9|COMPLETED|Period 3||2
10409|NCT02308748|25613|P8|COMPLETED|Period 3||1
10410|NCT02308748|25614|P7|COMPLETED|Period 3||2
10411|NCT02308748|25615|P6|COMPLETED|Period 3||3
10412|NCT02308748|25616|P5|COMPLETED|Period 3||2
10413|NCT02308748|25617|P4|COMPLETED|Period 3||2
10414|NCT02308748|25618|P3|COMPLETED|Period 3||1
10415|NCT02308748|25619|P2|COMPLETED|Period 3||2
10416|NCT02308748|25620|P1|COMPLETED|Period 3||2
10417|NCT02308748|25611|P10|STARTED|Period 3||3
10418|NCT02308748|25612|P9|STARTED|Period 3||2
10419|NCT02308748|25613|P8|STARTED|Period 3||1
10420|NCT02308748|25614|P7|STARTED|Period 3||2
10421|NCT02308748|25615|P6|STARTED|Period 3||3
10422|NCT02308748|25616|P5|STARTED|Period 3||2
10423|NCT02308748|25617|P4|STARTED|Period 3||2
10424|NCT02308748|25618|P3|STARTED|Period 3||1
10425|NCT02308748|25619|P2|STARTED|Period 3||2
10426|NCT02308748|25620|P1|STARTED|Period 3||2
10427|NCT02308748|25611|P10|NOT COMPLETED|Period 2||0
10428|NCT02308748|25612|P9|NOT COMPLETED|Period 2||0
10429|NCT02308748|25613|P8|NOT COMPLETED|Period 2||1
10430|NCT02308748|25614|P7|NOT COMPLETED|Period 2||0
10431|NCT02308748|25615|P6|NOT COMPLETED|Period 2||0
10432|NCT02308748|25616|P5|NOT COMPLETED|Period 2||0
10433|NCT02308748|25617|P4|NOT COMPLETED|Period 2||0
10434|NCT02308748|25618|P3|NOT COMPLETED|Period 2||0
10435|NCT02308748|25619|P2|NOT COMPLETED|Period 2||0
10436|NCT02308748|25620|P1|NOT COMPLETED|Period 2||0
10437|NCT02308748|25611|P10|COMPLETED|Period 2||3
10438|NCT02308748|25612|P9|COMPLETED|Period 2||2
10439|NCT02308748|25613|P8|COMPLETED|Period 2||1
10440|NCT02308748|25614|P7|COMPLETED|Period 2||2
10441|NCT02308748|25615|P6|COMPLETED|Period 2||3
10442|NCT02308748|25616|P5|COMPLETED|Period 2||2
10443|NCT02308748|25617|P4|COMPLETED|Period 2||2
10444|NCT02308748|25618|P3|COMPLETED|Period 2||1
10445|NCT02308748|25619|P2|COMPLETED|Period 2||2
10446|NCT02308748|25620|P1|COMPLETED|Period 2||2
10447|NCT02308748|25611|P10|STARTED|Period 2||3
10448|NCT02308748|25612|P9|STARTED|Period 2||2
10449|NCT02308748|25613|P8|STARTED|Period 2||2
10450|NCT02308748|25614|P7|STARTED|Period 2||2
10451|NCT02308748|25615|P6|STARTED|Period 2||3
10452|NCT02308748|25616|P5|STARTED|Period 2||2
10453|NCT02308748|25617|P4|STARTED|Period 2||2
10454|NCT02308748|25618|P3|STARTED|Period 2||1
10455|NCT02308748|25619|P2|STARTED|Period 2||2
10456|NCT02308748|25620|P1|STARTED|Period 2||2
10457|NCT02308748|25611|P10|NOT COMPLETED|Period 1||0
10458|NCT02308748|25612|P9|NOT COMPLETED|Period 1||0
10459|NCT02308748|25613|P8|NOT COMPLETED|Period 1||0
10460|NCT02308748|25614|P7|NOT COMPLETED|Period 1||0
10461|NCT02308748|25615|P6|NOT COMPLETED|Period 1||0
10462|NCT02308748|25616|P5|NOT COMPLETED|Period 1||0
10463|NCT02308748|25617|P4|NOT COMPLETED|Period 1||0
10464|NCT02308748|25618|P3|NOT COMPLETED|Period 1||1
10465|NCT02308748|25619|P2|NOT COMPLETED|Period 1||0
10466|NCT02308748|25620|P1|NOT COMPLETED|Period 1||0
10467|NCT02308748|25611|P10|COMPLETED|Period 1||3
10468|NCT02308748|25612|P9|COMPLETED|Period 1||2
10469|NCT02308748|25613|P8|COMPLETED|Period 1||2
10470|NCT02308748|25614|P7|COMPLETED|Period 1||2
10471|NCT02308748|25615|P6|COMPLETED|Period 1||3
10472|NCT02308748|25616|P5|COMPLETED|Period 1||2
10473|NCT02308748|25617|P4|COMPLETED|Period 1||2
10474|NCT02308748|25618|P3|COMPLETED|Period 1|One subject withdraw consent before starting Period 2|1
10475|NCT02308748|25619|P2|COMPLETED|Period 1||2
10476|NCT02308748|25620|P1|COMPLETED|Period 1||2
10477|NCT02308748|25611|P10|STARTED|Period 1||3
10478|NCT02308748|25612|P9|STARTED|Period 1||2
10479|NCT02308748|25613|P8|STARTED|Period 1||2
10480|NCT02308748|25614|P7|STARTED|Period 1||2
10481|NCT02308748|25615|P6|STARTED|Period 1||3
10482|NCT02308748|25616|P5|STARTED|Period 1||2
10483|NCT02308748|25617|P4|STARTED|Period 1||2
10484|NCT02308748|25618|P3|STARTED|Period 1||2
10485|NCT02308748|25619|P2|STARTED|Period 1||2
10486|NCT02308748|25620|P1|STARTED|Period 1||2
10487|NCT02308371|25634|P2|NOT COMPLETED|Overall Study||0
10488|NCT02308371|25635|P1|NOT COMPLETED|Overall Study||0
10489|NCT02308371|25634|P2|COMPLETED|Overall Study|Consider eligible for retrospective enrollment if admitted up until 10/15/2012|50
10490|NCT02308371|25635|P1|COMPLETED|Overall Study|Ended enrollment and recruitment 3/1/2016|50
10491|NCT02308371|25634|P2|STARTED|Overall Study|Consider eligible for retrospective enrollment if admitted after 4/1/2012|50
10492|NCT02308371|25635|P1|STARTED|Overall Study|Started enrollment and recruitment 11/26/2014|50
10493|NCT02308124|25652|P3|NOT COMPLETED|Overall Study||8
10494|NCT02308124|25653|P2|NOT COMPLETED|Overall Study||8
10495|NCT02308124|25654|P1|NOT COMPLETED|Overall Study||6
10496|NCT02308124|25652|P3|COMPLETED|Overall Study||21
10497|NCT02308124|25653|P2|COMPLETED|Overall Study||21
10498|NCT02308124|25654|P1|COMPLETED|Overall Study||23
10499|NCT02308124|25652|P3|STARTED|Overall Study||29
10500|NCT02308124|25653|P2|STARTED|Overall Study||29
10501|NCT02308124|25654|P1|STARTED|Overall Study||29
10502|NCT02307838|25677|P3|NOT COMPLETED|Overall Study||0
10503|NCT02307838|25678|P2|NOT COMPLETED|Overall Study||0
10504|NCT02307838|25679|P1|NOT COMPLETED|Overall Study||0
10505|NCT02307838|25677|P3|COMPLETED|Overall Study||55
10506|NCT02307838|25678|P2|COMPLETED|Overall Study||64
10507|NCT02307838|25679|P1|COMPLETED|Overall Study||56
10508|NCT02307838|25677|P3|STARTED|Overall Study||55
10509|NCT02307838|25678|P2|STARTED|Overall Study||64
10510|NCT02307838|25679|P1|STARTED|Overall Study||56
10511|NCT02307552|25722|P1|NOT COMPLETED|Overall Study||0
10512|NCT02307552|25722|P1|COMPLETED|Overall Study||1
10513|NCT02307552|25722|P1|STARTED|Overall Study||1
10514|NCT02307526|25726|P1|NOT COMPLETED|Day 2 - 60 mg of Pyridostigmine||0
10515|NCT02307526|25726|P1|COMPLETED|Day 2 - 60 mg of Pyridostigmine||10
10516|NCT02307526|25726|P1|STARTED|Day 2 - 60 mg of Pyridostigmine||10
10517|NCT02307526|25726|P1|NOT COMPLETED|Day 1 - No Drug||0
10518|NCT02307526|25726|P1|COMPLETED|Day 1 - No Drug||10
10519|NCT02307526|25726|P1|STARTED|Day 1 - No Drug||10
10520|NCT02307318|25736|P1|NOT COMPLETED|Overall Study||0
10521|NCT02307318|25736|P1|COMPLETED|Overall Study||51
10522|NCT02307318|25736|P1|STARTED|Overall Study||51
10523|NCT02307266|25746|P3|NOT COMPLETED|Overall Study||6
10524|NCT02307266|25747|P2|NOT COMPLETED|Overall Study||1
10525|NCT02307266|25748|P1|NOT COMPLETED|Overall Study||8
10526|NCT02307266|25746|P3|COMPLETED|Overall Study||25
10527|NCT02307266|25747|P2|COMPLETED|Overall Study||32
10528|NCT02307266|25748|P1|COMPLETED|Overall Study||25
10529|NCT02307266|25746|P3|STARTED|Overall Study||31
10530|NCT02307266|25747|P2|STARTED|Overall Study||33
10531|NCT02307266|25748|P1|STARTED|Overall Study||33
10532|NCT02307188|25756|P1|NOT COMPLETED|Overall Study||4
10533|NCT02307188|25756|P1|COMPLETED|Overall Study|Four of 5 patients did not meet required criteria to complete the study after they were enrolled.|1
10534|NCT02307188|25756|P1|STARTED|Overall Study||5
10535|NCT02307123|25760|P1|NOT COMPLETED|Overall Study||0
10536|NCT02307123|25760|P1|COMPLETED|Overall Study||483
10537|NCT02307123|25760|P1|STARTED|Overall Study||483
10538|NCT02306928|25765|P1|NOT COMPLETED|Overall Study||0
10539|NCT02306928|25765|P1|COMPLETED|Overall Study||15
10540|NCT02306928|25765|P1|STARTED|Overall Study||15
10541|NCT02306759|25775|P2|NOT COMPLETED|Overall Study||0
10542|NCT02306759|25776|P1|NOT COMPLETED|Overall Study||0
10543|NCT02306759|25775|P2|COMPLETED|Overall Study||30
10544|NCT02306759|25776|P1|COMPLETED|Overall Study||30
10545|NCT02306759|25775|P2|STARTED|Overall Study||30
10546|NCT02306759|25776|P1|STARTED|Overall Study||30
10547|NCT02305446|25790|P1|NOT COMPLETED|Overall Study||1
10548|NCT02305446|25790|P1|COMPLETED|Overall Study||54
10549|NCT02305446|25790|P1|STARTED|Overall Study||55
10550|NCT02305329|25799|P4|NOT COMPLETED|Overall Study||0
10551|NCT02305329|25800|P3|NOT COMPLETED|Overall Study||0
10552|NCT02305329|25801|P2|NOT COMPLETED|Overall Study||1
10553|NCT02305329|25802|P1|NOT COMPLETED|Overall Study||0
10554|NCT02305329|25799|P4|COMPLETED|Overall Study||14
10555|NCT02305329|25800|P3|COMPLETED|Overall Study||14
10556|NCT02305329|25801|P2|COMPLETED|Overall Study||13
10557|NCT02305329|25802|P1|COMPLETED|Overall Study||14
10558|NCT02305329|25799|P4|Period 2|Overall Study||14
10559|NCT02305329|25800|P3|Period 2|Overall Study||14
10560|NCT02305329|25801|P2|Period 2|Overall Study||13
10561|NCT02305329|25802|P1|Period 2|Overall Study||14
10562|NCT02305329|25799|P4|Period 1|Overall Study||14
10563|NCT02305329|25800|P3|Period 1|Overall Study||14
10564|NCT02305329|25801|P2|Period 1|Overall Study||14
10565|NCT02305329|25802|P1|Period 1|Overall Study||14
10566|NCT02305329|25799|P4|STARTED|Overall Study||14
10567|NCT02305329|25800|P3|STARTED|Overall Study||14
10568|NCT02305329|25801|P2|STARTED|Overall Study||14
10569|NCT02305329|25802|P1|STARTED|Overall Study||14
10570|NCT02305316|25826|P2|NOT COMPLETED|Overall Study||0
10571|NCT02305316|25827|P1|NOT COMPLETED|Overall Study||0
10572|NCT02305316|25826|P2|COMPLETED|Overall Study||14
10573|NCT02305316|25827|P1|COMPLETED|Overall Study||14
10574|NCT02305316|25826|P2|STARTED|Overall Study||14
10575|NCT02305316|25827|P1|STARTED|Overall Study||14
10576|NCT02305277|25845|P6|NOT COMPLETED|Overall Study||0
10577|NCT02305277|25846|P5|NOT COMPLETED|Overall Study||1
10578|NCT02305277|25847|P4|NOT COMPLETED|Overall Study||0
10579|NCT02305277|25848|P3|NOT COMPLETED|Overall Study||0
10580|NCT02305277|25849|P2|NOT COMPLETED|Overall Study||0
10581|NCT02305277|25850|P1|NOT COMPLETED|Overall Study||1
10582|NCT02305277|25845|P6|COMPLETED|Overall Study||14
10583|NCT02305277|25846|P5|COMPLETED|Overall Study||13
10584|NCT02305277|25847|P4|COMPLETED|Overall Study||14
10585|NCT02305277|25848|P3|COMPLETED|Overall Study||14
10586|NCT02305277|25849|P2|COMPLETED|Overall Study||14
10587|NCT02305277|25850|P1|COMPLETED|Overall Study||14
10588|NCT02305277|25845|P6|Received TBM|Overall Study||14
10589|NCT02305277|25846|P5|Received TBM|Overall Study||14
10590|NCT02305277|25847|P4|Received TBM|Overall Study||14
10591|NCT02305277|25848|P3|Received TBM|Overall Study||14
10592|NCT02305277|25849|P2|Received TBM|Overall Study||14
10593|NCT02305277|25850|P1|Received TBM|Overall Study||15
10594|NCT02305277|25845|P6|Received CM|Overall Study||14
10595|NCT02305277|25846|P5|Received CM|Overall Study||14
10596|NCT02305277|25847|P4|Received CM|Overall Study||14
10597|NCT02305277|25848|P3|Received CM|Overall Study||14
10598|NCT02305277|25849|P2|Received CM|Overall Study||14
10599|NCT02305277|25850|P1|Received CM|Overall Study||15
10600|NCT02305277|25845|P6|STARTED|Overall Study||14
10601|NCT02305277|25846|P5|STARTED|Overall Study||14
10602|NCT02305277|25847|P4|STARTED|Overall Study||14
10603|NCT02305277|25848|P3|STARTED|Overall Study||14
10604|NCT02305277|25849|P2|STARTED|Overall Study||14
10605|NCT02305277|25850|P1|STARTED|Overall Study||15
10606|NCT02305017|25878|P2|NOT COMPLETED|Overall Study||0
10607|NCT02305017|25879|P1|NOT COMPLETED|Overall Study||0
10608|NCT02305017|25878|P2|COMPLETED|Overall Study||14
10609|NCT02305017|25879|P1|COMPLETED|Overall Study||14
10610|NCT02305017|25878|P2|STARTED|Overall Study||14
10611|NCT02305017|25879|P1|STARTED|Overall Study||14
10612|NCT02304926|25893|P2|NOT COMPLETED|Overall Study||1
10613|NCT02304926|25894|P1|NOT COMPLETED|Overall Study||2
10614|NCT02304926|25893|P2|COMPLETED|Overall Study||19
10615|NCT02304926|25894|P1|COMPLETED|Overall Study||20
10616|NCT02304926|25893|P2|STARTED|Overall Study||20
10617|NCT02304926|25894|P1|STARTED|Overall Study||22
10618|NCT02303743|25940|P2|NOT COMPLETED|Overall Study||0
10619|NCT02303743|25941|P1|NOT COMPLETED|Overall Study||0
10620|NCT02303743|25940|P2|COMPLETED|Overall Study||152
10621|NCT02303743|25941|P1|COMPLETED|Overall Study||108
10622|NCT02303743|25940|P2|STARTED|Overall Study||152
10623|NCT02303743|25941|P1|STARTED|Overall Study||108
10624|NCT02303704|25951|P2|NOT COMPLETED|Overall Study||9
10625|NCT02303704|25952|P1|NOT COMPLETED|Overall Study||5
10626|NCT02303704|25951|P2|COMPLETED|Overall Study||219
10627|NCT02303704|25952|P1|COMPLETED|Overall Study||215
10628|NCT02303704|25951|P2|STARTED|Overall Study||228
10629|NCT02303704|25952|P1|STARTED|Overall Study||220
10630|NCT02302365|25968|P1|NOT COMPLETED|Overall Study||2
10631|NCT02302365|25968|P1|COMPLETED|Overall Study|The Per-protocol Analysis Set comprised 54 procedures performed in 41 subjects|41
10717|NCT02300129|26089|P4|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10632|NCT02302365|25968|P1|STARTED|Overall Study|Data were collected from 58 WBCD procedures performed in 43 subjects - Full and Safety Analysis Sets|43
10633|NCT02301975|25987|P3|NOT COMPLETED|Overall Study||22
10634|NCT02301975|25988|P2|NOT COMPLETED|Overall Study||25
10635|NCT02301975|25989|P1|NOT COMPLETED|Overall Study||31
10636|NCT02301975|25987|P3|COMPLETED|Overall Study||477
10637|NCT02301975|25988|P2|COMPLETED|Overall Study||476
10638|NCT02301975|25989|P1|COMPLETED|Overall Study||473
10639|NCT02301975|25987|P3|STARTED|Overall Study||499
10640|NCT02301975|25988|P2|STARTED|Overall Study||501
10641|NCT02301975|25989|P1|STARTED|Overall Study||504
10642|NCT02301936|26017|P2|NOT COMPLETED|Overall Study||0
10643|NCT02301936|26018|P1|NOT COMPLETED|Overall Study||1
10644|NCT02301936|26017|P2|COMPLETED|Overall Study||1
10645|NCT02301936|26018|P1|COMPLETED|Overall Study||8
10646|NCT02301936|26017|P2|STARTED|Overall Study||1
10647|NCT02301936|26018|P1|STARTED|Overall Study||9
10648|NCT02301429|26040|P1|NOT COMPLETED|Overall Study||3
10649|NCT02301429|26040|P1|COMPLETED|Overall Study||13
10650|NCT02301429|26040|P1|STARTED|Overall Study||16
10651|NCT02301377|26046|P2|NOT COMPLETED|Overall Study||0
10652|NCT02301377|26047|P1|NOT COMPLETED|Overall Study||0
10653|NCT02301377|26046|P2|COMPLETED|Overall Study||2
10654|NCT02301377|26047|P1|COMPLETED|Overall Study||3
10655|NCT02301377|26046|P2|STARTED|Overall Study||2
10656|NCT02301377|26047|P1|STARTED|Overall Study||3
10657|NCT02301169|26059|P2|NOT COMPLETED|Overall Study||0
10658|NCT02301169|26060|P1|NOT COMPLETED|Overall Study||1
10659|NCT02301169|26059|P2|COMPLETED|Overall Study||21
10660|NCT02301169|26060|P1|COMPLETED|Overall Study||20
10661|NCT02301169|26059|P2|STARTED|Overall Study||21
10662|NCT02301169|26060|P1|STARTED|Overall Study||21
10663|NCT02300311|26076|P2|NOT COMPLETED|Overall Study||0
10664|NCT02300311|26077|P1|NOT COMPLETED|Overall Study||19
10665|NCT02300311|26076|P2|COMPLETED|Overall Study||69
10666|NCT02300311|26077|P1|COMPLETED|Overall Study||50
10667|NCT02300311|26076|P2|STARTED|Overall Study||69
10668|NCT02300311|26077|P1|STARTED|Overall Study||69
10669|NCT02300129|26089|P4|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10670|NCT02300129|26090|P3|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10671|NCT02300129|26091|P2|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10672|NCT02300129|26092|P1|NOT COMPLETED|Period 2 Treatment 2 (2 Weeks)||0
10673|NCT02300129|26089|P4|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
10674|NCT02300129|26090|P3|COMPLETED|Period 2 Treatment 2 (2 Weeks)||7
10675|NCT02300129|26091|P2|COMPLETED|Period 2 Treatment 2 (2 Weeks)||4
10676|NCT02300129|26092|P1|COMPLETED|Period 2 Treatment 2 (2 Weeks)||10
10677|NCT02300129|26089|P4|STARTED|Period 2 Treatment 2 (2 Weeks)||10
10678|NCT02300129|26090|P3|STARTED|Period 2 Treatment 2 (2 Weeks)||7
10679|NCT02300129|26091|P2|STARTED|Period 2 Treatment 2 (2 Weeks)||4
10680|NCT02300129|26092|P1|STARTED|Period 2 Treatment 2 (2 Weeks)||10
10681|NCT02300129|26089|P4|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
10682|NCT02300129|26090|P3|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
10683|NCT02300129|26091|P2|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||0
10684|NCT02300129|26092|P1|NOT COMPLETED|Period 2 Treatment 1 (2 Weeks)||1
10685|NCT02300129|26089|P4|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
10686|NCT02300129|26090|P3|COMPLETED|Period 2 Treatment 1 (2 Weeks)||7
10687|NCT02300129|26091|P2|COMPLETED|Period 2 Treatment 1 (2 Weeks)||4
10688|NCT02300129|26092|P1|COMPLETED|Period 2 Treatment 1 (2 Weeks)||10
10689|NCT02300129|26089|P4|STARTED|Period 2 Treatment 1 (2 Weeks)|Withdrawal consent of 1 subject between the Period 1 and Period 2|11
10690|NCT02300129|26090|P3|STARTED|Period 2 Treatment 1 (2 Weeks)||7
10691|NCT02300129|26091|P2|STARTED|Period 2 Treatment 1 (2 Weeks)||4
10692|NCT02300129|26092|P1|STARTED|Period 2 Treatment 1 (2 Weeks)||11
10693|NCT02300129|26089|P4|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10694|NCT02300129|26090|P3|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10695|NCT02300129|26091|P2|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10696|NCT02300129|26092|P1|NOT COMPLETED|Period 1 Session 3 (Day 5)||0
10697|NCT02300129|26089|P4|COMPLETED|Period 1 Session 3 (Day 5)||11
10698|NCT02300129|26090|P3|COMPLETED|Period 1 Session 3 (Day 5)||7
10699|NCT02300129|26091|P2|COMPLETED|Period 1 Session 3 (Day 5)||4
10700|NCT02300129|26092|P1|COMPLETED|Period 1 Session 3 (Day 5)||11
10701|NCT02300129|26089|P4|STARTED|Period 1 Session 3 (Day 5)||11
10702|NCT02300129|26090|P3|STARTED|Period 1 Session 3 (Day 5)||7
10703|NCT02300129|26091|P2|STARTED|Period 1 Session 3 (Day 5)||4
10704|NCT02300129|26092|P1|STARTED|Period 1 Session 3 (Day 5)||11
10705|NCT02300129|26089|P4|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10706|NCT02300129|26090|P3|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10707|NCT02300129|26091|P2|NOT COMPLETED|Period 1 Session 2 (Day 3)||1
10708|NCT02300129|26092|P1|NOT COMPLETED|Period 1 Session 2 (Day 3)||0
10709|NCT02300129|26089|P4|COMPLETED|Period 1 Session 2 (Day 3)||11
10710|NCT02300129|26090|P3|COMPLETED|Period 1 Session 2 (Day 3)||7
10711|NCT02300129|26091|P2|COMPLETED|Period 1 Session 2 (Day 3)||4
10712|NCT02300129|26092|P1|COMPLETED|Period 1 Session 2 (Day 3)||11
10713|NCT02300129|26089|P4|STARTED|Period 1 Session 2 (Day 3)||11
10714|NCT02300129|26090|P3|STARTED|Period 1 Session 2 (Day 3)||7
10715|NCT02300129|26091|P2|STARTED|Period 1 Session 2 (Day 3)|Withdrawal consent of 1 subject between Day 1 and Day 3|5
10716|NCT02300129|26092|P1|STARTED|Period 1 Session 2 (Day 3)||11
10718|NCT02300129|26090|P3|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10719|NCT02300129|26091|P2|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10720|NCT02300129|26092|P1|NOT COMPLETED|Period 1 Session 1 (Day 1)||0
10721|NCT02300129|26089|P4|COMPLETED|Period 1 Session 1 (Day 1)||11
10722|NCT02300129|26090|P3|COMPLETED|Period 1 Session 1 (Day 1)||7
10723|NCT02300129|26091|P2|COMPLETED|Period 1 Session 1 (Day 1)||5
10724|NCT02300129|26092|P1|COMPLETED|Period 1 Session 1 (Day 1)||11
10725|NCT02300129|26089|P4|STARTED|Period 1 Session 1 (Day 1)||11
10726|NCT02300129|26090|P3|STARTED|Period 1 Session 1 (Day 1)||7
10727|NCT02300129|26091|P2|STARTED|Period 1 Session 1 (Day 1)||5
10728|NCT02300129|26092|P1|STARTED|Period 1 Session 1 (Day 1)||11
10729|NCT02300103|26102|P1|NOT COMPLETED|Overall Study||6
10730|NCT02300103|26102|P1|COMPLETED|Overall Study||63
10731|NCT02300103|26102|P1|STARTED|Overall Study||69
10732|NCT02300025|26115|P4|NOT COMPLETED|Overall Study||0
10733|NCT02300025|26116|P3|NOT COMPLETED|Overall Study||0
10734|NCT02300025|26117|P2|NOT COMPLETED|Overall Study||0
10735|NCT02300025|26118|P1|NOT COMPLETED|Overall Study||0
10736|NCT02300025|26115|P4|COMPLETED|Overall Study||6
10737|NCT02300025|26116|P3|COMPLETED|Overall Study||6
10738|NCT02300025|26117|P2|COMPLETED|Overall Study||6
10739|NCT02300025|26118|P1|COMPLETED|Overall Study||10
10740|NCT02300025|26115|P4|STARTED|Overall Study||6
10741|NCT02300025|26116|P3|STARTED|Overall Study||6
10742|NCT02300025|26117|P2|STARTED|Overall Study||6
10743|NCT02300025|26118|P1|STARTED|Overall Study||10
10744|NCT02299869|26164|P4|NOT COMPLETED|Overall Study||0
10745|NCT02299869|26165|P3|NOT COMPLETED|Overall Study||0
10746|NCT02299869|26166|P2|NOT COMPLETED|Overall Study||0
10747|NCT02299869|26167|P1|NOT COMPLETED|Overall Study||0
10748|NCT02299869|26164|P4|COMPLETED|Overall Study||10
10749|NCT02299869|26165|P3|COMPLETED|Overall Study||10
10750|NCT02299869|26166|P2|COMPLETED|Overall Study||10
10751|NCT02299869|26167|P1|COMPLETED|Overall Study||10
10752|NCT02299869|26164|P4|STARTED|Overall Study||10
10753|NCT02299869|26165|P3|STARTED|Overall Study||10
10754|NCT02299869|26166|P2|STARTED|Overall Study||10
10755|NCT02299869|26167|P1|STARTED|Overall Study||10
10756|NCT02299635|26190|P1|NOT COMPLETED|Overall Study||19
10757|NCT02299635|26190|P1|COMPLETED|Overall Study||0
10758|NCT02299635|26190|P1|STARTED|Overall Study||19
10759|NCT02299427|26211|P2|NOT COMPLETED|Overall Study||3
10760|NCT02299427|26212|P1|NOT COMPLETED|Overall Study||23
10761|NCT02299427|26211|P2|COMPLETED|Overall Study||31
10762|NCT02299427|26212|P1|COMPLETED|Overall Study||12
10763|NCT02299427|26211|P2|STARTED|Overall Study||34
10764|NCT02299427|26212|P1|STARTED|Overall Study||35
10765|NCT02299349|26222|P2|NOT COMPLETED|Overall Study||0
10766|NCT02299349|26223|P1|NOT COMPLETED|Overall Study||0
10767|NCT02299349|26222|P2|COMPLETED|Overall Study||35
10768|NCT02299349|26223|P1|COMPLETED|Overall Study||35
10769|NCT02299349|26222|P2|STARTED|Overall Study||35
10770|NCT02299349|26223|P1|STARTED|Overall Study||35
10771|NCT02299258|26233|P2|NOT COMPLETED|Overall Study||1
10772|NCT02299258|26234|P1|NOT COMPLETED|Overall Study||1
10773|NCT02299258|26233|P2|COMPLETED|Overall Study||30
10774|NCT02299258|26234|P1|COMPLETED|Overall Study||31
10775|NCT02299258|26233|P2|STARTED|Overall Study||31
10776|NCT02299258|26234|P1|STARTED|Overall Study||32
10777|NCT02298868|26242|P1|NOT COMPLETED|Overall Study||3
10778|NCT02298868|26242|P1|COMPLETED|Overall Study||7
10779|NCT02298868|26242|P1|STARTED|Overall Study||10
10780|NCT02298842|26256|P2|NOT COMPLETED|Second Platelet Donation (Day 6-8)||6
10781|NCT02298842|26257|P1|NOT COMPLETED|Second Platelet Donation (Day 6-8)||8
10782|NCT02298842|26256|P2|COMPLETED|Second Platelet Donation (Day 6-8)||30
10783|NCT02298842|26257|P1|COMPLETED|Second Platelet Donation (Day 6-8)||30
10784|NCT02298842|26256|P2|STARTED|Second Platelet Donation (Day 6-8)||36
10785|NCT02298842|26257|P1|STARTED|Second Platelet Donation (Day 6-8)||38
10786|NCT02298842|26256|P2|NOT COMPLETED|First Platelet Donation (Day 0)||5
10787|NCT02298842|26257|P1|NOT COMPLETED|First Platelet Donation (Day 0)||6
10788|NCT02298842|26256|P2|COMPLETED|First Platelet Donation (Day 0)||36
10789|NCT02298842|26257|P1|COMPLETED|First Platelet Donation (Day 0)||38
10790|NCT02298842|26256|P2|STARTED|First Platelet Donation (Day 0)||41
10791|NCT02298842|26257|P1|STARTED|First Platelet Donation (Day 0)||44
10792|NCT02298361|26284|P3|NOT COMPLETED|Overall Study||0
10793|NCT02298361|26285|P2|NOT COMPLETED|Overall Study||0
10794|NCT02298361|26286|P1|NOT COMPLETED|Overall Study||0
10795|NCT02298361|26284|P3|COMPLETED|Overall Study||12227
10796|NCT02298361|26285|P2|COMPLETED|Overall Study||12784
10797|NCT02298361|26286|P1|COMPLETED|Overall Study||2240
10798|NCT02298361|26284|P3|STARTED|Overall Study||12227
10799|NCT02298361|26285|P2|STARTED|Overall Study||12784
10800|NCT02298361|26286|P1|STARTED|Overall Study||2240
10801|NCT02298192|26302|P2|NOT COMPLETED|Overall Study||6
10802|NCT02298192|26303|P1|NOT COMPLETED|Overall Study||19
10803|NCT02298192|26302|P2|COMPLETED|Overall Study||204
10804|NCT02298192|26303|P1|COMPLETED|Overall Study||191
10805|NCT02298192|26302|P2|STARTED|Overall Study||210
10806|NCT02298192|26303|P1|STARTED|Overall Study||210
10807|NCT02297841|26315|P1|NOT COMPLETED|Overall Study||8
10808|NCT02297841|26315|P1|COMPLETED|Overall Study||201
10809|NCT02297841|26315|P1|Challenge Phase|Overall Study||201
10810|NCT02297841|26315|P1|Induction Phase|Overall Study||209
10811|NCT02297841|26315|P1|STARTED|Overall Study||209
10812|NCT02297308|26319|P1|NOT COMPLETED|Overall Study||0
10813|NCT02297308|26319|P1|COMPLETED|Overall Study||90
10814|NCT02297308|26319|P1|STARTED|Overall Study||90
10815|NCT02296931|26326|P2|NOT COMPLETED|Overall Study||2
10816|NCT02296931|26327|P1|NOT COMPLETED|Overall Study||0
10817|NCT02296931|26326|P2|COMPLETED|Overall Study||22
10818|NCT02296931|26327|P1|COMPLETED|Overall Study||10
10819|NCT02296931|26326|P2|STARTED|Overall Study||24
10820|NCT02296931|26327|P1|STARTED|Overall Study||10
10821|NCT02295774|26333|P1|NOT COMPLETED|Overall Study||3
10822|NCT02295774|26333|P1|COMPLETED|Overall Study||10
10823|NCT02295774|26333|P1|STARTED|Overall Study||13
10824|NCT02295644|26341|P4|NOT COMPLETED|Overall Study||0
10825|NCT02295644|26342|P3|NOT COMPLETED|Overall Study||0
10826|NCT02295644|26343|P2|NOT COMPLETED|Overall Study||0
10827|NCT02295644|26344|P1|NOT COMPLETED|Overall Study||0
10828|NCT02295644|26341|P4|COMPLETED|Overall Study||7
10829|NCT02295644|26342|P3|COMPLETED|Overall Study||7
10830|NCT02295644|26343|P2|COMPLETED|Overall Study||7
10831|NCT02295644|26344|P1|COMPLETED|Overall Study||7
10832|NCT02295644|26341|P4|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10833|NCT02295644|26342|P3|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10834|NCT02295644|26343|P2|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10835|NCT02295644|26344|P1|STARTED|Overall Study|All groups were randomly allocated to subjects upon the start of their individual trials|7
10836|NCT02295020|26364|P2|NOT COMPLETED|Overall Study||3
10837|NCT02295020|26365|P1|NOT COMPLETED|Overall Study||3
10838|NCT02295020|26364|P2|COMPLETED|Overall Study||17
10839|NCT02295020|26365|P1|COMPLETED|Overall Study||17
10840|NCT02295020|26364|P2|STARTED|Overall Study||20
10841|NCT02295020|26365|P1|STARTED|Overall Study||20
10842|NCT02294773|26397|P2|NOT COMPLETED|Overall Study||2
10843|NCT02294773|26398|P1|NOT COMPLETED|Overall Study||0
10844|NCT02294773|26397|P2|COMPLETED|Overall Study||4
10845|NCT02294773|26398|P1|COMPLETED|Overall Study||7
10846|NCT02294773|26397|P2|STARTED|Overall Study||6
10847|NCT02294773|26398|P1|STARTED|Overall Study||7
10848|NCT02294734|26414|P2|NOT COMPLETED|Overall Study||8
10849|NCT02294734|26415|P1|NOT COMPLETED|Overall Study||14
10850|NCT02294734|26414|P2|COMPLETED|Overall Study||55
10851|NCT02294734|26415|P1|COMPLETED|Overall Study||49
10852|NCT02294734|26414|P2|STARTED|Overall Study||63
10853|NCT02294734|26415|P1|STARTED|Overall Study||63
10854|NCT02294682|26467|P2|NOT COMPLETED|Overall Study||0
10855|NCT02294682|26468|P1|NOT COMPLETED|Overall Study||1
10856|NCT02294682|26467|P2|COMPLETED|Overall Study||53
10857|NCT02294682|26468|P1|COMPLETED|Overall Study||52
10858|NCT02294682|26467|P2|STARTED|Overall Study||53
10859|NCT02294682|26468|P1|STARTED|Overall Study||53
10860|NCT02294604|26511|P3|NOT COMPLETED|Overall Study||0
10861|NCT02294604|26512|P2|NOT COMPLETED|Overall Study||3
10862|NCT02294604|26513|P1|NOT COMPLETED|Overall Study||1
10863|NCT02294604|26511|P3|COMPLETED|Overall Study||80
10864|NCT02294604|26512|P2|COMPLETED|Overall Study||77
10865|NCT02294604|26513|P1|COMPLETED|Overall Study||79
10866|NCT02294604|26511|P3|STARTED|Overall Study||80
10867|NCT02294604|26512|P2|STARTED|Overall Study||80
10868|NCT02294604|26513|P1|STARTED|Overall Study||80
10869|NCT02294461|26532|P2|NOT COMPLETED|Overall Study||137
10870|NCT02294461|26533|P1|NOT COMPLETED|Overall Study||65
10871|NCT02294461|26532|P2|COMPLETED|Overall Study||63
10872|NCT02294461|26533|P1|COMPLETED|Overall Study|Participants still receiving treatment as of 20 Sept 2016. Data cutoff date: 20 Sep 2015/20 Jan 2016|144
10873|NCT02294461|26532|P2|Treated/Received Study Drug|Overall Study||200
10874|NCT02294461|26533|P1|Treated/Received Study Drug|Overall Study||209
10875|NCT02294461|26532|P2|STARTED|Overall Study||200
10876|NCT02294461|26533|P1|STARTED|Overall Study||209
10877|NCT02294019|26585|P1|NOT COMPLETED|Overall Study||103
10878|NCT02294019|26585|P1|COMPLETED|Overall Study||635
10879|NCT02294019|26585|P1|STARTED|Overall Study||738
10880|NCT02293538|26592|P2|NOT COMPLETED|Overall Study||2
10881|NCT02293538|26593|P1|NOT COMPLETED|Overall Study||1
10882|NCT02293538|26592|P2|COMPLETED|Overall Study||69
10883|NCT02293538|26593|P1|COMPLETED|Overall Study||72
10884|NCT02293538|26592|P2|STARTED|Overall Study||71
10885|NCT02293538|26593|P1|STARTED|Overall Study||73
10886|NCT02292433|26609|P3|NOT COMPLETED|Third Intervention Period (7 Days)||0
10887|NCT02292433|26610|P2|NOT COMPLETED|Third Intervention Period (7 Days)||0
10888|NCT02292433|26611|P1|NOT COMPLETED|Third Intervention Period (7 Days)||0
10889|NCT02292433|26609|P3|COMPLETED|Third Intervention Period (7 Days)||4
10890|NCT02292433|26610|P2|COMPLETED|Third Intervention Period (7 Days)||4
10891|NCT02292433|26611|P1|COMPLETED|Third Intervention Period (7 Days)||4
10892|NCT02292433|26609|P3|STARTED|Third Intervention Period (7 Days)||4
10893|NCT02292433|26610|P2|STARTED|Third Intervention Period (7 Days)||4
10894|NCT02292433|26611|P1|STARTED|Third Intervention Period (7 Days)||4
10895|NCT02292433|26609|P3|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10896|NCT02292433|26610|P2|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10897|NCT02292433|26611|P1|NOT COMPLETED|Second Washout Period (7 to 14 Days)||0
10898|NCT02292433|26609|P3|COMPLETED|Second Washout Period (7 to 14 Days)||4
10899|NCT02292433|26610|P2|COMPLETED|Second Washout Period (7 to 14 Days)||4
10900|NCT02292433|26611|P1|COMPLETED|Second Washout Period (7 to 14 Days)||4
10901|NCT02292433|26609|P3|STARTED|Second Washout Period (7 to 14 Days)||4
10902|NCT02292433|26610|P2|STARTED|Second Washout Period (7 to 14 Days)||4
10903|NCT02292433|26611|P1|STARTED|Second Washout Period (7 to 14 Days)||4
10904|NCT02292433|26609|P3|NOT COMPLETED|Second Intervention Period (7 Days)||0
10905|NCT02292433|26610|P2|NOT COMPLETED|Second Intervention Period (7 Days)||0
10906|NCT02292433|26611|P1|NOT COMPLETED|Second Intervention Period (7 Days)||0
10907|NCT02292433|26609|P3|COMPLETED|Second Intervention Period (7 Days)||4
10908|NCT02292433|26610|P2|COMPLETED|Second Intervention Period (7 Days)||4
10909|NCT02292433|26611|P1|COMPLETED|Second Intervention Period (7 Days)||4
10910|NCT02292433|26609|P3|STARTED|Second Intervention Period (7 Days)||4
10911|NCT02292433|26610|P2|STARTED|Second Intervention Period (7 Days)||4
10912|NCT02292433|26611|P1|STARTED|Second Intervention Period (7 Days)||4
10913|NCT02292433|26609|P3|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10914|NCT02292433|26610|P2|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10915|NCT02292433|26611|P1|NOT COMPLETED|First Washout Period (7 to 14 Days)||0
10916|NCT02292433|26609|P3|COMPLETED|First Washout Period (7 to 14 Days)||4
10917|NCT02292433|26610|P2|COMPLETED|First Washout Period (7 to 14 Days)||4
10918|NCT02292433|26611|P1|COMPLETED|First Washout Period (7 to 14 Days)||4
10919|NCT02292433|26609|P3|STARTED|First Washout Period (7 to 14 Days)||4
10920|NCT02292433|26610|P2|STARTED|First Washout Period (7 to 14 Days)||4
10921|NCT02292433|26611|P1|STARTED|First Washout Period (7 to 14 Days)||4
10922|NCT02292433|26609|P3|NOT COMPLETED|First Intervention Period (7 Days)||0
10923|NCT02292433|26610|P2|NOT COMPLETED|First Intervention Period (7 Days)||0
10924|NCT02292433|26611|P1|NOT COMPLETED|First Intervention Period (7 Days)||0
10925|NCT02292433|26609|P3|COMPLETED|First Intervention Period (7 Days)||4
10926|NCT02292433|26610|P2|COMPLETED|First Intervention Period (7 Days)||4
10927|NCT02292433|26611|P1|COMPLETED|First Intervention Period (7 Days)||4
10928|NCT02292433|26609|P3|STARTED|First Intervention Period (7 Days)||4
10929|NCT02292433|26610|P2|STARTED|First Intervention Period (7 Days)||4
10930|NCT02292433|26611|P1|STARTED|First Intervention Period (7 Days)||4
10931|NCT02292212|26682|P1|NOT COMPLETED|Post-ViE Phase||0
10932|NCT02292212|26682|P1|COMPLETED|Post-ViE Phase||14
10933|NCT02292212|26682|P1|STARTED|Post-ViE Phase||14
10934|NCT02292212|26682|P1|NOT COMPLETED|ViE Phase||3
10935|NCT02292212|26682|P1|COMPLETED|ViE Phase||14
10936|NCT02292212|26682|P1|STARTED|ViE Phase||17
10937|NCT02292212|26682|P1|NOT COMPLETED|Pre-ViE Phase||0
10938|NCT02292212|26682|P1|COMPLETED|Pre-ViE Phase||17
10939|NCT02292212|26682|P1|STARTED|Pre-ViE Phase||17
10940|NCT02291718|26717|P3|NOT COMPLETED|Overall Study||0
10941|NCT02291718|26718|P2|NOT COMPLETED|Overall Study||0
10942|NCT02291718|26719|P1|NOT COMPLETED|Overall Study||0
10943|NCT02291718|26717|P3|COMPLETED|Overall Study||50
10944|NCT02291718|26718|P2|COMPLETED|Overall Study||50
10945|NCT02291718|26719|P1|COMPLETED|Overall Study||50
10946|NCT02291718|26717|P3|STARTED|Overall Study||50
10947|NCT02291718|26718|P2|STARTED|Overall Study||50
10948|NCT02291718|26719|P1|STARTED|Overall Study||50
10949|NCT02291679|26739|P3|NOT COMPLETED|Overall Study||59
10950|NCT02291679|26740|P2|NOT COMPLETED|Overall Study||42
10951|NCT02291679|26741|P1|NOT COMPLETED|Overall Study||44
10952|NCT02291679|26739|P3|COMPLETED|Overall Study||352
10953|NCT02291679|26740|P2|COMPLETED|Overall Study||369
10954|NCT02291679|26741|P1|COMPLETED|Overall Study||357
10955|NCT02291679|26739|P3|STARTED|Overall Study||411
10956|NCT02291679|26740|P2|STARTED|Overall Study||411
10957|NCT02291679|26741|P1|STARTED|Overall Study||401
10958|NCT02291510|26774|P4|NOT COMPLETED|Overall Study||1
10959|NCT02291510|26775|P3|NOT COMPLETED|Overall Study||0
10960|NCT02291510|26776|P2|NOT COMPLETED|Overall Study||0
10961|NCT02291510|26777|P1|NOT COMPLETED|Overall Study||0
10962|NCT02291510|26774|P4|COMPLETED|Overall Study||4
10963|NCT02291510|26775|P3|COMPLETED|Overall Study||5
10964|NCT02291510|26776|P2|COMPLETED|Overall Study||5
10965|NCT02291510|26777|P1|COMPLETED|Overall Study||5
10966|NCT02291510|26774|P4|Completed Treatment D|Overall Study||5
10967|NCT02291510|26775|P3|Completed Treatment D|Overall Study||5
10968|NCT02291510|26776|P2|Completed Treatment D|Overall Study||5
10969|NCT02291510|26777|P1|Completed Treatment D|Overall Study||5
10970|NCT02291510|26774|P4|Completed Treatment C|Overall Study||4
10971|NCT02291510|26775|P3|Completed Treatment C|Overall Study||5
10972|NCT02291510|26776|P2|Completed Treatment C|Overall Study||5
10973|NCT02291510|26777|P1|Completed Treatment C|Overall Study||5
10974|NCT02291510|26774|P4|Completed Treatment B|Overall Study||4
10975|NCT02291510|26775|P3|Completed Treatment B|Overall Study||5
10976|NCT02291510|26776|P2|Completed Treatment B|Overall Study||5
10977|NCT02291510|26777|P1|Completed Treatment B|Overall Study||5
10978|NCT02291510|26774|P4|Completed Treatment A|Overall Study||5
10979|NCT02291510|26775|P3|Completed Treatment A|Overall Study||5
10980|NCT02291510|26776|P2|Completed Treatment A|Overall Study||5
10981|NCT02291510|26777|P1|Completed Treatment A|Overall Study||5
10982|NCT02291510|26774|P4|STARTED|Overall Study||5
10983|NCT02291510|26775|P3|STARTED|Overall Study||5
10984|NCT02291510|26776|P2|STARTED|Overall Study||5
10985|NCT02291510|26777|P1|STARTED|Overall Study||5
10986|NCT02291419|26793|P2|NOT COMPLETED|Overall Study||5
10987|NCT02291419|26794|P1|NOT COMPLETED|Overall Study||1
10988|NCT02291419|26793|P2|COMPLETED|Overall Study||0
10989|NCT02291419|26794|P1|COMPLETED|Overall Study||0
10990|NCT02291419|26793|P2|STARTED|Overall Study||5
10991|NCT02291419|26794|P1|STARTED|Overall Study||1
10992|NCT02290821|26812|P2|NOT COMPLETED|Overall Study||3
10993|NCT02290821|26813|P1|NOT COMPLETED|Overall Study||6
10994|NCT02290821|26812|P2|COMPLETED|Overall Study||103
10995|NCT02290821|26813|P1|COMPLETED|Overall Study||103
10996|NCT02290821|26812|P2|STARTED|Overall Study||106
10997|NCT02290821|26813|P1|STARTED|Overall Study||109
10998|NCT02290509|26821|P2|NOT COMPLETED|Overall Study||14
10999|NCT02290509|26822|P1|NOT COMPLETED|Overall Study||49
11000|NCT02290509|26821|P2|COMPLETED|Overall Study||325
11001|NCT02290509|26822|P1|COMPLETED|Overall Study||962
11002|NCT02290509|26821|P2|STARTED|Overall Study||339
11003|NCT02290509|26822|P1|STARTED|Overall Study||1011
11004|NCT02289989|26836|P2|NOT COMPLETED|Overall Study||0
11005|NCT02289989|26837|P1|NOT COMPLETED|Overall Study||0
11006|NCT02289989|26836|P2|COMPLETED|Overall Study||1
11007|NCT02289989|26837|P1|COMPLETED|Overall Study||0
11008|NCT02289989|26836|P2|STARTED|Overall Study||1
11009|NCT02289989|26837|P1|STARTED|Overall Study||0
11010|NCT02289963|26855|P2|NOT COMPLETED|Overall Study||10
11011|NCT02289963|26856|P1|NOT COMPLETED|Overall Study||5
11012|NCT02289963|26855|P2|COMPLETED|Overall Study||87
11013|NCT02289963|26856|P1|COMPLETED|Overall Study||97
11014|NCT02289963|26855|P2|Treated|Overall Study||97
11015|NCT02289963|26856|P1|Treated|Overall Study||102
11016|NCT02289963|26855|P2|STARTED|Overall Study|Randomized|97
11017|NCT02289963|26856|P1|STARTED|Overall Study|Randomized|102
11018|NCT02289755|26904|P1|NOT COMPLETED|Follow up Period [4 Days]||0
11019|NCT02289755|26904|P1|COMPLETED|Follow up Period [4 Days]||16
11020|NCT02289755|26904|P1|STARTED|Follow up Period [4 Days]||16
11021|NCT02289755|26904|P1|NOT COMPLETED|ALLN-177 Treatment Period [4 Days]||0
11022|NCT02289755|26904|P1|COMPLETED|ALLN-177 Treatment Period [4 Days]||16
11023|NCT02289755|26904|P1|STARTED|ALLN-177 Treatment Period [4 Days]||16
11024|NCT02289755|26904|P1|NOT COMPLETED|Baseline Period [No Treatment, 3 Days]||0
11025|NCT02289755|26904|P1|COMPLETED|Baseline Period [No Treatment, 3 Days]||16
11026|NCT02289755|26904|P1|STARTED|Baseline Period [No Treatment, 3 Days]||16
11027|NCT02289742|26911|P4|NOT COMPLETED|Third Wear Period||1
11028|NCT02289742|26912|P3|NOT COMPLETED|Third Wear Period||0
11029|NCT02289742|26913|P2|NOT COMPLETED|Third Wear Period||1
11030|NCT02289742|26914|P1|NOT COMPLETED|Third Wear Period||0
11031|NCT02289742|26911|P4|COMPLETED|Third Wear Period||8
11032|NCT02289742|26912|P3|COMPLETED|Third Wear Period||11
11033|NCT02289742|26913|P2|COMPLETED|Third Wear Period||10
11034|NCT02289742|26914|P1|COMPLETED|Third Wear Period||11
11035|NCT02289742|26911|P4|STARTED|Third Wear Period||9
11036|NCT02289742|26912|P3|STARTED|Third Wear Period||11
11037|NCT02289742|26913|P2|STARTED|Third Wear Period||11
11038|NCT02289742|26914|P1|STARTED|Third Wear Period||11
11039|NCT02289742|26911|P4|NOT COMPLETED|Second Wear Period||0
11040|NCT02289742|26912|P3|NOT COMPLETED|Second Wear Period||0
11041|NCT02289742|26913|P2|NOT COMPLETED|Second Wear Period||0
11042|NCT02289742|26914|P1|NOT COMPLETED|Second Wear Period||0
11043|NCT02289742|26911|P4|COMPLETED|Second Wear Period||9
11044|NCT02289742|26912|P3|COMPLETED|Second Wear Period||11
11045|NCT02289742|26913|P2|COMPLETED|Second Wear Period||11
11046|NCT02289742|26914|P1|COMPLETED|Second Wear Period||11
11047|NCT02289742|26911|P4|STARTED|Second Wear Period||9
11048|NCT02289742|26912|P3|STARTED|Second Wear Period||11
11049|NCT02289742|26913|P2|STARTED|Second Wear Period||11
11050|NCT02289742|26914|P1|STARTED|Second Wear Period||11
11051|NCT02289742|26911|P4|NOT COMPLETED|First Wear Period||1
11052|NCT02289742|26912|P3|NOT COMPLETED|First Wear Period||1
11053|NCT02289742|26913|P2|NOT COMPLETED|First Wear Period||1
11054|NCT02289742|26914|P1|NOT COMPLETED|First Wear Period||0
11055|NCT02289742|26911|P4|COMPLETED|First Wear Period||9
11056|NCT02289742|26912|P3|COMPLETED|First Wear Period||11
11057|NCT02289742|26913|P2|COMPLETED|First Wear Period||11
11058|NCT02289742|26914|P1|COMPLETED|First Wear Period||11
11059|NCT02289742|26911|P4|Treated|First Wear Period||9
11060|NCT02289742|26912|P3|Treated|First Wear Period||12
11061|NCT02289742|26913|P2|Treated|First Wear Period||11
11062|NCT02289742|26914|P1|Treated|First Wear Period||11
11063|NCT02289742|26911|P4|STARTED|First Wear Period||10
11064|NCT02289742|26912|P3|STARTED|First Wear Period||12
11065|NCT02289742|26913|P2|STARTED|First Wear Period||12
11066|NCT02289742|26914|P1|STARTED|First Wear Period||11
11067|NCT02289469|26933|P2|NOT COMPLETED|Overall Study||0
11068|NCT02289469|26934|P1|NOT COMPLETED|Overall Study||6
11069|NCT02289469|26933|P2|COMPLETED|Overall Study||244
11070|NCT02289469|26934|P1|COMPLETED|Overall Study||244
11071|NCT02289469|26933|P2|STARTED|Overall Study||244
11072|NCT02289469|26934|P1|STARTED|Overall Study||250
11073|NCT02289105|26944|P2|NOT COMPLETED|Overall Study||0
11074|NCT02289105|26945|P1|NOT COMPLETED|Overall Study||0
11075|NCT02289105|26944|P2|COMPLETED|Overall Study||637
11076|NCT02289105|26945|P1|COMPLETED|Overall Study||642
11077|NCT02289105|26944|P2|STARTED|Overall Study||637
11078|NCT02289105|26945|P1|STARTED|Overall Study||642
11079|NCT02289079|26957|P2|NOT COMPLETED|Overall Study||1
11080|NCT02289079|26958|P1|NOT COMPLETED|Overall Study||2
11081|NCT02289079|26957|P2|COMPLETED|Overall Study||29
11082|NCT02289079|26958|P1|COMPLETED|Overall Study||28
11083|NCT02289079|26957|P2|STARTED|Overall Study||30
11084|NCT02289079|26958|P1|STARTED|Overall Study||30
11085|NCT02288364|26972|P2|NOT COMPLETED|Overall Study||0
11086|NCT02288364|26973|P1|NOT COMPLETED|Overall Study||0
11087|NCT02288364|26972|P2|COMPLETED|Overall Study||44
11088|NCT02288364|26973|P1|COMPLETED|Overall Study||42
11089|NCT02288364|26972|P2|STARTED|Overall Study||44
11090|NCT02288364|26973|P1|STARTED|Overall Study||42
11091|NCT02288312|27000|P3|NOT COMPLETED|Overall Study||0
11092|NCT02288312|27001|P2|NOT COMPLETED|Overall Study||0
11093|NCT02288312|27002|P1|NOT COMPLETED|Overall Study||1
11094|NCT02288312|27000|P3|COMPLETED|Overall Study||6
11095|NCT02288312|27001|P2|COMPLETED|Overall Study||6
11096|NCT02288312|27002|P1|COMPLETED|Overall Study||5
11097|NCT02288312|27000|P3|STARTED|Overall Study||6
11098|NCT02288312|27001|P2|STARTED|Overall Study||6
11099|NCT02288312|27002|P1|STARTED|Overall Study||6
11100|NCT02288273|27021|P2|NOT COMPLETED|Overall Study||8
11101|NCT02288273|27022|P1|NOT COMPLETED|Overall Study||8
11102|NCT02288273|27021|P2|COMPLETED|Overall Study||48
11103|NCT02288273|27022|P1|COMPLETED|Overall Study||53
11104|NCT02288273|27021|P2|STARTED|Overall Study||56
11105|NCT02288273|27022|P1|STARTED|Overall Study||61
11106|NCT02287779|27048|P8|NOT COMPLETED|Overall Study||0
11107|NCT02287779|27049|P7|NOT COMPLETED|Overall Study||0
11108|NCT02287779|27050|P6|NOT COMPLETED|Overall Study||0
11109|NCT02287779|27051|P5|NOT COMPLETED|Overall Study||0
11110|NCT02287779|27052|P4|NOT COMPLETED|Overall Study||0
11111|NCT02287779|27053|P3|NOT COMPLETED|Overall Study||0
11112|NCT02287779|27054|P2|NOT COMPLETED|Overall Study||0
11113|NCT02287779|27055|P1|NOT COMPLETED|Overall Study||0
11114|NCT02287779|27048|P8|COMPLETED|Overall Study||9
11115|NCT02287779|27049|P7|COMPLETED|Overall Study||9
11116|NCT02287779|27050|P6|COMPLETED|Overall Study||9
11117|NCT02287779|27051|P5|COMPLETED|Overall Study||9
11118|NCT02287779|27052|P4|COMPLETED|Overall Study||9
11119|NCT02287779|27053|P3|COMPLETED|Overall Study||9
11120|NCT02287779|27054|P2|COMPLETED|Overall Study||9
11121|NCT02287779|27055|P1|COMPLETED|Overall Study||21
11122|NCT02287779|27048|P8|STARTED|Overall Study||9
11123|NCT02287779|27049|P7|STARTED|Overall Study||9
11124|NCT02287779|27050|P6|STARTED|Overall Study||9
11125|NCT02287779|27051|P5|STARTED|Overall Study||9
11126|NCT02287779|27052|P4|STARTED|Overall Study||9
11127|NCT02287779|27053|P3|STARTED|Overall Study||9
11128|NCT02287779|27054|P2|STARTED|Overall Study||9
11129|NCT02287779|27055|P1|STARTED|Overall Study||21
11130|NCT02287623|27195|P2|NOT COMPLETED|Overall Study||1
11131|NCT02287623|27196|P1|NOT COMPLETED|Overall Study||0
11132|NCT02287623|27195|P2|COMPLETED|Overall Study||29
11133|NCT02287623|27196|P1|COMPLETED|Overall Study||30
11134|NCT02287623|27195|P2|STARTED|Overall Study||30
11135|NCT02287623|27196|P1|STARTED|Overall Study||30
11136|NCT02287610|27212|P1|NOT COMPLETED|Overall Study||16
11137|NCT02287610|27212|P1|COMPLETED|Overall Study||48
11138|NCT02287610|27212|P1|Per Protocol Follow-Up|Overall Study||56
11139|NCT02287610|27212|P1|STARTED|Overall Study||64
11140|NCT02287415|27245|P1|NOT COMPLETED|Overall Study||0
11141|NCT02287415|27245|P1|COMPLETED|Overall Study||13
11142|NCT02287415|27245|P1|STARTED|Overall Study||13
11143|NCT02287402|27251|P1|NOT COMPLETED|Follow-up||3
11144|NCT02287402|27251|P1|COMPLETED|Follow-up||103
11145|NCT02287402|27251|P1|STARTED|Follow-up|64 participants who completed the Treatment Period did not continue to Follow-up.|106
11146|NCT02287402|27251|P1|NOT COMPLETED|Treatment Period||27
11147|NCT02287402|27251|P1|COMPLETED|Treatment Period||170
11148|NCT02287402|27251|P1|STARTED|Treatment Period||197
11149|NCT02287376|27266|P1|NOT COMPLETED|Overall Study||0
11150|NCT02287376|27266|P1|COMPLETED|Overall Study||25
11151|NCT02287376|27266|P1|STARTED|Overall Study||25
11152|NCT02287350|27309|P1|NOT COMPLETED|Overall Study||3
11153|NCT02287350|27309|P1|COMPLETED|Overall Study||48
11154|NCT02287350|27309|P1|STARTED|Overall Study||51
11155|NCT02286518|27368|P14|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11156|NCT02286518|27369|P13|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11157|NCT02286518|27370|P12|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11158|NCT02286518|27371|P11|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11159|NCT02286518|27372|P10|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11160|NCT02286518|27373|P9|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11161|NCT02286518|27374|P8|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11162|NCT02286518|27375|P7|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11163|NCT02286518|27376|P6|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11164|NCT02286518|27377|P5|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11165|NCT02286518|27378|P4|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11166|NCT02286518|27379|P3|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11167|NCT02286518|27380|P2|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11168|NCT02286518|27381|P1|NOT COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11244|NCT02286518|27373|P9|NOT COMPLETED|All Parts (16 Days)||0
11169|NCT02286518|27368|P14|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11170|NCT02286518|27369|P13|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11171|NCT02286518|27370|P12|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11172|NCT02286518|27371|P11|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11173|NCT02286518|27372|P10|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11174|NCT02286518|27373|P9|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
11175|NCT02286518|27374|P8|COMPLETED|Crossover Treatment (Part 2: 3 Days)||6
11176|NCT02286518|27375|P7|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11177|NCT02286518|27376|P6|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11178|NCT02286518|27377|P5|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11179|NCT02286518|27378|P4|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11180|NCT02286518|27379|P3|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11181|NCT02286518|27380|P2|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11182|NCT02286518|27381|P1|COMPLETED|Crossover Treatment (Part 2: 3 Days)||0
11183|NCT02286518|27368|P14|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11184|NCT02286518|27369|P13|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11185|NCT02286518|27370|P12|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11186|NCT02286518|27371|P11|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11187|NCT02286518|27372|P10|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11188|NCT02286518|27373|P9|STARTED|Crossover Treatment (Part 2: 3 Days)||6
11189|NCT02286518|27374|P8|STARTED|Crossover Treatment (Part 2: 3 Days)||6
11190|NCT02286518|27375|P7|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11191|NCT02286518|27376|P6|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11192|NCT02286518|27377|P5|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11193|NCT02286518|27378|P4|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11194|NCT02286518|27379|P3|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11195|NCT02286518|27380|P2|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11196|NCT02286518|27381|P1|STARTED|Crossover Treatment (Part 2: 3 Days)||0
11197|NCT02286518|27368|P14|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11198|NCT02286518|27369|P13|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11199|NCT02286518|27370|P12|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11200|NCT02286518|27371|P11|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11201|NCT02286518|27372|P10|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11202|NCT02286518|27373|P9|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11203|NCT02286518|27374|P8|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11204|NCT02286518|27375|P7|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11205|NCT02286518|27376|P6|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11206|NCT02286518|27377|P5|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11207|NCT02286518|27378|P4|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11208|NCT02286518|27379|P3|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11209|NCT02286518|27380|P2|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11210|NCT02286518|27381|P1|NOT COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11211|NCT02286518|27368|P14|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11212|NCT02286518|27369|P13|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11213|NCT02286518|27370|P12|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11214|NCT02286518|27371|P11|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11215|NCT02286518|27372|P10|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11216|NCT02286518|27373|P9|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
11217|NCT02286518|27374|P8|COMPLETED|Washout Crossover Period(Part 2:14 Days)||6
11218|NCT02286518|27375|P7|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11219|NCT02286518|27376|P6|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11220|NCT02286518|27377|P5|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11221|NCT02286518|27378|P4|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11222|NCT02286518|27379|P3|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11223|NCT02286518|27380|P2|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11224|NCT02286518|27381|P1|COMPLETED|Washout Crossover Period(Part 2:14 Days)||0
11225|NCT02286518|27368|P14|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11226|NCT02286518|27369|P13|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11227|NCT02286518|27370|P12|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11228|NCT02286518|27371|P11|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11229|NCT02286518|27372|P10|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11230|NCT02286518|27373|P9|STARTED|Washout Crossover Period(Part 2:14 Days)||6
11231|NCT02286518|27374|P8|STARTED|Washout Crossover Period(Part 2:14 Days)||6
11232|NCT02286518|27375|P7|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11233|NCT02286518|27376|P6|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11234|NCT02286518|27377|P5|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11235|NCT02286518|27378|P4|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11236|NCT02286518|27379|P3|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11237|NCT02286518|27380|P2|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11238|NCT02286518|27381|P1|STARTED|Washout Crossover Period(Part 2:14 Days)||0
11239|NCT02286518|27368|P14|NOT COMPLETED|All Parts (16 Days)||0
11240|NCT02286518|27369|P13|NOT COMPLETED|All Parts (16 Days)||0
11241|NCT02286518|27370|P12|NOT COMPLETED|All Parts (16 Days)||0
11242|NCT02286518|27371|P11|NOT COMPLETED|All Parts (16 Days)||0
11243|NCT02286518|27372|P10|NOT COMPLETED|All Parts (16 Days)||0
11245|NCT02286518|27374|P8|NOT COMPLETED|All Parts (16 Days)||0
11246|NCT02286518|27375|P7|NOT COMPLETED|All Parts (16 Days)||0
11247|NCT02286518|27376|P6|NOT COMPLETED|All Parts (16 Days)||0
11248|NCT02286518|27377|P5|NOT COMPLETED|All Parts (16 Days)||0
11249|NCT02286518|27378|P4|NOT COMPLETED|All Parts (16 Days)||0
11250|NCT02286518|27379|P3|NOT COMPLETED|All Parts (16 Days)||0
11251|NCT02286518|27380|P2|NOT COMPLETED|All Parts (16 Days)||0
11252|NCT02286518|27381|P1|NOT COMPLETED|All Parts (16 Days)||0
11253|NCT02286518|27368|P14|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11254|NCT02286518|27369|P13|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11255|NCT02286518|27370|P12|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11256|NCT02286518|27371|P11|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11257|NCT02286518|27372|P10|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|4
11258|NCT02286518|27373|P9|COMPLETED|All Parts (16 Days)|Only participants of Part 2 would continue in next period.|6
11259|NCT02286518|27374|P8|COMPLETED|All Parts (16 Days)|Only participants of Part 2 continued in next period.|6
11260|NCT02286518|27375|P7|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11261|NCT02286518|27376|P6|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11262|NCT02286518|27377|P5|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11263|NCT02286518|27378|P4|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11264|NCT02286518|27379|P3|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11265|NCT02286518|27380|P2|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11266|NCT02286518|27381|P1|COMPLETED|All Parts (16 Days)|Participants from Part 1 and 3 did not continued in the washout period of Part 2 (crossover part).|6
11267|NCT02286518|27368|P14|STARTED|All Parts (16 Days)||6
11268|NCT02286518|27369|P13|STARTED|All Parts (16 Days)||6
11269|NCT02286518|27370|P12|STARTED|All Parts (16 Days)||6
11270|NCT02286518|27371|P11|STARTED|All Parts (16 Days)||6
11271|NCT02286518|27372|P10|STARTED|All Parts (16 Days)||4
11272|NCT02286518|27373|P9|STARTED|All Parts (16 Days)||6
11273|NCT02286518|27374|P8|STARTED|All Parts (16 Days)||6
11274|NCT02286518|27375|P7|STARTED|All Parts (16 Days)||6
11275|NCT02286518|27376|P6|STARTED|All Parts (16 Days)||6
11276|NCT02286518|27377|P5|STARTED|All Parts (16 Days)||6
11277|NCT02286518|27378|P4|STARTED|All Parts (16 Days)||6
11278|NCT02286518|27379|P3|STARTED|All Parts (16 Days)||6
11279|NCT02286518|27380|P2|STARTED|All Parts (16 Days)||6
11280|NCT02286518|27381|P1|STARTED|All Parts (16 Days)||6
11281|NCT02286193|27521|P1|NOT COMPLETED|Overall Study||204
11282|NCT02286193|27521|P1|COMPLETED|Overall Study||418
11283|NCT02286193|27521|P1|STARTED|Overall Study||622
11284|NCT02286102|27528|P2|NOT COMPLETED|Overall Study||1
11285|NCT02286102|27529|P1|NOT COMPLETED|Overall Study||1
11286|NCT02286102|27528|P2|COMPLETED|Overall Study||33
11287|NCT02286102|27529|P1|COMPLETED|Overall Study||35
11288|NCT02286102|27528|P2|STARTED|Overall Study||34
11289|NCT02286102|27529|P1|STARTED|Overall Study||36
11290|NCT02285998|27541|P2|NOT COMPLETED|Overall Study||253
11291|NCT02285998|27542|P1|NOT COMPLETED|Overall Study||246
11292|NCT02285998|27541|P2|COMPLETED|Overall Study||4236
11293|NCT02285998|27542|P1|COMPLETED|Overall Study||4228
11294|NCT02285998|27541|P2|STARTED|Overall Study||4489
11295|NCT02285998|27542|P1|STARTED|Overall Study||4474
11296|NCT02285270|27566|P1|NOT COMPLETED|Overall Study||5
11297|NCT02285270|27566|P1|COMPLETED|Overall Study||5
11298|NCT02285270|27566|P1|STARTED|Overall Study||10
11299|NCT02284880|27574|P4|NOT COMPLETED|Overall Study||0
11300|NCT02284880|27575|P3|NOT COMPLETED|Overall Study||2
11301|NCT02284880|27576|P2|NOT COMPLETED|Overall Study||0
11302|NCT02284880|27577|P1|NOT COMPLETED|Overall Study||0
11303|NCT02284880|27574|P4|COMPLETED|Overall Study||10
11304|NCT02284880|27575|P3|COMPLETED|Overall Study||8
11305|NCT02284880|27576|P2|COMPLETED|Overall Study||9
11306|NCT02284880|27577|P1|COMPLETED|Overall Study||11
11307|NCT02284880|27574|P4|Second Period (4 Days)|Overall Study||10
11308|NCT02284880|27575|P3|Second Period (4 Days)|Overall Study||8
11309|NCT02284880|27576|P2|Second Period (4 Days)|Overall Study||9
11310|NCT02284880|27577|P1|Second Period (4 Days)|Overall Study||11
11311|NCT02284880|27574|P4|Wash-out Period (7 Days)|Overall Study||10
11312|NCT02284880|27575|P3|Wash-out Period (7 Days)|Overall Study||10
11313|NCT02284880|27576|P2|Wash-out Period (7 Days)|Overall Study||9
11314|NCT02284880|27577|P1|Wash-out Period (7 Days)|Overall Study||11
11315|NCT02284880|27574|P4|First Period (4 Days)|Overall Study||10
11316|NCT02284880|27575|P3|First Period (4 Days)|Overall Study||10
11317|NCT02284880|27576|P2|First Period (4 Days)|Overall Study||9
11318|NCT02284880|27577|P1|First Period (4 Days)|Overall Study||11
11319|NCT02284880|27574|P4|STARTED|Overall Study||10
11320|NCT02284880|27575|P3|STARTED|Overall Study||10
11321|NCT02284880|27576|P2|STARTED|Overall Study||9
11322|NCT02284880|27577|P1|STARTED|Overall Study||11
11323|NCT02284867|27593|P2|NOT COMPLETED|Overall Study||0
11324|NCT02284867|27594|P1|NOT COMPLETED|Overall Study||0
11325|NCT02284867|27593|P2|COMPLETED|Overall Study||30
11326|NCT02284867|27594|P1|COMPLETED|Overall Study||30
11327|NCT02284867|27593|P2|STARTED|Overall Study||30
11328|NCT02284867|27594|P1|STARTED|Overall Study||30
11329|NCT02284854|27604|P2|NOT COMPLETED|Overall Study||0
11330|NCT02284854|27605|P1|NOT COMPLETED|Overall Study||5
11331|NCT02284854|27604|P2|COMPLETED|Overall Study||20
11332|NCT02284854|27605|P1|COMPLETED|Overall Study||18
11333|NCT02284854|27604|P2|STARTED|Overall Study||20
11334|NCT02284854|27605|P1|STARTED|Overall Study||23
11335|NCT02284828|27622|P1|NOT COMPLETED|Overall Study||4
11336|NCT02284828|27622|P1|COMPLETED|Overall Study||22
11337|NCT02284828|27622|P1|STARTED|Overall Study||26
11338|NCT02284555|27634|P1|NOT COMPLETED|Overall Study||0
11339|NCT02284555|27634|P1|COMPLETED|Overall Study||12
11340|NCT02284555|27634|P1|STARTED|Overall Study||12
11341|NCT02284516|27641|P2|NOT COMPLETED|Overall Study||36
11342|NCT02284516|27642|P1|NOT COMPLETED|Overall Study||38
11343|NCT02284516|27641|P2|COMPLETED|Overall Study||319
11344|NCT02284516|27642|P1|COMPLETED|Overall Study||318
11345|NCT02284516|27641|P2|Safety Population|Overall Study|Two placebo participants were included in Lifitegrast arm for safety analysis set (N=357).|357
11346|NCT02284516|27642|P1|Safety Population|Overall Study|Two placebo participants were considered for Lifitegrast arm; Placebo safety analysis set (N= 354).|354
11347|NCT02284516|27641|P2|STARTED|Overall Study||355
11348|NCT02284516|27642|P1|STARTED|Overall Study||356
11349|NCT02284386|27650|P1|NOT COMPLETED|Overall Study||0
11350|NCT02284386|27650|P1|COMPLETED|Overall Study||15
11351|NCT02284386|27650|P1|STARTED|Overall Study||15
11352|NCT02284347|27659|P1|NOT COMPLETED|Overall Study||3
11353|NCT02284347|27659|P1|COMPLETED|Overall Study||48
11354|NCT02284347|27659|P1|STARTED|Overall Study||51
11355|NCT02284243|27667|P2|NOT COMPLETED|Overall Study||3
11356|NCT02284243|27668|P1|NOT COMPLETED|Overall Study||4
11357|NCT02284243|27667|P2|COMPLETED|Overall Study||81
11358|NCT02284243|27668|P1|COMPLETED|Overall Study||80
11359|NCT02284243|27667|P2|STARTED|Overall Study||84
11360|NCT02284243|27668|P1|STARTED|Overall Study||84
11361|NCT02284165|27689|P3|NOT COMPLETED|Overall Study||0
11362|NCT02284165|27690|P2|NOT COMPLETED|Overall Study||0
11363|NCT02284165|27691|P1|NOT COMPLETED|Overall Study||0
11364|NCT02284165|27689|P3|COMPLETED|Overall Study||70996
11365|NCT02284165|27690|P2|COMPLETED|Overall Study||40272
11366|NCT02284165|27691|P1|COMPLETED|Overall Study||36448
11367|NCT02284165|27689|P3|STARTED|Overall Study||70996
11368|NCT02284165|27690|P2|STARTED|Overall Study||40272
11369|NCT02284165|27691|P1|STARTED|Overall Study||36448
11370|NCT02283840|27710|P3|NOT COMPLETED|Overall Study||0
11371|NCT02283840|27711|P2|NOT COMPLETED|Overall Study||1
11372|NCT02283840|27712|P1|NOT COMPLETED|Overall Study||0
11373|NCT02283840|27710|P3|COMPLETED|Overall Study||20
11374|NCT02283840|27711|P2|COMPLETED|Overall Study||19
11375|NCT02283840|27712|P1|COMPLETED|Overall Study||20
11376|NCT02283840|27710|P3|STARTED|Overall Study||20
11377|NCT02283840|27711|P2|STARTED|Overall Study||20
11378|NCT02283840|27712|P1|STARTED|Overall Study||20
11379|NCT02283827|27731|P2|NOT COMPLETED|Overall Study||3
11380|NCT02283827|27732|P1|NOT COMPLETED|Overall Study||1
11381|NCT02283827|27731|P2|COMPLETED|Overall Study||13
11382|NCT02283827|27732|P1|COMPLETED|Overall Study||15
11383|NCT02283827|27731|P2|STARTED|Overall Study||16
11384|NCT02283827|27732|P1|STARTED|Overall Study||16
11385|NCT02283814|27749|P2|NOT COMPLETED|Overall Study||2
11386|NCT02283814|27750|P1|NOT COMPLETED|Overall Study||3
11387|NCT02283814|27749|P2|COMPLETED|Overall Study||14
11388|NCT02283814|27750|P1|COMPLETED|Overall Study||13
11389|NCT02283814|27749|P2|STARTED|Overall Study||16
11390|NCT02283814|27750|P1|STARTED|Overall Study||16
11391|NCT02283788|27764|P4|NOT COMPLETED|Overall Study||2
11392|NCT02283788|27765|P3|NOT COMPLETED|Overall Study||5
11393|NCT02283788|27766|P2|NOT COMPLETED|Overall Study||4
11394|NCT02283788|27767|P1|NOT COMPLETED|Overall Study||1
11395|NCT02283788|27764|P4|COMPLETED|Overall Study||14
11396|NCT02283788|27765|P3|COMPLETED|Overall Study||12
11397|NCT02283788|27766|P2|COMPLETED|Overall Study||13
11398|NCT02283788|27767|P1|COMPLETED|Overall Study||16
11399|NCT02283788|27764|P4|STARTED|Overall Study||16
11400|NCT02283788|27765|P3|STARTED|Overall Study||17
11401|NCT02283788|27766|P2|STARTED|Overall Study||17
11402|NCT02283788|27767|P1|STARTED|Overall Study||17
11406|NCT02282982|27838|P1|NOT COMPLETED|Overall Study||206
11407|NCT02282982|27838|P1|COMPLETED|Overall Study||153
11408|NCT02282982|27838|P1|Attended Follow-up Visit|Overall Study||349
11409|NCT02282982|27838|P1|Attended Visit 5|Overall Study||83
11410|NCT02282982|27838|P1|Attended Visit 4|Overall Study||194
11411|NCT02282982|27838|P1|Attended Visit 3|Overall Study||298
11412|NCT02282982|27838|P1|Attended Visit 2|Overall Study||341
11413|NCT02282982|27838|P1|Attended Visit 1|Overall Study||359
11414|NCT02282982|27838|P1|STARTED|Overall Study||359
11415|NCT02282813|27856|P3|NOT COMPLETED|Overall Study||3
11416|NCT02282813|27857|P2|NOT COMPLETED|Overall Study||23
11417|NCT02282813|27858|P1|NOT COMPLETED|Overall Study||12
11418|NCT02282813|27856|P3|COMPLETED|Overall Study||39
11419|NCT02282813|27857|P2|COMPLETED|Overall Study||130
11420|NCT02282813|27858|P1|COMPLETED|Overall Study||91
11421|NCT02282813|27856|P3|STARTED|Overall Study|Randomization to take adjunctive treatment in addition to CTAP101 capsules began after week 12.|42
11422|NCT02282813|27857|P2|STARTED|Overall Study|ITT Population - not randomized or randomized to CTAP101 monotherapy|153
11423|NCT02282813|27858|P1|STARTED|Overall Study|ITT Population|103
11424|NCT02282631|27877|P2|NOT COMPLETED|Overall Study||0
11425|NCT02282631|27878|P1|NOT COMPLETED|Overall Study||2
11426|NCT02282631|27877|P2|COMPLETED|Overall Study||15
11427|NCT02282631|27878|P1|COMPLETED|Overall Study||12
11428|NCT02282631|27877|P2|STARTED|Overall Study||15
11429|NCT02282631|27878|P1|STARTED|Overall Study|The two dropouts happened on the 2nd and 3rd weeks post-baseline, respectively|14
11430|NCT02282605|27919|P3|NOT COMPLETED|Overall Study||0
11431|NCT02282605|27920|P2|NOT COMPLETED|Overall Study||0
11432|NCT02282605|27921|P1|NOT COMPLETED|Overall Study||3
11433|NCT02282605|27919|P3|COMPLETED|Overall Study||24
11434|NCT02282605|27920|P2|COMPLETED|Overall Study||12
11435|NCT02282605|27921|P1|COMPLETED|Overall Study||24
11436|NCT02282605|27919|P3|STARTED|Overall Study||24
11437|NCT02282605|27920|P2|STARTED|Overall Study||12
11438|NCT02282605|27921|P1|STARTED|Overall Study||27
11439|NCT02282527|27943|P2|NOT COMPLETED|Overall Study||1
11440|NCT02282527|27944|P1|NOT COMPLETED|Overall Study||1
11441|NCT02282527|27943|P2|COMPLETED|Overall Study||15
11442|NCT02282527|27944|P1|COMPLETED|Overall Study||15
11443|NCT02282527|27943|P2|STARTED|Overall Study||16
11444|NCT02282527|27944|P1|STARTED|Overall Study||16
11445|NCT02281591|27958|P4|NOT COMPLETED|Overall Study||0
11446|NCT02281591|27959|P3|NOT COMPLETED|Overall Study||0
11447|NCT02281591|27960|P2|NOT COMPLETED|Overall Study||0
11448|NCT02281591|27961|P1|NOT COMPLETED|Overall Study||0
11449|NCT02281591|27958|P4|COMPLETED|Overall Study||8
11450|NCT02281591|27959|P3|COMPLETED|Overall Study||8
11451|NCT02281591|27960|P2|COMPLETED|Overall Study||8
11452|NCT02281591|27961|P1|COMPLETED|Overall Study||8
11453|NCT02281591|27958|P4|STARTED|Overall Study||8
11454|NCT02281591|27959|P3|STARTED|Overall Study||8
11455|NCT02281591|27960|P2|STARTED|Overall Study||8
11456|NCT02281591|27961|P1|STARTED|Overall Study||8
11457|NCT02281526|27985|P2|NOT COMPLETED|Overall Study||0
11458|NCT02281526|27986|P1|NOT COMPLETED|Overall Study||1
11459|NCT02281526|27985|P2|COMPLETED|Overall Study||8
11460|NCT02281526|27986|P1|COMPLETED|Overall Study||8
11461|NCT02281526|27985|P2|STARTED|Overall Study||8
11462|NCT02281526|27986|P1|STARTED|Overall Study||9
11463|NCT02281448|27996|P2|NOT COMPLETED|Overall Study||1
11464|NCT02281448|27997|P1|NOT COMPLETED|Overall Study||2
11465|NCT02281448|27996|P2|COMPLETED|Overall Study||9
11466|NCT02281448|27997|P1|COMPLETED|Overall Study||8
11467|NCT02281448|27996|P2|STARTED|Overall Study||10
11468|NCT02281448|27997|P1|STARTED|Overall Study||10
11469|NCT02281422|28010|P5|NOT COMPLETED|Overall Study||0
11470|NCT02281422|28011|P4|NOT COMPLETED|Overall Study||0
11471|NCT02281422|28012|P3|NOT COMPLETED|Overall Study||0
11472|NCT02281422|28013|P2|NOT COMPLETED|Overall Study||0
11473|NCT02281422|28014|P1|NOT COMPLETED|Overall Study||0
11474|NCT02281422|28010|P5|COMPLETED|Overall Study||8
11475|NCT02281422|28011|P4|COMPLETED|Overall Study||8
11476|NCT02281422|28012|P3|COMPLETED|Overall Study||8
11477|NCT02281422|28013|P2|COMPLETED|Overall Study||8
11478|NCT02281422|28014|P1|COMPLETED|Overall Study||8
11479|NCT02281422|28010|P5|STARTED|Overall Study||8
11480|NCT02281422|28011|P4|STARTED|Overall Study||8
11481|NCT02281422|28012|P3|STARTED|Overall Study||8
11482|NCT02281422|28013|P2|STARTED|Overall Study||8
11483|NCT02281422|28014|P1|STARTED|Overall Study||8
11484|NCT02281318|28038|P2|NOT COMPLETED|Overall Study||5
11485|NCT02281318|28039|P1|NOT COMPLETED|Overall Study||14
11486|NCT02281318|28038|P2|COMPLETED|Overall Study||269
11487|NCT02281318|28039|P1|COMPLETED|Overall Study||263
11488|NCT02281318|28038|P2|STARTED|Overall Study||274
11489|NCT02281318|28039|P1|STARTED|Overall Study||277
11490|NCT02281136|28051|P1|NOT COMPLETED|Overall Study||0
11491|NCT02281136|28051|P1|COMPLETED|Overall Study||29
11492|NCT02281136|28051|P1|STARTED|Overall Study||29
11493|NCT02280811|28088|P5|NOT COMPLETED|Retreated at the MTD||0
11494|NCT02280811|28089|P4|NOT COMPLETED|Retreated at the MTD||0
11495|NCT02280811|28090|P3|NOT COMPLETED|Retreated at the MTD||0
11496|NCT02280811|28091|P2|NOT COMPLETED|Retreated at the MTD||0
11497|NCT02280811|28092|P1|NOT COMPLETED|Retreated at the MTD||0
11498|NCT02280811|28088|P5|COMPLETED|Retreated at the MTD||1
11499|NCT02280811|28089|P4|COMPLETED|Retreated at the MTD||0
11500|NCT02280811|28090|P3|COMPLETED|Retreated at the MTD||0
11501|NCT02280811|28091|P2|COMPLETED|Retreated at the MTD||0
11502|NCT02280811|28092|P1|COMPLETED|Retreated at the MTD||0
11503|NCT02280811|28088|P5|STARTED|Retreated at the MTD|Patient originally started in Grp1(HPV-16 E6mTCR PBL 1x10^9+HD IL-2) and was retreated at the MTD.|1
11504|NCT02280811|28089|P4|STARTED|Retreated at the MTD||0
11505|NCT02280811|28090|P3|STARTED|Retreated at the MTD||0
11506|NCT02280811|28091|P2|STARTED|Retreated at the MTD||0
11507|NCT02280811|28092|P1|STARTED|Retreated at the MTD||0
11508|NCT02280811|28088|P5|NOT COMPLETED|Drug Administration||0
11509|NCT02280811|28089|P4|NOT COMPLETED|Drug Administration||0
11510|NCT02280811|28090|P3|NOT COMPLETED|Drug Administration||0
11511|NCT02280811|28091|P2|NOT COMPLETED|Drug Administration||0
11512|NCT02280811|28092|P1|NOT COMPLETED|Drug Administration||0
11513|NCT02280811|28088|P5|COMPLETED|Drug Administration||2
11514|NCT02280811|28089|P4|COMPLETED|Drug Administration||6
11515|NCT02280811|28090|P3|COMPLETED|Drug Administration||1
11516|NCT02280811|28091|P2|COMPLETED|Drug Administration||2
11517|NCT02280811|28092|P1|COMPLETED|Drug Administration||1
11518|NCT02280811|28088|P5|STARTED|Drug Administration||2
11519|NCT02280811|28089|P4|STARTED|Drug Administration||6
11520|NCT02280811|28090|P3|STARTED|Drug Administration||1
11521|NCT02280811|28091|P2|STARTED|Drug Administration||2
11522|NCT02280811|28092|P1|STARTED|Drug Administration||1
11523|NCT02280655|28133|P2|NOT COMPLETED|Overall Study||0
11524|NCT02280655|28134|P1|NOT COMPLETED|Overall Study||0
11525|NCT02280655|28133|P2|COMPLETED|Overall Study||18
11526|NCT02280655|28134|P1|COMPLETED|Overall Study||25
11527|NCT02280655|28133|P2|STARTED|Overall Study||18
11528|NCT02280655|28134|P1|STARTED|Overall Study||25
11529|NCT02280499|28142|P1|NOT COMPLETED|Overall Study||61
11530|NCT02280499|28142|P1|COMPLETED|Overall Study||26
11531|NCT02280499|28142|P1|STARTED|Overall Study||87
11532|NCT02280473|28150|P2|NOT COMPLETED|Overall Study||3
11533|NCT02280473|28151|P1|NOT COMPLETED|Overall Study||1
11534|NCT02280473|28150|P2|COMPLETED|Overall Study||91
11535|NCT02280473|28151|P1|COMPLETED|Overall Study||93
11536|NCT02280473|28150|P2|STARTED|Overall Study||94
11537|NCT02280473|28151|P1|STARTED|Overall Study||94
11538|NCT02280187|28165|P1|NOT COMPLETED|Overall Study||218
11539|NCT02280187|28165|P1|COMPLETED|Overall Study||182
11540|NCT02280187|28165|P1|STARTED|Overall Study||400
11541|NCT02280122|28183|P3|NOT COMPLETED|Overall Study||0
11542|NCT02280122|28184|P2|NOT COMPLETED|Overall Study||0
11543|NCT02280122|28185|P1|NOT COMPLETED|Overall Study||0
11544|NCT02280122|28183|P3|COMPLETED|Overall Study||30
11545|NCT02280122|28184|P2|COMPLETED|Overall Study||15
11546|NCT02280122|28185|P1|COMPLETED|Overall Study||15
11547|NCT02280122|28183|P3|STARTED|Overall Study||30
11548|NCT02280122|28184|P2|STARTED|Overall Study||15
11549|NCT02280122|28185|P1|STARTED|Overall Study||15
11550|NCT02279667|28194|P3|NOT COMPLETED|Overall Study||0
11551|NCT02279667|28195|P2|NOT COMPLETED|Overall Study||0
11552|NCT02279667|28196|P1|NOT COMPLETED|Overall Study||0
11553|NCT02279667|28194|P3|COMPLETED|Overall Study||6
11554|NCT02279667|28195|P2|COMPLETED|Overall Study||6
11555|NCT02279667|28196|P1|COMPLETED|Overall Study||6
11556|NCT02279667|28194|P3|STARTED|Overall Study||6
11557|NCT02279667|28195|P2|STARTED|Overall Study||6
11558|NCT02279667|28196|P1|STARTED|Overall Study||6
11559|NCT02279420|28214|P1|NOT COMPLETED|Overall Study||23
11560|NCT02279420|28214|P1|COMPLETED|Overall Study||50
11561|NCT02279420|28214|P1|STARTED|Overall Study||73
11562|NCT02279407|28222|P4|NOT COMPLETED|Overall Study||1
11563|NCT02279407|28223|P3|NOT COMPLETED|Overall Study||5
11564|NCT02279407|28224|P2|NOT COMPLETED|Overall Study||1
11565|NCT02279407|28225|P1|NOT COMPLETED|Overall Study||2
11566|NCT02279407|28222|P4|COMPLETED|Overall Study||20
11567|NCT02279407|28223|P3|COMPLETED|Overall Study||15
11568|NCT02279407|28224|P2|COMPLETED|Overall Study||20
11569|NCT02279407|28225|P1|COMPLETED|Overall Study||20
11570|NCT02279407|28222|P4|STARTED|Overall Study||21
11571|NCT02279407|28223|P3|STARTED|Overall Study||20
11572|NCT02279407|28224|P2|STARTED|Overall Study||21
11573|NCT02279407|28225|P1|STARTED|Overall Study||22
11574|NCT02279082|28236|P1|NOT COMPLETED|Overall Study||33
11575|NCT02279082|28236|P1|COMPLETED|Overall Study||134
11576|NCT02279082|28236|P1|STARTED|Overall Study|Intentions were to have 173 participants, but only 167 participants received study drug.|167
11577|NCT02278783|28240|P1|NOT COMPLETED|Overall Study||0
11578|NCT02278783|28240|P1|COMPLETED|Overall Study||1
11579|NCT02278783|28240|P1|STARTED|Overall Study||1
11580|NCT02278640|28247|P1|NOT COMPLETED|Overall Study||0
11581|NCT02278640|28247|P1|COMPLETED|Overall Study||40
11582|NCT02278640|28247|P1|STARTED|Overall Study||40
11583|NCT02278614|28256|P2|NOT COMPLETED|Overall Study||5
11584|NCT02278614|28257|P1|NOT COMPLETED|Overall Study||5
11585|NCT02278614|28256|P2|COMPLETED|Overall Study||110
11586|NCT02278614|28257|P1|COMPLETED|Overall Study||122
11587|NCT02278614|28256|P2|STARTED|Overall Study||115
11588|NCT02278614|28257|P1|STARTED|Overall Study||127
11589|NCT02278484|28263|P1|NOT COMPLETED|Overall Study||0
11590|NCT02278484|28263|P1|COMPLETED|Overall Study||50
11591|NCT02278484|28263|P1|STARTED|Overall Study||50
11592|NCT02278146|28272|P2|NOT COMPLETED|Overall Study||2
11593|NCT02278146|28273|P1|NOT COMPLETED|Overall Study||0
11594|NCT02278146|28272|P2|COMPLETED|Overall Study||8
11595|NCT02278146|28273|P1|COMPLETED|Overall Study||6
11596|NCT02278146|28272|P2|STARTED|Overall Study||10
11597|NCT02278146|28273|P1|STARTED|Overall Study||6
11598|NCT02277691|28283|P1|NOT COMPLETED|Overall Study||46
11599|NCT02277691|28283|P1|COMPLETED|Overall Study||295
11600|NCT02277691|28283|P1|STARTED|Overall Study||341
11601|NCT02277626|28293|P2|NOT COMPLETED|Overall Study||0
11602|NCT02277626|28294|P1|NOT COMPLETED|Overall Study||0
11603|NCT02277626|28293|P2|COMPLETED|Overall Study||9
11604|NCT02277626|28294|P1|COMPLETED|Overall Study||6
11605|NCT02277626|28293|P2|STARTED|Overall Study||9
11606|NCT02277626|28294|P1|STARTED|Overall Study||6
11607|NCT02277249|28310|P2|NOT COMPLETED|Overall Study||0
11608|NCT02277249|28311|P1|NOT COMPLETED|Overall Study||0
11609|NCT02277249|28310|P2|COMPLETED|Overall Study||30
11610|NCT02277249|28311|P1|COMPLETED|Overall Study||30
11611|NCT02277249|28310|P2|STARTED|Overall Study||30
11612|NCT02277249|28311|P1|STARTED|Overall Study||30
11613|NCT02277119|28320|P3|NOT COMPLETED|Overall Study||8
11614|NCT02277119|28321|P2|NOT COMPLETED|Overall Study||4
11615|NCT02277119|28322|P1|NOT COMPLETED|Overall Study||3
11616|NCT02277119|28320|P3|COMPLETED|Overall Study||19
11617|NCT02277119|28321|P2|COMPLETED|Overall Study||20
11618|NCT02277119|28322|P1|COMPLETED|Overall Study||55
11619|NCT02277119|28320|P3|STARTED|Overall Study||27
11620|NCT02277119|28321|P2|STARTED|Overall Study||24
11621|NCT02277119|28322|P1|STARTED|Overall Study||58
11622|NCT02277093|28339|P1|NOT COMPLETED|Overall Study||0
11623|NCT02277093|28339|P1|COMPLETED|Overall Study||11
11624|NCT02277093|28339|P1|STARTED|Overall Study||11
11625|NCT02276560|28350|P3|NOT COMPLETED|Overall Study||0
11626|NCT02276560|28351|P2|NOT COMPLETED|Overall Study||0
11627|NCT02276560|28352|P1|NOT COMPLETED|Overall Study||1
11628|NCT02276560|28350|P3|COMPLETED|Overall Study||0
11629|NCT02276560|28351|P2|COMPLETED|Overall Study||0
11630|NCT02276560|28352|P1|COMPLETED|Overall Study||0
11631|NCT02276560|28350|P3|STARTED|Overall Study||0
11632|NCT02276560|28351|P2|STARTED|Overall Study||0
11633|NCT02276560|28352|P1|STARTED|Overall Study||1
11634|NCT02276274|28362|P2|NOT COMPLETED|Second Intervention Period||0
11635|NCT02276274|28363|P1|NOT COMPLETED|Second Intervention Period||0
11636|NCT02276274|28362|P2|COMPLETED|Second Intervention Period||6
11637|NCT02276274|28363|P1|COMPLETED|Second Intervention Period||6
11638|NCT02276274|28362|P2|STARTED|Second Intervention Period||6
11639|NCT02276274|28363|P1|STARTED|Second Intervention Period||6
11640|NCT02276274|28362|P2|NOT COMPLETED|Washout Period (at Least 15 Days)||0
11641|NCT02276274|28363|P1|NOT COMPLETED|Washout Period (at Least 15 Days)||0
11642|NCT02276274|28362|P2|COMPLETED|Washout Period (at Least 15 Days)||6
11643|NCT02276274|28363|P1|COMPLETED|Washout Period (at Least 15 Days)||6
11644|NCT02276274|28362|P2|STARTED|Washout Period (at Least 15 Days)||6
11645|NCT02276274|28363|P1|STARTED|Washout Period (at Least 15 Days)||6
11646|NCT02276274|28362|P2|NOT COMPLETED|First Intervention Period||0
11647|NCT02276274|28363|P1|NOT COMPLETED|First Intervention Period||0
11648|NCT02276274|28362|P2|COMPLETED|First Intervention Period||6
11649|NCT02276274|28363|P1|COMPLETED|First Intervention Period||6
11650|NCT02276274|28362|P2|STARTED|First Intervention Period||6
11651|NCT02276274|28363|P1|STARTED|First Intervention Period||6
11652|NCT02275767|28474|P3|NOT COMPLETED|Overall Study||3
11653|NCT02275767|28475|P2|NOT COMPLETED|Overall Study||4
11654|NCT02275767|28476|P1|NOT COMPLETED|Overall Study||2
11655|NCT02275767|28474|P3|COMPLETED|Overall Study||19
11656|NCT02275767|28475|P2|COMPLETED|Overall Study||18
11657|NCT02275767|28476|P1|COMPLETED|Overall Study||20
11658|NCT02275767|28474|P3|STARTED|Overall Study||22
11659|NCT02275767|28475|P2|STARTED|Overall Study||22
11660|NCT02275767|28476|P1|STARTED|Overall Study||22
11661|NCT02275611|28491|P4|NOT COMPLETED|Outpatient Drinking||0
11662|NCT02275611|28492|P3|NOT COMPLETED|Outpatient Drinking||0
11663|NCT02275611|28493|P2|NOT COMPLETED|Outpatient Drinking||0
11664|NCT02275611|28494|P1|NOT COMPLETED|Outpatient Drinking||0
11665|NCT02275611|28491|P4|COMPLETED|Outpatient Drinking||3
11666|NCT02275611|28492|P3|COMPLETED|Outpatient Drinking||6
11667|NCT02275611|28493|P2|COMPLETED|Outpatient Drinking||0
11668|NCT02275611|28494|P1|COMPLETED|Outpatient Drinking||0
11669|NCT02275611|28491|P4|STARTED|Outpatient Drinking||3
11670|NCT02275611|28492|P3|STARTED|Outpatient Drinking||6
11671|NCT02275611|28493|P2|STARTED|Outpatient Drinking||0
11672|NCT02275611|28494|P1|STARTED|Outpatient Drinking||0
11673|NCT02275611|28491|P4|NOT COMPLETED|Inpatient Withdrawal||0
11674|NCT02275611|28492|P3|NOT COMPLETED|Inpatient Withdrawal||0
11675|NCT02275611|28493|P2|NOT COMPLETED|Inpatient Withdrawal||0
11676|NCT02275611|28494|P1|NOT COMPLETED|Inpatient Withdrawal||1
11677|NCT02275611|28491|P4|COMPLETED|Inpatient Withdrawal||0
11678|NCT02275611|28492|P3|COMPLETED|Inpatient Withdrawal||0
11679|NCT02275611|28493|P2|COMPLETED|Inpatient Withdrawal||4
11680|NCT02275611|28494|P1|COMPLETED|Inpatient Withdrawal||4
11681|NCT02275611|28491|P4|STARTED|Inpatient Withdrawal||0
11682|NCT02275611|28492|P3|STARTED|Inpatient Withdrawal||0
11683|NCT02275611|28493|P2|STARTED|Inpatient Withdrawal||4
11684|NCT02275611|28494|P1|STARTED|Inpatient Withdrawal||5
11685|NCT02275546|28506|P2|NOT COMPLETED|Treatment Period 2||2
11686|NCT02275546|28507|P1|NOT COMPLETED|Treatment Period 2||2
11687|NCT02275546|28506|P2|COMPLETED|Treatment Period 2||81
11688|NCT02275546|28507|P1|COMPLETED|Treatment Period 2||79
11689|NCT02275546|28506|P2|STARTED|Treatment Period 2||83
11690|NCT02275546|28507|P1|STARTED|Treatment Period 2||81
11691|NCT02275546|28506|P2|NOT COMPLETED|Treatment Period 1||0
11692|NCT02275546|28507|P1|NOT COMPLETED|Treatment Period 1||0
11693|NCT02275546|28506|P2|COMPLETED|Treatment Period 1||83
11694|NCT02275546|28507|P1|COMPLETED|Treatment Period 1||81
11695|NCT02275546|28506|P2|STARTED|Treatment Period 1||83
11696|NCT02275546|28507|P1|STARTED|Treatment Period 1||81
11697|NCT02275364|28515|P2|NOT COMPLETED|Period 4||0
11698|NCT02275364|28516|P1|NOT COMPLETED|Period 4||0
11699|NCT02275364|28515|P2|COMPLETED|Period 4||14
11700|NCT02275364|28516|P1|COMPLETED|Period 4||12
11701|NCT02275364|28515|P2|STARTED|Period 4||14
11702|NCT02275364|28516|P1|STARTED|Period 4||12
11703|NCT02275364|28515|P2|NOT COMPLETED|Period 3||0
11704|NCT02275364|28516|P1|NOT COMPLETED|Period 3||0
11705|NCT02275364|28515|P2|COMPLETED|Period 3||14
11706|NCT02275364|28516|P1|COMPLETED|Period 3||12
11707|NCT02275364|28515|P2|STARTED|Period 3||14
11708|NCT02275364|28516|P1|STARTED|Period 3||12
11709|NCT02275364|28515|P2|NOT COMPLETED|Washout Period 2||0
11710|NCT02275364|28516|P1|NOT COMPLETED|Washout Period 2||0
11711|NCT02275364|28515|P2|COMPLETED|Washout Period 2||14
11712|NCT02275364|28516|P1|COMPLETED|Washout Period 2||12
11713|NCT02275364|28515|P2|STARTED|Washout Period 2||14
11714|NCT02275364|28516|P1|STARTED|Washout Period 2||12
11715|NCT02275364|28515|P2|NOT COMPLETED|Period 2||0
11716|NCT02275364|28516|P1|NOT COMPLETED|Period 2||0
11717|NCT02275364|28515|P2|COMPLETED|Period 2||14
11718|NCT02275364|28516|P1|COMPLETED|Period 2||12
11719|NCT02275364|28515|P2|STARTED|Period 2||14
11720|NCT02275364|28516|P1|STARTED|Period 2||12
11721|NCT02275364|28515|P2|NOT COMPLETED|Washout Period 1||0
11722|NCT02275364|28516|P1|NOT COMPLETED|Washout Period 1||0
11723|NCT02275364|28515|P2|COMPLETED|Washout Period 1||14
11724|NCT02275364|28516|P1|COMPLETED|Washout Period 1||12
11725|NCT02275364|28515|P2|STARTED|Washout Period 1||14
11726|NCT02275364|28516|P1|STARTED|Washout Period 1||12
11727|NCT02275364|28515|P2|NOT COMPLETED|Period 1||0
11728|NCT02275364|28516|P1|NOT COMPLETED|Period 1||2
11729|NCT02275364|28515|P2|COMPLETED|Period 1||14
11730|NCT02275364|28516|P1|COMPLETED|Period 1||12
11731|NCT02275364|28515|P2|STARTED|Period 1||14
11732|NCT02275364|28516|P1|STARTED|Period 1||14
11733|NCT02275156|28548|P3|NOT COMPLETED|Overall Study||0
11734|NCT02275156|28549|P2|NOT COMPLETED|Overall Study||0
11735|NCT02275156|28550|P1|NOT COMPLETED|Overall Study||0
11736|NCT02275156|28548|P3|COMPLETED|Overall Study||6
11737|NCT02275156|28549|P2|COMPLETED|Overall Study||6
11738|NCT02275156|28550|P1|COMPLETED|Overall Study||6
11739|NCT02275156|28548|P3|STARTED|Overall Study||6
11740|NCT02275156|28549|P2|STARTED|Overall Study||6
11741|NCT02275156|28550|P1|STARTED|Overall Study||6
11742|NCT02275052|28577|P4|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||14
11743|NCT02275052|28578|P3|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||5
11744|NCT02275052|28579|P2|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11745|NCT02275052|28580|P1|NOT COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11746|NCT02275052|28577|P4|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||72
11747|NCT02275052|28578|P3|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||88
11748|NCT02275052|28579|P2|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11749|NCT02275052|28580|P1|COMPLETED|Period 2: Treatment Period 2 (12 Weeks)||0
11750|NCT02275052|28577|P4|STARTED|Period 2: Treatment Period 2 (12 Weeks)||86
11751|NCT02275052|28578|P3|STARTED|Period 2: Treatment Period 2 (12 Weeks)||93
11752|NCT02275052|28579|P2|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
11753|NCT02275052|28580|P1|STARTED|Period 2: Treatment Period 2 (12 Weeks)||0
11754|NCT02275052|28577|P4|NOT COMPLETED|Washout Period (12-17 Days)||0
11755|NCT02275052|28578|P3|NOT COMPLETED|Washout Period (12-17 Days)||0
11756|NCT02275052|28579|P2|NOT COMPLETED|Washout Period (12-17 Days)||0
11757|NCT02275052|28580|P1|NOT COMPLETED|Washout Period (12-17 Days)||4
11758|NCT02275052|28577|P4|COMPLETED|Washout Period (12-17 Days)||0
11759|NCT02275052|28578|P3|COMPLETED|Washout Period (12-17 Days)||0
11760|NCT02275052|28579|P2|COMPLETED|Washout Period (12-17 Days)||93
11761|NCT02275052|28580|P1|COMPLETED|Washout Period (12-17 Days)||86
11762|NCT02275052|28577|P4|STARTED|Washout Period (12-17 Days)||0
11763|NCT02275052|28578|P3|STARTED|Washout Period (12-17 Days)||0
11764|NCT02275052|28579|P2|STARTED|Washout Period (12-17 Days)||93
11765|NCT02275052|28580|P1|STARTED|Washout Period (12-17 Days)||90
11766|NCT02275052|28577|P4|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11767|NCT02275052|28578|P3|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11768|NCT02275052|28579|P2|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||6
11769|NCT02275052|28580|P1|NOT COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||9
11770|NCT02275052|28577|P4|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11771|NCT02275052|28578|P3|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||0
11772|NCT02275052|28579|P2|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||93
11773|NCT02275052|28580|P1|COMPLETED|Period 1: Treatment Period 1 (12 Weeks)||90
11774|NCT02275052|28577|P4|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
11775|NCT02275052|28578|P3|STARTED|Period 1: Treatment Period 1 (12 Weeks)||0
11776|NCT02275052|28579|P2|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
11777|NCT02275052|28580|P1|STARTED|Period 1: Treatment Period 1 (12 Weeks)||99
11778|NCT02274948|28594|P2|NOT COMPLETED|Overall Study||91
11779|NCT02274948|28595|P1|NOT COMPLETED|Overall Study||98
11780|NCT02274948|28594|P2|COMPLETED|Overall Study||82
11781|NCT02274948|28595|P1|COMPLETED|Overall Study||68
11782|NCT02274948|28594|P2|STARTED|Overall Study||173
11783|NCT02274948|28595|P1|STARTED|Overall Study||166
11784|NCT02274792|28609|P1|NOT COMPLETED|Overall Study||25
11785|NCT02274792|28609|P1|COMPLETED|Overall Study||107
11786|NCT02274792|28609|P1|Received Treatment|Overall Study||131
11787|NCT02274792|28609|P1|STARTED|Overall Study||132
11788|NCT02274688|28619|P2|NOT COMPLETED|Overall Study||13
11789|NCT02274688|28620|P1|NOT COMPLETED|Overall Study||14
11790|NCT02274688|28619|P2|COMPLETED|Overall Study||72
11791|NCT02274688|28620|P1|COMPLETED|Overall Study||72
11792|NCT02274688|28619|P2|STARTED|Overall Study||85
11793|NCT02274688|28620|P1|STARTED|Overall Study||86
11794|NCT02274675|28642|P1|NOT COMPLETED|Overall Study||0
11795|NCT02274675|28642|P1|COMPLETED|Overall Study||7
11796|NCT02274675|28642|P1|STARTED|Overall Study||7
11797|NCT02274558|28655|P3|NOT COMPLETED|Overall Study||9
11798|NCT02274558|28656|P2|NOT COMPLETED|Overall Study||13
11799|NCT02274558|28657|P1|NOT COMPLETED|Overall Study||7
11800|NCT02274558|28655|P3|COMPLETED|Overall Study||71
11801|NCT02274558|28656|P2|COMPLETED|Overall Study||63
11802|NCT02274558|28657|P1|COMPLETED|Overall Study||71
11803|NCT02274558|28655|P3|Included in the Safety Analysis Set|Overall Study||79
11804|NCT02274558|28656|P2|Included in the Safety Analysis Set|Overall Study||72
11805|NCT02274558|28657|P1|Included in the Safety Analysis Set|Overall Study||76
11806|NCT02274558|28655|P3|STARTED|Overall Study||80
11807|NCT02274558|28656|P2|STARTED|Overall Study||76
11808|NCT02274558|28657|P1|STARTED|Overall Study||78
11809|NCT02273908|28673|P2|NOT COMPLETED|Overall Study||5
11810|NCT02273908|28674|P1|NOT COMPLETED|Overall Study||33
11811|NCT02273908|28673|P2|COMPLETED|Overall Study||169
11812|NCT02273908|28674|P1|COMPLETED|Overall Study||124
11813|NCT02273908|28673|P2|STARTED|Overall Study||174
11814|NCT02273908|28674|P1|STARTED|Overall Study||157
11815|NCT02273752|28696|P1|NOT COMPLETED|Overall Study||2
11816|NCT02273752|28696|P1|COMPLETED|Overall Study||0
11817|NCT02273752|28696|P1|STARTED|Overall Study||2
11818|NCT02273323|28707|P2|NOT COMPLETED|Overall Study||0
11819|NCT02273323|28708|P1|NOT COMPLETED|Overall Study||0
11820|NCT02273323|28707|P2|COMPLETED|Overall Study||15
11821|NCT02273323|28708|P1|COMPLETED|Overall Study||15
11822|NCT02273323|28707|P2|STARTED|Overall Study||15
11823|NCT02273323|28708|P1|STARTED|Overall Study||15
11824|NCT02273310|28726|P2|NOT COMPLETED|Overall Study||3
11825|NCT02273310|28727|P1|NOT COMPLETED|Overall Study||18
11826|NCT02273310|28726|P2|COMPLETED|Overall Study||38
11827|NCT02273310|28727|P1|COMPLETED|Overall Study||24
11828|NCT02273310|28726|P2|STARTED|Overall Study||41
11829|NCT02273310|28727|P1|STARTED|Overall Study||42
11830|NCT02273167|28741|P3|NOT COMPLETED|Overall Study||21
11831|NCT02273167|28742|P2|NOT COMPLETED|Overall Study||23
11832|NCT02273167|28743|P1|NOT COMPLETED|Overall Study||24
11833|NCT02273167|28741|P3|COMPLETED|Overall Study||262
11834|NCT02273167|28742|P2|COMPLETED|Overall Study||260
11835|NCT02273167|28743|P1|COMPLETED|Overall Study||259
11836|NCT02273167|28741|P3|STARTED|Overall Study||283
11837|NCT02273167|28742|P2|STARTED|Overall Study||283
11838|NCT02273167|28743|P1|STARTED|Overall Study||283
11839|NCT02273141|28768|P2|NOT COMPLETED|Overall Study||25
11840|NCT02273141|28769|P1|NOT COMPLETED|Overall Study||17
11841|NCT02273141|28768|P2|COMPLETED|Overall Study||233
11842|NCT02273141|28769|P1|COMPLETED|Overall Study||240
11843|NCT02273141|28768|P2|STARTED|Overall Study||258
11844|NCT02273141|28769|P1|STARTED|Overall Study||257
11845|NCT02273115|28789|P4|NOT COMPLETED|Overall Study||1
11846|NCT02273115|28790|P3|NOT COMPLETED|Overall Study||0
11847|NCT02273115|28791|P2|NOT COMPLETED|Overall Study||0
11848|NCT02273115|28792|P1|NOT COMPLETED|Overall Study||0
11849|NCT02273115|28789|P4|COMPLETED|Overall Study||71
11850|NCT02273115|28790|P3|COMPLETED|Overall Study||67
11851|NCT02273115|28791|P2|COMPLETED|Overall Study||90
11852|NCT02273115|28792|P1|COMPLETED|Overall Study||94
11853|NCT02273115|28789|P4|STARTED|Overall Study||72
11854|NCT02273115|28790|P3|STARTED|Overall Study||67
11855|NCT02273115|28791|P2|STARTED|Overall Study||90
11856|NCT02273115|28792|P1|STARTED|Overall Study||94
11857|NCT02272725|28836|P2|NOT COMPLETED|Overall Study||0
11858|NCT02272725|28837|P1|NOT COMPLETED|Overall Study||2
11859|NCT02272725|28836|P2|COMPLETED|Overall Study||42
11860|NCT02272725|28837|P1|COMPLETED|Overall Study||47
11861|NCT02272725|28836|P2|STARTED|Overall Study||42
11862|NCT02272725|28837|P1|STARTED|Overall Study||49
11863|NCT02271854|28847|P1|NOT COMPLETED|Overall Study||4
11864|NCT02271854|28847|P1|COMPLETED|Overall Study||98
11865|NCT02271854|28847|P1|STARTED|Overall Study||102
11866|NCT02271698|28858|P4|NOT COMPLETED|Overall Study||0
11867|NCT02271698|28859|P3|NOT COMPLETED|Overall Study||0
11868|NCT02271698|28860|P2|NOT COMPLETED|Overall Study||0
11869|NCT02271698|28861|P1|NOT COMPLETED|Overall Study||0
11870|NCT02271698|28858|P4|COMPLETED|Overall Study||11
11871|NCT02271698|28859|P3|COMPLETED|Overall Study||10
11872|NCT02271698|28860|P2|COMPLETED|Overall Study||10
11873|NCT02271698|28861|P1|COMPLETED|Overall Study||11
11874|NCT02271698|28858|P4|STARTED|Overall Study||11
11875|NCT02271698|28859|P3|STARTED|Overall Study||10
11876|NCT02271698|28860|P2|STARTED|Overall Study||10
11877|NCT02271698|28861|P1|STARTED|Overall Study||11
11878|NCT02271529|28875|P1|NOT COMPLETED|Overall Study||1
11879|NCT02271529|28875|P1|COMPLETED|Overall Study||39
11880|NCT02271529|28875|P1|STARTED|Overall Study||40
11881|NCT02271477|28881|P2|NOT COMPLETED|Overall Study||0
11882|NCT02271477|28882|P1|NOT COMPLETED|Overall Study||0
11883|NCT02271477|28881|P2|COMPLETED|Overall Study||80
11884|NCT02271477|28882|P1|COMPLETED|Overall Study||80
11885|NCT02271477|28881|P2|STARTED|Overall Study||80
11886|NCT02271477|28882|P1|STARTED|Overall Study||80
11887|NCT02270944|28896|P2|NOT COMPLETED|Overall Study||5
11888|NCT02270944|28897|P1|NOT COMPLETED|Overall Study||11
11889|NCT02270944|28896|P2|COMPLETED|Overall Study||516
11890|NCT02270944|28897|P1|COMPLETED|Overall Study||518
11891|NCT02270944|28896|P2|STARTED|Overall Study||521
11892|NCT02270944|28897|P1|STARTED|Overall Study||529
11893|NCT02270684|28913|P2|NOT COMPLETED|Overall Study||3
11894|NCT02270684|28914|P1|NOT COMPLETED|Overall Study||1
11895|NCT02270684|28913|P2|COMPLETED|Overall Study||0
11896|NCT02270684|28914|P1|COMPLETED|Overall Study||0
11897|NCT02270684|28913|P2|STARTED|Overall Study||3
11898|NCT02270684|28914|P1|STARTED|Overall Study||1
11899|NCT02270515|28920|P1|NOT COMPLETED|Intervention Period 3: 12-18 Months||24
11900|NCT02270515|28920|P1|COMPLETED|Intervention Period 3: 12-18 Months||103
11901|NCT02270515|28920|P1|STARTED|Intervention Period 3: 12-18 Months||127
11902|NCT02270515|28920|P1|NOT COMPLETED|Intervention Period 2: 6-12 Months||32
11903|NCT02270515|28920|P1|COMPLETED|Intervention Period 2: 6-12 Months||127
11904|NCT02270515|28920|P1|STARTED|Intervention Period 2: 6-12 Months||159
11905|NCT02270515|28920|P1|NOT COMPLETED|Intervention Period 1: 0-6 Months||16
11906|NCT02270515|28920|P1|COMPLETED|Intervention Period 1: 0-6 Months||159
11907|NCT02270515|28920|P1|STARTED|Intervention Period 1: 0-6 Months||175
11908|NCT02269709|28935|P1|NOT COMPLETED|Six Month Follow-up||12
11909|NCT02269709|28935|P1|COMPLETED|Six Month Follow-up||5
11910|NCT02269709|28935|P1|STARTED|Six Month Follow-up||17
11911|NCT02269709|28935|P1|NOT COMPLETED|Prior to Hospital Discharge||0
11912|NCT02269709|28935|P1|COMPLETED|Prior to Hospital Discharge||17
11913|NCT02269709|28935|P1|STARTED|Prior to Hospital Discharge||17
11914|NCT02269709|28935|P1|NOT COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||1
11915|NCT02269709|28935|P1|COMPLETED|Follow-up #1 (24-72 Hours Post-surgery)||17
11916|NCT02269709|28935|P1|STARTED|Follow-up #1 (24-72 Hours Post-surgery)||18
11917|NCT02269709|28935|P1|NOT COMPLETED|Time of Enrollment||3
11918|NCT02269709|28935|P1|COMPLETED|Time of Enrollment||18
11919|NCT02269709|28935|P1|STARTED|Time of Enrollment||21
11920|NCT02269657|28940|P1|NOT COMPLETED|Overall Study||3
11921|NCT02269657|28940|P1|COMPLETED|Overall Study||37
11922|NCT02269657|28940|P1|STARTED|Overall Study||40
11923|NCT02269488|28954|P1|NOT COMPLETED|Overall Study||0
11924|NCT02269488|28954|P1|COMPLETED|Overall Study||100
11925|NCT02269488|28954|P1|STARTED|Overall Study||100
11926|NCT02269475|28960|P2|NOT COMPLETED|Overall Study||1
11927|NCT02269475|28961|P1|NOT COMPLETED|Overall Study||3
11928|NCT02269475|28960|P2|COMPLETED|Overall Study||432
11929|NCT02269475|28961|P1|COMPLETED|Overall Study||865
11930|NCT02269475|28960|P2|Per Protocol Population|Overall Study||430
11931|NCT02269475|28961|P1|Per Protocol Population|Overall Study||849
11932|NCT02269475|28960|P2|Received IP (Safety Population)|Overall Study||433
11933|NCT02269475|28961|P1|Received IP (Safety Population)|Overall Study||868
11934|NCT02269475|28960|P2|STARTED|Overall Study||433
11935|NCT02269475|28961|P1|STARTED|Overall Study||868
11936|NCT02269098|28974|P2|NOT COMPLETED|Overall Study||9
11937|NCT02269098|28975|P1|NOT COMPLETED|Overall Study||14
11938|NCT02269098|28974|P2|COMPLETED|Overall Study||41
11939|NCT02269098|28975|P1|COMPLETED|Overall Study||37
11940|NCT02269098|28974|P2|STARTED|Overall Study||50
11941|NCT02269098|28975|P1|STARTED|Overall Study||51
11942|NCT02268877|28991|P2|NOT COMPLETED|Overall Study||5
11943|NCT02268877|28992|P1|NOT COMPLETED|Overall Study||4
11944|NCT02268877|28991|P2|COMPLETED|Overall Study|106 patients received the intervention.|106
11945|NCT02268877|28992|P1|COMPLETED|Overall Study||118
11946|NCT02268877|28991|P2|STARTED|Overall Study|111 patients were randomized to this arm.|111
11947|NCT02268877|28992|P1|STARTED|Overall Study||122
11948|NCT02268864|29003|P3|NOT COMPLETED|Overall Study||0
11949|NCT02268864|29004|P2|NOT COMPLETED|Overall Study||1
11950|NCT02268864|29005|P1|NOT COMPLETED|Overall Study||2
11951|NCT02268864|29003|P3|COMPLETED|Overall Study||64
11952|NCT02268864|29004|P2|COMPLETED|Overall Study||24
11953|NCT02268864|29005|P1|COMPLETED|Overall Study||15
11954|NCT02268864|29003|P3|STARTED|Overall Study||64
11955|NCT02268864|29004|P2|STARTED|Overall Study||25
11956|NCT02268864|29005|P1|STARTED|Overall Study||17
11957|NCT02268396|29027|P1|NOT COMPLETED|Overall Study||12
11958|NCT02268396|29027|P1|COMPLETED|Overall Study||126
11959|NCT02268396|29027|P1|STARTED|Overall Study||138
11960|NCT02268058|29040|P4|NOT COMPLETED|Overall Study||0
11961|NCT02268058|29041|P3|NOT COMPLETED|Overall Study||0
11962|NCT02268058|29042|P2|NOT COMPLETED|Overall Study||0
11963|NCT02268058|29043|P1|NOT COMPLETED|Overall Study||1
11964|NCT02268058|29040|P4|COMPLETED|Overall Study||20
11965|NCT02268058|29041|P3|COMPLETED|Overall Study||20
11966|NCT02268058|29042|P2|COMPLETED|Overall Study||20
11967|NCT02268058|29043|P1|COMPLETED|Overall Study||19
11968|NCT02268058|29040|P4|STARTED|Overall Study||20
11969|NCT02268058|29041|P3|STARTED|Overall Study||20
11970|NCT02268058|29042|P2|STARTED|Overall Study||20
11971|NCT02268058|29043|P1|STARTED|Overall Study||20
11972|NCT02267837|29067|P2|NOT COMPLETED|Overall Study||0
11973|NCT02267837|29068|P1|NOT COMPLETED|Overall Study||0
11974|NCT02267837|29067|P2|COMPLETED|Overall Study||9
11975|NCT02267837|29068|P1|COMPLETED|Overall Study||11
11976|NCT02267837|29067|P2|STARTED|Overall Study||9
11977|NCT02267837|29068|P1|STARTED|Overall Study||11
11978|NCT02267824|29076|P2|NOT COMPLETED|Overall Study||1
11979|NCT02267824|29077|P1|NOT COMPLETED|Overall Study||10
11980|NCT02267824|29076|P2|COMPLETED|Overall Study||17
11981|NCT02267824|29077|P1|COMPLETED|Overall Study||73
11982|NCT02267824|29076|P2|STARTED|Overall Study||18
11983|NCT02267824|29077|P1|STARTED|Overall Study||83
11984|NCT02267629|29083|P1|NOT COMPLETED|Overall Study||0
11985|NCT02267629|29083|P1|COMPLETED|Overall Study||7
11986|NCT02267629|29083|P1|STARTED|Overall Study||7
11987|NCT02267447|29090|P2|NOT COMPLETED|Overall Study||0
11988|NCT02267447|29091|P1|NOT COMPLETED|Overall Study||0
11989|NCT02267447|29090|P2|COMPLETED|Overall Study||26968
11990|NCT02267447|29091|P1|COMPLETED|Overall Study||77251
11991|NCT02267447|29090|P2|STARTED|Overall Study||26968
11992|NCT02267447|29091|P1|STARTED|Overall Study||77251
11993|NCT02266797|29101|P2|NOT COMPLETED|Overall Study||1
11994|NCT02266797|29102|P1|NOT COMPLETED|Overall Study||0
11995|NCT02266797|29101|P2|COMPLETED|Overall Study||2
11996|NCT02266797|29102|P1|COMPLETED|Overall Study||1
11997|NCT02266797|29101|P2|STARTED|Overall Study||3
11998|NCT02266797|29102|P1|STARTED|Overall Study||1
11999|NCT02266472|29120|P2|NOT COMPLETED|Period 2+ Washout||0
12000|NCT02266472|29121|P1|NOT COMPLETED|Period 2+ Washout||0
12001|NCT02266472|29120|P2|COMPLETED|Period 2+ Washout||15
12002|NCT02266472|29121|P1|COMPLETED|Period 2+ Washout||15
12003|NCT02266472|29120|P2|STARTED|Period 2+ Washout||15
12004|NCT02266472|29121|P1|STARTED|Period 2+ Washout||15
12005|NCT02266472|29120|P2|NOT COMPLETED|Period 1+ Washout||0
12006|NCT02266472|29121|P1|NOT COMPLETED|Period 1+ Washout||0
12007|NCT02266472|29120|P2|COMPLETED|Period 1+ Washout||15
12008|NCT02266472|29121|P1|COMPLETED|Period 1+ Washout||15
12009|NCT02266472|29120|P2|STARTED|Period 1+ Washout||15
12010|NCT02266472|29121|P1|STARTED|Period 1+ Washout||15
12011|NCT02266381|29140|P3|NOT COMPLETED|Overall Study||4
12012|NCT02266381|29141|P2|NOT COMPLETED|Overall Study||5
12013|NCT02266381|29142|P1|NOT COMPLETED|Overall Study||3
12014|NCT02266381|29140|P3|COMPLETED|Overall Study||146
12015|NCT02266381|29141|P2|COMPLETED|Overall Study||145
12016|NCT02266381|29142|P1|COMPLETED|Overall Study||147
12017|NCT02266381|29140|P3|STARTED|Overall Study||150
12018|NCT02266381|29141|P2|STARTED|Overall Study||150
12019|NCT02266381|29142|P1|STARTED|Overall Study||150
12020|NCT02266277|29165|P6|NOT COMPLETED|Overall Study||0
12021|NCT02266277|29166|P5|NOT COMPLETED|Overall Study||0
12022|NCT02266277|29167|P4|NOT COMPLETED|Overall Study||0
12023|NCT02266277|29168|P3|NOT COMPLETED|Overall Study||0
12024|NCT02266277|29169|P2|NOT COMPLETED|Overall Study||0
12025|NCT02266277|29170|P1|NOT COMPLETED|Overall Study||0
12026|NCT02266277|29165|P6|COMPLETED|Overall Study||5000
12027|NCT02266277|29166|P5|COMPLETED|Overall Study||5000
12028|NCT02266277|29167|P4|COMPLETED|Overall Study||5000
12029|NCT02266277|29168|P3|COMPLETED|Overall Study||5000
12030|NCT02266277|29169|P2|COMPLETED|Overall Study||5000
12031|NCT02266277|29170|P1|COMPLETED|Overall Study||5000
12032|NCT02266277|29165|P6|STARTED|Overall Study||5000
12033|NCT02266277|29166|P5|STARTED|Overall Study||5000
12034|NCT02266277|29167|P4|STARTED|Overall Study||5000
12035|NCT02266277|29168|P3|STARTED|Overall Study||5000
12036|NCT02266277|29169|P2|STARTED|Overall Study||5000
12037|NCT02266277|29170|P1|STARTED|Overall Study||5000
12038|NCT02265848|29194|P2|NOT COMPLETED|Overall Study||0
12039|NCT02265848|29195|P1|NOT COMPLETED|Overall Study||0
12040|NCT02265848|29194|P2|COMPLETED|Overall Study|Last subject for this study completed the visit on December 24, 2014|11
12041|NCT02265848|29195|P1|COMPLETED|Overall Study||11
12042|NCT02265848|29194|P2|STARTED|Overall Study||11
12043|NCT02265848|29195|P1|STARTED|Overall Study|First subject for this study was randomized on October 1st 2014|11
12044|NCT02265783|29207|P1|NOT COMPLETED|Overall Study||0
12045|NCT02265783|29207|P1|COMPLETED|Overall Study|All subjects completed, one excluded from the analysis due to an issue with the data collection|20
12046|NCT02265783|29207|P1|STARTED|Overall Study||20
12047|NCT02265237|29215|P4|NOT COMPLETED|As Treated (Overall Study)||1
12048|NCT02265237|29216|P3|NOT COMPLETED|As Treated (Overall Study)||10
12049|NCT02265237|29217|P2|NOT COMPLETED|As Treated (Overall Study)||3
12050|NCT02265237|29218|P1|NOT COMPLETED|As Treated (Overall Study)||5
12051|NCT02265237|29215|P4|COMPLETED|As Treated (Overall Study)||2
12052|NCT02265237|29216|P3|COMPLETED|As Treated (Overall Study)||51
12053|NCT02265237|29217|P2|COMPLETED|As Treated (Overall Study)||57
12054|NCT02265237|29218|P1|COMPLETED|As Treated (Overall Study)||55
12055|NCT02265237|29215|P4|STARTED|As Treated (Overall Study)||3
12056|NCT02265237|29216|P3|STARTED|As Treated (Overall Study)||61
12057|NCT02265237|29217|P2|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
12058|NCT02265237|29218|P1|STARTED|As Treated (Overall Study)|One arm B subject received the drug for the duration for arm A and was included in arm A for safety.|60
12059|NCT02265237|29215|P4|NOT COMPLETED|As Enrolled (Overall Study)||1
12060|NCT02265237|29216|P3|NOT COMPLETED|As Enrolled (Overall Study)||10
12061|NCT02265237|29217|P2|NOT COMPLETED|As Enrolled (Overall Study)||3
12062|NCT02265237|29218|P1|NOT COMPLETED|As Enrolled (Overall Study)||5
12063|NCT02265237|29215|P4|COMPLETED|As Enrolled (Overall Study)||2
12064|NCT02265237|29216|P3|COMPLETED|As Enrolled (Overall Study)||51
12065|NCT02265237|29217|P2|COMPLETED|As Enrolled (Overall Study)||58
12066|NCT02265237|29218|P1|COMPLETED|As Enrolled (Overall Study)||54
12067|NCT02265237|29215|P4|STARTED|As Enrolled (Overall Study)||3
12068|NCT02265237|29216|P3|STARTED|As Enrolled (Overall Study)||61
12069|NCT02265237|29217|P2|STARTED|As Enrolled (Overall Study)||61
12070|NCT02265237|29218|P1|STARTED|As Enrolled (Overall Study)||59
12071|NCT02264977|29237|P1|NOT COMPLETED|Overall Study||7
12072|NCT02264977|29237|P1|COMPLETED|Overall Study||2
12073|NCT02264977|29237|P1|STARTED|Overall Study||9
12074|NCT02264821|29248|P3|NOT COMPLETED|Overall Study||6
12075|NCT02264821|29249|P2|NOT COMPLETED|Overall Study||3
12076|NCT02264821|29250|P1|NOT COMPLETED|Overall Study||1
12077|NCT02264821|29248|P3|COMPLETED|Overall Study||58
12078|NCT02264821|29249|P2|COMPLETED|Overall Study||61
12079|NCT02264821|29250|P1|COMPLETED|Overall Study||63
12080|NCT02264821|29248|P3|STARTED|Overall Study|Double Blind|64
12081|NCT02264821|29249|P2|STARTED|Overall Study|Double Blind|64
12082|NCT02264821|29250|P1|STARTED|Overall Study|Double Blind|64
12083|NCT02264249|29264|P3|NOT COMPLETED|Overall Study||0
12084|NCT02264249|29265|P2|NOT COMPLETED|Overall Study||0
12085|NCT02264249|29266|P1|NOT COMPLETED|Overall Study||0
12086|NCT02264249|29264|P3|COMPLETED|Overall Study||241
12087|NCT02264249|29265|P2|COMPLETED|Overall Study||187
12088|NCT02264249|29266|P1|COMPLETED|Overall Study||21
12089|NCT02264249|29264|P3|STARTED|Overall Study||241
12090|NCT02264249|29265|P2|STARTED|Overall Study||187
12091|NCT02264249|29266|P1|STARTED|Overall Study||21
12092|NCT02263911|29280|P4|NOT COMPLETED|Period 5||0
12093|NCT02263911|29281|P3|NOT COMPLETED|Period 5||0
12094|NCT02263911|29282|P2|NOT COMPLETED|Period 5||0
12095|NCT02263911|29283|P1|NOT COMPLETED|Period 5||0
12096|NCT02263911|29280|P4|COMPLETED|Period 5||4
12097|NCT02263911|29281|P3|COMPLETED|Period 5||4
12098|NCT02263911|29282|P2|COMPLETED|Period 5||4
12099|NCT02263911|29283|P1|COMPLETED|Period 5||4
12100|NCT02263911|29280|P4|STARTED|Period 5||4
12101|NCT02263911|29281|P3|STARTED|Period 5||4
12102|NCT02263911|29282|P2|STARTED|Period 5||4
12103|NCT02263911|29283|P1|STARTED|Period 5||4
12104|NCT02263911|29280|P4|NOT COMPLETED|Period 4 Washout||0
12105|NCT02263911|29281|P3|NOT COMPLETED|Period 4 Washout||0
12106|NCT02263911|29282|P2|NOT COMPLETED|Period 4 Washout||0
12107|NCT02263911|29283|P1|NOT COMPLETED|Period 4 Washout||0
12108|NCT02263911|29280|P4|COMPLETED|Period 4 Washout||4
12109|NCT02263911|29281|P3|COMPLETED|Period 4 Washout||4
12110|NCT02263911|29282|P2|COMPLETED|Period 4 Washout||4
12111|NCT02263911|29283|P1|COMPLETED|Period 4 Washout||4
12112|NCT02263911|29280|P4|STARTED|Period 4 Washout||4
12113|NCT02263911|29281|P3|STARTED|Period 4 Washout||4
12114|NCT02263911|29282|P2|STARTED|Period 4 Washout||4
12115|NCT02263911|29283|P1|STARTED|Period 4 Washout||4
12116|NCT02263911|29280|P4|NOT COMPLETED|Period 4||0
12117|NCT02263911|29281|P3|NOT COMPLETED|Period 4||0
12118|NCT02263911|29282|P2|NOT COMPLETED|Period 4||0
12119|NCT02263911|29283|P1|NOT COMPLETED|Period 4||0
12120|NCT02263911|29280|P4|COMPLETED|Period 4||4
12121|NCT02263911|29281|P3|COMPLETED|Period 4||4
12122|NCT02263911|29282|P2|COMPLETED|Period 4||4
12123|NCT02263911|29283|P1|COMPLETED|Period 4||4
12124|NCT02263911|29280|P4|STARTED|Period 4||4
12125|NCT02263911|29281|P3|STARTED|Period 4||4
12126|NCT02263911|29282|P2|STARTED|Period 4||4
12127|NCT02263911|29283|P1|STARTED|Period 4||4
12128|NCT02263911|29280|P4|NOT COMPLETED|Period 3 Washout||0
12129|NCT02263911|29281|P3|NOT COMPLETED|Period 3 Washout||0
12130|NCT02263911|29282|P2|NOT COMPLETED|Period 3 Washout||0
12131|NCT02263911|29283|P1|NOT COMPLETED|Period 3 Washout||0
12132|NCT02263911|29280|P4|COMPLETED|Period 3 Washout||4
12133|NCT02263911|29281|P3|COMPLETED|Period 3 Washout||4
12134|NCT02263911|29282|P2|COMPLETED|Period 3 Washout||4
12135|NCT02263911|29283|P1|COMPLETED|Period 3 Washout||4
12136|NCT02263911|29280|P4|STARTED|Period 3 Washout||4
12137|NCT02263911|29281|P3|STARTED|Period 3 Washout||4
12138|NCT02263911|29282|P2|STARTED|Period 3 Washout||4
12139|NCT02263911|29283|P1|STARTED|Period 3 Washout||4
12140|NCT02263911|29280|P4|NOT COMPLETED|Period 3||0
12141|NCT02263911|29281|P3|NOT COMPLETED|Period 3||0
12142|NCT02263911|29282|P2|NOT COMPLETED|Period 3||0
12143|NCT02263911|29283|P1|NOT COMPLETED|Period 3||0
12144|NCT02263911|29280|P4|COMPLETED|Period 3||4
12145|NCT02263911|29281|P3|COMPLETED|Period 3||4
12146|NCT02263911|29282|P2|COMPLETED|Period 3||4
12147|NCT02263911|29283|P1|COMPLETED|Period 3||4
12148|NCT02263911|29280|P4|STARTED|Period 3||4
12149|NCT02263911|29281|P3|STARTED|Period 3||4
12150|NCT02263911|29282|P2|STARTED|Period 3||4
12151|NCT02263911|29283|P1|STARTED|Period 3||4
12152|NCT02263911|29280|P4|NOT COMPLETED|Period 2 Washout||0
12153|NCT02263911|29281|P3|NOT COMPLETED|Period 2 Washout||0
12154|NCT02263911|29282|P2|NOT COMPLETED|Period 2 Washout||0
12155|NCT02263911|29283|P1|NOT COMPLETED|Period 2 Washout||0
12156|NCT02263911|29280|P4|COMPLETED|Period 2 Washout||4
12157|NCT02263911|29281|P3|COMPLETED|Period 2 Washout||4
12158|NCT02263911|29282|P2|COMPLETED|Period 2 Washout||4
12159|NCT02263911|29283|P1|COMPLETED|Period 2 Washout||4
12160|NCT02263911|29280|P4|STARTED|Period 2 Washout||4
12161|NCT02263911|29281|P3|STARTED|Period 2 Washout||4
12162|NCT02263911|29282|P2|STARTED|Period 2 Washout||4
12163|NCT02263911|29283|P1|STARTED|Period 2 Washout||4
12164|NCT02263911|29280|P4|NOT COMPLETED|Period 2||0
12165|NCT02263911|29281|P3|NOT COMPLETED|Period 2||0
12166|NCT02263911|29282|P2|NOT COMPLETED|Period 2||0
12167|NCT02263911|29283|P1|NOT COMPLETED|Period 2||0
12168|NCT02263911|29280|P4|COMPLETED|Period 2||4
12169|NCT02263911|29281|P3|COMPLETED|Period 2||4
12170|NCT02263911|29282|P2|COMPLETED|Period 2||4
12171|NCT02263911|29283|P1|COMPLETED|Period 2||4
12172|NCT02263911|29280|P4|STARTED|Period 2||4
12173|NCT02263911|29281|P3|STARTED|Period 2||4
12174|NCT02263911|29282|P2|STARTED|Period 2||4
12175|NCT02263911|29283|P1|STARTED|Period 2||4
12176|NCT02263911|29280|P4|NOT COMPLETED|Period 1 Washout||0
12177|NCT02263911|29281|P3|NOT COMPLETED|Period 1 Washout||0
12178|NCT02263911|29282|P2|NOT COMPLETED|Period 1 Washout||0
12179|NCT02263911|29283|P1|NOT COMPLETED|Period 1 Washout||0
12180|NCT02263911|29280|P4|COMPLETED|Period 1 Washout||4
12181|NCT02263911|29281|P3|COMPLETED|Period 1 Washout||4
12182|NCT02263911|29282|P2|COMPLETED|Period 1 Washout||4
12183|NCT02263911|29283|P1|COMPLETED|Period 1 Washout||4
12184|NCT02263911|29280|P4|STARTED|Period 1 Washout||4
12185|NCT02263911|29281|P3|STARTED|Period 1 Washout||4
12186|NCT02263911|29282|P2|STARTED|Period 1 Washout||4
12187|NCT02263911|29283|P1|STARTED|Period 1 Washout||4
12188|NCT02263911|29280|P4|NOT COMPLETED|Period 1||0
12189|NCT02263911|29281|P3|NOT COMPLETED|Period 1||0
12190|NCT02263911|29282|P2|NOT COMPLETED|Period 1||0
12191|NCT02263911|29283|P1|NOT COMPLETED|Period 1||0
12192|NCT02263911|29280|P4|COMPLETED|Period 1||4
12193|NCT02263911|29281|P3|COMPLETED|Period 1||4
12194|NCT02263911|29282|P2|COMPLETED|Period 1||4
12195|NCT02263911|29283|P1|COMPLETED|Period 1||4
12196|NCT02263911|29280|P4|STARTED|Period 1||4
12197|NCT02263911|29281|P3|STARTED|Period 1||4
12198|NCT02263911|29282|P2|STARTED|Period 1||4
12199|NCT02263911|29283|P1|STARTED|Period 1||4
12200|NCT02263833|29305|P1|NOT COMPLETED|Overall Study||0
12201|NCT02263833|29305|P1|COMPLETED|Overall Study||742
12202|NCT02263833|29305|P1|STARTED|Overall Study||742
12203|NCT02263131|29312|P2|NOT COMPLETED|Overall Study||1
12204|NCT02263131|29313|P1|NOT COMPLETED|Overall Study||10
12205|NCT02263131|29312|P2|COMPLETED|Overall Study||68
12206|NCT02263131|29313|P1|COMPLETED|Overall Study||337
12207|NCT02263131|29312|P2|STARTED|Overall Study||69
12208|NCT02263131|29313|P1|STARTED|Overall Study||347
12209|NCT02263118|29325|P4|NOT COMPLETED|Overall Study||2
12210|NCT02263118|29326|P3|NOT COMPLETED|Overall Study||8
12211|NCT02263118|29327|P2|NOT COMPLETED|Overall Study||8
12212|NCT02263118|29328|P1|NOT COMPLETED|Overall Study||4
12213|NCT02263118|29325|P4|COMPLETED|Overall Study||12
12214|NCT02263118|29326|P3|COMPLETED|Overall Study||22
12215|NCT02263118|29327|P2|COMPLETED|Overall Study||24
12216|NCT02263118|29328|P1|COMPLETED|Overall Study||20
12217|NCT02263118|29325|P4|STARTED|Overall Study||14
12218|NCT02263118|29326|P3|STARTED|Overall Study||30
12219|NCT02263118|29327|P2|STARTED|Overall Study||32
12220|NCT02263118|29328|P1|STARTED|Overall Study||24
12221|NCT02262754|29353|P3|NOT COMPLETED|Overall Study||9
12222|NCT02262754|29354|P2|NOT COMPLETED|Overall Study||9
12223|NCT02262754|29355|P1|NOT COMPLETED|Overall Study||16
12224|NCT02262754|29353|P3|COMPLETED|Overall Study||65
12225|NCT02262754|29354|P2|COMPLETED|Overall Study||65
12226|NCT02262754|29355|P1|COMPLETED|Overall Study||58
12227|NCT02262754|29353|P3|STARTED|Overall Study||74
12228|NCT02262754|29354|P2|STARTED|Overall Study||74
12229|NCT02262754|29355|P1|STARTED|Overall Study||74
12230|NCT02262728|29430|P2|NOT COMPLETED|Overall Study||0
12231|NCT02262728|29431|P1|NOT COMPLETED|Overall Study||0
12232|NCT02262728|29430|P2|COMPLETED|Overall Study||21
12233|NCT02262728|29431|P1|COMPLETED|Overall Study||19
12234|NCT02262728|29430|P2|STARTED|Overall Study||21
12235|NCT02262728|29431|P1|STARTED|Overall Study||19
12236|NCT02262078|29461|P2|NOT COMPLETED|Overall Study||0
12237|NCT02262078|29462|P1|NOT COMPLETED|Overall Study||0
12238|NCT02262078|29461|P2|COMPLETED|Overall Study||13
12239|NCT02262078|29462|P1|COMPLETED|Overall Study||13
12240|NCT02262078|29461|P2|STARTED|Overall Study||13
12241|NCT02262078|29462|P1|STARTED|Overall Study||13
12242|NCT02262039|29470|P2|NOT COMPLETED|Overall Study||0
12243|NCT02262039|29471|P1|NOT COMPLETED|Overall Study||0
12244|NCT02262039|29470|P2|COMPLETED|Overall Study||27
12245|NCT02262039|29471|P1|COMPLETED|Overall Study||14
12246|NCT02262039|29470|P2|STARTED|Overall Study||27
12247|NCT02262039|29471|P1|STARTED|Overall Study||14
12248|NCT02261948|29491|P2|NOT COMPLETED|Overall Study||0
12249|NCT02261948|29492|P1|NOT COMPLETED|Overall Study||0
12250|NCT02261948|29491|P2|COMPLETED|Overall Study||19
12251|NCT02261948|29492|P1|COMPLETED|Overall Study||23
12252|NCT02261948|29491|P2|STARTED|Overall Study||19
12253|NCT02261948|29492|P1|STARTED|Overall Study||23
12254|NCT02261493|29505|P3|NOT COMPLETED|Overall Study||26
12255|NCT02261493|29506|P2|NOT COMPLETED|Overall Study||47
12256|NCT02261493|29507|P1|NOT COMPLETED|Overall Study||30
12257|NCT02261493|29505|P3|COMPLETED|Overall Study||287
12258|NCT02261493|29506|P2|COMPLETED|Overall Study||271
12259|NCT02261493|29507|P1|COMPLETED|Overall Study||126
12260|NCT02261493|29505|P3|STARTED|Overall Study||313
12261|NCT02261493|29506|P2|STARTED|Overall Study||318
12262|NCT02261493|29507|P1|STARTED|Overall Study||156
12263|NCT02261467|29535|P2|NOT COMPLETED|Overall Study||37
12264|NCT02261467|29536|P1|NOT COMPLETED|Overall Study||21
12265|NCT02261467|29535|P2|COMPLETED|Overall Study||253
12266|NCT02261467|29536|P1|COMPLETED|Overall Study||80
12267|NCT02261467|29535|P2|STARTED|Overall Study||290
12268|NCT02261467|29536|P1|STARTED|Overall Study||101
12269|NCT02261428|29556|P2|NOT COMPLETED|Overall Study||0
12270|NCT02261428|29557|P1|NOT COMPLETED|Overall Study||0
12271|NCT02261428|29556|P2|COMPLETED|Overall Study||10
12272|NCT02261428|29557|P1|COMPLETED|Overall Study||10
12273|NCT02261428|29556|P2|STARTED|Overall Study|Washout (30 minutes)|10
12274|NCT02261428|29557|P1|STARTED|Overall Study|Washout (30 minutes)|10
12275|NCT02260882|29577|P2|NOT COMPLETED|Overall Study||1
12276|NCT02260882|29578|P1|NOT COMPLETED|Overall Study||0
12277|NCT02260882|29577|P2|COMPLETED|Overall Study||81
12278|NCT02260882|29578|P1|COMPLETED|Overall Study||161
12279|NCT02260882|29577|P2|STARTED|Overall Study||82
12280|NCT02260882|29578|P1|STARTED|Overall Study||161
12281|NCT02260492|29603|P3|NOT COMPLETED|Overall Study||5
12282|NCT02260492|29604|P2|NOT COMPLETED|Overall Study||13
12283|NCT02260492|29605|P1|NOT COMPLETED|Overall Study||23
12284|NCT02260492|29603|P3|COMPLETED|Overall Study||37
12285|NCT02260492|29604|P2|COMPLETED|Overall Study||406
12286|NCT02260492|29605|P1|COMPLETED|Overall Study||395
12287|NCT02260492|29603|P3|Completed Day 1|Overall Study||42
12288|NCT02260492|29604|P2|Completed Day 1|Overall Study||419
12289|NCT02260492|29605|P1|Completed Day 1|Overall Study||418
12290|NCT02260492|29603|P3|STARTED|Overall Study||42
12291|NCT02260492|29604|P2|STARTED|Overall Study||419
12292|NCT02260492|29605|P1|STARTED|Overall Study||418
12293|NCT02260440|29619|P1|NOT COMPLETED|Overall Study||0
12294|NCT02260440|29619|P1|COMPLETED|Overall Study||31
12295|NCT02260440|29619|P1|STARTED|Overall Study||31
12296|NCT02260401|29627|P2|NOT COMPLETED|Overall Study||12
12297|NCT02260401|29628|P1|NOT COMPLETED|Overall Study||5
12298|NCT02260401|29627|P2|COMPLETED|Overall Study||73
12299|NCT02260401|29628|P1|COMPLETED|Overall Study||75
12300|NCT02260401|29627|P2|STARTED|Overall Study||85
12301|NCT02260401|29628|P1|STARTED|Overall Study||80
12302|NCT02259608|29634|P1|NOT COMPLETED|Overall Study||0
12303|NCT02259608|29634|P1|COMPLETED|Overall Study||15
12304|NCT02259608|29634|P1|STARTED|Overall Study||15
12305|NCT02259400|29641|P2|NOT COMPLETED|Overall Study||2
12306|NCT02259400|29642|P1|NOT COMPLETED|Overall Study||0
12307|NCT02259400|29641|P2|COMPLETED|Overall Study||60
12308|NCT02259400|29642|P1|COMPLETED|Overall Study||62
12309|NCT02259400|29641|P2|STARTED|Overall Study||62
12310|NCT02259400|29642|P1|STARTED|Overall Study||62
12311|NCT02259348|29674|P1|NOT COMPLETED|Overall Study||10
12312|NCT02259348|29674|P1|COMPLETED|Overall Study||2
12313|NCT02259348|29674|P1|One Year Post-transplant|Overall Study||2
12314|NCT02259348|29674|P1|STARTED|Overall Study||12
12315|NCT02258529|29686|P1|NOT COMPLETED|Overall Study||10
12316|NCT02258529|29686|P1|COMPLETED|Overall Study||0
12317|NCT02258529|29686|P1|STARTED|Overall Study||10
12318|NCT02258477|29698|P4|NOT COMPLETED|Fourth Intervention (1 Week)||0
12319|NCT02258477|29699|P3|NOT COMPLETED|Fourth Intervention (1 Week)||0
12320|NCT02258477|29700|P2|NOT COMPLETED|Fourth Intervention (1 Week)||0
12321|NCT02258477|29701|P1|NOT COMPLETED|Fourth Intervention (1 Week)||0
12322|NCT02258477|29698|P4|COMPLETED|Fourth Intervention (1 Week)||8
12323|NCT02258477|29699|P3|COMPLETED|Fourth Intervention (1 Week)||8
12324|NCT02258477|29700|P2|COMPLETED|Fourth Intervention (1 Week)||8
12325|NCT02258477|29701|P1|COMPLETED|Fourth Intervention (1 Week)||9
12326|NCT02258477|29698|P4|STARTED|Fourth Intervention (1 Week)||8
12327|NCT02258477|29699|P3|STARTED|Fourth Intervention (1 Week)||8
12328|NCT02258477|29700|P2|STARTED|Fourth Intervention (1 Week)||8
12329|NCT02258477|29701|P1|STARTED|Fourth Intervention (1 Week)||9
12330|NCT02258477|29698|P4|NOT COMPLETED|Third Intervention (1 Week)||0
12331|NCT02258477|29699|P3|NOT COMPLETED|Third Intervention (1 Week)||0
12332|NCT02258477|29700|P2|NOT COMPLETED|Third Intervention (1 Week)||0
12333|NCT02258477|29701|P1|NOT COMPLETED|Third Intervention (1 Week)||0
12334|NCT02258477|29698|P4|COMPLETED|Third Intervention (1 Week)||8
12335|NCT02258477|29699|P3|COMPLETED|Third Intervention (1 Week)||8
12336|NCT02258477|29700|P2|COMPLETED|Third Intervention (1 Week)||8
12337|NCT02258477|29701|P1|COMPLETED|Third Intervention (1 Week)||9
12338|NCT02258477|29698|P4|STARTED|Third Intervention (1 Week)||8
12339|NCT02258477|29699|P3|STARTED|Third Intervention (1 Week)||8
12340|NCT02258477|29700|P2|STARTED|Third Intervention (1 Week)||8
12341|NCT02258477|29701|P1|STARTED|Third Intervention (1 Week)||9
12342|NCT02258477|29698|P4|NOT COMPLETED|Second Intervention (1 Week)||1
12343|NCT02258477|29699|P3|NOT COMPLETED|Second Intervention (1 Week)||1
12344|NCT02258477|29700|P2|NOT COMPLETED|Second Intervention (1 Week)||0
12345|NCT02258477|29701|P1|NOT COMPLETED|Second Intervention (1 Week)||0
12346|NCT02258477|29698|P4|COMPLETED|Second Intervention (1 Week)||8
12347|NCT02258477|29699|P3|COMPLETED|Second Intervention (1 Week)||8
12348|NCT02258477|29700|P2|COMPLETED|Second Intervention (1 Week)||8
12349|NCT02258477|29701|P1|COMPLETED|Second Intervention (1 Week)||9
12350|NCT02258477|29698|P4|STARTED|Second Intervention (1 Week)||9
12351|NCT02258477|29699|P3|STARTED|Second Intervention (1 Week)||9
12352|NCT02258477|29700|P2|STARTED|Second Intervention (1 Week)||8
12353|NCT02258477|29701|P1|STARTED|Second Intervention (1 Week)||9
12354|NCT02258477|29698|P4|NOT COMPLETED|First Intervention (1 Week)||0
12355|NCT02258477|29699|P3|NOT COMPLETED|First Intervention (1 Week)||0
12356|NCT02258477|29700|P2|NOT COMPLETED|First Intervention (1 Week)||1
12357|NCT02258477|29701|P1|NOT COMPLETED|First Intervention (1 Week)||1
12358|NCT02258477|29698|P4|COMPLETED|First Intervention (1 Week)||9
12359|NCT02258477|29699|P3|COMPLETED|First Intervention (1 Week)||9
12360|NCT02258477|29700|P2|COMPLETED|First Intervention (1 Week)||8
12361|NCT02258477|29701|P1|COMPLETED|First Intervention (1 Week)||9
12362|NCT02258477|29698|P4|STARTED|First Intervention (1 Week)||9
12363|NCT02258477|29699|P3|STARTED|First Intervention (1 Week)||9
12364|NCT02258477|29700|P2|STARTED|First Intervention (1 Week)||9
12365|NCT02258477|29701|P1|STARTED|First Intervention (1 Week)||10
12366|NCT02258412|29719|P3|NOT COMPLETED|Overall Study||0
12367|NCT02258412|29720|P2|NOT COMPLETED|Overall Study||0
12368|NCT02258412|29721|P1|NOT COMPLETED|Overall Study||0
12369|NCT02258412|29719|P3|COMPLETED|Overall Study||61
12370|NCT02258412|29720|P2|COMPLETED|Overall Study||25
12371|NCT02258412|29721|P1|COMPLETED|Overall Study||26
12372|NCT02258412|29719|P3|STARTED|Overall Study||61
12373|NCT02258412|29720|P2|STARTED|Overall Study||25
12374|NCT02258412|29721|P1|STARTED|Overall Study||26
12375|NCT02258334|29732|P4|NOT COMPLETED|Overall Study||0
12376|NCT02258334|29733|P3|NOT COMPLETED|Overall Study||0
12377|NCT02258334|29734|P2|NOT COMPLETED|Overall Study||0
12378|NCT02258334|29735|P1|NOT COMPLETED|Overall Study||1
12379|NCT02258334|29732|P4|COMPLETED|Overall Study||52
12380|NCT02258334|29733|P3|COMPLETED|Overall Study||52
12381|NCT02258334|29734|P2|COMPLETED|Overall Study||54
12382|NCT02258334|29735|P1|COMPLETED|Overall Study||49
12383|NCT02258334|29732|P4|STARTED|Overall Study||52
12384|NCT02258334|29733|P3|STARTED|Overall Study||52
12385|NCT02258334|29734|P2|STARTED|Overall Study||54
12386|NCT02258334|29735|P1|STARTED|Overall Study||50
12387|NCT02257918|29764|P3|NOT COMPLETED|Overall Study||2
12388|NCT02257918|29765|P2|NOT COMPLETED|Overall Study||1
12389|NCT02257918|29766|P1|NOT COMPLETED|Overall Study||4
12390|NCT02257918|29764|P3|COMPLETED|Overall Study||39
12391|NCT02257918|29765|P2|COMPLETED|Overall Study||66
12392|NCT02257918|29766|P1|COMPLETED|Overall Study||68
12393|NCT02257918|29764|P3|Test of Cure Visit|Overall Study||40
12394|NCT02257918|29765|P2|Test of Cure Visit|Overall Study||67
12395|NCT02257918|29766|P1|Test of Cure Visit|Overall Study||72
12396|NCT02257918|29764|P3|STARTED|Overall Study||41
12397|NCT02257918|29765|P2|STARTED|Overall Study||67
12398|NCT02257918|29766|P1|STARTED|Overall Study||72
12399|NCT02257684|29816|P1|NOT COMPLETED|Overall Study||4
12400|NCT02257684|29816|P1|COMPLETED|Overall Study||0
12401|NCT02257684|29816|P1|STARTED|Overall Study||4
12402|NCT02257385|29826|P2|NOT COMPLETED|Overall Study||22
12403|NCT02257385|29827|P1|NOT COMPLETED|Overall Study||22
12404|NCT02257385|29826|P2|COMPLETED|Overall Study||457
12405|NCT02257385|29827|P1|COMPLETED|Overall Study||460
12406|NCT02257385|29826|P2|STARTED|Overall Study||479
12407|NCT02257385|29827|P1|STARTED|Overall Study||482
12408|NCT02257372|29837|P2|NOT COMPLETED|Overall Study||10
12409|NCT02257372|29838|P1|NOT COMPLETED|Overall Study||7
12410|NCT02257372|29837|P2|COMPLETED|Overall Study||109
12411|NCT02257372|29838|P1|COMPLETED|Overall Study||110
12412|NCT02257372|29837|P2|STARTED|Overall Study||119
12413|NCT02257372|29838|P1|STARTED|Overall Study||117
12414|NCT02256982|29848|P2|NOT COMPLETED|Overall Study||1
12415|NCT02256982|29849|P1|NOT COMPLETED|Overall Study||0
12416|NCT02256982|29848|P2|COMPLETED|Overall Study||1
12417|NCT02256982|29849|P1|COMPLETED|Overall Study||1
12418|NCT02256982|29848|P2|STARTED|Overall Study||2
12419|NCT02256982|29849|P1|STARTED|Overall Study||1
12420|NCT02256969|29858|P3|NOT COMPLETED|Overall Study||1
12421|NCT02256969|29859|P2|NOT COMPLETED|Overall Study||1
12422|NCT02256969|29860|P1|NOT COMPLETED|Overall Study||2
12423|NCT02256969|29858|P3|COMPLETED|Overall Study||14
12424|NCT02256969|29859|P2|COMPLETED|Overall Study||14
12425|NCT02256969|29860|P1|COMPLETED|Overall Study||13
12426|NCT02256969|29858|P3|STARTED|Overall Study||15
12427|NCT02256969|29859|P2|STARTED|Overall Study||15
12428|NCT02256969|29860|P1|STARTED|Overall Study||15
12429|NCT02256891|29879|P2|NOT COMPLETED|Overall Study||13
12430|NCT02256891|29880|P1|NOT COMPLETED|Overall Study||12
12431|NCT02256891|29879|P2|COMPLETED|Overall Study||29
12432|NCT02256891|29880|P1|COMPLETED|Overall Study||43
12433|NCT02256891|29879|P2|STARTED|Overall Study||42
12434|NCT02256891|29880|P1|STARTED|Overall Study||55
12435|NCT02256553|29904|P1|NOT COMPLETED|Period III||3
12436|NCT02256553|29904|P1|COMPLETED|Period III||91
12437|NCT02256553|29904|P1|STARTED|Period III||94
12438|NCT02256553|29904|P1|NOT COMPLETED|Period II||2
12439|NCT02256553|29904|P1|COMPLETED|Period II||94
12440|NCT02256553|29904|P1|STARTED|Period II||96
12441|NCT02256553|29904|P1|NOT COMPLETED|Period I||6
12442|NCT02256553|29904|P1|COMPLETED|Period I||96
12443|NCT02256553|29904|P1|STARTED|Period I||102
12444|NCT02256488|29917|P4|NOT COMPLETED|Overall Study||6
12445|NCT02256488|29918|P3|NOT COMPLETED|Overall Study||10
12446|NCT02256488|29919|P2|NOT COMPLETED|Overall Study||6
12447|NCT02256488|29920|P1|NOT COMPLETED|Overall Study||8
12448|NCT02256488|29917|P4|COMPLETED|Overall Study||384
12449|NCT02256488|29918|P3|COMPLETED|Overall Study||382
12450|NCT02256488|29919|P2|COMPLETED|Overall Study||386
12451|NCT02256488|29920|P1|COMPLETED|Overall Study||379
12452|NCT02256488|29917|P4|STARTED|Overall Study||390
12453|NCT02256488|29918|P3|STARTED|Overall Study||392
12454|NCT02256488|29919|P2|STARTED|Overall Study||392
12455|NCT02256488|29920|P1|STARTED|Overall Study||387
12456|NCT02256436|29936|P2|NOT COMPLETED|Overall Study||272
12457|NCT02256436|29937|P1|NOT COMPLETED|Overall Study||270
12458|NCT02256436|29936|P2|COMPLETED|Overall Study||0
12459|NCT02256436|29937|P1|COMPLETED|Overall Study||0
12460|NCT02256436|29936|P2|Treated|Overall Study||255
12461|NCT02256436|29937|P1|Treated|Overall Study||266
12462|NCT02256436|29936|P2|STARTED|Overall Study||272
12463|NCT02256436|29937|P1|STARTED|Overall Study||270
12464|NCT02256358|29975|P2|NOT COMPLETED|Overall Study||1
12465|NCT02256358|29976|P1|NOT COMPLETED|Overall Study||0
12466|NCT02256358|29975|P2|COMPLETED|Overall Study||33
12467|NCT02256358|29976|P1|COMPLETED|Overall Study||34
12468|NCT02256358|29975|P2|STARTED|Overall Study||34
12469|NCT02256358|29976|P1|STARTED|Overall Study||34
12470|NCT02256072|29984|P2|NOT COMPLETED|Overall Study||29
12471|NCT02256072|29985|P1|NOT COMPLETED|Overall Study||42
12472|NCT02256072|29984|P2|COMPLETED|Overall Study||162
12473|NCT02256072|29985|P1|COMPLETED|Overall Study|Completed the 3-month follow-up|152
12474|NCT02256072|29984|P2|Completed 1 Month Follow-Up|Overall Study||179
12475|NCT02256072|29985|P1|Completed 1 Month Follow-Up|Overall Study|Completed the 1-month follow-up|167
12476|NCT02256072|29984|P2|STARTED|Overall Study||191
12477|NCT02256072|29985|P1|STARTED|Overall Study||194
12478|NCT02255565|30002|P3|NOT COMPLETED|Overall Study||0
12479|NCT02255565|30003|P2|NOT COMPLETED|Overall Study||1
12480|NCT02255565|30004|P1|NOT COMPLETED|Overall Study||0
12481|NCT02255565|30002|P3|COMPLETED|Overall Study||9
12482|NCT02255565|30003|P2|COMPLETED|Overall Study||8
12483|NCT02255565|30004|P1|COMPLETED|Overall Study||9
12484|NCT02255565|30002|P3|STARTED|Overall Study||9
12485|NCT02255565|30003|P2|STARTED|Overall Study||9
12486|NCT02255565|30004|P1|STARTED|Overall Study||9
12487|NCT02255279|30065|P2|NOT COMPLETED|Overall Study||9
12488|NCT02255279|30066|P1|NOT COMPLETED|Overall Study||5
12489|NCT02255279|30065|P2|COMPLETED|Overall Study||134
12490|NCT02255279|30066|P1|COMPLETED|Overall Study||139
12491|NCT02255279|30065|P2|STARTED|Overall Study||143
12492|NCT02255279|30066|P1|STARTED|Overall Study||144
12493|NCT02255149|30092|P1|NOT COMPLETED|Overall Study||5
12494|NCT02255149|30092|P1|COMPLETED|Overall Study||5
12495|NCT02255149|30092|P1|STARTED|Overall Study||10
12496|NCT02255097|30096|P1|NOT COMPLETED|Overall Study||172
12497|NCT02255097|30096|P1|COMPLETED|Overall Study||0
12498|NCT02255097|30096|P1|Treated|Overall Study||171
12499|NCT02255097|30096|P1|STARTED|Overall Study||172
12500|NCT02254551|30117|P1|NOT COMPLETED|Maintenance||0
12501|NCT02254551|30117|P1|COMPLETED|Maintenance||0
12502|NCT02254551|30117|P1|STARTED|Maintenance||0
12503|NCT02254551|30117|P1|NOT COMPLETED|Expansion||0
12504|NCT02254551|30117|P1|COMPLETED|Expansion||0
12505|NCT02254551|30117|P1|STARTED|Expansion||0
12506|NCT02254551|30117|P1|NOT COMPLETED|Dose Escalation||3
12507|NCT02254551|30117|P1|COMPLETED|Dose Escalation|Due to toxicity and lack of efficacy, no other dose levels were examined.|4
12508|NCT02254551|30117|P1|Cohort 3: LDE225 800mg|Dose Escalation||0
12509|NCT02254551|30117|P1|Cohort 2: LDE225 600mg|Dose Escalation||0
12510|NCT02254551|30117|P1|Cohort 1: LDE225 400mg|Dose Escalation|1 patient was found to be refractory to bortezomib and deemed ineligible.|7
12511|NCT02254551|30117|P1|STARTED|Dose Escalation||7
12512|NCT02254486|30127|P2|NOT COMPLETED|Overall Study||55
12513|NCT02254486|30128|P1|NOT COMPLETED|Overall Study||50
12514|NCT02254486|30127|P2|COMPLETED|Overall Study||255
12515|NCT02254486|30128|P1|COMPLETED|Overall Study||261
12516|NCT02254486|30127|P2|STARTED|Overall Study||310
12517|NCT02254486|30128|P1|STARTED|Overall Study||311
12518|NCT02254460|30144|P2|NOT COMPLETED|Overall Study||0
12519|NCT02254460|30145|P1|NOT COMPLETED|Overall Study||1
12520|NCT02254460|30144|P2|COMPLETED|Overall Study||12
12521|NCT02254460|30145|P1|COMPLETED|Overall Study||12
12522|NCT02254460|30144|P2|STARTED|Overall Study||12
12523|NCT02254460|30145|P1|STARTED|Overall Study||13
12524|NCT02254252|30153|P2|NOT COMPLETED|Overall Study||2
12525|NCT02254252|30154|P1|NOT COMPLETED|Overall Study||3
12526|NCT02254252|30153|P2|COMPLETED|Overall Study||25
12527|NCT02254252|30154|P1|COMPLETED|Overall Study||24
12528|NCT02254252|30153|P2|STARTED|Overall Study||27
12529|NCT02254252|30154|P1|STARTED|Overall Study||27
12530|NCT02253654|30166|P2|NOT COMPLETED|Overall Study||18
12531|NCT02253654|30167|P1|NOT COMPLETED|Overall Study||23
12532|NCT02253654|30166|P2|COMPLETED|Overall Study||90
12533|NCT02253654|30167|P1|COMPLETED|Overall Study||85
12534|NCT02253654|30166|P2|Received Treatment|Overall Study||107
12535|NCT02253654|30167|P1|Received Treatment|Overall Study||104
12536|NCT02253654|30166|P2|STARTED|Overall Study||108
12537|NCT02253654|30167|P1|STARTED|Overall Study||108
12538|NCT02253173|30191|P4|NOT COMPLETED|Overall Study||14
12539|NCT02253173|30192|P3|NOT COMPLETED|Overall Study||13
12540|NCT02253173|30193|P2|NOT COMPLETED|Overall Study||17
12541|NCT02253173|30194|P1|NOT COMPLETED|Overall Study||16
12542|NCT02253173|30191|P4|COMPLETED|Overall Study||178
12543|NCT02253173|30192|P3|COMPLETED|Overall Study||177
12544|NCT02253173|30193|P2|COMPLETED|Overall Study||174
12545|NCT02253173|30194|P1|COMPLETED|Overall Study||175
12546|NCT02253173|30191|P4|STARTED|Overall Study||192
12547|NCT02253173|30192|P3|STARTED|Overall Study||190
12548|NCT02253173|30193|P2|STARTED|Overall Study||191
12549|NCT02253173|30194|P1|STARTED|Overall Study||191
12550|NCT02253160|30391|P3|NOT COMPLETED|Overall Study||0
12551|NCT02253160|30392|P2|NOT COMPLETED|Overall Study||0
12552|NCT02253160|30393|P1|NOT COMPLETED|Overall Study||0
12553|NCT02253160|30391|P3|COMPLETED|Overall Study||10
12554|NCT02253160|30392|P2|COMPLETED|Overall Study||12
12555|NCT02253160|30393|P1|COMPLETED|Overall Study||1
12556|NCT02253160|30391|P3|STARTED|Overall Study||10
12557|NCT02253160|30392|P2|STARTED|Overall Study||12
12558|NCT02253160|30393|P1|STARTED|Overall Study||1
12559|NCT02252965|30431|P2|NOT COMPLETED|Overall Study||43
12560|NCT02252965|30432|P1|NOT COMPLETED|Overall Study||40
12561|NCT02252965|30431|P2|COMPLETED|Overall Study||222
12562|NCT02252965|30432|P1|COMPLETED|Overall Study||227
12563|NCT02252965|30431|P2|Safety Population|Overall Study||264
12564|NCT02252965|30432|P1|Safety Population|Overall Study|Out of 261, 12 subjects intolerant to the Metformin IR switched to Metformin XR group.|261
12565|NCT02252965|30431|P2|STARTED|Overall Study||265
12566|NCT02252965|30432|P1|STARTED|Overall Study||267
12567|NCT02252744|30459|P1|NOT COMPLETED|Overall Study||0
12568|NCT02252744|30459|P1|COMPLETED|Overall Study||286
12569|NCT02252744|30459|P1|STARTED|Overall Study||286
12570|NCT02252718|30463|P1|NOT COMPLETED|Overall Study||0
12571|NCT02252718|30463|P1|COMPLETED|Overall Study||100
12572|NCT02252718|30463|P1|STARTED|Overall Study||100
12573|NCT02252445|30469|P2|NOT COMPLETED|Overall Study||0
12574|NCT02252445|30470|P1|NOT COMPLETED|Overall Study||0
12575|NCT02252445|30469|P2|COMPLETED|Overall Study||41
12576|NCT02252445|30470|P1|COMPLETED|Overall Study||41
12577|NCT02252445|30469|P2|STARTED|Overall Study||41
12578|NCT02252445|30470|P1|STARTED|Overall Study||41
12579|NCT02252354|30496|P2|NOT COMPLETED|Overall Study||0
12580|NCT02252354|30497|P1|NOT COMPLETED|Overall Study||0
12581|NCT02252354|30496|P2|COMPLETED|Overall Study||6
12582|NCT02252354|30497|P1|COMPLETED|Overall Study||6
12583|NCT02252354|30496|P2|STARTED|Overall Study||6
12584|NCT02252354|30497|P1|STARTED|Overall Study||6
12585|NCT02252133|30542|P2|NOT COMPLETED|Period 2||0
12586|NCT02252133|30543|P1|NOT COMPLETED|Period 2||0
12587|NCT02252133|30542|P2|COMPLETED|Period 2||24
12588|NCT02252133|30543|P1|COMPLETED|Period 2||23
12589|NCT02252133|30542|P2|STARTED|Period 2||24
12590|NCT02252133|30543|P1|STARTED|Period 2||23
12591|NCT02252133|30542|P2|NOT COMPLETED|Period 1||0
12592|NCT02252133|30543|P1|NOT COMPLETED|Period 1||0
12593|NCT02252133|30542|P2|COMPLETED|Period 1||24
12594|NCT02252133|30543|P1|COMPLETED|Period 1||23
12595|NCT02252133|30542|P2|STARTED|Period 1||24
12596|NCT02252133|30543|P1|STARTED|Period 1||23
12597|NCT02252016|30551|P2|NOT COMPLETED|Overall Study||3
12598|NCT02252016|30552|P1|NOT COMPLETED|Overall Study||3
12599|NCT02252016|30551|P2|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|49
12600|NCT02252016|30552|P1|COMPLETED|Overall Study|Completed = completed 24 weeks of follow-up|104
12601|NCT02252016|30551|P2|STARTED|Overall Study||52
12602|NCT02252016|30552|P1|STARTED|Overall Study||107
12603|NCT02251912|30566|P2|NOT COMPLETED|Overall Study||5
12604|NCT02251912|30567|P1|NOT COMPLETED|Overall Study||2
12605|NCT02251912|30566|P2|COMPLETED|Overall Study||5
12606|NCT02251912|30567|P1|COMPLETED|Overall Study||10
12607|NCT02251912|30566|P2|STARTED|Overall Study||10
12608|NCT02251912|30567|P1|STARTED|Overall Study||12
12609|NCT02251886|30581|P4|NOT COMPLETED|Overall Study||0
12610|NCT02251886|30582|P3|NOT COMPLETED|Overall Study||0
12611|NCT02251886|30583|P2|NOT COMPLETED|Overall Study||0
12612|NCT02251886|30584|P1|NOT COMPLETED|Overall Study||0
12613|NCT02251886|30581|P4|COMPLETED|Overall Study||54
12614|NCT02251886|30582|P3|COMPLETED|Overall Study||44
12615|NCT02251886|30583|P2|COMPLETED|Overall Study||54
12616|NCT02251886|30584|P1|COMPLETED|Overall Study||48
12617|NCT02251886|30581|P4|STARTED|Overall Study||54
12618|NCT02251886|30582|P3|STARTED|Overall Study||44
12619|NCT02251886|30583|P2|STARTED|Overall Study||54
12620|NCT02251886|30584|P1|STARTED|Overall Study||48
12621|NCT02251652|30594|P1|NOT COMPLETED|Overall Study||1
12622|NCT02251652|30594|P1|COMPLETED|Overall Study||16
12623|NCT02251652|30594|P1|STARTED|Overall Study||17
12624|NCT02251613|30604|P1|NOT COMPLETED|Overall Study||0
12625|NCT02251613|30604|P1|COMPLETED|Overall Study||50
12626|NCT02251613|30604|P1|STARTED|Overall Study||50
12627|NCT02251561|30612|P1|NOT COMPLETED|Overall Study||0
12628|NCT02251561|30612|P1|COMPLETED|Overall Study||28
12629|NCT02251561|30612|P1|STARTED|Overall Study||28
12630|NCT02250807|30620|P1|NOT COMPLETED|Overall Study||0
12631|NCT02250807|30620|P1|COMPLETED|Overall Study||40
12632|NCT02250807|30620|P1|STARTED|Overall Study||40
12633|NCT02250703|30632|P2|NOT COMPLETED|Overall Study||1
12634|NCT02250703|30633|P1|NOT COMPLETED|Overall Study||1
12635|NCT02250703|30632|P2|COMPLETED|Overall Study||36
12636|NCT02250703|30633|P1|COMPLETED|Overall Study||37
12637|NCT02250703|30632|P2|STARTED|Overall Study||37
12638|NCT02250703|30633|P1|STARTED|Overall Study||38
12639|NCT02250274|30647|P2|NOT COMPLETED|Overall Study||6
12640|NCT02250274|30648|P1|NOT COMPLETED|Overall Study||7
12641|NCT02250274|30647|P2|COMPLETED|Overall Study||40
12642|NCT02250274|30648|P1|COMPLETED|Overall Study||78
12643|NCT02250274|30647|P2|STARTED|Overall Study||46
12644|NCT02250274|30648|P1|STARTED|Overall Study||85
12645|NCT02249728|30658|P1|NOT COMPLETED|Part Two (up to 6 Days)||0
12646|NCT02249728|30658|P1|COMPLETED|Part Two (up to 6 Days)||6
12647|NCT02249728|30658|P1|STARTED|Part Two (up to 6 Days)||6
12648|NCT02249728|30658|P1|NOT COMPLETED|Part One (4 Days)||0
12649|NCT02249728|30658|P1|COMPLETED|Part One (4 Days)||6
12650|NCT02249728|30658|P1|STARTED|Part One (4 Days)||6
12651|NCT02249104|30668|P1|NOT COMPLETED|Overall Study||3
12652|NCT02249104|30668|P1|COMPLETED|Overall Study||25
12653|NCT02249104|30668|P1|STARTED|Overall Study||28
12654|NCT02249052|30677|P1|NOT COMPLETED|Overall Study||0
12655|NCT02249052|30677|P1|COMPLETED|Overall Study||19
12656|NCT02249052|30677|P1|STARTED|Overall Study||19
12657|NCT02248818|30701|P9|NOT COMPLETED|Randomised Study||0
12658|NCT02248818|30702|P8|NOT COMPLETED|Randomised Study||0
12659|NCT02248818|30703|P7|NOT COMPLETED|Randomised Study||0
12660|NCT02248818|30704|P6|NOT COMPLETED|Randomised Study||8
12661|NCT02248818|30705|P5|NOT COMPLETED|Randomised Study||0
12662|NCT02248818|30706|P4|NOT COMPLETED|Randomised Study||0
12663|NCT02248818|30707|P3|NOT COMPLETED|Randomised Study||0
12664|NCT02248818|30708|P2|NOT COMPLETED|Randomised Study||0
12665|NCT02248818|30709|P1|NOT COMPLETED|Randomised Study||0
12666|NCT02248818|30701|P9|COMPLETED|Randomised Study||0
12667|NCT02248818|30702|P8|COMPLETED|Randomised Study||4
12668|NCT02248818|30703|P7|COMPLETED|Randomised Study||6
12669|NCT02248818|30704|P6|COMPLETED|Randomised Study||0
12670|NCT02248818|30705|P5|COMPLETED|Randomised Study||6
12671|NCT02248818|30706|P4|COMPLETED|Randomised Study||6
12672|NCT02248818|30707|P3|COMPLETED|Randomised Study||6
12673|NCT02248818|30708|P2|COMPLETED|Randomised Study||6
12674|NCT02248818|30709|P1|COMPLETED|Randomised Study||6
12675|NCT02248818|30701|P9|STARTED|Randomised Study||0
12676|NCT02248818|30702|P8|STARTED|Randomised Study||4
12677|NCT02248818|30703|P7|STARTED|Randomised Study||6
12678|NCT02248818|30704|P6|STARTED|Randomised Study||8
12679|NCT02248818|30705|P5|STARTED|Randomised Study||6
12680|NCT02248818|30706|P4|STARTED|Randomised Study||6
12681|NCT02248818|30707|P3|STARTED|Randomised Study||6
12682|NCT02248818|30708|P2|STARTED|Randomised Study||6
12683|NCT02248818|30709|P1|STARTED|Randomised Study||6
12684|NCT02248818|30701|P9|NOT COMPLETED|Screening||107
12685|NCT02248818|30702|P8|NOT COMPLETED|Screening||0
12686|NCT02248818|30703|P7|NOT COMPLETED|Screening||0
12687|NCT02248818|30704|P6|NOT COMPLETED|Screening||0
12688|NCT02248818|30705|P5|NOT COMPLETED|Screening||0
12689|NCT02248818|30706|P4|NOT COMPLETED|Screening||0
12690|NCT02248818|30707|P3|NOT COMPLETED|Screening||0
12691|NCT02248818|30708|P2|NOT COMPLETED|Screening||0
12692|NCT02248818|30709|P1|NOT COMPLETED|Screening||0
12693|NCT02248818|30701|P9|COMPLETED|Screening||48
12694|NCT02248818|30702|P8|COMPLETED|Screening||0
12695|NCT02248818|30703|P7|COMPLETED|Screening||0
12696|NCT02248818|30704|P6|COMPLETED|Screening||0
12697|NCT02248818|30705|P5|COMPLETED|Screening||0
12698|NCT02248818|30706|P4|COMPLETED|Screening||0
12699|NCT02248818|30707|P3|COMPLETED|Screening||0
12700|NCT02248818|30708|P2|COMPLETED|Screening||0
12701|NCT02248818|30709|P1|COMPLETED|Screening||0
12702|NCT02248818|30701|P9|STARTED|Screening||155
12703|NCT02248818|30702|P8|STARTED|Screening||0
12704|NCT02248818|30703|P7|STARTED|Screening||0
12705|NCT02248818|30704|P6|STARTED|Screening||0
12706|NCT02248818|30705|P5|STARTED|Screening||0
12707|NCT02248818|30706|P4|STARTED|Screening||0
12708|NCT02248818|30707|P3|STARTED|Screening||0
12709|NCT02248818|30708|P2|STARTED|Screening||0
12710|NCT02248818|30709|P1|STARTED|Screening||0
12711|NCT02248766|30847|P1|NOT COMPLETED|Overall Study||0
12712|NCT02248766|30847|P1|COMPLETED|Overall Study||30
12713|NCT02248766|30847|P1|STARTED|Overall Study||30
12714|NCT02248727|30859|P1|NOT COMPLETED|Overall Study||0
12715|NCT02248727|30859|P1|COMPLETED|Overall Study||30
12716|NCT02248727|30859|P1|STARTED|Overall Study||30
12717|NCT02248675|30872|P2|NOT COMPLETED|Overall Study||1
12718|NCT02248675|30873|P1|NOT COMPLETED|Overall Study||3
12719|NCT02248675|30872|P2|COMPLETED|Overall Study||27
12720|NCT02248675|30873|P1|COMPLETED|Overall Study||23
12721|NCT02248675|30872|P2|STARTED|Overall Study||28
12722|NCT02248675|30873|P1|STARTED|Overall Study||26
12723|NCT02248558|30887|P2|NOT COMPLETED|Overall Study||45
12724|NCT02248558|30888|P1|NOT COMPLETED|Overall Study||52
12725|NCT02248558|30887|P2|COMPLETED|Overall Study||307
12726|NCT02248558|30888|P1|COMPLETED|Overall Study||317
12727|NCT02248558|30887|P2|STARTED|Overall Study||352
12728|NCT02248558|30888|P1|STARTED|Overall Study||369
12729|NCT02248480|30900|P2|NOT COMPLETED|Overall Study||14
12730|NCT02248480|30901|P1|NOT COMPLETED|Overall Study||17
12731|NCT02248480|30900|P2|COMPLETED|Overall Study||162
12732|NCT02248480|30901|P1|COMPLETED|Overall Study||161
12733|NCT02248480|30900|P2|Efficacy Population|Overall Study||176
12734|NCT02248480|30901|P1|Efficacy Population|Overall Study||177
12735|NCT02248480|30900|P2|STARTED|Overall Study||176
12736|NCT02248480|30901|P1|STARTED|Overall Study||178
12737|NCT02248246|30939|P1|NOT COMPLETED|Overall Study||0
12738|NCT02248246|30939|P1|COMPLETED|Overall Study||40
12739|NCT02248246|30939|P1|STARTED|Overall Study||40
12740|NCT02248103|30946|P2|NOT COMPLETED|Overall Study||0
12741|NCT02248103|30947|P1|NOT COMPLETED|Overall Study||0
12742|NCT02248103|30946|P2|COMPLETED|Overall Study||10
12743|NCT02248103|30947|P1|COMPLETED|Overall Study||10
12744|NCT02248103|30946|P2|STARTED|Overall Study||10
12745|NCT02248103|30947|P1|STARTED|Overall Study||10
12746|NCT02247960|30959|P2|NOT COMPLETED|Catheter Removed||10
12747|NCT02247960|30960|P1|NOT COMPLETED|Catheter Removed||7
12748|NCT02247960|30959|P2|COMPLETED|Catheter Removed||74
12749|NCT02247960|30960|P1|COMPLETED|Catheter Removed||76
12750|NCT02247960|30959|P2|STARTED|Catheter Removed||84
12751|NCT02247960|30960|P1|STARTED|Catheter Removed||83
12752|NCT02247960|30959|P2|NOT COMPLETED|Patient Consent and Randomization||6
12753|NCT02247960|30960|P1|NOT COMPLETED|Patient Consent and Randomization||2
12754|NCT02247960|30959|P2|COMPLETED|Patient Consent and Randomization||84
12755|NCT02247960|30960|P1|COMPLETED|Patient Consent and Randomization||83
12756|NCT02247960|30959|P2|STARTED|Patient Consent and Randomization||90
12757|NCT02247960|30960|P1|STARTED|Patient Consent and Randomization||85
12758|NCT02247765|30970|P1|NOT COMPLETED|Overall Study||0
12759|NCT02247765|30970|P1|COMPLETED|Overall Study||18
12760|NCT02247765|30970|P1|STARTED|Overall Study||18
12761|NCT02247401|30978|P3|NOT COMPLETED|Overall Study||2
12762|NCT02247401|30979|P2|NOT COMPLETED|Overall Study||2
12763|NCT02247401|30980|P1|NOT COMPLETED|Overall Study||6
12764|NCT02247401|30978|P3|COMPLETED|Overall Study||27
12765|NCT02247401|30979|P2|COMPLETED|Overall Study||29
12766|NCT02247401|30980|P1|COMPLETED|Overall Study||94
12767|NCT02247401|30978|P3|STARTED|Overall Study||29
12768|NCT02247401|30979|P2|STARTED|Overall Study||31
12769|NCT02247401|30980|P1|STARTED|Overall Study||100
12770|NCT02247011|30999|P1|NOT COMPLETED|Overall Study||125
12771|NCT02247011|30999|P1|COMPLETED|Overall Study||975
12772|NCT02247011|30999|P1|STARTED|Overall Study||1100
12773|NCT02246673|31021|P5|NOT COMPLETED|Overall Study||1
12774|NCT02246673|31022|P4|NOT COMPLETED|Overall Study||2
12775|NCT02246673|31023|P3|NOT COMPLETED|Overall Study||0
12776|NCT02246673|31024|P2|NOT COMPLETED|Overall Study||0
12777|NCT02246673|31025|P1|NOT COMPLETED|Overall Study||1
12778|NCT02246673|31021|P5|COMPLETED|Overall Study||11
12779|NCT02246673|31022|P4|COMPLETED|Overall Study||12
12780|NCT02246673|31023|P3|COMPLETED|Overall Study||12
12781|NCT02246673|31024|P2|COMPLETED|Overall Study||12
12782|NCT02246673|31025|P1|COMPLETED|Overall Study||13
12783|NCT02246673|31021|P5|STARTED|Overall Study||12
12784|NCT02246673|31022|P4|STARTED|Overall Study||14
12785|NCT02246673|31023|P3|STARTED|Overall Study||12
12786|NCT02246673|31024|P2|STARTED|Overall Study||12
12787|NCT02246673|31025|P1|STARTED|Overall Study||14
12788|NCT02246582|31130|P2|NOT COMPLETED|Overall Study||4
12789|NCT02246582|31131|P1|NOT COMPLETED|Overall Study||3
12790|NCT02246582|31130|P2|COMPLETED|Overall Study||41
12791|NCT02246582|31131|P1|COMPLETED|Overall Study||41
12792|NCT02246582|31130|P2|STARTED|Overall Study||45
12793|NCT02246582|31131|P1|STARTED|Overall Study||44
12794|NCT02246166|31139|P2|NOT COMPLETED|Overall Study||0
12795|NCT02246166|31140|P1|NOT COMPLETED|Overall Study||1
12796|NCT02246166|31139|P2|COMPLETED|Overall Study||27
12797|NCT02246166|31140|P1|COMPLETED|Overall Study||25
12798|NCT02246166|31139|P2|STARTED|Overall Study||27
12799|NCT02246166|31140|P1|STARTED|Overall Study||26
12800|NCT02246114|31176|P2|NOT COMPLETED|Overall Study||0
12801|NCT02246114|31177|P1|NOT COMPLETED|Overall Study||1
12802|NCT02246114|31176|P2|COMPLETED|Overall Study||0
12803|NCT02246114|31177|P1|COMPLETED|Overall Study||0
12804|NCT02246114|31176|P2|STARTED|Overall Study||0
12805|NCT02246114|31177|P1|STARTED|Overall Study||1
12806|NCT02246062|31187|P4|NOT COMPLETED|Overall Study||0
12807|NCT02246062|31188|P3|NOT COMPLETED|Overall Study||0
12808|NCT02246062|31189|P2|NOT COMPLETED|Overall Study||0
12809|NCT02246062|31190|P1|NOT COMPLETED|Overall Study||0
12810|NCT02246062|31187|P4|COMPLETED|Overall Study||21
12811|NCT02246062|31188|P3|COMPLETED|Overall Study||21
12812|NCT02246062|31189|P2|COMPLETED|Overall Study||21
12813|NCT02246062|31190|P1|COMPLETED|Overall Study||21
12814|NCT02246062|31187|P4|STARTED|Overall Study||21
12815|NCT02246062|31188|P3|STARTED|Overall Study||21
12816|NCT02246062|31189|P2|STARTED|Overall Study||21
12817|NCT02246062|31190|P1|STARTED|Overall Study||21
12818|NCT02245360|31210|P2|NOT COMPLETED|Overall Study||2
12819|NCT02245360|31211|P1|NOT COMPLETED|Overall Study||5
12820|NCT02245360|31210|P2|COMPLETED|Overall Study||52
12821|NCT02245360|31211|P1|COMPLETED|Overall Study||48
12822|NCT02245360|31210|P2|STARTED|Overall Study||54
12823|NCT02245360|31211|P1|STARTED|Overall Study||53
12824|NCT02244840|31219|P1|NOT COMPLETED|Overall Study||0
12825|NCT02244840|31219|P1|COMPLETED|Overall Study||40
12826|NCT02244840|31219|P1|STARTED|Overall Study||40
12827|NCT02244619|31225|P2|NOT COMPLETED|Overall Study||21
12828|NCT02244619|31226|P1|NOT COMPLETED|Overall Study||8
12829|NCT02244619|31225|P2|COMPLETED|Overall Study||245
12830|NCT02244619|31226|P1|COMPLETED|Overall Study||241
12831|NCT02244619|31225|P2|STARTED|Overall Study||266
12832|NCT02244619|31226|P1|STARTED|Overall Study||249
12833|NCT02244580|31244|P1|NOT COMPLETED|Overall Study||241
12834|NCT02244580|31244|P1|COMPLETED|Overall Study|An RT-qPCR assay was performed from breast cancer tissues of 769 out of the 1010 patients.|769
12835|NCT02244580|31244|P1|STARTED|Overall Study||1010
12836|NCT02243943|31254|P2|NOT COMPLETED|Overall Study||0
12837|NCT02243943|31255|P1|NOT COMPLETED|Overall Study||0
12838|NCT02243943|31254|P2|COMPLETED|Overall Study||50
12839|NCT02243943|31255|P1|COMPLETED|Overall Study||50
12840|NCT02243943|31254|P2|STARTED|Overall Study||50
12841|NCT02243943|31255|P1|STARTED|Overall Study||50
12842|NCT02243280|31276|P11|NOT COMPLETED|Treated||3
12843|NCT02243280|31277|P10|NOT COMPLETED|Treated||0
12844|NCT02243280|31278|P9|NOT COMPLETED|Treated||1
12845|NCT02243280|31279|P8|NOT COMPLETED|Treated||0
12846|NCT02243280|31280|P7|NOT COMPLETED|Treated||0
12847|NCT02243280|31281|P6|NOT COMPLETED|Treated||0
12848|NCT02243280|31282|P5|NOT COMPLETED|Treated||0
12849|NCT02243280|31283|P4|NOT COMPLETED|Treated||0
12850|NCT02243280|31284|P3|NOT COMPLETED|Treated||0
12851|NCT02243280|31285|P2|NOT COMPLETED|Treated||0
12852|NCT02243280|31286|P1|NOT COMPLETED|Treated||1
12853|NCT02243280|31276|P11|COMPLETED|Treated||31
12854|NCT02243280|31277|P10|COMPLETED|Treated||0
12855|NCT02243280|31278|P9|COMPLETED|Treated||31
12856|NCT02243280|31279|P8|COMPLETED|Treated||0
12857|NCT02243280|31280|P7|COMPLETED|Treated||0
12858|NCT02243280|31281|P6|COMPLETED|Treated||27
12859|NCT02243280|31282|P5|COMPLETED|Treated||0
12860|NCT02243280|31283|P4|COMPLETED|Treated||0
12861|NCT02243280|31284|P3|COMPLETED|Treated||0
12862|NCT02243280|31285|P2|COMPLETED|Treated||39
12863|NCT02243280|31286|P1|COMPLETED|Treated||41
12864|NCT02243280|31276|P11|Completed Treatment|Treated||33
12865|NCT02243280|31277|P10|Completed Treatment|Treated||0
12866|NCT02243280|31278|P9|Completed Treatment|Treated||32
12867|NCT02243280|31279|P8|Completed Treatment|Treated||0
12868|NCT02243280|31280|P7|Completed Treatment|Treated||0
12869|NCT02243280|31281|P6|Completed Treatment|Treated||27
12870|NCT02243280|31282|P5|Completed Treatment|Treated||0
12871|NCT02243280|31283|P4|Completed Treatment|Treated||0
12872|NCT02243280|31284|P3|Completed Treatment|Treated||0
12873|NCT02243280|31285|P2|Completed Treatment|Treated||38
12874|NCT02243280|31286|P1|Completed Treatment|Treated||42
12875|NCT02243280|31276|P11|STARTED|Treated||34
12876|NCT02243280|31277|P10|STARTED|Treated||0
12877|NCT02243280|31278|P9|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|32
12878|NCT02243280|31279|P8|STARTED|Treated||0
12879|NCT02243280|31280|P7|STARTED|Treated||0
12880|NCT02243280|31281|P6|STARTED|Treated||27
12881|NCT02243280|31282|P5|STARTED|Treated||0
12882|NCT02243280|31283|P4|STARTED|Treated||0
12883|NCT02243280|31284|P3|STARTED|Treated||0
12884|NCT02243280|31285|P2|STARTED|Treated||39
12885|NCT02243280|31286|P1|STARTED|Treated|Two Arm I participants received ABT-493 doses of 200 mg instead of 300 mg and are included in Arm A|42
12886|NCT02243280|31276|P11|NOT COMPLETED|Enrolled||0
12887|NCT02243280|31277|P10|NOT COMPLETED|Enrolled||0
12888|NCT02243280|31278|P9|NOT COMPLETED|Enrolled||0
12889|NCT02243280|31279|P8|NOT COMPLETED|Enrolled||0
12890|NCT02243280|31280|P7|NOT COMPLETED|Enrolled||0
12891|NCT02243280|31281|P6|NOT COMPLETED|Enrolled||0
12892|NCT02243280|31282|P5|NOT COMPLETED|Enrolled||0
12893|NCT02243280|31283|P4|NOT COMPLETED|Enrolled||0
12894|NCT02243280|31284|P3|NOT COMPLETED|Enrolled||0
12895|NCT02243280|31285|P2|NOT COMPLETED|Enrolled||0
12896|NCT02243280|31286|P1|NOT COMPLETED|Enrolled||0
12897|NCT02243280|31276|P11|COMPLETED|Enrolled||34
12898|NCT02243280|31277|P10|COMPLETED|Enrolled||0
12899|NCT02243280|31278|P9|COMPLETED|Enrolled||34
12900|NCT02243280|31279|P8|COMPLETED|Enrolled||0
12901|NCT02243280|31280|P7|COMPLETED|Enrolled||0
12902|NCT02243280|31281|P6|COMPLETED|Enrolled||27
12903|NCT02243280|31282|P5|COMPLETED|Enrolled||0
12904|NCT02243280|31283|P4|COMPLETED|Enrolled||0
12905|NCT02243280|31284|P3|COMPLETED|Enrolled||0
12906|NCT02243280|31285|P2|COMPLETED|Enrolled||39
12907|NCT02243280|31286|P1|COMPLETED|Enrolled||40
12908|NCT02243280|31276|P11|STARTED|Enrolled||34
12909|NCT02243280|31277|P10|STARTED|Enrolled||0
12910|NCT02243280|31278|P9|STARTED|Enrolled||34
12911|NCT02243280|31279|P8|STARTED|Enrolled||0
12912|NCT02243280|31280|P7|STARTED|Enrolled||0
12913|NCT02243280|31281|P6|STARTED|Enrolled||27
12914|NCT02243280|31282|P5|STARTED|Enrolled||0
12915|NCT02243280|31283|P4|STARTED|Enrolled||0
12916|NCT02243280|31284|P3|STARTED|Enrolled||0
12917|NCT02243280|31285|P2|STARTED|Enrolled||39
12918|NCT02243280|31286|P1|STARTED|Enrolled||40
12919|NCT02243202|31341|P4|NOT COMPLETED|Overall Study||23
12920|NCT02243202|31342|P3|NOT COMPLETED|Overall Study||31
12921|NCT02243202|31343|P2|NOT COMPLETED|Overall Study||25
12922|NCT02243202|31344|P1|NOT COMPLETED|Overall Study||25
12923|NCT02243202|31341|P4|COMPLETED|Overall Study||61
12924|NCT02243202|31342|P3|COMPLETED|Overall Study||53
12925|NCT02243202|31343|P2|COMPLETED|Overall Study||60
12926|NCT02243202|31344|P1|COMPLETED|Overall Study||57
12927|NCT02243202|31341|P4|Treated|Overall Study||83
12928|NCT02243202|31342|P3|Treated|Overall Study||84
12929|NCT02243202|31343|P2|Treated|Overall Study||85
12930|NCT02243202|31344|P1|Treated|Overall Study||82
12931|NCT02243202|31341|P4|STARTED|Overall Study||84
12932|NCT02243202|31342|P3|STARTED|Overall Study||84
12933|NCT02243202|31343|P2|STARTED|Overall Study||85
12934|NCT02243202|31344|P1|STARTED|Overall Study||82
12935|NCT02243176|31380|P2|NOT COMPLETED|Overall Study||15
12936|NCT02243176|31381|P1|NOT COMPLETED|Overall Study||14
12937|NCT02243176|31380|P2|COMPLETED|Overall Study||229
12938|NCT02243176|31381|P1|COMPLETED|Overall Study||230
12939|NCT02243176|31380|P2|STARTED|Overall Study||244
12940|NCT02243176|31381|P1|STARTED|Overall Study|3 of the randomized subjects withdrew before taking any medication|244
12941|NCT02243046|31406|P3|NOT COMPLETED|Overall Study||4
12942|NCT02243046|31407|P2|NOT COMPLETED|Overall Study||1
12943|NCT02243046|31408|P1|NOT COMPLETED|Overall Study||1
12944|NCT02243046|31406|P3|COMPLETED|Overall Study||49
12945|NCT02243046|31407|P2|COMPLETED|Overall Study||53
12946|NCT02243046|31408|P1|COMPLETED|Overall Study||54
12947|NCT02243046|31406|P3|6 Month|Overall Study|2 subjects didn't return for 6 month clinic visit|49
12948|NCT02243046|31407|P2|6 Month|Overall Study||53
12949|NCT02243046|31408|P1|6 Month|Overall Study||54
12950|NCT02243046|31406|P3|3 Month|Overall Study|2 subjects didn't return for 3 month clinic visit|51
12951|NCT02243046|31407|P2|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|53
12952|NCT02243046|31408|P1|3 Month|Overall Study|1 subject didn't return for 3 month clinic visit|54
12953|NCT02243046|31406|P3|STARTED|Overall Study||53
12954|NCT02243046|31407|P2|STARTED|Overall Study||54
12955|NCT02243046|31408|P1|STARTED|Overall Study||55
12956|NCT02243007|31433|P2|NOT COMPLETED|Overall Study||0
12957|NCT02243007|31434|P1|NOT COMPLETED|Overall Study||0
12958|NCT02243007|31433|P2|COMPLETED|Overall Study||3
12959|NCT02243007|31434|P1|COMPLETED|Overall Study||4
12960|NCT02243007|31433|P2|STARTED|Overall Study||3
12961|NCT02243007|31434|P1|STARTED|Overall Study||4
12962|NCT02242994|31456|P1|NOT COMPLETED|Overall Study||0
12963|NCT02242994|31456|P1|COMPLETED|Overall Study||5
12964|NCT02242994|31456|P1|STARTED|Overall Study||5
12965|NCT02242643|31463|P2|NOT COMPLETED|Overall Study||78
12966|NCT02242643|31464|P1|NOT COMPLETED|Overall Study||75
12967|NCT02242643|31463|P2|COMPLETED|Overall Study||1139
12968|NCT02242643|31464|P1|COMPLETED|Overall Study||1132
12969|NCT02242643|31463|P2|STARTED|Overall Study||1217
12970|NCT02242643|31464|P1|STARTED|Overall Study||1207
12971|NCT02242630|31500|P4|NOT COMPLETED|Overall Study||0
12972|NCT02242630|31501|P3|NOT COMPLETED|Overall Study||0
12973|NCT02242630|31502|P2|NOT COMPLETED|Overall Study||0
12974|NCT02242630|31503|P1|NOT COMPLETED|Overall Study||0
12975|NCT02242630|31500|P4|COMPLETED|Overall Study||16
12976|NCT02242630|31501|P3|COMPLETED|Overall Study||15
12977|NCT02242630|31502|P2|COMPLETED|Overall Study||15
12978|NCT02242630|31503|P1|COMPLETED|Overall Study||15
12979|NCT02242630|31500|P4|STARTED|Overall Study||16
12980|NCT02242630|31501|P3|STARTED|Overall Study||15
12981|NCT02242630|31502|P2|STARTED|Overall Study||15
12982|NCT02242630|31503|P1|STARTED|Overall Study||15
12983|NCT02242305|31519|P2|NOT COMPLETED|Overall Study||10
12984|NCT02242305|31520|P1|NOT COMPLETED|Overall Study||6
12985|NCT02242305|31519|P2|COMPLETED|Overall Study||141
12986|NCT02242305|31520|P1|COMPLETED|Overall Study||145
12987|NCT02242305|31519|P2|STARTED|Overall Study||151
12988|NCT02242305|31520|P1|STARTED|Overall Study||151
12989|NCT02242019|31538|P1|NOT COMPLETED|Overall Study||0
12990|NCT02242019|31538|P1|COMPLETED|Overall Study||109
12991|NCT02242019|31538|P1|STARTED|Overall Study||109
12992|NCT02241889|31544|P6|NOT COMPLETED|Overall Study||1
12993|NCT02241889|31545|P5|NOT COMPLETED|Overall Study||0
12994|NCT02241889|31546|P4|NOT COMPLETED|Overall Study||0
12995|NCT02241889|31547|P3|NOT COMPLETED|Overall Study||1
12996|NCT02241889|31548|P2|NOT COMPLETED|Overall Study||0
12997|NCT02241889|31549|P1|NOT COMPLETED|Overall Study||0
12998|NCT02241889|31544|P6|COMPLETED|Overall Study||3
12999|NCT02241889|31545|P5|COMPLETED|Overall Study||5
13000|NCT02241889|31546|P4|COMPLETED|Overall Study||3
13001|NCT02241889|31547|P3|COMPLETED|Overall Study||2
13002|NCT02241889|31548|P2|COMPLETED|Overall Study||4
13003|NCT02241889|31549|P1|COMPLETED|Overall Study||4
13004|NCT02241889|31544|P6|STARTED|Overall Study||4
13005|NCT02241889|31545|P5|STARTED|Overall Study||5
13006|NCT02241889|31546|P4|STARTED|Overall Study||3
13007|NCT02241889|31547|P3|STARTED|Overall Study||3
13008|NCT02241889|31548|P2|STARTED|Overall Study||4
13009|NCT02241889|31549|P1|STARTED|Overall Study||4
13010|NCT02241785|31584|P1|NOT COMPLETED|Overall Study||47
13011|NCT02241785|31584|P1|COMPLETED|Overall Study||0
13012|NCT02241785|31584|P1|STARTED|Overall Study||47
13013|NCT02241486|31592|P1|NOT COMPLETED|Overall Study||0
13014|NCT02241486|31592|P1|COMPLETED|Overall Study||2
13015|NCT02241486|31592|P1|STARTED|Overall Study||2
13016|NCT02240628|31598|P2|NOT COMPLETED|Overall Study||5
13017|NCT02240628|31599|P1|NOT COMPLETED|Overall Study||6
13018|NCT02240628|31598|P2|COMPLETED|Overall Study||33
13019|NCT02240628|31599|P1|COMPLETED|Overall Study||32
13020|NCT02240628|31598|P2|STARTED|Overall Study||38
13021|NCT02240628|31599|P1|STARTED|Overall Study||38
13022|NCT02240589|31609|P2|NOT COMPLETED|Overall Study||2
13023|NCT02240589|31610|P1|NOT COMPLETED|Overall Study||2
13024|NCT02240589|31609|P2|COMPLETED|Overall Study||4
13025|NCT02240589|31610|P1|COMPLETED|Overall Study||3
13026|NCT02240589|31609|P2|STARTED|Overall Study||6
13027|NCT02240589|31610|P1|STARTED|Overall Study||5
13028|NCT02240368|31633|P3|NOT COMPLETED|Overall Study||1
13029|NCT02240368|31634|P2|NOT COMPLETED|Overall Study||0
13030|NCT02240368|31635|P1|NOT COMPLETED|Overall Study||1
13031|NCT02240368|31633|P3|COMPLETED|Overall Study||18
13032|NCT02240368|31634|P2|COMPLETED|Overall Study||22
13033|NCT02240368|31635|P1|COMPLETED|Overall Study||8
13034|NCT02240368|31633|P3|STARTED|Overall Study||19
13035|NCT02240368|31634|P2|STARTED|Overall Study||22
13036|NCT02240368|31635|P1|STARTED|Overall Study||9
13037|NCT02240329|31652|P1|NOT COMPLETED|Overall Study||0
13038|NCT02240329|31652|P1|COMPLETED|Overall Study||4
13039|NCT02240329|31652|P1|Determination of Urge to Cough|Overall Study||4
13040|NCT02240329|31652|P1|STARTED|Overall Study||4
13041|NCT02239978|31659|P2|NOT COMPLETED|Overall Study||0
13042|NCT02239978|31660|P1|NOT COMPLETED|Overall Study||2
13043|NCT02239978|31659|P2|COMPLETED|Overall Study||12
13044|NCT02239978|31660|P1|COMPLETED|Overall Study||28
13045|NCT02239978|31659|P2|STARTED|Overall Study||12
13046|NCT02239978|31660|P1|STARTED|Overall Study||30
13047|NCT02239926|31677|P2|NOT COMPLETED|Overall Study||1
13048|NCT02239926|31678|P1|NOT COMPLETED|Overall Study||0
13049|NCT02239926|31677|P2|COMPLETED|Overall Study||1
13050|NCT02239926|31678|P1|COMPLETED|Overall Study||0
13051|NCT02239926|31677|P2|STARTED|Overall Study||2
13052|NCT02239926|31678|P1|STARTED|Overall Study||0
13053|NCT02239744|31688|P2|NOT COMPLETED|Period 2||0
13054|NCT02239744|31689|P1|NOT COMPLETED|Period 2||0
13055|NCT02239744|31688|P2|COMPLETED|Period 2||18
13056|NCT02239744|31689|P1|COMPLETED|Period 2||17
13057|NCT02239744|31688|P2|STARTED|Period 2||18
13058|NCT02239744|31689|P1|STARTED|Period 2||17
13059|NCT02239744|31688|P2|NOT COMPLETED|Period 1||0
13060|NCT02239744|31689|P1|NOT COMPLETED|Period 1||0
13061|NCT02239744|31688|P2|COMPLETED|Period 1||18
13062|NCT02239744|31689|P1|COMPLETED|Period 1||17
13063|NCT02239744|31688|P2|STARTED|Period 1||18
13064|NCT02239744|31689|P1|STARTED|Period 1||17
13065|NCT02239692|31703|P2|NOT COMPLETED|Overall Study||13
13066|NCT02239692|31704|P1|NOT COMPLETED|Overall Study||6
13067|NCT02239692|31703|P2|COMPLETED|Overall Study||118
13068|NCT02239692|31704|P1|COMPLETED|Overall Study||67
13069|NCT02239692|31703|P2|Safety Analysis Set|Overall Study||125
13070|NCT02239692|31704|P1|Safety Analysis Set|Overall Study||70
13071|NCT02239692|31703|P2|Per-protocol Analysis Set|Overall Study||120
13072|NCT02239692|31704|P1|Per-protocol Analysis Set|Overall Study||66
13073|NCT02239692|31703|P2|Intention-to-treat Analysis Set|Overall Study||131
13074|NCT02239692|31704|P1|Intention-to-treat Analysis Set|Overall Study||73
13075|NCT02239692|31703|P2|STARTED|Overall Study||131
13076|NCT02239692|31704|P1|STARTED|Overall Study||73
13077|NCT02239289|31720|P1|NOT COMPLETED|Overall Study||0
13078|NCT02239289|31720|P1|COMPLETED|Overall Study||21
13079|NCT02239289|31720|P1|STARTED|Overall Study||21
13080|NCT02238782|31739|P1|NOT COMPLETED|Overall Study||0
13081|NCT02238782|31739|P1|COMPLETED|Overall Study||12
13082|NCT02238782|31739|P1|Subjects Treated|Overall Study||12
13083|NCT02238782|31739|P1|STARTED|Overall Study||12
13084|NCT02238379|31745|P2|NOT COMPLETED|Overall Study||0
13085|NCT02238379|31746|P1|NOT COMPLETED|Overall Study||1
13086|NCT02238379|31745|P2|COMPLETED|Overall Study||14
13087|NCT02238379|31746|P1|COMPLETED|Overall Study||11
13088|NCT02238379|31745|P2|STARTED|Overall Study||14
13089|NCT02238379|31746|P1|STARTED|Overall Study||12
13090|NCT02238080|31772|P1|NOT COMPLETED|Overall Study||25
13091|NCT02238080|31772|P1|COMPLETED|Overall Study||172
13092|NCT02238080|31772|P1|STARTED|Overall Study||197
13093|NCT02238067|31786|P1|NOT COMPLETED|Overall Study||45
13094|NCT02238067|31786|P1|COMPLETED|Overall Study||151
13095|NCT02238067|31786|P1|STARTED|Overall Study||196
13096|NCT02238028|31809|P2|NOT COMPLETED|Overall Study||2
13097|NCT02238028|31810|P1|NOT COMPLETED|Overall Study||2
13098|NCT02238028|31809|P2|COMPLETED|Overall Study||12
13099|NCT02238028|31810|P1|COMPLETED|Overall Study||12
13100|NCT02238028|31809|P2|STARTED|Overall Study||14
13101|NCT02238028|31810|P1|STARTED|Overall Study||14
13102|NCT02237118|31831|P2|NOT COMPLETED|Overall Study||1
13103|NCT02237118|31832|P1|NOT COMPLETED|Overall Study||1
13104|NCT02237118|31831|P2|COMPLETED|Overall Study||62
13105|NCT02237118|31832|P1|COMPLETED|Overall Study||59
13106|NCT02237118|31831|P2|STARTED|Overall Study||63
13107|NCT02237118|31832|P1|STARTED|Overall Study||60
13108|NCT02237092|31846|P1|NOT COMPLETED|Overall Study||0
13109|NCT02237092|31846|P1|COMPLETED|Overall Study||196
13110|NCT02237092|31846|P1|STARTED|Overall Study||196
13111|NCT02236767|31863|P1|NOT COMPLETED|Overall Study||0
13112|NCT02236767|31863|P1|COMPLETED|Overall Study||1
13113|NCT02236767|31863|P1|STARTED|Overall Study||1
13114|NCT02236611|31869|P2|NOT COMPLETED|Overall Study||34
13115|NCT02236611|31870|P1|NOT COMPLETED|Overall Study||26
13116|NCT02236611|31869|P2|COMPLETED|Overall Study||484
13117|NCT02236611|31870|P1|COMPLETED|Overall Study||490
13118|NCT02236611|31869|P2|STARTED|Overall Study||518
13119|NCT02236611|31870|P1|STARTED|Overall Study||516
13120|NCT02236598|31878|P2|NOT COMPLETED|Overall Study||2
13121|NCT02236598|31879|P1|NOT COMPLETED|Overall Study||0
13122|NCT02236598|31878|P2|COMPLETED|Overall Study||12
13123|NCT02236598|31879|P1|COMPLETED|Overall Study||15
13124|NCT02236598|31878|P2|STARTED|Overall Study||14
13125|NCT02236598|31879|P1|STARTED|Overall Study||15
13126|NCT02236546|31891|P1|NOT COMPLETED|Overall Study||0
13127|NCT02236546|31891|P1|COMPLETED|Overall Study||3
13128|NCT02236546|31891|P1|STARTED|Overall Study||3
13129|NCT02236130|31900|P2|NOT COMPLETED|Overall Study||12
13130|NCT02236130|31901|P1|NOT COMPLETED|Overall Study||7
13131|NCT02236130|31900|P2|COMPLETED|Overall Study||15
13132|NCT02236130|31901|P1|COMPLETED|Overall Study||15
13133|NCT02236130|31900|P2|STARTED|Overall Study||27
13134|NCT02236130|31901|P1|STARTED|Overall Study||22
13135|NCT02235831|31909|P6|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
13136|NCT02235831|31910|P5|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
13137|NCT02235831|31911|P4|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
13138|NCT02235831|31912|P3|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
13139|NCT02235831|31913|P2|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
13140|NCT02235831|31914|P1|NOT COMPLETED|Period 3, Third 5 Days of Wear||0
13141|NCT02235831|31909|P6|COMPLETED|Period 3, Third 5 Days of Wear||4
13142|NCT02235831|31910|P5|COMPLETED|Period 3, Third 5 Days of Wear||4
13143|NCT02235831|31911|P4|COMPLETED|Period 3, Third 5 Days of Wear||4
13144|NCT02235831|31912|P3|COMPLETED|Period 3, Third 5 Days of Wear||4
13145|NCT02235831|31913|P2|COMPLETED|Period 3, Third 5 Days of Wear||4
13146|NCT02235831|31914|P1|COMPLETED|Period 3, Third 5 Days of Wear||4
13147|NCT02235831|31909|P6|STARTED|Period 3, Third 5 Days of Wear||4
13148|NCT02235831|31910|P5|STARTED|Period 3, Third 5 Days of Wear||4
13149|NCT02235831|31911|P4|STARTED|Period 3, Third 5 Days of Wear||4
13150|NCT02235831|31912|P3|STARTED|Period 3, Third 5 Days of Wear||4
13151|NCT02235831|31913|P2|STARTED|Period 3, Third 5 Days of Wear||4
13152|NCT02235831|31914|P1|STARTED|Period 3, Third 5 Days of Wear||4
13153|NCT02235831|31909|P6|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
13154|NCT02235831|31910|P5|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
13155|NCT02235831|31911|P4|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
13156|NCT02235831|31912|P3|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
13157|NCT02235831|31913|P2|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
13158|NCT02235831|31914|P1|NOT COMPLETED|Period 2, Second 5 Days of Wear||0
13159|NCT02235831|31909|P6|COMPLETED|Period 2, Second 5 Days of Wear||4
13160|NCT02235831|31910|P5|COMPLETED|Period 2, Second 5 Days of Wear||4
13161|NCT02235831|31911|P4|COMPLETED|Period 2, Second 5 Days of Wear||4
13162|NCT02235831|31912|P3|COMPLETED|Period 2, Second 5 Days of Wear||4
13163|NCT02235831|31913|P2|COMPLETED|Period 2, Second 5 Days of Wear||4
13164|NCT02235831|31914|P1|COMPLETED|Period 2, Second 5 Days of Wear||4
13165|NCT02235831|31909|P6|STARTED|Period 2, Second 5 Days of Wear||4
13166|NCT02235831|31910|P5|STARTED|Period 2, Second 5 Days of Wear||4
13167|NCT02235831|31911|P4|STARTED|Period 2, Second 5 Days of Wear||4
13168|NCT02235831|31912|P3|STARTED|Period 2, Second 5 Days of Wear||4
13169|NCT02235831|31913|P2|STARTED|Period 2, Second 5 Days of Wear||4
13170|NCT02235831|31914|P1|STARTED|Period 2, Second 5 Days of Wear||4
13171|NCT02235831|31909|P6|NOT COMPLETED|Period 1, First 5 Days of Wear||0
13172|NCT02235831|31910|P5|NOT COMPLETED|Period 1, First 5 Days of Wear||0
13173|NCT02235831|31911|P4|NOT COMPLETED|Period 1, First 5 Days of Wear||0
13174|NCT02235831|31912|P3|NOT COMPLETED|Period 1, First 5 Days of Wear||0
13175|NCT02235831|31913|P2|NOT COMPLETED|Period 1, First 5 Days of Wear||0
13176|NCT02235831|31914|P1|NOT COMPLETED|Period 1, First 5 Days of Wear||0
13177|NCT02235831|31909|P6|COMPLETED|Period 1, First 5 Days of Wear||4
13178|NCT02235831|31910|P5|COMPLETED|Period 1, First 5 Days of Wear||4
13179|NCT02235831|31911|P4|COMPLETED|Period 1, First 5 Days of Wear||4
13180|NCT02235831|31912|P3|COMPLETED|Period 1, First 5 Days of Wear||4
13181|NCT02235831|31913|P2|COMPLETED|Period 1, First 5 Days of Wear||4
13182|NCT02235831|31914|P1|COMPLETED|Period 1, First 5 Days of Wear||4
13183|NCT02235831|31909|P6|STARTED|Period 1, First 5 Days of Wear||4
13184|NCT02235831|31910|P5|STARTED|Period 1, First 5 Days of Wear||4
13185|NCT02235831|31911|P4|STARTED|Period 1, First 5 Days of Wear||4
13186|NCT02235831|31912|P3|STARTED|Period 1, First 5 Days of Wear||4
13187|NCT02235831|31913|P2|STARTED|Period 1, First 5 Days of Wear||4
13188|NCT02235831|31914|P1|STARTED|Period 1, First 5 Days of Wear||4
13189|NCT02235493|31921|P1|NOT COMPLETED|Overall Study||0
13190|NCT02235493|31921|P1|COMPLETED|Overall Study||6
13191|NCT02235493|31921|P1|STARTED|Overall Study||6
13192|NCT02235454|31926|P1|NOT COMPLETED|Overall Study||2
13193|NCT02235454|31926|P1|COMPLETED|Overall Study||55
13194|NCT02235454|31926|P1|STARTED|Overall Study||57
13195|NCT02235311|31932|P2|NOT COMPLETED|Overall Study||2
13196|NCT02235311|31933|P1|NOT COMPLETED|Overall Study||0
13197|NCT02235311|31932|P2|COMPLETED|Overall Study||0
13198|NCT02235311|31933|P1|COMPLETED|Overall Study||1
13199|NCT02235311|31932|P2|STARTED|Overall Study||2
13200|NCT02235311|31933|P1|STARTED|Overall Study||1
13201|NCT02235285|31945|P1|NOT COMPLETED|Overall Study||13
13202|NCT02235285|31945|P1|COMPLETED|Overall Study||149
13203|NCT02235285|31945|P1|STARTED|Overall Study||162
13204|NCT02235077|31951|P2|NOT COMPLETED|Overall Study||19
13205|NCT02235077|31952|P1|NOT COMPLETED|Overall Study||18
13206|NCT02235077|31951|P2|COMPLETED|Overall Study||159
13207|NCT02235077|31952|P1|COMPLETED|Overall Study||164
13208|NCT02235077|31951|P2|STARTED|Overall Study||178
13209|NCT02235077|31952|P1|STARTED|Overall Study||182
13210|NCT02235064|31980|P2|NOT COMPLETED|Overall Study||0
13211|NCT02235064|31981|P1|NOT COMPLETED|Overall Study||0
13212|NCT02235064|31980|P2|COMPLETED|Overall Study||1
13213|NCT02235064|31981|P1|COMPLETED|Overall Study||1
13214|NCT02235064|31980|P2|STARTED|Overall Study||1
13215|NCT02235064|31981|P1|STARTED|Overall Study||1
13216|NCT02234479|32009|P2|NOT COMPLETED|Overall Study||3
13217|NCT02234479|32010|P1|NOT COMPLETED|Overall Study||1
13218|NCT02234479|32009|P2|COMPLETED|Overall Study||15
13219|NCT02234479|32010|P1|COMPLETED|Overall Study||15
13220|NCT02234479|32009|P2|STARTED|Overall Study||18
13221|NCT02234479|32010|P1|STARTED|Overall Study||16
13222|NCT02234427|32016|P1|NOT COMPLETED|Overall Study||1
13223|NCT02234427|32016|P1|COMPLETED|Overall Study|One individual withdrew after first visit|33
13224|NCT02234427|32016|P1|STARTED|Overall Study||34
13225|NCT02234362|32020|P1|NOT COMPLETED|Overall Study||26
13226|NCT02234362|32020|P1|COMPLETED|Overall Study||21
13227|NCT02234362|32020|P1|Received at Least One Dose of Medication|Overall Study||27
13228|NCT02234362|32020|P1|STARTED|Overall Study||47
13229|NCT02234011|32037|P1|NOT COMPLETED|Overall Study||0
13230|NCT02234011|32037|P1|COMPLETED|Overall Study||0
13231|NCT02234011|32037|P1|STARTED|Overall Study||0
13232|NCT02233998|32044|P3|NOT COMPLETED|Overall Study||0
13233|NCT02233998|32045|P2|NOT COMPLETED|Overall Study||0
13234|NCT02233998|32046|P1|NOT COMPLETED|Overall Study||0
13235|NCT02233998|32044|P3|COMPLETED|Overall Study||53
13236|NCT02233998|32045|P2|COMPLETED|Overall Study||52
13237|NCT02233998|32046|P1|COMPLETED|Overall Study||53
13238|NCT02233998|32044|P3|STARTED|Overall Study||53
13239|NCT02233998|32045|P2|STARTED|Overall Study||52
13240|NCT02233998|32046|P1|STARTED|Overall Study||53
13241|NCT02233985|32080|P2|NOT COMPLETED|Overall Study||0
13242|NCT02233985|32081|P1|NOT COMPLETED|Overall Study||0
13243|NCT02233985|32080|P2|COMPLETED|Overall Study||31
13244|NCT02233985|32081|P1|COMPLETED|Overall Study||33
13245|NCT02233985|32080|P2|STARTED|Overall Study||31
13246|NCT02233985|32081|P1|STARTED|Overall Study||33
13247|NCT02233842|32089|P1|NOT COMPLETED|Questionnaire 3 Version 2||0
13248|NCT02233842|32089|P1|COMPLETED|Questionnaire 3 Version 2||5
13249|NCT02233842|32089|P1|STARTED|Questionnaire 3 Version 2||5
13250|NCT02233842|32089|P1|NOT COMPLETED|Questionnaire 3 Version 1||0
13251|NCT02233842|32089|P1|COMPLETED|Questionnaire 3 Version 1||5
13252|NCT02233842|32089|P1|STARTED|Questionnaire 3 Version 1||5
13253|NCT02233842|32089|P1|NOT COMPLETED|Questionnaire 2 Version 2||0
13254|NCT02233842|32089|P1|COMPLETED|Questionnaire 2 Version 2||5
13255|NCT02233842|32089|P1|STARTED|Questionnaire 2 Version 2||5
13256|NCT02233842|32089|P1|NOT COMPLETED|Questionnaire 2 Version 1||0
13257|NCT02233842|32089|P1|COMPLETED|Questionnaire 2 Version 1||5
13258|NCT02233842|32089|P1|STARTED|Questionnaire 2 Version 1||5
13259|NCT02233842|32089|P1|NOT COMPLETED|Questionnaire 1 Version 2||0
13260|NCT02233842|32089|P1|COMPLETED|Questionnaire 1 Version 2||5
13261|NCT02233842|32089|P1|STARTED|Questionnaire 1 Version 2||5
13262|NCT02233842|32089|P1|NOT COMPLETED|Questionnaire 1 Version 1||0
13263|NCT02233842|32089|P1|COMPLETED|Questionnaire 1 Version 1||5
13264|NCT02233842|32089|P1|STARTED|Questionnaire 1 Version 1||5
13265|NCT02233803|32096|P2|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
13266|NCT02233803|32097|P1|NOT COMPLETED|Treatment Period 2 (4-Wks)||2
13267|NCT02233803|32096|P2|COMPLETED|Treatment Period 2 (4-Wks)||91
13268|NCT02233803|32097|P1|COMPLETED|Treatment Period 2 (4-Wks)||93
13269|NCT02233803|32096|P2|STARTED|Treatment Period 2 (4-Wks)||93
13270|NCT02233803|32097|P1|STARTED|Treatment Period 2 (4-Wks)||95
13271|NCT02233803|32096|P2|NOT COMPLETED|Washout Period (4-Wks)||2
13272|NCT02233803|32097|P1|NOT COMPLETED|Washout Period (4-Wks)||2
13273|NCT02233803|32096|P2|COMPLETED|Washout Period (4-Wks)||93
13274|NCT02233803|32097|P1|COMPLETED|Washout Period (4-Wks)||95
13275|NCT02233803|32096|P2|STARTED|Washout Period (4-Wks)||95
13276|NCT02233803|32097|P1|STARTED|Washout Period (4-Wks)||97
13277|NCT02233803|32096|P2|NOT COMPLETED|Treatment Period 1 (4-Wks)||4
13278|NCT02233803|32097|P1|NOT COMPLETED|Treatment Period 1 (4-Wks)||3
13279|NCT02233803|32096|P2|COMPLETED|Treatment Period 1 (4-Wks)||95
13280|NCT02233803|32097|P1|COMPLETED|Treatment Period 1 (4-Wks)||97
13281|NCT02233803|32096|P2|STARTED|Treatment Period 1 (4-Wks)||99
13282|NCT02233803|32097|P1|STARTED|Treatment Period 1 (4-Wks)||100
13283|NCT02233647|32107|P1|NOT COMPLETED|Overall Study||1
13284|NCT02233647|32107|P1|COMPLETED|Overall Study||10
13285|NCT02233647|32107|P1|80 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
13286|NCT02233647|32107|P1|40 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
13287|NCT02233647|32107|P1|20 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
13288|NCT02233647|32107|P1|10 mg Cocaine with210 mg Phendimetrazine|Overall Study||10
13289|NCT02233647|32107|P1|0 mg Cocaine With 210 mg Phendimetrazine|Overall Study||10
13290|NCT02233647|32107|P1|80 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
13291|NCT02233647|32107|P1|40 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
13292|NCT02233647|32107|P1|20 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
13293|NCT02233647|32107|P1|10 mg Cocaine with140 mg Phendimetrazine|Overall Study||10
13294|NCT02233647|32107|P1|0 mg Cocaine With 140 mg Phendimetrazine|Overall Study||10
13295|NCT02233647|32107|P1|80 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
13296|NCT02233647|32107|P1|40 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
13297|NCT02233647|32107|P1|20 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
13298|NCT02233647|32107|P1|10 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
13299|NCT02233647|32107|P1|0 mg Cocaine With 70 mg Phendimetrazine|Overall Study||10
13300|NCT02233647|32107|P1|80 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
13301|NCT02233647|32107|P1|40 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
13302|NCT02233647|32107|P1|20 mg Cocaine With 0 mg Phendimetrazine|Overall Study||10
13303|NCT02233647|32107|P1|10 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
13304|NCT02233647|32107|P1|0 mg Cocaine With 0 mg Phendimetrazine|Overall Study||11
13305|NCT02233647|32107|P1|STARTED|Overall Study||11
13306|NCT02233309|32136|P1|NOT COMPLETED|Overall Study||5
13307|NCT02233309|32136|P1|COMPLETED|Overall Study||31
13308|NCT02233309|32136|P1|STARTED|Overall Study||36
13309|NCT02233296|32142|P2|NOT COMPLETED|Overall Study||0
13310|NCT02233296|32143|P1|NOT COMPLETED|Overall Study||0
13311|NCT02233296|32142|P2|COMPLETED|Overall Study||14
13312|NCT02233296|32143|P1|COMPLETED|Overall Study||16
13313|NCT02233296|32142|P2|STARTED|Overall Study||14
13314|NCT02233296|32143|P1|STARTED|Overall Study||16
13315|NCT02233101|32161|P2|NOT COMPLETED|Overall Study||1
13316|NCT02233101|32162|P1|NOT COMPLETED|Overall Study||12
13317|NCT02233101|32161|P2|COMPLETED|Overall Study||80
13318|NCT02233101|32162|P1|COMPLETED|Overall Study||74
13319|NCT02233101|32161|P2|STARTED|Overall Study||81
13320|NCT02233101|32162|P1|STARTED|Overall Study||86
13321|NCT02232880|32170|P1|NOT COMPLETED|Overall Study||1
13322|NCT02232880|32170|P1|COMPLETED|Overall Study||0
13323|NCT02232880|32170|P1|STARTED|Overall Study||1
13324|NCT02232698|32179|P2|NOT COMPLETED|Overall Study||20
13325|NCT02232698|32180|P1|NOT COMPLETED|Overall Study||10
13326|NCT02232698|32179|P2|COMPLETED|Overall Study||101
13327|NCT02232698|32180|P1|COMPLETED|Overall Study||110
13328|NCT02232698|32179|P2|STARTED|Overall Study||121
13329|NCT02232698|32180|P1|STARTED|Overall Study||120
13330|NCT02232126|32203|P2|NOT COMPLETED|Overall Study||0
13331|NCT02232126|32204|P1|NOT COMPLETED|Overall Study||0
13332|NCT02232126|32203|P2|COMPLETED|Overall Study||90
13333|NCT02232126|32204|P1|COMPLETED|Overall Study||91
13334|NCT02232126|32203|P2|STARTED|Overall Study||90
13335|NCT02232126|32204|P1|STARTED|Overall Study||91
13336|NCT02231918|32215|P3|NOT COMPLETED|Overall Study||1
13337|NCT02231918|32216|P2|NOT COMPLETED|Overall Study||1
13338|NCT02231918|32217|P1|NOT COMPLETED|Overall Study||0
13339|NCT02231918|32215|P3|COMPLETED|Overall Study||1
13340|NCT02231918|32216|P2|COMPLETED|Overall Study||14
13341|NCT02231918|32217|P1|COMPLETED|Overall Study||9
13342|NCT02231918|32215|P3|STARTED|Overall Study||2
13343|NCT02231918|32216|P2|STARTED|Overall Study||15
13344|NCT02231918|32217|P1|STARTED|Overall Study||9
13345|NCT02231177|32279|P6|NOT COMPLETED|Treatment Period 3 (21 Days)||0
13346|NCT02231177|32280|P5|NOT COMPLETED|Treatment Period 3 (21 Days)||0
13347|NCT02231177|32281|P4|NOT COMPLETED|Treatment Period 3 (21 Days)||0
13348|NCT02231177|32282|P3|NOT COMPLETED|Treatment Period 3 (21 Days)||0
13349|NCT02231177|32283|P2|NOT COMPLETED|Treatment Period 3 (21 Days)||0
13350|NCT02231177|32284|P1|NOT COMPLETED|Treatment Period 3 (21 Days)||0
13351|NCT02231177|32279|P6|COMPLETED|Treatment Period 3 (21 Days)||9
13352|NCT02231177|32280|P5|COMPLETED|Treatment Period 3 (21 Days)||8
13353|NCT02231177|32281|P4|COMPLETED|Treatment Period 3 (21 Days)||7
13354|NCT02231177|32282|P3|COMPLETED|Treatment Period 3 (21 Days)||8
13355|NCT02231177|32283|P2|COMPLETED|Treatment Period 3 (21 Days)||7
13356|NCT02231177|32284|P1|COMPLETED|Treatment Period 3 (21 Days)||8
13357|NCT02231177|32279|P6|STARTED|Treatment Period 3 (21 Days)||9
13358|NCT02231177|32280|P5|STARTED|Treatment Period 3 (21 Days)||8
13359|NCT02231177|32281|P4|STARTED|Treatment Period 3 (21 Days)||7
13360|NCT02231177|32282|P3|STARTED|Treatment Period 3 (21 Days)||8
13361|NCT02231177|32283|P2|STARTED|Treatment Period 3 (21 Days)||7
13362|NCT02231177|32284|P1|STARTED|Treatment Period 3 (21 Days)||8
13363|NCT02231177|32279|P6|NOT COMPLETED|Treatment Period 2 (21 Days)||0
13364|NCT02231177|32280|P5|NOT COMPLETED|Treatment Period 2 (21 Days)||0
13365|NCT02231177|32281|P4|NOT COMPLETED|Treatment Period 2 (21 Days)||0
13366|NCT02231177|32282|P3|NOT COMPLETED|Treatment Period 2 (21 Days)||0
13367|NCT02231177|32283|P2|NOT COMPLETED|Treatment Period 2 (21 Days)||0
13368|NCT02231177|32284|P1|NOT COMPLETED|Treatment Period 2 (21 Days)||0
13369|NCT02231177|32279|P6|COMPLETED|Treatment Period 2 (21 Days)||9
13370|NCT02231177|32280|P5|COMPLETED|Treatment Period 2 (21 Days)||8
13371|NCT02231177|32281|P4|COMPLETED|Treatment Period 2 (21 Days)||7
13372|NCT02231177|32282|P3|COMPLETED|Treatment Period 2 (21 Days)||8
13373|NCT02231177|32283|P2|COMPLETED|Treatment Period 2 (21 Days)||7
13374|NCT02231177|32284|P1|COMPLETED|Treatment Period 2 (21 Days)||8
13375|NCT02231177|32279|P6|STARTED|Treatment Period 2 (21 Days)||9
13376|NCT02231177|32280|P5|STARTED|Treatment Period 2 (21 Days)||8
13377|NCT02231177|32281|P4|STARTED|Treatment Period 2 (21 Days)||7
13378|NCT02231177|32282|P3|STARTED|Treatment Period 2 (21 Days)||8
13379|NCT02231177|32283|P2|STARTED|Treatment Period 2 (21 Days)||7
13380|NCT02231177|32284|P1|STARTED|Treatment Period 2 (21 Days)||8
13381|NCT02231177|32279|P6|NOT COMPLETED|Treatment Period 1 (21 Days)||0
13382|NCT02231177|32280|P5|NOT COMPLETED|Treatment Period 1 (21 Days)||0
13383|NCT02231177|32281|P4|NOT COMPLETED|Treatment Period 1 (21 Days)||0
13384|NCT02231177|32282|P3|NOT COMPLETED|Treatment Period 1 (21 Days)||0
13385|NCT02231177|32283|P2|NOT COMPLETED|Treatment Period 1 (21 Days)||0
13386|NCT02231177|32284|P1|NOT COMPLETED|Treatment Period 1 (21 Days)||0
13387|NCT02231177|32279|P6|COMPLETED|Treatment Period 1 (21 Days)||9
13388|NCT02231177|32280|P5|COMPLETED|Treatment Period 1 (21 Days)||8
13389|NCT02231177|32281|P4|COMPLETED|Treatment Period 1 (21 Days)||7
13390|NCT02231177|32282|P3|COMPLETED|Treatment Period 1 (21 Days)||8
13391|NCT02231177|32283|P2|COMPLETED|Treatment Period 1 (21 Days)||7
13392|NCT02231177|32284|P1|COMPLETED|Treatment Period 1 (21 Days)||8
13393|NCT02231177|32279|P6|STARTED|Treatment Period 1 (21 Days)||9
13394|NCT02231177|32280|P5|STARTED|Treatment Period 1 (21 Days)||8
13395|NCT02231177|32281|P4|STARTED|Treatment Period 1 (21 Days)||7
13396|NCT02231177|32282|P3|STARTED|Treatment Period 1 (21 Days)||8
13397|NCT02231177|32283|P2|STARTED|Treatment Period 1 (21 Days)||7
13398|NCT02231177|32284|P1|STARTED|Treatment Period 1 (21 Days)||8
13399|NCT02231164|32340|P2|NOT COMPLETED|Overall Study||6
13400|NCT02231164|32341|P1|NOT COMPLETED|Overall Study||6
13401|NCT02231164|32340|P2|COMPLETED|Overall Study||0
13402|NCT02231164|32341|P1|COMPLETED|Overall Study||0
13403|NCT02231164|32340|P2|STARTED|Overall Study||6
13404|NCT02231164|32341|P1|STARTED|Overall Study||6
13405|NCT02229864|32347|P1|NOT COMPLETED|1 - Year Visit||1
13406|NCT02229864|32347|P1|COMPLETED|1 - Year Visit||11
13407|NCT02229864|32347|P1|STARTED|1 - Year Visit||12
13408|NCT02229864|32347|P1|NOT COMPLETED|6 - Month Visit||0
13409|NCT02229864|32347|P1|COMPLETED|6 - Month Visit||12
13410|NCT02229864|32347|P1|STARTED|6 - Month Visit||12
13411|NCT02229864|32347|P1|NOT COMPLETED|1 - Month Visit||0
13412|NCT02229864|32347|P1|COMPLETED|1 - Month Visit||12
13413|NCT02229864|32347|P1|STARTED|1 - Month Visit||12
13414|NCT02230995|32387|P2|NOT COMPLETED|Period 2 + Washout||0
13415|NCT02230995|32388|P1|NOT COMPLETED|Period 2 + Washout||0
13416|NCT02230995|32387|P2|COMPLETED|Period 2 + Washout||15
13417|NCT02230995|32388|P1|COMPLETED|Period 2 + Washout||15
13418|NCT02230995|32387|P2|STARTED|Period 2 + Washout||15
13419|NCT02230995|32388|P1|STARTED|Period 2 + Washout||15
13420|NCT02230995|32387|P2|NOT COMPLETED|Period 1 + Washout||0
13421|NCT02230995|32388|P1|NOT COMPLETED|Period 1 + Washout||0
13422|NCT02230995|32387|P2|COMPLETED|Period 1 + Washout||15
13423|NCT02230995|32388|P1|COMPLETED|Period 1 + Washout||15
13424|NCT02230995|32387|P2|STARTED|Period 1 + Washout||15
13425|NCT02230995|32388|P1|STARTED|Period 1 + Washout||15
13426|NCT02230956|32407|P3|NOT COMPLETED|Overall Study||7
13427|NCT02230956|32408|P2|NOT COMPLETED|Overall Study||6
13428|NCT02230956|32409|P1|NOT COMPLETED|Overall Study||5
13429|NCT02230956|32407|P3|COMPLETED|Overall Study||82
13430|NCT02230956|32408|P2|COMPLETED|Overall Study||37
13431|NCT02230956|32409|P1|COMPLETED|Overall Study||39
13432|NCT02230956|32407|P3|STARTED|Overall Study||89
13433|NCT02230956|32408|P2|STARTED|Overall Study||43
13434|NCT02230956|32409|P1|STARTED|Overall Study||44
13435|NCT02230904|32431|P2|NOT COMPLETED|Overall Study||1
13436|NCT02230904|32432|P1|NOT COMPLETED|Overall Study||0
13437|NCT02230904|32431|P2|COMPLETED|Overall Study||27
13438|NCT02230904|32432|P1|COMPLETED|Overall Study||29
13439|NCT02230904|32431|P2|STARTED|Overall Study||28
13440|NCT02230904|32432|P1|STARTED|Overall Study||29
13441|NCT02230761|32454|P2|NOT COMPLETED|Overall Study||1
13442|NCT02230761|32455|P1|NOT COMPLETED|Overall Study||0
13443|NCT02230761|32454|P2|COMPLETED|Overall Study||29
13444|NCT02230761|32455|P1|COMPLETED|Overall Study||60
13445|NCT02230761|32454|P2|STARTED|Overall Study||30
13446|NCT02230761|32455|P1|STARTED|Overall Study||60
13447|NCT02230683|32465|P1|NOT COMPLETED|Overall Study||1
13448|NCT02230683|32465|P1|COMPLETED|Overall Study||22
13449|NCT02230683|32465|P1|STARTED|Overall Study||23
13450|NCT02230670|32482|P2|NOT COMPLETED|Overall Study||8
13451|NCT02230670|32483|P1|NOT COMPLETED|Overall Study||4
13452|NCT02230670|32482|P2|COMPLETED|Overall Study||34
13453|NCT02230670|32483|P1|COMPLETED|Overall Study||40
13454|NCT02230670|32482|P2|STARTED|Overall Study|One subject randomized to placebo withdrew from the study before receiving any study treatment.|42
13455|NCT02230670|32483|P1|STARTED|Overall Study||44
13456|NCT02230540|32493|P2|NOT COMPLETED|Overall Study||0
13457|NCT02230540|32494|P1|NOT COMPLETED|Overall Study||0
13458|NCT02230540|32493|P2|COMPLETED|Overall Study||0
13459|NCT02230540|32494|P1|COMPLETED|Overall Study||8
13460|NCT02230540|32493|P2|STARTED|Overall Study|The study was terminated before initiation of sequence B. Sequence B was therefore not initiated.|0
13461|NCT02230540|32494|P1|STARTED|Overall Study||8
13462|NCT02230085|32498|P1|NOT COMPLETED|Overall Study||4
13463|NCT02230085|32498|P1|COMPLETED|Overall Study||106
13464|NCT02230085|32498|P1|STARTED|Overall Study||110
13465|NCT02229539|32505|P3|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||10
13466|NCT02229539|32506|P2|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||7
13467|NCT02229539|32507|P1|NOT COMPLETED|Cycle 2 (Optional Continuation Phase)||9
13468|NCT02229539|32505|P3|COMPLETED|Cycle 2 (Optional Continuation Phase)||22
13469|NCT02229539|32506|P2|COMPLETED|Cycle 2 (Optional Continuation Phase)||29
13470|NCT02229539|32507|P1|COMPLETED|Cycle 2 (Optional Continuation Phase)||26
13471|NCT02229539|32505|P3|STARTED|Cycle 2 (Optional Continuation Phase)||32
13472|NCT02229539|32506|P2|STARTED|Cycle 2 (Optional Continuation Phase)||36
13473|NCT02229539|32507|P1|STARTED|Cycle 2 (Optional Continuation Phase)||35
13474|NCT02229539|32505|P3|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
13475|NCT02229539|32506|P2|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||5
13476|NCT02229539|32507|P1|NOT COMPLETED|Cycle 1 (Treatment Per Protocol)||3
13477|NCT02229539|32505|P3|COMPLETED|Cycle 1 (Treatment Per Protocol)||72
13478|NCT02229539|32506|P2|COMPLETED|Cycle 1 (Treatment Per Protocol)||71
13479|NCT02229539|32507|P1|COMPLETED|Cycle 1 (Treatment Per Protocol)||74
13480|NCT02229539|32505|P3|STARTED|Cycle 1 (Treatment Per Protocol)||75
13481|NCT02229539|32506|P2|STARTED|Cycle 1 (Treatment Per Protocol)||76
13482|NCT02229539|32507|P1|STARTED|Cycle 1 (Treatment Per Protocol)||77
13483|NCT02229513|32517|P2|NOT COMPLETED|Overall Study||0
13484|NCT02229513|32518|P1|NOT COMPLETED|Overall Study||0
13485|NCT02229513|32517|P2|COMPLETED|Overall Study||100
13486|NCT02229513|32518|P1|COMPLETED|Overall Study||100
13487|NCT02229513|32517|P2|STARTED|Overall Study||100
13488|NCT02229513|32518|P1|STARTED|Overall Study||100
13489|NCT02229487|32554|P2|NOT COMPLETED|Overall Study||0
13490|NCT02229487|32555|P1|NOT COMPLETED|Overall Study||0
13491|NCT02229487|32554|P2|COMPLETED|Overall Study||27
13492|NCT02229487|32555|P1|COMPLETED|Overall Study||24
13493|NCT02229487|32554|P2|STARTED|Overall Study||27
13494|NCT02229487|32555|P1|STARTED|Overall Study||24
13495|NCT02229461|32568|P6|NOT COMPLETED|Overall Study||0
13496|NCT02229461|32569|P5|NOT COMPLETED|Overall Study||0
13497|NCT02229461|32570|P4|NOT COMPLETED|Overall Study||0
13498|NCT02229461|32571|P3|NOT COMPLETED|Overall Study||0
13499|NCT02229461|32572|P2|NOT COMPLETED|Overall Study||0
13500|NCT02229461|32573|P1|NOT COMPLETED|Overall Study||0
13501|NCT02229461|32568|P6|COMPLETED|Overall Study||17
13502|NCT02229461|32569|P5|COMPLETED|Overall Study||17
13503|NCT02229461|32570|P4|COMPLETED|Overall Study||17
13504|NCT02229461|32571|P3|COMPLETED|Overall Study||17
13505|NCT02229461|32572|P2|COMPLETED|Overall Study||17
13506|NCT02229461|32573|P1|COMPLETED|Overall Study||17
13507|NCT02229461|32568|P6|STARTED|Overall Study|Randomized and received treatment|17
13508|NCT02229461|32569|P5|STARTED|Overall Study|Randomized and received treatment|17
13509|NCT02229461|32570|P4|STARTED|Overall Study|Randomized and received treatment|17
13510|NCT02229461|32571|P3|STARTED|Overall Study|Randomized and received treatment|17
13511|NCT02229461|32572|P2|STARTED|Overall Study|Randomized and received treatment|17
13512|NCT02229461|32573|P1|STARTED|Overall Study|Randomized and received treatment|17
13513|NCT02229318|32606|P1|NOT COMPLETED|Overall Study||0
13514|NCT02229318|32606|P1|COMPLETED|Overall Study|September 15th 2014 11 completed|11
13515|NCT02229318|32606|P1|STARTED|Overall Study|September 6th 2014 11 enrolled|11
13516|NCT02229214|32613|P2|NOT COMPLETED|Overall Study||0
13517|NCT02229214|32614|P1|NOT COMPLETED|Overall Study||6
13518|NCT02229214|32613|P2|COMPLETED|Overall Study||10
13519|NCT02229214|32614|P1|COMPLETED|Overall Study||35
13520|NCT02229214|32613|P2|STARTED|Overall Study||10
13521|NCT02229214|32614|P1|STARTED|Overall Study||41
13522|NCT02228980|32638|P4|NOT COMPLETED|Overall Study||3
13523|NCT02228980|32639|P3|NOT COMPLETED|Overall Study||2
13524|NCT02228980|32640|P2|NOT COMPLETED|Overall Study||3
13525|NCT02228980|32641|P1|NOT COMPLETED|Overall Study||24
13526|NCT02228980|32638|P4|COMPLETED|Overall Study||148
13527|NCT02228980|32639|P3|COMPLETED|Overall Study||149
13528|NCT02228980|32640|P2|COMPLETED|Overall Study||147
13529|NCT02228980|32641|P1|COMPLETED|Overall Study||126
13530|NCT02228980|32638|P4|STARTED|Overall Study||151
13531|NCT02228980|32639|P3|STARTED|Overall Study||151
13532|NCT02228980|32640|P2|STARTED|Overall Study||150
13533|NCT02228980|32641|P1|STARTED|Overall Study||150
13534|NCT02228720|32663|P1|NOT COMPLETED|Open Label - Day 90||0
13535|NCT02228720|32663|P1|COMPLETED|Open Label - Day 90||14
13536|NCT02228720|32663|P1|STARTED|Open Label - Day 90||14
13537|NCT02228720|32663|P1|NOT COMPLETED|Open Label - Day 30||1
13538|NCT02228720|32663|P1|COMPLETED|Open Label - Day 30||14
13539|NCT02228720|32663|P1|STARTED|Open Label - Day 30||15
13540|NCT02228720|32663|P1|NOT COMPLETED|Open Label - Baseline||0
13541|NCT02228720|32663|P1|COMPLETED|Open Label - Baseline||15
13542|NCT02228720|32663|P1|STARTED|Open Label - Baseline||15
13543|NCT02228395|32671|P3|NOT COMPLETED|Third Intervention Period||0
13544|NCT02228395|32672|P2|NOT COMPLETED|Third Intervention Period||0
13545|NCT02228395|32673|P1|NOT COMPLETED|Third Intervention Period||0
13546|NCT02228395|32671|P3|COMPLETED|Third Intervention Period||3
13547|NCT02228395|32672|P2|COMPLETED|Third Intervention Period||3
13548|NCT02228395|32673|P1|COMPLETED|Third Intervention Period||3
13549|NCT02228395|32671|P3|STARTED|Third Intervention Period||3
13550|NCT02228395|32672|P2|STARTED|Third Intervention Period||3
13551|NCT02228395|32673|P1|STARTED|Third Intervention Period||3
13552|NCT02228395|32671|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
13553|NCT02228395|32672|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
13554|NCT02228395|32673|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
13555|NCT02228395|32671|P3|COMPLETED|Washout Period (at Least 10 Days)||3
13556|NCT02228395|32672|P2|COMPLETED|Washout Period (at Least 10 Days)||3
13557|NCT02228395|32673|P1|COMPLETED|Washout Period (at Least 10 Days)||3
13558|NCT02228395|32671|P3|STARTED|Washout Period (at Least 10 Days)||3
13559|NCT02228395|32672|P2|STARTED|Washout Period (at Least 10 Days)||3
13560|NCT02228395|32673|P1|STARTED|Washout Period (at Least 10 Days)||3
13561|NCT02228395|32671|P3|NOT COMPLETED|Second Intervention Period||0
13562|NCT02228395|32672|P2|NOT COMPLETED|Second Intervention Period||0
13563|NCT02228395|32673|P1|NOT COMPLETED|Second Intervention Period||0
13564|NCT02228395|32671|P3|COMPLETED|Second Intervention Period||3
13565|NCT02228395|32672|P2|COMPLETED|Second Intervention Period||3
13566|NCT02228395|32673|P1|COMPLETED|Second Intervention Period||3
13567|NCT02228395|32671|P3|STARTED|Second Intervention Period||3
13568|NCT02228395|32672|P2|STARTED|Second Intervention Period||3
13569|NCT02228395|32673|P1|STARTED|Second Intervention Period||3
13570|NCT02228395|32671|P3|NOT COMPLETED|Washout Period (at Least 10 Days)||0
13571|NCT02228395|32672|P2|NOT COMPLETED|Washout Period (at Least 10 Days)||0
13572|NCT02228395|32673|P1|NOT COMPLETED|Washout Period (at Least 10 Days)||0
13573|NCT02228395|32671|P3|COMPLETED|Washout Period (at Least 10 Days)||3
13574|NCT02228395|32672|P2|COMPLETED|Washout Period (at Least 10 Days)||3
13575|NCT02228395|32673|P1|COMPLETED|Washout Period (at Least 10 Days)||3
13576|NCT02228395|32671|P3|STARTED|Washout Period (at Least 10 Days)||3
13577|NCT02228395|32672|P2|STARTED|Washout Period (at Least 10 Days)||3
13578|NCT02228395|32673|P1|STARTED|Washout Period (at Least 10 Days)||3
13579|NCT02228395|32671|P3|NOT COMPLETED|First Intervention Period||1
13580|NCT02228395|32672|P2|NOT COMPLETED|First Intervention Period||1
13581|NCT02228395|32673|P1|NOT COMPLETED|First Intervention Period||1
13582|NCT02228395|32671|P3|COMPLETED|First Intervention Period||2
13583|NCT02228395|32672|P2|COMPLETED|First Intervention Period||2
13584|NCT02228395|32673|P1|COMPLETED|First Intervention Period||2
13585|NCT02228395|32671|P3|STARTED|First Intervention Period||3
13586|NCT02228395|32672|P2|STARTED|First Intervention Period||3
13587|NCT02228395|32673|P1|STARTED|First Intervention Period||3
13588|NCT02227810|32739|P2|NOT COMPLETED|Overall Study||5
13589|NCT02227810|32740|P1|NOT COMPLETED|Overall Study||2
13590|NCT02227810|32739|P2|COMPLETED|Overall Study||29
13591|NCT02227810|32740|P1|COMPLETED|Overall Study||17
13592|NCT02227810|32739|P2|STARTED|Overall Study||34
13593|NCT02227810|32740|P1|STARTED|Overall Study||19
13594|NCT02227485|32754|P2|NOT COMPLETED|Second Follow-up||2
13595|NCT02227485|32755|P1|NOT COMPLETED|Second Follow-up||2
13596|NCT02227485|32754|P2|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|36
13597|NCT02227485|32755|P1|COMPLETED|Second Follow-up|At the second follow-up we lost 2 patients.|34
13598|NCT02227485|32754|P2|STARTED|Second Follow-up||38
13599|NCT02227485|32755|P1|STARTED|Second Follow-up||36
13600|NCT02227485|32754|P2|NOT COMPLETED|First Follow-up||2
13601|NCT02227485|32755|P1|NOT COMPLETED|First Follow-up||4
13602|NCT02227485|32754|P2|COMPLETED|First Follow-up|After 2 weeks, 2 patients had withdrew the study.|38
13603|NCT02227485|32755|P1|COMPLETED|First Follow-up|At the first follow-up we lost 4 patients.|36
13604|NCT02227485|32754|P2|STARTED|First Follow-up||40
13605|NCT02227485|32755|P1|STARTED|First Follow-up||40
13606|NCT02227368|32773|P2|NOT COMPLETED|Overall Study||4
13607|NCT02227368|32774|P1|NOT COMPLETED|Overall Study||2
13608|NCT02227368|32773|P2|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|20
13609|NCT02227368|32774|P1|COMPLETED|Overall Study|Subjects who discontinued treatment were encouraged to remain in the study.|14
13610|NCT02227368|32773|P2|Sujects Who Completed Treatment|Overall Study||17
13611|NCT02227368|32774|P1|Sujects Who Completed Treatment|Overall Study||10
13612|NCT02227368|32773|P2|Sujects Who Received Treatment|Overall Study||24
13613|NCT02227368|32774|P1|Sujects Who Received Treatment|Overall Study||16
13614|NCT02227368|32773|P2|STARTED|Overall Study||24
13615|NCT02227368|32774|P1|STARTED|Overall Study||16
13616|NCT02227121|32782|P1|NOT COMPLETED|Overall Study||0
13617|NCT02227121|32782|P1|COMPLETED|Overall Study||16
13618|NCT02227121|32782|P1|STARTED|Overall Study||16
13619|NCT02227108|32786|P1|NOT COMPLETED|Overall Study||31
13620|NCT02227108|32786|P1|COMPLETED|Overall Study||1
13621|NCT02227108|32786|P1|Treated|Overall Study||30
13622|NCT02227108|32786|P1|STARTED|Overall Study||32
13623|NCT02226562|32815|P2|NOT COMPLETED|Overall Study||1
13624|NCT02226562|32816|P1|NOT COMPLETED|Overall Study||0
13625|NCT02226562|32815|P2|COMPLETED|Overall Study|Lost to follow up|95
13626|NCT02226562|32816|P1|COMPLETED|Overall Study||95
13627|NCT02226562|32815|P2|STARTED|Overall Study||96
13628|NCT02226562|32816|P1|STARTED|Overall Study||95
13629|NCT02226549|32834|P2|NOT COMPLETED|Overall Study||1
13630|NCT02226549|32835|P1|NOT COMPLETED|Overall Study||1
13631|NCT02226549|32834|P2|COMPLETED|Overall Study||23
13632|NCT02226549|32835|P1|COMPLETED|Overall Study||22
13633|NCT02226549|32834|P2|STARTED|Overall Study||24
13634|NCT02226549|32835|P1|STARTED|Overall Study||23
13635|NCT02226198|32845|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
13636|NCT02226198|32846|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
13637|NCT02226198|32847|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||0
13638|NCT02226198|32845|P3|COMPLETED|Maintenance Phase (12 Weeks)||0
13639|NCT02226198|32846|P2|COMPLETED|Maintenance Phase (12 Weeks)||0
13640|NCT02226198|32847|P1|COMPLETED|Maintenance Phase (12 Weeks)||13
13641|NCT02226198|32845|P3|STARTED|Maintenance Phase (12 Weeks)||0
13642|NCT02226198|32846|P2|STARTED|Maintenance Phase (12 Weeks)||0
13643|NCT02226198|32847|P1|STARTED|Maintenance Phase (12 Weeks)||13
13644|NCT02226198|32845|P3|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
13645|NCT02226198|32846|P2|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
13646|NCT02226198|32847|P1|NOT COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
13647|NCT02226198|32845|P3|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||7
13648|NCT02226198|32846|P2|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||6
13649|NCT02226198|32847|P1|COMPLETED|Cross-Over: Second Interv. (6 Weeks)||0
13650|NCT02226198|32845|P3|STARTED|Cross-Over: Second Interv. (6 Weeks)||7
13651|NCT02226198|32846|P2|STARTED|Cross-Over: Second Interv. (6 Weeks)||6
13652|NCT02226198|32847|P1|STARTED|Cross-Over: Second Interv. (6 Weeks)||0
13653|NCT02226198|32845|P3|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
13654|NCT02226198|32846|P2|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||1
13655|NCT02226198|32847|P1|NOT COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
13656|NCT02226198|32845|P3|COMPLETED|Cross-Over: First Intervention (6 Weeks)||7
13657|NCT02226198|32846|P2|COMPLETED|Cross-Over: First Intervention (6 Weeks)||6
13658|NCT02226198|32847|P1|COMPLETED|Cross-Over: First Intervention (6 Weeks)||0
13659|NCT02226198|32845|P3|STARTED|Cross-Over: First Intervention (6 Weeks)||7
13660|NCT02226198|32846|P2|STARTED|Cross-Over: First Intervention (6 Weeks)||7
13661|NCT02226198|32847|P1|STARTED|Cross-Over: First Intervention (6 Weeks)||0
13662|NCT02226198|32845|P3|NOT COMPLETED|Lead-in Phase||0
13663|NCT02226198|32846|P2|NOT COMPLETED|Lead-in Phase||0
13664|NCT02226198|32847|P1|NOT COMPLETED|Lead-in Phase||1
13665|NCT02226198|32845|P3|COMPLETED|Lead-in Phase||0
13666|NCT02226198|32846|P2|COMPLETED|Lead-in Phase||0
13667|NCT02226198|32847|P1|COMPLETED|Lead-in Phase||10
13668|NCT02226198|32845|P3|STARTED|Lead-in Phase||0
13669|NCT02226198|32846|P2|STARTED|Lead-in Phase||0
13670|NCT02226198|32847|P1|STARTED|Lead-in Phase||11
13671|NCT02226003|32923|P3|NOT COMPLETED|Overall Study||6
13672|NCT02226003|32924|P2|NOT COMPLETED|Overall Study||1
13673|NCT02226003|32925|P1|NOT COMPLETED|Overall Study||2
13674|NCT02226003|32923|P3|COMPLETED|Overall Study||91
13675|NCT02226003|32924|P2|COMPLETED|Overall Study||95
13676|NCT02226003|32925|P1|COMPLETED|Overall Study||96
13677|NCT02226003|32923|P3|STARTED|Overall Study||97
13678|NCT02226003|32924|P2|STARTED|Overall Study||96
13679|NCT02226003|32925|P1|STARTED|Overall Study||98
13680|NCT02225860|32959|P2|NOT COMPLETED|Overall Study||0
13681|NCT02225860|32960|P1|NOT COMPLETED|Overall Study||1
13682|NCT02225860|32959|P2|COMPLETED|Overall Study||17
13683|NCT02225860|32960|P1|COMPLETED|Overall Study||16
13684|NCT02225860|32959|P2|STARTED|Overall Study||17
13685|NCT02225860|32960|P1|STARTED|Overall Study||17
13686|NCT02224820|32970|P1|NOT COMPLETED|Overall Study||0
13687|NCT02224820|32970|P1|COMPLETED|Overall Study|One patient did not receive full dose|8
13688|NCT02224820|32970|P1|STARTED|Overall Study||8
13689|NCT02224664|32978|P5|NOT COMPLETED|Dose Escalation Period (21 Days)||11
13690|NCT02224664|32979|P4|NOT COMPLETED|Dose Escalation Period (21 Days)||3
13691|NCT02224664|32980|P3|NOT COMPLETED|Dose Escalation Period (21 Days)||2
13692|NCT02224664|32981|P2|NOT COMPLETED|Dose Escalation Period (21 Days)||0
13693|NCT02224664|32982|P1|NOT COMPLETED|Dose Escalation Period (21 Days)||0
13694|NCT02224664|32978|P5|COMPLETED|Dose Escalation Period (21 Days)||8
13695|NCT02224664|32979|P4|COMPLETED|Dose Escalation Period (21 Days)||3
13696|NCT02224664|32980|P3|COMPLETED|Dose Escalation Period (21 Days)||9
13697|NCT02224664|32981|P2|COMPLETED|Dose Escalation Period (21 Days)||9
13698|NCT02224664|32982|P1|COMPLETED|Dose Escalation Period (21 Days)||0
13699|NCT02224664|32978|P5|STARTED|Dose Escalation Period (21 Days)||19
13700|NCT02224664|32979|P4|STARTED|Dose Escalation Period (21 Days)||6
13701|NCT02224664|32980|P3|STARTED|Dose Escalation Period (21 Days)||11
13702|NCT02224664|32981|P2|STARTED|Dose Escalation Period (21 Days)||9
13703|NCT02224664|32982|P1|STARTED|Dose Escalation Period (21 Days)||0
13704|NCT02224664|32978|P5|NOT COMPLETED|Lead-in Period (3 Days)||0
13705|NCT02224664|32979|P4|NOT COMPLETED|Lead-in Period (3 Days)||0
13706|NCT02224664|32980|P3|NOT COMPLETED|Lead-in Period (3 Days)||0
13707|NCT02224664|32981|P2|NOT COMPLETED|Lead-in Period (3 Days)||0
13708|NCT02224664|32982|P1|NOT COMPLETED|Lead-in Period (3 Days)||5
13709|NCT02224664|32978|P5|COMPLETED|Lead-in Period (3 Days)||0
13710|NCT02224664|32979|P4|COMPLETED|Lead-in Period (3 Days)||0
13711|NCT02224664|32980|P3|COMPLETED|Lead-in Period (3 Days)||0
13712|NCT02224664|32981|P2|COMPLETED|Lead-in Period (3 Days)||0
13713|NCT02224664|32982|P1|COMPLETED|Lead-in Period (3 Days)||45
13714|NCT02224664|32978|P5|STARTED|Lead-in Period (3 Days)||0
13715|NCT02224664|32979|P4|STARTED|Lead-in Period (3 Days)||0
13716|NCT02224664|32980|P3|STARTED|Lead-in Period (3 Days)||0
13717|NCT02224664|32981|P2|STARTED|Lead-in Period (3 Days)||0
13718|NCT02224664|32982|P1|STARTED|Lead-in Period (3 Days)||50
13719|NCT02224625|33062|P1|NOT COMPLETED|Sensitization||55
13720|NCT02224625|33062|P1|COMPLETED|Sensitization||194
13721|NCT02224625|33062|P1|STARTED|Sensitization|Subjects from Irritation study also participated in Sensitization Study|249
13722|NCT02224625|33062|P1|NOT COMPLETED|Irritation||6
13723|NCT02224625|33062|P1|COMPLETED|Irritation||33
13724|NCT02224625|33062|P1|STARTED|Irritation||39
13725|NCT02224508|33076|P2|NOT COMPLETED|Overall Study||0
13726|NCT02224508|33077|P1|NOT COMPLETED|Overall Study||0
13727|NCT02224508|33076|P2|COMPLETED|Overall Study||653
13728|NCT02224508|33077|P1|COMPLETED|Overall Study||935
13729|NCT02224508|33076|P2|STARTED|Overall Study|Number of patients surveyed in the control segment of the health plan (contracted care).|653
13730|NCT02224508|33077|P1|STARTED|Overall Study|Number of patients surveyed in intervention segment of the health plan (group practice).|935
13731|NCT02224404|33087|P1|NOT COMPLETED|Overall Study||0
13732|NCT02224404|33087|P1|COMPLETED|Overall Study||21
13733|NCT02224404|33087|P1|STARTED|Overall Study||21
13734|NCT02224053|33092|P1|NOT COMPLETED|AZD9291 Alone||0
13735|NCT02224053|33092|P1|COMPLETED|AZD9291 Alone||47
13736|NCT02224053|33092|P1|STARTED|AZD9291 Alone||47
13737|NCT02224053|33092|P1|NOT COMPLETED|AZD9291 and Omeprazole Co-administration||21
13738|NCT02224053|33092|P1|COMPLETED|AZD9291 and Omeprazole Co-administration||47
13739|NCT02224053|33092|P1|STARTED|AZD9291 and Omeprazole Co-administration||68
13740|NCT02223871|33124|P1|NOT COMPLETED|Overall Study||0
13741|NCT02223871|33124|P1|COMPLETED|Overall Study||8
13742|NCT02223871|33124|P1|STARTED|Overall Study||8
13743|NCT02223754|33138|P2|NOT COMPLETED|Period 2||3
13744|NCT02223754|33139|P1|NOT COMPLETED|Period 2||3
13745|NCT02223754|33138|P2|COMPLETED|Period 2||141
13746|NCT02223754|33139|P1|COMPLETED|Period 2||156
13747|NCT02223754|33138|P2|STARTED|Period 2||144
13748|NCT02223754|33139|P1|STARTED|Period 2||159
13749|NCT02223754|33138|P2|NOT COMPLETED|Period 1||15
13750|NCT02223754|33139|P1|NOT COMPLETED|Period 1||4
13751|NCT02223754|33138|P2|COMPLETED|Period 1||144
13752|NCT02223754|33139|P1|COMPLETED|Period 1||159
13753|NCT02223754|33138|P2|STARTED|Period 1||159
13754|NCT02223754|33139|P1|STARTED|Period 1||163
13755|NCT02223715|33159|P1|NOT COMPLETED|Overall Study||104
13756|NCT02223715|33159|P1|COMPLETED|Overall Study||496
13757|NCT02223715|33159|P1|STARTED|Overall Study||600
13758|NCT02223650|33168|P2|NOT COMPLETED|Overall Study||0
13759|NCT02223650|33169|P1|NOT COMPLETED|Overall Study||0
13760|NCT02223650|33168|P2|COMPLETED|Overall Study||31
13761|NCT02223650|33169|P1|COMPLETED|Overall Study||27
13762|NCT02223650|33168|P2|STARTED|Overall Study||31
13763|NCT02223650|33169|P1|STARTED|Overall Study||27
13764|NCT02223429|33203|P4|NOT COMPLETED|Overall Study||0
13765|NCT02223429|33204|P3|NOT COMPLETED|Overall Study||0
13766|NCT02223429|33205|P2|NOT COMPLETED|Overall Study||0
13767|NCT02223429|33206|P1|NOT COMPLETED|Overall Study||1
13768|NCT02223429|33203|P4|COMPLETED|Overall Study||8
13769|NCT02223429|33204|P3|COMPLETED|Overall Study||8
13770|NCT02223429|33205|P2|COMPLETED|Overall Study||8
13771|NCT02223429|33206|P1|COMPLETED|Overall Study||7
13772|NCT02223429|33203|P4|STARTED|Overall Study||8
13773|NCT02223429|33204|P3|STARTED|Overall Study||8
13774|NCT02223429|33205|P2|STARTED|Overall Study||8
13775|NCT02223429|33206|P1|STARTED|Overall Study||8
13785|NCT02223260|33289|P1|NOT COMPLETED|Overall Study||0
13786|NCT02223260|33289|P1|COMPLETED|Overall Study||8
13787|NCT02223260|33289|P1|STARTED|Overall Study||8
13788|NCT02223065|33307|P2|NOT COMPLETED|Overall Study||0
13789|NCT02223065|33308|P1|NOT COMPLETED|Overall Study||0
13790|NCT02223065|33307|P2|COMPLETED|Overall Study||18
13791|NCT02223065|33308|P1|COMPLETED|Overall Study||18
13792|NCT02223065|33307|P2|STARTED|Overall Study||18
13793|NCT02223065|33308|P1|STARTED|Overall Study||18
13794|NCT02222870|33326|P2|NOT COMPLETED|Overall Study||0
13795|NCT02222870|33327|P1|NOT COMPLETED|Overall Study||0
13796|NCT02222870|33326|P2|COMPLETED|Overall Study||30
13797|NCT02222870|33327|P1|COMPLETED|Overall Study||30
13798|NCT02222870|33326|P2|STARTED|Overall Study||30
13799|NCT02222870|33327|P1|STARTED|Overall Study||30
13800|NCT02222818|33343|P2|NOT COMPLETED|Period 2||0
13801|NCT02222818|33344|P1|NOT COMPLETED|Period 2||0
13802|NCT02222818|33343|P2|COMPLETED|Period 2|End of CAFR evaluation period|30
13803|NCT02222818|33344|P1|COMPLETED|Period 2|End of CAFRPlus evaluation period|33
13804|NCT02222818|33343|P2|STARTED|Period 2|Start of CAFR evaluation period|30
13805|NCT02222818|33344|P1|STARTED|Period 2|Start of CAFRPlus evaluation period|33
13806|NCT02222818|33343|P2|NOT COMPLETED|Period 1||3
13807|NCT02222818|33344|P1|NOT COMPLETED|Period 1||0
13808|NCT02222818|33343|P2|COMPLETED|Period 1|End of CAFRPlus evaluation period|30
13809|NCT02222818|33344|P1|COMPLETED|Period 1|End of CAFR evaluation period|33
13810|NCT02222818|33343|P2|STARTED|Period 1|Start of CAFRPlus evaluation period|33
13811|NCT02222818|33344|P1|STARTED|Period 1|Start of CAFR evaluation period|33
13812|NCT02222558|33351|P6|NOT COMPLETED|Period 3||1
13813|NCT02222558|33352|P5|NOT COMPLETED|Period 3||0
13814|NCT02222558|33353|P4|NOT COMPLETED|Period 3||0
13815|NCT02222558|33354|P3|NOT COMPLETED|Period 3||0
13816|NCT02222558|33355|P2|NOT COMPLETED|Period 3||0
13817|NCT02222558|33356|P1|NOT COMPLETED|Period 3||0
13818|NCT02222558|33351|P6|COMPLETED|Period 3||7
13819|NCT02222558|33352|P5|COMPLETED|Period 3||8
13820|NCT02222558|33353|P4|COMPLETED|Period 3||1
13821|NCT02222558|33354|P3|COMPLETED|Period 3||4
13822|NCT02222558|33355|P2|COMPLETED|Period 3||0
13823|NCT02222558|33356|P1|COMPLETED|Period 3||0
13824|NCT02222558|33351|P6|STARTED|Period 3||8
13825|NCT02222558|33352|P5|STARTED|Period 3||8
13826|NCT02222558|33353|P4|STARTED|Period 3||1
13827|NCT02222558|33354|P3|STARTED|Period 3||4
13828|NCT02222558|33355|P2|STARTED|Period 3||0
13829|NCT02222558|33356|P1|STARTED|Period 3||0
13830|NCT02222558|33351|P6|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13831|NCT02222558|33352|P5|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13832|NCT02222558|33353|P4|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13833|NCT02222558|33354|P3|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13834|NCT02222558|33355|P2|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13835|NCT02222558|33356|P1|NOT COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13836|NCT02222558|33351|P6|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13837|NCT02222558|33352|P5|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13838|NCT02222558|33353|P4|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13839|NCT02222558|33354|P3|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13840|NCT02222558|33355|P2|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||21
13841|NCT02222558|33356|P1|COMPLETED|Period 2: Two Times Daily Dosing 90 mg||0
13842|NCT02222558|33351|P6|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
13843|NCT02222558|33352|P5|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
13844|NCT02222558|33353|P4|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
13845|NCT02222558|33354|P3|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
13846|NCT02222558|33355|P2|STARTED|Period 2: Two Times Daily Dosing 90 mg||21
13847|NCT02222558|33356|P1|STARTED|Period 2: Two Times Daily Dosing 90 mg||0
13848|NCT02222558|33351|P6|NOT COMPLETED|Period 1: Single Dose||0
13849|NCT02222558|33352|P5|NOT COMPLETED|Period 1: Single Dose||0
13850|NCT02222558|33353|P4|NOT COMPLETED|Period 1: Single Dose||0
13851|NCT02222558|33354|P3|NOT COMPLETED|Period 1: Single Dose||0
13852|NCT02222558|33355|P2|NOT COMPLETED|Period 1: Single Dose||0
13853|NCT02222558|33356|P1|NOT COMPLETED|Period 1: Single Dose||4
13854|NCT02222558|33351|P6|COMPLETED|Period 1: Single Dose||0
13855|NCT02222558|33352|P5|COMPLETED|Period 1: Single Dose||0
13856|NCT02222558|33353|P4|COMPLETED|Period 1: Single Dose||0
13857|NCT02222558|33354|P3|COMPLETED|Period 1: Single Dose||0
13858|NCT02222558|33355|P2|COMPLETED|Period 1: Single Dose||0
13859|NCT02222558|33356|P1|COMPLETED|Period 1: Single Dose||21
13860|NCT02222558|33351|P6|STARTED|Period 1: Single Dose||0
13861|NCT02222558|33352|P5|STARTED|Period 1: Single Dose||0
13862|NCT02222558|33353|P4|STARTED|Period 1: Single Dose||0
13863|NCT02222558|33354|P3|STARTED|Period 1: Single Dose||0
13864|NCT02222558|33355|P2|STARTED|Period 1: Single Dose||0
13865|NCT02222558|33356|P1|STARTED|Period 1: Single Dose||25
13866|NCT02222246|33372|P2|NOT COMPLETED|Overall Study||27
13867|NCT02222246|33373|P1|NOT COMPLETED|Overall Study||27
13868|NCT02222246|33372|P2|COMPLETED|Overall Study||26
13869|NCT02222246|33373|P1|COMPLETED|Overall Study||26
13870|NCT02222246|33372|P2|STARTED|Overall Study||53
13871|NCT02222246|33373|P1|STARTED|Overall Study||53
13872|NCT02222207|33401|P1|NOT COMPLETED|Overall Study||4
13873|NCT02222207|33401|P1|COMPLETED|Overall Study||48
13874|NCT02222207|33401|P1|Treated and Valid for Full Analysis Set|Overall Study||51
13875|NCT02222207|33401|P1|STARTED|Overall Study||52
13876|NCT02222181|33408|P1|NOT COMPLETED|Overall Study||108
13877|NCT02222181|33408|P1|COMPLETED|Overall Study||55
13878|NCT02222181|33408|P1|STARTED|Overall Study||163
13879|NCT02222129|33420|P2|NOT COMPLETED|Overall Study||0
13880|NCT02222129|33421|P1|NOT COMPLETED|Overall Study||0
13881|NCT02222129|33420|P2|COMPLETED|Overall Study||106
13882|NCT02222129|33421|P1|COMPLETED|Overall Study||100
13883|NCT02222129|33420|P2|STARTED|Overall Study||106
13884|NCT02222129|33421|P1|STARTED|Overall Study||100
13885|NCT02221947|33429|P2|NOT COMPLETED|Overall Study||0
13886|NCT02221947|33430|P1|NOT COMPLETED|Overall Study||0
13887|NCT02221947|33429|P2|COMPLETED|Overall Study||3
13888|NCT02221947|33430|P1|COMPLETED|Overall Study||6
13889|NCT02221947|33429|P2|STARTED|Overall Study||3
13890|NCT02221947|33430|P1|STARTED|Overall Study||6
13891|NCT02221648|33438|P2|NOT COMPLETED|Overall Study||3
13892|NCT02221648|33439|P1|NOT COMPLETED|Overall Study||3
13893|NCT02221648|33438|P2|COMPLETED|Overall Study||18
13894|NCT02221648|33439|P1|COMPLETED|Overall Study||19
13895|NCT02221648|33438|P2|STARTED|Overall Study||21
13896|NCT02221648|33439|P1|STARTED|Overall Study||22
13897|NCT02221557|33449|P1|NOT COMPLETED|Overall Study||3
13898|NCT02221557|33449|P1|COMPLETED|Overall Study||5
13899|NCT02221557|33449|P1|STARTED|Overall Study||8
13900|NCT02220998|33455|P2|NOT COMPLETED|Overall Study||11
13901|NCT02220998|33456|P1|NOT COMPLETED|Overall Study||7
13902|NCT02220998|33455|P2|COMPLETED|Overall Study||123
13903|NCT02220998|33456|P1|COMPLETED|Overall Study||128
13904|NCT02220998|33455|P2|STARTED|Overall Study||134
13905|NCT02220998|33456|P1|STARTED|Overall Study||135
13906|NCT02220920|33474|P2|NOT COMPLETED|Overall Study||3
13907|NCT02220920|33475|P1|NOT COMPLETED|Overall Study||3
13908|NCT02220920|33474|P2|COMPLETED|Overall Study||67
13909|NCT02220920|33475|P1|COMPLETED|Overall Study||73
13910|NCT02220920|33474|P2|STARTED|Overall Study||70
13911|NCT02220920|33475|P1|STARTED|Overall Study||76
13912|NCT02220764|33491|P2|NOT COMPLETED|Overall Study||1
13913|NCT02220764|33492|P1|NOT COMPLETED|Overall Study||4
13914|NCT02220764|33491|P2|COMPLETED|Overall Study||7
13915|NCT02220764|33492|P1|COMPLETED|Overall Study||20
13916|NCT02220764|33491|P2|STARTED|Overall Study||8
13917|NCT02220764|33492|P1|STARTED|Overall Study||24
13918|NCT02220205|33504|P2|NOT COMPLETED|Overall Study||0
13919|NCT02220205|33505|P1|NOT COMPLETED|Overall Study||1
13920|NCT02220205|33504|P2|COMPLETED|Overall Study||30
13921|NCT02220205|33505|P1|COMPLETED|Overall Study||29
13922|NCT02220205|33504|P2|STARTED|Overall Study||30
13923|NCT02220205|33505|P1|STARTED|Overall Study||30
13924|NCT02219997|33515|P3|NOT COMPLETED|Second Filter||0
13925|NCT02219997|33516|P2|NOT COMPLETED|Second Filter||0
13926|NCT02219997|33517|P1|NOT COMPLETED|Second Filter||0
13927|NCT02219997|33515|P3|COMPLETED|Second Filter||18
13928|NCT02219997|33516|P2|COMPLETED|Second Filter||17
13929|NCT02219997|33517|P1|COMPLETED|Second Filter||0
13930|NCT02219997|33515|P3|STARTED|Second Filter||18
13931|NCT02219997|33516|P2|STARTED|Second Filter||17
13932|NCT02219997|33517|P1|STARTED|Second Filter||0
13933|NCT02219997|33515|P3|NOT COMPLETED|First Filter||0
13934|NCT02219997|33516|P2|NOT COMPLETED|First Filter||0
13935|NCT02219997|33517|P1|NOT COMPLETED|First Filter||0
13936|NCT02219997|33515|P3|COMPLETED|First Filter||18
13937|NCT02219997|33516|P2|COMPLETED|First Filter||17
13938|NCT02219997|33517|P1|COMPLETED|First Filter||33
13939|NCT02219997|33515|P3|STARTED|First Filter||18
13940|NCT02219997|33516|P2|STARTED|First Filter||17
13941|NCT02219997|33517|P1|STARTED|First Filter||33
13942|NCT02219932|33530|P2|NOT COMPLETED|Overall Study||51
13943|NCT02219932|33531|P1|NOT COMPLETED|Overall Study||65
13944|NCT02219932|33530|P2|COMPLETED|Overall Study||266
13945|NCT02219932|33531|P1|COMPLETED|Overall Study||254
13946|NCT02219932|33530|P2|Randomized, Not Treated|Overall Study||1
13947|NCT02219932|33531|P1|Randomized, Not Treated|Overall Study||0
13948|NCT02219932|33530|P2|STARTED|Overall Study||317
13949|NCT02219932|33531|P1|STARTED|Overall Study||319
13950|NCT02219685|33547|P2|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
13951|NCT02219685|33548|P1|NOT COMPLETED|Open-Label (After Posttreatment Week 4)||0
13952|NCT02219685|33547|P2|COMPLETED|Open-Label (After Posttreatment Week 4)||14
13953|NCT02219685|33548|P1|COMPLETED|Open-Label (After Posttreatment Week 4)||0
13954|NCT02219685|33547|P2|STARTED|Open-Label (After Posttreatment Week 4)||14
13955|NCT02219685|33548|P1|STARTED|Open-Label (After Posttreatment Week 4)|Only participants from the Placebo arm were eligible to enroll in the Open-Label Phase.|0
13956|NCT02219685|33547|P2|NOT COMPLETED|Blinded Treatment Phase||0
13957|NCT02219685|33548|P1|NOT COMPLETED|Blinded Treatment Phase||2
13958|NCT02219685|33547|P2|COMPLETED|Blinded Treatment Phase||14
13959|NCT02219685|33548|P1|COMPLETED|Blinded Treatment Phase||24
13960|NCT02219685|33547|P2|STARTED|Blinded Treatment Phase||14
13961|NCT02219685|33548|P1|STARTED|Blinded Treatment Phase||26
13962|NCT02219516|33596|P4|NOT COMPLETED|Overall Study||0
13963|NCT02219516|33597|P3|NOT COMPLETED|Overall Study||0
13964|NCT02219516|33598|P2|NOT COMPLETED|Overall Study||0
13965|NCT02219516|33599|P1|NOT COMPLETED|Overall Study||0
13966|NCT02219516|33596|P4|COMPLETED|Overall Study||8
13967|NCT02219516|33597|P3|COMPLETED|Overall Study||7
13968|NCT02219516|33598|P2|COMPLETED|Overall Study||8
13969|NCT02219516|33599|P1|COMPLETED|Overall Study||8
13970|NCT02219516|33596|P4|STARTED|Overall Study||8
13971|NCT02219516|33597|P3|STARTED|Overall Study||7
13972|NCT02219516|33598|P2|STARTED|Overall Study||8
13973|NCT02219516|33599|P1|STARTED|Overall Study||8
13974|NCT02219503|33645|P1|NOT COMPLETED|Overall Study||0
13975|NCT02219503|33645|P1|COMPLETED|Overall Study||60
13976|NCT02219503|33645|P1|STARTED|Overall Study||60
13977|NCT02219477|33654|P3|NOT COMPLETED|Overall Study||1
13978|NCT02219477|33655|P2|NOT COMPLETED|Overall Study||2
13979|NCT02219477|33656|P1|NOT COMPLETED|Overall Study||0
13980|NCT02219477|33654|P3|COMPLETED|Overall Study||2
13981|NCT02219477|33655|P2|COMPLETED|Overall Study||22
13982|NCT02219477|33656|P1|COMPLETED|Overall Study||9
13983|NCT02219477|33654|P3|STARTED|Overall Study||3
13984|NCT02219477|33655|P2|STARTED|Overall Study||24
13985|NCT02219477|33656|P1|STARTED|Overall Study||9
13986|NCT02219464|33684|P2|NOT COMPLETED|Overall Study||0
13987|NCT02219464|33685|P1|NOT COMPLETED|Overall Study||3
13988|NCT02219464|33684|P2|COMPLETED|Overall Study||30
13989|NCT02219464|33685|P1|COMPLETED|Overall Study||27
13990|NCT02219464|33684|P2|STARTED|Overall Study||30
13991|NCT02219464|33685|P1|STARTED|Overall Study||30
13992|NCT02219282|33695|P2|NOT COMPLETED|Overall Study||1
13993|NCT02219282|33696|P1|NOT COMPLETED|Overall Study||1
13994|NCT02219282|33695|P2|COMPLETED|Overall Study||32
13995|NCT02219282|33696|P1|COMPLETED|Overall Study||32
13996|NCT02219282|33695|P2|STARTED|Overall Study||33
13997|NCT02219282|33696|P1|STARTED|Overall Study||33
13998|NCT02219256|33722|P12|NOT COMPLETED|Overall Study||0
13999|NCT02219256|33723|P11|NOT COMPLETED|Overall Study||0
14000|NCT02219256|33724|P10|NOT COMPLETED|Overall Study||0
14001|NCT02219256|33725|P9|NOT COMPLETED|Overall Study||0
14002|NCT02219256|33726|P8|NOT COMPLETED|Overall Study||0
14003|NCT02219256|33727|P7|NOT COMPLETED|Overall Study||0
14004|NCT02219256|33728|P6|NOT COMPLETED|Overall Study||0
14005|NCT02219256|33729|P5|NOT COMPLETED|Overall Study||0
14006|NCT02219256|33730|P4|NOT COMPLETED|Overall Study||0
14007|NCT02219256|33731|P3|NOT COMPLETED|Overall Study||0
14008|NCT02219256|33732|P2|NOT COMPLETED|Overall Study||0
14009|NCT02219256|33733|P1|NOT COMPLETED|Overall Study||0
14010|NCT02219256|33722|P12|COMPLETED|Overall Study||6
14011|NCT02219256|33723|P11|COMPLETED|Overall Study||6
14012|NCT02219256|33724|P10|COMPLETED|Overall Study||6
14013|NCT02219256|33725|P9|COMPLETED|Overall Study||6
14014|NCT02219256|33726|P8|COMPLETED|Overall Study||8
14015|NCT02219256|33727|P7|COMPLETED|Overall Study||6
14016|NCT02219256|33728|P6|COMPLETED|Overall Study||6
14017|NCT02219256|33729|P5|COMPLETED|Overall Study||6
14018|NCT02219256|33730|P4|COMPLETED|Overall Study||4
14019|NCT02219256|33731|P3|COMPLETED|Overall Study||4
14020|NCT02219256|33732|P2|COMPLETED|Overall Study||4
14021|NCT02219256|33733|P1|COMPLETED|Overall Study||12
14022|NCT02219256|33722|P12|STARTED|Overall Study||6
14023|NCT02219256|33723|P11|STARTED|Overall Study||6
14024|NCT02219256|33724|P10|STARTED|Overall Study||6
14025|NCT02219256|33725|P9|STARTED|Overall Study||6
14026|NCT02219256|33726|P8|STARTED|Overall Study||8
14027|NCT02219256|33727|P7|STARTED|Overall Study||6
14028|NCT02219256|33728|P6|STARTED|Overall Study||6
14029|NCT02219256|33729|P5|STARTED|Overall Study||6
14030|NCT02219256|33730|P4|STARTED|Overall Study||4
14031|NCT02219256|33731|P3|STARTED|Overall Study||4
14032|NCT02219256|33732|P2|STARTED|Overall Study||4
14033|NCT02219256|33733|P1|STARTED|Overall Study||12
14034|NCT02218697|33845|P2|NOT COMPLETED|Overall Study||6
14035|NCT02218697|33846|P1|NOT COMPLETED|Overall Study||2
14036|NCT02218697|33845|P2|COMPLETED|Overall Study||171
14037|NCT02218697|33846|P1|COMPLETED|Overall Study||177
14038|NCT02218697|33845|P2|STARTED|Overall Study||177
14039|NCT02218697|33846|P1|STARTED|Overall Study||179
14040|NCT02218307|33886|P2|NOT COMPLETED|Overall Study||1
14041|NCT02218307|33887|P1|NOT COMPLETED|Overall Study||9
14042|NCT02218307|33886|P2|COMPLETED|Overall Study||33
14043|NCT02218307|33887|P1|COMPLETED|Overall Study||25
14044|NCT02218307|33886|P2|STARTED|Overall Study||34
14045|NCT02218307|33887|P1|STARTED|Overall Study||34
14046|NCT02218268|33895|P2|NOT COMPLETED|Final Phase (2 Hours)||0
14047|NCT02218268|33896|P1|NOT COMPLETED|Final Phase (2 Hours)||0
14048|NCT02218268|33895|P2|COMPLETED|Final Phase (2 Hours)||21
14049|NCT02218268|33896|P1|COMPLETED|Final Phase (2 Hours)||19
14050|NCT02218268|33895|P2|STARTED|Final Phase (2 Hours)||21
14051|NCT02218268|33896|P1|STARTED|Final Phase (2 Hours)||19
14052|NCT02218268|33895|P2|NOT COMPLETED|24 Hour Washout||9
14053|NCT02218268|33896|P1|NOT COMPLETED|24 Hour Washout||11
14054|NCT02218268|33895|P2|COMPLETED|24 Hour Washout||21
14055|NCT02218268|33896|P1|COMPLETED|24 Hour Washout||19
14056|NCT02218268|33895|P2|STARTED|24 Hour Washout||30
14057|NCT02218268|33896|P1|STARTED|24 Hour Washout||30
14058|NCT02218268|33895|P2|NOT COMPLETED|First Phase (2 Hours)||0
14059|NCT02218268|33896|P1|NOT COMPLETED|First Phase (2 Hours)||0
14060|NCT02218268|33895|P2|COMPLETED|First Phase (2 Hours)||30
14061|NCT02218268|33896|P1|COMPLETED|First Phase (2 Hours)||30
14062|NCT02218268|33895|P2|STARTED|First Phase (2 Hours)||30
14063|NCT02218268|33896|P1|STARTED|First Phase (2 Hours)||30
14064|NCT02218216|33904|P3|NOT COMPLETED|Overall Study||0
14065|NCT02218216|33905|P2|NOT COMPLETED|Overall Study||0
14066|NCT02218216|33906|P1|NOT COMPLETED|Overall Study||6
14067|NCT02218216|33904|P3|COMPLETED|Overall Study||3
14068|NCT02218216|33905|P2|COMPLETED|Overall Study||2
14069|NCT02218216|33906|P1|COMPLETED|Overall Study||8
14070|NCT02218216|33904|P3|STARTED|Overall Study||3
14071|NCT02218216|33905|P2|STARTED|Overall Study||2
14072|NCT02218216|33906|P1|STARTED|Overall Study||14
14073|NCT02217982|33916|P2|NOT COMPLETED|Overall Study||1
14074|NCT02217982|33917|P1|NOT COMPLETED|Overall Study||1
14075|NCT02217982|33916|P2|COMPLETED|Overall Study||3
14076|NCT02217982|33917|P1|COMPLETED|Overall Study|Trial closed before patient finished|0
14077|NCT02217982|33916|P2|STARTED|Overall Study||4
14078|NCT02217982|33917|P1|STARTED|Overall Study||1
14079|NCT02217878|33927|P2|NOT COMPLETED|Overall Study||2
14080|NCT02217878|33928|P1|NOT COMPLETED|Overall Study||2
14081|NCT02217878|33927|P2|COMPLETED|Overall Study||35
14082|NCT02217878|33928|P1|COMPLETED|Overall Study||35
14083|NCT02217878|33927|P2|STARTED|Overall Study||37
14084|NCT02217878|33928|P1|STARTED|Overall Study||37
14085|NCT02217280|34008|P1|NOT COMPLETED|Overall Study||4
14086|NCT02217280|34008|P1|COMPLETED|Overall Study||16
14087|NCT02217280|34008|P1|STARTED|Overall Study||20
14088|NCT02216695|34013|P1|NOT COMPLETED|Overall Study||0
14089|NCT02216695|34013|P1|COMPLETED|Overall Study|This is a database study and hence, 64882 patients were finally included|64882
14090|NCT02216695|34013|P1|STARTED|Overall Study||64882
14091|NCT02216591|34024|P2|NOT COMPLETED|Overall Study||1
14092|NCT02216591|34025|P1|NOT COMPLETED|Overall Study||0
14093|NCT02216591|34024|P2|COMPLETED|Overall Study||9
14094|NCT02216591|34025|P1|COMPLETED|Overall Study||11
14095|NCT02216591|34024|P2|STARTED|Overall Study||10
14096|NCT02216591|34025|P1|STARTED|Overall Study||11
14097|NCT02216422|34035|P1|NOT COMPLETED|Overall Study||0
14098|NCT02216422|34035|P1|COMPLETED|Overall Study||36
14099|NCT02216422|34035|P1|STARTED|Overall Study||36
14100|NCT02216357|34043|P2|NOT COMPLETED|Overall Study||1
14101|NCT02216357|34044|P1|NOT COMPLETED|Overall Study||2
14102|NCT02216357|34043|P2|COMPLETED|Overall Study||4
14103|NCT02216357|34044|P1|COMPLETED|Overall Study||12
14104|NCT02216357|34043|P2|STARTED|Overall Study||5
14105|NCT02216357|34044|P1|STARTED|Overall Study||14
14106|NCT02216097|34070|P2|NOT COMPLETED|Overall Study||0
14107|NCT02216097|34071|P1|NOT COMPLETED|Overall Study||0
14108|NCT02216097|34070|P2|COMPLETED|Overall Study||6
14109|NCT02216097|34071|P1|COMPLETED|Overall Study||8
14110|NCT02216097|34070|P2|STARTED|Overall Study||6
14111|NCT02216097|34071|P1|STARTED|Overall Study||8
14112|NCT02215954|34096|P3|NOT COMPLETED|Overall Study||6
14113|NCT02215954|34097|P2|NOT COMPLETED|Overall Study||1
14114|NCT02215954|34098|P1|NOT COMPLETED|Overall Study||1
14115|NCT02215954|34096|P3|COMPLETED|Overall Study||205
14116|NCT02215954|34097|P2|COMPLETED|Overall Study||211
14117|NCT02215954|34098|P1|COMPLETED|Overall Study||213
14118|NCT02215954|34096|P3|Safety Analysis Set|Overall Study||208
14119|NCT02215954|34097|P2|Safety Analysis Set|Overall Study||211
14120|NCT02215954|34098|P1|Safety Analysis Set|Overall Study||213
14121|NCT02215954|34096|P3|Per Protocol (PP) Analysis Set|Overall Study||205
14122|NCT02215954|34097|P2|Per Protocol (PP) Analysis Set|Overall Study||208
14123|NCT02215954|34098|P1|Per Protocol (PP) Analysis Set|Overall Study||212
14124|NCT02215954|34096|P3|Intention-To-Treat (ITT) Analysis Set|Overall Study||211
14125|NCT02215954|34097|P2|Intention-To-Treat (ITT) Analysis Set|Overall Study||212
14126|NCT02215954|34098|P1|Intention-To-Treat (ITT) Analysis Set|Overall Study||214
14127|NCT02215954|34096|P3|STARTED|Overall Study||211
14128|NCT02215954|34097|P2|STARTED|Overall Study||212
14129|NCT02215954|34098|P1|STARTED|Overall Study||214
14130|NCT02215252|34121|P3|NOT COMPLETED|Overall Study||4
14131|NCT02215252|34122|P2|NOT COMPLETED|Overall Study||8
14132|NCT02215252|34123|P1|NOT COMPLETED|Overall Study||2
14133|NCT02215252|34121|P3|COMPLETED|Overall Study||41
14134|NCT02215252|34122|P2|COMPLETED|Overall Study||38
14135|NCT02215252|34123|P1|COMPLETED|Overall Study||42
14136|NCT02215252|34121|P3|STARTED|Overall Study||45
14137|NCT02215252|34122|P2|STARTED|Overall Study||46
14138|NCT02215252|34123|P1|STARTED|Overall Study||44
14139|NCT02214615|34182|P2|NOT COMPLETED|Second Intervention||0
14140|NCT02214615|34183|P1|NOT COMPLETED|Second Intervention||0
14141|NCT02214615|34182|P2|COMPLETED|Second Intervention||1
14142|NCT02214615|34183|P1|COMPLETED|Second Intervention||1
14143|NCT02214615|34182|P2|STARTED|Second Intervention||1
14144|NCT02214615|34183|P1|STARTED|Second Intervention||1
14145|NCT02214615|34182|P2|NOT COMPLETED|Washout||0
14146|NCT02214615|34183|P1|NOT COMPLETED|Washout||0
14147|NCT02214615|34182|P2|COMPLETED|Washout||1
14148|NCT02214615|34183|P1|COMPLETED|Washout||1
14149|NCT02214615|34182|P2|STARTED|Washout||1
14150|NCT02214615|34183|P1|STARTED|Washout||1
14151|NCT02214615|34182|P2|NOT COMPLETED|First Intervention||0
14152|NCT02214615|34183|P1|NOT COMPLETED|First Intervention||0
14153|NCT02214615|34182|P2|COMPLETED|First Intervention||1
14154|NCT02214615|34183|P1|COMPLETED|First Intervention||1
14155|NCT02214615|34182|P2|STARTED|First Intervention||1
14156|NCT02214615|34183|P1|STARTED|First Intervention||1
14157|NCT02214238|34193|P2|NOT COMPLETED|Overall Study||6
14158|NCT02214238|34194|P1|NOT COMPLETED|Overall Study||6
14159|NCT02214238|34193|P2|COMPLETED|Overall Study||17
14160|NCT02214238|34194|P1|COMPLETED|Overall Study||20
14161|NCT02214238|34193|P2|STARTED|Overall Study||23
14162|NCT02214238|34194|P1|STARTED|Overall Study||26
14163|NCT02214225|34207|P3|NOT COMPLETED|Overall Study||22
14164|NCT02214225|34208|P2|NOT COMPLETED|Overall Study||19
14165|NCT02214225|34209|P1|NOT COMPLETED|Overall Study||55
14166|NCT02214225|34207|P3|COMPLETED|Overall Study||850
14167|NCT02214225|34208|P2|COMPLETED|Overall Study||852
14168|NCT02214225|34209|P1|COMPLETED|Overall Study||1686
14169|NCT02214225|34207|P3|STARTED|Overall Study||872
14170|NCT02214225|34208|P2|STARTED|Overall Study||871
14171|NCT02214225|34209|P1|STARTED|Overall Study||1741
14172|NCT02214186|34268|P2|NOT COMPLETED|Overall Study||2
14173|NCT02214186|34269|P1|NOT COMPLETED|Overall Study||2
14174|NCT02214186|34268|P2|COMPLETED|Overall Study||21
14175|NCT02214186|34269|P1|COMPLETED|Overall Study||21
14176|NCT02214186|34268|P2|STARTED|Overall Study||23
14177|NCT02214186|34269|P1|STARTED|Overall Study||23
14178|NCT02213900|34293|P2|NOT COMPLETED|Overall Study||0
14179|NCT02213900|34294|P1|NOT COMPLETED|Overall Study||0
14180|NCT02213900|34293|P2|COMPLETED|Overall Study||67
14181|NCT02213900|34294|P1|COMPLETED|Overall Study||68
14182|NCT02213900|34293|P2|STARTED|Overall Study||67
14183|NCT02213900|34294|P1|STARTED|Overall Study||68
14184|NCT02213666|34306|P1|NOT COMPLETED|Overall Study||1
14185|NCT02213666|34306|P1|COMPLETED|Overall Study||71
14186|NCT02213666|34306|P1|STARTED|Overall Study||72
14187|NCT02213510|34312|P2|NOT COMPLETED|Overall Study||1
14188|NCT02213510|34313|P1|NOT COMPLETED|Overall Study||1
14189|NCT02213510|34312|P2|COMPLETED|Overall Study||18
14190|NCT02213510|34313|P1|COMPLETED|Overall Study||20
14191|NCT02213510|34312|P2|STARTED|Overall Study||19
14192|NCT02213510|34313|P1|STARTED|Overall Study||21
14193|NCT02213250|34339|P2|NOT COMPLETED|Overall Study||0
14194|NCT02213250|34340|P1|NOT COMPLETED|Overall Study||0
14195|NCT02213250|34339|P2|COMPLETED|Overall Study||8
14196|NCT02213250|34340|P1|COMPLETED|Overall Study||4
14197|NCT02213250|34339|P2|STARTED|Overall Study||8
14198|NCT02213250|34340|P1|STARTED|Overall Study||4
14199|NCT02213198|34371|P2|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||7
14200|NCT02213198|34372|P1|NOT COMPLETED|Follow up 2 6 Months Post TCC Treatment||23
14201|NCT02213198|34371|P2|COMPLETED|Follow up 2 6 Months Post TCC Treatment||60
14202|NCT02213198|34372|P1|COMPLETED|Follow up 2 6 Months Post TCC Treatment||102
14203|NCT02213198|34371|P2|STARTED|Follow up 2 6 Months Post TCC Treatment||67
14204|NCT02213198|34372|P1|STARTED|Follow up 2 6 Months Post TCC Treatment||125
14205|NCT02213198|34371|P2|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||41
14206|NCT02213198|34372|P1|NOT COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||93
14207|NCT02213198|34371|P2|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||67
14208|NCT02213198|34372|P1|COMPLETED|Follow up 1 3 Mos Post BL End of TCC tx||125
14209|NCT02213198|34371|P2|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||108
14210|NCT02213198|34372|P1|STARTED|Follow up 1 3 Mos Post BL End of TCC tx||218
14211|NCT02213198|34371|P2|NOT COMPLETED|Baseline||51
14212|NCT02213198|34372|P1|NOT COMPLETED|Baseline||88
14213|NCT02213198|34371|P2|COMPLETED|Baseline||108
14214|NCT02213198|34372|P1|COMPLETED|Baseline||218
14215|NCT02213198|34371|P2|STARTED|Baseline||159
14216|NCT02213198|34372|P1|STARTED|Baseline||306
14217|NCT02213055|34382|P2|NOT COMPLETED|Overall Study||0
14218|NCT02213055|34383|P1|NOT COMPLETED|Overall Study||39
14219|NCT02213055|34382|P2|COMPLETED|Overall Study||0
14220|NCT02213055|34383|P1|COMPLETED|Overall Study||58
14221|NCT02213055|34382|P2|STARTED|Overall Study||0
14222|NCT02213055|34383|P1|STARTED|Overall Study||97
14223|NCT02212977|34391|P2|NOT COMPLETED|Overall Study||6
14224|NCT02212977|34392|P1|NOT COMPLETED|Overall Study||5
14225|NCT02212977|34391|P2|COMPLETED|Overall Study||48
14226|NCT02212977|34392|P1|COMPLETED|Overall Study||50
14227|NCT02212977|34391|P2|STARTED|Overall Study||54
14228|NCT02212977|34392|P1|STARTED|Overall Study||55
14229|NCT02212834|34408|P2|NOT COMPLETED|Overall Study||0
14230|NCT02212834|34409|P1|NOT COMPLETED|Overall Study||0
14231|NCT02212834|34408|P2|COMPLETED|Overall Study||2506
14232|NCT02212834|34409|P1|COMPLETED|Overall Study||33938
14233|NCT02212834|34408|P2|STARTED|Overall Study||2506
14234|NCT02212834|34409|P1|STARTED|Overall Study||33938
14235|NCT02212457|34421|P6|NOT COMPLETED|Overall Study||13
14236|NCT02212457|34422|P5|NOT COMPLETED|Overall Study||15
14237|NCT02212457|34423|P4|NOT COMPLETED|Overall Study||11
14238|NCT02212457|34424|P3|NOT COMPLETED|Overall Study||16
14239|NCT02212457|34425|P2|NOT COMPLETED|Overall Study||21
14240|NCT02212457|34426|P1|NOT COMPLETED|Overall Study||19
14241|NCT02212457|34421|P6|COMPLETED|Overall Study||147
14242|NCT02212457|34422|P5|COMPLETED|Overall Study||137
14243|NCT02212457|34423|P4|COMPLETED|Overall Study||123
14244|NCT02212457|34424|P3|COMPLETED|Overall Study||141
14245|NCT02212457|34425|P2|COMPLETED|Overall Study||211
14246|NCT02212457|34426|P1|COMPLETED|Overall Study||209
14247|NCT02212457|34421|P6|STARTED|Overall Study||160
14248|NCT02212457|34422|P5|STARTED|Overall Study||152
14249|NCT02212457|34423|P4|STARTED|Overall Study||134
14250|NCT02212457|34424|P3|STARTED|Overall Study||157
14251|NCT02212457|34425|P2|STARTED|Overall Study||232
14252|NCT02212457|34426|P1|STARTED|Overall Study||228
14253|NCT02212301|34464|P2|NOT COMPLETED|Period 2||0
14254|NCT02212301|34465|P1|NOT COMPLETED|Period 2||0
14255|NCT02212301|34464|P2|COMPLETED|Period 2||21
14256|NCT02212301|34465|P1|COMPLETED|Period 2||21
14257|NCT02212301|34464|P2|STARTED|Period 2||21
14258|NCT02212301|34465|P1|STARTED|Period 2||21
14259|NCT02212301|34464|P2|NOT COMPLETED|Period 1||1
14260|NCT02212301|34465|P1|NOT COMPLETED|Period 1||0
14261|NCT02212301|34464|P2|COMPLETED|Period 1||21
14262|NCT02212301|34465|P1|COMPLETED|Period 1||21
14263|NCT02212301|34464|P2|STARTED|Period 1||22
14264|NCT02212301|34465|P1|STARTED|Period 1||21
14265|NCT02212197|34476|P3|NOT COMPLETED|Overall Study||0
14266|NCT02212197|34477|P2|NOT COMPLETED|Overall Study||0
14267|NCT02212197|34478|P1|NOT COMPLETED|Overall Study||1
14268|NCT02212197|34476|P3|COMPLETED|Overall Study||17
14269|NCT02212197|34477|P2|COMPLETED|Overall Study||15
14270|NCT02212197|34478|P1|COMPLETED|Overall Study||18
14271|NCT02212197|34476|P3|STARTED|Overall Study||17
14272|NCT02212197|34477|P2|STARTED|Overall Study||15
14273|NCT02212197|34478|P1|STARTED|Overall Study||19
14274|NCT02212106|34503|P2|NOT COMPLETED|Overall Study||4
14275|NCT02212106|34504|P1|NOT COMPLETED|Overall Study||10
14276|NCT02212106|34503|P2|COMPLETED|Overall Study||96
14277|NCT02212106|34504|P1|COMPLETED|Overall Study||292
14278|NCT02212106|34503|P2|STARTED|Overall Study||100
14279|NCT02212106|34504|P1|STARTED|Overall Study||302
14280|NCT02212028|34522|P2|NOT COMPLETED|Overall Study||0
14281|NCT02212028|34523|P1|NOT COMPLETED|Overall Study||0
14282|NCT02212028|34522|P2|COMPLETED|Overall Study||26
14283|NCT02212028|34523|P1|COMPLETED|Overall Study||26
14284|NCT02212028|34522|P2|STARTED|Overall Study||26
14285|NCT02212028|34523|P1|STARTED|Overall Study||26
14286|NCT02210208|34531|P1|NOT COMPLETED|Overall Study||5
14287|NCT02210208|34531|P1|COMPLETED|Overall Study||23
14288|NCT02210208|34531|P1|STARTED|Overall Study||28
14289|NCT02210195|34537|P2|NOT COMPLETED|Overall Study||0
14290|NCT02210195|34538|P1|NOT COMPLETED|Overall Study||4
14291|NCT02210195|34537|P2|COMPLETED|Overall Study||10
14292|NCT02210195|34538|P1|COMPLETED|Overall Study||6
14293|NCT02210195|34537|P2|STARTED|Overall Study||10
14294|NCT02210195|34538|P1|STARTED|Overall Study||10
14295|NCT02210091|34548|P2|NOT COMPLETED|Overall Study||2
14296|NCT02210091|34549|P1|NOT COMPLETED|Overall Study||0
14297|NCT02210091|34548|P2|COMPLETED|Overall Study||32
14298|NCT02210091|34549|P1|COMPLETED|Overall Study||32
14299|NCT02210091|34548|P2|STARTED|Overall Study||34
14300|NCT02210091|34549|P1|STARTED|Overall Study||32
14301|NCT02210052|34621|P1|NOT COMPLETED|Overall Study||0
14302|NCT02210052|34621|P1|COMPLETED|Overall Study||6
14303|NCT02210052|34621|P1|STARTED|Overall Study||6
14304|NCT02209766|34629|P5|NOT COMPLETED|Overall Study||0
14305|NCT02209766|34630|P4|NOT COMPLETED|Overall Study||1
14306|NCT02209766|34631|P3|NOT COMPLETED|Overall Study||0
14307|NCT02209766|34632|P2|NOT COMPLETED|Overall Study||0
14308|NCT02209766|34633|P1|NOT COMPLETED|Overall Study||0
14309|NCT02209766|34629|P5|COMPLETED|Overall Study||6
14310|NCT02209766|34630|P4|COMPLETED|Overall Study||2
14311|NCT02209766|34631|P3|COMPLETED|Overall Study||6
14312|NCT02209766|34632|P2|COMPLETED|Overall Study||3
14313|NCT02209766|34633|P1|COMPLETED|Overall Study||6
14314|NCT02209766|34629|P5|STARTED|Overall Study||6
14315|NCT02209766|34630|P4|STARTED|Overall Study||3
14316|NCT02209766|34631|P3|STARTED|Overall Study||6
14317|NCT02209766|34632|P2|STARTED|Overall Study||3
14318|NCT02209766|34633|P1|STARTED|Overall Study||6
14319|NCT02209506|34684|P5|NOT COMPLETED|Overall Study||1
14320|NCT02209506|34685|P4|NOT COMPLETED|Overall Study||0
14321|NCT02209506|34686|P3|NOT COMPLETED|Overall Study||0
14322|NCT02209506|34687|P2|NOT COMPLETED|Overall Study||0
14323|NCT02209506|34688|P1|NOT COMPLETED|Overall Study||0
14324|NCT02209506|34684|P5|COMPLETED|Overall Study||5
14325|NCT02209506|34685|P4|COMPLETED|Overall Study||2
14326|NCT02209506|34686|P3|COMPLETED|Overall Study||6
14327|NCT02209506|34687|P2|COMPLETED|Overall Study||6
14328|NCT02209506|34688|P1|COMPLETED|Overall Study||3
14329|NCT02209506|34684|P5|STARTED|Overall Study||6
14330|NCT02209506|34685|P4|STARTED|Overall Study||2
14331|NCT02209506|34686|P3|STARTED|Overall Study||6
14332|NCT02209506|34687|P2|STARTED|Overall Study||6
14333|NCT02209506|34688|P1|STARTED|Overall Study||3
14334|NCT02209454|34763|P2|NOT COMPLETED|Second Period||0
14335|NCT02209454|34764|P1|NOT COMPLETED|Second Period||1
14336|NCT02209454|34763|P2|COMPLETED|Second Period||13
14337|NCT02209454|34764|P1|COMPLETED|Second Period||12
14338|NCT02209454|34763|P2|STARTED|Second Period||13
14339|NCT02209454|34764|P1|STARTED|Second Period||13
14340|NCT02209454|34763|P2|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
14341|NCT02209454|34764|P1|NOT COMPLETED|Washout Period a Minimum of a 7 Day||0
14342|NCT02209454|34763|P2|COMPLETED|Washout Period a Minimum of a 7 Day||13
14343|NCT02209454|34764|P1|COMPLETED|Washout Period a Minimum of a 7 Day||13
14344|NCT02209454|34763|P2|STARTED|Washout Period a Minimum of a 7 Day||13
14345|NCT02209454|34764|P1|STARTED|Washout Period a Minimum of a 7 Day||13
14346|NCT02209454|34763|P2|NOT COMPLETED|First Period||0
14347|NCT02209454|34764|P1|NOT COMPLETED|First Period||0
14348|NCT02209454|34763|P2|COMPLETED|First Period||13
14349|NCT02209454|34764|P1|COMPLETED|First Period||13
14350|NCT02209454|34763|P2|STARTED|First Period||13
14351|NCT02209454|34764|P1|STARTED|First Period||13
14352|NCT02209181|34782|P4|NOT COMPLETED|Overall Study||0
14353|NCT02209181|34783|P3|NOT COMPLETED|Overall Study||1
14354|NCT02209181|34784|P2|NOT COMPLETED|Overall Study||1
14355|NCT02209181|34785|P1|NOT COMPLETED|Overall Study||1
14356|NCT02209181|34782|P4|COMPLETED|Overall Study||66
14357|NCT02209181|34783|P3|COMPLETED|Overall Study||68
14358|NCT02209181|34784|P2|COMPLETED|Overall Study||66
14359|NCT02209181|34785|P1|COMPLETED|Overall Study||66
14360|NCT02209181|34782|P4|STARTED|Overall Study||66
14361|NCT02209181|34783|P3|STARTED|Overall Study||69
14362|NCT02209181|34784|P2|STARTED|Overall Study||67
14363|NCT02209181|34785|P1|STARTED|Overall Study||67
14364|NCT02209064|34947|P1|NOT COMPLETED|Overall Study||0
14365|NCT02209064|34947|P1|COMPLETED|Overall Study||25
14366|NCT02209064|34947|P1|STARTED|Overall Study||25
14367|NCT02207907|34956|P2|NOT COMPLETED|Overall Study||8
14368|NCT02207907|34957|P1|NOT COMPLETED|Overall Study||11
14369|NCT02207907|34956|P2|COMPLETED|Overall Study||115
14370|NCT02207907|34957|P1|COMPLETED|Overall Study||113
14371|NCT02207907|34956|P2|STARTED|Overall Study||123
14372|NCT02207907|34957|P1|STARTED|Overall Study||124
14373|NCT02207829|34975|P2|NOT COMPLETED|Overall Study||34
14374|NCT02207829|34976|P1|NOT COMPLETED|Overall Study||42
14375|NCT02207829|34975|P2|COMPLETED|Overall Study||474
14376|NCT02207829|34976|P1|COMPLETED|Overall Study||467
14377|NCT02207829|34975|P2|STARTED|Overall Study||508
14378|NCT02207829|34976|P1|STARTED|Overall Study||509
14379|NCT02207608|34984|P2|NOT COMPLETED|Overall Study||0
14380|NCT02207608|34985|P1|NOT COMPLETED|Overall Study||1
14381|NCT02207608|34984|P2|COMPLETED|Overall Study||15
14382|NCT02207608|34985|P1|COMPLETED|Overall Study||14
14383|NCT02207608|34984|P2|STARTED|Overall Study||15
14384|NCT02207608|34985|P1|STARTED|Overall Study||15
14385|NCT02207478|34993|P2|NOT COMPLETED|Overall Study||0
14386|NCT02207478|34994|P1|NOT COMPLETED|Overall Study||0
14387|NCT02207478|34993|P2|COMPLETED|Overall Study||46
14388|NCT02207478|34994|P1|COMPLETED|Overall Study||40
14389|NCT02207478|34993|P2|STARTED|Overall Study||46
14390|NCT02207478|34994|P1|STARTED|Overall Study||40
14391|NCT02207413|35008|P6|NOT COMPLETED|Overall Study||13
14392|NCT02207413|35009|P5|NOT COMPLETED|Overall Study||7
14393|NCT02207413|35010|P4|NOT COMPLETED|Overall Study||1
14394|NCT02207413|35011|P3|NOT COMPLETED|Overall Study||0
14395|NCT02207413|35012|P2|NOT COMPLETED|Overall Study||0
14396|NCT02207413|35013|P1|NOT COMPLETED|Overall Study||1
14397|NCT02207413|35008|P6|COMPLETED|Overall Study|Primed subjects: 41; Unprimed subjects: 420|461
14398|NCT02207413|35009|P5|COMPLETED|Overall Study|Primed subjects: 40; Unprimed subjects: 419|459
14399|NCT02207413|35010|P4|COMPLETED|Overall Study|Primed subjects: 312; Unprimed subjects: 98|410
14400|NCT02207413|35011|P3|COMPLETED|Overall Study|Primed subjects: 309; Unprimed subjects: 101|410
14401|NCT02207413|35012|P2|COMPLETED|Overall Study||60
14402|NCT02207413|35013|P1|COMPLETED|Overall Study||59
14403|NCT02207413|35008|P6|STARTED|Overall Study||474
14404|NCT02207413|35009|P5|STARTED|Overall Study||466
14405|NCT02207413|35010|P4|STARTED|Overall Study||411
14406|NCT02207413|35011|P3|STARTED|Overall Study||410
14407|NCT02207413|35012|P2|STARTED|Overall Study||60
14408|NCT02207413|35013|P1|STARTED|Overall Study||60
14409|NCT02207400|35109|P2|NOT COMPLETED|Overall Study||14
14410|NCT02207400|35110|P1|NOT COMPLETED|Overall Study||16
14411|NCT02207400|35109|P2|COMPLETED|Overall Study||109
14412|NCT02207400|35110|P1|COMPLETED|Overall Study||107
14413|NCT02207400|35109|P2|STARTED|Overall Study||123
14414|NCT02207400|35110|P1|STARTED|Overall Study||123
14415|NCT02206776|35130|P2|NOT COMPLETED|Overall Study||0
14416|NCT02206776|35131|P1|NOT COMPLETED|Overall Study||0
14417|NCT02206776|35130|P2|COMPLETED|Overall Study||1
14418|NCT02206776|35131|P1|COMPLETED|Overall Study||1
14419|NCT02206776|35130|P2|STARTED|Overall Study||1
14420|NCT02206776|35131|P1|STARTED|Overall Study||1
14421|NCT02206607|35137|P5|NOT COMPLETED|Fourth Intervention Period||0
14422|NCT02206607|35138|P4|NOT COMPLETED|Fourth Intervention Period||0
14423|NCT02206607|35139|P3|NOT COMPLETED|Fourth Intervention Period||0
14424|NCT02206607|35140|P2|NOT COMPLETED|Fourth Intervention Period||0
14425|NCT02206607|35141|P1|NOT COMPLETED|Fourth Intervention Period||0
14426|NCT02206607|35137|P5|COMPLETED|Fourth Intervention Period||10
14427|NCT02206607|35138|P4|COMPLETED|Fourth Intervention Period||10
14428|NCT02206607|35139|P3|COMPLETED|Fourth Intervention Period||9
14429|NCT02206607|35140|P2|COMPLETED|Fourth Intervention Period||9
14430|NCT02206607|35141|P1|COMPLETED|Fourth Intervention Period||0
14431|NCT02206607|35137|P5|STARTED|Fourth Intervention Period||10
14432|NCT02206607|35138|P4|STARTED|Fourth Intervention Period||10
14433|NCT02206607|35139|P3|STARTED|Fourth Intervention Period||9
14434|NCT02206607|35140|P2|STARTED|Fourth Intervention Period||9
14435|NCT02206607|35141|P1|STARTED|Fourth Intervention Period||0
14436|NCT02206607|35137|P5|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
14437|NCT02206607|35138|P4|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
14438|NCT02206607|35139|P3|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
14439|NCT02206607|35140|P2|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
14440|NCT02206607|35141|P1|NOT COMPLETED|Third Washout Period 5 to 10 Days||0
14441|NCT02206607|35137|P5|COMPLETED|Third Washout Period 5 to 10 Days||10
14442|NCT02206607|35138|P4|COMPLETED|Third Washout Period 5 to 10 Days||10
14443|NCT02206607|35139|P3|COMPLETED|Third Washout Period 5 to 10 Days||9
14444|NCT02206607|35140|P2|COMPLETED|Third Washout Period 5 to 10 Days||9
14445|NCT02206607|35141|P1|COMPLETED|Third Washout Period 5 to 10 Days||0
14446|NCT02206607|35137|P5|STARTED|Third Washout Period 5 to 10 Days||10
14447|NCT02206607|35138|P4|STARTED|Third Washout Period 5 to 10 Days||10
14448|NCT02206607|35139|P3|STARTED|Third Washout Period 5 to 10 Days||9
14449|NCT02206607|35140|P2|STARTED|Third Washout Period 5 to 10 Days||9
14450|NCT02206607|35141|P1|STARTED|Third Washout Period 5 to 10 Days||0
14451|NCT02206607|35137|P5|NOT COMPLETED|Third Intervention Period||0
14452|NCT02206607|35138|P4|NOT COMPLETED|Third Intervention Period||0
14453|NCT02206607|35139|P3|NOT COMPLETED|Third Intervention Period||0
14454|NCT02206607|35140|P2|NOT COMPLETED|Third Intervention Period||0
14455|NCT02206607|35141|P1|NOT COMPLETED|Third Intervention Period||0
14456|NCT02206607|35137|P5|COMPLETED|Third Intervention Period||10
14457|NCT02206607|35138|P4|COMPLETED|Third Intervention Period||10
14458|NCT02206607|35139|P3|COMPLETED|Third Intervention Period||9
14459|NCT02206607|35140|P2|COMPLETED|Third Intervention Period||9
14460|NCT02206607|35141|P1|COMPLETED|Third Intervention Period||0
14461|NCT02206607|35137|P5|STARTED|Third Intervention Period||10
14462|NCT02206607|35138|P4|STARTED|Third Intervention Period||10
14463|NCT02206607|35139|P3|STARTED|Third Intervention Period||9
14464|NCT02206607|35140|P2|STARTED|Third Intervention Period||9
14465|NCT02206607|35141|P1|STARTED|Third Intervention Period||0
14466|NCT02206607|35137|P5|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
14467|NCT02206607|35138|P4|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
14468|NCT02206607|35139|P3|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
14469|NCT02206607|35140|P2|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
14470|NCT02206607|35141|P1|NOT COMPLETED|Second Washout Period 5 to 10 Days||0
14471|NCT02206607|35137|P5|COMPLETED|Second Washout Period 5 to 10 Days||10
14472|NCT02206607|35138|P4|COMPLETED|Second Washout Period 5 to 10 Days||10
14473|NCT02206607|35139|P3|COMPLETED|Second Washout Period 5 to 10 Days||9
14474|NCT02206607|35140|P2|COMPLETED|Second Washout Period 5 to 10 Days||9
14475|NCT02206607|35141|P1|COMPLETED|Second Washout Period 5 to 10 Days||0
14476|NCT02206607|35137|P5|STARTED|Second Washout Period 5 to 10 Days||10
14477|NCT02206607|35138|P4|STARTED|Second Washout Period 5 to 10 Days||10
14478|NCT02206607|35139|P3|STARTED|Second Washout Period 5 to 10 Days||9
14479|NCT02206607|35140|P2|STARTED|Second Washout Period 5 to 10 Days||9
14480|NCT02206607|35141|P1|STARTED|Second Washout Period 5 to 10 Days||0
14481|NCT02206607|35137|P5|NOT COMPLETED|Second Intervention Period||0
14482|NCT02206607|35138|P4|NOT COMPLETED|Second Intervention Period||1
14483|NCT02206607|35139|P3|NOT COMPLETED|Second Intervention Period||0
14484|NCT02206607|35140|P2|NOT COMPLETED|Second Intervention Period||0
14485|NCT02206607|35141|P1|NOT COMPLETED|Second Intervention Period||0
14486|NCT02206607|35137|P5|COMPLETED|Second Intervention Period||10
14487|NCT02206607|35138|P4|COMPLETED|Second Intervention Period||10
14488|NCT02206607|35139|P3|COMPLETED|Second Intervention Period||9
14489|NCT02206607|35140|P2|COMPLETED|Second Intervention Period||9
14490|NCT02206607|35141|P1|COMPLETED|Second Intervention Period||0
14491|NCT02206607|35137|P5|STARTED|Second Intervention Period||10
14492|NCT02206607|35138|P4|STARTED|Second Intervention Period||11
14493|NCT02206607|35139|P3|STARTED|Second Intervention Period||9
14494|NCT02206607|35140|P2|STARTED|Second Intervention Period||9
14495|NCT02206607|35141|P1|STARTED|Second Intervention Period||0
14496|NCT02206607|35137|P5|NOT COMPLETED|First Washout Period 5 to 10 Days||0
14497|NCT02206607|35138|P4|NOT COMPLETED|First Washout Period 5 to 10 Days||0
14498|NCT02206607|35139|P3|NOT COMPLETED|First Washout Period 5 to 10 Days||0
14499|NCT02206607|35140|P2|NOT COMPLETED|First Washout Period 5 to 10 Days||0
14500|NCT02206607|35141|P1|NOT COMPLETED|First Washout Period 5 to 10 Days||0
14501|NCT02206607|35137|P5|COMPLETED|First Washout Period 5 to 10 Days||10
14502|NCT02206607|35138|P4|COMPLETED|First Washout Period 5 to 10 Days||11
14503|NCT02206607|35139|P3|COMPLETED|First Washout Period 5 to 10 Days||9
14504|NCT02206607|35140|P2|COMPLETED|First Washout Period 5 to 10 Days||9
14505|NCT02206607|35141|P1|COMPLETED|First Washout Period 5 to 10 Days||0
14506|NCT02206607|35137|P5|STARTED|First Washout Period 5 to 10 Days||10
14507|NCT02206607|35138|P4|STARTED|First Washout Period 5 to 10 Days||11
14508|NCT02206607|35139|P3|STARTED|First Washout Period 5 to 10 Days||9
14509|NCT02206607|35140|P2|STARTED|First Washout Period 5 to 10 Days||9
14510|NCT02206607|35141|P1|STARTED|First Washout Period 5 to 10 Days||0
14511|NCT02206607|35137|P5|NOT COMPLETED|First Intervention Period||0
14512|NCT02206607|35138|P4|NOT COMPLETED|First Intervention Period||0
14513|NCT02206607|35139|P3|NOT COMPLETED|First Intervention Period||0
14514|NCT02206607|35140|P2|NOT COMPLETED|First Intervention Period||0
14515|NCT02206607|35141|P1|NOT COMPLETED|First Intervention Period||0
14516|NCT02206607|35137|P5|COMPLETED|First Intervention Period||10
14517|NCT02206607|35138|P4|COMPLETED|First Intervention Period||11
14518|NCT02206607|35139|P3|COMPLETED|First Intervention Period||9
14519|NCT02206607|35140|P2|COMPLETED|First Intervention Period||9
14520|NCT02206607|35141|P1|COMPLETED|First Intervention Period||0
14521|NCT02206607|35137|P5|STARTED|First Intervention Period||10
14522|NCT02206607|35138|P4|STARTED|First Intervention Period||11
14523|NCT02206607|35139|P3|STARTED|First Intervention Period||9
14524|NCT02206607|35140|P2|STARTED|First Intervention Period||9
14525|NCT02206607|35141|P1|STARTED|First Intervention Period||0
14526|NCT02206607|35137|P5|NOT COMPLETED|Open-Label Run-In||0
14527|NCT02206607|35138|P4|NOT COMPLETED|Open-Label Run-In||0
14528|NCT02206607|35139|P3|NOT COMPLETED|Open-Label Run-In||0
14529|NCT02206607|35140|P2|NOT COMPLETED|Open-Label Run-In||0
14530|NCT02206607|35141|P1|NOT COMPLETED|Open-Label Run-In||3
14531|NCT02206607|35137|P5|COMPLETED|Open-Label Run-In||0
14532|NCT02206607|35138|P4|COMPLETED|Open-Label Run-In||0
14533|NCT02206607|35139|P3|COMPLETED|Open-Label Run-In||0
14534|NCT02206607|35140|P2|COMPLETED|Open-Label Run-In||0
14535|NCT02206607|35141|P1|COMPLETED|Open-Label Run-In||39
14536|NCT02206607|35137|P5|STARTED|Open-Label Run-In||0
14537|NCT02206607|35138|P4|STARTED|Open-Label Run-In||0
14538|NCT02206607|35139|P3|STARTED|Open-Label Run-In||0
14539|NCT02206607|35140|P2|STARTED|Open-Label Run-In||0
14540|NCT02206607|35141|P1|STARTED|Open-Label Run-In||42
14541|NCT02205814|35197|P4|NOT COMPLETED|Overall Study||4
14542|NCT02205814|35198|P3|NOT COMPLETED|Overall Study||5
14543|NCT02205814|35199|P2|NOT COMPLETED|Overall Study||1
14544|NCT02205814|35200|P1|NOT COMPLETED|Overall Study||2
14545|NCT02205814|35197|P4|COMPLETED|Overall Study||104
14546|NCT02205814|35198|P3|COMPLETED|Overall Study||103
14547|NCT02205814|35199|P2|COMPLETED|Overall Study||109
14548|NCT02205814|35200|P1|COMPLETED|Overall Study||108
14549|NCT02205814|35197|P4|STARTED|Overall Study||108
14550|NCT02205814|35198|P3|STARTED|Overall Study||108
14551|NCT02205814|35199|P2|STARTED|Overall Study||110
14552|NCT02205814|35200|P1|STARTED|Overall Study||110
14553|NCT02205476|35224|P2|NOT COMPLETED|Overall Study||3
14554|NCT02205476|35225|P1|NOT COMPLETED|Overall Study||7
14555|NCT02205476|35224|P2|COMPLETED|Overall Study||0
14556|NCT02205476|35225|P1|COMPLETED|Overall Study||0
14557|NCT02205476|35224|P2|STARTED|Overall Study||3
14558|NCT02205476|35225|P1|STARTED|Overall Study||7
14559|NCT02205333|35264|P9|NOT COMPLETED|Overall Study||0
14560|NCT02205333|35265|P8|NOT COMPLETED|Overall Study||2
14561|NCT02205333|35266|P7|NOT COMPLETED|Overall Study||5
14562|NCT02205333|35267|P6|NOT COMPLETED|Overall Study||3
14563|NCT02205333|35268|P5|NOT COMPLETED|Overall Study||5
14564|NCT02205333|35269|P4|NOT COMPLETED|Overall Study||7
14565|NCT02205333|35270|P3|NOT COMPLETED|Overall Study||2
14566|NCT02205333|35271|P2|NOT COMPLETED|Overall Study||6
14567|NCT02205333|35272|P1|NOT COMPLETED|Overall Study||6
14568|NCT02205333|35264|P9|COMPLETED|Overall Study||1
14569|NCT02205333|35265|P8|COMPLETED|Overall Study||1
14570|NCT02205333|35266|P7|COMPLETED|Overall Study||2
14571|NCT02205333|35267|P6|COMPLETED|Overall Study||4
14572|NCT02205333|35268|P5|COMPLETED|Overall Study||1
14573|NCT02205333|35269|P4|COMPLETED|Overall Study||0
14574|NCT02205333|35270|P3|COMPLETED|Overall Study||1
14575|NCT02205333|35271|P2|COMPLETED|Overall Study||0
14576|NCT02205333|35272|P1|COMPLETED|Overall Study||2
14577|NCT02205333|35264|P9|STARTED|Overall Study||1
14578|NCT02205333|35265|P8|STARTED|Overall Study||3
14579|NCT02205333|35266|P7|STARTED|Overall Study||7
14580|NCT02205333|35267|P6|STARTED|Overall Study||7
14581|NCT02205333|35268|P5|STARTED|Overall Study||6
14582|NCT02205333|35269|P4|STARTED|Overall Study||7
14583|NCT02205333|35270|P3|STARTED|Overall Study||3
14584|NCT02205333|35271|P2|STARTED|Overall Study||6
14585|NCT02205333|35272|P1|STARTED|Overall Study||8
14586|NCT02204748|35445|P1|NOT COMPLETED|Overall Study||0
14587|NCT02204748|35445|P1|COMPLETED|Overall Study||5
14588|NCT02204748|35445|P1|STARTED|Overall Study||5
14589|NCT02204657|35459|P2|NOT COMPLETED|Overall Study||0
14590|NCT02204657|35460|P1|NOT COMPLETED|Overall Study||7
14591|NCT02204657|35459|P2|COMPLETED|Overall Study||25
14592|NCT02204657|35460|P1|COMPLETED|Overall Study||25
14593|NCT02204657|35459|P2|STARTED|Overall Study||25
14594|NCT02204657|35460|P1|STARTED|Overall Study||32
14595|NCT02204579|35468|P1|NOT COMPLETED|Overall Study||2
14596|NCT02204579|35468|P1|COMPLETED|Overall Study||5
14597|NCT02204579|35468|P1|Treated|Overall Study||5
14598|NCT02204579|35468|P1|Participants Started in Post-Amendment|Overall Study|Two participants from pre-amendment were re-enrolled with different identification numbers.|5
14599|NCT02204579|35468|P1|Participants Started in Pre-Amendment|Overall Study|Two participants completed treatment in pre-amendment and were re-enrolled in post-amendment.|2
14600|NCT02204579|35468|P1|STARTED|Overall Study||7
14601|NCT02204449|35522|P2|NOT COMPLETED|Overall Study||11
14602|NCT02204449|35523|P1|NOT COMPLETED|Overall Study||7
14603|NCT02204449|35522|P2|COMPLETED|Overall Study||37
14604|NCT02204449|35523|P1|COMPLETED|Overall Study||39
14605|NCT02204449|35522|P2|STARTED|Overall Study||48
14606|NCT02204449|35523|P1|STARTED|Overall Study||46
14607|NCT02204410|35533|P1|NOT COMPLETED|Overall Study||11
14608|NCT02204410|35533|P1|COMPLETED|Overall Study||10
14609|NCT02204410|35533|P1|STARTED|Overall Study||21
14610|NCT02204371|35538|P1|NOT COMPLETED|Overall Study||1
14611|NCT02204371|35538|P1|COMPLETED|Overall Study||6
14612|NCT02204371|35538|P1|STARTED|Overall Study||7
14613|NCT02204319|35561|P1|NOT COMPLETED|Overall Study||3
14614|NCT02204319|35561|P1|COMPLETED|Overall Study|3 did not complete study.|7
14615|NCT02204319|35561|P1|STARTED|Overall Study||10
14616|NCT02204007|35569|P2|NOT COMPLETED|Overall Study||1
14617|NCT02204007|35570|P1|NOT COMPLETED|Overall Study||1
14618|NCT02204007|35569|P2|COMPLETED|Overall Study||17
14619|NCT02204007|35570|P1|COMPLETED|Overall Study||17
14620|NCT02204007|35569|P2|STARTED|Overall Study||18
14621|NCT02204007|35570|P1|STARTED|Overall Study||18
14622|NCT02203916|35581|P3|NOT COMPLETED|Overall Study||11
14623|NCT02203916|35582|P2|NOT COMPLETED|Overall Study||10
14624|NCT02203916|35583|P1|NOT COMPLETED|Overall Study||8
14625|NCT02203916|35581|P3|COMPLETED|Overall Study||120
14626|NCT02203916|35582|P2|COMPLETED|Overall Study||122
14627|NCT02203916|35583|P1|COMPLETED|Overall Study||57
14628|NCT02203916|35581|P3|Safety Analysis Set (SAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the SAS.|130
14629|NCT02203916|35582|P2|Safety Analysis Set (SAS)|Overall Study||132
14630|NCT02203916|35583|P1|Safety Analysis Set (SAS)|Overall Study||65
14631|NCT02203916|35581|P3|Full Analysis Set (FAS)|Overall Study|1 participant was randomized twice, counted once in randomized set, and excluded from the FAS.|130
14632|NCT02203916|35582|P2|Full Analysis Set (FAS)|Overall Study||132
14633|NCT02203916|35583|P1|Full Analysis Set (FAS)|Overall Study||65
14634|NCT02203916|35581|P3|STARTED|Overall Study|1 participant was randomized twice and counted only once.|131
14635|NCT02203916|35582|P2|STARTED|Overall Study||132
14636|NCT02203916|35583|P1|STARTED|Overall Study||65
14637|NCT02203786|35607|P4|NOT COMPLETED|Overall Study||0
14638|NCT02203786|35608|P3|NOT COMPLETED|Overall Study||2
14639|NCT02203786|35609|P2|NOT COMPLETED|Overall Study||0
14640|NCT02203786|35610|P1|NOT COMPLETED|Overall Study||0
14641|NCT02203786|35607|P4|COMPLETED|Overall Study||15
14642|NCT02203786|35608|P3|COMPLETED|Overall Study||15
14643|NCT02203786|35609|P2|COMPLETED|Overall Study||15
14644|NCT02203786|35610|P1|COMPLETED|Overall Study||15
14645|NCT02203786|35607|P4|STARTED|Overall Study||15
14646|NCT02203786|35608|P3|STARTED|Overall Study||17
14647|NCT02203786|35609|P2|STARTED|Overall Study||15
14648|NCT02203786|35610|P1|STARTED|Overall Study||15
14649|NCT02203747|35642|P2|NOT COMPLETED|Overall Study||0
14650|NCT02203747|35643|P1|NOT COMPLETED|Overall Study||0
14651|NCT02203747|35642|P2|COMPLETED|Overall Study||34
14652|NCT02203747|35643|P1|COMPLETED|Overall Study||45
14653|NCT02203747|35642|P2|STARTED|Overall Study||34
14654|NCT02203747|35643|P1|STARTED|Overall Study||45
14655|NCT02203721|35653|P2|NOT COMPLETED|Overall Study||3
14656|NCT02203721|35654|P1|NOT COMPLETED|Overall Study||1
14657|NCT02203721|35653|P2|COMPLETED|Overall Study||148
14658|NCT02203721|35654|P1|COMPLETED|Overall Study||147
14659|NCT02203721|35653|P2|STARTED|Overall Study||151
14660|NCT02203721|35654|P1|STARTED|Overall Study||148
14661|NCT02203578|35662|P1|NOT COMPLETED|Overall Study||0
14662|NCT02203578|35662|P1|COMPLETED|Overall Study||1
14663|NCT02203578|35662|P1|STARTED|Overall Study||1
14664|NCT02203565|35674|P1|NOT COMPLETED|Overall Study||1
14665|NCT02203565|35674|P1|COMPLETED|Overall Study||19
14666|NCT02203565|35674|P1|STARTED|Overall Study||20
14667|NCT02203162|35678|P1|NOT COMPLETED|Overall Study||0
14668|NCT02203162|35678|P1|COMPLETED|Overall Study||30
14669|NCT02203162|35678|P1|STARTED|Overall Study||30
14670|NCT02203149|35687|P5|NOT COMPLETED|Part 2||1
14671|NCT02203149|35688|P4|NOT COMPLETED|Part 2||3
14672|NCT02203149|35689|P3|NOT COMPLETED|Part 2||1
14673|NCT02203149|35690|P2|NOT COMPLETED|Part 2||0
14674|NCT02203149|35691|P1|NOT COMPLETED|Part 2||0
14675|NCT02203149|35687|P5|COMPLETED|Part 2||34
14676|NCT02203149|35688|P4|COMPLETED|Part 2||71
14677|NCT02203149|35689|P3|COMPLETED|Part 2||226
14678|NCT02203149|35690|P2|COMPLETED|Part 2||0
14679|NCT02203149|35691|P1|COMPLETED|Part 2||0
14680|NCT02203149|35687|P5|Started Deferred Active Treatment|Part 2||0
14681|NCT02203149|35688|P4|Started Deferred Active Treatment|Part 2|1 participant in Deferred Treatment Arm receiving Placebo did not receive Deferred Active Treatment.|73
14682|NCT02203149|35689|P3|Started Deferred Active Treatment|Part 2||0
14683|NCT02203149|35690|P2|Started Deferred Active Treatment|Part 2||0
14684|NCT02203149|35691|P1|Started Deferred Active Treatment|Part 2||0
14685|NCT02203149|35687|P5|STARTED|Part 2||35
14686|NCT02203149|35688|P4|STARTED|Part 2||74
14687|NCT02203149|35689|P3|STARTED|Part 2||227
14688|NCT02203149|35690|P2|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
14689|NCT02203149|35691|P1|STARTED|Part 2|Participants of Part 1 did not enter Part 2|0
14690|NCT02203149|35687|P5|NOT COMPLETED|Part 1||0
14691|NCT02203149|35688|P4|NOT COMPLETED|Part 1||0
14692|NCT02203149|35689|P3|NOT COMPLETED|Part 1||0
14693|NCT02203149|35690|P2|NOT COMPLETED|Part 1||1
14694|NCT02203149|35691|P1|NOT COMPLETED|Part 1||0
14695|NCT02203149|35687|P5|COMPLETED|Part 1||0
14696|NCT02203149|35688|P4|COMPLETED|Part 1||0
14697|NCT02203149|35689|P3|COMPLETED|Part 1||0
14698|NCT02203149|35690|P2|COMPLETED|Part 1||31
14699|NCT02203149|35691|P1|COMPLETED|Part 1||31
14700|NCT02203149|35687|P5|STARTED|Part 1||0
14701|NCT02203149|35688|P4|STARTED|Part 1||0
14702|NCT02203149|35689|P3|STARTED|Part 1||0
14703|NCT02203149|35690|P2|STARTED|Part 1||32
14704|NCT02203149|35691|P1|STARTED|Part 1||31
14705|NCT02203032|35724|P4|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||46
14706|NCT02203032|35725|P3|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||26
14707|NCT02203032|35726|P2|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||15
14708|NCT02203032|35727|P1|NOT COMPLETED|Blinded Phase (Week 16 to Week 44)||0
14709|NCT02203032|35724|P4|COMPLETED|Blinded Phase (Week 16 to Week 44)||539
14710|NCT02203032|35725|P3|COMPLETED|Blinded Phase (Week 16 to Week 44)||107
14711|NCT02203032|35726|P2|COMPLETED|Blinded Phase (Week 16 to Week 44)||120
14712|NCT02203032|35727|P1|COMPLETED|Blinded Phase (Week 16 to Week 44)||0
14713|NCT02203032|35724|P4|STARTED|Blinded Phase (Week 16 to Week 44)||585
14714|NCT02203032|35725|P3|STARTED|Blinded Phase (Week 16 to Week 44)||133
14715|NCT02203032|35726|P2|STARTED|Blinded Phase (Week 16 to Week 44)||135
14716|NCT02203032|35727|P1|STARTED|Blinded Phase (Week 16 to Week 44)||0
14717|NCT02203032|35724|P4|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
14718|NCT02203032|35725|P3|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
14719|NCT02203032|35726|P2|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
14720|NCT02203032|35727|P1|NOT COMPLETED|Open Label Run-in (Week 0 to Week 16)||18
14721|NCT02203032|35724|P4|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
14722|NCT02203032|35725|P3|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
14723|NCT02203032|35726|P2|COMPLETED|Open Label Run-in (Week 0 to Week 16)||0
14724|NCT02203032|35727|P1|COMPLETED|Open Label Run-in (Week 0 to Week 16)||853
14725|NCT02203032|35724|P4|STARTED|Open Label Run-in (Week 0 to Week 16)||0
14726|NCT02203032|35725|P3|STARTED|Open Label Run-in (Week 0 to Week 16)||0
14727|NCT02203032|35726|P2|STARTED|Open Label Run-in (Week 0 to Week 16)||0
14728|NCT02203032|35727|P1|STARTED|Open Label Run-in (Week 0 to Week 16)||871
14729|NCT02202785|35744|P3|NOT COMPLETED|Overall Study||17
14730|NCT02202785|35745|P2|NOT COMPLETED|Overall Study||15
14731|NCT02202785|35746|P1|NOT COMPLETED|Overall Study||11
14732|NCT02202785|35744|P3|COMPLETED|Overall Study||0
14733|NCT02202785|35745|P2|COMPLETED|Overall Study||0
14734|NCT02202785|35746|P1|COMPLETED|Overall Study||0
14735|NCT02202785|35744|P3|STARTED|Overall Study||17
14736|NCT02202785|35745|P2|STARTED|Overall Study||15
14737|NCT02202785|35746|P1|STARTED|Overall Study||11
14738|NCT02202759|35783|P3|NOT COMPLETED|Overall Study||14
14739|NCT02202759|35784|P2|NOT COMPLETED|Overall Study||15
14740|NCT02202759|35785|P1|NOT COMPLETED|Overall Study||9
14741|NCT02202759|35783|P3|COMPLETED|Overall Study||0
14742|NCT02202759|35784|P2|COMPLETED|Overall Study||0
14743|NCT02202759|35785|P1|COMPLETED|Overall Study||0
14744|NCT02202759|35783|P3|STARTED|Overall Study||14
14745|NCT02202759|35784|P2|STARTED|Overall Study||15
14746|NCT02202759|35785|P1|STARTED|Overall Study||9
14747|NCT02202538|35819|P1|NOT COMPLETED|Overall Study||8
14748|NCT02202538|35819|P1|COMPLETED|Overall Study||45
14749|NCT02202538|35819|P1|Screen Failure|Overall Study||2
14750|NCT02202538|35819|P1|STARTED|Overall Study||53
14751|NCT02202252|35832|P2|NOT COMPLETED|Overall Study||0
14752|NCT02202252|35833|P1|NOT COMPLETED|Overall Study||0
14753|NCT02202252|35832|P2|COMPLETED|Overall Study||30
14754|NCT02202252|35833|P1|COMPLETED|Overall Study||30
14755|NCT02202252|35832|P2|STARTED|Overall Study||30
14756|NCT02202252|35833|P1|STARTED|Overall Study||30
14757|NCT02202135|35843|P1|NOT COMPLETED|Overall Study||0
14758|NCT02202135|35843|P1|COMPLETED|Overall Study||4
14759|NCT02202135|35843|P1|STARTED|Overall Study||4
14760|NCT02201953|35849|P2|NOT COMPLETED|Overall Study||56
14761|NCT02201953|35850|P1|NOT COMPLETED|Overall Study||20
14762|NCT02201953|35849|P2|COMPLETED|Overall Study||224
14763|NCT02201953|35850|P1|COMPLETED|Overall Study||258
14764|NCT02201953|35849|P2|STARTED|Overall Study||280
14765|NCT02201953|35850|P1|STARTED|Overall Study||278
14766|NCT02201940|35868|P2|NOT COMPLETED|Overall Study||116
14767|NCT02201940|35869|P1|NOT COMPLETED|Overall Study||12
14768|NCT02201940|35868|P2|COMPLETED|Overall Study||0
14769|NCT02201940|35869|P1|COMPLETED|Overall Study||613
14770|NCT02201940|35868|P2|STARTED|Overall Study||116
14771|NCT02201940|35869|P1|STARTED|Overall Study||625
14772|NCT02201901|35888|P3|NOT COMPLETED|Overall Study||13
14773|NCT02201901|35889|P2|NOT COMPLETED|Overall Study||9
14774|NCT02201901|35890|P1|NOT COMPLETED|Overall Study||15
14775|NCT02201901|35888|P3|COMPLETED|Overall Study||77
14776|NCT02201901|35889|P2|COMPLETED|Overall Study||79
14777|NCT02201901|35890|P1|COMPLETED|Overall Study||75
14778|NCT02201901|35888|P3|STARTED|Overall Study||90
14779|NCT02201901|35889|P2|STARTED|Overall Study||88
14780|NCT02201901|35890|P1|STARTED|Overall Study||90
14781|NCT02201784|35921|P2|NOT COMPLETED|Overall Study||0
14782|NCT02201784|35922|P1|NOT COMPLETED|Overall Study||2
14783|NCT02201784|35921|P2|COMPLETED|Overall Study||30
14784|NCT02201784|35922|P1|COMPLETED|Overall Study||28
14785|NCT02201784|35921|P2|STARTED|Overall Study||30
14786|NCT02201784|35922|P1|STARTED|Overall Study||30
14787|NCT02201524|35940|P4|NOT COMPLETED|Overall Study||4
14788|NCT02201524|35941|P3|NOT COMPLETED|Overall Study||4
14789|NCT02201524|35942|P2|NOT COMPLETED|Overall Study||3
14790|NCT02201524|35943|P1|NOT COMPLETED|Overall Study||2
14791|NCT02201524|35940|P4|COMPLETED|Overall Study||10
14792|NCT02201524|35941|P3|COMPLETED|Overall Study||12
14793|NCT02201524|35942|P2|COMPLETED|Overall Study||12
14794|NCT02201524|35943|P1|COMPLETED|Overall Study||12
14795|NCT02201524|35940|P4|STARTED|Overall Study||14
14796|NCT02201524|35941|P3|STARTED|Overall Study||16
14797|NCT02201524|35942|P2|STARTED|Overall Study||15
14798|NCT02201524|35943|P1|STARTED|Overall Study||14
14799|NCT02201446|36027|P2|NOT COMPLETED|Overall Study||0
14800|NCT02201446|36028|P1|NOT COMPLETED|Overall Study||0
14801|NCT02201446|36027|P2|COMPLETED|Overall Study||58
14802|NCT02201446|36028|P1|COMPLETED|Overall Study||81
14803|NCT02201446|36027|P2|STARTED|Overall Study||58
14804|NCT02201446|36028|P1|STARTED|Overall Study||81
14805|NCT02201420|36056|P1|NOT COMPLETED|Overall Study||0
14806|NCT02201420|36056|P1|COMPLETED|Overall Study||5
14807|NCT02201420|36056|P1|STARTED|Overall Study||5
14808|NCT02201056|36068|P7|NOT COMPLETED|Overall Study||0
14809|NCT02201056|36069|P6|NOT COMPLETED|Overall Study||0
14810|NCT02201056|36070|P5|NOT COMPLETED|Overall Study||0
14811|NCT02201056|36071|P4|NOT COMPLETED|Overall Study||0
14812|NCT02201056|36072|P3|NOT COMPLETED|Overall Study||0
14813|NCT02201056|36073|P2|NOT COMPLETED|Overall Study||0
14814|NCT02201056|36074|P1|NOT COMPLETED|Overall Study||0
14815|NCT02201056|36068|P7|COMPLETED|Overall Study||6
14816|NCT02201056|36069|P6|COMPLETED|Overall Study||6
14817|NCT02201056|36070|P5|COMPLETED|Overall Study||6
14818|NCT02201056|36071|P4|COMPLETED|Overall Study||6
14819|NCT02201056|36072|P3|COMPLETED|Overall Study||6
14820|NCT02201056|36073|P2|COMPLETED|Overall Study||6
14821|NCT02201056|36074|P1|COMPLETED|Overall Study||12
14822|NCT02201056|36068|P7|STARTED|Overall Study||6
14823|NCT02201056|36069|P6|STARTED|Overall Study||6
14824|NCT02201056|36070|P5|STARTED|Overall Study||6
14825|NCT02201056|36071|P4|STARTED|Overall Study||6
14826|NCT02201056|36072|P3|STARTED|Overall Study||6
14827|NCT02201056|36073|P2|STARTED|Overall Study||6
14828|NCT02201056|36074|P1|STARTED|Overall Study||12
14829|NCT02200536|36132|P3|NOT COMPLETED|Overall Study||0
14830|NCT02200536|36133|P2|NOT COMPLETED|Overall Study||0
14831|NCT02200536|36134|P1|NOT COMPLETED|Overall Study||0
14832|NCT02200536|36132|P3|COMPLETED|Overall Study||30
14833|NCT02200536|36133|P2|COMPLETED|Overall Study||30
14834|NCT02200536|36134|P1|COMPLETED|Overall Study||32
14835|NCT02200536|36132|P3|STARTED|Overall Study||30
14836|NCT02200536|36133|P2|STARTED|Overall Study||30
14837|NCT02200536|36134|P1|STARTED|Overall Study||32
14838|NCT02200458|36145|P1|NOT COMPLETED|Overall Study||0
14839|NCT02200458|36145|P1|COMPLETED|Overall Study||62
14840|NCT02200458|36145|P1|STARTED|Overall Study||62
14841|NCT02200328|36151|P2|NOT COMPLETED|Overall Study||33
14842|NCT02200328|36152|P1|NOT COMPLETED|Overall Study||43
14843|NCT02200328|36151|P2|COMPLETED|Overall Study||0
14844|NCT02200328|36152|P1|COMPLETED|Overall Study||0
14845|NCT02200328|36151|P2|STARTED|Overall Study||33
14846|NCT02200328|36152|P1|STARTED|Overall Study||43
14847|NCT02199717|36160|P1|NOT COMPLETED|Overall Study||0
14848|NCT02199717|36160|P1|COMPLETED|Overall Study||66
14849|NCT02199717|36160|P1|STARTED|Overall Study||66
14850|NCT02199574|36167|P1|NOT COMPLETED|Overall Study||0
14851|NCT02199574|36167|P1|COMPLETED|Overall Study||12
14852|NCT02199574|36167|P1|STARTED|Overall Study||12
14853|NCT02199509|36176|P2|NOT COMPLETED|Overall Study||1
14854|NCT02199509|36177|P1|NOT COMPLETED|Overall Study||1
14855|NCT02199509|36176|P2|COMPLETED|Overall Study||3
14856|NCT02199509|36177|P1|COMPLETED|Overall Study||2
14857|NCT02199509|36176|P2|STARTED|Overall Study||4
14858|NCT02199509|36177|P1|STARTED|Overall Study||3
14859|NCT02198963|36189|P1|NOT COMPLETED|Overall Study||7
14860|NCT02198963|36189|P1|COMPLETED|Overall Study||36
14861|NCT02198963|36189|P1|STARTED|Overall Study||43
14862|NCT02198833|36200|P2|NOT COMPLETED|Overall Study||0
14863|NCT02198833|36201|P1|NOT COMPLETED|Overall Study||0
14864|NCT02198833|36200|P2|COMPLETED|Overall Study||1
14865|NCT02198833|36201|P1|COMPLETED|Overall Study||1
14866|NCT02198833|36200|P2|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed.|1
14867|NCT02198833|36201|P1|STARTED|Overall Study|Unable to clear urine of bacteria for all but one patient therefore catheter not placed|1
14868|NCT02198430|36215|P2|NOT COMPLETED|Overall Study||0
14869|NCT02198430|36216|P1|NOT COMPLETED|Overall Study||0
14870|NCT02198430|36215|P2|COMPLETED|Overall Study||51
14871|NCT02198430|36216|P1|COMPLETED|Overall Study||53
14872|NCT02198430|36215|P2|STARTED|Overall Study||51
14873|NCT02198430|36216|P1|STARTED|Overall Study||53
14874|NCT02198235|36231|P3|NOT COMPLETED|Overall Study||2
14875|NCT02198235|36232|P2|NOT COMPLETED|Overall Study||2
14876|NCT02198235|36233|P1|NOT COMPLETED|Overall Study||3
14877|NCT02198235|36231|P3|COMPLETED|Overall Study||28
14878|NCT02198235|36232|P2|COMPLETED|Overall Study||28
14879|NCT02198235|36233|P1|COMPLETED|Overall Study||27
14880|NCT02198235|36231|P3|STARTED|Overall Study||30
14881|NCT02198235|36232|P2|STARTED|Overall Study||30
14882|NCT02198235|36233|P1|STARTED|Overall Study||30
14883|NCT02198040|36253|P3|NOT COMPLETED|Overall Study||1
14884|NCT02198040|36254|P2|NOT COMPLETED|Overall Study||1
14885|NCT02198040|36255|P1|NOT COMPLETED|Overall Study||0
14886|NCT02198040|36253|P3|COMPLETED|Overall Study||8
14887|NCT02198040|36254|P2|COMPLETED|Overall Study||8
14888|NCT02198040|36255|P1|COMPLETED|Overall Study||9
14889|NCT02198040|36253|P3|STARTED|Overall Study||9
14890|NCT02198040|36254|P2|STARTED|Overall Study||9
14891|NCT02198040|36255|P1|STARTED|Overall Study||9
14892|NCT02197806|36285|P4|NOT COMPLETED|Overall Study||1
14893|NCT02197806|36286|P3|NOT COMPLETED|Overall Study||0
14894|NCT02197806|36287|P2|NOT COMPLETED|Overall Study||1
14895|NCT02197806|36288|P1|NOT COMPLETED|Overall Study||0
14896|NCT02197806|36285|P4|COMPLETED|Overall Study||16
14897|NCT02197806|36286|P3|COMPLETED|Overall Study||16
14898|NCT02197806|36287|P2|COMPLETED|Overall Study||16
14899|NCT02197806|36288|P1|COMPLETED|Overall Study||15
14900|NCT02197806|36285|P4|STARTED|Overall Study||17
14901|NCT02197806|36286|P3|STARTED|Overall Study||16
14902|NCT02197806|36287|P2|STARTED|Overall Study||17
14903|NCT02197806|36288|P1|STARTED|Overall Study||15
14904|NCT02197455|36298|P1|NOT COMPLETED|Overall Study||0
14905|NCT02197455|36298|P1|COMPLETED|Overall Study||30
14906|NCT02197455|36298|P1|STARTED|Overall Study||30
14907|NCT02197273|36305|P2|NOT COMPLETED|Overall Study||0
14908|NCT02197273|36306|P1|NOT COMPLETED|Overall Study||0
14909|NCT02197273|36305|P2|COMPLETED|Overall Study||104
14910|NCT02197273|36306|P1|COMPLETED|Overall Study||107
14911|NCT02197273|36305|P2|STARTED|Overall Study||104
14912|NCT02197273|36306|P1|STARTED|Overall Study||107
14913|NCT02197247|36316|P1|NOT COMPLETED|Period 3||5
14914|NCT02197247|36316|P1|COMPLETED|Period 3||32
14915|NCT02197247|36316|P1|STARTED|Period 3||37
14916|NCT02197247|36316|P1|NOT COMPLETED|Period 2||4
14917|NCT02197247|36316|P1|COMPLETED|Period 2||37
14918|NCT02197247|36316|P1|STARTED|Period 2||41
14919|NCT02197247|36316|P1|NOT COMPLETED|Period 1||0
14920|NCT02197247|36316|P1|COMPLETED|Period 1||41
14921|NCT02197247|36316|P1|STARTED|Period 1||41
14922|NCT02197234|36359|P1|NOT COMPLETED|Part B: Day 33 to End Part B (AZD9291)||30
14923|NCT02197234|36359|P1|COMPLETED|Part B: Day 33 to End Part B (AZD9291)||20
14924|NCT02197234|36359|P1|STARTED|Part B: Day 33 to End Part B (AZD9291)|49 completed Part A + 1 entered Part B without completing Part A (due to AE) = 50 started Part B|50
14925|NCT02197234|36359|P1|NOT COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||0
14926|NCT02197234|36359|P1|COMPLETED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
14927|NCT02197234|36359|P1|STARTED|Part A: Day 31-32 (Simvastatin+AZD9291)||49
14928|NCT02197234|36359|P1|NOT COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||3
14929|NCT02197234|36359|P1|COMPLETED|Part A: Day 3-30 (AZD9291 Alone)||49
14930|NCT02197234|36359|P1|STARTED|Part A: Day 3-30 (AZD9291 Alone)||52
14931|NCT02197234|36359|P1|NOT COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||0
14932|NCT02197234|36359|P1|COMPLETED|Part A: Day 1-2 (Simvastatin Alone)||52
14933|NCT02197234|36359|P1|STARTED|Part A: Day 1-2 (Simvastatin Alone)||52
14934|NCT02197065|36380|P2|NOT COMPLETED|Overall Study||0
14935|NCT02197065|36381|P1|NOT COMPLETED|Overall Study||0
14936|NCT02197065|36380|P2|COMPLETED|Overall Study||10
14937|NCT02197065|36381|P1|COMPLETED|Overall Study||10
14938|NCT02197065|36380|P2|STARTED|Overall Study||10
14939|NCT02197065|36381|P1|STARTED|Overall Study||10
14940|NCT02196766|36390|P2|NOT COMPLETED|Second Intervention (7 Days)||0
14941|NCT02196766|36391|P1|NOT COMPLETED|Second Intervention (7 Days)||0
14942|NCT02196766|36390|P2|COMPLETED|Second Intervention (7 Days)||15
14943|NCT02196766|36391|P1|COMPLETED|Second Intervention (7 Days)||15
14944|NCT02196766|36390|P2|STARTED|Second Intervention (7 Days)||15
14945|NCT02196766|36391|P1|STARTED|Second Intervention (7 Days)||15
14946|NCT02196766|36390|P2|NOT COMPLETED|First Intervention (7 Days)||0
14947|NCT02196766|36391|P1|NOT COMPLETED|First Intervention (7 Days)||0
14948|NCT02196766|36390|P2|COMPLETED|First Intervention (7 Days)||15
14949|NCT02196766|36391|P1|COMPLETED|First Intervention (7 Days)||15
14950|NCT02196766|36390|P2|STARTED|First Intervention (7 Days)||15
14951|NCT02196766|36391|P1|STARTED|First Intervention (7 Days)||15
14952|NCT02196714|36407|P4|NOT COMPLETED|Overall Study||0
14953|NCT02196714|36408|P3|NOT COMPLETED|Overall Study||1
14954|NCT02196714|36409|P2|NOT COMPLETED|Overall Study||0
14955|NCT02196714|36410|P1|NOT COMPLETED|Overall Study||0
14956|NCT02196714|36407|P4|COMPLETED|Overall Study||24
14957|NCT02196714|36408|P3|COMPLETED|Overall Study||23
14958|NCT02196714|36409|P2|COMPLETED|Overall Study||23
14959|NCT02196714|36410|P1|COMPLETED|Overall Study||24
14960|NCT02196714|36407|P4|STARTED|Overall Study||24
14961|NCT02196714|36408|P3|STARTED|Overall Study||24
14962|NCT02196714|36409|P2|STARTED|Overall Study||23
14963|NCT02196714|36410|P1|STARTED|Overall Study||24
14964|NCT02196675|36533|P3|NOT COMPLETED|Overall Study||1
14965|NCT02196675|36534|P2|NOT COMPLETED|Overall Study||2
14966|NCT02196675|36535|P1|NOT COMPLETED|Overall Study||2
14967|NCT02196675|36533|P3|COMPLETED|Overall Study||7
14968|NCT02196675|36534|P2|COMPLETED|Overall Study||68
14969|NCT02196675|36535|P1|COMPLETED|Overall Study||25
14970|NCT02196675|36533|P3|STARTED|Overall Study||8
14971|NCT02196675|36534|P2|STARTED|Overall Study||70
14972|NCT02196675|36535|P1|STARTED|Overall Study||27
14973|NCT02196259|36558|P3|NOT COMPLETED|Overall Study||1
14974|NCT02196259|36559|P2|NOT COMPLETED|Overall Study||3
14975|NCT02196259|36560|P1|NOT COMPLETED|Overall Study||0
14976|NCT02196259|36558|P3|COMPLETED|Overall Study||2
14977|NCT02196259|36559|P2|COMPLETED|Overall Study||4
14978|NCT02196259|36560|P1|COMPLETED|Overall Study||3
14979|NCT02196259|36558|P3|STARTED|Overall Study||3
14980|NCT02196259|36559|P2|STARTED|Overall Study||7
14981|NCT02196259|36560|P1|STARTED|Overall Study||3
14982|NCT02196168|36569|P2|NOT COMPLETED|Overall Study||0
14983|NCT02196168|36570|P1|NOT COMPLETED|Overall Study||0
14984|NCT02196168|36569|P2|COMPLETED|Overall Study||0
14985|NCT02196168|36570|P1|COMPLETED|Overall Study||6
14986|NCT02196168|36569|P2|STARTED|Overall Study||0
14987|NCT02196168|36570|P1|STARTED|Overall Study||6
14988|NCT02196077|36588|P1|NOT COMPLETED|Overall Study||47
14989|NCT02196077|36588|P1|COMPLETED|Overall Study||133
14990|NCT02196077|36588|P1|FF MDI 9.6 μg|Overall Study||157
14991|NCT02196077|36588|P1|BD MDI 320 μg|Overall Study||108
14992|NCT02196077|36588|P1|BFF MDI 80/9.6 μg|Overall Study||103
14993|NCT02196077|36588|P1|BFF MDI 160/9.6 μg|Overall Study||106
14994|NCT02196077|36588|P1|BFF MDI 320/9.6 μg|Overall Study||155
14995|NCT02196077|36588|P1|STARTED|Overall Study||180
14996|NCT02195713|36637|P2|NOT COMPLETED|Overall Study||0
14997|NCT02195713|36638|P1|NOT COMPLETED|Overall Study||0
14998|NCT02195713|36637|P2|COMPLETED|Overall Study||10
14999|NCT02195713|36638|P1|COMPLETED|Overall Study||10
15000|NCT02195713|36637|P2|STARTED|Overall Study||10
15001|NCT02195713|36638|P1|STARTED|Overall Study||10
15002|NCT02195687|36646|P2|NOT COMPLETED|Overall Study||2
15003|NCT02195687|36647|P1|NOT COMPLETED|Overall Study||5
15004|NCT02195687|36646|P2|COMPLETED|Overall Study||99
15005|NCT02195687|36647|P1|COMPLETED|Overall Study||311
15006|NCT02195687|36646|P2|STARTED|Overall Study||101
15007|NCT02195687|36647|P1|STARTED|Overall Study||316
15008|NCT02195583|36663|P1|NOT COMPLETED|Overall Study||9
15009|NCT02195583|36663|P1|COMPLETED|Overall Study||53
15096|NCT02193087|36915|P1|STARTED|Overall Study||199
15097|NCT02193074|36960|P2|NOT COMPLETED|Overall Study||15
15010|NCT02195583|36663|P1|Sodium Fluoride (1426 Ppm) + Zinc Base B|Overall Study|Discontinuations: 1 withdrawal of consent in Period 2;1 adverse event each in Period 3 and Period 4|60
15011|NCT02195583|36663|P1|Sodium Fluoride (1426 Ppm)|Overall Study|Discontinuation:1 lost to follow up, 1 withdrawal of consent in Period 2, 1 other reason in Period 5|59
15012|NCT02195583|36663|P1|Sodium Fluoride (250 Ppm)|Overall Study||55
15013|NCT02195583|36663|P1|Sodium Fluoride (1426 Ppm) + Zinc Base A|Overall Study|Discontinuations: 1 withdrawal of consent in Period 3 and 1 withdrawal of consent in Period 4|58
15014|NCT02195583|36663|P1|Sodium Fluoride (0 Ppm)|Overall Study||59
15015|NCT02195583|36663|P1|Sodium Fluoride (1150 Ppm)|Overall Study|Discontinuations: 1 due to other reason in Period 5|57
15016|NCT02195583|36663|P1|STARTED|Overall Study||62
15017|NCT02195414|36695|P1|NOT COMPLETED|Overall Study||0
15018|NCT02195414|36695|P1|COMPLETED|Overall Study||31
15019|NCT02195414|36695|P1|Primary Endpoint|Overall Study||31
15020|NCT02195414|36695|P1|STARTED|Overall Study||31
15021|NCT02194621|36705|P3|NOT COMPLETED|Overall Study||9
15022|NCT02194621|36706|P2|NOT COMPLETED|Overall Study||6
15023|NCT02194621|36707|P1|NOT COMPLETED|Overall Study||6
15024|NCT02194621|36705|P3|COMPLETED|Overall Study||34
15025|NCT02194621|36706|P2|COMPLETED|Overall Study||36
15026|NCT02194621|36707|P1|COMPLETED|Overall Study||37
15027|NCT02194621|36705|P3|STARTED|Overall Study||43
15028|NCT02194621|36706|P2|STARTED|Overall Study||42
15029|NCT02194621|36707|P1|STARTED|Overall Study||43
15030|NCT02194088|36726|P2|NOT COMPLETED|Overall Study||0
15031|NCT02194088|36727|P1|NOT COMPLETED|Overall Study||0
15032|NCT02194088|36726|P2|COMPLETED|Overall Study||25
15033|NCT02194088|36727|P1|COMPLETED|Overall Study||75
15034|NCT02194088|36726|P2|STARTED|Overall Study||25
15035|NCT02194088|36727|P1|STARTED|Overall Study||75
15036|NCT02194062|36740|P3|NOT COMPLETED|Overall Study||5
15037|NCT02194062|36741|P2|NOT COMPLETED|Overall Study||2
15038|NCT02194062|36742|P1|NOT COMPLETED|Overall Study||2
15039|NCT02194062|36740|P3|COMPLETED|Overall Study||7
15040|NCT02194062|36741|P2|COMPLETED|Overall Study||8
15041|NCT02194062|36742|P1|COMPLETED|Overall Study||8
15042|NCT02194062|36740|P3|STARTED|Overall Study||12
15043|NCT02194062|36741|P2|STARTED|Overall Study||10
15044|NCT02194062|36742|P1|STARTED|Overall Study||10
15045|NCT02193828|36757|P4|NOT COMPLETED|Overall Study||1
15046|NCT02193828|36758|P3|NOT COMPLETED|Overall Study||1
15047|NCT02193828|36759|P2|NOT COMPLETED|Overall Study||0
15048|NCT02193828|36760|P1|NOT COMPLETED|Overall Study||0
15049|NCT02193828|36757|P4|COMPLETED|Overall Study||16
15050|NCT02193828|36758|P3|COMPLETED|Overall Study||22
15051|NCT02193828|36759|P2|COMPLETED|Overall Study||18
15052|NCT02193828|36760|P1|COMPLETED|Overall Study||18
15053|NCT02193828|36757|P4|STARTED|Overall Study||17
15054|NCT02193828|36758|P3|STARTED|Overall Study||23
15055|NCT02193828|36759|P2|STARTED|Overall Study||18
15056|NCT02193828|36760|P1|STARTED|Overall Study||18
15057|NCT02193815|36798|P1|NOT COMPLETED|Overall Study||0
15058|NCT02193815|36798|P1|COMPLETED|Overall Study||15
15059|NCT02193815|36798|P1|STARTED|Overall Study||15
15060|NCT02193178|36833|P1|NOT COMPLETED|Overall Study||2
15061|NCT02193178|36833|P1|COMPLETED|Overall Study||13
15062|NCT02193178|36833|P1|STARTED|Overall Study||15
15063|NCT02193165|36883|P3|NOT COMPLETED|6 Week Product Use||0
15064|NCT02193165|36884|P2|NOT COMPLETED|6 Week Product Use||1
15065|NCT02193165|36885|P1|NOT COMPLETED|6 Week Product Use||0
15066|NCT02193165|36883|P3|COMPLETED|6 Week Product Use||39
15067|NCT02193165|36884|P2|COMPLETED|6 Week Product Use|1 subject failed to keep appointment time and didn't return to clinical site.|38
15068|NCT02193165|36885|P1|COMPLETED|6 Week Product Use||39
15069|NCT02193165|36883|P3|STARTED|6 Week Product Use||39
15070|NCT02193165|36884|P2|STARTED|6 Week Product Use||39
15071|NCT02193165|36885|P1|STARTED|6 Week Product Use||39
15072|NCT02193165|36883|P3|NOT COMPLETED|4 Week Product Use||1
15073|NCT02193165|36884|P2|NOT COMPLETED|4 Week Product Use||1
15074|NCT02193165|36885|P1|NOT COMPLETED|4 Week Product Use||1
15075|NCT02193165|36883|P3|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
15076|NCT02193165|36884|P2|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
15077|NCT02193165|36885|P1|COMPLETED|4 Week Product Use|1 subject failed to keep appointments and didn't return to clinical site|39
15078|NCT02193165|36883|P3|STARTED|4 Week Product Use||40
15079|NCT02193165|36884|P2|STARTED|4 Week Product Use||40
15080|NCT02193165|36885|P1|STARTED|4 Week Product Use||40
15081|NCT02193087|36912|P4|NOT COMPLETED|Overall Study||79
15082|NCT02193087|36913|P3|NOT COMPLETED|Overall Study||7
15083|NCT02193087|36914|P2|NOT COMPLETED|Overall Study||14
15084|NCT02193087|36915|P1|NOT COMPLETED|Overall Study||37
15085|NCT02193087|36912|P4|COMPLETED|Overall Study||524
15086|NCT02193087|36913|P3|COMPLETED|Overall Study||93
15087|NCT02193087|36914|P2|COMPLETED|Overall Study||86
15088|NCT02193087|36915|P1|COMPLETED|Overall Study||162
15089|NCT02193087|36912|P4|Received Vaccination|Overall Study||602
15090|NCT02193087|36913|P3|Received Vaccination|Overall Study||100
15091|NCT02193087|36914|P2|Received Vaccination|Overall Study||97
15092|NCT02193087|36915|P1|Received Vaccination|Overall Study||197
15093|NCT02193087|36912|P4|STARTED|Overall Study||603
15094|NCT02193087|36913|P3|STARTED|Overall Study||100
15095|NCT02193087|36914|P2|STARTED|Overall Study||100
15098|NCT02193074|36961|P1|NOT COMPLETED|Overall Study||17
15099|NCT02193074|36960|P2|COMPLETED|Overall Study||65
15100|NCT02193074|36961|P1|COMPLETED|Overall Study||24
15101|NCT02193074|36960|P2|Completed Due to Early Study Termination|Overall Study||39
15102|NCT02193074|36961|P1|Completed Due to Early Study Termination|Overall Study||13
15103|NCT02193074|36960|P2|Completed During Follow-Up Period|Overall Study||26
15104|NCT02193074|36961|P1|Completed During Follow-Up Period|Overall Study||11
15105|NCT02193074|36960|P2|STARTED|Overall Study|Randomized and received double-blind treatment.|80
15106|NCT02193074|36961|P1|STARTED|Overall Study|Randomized and received double-blind treatment.|41
15107|NCT02192879|36996|P3|NOT COMPLETED|Overall Study||0
15108|NCT02192879|36997|P2|NOT COMPLETED|Overall Study||0
15109|NCT02192879|36998|P1|NOT COMPLETED|Overall Study||0
15110|NCT02192879|36996|P3|COMPLETED|Overall Study||3
15111|NCT02192879|36997|P2|COMPLETED|Overall Study||4
15112|NCT02192879|36998|P1|COMPLETED|Overall Study||3
15113|NCT02192879|36996|P3|STARTED|Overall Study||3
15114|NCT02192879|36997|P2|STARTED|Overall Study||4
15115|NCT02192879|36998|P1|STARTED|Overall Study||3
15116|NCT02192814|37024|P1|NOT COMPLETED|Overall Study||0
15117|NCT02192814|37024|P1|COMPLETED|Overall Study||9
15118|NCT02192814|37024|P1|STARTED|Overall Study||9
15119|NCT02192684|37037|P2|NOT COMPLETED|Overall Study||0
15120|NCT02192684|37038|P1|NOT COMPLETED|Overall Study||0
15121|NCT02192684|37037|P2|COMPLETED|Overall Study||15
15122|NCT02192684|37038|P1|COMPLETED|Overall Study||30
15123|NCT02192684|37037|P2|STARTED|Overall Study||15
15124|NCT02192684|37038|P1|STARTED|Overall Study||30
15125|NCT02192164|37044|P1|NOT COMPLETED|Overall Study||14
15126|NCT02192164|37044|P1|COMPLETED|Overall Study||112
15127|NCT02192164|37044|P1|Etanercept Treated Population|Overall Study||112
15128|NCT02192164|37044|P1|STARTED|Overall Study||126
15129|NCT02191865|37063|P3|NOT COMPLETED|Overall Study||0
15130|NCT02191865|37064|P2|NOT COMPLETED|Overall Study||0
15131|NCT02191865|37065|P1|NOT COMPLETED|Overall Study||0
15132|NCT02191865|37063|P3|COMPLETED|Overall Study||17
15133|NCT02191865|37064|P2|COMPLETED|Overall Study||8
15134|NCT02191865|37065|P1|COMPLETED|Overall Study||8
15135|NCT02191865|37063|P3|STARTED|Overall Study||17
15136|NCT02191865|37064|P2|STARTED|Overall Study||8
15137|NCT02191865|37065|P1|STARTED|Overall Study||8
15138|NCT02191046|37087|P2|NOT COMPLETED|Overall Study||1
15139|NCT02191046|37088|P1|NOT COMPLETED|Overall Study||5
15140|NCT02191046|37087|P2|COMPLETED|Overall Study|exclude 1 patient because low compliance|38
15141|NCT02191046|37088|P1|COMPLETED|Overall Study|exclude 5 patients because low compliance|36
15142|NCT02191046|37087|P2|STARTED|Overall Study||39
15143|NCT02191046|37088|P1|STARTED|Overall Study||41
15144|NCT02191033|37096|P2|NOT COMPLETED|Overall Study||1
15145|NCT02191033|37097|P1|NOT COMPLETED|Overall Study||2
15146|NCT02191033|37096|P2|COMPLETED|Overall Study||19
15147|NCT02191033|37097|P1|COMPLETED|Overall Study||18
15148|NCT02191033|37096|P2|STARTED|Overall Study||20
15149|NCT02191033|37097|P1|STARTED|Overall Study||20
15150|NCT02190604|37126|P19|NOT COMPLETED|Part 3 (Patients)||0
15151|NCT02190604|37127|P18|NOT COMPLETED|Part 3 (Patients)||0
15152|NCT02190604|37128|P17|NOT COMPLETED|Part 3 (Patients)||0
15153|NCT02190604|37129|P16|NOT COMPLETED|Part 3 (Patients)||0
15154|NCT02190604|37130|P15|NOT COMPLETED|Part 3 (Patients)||0
15155|NCT02190604|37131|P14|NOT COMPLETED|Part 3 (Patients)||0
15156|NCT02190604|37132|P13|NOT COMPLETED|Part 3 (Patients)||0
15157|NCT02190604|37133|P12|NOT COMPLETED|Part 3 (Patients)||0
15158|NCT02190604|37134|P11|NOT COMPLETED|Part 3 (Patients)||0
15159|NCT02190604|37135|P10|NOT COMPLETED|Part 3 (Patients)||0
15160|NCT02190604|37136|P9|NOT COMPLETED|Part 3 (Patients)||0
15161|NCT02190604|37137|P8|NOT COMPLETED|Part 3 (Patients)||0
15162|NCT02190604|37138|P7|NOT COMPLETED|Part 3 (Patients)||0
15163|NCT02190604|37139|P6|NOT COMPLETED|Part 3 (Patients)||0
15164|NCT02190604|37140|P5|NOT COMPLETED|Part 3 (Patients)||0
15165|NCT02190604|37141|P4|NOT COMPLETED|Part 3 (Patients)||0
15166|NCT02190604|37142|P3|NOT COMPLETED|Part 3 (Patients)||0
15167|NCT02190604|37143|P2|NOT COMPLETED|Part 3 (Patients)||0
15168|NCT02190604|37144|P1|NOT COMPLETED|Part 3 (Patients)||0
15169|NCT02190604|37126|P19|COMPLETED|Part 3 (Patients)||12
15170|NCT02190604|37127|P18|COMPLETED|Part 3 (Patients)||19
15171|NCT02190604|37128|P17|COMPLETED|Part 3 (Patients)||12
15172|NCT02190604|37129|P16|COMPLETED|Part 3 (Patients)||6
15173|NCT02190604|37130|P15|COMPLETED|Part 3 (Patients)||0
15174|NCT02190604|37131|P14|COMPLETED|Part 3 (Patients)||0
15175|NCT02190604|37132|P13|COMPLETED|Part 3 (Patients)||0
15176|NCT02190604|37133|P12|COMPLETED|Part 3 (Patients)||0
15177|NCT02190604|37134|P11|COMPLETED|Part 3 (Patients)||0
15178|NCT02190604|37135|P10|COMPLETED|Part 3 (Patients)||0
15179|NCT02190604|37136|P9|COMPLETED|Part 3 (Patients)||0
15180|NCT02190604|37137|P8|COMPLETED|Part 3 (Patients)||0
15181|NCT02190604|37138|P7|COMPLETED|Part 3 (Patients)||0
15182|NCT02190604|37139|P6|COMPLETED|Part 3 (Patients)||0
15183|NCT02190604|37140|P5|COMPLETED|Part 3 (Patients)||0
15184|NCT02190604|37141|P4|COMPLETED|Part 3 (Patients)||0
15185|NCT02190604|37142|P3|COMPLETED|Part 3 (Patients)||0
15186|NCT02190604|37143|P2|COMPLETED|Part 3 (Patients)||0
15187|NCT02190604|37144|P1|COMPLETED|Part 3 (Patients)||0
15188|NCT02190604|37126|P19|STARTED|Part 3 (Patients)||12
15189|NCT02190604|37127|P18|STARTED|Part 3 (Patients)||19
15190|NCT02190604|37128|P17|STARTED|Part 3 (Patients)||12
15191|NCT02190604|37129|P16|STARTED|Part 3 (Patients)||6
15192|NCT02190604|37130|P15|STARTED|Part 3 (Patients)||0
15193|NCT02190604|37131|P14|STARTED|Part 3 (Patients)||0
15194|NCT02190604|37132|P13|STARTED|Part 3 (Patients)||0
15195|NCT02190604|37133|P12|STARTED|Part 3 (Patients)||0
15196|NCT02190604|37134|P11|STARTED|Part 3 (Patients)||0
15197|NCT02190604|37135|P10|STARTED|Part 3 (Patients)||0
15198|NCT02190604|37136|P9|STARTED|Part 3 (Patients)||0
15199|NCT02190604|37137|P8|STARTED|Part 3 (Patients)||0
15200|NCT02190604|37138|P7|STARTED|Part 3 (Patients)||0
15201|NCT02190604|37139|P6|STARTED|Part 3 (Patients)||0
15202|NCT02190604|37140|P5|STARTED|Part 3 (Patients)||0
15203|NCT02190604|37141|P4|STARTED|Part 3 (Patients)||0
15204|NCT02190604|37142|P3|STARTED|Part 3 (Patients)||0
15205|NCT02190604|37143|P2|STARTED|Part 3 (Patients)||0
15206|NCT02190604|37144|P1|STARTED|Part 3 (Patients)||0
15207|NCT02190604|37126|P19|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15208|NCT02190604|37127|P18|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15209|NCT02190604|37128|P17|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15210|NCT02190604|37129|P16|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15211|NCT02190604|37130|P15|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||2
15212|NCT02190604|37131|P14|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||1
15213|NCT02190604|37132|P13|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15214|NCT02190604|37133|P12|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15215|NCT02190604|37134|P11|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15216|NCT02190604|37135|P10|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15217|NCT02190604|37136|P9|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15218|NCT02190604|37137|P8|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15219|NCT02190604|37138|P7|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15220|NCT02190604|37139|P6|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15221|NCT02190604|37140|P5|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15222|NCT02190604|37141|P4|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15223|NCT02190604|37142|P3|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15224|NCT02190604|37143|P2|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15225|NCT02190604|37144|P1|NOT COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15226|NCT02190604|37126|P19|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15227|NCT02190604|37127|P18|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15228|NCT02190604|37128|P17|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15229|NCT02190604|37129|P16|COMPLETED|Part 1 and 2 (Healthy Volunteers)||0
15230|NCT02190604|37130|P15|COMPLETED|Part 1 and 2 (Healthy Volunteers)||8
15231|NCT02190604|37131|P14|COMPLETED|Part 1 and 2 (Healthy Volunteers)||5
15232|NCT02190604|37132|P13|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15233|NCT02190604|37133|P12|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15234|NCT02190604|37134|P11|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15235|NCT02190604|37135|P10|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15236|NCT02190604|37136|P9|COMPLETED|Part 1 and 2 (Healthy Volunteers)||16
15237|NCT02190604|37137|P8|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15238|NCT02190604|37138|P7|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15239|NCT02190604|37139|P6|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15240|NCT02190604|37140|P5|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15241|NCT02190604|37141|P4|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15242|NCT02190604|37142|P3|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15243|NCT02190604|37143|P2|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15244|NCT02190604|37144|P1|COMPLETED|Part 1 and 2 (Healthy Volunteers)||6
15245|NCT02190604|37126|P19|STARTED|Part 1 and 2 (Healthy Volunteers)||0
15246|NCT02190604|37127|P18|STARTED|Part 1 and 2 (Healthy Volunteers)||0
15247|NCT02190604|37128|P17|STARTED|Part 1 and 2 (Healthy Volunteers)||0
15248|NCT02190604|37129|P16|STARTED|Part 1 and 2 (Healthy Volunteers)||0
15249|NCT02190604|37130|P15|STARTED|Part 1 and 2 (Healthy Volunteers)||10
15250|NCT02190604|37131|P14|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15251|NCT02190604|37132|P13|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15252|NCT02190604|37133|P12|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15253|NCT02190604|37134|P11|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15254|NCT02190604|37135|P10|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15255|NCT02190604|37136|P9|STARTED|Part 1 and 2 (Healthy Volunteers)||16
15256|NCT02190604|37137|P8|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15257|NCT02190604|37138|P7|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15258|NCT02190604|37139|P6|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15259|NCT02190604|37140|P5|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15260|NCT02190604|37141|P4|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15261|NCT02190604|37142|P3|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15262|NCT02190604|37143|P2|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15263|NCT02190604|37144|P1|STARTED|Part 1 and 2 (Healthy Volunteers)||6
15264|NCT02190591|37335|P2|NOT COMPLETED|Overall Study||11
15265|NCT02190591|37336|P1|NOT COMPLETED|Overall Study||2
15266|NCT02190591|37335|P2|COMPLETED|Overall Study||91
15267|NCT02190591|37336|P1|COMPLETED|Overall Study||100
15268|NCT02190591|37335|P2|STARTED|Overall Study||102
15269|NCT02190591|37336|P1|STARTED|Overall Study||102
15270|NCT02190435|37348|P2|NOT COMPLETED|Overall Study||0
15271|NCT02190435|37349|P1|NOT COMPLETED|Overall Study||15
15272|NCT02190435|37348|P2|COMPLETED|Overall Study||24
15273|NCT02190435|37349|P1|COMPLETED|Overall Study||26
15274|NCT02190435|37348|P2|STARTED|Overall Study||24
15275|NCT02190435|37349|P1|STARTED|Overall Study||41
15276|NCT02189954|37359|P2|NOT COMPLETED|Overall Study||0
15277|NCT02189954|37360|P1|NOT COMPLETED|Overall Study||0
15278|NCT02189954|37359|P2|COMPLETED|Overall Study||45
15279|NCT02189954|37360|P1|COMPLETED|Overall Study||45
15280|NCT02189954|37359|P2|STARTED|Overall Study||45
15281|NCT02189954|37360|P1|STARTED|Overall Study||45
15282|NCT02189941|37368|P3|NOT COMPLETED|Overall Study||1
15283|NCT02189941|37369|P2|NOT COMPLETED|Overall Study||0
15284|NCT02189941|37370|P1|NOT COMPLETED|Overall Study||0
15285|NCT02189941|37368|P3|COMPLETED|Overall Study||2
15286|NCT02189941|37369|P2|COMPLETED|Overall Study||4
15287|NCT02189941|37370|P1|COMPLETED|Overall Study||4
15288|NCT02189941|37368|P3|STARTED|Overall Study||3
15289|NCT02189941|37369|P2|STARTED|Overall Study||4
15290|NCT02189941|37370|P1|STARTED|Overall Study||4
15291|NCT02189915|37393|P1|NOT COMPLETED|Overall Study||3
15292|NCT02189915|37393|P1|COMPLETED|Overall Study||11
15293|NCT02189915|37393|P1|STARTED|Overall Study||14
15294|NCT02189863|37398|P2|NOT COMPLETED|Second 2 Weeks||0
15295|NCT02189863|37399|P1|NOT COMPLETED|Second 2 Weeks||0
15296|NCT02189863|37398|P2|COMPLETED|Second 2 Weeks||13
15297|NCT02189863|37399|P1|COMPLETED|Second 2 Weeks||8
15298|NCT02189863|37398|P2|STARTED|Second 2 Weeks||13
15299|NCT02189863|37399|P1|STARTED|Second 2 Weeks||8
15300|NCT02189863|37398|P2|NOT COMPLETED|First 2 Weeks||2
15301|NCT02189863|37399|P1|NOT COMPLETED|First 2 Weeks||4
15302|NCT02189863|37398|P2|COMPLETED|First 2 Weeks||13
15303|NCT02189863|37399|P1|COMPLETED|First 2 Weeks||8
15304|NCT02189863|37398|P2|STARTED|First 2 Weeks||15
15305|NCT02189863|37399|P1|STARTED|First 2 Weeks||12
15306|NCT02189837|37414|P4|NOT COMPLETED|Overall Study||2
15307|NCT02189837|37415|P3|NOT COMPLETED|Overall Study||3
15308|NCT02189837|37416|P2|NOT COMPLETED|Overall Study||1
15309|NCT02189837|37417|P1|NOT COMPLETED|Overall Study||2
15310|NCT02189837|37414|P4|COMPLETED|Overall Study||19
15311|NCT02189837|37415|P3|COMPLETED|Overall Study||20
15312|NCT02189837|37416|P2|COMPLETED|Overall Study||22
15313|NCT02189837|37417|P1|COMPLETED|Overall Study||20
15314|NCT02189837|37414|P4|Received Treatment|Overall Study||20
15315|NCT02189837|37415|P3|Received Treatment|Overall Study||22
15316|NCT02189837|37416|P2|Received Treatment|Overall Study||22
15317|NCT02189837|37417|P1|Received Treatment|Overall Study||21
15318|NCT02189837|37414|P4|STARTED|Overall Study||21
15319|NCT02189837|37415|P3|STARTED|Overall Study||23
15320|NCT02189837|37416|P2|STARTED|Overall Study||23
15321|NCT02189837|37417|P1|STARTED|Overall Study||22
15322|NCT02189759|37447|P4|NOT COMPLETED|Overall Study||5
15323|NCT02189759|37448|P3|NOT COMPLETED|Overall Study||2
15324|NCT02189759|37449|P2|NOT COMPLETED|Overall Study||0
15325|NCT02189759|37450|P1|NOT COMPLETED|Overall Study||0
15326|NCT02189759|37447|P4|COMPLETED|Overall Study||84
15327|NCT02189759|37448|P3|COMPLETED|Overall Study||81
15328|NCT02189759|37449|P2|COMPLETED|Overall Study||101
15329|NCT02189759|37450|P1|COMPLETED|Overall Study||102
15330|NCT02189759|37447|P4|STARTED|Overall Study||89
15331|NCT02189759|37448|P3|STARTED|Overall Study||83
15332|NCT02189759|37449|P2|STARTED|Overall Study||101
15333|NCT02189759|37450|P1|STARTED|Overall Study||102
15334|NCT02189317|37470|P2|NOT COMPLETED|Overall Study||0
15335|NCT02189317|37471|P1|NOT COMPLETED|Overall Study||0
15336|NCT02189317|37470|P2|COMPLETED|Overall Study||16
15337|NCT02189317|37471|P1|COMPLETED|Overall Study||16
15338|NCT02189317|37470|P2|STARTED|Overall Study||16
15339|NCT02189317|37471|P1|STARTED|Overall Study||16
15340|NCT02189252|37485|P4|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
15341|NCT02189252|37486|P3|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
15342|NCT02189252|37487|P2|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
15343|NCT02189252|37488|P1|NOT COMPLETED|Period 2 (Visit6b, Week 12)||0
15344|NCT02189252|37485|P4|COMPLETED|Period 2 (Visit6b, Week 12)||4
15345|NCT02189252|37486|P3|COMPLETED|Period 2 (Visit6b, Week 12)||3
15346|NCT02189252|37487|P2|COMPLETED|Period 2 (Visit6b, Week 12)||2
15347|NCT02189252|37488|P1|COMPLETED|Period 2 (Visit6b, Week 12)||4
15348|NCT02189252|37485|P4|STARTED|Period 2 (Visit6b, Week 12)||4
15349|NCT02189252|37486|P3|STARTED|Period 2 (Visit6b, Week 12)||3
15350|NCT02189252|37487|P2|STARTED|Period 2 (Visit6b, Week 12)||2
15351|NCT02189252|37488|P1|STARTED|Period 2 (Visit6b, Week 12)||4
15352|NCT02189252|37485|P4|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
15353|NCT02189252|37486|P3|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
15354|NCT02189252|37487|P2|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||2
15355|NCT02189252|37488|P1|NOT COMPLETED|Period 1 (Visit 4b, Week 4)||0
15356|NCT02189252|37485|P4|COMPLETED|Period 1 (Visit 4b, Week 4)||4
15357|NCT02189252|37486|P3|COMPLETED|Period 1 (Visit 4b, Week 4)||3
15358|NCT02189252|37487|P2|COMPLETED|Period 1 (Visit 4b, Week 4)||2
15359|NCT02189252|37488|P1|COMPLETED|Period 1 (Visit 4b, Week 4)||4
15360|NCT02189252|37485|P4|STARTED|Period 1 (Visit 4b, Week 4)||4
15361|NCT02189252|37486|P3|STARTED|Period 1 (Visit 4b, Week 4)||3
15362|NCT02189252|37487|P2|STARTED|Period 1 (Visit 4b, Week 4)||4
15363|NCT02189252|37488|P1|STARTED|Period 1 (Visit 4b, Week 4)||4
15364|NCT02189161|37520|P1|NOT COMPLETED|Overall Study||0
15365|NCT02189161|37520|P1|COMPLETED|Overall Study||10
15366|NCT02189161|37520|P1|STARTED|Overall Study||10
15367|NCT02189122|37528|P2|NOT COMPLETED|Overall Study||0
15368|NCT02189122|37529|P1|NOT COMPLETED|Overall Study||0
15369|NCT02189122|37528|P2|COMPLETED|Overall Study||18
15370|NCT02189122|37529|P1|COMPLETED|Overall Study||18
15371|NCT02189122|37528|P2|STARTED|Overall Study||18
15372|NCT02189122|37529|P1|STARTED|Overall Study||18
15373|NCT02188849|37547|P2|NOT COMPLETED|Overall Study||8
15374|NCT02188849|37548|P1|NOT COMPLETED|Overall Study||3
15375|NCT02188849|37547|P2|COMPLETED|Overall Study||17
15376|NCT02188849|37548|P1|COMPLETED|Overall Study||22
15377|NCT02188849|37547|P2|STARTED|Overall Study||25
15378|NCT02188849|37548|P1|STARTED|Overall Study||25
15379|NCT02188784|37562|P2|NOT COMPLETED|Overall Study||13
15380|NCT02188784|37563|P1|NOT COMPLETED|Overall Study||9
15381|NCT02188784|37562|P2|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|101
15382|NCT02188784|37563|P1|COMPLETED|Overall Study|Patients completing the protocol excluding death, lost to follow-up and withdrawn consent.|102
15383|NCT02188784|37562|P2|STARTED|Overall Study||114
15384|NCT02188784|37563|P1|STARTED|Overall Study||111
15385|NCT02188589|37579|P1|NOT COMPLETED|Overall Study||0
15386|NCT02188589|37579|P1|COMPLETED|Overall Study||30
15387|NCT02188589|37579|P1|STARTED|Overall Study||30
15388|NCT02187809|37584|P1|NOT COMPLETED|Overall Study||3
15389|NCT02187809|37584|P1|COMPLETED|Overall Study||0
15390|NCT02187809|37584|P1|Treated|Overall Study||1
15391|NCT02187809|37584|P1|STARTED|Overall Study||3
15392|NCT02187744|37596|P2|NOT COMPLETED|Treatment||5
15393|NCT02187744|37597|P1|NOT COMPLETED|Treatment||4
15394|NCT02187744|37596|P2|COMPLETED|Treatment||107
15395|NCT02187744|37597|P1|COMPLETED|Treatment||109
15396|NCT02187744|37596|P2|STARTED|Treatment||112
15397|NCT02187744|37597|P1|STARTED|Treatment||113
15398|NCT02187744|37596|P2|NOT COMPLETED|Study||6
15399|NCT02187744|37597|P1|NOT COMPLETED|Study||4
15400|NCT02187744|37596|P2|COMPLETED|Study||106
15401|NCT02187744|37597|P1|COMPLETED|Study||109
15402|NCT02187744|37596|P2|STARTED|Study|Received treatment|112
15403|NCT02187744|37597|P1|STARTED|Study|Received treatment|113
15404|NCT02187029|37617|P4|NOT COMPLETED|Overall Study||3
15405|NCT02187029|37618|P3|NOT COMPLETED|Overall Study||11
15406|NCT02187029|37619|P2|NOT COMPLETED|Overall Study||1
15407|NCT02187029|37620|P1|NOT COMPLETED|Overall Study||1
15408|NCT02187029|37617|P4|COMPLETED|Overall Study||6
15409|NCT02187029|37618|P3|COMPLETED|Overall Study||0
15410|NCT02187029|37619|P2|COMPLETED|Overall Study||2
15411|NCT02187029|37620|P1|COMPLETED|Overall Study||6
15412|NCT02187029|37617|P4|STARTED|Overall Study||9
15413|NCT02187029|37618|P3|STARTED|Overall Study||11
15414|NCT02187029|37619|P2|STARTED|Overall Study||3
15415|NCT02187029|37620|P1|STARTED|Overall Study||7
15416|NCT02187016|37696|P4|NOT COMPLETED|Overall Study||0
15417|NCT02187016|37697|P3|NOT COMPLETED|Overall Study||1
15418|NCT02187016|37698|P2|NOT COMPLETED|Overall Study||2
15419|NCT02187016|37699|P1|NOT COMPLETED|Overall Study||1
15420|NCT02187016|37696|P4|COMPLETED|Overall Study||51
15421|NCT02187016|37697|P3|COMPLETED|Overall Study||78
15422|NCT02187016|37698|P2|COMPLETED|Overall Study||78
15423|NCT02187016|37699|P1|COMPLETED|Overall Study||79
15424|NCT02187016|37696|P4|STARTED|Overall Study||51
15425|NCT02187016|37697|P3|STARTED|Overall Study||79
15426|NCT02187016|37698|P2|STARTED|Overall Study||80
15427|NCT02187016|37699|P1|STARTED|Overall Study||80
15428|NCT02186808|37729|P1|NOT COMPLETED|Overall Study||13
15429|NCT02186808|37729|P1|COMPLETED|Overall Study||67
15430|NCT02186808|37729|P1|STARTED|Overall Study||80
15431|NCT02186665|37736|P2|NOT COMPLETED|Overall Study||1
15432|NCT02186665|37737|P1|NOT COMPLETED|Overall Study||0
15433|NCT02186665|37736|P2|COMPLETED|Overall Study||10
15434|NCT02186665|37737|P1|COMPLETED|Overall Study||8
15435|NCT02186665|37736|P2|STARTED|Overall Study||11
15436|NCT02186665|37737|P1|STARTED|Overall Study||8
15437|NCT02186587|37745|P2|NOT COMPLETED|Overall Study||0
15438|NCT02186587|37746|P1|NOT COMPLETED|Overall Study||5
15439|NCT02186587|37745|P2|COMPLETED|Overall Study||0
15440|NCT02186587|37746|P1|COMPLETED|Overall Study||23
15441|NCT02186587|37745|P2|STARTED|Overall Study||0
15442|NCT02186587|37746|P1|STARTED|Overall Study||28
15443|NCT02186223|37751|P1|NOT COMPLETED|Overall Study||21
15444|NCT02186223|37751|P1|COMPLETED|Overall Study||151
15445|NCT02186223|37751|P1|Device Placed|Overall Study||163
15446|NCT02186223|37751|P1|STARTED|Overall Study||172
15447|NCT02185729|37760|P1|NOT COMPLETED|24 Hours Into Dextrose Infusion||0
15448|NCT02185729|37760|P1|COMPLETED|24 Hours Into Dextrose Infusion||12
15449|NCT02185729|37760|P1|STARTED|24 Hours Into Dextrose Infusion||12
15450|NCT02185729|37760|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
15451|NCT02185729|37760|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
15452|NCT02185729|37760|P1|STARTED|4 Hours Into Dextrose Infusion||12
15453|NCT02185729|37760|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
15454|NCT02185729|37760|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
15455|NCT02185729|37760|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
15456|NCT02185729|37760|P1|NOT COMPLETED|24 Hours Into ClinOleic Infusion||0
15457|NCT02185729|37760|P1|COMPLETED|24 Hours Into ClinOleic Infusion||12
15458|NCT02185729|37760|P1|STARTED|24 Hours Into ClinOleic Infusion||12
15459|NCT02185729|37760|P1|NOT COMPLETED|4 Hours Into ClinOleic Infusion||0
15460|NCT02185729|37760|P1|COMPLETED|4 Hours Into ClinOleic Infusion||12
15461|NCT02185729|37760|P1|STARTED|4 Hours Into ClinOleic Infusion||12
15462|NCT02185729|37760|P1|NOT COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||0
15463|NCT02185729|37760|P1|COMPLETED|0 Hour (Baseline) of ClinOleic Infusion||12
15464|NCT02185729|37760|P1|STARTED|0 Hour (Baseline) of ClinOleic Infusion||12
15465|NCT02185729|37760|P1|NOT COMPLETED|24 Hours Into Intralipid Infusion||0
15466|NCT02185729|37760|P1|COMPLETED|24 Hours Into Intralipid Infusion||12
15467|NCT02185729|37760|P1|STARTED|24 Hours Into Intralipid Infusion||12
15468|NCT02185729|37760|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
15469|NCT02185729|37760|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
15470|NCT02185729|37760|P1|STARTED|4 Hours Into Intralipid Infusion||12
15471|NCT02185729|37760|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
15472|NCT02185729|37760|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
15473|NCT02185729|37760|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
15474|NCT02185729|37760|P1|NOT COMPLETED|24 Hours Into Saline Infusion||0
15475|NCT02185729|37760|P1|COMPLETED|24 Hours Into Saline Infusion||12
15476|NCT02185729|37760|P1|STARTED|24 Hours Into Saline Infusion||12
15477|NCT02185729|37760|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
15478|NCT02185729|37760|P1|COMPLETED|4 Hours Into Saline Infusion||12
15479|NCT02185729|37760|P1|STARTED|4 Hours Into Saline Infusion||12
15480|NCT02185729|37760|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
15481|NCT02185729|37760|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
15482|NCT02185729|37760|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
15483|NCT02185534|37781|P6|NOT COMPLETED|Third Period||0
15484|NCT02185534|37782|P5|NOT COMPLETED|Third Period||0
15485|NCT02185534|37783|P4|NOT COMPLETED|Third Period||0
15486|NCT02185534|37784|P3|NOT COMPLETED|Third Period||0
15487|NCT02185534|37785|P2|NOT COMPLETED|Third Period||0
15488|NCT02185534|37786|P1|NOT COMPLETED|Third Period||0
15489|NCT02185534|37781|P6|COMPLETED|Third Period||13
15490|NCT02185534|37782|P5|COMPLETED|Third Period||13
15491|NCT02185534|37783|P4|COMPLETED|Third Period||13
15492|NCT02185534|37784|P3|COMPLETED|Third Period||14
15493|NCT02185534|37785|P2|COMPLETED|Third Period||14
15494|NCT02185534|37786|P1|COMPLETED|Third Period||13
15495|NCT02185534|37781|P6|STARTED|Third Period||13
15496|NCT02185534|37782|P5|STARTED|Third Period||13
15497|NCT02185534|37783|P4|STARTED|Third Period||13
15498|NCT02185534|37784|P3|STARTED|Third Period||14
15499|NCT02185534|37785|P2|STARTED|Third Period||14
15500|NCT02185534|37786|P1|STARTED|Third Period||13
15501|NCT02185534|37781|P6|NOT COMPLETED|Second Washout Period||0
15502|NCT02185534|37782|P5|NOT COMPLETED|Second Washout Period||0
15503|NCT02185534|37783|P4|NOT COMPLETED|Second Washout Period||0
15504|NCT02185534|37784|P3|NOT COMPLETED|Second Washout Period||0
15505|NCT02185534|37785|P2|NOT COMPLETED|Second Washout Period||0
15506|NCT02185534|37786|P1|NOT COMPLETED|Second Washout Period||0
15507|NCT02185534|37781|P6|COMPLETED|Second Washout Period||13
15508|NCT02185534|37782|P5|COMPLETED|Second Washout Period||13
15509|NCT02185534|37783|P4|COMPLETED|Second Washout Period||13
15510|NCT02185534|37784|P3|COMPLETED|Second Washout Period||14
15511|NCT02185534|37785|P2|COMPLETED|Second Washout Period||14
15512|NCT02185534|37786|P1|COMPLETED|Second Washout Period||13
15513|NCT02185534|37781|P6|STARTED|Second Washout Period||13
15514|NCT02185534|37782|P5|STARTED|Second Washout Period||13
15515|NCT02185534|37783|P4|STARTED|Second Washout Period||13
15516|NCT02185534|37784|P3|STARTED|Second Washout Period||14
15517|NCT02185534|37785|P2|STARTED|Second Washout Period||14
15518|NCT02185534|37786|P1|STARTED|Second Washout Period||13
15519|NCT02185534|37781|P6|NOT COMPLETED|Second Period||0
15520|NCT02185534|37782|P5|NOT COMPLETED|Second Period||0
15521|NCT02185534|37783|P4|NOT COMPLETED|Second Period||0
15522|NCT02185534|37784|P3|NOT COMPLETED|Second Period||0
15523|NCT02185534|37785|P2|NOT COMPLETED|Second Period||0
15524|NCT02185534|37786|P1|NOT COMPLETED|Second Period||0
15525|NCT02185534|37781|P6|COMPLETED|Second Period||13
15526|NCT02185534|37782|P5|COMPLETED|Second Period||13
15527|NCT02185534|37783|P4|COMPLETED|Second Period||13
15528|NCT02185534|37784|P3|COMPLETED|Second Period||14
15529|NCT02185534|37785|P2|COMPLETED|Second Period||14
15530|NCT02185534|37786|P1|COMPLETED|Second Period||13
15531|NCT02185534|37781|P6|STARTED|Second Period||13
15532|NCT02185534|37782|P5|STARTED|Second Period||13
15533|NCT02185534|37783|P4|STARTED|Second Period||13
15534|NCT02185534|37784|P3|STARTED|Second Period||14
15535|NCT02185534|37785|P2|STARTED|Second Period||14
15536|NCT02185534|37786|P1|STARTED|Second Period||13
15537|NCT02185534|37781|P6|NOT COMPLETED|First Washout Period||1
15538|NCT02185534|37782|P5|NOT COMPLETED|First Washout Period||1
15539|NCT02185534|37783|P4|NOT COMPLETED|First Washout Period||0
15540|NCT02185534|37784|P3|NOT COMPLETED|First Washout Period||0
15541|NCT02185534|37785|P2|NOT COMPLETED|First Washout Period||0
15542|NCT02185534|37786|P1|NOT COMPLETED|First Washout Period||1
15543|NCT02185534|37781|P6|COMPLETED|First Washout Period||13
15544|NCT02185534|37782|P5|COMPLETED|First Washout Period||13
15545|NCT02185534|37783|P4|COMPLETED|First Washout Period||13
15546|NCT02185534|37784|P3|COMPLETED|First Washout Period||14
15547|NCT02185534|37785|P2|COMPLETED|First Washout Period||14
15548|NCT02185534|37786|P1|COMPLETED|First Washout Period||13
15549|NCT02185534|37781|P6|STARTED|First Washout Period||14
15550|NCT02185534|37782|P5|STARTED|First Washout Period||14
15551|NCT02185534|37783|P4|STARTED|First Washout Period||13
15552|NCT02185534|37784|P3|STARTED|First Washout Period||14
15553|NCT02185534|37785|P2|STARTED|First Washout Period||14
15554|NCT02185534|37786|P1|STARTED|First Washout Period||14
15555|NCT02185534|37781|P6|NOT COMPLETED|First Period||0
15556|NCT02185534|37782|P5|NOT COMPLETED|First Period||0
15557|NCT02185534|37783|P4|NOT COMPLETED|First Period||1
15558|NCT02185534|37784|P3|NOT COMPLETED|First Period||0
15559|NCT02185534|37785|P2|NOT COMPLETED|First Period||0
15560|NCT02185534|37786|P1|NOT COMPLETED|First Period||0
15561|NCT02185534|37781|P6|COMPLETED|First Period||14
15562|NCT02185534|37782|P5|COMPLETED|First Period||14
15563|NCT02185534|37783|P4|COMPLETED|First Period||13
15564|NCT02185534|37784|P3|COMPLETED|First Period||14
15565|NCT02185534|37785|P2|COMPLETED|First Period||14
15566|NCT02185534|37786|P1|COMPLETED|First Period||14
15567|NCT02185534|37781|P6|STARTED|First Period||14
15568|NCT02185534|37782|P5|STARTED|First Period||14
15569|NCT02185534|37783|P4|STARTED|First Period||14
15570|NCT02185534|37784|P3|STARTED|First Period||14
15571|NCT02185534|37785|P2|STARTED|First Period||14
15572|NCT02185534|37786|P1|STARTED|First Period||14
15573|NCT02185339|37803|P2|NOT COMPLETED|Overall Study||1
15574|NCT02185339|37804|P1|NOT COMPLETED|Overall Study||0
15575|NCT02185339|37803|P2|COMPLETED|Overall Study||30
15576|NCT02185339|37804|P1|COMPLETED|Overall Study||30
15577|NCT02185339|37803|P2|STARTED|Overall Study||31
15578|NCT02185339|37804|P1|STARTED|Overall Study||30
15579|NCT02185183|37826|P1|NOT COMPLETED|Overall Study||0
15580|NCT02185183|37826|P1|COMPLETED|Overall Study||14
15581|NCT02185183|37826|P1|STARTED|Overall Study||14
15582|NCT02185131|37832|P2|NOT COMPLETED|Overall Study||1
15583|NCT02185131|37833|P1|NOT COMPLETED|Overall Study||1
15584|NCT02185131|37832|P2|COMPLETED|Overall Study||8
15585|NCT02185131|37833|P1|COMPLETED|Overall Study||6
15586|NCT02185131|37832|P2|STARTED|Overall Study||9
15587|NCT02185131|37833|P1|STARTED|Overall Study||7
15588|NCT02185105|37841|P1|NOT COMPLETED|Overall Study||0
15589|NCT02185105|37841|P1|COMPLETED|Overall Study||30
15590|NCT02185105|37841|P1|STARTED|Overall Study||30
15591|NCT02184624|37889|P5|NOT COMPLETED|Overall Study||0
15592|NCT02184624|37890|P4|NOT COMPLETED|Overall Study||0
15593|NCT02184624|37891|P3|NOT COMPLETED|Overall Study||0
15594|NCT02184624|37892|P2|NOT COMPLETED|Overall Study||0
15595|NCT02184624|37893|P1|NOT COMPLETED|Overall Study||0
15596|NCT02184624|37889|P5|COMPLETED|Overall Study||98
15597|NCT02184624|37890|P4|COMPLETED|Overall Study||118
15598|NCT02184624|37891|P3|COMPLETED|Overall Study||100
15599|NCT02184624|37892|P2|COMPLETED|Overall Study||80
15600|NCT02184624|37893|P1|COMPLETED|Overall Study||171
15601|NCT02184624|37889|P5|STARTED|Overall Study||98
15602|NCT02184624|37890|P4|STARTED|Overall Study||118
15603|NCT02184624|37891|P3|STARTED|Overall Study||100
15604|NCT02184624|37892|P2|STARTED|Overall Study||80
15605|NCT02184624|37893|P1|STARTED|Overall Study||171
15606|NCT02184494|37938|P3|NOT COMPLETED|Overall Study||0
15607|NCT02184494|37939|P2|NOT COMPLETED|Overall Study||2
15608|NCT02184494|37940|P1|NOT COMPLETED|Overall Study||1
15609|NCT02184494|37938|P3|COMPLETED|Overall Study||8
15610|NCT02184494|37939|P2|COMPLETED|Overall Study||11
15611|NCT02184494|37940|P1|COMPLETED|Overall Study||12
15612|NCT02184494|37938|P3|STARTED|Overall Study||8
15613|NCT02184494|37939|P2|STARTED|Overall Study||13
15614|NCT02184494|37940|P1|STARTED|Overall Study||13
15615|NCT02182895|37962|P2|NOT COMPLETED|Overall Study||4
15616|NCT02182895|37963|P1|NOT COMPLETED|Overall Study||2
15617|NCT02182895|37962|P2|COMPLETED|Overall Study||33
15618|NCT02182895|37963|P1|COMPLETED|Overall Study||33
15619|NCT02182895|37962|P2|STARTED|Overall Study||37
15620|NCT02182895|37963|P1|STARTED|Overall Study||35
15621|NCT02183675|37989|P6|NOT COMPLETED|Treatment Period 3 (10 Days)||0
15622|NCT02183675|37990|P5|NOT COMPLETED|Treatment Period 3 (10 Days)||0
15623|NCT02183675|37991|P4|NOT COMPLETED|Treatment Period 3 (10 Days)||0
15624|NCT02183675|37992|P3|NOT COMPLETED|Treatment Period 3 (10 Days)||0
15625|NCT02183675|37993|P2|NOT COMPLETED|Treatment Period 3 (10 Days)||0
15626|NCT02183675|37994|P1|NOT COMPLETED|Treatment Period 3 (10 Days)||0
15627|NCT02183675|37989|P6|COMPLETED|Treatment Period 3 (10 Days)||4
15628|NCT02183675|37990|P5|COMPLETED|Treatment Period 3 (10 Days)||6
15629|NCT02183675|37991|P4|COMPLETED|Treatment Period 3 (10 Days)||6
15630|NCT02183675|37992|P3|COMPLETED|Treatment Period 3 (10 Days)||6
15631|NCT02183675|37993|P2|COMPLETED|Treatment Period 3 (10 Days)||6
15632|NCT02183675|37994|P1|COMPLETED|Treatment Period 3 (10 Days)||6
15633|NCT02183675|37989|P6|STARTED|Treatment Period 3 (10 Days)||4
15634|NCT02183675|37990|P5|STARTED|Treatment Period 3 (10 Days)||6
15635|NCT02183675|37991|P4|STARTED|Treatment Period 3 (10 Days)||6
15636|NCT02183675|37992|P3|STARTED|Treatment Period 3 (10 Days)||6
15637|NCT02183675|37993|P2|STARTED|Treatment Period 3 (10 Days)||6
15638|NCT02183675|37994|P1|STARTED|Treatment Period 3 (10 Days)||6
15639|NCT02183675|37989|P6|NOT COMPLETED|Treatment Period 2 (10 Days)||2
15640|NCT02183675|37990|P5|NOT COMPLETED|Treatment Period 2 (10 Days)||0
15641|NCT02183675|37991|P4|NOT COMPLETED|Treatment Period 2 (10 Days)||0
15642|NCT02183675|37992|P3|NOT COMPLETED|Treatment Period 2 (10 Days)||0
15643|NCT02183675|37993|P2|NOT COMPLETED|Treatment Period 2 (10 Days)||0
15644|NCT02183675|37994|P1|NOT COMPLETED|Treatment Period 2 (10 Days)||0
15645|NCT02183675|37989|P6|COMPLETED|Treatment Period 2 (10 Days)|Patients withdrew after completion of treatment period 2 but before beginning of treatment period 3|4
15646|NCT02183675|37990|P5|COMPLETED|Treatment Period 2 (10 Days)||6
15647|NCT02183675|37991|P4|COMPLETED|Treatment Period 2 (10 Days)||6
15648|NCT02183675|37992|P3|COMPLETED|Treatment Period 2 (10 Days)||6
15649|NCT02183675|37993|P2|COMPLETED|Treatment Period 2 (10 Days)||6
15650|NCT02183675|37994|P1|COMPLETED|Treatment Period 2 (10 Days)||6
15651|NCT02183675|37989|P6|STARTED|Treatment Period 2 (10 Days)||6
15652|NCT02183675|37990|P5|STARTED|Treatment Period 2 (10 Days)||6
15653|NCT02183675|37991|P4|STARTED|Treatment Period 2 (10 Days)||6
15654|NCT02183675|37992|P3|STARTED|Treatment Period 2 (10 Days)||6
15655|NCT02183675|37993|P2|STARTED|Treatment Period 2 (10 Days)||6
15656|NCT02183675|37994|P1|STARTED|Treatment Period 2 (10 Days)||6
15657|NCT02183675|37989|P6|NOT COMPLETED|Treatment Period 1 (10 Days)||0
15658|NCT02183675|37990|P5|NOT COMPLETED|Treatment Period 1 (10 Days)||0
15659|NCT02183675|37991|P4|NOT COMPLETED|Treatment Period 1 (10 Days)||0
15660|NCT02183675|37992|P3|NOT COMPLETED|Treatment Period 1 (10 Days)||0
15661|NCT02183675|37993|P2|NOT COMPLETED|Treatment Period 1 (10 Days)||0
15662|NCT02183675|37994|P1|NOT COMPLETED|Treatment Period 1 (10 Days)||0
15663|NCT02183675|37989|P6|COMPLETED|Treatment Period 1 (10 Days)||6
15664|NCT02183675|37990|P5|COMPLETED|Treatment Period 1 (10 Days)||6
15665|NCT02183675|37991|P4|COMPLETED|Treatment Period 1 (10 Days)||6
15666|NCT02183675|37992|P3|COMPLETED|Treatment Period 1 (10 Days)||6
15667|NCT02183675|37993|P2|COMPLETED|Treatment Period 1 (10 Days)||6
15668|NCT02183675|37994|P1|COMPLETED|Treatment Period 1 (10 Days)||6
15669|NCT02183675|37989|P6|STARTED|Treatment Period 1 (10 Days)||6
15670|NCT02183675|37990|P5|STARTED|Treatment Period 1 (10 Days)||6
15671|NCT02183675|37991|P4|STARTED|Treatment Period 1 (10 Days)||6
15672|NCT02183675|37992|P3|STARTED|Treatment Period 1 (10 Days)||6
15673|NCT02183675|37993|P2|STARTED|Treatment Period 1 (10 Days)||6
15674|NCT02183675|37994|P1|STARTED|Treatment Period 1 (10 Days)||6
15675|NCT02183519|38018|P2|NOT COMPLETED|Overall Study||3
15676|NCT02183519|38019|P1|NOT COMPLETED|Overall Study||3
15677|NCT02183519|38018|P2|COMPLETED|Overall Study||13
15678|NCT02183519|38019|P1|COMPLETED|Overall Study||25
15679|NCT02183519|38018|P2|STARTED|Overall Study||16
15680|NCT02183519|38019|P1|STARTED|Overall Study||28
15681|NCT02181790|38027|P2|NOT COMPLETED|Overall Study||0
15682|NCT02181790|38028|P1|NOT COMPLETED|Overall Study||2
15683|NCT02181790|38027|P2|COMPLETED|Overall Study||0
15684|NCT02181790|38028|P1|COMPLETED|Overall Study||0
15685|NCT02181790|38027|P2|STARTED|Overall Study||0
15686|NCT02181790|38028|P1|STARTED|Overall Study||2
15687|NCT02181530|38036|P1|NOT COMPLETED|Overall Study||0
15688|NCT02181530|38036|P1|COMPLETED|Overall Study||43
15689|NCT02181530|38036|P1|STARTED|Overall Study||43
15690|NCT02181517|38049|P3|NOT COMPLETED|Overall Study||0
15691|NCT02181517|38050|P2|NOT COMPLETED|Overall Study||0
15692|NCT02181517|38051|P1|NOT COMPLETED|Overall Study||0
15693|NCT02181517|38049|P3|COMPLETED|Overall Study||5
15694|NCT02181517|38050|P2|COMPLETED|Overall Study||10
15695|NCT02181517|38051|P1|COMPLETED|Overall Study||10
15696|NCT02181517|38049|P3|STARTED|Overall Study||5
15697|NCT02181517|38050|P2|STARTED|Overall Study||10
15698|NCT02181517|38051|P1|STARTED|Overall Study||10
15699|NCT02181504|38074|P3|NOT COMPLETED|Overall Study||1
15700|NCT02181504|38075|P2|NOT COMPLETED|Overall Study||1
15701|NCT02181504|38076|P1|NOT COMPLETED|Overall Study||1
15702|NCT02181504|38074|P3|COMPLETED|Overall Study||4
15703|NCT02181504|38075|P2|COMPLETED|Overall Study||9
15704|NCT02181504|38076|P1|COMPLETED|Overall Study||9
15705|NCT02181504|38074|P3|STARTED|Overall Study||5
15706|NCT02181504|38075|P2|STARTED|Overall Study||10
15707|NCT02181504|38076|P1|STARTED|Overall Study||10
15708|NCT02181387|38098|P2|NOT COMPLETED|Overall Study||4
15709|NCT02181387|38099|P1|NOT COMPLETED|Overall Study||2
15710|NCT02181387|38098|P2|COMPLETED|Overall Study||15
15711|NCT02181387|38099|P1|COMPLETED|Overall Study||12
15712|NCT02181387|38098|P2|STARTED|Overall Study||19
15713|NCT02181387|38099|P1|STARTED|Overall Study||14
15714|NCT02181140|38105|P1|NOT COMPLETED|Overall Study||0
15715|NCT02181140|38105|P1|COMPLETED|Overall Study||56
15716|NCT02181140|38105|P1|STARTED|Overall Study||56
15717|NCT02181127|38111|P1|NOT COMPLETED|Overall Study||0
15718|NCT02181127|38111|P1|COMPLETED|Overall Study||22
15719|NCT02181127|38111|P1|STARTED|Overall Study||22
15720|NCT02180893|38118|P2|NOT COMPLETED|Overall Study||7
15721|NCT02180893|38119|P1|NOT COMPLETED|Overall Study||3
15722|NCT02180893|38118|P2|COMPLETED|Overall Study||23
15723|NCT02180893|38119|P1|COMPLETED|Overall Study||27
15724|NCT02180893|38118|P2|STARTED|Overall Study||30
15725|NCT02180893|38119|P1|STARTED|Overall Study||30
15726|NCT02180828|38133|P2|NOT COMPLETED|Overall Study||7
15727|NCT02180828|38134|P1|NOT COMPLETED|Overall Study||5
15728|NCT02180828|38133|P2|COMPLETED|Overall Study||113
15729|NCT02180828|38134|P1|COMPLETED|Overall Study||115
15730|NCT02180828|38133|P2|STARTED|Overall Study||120
15731|NCT02180828|38134|P1|STARTED|Overall Study||120
15732|NCT02180646|38158|P2|NOT COMPLETED|Second Intervention (7 Days)||0
15733|NCT02180646|38159|P1|NOT COMPLETED|Second Intervention (7 Days)||0
15734|NCT02180646|38158|P2|COMPLETED|Second Intervention (7 Days)||6
15735|NCT02180646|38159|P1|COMPLETED|Second Intervention (7 Days)||6
15736|NCT02180646|38158|P2|STARTED|Second Intervention (7 Days)||6
15737|NCT02180646|38159|P1|STARTED|Second Intervention (7 Days)||6
15738|NCT02180646|38158|P2|NOT COMPLETED|Washout (7 Days)||0
15739|NCT02180646|38159|P1|NOT COMPLETED|Washout (7 Days)||0
15740|NCT02180646|38158|P2|COMPLETED|Washout (7 Days)||6
15741|NCT02180646|38159|P1|COMPLETED|Washout (7 Days)||6
15742|NCT02180646|38158|P2|STARTED|Washout (7 Days)||6
15743|NCT02180646|38159|P1|STARTED|Washout (7 Days)||6
15744|NCT02180646|38158|P2|NOT COMPLETED|First Intervention (7 Days)||0
15745|NCT02180646|38159|P1|NOT COMPLETED|First Intervention (7 Days)||0
15746|NCT02180646|38158|P2|COMPLETED|First Intervention (7 Days)||6
15747|NCT02180646|38159|P1|COMPLETED|First Intervention (7 Days)||6
15748|NCT02180646|38158|P2|STARTED|First Intervention (7 Days)||6
15749|NCT02180646|38159|P1|STARTED|First Intervention (7 Days)||6
15750|NCT02180230|38169|P1|NOT COMPLETED|Overall Study||7
15751|NCT02180230|38169|P1|COMPLETED|Overall Study||31
15752|NCT02180230|38169|P1|STARTED|Overall Study||38
15753|NCT02180061|38176|P2|NOT COMPLETED|Overall Study||8
15754|NCT02180061|38177|P1|NOT COMPLETED|Overall Study||34
15755|NCT02180061|38176|P2|COMPLETED|Overall Study||0
15756|NCT02180061|38177|P1|COMPLETED|Overall Study||0
15757|NCT02180061|38176|P2|STARTED|Overall Study||8
15758|NCT02180061|38177|P1|STARTED|Overall Study||34
15759|NCT02179892|38193|P2|NOT COMPLETED|Overall Study||0
15760|NCT02179892|38194|P1|NOT COMPLETED|Overall Study||0
15761|NCT02179892|38193|P2|COMPLETED|Overall Study||4
15762|NCT02179892|38194|P1|COMPLETED|Overall Study||5
15763|NCT02179892|38193|P2|STARTED|Overall Study||4
15764|NCT02179892|38194|P1|STARTED|Overall Study||5
15765|NCT02179424|38210|P4|NOT COMPLETED|Overall Study||0
15766|NCT02179424|38211|P3|NOT COMPLETED|Overall Study||0
15767|NCT02179424|38212|P2|NOT COMPLETED|Overall Study||0
15768|NCT02179424|38213|P1|NOT COMPLETED|Overall Study||0
15769|NCT02179424|38210|P4|COMPLETED|Overall Study||39
15770|NCT02179424|38211|P3|COMPLETED|Overall Study||516
15771|NCT02179424|38212|P2|COMPLETED|Overall Study||11
15772|NCT02179424|38213|P1|COMPLETED|Overall Study||76
15773|NCT02179424|38210|P4|STARTED|Overall Study||39
15774|NCT02179424|38211|P3|STARTED|Overall Study||516
15775|NCT02179424|38212|P2|STARTED|Overall Study||11
15776|NCT02179424|38213|P1|STARTED|Overall Study||76
15777|NCT02179398|38230|P2|NOT COMPLETED|Overall Study||4
15778|NCT02179398|38231|P1|NOT COMPLETED|Overall Study||3
15779|NCT02179398|38230|P2|COMPLETED|Overall Study||140
15780|NCT02179398|38231|P1|COMPLETED|Overall Study||131
15781|NCT02179398|38230|P2|STARTED|Overall Study||144
15782|NCT02179398|38231|P1|STARTED|Overall Study||134
15783|NCT02178995|38251|P9|NOT COMPLETED|Open Label||0
15784|NCT02178995|38252|P8|NOT COMPLETED|Open Label||0
15785|NCT02178995|38253|P7|NOT COMPLETED|Open Label||0
15786|NCT02178995|38254|P6|NOT COMPLETED|Open Label||0
15787|NCT02178995|38255|P5|NOT COMPLETED|Open Label||0
15788|NCT02178995|38256|P4|NOT COMPLETED|Open Label||0
15789|NCT02178995|38257|P3|NOT COMPLETED|Open Label||0
15790|NCT02178995|38258|P2|NOT COMPLETED|Open Label||0
15791|NCT02178995|38259|P1|NOT COMPLETED|Open Label||2
15792|NCT02178995|38251|P9|COMPLETED|Open Label||0
15793|NCT02178995|38252|P8|COMPLETED|Open Label||0
15794|NCT02178995|38253|P7|COMPLETED|Open Label||0
15795|NCT02178995|38254|P6|COMPLETED|Open Label||0
15796|NCT02178995|38255|P5|COMPLETED|Open Label||0
15797|NCT02178995|38256|P4|COMPLETED|Open Label||0
15798|NCT02178995|38257|P3|COMPLETED|Open Label||0
15799|NCT02178995|38258|P2|COMPLETED|Open Label||14
15800|NCT02178995|38259|P1|COMPLETED|Open Label||28
15801|NCT02178995|38251|P9|STARTED|Open Label||0
15802|NCT02178995|38252|P8|STARTED|Open Label||0
15803|NCT02178995|38253|P7|STARTED|Open Label||0
15804|NCT02178995|38254|P6|STARTED|Open Label||0
15805|NCT02178995|38255|P5|STARTED|Open Label||0
15806|NCT02178995|38256|P4|STARTED|Open Label||0
15807|NCT02178995|38257|P3|STARTED|Open Label||0
15808|NCT02178995|38258|P2|STARTED|Open Label|One was lost to follow-up after completion of visit 4.|14
15809|NCT02178995|38259|P1|STARTED|Open Label|2 declined to join open-label. 1 withdrew from double-blind but rejoined open-label due to benefit.|30
15810|NCT02178995|38251|P9|NOT COMPLETED|Double Blind||1
15811|NCT02178995|38252|P8|NOT COMPLETED|Double Blind||2
15812|NCT02178995|38253|P7|NOT COMPLETED|Double Blind||0
15813|NCT02178995|38254|P6|NOT COMPLETED|Double Blind||1
15814|NCT02178995|38255|P5|NOT COMPLETED|Double Blind||0
15815|NCT02178995|38256|P4|NOT COMPLETED|Double Blind||0
15816|NCT02178995|38257|P3|NOT COMPLETED|Double Blind||0
15817|NCT02178995|38258|P2|NOT COMPLETED|Double Blind||1
15818|NCT02178995|38259|P1|NOT COMPLETED|Double Blind||0
15819|NCT02178995|38251|P9|COMPLETED|Double Blind||0
15820|NCT02178995|38252|P8|COMPLETED|Double Blind||4
15821|NCT02178995|38253|P7|COMPLETED|Double Blind||5
15822|NCT02178995|38254|P6|COMPLETED|Double Blind||5
15823|NCT02178995|38255|P5|COMPLETED|Double Blind||6
15824|NCT02178995|38256|P4|COMPLETED|Double Blind||6
15825|NCT02178995|38257|P3|COMPLETED|Double Blind||5
15826|NCT02178995|38258|P2|COMPLETED|Double Blind||15
15827|NCT02178995|38259|P1|COMPLETED|Double Blind||0
15828|NCT02178995|38251|P9|STARTED|Double Blind||1
15829|NCT02178995|38252|P8|STARTED|Double Blind||6
15830|NCT02178995|38253|P7|STARTED|Double Blind||5
15831|NCT02178995|38254|P6|STARTED|Double Blind||6
15832|NCT02178995|38255|P5|STARTED|Double Blind||6
15833|NCT02178995|38256|P4|STARTED|Double Blind||6
15834|NCT02178995|38257|P3|STARTED|Double Blind||5
15835|NCT02178995|38258|P2|STARTED|Double Blind||16
15836|NCT02178995|38259|P1|STARTED|Double Blind||0
15837|NCT02178787|38332|P2|NOT COMPLETED|Overall Study||9
15838|NCT02178787|38333|P1|NOT COMPLETED|Overall Study||5
15839|NCT02178787|38332|P2|COMPLETED|Overall Study||30
15840|NCT02178787|38333|P1|COMPLETED|Overall Study||30
15841|NCT02178787|38332|P2|STARTED|Overall Study||39
15842|NCT02178787|38333|P1|STARTED|Overall Study||35
15843|NCT02178540|38341|P1|NOT COMPLETED|Overall Study||0
15844|NCT02178540|38341|P1|COMPLETED|Overall Study||45
15845|NCT02178540|38341|P1|STARTED|Overall Study||45
15846|NCT02178059|38348|P2|NOT COMPLETED|Second Intervention||0
15847|NCT02178059|38349|P1|NOT COMPLETED|Second Intervention||0
15848|NCT02178059|38348|P2|COMPLETED|Second Intervention||17
15849|NCT02178059|38349|P1|COMPLETED|Second Intervention||16
15850|NCT02178059|38348|P2|STARTED|Second Intervention||17
15851|NCT02178059|38349|P1|STARTED|Second Intervention||16
15852|NCT02178059|38348|P2|NOT COMPLETED|Washout||0
15853|NCT02178059|38349|P1|NOT COMPLETED|Washout||1
15854|NCT02178059|38348|P2|COMPLETED|Washout||17
15855|NCT02178059|38349|P1|COMPLETED|Washout||16
15856|NCT02178059|38348|P2|STARTED|Washout||17
15857|NCT02178059|38349|P1|STARTED|Washout||17
15858|NCT02178059|38348|P2|NOT COMPLETED|First Intervention||0
15859|NCT02178059|38349|P1|NOT COMPLETED|First Intervention||0
15860|NCT02178059|38348|P2|COMPLETED|First Intervention||17
15861|NCT02178059|38349|P1|COMPLETED|First Intervention||17
15862|NCT02178059|38348|P2|STARTED|First Intervention||17
15863|NCT02178059|38349|P1|STARTED|First Intervention||17
15864|NCT02177266|38367|P2|NOT COMPLETED|Overall Study||1
15865|NCT02177266|38368|P1|NOT COMPLETED|Overall Study||1
15866|NCT02177266|38367|P2|COMPLETED|Overall Study||0
15867|NCT02177266|38368|P1|COMPLETED|Overall Study||0
15868|NCT02177266|38367|P2|STARTED|Overall Study||1
15869|NCT02177266|38368|P1|STARTED|Overall Study||1
15870|NCT02177201|38380|P2|NOT COMPLETED|Overall Study||3
15871|NCT02177201|38381|P1|NOT COMPLETED|Overall Study||3
15872|NCT02177201|38380|P2|COMPLETED|Overall Study||77
15873|NCT02177201|38381|P1|COMPLETED|Overall Study||77
15874|NCT02177201|38380|P2|STARTED|Overall Study||80
15875|NCT02177201|38381|P1|STARTED|Overall Study||80
15876|NCT02177032|38391|P4|NOT COMPLETED|Overall Study||0
15877|NCT02177032|38392|P3|NOT COMPLETED|Overall Study||3
15878|NCT02177032|38393|P2|NOT COMPLETED|Overall Study||2
15879|NCT02177032|38394|P1|NOT COMPLETED|Overall Study||5
15880|NCT02177032|38391|P4|COMPLETED|Overall Study||88
15881|NCT02177032|38392|P3|COMPLETED|Overall Study||351
15882|NCT02177032|38393|P2|COMPLETED|Overall Study||86
15883|NCT02177032|38394|P1|COMPLETED|Overall Study||350
15884|NCT02177032|38391|P4|STARTED|Overall Study||88
15885|NCT02177032|38392|P3|STARTED|Overall Study||354
15886|NCT02177032|38393|P2|STARTED|Overall Study||88
15887|NCT02177032|38394|P1|STARTED|Overall Study||355
15888|NCT02176655|38428|P1|NOT COMPLETED|Overall Study||6
15889|NCT02176655|38428|P1|COMPLETED|Overall Study||25
15890|NCT02176655|38428|P1|STARTED|Overall Study||31
15891|NCT02176525|38457|P8|NOT COMPLETED|Overall Study||0
15892|NCT02176525|38458|P7|NOT COMPLETED|Overall Study||1
15893|NCT02176525|38459|P6|NOT COMPLETED|Overall Study||1
15894|NCT02176525|38460|P5|NOT COMPLETED|Overall Study||1
15895|NCT02176525|38461|P4|NOT COMPLETED|Overall Study||1
15896|NCT02176525|38462|P3|NOT COMPLETED|Overall Study||0
15897|NCT02176525|38463|P2|NOT COMPLETED|Overall Study||0
15898|NCT02176525|38464|P1|NOT COMPLETED|Overall Study||1
15899|NCT02176525|38457|P8|COMPLETED|Overall Study||10
15900|NCT02176525|38458|P7|COMPLETED|Overall Study||8
15901|NCT02176525|38459|P6|COMPLETED|Overall Study||5
15902|NCT02176525|38460|P5|COMPLETED|Overall Study||7
15903|NCT02176525|38461|P4|COMPLETED|Overall Study||8
15904|NCT02176525|38462|P3|COMPLETED|Overall Study||9
15905|NCT02176525|38463|P2|COMPLETED|Overall Study||9
15906|NCT02176525|38464|P1|COMPLETED|Overall Study||14
15907|NCT02176525|38457|P8|STARTED|Overall Study||10
15908|NCT02176525|38458|P7|STARTED|Overall Study||9
15909|NCT02176525|38459|P6|STARTED|Overall Study|6 subjects randomized, 5 subjects treated with at least one dose, 1 subject was not treated|6
15910|NCT02176525|38460|P5|STARTED|Overall Study||8
15911|NCT02176525|38461|P4|STARTED|Overall Study||9
15912|NCT02176525|38462|P3|STARTED|Overall Study||9
15913|NCT02176525|38463|P2|STARTED|Overall Study||9
15914|NCT02176525|38464|P1|STARTED|Overall Study|15 subjects randomized, 14 subjects treated with at least one dose, 1 subject was not treated|15
15915|NCT02176421|38641|P1|NOT COMPLETED|Overall Study||5
15916|NCT02176421|38641|P1|COMPLETED|Overall Study||75
15917|NCT02176421|38641|P1|STARTED|Overall Study||80
15918|NCT02176356|38650|P1|NOT COMPLETED|Overall Study||23
15919|NCT02176356|38650|P1|COMPLETED|Overall Study||93
15920|NCT02176356|38650|P1|Eligible and Received Treatment|Overall Study||100
15921|NCT02176356|38650|P1|STARTED|Overall Study||116
15922|NCT02176343|38667|P1|NOT COMPLETED|Overall Study||0
15923|NCT02176343|38667|P1|COMPLETED|Overall Study||31
15924|NCT02176343|38667|P1|STARTED|Overall Study||31
15925|NCT02175771|38686|P9|NOT COMPLETED|Treatment Period||6
15926|NCT02175771|38687|P8|NOT COMPLETED|Treatment Period||17
15927|NCT02175771|38688|P7|NOT COMPLETED|Treatment Period||5
15928|NCT02175771|38689|P6|NOT COMPLETED|Treatment Period||10
15929|NCT02175771|38690|P5|NOT COMPLETED|Treatment Period||5
15930|NCT02175771|38691|P4|NOT COMPLETED|Treatment Period||13
15931|NCT02175771|38692|P3|NOT COMPLETED|Treatment Period||7
15932|NCT02175771|38693|P2|NOT COMPLETED|Treatment Period||16
15933|NCT02175771|38694|P1|NOT COMPLETED|Treatment Period||0
15934|NCT02175771|38686|P9|COMPLETED|Treatment Period||38
15935|NCT02175771|38687|P8|COMPLETED|Treatment Period||116
15936|NCT02175771|38688|P7|COMPLETED|Treatment Period||36
15937|NCT02175771|38689|P6|COMPLETED|Treatment Period||110
15938|NCT02175771|38690|P5|COMPLETED|Treatment Period||36
15939|NCT02175771|38691|P4|COMPLETED|Treatment Period||113
15940|NCT02175771|38692|P3|COMPLETED|Treatment Period||35
15941|NCT02175771|38693|P2|COMPLETED|Treatment Period||111
15942|NCT02175771|38694|P1|COMPLETED|Treatment Period||0
15943|NCT02175771|38686|P9|STARTED|Treatment Period||44
15944|NCT02175771|38687|P8|STARTED|Treatment Period||133
15945|NCT02175771|38688|P7|STARTED|Treatment Period||41
15946|NCT02175771|38689|P6|STARTED|Treatment Period||120
15947|NCT02175771|38690|P5|STARTED|Treatment Period||41
15948|NCT02175771|38691|P4|STARTED|Treatment Period||126
15949|NCT02175771|38692|P3|STARTED|Treatment Period||42
15950|NCT02175771|38693|P2|STARTED|Treatment Period||127
15951|NCT02175771|38694|P1|STARTED|Treatment Period||0
15952|NCT02175771|38686|P9|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15953|NCT02175771|38687|P8|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15954|NCT02175771|38688|P7|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15955|NCT02175771|38689|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15956|NCT02175771|38690|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15957|NCT02175771|38691|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15958|NCT02175771|38692|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15959|NCT02175771|38693|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
15960|NCT02175771|38694|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||84
15961|NCT02175771|38686|P9|COMPLETED|Run-In Period (Pre-assignment)||0
15962|NCT02175771|38687|P8|COMPLETED|Run-In Period (Pre-assignment)||0
15963|NCT02175771|38688|P7|COMPLETED|Run-In Period (Pre-assignment)||0
15964|NCT02175771|38689|P6|COMPLETED|Run-In Period (Pre-assignment)||0
15965|NCT02175771|38690|P5|COMPLETED|Run-In Period (Pre-assignment)||0
15966|NCT02175771|38691|P4|COMPLETED|Run-In Period (Pre-assignment)||0
15967|NCT02175771|38692|P3|COMPLETED|Run-In Period (Pre-assignment)||0
15968|NCT02175771|38693|P2|COMPLETED|Run-In Period (Pre-assignment)||0
15969|NCT02175771|38694|P1|COMPLETED|Run-In Period (Pre-assignment)||674
15970|NCT02175771|38686|P9|STARTED|Run-In Period (Pre-assignment)||0
15971|NCT02175771|38687|P8|STARTED|Run-In Period (Pre-assignment)||0
15972|NCT02175771|38688|P7|STARTED|Run-In Period (Pre-assignment)||0
15973|NCT02175771|38689|P6|STARTED|Run-In Period (Pre-assignment)||0
15974|NCT02175771|38690|P5|STARTED|Run-In Period (Pre-assignment)||0
15975|NCT02175771|38691|P4|STARTED|Run-In Period (Pre-assignment)||0
15976|NCT02175771|38692|P3|STARTED|Run-In Period (Pre-assignment)||0
15977|NCT02175771|38693|P2|STARTED|Run-In Period (Pre-assignment)||0
15978|NCT02175771|38694|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled; two participants were enrolled but had no enrollment date in their records.|758
15979|NCT02175745|38752|P1|NOT COMPLETED|Overall Study||1
15980|NCT02175745|38752|P1|COMPLETED|Overall Study||1
15981|NCT02175745|38752|P1|STARTED|Overall Study||2
15982|NCT02175212|38759|P2|NOT COMPLETED|Overall Study||147
15983|NCT02175212|38760|P1|NOT COMPLETED|Overall Study||163
15984|NCT02175212|38759|P2|COMPLETED|Overall Study||31
15985|NCT02175212|38760|P1|COMPLETED|Overall Study||14
15986|NCT02175212|38759|P2|STARTED|Overall Study||178
15987|NCT02175212|38760|P1|STARTED|Overall Study||177
15988|NCT02175199|38776|P2|NOT COMPLETED|Overall Study||5
15989|NCT02175199|38777|P1|NOT COMPLETED|Overall Study||3
15990|NCT02175199|38776|P2|COMPLETED|Overall Study||71
15991|NCT02175199|38777|P1|COMPLETED|Overall Study||71
15992|NCT02175199|38776|P2|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|74
15993|NCT02175199|38777|P1|Dispensed|Overall Study|Two subjects were randomized but never dispensed study lenses.|72
15994|NCT02175199|38776|P2|STARTED|Overall Study||76
15995|NCT02175199|38777|P1|STARTED|Overall Study||74
15996|NCT02175121|38791|P5|NOT COMPLETED|Overall Study||1
15997|NCT02175121|38792|P4|NOT COMPLETED|Overall Study||1
15998|NCT02175121|38793|P3|NOT COMPLETED|Overall Study||2
15999|NCT02175121|38794|P2|NOT COMPLETED|Overall Study||1
16000|NCT02175121|38795|P1|NOT COMPLETED|Overall Study||1
16001|NCT02175121|38791|P5|COMPLETED|Overall Study||33
16002|NCT02175121|38792|P4|COMPLETED|Overall Study||34
16003|NCT02175121|38793|P3|COMPLETED|Overall Study||32
16004|NCT02175121|38794|P2|COMPLETED|Overall Study||34
16005|NCT02175121|38795|P1|COMPLETED|Overall Study||33
16006|NCT02175121|38791|P5|STARTED|Overall Study||34
16007|NCT02175121|38792|P4|STARTED|Overall Study||35
16008|NCT02175121|38793|P3|STARTED|Overall Study||34
16009|NCT02175121|38794|P2|STARTED|Overall Study||35
16010|NCT02175121|38795|P1|STARTED|Overall Study||34
16011|NCT02173769|38922|P1|NOT COMPLETED|Overall Study||4
16012|NCT02173769|38922|P1|COMPLETED|Overall Study||1854
16013|NCT02173769|38922|P1|STARTED|Overall Study||1858
16014|NCT02173535|38953|P20|NOT COMPLETED|Period 5||0
16015|NCT02173535|38954|P19|NOT COMPLETED|Period 5||0
16016|NCT02173535|38955|P18|NOT COMPLETED|Period 5||0
16017|NCT02173535|38956|P17|NOT COMPLETED|Period 5||0
16018|NCT02173535|38957|P16|NOT COMPLETED|Period 5||0
16019|NCT02173535|38958|P15|NOT COMPLETED|Period 5||0
16020|NCT02173535|38959|P14|NOT COMPLETED|Period 5||0
16021|NCT02173535|38960|P13|NOT COMPLETED|Period 5||0
16022|NCT02173535|38961|P12|NOT COMPLETED|Period 5||0
16023|NCT02173535|38962|P11|NOT COMPLETED|Period 5||0
16024|NCT02173535|38963|P10|NOT COMPLETED|Period 5||0
16025|NCT02173535|38964|P9|NOT COMPLETED|Period 5||0
16026|NCT02173535|38965|P8|NOT COMPLETED|Period 5||0
16027|NCT02173535|38966|P7|NOT COMPLETED|Period 5||0
16028|NCT02173535|38967|P6|NOT COMPLETED|Period 5||0
16029|NCT02173535|38968|P5|NOT COMPLETED|Period 5||0
16030|NCT02173535|38969|P4|NOT COMPLETED|Period 5||0
16031|NCT02173535|38970|P3|NOT COMPLETED|Period 5||0
16032|NCT02173535|38971|P2|NOT COMPLETED|Period 5||0
16033|NCT02173535|38972|P1|NOT COMPLETED|Period 5||0
16034|NCT02173535|38953|P20|COMPLETED|Period 5||12
16035|NCT02173535|38954|P19|COMPLETED|Period 5||12
16036|NCT02173535|38955|P18|COMPLETED|Period 5||12
16037|NCT02173535|38956|P17|COMPLETED|Period 5||12
16038|NCT02173535|38957|P16|COMPLETED|Period 5||12
16039|NCT02173535|38958|P15|COMPLETED|Period 5||12
16040|NCT02173535|38959|P14|COMPLETED|Period 5||12
16041|NCT02173535|38960|P13|COMPLETED|Period 5||12
16042|NCT02173535|38961|P12|COMPLETED|Period 5||12
16043|NCT02173535|38962|P11|COMPLETED|Period 5||12
16044|NCT02173535|38963|P10|COMPLETED|Period 5||12
16045|NCT02173535|38964|P9|COMPLETED|Period 5||12
16046|NCT02173535|38965|P8|COMPLETED|Period 5||12
16047|NCT02173535|38966|P7|COMPLETED|Period 5||12
16048|NCT02173535|38967|P6|COMPLETED|Period 5||12
16049|NCT02173535|38968|P5|COMPLETED|Period 5||12
16050|NCT02173535|38969|P4|COMPLETED|Period 5||12
16051|NCT02173535|38970|P3|COMPLETED|Period 5||12
16052|NCT02173535|38971|P2|COMPLETED|Period 5||12
16053|NCT02173535|38972|P1|COMPLETED|Period 5||12
16054|NCT02173535|38953|P20|STARTED|Period 5||12
16055|NCT02173535|38954|P19|STARTED|Period 5||12
16056|NCT02173535|38955|P18|STARTED|Period 5||12
16057|NCT02173535|38956|P17|STARTED|Period 5||12
16058|NCT02173535|38957|P16|STARTED|Period 5||12
16059|NCT02173535|38958|P15|STARTED|Period 5||12
16060|NCT02173535|38959|P14|STARTED|Period 5||12
16061|NCT02173535|38960|P13|STARTED|Period 5||12
16062|NCT02173535|38961|P12|STARTED|Period 5||12
16063|NCT02173535|38962|P11|STARTED|Period 5||12
16064|NCT02173535|38963|P10|STARTED|Period 5||12
16065|NCT02173535|38964|P9|STARTED|Period 5||12
16066|NCT02173535|38965|P8|STARTED|Period 5||12
16067|NCT02173535|38966|P7|STARTED|Period 5||12
16068|NCT02173535|38967|P6|STARTED|Period 5||12
16069|NCT02173535|38968|P5|STARTED|Period 5||12
16070|NCT02173535|38969|P4|STARTED|Period 5||12
16071|NCT02173535|38970|P3|STARTED|Period 5||12
16072|NCT02173535|38971|P2|STARTED|Period 5||12
16073|NCT02173535|38972|P1|STARTED|Period 5||12
16074|NCT02173535|38953|P20|NOT COMPLETED|Period 4||0
16075|NCT02173535|38954|P19|NOT COMPLETED|Period 4||0
16076|NCT02173535|38955|P18|NOT COMPLETED|Period 4||0
16077|NCT02173535|38956|P17|NOT COMPLETED|Period 4||0
16078|NCT02173535|38957|P16|NOT COMPLETED|Period 4||0
16079|NCT02173535|38958|P15|NOT COMPLETED|Period 4||0
16080|NCT02173535|38959|P14|NOT COMPLETED|Period 4||0
16081|NCT02173535|38960|P13|NOT COMPLETED|Period 4||0
16082|NCT02173535|38961|P12|NOT COMPLETED|Period 4||0
16083|NCT02173535|38962|P11|NOT COMPLETED|Period 4||0
16084|NCT02173535|38963|P10|NOT COMPLETED|Period 4||0
16085|NCT02173535|38964|P9|NOT COMPLETED|Period 4||0
16086|NCT02173535|38965|P8|NOT COMPLETED|Period 4||0
16087|NCT02173535|38966|P7|NOT COMPLETED|Period 4||0
16088|NCT02173535|38967|P6|NOT COMPLETED|Period 4||0
16089|NCT02173535|38968|P5|NOT COMPLETED|Period 4||0
16090|NCT02173535|38969|P4|NOT COMPLETED|Period 4||0
16091|NCT02173535|38970|P3|NOT COMPLETED|Period 4||0
16092|NCT02173535|38971|P2|NOT COMPLETED|Period 4||0
16093|NCT02173535|38972|P1|NOT COMPLETED|Period 4||0
16094|NCT02173535|38953|P20|COMPLETED|Period 4||12
16095|NCT02173535|38954|P19|COMPLETED|Period 4||12
16096|NCT02173535|38955|P18|COMPLETED|Period 4||12
16097|NCT02173535|38956|P17|COMPLETED|Period 4||12
16098|NCT02173535|38957|P16|COMPLETED|Period 4||12
16099|NCT02173535|38958|P15|COMPLETED|Period 4||12
16100|NCT02173535|38959|P14|COMPLETED|Period 4||12
16101|NCT02173535|38960|P13|COMPLETED|Period 4||12
16102|NCT02173535|38961|P12|COMPLETED|Period 4||12
16103|NCT02173535|38962|P11|COMPLETED|Period 4||12
16104|NCT02173535|38963|P10|COMPLETED|Period 4||12
16105|NCT02173535|38964|P9|COMPLETED|Period 4||12
16106|NCT02173535|38965|P8|COMPLETED|Period 4||12
16107|NCT02173535|38966|P7|COMPLETED|Period 4||12
16108|NCT02173535|38967|P6|COMPLETED|Period 4||12
16109|NCT02173535|38968|P5|COMPLETED|Period 4||12
16110|NCT02173535|38969|P4|COMPLETED|Period 4||12
16111|NCT02173535|38970|P3|COMPLETED|Period 4||12
16112|NCT02173535|38971|P2|COMPLETED|Period 4||12
16113|NCT02173535|38972|P1|COMPLETED|Period 4||12
16114|NCT02173535|38953|P20|STARTED|Period 4||12
16115|NCT02173535|38954|P19|STARTED|Period 4||12
16116|NCT02173535|38955|P18|STARTED|Period 4||12
16117|NCT02173535|38956|P17|STARTED|Period 4||12
16118|NCT02173535|38957|P16|STARTED|Period 4||12
16119|NCT02173535|38958|P15|STARTED|Period 4||12
16120|NCT02173535|38959|P14|STARTED|Period 4||12
16121|NCT02173535|38960|P13|STARTED|Period 4||12
16122|NCT02173535|38961|P12|STARTED|Period 4||12
16123|NCT02173535|38962|P11|STARTED|Period 4||12
16124|NCT02173535|38963|P10|STARTED|Period 4||12
16125|NCT02173535|38964|P9|STARTED|Period 4||12
16126|NCT02173535|38965|P8|STARTED|Period 4||12
16127|NCT02173535|38966|P7|STARTED|Period 4||12
16128|NCT02173535|38967|P6|STARTED|Period 4||12
16129|NCT02173535|38968|P5|STARTED|Period 4||12
16130|NCT02173535|38969|P4|STARTED|Period 4||12
16131|NCT02173535|38970|P3|STARTED|Period 4||12
16132|NCT02173535|38971|P2|STARTED|Period 4||12
16133|NCT02173535|38972|P1|STARTED|Period 4||12
16134|NCT02173535|38953|P20|NOT COMPLETED|Period 3||0
16135|NCT02173535|38954|P19|NOT COMPLETED|Period 3||0
16136|NCT02173535|38955|P18|NOT COMPLETED|Period 3||0
16137|NCT02173535|38956|P17|NOT COMPLETED|Period 3||0
16138|NCT02173535|38957|P16|NOT COMPLETED|Period 3||0
16139|NCT02173535|38958|P15|NOT COMPLETED|Period 3||0
16140|NCT02173535|38959|P14|NOT COMPLETED|Period 3||0
16141|NCT02173535|38960|P13|NOT COMPLETED|Period 3||0
16142|NCT02173535|38961|P12|NOT COMPLETED|Period 3||0
16143|NCT02173535|38962|P11|NOT COMPLETED|Period 3||0
16144|NCT02173535|38963|P10|NOT COMPLETED|Period 3||0
16145|NCT02173535|38964|P9|NOT COMPLETED|Period 3||0
16146|NCT02173535|38965|P8|NOT COMPLETED|Period 3||0
16147|NCT02173535|38966|P7|NOT COMPLETED|Period 3||0
16148|NCT02173535|38967|P6|NOT COMPLETED|Period 3||0
16149|NCT02173535|38968|P5|NOT COMPLETED|Period 3||0
16150|NCT02173535|38969|P4|NOT COMPLETED|Period 3||0
16151|NCT02173535|38970|P3|NOT COMPLETED|Period 3||0
16152|NCT02173535|38971|P2|NOT COMPLETED|Period 3||0
16153|NCT02173535|38972|P1|NOT COMPLETED|Period 3||0
16154|NCT02173535|38953|P20|COMPLETED|Period 3||12
16155|NCT02173535|38954|P19|COMPLETED|Period 3||12
16156|NCT02173535|38955|P18|COMPLETED|Period 3||12
16157|NCT02173535|38956|P17|COMPLETED|Period 3||12
16158|NCT02173535|38957|P16|COMPLETED|Period 3||12
16159|NCT02173535|38958|P15|COMPLETED|Period 3||12
16160|NCT02173535|38959|P14|COMPLETED|Period 3||12
16161|NCT02173535|38960|P13|COMPLETED|Period 3||12
16162|NCT02173535|38961|P12|COMPLETED|Period 3||12
16163|NCT02173535|38962|P11|COMPLETED|Period 3||12
16164|NCT02173535|38963|P10|COMPLETED|Period 3||12
16165|NCT02173535|38964|P9|COMPLETED|Period 3||12
16166|NCT02173535|38965|P8|COMPLETED|Period 3||12
16167|NCT02173535|38966|P7|COMPLETED|Period 3||12
16168|NCT02173535|38967|P6|COMPLETED|Period 3||12
16169|NCT02173535|38968|P5|COMPLETED|Period 3||12
16170|NCT02173535|38969|P4|COMPLETED|Period 3||12
16171|NCT02173535|38970|P3|COMPLETED|Period 3||12
16172|NCT02173535|38971|P2|COMPLETED|Period 3||12
16173|NCT02173535|38972|P1|COMPLETED|Period 3||12
16174|NCT02173535|38953|P20|STARTED|Period 3||12
16175|NCT02173535|38954|P19|STARTED|Period 3||12
16176|NCT02173535|38955|P18|STARTED|Period 3||12
16177|NCT02173535|38956|P17|STARTED|Period 3||12
16178|NCT02173535|38957|P16|STARTED|Period 3||12
16179|NCT02173535|38958|P15|STARTED|Period 3||12
16180|NCT02173535|38959|P14|STARTED|Period 3||12
16181|NCT02173535|38960|P13|STARTED|Period 3||12
16182|NCT02173535|38961|P12|STARTED|Period 3||12
16183|NCT02173535|38962|P11|STARTED|Period 3||12
16184|NCT02173535|38963|P10|STARTED|Period 3||12
16185|NCT02173535|38964|P9|STARTED|Period 3||12
16186|NCT02173535|38965|P8|STARTED|Period 3||12
16187|NCT02173535|38966|P7|STARTED|Period 3||12
16188|NCT02173535|38967|P6|STARTED|Period 3||12
16189|NCT02173535|38968|P5|STARTED|Period 3||12
16190|NCT02173535|38969|P4|STARTED|Period 3||12
16191|NCT02173535|38970|P3|STARTED|Period 3||12
16192|NCT02173535|38971|P2|STARTED|Period 3||12
16193|NCT02173535|38972|P1|STARTED|Period 3||12
16194|NCT02173535|38953|P20|NOT COMPLETED|Period 2||0
16195|NCT02173535|38954|P19|NOT COMPLETED|Period 2||0
16196|NCT02173535|38955|P18|NOT COMPLETED|Period 2||0
16197|NCT02173535|38956|P17|NOT COMPLETED|Period 2||0
16198|NCT02173535|38957|P16|NOT COMPLETED|Period 2||0
16199|NCT02173535|38958|P15|NOT COMPLETED|Period 2||0
16200|NCT02173535|38959|P14|NOT COMPLETED|Period 2||0
16201|NCT02173535|38960|P13|NOT COMPLETED|Period 2||0
16202|NCT02173535|38961|P12|NOT COMPLETED|Period 2||0
16203|NCT02173535|38962|P11|NOT COMPLETED|Period 2||0
16204|NCT02173535|38963|P10|NOT COMPLETED|Period 2||0
16205|NCT02173535|38964|P9|NOT COMPLETED|Period 2||0
16206|NCT02173535|38965|P8|NOT COMPLETED|Period 2||0
16207|NCT02173535|38966|P7|NOT COMPLETED|Period 2||0
16208|NCT02173535|38967|P6|NOT COMPLETED|Period 2||0
16209|NCT02173535|38968|P5|NOT COMPLETED|Period 2||0
16210|NCT02173535|38969|P4|NOT COMPLETED|Period 2||0
16211|NCT02173535|38970|P3|NOT COMPLETED|Period 2||0
16212|NCT02173535|38971|P2|NOT COMPLETED|Period 2||0
16213|NCT02173535|38972|P1|NOT COMPLETED|Period 2||0
16214|NCT02173535|38953|P20|COMPLETED|Period 2||12
16215|NCT02173535|38954|P19|COMPLETED|Period 2||12
16216|NCT02173535|38955|P18|COMPLETED|Period 2||12
16217|NCT02173535|38956|P17|COMPLETED|Period 2||12
16218|NCT02173535|38957|P16|COMPLETED|Period 2||12
16219|NCT02173535|38958|P15|COMPLETED|Period 2||12
16220|NCT02173535|38959|P14|COMPLETED|Period 2||12
16221|NCT02173535|38960|P13|COMPLETED|Period 2||12
16222|NCT02173535|38961|P12|COMPLETED|Period 2||12
16223|NCT02173535|38962|P11|COMPLETED|Period 2||12
16224|NCT02173535|38963|P10|COMPLETED|Period 2||12
16225|NCT02173535|38964|P9|COMPLETED|Period 2||12
16226|NCT02173535|38965|P8|COMPLETED|Period 2||12
16227|NCT02173535|38966|P7|COMPLETED|Period 2||12
16228|NCT02173535|38967|P6|COMPLETED|Period 2||12
16229|NCT02173535|38968|P5|COMPLETED|Period 2||12
16230|NCT02173535|38969|P4|COMPLETED|Period 2||12
16231|NCT02173535|38970|P3|COMPLETED|Period 2||12
16232|NCT02173535|38971|P2|COMPLETED|Period 2||12
16233|NCT02173535|38972|P1|COMPLETED|Period 2||12
16234|NCT02173535|38953|P20|STARTED|Period 2||12
16235|NCT02173535|38954|P19|STARTED|Period 2||12
16236|NCT02173535|38955|P18|STARTED|Period 2||12
16237|NCT02173535|38956|P17|STARTED|Period 2||12
16238|NCT02173535|38957|P16|STARTED|Period 2||12
16239|NCT02173535|38958|P15|STARTED|Period 2||12
16240|NCT02173535|38959|P14|STARTED|Period 2||12
16241|NCT02173535|38960|P13|STARTED|Period 2||12
16242|NCT02173535|38961|P12|STARTED|Period 2||12
16243|NCT02173535|38962|P11|STARTED|Period 2||12
16244|NCT02173535|38963|P10|STARTED|Period 2||12
16245|NCT02173535|38964|P9|STARTED|Period 2||12
16246|NCT02173535|38965|P8|STARTED|Period 2||12
16247|NCT02173535|38966|P7|STARTED|Period 2||12
16248|NCT02173535|38967|P6|STARTED|Period 2||12
16249|NCT02173535|38968|P5|STARTED|Period 2||12
16250|NCT02173535|38969|P4|STARTED|Period 2||12
16251|NCT02173535|38970|P3|STARTED|Period 2||12
16252|NCT02173535|38971|P2|STARTED|Period 2||12
16253|NCT02173535|38972|P1|STARTED|Period 2||12
16254|NCT02173535|38953|P20|NOT COMPLETED|Period 1||0
16255|NCT02173535|38954|P19|NOT COMPLETED|Period 1||0
16256|NCT02173535|38955|P18|NOT COMPLETED|Period 1||0
16257|NCT02173535|38956|P17|NOT COMPLETED|Period 1||0
16258|NCT02173535|38957|P16|NOT COMPLETED|Period 1||0
16259|NCT02173535|38958|P15|NOT COMPLETED|Period 1||0
16260|NCT02173535|38959|P14|NOT COMPLETED|Period 1||0
16261|NCT02173535|38960|P13|NOT COMPLETED|Period 1||0
16262|NCT02173535|38961|P12|NOT COMPLETED|Period 1||0
16263|NCT02173535|38962|P11|NOT COMPLETED|Period 1||0
16264|NCT02173535|38963|P10|NOT COMPLETED|Period 1||0
16265|NCT02173535|38964|P9|NOT COMPLETED|Period 1||0
16266|NCT02173535|38965|P8|NOT COMPLETED|Period 1||0
16267|NCT02173535|38966|P7|NOT COMPLETED|Period 1||0
16268|NCT02173535|38967|P6|NOT COMPLETED|Period 1||0
16269|NCT02173535|38968|P5|NOT COMPLETED|Period 1||0
16270|NCT02173535|38969|P4|NOT COMPLETED|Period 1||0
16271|NCT02173535|38970|P3|NOT COMPLETED|Period 1||0
16272|NCT02173535|38971|P2|NOT COMPLETED|Period 1||0
16273|NCT02173535|38972|P1|NOT COMPLETED|Period 1||0
16274|NCT02173535|38953|P20|COMPLETED|Period 1||12
16275|NCT02173535|38954|P19|COMPLETED|Period 1||12
16276|NCT02173535|38955|P18|COMPLETED|Period 1||12
16277|NCT02173535|38956|P17|COMPLETED|Period 1||12
16278|NCT02173535|38957|P16|COMPLETED|Period 1||12
16279|NCT02173535|38958|P15|COMPLETED|Period 1||12
16280|NCT02173535|38959|P14|COMPLETED|Period 1||12
16281|NCT02173535|38960|P13|COMPLETED|Period 1||12
16282|NCT02173535|38961|P12|COMPLETED|Period 1||12
16283|NCT02173535|38962|P11|COMPLETED|Period 1||12
16284|NCT02173535|38963|P10|COMPLETED|Period 1||12
16285|NCT02173535|38964|P9|COMPLETED|Period 1||12
16286|NCT02173535|38965|P8|COMPLETED|Period 1||12
16287|NCT02173535|38966|P7|COMPLETED|Period 1||12
16288|NCT02173535|38967|P6|COMPLETED|Period 1||12
16289|NCT02173535|38968|P5|COMPLETED|Period 1||12
16290|NCT02173535|38969|P4|COMPLETED|Period 1||12
16291|NCT02173535|38970|P3|COMPLETED|Period 1||12
16292|NCT02173535|38971|P2|COMPLETED|Period 1||12
16293|NCT02173535|38972|P1|COMPLETED|Period 1||12
16294|NCT02173535|38953|P20|STARTED|Period 1||12
16295|NCT02173535|38954|P19|STARTED|Period 1||12
16296|NCT02173535|38955|P18|STARTED|Period 1||12
16297|NCT02173535|38956|P17|STARTED|Period 1||12
16298|NCT02173535|38957|P16|STARTED|Period 1||12
16299|NCT02173535|38958|P15|STARTED|Period 1||12
16300|NCT02173535|38959|P14|STARTED|Period 1||12
16301|NCT02173535|38960|P13|STARTED|Period 1||12
16302|NCT02173535|38961|P12|STARTED|Period 1||12
16303|NCT02173535|38962|P11|STARTED|Period 1||12
16304|NCT02173535|38963|P10|STARTED|Period 1||12
16305|NCT02173535|38964|P9|STARTED|Period 1||12
16306|NCT02173535|38965|P8|STARTED|Period 1||12
16307|NCT02173535|38966|P7|STARTED|Period 1||12
16308|NCT02173535|38967|P6|STARTED|Period 1||12
16309|NCT02173535|38968|P5|STARTED|Period 1||12
16310|NCT02173535|38969|P4|STARTED|Period 1||12
16311|NCT02173535|38970|P3|STARTED|Period 1||12
16312|NCT02173535|38971|P2|STARTED|Period 1||12
16313|NCT02173535|38972|P1|STARTED|Period 1||12
16314|NCT02173392|39011|P2|NOT COMPLETED|Overall Study||4
16315|NCT02173392|39012|P1|NOT COMPLETED|Overall Study||14
16316|NCT02173392|39011|P2|COMPLETED|Overall Study||68
16317|NCT02173392|39012|P1|COMPLETED|Overall Study||59
16318|NCT02173392|39011|P2|STARTED|Overall Study||72
16319|NCT02173392|39012|P1|STARTED|Overall Study||73
16320|NCT02173054|39025|P3|NOT COMPLETED|Overall Study||1
16321|NCT02173054|39026|P2|NOT COMPLETED|Overall Study||0
16322|NCT02173054|39027|P1|NOT COMPLETED|Overall Study||1
16323|NCT02173054|39025|P3|COMPLETED|Overall Study||39
16324|NCT02173054|39026|P2|COMPLETED|Overall Study||40
16325|NCT02173054|39027|P1|COMPLETED|Overall Study||39
16326|NCT02173054|39025|P3|STARTED|Overall Study||40
16327|NCT02173054|39026|P2|STARTED|Overall Study||40
16328|NCT02173054|39027|P1|STARTED|Overall Study||40
16329|NCT02172755|39049|P2|NOT COMPLETED|Overall Study||4
16330|NCT02172755|39050|P1|NOT COMPLETED|Overall Study||2
16331|NCT02172755|39049|P2|COMPLETED|Overall Study||12
16332|NCT02172755|39050|P1|COMPLETED|Overall Study||12
16333|NCT02172755|39049|P2|STARTED|Overall Study||16
16334|NCT02172755|39050|P1|STARTED|Overall Study||14
16335|NCT02172742|39062|P2|NOT COMPLETED|Overall Study||0
16336|NCT02172742|39063|P1|NOT COMPLETED|Overall Study||1
16337|NCT02172742|39062|P2|COMPLETED|Overall Study||6
16338|NCT02172742|39063|P1|COMPLETED|Overall Study||6
16339|NCT02172742|39062|P2|STARTED|Overall Study||6
16340|NCT02172742|39063|P1|STARTED|Overall Study||7
16341|NCT02172625|39072|P2|NOT COMPLETED|Overall Study||3
16342|NCT02172625|39073|P1|NOT COMPLETED|Overall Study||0
16343|NCT02172625|39072|P2|COMPLETED|Overall Study||16
16344|NCT02172625|39073|P1|COMPLETED|Overall Study||19
16345|NCT02172625|39072|P2|STARTED|Overall Study||19
16346|NCT02172625|39073|P1|STARTED|Overall Study||19
16347|NCT02171611|39091|P6|NOT COMPLETED|Overall Study||0
16348|NCT02171611|39092|P5|NOT COMPLETED|Overall Study||0
16349|NCT02171611|39093|P4|NOT COMPLETED|Overall Study||0
16350|NCT02171611|39094|P3|NOT COMPLETED|Overall Study||0
16351|NCT02171611|39095|P2|NOT COMPLETED|Overall Study||0
16352|NCT02171611|39096|P1|NOT COMPLETED|Overall Study||0
16353|NCT02171611|39091|P6|COMPLETED|Overall Study||5
16354|NCT02171611|39092|P5|COMPLETED|Overall Study||5
16355|NCT02171611|39093|P4|COMPLETED|Overall Study||5
16356|NCT02171611|39094|P3|COMPLETED|Overall Study||5
16357|NCT02171611|39095|P2|COMPLETED|Overall Study||5
16358|NCT02171611|39096|P1|COMPLETED|Overall Study||5
16359|NCT02171611|39091|P6|STARTED|Overall Study||5
16360|NCT02171611|39092|P5|STARTED|Overall Study||5
16361|NCT02171611|39093|P4|STARTED|Overall Study||5
16362|NCT02171611|39094|P3|STARTED|Overall Study||5
16363|NCT02171611|39095|P2|STARTED|Overall Study||5
16364|NCT02171611|39096|P1|STARTED|Overall Study||5
16365|NCT02171247|39166|P2|NOT COMPLETED|Overall Study||0
16366|NCT02171247|39167|P1|NOT COMPLETED|Overall Study||0
16367|NCT02171247|39166|P2|COMPLETED|Overall Study||17
16368|NCT02171247|39167|P1|COMPLETED|Overall Study||16
16369|NCT02171247|39166|P2|STARTED|Overall Study||17
16370|NCT02171247|39167|P1|STARTED|Overall Study||16
16371|NCT02171234|39184|P5|NOT COMPLETED|Overall Study||0
16372|NCT02171234|39185|P4|NOT COMPLETED|Overall Study||0
16373|NCT02171234|39186|P3|NOT COMPLETED|Overall Study||0
16374|NCT02171234|39187|P2|NOT COMPLETED|Overall Study||0
16375|NCT02171234|39188|P1|NOT COMPLETED|Overall Study||0
16376|NCT02171234|39184|P5|COMPLETED|Overall Study||6
16377|NCT02171234|39185|P4|COMPLETED|Overall Study||6
16378|NCT02171234|39186|P3|COMPLETED|Overall Study||6
16379|NCT02171234|39187|P2|COMPLETED|Overall Study||6
16380|NCT02171234|39188|P1|COMPLETED|Overall Study||8
16381|NCT02171234|39184|P5|STARTED|Overall Study||6
16382|NCT02171234|39185|P4|STARTED|Overall Study||6
16383|NCT02171234|39186|P3|STARTED|Overall Study||6
16384|NCT02171234|39187|P2|STARTED|Overall Study||6
16385|NCT02171234|39188|P1|STARTED|Overall Study||8
16386|NCT02171195|39217|P9|NOT COMPLETED|Overall Study||0
16387|NCT02171195|39218|P8|NOT COMPLETED|Overall Study||0
16388|NCT02171195|39219|P7|NOT COMPLETED|Overall Study||0
16389|NCT02171195|39220|P6|NOT COMPLETED|Overall Study||0
16390|NCT02171195|39221|P5|NOT COMPLETED|Overall Study||0
16391|NCT02171195|39222|P4|NOT COMPLETED|Overall Study||0
16392|NCT02171195|39223|P3|NOT COMPLETED|Overall Study||0
16393|NCT02171195|39224|P2|NOT COMPLETED|Overall Study||0
16394|NCT02171195|39225|P1|NOT COMPLETED|Overall Study||0
16395|NCT02171195|39217|P9|COMPLETED|Overall Study||6
16396|NCT02171195|39218|P8|COMPLETED|Overall Study||6
16397|NCT02171195|39219|P7|COMPLETED|Overall Study||6
16398|NCT02171195|39220|P6|COMPLETED|Overall Study||6
16399|NCT02171195|39221|P5|COMPLETED|Overall Study||6
16400|NCT02171195|39222|P4|COMPLETED|Overall Study||6
16401|NCT02171195|39223|P3|COMPLETED|Overall Study||6
16402|NCT02171195|39224|P2|COMPLETED|Overall Study||6
16403|NCT02171195|39225|P1|COMPLETED|Overall Study||16
16404|NCT02171195|39217|P9|STARTED|Overall Study||6
16405|NCT02171195|39218|P8|STARTED|Overall Study||6
16406|NCT02171195|39219|P7|STARTED|Overall Study||6
16407|NCT02171195|39220|P6|STARTED|Overall Study||6
16408|NCT02171195|39221|P5|STARTED|Overall Study||6
16409|NCT02171195|39222|P4|STARTED|Overall Study||6
16410|NCT02171195|39223|P3|STARTED|Overall Study||6
16411|NCT02171195|39224|P2|STARTED|Overall Study||6
16412|NCT02171195|39225|P1|STARTED|Overall Study||16
16413|NCT02170779|39247|P2|NOT COMPLETED|Overall Study||1
16414|NCT02170779|39248|P1|NOT COMPLETED|Overall Study||1
16415|NCT02170779|39247|P2|COMPLETED|Overall Study||19
16416|NCT02170779|39248|P1|COMPLETED|Overall Study||19
16417|NCT02170779|39247|P2|STARTED|Overall Study||20
16418|NCT02170779|39248|P1|STARTED|Overall Study||20
16419|NCT02170688|39275|P5|NOT COMPLETED|Overall Study||0
16420|NCT02170688|39276|P4|NOT COMPLETED|Overall Study||2
16421|NCT02170688|39277|P3|NOT COMPLETED|Overall Study||4
16422|NCT02170688|39278|P2|NOT COMPLETED|Overall Study||3
16423|NCT02170688|39279|P1|NOT COMPLETED|Overall Study||4
16424|NCT02170688|39275|P5|COMPLETED|Overall Study||25
16425|NCT02170688|39276|P4|COMPLETED|Overall Study||25
16426|NCT02170688|39277|P3|COMPLETED|Overall Study||25
16427|NCT02170688|39278|P2|COMPLETED|Overall Study||26
16428|NCT02170688|39279|P1|COMPLETED|Overall Study||25
16429|NCT02170688|39275|P5|STARTED|Overall Study||25
16430|NCT02170688|39276|P4|STARTED|Overall Study||27
16431|NCT02170688|39277|P3|STARTED|Overall Study||29
16432|NCT02170688|39278|P2|STARTED|Overall Study||29
16433|NCT02170688|39279|P1|STARTED|Overall Study||29
16434|NCT02170662|39298|P2|NOT COMPLETED|Overall Study||0
16435|NCT02170662|39299|P1|NOT COMPLETED|Overall Study||0
16436|NCT02170662|39298|P2|COMPLETED|Overall Study||6
16437|NCT02170662|39299|P1|COMPLETED|Overall Study||3
16438|NCT02170662|39298|P2|STARTED|Overall Study||6
16439|NCT02170662|39299|P1|STARTED|Overall Study||3
16440|NCT02170649|39311|P1|NOT COMPLETED|Fed Period||0
16441|NCT02170649|39311|P1|COMPLETED|Fed Period||12
16442|NCT02170649|39311|P1|STARTED|Fed Period||12
16443|NCT02170649|39311|P1|NOT COMPLETED|Fasting Period||0
16444|NCT02170649|39311|P1|COMPLETED|Fasting Period||12
16445|NCT02170649|39311|P1|STARTED|Fasting Period||12
16446|NCT02170532|39318|P1|NOT COMPLETED|Overall Study||0
16447|NCT02170532|39318|P1|COMPLETED|Overall Study||10
16448|NCT02170532|39318|P1|STARTED|Overall Study||10
16449|NCT02170519|39348|P2|NOT COMPLETED|Overall Study||0
16450|NCT02170519|39349|P1|NOT COMPLETED|Overall Study||0
16451|NCT02170519|39348|P2|COMPLETED|Overall Study||5
16452|NCT02170519|39349|P1|COMPLETED|Overall Study||22
16453|NCT02170519|39348|P2|STARTED|Overall Study||5
16454|NCT02170519|39349|P1|STARTED|Overall Study||22
16455|NCT02170376|39370|P5|NOT COMPLETED|Overall Study||0
16456|NCT02170376|39371|P4|NOT COMPLETED|Overall Study||0
16457|NCT02170376|39372|P3|NOT COMPLETED|Overall Study||0
16458|NCT02170376|39373|P2|NOT COMPLETED|Overall Study||1
16459|NCT02170376|39374|P1|NOT COMPLETED|Overall Study||0
16460|NCT02170376|39370|P5|COMPLETED|Overall Study||16
16461|NCT02170376|39371|P4|COMPLETED|Overall Study||16
16462|NCT02170376|39372|P3|COMPLETED|Overall Study||16
16463|NCT02170376|39373|P2|COMPLETED|Overall Study||15
16464|NCT02170376|39374|P1|COMPLETED|Overall Study||16
16465|NCT02170376|39370|P5|Pharmacokinetic Population|Overall Study||16
16466|NCT02170376|39371|P4|Pharmacokinetic Population|Overall Study||16
16467|NCT02170376|39372|P3|Pharmacokinetic Population|Overall Study||16
16468|NCT02170376|39373|P2|Pharmacokinetic Population|Overall Study||15
16469|NCT02170376|39374|P1|Pharmacokinetic Population|Overall Study||16
16470|NCT02170376|39370|P5|STARTED|Overall Study||16
16471|NCT02170376|39371|P4|STARTED|Overall Study||16
16472|NCT02170376|39372|P3|STARTED|Overall Study||16
16473|NCT02170376|39373|P2|STARTED|Overall Study||16
16474|NCT02170376|39374|P1|STARTED|Overall Study||16
16475|NCT02170220|39413|P2|NOT COMPLETED|Overall Study||0
16476|NCT02170220|39414|P1|NOT COMPLETED|Overall Study||0
16477|NCT02170220|39413|P2|COMPLETED|Overall Study||6
16478|NCT02170220|39414|P1|COMPLETED|Overall Study||6
16479|NCT02170220|39413|P2|STARTED|Overall Study||6
16480|NCT02170220|39414|P1|STARTED|Overall Study||6
16481|NCT02170207|39440|P1|NOT COMPLETED|Overall Study||5
16482|NCT02170207|39440|P1|COMPLETED|Overall Study||58
16483|NCT02170207|39440|P1|STARTED|Overall Study||63
16484|NCT02170077|39451|P3|NOT COMPLETED|Overall Study||12
16485|NCT02170077|39452|P2|NOT COMPLETED|Overall Study||13
16486|NCT02170077|39453|P1|NOT COMPLETED|Overall Study||9
16487|NCT02170077|39451|P3|COMPLETED|Overall Study||35
16488|NCT02170077|39452|P2|COMPLETED|Overall Study||34
16489|NCT02170077|39453|P1|COMPLETED|Overall Study||41
16490|NCT02170077|39451|P3|Intent to Treat (ITT) Population|Overall Study||47
16491|NCT02170077|39452|P2|Intent to Treat (ITT) Population|Overall Study||46
16492|NCT02170077|39453|P1|Intent to Treat (ITT) Population|Overall Study||50
16493|NCT02170077|39451|P3|STARTED|Overall Study||47
16494|NCT02170077|39452|P2|STARTED|Overall Study||47
16495|NCT02170077|39453|P1|STARTED|Overall Study||50
16496|NCT02170064|39464|P3|NOT COMPLETED|Overall Study||1
16497|NCT02170064|39465|P2|NOT COMPLETED|Overall Study||2
16498|NCT02170064|39466|P1|NOT COMPLETED|Overall Study||6
16499|NCT02170064|39464|P3|COMPLETED|Overall Study||10
16500|NCT02170064|39465|P2|COMPLETED|Overall Study||7
16501|NCT02170064|39466|P1|COMPLETED|Overall Study||9
16502|NCT02170064|39464|P3|Efficacy Population (EP)|Overall Study||10
16503|NCT02170064|39465|P2|Efficacy Population (EP)|Overall Study||8
16504|NCT02170064|39466|P1|Efficacy Population (EP)|Overall Study||11
16505|NCT02170064|39464|P3|Pharmacokinetic Population (PKP)|Overall Study||10
16506|NCT02170064|39465|P2|Pharmacokinetic Population (PKP)|Overall Study||8
16507|NCT02170064|39466|P1|Pharmacokinetic Population (PKP)|Overall Study||11
16508|NCT02170064|39464|P3|Safety Population (SP)|Overall Study||11
16509|NCT02170064|39465|P2|Safety Population (SP)|Overall Study||8
16510|NCT02170064|39466|P1|Safety Population (SP)|Overall Study||12
16511|NCT02170064|39464|P3|STARTED|Overall Study||11
16512|NCT02170064|39465|P2|STARTED|Overall Study||9
16513|NCT02170064|39466|P1|STARTED|Overall Study||15
16514|NCT02169895|39484|P4|NOT COMPLETED|Overall Study||2
16515|NCT02169895|39485|P3|NOT COMPLETED|Overall Study||0
16516|NCT02169895|39486|P2|NOT COMPLETED|Overall Study||0
16517|NCT02169895|39487|P1|NOT COMPLETED|Overall Study||0
16518|NCT02169895|39484|P4|COMPLETED|Overall Study||2
16519|NCT02169895|39485|P3|COMPLETED|Overall Study||4
16520|NCT02169895|39486|P2|COMPLETED|Overall Study||4
16521|NCT02169895|39487|P1|COMPLETED|Overall Study||4
16522|NCT02169895|39484|P4|Placebo|Overall Study||4
16523|NCT02169895|39485|P3|Placebo|Overall Study||4
16524|NCT02169895|39486|P2|Placebo|Overall Study||4
16525|NCT02169895|39487|P1|Placebo|Overall Study||4
16526|NCT02169895|39484|P4|100 mg BIA 9-1067|Overall Study||2
16527|NCT02169895|39485|P3|100 mg BIA 9-1067|Overall Study||4
16528|NCT02169895|39486|P2|100 mg BIA 9-1067|Overall Study||4
16529|NCT02169895|39487|P1|100 mg BIA 9-1067|Overall Study||4
16530|NCT02169895|39484|P4|50 mg BIA 9-1067|Overall Study||4
16531|NCT02169895|39485|P3|50 mg BIA 9-1067|Overall Study||4
16532|NCT02169895|39486|P2|50 mg BIA 9-1067|Overall Study||4
16533|NCT02169895|39487|P1|50 mg BIA 9-1067|Overall Study||4
16534|NCT02169895|39484|P4|25 mg BIA 9-1067|Overall Study||4
16535|NCT02169895|39485|P3|25 mg BIA 9-1067|Overall Study||4
16536|NCT02169895|39486|P2|25 mg BIA 9-1067|Overall Study||4
16537|NCT02169895|39487|P1|25 mg BIA 9-1067|Overall Study||4
16538|NCT02169895|39484|P4|STARTED|Overall Study||4
16539|NCT02169895|39485|P3|STARTED|Overall Study||4
16540|NCT02169895|39486|P2|STARTED|Overall Study||4
16541|NCT02169895|39487|P1|STARTED|Overall Study||4
16542|NCT02169479|39509|P4|NOT COMPLETED|Overall Study||0
16543|NCT02169479|39510|P3|NOT COMPLETED|Overall Study||0
16544|NCT02169479|39511|P2|NOT COMPLETED|Overall Study||1
16545|NCT02169479|39512|P1|NOT COMPLETED|Overall Study||1
16546|NCT02169479|39509|P4|COMPLETED|Overall Study||4
16547|NCT02169479|39510|P3|COMPLETED|Overall Study||4
16548|NCT02169479|39511|P2|COMPLETED|Overall Study||3
16549|NCT02169479|39512|P1|COMPLETED|Overall Study||3
16550|NCT02169479|39509|P4|Placebo|Overall Study||4
16551|NCT02169479|39510|P3|Placebo|Overall Study||4
16552|NCT02169479|39511|P2|Placebo|Overall Study||3
16553|NCT02169479|39512|P1|Placebo|Overall Study||3
16554|NCT02169479|39509|P4|100 mg BIA 9-1067|Overall Study||4
16555|NCT02169479|39510|P3|100 mg BIA 9-1067|Overall Study||4
16556|NCT02169479|39511|P2|100 mg BIA 9-1067|Overall Study||4
16557|NCT02169479|39512|P1|100 mg BIA 9-1067|Overall Study||3
16558|NCT02169479|39509|P4|50 mg BIA 9-1067|Overall Study||4
16559|NCT02169479|39510|P3|50 mg BIA 9-1067|Overall Study||4
16560|NCT02169479|39511|P2|50 mg BIA 9-1067|Overall Study||4
16561|NCT02169479|39512|P1|50 mg BIA 9-1067|Overall Study||4
16562|NCT02169479|39509|P4|25 mg BIA 9-1067|Overall Study||4
16563|NCT02169479|39510|P3|25 mg BIA 9-1067|Overall Study||4
16564|NCT02169479|39511|P2|25 mg BIA 9-1067|Overall Study||3
16565|NCT02169479|39512|P1|25 mg BIA 9-1067|Overall Study||4
16566|NCT02169479|39509|P4|STARTED|Overall Study||4
16567|NCT02169479|39510|P3|STARTED|Overall Study||4
16568|NCT02169479|39511|P2|STARTED|Overall Study||4
16569|NCT02169479|39512|P1|STARTED|Overall Study||4
16570|NCT02169466|39534|P4|NOT COMPLETED|Overall Study||0
16571|NCT02169466|39535|P3|NOT COMPLETED|Overall Study||0
16572|NCT02169466|39536|P2|NOT COMPLETED|Overall Study||1
16573|NCT02169466|39537|P1|NOT COMPLETED|Overall Study||1
16574|NCT02169466|39534|P4|COMPLETED|Overall Study||5
16575|NCT02169466|39535|P3|COMPLETED|Overall Study||5
16576|NCT02169466|39536|P2|COMPLETED|Overall Study||5
16577|NCT02169466|39537|P1|COMPLETED|Overall Study||5
16578|NCT02169466|39534|P4|Placebo|Overall Study||5
16579|NCT02169466|39535|P3|Placebo|Overall Study||5
16580|NCT02169466|39536|P2|Placebo|Overall Study||6
16581|NCT02169466|39537|P1|Placebo|Overall Study||5
16582|NCT02169466|39534|P4|100 mg BIA 9-1067|Overall Study||5
16583|NCT02169466|39535|P3|100 mg BIA 9-1067|Overall Study||5
16584|NCT02169466|39536|P2|100 mg BIA 9-1067|Overall Study||6
16585|NCT02169466|39537|P1|100 mg BIA 9-1067|Overall Study||6
16586|NCT02169466|39534|P4|50 mg BIA 9-1067|Overall Study||5
16587|NCT02169466|39535|P3|50 mg BIA 9-1067|Overall Study||5
16588|NCT02169466|39536|P2|50 mg BIA 9-1067|Overall Study||6
16589|NCT02169466|39537|P1|50 mg BIA 9-1067|Overall Study||6
16590|NCT02169466|39534|P4|25 mg BIA 9-1067|Overall Study||5
16591|NCT02169466|39535|P3|25 mg BIA 9-1067|Overall Study||5
16592|NCT02169466|39536|P2|25 mg BIA 9-1067|Overall Study||5
16593|NCT02169466|39537|P1|25 mg BIA 9-1067|Overall Study||6
16594|NCT02169466|39534|P4|STARTED|Overall Study||5
16595|NCT02169466|39535|P3|STARTED|Overall Study||5
16596|NCT02169466|39536|P2|STARTED|Overall Study||6
16597|NCT02169466|39537|P1|STARTED|Overall Study||6
16598|NCT02169453|39563|P4|NOT COMPLETED|Overall Study||0
16599|NCT02169453|39564|P3|NOT COMPLETED|Overall Study||1
16600|NCT02169453|39565|P2|NOT COMPLETED|Overall Study||0
16601|NCT02169453|39566|P1|NOT COMPLETED|Overall Study||0
16602|NCT02169453|39563|P4|COMPLETED|Overall Study||3
16603|NCT02169453|39564|P3|COMPLETED|Overall Study||2
16604|NCT02169453|39565|P2|COMPLETED|Overall Study||3
16605|NCT02169453|39566|P1|COMPLETED|Overall Study||3
16606|NCT02169453|39563|P4|Placebo|Overall Study||3
16607|NCT02169453|39564|P3|Placebo|Overall Study||3
16608|NCT02169453|39565|P2|Placebo|Overall Study||3
16609|NCT02169453|39566|P1|Placebo|Overall Study||3
16610|NCT02169453|39563|P4|100 mg BIA 9-1067|Overall Study||3
16611|NCT02169453|39564|P3|100 mg BIA 9-1067|Overall Study||3
16612|NCT02169453|39565|P2|100 mg BIA 9-1067|Overall Study||3
16613|NCT02169453|39566|P1|100 mg BIA 9-1067|Overall Study||3
16614|NCT02169453|39563|P4|50 mg BIA 9-1067|Overall Study||3
16615|NCT02169453|39564|P3|50 mg BIA 9-1067|Overall Study||2
16616|NCT02169453|39565|P2|50 mg BIA 9-1067|Overall Study||3
16617|NCT02169453|39566|P1|50 mg BIA 9-1067|Overall Study||3
16618|NCT02169453|39563|P4|25 mg BIA 9-1067|Overall Study||3
16619|NCT02169453|39564|P3|25 mg BIA 9-1067|Overall Study||3
16620|NCT02169453|39565|P2|25 mg BIA 9-1067|Overall Study||3
16621|NCT02169453|39566|P1|25 mg BIA 9-1067|Overall Study||3
16622|NCT02169453|39563|P4|STARTED|Overall Study||3
16623|NCT02169453|39564|P3|STARTED|Overall Study||3
16624|NCT02169453|39565|P2|STARTED|Overall Study||3
16625|NCT02169453|39566|P1|STARTED|Overall Study||3
16626|NCT02169440|39598|P2|NOT COMPLETED|Overall Study||0
16627|NCT02169440|39599|P1|NOT COMPLETED|Overall Study||0
16628|NCT02169440|39598|P2|COMPLETED|Overall Study||10
16629|NCT02169440|39599|P1|COMPLETED|Overall Study||10
16630|NCT02169440|39598|P2|STARTED|Overall Study||10
16631|NCT02169440|39599|P1|STARTED|Overall Study||10
16632|NCT02169427|39612|P1|NOT COMPLETED|Overall Study||0
16633|NCT02169427|39612|P1|COMPLETED|Overall Study||6
16634|NCT02169427|39612|P1|STARTED|Overall Study||6
16635|NCT02169414|39622|P4|NOT COMPLETED|Overall Study||0
16636|NCT02169414|39623|P3|NOT COMPLETED|Overall Study||0
16637|NCT02169414|39624|P2|NOT COMPLETED|Overall Study||1
16638|NCT02169414|39625|P1|NOT COMPLETED|Overall Study||1
16639|NCT02169414|39622|P4|COMPLETED|Overall Study||18
16640|NCT02169414|39623|P3|COMPLETED|Overall Study||18
16641|NCT02169414|39624|P2|COMPLETED|Overall Study||18
16642|NCT02169414|39625|P1|COMPLETED|Overall Study||18
16643|NCT02169414|39622|P4|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
16644|NCT02169414|39623|P3|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
16645|NCT02169414|39624|P2|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
16646|NCT02169414|39625|P1|BIA 9-1067 + Levodopa/Benserazide|Overall Study||18
16647|NCT02169414|39622|P4|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
16648|NCT02169414|39623|P3|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
16649|NCT02169414|39624|P2|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||19
16650|NCT02169414|39625|P1|BIA 9-1067 + Levodopa/Carbidopa|Overall Study||18
16651|NCT02169414|39622|P4|STARTED|Overall Study||18
16652|NCT02169414|39623|P3|STARTED|Overall Study||18
16653|NCT02169414|39624|P2|STARTED|Overall Study||19
16654|NCT02169414|39625|P1|STARTED|Overall Study||19
16655|NCT02169336|39666|P3|NOT COMPLETED|Overall Study||3
16656|NCT02169336|39667|P2|NOT COMPLETED|Overall Study||4
16657|NCT02169336|39668|P1|NOT COMPLETED|Overall Study||4
16658|NCT02169336|39666|P3|COMPLETED|Overall Study||29
16659|NCT02169336|39667|P2|COMPLETED|Overall Study||28
16660|NCT02169336|39668|P1|COMPLETED|Overall Study||27
16661|NCT02169336|39666|P3|STARTED|Overall Study||32
16662|NCT02169336|39667|P2|STARTED|Overall Study||32
16663|NCT02169336|39668|P1|STARTED|Overall Study||31
16664|NCT02169115|39679|P3|NOT COMPLETED|Overall Study||0
16665|NCT02169115|39680|P2|NOT COMPLETED|Overall Study||0
16666|NCT02169115|39681|P1|NOT COMPLETED|Overall Study||0
16667|NCT02169115|39679|P3|COMPLETED|Overall Study||21
16668|NCT02169115|39680|P2|COMPLETED|Overall Study||21
16669|NCT02169115|39681|P1|COMPLETED|Overall Study||19
16670|NCT02169115|39679|P3|STARTED|Overall Study||21
16671|NCT02169115|39680|P2|STARTED|Overall Study||21
16672|NCT02169115|39681|P1|STARTED|Overall Study||19
16673|NCT02168491|39689|P1|NOT COMPLETED|Overall Study||1
16674|NCT02168491|39689|P1|COMPLETED|Overall Study||8
16675|NCT02168491|39689|P1|STARTED|Overall Study||9
16676|NCT02168478|39695|P1|NOT COMPLETED|Overall Study||4
16677|NCT02168478|39695|P1|COMPLETED|Overall Study||202
16678|NCT02168478|39695|P1|STARTED|Overall Study||206
16679|NCT02168439|39701|P2|NOT COMPLETED|Overall Study||2
16680|NCT02168439|39702|P1|NOT COMPLETED|Overall Study||0
16681|NCT02168439|39701|P2|COMPLETED|Overall Study||18
16682|NCT02168439|39702|P1|COMPLETED|Overall Study||20
16683|NCT02168439|39701|P2|STARTED|Overall Study||20
16684|NCT02168439|39702|P1|STARTED|Overall Study||20
16685|NCT02168387|39720|P2|NOT COMPLETED|Overall Study||3
16686|NCT02168387|39721|P1|NOT COMPLETED|Overall Study||7
16687|NCT02168387|39720|P2|COMPLETED|Overall Study||16
16688|NCT02168387|39721|P1|COMPLETED|Overall Study||13
16689|NCT02168387|39720|P2|STARTED|Overall Study||19
16690|NCT02168387|39721|P1|STARTED|Overall Study||20
16691|NCT02168361|39733|P2|NOT COMPLETED|Overall Study||10
16692|NCT02168361|39734|P1|NOT COMPLETED|Overall Study||5
16693|NCT02168361|39733|P2|COMPLETED|Overall Study||21
16694|NCT02168361|39734|P1|COMPLETED|Overall Study||57
16695|NCT02168361|39733|P2|STARTED|Overall Study||31
16696|NCT02168361|39734|P1|STARTED|Overall Study||62
16697|NCT02167893|39742|P1|NOT COMPLETED|Overall Study||163
16698|NCT02167893|39742|P1|COMPLETED|Overall Study||11125
16699|NCT02167893|39742|P1|STARTED|Overall Study||11288
16700|NCT02167867|39753|P2|NOT COMPLETED|Overall Study||0
16701|NCT02167867|39754|P1|NOT COMPLETED|Overall Study||0
16702|NCT02167867|39753|P2|COMPLETED|Overall Study||22
16703|NCT02167867|39754|P1|COMPLETED|Overall Study||22
16704|NCT02167867|39753|P2|STARTED|Overall Study||22
16705|NCT02167867|39754|P1|STARTED|Overall Study||22
16706|NCT02167815|39762|P2|NOT COMPLETED|Overall Study||0
16707|NCT02167815|39763|P1|NOT COMPLETED|Overall Study||0
16708|NCT02167815|39762|P2|COMPLETED|Overall Study||21
16709|NCT02167815|39763|P1|COMPLETED|Overall Study||9
16710|NCT02167815|39762|P2|STARTED|Overall Study||21
16711|NCT02167815|39763|P1|STARTED|Overall Study||9
16712|NCT02167139|39776|P4|NOT COMPLETED|Transition-extension||5
16713|NCT02167139|39777|P3|NOT COMPLETED|Transition-extension||8
16714|NCT02167139|39778|P2|NOT COMPLETED|Transition-extension||0
16715|NCT02167139|39779|P1|NOT COMPLETED|Transition-extension||6
16716|NCT02167139|39776|P4|COMPLETED|Transition-extension||124
16717|NCT02167139|39777|P3|COMPLETED|Transition-extension||117
16718|NCT02167139|39778|P2|COMPLETED|Transition-extension||0
16719|NCT02167139|39779|P1|COMPLETED|Transition-extension||248
16720|NCT02167139|39776|P4|STARTED|Transition-extension||129
16721|NCT02167139|39777|P3|STARTED|Transition-extension||125
16722|NCT02167139|39778|P2|STARTED|Transition-extension||0
16723|NCT02167139|39779|P1|STARTED|Transition-extension||254
16724|NCT02167139|39776|P4|NOT COMPLETED|Randomised, Double-blind||0
16725|NCT02167139|39777|P3|NOT COMPLETED|Randomised, Double-blind||0
16726|NCT02167139|39778|P2|NOT COMPLETED|Randomised, Double-blind||19
16727|NCT02167139|39779|P1|NOT COMPLETED|Randomised, Double-blind||17
16728|NCT02167139|39776|P4|COMPLETED|Randomised, Double-blind||0
16729|NCT02167139|39777|P3|COMPLETED|Randomised, Double-blind||0
16730|NCT02167139|39778|P2|COMPLETED|Randomised, Double-blind||254
16731|NCT02167139|39779|P1|COMPLETED|Randomised, Double-blind||254
16732|NCT02167139|39776|P4|STARTED|Randomised, Double-blind||0
16733|NCT02167139|39777|P3|STARTED|Randomised, Double-blind||0
16734|NCT02167139|39778|P2|STARTED|Randomised, Double-blind||273
16735|NCT02167139|39779|P1|STARTED|Randomised, Double-blind||271
16736|NCT02166697|39793|P1|NOT COMPLETED|Overall Study||347
16737|NCT02166697|39793|P1|COMPLETED|Overall Study||13804
16738|NCT02166697|39793|P1|STARTED|Overall Study||14151
16739|NCT02165826|39805|P3|NOT COMPLETED|Down-Titration Period||7
16740|NCT02165826|39806|P2|NOT COMPLETED|Down-Titration Period||11
16741|NCT02165826|39807|P1|NOT COMPLETED|Down-Titration Period||7
16742|NCT02165826|39805|P3|COMPLETED|Down-Titration Period||31
16743|NCT02165826|39806|P2|COMPLETED|Down-Titration Period||28
16744|NCT02165826|39807|P1|COMPLETED|Down-Titration Period||20
16745|NCT02165826|39805|P3|Safety Analysis Set: Received Study Drug|Down-Titration Period||38
16746|NCT02165826|39806|P2|Safety Analysis Set: Received Study Drug|Down-Titration Period||39
16747|NCT02165826|39807|P1|Safety Analysis Set: Received Study Drug|Down-Titration Period||27
16748|NCT02165826|39805|P3|STARTED|Down-Titration Period||38
16749|NCT02165826|39806|P2|STARTED|Down-Titration Period||39
16750|NCT02165826|39807|P1|STARTED|Down-Titration Period||27
16751|NCT02165826|39805|P3|NOT COMPLETED|Main Treatment Period||109
16752|NCT02165826|39806|P2|NOT COMPLETED|Main Treatment Period||90
16753|NCT02165826|39807|P1|NOT COMPLETED|Main Treatment Period||81
16754|NCT02165826|39805|P3|COMPLETED|Main Treatment Period||334
16755|NCT02165826|39806|P2|COMPLETED|Main Treatment Period||349
16756|NCT02165826|39807|P1|COMPLETED|Main Treatment Period||360
16757|NCT02165826|39805|P3|Safety Analysis Set: Received Study Drug|Main Treatment Period||443
16758|NCT02165826|39806|P2|Safety Analysis Set: Received Study Drug|Main Treatment Period||437
16759|NCT02165826|39807|P1|Safety Analysis Set: Received Study Drug|Main Treatment Period||441
16760|NCT02165826|39805|P3|STARTED|Main Treatment Period||443
16761|NCT02165826|39806|P2|STARTED|Main Treatment Period||439
16762|NCT02165826|39807|P1|STARTED|Main Treatment Period||441
16763|NCT02165462|39864|P1|NOT COMPLETED|Overall Study||0
16764|NCT02165462|39864|P1|COMPLETED|Overall Study||17
16765|NCT02165462|39864|P1|STARTED|Overall Study||17
16766|NCT02165111|39883|P2|NOT COMPLETED|Overall Study||0
16767|NCT02165111|39884|P1|NOT COMPLETED|Overall Study||0
16768|NCT02165111|39883|P2|COMPLETED|Overall Study||40
16769|NCT02165111|39884|P1|COMPLETED|Overall Study||40
16770|NCT02165111|39883|P2|STARTED|Overall Study||40
16771|NCT02165111|39884|P1|STARTED|Overall Study||40
16772|NCT02165072|39900|P1|NOT COMPLETED|Overall Study||0
16773|NCT02165072|39900|P1|COMPLETED|Overall Study||30
16774|NCT02165072|39900|P1|STARTED|Overall Study||30
16775|NCT02164539|39911|P7|NOT COMPLETED|Treatment Phase C (1 Week)||2
16776|NCT02164539|39912|P6|NOT COMPLETED|Treatment Phase C (1 Week)||0
16777|NCT02164539|39913|P5|NOT COMPLETED|Treatment Phase C (1 Week)||0
16778|NCT02164539|39914|P4|NOT COMPLETED|Treatment Phase C (1 Week)||0
16779|NCT02164539|39915|P3|NOT COMPLETED|Treatment Phase C (1 Week)||0
16780|NCT02164539|39916|P2|NOT COMPLETED|Treatment Phase C (1 Week)||0
16781|NCT02164539|39917|P1|NOT COMPLETED|Treatment Phase C (1 Week)||1
16782|NCT02164539|39911|P7|COMPLETED|Treatment Phase C (1 Week)||78
16783|NCT02164539|39912|P6|COMPLETED|Treatment Phase C (1 Week)||82
16784|NCT02164539|39913|P5|COMPLETED|Treatment Phase C (1 Week)||84
16785|NCT02164539|39914|P4|COMPLETED|Treatment Phase C (1 Week)||0
16786|NCT02164539|39915|P3|COMPLETED|Treatment Phase C (1 Week)||0
16787|NCT02164539|39916|P2|COMPLETED|Treatment Phase C (1 Week)||0
16788|NCT02164539|39917|P1|COMPLETED|Treatment Phase C (1 Week)||78
16789|NCT02164539|39911|P7|STARTED|Treatment Phase C (1 Week)||80
16790|NCT02164539|39912|P6|STARTED|Treatment Phase C (1 Week)||82
16791|NCT02164539|39913|P5|STARTED|Treatment Phase C (1 Week)||84
16792|NCT02164539|39914|P4|STARTED|Treatment Phase C (1 Week)||0
16793|NCT02164539|39915|P3|STARTED|Treatment Phase C (1 Week)||0
16794|NCT02164539|39916|P2|STARTED|Treatment Phase C (1 Week)||0
16795|NCT02164539|39917|P1|STARTED|Treatment Phase C (1 Week)||79
16796|NCT02164539|39911|P7|NOT COMPLETED|Treatment Phase B (1 Week)||1
16797|NCT02164539|39912|P6|NOT COMPLETED|Treatment Phase B (1 Week)||0
16798|NCT02164539|39913|P5|NOT COMPLETED|Treatment Phase B (1 Week)||3
16799|NCT02164539|39914|P4|NOT COMPLETED|Treatment Phase B (1 Week)||0
16800|NCT02164539|39915|P3|NOT COMPLETED|Treatment Phase B (1 Week)||0
16801|NCT02164539|39916|P2|NOT COMPLETED|Treatment Phase B (1 Week)||0
16802|NCT02164539|39917|P1|NOT COMPLETED|Treatment Phase B (1 Week)||0
16803|NCT02164539|39911|P7|COMPLETED|Treatment Phase B (1 Week)||162
16804|NCT02164539|39912|P6|COMPLETED|Treatment Phase B (1 Week)||0
16805|NCT02164539|39913|P5|COMPLETED|Treatment Phase B (1 Week)||163
16806|NCT02164539|39914|P4|COMPLETED|Treatment Phase B (1 Week)||0
16807|NCT02164539|39915|P3|COMPLETED|Treatment Phase B (1 Week)||0
16808|NCT02164539|39916|P2|COMPLETED|Treatment Phase B (1 Week)||0
16809|NCT02164539|39917|P1|COMPLETED|Treatment Phase B (1 Week)||0
16810|NCT02164539|39911|P7|STARTED|Treatment Phase B (1 Week)||163
16811|NCT02164539|39912|P6|STARTED|Treatment Phase B (1 Week)||0
16812|NCT02164539|39913|P5|STARTED|Treatment Phase B (1 Week)||166
16813|NCT02164539|39914|P4|STARTED|Treatment Phase B (1 Week)||0
16814|NCT02164539|39915|P3|STARTED|Treatment Phase B (1 Week)||0
16815|NCT02164539|39916|P2|STARTED|Treatment Phase B (1 Week)||0
16816|NCT02164539|39917|P1|STARTED|Treatment Phase B (1 Week)||0
16817|NCT02164539|39911|P7|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
16818|NCT02164539|39912|P6|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
16819|NCT02164539|39913|P5|NOT COMPLETED|Treatment Phase A (4 Weeks)||3
16820|NCT02164539|39914|P4|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
16821|NCT02164539|39915|P3|NOT COMPLETED|Treatment Phase A (4 Weeks)||1
16822|NCT02164539|39916|P2|NOT COMPLETED|Treatment Phase A (4 Weeks)||0
16823|NCT02164539|39917|P1|NOT COMPLETED|Treatment Phase A (4 Weeks)||2
16824|NCT02164539|39911|P7|COMPLETED|Treatment Phase A (4 Weeks)||0
16825|NCT02164539|39912|P6|COMPLETED|Treatment Phase A (4 Weeks)||83
16826|NCT02164539|39913|P5|COMPLETED|Treatment Phase A (4 Weeks)||82
16827|NCT02164539|39914|P4|COMPLETED|Treatment Phase A (4 Weeks)||44
16828|NCT02164539|39915|P3|COMPLETED|Treatment Phase A (4 Weeks)||39
16829|NCT02164539|39916|P2|COMPLETED|Treatment Phase A (4 Weeks)||42
16830|NCT02164539|39917|P1|COMPLETED|Treatment Phase A (4 Weeks)||39
16831|NCT02164539|39911|P7|STARTED|Treatment Phase A (4 Weeks)||0
16832|NCT02164539|39912|P6|STARTED|Treatment Phase A (4 Weeks)||84
16833|NCT02164539|39913|P5|STARTED|Treatment Phase A (4 Weeks)||85
16834|NCT02164539|39914|P4|STARTED|Treatment Phase A (4 Weeks)||46
16835|NCT02164539|39915|P3|STARTED|Treatment Phase A (4 Weeks)||40
16836|NCT02164539|39916|P2|STARTED|Treatment Phase A (4 Weeks)||42
16837|NCT02164539|39917|P1|STARTED|Treatment Phase A (4 Weeks)||41
16838|NCT02164396|39965|P3|NOT COMPLETED|Overall Study||0
16839|NCT02164396|39966|P2|NOT COMPLETED|Overall Study||0
16840|NCT02164396|39967|P1|NOT COMPLETED|Overall Study||0
16841|NCT02164396|39965|P3|COMPLETED|Overall Study||10
16842|NCT02164396|39966|P2|COMPLETED|Overall Study||10
16843|NCT02164396|39967|P1|COMPLETED|Overall Study||10
16844|NCT02164396|39965|P3|STARTED|Overall Study||10
16845|NCT02164396|39966|P2|STARTED|Overall Study||10
16846|NCT02164396|39967|P1|STARTED|Overall Study||10
16847|NCT02164318|39979|P4|NOT COMPLETED|Overall Study||1
16848|NCT02164318|39980|P3|NOT COMPLETED|Overall Study||0
16849|NCT02164318|39981|P2|NOT COMPLETED|Overall Study||1
16850|NCT02164318|39982|P1|NOT COMPLETED|Overall Study||0
16851|NCT02164318|39979|P4|COMPLETED|Overall Study||2
16852|NCT02164318|39980|P3|COMPLETED|Overall Study||1
16853|NCT02164318|39981|P2|COMPLETED|Overall Study||2
16854|NCT02164318|39982|P1|COMPLETED|Overall Study||4
16855|NCT02164318|39979|P4|STARTED|Overall Study||3
16856|NCT02164318|39980|P3|STARTED|Overall Study||1
16857|NCT02164318|39981|P2|STARTED|Overall Study||3
16858|NCT02164318|39982|P1|STARTED|Overall Study||4
16859|NCT02163915|40005|P5|NOT COMPLETED|Overall Study||4
16860|NCT02163915|40006|P4|NOT COMPLETED|Overall Study||3
16861|NCT02163915|40007|P3|NOT COMPLETED|Overall Study||2
16862|NCT02163915|40008|P2|NOT COMPLETED|Overall Study||0
16863|NCT02163915|40009|P1|NOT COMPLETED|Overall Study||3
16864|NCT02163915|40005|P5|COMPLETED|Overall Study||6
16865|NCT02163915|40006|P4|COMPLETED|Overall Study||6
16866|NCT02163915|40007|P3|COMPLETED|Overall Study||8
16867|NCT02163915|40008|P2|COMPLETED|Overall Study||8
16868|NCT02163915|40009|P1|COMPLETED|Overall Study||7
16869|NCT02163915|40005|P5|STARTED|Overall Study||10
16870|NCT02163915|40006|P4|STARTED|Overall Study||9
16871|NCT02163915|40007|P3|STARTED|Overall Study||10
16872|NCT02163915|40008|P2|STARTED|Overall Study||8
16873|NCT02163915|40009|P1|STARTED|Overall Study||10
16874|NCT02163733|40064|P3|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||24
16875|NCT02163733|40065|P2|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
16876|NCT02163733|40066|P1|NOT COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
16877|NCT02163733|40064|P3|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||14
16878|NCT02163733|40065|P2|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
16879|NCT02163733|40066|P1|COMPLETED|Part B: Day 15 to End Part B (AZD9291)||0
16880|NCT02163733|40064|P3|STARTED|Part B: Day 15 to End Part B (AZD9291)|No patients completed previous period as relates to Part A and arm is applicable only for Part B.|38
16881|NCT02163733|40065|P2|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
16882|NCT02163733|40066|P1|STARTED|Part B: Day 15 to End Part B (AZD9291)|Only the AZD9291 once daily (Part B) arm is applicable for this period.|0
16883|NCT02163733|40064|P3|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
16884|NCT02163733|40065|P2|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
16885|NCT02163733|40066|P1|NOT COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
16886|NCT02163733|40064|P3|COMPLETED|Part A: Day 10-15 (2nd Intervention)||0
16887|NCT02163733|40065|P2|COMPLETED|Part A: Day 10-15 (2nd Intervention)||20
16888|NCT02163733|40066|P1|COMPLETED|Part A: Day 10-15 (2nd Intervention)||18
16889|NCT02163733|40064|P3|STARTED|Part A: Day 10-15 (2nd Intervention)||0
16890|NCT02163733|40065|P2|STARTED|Part A: Day 10-15 (2nd Intervention)||20
16891|NCT02163733|40066|P1|STARTED|Part A: Day 10-15 (2nd Intervention)||18
16892|NCT02163733|40064|P3|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
16893|NCT02163733|40065|P2|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
16894|NCT02163733|40066|P1|NOT COMPLETED|Part A: Day 1-9 (1st Intervention)||0
16895|NCT02163733|40064|P3|COMPLETED|Part A: Day 1-9 (1st Intervention)||0
16896|NCT02163733|40065|P2|COMPLETED|Part A: Day 1-9 (1st Intervention)||20
16897|NCT02163733|40066|P1|COMPLETED|Part A: Day 1-9 (1st Intervention)||18
16898|NCT02163733|40064|P3|STARTED|Part A: Day 1-9 (1st Intervention)||0
16899|NCT02163733|40065|P2|STARTED|Part A: Day 1-9 (1st Intervention)||20
16900|NCT02163733|40066|P1|STARTED|Part A: Day 1-9 (1st Intervention)||18
16901|NCT02163421|40105|P4|NOT COMPLETED|Overall Study||0
16902|NCT02163421|40106|P3|NOT COMPLETED|Overall Study||0
16903|NCT02163421|40107|P2|NOT COMPLETED|Overall Study||0
16904|NCT02163421|40108|P1|NOT COMPLETED|Overall Study||0
16905|NCT02163421|40105|P4|COMPLETED|Overall Study||12
16906|NCT02163421|40106|P3|COMPLETED|Overall Study||12
16907|NCT02163421|40107|P2|COMPLETED|Overall Study||12
16908|NCT02163421|40108|P1|COMPLETED|Overall Study||12
16909|NCT02163421|40105|P4|STARTED|Overall Study||12
16910|NCT02163421|40106|P3|STARTED|Overall Study||12
16911|NCT02163421|40107|P2|STARTED|Overall Study||12
16912|NCT02163421|40108|P1|STARTED|Overall Study||12
16913|NCT02163395|40115|P1|NOT COMPLETED|Overall Study||5
16914|NCT02163395|40115|P1|COMPLETED|Overall Study||39
16915|NCT02163395|40115|P1|STARTED|Overall Study||44
16916|NCT02162979|40124|P2|NOT COMPLETED|Overall Study||0
16917|NCT02162979|40125|P1|NOT COMPLETED|Overall Study||0
16918|NCT02162979|40124|P2|COMPLETED|Overall Study||0
16919|NCT02162979|40125|P1|COMPLETED|Overall Study||0
16920|NCT02162979|40124|P2|STARTED|Overall Study||0
16921|NCT02162979|40125|P1|STARTED|Overall Study||0
16922|NCT02162758|40133|P2|NOT COMPLETED|Overall Study||1
16923|NCT02162758|40134|P1|NOT COMPLETED|Overall Study||0
16924|NCT02162758|40133|P2|COMPLETED|Overall Study||2
16925|NCT02162758|40134|P1|COMPLETED|Overall Study||3
16926|NCT02162758|40133|P2|STARTED|Overall Study||3
16927|NCT02162758|40134|P1|STARTED|Overall Study||3
16928|NCT02162680|40149|P3|NOT COMPLETED|Overall Study||0
16929|NCT02162680|40150|P2|NOT COMPLETED|Overall Study||0
16930|NCT02162680|40151|P1|NOT COMPLETED|Overall Study||0
16931|NCT02162680|40149|P3|COMPLETED|Overall Study||32
16932|NCT02162680|40150|P2|COMPLETED|Overall Study||33
16933|NCT02162680|40151|P1|COMPLETED|Overall Study||33
16934|NCT02162680|40149|P3|STARTED|Overall Study||32
16935|NCT02162680|40150|P2|STARTED|Overall Study||33
16936|NCT02162680|40151|P1|STARTED|Overall Study||33
16937|NCT02161549|40161|P2|NOT COMPLETED|Overall Study||2
16938|NCT02161549|40162|P1|NOT COMPLETED|Overall Study||6
16939|NCT02161549|40161|P2|COMPLETED|Overall Study||29
16940|NCT02161549|40162|P1|COMPLETED|Overall Study||34
16941|NCT02161549|40161|P2|STARTED|Overall Study||31
16942|NCT02161549|40162|P1|STARTED|Overall Study||40
16943|NCT02161146|40173|P5|NOT COMPLETED|Overall Study||1
16944|NCT02161146|40174|P4|NOT COMPLETED|Overall Study||3
16945|NCT02161146|40175|P3|NOT COMPLETED|Overall Study||0
16946|NCT02161146|40176|P2|NOT COMPLETED|Overall Study||4
16947|NCT02161146|40177|P1|NOT COMPLETED|Overall Study||1
16948|NCT02161146|40173|P5|COMPLETED|Overall Study||48
16949|NCT02161146|40174|P4|COMPLETED|Overall Study||45
16950|NCT02161146|40175|P3|COMPLETED|Overall Study||49
16951|NCT02161146|40176|P2|COMPLETED|Overall Study||43
16952|NCT02161146|40177|P1|COMPLETED|Overall Study||46
16953|NCT02161146|40173|P5|STARTED|Overall Study||49
16954|NCT02161146|40174|P4|STARTED|Overall Study||48
16955|NCT02161146|40175|P3|STARTED|Overall Study||49
16956|NCT02161146|40176|P2|STARTED|Overall Study||47
16957|NCT02161146|40177|P1|STARTED|Overall Study||47
16958|NCT02161016|40190|P1|NOT COMPLETED|Overall Study||1
16959|NCT02161016|40190|P1|COMPLETED|Overall Study||0
16960|NCT02161016|40190|P1|STARTED|Overall Study||1
16961|NCT02160990|40200|P2|NOT COMPLETED|Overall Study||0
16962|NCT02160990|40201|P1|NOT COMPLETED|Overall Study||0
16963|NCT02160990|40200|P2|COMPLETED|Overall Study||10
16964|NCT02160990|40201|P1|COMPLETED|Overall Study||10
16965|NCT02160990|40200|P2|STARTED|Overall Study||10
16966|NCT02160990|40201|P1|STARTED|Overall Study||10
16967|NCT02160977|40221|P2|NOT COMPLETED|Six Months After Surgery||1
16968|NCT02160977|40222|P1|NOT COMPLETED|Six Months After Surgery||2
16969|NCT02160977|40221|P2|COMPLETED|Six Months After Surgery||42
16970|NCT02160977|40222|P1|COMPLETED|Six Months After Surgery||42
16971|NCT02160977|40221|P2|STARTED|Six Months After Surgery||43
16972|NCT02160977|40222|P1|STARTED|Six Months After Surgery||44
16973|NCT02160977|40221|P2|NOT COMPLETED|Three Months After Surgery||2
16974|NCT02160977|40222|P1|NOT COMPLETED|Three Months After Surgery||0
16975|NCT02160977|40221|P2|COMPLETED|Three Months After Surgery||43
16976|NCT02160977|40222|P1|COMPLETED|Three Months After Surgery||44
16977|NCT02160977|40221|P2|STARTED|Three Months After Surgery||45
16978|NCT02160977|40222|P1|STARTED|Three Months After Surgery||44
16979|NCT02160977|40221|P2|NOT COMPLETED|Six Weeks After Surgery||0
16980|NCT02160977|40222|P1|NOT COMPLETED|Six Weeks After Surgery||1
16981|NCT02160977|40221|P2|COMPLETED|Six Weeks After Surgery||45
16982|NCT02160977|40222|P1|COMPLETED|Six Weeks After Surgery||44
16983|NCT02160977|40221|P2|STARTED|Six Weeks After Surgery||45
16984|NCT02160977|40222|P1|STARTED|Six Weeks After Surgery||45
16985|NCT02160977|40221|P2|NOT COMPLETED|One Week After Surgery||0
16986|NCT02160977|40222|P1|NOT COMPLETED|One Week After Surgery||0
16987|NCT02160977|40221|P2|COMPLETED|One Week After Surgery||45
16988|NCT02160977|40222|P1|COMPLETED|One Week After Surgery||45
16989|NCT02160977|40221|P2|STARTED|One Week After Surgery||45
16990|NCT02160977|40222|P1|STARTED|One Week After Surgery||45
16991|NCT02160873|40234|P2|NOT COMPLETED|Overall Study||0
16992|NCT02160873|40235|P1|NOT COMPLETED|Overall Study||0
16993|NCT02160873|40234|P2|COMPLETED|Overall Study||6
16994|NCT02160873|40235|P1|COMPLETED|Overall Study||6
16995|NCT02160873|40234|P2|STARTED|Overall Study||6
16996|NCT02160873|40235|P1|STARTED|Overall Study||6
16997|NCT02160314|40249|P2|NOT COMPLETED|Overall Study||13
16998|NCT02160314|40250|P1|NOT COMPLETED|Overall Study||1
16999|NCT02160314|40249|P2|COMPLETED|Overall Study||59
17000|NCT02160314|40250|P1|COMPLETED|Overall Study||72
17001|NCT02160314|40249|P2|STARTED|Overall Study||72
17002|NCT02160314|40250|P1|STARTED|Overall Study||73
17003|NCT02159950|40258|P2|NOT COMPLETED|Overall Study||2
17004|NCT02159950|40259|P1|NOT COMPLETED|Overall Study||0
17005|NCT02159950|40258|P2|COMPLETED|Overall Study||0
17006|NCT02159950|40259|P1|COMPLETED|Overall Study||0
17007|NCT02159950|40258|P2|STARTED|Overall Study||2
17008|NCT02159950|40259|P1|STARTED|Overall Study||0
17009|NCT02159859|40291|P1|NOT COMPLETED|Overall Study||0
17010|NCT02159859|40291|P1|COMPLETED|Overall Study||7
17011|NCT02159859|40291|P1|STARTED|Overall Study||7
17012|NCT02159768|40304|P1|NOT COMPLETED|Overall Study||0
17013|NCT02159768|40304|P1|COMPLETED|Overall Study|Completed 27 July 2015|30
17014|NCT02159768|40304|P1|STARTED|Overall Study|Started 16 July 2014|30
17015|NCT02159547|40311|P2|NOT COMPLETED|Overall Study||0
17016|NCT02159547|40312|P1|NOT COMPLETED|Overall Study||0
17017|NCT02159547|40311|P2|COMPLETED|Overall Study||112
17018|NCT02159547|40312|P1|COMPLETED|Overall Study||112
17019|NCT02159547|40311|P2|STARTED|Overall Study||112
17020|NCT02159547|40312|P1|STARTED|Overall Study||112
17021|NCT02159482|40320|P1|NOT COMPLETED|Overall Study||5
17022|NCT02159482|40320|P1|COMPLETED|Overall Study||6
17023|NCT02159482|40320|P1|STARTED|Overall Study||11
17024|NCT02159365|40325|P1|NOT COMPLETED|Overall Study||22
17025|NCT02159365|40325|P1|COMPLETED|Overall Study|Completed = Still on Treatment|48
17026|NCT02159365|40325|P1|STARTED|Overall Study||70
17027|NCT02159352|40331|P2|NOT COMPLETED|Overall Study||2
17028|NCT02159352|40332|P1|NOT COMPLETED|Overall Study||3
17029|NCT02159352|40331|P2|COMPLETED|Overall Study||12
17030|NCT02159352|40332|P1|COMPLETED|Overall Study||11
17031|NCT02159352|40331|P2|Phase 2 (Day 5-14)|Overall Study||12
17032|NCT02159352|40332|P1|Phase 2 (Day 5-14)|Overall Study||11
17033|NCT02159352|40331|P2|Phase 1 (Day 1- 4)|Overall Study||14
17034|NCT02159352|40332|P1|Phase 1 (Day 1- 4)|Overall Study||14
17035|NCT02159352|40331|P2|STARTED|Overall Study||14
17036|NCT02159352|40332|P1|STARTED|Overall Study||14
17037|NCT02159118|40384|P2|NOT COMPLETED|Overall Study||0
17038|NCT02159118|40385|P1|NOT COMPLETED|Overall Study||0
17039|NCT02159118|40384|P2|COMPLETED|Overall Study||22
17040|NCT02159118|40385|P1|COMPLETED|Overall Study||22
17041|NCT02159118|40384|P2|STARTED|Overall Study||22
17042|NCT02159118|40385|P1|STARTED|Overall Study||22
17043|NCT02159040|40407|P1|NOT COMPLETED|Overall Study||1
17044|NCT02159040|40407|P1|COMPLETED|Overall Study||0
17045|NCT02159040|40407|P1|STARTED|Overall Study||1
17046|NCT02158728|40420|P1|NOT COMPLETED|Overall Study||27
17047|NCT02158728|40420|P1|COMPLETED|Overall Study||53
17048|NCT02158728|40420|P1|STARTED|Overall Study||80
17049|NCT02158442|40426|P2|NOT COMPLETED|Overall Study||0
17050|NCT02158442|40427|P1|NOT COMPLETED|Overall Study||2
17051|NCT02158442|40426|P2|COMPLETED|Overall Study||7
17052|NCT02158442|40427|P1|COMPLETED|Overall Study||6
17053|NCT02158442|40426|P2|STARTED|Overall Study||7
17054|NCT02158442|40427|P1|STARTED|Overall Study||8
17055|NCT02158273|40435|P2|NOT COMPLETED|Overall Study||3
17056|NCT02158273|40436|P1|NOT COMPLETED|Overall Study||3
17057|NCT02158273|40435|P2|COMPLETED|Overall Study||22
17058|NCT02158273|40436|P1|COMPLETED|Overall Study||22
17059|NCT02158273|40435|P2|STARTED|Overall Study||25
17060|NCT02158273|40436|P1|STARTED|Overall Study||25
17061|NCT02158247|40446|P1|NOT COMPLETED|Overall Study||5
17062|NCT02158247|40446|P1|COMPLETED|Overall Study||176
17063|NCT02158247|40446|P1|STARTED|Overall Study||181
17064|NCT02158039|40462|P1|NOT COMPLETED|Overall Study||10
17065|NCT02158039|40462|P1|COMPLETED|Overall Study||23
17066|NCT02158039|40462|P1|STARTED|Overall Study||33
17067|NCT02157948|40469|P2|NOT COMPLETED|Overall Study||9
17068|NCT02157948|40470|P1|NOT COMPLETED|Overall Study||9
17069|NCT02157948|40469|P2|COMPLETED|Overall Study||188
17070|NCT02157948|40470|P1|COMPLETED|Overall Study||188
17071|NCT02157948|40469|P2|Received Treatment|Overall Study||196
17072|NCT02157948|40470|P1|Received Treatment|Overall Study||196
17073|NCT02157948|40469|P2|STARTED|Overall Study||197
17074|NCT02157948|40470|P1|STARTED|Overall Study||197
17075|NCT02157935|40482|P2|NOT COMPLETED|Overall Study||65
17076|NCT02157935|40483|P1|NOT COMPLETED|Overall Study||39
17077|NCT02157935|40482|P2|COMPLETED|Overall Study||548
17078|NCT02157935|40483|P1|COMPLETED|Overall Study||567
17079|NCT02157935|40482|P2|STARTED|Overall Study||613
17080|NCT02157935|40483|P1|STARTED|Overall Study||606
17081|NCT02157909|40501|P2|NOT COMPLETED|Overall Study||0
17082|NCT02157909|40502|P1|NOT COMPLETED|Overall Study||0
17083|NCT02157909|40501|P2|COMPLETED|Overall Study||66
17084|NCT02157909|40502|P1|COMPLETED|Overall Study||66
17085|NCT02157909|40501|P2|STARTED|Overall Study||66
17086|NCT02157909|40502|P1|STARTED|Overall Study||66
17087|NCT02157883|40509|P1|NOT COMPLETED|Part B: Day 19 to End Part B (AZD9291)||22
17088|NCT02157883|40509|P1|COMPLETED|Part B: Day 19 to End Part B (AZD9291)||16
17089|NCT02157883|40509|P1|STARTED|Part B: Day 19 to End Part B (AZD9291)||38
17090|NCT02157883|40509|P1|NOT COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||1
17091|NCT02157883|40509|P1|COMPLETED|Part A: Day 6-18 (AZD9291+Itraconozole)||38
17092|NCT02157883|40509|P1|STARTED|Part A: Day 6-18 (AZD9291+Itraconozole)||39
17093|NCT02157883|40509|P1|NOT COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||0
17094|NCT02157883|40509|P1|COMPLETED|Part A: Day 1-5 (AZD9291 Alone)||39
17095|NCT02157883|40509|P1|STARTED|Part A: Day 1-5 (AZD9291 Alone)||39
17096|NCT02157623|40540|P2|NOT COMPLETED|Overall Study||3
17097|NCT02157623|40541|P1|NOT COMPLETED|Overall Study||4
17098|NCT02157623|40540|P2|COMPLETED|Overall Study||0
17099|NCT02157623|40541|P1|COMPLETED|Overall Study||0
17100|NCT02157623|40540|P2|STARTED|Overall Study||3
17101|NCT02157623|40541|P1|STARTED|Overall Study||4
17102|NCT02157376|40549|P2|NOT COMPLETED|Overall Study||18
17103|NCT02157376|40550|P1|NOT COMPLETED|Overall Study||22
17104|NCT02157376|40549|P2|COMPLETED|Overall Study||138
17105|NCT02157376|40550|P1|COMPLETED|Overall Study||133
17106|NCT02157376|40549|P2|STARTED|Overall Study||156
17107|NCT02157376|40550|P1|STARTED|Overall Study||155
17108|NCT02157298|40560|P2|NOT COMPLETED|Overall Study||2
17109|NCT02157298|40561|P1|NOT COMPLETED|Overall Study||4
17110|NCT02157298|40560|P2|COMPLETED|Overall Study||58
17111|NCT02157298|40561|P1|COMPLETED|Overall Study||119
17112|NCT02157298|40560|P2|STARTED|Overall Study||60
17113|NCT02157298|40561|P1|STARTED|Overall Study||123
17114|NCT02157116|40575|P1|NOT COMPLETED|Overall Study||9
17115|NCT02157116|40575|P1|COMPLETED|Overall Study||4
17116|NCT02157116|40575|P1|STARTED|Overall Study|signed consent form|13
17117|NCT02156466|40589|P5|NOT COMPLETED|Overall Study||0
17118|NCT02156466|40590|P4|NOT COMPLETED|Overall Study||2
17119|NCT02156466|40591|P3|NOT COMPLETED|Overall Study||1
17120|NCT02156466|40592|P2|NOT COMPLETED|Overall Study||0
17121|NCT02156466|40593|P1|NOT COMPLETED|Overall Study||0
17122|NCT02156466|40589|P5|COMPLETED|Overall Study||8
17123|NCT02156466|40590|P4|COMPLETED|Overall Study||7
17124|NCT02156466|40591|P3|COMPLETED|Overall Study||7
17125|NCT02156466|40592|P2|COMPLETED|Overall Study||8
17126|NCT02156466|40593|P1|COMPLETED|Overall Study||8
17127|NCT02156466|40589|P5|STARTED|Overall Study||8
17128|NCT02156466|40590|P4|STARTED|Overall Study||9
17129|NCT02156466|40591|P3|STARTED|Overall Study||8
17130|NCT02156466|40592|P2|STARTED|Overall Study||8
17131|NCT02156466|40593|P1|STARTED|Overall Study||8
17132|NCT02156271|40774|P2|NOT COMPLETED|Overall Study||3
17133|NCT02156271|40775|P1|NOT COMPLETED|Overall Study||4
17134|NCT02156271|40774|P2|COMPLETED|Overall Study||10
17135|NCT02156271|40775|P1|COMPLETED|Overall Study||22
17136|NCT02156271|40774|P2|STARTED|Overall Study||13
17137|NCT02156271|40775|P1|STARTED|Overall Study||26
17138|NCT02156167|40807|P1|NOT COMPLETED|Overall Study||0
17139|NCT02156167|40807|P1|COMPLETED|Overall Study||15
17140|NCT02156167|40807|P1|STARTED|Overall Study||15
17141|NCT02155985|40814|P3|NOT COMPLETED|Overall Study||1
17142|NCT02155985|40815|P2|NOT COMPLETED|Overall Study||0
17143|NCT02155985|40816|P1|NOT COMPLETED|Overall Study||1
17144|NCT02155985|40814|P3|COMPLETED|Overall Study||39
17145|NCT02155985|40815|P2|COMPLETED|Overall Study||41
17146|NCT02155985|40816|P1|COMPLETED|Overall Study||39
17147|NCT02155985|40814|P3|STARTED|Overall Study||40
17148|NCT02155985|40815|P2|STARTED|Overall Study||41
17149|NCT02155985|40816|P1|STARTED|Overall Study||40
17150|NCT02155881|40883|P2|NOT COMPLETED|Overall Study||4
17151|NCT02155881|40884|P1|NOT COMPLETED|Overall Study||2
17152|NCT02155881|40883|P2|COMPLETED|Overall Study||36
17153|NCT02155881|40884|P1|COMPLETED|Overall Study||38
17154|NCT02155881|40883|P2|STARTED|Overall Study||40
17155|NCT02155881|40884|P1|STARTED|Overall Study||40
17156|NCT02155543|40911|P7|NOT COMPLETED|Overall Study||0
17157|NCT02155543|40912|P6|NOT COMPLETED|Overall Study||0
17158|NCT02155543|40913|P5|NOT COMPLETED|Overall Study||0
17159|NCT02155543|40914|P4|NOT COMPLETED|Overall Study||0
17160|NCT02155543|40915|P3|NOT COMPLETED|Overall Study||0
17161|NCT02155543|40916|P2|NOT COMPLETED|Overall Study||0
17162|NCT02155543|40917|P1|NOT COMPLETED|Overall Study||0
17163|NCT02155543|40911|P7|COMPLETED|Overall Study||9
17164|NCT02155543|40912|P6|COMPLETED|Overall Study||3
17165|NCT02155543|40913|P5|COMPLETED|Overall Study||3
17166|NCT02155543|40914|P4|COMPLETED|Overall Study||9
17167|NCT02155543|40915|P3|COMPLETED|Overall Study||9
17168|NCT02155543|40916|P2|COMPLETED|Overall Study||9
17169|NCT02155543|40917|P1|COMPLETED|Overall Study||9
17170|NCT02155543|40911|P7|STARTED|Overall Study||9
17171|NCT02155543|40912|P6|STARTED|Overall Study||3
17172|NCT02155543|40913|P5|STARTED|Overall Study||3
17173|NCT02155543|40914|P4|STARTED|Overall Study||9
17174|NCT02155543|40915|P3|STARTED|Overall Study||9
17175|NCT02155543|40916|P2|STARTED|Overall Study||9
17176|NCT02155543|40917|P1|STARTED|Overall Study||9
17177|NCT02155335|40930|P2|NOT COMPLETED|Period 2||0
17178|NCT02155335|40931|P1|NOT COMPLETED|Period 2||0
17179|NCT02155335|40930|P2|COMPLETED|Period 2||49
17180|NCT02155335|40931|P1|COMPLETED|Period 2||50
17181|NCT02155335|40930|P2|STARTED|Period 2||49
17182|NCT02155335|40931|P1|STARTED|Period 2||50
17183|NCT02155335|40930|P2|NOT COMPLETED|Period 1||1
17184|NCT02155335|40931|P1|NOT COMPLETED|Period 1||0
17185|NCT02155335|40930|P2|COMPLETED|Period 1||49
17186|NCT02155335|40931|P1|COMPLETED|Period 1||50
17187|NCT02155335|40930|P2|Treated|Period 1||49
17188|NCT02155335|40931|P1|Treated|Period 1||50
17189|NCT02155335|40930|P2|STARTED|Period 1||50
17190|NCT02155335|40931|P1|STARTED|Period 1||50
17191|NCT02155322|40936|P1|NOT COMPLETED|Overall Study||14
17192|NCT02155322|40936|P1|COMPLETED|Overall Study||19
17193|NCT02155322|40936|P1|Treated|Overall Study|32 of 33 participants treated. 1 participant not treated at the discretion of the investigator.|32
17194|NCT02155322|40936|P1|STARTED|Overall Study||33
17195|NCT02155283|40941|P1|NOT COMPLETED|Overall Study||7
17196|NCT02155283|40941|P1|COMPLETED|Overall Study||9
17197|NCT02155283|40941|P1|STARTED|Overall Study||16
17198|NCT02155010|40948|P2|NOT COMPLETED|Overall Study||6
17199|NCT02155010|40949|P1|NOT COMPLETED|Overall Study||6
17200|NCT02155010|40948|P2|COMPLETED|Overall Study||31
17201|NCT02155010|40949|P1|COMPLETED|Overall Study||31
17202|NCT02155010|40948|P2|STARTED|Overall Study||37
17203|NCT02155010|40949|P1|STARTED|Overall Study||37
17204|NCT02154906|40959|P2|NOT COMPLETED|Overall Study||3
17205|NCT02154906|40960|P1|NOT COMPLETED|Overall Study||2
17206|NCT02154906|40959|P2|COMPLETED|Overall Study||17
17207|NCT02154906|40960|P1|COMPLETED|Overall Study||19
17208|NCT02154906|40959|P2|STARTED|Overall Study||20
17209|NCT02154906|40960|P1|STARTED|Overall Study||21
17216|NCT02154386|41000|P2|NOT COMPLETED|Overall Study||2
17217|NCT02154386|41001|P1|NOT COMPLETED|Overall Study||1
17218|NCT02154386|41000|P2|COMPLETED|Overall Study||21
17219|NCT02154386|41001|P1|COMPLETED|Overall Study||22
17220|NCT02154386|41000|P2|STARTED|Overall Study||23
17221|NCT02154386|41001|P1|STARTED|Overall Study||23
17222|NCT02154243|41014|P3|NOT COMPLETED|Overall Study||0
17223|NCT02154243|41015|P2|NOT COMPLETED|Overall Study||0
17224|NCT02154243|41016|P1|NOT COMPLETED|Overall Study||0
17225|NCT02154243|41014|P3|COMPLETED|Overall Study||4
17226|NCT02154243|41015|P2|COMPLETED|Overall Study||4
17227|NCT02154243|41016|P1|COMPLETED|Overall Study||5
17228|NCT02154243|41014|P3|STARTED|Overall Study||4
17229|NCT02154243|41015|P2|STARTED|Overall Study||4
17230|NCT02154243|41016|P1|STARTED|Overall Study||5
17231|NCT02154139|41027|P1|NOT COMPLETED|Overall Study||7
17232|NCT02154139|41027|P1|COMPLETED|Overall Study||644
17233|NCT02154139|41027|P1|STARTED|Overall Study||651
17234|NCT02154087|41035|P1|NOT COMPLETED|Overall Study||1
17235|NCT02154087|41035|P1|COMPLETED|Overall Study||0
17236|NCT02154087|41035|P1|STARTED|Overall Study||1
17237|NCT02154048|41042|P3|NOT COMPLETED|Overall Study||0
17238|NCT02154048|41043|P2|NOT COMPLETED|Overall Study||0
17239|NCT02154048|41044|P1|NOT COMPLETED|Overall Study||0
17240|NCT02154048|41042|P3|COMPLETED|Overall Study||1
17241|NCT02154048|41043|P2|COMPLETED|Overall Study||2
17242|NCT02154048|41044|P1|COMPLETED|Overall Study||2
17243|NCT02154048|41042|P3|STARTED|Overall Study||1
17244|NCT02154048|41043|P2|STARTED|Overall Study||2
17245|NCT02154048|41044|P1|STARTED|Overall Study||2
17246|NCT02153827|41054|P2|NOT COMPLETED|Overall Study||9
17247|NCT02153827|41055|P1|NOT COMPLETED|Overall Study||3
17248|NCT02153827|41054|P2|COMPLETED|Overall Study||14
17249|NCT02153827|41055|P1|COMPLETED|Overall Study||22
17250|NCT02153827|41054|P2|STARTED|Overall Study||23
17251|NCT02153827|41055|P1|STARTED|Overall Study||25
17252|NCT02153788|41071|P2|NOT COMPLETED|Overall Study||1
17253|NCT02153788|41072|P1|NOT COMPLETED|Overall Study||2
17254|NCT02153788|41071|P2|COMPLETED|Overall Study||18
17255|NCT02153788|41072|P1|COMPLETED|Overall Study||23
17256|NCT02153788|41071|P2|STARTED|Overall Study||19
17257|NCT02153788|41072|P1|STARTED|Overall Study||25
17258|NCT02153489|41090|P2|NOT COMPLETED|Period 2||0
17259|NCT02153489|41091|P1|NOT COMPLETED|Period 2||0
17260|NCT02153489|41090|P2|COMPLETED|Period 2||15
17261|NCT02153489|41091|P1|COMPLETED|Period 2||15
17262|NCT02153489|41090|P2|STARTED|Period 2||15
17263|NCT02153489|41091|P1|STARTED|Period 2||15
17264|NCT02153489|41090|P2|NOT COMPLETED|Period 1||0
17265|NCT02153489|41091|P1|NOT COMPLETED|Period 1||0
17266|NCT02153489|41090|P2|COMPLETED|Period 1||15
17267|NCT02153489|41091|P1|COMPLETED|Period 1||15
17268|NCT02153489|41090|P2|STARTED|Period 1||15
17269|NCT02153489|41091|P1|STARTED|Period 1||15
17270|NCT02153398|41134|P5|NOT COMPLETED|Overall Study||0
17271|NCT02153398|41135|P4|NOT COMPLETED|Overall Study||1
17272|NCT02153398|41136|P3|NOT COMPLETED|Overall Study||1
17273|NCT02153398|41137|P2|NOT COMPLETED|Overall Study||0
17274|NCT02153398|41138|P1|NOT COMPLETED|Overall Study||1
17275|NCT02153398|41134|P5|COMPLETED|Overall Study||10
17276|NCT02153398|41135|P4|COMPLETED|Overall Study||9
17277|NCT02153398|41136|P3|COMPLETED|Overall Study||9
17278|NCT02153398|41137|P2|COMPLETED|Overall Study||10
17279|NCT02153398|41138|P1|COMPLETED|Overall Study||9
17280|NCT02153398|41134|P5|STARTED|Overall Study||10
17281|NCT02153398|41135|P4|STARTED|Overall Study||10
17282|NCT02153398|41136|P3|STARTED|Overall Study||10
17283|NCT02153398|41137|P2|STARTED|Overall Study||10
17284|NCT02153398|41138|P1|STARTED|Overall Study||10
17285|NCT02153346|41260|P1|NOT COMPLETED|Overall Study||11
17286|NCT02153346|41260|P1|COMPLETED|Overall Study||90
17287|NCT02153346|41260|P1|STARTED|Overall Study||101
17288|NCT02153099|41274|P7|NOT COMPLETED|Overall Study||0
17289|NCT02153099|41275|P6|NOT COMPLETED|Overall Study||0
17290|NCT02153099|41276|P5|NOT COMPLETED|Overall Study||0
17291|NCT02153099|41277|P4|NOT COMPLETED|Overall Study||0
17292|NCT02153099|41278|P3|NOT COMPLETED|Overall Study||0
17293|NCT02153099|41279|P2|NOT COMPLETED|Overall Study||0
17294|NCT02153099|41280|P1|NOT COMPLETED|Overall Study||0
17295|NCT02153099|41274|P7|COMPLETED|Overall Study||12
17296|NCT02153099|41275|P6|COMPLETED|Overall Study||6
17297|NCT02153099|41276|P5|COMPLETED|Overall Study||6
17298|NCT02153099|41277|P4|COMPLETED|Overall Study||6
17299|NCT02153099|41278|P3|COMPLETED|Overall Study||6
17300|NCT02153099|41279|P2|COMPLETED|Overall Study||6
17301|NCT02153099|41280|P1|COMPLETED|Overall Study||6
17302|NCT02153099|41274|P7|STARTED|Overall Study||12
17303|NCT02153099|41275|P6|STARTED|Overall Study||6
17304|NCT02153099|41276|P5|STARTED|Overall Study||6
17305|NCT02153099|41277|P4|STARTED|Overall Study||6
17306|NCT02153099|41278|P3|STARTED|Overall Study||6
17307|NCT02153099|41279|P2|STARTED|Overall Study||6
17308|NCT02153099|41280|P1|STARTED|Overall Study||6
17309|NCT02153086|41334|P1|NOT COMPLETED|Overall Study||4
17310|NCT02153086|41334|P1|COMPLETED|Overall Study||232
17311|NCT02153086|41334|P1|STARTED|Overall Study||236
17312|NCT02152605|41350|P2|NOT COMPLETED|Overall Study||18
17313|NCT02152605|41351|P1|NOT COMPLETED|Overall Study||19
17314|NCT02152605|41350|P2|COMPLETED|Overall Study||230
17315|NCT02152605|41351|P1|COMPLETED|Overall Study||229
17316|NCT02152605|41350|P2|STARTED|Overall Study||248
17317|NCT02152605|41351|P1|STARTED|Overall Study||248
17318|NCT02152566|41361|P1|NOT COMPLETED|Overall Study||3
17319|NCT02152566|41361|P1|COMPLETED|Overall Study||3
17320|NCT02152566|41361|P1|STARTED|Overall Study||6
17321|NCT02152371|41367|P2|NOT COMPLETED|Overall Study||16
17322|NCT02152371|41368|P1|NOT COMPLETED|Overall Study||12
17323|NCT02152371|41367|P2|COMPLETED|Overall Study||134
17324|NCT02152371|41368|P1|COMPLETED|Overall Study||138
17325|NCT02152371|41367|P2|Received at Least 1 Dose of Study Drug.|Overall Study||150
17326|NCT02152371|41368|P1|Received at Least 1 Dose of Study Drug.|Overall Study||150
17327|NCT02152371|41367|P2|STARTED|Overall Study||150
17328|NCT02152371|41368|P1|STARTED|Overall Study||150
17329|NCT02152007|41404|P1|NOT COMPLETED|Overall Study||1
17330|NCT02152007|41404|P1|COMPLETED|Overall Study||14
17331|NCT02152007|41404|P1|STARTED|Overall Study||15
17332|NCT02151994|41413|P13|NOT COMPLETED|Food Effect (FE): Fed||0
17333|NCT02151994|41414|P12|NOT COMPLETED|Food Effect (FE): Fed||0
17334|NCT02151994|41415|P11|NOT COMPLETED|Food Effect (FE): Fed||0
17335|NCT02151994|41416|P10|NOT COMPLETED|Food Effect (FE): Fed||0
17336|NCT02151994|41417|P9|NOT COMPLETED|Food Effect (FE): Fed||0
17337|NCT02151994|41418|P8|NOT COMPLETED|Food Effect (FE): Fed||0
17338|NCT02151994|41419|P7|NOT COMPLETED|Food Effect (FE): Fed||0
17339|NCT02151994|41420|P6|NOT COMPLETED|Food Effect (FE): Fed||0
17340|NCT02151994|41421|P5|NOT COMPLETED|Food Effect (FE): Fed||0
17341|NCT02151994|41422|P4|NOT COMPLETED|Food Effect (FE): Fed||0
17342|NCT02151994|41423|P3|NOT COMPLETED|Food Effect (FE): Fed||0
17343|NCT02151994|41424|P2|NOT COMPLETED|Food Effect (FE): Fed||0
17344|NCT02151994|41425|P1|NOT COMPLETED|Food Effect (FE): Fed||0
17345|NCT02151994|41413|P13|COMPLETED|Food Effect (FE): Fed||12
17346|NCT02151994|41414|P12|COMPLETED|Food Effect (FE): Fed||0
17347|NCT02151994|41415|P11|COMPLETED|Food Effect (FE): Fed||0
17348|NCT02151994|41416|P10|COMPLETED|Food Effect (FE): Fed||0
17349|NCT02151994|41417|P9|COMPLETED|Food Effect (FE): Fed||0
17350|NCT02151994|41418|P8|COMPLETED|Food Effect (FE): Fed||0
17351|NCT02151994|41419|P7|COMPLETED|Food Effect (FE): Fed||0
17352|NCT02151994|41420|P6|COMPLETED|Food Effect (FE): Fed||0
17353|NCT02151994|41421|P5|COMPLETED|Food Effect (FE): Fed||0
17354|NCT02151994|41422|P4|COMPLETED|Food Effect (FE): Fed||0
17355|NCT02151994|41423|P3|COMPLETED|Food Effect (FE): Fed||0
17356|NCT02151994|41424|P2|COMPLETED|Food Effect (FE): Fed||0
17357|NCT02151994|41425|P1|COMPLETED|Food Effect (FE): Fed||0
17358|NCT02151994|41413|P13|STARTED|Food Effect (FE): Fed||12
17359|NCT02151994|41414|P12|STARTED|Food Effect (FE): Fed||0
17360|NCT02151994|41415|P11|STARTED|Food Effect (FE): Fed||0
17361|NCT02151994|41416|P10|STARTED|Food Effect (FE): Fed||0
17362|NCT02151994|41417|P9|STARTED|Food Effect (FE): Fed||0
17363|NCT02151994|41418|P8|STARTED|Food Effect (FE): Fed||0
17364|NCT02151994|41419|P7|STARTED|Food Effect (FE): Fed||0
17365|NCT02151994|41420|P6|STARTED|Food Effect (FE): Fed||0
17366|NCT02151994|41421|P5|STARTED|Food Effect (FE): Fed||0
17367|NCT02151994|41422|P4|STARTED|Food Effect (FE): Fed||0
17368|NCT02151994|41423|P3|STARTED|Food Effect (FE): Fed||0
17369|NCT02151994|41424|P2|STARTED|Food Effect (FE): Fed||0
17370|NCT02151994|41425|P1|STARTED|Food Effect (FE): Fed||0
17371|NCT02151994|41413|P13|NOT COMPLETED|Food Effect (FE): Fasted||0
17372|NCT02151994|41414|P12|NOT COMPLETED|Food Effect (FE): Fasted||0
17373|NCT02151994|41415|P11|NOT COMPLETED|Food Effect (FE): Fasted||0
17374|NCT02151994|41416|P10|NOT COMPLETED|Food Effect (FE): Fasted||0
17375|NCT02151994|41417|P9|NOT COMPLETED|Food Effect (FE): Fasted||0
17376|NCT02151994|41418|P8|NOT COMPLETED|Food Effect (FE): Fasted||0
17377|NCT02151994|41419|P7|NOT COMPLETED|Food Effect (FE): Fasted||0
17378|NCT02151994|41420|P6|NOT COMPLETED|Food Effect (FE): Fasted||0
17379|NCT02151994|41421|P5|NOT COMPLETED|Food Effect (FE): Fasted||0
17380|NCT02151994|41422|P4|NOT COMPLETED|Food Effect (FE): Fasted||0
17381|NCT02151994|41423|P3|NOT COMPLETED|Food Effect (FE): Fasted||0
17382|NCT02151994|41424|P2|NOT COMPLETED|Food Effect (FE): Fasted||0
17383|NCT02151994|41425|P1|NOT COMPLETED|Food Effect (FE): Fasted||0
17384|NCT02151994|41413|P13|COMPLETED|Food Effect (FE): Fasted||0
17385|NCT02151994|41414|P12|COMPLETED|Food Effect (FE): Fasted||12
17386|NCT02151994|41415|P11|COMPLETED|Food Effect (FE): Fasted||0
17387|NCT02151994|41416|P10|COMPLETED|Food Effect (FE): Fasted||0
17388|NCT02151994|41417|P9|COMPLETED|Food Effect (FE): Fasted||0
17389|NCT02151994|41418|P8|COMPLETED|Food Effect (FE): Fasted||0
17390|NCT02151994|41419|P7|COMPLETED|Food Effect (FE): Fasted||0
17391|NCT02151994|41420|P6|COMPLETED|Food Effect (FE): Fasted||0
17392|NCT02151994|41421|P5|COMPLETED|Food Effect (FE): Fasted||0
17393|NCT02151994|41422|P4|COMPLETED|Food Effect (FE): Fasted||0
17394|NCT02151994|41423|P3|COMPLETED|Food Effect (FE): Fasted||0
17395|NCT02151994|41424|P2|COMPLETED|Food Effect (FE): Fasted||0
17396|NCT02151994|41425|P1|COMPLETED|Food Effect (FE): Fasted||0
17397|NCT02151994|41413|P13|STARTED|Food Effect (FE): Fasted||0
17398|NCT02151994|41414|P12|STARTED|Food Effect (FE): Fasted||12
17399|NCT02151994|41415|P11|STARTED|Food Effect (FE): Fasted||0
17400|NCT02151994|41416|P10|STARTED|Food Effect (FE): Fasted||0
17401|NCT02151994|41417|P9|STARTED|Food Effect (FE): Fasted||0
17402|NCT02151994|41418|P8|STARTED|Food Effect (FE): Fasted||0
17403|NCT02151994|41419|P7|STARTED|Food Effect (FE): Fasted||0
17404|NCT02151994|41420|P6|STARTED|Food Effect (FE): Fasted||0
17405|NCT02151994|41421|P5|STARTED|Food Effect (FE): Fasted||0
17406|NCT02151994|41422|P4|STARTED|Food Effect (FE): Fasted||0
17407|NCT02151994|41423|P3|STARTED|Food Effect (FE): Fasted||0
17408|NCT02151994|41424|P2|STARTED|Food Effect (FE): Fasted||0
17409|NCT02151994|41425|P1|STARTED|Food Effect (FE): Fasted||0
17410|NCT02151994|41413|P13|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17411|NCT02151994|41414|P12|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17412|NCT02151994|41415|P11|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17413|NCT02151994|41416|P10|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17414|NCT02151994|41417|P9|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17415|NCT02151994|41418|P8|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17416|NCT02151994|41419|P7|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17417|NCT02151994|41420|P6|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17418|NCT02151994|41421|P5|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17419|NCT02151994|41422|P4|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17420|NCT02151994|41423|P3|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17421|NCT02151994|41424|P2|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17422|NCT02151994|41425|P1|NOT COMPLETED|Multiple Ascending Dose (MAD)||0
17423|NCT02151994|41413|P13|COMPLETED|Multiple Ascending Dose (MAD)||0
17424|NCT02151994|41414|P12|COMPLETED|Multiple Ascending Dose (MAD)||0
17425|NCT02151994|41415|P11|COMPLETED|Multiple Ascending Dose (MAD)||0
17426|NCT02151994|41416|P10|COMPLETED|Multiple Ascending Dose (MAD)||0
17427|NCT02151994|41417|P9|COMPLETED|Multiple Ascending Dose (MAD)||6
17428|NCT02151994|41418|P8|COMPLETED|Multiple Ascending Dose (MAD)||0
17429|NCT02151994|41419|P7|COMPLETED|Multiple Ascending Dose (MAD)||6
17430|NCT02151994|41420|P6|COMPLETED|Multiple Ascending Dose (MAD)||6
17431|NCT02151994|41421|P5|COMPLETED|Multiple Ascending Dose (MAD)||6
17432|NCT02151994|41422|P4|COMPLETED|Multiple Ascending Dose (MAD)||6
17433|NCT02151994|41423|P3|COMPLETED|Multiple Ascending Dose (MAD)||0
17434|NCT02151994|41424|P2|COMPLETED|Multiple Ascending Dose (MAD)||0
17435|NCT02151994|41425|P1|COMPLETED|Multiple Ascending Dose (MAD)||10
17436|NCT02151994|41413|P13|STARTED|Multiple Ascending Dose (MAD)||0
17437|NCT02151994|41414|P12|STARTED|Multiple Ascending Dose (MAD)||0
17438|NCT02151994|41415|P11|STARTED|Multiple Ascending Dose (MAD)||0
17439|NCT02151994|41416|P10|STARTED|Multiple Ascending Dose (MAD)||0
17440|NCT02151994|41417|P9|STARTED|Multiple Ascending Dose (MAD)||6
17441|NCT02151994|41418|P8|STARTED|Multiple Ascending Dose (MAD)||0
17442|NCT02151994|41419|P7|STARTED|Multiple Ascending Dose (MAD)||6
17443|NCT02151994|41420|P6|STARTED|Multiple Ascending Dose (MAD)||6
17444|NCT02151994|41421|P5|STARTED|Multiple Ascending Dose (MAD)||6
17445|NCT02151994|41422|P4|STARTED|Multiple Ascending Dose (MAD)||6
17446|NCT02151994|41423|P3|STARTED|Multiple Ascending Dose (MAD)||0
17447|NCT02151994|41424|P2|STARTED|Multiple Ascending Dose (MAD)||0
17448|NCT02151994|41425|P1|STARTED|Multiple Ascending Dose (MAD)||10
17449|NCT02151994|41413|P13|NOT COMPLETED|Single Ascending Dose (SAD)||0
17450|NCT02151994|41414|P12|NOT COMPLETED|Single Ascending Dose (SAD)||0
17451|NCT02151994|41415|P11|NOT COMPLETED|Single Ascending Dose (SAD)||0
17452|NCT02151994|41416|P10|NOT COMPLETED|Single Ascending Dose (SAD)||0
17453|NCT02151994|41417|P9|NOT COMPLETED|Single Ascending Dose (SAD)||0
17454|NCT02151994|41418|P8|NOT COMPLETED|Single Ascending Dose (SAD)||0
17455|NCT02151994|41419|P7|NOT COMPLETED|Single Ascending Dose (SAD)||0
17456|NCT02151994|41420|P6|NOT COMPLETED|Single Ascending Dose (SAD)||0
17457|NCT02151994|41421|P5|NOT COMPLETED|Single Ascending Dose (SAD)||0
17458|NCT02151994|41422|P4|NOT COMPLETED|Single Ascending Dose (SAD)||0
17459|NCT02151994|41423|P3|NOT COMPLETED|Single Ascending Dose (SAD)||0
17460|NCT02151994|41424|P2|NOT COMPLETED|Single Ascending Dose (SAD)||0
17461|NCT02151994|41425|P1|NOT COMPLETED|Single Ascending Dose (SAD)||0
17462|NCT02151994|41413|P13|COMPLETED|Single Ascending Dose (SAD)||0
17463|NCT02151994|41414|P12|COMPLETED|Single Ascending Dose (SAD)||0
17464|NCT02151994|41415|P11|COMPLETED|Single Ascending Dose (SAD)||6
17465|NCT02151994|41416|P10|COMPLETED|Single Ascending Dose (SAD)||6
17466|NCT02151994|41417|P9|COMPLETED|Single Ascending Dose (SAD)||0
17467|NCT02151994|41418|P8|COMPLETED|Single Ascending Dose (SAD)||6
17468|NCT02151994|41419|P7|COMPLETED|Single Ascending Dose (SAD)||6
17469|NCT02151994|41420|P6|COMPLETED|Single Ascending Dose (SAD)||6
17470|NCT02151994|41421|P5|COMPLETED|Single Ascending Dose (SAD)||6
17471|NCT02151994|41422|P4|COMPLETED|Single Ascending Dose (SAD)||6
17472|NCT02151994|41423|P3|COMPLETED|Single Ascending Dose (SAD)||6
17473|NCT02151994|41424|P2|COMPLETED|Single Ascending Dose (SAD)||6
17474|NCT02151994|41425|P1|COMPLETED|Single Ascending Dose (SAD)||18
17475|NCT02151994|41413|P13|STARTED|Single Ascending Dose (SAD)||0
17476|NCT02151994|41414|P12|STARTED|Single Ascending Dose (SAD)||0
17477|NCT02151994|41415|P11|STARTED|Single Ascending Dose (SAD)||6
17478|NCT02151994|41416|P10|STARTED|Single Ascending Dose (SAD)||6
17479|NCT02151994|41417|P9|STARTED|Single Ascending Dose (SAD)||0
17480|NCT02151994|41418|P8|STARTED|Single Ascending Dose (SAD)||6
17481|NCT02151994|41419|P7|STARTED|Single Ascending Dose (SAD)||6
17482|NCT02151994|41420|P6|STARTED|Single Ascending Dose (SAD)||6
17483|NCT02151994|41421|P5|STARTED|Single Ascending Dose (SAD)||6
17484|NCT02151994|41422|P4|STARTED|Single Ascending Dose (SAD)||6
17485|NCT02151994|41423|P3|STARTED|Single Ascending Dose (SAD)||6
17486|NCT02151994|41424|P2|STARTED|Single Ascending Dose (SAD)||6
17487|NCT02151994|41425|P1|STARTED|Single Ascending Dose (SAD)||18
17488|NCT02151981|41465|P2|NOT COMPLETED|Overall Study||140
17489|NCT02151981|41466|P1|NOT COMPLETED|Overall Study||279
17490|NCT02151981|41465|P2|COMPLETED|Overall Study||0
17491|NCT02151981|41466|P1|COMPLETED|Overall Study||0
17492|NCT02151981|41465|P2|Crossed Over AZD9291|Overall Study|Patients randomised to chemotherapy were allowed to crossover to AZD9291 after progression|82
17493|NCT02151981|41466|P1|Crossed Over AZD9291|Overall Study||0
17494|NCT02151981|41465|P2|Did Not Receive Treatment|Overall Study||4
17495|NCT02151981|41466|P1|Did Not Receive Treatment|Overall Study||0
17496|NCT02151981|41465|P2|Received Randomised Treatment Only|Overall Study||54
17497|NCT02151981|41466|P1|Received Randomised Treatment Only|Overall Study||279
17498|NCT02151981|41465|P2|STARTED|Overall Study||140
17499|NCT02151981|41466|P1|STARTED|Overall Study||279
17500|NCT02151786|41482|P1|NOT COMPLETED|Overall Study||36
17501|NCT02151786|41482|P1|COMPLETED|Overall Study||1084
17502|NCT02151786|41482|P1|STARTED|Overall Study||1120
17503|NCT02151773|41493|P1|NOT COMPLETED|Overall Study||64
17504|NCT02151773|41493|P1|COMPLETED|Overall Study||3429
17505|NCT02151773|41493|P1|STARTED|Overall Study||3493
17506|NCT02151253|41498|P2|NOT COMPLETED|Overall Study||0
17507|NCT02151253|41499|P1|NOT COMPLETED|Overall Study||0
17508|NCT02151253|41498|P2|COMPLETED|Overall Study||15
17509|NCT02151253|41499|P1|COMPLETED|Overall Study||13
17510|NCT02151253|41498|P2|STARTED|Overall Study||15
17511|NCT02151253|41499|P1|STARTED|Overall Study||13
17512|NCT02151058|41516|P3|NOT COMPLETED|Overall Study||5
17513|NCT02151058|41517|P2|NOT COMPLETED|Overall Study||1
17514|NCT02151058|41518|P1|NOT COMPLETED|Overall Study||2
17515|NCT02151058|41516|P3|COMPLETED|Overall Study||86
17516|NCT02151058|41517|P2|COMPLETED|Overall Study||90
17517|NCT02151058|41518|P1|COMPLETED|Overall Study||43
17518|NCT02151058|41516|P3|STARTED|Overall Study||91
17519|NCT02151058|41517|P2|STARTED|Overall Study||91
17520|NCT02151058|41518|P1|STARTED|Overall Study||45
17521|NCT02150954|41552|P2|NOT COMPLETED|Overall Study||0
17522|NCT02150954|41553|P1|NOT COMPLETED|Overall Study||1
17523|NCT02150954|41552|P2|COMPLETED|Overall Study||59
17524|NCT02150954|41553|P1|COMPLETED|Overall Study||57
17525|NCT02150954|41552|P2|STARTED|Overall Study||59
17526|NCT02150954|41553|P1|STARTED|Overall Study||58
17527|NCT02150499|41577|P2|NOT COMPLETED|Overall Study||0
17528|NCT02150499|41578|P1|NOT COMPLETED|Overall Study||0
17529|NCT02150499|41577|P2|COMPLETED|Overall Study||9
17530|NCT02150499|41578|P1|COMPLETED|Overall Study||9
17531|NCT02150499|41577|P2|STARTED|Overall Study||9
17532|NCT02150499|41578|P1|STARTED|Overall Study||9
17533|NCT02150460|41600|P2|NOT COMPLETED|Overall Study||0
17534|NCT02150460|41601|P1|NOT COMPLETED|Overall Study||0
17535|NCT02150460|41600|P2|COMPLETED|Overall Study||50
17536|NCT02150460|41601|P1|COMPLETED|Overall Study||50
17537|NCT02150460|41600|P2|STARTED|Overall Study||50
17538|NCT02150460|41601|P1|STARTED|Overall Study||50
17539|NCT02150213|41625|P1|NOT COMPLETED|Overall Study||2
17540|NCT02150213|41625|P1|COMPLETED|Overall Study||57
17541|NCT02150213|41625|P1|STARTED|Overall Study||59
17542|NCT02150109|41630|P1|NOT COMPLETED|Overall Study||0
17543|NCT02150109|41630|P1|COMPLETED|Overall Study||372
17544|NCT02150109|41630|P1|STARTED|Overall Study||372
17545|NCT02150044|41642|P1|NOT COMPLETED|Overall Study||0
17546|NCT02150044|41642|P1|COMPLETED|Overall Study||29
17547|NCT02150044|41642|P1|Study Cohort|Overall Study||13
17548|NCT02150044|41642|P1|Lead-In Subjects|Overall Study||16
17549|NCT02150044|41642|P1|STARTED|Overall Study||29
17550|NCT02149875|41651|P3|NOT COMPLETED|Overall Study||9
17551|NCT02149875|41652|P2|NOT COMPLETED|Overall Study||8
17552|NCT02149875|41653|P1|NOT COMPLETED|Overall Study||7
17553|NCT02149875|41651|P3|COMPLETED|Overall Study||20
17554|NCT02149875|41652|P2|COMPLETED|Overall Study||20
17555|NCT02149875|41653|P1|COMPLETED|Overall Study||20
17556|NCT02149875|41651|P3|STARTED|Overall Study||29
17557|NCT02149875|41652|P2|STARTED|Overall Study||28
17558|NCT02149875|41653|P1|STARTED|Overall Study||27
17559|NCT02149342|41664|P1|NOT COMPLETED|Overall Study||0
17560|NCT02149342|41664|P1|COMPLETED|Overall Study|14 patients|14
17561|NCT02149342|41664|P1|STARTED|Overall Study|14 patients|14
17562|NCT02149303|41676|P1|NOT COMPLETED|Overall Study||0
17563|NCT02149303|41676|P1|COMPLETED|Overall Study||191
17564|NCT02149303|41676|P1|STARTED|Overall Study||191
17565|NCT02149264|41682|P1|NOT COMPLETED|Overall Study||20
17566|NCT02149264|41682|P1|COMPLETED|Overall Study||139
17567|NCT02149264|41682|P1|STARTED|Overall Study|Of the 160 enrolled subjects, one discontinued before receiving treatment.|159
17568|NCT02149108|41697|P2|NOT COMPLETED|Overall Study||383
17569|NCT02149108|41698|P1|NOT COMPLETED|Overall Study||380
17570|NCT02149108|41697|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|3
17571|NCT02149108|41698|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (14JUN2016).|2
17572|NCT02149108|41697|P2|STARTED|Overall Study|Randomised patients.|386
17573|NCT02149108|41698|P1|STARTED|Overall Study|Randomised patients.|382
17574|NCT02148809|41710|P1|NOT COMPLETED|Overall Study||0
17575|NCT02148809|41710|P1|COMPLETED|Overall Study||14
17576|NCT02148809|41710|P1|STARTED|Overall Study||14
17577|NCT02148718|41715|P1|NOT COMPLETED|Overall Study||18
17578|NCT02148718|41715|P1|COMPLETED|Overall Study||62
17579|NCT02148718|41715|P1|STARTED|Overall Study||80
17580|NCT02148523|41722|P3|NOT COMPLETED|Overall Study||0
17581|NCT02148523|41723|P2|NOT COMPLETED|Overall Study||0
17582|NCT02148523|41724|P1|NOT COMPLETED|Overall Study||0
17583|NCT02148523|41722|P3|COMPLETED|Overall Study||67
17584|NCT02148523|41723|P2|COMPLETED|Overall Study||67
17585|NCT02148523|41724|P1|COMPLETED|Overall Study||67
17586|NCT02148523|41722|P3|STARTED|Overall Study||67
17587|NCT02148523|41723|P2|STARTED|Overall Study||67
17588|NCT02148523|41724|P1|STARTED|Overall Study||67
17589|NCT02148445|41737|P2|NOT COMPLETED|Overall Study||3
17590|NCT02148445|41738|P1|NOT COMPLETED|Overall Study||1
17591|NCT02148445|41737|P2|COMPLETED|Overall Study||197
17592|NCT02148445|41738|P1|COMPLETED|Overall Study||197
17593|NCT02148445|41737|P2|STARTED|Overall Study||200
17594|NCT02148445|41738|P1|STARTED|Overall Study||198
17595|NCT02148107|41773|P3|NOT COMPLETED|Overall Study||0
17596|NCT02148107|41774|P2|NOT COMPLETED|Overall Study||0
17597|NCT02148107|41775|P1|NOT COMPLETED|Overall Study||0
17598|NCT02148107|41773|P3|COMPLETED|Overall Study||3
17599|NCT02148107|41774|P2|COMPLETED|Overall Study||7
17600|NCT02148107|41775|P1|COMPLETED|Overall Study||8
17601|NCT02148107|41773|P3|STARTED|Overall Study||3
17602|NCT02148107|41774|P2|STARTED|Overall Study||7
17603|NCT02148107|41775|P1|STARTED|Overall Study||8
17604|NCT02147691|41793|P2|NOT COMPLETED|Overall Study||1
17605|NCT02147691|41794|P1|NOT COMPLETED|Overall Study||4
17606|NCT02147691|41793|P2|COMPLETED|Overall Study||11
17607|NCT02147691|41794|P1|COMPLETED|Overall Study||6
17608|NCT02147691|41793|P2|STARTED|Overall Study||12
17609|NCT02147691|41794|P1|STARTED|Overall Study||10
17610|NCT02147561|41838|P1|NOT COMPLETED|Overall Study||4
17611|NCT02147561|41838|P1|COMPLETED|Overall Study||276
17612|NCT02147561|41838|P1|STARTED|Overall Study||280
17613|NCT02147522|41846|P2|NOT COMPLETED|Overall Study||48
17614|NCT02147522|41847|P1|NOT COMPLETED|Overall Study||56
17615|NCT02147522|41846|P2|COMPLETED|Overall Study||122
17616|NCT02147522|41847|P1|COMPLETED|Overall Study||122
17617|NCT02147522|41846|P2|STARTED|Overall Study||170
17618|NCT02147522|41847|P1|STARTED|Overall Study||178
17619|NCT02147288|41859|P10|NOT COMPLETED|Overall Study||0
17620|NCT02147288|41860|P9|NOT COMPLETED|Overall Study||0
17621|NCT02147288|41861|P8|NOT COMPLETED|Overall Study||0
17622|NCT02147288|41862|P7|NOT COMPLETED|Overall Study||0
17623|NCT02147288|41863|P6|NOT COMPLETED|Overall Study||0
17624|NCT02147288|41864|P5|NOT COMPLETED|Overall Study||0
17625|NCT02147288|41865|P4|NOT COMPLETED|Overall Study||0
17626|NCT02147288|41866|P3|NOT COMPLETED|Overall Study||0
17627|NCT02147288|41867|P2|NOT COMPLETED|Overall Study||2
17628|NCT02147288|41868|P1|NOT COMPLETED|Overall Study||1
17629|NCT02147288|41859|P10|COMPLETED|Overall Study||0
17630|NCT02147288|41860|P9|COMPLETED|Overall Study||0
17631|NCT02147288|41861|P8|COMPLETED|Overall Study||0
17632|NCT02147288|41862|P7|COMPLETED|Overall Study||0
17633|NCT02147288|41863|P6|COMPLETED|Overall Study||0
17634|NCT02147288|41864|P5|COMPLETED|Overall Study||0
17635|NCT02147288|41865|P4|COMPLETED|Overall Study||0
17636|NCT02147288|41866|P3|COMPLETED|Overall Study||0
17637|NCT02147288|41867|P2|COMPLETED|Overall Study||22
17638|NCT02147288|41868|P1|COMPLETED|Overall Study||21
17639|NCT02147288|41859|P10|STARTED|Overall Study||0
17640|NCT02147288|41860|P9|STARTED|Overall Study||0
17641|NCT02147288|41861|P8|STARTED|Overall Study||0
17642|NCT02147288|41862|P7|STARTED|Overall Study||0
17643|NCT02147288|41863|P6|STARTED|Overall Study||0
17644|NCT02147288|41864|P5|STARTED|Overall Study||0
17645|NCT02147288|41865|P4|STARTED|Overall Study||0
17646|NCT02147288|41866|P3|STARTED|Overall Study||0
17647|NCT02147288|41867|P2|STARTED|Overall Study||24
17648|NCT02147288|41868|P1|STARTED|Overall Study||22
17649|NCT02147093|41876|P2|NOT COMPLETED|Period 2||0
17650|NCT02147093|41877|P1|NOT COMPLETED|Period 2||2
17651|NCT02147093|41876|P2|COMPLETED|Period 2||19
17652|NCT02147093|41877|P1|COMPLETED|Period 2||18
17653|NCT02147093|41876|P2|STARTED|Period 2||19
17654|NCT02147093|41877|P1|STARTED|Period 2||20
17655|NCT02147093|41876|P2|NOT COMPLETED|Period 1||1
17656|NCT02147093|41877|P1|NOT COMPLETED|Period 1||0
17657|NCT02147093|41876|P2|COMPLETED|Period 1||19
17658|NCT02147093|41877|P1|COMPLETED|Period 1||20
17659|NCT02147093|41876|P2|STARTED|Period 1||20
17660|NCT02147093|41877|P1|STARTED|Period 1||20
17661|NCT02146599|41885|P1|NOT COMPLETED|Overall Study||5
17662|NCT02146599|41885|P1|COMPLETED|Overall Study||296
17663|NCT02146599|41885|P1|STARTED|Overall Study||301
17664|NCT02146482|41891|P2|NOT COMPLETED|Overall Study||0
17665|NCT02146482|41892|P1|NOT COMPLETED|Overall Study||0
17666|NCT02146482|41891|P2|COMPLETED|Overall Study||25
17667|NCT02146482|41892|P1|COMPLETED|Overall Study||21
17668|NCT02146482|41891|P2|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|25
17669|NCT02146482|41892|P1|STARTED|Overall Study|11 participants total enrolled in study but withdrew prior to randomization|21
17670|NCT02146352|41898|P1|NOT COMPLETED|Overall Study||2
17671|NCT02146352|41898|P1|COMPLETED|Overall Study||28
17672|NCT02146352|41898|P1|7 Days Post-stent Removal|Overall Study||28
17673|NCT02146352|41898|P1|30 or 60 Days Post-procedure|Overall Study||30
17674|NCT02146352|41898|P1|STARTED|Overall Study||30
17675|NCT02146326|41916|P4|NOT COMPLETED|Overall Study||48
17676|NCT02146326|41917|P3|NOT COMPLETED|Overall Study||43
17677|NCT02146326|41918|P2|NOT COMPLETED|Overall Study||37
17678|NCT02146326|41919|P1|NOT COMPLETED|Overall Study||28
17679|NCT02146326|41916|P4|COMPLETED|Overall Study||210
17680|NCT02146326|41917|P3|COMPLETED|Overall Study||168
17681|NCT02146326|41918|P2|COMPLETED|Overall Study||66
17682|NCT02146326|41919|P1|COMPLETED|Overall Study||61
17683|NCT02146326|41916|P4|12 Months|Overall Study||210
17684|NCT02146326|41917|P3|12 Months|Overall Study||168
17685|NCT02146326|41918|P2|12 Months|Overall Study||66
17686|NCT02146326|41919|P1|12 Months|Overall Study||61
17687|NCT02146326|41916|P4|6 Months|Overall Study||235
17688|NCT02146326|41917|P3|6 Months|Overall Study||186
17689|NCT02146326|41918|P2|6 Months|Overall Study||71
17690|NCT02146326|41919|P1|6 Months|Overall Study||71
17691|NCT02146326|41916|P4|3 Months|Overall Study||0
17692|NCT02146326|41917|P3|3 Months|Overall Study||0
17693|NCT02146326|41918|P2|3 Months|Overall Study||83
17694|NCT02146326|41919|P1|3 Months|Overall Study||71
17695|NCT02146326|41916|P4|Baseline|Overall Study||258
17696|NCT02146326|41917|P3|Baseline|Overall Study||211
17697|NCT02146326|41918|P2|Baseline|Overall Study||103
17698|NCT02146326|41919|P1|Baseline|Overall Study||89
17699|NCT02146326|41916|P4|STARTED|Overall Study||258
17700|NCT02146326|41917|P3|STARTED|Overall Study||211
17701|NCT02146326|41918|P2|STARTED|Overall Study||103
17702|NCT02146326|41919|P1|STARTED|Overall Study||89
17703|NCT02146248|42081|P1|NOT COMPLETED|Overall Study||2
17704|NCT02146248|42081|P1|COMPLETED|Overall Study||9
17705|NCT02146248|42081|P1|HSG 5|Overall Study||1
17706|NCT02146248|42081|P1|HSG 4|Overall Study||7
17707|NCT02146248|42081|P1|HSG 3|Overall Study||9
17708|NCT02146248|42081|P1|HSG 2|Overall Study||10
17709|NCT02146248|42081|P1|HSG 1|Overall Study||10
17710|NCT02146248|42081|P1|Uterine Sounding|Overall Study|one subject dropped out after uterine sound before HSG #1|11
17711|NCT02146248|42081|P1|Enrolled|Overall Study||11
17712|NCT02146248|42081|P1|STARTED|Overall Study||11
17713|NCT02146105|42089|P1|NOT COMPLETED|Overall Study||6
17714|NCT02146105|42089|P1|COMPLETED|Overall Study||39
17715|NCT02146105|42089|P1|STARTED|Overall Study||45
17716|NCT02146001|42095|P2|NOT COMPLETED|Overall Study||0
17717|NCT02146001|42096|P1|NOT COMPLETED|Overall Study||0
17718|NCT02146001|42095|P2|COMPLETED|Overall Study||19
17719|NCT02146001|42096|P1|COMPLETED|Overall Study||19
17720|NCT02146001|42095|P2|STARTED|Overall Study||19
17721|NCT02146001|42096|P1|STARTED|Overall Study||19
17722|NCT02145754|42106|P1|NOT COMPLETED|Overall Study||0
17723|NCT02145754|42106|P1|COMPLETED|Overall Study||235
17724|NCT02145754|42106|P1|STARTED|Overall Study||235
17725|NCT02145676|42113|P3|NOT COMPLETED|Overall Study||0
17726|NCT02145676|42114|P2|NOT COMPLETED|Overall Study||0
17727|NCT02145676|42115|P1|NOT COMPLETED|Overall Study||0
17728|NCT02145676|42113|P3|COMPLETED|Overall Study||18
17729|NCT02145676|42114|P2|COMPLETED|Overall Study||18
17730|NCT02145676|42115|P1|COMPLETED|Overall Study||17
17731|NCT02145676|42113|P3|STARTED|Overall Study||18
17732|NCT02145676|42114|P2|STARTED|Overall Study||18
17733|NCT02145676|42115|P1|STARTED|Overall Study||17
17734|NCT02145468|42140|P2|NOT COMPLETED|Overall Study||8
17735|NCT02145468|42141|P1|NOT COMPLETED|Overall Study||5
17736|NCT02145468|42140|P2|COMPLETED|Overall Study||1723
17737|NCT02145468|42141|P1|COMPLETED|Overall Study||1753
17738|NCT02145468|42140|P2|STARTED|Overall Study||1731
17739|NCT02145468|42141|P1|STARTED|Overall Study||1758
17740|NCT02145299|42199|P2|NOT COMPLETED|Overall Study||0
17741|NCT02145299|42200|P1|NOT COMPLETED|Overall Study||0
17742|NCT02145299|42199|P2|COMPLETED|Overall Study||2
17743|NCT02145299|42200|P1|COMPLETED|Overall Study||6
17744|NCT02145299|42199|P2|STARTED|Overall Study||2
17745|NCT02145299|42200|P1|STARTED|Overall Study||6
17746|NCT02145156|42229|P3|NOT COMPLETED|Overall Study||41
17747|NCT02145156|42230|P2|NOT COMPLETED|Overall Study||52
17748|NCT02145156|42231|P1|NOT COMPLETED|Overall Study||60
17749|NCT02145156|42229|P3|COMPLETED|Overall Study||398
17750|NCT02145156|42230|P2|COMPLETED|Overall Study||373
17751|NCT02145156|42231|P1|COMPLETED|Overall Study||370
17752|NCT02145156|42229|P3|STARTED|Overall Study||439
17753|NCT02145156|42230|P2|STARTED|Overall Study||425
17754|NCT02145156|42231|P1|STARTED|Overall Study||430
17755|NCT02144337|42274|P2|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||0
17756|NCT02144337|42275|P1|NOT COMPLETED|T3 Follow-up (3 Month Post-intervention)||3
17757|NCT02144337|42274|P2|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
17758|NCT02144337|42275|P1|COMPLETED|T3 Follow-up (3 Month Post-intervention)||5
17850|NCT02142153|42622|P10|NOT COMPLETED|Overall Study||0
17759|NCT02144337|42274|P2|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|5
17760|NCT02144337|42275|P1|STARTED|T3 Follow-up (3 Month Post-intervention)|Number not the same as number who completed previous period due to absence/loss of data at T2|8
17761|NCT02144337|42274|P2|NOT COMPLETED|T2 Follow-up (Post-intervention)||1
17762|NCT02144337|42275|P1|NOT COMPLETED|T2 Follow-up (Post-intervention)||4
17763|NCT02144337|42274|P2|COMPLETED|T2 Follow-up (Post-intervention)||4
17764|NCT02144337|42275|P1|COMPLETED|T2 Follow-up (Post-intervention)||4
17765|NCT02144337|42274|P2|STARTED|T2 Follow-up (Post-intervention)||5
17766|NCT02144337|42275|P1|STARTED|T2 Follow-up (Post-intervention)||8
17767|NCT02144337|42274|P2|NOT COMPLETED|Baseline 0 Months||0
17768|NCT02144337|42275|P1|NOT COMPLETED|Baseline 0 Months||0
17769|NCT02144337|42274|P2|COMPLETED|Baseline 0 Months||5
17770|NCT02144337|42275|P1|COMPLETED|Baseline 0 Months||8
17771|NCT02144337|42274|P2|STARTED|Baseline 0 Months||5
17772|NCT02144337|42275|P1|STARTED|Baseline 0 Months||8
17773|NCT02144259|42288|P3|NOT COMPLETED|Overall Study||18
17774|NCT02144259|42289|P2|NOT COMPLETED|Overall Study||5
17775|NCT02144259|42290|P1|NOT COMPLETED|Overall Study||10
17776|NCT02144259|42288|P3|COMPLETED|Overall Study||16
17777|NCT02144259|42289|P2|COMPLETED|Overall Study||28
17778|NCT02144259|42290|P1|COMPLETED|Overall Study||23
17779|NCT02144259|42288|P3|STARTED|Overall Study||34
17780|NCT02144259|42289|P2|STARTED|Overall Study||33
17781|NCT02144259|42290|P1|STARTED|Overall Study||33
17782|NCT02144220|42304|P1|NOT COMPLETED|Overall Study||19
17783|NCT02144220|42304|P1|COMPLETED|Overall Study||258
17784|NCT02144220|42304|P1|STARTED|Overall Study||277
17785|NCT02144012|42314|P2|NOT COMPLETED|Overall Study||15
17786|NCT02144012|42315|P1|NOT COMPLETED|Overall Study||34
17787|NCT02144012|42314|P2|COMPLETED|Overall Study||0
17788|NCT02144012|42315|P1|COMPLETED|Overall Study||0
17789|NCT02144012|42314|P2|STARTED|Overall Study||15
17790|NCT02144012|42315|P1|STARTED|Overall Study||34
17791|NCT02143947|42352|P2|NOT COMPLETED|Overall Study||2
17792|NCT02143947|42353|P1|NOT COMPLETED|Overall Study||4
17793|NCT02143947|42352|P2|COMPLETED|Overall Study||42
17794|NCT02143947|42353|P1|COMPLETED|Overall Study||32
17795|NCT02143947|42352|P2|STARTED|Overall Study||44
17796|NCT02143947|42353|P1|STARTED|Overall Study||36
17797|NCT02143583|42368|P3|NOT COMPLETED|Overall Study||2
17798|NCT02143583|42369|P2|NOT COMPLETED|Overall Study||0
17799|NCT02143583|42370|P1|NOT COMPLETED|Overall Study||1
17800|NCT02143583|42368|P3|COMPLETED|Overall Study||66
17801|NCT02143583|42369|P2|COMPLETED|Overall Study||66
17802|NCT02143583|42370|P1|COMPLETED|Overall Study||61
17803|NCT02143583|42368|P3|STARTED|Overall Study||68
17804|NCT02143583|42369|P2|STARTED|Overall Study||66
17805|NCT02143583|42370|P1|STARTED|Overall Study||62
17806|NCT02142738|42383|P2|NOT COMPLETED|Overall Study||151
17807|NCT02142738|42384|P1|NOT COMPLETED|Overall Study||154
17808|NCT02142738|42383|P2|COMPLETED|Overall Study||0
17809|NCT02142738|42384|P1|COMPLETED|Overall Study||0
17810|NCT02142738|42383|P2|Treated|Overall Study||150
17811|NCT02142738|42384|P1|Treated|Overall Study||154
17812|NCT02142738|42383|P2|STARTED|Overall Study||151
17813|NCT02142738|42384|P1|STARTED|Overall Study||154
17814|NCT02142712|42397|P4|NOT COMPLETED|Overall Study||0
17815|NCT02142712|42398|P3|NOT COMPLETED|Overall Study||1
17816|NCT02142712|42399|P2|NOT COMPLETED|Overall Study||1
17817|NCT02142712|42400|P1|NOT COMPLETED|Overall Study||1
17818|NCT02142712|42397|P4|COMPLETED|Overall Study||0
17819|NCT02142712|42398|P3|COMPLETED|Overall Study||0
17820|NCT02142712|42399|P2|COMPLETED|Overall Study||0
17821|NCT02142712|42400|P1|COMPLETED|Overall Study||0
17822|NCT02142712|42397|P4|STARTED|Overall Study||0
17823|NCT02142712|42398|P3|STARTED|Overall Study||1
17824|NCT02142712|42399|P2|STARTED|Overall Study||1
17825|NCT02142712|42400|P1|STARTED|Overall Study||1
17826|NCT02142504|42423|P3|NOT COMPLETED|Overall Study||43
17827|NCT02142504|42424|P2|NOT COMPLETED|Overall Study||42
17828|NCT02142504|42425|P1|NOT COMPLETED|Overall Study||31
17829|NCT02142504|42423|P3|COMPLETED|Overall Study||111
17830|NCT02142504|42424|P2|COMPLETED|Overall Study||105
17831|NCT02142504|42425|P1|COMPLETED|Overall Study||122
17832|NCT02142504|42423|P3|Received Booster (Second Vaccination)|Overall Study||116
17833|NCT02142504|42424|P2|Received Booster (Second Vaccination)|Overall Study||109
17834|NCT02142504|42425|P1|Received Booster (Second Vaccination)|Overall Study||126
17835|NCT02142504|42423|P3|Randomized and Received Treatment|Overall Study||154
17836|NCT02142504|42424|P2|Randomized and Received Treatment|Overall Study||145
17837|NCT02142504|42425|P1|Randomized and Received Treatment|Overall Study||153
17838|NCT02142504|42423|P3|STARTED|Overall Study||154
17839|NCT02142504|42424|P2|STARTED|Overall Study||147
17840|NCT02142504|42425|P1|STARTED|Overall Study||153
17841|NCT02142361|42511|P3|NOT COMPLETED|Overall Study||0
17842|NCT02142361|42512|P2|NOT COMPLETED|Overall Study||0
17843|NCT02142361|42513|P1|NOT COMPLETED|Overall Study||0
17844|NCT02142361|42511|P3|COMPLETED|Overall Study||20
17845|NCT02142361|42512|P2|COMPLETED|Overall Study||20
17846|NCT02142361|42513|P1|COMPLETED|Overall Study||20
17847|NCT02142361|42511|P3|STARTED|Overall Study||20
17848|NCT02142361|42512|P2|STARTED|Overall Study||20
17849|NCT02142361|42513|P1|STARTED|Overall Study||20
17851|NCT02142153|42623|P9|NOT COMPLETED|Overall Study||0
17852|NCT02142153|42624|P8|NOT COMPLETED|Overall Study||0
17853|NCT02142153|42625|P7|NOT COMPLETED|Overall Study||0
17854|NCT02142153|42626|P6|NOT COMPLETED|Overall Study||0
17855|NCT02142153|42627|P5|NOT COMPLETED|Overall Study||0
17856|NCT02142153|42628|P4|NOT COMPLETED|Overall Study||0
17857|NCT02142153|42629|P3|NOT COMPLETED|Overall Study||0
17858|NCT02142153|42630|P2|NOT COMPLETED|Overall Study||0
17859|NCT02142153|42631|P1|NOT COMPLETED|Overall Study||0
17860|NCT02142153|42622|P10|COMPLETED|Overall Study||2
17861|NCT02142153|42623|P9|COMPLETED|Overall Study||6
17862|NCT02142153|42624|P8|COMPLETED|Overall Study||2
17863|NCT02142153|42625|P7|COMPLETED|Overall Study||6
17864|NCT02142153|42626|P6|COMPLETED|Overall Study||2
17865|NCT02142153|42627|P5|COMPLETED|Overall Study||6
17866|NCT02142153|42628|P4|COMPLETED|Overall Study||2
17867|NCT02142153|42629|P3|COMPLETED|Overall Study||6
17868|NCT02142153|42630|P2|COMPLETED|Overall Study||2
17869|NCT02142153|42631|P1|COMPLETED|Overall Study||6
17870|NCT02142153|42622|P10|STARTED|Overall Study||2
17871|NCT02142153|42623|P9|STARTED|Overall Study||6
17872|NCT02142153|42624|P8|STARTED|Overall Study||2
17873|NCT02142153|42625|P7|STARTED|Overall Study||6
17874|NCT02142153|42626|P6|STARTED|Overall Study||2
17875|NCT02142153|42627|P5|STARTED|Overall Study||6
17876|NCT02142153|42628|P4|STARTED|Overall Study||2
17877|NCT02142153|42629|P3|STARTED|Overall Study||6
17878|NCT02142153|42630|P2|STARTED|Overall Study||2
17879|NCT02142153|42631|P1|STARTED|Overall Study||6
17880|NCT02141997|42667|P4|NOT COMPLETED|Overall Study||1
17881|NCT02141997|42668|P3|NOT COMPLETED|Overall Study||3
17882|NCT02141997|42669|P2|NOT COMPLETED|Overall Study||6
17883|NCT02141997|42670|P1|NOT COMPLETED|Overall Study||3
17884|NCT02141997|42667|P4|COMPLETED|Overall Study||54
17885|NCT02141997|42668|P3|COMPLETED|Overall Study||53
17886|NCT02141997|42669|P2|COMPLETED|Overall Study||49
17887|NCT02141997|42670|P1|COMPLETED|Overall Study||53
17888|NCT02141997|42667|P4|STARTED|Overall Study||55
17889|NCT02141997|42668|P3|STARTED|Overall Study||56
17890|NCT02141997|42669|P2|STARTED|Overall Study||55
17891|NCT02141997|42670|P1|STARTED|Overall Study||56
17892|NCT02141984|42708|P1|NOT COMPLETED|Overall Study||2
17893|NCT02141984|42708|P1|COMPLETED|Overall Study||26
17894|NCT02141984|42708|P1|STARTED|Overall Study||28
17895|NCT02141867|42715|P1|NOT COMPLETED|Overall Study||94
17896|NCT02141867|42715|P1|COMPLETED|Overall Study||3927
17897|NCT02141867|42715|P1|STARTED|Overall Study||4021
17898|NCT02141854|42727|P6|NOT COMPLETED|Treatment Period||38
17899|NCT02141854|42728|P5|NOT COMPLETED|Treatment Period||10
17900|NCT02141854|42729|P4|NOT COMPLETED|Treatment Period||11
17901|NCT02141854|42730|P3|NOT COMPLETED|Treatment Period||9
17902|NCT02141854|42731|P2|NOT COMPLETED|Treatment Period||10
17903|NCT02141854|42732|P1|NOT COMPLETED|Treatment Period||0
17904|NCT02141854|42727|P6|COMPLETED|Treatment Period||107
17905|NCT02141854|42728|P5|COMPLETED|Treatment Period||136
17906|NCT02141854|42729|P4|COMPLETED|Treatment Period||135
17907|NCT02141854|42730|P3|COMPLETED|Treatment Period||136
17908|NCT02141854|42731|P2|COMPLETED|Treatment Period||136
17909|NCT02141854|42732|P1|COMPLETED|Treatment Period||0
17910|NCT02141854|42727|P6|Full Analysis Set|Treatment Period||143
17911|NCT02141854|42728|P5|Full Analysis Set|Treatment Period||145
17912|NCT02141854|42729|P4|Full Analysis Set|Treatment Period||146
17913|NCT02141854|42730|P3|Full Analysis Set|Treatment Period||141
17914|NCT02141854|42731|P2|Full Analysis Set|Treatment Period||145
17915|NCT02141854|42732|P1|Full Analysis Set|Treatment Period||0
17916|NCT02141854|42727|P6|Safety Population|Treatment Period||144
17917|NCT02141854|42728|P5|Safety Population|Treatment Period||145
17918|NCT02141854|42729|P4|Safety Population|Treatment Period||146
17919|NCT02141854|42730|P3|Safety Population|Treatment Period||143
17920|NCT02141854|42731|P2|Safety Population|Treatment Period||145
17921|NCT02141854|42732|P1|Safety Population|Treatment Period||0
17922|NCT02141854|42727|P6|Intent to Treat Population|Treatment Period||145
17923|NCT02141854|42728|P5|Intent to Treat Population|Treatment Period||146
17924|NCT02141854|42729|P4|Intent to Treat Population|Treatment Period||146
17925|NCT02141854|42730|P3|Intent to Treat Population|Treatment Period||145
17926|NCT02141854|42731|P2|Intent to Treat Population|Treatment Period||146
17927|NCT02141854|42732|P1|Intent to Treat Population|Treatment Period||0
17928|NCT02141854|42727|P6|STARTED|Treatment Period||145
17929|NCT02141854|42728|P5|STARTED|Treatment Period||146
17930|NCT02141854|42729|P4|STARTED|Treatment Period||146
17931|NCT02141854|42730|P3|STARTED|Treatment Period||145
17932|NCT02141854|42731|P2|STARTED|Treatment Period||146
17933|NCT02141854|42732|P1|STARTED|Treatment Period||0
17934|NCT02141854|42727|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
17935|NCT02141854|42728|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
17936|NCT02141854|42729|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
17937|NCT02141854|42730|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
17938|NCT02141854|42731|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
17939|NCT02141854|42732|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||154
17940|NCT02141854|42727|P6|COMPLETED|Run-In Period (Pre-assignment)||0
17941|NCT02141854|42728|P5|COMPLETED|Run-In Period (Pre-assignment)||0
17942|NCT02141854|42729|P4|COMPLETED|Run-In Period (Pre-assignment)||0
17943|NCT02141854|42730|P3|COMPLETED|Run-In Period (Pre-assignment)||0
17944|NCT02141854|42731|P2|COMPLETED|Run-In Period (Pre-assignment)||0
17945|NCT02141854|42732|P1|COMPLETED|Run-In Period (Pre-assignment)||728
17946|NCT02141854|42727|P6|STARTED|Run-In Period (Pre-assignment)||0
17947|NCT02141854|42728|P5|STARTED|Run-In Period (Pre-assignment)||0
17948|NCT02141854|42729|P4|STARTED|Run-In Period (Pre-assignment)||0
17949|NCT02141854|42730|P3|STARTED|Run-In Period (Pre-assignment)||0
17950|NCT02141854|42731|P2|STARTED|Run-In Period (Pre-assignment)||0
17951|NCT02141854|42732|P1|STARTED|Run-In Period (Pre-assignment)||882
17952|NCT02141633|42786|P2|NOT COMPLETED|Overall Study||0
17953|NCT02141633|42787|P1|NOT COMPLETED|Overall Study||1
17954|NCT02141633|42786|P2|COMPLETED|Overall Study||15
17955|NCT02141633|42787|P1|COMPLETED|Overall Study||15
17956|NCT02141633|42786|P2|STARTED|Overall Study||15
17957|NCT02141633|42787|P1|STARTED|Overall Study||16
17958|NCT02141620|42795|P2|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
17959|NCT02141620|42796|P1|NOT COMPLETED|Treatment Condition 2 (7 Days)||0
17960|NCT02141620|42795|P2|COMPLETED|Treatment Condition 2 (7 Days)||7
17961|NCT02141620|42796|P1|COMPLETED|Treatment Condition 2 (7 Days)||7
17962|NCT02141620|42795|P2|STARTED|Treatment Condition 2 (7 Days)||7
17963|NCT02141620|42796|P1|STARTED|Treatment Condition 2 (7 Days)||7
17964|NCT02141620|42795|P2|NOT COMPLETED|Treatment Condition 1 (7 Days)||0
17965|NCT02141620|42796|P1|NOT COMPLETED|Treatment Condition 1 (7 Days)||1
17966|NCT02141620|42795|P2|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to placebo for Condition 2.|7
17967|NCT02141620|42796|P1|COMPLETED|Treatment Condition 1 (7 Days)|7 completing subjects switched to n-acetylcysteine for Condition 2.|7
17968|NCT02141620|42795|P2|STARTED|Treatment Condition 1 (7 Days)||7
17969|NCT02141620|42796|P1|STARTED|Treatment Condition 1 (7 Days)||8
17970|NCT02141581|42857|P3|NOT COMPLETED|Overall Study||0
17971|NCT02141581|42858|P2|NOT COMPLETED|Overall Study||0
17972|NCT02141581|42859|P1|NOT COMPLETED|Overall Study||0
17973|NCT02141581|42857|P3|COMPLETED|Overall Study||25
17974|NCT02141581|42858|P2|COMPLETED|Overall Study||19
17975|NCT02141581|42859|P1|COMPLETED|Overall Study||42
17976|NCT02141581|42857|P3|STARTED|Overall Study||25
17977|NCT02141581|42858|P2|STARTED|Overall Study||19
17978|NCT02141581|42859|P1|STARTED|Overall Study||42
17979|NCT02141516|42873|P3|NOT COMPLETED|Overall Study||0
17980|NCT02141516|42874|P2|NOT COMPLETED|Overall Study||5
17981|NCT02141516|42875|P1|NOT COMPLETED|Overall Study||0
17982|NCT02141516|42873|P3|COMPLETED|Overall Study||87
17983|NCT02141516|42874|P2|COMPLETED|Overall Study||107
17984|NCT02141516|42875|P1|COMPLETED|Overall Study||40
17985|NCT02141516|42873|P3|STARTED|Overall Study||87
17986|NCT02141516|42874|P2|STARTED|Overall Study||112
17987|NCT02141516|42875|P1|STARTED|Overall Study||40
17988|NCT02141360|42925|P3|NOT COMPLETED|Overall Study||0
17989|NCT02141360|42926|P2|NOT COMPLETED|Overall Study||0
17990|NCT02141360|42927|P1|NOT COMPLETED|Overall Study||7
17991|NCT02141360|42925|P3|COMPLETED|Overall Study||6
17992|NCT02141360|42926|P2|COMPLETED|Overall Study||6
17993|NCT02141360|42927|P1|COMPLETED|Overall Study||4
17994|NCT02141360|42925|P3|STARTED|Overall Study||6
17995|NCT02141360|42926|P2|STARTED|Overall Study||6
17996|NCT02141360|42927|P1|STARTED|Overall Study||11
17997|NCT02140164|42935|P1|NOT COMPLETED|Overall Study||2
17998|NCT02140164|42935|P1|COMPLETED|Overall Study||5
17999|NCT02140164|42935|P1|STARTED|Overall Study||7
18000|NCT02141217|42948|P2|NOT COMPLETED|Overall Study||8
18001|NCT02141217|42949|P1|NOT COMPLETED|Overall Study||11
18002|NCT02141217|42948|P2|COMPLETED|Overall Study||229
18003|NCT02141217|42949|P1|COMPLETED|Overall Study||223
18004|NCT02141217|42948|P2|ITT Population-Actual Treatment Received|Overall Study||235
18005|NCT02141217|42949|P1|ITT Population-Actual Treatment Received|Overall Study||236
18006|NCT02141217|42948|P2|ITT Population-Randomized Treatment Arm|Overall Study||237
18007|NCT02141217|42949|P1|ITT Population-Randomized Treatment Arm|Overall Study||234
18008|NCT02141217|42948|P2|STARTED|Overall Study||237
18009|NCT02141217|42949|P1|STARTED|Overall Study||234
18010|NCT02140957|42969|P2|NOT COMPLETED|Overall Study||23
18011|NCT02140957|42970|P1|NOT COMPLETED|Overall Study||27
18012|NCT02140957|42969|P2|COMPLETED|Overall Study||99
18013|NCT02140957|42970|P1|COMPLETED|Overall Study||102
18014|NCT02140957|42969|P2|STARTED|Overall Study||122
18015|NCT02140957|42970|P1|STARTED|Overall Study||129
18016|NCT02140788|42980|P4|NOT COMPLETED|Overall Study||0
18017|NCT02140788|42981|P3|NOT COMPLETED|Overall Study||0
18018|NCT02140788|42982|P2|NOT COMPLETED|Overall Study||0
18019|NCT02140788|42983|P1|NOT COMPLETED|Overall Study||0
18020|NCT02140788|42980|P4|COMPLETED|Overall Study||0
18021|NCT02140788|42981|P3|COMPLETED|Overall Study||0
18022|NCT02140788|42982|P2|COMPLETED|Overall Study||0
18023|NCT02140788|42983|P1|COMPLETED|Overall Study||0
18024|NCT02140788|42980|P4|STARTED|Overall Study||0
18025|NCT02140788|42981|P3|STARTED|Overall Study||0
18026|NCT02140788|42982|P2|STARTED|Overall Study||0
18027|NCT02140788|42983|P1|STARTED|Overall Study||0
18028|NCT02140645|43015|P6|NOT COMPLETED|Overall Study||70896
18029|NCT02140645|43016|P5|NOT COMPLETED|Overall Study||3286
18030|NCT02140645|43017|P4|NOT COMPLETED|Overall Study||13833
18031|NCT02140645|43018|P3|NOT COMPLETED|Overall Study||4236
18032|NCT02140645|43019|P2|NOT COMPLETED|Overall Study||61654
18033|NCT02140645|43020|P1|NOT COMPLETED|Overall Study||5489
18034|NCT02140645|43015|P6|COMPLETED|Overall Study||3050
18035|NCT02140645|43016|P5|COMPLETED|Overall Study||150
18036|NCT02140645|43017|P4|COMPLETED|Overall Study||530
18037|NCT02140645|43018|P3|COMPLETED|Overall Study||205
18038|NCT02140645|43019|P2|COMPLETED|Overall Study||3041
18039|NCT02140645|43020|P1|COMPLETED|Overall Study||243
18040|NCT02140645|43015|P6|STARTED|Overall Study||73946
18041|NCT02140645|43016|P5|STARTED|Overall Study||3436
18042|NCT02140645|43017|P4|STARTED|Overall Study||14363
18043|NCT02140645|43018|P3|STARTED|Overall Study||4441
18044|NCT02140645|43019|P2|STARTED|Overall Study||64695
18045|NCT02140645|43020|P1|STARTED|Overall Study||5732
18046|NCT02140593|43109|P2|NOT COMPLETED|Overall Study||0
18047|NCT02140593|43110|P1|NOT COMPLETED|Overall Study||0
18048|NCT02140593|43109|P2|COMPLETED|Overall Study||65
18049|NCT02140593|43110|P1|COMPLETED|Overall Study||63
18050|NCT02140593|43109|P2|STARTED|Overall Study||65
18051|NCT02140593|43110|P1|STARTED|Overall Study||63
18052|NCT02140372|43118|P1|NOT COMPLETED|Overall Study||0
18053|NCT02140372|43118|P1|COMPLETED|Overall Study||10
18054|NCT02140372|43118|P1|STARTED|Overall Study||10
18055|NCT02140060|43135|P6|NOT COMPLETED|Overall Study||1
18056|NCT02140060|43136|P5|NOT COMPLETED|Overall Study||1
18057|NCT02140060|43137|P4|NOT COMPLETED|Overall Study||2
18058|NCT02140060|43138|P3|NOT COMPLETED|Overall Study||0
18059|NCT02140060|43139|P2|NOT COMPLETED|Overall Study||0
18060|NCT02140060|43140|P1|NOT COMPLETED|Overall Study||0
18061|NCT02140060|43135|P6|COMPLETED|Overall Study||43
18062|NCT02140060|43136|P5|COMPLETED|Overall Study||44
18063|NCT02140060|43137|P4|COMPLETED|Overall Study||43
18064|NCT02140060|43138|P3|COMPLETED|Overall Study||44
18065|NCT02140060|43139|P2|COMPLETED|Overall Study||44
18066|NCT02140060|43140|P1|COMPLETED|Overall Study||44
18067|NCT02140060|43135|P6|STARTED|Overall Study||44
18068|NCT02140060|43136|P5|STARTED|Overall Study||45
18069|NCT02140060|43137|P4|STARTED|Overall Study||45
18070|NCT02140060|43138|P3|STARTED|Overall Study||44
18071|NCT02140060|43139|P2|STARTED|Overall Study||44
18072|NCT02140060|43140|P1|STARTED|Overall Study||44
18073|NCT02139982|43165|P10|NOT COMPLETED|Overall Study||0
18074|NCT02139982|43166|P9|NOT COMPLETED|Overall Study||0
18075|NCT02139982|43167|P8|NOT COMPLETED|Overall Study||0
18076|NCT02139982|43168|P7|NOT COMPLETED|Overall Study||0
18077|NCT02139982|43169|P6|NOT COMPLETED|Overall Study||0
18078|NCT02139982|43170|P5|NOT COMPLETED|Overall Study||0
18079|NCT02139982|43171|P4|NOT COMPLETED|Overall Study||1
18080|NCT02139982|43172|P3|NOT COMPLETED|Overall Study||0
18081|NCT02139982|43173|P2|NOT COMPLETED|Overall Study||1
18082|NCT02139982|43174|P1|NOT COMPLETED|Overall Study||0
18083|NCT02139982|43165|P10|COMPLETED|Overall Study||13
18084|NCT02139982|43166|P9|COMPLETED|Overall Study||13
18085|NCT02139982|43167|P8|COMPLETED|Overall Study||13
18086|NCT02139982|43168|P7|COMPLETED|Overall Study||13
18087|NCT02139982|43169|P6|COMPLETED|Overall Study||13
18088|NCT02139982|43170|P5|COMPLETED|Overall Study||13
18089|NCT02139982|43171|P4|COMPLETED|Overall Study||7
18090|NCT02139982|43172|P3|COMPLETED|Overall Study||8
18091|NCT02139982|43173|P2|COMPLETED|Overall Study||7
18092|NCT02139982|43174|P1|COMPLETED|Overall Study||8
18093|NCT02139982|43165|P10|STARTED|Overall Study||13
18094|NCT02139982|43166|P9|STARTED|Overall Study||13
18095|NCT02139982|43167|P8|STARTED|Overall Study||13
18096|NCT02139982|43168|P7|STARTED|Overall Study||13
18097|NCT02139982|43169|P6|STARTED|Overall Study||13
18098|NCT02139982|43170|P5|STARTED|Overall Study||13
18099|NCT02139982|43171|P4|STARTED|Overall Study||8
18100|NCT02139982|43172|P3|STARTED|Overall Study||8
18101|NCT02139982|43173|P2|STARTED|Overall Study||8
18102|NCT02139982|43174|P1|STARTED|Overall Study||8
18103|NCT02139943|43219|P3|NOT COMPLETED|Overall Study||7
18104|NCT02139943|43220|P2|NOT COMPLETED|Overall Study||6
18105|NCT02139943|43221|P1|NOT COMPLETED|Overall Study||10
18106|NCT02139943|43219|P3|COMPLETED|Overall Study||110
18107|NCT02139943|43220|P2|COMPLETED|Overall Study||111
18108|NCT02139943|43221|P1|COMPLETED|Overall Study||107
18109|NCT02139943|43219|P3|STARTED|Overall Study||117
18110|NCT02139943|43220|P2|STARTED|Overall Study||117
18111|NCT02139943|43221|P1|STARTED|Overall Study||117
18112|NCT02139878|43232|P2|NOT COMPLETED|Second Intervention (7 Days)||0
18113|NCT02139878|43233|P1|NOT COMPLETED|Second Intervention (7 Days)||0
18114|NCT02139878|43232|P2|COMPLETED|Second Intervention (7 Days)||10
18115|NCT02139878|43233|P1|COMPLETED|Second Intervention (7 Days)||9
18116|NCT02139878|43232|P2|STARTED|Second Intervention (7 Days)||10
18117|NCT02139878|43233|P1|STARTED|Second Intervention (7 Days)||9
18118|NCT02139878|43232|P2|NOT COMPLETED|Washout Period (8 Days)||0
18119|NCT02139878|43233|P1|NOT COMPLETED|Washout Period (8 Days)||0
18120|NCT02139878|43232|P2|COMPLETED|Washout Period (8 Days)||10
18121|NCT02139878|43233|P1|COMPLETED|Washout Period (8 Days)||9
18122|NCT02139878|43232|P2|STARTED|Washout Period (8 Days)||10
18123|NCT02139878|43233|P1|STARTED|Washout Period (8 Days)||9
18124|NCT02139878|43232|P2|NOT COMPLETED|First Intervention (7 Days)||0
18125|NCT02139878|43233|P1|NOT COMPLETED|First Intervention (7 Days)||1
18126|NCT02139878|43232|P2|COMPLETED|First Intervention (7 Days)||10
18127|NCT02139878|43233|P1|COMPLETED|First Intervention (7 Days)||9
18128|NCT02139878|43232|P2|STARTED|First Intervention (7 Days)||10
18129|NCT02139878|43233|P1|STARTED|First Intervention (7 Days)||10
18130|NCT02139644|43246|P6|NOT COMPLETED|Treatment Period||17
18131|NCT02139644|43247|P5|NOT COMPLETED|Treatment Period||8
18132|NCT02139644|43248|P4|NOT COMPLETED|Treatment Period||9
18133|NCT02139644|43249|P3|NOT COMPLETED|Treatment Period||8
18134|NCT02139644|43250|P2|NOT COMPLETED|Treatment Period||3
18135|NCT02139644|43251|P1|NOT COMPLETED|Treatment Period||0
18136|NCT02139644|43246|P6|COMPLETED|Treatment Period||113
18137|NCT02139644|43247|P5|COMPLETED|Treatment Period||121
18138|NCT02139644|43248|P4|COMPLETED|Treatment Period||121
18139|NCT02139644|43249|P3|COMPLETED|Treatment Period||121
18140|NCT02139644|43250|P2|COMPLETED|Treatment Period||126
18141|NCT02139644|43251|P1|COMPLETED|Treatment Period||0
18142|NCT02139644|43246|P6|STARTED|Treatment Period|Randomized|130
18143|NCT02139644|43247|P5|STARTED|Treatment Period|Randomized|129
18144|NCT02139644|43248|P4|STARTED|Treatment Period|Randomized|130
18145|NCT02139644|43249|P3|STARTED|Treatment Period|Randomized|129
18146|NCT02139644|43250|P2|STARTED|Treatment Period|Randomized|129
18147|NCT02139644|43251|P1|STARTED|Treatment Period||0
18236|NCT02138747|43409|P1|NOT COMPLETED|Treatment Period 2||17
18148|NCT02139644|43246|P6|NOT COMPLETED|Run-In Period (Pre-assignment)||0
18149|NCT02139644|43247|P5|NOT COMPLETED|Run-In Period (Pre-assignment)||0
18150|NCT02139644|43248|P4|NOT COMPLETED|Run-In Period (Pre-assignment)||0
18151|NCT02139644|43249|P3|NOT COMPLETED|Run-In Period (Pre-assignment)||0
18152|NCT02139644|43250|P2|NOT COMPLETED|Run-In Period (Pre-assignment)||0
18153|NCT02139644|43251|P1|NOT COMPLETED|Run-In Period (Pre-assignment)||140
18154|NCT02139644|43246|P6|COMPLETED|Run-In Period (Pre-assignment)||0
18155|NCT02139644|43247|P5|COMPLETED|Run-In Period (Pre-assignment)||0
18156|NCT02139644|43248|P4|COMPLETED|Run-In Period (Pre-assignment)||0
18157|NCT02139644|43249|P3|COMPLETED|Run-In Period (Pre-assignment)||0
18158|NCT02139644|43250|P2|COMPLETED|Run-In Period (Pre-assignment)||0
18159|NCT02139644|43251|P1|COMPLETED|Run-In Period (Pre-assignment)||647
18160|NCT02139644|43246|P6|STARTED|Run-In Period (Pre-assignment)||0
18161|NCT02139644|43247|P5|STARTED|Run-In Period (Pre-assignment)||0
18162|NCT02139644|43248|P4|STARTED|Run-In Period (Pre-assignment)||0
18163|NCT02139644|43249|P3|STARTED|Run-In Period (Pre-assignment)||0
18164|NCT02139644|43250|P2|STARTED|Run-In Period (Pre-assignment)||0
18165|NCT02139644|43251|P1|STARTED|Run-In Period (Pre-assignment)|Enrolled|787
18166|NCT02139228|43305|P2|NOT COMPLETED|Overall Study||0
18167|NCT02139228|43306|P1|NOT COMPLETED|Overall Study||0
18168|NCT02139228|43305|P2|COMPLETED|Overall Study||211
18169|NCT02139228|43306|P1|COMPLETED|Overall Study||215
18170|NCT02139228|43305|P2|STARTED|Overall Study||211
18171|NCT02139228|43306|P1|STARTED|Overall Study||215
18172|NCT02139176|43316|P2|NOT COMPLETED|Overall Study||0
18173|NCT02139176|43317|P1|NOT COMPLETED|Overall Study||0
18174|NCT02139176|43316|P2|COMPLETED|Overall Study||100
18175|NCT02139176|43317|P1|COMPLETED|Overall Study||100
18176|NCT02139176|43316|P2|STARTED|Overall Study||100
18177|NCT02139176|43317|P1|STARTED|Overall Study||100
18178|NCT02139137|43329|P2|NOT COMPLETED|Overall Study||10
18179|NCT02139137|43330|P1|NOT COMPLETED|Overall Study||7
18180|NCT02139137|43329|P2|COMPLETED|Overall Study||10
18181|NCT02139137|43330|P1|COMPLETED|Overall Study||15
18182|NCT02139137|43329|P2|STARTED|Overall Study||20
18183|NCT02139137|43330|P1|STARTED|Overall Study||22
18184|NCT02139046|43349|P5|NOT COMPLETED|Overall Study||57
18185|NCT02139046|43350|P4|NOT COMPLETED|Overall Study||68
18186|NCT02139046|43351|P3|NOT COMPLETED|Overall Study||59
18187|NCT02139046|43352|P2|NOT COMPLETED|Overall Study||54
18188|NCT02139046|43353|P1|NOT COMPLETED|Overall Study||62
18189|NCT02139046|43349|P5|COMPLETED|Overall Study||301
18190|NCT02139046|43350|P4|COMPLETED|Overall Study||290
18191|NCT02139046|43351|P3|COMPLETED|Overall Study||298
18192|NCT02139046|43352|P2|COMPLETED|Overall Study||305
18193|NCT02139046|43353|P1|COMPLETED|Overall Study|Completed=Completed Study Drug|296
18194|NCT02139046|43349|P5|Full Analysis Set|Overall Study||357
18195|NCT02139046|43350|P4|Full Analysis Set|Overall Study||357
18196|NCT02139046|43351|P3|Full Analysis Set|Overall Study||355
18197|NCT02139046|43352|P2|Full Analysis Set|Overall Study||357
18198|NCT02139046|43353|P1|Full Analysis Set|Overall Study||357
18199|NCT02139046|43349|P5|Safety Analysis Set|Overall Study||357
18200|NCT02139046|43350|P4|Safety Analysis Set|Overall Study||357
18201|NCT02139046|43351|P3|Safety Analysis Set|Overall Study||355
18202|NCT02139046|43352|P2|Safety Analysis Set|Overall Study||358
18203|NCT02139046|43353|P1|Safety Analysis Set|Overall Study||356
18204|NCT02139046|43349|P5|STARTED|Overall Study||358
18205|NCT02139046|43350|P4|STARTED|Overall Study||358
18206|NCT02139046|43351|P3|STARTED|Overall Study||357
18207|NCT02139046|43352|P2|STARTED|Overall Study||359
18208|NCT02139046|43353|P1|STARTED|Overall Study||358
18209|NCT02139007|43377|P2|NOT COMPLETED|Patient Participant Recruitment||1
18210|NCT02139007|43378|P1|NOT COMPLETED|Patient Participant Recruitment||2
18211|NCT02139007|43377|P2|COMPLETED|Patient Participant Recruitment||13
18212|NCT02139007|43378|P1|COMPLETED|Patient Participant Recruitment||11
18213|NCT02139007|43377|P2|STARTED|Patient Participant Recruitment||14
18214|NCT02139007|43378|P1|STARTED|Patient Participant Recruitment||13
18215|NCT02139007|43377|P2|NOT COMPLETED|Study Site Recruitment||4
18216|NCT02139007|43378|P1|NOT COMPLETED|Study Site Recruitment||3
18217|NCT02139007|43377|P2|COMPLETED|Study Site Recruitment||1
18218|NCT02139007|43378|P1|COMPLETED|Study Site Recruitment||1
18219|NCT02139007|43377|P2|STARTED|Study Site Recruitment||5
18220|NCT02139007|43378|P1|STARTED|Study Site Recruitment||4
18221|NCT02138825|43393|P2|NOT COMPLETED|Long-term Extension||0
18222|NCT02138825|43394|P1|NOT COMPLETED|Long-term Extension||0
18223|NCT02138825|43393|P2|COMPLETED|Long-term Extension||38
18224|NCT02138825|43394|P1|COMPLETED|Long-term Extension||32
18225|NCT02138825|43393|P2|STARTED|Long-term Extension||38
18226|NCT02138825|43394|P1|STARTED|Long-term Extension||32
18227|NCT02138825|43393|P2|NOT COMPLETED|Main Study Treatment||35
18228|NCT02138825|43394|P1|NOT COMPLETED|Main Study Treatment||40
18229|NCT02138825|43393|P2|COMPLETED|Main Study Treatment||39
18230|NCT02138825|43394|P1|COMPLETED|Main Study Treatment||33
18231|NCT02138825|43393|P2|STARTED|Main Study Treatment|safety population|74
18232|NCT02138825|43394|P1|STARTED|Main Study Treatment|safety population|73
18233|NCT02138747|43406|P4|NOT COMPLETED|Treatment Period 2||3
18234|NCT02138747|43407|P3|NOT COMPLETED|Treatment Period 2||2
18235|NCT02138747|43408|P2|NOT COMPLETED|Treatment Period 2||7
18237|NCT02138747|43406|P4|COMPLETED|Treatment Period 2||24
18238|NCT02138747|43407|P3|COMPLETED|Treatment Period 2||24
18239|NCT02138747|43408|P2|COMPLETED|Treatment Period 2||125
18240|NCT02138747|43409|P1|COMPLETED|Treatment Period 2||121
18241|NCT02138747|43406|P4|STARTED|Treatment Period 2|One participant completed treatment in period 1.|27
18242|NCT02138747|43407|P3|STARTED|Treatment Period 2|One participant completed treatment in period 1.|26
18243|NCT02138747|43408|P2|STARTED|Treatment Period 2||132
18244|NCT02138747|43409|P1|STARTED|Treatment Period 2|Two participants who discontinued treatment in period 1 entered period 2.|138
18245|NCT02138747|43406|P4|NOT COMPLETED|Treatment Period 1||4
18246|NCT02138747|43407|P3|NOT COMPLETED|Treatment Period 1||4
18247|NCT02138747|43408|P2|NOT COMPLETED|Treatment Period 1||25
18248|NCT02138747|43409|P1|NOT COMPLETED|Treatment Period 1||20
18249|NCT02138747|43406|P4|COMPLETED|Treatment Period 1||28
18250|NCT02138747|43407|P3|COMPLETED|Treatment Period 1||27
18251|NCT02138747|43408|P2|COMPLETED|Treatment Period 1||132
18252|NCT02138747|43409|P1|COMPLETED|Treatment Period 1||136
18253|NCT02138747|43406|P4|STARTED|Treatment Period 1||32
18254|NCT02138747|43407|P3|STARTED|Treatment Period 1||31
18255|NCT02138747|43408|P2|STARTED|Treatment Period 1||157
18256|NCT02138747|43409|P1|STARTED|Treatment Period 1||156
18257|NCT02138461|43443|P2|NOT COMPLETED|Overall Study||0
18258|NCT02138461|43444|P1|NOT COMPLETED|Overall Study||0
18259|NCT02138461|43443|P2|COMPLETED|Overall Study||110
18260|NCT02138461|43444|P1|COMPLETED|Overall Study||101
18261|NCT02138461|43443|P2|STARTED|Overall Study||110
18262|NCT02138461|43444|P1|STARTED|Overall Study||101
18263|NCT02138097|43468|P2|NOT COMPLETED|Overall Study||0
18264|NCT02138097|43469|P1|NOT COMPLETED|Overall Study||0
18265|NCT02138097|43468|P2|COMPLETED|Overall Study||459722
18266|NCT02138097|43469|P1|COMPLETED|Overall Study||155345
18267|NCT02138097|43468|P2|STARTED|Overall Study||459722
18268|NCT02138097|43469|P1|STARTED|Overall Study||155345
18269|NCT02138006|43661|P2|NOT COMPLETED|Overall Study||0
18270|NCT02138006|43662|P1|NOT COMPLETED|Overall Study||0
18271|NCT02138006|43661|P2|COMPLETED|Overall Study||54
18272|NCT02138006|43662|P1|COMPLETED|Overall Study||48
18273|NCT02138006|43661|P2|STARTED|Overall Study||54
18274|NCT02138006|43662|P1|STARTED|Overall Study||48
18275|NCT02137785|43672|P2|NOT COMPLETED|Overall Study||4
18276|NCT02137785|43673|P1|NOT COMPLETED|Overall Study||3
18277|NCT02137785|43672|P2|COMPLETED|Overall Study||130
18278|NCT02137785|43673|P1|COMPLETED|Overall Study||132
18279|NCT02137785|43672|P2|STARTED|Overall Study||134
18280|NCT02137785|43673|P1|STARTED|Overall Study||135
18281|NCT02137603|43781|P2|NOT COMPLETED|Overall Study||0
18282|NCT02137603|43782|P1|NOT COMPLETED|Overall Study||2
18283|NCT02137603|43781|P2|COMPLETED|Overall Study||18
18284|NCT02137603|43782|P1|COMPLETED|Overall Study||16
18285|NCT02137603|43781|P2|STARTED|Overall Study||18
18286|NCT02137603|43782|P1|STARTED|Overall Study||18
18287|NCT02137512|43790|P1|NOT COMPLETED|Overall Study||0
18288|NCT02137512|43790|P1|COMPLETED|Overall Study||30
18289|NCT02137512|43790|P1|STARTED|Overall Study||30
18290|NCT02137447|43806|P1|NOT COMPLETED|Overall Study||0
18291|NCT02137447|43806|P1|COMPLETED|Overall Study||10
18292|NCT02137447|43806|P1|STARTED|Overall Study||10
18293|NCT02137382|43811|P2|NOT COMPLETED|Cross-over Period 2||0
18294|NCT02137382|43812|P1|NOT COMPLETED|Cross-over Period 2||0
18295|NCT02137382|43811|P2|COMPLETED|Cross-over Period 2||21
18296|NCT02137382|43812|P1|COMPLETED|Cross-over Period 2||18
18297|NCT02137382|43811|P2|STARTED|Cross-over Period 2||21
18298|NCT02137382|43812|P1|STARTED|Cross-over Period 2||18
18299|NCT02137382|43811|P2|NOT COMPLETED|Wash Out||0
18300|NCT02137382|43812|P1|NOT COMPLETED|Wash Out||0
18301|NCT02137382|43811|P2|COMPLETED|Wash Out||21
18302|NCT02137382|43812|P1|COMPLETED|Wash Out||18
18303|NCT02137382|43811|P2|STARTED|Wash Out||21
18304|NCT02137382|43812|P1|STARTED|Wash Out||18
18305|NCT02137382|43811|P2|NOT COMPLETED|Cross-over Period 1||0
18306|NCT02137382|43812|P1|NOT COMPLETED|Cross-over Period 1||2
18307|NCT02137382|43811|P2|COMPLETED|Cross-over Period 1||21
18308|NCT02137382|43812|P1|COMPLETED|Cross-over Period 1||18
18309|NCT02137382|43811|P2|STARTED|Cross-over Period 1||21
18310|NCT02137382|43812|P1|STARTED|Cross-over Period 1||20
18311|NCT02136498|43832|P2|NOT COMPLETED|Overall Study||0
18312|NCT02136498|43833|P1|NOT COMPLETED|Overall Study||0
18313|NCT02136498|43832|P2|COMPLETED|Overall Study||33
18314|NCT02136498|43833|P1|COMPLETED|Overall Study||33
18315|NCT02136498|43832|P2|STARTED|Overall Study||33
18316|NCT02136498|43833|P1|STARTED|Overall Study||33
18317|NCT02136238|43843|P3|NOT COMPLETED|Overall Study||0
18318|NCT02136238|43844|P2|NOT COMPLETED|Overall Study||0
18319|NCT02136238|43845|P1|NOT COMPLETED|Overall Study||0
18320|NCT02136238|43843|P3|COMPLETED|Overall Study||10
18321|NCT02136238|43844|P2|COMPLETED|Overall Study||4
18322|NCT02136238|43845|P1|COMPLETED|Overall Study||4
18323|NCT02136238|43843|P3|STARTED|Overall Study||10
18324|NCT02136238|43844|P2|STARTED|Overall Study||4
18325|NCT02136238|43845|P1|STARTED|Overall Study||4
18326|NCT02136134|43858|P2|NOT COMPLETED|Overall Study||251
18327|NCT02136134|43859|P1|NOT COMPLETED|Overall Study||247
18328|NCT02136134|43858|P2|COMPLETED|Overall Study||0
18329|NCT02136134|43859|P1|COMPLETED|Overall Study||0
18330|NCT02136134|43858|P2|Treated|Overall Study||243
18331|NCT02136134|43859|P1|Treated|Overall Study||237
18332|NCT02136134|43858|P2|STARTED|Overall Study||251
18333|NCT02136134|43859|P1|STARTED|Overall Study||247
18334|NCT02136004|43877|P1|NOT COMPLETED|Overall Study||1
18335|NCT02136004|43877|P1|COMPLETED|Overall Study||219
18336|NCT02136004|43877|P1|STARTED|Overall Study|Enrollment commenced on May 20, 2014 and the last subject completed follow-up on February 28, 2015|220
18337|NCT02135900|43888|P1|NOT COMPLETED|Overall Study||0
18338|NCT02135900|43888|P1|COMPLETED|Overall Study||32
18339|NCT02135900|43888|P1|STARTED|Overall Study|32 subjects started the study. 50 subjects were screened.|32
18340|NCT02135445|43897|P2|NOT COMPLETED|Overall Study||0
18341|NCT02135445|43898|P1|NOT COMPLETED|Overall Study||2
18342|NCT02135445|43897|P2|COMPLETED|Overall Study||38
18343|NCT02135445|43898|P1|COMPLETED|Overall Study||63
18344|NCT02135445|43897|P2|STARTED|Overall Study||38
18345|NCT02135445|43898|P1|STARTED|Overall Study||65
18346|NCT02135432|43949|P2|NOT COMPLETED|Overall Study||0
18347|NCT02135432|43950|P1|NOT COMPLETED|Overall Study||0
18348|NCT02135432|43949|P2|COMPLETED|Overall Study||4
18349|NCT02135432|43950|P1|COMPLETED|Overall Study||8
18350|NCT02135432|43949|P2|STARTED|Overall Study||4
18351|NCT02135432|43950|P1|STARTED|Overall Study||8
18352|NCT02135016|43965|P3|NOT COMPLETED|Overall Study||0
18353|NCT02135016|43966|P2|NOT COMPLETED|Overall Study||0
18354|NCT02135016|43967|P1|NOT COMPLETED|Overall Study||0
18355|NCT02135016|43965|P3|COMPLETED|Overall Study||15
18356|NCT02135016|43966|P2|COMPLETED|Overall Study||15
18357|NCT02135016|43967|P1|COMPLETED|Overall Study||15
18358|NCT02135016|43965|P3|STARTED|Overall Study||15
18359|NCT02135016|43966|P2|STARTED|Overall Study||15
18360|NCT02135016|43967|P1|STARTED|Overall Study||15
18361|NCT02134977|43987|P1|NOT COMPLETED|Overall Study||102
18362|NCT02134977|43987|P1|COMPLETED|Overall Study||2714
18363|NCT02134977|43987|P1|STARTED|Overall Study||2816
18364|NCT02134717|44008|P1|NOT COMPLETED|Overall Study||0
18365|NCT02134717|44008|P1|COMPLETED|Overall Study||3
18366|NCT02134717|44008|P1|STARTED|Overall Study||3
18367|NCT02134587|44012|P1|NOT COMPLETED|Overall Study||30
18368|NCT02134587|44012|P1|COMPLETED|Overall Study||173
18369|NCT02134587|44012|P1|STARTED|Overall Study||203
18370|NCT02134184|44024|P3|NOT COMPLETED|Overall Study||0
18371|NCT02134184|44025|P2|NOT COMPLETED|Overall Study||0
18372|NCT02134184|44026|P1|NOT COMPLETED|Overall Study||0
18373|NCT02134184|44024|P3|COMPLETED|Overall Study||8
18374|NCT02134184|44025|P2|COMPLETED|Overall Study||37
18375|NCT02134184|44026|P1|COMPLETED|Overall Study||33
18376|NCT02134184|44024|P3|STARTED|Overall Study||8
18377|NCT02134184|44025|P2|STARTED|Overall Study||37
18378|NCT02134184|44026|P1|STARTED|Overall Study||33
18379|NCT02134119|44039|P2|NOT COMPLETED|Overall Study||0
18380|NCT02134119|44040|P1|NOT COMPLETED|Overall Study||0
18381|NCT02134119|44039|P2|COMPLETED|Overall Study||15
18382|NCT02134119|44040|P1|COMPLETED|Overall Study||30
18383|NCT02134119|44039|P2|STARTED|Overall Study||15
18384|NCT02134119|44040|P1|STARTED|Overall Study||30
18385|NCT02133781|44081|P3|NOT COMPLETED|Overall Study||0
18386|NCT02133781|44082|P2|NOT COMPLETED|Overall Study||0
18387|NCT02133781|44083|P1|NOT COMPLETED|Overall Study||0
18388|NCT02133781|44081|P3|COMPLETED|Overall Study||21
18389|NCT02133781|44082|P2|COMPLETED|Overall Study||24
18390|NCT02133781|44083|P1|COMPLETED|Overall Study||6
18391|NCT02133781|44081|P3|STARTED|Overall Study||21
18392|NCT02133781|44082|P2|STARTED|Overall Study||24
18393|NCT02133781|44083|P1|STARTED|Overall Study||6
18394|NCT02133664|44096|P2|NOT COMPLETED|Overall Study||7
18395|NCT02133664|44097|P1|NOT COMPLETED|Overall Study||5
18396|NCT02133664|44096|P2|COMPLETED|Overall Study||21
18397|NCT02133664|44097|P1|COMPLETED|Overall Study||21
18398|NCT02133664|44096|P2|STARTED|Overall Study||28
18399|NCT02133664|44097|P1|STARTED|Overall Study||26
18400|NCT02133534|44109|P1|NOT COMPLETED|Overall Study||0
18401|NCT02133534|44109|P1|COMPLETED|Overall Study||1
18402|NCT02133534|44109|P1|STARTED|Overall Study||1
18403|NCT02133352|44113|P1|NOT COMPLETED|Longer Term Extension||6
18404|NCT02133352|44113|P1|COMPLETED|Longer Term Extension||4
18405|NCT02133352|44113|P1|STARTED|Longer Term Extension||10
18406|NCT02133352|44113|P1|NOT COMPLETED|Main Study (180 Day)||0
18407|NCT02133352|44113|P1|COMPLETED|Main Study (180 Day)||10
18408|NCT02133352|44113|P1|STARTED|Main Study (180 Day)||10
18409|NCT02133235|44124|P2|NOT COMPLETED|Overall Study||0
18410|NCT02133235|44125|P1|NOT COMPLETED|Overall Study||0
18411|NCT02133235|44124|P2|COMPLETED|Overall Study||57
18412|NCT02133235|44125|P1|COMPLETED|Overall Study||55
18413|NCT02133235|44124|P2|STARTED|Overall Study||57
18414|NCT02133235|44125|P1|STARTED|Overall Study||55
18415|NCT02133131|44144|P7|NOT COMPLETED|Overall Study||12
18416|NCT02133131|44145|P6|NOT COMPLETED|Overall Study||14
18417|NCT02133131|44146|P5|NOT COMPLETED|Overall Study||15
18418|NCT02133131|44147|P4|NOT COMPLETED|Overall Study||6
18419|NCT02133131|44148|P3|NOT COMPLETED|Overall Study||1
18420|NCT02133131|44149|P2|NOT COMPLETED|Overall Study||5
18421|NCT02133131|44150|P1|NOT COMPLETED|Overall Study||5
18422|NCT02133131|44144|P7|COMPLETED|Overall Study||0
18423|NCT02133131|44145|P6|COMPLETED|Overall Study||0
18424|NCT02133131|44146|P5|COMPLETED|Overall Study||0
18425|NCT02133131|44147|P4|COMPLETED|Overall Study||15
18426|NCT02133131|44148|P3|COMPLETED|Overall Study||19
18427|NCT02133131|44149|P2|COMPLETED|Overall Study||25
18428|NCT02133131|44150|P1|COMPLETED|Overall Study||26
18429|NCT02133131|44144|P7|STARTED|Overall Study||12
18430|NCT02133131|44145|P6|STARTED|Overall Study||14
18431|NCT02133131|44146|P5|STARTED|Overall Study||15
18432|NCT02133131|44147|P4|STARTED|Overall Study||21
18433|NCT02133131|44148|P3|STARTED|Overall Study||20
18434|NCT02133131|44149|P2|STARTED|Overall Study||30
18435|NCT02133131|44150|P1|STARTED|Overall Study||31
18436|NCT02133066|44189|P2|NOT COMPLETED|Overall Study||0
18437|NCT02133066|44190|P1|NOT COMPLETED|Overall Study||0
18438|NCT02133066|44189|P2|COMPLETED|Overall Study||64
18439|NCT02133066|44190|P1|COMPLETED|Overall Study||64
18440|NCT02133066|44189|P2|STARTED|Overall Study||64
18441|NCT02133066|44190|P1|STARTED|Overall Study||64
18442|NCT02132949|44204|P2|NOT COMPLETED|Adjuvant Treatment Period||167
18443|NCT02132949|44205|P1|NOT COMPLETED|Adjuvant Treatment Period||149
18444|NCT02132949|44204|P2|COMPLETED|Adjuvant Treatment Period||23
18445|NCT02132949|44205|P1|COMPLETED|Adjuvant Treatment Period||29
18446|NCT02132949|44204|P2|STARTED|Adjuvant Treatment Period|Includes a participant who did not complete neoadjuvant treatment but started adjuvant treatment.|190
18447|NCT02132949|44205|P1|STARTED|Adjuvant Treatment Period|At clinical cutoff (03 March 2016), some participants had not yet received adjuvant treatment.|178
18448|NCT02132949|44204|P2|NOT COMPLETED|Neoadjuvant Treatment Period||12
18449|NCT02132949|44205|P1|NOT COMPLETED|Neoadjuvant Treatment Period||17
18450|NCT02132949|44204|P2|COMPLETED|Neoadjuvant Treatment Period||189
18451|NCT02132949|44205|P1|COMPLETED|Neoadjuvant Treatment Period||182
18452|NCT02132949|44204|P2|No Treatment|Neoadjuvant Treatment Period||3
18453|NCT02132949|44205|P1|No Treatment|Neoadjuvant Treatment Period||1
18454|NCT02132949|44204|P2|STARTED|Neoadjuvant Treatment Period||201
18455|NCT02132949|44205|P1|STARTED|Neoadjuvant Treatment Period|A participant enrolled in Cohort B received Cohort A treatment, hence counted under Cohort A.|199
18456|NCT02132936|44237|P4|NOT COMPLETED|Overall Study||14
18457|NCT02132936|44238|P3|NOT COMPLETED|Overall Study||14
18458|NCT02132936|44239|P2|NOT COMPLETED|Overall Study||9
18459|NCT02132936|44240|P1|NOT COMPLETED|Overall Study||10
18460|NCT02132936|44237|P4|COMPLETED|Overall Study||29
18461|NCT02132936|44238|P3|COMPLETED|Overall Study||174
18462|NCT02132936|44239|P2|COMPLETED|Overall Study||38
18463|NCT02132936|44240|P1|COMPLETED|Overall Study||175
18464|NCT02132936|44237|P4|STARTED|Overall Study||43
18465|NCT02132936|44238|P3|STARTED|Overall Study||188
18466|NCT02132936|44239|P2|STARTED|Overall Study||47
18467|NCT02132936|44240|P1|STARTED|Overall Study||185
18468|NCT02132832|44258|P2|NOT COMPLETED|Overall Study||7
18469|NCT02132832|44259|P1|NOT COMPLETED|Overall Study||3
18470|NCT02132832|44258|P2|COMPLETED|Overall Study||16
18471|NCT02132832|44259|P1|COMPLETED|Overall Study||16
18472|NCT02132832|44258|P2|STARTED|Overall Study||23
18473|NCT02132832|44259|P1|STARTED|Overall Study||19
18474|NCT02132767|44289|P2|NOT COMPLETED|Overall Study||15
18475|NCT02132767|44290|P1|NOT COMPLETED|Overall Study||17
18476|NCT02132767|44289|P2|COMPLETED|Overall Study||246
18477|NCT02132767|44290|P1|COMPLETED|Overall Study||245
18478|NCT02132767|44289|P2|STARTED|Overall Study||261
18479|NCT02132767|44290|P1|STARTED|Overall Study||262
18480|NCT02132611|44310|P1|NOT COMPLETED|Overall Study||2
18481|NCT02132611|44310|P1|COMPLETED|Overall Study||98
18482|NCT02132611|44310|P1|STARTED|Overall Study||100
18483|NCT02132572|44315|P1|NOT COMPLETED|Overall Study||0
18484|NCT02132572|44315|P1|COMPLETED|Overall Study||201
18485|NCT02132572|44315|P1|STARTED|Overall Study||201
18486|NCT02132169|44321|P2|NOT COMPLETED|Overall Study||9
18487|NCT02132169|44322|P1|NOT COMPLETED|Overall Study||15
18488|NCT02132169|44321|P2|COMPLETED|Overall Study||162
18489|NCT02132169|44322|P1|COMPLETED|Overall Study||326
18490|NCT02132169|44321|P2|STARTED|Overall Study||171
18491|NCT02132169|44322|P1|STARTED|Overall Study||341
18492|NCT02132117|44336|P2|NOT COMPLETED|Overall Study||5
18493|NCT02132117|44337|P1|NOT COMPLETED|Overall Study||11
18494|NCT02132117|44336|P2|COMPLETED|Overall Study||216
18495|NCT02132117|44337|P1|COMPLETED|Overall Study||213
18496|NCT02132117|44336|P2|STARTED|Overall Study||221
18497|NCT02132117|44337|P1|STARTED|Overall Study||224
18498|NCT02131636|44355|P2|NOT COMPLETED|Overall Study||5
18499|NCT02131636|44356|P1|NOT COMPLETED|Overall Study||12
18500|NCT02131636|44355|P2|COMPLETED|Overall Study||213
18501|NCT02131636|44356|P1|COMPLETED|Overall Study||210
18502|NCT02131636|44355|P2|STARTED|Overall Study||218
18503|NCT02131636|44356|P1|STARTED|Overall Study||222
18504|NCT02131532|44372|P1|NOT COMPLETED|Overall Study||4
18505|NCT02131532|44372|P1|COMPLETED|Overall Study||8
18506|NCT02131532|44372|P1|STARTED|Overall Study||12
18507|NCT02131402|44391|P1|NOT COMPLETED|Overall Study||0
18508|NCT02131402|44391|P1|COMPLETED|Overall Study||60
18509|NCT02131402|44391|P1|STARTED|Overall Study||60
18510|NCT02131311|44462|P1|NOT COMPLETED|Overall Study||4
18511|NCT02131311|44462|P1|COMPLETED|Overall Study||86
18512|NCT02131311|44462|P1|STARTED|Overall Study||90
18513|NCT02131233|44474|P2|NOT COMPLETED|Overall Study||27
18514|NCT02131233|44475|P1|NOT COMPLETED|Overall Study||43
18515|NCT02131233|44474|P2|COMPLETED|Overall Study|Completed to Week 48|242
18516|NCT02131233|44475|P1|COMPLETED|Overall Study|Completed to Week 48|490
18517|NCT02131233|44474|P2|Treated|Overall Study||266
18518|NCT02131233|44475|P1|Treated|Overall Study||531
18519|NCT02131233|44474|P2|STARTED|Overall Study|Enrolled participants|269
18520|NCT02131233|44475|P1|STARTED|Overall Study|Enrolled participants|533
18521|NCT02131064|44495|P2|NOT COMPLETED|Overall Study||223
18522|NCT02131064|44496|P1|NOT COMPLETED|Overall Study||221
18523|NCT02131064|44495|P2|COMPLETED|Overall Study||0
18524|NCT02131064|44496|P1|COMPLETED|Overall Study||0
18525|NCT02131064|44495|P2|STARTED|Overall Study||223
18526|NCT02131064|44496|P1|STARTED|Overall Study||221
18527|NCT02130999|44528|P2|NOT COMPLETED|Overall Study||0
18528|NCT02130999|44529|P1|NOT COMPLETED|Overall Study||0
18529|NCT02130999|44528|P2|COMPLETED|Overall Study||8
18530|NCT02130999|44529|P1|COMPLETED|Overall Study||6
18531|NCT02130999|44528|P2|STARTED|Overall Study||8
18532|NCT02130999|44529|P1|STARTED|Overall Study||6
18533|NCT02130635|44564|P9|NOT COMPLETED|Part B-Dose-Response Relationship||0
18534|NCT02130635|44565|P8|NOT COMPLETED|Part B-Dose-Response Relationship||0
18535|NCT02130635|44566|P7|NOT COMPLETED|Part B-Dose-Response Relationship||0
18536|NCT02130635|44567|P6|NOT COMPLETED|Part B-Dose-Response Relationship||0
18537|NCT02130635|44568|P5|NOT COMPLETED|Part B-Dose-Response Relationship||0
18538|NCT02130635|44569|P4|NOT COMPLETED|Part B-Dose-Response Relationship||0
18539|NCT02130635|44570|P3|NOT COMPLETED|Part B-Dose-Response Relationship||0
18540|NCT02130635|44571|P2|NOT COMPLETED|Part B-Dose-Response Relationship||0
18541|NCT02130635|44572|P1|NOT COMPLETED|Part B-Dose-Response Relationship||0
18542|NCT02130635|44564|P9|COMPLETED|Part B-Dose-Response Relationship||5
18543|NCT02130635|44565|P8|COMPLETED|Part B-Dose-Response Relationship||5
18544|NCT02130635|44566|P7|COMPLETED|Part B-Dose-Response Relationship||6
18545|NCT02130635|44567|P6|COMPLETED|Part B-Dose-Response Relationship||5
18546|NCT02130635|44568|P5|COMPLETED|Part B-Dose-Response Relationship||5
18547|NCT02130635|44569|P4|COMPLETED|Part B-Dose-Response Relationship||5
18548|NCT02130635|44570|P3|COMPLETED|Part B-Dose-Response Relationship||5
18549|NCT02130635|44571|P2|COMPLETED|Part B-Dose-Response Relationship||0
18550|NCT02130635|44572|P1|COMPLETED|Part B-Dose-Response Relationship||0
18551|NCT02130635|44564|P9|STARTED|Part B-Dose-Response Relationship||5
18552|NCT02130635|44565|P8|STARTED|Part B-Dose-Response Relationship||5
18553|NCT02130635|44566|P7|STARTED|Part B-Dose-Response Relationship||6
18554|NCT02130635|44567|P6|STARTED|Part B-Dose-Response Relationship||5
18555|NCT02130635|44568|P5|STARTED|Part B-Dose-Response Relationship||5
18556|NCT02130635|44569|P4|STARTED|Part B-Dose-Response Relationship||5
18557|NCT02130635|44570|P3|STARTED|Part B-Dose-Response Relationship||5
18558|NCT02130635|44571|P2|STARTED|Part B-Dose-Response Relationship||0
18559|NCT02130635|44572|P1|STARTED|Part B-Dose-Response Relationship||0
18560|NCT02130635|44564|P9|NOT COMPLETED|Part A-Safety and Tolerability||0
18561|NCT02130635|44565|P8|NOT COMPLETED|Part A-Safety and Tolerability||0
18562|NCT02130635|44566|P7|NOT COMPLETED|Part A-Safety and Tolerability||0
18563|NCT02130635|44567|P6|NOT COMPLETED|Part A-Safety and Tolerability||0
18564|NCT02130635|44568|P5|NOT COMPLETED|Part A-Safety and Tolerability||0
18565|NCT02130635|44569|P4|NOT COMPLETED|Part A-Safety and Tolerability||0
18566|NCT02130635|44570|P3|NOT COMPLETED|Part A-Safety and Tolerability||0
18567|NCT02130635|44571|P2|NOT COMPLETED|Part A-Safety and Tolerability||0
18568|NCT02130635|44572|P1|NOT COMPLETED|Part A-Safety and Tolerability||0
18569|NCT02130635|44564|P9|COMPLETED|Part A-Safety and Tolerability||0
18570|NCT02130635|44565|P8|COMPLETED|Part A-Safety and Tolerability||0
18571|NCT02130635|44566|P7|COMPLETED|Part A-Safety and Tolerability||0
18572|NCT02130635|44567|P6|COMPLETED|Part A-Safety and Tolerability||0
18573|NCT02130635|44568|P5|COMPLETED|Part A-Safety and Tolerability||0
18574|NCT02130635|44569|P4|COMPLETED|Part A-Safety and Tolerability||0
18575|NCT02130635|44570|P3|COMPLETED|Part A-Safety and Tolerability||0
18576|NCT02130635|44571|P2|COMPLETED|Part A-Safety and Tolerability||21
18577|NCT02130635|44572|P1|COMPLETED|Part A-Safety and Tolerability||7
18578|NCT02130635|44564|P9|STARTED|Part A-Safety and Tolerability||0
18579|NCT02130635|44565|P8|STARTED|Part A-Safety and Tolerability||0
18580|NCT02130635|44566|P7|STARTED|Part A-Safety and Tolerability||0
18581|NCT02130635|44567|P6|STARTED|Part A-Safety and Tolerability||0
18582|NCT02130635|44568|P5|STARTED|Part A-Safety and Tolerability||0
18583|NCT02130635|44569|P4|STARTED|Part A-Safety and Tolerability||0
18584|NCT02130635|44570|P3|STARTED|Part A-Safety and Tolerability||0
18585|NCT02130635|44571|P2|STARTED|Part A-Safety and Tolerability||21
18586|NCT02130635|44572|P1|STARTED|Part A-Safety and Tolerability||7
18587|NCT02130284|44744|P1|NOT COMPLETED|Overall Study||9
18588|NCT02130284|44744|P1|COMPLETED|Overall Study||71
18589|NCT02130284|44744|P1|STARTED|Overall Study||80
18590|NCT02130193|44757|P3|NOT COMPLETED|Part B: 52-week Double-blind Period||8
18591|NCT02130193|44758|P2|NOT COMPLETED|Part B: 52-week Double-blind Period||10
18592|NCT02130193|44759|P1|NOT COMPLETED|Part B: 52-week Double-blind Period||0
18593|NCT02130193|44757|P3|COMPLETED|Part B: 52-week Double-blind Period||37
18594|NCT02130193|44758|P2|COMPLETED|Part B: 52-week Double-blind Period||38
18595|NCT02130193|44759|P1|COMPLETED|Part B: 52-week Double-blind Period||0
18596|NCT02130193|44757|P3|STARTED|Part B: 52-week Double-blind Period||45
18597|NCT02130193|44758|P2|STARTED|Part B: 52-week Double-blind Period||48
18598|NCT02130193|44759|P1|STARTED|Part B: 52-week Double-blind Period||0
18599|NCT02130193|44757|P3|NOT COMPLETED|Part A: 4-week Open-label Period||0
18600|NCT02130193|44758|P2|NOT COMPLETED|Part A: 4-week Open-label Period||0
18601|NCT02130193|44759|P1|NOT COMPLETED|Part A: 4-week Open-label Period||0
18602|NCT02130193|44757|P3|COMPLETED|Part A: 4-week Open-label Period||0
18603|NCT02130193|44758|P2|COMPLETED|Part A: 4-week Open-label Period||0
18604|NCT02130193|44759|P1|COMPLETED|Part A: 4-week Open-label Period||9
18605|NCT02130193|44757|P3|STARTED|Part A: 4-week Open-label Period||0
18606|NCT02130193|44758|P2|STARTED|Part A: 4-week Open-label Period||0
18607|NCT02130193|44759|P1|STARTED|Part A: 4-week Open-label Period||9
18608|NCT02129777|44828|P7|NOT COMPLETED|Open-Label Period||48
18609|NCT02129777|44829|P6|NOT COMPLETED|Open-Label Period||12
18610|NCT02129777|44830|P5|NOT COMPLETED|Open-Label Period||0
18611|NCT02129777|44831|P4|NOT COMPLETED|Open-Label Period||0
18612|NCT02129777|44832|P3|NOT COMPLETED|Open-Label Period||0
18613|NCT02129777|44833|P2|NOT COMPLETED|Open-Label Period||0
18614|NCT02129777|44834|P1|NOT COMPLETED|Open-Label Period||0
18615|NCT02129777|44828|P7|COMPLETED|Open-Label Period||0
18616|NCT02129777|44829|P6|COMPLETED|Open-Label Period||0
18617|NCT02129777|44830|P5|COMPLETED|Open-Label Period||0
18618|NCT02129777|44831|P4|COMPLETED|Open-Label Period||0
18619|NCT02129777|44832|P3|COMPLETED|Open-Label Period||0
18620|NCT02129777|44833|P2|COMPLETED|Open-Label Period||0
18621|NCT02129777|44834|P1|COMPLETED|Open-Label Period||0
18622|NCT02129777|44828|P7|STARTED|Open-Label Period||48
18623|NCT02129777|44829|P6|STARTED|Open-Label Period||12
18624|NCT02129777|44830|P5|STARTED|Open-Label Period||0
18625|NCT02129777|44831|P4|STARTED|Open-Label Period||0
18626|NCT02129777|44832|P3|STARTED|Open-Label Period||0
18627|NCT02129777|44833|P2|STARTED|Open-Label Period||0
18628|NCT02129777|44834|P1|STARTED|Open-Label Period||0
18629|NCT02129777|44828|P7|NOT COMPLETED|Double-Blind Period||0
18630|NCT02129777|44829|P6|NOT COMPLETED|Double-Blind Period||0
18631|NCT02129777|44830|P5|NOT COMPLETED|Double-Blind Period||7
18632|NCT02129777|44831|P4|NOT COMPLETED|Double-Blind Period||7
18633|NCT02129777|44832|P3|NOT COMPLETED|Double-Blind Period||4
18634|NCT02129777|44833|P2|NOT COMPLETED|Double-Blind Period||8
18635|NCT02129777|44834|P1|NOT COMPLETED|Double-Blind Period||7
18636|NCT02129777|44828|P7|COMPLETED|Double-Blind Period||0
18637|NCT02129777|44829|P6|COMPLETED|Double-Blind Period||0
18638|NCT02129777|44830|P5|COMPLETED|Double-Blind Period||18
18639|NCT02129777|44831|P4|COMPLETED|Double-Blind Period||18
18640|NCT02129777|44832|P3|COMPLETED|Double-Blind Period||20
18641|NCT02129777|44833|P2|COMPLETED|Double-Blind Period||16
18642|NCT02129777|44834|P1|COMPLETED|Double-Blind Period||17
18643|NCT02129777|44828|P7|STARTED|Double-Blind Period||0
18644|NCT02129777|44829|P6|STARTED|Double-Blind Period||0
18645|NCT02129777|44830|P5|STARTED|Double-Blind Period||25
18646|NCT02129777|44831|P4|STARTED|Double-Blind Period||25
18647|NCT02129777|44832|P3|STARTED|Double-Blind Period||24
18648|NCT02129777|44833|P2|STARTED|Double-Blind Period||24
18649|NCT02129777|44834|P1|STARTED|Double-Blind Period||24
18650|NCT02129725|44940|P2|NOT COMPLETED|Overall Study||3
18651|NCT02129725|44941|P1|NOT COMPLETED|Overall Study||2
18652|NCT02129725|44940|P2|COMPLETED|Overall Study||4
18653|NCT02129725|44941|P1|COMPLETED|Overall Study||6
18654|NCT02129725|44940|P2|STARTED|Overall Study||7
18655|NCT02129725|44941|P1|STARTED|Overall Study||8
18656|NCT02129608|44950|P3|NOT COMPLETED|Overall Study||3
18657|NCT02129608|44951|P2|NOT COMPLETED|Overall Study||1
18658|NCT02129608|44952|P1|NOT COMPLETED|Overall Study||0
18659|NCT02129608|44950|P3|COMPLETED|Overall Study||12
18660|NCT02129608|44951|P2|COMPLETED|Overall Study||13
18661|NCT02129608|44952|P1|COMPLETED|Overall Study||15
18662|NCT02129608|44950|P3|End of Treatment|Overall Study||12
18663|NCT02129608|44951|P2|End of Treatment|Overall Study||13
18664|NCT02129608|44952|P1|End of Treatment|Overall Study||15
18665|NCT02129608|44950|P3|STARTED|Overall Study||15
18666|NCT02129608|44951|P2|STARTED|Overall Study||14
18667|NCT02129608|44952|P1|STARTED|Overall Study||15
18668|NCT02129192|44965|P2|NOT COMPLETED|Period 5||0
18669|NCT02129192|44966|P1|NOT COMPLETED|Period 5||0
18670|NCT02129192|44965|P2|COMPLETED|Period 5||0
18671|NCT02129192|44966|P1|COMPLETED|Period 5||36
18672|NCT02129192|44965|P2|STARTED|Period 5|This sequence consists of only 4 periods.|0
18673|NCT02129192|44966|P1|STARTED|Period 5||36
18674|NCT02129192|44965|P2|NOT COMPLETED|Period 4 Including Washout Period||0
18675|NCT02129192|44966|P1|NOT COMPLETED|Period 4 Including Washout Period||0
18676|NCT02129192|44965|P2|COMPLETED|Period 4 Including Washout Period||35
18677|NCT02129192|44966|P1|COMPLETED|Period 4 Including Washout Period||36
18678|NCT02129192|44965|P2|STARTED|Period 4 Including Washout Period||35
18679|NCT02129192|44966|P1|STARTED|Period 4 Including Washout Period||36
18680|NCT02129192|44965|P2|NOT COMPLETED|Period 3 Including Washout Period||0
18681|NCT02129192|44966|P1|NOT COMPLETED|Period 3 Including Washout Period||0
18682|NCT02129192|44965|P2|COMPLETED|Period 3 Including Washout Period||35
18683|NCT02129192|44966|P1|COMPLETED|Period 3 Including Washout Period||36
18684|NCT02129192|44965|P2|STARTED|Period 3 Including Washout Period||35
18685|NCT02129192|44966|P1|STARTED|Period 3 Including Washout Period||36
18686|NCT02129192|44965|P2|NOT COMPLETED|Period 2 Including Washout Period||0
18687|NCT02129192|44966|P1|NOT COMPLETED|Period 2 Including Washout Period||0
18688|NCT02129192|44965|P2|COMPLETED|Period 2 Including Washout Period||35
18689|NCT02129192|44966|P1|COMPLETED|Period 2 Including Washout Period||36
18690|NCT02129192|44965|P2|STARTED|Period 2 Including Washout Period||35
18691|NCT02129192|44966|P1|STARTED|Period 2 Including Washout Period||36
18692|NCT02129192|44965|P2|NOT COMPLETED|Period 1 Including Washout Period||1
18693|NCT02129192|44966|P1|NOT COMPLETED|Period 1 Including Washout Period||0
18694|NCT02129192|44965|P2|COMPLETED|Period 1 Including Washout Period|Withdrawal by one subject in washout period|35
18695|NCT02129192|44966|P1|COMPLETED|Period 1 Including Washout Period||36
18696|NCT02129192|44965|P2|STARTED|Period 1 Including Washout Period||36
18697|NCT02129192|44966|P1|STARTED|Period 1 Including Washout Period||36
18698|NCT02129062|44983|P1|NOT COMPLETED|Overall Study||3
18699|NCT02129062|44983|P1|COMPLETED|Overall Study||0
18700|NCT02129062|44983|P1|STARTED|Overall Study||3
18701|NCT02128919|44990|P2|NOT COMPLETED|Overall Study||1
18702|NCT02128919|44991|P1|NOT COMPLETED|Overall Study||3
18703|NCT02128919|44990|P2|COMPLETED|Overall Study||15
18704|NCT02128919|44991|P1|COMPLETED|Overall Study||14
18705|NCT02128919|44990|P2|STARTED|Overall Study||16
18706|NCT02128919|44991|P1|STARTED|Overall Study||17
18707|NCT02128867|45004|P3|NOT COMPLETED|Overall Study||4
18708|NCT02128867|45005|P2|NOT COMPLETED|Overall Study||2
18709|NCT02128867|45006|P1|NOT COMPLETED|Overall Study||3
18710|NCT02128867|45004|P3|COMPLETED|Overall Study||50
18711|NCT02128867|45005|P2|COMPLETED|Overall Study||50
18712|NCT02128867|45006|P1|COMPLETED|Overall Study||50
18713|NCT02128867|45004|P3|STARTED|Overall Study||54
18714|NCT02128867|45005|P2|STARTED|Overall Study||52
18715|NCT02128867|45006|P1|STARTED|Overall Study||53
18716|NCT02128542|45016|P2|NOT COMPLETED|Overall Study||0
18717|NCT02128542|45017|P1|NOT COMPLETED|Overall Study||4
18718|NCT02128542|45016|P2|COMPLETED|Overall Study||19
18719|NCT02128542|45017|P1|COMPLETED|Overall Study||43
18720|NCT02128542|45016|P2|STARTED|Overall Study||19
18721|NCT02128542|45017|P1|STARTED|Overall Study||47
18722|NCT02128490|45035|P5|NOT COMPLETED|Overall Study||7
18723|NCT02128490|45036|P4|NOT COMPLETED|Overall Study||6
18724|NCT02128490|45037|P3|NOT COMPLETED|Overall Study||5
18725|NCT02128490|45038|P2|NOT COMPLETED|Overall Study||6
18726|NCT02128490|45039|P1|NOT COMPLETED|Overall Study||5
18727|NCT02128490|45035|P5|COMPLETED|Overall Study||31
18728|NCT02128490|45036|P4|COMPLETED|Overall Study||31
18729|NCT02128490|45037|P3|COMPLETED|Overall Study||34
18730|NCT02128490|45038|P2|COMPLETED|Overall Study||31
18731|NCT02128490|45039|P1|COMPLETED|Overall Study||33
18732|NCT02128490|45035|P5|STARTED|Overall Study||38
18733|NCT02128490|45036|P4|STARTED|Overall Study||37
18734|NCT02128490|45037|P3|STARTED|Overall Study||39
18735|NCT02128490|45038|P2|STARTED|Overall Study||37
18736|NCT02128490|45039|P1|STARTED|Overall Study||38
18737|NCT02128269|45061|P1|NOT COMPLETED|Follow-up||0
18738|NCT02128269|45061|P1|COMPLETED|Follow-up||9
18739|NCT02128269|45061|P1|STARTED|Follow-up|All enrolled patients were followed for 12 weeks after their last infusion of ALXN1007.|9
18740|NCT02128269|45061|P1|NOT COMPLETED|Treatment Period||2
18741|NCT02128269|45061|P1|COMPLETED|Treatment Period||7
18742|NCT02128269|45061|P1|STARTED|Treatment Period||9
18743|NCT02127567|45065|P1|NOT COMPLETED|Overall Study||0
18744|NCT02127567|45065|P1|COMPLETED|Overall Study||41
18745|NCT02127567|45065|P1|STARTED|Overall Study|41 participants completed 123 domains, 3 domains were completed with the tool per participant|41
18746|NCT02127372|45087|P2|NOT COMPLETED|Overall Study||0
18747|NCT02127372|45088|P1|NOT COMPLETED|Overall Study||1
18748|NCT02127372|45087|P2|COMPLETED|Overall Study||28
18749|NCT02127372|45088|P1|COMPLETED|Overall Study|Completed at least one cycle and were available for dose limiting toxicity (DLT) evaluation.|14
18750|NCT02127372|45087|P2|Started Study Treatment|Overall Study||28
18751|NCT02127372|45088|P1|Started Study Treatment|Overall Study||15
18752|NCT02127372|45087|P2|STARTED|Overall Study|Signed Consent|28
18753|NCT02127372|45088|P1|STARTED|Overall Study|Signed Consent|15
18754|NCT02127307|45098|P1|NOT COMPLETED|Overall Study||308
18755|NCT02127307|45098|P1|COMPLETED|Overall Study||656
18756|NCT02127307|45098|P1|STARTED|Overall Study||964
18757|NCT02126839|45104|P2|NOT COMPLETED|Overall Study||14
18758|NCT02126839|45105|P1|NOT COMPLETED|Overall Study||10
18759|NCT02126839|45104|P2|COMPLETED|Overall Study||80
18760|NCT02126839|45105|P1|COMPLETED|Overall Study||82
18761|NCT02126839|45104|P2|Full Analysis Set|Overall Study||92
18762|NCT02126839|45105|P1|Full Analysis Set|Overall Study||92
18763|NCT02126839|45104|P2|Safety Population|Overall Study||93
18764|NCT02126839|45105|P1|Safety Population|Overall Study||92
18765|NCT02126839|45104|P2|STARTED|Overall Study||94
18766|NCT02126839|45105|P1|STARTED|Overall Study||92
18767|NCT02126748|45118|P3|NOT COMPLETED|Overall Study||5
18768|NCT02126748|45119|P2|NOT COMPLETED|Overall Study||3
18769|NCT02126748|45120|P1|NOT COMPLETED|Overall Study||2
18770|NCT02126748|45118|P3|COMPLETED|Overall Study||31
18771|NCT02126748|45119|P2|COMPLETED|Overall Study||31
18772|NCT02126748|45120|P1|COMPLETED|Overall Study||31
18773|NCT02126748|45118|P3|STARTED|Overall Study||36
18774|NCT02126748|45119|P2|STARTED|Overall Study||34
18775|NCT02126748|45120|P1|STARTED|Overall Study||33
18776|NCT02126670|45132|P4|NOT COMPLETED|Overall Study||1
18777|NCT02126670|45133|P3|NOT COMPLETED|Overall Study||0
18778|NCT02126670|45134|P2|NOT COMPLETED|Overall Study||0
18779|NCT02126670|45135|P1|NOT COMPLETED|Overall Study||1
18780|NCT02126670|45132|P4|COMPLETED|Overall Study||24
18781|NCT02126670|45133|P3|COMPLETED|Overall Study||25
18782|NCT02126670|45134|P2|COMPLETED|Overall Study||24
18783|NCT02126670|45135|P1|COMPLETED|Overall Study||25
18784|NCT02126670|45132|P4|STARTED|Overall Study||25
18785|NCT02126670|45133|P3|STARTED|Overall Study||25
18786|NCT02126670|45134|P2|STARTED|Overall Study||24
18787|NCT02126670|45135|P1|STARTED|Overall Study||26
18788|NCT02126319|45151|P2|NOT COMPLETED|Overall Study||24
18789|NCT02126319|45152|P1|NOT COMPLETED|Overall Study||21
18790|NCT02126319|45151|P2|COMPLETED|Overall Study||43
18791|NCT02126319|45152|P1|COMPLETED|Overall Study||40
18792|NCT02126319|45151|P2|STARTED|Overall Study||67
18793|NCT02126319|45152|P1|STARTED|Overall Study||61
18794|NCT02126306|45178|P2|NOT COMPLETED|Overall Study||0
18795|NCT02126306|45179|P1|NOT COMPLETED|Overall Study||0
18796|NCT02126306|45178|P2|COMPLETED|Overall Study||13
18797|NCT02126306|45179|P1|COMPLETED|Overall Study||10
18798|NCT02126306|45178|P2|STARTED|Overall Study||13
18799|NCT02126306|45179|P1|STARTED|Overall Study||10
18800|NCT02125877|45187|P2|NOT COMPLETED|Overall Study||10
18801|NCT02125877|45188|P1|NOT COMPLETED|Overall Study||13
18802|NCT02125877|45187|P2|COMPLETED|Overall Study||77
18803|NCT02125877|45188|P1|COMPLETED|Overall Study||73
18804|NCT02125877|45187|P2|Safety Set|Overall Study||87
18805|NCT02125877|45188|P1|Safety Set|Overall Study||86
18806|NCT02125877|45187|P2|Pharmacokinetic Subset A|Overall Study||15
18807|NCT02125877|45188|P1|Pharmacokinetic Subset A|Overall Study||16
18808|NCT02125877|45187|P2|Pharmacokinetic Analysis Set|Overall Study||83
18809|NCT02125877|45188|P1|Pharmacokinetic Analysis Set|Overall Study||83
18810|NCT02125877|45187|P2|STARTED|Overall Study||87
18811|NCT02125877|45188|P1|STARTED|Overall Study||86
18812|NCT02125838|45218|P2|NOT COMPLETED|Overall Study||4
18813|NCT02125838|45219|P1|NOT COMPLETED|Overall Study||4
18814|NCT02125838|45218|P2|COMPLETED|Overall Study|Analysed (n=50 )|50
18815|NCT02125838|45219|P1|COMPLETED|Overall Study|Analysed (n=50 )|50
18816|NCT02125838|45218|P2|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions) (n= 2) NBA used (n= 2)|54
18817|NCT02125838|45219|P1|STARTED|Overall Study|Lost to follow-up (n= 4 ) Turned to laparotomy (Adhesions)(n= 2) NBA used (n= 2)|54
18818|NCT02125734|45237|P2|NOT COMPLETED|Period 2||1
18819|NCT02125734|45238|P1|NOT COMPLETED|Period 2||0
18820|NCT02125734|45237|P2|COMPLETED|Period 2||47
18821|NCT02125734|45238|P1|COMPLETED|Period 2||40
18822|NCT02125734|45237|P2|STARTED|Period 2||48
18823|NCT02125734|45238|P1|STARTED|Period 2||40
18824|NCT02125734|45237|P2|NOT COMPLETED|Period 1||0
18825|NCT02125734|45238|P1|NOT COMPLETED|Period 1||0
18826|NCT02125734|45237|P2|COMPLETED|Period 1||48
18827|NCT02125734|45238|P1|COMPLETED|Period 1||40
18828|NCT02125734|45237|P2|STARTED|Period 1||48
18829|NCT02125734|45238|P1|STARTED|Period 1||40
18830|NCT02125604|45248|P1|NOT COMPLETED|Overall Study||31
18831|NCT02125604|45248|P1|COMPLETED|Overall Study||180
18832|NCT02125604|45248|P1|STARTED|Overall Study|enrolled and received at least 1 dose of study drug|211
18833|NCT02125292|45262|P6|NOT COMPLETED|Third Intervention (1 Hour)||0
18834|NCT02125292|45263|P5|NOT COMPLETED|Third Intervention (1 Hour)||0
18835|NCT02125292|45264|P4|NOT COMPLETED|Third Intervention (1 Hour)||0
18836|NCT02125292|45265|P3|NOT COMPLETED|Third Intervention (1 Hour)||0
18837|NCT02125292|45266|P2|NOT COMPLETED|Third Intervention (1 Hour)||0
18838|NCT02125292|45267|P1|NOT COMPLETED|Third Intervention (1 Hour)||0
18839|NCT02125292|45262|P6|COMPLETED|Third Intervention (1 Hour)||3
18840|NCT02125292|45263|P5|COMPLETED|Third Intervention (1 Hour)||3
18841|NCT02125292|45264|P4|COMPLETED|Third Intervention (1 Hour)||3
18842|NCT02125292|45265|P3|COMPLETED|Third Intervention (1 Hour)||3
18843|NCT02125292|45266|P2|COMPLETED|Third Intervention (1 Hour)||3
18844|NCT02125292|45267|P1|COMPLETED|Third Intervention (1 Hour)||3
18845|NCT02125292|45262|P6|STARTED|Third Intervention (1 Hour)||3
18846|NCT02125292|45263|P5|STARTED|Third Intervention (1 Hour)||3
18847|NCT02125292|45264|P4|STARTED|Third Intervention (1 Hour)||3
18848|NCT02125292|45265|P3|STARTED|Third Intervention (1 Hour)||3
18849|NCT02125292|45266|P2|STARTED|Third Intervention (1 Hour)||3
18850|NCT02125292|45267|P1|STARTED|Third Intervention (1 Hour)||3
18851|NCT02125292|45262|P6|NOT COMPLETED|Washout (2 Hours)||0
18852|NCT02125292|45263|P5|NOT COMPLETED|Washout (2 Hours)||0
18853|NCT02125292|45264|P4|NOT COMPLETED|Washout (2 Hours)||0
18854|NCT02125292|45265|P3|NOT COMPLETED|Washout (2 Hours)||0
18855|NCT02125292|45266|P2|NOT COMPLETED|Washout (2 Hours)||0
18856|NCT02125292|45267|P1|NOT COMPLETED|Washout (2 Hours)||0
18857|NCT02125292|45262|P6|COMPLETED|Washout (2 Hours)||3
18858|NCT02125292|45263|P5|COMPLETED|Washout (2 Hours)||3
18859|NCT02125292|45264|P4|COMPLETED|Washout (2 Hours)||3
18860|NCT02125292|45265|P3|COMPLETED|Washout (2 Hours)||3
18861|NCT02125292|45266|P2|COMPLETED|Washout (2 Hours)||3
18862|NCT02125292|45267|P1|COMPLETED|Washout (2 Hours)||3
18863|NCT02125292|45262|P6|STARTED|Washout (2 Hours)||3
18864|NCT02125292|45263|P5|STARTED|Washout (2 Hours)||3
18865|NCT02125292|45264|P4|STARTED|Washout (2 Hours)||3
18866|NCT02125292|45265|P3|STARTED|Washout (2 Hours)||3
18867|NCT02125292|45266|P2|STARTED|Washout (2 Hours)||3
18868|NCT02125292|45267|P1|STARTED|Washout (2 Hours)||3
18869|NCT02125292|45262|P6|NOT COMPLETED|Second Intervention (1 Hour)||0
18870|NCT02125292|45263|P5|NOT COMPLETED|Second Intervention (1 Hour)||0
18871|NCT02125292|45264|P4|NOT COMPLETED|Second Intervention (1 Hour)||0
18872|NCT02125292|45265|P3|NOT COMPLETED|Second Intervention (1 Hour)||0
18873|NCT02125292|45266|P2|NOT COMPLETED|Second Intervention (1 Hour)||0
18874|NCT02125292|45267|P1|NOT COMPLETED|Second Intervention (1 Hour)||0
18875|NCT02125292|45262|P6|COMPLETED|Second Intervention (1 Hour)||3
18876|NCT02125292|45263|P5|COMPLETED|Second Intervention (1 Hour)||3
18877|NCT02125292|45264|P4|COMPLETED|Second Intervention (1 Hour)||3
18878|NCT02125292|45265|P3|COMPLETED|Second Intervention (1 Hour)||3
18879|NCT02125292|45266|P2|COMPLETED|Second Intervention (1 Hour)||3
18880|NCT02125292|45267|P1|COMPLETED|Second Intervention (1 Hour)||3
18881|NCT02125292|45262|P6|STARTED|Second Intervention (1 Hour)||3
18882|NCT02125292|45263|P5|STARTED|Second Intervention (1 Hour)||3
18883|NCT02125292|45264|P4|STARTED|Second Intervention (1 Hour)||3
18884|NCT02125292|45265|P3|STARTED|Second Intervention (1 Hour)||3
18885|NCT02125292|45266|P2|STARTED|Second Intervention (1 Hour)||3
18886|NCT02125292|45267|P1|STARTED|Second Intervention (1 Hour)||3
18887|NCT02125292|45262|P6|NOT COMPLETED|Washout (2 Hours)||0
18888|NCT02125292|45263|P5|NOT COMPLETED|Washout (2 Hours)||0
18889|NCT02125292|45264|P4|NOT COMPLETED|Washout (2 Hours)||0
18890|NCT02125292|45265|P3|NOT COMPLETED|Washout (2 Hours)||0
18891|NCT02125292|45266|P2|NOT COMPLETED|Washout (2 Hours)||0
18892|NCT02125292|45267|P1|NOT COMPLETED|Washout (2 Hours)||0
18893|NCT02125292|45262|P6|COMPLETED|Washout (2 Hours)||3
18894|NCT02125292|45263|P5|COMPLETED|Washout (2 Hours)||3
18895|NCT02125292|45264|P4|COMPLETED|Washout (2 Hours)||3
18896|NCT02125292|45265|P3|COMPLETED|Washout (2 Hours)||3
18897|NCT02125292|45266|P2|COMPLETED|Washout (2 Hours)||3
18898|NCT02125292|45267|P1|COMPLETED|Washout (2 Hours)||3
18899|NCT02125292|45262|P6|STARTED|Washout (2 Hours)||3
18900|NCT02125292|45263|P5|STARTED|Washout (2 Hours)||3
18901|NCT02125292|45264|P4|STARTED|Washout (2 Hours)||3
18902|NCT02125292|45265|P3|STARTED|Washout (2 Hours)||3
18903|NCT02125292|45266|P2|STARTED|Washout (2 Hours)||3
18904|NCT02125292|45267|P1|STARTED|Washout (2 Hours)||3
18905|NCT02125292|45262|P6|NOT COMPLETED|First Intervention (1 Hour)||0
18906|NCT02125292|45263|P5|NOT COMPLETED|First Intervention (1 Hour)||0
18907|NCT02125292|45264|P4|NOT COMPLETED|First Intervention (1 Hour)||0
18908|NCT02125292|45265|P3|NOT COMPLETED|First Intervention (1 Hour)||0
18909|NCT02125292|45266|P2|NOT COMPLETED|First Intervention (1 Hour)||0
18910|NCT02125292|45267|P1|NOT COMPLETED|First Intervention (1 Hour)||0
18911|NCT02125292|45262|P6|COMPLETED|First Intervention (1 Hour)||3
18912|NCT02125292|45263|P5|COMPLETED|First Intervention (1 Hour)||3
18913|NCT02125292|45264|P4|COMPLETED|First Intervention (1 Hour)||3
18914|NCT02125292|45265|P3|COMPLETED|First Intervention (1 Hour)||3
18915|NCT02125292|45266|P2|COMPLETED|First Intervention (1 Hour)||3
18916|NCT02125292|45267|P1|COMPLETED|First Intervention (1 Hour)||3
18917|NCT02125292|45262|P6|STARTED|First Intervention (1 Hour)||3
18918|NCT02125292|45263|P5|STARTED|First Intervention (1 Hour)||3
18919|NCT02125292|45264|P4|STARTED|First Intervention (1 Hour)||3
18920|NCT02125292|45265|P3|STARTED|First Intervention (1 Hour)||3
18921|NCT02125292|45266|P2|STARTED|First Intervention (1 Hour)||3
18922|NCT02125292|45267|P1|STARTED|First Intervention (1 Hour)||3
18923|NCT02124863|45288|P1|NOT COMPLETED|Overall Study||17
18924|NCT02124863|45288|P1|COMPLETED|Overall Study||50
18925|NCT02124863|45288|P1|STARTED|Overall Study||67
18926|NCT02124798|45294|P1|NOT COMPLETED|Overall Study||4
18927|NCT02124798|45294|P1|COMPLETED|Overall Study||91
18928|NCT02124798|45294|P1|STARTED|Overall Study||95
18929|NCT02124603|45300|P1|NOT COMPLETED|Overall Study||0
18930|NCT02124603|45300|P1|COMPLETED|Overall Study||120
18931|NCT02124603|45300|P1|STARTED|Overall Study||120
18932|NCT02124460|45308|P2|NOT COMPLETED|Overall Study||24
18933|NCT02124460|45309|P1|NOT COMPLETED|Overall Study||33
18934|NCT02124460|45308|P2|COMPLETED|Overall Study||336
18935|NCT02124460|45309|P1|COMPLETED|Overall Study||328
18936|NCT02124460|45308|P2|STARTED|Overall Study||360
18937|NCT02124460|45309|P1|STARTED|Overall Study||361
18938|NCT02124304|45341|P2|NOT COMPLETED|Overall Study||0
18939|NCT02124304|45342|P1|NOT COMPLETED|Overall Study||0
18940|NCT02124304|45341|P2|COMPLETED|Overall Study||15
18941|NCT02124304|45342|P1|COMPLETED|Overall Study||15
18942|NCT02124304|45341|P2|STARTED|Overall Study||15
18943|NCT02124304|45342|P1|STARTED|Overall Study||15
18944|NCT02124161|45352|P2|NOT COMPLETED|Overall Study||15
18945|NCT02124161|45353|P1|NOT COMPLETED|Overall Study||16
18946|NCT02124161|45352|P2|COMPLETED|Overall Study||426
18947|NCT02124161|45353|P1|COMPLETED|Overall Study||425
18948|NCT02124161|45352|P2|Vaccination 2|Overall Study||432
18949|NCT02124161|45353|P1|Vaccination 2|Overall Study||431
18950|NCT02124161|45352|P2|Vaccination 1|Overall Study||437
18951|NCT02124161|45353|P1|Vaccination 1|Overall Study||439
18952|NCT02124161|45352|P2|STARTED|Overall Study||441
18953|NCT02124161|45353|P1|STARTED|Overall Study||441
18954|NCT02124122|45385|P2|NOT COMPLETED|Overall Study||0
18955|NCT02124122|45386|P1|NOT COMPLETED|Overall Study||0
18956|NCT02124122|45385|P2|COMPLETED|Overall Study||19
18957|NCT02124122|45386|P1|COMPLETED|Overall Study||41
18958|NCT02124122|45385|P2|STARTED|Overall Study||19
18959|NCT02124122|45386|P1|STARTED|Overall Study||41
18960|NCT02124044|45396|P2|NOT COMPLETED|Overall Study||1
18961|NCT02124044|45397|P1|NOT COMPLETED|Overall Study||0
18962|NCT02124044|45396|P2|COMPLETED|Overall Study||9
18963|NCT02124044|45397|P1|COMPLETED|Overall Study||20
18964|NCT02124044|45396|P2|STARTED|Overall Study||10
18965|NCT02124044|45397|P1|STARTED|Overall Study||20
18966|NCT02123745|45403|P1|NOT COMPLETED|Overall Study||0
18967|NCT02123745|45403|P1|COMPLETED|Overall Study||71
18968|NCT02123745|45403|P1|STARTED|Overall Study||71
18969|NCT02123472|45411|P2|NOT COMPLETED|Period 2 (7 Days)||1
18970|NCT02123472|45412|P1|NOT COMPLETED|Period 2 (7 Days)||0
18971|NCT02123472|45411|P2|COMPLETED|Period 2 (7 Days)||13
18972|NCT02123472|45412|P1|COMPLETED|Period 2 (7 Days)||14
18973|NCT02123472|45411|P2|STARTED|Period 2 (7 Days)||14
18974|NCT02123472|45412|P1|STARTED|Period 2 (7 Days)||14
18975|NCT02123472|45411|P2|NOT COMPLETED|Washout Period (1 Day)||0
18976|NCT02123472|45412|P1|NOT COMPLETED|Washout Period (1 Day)||0
18977|NCT02123472|45411|P2|COMPLETED|Washout Period (1 Day)||14
18978|NCT02123472|45412|P1|COMPLETED|Washout Period (1 Day)||14
18979|NCT02123472|45411|P2|STARTED|Washout Period (1 Day)||14
18980|NCT02123472|45412|P1|STARTED|Washout Period (1 Day)||14
18981|NCT02123472|45411|P2|NOT COMPLETED|Period 1 (7 Days)||0
18982|NCT02123472|45412|P1|NOT COMPLETED|Period 1 (7 Days)||0
18983|NCT02123472|45411|P2|COMPLETED|Period 1 (7 Days)||14
18984|NCT02123472|45412|P1|COMPLETED|Period 1 (7 Days)||14
18985|NCT02123472|45411|P2|STARTED|Period 1 (7 Days)||14
18986|NCT02123472|45412|P1|STARTED|Period 1 (7 Days)||14
18987|NCT02123459|45422|P2|NOT COMPLETED|Period 2 (7 Days)||0
18988|NCT02123459|45423|P1|NOT COMPLETED|Period 2 (7 Days)||0
18989|NCT02123459|45422|P2|COMPLETED|Period 2 (7 Days)||14
18990|NCT02123459|45423|P1|COMPLETED|Period 2 (7 Days)||13
18991|NCT02123459|45422|P2|STARTED|Period 2 (7 Days)||14
18992|NCT02123459|45423|P1|STARTED|Period 2 (7 Days)||13
18993|NCT02123459|45422|P2|NOT COMPLETED|Washout Period (1 Day)||0
18994|NCT02123459|45423|P1|NOT COMPLETED|Washout Period (1 Day)||1
18995|NCT02123459|45422|P2|COMPLETED|Washout Period (1 Day)||14
18996|NCT02123459|45423|P1|COMPLETED|Washout Period (1 Day)||13
18997|NCT02123459|45422|P2|STARTED|Washout Period (1 Day)||14
18998|NCT02123459|45423|P1|STARTED|Washout Period (1 Day)||14
18999|NCT02123459|45422|P2|NOT COMPLETED|Period 1 (7 Days)||0
19000|NCT02123459|45423|P1|NOT COMPLETED|Period 1 (7 Days)||0
19001|NCT02123459|45422|P2|COMPLETED|Period 1 (7 Days)||14
19002|NCT02123459|45423|P1|COMPLETED|Period 1 (7 Days)||14
19003|NCT02123459|45422|P2|STARTED|Period 1 (7 Days)||14
19004|NCT02123459|45423|P1|STARTED|Period 1 (7 Days)||14
19005|NCT02123446|45433|P2|NOT COMPLETED|Period 2 (7 Days)||0
19006|NCT02123446|45434|P1|NOT COMPLETED|Period 2 (7 Days)||0
19007|NCT02123446|45433|P2|COMPLETED|Period 2 (7 Days)||14
19008|NCT02123446|45434|P1|COMPLETED|Period 2 (7 Days)||13
19009|NCT02123446|45433|P2|STARTED|Period 2 (7 Days)||14
19010|NCT02123446|45434|P1|STARTED|Period 2 (7 Days)||13
19011|NCT02123446|45433|P2|NOT COMPLETED|Washout Period (1 Day)||0
19012|NCT02123446|45434|P1|NOT COMPLETED|Washout Period (1 Day)||1
19013|NCT02123446|45433|P2|COMPLETED|Washout Period (1 Day)||14
19014|NCT02123446|45434|P1|COMPLETED|Washout Period (1 Day)||13
19015|NCT02123446|45433|P2|STARTED|Washout Period (1 Day)||14
19016|NCT02123446|45434|P1|STARTED|Washout Period (1 Day)||14
19017|NCT02123446|45433|P2|NOT COMPLETED|Period 1 (7 Days)||0
19018|NCT02123446|45434|P1|NOT COMPLETED|Period 1 (7 Days)||0
19019|NCT02123446|45433|P2|COMPLETED|Period 1 (7 Days)||14
19020|NCT02123446|45434|P1|COMPLETED|Period 1 (7 Days)||14
19021|NCT02123446|45433|P2|STARTED|Period 1 (7 Days)||14
19022|NCT02123446|45434|P1|STARTED|Period 1 (7 Days)||14
19023|NCT02123017|45447|P3|NOT COMPLETED|Overall Study||0
19024|NCT02123017|45448|P2|NOT COMPLETED|Overall Study||0
19025|NCT02123017|45449|P1|NOT COMPLETED|Overall Study||0
19026|NCT02123017|45447|P3|COMPLETED|Overall Study||12
19027|NCT02123017|45448|P2|COMPLETED|Overall Study||12
19028|NCT02123017|45449|P1|COMPLETED|Overall Study||8
19029|NCT02123017|45447|P3|STARTED|Overall Study||12
19030|NCT02123017|45448|P2|STARTED|Overall Study||12
19031|NCT02123017|45449|P1|STARTED|Overall Study||8
19032|NCT02122549|45466|P1|NOT COMPLETED|Overall Study||0
19033|NCT02122549|45466|P1|COMPLETED|Overall Study||59
19034|NCT02122549|45466|P1|STARTED|Overall Study||59
19035|NCT02122445|45470|P1|NOT COMPLETED|Overall Study||0
19036|NCT02122445|45470|P1|COMPLETED|Overall Study||20
19037|NCT02122445|45470|P1|STARTED|Overall Study||20
19038|NCT02122406|45475|P1|NOT COMPLETED|Overall Study||0
19039|NCT02122406|45475|P1|COMPLETED|Overall Study||200
19040|NCT02122406|45475|P1|STARTED|Overall Study||200
19041|NCT02121860|45483|P4|NOT COMPLETED|Overall Study||0
19042|NCT02121860|45484|P3|NOT COMPLETED|Overall Study||0
19043|NCT02121860|45485|P2|NOT COMPLETED|Overall Study||0
19044|NCT02121860|45486|P1|NOT COMPLETED|Overall Study||0
19045|NCT02121860|45483|P4|COMPLETED|Overall Study||8
19046|NCT02121860|45484|P3|COMPLETED|Overall Study||8
19047|NCT02121860|45485|P2|COMPLETED|Overall Study||12
19048|NCT02121860|45486|P1|COMPLETED|Overall Study||8
19049|NCT02121860|45483|P4|STARTED|Overall Study||8
19050|NCT02121860|45484|P3|STARTED|Overall Study||8
19051|NCT02121860|45485|P2|STARTED|Overall Study||12
19052|NCT02121860|45486|P1|STARTED|Overall Study||8
19053|NCT02121847|45505|P1|NOT COMPLETED|Overall Study||3
19054|NCT02121847|45505|P1|COMPLETED|Overall Study||37
19055|NCT02121847|45505|P1|STARTED|Overall Study||40
19056|NCT02121795|45526|P2|NOT COMPLETED|Overall Study||334
19057|NCT02121795|45527|P1|NOT COMPLETED|Overall Study||334
19058|NCT02121795|45526|P2|COMPLETED|Overall Study||0
19059|NCT02121795|45527|P1|COMPLETED|Overall Study||0
19060|NCT02121795|45526|P2|STARTED|Overall Study||334
19061|NCT02121795|45527|P1|STARTED|Overall Study||334
19062|NCT02121535|45543|P2|NOT COMPLETED|Period 4 (8 Trial Days)||0
19063|NCT02121535|45544|P1|NOT COMPLETED|Period 4 (8 Trial Days)||0
19064|NCT02121535|45543|P2|COMPLETED|Period 4 (8 Trial Days)||35
19065|NCT02121535|45544|P1|COMPLETED|Period 4 (8 Trial Days)||35
19066|NCT02121535|45543|P2|STARTED|Period 4 (8 Trial Days)||35
19067|NCT02121535|45544|P1|STARTED|Period 4 (8 Trial Days)||35
19068|NCT02121535|45543|P2|NOT COMPLETED|Period 3 (8 Trial Days)||0
19069|NCT02121535|45544|P1|NOT COMPLETED|Period 3 (8 Trial Days)||1
19070|NCT02121535|45543|P2|COMPLETED|Period 3 (8 Trial Days)||35
19071|NCT02121535|45544|P1|COMPLETED|Period 3 (8 Trial Days)|1 subject withdrew consent during the washout period between Period 3 and 4.|35
19072|NCT02121535|45543|P2|STARTED|Period 3 (8 Trial Days)||35
19073|NCT02121535|45544|P1|STARTED|Period 3 (8 Trial Days)||36
19074|NCT02121535|45543|P2|NOT COMPLETED|Period 2 (8 Trial Days)||0
19075|NCT02121535|45544|P1|NOT COMPLETED|Period 2 (8 Trial Days)||0
19076|NCT02121535|45543|P2|COMPLETED|Period 2 (8 Trial Days)||35
19077|NCT02121535|45544|P1|COMPLETED|Period 2 (8 Trial Days)||36
19078|NCT02121535|45543|P2|STARTED|Period 2 (8 Trial Days)||35
19079|NCT02121535|45544|P1|STARTED|Period 2 (8 Trial Days)||36
19080|NCT02121535|45543|P2|NOT COMPLETED|Period 1 (8 Trial Days)||1
19081|NCT02121535|45544|P1|NOT COMPLETED|Period 1 (8 Trial Days)||0
19082|NCT02121535|45543|P2|COMPLETED|Period 1 (8 Trial Days)|1 subject withdrew his consent during the washout period between Period 1 and 2.|35
19083|NCT02121535|45544|P1|COMPLETED|Period 1 (8 Trial Days)||36
19084|NCT02121535|45543|P2|STARTED|Period 1 (8 Trial Days)||36
19085|NCT02121535|45544|P1|STARTED|Period 1 (8 Trial Days)||36
19086|NCT02121522|45567|P1|NOT COMPLETED|Overall Study||1
19087|NCT02121522|45567|P1|COMPLETED|Overall Study||13
19088|NCT02121522|45567|P1|STARTED|Overall Study||14
19089|NCT02121509|45574|P4|NOT COMPLETED|Treatment Period-2 (4 Days)||0
19090|NCT02121509|45575|P3|NOT COMPLETED|Treatment Period-2 (4 Days)||0
19091|NCT02121509|45576|P2|NOT COMPLETED|Treatment Period-2 (4 Days)||0
19092|NCT02121509|45577|P1|NOT COMPLETED|Treatment Period-2 (4 Days)||0
19093|NCT02121509|45574|P4|COMPLETED|Treatment Period-2 (4 Days)||8
19094|NCT02121509|45575|P3|COMPLETED|Treatment Period-2 (4 Days)||8
19095|NCT02121509|45576|P2|COMPLETED|Treatment Period-2 (4 Days)||24
19096|NCT02121509|45577|P1|COMPLETED|Treatment Period-2 (4 Days)||28
19097|NCT02121509|45574|P4|STARTED|Treatment Period-2 (4 Days)||8
19098|NCT02121509|45575|P3|STARTED|Treatment Period-2 (4 Days)||8
19099|NCT02121509|45576|P2|STARTED|Treatment Period-2 (4 Days)||24
19100|NCT02121509|45577|P1|STARTED|Treatment Period-2 (4 Days)||28
19101|NCT02121509|45574|P4|NOT COMPLETED|Washout Period (35 Days)||0
19102|NCT02121509|45575|P3|NOT COMPLETED|Washout Period (35 Days)||0
19103|NCT02121509|45576|P2|NOT COMPLETED|Washout Period (35 Days)||4
19104|NCT02121509|45577|P1|NOT COMPLETED|Washout Period (35 Days)||2
19105|NCT02121509|45574|P4|COMPLETED|Washout Period (35 Days)||8
19106|NCT02121509|45575|P3|COMPLETED|Washout Period (35 Days)||8
19107|NCT02121509|45576|P2|COMPLETED|Washout Period (35 Days)||24
19108|NCT02121509|45577|P1|COMPLETED|Washout Period (35 Days)||28
19109|NCT02121509|45574|P4|STARTED|Washout Period (35 Days)||8
19110|NCT02121509|45575|P3|STARTED|Washout Period (35 Days)||8
19111|NCT02121509|45576|P2|STARTED|Washout Period (35 Days)||28
19112|NCT02121509|45577|P1|STARTED|Washout Period (35 Days)||30
19113|NCT02121509|45574|P4|NOT COMPLETED|Treatment Period-1 (4 Days)||0
19114|NCT02121509|45575|P3|NOT COMPLETED|Treatment Period-1 (4 Days)||0
19115|NCT02121509|45576|P2|NOT COMPLETED|Treatment Period-1 (4 Days)||0
19116|NCT02121509|45577|P1|NOT COMPLETED|Treatment Period-1 (4 Days)||0
19117|NCT02121509|45574|P4|COMPLETED|Treatment Period-1 (4 Days)||8
19118|NCT02121509|45575|P3|COMPLETED|Treatment Period-1 (4 Days)||8
19119|NCT02121509|45576|P2|COMPLETED|Treatment Period-1 (4 Days)||28
19120|NCT02121509|45577|P1|COMPLETED|Treatment Period-1 (4 Days)||30
19121|NCT02121509|45574|P4|STARTED|Treatment Period-1 (4 Days)||8
19122|NCT02121509|45575|P3|STARTED|Treatment Period-1 (4 Days)||8
19123|NCT02121509|45576|P2|STARTED|Treatment Period-1 (4 Days)||28
19124|NCT02121509|45577|P1|STARTED|Treatment Period-1 (4 Days)||30
19125|NCT02121483|45610|P3|NOT COMPLETED|Overall Study||0
19126|NCT02121483|45611|P2|NOT COMPLETED|Overall Study||0
19127|NCT02121483|45612|P1|NOT COMPLETED|Overall Study||0
19128|NCT02121483|45610|P3|COMPLETED|Overall Study||10
19129|NCT02121483|45611|P2|COMPLETED|Overall Study||8
19130|NCT02121483|45612|P1|COMPLETED|Overall Study||9
19131|NCT02121483|45610|P3|STARTED|Overall Study||10
19132|NCT02121483|45611|P2|STARTED|Overall Study||8
19133|NCT02121483|45612|P1|STARTED|Overall Study||9
19134|NCT02121210|45643|P2|NOT COMPLETED|Overall Study||9
19135|NCT02121210|45644|P1|NOT COMPLETED|Overall Study||7
19136|NCT02121210|45643|P2|COMPLETED|Overall Study||58
19137|NCT02121210|45644|P1|COMPLETED|Overall Study||58
19138|NCT02121210|45643|P2|STARTED|Overall Study||67
19139|NCT02121210|45644|P1|STARTED|Overall Study||65
19140|NCT02121067|45652|P1|NOT COMPLETED|Overall Study||0
19141|NCT02121067|45652|P1|COMPLETED|Overall Study||50
19142|NCT02121067|45652|P1|STARTED|Overall Study||50
19143|NCT02121041|45660|P2|NOT COMPLETED|Overall Study||6
19144|NCT02121041|45661|P1|NOT COMPLETED|Overall Study||1
19145|NCT02121041|45660|P2|COMPLETED|Overall Study||8
19146|NCT02121041|45661|P1|COMPLETED|Overall Study||13
19147|NCT02121041|45660|P2|STARTED|Overall Study||14
19148|NCT02121041|45661|P1|STARTED|Overall Study||14
19149|NCT02120833|45669|P2|NOT COMPLETED|Overall Study||1
19150|NCT02120833|45670|P1|NOT COMPLETED|Overall Study||4
19151|NCT02120833|45669|P2|COMPLETED|Overall Study||11
19152|NCT02120833|45670|P1|COMPLETED|Overall Study||35
19153|NCT02120833|45669|P2|STARTED|Overall Study||12
19154|NCT02120833|45670|P1|STARTED|Overall Study||39
19155|NCT02120664|45829|P5|NOT COMPLETED|Overall Study||0
19156|NCT02120664|45830|P4|NOT COMPLETED|Overall Study||1
19157|NCT02120664|45831|P3|NOT COMPLETED|Overall Study||0
19158|NCT02120664|45832|P2|NOT COMPLETED|Overall Study||0
19159|NCT02120664|45833|P1|NOT COMPLETED|Overall Study||0
19160|NCT02120664|45829|P5|COMPLETED|Overall Study||10
19161|NCT02120664|45830|P4|COMPLETED|Overall Study||3
19162|NCT02120664|45831|P3|COMPLETED|Overall Study||7
19163|NCT02120664|45832|P2|COMPLETED|Overall Study||4
19164|NCT02120664|45833|P1|COMPLETED|Overall Study||10
19165|NCT02120664|45829|P5|STARTED|Overall Study||10
19166|NCT02120664|45830|P4|STARTED|Overall Study||4
19167|NCT02120664|45831|P3|STARTED|Overall Study||7
19168|NCT02120664|45832|P2|STARTED|Overall Study||4
19169|NCT02120664|45833|P1|STARTED|Overall Study||10
19170|NCT02120625|45851|P1|NOT COMPLETED|Overall Study||2
19171|NCT02120625|45851|P1|COMPLETED|Overall Study||6
19172|NCT02120625|45851|P1|STARTED|Overall Study||8
19173|NCT02120443|45858|P1|NOT COMPLETED|Overall Study||0
19174|NCT02120443|45858|P1|COMPLETED|Overall Study||43
19175|NCT02120443|45858|P1|STARTED|Overall Study||43
19176|NCT02120417|45866|P2|NOT COMPLETED|Overall Study||68
19177|NCT02120417|45867|P1|NOT COMPLETED|Overall Study||60
19178|NCT02120417|45866|P2|COMPLETED|Overall Study||5
19179|NCT02120417|45867|P1|COMPLETED|Overall Study||16
19180|NCT02120417|45866|P2|STARTED|Overall Study||73
19181|NCT02120417|45867|P1|STARTED|Overall Study||76
19182|NCT02120300|45889|P4|NOT COMPLETED|Overall Study||1
19183|NCT02120300|45890|P3|NOT COMPLETED|Overall Study||0
19184|NCT02120300|45891|P2|NOT COMPLETED|Overall Study||0
19185|NCT02120300|45892|P1|NOT COMPLETED|Overall Study||3
19186|NCT02120300|45889|P4|COMPLETED|Overall Study||5
19187|NCT02120300|45890|P3|COMPLETED|Overall Study||10
19188|NCT02120300|45891|P2|COMPLETED|Overall Study||5
19189|NCT02120300|45892|P1|COMPLETED|Overall Study||98
19190|NCT02120300|45889|P4|STARTED|Overall Study||6
19191|NCT02120300|45890|P3|STARTED|Overall Study||10
19192|NCT02120300|45891|P2|STARTED|Overall Study||5
19193|NCT02120300|45892|P1|STARTED|Overall Study||101
19194|NCT02120027|45930|P2|NOT COMPLETED|Overall Study||119
19195|NCT02120027|45931|P1|NOT COMPLETED|Overall Study||116
19196|NCT02120027|45930|P2|COMPLETED|Overall Study||160
19197|NCT02120027|45931|P1|COMPLETED|Overall Study||161
19198|NCT02120027|45930|P2|STARTED|Overall Study||279
19199|NCT02120027|45931|P1|STARTED|Overall Study||277
19200|NCT02120001|45947|P2|NOT COMPLETED|Overall Study||0
19201|NCT02120001|45948|P1|NOT COMPLETED|Overall Study||0
19202|NCT02120001|45947|P2|COMPLETED|Overall Study||19
19203|NCT02120001|45948|P1|COMPLETED|Overall Study||17
19204|NCT02120001|45947|P2|STARTED|Overall Study||19
19205|NCT02120001|45948|P1|STARTED|Overall Study||17
19206|NCT02119676|45960|P4|NOT COMPLETED|Overall Study||101
19207|NCT02119676|45961|P3|NOT COMPLETED|Overall Study||97
19208|NCT02119676|45962|P2|NOT COMPLETED|Overall Study||86
19209|NCT02119676|45963|P1|NOT COMPLETED|Overall Study||83
19210|NCT02119676|45960|P4|COMPLETED|Overall Study||10
19211|NCT02119676|45961|P3|COMPLETED|Overall Study||13
19212|NCT02119676|45962|P2|COMPLETED|Overall Study||2
19213|NCT02119676|45963|P1|COMPLETED|Overall Study||4
19214|NCT02119676|45960|P4|Treated Patients|Overall Study||106
19215|NCT02119676|45961|P3|Treated Patients|Overall Study||106
19216|NCT02119676|45962|P2|Treated Patients|Overall Study||86
19217|NCT02119676|45963|P1|Treated Patients|Overall Study||85
19218|NCT02119676|45960|P4|STARTED|Overall Study||111
19219|NCT02119676|45961|P3|STARTED|Overall Study||110
19220|NCT02119676|45962|P2|STARTED|Overall Study||88
19221|NCT02119676|45963|P1|STARTED|Overall Study||87
19222|NCT02119663|45995|P2|NOT COMPLETED|Overall Study||41
19223|NCT02119663|45996|P1|NOT COMPLETED|Overall Study||40
19224|NCT02119663|45995|P2|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|2
19225|NCT02119663|45996|P1|COMPLETED|Overall Study|Treatment ongoing as of 13APR2016 for remaining participants in the study.|3
19226|NCT02119663|45995|P2|STARTED|Overall Study||43
19227|NCT02119663|45996|P1|STARTED|Overall Study||43
19228|NCT02119650|46014|P2|NOT COMPLETED|Overall Study||26
19229|NCT02119650|46015|P1|NOT COMPLETED|Overall Study||25
19230|NCT02119650|46014|P2|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|11
19231|NCT02119650|46015|P1|COMPLETED|Overall Study|Participants with treatment ongoing when the study was terminated.|14
19232|NCT02119650|46014|P2|STARTED|Overall Study||37
19233|NCT02119650|46015|P1|STARTED|Overall Study||39
19234|NCT02119325|46029|P2|NOT COMPLETED|Period 2||0
19235|NCT02119325|46030|P1|NOT COMPLETED|Period 2||0
19236|NCT02119325|46029|P2|COMPLETED|Period 2||47
19237|NCT02119325|46030|P1|COMPLETED|Period 2||48
19238|NCT02119325|46029|P2|STARTED|Period 2||47
19239|NCT02119325|46030|P1|STARTED|Period 2||48
19240|NCT02119325|46029|P2|NOT COMPLETED|Washout Period 1||1
19241|NCT02119325|46030|P1|NOT COMPLETED|Washout Period 1||0
19242|NCT02119325|46029|P2|COMPLETED|Washout Period 1||47
19243|NCT02119325|46030|P1|COMPLETED|Washout Period 1||48
19244|NCT02119325|46029|P2|STARTED|Washout Period 1||48
19245|NCT02119325|46030|P1|STARTED|Washout Period 1||48
19246|NCT02119325|46029|P2|NOT COMPLETED|Period 1||0
19247|NCT02119325|46030|P1|NOT COMPLETED|Period 1||0
19248|NCT02119325|46029|P2|COMPLETED|Period 1||48
19249|NCT02119325|46030|P1|COMPLETED|Period 1||48
19250|NCT02119325|46029|P2|STARTED|Period 1||48
19251|NCT02119325|46030|P1|STARTED|Period 1||48
19252|NCT02119299|46074|P1|NOT COMPLETED|Overall Study||9
19253|NCT02119299|46074|P1|COMPLETED|Overall Study||67
19254|NCT02119299|46074|P1|STARTED|Overall Study||76
19255|NCT02119286|46088|P3|NOT COMPLETED|Overall Study||7
19256|NCT02119286|46089|P2|NOT COMPLETED|Overall Study||11
19257|NCT02119286|46090|P1|NOT COMPLETED|Overall Study||26
19258|NCT02119286|46088|P3|COMPLETED|Overall Study||200
19259|NCT02119286|46089|P2|COMPLETED|Overall Study||195
19260|NCT02119286|46090|P1|COMPLETED|Overall Study||180
19261|NCT02119286|46088|P3|STARTED|Overall Study||207
19262|NCT02119286|46089|P2|STARTED|Overall Study||206
19263|NCT02119286|46090|P1|STARTED|Overall Study||206
19264|NCT02119104|46101|P1|NOT COMPLETED|Overall Study||16
19265|NCT02119104|46101|P1|COMPLETED|Overall Study||1071
19266|NCT02119104|46101|P1|STARTED|Overall Study||1087
19267|NCT02118961|46107|P2|NOT COMPLETED|Overall Study||0
19268|NCT02118961|46108|P1|NOT COMPLETED|Overall Study||1
19269|NCT02118961|46107|P2|COMPLETED|Overall Study||222
19270|NCT02118961|46108|P1|COMPLETED|Overall Study||223
19271|NCT02118961|46107|P2|STARTED|Overall Study||222
19272|NCT02118961|46108|P1|STARTED|Overall Study||224
19273|NCT02118896|46136|P10|NOT COMPLETED|Overall Study||2
19274|NCT02118896|46137|P9|NOT COMPLETED|Overall Study||4
19275|NCT02118896|46138|P8|NOT COMPLETED|Overall Study||2
19276|NCT02118896|46139|P7|NOT COMPLETED|Overall Study||2
19277|NCT02118896|46140|P6|NOT COMPLETED|Overall Study||28
19278|NCT02118896|46141|P5|NOT COMPLETED|Overall Study||17
19279|NCT02118896|46142|P4|NOT COMPLETED|Overall Study||24
19280|NCT02118896|46143|P3|NOT COMPLETED|Overall Study||14
19281|NCT02118896|46144|P2|NOT COMPLETED|Overall Study||15
19282|NCT02118896|46145|P1|NOT COMPLETED|Overall Study||17
19283|NCT02118896|46136|P10|COMPLETED|Overall Study||7
19284|NCT02118896|46137|P9|COMPLETED|Overall Study||84
19285|NCT02118896|46138|P8|COMPLETED|Overall Study||105
19286|NCT02118896|46139|P7|COMPLETED|Overall Study||83
19287|NCT02118896|46140|P6|COMPLETED|Overall Study||163
19288|NCT02118896|46141|P5|COMPLETED|Overall Study||113
19289|NCT02118896|46142|P4|COMPLETED|Overall Study||55
19290|NCT02118896|46143|P3|COMPLETED|Overall Study||53
19291|NCT02118896|46144|P2|COMPLETED|Overall Study||32
19292|NCT02118896|46145|P1|COMPLETED|Overall Study||30
19293|NCT02118896|46136|P10|STARTED|Overall Study||9
19294|NCT02118896|46137|P9|STARTED|Overall Study||88
19295|NCT02118896|46138|P8|STARTED|Overall Study||107
19296|NCT02118896|46139|P7|STARTED|Overall Study||85
19297|NCT02118896|46140|P6|STARTED|Overall Study||191
19298|NCT02118896|46141|P5|STARTED|Overall Study||130
19299|NCT02118896|46142|P4|STARTED|Overall Study||79
19300|NCT02118896|46143|P3|STARTED|Overall Study||67
19301|NCT02118896|46144|P2|STARTED|Overall Study||47
19302|NCT02118896|46145|P1|STARTED|Overall Study||47
19303|NCT02118831|46220|P3|NOT COMPLETED|Overall Study||0
19304|NCT02118831|46221|P2|NOT COMPLETED|Overall Study||0
19305|NCT02118831|46222|P1|NOT COMPLETED|Overall Study||0
19306|NCT02118831|46220|P3|COMPLETED|Overall Study||20
19307|NCT02118831|46221|P2|COMPLETED|Overall Study||15
19308|NCT02118831|46222|P1|COMPLETED|Overall Study||21
19309|NCT02118831|46220|P3|STARTED|Overall Study||20
19310|NCT02118831|46221|P2|STARTED|Overall Study||15
19311|NCT02118831|46222|P1|STARTED|Overall Study||21
19312|NCT02118792|46235|P2|NOT COMPLETED|Overall Study||37
19313|NCT02118792|46236|P1|NOT COMPLETED|Overall Study||31
19314|NCT02118792|46235|P2|COMPLETED|Overall Study||213
19315|NCT02118792|46236|P1|COMPLETED|Overall Study||483
19316|NCT02118792|46235|P2|Treated|Overall Study||250
19317|NCT02118792|46236|P1|Treated|Overall Study||513
19318|NCT02118792|46235|P2|STARTED|Overall Study||250
19319|NCT02118792|46236|P1|STARTED|Overall Study||514
19320|NCT02118766|46278|P2|NOT COMPLETED|Overall Study||31
19321|NCT02118766|46279|P1|NOT COMPLETED|Overall Study||30
19322|NCT02118766|46278|P2|COMPLETED|Overall Study||225
19323|NCT02118766|46279|P1|COMPLETED|Overall Study||477
19324|NCT02118766|46278|P2|Treated|Overall Study||256
19325|NCT02118766|46279|P1|Treated|Overall Study||503
19326|NCT02118766|46278|P2|STARTED|Overall Study||256
19327|NCT02118766|46279|P1|STARTED|Overall Study||507
19328|NCT02118597|46301|P1|NOT COMPLETED|Overall Study||16
19329|NCT02118597|46301|P1|COMPLETED|Overall Study||3
19330|NCT02118597|46301|P1|STARTED|Overall Study||19
19331|NCT02118441|46317|P2|NOT COMPLETED|Overall Study||1
19332|NCT02118441|46318|P1|NOT COMPLETED|Overall Study||3
19333|NCT02118441|46317|P2|COMPLETED|Overall Study||63
19334|NCT02118441|46318|P1|COMPLETED|Overall Study||62
19335|NCT02118441|46317|P2|STARTED|Overall Study||64
19336|NCT02118441|46318|P1|STARTED|Overall Study||65
19337|NCT02117687|46332|P2|NOT COMPLETED|Overall Study||4
19338|NCT02117687|46333|P1|NOT COMPLETED|Overall Study||1
19339|NCT02117687|46332|P2|COMPLETED|Overall Study||36
19340|NCT02117687|46333|P1|COMPLETED|Overall Study||39
19341|NCT02117687|46332|P2|STARTED|Overall Study||40
19342|NCT02117687|46333|P1|STARTED|Overall Study||40
19343|NCT02117570|46368|P3|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||6
19344|NCT02117570|46369|P2|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||3
19345|NCT02117570|46370|P1|NOT COMPLETED|Stage 2 Participants Aged 65 to 85 Years||1
19346|NCT02117570|46368|P3|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||54
19347|NCT02117570|46369|P2|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||59
19348|NCT02117570|46370|P1|COMPLETED|Stage 2 Participants Aged 65 to 85 Years||20
19349|NCT02117570|46368|P3|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
19350|NCT02117570|46369|P2|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||12
19351|NCT02117570|46370|P1|Vaccine: Dose 3|Stage 2 Participants Aged 65 to 85 Years||4
19352|NCT02117570|46368|P3|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||50
19353|NCT02117570|46369|P2|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||53
19354|NCT02117570|46370|P1|Vaccine: Dose 2|Stage 2 Participants Aged 65 to 85 Years||17
19355|NCT02117570|46368|P3|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||60
19356|NCT02117570|46369|P2|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||61
19357|NCT02117570|46370|P1|Vaccine: Dose 1|Stage 2 Participants Aged 65 to 85 Years||21
19358|NCT02117570|46368|P3|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|60
19359|NCT02117570|46369|P2|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|62
19360|NCT02117570|46370|P1|STARTED|Stage 2 Participants Aged 65 to 85 Years|Randomized|21
19361|NCT02117570|46368|P3|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
19362|NCT02117570|46369|P2|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||3
19363|NCT02117570|46370|P1|NOT COMPLETED|Stage 1 Participants Aged 50 to 64 Years||1
19364|NCT02117570|46368|P3|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||17
19365|NCT02117570|46369|P2|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||15
19366|NCT02117570|46370|P1|COMPLETED|Stage 1 Participants Aged 50 to 64 Years||5
19367|NCT02117570|46368|P3|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||18
19368|NCT02117570|46369|P2|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||17
19369|NCT02117570|46370|P1|Vaccine: Dose 3|Stage 1 Participants Aged 50 to 64 Years||6
19370|NCT02117570|46368|P3|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
19371|NCT02117570|46369|P2|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||18
19372|NCT02117570|46370|P1|Vaccine: Dose 2|Stage 1 Participants Aged 50 to 64 Years||6
19373|NCT02117570|46368|P3|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
19374|NCT02117570|46369|P2|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||18
19375|NCT02117570|46370|P1|Vaccine: Dose 1|Stage 1 Participants Aged 50 to 64 Years||6
19376|NCT02117570|46368|P3|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
19377|NCT02117570|46369|P2|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|18
19378|NCT02117570|46370|P1|STARTED|Stage 1 Participants Aged 50 to 64 Years|Randomized|6
19379|NCT02117544|46420|P2|NOT COMPLETED|Period 2||0
19380|NCT02117544|46421|P1|NOT COMPLETED|Period 2||0
19381|NCT02117544|46420|P2|COMPLETED|Period 2||55
19382|NCT02117544|46421|P1|COMPLETED|Period 2||52
19383|NCT02117544|46420|P2|STARTED|Period 2||55
19384|NCT02117544|46421|P1|STARTED|Period 2||52
19385|NCT02117544|46420|P2|NOT COMPLETED|Period 1||0
19386|NCT02117544|46421|P1|NOT COMPLETED|Period 1||2
19387|NCT02117544|46420|P2|COMPLETED|Period 1||55
19388|NCT02117544|46421|P1|COMPLETED|Period 1||52
19389|NCT02117544|46420|P2|Treated|Period 1||55
19390|NCT02117544|46421|P1|Treated|Period 1||52
19391|NCT02117544|46420|P2|STARTED|Period 1||55
19392|NCT02117544|46421|P1|STARTED|Period 1||54
19393|NCT02117479|46436|P2|NOT COMPLETED|Overall Study||156
19394|NCT02117479|46437|P1|NOT COMPLETED|Overall Study||156
19395|NCT02117479|46436|P2|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|4
19396|NCT02117479|46437|P1|COMPLETED|Overall Study|Treatment ongoing as of 20APR2016 for remaining participants in the study.|5
19397|NCT02117479|46436|P2|STARTED|Overall Study||160
19398|NCT02117479|46437|P1|STARTED|Overall Study||161
19399|NCT02117414|46455|P2|NOT COMPLETED|Overall Study||6
19400|NCT02117414|46456|P1|NOT COMPLETED|Overall Study||15
19401|NCT02117414|46455|P2|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the Control group.|82
19402|NCT02117414|46456|P1|COMPLETED|Overall Study|Subject followed up at least to the one-month post MRI/Waiting period visit in the MRI group.|160
19403|NCT02117414|46455|P2|STARTED|Overall Study|Subjects randomized to the Control group.|88
19404|NCT02117414|46456|P1|STARTED|Overall Study|Subjects randomized to the MRI group.|175
19405|NCT02117310|46474|P1|NOT COMPLETED|Overall Study||0
19406|NCT02117310|46474|P1|COMPLETED|Overall Study||5
19407|NCT02117310|46474|P1|STARTED|Overall Study||5
19408|NCT02117193|46478|P1|NOT COMPLETED|Overall Study||0
19409|NCT02117193|46478|P1|COMPLETED|Overall Study||10
19410|NCT02117193|46478|P1|Placebo Intake + Sleep Deprivation|Overall Study||10
19411|NCT02117193|46478|P1|Alcohol Intake + Sleep Deprivation|Overall Study||10
19412|NCT02117193|46478|P1|Placebo Intake + Normal Sleep|Overall Study||10
19413|NCT02117193|46478|P1|Alcohol Intake + Normal Sleep|Overall Study||10
19414|NCT02117193|46478|P1|STARTED|Overall Study||10
19415|NCT02117050|46500|P1|NOT COMPLETED|Overall Study||1
19416|NCT02117050|46500|P1|COMPLETED|Overall Study||0
19417|NCT02117050|46500|P1|STARTED|Overall Study||1
19422|NCT02116530|46522|P2|NOT COMPLETED|Overall Study||4
19423|NCT02116530|46523|P1|NOT COMPLETED|Overall Study||9
19424|NCT02116530|46522|P2|COMPLETED|Overall Study||184
19425|NCT02116530|46523|P1|COMPLETED|Overall Study||183
19426|NCT02116530|46522|P2|STARTED|Overall Study||188
19427|NCT02116530|46523|P1|STARTED|Overall Study||192
19428|NCT02116322|46537|P1|NOT COMPLETED|Overall Study||0
19429|NCT02116322|46537|P1|COMPLETED|Overall Study||1
19430|NCT02116322|46537|P1|STARTED|Overall Study||1
19431|NCT02115984|46544|P2|NOT COMPLETED|Overall Study||7
19432|NCT02115984|46545|P1|NOT COMPLETED|Overall Study||6
19433|NCT02115984|46544|P2|COMPLETED|Overall Study||16
19434|NCT02115984|46545|P1|COMPLETED|Overall Study||51
19435|NCT02115984|46544|P2|STARTED|Overall Study||23
19436|NCT02115984|46545|P1|STARTED|Overall Study||57
19437|NCT02115815|46558|P7|NOT COMPLETED|Overall Study||0
19438|NCT02115815|46559|P6|NOT COMPLETED|Overall Study||2
19439|NCT02115815|46560|P5|NOT COMPLETED|Overall Study||0
19440|NCT02115815|46561|P4|NOT COMPLETED|Overall Study||0
19441|NCT02115815|46562|P3|NOT COMPLETED|Overall Study||0
19442|NCT02115815|46563|P2|NOT COMPLETED|Overall Study||0
19443|NCT02115815|46564|P1|NOT COMPLETED|Overall Study||2
19444|NCT02115815|46558|P7|COMPLETED|Overall Study||20
19445|NCT02115815|46559|P6|COMPLETED|Overall Study||20
19446|NCT02115815|46560|P5|COMPLETED|Overall Study||20
19447|NCT02115815|46561|P4|COMPLETED|Overall Study||20
19448|NCT02115815|46562|P3|COMPLETED|Overall Study||20
19449|NCT02115815|46563|P2|COMPLETED|Overall Study||20
19450|NCT02115815|46564|P1|COMPLETED|Overall Study||22
19451|NCT02115815|46558|P7|STARTED|Overall Study||20
19452|NCT02115815|46559|P6|STARTED|Overall Study||22
19453|NCT02115815|46560|P5|STARTED|Overall Study||20
19454|NCT02115815|46561|P4|STARTED|Overall Study||20
19455|NCT02115815|46562|P3|STARTED|Overall Study||20
19456|NCT02115815|46563|P2|STARTED|Overall Study||20
19457|NCT02115815|46564|P1|STARTED|Overall Study||24
19458|NCT02115581|46659|P2|NOT COMPLETED|Overall Study||0
19459|NCT02115581|46660|P1|NOT COMPLETED|Overall Study||0
19460|NCT02115581|46659|P2|COMPLETED|Overall Study||21
19461|NCT02115581|46660|P1|COMPLETED|Overall Study||17
19462|NCT02115581|46659|P2|STARTED|Overall Study||21
19463|NCT02115581|46660|P1|STARTED|Overall Study||17
19464|NCT02115321|46672|P2|NOT COMPLETED|Overall Study||0
19465|NCT02115321|46673|P1|NOT COMPLETED|Overall Study||1
19466|NCT02115321|46672|P2|COMPLETED|Overall Study||10
19467|NCT02115321|46673|P1|COMPLETED|Overall Study||29
19468|NCT02115321|46672|P2|STARTED|Overall Study||10
19469|NCT02115321|46673|P1|STARTED|Overall Study||30
19470|NCT02115256|46695|P2|NOT COMPLETED|Overall Study||1
19471|NCT02115256|46696|P1|NOT COMPLETED|Overall Study||0
19472|NCT02115256|46695|P2|COMPLETED|Overall Study||2
19473|NCT02115256|46696|P1|COMPLETED|Overall Study||3
19474|NCT02115256|46695|P2|STARTED|Overall Study||3
19475|NCT02115256|46696|P1|STARTED|Overall Study||3
19476|NCT02114931|46710|P2|NOT COMPLETED|Overall Study||30
19477|NCT02114931|46711|P1|NOT COMPLETED|Overall Study||25
19478|NCT02114931|46710|P2|COMPLETED|Overall Study||207
19479|NCT02114931|46711|P1|COMPLETED|Overall Study||205
19480|NCT02114931|46710|P2|Received Treatment|Overall Study||237
19481|NCT02114931|46711|P1|Received Treatment|Overall Study|One participant was enrolled in error and did not receive treatment in the extension study|229
19482|NCT02114931|46710|P2|STARTED|Overall Study||237
19483|NCT02114931|46711|P1|STARTED|Overall Study||230
19484|NCT02114892|46727|P2|NOT COMPLETED|Overall Study||2
19485|NCT02114892|46728|P1|NOT COMPLETED|Overall Study||1
19486|NCT02114892|46727|P2|COMPLETED|Overall Study|Two patients did not complete the study due to early withdrawl|10
19487|NCT02114892|46728|P1|COMPLETED|Overall Study|One patient did not complete the study due to early withdrawl|11
19488|NCT02114892|46727|P2|STARTED|Overall Study||12
19489|NCT02114892|46728|P1|STARTED|Overall Study||12
19490|NCT02114268|46768|P6|NOT COMPLETED|Overall Study||3
19491|NCT02114268|46769|P5|NOT COMPLETED|Overall Study||0
19492|NCT02114268|46770|P4|NOT COMPLETED|Overall Study||0
19493|NCT02114268|46771|P3|NOT COMPLETED|Overall Study||1
19494|NCT02114268|46772|P2|NOT COMPLETED|Overall Study||1
19495|NCT02114268|46773|P1|NOT COMPLETED|Overall Study||6
19496|NCT02114268|46768|P6|COMPLETED|Overall Study||75
19497|NCT02114268|46769|P5|COMPLETED|Overall Study||6
19498|NCT02114268|46770|P4|COMPLETED|Overall Study||6
19499|NCT02114268|46771|P3|COMPLETED|Overall Study||5
19500|NCT02114268|46772|P2|COMPLETED|Overall Study||5
19501|NCT02114268|46773|P1|COMPLETED|Overall Study||28
19502|NCT02114268|46768|P6|STARTED|Overall Study||78
19503|NCT02114268|46769|P5|STARTED|Overall Study||6
19504|NCT02114268|46770|P4|STARTED|Overall Study||6
19505|NCT02114268|46771|P3|STARTED|Overall Study||6
19506|NCT02114268|46772|P2|STARTED|Overall Study||6
19507|NCT02114268|46773|P1|STARTED|Overall Study||34
19508|NCT02114216|46826|P3|NOT COMPLETED|Overall Study||0
19509|NCT02114216|46827|P2|NOT COMPLETED|Overall Study||0
19510|NCT02114216|46828|P1|NOT COMPLETED|Overall Study||0
19511|NCT02114216|46826|P3|COMPLETED|Overall Study||14
19512|NCT02114216|46827|P2|COMPLETED|Overall Study||45
19513|NCT02114216|46828|P1|COMPLETED|Overall Study||16
19514|NCT02114216|46826|P3|STARTED|Overall Study||14
19515|NCT02114216|46827|P2|STARTED|Overall Study||45
19516|NCT02114216|46828|P1|STARTED|Overall Study||16
19517|NCT02114177|46841|P2|NOT COMPLETED|Overall Study||4
19518|NCT02114177|46842|P1|NOT COMPLETED|Overall Study||9
19519|NCT02114177|46841|P2|COMPLETED|Overall Study||151
19520|NCT02114177|46842|P1|COMPLETED|Overall Study||146
19521|NCT02114177|46841|P2|STARTED|Overall Study||155
19522|NCT02114177|46842|P1|STARTED|Overall Study||155
19523|NCT02114151|46866|P1|NOT COMPLETED|Overall Study||7
19524|NCT02114151|46866|P1|COMPLETED|Overall Study||96
19525|NCT02114151|46866|P1|STARTED|Overall Study||103
19526|NCT02113579|46883|P2|NOT COMPLETED|Overall Study||4
19527|NCT02113579|46884|P1|NOT COMPLETED|Overall Study||10
19528|NCT02113579|46883|P2|COMPLETED|Overall Study||185
19529|NCT02113579|46884|P1|COMPLETED|Overall Study||176
19530|NCT02113579|46883|P2|STARTED|Overall Study||189
19531|NCT02113579|46884|P1|STARTED|Overall Study||186
19532|NCT02113449|46908|P1|NOT COMPLETED|Overall Study||4
19533|NCT02113449|46908|P1|COMPLETED|Overall Study||143
19534|NCT02113449|46908|P1|STARTED|Overall Study||147
19535|NCT02113436|46924|P4|NOT COMPLETED|Period 2: 16 Weeks||11
19536|NCT02113436|46925|P3|NOT COMPLETED|Period 2: 16 Weeks||9
19537|NCT02113436|46926|P2|NOT COMPLETED|Period 2: 16 Weeks||0
19538|NCT02113436|46927|P1|NOT COMPLETED|Period 2: 16 Weeks||0
19539|NCT02113436|46924|P4|COMPLETED|Period 2: 16 Weeks||136
19540|NCT02113436|46925|P3|COMPLETED|Period 2: 16 Weeks||132
19541|NCT02113436|46926|P2|COMPLETED|Period 2: 16 Weeks||0
19542|NCT02113436|46927|P1|COMPLETED|Period 2: 16 Weeks||0
19543|NCT02113436|46924|P4|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|147
19544|NCT02113436|46925|P3|STARTED|Period 2: 16 Weeks|Par. started TP2 are not equal to that completed TP1 as 1 par. in each arm didn’t transfer to TP2.|141
19545|NCT02113436|46926|P2|STARTED|Period 2: 16 Weeks||0
19546|NCT02113436|46927|P1|STARTED|Period 2: 16 Weeks||0
19547|NCT02113436|46924|P4|NOT COMPLETED|Period 1: 8 Weeks||0
19548|NCT02113436|46925|P3|NOT COMPLETED|Period 1: 8 Weeks||0
19549|NCT02113436|46926|P2|NOT COMPLETED|Period 1: 8 Weeks||2
19550|NCT02113436|46927|P1|NOT COMPLETED|Period 1: 8 Weeks||8
19551|NCT02113436|46924|P4|COMPLETED|Period 1: 8 Weeks||0
19552|NCT02113436|46925|P3|COMPLETED|Period 1: 8 Weeks||0
19553|NCT02113436|46926|P2|COMPLETED|Period 1: 8 Weeks||148
19554|NCT02113436|46927|P1|COMPLETED|Period 1: 8 Weeks||142
19555|NCT02113436|46924|P4|STARTED|Period 1: 8 Weeks||0
19556|NCT02113436|46925|P3|STARTED|Period 1: 8 Weeks||0
19557|NCT02113436|46926|P2|STARTED|Period 1: 8 Weeks||150
19558|NCT02113436|46927|P1|STARTED|Period 1: 8 Weeks||150
19559|NCT02113124|46950|P2|NOT COMPLETED|Overall Study||1
19560|NCT02113124|46951|P1|NOT COMPLETED|Overall Study||1
19561|NCT02113124|46950|P2|COMPLETED|Overall Study||24
19562|NCT02113124|46951|P1|COMPLETED|Overall Study||17
19563|NCT02113124|46950|P2|STARTED|Overall Study||25
19564|NCT02113124|46951|P1|STARTED|Overall Study||18
19565|NCT02113007|46957|P1|NOT COMPLETED|Overall Study||2
19566|NCT02113007|46957|P1|COMPLETED|Overall Study||0
19567|NCT02113007|46957|P1|STARTED|Overall Study||2
19568|NCT02112448|46965|P2|NOT COMPLETED|Overall Study||10
19569|NCT02112448|46966|P1|NOT COMPLETED|Overall Study||8
19570|NCT02112448|46965|P2|COMPLETED|Overall Study||30
19571|NCT02112448|46966|P1|COMPLETED|Overall Study||30
19572|NCT02112448|46965|P2|STARTED|Overall Study||40
19573|NCT02112448|46966|P1|STARTED|Overall Study||38
19574|NCT02112370|46976|P2|NOT COMPLETED|Overall Study||0
19575|NCT02112370|46977|P1|NOT COMPLETED|Overall Study||0
19576|NCT02112370|46976|P2|COMPLETED|Overall Study||74
19577|NCT02112370|46977|P1|COMPLETED|Overall Study||74
19578|NCT02112370|46976|P2|STARTED|Overall Study||74
19579|NCT02112370|46977|P1|STARTED|Overall Study||74
19580|NCT02111603|46997|P1|NOT COMPLETED|Overall Study||1
19581|NCT02111603|46997|P1|COMPLETED|Overall Study||12
19582|NCT02111603|46997|P1|STARTED|Overall Study||13
19583|NCT02111369|47006|P1|NOT COMPLETED|Overall Study||3
19584|NCT02111369|47006|P1|COMPLETED|Overall Study||15
19585|NCT02111369|47006|P1|STARTED|Overall Study||18
19586|NCT02111252|47014|P1|NOT COMPLETED|Overall Study||0
19587|NCT02111252|47014|P1|COMPLETED|Overall Study||55
19588|NCT02111252|47014|P1|STARTED|Overall Study||55
19589|NCT02111083|47030|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
19590|NCT02111083|47031|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
19591|NCT02111083|47030|P2|COMPLETED|Fourth Intervention (1 Day)||18
19592|NCT02111083|47031|P1|COMPLETED|Fourth Intervention (1 Day)||18
19593|NCT02111083|47030|P2|STARTED|Fourth Intervention (1 Day)||18
19594|NCT02111083|47031|P1|STARTED|Fourth Intervention (1 Day)||18
19595|NCT02111083|47030|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
19596|NCT02111083|47031|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||1
19597|NCT02111083|47030|P2|COMPLETED|Interval Between Dosing (7-8 Days)||18
19598|NCT02111083|47031|P1|COMPLETED|Interval Between Dosing (7-8 Days)||18
19599|NCT02111083|47030|P2|STARTED|Interval Between Dosing (7-8 Days)||19
19600|NCT02111083|47031|P1|STARTED|Interval Between Dosing (7-8 Days)||19
19601|NCT02111083|47030|P2|NOT COMPLETED|Third Intervention (1 Day)||0
19602|NCT02111083|47031|P1|NOT COMPLETED|Third Intervention (1 Day)||0
19603|NCT02111083|47030|P2|COMPLETED|Third Intervention (1 Day)||19
19604|NCT02111083|47031|P1|COMPLETED|Third Intervention (1 Day)||19
19605|NCT02111083|47030|P2|STARTED|Third Intervention (1 Day)||19
19606|NCT02111083|47031|P1|STARTED|Third Intervention (1 Day)||19
19607|NCT02111083|47030|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
19608|NCT02111083|47031|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
19609|NCT02111083|47030|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
19610|NCT02111083|47031|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
19611|NCT02111083|47030|P2|STARTED|Interval Between Dosing (7-8 Days)||19
19612|NCT02111083|47031|P1|STARTED|Interval Between Dosing (7-8 Days)||19
19613|NCT02111083|47030|P2|NOT COMPLETED|Second Intervention (1 Day)||0
19614|NCT02111083|47031|P1|NOT COMPLETED|Second Intervention (1 Day)||0
19615|NCT02111083|47030|P2|COMPLETED|Second Intervention (1 Day)||19
19616|NCT02111083|47031|P1|COMPLETED|Second Intervention (1 Day)||19
19617|NCT02111083|47030|P2|STARTED|Second Intervention (1 Day)||19
19618|NCT02111083|47031|P1|STARTED|Second Intervention (1 Day)||19
19619|NCT02111083|47030|P2|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
19620|NCT02111083|47031|P1|NOT COMPLETED|Interval Between Dosing (7-8 Days)||0
19621|NCT02111083|47030|P2|COMPLETED|Interval Between Dosing (7-8 Days)||19
19622|NCT02111083|47031|P1|COMPLETED|Interval Between Dosing (7-8 Days)||19
19623|NCT02111083|47030|P2|STARTED|Interval Between Dosing (7-8 Days)||19
19624|NCT02111083|47031|P1|STARTED|Interval Between Dosing (7-8 Days)||19
19625|NCT02111083|47030|P2|NOT COMPLETED|First Intervention (1 Day)||0
19626|NCT02111083|47031|P1|NOT COMPLETED|First Intervention (1 Day)||0
19627|NCT02111083|47030|P2|COMPLETED|First Intervention (1 Day)||19
19628|NCT02111083|47031|P1|COMPLETED|First Intervention (1 Day)||19
19629|NCT02111083|47030|P2|STARTED|First Intervention (1 Day)||19
19630|NCT02111083|47031|P1|STARTED|First Intervention (1 Day)||19
19631|NCT02110381|47051|P2|NOT COMPLETED|Dual Modality||1
19632|NCT02110381|47052|P1|NOT COMPLETED|Dual Modality||2
19633|NCT02110381|47051|P2|COMPLETED|Dual Modality||7
19634|NCT02110381|47052|P1|COMPLETED|Dual Modality||5
19635|NCT02110381|47051|P2|Began Active Treatment|Dual Modality||7
19636|NCT02110381|47052|P1|Began Active Treatment|Dual Modality||7
19637|NCT02110381|47051|P2|STARTED|Dual Modality||8
19638|NCT02110381|47052|P1|STARTED|Dual Modality||7
19639|NCT02110381|47051|P2|NOT COMPLETED|Single Modality||1
19640|NCT02110381|47052|P1|NOT COMPLETED|Single Modality||2
19641|NCT02110381|47051|P2|COMPLETED|Single Modality||8
19642|NCT02110381|47052|P1|COMPLETED|Single Modality||7
19643|NCT02110381|47051|P2|STARTED|Single Modality||9
19644|NCT02110381|47052|P1|STARTED|Single Modality||9
19645|NCT02110238|47065|P2|NOT COMPLETED|14 Week Blinded Extension Phase||12
19646|NCT02110238|47066|P1|NOT COMPLETED|14 Week Blinded Extension Phase||12
19647|NCT02110238|47065|P2|COMPLETED|14 Week Blinded Extension Phase||188
19648|NCT02110238|47066|P1|COMPLETED|14 Week Blinded Extension Phase||190
19649|NCT02110238|47065|P2|STARTED|14 Week Blinded Extension Phase||200
19650|NCT02110238|47066|P1|STARTED|14 Week Blinded Extension Phase||202
19651|NCT02110238|47065|P2|NOT COMPLETED|12 Week Pivotal Phase||9
19652|NCT02110238|47066|P1|NOT COMPLETED|12 Week Pivotal Phase||10
19653|NCT02110238|47065|P2|COMPLETED|12 Week Pivotal Phase||200
19654|NCT02110238|47066|P1|COMPLETED|12 Week Pivotal Phase||202
19655|NCT02110238|47065|P2|STARTED|12 Week Pivotal Phase||209
19656|NCT02110238|47066|P1|STARTED|12 Week Pivotal Phase|One subject was randomized but not treated. As a result there were 211 safety subjects|212
19657|NCT02110147|47072|P1|NOT COMPLETED|Overall Study||0
19658|NCT02110147|47072|P1|COMPLETED|Overall Study||4
19659|NCT02110147|47072|P1|STARTED|Overall Study||4
19660|NCT02109731|47078|P1|NOT COMPLETED|Overall Study||0
19661|NCT02109731|47078|P1|COMPLETED|Overall Study||15
19662|NCT02109731|47078|P1|STARTED|Overall Study||15
19663|NCT02109640|47084|P2|NOT COMPLETED|Overall Study||0
19664|NCT02109640|47085|P1|NOT COMPLETED|Overall Study||0
19665|NCT02109640|47084|P2|COMPLETED|Overall Study||23
19666|NCT02109640|47085|P1|COMPLETED|Overall Study||27
19667|NCT02109640|47084|P2|STARTED|Overall Study||23
19668|NCT02109640|47085|P1|STARTED|Overall Study||27
19669|NCT02109497|47095|P1|NOT COMPLETED|Overall Study||1
19670|NCT02109497|47095|P1|COMPLETED|Overall Study|One participant completed the safety assessments but did not complete all doses of the study drugs.|17
19671|NCT02109497|47095|P1|STARTED|Overall Study||18
19672|NCT02109458|47100|P1|NOT COMPLETED|Overall Study||0
19673|NCT02109458|47100|P1|COMPLETED|Overall Study||24
19674|NCT02109458|47100|P1|STARTED|Overall Study||24
19675|NCT02109445|47107|P1|NOT COMPLETED|Overall Study||3
19676|NCT02109445|47107|P1|COMPLETED|Overall Study||0
19677|NCT02109445|47107|P1|STARTED|Overall Study||3
19678|NCT02109172|47140|P6|NOT COMPLETED|Overall Study||1
19679|NCT02109172|47141|P5|NOT COMPLETED|Overall Study||1
19680|NCT02109172|47142|P4|NOT COMPLETED|Overall Study||1
19681|NCT02109172|47143|P3|NOT COMPLETED|Overall Study||1
19682|NCT02109172|47144|P2|NOT COMPLETED|Overall Study||0
19683|NCT02109172|47145|P1|NOT COMPLETED|Overall Study||1
19684|NCT02109172|47140|P6|COMPLETED|Overall Study||10
19685|NCT02109172|47141|P5|COMPLETED|Overall Study||9
19686|NCT02109172|47142|P4|COMPLETED|Overall Study||10
19687|NCT02109172|47143|P3|COMPLETED|Overall Study||9
19688|NCT02109172|47144|P2|COMPLETED|Overall Study||11
19689|NCT02109172|47145|P1|COMPLETED|Overall Study||10
19690|NCT02109172|47140|P6|STARTED|Overall Study||11
19691|NCT02109172|47141|P5|STARTED|Overall Study||10
19692|NCT02109172|47142|P4|STARTED|Overall Study||11
19693|NCT02109172|47143|P3|STARTED|Overall Study||10
19694|NCT02109172|47144|P2|STARTED|Overall Study||11
19695|NCT02109172|47145|P1|STARTED|Overall Study||11
19696|NCT02109159|47155|P2|NOT COMPLETED|Overall Study||0
19697|NCT02109159|47156|P1|NOT COMPLETED|Overall Study||0
19698|NCT02109159|47155|P2|COMPLETED|Overall Study||4175
19699|NCT02109159|47156|P1|COMPLETED|Overall Study||4178
19700|NCT02109159|47155|P2|STARTED|Overall Study||4175
19701|NCT02109159|47156|P1|STARTED|Overall Study||4178
19702|NCT02109133|47166|P2|NOT COMPLETED|Overall Study||0
19703|NCT02109133|47167|P1|NOT COMPLETED|Overall Study||1
19704|NCT02109133|47166|P2|COMPLETED|Overall Study||34
19705|NCT02109133|47167|P1|COMPLETED|Overall Study||32
19706|NCT02109133|47166|P2|STARTED|Overall Study||34
19707|NCT02109133|47167|P1|STARTED|Overall Study||33
19708|NCT02109107|47179|P1|NOT COMPLETED|Overall Study||2
19709|NCT02109107|47179|P1|COMPLETED|Overall Study||52
19710|NCT02109107|47179|P1|STARTED|Overall Study||54
19711|NCT02108977|47188|P2|NOT COMPLETED|Overall Study||1
19712|NCT02108977|47189|P1|NOT COMPLETED|Overall Study||10
19713|NCT02108977|47188|P2|COMPLETED|Overall Study||19
19714|NCT02108977|47189|P1|COMPLETED|Overall Study||8
19715|NCT02108977|47188|P2|STARTED|Overall Study||20
19716|NCT02108977|47189|P1|STARTED|Overall Study||18
19717|NCT02108691|47203|P2|NOT COMPLETED|Overall Study||9
19718|NCT02108691|47204|P1|NOT COMPLETED|Overall Study||8
19719|NCT02108691|47203|P2|COMPLETED|Overall Study||31
19720|NCT02108691|47204|P1|COMPLETED|Overall Study||32
19721|NCT02108691|47203|P2|STARTED|Overall Study||40
19722|NCT02108691|47204|P1|STARTED|Overall Study||40
19723|NCT02108652|47222|P1|NOT COMPLETED|Overall Study||310
19724|NCT02108652|47222|P1|COMPLETED|Overall Study||0
19725|NCT02108652|47222|P1|STARTED|Overall Study||310
19726|NCT02108288|47246|P3|NOT COMPLETED|Overall Study||0
19727|NCT02108288|47247|P2|NOT COMPLETED|Overall Study||0
19728|NCT02108288|47248|P1|NOT COMPLETED|Overall Study||0
19729|NCT02108288|47246|P3|COMPLETED|Overall Study||10
19730|NCT02108288|47247|P2|COMPLETED|Overall Study||10
19731|NCT02108288|47248|P1|COMPLETED|Overall Study||10
19732|NCT02108288|47246|P3|STARTED|Overall Study||10
19733|NCT02108288|47247|P2|STARTED|Overall Study||10
19734|NCT02108288|47248|P1|STARTED|Overall Study||10
19735|NCT02107196|47263|P2|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||5
19736|NCT02107196|47264|P1|NOT COMPLETED|4-week Randomized Withdrawal (RW) Period||23
19737|NCT02107196|47263|P2|COMPLETED|4-week Randomized Withdrawal (RW) Period||109
19738|NCT02107196|47264|P1|COMPLETED|4-week Randomized Withdrawal (RW) Period||315
19739|NCT02107196|47263|P2|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|90
19740|NCT02107196|47264|P1|Modified RW Population|4-week Randomized Withdrawal (RW) Period|all RW patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|272
19741|NCT02107196|47263|P2|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of placebo during RW period|114
19742|NCT02107196|47264|P1|RW Population|4-week Randomized Withdrawal (RW) Period|All re-randomized ITT patients,who received at least 1 dose of ibodutant during RW period|338
19743|NCT02107196|47263|P2|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|114
19744|NCT02107196|47264|P1|STARTED|4-week Randomized Withdrawal (RW) Period|all re-randomized patients at Visit 6 [Day85]|338
19745|NCT02107196|47263|P2|NOT COMPLETED|12-week Treatment Period||39
19746|NCT02107196|47264|P1|NOT COMPLETED|12-week Treatment Period||44
19747|NCT02107196|47263|P2|COMPLETED|12-week Treatment Period||225
19748|NCT02107196|47264|P1|COMPLETED|12-week Treatment Period||227
19749|NCT02107196|47263|P2|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|216
19750|NCT02107196|47264|P1|Modified ITT|12-week Treatment Period|All ITT patients, excluding patients of two sites (serious breach of GCP, disqualified Investigator)|221
19751|NCT02107196|47263|P2|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|264
19752|NCT02107196|47264|P1|Intention To Treat (ITT)|12-week Treatment Period|All randomised patients who took at least one dose of study drug during 12-week treatment period|271
19753|NCT02107196|47263|P2|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|264
19754|NCT02107196|47264|P1|STARTED|12-week Treatment Period|Safety population, all enrolled patients who received at least one dose of study drug|271
19755|NCT02108223|47280|P3|NOT COMPLETED|Overall Study||0
19756|NCT02108223|47281|P2|NOT COMPLETED|Overall Study||0
19757|NCT02108223|47282|P1|NOT COMPLETED|Overall Study||0
19758|NCT02108223|47280|P3|COMPLETED|Overall Study||35
19759|NCT02108223|47281|P2|COMPLETED|Overall Study||50
19760|NCT02108223|47282|P1|COMPLETED|Overall Study||52
19761|NCT02108223|47280|P3|STARTED|Overall Study||35
19762|NCT02108223|47281|P2|STARTED|Overall Study||50
19763|NCT02108223|47282|P1|STARTED|Overall Study||52
19764|NCT02108171|47304|P2|NOT COMPLETED|Overall Study||0
19765|NCT02108171|47305|P1|NOT COMPLETED|Overall Study||0
19766|NCT02108171|47304|P2|COMPLETED|Overall Study||41
19767|NCT02108171|47305|P1|COMPLETED|Overall Study||40
19768|NCT02108171|47304|P2|STARTED|Overall Study||41
19769|NCT02108171|47305|P1|STARTED|Overall Study||40
19770|NCT02107898|47407|P2|NOT COMPLETED|Overall Study||12
19771|NCT02107898|47408|P1|NOT COMPLETED|Overall Study||6
19772|NCT02107898|47407|P2|COMPLETED|Overall Study||132
19773|NCT02107898|47408|P1|COMPLETED|Overall Study||66
19774|NCT02107898|47407|P2|Treated|Overall Study||143
19775|NCT02107898|47408|P1|Treated|Overall Study||72
19776|NCT02107898|47407|P2|STARTED|Overall Study|Randomized|144
19777|NCT02107898|47408|P1|STARTED|Overall Study|Randomized|72
19778|NCT02107599|47460|P1|NOT COMPLETED|Overall Study||0
19779|NCT02107599|47460|P1|COMPLETED|Overall Study||96
19780|NCT02107599|47460|P1|STARTED|Overall Study||96
19781|NCT02107482|47467|P1|NOT COMPLETED|Overall Study||4
19782|NCT02107482|47467|P1|COMPLETED|Overall Study||17
19783|NCT02107482|47467|P1|STARTED|Overall Study|21 participants enrolled. Total of 21 participants recvd both active and sham|21
19784|NCT02107339|47475|P2|NOT COMPLETED|Overall Study||4
19785|NCT02107339|47476|P1|NOT COMPLETED|Overall Study||1
19786|NCT02107339|47475|P2|COMPLETED|Overall Study||53
19787|NCT02107339|47476|P1|COMPLETED|Overall Study||62
19788|NCT02107339|47475|P2|STARTED|Overall Study||57
19789|NCT02107339|47476|P1|STARTED|Overall Study||63
19790|NCT02107313|47504|P2|NOT COMPLETED|Overall Study||1
19791|NCT02107313|47505|P1|NOT COMPLETED|Overall Study||0
19792|NCT02107313|47504|P2|COMPLETED|Overall Study||8
19793|NCT02107313|47505|P1|COMPLETED|Overall Study||9
19794|NCT02107313|47504|P2|STARTED|Overall Study|One participant from the study did not cross over and participate in the FED cohort|9
19795|NCT02107313|47505|P1|STARTED|Overall Study||9
19796|NCT02107274|47515|P2|NOT COMPLETED|Control Phase||2
19797|NCT02107274|47516|P1|NOT COMPLETED|Control Phase||3
19798|NCT02107274|47515|P2|COMPLETED|Control Phase||35
19799|NCT02107274|47516|P1|COMPLETED|Control Phase||33
19800|NCT02107274|47515|P2|STARTED|Control Phase||37
19801|NCT02107274|47516|P1|STARTED|Control Phase||36
19802|NCT02107274|47515|P2|NOT COMPLETED|Treatment vs. Placebo||2
19803|NCT02107274|47516|P1|NOT COMPLETED|Treatment vs. Placebo||3
19804|NCT02107274|47515|P2|COMPLETED|Treatment vs. Placebo||37
19805|NCT02107274|47516|P1|COMPLETED|Treatment vs. Placebo||36
19806|NCT02107274|47515|P2|STARTED|Treatment vs. Placebo||39
19807|NCT02107274|47516|P1|STARTED|Treatment vs. Placebo||39
19808|NCT02107014|47528|P1|NOT COMPLETED|Overall Study||1
19809|NCT02107014|47528|P1|COMPLETED|Overall Study||8
19810|NCT02107014|47528|P1|STARTED|Overall Study||9
19811|NCT02106923|47599|P6|NOT COMPLETED|Overall Study||1
19812|NCT02106923|47600|P5|NOT COMPLETED|Overall Study||0
19813|NCT02106923|47601|P4|NOT COMPLETED|Overall Study||0
19814|NCT02106923|47602|P3|NOT COMPLETED|Overall Study||0
19815|NCT02106923|47603|P2|NOT COMPLETED|Overall Study||0
19816|NCT02106923|47604|P1|NOT COMPLETED|Overall Study||0
19817|NCT02106923|47599|P6|COMPLETED|Overall Study||11
19818|NCT02106923|47600|P5|COMPLETED|Overall Study||12
19819|NCT02106923|47601|P4|COMPLETED|Overall Study||12
19820|NCT02106923|47602|P3|COMPLETED|Overall Study||12
19821|NCT02106923|47603|P2|COMPLETED|Overall Study||12
19822|NCT02106923|47604|P1|COMPLETED|Overall Study||12
19823|NCT02106923|47599|P6|STARTED|Overall Study||12
19824|NCT02106923|47600|P5|STARTED|Overall Study||12
19825|NCT02106923|47601|P4|STARTED|Overall Study||12
19826|NCT02106923|47602|P3|STARTED|Overall Study||12
19827|NCT02106923|47603|P2|STARTED|Overall Study||12
19828|NCT02106923|47604|P1|STARTED|Overall Study||12
19829|NCT02106728|47650|P2|NOT COMPLETED|Overall Study||0
19830|NCT02106728|47651|P1|NOT COMPLETED|Overall Study||0
19831|NCT02106728|47650|P2|COMPLETED|Overall Study||47
19832|NCT02106728|47651|P1|COMPLETED|Overall Study||70
19833|NCT02106728|47650|P2|STARTED|Overall Study||47
19834|NCT02106728|47651|P1|STARTED|Overall Study||70
19835|NCT02106494|47667|P2|NOT COMPLETED|Overall Study||25
19836|NCT02106494|47668|P1|NOT COMPLETED|Overall Study||26
19837|NCT02106494|47667|P2|COMPLETED|Overall Study||446
19838|NCT02106494|47668|P1|COMPLETED|Overall Study||445
19839|NCT02106494|47667|P2|Efficacy Population|Overall Study||452
19840|NCT02106494|47668|P1|Efficacy Population|Overall Study||450
19841|NCT02106494|47667|P2|Safety Population|Overall Study||459
19842|NCT02106494|47668|P1|Safety Population|Overall Study||456
19843|NCT02106494|47667|P2|STARTED|Overall Study||471
19844|NCT02106494|47668|P1|STARTED|Overall Study||471
19845|NCT02106403|47682|P6|NOT COMPLETED|Follow-Up Visit 3||1
19846|NCT02106403|47683|P5|NOT COMPLETED|Follow-Up Visit 3||0
19847|NCT02106403|47684|P4|NOT COMPLETED|Follow-Up Visit 3||0
19848|NCT02106403|47685|P3|NOT COMPLETED|Follow-Up Visit 3||0
19849|NCT02106403|47686|P2|NOT COMPLETED|Follow-Up Visit 3||0
19850|NCT02106403|47687|P1|NOT COMPLETED|Follow-Up Visit 3||0
19851|NCT02106403|47682|P6|COMPLETED|Follow-Up Visit 3||8
19852|NCT02106403|47683|P5|COMPLETED|Follow-Up Visit 3||8
19853|NCT02106403|47684|P4|COMPLETED|Follow-Up Visit 3||8
19854|NCT02106403|47685|P3|COMPLETED|Follow-Up Visit 3||9
19855|NCT02106403|47686|P2|COMPLETED|Follow-Up Visit 3||8
19856|NCT02106403|47687|P1|COMPLETED|Follow-Up Visit 3||8
19857|NCT02106403|47682|P6|STARTED|Follow-Up Visit 3||9
19858|NCT02106403|47683|P5|STARTED|Follow-Up Visit 3||8
19859|NCT02106403|47684|P4|STARTED|Follow-Up Visit 3||8
19860|NCT02106403|47685|P3|STARTED|Follow-Up Visit 3||9
19861|NCT02106403|47686|P2|STARTED|Follow-Up Visit 3||8
19862|NCT02106403|47687|P1|STARTED|Follow-Up Visit 3||8
19863|NCT02106403|47682|P6|NOT COMPLETED|Follow-Up Visit 2||0
19864|NCT02106403|47683|P5|NOT COMPLETED|Follow-Up Visit 2||0
19865|NCT02106403|47684|P4|NOT COMPLETED|Follow-Up Visit 2||0
19866|NCT02106403|47685|P3|NOT COMPLETED|Follow-Up Visit 2||0
19867|NCT02106403|47686|P2|NOT COMPLETED|Follow-Up Visit 2||0
19868|NCT02106403|47687|P1|NOT COMPLETED|Follow-Up Visit 2||0
19869|NCT02106403|47682|P6|COMPLETED|Follow-Up Visit 2||9
19870|NCT02106403|47683|P5|COMPLETED|Follow-Up Visit 2||8
19871|NCT02106403|47684|P4|COMPLETED|Follow-Up Visit 2||8
19872|NCT02106403|47685|P3|COMPLETED|Follow-Up Visit 2||9
19873|NCT02106403|47686|P2|COMPLETED|Follow-Up Visit 2||8
19874|NCT02106403|47687|P1|COMPLETED|Follow-Up Visit 2||8
19875|NCT02106403|47682|P6|STARTED|Follow-Up Visit 2||9
19876|NCT02106403|47683|P5|STARTED|Follow-Up Visit 2||8
19877|NCT02106403|47684|P4|STARTED|Follow-Up Visit 2||8
19878|NCT02106403|47685|P3|STARTED|Follow-Up Visit 2||9
19879|NCT02106403|47686|P2|STARTED|Follow-Up Visit 2||8
19880|NCT02106403|47687|P1|STARTED|Follow-Up Visit 2||8
19881|NCT02106403|47682|P6|NOT COMPLETED|Visit 1, Treatment Period 3||0
19882|NCT02106403|47683|P5|NOT COMPLETED|Visit 1, Treatment Period 3||0
19883|NCT02106403|47684|P4|NOT COMPLETED|Visit 1, Treatment Period 3||0
19884|NCT02106403|47685|P3|NOT COMPLETED|Visit 1, Treatment Period 3||0
19885|NCT02106403|47686|P2|NOT COMPLETED|Visit 1, Treatment Period 3||0
19886|NCT02106403|47687|P1|NOT COMPLETED|Visit 1, Treatment Period 3||0
19887|NCT02106403|47682|P6|COMPLETED|Visit 1, Treatment Period 3||9
19888|NCT02106403|47683|P5|COMPLETED|Visit 1, Treatment Period 3||8
19889|NCT02106403|47684|P4|COMPLETED|Visit 1, Treatment Period 3||8
19890|NCT02106403|47685|P3|COMPLETED|Visit 1, Treatment Period 3||9
19891|NCT02106403|47686|P2|COMPLETED|Visit 1, Treatment Period 3||8
19892|NCT02106403|47687|P1|COMPLETED|Visit 1, Treatment Period 3||8
19893|NCT02106403|47682|P6|STARTED|Visit 1, Treatment Period 3||9
19894|NCT02106403|47683|P5|STARTED|Visit 1, Treatment Period 3||8
19895|NCT02106403|47684|P4|STARTED|Visit 1, Treatment Period 3||8
19896|NCT02106403|47685|P3|STARTED|Visit 1, Treatment Period 3||9
19897|NCT02106403|47686|P2|STARTED|Visit 1, Treatment Period 3||8
19898|NCT02106403|47687|P1|STARTED|Visit 1, Treatment Period 3||8
19899|NCT02106403|47682|P6|NOT COMPLETED|Visit 1, Treatment Period 2||0
19900|NCT02106403|47683|P5|NOT COMPLETED|Visit 1, Treatment Period 2||0
19901|NCT02106403|47684|P4|NOT COMPLETED|Visit 1, Treatment Period 2||0
19902|NCT02106403|47685|P3|NOT COMPLETED|Visit 1, Treatment Period 2||0
19903|NCT02106403|47686|P2|NOT COMPLETED|Visit 1, Treatment Period 2||0
19904|NCT02106403|47687|P1|NOT COMPLETED|Visit 1, Treatment Period 2||0
19905|NCT02106403|47682|P6|COMPLETED|Visit 1, Treatment Period 2||9
19906|NCT02106403|47683|P5|COMPLETED|Visit 1, Treatment Period 2||8
19907|NCT02106403|47684|P4|COMPLETED|Visit 1, Treatment Period 2||8
19908|NCT02106403|47685|P3|COMPLETED|Visit 1, Treatment Period 2||9
19909|NCT02106403|47686|P2|COMPLETED|Visit 1, Treatment Period 2||8
19910|NCT02106403|47687|P1|COMPLETED|Visit 1, Treatment Period 2||8
19911|NCT02106403|47682|P6|STARTED|Visit 1, Treatment Period 2||9
19912|NCT02106403|47683|P5|STARTED|Visit 1, Treatment Period 2||8
19913|NCT02106403|47684|P4|STARTED|Visit 1, Treatment Period 2||8
19914|NCT02106403|47685|P3|STARTED|Visit 1, Treatment Period 2||9
19915|NCT02106403|47686|P2|STARTED|Visit 1, Treatment Period 2||8
19916|NCT02106403|47687|P1|STARTED|Visit 1, Treatment Period 2||8
19917|NCT02106403|47682|P6|NOT COMPLETED|Visit 1, Treatment Period 1||0
19918|NCT02106403|47683|P5|NOT COMPLETED|Visit 1, Treatment Period 1||0
19919|NCT02106403|47684|P4|NOT COMPLETED|Visit 1, Treatment Period 1||0
19920|NCT02106403|47685|P3|NOT COMPLETED|Visit 1, Treatment Period 1||0
19921|NCT02106403|47686|P2|NOT COMPLETED|Visit 1, Treatment Period 1||0
19922|NCT02106403|47687|P1|NOT COMPLETED|Visit 1, Treatment Period 1||0
19923|NCT02106403|47682|P6|COMPLETED|Visit 1, Treatment Period 1||9
19924|NCT02106403|47683|P5|COMPLETED|Visit 1, Treatment Period 1||8
19925|NCT02106403|47684|P4|COMPLETED|Visit 1, Treatment Period 1||8
19926|NCT02106403|47685|P3|COMPLETED|Visit 1, Treatment Period 1||9
19927|NCT02106403|47686|P2|COMPLETED|Visit 1, Treatment Period 1||8
19928|NCT02106403|47687|P1|COMPLETED|Visit 1, Treatment Period 1||8
19929|NCT02106403|47682|P6|STARTED|Visit 1, Treatment Period 1||9
19930|NCT02106403|47683|P5|STARTED|Visit 1, Treatment Period 1||8
19931|NCT02106403|47684|P4|STARTED|Visit 1, Treatment Period 1||8
19932|NCT02106403|47685|P3|STARTED|Visit 1, Treatment Period 1||9
19933|NCT02106403|47686|P2|STARTED|Visit 1, Treatment Period 1||8
19934|NCT02106403|47687|P1|STARTED|Visit 1, Treatment Period 1||8
19935|NCT02106156|47710|P3|NOT COMPLETED|Overall Study||0
19936|NCT02106156|47711|P2|NOT COMPLETED|Overall Study||40
19937|NCT02106156|47712|P1|NOT COMPLETED|Overall Study||2549
19938|NCT02106156|47710|P3|COMPLETED|Overall Study||518
19939|NCT02106156|47711|P2|COMPLETED|Overall Study||50
19940|NCT02106156|47712|P1|COMPLETED|Overall Study||7071
19941|NCT02106156|47710|P3|STARTED|Overall Study||518
19942|NCT02106156|47711|P2|STARTED|Overall Study||90
19943|NCT02106156|47712|P1|STARTED|Overall Study||9620
19944|NCT02105987|47736|P6|NOT COMPLETED|Continuation Phase||0
19945|NCT02105987|47737|P5|NOT COMPLETED|Continuation Phase||1
19946|NCT02105987|47738|P4|NOT COMPLETED|Continuation Phase||0
19947|NCT02105987|47739|P3|NOT COMPLETED|Continuation Phase||0
19948|NCT02105987|47740|P2|NOT COMPLETED|Continuation Phase||0
19949|NCT02105987|47741|P1|NOT COMPLETED|Continuation Phase||0
19950|NCT02105987|47736|P6|COMPLETED|Continuation Phase||23
19951|NCT02105987|47737|P5|COMPLETED|Continuation Phase||13
19952|NCT02105987|47738|P4|COMPLETED|Continuation Phase||0
19953|NCT02105987|47739|P3|COMPLETED|Continuation Phase||0
19954|NCT02105987|47740|P2|COMPLETED|Continuation Phase||0
19955|NCT02105987|47741|P1|COMPLETED|Continuation Phase||0
19956|NCT02105987|47736|P6|STARTED|Continuation Phase||23
19957|NCT02105987|47737|P5|STARTED|Continuation Phase||14
19958|NCT02105987|47738|P4|STARTED|Continuation Phase||0
19959|NCT02105987|47739|P3|STARTED|Continuation Phase||0
19960|NCT02105987|47740|P2|STARTED|Continuation Phase||0
19961|NCT02105987|47741|P1|STARTED|Continuation Phase||0
19962|NCT02105987|47736|P6|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
19963|NCT02105987|47737|P5|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
19964|NCT02105987|47738|P4|NOT COMPLETED|Late Switch Phase (24 Weeks)||14
19965|NCT02105987|47739|P3|NOT COMPLETED|Late Switch Phase (24 Weeks)||45
19966|NCT02105987|47740|P2|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
19967|NCT02105987|47741|P1|NOT COMPLETED|Late Switch Phase (24 Weeks)||0
19968|NCT02105987|47736|P6|COMPLETED|Late Switch Phase (24 Weeks)||0
19969|NCT02105987|47737|P5|COMPLETED|Late Switch Phase (24 Weeks)||0
19970|NCT02105987|47738|P4|COMPLETED|Late Switch Phase (24 Weeks)||230
19971|NCT02105987|47739|P3|COMPLETED|Late Switch Phase (24 Weeks)||230
19972|NCT02105987|47740|P2|COMPLETED|Late Switch Phase (24 Weeks)||0
19973|NCT02105987|47741|P1|COMPLETED|Late Switch Phase (24 Weeks)||0
19974|NCT02105987|47736|P6|STARTED|Late Switch Phase (24 Weeks)||0
19975|NCT02105987|47737|P5|STARTED|Late Switch Phase (24 Weeks)||0
19976|NCT02105987|47738|P4|STARTED|Late Switch Phase (24 Weeks)||244
19977|NCT02105987|47739|P3|STARTED|Late Switch Phase (24 Weeks)||275
19978|NCT02105987|47740|P2|STARTED|Late Switch Phase (24 Weeks)||0
19979|NCT02105987|47741|P1|STARTED|Late Switch Phase (24 Weeks)||0
19980|NCT02105987|47736|P6|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
19981|NCT02105987|47737|P5|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
19982|NCT02105987|47738|P4|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
19983|NCT02105987|47739|P3|NOT COMPLETED|Early Switch Phase (24 Weeks)||0
19984|NCT02105987|47740|P2|NOT COMPLETED|Early Switch Phase (24 Weeks)||34
19985|NCT02105987|47741|P1|NOT COMPLETED|Early Switch Phase (24 Weeks)||36
19986|NCT02105987|47736|P6|COMPLETED|Early Switch Phase (24 Weeks)||0
19987|NCT02105987|47737|P5|COMPLETED|Early Switch Phase (24 Weeks)||0
19988|NCT02105987|47738|P4|COMPLETED|Early Switch Phase (24 Weeks)||0
19989|NCT02105987|47739|P3|COMPLETED|Early Switch Phase (24 Weeks)||0
19990|NCT02105987|47740|P2|COMPLETED|Early Switch Phase (24 Weeks)||244
19991|NCT02105987|47741|P1|COMPLETED|Early Switch Phase (24 Weeks)||239
19992|NCT02105987|47736|P6|STARTED|Early Switch Phase (24 Weeks)||0
19993|NCT02105987|47737|P5|STARTED|Early Switch Phase (24 Weeks)||0
19994|NCT02105987|47738|P4|STARTED|Early Switch Phase (24 Weeks)||0
19995|NCT02105987|47739|P3|STARTED|Early Switch Phase (24 Weeks)||0
20072|NCT02105467|47882|P2|COMPLETED|Period 1||105
20073|NCT02105467|47883|P1|COMPLETED|Period 1||314
19996|NCT02105987|47740|P2|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|278
19997|NCT02105987|47741|P1|STARTED|Early Switch Phase (24 Weeks)|Number Started represents the number of par. in the Intent-To-Treat Exposed (ITT-E) Population.|275
19998|NCT02105974|47795|P3|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||58
19999|NCT02105974|47796|P2|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||42
20000|NCT02105974|47797|P1|NOT COMPLETED|12 Week (Wk) Treatment Period (TP)||0
20001|NCT02105974|47795|P3|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|756
20002|NCT02105974|47796|P2|COMPLETED|12 Week (Wk) Treatment Period (TP)|Par. completed study if attended visit 7, had follow-up contact and no early withdrawal|764
20003|NCT02105974|47797|P1|COMPLETED|12 Week (Wk) Treatment Period (TP)||0
20004|NCT02105974|47795|P3|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|754
20005|NCT02105974|47796|P2|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)|Par completed TP if attended Visit (V7, Wk12), did not withdraw at V7 and did not stop trt before V7|764
20006|NCT02105974|47797|P1|Completed the Treatment(Trt) Period|12 Week (Wk) Treatment Period (TP)||0
20007|NCT02105974|47795|P3|STARTED|12 Week (Wk) Treatment Period (TP)||814
20008|NCT02105974|47796|P2|STARTED|12 Week (Wk) Treatment Period (TP)||806
20009|NCT02105974|47797|P1|STARTED|12 Week (Wk) Treatment Period (TP)||0
20010|NCT02105974|47795|P3|NOT COMPLETED|2 Week Run-in Period||0
20011|NCT02105974|47796|P2|NOT COMPLETED|2 Week Run-in Period||0
20012|NCT02105974|47797|P1|NOT COMPLETED|2 Week Run-in Period||801
20013|NCT02105974|47795|P3|COMPLETED|2 Week Run-in Period||0
20014|NCT02105974|47796|P2|COMPLETED|2 Week Run-in Period||0
20015|NCT02105974|47797|P1|COMPLETED|2 Week Run-in Period||1622
20016|NCT02105974|47795|P3|STARTED|2 Week Run-in Period||0
20017|NCT02105974|47796|P2|STARTED|2 Week Run-in Period||0
20018|NCT02105974|47797|P1|STARTED|2 Week Run-in Period||2423
20019|NCT02105740|47809|P2|NOT COMPLETED|Overall Study||1
20020|NCT02105740|47810|P1|NOT COMPLETED|Overall Study||0
20021|NCT02105740|47809|P2|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|11
20022|NCT02105740|47810|P1|COMPLETED|Overall Study|Application of EVA and HADS scales and data analysis|12
20023|NCT02105740|47809|P2|Second|Overall Study|Application of EVA and HADS scales. One accompanying lost|11
20024|NCT02105740|47810|P1|Second|Overall Study|Intervention with hypnosis and application of EVA scales and HADS (n = 12)|12
20025|NCT02105740|47809|P2|STARTED|Overall Study|Application of EVA and HADS scales|12
20026|NCT02105740|47810|P1|STARTED|Overall Study|Application of EVA and HADS scales and after that application of hypnosis intervention|12
20027|NCT02105701|47822|P4|NOT COMPLETED|Overall Study||2
20028|NCT02105701|47823|P3|NOT COMPLETED|Overall Study||3
20029|NCT02105701|47824|P2|NOT COMPLETED|Overall Study||1
20030|NCT02105701|47825|P1|NOT COMPLETED|Overall Study||4
20031|NCT02105701|47822|P4|COMPLETED|Overall Study||104
20032|NCT02105701|47823|P3|COMPLETED|Overall Study||102
20033|NCT02105701|47824|P2|COMPLETED|Overall Study||103
20034|NCT02105701|47825|P1|COMPLETED|Overall Study||101
20035|NCT02105701|47822|P4|STARTED|Overall Study||106
20036|NCT02105701|47823|P3|STARTED|Overall Study||105
20037|NCT02105701|47824|P2|STARTED|Overall Study||104
20038|NCT02105701|47825|P1|STARTED|Overall Study||105
20039|NCT02105688|47849|P2|NOT COMPLETED|Overall Study||99
20040|NCT02105688|47850|P1|NOT COMPLETED|Overall Study||26
20041|NCT02105688|47849|P2|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|1
20042|NCT02105688|47850|P1|COMPLETED|Overall Study|Completed means participant completed Follow-Up Week 24 visit|175
20043|NCT02105688|47849|P2|Not Reached FU Week 12 Visit|Overall Study||15
20044|NCT02105688|47850|P1|Not Reached FU Week 12 Visit|Overall Study||2
20045|NCT02105688|47849|P2|Completed FU Week 12 Visit, Still in FU|Overall Study||75
20046|NCT02105688|47850|P1|Completed FU Week 12 Visit, Still in FU|Overall Study||10
20047|NCT02105688|47849|P2|STARTED|Overall Study||100
20048|NCT02105688|47850|P1|STARTED|Overall Study||201
20049|NCT02105662|47860|P1|NOT COMPLETED|Overall Study||6
20050|NCT02105662|47860|P1|COMPLETED|Overall Study||212
20051|NCT02105662|47860|P1|STARTED|Overall Study||218
20052|NCT02105636|47869|P2|NOT COMPLETED|Overall Study||108
20053|NCT02105636|47870|P1|NOT COMPLETED|Overall Study||195
20054|NCT02105636|47869|P2|COMPLETED|Overall Study|Completed=Still on Treatment|3
20055|NCT02105636|47870|P1|COMPLETED|Overall Study|Completed=Still on Treatment|41
20056|NCT02105636|47869|P2|STARTED|Overall Study||111
20057|NCT02105636|47870|P1|STARTED|Overall Study||236
20058|NCT02105467|47882|P2|NOT COMPLETED|Period 3||1
20059|NCT02105467|47883|P1|NOT COMPLETED|Period 3||0
20060|NCT02105467|47882|P2|COMPLETED|Period 3||102
20061|NCT02105467|47883|P1|COMPLETED|Period 3||0
20062|NCT02105467|47882|P2|STARTED|Period 3|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|103
20063|NCT02105467|47883|P1|STARTED|Period 3|The Immediate Treatment Group completed the study with Period 2|0
20064|NCT02105467|47882|P2|NOT COMPLETED|Period 2||2
20065|NCT02105467|47883|P1|NOT COMPLETED|Period 2||2
20066|NCT02105467|47882|P2|COMPLETED|Period 2||102
20067|NCT02105467|47883|P1|COMPLETED|Period 2||312
20068|NCT02105467|47882|P2|STARTED|Period 2|One participant did not receive deferred treatment (Period 2) but proceeded directly to Period 3|104
20069|NCT02105467|47883|P1|STARTED|Period 2||314
20070|NCT02105467|47882|P2|NOT COMPLETED|Period 1||0
20071|NCT02105467|47883|P1|NOT COMPLETED|Period 1||2
20074|NCT02105467|47882|P2|STARTED|Period 1||105
20075|NCT02105467|47883|P1|STARTED|Period 1||316
20076|NCT02105454|47895|P1|NOT COMPLETED|Overall Study||1
20077|NCT02105454|47895|P1|COMPLETED|Overall Study||78
20078|NCT02105454|47895|P1|STARTED|Overall Study||79
20079|NCT02105285|47905|P3|NOT COMPLETED|Overall Study||0
20080|NCT02105285|47906|P2|NOT COMPLETED|Overall Study||2
20081|NCT02105285|47907|P1|NOT COMPLETED|Overall Study||2
20082|NCT02105285|47905|P3|COMPLETED|Overall Study||37
20083|NCT02105285|47906|P2|COMPLETED|Overall Study||76
20084|NCT02105285|47907|P1|COMPLETED|Overall Study||76
20085|NCT02105285|47905|P3|STARTED|Overall Study||37
20086|NCT02105285|47906|P2|STARTED|Overall Study||78
20087|NCT02105285|47907|P1|STARTED|Overall Study||78
20088|NCT02105272|47926|P2|NOT COMPLETED|Overall Study||3
20089|NCT02105272|47927|P1|NOT COMPLETED|Overall Study||5
20090|NCT02105272|47926|P2|COMPLETED|Overall Study||116
20091|NCT02105272|47927|P1|COMPLETED|Overall Study||113
20092|NCT02105272|47926|P2|STARTED|Overall Study||119
20093|NCT02105272|47927|P1|STARTED|Overall Study||118
20094|NCT02105012|47943|P1|NOT COMPLETED|Overall Study||33
20095|NCT02105012|47943|P1|COMPLETED|Overall Study||114
20096|NCT02105012|47943|P1|Placebo MDI|Overall Study||127
20097|NCT02105012|47943|P1|BD MDI 40 µg|Overall Study||63
20098|NCT02105012|47943|P1|BD MDI 80 µg|Overall Study||64
20099|NCT02105012|47943|P1|BD MDI 160 µg|Overall Study||132
20100|NCT02105012|47943|P1|BD MDI 320 µg|Overall Study||124
20101|NCT02105012|47943|P1|STARTED|Overall Study||147
20102|NCT02104947|47977|P2|NOT COMPLETED|Overall Study||56
20103|NCT02104947|47978|P1|NOT COMPLETED|Overall Study||79
20104|NCT02104947|47977|P2|COMPLETED|Overall Study||146
20105|NCT02104947|47978|P1|COMPLETED|Overall Study||222
20106|NCT02104947|47977|P2|STARTED|Overall Study||202
20107|NCT02104947|47978|P1|STARTED|Overall Study||301
20108|NCT02104895|47996|P2|NOT COMPLETED|Overall Study||14
20109|NCT02104895|47997|P1|NOT COMPLETED|Overall Study||0
20110|NCT02104895|47996|P2|COMPLETED|Overall Study||246
20111|NCT02104895|47997|P1|COMPLETED|Overall Study||260
20112|NCT02104895|47996|P2|STARTED|Overall Study||260
20113|NCT02104895|47997|P1|STARTED|Overall Study||260
20114|NCT02104830|48010|P3|NOT COMPLETED|Overall Study||7
20115|NCT02104830|48011|P2|NOT COMPLETED|Overall Study||7
20116|NCT02104830|48012|P1|NOT COMPLETED|Overall Study||4
20117|NCT02104830|48010|P3|COMPLETED|Overall Study||36
20118|NCT02104830|48011|P2|COMPLETED|Overall Study||36
20119|NCT02104830|48012|P1|COMPLETED|Overall Study||38
20120|NCT02104830|48010|P3|STARTED|Overall Study||43
20121|NCT02104830|48011|P2|STARTED|Overall Study||43
20122|NCT02104830|48012|P1|STARTED|Overall Study||42
20123|NCT02104219|48035|P1|NOT COMPLETED|Overall Study||0
20124|NCT02104219|48035|P1|COMPLETED|Overall Study||32
20125|NCT02104219|48035|P1|STARTED|Overall Study||32
20126|NCT02103855|48042|P1|NOT COMPLETED|Overall Study||2
20127|NCT02103855|48042|P1|COMPLETED|Overall Study||4
20128|NCT02103855|48042|P1|STARTED|Overall Study||6
20129|NCT02103439|48052|P2|NOT COMPLETED|Overall Study||3
20130|NCT02103439|48053|P1|NOT COMPLETED|Overall Study||3
20131|NCT02103439|48052|P2|COMPLETED|Overall Study||67
20132|NCT02103439|48053|P1|COMPLETED|Overall Study||67
20133|NCT02103439|48052|P2|STARTED|Overall Study||70
20134|NCT02103439|48053|P1|STARTED|Overall Study||70
20135|NCT02103309|48073|P2|NOT COMPLETED|Overall Study||0
20136|NCT02103309|48074|P1|NOT COMPLETED|Overall Study||0
20137|NCT02103309|48073|P2|COMPLETED|Overall Study||22
20138|NCT02103309|48074|P1|COMPLETED|Overall Study||20
20139|NCT02103309|48073|P2|STARTED|Overall Study||22
20140|NCT02103309|48074|P1|STARTED|Overall Study||20
20141|NCT02103114|48088|P2|NOT COMPLETED|Overall Study||1
20142|NCT02103114|48089|P1|NOT COMPLETED|Overall Study||0
20143|NCT02103114|48088|P2|COMPLETED|Overall Study||19
20144|NCT02103114|48089|P1|COMPLETED|Overall Study||20
20145|NCT02103114|48088|P2|STARTED|Overall Study||20
20146|NCT02103114|48089|P1|STARTED|Overall Study||20
20147|NCT02103062|48145|P2|NOT COMPLETED|Overall Study||23
20148|NCT02103062|48146|P1|NOT COMPLETED|Overall Study||18
20149|NCT02103062|48145|P2|COMPLETED|Overall Study||0
20150|NCT02103062|48146|P1|COMPLETED|Overall Study||0
20151|NCT02103062|48145|P2|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|20
20152|NCT02103062|48146|P1|Intent to Treat Population|Overall Study|Includes participants who met all eligibility criteria and received at least one dose of study drug.|17
20153|NCT02103062|48145|P2|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|23
20154|NCT02103062|48146|P1|Safety Population|Overall Study|Includes participants who received at least one dose of study drug.|18
20155|NCT02103062|48145|P2|STARTED|Overall Study||23
20156|NCT02103062|48146|P1|STARTED|Overall Study||18
20157|NCT02102932|48172|P8|NOT COMPLETED|Overall Study||0
20158|NCT02102932|48173|P7|NOT COMPLETED|Overall Study||0
20159|NCT02102932|48174|P6|NOT COMPLETED|Overall Study||0
20160|NCT02102932|48175|P5|NOT COMPLETED|Overall Study||0
20161|NCT02102932|48176|P4|NOT COMPLETED|Overall Study||0
20162|NCT02102932|48177|P3|NOT COMPLETED|Overall Study||0
20163|NCT02102932|48178|P2|NOT COMPLETED|Overall Study||0
20164|NCT02102932|48179|P1|NOT COMPLETED|Overall Study||0
20165|NCT02102932|48172|P8|COMPLETED|Overall Study||12
20166|NCT02102932|48173|P7|COMPLETED|Overall Study||12
20167|NCT02102932|48174|P6|COMPLETED|Overall Study||12
20168|NCT02102932|48175|P5|COMPLETED|Overall Study||12
20169|NCT02102932|48176|P4|COMPLETED|Overall Study||12
20170|NCT02102932|48177|P3|COMPLETED|Overall Study||12
20171|NCT02102932|48178|P2|COMPLETED|Overall Study||12
20172|NCT02102932|48179|P1|COMPLETED|Overall Study||12
20173|NCT02102932|48172|P8|STARTED|Overall Study||12
20174|NCT02102932|48173|P7|STARTED|Overall Study||12
20175|NCT02102932|48174|P6|STARTED|Overall Study||12
20176|NCT02102932|48175|P5|STARTED|Overall Study||12
20177|NCT02102932|48176|P4|STARTED|Overall Study||12
20178|NCT02102932|48177|P3|STARTED|Overall Study||12
20179|NCT02102932|48178|P2|STARTED|Overall Study||12
20180|NCT02102932|48179|P1|STARTED|Overall Study||12
20181|NCT02102399|48239|P2|NOT COMPLETED|Overall Study||4
20182|NCT02102399|48240|P1|NOT COMPLETED|Overall Study||6
20183|NCT02102399|48239|P2|COMPLETED|Overall Study||17
20184|NCT02102399|48240|P1|COMPLETED|Overall Study||14
20185|NCT02102399|48239|P2|STARTED|Overall Study||21
20186|NCT02102399|48240|P1|STARTED|Overall Study||20
20187|NCT02101359|48290|P2|NOT COMPLETED|Overall Study||19
20188|NCT02101359|48291|P1|NOT COMPLETED|Overall Study||29
20189|NCT02101359|48290|P2|COMPLETED|Overall Study||277
20190|NCT02101359|48291|P1|COMPLETED|Overall Study||266
20191|NCT02101359|48290|P2|STARTED|Overall Study||296
20192|NCT02101359|48291|P1|STARTED|Overall Study||295
20193|NCT02101294|48297|P1|NOT COMPLETED|Overall Study||11
20194|NCT02101294|48297|P1|COMPLETED|Overall Study||20
20195|NCT02101294|48297|P1|STARTED|Overall Study||31
20196|NCT02101190|48306|P2|NOT COMPLETED|Overall Study||0
20197|NCT02101190|48307|P1|NOT COMPLETED|Overall Study||0
20198|NCT02101190|48306|P2|COMPLETED|Overall Study||8
20199|NCT02101190|48307|P1|COMPLETED|Overall Study||8
20200|NCT02101190|48306|P2|STARTED|Overall Study||8
20201|NCT02101190|48307|P1|STARTED|Overall Study||8
20202|NCT02101112|48317|P6|NOT COMPLETED|Overall Study||0
20203|NCT02101112|48318|P5|NOT COMPLETED|Overall Study||1
20204|NCT02101112|48319|P4|NOT COMPLETED|Overall Study||0
20205|NCT02101112|48320|P3|NOT COMPLETED|Overall Study||1
20206|NCT02101112|48321|P2|NOT COMPLETED|Overall Study||0
20207|NCT02101112|48322|P1|NOT COMPLETED|Overall Study||0
20208|NCT02101112|48317|P6|COMPLETED|Overall Study||5
20209|NCT02101112|48318|P5|COMPLETED|Overall Study||5
20210|NCT02101112|48319|P4|COMPLETED|Overall Study||5
20211|NCT02101112|48320|P3|COMPLETED|Overall Study||5
20212|NCT02101112|48321|P2|COMPLETED|Overall Study||5
20213|NCT02101112|48322|P1|COMPLETED|Overall Study||6
20214|NCT02101112|48317|P6|STARTED|Overall Study||5
20215|NCT02101112|48318|P5|STARTED|Overall Study||6
20216|NCT02101112|48319|P4|STARTED|Overall Study||5
20217|NCT02101112|48320|P3|STARTED|Overall Study||6
20218|NCT02101112|48321|P2|STARTED|Overall Study||5
20219|NCT02101112|48322|P1|STARTED|Overall Study||6
20220|NCT02101008|48347|P1|NOT COMPLETED|Overall Study||0
20221|NCT02101008|48347|P1|COMPLETED|Overall Study||12
20222|NCT02101008|48347|P1|STARTED|Overall Study||12
20223|NCT02100839|48354|P2|NOT COMPLETED|Multiple Ascending Dose||0
20224|NCT02100839|48355|P1|NOT COMPLETED|Multiple Ascending Dose||4
20225|NCT02100839|48354|P2|COMPLETED|Multiple Ascending Dose||3
20226|NCT02100839|48355|P1|COMPLETED|Multiple Ascending Dose||9
20227|NCT02100839|48354|P2|STARTED|Multiple Ascending Dose||3
20228|NCT02100839|48355|P1|STARTED|Multiple Ascending Dose||13
20229|NCT02100839|48354|P2|NOT COMPLETED|Single Ascending Dose||0
20230|NCT02100839|48355|P1|NOT COMPLETED|Single Ascending Dose||0
20231|NCT02100839|48354|P2|COMPLETED|Single Ascending Dose||12
20232|NCT02100839|48355|P1|COMPLETED|Single Ascending Dose||24
20233|NCT02100839|48354|P2|STARTED|Single Ascending Dose||12
20234|NCT02100839|48355|P1|STARTED|Single Ascending Dose||24
20235|NCT02100826|48367|P2|NOT COMPLETED|Period 2 (7 Days)||0
20236|NCT02100826|48368|P1|NOT COMPLETED|Period 2 (7 Days)||0
20237|NCT02100826|48367|P2|COMPLETED|Period 2 (7 Days)||14
20238|NCT02100826|48368|P1|COMPLETED|Period 2 (7 Days)||14
20239|NCT02100826|48367|P2|STARTED|Period 2 (7 Days)||14
20240|NCT02100826|48368|P1|STARTED|Period 2 (7 Days)||14
20241|NCT02100826|48367|P2|NOT COMPLETED|Washout Period (1 Day)||0
20242|NCT02100826|48368|P1|NOT COMPLETED|Washout Period (1 Day)||0
20243|NCT02100826|48367|P2|COMPLETED|Washout Period (1 Day)||14
20244|NCT02100826|48368|P1|COMPLETED|Washout Period (1 Day)||14
20245|NCT02100826|48367|P2|STARTED|Washout Period (1 Day)||14
20246|NCT02100826|48368|P1|STARTED|Washout Period (1 Day)||14
20247|NCT02100826|48367|P2|NOT COMPLETED|Period 1 (7 Days)||0
20248|NCT02100826|48368|P1|NOT COMPLETED|Period 1 (7 Days)||0
20249|NCT02100826|48367|P2|COMPLETED|Period 1 (7 Days)||14
20250|NCT02100826|48368|P1|COMPLETED|Period 1 (7 Days)||14
20251|NCT02100826|48367|P2|STARTED|Period 1 (7 Days)||14
20252|NCT02100826|48368|P1|STARTED|Period 1 (7 Days)||14
20253|NCT02100644|48378|P3|NOT COMPLETED|LTG and VPA Maintenance Phase||0
20254|NCT02100644|48379|P2|NOT COMPLETED|LTG and VPA Maintenance Phase||0
20255|NCT02100644|48380|P1|NOT COMPLETED|LTG and VPA Maintenance Phase||0
20256|NCT02100644|48378|P3|COMPLETED|LTG and VPA Maintenance Phase||20
20257|NCT02100644|48379|P2|COMPLETED|LTG and VPA Maintenance Phase||0
20258|NCT02100644|48380|P1|COMPLETED|LTG and VPA Maintenance Phase||0
20259|NCT02100644|48378|P3|STARTED|LTG and VPA Maintenance Phase||20
20260|NCT02100644|48379|P2|STARTED|LTG and VPA Maintenance Phase||0
20261|NCT02100644|48380|P1|STARTED|LTG and VPA Maintenance Phase||0
20262|NCT02100644|48378|P3|NOT COMPLETED|VPA Reduction Phase||0
20263|NCT02100644|48379|P2|NOT COMPLETED|VPA Reduction Phase||0
20264|NCT02100644|48380|P1|NOT COMPLETED|VPA Reduction Phase||0
20265|NCT02100644|48378|P3|COMPLETED|VPA Reduction Phase||0
20266|NCT02100644|48379|P2|COMPLETED|VPA Reduction Phase||20
20267|NCT02100644|48380|P1|COMPLETED|VPA Reduction Phase||0
20268|NCT02100644|48378|P3|STARTED|VPA Reduction Phase||0
20269|NCT02100644|48379|P2|STARTED|VPA Reduction Phase||20
20270|NCT02100644|48380|P1|STARTED|VPA Reduction Phase||0
20271|NCT02100644|48378|P3|NOT COMPLETED|LTG Escalation Phase||0
20272|NCT02100644|48379|P2|NOT COMPLETED|LTG Escalation Phase||0
20273|NCT02100644|48380|P1|NOT COMPLETED|LTG Escalation Phase||13
20274|NCT02100644|48378|P3|COMPLETED|LTG Escalation Phase||0
20275|NCT02100644|48379|P2|COMPLETED|LTG Escalation Phase||0
20276|NCT02100644|48380|P1|COMPLETED|LTG Escalation Phase||20
20277|NCT02100644|48378|P3|STARTED|LTG Escalation Phase||0
20278|NCT02100644|48379|P2|STARTED|LTG Escalation Phase||0
20279|NCT02100644|48380|P1|STARTED|LTG Escalation Phase||33
20280|NCT02100579|48392|P2|NOT COMPLETED|Overall Study||0
20281|NCT02100579|48393|P1|NOT COMPLETED|Overall Study||0
20282|NCT02100579|48392|P2|COMPLETED|Overall Study||20
20283|NCT02100579|48393|P1|COMPLETED|Overall Study||20
20284|NCT02100579|48392|P2|STARTED|Overall Study||20
20285|NCT02100579|48393|P1|STARTED|Overall Study||20
20286|NCT02100514|48405|P2|NOT COMPLETED|Overall Study||74
20287|NCT02100514|48406|P1|NOT COMPLETED|Overall Study||29
20288|NCT02100514|48405|P2|COMPLETED|Overall Study||425
20289|NCT02100514|48406|P1|COMPLETED|Overall Study||218
20290|NCT02100514|48405|P2|STARTED|Overall Study||499
20291|NCT02100514|48406|P1|STARTED|Overall Study||247
20292|NCT02100475|48466|P2|NOT COMPLETED|Overall Study||2
20293|NCT02100475|48467|P1|NOT COMPLETED|Overall Study||2
20294|NCT02100475|48466|P2|COMPLETED|Overall Study||13
20295|NCT02100475|48467|P1|COMPLETED|Overall Study||14
20296|NCT02100475|48466|P2|STARTED|Overall Study||15
20297|NCT02100475|48467|P1|STARTED|Overall Study||16
20298|NCT02100410|48477|P6|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
20299|NCT02100410|48478|P5|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
20300|NCT02100410|48479|P4|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
20301|NCT02100410|48480|P3|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
20302|NCT02100410|48481|P2|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
20303|NCT02100410|48482|P1|NOT COMPLETED|Exposure Pair 3, 30 Minutes||0
20304|NCT02100410|48477|P6|COMPLETED|Exposure Pair 3, 30 Minutes||9
20305|NCT02100410|48478|P5|COMPLETED|Exposure Pair 3, 30 Minutes||8
20306|NCT02100410|48479|P4|COMPLETED|Exposure Pair 3, 30 Minutes||8
20307|NCT02100410|48480|P3|COMPLETED|Exposure Pair 3, 30 Minutes||8
20308|NCT02100410|48481|P2|COMPLETED|Exposure Pair 3, 30 Minutes||8
20309|NCT02100410|48482|P1|COMPLETED|Exposure Pair 3, 30 Minutes||8
20310|NCT02100410|48477|P6|STARTED|Exposure Pair 3, 30 Minutes||9
20311|NCT02100410|48478|P5|STARTED|Exposure Pair 3, 30 Minutes||8
20312|NCT02100410|48479|P4|STARTED|Exposure Pair 3, 30 Minutes||8
20313|NCT02100410|48480|P3|STARTED|Exposure Pair 3, 30 Minutes||8
20314|NCT02100410|48481|P2|STARTED|Exposure Pair 3, 30 Minutes||8
20315|NCT02100410|48482|P1|STARTED|Exposure Pair 3, 30 Minutes||8
20316|NCT02100410|48477|P6|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
20317|NCT02100410|48478|P5|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
20318|NCT02100410|48479|P4|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
20319|NCT02100410|48480|P3|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
20320|NCT02100410|48481|P2|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
20321|NCT02100410|48482|P1|NOT COMPLETED|Exposure Pair 2, 30 Minutes||0
20322|NCT02100410|48477|P6|COMPLETED|Exposure Pair 2, 30 Minutes||9
20323|NCT02100410|48478|P5|COMPLETED|Exposure Pair 2, 30 Minutes||8
20324|NCT02100410|48479|P4|COMPLETED|Exposure Pair 2, 30 Minutes||8
20325|NCT02100410|48480|P3|COMPLETED|Exposure Pair 2, 30 Minutes||8
20326|NCT02100410|48481|P2|COMPLETED|Exposure Pair 2, 30 Minutes||8
20327|NCT02100410|48482|P1|COMPLETED|Exposure Pair 2, 30 Minutes||8
20328|NCT02100410|48477|P6|STARTED|Exposure Pair 2, 30 Minutes||9
20329|NCT02100410|48478|P5|STARTED|Exposure Pair 2, 30 Minutes||8
20330|NCT02100410|48479|P4|STARTED|Exposure Pair 2, 30 Minutes||8
20331|NCT02100410|48480|P3|STARTED|Exposure Pair 2, 30 Minutes||8
20332|NCT02100410|48481|P2|STARTED|Exposure Pair 2, 30 Minutes||8
20333|NCT02100410|48482|P1|STARTED|Exposure Pair 2, 30 Minutes||8
20334|NCT02100410|48477|P6|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
20335|NCT02100410|48478|P5|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
20336|NCT02100410|48479|P4|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
20337|NCT02100410|48480|P3|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
20338|NCT02100410|48481|P2|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
20339|NCT02100410|48482|P1|NOT COMPLETED|Exposure Pair 1, 30 Minutes||0
20340|NCT02100410|48477|P6|COMPLETED|Exposure Pair 1, 30 Minutes||9
20341|NCT02100410|48478|P5|COMPLETED|Exposure Pair 1, 30 Minutes||8
20342|NCT02100410|48479|P4|COMPLETED|Exposure Pair 1, 30 Minutes||8
20343|NCT02100410|48480|P3|COMPLETED|Exposure Pair 1, 30 Minutes||8
20344|NCT02100410|48481|P2|COMPLETED|Exposure Pair 1, 30 Minutes||8
20345|NCT02100410|48482|P1|COMPLETED|Exposure Pair 1, 30 Minutes||8
20346|NCT02100410|48477|P6|STARTED|Exposure Pair 1, 30 Minutes||9
20347|NCT02100410|48478|P5|STARTED|Exposure Pair 1, 30 Minutes||8
20348|NCT02100410|48479|P4|STARTED|Exposure Pair 1, 30 Minutes||8
20349|NCT02100410|48480|P3|STARTED|Exposure Pair 1, 30 Minutes||8
20350|NCT02100410|48481|P2|STARTED|Exposure Pair 1, 30 Minutes||8
20351|NCT02100410|48482|P1|STARTED|Exposure Pair 1, 30 Minutes||8
20352|NCT02100189|48498|P1|NOT COMPLETED|Overall Study||0
20353|NCT02100189|48498|P1|COMPLETED|Overall Study||50
20354|NCT02100189|48498|P1|STARTED|Overall Study||50
20355|NCT02099838|48507|P2|NOT COMPLETED|Overall Study||2
20356|NCT02099838|48508|P1|NOT COMPLETED|Overall Study||4
20357|NCT02099838|48507|P2|COMPLETED|Overall Study||49
20358|NCT02099838|48508|P1|COMPLETED|Overall Study||43
20359|NCT02099838|48507|P2|STARTED|Overall Study||51
20360|NCT02099838|48508|P1|STARTED|Overall Study||47
20361|NCT02099708|48538|P1|NOT COMPLETED|Overall Study||200
20362|NCT02099708|48538|P1|COMPLETED|Overall Study||3302
20363|NCT02099708|48538|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3302
20364|NCT02099708|48538|P1|STARTED|Overall Study|Number of cases.|3502
20365|NCT02099682|48549|P1|NOT COMPLETED|Overall Study||111
20366|NCT02099682|48549|P1|COMPLETED|Overall Study||3255
20367|NCT02099682|48549|P1|Safety Analysis Set (SAS)|Overall Study|All participants who took the study drug at least once.|3255
20368|NCT02099682|48549|P1|STARTED|Overall Study|Number of cases.|3366
20369|NCT02099461|48563|P3|NOT COMPLETED|Overall Study||0
20370|NCT02099461|48564|P2|NOT COMPLETED|Overall Study||0
20371|NCT02099461|48565|P1|NOT COMPLETED|Overall Study||0
20372|NCT02099461|48563|P3|COMPLETED|Overall Study||28
20373|NCT02099461|48564|P2|COMPLETED|Overall Study||27
20374|NCT02099461|48565|P1|COMPLETED|Overall Study||27
20375|NCT02099461|48563|P3|STARTED|Overall Study||28
20376|NCT02099461|48564|P2|STARTED|Overall Study||27
20377|NCT02099461|48565|P1|STARTED|Overall Study||27
20378|NCT02099344|48575|P2|NOT COMPLETED|Overall Study||0
20379|NCT02099344|48576|P1|NOT COMPLETED|Overall Study||1
20380|NCT02099344|48575|P2|COMPLETED|Overall Study||0
20381|NCT02099344|48576|P1|COMPLETED|Overall Study||0
20382|NCT02099344|48575|P2|STARTED|Overall Study||0
20383|NCT02099344|48576|P1|STARTED|Overall Study||1
20384|NCT02099318|48584|P2|NOT COMPLETED|Overall Study||0
20385|NCT02099318|48585|P1|NOT COMPLETED|Overall Study||0
20386|NCT02099318|48584|P2|COMPLETED|Overall Study||20
20387|NCT02099318|48585|P1|COMPLETED|Overall Study||20
20388|NCT02099318|48584|P2|STARTED|Overall Study||20
20389|NCT02099318|48585|P1|STARTED|Overall Study||20
20390|NCT02099266|48599|P1|NOT COMPLETED|Overall Study||0
20391|NCT02099266|48599|P1|COMPLETED|Overall Study||15
20392|NCT02099266|48599|P1|STARTED|Overall Study||15
20393|NCT02099084|48606|P2|NOT COMPLETED|Second Intervention||0
20394|NCT02099084|48607|P1|NOT COMPLETED|Second Intervention||0
20395|NCT02099084|48606|P2|COMPLETED|Second Intervention||4
20396|NCT02099084|48607|P1|COMPLETED|Second Intervention||4
20397|NCT02099084|48606|P2|STARTED|Second Intervention||4
20398|NCT02099084|48607|P1|STARTED|Second Intervention||4
20399|NCT02099084|48606|P2|NOT COMPLETED|Washout Period of 14 Days||0
20400|NCT02099084|48607|P1|NOT COMPLETED|Washout Period of 14 Days||0
20401|NCT02099084|48606|P2|COMPLETED|Washout Period of 14 Days||4
20402|NCT02099084|48607|P1|COMPLETED|Washout Period of 14 Days||4
20403|NCT02099084|48606|P2|STARTED|Washout Period of 14 Days||4
20404|NCT02099084|48607|P1|STARTED|Washout Period of 14 Days||4
20405|NCT02099084|48606|P2|NOT COMPLETED|First Intervention||0
20406|NCT02099084|48607|P1|NOT COMPLETED|First Intervention||0
20407|NCT02099084|48606|P2|COMPLETED|First Intervention||4
20408|NCT02099084|48607|P1|COMPLETED|First Intervention||4
20409|NCT02099084|48606|P2|STARTED|First Intervention||4
20410|NCT02099084|48607|P1|STARTED|First Intervention||4
20411|NCT02099006|48625|P1|NOT COMPLETED|Overall Study||1
20412|NCT02099006|48625|P1|COMPLETED|Overall Study||8
20413|NCT02099006|48625|P1|Received Gabapentin|Overall Study||8
20414|NCT02099006|48625|P1|Received Ketamine|Overall Study||6
20415|NCT02099006|48625|P1|Received Loperamide|Overall Study||7
20416|NCT02099006|48625|P1|Received Ketoprofen|Overall Study||3
20417|NCT02099006|48625|P1|Received Amitriptyline/ Baclofen|Overall Study||7
20418|NCT02099006|48625|P1|Received Placebo|Overall Study||9
20419|NCT02099006|48625|P1|STARTED|Overall Study||9
20420|NCT02098746|48633|P1|NOT COMPLETED|Overall Study||5
20421|NCT02098746|48633|P1|COMPLETED|Overall Study||289
20422|NCT02098746|48633|P1|STARTED|Overall Study||294
20423|NCT02098733|48641|P1|NOT COMPLETED|Overall Study||10
20424|NCT02098733|48641|P1|COMPLETED|Overall Study||1158
20425|NCT02098733|48641|P1|STARTED|Overall Study||1168
20426|NCT02098395|48655|P4|NOT COMPLETED|Overall Study||27
20427|NCT02098395|48656|P3|NOT COMPLETED|Overall Study||42
20428|NCT02098395|48657|P2|NOT COMPLETED|Overall Study||32
20429|NCT02098395|48658|P1|NOT COMPLETED|Overall Study||26
20430|NCT02098395|48655|P4|COMPLETED|Overall Study||180
20431|NCT02098395|48656|P3|COMPLETED|Overall Study||165
20432|NCT02098395|48657|P2|COMPLETED|Overall Study||177
20433|NCT02098395|48658|P1|COMPLETED|Overall Study||186
20434|NCT02098395|48655|P4|Exposed|Overall Study||206
20435|NCT02098395|48656|P3|Exposed|Overall Study||206
20436|NCT02098395|48657|P2|Exposed|Overall Study||209
20437|NCT02098395|48658|P1|Exposed|Overall Study||211
20438|NCT02098395|48655|P4|STARTED|Overall Study||207
20439|NCT02098395|48656|P3|STARTED|Overall Study||207
20440|NCT02098395|48657|P2|STARTED|Overall Study||209
20441|NCT02098395|48658|P1|STARTED|Overall Study||212
20442|NCT02098304|48676|P1|NOT COMPLETED|Overall Study||0
20443|NCT02098304|48676|P1|COMPLETED|Overall Study||42
20444|NCT02098304|48676|P1|STARTED|Overall Study||42
20445|NCT02098109|48685|P2|NOT COMPLETED|Overall Study||0
20446|NCT02098109|48686|P1|NOT COMPLETED|Overall Study||3
20447|NCT02098109|48685|P2|COMPLETED|Overall Study||51
20448|NCT02098109|48686|P1|COMPLETED|Overall Study||46
20449|NCT02098109|48685|P2|STARTED|Overall Study||51
20450|NCT02098109|48686|P1|STARTED|Overall Study||49
20451|NCT02097992|48712|P4|NOT COMPLETED|Overall Study||0
20452|NCT02097992|48713|P3|NOT COMPLETED|Overall Study||0
20453|NCT02097992|48714|P2|NOT COMPLETED|Overall Study||0
20454|NCT02097992|48715|P1|NOT COMPLETED|Overall Study||0
20455|NCT02097992|48712|P4|COMPLETED|Overall Study||2
20456|NCT02097992|48713|P3|COMPLETED|Overall Study||4
20457|NCT02097992|48714|P2|COMPLETED|Overall Study||3
20458|NCT02097992|48715|P1|COMPLETED|Overall Study||2
20459|NCT02097992|48712|P4|STARTED|Overall Study||2
20460|NCT02097992|48713|P3|STARTED|Overall Study||4
20461|NCT02097992|48714|P2|STARTED|Overall Study||3
20462|NCT02097992|48715|P1|STARTED|Overall Study||2
20463|NCT02097849|48723|P2|NOT COMPLETED|Overall Study||0
20464|NCT02097849|48724|P1|NOT COMPLETED|Overall Study||0
20465|NCT02097849|48723|P2|COMPLETED|Overall Study||38
20466|NCT02097849|48724|P1|COMPLETED|Overall Study||33
20467|NCT02097849|48723|P2|STARTED|Overall Study||38
20468|NCT02097849|48724|P1|STARTED|Overall Study||33
20469|NCT02097823|48762|P2|NOT COMPLETED|Overall Study||1
20470|NCT02097823|48763|P1|NOT COMPLETED|Overall Study||1
20471|NCT02097823|48762|P2|COMPLETED|Overall Study||3
20472|NCT02097823|48763|P1|COMPLETED|Overall Study||10
20473|NCT02097823|48762|P2|STARTED|Overall Study||4
20474|NCT02097823|48763|P1|STARTED|Overall Study||11
20475|NCT02097745|48778|P1|NOT COMPLETED|Overall Study||178
20476|NCT02097745|48778|P1|COMPLETED|Overall Study||157
20477|NCT02097745|48778|P1|STARTED|Overall Study|Six participants did not receive any treatment and were not included in any analyses.|335
20478|NCT02097719|48802|P2|NOT COMPLETED|Overall Study||1
20479|NCT02097719|48803|P1|NOT COMPLETED|Overall Study||3
20480|NCT02097719|48802|P2|COMPLETED|Overall Study||50
20481|NCT02097719|48803|P1|COMPLETED|Overall Study||46
20482|NCT02097719|48802|P2|STARTED|Overall Study||51
20483|NCT02097719|48803|P1|STARTED|Overall Study||49
20484|NCT02097537|48809|P1|NOT COMPLETED|Overall Study||0
20485|NCT02097537|48809|P1|COMPLETED|Overall Study||10
20486|NCT02097537|48809|P1|Follow-Up|Overall Study||10
20487|NCT02097537|48809|P1|Enrollment|Overall Study|Inhalation of Methacholine Chloride|10
20488|NCT02097537|48809|P1|STARTED|Overall Study||10
20489|NCT02097108|48815|P1|NOT COMPLETED|Overall Study||2
20490|NCT02097108|48815|P1|COMPLETED|Overall Study||9
20491|NCT02097108|48815|P1|STARTED|Overall Study||11
20492|NCT02097056|48822|P1|NOT COMPLETED|Overall Study||58
20493|NCT02097056|48822|P1|COMPLETED|Overall Study||113
20494|NCT02097056|48822|P1|ParticipantsTreated|Overall Study||170
20495|NCT02097056|48822|P1|STARTED|Overall Study||171
20496|NCT02097030|48830|P2|NOT COMPLETED|Second Intervention (3 Days)||0
20497|NCT02097030|48831|P1|NOT COMPLETED|Second Intervention (3 Days)||0
20498|NCT02097030|48830|P2|COMPLETED|Second Intervention (3 Days)||16
20499|NCT02097030|48831|P1|COMPLETED|Second Intervention (3 Days)||14
20500|NCT02097030|48830|P2|STARTED|Second Intervention (3 Days)||16
20501|NCT02097030|48831|P1|STARTED|Second Intervention (3 Days)||14
20502|NCT02097030|48830|P2|NOT COMPLETED|First Intervention (3 Days)||1
20503|NCT02097030|48831|P1|NOT COMPLETED|First Intervention (3 Days)||1
20504|NCT02097030|48830|P2|COMPLETED|First Intervention (3 Days)||16
20505|NCT02097030|48831|P1|COMPLETED|First Intervention (3 Days)||14
20506|NCT02097030|48830|P2|STARTED|First Intervention (3 Days)||17
20507|NCT02097030|48831|P1|STARTED|First Intervention (3 Days)||15
20508|NCT02096900|48894|P2|NOT COMPLETED|Overall Study||2
20509|NCT02096900|48895|P1|NOT COMPLETED|Overall Study||4
20510|NCT02096900|48894|P2|COMPLETED|Overall Study||42
20511|NCT02096900|48895|P1|COMPLETED|Overall Study||38
20512|NCT02096900|48894|P2|STARTED|Overall Study|Allocated to Zolpidem|44
20513|NCT02096900|48895|P1|STARTED|Overall Study|Allocated to Midazolam|42
20514|NCT02096835|48912|P3|NOT COMPLETED|Overall Study||1
20515|NCT02096835|48913|P2|NOT COMPLETED|Overall Study||0
20516|NCT02096835|48914|P1|NOT COMPLETED|Overall Study||3
20517|NCT02096835|48912|P3|COMPLETED|Overall Study||50
20518|NCT02096835|48913|P2|COMPLETED|Overall Study||53
20519|NCT02096835|48914|P1|COMPLETED|Overall Study||50
20520|NCT02096835|48912|P3|STARTED|Overall Study||51
20521|NCT02096835|48913|P2|STARTED|Overall Study||53
20522|NCT02096835|48914|P1|STARTED|Overall Study||53
20523|NCT02096744|48931|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||1
20524|NCT02096744|48932|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
20525|NCT02096744|48931|P2|COMPLETED|Treatment Period 3 (7 Days)||27
20526|NCT02096744|48932|P1|COMPLETED|Treatment Period 3 (7 Days)||28
20527|NCT02096744|48931|P2|STARTED|Treatment Period 3 (7 Days)||28
20528|NCT02096744|48932|P1|STARTED|Treatment Period 3 (7 Days)||28
20529|NCT02096744|48931|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
20530|NCT02096744|48932|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
20531|NCT02096744|48931|P2|COMPLETED|Washout Period 2 (3 Days)||28
20532|NCT02096744|48932|P1|COMPLETED|Washout Period 2 (3 Days)||28
20533|NCT02096744|48931|P2|STARTED|Washout Period 2 (3 Days)||28
20534|NCT02096744|48932|P1|STARTED|Washout Period 2 (3 Days)||28
20535|NCT02096744|48931|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
20536|NCT02096744|48932|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
20537|NCT02096744|48931|P2|COMPLETED|Treatment Period 2 (7 Days)||28
20538|NCT02096744|48932|P1|COMPLETED|Treatment Period 2 (7 Days)||28
20539|NCT02096744|48931|P2|STARTED|Treatment Period 2 (7 Days)||28
20540|NCT02096744|48932|P1|STARTED|Treatment Period 2 (7 Days)||28
20541|NCT02096744|48931|P2|NOT COMPLETED|Washout Period 1(7 Days)||0
20542|NCT02096744|48932|P1|NOT COMPLETED|Washout Period 1(7 Days)||0
20543|NCT02096744|48931|P2|COMPLETED|Washout Period 1(7 Days)||28
20544|NCT02096744|48932|P1|COMPLETED|Washout Period 1(7 Days)||28
20545|NCT02096744|48931|P2|STARTED|Washout Period 1(7 Days)||28
20546|NCT02096744|48932|P1|STARTED|Washout Period 1(7 Days)||28
20547|NCT02096744|48931|P2|NOT COMPLETED|Treatment Period 1(7 Days)||1
20548|NCT02096744|48932|P1|NOT COMPLETED|Treatment Period 1(7 Days)||1
20549|NCT02096744|48931|P2|COMPLETED|Treatment Period 1(7 Days)||28
20550|NCT02096744|48932|P1|COMPLETED|Treatment Period 1(7 Days)||28
20551|NCT02096744|48931|P2|STARTED|Treatment Period 1(7 Days)||29
20552|NCT02096744|48932|P1|STARTED|Treatment Period 1(7 Days)||29
20553|NCT02096731|48947|P2|NOT COMPLETED|Overall Study||0
20554|NCT02096731|48948|P1|NOT COMPLETED|Overall Study||0
20555|NCT02096731|48947|P2|COMPLETED|Overall Study||88955
20556|NCT02096731|48948|P1|COMPLETED|Overall Study||26442
20557|NCT02096731|48947|P2|STARTED|Overall Study||88955
20558|NCT02096731|48948|P1|STARTED|Overall Study||26442
20559|NCT02096718|48965|P3|NOT COMPLETED|Overall Study||0
20560|NCT02096718|48966|P2|NOT COMPLETED|Overall Study||0
20561|NCT02096718|48967|P1|NOT COMPLETED|Overall Study||0
20562|NCT02096718|48965|P3|COMPLETED|Overall Study||14
20563|NCT02096718|48966|P2|COMPLETED|Overall Study||8
20564|NCT02096718|48967|P1|COMPLETED|Overall Study||8
20565|NCT02096718|48965|P3|STARTED|Overall Study||14
20566|NCT02096718|48966|P2|STARTED|Overall Study||8
20567|NCT02096718|48967|P1|STARTED|Overall Study||8
20568|NCT02096705|48986|P2|NOT COMPLETED|Follow-up||4
20569|NCT02096705|48987|P1|NOT COMPLETED|Follow-up||4
20570|NCT02096705|48986|P2|COMPLETED|Follow-up||135
20571|NCT02096705|48987|P1|COMPLETED|Follow-up||125
20572|NCT02096705|48986|P2|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|139
20573|NCT02096705|48987|P1|STARTED|Follow-up|5 participants in this arm did not complete the treatment period and rejoined for follow-up|129
20574|NCT02096705|48986|P2|NOT COMPLETED|Treatment||5
20575|NCT02096705|48987|P1|NOT COMPLETED|Treatment||9
20576|NCT02096705|48986|P2|COMPLETED|Treatment||134
20577|NCT02096705|48987|P1|COMPLETED|Treatment||124
20578|NCT02096705|48986|P2|STARTED|Treatment||139
20579|NCT02096705|48987|P1|STARTED|Treatment||133
20580|NCT02096692|48999|P1|NOT COMPLETED|Overall Study||4
20581|NCT02096692|48999|P1|COMPLETED|Overall Study||150
20582|NCT02096692|48999|P1|STARTED|Overall Study||154
20583|NCT02096679|49005|P1|NOT COMPLETED|Overall Study||0
20584|NCT02096679|49005|P1|COMPLETED|Overall Study||8
20585|NCT02096679|49005|P1|STARTED|Overall Study||8
20586|NCT02096575|49030|P3|NOT COMPLETED|Overall Study||5
20587|NCT02096575|49031|P2|NOT COMPLETED|Overall Study||0
20588|NCT02096575|49032|P1|NOT COMPLETED|Overall Study||0
20589|NCT02096575|49030|P3|COMPLETED|Overall Study||0
20590|NCT02096575|49031|P2|COMPLETED|Overall Study||67
20591|NCT02096575|49032|P1|COMPLETED|Overall Study||68
20592|NCT02096575|49030|P3|STARTED|Overall Study||5
20593|NCT02096575|49031|P2|STARTED|Overall Study||67
20594|NCT02096575|49032|P1|STARTED|Overall Study||68
20595|NCT02096458|49046|P1|NOT COMPLETED|Overall Study||0
20596|NCT02096458|49046|P1|COMPLETED|Overall Study||8
20597|NCT02096458|49046|P1|STARTED|Overall Study||8
20598|NCT02096081|49052|P2|NOT COMPLETED|Overall Study||4
20599|NCT02096081|49053|P1|NOT COMPLETED|Overall Study||3
20600|NCT02096081|49052|P2|COMPLETED|Overall Study||124
20601|NCT02096081|49053|P1|COMPLETED|Overall Study||119
20602|NCT02096081|49052|P2|STARTED|Overall Study||128
20603|NCT02096081|49053|P1|STARTED|Overall Study||122
20604|NCT02095873|49087|P2|NOT COMPLETED|Second Intervention (8 Weeks)||0
20605|NCT02095873|49088|P1|NOT COMPLETED|Second Intervention (8 Weeks)||2
20606|NCT02095873|49087|P2|COMPLETED|Second Intervention (8 Weeks)||16
20607|NCT02095873|49088|P1|COMPLETED|Second Intervention (8 Weeks)||13
20608|NCT02095873|49087|P2|STARTED|Second Intervention (8 Weeks)||16
20609|NCT02095873|49088|P1|STARTED|Second Intervention (8 Weeks)||15
20610|NCT02095873|49087|P2|NOT COMPLETED|First Intervention (8 Weeks)||0
20611|NCT02095873|49088|P1|NOT COMPLETED|First Intervention (8 Weeks)||1
20612|NCT02095873|49087|P2|COMPLETED|First Intervention (8 Weeks)||16
20613|NCT02095873|49088|P1|COMPLETED|First Intervention (8 Weeks)||15
20614|NCT02095873|49087|P2|STARTED|First Intervention (8 Weeks)||16
20615|NCT02095873|49088|P1|STARTED|First Intervention (8 Weeks)||16
20616|NCT02095691|49100|P1|NOT COMPLETED|Overall Study||1
20617|NCT02095691|49100|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months.|18
20706|NCT02094573|49349|P1|COMPLETED|Overall Study||0
20618|NCT02095691|49100|P1|STARTED|Overall Study|Subjects who were consented and treated with study ablation catheter.|19
20619|NCT02095561|49119|P2|NOT COMPLETED|Overall Study||0
20620|NCT02095561|49120|P1|NOT COMPLETED|Overall Study||0
20621|NCT02095561|49119|P2|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|2964
20622|NCT02095561|49120|P1|COMPLETED|Overall Study|All women are part of the study, independently of whether they were tested or not.|3049
20623|NCT02095561|49119|P2|HPV Tested at Health Centers|Overall Study||599
20624|NCT02095561|49120|P1|HPV Tested at Health Centers|Overall Study||99
20625|NCT02095561|49119|P2|HPV Self-tested Women|Overall Study|HPV self-testing only applies to the HPV self-testing arm|0
20626|NCT02095561|49120|P1|HPV Self-tested Women|Overall Study||2519
20627|NCT02095561|49119|P2|Self-testing Acceptability|Overall Study|Acceptablity only applies to the group of women being offered self-testing.|0
20628|NCT02095561|49120|P1|Self-testing Acceptability|Overall Study||2616
20629|NCT02095561|49119|P2|STARTED|Overall Study||2964
20630|NCT02095561|49120|P1|STARTED|Overall Study||3049
20631|NCT02095535|49132|P1|NOT COMPLETED|Analysis||0
20632|NCT02095535|49132|P1|COMPLETED|Analysis||18
20633|NCT02095535|49132|P1|STARTED|Analysis||18
20634|NCT02095535|49132|P1|NOT COMPLETED|Recruitment||2
20635|NCT02095535|49132|P1|COMPLETED|Recruitment||18
20636|NCT02095535|49132|P1|STARTED|Recruitment||20
20637|NCT02095223|49138|P2|NOT COMPLETED|Overall Study||0
20638|NCT02095223|49139|P1|NOT COMPLETED|Overall Study||1
20639|NCT02095223|49138|P2|COMPLETED|Overall Study||2
20640|NCT02095223|49139|P1|COMPLETED|Overall Study|1 participant dropped out of this study due to the time commitment associated with participation.|1
20641|NCT02095223|49138|P2|STARTED|Overall Study||2
20642|NCT02095223|49139|P1|STARTED|Overall Study||2
20643|NCT02095197|49149|P2|NOT COMPLETED|Overall Study||3
20644|NCT02095197|49150|P1|NOT COMPLETED|Overall Study||0
20645|NCT02095197|49149|P2|COMPLETED|Overall Study||36
20646|NCT02095197|49150|P1|COMPLETED|Overall Study||40
20647|NCT02095197|49149|P2|STARTED|Overall Study||39
20648|NCT02095197|49150|P1|STARTED|Overall Study||40
20649|NCT02095158|49162|P1|NOT COMPLETED|Overall Study||75
20650|NCT02095158|49162|P1|COMPLETED|Overall Study||365
20651|NCT02095158|49162|P1|STARTED|Overall Study||440
20652|NCT02094937|49167|P4|NOT COMPLETED|12 Weeks in Period 2||12
20653|NCT02094937|49168|P3|NOT COMPLETED|12 Weeks in Period 2||12
20654|NCT02094937|49169|P2|NOT COMPLETED|12 Weeks in Period 2||11
20655|NCT02094937|49170|P1|NOT COMPLETED|12 Weeks in Period 2||0
20656|NCT02094937|49167|P4|COMPLETED|12 Weeks in Period 2||112
20657|NCT02094937|49168|P3|COMPLETED|12 Weeks in Period 2||112
20658|NCT02094937|49169|P2|COMPLETED|12 Weeks in Period 2||112
20659|NCT02094937|49170|P1|COMPLETED|12 Weeks in Period 2||0
20660|NCT02094937|49167|P4|STARTED|12 Weeks in Period 2||124
20661|NCT02094937|49168|P3|STARTED|12 Weeks in Period 2||124
20662|NCT02094937|49169|P2|STARTED|12 Weeks in Period 2||123
20663|NCT02094937|49170|P1|STARTED|12 Weeks in Period 2||0
20664|NCT02094937|49167|P4|NOT COMPLETED|8 Weeks in Period 1||0
20665|NCT02094937|49168|P3|NOT COMPLETED|8 Weeks in Period 1||0
20666|NCT02094937|49169|P2|NOT COMPLETED|8 Weeks in Period 1||0
20667|NCT02094937|49170|P1|NOT COMPLETED|8 Weeks in Period 1||60
20668|NCT02094937|49167|P4|COMPLETED|8 Weeks in Period 1||0
20669|NCT02094937|49168|P3|COMPLETED|8 Weeks in Period 1||0
20670|NCT02094937|49169|P2|COMPLETED|8 Weeks in Period 1||0
20671|NCT02094937|49170|P1|COMPLETED|8 Weeks in Period 1||370
20672|NCT02094937|49167|P4|STARTED|8 Weeks in Period 1||0
20673|NCT02094937|49168|P3|STARTED|8 Weeks in Period 1||0
20674|NCT02094937|49169|P2|STARTED|8 Weeks in Period 1||0
20675|NCT02094937|49170|P1|STARTED|8 Weeks in Period 1||430
20676|NCT02094898|49200|P1|NOT COMPLETED|Overall Study||5
20677|NCT02094898|49200|P1|COMPLETED|Overall Study||7
20678|NCT02094898|49200|P1|STARTED|Overall Study||12
20679|NCT02094885|49247|P2|NOT COMPLETED|Overall Study||5
20680|NCT02094885|49248|P1|NOT COMPLETED|Overall Study||2
20681|NCT02094885|49247|P2|COMPLETED|Overall Study||122
20682|NCT02094885|49248|P1|COMPLETED|Overall Study||123
20683|NCT02094885|49247|P2|STARTED|Overall Study||127
20684|NCT02094885|49248|P1|STARTED|Overall Study||125
20685|NCT02094677|49262|P2|NOT COMPLETED|Overall Study||1
20686|NCT02094677|49263|P1|NOT COMPLETED|Overall Study||3
20687|NCT02094677|49262|P2|COMPLETED|Overall Study||30
20688|NCT02094677|49263|P1|COMPLETED|Overall Study||40
20689|NCT02094677|49262|P2|STARTED|Overall Study||31
20690|NCT02094677|49263|P1|STARTED|Overall Study||43
20691|NCT02094612|49327|P2|NOT COMPLETED|Overall Study||70
20692|NCT02094612|49328|P1|NOT COMPLETED|Overall Study||79
20693|NCT02094612|49327|P2|COMPLETED|Overall Study||25
20694|NCT02094612|49328|P1|COMPLETED|Overall Study||33
20695|NCT02094612|49327|P2|6 Month Follow up|Overall Study||25
20696|NCT02094612|49328|P1|6 Month Follow up|Overall Study||33
20697|NCT02094612|49327|P2|3 Month Follow up|Overall Study||43
20698|NCT02094612|49328|P1|3 Month Follow up|Overall Study||50
20699|NCT02094612|49327|P2|1 Month Follow up|Overall Study||50
20700|NCT02094612|49328|P1|1 Month Follow up|Overall Study||67
20701|NCT02094612|49327|P2|STARTED|Overall Study||95
20702|NCT02094612|49328|P1|STARTED|Overall Study||112
20703|NCT02094573|49348|P2|NOT COMPLETED|Overall Study||110
20704|NCT02094573|49349|P1|NOT COMPLETED|Overall Study||112
20705|NCT02094573|49348|P2|COMPLETED|Overall Study||0
20707|NCT02094573|49348|P2|Treated|Overall Study||110
20708|NCT02094573|49349|P1|Treated|Overall Study||109
20709|NCT02094573|49348|P2|STARTED|Overall Study||110
20710|NCT02094573|49349|P1|STARTED|Overall Study||112
20711|NCT02094534|49383|P2|NOT COMPLETED|Overall Study||0
20712|NCT02094534|49384|P1|NOT COMPLETED|Overall Study||0
20713|NCT02094534|49383|P2|COMPLETED|Overall Study||10
20714|NCT02094534|49384|P1|COMPLETED|Overall Study||15
20715|NCT02094534|49383|P2|STARTED|Overall Study||10
20716|NCT02094534|49384|P1|STARTED|Overall Study||15
20717|NCT02094443|49394|P2|NOT COMPLETED|Overall Study||17
20718|NCT02094443|49395|P1|NOT COMPLETED|Overall Study||15
20719|NCT02094443|49394|P2|COMPLETED|Overall Study||9
20720|NCT02094443|49395|P1|COMPLETED|Overall Study||11
20721|NCT02094443|49394|P2|Completed at Week 24|Overall Study||8
20722|NCT02094443|49395|P1|Completed at Week 24|Overall Study||11
20723|NCT02094443|49394|P2|Completed at Week 12|Overall Study||1
20724|NCT02094443|49395|P1|Completed at Week 12|Overall Study||0
20725|NCT02094443|49394|P2|STARTED|Overall Study||26
20726|NCT02094443|49395|P1|STARTED|Overall Study||26
20727|NCT02094352|49415|P2|NOT COMPLETED|Overall Study||0
20728|NCT02094352|49416|P1|NOT COMPLETED|Overall Study||0
20729|NCT02094352|49415|P2|COMPLETED|Overall Study||1
20730|NCT02094352|49416|P1|COMPLETED|Overall Study||2
20731|NCT02094352|49415|P2|STARTED|Overall Study||1
20732|NCT02094352|49416|P1|STARTED|Overall Study||2
20733|NCT02094326|49422|P1|NOT COMPLETED|Overall Study||0
20734|NCT02094326|49422|P1|COMPLETED|Overall Study||301
20735|NCT02094326|49422|P1|STARTED|Overall Study||301
20736|NCT02094300|49431|P1|NOT COMPLETED|Overall Study||20
20737|NCT02094300|49431|P1|COMPLETED|Overall Study||6
20738|NCT02094300|49431|P1|30 Days|Overall Study||24
20739|NCT02094300|49431|P1|STARTED|Overall Study||26
20740|NCT02094261|49435|P1|NOT COMPLETED|Overall Study||210
20741|NCT02094261|49435|P1|COMPLETED|Overall Study||0
20742|NCT02094261|49435|P1|STARTED|Overall Study||210
20743|NCT02093962|49444|P2|NOT COMPLETED|Overall Study||131
20744|NCT02093962|49445|P1|NOT COMPLETED|Overall Study||134
20745|NCT02093962|49444|P2|COMPLETED|Overall Study||0
20746|NCT02093962|49445|P1|COMPLETED|Overall Study||0
20747|NCT02093962|49444|P2|STARTED|Overall Study|131 patients randomized, 130 patients treated|131
20748|NCT02093962|49445|P1|STARTED|Overall Study|134 patients randomized, 130 patients treated|134
20749|NCT02093949|49453|P2|NOT COMPLETED|Overall Study||0
20750|NCT02093949|49454|P1|NOT COMPLETED|Overall Study||0
20751|NCT02093949|49453|P2|COMPLETED|Overall Study||47
20752|NCT02093949|49454|P1|COMPLETED|Overall Study||105
20753|NCT02093949|49453|P2|STARTED|Overall Study||47
20754|NCT02093949|49454|P1|STARTED|Overall Study||105
20755|NCT02093923|49477|P5|NOT COMPLETED|Overall Study||0
20756|NCT02093923|49478|P4|NOT COMPLETED|Overall Study||2
20757|NCT02093923|49479|P3|NOT COMPLETED|Overall Study||0
20758|NCT02093923|49480|P2|NOT COMPLETED|Overall Study||0
20759|NCT02093923|49481|P1|NOT COMPLETED|Overall Study||0
20760|NCT02093923|49477|P5|COMPLETED|Overall Study||13
20761|NCT02093923|49478|P4|COMPLETED|Overall Study||10
20762|NCT02093923|49479|P3|COMPLETED|Overall Study||5
20763|NCT02093923|49480|P2|COMPLETED|Overall Study||4
20764|NCT02093923|49481|P1|COMPLETED|Overall Study||4
20765|NCT02093923|49477|P5|Treated - 2 Doses:|Overall Study||13
20766|NCT02093923|49478|P4|Treated - 2 Doses:|Overall Study||10
20767|NCT02093923|49479|P3|Treated - 2 Doses:|Overall Study||5
20768|NCT02093923|49480|P2|Treated - 2 Doses:|Overall Study||4
20769|NCT02093923|49481|P1|Treated - 2 Doses:|Overall Study||4
20770|NCT02093923|49477|P5|Treated - 1 Dose Only:|Overall Study||0
20771|NCT02093923|49478|P4|Treated - 1 Dose Only:|Overall Study||1
20772|NCT02093923|49479|P3|Treated - 1 Dose Only:|Overall Study||0
20773|NCT02093923|49480|P2|Treated - 1 Dose Only:|Overall Study||0
20774|NCT02093923|49481|P1|Treated - 1 Dose Only:|Overall Study||0
20775|NCT02093923|49477|P5|Total Treated|Overall Study||13
20776|NCT02093923|49478|P4|Total Treated|Overall Study||11
20777|NCT02093923|49479|P3|Total Treated|Overall Study||5
20778|NCT02093923|49480|P2|Total Treated|Overall Study||4
20779|NCT02093923|49481|P1|Total Treated|Overall Study||4
20780|NCT02093923|49477|P5|STARTED|Overall Study||13
20781|NCT02093923|49478|P4|STARTED|Overall Study||12
20782|NCT02093923|49479|P3|STARTED|Overall Study||5
20783|NCT02093923|49480|P2|STARTED|Overall Study||4
20784|NCT02093923|49481|P1|STARTED|Overall Study||4
20785|NCT02093897|49536|P1|NOT COMPLETED|Overall Study||19
20786|NCT02093897|49536|P1|COMPLETED|Overall Study||65
20787|NCT02093897|49536|P1|STARTED|Overall Study||84
20788|NCT02093819|49564|P8|NOT COMPLETED|Overall Study||0
20789|NCT02093819|49565|P7|NOT COMPLETED|Overall Study||0
20790|NCT02093819|49566|P6|NOT COMPLETED|Overall Study||0
20791|NCT02093819|49567|P5|NOT COMPLETED|Overall Study||0
20792|NCT02093819|49568|P4|NOT COMPLETED|Overall Study||0
20793|NCT02093819|49569|P3|NOT COMPLETED|Overall Study||0
20794|NCT02093819|49570|P2|NOT COMPLETED|Overall Study||0
20795|NCT02093819|49571|P1|NOT COMPLETED|Overall Study||0
20796|NCT02093819|49564|P8|COMPLETED|Overall Study||6
20797|NCT02093819|49565|P7|COMPLETED|Overall Study||5
20798|NCT02093819|49566|P6|COMPLETED|Overall Study||6
20799|NCT02093819|49567|P5|COMPLETED|Overall Study||6
20800|NCT02093819|49568|P4|COMPLETED|Overall Study||6
20801|NCT02093819|49569|P3|COMPLETED|Overall Study||10
20802|NCT02093819|49570|P2|COMPLETED|Overall Study||6
20803|NCT02093819|49571|P1|COMPLETED|Overall Study||15
20804|NCT02093819|49564|P8|STARTED|Overall Study||6
20805|NCT02093819|49565|P7|STARTED|Overall Study||5
20806|NCT02093819|49566|P6|STARTED|Overall Study||6
20807|NCT02093819|49567|P5|STARTED|Overall Study||6
20808|NCT02093819|49568|P4|STARTED|Overall Study||6
20809|NCT02093819|49569|P3|STARTED|Overall Study||10
20810|NCT02093819|49570|P2|STARTED|Overall Study||6
20811|NCT02093819|49571|P1|STARTED|Overall Study||15
20812|NCT02093702|49607|P2|NOT COMPLETED|Overall Study||0
20813|NCT02093702|49608|P1|NOT COMPLETED|Overall Study||0
20814|NCT02093702|49607|P2|COMPLETED|Overall Study||3
20815|NCT02093702|49608|P1|COMPLETED|Overall Study||2
20816|NCT02093702|49607|P2|STARTED|Overall Study||3
20817|NCT02093702|49608|P1|STARTED|Overall Study||2
20818|NCT02093520|49638|P2|NOT COMPLETED|Overall Study||22
20819|NCT02093520|49639|P1|NOT COMPLETED|Overall Study||6
20820|NCT02093520|49638|P2|COMPLETED|Overall Study||131
20821|NCT02093520|49639|P1|COMPLETED|Overall Study||143
20822|NCT02093520|49638|P2|STARTED|Overall Study||153
20823|NCT02093520|49639|P1|STARTED|Overall Study||149
20824|NCT02093390|49651|P2|NOT COMPLETED|Overall Study||1
20825|NCT02093390|49652|P1|NOT COMPLETED|Overall Study||0
20826|NCT02093390|49651|P2|COMPLETED|Overall Study||19
20827|NCT02093390|49652|P1|COMPLETED|Overall Study||20
20828|NCT02093390|49651|P2|STARTED|Overall Study||20
20829|NCT02093390|49652|P1|STARTED|Overall Study||20
20830|NCT02093351|49691|P3|NOT COMPLETED|Overall Study||3
20831|NCT02093351|49692|P2|NOT COMPLETED|Overall Study||2
20832|NCT02093351|49693|P1|NOT COMPLETED|Overall Study||2
20833|NCT02093351|49691|P3|COMPLETED|Overall Study||23
20834|NCT02093351|49692|P2|COMPLETED|Overall Study||21
20835|NCT02093351|49693|P1|COMPLETED|Overall Study||28
20836|NCT02093351|49691|P3|Completing Treatment Period 3|Overall Study||23
20837|NCT02093351|49692|P2|Completing Treatment Period 3|Overall Study||21
20838|NCT02093351|49693|P1|Completing Treatment Period 3|Overall Study||28
20839|NCT02093351|49691|P3|Completing Treatment Period 2|Overall Study||23
20840|NCT02093351|49692|P2|Completing Treatment Period 2|Overall Study||21
20841|NCT02093351|49693|P1|Completing Treatment Period 2|Overall Study||29
20842|NCT02093351|49691|P3|Completing Treatment Period 1|Overall Study||23
20843|NCT02093351|49692|P2|Completing Treatment Period 1|Overall Study||22
20844|NCT02093351|49693|P1|Completing Treatment Period 1|Overall Study||29
20845|NCT02093351|49691|P3|STARTED|Overall Study||26
20846|NCT02093351|49692|P2|STARTED|Overall Study||23
20847|NCT02093351|49693|P1|STARTED|Overall Study||30
20848|NCT02093234|49725|P3|NOT COMPLETED|Overall Study||4
20849|NCT02093234|49726|P2|NOT COMPLETED|Overall Study||4
20850|NCT02093234|49727|P1|NOT COMPLETED|Overall Study||3
20851|NCT02093234|49725|P3|COMPLETED|Overall Study||50
20852|NCT02093234|49726|P2|COMPLETED|Overall Study||52
20853|NCT02093234|49727|P1|COMPLETED|Overall Study||53
20854|NCT02093234|49725|P3|STARTED|Overall Study||54
20855|NCT02093234|49726|P2|STARTED|Overall Study||56
20856|NCT02093234|49727|P1|STARTED|Overall Study||56
20857|NCT02093026|49744|P1|NOT COMPLETED|Overall Study||193
20858|NCT02093026|49744|P1|COMPLETED|Overall Study|At predefined end-of-treatment date, 272 ongoing participants were designated as completed study.|272
20859|NCT02093026|49744|P1|STARTED|Overall Study||465
20860|NCT02092961|49766|P3|NOT COMPLETED|Overall Study||16
20861|NCT02092961|49767|P2|NOT COMPLETED|Overall Study||14
20862|NCT02092961|49768|P1|NOT COMPLETED|Overall Study||21
20863|NCT02092961|49766|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|13
20864|NCT02092961|49767|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|14
20865|NCT02092961|49768|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|12
20866|NCT02092961|49766|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
20867|NCT02092961|49767|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/study stopped|5
20868|NCT02092961|49768|P1|Randomised But Did Not Receive Treatment|Overall Study|Study stopped|1
20869|NCT02092961|49766|P3|STARTED|Overall Study|Patients who received treatment|29
20870|NCT02092961|49767|P2|STARTED|Overall Study|Patients who received treatment|28
20871|NCT02092961|49768|P1|STARTED|Overall Study|Patients who received treatment|33
20872|NCT02092857|49792|P3|NOT COMPLETED|Overall Study||13
20873|NCT02092857|49793|P2|NOT COMPLETED|Overall Study||12
20874|NCT02092857|49794|P1|NOT COMPLETED|Overall Study||10
20875|NCT02092857|49792|P3|COMPLETED|Overall Study||16
20876|NCT02092857|49793|P2|COMPLETED|Overall Study||18
20877|NCT02092857|49794|P1|COMPLETED|Overall Study||20
20878|NCT02092857|49792|P3|STARTED|Overall Study||29
20879|NCT02092857|49793|P2|STARTED|Overall Study||30
20880|NCT02092857|49794|P1|STARTED|Overall Study||30
20881|NCT02092662|49804|P2|NOT COMPLETED|Overall Study||0
20882|NCT02092662|49805|P1|NOT COMPLETED|Overall Study||13
20883|NCT02092662|49804|P2|COMPLETED|Overall Study||19
20884|NCT02092662|49805|P1|COMPLETED|Overall Study||25
20885|NCT02092662|49804|P2|Recruited|Overall Study||19
20886|NCT02092662|49805|P1|Recruited|Overall Study||38
20887|NCT02092662|49804|P2|STARTED|Overall Study||19
20888|NCT02092662|49805|P1|STARTED|Overall Study||38
20889|NCT02092649|49814|P2|NOT COMPLETED|Overall Study||0
20890|NCT02092649|49815|P1|NOT COMPLETED|Overall Study||0
20891|NCT02092649|49814|P2|COMPLETED|Overall Study|13 participants finished study|13
20892|NCT02092649|49815|P1|COMPLETED|Overall Study|13 participants finished study|13
20893|NCT02092649|49814|P2|STARTED|Overall Study|13 participants recruited|13
20894|NCT02092649|49815|P1|STARTED|Overall Study|13 participants recruited|13
20895|NCT02092610|49833|P2|NOT COMPLETED|Overall Study||12
20896|NCT02092610|49834|P1|NOT COMPLETED|Overall Study||8
20897|NCT02092610|49833|P2|COMPLETED|Overall Study||40
20898|NCT02092610|49834|P1|COMPLETED|Overall Study||17
20899|NCT02092610|49833|P2|STARTED|Overall Study||52
20900|NCT02092610|49834|P1|STARTED|Overall Study||25
20901|NCT02092441|49848|P2|NOT COMPLETED|Overall Study||0
20902|NCT02092441|49849|P1|NOT COMPLETED|Overall Study||0
20903|NCT02092441|49848|P2|COMPLETED|Overall Study||43
20904|NCT02092441|49849|P1|COMPLETED|Overall Study||37
20905|NCT02092441|49848|P2|STARTED|Overall Study||43
20906|NCT02092441|49849|P1|STARTED|Overall Study||37
20907|NCT02092415|49859|P1|NOT COMPLETED|Overall Study||0
20908|NCT02092415|49859|P1|COMPLETED|Overall Study||10
20909|NCT02092415|49859|P1|STARTED|Overall Study||10
20910|NCT02092389|49864|P1|NOT COMPLETED|Overall Study||6
20911|NCT02092389|49864|P1|COMPLETED|Overall Study||4
20912|NCT02092389|49864|P1|STARTED|Overall Study||10
20913|NCT02092350|49876|P2|NOT COMPLETED|Overall Study||12
20914|NCT02092350|49877|P1|NOT COMPLETED|Overall Study||10
20915|NCT02092350|49876|P2|COMPLETED|Overall Study||102
20916|NCT02092350|49877|P1|COMPLETED|Overall Study||113
20917|NCT02092350|49876|P2|STARTED|Overall Study||114
20918|NCT02092350|49877|P1|STARTED|Overall Study||123
20919|NCT02092311|49894|P2|NOT COMPLETED|Overall Study||0
20920|NCT02092311|49895|P1|NOT COMPLETED|Overall Study||0
20921|NCT02092311|49894|P2|COMPLETED|Overall Study||285
20922|NCT02092311|49895|P1|COMPLETED|Overall Study||285
20923|NCT02092311|49894|P2|STARTED|Overall Study||285
20924|NCT02092311|49895|P1|STARTED|Overall Study||285
20925|NCT02092168|49907|P2|NOT COMPLETED|Overall Study||0
20926|NCT02092168|49908|P1|NOT COMPLETED|Overall Study||0
20927|NCT02092168|49907|P2|COMPLETED|Overall Study||12
20928|NCT02092168|49908|P1|COMPLETED|Overall Study||12
20929|NCT02092168|49907|P2|STARTED|Overall Study||12
20930|NCT02092168|49908|P1|STARTED|Overall Study||12
20931|NCT02092116|49920|P2|NOT COMPLETED|Overall Study||4
20932|NCT02092116|49921|P1|NOT COMPLETED|Overall Study||0
20933|NCT02092116|49920|P2|COMPLETED|Overall Study||16
20934|NCT02092116|49921|P1|COMPLETED|Overall Study||6
20935|NCT02092116|49920|P2|STARTED|Overall Study||20
20936|NCT02092116|49921|P1|STARTED|Overall Study||6
20937|NCT02091986|49933|P3|NOT COMPLETED|Overall Study||8
20938|NCT02091986|49934|P2|NOT COMPLETED|Overall Study||11
20939|NCT02091986|49935|P1|NOT COMPLETED|Overall Study||7
20940|NCT02091986|49933|P3|COMPLETED|Overall Study||84
20941|NCT02091986|49934|P2|COMPLETED|Overall Study||84
20942|NCT02091986|49935|P1|COMPLETED|Overall Study||85
20943|NCT02091986|49933|P3|STARTED|Overall Study||92
20944|NCT02091986|49934|P2|STARTED|Overall Study||95
20945|NCT02091986|49935|P1|STARTED|Overall Study||92
20946|NCT02091869|49984|P2|NOT COMPLETED|Overall Study||3
20947|NCT02091869|49985|P1|NOT COMPLETED|Overall Study||0
20948|NCT02091869|49984|P2|COMPLETED|Overall Study||14
20949|NCT02091869|49985|P1|COMPLETED|Overall Study||17
20950|NCT02091869|49984|P2|STARTED|Overall Study||17
20951|NCT02091869|49985|P1|STARTED|Overall Study||17
20952|NCT02091856|50000|P3|NOT COMPLETED|Follow-up Assessment||0
20953|NCT02091856|50001|P2|NOT COMPLETED|Follow-up Assessment||3
20954|NCT02091856|50002|P1|NOT COMPLETED|Follow-up Assessment||5
20955|NCT02091856|50000|P3|COMPLETED|Follow-up Assessment||0
20956|NCT02091856|50001|P2|COMPLETED|Follow-up Assessment||9
20957|NCT02091856|50002|P1|COMPLETED|Follow-up Assessment||10
20958|NCT02091856|50000|P3|STARTED|Follow-up Assessment|WLCG participants were lost at follow-up.|0
20959|NCT02091856|50001|P2|STARTED|Follow-up Assessment|Only a subset of R-CBT participants responded to our request to complete the follow-up assessment.|12
20960|NCT02091856|50002|P1|STARTED|Follow-up Assessment|Only a subset of C-CBT participants responded to our request to complete the follow-up assessment.|15
20961|NCT02091856|50000|P3|NOT COMPLETED|Active Intervention Interval||7
20962|NCT02091856|50001|P2|NOT COMPLETED|Active Intervention Interval||7
20963|NCT02091856|50002|P1|NOT COMPLETED|Active Intervention Interval||19
20964|NCT02091856|50000|P3|COMPLETED|Active Intervention Interval||19
20965|NCT02091856|50001|P2|COMPLETED|Active Intervention Interval||12
20966|NCT02091856|50002|P1|COMPLETED|Active Intervention Interval||15
20967|NCT02091856|50000|P3|STARTED|Active Intervention Interval||26
20968|NCT02091856|50001|P2|STARTED|Active Intervention Interval||19
20969|NCT02091856|50002|P1|STARTED|Active Intervention Interval||34
20970|NCT02091778|50022|P1|NOT COMPLETED|Overall Study||1
20971|NCT02091778|50022|P1|COMPLETED|Overall Study||20
20972|NCT02091778|50022|P1|STARTED|Overall Study||21
20973|NCT02091752|50026|P1|NOT COMPLETED|Overall Study||3
20974|NCT02091752|50026|P1|COMPLETED|Overall Study||0
20975|NCT02091752|50026|P1|STARTED|Overall Study||3
20976|NCT02091726|50037|P1|NOT COMPLETED|Overall Study||6
20977|NCT02091726|50037|P1|COMPLETED|Overall Study||104
20978|NCT02091726|50037|P1|4 Week Followup|Overall Study||104
20979|NCT02091726|50037|P1|1 Week Followup|Overall Study||110
20980|NCT02091726|50037|P1|STARTED|Overall Study||110
20981|NCT02091466|50047|P2|NOT COMPLETED|Overall Study||0
20982|NCT02091466|50048|P1|NOT COMPLETED|Overall Study||0
20983|NCT02091466|50047|P2|COMPLETED|Overall Study||20
20984|NCT02091466|50048|P1|COMPLETED|Overall Study||20
20985|NCT02091466|50047|P2|STARTED|Overall Study||20
20986|NCT02091466|50048|P1|STARTED|Overall Study||20
20987|NCT02091414|50054|P1|NOT COMPLETED|Overall Study||4
20988|NCT02091414|50054|P1|COMPLETED|Overall Study||32
20989|NCT02091414|50054|P1|STARTED|Overall Study||36
20990|NCT02090855|50066|P1|NOT COMPLETED|Overall Study||2
20991|NCT02090855|50066|P1|COMPLETED|Overall Study||106
20992|NCT02090855|50066|P1|STARTED|Overall Study||108
20993|NCT02090777|50073|P1|NOT COMPLETED|Overall Study||0
20994|NCT02090777|50073|P1|COMPLETED|Overall Study||4
20995|NCT02090777|50073|P1|STARTED|Overall Study||4
20996|NCT02090764|50079|P2|NOT COMPLETED|Overall Study||20
20997|NCT02090764|50080|P1|NOT COMPLETED|Overall Study||6
20998|NCT02090764|50079|P2|COMPLETED|Overall Study||186
20999|NCT02090764|50080|P1|COMPLETED|Overall Study||200
21000|NCT02090764|50079|P2|STARTED|Overall Study||206
21001|NCT02090764|50080|P1|STARTED|Overall Study||206
21002|NCT02090413|50089|P3|NOT COMPLETED|Overall Study||23
21003|NCT02090413|50090|P2|NOT COMPLETED|Overall Study||20
21004|NCT02090413|50091|P1|NOT COMPLETED|Overall Study||19
21005|NCT02090413|50089|P3|COMPLETED|Overall Study||57
21006|NCT02090413|50090|P2|COMPLETED|Overall Study||60
21007|NCT02090413|50091|P1|COMPLETED|Overall Study||62
21008|NCT02090413|50089|P3|STARTED|Overall Study||80
21009|NCT02090413|50090|P2|STARTED|Overall Study||80
21010|NCT02090413|50091|P1|STARTED|Overall Study||81
21011|NCT02090088|50165|P1|NOT COMPLETED|Overall Study||0
21012|NCT02090088|50165|P1|COMPLETED|Overall Study||4
21013|NCT02090088|50165|P1|Gave Birth|Overall Study||4
21014|NCT02090088|50165|P1|STARTED|Overall Study||4
21015|NCT02089737|50177|P1|NOT COMPLETED|Overall Study||6
21016|NCT02089737|50177|P1|COMPLETED|Overall Study||3085
21017|NCT02089737|50177|P1|STARTED|Overall Study||3091
21018|NCT02089347|50186|P2|NOT COMPLETED|Overall Study||0
21019|NCT02089347|50187|P1|NOT COMPLETED|Overall Study||1
21020|NCT02089347|50186|P2|COMPLETED|Overall Study||178
21021|NCT02089347|50187|P1|COMPLETED|Overall Study||355
21022|NCT02089347|50186|P2|STARTED|Overall Study||178
21023|NCT02089347|50187|P1|STARTED|Overall Study||356
21024|NCT02089191|50209|P2|NOT COMPLETED|Period 2, Second 12 Hours||0
21025|NCT02089191|50210|P1|NOT COMPLETED|Period 2, Second 12 Hours||0
21026|NCT02089191|50209|P2|COMPLETED|Period 2, Second 12 Hours||15
21027|NCT02089191|50210|P1|COMPLETED|Period 2, Second 12 Hours||15
21028|NCT02089191|50209|P2|STARTED|Period 2, Second 12 Hours||15
21029|NCT02089191|50210|P1|STARTED|Period 2, Second 12 Hours|One participant discontinued between Period 1 and Period 2 due to availability|15
21030|NCT02089191|50209|P2|NOT COMPLETED|Period 1, First 12 Hours||0
21031|NCT02089191|50210|P1|NOT COMPLETED|Period 1, First 12 Hours||0
21032|NCT02089191|50209|P2|COMPLETED|Period 1, First 12 Hours||15
21033|NCT02089191|50210|P1|COMPLETED|Period 1, First 12 Hours||16
21034|NCT02089191|50209|P2|STARTED|Period 1, First 12 Hours||15
21035|NCT02089191|50210|P1|STARTED|Period 1, First 12 Hours||16
21036|NCT02089113|50220|P2|NOT COMPLETED|Overall Study||0
21037|NCT02089113|50221|P1|NOT COMPLETED|Overall Study||1
21038|NCT02089113|50220|P2|COMPLETED|Overall Study||80
21039|NCT02089113|50221|P1|COMPLETED|Overall Study||160
21040|NCT02089113|50220|P2|STARTED|Overall Study||80
21041|NCT02089113|50221|P1|STARTED|Overall Study||161
21042|NCT02088957|50227|P2|NOT COMPLETED|Overall Study||0
21043|NCT02088957|50228|P1|NOT COMPLETED|Overall Study||1
21044|NCT02088957|50227|P2|COMPLETED|Overall Study||0
21045|NCT02088957|50228|P1|COMPLETED|Overall Study||0
21046|NCT02088957|50227|P2|STARTED|Overall Study||0
21047|NCT02088957|50228|P1|STARTED|Overall Study||1
21048|NCT02088177|50244|P1|NOT COMPLETED|Overall Study||3
21049|NCT02088177|50244|P1|COMPLETED|Overall Study||9
21050|NCT02088177|50244|P1|STARTED|Overall Study||12
21051|NCT02087995|50249|P1|NOT COMPLETED|Overall Study||0
21052|NCT02087995|50249|P1|COMPLETED|Overall Study||51
21053|NCT02087995|50249|P1|STARTED|Overall Study||51
21054|NCT02087943|50256|P5|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
21055|NCT02087943|50257|P4|NOT COMPLETED|Observational Follow-up Phase Week 24-30||1
21056|NCT02087943|50258|P3|NOT COMPLETED|Observational Follow-up Phase Week 24-30||3
21057|NCT02087943|50259|P2|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
21058|NCT02087943|50260|P1|NOT COMPLETED|Observational Follow-up Phase Week 24-30||0
21059|NCT02087943|50256|P5|COMPLETED|Observational Follow-up Phase Week 24-30||22
21060|NCT02087943|50257|P4|COMPLETED|Observational Follow-up Phase Week 24-30||23
21061|NCT02087943|50258|P3|COMPLETED|Observational Follow-up Phase Week 24-30||45
21062|NCT02087943|50259|P2|COMPLETED|Observational Follow-up Phase Week 24-30||46
21063|NCT02087943|50260|P1|COMPLETED|Observational Follow-up Phase Week 24-30||0
21064|NCT02087943|50256|P5|STARTED|Observational Follow-up Phase Week 24-30||23
21065|NCT02087943|50257|P4|STARTED|Observational Follow-up Phase Week 24-30||24
21066|NCT02087943|50258|P3|STARTED|Observational Follow-up Phase Week 24-30||48
21067|NCT02087943|50259|P2|STARTED|Observational Follow-up Phase Week 24-30||46
21068|NCT02087943|50260|P1|STARTED|Observational Follow-up Phase Week 24-30||0
21069|NCT02087943|50256|P5|NOT COMPLETED|Active Treatment Phase Week 12-24||2
21070|NCT02087943|50257|P4|NOT COMPLETED|Active Treatment Phase Week 12-24||2
21071|NCT02087943|50258|P3|NOT COMPLETED|Active Treatment Phase Week 12-24||5
21072|NCT02087943|50259|P2|NOT COMPLETED|Active Treatment Phase Week 12-24||4
21073|NCT02087943|50260|P1|NOT COMPLETED|Active Treatment Phase Week 12-24||0
21074|NCT02087943|50256|P5|COMPLETED|Active Treatment Phase Week 12-24||21
21075|NCT02087943|50257|P4|COMPLETED|Active Treatment Phase Week 12-24||22
21076|NCT02087943|50258|P3|COMPLETED|Active Treatment Phase Week 12-24||44
21077|NCT02087943|50259|P2|COMPLETED|Active Treatment Phase Week 12-24||42
21078|NCT02087943|50260|P1|COMPLETED|Active Treatment Phase Week 12-24||0
21079|NCT02087943|50256|P5|STARTED|Active Treatment Phase Week 12-24||23
21080|NCT02087943|50257|P4|STARTED|Active Treatment Phase Week 12-24||24
21081|NCT02087943|50258|P3|STARTED|Active Treatment Phase Week 12-24||49
21082|NCT02087943|50259|P2|STARTED|Active Treatment Phase Week 12-24||46
21083|NCT02087943|50260|P1|STARTED|Active Treatment Phase Week 12-24||0
21084|NCT02087943|50256|P5|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
21085|NCT02087943|50257|P4|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||0
21086|NCT02087943|50258|P3|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||13
21087|NCT02087943|50259|P2|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||12
21088|NCT02087943|50260|P1|NOT COMPLETED|Placebo-Controlled Phase Week 0-12||14
21089|NCT02087943|50256|P5|COMPLETED|Placebo-Controlled Phase Week 0-12||0
21090|NCT02087943|50257|P4|COMPLETED|Placebo-Controlled Phase Week 0-12||0
21091|NCT02087943|50258|P3|COMPLETED|Placebo-Controlled Phase Week 0-12|1 participant who completed week 12 did not enter the active treatment phase.|50
21092|NCT02087943|50259|P2|COMPLETED|Placebo-Controlled Phase Week 0-12||46
21093|NCT02087943|50260|P1|COMPLETED|Placebo-Controlled Phase Week 0-12|3 participants who completed week 12 did not enter the active treatment phase.|50
21094|NCT02087943|50256|P5|Safety Population|Placebo-Controlled Phase Week 0-12||0
21095|NCT02087943|50257|P4|Safety Population|Placebo-Controlled Phase Week 0-12||0
21096|NCT02087943|50258|P3|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|63
21097|NCT02087943|50259|P2|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|58
21098|NCT02087943|50260|P1|Safety Population|Placebo-Controlled Phase Week 0-12|Includes all participants who received at least one dose of study drug.|64
21099|NCT02087943|50256|P5|STARTED|Placebo-Controlled Phase Week 0-12||0
21100|NCT02087943|50257|P4|STARTED|Placebo-Controlled Phase Week 0-12||0
21101|NCT02087943|50258|P3|STARTED|Placebo-Controlled Phase Week 0-12||63
21102|NCT02087943|50259|P2|STARTED|Placebo-Controlled Phase Week 0-12||58
21103|NCT02087943|50260|P1|STARTED|Placebo-Controlled Phase Week 0-12||64
21104|NCT02087774|50286|P2|NOT COMPLETED|Overall Study||20
21105|NCT02087774|50287|P1|NOT COMPLETED|Overall Study||8
21106|NCT02087774|50286|P2|COMPLETED|Overall Study||130
21107|NCT02087774|50287|P1|COMPLETED|Overall Study||142
21108|NCT02087774|50286|P2|STARTED|Overall Study||150
21109|NCT02087774|50287|P1|STARTED|Overall Study||150
21110|NCT02087748|50295|P1|NOT COMPLETED|Overall Study||0
21111|NCT02087748|50295|P1|COMPLETED|Overall Study||24
21112|NCT02087748|50295|P1|STARTED|Overall Study||24
21113|NCT02087670|50307|P2|NOT COMPLETED|Overall Study||2
21114|NCT02087670|50308|P1|NOT COMPLETED|Overall Study||3
21115|NCT02087670|50307|P2|COMPLETED|Overall Study||20
21116|NCT02087670|50308|P1|COMPLETED|Overall Study||17
21117|NCT02087670|50307|P2|STARTED|Overall Study||22
21118|NCT02087670|50308|P1|STARTED|Overall Study||20
21119|NCT02087241|50320|P4|NOT COMPLETED|Overall Study||7
21120|NCT02087241|50321|P3|NOT COMPLETED|Overall Study||1
21121|NCT02087241|50322|P2|NOT COMPLETED|Overall Study||3
21122|NCT02087241|50323|P1|NOT COMPLETED|Overall Study||3
21123|NCT02087241|50320|P4|COMPLETED|Overall Study||0
21124|NCT02087241|50321|P3|COMPLETED|Overall Study||0
21125|NCT02087241|50322|P2|COMPLETED|Overall Study||0
21126|NCT02087241|50323|P1|COMPLETED|Overall Study||0
21127|NCT02087241|50320|P4|STARTED|Overall Study||7
21128|NCT02087241|50321|P3|STARTED|Overall Study||1
21129|NCT02087241|50322|P2|STARTED|Overall Study||3
21130|NCT02087241|50323|P1|STARTED|Overall Study||3
21131|NCT02087176|50349|P1|NOT COMPLETED|Overall Study||32
21132|NCT02087176|50349|P1|COMPLETED|Overall Study|The sponsor terminated the study early.|0
21133|NCT02087176|50349|P1|STARTED|Overall Study||32
21134|NCT02087059|50354|P1|NOT COMPLETED|Overall Study||7
21135|NCT02087059|50354|P1|COMPLETED|Overall Study||44
21136|NCT02087059|50354|P1|STARTED|Overall Study||51
21137|NCT02086786|50364|P2|NOT COMPLETED|Overall Study||16
21138|NCT02086786|50365|P1|NOT COMPLETED|Overall Study||18
21139|NCT02086786|50364|P2|COMPLETED|Overall Study||19
21140|NCT02086786|50365|P1|COMPLETED|Overall Study||17
21141|NCT02086786|50364|P2|STARTED|Overall Study||35
21142|NCT02086786|50365|P1|STARTED|Overall Study||35
21143|NCT02086708|50389|P1|NOT COMPLETED|Overall Study||0
21144|NCT02086708|50389|P1|COMPLETED|Overall Study||24
21145|NCT02086708|50389|P1|STARTED|Overall Study||24
21146|NCT02086591|50401|P1|NOT COMPLETED|Overall Study||5
21147|NCT02086591|50401|P1|COMPLETED|Overall Study||2
21148|NCT02086591|50401|P1|STARTED|Overall Study||7
21149|NCT02085785|50409|P2|NOT COMPLETED|Overall Study||2
21150|NCT02085785|50410|P1|NOT COMPLETED|Overall Study||2
21151|NCT02085785|50409|P2|COMPLETED|Overall Study||6
21152|NCT02085785|50410|P1|COMPLETED|Overall Study||5
21153|NCT02085785|50409|P2|STARTED|Overall Study||8
21154|NCT02085785|50410|P1|STARTED|Overall Study||7
21155|NCT02085720|50422|P1|NOT COMPLETED|Overall Study||0
21156|NCT02085720|50422|P1|COMPLETED|Overall Study||819
21157|NCT02085720|50422|P1|STARTED|Overall Study||819
21158|NCT02085161|50434|P4|NOT COMPLETED|Overall Study||10
21159|NCT02085161|50435|P3|NOT COMPLETED|Overall Study||5
21160|NCT02085161|50436|P2|NOT COMPLETED|Overall Study||10
21161|NCT02085161|50437|P1|NOT COMPLETED|Overall Study||12
21162|NCT02085161|50434|P4|COMPLETED|Overall Study||66
21163|NCT02085161|50435|P3|COMPLETED|Overall Study||71
21164|NCT02085161|50436|P2|COMPLETED|Overall Study||66
21165|NCT02085161|50437|P1|COMPLETED|Overall Study||64
21166|NCT02085161|50434|P4|STARTED|Overall Study||76
21167|NCT02085161|50435|P3|STARTED|Overall Study||76
21168|NCT02085161|50436|P2|STARTED|Overall Study||76
21169|NCT02085161|50437|P1|STARTED|Overall Study||76
21170|NCT02084797|50476|P1|NOT COMPLETED|Overall Study||0
21171|NCT02084797|50476|P1|COMPLETED|Overall Study||10
21172|NCT02084797|50476|P1|STARTED|Overall Study||10
21173|NCT02084706|50485|P2|NOT COMPLETED|Overall Study||0
21174|NCT02084706|50486|P1|NOT COMPLETED|Overall Study||0
21175|NCT02084706|50485|P2|COMPLETED|Overall Study||31
21176|NCT02084706|50486|P1|COMPLETED|Overall Study||29
21177|NCT02084706|50485|P2|STARTED|Overall Study||31
21178|NCT02084706|50486|P1|STARTED|Overall Study||29
21179|NCT02084628|50492|P1|NOT COMPLETED|Overall Study||0
21180|NCT02084628|50492|P1|COMPLETED|Overall Study||1
21181|NCT02084628|50492|P1|STARTED|Overall Study||1
21182|NCT02084238|50505|P1|NOT COMPLETED|Overall Study||2
21183|NCT02084238|50505|P1|COMPLETED|Overall Study||38
21184|NCT02084238|50505|P1|STARTED|Overall Study||40
21185|NCT02084082|50518|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21186|NCT02084082|50519|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21187|NCT02084082|50520|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21188|NCT02084082|50521|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21189|NCT02084082|50518|P4|COMPLETED|Treatment Period 2 (4 Days)||6
21190|NCT02084082|50519|P3|COMPLETED|Treatment Period 2 (4 Days)||7
21191|NCT02084082|50520|P2|COMPLETED|Treatment Period 2 (4 Days)||26
21192|NCT02084082|50521|P1|COMPLETED|Treatment Period 2 (4 Days)||26
21193|NCT02084082|50518|P4|STARTED|Treatment Period 2 (4 Days)||6
21194|NCT02084082|50519|P3|STARTED|Treatment Period 2 (4 Days)||7
21195|NCT02084082|50520|P2|STARTED|Treatment Period 2 (4 Days)||26
21196|NCT02084082|50521|P1|STARTED|Treatment Period 2 (4 Days)||26
21197|NCT02084082|50518|P4|NOT COMPLETED|Washout Period 1 (35 Days)||2
21198|NCT02084082|50519|P3|NOT COMPLETED|Washout Period 1 (35 Days)||1
21199|NCT02084082|50520|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
21200|NCT02084082|50521|P1|NOT COMPLETED|Washout Period 1 (35 Days)||0
21201|NCT02084082|50518|P4|COMPLETED|Washout Period 1 (35 Days)||6
21202|NCT02084082|50519|P3|COMPLETED|Washout Period 1 (35 Days)||7
21203|NCT02084082|50520|P2|COMPLETED|Washout Period 1 (35 Days)||26
21204|NCT02084082|50521|P1|COMPLETED|Washout Period 1 (35 Days)||26
21205|NCT02084082|50518|P4|STARTED|Washout Period 1 (35 Days)||8
21206|NCT02084082|50519|P3|STARTED|Washout Period 1 (35 Days)||8
21207|NCT02084082|50520|P2|STARTED|Washout Period 1 (35 Days)||26
21208|NCT02084082|50521|P1|STARTED|Washout Period 1 (35 Days)||26
21209|NCT02084082|50518|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21210|NCT02084082|50519|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21211|NCT02084082|50520|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21212|NCT02084082|50521|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21213|NCT02084082|50518|P4|COMPLETED|Treatment Period 1 (4 Days)||8
21214|NCT02084082|50519|P3|COMPLETED|Treatment Period 1 (4 Days)||8
21215|NCT02084082|50520|P2|COMPLETED|Treatment Period 1 (4 Days)||26
21216|NCT02084082|50521|P1|COMPLETED|Treatment Period 1 (4 Days)||26
21217|NCT02084082|50518|P4|STARTED|Treatment Period 1 (4 Days)||8
21218|NCT02084082|50519|P3|STARTED|Treatment Period 1 (4 Days)||8
21219|NCT02084082|50520|P2|STARTED|Treatment Period 1 (4 Days)||26
21220|NCT02084082|50521|P1|STARTED|Treatment Period 1 (4 Days)||26
21221|NCT02084069|50553|P2|NOT COMPLETED|Overall Study||0
21222|NCT02084069|50554|P1|NOT COMPLETED|Overall Study||0
21223|NCT02084069|50553|P2|COMPLETED|Overall Study||29
21224|NCT02084069|50554|P1|COMPLETED|Overall Study||29
21225|NCT02084069|50553|P2|STARTED|Overall Study||29
21226|NCT02084069|50554|P1|STARTED|Overall Study||29
21227|NCT02084056|50562|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21228|NCT02084056|50563|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21229|NCT02084056|50564|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21230|NCT02084056|50565|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
21231|NCT02084056|50562|P4|COMPLETED|Treatment Period 2 (4 Days)||8
21232|NCT02084056|50563|P3|COMPLETED|Treatment Period 2 (4 Days)||8
21233|NCT02084056|50564|P2|COMPLETED|Treatment Period 2 (4 Days)||30
21234|NCT02084056|50565|P1|COMPLETED|Treatment Period 2 (4 Days)||26
21235|NCT02084056|50562|P4|STARTED|Treatment Period 2 (4 Days)||8
21236|NCT02084056|50563|P3|STARTED|Treatment Period 2 (4 Days)||8
21237|NCT02084056|50564|P2|STARTED|Treatment Period 2 (4 Days)||30
21238|NCT02084056|50565|P1|STARTED|Treatment Period 2 (4 Days)||26
21239|NCT02084056|50562|P4|NOT COMPLETED|Washout Period 1 (35 Days)||0
21240|NCT02084056|50563|P3|NOT COMPLETED|Washout Period 1 (35 Days)||0
21241|NCT02084056|50564|P2|NOT COMPLETED|Washout Period 1 (35 Days)||0
21242|NCT02084056|50565|P1|NOT COMPLETED|Washout Period 1 (35 Days)||1
21243|NCT02084056|50562|P4|COMPLETED|Washout Period 1 (35 Days)||8
21244|NCT02084056|50563|P3|COMPLETED|Washout Period 1 (35 Days)||8
21245|NCT02084056|50564|P2|COMPLETED|Washout Period 1 (35 Days)||30
21246|NCT02084056|50565|P1|COMPLETED|Washout Period 1 (35 Days)||26
21247|NCT02084056|50562|P4|STARTED|Washout Period 1 (35 Days)||8
21248|NCT02084056|50563|P3|STARTED|Washout Period 1 (35 Days)||8
21249|NCT02084056|50564|P2|STARTED|Washout Period 1 (35 Days)||30
21250|NCT02084056|50565|P1|STARTED|Washout Period 1 (35 Days)||27
21251|NCT02084056|50562|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21252|NCT02084056|50563|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21253|NCT02084056|50564|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
21254|NCT02084056|50565|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||1
21255|NCT02084056|50562|P4|COMPLETED|Treatment Period 1 (4 Days)||8
21256|NCT02084056|50563|P3|COMPLETED|Treatment Period 1 (4 Days)||8
21257|NCT02084056|50564|P2|COMPLETED|Treatment Period 1 (4 Days)||30
21258|NCT02084056|50565|P1|COMPLETED|Treatment Period 1 (4 Days)||27
21259|NCT02084056|50562|P4|STARTED|Treatment Period 1 (4 Days)||8
21260|NCT02084056|50563|P3|STARTED|Treatment Period 1 (4 Days)||8
21261|NCT02084056|50564|P2|STARTED|Treatment Period 1 (4 Days)||30
21262|NCT02084056|50565|P1|STARTED|Treatment Period 1 (4 Days)||28
21263|NCT02083965|50597|P2|NOT COMPLETED|Treatment Period||0
21264|NCT02083965|50598|P1|NOT COMPLETED|Treatment Period||1
21265|NCT02083965|50597|P2|COMPLETED|Treatment Period||8
21266|NCT02083965|50598|P1|COMPLETED|Treatment Period||9
21267|NCT02083965|50597|P2|STARTED|Treatment Period|1 participant completed PK period 1 and 2, then chose to withdraw and did not enter treatment period|8
21268|NCT02083965|50598|P1|STARTED|Treatment Period||10
21269|NCT02083965|50597|P2|NOT COMPLETED|PK Period 2||0
21270|NCT02083965|50598|P1|NOT COMPLETED|PK Period 2||0
21271|NCT02083965|50597|P2|COMPLETED|PK Period 2||9
21272|NCT02083965|50598|P1|COMPLETED|PK Period 2||10
21273|NCT02083965|50597|P2|STARTED|PK Period 2||9
21274|NCT02083965|50598|P1|STARTED|PK Period 2||10
21275|NCT02083965|50597|P2|NOT COMPLETED|Washout Period||0
21276|NCT02083965|50598|P1|NOT COMPLETED|Washout Period||0
21277|NCT02083965|50597|P2|COMPLETED|Washout Period||9
21278|NCT02083965|50598|P1|COMPLETED|Washout Period||10
21279|NCT02083965|50597|P2|STARTED|Washout Period||9
21280|NCT02083965|50598|P1|STARTED|Washout Period||10
21281|NCT02083965|50597|P2|NOT COMPLETED|PK Period 1||0
21282|NCT02083965|50598|P1|NOT COMPLETED|PK Period 1||0
21283|NCT02083965|50597|P2|COMPLETED|PK Period 1||9
21284|NCT02083965|50598|P1|COMPLETED|PK Period 1||10
21285|NCT02083965|50597|P2|STARTED|PK Period 1||9
21286|NCT02083965|50598|P1|STARTED|PK Period 1||10
21287|NCT02083679|50658|P4|NOT COMPLETED|Overall Study||0
21288|NCT02083679|50659|P3|NOT COMPLETED|Overall Study||0
21289|NCT02083679|50660|P2|NOT COMPLETED|Overall Study||0
21290|NCT02083679|50661|P1|NOT COMPLETED|Overall Study||0
21291|NCT02083679|50658|P4|COMPLETED|Overall Study||3
21292|NCT02083679|50659|P3|COMPLETED|Overall Study||3
21293|NCT02083679|50660|P2|COMPLETED|Overall Study||6
21294|NCT02083679|50661|P1|COMPLETED|Overall Study||3
21295|NCT02083679|50658|P4|STARTED|Overall Study||3
21296|NCT02083679|50659|P3|STARTED|Overall Study||3
21297|NCT02083679|50660|P2|STARTED|Overall Study||6
21298|NCT02083679|50661|P1|STARTED|Overall Study||3
21299|NCT02083406|50678|P3|NOT COMPLETED|Overall Study||0
21300|NCT02083406|50679|P2|NOT COMPLETED|Overall Study||0
21301|NCT02083406|50680|P1|NOT COMPLETED|Overall Study||0
21302|NCT02083406|50678|P3|COMPLETED|Overall Study||7
21303|NCT02083406|50679|P2|COMPLETED|Overall Study||8
21304|NCT02083406|50680|P1|COMPLETED|Overall Study||7
21305|NCT02083406|50678|P3|STARTED|Overall Study||7
21306|NCT02083406|50679|P2|STARTED|Overall Study||8
21307|NCT02083406|50680|P1|STARTED|Overall Study||7
21308|NCT02083380|50700|P3|NOT COMPLETED|Overall Study||84
21309|NCT02083380|50701|P2|NOT COMPLETED|Overall Study||95
21310|NCT02083380|50702|P1|NOT COMPLETED|Overall Study||91
21311|NCT02083380|50700|P3|COMPLETED|Overall Study||65
21312|NCT02083380|50701|P2|COMPLETED|Overall Study||56
21313|NCT02083380|50702|P1|COMPLETED|Overall Study||57
21314|NCT02083380|50700|P3|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|149
21315|NCT02083380|50701|P2|STARTED|Overall Study|3 subjects excluded from safety / ITT population - no drug administered|151
21316|NCT02083380|50702|P1|STARTED|Overall Study|5 subjects excluded from safety / ITT population - no drug administered|148
21317|NCT02083263|50797|P2|NOT COMPLETED|Overall Study||0
21318|NCT02083263|50798|P1|NOT COMPLETED|Overall Study||0
21319|NCT02083263|50797|P2|COMPLETED|Overall Study||16
21320|NCT02083263|50798|P1|COMPLETED|Overall Study||16
21321|NCT02083263|50797|P2|STARTED|Overall Study||16
21322|NCT02083263|50798|P1|STARTED|Overall Study||16
21323|NCT02083107|50807|P3|NOT COMPLETED|Overall Study||0
21324|NCT02083107|50808|P2|NOT COMPLETED|Overall Study||0
21325|NCT02083107|50809|P1|NOT COMPLETED|Overall Study||0
21326|NCT02083107|50807|P3|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
21415|NCT02081586|51099|P2|NOT COMPLETED|Overall Study||1
21327|NCT02083107|50808|P2|COMPLETED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
21328|NCT02083107|50809|P1|COMPLETED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
21329|NCT02083107|50807|P3|STARTED|Overall Study|212 women received 2 tablets of Misotac® rectally and 2 placebo tablets sublingually.|212
21330|NCT02083107|50808|P2|STARTED|Overall Study|212 women received 2 tablets of placebo sublingually and 2 placebo tablets rectally.|212
21331|NCT02083107|50809|P1|STARTED|Overall Study|212 women received 2 tablets of Misotac® sublingually and 2 placebo tablets rectally.|212
21332|NCT02082912|50846|P2|NOT COMPLETED|Overall Study||1
21333|NCT02082912|50847|P1|NOT COMPLETED|Overall Study||0
21334|NCT02082912|50846|P2|COMPLETED|Overall Study||6
21335|NCT02082912|50847|P1|COMPLETED|Overall Study||7
21336|NCT02082912|50846|P2|STARTED|Overall Study||7
21337|NCT02082912|50847|P1|STARTED|Overall Study||7
21338|NCT02082769|50856|P3|NOT COMPLETED|Overall Study||36
21339|NCT02082769|50857|P2|NOT COMPLETED|Overall Study||27
21340|NCT02082769|50858|P1|NOT COMPLETED|Overall Study||24
21341|NCT02082769|50856|P3|COMPLETED|Overall Study||132
21342|NCT02082769|50857|P2|COMPLETED|Overall Study||141
21343|NCT02082769|50858|P1|COMPLETED|Overall Study||144
21344|NCT02082769|50856|P3|STARTED|Overall Study||168
21345|NCT02082769|50857|P2|STARTED|Overall Study||168
21346|NCT02082769|50858|P1|STARTED|Overall Study||168
21347|NCT02082392|50874|P2|NOT COMPLETED|Overall Study||0
21348|NCT02082392|50875|P1|NOT COMPLETED|Overall Study||0
21349|NCT02082392|50874|P2|COMPLETED|Overall Study||1
21350|NCT02082392|50875|P1|COMPLETED|Overall Study||2
21351|NCT02082392|50874|P2|STARTED|Overall Study||1
21352|NCT02082392|50875|P1|STARTED|Overall Study||2
21353|NCT02082288|50907|P1|NOT COMPLETED|Overall Study||0
21354|NCT02082288|50907|P1|COMPLETED|Overall Study||243
21355|NCT02082288|50907|P1|STARTED|Overall Study||243
21356|NCT02082262|50911|P1|NOT COMPLETED|Overall Study||51
21357|NCT02082262|50911|P1|COMPLETED|Overall Study||89
21358|NCT02082262|50911|P1|STARTED|Overall Study||140
21359|NCT02082184|50917|P2|NOT COMPLETED|Overall Study||13
21360|NCT02082184|50918|P1|NOT COMPLETED|Overall Study||10
21361|NCT02082184|50917|P2|COMPLETED|Overall Study||62
21362|NCT02082184|50918|P1|COMPLETED|Overall Study||139
21363|NCT02082184|50917|P2|STARTED|Overall Study||75
21364|NCT02082184|50918|P1|STARTED|Overall Study||149
21365|NCT02082158|50943|P6|NOT COMPLETED|Overall Study||7
21366|NCT02082158|50944|P5|NOT COMPLETED|Overall Study||4
21367|NCT02082158|50945|P4|NOT COMPLETED|Overall Study||4
21368|NCT02082158|50946|P3|NOT COMPLETED|Overall Study||14
21369|NCT02082158|50947|P2|NOT COMPLETED|Overall Study||8
21370|NCT02082158|50948|P1|NOT COMPLETED|Overall Study||8
21371|NCT02082158|50943|P6|COMPLETED|Overall Study||56
21372|NCT02082158|50944|P5|COMPLETED|Overall Study||64
21373|NCT02082158|50945|P4|COMPLETED|Overall Study|Includes completion with respirator from secondary randomization after fit-test failure of 1st model|68
21374|NCT02082158|50946|P3|COMPLETED|Overall Study||38
21375|NCT02082158|50947|P2|COMPLETED|Overall Study||53
21376|NCT02082158|50948|P1|COMPLETED|Overall Study||58
21377|NCT02082158|50943|P6|STARTED|Overall Study||63
21378|NCT02082158|50944|P5|STARTED|Overall Study||68
21379|NCT02082158|50945|P4|STARTED|Overall Study||72
21380|NCT02082158|50946|P3|STARTED|Overall Study||52
21381|NCT02082158|50947|P2|STARTED|Overall Study||61
21382|NCT02082158|50948|P1|STARTED|Overall Study||66
21383|NCT02081859|50970|P2|NOT COMPLETED|Overall Study||31
21384|NCT02081859|50971|P1|NOT COMPLETED|Overall Study||34
21385|NCT02081859|50970|P2|COMPLETED|Overall Study||119
21386|NCT02081859|50971|P1|COMPLETED|Overall Study||116
21387|NCT02081859|50970|P2|STARTED|Overall Study||150
21388|NCT02081859|50971|P1|STARTED|Overall Study||150
21389|NCT02081677|50983|P4|NOT COMPLETED|Overall Study||0
21390|NCT02081677|50984|P3|NOT COMPLETED|Overall Study||2
21391|NCT02081677|50985|P2|NOT COMPLETED|Overall Study||1
21392|NCT02081677|50986|P1|NOT COMPLETED|Overall Study||1
21393|NCT02081677|50983|P4|COMPLETED|Overall Study||19
21394|NCT02081677|50984|P3|COMPLETED|Overall Study||17
21395|NCT02081677|50985|P2|COMPLETED|Overall Study||18
21396|NCT02081677|50986|P1|COMPLETED|Overall Study||18
21397|NCT02081677|50983|P4|STARTED|Overall Study||19
21398|NCT02081677|50984|P3|STARTED|Overall Study||19
21399|NCT02081677|50985|P2|STARTED|Overall Study||19
21400|NCT02081677|50986|P1|STARTED|Overall Study||19
21401|NCT02081599|51078|P2|NOT COMPLETED|Period 2：Open-label Period||4
21402|NCT02081599|51079|P1|NOT COMPLETED|Period 2：Open-label Period||6
21403|NCT02081599|51078|P2|COMPLETED|Period 2：Open-label Period||71
21404|NCT02081599|51079|P1|COMPLETED|Period 2：Open-label Period||57
21405|NCT02081599|51078|P2|STARTED|Period 2：Open-label Period||75
21406|NCT02081599|51079|P1|STARTED|Period 2：Open-label Period||63
21407|NCT02081599|51078|P2|NOT COMPLETED|Period 1：Double-blind Period||2
21408|NCT02081599|51079|P1|NOT COMPLETED|Period 1：Double-blind Period||8
21409|NCT02081599|51078|P2|COMPLETED|Period 1：Double-blind Period||75
21410|NCT02081599|51079|P1|COMPLETED|Period 1：Double-blind Period||63
21411|NCT02081599|51078|P2|STARTED|Period 1：Double-blind Period||77
21412|NCT02081599|51079|P1|STARTED|Period 1：Double-blind Period||71
21413|NCT02081586|51097|P4|NOT COMPLETED|Overall Study||1
21414|NCT02081586|51098|P3|NOT COMPLETED|Overall Study||1
21416|NCT02081586|51100|P1|NOT COMPLETED|Overall Study||0
21417|NCT02081586|51097|P4|COMPLETED|Overall Study||2
21418|NCT02081586|51098|P3|COMPLETED|Overall Study||3
21419|NCT02081586|51099|P2|COMPLETED|Overall Study||2
21420|NCT02081586|51100|P1|COMPLETED|Overall Study||3
21421|NCT02081586|51097|P4|STARTED|Overall Study||3
21422|NCT02081586|51098|P3|STARTED|Overall Study||4
21423|NCT02081586|51099|P2|STARTED|Overall Study||3
21424|NCT02081586|51100|P1|STARTED|Overall Study||3
21425|NCT02081443|51129|P2|NOT COMPLETED|Overall Study||0
21426|NCT02081443|51130|P1|NOT COMPLETED|Overall Study||0
21427|NCT02081443|51129|P2|COMPLETED|Overall Study||30
21428|NCT02081443|51130|P1|COMPLETED|Overall Study||30
21429|NCT02081443|51129|P2|STARTED|Overall Study||30
21430|NCT02081443|51130|P1|STARTED|Overall Study||30
21431|NCT02081365|51142|P2|NOT COMPLETED|Overall Study||23
21432|NCT02081365|51143|P1|NOT COMPLETED|Overall Study||30
21433|NCT02081365|51142|P2|COMPLETED|Overall Study||54
21434|NCT02081365|51143|P1|COMPLETED|Overall Study||44
21435|NCT02081365|51142|P2|Received Allocated Intervention|Overall Study||59
21436|NCT02081365|51143|P1|Received Allocated Intervention|Overall Study||46
21437|NCT02081365|51142|P2|STARTED|Overall Study||77
21438|NCT02081365|51143|P1|STARTED|Overall Study||74
21439|NCT02081183|51157|P2|NOT COMPLETED|Overall Study||4
21440|NCT02081183|51158|P1|NOT COMPLETED|Overall Study||4
21441|NCT02081183|51157|P2|COMPLETED|Overall Study||2
21442|NCT02081183|51158|P1|COMPLETED|Overall Study||1
21443|NCT02081183|51157|P2|STARTED|Overall Study||6
21444|NCT02081183|51158|P1|STARTED|Overall Study||5
21445|NCT02081079|51174|P2|NOT COMPLETED|Overall Study||2
21446|NCT02081079|51175|P1|NOT COMPLETED|Overall Study||4
21447|NCT02081079|51174|P2|COMPLETED|Overall Study||39
21448|NCT02081079|51175|P1|COMPLETED|Overall Study||40
21449|NCT02081079|51174|P2|STARTED|Overall Study||41
21450|NCT02081079|51175|P1|STARTED|Overall Study||44
21451|NCT02081014|51197|P6|NOT COMPLETED|Overall Study||0
21452|NCT02081014|51198|P5|NOT COMPLETED|Overall Study||0
21453|NCT02081014|51199|P4|NOT COMPLETED|Overall Study||0
21454|NCT02081014|51200|P3|NOT COMPLETED|Overall Study||0
21455|NCT02081014|51201|P2|NOT COMPLETED|Overall Study||0
21456|NCT02081014|51202|P1|NOT COMPLETED|Overall Study||0
21457|NCT02081014|51197|P6|COMPLETED|Overall Study||2
21458|NCT02081014|51198|P5|COMPLETED|Overall Study||2
21459|NCT02081014|51199|P4|COMPLETED|Overall Study||2
21460|NCT02081014|51200|P3|COMPLETED|Overall Study||2
21461|NCT02081014|51201|P2|COMPLETED|Overall Study||2
21462|NCT02081014|51202|P1|COMPLETED|Overall Study||2
21463|NCT02081014|51197|P6|STARTED|Overall Study||2
21464|NCT02081014|51198|P5|STARTED|Overall Study||2
21465|NCT02081014|51199|P4|STARTED|Overall Study||2
21466|NCT02081014|51200|P3|STARTED|Overall Study||2
21467|NCT02081014|51201|P2|STARTED|Overall Study||2
21468|NCT02081014|51202|P1|STARTED|Overall Study||2
21469|NCT02081001|51248|P12|NOT COMPLETED|Overall Study||0
21470|NCT02081001|51249|P11|NOT COMPLETED|Overall Study||0
21471|NCT02081001|51250|P10|NOT COMPLETED|Overall Study||0
21472|NCT02081001|51251|P9|NOT COMPLETED|Overall Study||0
21473|NCT02081001|51252|P8|NOT COMPLETED|Overall Study||0
21474|NCT02081001|51253|P7|NOT COMPLETED|Overall Study||0
21475|NCT02081001|51254|P6|NOT COMPLETED|Overall Study||0
21476|NCT02081001|51255|P5|NOT COMPLETED|Overall Study||1
21477|NCT02081001|51256|P4|NOT COMPLETED|Overall Study||0
21478|NCT02081001|51257|P3|NOT COMPLETED|Overall Study||0
21479|NCT02081001|51258|P2|NOT COMPLETED|Overall Study||0
21480|NCT02081001|51259|P1|NOT COMPLETED|Overall Study||0
21481|NCT02081001|51248|P12|COMPLETED|Overall Study||1
21482|NCT02081001|51249|P11|COMPLETED|Overall Study||2
21483|NCT02081001|51250|P10|COMPLETED|Overall Study||1
21484|NCT02081001|51251|P9|COMPLETED|Overall Study||2
21485|NCT02081001|51252|P8|COMPLETED|Overall Study||1
21486|NCT02081001|51253|P7|COMPLETED|Overall Study||2
21487|NCT02081001|51254|P6|COMPLETED|Overall Study||1
21488|NCT02081001|51255|P5|COMPLETED|Overall Study||2
21489|NCT02081001|51256|P4|COMPLETED|Overall Study||1
21490|NCT02081001|51257|P3|COMPLETED|Overall Study||2
21491|NCT02081001|51258|P2|COMPLETED|Overall Study||1
21492|NCT02081001|51259|P1|COMPLETED|Overall Study||2
21493|NCT02081001|51248|P12|STARTED|Overall Study||1
21494|NCT02081001|51249|P11|STARTED|Overall Study||2
21495|NCT02081001|51250|P10|STARTED|Overall Study||1
21496|NCT02081001|51251|P9|STARTED|Overall Study||2
21497|NCT02081001|51252|P8|STARTED|Overall Study||1
21498|NCT02081001|51253|P7|STARTED|Overall Study||2
21499|NCT02081001|51254|P6|STARTED|Overall Study||1
21500|NCT02081001|51255|P5|STARTED|Overall Study||3
21501|NCT02081001|51256|P4|STARTED|Overall Study||1
21502|NCT02081001|51257|P3|STARTED|Overall Study||2
21503|NCT02081001|51258|P2|STARTED|Overall Study||1
21504|NCT02081001|51259|P1|STARTED|Overall Study||2
21505|NCT02080780|51323|P1|NOT COMPLETED|Overall Study||0
21506|NCT02080780|51323|P1|COMPLETED|Overall Study||24
21507|NCT02080780|51323|P1|STARTED|Overall Study||24
21508|NCT02080546|51332|P2|NOT COMPLETED|Overall Study||11
21509|NCT02080546|51333|P1|NOT COMPLETED|Overall Study||8
21510|NCT02080546|51332|P2|COMPLETED|Overall Study||52
21511|NCT02080546|51333|P1|COMPLETED|Overall Study||49
21512|NCT02080546|51332|P2|STARTED|Overall Study||63
21513|NCT02080546|51333|P1|STARTED|Overall Study||57
21514|NCT02080507|51343|P2|NOT COMPLETED|Overall Study||0
21515|NCT02080507|51344|P1|NOT COMPLETED|Overall Study||0
21516|NCT02080507|51343|P2|COMPLETED|Overall Study||7
21517|NCT02080507|51344|P1|COMPLETED|Overall Study||5
21518|NCT02080507|51343|P2|STARTED|Overall Study||7
21519|NCT02080507|51344|P1|STARTED|Overall Study||5
21520|NCT02080481|51354|P2|NOT COMPLETED|Overall Study||0
21521|NCT02080481|51355|P1|NOT COMPLETED|Overall Study||1
21522|NCT02080481|51354|P2|COMPLETED|Overall Study||67
21523|NCT02080481|51355|P1|COMPLETED|Overall Study||67
21524|NCT02080481|51354|P2|STARTED|Overall Study||67
21525|NCT02080481|51355|P1|STARTED|Overall Study||68
21526|NCT02080312|51367|P1|NOT COMPLETED|Overall Study||0
21527|NCT02080312|51367|P1|COMPLETED|Overall Study||6
21528|NCT02080312|51367|P1|STARTED|Overall Study||6
21529|NCT02080091|51373|P1|NOT COMPLETED|Overall Study||25
21530|NCT02080091|51373|P1|COMPLETED|Overall Study||0
21531|NCT02080091|51373|P1|STARTED|Overall Study||25
21532|NCT02079844|51382|P3|NOT COMPLETED|Treatment Period 3||0
21533|NCT02079844|51383|P2|NOT COMPLETED|Treatment Period 3||0
21534|NCT02079844|51384|P1|NOT COMPLETED|Treatment Period 3||0
21535|NCT02079844|51382|P3|COMPLETED|Treatment Period 3||5
21536|NCT02079844|51383|P2|COMPLETED|Treatment Period 3||5
21537|NCT02079844|51384|P1|COMPLETED|Treatment Period 3||5
21538|NCT02079844|51382|P3|STARTED|Treatment Period 3||5
21539|NCT02079844|51383|P2|STARTED|Treatment Period 3|1 Participant Voluntarily Withdrew after completing Period 2.|5
21540|NCT02079844|51384|P1|STARTED|Treatment Period 3||5
21541|NCT02079844|51382|P3|NOT COMPLETED|Treatment Period 2||0
21542|NCT02079844|51383|P2|NOT COMPLETED|Treatment Period 2||1
21543|NCT02079844|51384|P1|NOT COMPLETED|Treatment Period 2||0
21544|NCT02079844|51382|P3|COMPLETED|Treatment Period 2||5
21545|NCT02079844|51383|P2|COMPLETED|Treatment Period 2||6
21546|NCT02079844|51384|P1|COMPLETED|Treatment Period 2||5
21547|NCT02079844|51382|P3|STARTED|Treatment Period 2||5
21548|NCT02079844|51383|P2|STARTED|Treatment Period 2||7
21549|NCT02079844|51384|P1|STARTED|Treatment Period 2|1 Participant was withdrawn due to an Adverse Event after completing Period 1.|5
21550|NCT02079844|51382|P3|NOT COMPLETED|Treatment Period 1||2
21551|NCT02079844|51383|P2|NOT COMPLETED|Treatment Period 1||0
21552|NCT02079844|51384|P1|NOT COMPLETED|Treatment Period 1||0
21553|NCT02079844|51382|P3|COMPLETED|Treatment Period 1||5
21554|NCT02079844|51383|P2|COMPLETED|Treatment Period 1||7
21555|NCT02079844|51384|P1|COMPLETED|Treatment Period 1||6
21556|NCT02079844|51382|P3|STARTED|Treatment Period 1||7
21557|NCT02079844|51383|P2|STARTED|Treatment Period 1||7
21558|NCT02079844|51384|P1|STARTED|Treatment Period 1||6
21559|NCT02079805|51442|P2|NOT COMPLETED|Overall Study||2
21560|NCT02079805|51443|P1|NOT COMPLETED|Overall Study||0
21561|NCT02079805|51442|P2|COMPLETED|Overall Study||15
21562|NCT02079805|51443|P1|COMPLETED|Overall Study||16
21563|NCT02079805|51442|P2|STARTED|Overall Study||17
21564|NCT02079805|51443|P1|STARTED|Overall Study||16
21565|NCT02079649|51465|P4|NOT COMPLETED|Overall Study||2
21566|NCT02079649|51466|P3|NOT COMPLETED|Overall Study||1
21567|NCT02079649|51467|P2|NOT COMPLETED|Overall Study||0
21568|NCT02079649|51468|P1|NOT COMPLETED|Overall Study||1
21569|NCT02079649|51465|P4|COMPLETED|Overall Study||38
21570|NCT02079649|51466|P3|COMPLETED|Overall Study||40
21571|NCT02079649|51467|P2|COMPLETED|Overall Study||41
21572|NCT02079649|51468|P1|COMPLETED|Overall Study||41
21573|NCT02079649|51465|P4|Treated|Overall Study||40
21574|NCT02079649|51466|P3|Treated|Overall Study||40
21575|NCT02079649|51467|P2|Treated|Overall Study||41
21576|NCT02079649|51468|P1|Treated|Overall Study||41
21577|NCT02079649|51465|P4|STARTED|Overall Study||40
21578|NCT02079649|51466|P3|STARTED|Overall Study||41
21579|NCT02079649|51467|P2|STARTED|Overall Study||41
21580|NCT02079649|51468|P1|STARTED|Overall Study||42
21581|NCT02079532|51483|P1|NOT COMPLETED|Overall Study||29
21582|NCT02079532|51483|P1|COMPLETED|Overall Study||273
21583|NCT02079532|51483|P1|STARTED|Overall Study||302
21584|NCT02079519|51505|P1|NOT COMPLETED|Overall Study||10
21585|NCT02079519|51505|P1|COMPLETED|Overall Study||0
21586|NCT02079519|51505|P1|STARTED|Overall Study||10
21587|NCT02079311|51511|P2|NOT COMPLETED|Overall Study||1
21588|NCT02079311|51512|P1|NOT COMPLETED|Overall Study||0
21589|NCT02079311|51511|P2|COMPLETED|Overall Study||26
21590|NCT02079311|51512|P1|COMPLETED|Overall Study||28
21591|NCT02079311|51511|P2|STARTED|Overall Study||27
21592|NCT02079311|51512|P1|STARTED|Overall Study||28
21593|NCT02078492|51521|P3|NOT COMPLETED|Overall Study||0
21594|NCT02078492|51522|P2|NOT COMPLETED|Overall Study||0
21595|NCT02078492|51523|P1|NOT COMPLETED|Overall Study||0
21596|NCT02078492|51521|P3|COMPLETED|Overall Study||80
21597|NCT02078492|51522|P2|COMPLETED|Overall Study||80
21598|NCT02078492|51523|P1|COMPLETED|Overall Study||80
21599|NCT02078492|51521|P3|STARTED|Overall Study||80
21600|NCT02078492|51522|P2|STARTED|Overall Study||80
21601|NCT02078492|51523|P1|STARTED|Overall Study||80
21602|NCT02078193|51540|P1|NOT COMPLETED|Overall Study||0
21603|NCT02078193|51540|P1|COMPLETED|Overall Study||3
21604|NCT02078193|51540|P1|STARTED|Overall Study||3
21605|NCT02077374|51548|P2|NOT COMPLETED|Overall Study||2
21606|NCT02077374|51549|P1|NOT COMPLETED|Overall Study||0
21607|NCT02077374|51548|P2|COMPLETED|Overall Study||17
21608|NCT02077374|51549|P1|COMPLETED|Overall Study||19
21609|NCT02077374|51548|P2|STARTED|Overall Study||19
21610|NCT02077374|51549|P1|STARTED|Overall Study||19
21611|NCT02076919|51577|P4|NOT COMPLETED|Overall Study||0
21612|NCT02076919|51578|P3|NOT COMPLETED|Overall Study||0
21613|NCT02076919|51579|P2|NOT COMPLETED|Overall Study||0
21614|NCT02076919|51580|P1|NOT COMPLETED|Overall Study||0
21615|NCT02076919|51577|P4|COMPLETED|Overall Study||12
21616|NCT02076919|51578|P3|COMPLETED|Overall Study||36
21617|NCT02076919|51579|P2|COMPLETED|Overall Study||8
21618|NCT02076919|51580|P1|COMPLETED|Overall Study||24
21619|NCT02076919|51577|P4|STARTED|Overall Study||12
21620|NCT02076919|51578|P3|STARTED|Overall Study||36
21621|NCT02076919|51579|P2|STARTED|Overall Study||8
21622|NCT02076919|51580|P1|STARTED|Overall Study||24
21623|NCT02076334|51682|P4|NOT COMPLETED|Overall Study||1
21624|NCT02076334|51683|P3|NOT COMPLETED|Overall Study||1
21625|NCT02076334|51684|P2|NOT COMPLETED|Overall Study||1
21626|NCT02076334|51685|P1|NOT COMPLETED|Overall Study||1
21627|NCT02076334|51682|P4|COMPLETED|Overall Study||20
21628|NCT02076334|51683|P3|COMPLETED|Overall Study||20
21629|NCT02076334|51684|P2|COMPLETED|Overall Study||20
21630|NCT02076334|51685|P1|COMPLETED|Overall Study||20
21631|NCT02076334|51682|P4|STARTED|Overall Study||21
21632|NCT02076334|51683|P3|STARTED|Overall Study||21
21633|NCT02076334|51684|P2|STARTED|Overall Study||21
21634|NCT02076334|51685|P1|STARTED|Overall Study||21
21635|NCT02076009|51701|P2|NOT COMPLETED|Overall Study||286
21636|NCT02076009|51702|P1|NOT COMPLETED|Overall Study||283
21637|NCT02076009|51701|P2|COMPLETED|Overall Study||0
21638|NCT02076009|51702|P1|COMPLETED|Overall Study||0
21639|NCT02076009|51701|P2|Treated|Overall Study||283
21640|NCT02076009|51702|P1|Treated|Overall Study||281
21641|NCT02076009|51701|P2|STARTED|Overall Study||286
21642|NCT02076009|51702|P1|STARTED|Overall Study||283
21643|NCT02075632|51724|P2|NOT COMPLETED|Overall Study||5
21644|NCT02075632|51725|P1|NOT COMPLETED|Overall Study||1
21645|NCT02075632|51724|P2|COMPLETED|Overall Study||143
21646|NCT02075632|51725|P1|COMPLETED|Overall Study||161
21647|NCT02075632|51724|P2|STARTED|Overall Study||148
21648|NCT02075632|51725|P1|STARTED|Overall Study||162
21649|NCT02075515|51738|P3|NOT COMPLETED|Overall Study||8
21650|NCT02075515|51739|P2|NOT COMPLETED|Overall Study||5
21651|NCT02075515|51740|P1|NOT COMPLETED|Overall Study||4
21652|NCT02075515|51738|P3|COMPLETED|Overall Study||208
21653|NCT02075515|51739|P2|COMPLETED|Overall Study||212
21654|NCT02075515|51740|P1|COMPLETED|Overall Study||214
21655|NCT02075515|51738|P3|STARTED|Overall Study||216
21656|NCT02075515|51739|P2|STARTED|Overall Study||217
21657|NCT02075515|51740|P1|STARTED|Overall Study||218
21658|NCT02075463|51775|P1|NOT COMPLETED|Overall Study||8
21659|NCT02075463|51775|P1|COMPLETED|Overall Study||7
21660|NCT02075463|51775|P1|STARTED|Overall Study||15
21661|NCT02075411|51804|P4|NOT COMPLETED|Overall Study||0
21662|NCT02075411|51805|P3|NOT COMPLETED|Overall Study||0
21663|NCT02075411|51806|P2|NOT COMPLETED|Overall Study||0
21664|NCT02075411|51807|P1|NOT COMPLETED|Overall Study||0
21665|NCT02075411|51804|P4|COMPLETED|Overall Study||1
21666|NCT02075411|51805|P3|COMPLETED|Overall Study||0
21667|NCT02075411|51806|P2|COMPLETED|Overall Study||0
21668|NCT02075411|51807|P1|COMPLETED|Overall Study||0
21669|NCT02075411|51804|P4|STARTED|Overall Study||1
21670|NCT02075411|51805|P3|STARTED|Overall Study||0
21671|NCT02075411|51806|P2|STARTED|Overall Study||0
21672|NCT02075411|51807|P1|STARTED|Overall Study||0
21673|NCT02075125|51827|P2|NOT COMPLETED|Overall Study||1
21674|NCT02075125|51828|P1|NOT COMPLETED|Overall Study||0
21675|NCT02075125|51827|P2|COMPLETED|Overall Study|One patient switched to clopidogrel treatment after 18 days of ticagrelor treatment.|19
21676|NCT02075125|51828|P1|COMPLETED|Overall Study||19
21677|NCT02075125|51827|P2|STARTED|Overall Study||20
21678|NCT02075125|51828|P1|STARTED|Overall Study||19
21679|NCT02075073|51849|P3|NOT COMPLETED|Overall Study||0
21680|NCT02075073|51850|P2|NOT COMPLETED|Overall Study||1
21681|NCT02075073|51851|P1|NOT COMPLETED|Overall Study||0
21682|NCT02075073|51849|P3|COMPLETED|Overall Study||36
21683|NCT02075073|51850|P2|COMPLETED|Overall Study||36
21684|NCT02075073|51851|P1|COMPLETED|Overall Study||36
21685|NCT02075073|51849|P3|STARTED|Overall Study||36
21686|NCT02075073|51850|P2|STARTED|Overall Study||37
21687|NCT02075073|51851|P1|STARTED|Overall Study||36
21688|NCT02075008|51868|P1|NOT COMPLETED|Overall Study||176
21689|NCT02075008|51868|P1|COMPLETED|Overall Study||94
21690|NCT02075008|51868|P1|STARTED|Overall Study||270
21691|NCT02074995|51872|P3|NOT COMPLETED|Overall Study||0
21692|NCT02074995|51873|P2|NOT COMPLETED|Overall Study||0
21693|NCT02074995|51874|P1|NOT COMPLETED|Overall Study||0
21694|NCT02074995|51872|P3|COMPLETED|Overall Study||0
21695|NCT02074995|51873|P2|COMPLETED|Overall Study||0
21696|NCT02074995|51874|P1|COMPLETED|Overall Study||1
21697|NCT02074995|51872|P3|STARTED|Overall Study||0
21698|NCT02074995|51873|P2|STARTED|Overall Study||0
21699|NCT02074995|51874|P1|STARTED|Overall Study||1
21700|NCT02074982|51891|P2|NOT COMPLETED|Overall Study||54
21701|NCT02074982|51892|P1|NOT COMPLETED|Overall Study||51
21702|NCT02074982|51891|P2|COMPLETED|Overall Study||285
21703|NCT02074982|51892|P1|COMPLETED|Overall Study||286
21704|NCT02074982|51891|P2|Safety Set (SF)|Overall Study||336
21705|NCT02074982|51892|P1|Safety Set (SF)|Overall Study||335
21706|NCT02074982|51891|P2|Full Analysis Set (FAS)|Overall Study||339
21707|NCT02074982|51892|P1|Full Analysis Set (FAS)|Overall Study||336
21708|NCT02074982|51891|P2|STARTED|Overall Study||339
21709|NCT02074982|51892|P1|STARTED|Overall Study||337
21710|NCT02074709|51904|P2|NOT COMPLETED|Overall Study||1
21711|NCT02074709|51905|P1|NOT COMPLETED|Overall Study||1
21712|NCT02074709|51904|P2|COMPLETED|Overall Study||29
21713|NCT02074709|51905|P1|COMPLETED|Overall Study||29
21714|NCT02074709|51904|P2|STARTED|Overall Study||30
21715|NCT02074709|51905|P1|STARTED|Overall Study||30
21716|NCT02074553|51913|P8|NOT COMPLETED|Intervention Period 4||0
21717|NCT02074553|51914|P7|NOT COMPLETED|Intervention Period 4||0
21718|NCT02074553|51915|P6|NOT COMPLETED|Intervention Period 4||0
21719|NCT02074553|51916|P5|NOT COMPLETED|Intervention Period 4||0
21720|NCT02074553|51917|P4|NOT COMPLETED|Intervention Period 4||0
21721|NCT02074553|51918|P3|NOT COMPLETED|Intervention Period 4||0
21722|NCT02074553|51919|P2|NOT COMPLETED|Intervention Period 4||0
21723|NCT02074553|51920|P1|NOT COMPLETED|Intervention Period 4||0
21724|NCT02074553|51913|P8|COMPLETED|Intervention Period 4||11
21725|NCT02074553|51914|P7|COMPLETED|Intervention Period 4||11
21726|NCT02074553|51915|P6|COMPLETED|Intervention Period 4||10
21727|NCT02074553|51916|P5|COMPLETED|Intervention Period 4||12
21728|NCT02074553|51917|P4|COMPLETED|Intervention Period 4||11
21729|NCT02074553|51918|P3|COMPLETED|Intervention Period 4||11
21730|NCT02074553|51919|P2|COMPLETED|Intervention Period 4||12
21731|NCT02074553|51920|P1|COMPLETED|Intervention Period 4||11
21732|NCT02074553|51913|P8|STARTED|Intervention Period 4||11
21733|NCT02074553|51914|P7|STARTED|Intervention Period 4||11
21734|NCT02074553|51915|P6|STARTED|Intervention Period 4||10
21735|NCT02074553|51916|P5|STARTED|Intervention Period 4||12
21736|NCT02074553|51917|P4|STARTED|Intervention Period 4||11
21737|NCT02074553|51918|P3|STARTED|Intervention Period 4||11
21738|NCT02074553|51919|P2|STARTED|Intervention Period 4||12
21739|NCT02074553|51920|P1|STARTED|Intervention Period 4||11
21740|NCT02074553|51913|P8|NOT COMPLETED|Washout Period 3||1
21741|NCT02074553|51914|P7|NOT COMPLETED|Washout Period 3||0
21742|NCT02074553|51915|P6|NOT COMPLETED|Washout Period 3||0
21743|NCT02074553|51916|P5|NOT COMPLETED|Washout Period 3||0
21744|NCT02074553|51917|P4|NOT COMPLETED|Washout Period 3||0
21745|NCT02074553|51918|P3|NOT COMPLETED|Washout Period 3||0
21746|NCT02074553|51919|P2|NOT COMPLETED|Washout Period 3||0
21747|NCT02074553|51920|P1|NOT COMPLETED|Washout Period 3||0
21748|NCT02074553|51913|P8|COMPLETED|Washout Period 3||11
21749|NCT02074553|51914|P7|COMPLETED|Washout Period 3||11
21750|NCT02074553|51915|P6|COMPLETED|Washout Period 3||10
21751|NCT02074553|51916|P5|COMPLETED|Washout Period 3||12
21752|NCT02074553|51917|P4|COMPLETED|Washout Period 3||11
21753|NCT02074553|51918|P3|COMPLETED|Washout Period 3||11
21754|NCT02074553|51919|P2|COMPLETED|Washout Period 3||12
21755|NCT02074553|51920|P1|COMPLETED|Washout Period 3||11
21756|NCT02074553|51913|P8|STARTED|Washout Period 3||12
21757|NCT02074553|51914|P7|STARTED|Washout Period 3||11
21758|NCT02074553|51915|P6|STARTED|Washout Period 3||10
21759|NCT02074553|51916|P5|STARTED|Washout Period 3||12
21760|NCT02074553|51917|P4|STARTED|Washout Period 3||11
21761|NCT02074553|51918|P3|STARTED|Washout Period 3||11
21762|NCT02074553|51919|P2|STARTED|Washout Period 3||12
21763|NCT02074553|51920|P1|STARTED|Washout Period 3||11
21764|NCT02074553|51913|P8|NOT COMPLETED|Intervention Period 3||0
21765|NCT02074553|51914|P7|NOT COMPLETED|Intervention Period 3||0
21766|NCT02074553|51915|P6|NOT COMPLETED|Intervention Period 3||0
21767|NCT02074553|51916|P5|NOT COMPLETED|Intervention Period 3||0
21768|NCT02074553|51917|P4|NOT COMPLETED|Intervention Period 3||0
21769|NCT02074553|51918|P3|NOT COMPLETED|Intervention Period 3||0
21770|NCT02074553|51919|P2|NOT COMPLETED|Intervention Period 3||0
21771|NCT02074553|51920|P1|NOT COMPLETED|Intervention Period 3||0
21772|NCT02074553|51913|P8|COMPLETED|Intervention Period 3||12
21773|NCT02074553|51914|P7|COMPLETED|Intervention Period 3||11
21774|NCT02074553|51915|P6|COMPLETED|Intervention Period 3||10
21775|NCT02074553|51916|P5|COMPLETED|Intervention Period 3||12
21776|NCT02074553|51917|P4|COMPLETED|Intervention Period 3||11
21777|NCT02074553|51918|P3|COMPLETED|Intervention Period 3||11
21778|NCT02074553|51919|P2|COMPLETED|Intervention Period 3||12
21779|NCT02074553|51920|P1|COMPLETED|Intervention Period 3||11
21780|NCT02074553|51913|P8|STARTED|Intervention Period 3||12
21781|NCT02074553|51914|P7|STARTED|Intervention Period 3||11
21782|NCT02074553|51915|P6|STARTED|Intervention Period 3||10
21783|NCT02074553|51916|P5|STARTED|Intervention Period 3||12
21784|NCT02074553|51917|P4|STARTED|Intervention Period 3||11
21785|NCT02074553|51918|P3|STARTED|Intervention Period 3||11
21786|NCT02074553|51919|P2|STARTED|Intervention Period 3||12
21787|NCT02074553|51920|P1|STARTED|Intervention Period 3||11
21788|NCT02074553|51913|P8|NOT COMPLETED|Washout Period 2||0
21789|NCT02074553|51914|P7|NOT COMPLETED|Washout Period 2||1
21790|NCT02074553|51915|P6|NOT COMPLETED|Washout Period 2||1
21791|NCT02074553|51916|P5|NOT COMPLETED|Washout Period 2||0
21792|NCT02074553|51917|P4|NOT COMPLETED|Washout Period 2||0
21793|NCT02074553|51918|P3|NOT COMPLETED|Washout Period 2||1
21794|NCT02074553|51919|P2|NOT COMPLETED|Washout Period 2||0
21795|NCT02074553|51920|P1|NOT COMPLETED|Washout Period 2||0
21796|NCT02074553|51913|P8|COMPLETED|Washout Period 2||12
21797|NCT02074553|51914|P7|COMPLETED|Washout Period 2||11
21798|NCT02074553|51915|P6|COMPLETED|Washout Period 2||10
21799|NCT02074553|51916|P5|COMPLETED|Washout Period 2||12
21800|NCT02074553|51917|P4|COMPLETED|Washout Period 2||11
21801|NCT02074553|51918|P3|COMPLETED|Washout Period 2||11
21802|NCT02074553|51919|P2|COMPLETED|Washout Period 2||12
21803|NCT02074553|51920|P1|COMPLETED|Washout Period 2||11
21804|NCT02074553|51913|P8|STARTED|Washout Period 2||12
21805|NCT02074553|51914|P7|STARTED|Washout Period 2||12
21806|NCT02074553|51915|P6|STARTED|Washout Period 2||11
21807|NCT02074553|51916|P5|STARTED|Washout Period 2||12
21808|NCT02074553|51917|P4|STARTED|Washout Period 2||11
21809|NCT02074553|51918|P3|STARTED|Washout Period 2||12
21810|NCT02074553|51919|P2|STARTED|Washout Period 2||12
21811|NCT02074553|51920|P1|STARTED|Washout Period 2||11
21812|NCT02074553|51913|P8|NOT COMPLETED|Intervention Period 2||0
21813|NCT02074553|51914|P7|NOT COMPLETED|Intervention Period 2||0
21814|NCT02074553|51915|P6|NOT COMPLETED|Intervention Period 2||0
21815|NCT02074553|51916|P5|NOT COMPLETED|Intervention Period 2||0
21816|NCT02074553|51917|P4|NOT COMPLETED|Intervention Period 2||0
21817|NCT02074553|51918|P3|NOT COMPLETED|Intervention Period 2||0
21818|NCT02074553|51919|P2|NOT COMPLETED|Intervention Period 2||0
21819|NCT02074553|51920|P1|NOT COMPLETED|Intervention Period 2||0
21820|NCT02074553|51913|P8|COMPLETED|Intervention Period 2||12
21821|NCT02074553|51914|P7|COMPLETED|Intervention Period 2||12
21822|NCT02074553|51915|P6|COMPLETED|Intervention Period 2||11
21823|NCT02074553|51916|P5|COMPLETED|Intervention Period 2||12
21824|NCT02074553|51917|P4|COMPLETED|Intervention Period 2||11
21825|NCT02074553|51918|P3|COMPLETED|Intervention Period 2||12
21826|NCT02074553|51919|P2|COMPLETED|Intervention Period 2||12
21827|NCT02074553|51920|P1|COMPLETED|Intervention Period 2||11
21828|NCT02074553|51913|P8|STARTED|Intervention Period 2||12
21829|NCT02074553|51914|P7|STARTED|Intervention Period 2||12
21830|NCT02074553|51915|P6|STARTED|Intervention Period 2||11
21831|NCT02074553|51916|P5|STARTED|Intervention Period 2||12
21832|NCT02074553|51917|P4|STARTED|Intervention Period 2||11
21833|NCT02074553|51918|P3|STARTED|Intervention Period 2||12
21834|NCT02074553|51919|P2|STARTED|Intervention Period 2||12
21835|NCT02074553|51920|P1|STARTED|Intervention Period 2||11
21836|NCT02074553|51913|P8|NOT COMPLETED|Washout Period 1||0
21837|NCT02074553|51914|P7|NOT COMPLETED|Washout Period 1||0
21838|NCT02074553|51915|P6|NOT COMPLETED|Washout Period 1||1
21839|NCT02074553|51916|P5|NOT COMPLETED|Washout Period 1||0
21840|NCT02074553|51917|P4|NOT COMPLETED|Washout Period 1||1
21841|NCT02074553|51918|P3|NOT COMPLETED|Washout Period 1||0
21842|NCT02074553|51919|P2|NOT COMPLETED|Washout Period 1||0
21843|NCT02074553|51920|P1|NOT COMPLETED|Washout Period 1||1
21844|NCT02074553|51913|P8|COMPLETED|Washout Period 1||12
21845|NCT02074553|51914|P7|COMPLETED|Washout Period 1||12
21846|NCT02074553|51915|P6|COMPLETED|Washout Period 1||11
21847|NCT02074553|51916|P5|COMPLETED|Washout Period 1||12
21848|NCT02074553|51917|P4|COMPLETED|Washout Period 1||11
21849|NCT02074553|51918|P3|COMPLETED|Washout Period 1||12
21850|NCT02074553|51919|P2|COMPLETED|Washout Period 1||12
21851|NCT02074553|51920|P1|COMPLETED|Washout Period 1||11
21852|NCT02074553|51913|P8|STARTED|Washout Period 1||12
21853|NCT02074553|51914|P7|STARTED|Washout Period 1||12
21854|NCT02074553|51915|P6|STARTED|Washout Period 1||12
21855|NCT02074553|51916|P5|STARTED|Washout Period 1||12
21856|NCT02074553|51917|P4|STARTED|Washout Period 1||12
21857|NCT02074553|51918|P3|STARTED|Washout Period 1||12
21858|NCT02074553|51919|P2|STARTED|Washout Period 1||12
21859|NCT02074553|51920|P1|STARTED|Washout Period 1||12
21860|NCT02074553|51913|P8|NOT COMPLETED|Intervention Period 1||0
21861|NCT02074553|51914|P7|NOT COMPLETED|Intervention Period 1||0
21862|NCT02074553|51915|P6|NOT COMPLETED|Intervention Period 1||0
21863|NCT02074553|51916|P5|NOT COMPLETED|Intervention Period 1||0
21864|NCT02074553|51917|P4|NOT COMPLETED|Intervention Period 1||1
21865|NCT02074553|51918|P3|NOT COMPLETED|Intervention Period 1||0
21866|NCT02074553|51919|P2|NOT COMPLETED|Intervention Period 1||0
21867|NCT02074553|51920|P1|NOT COMPLETED|Intervention Period 1||0
21868|NCT02074553|51913|P8|COMPLETED|Intervention Period 1||12
21869|NCT02074553|51914|P7|COMPLETED|Intervention Period 1||12
21870|NCT02074553|51915|P6|COMPLETED|Intervention Period 1||12
21871|NCT02074553|51916|P5|COMPLETED|Intervention Period 1||12
21872|NCT02074553|51917|P4|COMPLETED|Intervention Period 1||12
21873|NCT02074553|51918|P3|COMPLETED|Intervention Period 1||12
21874|NCT02074553|51919|P2|COMPLETED|Intervention Period 1||12
21875|NCT02074553|51920|P1|COMPLETED|Intervention Period 1||12
21876|NCT02074553|51913|P8|STARTED|Intervention Period 1||12
21877|NCT02074553|51914|P7|STARTED|Intervention Period 1||12
21878|NCT02074553|51915|P6|STARTED|Intervention Period 1||12
21879|NCT02074553|51916|P5|STARTED|Intervention Period 1||12
21880|NCT02074553|51917|P4|STARTED|Intervention Period 1||13
21881|NCT02074553|51918|P3|STARTED|Intervention Period 1||12
21882|NCT02074553|51919|P2|STARTED|Intervention Period 1||12
21883|NCT02074553|51920|P1|STARTED|Intervention Period 1||12
21884|NCT02074514|52102|P2|NOT COMPLETED|Overall Study||4
21885|NCT02074514|52103|P1|NOT COMPLETED|Overall Study||3
21886|NCT02074514|52102|P2|COMPLETED|Overall Study||54
21887|NCT02074514|52103|P1|COMPLETED|Overall Study||56
21888|NCT02074514|52102|P2|STARTED|Overall Study||58
21889|NCT02074514|52103|P1|STARTED|Overall Study||59
21890|NCT02074384|52124|P3|NOT COMPLETED|Overall Study||0
21891|NCT02074384|52125|P2|NOT COMPLETED|Overall Study||0
21892|NCT02074384|52126|P1|NOT COMPLETED|Overall Study||0
21893|NCT02074384|52124|P3|COMPLETED|Overall Study||17
21894|NCT02074384|52125|P2|COMPLETED|Overall Study||70
21895|NCT02074384|52126|P1|COMPLETED|Overall Study||74
21896|NCT02074384|52124|P3|STARTED|Overall Study||17
21897|NCT02074384|52125|P2|STARTED|Overall Study||70
21898|NCT02074384|52126|P1|STARTED|Overall Study||74
21899|NCT02074358|52134|P6|NOT COMPLETED|Overall Study||0
21900|NCT02074358|52135|P5|NOT COMPLETED|Overall Study||0
21901|NCT02074358|52136|P4|NOT COMPLETED|Overall Study||0
21902|NCT02074358|52137|P3|NOT COMPLETED|Overall Study||0
21903|NCT02074358|52138|P2|NOT COMPLETED|Overall Study||0
21904|NCT02074358|52139|P1|NOT COMPLETED|Overall Study||0
21905|NCT02074358|52134|P6|COMPLETED|Overall Study||2
21906|NCT02074358|52135|P5|COMPLETED|Overall Study||3
21907|NCT02074358|52136|P4|COMPLETED|Overall Study||2
21908|NCT02074358|52137|P3|COMPLETED|Overall Study||2
21909|NCT02074358|52138|P2|COMPLETED|Overall Study||3
21910|NCT02074358|52139|P1|COMPLETED|Overall Study||3
21911|NCT02074358|52134|P6|STARTED|Overall Study||2
21912|NCT02074358|52135|P5|STARTED|Overall Study||3
21913|NCT02074358|52136|P4|STARTED|Overall Study||2
21914|NCT02074358|52137|P3|STARTED|Overall Study||2
21915|NCT02074358|52138|P2|STARTED|Overall Study||3
21916|NCT02074358|52139|P1|STARTED|Overall Study||3
21917|NCT02074345|52228|P1|NOT COMPLETED|Overall Study||0
21918|NCT02074345|52228|P1|COMPLETED|Overall Study||31
21919|NCT02074345|52228|P1|STARTED|Overall Study||31
21920|NCT02074059|52244|P6|NOT COMPLETED|Overall Study||1
21921|NCT02074059|52245|P5|NOT COMPLETED|Overall Study||1
21922|NCT02074059|52246|P4|NOT COMPLETED|Overall Study||0
21923|NCT02074059|52247|P3|NOT COMPLETED|Overall Study||0
21924|NCT02074059|52248|P2|NOT COMPLETED|Overall Study||0
21925|NCT02074059|52249|P1|NOT COMPLETED|Overall Study||0
21926|NCT02074059|52244|P6|COMPLETED|Overall Study||39
21927|NCT02074059|52245|P5|COMPLETED|Overall Study||7
21928|NCT02074059|52246|P4|COMPLETED|Overall Study||8
21929|NCT02074059|52247|P3|COMPLETED|Overall Study||8
21930|NCT02074059|52248|P2|COMPLETED|Overall Study||8
21931|NCT02074059|52249|P1|COMPLETED|Overall Study||8
21932|NCT02074059|52244|P6|STARTED|Overall Study||40
21933|NCT02074059|52245|P5|STARTED|Overall Study||8
21934|NCT02074059|52246|P4|STARTED|Overall Study||8
21935|NCT02074059|52247|P3|STARTED|Overall Study||8
21936|NCT02074059|52248|P2|STARTED|Overall Study||8
21937|NCT02074059|52249|P1|STARTED|Overall Study||8
21938|NCT02073747|52289|P2|NOT COMPLETED|Overall Study||1
21939|NCT02073747|52290|P1|NOT COMPLETED|Overall Study||1
21940|NCT02073747|52289|P2|COMPLETED|Overall Study||14
21941|NCT02073747|52290|P1|COMPLETED|Overall Study||14
21942|NCT02073747|52289|P2|STARTED|Overall Study||15
21943|NCT02073747|52290|P1|STARTED|Overall Study||15
21944|NCT02073656|52296|P1|NOT COMPLETED|Retreatment Substudy||0
21945|NCT02073656|52296|P1|COMPLETED|Retreatment Substudy||9
21946|NCT02073656|52296|P1|STARTED|Retreatment Substudy|Only participants experiencing virologic relapse in the Primary Study were eligible for retreatment.|9
21947|NCT02073656|52296|P1|NOT COMPLETED|Primary Study||8
21948|NCT02073656|52296|P1|COMPLETED|Primary Study||327
21949|NCT02073656|52296|P1|STARTED|Primary Study||335
21950|NCT02073461|52315|P3|NOT COMPLETED|Overall Study||1
21951|NCT02073461|52316|P2|NOT COMPLETED|Overall Study||1
21952|NCT02073461|52317|P1|NOT COMPLETED|Overall Study||4
21953|NCT02073461|52315|P3|COMPLETED|Overall Study||78
21954|NCT02073461|52316|P2|COMPLETED|Overall Study||77
21955|NCT02073461|52317|P1|COMPLETED|Overall Study||75
21956|NCT02073461|52315|P3|STARTED|Overall Study||79
21957|NCT02073461|52316|P2|STARTED|Overall Study||78
21958|NCT02073461|52317|P1|STARTED|Overall Study||79
21959|NCT02073448|52346|P3|NOT COMPLETED|Overall Study||5
21960|NCT02073448|52347|P2|NOT COMPLETED|Overall Study||12
21961|NCT02073448|52348|P1|NOT COMPLETED|Overall Study||2
21962|NCT02073448|52346|P3|COMPLETED|Overall Study||99
21963|NCT02073448|52347|P2|COMPLETED|Overall Study||200
21964|NCT02073448|52348|P1|COMPLETED|Overall Study||99
21965|NCT02073448|52346|P3|STARTED|Overall Study||104
21966|NCT02073448|52347|P2|STARTED|Overall Study||212
21967|NCT02073448|52348|P1|STARTED|Overall Study||101
21968|NCT02072980|52374|P2|NOT COMPLETED|Period 2, Second Wear||1
21969|NCT02072980|52375|P1|NOT COMPLETED|Period 2, Second Wear||0
21970|NCT02072980|52374|P2|COMPLETED|Period 2, Second Wear||7
21971|NCT02072980|52375|P1|COMPLETED|Period 2, Second Wear||7
21972|NCT02072980|52374|P2|STARTED|Period 2, Second Wear||8
21973|NCT02072980|52375|P1|STARTED|Period 2, Second Wear||7
21974|NCT02072980|52374|P2|NOT COMPLETED|Period 1, First Wear||0
21975|NCT02072980|52375|P1|NOT COMPLETED|Period 1, First Wear||0
21976|NCT02072980|52374|P2|COMPLETED|Period 1, First Wear||8
21977|NCT02072980|52375|P1|COMPLETED|Period 1, First Wear||7
21978|NCT02072980|52374|P2|STARTED|Period 1, First Wear||8
21979|NCT02072980|52375|P1|STARTED|Period 1, First Wear||7
21980|NCT02072421|52381|P1|NOT COMPLETED|Overall Study||390
21981|NCT02072421|52381|P1|COMPLETED|Overall Study||2489
21982|NCT02072421|52381|P1|STARTED|Overall Study||2879
21983|NCT02072200|52389|P1|NOT COMPLETED|Overall Study||2
21984|NCT02072200|52389|P1|COMPLETED|Overall Study||145
21985|NCT02072200|52389|P1|STARTED|Overall Study||147
21986|NCT02072096|52397|P2|NOT COMPLETED|Overall Study||78
21987|NCT02072096|52398|P1|NOT COMPLETED|Overall Study||85
21988|NCT02072096|52397|P2|COMPLETED|Overall Study||15
21989|NCT02072096|52398|P1|COMPLETED|Overall Study||14
21990|NCT02072096|52397|P2|Received at Least One Dose of Study Drug|Overall Study||93
21991|NCT02072096|52398|P1|Received at Least One Dose of Study Drug|Overall Study||98
21992|NCT02072096|52397|P2|STARTED|Overall Study||93
21993|NCT02072096|52398|P1|STARTED|Overall Study||99
21994|NCT02071849|52420|P1|NOT COMPLETED|2-year Extended Follow-up||1
21995|NCT02071849|52420|P1|COMPLETED|2-year Extended Follow-up||14
21996|NCT02071849|52420|P1|STARTED|2-year Extended Follow-up||15
21997|NCT02071849|52420|P1|NOT COMPLETED|6-month Primary Endpoint||5
21998|NCT02071849|52420|P1|COMPLETED|6-month Primary Endpoint||15
21999|NCT02071849|52420|P1|STARTED|6-month Primary Endpoint||20
22000|NCT02071823|52454|P2|NOT COMPLETED|Overall Study||0
22001|NCT02071823|52455|P1|NOT COMPLETED|Overall Study||1
22002|NCT02071823|52454|P2|COMPLETED|Overall Study||6
22003|NCT02071823|52455|P1|COMPLETED|Overall Study||5
22004|NCT02071823|52454|P2|STARTED|Overall Study||6
22005|NCT02071823|52455|P1|STARTED|Overall Study||6
22006|NCT02071810|52470|P5|NOT COMPLETED|Overall Study||1
22007|NCT02071810|52471|P4|NOT COMPLETED|Overall Study||1
22008|NCT02071810|52472|P3|NOT COMPLETED|Overall Study||0
22009|NCT02071810|52473|P2|NOT COMPLETED|Overall Study||0
22010|NCT02071810|52474|P1|NOT COMPLETED|Overall Study||0
22011|NCT02071810|52470|P5|COMPLETED|Overall Study||8
22012|NCT02071810|52471|P4|COMPLETED|Overall Study||6
22013|NCT02071810|52472|P3|COMPLETED|Overall Study||6
22014|NCT02071810|52473|P2|COMPLETED|Overall Study||6
22015|NCT02071810|52474|P1|COMPLETED|Overall Study||6
22016|NCT02071810|52470|P5|STARTED|Overall Study||9
22017|NCT02071810|52471|P4|STARTED|Overall Study||7
22018|NCT02071810|52472|P3|STARTED|Overall Study||6
22019|NCT02071810|52473|P2|STARTED|Overall Study||6
22020|NCT02071810|52474|P1|STARTED|Overall Study||6
22021|NCT02071771|52486|P2|NOT COMPLETED|Period 2: Second 10 Days||0
22022|NCT02071771|52487|P1|NOT COMPLETED|Period 2: Second 10 Days||0
22023|NCT02071771|52486|P2|COMPLETED|Period 2: Second 10 Days||38
22024|NCT02071771|52487|P1|COMPLETED|Period 2: Second 10 Days||39
22025|NCT02071771|52486|P2|STARTED|Period 2: Second 10 Days|One participant completed Period 1 but did not start Period 2 due to unacceptable fit with DACP T.|38
22026|NCT02071771|52487|P1|STARTED|Period 2: Second 10 Days||39
22027|NCT02071771|52486|P2|NOT COMPLETED|Period 1: First 10 Days||0
22028|NCT02071771|52487|P1|NOT COMPLETED|Period 1: First 10 Days||2
22029|NCT02071771|52486|P2|COMPLETED|Period 1: First 10 Days||39
22030|NCT02071771|52487|P1|COMPLETED|Period 1: First 10 Days||39
22031|NCT02071771|52486|P2|Dispensed|Period 1: First 10 Days||39
22032|NCT02071771|52487|P1|Dispensed|Period 1: First 10 Days||39
22033|NCT02071771|52486|P2|STARTED|Period 1: First 10 Days||39
22034|NCT02071771|52487|P1|STARTED|Period 1: First 10 Days||41
22035|NCT02071108|52495|P1|NOT COMPLETED|Overall Study||0
22036|NCT02071108|52495|P1|COMPLETED|Overall Study||35
22037|NCT02071108|52495|P1|STARTED|Overall Study||35
22038|NCT02071082|52516|P2|NOT COMPLETED|Overall Study||75
22039|NCT02071082|52517|P1|NOT COMPLETED|Overall Study||4
22040|NCT02071082|52516|P2|COMPLETED|Overall Study||0
22041|NCT02071082|52517|P1|COMPLETED|Overall Study||0
22042|NCT02071082|52516|P2|STARTED|Overall Study||75
22043|NCT02071082|52517|P1|STARTED|Overall Study||4
22044|NCT02070965|52548|P3|NOT COMPLETED|Overall Study||1
22045|NCT02070965|52549|P2|NOT COMPLETED|Overall Study||2
22046|NCT02070965|52550|P1|NOT COMPLETED|Overall Study||2
22047|NCT02070965|52548|P3|COMPLETED|Overall Study||24
22048|NCT02070965|52549|P2|COMPLETED|Overall Study||21
22049|NCT02070965|52550|P1|COMPLETED|Overall Study||25
22050|NCT02070965|52548|P3|STARTED|Overall Study||25
22051|NCT02070965|52549|P2|STARTED|Overall Study||23
22052|NCT02070965|52550|P1|STARTED|Overall Study||27
22053|NCT02070692|52560|P2|NOT COMPLETED|Overall Study||12
22054|NCT02070692|52561|P1|NOT COMPLETED|Overall Study||10
22055|NCT02070692|52560|P2|COMPLETED|Overall Study||16
22056|NCT02070692|52561|P1|COMPLETED|Overall Study||18
22057|NCT02070692|52560|P2|STARTED|Overall Study||28
22058|NCT02070692|52561|P1|STARTED|Overall Study||28
22059|NCT02070640|52577|P2|NOT COMPLETED|Overall Study||0
22060|NCT02070640|52578|P1|NOT COMPLETED|Overall Study||11
22061|NCT02070640|52577|P2|COMPLETED|Overall Study||6
22062|NCT02070640|52578|P1|COMPLETED|Overall Study||82
22063|NCT02070640|52577|P2|STARTED|Overall Study||6
22064|NCT02070640|52578|P1|STARTED|Overall Study||93
22065|NCT02070588|52591|P3|NOT COMPLETED|Overall Study||0
22066|NCT02070588|52592|P2|NOT COMPLETED|Overall Study||1
22067|NCT02070588|52593|P1|NOT COMPLETED|Overall Study||39
22068|NCT02070588|52591|P3|COMPLETED|Overall Study||0
22069|NCT02070588|52592|P2|COMPLETED|Overall Study||25
22070|NCT02070588|52593|P1|COMPLETED|Overall Study||47
22071|NCT02070588|52591|P3|STARTED|Overall Study||0
22072|NCT02070588|52592|P2|STARTED|Overall Study||26
22073|NCT02070588|52593|P1|STARTED|Overall Study||86
22074|NCT02070380|52611|P4|NOT COMPLETED|Second Injection||5
22075|NCT02070380|52612|P3|NOT COMPLETED|Second Injection||1
22076|NCT02070380|52613|P2|NOT COMPLETED|Second Injection||2
22077|NCT02070380|52614|P1|NOT COMPLETED|Second Injection||0
22078|NCT02070380|52611|P4|COMPLETED|Second Injection||46
22079|NCT02070380|52612|P3|COMPLETED|Second Injection||50
22080|NCT02070380|52613|P2|COMPLETED|Second Injection||32
22081|NCT02070380|52614|P1|COMPLETED|Second Injection||31
22082|NCT02070380|52611|P4|STARTED|Second Injection||51
22083|NCT02070380|52612|P3|STARTED|Second Injection||51
22084|NCT02070380|52613|P2|STARTED|Second Injection||34
22085|NCT02070380|52614|P1|STARTED|Second Injection||31
22086|NCT02070380|52611|P4|NOT COMPLETED|Washout (no Second Injection/MRI)||3
22087|NCT02070380|52612|P3|NOT COMPLETED|Washout (no Second Injection/MRI)||2
22088|NCT02070380|52613|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||5
22089|NCT02070380|52614|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||0
22090|NCT02070380|52611|P4|COMPLETED|Washout (no Second Injection/MRI)||51
22091|NCT02070380|52612|P3|COMPLETED|Washout (no Second Injection/MRI)||51
22092|NCT02070380|52613|P2|COMPLETED|Washout (no Second Injection/MRI)||34
22093|NCT02070380|52614|P1|COMPLETED|Washout (no Second Injection/MRI)||31
22094|NCT02070380|52611|P4|STARTED|Washout (no Second Injection/MRI)||54
22095|NCT02070380|52612|P3|STARTED|Washout (no Second Injection/MRI)||53
22096|NCT02070380|52613|P2|STARTED|Washout (no Second Injection/MRI)||39
22097|NCT02070380|52614|P1|STARTED|Washout (no Second Injection/MRI)||31
22098|NCT02070380|52611|P4|NOT COMPLETED|First Injection||0
22099|NCT02070380|52612|P3|NOT COMPLETED|First Injection||0
22100|NCT02070380|52613|P2|NOT COMPLETED|First Injection||0
22101|NCT02070380|52614|P1|NOT COMPLETED|First Injection||0
22102|NCT02070380|52611|P4|COMPLETED|First Injection||54
22103|NCT02070380|52612|P3|COMPLETED|First Injection||53
22104|NCT02070380|52613|P2|COMPLETED|First Injection||39
22105|NCT02070380|52614|P1|COMPLETED|First Injection||31
22106|NCT02070380|52611|P4|STARTED|First Injection||54
22107|NCT02070380|52612|P3|STARTED|First Injection||53
22108|NCT02070380|52613|P2|STARTED|First Injection||39
22109|NCT02070380|52614|P1|STARTED|First Injection||31
22110|NCT02070237|52664|P2|NOT COMPLETED|Overall Study||3
22111|NCT02070237|52665|P1|NOT COMPLETED|Overall Study||3
22112|NCT02070237|52664|P2|COMPLETED|Overall Study||42
22113|NCT02070237|52665|P1|COMPLETED|Overall Study||42
22114|NCT02070237|52664|P2|STARTED|Overall Study||45
22115|NCT02070237|52665|P1|STARTED|Overall Study||45
22116|NCT02069093|52673|P1|NOT COMPLETED|Overall Study||30
22117|NCT02069093|52673|P1|COMPLETED|Overall Study||56
22118|NCT02069093|52673|P1|Pharmacokinetic Analysis Set|Overall Study||50
22119|NCT02069093|52673|P1|STARTED|Overall Study||86
22120|NCT02068443|52685|P3|NOT COMPLETED|Overall Study||3
22121|NCT02068443|52686|P2|NOT COMPLETED|Overall Study||6
22122|NCT02068443|52687|P1|NOT COMPLETED|Overall Study||7
22123|NCT02068443|52685|P3|COMPLETED|Overall Study||148
22124|NCT02068443|52686|P2|COMPLETED|Overall Study||146
22125|NCT02068443|52687|P1|COMPLETED|Overall Study||64
22126|NCT02068443|52685|P3|STARTED|Overall Study||151
22127|NCT02068443|52686|P2|STARTED|Overall Study||152
22128|NCT02068443|52687|P1|STARTED|Overall Study||71
22129|NCT02068222|52722|P1|NOT COMPLETED|Overall Study||1
22130|NCT02068222|52722|P1|COMPLETED|Overall Study||9
22131|NCT02068222|52722|P1|STARTED|Overall Study||10
22132|NCT02068157|52729|P1|NOT COMPLETED|Overall Study||0
22133|NCT02068157|52729|P1|COMPLETED|Overall Study||3
22134|NCT02068157|52729|P1|STARTED|Overall Study||3
22135|NCT02068027|52736|P2|NOT COMPLETED|Overall Study||16
22136|NCT02068027|52737|P1|NOT COMPLETED|Overall Study||13
22137|NCT02068027|52736|P2|COMPLETED|Overall Study||114
22138|NCT02068027|52737|P1|COMPLETED|Overall Study||117
22139|NCT02068027|52736|P2|STARTED|Overall Study||130
22140|NCT02068027|52737|P1|STARTED|Overall Study||130
22141|NCT02067728|52747|P2|NOT COMPLETED|6 Month Measurements||97
22142|NCT02067728|52748|P1|NOT COMPLETED|6 Month Measurements||114
22143|NCT02067728|52747|P2|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|113
22144|NCT02067728|52748|P1|COMPLETED|6 Month Measurements|Number includes 6 month measurements & chart review for visits at 6 months +/- 2 months from initial|106
22145|NCT02067728|52747|P2|STARTED|6 Month Measurements||210
22146|NCT02067728|52748|P1|STARTED|6 Month Measurements||220
22147|NCT02067728|52747|P2|NOT COMPLETED|6 Month Follow up Survey||60
22148|NCT02067728|52748|P1|NOT COMPLETED|6 Month Follow up Survey||48
22149|NCT02067728|52747|P2|COMPLETED|6 Month Follow up Survey|150 parent/guardians completed surveys at this time point, along with 69 teens.|150
22150|NCT02067728|52748|P1|COMPLETED|6 Month Follow up Survey|172 parent/guardians completed surveys at this time point, along with 71 teens.|172
22151|NCT02067728|52747|P2|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|210
22152|NCT02067728|52748|P1|STARTED|6 Month Follow up Survey|Participants completed the 6 month follow up even if 1 month data wasn't able to be collected.|220
22153|NCT02067728|52747|P2|NOT COMPLETED|Baseline - 1 Month Follow up Survey||28
22154|NCT02067728|52748|P1|NOT COMPLETED|Baseline - 1 Month Follow up Survey||7
22155|NCT02067728|52747|P2|COMPLETED|Baseline - 1 Month Follow up Survey|182 parent/guardians completed the surveys, along with 75 teens.|182
22156|NCT02067728|52748|P1|COMPLETED|Baseline - 1 Month Follow up Survey|213 parents/guardians completed the surveys, along with 82 teens.|213
22157|NCT02067728|52747|P2|STARTED|Baseline - 1 Month Follow up Survey||210
22158|NCT02067728|52748|P1|STARTED|Baseline - 1 Month Follow up Survey||220
22159|NCT02067585|52779|P3|NOT COMPLETED|Overall Study||0
22160|NCT02067585|52780|P2|NOT COMPLETED|Overall Study||0
22161|NCT02067585|52781|P1|NOT COMPLETED|Overall Study||0
22162|NCT02067585|52779|P3|COMPLETED|Overall Study||16
22163|NCT02067585|52780|P2|COMPLETED|Overall Study||16
22164|NCT02067585|52781|P1|COMPLETED|Overall Study||16
22165|NCT02067585|52779|P3|STARTED|Overall Study||16
22166|NCT02067585|52780|P2|STARTED|Overall Study||16
22167|NCT02067585|52781|P1|STARTED|Overall Study||16
22168|NCT02067533|52818|P2|NOT COMPLETED|Overall Study||2
22169|NCT02067533|52819|P1|NOT COMPLETED|Overall Study||4
22170|NCT02067533|52818|P2|COMPLETED|Overall Study||44
22171|NCT02067533|52819|P1|COMPLETED|Overall Study||41
22172|NCT02067533|52818|P2|STARTED|Overall Study||46
22173|NCT02067533|52819|P1|STARTED|Overall Study||45
22174|NCT02067273|52827|P2|NOT COMPLETED|Overall Study||3
22175|NCT02067273|52828|P1|NOT COMPLETED|Overall Study||0
22176|NCT02067273|52827|P2|COMPLETED|Overall Study||12
22177|NCT02067273|52828|P1|COMPLETED|Overall Study||5
22178|NCT02067273|52827|P2|STARTED|Overall Study||15
22179|NCT02067273|52828|P1|STARTED|Overall Study||5
22180|NCT02066922|52834|P1|NOT COMPLETED|Overall Study||1
22181|NCT02066922|52834|P1|COMPLETED|Overall Study||14
22182|NCT02066922|52834|P1|STARTED|Overall Study||15
22183|NCT02066896|52844|P2|NOT COMPLETED|Overall Study||0
22184|NCT02066896|52845|P1|NOT COMPLETED|Overall Study||0
22185|NCT02066896|52844|P2|COMPLETED|Overall Study||33
22186|NCT02066896|52845|P1|COMPLETED|Overall Study||33
22187|NCT02066896|52844|P2|STARTED|Overall Study||33
22188|NCT02066896|52845|P1|STARTED|Overall Study||33
22189|NCT02066857|52857|P2|NOT COMPLETED|Overall Study||1
22190|NCT02066857|52858|P1|NOT COMPLETED|Overall Study||1
22191|NCT02066857|52857|P2|COMPLETED|Overall Study||3
22192|NCT02066857|52858|P1|COMPLETED|Overall Study||0
22193|NCT02066857|52857|P2|STARTED|Overall Study||4
22194|NCT02066857|52858|P1|STARTED|Overall Study||1
22195|NCT02066740|52872|P1|NOT COMPLETED|Overall Study||2
22196|NCT02066740|52872|P1|COMPLETED|Overall Study||32
22197|NCT02066740|52872|P1|STARTED|Overall Study||34
22198|NCT02066727|52879|P2|NOT COMPLETED|Overall Study||0
22199|NCT02066727|52880|P1|NOT COMPLETED|Overall Study||0
22200|NCT02066727|52879|P2|COMPLETED|Overall Study||30
22201|NCT02066727|52880|P1|COMPLETED|Overall Study||30
22202|NCT02066727|52879|P2|STARTED|Overall Study||30
22203|NCT02066727|52880|P1|STARTED|Overall Study||30
22204|NCT02066402|52888|P2|NOT COMPLETED|Overall Study||23
22205|NCT02066402|52889|P1|NOT COMPLETED|Overall Study||26
22206|NCT02066402|52888|P2|COMPLETED|Overall Study||275
22207|NCT02066402|52889|P1|COMPLETED|Overall Study||274
22208|NCT02066402|52888|P2|Completed Study Treatment Period|Overall Study||256
22209|NCT02066402|52889|P1|Completed Study Treatment Period|Overall Study||261
22210|NCT02066402|52888|P2|Participants Received Treatment|Overall Study||297
22211|NCT02066402|52889|P1|Participants Received Treatment|Overall Study||292
22212|NCT02066402|52888|P2|STARTED|Overall Study||298
22213|NCT02066402|52889|P1|STARTED|Overall Study||300
22214|NCT02066233|52917|P2|NOT COMPLETED|Standard Endoscopy (Day 2)||0
22215|NCT02066233|52918|P1|NOT COMPLETED|Standard Endoscopy (Day 2)||0
22216|NCT02066233|52917|P2|COMPLETED|Standard Endoscopy (Day 2)||44
22217|NCT02066233|52918|P1|COMPLETED|Standard Endoscopy (Day 2)||44
22218|NCT02066233|52917|P2|STARTED|Standard Endoscopy (Day 2)||44
22219|NCT02066233|52918|P1|STARTED|Standard Endoscopy (Day 2)||44
22220|NCT02066233|52917|P2|NOT COMPLETED|EG Scan II (Day 1)||6
22221|NCT02066233|52918|P1|NOT COMPLETED|EG Scan II (Day 1)||6
22222|NCT02066233|52917|P2|COMPLETED|EG Scan II (Day 1)||44
22223|NCT02066233|52918|P1|COMPLETED|EG Scan II (Day 1)||44
22224|NCT02066233|52917|P2|STARTED|EG Scan II (Day 1)||50
22225|NCT02066233|52918|P1|STARTED|EG Scan II (Day 1)||50
22226|NCT02066051|52926|P1|NOT COMPLETED|Overall Study||1
22227|NCT02066051|52926|P1|COMPLETED|Overall Study||7
22228|NCT02066051|52926|P1|STARTED|Overall Study||8
22229|NCT02065453|52933|P2|NOT COMPLETED|Overall Study||4
22230|NCT02065453|52934|P1|NOT COMPLETED|Overall Study||3
22231|NCT02065453|52933|P2|COMPLETED|Overall Study||21
22232|NCT02065453|52934|P1|COMPLETED|Overall Study||24
22233|NCT02065453|52933|P2|STARTED|Overall Study||25
22234|NCT02065453|52934|P1|STARTED|Overall Study||27
22235|NCT02064985|52942|P3|NOT COMPLETED|Overall Study||0
22236|NCT02064985|52943|P2|NOT COMPLETED|Overall Study||0
22237|NCT02064985|52944|P1|NOT COMPLETED|Overall Study||0
22238|NCT02064985|52942|P3|COMPLETED|Overall Study||12
22239|NCT02064985|52943|P2|COMPLETED|Overall Study||12
22240|NCT02064985|52944|P1|COMPLETED|Overall Study||12
22241|NCT02064985|52942|P3|STARTED|Overall Study||12
22242|NCT02064985|52943|P2|STARTED|Overall Study||12
22243|NCT02064985|52944|P1|STARTED|Overall Study||12
22244|NCT02064920|53107|P2|NOT COMPLETED|Overall Study||9
22245|NCT02064920|53108|P1|NOT COMPLETED|Overall Study||1
22246|NCT02064920|53107|P2|COMPLETED|Overall Study||21
22247|NCT02064920|53108|P1|COMPLETED|Overall Study||5
22248|NCT02064920|53107|P2|Treated|Overall Study|Two participants discontinued from study prior to treatment|28
22249|NCT02064920|53108|P1|Treated|Overall Study||6
22250|NCT02064920|53107|P2|STARTED|Overall Study||30
22251|NCT02064920|53108|P1|STARTED|Overall Study||6
22252|NCT02064907|53118|P2|NOT COMPLETED|Period 2||0
22253|NCT02064907|53119|P1|NOT COMPLETED|Period 2||0
22254|NCT02064907|53118|P2|COMPLETED|Period 2||26
22255|NCT02064907|53119|P1|COMPLETED|Period 2||26
22256|NCT02064907|53118|P2|STARTED|Period 2||26
22257|NCT02064907|53119|P1|STARTED|Period 2||26
22258|NCT02064907|53118|P2|NOT COMPLETED|Period 1||0
22259|NCT02064907|53119|P1|NOT COMPLETED|Period 1||0
22260|NCT02064907|53118|P2|COMPLETED|Period 1||26
22261|NCT02064907|53119|P1|COMPLETED|Period 1||26
22262|NCT02064907|53118|P2|STARTED|Period 1||26
22263|NCT02064907|53119|P1|STARTED|Period 1||26
22264|NCT02064894|53138|P3|NOT COMPLETED|Overall Study||115
22265|NCT02064894|53139|P2|NOT COMPLETED|Overall Study||102
22266|NCT02064894|53140|P1|NOT COMPLETED|Overall Study||43
22267|NCT02064894|53138|P3|COMPLETED|Overall Study||86
22268|NCT02064894|53139|P2|COMPLETED|Overall Study||99
22269|NCT02064894|53140|P1|COMPLETED|Overall Study||56
22270|NCT02064894|53138|P3|Avalaible at T-90|Overall Study||129
22271|NCT02064894|53139|P2|Avalaible at T-90|Overall Study||134
22272|NCT02064894|53140|P1|Avalaible at T-90|Overall Study||74
22273|NCT02064894|53138|P3|Available at T-60|Overall Study||177
22274|NCT02064894|53139|P2|Available at T-60|Overall Study||188
22275|NCT02064894|53140|P1|Available at T-60|Overall Study||91
22276|NCT02064894|53138|P3|STARTED|Overall Study|"Received allocated intervention (n=199)
Did not receive allocated intervention (n=2)"|201
22277|NCT02064894|53139|P2|STARTED|Overall Study|"Received allocated intervention (n=198)
Did not receive allocated intervention (n=3)"|201
22278|NCT02064894|53140|P1|STARTED|Overall Study|"Received allocated intervention (n=98)
Did not receive intervention (n=1)"|99
22279|NCT02064231|53151|P4|NOT COMPLETED|Third Test Period (Own Product)||0
22280|NCT02064231|53152|P3|NOT COMPLETED|Third Test Period (Own Product)||0
22281|NCT02064231|53153|P2|NOT COMPLETED|Third Test Period (Own Product)||0
22282|NCT02064231|53154|P1|NOT COMPLETED|Third Test Period (Own Product)||0
22283|NCT02064231|53151|P4|COMPLETED|Third Test Period (Own Product)||1
22284|NCT02064231|53152|P3|COMPLETED|Third Test Period (Own Product)||0
22285|NCT02064231|53153|P2|COMPLETED|Third Test Period (Own Product)||8
22286|NCT02064231|53154|P1|COMPLETED|Third Test Period (Own Product)||8
22287|NCT02064231|53151|P4|STARTED|Third Test Period (Own Product)||1
22288|NCT02064231|53152|P3|STARTED|Third Test Period (Own Product)||0
22289|NCT02064231|53153|P2|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test C proceeded to test Own product afterwards|8
22290|NCT02064231|53154|P1|STARTED|Third Test Period (Own Product)|One subject who discontinued testing Test A proceeded to test Own product afterwards.|8
22291|NCT02064231|53151|P4|NOT COMPLETED|Second Test Period (Test B or Test D)||0
22292|NCT02064231|53152|P3|NOT COMPLETED|Second Test Period (Test B or Test D)||0
22293|NCT02064231|53153|P2|NOT COMPLETED|Second Test Period (Test B or Test D)||1
22294|NCT02064231|53154|P1|NOT COMPLETED|Second Test Period (Test B or Test D)||1
22295|NCT02064231|53151|P4|COMPLETED|Second Test Period (Test B or Test D)||1
22296|NCT02064231|53152|P3|COMPLETED|Second Test Period (Test B or Test D)||0
22297|NCT02064231|53153|P2|COMPLETED|Second Test Period (Test B or Test D)||7
22298|NCT02064231|53154|P1|COMPLETED|Second Test Period (Test B or Test D)||6
22299|NCT02064231|53151|P4|STARTED|Second Test Period (Test B or Test D)||1
22300|NCT02064231|53152|P3|STARTED|Second Test Period (Test B or Test D)||0
22301|NCT02064231|53153|P2|STARTED|Second Test Period (Test B or Test D)||8
22302|NCT02064231|53154|P1|STARTED|Second Test Period (Test B or Test D)||7
22303|NCT02064231|53151|P4|NOT COMPLETED|First Test Period (Test A or Test C)||0
22304|NCT02064231|53152|P3|NOT COMPLETED|First Test Period (Test A or Test C)||1
22305|NCT02064231|53153|P2|NOT COMPLETED|First Test Period (Test A or Test C)||4
22306|NCT02064231|53154|P1|NOT COMPLETED|First Test Period (Test A or Test C)||7
22307|NCT02064231|53151|P4|COMPLETED|First Test Period (Test A or Test C)||1
22308|NCT02064231|53152|P3|COMPLETED|First Test Period (Test A or Test C)||0
22309|NCT02064231|53153|P2|COMPLETED|First Test Period (Test A or Test C)||8
22310|NCT02064231|53154|P1|COMPLETED|First Test Period (Test A or Test C)||7
22311|NCT02064231|53151|P4|STARTED|First Test Period (Test A or Test C)||1
22312|NCT02064231|53152|P3|STARTED|First Test Period (Test A or Test C)||1
22313|NCT02064231|53153|P2|STARTED|First Test Period (Test A or Test C)||12
22314|NCT02064231|53154|P1|STARTED|First Test Period (Test A or Test C)||14
22315|NCT02064205|53166|P1|NOT COMPLETED|Overall Study||1
22316|NCT02064205|53166|P1|COMPLETED|Overall Study||31
22317|NCT02064205|53166|P1|Condition D|Overall Study||32
22318|NCT02064205|53166|P1|Condition C|Overall Study||31
22319|NCT02064205|53166|P1|Condition B|Overall Study||32
22320|NCT02064205|53166|P1|Condition A|Overall Study||32
22321|NCT02064205|53166|P1|STARTED|Overall Study||32
22322|NCT02063880|53184|P2|NOT COMPLETED|Overall Study||27
22323|NCT02063880|53185|P1|NOT COMPLETED|Overall Study||28
22324|NCT02063880|53184|P2|COMPLETED|Overall Study||66
22325|NCT02063880|53185|P1|COMPLETED|Overall Study||62
22326|NCT02063880|53184|P2|STARTED|Overall Study||93
22327|NCT02063880|53185|P1|STARTED|Overall Study||90
22328|NCT02063854|53202|P7|NOT COMPLETED|Overall Study||6
22329|NCT02063854|53203|P6|NOT COMPLETED|Overall Study||31
22330|NCT02063854|53204|P5|NOT COMPLETED|Overall Study||11
22331|NCT02063854|53205|P4|NOT COMPLETED|Overall Study||10
22332|NCT02063854|53206|P3|NOT COMPLETED|Overall Study||30
22333|NCT02063854|53207|P2|NOT COMPLETED|Overall Study||12
22334|NCT02063854|53208|P1|NOT COMPLETED|Overall Study||21
22335|NCT02063854|53202|P7|COMPLETED|Overall Study||60
22336|NCT02063854|53203|P6|COMPLETED|Overall Study||170
22337|NCT02063854|53204|P5|COMPLETED|Overall Study||54
22338|NCT02063854|53205|P4|COMPLETED|Overall Study||58
22339|NCT02063854|53206|P3|COMPLETED|Overall Study||176
22340|NCT02063854|53207|P2|COMPLETED|Overall Study||54
22341|NCT02063854|53208|P1|COMPLETED|Overall Study||178
22342|NCT02063854|53202|P7|Full Analysis Set: Received Study Drug|Overall Study||66
22343|NCT02063854|53203|P6|Full Analysis Set: Received Study Drug|Overall Study||200
22344|NCT02063854|53204|P5|Full Analysis Set: Received Study Drug|Overall Study||65
22345|NCT02063854|53205|P4|Full Analysis Set: Received Study Drug|Overall Study||68
22346|NCT02063854|53206|P3|Full Analysis Set: Received Study Drug|Overall Study||206
22347|NCT02063854|53207|P2|Full Analysis Set: Received Study Drug|Overall Study||66
22348|NCT02063854|53208|P1|Full Analysis Set: Received Study Drug|Overall Study||199
22349|NCT02063854|53202|P7|STARTED|Overall Study||66
22350|NCT02063854|53203|P6|STARTED|Overall Study||201
22351|NCT02063854|53204|P5|STARTED|Overall Study||65
22352|NCT02063854|53205|P4|STARTED|Overall Study||68
22353|NCT02063854|53206|P3|STARTED|Overall Study||206
22354|NCT02063854|53207|P2|STARTED|Overall Study||66
22355|NCT02063854|53208|P1|STARTED|Overall Study||199
22356|NCT02063737|53292|P2|NOT COMPLETED|Overall Study||4
22357|NCT02063737|53293|P1|NOT COMPLETED|Overall Study||11
22358|NCT02063737|53292|P2|COMPLETED|Overall Study||44
22359|NCT02063737|53293|P1|COMPLETED|Overall Study||41
22360|NCT02063737|53292|P2|STARTED|Overall Study||48
22361|NCT02063737|53293|P1|STARTED|Overall Study||52
22362|NCT02063516|53327|P2|NOT COMPLETED|Overall Study||0
22363|NCT02063516|53328|P1|NOT COMPLETED|Overall Study||0
22364|NCT02063516|53327|P2|COMPLETED|Overall Study||40
22365|NCT02063516|53328|P1|COMPLETED|Overall Study||40
22366|NCT02063516|53327|P2|STARTED|Overall Study||40
22367|NCT02063516|53328|P1|STARTED|Overall Study||40
22368|NCT02063230|53342|P4|NOT COMPLETED|Overall Study||0
22369|NCT02063230|53343|P3|NOT COMPLETED|Overall Study||0
22370|NCT02063230|53344|P2|NOT COMPLETED|Overall Study||0
22371|NCT02063230|53345|P1|NOT COMPLETED|Overall Study||0
22372|NCT02063230|53342|P4|COMPLETED|Overall Study||8
22373|NCT02063230|53343|P3|COMPLETED|Overall Study||8
22374|NCT02063230|53344|P2|COMPLETED|Overall Study||8
22375|NCT02063230|53345|P1|COMPLETED|Overall Study||8
22376|NCT02063230|53342|P4|Received Treatment|Overall Study||8
22377|NCT02063230|53343|P3|Received Treatment|Overall Study||8
22378|NCT02063230|53344|P2|Received Treatment|Overall Study||8
22379|NCT02063230|53345|P1|Received Treatment|Overall Study||8
22380|NCT02063230|53342|P4|STARTED|Overall Study||8
22381|NCT02063230|53343|P3|STARTED|Overall Study||8
22382|NCT02063230|53344|P2|STARTED|Overall Study||8
22383|NCT02063230|53345|P1|STARTED|Overall Study||8
22384|NCT02063035|53377|P2|NOT COMPLETED|Overall Study||0
22385|NCT02063035|53378|P1|NOT COMPLETED|Overall Study||0
22386|NCT02063035|53377|P2|COMPLETED|Overall Study||17
22387|NCT02063035|53378|P1|COMPLETED|Overall Study||12
22388|NCT02063035|53377|P2|STARTED|Overall Study||17
22389|NCT02063035|53378|P1|STARTED|Overall Study||12
22390|NCT02062905|53392|P2|NOT COMPLETED|Overall Study||2
22391|NCT02062905|53393|P1|NOT COMPLETED|Overall Study||7
22392|NCT02062905|53392|P2|COMPLETED|Overall Study||31
22393|NCT02062905|53393|P1|COMPLETED|Overall Study||28
22394|NCT02062905|53392|P2|STARTED|Overall Study||33
22395|NCT02062905|53393|P1|STARTED|Overall Study||35
22396|NCT02062801|53403|P2|NOT COMPLETED|Overall Study||4
22397|NCT02062801|53404|P1|NOT COMPLETED|Overall Study||2
22398|NCT02062801|53403|P2|COMPLETED|Overall Study||297
22399|NCT02062801|53404|P1|COMPLETED|Overall Study||299
22400|NCT02062801|53403|P2|STARTED|Overall Study||301
22401|NCT02062801|53404|P1|STARTED|Overall Study||301
22402|NCT02062710|53414|P6|NOT COMPLETED|Overall Study||0
22403|NCT02062710|53415|P5|NOT COMPLETED|Overall Study||0
22404|NCT02062710|53416|P4|NOT COMPLETED|Overall Study||0
22405|NCT02062710|53417|P3|NOT COMPLETED|Overall Study||0
22406|NCT02062710|53418|P2|NOT COMPLETED|Overall Study||0
22407|NCT02062710|53419|P1|NOT COMPLETED|Overall Study||0
22408|NCT02062710|53414|P6|COMPLETED|Overall Study||4
22409|NCT02062710|53415|P5|COMPLETED|Overall Study||3
22410|NCT02062710|53416|P4|COMPLETED|Overall Study||3
22411|NCT02062710|53417|P3|COMPLETED|Overall Study||5
22412|NCT02062710|53418|P2|COMPLETED|Overall Study||4
22413|NCT02062710|53419|P1|COMPLETED|Overall Study||3
22414|NCT02062710|53414|P6|STARTED|Overall Study|4 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
22415|NCT02062710|53415|P5|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this aprticular sequence|3
22416|NCT02062710|53416|P4|STARTED|Overall Study|3 of 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
22417|NCT02062710|53417|P3|STARTED|Overall Study|5 of total of 22 subjects randomized to receive the 3 study drugs in this particular sequence|5
22418|NCT02062710|53418|P2|STARTED|Overall Study|4 of the total 22 subjects randomized to receive the 3 study drugs in this particular sequence|4
22419|NCT02062710|53419|P1|STARTED|Overall Study|3 of total 22 subjects randomized to receive the 3 study drugs in this particular sequence|3
22420|NCT02062658|53427|P1|NOT COMPLETED|Overall Study||2
22421|NCT02062658|53427|P1|COMPLETED|Overall Study||8
22422|NCT02062658|53427|P1|STARTED|Overall Study||10
22423|NCT02062645|53431|P1|NOT COMPLETED|Overall Study||15
22424|NCT02062645|53431|P1|COMPLETED|Overall Study||100
22425|NCT02062645|53431|P1|STARTED|Overall Study||115
22426|NCT02062580|53441|P2|NOT COMPLETED|Overall Study||13
22427|NCT02062580|53442|P1|NOT COMPLETED|Overall Study||12
22428|NCT02062580|53441|P2|COMPLETED|Overall Study||65
22429|NCT02062580|53442|P1|COMPLETED|Overall Study||59
22430|NCT02062580|53441|P2|STARTED|Overall Study||78
22431|NCT02062580|53442|P1|STARTED|Overall Study||71
22432|NCT02062502|53452|P2|NOT COMPLETED|Overall Study||35
22433|NCT02062502|53453|P1|NOT COMPLETED|Overall Study||43
22434|NCT02062502|53452|P2|COMPLETED|Overall Study||270
22435|NCT02062502|53453|P1|COMPLETED|Overall Study||263
22436|NCT02062502|53452|P2|Vaccinated Dose 1|Overall Study||305
22437|NCT02062502|53453|P1|Vaccinated Dose 1|Overall Study||306
22438|NCT02062502|53452|P2|STARTED|Overall Study||305
22439|NCT02062502|53453|P1|STARTED|Overall Study||306
22440|NCT02062450|53473|P1|NOT COMPLETED|Overall Study||124
22441|NCT02062450|53473|P1|COMPLETED|Overall Study||255
22442|NCT02062450|53473|P1|Per Protocol Cohort|Overall Study|255 patients attended their 2-year follow-up visit.|255
22535|NCT02061358|53676|P6|STARTED|Overall Study||6
22443|NCT02062450|53473|P1|STARTED|Overall Study|379 patients were successfully reached by phone and convoked for the 2-year follow-up visit.|379
22444|NCT02062437|53487|P1|NOT COMPLETED|Overall Study||52
22445|NCT02062437|53487|P1|COMPLETED|Overall Study|80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.|80
22446|NCT02062437|53487|P1|STARTED|Overall Study|132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified|132
22447|NCT02062385|53500|P4|NOT COMPLETED|Overall Study||9
22448|NCT02062385|53501|P3|NOT COMPLETED|Overall Study||12
22449|NCT02062385|53502|P2|NOT COMPLETED|Overall Study||65
22450|NCT02062385|53503|P1|NOT COMPLETED|Overall Study||78
22451|NCT02062385|53500|P4|COMPLETED|Overall Study||391
22452|NCT02062385|53501|P3|COMPLETED|Overall Study||388
22453|NCT02062385|53502|P2|COMPLETED|Overall Study||1555
22454|NCT02062385|53503|P1|COMPLETED|Overall Study||1542
22455|NCT02062385|53500|P4|Received Vaccination 3|Overall Study||392
22456|NCT02062385|53501|P3|Received Vaccination 3|Overall Study||389
22457|NCT02062385|53502|P2|Received Vaccination 3|Overall Study||1554
22458|NCT02062385|53503|P1|Received Vaccination 3|Overall Study||1543
22459|NCT02062385|53500|P4|Received Vaccination 2|Overall Study||393
22460|NCT02062385|53501|P3|Received Vaccination 2|Overall Study||392
22461|NCT02062385|53502|P2|Received Vaccination 2|Overall Study||1566
22462|NCT02062385|53503|P1|Received Vaccination 2|Overall Study||1554
22463|NCT02062385|53500|P4|Received Vaccination 1|Overall Study||400
22464|NCT02062385|53501|P3|Received Vaccination 1|Overall Study||400
22465|NCT02062385|53502|P2|Received Vaccination 1|Overall Study||1619
22466|NCT02062385|53503|P1|Received Vaccination 1|Overall Study||1618
22467|NCT02062385|53500|P4|STARTED|Overall Study||400
22468|NCT02062385|53501|P3|STARTED|Overall Study||400
22469|NCT02062385|53502|P2|STARTED|Overall Study||1620
22470|NCT02062385|53503|P1|STARTED|Overall Study||1620
22471|NCT02062359|53523|P1|NOT COMPLETED|Overall Study||0
22472|NCT02062359|53523|P1|COMPLETED|Overall Study||2
22473|NCT02062359|53523|P1|STARTED|Overall Study||2
22474|NCT02062294|53529|P1|NOT COMPLETED|Overall Study||0
22475|NCT02062294|53529|P1|COMPLETED|Overall Study||14
22476|NCT02062294|53529|P1|STARTED|Overall Study||14
22477|NCT02062177|53536|P2|NOT COMPLETED|Overall Study||0
22478|NCT02062177|53537|P1|NOT COMPLETED|Overall Study||0
22479|NCT02062177|53536|P2|COMPLETED|Overall Study||70
22480|NCT02062177|53537|P1|COMPLETED|Overall Study||70
22481|NCT02062177|53536|P2|STARTED|Overall Study||70
22482|NCT02062177|53537|P1|STARTED|Overall Study||70
22483|NCT02061748|53549|P2|NOT COMPLETED|Overall Study||0
22484|NCT02061748|53550|P1|NOT COMPLETED|Overall Study||0
22485|NCT02061748|53549|P2|COMPLETED|Overall Study||30853
22486|NCT02061748|53550|P1|COMPLETED|Overall Study||7646
22487|NCT02061748|53549|P2|STARTED|Overall Study||30853
22488|NCT02061748|53550|P1|STARTED|Overall Study||7646
22489|NCT02061696|53624|P2|NOT COMPLETED|Overall Study||0
22490|NCT02061696|53625|P1|NOT COMPLETED|Overall Study||0
22491|NCT02061696|53624|P2|COMPLETED|Overall Study||22
22492|NCT02061696|53625|P1|COMPLETED|Overall Study||17
22493|NCT02061696|53624|P2|STARTED|Overall Study||22
22494|NCT02061696|53625|P1|STARTED|Overall Study||17
22495|NCT02061683|53631|P1|NOT COMPLETED|Overall Study||60
22496|NCT02061683|53631|P1|COMPLETED|Overall Study||203
22497|NCT02061683|53631|P1|STARTED|Overall Study||263
22498|NCT02061592|53638|P2|NOT COMPLETED|Period 2||1
22499|NCT02061592|53639|P1|NOT COMPLETED|Period 2||0
22500|NCT02061592|53638|P2|COMPLETED|Period 2||61
22501|NCT02061592|53639|P1|COMPLETED|Period 2||64
22502|NCT02061592|53638|P2|STARTED|Period 2||62
22503|NCT02061592|53639|P1|STARTED|Period 2||64
22504|NCT02061592|53638|P2|NOT COMPLETED|Period 1||0
22505|NCT02061592|53639|P1|NOT COMPLETED|Period 1||2
22506|NCT02061592|53638|P2|COMPLETED|Period 1||62
22507|NCT02061592|53639|P1|COMPLETED|Period 1||64
22508|NCT02061592|53638|P2|STARTED|Period 1||62
22509|NCT02061592|53639|P1|STARTED|Period 1||66
22510|NCT02061540|53651|P1|NOT COMPLETED|Overall Study||4
22511|NCT02061540|53651|P1|COMPLETED|Overall Study||23
22512|NCT02061540|53651|P1|Down-Titrated on LUM001 During the Study|Overall Study||5
22513|NCT02061540|53651|P1|STARTED|Overall Study||27
22514|NCT02061358|53673|P9|NOT COMPLETED|Overall Study||0
22515|NCT02061358|53674|P8|NOT COMPLETED|Overall Study||0
22516|NCT02061358|53675|P7|NOT COMPLETED|Overall Study||0
22517|NCT02061358|53676|P6|NOT COMPLETED|Overall Study||0
22518|NCT02061358|53677|P5|NOT COMPLETED|Overall Study||0
22519|NCT02061358|53678|P4|NOT COMPLETED|Overall Study||0
22520|NCT02061358|53679|P3|NOT COMPLETED|Overall Study||0
22521|NCT02061358|53680|P2|NOT COMPLETED|Overall Study||0
22522|NCT02061358|53681|P1|NOT COMPLETED|Overall Study||0
22523|NCT02061358|53673|P9|COMPLETED|Overall Study||16
22524|NCT02061358|53674|P8|COMPLETED|Overall Study||6
22525|NCT02061358|53675|P7|COMPLETED|Overall Study||6
22526|NCT02061358|53676|P6|COMPLETED|Overall Study||6
22527|NCT02061358|53677|P5|COMPLETED|Overall Study||6
22528|NCT02061358|53678|P4|COMPLETED|Overall Study||6
22529|NCT02061358|53679|P3|COMPLETED|Overall Study||6
22530|NCT02061358|53680|P2|COMPLETED|Overall Study||6
22531|NCT02061358|53681|P1|COMPLETED|Overall Study||6
22532|NCT02061358|53673|P9|STARTED|Overall Study||16
22533|NCT02061358|53674|P8|STARTED|Overall Study||6
22534|NCT02061358|53675|P7|STARTED|Overall Study||6
22536|NCT02061358|53677|P5|STARTED|Overall Study||6
22537|NCT02061358|53678|P4|STARTED|Overall Study||6
22538|NCT02061358|53679|P3|STARTED|Overall Study||6
22539|NCT02061358|53680|P2|STARTED|Overall Study||6
22540|NCT02061358|53681|P1|STARTED|Overall Study||6
22541|NCT02060838|53819|P2|NOT COMPLETED|Overall Study||0
22542|NCT02060838|53820|P1|NOT COMPLETED|Overall Study||0
22543|NCT02060838|53819|P2|COMPLETED|Overall Study||22
22544|NCT02060838|53820|P1|COMPLETED|Overall Study||28
22545|NCT02060838|53819|P2|STARTED|Overall Study||22
22546|NCT02060838|53820|P1|STARTED|Overall Study||28
22547|NCT02060539|53828|P1|NOT COMPLETED|Overall Study||0
22548|NCT02060539|53828|P1|COMPLETED|Overall Study||19
22549|NCT02060539|53828|P1|STARTED|Overall Study||19
22550|NCT02060526|53876|P3|NOT COMPLETED|Overall Study||0
22551|NCT02060526|53877|P2|NOT COMPLETED|Overall Study||0
22552|NCT02060526|53878|P1|NOT COMPLETED|Overall Study||0
22553|NCT02060526|53876|P3|COMPLETED|Overall Study||7
22554|NCT02060526|53877|P2|COMPLETED|Overall Study||7
22555|NCT02060526|53878|P1|COMPLETED|Overall Study||7
22556|NCT02060526|53876|P3|STARTED|Overall Study||7
22557|NCT02060526|53877|P2|STARTED|Overall Study||7
22558|NCT02060526|53878|P1|STARTED|Overall Study||7
22559|NCT02059993|53916|P2|NOT COMPLETED|Overall Study||4
22560|NCT02059993|53917|P1|NOT COMPLETED|Overall Study||2
22561|NCT02059993|53916|P2|COMPLETED|Overall Study||37
22562|NCT02059993|53917|P1|COMPLETED|Overall Study||40
22563|NCT02059993|53916|P2|STARTED|Overall Study||41
22564|NCT02059993|53917|P1|STARTED|Overall Study||42
22565|NCT02059928|53923|P1|NOT COMPLETED|Overall Study||0
22566|NCT02059928|53923|P1|COMPLETED|Overall Study||20
22567|NCT02059928|53923|P1|STARTED|Overall Study||20
22568|NCT02059902|53929|P2|NOT COMPLETED|Overall Study||4
22569|NCT02059902|53930|P1|NOT COMPLETED|Overall Study||4
22570|NCT02059902|53929|P2|COMPLETED|Overall Study||14
22571|NCT02059902|53930|P1|COMPLETED|Overall Study||14
22572|NCT02059902|53929|P2|STARTED|Overall Study||18
22573|NCT02059902|53930|P1|STARTED|Overall Study||18
22574|NCT02059642|53938|P2|NOT COMPLETED|Overall Study||24
22575|NCT02059642|53939|P1|NOT COMPLETED|Overall Study||27
22576|NCT02059642|53938|P2|COMPLETED|Overall Study||128
22577|NCT02059642|53939|P1|COMPLETED|Overall Study||121
22578|NCT02059642|53938|P2|STARTED|Overall Study||152
22579|NCT02059642|53939|P1|STARTED|Overall Study||148
22580|NCT02059291|53953|P6|NOT COMPLETED|Overall Study||2
22581|NCT02059291|53954|P5|NOT COMPLETED|Overall Study||0
22582|NCT02059291|53955|P4|NOT COMPLETED|Overall Study||2
22583|NCT02059291|53956|P3|NOT COMPLETED|Overall Study||1
22584|NCT02059291|53957|P2|NOT COMPLETED|Overall Study||1
22585|NCT02059291|53958|P1|NOT COMPLETED|Overall Study||0
22586|NCT02059291|53953|P6|COMPLETED|Overall Study||22
22587|NCT02059291|53954|P5|COMPLETED|Overall Study||22
22588|NCT02059291|53955|P4|COMPLETED|Overall Study||33
22589|NCT02059291|53956|P3|COMPLETED|Overall Study||36
22590|NCT02059291|53957|P2|COMPLETED|Overall Study||31
22591|NCT02059291|53958|P1|COMPLETED|Overall Study||31
22592|NCT02059291|53953|P6|STARTED|Overall Study||24
22593|NCT02059291|53954|P5|STARTED|Overall Study||22
22594|NCT02059291|53955|P4|STARTED|Overall Study||35
22595|NCT02059291|53956|P3|STARTED|Overall Study||37
22596|NCT02059291|53957|P2|STARTED|Overall Study||32
22597|NCT02059291|53958|P1|STARTED|Overall Study||31
22598|NCT02059187|53974|P2|NOT COMPLETED|Overall Study||22
22599|NCT02059187|53975|P1|NOT COMPLETED|Overall Study||25
22600|NCT02059187|53974|P2|COMPLETED|Overall Study||244
22601|NCT02059187|53975|P1|COMPLETED|Overall Study||240
22602|NCT02059187|53974|P2|STARTED|Overall Study||266
22603|NCT02059187|53975|P1|STARTED|Overall Study||265
22604|NCT02059174|54001|P2|NOT COMPLETED|Period 4||0
22605|NCT02059174|54002|P1|NOT COMPLETED|Period 4||0
22606|NCT02059174|54001|P2|COMPLETED|Period 4||35
22607|NCT02059174|54002|P1|COMPLETED|Period 4||35
22608|NCT02059174|54001|P2|STARTED|Period 4||35
22609|NCT02059174|54002|P1|STARTED|Period 4||35
22610|NCT02059174|54001|P2|NOT COMPLETED|Period 3||0
22611|NCT02059174|54002|P1|NOT COMPLETED|Period 3||1
22612|NCT02059174|54001|P2|COMPLETED|Period 3||35
22613|NCT02059174|54002|P1|COMPLETED|Period 3||35
22614|NCT02059174|54001|P2|STARTED|Period 3||35
22615|NCT02059174|54002|P1|STARTED|Period 3||36
22616|NCT02059174|54001|P2|NOT COMPLETED|Period 2||2
22617|NCT02059174|54002|P1|NOT COMPLETED|Period 2||1
22618|NCT02059174|54001|P2|COMPLETED|Period 2||35
22619|NCT02059174|54002|P1|COMPLETED|Period 2||36
22620|NCT02059174|54001|P2|STARTED|Period 2||37
22621|NCT02059174|54002|P1|STARTED|Period 2||37
22622|NCT02059174|54001|P2|NOT COMPLETED|Period 1||2
22623|NCT02059174|54002|P1|NOT COMPLETED|Period 1||0
22624|NCT02059174|54001|P2|COMPLETED|Period 1||37
22625|NCT02059174|54002|P1|COMPLETED|Period 1||37
22626|NCT02059174|54001|P2|STARTED|Period 1||39
22627|NCT02059174|54002|P1|STARTED|Period 1||37
22628|NCT02059161|54026|P2|NOT COMPLETED|Overall Study||41
22629|NCT02059161|54027|P1|NOT COMPLETED|Overall Study||49
22630|NCT02059161|54026|P2|COMPLETED|Overall Study||222
22631|NCT02059161|54027|P1|COMPLETED|Overall Study||196
22632|NCT02059161|54026|P2|Treated|Overall Study||258
22633|NCT02059161|54027|P1|Treated|Overall Study||241
22634|NCT02059161|54026|P2|STARTED|Overall Study||263
22635|NCT02059161|54027|P1|STARTED|Overall Study||245
22636|NCT02059135|54089|P2|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
22637|NCT02059135|54090|P1|NOT COMPLETED|Neonatal Follow-up (Safety Population)||4
22638|NCT02059135|54089|P2|COMPLETED|Neonatal Follow-up (Safety Population)||50
22639|NCT02059135|54090|P1|COMPLETED|Neonatal Follow-up (Safety Population)||56
22640|NCT02059135|54089|P2|STARTED|Neonatal Follow-up (Safety Population)||54
22641|NCT02059135|54090|P1|STARTED|Neonatal Follow-up (Safety Population)||60
22642|NCT02059135|54089|P2|NOT COMPLETED|Maternal Follow-up (ITT Population)||7
22643|NCT02059135|54090|P1|NOT COMPLETED|Maternal Follow-up (ITT Population)||3
22644|NCT02059135|54089|P2|COMPLETED|Maternal Follow-up (ITT Population)||51
22645|NCT02059135|54090|P1|COMPLETED|Maternal Follow-up (ITT Population)||59
22646|NCT02059135|54089|P2|STARTED|Maternal Follow-up (ITT Population)||58
22647|NCT02059135|54090|P1|STARTED|Maternal Follow-up (ITT Population)||62
22648|NCT02059070|54104|P2|NOT COMPLETED|Overall Study||4
22649|NCT02059070|54105|P1|NOT COMPLETED|Overall Study||5
22650|NCT02059070|54104|P2|COMPLETED|Overall Study||16
22651|NCT02059070|54105|P1|COMPLETED|Overall Study||14
22652|NCT02059070|54104|P2|STARTED|Overall Study||20
22653|NCT02059070|54105|P1|STARTED|Overall Study||19
22654|NCT02058992|54117|P1|NOT COMPLETED|Overall Study||116
22655|NCT02058992|54117|P1|COMPLETED|Overall Study||3223
22656|NCT02058992|54117|P1|STARTED|Overall Study||3339
22657|NCT02058628|54128|P2|NOT COMPLETED|Overall Study||8
22658|NCT02058628|54129|P1|NOT COMPLETED|Overall Study||7
22659|NCT02058628|54128|P2|COMPLETED|Overall Study||102
22660|NCT02058628|54129|P1|COMPLETED|Overall Study||104
22661|NCT02058628|54128|P2|STARTED|Overall Study||110
22662|NCT02058628|54129|P1|STARTED|Overall Study||111
22663|NCT02058563|54161|P2|NOT COMPLETED|Overall Study||24
22664|NCT02058563|54162|P1|NOT COMPLETED|Overall Study||28
22665|NCT02058563|54161|P2|COMPLETED|Overall Study||433
22666|NCT02058563|54162|P1|COMPLETED|Overall Study||426
22667|NCT02058563|54161|P2|STARTED|Overall Study||457
22668|NCT02058563|54162|P1|STARTED|Overall Study||454
22669|NCT02058537|54198|P1|NOT COMPLETED|Overall Study||1
22670|NCT02058537|54198|P1|COMPLETED|Overall Study||2
22671|NCT02058537|54198|P1|STARTED|Overall Study||3
22672|NCT02058498|54204|P1|NOT COMPLETED|Overall Study||4
22673|NCT02058498|54204|P1|COMPLETED|Overall Study||8
22674|NCT02058498|54204|P1|6 Weeks|Overall Study||8
22675|NCT02058498|54204|P1|STARTED|Overall Study||12
22676|NCT02058290|54212|P2|NOT COMPLETED|Overall Study||9
22677|NCT02058290|54213|P1|NOT COMPLETED|Overall Study||11
22678|NCT02058290|54212|P2|COMPLETED|Overall Study||36
22679|NCT02058290|54213|P1|COMPLETED|Overall Study||66
22680|NCT02058290|54212|P2|STARTED|Overall Study||45
22681|NCT02058290|54213|P1|STARTED|Overall Study||77
22682|NCT02058160|54229|P2|NOT COMPLETED|Overall Study||14
22683|NCT02058160|54230|P1|NOT COMPLETED|Overall Study||31
22684|NCT02058160|54229|P2|COMPLETED|Overall Study||355
22685|NCT02058160|54230|P1|COMPLETED|Overall Study||336
22686|NCT02058160|54229|P2|Treated|Overall Study||365
22687|NCT02058160|54230|P1|Treated|Overall Study||365
22688|NCT02058160|54229|P2|STARTED|Overall Study||369
22689|NCT02058160|54230|P1|STARTED|Overall Study||367
22690|NCT02058147|54267|P3|NOT COMPLETED|Overall Study||29
22691|NCT02058147|54268|P2|NOT COMPLETED|Overall Study||27
22692|NCT02058147|54269|P1|NOT COMPLETED|Overall Study||29
22693|NCT02058147|54267|P3|COMPLETED|Overall Study||205
22694|NCT02058147|54268|P2|COMPLETED|Overall Study||440
22695|NCT02058147|54269|P1|COMPLETED|Overall Study||440
22696|NCT02058147|54267|P3|Treated|Overall Study||233
22697|NCT02058147|54268|P2|Treated|Overall Study||467
22698|NCT02058147|54269|P1|Treated|Overall Study||469
22699|NCT02058147|54267|P3|STARTED|Overall Study||234
22700|NCT02058147|54268|P2|STARTED|Overall Study||467
22701|NCT02058147|54269|P1|STARTED|Overall Study||469
22702|NCT02058069|54318|P1|NOT COMPLETED|Overall Study||11
22703|NCT02058069|54318|P1|COMPLETED|Overall Study||89
22704|NCT02058069|54318|P1|STARTED|Overall Study||100
22705|NCT02057835|54337|P10|NOT COMPLETED|Overall Study||0
22706|NCT02057835|54338|P9|NOT COMPLETED|Overall Study||0
22707|NCT02057835|54339|P8|NOT COMPLETED|Overall Study||0
22708|NCT02057835|54340|P7|NOT COMPLETED|Overall Study||0
22709|NCT02057835|54341|P6|NOT COMPLETED|Overall Study||0
22710|NCT02057835|54342|P5|NOT COMPLETED|Overall Study||0
22711|NCT02057835|54343|P4|NOT COMPLETED|Overall Study||0
22712|NCT02057835|54344|P3|NOT COMPLETED|Overall Study||0
22713|NCT02057835|54345|P2|NOT COMPLETED|Overall Study||2
22714|NCT02057835|54346|P1|NOT COMPLETED|Overall Study||0
22715|NCT02057835|54337|P10|COMPLETED|Overall Study||6
22716|NCT02057835|54338|P9|COMPLETED|Overall Study||6
22717|NCT02057835|54339|P8|COMPLETED|Overall Study||6
22718|NCT02057835|54340|P7|COMPLETED|Overall Study||6
22719|NCT02057835|54341|P6|COMPLETED|Overall Study||8
22720|NCT02057835|54342|P5|COMPLETED|Overall Study||6
22721|NCT02057835|54343|P4|COMPLETED|Overall Study||6
22722|NCT02057835|54344|P3|COMPLETED|Overall Study||6
22723|NCT02057835|54345|P2|COMPLETED|Overall Study||4
22724|NCT02057835|54346|P1|COMPLETED|Overall Study||8
22725|NCT02057835|54337|P10|STARTED|Overall Study||6
22726|NCT02057835|54338|P9|STARTED|Overall Study||6
22727|NCT02057835|54339|P8|STARTED|Overall Study||6
22728|NCT02057835|54340|P7|STARTED|Overall Study||6
22729|NCT02057835|54341|P6|STARTED|Overall Study||8
22730|NCT02057835|54342|P5|STARTED|Overall Study||6
22731|NCT02057835|54343|P4|STARTED|Overall Study||6
22732|NCT02057835|54344|P3|STARTED|Overall Study||6
22733|NCT02057835|54345|P2|STARTED|Overall Study||6
22734|NCT02057835|54346|P1|STARTED|Overall Study||8
22735|NCT02057549|54425|P2|NOT COMPLETED|Overall Study||0
22736|NCT02057549|54426|P1|NOT COMPLETED|Overall Study||3
22737|NCT02057549|54425|P2|COMPLETED|Overall Study||18
22738|NCT02057549|54426|P1|COMPLETED|Overall Study||15
22739|NCT02057549|54425|P2|STARTED|Overall Study||18
22740|NCT02057549|54426|P1|STARTED|Overall Study||18
22741|NCT02057406|54449|P3|NOT COMPLETED|Overall Study||4
22742|NCT02057406|54450|P2|NOT COMPLETED|Overall Study||3
22743|NCT02057406|54451|P1|NOT COMPLETED|Overall Study||1
22744|NCT02057406|54449|P3|COMPLETED|Overall Study||32
22745|NCT02057406|54450|P2|COMPLETED|Overall Study||33
22746|NCT02057406|54451|P1|COMPLETED|Overall Study||35
22747|NCT02057406|54449|P3|STARTED|Overall Study||36
22748|NCT02057406|54450|P2|STARTED|Overall Study||36
22749|NCT02057406|54451|P1|STARTED|Overall Study||36
22750|NCT02057393|54462|P1|NOT COMPLETED|Overall Study||2
22751|NCT02057393|54462|P1|COMPLETED|Overall Study||87
22752|NCT02057393|54462|P1|STARTED|Overall Study||89
22753|NCT02057276|54468|P2|NOT COMPLETED|Overall Study||0
22754|NCT02057276|54469|P1|NOT COMPLETED|Overall Study||0
22755|NCT02057276|54468|P2|COMPLETED|Overall Study||0
22756|NCT02057276|54469|P1|COMPLETED|Overall Study||0
22757|NCT02057276|54468|P2|STARTED|Overall Study||0
22758|NCT02057276|54469|P1|STARTED|Overall Study||0
22759|NCT02057250|54483|P5|NOT COMPLETED|Extension Phase||36
22760|NCT02057250|54484|P4|NOT COMPLETED|Extension Phase||0
22761|NCT02057250|54485|P3|NOT COMPLETED|Extension Phase||0
22762|NCT02057250|54486|P2|NOT COMPLETED|Extension Phase||0
22763|NCT02057250|54487|P1|NOT COMPLETED|Extension Phase||0
22764|NCT02057250|54483|P5|COMPLETED|Extension Phase||156
22765|NCT02057250|54484|P4|COMPLETED|Extension Phase||0
22766|NCT02057250|54485|P3|COMPLETED|Extension Phase||0
22767|NCT02057250|54486|P2|COMPLETED|Extension Phase||0
22768|NCT02057250|54487|P1|COMPLETED|Extension Phase||0
22769|NCT02057250|54483|P5|Treated|Extension Phase||188
22770|NCT02057250|54484|P4|Treated|Extension Phase||0
22771|NCT02057250|54485|P3|Treated|Extension Phase||0
22772|NCT02057250|54486|P2|Treated|Extension Phase||0
22773|NCT02057250|54487|P1|Treated|Extension Phase||0
22774|NCT02057250|54483|P5|STARTED|Extension Phase|9 participants who completed AID Assessment phase did not enter extension phase.|192
22775|NCT02057250|54484|P4|STARTED|Extension Phase||0
22776|NCT02057250|54485|P3|STARTED|Extension Phase||0
22777|NCT02057250|54486|P2|STARTED|Extension Phase||0
22778|NCT02057250|54487|P1|STARTED|Extension Phase||0
22779|NCT02057250|54483|P5|NOT COMPLETED|AID Assessment Phase||0
22780|NCT02057250|54484|P4|NOT COMPLETED|AID Assessment Phase||2
22781|NCT02057250|54485|P3|NOT COMPLETED|AID Assessment Phase||7
22782|NCT02057250|54486|P2|NOT COMPLETED|AID Assessment Phase||3
22783|NCT02057250|54487|P1|NOT COMPLETED|AID Assessment Phase||4
22784|NCT02057250|54483|P5|COMPLETED|AID Assessment Phase||0
22785|NCT02057250|54484|P4|COMPLETED|AID Assessment Phase||54
22786|NCT02057250|54485|P3|COMPLETED|AID Assessment Phase||45
22787|NCT02057250|54486|P2|COMPLETED|AID Assessment Phase||50
22788|NCT02057250|54487|P1|COMPLETED|AID Assessment Phase||52
22789|NCT02057250|54483|P5|STARTED|AID Assessment Phase||0
22790|NCT02057250|54484|P4|STARTED|AID Assessment Phase||56
22791|NCT02057250|54485|P3|STARTED|AID Assessment Phase||52
22792|NCT02057250|54486|P2|STARTED|AID Assessment Phase||53
22793|NCT02057250|54487|P1|STARTED|AID Assessment Phase||56
22794|NCT02057237|54500|P1|NOT COMPLETED|Overall Study||0
22795|NCT02057237|54500|P1|COMPLETED|Overall Study||1
22796|NCT02057237|54500|P1|STARTED|Overall Study||1
22797|NCT02056834|54505|P1|NOT COMPLETED|Overall Study||7
22798|NCT02056834|54505|P1|COMPLETED|Overall Study||29
22799|NCT02056834|54505|P1|6 Months|Overall Study||31
22800|NCT02056834|54505|P1|6 Weeks|Overall Study||34
22801|NCT02056834|54505|P1|STARTED|Overall Study||36
22802|NCT02056392|54530|P6|NOT COMPLETED|Overall Study||0
22803|NCT02056392|54531|P5|NOT COMPLETED|Overall Study||1
22804|NCT02056392|54532|P4|NOT COMPLETED|Overall Study||0
22805|NCT02056392|54533|P3|NOT COMPLETED|Overall Study||3
22806|NCT02056392|54534|P2|NOT COMPLETED|Overall Study||1
22807|NCT02056392|54535|P1|NOT COMPLETED|Overall Study||2
22808|NCT02056392|54530|P6|COMPLETED|Overall Study||9
22809|NCT02056392|54531|P5|COMPLETED|Overall Study||7
22810|NCT02056392|54532|P4|COMPLETED|Overall Study||9
22811|NCT02056392|54533|P3|COMPLETED|Overall Study||6
22812|NCT02056392|54534|P2|COMPLETED|Overall Study||8
22813|NCT02056392|54535|P1|COMPLETED|Overall Study||8
22814|NCT02056392|54530|P6|STARTED|Overall Study||9
22815|NCT02056392|54531|P5|STARTED|Overall Study||8
22816|NCT02056392|54532|P4|STARTED|Overall Study||9
22817|NCT02056392|54533|P3|STARTED|Overall Study||9
22818|NCT02056392|54534|P2|STARTED|Overall Study||9
22819|NCT02056392|54535|P1|STARTED|Overall Study||10
22820|NCT02055430|54572|P2|NOT COMPLETED|Overall Study||0
22821|NCT02055430|54573|P1|NOT COMPLETED|Overall Study||0
22822|NCT02055430|54572|P2|COMPLETED|Overall Study||45
22823|NCT02055430|54573|P1|COMPLETED|Overall Study||45
22824|NCT02055430|54572|P2|STARTED|Overall Study||45
22825|NCT02055430|54573|P1|STARTED|Overall Study||45
22826|NCT02055404|54579|P1|NOT COMPLETED|Overall Study||0
22827|NCT02055404|54579|P1|COMPLETED|Overall Study||3
22828|NCT02055404|54579|P1|STARTED|Overall Study||3
22829|NCT02055352|54594|P2|NOT COMPLETED|Overall Study||17
22830|NCT02055352|54595|P1|NOT COMPLETED|Overall Study||6
22831|NCT02055352|54594|P2|COMPLETED|Overall Study||96
22832|NCT02055352|54595|P1|COMPLETED|Overall Study||103
22833|NCT02055352|54594|P2|Per-Protocol Set (PPS)|Overall Study||111
22834|NCT02055352|54595|P1|Per-Protocol Set (PPS)|Overall Study||108
22835|NCT02055352|54594|P2|STARTED|Overall Study||113
22836|NCT02055352|54595|P1|STARTED|Overall Study||109
22837|NCT02054910|54611|P2|NOT COMPLETED|Overall Study||1
22838|NCT02054910|54612|P1|NOT COMPLETED|Overall Study||4
22839|NCT02054910|54611|P2|COMPLETED|Overall Study||0
22840|NCT02054910|54612|P1|COMPLETED|Overall Study||0
22841|NCT02054910|54611|P2|STARTED|Overall Study||1
22842|NCT02054910|54612|P1|STARTED|Overall Study||4
22843|NCT02054754|54630|P6|NOT COMPLETED|Overall Study||0
22844|NCT02054754|54631|P5|NOT COMPLETED|Overall Study||0
22845|NCT02054754|54632|P4|NOT COMPLETED|Overall Study||0
22846|NCT02054754|54633|P3|NOT COMPLETED|Overall Study||0
22847|NCT02054754|54634|P2|NOT COMPLETED|Overall Study||0
22848|NCT02054754|54635|P1|NOT COMPLETED|Overall Study||0
22849|NCT02054754|54630|P6|COMPLETED|Overall Study||10
22850|NCT02054754|54631|P5|COMPLETED|Overall Study||6
22851|NCT02054754|54632|P4|COMPLETED|Overall Study||6
22852|NCT02054754|54633|P3|COMPLETED|Overall Study||6
22853|NCT02054754|54634|P2|COMPLETED|Overall Study||6
22854|NCT02054754|54635|P1|COMPLETED|Overall Study||6
22855|NCT02054754|54630|P6|STARTED|Overall Study||10
22856|NCT02054754|54631|P5|STARTED|Overall Study||6
22857|NCT02054754|54632|P4|STARTED|Overall Study||6
22858|NCT02054754|54633|P3|STARTED|Overall Study||6
22859|NCT02054754|54634|P2|STARTED|Overall Study||6
22860|NCT02054754|54635|P1|STARTED|Overall Study||6
22861|NCT02054715|54652|P2|NOT COMPLETED|Follow-up 2||19
22862|NCT02054715|54653|P1|NOT COMPLETED|Follow-up 2||19
22863|NCT02054715|54652|P2|COMPLETED|Follow-up 2||173
22864|NCT02054715|54653|P1|COMPLETED|Follow-up 2||192
22865|NCT02054715|54652|P2|STARTED|Follow-up 2||192
22866|NCT02054715|54653|P1|STARTED|Follow-up 2||211
22867|NCT02054715|54652|P2|NOT COMPLETED|Baseline/Follow-up 1||7
22868|NCT02054715|54653|P1|NOT COMPLETED|Baseline/Follow-up 1||8
22869|NCT02054715|54652|P2|COMPLETED|Baseline/Follow-up 1||192
22870|NCT02054715|54653|P1|COMPLETED|Baseline/Follow-up 1||211
22871|NCT02054715|54652|P2|STARTED|Baseline/Follow-up 1||199
22872|NCT02054715|54653|P1|STARTED|Baseline/Follow-up 1||219
22873|NCT02054702|54667|P2|NOT COMPLETED|Overall Study||12
22874|NCT02054702|54668|P1|NOT COMPLETED|Overall Study||24
22875|NCT02054702|54667|P2|COMPLETED|Overall Study||21
22876|NCT02054702|54668|P1|COMPLETED|Overall Study||40
22877|NCT02054702|54667|P2|STARTED|Overall Study||33
22878|NCT02054702|54668|P1|STARTED|Overall Study||64
22879|NCT02054572|54696|P1|NOT COMPLETED|Overall Study||0
22880|NCT02054572|54696|P1|COMPLETED|Overall Study||6
22881|NCT02054572|54696|P1|STARTED|Overall Study||6
22882|NCT02054481|54723|P4|NOT COMPLETED|Overall Study||1
22883|NCT02054481|54724|P3|NOT COMPLETED|Overall Study||2
22884|NCT02054481|54725|P2|NOT COMPLETED|Overall Study||2
22885|NCT02054481|54726|P1|NOT COMPLETED|Overall Study||4
22886|NCT02054481|54723|P4|COMPLETED|Overall Study||39
22887|NCT02054481|54724|P3|COMPLETED|Overall Study||40
22888|NCT02054481|54725|P2|COMPLETED|Overall Study||39
22889|NCT02054481|54726|P1|COMPLETED|Overall Study||39
22890|NCT02054481|54723|P4|STARTED|Overall Study||40
22891|NCT02054481|54724|P3|STARTED|Overall Study||42
22892|NCT02054481|54725|P2|STARTED|Overall Study||41
22893|NCT02054481|54726|P1|STARTED|Overall Study||43
22894|NCT02054325|54774|P2|NOT COMPLETED|Overall Study||5
22895|NCT02054325|54775|P1|NOT COMPLETED|Overall Study||8
22896|NCT02054325|54774|P2|COMPLETED|Overall Study||50
22897|NCT02054325|54775|P1|COMPLETED|Overall Study||43
22898|NCT02054325|54774|P2|STARTED|Overall Study||55
22899|NCT02054325|54775|P1|STARTED|Overall Study||51
22900|NCT02053610|54785|P2|NOT COMPLETED|Overall Study||174
22901|NCT02053610|54786|P1|NOT COMPLETED|Overall Study||235
22902|NCT02053610|54785|P2|COMPLETED|Overall Study|Completed=Completed Treatment|159
22903|NCT02053610|54786|P1|COMPLETED|Overall Study|Completed=Completed Treatment|95
22904|NCT02053610|54785|P2|Received Study Drug|Overall Study||331
22905|NCT02053610|54786|P1|Received Study Drug|Overall Study||326
22906|NCT02053610|54785|P2|STARTED|Overall Study||333
22907|NCT02053610|54786|P1|STARTED|Overall Study||330
22908|NCT02053493|54818|P2|NOT COMPLETED|Overall Study||1
22909|NCT02053493|54819|P1|NOT COMPLETED|Overall Study||1
22910|NCT02053493|54818|P2|COMPLETED|Overall Study||58
22911|NCT02053493|54819|P1|COMPLETED|Overall Study||50
22912|NCT02053493|54818|P2|STARTED|Overall Study||59
22913|NCT02053493|54819|P1|STARTED|Overall Study||51
22914|NCT02052895|54860|P3|NOT COMPLETED|Overall Study||0
22915|NCT02052895|54861|P2|NOT COMPLETED|Overall Study||0
22916|NCT02052895|54862|P1|NOT COMPLETED|Overall Study||0
22917|NCT02052895|54860|P3|COMPLETED|Overall Study||15
22918|NCT02052895|54861|P2|COMPLETED|Overall Study||15
22919|NCT02052895|54862|P1|COMPLETED|Overall Study||196
22920|NCT02052895|54860|P3|STARTED|Overall Study||15
22921|NCT02052895|54861|P2|STARTED|Overall Study||15
22922|NCT02052895|54862|P1|STARTED|Overall Study||196
22923|NCT02052752|54872|P3|NOT COMPLETED|Overall Study||0
22924|NCT02052752|54873|P2|NOT COMPLETED|Overall Study||0
22925|NCT02052752|54874|P1|NOT COMPLETED|Overall Study||0
22926|NCT02052752|54872|P3|COMPLETED|Overall Study||30
22927|NCT02052752|54873|P2|COMPLETED|Overall Study||30
22928|NCT02052752|54874|P1|COMPLETED|Overall Study||30
22929|NCT02052752|54872|P3|STARTED|Overall Study||30
22930|NCT02052752|54873|P2|STARTED|Overall Study||30
22931|NCT02052752|54874|P1|STARTED|Overall Study||30
22932|NCT02052661|54897|P1|NOT COMPLETED|Overall Study||0
22933|NCT02052661|54897|P1|COMPLETED|Overall Study||300
22934|NCT02052661|54897|P1|STARTED|Overall Study||300
22935|NCT02052635|54911|P2|NOT COMPLETED|Overall Study||0
22936|NCT02052635|54912|P1|NOT COMPLETED|Overall Study||0
22937|NCT02052635|54911|P2|COMPLETED|Overall Study||6
22938|NCT02052635|54912|P1|COMPLETED|Overall Study||7
22939|NCT02052635|54911|P2|STARTED|Overall Study||6
22940|NCT02052635|54912|P1|STARTED|Overall Study||7
22941|NCT02052544|54920|P1|NOT COMPLETED|Overall Study||0
22942|NCT02052544|54920|P1|COMPLETED|Overall Study|Last Subject Out|123
22943|NCT02052544|54920|P1|STARTED|Overall Study|First Subject In|123
22944|NCT02052466|54925|P1|NOT COMPLETED|Overall Study||2
22945|NCT02052466|54925|P1|COMPLETED|Overall Study||30
22946|NCT02052466|54925|P1|STARTED|Overall Study||32
22947|NCT02052414|54940|P1|NOT COMPLETED|Overall Study||17
22948|NCT02052414|54940|P1|COMPLETED|Overall Study||17
22949|NCT02052414|54940|P1|STARTED|Overall Study||34
22950|NCT02052011|54950|P2|NOT COMPLETED|Overall Study||2
22951|NCT02052011|54951|P1|NOT COMPLETED|Overall Study||4
22952|NCT02052011|54950|P2|COMPLETED|Overall Study||8
22953|NCT02052011|54951|P1|COMPLETED|Overall Study||17
22954|NCT02052011|54950|P2|STARTED|Overall Study||10
22955|NCT02052011|54951|P1|STARTED|Overall Study||21
22956|NCT02051816|54961|P4|NOT COMPLETED|Overall Study||0
22957|NCT02051816|54962|P3|NOT COMPLETED|Overall Study||0
22958|NCT02051816|54963|P2|NOT COMPLETED|Overall Study||0
22959|NCT02051816|54964|P1|NOT COMPLETED|Overall Study||0
22960|NCT02051816|54961|P4|COMPLETED|Overall Study||36
22961|NCT02051816|54962|P3|COMPLETED|Overall Study||37
22962|NCT02051816|54963|P2|COMPLETED|Overall Study||40
22963|NCT02051816|54964|P1|COMPLETED|Overall Study||37
22964|NCT02051816|54961|P4|STARTED|Overall Study||36
22965|NCT02051816|54962|P3|STARTED|Overall Study||37
22966|NCT02051816|54963|P2|STARTED|Overall Study||40
22967|NCT02051816|54964|P1|STARTED|Overall Study||37
22968|NCT02051790|55002|P1|NOT COMPLETED|Overall Study||0
22969|NCT02051790|55002|P1|COMPLETED|Overall Study||241
22970|NCT02051790|55002|P1|STARTED|Overall Study||241
22971|NCT02051595|55006|P1|NOT COMPLETED|Overall Study||0
22972|NCT02051595|55006|P1|COMPLETED|Overall Study||25
22973|NCT02051595|55006|P1|STARTED|Overall Study||25
22974|NCT02051426|55012|P2|NOT COMPLETED|Second Intervention||0
22975|NCT02051426|55013|P1|NOT COMPLETED|Second Intervention||0
22976|NCT02051426|55012|P2|COMPLETED|Second Intervention||19
22977|NCT02051426|55013|P1|COMPLETED|Second Intervention||16
22978|NCT02051426|55012|P2|STARTED|Second Intervention||19
22979|NCT02051426|55013|P1|STARTED|Second Intervention||16
22980|NCT02051426|55012|P2|NOT COMPLETED|Washout Period of 1 Month||0
22981|NCT02051426|55013|P1|NOT COMPLETED|Washout Period of 1 Month||0
22982|NCT02051426|55012|P2|COMPLETED|Washout Period of 1 Month||19
22983|NCT02051426|55013|P1|COMPLETED|Washout Period of 1 Month||16
22984|NCT02051426|55012|P2|STARTED|Washout Period of 1 Month||19
22985|NCT02051426|55013|P1|STARTED|Washout Period of 1 Month||16
22986|NCT02051426|55012|P2|NOT COMPLETED|First Intervention||0
22987|NCT02051426|55013|P1|NOT COMPLETED|First Intervention||0
22988|NCT02051426|55012|P2|COMPLETED|First Intervention||19
22989|NCT02051426|55013|P1|COMPLETED|First Intervention||16
22990|NCT02051426|55012|P2|STARTED|First Intervention||19
22991|NCT02051426|55013|P1|STARTED|First Intervention||16
22992|NCT02051335|55027|P4|NOT COMPLETED|Period 4||0
22993|NCT02051335|55028|P3|NOT COMPLETED|Period 4||0
22994|NCT02051335|55029|P2|NOT COMPLETED|Period 4||0
22995|NCT02051335|55030|P1|NOT COMPLETED|Period 4||0
22996|NCT02051335|55027|P4|COMPLETED|Period 4||4
22997|NCT02051335|55028|P3|COMPLETED|Period 4||5
22998|NCT02051335|55029|P2|COMPLETED|Period 4||7
22999|NCT02051335|55030|P1|COMPLETED|Period 4||7
23000|NCT02051335|55027|P4|STARTED|Period 4||4
23001|NCT02051335|55028|P3|STARTED|Period 4||5
23002|NCT02051335|55029|P2|STARTED|Period 4||7
23003|NCT02051335|55030|P1|STARTED|Period 4||7
23004|NCT02051335|55027|P4|NOT COMPLETED|Period 3||0
23005|NCT02051335|55028|P3|NOT COMPLETED|Period 3||0
23006|NCT02051335|55029|P2|NOT COMPLETED|Period 3||0
23007|NCT02051335|55030|P1|NOT COMPLETED|Period 3||0
23008|NCT02051335|55027|P4|COMPLETED|Period 3||4
23009|NCT02051335|55028|P3|COMPLETED|Period 3||5
23010|NCT02051335|55029|P2|COMPLETED|Period 3||7
23011|NCT02051335|55030|P1|COMPLETED|Period 3||7
23012|NCT02051335|55027|P4|STARTED|Period 3||4
23013|NCT02051335|55028|P3|STARTED|Period 3|2 Participants received treatment in Period 2 but discontinued prior to Period 3.|5
23014|NCT02051335|55029|P2|STARTED|Period 3||7
23015|NCT02051335|55030|P1|STARTED|Period 3||7
23016|NCT02051335|55027|P4|NOT COMPLETED|Period 2||0
23017|NCT02051335|55028|P3|NOT COMPLETED|Period 2||0
23018|NCT02051335|55029|P2|NOT COMPLETED|Period 2||0
23019|NCT02051335|55030|P1|NOT COMPLETED|Period 2||0
23020|NCT02051335|55027|P4|COMPLETED|Period 2||4
23021|NCT02051335|55028|P3|COMPLETED|Period 2||7
23022|NCT02051335|55029|P2|COMPLETED|Period 2||7
23023|NCT02051335|55030|P1|COMPLETED|Period 2||7
23024|NCT02051335|55027|P4|STARTED|Period 2|2 Participants received treatment in Period 1 but discontinued prior to Period 2.|4
23025|NCT02051335|55028|P3|STARTED|Period 2||7
23026|NCT02051335|55029|P2|STARTED|Period 2||7
23027|NCT02051335|55030|P1|STARTED|Period 2||7
23028|NCT02051335|55027|P4|NOT COMPLETED|Period 1||0
23029|NCT02051335|55028|P3|NOT COMPLETED|Period 1||0
23030|NCT02051335|55029|P2|NOT COMPLETED|Period 1||0
23031|NCT02051335|55030|P1|NOT COMPLETED|Period 1||0
23032|NCT02051335|55027|P4|COMPLETED|Period 1||6
23033|NCT02051335|55028|P3|COMPLETED|Period 1||7
23034|NCT02051335|55029|P2|COMPLETED|Period 1||7
23035|NCT02051335|55030|P1|COMPLETED|Period 1||7
23036|NCT02051335|55027|P4|STARTED|Period 1||6
23037|NCT02051335|55028|P3|STARTED|Period 1||7
23038|NCT02051335|55029|P2|STARTED|Period 1||7
23039|NCT02051335|55030|P1|STARTED|Period 1||7
23040|NCT02050334|55082|P2|NOT COMPLETED|Overall Study||0
23041|NCT02050334|55083|P1|NOT COMPLETED|Overall Study||0
23042|NCT02050334|55082|P2|COMPLETED|Overall Study||9
23043|NCT02050334|55083|P1|COMPLETED|Overall Study||9
23044|NCT02050334|55082|P2|STARTED|Overall Study||9
23045|NCT02050334|55083|P1|STARTED|Overall Study||9
23046|NCT02050321|55091|P1|NOT COMPLETED|Overall Study||2
23047|NCT02050321|55091|P1|COMPLETED|Overall Study||0
23048|NCT02050321|55091|P1|STARTED|Overall Study||2
23049|NCT02050048|55097|P2|NOT COMPLETED|Overall Study||2
23050|NCT02050048|55098|P1|NOT COMPLETED|Overall Study||5
23051|NCT02050048|55097|P2|COMPLETED|Overall Study||10
23052|NCT02050048|55098|P1|COMPLETED|Overall Study||9
23053|NCT02050048|55097|P2|STARTED|Overall Study||12
23054|NCT02050048|55098|P1|STARTED|Overall Study||14
23055|NCT02049931|55107|P3|NOT COMPLETED|Overall Study||3
23056|NCT02049931|55108|P2|NOT COMPLETED|Overall Study||5
23057|NCT02049931|55109|P1|NOT COMPLETED|Overall Study||3
23058|NCT02049931|55107|P3|COMPLETED|Overall Study||17
23059|NCT02049931|55108|P2|COMPLETED|Overall Study||15
23060|NCT02049931|55109|P1|COMPLETED|Overall Study||17
23061|NCT02049931|55107|P3|STARTED|Overall Study||20
23062|NCT02049931|55108|P2|STARTED|Overall Study||20
23063|NCT02049931|55109|P1|STARTED|Overall Study||20
23064|NCT02049450|55117|P1|NOT COMPLETED|Overall Study||4
23065|NCT02049450|55117|P1|COMPLETED|Overall Study|Completed = Completed Core phase of study|26
23066|NCT02049450|55117|P1|Entered Extension Phase|Overall Study|Of 26 who completed Core phase 18 moved into Ext. phase; All 18 eventually discontinued Ext. phase|18
23067|NCT02049450|55117|P1|Discontinued Treatment Prior to Week 30|Overall Study||4
23068|NCT02049450|55117|P1|STARTED|Overall Study||30
23069|NCT02049151|55133|P2|NOT COMPLETED|Overall Study||0
23070|NCT02049151|55134|P1|NOT COMPLETED|Overall Study||0
23071|NCT02049151|55133|P2|COMPLETED|Overall Study||17
23072|NCT02049151|55134|P1|COMPLETED|Overall Study||15
23073|NCT02049151|55133|P2|STARTED|Overall Study|1 subject did not receive treatment|17
23074|NCT02049151|55134|P1|STARTED|Overall Study|2 subjects did not receive treatment|15
23075|NCT02048904|55148|P1|NOT COMPLETED|Overall Study||77
23076|NCT02048904|55148|P1|COMPLETED|Overall Study||65
23077|NCT02048904|55148|P1|STARTED|Overall Study||142
23078|NCT02048891|55154|P2|NOT COMPLETED|Overall Study||0
23079|NCT02048891|55155|P1|NOT COMPLETED|Overall Study||0
23080|NCT02048891|55154|P2|COMPLETED|Overall Study||1
23081|NCT02048891|55155|P1|COMPLETED|Overall Study||2
23082|NCT02048891|55154|P2|STARTED|Overall Study||1
23083|NCT02048891|55155|P1|STARTED|Overall Study||2
23084|NCT02048072|55161|P1|NOT COMPLETED|Overall Study||4
23085|NCT02048072|55161|P1|COMPLETED|Overall Study||29
23086|NCT02048072|55161|P1|STARTED|Overall Study||33
23087|NCT02047747|55165|P1|NOT COMPLETED|Overall Study||3
23088|NCT02047747|55165|P1|COMPLETED|Overall Study||1
23089|NCT02047747|55165|P1|STARTED|Overall Study||4
23090|NCT02047227|55172|P2|NOT COMPLETED|Overall Study||130
23091|NCT02047227|55173|P1|NOT COMPLETED|Overall Study||144
23092|NCT02047227|55172|P2|COMPLETED|Overall Study||347
23093|NCT02047227|55173|P1|COMPLETED|Overall Study||318
23094|NCT02047227|55172|P2|Completed Ovarian Stimulation Phase|Overall Study||440
23095|NCT02047227|55173|P1|Completed Ovarian Stimulation Phase|Overall Study||424
23096|NCT02047227|55172|P2|STARTED|Overall Study||477
23097|NCT02047227|55173|P1|STARTED|Overall Study||462
23098|NCT02046993|55191|P2|NOT COMPLETED|Overall Study||11
23099|NCT02046993|55192|P1|NOT COMPLETED|Overall Study||3
23100|NCT02046993|55191|P2|COMPLETED|Overall Study||94
23101|NCT02046993|55192|P1|COMPLETED|Overall Study||102
23102|NCT02046993|55191|P2|6th Month|Overall Study||94
23103|NCT02046993|55192|P1|6th Month|Overall Study||102
23104|NCT02046993|55191|P2|3rd Month|Overall Study||97
23105|NCT02046993|55192|P1|3rd Month|Overall Study||104
23106|NCT02046993|55191|P2|STARTED|Overall Study||105
23107|NCT02046993|55192|P1|STARTED|Overall Study||105
23108|NCT02046980|55211|P3|NOT COMPLETED|Overall Study||1
23109|NCT02046980|55212|P2|NOT COMPLETED|Overall Study||5
23110|NCT02046980|55213|P1|NOT COMPLETED|Overall Study||2
23111|NCT02046980|55211|P3|COMPLETED|Overall Study||72
23112|NCT02046980|55212|P2|COMPLETED|Overall Study||67
23113|NCT02046980|55213|P1|COMPLETED|Overall Study||70
23114|NCT02046980|55211|P3|STARTED|Overall Study||73
23115|NCT02046980|55212|P2|STARTED|Overall Study||72
23116|NCT02046980|55213|P1|STARTED|Overall Study||72
23117|NCT02046863|55221|P1|NOT COMPLETED|Overall Study||0
23118|NCT02046863|55221|P1|COMPLETED|Overall Study||7
23119|NCT02046863|55221|P1|STARTED|Overall Study||7
23120|NCT02046772|55227|P2|NOT COMPLETED|Overall Study||0
23121|NCT02046772|55228|P1|NOT COMPLETED|Overall Study||0
23122|NCT02046772|55227|P2|COMPLETED|Overall Study||33
23123|NCT02046772|55228|P1|COMPLETED|Overall Study||30
23124|NCT02046772|55227|P2|STARTED|Overall Study||33
23125|NCT02046772|55228|P1|STARTED|Overall Study||30
23126|NCT02046265|55246|P4|NOT COMPLETED|Overall Study||2
23127|NCT02046265|55247|P3|NOT COMPLETED|Overall Study||2
23128|NCT02046265|55248|P2|NOT COMPLETED|Overall Study||2
23129|NCT02046265|55249|P1|NOT COMPLETED|Overall Study||1
23130|NCT02046265|55246|P4|COMPLETED|Overall Study||12
23131|NCT02046265|55247|P3|COMPLETED|Overall Study||10
23132|NCT02046265|55248|P2|COMPLETED|Overall Study||15
23133|NCT02046265|55249|P1|COMPLETED|Overall Study||16
23134|NCT02046265|55246|P4|STARTED|Overall Study||14
23135|NCT02046265|55247|P3|STARTED|Overall Study||12
23136|NCT02046265|55248|P2|STARTED|Overall Study||17
23137|NCT02046265|55249|P1|STARTED|Overall Study||17
23138|NCT02046226|55259|P1|NOT COMPLETED|Overall Study||7
23139|NCT02046226|55259|P1|COMPLETED|Overall Study||0
23140|NCT02046226|55259|P1|STARTED|Overall Study||7
23141|NCT02046200|55266|P2|NOT COMPLETED|Second Intervention (1 Day)||0
23142|NCT02046200|55267|P1|NOT COMPLETED|Second Intervention (1 Day)||0
23143|NCT02046200|55266|P2|COMPLETED|Second Intervention (1 Day)||6
23144|NCT02046200|55267|P1|COMPLETED|Second Intervention (1 Day)||5
23145|NCT02046200|55266|P2|STARTED|Second Intervention (1 Day)||6
23146|NCT02046200|55267|P1|STARTED|Second Intervention (1 Day)||5
23147|NCT02046200|55266|P2|NOT COMPLETED|First Intervention (1 Day)||0
23148|NCT02046200|55267|P1|NOT COMPLETED|First Intervention (1 Day)||0
23149|NCT02046200|55266|P2|COMPLETED|First Intervention (1 Day)||6
23150|NCT02046200|55267|P1|COMPLETED|First Intervention (1 Day)||5
23151|NCT02046200|55266|P2|STARTED|First Intervention (1 Day)||6
23152|NCT02046200|55267|P1|STARTED|First Intervention (1 Day)||5
23153|NCT02046148|55307|P2|NOT COMPLETED|Overall Study||3
23154|NCT02046148|55308|P1|NOT COMPLETED|Overall Study||1
23155|NCT02046148|55307|P2|COMPLETED|Overall Study||23
23156|NCT02046148|55308|P1|COMPLETED|Overall Study||48
23157|NCT02046148|55307|P2|STARTED|Overall Study||26
23158|NCT02046148|55308|P1|STARTED|Overall Study||49
23159|NCT02045836|55354|P2|NOT COMPLETED|Overall Study||14
23160|NCT02045836|55355|P1|NOT COMPLETED|Overall Study||9
23161|NCT02045836|55354|P2|COMPLETED|Overall Study||419
23162|NCT02045836|55355|P1|COMPLETED|Overall Study||423
23163|NCT02045836|55354|P2|STARTED|Overall Study||433
23164|NCT02045836|55355|P1|STARTED|Overall Study||432
23165|NCT02045732|55384|P2|NOT COMPLETED|Overall Study||1
23166|NCT02045732|55385|P1|NOT COMPLETED|Overall Study||1
23167|NCT02045732|55384|P2|COMPLETED|Overall Study||2
23168|NCT02045732|55385|P1|COMPLETED|Overall Study||0
23169|NCT02045732|55384|P2|STARTED|Overall Study||3
23170|NCT02045732|55385|P1|STARTED|Overall Study||1
23171|NCT02045264|55403|P1|NOT COMPLETED|Overall Study||0
23172|NCT02045264|55403|P1|COMPLETED|Overall Study||12
23173|NCT02045264|55403|P1|STARTED|Overall Study||12
23174|NCT02045238|55420|P2|NOT COMPLETED|Overall Study||1
23175|NCT02045238|55421|P1|NOT COMPLETED|Overall Study||7
23176|NCT02045238|55420|P2|COMPLETED|Overall Study||14
23177|NCT02045238|55421|P1|COMPLETED|Overall Study||9
23178|NCT02045238|55420|P2|STARTED|Overall Study||15
23179|NCT02045238|55421|P1|STARTED|Overall Study||16
23180|NCT02044991|55431|P2|NOT COMPLETED|Overall Study||0
23181|NCT02044991|55432|P1|NOT COMPLETED|Overall Study||0
23182|NCT02044991|55431|P2|COMPLETED|Overall Study||0
23183|NCT02044991|55432|P1|COMPLETED|Overall Study||2
23184|NCT02044991|55431|P2|STARTED|Overall Study||0
23185|NCT02044991|55432|P1|STARTED|Overall Study||2
23186|NCT02044848|55444|P2|NOT COMPLETED|Overall Study||3
23187|NCT02044848|55445|P1|NOT COMPLETED|Overall Study||2
23188|NCT02044848|55444|P2|COMPLETED|Overall Study||0
23189|NCT02044848|55445|P1|COMPLETED|Overall Study||0
23190|NCT02044848|55444|P2|STARTED|Overall Study||3
23191|NCT02044848|55445|P1|STARTED|Overall Study||2
23192|NCT02044822|55451|P1|NOT COMPLETED|Overall Study||93
23193|NCT02044822|55451|P1|COMPLETED|Overall Study|Completed = reached primary efficacy endpoint of progressive disease or death.|9
23194|NCT02044822|55451|P1|STARTED|Overall Study||102
23195|NCT02044458|55463|P2|NOT COMPLETED|Overall Study||8
23196|NCT02044458|55464|P1|NOT COMPLETED|Overall Study||3
23197|NCT02044458|55463|P2|COMPLETED|Overall Study||61
23198|NCT02044458|55464|P1|COMPLETED|Overall Study||62
23199|NCT02044458|55463|P2|STARTED|Overall Study||69
23200|NCT02044458|55464|P1|STARTED|Overall Study||65
23201|NCT02044393|55476|P2|NOT COMPLETED|Period 2||0
23202|NCT02044393|55477|P1|NOT COMPLETED|Period 2||0
23203|NCT02044393|55476|P2|COMPLETED|Period 2||10
23204|NCT02044393|55477|P1|COMPLETED|Period 2||10
23205|NCT02044393|55476|P2|STARTED|Period 2||10
23206|NCT02044393|55477|P1|STARTED|Period 2||10
23207|NCT02044393|55476|P2|NOT COMPLETED|Period 1||0
23208|NCT02044393|55477|P1|NOT COMPLETED|Period 1||0
23209|NCT02044393|55476|P2|COMPLETED|Period 1||10
23210|NCT02044393|55477|P1|COMPLETED|Period 1||10
23211|NCT02044393|55476|P2|STARTED|Period 1||10
23212|NCT02044393|55477|P1|STARTED|Period 1||10
23213|NCT02044380|55490|P1|NOT COMPLETED|Overall Study||0
23214|NCT02044380|55490|P1|COMPLETED|Overall Study||14
23215|NCT02044380|55490|P1|STARTED|Overall Study|Started are the treated patients|14
23216|NCT02044367|55494|P6|NOT COMPLETED|Overall Study||0
23217|NCT02044367|55495|P5|NOT COMPLETED|Overall Study||0
23218|NCT02044367|55496|P4|NOT COMPLETED|Overall Study||0
23219|NCT02044367|55497|P3|NOT COMPLETED|Overall Study||0
23220|NCT02044367|55498|P2|NOT COMPLETED|Overall Study||0
23221|NCT02044367|55499|P1|NOT COMPLETED|Overall Study||0
23222|NCT02044367|55494|P6|COMPLETED|Overall Study||9
23223|NCT02044367|55495|P5|COMPLETED|Overall Study||9
23224|NCT02044367|55496|P4|COMPLETED|Overall Study||9
23225|NCT02044367|55497|P3|COMPLETED|Overall Study||9
23226|NCT02044367|55498|P2|COMPLETED|Overall Study||9
23227|NCT02044367|55499|P1|COMPLETED|Overall Study||9
23228|NCT02044367|55494|P6|STARTED|Overall Study||9
23229|NCT02044367|55495|P5|STARTED|Overall Study||9
23230|NCT02044367|55496|P4|STARTED|Overall Study||9
23231|NCT02044367|55497|P3|STARTED|Overall Study||9
23232|NCT02044367|55498|P2|STARTED|Overall Study||9
23233|NCT02044367|55499|P1|STARTED|Overall Study||9
23234|NCT02044302|55522|P2|NOT COMPLETED|Overall Study||0
23235|NCT02044302|55523|P1|NOT COMPLETED|Overall Study||2
23236|NCT02044302|55522|P2|COMPLETED|Overall Study||0
23237|NCT02044302|55523|P1|COMPLETED|Overall Study||0
23238|NCT02044302|55522|P2|STARTED|Overall Study||0
23239|NCT02044302|55523|P1|STARTED|Overall Study||2
23240|NCT02043808|55531|P2|NOT COMPLETED|Overall Study||0
23241|NCT02043808|55532|P1|NOT COMPLETED|Overall Study||0
23242|NCT02043808|55531|P2|COMPLETED|Overall Study||12793
23243|NCT02043808|55532|P1|COMPLETED|Overall Study||12793
23244|NCT02043808|55531|P2|STARTED|Overall Study||12793
23245|NCT02043808|55532|P1|STARTED|Overall Study||12793
23246|NCT02043782|55570|P6|NOT COMPLETED|Period 3||0
23247|NCT02043782|55571|P5|NOT COMPLETED|Period 3||0
23248|NCT02043782|55572|P4|NOT COMPLETED|Period 3||0
23249|NCT02043782|55573|P3|NOT COMPLETED|Period 3||0
23250|NCT02043782|55574|P2|NOT COMPLETED|Period 3||0
23251|NCT02043782|55575|P1|NOT COMPLETED|Period 3||0
23252|NCT02043782|55570|P6|COMPLETED|Period 3||6
23253|NCT02043782|55571|P5|COMPLETED|Period 3||6
23254|NCT02043782|55572|P4|COMPLETED|Period 3||6
23255|NCT02043782|55573|P3|COMPLETED|Period 3||6
23256|NCT02043782|55574|P2|COMPLETED|Period 3||6
23257|NCT02043782|55575|P1|COMPLETED|Period 3||7
23258|NCT02043782|55570|P6|STARTED|Period 3||6
23259|NCT02043782|55571|P5|STARTED|Period 3||6
23260|NCT02043782|55572|P4|STARTED|Period 3||6
23261|NCT02043782|55573|P3|STARTED|Period 3||6
23262|NCT02043782|55574|P2|STARTED|Period 3||6
23263|NCT02043782|55575|P1|STARTED|Period 3||7
23264|NCT02043782|55570|P6|NOT COMPLETED|Period 2||0
23265|NCT02043782|55571|P5|NOT COMPLETED|Period 2||0
23266|NCT02043782|55572|P4|NOT COMPLETED|Period 2||0
23267|NCT02043782|55573|P3|NOT COMPLETED|Period 2||0
23268|NCT02043782|55574|P2|NOT COMPLETED|Period 2||0
23269|NCT02043782|55575|P1|NOT COMPLETED|Period 2||0
23270|NCT02043782|55570|P6|COMPLETED|Period 2||6
23271|NCT02043782|55571|P5|COMPLETED|Period 2||6
23272|NCT02043782|55572|P4|COMPLETED|Period 2||6
23273|NCT02043782|55573|P3|COMPLETED|Period 2||6
23274|NCT02043782|55574|P2|COMPLETED|Period 2||6
23275|NCT02043782|55575|P1|COMPLETED|Period 2||7
23276|NCT02043782|55570|P6|STARTED|Period 2||6
23277|NCT02043782|55571|P5|STARTED|Period 2||6
23278|NCT02043782|55572|P4|STARTED|Period 2||6
23279|NCT02043782|55573|P3|STARTED|Period 2||6
23280|NCT02043782|55574|P2|STARTED|Period 2||6
23281|NCT02043782|55575|P1|STARTED|Period 2||7
23282|NCT02043782|55570|P6|NOT COMPLETED|Period 1||0
23283|NCT02043782|55571|P5|NOT COMPLETED|Period 1||0
23284|NCT02043782|55572|P4|NOT COMPLETED|Period 1||0
23285|NCT02043782|55573|P3|NOT COMPLETED|Period 1||1
23286|NCT02043782|55574|P2|NOT COMPLETED|Period 1||0
23287|NCT02043782|55575|P1|NOT COMPLETED|Period 1||0
23288|NCT02043782|55570|P6|COMPLETED|Period 1||6
23289|NCT02043782|55571|P5|COMPLETED|Period 1||6
23290|NCT02043782|55572|P4|COMPLETED|Period 1||6
23291|NCT02043782|55573|P3|COMPLETED|Period 1|One subject discontinued due to an adverse event while testing own product|6
23292|NCT02043782|55574|P2|COMPLETED|Period 1||6
23293|NCT02043782|55575|P1|COMPLETED|Period 1||7
23294|NCT02043782|55570|P6|STARTED|Period 1||6
23295|NCT02043782|55571|P5|STARTED|Period 1||6
23296|NCT02043782|55572|P4|STARTED|Period 1||6
23297|NCT02043782|55573|P3|STARTED|Period 1||7
23298|NCT02043782|55574|P2|STARTED|Period 1||6
23299|NCT02043782|55575|P1|STARTED|Period 1||7
23300|NCT02043379|55585|P2|NOT COMPLETED|Overall Study||0
23301|NCT02043379|55586|P1|NOT COMPLETED|Overall Study||0
23302|NCT02043379|55585|P2|COMPLETED|Overall Study||20
23303|NCT02043379|55586|P1|COMPLETED|Overall Study||30
23304|NCT02043379|55585|P2|STARTED|Overall Study||20
23305|NCT02043379|55586|P1|STARTED|Overall Study||30
23306|NCT02043366|55648|P6|NOT COMPLETED|Overall Study||2
23307|NCT02043366|55649|P5|NOT COMPLETED|Overall Study||2
23308|NCT02043366|55650|P4|NOT COMPLETED|Overall Study||2
23309|NCT02043366|55651|P3|NOT COMPLETED|Overall Study||2
23310|NCT02043366|55652|P2|NOT COMPLETED|Overall Study||2
23311|NCT02043366|55653|P1|NOT COMPLETED|Overall Study||2
23312|NCT02043366|55648|P6|COMPLETED|Overall Study||28
23313|NCT02043366|55649|P5|COMPLETED|Overall Study||28
23314|NCT02043366|55650|P4|COMPLETED|Overall Study||28
23315|NCT02043366|55651|P3|COMPLETED|Overall Study||28
23316|NCT02043366|55652|P2|COMPLETED|Overall Study||28
23317|NCT02043366|55653|P1|COMPLETED|Overall Study||28
23318|NCT02043366|55648|P6|STARTED|Overall Study||30
23319|NCT02043366|55649|P5|STARTED|Overall Study||30
23320|NCT02043366|55650|P4|STARTED|Overall Study||30
23321|NCT02043366|55651|P3|STARTED|Overall Study||30
23322|NCT02043366|55652|P2|STARTED|Overall Study||30
23323|NCT02043366|55653|P1|STARTED|Overall Study||30
23324|NCT02043145|55676|P3|NOT COMPLETED|Overall Study||0
23325|NCT02043145|55677|P2|NOT COMPLETED|Overall Study||0
23326|NCT02043145|55678|P1|NOT COMPLETED|Overall Study||0
23327|NCT02043145|55676|P3|COMPLETED|Overall Study||425
23328|NCT02043145|55677|P2|COMPLETED|Overall Study||247
23329|NCT02043145|55678|P1|COMPLETED|Overall Study||55
23330|NCT02043145|55676|P3|STARTED|Overall Study||425
23331|NCT02043145|55677|P2|STARTED|Overall Study||247
23332|NCT02043145|55678|P1|STARTED|Overall Study||55
23333|NCT02043132|55691|P2|NOT COMPLETED|Overall Study||9
23334|NCT02043132|55692|P1|NOT COMPLETED|Overall Study||5
23335|NCT02043132|55691|P2|COMPLETED|Overall Study||49
23336|NCT02043132|55692|P1|COMPLETED|Overall Study||53
23337|NCT02043132|55691|P2|STARTED|Overall Study||58
23338|NCT02043132|55692|P1|STARTED|Overall Study||58
23339|NCT02042924|55712|P1|NOT COMPLETED|Overall Study||1
23340|NCT02042924|55712|P1|COMPLETED|Overall Study||1
23341|NCT02042924|55712|P1|STARTED|Overall Study||2
23342|NCT02042911|55718|P1|NOT COMPLETED|Overall Study||1
23343|NCT02042911|55718|P1|COMPLETED|Overall Study||9
23344|NCT02042911|55718|P1|STARTED|Overall Study||10
23345|NCT02042872|55732|P2|NOT COMPLETED|Overall Study||5
23346|NCT02042872|55733|P1|NOT COMPLETED|Overall Study||0
23347|NCT02042872|55732|P2|COMPLETED|Overall Study||8
23348|NCT02042872|55733|P1|COMPLETED|Overall Study||8
23349|NCT02042872|55732|P2|STARTED|Overall Study||13
23350|NCT02042872|55733|P1|STARTED|Overall Study||8
23351|NCT02042534|55743|P2|NOT COMPLETED|Overall Study||0
23352|NCT02042534|55744|P1|NOT COMPLETED|Overall Study||0
23353|NCT02042534|55743|P2|COMPLETED|Overall Study||94
23354|NCT02042534|55744|P1|COMPLETED|Overall Study||101
23355|NCT02042534|55743|P2|STARTED|Overall Study||94
23356|NCT02042534|55744|P1|STARTED|Overall Study||101
23357|NCT02042443|55760|P2|NOT COMPLETED|Overall Study||26
23358|NCT02042443|55761|P1|NOT COMPLETED|Overall Study||27
23359|NCT02042443|55760|P2|COMPLETED|Overall Study||0
23360|NCT02042443|55761|P1|COMPLETED|Overall Study||0
23361|NCT02042443|55760|P2|Eligible and Analyzable|Overall Study||20
23362|NCT02042443|55761|P1|Eligible and Analyzable|Overall Study||24
23363|NCT02042443|55760|P2|STARTED|Overall Study||26
23364|NCT02042443|55761|P1|STARTED|Overall Study||27
23365|NCT02042404|55773|P2|NOT COMPLETED|Overall Study||0
23366|NCT02042404|55774|P1|NOT COMPLETED|Overall Study||5
23367|NCT02042404|55773|P2|COMPLETED|Overall Study||5
23368|NCT02042404|55774|P1|COMPLETED|Overall Study|39 subjects completed 30 days evaluation. 38 subjects completed 120 days evaluation.|38
23369|NCT02042404|55773|P2|STARTED|Overall Study||5
23370|NCT02042404|55774|P1|STARTED|Overall Study|Enrollment was stopped after 43 were enrolled, had approval to enroll 45 primary cohort subjects|43
23371|NCT02042274|55785|P1|NOT COMPLETED|Overall Study||0
23372|NCT02042274|55785|P1|COMPLETED|Overall Study||12
23373|NCT02042274|55785|P1|STARTED|Overall Study||12
23374|NCT02042131|55793|P3|NOT COMPLETED|Overall Study||0
23375|NCT02042131|55794|P2|NOT COMPLETED|Overall Study||0
23376|NCT02042131|55795|P1|NOT COMPLETED|Overall Study||0
23377|NCT02042131|55793|P3|COMPLETED|Overall Study||33
23378|NCT02042131|55794|P2|COMPLETED|Overall Study||32
23379|NCT02042131|55795|P1|COMPLETED|Overall Study||32
23380|NCT02042131|55793|P3|STARTED|Overall Study||33
23381|NCT02042131|55794|P2|STARTED|Overall Study||32
23382|NCT02042131|55795|P1|STARTED|Overall Study||32
23383|NCT02041533|55814|P2|NOT COMPLETED|Overall Study||258
23384|NCT02041533|55815|P1|NOT COMPLETED|Overall Study||228
23385|NCT02041533|55814|P2|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|12
23386|NCT02041533|55815|P1|COMPLETED|Overall Study|Completed = Participants continuing in the treatment period|43
23387|NCT02041533|55814|P2|Began Treatment|Overall Study||263
23388|NCT02041533|55815|P1|Began Treatment|Overall Study||267
23389|NCT02041533|55814|P2|STARTED|Overall Study||270
23390|NCT02041533|55815|P1|STARTED|Overall Study||271
23391|NCT02041520|55837|P2|NOT COMPLETED|Overall Study||7
23392|NCT02041520|55838|P1|NOT COMPLETED|Overall Study||6
23393|NCT02041520|55837|P2|COMPLETED|Overall Study||28
23394|NCT02041520|55838|P1|COMPLETED|Overall Study||29
23395|NCT02041520|55837|P2|STARTED|Overall Study|35 patients randomly assigned to placebo|35
23396|NCT02041520|55838|P1|STARTED|Overall Study|35 patients randomly assigned to omega 3 fatty acids|35
23397|NCT02041377|55858|P1|NOT COMPLETED|Overall Study||0
23398|NCT02041377|55858|P1|COMPLETED|Overall Study||134
23399|NCT02041377|55858|P1|STARTED|Overall Study||134
23400|NCT02041325|55868|P2|NOT COMPLETED|Overall Study||3
23401|NCT02041325|55869|P1|NOT COMPLETED|Overall Study||3
23402|NCT02041325|55868|P2|COMPLETED|Overall Study||13
23403|NCT02041325|55869|P1|COMPLETED|Overall Study||19
23404|NCT02041325|55868|P2|STARTED|Overall Study||16
23405|NCT02041325|55869|P1|STARTED|Overall Study||22
23406|NCT02041286|55881|P1|NOT COMPLETED|Overall Study||1
23407|NCT02041286|55881|P1|COMPLETED|Overall Study|One subject discontinued from testing after low BG fingerstick result (hypoglycemia AE).|135
23408|NCT02041286|55881|P1|STARTED|Overall Study||136
23409|NCT02041221|55895|P6|NOT COMPLETED|Part 2||0
23410|NCT02041221|55896|P5|NOT COMPLETED|Part 2||0
23411|NCT02041221|55897|P4|NOT COMPLETED|Part 2||0
23412|NCT02041221|55898|P3|NOT COMPLETED|Part 2||1
23413|NCT02041221|55899|P2|NOT COMPLETED|Part 2||0
23414|NCT02041221|55900|P1|NOT COMPLETED|Part 2||0
23415|NCT02041221|55895|P6|COMPLETED|Part 2||6
23416|NCT02041221|55896|P5|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
23417|NCT02041221|55897|P4|COMPLETED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
23418|NCT02041221|55898|P3|COMPLETED|Part 2||5
23419|NCT02041221|55899|P2|COMPLETED|Part 2||6
23420|NCT02041221|55900|P1|COMPLETED|Part 2||6
23421|NCT02041221|55895|P6|STARTED|Part 2||6
23422|NCT02041221|55896|P5|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually|0
23423|NCT02041221|55897|P4|STARTED|Part 2|Part 1 data fields are by default copied in Part 2. There is no dose 4 and 5 actually.|0
23424|NCT02041221|55898|P3|STARTED|Part 2||6
23425|NCT02041221|55899|P2|STARTED|Part 2||6
23426|NCT02041221|55900|P1|STARTED|Part 2||6
23427|NCT02041221|55895|P6|NOT COMPLETED|Part 1||0
23428|NCT02041221|55896|P5|NOT COMPLETED|Part 1||0
23429|NCT02041221|55897|P4|NOT COMPLETED|Part 1||0
23430|NCT02041221|55898|P3|NOT COMPLETED|Part 1||0
23431|NCT02041221|55899|P2|NOT COMPLETED|Part 1||0
23432|NCT02041221|55900|P1|NOT COMPLETED|Part 1||0
23433|NCT02041221|55895|P6|COMPLETED|Part 1||10
23434|NCT02041221|55896|P5|COMPLETED|Part 1||6
23435|NCT02041221|55897|P4|COMPLETED|Part 1||6
23436|NCT02041221|55898|P3|COMPLETED|Part 1||6
23437|NCT02041221|55899|P2|COMPLETED|Part 1||6
23438|NCT02041221|55900|P1|COMPLETED|Part 1||6
23439|NCT02041221|55895|P6|STARTED|Part 1||10
23440|NCT02041221|55896|P5|STARTED|Part 1||6
23441|NCT02041221|55897|P4|STARTED|Part 1||6
23442|NCT02041221|55898|P3|STARTED|Part 1||6
23443|NCT02041221|55899|P2|STARTED|Part 1||6
23444|NCT02041221|55900|P1|STARTED|Part 1||6
23445|NCT02040792|55919|P5|NOT COMPLETED|Overall Study||7
23446|NCT02040792|55920|P4|NOT COMPLETED|Overall Study||7
23447|NCT02040792|55921|P3|NOT COMPLETED|Overall Study||3
23448|NCT02040792|55922|P2|NOT COMPLETED|Overall Study||3
23449|NCT02040792|55923|P1|NOT COMPLETED|Overall Study||6
23450|NCT02040792|55919|P5|COMPLETED|Overall Study||67
23451|NCT02040792|55920|P4|COMPLETED|Overall Study||64
23452|NCT02040792|55921|P3|COMPLETED|Overall Study||68
23453|NCT02040792|55922|P2|COMPLETED|Overall Study||65
23454|NCT02040792|55923|P1|COMPLETED|Overall Study||64
23455|NCT02040792|55919|P5|STARTED|Overall Study||74
23456|NCT02040792|55920|P4|STARTED|Overall Study||71
23457|NCT02040792|55921|P3|STARTED|Overall Study||71
23458|NCT02040792|55922|P2|STARTED|Overall Study||68
23459|NCT02040792|55923|P1|STARTED|Overall Study||70
23460|NCT02040623|55938|P3|NOT COMPLETED|Overall Study||2
23461|NCT02040623|55939|P2|NOT COMPLETED|Overall Study||6
23462|NCT02040623|55940|P1|NOT COMPLETED|Overall Study||4
23463|NCT02040623|55938|P3|COMPLETED|Overall Study||10
23464|NCT02040623|55939|P2|COMPLETED|Overall Study||6
23465|NCT02040623|55940|P1|COMPLETED|Overall Study||7
23466|NCT02040623|55938|P3|STARTED|Overall Study||12
23467|NCT02040623|55939|P2|STARTED|Overall Study||12
23468|NCT02040623|55940|P1|STARTED|Overall Study||11
23469|NCT02040532|55948|P1|NOT COMPLETED|Overall Study||12
23470|NCT02040532|55948|P1|COMPLETED|Overall Study||20
23471|NCT02040532|55948|P1|Received at Least One Dose of Medication|Overall Study||26
23472|NCT02040532|55948|P1|STARTED|Overall Study||32
23473|NCT02040428|55961|P2|NOT COMPLETED|Overall Study||4
23474|NCT02040428|55962|P1|NOT COMPLETED|Overall Study||5
23475|NCT02040428|55961|P2|COMPLETED|Overall Study||77
23476|NCT02040428|55962|P1|COMPLETED|Overall Study||70
23477|NCT02040428|55961|P2|Intent to Treat (Randomized Subjects)|Overall Study||80
23478|NCT02040428|55962|P1|Intent to Treat (Randomized Subjects)|Overall Study||76
23479|NCT02040428|55961|P2|STARTED|Overall Study||81
23480|NCT02040428|55962|P1|STARTED|Overall Study||75
23481|NCT02039817|55976|P2|NOT COMPLETED|Overall Study||0
23482|NCT02039817|55977|P1|NOT COMPLETED|Overall Study||0
23483|NCT02039817|55976|P2|COMPLETED|Overall Study||8
23484|NCT02039817|55977|P1|COMPLETED|Overall Study||8
23485|NCT02039817|55976|P2|STARTED|Overall Study||8
23486|NCT02039817|55977|P1|STARTED|Overall Study||8
23487|NCT02039778|55986|P1|NOT COMPLETED|Overall Study||4
23488|NCT02039778|55986|P1|COMPLETED|Overall Study||0
23489|NCT02039778|55986|P1|STARTED|Overall Study||4
23490|NCT02039687|55998|P4|NOT COMPLETED|Overall Study||0
23491|NCT02039687|55999|P3|NOT COMPLETED|Overall Study||3
23492|NCT02039687|56000|P2|NOT COMPLETED|Overall Study||1
23493|NCT02039687|56001|P1|NOT COMPLETED|Overall Study||0
23494|NCT02039687|55998|P4|COMPLETED|Overall Study||16
23495|NCT02039687|55999|P3|COMPLETED|Overall Study||13
23496|NCT02039687|56000|P2|COMPLETED|Overall Study||15
23497|NCT02039687|56001|P1|COMPLETED|Overall Study||16
23498|NCT02039687|55998|P4|STARTED|Overall Study||16
23499|NCT02039687|55999|P3|STARTED|Overall Study||16
23500|NCT02039687|56000|P2|STARTED|Overall Study||16
23501|NCT02039687|56001|P1|STARTED|Overall Study||16
23502|NCT02039427|56031|P4|NOT COMPLETED|Overall Study||5
23503|NCT02039427|56032|P3|NOT COMPLETED|Overall Study||3
23504|NCT02039427|56033|P2|NOT COMPLETED|Overall Study||1
23505|NCT02039427|56034|P1|NOT COMPLETED|Overall Study||3
23506|NCT02039427|56031|P4|COMPLETED|Overall Study||43
23507|NCT02039427|56032|P3|COMPLETED|Overall Study||45
23508|NCT02039427|56033|P2|COMPLETED|Overall Study||47
23509|NCT02039427|56034|P1|COMPLETED|Overall Study||45
23510|NCT02039427|56031|P4|STARTED|Overall Study||48
23511|NCT02039427|56032|P3|STARTED|Overall Study||48
23512|NCT02039427|56033|P2|STARTED|Overall Study||48
23513|NCT02039427|56034|P1|STARTED|Overall Study||48
23514|NCT02039414|56054|P2|NOT COMPLETED|Overall Study||2
23515|NCT02039414|56055|P1|NOT COMPLETED|Overall Study||6
23516|NCT02039414|56054|P2|COMPLETED|Overall Study||16
23517|NCT02039414|56055|P1|COMPLETED|Overall Study||16
23518|NCT02039414|56054|P2|STARTED|Overall Study||18
23519|NCT02039414|56055|P1|STARTED|Overall Study||22
23520|NCT02038959|56069|P2|NOT COMPLETED|Overall Study||8
23521|NCT02038959|56070|P1|NOT COMPLETED|Overall Study||6
23522|NCT02038959|56069|P2|COMPLETED|Overall Study||89
23523|NCT02038959|56070|P1|COMPLETED|Overall Study||92
23524|NCT02038959|56069|P2|STARTED|Overall Study||97
23525|NCT02038959|56070|P1|STARTED|Overall Study||98
23526|NCT02038933|56098|P1|NOT COMPLETED|Follow-up||19
23527|NCT02038933|56098|P1|COMPLETED|Follow-up|Includes subjects still on-treatment and subjects off-treatment continuing in the Follow-up period.|102
23528|NCT02038933|56098|P1|STARTED|Follow-up||121
23529|NCT02038933|56098|P1|NOT COMPLETED|Treatment||114
23530|NCT02038933|56098|P1|COMPLETED|Treatment|Subjects continuing in the treatment period|7
23531|NCT02038933|56098|P1|STARTED|Treatment||121
23532|NCT02038907|56131|P14|NOT COMPLETED|Overall Study||0
23533|NCT02038907|56132|P13|NOT COMPLETED|Overall Study||0
23534|NCT02038907|56133|P12|NOT COMPLETED|Overall Study||0
23535|NCT02038907|56134|P11|NOT COMPLETED|Overall Study||2
23536|NCT02038907|56135|P10|NOT COMPLETED|Overall Study||0
23537|NCT02038907|56136|P9|NOT COMPLETED|Overall Study||0
23538|NCT02038907|56137|P8|NOT COMPLETED|Overall Study||0
23539|NCT02038907|56138|P7|NOT COMPLETED|Overall Study||0
23540|NCT02038907|56139|P6|NOT COMPLETED|Overall Study||0
23541|NCT02038907|56140|P5|NOT COMPLETED|Overall Study||0
23542|NCT02038907|56141|P4|NOT COMPLETED|Overall Study||0
23543|NCT02038907|56142|P3|NOT COMPLETED|Overall Study||0
23544|NCT02038907|56143|P2|NOT COMPLETED|Overall Study||0
23545|NCT02038907|56144|P1|NOT COMPLETED|Overall Study||0
23546|NCT02038907|56131|P14|COMPLETED|Overall Study||31
23547|NCT02038907|56132|P13|COMPLETED|Overall Study||29
23548|NCT02038907|56133|P12|COMPLETED|Overall Study||28
23549|NCT02038907|56134|P11|COMPLETED|Overall Study||27
23550|NCT02038907|56135|P10|COMPLETED|Overall Study||30
23551|NCT02038907|56136|P9|COMPLETED|Overall Study||29
23552|NCT02038907|56137|P8|COMPLETED|Overall Study||32
23553|NCT02038907|56138|P7|COMPLETED|Overall Study||30
23554|NCT02038907|56139|P6|COMPLETED|Overall Study||31
23555|NCT02038907|56140|P5|COMPLETED|Overall Study||30
23556|NCT02038907|56141|P4|COMPLETED|Overall Study||31
23557|NCT02038907|56142|P3|COMPLETED|Overall Study||30
23558|NCT02038907|56143|P2|COMPLETED|Overall Study||30
23559|NCT02038907|56144|P1|COMPLETED|Overall Study||30
23560|NCT02038907|56131|P14|STARTED|Overall Study||31
23561|NCT02038907|56132|P13|STARTED|Overall Study||29
23562|NCT02038907|56133|P12|STARTED|Overall Study||28
23563|NCT02038907|56134|P11|STARTED|Overall Study||29
23564|NCT02038907|56135|P10|STARTED|Overall Study||30
23565|NCT02038907|56136|P9|STARTED|Overall Study||29
23566|NCT02038907|56137|P8|STARTED|Overall Study||32
23567|NCT02038907|56138|P7|STARTED|Overall Study||30
23568|NCT02038907|56139|P6|STARTED|Overall Study||31
23569|NCT02038907|56140|P5|STARTED|Overall Study||30
23570|NCT02038907|56141|P4|STARTED|Overall Study||31
23571|NCT02038907|56142|P3|STARTED|Overall Study||30
23572|NCT02038907|56143|P2|STARTED|Overall Study||30
23573|NCT02038907|56144|P1|STARTED|Overall Study||30
23574|NCT02038790|56672|P2|NOT COMPLETED|Day 1 - Second Treatment||0
23575|NCT02038790|56673|P1|NOT COMPLETED|Day 1 - Second Treatment||0
23576|NCT02038790|56672|P2|COMPLETED|Day 1 - Second Treatment||16
23577|NCT02038790|56673|P1|COMPLETED|Day 1 - Second Treatment||15
23578|NCT02038790|56672|P2|STARTED|Day 1 - Second Treatment||16
23579|NCT02038790|56673|P1|STARTED|Day 1 - Second Treatment||15
23580|NCT02038790|56672|P2|NOT COMPLETED|Day 0 - First Treatment||1
23581|NCT02038790|56673|P1|NOT COMPLETED|Day 0 - First Treatment||1
23582|NCT02038790|56672|P2|COMPLETED|Day 0 - First Treatment||16
23583|NCT02038790|56673|P1|COMPLETED|Day 0 - First Treatment||15
23584|NCT02038790|56672|P2|STARTED|Day 0 - First Treatment||17
23585|NCT02038790|56673|P1|STARTED|Day 0 - First Treatment||16
23586|NCT02038543|56708|P4|NOT COMPLETED|Overall Study||2
23587|NCT02038543|56709|P3|NOT COMPLETED|Overall Study||0
23588|NCT02038543|56710|P2|NOT COMPLETED|Overall Study||0
23589|NCT02038543|56711|P1|NOT COMPLETED|Overall Study||0
23590|NCT02038543|56708|P4|COMPLETED|Overall Study||1
23591|NCT02038543|56709|P3|COMPLETED|Overall Study||8
23592|NCT02038543|56710|P2|COMPLETED|Overall Study||4
23593|NCT02038543|56711|P1|COMPLETED|Overall Study||7
23594|NCT02038543|56708|P4|STARTED|Overall Study||3
23595|NCT02038543|56709|P3|STARTED|Overall Study||8
23596|NCT02038543|56710|P2|STARTED|Overall Study||4
23597|NCT02038543|56711|P1|STARTED|Overall Study||7
23598|NCT02038075|56727|P2|NOT COMPLETED|Overall Study||0
23599|NCT02038075|56728|P1|NOT COMPLETED|Overall Study||3
23600|NCT02038075|56727|P2|COMPLETED|Overall Study||76
23601|NCT02038075|56728|P1|COMPLETED|Overall Study||73
23602|NCT02038075|56727|P2|STARTED|Overall Study||76
23603|NCT02038075|56728|P1|STARTED|Overall Study||76
23604|NCT02037776|56736|P2|NOT COMPLETED|Overall Study||4
23605|NCT02037776|56737|P1|NOT COMPLETED|Overall Study||5
23606|NCT02037776|56736|P2|COMPLETED|Overall Study||60
23607|NCT02037776|56737|P1|COMPLETED|Overall Study||56
23608|NCT02037776|56736|P2|STARTED|Overall Study||64
23609|NCT02037776|56737|P1|STARTED|Overall Study||61
23610|NCT02037607|56753|P1|NOT COMPLETED|Overall Study||9
23611|NCT02037607|56753|P1|COMPLETED|Overall Study||91
23612|NCT02037607|56753|P1|STARTED|Overall Study||100
23613|NCT02037477|56761|P4|NOT COMPLETED|Treatment Period 2||0
23614|NCT02037477|56762|P3|NOT COMPLETED|Treatment Period 2||0
23615|NCT02037477|56763|P2|NOT COMPLETED|Treatment Period 2||0
23616|NCT02037477|56764|P1|NOT COMPLETED|Treatment Period 2||0
23617|NCT02037477|56761|P4|COMPLETED|Treatment Period 2||5
23618|NCT02037477|56762|P3|COMPLETED|Treatment Period 2||4
23619|NCT02037477|56763|P2|COMPLETED|Treatment Period 2||5
23620|NCT02037477|56764|P1|COMPLETED|Treatment Period 2||5
23621|NCT02037477|56761|P4|STARTED|Treatment Period 2||5
23622|NCT02037477|56762|P3|STARTED|Treatment Period 2||4
23623|NCT02037477|56763|P2|STARTED|Treatment Period 2||5
23624|NCT02037477|56764|P1|STARTED|Treatment Period 2||5
23625|NCT02037477|56761|P4|NOT COMPLETED|Treatment Period 1||0
23626|NCT02037477|56762|P3|NOT COMPLETED|Treatment Period 1||1
23627|NCT02037477|56763|P2|NOT COMPLETED|Treatment Period 1||0
23628|NCT02037477|56764|P1|NOT COMPLETED|Treatment Period 1||0
23629|NCT02037477|56761|P4|COMPLETED|Treatment Period 1||5
23630|NCT02037477|56762|P3|COMPLETED|Treatment Period 1||4
23631|NCT02037477|56763|P2|COMPLETED|Treatment Period 1||5
23632|NCT02037477|56764|P1|COMPLETED|Treatment Period 1||5
23633|NCT02037477|56761|P4|STARTED|Treatment Period 1||5
23634|NCT02037477|56762|P3|STARTED|Treatment Period 1||5
23635|NCT02037477|56763|P2|STARTED|Treatment Period 1||5
23636|NCT02037477|56764|P1|STARTED|Treatment Period 1||5
23637|NCT02037425|56790|P1|NOT COMPLETED|Overall Study||26
23638|NCT02037425|56790|P1|COMPLETED|Overall Study||18
23639|NCT02037425|56790|P1|Randomized to Treatment|Overall Study||32
23640|NCT02037425|56790|P1|STARTED|Overall Study||44
23641|NCT02037347|56832|P1|NOT COMPLETED|Overall Study||0
23642|NCT02037347|56832|P1|COMPLETED|Overall Study||1
23643|NCT02037347|56832|P1|STARTED|Overall Study||1
23644|NCT02036840|56838|P1|NOT COMPLETED|Overall Study||0
23645|NCT02036840|56838|P1|COMPLETED|Overall Study||513
23646|NCT02036840|56838|P1|STARTED|Overall Study||513
23647|NCT02036775|56842|P6|NOT COMPLETED|Treatment Period 3 (6 Days)||0
23648|NCT02036775|56843|P5|NOT COMPLETED|Treatment Period 3 (6 Days)||0
23649|NCT02036775|56844|P4|NOT COMPLETED|Treatment Period 3 (6 Days)||0
23650|NCT02036775|56845|P3|NOT COMPLETED|Treatment Period 3 (6 Days)||0
23651|NCT02036775|56846|P2|NOT COMPLETED|Treatment Period 3 (6 Days)||0
23652|NCT02036775|56847|P1|NOT COMPLETED|Treatment Period 3 (6 Days)||0
23653|NCT02036775|56842|P6|COMPLETED|Treatment Period 3 (6 Days)||3
23654|NCT02036775|56843|P5|COMPLETED|Treatment Period 3 (6 Days)||4
23655|NCT02036775|56844|P4|COMPLETED|Treatment Period 3 (6 Days)||4
23656|NCT02036775|56845|P3|COMPLETED|Treatment Period 3 (6 Days)||4
23657|NCT02036775|56846|P2|COMPLETED|Treatment Period 3 (6 Days)||4
23658|NCT02036775|56847|P1|COMPLETED|Treatment Period 3 (6 Days)||4
23659|NCT02036775|56842|P6|STARTED|Treatment Period 3 (6 Days)||3
23660|NCT02036775|56843|P5|STARTED|Treatment Period 3 (6 Days)||4
23661|NCT02036775|56844|P4|STARTED|Treatment Period 3 (6 Days)||4
23662|NCT02036775|56845|P3|STARTED|Treatment Period 3 (6 Days)||4
23663|NCT02036775|56846|P2|STARTED|Treatment Period 3 (6 Days)||4
23664|NCT02036775|56847|P1|STARTED|Treatment Period 3 (6 Days)||4
23665|NCT02036775|56842|P6|NOT COMPLETED|Treatment Period 2 (6 Days)||1
23666|NCT02036775|56843|P5|NOT COMPLETED|Treatment Period 2 (6 Days)||0
23667|NCT02036775|56844|P4|NOT COMPLETED|Treatment Period 2 (6 Days)||0
23668|NCT02036775|56845|P3|NOT COMPLETED|Treatment Period 2 (6 Days)||0
23669|NCT02036775|56846|P2|NOT COMPLETED|Treatment Period 2 (6 Days)||0
23670|NCT02036775|56847|P1|NOT COMPLETED|Treatment Period 2 (6 Days)||0
23671|NCT02036775|56842|P6|COMPLETED|Treatment Period 2 (6 Days)||3
23672|NCT02036775|56843|P5|COMPLETED|Treatment Period 2 (6 Days)||4
23673|NCT02036775|56844|P4|COMPLETED|Treatment Period 2 (6 Days)||4
23674|NCT02036775|56845|P3|COMPLETED|Treatment Period 2 (6 Days)||4
23675|NCT02036775|56846|P2|COMPLETED|Treatment Period 2 (6 Days)||4
23676|NCT02036775|56847|P1|COMPLETED|Treatment Period 2 (6 Days)||4
23677|NCT02036775|56842|P6|STARTED|Treatment Period 2 (6 Days)||4
23678|NCT02036775|56843|P5|STARTED|Treatment Period 2 (6 Days)||4
23679|NCT02036775|56844|P4|STARTED|Treatment Period 2 (6 Days)||4
23680|NCT02036775|56845|P3|STARTED|Treatment Period 2 (6 Days)||4
23681|NCT02036775|56846|P2|STARTED|Treatment Period 2 (6 Days)||4
23682|NCT02036775|56847|P1|STARTED|Treatment Period 2 (6 Days)||4
23683|NCT02036775|56842|P6|NOT COMPLETED|Treatment Period 1 (6 Days)||0
23684|NCT02036775|56843|P5|NOT COMPLETED|Treatment Period 1 (6 Days)||0
23685|NCT02036775|56844|P4|NOT COMPLETED|Treatment Period 1 (6 Days)||0
23686|NCT02036775|56845|P3|NOT COMPLETED|Treatment Period 1 (6 Days)||0
23687|NCT02036775|56846|P2|NOT COMPLETED|Treatment Period 1 (6 Days)||0
23688|NCT02036775|56847|P1|NOT COMPLETED|Treatment Period 1 (6 Days)||0
23689|NCT02036775|56842|P6|COMPLETED|Treatment Period 1 (6 Days)||4
23690|NCT02036775|56843|P5|COMPLETED|Treatment Period 1 (6 Days)||4
23691|NCT02036775|56844|P4|COMPLETED|Treatment Period 1 (6 Days)||4
23692|NCT02036775|56845|P3|COMPLETED|Treatment Period 1 (6 Days)||4
23693|NCT02036775|56846|P2|COMPLETED|Treatment Period 1 (6 Days)||4
23694|NCT02036775|56847|P1|COMPLETED|Treatment Period 1 (6 Days)||4
23695|NCT02036775|56842|P6|STARTED|Treatment Period 1 (6 Days)||4
23696|NCT02036775|56843|P5|STARTED|Treatment Period 1 (6 Days)||4
23697|NCT02036775|56844|P4|STARTED|Treatment Period 1 (6 Days)||4
23698|NCT02036775|56845|P3|STARTED|Treatment Period 1 (6 Days)||4
23699|NCT02036775|56846|P2|STARTED|Treatment Period 1 (6 Days)||4
23700|NCT02036775|56847|P1|STARTED|Treatment Period 1 (6 Days)||4
23701|NCT02036580|56888|P3|NOT COMPLETED|Overall Study||0
23702|NCT02036580|56889|P2|NOT COMPLETED|Overall Study||1
23703|NCT02036580|56890|P1|NOT COMPLETED|Overall Study||1
23704|NCT02036580|56888|P3|COMPLETED|Overall Study||4
23705|NCT02036580|56889|P2|COMPLETED|Overall Study||7
23706|NCT02036580|56890|P1|COMPLETED|Overall Study||7
23707|NCT02036580|56888|P3|STARTED|Overall Study||4
23708|NCT02036580|56889|P2|STARTED|Overall Study||8
23709|NCT02036580|56890|P1|STARTED|Overall Study||8
23710|NCT02036541|56903|P1|NOT COMPLETED|Overall Study||16
23711|NCT02036541|56903|P1|COMPLETED|Overall Study||49
23712|NCT02036541|56903|P1|Completed Endpoint Visit|Overall Study||54
23713|NCT02036541|56903|P1|STARTED|Overall Study||65
23714|NCT02036515|56911|P3|NOT COMPLETED|Overall Study||14
23715|NCT02036515|56912|P2|NOT COMPLETED|Overall Study||12
23716|NCT02036515|56913|P1|NOT COMPLETED|Overall Study||5
23717|NCT02036515|56911|P3|COMPLETED|Overall Study||139
23718|NCT02036515|56912|P2|COMPLETED|Overall Study||143
23719|NCT02036515|56913|P1|COMPLETED|Overall Study||151
23720|NCT02036515|56911|P3|Treated|Overall Study||153
23721|NCT02036515|56912|P2|Treated|Overall Study||153
23722|NCT02036515|56913|P1|Treated|Overall Study||156
23723|NCT02036515|56911|P3|STARTED|Overall Study||153
23724|NCT02036515|56912|P2|STARTED|Overall Study||155
23725|NCT02036515|56913|P1|STARTED|Overall Study||156
23726|NCT02036424|56992|P2|NOT COMPLETED|Overall Study||0
23727|NCT02036424|56993|P1|NOT COMPLETED|Overall Study||0
23728|NCT02036424|56992|P2|COMPLETED|Overall Study|27 study eyes, not number of subjects|27
23729|NCT02036424|56993|P1|COMPLETED|Overall Study|23 study eyes, not number of subjects|23
23730|NCT02036424|56992|P2|STARTED|Overall Study|27 study eyes, not number of subjects|27
23731|NCT02036424|56993|P1|STARTED|Overall Study|23 study eyes, not number of subjects|23
23732|NCT02036320|57001|P2|NOT COMPLETED|Period 2||0
23733|NCT02036320|57002|P1|NOT COMPLETED|Period 2||0
23734|NCT02036320|57001|P2|COMPLETED|Period 2||95
23735|NCT02036320|57002|P1|COMPLETED|Period 2||95
23736|NCT02036320|57001|P2|STARTED|Period 2||95
23737|NCT02036320|57002|P1|STARTED|Period 2||95
23738|NCT02036320|57001|P2|NOT COMPLETED|Period 1||0
23739|NCT02036320|57002|P1|NOT COMPLETED|Period 1||0
23740|NCT02036320|57001|P2|COMPLETED|Period 1||95
23741|NCT02036320|57002|P1|COMPLETED|Period 1||95
23742|NCT02036320|57001|P2|STARTED|Period 1||95
23743|NCT02036320|57002|P1|STARTED|Period 1||95
23744|NCT02035748|57012|P1|NOT COMPLETED|Overall Study||20
23745|NCT02035748|57012|P1|COMPLETED|Overall Study||448
23746|NCT02035748|57012|P1|STARTED|Overall Study||468
23747|NCT02035696|57026|P4|NOT COMPLETED|Overall Study||3
23748|NCT02035696|57027|P3|NOT COMPLETED|Overall Study||3
23749|NCT02035696|57028|P2|NOT COMPLETED|Overall Study||3
23750|NCT02035696|57029|P1|NOT COMPLETED|Overall Study||3
23751|NCT02035696|57026|P4|COMPLETED|Overall Study||161
23752|NCT02035696|57027|P3|COMPLETED|Overall Study||164
23753|NCT02035696|57028|P2|COMPLETED|Overall Study||163
23754|NCT02035696|57029|P1|COMPLETED|Overall Study||171
23755|NCT02035696|57026|P4|STARTED|Overall Study||164
23756|NCT02035696|57027|P3|STARTED|Overall Study||167
23757|NCT02035696|57028|P2|STARTED|Overall Study||166
23758|NCT02035696|57029|P1|STARTED|Overall Study||174
23759|NCT02035475|57071|P1|NOT COMPLETED|Overall Study||6
23760|NCT02035475|57071|P1|COMPLETED|Overall Study|Six subjects did not complete the study due to withdrawal of consent.|114
23761|NCT02035475|57071|P1|STARTED|Overall Study|120 subjects were consented for participation in the study.|120
23762|NCT02035345|57077|P1|NOT COMPLETED|Overall Study||0
23763|NCT02035345|57077|P1|COMPLETED|Overall Study||15
23764|NCT02035345|57077|P1|STARTED|Overall Study||15
23765|NCT02035332|57082|P1|NOT COMPLETED|Overall Study||1
23766|NCT02035332|57082|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|20
23767|NCT02035332|57082|P1|Treated|Overall Study|Treatment Completed|20
23768|NCT02035332|57082|P1|STARTED|Overall Study|Treatment Attempted|21
23769|NCT02034877|57090|P2|NOT COMPLETED|Overall Study||6
23770|NCT02034877|57091|P1|NOT COMPLETED|Overall Study||0
23771|NCT02034877|57090|P2|COMPLETED|Overall Study||993
23772|NCT02034877|57091|P1|COMPLETED|Overall Study||200
23773|NCT02034877|57090|P2|STARTED|Overall Study||999
23774|NCT02034877|57091|P1|STARTED|Overall Study||200
23775|NCT02034708|57109|P2|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
23776|NCT02034708|57110|P1|NOT COMPLETED|Second Contrast Agent Injection (1 Day)||0
23777|NCT02034708|57109|P2|COMPLETED|Second Contrast Agent Injection (1 Day)||120
23778|NCT02034708|57110|P1|COMPLETED|Second Contrast Agent Injection (1 Day)||129
23779|NCT02034708|57109|P2|STARTED|Second Contrast Agent Injection (1 Day)||120
23780|NCT02034708|57110|P1|STARTED|Second Contrast Agent Injection (1 Day)||129
23781|NCT02034708|57109|P2|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||10
23782|NCT02034708|57110|P1|NOT COMPLETED|Wash-out (From 2 Days up to 14 Days)||9
23783|NCT02034708|57109|P2|COMPLETED|Wash-out (From 2 Days up to 14 Days)||120
23784|NCT02034708|57110|P1|COMPLETED|Wash-out (From 2 Days up to 14 Days)||129
23785|NCT02034708|57109|P2|STARTED|Wash-out (From 2 Days up to 14 Days)||130
23786|NCT02034708|57110|P1|STARTED|Wash-out (From 2 Days up to 14 Days)||138
23787|NCT02034708|57109|P2|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
23788|NCT02034708|57110|P1|NOT COMPLETED|First Contrast Agent Injection (1 Day)||0
23789|NCT02034708|57109|P2|COMPLETED|First Contrast Agent Injection (1 Day)||130
23790|NCT02034708|57110|P1|COMPLETED|First Contrast Agent Injection (1 Day)||138
23791|NCT02034708|57109|P2|STARTED|First Contrast Agent Injection (1 Day)||130
23792|NCT02034708|57110|P1|STARTED|First Contrast Agent Injection (1 Day)||138
23793|NCT02034591|57121|P6|NOT COMPLETED|Overall Study||0
23794|NCT02034591|57122|P5|NOT COMPLETED|Overall Study||1
23795|NCT02034591|57123|P4|NOT COMPLETED|Overall Study||0
23796|NCT02034591|57124|P3|NOT COMPLETED|Overall Study||0
23797|NCT02034591|57125|P2|NOT COMPLETED|Overall Study||0
23798|NCT02034591|57126|P1|NOT COMPLETED|Overall Study||0
23799|NCT02034591|57121|P6|COMPLETED|Overall Study||3
23800|NCT02034591|57122|P5|COMPLETED|Overall Study||3
23801|NCT02034591|57123|P4|COMPLETED|Overall Study||3
23802|NCT02034591|57124|P3|COMPLETED|Overall Study||4
23803|NCT02034591|57125|P2|COMPLETED|Overall Study||3
23804|NCT02034591|57126|P1|COMPLETED|Overall Study||4
23805|NCT02034591|57121|P6|STARTED|Overall Study||3
23806|NCT02034591|57122|P5|STARTED|Overall Study||4
23807|NCT02034591|57123|P4|STARTED|Overall Study||3
23808|NCT02034591|57124|P3|STARTED|Overall Study||4
23809|NCT02034591|57125|P2|STARTED|Overall Study||3
23810|NCT02034591|57126|P1|STARTED|Overall Study||4
23811|NCT02034578|57149|P6|NOT COMPLETED|Overall Study||0
23812|NCT02034578|57150|P5|NOT COMPLETED|Overall Study||0
23813|NCT02034578|57151|P4|NOT COMPLETED|Overall Study||0
23814|NCT02034578|57152|P3|NOT COMPLETED|Overall Study||0
23815|NCT02034578|57153|P2|NOT COMPLETED|Overall Study||0
23816|NCT02034578|57154|P1|NOT COMPLETED|Overall Study||0
23817|NCT02034578|57149|P6|COMPLETED|Overall Study||3
23818|NCT02034578|57150|P5|COMPLETED|Overall Study||4
23819|NCT02034578|57151|P4|COMPLETED|Overall Study||3
23820|NCT02034578|57152|P3|COMPLETED|Overall Study||4
23821|NCT02034578|57153|P2|COMPLETED|Overall Study||3
23822|NCT02034578|57154|P1|COMPLETED|Overall Study||4
23823|NCT02034578|57149|P6|STARTED|Overall Study||3
23824|NCT02034578|57150|P5|STARTED|Overall Study||4
23825|NCT02034578|57151|P4|STARTED|Overall Study||3
23826|NCT02034578|57152|P3|STARTED|Overall Study||4
23827|NCT02034578|57153|P2|STARTED|Overall Study||3
23828|NCT02034578|57154|P1|STARTED|Overall Study||4
23829|NCT02034565|57181|P2|NOT COMPLETED|Overall Study||0
23830|NCT02034565|57182|P1|NOT COMPLETED|Overall Study||1
23831|NCT02034565|57181|P2|COMPLETED|Overall Study||7
23832|NCT02034565|57182|P1|COMPLETED|Overall Study||6
23833|NCT02034565|57181|P2|STARTED|Overall Study||7
23834|NCT02034565|57182|P1|STARTED|Overall Study||7
23835|NCT02034552|57199|P3|NOT COMPLETED|Overall Study||15
23836|NCT02034552|57200|P2|NOT COMPLETED|Overall Study||17
23837|NCT02034552|57201|P1|NOT COMPLETED|Overall Study||6
23838|NCT02034552|57199|P3|COMPLETED|Overall Study||7
23839|NCT02034552|57200|P2|COMPLETED|Overall Study||7
23840|NCT02034552|57201|P1|COMPLETED|Overall Study||16
23841|NCT02034552|57199|P3|Received Treatment|Overall Study||22
23842|NCT02034552|57200|P2|Received Treatment|Overall Study||22
23843|NCT02034552|57201|P1|Received Treatment|Overall Study||19
23844|NCT02034552|57199|P3|STARTED|Overall Study||22
23845|NCT02034552|57200|P2|STARTED|Overall Study||24
23846|NCT02034552|57201|P1|STARTED|Overall Study||22
23847|NCT02034513|57226|P2|NOT COMPLETED|Overall Study||57
23848|NCT02034513|57227|P1|NOT COMPLETED|Overall Study||49
23849|NCT02034513|57226|P2|COMPLETED|Overall Study||195
23850|NCT02034513|57227|P1|COMPLETED|Overall Study||200
23851|NCT02034513|57226|P2|Exposed|Overall Study||251
23852|NCT02034513|57227|P1|Exposed|Overall Study||249
23853|NCT02034513|57226|P2|STARTED|Overall Study||252
23854|NCT02034513|57227|P1|STARTED|Overall Study||249
23855|NCT02034162|57245|P3|NOT COMPLETED|Open-label||0
23856|NCT02034162|57246|P2|NOT COMPLETED|Open-label||0
23857|NCT02034162|57247|P1|NOT COMPLETED|Open-label||0
23858|NCT02034162|57245|P3|COMPLETED|Open-label||278
23859|NCT02034162|57246|P2|COMPLETED|Open-label||0
23860|NCT02034162|57247|P1|COMPLETED|Open-label||0
23861|NCT02034162|57245|P3|STARTED|Open-label||278
23862|NCT02034162|57246|P2|STARTED|Open-label||0
23863|NCT02034162|57247|P1|STARTED|Open-label||0
23864|NCT02034162|57245|P3|NOT COMPLETED|Double-blind||0
23865|NCT02034162|57246|P2|NOT COMPLETED|Double-blind||8
23866|NCT02034162|57247|P1|NOT COMPLETED|Double-blind||9
23867|NCT02034162|57245|P3|COMPLETED|Double-blind||0
23868|NCT02034162|57246|P2|COMPLETED|Double-blind||141
23869|NCT02034162|57247|P1|COMPLETED|Double-blind||137
23870|NCT02034162|57245|P3|STARTED|Double-blind||0
23871|NCT02034162|57246|P2|STARTED|Double-blind||149
23872|NCT02034162|57247|P1|STARTED|Double-blind||146
23873|NCT02033317|57275|P1|NOT COMPLETED|Overall Study||0
23874|NCT02033317|57275|P1|COMPLETED|Overall Study||6
23875|NCT02033317|57275|P1|STARTED|Overall Study||6
23876|NCT02033213|57282|P2|NOT COMPLETED|Overall Study||0
23877|NCT02033213|57283|P1|NOT COMPLETED|Overall Study||0
23878|NCT02033213|57282|P2|COMPLETED|Overall Study||8
23879|NCT02033213|57283|P1|COMPLETED|Overall Study||8
23880|NCT02033213|57282|P2|STARTED|Overall Study||8
23881|NCT02033213|57283|P1|STARTED|Overall Study||8
23882|NCT02033200|57301|P2|NOT COMPLETED|Overall Study||0
23883|NCT02033200|57302|P1|NOT COMPLETED|Overall Study||0
23884|NCT02033200|57301|P2|COMPLETED|Overall Study||40
23885|NCT02033200|57302|P1|COMPLETED|Overall Study||40
23886|NCT02033200|57301|P2|STARTED|Overall Study||40
23887|NCT02033200|57302|P1|STARTED|Overall Study||40
23888|NCT02033174|57322|P2|NOT COMPLETED|Second Intervention||0
23889|NCT02033174|57323|P1|NOT COMPLETED|Second Intervention||0
23890|NCT02033174|57322|P2|COMPLETED|Second Intervention||8
23891|NCT02033174|57323|P1|COMPLETED|Second Intervention||8
23892|NCT02033174|57322|P2|STARTED|Second Intervention||8
23893|NCT02033174|57323|P1|STARTED|Second Intervention||8
23894|NCT02033174|57322|P2|NOT COMPLETED|Washout (1 Week)||0
23895|NCT02033174|57323|P1|NOT COMPLETED|Washout (1 Week)||0
23896|NCT02033174|57322|P2|COMPLETED|Washout (1 Week)||8
23897|NCT02033174|57323|P1|COMPLETED|Washout (1 Week)||8
23898|NCT02033174|57322|P2|STARTED|Washout (1 Week)||8
23899|NCT02033174|57323|P1|STARTED|Washout (1 Week)||8
23900|NCT02033174|57322|P2|NOT COMPLETED|First Intervention||0
23901|NCT02033174|57323|P1|NOT COMPLETED|First Intervention||0
23902|NCT02033174|57322|P2|COMPLETED|First Intervention||8
23903|NCT02033174|57323|P1|COMPLETED|First Intervention||8
23904|NCT02033174|57322|P2|STARTED|First Intervention||8
23905|NCT02033174|57323|P1|STARTED|First Intervention||8
23906|NCT02032901|57331|P2|NOT COMPLETED|Follow-Up Period (24 Weeks)||1
23907|NCT02032901|57332|P1|NOT COMPLETED|Follow-Up Period (24 Weeks)||0
23908|NCT02032901|57331|P2|COMPLETED|Follow-Up Period (24 Weeks)||50
23909|NCT02032901|57332|P1|COMPLETED|Follow-Up Period (24 Weeks)||101
23910|NCT02032901|57331|P2|STARTED|Follow-Up Period (24 Weeks)||51
23911|NCT02032901|57332|P1|STARTED|Follow-Up Period (24 Weeks)|Participant could enter follow up period even if the treatment period was not completed.|101
23912|NCT02032901|57331|P2|NOT COMPLETED|Treatment Period (12 Weeks)||0
23913|NCT02032901|57332|P1|NOT COMPLETED|Treatment Period (12 Weeks)||1
23914|NCT02032901|57331|P2|COMPLETED|Treatment Period (12 Weeks)||51
23915|NCT02032901|57332|P1|COMPLETED|Treatment Period (12 Weeks)||100
23916|NCT02032901|57331|P2|STARTED|Treatment Period (12 Weeks)||51
23917|NCT02032901|57332|P1|STARTED|Treatment Period (12 Weeks)||101
23918|NCT02032888|57356|P3|NOT COMPLETED|Follow-up Period||0
23919|NCT02032888|57357|P2|NOT COMPLETED|Follow-up Period||2
23920|NCT02032888|57358|P1|NOT COMPLETED|Follow-up Period||3
23921|NCT02032888|57356|P3|COMPLETED|Follow-up Period||52
23922|NCT02032888|57357|P2|COMPLETED|Follow-up Period||47
23923|NCT02032888|57358|P1|COMPLETED|Follow-up Period||97
23924|NCT02032888|57356|P3|STARTED|Follow-up Period||52
23925|NCT02032888|57357|P2|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|49
23926|NCT02032888|57358|P1|STARTED|Follow-up Period|All patients who received study drug and not a nonstudy HCV therapy before treatment Week 4|100
23927|NCT02032888|57356|P3|NOT COMPLETED|Treatment Period||0
23928|NCT02032888|57357|P2|NOT COMPLETED|Treatment Period||2
23929|NCT02032888|57358|P1|NOT COMPLETED|Treatment Period||2
23930|NCT02032888|57356|P3|COMPLETED|Treatment Period||52
23931|NCT02032888|57357|P2|COMPLETED|Treatment Period||48
23932|NCT02032888|57358|P1|COMPLETED|Treatment Period||99
23933|NCT02032888|57356|P3|STARTED|Treatment Period||52
23934|NCT02032888|57357|P2|STARTED|Treatment Period||50
23935|NCT02032888|57358|P1|STARTED|Treatment Period||101
23936|NCT02032875|57389|P2|NOT COMPLETED|Follow-up Period||11
23937|NCT02032875|57390|P1|NOT COMPLETED|Follow-up Period||3
23938|NCT02032875|57389|P2|COMPLETED|Follow-up Period||46
23939|NCT02032875|57390|P1|COMPLETED|Follow-up Period||50
23940|NCT02032875|57389|P2|STARTED|Follow-up Period|Of 60 participants in treatment period, 57 continued in follow-up, 3 entered treatment extension.|57
23941|NCT02032875|57390|P1|STARTED|Follow-up Period|Out of 53 participants who entered the treatment period, all 53 continued in the follow-up period.|53
23942|NCT02032875|57389|P2|NOT COMPLETED|Treatment Period||4
23943|NCT02032875|57390|P1|NOT COMPLETED|Treatment Period||1
23944|NCT02032875|57389|P2|COMPLETED|Treatment Period||56
23945|NCT02032875|57390|P1|COMPLETED|Treatment Period||52
23946|NCT02032875|57389|P2|STARTED|Treatment Period||60
23947|NCT02032875|57390|P1|STARTED|Treatment Period||53
23948|NCT02032758|57410|P2|NOT COMPLETED|Overall Study||0
23949|NCT02032758|57411|P1|NOT COMPLETED|Overall Study||0
23950|NCT02032758|57410|P2|COMPLETED|Overall Study||11
23951|NCT02032758|57411|P1|COMPLETED|Overall Study||27
23952|NCT02032758|57410|P2|STARTED|Overall Study||11
23953|NCT02032758|57411|P1|STARTED|Overall Study||27
23954|NCT02032706|57419|P1|NOT COMPLETED|Overall Study||6
23955|NCT02032706|57419|P1|COMPLETED|Overall Study||30
23956|NCT02032706|57419|P1|STARTED|Overall Study||36
23957|NCT02032641|57432|P1|NOT COMPLETED|Overall Study||1
23958|NCT02032641|57432|P1|COMPLETED|Overall Study|16 brows completed study (half underwent treatment, half were control)|8
23959|NCT02032641|57432|P1|STARTED|Overall Study|18 Brows enrolled for evaluation|9
23960|NCT02032420|57444|P2|NOT COMPLETED|Overall Study||0
23961|NCT02032420|57445|P1|NOT COMPLETED|Overall Study||0
23962|NCT02032420|57444|P2|COMPLETED|Overall Study||17
23963|NCT02032420|57445|P1|COMPLETED|Overall Study||18
23964|NCT02032420|57444|P2|STARTED|Overall Study||17
23965|NCT02032420|57445|P1|STARTED|Overall Study||18
23966|NCT02032407|57457|P1|NOT COMPLETED|Overall Study||5
23967|NCT02032407|57457|P1|COMPLETED|Overall Study||63
23968|NCT02032407|57457|P1|STARTED|Overall Study||68
23969|NCT02032238|57470|P2|NOT COMPLETED|Overall Study||0
23970|NCT02032238|57471|P1|NOT COMPLETED|Overall Study||2
23971|NCT02032238|57470|P2|COMPLETED|Overall Study||0
23972|NCT02032238|57471|P1|COMPLETED|Overall Study||10
23973|NCT02032238|57470|P2|STARTED|Overall Study|Study Terminated due to slow enrollment, no subjects enrolled in this study arm|0
23974|NCT02032238|57471|P1|STARTED|Overall Study||12
23975|NCT02032212|57481|P4|NOT COMPLETED|Overall Study||0
23976|NCT02032212|57482|P3|NOT COMPLETED|Overall Study||0
23977|NCT02032212|57483|P2|NOT COMPLETED|Overall Study||0
23978|NCT02032212|57484|P1|NOT COMPLETED|Overall Study||0
23979|NCT02032212|57481|P4|COMPLETED|Overall Study||3
23980|NCT02032212|57482|P3|COMPLETED|Overall Study||3
23981|NCT02032212|57483|P2|COMPLETED|Overall Study||3
23982|NCT02032212|57484|P1|COMPLETED|Overall Study||3
23983|NCT02032212|57481|P4|STARTED|Overall Study||3
23984|NCT02032212|57482|P3|STARTED|Overall Study||3
23985|NCT02032212|57483|P2|STARTED|Overall Study||3
23986|NCT02032212|57484|P1|STARTED|Overall Study||3
23987|NCT02031679|57512|P2|NOT COMPLETED|Overall Study||2
23988|NCT02031679|57513|P1|NOT COMPLETED|Overall Study||0
23989|NCT02031679|57512|P2|COMPLETED|Overall Study||12
23990|NCT02031679|57513|P1|COMPLETED|Overall Study||14
23991|NCT02031679|57512|P2|STARTED|Overall Study||14
23992|NCT02031679|57513|P1|STARTED|Overall Study||14
23993|NCT02031471|57523|P1|NOT COMPLETED|Long Term Extension (LTE) Period||2
23994|NCT02031471|57523|P1|COMPLETED|Long Term Extension (LTE) Period||37
23995|NCT02031471|57523|P1|STARTED|Long Term Extension (LTE) Period|Only participants who achieved at least a moderate EULAR response at Week 24 entered the LTE Period.|39
23996|NCT02031471|57523|P1|NOT COMPLETED|24 Week Treatment Period||11
23997|NCT02031471|57523|P1|COMPLETED|24 Week Treatment Period||46
23998|NCT02031471|57523|P1|STARTED|24 Week Treatment Period||57
23999|NCT02031458|57556|P3|NOT COMPLETED|Overall Study||253
24000|NCT02031458|57557|P2|NOT COMPLETED|Overall Study||267
24001|NCT02031458|57558|P1|NOT COMPLETED|Overall Study||139
24002|NCT02031458|57556|P3|COMPLETED|Overall Study||0
24003|NCT02031458|57557|P2|COMPLETED|Overall Study||0
24004|NCT02031458|57558|P1|COMPLETED|Overall Study||0
24005|NCT02031458|57556|P3|STARTED|Overall Study||253
24006|NCT02031458|57557|P2|STARTED|Overall Study||267
24007|NCT02031458|57558|P1|STARTED|Overall Study||139
24008|NCT02030600|57654|P2|NOT COMPLETED|Treatment Period 2||18
24009|NCT02030600|57655|P1|NOT COMPLETED|Treatment Period 2||25
24010|NCT02030600|57654|P2|COMPLETED|Treatment Period 2||297
24011|NCT02030600|57655|P1|COMPLETED|Treatment Period 2||283
24012|NCT02030600|57654|P2|STARTED|Treatment Period 2||315
24013|NCT02030600|57655|P1|STARTED|Treatment Period 2||308
24014|NCT02030600|57654|P2|NOT COMPLETED|Treatment Period 1||45
24015|NCT02030600|57655|P1|NOT COMPLETED|Treatment Period 1||53
24016|NCT02030600|57654|P2|COMPLETED|Treatment Period 1||315
24017|NCT02030600|57655|P1|COMPLETED|Treatment Period 1||308
24018|NCT02030600|57654|P2|Exposed|Treatment Period 1||357
24019|NCT02030600|57655|P1|Exposed|Treatment Period 1||356
24020|NCT02030600|57654|P2|STARTED|Treatment Period 1||360
24021|NCT02030600|57655|P1|STARTED|Treatment Period 1||361
24022|NCT02030574|57671|P1|NOT COMPLETED|Overall Study||0
24023|NCT02030574|57671|P1|COMPLETED|Overall Study||2
24024|NCT02030574|57671|P1|STARTED|Overall Study||2
24025|NCT02030535|57676|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
24026|NCT02030535|57676|P1|COMPLETED|Treatment Period 3 (1 Day)||52
24027|NCT02030535|57676|P1|STARTED|Treatment Period 3 (1 Day)||52
24028|NCT02030535|57676|P1|NOT COMPLETED|Washout Period 2 (21 Days)||0
24029|NCT02030535|57676|P1|COMPLETED|Washout Period 2 (21 Days)||52
24030|NCT02030535|57676|P1|STARTED|Washout Period 2 (21 Days)||52
24031|NCT02030535|57676|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
24032|NCT02030535|57676|P1|COMPLETED|Treatment Period 2 (1 Day)||52
24033|NCT02030535|57676|P1|STARTED|Treatment Period 2 (1 Day)||52
24034|NCT02030535|57676|P1|NOT COMPLETED|Washout Period 1 (21 Days)||1
24035|NCT02030535|57676|P1|COMPLETED|Washout Period 1 (21 Days)||52
24036|NCT02030535|57676|P1|STARTED|Washout Period 1 (21 Days)||53
24037|NCT02030535|57676|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
24038|NCT02030535|57676|P1|COMPLETED|Treatment Period 1 (1 Day)||53
24039|NCT02030535|57676|P1|STARTED|Treatment Period 1 (1 Day)||53
24040|NCT02030405|57744|P1|NOT COMPLETED|Overall Study||2
24041|NCT02030405|57744|P1|COMPLETED|Overall Study||2
24042|NCT02030405|57744|P1|STARTED|Overall Study||4
24043|NCT02030041|57752|P3|NOT COMPLETED|Overall Study||1
24044|NCT02030041|57753|P2|NOT COMPLETED|Overall Study||2
24045|NCT02030041|57754|P1|NOT COMPLETED|Overall Study||2
24046|NCT02030041|57752|P3|COMPLETED|Overall Study||10
24047|NCT02030041|57753|P2|COMPLETED|Overall Study||9
24048|NCT02030041|57754|P1|COMPLETED|Overall Study||9
24049|NCT02030041|57752|P3|STARTED|Overall Study||11
24050|NCT02030041|57753|P2|STARTED|Overall Study||11
24051|NCT02030041|57754|P1|STARTED|Overall Study||11
24052|NCT02029989|57767|P2|NOT COMPLETED|Overall Study||11
24053|NCT02029989|57768|P1|NOT COMPLETED|Overall Study||16
24054|NCT02029989|57767|P2|COMPLETED|Overall Study||49
24055|NCT02029989|57768|P1|COMPLETED|Overall Study||45
24056|NCT02029989|57767|P2|STARTED|Overall Study||60
24057|NCT02029989|57768|P1|STARTED|Overall Study|A subject was given the same ID# as withdrawn subject (ID # counted twice) causing N=61 discrepancy.|61
24058|NCT02029911|57774|P1|NOT COMPLETED|Overall Study||0
24059|NCT02029911|57774|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|60
24060|NCT02029911|57774|P1|Treated|Overall Study|Treatment Completed|60
24061|NCT02029911|57774|P1|STARTED|Overall Study|Treatment Attempted|60
24062|NCT02029846|57782|P2|NOT COMPLETED|Overall Study||0
24063|NCT02029846|57783|P1|NOT COMPLETED|Overall Study||0
24064|NCT02029846|57782|P2|COMPLETED|Overall Study||0
24065|NCT02029846|57783|P1|COMPLETED|Overall Study||0
24066|NCT02029846|57782|P2|STARTED|Overall Study||0
24067|NCT02029846|57783|P1|STARTED|Overall Study||0
24068|NCT02029755|57796|P3|NOT COMPLETED|Overall Study||0
24069|NCT02029755|57797|P2|NOT COMPLETED|Overall Study||0
24070|NCT02029755|57798|P1|NOT COMPLETED|Overall Study||0
24071|NCT02029755|57796|P3|COMPLETED|Overall Study||36
24072|NCT02029755|57797|P2|COMPLETED|Overall Study||36
24073|NCT02029755|57798|P1|COMPLETED|Overall Study||36
24074|NCT02029755|57796|P3|STARTED|Overall Study||36
24075|NCT02029755|57797|P2|STARTED|Overall Study||36
24076|NCT02029755|57798|P1|STARTED|Overall Study||36
24077|NCT02029703|57811|P2|NOT COMPLETED|Overall Study||0
24078|NCT02029703|57812|P1|NOT COMPLETED|Overall Study||0
24079|NCT02029703|57811|P2|COMPLETED|Overall Study||22
24080|NCT02029703|57812|P1|COMPLETED|Overall Study||20
24081|NCT02029703|57811|P2|STARTED|Overall Study||22
24082|NCT02029703|57812|P1|STARTED|Overall Study||20
24083|NCT02029521|57820|P2|NOT COMPLETED|Overall Study||1
24084|NCT02029521|57821|P1|NOT COMPLETED|Overall Study||2
24085|NCT02029521|57820|P2|COMPLETED|Overall Study||22
24086|NCT02029521|57821|P1|COMPLETED|Overall Study||22
24087|NCT02029521|57820|P2|STARTED|Overall Study||23
24088|NCT02029521|57821|P1|STARTED|Overall Study||24
24089|NCT02029495|57906|P3|NOT COMPLETED|Overall Study||2
24090|NCT02029495|57907|P2|NOT COMPLETED|Overall Study||0
24091|NCT02029495|57908|P1|NOT COMPLETED|Overall Study||1
24092|NCT02029495|57906|P3|COMPLETED|Overall Study||159
24093|NCT02029495|57907|P2|COMPLETED|Overall Study||158
24094|NCT02029495|57908|P1|COMPLETED|Overall Study||158
24095|NCT02029495|57906|P3|STARTED|Overall Study||161
24096|NCT02029495|57907|P2|STARTED|Overall Study||158
24097|NCT02029495|57908|P1|STARTED|Overall Study||159
24098|NCT02029417|57919|P1|NOT COMPLETED|Overall Study||2
24099|NCT02029417|57919|P1|COMPLETED|Overall Study||0
24100|NCT02029417|57919|P1|STARTED|Overall Study||2
24101|NCT02029196|57926|P2|NOT COMPLETED|Overall Study||1
24102|NCT02029196|57927|P1|NOT COMPLETED|Overall Study||20
24103|NCT02029196|57926|P2|COMPLETED|Overall Study||101
24104|NCT02029196|57927|P1|COMPLETED|Overall Study||286
24105|NCT02029196|57926|P2|STARTED|Overall Study||102
24106|NCT02029196|57927|P1|STARTED|Overall Study||306
24107|NCT02028780|57947|P12|NOT COMPLETED|Follow up Phase||0
24108|NCT02028780|57948|P11|NOT COMPLETED|Follow up Phase||0
24109|NCT02028780|57949|P10|NOT COMPLETED|Follow up Phase||0
24110|NCT02028780|57950|P9|NOT COMPLETED|Follow up Phase||0
24111|NCT02028780|57951|P8|NOT COMPLETED|Follow up Phase||0
24112|NCT02028780|57952|P7|NOT COMPLETED|Follow up Phase||0
24113|NCT02028780|57953|P6|NOT COMPLETED|Follow up Phase||0
24114|NCT02028780|57954|P5|NOT COMPLETED|Follow up Phase||0
24115|NCT02028780|57955|P4|NOT COMPLETED|Follow up Phase||0
24116|NCT02028780|57956|P3|NOT COMPLETED|Follow up Phase||0
24117|NCT02028780|57957|P2|NOT COMPLETED|Follow up Phase||0
24118|NCT02028780|57958|P1|NOT COMPLETED|Follow up Phase||0
24119|NCT02028780|57947|P12|COMPLETED|Follow up Phase||9
24120|NCT02028780|57948|P11|COMPLETED|Follow up Phase||9
24121|NCT02028780|57949|P10|COMPLETED|Follow up Phase||9
24122|NCT02028780|57950|P9|COMPLETED|Follow up Phase||9
24123|NCT02028780|57951|P8|COMPLETED|Follow up Phase||3
24124|NCT02028780|57952|P7|COMPLETED|Follow up Phase||9
24125|NCT02028780|57953|P6|COMPLETED|Follow up Phase||6
24126|NCT02028780|57954|P5|COMPLETED|Follow up Phase||6
24127|NCT02028780|57955|P4|COMPLETED|Follow up Phase||6
24128|NCT02028780|57956|P3|COMPLETED|Follow up Phase||6
24129|NCT02028780|57957|P2|COMPLETED|Follow up Phase||2
24130|NCT02028780|57958|P1|COMPLETED|Follow up Phase||6
24131|NCT02028780|57947|P12|STARTED|Follow up Phase||9
24132|NCT02028780|57948|P11|STARTED|Follow up Phase||9
24133|NCT02028780|57949|P10|STARTED|Follow up Phase||9
24134|NCT02028780|57950|P9|STARTED|Follow up Phase||9
24135|NCT02028780|57951|P8|STARTED|Follow up Phase||3
24136|NCT02028780|57952|P7|STARTED|Follow up Phase||9
24137|NCT02028780|57953|P6|STARTED|Follow up Phase||6
24138|NCT02028780|57954|P5|STARTED|Follow up Phase||6
24139|NCT02028780|57955|P4|STARTED|Follow up Phase||6
24140|NCT02028780|57956|P3|STARTED|Follow up Phase||6
24141|NCT02028780|57957|P2|STARTED|Follow up Phase||2
24142|NCT02028780|57958|P1|STARTED|Follow up Phase||6
24143|NCT02028780|57947|P12|NOT COMPLETED|Observation Phase||0
24144|NCT02028780|57948|P11|NOT COMPLETED|Observation Phase||0
24145|NCT02028780|57949|P10|NOT COMPLETED|Observation Phase||0
24146|NCT02028780|57950|P9|NOT COMPLETED|Observation Phase||0
24147|NCT02028780|57951|P8|NOT COMPLETED|Observation Phase||0
24148|NCT02028780|57952|P7|NOT COMPLETED|Observation Phase||0
24149|NCT02028780|57953|P6|NOT COMPLETED|Observation Phase||0
24150|NCT02028780|57954|P5|NOT COMPLETED|Observation Phase||0
24151|NCT02028780|57955|P4|NOT COMPLETED|Observation Phase||0
24152|NCT02028780|57956|P3|NOT COMPLETED|Observation Phase||0
24153|NCT02028780|57957|P2|NOT COMPLETED|Observation Phase||0
24154|NCT02028780|57958|P1|NOT COMPLETED|Observation Phase||0
24155|NCT02028780|57947|P12|COMPLETED|Observation Phase||9
24156|NCT02028780|57948|P11|COMPLETED|Observation Phase||9
24157|NCT02028780|57949|P10|COMPLETED|Observation Phase||9
24158|NCT02028780|57950|P9|COMPLETED|Observation Phase||9
24159|NCT02028780|57951|P8|COMPLETED|Observation Phase||3
24160|NCT02028780|57952|P7|COMPLETED|Observation Phase||9
24161|NCT02028780|57953|P6|COMPLETED|Observation Phase||6
24162|NCT02028780|57954|P5|COMPLETED|Observation Phase||6
24163|NCT02028780|57955|P4|COMPLETED|Observation Phase||6
24164|NCT02028780|57956|P3|COMPLETED|Observation Phase||6
24165|NCT02028780|57957|P2|COMPLETED|Observation Phase||2
24166|NCT02028780|57958|P1|COMPLETED|Observation Phase||6
24167|NCT02028780|57947|P12|STARTED|Observation Phase||9
24168|NCT02028780|57948|P11|STARTED|Observation Phase||9
24169|NCT02028780|57949|P10|STARTED|Observation Phase||9
24170|NCT02028780|57950|P9|STARTED|Observation Phase||9
24171|NCT02028780|57951|P8|STARTED|Observation Phase||3
24172|NCT02028780|57952|P7|STARTED|Observation Phase||9
24173|NCT02028780|57953|P6|STARTED|Observation Phase||6
24174|NCT02028780|57954|P5|STARTED|Observation Phase||6
24175|NCT02028780|57955|P4|STARTED|Observation Phase||6
24176|NCT02028780|57956|P3|STARTED|Observation Phase||6
24177|NCT02028780|57957|P2|STARTED|Observation Phase||2
24178|NCT02028780|57958|P1|STARTED|Observation Phase||6
24179|NCT02028767|58023|P2|NOT COMPLETED|Treatment Period 2||0
24180|NCT02028767|58024|P1|NOT COMPLETED|Treatment Period 2||2
24181|NCT02028767|58023|P2|COMPLETED|Treatment Period 2||16
24182|NCT02028767|58024|P1|COMPLETED|Treatment Period 2||14
24183|NCT02028767|58023|P2|STARTED|Treatment Period 2||16
24184|NCT02028767|58024|P1|STARTED|Treatment Period 2||16
24185|NCT02028767|58023|P2|NOT COMPLETED|Treatment Period 1||0
24186|NCT02028767|58024|P1|NOT COMPLETED|Treatment Period 1||0
24187|NCT02028767|58023|P2|COMPLETED|Treatment Period 1||16
24188|NCT02028767|58024|P1|COMPLETED|Treatment Period 1||16
24189|NCT02028767|58023|P2|STARTED|Treatment Period 1||16
24190|NCT02028767|58024|P1|STARTED|Treatment Period 1||16
24191|NCT02028754|58036|P2|NOT COMPLETED|Overall Study||8
24192|NCT02028754|58037|P1|NOT COMPLETED|Overall Study||7
24193|NCT02028754|58036|P2|COMPLETED|Overall Study||82
24194|NCT02028754|58037|P1|COMPLETED|Overall Study||83
24195|NCT02028754|58036|P2|STARTED|Overall Study||90
24196|NCT02028754|58037|P1|STARTED|Overall Study||90
24197|NCT02028676|58064|P9|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24198|NCT02028676|58065|P8|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24199|NCT02028676|58066|P7|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24200|NCT02028676|58067|P6|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24201|NCT02028676|58068|P5|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24202|NCT02028676|58069|P4|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24203|NCT02028676|58070|P3|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24204|NCT02028676|58071|P2|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24205|NCT02028676|58072|P1|NOT COMPLETED|Subsequent Cotrimoxazole Randomization||0
24206|NCT02028676|58064|P9|COMPLETED|Subsequent Cotrimoxazole Randomization||382
24207|NCT02028676|58065|P8|COMPLETED|Subsequent Cotrimoxazole Randomization||376
24208|NCT02028676|58066|P7|COMPLETED|Subsequent Cotrimoxazole Randomization||0
24209|NCT02028676|58067|P6|COMPLETED|Subsequent Cotrimoxazole Randomization||0
24210|NCT02028676|58068|P5|COMPLETED|Subsequent Cotrimoxazole Randomization||0
24211|NCT02028676|58069|P4|COMPLETED|Subsequent Cotrimoxazole Randomization||0
24212|NCT02028676|58070|P3|COMPLETED|Subsequent Cotrimoxazole Randomization||0
24213|NCT02028676|58071|P2|COMPLETED|Subsequent Cotrimoxazole Randomization||0
24214|NCT02028676|58072|P1|COMPLETED|Subsequent Cotrimoxazole Randomization||0
24215|NCT02028676|58064|P9|STARTED|Subsequent Cotrimoxazole Randomization||382
24216|NCT02028676|58065|P8|STARTED|Subsequent Cotrimoxazole Randomization||376
24217|NCT02028676|58066|P7|STARTED|Subsequent Cotrimoxazole Randomization||0
24218|NCT02028676|58067|P6|STARTED|Subsequent Cotrimoxazole Randomization||0
24219|NCT02028676|58068|P5|STARTED|Subsequent Cotrimoxazole Randomization||0
24220|NCT02028676|58069|P4|STARTED|Subsequent Cotrimoxazole Randomization||0
24221|NCT02028676|58070|P3|STARTED|Subsequent Cotrimoxazole Randomization||0
24222|NCT02028676|58071|P2|STARTED|Subsequent Cotrimoxazole Randomization||0
24223|NCT02028676|58072|P1|STARTED|Subsequent Cotrimoxazole Randomization||0
24224|NCT02028676|58064|P9|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24225|NCT02028676|58065|P8|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24226|NCT02028676|58066|P7|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24227|NCT02028676|58067|P6|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24228|NCT02028676|58068|P5|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24229|NCT02028676|58069|P4|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24230|NCT02028676|58070|P3|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24231|NCT02028676|58071|P2|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24232|NCT02028676|58072|P1|NOT COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24233|NCT02028676|58064|P9|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24234|NCT02028676|58065|P8|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24235|NCT02028676|58066|P7|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||333
24236|NCT02028676|58067|P6|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||336
24237|NCT02028676|58068|P5|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24238|NCT02028676|58069|P4|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24239|NCT02028676|58070|P3|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24240|NCT02028676|58071|P2|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24241|NCT02028676|58072|P1|COMPLETED|Subsequent Once vs Twice Daily ABC+3TC||0
24242|NCT02028676|58064|P9|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
24243|NCT02028676|58065|P8|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
24244|NCT02028676|58066|P7|STARTED|Subsequent Once vs Twice Daily ABC+3TC||333
24245|NCT02028676|58067|P6|STARTED|Subsequent Once vs Twice Daily ABC+3TC||336
24246|NCT02028676|58068|P5|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
24247|NCT02028676|58069|P4|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
24248|NCT02028676|58070|P3|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
24249|NCT02028676|58071|P2|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
24250|NCT02028676|58072|P1|STARTED|Subsequent Once vs Twice Daily ABC+3TC||0
24251|NCT02028676|58064|P9|NOT COMPLETED|Initial Enrolment: Induction ART||0
24252|NCT02028676|58065|P8|NOT COMPLETED|Initial Enrolment: Induction ART||0
24253|NCT02028676|58066|P7|NOT COMPLETED|Initial Enrolment: Induction ART||0
24254|NCT02028676|58067|P6|NOT COMPLETED|Initial Enrolment: Induction ART||0
24255|NCT02028676|58068|P5|NOT COMPLETED|Initial Enrolment: Induction ART||0
24256|NCT02028676|58069|P4|NOT COMPLETED|Initial Enrolment: Induction ART||0
24257|NCT02028676|58070|P3|NOT COMPLETED|Initial Enrolment: Induction ART||0
24258|NCT02028676|58071|P2|NOT COMPLETED|Initial Enrolment: Induction ART||0
24259|NCT02028676|58072|P1|NOT COMPLETED|Initial Enrolment: Induction ART||0
24260|NCT02028676|58064|P9|COMPLETED|Initial Enrolment: Induction ART||0
24261|NCT02028676|58065|P8|COMPLETED|Initial Enrolment: Induction ART||0
24262|NCT02028676|58066|P7|COMPLETED|Initial Enrolment: Induction ART||0
24263|NCT02028676|58067|P6|COMPLETED|Initial Enrolment: Induction ART||0
24264|NCT02028676|58068|P5|COMPLETED|Initial Enrolment: Induction ART||405
24265|NCT02028676|58069|P4|COMPLETED|Initial Enrolment: Induction ART||404
24266|NCT02028676|58070|P3|COMPLETED|Initial Enrolment: Induction ART||397
24267|NCT02028676|58071|P2|COMPLETED|Initial Enrolment: Induction ART||0
24268|NCT02028676|58072|P1|COMPLETED|Initial Enrolment: Induction ART||0
24269|NCT02028676|58064|P9|STARTED|Initial Enrolment: Induction ART||0
24270|NCT02028676|58065|P8|STARTED|Initial Enrolment: Induction ART||0
24271|NCT02028676|58066|P7|STARTED|Initial Enrolment: Induction ART||0
24272|NCT02028676|58067|P6|STARTED|Initial Enrolment: Induction ART||0
24273|NCT02028676|58068|P5|STARTED|Initial Enrolment: Induction ART||405
24274|NCT02028676|58069|P4|STARTED|Initial Enrolment: Induction ART||404
24275|NCT02028676|58070|P3|STARTED|Initial Enrolment: Induction ART||397
24276|NCT02028676|58071|P2|STARTED|Initial Enrolment: Induction ART||0
24277|NCT02028676|58072|P1|STARTED|Initial Enrolment: Induction ART||0
24278|NCT02028676|58064|P9|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24279|NCT02028676|58065|P8|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24280|NCT02028676|58066|P7|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24281|NCT02028676|58067|P6|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24282|NCT02028676|58068|P5|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24283|NCT02028676|58069|P4|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24284|NCT02028676|58070|P3|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24285|NCT02028676|58071|P2|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24286|NCT02028676|58072|P1|NOT COMPLETED|Initial Enrolment: CDM vs LCM||0
24287|NCT02028676|58064|P9|COMPLETED|Initial Enrolment: CDM vs LCM||0
24288|NCT02028676|58065|P8|COMPLETED|Initial Enrolment: CDM vs LCM||0
24289|NCT02028676|58066|P7|COMPLETED|Initial Enrolment: CDM vs LCM||0
24290|NCT02028676|58067|P6|COMPLETED|Initial Enrolment: CDM vs LCM||0
24291|NCT02028676|58068|P5|COMPLETED|Initial Enrolment: CDM vs LCM||0
24292|NCT02028676|58069|P4|COMPLETED|Initial Enrolment: CDM vs LCM||0
24293|NCT02028676|58070|P3|COMPLETED|Initial Enrolment: CDM vs LCM||0
24294|NCT02028676|58071|P2|COMPLETED|Initial Enrolment: CDM vs LCM||600
24295|NCT02028676|58072|P1|COMPLETED|Initial Enrolment: CDM vs LCM||606
24296|NCT02028676|58064|P9|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
24297|NCT02028676|58065|P8|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
24298|NCT02028676|58066|P7|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
24299|NCT02028676|58067|P6|STARTED|Initial Enrolment: CDM vs LCM|Secondary partial factorial randomization: Only a subset of ARROW children were eligible|0
24300|NCT02028676|58068|P5|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
24301|NCT02028676|58069|P4|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
24302|NCT02028676|58070|P3|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|0
24303|NCT02028676|58071|P2|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|600
24304|NCT02028676|58072|P1|STARTED|Initial Enrolment: CDM vs LCM|Factorial randomization at enrolment: Number of eligible children randomized to this group in ARROW|606
24305|NCT02028325|58245|P1|NOT COMPLETED|Overall Study||10
24306|NCT02028325|58245|P1|COMPLETED|Overall Study||126
24307|NCT02028325|58245|P1|STARTED|Overall Study||136
24308|NCT02028169|58249|P1|NOT COMPLETED|Overall Study||28
24309|NCT02028169|58249|P1|COMPLETED|Overall Study||92
24310|NCT02028169|58249|P1|STARTED|Overall Study||120
24311|NCT02028065|58275|P3|NOT COMPLETED|Treatment Through Study Completion||14
24312|NCT02028065|58276|P2|NOT COMPLETED|Treatment Through Study Completion||15
24313|NCT02028065|58277|P1|NOT COMPLETED|Treatment Through Study Completion||12
24314|NCT02028065|58275|P3|COMPLETED|Treatment Through Study Completion||134
24315|NCT02028065|58276|P2|COMPLETED|Treatment Through Study Completion||136
24316|NCT02028065|58277|P1|COMPLETED|Treatment Through Study Completion||64
24317|NCT02028065|58275|P3|Received Third Dose|Treatment Through Study Completion||134
24318|NCT02028065|58276|P2|Received Third Dose|Treatment Through Study Completion||136
24319|NCT02028065|58277|P1|Received Third Dose|Treatment Through Study Completion||64
24320|NCT02028065|58275|P3|Received Second Dose|Treatment Through Study Completion||138
24321|NCT02028065|58276|P2|Received Second Dose|Treatment Through Study Completion||140
24322|NCT02028065|58277|P1|Received Second Dose|Treatment Through Study Completion||69
24323|NCT02028065|58275|P3|Received First Dose|Treatment Through Study Completion||148
24324|NCT02028065|58276|P2|Received First Dose|Treatment Through Study Completion||151
24325|NCT02028065|58277|P1|Received First Dose|Treatment Through Study Completion||76
24326|NCT02028065|58275|P3|STARTED|Treatment Through Study Completion|Does not include the 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|148
24327|NCT02028065|58276|P2|STARTED|Treatment Through Study Completion||151
24328|NCT02028065|58277|P1|STARTED|Treatment Through Study Completion|Includes 1 participant randomized to sugammadex 16 mg/kg who actually received placebo|76
24329|NCT02028065|58275|P3|NOT COMPLETED|Randomization Through Start Treatment||3
24330|NCT02028065|58276|P2|NOT COMPLETED|Randomization Through Start Treatment||3
24331|NCT02028065|58277|P1|NOT COMPLETED|Randomization Through Start Treatment||1
24332|NCT02028065|58275|P3|COMPLETED|Randomization Through Start Treatment||149
24333|NCT02028065|58276|P2|COMPLETED|Randomization Through Start Treatment||151
24334|NCT02028065|58277|P1|COMPLETED|Randomization Through Start Treatment||75
24335|NCT02028065|58275|P3|STARTED|Randomization Through Start Treatment|Randomized|152
24336|NCT02028065|58276|P2|STARTED|Randomization Through Start Treatment|Randomized|154
24337|NCT02028065|58277|P1|STARTED|Randomization Through Start Treatment|Randomized|76
24338|NCT02027883|58290|P2|NOT COMPLETED|Overall Study||0
24339|NCT02027883|58291|P1|NOT COMPLETED|Overall Study||0
24340|NCT02027883|58290|P2|COMPLETED|Overall Study||50
24341|NCT02027883|58291|P1|COMPLETED|Overall Study||50
24342|NCT02027883|58290|P2|STARTED|Overall Study||50
24343|NCT02027883|58291|P1|STARTED|Overall Study||50
24344|NCT02027844|58304|P3|NOT COMPLETED|Overall Study||2
24345|NCT02027844|58305|P2|NOT COMPLETED|Overall Study||6
24346|NCT02027844|58306|P1|NOT COMPLETED|Overall Study||5
24347|NCT02027844|58304|P3|COMPLETED|Overall Study||37
24348|NCT02027844|58305|P2|COMPLETED|Overall Study||33
24349|NCT02027844|58306|P1|COMPLETED|Overall Study||34
24350|NCT02027844|58304|P3|STARTED|Overall Study||39
24351|NCT02027844|58305|P2|STARTED|Overall Study||39
24352|NCT02027844|58306|P1|STARTED|Overall Study||39
24353|NCT02027402|58325|P2|NOT COMPLETED|Overall Study||1
24354|NCT02027402|58326|P1|NOT COMPLETED|Overall Study||4
24355|NCT02027402|58325|P2|COMPLETED|Overall Study||99
24356|NCT02027402|58326|P1|COMPLETED|Overall Study||94
24357|NCT02027402|58325|P2|STARTED|Overall Study||100
24358|NCT02027402|58326|P1|STARTED|Overall Study||98
24359|NCT02027311|58340|P2|NOT COMPLETED|Overall Study||2
24360|NCT02027311|58341|P1|NOT COMPLETED|Overall Study||3
24361|NCT02027311|58340|P2|COMPLETED|Overall Study|1 cases was dropped due to tachycardia and 1 were desaturation.|33
24362|NCT02027311|58341|P1|COMPLETED|Overall Study|1 case was dropped due to hypotension and 2 were desaturation.|30
24363|NCT02027311|58340|P2|STARTED|Overall Study||35
24364|NCT02027311|58341|P1|STARTED|Overall Study||33
24365|NCT02027272|58351|P2|NOT COMPLETED|Overall Study||1
24366|NCT02027272|58352|P1|NOT COMPLETED|Overall Study||0
24367|NCT02027272|58351|P2|COMPLETED|Overall Study||0
24368|NCT02027272|58352|P1|COMPLETED|Overall Study||0
24369|NCT02027272|58351|P2|STARTED|Overall Study||1
24370|NCT02027272|58352|P1|STARTED|Overall Study||0
24371|NCT02026258|58360|P2|NOT COMPLETED|Recieved Allocated Intervention||2
24372|NCT02026258|58361|P1|NOT COMPLETED|Recieved Allocated Intervention||1
24373|NCT02026258|58360|P2|COMPLETED|Recieved Allocated Intervention||17
24374|NCT02026258|58361|P1|COMPLETED|Recieved Allocated Intervention||15
24375|NCT02026258|58360|P2|STARTED|Recieved Allocated Intervention||19
24376|NCT02026258|58361|P1|STARTED|Recieved Allocated Intervention||16
24377|NCT02026258|58360|P2|NOT COMPLETED|Randomized||2
24378|NCT02026258|58361|P1|NOT COMPLETED|Randomized||4
24379|NCT02026258|58360|P2|COMPLETED|Randomized||19
24380|NCT02026258|58361|P1|COMPLETED|Randomized||16
24381|NCT02026258|58360|P2|STARTED|Randomized||21
24382|NCT02026258|58361|P1|STARTED|Randomized||20
24383|NCT02026206|58375|P2|NOT COMPLETED|Overall Study||8
24384|NCT02026206|58376|P1|NOT COMPLETED|Overall Study||4
24385|NCT02026206|58375|P2|COMPLETED|Overall Study||36
24386|NCT02026206|58376|P1|COMPLETED|Overall Study||40
24387|NCT02026206|58375|P2|STARTED|Overall Study||44
24388|NCT02026206|58376|P1|STARTED|Overall Study||44
24389|NCT02026193|58386|P2|NOT COMPLETED|Overall Study||0
24390|NCT02026193|58387|P1|NOT COMPLETED|Overall Study||0
24391|NCT02026193|58386|P2|COMPLETED|Overall Study||8
24392|NCT02026193|58387|P1|COMPLETED|Overall Study||3
24393|NCT02026193|58386|P2|STARTED|Overall Study||8
24394|NCT02026193|58387|P1|STARTED|Overall Study||3
24395|NCT02026141|58395|P2|NOT COMPLETED|Overall Study||1
24396|NCT02026141|58396|P1|NOT COMPLETED|Overall Study||0
24397|NCT02026141|58395|P2|COMPLETED|Overall Study||19
24398|NCT02026141|58396|P1|COMPLETED|Overall Study||20
24399|NCT02026141|58395|P2|STARTED|Overall Study||20
24400|NCT02026141|58396|P1|STARTED|Overall Study||20
24401|NCT02025907|58404|P2|NOT COMPLETED|Overall Study||12
24402|NCT02025907|58405|P1|NOT COMPLETED|Overall Study||27
24403|NCT02025907|58404|P2|COMPLETED|Overall Study||96
24404|NCT02025907|58405|P1|COMPLETED|Overall Study||81
24405|NCT02025907|58404|P2|STARTED|Overall Study|Participant flow is presented for safety population.|108
24406|NCT02025907|58405|P1|STARTED|Overall Study|Participant flow is presented for safety population.|108
24407|NCT02025829|58421|P2|NOT COMPLETED|Overall Study||0
24408|NCT02025829|58422|P1|NOT COMPLETED|Overall Study||0
24409|NCT02025829|58421|P2|COMPLETED|Overall Study||11
24410|NCT02025829|58422|P1|COMPLETED|Overall Study||3
24411|NCT02025829|58421|P2|STARTED|Overall Study||11
24412|NCT02025829|58422|P1|STARTED|Overall Study||3
24413|NCT02025647|58431|P1|NOT COMPLETED|Overall Study||0
24414|NCT02025647|58431|P1|COMPLETED|Overall Study||139
24415|NCT02025647|58431|P1|Session 3 (Rating Module: 30-45 Days)|Overall Study|"27 did not generate IRS
36 lost to follow up"|76
24416|NCT02025647|58431|P1|Session 2 (Narrative Module: 24-48 Hrs)|Overall Study|"19 lost to follow up or technology issues
3 administered wrong session"|117
24503|NCT02024165|58645|P1|STARTED|Overall Study||71
24417|NCT02025647|58431|P1|Immediate Retest (Rating Module: 5 Min)|Overall Study|"27 did not generate IRS
15 technology issues or administered wrong session"|97
24418|NCT02025647|58431|P1|Session 1 (Narrative Module)|Overall Study||139
24419|NCT02025647|58431|P1|STARTED|Overall Study||139
24420|NCT02025075|58462|P2|NOT COMPLETED|Overall Study||2
24421|NCT02025075|58463|P1|NOT COMPLETED|Overall Study||0
24422|NCT02025075|58462|P2|COMPLETED|Overall Study||19
24423|NCT02025075|58463|P1|COMPLETED|Overall Study||16
24424|NCT02025075|58462|P2|STARTED|Overall Study||21
24425|NCT02025075|58463|P1|STARTED|Overall Study||16
24426|NCT02024971|58487|P1|NOT COMPLETED|Overall Study||36
24427|NCT02024971|58487|P1|COMPLETED|Overall Study|Including 162 patients with missing efficacy data at two or more time points.|1067
24428|NCT02024971|58487|P1|Safety Analysis Set|Overall Study|All participants with available data who were enrolled prior to Day 15 of the start of treatment.|1067
24429|NCT02024971|58487|P1|STARTED|Overall Study||1103
24430|NCT02024932|58500|P6|NOT COMPLETED|Overall Study||0
24431|NCT02024932|58501|P5|NOT COMPLETED|Overall Study||2
24432|NCT02024932|58502|P4|NOT COMPLETED|Overall Study||2
24433|NCT02024932|58503|P3|NOT COMPLETED|Overall Study||0
24434|NCT02024932|58504|P2|NOT COMPLETED|Overall Study||3
24435|NCT02024932|58505|P1|NOT COMPLETED|Overall Study||2
24436|NCT02024932|58500|P6|COMPLETED|Overall Study||9
24437|NCT02024932|58501|P5|COMPLETED|Overall Study||16
24438|NCT02024932|58502|P4|COMPLETED|Overall Study||0
24439|NCT02024932|58503|P3|COMPLETED|Overall Study||2
24440|NCT02024932|58504|P2|COMPLETED|Overall Study||1
24441|NCT02024932|58505|P1|COMPLETED|Overall Study||0
24442|NCT02024932|58500|P6|Pharmacodynamic (PD) Analysis Set|Overall Study||9
24443|NCT02024932|58501|P5|Pharmacodynamic (PD) Analysis Set|Overall Study||18
24444|NCT02024932|58502|P4|Pharmacodynamic (PD) Analysis Set|Overall Study||2
24445|NCT02024932|58503|P3|Pharmacodynamic (PD) Analysis Set|Overall Study||2
24446|NCT02024932|58504|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||4
24447|NCT02024932|58505|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||2
24448|NCT02024932|58500|P6|Pharmacokinetic (PK) Analysis Set|Overall Study||0
24449|NCT02024932|58501|P5|Pharmacokinetic (PK) Analysis Set|Overall Study||18
24450|NCT02024932|58502|P4|Pharmacokinetic (PK) Analysis Set|Overall Study||2
24451|NCT02024932|58503|P3|Pharmacokinetic (PK) Analysis Set|Overall Study||0
24452|NCT02024932|58504|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||4
24453|NCT02024932|58505|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||2
24454|NCT02024932|58500|P6|Safety Analysis Set|Overall Study||9
24455|NCT02024932|58501|P5|Safety Analysis Set|Overall Study||18
24456|NCT02024932|58502|P4|Safety Analysis Set|Overall Study||2
24457|NCT02024932|58503|P3|Safety Analysis Set|Overall Study||2
24458|NCT02024932|58504|P2|Safety Analysis Set|Overall Study||4
24459|NCT02024932|58505|P1|Safety Analysis Set|Overall Study||2
24460|NCT02024932|58500|P6|STARTED|Overall Study||9
24461|NCT02024932|58501|P5|STARTED|Overall Study||18
24462|NCT02024932|58502|P4|STARTED|Overall Study||2
24463|NCT02024932|58503|P3|STARTED|Overall Study||2
24464|NCT02024932|58504|P2|STARTED|Overall Study||4
24465|NCT02024932|58505|P1|STARTED|Overall Study||2
24466|NCT02024867|58564|P2|NOT COMPLETED|Overall Study||7
24467|NCT02024867|58565|P1|NOT COMPLETED|Overall Study||9
24468|NCT02024867|58564|P2|COMPLETED|Overall Study||124
24469|NCT02024867|58565|P1|COMPLETED|Overall Study||125
24470|NCT02024867|58564|P2|STARTED|Overall Study||131
24471|NCT02024867|58565|P1|STARTED|Overall Study||134
24472|NCT02024724|58583|P2|NOT COMPLETED|Overall Study||0
24473|NCT02024724|58584|P1|NOT COMPLETED|Overall Study||1
24474|NCT02024724|58583|P2|COMPLETED|Overall Study||30
24475|NCT02024724|58584|P1|COMPLETED|Overall Study||29
24476|NCT02024724|58583|P2|STARTED|Overall Study||30
24477|NCT02024724|58584|P1|STARTED|Overall Study||30
24478|NCT02024698|58590|P2|NOT COMPLETED|Second Intervention (7 Days)||0
24479|NCT02024698|58591|P1|NOT COMPLETED|Second Intervention (7 Days)||0
24480|NCT02024698|58590|P2|COMPLETED|Second Intervention (7 Days)||26
24481|NCT02024698|58591|P1|COMPLETED|Second Intervention (7 Days)||16
24482|NCT02024698|58590|P2|Received Etafilcon A Twice|Second Intervention (7 Days)||0
24483|NCT02024698|58591|P1|Received Etafilcon A Twice|Second Intervention (7 Days)||1
24484|NCT02024698|58590|P2|STARTED|Second Intervention (7 Days)||26
24485|NCT02024698|58591|P1|STARTED|Second Intervention (7 Days)||16
24486|NCT02024698|58590|P2|NOT COMPLETED|First Intervention (7 Days)||1
24487|NCT02024698|58591|P1|NOT COMPLETED|First Intervention (7 Days)||0
24488|NCT02024698|58590|P2|COMPLETED|First Intervention (7 Days)||26
24489|NCT02024698|58591|P1|COMPLETED|First Intervention (7 Days)||16
24490|NCT02024698|58590|P2|STARTED|First Intervention (7 Days)||27
24491|NCT02024698|58591|P1|STARTED|First Intervention (7 Days)||16
24492|NCT02024386|58620|P3|NOT COMPLETED|Overall Study||0
24493|NCT02024386|58621|P2|NOT COMPLETED|Overall Study||0
24494|NCT02024386|58622|P1|NOT COMPLETED|Overall Study||0
24495|NCT02024386|58620|P3|COMPLETED|Overall Study||5
24496|NCT02024386|58621|P2|COMPLETED|Overall Study||11
24497|NCT02024386|58622|P1|COMPLETED|Overall Study||6
24498|NCT02024386|58620|P3|STARTED|Overall Study||5
24499|NCT02024386|58621|P2|STARTED|Overall Study||11
24500|NCT02024386|58622|P1|STARTED|Overall Study||6
24501|NCT02024165|58645|P1|NOT COMPLETED|Overall Study||0
24502|NCT02024165|58645|P1|COMPLETED|Overall Study||71
24504|NCT02023983|58652|P2|NOT COMPLETED|Overall Study||0
24505|NCT02023983|58653|P1|NOT COMPLETED|Overall Study||0
24506|NCT02023983|58652|P2|COMPLETED|Overall Study||75
24507|NCT02023983|58653|P1|COMPLETED|Overall Study||76
24508|NCT02023983|58652|P2|STARTED|Overall Study||75
24509|NCT02023983|58653|P1|STARTED|Overall Study||76
24510|NCT02023918|58661|P1|NOT COMPLETED|Overall Study||0
24511|NCT02023918|58661|P1|COMPLETED|Overall Study||6
24512|NCT02023918|58661|P1|STARTED|Overall Study||6
24513|NCT02023879|58669|P3|NOT COMPLETED|Overall Study||9
24514|NCT02023879|58670|P2|NOT COMPLETED|Overall Study||9
24515|NCT02023879|58671|P1|NOT COMPLETED|Overall Study||4
24516|NCT02023879|58669|P3|COMPLETED|Overall Study|48 participants entered open-label extension treatment period.|50
24517|NCT02023879|58670|P2|COMPLETED|Overall Study|106 participants entered open-label extension treatment period.|107
24518|NCT02023879|58671|P1|COMPLETED|Overall Study|51 participants entered open-label extension treatment period.|54
24519|NCT02023879|58669|P3|Treated|Overall Study||58
24520|NCT02023879|58670|P2|Treated|Overall Study||115
24521|NCT02023879|58671|P1|Treated|Overall Study||58
24522|NCT02023879|58669|P3|STARTED|Overall Study||59
24523|NCT02023879|58670|P2|STARTED|Overall Study||116
24524|NCT02023879|58671|P1|STARTED|Overall Study||58
24525|NCT02023801|58754|P1|NOT COMPLETED|Overall Study||0
24526|NCT02023801|58754|P1|COMPLETED|Overall Study|Completed 12 Month Follow-up|24
24527|NCT02023801|58754|P1|Treated|Overall Study|Treatment Completed|24
24528|NCT02023801|58754|P1|STARTED|Overall Study|Treatment Attempted|24
24529|NCT02023515|58762|P2|NOT COMPLETED|Overall Study||3
24530|NCT02023515|58763|P1|NOT COMPLETED|Overall Study||1
24531|NCT02023515|58762|P2|COMPLETED|Overall Study||22
24532|NCT02023515|58763|P1|COMPLETED|Overall Study||23
24533|NCT02023515|58762|P2|STARTED|Overall Study||25
24534|NCT02023515|58763|P1|STARTED|Overall Study||24
24535|NCT02023268|58773|P2|NOT COMPLETED|Overall Study||4
24536|NCT02023268|58774|P1|NOT COMPLETED|Overall Study||0
24537|NCT02023268|58773|P2|COMPLETED|Overall Study||49
24538|NCT02023268|58774|P1|COMPLETED|Overall Study||52
24539|NCT02023268|58773|P2|STARTED|Overall Study||53
24540|NCT02023268|58774|P1|STARTED|Overall Study||52
24541|NCT02023125|58782|P3|NOT COMPLETED|Period 2||0
24542|NCT02023125|58783|P2|NOT COMPLETED|Period 2||0
24543|NCT02023125|58784|P1|NOT COMPLETED|Period 2||0
24544|NCT02023125|58782|P3|COMPLETED|Period 2||24
24545|NCT02023125|58783|P2|COMPLETED|Period 2||9
24546|NCT02023125|58784|P1|COMPLETED|Period 2||9
24547|NCT02023125|58782|P3|STARTED|Period 2||24
24548|NCT02023125|58783|P2|STARTED|Period 2||9
24549|NCT02023125|58784|P1|STARTED|Period 2||9
24550|NCT02023125|58782|P3|NOT COMPLETED|Washout Period||0
24551|NCT02023125|58783|P2|NOT COMPLETED|Washout Period||0
24552|NCT02023125|58784|P1|NOT COMPLETED|Washout Period||0
24553|NCT02023125|58782|P3|COMPLETED|Washout Period||24
24554|NCT02023125|58783|P2|COMPLETED|Washout Period||9
24555|NCT02023125|58784|P1|COMPLETED|Washout Period||9
24556|NCT02023125|58782|P3|STARTED|Washout Period||24
24557|NCT02023125|58783|P2|STARTED|Washout Period||9
24558|NCT02023125|58784|P1|STARTED|Washout Period||9
24559|NCT02023125|58782|P3|NOT COMPLETED|Period 1||0
24560|NCT02023125|58783|P2|NOT COMPLETED|Period 1||0
24561|NCT02023125|58784|P1|NOT COMPLETED|Period 1||0
24562|NCT02023125|58782|P3|COMPLETED|Period 1||24
24563|NCT02023125|58783|P2|COMPLETED|Period 1||9
24564|NCT02023125|58784|P1|COMPLETED|Period 1||9
24565|NCT02023125|58782|P3|STARTED|Period 1||24
24566|NCT02023125|58783|P2|STARTED|Period 1||9
24567|NCT02023125|58784|P1|STARTED|Period 1||9
24568|NCT02023112|58845|P2|NOT COMPLETED|Overall Study||1
24569|NCT02023112|58846|P1|NOT COMPLETED|Overall Study||2
24570|NCT02023112|58845|P2|COMPLETED|Overall Study||85
24571|NCT02023112|58846|P1|COMPLETED|Overall Study||83
24572|NCT02023112|58845|P2|STARTED|Overall Study||86
24573|NCT02023112|58846|P1|STARTED|Overall Study||85
24574|NCT02023099|58867|P3|NOT COMPLETED|Overall Study||3
24575|NCT02023099|58868|P2|NOT COMPLETED|Overall Study||0
24576|NCT02023099|58869|P1|NOT COMPLETED|Overall Study||3
24577|NCT02023099|58867|P3|COMPLETED|Overall Study||39
24578|NCT02023099|58868|P2|COMPLETED|Overall Study||106
24579|NCT02023099|58869|P1|COMPLETED|Overall Study||212
24580|NCT02023099|58867|P3|STARTED|Overall Study||42
24581|NCT02023099|58868|P2|STARTED|Overall Study||106
24582|NCT02023099|58869|P1|STARTED|Overall Study||215
24583|NCT02022670|58888|P3|NOT COMPLETED|Overall Study||1
24584|NCT02022670|58889|P2|NOT COMPLETED|Overall Study||0
24585|NCT02022670|58890|P1|NOT COMPLETED|Overall Study||1
24586|NCT02022670|58888|P3|COMPLETED|Overall Study||11
24587|NCT02022670|58889|P2|COMPLETED|Overall Study||10
24588|NCT02022670|58890|P1|COMPLETED|Overall Study||10
24589|NCT02022670|58888|P3|STARTED|Overall Study||12
24590|NCT02022670|58889|P2|STARTED|Overall Study||10
24591|NCT02022670|58890|P1|STARTED|Overall Study||11
24592|NCT02022085|58904|P1|NOT COMPLETED|Overall Study||1
24593|NCT02022085|58904|P1|COMPLETED|Overall Study||53
24594|NCT02022085|58904|P1|STARTED|Overall Study||54
24595|NCT02022020|58925|P1|NOT COMPLETED|Overall Study||0
24596|NCT02022020|58925|P1|COMPLETED|Overall Study||220
24597|NCT02022020|58925|P1|STARTED|Overall Study||220
24598|NCT02022007|58934|P3|NOT COMPLETED|Overall Study||2
24599|NCT02022007|58935|P2|NOT COMPLETED|Overall Study||1
24600|NCT02022007|58936|P1|NOT COMPLETED|Overall Study||1
24601|NCT02022007|58934|P3|COMPLETED|Overall Study||11
24602|NCT02022007|58935|P2|COMPLETED|Overall Study||11
24603|NCT02022007|58936|P1|COMPLETED|Overall Study||12
24604|NCT02022007|58934|P3|STARTED|Overall Study||13
24605|NCT02022007|58935|P2|STARTED|Overall Study||12
24606|NCT02022007|58936|P1|STARTED|Overall Study||13
24607|NCT02021812|58977|P1|NOT COMPLETED|Overall Study||26
24608|NCT02021812|58977|P1|COMPLETED|Overall Study||5
24609|NCT02021812|58977|P1|STARTED|Overall Study||31
24610|NCT02021461|58985|P1|NOT COMPLETED|Overall Study||0
24611|NCT02021461|58985|P1|COMPLETED|Overall Study||38
24612|NCT02021461|58985|P1|STARTED|Overall Study||38
24613|NCT02021331|58993|P2|NOT COMPLETED|Overall Study||2
24614|NCT02021331|58994|P1|NOT COMPLETED|Overall Study||0
24615|NCT02021331|58993|P2|COMPLETED|Overall Study||1
24616|NCT02021331|58994|P1|COMPLETED|Overall Study||2
24617|NCT02021331|58993|P2|STARTED|Overall Study||3
24618|NCT02021331|58994|P1|STARTED|Overall Study||2
24619|NCT02021071|59006|P2|NOT COMPLETED|Overall Study||0
24620|NCT02021071|59007|P1|NOT COMPLETED|Overall Study||0
24621|NCT02021071|59006|P2|COMPLETED|Overall Study||12
24622|NCT02021071|59007|P1|COMPLETED|Overall Study||12
24623|NCT02021071|59006|P2|STARTED|Overall Study||12
24624|NCT02021071|59007|P1|STARTED|Overall Study||12
24625|NCT02020941|59014|P1|NOT COMPLETED|Overall Study||8
24626|NCT02020941|59014|P1|COMPLETED|Overall Study||2
24627|NCT02020941|59014|P1|STARTED|Overall Study||10
24628|NCT02020863|59023|P1|NOT COMPLETED|Overall Study||5
24629|NCT02020863|59023|P1|COMPLETED|Overall Study||35
24630|NCT02020863|59023|P1|STARTED|Overall Study||40
24631|NCT02020577|59029|P2|NOT COMPLETED|Overall Study||55
24632|NCT02020577|59030|P1|NOT COMPLETED|Overall Study||3
24633|NCT02020577|59029|P2|COMPLETED|Overall Study||0
24634|NCT02020577|59030|P1|COMPLETED|Overall Study||0
24635|NCT02020577|59029|P2|STARTED|Overall Study||55
24636|NCT02020577|59030|P1|STARTED|Overall Study||3
24637|NCT02020512|59057|P1|NOT COMPLETED|Overall Study||8
24638|NCT02020512|59057|P1|COMPLETED|Overall Study||79
24639|NCT02020512|59057|P1|STARTED|Overall Study||87
24640|NCT02020369|59063|P2|NOT COMPLETED|Overall Study||2
24641|NCT02020369|59064|P1|NOT COMPLETED|Overall Study||3
24642|NCT02020369|59063|P2|COMPLETED|Overall Study||11
24643|NCT02020369|59064|P1|COMPLETED|Overall Study||11
24644|NCT02020369|59063|P2|STARTED|Overall Study||13
24645|NCT02020369|59064|P1|STARTED|Overall Study||14
24646|NCT02020304|59080|P2|NOT COMPLETED|Overall Study||2
24647|NCT02020304|59081|P1|NOT COMPLETED|Overall Study||3
24648|NCT02020304|59080|P2|COMPLETED|Overall Study||26
24649|NCT02020304|59081|P1|COMPLETED|Overall Study||27
24650|NCT02020304|59080|P2|STARTED|Overall Study||28
24651|NCT02020304|59081|P1|STARTED|Overall Study||30
24652|NCT02020135|59097|P1|NOT COMPLETED|Overall Study||9
24653|NCT02020135|59097|P1|COMPLETED|Overall Study||0
24654|NCT02020135|59097|P1|STARTED|Overall Study||9
24655|NCT02020031|59109|P2|NOT COMPLETED|Overall Study||1
24656|NCT02020031|59110|P1|NOT COMPLETED|Overall Study||1
24657|NCT02020031|59109|P2|COMPLETED|Overall Study||10
24658|NCT02020031|59110|P1|COMPLETED|Overall Study||10
24659|NCT02020031|59109|P2|STARTED|Overall Study||11
24660|NCT02020031|59110|P1|STARTED|Overall Study||11
24661|NCT02019563|59120|P2|NOT COMPLETED|Overall Study||0
24662|NCT02019563|59121|P1|NOT COMPLETED|Overall Study||0
24663|NCT02019563|59120|P2|COMPLETED|Overall Study|72 incisors were treated in the RCT group|30
24664|NCT02019563|59121|P1|COMPLETED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
24665|NCT02019563|59120|P2|STARTED|Overall Study|72 incisors were treated in the RCT group|30
24666|NCT02019563|59121|P1|STARTED|Overall Study|100 incisors were treated in the MTA/FS pulpotomy group|40
24667|NCT02019550|59137|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
24668|NCT02019550|59138|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
24669|NCT02019550|59137|P2|COMPLETED|Treatment Period 2 (4 Weeks)||50
24670|NCT02019550|59138|P1|COMPLETED|Treatment Period 2 (4 Weeks)||46
24671|NCT02019550|59137|P2|STARTED|Treatment Period 2 (4 Weeks)||50
24672|NCT02019550|59138|P1|STARTED|Treatment Period 2 (4 Weeks)||46
24673|NCT02019550|59137|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
24674|NCT02019550|59138|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
24675|NCT02019550|59137|P2|COMPLETED|Treatment Period 1 (4 Weeks)||50
24676|NCT02019550|59138|P1|COMPLETED|Treatment Period 1 (4 Weeks)||46
24677|NCT02019550|59137|P2|STARTED|Treatment Period 1 (4 Weeks)||51
24678|NCT02019550|59138|P1|STARTED|Treatment Period 1 (4 Weeks)||46
24679|NCT02018809|59180|P4|NOT COMPLETED|Overall Study||0
24680|NCT02018809|59181|P3|NOT COMPLETED|Overall Study||0
24681|NCT02018809|59182|P2|NOT COMPLETED|Overall Study||0
24682|NCT02018809|59183|P1|NOT COMPLETED|Overall Study||0
24683|NCT02018809|59180|P4|COMPLETED|Overall Study||50
24684|NCT02018809|59181|P3|COMPLETED|Overall Study||50
24685|NCT02018809|59182|P2|COMPLETED|Overall Study||50
24686|NCT02018809|59183|P1|COMPLETED|Overall Study||50
24687|NCT02018809|59180|P4|STARTED|Overall Study||50
24688|NCT02018809|59181|P3|STARTED|Overall Study||50
24689|NCT02018809|59182|P2|STARTED|Overall Study||50
24690|NCT02018809|59183|P1|STARTED|Overall Study||50
24691|NCT02017574|59199|P2|NOT COMPLETED|Overall Study||0
24692|NCT02017574|59200|P1|NOT COMPLETED|Overall Study||0
24693|NCT02017574|59199|P2|COMPLETED|Overall Study||12
24694|NCT02017574|59200|P1|COMPLETED|Overall Study||12
24695|NCT02017574|59199|P2|STARTED|Overall Study||12
24696|NCT02017574|59200|P1|STARTED|Overall Study||12
24697|NCT02017093|59210|P2|NOT COMPLETED|Overall Study||0
24698|NCT02017093|59211|P1|NOT COMPLETED|Overall Study||0
24699|NCT02017093|59210|P2|COMPLETED|Overall Study||3
24700|NCT02017093|59211|P1|COMPLETED|Overall Study||4
24701|NCT02017093|59210|P2|STARTED|Overall Study||3
24702|NCT02017093|59211|P1|STARTED|Overall Study||4
24703|NCT02017015|59219|P1|NOT COMPLETED|Overall Study||69
24704|NCT02017015|59219|P1|COMPLETED|Overall Study|Completed = Participants remaining on treatment at the time of the data cut-off of 01 Jun 2015|14
24705|NCT02017015|59219|P1|Safety Population|Overall Study||83
24706|NCT02017015|59219|P1|STARTED|Overall Study||83
24707|NCT02016963|59226|P1|NOT COMPLETED|Overall Study||0
24708|NCT02016963|59226|P1|COMPLETED|Overall Study||20
24709|NCT02016963|59226|P1|STARTED|Overall Study||20
24710|NCT02016690|59242|P1|NOT COMPLETED|Overall Study||24
24711|NCT02016690|59242|P1|COMPLETED|Overall Study|(Effectiveness analysis set)|288
24712|NCT02016690|59242|P1|Safety Analysis Set (SAS)|Overall Study||304
24713|NCT02016690|59242|P1|Treated|Overall Study||312
24714|NCT02016690|59242|P1|STARTED|Overall Study||312
24715|NCT02016625|59255|P2|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||0
24716|NCT02016625|59256|P1|NOT COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||3
24965|NCT02014480|59770|P3|STARTED|Washout Period 2 (10 to 14 Days)||30
24717|NCT02016625|59255|P2|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
24718|NCT02016625|59256|P1|COMPLETED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||13
24719|NCT02016625|59255|P2|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||15
24720|NCT02016625|59256|P1|STARTED|Cyclo or Tac (Day 1) + FDV (Day -7 to 7)||16
24721|NCT02016625|59255|P2|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||1
24722|NCT02016625|59256|P1|NOT COMPLETED|Cyclo or Tac (Single Dose, Day 1)||0
24723|NCT02016625|59255|P2|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||15
24724|NCT02016625|59256|P1|COMPLETED|Cyclo or Tac (Single Dose, Day 1)||16
24725|NCT02016625|59255|P2|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
24726|NCT02016625|59256|P1|STARTED|Cyclo or Tac (Single Dose, Day 1)||16
24727|NCT02016482|59290|P2|NOT COMPLETED|Period B||7
24728|NCT02016482|59291|P1|NOT COMPLETED|Period B||13
24729|NCT02016482|59290|P2|COMPLETED|Period B||87
24730|NCT02016482|59291|P1|COMPLETED|Period B||81
24731|NCT02016482|59290|P2|STARTED|Period B||94
24732|NCT02016482|59291|P1|STARTED|Period B||94
24733|NCT02016482|59290|P2|NOT COMPLETED|Period A||15
24734|NCT02016482|59291|P1|NOT COMPLETED|Period A||14
24735|NCT02016482|59290|P2|COMPLETED|Period A|8 participants early escaped to the end of Period A and 86 continued to the end of Period A.|94
24736|NCT02016482|59291|P1|COMPLETED|Period A|56 participants early escaped to the end of Period A and 38 continued to the end of Period A.|94
24737|NCT02016482|59290|P2|STARTED|Period A||109
24738|NCT02016482|59291|P1|STARTED|Period A||108
24739|NCT02016170|59382|P3|NOT COMPLETED|Overall Study||0
24740|NCT02016170|59383|P2|NOT COMPLETED|Overall Study||1
24741|NCT02016170|59384|P1|NOT COMPLETED|Overall Study||2
24742|NCT02016170|59382|P3|COMPLETED|Overall Study||27
24743|NCT02016170|59383|P2|COMPLETED|Overall Study||27
24744|NCT02016170|59384|P1|COMPLETED|Overall Study||25
24745|NCT02016170|59382|P3|STARTED|Overall Study||27
24746|NCT02016170|59383|P2|STARTED|Overall Study||28
24747|NCT02016170|59384|P1|STARTED|Overall Study||27
24748|NCT02016105|59395|P6|NOT COMPLETED|EXTENSION PERIOD||6
24749|NCT02016105|59396|P5|NOT COMPLETED|EXTENSION PERIOD||6
24750|NCT02016105|59397|P4|NOT COMPLETED|EXTENSION PERIOD||5
24751|NCT02016105|59398|P3|NOT COMPLETED|EXTENSION PERIOD||5
24752|NCT02016105|59399|P2|NOT COMPLETED|EXTENSION PERIOD||0
24753|NCT02016105|59400|P1|NOT COMPLETED|EXTENSION PERIOD||0
24754|NCT02016105|59395|P6|COMPLETED|EXTENSION PERIOD||100
24755|NCT02016105|59396|P5|COMPLETED|EXTENSION PERIOD||50
24756|NCT02016105|59397|P4|COMPLETED|EXTENSION PERIOD||104
24757|NCT02016105|59398|P3|COMPLETED|EXTENSION PERIOD||47
24758|NCT02016105|59399|P2|COMPLETED|EXTENSION PERIOD||0
24759|NCT02016105|59400|P1|COMPLETED|EXTENSION PERIOD||0
24760|NCT02016105|59395|P6|STARTED|EXTENSION PERIOD|6 patients did not proceed from Treatment Period 2 into Extension Period|106
24761|NCT02016105|59396|P5|STARTED|EXTENSION PERIOD|3 patients did not proceed from Treatment Period 2 into Extension Period|56
24762|NCT02016105|59397|P4|STARTED|EXTENSION PERIOD|7 patients did not proceed from Treatment Period 2 into Extension Period|109
24763|NCT02016105|59398|P3|STARTED|EXTENSION PERIOD|5 patients did not proceed from Treatment Period 2 into Extension Period|52
24764|NCT02016105|59399|P2|STARTED|EXTENSION PERIOD||0
24765|NCT02016105|59400|P1|STARTED|EXTENSION PERIOD||0
24766|NCT02016105|59395|P6|NOT COMPLETED|TREATMENT PERIOD 2||14
24767|NCT02016105|59396|P5|NOT COMPLETED|TREATMENT PERIOD 2||4
24768|NCT02016105|59397|P4|NOT COMPLETED|TREATMENT PERIOD 2||11
24769|NCT02016105|59398|P3|NOT COMPLETED|TREATMENT PERIOD 2||6
24770|NCT02016105|59399|P2|NOT COMPLETED|TREATMENT PERIOD 2||0
24771|NCT02016105|59400|P1|NOT COMPLETED|TREATMENT PERIOD 2||0
24772|NCT02016105|59395|P6|COMPLETED|TREATMENT PERIOD 2||112
24773|NCT02016105|59396|P5|COMPLETED|TREATMENT PERIOD 2||59
24774|NCT02016105|59397|P4|COMPLETED|TREATMENT PERIOD 2||116
24775|NCT02016105|59398|P3|COMPLETED|TREATMENT PERIOD 2||57
24776|NCT02016105|59399|P2|COMPLETED|TREATMENT PERIOD 2||0
24777|NCT02016105|59400|P1|COMPLETED|TREATMENT PERIOD 2||0
24778|NCT02016105|59395|P6|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|126
24779|NCT02016105|59396|P5|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from GP2017 adalimumab treatment arm in Treatment Period 1"|63
24780|NCT02016105|59397|P4|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|127
24781|NCT02016105|59398|P3|STARTED|TREATMENT PERIOD 2|"Patients re-randomized from Humira ® adalimumab treatment arm in Treatment Period 1"|63
24782|NCT02016105|59399|P2|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
24783|NCT02016105|59400|P1|STARTED|TREATMENT PERIOD 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
24784|NCT02016105|59395|P6|NOT COMPLETED|TREATMENT PERIOD 1||0
24785|NCT02016105|59396|P5|NOT COMPLETED|TREATMENT PERIOD 1||0
24786|NCT02016105|59397|P4|NOT COMPLETED|TREATMENT PERIOD 1||0
24787|NCT02016105|59398|P3|NOT COMPLETED|TREATMENT PERIOD 1||0
24788|NCT02016105|59399|P2|NOT COMPLETED|TREATMENT PERIOD 1||33
24789|NCT02016105|59400|P1|NOT COMPLETED|TREATMENT PERIOD 1||30
24790|NCT02016105|59395|P6|COMPLETED|TREATMENT PERIOD 1||0
24791|NCT02016105|59396|P5|COMPLETED|TREATMENT PERIOD 1||0
24792|NCT02016105|59397|P4|COMPLETED|TREATMENT PERIOD 1||0
24793|NCT02016105|59398|P3|COMPLETED|TREATMENT PERIOD 1||0
24794|NCT02016105|59399|P2|COMPLETED|TREATMENT PERIOD 1|11 patients did not proceed into Treatment Period 2|201
24795|NCT02016105|59400|P1|COMPLETED|TREATMENT PERIOD 1|12 patients did not proceed into Treatment Period 2|201
24796|NCT02016105|59395|P6|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
24797|NCT02016105|59396|P5|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
24798|NCT02016105|59397|P4|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
24799|NCT02016105|59398|P3|STARTED|TREATMENT PERIOD 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
24800|NCT02016105|59399|P2|STARTED|TREATMENT PERIOD 1||234
24801|NCT02016105|59400|P1|STARTED|TREATMENT PERIOD 1||231
24802|NCT02015910|59450|P2|NOT COMPLETED|Overall Study||0
24803|NCT02015910|59451|P1|NOT COMPLETED|Overall Study||0
24804|NCT02015910|59450|P2|COMPLETED|Overall Study||1
24805|NCT02015910|59451|P1|COMPLETED|Overall Study||0
24806|NCT02015910|59450|P2|STARTED|Overall Study||1
24807|NCT02015910|59451|P1|STARTED|Overall Study||0
24808|NCT02015793|59459|P2|NOT COMPLETED|Overall Study||4
24809|NCT02015793|59460|P1|NOT COMPLETED|Overall Study||4
24810|NCT02015793|59459|P2|COMPLETED|Overall Study||11
24811|NCT02015793|59460|P1|COMPLETED|Overall Study||11
24812|NCT02015793|59459|P2|Entered Open-label Extension Period|Overall Study||14
24813|NCT02015793|59460|P1|Entered Open-label Extension Period|Overall Study||13
24814|NCT02015793|59459|P2|Completed Double-Blind Period|Overall Study||14
24815|NCT02015793|59460|P1|Completed Double-Blind Period|Overall Study||14
24816|NCT02015793|59459|P2|STARTED|Overall Study||15
24817|NCT02015793|59460|P1|STARTED|Overall Study||15
24818|NCT02015676|59493|P3|NOT COMPLETED|Overall Study||3
24819|NCT02015676|59494|P2|NOT COMPLETED|Overall Study||34
24820|NCT02015676|59495|P1|NOT COMPLETED|Overall Study||9
24821|NCT02015676|59493|P3|COMPLETED|Overall Study||3
24822|NCT02015676|59494|P2|COMPLETED|Overall Study||14
24823|NCT02015676|59495|P1|COMPLETED|Overall Study||6
24824|NCT02015676|59493|P3|STARTED|Overall Study||6
24825|NCT02015676|59494|P2|STARTED|Overall Study||48
24826|NCT02015676|59495|P1|STARTED|Overall Study||15
24827|NCT02015663|59511|P2|NOT COMPLETED|Overall Study||12
24828|NCT02015663|59512|P1|NOT COMPLETED|Overall Study||15
24829|NCT02015663|59511|P2|COMPLETED|Overall Study||4
24830|NCT02015663|59512|P1|COMPLETED|Overall Study||1
24831|NCT02015663|59511|P2|STARTED|Overall Study||16
24832|NCT02015663|59512|P1|STARTED|Overall Study||16
24833|NCT02015546|59544|P3|NOT COMPLETED|Overall Study||4
24834|NCT02015546|59545|P2|NOT COMPLETED|Overall Study||2
24835|NCT02015546|59546|P1|NOT COMPLETED|Overall Study||3
24836|NCT02015546|59544|P3|COMPLETED|Overall Study||22
24837|NCT02015546|59545|P2|COMPLETED|Overall Study||19
24838|NCT02015546|59546|P1|COMPLETED|Overall Study||20
24839|NCT02015546|59544|P3|STARTED|Overall Study||26
24840|NCT02015546|59545|P2|STARTED|Overall Study||21
24841|NCT02015546|59546|P1|STARTED|Overall Study||23
24842|NCT02015481|59578|P1|NOT COMPLETED|Overall Study||1
24843|NCT02015481|59578|P1|COMPLETED|Overall Study||24
24844|NCT02015481|59578|P1|STARTED|Overall Study||25
24845|NCT02015234|59587|P2|NOT COMPLETED|Overall Study||25
24846|NCT02015234|59588|P1|NOT COMPLETED|Overall Study||36
24847|NCT02015234|59587|P2|COMPLETED|Overall Study||54
24848|NCT02015234|59588|P1|COMPLETED|Overall Study||43
24849|NCT02015234|59587|P2|STARTED|Overall Study||79
24850|NCT02015234|59588|P1|STARTED|Overall Study||79
24851|NCT02015221|59602|P2|NOT COMPLETED|Overall Study||6
24852|NCT02015221|59603|P1|NOT COMPLETED|Overall Study||9
24853|NCT02015221|59602|P2|COMPLETED|Overall Study||34
24854|NCT02015221|59603|P1|COMPLETED|Overall Study||32
24855|NCT02015221|59602|P2|STARTED|Overall Study||40
24856|NCT02015221|59603|P1|STARTED|Overall Study||41
24857|NCT02015195|59616|P7|NOT COMPLETED|Overall Study||0
24858|NCT02015195|59617|P6|NOT COMPLETED|Overall Study||0
24859|NCT02015195|59618|P5|NOT COMPLETED|Overall Study||0
24860|NCT02015195|59619|P4|NOT COMPLETED|Overall Study||1
24861|NCT02015195|59620|P3|NOT COMPLETED|Overall Study||0
24862|NCT02015195|59621|P2|NOT COMPLETED|Overall Study||0
24863|NCT02015195|59622|P1|NOT COMPLETED|Overall Study||0
24864|NCT02015195|59616|P7|COMPLETED|Overall Study||16
24865|NCT02015195|59617|P6|COMPLETED|Overall Study||16
24866|NCT02015195|59618|P5|COMPLETED|Overall Study||16
24867|NCT02015195|59619|P4|COMPLETED|Overall Study||0
24868|NCT02015195|59620|P3|COMPLETED|Overall Study||16
24869|NCT02015195|59621|P2|COMPLETED|Overall Study||16
24870|NCT02015195|59622|P1|COMPLETED|Overall Study||16
24871|NCT02015195|59616|P7|STARTED|Overall Study||16
24872|NCT02015195|59617|P6|STARTED|Overall Study||16
24873|NCT02015195|59618|P5|STARTED|Overall Study||16
24874|NCT02015195|59619|P4|STARTED|Overall Study||1
24875|NCT02015195|59620|P3|STARTED|Overall Study||16
24876|NCT02015195|59621|P2|STARTED|Overall Study||16
24877|NCT02015195|59622|P1|STARTED|Overall Study||16
24878|NCT02014584|59645|P6|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24879|NCT02014584|59646|P5|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||1
24880|NCT02014584|59647|P4|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24881|NCT02014584|59648|P3|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24882|NCT02014584|59649|P2|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24883|NCT02014584|59650|P1|NOT COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24884|NCT02014584|59645|P6|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
24885|NCT02014584|59646|P5|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||2
24886|NCT02014584|59647|P4|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24887|NCT02014584|59648|P3|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24888|NCT02014584|59649|P2|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24889|NCT02014584|59650|P1|COMPLETED|Target Follow-up (F/U) Period (24 Weeks)||0
24890|NCT02014584|59645|P6|STARTED|Target Follow-up (F/U) Period (24 Weeks)||2
24891|NCT02014584|59646|P5|STARTED|Target Follow-up (F/U) Period (24 Weeks)||3
24892|NCT02014584|59647|P4|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
24893|NCT02014584|59648|P3|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
24894|NCT02014584|59649|P2|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
24895|NCT02014584|59650|P1|STARTED|Target Follow-up (F/U) Period (24 Weeks)||0
24896|NCT02014584|59645|P6|NOT COMPLETED|Open-Label Period (24 Weeks)||0
24897|NCT02014584|59646|P5|NOT COMPLETED|Open-Label Period (24 Weeks)||0
24898|NCT02014584|59647|P4|NOT COMPLETED|Open-Label Period (24 Weeks)||1
24899|NCT02014584|59648|P3|NOT COMPLETED|Open-Label Period (24 Weeks)||5
24900|NCT02014584|59649|P2|NOT COMPLETED|Open-Label Period (24 Weeks)||0
24901|NCT02014584|59650|P1|NOT COMPLETED|Open-Label Period (24 Weeks)||0
24902|NCT02014584|59645|P6|COMPLETED|Open-Label Period (24 Weeks)||0
24903|NCT02014584|59646|P5|COMPLETED|Open-Label Period (24 Weeks)||0
24904|NCT02014584|59647|P4|COMPLETED|Open-Label Period (24 Weeks)||47
24905|NCT02014584|59648|P3|COMPLETED|Open-Label Period (24 Weeks)||44
24906|NCT02014584|59649|P2|COMPLETED|Open-Label Period (24 Weeks)||0
24907|NCT02014584|59650|P1|COMPLETED|Open-Label Period (24 Weeks)||0
24908|NCT02014584|59645|P6|STARTED|Open-Label Period (24 Weeks)||0
24909|NCT02014584|59646|P5|STARTED|Open-Label Period (24 Weeks)||0
24910|NCT02014584|59647|P4|STARTED|Open-Label Period (24 Weeks)||48
24911|NCT02014584|59648|P3|STARTED|Open-Label Period (24 Weeks)||49
24912|NCT02014584|59649|P2|STARTED|Open-Label Period (24 Weeks)||0
24913|NCT02014584|59650|P1|STARTED|Open-Label Period (24 Weeks)||0
24914|NCT02014584|59645|P6|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
24915|NCT02014584|59646|P5|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
24916|NCT02014584|59647|P4|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
24917|NCT02014584|59648|P3|NOT COMPLETED|Double-Blind Period (24 Weeks)||0
24918|NCT02014584|59649|P2|NOT COMPLETED|Double-Blind Period (24 Weeks)||6
24919|NCT02014584|59650|P1|NOT COMPLETED|Double-Blind Period (24 Weeks)||2
24920|NCT02014584|59645|P6|COMPLETED|Double-Blind Period (24 Weeks)||0
24921|NCT02014584|59646|P5|COMPLETED|Double-Blind Period (24 Weeks)||0
24922|NCT02014584|59647|P4|COMPLETED|Double-Blind Period (24 Weeks)||0
24923|NCT02014584|59648|P3|COMPLETED|Double-Blind Period (24 Weeks)||0
24924|NCT02014584|59649|P2|COMPLETED|Double-Blind Period (24 Weeks)||52
24925|NCT02014584|59650|P1|COMPLETED|Double-Blind Period (24 Weeks)||57
24926|NCT02014584|59645|P6|STARTED|Double-Blind Period (24 Weeks)||0
24927|NCT02014584|59646|P5|STARTED|Double-Blind Period (24 Weeks)||0
24928|NCT02014584|59647|P4|STARTED|Double-Blind Period (24 Weeks)||0
24929|NCT02014584|59648|P3|STARTED|Double-Blind Period (24 Weeks)||0
24930|NCT02014584|59649|P2|STARTED|Double-Blind Period (24 Weeks)||58
24931|NCT02014584|59650|P1|STARTED|Double-Blind Period (24 Weeks)||59
24932|NCT02014480|59767|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
24933|NCT02014480|59768|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
24934|NCT02014480|59769|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
24935|NCT02014480|59770|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
24936|NCT02014480|59771|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
24937|NCT02014480|59772|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
24938|NCT02014480|59767|P6|COMPLETED|Treatment Period 3 (14 Days)||32
24939|NCT02014480|59768|P5|COMPLETED|Treatment Period 3 (14 Days)||34
24940|NCT02014480|59769|P4|COMPLETED|Treatment Period 3 (14 Days)||31
24941|NCT02014480|59770|P3|COMPLETED|Treatment Period 3 (14 Days)||29
24942|NCT02014480|59771|P2|COMPLETED|Treatment Period 3 (14 Days)||32
24943|NCT02014480|59772|P1|COMPLETED|Treatment Period 3 (14 Days)||34
24944|NCT02014480|59767|P6|STARTED|Treatment Period 3 (14 Days)||34
24945|NCT02014480|59768|P5|STARTED|Treatment Period 3 (14 Days)||34
24946|NCT02014480|59769|P4|STARTED|Treatment Period 3 (14 Days)||31
24947|NCT02014480|59770|P3|STARTED|Treatment Period 3 (14 Days)||30
24948|NCT02014480|59771|P2|STARTED|Treatment Period 3 (14 Days)||33
24949|NCT02014480|59772|P1|STARTED|Treatment Period 3 (14 Days)||34
24950|NCT02014480|59767|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
24951|NCT02014480|59768|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
24952|NCT02014480|59769|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
24953|NCT02014480|59770|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
24954|NCT02014480|59771|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
24955|NCT02014480|59772|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
24956|NCT02014480|59767|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||34
24957|NCT02014480|59768|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||34
24958|NCT02014480|59769|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||31
24959|NCT02014480|59770|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||30
24960|NCT02014480|59771|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||33
24961|NCT02014480|59772|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||34
24962|NCT02014480|59767|P6|STARTED|Washout Period 2 (10 to 14 Days)||34
24963|NCT02014480|59768|P5|STARTED|Washout Period 2 (10 to 14 Days)||34
24964|NCT02014480|59769|P4|STARTED|Washout Period 2 (10 to 14 Days)||31
24966|NCT02014480|59771|P2|STARTED|Washout Period 2 (10 to 14 Days)||33
24967|NCT02014480|59772|P1|STARTED|Washout Period 2 (10 to 14 Days)||34
24968|NCT02014480|59767|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
24969|NCT02014480|59768|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
24970|NCT02014480|59769|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
24971|NCT02014480|59770|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
24972|NCT02014480|59771|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
24973|NCT02014480|59772|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
24974|NCT02014480|59767|P6|COMPLETED|Treatment Period 2 (14 Days)||34
24975|NCT02014480|59768|P5|COMPLETED|Treatment Period 2 (14 Days)||34
24976|NCT02014480|59769|P4|COMPLETED|Treatment Period 2 (14 Days)||31
24977|NCT02014480|59770|P3|COMPLETED|Treatment Period 2 (14 Days)||30
24978|NCT02014480|59771|P2|COMPLETED|Treatment Period 2 (14 Days)||33
24979|NCT02014480|59772|P1|COMPLETED|Treatment Period 2 (14 Days)||34
24980|NCT02014480|59767|P6|STARTED|Treatment Period 2 (14 Days)||34
24981|NCT02014480|59768|P5|STARTED|Treatment Period 2 (14 Days)||34
24982|NCT02014480|59769|P4|STARTED|Treatment Period 2 (14 Days)||32
24983|NCT02014480|59770|P3|STARTED|Treatment Period 2 (14 Days)||32
24984|NCT02014480|59771|P2|STARTED|Treatment Period 2 (14 Days)||34
24985|NCT02014480|59772|P1|STARTED|Treatment Period 2 (14 Days)||35
24986|NCT02014480|59767|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
24987|NCT02014480|59768|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
24988|NCT02014480|59769|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
24989|NCT02014480|59770|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
24990|NCT02014480|59771|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
24991|NCT02014480|59772|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
24992|NCT02014480|59767|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||34
24993|NCT02014480|59768|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||34
24994|NCT02014480|59769|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||32
24995|NCT02014480|59770|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||32
24996|NCT02014480|59771|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||34
24997|NCT02014480|59772|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||35
24998|NCT02014480|59767|P6|STARTED|Washout Period 1 (10 to 14 Days)||34
24999|NCT02014480|59768|P5|STARTED|Washout Period 1 (10 to 14 Days)||34
25000|NCT02014480|59769|P4|STARTED|Washout Period 1 (10 to 14 Days)||32
25001|NCT02014480|59770|P3|STARTED|Washout Period 1 (10 to 14 Days)||33
25002|NCT02014480|59771|P2|STARTED|Washout Period 1 (10 to 14 Days)||34
25003|NCT02014480|59772|P1|STARTED|Washout Period 1 (10 to 14 Days)||35
25004|NCT02014480|59767|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||0
25005|NCT02014480|59768|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||1
25006|NCT02014480|59769|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
25007|NCT02014480|59770|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
25008|NCT02014480|59771|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
25009|NCT02014480|59772|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
25010|NCT02014480|59767|P6|COMPLETED|Treatment Period 1 (14 Days)||34
25011|NCT02014480|59768|P5|COMPLETED|Treatment Period 1 (14 Days)||34
25012|NCT02014480|59769|P4|COMPLETED|Treatment Period 1 (14 Days)||32
25013|NCT02014480|59770|P3|COMPLETED|Treatment Period 1 (14 Days)||33
25014|NCT02014480|59771|P2|COMPLETED|Treatment Period 1 (14 Days)||34
25015|NCT02014480|59772|P1|COMPLETED|Treatment Period 1 (14 Days)||35
25016|NCT02014480|59767|P6|STARTED|Treatment Period 1 (14 Days)|One participant randomized to Sequence 6 actually received UMEC in Treatment Periods 2 and 3.|34
25017|NCT02014480|59768|P5|STARTED|Treatment Period 1 (14 Days)||35
25018|NCT02014480|59769|P4|STARTED|Treatment Period 1 (14 Days)||34
25019|NCT02014480|59770|P3|STARTED|Treatment Period 1 (14 Days)||34
25020|NCT02014480|59771|P2|STARTED|Treatment Period 1 (14 Days)||35
25021|NCT02014480|59772|P1|STARTED|Treatment Period 1 (14 Days)||35
25022|NCT02014467|59791|P2|NOT COMPLETED|Overall Study||7
25023|NCT02014467|59792|P1|NOT COMPLETED|Overall Study||25
25024|NCT02014467|59791|P2|COMPLETED|Overall Study||112
25025|NCT02014467|59792|P1|COMPLETED|Overall Study||340
25026|NCT02014467|59791|P2|STARTED|Overall Study||119
25027|NCT02014467|59792|P1|STARTED|Overall Study||365
25028|NCT02014441|59852|P1|NOT COMPLETED|Overall Study||30
25029|NCT02014441|59852|P1|COMPLETED|Overall Study||31
25030|NCT02014441|59852|P1|Received Treatment|Overall Study||60
25031|NCT02014441|59852|P1|STARTED|Overall Study||61
25032|NCT02014402|59948|P4|NOT COMPLETED|Overall Study||3
25033|NCT02014402|59949|P3|NOT COMPLETED|Overall Study||3
25034|NCT02014402|59950|P2|NOT COMPLETED|Overall Study||3
25035|NCT02014402|59951|P1|NOT COMPLETED|Overall Study||2
25036|NCT02014402|59948|P4|COMPLETED|Overall Study||82
25037|NCT02014402|59949|P3|COMPLETED|Overall Study||32
25038|NCT02014402|59950|P2|COMPLETED|Overall Study||27
25039|NCT02014402|59951|P1|COMPLETED|Overall Study||29
25040|NCT02014402|59948|P4|Bovine Thrombin|Overall Study||28
25041|NCT02014402|59949|P3|Bovine Thrombin|Overall Study||12
25042|NCT02014402|59950|P2|Bovine Thrombin|Overall Study||10
25043|NCT02014402|59951|P1|Bovine Thrombin|Overall Study||11
25044|NCT02014402|59948|P4|Human Thrombin|Overall Study||57
25045|NCT02014402|59949|P3|Human Thrombin|Overall Study||23
25046|NCT02014402|59950|P2|Human Thrombin|Overall Study||20
25047|NCT02014402|59951|P1|Human Thrombin|Overall Study||20
25048|NCT02014402|59948|P4|STARTED|Overall Study||85
25049|NCT02014402|59949|P3|STARTED|Overall Study||35
25050|NCT02014402|59950|P2|STARTED|Overall Study||30
25051|NCT02014402|59951|P1|STARTED|Overall Study||31
25052|NCT02014363|59981|P3|NOT COMPLETED|Overall Study||24
25053|NCT02014363|59982|P2|NOT COMPLETED|Overall Study||19
25054|NCT02014363|59983|P1|NOT COMPLETED|Overall Study||17
25055|NCT02014363|59981|P3|COMPLETED|Overall Study||31
25056|NCT02014363|59982|P2|COMPLETED|Overall Study||35
25057|NCT02014363|59983|P1|COMPLETED|Overall Study||38
25058|NCT02014363|59981|P3|STARTED|Overall Study||55
25059|NCT02014363|59982|P2|STARTED|Overall Study||54
25060|NCT02014363|59983|P1|STARTED|Overall Study||55
25061|NCT02013245|59995|P4|NOT COMPLETED|Overall Study||0
25062|NCT02013245|59996|P3|NOT COMPLETED|Overall Study||0
25063|NCT02013245|59997|P2|NOT COMPLETED|Overall Study||1
25064|NCT02013245|59998|P1|NOT COMPLETED|Overall Study||0
25065|NCT02013245|59995|P4|COMPLETED|Overall Study||9
25066|NCT02013245|59996|P3|COMPLETED|Overall Study||9
25067|NCT02013245|59997|P2|COMPLETED|Overall Study||8
25068|NCT02013245|59998|P1|COMPLETED|Overall Study||9
25069|NCT02013245|59995|P4|STARTED|Overall Study||9
25070|NCT02013245|59996|P3|STARTED|Overall Study||9
25071|NCT02013245|59997|P2|STARTED|Overall Study||9
25072|NCT02013245|59998|P1|STARTED|Overall Study||9
25073|NCT02013206|60014|P2|NOT COMPLETED|Overall Study||22
25074|NCT02013206|60015|P1|NOT COMPLETED|Overall Study||27
25075|NCT02013206|60014|P2|COMPLETED|Overall Study||1
25076|NCT02013206|60015|P1|COMPLETED|Overall Study|3 Patients were on-going at clinical cut-off. Not Completed=patients who discontinued treatment.|2
25077|NCT02013206|60014|P2|Received Study Drug|Overall Study||23
25078|NCT02013206|60015|P1|Received Study Drug|Overall Study||26
25079|NCT02013206|60014|P2|STARTED|Overall Study||23
25080|NCT02013206|60015|P1|STARTED|Overall Study||29
25081|NCT02014272|60035|P2|NOT COMPLETED|Intervention Period 2||0
25082|NCT02014272|60036|P1|NOT COMPLETED|Intervention Period 2||0
25083|NCT02014272|60035|P2|COMPLETED|Intervention Period 2||13
25084|NCT02014272|60036|P1|COMPLETED|Intervention Period 2||13
25085|NCT02014272|60035|P2|STARTED|Intervention Period 2||13
25086|NCT02014272|60036|P1|STARTED|Intervention Period 2||13
25087|NCT02014272|60035|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
25088|NCT02014272|60036|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
25089|NCT02014272|60035|P2|COMPLETED|Washout Period 1 (7 Days)||13
25090|NCT02014272|60036|P1|COMPLETED|Washout Period 1 (7 Days)||13
25091|NCT02014272|60035|P2|STARTED|Washout Period 1 (7 Days)||13
25092|NCT02014272|60036|P1|STARTED|Washout Period 1 (7 Days)||13
25093|NCT02014272|60035|P2|NOT COMPLETED|Intervention Period 1||1
25094|NCT02014272|60036|P1|NOT COMPLETED|Intervention Period 1||1
25095|NCT02014272|60035|P2|COMPLETED|Intervention Period 1||13
25096|NCT02014272|60036|P1|COMPLETED|Intervention Period 1||13
25097|NCT02014272|60035|P2|STARTED|Intervention Period 1||14
25098|NCT02014272|60036|P1|STARTED|Intervention Period 1||14
25099|NCT02014051|60054|P2|NOT COMPLETED|Overall Study||1
25100|NCT02014051|60055|P1|NOT COMPLETED|Overall Study||1
25101|NCT02014051|60054|P2|COMPLETED|Overall Study||5
25102|NCT02014051|60055|P1|COMPLETED|Overall Study||2
25103|NCT02014051|60054|P2|STARTED|Overall Study||6
25104|NCT02014051|60055|P1|STARTED|Overall Study||3
25105|NCT02013830|60068|P1|NOT COMPLETED|Overall Study||30
25106|NCT02013830|60068|P1|COMPLETED|Overall Study||15
25107|NCT02013830|60068|P1|STARTED|Overall Study||45
25108|NCT02013817|60079|P1|NOT COMPLETED|Overall Study||27
25109|NCT02013817|60079|P1|COMPLETED|Overall Study||16
25110|NCT02013817|60079|P1|STARTED|Overall Study||43
25111|NCT02013765|60088|P1|NOT COMPLETED|Overall Study||1
25112|NCT02013765|60088|P1|COMPLETED|Overall Study||4
25113|NCT02013765|60088|P1|STARTED|Overall Study||5
25114|NCT02013687|60102|P4|NOT COMPLETED|Overall Study||2
25115|NCT02013687|60103|P3|NOT COMPLETED|Overall Study||2
25116|NCT02013687|60104|P2|NOT COMPLETED|Overall Study||0
25117|NCT02013687|60105|P1|NOT COMPLETED|Overall Study||0
25118|NCT02013687|60102|P4|COMPLETED|Overall Study||14
25119|NCT02013687|60103|P3|COMPLETED|Overall Study||14
25120|NCT02013687|60104|P2|COMPLETED|Overall Study||6
25121|NCT02013687|60105|P1|COMPLETED|Overall Study||6
25122|NCT02013687|60102|P4|STARTED|Overall Study||16
25123|NCT02013687|60103|P3|STARTED|Overall Study||16
25124|NCT02013687|60104|P2|STARTED|Overall Study||6
25125|NCT02013687|60105|P1|STARTED|Overall Study||6
25126|NCT02013622|60135|P1|NOT COMPLETED|Overall Study||24
25127|NCT02013622|60135|P1|COMPLETED|Overall Study||25
25128|NCT02013622|60135|P1|STARTED|Overall Study||49
25129|NCT02013609|60155|P1|NOT COMPLETED|Overall Study||18
25130|NCT02013609|60155|P1|COMPLETED|Overall Study||29
25131|NCT02013609|60155|P1|STARTED|Overall Study|One participant out of 48 participants enrolled had discontinued before receiving study medication.|47
25132|NCT02013544|60180|P2|NOT COMPLETED|Overall Study||20
25133|NCT02013544|60181|P1|NOT COMPLETED|Overall Study||11
25134|NCT02013544|60180|P2|COMPLETED|Overall Study||356
25135|NCT02013544|60181|P1|COMPLETED|Overall Study||171
25136|NCT02013544|60180|P2|ITT Population|Overall Study||325
25137|NCT02013544|60181|P1|ITT Population|Overall Study||157
25138|NCT02013544|60180|P2|Safety Population|Overall Study||374
25139|NCT02013544|60181|P1|Safety Population|Overall Study||180
25140|NCT02013544|60180|P2|STARTED|Overall Study||376
25141|NCT02013544|60181|P1|STARTED|Overall Study||182
25142|NCT02013531|60203|P1|NOT COMPLETED|Overall Study||5
25143|NCT02013531|60203|P1|COMPLETED|Overall Study||32
25144|NCT02013531|60203|P1|STARTED|Overall Study||37
25145|NCT02013388|60233|P8|NOT COMPLETED|Overall Study||0
25146|NCT02013388|60234|P7|NOT COMPLETED|Overall Study||0
25147|NCT02013388|60235|P6|NOT COMPLETED|Overall Study||0
25148|NCT02013388|60236|P5|NOT COMPLETED|Overall Study||1
25149|NCT02013388|60237|P4|NOT COMPLETED|Overall Study||0
25150|NCT02013388|60238|P3|NOT COMPLETED|Overall Study||0
25151|NCT02013388|60239|P2|NOT COMPLETED|Overall Study||0
25152|NCT02013388|60240|P1|NOT COMPLETED|Overall Study||1
25153|NCT02013388|60233|P8|COMPLETED|Overall Study||4
25154|NCT02013388|60234|P7|COMPLETED|Overall Study||6
25155|NCT02013388|60235|P6|COMPLETED|Overall Study||6
25156|NCT02013388|60236|P5|COMPLETED|Overall Study||5
25157|NCT02013388|60237|P4|COMPLETED|Overall Study||6
25158|NCT02013388|60238|P3|COMPLETED|Overall Study||6
25159|NCT02013388|60239|P2|COMPLETED|Overall Study||6
25160|NCT02013388|60240|P1|COMPLETED|Overall Study||8
25161|NCT02013388|60233|P8|STARTED|Overall Study||4
25162|NCT02013388|60234|P7|STARTED|Overall Study||6
25163|NCT02013388|60235|P6|STARTED|Overall Study||6
25164|NCT02013388|60236|P5|STARTED|Overall Study||6
25165|NCT02013388|60237|P4|STARTED|Overall Study||6
25166|NCT02013388|60238|P3|STARTED|Overall Study||6
25167|NCT02013388|60239|P2|STARTED|Overall Study||6
25168|NCT02013388|60240|P1|STARTED|Overall Study||9
25169|NCT02013167|60276|P2|NOT COMPLETED|Overall Study||178
25170|NCT02013167|60277|P1|NOT COMPLETED|Overall Study||101
25171|NCT02013167|60276|P2|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off; 22 were receiving treatment|93
25172|NCT02013167|60277|P1|COMPLETED|Overall Study|Indicates participants continuing study at time of data cut-off|33
25173|NCT02013167|60276|P2|Received Treatment|Overall Study||267
25174|NCT02013167|60277|P1|Received Treatment|Overall Study||109
25175|NCT02013167|60276|P2|STARTED|Overall Study||271
25176|NCT02013167|60277|P1|STARTED|Overall Study||134
25177|NCT02013050|60308|P4|NOT COMPLETED|Overall Study||4
25178|NCT02013050|60309|P3|NOT COMPLETED|Overall Study||0
25179|NCT02013050|60310|P2|NOT COMPLETED|Overall Study||5
25180|NCT02013050|60311|P1|NOT COMPLETED|Overall Study||4
25181|NCT02013050|60308|P4|COMPLETED|Overall Study||19
25182|NCT02013050|60309|P3|COMPLETED|Overall Study||3
25183|NCT02013050|60310|P2|COMPLETED|Overall Study||36
25184|NCT02013050|60311|P1|COMPLETED|Overall Study||38
25185|NCT02013050|60308|P4|STARTED|Overall Study||23
25186|NCT02013050|60309|P3|STARTED|Overall Study||3
25187|NCT02013050|60310|P2|STARTED|Overall Study||41
25188|NCT02013050|60311|P1|STARTED|Overall Study||42
25189|NCT02012686|60355|P2|NOT COMPLETED|Overall Study||2
25190|NCT02012686|60356|P1|NOT COMPLETED|Overall Study||0
25191|NCT02012686|60355|P2|COMPLETED|Overall Study||48
25192|NCT02012686|60356|P1|COMPLETED|Overall Study||50
25193|NCT02012686|60355|P2|STARTED|Overall Study||50
25194|NCT02012686|60356|P1|STARTED|Overall Study||50
25195|NCT02012582|60372|P4|NOT COMPLETED|Overall Study||1
25196|NCT02012582|60373|P3|NOT COMPLETED|Overall Study||0
25197|NCT02012582|60374|P2|NOT COMPLETED|Overall Study||0
25198|NCT02012582|60375|P1|NOT COMPLETED|Overall Study||0
25199|NCT02012582|60372|P4|COMPLETED|Overall Study||7
25200|NCT02012582|60373|P3|COMPLETED|Overall Study||8
25201|NCT02012582|60374|P2|COMPLETED|Overall Study||8
25202|NCT02012582|60375|P1|COMPLETED|Overall Study||8
25203|NCT02012582|60372|P4|STARTED|Overall Study||8
25204|NCT02012582|60373|P3|STARTED|Overall Study||8
25205|NCT02012582|60374|P2|STARTED|Overall Study||8
25206|NCT02012582|60375|P1|STARTED|Overall Study||8
25207|NCT02012452|60403|P2|NOT COMPLETED|Overall Study||1
25208|NCT02012452|60404|P1|NOT COMPLETED|Overall Study||6
25209|NCT02012452|60403|P2|COMPLETED|Overall Study||1
25210|NCT02012452|60404|P1|COMPLETED|Overall Study||1
25211|NCT02012452|60403|P2|STARTED|Overall Study||2
25212|NCT02012452|60404|P1|STARTED|Overall Study||7
25213|NCT02012218|60417|P5|NOT COMPLETED|Overall Study||1
25214|NCT02012218|60418|P4|NOT COMPLETED|Overall Study||2
25215|NCT02012218|60419|P3|NOT COMPLETED|Overall Study||2
25216|NCT02012218|60420|P2|NOT COMPLETED|Overall Study||1
25217|NCT02012218|60421|P1|NOT COMPLETED|Overall Study||4
25218|NCT02012218|60417|P5|COMPLETED|Overall Study||5
25219|NCT02012218|60418|P4|COMPLETED|Overall Study||17
25220|NCT02012218|60419|P3|COMPLETED|Overall Study||11
25221|NCT02012218|60420|P2|COMPLETED|Overall Study||10
25222|NCT02012218|60421|P1|COMPLETED|Overall Study||8
25223|NCT02012218|60417|P5|STARTED|Overall Study||6
25224|NCT02012218|60418|P4|STARTED|Overall Study||19
25225|NCT02012218|60419|P3|STARTED|Overall Study||13
25226|NCT02012218|60420|P2|STARTED|Overall Study||11
25227|NCT02012218|60421|P1|STARTED|Overall Study||12
25228|NCT02011893|60433|P3|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||1
25229|NCT02011893|60434|P2|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
25230|NCT02011893|60435|P1|NOT COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
25231|NCT02011893|60433|P3|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||51
25232|NCT02011893|60434|P2|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||45
25233|NCT02011893|60435|P1|COMPLETED|Period 2 (12 Weeks to 24 Weeks)||0
25234|NCT02011893|60433|P3|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
25235|NCT02011893|60434|P2|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||45
25236|NCT02011893|60435|P1|24 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
25237|NCT02011893|60433|P3|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||51
25238|NCT02011893|60434|P2|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||44
25239|NCT02011893|60435|P1|18 Week Follow-up|Period 2 (12 Weeks to 24 Weeks)||0
25240|NCT02011893|60433|P3|STARTED|Period 2 (12 Weeks to 24 Weeks)||52
25241|NCT02011893|60434|P2|STARTED|Period 2 (12 Weeks to 24 Weeks)||45
25242|NCT02011893|60435|P1|STARTED|Period 2 (12 Weeks to 24 Weeks)||0
25243|NCT02011893|60433|P3|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||3
25244|NCT02011893|60434|P2|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
25245|NCT02011893|60435|P1|NOT COMPLETED|Period 1 (Randomization to 12 Weeks)||0
25246|NCT02011893|60433|P3|COMPLETED|Period 1 (Randomization to 12 Weeks)||52
25247|NCT02011893|60434|P2|COMPLETED|Period 1 (Randomization to 12 Weeks)||45
25248|NCT02011893|60435|P1|COMPLETED|Period 1 (Randomization to 12 Weeks)||0
25249|NCT02011893|60433|P3|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
25250|NCT02011893|60434|P2|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
25251|NCT02011893|60435|P1|12 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
25252|NCT02011893|60433|P3|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||52
25253|NCT02011893|60434|P2|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||45
25254|NCT02011893|60435|P1|6 Week Follow-up|Period 1 (Randomization to 12 Weeks)||0
25255|NCT02011893|60433|P3|STARTED|Period 1 (Randomization to 12 Weeks)||55
25256|NCT02011893|60434|P2|STARTED|Period 1 (Randomization to 12 Weeks)||45
25257|NCT02011893|60435|P1|STARTED|Period 1 (Randomization to 12 Weeks)||0
25258|NCT02011893|60433|P3|NOT COMPLETED|Enrollment to Randomization||0
25259|NCT02011893|60434|P2|NOT COMPLETED|Enrollment to Randomization||0
25260|NCT02011893|60435|P1|NOT COMPLETED|Enrollment to Randomization||73
25261|NCT02011893|60433|P3|COMPLETED|Enrollment to Randomization||0
25262|NCT02011893|60434|P2|COMPLETED|Enrollment to Randomization||0
25263|NCT02011893|60435|P1|COMPLETED|Enrollment to Randomization||100
25264|NCT02011893|60433|P3|Randomization|Enrollment to Randomization||0
25265|NCT02011893|60434|P2|Randomization|Enrollment to Randomization||0
25266|NCT02011893|60435|P1|Randomization|Enrollment to Randomization||100
25267|NCT02011893|60433|P3|Permanent Stimulation Implant|Enrollment to Randomization||0
25268|NCT02011893|60434|P2|Permanent Stimulation Implant|Enrollment to Randomization||0
25269|NCT02011893|60435|P1|Permanent Stimulation Implant|Enrollment to Randomization||101
25270|NCT02011893|60433|P3|Trial Stimulation Implant|Enrollment to Randomization||0
25271|NCT02011893|60434|P2|Trial Stimulation Implant|Enrollment to Randomization||0
25272|NCT02011893|60435|P1|Trial Stimulation Implant|Enrollment to Randomization||121
25273|NCT02011893|60433|P3|Baseline|Enrollment to Randomization||0
25274|NCT02011893|60434|P2|Baseline|Enrollment to Randomization||0
25275|NCT02011893|60435|P1|Baseline|Enrollment to Randomization||141
25276|NCT02011893|60433|P3|STARTED|Enrollment to Randomization||0
25277|NCT02011893|60434|P2|STARTED|Enrollment to Randomization||0
25278|NCT02011893|60435|P1|STARTED|Enrollment to Randomization||173
25279|NCT02011516|60448|P2|NOT COMPLETED|Overall Study||2
25280|NCT02011516|60449|P1|NOT COMPLETED|Overall Study||4
25281|NCT02011516|60448|P2|COMPLETED|Overall Study||6
25282|NCT02011516|60449|P1|COMPLETED|Overall Study||4
25283|NCT02011516|60448|P2|STARTED|Overall Study||8
25284|NCT02011516|60449|P1|STARTED|Overall Study||8
25285|NCT02011490|60458|P6|NOT COMPLETED|Part 2||0
25286|NCT02011490|60459|P5|NOT COMPLETED|Part 2||0
25287|NCT02011490|60460|P4|NOT COMPLETED|Part 2||0
25288|NCT02011490|60461|P3|NOT COMPLETED|Part 2||0
25289|NCT02011490|60462|P2|NOT COMPLETED|Part 2||0
25290|NCT02011490|60463|P1|NOT COMPLETED|Part 2||0
25291|NCT02011490|60458|P6|COMPLETED|Part 2||6
25292|NCT02011490|60459|P5|COMPLETED|Part 2||6
25293|NCT02011490|60460|P4|COMPLETED|Part 2||6
25294|NCT02011490|60461|P3|COMPLETED|Part 2||0
25295|NCT02011490|60462|P2|COMPLETED|Part 2||0
25296|NCT02011490|60463|P1|COMPLETED|Part 2||0
25297|NCT02011490|60458|P6|STARTED|Part 2|2 had also participated in Part 1 (both in healthy group)|6
25298|NCT02011490|60459|P5|STARTED|Part 2|3 had also participated in Part 1 (2 in moderate, 1 in severe groups)|6
25299|NCT02011490|60460|P4|STARTED|Part 2|4 had also participated in Part 1 (all in severe group)|6
25300|NCT02011490|60461|P3|STARTED|Part 2||0
25301|NCT02011490|60462|P2|STARTED|Part 2||0
25302|NCT02011490|60463|P1|STARTED|Part 2||0
25303|NCT02011490|60458|P6|NOT COMPLETED|Part 1||0
25304|NCT02011490|60459|P5|NOT COMPLETED|Part 1||0
25305|NCT02011490|60460|P4|NOT COMPLETED|Part 1||0
25306|NCT02011490|60461|P3|NOT COMPLETED|Part 1||0
25307|NCT02011490|60462|P2|NOT COMPLETED|Part 1||0
25308|NCT02011490|60463|P1|NOT COMPLETED|Part 1||0
25309|NCT02011490|60458|P6|COMPLETED|Part 1||0
25310|NCT02011490|60459|P5|COMPLETED|Part 1||0
25311|NCT02011490|60460|P4|COMPLETED|Part 1||0
25312|NCT02011490|60461|P3|COMPLETED|Part 1||8
25313|NCT02011490|60462|P2|COMPLETED|Part 1||8
25314|NCT02011490|60463|P1|COMPLETED|Part 1||8
25315|NCT02011490|60458|P6|STARTED|Part 1||0
25316|NCT02011490|60459|P5|STARTED|Part 1||0
25317|NCT02011490|60460|P4|STARTED|Part 1||0
25318|NCT02011490|60461|P3|STARTED|Part 1||8
25319|NCT02011490|60462|P2|STARTED|Part 1||8
25320|NCT02011490|60463|P1|STARTED|Part 1||8
25321|NCT02011464|60551|P2|NOT COMPLETED|Overall Study||0
25322|NCT02011464|60552|P1|NOT COMPLETED|Overall Study||0
25323|NCT02011464|60551|P2|COMPLETED|Overall Study||10
25324|NCT02011464|60552|P1|COMPLETED|Overall Study||10
25325|NCT02011464|60551|P2|STARTED|Overall Study||10
25326|NCT02011464|60552|P1|STARTED|Overall Study||10
25327|NCT02011113|60572|P1|NOT COMPLETED|Overall Study||36
25328|NCT02011113|60572|P1|COMPLETED|Overall Study|Completed = participants with progressive disease were considered as completed.|0
25329|NCT02011113|60572|P1|STARTED|Overall Study||36
25330|NCT02010996|60588|P2|NOT COMPLETED|Overall Study||0
25331|NCT02010996|60589|P1|NOT COMPLETED|Overall Study||0
25332|NCT02010996|60588|P2|COMPLETED|Overall Study||36
25333|NCT02010996|60589|P1|COMPLETED|Overall Study||36
25334|NCT02010996|60588|P2|STARTED|Overall Study||36
25335|NCT02010996|60589|P1|STARTED|Overall Study||36
25336|NCT02010684|60601|P2|NOT COMPLETED|Overall Study||23
25337|NCT02010684|60602|P1|NOT COMPLETED|Overall Study||12
25338|NCT02010684|60601|P2|COMPLETED|Overall Study||59
25339|NCT02010684|60602|P1|COMPLETED|Overall Study||27
25340|NCT02010684|60601|P2|STARTED|Overall Study||82
25341|NCT02010684|60602|P1|STARTED|Overall Study||39
25342|NCT02010632|60620|P2|NOT COMPLETED|Second Intervention (7 Days)||0
25343|NCT02010632|60621|P1|NOT COMPLETED|Second Intervention (7 Days)||1
25344|NCT02010632|60620|P2|COMPLETED|Second Intervention (7 Days)||16
25345|NCT02010632|60621|P1|COMPLETED|Second Intervention (7 Days)||15
25346|NCT02010632|60620|P2|STARTED|Second Intervention (7 Days)||16
25347|NCT02010632|60621|P1|STARTED|Second Intervention (7 Days)||16
25348|NCT02010632|60620|P2|NOT COMPLETED|Wash Out Period (14 Days)||0
25349|NCT02010632|60621|P1|NOT COMPLETED|Wash Out Period (14 Days)||0
25350|NCT02010632|60620|P2|COMPLETED|Wash Out Period (14 Days)||16
25351|NCT02010632|60621|P1|COMPLETED|Wash Out Period (14 Days)||16
25352|NCT02010632|60620|P2|STARTED|Wash Out Period (14 Days)||16
25353|NCT02010632|60621|P1|STARTED|Wash Out Period (14 Days)||16
25354|NCT02010632|60620|P2|NOT COMPLETED|First Intervention (7 Days)||0
25355|NCT02010632|60621|P1|NOT COMPLETED|First Intervention (7 Days)||0
25356|NCT02010632|60620|P2|COMPLETED|First Intervention (7 Days)||16
25357|NCT02010632|60621|P1|COMPLETED|First Intervention (7 Days)||16
25358|NCT02010632|60620|P2|STARTED|First Intervention (7 Days)||16
25359|NCT02010632|60621|P1|STARTED|First Intervention (7 Days)||16
25360|NCT02010255|60641|P14|NOT COMPLETED|Overall Study||1
25361|NCT02010255|60642|P13|NOT COMPLETED|Overall Study||0
25362|NCT02010255|60643|P12|NOT COMPLETED|Overall Study||1
25363|NCT02010255|60644|P11|NOT COMPLETED|Overall Study||2
25364|NCT02010255|60645|P10|NOT COMPLETED|Overall Study||0
25365|NCT02010255|60646|P9|NOT COMPLETED|Overall Study||1
25366|NCT02010255|60647|P8|NOT COMPLETED|Overall Study||1
25367|NCT02010255|60648|P7|NOT COMPLETED|Overall Study||1
25368|NCT02010255|60649|P6|NOT COMPLETED|Overall Study||0
25369|NCT02010255|60650|P5|NOT COMPLETED|Overall Study||4
25370|NCT02010255|60651|P4|NOT COMPLETED|Overall Study||6
25371|NCT02010255|60652|P3|NOT COMPLETED|Overall Study||7
25372|NCT02010255|60653|P2|NOT COMPLETED|Overall Study||2
25373|NCT02010255|60654|P1|NOT COMPLETED|Overall Study||6
25374|NCT02010255|60641|P14|COMPLETED|Overall Study||2
25375|NCT02010255|60642|P13|COMPLETED|Overall Study||3
25376|NCT02010255|60643|P12|COMPLETED|Overall Study||4
25377|NCT02010255|60644|P11|COMPLETED|Overall Study||1
25378|NCT02010255|60645|P10|COMPLETED|Overall Study||23
25379|NCT02010255|60646|P9|COMPLETED|Overall Study||21
25380|NCT02010255|60647|P8|COMPLETED|Overall Study||32
25381|NCT02010255|60648|P7|COMPLETED|Overall Study||33
25382|NCT02010255|60649|P6|COMPLETED|Overall Study||49
25383|NCT02010255|60650|P5|COMPLETED|Overall Study||48
25384|NCT02010255|60651|P4|COMPLETED|Overall Study||20
25385|NCT02010255|60652|P3|COMPLETED|Overall Study||18
25386|NCT02010255|60653|P2|COMPLETED|Overall Study||26
25387|NCT02010255|60654|P1|COMPLETED|Overall Study||22
25388|NCT02010255|60641|P14|STARTED|Overall Study||3
25389|NCT02010255|60642|P13|STARTED|Overall Study||3
25390|NCT02010255|60643|P12|STARTED|Overall Study||5
25391|NCT02010255|60644|P11|STARTED|Overall Study||3
25392|NCT02010255|60645|P10|STARTED|Overall Study||23
25393|NCT02010255|60646|P9|STARTED|Overall Study||22
25394|NCT02010255|60647|P8|STARTED|Overall Study||33
25395|NCT02010255|60648|P7|STARTED|Overall Study||34
25396|NCT02010255|60649|P6|STARTED|Overall Study||49
25397|NCT02010255|60650|P5|STARTED|Overall Study||52
25398|NCT02010255|60651|P4|STARTED|Overall Study||26
25399|NCT02010255|60652|P3|STARTED|Overall Study||25
25400|NCT02010255|60653|P2|STARTED|Overall Study||28
25401|NCT02010255|60654|P1|STARTED|Overall Study||28
25402|NCT02010216|60978|P1|NOT COMPLETED|Overall Study||0
25403|NCT02010216|60978|P1|COMPLETED|Overall Study||23
25404|NCT02010216|60978|P1|STARTED|Overall Study||23
25405|NCT02009982|60986|P2|NOT COMPLETED|Overall Study||0
25406|NCT02009982|60987|P1|NOT COMPLETED|Overall Study||0
25407|NCT02009982|60986|P2|COMPLETED|Overall Study||2
25408|NCT02009982|60987|P1|COMPLETED|Overall Study||1
25409|NCT02009982|60986|P2|STARTED|Overall Study||2
25410|NCT02009982|60987|P1|STARTED|Overall Study||1
25411|NCT02009878|60998|P3|NOT COMPLETED|Overall Study||0
25412|NCT02009878|60999|P2|NOT COMPLETED|Overall Study||1
25413|NCT02009878|61000|P1|NOT COMPLETED|Overall Study||0
25414|NCT02009878|60998|P3|COMPLETED|Overall Study||9
25415|NCT02009878|60999|P2|COMPLETED|Overall Study||10
25416|NCT02009878|61000|P1|COMPLETED|Overall Study||10
25417|NCT02009878|60998|P3|STARTED|Overall Study||9
25418|NCT02009878|60999|P2|STARTED|Overall Study||11
25419|NCT02009878|61000|P1|STARTED|Overall Study||10
25420|NCT02009865|61034|P2|NOT COMPLETED|Overall Study||5
25421|NCT02009865|61035|P1|NOT COMPLETED|Overall Study||1
25422|NCT02009865|61034|P2|COMPLETED|Overall Study||76
25423|NCT02009865|61035|P1|COMPLETED|Overall Study||80
25424|NCT02009865|61034|P2|STARTED|Overall Study||81
25425|NCT02009865|61035|P1|STARTED|Overall Study||81
25426|NCT02009722|61051|P2|NOT COMPLETED|Overall Study||3
25427|NCT02009722|61052|P1|NOT COMPLETED|Overall Study||1
25428|NCT02009722|61051|P2|COMPLETED|Overall Study||40
25429|NCT02009722|61052|P1|COMPLETED|Overall Study||40
25430|NCT02009722|61051|P2|Received Intervention|Overall Study||42
25431|NCT02009722|61052|P1|Received Intervention|Overall Study||41
25432|NCT02009722|61051|P2|STARTED|Overall Study||43
25433|NCT02009722|61052|P1|STARTED|Overall Study||41
25434|NCT02009696|61076|P1|NOT COMPLETED|Overall Study||2
25435|NCT02009696|61076|P1|COMPLETED|Overall Study||219
25436|NCT02009696|61076|P1|STARTED|Overall Study||221
25437|NCT02009163|61084|P3|NOT COMPLETED|Randomized-withdrawal Period||35
25438|NCT02009163|61085|P2|NOT COMPLETED|Randomized-withdrawal Period||88
25439|NCT02009163|61086|P1|NOT COMPLETED|Randomized-withdrawal Period||0
25440|NCT02009163|61084|P3|COMPLETED|Randomized-withdrawal Period||102
25441|NCT02009163|61085|P2|COMPLETED|Randomized-withdrawal Period||50
25442|NCT02009163|61086|P1|COMPLETED|Randomized-withdrawal Period||0
25443|NCT02009163|61084|P3|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|137
25444|NCT02009163|61085|P2|STARTED|Randomized-withdrawal Period|The total who started the Placebo and SPD489 arms equals those who completed the open-label period.|138
25445|NCT02009163|61086|P1|STARTED|Randomized-withdrawal Period|The open-label treatment group is not an arm of the randomized-withdrawal period.|0
25446|NCT02009163|61084|P3|NOT COMPLETED|Open-label Period (Non-randomized)||0
25447|NCT02009163|61085|P2|NOT COMPLETED|Open-label Period (Non-randomized)||0
25448|NCT02009163|61086|P1|NOT COMPLETED|Open-label Period (Non-randomized)||143
25449|NCT02009163|61084|P3|COMPLETED|Open-label Period (Non-randomized)||0
25450|NCT02009163|61085|P2|COMPLETED|Open-label Period (Non-randomized)||0
25451|NCT02009163|61086|P1|COMPLETED|Open-label Period (Non-randomized)||275
25452|NCT02009163|61084|P3|STARTED|Open-label Period (Non-randomized)||0
25453|NCT02009163|61085|P2|STARTED|Open-label Period (Non-randomized)||0
25454|NCT02009163|61086|P1|STARTED|Open-label Period (Non-randomized)||418
25455|NCT02008942|61119|P2|NOT COMPLETED|Second Intervention||0
25456|NCT02008942|61120|P1|NOT COMPLETED|Second Intervention||1
25457|NCT02008942|61119|P2|COMPLETED|Second Intervention||30
25458|NCT02008942|61120|P1|COMPLETED|Second Intervention||25
25459|NCT02008942|61119|P2|STARTED|Second Intervention||30
25460|NCT02008942|61120|P1|STARTED|Second Intervention||26
25461|NCT02008942|61119|P2|NOT COMPLETED|First Intervention||0
25462|NCT02008942|61120|P1|NOT COMPLETED|First Intervention||0
25463|NCT02008942|61119|P2|COMPLETED|First Intervention||30
25464|NCT02008942|61120|P1|COMPLETED|First Intervention||27
25465|NCT02008942|61119|P2|STARTED|First Intervention||30
25466|NCT02008942|61120|P1|STARTED|First Intervention||27
25467|NCT02008682|61128|P2|NOT COMPLETED|Overall Study||14
25468|NCT02008682|61129|P1|NOT COMPLETED|Overall Study||27
25469|NCT02008682|61128|P2|COMPLETED|Overall Study|Completed without discontinuation of trial product|170
25470|NCT02008682|61129|P1|COMPLETED|Overall Study|Completed without discontinuation of trial product|157
25471|NCT02008682|61128|P2|Exposed|Overall Study||184
25472|NCT02008682|61129|P1|Exposed|Overall Study|1 subject withdrawn before exposure to trial product|183
25473|NCT02008682|61128|P2|STARTED|Overall Study||184
25474|NCT02008682|61129|P1|STARTED|Overall Study||184
25475|NCT02008617|61147|P2|NOT COMPLETED|Overall Study||0
25476|NCT02008617|61148|P1|NOT COMPLETED|Overall Study||0
25477|NCT02008617|61147|P2|COMPLETED|Overall Study||10
25478|NCT02008617|61148|P1|COMPLETED|Overall Study||8
25479|NCT02008617|61147|P2|STARTED|Overall Study||10
25480|NCT02008617|61148|P1|STARTED|Overall Study||8
25481|NCT02008227|61162|P2|NOT COMPLETED|Overall Study||613
25482|NCT02008227|61163|P1|NOT COMPLETED|Overall Study||612
25483|NCT02008227|61162|P2|COMPLETED|Overall Study||0
25484|NCT02008227|61163|P1|COMPLETED|Overall Study||0
25485|NCT02008227|61162|P2|Treated|Overall Study||608
25486|NCT02008227|61163|P1|Treated|Overall Study||579
25487|NCT02008227|61162|P2|STARTED|Overall Study||613
25488|NCT02008227|61163|P1|STARTED|Overall Study||612
25489|NCT02007954|61224|P1|NOT COMPLETED|Overall Study||7
25490|NCT02007954|61224|P1|COMPLETED|Overall Study||17
25491|NCT02007954|61224|P1|Completed First Clinical and Imaging|Overall Study|1 patient exited prior to first imaging follow-up due to unrelated serious adverse event and death|23
25492|NCT02007954|61224|P1|Completed First TACE|Overall Study||24
25493|NCT02007954|61224|P1|STARTED|Overall Study|A total of 32 participants were consented, with 8 patients screened out prior to treatment.|24
25494|NCT02007863|61237|P1|NOT COMPLETED|Overall Study||0
25495|NCT02007863|61237|P1|COMPLETED|Overall Study||2
25496|NCT02007863|61237|P1|STARTED|Overall Study||2
25497|NCT02007577|61243|P2|NOT COMPLETED|Overall Study||1
25498|NCT02007577|61244|P1|NOT COMPLETED|Overall Study||1
25499|NCT02007577|61243|P2|COMPLETED|Overall Study||13
25500|NCT02007577|61244|P1|COMPLETED|Overall Study||26
25501|NCT02007577|61243|P2|STARTED|Overall Study||14
25502|NCT02007577|61244|P1|STARTED|Overall Study||27
25503|NCT02007434|61260|P8|NOT COMPLETED|Overall Study||0
25504|NCT02007434|61261|P7|NOT COMPLETED|Overall Study||0
25505|NCT02007434|61262|P6|NOT COMPLETED|Overall Study||0
25506|NCT02007434|61263|P5|NOT COMPLETED|Overall Study||0
25507|NCT02007434|61264|P4|NOT COMPLETED|Overall Study||0
25508|NCT02007434|61265|P3|NOT COMPLETED|Overall Study||1
25509|NCT02007434|61266|P2|NOT COMPLETED|Overall Study||1
25510|NCT02007434|61267|P1|NOT COMPLETED|Overall Study||1
25511|NCT02007434|61260|P8|COMPLETED|Overall Study||4
25512|NCT02007434|61261|P7|COMPLETED|Overall Study||18
25513|NCT02007434|61262|P6|COMPLETED|Overall Study||4
25514|NCT02007434|61263|P5|COMPLETED|Overall Study||16
25515|NCT02007434|61264|P4|COMPLETED|Overall Study||4
25516|NCT02007434|61265|P3|COMPLETED|Overall Study||16
25517|NCT02007434|61266|P2|COMPLETED|Overall Study||3
25518|NCT02007434|61267|P1|COMPLETED|Overall Study||16
25519|NCT02007434|61260|P8|Received Treatment|Overall Study||4
25520|NCT02007434|61261|P7|Received Treatment|Overall Study||18
25521|NCT02007434|61262|P6|Received Treatment|Overall Study||4
25522|NCT02007434|61263|P5|Received Treatment|Overall Study||16
25523|NCT02007434|61264|P4|Received Treatment|Overall Study||4
25524|NCT02007434|61265|P3|Received Treatment|Overall Study||17
25525|NCT02007434|61266|P2|Received Treatment|Overall Study||3
25526|NCT02007434|61267|P1|Received Treatment|Overall Study||17
25527|NCT02007434|61260|P8|STARTED|Overall Study||4
25528|NCT02007434|61261|P7|STARTED|Overall Study||18
25529|NCT02007434|61262|P6|STARTED|Overall Study||4
25530|NCT02007434|61263|P5|STARTED|Overall Study||16
25531|NCT02007434|61264|P4|STARTED|Overall Study||4
25532|NCT02007434|61265|P3|STARTED|Overall Study||17
25533|NCT02007434|61266|P2|STARTED|Overall Study||4
25534|NCT02007434|61267|P1|STARTED|Overall Study||17
25535|NCT02007369|61368|P3|NOT COMPLETED|Overall Study||0
25536|NCT02007369|61369|P2|NOT COMPLETED|Overall Study||0
25537|NCT02007369|61370|P1|NOT COMPLETED|Overall Study||0
25538|NCT02007369|61368|P3|COMPLETED|Overall Study||54
25539|NCT02007369|61369|P2|COMPLETED|Overall Study||40
25540|NCT02007369|61370|P1|COMPLETED|Overall Study||42
25541|NCT02007369|61368|P3|STARTED|Overall Study||54
25542|NCT02007369|61369|P2|STARTED|Overall Study||40
25543|NCT02007369|61370|P1|STARTED|Overall Study||42
25544|NCT02007278|61389|P2|NOT COMPLETED|Overall Study||3
25545|NCT02007278|61390|P1|NOT COMPLETED|Overall Study||2
25546|NCT02007278|61389|P2|COMPLETED|Overall Study||17
25547|NCT02007278|61390|P1|COMPLETED|Overall Study||18
25548|NCT02007278|61389|P2|STARTED|Overall Study||20
25549|NCT02007278|61390|P1|STARTED|Overall Study||20
25550|NCT02007252|61412|P2|NOT COMPLETED|Overall Study||11
25551|NCT02007252|61413|P1|NOT COMPLETED|Overall Study||11
25552|NCT02007252|61412|P2|COMPLETED|Overall Study||22
25553|NCT02007252|61413|P1|COMPLETED|Overall Study||20
25554|NCT02007252|61412|P2|Pharmacodynamic Analysis Set|Overall Study||33
25555|NCT02007252|61413|P1|Pharmacodynamic Analysis Set|Overall Study||31
25556|NCT02007252|61412|P2|Safety Analysis Set|Overall Study||33
25557|NCT02007252|61413|P1|Safety Analysis Set|Overall Study||31
25558|NCT02007252|61412|P2|STARTED|Overall Study||33
25559|NCT02007252|61413|P1|STARTED|Overall Study||31
25560|NCT02007200|61419|P1|NOT COMPLETED|Overall Study||0
25561|NCT02007200|61419|P1|COMPLETED|Overall Study||55
25562|NCT02007200|61419|P1|STARTED|Overall Study||55
25563|NCT02007070|61426|P1|NOT COMPLETED|Overall Study||38
25564|NCT02007070|61426|P1|COMPLETED|Overall Study||0
25565|NCT02007070|61426|P1|STARTED|Overall Study||38
25566|NCT02006836|61438|P3|NOT COMPLETED|Self-control Period: Month 7-month 12||0
25567|NCT02006836|61439|P2|NOT COMPLETED|Self-control Period: Month 7-month 12||0
25568|NCT02006836|61440|P1|NOT COMPLETED|Self-control Period: Month 7-month 12||0
25569|NCT02006836|61438|P3|COMPLETED|Self-control Period: Month 7-month 12||19
25570|NCT02006836|61439|P2|COMPLETED|Self-control Period: Month 7-month 12||0
25571|NCT02006836|61440|P1|COMPLETED|Self-control Period: Month 7-month 12||0
25572|NCT02006836|61438|P3|STARTED|Self-control Period: Month 7-month 12||19
25573|NCT02006836|61439|P2|STARTED|Self-control Period: Month 7-month 12||0
25574|NCT02006836|61440|P1|STARTED|Self-control Period: Month 7-month 12||0
25575|NCT02006836|61438|P3|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
25576|NCT02006836|61439|P2|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
25577|NCT02006836|61440|P1|NOT COMPLETED|Case-control Period: Month 1- Month 6||0
25578|NCT02006836|61438|P3|COMPLETED|Case-control Period: Month 1- Month 6||0
25579|NCT02006836|61439|P2|COMPLETED|Case-control Period: Month 1- Month 6||20
25580|NCT02006836|61440|P1|COMPLETED|Case-control Period: Month 1- Month 6||20
25581|NCT02006836|61438|P3|STARTED|Case-control Period: Month 1- Month 6||0
25582|NCT02006836|61439|P2|STARTED|Case-control Period: Month 1- Month 6||20
25583|NCT02006836|61440|P1|STARTED|Case-control Period: Month 1- Month 6||20
25584|NCT02006732|61460|P4|NOT COMPLETED|Overall Study||4
25585|NCT02006732|61461|P3|NOT COMPLETED|Overall Study||9
25586|NCT02006732|61462|P2|NOT COMPLETED|Overall Study||12
25587|NCT02006732|61463|P1|NOT COMPLETED|Overall Study||20
25588|NCT02006732|61460|P4|COMPLETED|Overall Study||198
25589|NCT02006732|61461|P3|COMPLETED|Overall Study||193
25590|NCT02006732|61462|P2|COMPLETED|Overall Study||191
25591|NCT02006732|61463|P1|COMPLETED|Overall Study||182
25592|NCT02006732|61460|P4|STARTED|Overall Study||202
25593|NCT02006732|61461|P3|STARTED|Overall Study||202
25594|NCT02006732|61462|P2|STARTED|Overall Study||203
25595|NCT02006732|61463|P1|STARTED|Overall Study||202
25596|NCT02006719|61503|P2|NOT COMPLETED|Overall Study||5
25597|NCT02006719|61504|P1|NOT COMPLETED|Overall Study||18
25598|NCT02006719|61503|P2|COMPLETED|Overall Study||80
25599|NCT02006719|61504|P1|COMPLETED|Overall Study||219
25600|NCT02006719|61503|P2|STARTED|Overall Study||85
25601|NCT02006719|61504|P1|STARTED|Overall Study||237
25602|NCT02006706|61534|P1|NOT COMPLETED|Overall Study||1
25603|NCT02006706|61534|P1|COMPLETED|Overall Study||14
25604|NCT02006706|61534|P1|STARTED|Overall Study||15
25605|NCT02006667|61539|P1|NOT COMPLETED|Overall Study||6
25606|NCT02006667|61539|P1|COMPLETED|Overall Study||7
25607|NCT02006667|61539|P1|STARTED|Overall Study||13
25608|NCT02006407|61549|P1|NOT COMPLETED|Overall Study||0
25609|NCT02006407|61549|P1|COMPLETED|Overall Study||5
25610|NCT02006407|61549|P1|STARTED|Overall Study||5
25611|NCT02006342|61557|P2|NOT COMPLETED|Overall Study||0
25612|NCT02006342|61558|P1|NOT COMPLETED|Overall Study||1
25613|NCT02006342|61557|P2|COMPLETED|Overall Study||20
25614|NCT02006342|61558|P1|COMPLETED|Overall Study||19
25615|NCT02006342|61557|P2|STARTED|Overall Study||20
25616|NCT02006342|61558|P1|STARTED|Overall Study||20
25617|NCT02006108|61572|P1|NOT COMPLETED|Overall Study||2
25618|NCT02006108|61572|P1|COMPLETED|Overall Study||19
25619|NCT02006108|61572|P1|MR Imaging|Overall Study||19
25620|NCT02006108|61572|P1|STARTED|Overall Study||21
25621|NCT02005692|61577|P1|NOT COMPLETED|Overall Study||7
25622|NCT02005692|61577|P1|COMPLETED|Overall Study||63
25623|NCT02005692|61577|P1|STARTED|Overall Study||70
25624|NCT02005601|61584|P2|NOT COMPLETED|Overall Study||0
25625|NCT02005601|61585|P1|NOT COMPLETED|Overall Study||0
25626|NCT02005601|61584|P2|COMPLETED|Overall Study||53
25627|NCT02005601|61585|P1|COMPLETED|Overall Study||53
25628|NCT02005601|61584|P2|STARTED|Overall Study||53
25629|NCT02005601|61585|P1|STARTED|Overall Study||53
25630|NCT02005562|61597|P2|NOT COMPLETED|Overall Study||15
25631|NCT02005562|61598|P1|NOT COMPLETED|Overall Study||12
25632|NCT02005562|61597|P2|COMPLETED|Overall Study||110
25633|NCT02005562|61598|P1|COMPLETED|Overall Study||115
25634|NCT02005562|61597|P2|Transplanted|Overall Study||121
25635|NCT02005562|61598|P1|Transplanted|Overall Study||126
25636|NCT02005562|61597|P2|STARTED|Overall Study||125
25637|NCT02005562|61598|P1|STARTED|Overall Study||127
25638|NCT02005549|61626|P1|NOT COMPLETED|Overall Study||0
25639|NCT02005549|61626|P1|COMPLETED|Overall Study||18
25640|NCT02005549|61626|P1|STARTED|Overall Study||18
25641|NCT02005536|61632|P1|NOT COMPLETED|Overall Study||0
25642|NCT02005536|61632|P1|COMPLETED|Overall Study||60
25643|NCT02005536|61632|P1|STARTED|Overall Study||60
25644|NCT02005484|61640|P1|NOT COMPLETED|Overall Study||4
25645|NCT02005484|61640|P1|COMPLETED|Overall Study||2
25646|NCT02005484|61640|P1|STARTED|Overall Study||6
25647|NCT02005393|61650|P1|NOT COMPLETED|Overall Study||0
25648|NCT02005393|61650|P1|COMPLETED|Overall Study||20
25649|NCT02005393|61650|P1|STARTED|Overall Study||20
25650|NCT02005211|61661|P7|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25651|NCT02005211|61662|P6|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25652|NCT02005211|61663|P5|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||1
25653|NCT02005211|61664|P4|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25654|NCT02005211|61665|P3|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25655|NCT02005211|61666|P2|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25656|NCT02005211|61667|P1|NOT COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25657|NCT02005211|61661|P7|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
25658|NCT02005211|61662|P6|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
25659|NCT02005211|61663|P5|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||5
25660|NCT02005211|61664|P4|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25661|NCT02005211|61665|P3|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25662|NCT02005211|61666|P2|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25663|NCT02005211|61667|P1|COMPLETED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25664|NCT02005211|61661|P7|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||4
25665|NCT02005211|61662|P6|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
25666|NCT02005211|61663|P5|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||6
25667|NCT02005211|61664|P4|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25668|NCT02005211|61665|P3|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25669|NCT02005211|61666|P2|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25670|NCT02005211|61667|P1|STARTED|Part 2 - Elderly Subjects Cohorts 4 & 5||0
25671|NCT02005211|61661|P7|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25672|NCT02005211|61662|P6|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25673|NCT02005211|61663|P5|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25674|NCT02005211|61664|P4|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25675|NCT02005211|61665|P3|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25676|NCT02005211|61666|P2|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25677|NCT02005211|61667|P1|NOT COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25678|NCT02005211|61661|P7|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25679|NCT02005211|61662|P6|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25680|NCT02005211|61663|P5|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||0
25681|NCT02005211|61664|P4|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
25682|NCT02005211|61665|P3|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
25683|NCT02005211|61666|P2|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
25684|NCT02005211|61667|P1|COMPLETED|Part 1 - Cohorts 1-3 Adult Subjects||6
25685|NCT02005211|61661|P7|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
25686|NCT02005211|61662|P6|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
25687|NCT02005211|61663|P5|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||0
25688|NCT02005211|61664|P4|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
25689|NCT02005211|61665|P3|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
25690|NCT02005211|61666|P2|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
25691|NCT02005211|61667|P1|STARTED|Part 1 - Cohorts 1-3 Adult Subjects||6
25692|NCT02005029|61702|P2|NOT COMPLETED|Second Intervention (1 Day)||0
25693|NCT02005029|61703|P1|NOT COMPLETED|Second Intervention (1 Day)||0
25694|NCT02005029|61702|P2|COMPLETED|Second Intervention (1 Day)||5
25695|NCT02005029|61703|P1|COMPLETED|Second Intervention (1 Day)||4
25696|NCT02005029|61702|P2|STARTED|Second Intervention (1 Day)||5
25697|NCT02005029|61703|P1|STARTED|Second Intervention (1 Day)||4
25698|NCT02005029|61702|P2|NOT COMPLETED|Washout (2 Weeks)||0
25699|NCT02005029|61703|P1|NOT COMPLETED|Washout (2 Weeks)||0
25700|NCT02005029|61702|P2|COMPLETED|Washout (2 Weeks)||5
25701|NCT02005029|61703|P1|COMPLETED|Washout (2 Weeks)||4
25702|NCT02005029|61702|P2|STARTED|Washout (2 Weeks)||5
25703|NCT02005029|61703|P1|STARTED|Washout (2 Weeks)||4
25704|NCT02005029|61702|P2|NOT COMPLETED|First Intervention (1 Day)||0
25705|NCT02005029|61703|P1|NOT COMPLETED|First Intervention (1 Day)||1
25706|NCT02005029|61702|P2|COMPLETED|First Intervention (1 Day)||5
25707|NCT02005029|61703|P1|COMPLETED|First Intervention (1 Day)||4
25708|NCT02005029|61702|P2|STARTED|First Intervention (1 Day)||5
25709|NCT02005029|61703|P1|STARTED|First Intervention (1 Day)||5
25710|NCT02004990|61729|P1|NOT COMPLETED|Overall Study||0
25711|NCT02004990|61729|P1|COMPLETED|Overall Study||12
25712|NCT02004990|61729|P1|STARTED|Overall Study||12
25713|NCT02004886|61738|P4|NOT COMPLETED|Overall Study||0
25714|NCT02004886|61739|P3|NOT COMPLETED|Overall Study||0
25715|NCT02004886|61740|P2|NOT COMPLETED|Overall Study||1
25716|NCT02004886|61741|P1|NOT COMPLETED|Overall Study||1
25717|NCT02004886|61738|P4|COMPLETED|Overall Study||19
25718|NCT02004886|61739|P3|COMPLETED|Overall Study||18
25719|NCT02004886|61740|P2|COMPLETED|Overall Study||17
25720|NCT02004886|61741|P1|COMPLETED|Overall Study||18
25721|NCT02004886|61738|P4|STARTED|Overall Study||19
25722|NCT02004886|61739|P3|STARTED|Overall Study||18
25723|NCT02004886|61740|P2|STARTED|Overall Study||18
25724|NCT02004886|61741|P1|STARTED|Overall Study||19
25725|NCT02004873|61791|P1|NOT COMPLETED|Overall Study||424
25726|NCT02004873|61791|P1|COMPLETED|Overall Study|6-Month Follow-up|301
25727|NCT02004873|61791|P1|Micra Implant Success|Overall Study||719
25728|NCT02004873|61791|P1|STARTED|Overall Study|Micra Implant Attempt|725
25729|NCT02004847|61800|P2|NOT COMPLETED|Overall Study||1
25730|NCT02004847|61801|P1|NOT COMPLETED|Overall Study||1
25731|NCT02004847|61800|P2|COMPLETED|Overall Study||22
25732|NCT02004847|61801|P1|COMPLETED|Overall Study||23
25733|NCT02004847|61800|P2|STARTED|Overall Study||23
25734|NCT02004847|61801|P1|STARTED|Overall Study||24
25735|NCT02004236|61848|P3|NOT COMPLETED|Overall Study||16
25736|NCT02004236|61849|P2|NOT COMPLETED|Overall Study||0
25737|NCT02004236|61850|P1|NOT COMPLETED|Overall Study||0
25738|NCT02004236|61848|P3|COMPLETED|Overall Study|Leave the group because the parents does't find any clinical improvement.|59
25739|NCT02004236|61849|P2|COMPLETED|Overall Study||75
25740|NCT02004236|61850|P1|COMPLETED|Overall Study||75
25741|NCT02004236|61848|P3|STARTED|Overall Study||75
25742|NCT02004236|61849|P2|STARTED|Overall Study||75
25743|NCT02004236|61850|P1|STARTED|Overall Study||75
25744|NCT02004158|61894|P1|NOT COMPLETED|Overall Study||3
25745|NCT02004158|61894|P1|COMPLETED|Overall Study||20
25746|NCT02004158|61894|P1|STARTED|Overall Study||23
25747|NCT02004132|61902|P1|NOT COMPLETED|Overall Study||0
25748|NCT02004132|61902|P1|COMPLETED|Overall Study||12
25749|NCT02004132|61902|P1|Received Study Drug|Overall Study||12
25750|NCT02004132|61902|P1|STARTED|Overall Study||12
25751|NCT02004093|61910|P2|NOT COMPLETED|Overall Study||73
25752|NCT02004093|61911|P1|NOT COMPLETED|Overall Study||74
25753|NCT02004093|61910|P2|COMPLETED|Overall Study||1
25754|NCT02004093|61911|P1|COMPLETED|Overall Study||1
25755|NCT02004093|61910|P2|STARTED|Overall Study||74
25756|NCT02004093|61911|P1|STARTED|Overall Study|Includes 1 participant who was randomized to chemotherapy group but received pertuzumab+chemotherapy|75
25757|NCT02003963|61943|P2|NOT COMPLETED|Overall Study||1
25758|NCT02003963|61944|P1|NOT COMPLETED|Overall Study||2
25759|NCT02003963|61943|P2|COMPLETED|Overall Study|1 participant was removed from analysis for completing final visit outside of visit window.|18
25760|NCT02003963|61944|P1|COMPLETED|Overall Study|2 participants dropped out: 1 due to lack of interest and 1 due to a mental health hospitalization.|20
25761|NCT02003963|61943|P2|STARTED|Overall Study||19
25762|NCT02003963|61944|P1|STARTED|Overall Study||22
25763|NCT02003638|61962|P2|NOT COMPLETED|Overall Study||0
25764|NCT02003638|61963|P1|NOT COMPLETED|Overall Study||1
25765|NCT02003638|61962|P2|COMPLETED|Overall Study||3
25766|NCT02003638|61963|P1|COMPLETED|Overall Study|1 withdrew after developing bacterial pharyngitis. Not considered treatment-emergent.|5
25767|NCT02003638|61962|P2|STARTED|Overall Study||3
25768|NCT02003638|61963|P1|STARTED|Overall Study||6
25769|NCT02003534|61969|P1|NOT COMPLETED|Overall Study||47
25770|NCT02003534|61969|P1|COMPLETED|Overall Study||329
25771|NCT02003534|61969|P1|STARTED|Overall Study||376
25772|NCT02003404|61973|P1|NOT COMPLETED|Overall Study||0
25773|NCT02003404|61973|P1|COMPLETED|Overall Study||17
25774|NCT02003404|61973|P1|STARTED|Overall Study||17
25775|NCT02003391|61981|P2|NOT COMPLETED|Overall Study||2
25776|NCT02003391|61982|P1|NOT COMPLETED|Overall Study||3
25777|NCT02003391|61981|P2|COMPLETED|Overall Study||73
25778|NCT02003391|61982|P1|COMPLETED|Overall Study||78
25779|NCT02003391|61981|P2|Intent to Treat Population|Overall Study||73
25780|NCT02003391|61982|P1|Intent to Treat Population|Overall Study||78
25781|NCT02003391|61981|P2|Safety Population|Overall Study||75
25782|NCT02003391|61982|P1|Safety Population|Overall Study||81
25783|NCT02003391|61981|P2|STARTED|Overall Study||75
25784|NCT02003391|61982|P1|STARTED|Overall Study||81
25785|NCT02003352|61992|P1|NOT COMPLETED|Overall Study||0
25786|NCT02003352|61992|P1|COMPLETED|Overall Study||98
25787|NCT02003352|61992|P1|STARTED|Overall Study||98
25788|NCT02003014|61996|P1|NOT COMPLETED|Overall Study||19
25789|NCT02003014|61996|P1|COMPLETED|Overall Study||880
25790|NCT02003014|61996|P1|STARTED|Overall Study||899
25791|NCT02002936|62006|P1|NOT COMPLETED|Overall Study||0
25792|NCT02002936|62006|P1|COMPLETED|Overall Study||1
25793|NCT02002936|62006|P1|STARTED|Overall Study||1
25794|NCT02002871|62015|P1|NOT COMPLETED|Overall Study||1
25795|NCT02002871|62015|P1|COMPLETED|Overall Study||20
25796|NCT02002871|62015|P1|STARTED|Overall Study||21
25797|NCT02002702|62044|P3|NOT COMPLETED|Overall Study||0
25798|NCT02002702|62045|P2|NOT COMPLETED|Overall Study||0
25799|NCT02002702|62046|P1|NOT COMPLETED|Overall Study||0
25800|NCT02002702|62044|P3|COMPLETED|Overall Study||15
25801|NCT02002702|62045|P2|COMPLETED|Overall Study||15
25802|NCT02002702|62046|P1|COMPLETED|Overall Study||16
25803|NCT02002702|62044|P3|STARTED|Overall Study||15
25804|NCT02002702|62045|P2|STARTED|Overall Study||15
25805|NCT02002702|62046|P1|STARTED|Overall Study||16
25806|NCT02002689|62078|P1|NOT COMPLETED|Overall Study||10
25807|NCT02002689|62078|P1|COMPLETED|Overall Study||0
25808|NCT02002689|62078|P1|STARTED|Overall Study||10
25809|NCT02002650|62086|P2|NOT COMPLETED|Overall Study||0
25810|NCT02002650|62087|P1|NOT COMPLETED|Overall Study||0
25811|NCT02002650|62086|P2|COMPLETED|Overall Study||1303
25812|NCT02002650|62087|P1|COMPLETED|Overall Study||1297
25813|NCT02002650|62086|P2|STARTED|Overall Study||1303
25814|NCT02002650|62087|P1|STARTED|Overall Study||1297
25815|NCT02002221|62097|P2|NOT COMPLETED|Overall Study||3
25816|NCT02002221|62098|P1|NOT COMPLETED|Overall Study||2
25817|NCT02002221|62097|P2|COMPLETED|Overall Study||75
25818|NCT02002221|62098|P1|COMPLETED|Overall Study||76
25819|NCT02002221|62097|P2|STARTED|Overall Study||78
25820|NCT02002221|62098|P1|STARTED|Overall Study||78
25821|NCT02002208|62114|P2|NOT COMPLETED|Overall Study||40
25822|NCT02002208|62115|P1|NOT COMPLETED|Overall Study||37
25823|NCT02002208|62114|P2|COMPLETED|Overall Study||30
25824|NCT02002208|62115|P1|COMPLETED|Overall Study||32
25825|NCT02002208|62114|P2|STARTED|Overall Study||70
25826|NCT02002208|62115|P1|STARTED|Overall Study||69
25827|NCT02001181|62125|P2|NOT COMPLETED|Overall Study||3
25828|NCT02001181|62126|P1|NOT COMPLETED|Overall Study||1
25829|NCT02001181|62125|P2|COMPLETED|Overall Study||31
25830|NCT02001181|62126|P1|COMPLETED|Overall Study||34
25831|NCT02001181|62125|P2|STARTED|Overall Study||34
25832|NCT02001181|62126|P1|STARTED|Overall Study||35
25833|NCT02000973|62144|P4|NOT COMPLETED|Overall Study||0
25834|NCT02000973|62145|P3|NOT COMPLETED|Overall Study||0
25835|NCT02000973|62146|P2|NOT COMPLETED|Overall Study||0
25836|NCT02000973|62147|P1|NOT COMPLETED|Overall Study||0
25837|NCT02000973|62144|P4|COMPLETED|Overall Study||20
25838|NCT02000973|62145|P3|COMPLETED|Overall Study||20
25839|NCT02000973|62146|P2|COMPLETED|Overall Study||20
25840|NCT02000973|62147|P1|COMPLETED|Overall Study||20
25841|NCT02000973|62144|P4|STARTED|Overall Study||20
25842|NCT02000973|62145|P3|STARTED|Overall Study||20
25843|NCT02000973|62146|P2|STARTED|Overall Study||20
25844|NCT02000973|62147|P1|STARTED|Overall Study||20
25845|NCT02000921|62172|P3|NOT COMPLETED|Overall Study||10
25846|NCT02000921|62173|P2|NOT COMPLETED|Overall Study||16
25847|NCT02000921|62174|P1|NOT COMPLETED|Overall Study||5
25848|NCT02000921|62172|P3|COMPLETED|Overall Study||46
25849|NCT02000921|62173|P2|COMPLETED|Overall Study||37
25850|NCT02000921|62174|P1|COMPLETED|Overall Study||22
25851|NCT02000921|62172|P3|STARTED|Overall Study||56
25852|NCT02000921|62173|P2|STARTED|Overall Study||53
25853|NCT02000921|62174|P1|STARTED|Overall Study||27
25854|NCT02000752|62193|P2|NOT COMPLETED|Overall Study||13
25855|NCT02000752|62194|P1|NOT COMPLETED|Overall Study||31
25856|NCT02000752|62193|P2|COMPLETED|Overall Study||47
25857|NCT02000752|62194|P1|COMPLETED|Overall Study||29
25858|NCT02000752|62193|P2|STARTED|Overall Study||60
25859|NCT02000752|62194|P1|STARTED|Overall Study||60
25860|NCT02000531|62208|P2|NOT COMPLETED|Overall Study||8
25861|NCT02000531|62209|P1|NOT COMPLETED|Overall Study||4
25862|NCT02000531|62208|P2|COMPLETED|Overall Study||16
25863|NCT02000531|62209|P1|COMPLETED|Overall Study||17
25864|NCT02000531|62208|P2|Safety Population|Overall Study||24
25865|NCT02000531|62209|P1|Safety Population|Overall Study||21
25866|NCT02000531|62208|P2|STARTED|Overall Study||24
25867|NCT02000531|62209|P1|STARTED|Overall Study||21
25868|NCT02000440|62217|P1|NOT COMPLETED|Overall Study||4
25869|NCT02000440|62217|P1|COMPLETED|Overall Study||13
25870|NCT02000440|62217|P1|STARTED|Overall Study||17
25871|NCT02000427|62237|P1|NOT COMPLETED|Overall Study||22
25872|NCT02000427|62237|P1|COMPLETED|Overall Study|Indicates participants ongoing in study as of the data cut-off date of 20 May 2015.|23
25873|NCT02000427|62237|P1|STARTED|Overall Study||45
25874|NCT02000154|62252|P1|NOT COMPLETED|Overall Study||0
25875|NCT02000154|62252|P1|COMPLETED|Overall Study||1
25876|NCT02000154|62252|P1|STARTED|Overall Study||1
25877|NCT01999894|62260|P1|NOT COMPLETED|Overall Study||36
25878|NCT01999894|62260|P1|COMPLETED|Overall Study||66
25879|NCT01999894|62260|P1|STARTED|Overall Study||102
25880|NCT01999400|62265|P6|NOT COMPLETED|Fourth Intervention (1 Day)||0
25881|NCT01999400|62266|P5|NOT COMPLETED|Fourth Intervention (1 Day)||0
25882|NCT01999400|62267|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
25883|NCT01999400|62268|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
25884|NCT01999400|62269|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
25885|NCT01999400|62270|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
25886|NCT01999400|62265|P6|COMPLETED|Fourth Intervention (1 Day)||0
25887|NCT01999400|62266|P5|COMPLETED|Fourth Intervention (1 Day)||0
25888|NCT01999400|62267|P4|COMPLETED|Fourth Intervention (1 Day)||0
25889|NCT01999400|62268|P3|COMPLETED|Fourth Intervention (1 Day)||1
25890|NCT01999400|62269|P2|COMPLETED|Fourth Intervention (1 Day)||0
25891|NCT01999400|62270|P1|COMPLETED|Fourth Intervention (1 Day)||1
25892|NCT01999400|62265|P6|STARTED|Fourth Intervention (1 Day)||0
25893|NCT01999400|62266|P5|STARTED|Fourth Intervention (1 Day)||0
25894|NCT01999400|62267|P4|STARTED|Fourth Intervention (1 Day)||0
25895|NCT01999400|62268|P3|STARTED|Fourth Intervention (1 Day)||1
25896|NCT01999400|62269|P2|STARTED|Fourth Intervention (1 Day)||0
25897|NCT01999400|62270|P1|STARTED|Fourth Intervention (1 Day)||1
25898|NCT01999400|62265|P6|NOT COMPLETED|Washout (10 Days)||0
25899|NCT01999400|62266|P5|NOT COMPLETED|Washout (10 Days)||0
25900|NCT01999400|62267|P4|NOT COMPLETED|Washout (10 Days)||0
25901|NCT01999400|62268|P3|NOT COMPLETED|Washout (10 Days)||0
25902|NCT01999400|62269|P2|NOT COMPLETED|Washout (10 Days)||0
25903|NCT01999400|62270|P1|NOT COMPLETED|Washout (10 Days)||0
25904|NCT01999400|62265|P6|COMPLETED|Washout (10 Days)||0
25905|NCT01999400|62266|P5|COMPLETED|Washout (10 Days)||0
25906|NCT01999400|62267|P4|COMPLETED|Washout (10 Days)||0
25907|NCT01999400|62268|P3|COMPLETED|Washout (10 Days)||1
25908|NCT01999400|62269|P2|COMPLETED|Washout (10 Days)||0
25909|NCT01999400|62270|P1|COMPLETED|Washout (10 Days)||1
25910|NCT01999400|62265|P6|STARTED|Washout (10 Days)||0
25911|NCT01999400|62266|P5|STARTED|Washout (10 Days)||0
25912|NCT01999400|62267|P4|STARTED|Washout (10 Days)||0
25913|NCT01999400|62268|P3|STARTED|Washout (10 Days)||1
25914|NCT01999400|62269|P2|STARTED|Washout (10 Days)||0
25915|NCT01999400|62270|P1|STARTED|Washout (10 Days)||1
25916|NCT01999400|62265|P6|NOT COMPLETED|Third Intervention (1 Day)||1
25917|NCT01999400|62266|P5|NOT COMPLETED|Third Intervention (1 Day)||0
25918|NCT01999400|62267|P4|NOT COMPLETED|Third Intervention (1 Day)||0
25919|NCT01999400|62268|P3|NOT COMPLETED|Third Intervention (1 Day)||0
25920|NCT01999400|62269|P2|NOT COMPLETED|Third Intervention (1 Day)||0
25921|NCT01999400|62270|P1|NOT COMPLETED|Third Intervention (1 Day)||0
25922|NCT01999400|62265|P6|COMPLETED|Third Intervention (1 Day)||0
25923|NCT01999400|62266|P5|COMPLETED|Third Intervention (1 Day)||1
25924|NCT01999400|62267|P4|COMPLETED|Third Intervention (1 Day)||1
25925|NCT01999400|62268|P3|COMPLETED|Third Intervention (1 Day)||1
25926|NCT01999400|62269|P2|COMPLETED|Third Intervention (1 Day)||0
25927|NCT01999400|62270|P1|COMPLETED|Third Intervention (1 Day)||2
25928|NCT01999400|62265|P6|STARTED|Third Intervention (1 Day)||1
25929|NCT01999400|62266|P5|STARTED|Third Intervention (1 Day)||1
25930|NCT01999400|62267|P4|STARTED|Third Intervention (1 Day)||1
25931|NCT01999400|62268|P3|STARTED|Third Intervention (1 Day)||1
25932|NCT01999400|62269|P2|STARTED|Third Intervention (1 Day)||0
25933|NCT01999400|62270|P1|STARTED|Third Intervention (1 Day)||2
25934|NCT01999400|62265|P6|NOT COMPLETED|Washout (10 Days)||0
25935|NCT01999400|62266|P5|NOT COMPLETED|Washout (10 Days)||0
25936|NCT01999400|62267|P4|NOT COMPLETED|Washout (10 Days)||0
25937|NCT01999400|62268|P3|NOT COMPLETED|Washout (10 Days)||0
25938|NCT01999400|62269|P2|NOT COMPLETED|Washout (10 Days)||0
25939|NCT01999400|62270|P1|NOT COMPLETED|Washout (10 Days)||0
25940|NCT01999400|62265|P6|COMPLETED|Washout (10 Days)||1
25941|NCT01999400|62266|P5|COMPLETED|Washout (10 Days)||1
25942|NCT01999400|62267|P4|COMPLETED|Washout (10 Days)||1
25943|NCT01999400|62268|P3|COMPLETED|Washout (10 Days)||1
25944|NCT01999400|62269|P2|COMPLETED|Washout (10 Days)||0
25945|NCT01999400|62270|P1|COMPLETED|Washout (10 Days)||2
25946|NCT01999400|62265|P6|STARTED|Washout (10 Days)||1
25947|NCT01999400|62266|P5|STARTED|Washout (10 Days)||1
25948|NCT01999400|62267|P4|STARTED|Washout (10 Days)||1
25949|NCT01999400|62268|P3|STARTED|Washout (10 Days)||1
25950|NCT01999400|62269|P2|STARTED|Washout (10 Days)||0
25951|NCT01999400|62270|P1|STARTED|Washout (10 Days)||2
25952|NCT01999400|62265|P6|NOT COMPLETED|Second Intervention (1 Day)||0
25953|NCT01999400|62266|P5|NOT COMPLETED|Second Intervention (1 Day)||0
25954|NCT01999400|62267|P4|NOT COMPLETED|Second Intervention (1 Day)||0
25955|NCT01999400|62268|P3|NOT COMPLETED|Second Intervention (1 Day)||0
25956|NCT01999400|62269|P2|NOT COMPLETED|Second Intervention (1 Day)||0
25957|NCT01999400|62270|P1|NOT COMPLETED|Second Intervention (1 Day)||0
25958|NCT01999400|62265|P6|COMPLETED|Second Intervention (1 Day)||3
25959|NCT01999400|62266|P5|COMPLETED|Second Intervention (1 Day)||3
25960|NCT01999400|62267|P4|COMPLETED|Second Intervention (1 Day)||2
25961|NCT01999400|62268|P3|COMPLETED|Second Intervention (1 Day)||3
25962|NCT01999400|62269|P2|COMPLETED|Second Intervention (1 Day)||4
25963|NCT01999400|62270|P1|COMPLETED|Second Intervention (1 Day)||5
25964|NCT01999400|62265|P6|STARTED|Second Intervention (1 Day)||3
25965|NCT01999400|62266|P5|STARTED|Second Intervention (1 Day)||3
25966|NCT01999400|62267|P4|STARTED|Second Intervention (1 Day)||2
25967|NCT01999400|62268|P3|STARTED|Second Intervention (1 Day)||3
25968|NCT01999400|62269|P2|STARTED|Second Intervention (1 Day)||4
25969|NCT01999400|62270|P1|STARTED|Second Intervention (1 Day)||5
25970|NCT01999400|62265|P6|NOT COMPLETED|Washout (10 Days)||0
25971|NCT01999400|62266|P5|NOT COMPLETED|Washout (10 Days)||0
25972|NCT01999400|62267|P4|NOT COMPLETED|Washout (10 Days)||0
25973|NCT01999400|62268|P3|NOT COMPLETED|Washout (10 Days)||0
25974|NCT01999400|62269|P2|NOT COMPLETED|Washout (10 Days)||0
25975|NCT01999400|62270|P1|NOT COMPLETED|Washout (10 Days)||0
25976|NCT01999400|62265|P6|COMPLETED|Washout (10 Days)||3
25977|NCT01999400|62266|P5|COMPLETED|Washout (10 Days)||3
25978|NCT01999400|62267|P4|COMPLETED|Washout (10 Days)||2
25979|NCT01999400|62268|P3|COMPLETED|Washout (10 Days)||3
25980|NCT01999400|62269|P2|COMPLETED|Washout (10 Days)||4
25981|NCT01999400|62270|P1|COMPLETED|Washout (10 Days)||5
25982|NCT01999400|62265|P6|STARTED|Washout (10 Days)||3
25983|NCT01999400|62266|P5|STARTED|Washout (10 Days)||3
25984|NCT01999400|62267|P4|STARTED|Washout (10 Days)||2
25985|NCT01999400|62268|P3|STARTED|Washout (10 Days)||3
25986|NCT01999400|62269|P2|STARTED|Washout (10 Days)||4
25987|NCT01999400|62270|P1|STARTED|Washout (10 Days)||5
25988|NCT01999400|62265|P6|NOT COMPLETED|First Intervention (1 Day)||1
25989|NCT01999400|62266|P5|NOT COMPLETED|First Intervention (1 Day)||0
25990|NCT01999400|62267|P4|NOT COMPLETED|First Intervention (1 Day)||3
25991|NCT01999400|62268|P3|NOT COMPLETED|First Intervention (1 Day)||2
25992|NCT01999400|62269|P2|NOT COMPLETED|First Intervention (1 Day)||2
25993|NCT01999400|62270|P1|NOT COMPLETED|First Intervention (1 Day)||2
25994|NCT01999400|62265|P6|COMPLETED|First Intervention (1 Day)||3
25995|NCT01999400|62266|P5|COMPLETED|First Intervention (1 Day)||4
25996|NCT01999400|62267|P4|COMPLETED|First Intervention (1 Day)||2
25997|NCT01999400|62268|P3|COMPLETED|First Intervention (1 Day)||3
25998|NCT01999400|62269|P2|COMPLETED|First Intervention (1 Day)||4
25999|NCT01999400|62270|P1|COMPLETED|First Intervention (1 Day)||4
26000|NCT01999400|62265|P6|STARTED|First Intervention (1 Day)||4
26001|NCT01999400|62266|P5|STARTED|First Intervention (1 Day)||4
26002|NCT01999400|62267|P4|STARTED|First Intervention (1 Day)||5
26003|NCT01999400|62268|P3|STARTED|First Intervention (1 Day)||5
26004|NCT01999400|62269|P2|STARTED|First Intervention (1 Day)||6
26005|NCT01999400|62270|P1|STARTED|First Intervention (1 Day)||6
26006|NCT01999348|62290|P1|NOT COMPLETED|Overall Study||120
26007|NCT01999348|62290|P1|COMPLETED|Overall Study||1433
26008|NCT01999348|62290|P1|STARTED|Overall Study||1553
26009|NCT01999231|62304|P4|NOT COMPLETED|Overall Study||0
26010|NCT01999231|62305|P3|NOT COMPLETED|Overall Study||0
26011|NCT01999231|62306|P2|NOT COMPLETED|Overall Study||0
26012|NCT01999231|62307|P1|NOT COMPLETED|Overall Study||0
26013|NCT01999231|62304|P4|COMPLETED|Overall Study||6
26014|NCT01999231|62305|P3|COMPLETED|Overall Study||6
26015|NCT01999231|62306|P2|COMPLETED|Overall Study||6
26016|NCT01999231|62307|P1|COMPLETED|Overall Study||6
26017|NCT01999231|62304|P4|STARTED|Overall Study||6
26018|NCT01999231|62305|P3|STARTED|Overall Study||6
26019|NCT01999231|62306|P2|STARTED|Overall Study||6
26020|NCT01999231|62307|P1|STARTED|Overall Study||6
26021|NCT01999192|62341|P4|NOT COMPLETED|Extension Phase||0
26022|NCT01999192|62342|P3|NOT COMPLETED|Extension Phase||24
26023|NCT01999192|62343|P2|NOT COMPLETED|Extension Phase||18
26024|NCT01999192|62344|P1|NOT COMPLETED|Extension Phase||13
26025|NCT01999192|62341|P4|COMPLETED|Extension Phase||0
26026|NCT01999192|62342|P3|COMPLETED|Extension Phase||44
26027|NCT01999192|62343|P2|COMPLETED|Extension Phase||38
26028|NCT01999192|62344|P1|COMPLETED|Extension Phase||41
26029|NCT01999192|62341|P4|STARTED|Extension Phase|No Placebo arm for Extension Phase, all patients terminated or were switched to tregalizumab Groups.|0
26030|NCT01999192|62342|P3|STARTED|Extension Phase|Some patients terminated after Main Phase 2.|68
26031|NCT01999192|62343|P2|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|56
26032|NCT01999192|62344|P1|STARTED|Extension Phase|Some patients terminated or were switched to higher dose Level after Main Phase 2.|54
26033|NCT01999192|62341|P4|NOT COMPLETED|Main Phase II||1
26034|NCT01999192|62342|P3|NOT COMPLETED|Main Phase II||22
26035|NCT01999192|62343|P2|NOT COMPLETED|Main Phase II||9
26036|NCT01999192|62344|P1|NOT COMPLETED|Main Phase II||9
26037|NCT01999192|62341|P4|COMPLETED|Main Phase II||43
26038|NCT01999192|62342|P3|COMPLETED|Main Phase II||76
26039|NCT01999192|62343|P2|COMPLETED|Main Phase II||66
26040|NCT01999192|62344|P1|COMPLETED|Main Phase II||55
26041|NCT01999192|62341|P4|STARTED|Main Phase II|non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched|44
26042|NCT01999192|62342|P3|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|98
26043|NCT01999192|62343|P2|STARTED|Main Phase II|started Patient = completed patients + switched patients (non-responder) from other arms.|75
26044|NCT01999192|62344|P1|STARTED|Main Phase II|Non-responders were switched to higher dose Level after Main Phase 1, started = completed -switched.|64
26045|NCT01999192|62341|P4|NOT COMPLETED|Main Phase I||8
26046|NCT01999192|62342|P3|NOT COMPLETED|Main Phase I||8
26047|NCT01999192|62343|P2|NOT COMPLETED|Main Phase I||10
26048|NCT01999192|62344|P1|NOT COMPLETED|Main Phase I||11
26049|NCT01999192|62341|P4|COMPLETED|Main Phase I||72
26050|NCT01999192|62342|P3|COMPLETED|Main Phase I||70
26051|NCT01999192|62343|P2|COMPLETED|Main Phase I||70
26052|NCT01999192|62344|P1|COMPLETED|Main Phase I||72
26053|NCT01999192|62341|P4|STARTED|Main Phase I||80
26054|NCT01999192|62342|P3|STARTED|Main Phase I||78
26055|NCT01999192|62343|P2|STARTED|Main Phase I||80
26056|NCT01999192|62344|P1|STARTED|Main Phase I||83
26057|NCT01998919|62356|P2|NOT COMPLETED|Overall Study||35
26058|NCT01998919|62357|P1|NOT COMPLETED|Overall Study||42
26059|NCT01998919|62356|P2|COMPLETED|Overall Study||39
26060|NCT01998919|62357|P1|COMPLETED|Overall Study||37
26061|NCT01998919|62356|P2|Randomized|Overall Study|One participant withdrew consent prior to 1st dose and was excluded from safety analysis population.|76
26062|NCT01998919|62357|P1|Randomized|Overall Study|1 participant randomized to erlotinib didn't receive study drug; analyzed in placebo for safety|78
26063|NCT01998919|62356|P2|STARTED|Overall Study||74
26064|NCT01998919|62357|P1|STARTED|Overall Study||79
26065|NCT01998906|62378|P3|NOT COMPLETED|Overall Study||98
26066|NCT01998906|62379|P2|NOT COMPLETED|Overall Study||114
26067|NCT01998906|62380|P1|NOT COMPLETED|Overall Study||114
26068|NCT01998906|62378|P3|COMPLETED|Overall Study||1
26069|NCT01998906|62379|P2|COMPLETED|Overall Study||2
26070|NCT01998906|62380|P1|COMPLETED|Overall Study||1
26071|NCT01998906|62378|P3|STARTED|Overall Study||99
26072|NCT01998906|62379|P2|STARTED|Overall Study||116
26073|NCT01998906|62380|P1|STARTED|Overall Study||115
26074|NCT01998893|62424|P1|NOT COMPLETED|Overall Study||17
26075|NCT01998893|62424|P1|COMPLETED|Overall Study||21
26076|NCT01998893|62424|P1|2nd Treatment Cycle Completed Until PD|Overall Study||3
26077|NCT01998893|62424|P1|2nd Treatment Cycle Started|Overall Study||5
26078|NCT01998893|62424|P1|1st Treatment Cycle Completed Until PD|Overall Study|Progressive disease (PD)|30
26079|NCT01998893|62424|P1|STARTED|Overall Study||38
26080|NCT01998880|62436|P2|NOT COMPLETED|Overall Study||40
26081|NCT01998880|62437|P1|NOT COMPLETED|Overall Study||29
26082|NCT01998880|62436|P2|COMPLETED|Overall Study||78
26083|NCT01998880|62437|P1|COMPLETED|Overall Study|Completed=Completed treatment.|204
26084|NCT01998880|62436|P2|Received Study Drug|Overall Study||116
26085|NCT01998880|62437|P1|Received Study Drug|Overall Study||230
26086|NCT01998880|62436|P2|STARTED|Overall Study||118
26087|NCT01998880|62437|P1|STARTED|Overall Study||233
26088|NCT01998737|62455|P2|NOT COMPLETED|Overall Study||0
26089|NCT01998737|62456|P1|NOT COMPLETED|Overall Study||23
26090|NCT01998737|62455|P2|COMPLETED|Overall Study||100
26091|NCT01998737|62456|P1|COMPLETED|Overall Study||888
26092|NCT01998737|62455|P2|STARTED|Overall Study||100
26093|NCT01998737|62456|P1|STARTED|Overall Study||911
26094|NCT01998581|62468|P2|NOT COMPLETED|Overall Study||12
26095|NCT01998581|62469|P1|NOT COMPLETED|Overall Study||46
26096|NCT01998581|62468|P2|COMPLETED|Overall Study||44
26097|NCT01998581|62469|P1|COMPLETED|Overall Study||123
26098|NCT01998581|62468|P2|STARTED|Overall Study||56
26099|NCT01998581|62469|P1|STARTED|Overall Study||169
26100|NCT01998477|62481|P2|NOT COMPLETED|Overall Study||5
26101|NCT01998477|62482|P1|NOT COMPLETED|Overall Study||10
26102|NCT01998477|62481|P2|COMPLETED|Overall Study||143
26103|NCT01998477|62482|P1|COMPLETED|Overall Study||272
26104|NCT01998477|62481|P2|STARTED|Overall Study||148
26105|NCT01998477|62482|P1|STARTED|Overall Study||282
26106|NCT01998438|62516|P3|NOT COMPLETED|Overall Study||0
26107|NCT01998438|62517|P2|NOT COMPLETED|Overall Study||0
26108|NCT01998438|62518|P1|NOT COMPLETED|Overall Study||0
26109|NCT01998438|62516|P3|COMPLETED|Overall Study||318
26110|NCT01998438|62517|P2|COMPLETED|Overall Study||318
26111|NCT01998438|62518|P1|COMPLETED|Overall Study||319
26112|NCT01998438|62516|P3|STARTED|Overall Study||318
26113|NCT01998438|62517|P2|STARTED|Overall Study||318
26114|NCT01998438|62518|P1|STARTED|Overall Study||319
26115|NCT01998399|62528|P2|NOT COMPLETED|Overall Study||9
26116|NCT01998399|62529|P1|NOT COMPLETED|Overall Study||8
26117|NCT01998399|62528|P2|COMPLETED|Overall Study||4
26118|NCT01998399|62529|P1|COMPLETED|Overall Study||4
26119|NCT01998399|62528|P2|STARTED|Overall Study||13
26120|NCT01998399|62529|P1|STARTED|Overall Study||12
26121|NCT01998360|62537|P2|NOT COMPLETED|Overall Study||0
26122|NCT01998360|62538|P1|NOT COMPLETED|Overall Study||0
26123|NCT01998360|62537|P2|COMPLETED|Overall Study||50
26124|NCT01998360|62538|P1|COMPLETED|Overall Study||50
26125|NCT01998360|62537|P2|STARTED|Overall Study||50
26126|NCT01998360|62538|P1|STARTED|Overall Study||50
26127|NCT01998269|62552|P1|NOT COMPLETED|Overall Study||0
26128|NCT01998269|62552|P1|COMPLETED|Overall Study||193
26129|NCT01998269|62552|P1|STARTED|Overall Study||193
26130|NCT01997905|62556|P1|NOT COMPLETED|Overall Study||3
26131|NCT01997905|62556|P1|COMPLETED|Overall Study||10
26132|NCT01997905|62556|P1|Baseline Completed|Overall Study||11
26133|NCT01997905|62556|P1|STARTED|Overall Study||13
26134|NCT01997892|62565|P1|NOT COMPLETED|Overall Study||68
26135|NCT01997892|62565|P1|COMPLETED|Overall Study||959
26136|NCT01997892|62565|P1|Received Darbepoetin Alfa|Overall Study||987
26137|NCT01997892|62565|P1|STARTED|Overall Study||1027
26138|NCT01997723|62577|P1|NOT COMPLETED|Overall Study||0
26139|NCT01997723|62577|P1|COMPLETED|Overall Study||75
26140|NCT01997723|62577|P1|STARTED|Overall Study||75
26141|NCT01997567|62585|P2|NOT COMPLETED|Overall Study||0
26142|NCT01997567|62586|P1|NOT COMPLETED|Overall Study||0
26143|NCT01997567|62585|P2|COMPLETED|Overall Study||0
26144|NCT01997567|62586|P1|COMPLETED|Overall Study||0
26145|NCT01997567|62585|P2|STARTED|Overall Study||0
26146|NCT01997567|62586|P1|STARTED|Overall Study||0
26147|NCT01997437|62592|P1|NOT COMPLETED|Overall Study||0
26148|NCT01997437|62592|P1|COMPLETED|Overall Study||6
26149|NCT01997437|62592|P1|STARTED|Overall Study||6
26150|NCT01997411|62604|P8|NOT COMPLETED|Overall Study||0
26151|NCT01997411|62605|P7|NOT COMPLETED|Overall Study||0
26152|NCT01997411|62606|P6|NOT COMPLETED|Overall Study||1
26153|NCT01997411|62607|P5|NOT COMPLETED|Overall Study||0
26154|NCT01997411|62608|P4|NOT COMPLETED|Overall Study||0
26155|NCT01997411|62609|P3|NOT COMPLETED|Overall Study||0
26156|NCT01997411|62610|P2|NOT COMPLETED|Overall Study||0
26157|NCT01997411|62611|P1|NOT COMPLETED|Overall Study||0
26158|NCT01997411|62604|P8|COMPLETED|Overall Study||6
26159|NCT01997411|62605|P7|COMPLETED|Overall Study||6
26160|NCT01997411|62606|P6|COMPLETED|Overall Study||5
26161|NCT01997411|62607|P5|COMPLETED|Overall Study||6
26162|NCT01997411|62608|P4|COMPLETED|Overall Study||6
26163|NCT01997411|62609|P3|COMPLETED|Overall Study||6
26164|NCT01997411|62610|P2|COMPLETED|Overall Study||6
26165|NCT01997411|62611|P1|COMPLETED|Overall Study||6
26166|NCT01997411|62604|P8|STARTED|Overall Study||6
26167|NCT01997411|62605|P7|STARTED|Overall Study||6
26168|NCT01997411|62606|P6|STARTED|Overall Study||6
26169|NCT01997411|62607|P5|STARTED|Overall Study||6
26170|NCT01997411|62608|P4|STARTED|Overall Study||6
26171|NCT01997411|62609|P3|STARTED|Overall Study||6
26172|NCT01997411|62610|P2|STARTED|Overall Study||6
26173|NCT01997411|62611|P1|STARTED|Overall Study||6
26174|NCT01997398|62701|P1|NOT COMPLETED|Overall Study||1
26175|NCT01997398|62701|P1|COMPLETED|Overall Study|One patient took PD meds 3 hours prior to 6 mo. UPDRS testing and was excluded from the analysis.|34
26176|NCT01997398|62701|P1|STARTED|Overall Study||35
26177|NCT01997216|62710|P2|NOT COMPLETED|Second 9 Hours||0
26178|NCT01997216|62711|P1|NOT COMPLETED|Second 9 Hours||0
26179|NCT01997216|62710|P2|COMPLETED|Second 9 Hours||21
26180|NCT01997216|62711|P1|COMPLETED|Second 9 Hours||19
26181|NCT01997216|62710|P2|STARTED|Second 9 Hours||21
26277|NCT01995357|62852|P2|NOT COMPLETED|Period 4||0
26182|NCT01997216|62711|P1|STARTED|Second 9 Hours|One participant was not exposed to Pair 1 due to product unavailability, but was exposed to Pair 2.|19
26183|NCT01997216|62710|P2|NOT COMPLETED|First 9 Hours||0
26184|NCT01997216|62711|P1|NOT COMPLETED|First 9 Hours||0
26185|NCT01997216|62710|P2|COMPLETED|First 9 Hours||21
26186|NCT01997216|62711|P1|COMPLETED|First 9 Hours||18
26187|NCT01997216|62710|P2|STARTED|First 9 Hours||21
26188|NCT01997216|62711|P1|STARTED|First 9 Hours||18
26189|NCT01996904|62723|P2|NOT COMPLETED|Overall Study||27
26190|NCT01996904|62724|P1|NOT COMPLETED|Overall Study||38
26191|NCT01996904|62723|P2|COMPLETED|Overall Study||90
26192|NCT01996904|62724|P1|COMPLETED|Overall Study||101
26193|NCT01996904|62723|P2|STARTED|Overall Study||117
26194|NCT01996904|62724|P1|STARTED|Overall Study||139
26195|NCT01996813|62730|P1|NOT COMPLETED|Overall Study||0
26196|NCT01996813|62730|P1|COMPLETED|Overall Study||23
26197|NCT01996813|62730|P1|STARTED|Overall Study||23
26198|NCT01996748|62737|P2|NOT COMPLETED|Overall Study||6
26199|NCT01996748|62738|P1|NOT COMPLETED|Overall Study||8
26200|NCT01996748|62737|P2|COMPLETED|Overall Study||63
26201|NCT01996748|62738|P1|COMPLETED|Overall Study||58
26202|NCT01996748|62737|P2|STARTED|Overall Study||69
26203|NCT01996748|62738|P1|STARTED|Overall Study||66
26204|NCT01996709|62752|P2|NOT COMPLETED|Overall Study||1
26205|NCT01996709|62753|P1|NOT COMPLETED|Overall Study||5
26206|NCT01996709|62752|P2|COMPLETED|Overall Study||67
26207|NCT01996709|62753|P1|COMPLETED|Overall Study||61
26208|NCT01996709|62752|P2|STARTED|Overall Study||68
26209|NCT01996709|62753|P1|STARTED|Overall Study||66
26210|NCT01996657|62770|P3|NOT COMPLETED|Overall Study||14
26211|NCT01996657|62771|P2|NOT COMPLETED|Overall Study||11
26212|NCT01996657|62772|P1|NOT COMPLETED|Overall Study||13
26213|NCT01996657|62770|P3|COMPLETED|Overall Study||234
26214|NCT01996657|62771|P2|COMPLETED|Overall Study||239
26215|NCT01996657|62772|P1|COMPLETED|Overall Study||237
26216|NCT01996657|62770|P3|STARTED|Overall Study||248
26217|NCT01996657|62771|P2|STARTED|Overall Study||250
26218|NCT01996657|62772|P1|STARTED|Overall Study||250
26219|NCT01996410|62794|P8|NOT COMPLETED|Overall Study||0
26220|NCT01996410|62795|P7|NOT COMPLETED|Overall Study||0
26221|NCT01996410|62796|P6|NOT COMPLETED|Overall Study||0
26222|NCT01996410|62797|P5|NOT COMPLETED|Overall Study||0
26223|NCT01996410|62798|P4|NOT COMPLETED|Overall Study||0
26224|NCT01996410|62799|P3|NOT COMPLETED|Overall Study||0
26225|NCT01996410|62800|P2|NOT COMPLETED|Overall Study||0
26226|NCT01996410|62801|P1|NOT COMPLETED|Overall Study||0
26227|NCT01996410|62794|P8|COMPLETED|Overall Study||0
26228|NCT01996410|62795|P7|COMPLETED|Overall Study||0
26229|NCT01996410|62796|P6|COMPLETED|Overall Study||2
26230|NCT01996410|62797|P5|COMPLETED|Overall Study||2
26231|NCT01996410|62798|P4|COMPLETED|Overall Study||0
26232|NCT01996410|62799|P3|COMPLETED|Overall Study||0
26233|NCT01996410|62800|P2|COMPLETED|Overall Study||3
26234|NCT01996410|62801|P1|COMPLETED|Overall Study||3
26235|NCT01996410|62794|P8|STARTED|Overall Study||0
26236|NCT01996410|62795|P7|STARTED|Overall Study||0
26237|NCT01996410|62796|P6|STARTED|Overall Study||2
26238|NCT01996410|62797|P5|STARTED|Overall Study||2
26239|NCT01996410|62798|P4|STARTED|Overall Study||0
26240|NCT01996410|62799|P3|STARTED|Overall Study||0
26241|NCT01996410|62800|P2|STARTED|Overall Study||3
26242|NCT01996410|62801|P1|STARTED|Overall Study||3
26243|NCT01996332|62813|P1|NOT COMPLETED|Overall Study||1805
26244|NCT01996332|62813|P1|COMPLETED|Overall Study||0
26245|NCT01996332|62813|P1|STARTED|Overall Study||1805
26246|NCT01996319|62821|P2|NOT COMPLETED|Overall Study||3
26247|NCT01996319|62822|P1|NOT COMPLETED|Overall Study||8
26248|NCT01996319|62821|P2|COMPLETED|Overall Study||95
26249|NCT01996319|62822|P1|COMPLETED|Overall Study||88
26250|NCT01996319|62821|P2|STARTED|Overall Study||98
26251|NCT01996319|62822|P1|STARTED|Overall Study||96
26252|NCT01995461|62842|P1|NOT COMPLETED|Overall Study||5
26253|NCT01995461|62842|P1|COMPLETED|Overall Study||21
26254|NCT01995461|62842|P1|STARTED|Overall Study||26
26255|NCT01995357|62848|P6|NOT COMPLETED|Period 5||0
26256|NCT01995357|62849|P5|NOT COMPLETED|Period 5||0
26257|NCT01995357|62850|P4|NOT COMPLETED|Period 5||0
26258|NCT01995357|62851|P3|NOT COMPLETED|Period 5||1
26259|NCT01995357|62852|P2|NOT COMPLETED|Period 5||0
26260|NCT01995357|62853|P1|NOT COMPLETED|Period 5||2
26261|NCT01995357|62848|P6|COMPLETED|Period 5||4
26262|NCT01995357|62849|P5|COMPLETED|Period 5||4
26263|NCT01995357|62850|P4|COMPLETED|Period 5||3
26264|NCT01995357|62851|P3|COMPLETED|Period 5||3
26265|NCT01995357|62852|P2|COMPLETED|Period 5||3
26266|NCT01995357|62853|P1|COMPLETED|Period 5||2
26267|NCT01995357|62848|P6|STARTED|Period 5||4
26268|NCT01995357|62849|P5|STARTED|Period 5|1 subject terminated due to an adverse event. Subject counted as completed as some B products tested|4
26269|NCT01995357|62850|P4|STARTED|Period 5||3
26270|NCT01995357|62851|P3|STARTED|Period 5||4
26271|NCT01995357|62852|P2|STARTED|Period 5||3
26272|NCT01995357|62853|P1|STARTED|Period 5|The two discontinued subjects tested zero planned B products in period 5.|4
26273|NCT01995357|62848|P6|NOT COMPLETED|Period 4||0
26274|NCT01995357|62849|P5|NOT COMPLETED|Period 4||0
26275|NCT01995357|62850|P4|NOT COMPLETED|Period 4||0
26276|NCT01995357|62851|P3|NOT COMPLETED|Period 4||0
26278|NCT01995357|62853|P1|NOT COMPLETED|Period 4||0
26279|NCT01995357|62848|P6|COMPLETED|Period 4||4
26280|NCT01995357|62849|P5|COMPLETED|Period 4||4
26281|NCT01995357|62850|P4|COMPLETED|Period 4||3
26282|NCT01995357|62851|P3|COMPLETED|Period 4||4
26283|NCT01995357|62852|P2|COMPLETED|Period 4||3
26284|NCT01995357|62853|P1|COMPLETED|Period 4||4
26285|NCT01995357|62848|P6|STARTED|Period 4||4
26286|NCT01995357|62849|P5|STARTED|Period 4||4
26287|NCT01995357|62850|P4|STARTED|Period 4||3
26288|NCT01995357|62851|P3|STARTED|Period 4|The subject who did not complete period 5, erroneously used product A when B should have been used.|4
26289|NCT01995357|62852|P2|STARTED|Period 4||3
26290|NCT01995357|62853|P1|STARTED|Period 4||4
26291|NCT01995357|62848|P6|NOT COMPLETED|Period 3||0
26292|NCT01995357|62849|P5|NOT COMPLETED|Period 3||0
26293|NCT01995357|62850|P4|NOT COMPLETED|Period 3||0
26294|NCT01995357|62851|P3|NOT COMPLETED|Period 3||0
26295|NCT01995357|62852|P2|NOT COMPLETED|Period 3||0
26296|NCT01995357|62853|P1|NOT COMPLETED|Period 3||0
26297|NCT01995357|62848|P6|COMPLETED|Period 3||4
26298|NCT01995357|62849|P5|COMPLETED|Period 3||4
26299|NCT01995357|62850|P4|COMPLETED|Period 3||3
26300|NCT01995357|62851|P3|COMPLETED|Period 3||4
26301|NCT01995357|62852|P2|COMPLETED|Period 3||3
26302|NCT01995357|62853|P1|COMPLETED|Period 3||4
26303|NCT01995357|62848|P6|STARTED|Period 3||4
26304|NCT01995357|62849|P5|STARTED|Period 3||4
26305|NCT01995357|62850|P4|STARTED|Period 3||3
26306|NCT01995357|62851|P3|STARTED|Period 3||4
26307|NCT01995357|62852|P2|STARTED|Period 3||3
26308|NCT01995357|62853|P1|STARTED|Period 3||4
26309|NCT01995357|62848|P6|NOT COMPLETED|Period 2||0
26310|NCT01995357|62849|P5|NOT COMPLETED|Period 2||0
26311|NCT01995357|62850|P4|NOT COMPLETED|Period 2||0
26312|NCT01995357|62851|P3|NOT COMPLETED|Period 2||0
26313|NCT01995357|62852|P2|NOT COMPLETED|Period 2||0
26314|NCT01995357|62853|P1|NOT COMPLETED|Period 2||0
26315|NCT01995357|62848|P6|COMPLETED|Period 2||4
26316|NCT01995357|62849|P5|COMPLETED|Period 2||4
26317|NCT01995357|62850|P4|COMPLETED|Period 2||3
26318|NCT01995357|62851|P3|COMPLETED|Period 2||4
26319|NCT01995357|62852|P2|COMPLETED|Period 2||3
26320|NCT01995357|62853|P1|COMPLETED|Period 2||4
26321|NCT01995357|62848|P6|STARTED|Period 2||4
26322|NCT01995357|62849|P5|STARTED|Period 2||4
26323|NCT01995357|62850|P4|STARTED|Period 2||3
26324|NCT01995357|62851|P3|STARTED|Period 2||4
26325|NCT01995357|62852|P2|STARTED|Period 2||3
26326|NCT01995357|62853|P1|STARTED|Period 2||4
26327|NCT01995357|62848|P6|NOT COMPLETED|Period 1||0
26328|NCT01995357|62849|P5|NOT COMPLETED|Period 1||0
26329|NCT01995357|62850|P4|NOT COMPLETED|Period 1||0
26330|NCT01995357|62851|P3|NOT COMPLETED|Period 1||0
26331|NCT01995357|62852|P2|NOT COMPLETED|Period 1||0
26332|NCT01995357|62853|P1|NOT COMPLETED|Period 1||0
26333|NCT01995357|62848|P6|COMPLETED|Period 1||4
26334|NCT01995357|62849|P5|COMPLETED|Period 1||4
26335|NCT01995357|62850|P4|COMPLETED|Period 1||3
26336|NCT01995357|62851|P3|COMPLETED|Period 1||4
26337|NCT01995357|62852|P2|COMPLETED|Period 1||3
26338|NCT01995357|62853|P1|COMPLETED|Period 1||4
26339|NCT01995357|62848|P6|STARTED|Period 1||4
26340|NCT01995357|62849|P5|STARTED|Period 1||4
26341|NCT01995357|62850|P4|STARTED|Period 1||3
26342|NCT01995357|62851|P3|STARTED|Period 1||4
26343|NCT01995357|62852|P2|STARTED|Period 1||3
26344|NCT01995357|62853|P1|STARTED|Period 1||4
26345|NCT01995136|62869|P1|NOT COMPLETED|Overall Study||1
26346|NCT01995136|62869|P1|COMPLETED|Overall Study||31
26347|NCT01995136|62869|P1|STARTED|Overall Study||32
26348|NCT01995045|62875|P2|NOT COMPLETED|Overall Study||0
26349|NCT01995045|62876|P1|NOT COMPLETED|Overall Study||0
26350|NCT01995045|62875|P2|COMPLETED|Overall Study||28
26351|NCT01995045|62876|P1|COMPLETED|Overall Study||29
26352|NCT01995045|62875|P2|STARTED|Overall Study||28
26353|NCT01995045|62876|P1|STARTED|Overall Study||29
26354|NCT01994902|62888|P2|NOT COMPLETED|Test Period 2||6
26355|NCT01994902|62889|P1|NOT COMPLETED|Test Period 2||0
26356|NCT01994902|62888|P2|COMPLETED|Test Period 2||55
26357|NCT01994902|62889|P1|COMPLETED|Test Period 2||57
26358|NCT01994902|62888|P2|STARTED|Test Period 2||61
26359|NCT01994902|62889|P1|STARTED|Test Period 2||57
26360|NCT01994902|62888|P2|NOT COMPLETED|Test Period 1||3
26361|NCT01994902|62889|P1|NOT COMPLETED|Test Period 1||6
26362|NCT01994902|62888|P2|COMPLETED|Test Period 1|The subject testing Coloplast test product discontinued due to device deficiency with adverse event|61
26363|NCT01994902|62889|P1|COMPLETED|Test Period 1||57
26364|NCT01994902|62888|P2|STARTED|Test Period 1|Randomisation mistake:a subject randomised to SenSura Convex Light but tested Coloplast test product|64
26365|NCT01994902|62889|P1|STARTED|Test Period 1||63
26366|NCT01994876|62895|P2|NOT COMPLETED|Test Period 2||1
26367|NCT01994876|62896|P1|NOT COMPLETED|Test Period 2||1
26368|NCT01994876|62895|P2|COMPLETED|Test Period 2||6
26369|NCT01994876|62896|P1|COMPLETED|Test Period 2||8
26370|NCT01994876|62895|P2|STARTED|Test Period 2||7
26371|NCT01994876|62896|P1|STARTED|Test Period 2||9
26372|NCT01994876|62895|P2|NOT COMPLETED|Test Period 1||2
26373|NCT01994876|62896|P1|NOT COMPLETED|Test Period 1||0
26374|NCT01994876|62895|P2|COMPLETED|Test Period 1||7
26375|NCT01994876|62896|P1|COMPLETED|Test Period 1||9
26376|NCT01994876|62895|P2|STARTED|Test Period 1||9
26377|NCT01994876|62896|P1|STARTED|Test Period 1||9
26378|NCT01994876|62895|P2|NOT COMPLETED|Baseline - Own Product||0
26379|NCT01994876|62896|P1|NOT COMPLETED|Baseline - Own Product||0
26380|NCT01994876|62895|P2|COMPLETED|Baseline - Own Product||9
26381|NCT01994876|62896|P1|COMPLETED|Baseline - Own Product||9
26382|NCT01994876|62895|P2|STARTED|Baseline - Own Product||9
26383|NCT01994876|62896|P1|STARTED|Baseline - Own Product||9
26384|NCT01994863|62904|P2|NOT COMPLETED|Period 2||4
26385|NCT01994863|62905|P1|NOT COMPLETED|Period 2||1
26386|NCT01994863|62904|P2|COMPLETED|Period 2||5
26387|NCT01994863|62905|P1|COMPLETED|Period 2||7
26388|NCT01994863|62904|P2|STARTED|Period 2||9
26389|NCT01994863|62905|P1|STARTED|Period 2||8
26390|NCT01994863|62904|P2|NOT COMPLETED|Period 1||3
26391|NCT01994863|62905|P1|NOT COMPLETED|Period 1||7
26392|NCT01994863|62904|P2|COMPLETED|Period 1||9
26393|NCT01994863|62905|P1|COMPLETED|Period 1||4
26394|NCT01994863|62904|P2|STARTED|Period 1||12
26395|NCT01994863|62905|P1|STARTED|Period 1||11
26396|NCT01994785|62915|P4|NOT COMPLETED|Overall Study||3
26397|NCT01994785|62916|P3|NOT COMPLETED|Overall Study||0
26398|NCT01994785|62917|P2|NOT COMPLETED|Overall Study||1
26399|NCT01994785|62918|P1|NOT COMPLETED|Overall Study||8
26400|NCT01994785|62915|P4|COMPLETED|Overall Study||114
26401|NCT01994785|62916|P3|COMPLETED|Overall Study||117
26402|NCT01994785|62917|P2|COMPLETED|Overall Study||108
26403|NCT01994785|62918|P1|COMPLETED|Overall Study||101
26404|NCT01994785|62915|P4|STARTED|Overall Study||117
26405|NCT01994785|62916|P3|STARTED|Overall Study||117
26406|NCT01994785|62917|P2|STARTED|Overall Study||109
26407|NCT01994785|62918|P1|STARTED|Overall Study||109
26408|NCT01994746|62928|P2|NOT COMPLETED|Second Visit||0
26409|NCT01994746|62929|P1|NOT COMPLETED|Second Visit||0
26410|NCT01994746|62928|P2|COMPLETED|Second Visit||38
26411|NCT01994746|62929|P1|COMPLETED|Second Visit|Safety population|38
26412|NCT01994746|62928|P2|Efficacy|Second Visit||38
26413|NCT01994746|62929|P1|Efficacy|Second Visit|Those who completed both visits were included in the efficacy population.|37
26414|NCT01994746|62928|P2|STARTED|Second Visit||38
26415|NCT01994746|62929|P1|STARTED|Second Visit|One participant requested to withdraw after completing the first dosing visit.|38
26416|NCT01994746|62928|P2|NOT COMPLETED|First Visit||0
26417|NCT01994746|62929|P1|NOT COMPLETED|First Visit||0
26418|NCT01994746|62928|P2|COMPLETED|First Visit||38
26419|NCT01994746|62929|P1|COMPLETED|First Visit|Safety population|39
26420|NCT01994746|62928|P2|Efficacy|First Visit||38
26421|NCT01994746|62929|P1|Efficacy|First Visit|Those who completed both visits were included in the efficacy population.|37
26422|NCT01994746|62928|P2|STARTED|First Visit||38
26423|NCT01994746|62929|P1|STARTED|First Visit||39
26424|NCT01994720|62937|P2|NOT COMPLETED|Overall Study||56
26425|NCT01994720|62938|P1|NOT COMPLETED|Overall Study||46
26426|NCT01994720|62937|P2|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6554
26427|NCT01994720|62938|P1|COMPLETED|Overall Study|Includes patients who did not withdraw informed consent prior to the Study Closure Visit|6543
26428|NCT01994720|62937|P2|STARTED|Overall Study||6610
26429|NCT01994720|62938|P1|STARTED|Overall Study||6589
26430|NCT01994629|62980|P2|NOT COMPLETED|Overall Study||3
26431|NCT01994629|62981|P1|NOT COMPLETED|Overall Study||1
26432|NCT01994629|62980|P2|COMPLETED|Overall Study||99
26433|NCT01994629|62981|P1|COMPLETED|Overall Study||99
26434|NCT01994629|62980|P2|STARTED|Overall Study||102
26435|NCT01994629|62981|P1|STARTED|Overall Study||100
26436|NCT01994486|63005|P1|NOT COMPLETED|Overall Study||0
26437|NCT01994486|63005|P1|COMPLETED|Overall Study||20
26438|NCT01994486|63005|P1|STARTED|Overall Study||20
26439|NCT01994291|63017|P3|NOT COMPLETED|Overall Study||9
26440|NCT01994291|63018|P2|NOT COMPLETED|Overall Study||7
26441|NCT01994291|63019|P1|NOT COMPLETED|Overall Study||15
26442|NCT01994291|63017|P3|COMPLETED|Overall Study||47
26443|NCT01994291|63018|P2|COMPLETED|Overall Study||36
26444|NCT01994291|63019|P1|COMPLETED|Overall Study||84
26445|NCT01994291|63017|P3|Received Treatment|Overall Study||56
26446|NCT01994291|63018|P2|Received Treatment|Overall Study||43
26447|NCT01994291|63019|P1|Received Treatment|Overall Study||99
26448|NCT01994291|63017|P3|STARTED|Overall Study||56
26449|NCT01994291|63018|P2|STARTED|Overall Study||43
26450|NCT01994291|63019|P1|STARTED|Overall Study||99
26451|NCT01993940|63075|P2|NOT COMPLETED|Overall Study||44
26452|NCT01993940|63076|P1|NOT COMPLETED|Overall Study||40
26453|NCT01993940|63075|P2|COMPLETED|Overall Study||232
26454|NCT01993940|63076|P1|COMPLETED|Overall Study||237
26455|NCT01993940|63075|P2|Received Treatment|Overall Study||276
26456|NCT01993940|63076|P1|Received Treatment|Overall Study||272
26457|NCT01993940|63075|P2|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|276
26458|NCT01993940|63076|P1|STARTED|Overall Study|Includes one participant who enrolled at two different sites|277
26459|NCT01993888|63092|P2|NOT COMPLETED|Overall Study||3
26460|NCT01993888|63093|P1|NOT COMPLETED|Overall Study||2
26461|NCT01993888|63092|P2|COMPLETED|Overall Study||49
26462|NCT01993888|63093|P1|COMPLETED|Overall Study||48
26463|NCT01993888|63092|P2|STARTED|Overall Study||52
26464|NCT01993888|63093|P1|STARTED|Overall Study||50
26465|NCT01993823|63111|P2|NOT COMPLETED|Overall Study||16
26466|NCT01993823|63112|P1|NOT COMPLETED|Overall Study||7
26467|NCT01993823|63111|P2|COMPLETED|Overall Study||79
26468|NCT01993823|63112|P1|COMPLETED|Overall Study||88
26469|NCT01993823|63111|P2|STARTED|Overall Study||95
26470|NCT01993823|63112|P1|STARTED|Overall Study||95
26471|NCT01993238|63120|P1|NOT COMPLETED|Overall Study||0
26472|NCT01993238|63120|P1|COMPLETED|Overall Study||11
26473|NCT01993238|63120|P1|STARTED|Overall Study||11
26474|NCT01993030|63127|P2|NOT COMPLETED|Overall Study||4
26475|NCT01993030|63128|P1|NOT COMPLETED|Overall Study||0
26476|NCT01993030|63127|P2|COMPLETED|Overall Study||31
26477|NCT01993030|63128|P1|COMPLETED|Overall Study||36
26478|NCT01993030|63127|P2|STARTED|Overall Study||35
26479|NCT01993030|63128|P1|STARTED|Overall Study||36
26480|NCT01992874|63142|P3|NOT COMPLETED|Part B||0
26481|NCT01992874|63143|P2|NOT COMPLETED|Part B||0
26482|NCT01992874|63144|P1|NOT COMPLETED|Part B||0
26483|NCT01992874|63142|P3|COMPLETED|Part B||38
26484|NCT01992874|63143|P2|COMPLETED|Part B||0
26485|NCT01992874|63144|P1|COMPLETED|Part B||0
26486|NCT01992874|63142|P3|STARTED|Part B||38
26487|NCT01992874|63143|P2|STARTED|Part B||0
26488|NCT01992874|63144|P1|STARTED|Part B||0
26489|NCT01992874|63142|P3|NOT COMPLETED|Part A||0
26490|NCT01992874|63143|P2|NOT COMPLETED|Part A||0
26491|NCT01992874|63144|P1|NOT COMPLETED|Part A||0
26492|NCT01992874|63142|P3|COMPLETED|Part A||0
26493|NCT01992874|63143|P2|COMPLETED|Part A||17
26494|NCT01992874|63144|P1|COMPLETED|Part A||21
26495|NCT01992874|63142|P3|STARTED|Part A||0
26496|NCT01992874|63143|P2|STARTED|Part A||17
26497|NCT01992874|63144|P1|STARTED|Part A||21
26498|NCT01992536|63182|P10|NOT COMPLETED|Overall Study||1
26499|NCT01992536|63183|P9|NOT COMPLETED|Overall Study||1
26500|NCT01992536|63184|P8|NOT COMPLETED|Overall Study||0
26501|NCT01992536|63185|P7|NOT COMPLETED|Overall Study||7
26502|NCT01992536|63186|P6|NOT COMPLETED|Overall Study||1
26503|NCT01992536|63187|P5|NOT COMPLETED|Overall Study||0
26504|NCT01992536|63188|P4|NOT COMPLETED|Overall Study||2
26505|NCT01992536|63189|P3|NOT COMPLETED|Overall Study||1
26506|NCT01992536|63190|P2|NOT COMPLETED|Overall Study||3
26507|NCT01992536|63191|P1|NOT COMPLETED|Overall Study||4
26508|NCT01992536|63182|P10|COMPLETED|Overall Study||18
26509|NCT01992536|63183|P9|COMPLETED|Overall Study||18
26510|NCT01992536|63184|P8|COMPLETED|Overall Study||21
26511|NCT01992536|63185|P7|COMPLETED|Overall Study||0
26512|NCT01992536|63186|P6|COMPLETED|Overall Study||20
26513|NCT01992536|63187|P5|COMPLETED|Overall Study||11
26514|NCT01992536|63188|P4|COMPLETED|Overall Study||22
26515|NCT01992536|63189|P3|COMPLETED|Overall Study||16
26516|NCT01992536|63190|P2|COMPLETED|Overall Study||22
26517|NCT01992536|63191|P1|COMPLETED|Overall Study||22
26518|NCT01992536|63182|P10|STARTED|Overall Study||19
26519|NCT01992536|63183|P9|STARTED|Overall Study||19
26520|NCT01992536|63184|P8|STARTED|Overall Study||21
26521|NCT01992536|63185|P7|STARTED|Overall Study||7
26522|NCT01992536|63186|P6|STARTED|Overall Study||21
26523|NCT01992536|63187|P5|STARTED|Overall Study||11
26524|NCT01992536|63188|P4|STARTED|Overall Study||24
26525|NCT01992536|63189|P3|STARTED|Overall Study||17
26526|NCT01992536|63190|P2|STARTED|Overall Study||25
26527|NCT01992536|63191|P1|STARTED|Overall Study||26
26528|NCT01992523|63408|P2|NOT COMPLETED|Overall Study||0
26529|NCT01992523|63409|P1|NOT COMPLETED|Overall Study||0
26530|NCT01992523|63408|P2|COMPLETED|Overall Study||41
26531|NCT01992523|63409|P1|COMPLETED|Overall Study||41
26532|NCT01992523|63408|P2|STARTED|Overall Study||41
26533|NCT01992523|63409|P1|STARTED|Overall Study||41
26534|NCT01992185|63423|P2|NOT COMPLETED|Overall Study||0
26535|NCT01992185|63424|P1|NOT COMPLETED|Overall Study||0
26536|NCT01992185|63423|P2|COMPLETED|Overall Study||8
26537|NCT01992185|63424|P1|COMPLETED|Overall Study||7
26538|NCT01992185|63423|P2|STARTED|Overall Study||8
26539|NCT01992185|63424|P1|STARTED|Overall Study||7
26540|NCT01992172|63432|P2|NOT COMPLETED|Overall Study||0
26541|NCT01992172|63433|P1|NOT COMPLETED|Overall Study||0
26542|NCT01992172|63432|P2|COMPLETED|Overall Study||0
26543|NCT01992172|63433|P1|COMPLETED|Overall Study||7
26544|NCT01992172|63432|P2|STARTED|Overall Study||0
26545|NCT01992172|63433|P1|STARTED|Overall Study||7
26546|NCT01992107|63442|P3|NOT COMPLETED|Overall Study||36
26547|NCT01992107|63443|P2|NOT COMPLETED|Overall Study||33
26548|NCT01992107|63444|P1|NOT COMPLETED|Overall Study||68
26549|NCT01992107|63442|P3|COMPLETED|Overall Study||545
26550|NCT01992107|63443|P2|COMPLETED|Overall Study||560
26551|NCT01992107|63444|P1|COMPLETED|Overall Study||1091
26552|NCT01992107|63442|P3|STARTED|Overall Study||581
26553|NCT01992107|63443|P2|STARTED|Overall Study||593
26554|NCT01992107|63444|P1|STARTED|Overall Study||1159
26555|NCT01992094|63500|P3|NOT COMPLETED|Overall Study||21
26556|NCT01992094|63501|P2|NOT COMPLETED|Overall Study||24
26557|NCT01992094|63502|P1|NOT COMPLETED|Overall Study||50
26558|NCT01992094|63500|P3|COMPLETED|Overall Study||648
26559|NCT01992094|63501|P2|COMPLETED|Overall Study||652
26560|NCT01992094|63502|P1|COMPLETED|Overall Study||1285
26561|NCT01992094|63500|P3|STARTED|Overall Study||669
26562|NCT01992094|63501|P2|STARTED|Overall Study||676
26563|NCT01992094|63502|P1|STARTED|Overall Study||1335
26564|NCT01991990|63560|P2|NOT COMPLETED|Overall Study||0
26565|NCT01991990|63561|P1|NOT COMPLETED|Overall Study||0
26566|NCT01991990|63560|P2|COMPLETED|Overall Study||12
26567|NCT01991990|63561|P1|COMPLETED|Overall Study||6
26568|NCT01991990|63560|P2|STARTED|Overall Study||12
26569|NCT01991990|63561|P1|STARTED|Overall Study||6
26570|NCT01991548|63601|P1|NOT COMPLETED|Overall Study||1
26571|NCT01991548|63601|P1|COMPLETED|Overall Study||39
26572|NCT01991548|63601|P1|STARTED|Overall Study||40
26573|NCT01991314|63607|P2|NOT COMPLETED|Overall Study||11
26574|NCT01991314|63608|P1|NOT COMPLETED|Overall Study||11
26575|NCT01991314|63607|P2|COMPLETED|Overall Study||32
26576|NCT01991314|63608|P1|COMPLETED|Overall Study||34
26577|NCT01991314|63607|P2|STARTED|Overall Study||43
26578|NCT01991314|63608|P1|STARTED|Overall Study||45
26579|NCT01990898|63626|P1|NOT COMPLETED|Overall Study||4
26580|NCT01990898|63626|P1|COMPLETED|Overall Study||22
26581|NCT01990898|63626|P1|3 Months|Overall Study||22
26582|NCT01990898|63626|P1|STARTED|Overall Study||26
26583|NCT01990859|63630|P1|NOT COMPLETED|90 Day Follow Up for All Participants||0
26584|NCT01990859|63630|P1|COMPLETED|90 Day Follow Up for All Participants||20
26585|NCT01990859|63630|P1|STARTED|90 Day Follow Up for All Participants|All entered into 90 day follow-up whether treatment and/or post dose follow up was completed or not.|20
26586|NCT01990859|63630|P1|NOT COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||17
26587|NCT01990859|63630|P1|COMPLETED|Week 12 to Week 24 Post Dosing Follow Up||3
26588|NCT01990859|63630|P1|STARTED|Week 12 to Week 24 Post Dosing Follow Up|All were entered into follow-up whether dosing was completed or not.|20
26589|NCT01990859|63630|P1|NOT COMPLETED|Treatment (4 Doses Over 12 Weeks)||5
26590|NCT01990859|63630|P1|COMPLETED|Treatment (4 Doses Over 12 Weeks)||15
26591|NCT01990859|63630|P1|STARTED|Treatment (4 Doses Over 12 Weeks)||20
26592|NCT01990794|63641|P1|NOT COMPLETED|Overall Study||3
26593|NCT01990794|63641|P1|COMPLETED|Overall Study||10
26594|NCT01990794|63641|P1|One Month Into Study|Overall Study||10
26595|NCT01990794|63641|P1|STARTED|Overall Study||13
26596|NCT01990703|63755|P2|NOT COMPLETED|Overall Study||45
26597|NCT01990703|63756|P1|NOT COMPLETED|Overall Study||39
26598|NCT01990703|63755|P2|COMPLETED|Overall Study||93
26599|NCT01990703|63756|P1|COMPLETED|Overall Study||108
26600|NCT01990703|63755|P2|STARTED|Overall Study||138
26601|NCT01990703|63756|P1|STARTED|Overall Study||147
26602|NCT01990677|63766|P2|NOT COMPLETED|Overall Study||1
26603|NCT01990677|63767|P1|NOT COMPLETED|Overall Study||2
26604|NCT01990677|63766|P2|COMPLETED|Overall Study||5
26605|NCT01990677|63767|P1|COMPLETED|Overall Study||10
26606|NCT01990677|63766|P2|STARTED|Overall Study||6
26607|NCT01990677|63767|P1|STARTED|Overall Study||12
26608|NCT01990664|63779|P2|NOT COMPLETED|Overall Study||11
26609|NCT01990664|63780|P1|NOT COMPLETED|Overall Study||7
26610|NCT01990664|63779|P2|COMPLETED|Overall Study||79
26611|NCT01990664|63780|P1|COMPLETED|Overall Study||95
26612|NCT01990664|63779|P2|STARTED|Overall Study||90
26613|NCT01990664|63780|P1|STARTED|Overall Study||102
26614|NCT01990534|63786|P1|NOT COMPLETED|Overall Study||60
26615|NCT01990534|63786|P1|COMPLETED|Overall Study||0
26616|NCT01990534|63786|P1|Ongoing|Overall Study||36
26617|NCT01990534|63786|P1|STARTED|Overall Study||60
26618|NCT01990339|63802|P1|NOT COMPLETED|Overall Study||2312
26619|NCT01990339|63802|P1|COMPLETED|Overall Study||12653
26620|NCT01990339|63802|P1|STARTED|Overall Study||14965
26621|NCT01990261|63807|P1|NOT COMPLETED|Overall Study||25
26622|NCT01990261|63807|P1|COMPLETED|Overall Study||8
26623|NCT01990261|63807|P1|Treated|Overall Study||29
26624|NCT01990261|63807|P1|STARTED|Overall Study||33
26625|NCT01989689|63819|P2|NOT COMPLETED|Treatment Period ( 3 Months)||0
26626|NCT01989689|63820|P1|NOT COMPLETED|Treatment Period ( 3 Months)||0
26627|NCT01989689|63819|P2|COMPLETED|Treatment Period ( 3 Months)||10
26628|NCT01989689|63820|P1|COMPLETED|Treatment Period ( 3 Months)||11
26629|NCT01989689|63819|P2|STARTED|Treatment Period ( 3 Months)||10
26630|NCT01989689|63820|P1|STARTED|Treatment Period ( 3 Months)||11
26631|NCT01989689|63819|P2|NOT COMPLETED|Treatment Period 1 ( 3 Months)||3
26632|NCT01989689|63820|P1|NOT COMPLETED|Treatment Period 1 ( 3 Months)||0
26633|NCT01989689|63819|P2|COMPLETED|Treatment Period 1 ( 3 Months)||10
26634|NCT01989689|63820|P1|COMPLETED|Treatment Period 1 ( 3 Months)||11
26635|NCT01989689|63819|P2|STARTED|Treatment Period 1 ( 3 Months)||13
26636|NCT01989689|63820|P1|STARTED|Treatment Period 1 ( 3 Months)||11
26637|NCT01989689|63819|P2|NOT COMPLETED|Baseline||0
26638|NCT01989689|63820|P1|NOT COMPLETED|Baseline||0
26639|NCT01989689|63819|P2|COMPLETED|Baseline||13
26640|NCT01989689|63820|P1|COMPLETED|Baseline||11
26641|NCT01989689|63819|P2|STARTED|Baseline||13
26642|NCT01989689|63820|P1|STARTED|Baseline||11
26643|NCT01989572|63836|P6|NOT COMPLETED|Overall Study||110
26644|NCT01989572|63837|P5|NOT COMPLETED|Overall Study||98
26645|NCT01989572|63838|P4|NOT COMPLETED|Overall Study||51
26646|NCT01989572|63839|P3|NOT COMPLETED|Overall Study||62
26647|NCT01989572|63840|P2|NOT COMPLETED|Overall Study||58
26648|NCT01989572|63841|P1|NOT COMPLETED|Overall Study||55
26649|NCT01989572|63836|P6|COMPLETED|Overall Study||79
26650|NCT01989572|63837|P5|COMPLETED|Overall Study||92
26651|NCT01989572|63838|P4|COMPLETED|Overall Study||56
26652|NCT01989572|63839|P3|COMPLETED|Overall Study||47
26653|NCT01989572|63840|P2|COMPLETED|Overall Study||53
26654|NCT01989572|63841|P1|COMPLETED|Overall Study||54
26655|NCT01989572|63836|P6|Treated|Overall Study||171
26656|NCT01989572|63837|P5|Treated|Overall Study||186
26657|NCT01989572|63838|P4|Treated|Overall Study||104
26658|NCT01989572|63839|P3|Treated|Overall Study||107
26659|NCT01989572|63840|P2|Treated|Overall Study||110
26660|NCT01989572|63841|P1|Treated|Overall Study||104
26661|NCT01989572|63836|P6|STARTED|Overall Study||189
26662|NCT01989572|63837|P5|STARTED|Overall Study||190
26663|NCT01989572|63838|P4|STARTED|Overall Study||107
26664|NCT01989572|63839|P3|STARTED|Overall Study||109
26665|NCT01989572|63840|P2|STARTED|Overall Study||111
26666|NCT01989572|63841|P1|STARTED|Overall Study||109
26667|NCT01989455|63874|P5|NOT COMPLETED|Overall Study||1
26668|NCT01989455|63875|P4|NOT COMPLETED|Overall Study||0
26669|NCT01989455|63876|P3|NOT COMPLETED|Overall Study||1
26670|NCT01989455|63877|P2|NOT COMPLETED|Overall Study||2
26671|NCT01989455|63878|P1|NOT COMPLETED|Overall Study||0
26672|NCT01989455|63874|P5|COMPLETED|Overall Study||7
26673|NCT01989455|63875|P4|COMPLETED|Overall Study||14
26674|NCT01989455|63876|P3|COMPLETED|Overall Study||13
26675|NCT01989455|63877|P2|COMPLETED|Overall Study||12
26676|NCT01989455|63878|P1|COMPLETED|Overall Study||14
26677|NCT01989455|63874|P5|STARTED|Overall Study||8
26678|NCT01989455|63875|P4|STARTED|Overall Study||14
26679|NCT01989455|63876|P3|STARTED|Overall Study||14
26680|NCT01989455|63877|P2|STARTED|Overall Study||14
26681|NCT01989455|63878|P1|STARTED|Overall Study||14
26682|NCT01989195|63912|P1|NOT COMPLETED|Overall Study||0
26683|NCT01989195|63912|P1|COMPLETED|Overall Study||6
26684|NCT01989195|63912|P1|STARTED|Overall Study||6
26685|NCT01989169|63922|P2|NOT COMPLETED|Period 2||1
26686|NCT01989169|63923|P1|NOT COMPLETED|Period 2||0
26687|NCT01989169|63922|P2|COMPLETED|Period 2||14
26688|NCT01989169|63923|P1|COMPLETED|Period 2||15
26689|NCT01989169|63922|P2|STARTED|Period 2||15
26690|NCT01989169|63923|P1|STARTED|Period 2||15
26691|NCT01989169|63922|P2|NOT COMPLETED|Period 1||0
26692|NCT01989169|63923|P1|NOT COMPLETED|Period 1||0
26693|NCT01989169|63922|P2|COMPLETED|Period 1||15
26694|NCT01989169|63923|P1|COMPLETED|Period 1||15
26695|NCT01989169|63922|P2|STARTED|Period 1||15
26696|NCT01989169|63923|P1|STARTED|Period 1||15
26697|NCT01989156|63936|P3|NOT COMPLETED|End of Study (Population at Day 90)||3
26698|NCT01989156|63937|P2|NOT COMPLETED|End of Study (Population at Day 90)||5
26699|NCT01989156|63938|P1|NOT COMPLETED|End of Study (Population at Day 90)||7
26700|NCT01989156|63936|P3|COMPLETED|End of Study (Population at Day 90)||31
26701|NCT01989156|63937|P2|COMPLETED|End of Study (Population at Day 90)||35
26702|NCT01989156|63938|P1|COMPLETED|End of Study (Population at Day 90)||73
26703|NCT01989156|63936|P3|STARTED|End of Study (Population at Day 90)||34
26704|NCT01989156|63937|P2|STARTED|End of Study (Population at Day 90)||40
26705|NCT01989156|63938|P1|STARTED|End of Study (Population at Day 90)||80
26706|NCT01989156|63936|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||5
26707|NCT01989156|63937|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
26708|NCT01989156|63938|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||0
26709|NCT01989156|63936|P3|COMPLETED|Confinement Period (Population at Day 5)||34
26710|NCT01989156|63937|P2|COMPLETED|Confinement Period (Population at Day 5)||40
26711|NCT01989156|63938|P1|COMPLETED|Confinement Period (Population at Day 5)||80
26712|NCT01989156|63936|P3|STARTED|Confinement Period (Population at Day 5)||39
26713|NCT01989156|63937|P2|STARTED|Confinement Period (Population at Day 5)||41
26714|NCT01989156|63938|P1|STARTED|Confinement Period (Population at Day 5)||80
26715|NCT01989130|63960|P2|NOT COMPLETED|Overall Study||0
26716|NCT01989130|63961|P1|NOT COMPLETED|Overall Study||0
26717|NCT01989130|63960|P2|COMPLETED|Overall Study||27
26718|NCT01989130|63961|P1|COMPLETED|Overall Study||43
26719|NCT01989130|63960|P2|STARTED|Overall Study||27
26720|NCT01989130|63961|P1|STARTED|Overall Study||43
26721|NCT01988857|63973|P1|NOT COMPLETED|Overall Study||0
26722|NCT01988857|63973|P1|COMPLETED|Overall Study||300
26723|NCT01988857|63973|P1|STARTED|Overall Study||300
26724|NCT01988662|63982|P2|NOT COMPLETED|Overall Study||2
26725|NCT01988662|63983|P1|NOT COMPLETED|Overall Study||4
26726|NCT01988662|63982|P2|COMPLETED|Overall Study||99
26727|NCT01988662|63983|P1|COMPLETED|Overall Study||100
26728|NCT01988662|63982|P2|STARTED|Overall Study||101
26729|NCT01988662|63983|P1|STARTED|Overall Study||104
26730|NCT01988415|64000|P1|NOT COMPLETED|Overall Study||0
26731|NCT01988415|64000|P1|COMPLETED|Overall Study||26
26732|NCT01988415|64000|P1|STARTED|Overall Study|52 eyes of 26 subjects (paired-eyes: commercial and investigational software)|26
26733|NCT01988402|64010|P2|NOT COMPLETED|Overall Study||2
26734|NCT01988402|64011|P1|NOT COMPLETED|Overall Study||2
26735|NCT01988402|64010|P2|COMPLETED|Overall Study||17
26736|NCT01988402|64011|P1|COMPLETED|Overall Study||14
26737|NCT01988402|64010|P2|STARTED|Overall Study||19
26738|NCT01988402|64011|P1|STARTED|Overall Study||16
26739|NCT01988129|64021|P2|NOT COMPLETED|Overall Study||0
26740|NCT01988129|64022|P1|NOT COMPLETED|Overall Study||0
26741|NCT01988129|64021|P2|COMPLETED|Overall Study||588
26742|NCT01988129|64022|P1|COMPLETED|Overall Study||601
26743|NCT01988129|64021|P2|Completed 1-year Follow-up Survey|Overall Study||4
26744|NCT01988129|64022|P1|Completed 1-year Follow-up Survey|Overall Study||100
26745|NCT01988129|64021|P2|Screened for Sleep Disorders|Overall Study||15
26746|NCT01988129|64022|P1|Screened for Sleep Disorders|Overall Study||416
26747|NCT01988129|64021|P2|Attended Education Session|Overall Study||18
26748|NCT01988129|64022|P1|Attended Education Session|Overall Study||542
26749|NCT01988129|64021|P2|STARTED|Overall Study|Control participant data obtained from department. Individuals were not enrolled.|588
26750|NCT01988129|64022|P1|STARTED|Overall Study|Intervention participant data obtained from department. Individuals not enrolled for primary aim.|601
26751|NCT01988012|64049|P1|NOT COMPLETED|Overall Study||15
26752|NCT01988012|64049|P1|COMPLETED|Overall Study||85
26753|NCT01988012|64049|P1|STARTED|Overall Study||100
26754|NCT01987986|64075|P4|NOT COMPLETED|Overall Study||0
26755|NCT01987986|64076|P3|NOT COMPLETED|Overall Study||2
26756|NCT01987986|64077|P2|NOT COMPLETED|Overall Study||0
26757|NCT01987986|64078|P1|NOT COMPLETED|Overall Study||2
26758|NCT01987986|64075|P4|COMPLETED|Overall Study||24
26759|NCT01987986|64076|P3|COMPLETED|Overall Study||38
26760|NCT01987986|64077|P2|COMPLETED|Overall Study||43
26761|NCT01987986|64078|P1|COMPLETED|Overall Study||41
26762|NCT01987986|64075|P4|STARTED|Overall Study||24
26763|NCT01987986|64076|P3|STARTED|Overall Study||40
26764|NCT01987986|64077|P2|STARTED|Overall Study||43
26765|NCT01987986|64078|P1|STARTED|Overall Study||43
26766|NCT01987960|64118|P4|NOT COMPLETED|Period 3||71
26767|NCT01987960|64119|P3|NOT COMPLETED|Period 3||0
26768|NCT01987960|64120|P2|NOT COMPLETED|Period 3||0
26769|NCT01987960|64121|P1|NOT COMPLETED|Period 3||0
26770|NCT01987960|64118|P4|COMPLETED|Period 3||119
26771|NCT01987960|64119|P3|COMPLETED|Period 3||0
26772|NCT01987960|64120|P2|COMPLETED|Period 3||0
26773|NCT01987960|64121|P1|COMPLETED|Period 3||0
26774|NCT01987960|64118|P4|STARTED|Period 3||190
26775|NCT01987960|64119|P3|STARTED|Period 3||0
26776|NCT01987960|64120|P2|STARTED|Period 3||0
26777|NCT01987960|64121|P1|STARTED|Period 3||0
26778|NCT01987960|64118|P4|NOT COMPLETED|Period 2||0
26779|NCT01987960|64119|P3|NOT COMPLETED|Period 2||9
26780|NCT01987960|64120|P2|NOT COMPLETED|Period 2||5
26781|NCT01987960|64121|P1|NOT COMPLETED|Period 2||0
26782|NCT01987960|64118|P4|COMPLETED|Period 2||0
26783|NCT01987960|64119|P3|COMPLETED|Period 2||14
26784|NCT01987960|64120|P2|COMPLETED|Period 2||12
26785|NCT01987960|64121|P1|COMPLETED|Period 2||0
26786|NCT01987960|64118|P4|STARTED|Period 2||0
26787|NCT01987960|64119|P3|STARTED|Period 2||23
26788|NCT01987960|64120|P2|STARTED|Period 2||17
26789|NCT01987960|64121|P1|STARTED|Period 2||0
26790|NCT01987960|64118|P4|NOT COMPLETED|Period 1||0
26791|NCT01987960|64119|P3|NOT COMPLETED|Period 1||0
26792|NCT01987960|64120|P2|NOT COMPLETED|Period 1||0
26793|NCT01987960|64121|P1|NOT COMPLETED|Period 1||186
26794|NCT01987960|64118|P4|COMPLETED|Period 1||0
26795|NCT01987960|64119|P3|COMPLETED|Period 1||0
26796|NCT01987960|64120|P2|COMPLETED|Period 1||0
26797|NCT01987960|64121|P1|COMPLETED|Period 1||231
26798|NCT01987960|64118|P4|STARTED|Period 1||0
26799|NCT01987960|64119|P3|STARTED|Period 1||0
26800|NCT01987960|64120|P2|STARTED|Period 1||0
26801|NCT01987960|64121|P1|STARTED|Period 1||417
26802|NCT01987908|64133|P3|NOT COMPLETED|Post-Treatment Observation Period||0
26803|NCT01987908|64134|P2|NOT COMPLETED|Post-Treatment Observation Period||3
26804|NCT01987908|64135|P1|NOT COMPLETED|Post-Treatment Observation Period||0
26805|NCT01987908|64133|P3|COMPLETED|Post-Treatment Observation Period||2
26806|NCT01987908|64134|P2|COMPLETED|Post-Treatment Observation Period||7
26807|NCT01987908|64135|P1|COMPLETED|Post-Treatment Observation Period||0
26808|NCT01987908|64133|P3|STARTED|Post-Treatment Observation Period||2
26809|NCT01987908|64134|P2|STARTED|Post-Treatment Observation Period||10
26810|NCT01987908|64135|P1|STARTED|Post-Treatment Observation Period||0
26811|NCT01987908|64133|P3|NOT COMPLETED|Treatment Period||1
26812|NCT01987908|64134|P2|NOT COMPLETED|Treatment Period||1
26813|NCT01987908|64135|P1|NOT COMPLETED|Treatment Period||0
26814|NCT01987908|64133|P3|COMPLETED|Treatment Period||2
26815|NCT01987908|64134|P2|COMPLETED|Treatment Period||10
26816|NCT01987908|64135|P1|COMPLETED|Treatment Period||0
26817|NCT01987908|64133|P3|STARTED|Treatment Period||3
26818|NCT01987908|64134|P2|STARTED|Treatment Period||11
26819|NCT01987908|64135|P1|STARTED|Treatment Period||0
26820|NCT01987908|64133|P3|NOT COMPLETED|Placebo Lead-in Period||0
26821|NCT01987908|64134|P2|NOT COMPLETED|Placebo Lead-in Period||0
26822|NCT01987908|64135|P1|NOT COMPLETED|Placebo Lead-in Period||9
26823|NCT01987908|64133|P3|COMPLETED|Placebo Lead-in Period||0
26824|NCT01987908|64134|P2|COMPLETED|Placebo Lead-in Period||0
26825|NCT01987908|64135|P1|COMPLETED|Placebo Lead-in Period||14
26826|NCT01987908|64133|P3|STARTED|Placebo Lead-in Period||0
26827|NCT01987908|64134|P2|STARTED|Placebo Lead-in Period||0
26828|NCT01987908|64135|P1|STARTED|Placebo Lead-in Period||23
26829|NCT01987765|64216|P1|NOT COMPLETED|Overall Study||102
26830|NCT01987765|64216|P1|COMPLETED|Overall Study||745
26831|NCT01987765|64216|P1|STARTED|Overall Study||847
26832|NCT01987752|64221|P1|NOT COMPLETED|Overall Study||0
26833|NCT01987752|64221|P1|COMPLETED|Overall Study||732
26834|NCT01987752|64221|P1|STARTED|Overall Study||732
26835|NCT01987583|64228|P2|NOT COMPLETED|Overall Study||2
26836|NCT01987583|64229|P1|NOT COMPLETED|Overall Study||3
26837|NCT01987583|64228|P2|COMPLETED|Overall Study||38
26838|NCT01987583|64229|P1|COMPLETED|Overall Study||37
26839|NCT01987583|64228|P2|STARTED|Overall Study||40
26840|NCT01987583|64229|P1|STARTED|Overall Study||40
26841|NCT01987557|64240|P3|NOT COMPLETED|Overall Study||3
26842|NCT01987557|64241|P2|NOT COMPLETED|Overall Study||3
26843|NCT01987557|64242|P1|NOT COMPLETED|Overall Study||3
26844|NCT01987557|64240|P3|COMPLETED|Overall Study||13
26845|NCT01987557|64241|P2|COMPLETED|Overall Study||13
26846|NCT01987557|64242|P1|COMPLETED|Overall Study||13
26847|NCT01987557|64240|P3|STARTED|Overall Study||16
26848|NCT01987557|64241|P2|STARTED|Overall Study||16
26849|NCT01987557|64242|P1|STARTED|Overall Study||16
26850|NCT01987479|64250|P1|NOT COMPLETED|Overall Study||17
26851|NCT01987479|64250|P1|COMPLETED|Overall Study||133
26852|NCT01987479|64250|P1|STARTED|Overall Study||150
26853|NCT01987453|64278|P3|NOT COMPLETED|Overall Study||1
26854|NCT01987453|64279|P2|NOT COMPLETED|Overall Study||12
26855|NCT01987453|64280|P1|NOT COMPLETED|Overall Study||1
26856|NCT01987453|64278|P3|COMPLETED|Overall Study||7
26857|NCT01987453|64279|P2|COMPLETED|Overall Study||29
26858|NCT01987453|64280|P1|COMPLETED|Overall Study||50
26859|NCT01987453|64278|P3|STARTED|Overall Study||8
26860|NCT01987453|64279|P2|STARTED|Overall Study||41
26861|NCT01987453|64280|P1|STARTED|Overall Study||51
26862|NCT01987349|64311|P8|NOT COMPLETED|Overall Study||1
26863|NCT01987349|64312|P7|NOT COMPLETED|Overall Study||0
26864|NCT01987349|64313|P6|NOT COMPLETED|Overall Study||0
26865|NCT01987349|64314|P5|NOT COMPLETED|Overall Study||0
26866|NCT01987349|64315|P4|NOT COMPLETED|Overall Study||0
26867|NCT01987349|64316|P3|NOT COMPLETED|Overall Study||0
26868|NCT01987349|64317|P2|NOT COMPLETED|Overall Study||0
26869|NCT01987349|64318|P1|NOT COMPLETED|Overall Study||0
26870|NCT01987349|64311|P8|COMPLETED|Overall Study||24
26871|NCT01987349|64312|P7|COMPLETED|Overall Study||10
26872|NCT01987349|64313|P6|COMPLETED|Overall Study||6
26873|NCT01987349|64314|P5|COMPLETED|Overall Study||6
26874|NCT01987349|64315|P4|COMPLETED|Overall Study||6
26875|NCT01987349|64316|P3|COMPLETED|Overall Study||8
26876|NCT01987349|64317|P2|COMPLETED|Overall Study||6
26877|NCT01987349|64318|P1|COMPLETED|Overall Study||6
26878|NCT01987349|64311|P8|STARTED|Overall Study||25
26879|NCT01987349|64312|P7|STARTED|Overall Study||10
26880|NCT01987349|64313|P6|STARTED|Overall Study||6
26881|NCT01987349|64314|P5|STARTED|Overall Study||6
26882|NCT01987349|64315|P4|STARTED|Overall Study||6
26883|NCT01987349|64316|P3|STARTED|Overall Study||8
26884|NCT01987349|64317|P2|STARTED|Overall Study||6
26885|NCT01987349|64318|P1|STARTED|Overall Study||6
26886|NCT01987232|64349|P5|NOT COMPLETED|Overall Study||0
26887|NCT01987232|64350|P4|NOT COMPLETED|Overall Study||1
26888|NCT01987232|64351|P3|NOT COMPLETED|Overall Study||0
26889|NCT01987232|64352|P2|NOT COMPLETED|Overall Study||0
26890|NCT01987232|64353|P1|NOT COMPLETED|Overall Study||0
26891|NCT01987232|64349|P5|COMPLETED|Overall Study||6
26892|NCT01987232|64350|P4|COMPLETED|Overall Study||14
26893|NCT01987232|64351|P3|COMPLETED|Overall Study||3
26894|NCT01987232|64352|P2|COMPLETED|Overall Study||3
26895|NCT01987232|64353|P1|COMPLETED|Overall Study||5
26896|NCT01987232|64349|P5|STARTED|Overall Study||6
26897|NCT01987232|64350|P4|STARTED|Overall Study||15
26898|NCT01987232|64351|P3|STARTED|Overall Study||3
26899|NCT01987232|64352|P2|STARTED|Overall Study||3
26900|NCT01987232|64353|P1|STARTED|Overall Study||5
26901|NCT01987219|64418|P6|NOT COMPLETED|Overall Study||0
26902|NCT01987219|64419|P5|NOT COMPLETED|Overall Study||0
26903|NCT01987219|64420|P4|NOT COMPLETED|Overall Study||0
26904|NCT01987219|64421|P3|NOT COMPLETED|Overall Study||1
26905|NCT01987219|64422|P2|NOT COMPLETED|Overall Study||0
26906|NCT01987219|64423|P1|NOT COMPLETED|Overall Study||0
26907|NCT01987219|64418|P6|COMPLETED|Overall Study||1
26908|NCT01987219|64419|P5|COMPLETED|Overall Study||1
26909|NCT01987219|64420|P4|COMPLETED|Overall Study||2
26910|NCT01987219|64421|P3|COMPLETED|Overall Study||6
26911|NCT01987219|64422|P2|COMPLETED|Overall Study||2
26912|NCT01987219|64423|P1|COMPLETED|Overall Study||2
26913|NCT01987219|64418|P6|STARTED|Overall Study||1
26914|NCT01987219|64419|P5|STARTED|Overall Study||1
26915|NCT01987219|64420|P4|STARTED|Overall Study||2
26916|NCT01987219|64421|P3|STARTED|Overall Study||7
26917|NCT01987219|64422|P2|STARTED|Overall Study||2
26918|NCT01987219|64423|P1|STARTED|Overall Study||2
26919|NCT01986985|64440|P1|NOT COMPLETED|Overall Study||7
26920|NCT01986985|64440|P1|COMPLETED|Overall Study||51
26921|NCT01986985|64440|P1|STARTED|Overall Study||58
26922|NCT01986946|64446|P2|NOT COMPLETED|Overall Study||0
26923|NCT01986946|64447|P1|NOT COMPLETED|Overall Study||0
26924|NCT01986946|64446|P2|COMPLETED|Overall Study||9
26925|NCT01986946|64447|P1|COMPLETED|Overall Study||5
26926|NCT01986946|64446|P2|STARTED|Overall Study||9
26927|NCT01986946|64447|P1|STARTED|Overall Study||5
26928|NCT01986790|64480|P3|NOT COMPLETED|Overall Study||0
26929|NCT01986790|64481|P2|NOT COMPLETED|Overall Study||0
26930|NCT01986790|64482|P1|NOT COMPLETED|Overall Study||0
26931|NCT01986790|64480|P3|COMPLETED|Overall Study||98
26932|NCT01986790|64481|P2|COMPLETED|Overall Study||154
26933|NCT01986790|64482|P1|COMPLETED|Overall Study||91
26934|NCT01986790|64480|P3|STARTED|Overall Study||98
26935|NCT01986790|64481|P2|STARTED|Overall Study||154
26936|NCT01986790|64482|P1|STARTED|Overall Study||91
26937|NCT01986751|64498|P2|NOT COMPLETED|Overall Study||2
26938|NCT01986751|64499|P1|NOT COMPLETED|Overall Study||10
26939|NCT01986751|64498|P2|COMPLETED|Overall Study||2
26940|NCT01986751|64499|P1|COMPLETED|Overall Study||0
26941|NCT01986751|64498|P2|STARTED|Overall Study||4
26942|NCT01986751|64499|P1|STARTED|Overall Study||10
26943|NCT01986361|64521|P2|NOT COMPLETED|Overall Study||0
26944|NCT01986361|64522|P1|NOT COMPLETED|Overall Study||0
26945|NCT01986361|64521|P2|COMPLETED|Overall Study||21
26946|NCT01986361|64522|P1|COMPLETED|Overall Study||101
26947|NCT01986361|64521|P2|STARTED|Overall Study||21
26948|NCT01986361|64522|P1|STARTED|Overall Study||101
26949|NCT01986231|64544|P1|NOT COMPLETED|Overall Study||1
26950|NCT01986231|64544|P1|COMPLETED|Overall Study||11
26951|NCT01986231|64544|P1|STARTED|Overall Study||12
26952|NCT01986062|64551|P2|NOT COMPLETED|Overall Study||1
26953|NCT01986062|64552|P1|NOT COMPLETED|Overall Study||1
26954|NCT01986062|64551|P2|COMPLETED|Overall Study||49
26955|NCT01986062|64552|P1|COMPLETED|Overall Study||46
26956|NCT01986062|64551|P2|STARTED|Overall Study||50
26957|NCT01986062|64552|P1|STARTED|Overall Study||47
26958|NCT01985581|64570|P2|NOT COMPLETED|Second Intervention||4
26959|NCT01985581|64571|P1|NOT COMPLETED|Second Intervention||2
26960|NCT01985581|64570|P2|COMPLETED|Second Intervention||19
26961|NCT01985581|64571|P1|COMPLETED|Second Intervention||20
26962|NCT01985581|64570|P2|STARTED|Second Intervention||23
26963|NCT01985581|64571|P1|STARTED|Second Intervention||22
26964|NCT01985581|64570|P2|NOT COMPLETED|First Intervention||2
26965|NCT01985581|64571|P1|NOT COMPLETED|First Intervention||3
26966|NCT01985581|64570|P2|COMPLETED|First Intervention||23
26967|NCT01985581|64571|P1|COMPLETED|First Intervention||22
26968|NCT01985581|64570|P2|STARTED|First Intervention||25
26969|NCT01985581|64571|P1|STARTED|First Intervention||25
26970|NCT01985425|64591|P2|NOT COMPLETED|Overall Study||0
26971|NCT01985425|64592|P1|NOT COMPLETED|Overall Study||0
26972|NCT01985425|64591|P2|COMPLETED|Overall Study||51
26973|NCT01985425|64592|P1|COMPLETED|Overall Study||49
26974|NCT01985425|64591|P2|STARTED|Overall Study||51
26975|NCT01985425|64592|P1|STARTED|Overall Study||49
26976|NCT01985321|64612|P2|NOT COMPLETED|Overall Study||5
26977|NCT01985321|64613|P1|NOT COMPLETED|Overall Study||11
26978|NCT01985321|64612|P2|COMPLETED|Overall Study||78
26979|NCT01985321|64613|P1|COMPLETED|Overall Study||79
26980|NCT01985321|64612|P2|STARTED|Overall Study|This is treatment eligible subjects only|83
26981|NCT01985321|64613|P1|STARTED|Overall Study|This is Treatment Eligible Subjects only|90
26982|NCT01985126|64623|P2|NOT COMPLETED|Overall Study||106
26983|NCT01985126|64624|P1|NOT COMPLETED|Overall Study||18
26984|NCT01985126|64623|P2|COMPLETED|Overall Study||0
26985|NCT01985126|64624|P1|COMPLETED|Overall Study||0
26986|NCT01985126|64623|P2|STARTED|Overall Study||106
26987|NCT01985126|64624|P1|STARTED|Overall Study||18
26988|NCT01984697|64647|P5|NOT COMPLETED|Overall Study||314
26989|NCT01984697|64648|P4|NOT COMPLETED|Overall Study||301
26990|NCT01984697|64649|P3|NOT COMPLETED|Overall Study||301
26991|NCT01984697|64650|P2|NOT COMPLETED|Overall Study||301
26992|NCT01984697|64651|P1|NOT COMPLETED|Overall Study||301
26993|NCT01984697|64647|P5|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
26994|NCT01984697|64648|P4|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
26995|NCT01984697|64649|P3|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
26996|NCT01984697|64650|P2|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
26997|NCT01984697|64651|P1|COMPLETED|Overall Study|Follow-up continues for participants not discontinued|0
26998|NCT01984697|64647|P5|Vaccination 3|Overall Study||311
26999|NCT01984697|64648|P4|Vaccination 3|Overall Study||293
27000|NCT01984697|64649|P3|Vaccination 3|Overall Study||0
27001|NCT01984697|64650|P2|Vaccination 3|Overall Study||0
27002|NCT01984697|64651|P1|Vaccination 3|Overall Study||0
27003|NCT01984697|64647|P5|Vaccination 2|Overall Study||313
27004|NCT01984697|64648|P4|Vaccination 2|Overall Study||298
27005|NCT01984697|64649|P3|Vaccination 2|Overall Study||291
27006|NCT01984697|64650|P2|Vaccination 2|Overall Study||296
27007|NCT01984697|64651|P1|Vaccination 2|Overall Study||293
27008|NCT01984697|64647|P5|Vaccination 1|Overall Study||314
27009|NCT01984697|64648|P4|Vaccination 1|Overall Study||300
27010|NCT01984697|64649|P3|Vaccination 1|Overall Study||300
27011|NCT01984697|64650|P2|Vaccination 1|Overall Study||301
27012|NCT01984697|64651|P1|Vaccination 1|Overall Study||301
27013|NCT01984697|64647|P5|STARTED|Overall Study||314
27014|NCT01984697|64648|P4|STARTED|Overall Study||301
27015|NCT01984697|64649|P3|STARTED|Overall Study||301
27016|NCT01984697|64650|P2|STARTED|Overall Study||301
27017|NCT01984697|64651|P1|STARTED|Overall Study||301
27018|NCT01984684|64750|P2|NOT COMPLETED|Overall Study||59
27019|NCT01984684|64751|P1|NOT COMPLETED|Overall Study||57
27020|NCT01984684|64750|P2|COMPLETED|Overall Study||368
27021|NCT01984684|64751|P1|COMPLETED|Overall Study||366
27022|NCT01984684|64750|P2|STARTED|Overall Study||427
27023|NCT01984684|64751|P1|STARTED|Overall Study||423
27024|NCT01984515|64761|P1|NOT COMPLETED|Overall Study||19
27025|NCT01984515|64761|P1|COMPLETED|Overall Study||40
27026|NCT01984515|64761|P1|Received CBT Session|Overall Study||40
27027|NCT01984515|64761|P1|STARTED|Overall Study||59
27028|NCT01984294|64770|P3|NOT COMPLETED|Overall Study||7
27029|NCT01984294|64771|P2|NOT COMPLETED|Overall Study||3
27030|NCT01984294|64772|P1|NOT COMPLETED|Overall Study||4
27031|NCT01984294|64770|P3|COMPLETED|Overall Study||27
27032|NCT01984294|64771|P2|COMPLETED|Overall Study||29
27033|NCT01984294|64772|P1|COMPLETED|Overall Study||31
27034|NCT01984294|64770|P3|STARTED|Overall Study||34
27035|NCT01984294|64771|P2|STARTED|Overall Study||32
27036|NCT01984294|64772|P1|STARTED|Overall Study||35
27037|NCT01984229|64794|P2|NOT COMPLETED|Safety Follow-up Period||1
27038|NCT01984229|64795|P1|NOT COMPLETED|Safety Follow-up Period||2
27039|NCT01984229|64794|P2|COMPLETED|Safety Follow-up Period||16
27040|NCT01984229|64795|P1|COMPLETED|Safety Follow-up Period||4
27041|NCT01984229|64794|P2|STARTED|Safety Follow-up Period||17
27042|NCT01984229|64795|P1|STARTED|Safety Follow-up Period||6
27043|NCT01984229|64794|P2|NOT COMPLETED|Period 3||0
27044|NCT01984229|64795|P1|NOT COMPLETED|Period 3||0
27045|NCT01984229|64794|P2|COMPLETED|Period 3||17
27046|NCT01984229|64795|P1|COMPLETED|Period 3||6
27047|NCT01984229|64794|P2|STARTED|Period 3||17
27048|NCT01984229|64795|P1|STARTED|Period 3||6
27049|NCT01984229|64794|P2|NOT COMPLETED|Period 2||0
27050|NCT01984229|64795|P1|NOT COMPLETED|Period 2||0
27051|NCT01984229|64794|P2|COMPLETED|Period 2||17
27052|NCT01984229|64795|P1|COMPLETED|Period 2||6
27053|NCT01984229|64794|P2|STARTED|Period 2||17
27054|NCT01984229|64795|P1|STARTED|Period 2||6
27055|NCT01984229|64794|P2|NOT COMPLETED|Period 1||0
27056|NCT01984229|64795|P1|NOT COMPLETED|Period 1||0
27057|NCT01984229|64794|P2|COMPLETED|Period 1||17
27058|NCT01984229|64795|P1|COMPLETED|Period 1||6
27059|NCT01984229|64794|P2|STARTED|Period 1||17
27060|NCT01984229|64795|P1|STARTED|Period 1||6
27061|NCT01983878|64845|P1|NOT COMPLETED|Overall Study||0
27062|NCT01983878|64845|P1|COMPLETED|Overall Study||36
27063|NCT01983878|64845|P1|Received At Least One Dose of Study Drug|Overall Study||36
27064|NCT01983878|64845|P1|STARTED|Overall Study||36
27065|NCT01983839|64856|P1|NOT COMPLETED|Overall Study||0
27066|NCT01983839|64856|P1|COMPLETED|Overall Study||18
27067|NCT01983839|64856|P1|STARTED|Overall Study||18
27068|NCT01983787|64861|P1|NOT COMPLETED|Overall Study||0
27069|NCT01983787|64861|P1|COMPLETED|Overall Study||10
27070|NCT01983787|64861|P1|STARTED|Overall Study||10
27071|NCT01982695|64886|P2|NOT COMPLETED|Overall Study||1
27072|NCT01982695|64887|P1|NOT COMPLETED|Overall Study||0
27073|NCT01982695|64886|P2|COMPLETED|Overall Study||10
27074|NCT01982695|64887|P1|COMPLETED|Overall Study||12
27075|NCT01982695|64886|P2|STARTED|Overall Study||11
27076|NCT01982695|64887|P1|STARTED|Overall Study||12
27077|NCT01983566|64897|P4|NOT COMPLETED|Test Period 4||0
27078|NCT01983566|64898|P3|NOT COMPLETED|Test Period 4||0
27079|NCT01983566|64899|P2|NOT COMPLETED|Test Period 4||0
27080|NCT01983566|64900|P1|NOT COMPLETED|Test Period 4||0
27081|NCT01983566|64897|P4|COMPLETED|Test Period 4||0
27082|NCT01983566|64898|P3|COMPLETED|Test Period 4||0
27083|NCT01983566|64899|P2|COMPLETED|Test Period 4||0
27084|NCT01983566|64900|P1|COMPLETED|Test Period 4||0
27085|NCT01983566|64897|P4|STARTED|Test Period 4||0
27086|NCT01983566|64898|P3|STARTED|Test Period 4||0
27087|NCT01983566|64899|P2|STARTED|Test Period 4||0
27088|NCT01983566|64900|P1|STARTED|Test Period 4||0
27089|NCT01983566|64897|P4|NOT COMPLETED|Wash-Out 3||0
27090|NCT01983566|64898|P3|NOT COMPLETED|Wash-Out 3||0
27091|NCT01983566|64899|P2|NOT COMPLETED|Wash-Out 3||0
27092|NCT01983566|64900|P1|NOT COMPLETED|Wash-Out 3||0
27093|NCT01983566|64897|P4|COMPLETED|Wash-Out 3||0
27094|NCT01983566|64898|P3|COMPLETED|Wash-Out 3||0
27095|NCT01983566|64899|P2|COMPLETED|Wash-Out 3||0
27096|NCT01983566|64900|P1|COMPLETED|Wash-Out 3||0
27097|NCT01983566|64897|P4|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
27098|NCT01983566|64898|P3|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
27099|NCT01983566|64899|P2|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
27100|NCT01983566|64900|P1|STARTED|Wash-Out 3|Subjects starting may not equal number completing the previous period due to early study termination|0
27101|NCT01983566|64897|P4|NOT COMPLETED|Test Period 3||0
27102|NCT01983566|64898|P3|NOT COMPLETED|Test Period 3||0
27103|NCT01983566|64899|P2|NOT COMPLETED|Test Period 3||0
27104|NCT01983566|64900|P1|NOT COMPLETED|Test Period 3||0
27105|NCT01983566|64897|P4|COMPLETED|Test Period 3||4
27106|NCT01983566|64898|P3|COMPLETED|Test Period 3||2
27107|NCT01983566|64899|P2|COMPLETED|Test Period 3||3
27108|NCT01983566|64900|P1|COMPLETED|Test Period 3||2
27109|NCT01983566|64897|P4|STARTED|Test Period 3||4
27110|NCT01983566|64898|P3|STARTED|Test Period 3||2
27111|NCT01983566|64899|P2|STARTED|Test Period 3||3
27112|NCT01983566|64900|P1|STARTED|Test Period 3||2
27113|NCT01983566|64897|P4|NOT COMPLETED|Wash-Out 2||0
27114|NCT01983566|64898|P3|NOT COMPLETED|Wash-Out 2||0
27115|NCT01983566|64899|P2|NOT COMPLETED|Wash-Out 2||0
27116|NCT01983566|64900|P1|NOT COMPLETED|Wash-Out 2||0
27117|NCT01983566|64897|P4|COMPLETED|Wash-Out 2||4
27118|NCT01983566|64898|P3|COMPLETED|Wash-Out 2||2
27119|NCT01983566|64899|P2|COMPLETED|Wash-Out 2||3
27120|NCT01983566|64900|P1|COMPLETED|Wash-Out 2||2
27121|NCT01983566|64897|P4|STARTED|Wash-Out 2||4
27122|NCT01983566|64898|P3|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
27123|NCT01983566|64899|P2|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|3
27124|NCT01983566|64900|P1|STARTED|Wash-Out 2|Subjects starting may not equal number completing the previous period due to early study termination|2
27125|NCT01983566|64897|P4|NOT COMPLETED|Test Period 2||0
27126|NCT01983566|64898|P3|NOT COMPLETED|Test Period 2||0
27127|NCT01983566|64899|P2|NOT COMPLETED|Test Period 2||0
27128|NCT01983566|64900|P1|NOT COMPLETED|Test Period 2||0
27129|NCT01983566|64897|P4|COMPLETED|Test Period 2||4
27130|NCT01983566|64898|P3|COMPLETED|Test Period 2||4
27131|NCT01983566|64899|P2|COMPLETED|Test Period 2||4
27132|NCT01983566|64900|P1|COMPLETED|Test Period 2||4
27133|NCT01983566|64897|P4|STARTED|Test Period 2||4
27134|NCT01983566|64898|P3|STARTED|Test Period 2||4
27135|NCT01983566|64899|P2|STARTED|Test Period 2||4
27136|NCT01983566|64900|P1|STARTED|Test Period 2||4
27137|NCT01983566|64897|P4|NOT COMPLETED|Wash-Out 1||0
27138|NCT01983566|64898|P3|NOT COMPLETED|Wash-Out 1||0
27139|NCT01983566|64899|P2|NOT COMPLETED|Wash-Out 1||0
27140|NCT01983566|64900|P1|NOT COMPLETED|Wash-Out 1||0
27141|NCT01983566|64897|P4|COMPLETED|Wash-Out 1||4
27142|NCT01983566|64898|P3|COMPLETED|Wash-Out 1||4
27143|NCT01983566|64899|P2|COMPLETED|Wash-Out 1||4
27144|NCT01983566|64900|P1|COMPLETED|Wash-Out 1||4
27145|NCT01983566|64897|P4|STARTED|Wash-Out 1||4
27146|NCT01983566|64898|P3|STARTED|Wash-Out 1||4
27147|NCT01983566|64899|P2|STARTED|Wash-Out 1||4
27148|NCT01983566|64900|P1|STARTED|Wash-Out 1||4
27149|NCT01983566|64897|P4|NOT COMPLETED|Test Period 1||0
27150|NCT01983566|64898|P3|NOT COMPLETED|Test Period 1||0
27151|NCT01983566|64899|P2|NOT COMPLETED|Test Period 1||0
27152|NCT01983566|64900|P1|NOT COMPLETED|Test Period 1||0
27153|NCT01983566|64897|P4|COMPLETED|Test Period 1||4
27154|NCT01983566|64898|P3|COMPLETED|Test Period 1||4
27155|NCT01983566|64899|P2|COMPLETED|Test Period 1||4
27156|NCT01983566|64900|P1|COMPLETED|Test Period 1||4
27157|NCT01983566|64897|P4|STARTED|Test Period 1||4
27158|NCT01983566|64898|P3|STARTED|Test Period 1||4
27159|NCT01983566|64899|P2|STARTED|Test Period 1||4
27160|NCT01983566|64900|P1|STARTED|Test Period 1||4
27161|NCT01983254|64921|P2|NOT COMPLETED|Overall Study||30
27162|NCT01983254|64922|P1|NOT COMPLETED|Overall Study||34
27163|NCT01983254|64921|P2|COMPLETED|Overall Study|69 patients, 37 caregivers|106
27164|NCT01983254|64922|P1|COMPLETED|Overall Study|62 patients, 29 caregivers|91
27165|NCT01983254|64921|P2|Interview 3|Overall Study|69 patients, 37 caregivers|106
27166|NCT01983254|64922|P1|Interview 3|Overall Study|62 patients, 29 caregivers|91
27167|NCT01983254|64921|P2|Interview 2|Overall Study|71 patients, 39 caregivers|110
27168|NCT01983254|64922|P1|Interview 2|Overall Study|65 patients, 30 caregivers|95
27169|NCT01983254|64921|P2|Interview 1|Overall Study|89 patients, 47 caregivers|136
27170|NCT01983254|64922|P1|Interview 1|Overall Study|86 patients, 39 caregivers|125
27171|NCT01983254|64921|P2|STARTED|Overall Study|89 patients, 47 caregivers|136
27172|NCT01983254|64922|P1|STARTED|Overall Study|86 patients, 39 caregivers|125
27173|NCT01983111|64934|P2|NOT COMPLETED|Overall Study||7
27174|NCT01983111|64935|P1|NOT COMPLETED|Overall Study||12
27175|NCT01983111|64934|P2|COMPLETED|Overall Study||59
27176|NCT01983111|64935|P1|COMPLETED|Overall Study||58
27177|NCT01983111|64934|P2|STARTED|Overall Study||66
27178|NCT01983111|64935|P1|STARTED|Overall Study||70
27179|NCT01983020|64955|P4|NOT COMPLETED|Overall Study||0
27180|NCT01983020|64956|P3|NOT COMPLETED|Overall Study||0
27181|NCT01983020|64957|P2|NOT COMPLETED|Overall Study||0
27182|NCT01983020|64958|P1|NOT COMPLETED|Overall Study||0
27183|NCT01983020|64955|P4|COMPLETED|Overall Study||11
27184|NCT01983020|64956|P3|COMPLETED|Overall Study||12
27185|NCT01983020|64957|P2|COMPLETED|Overall Study||11
27186|NCT01983020|64958|P1|COMPLETED|Overall Study||12
27187|NCT01983020|64955|P4|STARTED|Overall Study||11
27188|NCT01983020|64956|P3|STARTED|Overall Study||12
27189|NCT01983020|64957|P2|STARTED|Overall Study||11
27190|NCT01983020|64958|P1|STARTED|Overall Study||12
27191|NCT01982812|64970|P2|NOT COMPLETED|Overall Study||10
27192|NCT01982812|64971|P1|NOT COMPLETED|Overall Study||1
27193|NCT01982812|64970|P2|COMPLETED|Overall Study||11
27194|NCT01982812|64971|P1|COMPLETED|Overall Study||22
27195|NCT01982812|64970|P2|STARTED|Overall Study||21
27196|NCT01982812|64971|P1|STARTED|Overall Study||23
27197|NCT01982539|64983|P1|NOT COMPLETED|Overall Study||0
27198|NCT01982539|64983|P1|COMPLETED|Overall Study||25
27199|NCT01982539|64983|P1|STARTED|Overall Study||25
27200|NCT01982435|64989|P2|NOT COMPLETED|Overall Study||0
27201|NCT01982435|64990|P1|NOT COMPLETED|Overall Study||1
27202|NCT01982435|64989|P2|COMPLETED|Overall Study||12
27203|NCT01982435|64990|P1|COMPLETED|Overall Study||14
27204|NCT01982435|64989|P2|STARTED|Overall Study||12
27205|NCT01982435|64990|P1|STARTED|Overall Study||15
27206|NCT01982292|65020|P2|NOT COMPLETED|Overall Study||1
27207|NCT01982292|65021|P1|NOT COMPLETED|Overall Study||12
27208|NCT01982292|65020|P2|COMPLETED|Overall Study||107
27209|NCT01982292|65021|P1|COMPLETED|Overall Study||203
27210|NCT01982292|65020|P2|Safety Set|Overall Study||108
27211|NCT01982292|65021|P1|Safety Set|Overall Study||212
27212|NCT01982292|65020|P2|Full Analaysis Set (FAS)|Overall Study||108
27213|NCT01982292|65021|P1|Full Analaysis Set (FAS)|Overall Study|FAS excludes mis-randomized patients|213
27214|NCT01982292|65020|P2|STARTED|Overall Study||108
27215|NCT01982292|65021|P1|STARTED|Overall Study|"Started indicates Randomized set"|215
27216|NCT01982253|65042|P3|NOT COMPLETED|Overall Study||4
27217|NCT01982253|65043|P2|NOT COMPLETED|Overall Study||4
27218|NCT01982253|65044|P1|NOT COMPLETED|Overall Study||2
27219|NCT01982253|65042|P3|COMPLETED|Overall Study||0
27220|NCT01982253|65043|P2|COMPLETED|Overall Study||0
27221|NCT01982253|65044|P1|COMPLETED|Overall Study||0
27222|NCT01982253|65042|P3|STARTED|Overall Study||4
27223|NCT01982253|65043|P2|STARTED|Overall Study||4
27224|NCT01982253|65044|P1|STARTED|Overall Study||2
27225|NCT01981967|65057|P2|NOT COMPLETED|Overall Study||0
27226|NCT01981967|65058|P1|NOT COMPLETED|Overall Study||0
27227|NCT01981967|65057|P2|COMPLETED|Overall Study||3149
27228|NCT01981967|65058|P1|COMPLETED|Overall Study||6851
27229|NCT01981967|65057|P2|STARTED|Overall Study||3149
27230|NCT01981967|65058|P1|STARTED|Overall Study||6851
27231|NCT01981863|65070|P2|NOT COMPLETED|Overall Study||0
27232|NCT01981863|65071|P1|NOT COMPLETED|Overall Study||0
27233|NCT01981863|65070|P2|COMPLETED|Overall Study||20
27234|NCT01981863|65071|P1|COMPLETED|Overall Study||20
27235|NCT01981863|65070|P2|STARTED|Overall Study||20
27236|NCT01981863|65071|P1|STARTED|Overall Study||20
27237|NCT01981616|65083|P2|NOT COMPLETED|Overall Study||1
27238|NCT01981616|65084|P1|NOT COMPLETED|Overall Study||1
27239|NCT01981616|65083|P2|COMPLETED|Overall Study||62
27240|NCT01981616|65084|P1|COMPLETED|Overall Study||63
27241|NCT01981616|65083|P2|STARTED|Overall Study||63
27242|NCT01981616|65084|P1|STARTED|Overall Study||64
27243|NCT01981473|65099|P3|NOT COMPLETED|Overall Study||8
27244|NCT01981473|65100|P2|NOT COMPLETED|Overall Study||0
27245|NCT01981473|65101|P1|NOT COMPLETED|Overall Study||2
27246|NCT01981473|65099|P3|COMPLETED|Overall Study||196
27247|NCT01981473|65100|P2|COMPLETED|Overall Study||199
27248|NCT01981473|65101|P1|COMPLETED|Overall Study||200
27249|NCT01981473|65099|P3|STARTED|Overall Study||204
27250|NCT01981473|65100|P2|STARTED|Overall Study||199
27251|NCT01981473|65101|P1|STARTED|Overall Study||202
27252|NCT01981356|65142|P2|NOT COMPLETED|Overall Study||2
27253|NCT01981356|65143|P1|NOT COMPLETED|Overall Study||7
27254|NCT01981356|65142|P2|COMPLETED|Overall Study||4
27255|NCT01981356|65143|P1|COMPLETED|Overall Study||5
27256|NCT01981356|65142|P2|STARTED|Overall Study||6
27257|NCT01981356|65143|P1|STARTED|Overall Study||12
27258|NCT01981057|65170|P2|NOT COMPLETED|Overall Study||0
27259|NCT01981057|65171|P1|NOT COMPLETED|Overall Study||0
27260|NCT01981057|65170|P2|COMPLETED|Overall Study||50
27261|NCT01981057|65171|P1|COMPLETED|Overall Study||50
27262|NCT01981057|65170|P2|STARTED|Overall Study||50
27263|NCT01981057|65171|P1|STARTED|Overall Study||50
27264|NCT01980992|65179|P2|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||1
27265|NCT01980992|65180|P1|NOT COMPLETED|52 Weeks Open Label Active Wheat OIT||3
27266|NCT01980992|65179|P2|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
27267|NCT01980992|65180|P1|COMPLETED|52 Weeks Open Label Active Wheat OIT||18
27268|NCT01980992|65179|P2|STARTED|52 Weeks Open Label Active Wheat OIT||19
27269|NCT01980992|65180|P1|STARTED|52 Weeks Open Label Active Wheat OIT||21
27270|NCT01980992|65179|P2|NOT COMPLETED|52 Weeks Blinded Study Treatment||4
27271|NCT01980992|65180|P1|NOT COMPLETED|52 Weeks Blinded Study Treatment||2
27272|NCT01980992|65179|P2|COMPLETED|52 Weeks Blinded Study Treatment||19
27273|NCT01980992|65180|P1|COMPLETED|52 Weeks Blinded Study Treatment||21
27274|NCT01980992|65179|P2|STARTED|52 Weeks Blinded Study Treatment||23
27275|NCT01980992|65180|P1|STARTED|52 Weeks Blinded Study Treatment||23
27276|NCT01980940|65194|P8|NOT COMPLETED|Overall Study||0
27277|NCT01980940|65195|P7|NOT COMPLETED|Overall Study||0
27278|NCT01980940|65196|P6|NOT COMPLETED|Overall Study||2
27279|NCT01980940|65197|P5|NOT COMPLETED|Overall Study||0
27280|NCT01980940|65198|P4|NOT COMPLETED|Overall Study||0
27281|NCT01980940|65199|P3|NOT COMPLETED|Overall Study||0
27282|NCT01980940|65200|P2|NOT COMPLETED|Overall Study||0
27283|NCT01980940|65201|P1|NOT COMPLETED|Overall Study||0
27284|NCT01980940|65194|P8|COMPLETED|Overall Study||24
27285|NCT01980940|65195|P7|COMPLETED|Overall Study||24
27286|NCT01980940|65196|P6|COMPLETED|Overall Study||0
27287|NCT01980940|65197|P5|COMPLETED|Overall Study||2
27288|NCT01980940|65198|P4|COMPLETED|Overall Study||3
27289|NCT01980940|65199|P3|COMPLETED|Overall Study||5
27290|NCT01980940|65200|P2|COMPLETED|Overall Study||5
27291|NCT01980940|65201|P1|COMPLETED|Overall Study||5
27292|NCT01980940|65194|P8|Treated|Overall Study||24
27293|NCT01980940|65195|P7|Treated|Overall Study||24
27294|NCT01980940|65196|P6|Treated|Overall Study||2
27295|NCT01980940|65197|P5|Treated|Overall Study||2
27296|NCT01980940|65198|P4|Treated|Overall Study||3
27297|NCT01980940|65199|P3|Treated|Overall Study||5
27298|NCT01980940|65200|P2|Treated|Overall Study||5
27299|NCT01980940|65201|P1|Treated|Overall Study||5
27300|NCT01980940|65194|P8|STARTED|Overall Study||24
27301|NCT01980940|65195|P7|STARTED|Overall Study||24
27302|NCT01980940|65196|P6|STARTED|Overall Study||2
27303|NCT01980940|65197|P5|STARTED|Overall Study||2
27304|NCT01980940|65198|P4|STARTED|Overall Study||3
27305|NCT01980940|65199|P3|STARTED|Overall Study||5
27306|NCT01980940|65200|P2|STARTED|Overall Study||5
27307|NCT01980940|65201|P1|STARTED|Overall Study||5
27308|NCT01980875|65256|P3|NOT COMPLETED|Overall Study||24
27309|NCT01980875|65257|P2|NOT COMPLETED|Overall Study||25
27310|NCT01980875|65258|P1|NOT COMPLETED|Overall Study||8
27311|NCT01980875|65256|P3|COMPLETED|Overall Study||0
27312|NCT01980875|65257|P2|COMPLETED|Overall Study||0
27313|NCT01980875|65258|P1|COMPLETED|Overall Study||0
27314|NCT01980875|65256|P3|STARTED|Overall Study||24
27315|NCT01980875|65257|P2|STARTED|Overall Study||25
27316|NCT01980875|65258|P1|STARTED|Overall Study||8
27317|NCT01980628|65281|P1|NOT COMPLETED|Overall Study||39
27318|NCT01980628|65281|P1|COMPLETED|Overall Study|Participants who remain on treatment at Primary Completion.|24
27319|NCT01980628|65281|P1|STARTED|Overall Study|Total number of patients enrolled to the study and received study treatment|63
27320|NCT01980589|65289|P3|NOT COMPLETED|Overall Study||0
27321|NCT01980589|65290|P2|NOT COMPLETED|Overall Study||0
27322|NCT01980589|65291|P1|NOT COMPLETED|Overall Study||0
27323|NCT01980589|65289|P3|COMPLETED|Overall Study||16
27324|NCT01980589|65290|P2|COMPLETED|Overall Study||3
27325|NCT01980589|65291|P1|COMPLETED|Overall Study||3
27326|NCT01980589|65289|P3|STARTED|Overall Study||16
27327|NCT01980589|65290|P2|STARTED|Overall Study||3
27328|NCT01980589|65291|P1|STARTED|Overall Study||3
27329|NCT01980524|65308|P2|NOT COMPLETED|Study Day 2||0
27330|NCT01980524|65309|P1|NOT COMPLETED|Study Day 2||0
27331|NCT01980524|65308|P2|COMPLETED|Study Day 2||4
27332|NCT01980524|65309|P1|COMPLETED|Study Day 2||4
27333|NCT01980524|65308|P2|STARTED|Study Day 2||4
27334|NCT01980524|65309|P1|STARTED|Study Day 2||4
27335|NCT01980524|65308|P2|NOT COMPLETED|Washout (at Least 2 Weeks)||0
27336|NCT01980524|65309|P1|NOT COMPLETED|Washout (at Least 2 Weeks)||0
27337|NCT01980524|65308|P2|COMPLETED|Washout (at Least 2 Weeks)||4
27338|NCT01980524|65309|P1|COMPLETED|Washout (at Least 2 Weeks)||4
27339|NCT01980524|65308|P2|STARTED|Washout (at Least 2 Weeks)||4
27340|NCT01980524|65309|P1|STARTED|Washout (at Least 2 Weeks)||4
27341|NCT01980524|65308|P2|NOT COMPLETED|Study Day 1||0
27342|NCT01980524|65309|P1|NOT COMPLETED|Study Day 1||0
27343|NCT01980524|65308|P2|COMPLETED|Study Day 1||4
27344|NCT01980524|65309|P1|COMPLETED|Study Day 1||4
27345|NCT01980524|65308|P2|STARTED|Study Day 1||4
27346|NCT01980524|65309|P1|STARTED|Study Day 1||4
27347|NCT01980095|65321|P2|NOT COMPLETED|Overall Study||11
27348|NCT01980095|65322|P1|NOT COMPLETED|Overall Study||14
27349|NCT01980095|65321|P2|COMPLETED|Overall Study||30
27350|NCT01980095|65322|P1|COMPLETED|Overall Study||63
27351|NCT01980095|65321|P2|Treated|Overall Study||41
27352|NCT01980095|65322|P1|Treated|Overall Study|Of 78 patients randomized, 1 patient erroneously randomized and not treated|77
27353|NCT01980095|65321|P2|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|41
27354|NCT01980095|65322|P1|STARTED|Overall Study|Protocol planned for 90 patients, protocol amendment increase up to 120 patients.|77
27355|NCT01979185|65332|P2|NOT COMPLETED|Period 2||1
27356|NCT01979185|65333|P1|NOT COMPLETED|Period 2||0
27357|NCT01979185|65332|P2|COMPLETED|Period 2|1 subject discontinued due to a positive drug test prior to receiving Simvastatin alone in Period 2.|14
27358|NCT01979185|65333|P1|COMPLETED|Period 2||15
27359|NCT01979185|65332|P2|STARTED|Period 2||15
27360|NCT01979185|65333|P1|STARTED|Period 2||15
27361|NCT01979185|65332|P2|NOT COMPLETED|Period 1||0
27362|NCT01979185|65333|P1|NOT COMPLETED|Period 1||0
27363|NCT01979185|65332|P2|COMPLETED|Period 1||15
27364|NCT01979185|65333|P1|COMPLETED|Period 1||15
27365|NCT01979185|65332|P2|STARTED|Period 1||15
27366|NCT01979185|65333|P1|STARTED|Period 1||15
27367|NCT01979133|65343|P1|NOT COMPLETED|Overall Study||3
27368|NCT01979133|65343|P1|COMPLETED|Overall Study||7
27369|NCT01979133|65343|P1|STARTED|Overall Study||10
27370|NCT01979029|65362|P2|NOT COMPLETED|Overall Study||0
27371|NCT01979029|65363|P1|NOT COMPLETED|Overall Study||0
27372|NCT01979029|65362|P2|COMPLETED|Overall Study||28
27373|NCT01979029|65363|P1|COMPLETED|Overall Study||29
27374|NCT01979029|65362|P2|STARTED|Overall Study||28
27375|NCT01979029|65363|P1|STARTED|Overall Study||29
27376|NCT01978743|65373|P1|NOT COMPLETED|Overall Study||0
27377|NCT01978743|65373|P1|COMPLETED|Overall Study||10
27378|NCT01978743|65373|P1|STARTED|Overall Study||10
27379|NCT01978600|65387|P2|NOT COMPLETED|Overall Study||0
27380|NCT01978600|65388|P1|NOT COMPLETED|Overall Study||0
27381|NCT01978600|65387|P2|COMPLETED|Overall Study||42
27382|NCT01978600|65388|P1|COMPLETED|Overall Study||44
27383|NCT01978600|65387|P2|STARTED|Overall Study||42
27384|NCT01978600|65388|P1|STARTED|Overall Study||44
27385|NCT01978145|65398|P2|NOT COMPLETED|Treatment Period 2||14
27386|NCT01978145|65399|P1|NOT COMPLETED|Treatment Period 2||19
27387|NCT01978145|65398|P2|COMPLETED|Treatment Period 2||179
27388|NCT01978145|65399|P1|COMPLETED|Treatment Period 2||185
27389|NCT01978145|65398|P2|STARTED|Treatment Period 2||193
27390|NCT01978145|65399|P1|STARTED|Treatment Period 2||204
27391|NCT01978145|65398|P2|NOT COMPLETED|Washout Period 1||3
27392|NCT01978145|65399|P1|NOT COMPLETED|Washout Period 1||1
27393|NCT01978145|65398|P2|COMPLETED|Washout Period 1||193
27394|NCT01978145|65399|P1|COMPLETED|Washout Period 1||204
27395|NCT01978145|65398|P2|STARTED|Washout Period 1||196
27396|NCT01978145|65399|P1|STARTED|Washout Period 1||205
27397|NCT01978145|65398|P2|NOT COMPLETED|Treatment Period 1||16
27398|NCT01978145|65399|P1|NOT COMPLETED|Treatment Period 1||9
27399|NCT01978145|65398|P2|COMPLETED|Treatment Period 1||196
27400|NCT01978145|65399|P1|COMPLETED|Treatment Period 1||205
27401|NCT01978145|65398|P2|STARTED|Treatment Period 1||212
27402|NCT01978145|65399|P1|STARTED|Treatment Period 1||214
27403|NCT01978119|65415|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||2
27404|NCT01978119|65416|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||0
27405|NCT01978119|65415|P2|COMPLETED|Treatment Period 2 (12 Weeks)||40
27406|NCT01978119|65416|P1|COMPLETED|Treatment Period 2 (12 Weeks)||38
27407|NCT01978119|65415|P2|STARTED|Treatment Period 2 (12 Weeks)||42
27408|NCT01978119|65416|P1|STARTED|Treatment Period 2 (12 Weeks)||38
27409|NCT01978119|65415|P2|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
27410|NCT01978119|65416|P1|NOT COMPLETED|Washout Period 1 (3 Weeks)||0
27411|NCT01978119|65415|P2|COMPLETED|Washout Period 1 (3 Weeks)||42
27412|NCT01978119|65416|P1|COMPLETED|Washout Period 1 (3 Weeks)||38
27413|NCT01978119|65415|P2|STARTED|Washout Period 1 (3 Weeks)||42
27414|NCT01978119|65416|P1|STARTED|Washout Period 1 (3 Weeks)||38
27415|NCT01978119|65415|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||0
27416|NCT01978119|65416|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
27417|NCT01978119|65415|P2|COMPLETED|Treatment Period 1 (12 Weeks)||42
27418|NCT01978119|65416|P1|COMPLETED|Treatment Period 1 (12 Weeks)||38
27419|NCT01978119|65415|P2|STARTED|Treatment Period 1 (12 Weeks)||42
27420|NCT01978119|65416|P1|STARTED|Treatment Period 1 (12 Weeks)||40
27421|NCT01977820|65442|P2|NOT COMPLETED|Overall Study||1
27422|NCT01977820|65443|P1|NOT COMPLETED|Overall Study||1
27423|NCT01977820|65442|P2|COMPLETED|Overall Study||0
27424|NCT01977820|65443|P1|COMPLETED|Overall Study||0
27425|NCT01977820|65442|P2|STARTED|Overall Study||1
27426|NCT01977820|65443|P1|STARTED|Overall Study||1
27427|NCT01977794|65451|P2|NOT COMPLETED|Overall Study||6
27428|NCT01977794|65452|P1|NOT COMPLETED|Overall Study||8
27429|NCT01977794|65451|P2|COMPLETED|Overall Study||94
27430|NCT01977794|65452|P1|COMPLETED|Overall Study||92
27431|NCT01977794|65451|P2|STARTED|Overall Study||100
27432|NCT01977794|65452|P1|STARTED|Overall Study||100
27433|NCT01977781|65468|P2|NOT COMPLETED|Overall Study||1
27434|NCT01977781|65469|P1|NOT COMPLETED|Overall Study||6
27435|NCT01977781|65468|P2|COMPLETED|Overall Study||15
27436|NCT01977781|65469|P1|COMPLETED|Overall Study||18
27437|NCT01977781|65468|P2|STARTED|Overall Study||16
27438|NCT01977781|65469|P1|STARTED|Overall Study||24
27439|NCT01977729|65487|P1|NOT COMPLETED|Overall Study||1
27440|NCT01977729|65487|P1|COMPLETED|Overall Study||0
27441|NCT01977729|65487|P1|STARTED|Overall Study||1
27442|NCT01977690|65499|P2|NOT COMPLETED|Overall Study||4
27443|NCT01977690|65500|P1|NOT COMPLETED|Overall Study||0
27444|NCT01977690|65499|P2|COMPLETED|Overall Study||11
27445|NCT01977690|65500|P1|COMPLETED|Overall Study||15
27446|NCT01977690|65499|P2|STARTED|Overall Study||15
27447|NCT01977690|65500|P1|STARTED|Overall Study||15
27448|NCT01977625|65506|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
27449|NCT01977625|65507|P1|NOT COMPLETED|Second Intervention (4 Weeks)||1
27450|NCT01977625|65506|P2|COMPLETED|Second Intervention (4 Weeks)||7
27451|NCT01977625|65507|P1|COMPLETED|Second Intervention (4 Weeks)||7
27452|NCT01977625|65506|P2|STARTED|Second Intervention (4 Weeks)||7
27453|NCT01977625|65507|P1|STARTED|Second Intervention (4 Weeks)||8
27454|NCT01977625|65506|P2|NOT COMPLETED|Washout (2 Weeks)||0
27455|NCT01977625|65507|P1|NOT COMPLETED|Washout (2 Weeks)||0
27456|NCT01977625|65506|P2|COMPLETED|Washout (2 Weeks)||7
27457|NCT01977625|65507|P1|COMPLETED|Washout (2 Weeks)||8
27458|NCT01977625|65506|P2|STARTED|Washout (2 Weeks)||7
27459|NCT01977625|65507|P1|STARTED|Washout (2 Weeks)||8
27460|NCT01977625|65506|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
27461|NCT01977625|65507|P1|NOT COMPLETED|First Intervention (4 Weeks)||3
27462|NCT01977625|65506|P2|COMPLETED|First Intervention (4 Weeks)||7
27463|NCT01977625|65507|P1|COMPLETED|First Intervention (4 Weeks)||8
27464|NCT01977625|65506|P2|STARTED|First Intervention (4 Weeks)||7
27465|NCT01977625|65507|P1|STARTED|First Intervention (4 Weeks)||11
27466|NCT01977612|65517|P2|NOT COMPLETED|Overall Study||1
27467|NCT01977612|65518|P1|NOT COMPLETED|Overall Study||1
27468|NCT01977612|65517|P2|COMPLETED|Overall Study||79
27469|NCT01977612|65518|P1|COMPLETED|Overall Study||84
27470|NCT01977612|65517|P2|STARTED|Overall Study||80
27471|NCT01977612|65518|P1|STARTED|Overall Study||85
27472|NCT01977573|65540|P4|NOT COMPLETED|Overall Study||3
27473|NCT01977573|65541|P3|NOT COMPLETED|Overall Study||4
27474|NCT01977573|65542|P2|NOT COMPLETED|Overall Study||3
27475|NCT01977573|65543|P1|NOT COMPLETED|Overall Study||20
27476|NCT01977573|65540|P4|COMPLETED|Overall Study||33
27477|NCT01977573|65541|P3|COMPLETED|Overall Study||32
27478|NCT01977573|65542|P2|COMPLETED|Overall Study||41
27479|NCT01977573|65543|P1|COMPLETED|Overall Study||116
27480|NCT01977573|65540|P4|STARTED|Overall Study||36
27481|NCT01977573|65541|P3|STARTED|Overall Study||36
27482|NCT01977573|65542|P2|STARTED|Overall Study||44
27483|NCT01977573|65543|P1|STARTED|Overall Study||136
27484|NCT01977482|65657|P6|NOT COMPLETED|Overall Study||5
27485|NCT01977482|65658|P5|NOT COMPLETED|Overall Study||3
27486|NCT01977482|65659|P4|NOT COMPLETED|Overall Study||4
27487|NCT01977482|65660|P3|NOT COMPLETED|Overall Study||5
27488|NCT01977482|65661|P2|NOT COMPLETED|Overall Study||9
27489|NCT01977482|65662|P1|NOT COMPLETED|Overall Study||3
27490|NCT01977482|65657|P6|COMPLETED|Overall Study||14
27491|NCT01977482|65658|P5|COMPLETED|Overall Study||37
27492|NCT01977482|65659|P4|COMPLETED|Overall Study||35
27493|NCT01977482|65660|P3|COMPLETED|Overall Study||35
27494|NCT01977482|65661|P2|COMPLETED|Overall Study||30
27495|NCT01977482|65662|P1|COMPLETED|Overall Study||36
27496|NCT01977482|65657|P6|STARTED|Overall Study||19
27497|NCT01977482|65658|P5|STARTED|Overall Study||40
27498|NCT01977482|65659|P4|STARTED|Overall Study||39
27499|NCT01977482|65660|P3|STARTED|Overall Study||40
27500|NCT01977482|65661|P2|STARTED|Overall Study||39
27501|NCT01977482|65662|P1|STARTED|Overall Study||39
27502|NCT01977456|65777|P1|NOT COMPLETED|Overall Study||5
27503|NCT01977456|65777|P1|COMPLETED|Overall Study||22
27504|NCT01977456|65777|P1|STARTED|Overall Study||27
27505|NCT01976988|65786|P2|NOT COMPLETED|Overall Study||18
27506|NCT01976988|65787|P1|NOT COMPLETED|Overall Study||16
27507|NCT01976988|65786|P2|COMPLETED|Overall Study||184
27508|NCT01976988|65787|P1|COMPLETED|Overall Study||192
27509|NCT01976988|65786|P2|STARTED|Overall Study||202
27510|NCT01976988|65787|P1|STARTED|Overall Study||208
27511|NCT01976871|65803|P1|NOT COMPLETED|Overall Study||1
27512|NCT01976871|65803|P1|COMPLETED|Overall Study||20
27513|NCT01976871|65803|P1|STARTED|Overall Study||21
27514|NCT01976845|65815|P3|NOT COMPLETED|Overall Study||3
27515|NCT01976845|65816|P2|NOT COMPLETED|Overall Study||8
27516|NCT01976845|65817|P1|NOT COMPLETED|Overall Study||8
27517|NCT01976845|65815|P3|COMPLETED|Overall Study||40
27518|NCT01976845|65816|P2|COMPLETED|Overall Study||40
27519|NCT01976845|65817|P1|COMPLETED|Overall Study||40
27520|NCT01976845|65815|P3|STARTED|Overall Study||43
27521|NCT01976845|65816|P2|STARTED|Overall Study||48
27522|NCT01976845|65817|P1|STARTED|Overall Study||48
27523|NCT01976819|65831|P1|NOT COMPLETED|Overall Study||5
27524|NCT01976819|65831|P1|COMPLETED|Overall Study||11
27525|NCT01976819|65831|P1|STARTED|Overall Study||16
27526|NCT01976806|65842|P2|NOT COMPLETED|Overall Study||6
27527|NCT01976806|65843|P1|NOT COMPLETED|Overall Study||3
27528|NCT01976806|65842|P2|COMPLETED|Overall Study||22
27529|NCT01976806|65843|P1|COMPLETED|Overall Study||24
27530|NCT01976806|65842|P2|STARTED|Overall Study||28
27531|NCT01976806|65843|P1|STARTED|Overall Study||27
27532|NCT01976663|65849|P1|NOT COMPLETED|Overall Study||42
27533|NCT01976663|65849|P1|COMPLETED|Overall Study||84
27534|NCT01976663|65849|P1|STARTED|Overall Study||126
27535|NCT01976650|65863|P1|NOT COMPLETED|Overall Study||6
27536|NCT01976650|65863|P1|COMPLETED|Overall Study||718
27537|NCT01976650|65863|P1|STARTED|Overall Study||724
27538|NCT01976624|65868|P1|NOT COMPLETED|Overall Study||14
27539|NCT01976624|65868|P1|COMPLETED|Overall Study||742
27540|NCT01976624|65868|P1|STARTED|Overall Study||756
27541|NCT01976572|65873|P3|NOT COMPLETED|Overall Study||0
27542|NCT01976572|65874|P2|NOT COMPLETED|Overall Study||0
27543|NCT01976572|65875|P1|NOT COMPLETED|Overall Study||0
27544|NCT01976572|65873|P3|COMPLETED|Overall Study||6
27545|NCT01976572|65874|P2|COMPLETED|Overall Study||6
27546|NCT01976572|65875|P1|COMPLETED|Overall Study||6
27547|NCT01976572|65873|P3|STARTED|Overall Study||6
27548|NCT01976572|65874|P2|STARTED|Overall Study||6
27549|NCT01976572|65875|P1|STARTED|Overall Study||6
27550|NCT01976442|65898|P2|NOT COMPLETED|Overall Study||0
27551|NCT01976442|65899|P1|NOT COMPLETED|Overall Study||0
27552|NCT01976442|65898|P2|COMPLETED|Overall Study||31
27553|NCT01976442|65899|P1|COMPLETED|Overall Study||69
27554|NCT01976442|65898|P2|STARTED|Overall Study||31
27555|NCT01976442|65899|P1|STARTED|Overall Study||69
27556|NCT01976338|65913|P2|NOT COMPLETED|Overall Study||4
27557|NCT01976338|65914|P1|NOT COMPLETED|Overall Study||13
27558|NCT01976338|65913|P2|COMPLETED|Overall Study|12 months|89
27559|NCT01976338|65914|P1|COMPLETED|Overall Study|12 months|177
27560|NCT01976338|65913|P2|Discontinued Study Prior to 6 Months|Overall Study||2
27561|NCT01976338|65914|P1|Discontinued Study Prior to 6 Months|Overall Study||5
27562|NCT01976338|65913|P2|Completed 6 Months|Overall Study||91
27563|NCT01976338|65914|P1|Completed 6 Months|Overall Study||185
27564|NCT01976338|65913|P2|STARTED|Overall Study||93
27565|NCT01976338|65914|P1|STARTED|Overall Study||190
27566|NCT01976312|65941|P2|NOT COMPLETED|Overall Study||9
27567|NCT01976312|65942|P1|NOT COMPLETED|Overall Study||17
27568|NCT01976312|65941|P2|COMPLETED|Overall Study|Completed study at 12 months|53
27569|NCT01976312|65942|P1|COMPLETED|Overall Study|Completed study at 12 months|173
27570|NCT01976312|65941|P2|Discontinued Study Prior to 3 Months|Overall Study||2
27571|NCT01976312|65942|P1|Discontinued Study Prior to 3 Months|Overall Study||4
27572|NCT01976312|65941|P2|Completed 3 Months|Overall Study||60
27573|NCT01976312|65942|P1|Completed 3 Months|Overall Study||186
27574|NCT01976312|65941|P2|STARTED|Overall Study||62
27575|NCT01976312|65942|P1|STARTED|Overall Study||190
27576|NCT01976299|65963|P2|NOT COMPLETED|Overall Study||6
27577|NCT01976299|65964|P1|NOT COMPLETED|Overall Study||23
27578|NCT01976299|65963|P2|COMPLETED|Overall Study|2 subjects did not proceed onto procedure in this arm.|280
27579|NCT01976299|65964|P1|COMPLETED|Overall Study|9 subjects did not proceed onto procedure in this arm.|269
27580|NCT01976299|65963|P2|Completed Procedure|Overall Study||284
27581|NCT01976299|65964|P1|Completed Procedure|Overall Study||283
27582|NCT01976299|65963|P2|STARTED|Overall Study||286
27583|NCT01976299|65964|P1|STARTED|Overall Study||292
27584|NCT01976273|65980|P2|NOT COMPLETED|Overall Study||1
27585|NCT01976273|65981|P1|NOT COMPLETED|Overall Study||1
27586|NCT01976273|65980|P2|COMPLETED|Overall Study||9
27587|NCT01976273|65981|P1|COMPLETED|Overall Study||9
27588|NCT01976273|65980|P2|STARTED|Overall Study||10
27589|NCT01976273|65981|P1|STARTED|Overall Study||10
27590|NCT01975974|65987|P1|NOT COMPLETED|Overall Study||0
27591|NCT01975974|65987|P1|COMPLETED|Overall Study||100
27592|NCT01975974|65987|P1|STARTED|Overall Study||100
27593|NCT01975948|65995|P4|NOT COMPLETED|Overall Study||6
27594|NCT01975948|65996|P3|NOT COMPLETED|Overall Study||7
27595|NCT01975948|65997|P2|NOT COMPLETED|Overall Study||21
27596|NCT01975948|65998|P1|NOT COMPLETED|Overall Study||17
27597|NCT01975948|65995|P4|COMPLETED|Overall Study||51
27598|NCT01975948|65996|P3|COMPLETED|Overall Study||65
27599|NCT01975948|65997|P2|COMPLETED|Overall Study||34
27600|NCT01975948|65998|P1|COMPLETED|Overall Study||39
27601|NCT01975948|65995|P4|STARTED|Overall Study||57
27602|NCT01975948|65996|P3|STARTED|Overall Study||72
27603|NCT01975948|65997|P2|STARTED|Overall Study||55
27604|NCT01975948|65998|P1|STARTED|Overall Study||56
27605|NCT01975935|66024|P2|NOT COMPLETED|Overall Study||1
27606|NCT01975935|66025|P1|NOT COMPLETED|Overall Study||3
27607|NCT01975935|66024|P2|COMPLETED|Overall Study||20
27608|NCT01975935|66025|P1|COMPLETED|Overall Study||18
27609|NCT01975935|66024|P2|STARTED|Overall Study||21
27610|NCT01975935|66025|P1|STARTED|Overall Study||21
27611|NCT01975909|66037|P2|NOT COMPLETED|Overall Study||0
27612|NCT01975909|66038|P1|NOT COMPLETED|Overall Study||0
27613|NCT01975909|66037|P2|COMPLETED|Overall Study||10
27614|NCT01975909|66038|P1|COMPLETED|Overall Study||10
27615|NCT01975909|66037|P2|STARTED|Overall Study||10
27616|NCT01975909|66038|P1|STARTED|Overall Study||10
27617|NCT01975675|66058|P4|NOT COMPLETED|Overall Study||0
27618|NCT01975675|66059|P3|NOT COMPLETED|Overall Study||0
27619|NCT01975675|66060|P2|NOT COMPLETED|Overall Study||1
27620|NCT01975675|66061|P1|NOT COMPLETED|Overall Study||0
27621|NCT01975675|66058|P4|COMPLETED|Overall Study||87
27622|NCT01975675|66059|P3|COMPLETED|Overall Study||88
27623|NCT01975675|66060|P2|COMPLETED|Overall Study||82
27624|NCT01975675|66061|P1|COMPLETED|Overall Study||83
27625|NCT01975675|66058|P4|STARTED|Overall Study||87
27626|NCT01975675|66059|P3|STARTED|Overall Study||88
27627|NCT01975675|66060|P2|STARTED|Overall Study||83
27628|NCT01975675|66061|P1|STARTED|Overall Study||83
27629|NCT01975467|66083|P2|NOT COMPLETED|Overall Study||0
27630|NCT01975467|66084|P1|NOT COMPLETED|Overall Study||0
27631|NCT01975467|66083|P2|COMPLETED|Overall Study||0
27632|NCT01975467|66084|P1|COMPLETED|Overall Study||0
27633|NCT01975467|66083|P2|STARTED|Overall Study|Study terminated before enrollment|0
27634|NCT01975467|66084|P1|STARTED|Overall Study|Study terminated before enrollment|0
27635|NCT01975285|66094|P2|NOT COMPLETED|Overall Study||2
27636|NCT01975285|66095|P1|NOT COMPLETED|Overall Study||2
27637|NCT01975285|66094|P2|COMPLETED|Overall Study||28
27638|NCT01975285|66095|P1|COMPLETED|Overall Study||28
27639|NCT01975285|66094|P2|STARTED|Overall Study||30
27640|NCT01975285|66095|P1|STARTED|Overall Study||30
27641|NCT01975246|66111|P2|NOT COMPLETED|Overall Study||2
27642|NCT01975246|66112|P1|NOT COMPLETED|Overall Study||4
27643|NCT01975246|66111|P2|COMPLETED|Overall Study||158
27644|NCT01975246|66112|P1|COMPLETED|Overall Study||145
27645|NCT01975246|66111|P2|STARTED|Overall Study||160
27646|NCT01975246|66112|P1|STARTED|Overall Study||149
27647|NCT01975220|66125|P6|NOT COMPLETED|Test Period 2||0
27648|NCT01975220|66126|P5|NOT COMPLETED|Test Period 2||0
27649|NCT01975220|66127|P4|NOT COMPLETED|Test Period 2||0
27650|NCT01975220|66128|P3|NOT COMPLETED|Test Period 2||0
27651|NCT01975220|66129|P2|NOT COMPLETED|Test Period 2||0
27652|NCT01975220|66130|P1|NOT COMPLETED|Test Period 2||0
27653|NCT01975220|66125|P6|COMPLETED|Test Period 2||12
27654|NCT01975220|66126|P5|COMPLETED|Test Period 2||12
27655|NCT01975220|66127|P4|COMPLETED|Test Period 2||12
27656|NCT01975220|66128|P3|COMPLETED|Test Period 2||12
27657|NCT01975220|66129|P2|COMPLETED|Test Period 2||11
27658|NCT01975220|66130|P1|COMPLETED|Test Period 2||12
27659|NCT01975220|66125|P6|STARTED|Test Period 2||12
27660|NCT01975220|66126|P5|STARTED|Test Period 2||12
27661|NCT01975220|66127|P4|STARTED|Test Period 2||12
27662|NCT01975220|66128|P3|STARTED|Test Period 2||12
27663|NCT01975220|66129|P2|STARTED|Test Period 2||11
27664|NCT01975220|66130|P1|STARTED|Test Period 2||12
27665|NCT01975220|66125|P6|NOT COMPLETED|Test Period 1||0
27666|NCT01975220|66126|P5|NOT COMPLETED|Test Period 1||0
27667|NCT01975220|66127|P4|NOT COMPLETED|Test Period 1||0
27668|NCT01975220|66128|P3|NOT COMPLETED|Test Period 1||0
27669|NCT01975220|66129|P2|NOT COMPLETED|Test Period 1||1
27670|NCT01975220|66130|P1|NOT COMPLETED|Test Period 1||0
27671|NCT01975220|66125|P6|COMPLETED|Test Period 1||12
27672|NCT01975220|66126|P5|COMPLETED|Test Period 1||12
27673|NCT01975220|66127|P4|COMPLETED|Test Period 1||12
27674|NCT01975220|66128|P3|COMPLETED|Test Period 1||12
27675|NCT01975220|66129|P2|COMPLETED|Test Period 1||11
27676|NCT01975220|66130|P1|COMPLETED|Test Period 1||12
27677|NCT01975220|66125|P6|STARTED|Test Period 1||12
27678|NCT01975220|66126|P5|STARTED|Test Period 1||12
27679|NCT01975220|66127|P4|STARTED|Test Period 1||12
27680|NCT01975220|66128|P3|STARTED|Test Period 1||12
27681|NCT01975220|66129|P2|STARTED|Test Period 1||12
27682|NCT01975220|66130|P1|STARTED|Test Period 1||12
27683|NCT01974895|66176|P2|NOT COMPLETED|Overall Study||15
27684|NCT01974895|66177|P1|NOT COMPLETED|Overall Study||15
27685|NCT01974895|66176|P2|COMPLETED|Overall Study||141
27686|NCT01974895|66177|P1|COMPLETED|Overall Study||143
27687|NCT01974895|66176|P2|STARTED|Overall Study||156
27688|NCT01974895|66177|P1|STARTED|Overall Study||158
27689|NCT01974817|66207|P1|NOT COMPLETED|Overall Study||8
27690|NCT01974817|66207|P1|COMPLETED|Overall Study||17
27691|NCT01974817|66207|P1|STARTED|Overall Study||25
27692|NCT01974752|66213|P2|NOT COMPLETED|Overall Study||15
27693|NCT01974752|66214|P1|NOT COMPLETED|Overall Study||37
27694|NCT01974752|66213|P2|COMPLETED|Overall Study||17
27695|NCT01974752|66214|P1|COMPLETED|Overall Study||60
27696|NCT01974752|66213|P2|STARTED|Overall Study||32
27697|NCT01974752|66214|P1|STARTED|Overall Study||97
27698|NCT01974700|66228|P2|NOT COMPLETED|Overall Study||0
27699|NCT01974700|66229|P1|NOT COMPLETED|Overall Study||0
27700|NCT01974700|66228|P2|COMPLETED|Overall Study||3
27701|NCT01974700|66229|P1|COMPLETED|Overall Study||5
27702|NCT01974700|66228|P2|STARTED|Overall Study||3
27703|NCT01974700|66229|P1|STARTED|Overall Study||5
27704|NCT01974323|66241|P2|NOT COMPLETED|Overall Study||93
27705|NCT01974323|66242|P1|NOT COMPLETED|Overall Study||92
27706|NCT01974323|66241|P2|COMPLETED|Overall Study||1027
27707|NCT01974323|66242|P1|COMPLETED|Overall Study||1026
27708|NCT01974323|66241|P2|STARTED|Overall Study||1120
27709|NCT01974323|66242|P1|STARTED|Overall Study||1118
27710|NCT01974245|66266|P2|NOT COMPLETED|Overall Study||8
27711|NCT01974245|66267|P1|NOT COMPLETED|Overall Study||9
27712|NCT01974245|66266|P2|COMPLETED|Overall Study||20
27713|NCT01974245|66267|P1|COMPLETED|Overall Study||18
27714|NCT01974245|66266|P2|STARTED|Overall Study||28
27715|NCT01974245|66267|P1|STARTED|Overall Study||27
27716|NCT01974141|66275|P2|NOT COMPLETED|Overall Study||82
27717|NCT01974141|66276|P1|NOT COMPLETED|Overall Study||96
27718|NCT01974141|66275|P2|COMPLETED|Overall Study||976
27719|NCT01974141|66276|P1|COMPLETED|Overall Study||948
27720|NCT01974141|66275|P2|STARTED|Overall Study||1058
27721|NCT01974141|66276|P1|STARTED|Overall Study||1044
27722|NCT01973777|66298|P1|NOT COMPLETED|Overall Study||7
27723|NCT01973777|66298|P1|COMPLETED|Overall Study||44
27724|NCT01973777|66298|P1|One Year Follow-up|Overall Study||44
27725|NCT01973777|66298|P1|STARTED|Overall Study|January 2014|51
27726|NCT01973608|66308|P4|NOT COMPLETED|Overall Study||0
27727|NCT01973608|66309|P3|NOT COMPLETED|Overall Study||0
27728|NCT01973608|66310|P2|NOT COMPLETED|Overall Study||0
27729|NCT01973608|66311|P1|NOT COMPLETED|Overall Study||0
27730|NCT01973608|66308|P4|COMPLETED|Overall Study||2
27731|NCT01973608|66309|P3|COMPLETED|Overall Study||6
27732|NCT01973608|66310|P2|COMPLETED|Overall Study||2
27733|NCT01973608|66311|P1|COMPLETED|Overall Study||2
27734|NCT01973608|66308|P4|STARTED|Overall Study||2
27735|NCT01973608|66309|P3|STARTED|Overall Study||6
27736|NCT01973608|66310|P2|STARTED|Overall Study||2
27737|NCT01973608|66311|P1|STARTED|Overall Study||2
27738|NCT01973595|66333|P4|NOT COMPLETED|Intervention Phase 2||0
27739|NCT01973595|66334|P3|NOT COMPLETED|Intervention Phase 2||0
27740|NCT01973595|66335|P2|NOT COMPLETED|Intervention Phase 2||0
27741|NCT01973595|66336|P1|NOT COMPLETED|Intervention Phase 2||0
27742|NCT01973595|66333|P4|COMPLETED|Intervention Phase 2||14
27743|NCT01973595|66334|P3|COMPLETED|Intervention Phase 2||14
27744|NCT01973595|66335|P2|COMPLETED|Intervention Phase 2||14
27745|NCT01973595|66336|P1|COMPLETED|Intervention Phase 2||14
27746|NCT01973595|66333|P4|STARTED|Intervention Phase 2||14
27747|NCT01973595|66334|P3|STARTED|Intervention Phase 2||14
27748|NCT01973595|66335|P2|STARTED|Intervention Phase 2||14
27749|NCT01973595|66336|P1|STARTED|Intervention Phase 2||14
27750|NCT01973595|66333|P4|NOT COMPLETED|Washout||0
27751|NCT01973595|66334|P3|NOT COMPLETED|Washout||1
27752|NCT01973595|66335|P2|NOT COMPLETED|Washout||0
27753|NCT01973595|66336|P1|NOT COMPLETED|Washout||1
27754|NCT01973595|66333|P4|COMPLETED|Washout||14
27755|NCT01973595|66334|P3|COMPLETED|Washout||14
27756|NCT01973595|66335|P2|COMPLETED|Washout||14
27757|NCT01973595|66336|P1|COMPLETED|Washout||14
27758|NCT01973595|66333|P4|STARTED|Washout||14
27759|NCT01973595|66334|P3|STARTED|Washout||15
27760|NCT01973595|66335|P2|STARTED|Washout||14
27761|NCT01973595|66336|P1|STARTED|Washout||15
27762|NCT01973595|66333|P4|NOT COMPLETED|Intervention Phase 1||0
27763|NCT01973595|66334|P3|NOT COMPLETED|Intervention Phase 1||0
27764|NCT01973595|66335|P2|NOT COMPLETED|Intervention Phase 1||0
27765|NCT01973595|66336|P1|NOT COMPLETED|Intervention Phase 1||0
27766|NCT01973595|66333|P4|COMPLETED|Intervention Phase 1||14
27767|NCT01973595|66334|P3|COMPLETED|Intervention Phase 1||15
27768|NCT01973595|66335|P2|COMPLETED|Intervention Phase 1||14
27769|NCT01973595|66336|P1|COMPLETED|Intervention Phase 1||15
27770|NCT01973595|66333|P4|STARTED|Intervention Phase 1||14
27771|NCT01973595|66334|P3|STARTED|Intervention Phase 1||15
27772|NCT01973595|66335|P2|STARTED|Intervention Phase 1||14
27773|NCT01973595|66336|P1|STARTED|Intervention Phase 1||15
27774|NCT01973491|66350|P1|NOT COMPLETED|Treatment Period (16 Weeks)||1
27775|NCT01973491|66350|P1|COMPLETED|Treatment Period (16 Weeks)||18
27776|NCT01973491|66350|P1|STARTED|Treatment Period (16 Weeks)||19
27777|NCT01973491|66350|P1|NOT COMPLETED|Titration Period(4 Weeks)||0
27778|NCT01973491|66350|P1|COMPLETED|Titration Period(4 Weeks)||19
27779|NCT01973491|66350|P1|STARTED|Titration Period(4 Weeks)||19
27780|NCT01973491|66350|P1|NOT COMPLETED|Baseline Control Period (8 Weeks)||18
27781|NCT01973491|66350|P1|COMPLETED|Baseline Control Period (8 Weeks)||19
27782|NCT01973491|66350|P1|STARTED|Baseline Control Period (8 Weeks)||37
27783|NCT01973439|66366|P1|NOT COMPLETED|Overall Study||5
27784|NCT01973439|66366|P1|COMPLETED|Overall Study||18
27785|NCT01973439|66366|P1|One Evaluable PK Day Only|Overall Study|5 children had only one evaluable PK day.|5
27786|NCT01973439|66366|P1|Two Evaluable PK Days|Overall Study|18 Children had two evaluable PK days|18
27787|NCT01973439|66366|P1|STARTED|Overall Study||23
27788|NCT01973413|66375|P2|NOT COMPLETED|Overall Study||0
27789|NCT01973413|66376|P1|NOT COMPLETED|Overall Study||1
27790|NCT01973413|66375|P2|COMPLETED|Overall Study||20
27791|NCT01973413|66376|P1|COMPLETED|Overall Study||11
27792|NCT01973413|66375|P2|STARTED|Overall Study||20
27793|NCT01973413|66376|P1|STARTED|Overall Study||12
27794|NCT01973387|66388|P2|NOT COMPLETED|Overall Study||18
27795|NCT01973387|66389|P1|NOT COMPLETED|Overall Study||106
27796|NCT01973387|66388|P2|COMPLETED|Overall Study||36
27797|NCT01973387|66389|P1|COMPLETED|Overall Study||0
27798|NCT01973387|66388|P2|Treated|Overall Study||52
27799|NCT01973387|66389|P1|Treated|Overall Study||104
27800|NCT01973387|66388|P2|STARTED|Overall Study||54
27801|NCT01973387|66389|P1|STARTED|Overall Study||106
27802|NCT01973348|66403|P4|NOT COMPLETED|Overall Study||0
27803|NCT01973348|66404|P3|NOT COMPLETED|Overall Study||0
27804|NCT01973348|66405|P2|NOT COMPLETED|Overall Study||3
27805|NCT01973348|66406|P1|NOT COMPLETED|Overall Study||8
27806|NCT01973348|66403|P4|COMPLETED|Overall Study||0
27807|NCT01973348|66404|P3|COMPLETED|Overall Study||0
27808|NCT01973348|66405|P2|COMPLETED|Overall Study||15
27809|NCT01973348|66406|P1|COMPLETED|Overall Study||19
27810|NCT01973348|66403|P4|STARTED|Overall Study||0
27811|NCT01973348|66404|P3|STARTED|Overall Study||0
27812|NCT01973348|66405|P2|STARTED|Overall Study||18
27813|NCT01973348|66406|P1|STARTED|Overall Study||27
27814|NCT01973231|66426|P2|NOT COMPLETED|Overall Study||12
27815|NCT01973231|66427|P1|NOT COMPLETED|Overall Study||11
27816|NCT01973231|66426|P2|COMPLETED|Overall Study||190
27817|NCT01973231|66427|P1|COMPLETED|Overall Study||191
27818|NCT01973231|66426|P2|STARTED|Overall Study||202
27819|NCT01973231|66427|P1|STARTED|Overall Study||202
27820|NCT01973218|66447|P2|NOT COMPLETED|Overall Study||0
27821|NCT01973218|66448|P1|NOT COMPLETED|Overall Study||2
27822|NCT01973218|66447|P2|COMPLETED|Overall Study||88
27823|NCT01973218|66448|P1|COMPLETED|Overall Study||174
27824|NCT01973218|66447|P2|STARTED|Overall Study||88
27825|NCT01973218|66448|P1|STARTED|Overall Study||176
27826|NCT01973205|66471|P2|NOT COMPLETED|Overall Study||22
27827|NCT01973205|66472|P1|NOT COMPLETED|Overall Study||30
27828|NCT01973205|66471|P2|COMPLETED|Overall Study||425
27829|NCT01973205|66472|P1|COMPLETED|Overall Study||423
27830|NCT01973205|66471|P2|STARTED|Overall Study||447
27831|NCT01973205|66472|P1|STARTED|Overall Study||453
27832|NCT01972776|66490|P6|NOT COMPLETED|Part 2||7
27833|NCT01972776|66491|P5|NOT COMPLETED|Part 2||13
27834|NCT01972776|66492|P4|NOT COMPLETED|Part 2||0
27835|NCT01972776|66493|P3|NOT COMPLETED|Part 2||0
27836|NCT01972776|66494|P2|NOT COMPLETED|Part 2||0
27837|NCT01972776|66495|P1|NOT COMPLETED|Part 2||0
27838|NCT01972776|66490|P6|COMPLETED|Part 2||0
27839|NCT01972776|66491|P5|COMPLETED|Part 2||1
27840|NCT01972776|66492|P4|COMPLETED|Part 2||0
27841|NCT01972776|66493|P3|COMPLETED|Part 2||0
27842|NCT01972776|66494|P2|COMPLETED|Part 2||0
27843|NCT01972776|66495|P1|COMPLETED|Part 2||0
27844|NCT01972776|66490|P6|STARTED|Part 2||7
27845|NCT01972776|66491|P5|STARTED|Part 2||14
27846|NCT01972776|66492|P4|STARTED|Part 2||0
27847|NCT01972776|66493|P3|STARTED|Part 2||0
27848|NCT01972776|66494|P2|STARTED|Part 2||0
27849|NCT01972776|66495|P1|STARTED|Part 2||0
27850|NCT01972776|66490|P6|NOT COMPLETED|Part 1||0
27851|NCT01972776|66491|P5|NOT COMPLETED|Part 1||0
27852|NCT01972776|66492|P4|NOT COMPLETED|Part 1||1
27853|NCT01972776|66493|P3|NOT COMPLETED|Part 1||2
27854|NCT01972776|66494|P2|NOT COMPLETED|Part 1||0
27855|NCT01972776|66495|P1|NOT COMPLETED|Part 1||0
27856|NCT01972776|66490|P6|COMPLETED|Part 1||0
27857|NCT01972776|66491|P5|COMPLETED|Part 1||0
27858|NCT01972776|66492|P4|COMPLETED|Part 1||6
27859|NCT01972776|66493|P3|COMPLETED|Part 1||6
27860|NCT01972776|66494|P2|COMPLETED|Part 1||6
27861|NCT01972776|66495|P1|COMPLETED|Part 1||6
27862|NCT01972776|66490|P6|STARTED|Part 1||0
27863|NCT01972776|66491|P5|STARTED|Part 1||0
27864|NCT01972776|66492|P4|STARTED|Part 1||7
27865|NCT01972776|66493|P3|STARTED|Part 1||8
27866|NCT01972776|66494|P2|STARTED|Part 1||6
27867|NCT01972776|66495|P1|STARTED|Part 1||6
27868|NCT01972659|66565|P2|NOT COMPLETED|Overall Study||3
27869|NCT01972659|66566|P1|NOT COMPLETED|Overall Study||4
27870|NCT01972659|66565|P2|COMPLETED|Overall Study||37
27871|NCT01972659|66566|P1|COMPLETED|Overall Study||36
27872|NCT01972659|66565|P2|STARTED|Overall Study||40
27873|NCT01972659|66566|P1|STARTED|Overall Study||40
27874|NCT01972516|66574|P2|NOT COMPLETED|Overall Study||0
27875|NCT01972516|66575|P1|NOT COMPLETED|Overall Study||0
27876|NCT01972516|66574|P2|COMPLETED|Overall Study||1
27877|NCT01972516|66575|P1|COMPLETED|Overall Study||3
27878|NCT01972516|66574|P2|STARTED|Overall Study||1
27879|NCT01972516|66575|P1|STARTED|Overall Study||3
27880|NCT01972438|66591|P2|NOT COMPLETED|Post Month 12 Study Period||4
27881|NCT01972438|66592|P1|NOT COMPLETED|Post Month 12 Study Period||3
27882|NCT01972438|66591|P2|COMPLETED|Post Month 12 Study Period||0
27883|NCT01972438|66592|P1|COMPLETED|Post Month 12 Study Period||0
27884|NCT01972438|66591|P2|STARTED|Post Month 12 Study Period||4
27885|NCT01972438|66592|P1|STARTED|Post Month 12 Study Period||3
27886|NCT01972438|66591|P2|NOT COMPLETED|Months 6-12 Study Period||2
27887|NCT01972438|66592|P1|NOT COMPLETED|Months 6-12 Study Period||3
27888|NCT01972438|66591|P2|COMPLETED|Months 6-12 Study Period||4
27889|NCT01972438|66592|P1|COMPLETED|Months 6-12 Study Period||3
27890|NCT01972438|66591|P2|STARTED|Months 6-12 Study Period||6
27891|NCT01972438|66592|P1|STARTED|Months 6-12 Study Period||6
27892|NCT01972438|66591|P2|NOT COMPLETED|Months 3-6 Crossover Period||1
27893|NCT01972438|66592|P1|NOT COMPLETED|Months 3-6 Crossover Period||0
27894|NCT01972438|66591|P2|COMPLETED|Months 3-6 Crossover Period||6
27895|NCT01972438|66592|P1|COMPLETED|Months 3-6 Crossover Period||6
27896|NCT01972438|66591|P2|STARTED|Months 3-6 Crossover Period|Two participants who missed Month 3 visit completed this pd but one who completed Month 3 didn't|7
27897|NCT01972438|66592|P1|STARTED|Months 3-6 Crossover Period||6
27898|NCT01972438|66591|P2|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
27899|NCT01972438|66592|P1|NOT COMPLETED|Baseline-Month 3 Crossover Period||3
27900|NCT01972438|66591|P2|COMPLETED|Baseline-Month 3 Crossover Period||6
27901|NCT01972438|66592|P1|COMPLETED|Baseline-Month 3 Crossover Period||6
27902|NCT01972438|66591|P2|STARTED|Baseline-Month 3 Crossover Period|One participant never started IP, as unable to donate blood for preparation of ASEDs|9
27903|NCT01972438|66592|P1|STARTED|Baseline-Month 3 Crossover Period|Two participants never started IP: one died and one did not meet the inclusion criteria|9
27904|NCT01972152|66644|P6|NOT COMPLETED|Third Treatment Visit||0
27905|NCT01972152|66645|P5|NOT COMPLETED|Third Treatment Visit||0
27906|NCT01972152|66646|P4|NOT COMPLETED|Third Treatment Visit||0
27907|NCT01972152|66647|P3|NOT COMPLETED|Third Treatment Visit||0
27908|NCT01972152|66648|P2|NOT COMPLETED|Third Treatment Visit||0
27909|NCT01972152|66649|P1|NOT COMPLETED|Third Treatment Visit||0
27910|NCT01972152|66644|P6|COMPLETED|Third Treatment Visit||5
27911|NCT01972152|66645|P5|COMPLETED|Third Treatment Visit||5
27912|NCT01972152|66646|P4|COMPLETED|Third Treatment Visit||5
27913|NCT01972152|66647|P3|COMPLETED|Third Treatment Visit||5
27914|NCT01972152|66648|P2|COMPLETED|Third Treatment Visit||3
27915|NCT01972152|66649|P1|COMPLETED|Third Treatment Visit||5
27916|NCT01972152|66644|P6|STARTED|Third Treatment Visit||5
27917|NCT01972152|66645|P5|STARTED|Third Treatment Visit||5
27918|NCT01972152|66646|P4|STARTED|Third Treatment Visit||5
27919|NCT01972152|66647|P3|STARTED|Third Treatment Visit||5
27920|NCT01972152|66648|P2|STARTED|Third Treatment Visit||3
27921|NCT01972152|66649|P1|STARTED|Third Treatment Visit||5
27922|NCT01972152|66644|P6|NOT COMPLETED|Second Treatment Visit||0
27923|NCT01972152|66645|P5|NOT COMPLETED|Second Treatment Visit||0
27924|NCT01972152|66646|P4|NOT COMPLETED|Second Treatment Visit||0
27925|NCT01972152|66647|P3|NOT COMPLETED|Second Treatment Visit||0
27926|NCT01972152|66648|P2|NOT COMPLETED|Second Treatment Visit||1
27927|NCT01972152|66649|P1|NOT COMPLETED|Second Treatment Visit||0
27928|NCT01972152|66644|P6|COMPLETED|Second Treatment Visit||5
27929|NCT01972152|66645|P5|COMPLETED|Second Treatment Visit||5
27930|NCT01972152|66646|P4|COMPLETED|Second Treatment Visit||5
27931|NCT01972152|66647|P3|COMPLETED|Second Treatment Visit||5
27932|NCT01972152|66648|P2|COMPLETED|Second Treatment Visit||3
27933|NCT01972152|66649|P1|COMPLETED|Second Treatment Visit||5
27934|NCT01972152|66644|P6|STARTED|Second Treatment Visit||5
27935|NCT01972152|66645|P5|STARTED|Second Treatment Visit||5
27936|NCT01972152|66646|P4|STARTED|Second Treatment Visit||5
27937|NCT01972152|66647|P3|STARTED|Second Treatment Visit||5
27938|NCT01972152|66648|P2|STARTED|Second Treatment Visit||4
27939|NCT01972152|66649|P1|STARTED|Second Treatment Visit||5
27940|NCT01972152|66644|P6|NOT COMPLETED|First Treatment Visit||0
27941|NCT01972152|66645|P5|NOT COMPLETED|First Treatment Visit||0
27942|NCT01972152|66646|P4|NOT COMPLETED|First Treatment Visit||0
27943|NCT01972152|66647|P3|NOT COMPLETED|First Treatment Visit||0
27944|NCT01972152|66648|P2|NOT COMPLETED|First Treatment Visit||1
27945|NCT01972152|66649|P1|NOT COMPLETED|First Treatment Visit||0
27946|NCT01972152|66644|P6|COMPLETED|First Treatment Visit||5
27947|NCT01972152|66645|P5|COMPLETED|First Treatment Visit||5
27948|NCT01972152|66646|P4|COMPLETED|First Treatment Visit||5
27949|NCT01972152|66647|P3|COMPLETED|First Treatment Visit||5
27950|NCT01972152|66648|P2|COMPLETED|First Treatment Visit||4
27951|NCT01972152|66649|P1|COMPLETED|First Treatment Visit||5
27952|NCT01972152|66644|P6|STARTED|First Treatment Visit||5
27953|NCT01972152|66645|P5|STARTED|First Treatment Visit||5
27954|NCT01972152|66646|P4|STARTED|First Treatment Visit||5
27955|NCT01972152|66647|P3|STARTED|First Treatment Visit||5
27956|NCT01972152|66648|P2|STARTED|First Treatment Visit||5
27957|NCT01972152|66649|P1|STARTED|First Treatment Visit||5
27958|NCT01971723|66686|P2|NOT COMPLETED|Overall Study||3
27959|NCT01971723|66687|P1|NOT COMPLETED|Overall Study||2
27960|NCT01971723|66686|P2|COMPLETED|Overall Study||13
27961|NCT01971723|66687|P1|COMPLETED|Overall Study||14
27962|NCT01971723|66686|P2|STARTED|Overall Study||16
27963|NCT01971723|66687|P1|STARTED|Overall Study||16
27964|NCT01971554|66721|P4|NOT COMPLETED|Overall Study||0
27965|NCT01971554|66722|P3|NOT COMPLETED|Overall Study||0
27966|NCT01971554|66723|P2|NOT COMPLETED|Overall Study||0
27967|NCT01971554|66724|P1|NOT COMPLETED|Overall Study||1
27968|NCT01971554|66721|P4|COMPLETED|Overall Study||18
27969|NCT01971554|66722|P3|COMPLETED|Overall Study||18
27970|NCT01971554|66723|P2|COMPLETED|Overall Study||18
27971|NCT01971554|66724|P1|COMPLETED|Overall Study||8
27972|NCT01971554|66721|P4|STARTED|Overall Study||18
27973|NCT01971554|66722|P3|STARTED|Overall Study||18
27974|NCT01971554|66723|P2|STARTED|Overall Study||18
27975|NCT01971554|66724|P1|STARTED|Overall Study||9
27976|NCT01971255|66760|P2|NOT COMPLETED|Overall Study||2
27977|NCT01971255|66761|P1|NOT COMPLETED|Overall Study||1
27978|NCT01971255|66760|P2|COMPLETED|Overall Study||40
27979|NCT01971255|66761|P1|COMPLETED|Overall Study||31
27980|NCT01971255|66760|P2|STARTED|Overall Study||42
27981|NCT01971255|66761|P1|STARTED|Overall Study||32
27982|NCT01971086|66777|P1|NOT COMPLETED|Overall Study||0
27983|NCT01971086|66777|P1|COMPLETED|Overall Study||300
27984|NCT01971086|66777|P1|STARTED|Overall Study||300
27985|NCT01970995|66792|P3|NOT COMPLETED|End of Study (Population at Day 90)||1
27986|NCT01970995|66793|P2|NOT COMPLETED|End of Study (Population at Day 90)||0
27987|NCT01970995|66794|P1|NOT COMPLETED|End of Study (Population at Day 90)||1
27988|NCT01970995|66792|P3|COMPLETED|End of Study (Population at Day 90)||38
27989|NCT01970995|66793|P2|COMPLETED|End of Study (Population at Day 90)||41
27990|NCT01970995|66794|P1|COMPLETED|End of Study (Population at Day 90)||76
27991|NCT01970995|66792|P3|STARTED|End of Study (Population at Day 90)||39
27992|NCT01970995|66793|P2|STARTED|End of Study (Population at Day 90)||41
27993|NCT01970995|66794|P1|STARTED|End of Study (Population at Day 90)||77
27994|NCT01970995|66792|P3|NOT COMPLETED|Confinement Period (Population at Day 5)||1
27995|NCT01970995|66793|P2|NOT COMPLETED|Confinement Period (Population at Day 5)||1
27996|NCT01970995|66794|P1|NOT COMPLETED|Confinement Period (Population at Day 5)||1
27997|NCT01970995|66792|P3|COMPLETED|Confinement Period (Population at Day 5)||39
27998|NCT01970995|66793|P2|COMPLETED|Confinement Period (Population at Day 5)||41
27999|NCT01970995|66794|P1|COMPLETED|Confinement Period (Population at Day 5)||77
28000|NCT01970995|66792|P3|STARTED|Confinement Period (Population at Day 5)||40
28001|NCT01970995|66793|P2|STARTED|Confinement Period (Population at Day 5)||42
28002|NCT01970995|66794|P1|STARTED|Confinement Period (Population at Day 5)||78
28003|NCT01970982|66817|P3|NOT COMPLETED|Overall Study||2
28004|NCT01970982|66818|P2|NOT COMPLETED|Overall Study||0
28005|NCT01970982|66819|P1|NOT COMPLETED|Overall Study||0
28006|NCT01970982|66817|P3|COMPLETED|Overall Study||38
28007|NCT01970982|66818|P2|COMPLETED|Overall Study||40
28008|NCT01970982|66819|P1|COMPLETED|Overall Study||80
28009|NCT01970982|66817|P3|STARTED|Overall Study||40
28010|NCT01970982|66818|P2|STARTED|Overall Study||40
28011|NCT01970982|66819|P1|STARTED|Overall Study||80
28012|NCT01970878|66841|P4|NOT COMPLETED|Overall Study||24
28013|NCT01970878|66842|P3|NOT COMPLETED|Overall Study||26
28014|NCT01970878|66843|P2|NOT COMPLETED|Overall Study||27
28015|NCT01970878|66844|P1|NOT COMPLETED|Overall Study||37
28016|NCT01970878|66841|P4|COMPLETED|Overall Study||147
28017|NCT01970878|66842|P3|COMPLETED|Overall Study||187
28018|NCT01970878|66843|P2|COMPLETED|Overall Study||191
28019|NCT01970878|66844|P1|COMPLETED|Overall Study||253
28020|NCT01970878|66841|P4|STARTED|Overall Study||171
28021|NCT01970878|66842|P3|STARTED|Overall Study||213
28022|NCT01970878|66843|P2|STARTED|Overall Study|218 subjects were reported in the CSR, 1 had no completion status|218
28023|NCT01970878|66844|P1|STARTED|Overall Study||290
28024|NCT01970787|66870|P1|NOT COMPLETED|Overall Study||1
28025|NCT01970787|66870|P1|COMPLETED|Overall Study||21
28026|NCT01970787|66870|P1|STARTED|Overall Study||22
28027|NCT01970488|66880|P5|NOT COMPLETED|Part 2: Post Week 16||8
28028|NCT01970488|66881|P4|NOT COMPLETED|Part 2: Post Week 16||8
28029|NCT01970488|66882|P3|NOT COMPLETED|Part 2: Post Week 16||17
28030|NCT01970488|66883|P2|NOT COMPLETED|Part 2: Post Week 16||0
28031|NCT01970488|66884|P1|NOT COMPLETED|Part 2: Post Week 16||0
28032|NCT01970488|66880|P5|COMPLETED|Part 2: Post Week 16||69
28033|NCT01970488|66881|P4|COMPLETED|Part 2: Post Week 16||71
28034|NCT01970488|66882|P3|COMPLETED|Part 2: Post Week 16||135
28035|NCT01970488|66883|P2|COMPLETED|Part 2: Post Week 16||0
28036|NCT01970488|66884|P1|COMPLETED|Part 2: Post Week 16||0
28037|NCT01970488|66880|P5|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|77
28038|NCT01970488|66881|P4|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|79
28039|NCT01970488|66882|P3|STARTED|Part 2: Post Week 16|Only participants who completed week 16 and with a PASI 50 response continued in Part 2|152
28040|NCT01970488|66883|P2|STARTED|Part 2: Post Week 16||0
28041|NCT01970488|66884|P1|STARTED|Part 2: Post Week 16||0
28042|NCT01970488|66880|P5|NOT COMPLETED|Part 1: Through Week 16||0
28043|NCT01970488|66881|P4|NOT COMPLETED|Part 1: Through Week 16||0
28044|NCT01970488|66882|P3|NOT COMPLETED|Part 1: Through Week 16||0
28045|NCT01970488|66883|P2|NOT COMPLETED|Part 1: Through Week 16||13
28046|NCT01970488|66884|P1|NOT COMPLETED|Part 1: Through Week 16||11
28047|NCT01970488|66880|P5|COMPLETED|Part 1: Through Week 16||0
28048|NCT01970488|66881|P4|COMPLETED|Part 1: Through Week 16||0
28049|NCT01970488|66882|P3|COMPLETED|Part 1: Through Week 16||0
28050|NCT01970488|66883|P2|COMPLETED|Part 1: Through Week 16||162
28051|NCT01970488|66884|P1|COMPLETED|Part 1: Through Week 16||164
28052|NCT01970488|66880|P5|Received Treatment|Part 1: Through Week 16||0
28053|NCT01970488|66881|P4|Received Treatment|Part 1: Through Week 16||0
28054|NCT01970488|66882|P3|Received Treatment|Part 1: Through Week 16||0
28055|NCT01970488|66883|P2|Received Treatment|Part 1: Through Week 16||173
28056|NCT01970488|66884|P1|Received Treatment|Part 1: Through Week 16||174
28057|NCT01970488|66880|P5|STARTED|Part 1: Through Week 16||0
28058|NCT01970488|66881|P4|STARTED|Part 1: Through Week 16||0
28059|NCT01970488|66882|P3|STARTED|Part 1: Through Week 16||0
28060|NCT01970488|66883|P2|STARTED|Part 1: Through Week 16||175
28061|NCT01970488|66884|P1|STARTED|Part 1: Through Week 16||175
28062|NCT01970475|66951|P2|NOT COMPLETED|Overall Study||11
28063|NCT01970475|66952|P1|NOT COMPLETED|Overall Study||21
28064|NCT01970475|66951|P2|COMPLETED|Overall Study||251
28065|NCT01970475|66952|P1|COMPLETED|Overall Study||243
28066|NCT01970475|66951|P2|STARTED|Overall Study||262
28067|NCT01970475|66952|P1|STARTED|Overall Study||264
28068|NCT01970397|66972|P2|NOT COMPLETED|Overall Study||5
28069|NCT01970397|66973|P1|NOT COMPLETED|Overall Study||2
28070|NCT01970397|66972|P2|COMPLETED|Overall Study||64
28071|NCT01970397|66973|P1|COMPLETED|Overall Study||67
28072|NCT01970397|66972|P2|STARTED|Overall Study||69
28073|NCT01970397|66973|P1|STARTED|Overall Study||69
28074|NCT01969799|66985|P2|NOT COMPLETED|Overall Study||14
28075|NCT01969799|66986|P1|NOT COMPLETED|Overall Study||17
28076|NCT01969799|66985|P2|COMPLETED|Overall Study||58
28077|NCT01969799|66986|P1|COMPLETED|Overall Study||54
28078|NCT01969799|66985|P2|STARTED|Overall Study||72
28079|NCT01969799|66986|P1|STARTED|Overall Study||71
28080|NCT01969747|67010|P4|NOT COMPLETED|Overall Study||0
28081|NCT01969747|67011|P3|NOT COMPLETED|Overall Study||0
28082|NCT01969747|67012|P2|NOT COMPLETED|Overall Study||0
28083|NCT01969747|67013|P1|NOT COMPLETED|Overall Study||0
28084|NCT01969747|67010|P4|COMPLETED|Overall Study||18
28085|NCT01969747|67011|P3|COMPLETED|Overall Study||19
28086|NCT01969747|67012|P2|COMPLETED|Overall Study||19
28087|NCT01969747|67013|P1|COMPLETED|Overall Study||19
28088|NCT01969747|67010|P4|STARTED|Overall Study||18
28089|NCT01969747|67011|P3|STARTED|Overall Study||19
28090|NCT01969747|67012|P2|STARTED|Overall Study||19
28091|NCT01969747|67013|P1|STARTED|Overall Study||19
28092|NCT01969721|67023|P4|NOT COMPLETED|Overall Study||6
28093|NCT01969721|67024|P3|NOT COMPLETED|Overall Study||5
28094|NCT01969721|67025|P2|NOT COMPLETED|Overall Study||12
28095|NCT01969721|67026|P1|NOT COMPLETED|Overall Study||4
28096|NCT01969721|67023|P4|COMPLETED|Overall Study||46
28097|NCT01969721|67024|P3|COMPLETED|Overall Study||45
28098|NCT01969721|67025|P2|COMPLETED|Overall Study||57
28099|NCT01969721|67026|P1|COMPLETED|Overall Study||54
28100|NCT01969721|67023|P4|STARTED|Overall Study||52
28101|NCT01969721|67024|P3|STARTED|Overall Study||50
28102|NCT01969721|67025|P2|STARTED|Overall Study||69
28103|NCT01969721|67026|P1|STARTED|Overall Study||58
28104|NCT01969565|67052|P1|NOT COMPLETED|Overall Study||1
28105|NCT01969565|67052|P1|COMPLETED|Overall Study||0
28106|NCT01969565|67052|P1|STARTED|Overall Study||1
28107|NCT01969539|67056|P1|NOT COMPLETED|Overall Study||0
28108|NCT01969539|67056|P1|COMPLETED|Overall Study||11
28109|NCT01969539|67056|P1|STARTED|Overall Study||11
28110|NCT01969435|67062|P1|NOT COMPLETED|Overall Study||0
28111|NCT01969435|67062|P1|COMPLETED|Overall Study||50
28112|NCT01969435|67062|P1|STARTED|Overall Study||50
28113|NCT01969162|67075|P1|NOT COMPLETED|Overall Study||0
28114|NCT01969162|67075|P1|COMPLETED|Overall Study||35
28115|NCT01969162|67075|P1|STARTED|Overall Study||35
28116|NCT01969084|67081|P2|NOT COMPLETED|Overall Study||1
28117|NCT01969084|67082|P1|NOT COMPLETED|Overall Study||0
28118|NCT01969084|67081|P2|COMPLETED|Overall Study|One subject withdrew due to unrelated serious adverse event|21
28119|NCT01969084|67082|P1|COMPLETED|Overall Study||19
28120|NCT01969084|67081|P2|STARTED|Overall Study||22
28121|NCT01969084|67082|P1|STARTED|Overall Study||19
28122|NCT01968980|67098|P2|NOT COMPLETED|Overall Study||14
28123|NCT01968980|67099|P1|NOT COMPLETED|Overall Study||16
28124|NCT01968980|67098|P2|COMPLETED|Overall Study||171
28125|NCT01968980|67099|P1|COMPLETED|Overall Study||169
28126|NCT01968980|67098|P2|STARTED|Overall Study||185
28127|NCT01968980|67099|P1|STARTED|Overall Study||185
28128|NCT01968967|67161|P2|NOT COMPLETED|Overall Study||134
28129|NCT01968967|67162|P1|NOT COMPLETED|Overall Study||146
28130|NCT01968967|67161|P2|COMPLETED|Overall Study||934
28131|NCT01968967|67162|P1|COMPLETED|Overall Study||925
28132|NCT01968967|67161|P2|Treated|Overall Study||1063
28133|NCT01968967|67162|P1|Treated|Overall Study||1065
28134|NCT01968967|67161|P2|STARTED|Overall Study||1068
28135|NCT01968967|67162|P1|STARTED|Overall Study||1071
28136|NCT01968954|67223|P2|NOT COMPLETED|Overall Study||43
28137|NCT01968954|67224|P1|NOT COMPLETED|Overall Study||40
28138|NCT01968954|67223|P2|COMPLETED|Overall Study||314
28139|NCT01968954|67224|P1|COMPLETED|Overall Study||314
28140|NCT01968954|67223|P2|Treated|Overall Study||356
28141|NCT01968954|67224|P1|Treated|Overall Study||353
28142|NCT01968954|67223|P2|STARTED|Overall Study||357
28143|NCT01968954|67224|P1|STARTED|Overall Study||354
28144|NCT01968811|67288|P1|NOT COMPLETED|Overall Study||5
28145|NCT01968811|67288|P1|COMPLETED|Overall Study||5
28146|NCT01968811|67288|P1|STARTED|Overall Study||10
28147|NCT01968694|67295|P2|NOT COMPLETED|Visit 2 (1 Day)||0
28148|NCT01968694|67296|P1|NOT COMPLETED|Visit 2 (1 Day)||0
28149|NCT01968694|67295|P2|COMPLETED|Visit 2 (1 Day)||8
28150|NCT01968694|67296|P1|COMPLETED|Visit 2 (1 Day)||10
28151|NCT01968694|67295|P2|STARTED|Visit 2 (1 Day)||8
28152|NCT01968694|67296|P1|STARTED|Visit 2 (1 Day)||10
28153|NCT01968694|67295|P2|NOT COMPLETED|Washout (1 Month)||1
28154|NCT01968694|67296|P1|NOT COMPLETED|Washout (1 Month)||0
28155|NCT01968694|67295|P2|COMPLETED|Washout (1 Month)||8
28156|NCT01968694|67296|P1|COMPLETED|Washout (1 Month)||10
28157|NCT01968694|67295|P2|STARTED|Washout (1 Month)||9
28158|NCT01968694|67296|P1|STARTED|Washout (1 Month)||10
28159|NCT01968694|67295|P2|NOT COMPLETED|Visit 1 (1 Day)||0
28160|NCT01968694|67296|P1|NOT COMPLETED|Visit 1 (1 Day)||0
28161|NCT01968694|67295|P2|COMPLETED|Visit 1 (1 Day)||9
28162|NCT01968694|67296|P1|COMPLETED|Visit 1 (1 Day)||10
28163|NCT01968694|67295|P2|STARTED|Visit 1 (1 Day)||9
28164|NCT01968694|67296|P1|STARTED|Visit 1 (1 Day)||10
28165|NCT01968551|67313|P3|NOT COMPLETED|Extension Phase||4
28166|NCT01968551|67314|P2|NOT COMPLETED|Extension Phase||1
28167|NCT01968551|67315|P1|NOT COMPLETED|Extension Phase||1
28168|NCT01968551|67313|P3|COMPLETED|Extension Phase||30
28169|NCT01968551|67314|P2|COMPLETED|Extension Phase||86
28170|NCT01968551|67315|P1|COMPLETED|Extension Phase||19
28171|NCT01968551|67313|P3|STARTED|Extension Phase|7 participant completed the Open-Label Phase, but did not enter in the Extension Phase|34
28172|NCT01968551|67314|P2|STARTED|Extension Phase||87
28173|NCT01968551|67315|P1|STARTED|Extension Phase||20
28174|NCT01968551|67313|P3|NOT COMPLETED|Open Label Phase (48 Weeks)||5
28175|NCT01968551|67314|P2|NOT COMPLETED|Open Label Phase (48 Weeks)||3
28176|NCT01968551|67315|P1|NOT COMPLETED|Open Label Phase (48 Weeks)||2
28177|NCT01968551|67313|P3|COMPLETED|Open Label Phase (48 Weeks)||41
28178|NCT01968551|67314|P2|COMPLETED|Open Label Phase (48 Weeks)||87
28179|NCT01968551|67315|P1|COMPLETED|Open Label Phase (48 Weeks)||20
28180|NCT01968551|67313|P3|STARTED|Open Label Phase (48 Weeks)||46
28181|NCT01968551|67314|P2|STARTED|Open Label Phase (48 Weeks)||90
28182|NCT01968551|67315|P1|STARTED|Open Label Phase (48 Weeks)||22
28183|NCT01968434|67331|P2|NOT COMPLETED|Overall Study||6
28184|NCT01968434|67332|P1|NOT COMPLETED|Overall Study||3
28185|NCT01968434|67331|P2|COMPLETED|Overall Study||66
28186|NCT01968434|67332|P1|COMPLETED|Overall Study||75
28187|NCT01968434|67331|P2|STARTED|Overall Study||72
28188|NCT01968434|67332|P1|STARTED|Overall Study||78
28189|NCT01968226|67342|P1|NOT COMPLETED|Overall Study||2
28190|NCT01968226|67342|P1|COMPLETED|Overall Study||1
28191|NCT01968226|67342|P1|STARTED|Overall Study||3
28192|NCT01968135|67348|P2|NOT COMPLETED|Overall Study||0
28193|NCT01968135|67349|P1|NOT COMPLETED|Overall Study||0
28194|NCT01968135|67348|P2|COMPLETED|Overall Study||16
28195|NCT01968135|67349|P1|COMPLETED|Overall Study||16
28196|NCT01968135|67348|P2|STARTED|Overall Study||16
28197|NCT01968135|67349|P1|STARTED|Overall Study||16
28198|NCT01968057|67361|P1|NOT COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||0
28199|NCT01968057|67361|P1|COMPLETED|Period 2 (At Dosing Day 4 to Day 7)||18
28200|NCT01968057|67361|P1|Received Baricitinib + Ciclosporin|Period 2 (At Dosing Day 4 to Day 7)||18
28201|NCT01968057|67361|P1|STARTED|Period 2 (At Dosing Day 4 to Day 7)||18
28202|NCT01968057|67361|P1|NOT COMPLETED|Period 1 (Day 1 to Predosing Day 4)||0
28203|NCT01968057|67361|P1|COMPLETED|Period 1 (Day 1 to Predosing Day 4)||18
28204|NCT01968057|67361|P1|Received Baricitinib|Period 1 (Day 1 to Predosing Day 4)||18
28205|NCT01968057|67361|P1|STARTED|Period 1 (Day 1 to Predosing Day 4)||18
28206|NCT01967940|67374|P3|NOT COMPLETED|Part 2||14
28207|NCT01967940|67375|P2|NOT COMPLETED|Part 2||16
28208|NCT01967940|67376|P1|NOT COMPLETED|Part 2||8
28209|NCT01967940|67374|P3|COMPLETED|Part 2||0
28210|NCT01967940|67375|P2|COMPLETED|Part 2||0
28211|NCT01967940|67376|P1|COMPLETED|Part 2||0
28212|NCT01967940|67374|P3|STARTED|Part 2|1 participant completed Part 1, but did not enter Part 2 of the study|14
28213|NCT01967940|67375|P2|STARTED|Part 2|12 participants completed Part 1, but did not enter Part 2 of the study|16
28214|NCT01967940|67376|P1|STARTED|Part 2|4 participants completed Part 1, but did not enter Part 2 of the study|8
28215|NCT01967940|67374|P3|NOT COMPLETED|Part 1||0
28216|NCT01967940|67375|P2|NOT COMPLETED|Part 1||0
28217|NCT01967940|67376|P1|NOT COMPLETED|Part 1||0
28218|NCT01967940|67374|P3|COMPLETED|Part 1||15
28219|NCT01967940|67375|P2|COMPLETED|Part 1||28
28220|NCT01967940|67376|P1|COMPLETED|Part 1||12
28221|NCT01967940|67374|P3|STARTED|Part 1||15
28222|NCT01967940|67375|P2|STARTED|Part 1||28
28223|NCT01967940|67376|P1|STARTED|Part 1||12
28224|NCT01967836|67387|P1|NOT COMPLETED|Overall Study||9
28225|NCT01967836|67387|P1|COMPLETED|Overall Study||11
28226|NCT01967836|67387|P1|STARTED|Overall Study||20
28227|NCT01967784|67393|P1|NOT COMPLETED|Overall Study||0
28228|NCT01967784|67393|P1|COMPLETED|Overall Study||100
28229|NCT01967784|67393|P1|STARTED|Overall Study||100
28230|NCT01967732|67403|P4|NOT COMPLETED|Second Intervention (Day 3)||0
28231|NCT01967732|67404|P3|NOT COMPLETED|Second Intervention (Day 3)||0
28232|NCT01967732|67405|P2|NOT COMPLETED|Second Intervention (Day 3)||0
28233|NCT01967732|67406|P1|NOT COMPLETED|Second Intervention (Day 3)||0
28234|NCT01967732|67403|P4|COMPLETED|Second Intervention (Day 3)||9
28235|NCT01967732|67404|P3|COMPLETED|Second Intervention (Day 3)||9
28236|NCT01967732|67405|P2|COMPLETED|Second Intervention (Day 3)||20
28237|NCT01967732|67406|P1|COMPLETED|Second Intervention (Day 3)||22
28238|NCT01967732|67403|P4|STARTED|Second Intervention (Day 3)||9
28239|NCT01967732|67404|P3|STARTED|Second Intervention (Day 3)||9
28240|NCT01967732|67405|P2|STARTED|Second Intervention (Day 3)||20
28241|NCT01967732|67406|P1|STARTED|Second Intervention (Day 3)||22
28242|NCT01967732|67403|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28243|NCT01967732|67404|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28244|NCT01967732|67405|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28245|NCT01967732|67406|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28246|NCT01967732|67403|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
28247|NCT01967732|67404|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
28248|NCT01967732|67405|P2|COMPLETED|Washout Period of 1 Day (Day 2)||20
28249|NCT01967732|67406|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
28250|NCT01967732|67403|P4|STARTED|Washout Period of 1 Day (Day 2)||9
28251|NCT01967732|67404|P3|STARTED|Washout Period of 1 Day (Day 2)||9
28252|NCT01967732|67405|P2|STARTED|Washout Period of 1 Day (Day 2)||20
28253|NCT01967732|67406|P1|STARTED|Washout Period of 1 Day (Day 2)||22
28254|NCT01967732|67403|P4|NOT COMPLETED|First Intervention (Day 1)||0
28255|NCT01967732|67404|P3|NOT COMPLETED|First Intervention (Day 1)||0
28256|NCT01967732|67405|P2|NOT COMPLETED|First Intervention (Day 1)||1
28257|NCT01967732|67406|P1|NOT COMPLETED|First Intervention (Day 1)||0
28258|NCT01967732|67403|P4|COMPLETED|First Intervention (Day 1)||9
28259|NCT01967732|67404|P3|COMPLETED|First Intervention (Day 1)||9
28260|NCT01967732|67405|P2|COMPLETED|First Intervention (Day 1)|Subject discontinued from the study prior to product use|20
28261|NCT01967732|67406|P1|COMPLETED|First Intervention (Day 1)||22
28262|NCT01967732|67403|P4|STARTED|First Intervention (Day 1)||9
28263|NCT01967732|67404|P3|STARTED|First Intervention (Day 1)||9
28264|NCT01967732|67405|P2|STARTED|First Intervention (Day 1)||21
28265|NCT01967732|67406|P1|STARTED|First Intervention (Day 1)||22
28266|NCT01967732|67403|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28267|NCT01967732|67404|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28268|NCT01967732|67405|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||1
28269|NCT01967732|67406|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28270|NCT01967732|67403|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
28271|NCT01967732|67404|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
28272|NCT01967732|67405|P2|COMPLETED|Washout Period of 1 Day (Day 0)||21
28273|NCT01967732|67406|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
28274|NCT01967732|67403|P4|STARTED|Washout Period of 1 Day (Day 0)||9
28275|NCT01967732|67404|P3|STARTED|Washout Period of 1 Day (Day 0)||9
28276|NCT01967732|67405|P2|STARTED|Washout Period of 1 Day (Day 0)||22
28277|NCT01967732|67406|P1|STARTED|Washout Period of 1 Day (Day 0)||22
28278|NCT01967719|67420|P4|NOT COMPLETED|Second Intervention (Day 3)||0
28279|NCT01967719|67421|P3|NOT COMPLETED|Second Intervention (Day 3)||0
28280|NCT01967719|67422|P2|NOT COMPLETED|Second Intervention (Day 3)||1
28281|NCT01967719|67423|P1|NOT COMPLETED|Second Intervention (Day 3)||0
28282|NCT01967719|67420|P4|COMPLETED|Second Intervention (Day 3)||8
28283|NCT01967719|67421|P3|COMPLETED|Second Intervention (Day 3)||9
28284|NCT01967719|67422|P2|COMPLETED|Second Intervention (Day 3)||20
28285|NCT01967719|67423|P1|COMPLETED|Second Intervention (Day 3)||22
28286|NCT01967719|67420|P4|STARTED|Second Intervention (Day 3)||8
28287|NCT01967719|67421|P3|STARTED|Second Intervention (Day 3)||9
28288|NCT01967719|67422|P2|STARTED|Second Intervention (Day 3)||21
28289|NCT01967719|67423|P1|STARTED|Second Intervention (Day 3)||22
28290|NCT01967719|67420|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28291|NCT01967719|67421|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28292|NCT01967719|67422|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28293|NCT01967719|67423|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28294|NCT01967719|67420|P4|COMPLETED|Washout Period of 1 Day (Day 2)||8
28295|NCT01967719|67421|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
28296|NCT01967719|67422|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
28297|NCT01967719|67423|P1|COMPLETED|Washout Period of 1 Day (Day 2)||22
28298|NCT01967719|67420|P4|STARTED|Washout Period of 1 Day (Day 2)||8
28299|NCT01967719|67421|P3|STARTED|Washout Period of 1 Day (Day 2)||9
28300|NCT01967719|67422|P2|STARTED|Washout Period of 1 Day (Day 2)||21
28301|NCT01967719|67423|P1|STARTED|Washout Period of 1 Day (Day 2)||22
28302|NCT01967719|67420|P4|NOT COMPLETED|First Intervention (Day 1)||1
28303|NCT01967719|67421|P3|NOT COMPLETED|First Intervention (Day 1)||0
28304|NCT01967719|67422|P2|NOT COMPLETED|First Intervention (Day 1)||1
28305|NCT01967719|67423|P1|NOT COMPLETED|First Intervention (Day 1)||0
28306|NCT01967719|67420|P4|COMPLETED|First Intervention (Day 1)||8
28307|NCT01967719|67421|P3|COMPLETED|First Intervention (Day 1)||9
28308|NCT01967719|67422|P2|COMPLETED|First Intervention (Day 1)||21
28309|NCT01967719|67423|P1|COMPLETED|First Intervention (Day 1)||22
28310|NCT01967719|67420|P4|STARTED|First Intervention (Day 1)||9
28311|NCT01967719|67421|P3|STARTED|First Intervention (Day 1)||9
28312|NCT01967719|67422|P2|STARTED|First Intervention (Day 1)||22
28313|NCT01967719|67423|P1|STARTED|First Intervention (Day 1)||22
28314|NCT01967719|67420|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28315|NCT01967719|67421|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28316|NCT01967719|67422|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28317|NCT01967719|67423|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28318|NCT01967719|67420|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
28319|NCT01967719|67421|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
28320|NCT01967719|67422|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
28321|NCT01967719|67423|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
28322|NCT01967719|67420|P4|STARTED|Washout Period of 1 Day (Day 0)||9
28323|NCT01967719|67421|P3|STARTED|Washout Period of 1 Day (Day 0)||9
28324|NCT01967719|67422|P2|STARTED|Washout Period of 1 Day (Day 0)||22
28325|NCT01967719|67423|P1|STARTED|Washout Period of 1 Day (Day 0)||22
28326|NCT01967706|67438|P4|NOT COMPLETED|Second Intervention (Day 3)||0
28327|NCT01967706|67439|P3|NOT COMPLETED|Second Intervention (Day 3)||0
28328|NCT01967706|67440|P2|NOT COMPLETED|Second Intervention (Day 3)||0
28329|NCT01967706|67441|P1|NOT COMPLETED|Second Intervention (Day 3)||0
28330|NCT01967706|67438|P4|COMPLETED|Second Intervention (Day 3)||9
28331|NCT01967706|67439|P3|COMPLETED|Second Intervention (Day 3)||9
28332|NCT01967706|67440|P2|COMPLETED|Second Intervention (Day 3)||22
28333|NCT01967706|67441|P1|COMPLETED|Second Intervention (Day 3)||21
28334|NCT01967706|67438|P4|STARTED|Second Intervention (Day 3)||9
28335|NCT01967706|67439|P3|STARTED|Second Intervention (Day 3)||9
28336|NCT01967706|67440|P2|STARTED|Second Intervention (Day 3)||22
28337|NCT01967706|67441|P1|STARTED|Second Intervention (Day 3)||21
28338|NCT01967706|67438|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28339|NCT01967706|67439|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28340|NCT01967706|67440|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28341|NCT01967706|67441|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28342|NCT01967706|67438|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
28343|NCT01967706|67439|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
28344|NCT01967706|67440|P2|COMPLETED|Washout Period of 1 Day (Day 2)||22
28345|NCT01967706|67441|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
28346|NCT01967706|67438|P4|STARTED|Washout Period of 1 Day (Day 2)||9
28347|NCT01967706|67439|P3|STARTED|Washout Period of 1 Day (Day 2)||9
28348|NCT01967706|67440|P2|STARTED|Washout Period of 1 Day (Day 2)||22
28349|NCT01967706|67441|P1|STARTED|Washout Period of 1 Day (Day 2)||21
28350|NCT01967706|67438|P4|NOT COMPLETED|First Intervention (Day 1)||0
28351|NCT01967706|67439|P3|NOT COMPLETED|First Intervention (Day 1)||0
28352|NCT01967706|67440|P2|NOT COMPLETED|First Intervention (Day 1)||0
28353|NCT01967706|67441|P1|NOT COMPLETED|First Intervention (Day 1)||1
28354|NCT01967706|67438|P4|COMPLETED|First Intervention (Day 1)||9
28355|NCT01967706|67439|P3|COMPLETED|First Intervention (Day 1)||9
28356|NCT01967706|67440|P2|COMPLETED|First Intervention (Day 1)||22
28357|NCT01967706|67441|P1|COMPLETED|First Intervention (Day 1)||21
28358|NCT01967706|67438|P4|STARTED|First Intervention (Day 1)||9
28359|NCT01967706|67439|P3|STARTED|First Intervention (Day 1)||9
28360|NCT01967706|67440|P2|STARTED|First Intervention (Day 1)||22
28361|NCT01967706|67441|P1|STARTED|First Intervention (Day 1)||22
28362|NCT01967706|67438|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28363|NCT01967706|67439|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28364|NCT01967706|67440|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28365|NCT01967706|67441|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28366|NCT01967706|67438|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
28367|NCT01967706|67439|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
28368|NCT01967706|67440|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
28369|NCT01967706|67441|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
28370|NCT01967706|67438|P4|STARTED|Washout Period of 1 Day (Day 0)||9
28371|NCT01967706|67439|P3|STARTED|Washout Period of 1 Day (Day 0)||9
28372|NCT01967706|67440|P2|STARTED|Washout Period of 1 Day (Day 0)||22
28373|NCT01967706|67441|P1|STARTED|Washout Period of 1 Day (Day 0)||22
28374|NCT01967550|67452|P2|NOT COMPLETED|Overall Study||2
28375|NCT01967550|67453|P1|NOT COMPLETED|Overall Study||5
28376|NCT01967550|67452|P2|COMPLETED|Overall Study||149
28377|NCT01967550|67453|P1|COMPLETED|Overall Study||148
28378|NCT01967550|67452|P2|STARTED|Overall Study||151
28379|NCT01967550|67453|P1|STARTED|Overall Study||153
28380|NCT01967342|67462|P3|NOT COMPLETED|Overall Study||29
28381|NCT01967342|67463|P2|NOT COMPLETED|Overall Study||25
28382|NCT01967342|67464|P1|NOT COMPLETED|Overall Study||27
28383|NCT01967342|67462|P3|COMPLETED|Overall Study||68
28384|NCT01967342|67463|P2|COMPLETED|Overall Study||70
28385|NCT01967342|67464|P1|COMPLETED|Overall Study||71
28386|NCT01967342|67462|P3|10-week Follow-up|Overall Study||80
28387|NCT01967342|67463|P2|10-week Follow-up|Overall Study||83
28388|NCT01967342|67464|P1|10-week Follow-up|Overall Study||78
28389|NCT01967342|67462|P3|5-week Follow-up|Overall Study||76
28390|NCT01967342|67463|P2|5-week Follow-up|Overall Study||78
28391|NCT01967342|67464|P1|5-week Follow-up|Overall Study||83
28392|NCT01967342|67462|P3|STARTED|Overall Study||97
28393|NCT01967342|67463|P2|STARTED|Overall Study||95
28394|NCT01967342|67464|P1|STARTED|Overall Study||98
28395|NCT01967277|67483|P2|NOT COMPLETED|Overall Study||3
28396|NCT01967277|67484|P1|NOT COMPLETED|Overall Study||1
28397|NCT01967277|67483|P2|COMPLETED|Overall Study||19
28398|NCT01967277|67484|P1|COMPLETED|Overall Study||21
28399|NCT01967277|67483|P2|STARTED|Overall Study||22
28400|NCT01967277|67484|P1|STARTED|Overall Study||22
28401|NCT01967147|67494|P2|NOT COMPLETED|Overall Study||20
28402|NCT01967147|67495|P1|NOT COMPLETED|Overall Study||13
28403|NCT01967147|67494|P2|COMPLETED|Overall Study||82
28404|NCT01967147|67495|P1|COMPLETED|Overall Study||99
28405|NCT01967147|67494|P2|STARTED|Overall Study||102
28406|NCT01967147|67495|P1|STARTED|Overall Study||112
28407|NCT01967121|67513|P3|NOT COMPLETED|Overall Study||0
28408|NCT01967121|67514|P2|NOT COMPLETED|Overall Study||0
28409|NCT01967121|67515|P1|NOT COMPLETED|Overall Study||0
28410|NCT01967121|67513|P3|COMPLETED|Overall Study||25
28411|NCT01967121|67514|P2|COMPLETED|Overall Study||25
28412|NCT01967121|67515|P1|COMPLETED|Overall Study||25
28413|NCT01967121|67513|P3|STARTED|Overall Study||25
28414|NCT01967121|67514|P2|STARTED|Overall Study||25
28415|NCT01967121|67515|P1|STARTED|Overall Study||25
28416|NCT01967069|67525|P2|NOT COMPLETED|Overall Study||8
28417|NCT01967069|67526|P1|NOT COMPLETED|Overall Study||8
28418|NCT01967069|67525|P2|COMPLETED|Overall Study||87
28419|NCT01967069|67526|P1|COMPLETED|Overall Study||174
28420|NCT01967069|67525|P2|STARTED|Overall Study||95
28421|NCT01967069|67526|P1|STARTED|Overall Study||182
28422|NCT01966926|67534|P2|NOT COMPLETED|Overall Study||0
28423|NCT01966926|67535|P1|NOT COMPLETED|Overall Study||0
28424|NCT01966926|67534|P2|COMPLETED|Overall Study||15
28425|NCT01966926|67535|P1|COMPLETED|Overall Study||15
28426|NCT01966926|67534|P2|STARTED|Overall Study||15
28427|NCT01966926|67535|P1|STARTED|Overall Study||15
28428|NCT01966770|67551|P1|NOT COMPLETED|Overall Study||0
28429|NCT01966770|67551|P1|COMPLETED|Overall Study||20
28430|NCT01966770|67551|P1|STARTED|Overall Study||20
28431|NCT01966718|67660|P1|NOT COMPLETED|Overall Study||0
28432|NCT01966718|67660|P1|COMPLETED|Overall Study||8
28433|NCT01966718|67660|P1|STARTED|Overall Study||8
28434|NCT01966432|67671|P3|NOT COMPLETED|Overall Study||26
28435|NCT01966432|67672|P2|NOT COMPLETED|Overall Study||13
28436|NCT01966432|67673|P1|NOT COMPLETED|Overall Study||5
28437|NCT01966432|67671|P3|COMPLETED|Overall Study||28
28438|NCT01966432|67672|P2|COMPLETED|Overall Study||21
28439|NCT01966432|67673|P1|COMPLETED|Overall Study||5
28440|NCT01966432|67671|P3|STARTED|Overall Study||54
28441|NCT01966432|67672|P2|STARTED|Overall Study||34
28442|NCT01966432|67673|P1|STARTED|Overall Study||10
28443|NCT01966380|67693|P2|NOT COMPLETED|Overall Study||1
28444|NCT01966380|67694|P1|NOT COMPLETED|Overall Study||0
28445|NCT01966380|67693|P2|COMPLETED|Overall Study||2
28446|NCT01966380|67694|P1|COMPLETED|Overall Study||3
28447|NCT01966380|67693|P2|STARTED|Overall Study||3
28448|NCT01966380|67694|P1|STARTED|Overall Study||3
28449|NCT01966354|67703|P3|NOT COMPLETED|Overall Study||0
28450|NCT01966354|67704|P2|NOT COMPLETED|Overall Study||0
28451|NCT01966354|67705|P1|NOT COMPLETED|Overall Study||0
28452|NCT01966354|67703|P3|COMPLETED|Overall Study||72
28453|NCT01966354|67704|P2|COMPLETED|Overall Study||73
28454|NCT01966354|67705|P1|COMPLETED|Overall Study||75
28455|NCT01966354|67703|P3|STARTED|Overall Study||72
28456|NCT01966354|67704|P2|STARTED|Overall Study||73
28457|NCT01966354|67705|P1|STARTED|Overall Study||75
28458|NCT01966159|67730|P2|NOT COMPLETED|Overall Study||0
28459|NCT01966159|67731|P1|NOT COMPLETED|Overall Study||0
28460|NCT01966159|67730|P2|COMPLETED|Overall Study||207
28461|NCT01966159|67731|P1|COMPLETED|Overall Study||205
28462|NCT01966159|67730|P2|STARTED|Overall Study||207
28463|NCT01966159|67731|P1|STARTED|Overall Study||205
28464|NCT01966120|67743|P2|NOT COMPLETED|Overall Study||6
28465|NCT01966120|67744|P1|NOT COMPLETED|Overall Study||1
28466|NCT01966120|67743|P2|COMPLETED|Overall Study||26
28467|NCT01966120|67744|P1|COMPLETED|Overall Study||54
28468|NCT01966120|67743|P2|STARTED|Overall Study||32
28469|NCT01966120|67744|P1|STARTED|Overall Study||55
28470|NCT01966068|67768|P1|NOT COMPLETED|Overall Study||138
28471|NCT01966068|67768|P1|COMPLETED|Overall Study||156
28472|NCT01966068|67768|P1|Use the MyAsthma Portal More Than Once|Overall Study||156
28473|NCT01966068|67768|P1|Used the MyAsthma Portal at Least Once|Overall Study||237
28474|NCT01966068|67768|P1|STARTED|Overall Study||294
28475|NCT01966042|67773|P1|NOT COMPLETED|Overall Study||2
28476|NCT01966042|67773|P1|COMPLETED|Overall Study||11
28477|NCT01966042|67773|P1|STARTED|Overall Study||13
28478|NCT01965938|67782|P2|NOT COMPLETED|Overall Study||0
28479|NCT01965938|67783|P1|NOT COMPLETED|Overall Study||1
28480|NCT01965938|67782|P2|COMPLETED|Overall Study||20
28481|NCT01965938|67783|P1|COMPLETED|Overall Study||20
28482|NCT01965938|67782|P2|STARTED|Overall Study||20
28483|NCT01965938|67783|P1|STARTED|Overall Study||21
28484|NCT01965899|67803|P1|NOT COMPLETED|Overall Study||6
28485|NCT01965899|67803|P1|COMPLETED|Overall Study||145
28486|NCT01965899|67803|P1|STARTED|Overall Study||151
28487|NCT01965834|67814|P1|NOT COMPLETED|Overall Study||4
28488|NCT01965834|67814|P1|COMPLETED|Overall Study||2
28489|NCT01965834|67814|P1|STARTED|Overall Study||6
28490|NCT01965665|67820|P1|NOT COMPLETED|Overall Study||1
28491|NCT01965665|67820|P1|COMPLETED|Overall Study||19
28492|NCT01965665|67820|P1|STARTED|Overall Study||20
28493|NCT01965652|67828|P2|NOT COMPLETED|Overall Study||210
28494|NCT01965652|67829|P1|NOT COMPLETED|Overall Study||210
28495|NCT01965652|67828|P2|COMPLETED|Overall Study||413
28496|NCT01965652|67829|P1|COMPLETED|Overall Study||413
28497|NCT01965652|67828|P2|Received Treatment|Overall Study||623
28498|NCT01965652|67829|P1|Received Treatment|Overall Study||622
28499|NCT01965652|67828|P2|STARTED|Overall Study|Includes three participants who each enrolled at two different sites|623
28500|NCT01965652|67829|P1|STARTED|Overall Study|Includes two participants who each enrolled at two different sites|623
28501|NCT01965600|67859|P4|NOT COMPLETED|Second Intervention||2
28502|NCT01965600|67860|P3|NOT COMPLETED|Second Intervention||2
28503|NCT01965600|67861|P2|NOT COMPLETED|Second Intervention||0
28504|NCT01965600|67862|P1|NOT COMPLETED|Second Intervention||0
28505|NCT01965600|67859|P4|COMPLETED|Second Intervention||0
28506|NCT01965600|67860|P3|COMPLETED|Second Intervention||1
28507|NCT01965600|67861|P2|COMPLETED|Second Intervention||4
28508|NCT01965600|67862|P1|COMPLETED|Second Intervention||4
28509|NCT01965600|67859|P4|STARTED|Second Intervention||2
28510|NCT01965600|67860|P3|STARTED|Second Intervention||3
28511|NCT01965600|67861|P2|STARTED|Second Intervention||4
28512|NCT01965600|67862|P1|STARTED|Second Intervention||4
28513|NCT01965600|67859|P4|NOT COMPLETED|Washout Period of Approximately 15 Days||2
28514|NCT01965600|67860|P3|NOT COMPLETED|Washout Period of Approximately 15 Days||2
28515|NCT01965600|67861|P2|NOT COMPLETED|Washout Period of Approximately 15 Days||4
28516|NCT01965600|67862|P1|NOT COMPLETED|Washout Period of Approximately 15 Days||2
28517|NCT01965600|67859|P4|COMPLETED|Washout Period of Approximately 15 Days||2
28518|NCT01965600|67860|P3|COMPLETED|Washout Period of Approximately 15 Days||3
28519|NCT01965600|67861|P2|COMPLETED|Washout Period of Approximately 15 Days||4
28520|NCT01965600|67862|P1|COMPLETED|Washout Period of Approximately 15 Days||4
28521|NCT01965600|67859|P4|STARTED|Washout Period of Approximately 15 Days||4
28522|NCT01965600|67860|P3|STARTED|Washout Period of Approximately 15 Days||5
28523|NCT01965600|67861|P2|STARTED|Washout Period of Approximately 15 Days||8
28524|NCT01965600|67862|P1|STARTED|Washout Period of Approximately 15 Days||6
28525|NCT01965600|67859|P4|NOT COMPLETED|First Intervention||0
28526|NCT01965600|67860|P3|NOT COMPLETED|First Intervention||0
28527|NCT01965600|67861|P2|NOT COMPLETED|First Intervention||0
28528|NCT01965600|67862|P1|NOT COMPLETED|First Intervention||0
28529|NCT01965600|67859|P4|COMPLETED|First Intervention||4
28530|NCT01965600|67860|P3|COMPLETED|First Intervention||5
28531|NCT01965600|67861|P2|COMPLETED|First Intervention||8
28532|NCT01965600|67862|P1|COMPLETED|First Intervention||6
28533|NCT01965600|67859|P4|Received at Least One Dose of Drug|First Intervention||4
28534|NCT01965600|67860|P3|Received at Least One Dose of Drug|First Intervention||5
28535|NCT01965600|67861|P2|Received at Least One Dose of Drug|First Intervention||8
28536|NCT01965600|67862|P1|Received at Least One Dose of Drug|First Intervention||6
28537|NCT01965600|67859|P4|STARTED|First Intervention||4
28538|NCT01965600|67860|P3|STARTED|First Intervention||5
28539|NCT01965600|67861|P2|STARTED|First Intervention||8
28540|NCT01965600|67862|P1|STARTED|First Intervention||6
28541|NCT01965561|67906|P1|NOT COMPLETED|Overall Study||0
28542|NCT01965561|67906|P1|COMPLETED|Overall Study||10
28543|NCT01965561|67906|P1|STARTED|Overall Study||10
28544|NCT01965535|67919|P2|NOT COMPLETED|Overall Study||1
28545|NCT01965535|67920|P1|NOT COMPLETED|Overall Study||2
28546|NCT01965535|67919|P2|COMPLETED|Overall Study||76
28547|NCT01965535|67920|P1|COMPLETED|Overall Study||76
28548|NCT01965535|67919|P2|STARTED|Overall Study||77
28549|NCT01965535|67920|P1|STARTED|Overall Study||78
28550|NCT01965431|67934|P6|NOT COMPLETED|Overall Study||6
28551|NCT01965431|67935|P5|NOT COMPLETED|Overall Study||6
28552|NCT01965431|67936|P4|NOT COMPLETED|Overall Study||6
28553|NCT01965431|67937|P3|NOT COMPLETED|Overall Study||6
28554|NCT01965431|67938|P2|NOT COMPLETED|Overall Study||6
28555|NCT01965431|67939|P1|NOT COMPLETED|Overall Study||6
28556|NCT01965431|67934|P6|COMPLETED|Overall Study||2
28557|NCT01965431|67935|P5|COMPLETED|Overall Study||2
28558|NCT01965431|67936|P4|COMPLETED|Overall Study||2
28559|NCT01965431|67937|P3|COMPLETED|Overall Study||2
28560|NCT01965431|67938|P2|COMPLETED|Overall Study||2
28561|NCT01965431|67939|P1|COMPLETED|Overall Study||2
28562|NCT01965431|67934|P6|STARTED|Overall Study||8
28563|NCT01965431|67935|P5|STARTED|Overall Study||8
28564|NCT01965431|67936|P4|STARTED|Overall Study||8
28565|NCT01965431|67937|P3|STARTED|Overall Study||8
28566|NCT01965431|67938|P2|STARTED|Overall Study||8
28567|NCT01965431|67939|P1|STARTED|Overall Study|Started are actually Treated subjects|8
28568|NCT01965327|67952|P1|NOT COMPLETED|Overall Study||2
28569|NCT01965327|67952|P1|COMPLETED|Overall Study|Prior to completion, 2 subjects were withdrawn by the PI for failure to adhere to study protocol.|10
28570|NCT01965327|67952|P1|STARTED|Overall Study||12
28571|NCT01965288|67959|P2|NOT COMPLETED|Overall Study||0
28572|NCT01965288|67960|P1|NOT COMPLETED|Overall Study||0
28573|NCT01965288|67959|P2|COMPLETED|Overall Study||30
28574|NCT01965288|67960|P1|COMPLETED|Overall Study||30
28575|NCT01965288|67959|P2|STARTED|Overall Study||30
28576|NCT01965288|67960|P1|STARTED|Overall Study||30
28577|NCT01965262|68166|P2|NOT COMPLETED|Second Intervention (7 Days)||10
28578|NCT01965262|68167|P1|NOT COMPLETED|Second Intervention (7 Days)||1
28579|NCT01965262|68166|P2|COMPLETED|Second Intervention (7 Days)||5
28580|NCT01965262|68167|P1|COMPLETED|Second Intervention (7 Days)||14
28581|NCT01965262|68166|P2|STARTED|Second Intervention (7 Days)||15
28582|NCT01965262|68167|P1|STARTED|Second Intervention (7 Days)||15
28583|NCT01965262|68166|P2|NOT COMPLETED|First Intervention (7 Days)||0
28584|NCT01965262|68167|P1|NOT COMPLETED|First Intervention (7 Days)||0
28585|NCT01965262|68166|P2|COMPLETED|First Intervention (7 Days)||15
28586|NCT01965262|68167|P1|COMPLETED|First Intervention (7 Days)||15
28587|NCT01965262|68166|P2|STARTED|First Intervention (7 Days)||15
28588|NCT01965262|68167|P1|STARTED|First Intervention (7 Days)||15
28589|NCT01965158|68231|P2|NOT COMPLETED|Overall Study||35
28590|NCT01965158|68232|P1|NOT COMPLETED|Overall Study||41
28591|NCT01965158|68231|P2|COMPLETED|Overall Study||238
28592|NCT01965158|68232|P1|COMPLETED|Overall Study||233
28593|NCT01965158|68231|P2|Received Treatment|Overall Study||273
28594|NCT01965158|68232|P1|Received Treatment|Overall Study||272
28595|NCT01965158|68231|P2|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|273
28688|NCT01963611|68491|P1|Safety Analysis Set|Overall Study||51
28596|NCT01965158|68232|P1|STARTED|Overall Study|Includes 1 participant enrolled at 2 different sites simultaneously|274
28597|NCT01965067|68248|P2|NOT COMPLETED|Overall Study||0
28598|NCT01965067|68249|P1|NOT COMPLETED|Overall Study||0
28599|NCT01965067|68248|P2|COMPLETED|Overall Study||30
28600|NCT01965067|68249|P1|COMPLETED|Overall Study||30
28601|NCT01965067|68248|P2|STARTED|Overall Study||30
28602|NCT01965067|68249|P1|STARTED|Overall Study||30
28603|NCT01964976|68267|P1|NOT COMPLETED|Overall Study||31
28604|NCT01964976|68267|P1|COMPLETED|Overall Study||1065
28605|NCT01964976|68267|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1096
28606|NCT01964950|68281|P1|NOT COMPLETED|Overall Study||25
28607|NCT01964950|68281|P1|COMPLETED|Overall Study||1076
28608|NCT01964950|68281|P1|STARTED|Overall Study|Data reports overall population,since data not collected separately per arm as specified in protocol|1101
28609|NCT01964898|68295|P2|NOT COMPLETED|Overall Study||7
28610|NCT01964898|68296|P1|NOT COMPLETED|Overall Study||7
28611|NCT01964898|68295|P2|COMPLETED|Overall Study||26
28612|NCT01964898|68296|P1|COMPLETED|Overall Study||24
28613|NCT01964898|68295|P2|12 Week Assessment|Overall Study||30
28614|NCT01964898|68296|P1|12 Week Assessment|Overall Study||25
28615|NCT01964898|68295|P2|STARTED|Overall Study||33
28616|NCT01964898|68296|P1|STARTED|Overall Study||31
28617|NCT01964716|68318|P2|NOT COMPLETED|Overall Study||6
28618|NCT01964716|68319|P1|NOT COMPLETED|Overall Study||5
28619|NCT01964716|68318|P2|COMPLETED|Overall Study||244
28620|NCT01964716|68319|P1|COMPLETED|Overall Study||245
28621|NCT01964716|68318|P2|Vaccinated Dose 3|Overall Study||244
28622|NCT01964716|68319|P1|Vaccinated Dose 3|Overall Study||247
28623|NCT01964716|68318|P2|Vaccinated Dose 2|Overall Study||248
28624|NCT01964716|68319|P1|Vaccinated Dose 2|Overall Study||249
28625|NCT01964716|68318|P2|Vaccinated Dose 1|Overall Study||250
28626|NCT01964716|68319|P1|Vaccinated Dose 1|Overall Study||250
28627|NCT01964716|68318|P2|STARTED|Overall Study||250
28628|NCT01964716|68319|P1|STARTED|Overall Study||250
28629|NCT01964547|68357|P2|NOT COMPLETED|Overall Study||11
28630|NCT01964547|68358|P1|NOT COMPLETED|Overall Study||12
28631|NCT01964547|68357|P2|COMPLETED|Overall Study||48
28632|NCT01964547|68358|P1|COMPLETED|Overall Study||50
28633|NCT01964547|68357|P2|STARTED|Overall Study||59
28634|NCT01964547|68358|P1|STARTED|Overall Study||62
28635|NCT01964352|68386|P4|NOT COMPLETED|Overall Study||8
28636|NCT01964352|68387|P3|NOT COMPLETED|Overall Study||6
28637|NCT01964352|68388|P2|NOT COMPLETED|Overall Study||11
28638|NCT01964352|68389|P1|NOT COMPLETED|Overall Study||26
28639|NCT01964352|68386|P4|COMPLETED|Overall Study||195
28640|NCT01964352|68387|P3|COMPLETED|Overall Study||196
28641|NCT01964352|68388|P2|COMPLETED|Overall Study||192
28642|NCT01964352|68389|P1|COMPLETED|Overall Study||178
28643|NCT01964352|68386|P4|STARTED|Overall Study||203
28644|NCT01964352|68387|P3|STARTED|Overall Study||202
28645|NCT01964352|68388|P2|STARTED|Overall Study||203
28646|NCT01964352|68389|P1|STARTED|Overall Study||204
28647|NCT01964326|68419|P1|NOT COMPLETED|Overall Study||297
28648|NCT01964326|68419|P1|COMPLETED|Overall Study||1014
28649|NCT01964326|68419|P1|STARTED|Overall Study||1311
28650|NCT01964222|68428|P2|NOT COMPLETED|Overall Study||11
28651|NCT01964222|68429|P1|NOT COMPLETED|Overall Study||15
28652|NCT01964222|68428|P2|COMPLETED|Overall Study||89
28653|NCT01964222|68429|P1|COMPLETED|Overall Study||86
28654|NCT01964222|68428|P2|STARTED|Overall Study||100
28655|NCT01964222|68429|P1|STARTED|Overall Study||101
28656|NCT01963845|68445|P2|NOT COMPLETED|Overall Study||0
28657|NCT01963845|68446|P1|NOT COMPLETED|Overall Study||0
28658|NCT01963845|68445|P2|COMPLETED|Overall Study||25
28659|NCT01963845|68446|P1|COMPLETED|Overall Study||25
28660|NCT01963845|68445|P2|STARTED|Overall Study||25
28661|NCT01963845|68446|P1|STARTED|Overall Study||25
28662|NCT01963767|68462|P2|NOT COMPLETED|Overall Study||2
28663|NCT01963767|68463|P1|NOT COMPLETED|Overall Study||6
28664|NCT01963767|68462|P2|COMPLETED|Overall Study||53
28665|NCT01963767|68463|P1|COMPLETED|Overall Study||52
28666|NCT01963767|68462|P2|STARTED|Overall Study||55
28667|NCT01963767|68463|P1|STARTED|Overall Study||58
28668|NCT01963676|68473|P2|NOT COMPLETED|Overall Study||0
28669|NCT01963676|68474|P1|NOT COMPLETED|Overall Study||1
28670|NCT01963676|68473|P2|COMPLETED|Overall Study||13
28671|NCT01963676|68474|P1|COMPLETED|Overall Study||13
28672|NCT01963676|68473|P2|STARTED|Overall Study||13
28673|NCT01963676|68474|P1|STARTED|Overall Study||14
28674|NCT01963611|68487|P5|NOT COMPLETED|Overall Study||51
28675|NCT01963611|68488|P4|NOT COMPLETED|Overall Study||52
28676|NCT01963611|68489|P3|NOT COMPLETED|Overall Study||52
28677|NCT01963611|68490|P2|NOT COMPLETED|Overall Study||49
28678|NCT01963611|68491|P1|NOT COMPLETED|Overall Study||51
28679|NCT01963611|68487|P5|COMPLETED|Overall Study||0
28680|NCT01963611|68488|P4|COMPLETED|Overall Study||0
28681|NCT01963611|68489|P3|COMPLETED|Overall Study||0
28682|NCT01963611|68490|P2|COMPLETED|Overall Study||0
28683|NCT01963611|68491|P1|COMPLETED|Overall Study||0
28684|NCT01963611|68487|P5|Safety Analysis Set|Overall Study||50
28685|NCT01963611|68488|P4|Safety Analysis Set|Overall Study||52
28686|NCT01963611|68489|P3|Safety Analysis Set|Overall Study||52
28687|NCT01963611|68490|P2|Safety Analysis Set|Overall Study||49
28689|NCT01963611|68487|P5|STARTED|Overall Study||51
28690|NCT01963611|68488|P4|STARTED|Overall Study||52
28691|NCT01963611|68489|P3|STARTED|Overall Study||52
28692|NCT01963611|68490|P2|STARTED|Overall Study||49
28693|NCT01963611|68491|P1|STARTED|Overall Study||51
28694|NCT01963403|68550|P2|NOT COMPLETED|Overall Study||4
28695|NCT01963403|68551|P1|NOT COMPLETED|Overall Study||2
28696|NCT01963403|68550|P2|COMPLETED|Overall Study|Follow-up over three months|9
28697|NCT01963403|68551|P1|COMPLETED|Overall Study|Follow-up over three months|11
28698|NCT01963403|68550|P2|STARTED|Overall Study||13
28699|NCT01963403|68551|P1|STARTED|Overall Study||13
28700|NCT01963260|68573|P10|NOT COMPLETED|Overall Study||0
28701|NCT01963260|68574|P9|NOT COMPLETED|Overall Study||0
28702|NCT01963260|68575|P8|NOT COMPLETED|Overall Study||0
28703|NCT01963260|68576|P7|NOT COMPLETED|Overall Study||0
28704|NCT01963260|68577|P6|NOT COMPLETED|Overall Study||0
28705|NCT01963260|68578|P5|NOT COMPLETED|Overall Study||2
28706|NCT01963260|68579|P4|NOT COMPLETED|Overall Study||1
28707|NCT01963260|68580|P3|NOT COMPLETED|Overall Study||0
28708|NCT01963260|68581|P2|NOT COMPLETED|Overall Study||0
28709|NCT01963260|68582|P1|NOT COMPLETED|Overall Study||2
28710|NCT01963260|68573|P10|COMPLETED|Overall Study||4
28711|NCT01963260|68574|P9|COMPLETED|Overall Study||1
28712|NCT01963260|68575|P8|COMPLETED|Overall Study||2
28713|NCT01963260|68576|P7|COMPLETED|Overall Study||3
28714|NCT01963260|68577|P6|COMPLETED|Overall Study||10
28715|NCT01963260|68578|P5|COMPLETED|Overall Study||4
28716|NCT01963260|68579|P4|COMPLETED|Overall Study||5
28717|NCT01963260|68580|P3|COMPLETED|Overall Study||6
28718|NCT01963260|68581|P2|COMPLETED|Overall Study||6
28719|NCT01963260|68582|P1|COMPLETED|Overall Study||4
28720|NCT01963260|68573|P10|Treated|Overall Study||4
28721|NCT01963260|68574|P9|Treated|Overall Study||1
28722|NCT01963260|68575|P8|Treated|Overall Study||2
28723|NCT01963260|68576|P7|Treated|Overall Study||3
28724|NCT01963260|68577|P6|Treated|Overall Study||10
28725|NCT01963260|68578|P5|Treated|Overall Study||6
28726|NCT01963260|68579|P4|Treated|Overall Study||6
28727|NCT01963260|68580|P3|Treated|Overall Study||6
28728|NCT01963260|68581|P2|Treated|Overall Study||6
28729|NCT01963260|68582|P1|Treated|Overall Study||6
28730|NCT01963260|68573|P10|STARTED|Overall Study||4
28731|NCT01963260|68574|P9|STARTED|Overall Study||1
28732|NCT01963260|68575|P8|STARTED|Overall Study||2
28733|NCT01963260|68576|P7|STARTED|Overall Study||3
28734|NCT01963260|68577|P6|STARTED|Overall Study||10
28735|NCT01963260|68578|P5|STARTED|Overall Study||6
28736|NCT01963260|68579|P4|STARTED|Overall Study||6
28737|NCT01963260|68580|P3|STARTED|Overall Study||6
28738|NCT01963260|68581|P2|STARTED|Overall Study||6
28739|NCT01963260|68582|P1|STARTED|Overall Study||6
28740|NCT01963143|68637|P3|NOT COMPLETED|Overall Study||1
28741|NCT01963143|68638|P2|NOT COMPLETED|Overall Study||1
28742|NCT01963143|68639|P1|NOT COMPLETED|Overall Study||0
28743|NCT01963143|68637|P3|COMPLETED|Overall Study||14
28744|NCT01963143|68638|P2|COMPLETED|Overall Study||18
28745|NCT01963143|68639|P1|COMPLETED|Overall Study||14
28746|NCT01963143|68637|P3|STARTED|Overall Study||15
28747|NCT01963143|68638|P2|STARTED|Overall Study||19
28748|NCT01963143|68639|P1|STARTED|Overall Study||14
28749|NCT01963091|68651|P2|NOT COMPLETED|Overall Study||0
28750|NCT01963091|68652|P1|NOT COMPLETED|Overall Study||0
28751|NCT01963091|68651|P2|COMPLETED|Overall Study||16
28752|NCT01963091|68652|P1|COMPLETED|Overall Study||17
28753|NCT01963091|68651|P2|STARTED|Overall Study||16
28754|NCT01963091|68652|P1|STARTED|Overall Study||17
28755|NCT01962974|68662|P1|NOT COMPLETED|Overall Study||7
28756|NCT01962974|68662|P1|COMPLETED|Overall Study||0
28757|NCT01962974|68662|P1|STARTED|Overall Study||7
28758|NCT01962961|68671|P3|NOT COMPLETED|Overall Study||1
28759|NCT01962961|68672|P2|NOT COMPLETED|Overall Study||1
28760|NCT01962961|68673|P1|NOT COMPLETED|Overall Study||0
28761|NCT01962961|68671|P3|COMPLETED|Overall Study||6
28762|NCT01962961|68672|P2|COMPLETED|Overall Study||7
28763|NCT01962961|68673|P1|COMPLETED|Overall Study||9
28764|NCT01962961|68671|P3|STARTED|Overall Study||7
28765|NCT01962961|68672|P2|STARTED|Overall Study||8
28766|NCT01962961|68673|P1|STARTED|Overall Study||9
28767|NCT01962922|68689|P2|NOT COMPLETED|Extendion Portion (up to Month 6)||3
28768|NCT01962922|68690|P1|NOT COMPLETED|Extendion Portion (up to Month 6)||5
28769|NCT01962922|68689|P2|COMPLETED|Extendion Portion (up to Month 6)||20
28770|NCT01962922|68690|P1|COMPLETED|Extendion Portion (up to Month 6)||18
28771|NCT01962922|68689|P2|STARTED|Extendion Portion (up to Month 6)||23
28772|NCT01962922|68690|P1|STARTED|Extendion Portion (up to Month 6)||23
28773|NCT01962922|68689|P2|NOT COMPLETED|PK Portion Day 21||0
28774|NCT01962922|68690|P1|NOT COMPLETED|PK Portion Day 21||0
28775|NCT01962922|68689|P2|COMPLETED|PK Portion Day 21||23
28776|NCT01962922|68690|P1|COMPLETED|PK Portion Day 21||23
28777|NCT01962922|68689|P2|STARTED|PK Portion Day 21||23
28778|NCT01962922|68690|P1|STARTED|PK Portion Day 21||23
28779|NCT01962922|68689|P2|NOT COMPLETED|PK Portion Day 14||0
28780|NCT01962922|68690|P1|NOT COMPLETED|PK Portion Day 14||0
28781|NCT01962922|68689|P2|COMPLETED|PK Portion Day 14||23
28782|NCT01962922|68690|P1|COMPLETED|PK Portion Day 14||23
28783|NCT01962922|68689|P2|STARTED|PK Portion Day 14||23
28784|NCT01962922|68690|P1|STARTED|PK Portion Day 14||23
28785|NCT01962922|68689|P2|NOT COMPLETED|PK Portion Day 7||0
28786|NCT01962922|68690|P1|NOT COMPLETED|PK Portion Day 7||4
28787|NCT01962922|68689|P2|COMPLETED|PK Portion Day 7||23
28788|NCT01962922|68690|P1|COMPLETED|PK Portion Day 7||23
28789|NCT01962922|68689|P2|STARTED|PK Portion Day 7||23
28790|NCT01962922|68690|P1|STARTED|PK Portion Day 7||27
28791|NCT01962675|68714|P2|NOT COMPLETED|Overall Study||0
28792|NCT01962675|68715|P1|NOT COMPLETED|Overall Study||0
28793|NCT01962675|68714|P2|COMPLETED|Overall Study||7
28794|NCT01962675|68715|P1|COMPLETED|Overall Study||7
28795|NCT01962675|68714|P2|STARTED|Overall Study||7
28796|NCT01962675|68715|P1|STARTED|Overall Study||7
28797|NCT01962493|68729|P2|NOT COMPLETED|Overall Study||5
28798|NCT01962493|68730|P1|NOT COMPLETED|Overall Study||5
28799|NCT01962493|68729|P2|COMPLETED|Overall Study||77
28800|NCT01962493|68730|P1|COMPLETED|Overall Study||73
28801|NCT01962493|68729|P2|STARTED|Overall Study||82
28802|NCT01962493|68730|P1|STARTED|Overall Study||78
28803|NCT01962441|68753|P3|NOT COMPLETED|Retreatment Substudy||0
28804|NCT01962441|68754|P2|NOT COMPLETED|Retreatment Substudy||0
28805|NCT01962441|68755|P1|NOT COMPLETED|Retreatment Substudy||2
28806|NCT01962441|68753|P3|COMPLETED|Retreatment Substudy||0
28807|NCT01962441|68754|P2|COMPLETED|Retreatment Substudy||10
28808|NCT01962441|68755|P1|COMPLETED|Retreatment Substudy||18
28809|NCT01962441|68753|P3|STARTED|Retreatment Substudy|Participants in the SOF+RBV+Peg-IFN group were not eligible to enroll in the Retreatment Substudy.|0
28810|NCT01962441|68754|P2|STARTED|Retreatment Substudy|10 participants who experienced virologic failure enrolled into the Retreatment Substudy.|10
28811|NCT01962441|68755|P1|STARTED|Retreatment Substudy|20 participants who experienced virologic failure enrolled into the Retreatment Substudy.|20
28812|NCT01962441|68753|P3|NOT COMPLETED|Randomized Period||11
28813|NCT01962441|68754|P2|NOT COMPLETED|Randomized Period||11
28814|NCT01962441|68755|P1|NOT COMPLETED|Randomized Period||10
28815|NCT01962441|68753|P3|COMPLETED|Randomized Period||189
28816|NCT01962441|68754|P2|COMPLETED|Randomized Period||190
28817|NCT01962441|68755|P1|COMPLETED|Randomized Period||190
28818|NCT01962441|68753|P3|STARTED|Randomized Period||200
28819|NCT01962441|68754|P2|STARTED|Randomized Period||201
28820|NCT01962441|68755|P1|STARTED|Randomized Period||200
28821|NCT01962428|68787|P2|NOT COMPLETED|Overall Study||6
28822|NCT01962428|68788|P1|NOT COMPLETED|Overall Study||10
28823|NCT01962428|68787|P2|COMPLETED|Overall Study||133
28824|NCT01962428|68788|P1|COMPLETED|Overall Study||129
28825|NCT01962428|68787|P2|STARTED|Overall Study||139
28826|NCT01962428|68788|P1|STARTED|Overall Study||139
28827|NCT01961544|68794|P1|NOT COMPLETED|Overall Study||13
28828|NCT01961544|68794|P1|COMPLETED|Overall Study||88
28829|NCT01961544|68794|P1|STARTED|Overall Study||101
28830|NCT01961349|68802|P3|NOT COMPLETED|Overall Study||2
28831|NCT01961349|68803|P2|NOT COMPLETED|Overall Study||6
28832|NCT01961349|68804|P1|NOT COMPLETED|Overall Study||3
28833|NCT01961349|68802|P3|COMPLETED|Overall Study||109
28834|NCT01961349|68803|P2|COMPLETED|Overall Study||101
28835|NCT01961349|68804|P1|COMPLETED|Overall Study||51
28836|NCT01961349|68802|P3|STARTED|Overall Study||111
28837|NCT01961349|68803|P2|STARTED|Overall Study||107
28838|NCT01961349|68804|P1|STARTED|Overall Study||54
28839|NCT01961271|68815|P1|NOT COMPLETED|Overall Study||50
28840|NCT01961271|68815|P1|COMPLETED|Overall Study||64
28841|NCT01961271|68815|P1|STARTED|Overall Study||114
28842|NCT01960907|68826|P2|NOT COMPLETED|Overall Study||45
28843|NCT01960907|68827|P1|NOT COMPLETED|Overall Study||36
28844|NCT01960907|68826|P2|COMPLETED|Overall Study||109
28845|NCT01960907|68827|P1|COMPLETED|Overall Study||122
28846|NCT01960907|68826|P2|STARTED|Overall Study||154
28847|NCT01960907|68827|P1|STARTED|Overall Study||158
28848|NCT01960842|68837|P1|NOT COMPLETED|Overall Study||3
28849|NCT01960842|68837|P1|COMPLETED|Overall Study||28
28850|NCT01960842|68837|P1|STARTED|Overall Study||31
28851|NCT01960816|68860|P1|NOT COMPLETED|Overall Study||1
28852|NCT01960816|68860|P1|COMPLETED|Overall Study||32
28853|NCT01960816|68860|P1|STARTED|Overall Study||33
28854|NCT01960725|68868|P2|NOT COMPLETED|Overall Study||5
28855|NCT01960725|68869|P1|NOT COMPLETED|Overall Study||6
28856|NCT01960725|68868|P2|COMPLETED|Overall Study||28
28857|NCT01960725|68869|P1|COMPLETED|Overall Study||27
28858|NCT01960725|68868|P2|Received Third Vaccine|Overall Study||32
28859|NCT01960725|68869|P1|Received Third Vaccine|Overall Study||32
28860|NCT01960725|68868|P2|Recieved Second Vaccine|Overall Study||33
28861|NCT01960725|68869|P1|Recieved Second Vaccine|Overall Study||33
28862|NCT01960725|68868|P2|Received First Vaccine|Overall Study||33
28863|NCT01960725|68869|P1|Received First Vaccine|Overall Study||33
28864|NCT01960725|68868|P2|STARTED|Overall Study||33
28865|NCT01960725|68869|P1|STARTED|Overall Study||33
28866|NCT01960530|68891|P1|NOT COMPLETED|Overall Study||0
28867|NCT01960530|68891|P1|COMPLETED|Overall Study||14
28868|NCT01960530|68891|P1|STARTED|Overall Study||14
28869|NCT01960400|68926|P2|NOT COMPLETED|Overall Study||0
28870|NCT01960400|68927|P1|NOT COMPLETED|Overall Study||0
28871|NCT01960400|68926|P2|COMPLETED|Overall Study||11
28872|NCT01960400|68927|P1|COMPLETED|Overall Study||11
28873|NCT01960400|68926|P2|STARTED|Overall Study||11
28874|NCT01960400|68927|P1|STARTED|Overall Study||11
28875|NCT01960387|68939|P1|NOT COMPLETED|Overall Study||0
28876|NCT01960387|68939|P1|COMPLETED|Overall Study||2
28877|NCT01960387|68939|P1|STARTED|Overall Study||2
28878|NCT01960296|68948|P2|NOT COMPLETED|Overall Study||3
28879|NCT01960296|68949|P1|NOT COMPLETED|Overall Study||2
28880|NCT01960296|68948|P2|COMPLETED|Overall Study||22
28881|NCT01960296|68949|P1|COMPLETED|Overall Study||21
28882|NCT01960296|68948|P2|STARTED|Overall Study||25
28883|NCT01960296|68949|P1|STARTED|Overall Study||23
28884|NCT01960140|68969|P1|NOT COMPLETED|Period 2 (Days 3-18)||2
28885|NCT01960140|68969|P1|COMPLETED|Period 2 (Days 3-18)||38
28886|NCT01960140|68969|P1|Received Simvastatin|Period 2 (Days 3-18)||38
28887|NCT01960140|68969|P1|Received At Least 1 Dose of Baricitinib|Period 2 (Days 3-18)||40
28888|NCT01960140|68969|P1|STARTED|Period 2 (Days 3-18)||40
28889|NCT01960140|68969|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
28890|NCT01960140|68969|P1|COMPLETED|Period 1 (Days 1-2)||40
28891|NCT01960140|68969|P1|Received Simvastatin|Period 1 (Days 1-2)||40
28892|NCT01960140|68969|P1|STARTED|Period 1 (Days 1-2)||40
28893|NCT01960114|68980|P2|NOT COMPLETED|Overall Study||1
28894|NCT01960114|68981|P1|NOT COMPLETED|Overall Study||1
28895|NCT01960114|68980|P2|COMPLETED|Overall Study||268
28896|NCT01960114|68981|P1|COMPLETED|Overall Study||133
28897|NCT01960114|68980|P2|STARTED|Overall Study||269
28898|NCT01960114|68981|P1|STARTED|Overall Study||134
28899|NCT01959945|68999|P4|NOT COMPLETED|Overall Study||16
28900|NCT01959945|69000|P3|NOT COMPLETED|Overall Study||19
28901|NCT01959945|69001|P2|NOT COMPLETED|Overall Study||3
28902|NCT01959945|69002|P1|NOT COMPLETED|Overall Study||4
28903|NCT01959945|68999|P4|COMPLETED|Overall Study||15
28904|NCT01959945|69000|P3|COMPLETED|Overall Study||9
28905|NCT01959945|69001|P2|COMPLETED|Overall Study||75
28906|NCT01959945|69002|P1|COMPLETED|Overall Study||76
28907|NCT01959945|68999|P4|STARTED|Overall Study||31
28908|NCT01959945|69000|P3|STARTED|Overall Study||28
28909|NCT01959945|69001|P2|STARTED|Overall Study||78
28910|NCT01959945|69002|P1|STARTED|Overall Study||80
28911|NCT01959932|69027|P3|NOT COMPLETED|Overall Study||0
28912|NCT01959932|69028|P2|NOT COMPLETED|Overall Study||0
28913|NCT01959932|69029|P1|NOT COMPLETED|Overall Study||1
28914|NCT01959932|69027|P3|COMPLETED|Overall Study||39
28915|NCT01959932|69028|P2|COMPLETED|Overall Study||41
28916|NCT01959932|69029|P1|COMPLETED|Overall Study||79
28917|NCT01959932|69027|P3|STARTED|Overall Study||39
28918|NCT01959932|69028|P2|STARTED|Overall Study||41
28919|NCT01959932|69029|P1|STARTED|Overall Study||80
28920|NCT01959880|69051|P4|NOT COMPLETED|Overall Study||181
28921|NCT01959880|69052|P3|NOT COMPLETED|Overall Study||208
28922|NCT01959880|69053|P2|NOT COMPLETED|Overall Study||369
28923|NCT01959880|69054|P1|NOT COMPLETED|Overall Study||1132
28924|NCT01959880|69051|P4|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
28925|NCT01959880|69052|P3|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|1
28926|NCT01959880|69053|P2|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
28927|NCT01959880|69054|P1|COMPLETED|Overall Study|FDA granted approval for devices leading to early study completion. One subject reached 10 years.|0
28928|NCT01959880|69051|P4|STARTED|Overall Study||181
28929|NCT01959880|69052|P3|STARTED|Overall Study||209
28930|NCT01959880|69053|P2|STARTED|Overall Study||369
28931|NCT01959880|69054|P1|STARTED|Overall Study||1132
28932|NCT01959685|69076|P1|NOT COMPLETED|Overall Study||0
28933|NCT01959685|69076|P1|COMPLETED|Overall Study||9
28934|NCT01959685|69076|P1|STARTED|Overall Study||9
28935|NCT01959607|69083|P4|NOT COMPLETED|Second Intervention (Day 3)||0
28936|NCT01959607|69084|P3|NOT COMPLETED|Second Intervention (Day 3)||0
28937|NCT01959607|69085|P2|NOT COMPLETED|Second Intervention (Day 3)||0
28938|NCT01959607|69086|P1|NOT COMPLETED|Second Intervention (Day 3)||0
28939|NCT01959607|69083|P4|COMPLETED|Second Intervention (Day 3)||9
28940|NCT01959607|69084|P3|COMPLETED|Second Intervention (Day 3)||9
28941|NCT01959607|69085|P2|COMPLETED|Second Intervention (Day 3)||21
28942|NCT01959607|69086|P1|COMPLETED|Second Intervention (Day 3)||21
28943|NCT01959607|69083|P4|STARTED|Second Intervention (Day 3)||9
28944|NCT01959607|69084|P3|STARTED|Second Intervention (Day 3)||9
28945|NCT01959607|69085|P2|STARTED|Second Intervention (Day 3)||21
28946|NCT01959607|69086|P1|STARTED|Second Intervention (Day 3)||21
28947|NCT01959607|69083|P4|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28948|NCT01959607|69084|P3|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28949|NCT01959607|69085|P2|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28950|NCT01959607|69086|P1|NOT COMPLETED|Washout Period of 1 Day (Day 2)||0
28951|NCT01959607|69083|P4|COMPLETED|Washout Period of 1 Day (Day 2)||9
28952|NCT01959607|69084|P3|COMPLETED|Washout Period of 1 Day (Day 2)||9
28953|NCT01959607|69085|P2|COMPLETED|Washout Period of 1 Day (Day 2)||21
28954|NCT01959607|69086|P1|COMPLETED|Washout Period of 1 Day (Day 2)||21
28955|NCT01959607|69083|P4|STARTED|Washout Period of 1 Day (Day 2)||9
28956|NCT01959607|69084|P3|STARTED|Washout Period of 1 Day (Day 2)||9
28957|NCT01959607|69085|P2|STARTED|Washout Period of 1 Day (Day 2)||21
28958|NCT01959607|69086|P1|STARTED|Washout Period of 1 Day (Day 2)||21
28959|NCT01959607|69083|P4|NOT COMPLETED|First Intervention (Day 1)||0
28960|NCT01959607|69084|P3|NOT COMPLETED|First Intervention (Day 1)||0
28961|NCT01959607|69085|P2|NOT COMPLETED|First Intervention (Day 1)||1
28962|NCT01959607|69086|P1|NOT COMPLETED|First Intervention (Day 1)||1
28963|NCT01959607|69083|P4|COMPLETED|First Intervention (Day 1)||9
28964|NCT01959607|69084|P3|COMPLETED|First Intervention (Day 1)||9
28965|NCT01959607|69085|P2|COMPLETED|First Intervention (Day 1)||21
28966|NCT01959607|69086|P1|COMPLETED|First Intervention (Day 1)||21
28967|NCT01959607|69083|P4|STARTED|First Intervention (Day 1)||9
28968|NCT01959607|69084|P3|STARTED|First Intervention (Day 1)||9
28969|NCT01959607|69085|P2|STARTED|First Intervention (Day 1)||22
28970|NCT01959607|69086|P1|STARTED|First Intervention (Day 1)||22
28971|NCT01959607|69083|P4|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28972|NCT01959607|69084|P3|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28973|NCT01959607|69085|P2|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28974|NCT01959607|69086|P1|NOT COMPLETED|Washout Period of 1 Day (Day 0)||0
28975|NCT01959607|69083|P4|COMPLETED|Washout Period of 1 Day (Day 0)||9
28976|NCT01959607|69084|P3|COMPLETED|Washout Period of 1 Day (Day 0)||9
28977|NCT01959607|69085|P2|COMPLETED|Washout Period of 1 Day (Day 0)||22
28978|NCT01959607|69086|P1|COMPLETED|Washout Period of 1 Day (Day 0)||22
28979|NCT01959607|69083|P4|STARTED|Washout Period of 1 Day (Day 0)||9
28980|NCT01959607|69084|P3|STARTED|Washout Period of 1 Day (Day 0)||9
28981|NCT01959607|69085|P2|STARTED|Washout Period of 1 Day (Day 0)||22
28982|NCT01959607|69086|P1|STARTED|Washout Period of 1 Day (Day 0)||22
28983|NCT01959581|69093|P1|NOT COMPLETED|Overall Study||5
28984|NCT01959581|69093|P1|COMPLETED|Overall Study||25
28985|NCT01959581|69093|P1|STARTED|Overall Study||30
28986|NCT01959516|69097|P2|NOT COMPLETED|Epoch 2||1
28987|NCT01959516|69098|P1|NOT COMPLETED|Epoch 2||2
28988|NCT01959516|69097|P2|COMPLETED|Epoch 2||62
28989|NCT01959516|69098|P1|COMPLETED|Epoch 2||61
28990|NCT01959516|69097|P2|STARTED|Epoch 2||63
28991|NCT01959516|69098|P1|STARTED|Epoch 2||63
28992|NCT01959516|69097|P2|NOT COMPLETED|Epoch 1||5
28993|NCT01959516|69098|P1|NOT COMPLETED|Epoch 1||10
28994|NCT01959516|69097|P2|COMPLETED|Epoch 1||58
28995|NCT01959516|69098|P1|COMPLETED|Epoch 1||53
28996|NCT01959516|69097|P2|ITT Population|Epoch 1||62
28997|NCT01959516|69098|P1|ITT Population|Epoch 1||62
28998|NCT01959516|69097|P2|Safety Population|Epoch 1||62
28999|NCT01959516|69098|P1|Safety Population|Epoch 1||62
29000|NCT01959516|69097|P2|STARTED|Epoch 1||63
29001|NCT01959516|69098|P1|STARTED|Epoch 1||63
29002|NCT01959503|69108|P2|NOT COMPLETED|Overall Study||2
29003|NCT01959503|69109|P1|NOT COMPLETED|Overall Study||3
29004|NCT01959503|69108|P2|COMPLETED|Overall Study||49
29005|NCT01959503|69109|P1|COMPLETED|Overall Study||104
29006|NCT01959503|69108|P2|STARTED|Overall Study||51
29007|NCT01959503|69109|P1|STARTED|Overall Study||107
29008|NCT01959412|69129|P6|NOT COMPLETED|Overall Study||0
29009|NCT01959412|69130|P5|NOT COMPLETED|Overall Study||3
29010|NCT01959412|69131|P4|NOT COMPLETED|Overall Study||2
29011|NCT01959412|69132|P3|NOT COMPLETED|Overall Study||0
29012|NCT01959412|69133|P2|NOT COMPLETED|Overall Study||1
29013|NCT01959412|69134|P1|NOT COMPLETED|Overall Study||1
29014|NCT01959412|69129|P6|COMPLETED|Overall Study||15
29015|NCT01959412|69130|P5|COMPLETED|Overall Study||13
29016|NCT01959412|69131|P4|COMPLETED|Overall Study||13
29017|NCT01959412|69132|P3|COMPLETED|Overall Study||15
29018|NCT01959412|69133|P2|COMPLETED|Overall Study||14
29019|NCT01959412|69134|P1|COMPLETED|Overall Study||14
29020|NCT01959412|69129|P6|STARTED|Overall Study||15
29021|NCT01959412|69130|P5|STARTED|Overall Study||16
29022|NCT01959412|69131|P4|STARTED|Overall Study||15
29023|NCT01959412|69132|P3|STARTED|Overall Study||15
29024|NCT01959412|69133|P2|STARTED|Overall Study||15
29025|NCT01959412|69134|P1|STARTED|Overall Study||15
29026|NCT01959035|69172|P1|NOT COMPLETED|Overall Study||11
29027|NCT01959035|69172|P1|COMPLETED|Overall Study||77
29028|NCT01959035|69172|P1|STARTED|Overall Study||88
29029|NCT01958827|69198|P1|NOT COMPLETED|Overall Study||10
29030|NCT01958827|69198|P1|COMPLETED|Overall Study||18
29031|NCT01958827|69198|P1|STARTED|Overall Study||28
29032|NCT01958788|69216|P1|NOT COMPLETED|Overall Study||0
29033|NCT01958788|69216|P1|COMPLETED|Overall Study||7
29034|NCT01958788|69216|P1|STARTED|Overall Study||7
29035|NCT01958645|69229|P3|NOT COMPLETED|Overall Study||0
29036|NCT01958645|69230|P2|NOT COMPLETED|Overall Study||0
29037|NCT01958645|69231|P1|NOT COMPLETED|Overall Study||0
29038|NCT01958645|69229|P3|COMPLETED|Overall Study||4
29039|NCT01958645|69230|P2|COMPLETED|Overall Study||4
29040|NCT01958645|69231|P1|COMPLETED|Overall Study||4
29041|NCT01958645|69229|P3|STARTED|Overall Study||4
29042|NCT01958645|69230|P2|STARTED|Overall Study||4
29043|NCT01958645|69231|P1|STARTED|Overall Study||4
29044|NCT01958619|69259|P4|NOT COMPLETED|Overall Study||0
29045|NCT01958619|69260|P3|NOT COMPLETED|Overall Study||1
29046|NCT01958619|69261|P2|NOT COMPLETED|Overall Study||0
29047|NCT01958619|69262|P1|NOT COMPLETED|Overall Study||2
29048|NCT01958619|69259|P4|COMPLETED|Overall Study||12
29049|NCT01958619|69260|P3|COMPLETED|Overall Study||13
29050|NCT01958619|69261|P2|COMPLETED|Overall Study||14
29051|NCT01958619|69262|P1|COMPLETED|Overall Study||13
29052|NCT01958619|69259|P4|STARTED|Overall Study||12
29053|NCT01958619|69260|P3|STARTED|Overall Study||14
29054|NCT01958619|69261|P2|STARTED|Overall Study||14
29055|NCT01958619|69262|P1|STARTED|Overall Study||15
29056|NCT01958606|69284|P2|NOT COMPLETED|Overall Study||0
29057|NCT01958606|69285|P1|NOT COMPLETED|Overall Study||2
29058|NCT01958606|69284|P2|COMPLETED|Overall Study||5
29059|NCT01958606|69285|P1|COMPLETED|Overall Study||11
29060|NCT01958606|69284|P2|STARTED|Overall Study||5
29061|NCT01958606|69285|P1|STARTED|Overall Study||13
29062|NCT01958346|69325|P2|NOT COMPLETED|Overall Study||0
29063|NCT01958346|69326|P1|NOT COMPLETED|Overall Study||0
29064|NCT01958346|69325|P2|COMPLETED|Overall Study||39
29065|NCT01958346|69326|P1|COMPLETED|Overall Study||39
29066|NCT01958346|69325|P2|STARTED|Overall Study||39
29067|NCT01958346|69326|P1|STARTED|Overall Study||39
29068|NCT01958164|69336|P2|NOT COMPLETED|Overall Study||5
29069|NCT01958164|69337|P1|NOT COMPLETED|Overall Study||2
29070|NCT01958164|69336|P2|COMPLETED|Overall Study||5
29071|NCT01958164|69337|P1|COMPLETED|Overall Study||4
29072|NCT01958164|69336|P2|STARTED|Overall Study|Randomised and treated|10
29073|NCT01958164|69337|P1|STARTED|Overall Study|Randomised and treated|6
29074|NCT01958060|69356|P6|NOT COMPLETED|Overall Study||0
29075|NCT01958060|69357|P5|NOT COMPLETED|Overall Study||1
29076|NCT01958060|69358|P4|NOT COMPLETED|Overall Study||0
29077|NCT01958060|69359|P3|NOT COMPLETED|Overall Study||0
29078|NCT01958060|69360|P2|NOT COMPLETED|Overall Study||0
29079|NCT01958060|69361|P1|NOT COMPLETED|Overall Study||2
29080|NCT01958060|69356|P6|COMPLETED|Overall Study|One subject in the 100 mg iv dose group did not receive complete dose of trial medication.|1
29081|NCT01958060|69357|P5|COMPLETED|Overall Study|One subject in the 50 mg iv dose group did not receive complete dose of trial medication.|6
29082|NCT01958060|69358|P4|COMPLETED|Overall Study||5
29083|NCT01958060|69359|P3|COMPLETED|Overall Study||6
29084|NCT01958060|69360|P2|COMPLETED|Overall Study||6
29085|NCT01958060|69361|P1|COMPLETED|Overall Study||8
29086|NCT01958060|69356|P6|STARTED|Overall Study||1
29087|NCT01958060|69357|P5|STARTED|Overall Study||7
29088|NCT01958060|69358|P4|STARTED|Overall Study||5
29089|NCT01958060|69359|P3|STARTED|Overall Study||6
29090|NCT01958060|69360|P2|STARTED|Overall Study||6
29091|NCT01958060|69361|P1|STARTED|Overall Study||10
29092|NCT01958021|69386|P2|NOT COMPLETED|Overall Study||180
29093|NCT01958021|69387|P1|NOT COMPLETED|Overall Study||139
29094|NCT01958021|69386|P2|COMPLETED|Overall Study|Completed = Treatment ongoing|154
29095|NCT01958021|69387|P1|COMPLETED|Overall Study|Completed = Treatment ongoing|195
29096|NCT01958021|69386|P2|Patients Treated|Overall Study||330
29097|NCT01958021|69387|P1|Patients Treated|Overall Study||334
29098|NCT01958021|69386|P2|Patients Untreated|Overall Study||4
29099|NCT01958021|69387|P1|Patients Untreated|Overall Study||0
29100|NCT01958021|69386|P2|STARTED|Overall Study||334
29101|NCT01958021|69387|P1|STARTED|Overall Study||334
29102|NCT01958008|69399|P4|NOT COMPLETED|Overall Study||0
29103|NCT01958008|69400|P3|NOT COMPLETED|Overall Study||1
29104|NCT01958008|69401|P2|NOT COMPLETED|Overall Study||0
29105|NCT01958008|69402|P1|NOT COMPLETED|Overall Study||1
29106|NCT01958008|69399|P4|COMPLETED|Overall Study||21
29107|NCT01958008|69400|P3|COMPLETED|Overall Study||20
29108|NCT01958008|69401|P2|COMPLETED|Overall Study||21
29109|NCT01958008|69402|P1|COMPLETED|Overall Study||20
29110|NCT01958008|69399|P4|STARTED|Overall Study||21
29111|NCT01958008|69400|P3|STARTED|Overall Study||21
29112|NCT01958008|69401|P2|STARTED|Overall Study||21
29113|NCT01958008|69402|P1|STARTED|Overall Study||21
29114|NCT01957930|69432|P2|NOT COMPLETED|Overall Study||0
29115|NCT01957930|69433|P1|NOT COMPLETED|Overall Study||0
29116|NCT01957930|69432|P2|COMPLETED|Overall Study||37
29117|NCT01957930|69433|P1|COMPLETED|Overall Study||35
29118|NCT01957930|69432|P2|STARTED|Overall Study||37
29119|NCT01957930|69433|P1|STARTED|Overall Study||35
29120|NCT01957865|69442|P3|NOT COMPLETED|Overall Study||3
29121|NCT01957865|69443|P2|NOT COMPLETED|Overall Study||2
29122|NCT01957865|69444|P1|NOT COMPLETED|Overall Study||0
29123|NCT01957865|69442|P3|COMPLETED|Overall Study||19
29124|NCT01957865|69443|P2|COMPLETED|Overall Study||18
29125|NCT01957865|69444|P1|COMPLETED|Overall Study||21
29126|NCT01957865|69442|P3|STARTED|Overall Study||22
29127|NCT01957865|69443|P2|STARTED|Overall Study||20
29128|NCT01957865|69444|P1|STARTED|Overall Study||21
29129|NCT01957761|69455|P1|NOT COMPLETED|Overall Study||0
29130|NCT01957761|69455|P1|COMPLETED|Overall Study||189
29131|NCT01957761|69455|P1|STARTED|Overall Study||189
29132|NCT01957657|69459|P1|NOT COMPLETED|Overall Study||0
29133|NCT01957657|69459|P1|COMPLETED|Overall Study||4
29134|NCT01957657|69459|P1|STARTED|Overall Study||4
29135|NCT01957579|69477|P4|NOT COMPLETED|Overall Study||0
29136|NCT01957579|69478|P3|NOT COMPLETED|Overall Study||2
29137|NCT01957579|69479|P2|NOT COMPLETED|Overall Study||1
29138|NCT01957579|69480|P1|NOT COMPLETED|Overall Study||0
29139|NCT01957579|69477|P4|COMPLETED|Overall Study||6
29140|NCT01957579|69478|P3|COMPLETED|Overall Study||2
29141|NCT01957579|69479|P2|COMPLETED|Overall Study||6
29142|NCT01957579|69480|P1|COMPLETED|Overall Study||3
29143|NCT01957579|69477|P4|STARTED|Overall Study||6
29144|NCT01957579|69478|P3|STARTED|Overall Study||4
29145|NCT01957579|69479|P2|STARTED|Overall Study||7
29146|NCT01957579|69480|P1|STARTED|Overall Study||3
29147|NCT01957553|69547|P2|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||7
29148|NCT01957553|69548|P1|NOT COMPLETED|Test Period 2 (21 +- 1 Days)||3
29149|NCT01957553|69547|P2|COMPLETED|Test Period 2 (21 +- 1 Days)||56
29150|NCT01957553|69548|P1|COMPLETED|Test Period 2 (21 +- 1 Days)||51
29151|NCT01957553|69547|P2|STARTED|Test Period 2 (21 +- 1 Days)||63
29152|NCT01957553|69548|P1|STARTED|Test Period 2 (21 +- 1 Days)||54
29153|NCT01957553|69547|P2|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||3
29154|NCT01957553|69548|P1|NOT COMPLETED|Test Period 1 (21 +- 1 Days)||7
29155|NCT01957553|69547|P2|COMPLETED|Test Period 1 (21 +- 1 Days)||63
29156|NCT01957553|69548|P1|COMPLETED|Test Period 1 (21 +- 1 Days)||54
29157|NCT01957553|69547|P2|STARTED|Test Period 1 (21 +- 1 Days)||66
29158|NCT01957553|69548|P1|STARTED|Test Period 1 (21 +- 1 Days)||61
29159|NCT01957488|69554|P6|NOT COMPLETED|Test Period 3||0
29160|NCT01957488|69555|P5|NOT COMPLETED|Test Period 3||0
29161|NCT01957488|69556|P4|NOT COMPLETED|Test Period 3||0
29162|NCT01957488|69557|P3|NOT COMPLETED|Test Period 3||0
29163|NCT01957488|69558|P2|NOT COMPLETED|Test Period 3||1
29164|NCT01957488|69559|P1|NOT COMPLETED|Test Period 3||1
29165|NCT01957488|69554|P6|COMPLETED|Test Period 3||23
29166|NCT01957488|69555|P5|COMPLETED|Test Period 3||25
29167|NCT01957488|69556|P4|COMPLETED|Test Period 3||28
29168|NCT01957488|69557|P3|COMPLETED|Test Period 3||25
29169|NCT01957488|69558|P2|COMPLETED|Test Period 3||26
29170|NCT01957488|69559|P1|COMPLETED|Test Period 3||23
29171|NCT01957488|69554|P6|STARTED|Test Period 3||23
29172|NCT01957488|69555|P5|STARTED|Test Period 3||25
29173|NCT01957488|69556|P4|STARTED|Test Period 3||28
29174|NCT01957488|69557|P3|STARTED|Test Period 3||25
29175|NCT01957488|69558|P2|STARTED|Test Period 3||27
29176|NCT01957488|69559|P1|STARTED|Test Period 3||24
29177|NCT01957488|69554|P6|NOT COMPLETED|Test Period 2||1
29178|NCT01957488|69555|P5|NOT COMPLETED|Test Period 2||2
29179|NCT01957488|69556|P4|NOT COMPLETED|Test Period 2||1
29180|NCT01957488|69557|P3|NOT COMPLETED|Test Period 2||1
29181|NCT01957488|69558|P2|NOT COMPLETED|Test Period 2||1
29182|NCT01957488|69559|P1|NOT COMPLETED|Test Period 2||3
29183|NCT01957488|69554|P6|COMPLETED|Test Period 2||23
29184|NCT01957488|69555|P5|COMPLETED|Test Period 2||25
29185|NCT01957488|69556|P4|COMPLETED|Test Period 2||28
29186|NCT01957488|69557|P3|COMPLETED|Test Period 2||25
29187|NCT01957488|69558|P2|COMPLETED|Test Period 2||27
29188|NCT01957488|69559|P1|COMPLETED|Test Period 2||24
29189|NCT01957488|69554|P6|STARTED|Test Period 2||24
29190|NCT01957488|69555|P5|STARTED|Test Period 2||27
29191|NCT01957488|69556|P4|STARTED|Test Period 2||29
29192|NCT01957488|69557|P3|STARTED|Test Period 2||26
29193|NCT01957488|69558|P2|STARTED|Test Period 2||28
29194|NCT01957488|69559|P1|STARTED|Test Period 2||27
29195|NCT01957488|69554|P6|NOT COMPLETED|Test Period 1||6
29196|NCT01957488|69555|P5|NOT COMPLETED|Test Period 1||3
29197|NCT01957488|69556|P4|NOT COMPLETED|Test Period 1||3
29198|NCT01957488|69557|P3|NOT COMPLETED|Test Period 1||4
29199|NCT01957488|69558|P2|NOT COMPLETED|Test Period 1||3
29200|NCT01957488|69559|P1|NOT COMPLETED|Test Period 1||3
29201|NCT01957488|69554|P6|COMPLETED|Test Period 1||24
29202|NCT01957488|69555|P5|COMPLETED|Test Period 1||27
29203|NCT01957488|69556|P4|COMPLETED|Test Period 1||29
29204|NCT01957488|69557|P3|COMPLETED|Test Period 1||26
29205|NCT01957488|69558|P2|COMPLETED|Test Period 1||28
29206|NCT01957488|69559|P1|COMPLETED|Test Period 1||27
29207|NCT01957488|69554|P6|STARTED|Test Period 1||30
29208|NCT01957488|69555|P5|STARTED|Test Period 1||30
29209|NCT01957488|69556|P4|STARTED|Test Period 1||32
29210|NCT01957488|69557|P3|STARTED|Test Period 1||30
29211|NCT01957488|69558|P2|STARTED|Test Period 1||31
29212|NCT01957488|69559|P1|STARTED|Test Period 1||30
29213|NCT01957475|69567|P2|NOT COMPLETED|Test Period 2||0
29214|NCT01957475|69568|P1|NOT COMPLETED|Test Period 2||1
29215|NCT01957475|69567|P2|COMPLETED|Test Period 2||8
29216|NCT01957475|69568|P1|COMPLETED|Test Period 2||8
29217|NCT01957475|69567|P2|STARTED|Test Period 2||8
29218|NCT01957475|69568|P1|STARTED|Test Period 2||9
29219|NCT01957475|69567|P2|NOT COMPLETED|Test Period 1||1
29220|NCT01957475|69568|P1|NOT COMPLETED|Test Period 1||2
29221|NCT01957475|69567|P2|COMPLETED|Test Period 1||9
29222|NCT01957475|69568|P1|COMPLETED|Test Period 1||8
29223|NCT01957475|69567|P2|STARTED|Test Period 1||10
29224|NCT01957475|69568|P1|STARTED|Test Period 1||10
29225|NCT01957462|69574|P2|NOT COMPLETED|Test Period 2||0
29226|NCT01957462|69575|P1|NOT COMPLETED|Test Period 2||0
29227|NCT01957462|69574|P2|COMPLETED|Test Period 2||15
29228|NCT01957462|69575|P1|COMPLETED|Test Period 2||14
29229|NCT01957462|69574|P2|STARTED|Test Period 2||15
29230|NCT01957462|69575|P1|STARTED|Test Period 2||14
29231|NCT01957462|69574|P2|NOT COMPLETED|Test Period 1||0
29232|NCT01957462|69575|P1|NOT COMPLETED|Test Period 1||2
29233|NCT01957462|69574|P2|COMPLETED|Test Period 1||15
29234|NCT01957462|69575|P1|COMPLETED|Test Period 1||14
29235|NCT01957462|69574|P2|STARTED|Test Period 1||15
29236|NCT01957462|69575|P1|STARTED|Test Period 1||16
29237|NCT01957410|69581|P1|NOT COMPLETED|Optional Open Label||0
29238|NCT01957410|69581|P1|COMPLETED|Optional Open Label||13
29239|NCT01957410|69581|P1|STARTED|Optional Open Label||13
29240|NCT01957410|69581|P1|NOT COMPLETED|Open Label||0
29241|NCT01957410|69581|P1|COMPLETED|Open Label||13
29242|NCT01957410|69581|P1|STARTED|Open Label||13
29243|NCT01957397|69586|P2|NOT COMPLETED|Test Period 3||2
29244|NCT01957397|69587|P1|NOT COMPLETED|Test Period 3||2
29245|NCT01957397|69586|P2|COMPLETED|Test Period 3||9
29246|NCT01957397|69587|P1|COMPLETED|Test Period 3||9
29247|NCT01957397|69586|P2|STARTED|Test Period 3||11
29248|NCT01957397|69587|P1|STARTED|Test Period 3||11
29249|NCT01957397|69586|P2|NOT COMPLETED|Test Period 2||1
29250|NCT01957397|69587|P1|NOT COMPLETED|Test Period 2||0
29251|NCT01957397|69586|P2|COMPLETED|Test Period 2||11
29252|NCT01957397|69587|P1|COMPLETED|Test Period 2||11
29253|NCT01957397|69586|P2|STARTED|Test Period 2||12
29254|NCT01957397|69587|P1|STARTED|Test Period 2||11
29255|NCT01957397|69586|P2|NOT COMPLETED|Test Period 1||1
29256|NCT01957397|69587|P1|NOT COMPLETED|Test Period 1||2
29257|NCT01957397|69586|P2|COMPLETED|Test Period 1||12
29258|NCT01957397|69587|P1|COMPLETED|Test Period 1||11
29259|NCT01957397|69586|P2|STARTED|Test Period 1||13
29260|NCT01957397|69587|P1|STARTED|Test Period 1||13
29261|NCT01957397|69586|P2|NOT COMPLETED|Baseline Own Product||0
29262|NCT01957397|69587|P1|NOT COMPLETED|Baseline Own Product||0
29263|NCT01957397|69586|P2|COMPLETED|Baseline Own Product||13
29264|NCT01957397|69587|P1|COMPLETED|Baseline Own Product||13
29265|NCT01957397|69586|P2|STARTED|Baseline Own Product||13
29266|NCT01957397|69587|P1|STARTED|Baseline Own Product||13
29267|NCT01957384|69597|P6|NOT COMPLETED|Test Period 3 (14 Days)||0
29268|NCT01957384|69598|P5|NOT COMPLETED|Test Period 3 (14 Days)||0
29269|NCT01957384|69599|P4|NOT COMPLETED|Test Period 3 (14 Days)||0
29270|NCT01957384|69600|P3|NOT COMPLETED|Test Period 3 (14 Days)||0
29271|NCT01957384|69601|P2|NOT COMPLETED|Test Period 3 (14 Days)||0
29272|NCT01957384|69602|P1|NOT COMPLETED|Test Period 3 (14 Days)||0
29273|NCT01957384|69597|P6|COMPLETED|Test Period 3 (14 Days)||3
29274|NCT01957384|69598|P5|COMPLETED|Test Period 3 (14 Days)||3
29275|NCT01957384|69599|P4|COMPLETED|Test Period 3 (14 Days)||4
29276|NCT01957384|69600|P3|COMPLETED|Test Period 3 (14 Days)||4
29277|NCT01957384|69601|P2|COMPLETED|Test Period 3 (14 Days)||4
29278|NCT01957384|69602|P1|COMPLETED|Test Period 3 (14 Days)||4
29279|NCT01957384|69597|P6|STARTED|Test Period 3 (14 Days)||3
29280|NCT01957384|69598|P5|STARTED|Test Period 3 (14 Days)||3
29281|NCT01957384|69599|P4|STARTED|Test Period 3 (14 Days)||4
29282|NCT01957384|69600|P3|STARTED|Test Period 3 (14 Days)||4
29283|NCT01957384|69601|P2|STARTED|Test Period 3 (14 Days)||4
29284|NCT01957384|69602|P1|STARTED|Test Period 3 (14 Days)||4
29285|NCT01957384|69597|P6|NOT COMPLETED|Test Period 2 (14 Days)||0
29286|NCT01957384|69598|P5|NOT COMPLETED|Test Period 2 (14 Days)||0
29287|NCT01957384|69599|P4|NOT COMPLETED|Test Period 2 (14 Days)||0
29288|NCT01957384|69600|P3|NOT COMPLETED|Test Period 2 (14 Days)||0
29289|NCT01957384|69601|P2|NOT COMPLETED|Test Period 2 (14 Days)||0
29290|NCT01957384|69602|P1|NOT COMPLETED|Test Period 2 (14 Days)||0
29291|NCT01957384|69597|P6|COMPLETED|Test Period 2 (14 Days)||3
29292|NCT01957384|69598|P5|COMPLETED|Test Period 2 (14 Days)||3
29293|NCT01957384|69599|P4|COMPLETED|Test Period 2 (14 Days)||4
29294|NCT01957384|69600|P3|COMPLETED|Test Period 2 (14 Days)||4
29295|NCT01957384|69601|P2|COMPLETED|Test Period 2 (14 Days)||4
29296|NCT01957384|69602|P1|COMPLETED|Test Period 2 (14 Days)||4
29297|NCT01957384|69597|P6|STARTED|Test Period 2 (14 Days)||3
29298|NCT01957384|69598|P5|STARTED|Test Period 2 (14 Days)||3
29299|NCT01957384|69599|P4|STARTED|Test Period 2 (14 Days)||4
29300|NCT01957384|69600|P3|STARTED|Test Period 2 (14 Days)||4
29301|NCT01957384|69601|P2|STARTED|Test Period 2 (14 Days)||4
29302|NCT01957384|69602|P1|STARTED|Test Period 2 (14 Days)||4
29303|NCT01957384|69597|P6|NOT COMPLETED|Test Period 1 (14 Days)||0
29304|NCT01957384|69598|P5|NOT COMPLETED|Test Period 1 (14 Days)||0
29305|NCT01957384|69599|P4|NOT COMPLETED|Test Period 1 (14 Days)||0
29306|NCT01957384|69600|P3|NOT COMPLETED|Test Period 1 (14 Days)||0
29307|NCT01957384|69601|P2|NOT COMPLETED|Test Period 1 (14 Days)||0
29308|NCT01957384|69602|P1|NOT COMPLETED|Test Period 1 (14 Days)||0
29309|NCT01957384|69597|P6|COMPLETED|Test Period 1 (14 Days)||3
29310|NCT01957384|69598|P5|COMPLETED|Test Period 1 (14 Days)||3
29311|NCT01957384|69599|P4|COMPLETED|Test Period 1 (14 Days)||4
29312|NCT01957384|69600|P3|COMPLETED|Test Period 1 (14 Days)||4
29313|NCT01957384|69601|P2|COMPLETED|Test Period 1 (14 Days)||4
29314|NCT01957384|69602|P1|COMPLETED|Test Period 1 (14 Days)||4
29315|NCT01957384|69597|P6|STARTED|Test Period 1 (14 Days)||3
29316|NCT01957384|69598|P5|STARTED|Test Period 1 (14 Days)||3
29317|NCT01957384|69599|P4|STARTED|Test Period 1 (14 Days)||4
29318|NCT01957384|69600|P3|STARTED|Test Period 1 (14 Days)||4
29319|NCT01957384|69601|P2|STARTED|Test Period 1 (14 Days)||4
29320|NCT01957384|69602|P1|STARTED|Test Period 1 (14 Days)||4
29321|NCT01957215|69612|P2|NOT COMPLETED|Overall Study||12
29322|NCT01957215|69613|P1|NOT COMPLETED|Overall Study||13
29323|NCT01957215|69612|P2|COMPLETED|Overall Study||123
29324|NCT01957215|69613|P1|COMPLETED|Overall Study||122
29325|NCT01957215|69612|P2|STARTED|Overall Study||135
29326|NCT01957215|69613|P1|STARTED|Overall Study||135
29327|NCT01957202|69641|P18|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29328|NCT01957202|69642|P17|NOT COMPLETED|Treatment Period 3 (8 Days)||1
29329|NCT01957202|69643|P16|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29330|NCT01957202|69644|P15|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29331|NCT01957202|69645|P14|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29332|NCT01957202|69646|P13|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29333|NCT01957202|69647|P12|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29334|NCT01957202|69648|P11|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29335|NCT01957202|69649|P10|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29336|NCT01957202|69650|P9|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29337|NCT01957202|69651|P8|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29338|NCT01957202|69652|P7|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29339|NCT01957202|69653|P6|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29340|NCT01957202|69654|P5|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29341|NCT01957202|69655|P4|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29342|NCT01957202|69656|P3|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29343|NCT01957202|69657|P2|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29344|NCT01957202|69658|P1|NOT COMPLETED|Treatment Period 3 (8 Days)||0
29345|NCT01957202|69641|P18|COMPLETED|Treatment Period 3 (8 Days)||3
29346|NCT01957202|69642|P17|COMPLETED|Treatment Period 3 (8 Days)||4
29347|NCT01957202|69643|P16|COMPLETED|Treatment Period 3 (8 Days)||3
29348|NCT01957202|69644|P15|COMPLETED|Treatment Period 3 (8 Days)||6
29349|NCT01957202|69645|P14|COMPLETED|Treatment Period 3 (8 Days)||3
29350|NCT01957202|69646|P13|COMPLETED|Treatment Period 3 (8 Days)||3
29351|NCT01957202|69647|P12|COMPLETED|Treatment Period 3 (8 Days)||6
29352|NCT01957202|69648|P11|COMPLETED|Treatment Period 3 (8 Days)||3
29353|NCT01957202|69649|P10|COMPLETED|Treatment Period 3 (8 Days)||6
29354|NCT01957202|69650|P9|COMPLETED|Treatment Period 3 (8 Days)||3
29355|NCT01957202|69651|P8|COMPLETED|Treatment Period 3 (8 Days)||3
29356|NCT01957202|69652|P7|COMPLETED|Treatment Period 3 (8 Days)||3
29357|NCT01957202|69653|P6|COMPLETED|Treatment Period 3 (8 Days)||2
29358|NCT01957202|69654|P5|COMPLETED|Treatment Period 3 (8 Days)||3
29359|NCT01957202|69655|P4|COMPLETED|Treatment Period 3 (8 Days)||3
29360|NCT01957202|69656|P3|COMPLETED|Treatment Period 3 (8 Days)||6
29361|NCT01957202|69657|P2|COMPLETED|Treatment Period 3 (8 Days)||5
29362|NCT01957202|69658|P1|COMPLETED|Treatment Period 3 (8 Days)||3
29363|NCT01957202|69641|P18|STARTED|Treatment Period 3 (8 Days)||3
29364|NCT01957202|69642|P17|STARTED|Treatment Period 3 (8 Days)||5
29365|NCT01957202|69643|P16|STARTED|Treatment Period 3 (8 Days)||3
29366|NCT01957202|69644|P15|STARTED|Treatment Period 3 (8 Days)||6
29367|NCT01957202|69645|P14|STARTED|Treatment Period 3 (8 Days)||3
29368|NCT01957202|69646|P13|STARTED|Treatment Period 3 (8 Days)||3
29369|NCT01957202|69647|P12|STARTED|Treatment Period 3 (8 Days)||6
29370|NCT01957202|69648|P11|STARTED|Treatment Period 3 (8 Days)||3
29371|NCT01957202|69649|P10|STARTED|Treatment Period 3 (8 Days)||6
29372|NCT01957202|69650|P9|STARTED|Treatment Period 3 (8 Days)||3
29373|NCT01957202|69651|P8|STARTED|Treatment Period 3 (8 Days)||3
29374|NCT01957202|69652|P7|STARTED|Treatment Period 3 (8 Days)||3
29375|NCT01957202|69653|P6|STARTED|Treatment Period 3 (8 Days)||2
29376|NCT01957202|69654|P5|STARTED|Treatment Period 3 (8 Days)||3
29377|NCT01957202|69655|P4|STARTED|Treatment Period 3 (8 Days)||3
29378|NCT01957202|69656|P3|STARTED|Treatment Period 3 (8 Days)||6
29379|NCT01957202|69657|P2|STARTED|Treatment Period 3 (8 Days)||5
29380|NCT01957202|69658|P1|STARTED|Treatment Period 3 (8 Days)||3
29381|NCT01957202|69641|P18|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29382|NCT01957202|69642|P17|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29383|NCT01957202|69643|P16|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29384|NCT01957202|69644|P15|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29385|NCT01957202|69645|P14|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29386|NCT01957202|69646|P13|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29387|NCT01957202|69647|P12|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29388|NCT01957202|69648|P11|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29389|NCT01957202|69649|P10|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29390|NCT01957202|69650|P9|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29391|NCT01957202|69651|P8|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29392|NCT01957202|69652|P7|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29393|NCT01957202|69653|P6|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29394|NCT01957202|69654|P5|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29395|NCT01957202|69655|P4|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29396|NCT01957202|69656|P3|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29397|NCT01957202|69657|P2|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29398|NCT01957202|69658|P1|NOT COMPLETED|Washout Period 2 (14 to 28 Days)||0
29399|NCT01957202|69641|P18|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29400|NCT01957202|69642|P17|COMPLETED|Washout Period 2 (14 to 28 Days)||5
29401|NCT01957202|69643|P16|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29402|NCT01957202|69644|P15|COMPLETED|Washout Period 2 (14 to 28 Days)||6
29403|NCT01957202|69645|P14|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29404|NCT01957202|69646|P13|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29405|NCT01957202|69647|P12|COMPLETED|Washout Period 2 (14 to 28 Days)||6
29406|NCT01957202|69648|P11|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29407|NCT01957202|69649|P10|COMPLETED|Washout Period 2 (14 to 28 Days)||6
29408|NCT01957202|69650|P9|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29409|NCT01957202|69651|P8|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29410|NCT01957202|69652|P7|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29411|NCT01957202|69653|P6|COMPLETED|Washout Period 2 (14 to 28 Days)||2
29412|NCT01957202|69654|P5|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29413|NCT01957202|69655|P4|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29414|NCT01957202|69656|P3|COMPLETED|Washout Period 2 (14 to 28 Days)||6
29415|NCT01957202|69657|P2|COMPLETED|Washout Period 2 (14 to 28 Days)||5
29416|NCT01957202|69658|P1|COMPLETED|Washout Period 2 (14 to 28 Days)||3
29417|NCT01957202|69641|P18|STARTED|Washout Period 2 (14 to 28 Days)||3
29418|NCT01957202|69642|P17|STARTED|Washout Period 2 (14 to 28 Days)||5
29419|NCT01957202|69643|P16|STARTED|Washout Period 2 (14 to 28 Days)||3
29420|NCT01957202|69644|P15|STARTED|Washout Period 2 (14 to 28 Days)||6
29421|NCT01957202|69645|P14|STARTED|Washout Period 2 (14 to 28 Days)||3
29422|NCT01957202|69646|P13|STARTED|Washout Period 2 (14 to 28 Days)||3
29423|NCT01957202|69647|P12|STARTED|Washout Period 2 (14 to 28 Days)||6
29424|NCT01957202|69648|P11|STARTED|Washout Period 2 (14 to 28 Days)||3
29425|NCT01957202|69649|P10|STARTED|Washout Period 2 (14 to 28 Days)||6
29426|NCT01957202|69650|P9|STARTED|Washout Period 2 (14 to 28 Days)||3
29427|NCT01957202|69651|P8|STARTED|Washout Period 2 (14 to 28 Days)||3
29428|NCT01957202|69652|P7|STARTED|Washout Period 2 (14 to 28 Days)||3
29429|NCT01957202|69653|P6|STARTED|Washout Period 2 (14 to 28 Days)||2
29430|NCT01957202|69654|P5|STARTED|Washout Period 2 (14 to 28 Days)||3
29431|NCT01957202|69655|P4|STARTED|Washout Period 2 (14 to 28 Days)||3
29432|NCT01957202|69656|P3|STARTED|Washout Period 2 (14 to 28 Days)||6
29433|NCT01957202|69657|P2|STARTED|Washout Period 2 (14 to 28 Days)||5
29434|NCT01957202|69658|P1|STARTED|Washout Period 2 (14 to 28 Days)||3
29435|NCT01957202|69641|P18|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29436|NCT01957202|69642|P17|NOT COMPLETED|Treatment Period 2 (8 Days)||1
29437|NCT01957202|69643|P16|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29438|NCT01957202|69644|P15|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29439|NCT01957202|69645|P14|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29440|NCT01957202|69646|P13|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29441|NCT01957202|69647|P12|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29442|NCT01957202|69648|P11|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29443|NCT01957202|69649|P10|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29444|NCT01957202|69650|P9|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29445|NCT01957202|69651|P8|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29446|NCT01957202|69652|P7|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29447|NCT01957202|69653|P6|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29448|NCT01957202|69654|P5|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29449|NCT01957202|69655|P4|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29450|NCT01957202|69656|P3|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29451|NCT01957202|69657|P2|NOT COMPLETED|Treatment Period 2 (8 Days)||1
29452|NCT01957202|69658|P1|NOT COMPLETED|Treatment Period 2 (8 Days)||0
29453|NCT01957202|69641|P18|COMPLETED|Treatment Period 2 (8 Days)||3
29454|NCT01957202|69642|P17|COMPLETED|Treatment Period 2 (8 Days)||5
29455|NCT01957202|69643|P16|COMPLETED|Treatment Period 2 (8 Days)||3
29456|NCT01957202|69644|P15|COMPLETED|Treatment Period 2 (8 Days)||6
29457|NCT01957202|69645|P14|COMPLETED|Treatment Period 2 (8 Days)||3
29458|NCT01957202|69646|P13|COMPLETED|Treatment Period 2 (8 Days)||3
29459|NCT01957202|69647|P12|COMPLETED|Treatment Period 2 (8 Days)||6
29460|NCT01957202|69648|P11|COMPLETED|Treatment Period 2 (8 Days)||3
29461|NCT01957202|69649|P10|COMPLETED|Treatment Period 2 (8 Days)||6
29462|NCT01957202|69650|P9|COMPLETED|Treatment Period 2 (8 Days)||3
29463|NCT01957202|69651|P8|COMPLETED|Treatment Period 2 (8 Days)||3
29464|NCT01957202|69652|P7|COMPLETED|Treatment Period 2 (8 Days)||3
29465|NCT01957202|69653|P6|COMPLETED|Treatment Period 2 (8 Days)||2
29466|NCT01957202|69654|P5|COMPLETED|Treatment Period 2 (8 Days)||3
29467|NCT01957202|69655|P4|COMPLETED|Treatment Period 2 (8 Days)||3
29468|NCT01957202|69656|P3|COMPLETED|Treatment Period 2 (8 Days)||6
29469|NCT01957202|69657|P2|COMPLETED|Treatment Period 2 (8 Days)||5
29470|NCT01957202|69658|P1|COMPLETED|Treatment Period 2 (8 Days)||3
29471|NCT01957202|69641|P18|STARTED|Treatment Period 2 (8 Days)||3
29472|NCT01957202|69642|P17|STARTED|Treatment Period 2 (8 Days)||6
29473|NCT01957202|69643|P16|STARTED|Treatment Period 2 (8 Days)||3
29474|NCT01957202|69644|P15|STARTED|Treatment Period 2 (8 Days)||6
29475|NCT01957202|69645|P14|STARTED|Treatment Period 2 (8 Days)||3
29476|NCT01957202|69646|P13|STARTED|Treatment Period 2 (8 Days)||3
29477|NCT01957202|69647|P12|STARTED|Treatment Period 2 (8 Days)||6
29478|NCT01957202|69648|P11|STARTED|Treatment Period 2 (8 Days)||3
29479|NCT01957202|69649|P10|STARTED|Treatment Period 2 (8 Days)||6
29480|NCT01957202|69650|P9|STARTED|Treatment Period 2 (8 Days)||3
29481|NCT01957202|69651|P8|STARTED|Treatment Period 2 (8 Days)||3
29482|NCT01957202|69652|P7|STARTED|Treatment Period 2 (8 Days)||3
29483|NCT01957202|69653|P6|STARTED|Treatment Period 2 (8 Days)||2
29484|NCT01957202|69654|P5|STARTED|Treatment Period 2 (8 Days)||3
29485|NCT01957202|69655|P4|STARTED|Treatment Period 2 (8 Days)||3
29486|NCT01957202|69656|P3|STARTED|Treatment Period 2 (8 Days)||6
29487|NCT01957202|69657|P2|STARTED|Treatment Period 2 (8 Days)||6
29488|NCT01957202|69658|P1|STARTED|Treatment Period 2 (8 Days)||3
29489|NCT01957202|69641|P18|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29490|NCT01957202|69642|P17|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29491|NCT01957202|69643|P16|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29492|NCT01957202|69644|P15|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29493|NCT01957202|69645|P14|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29494|NCT01957202|69646|P13|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29495|NCT01957202|69647|P12|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29496|NCT01957202|69648|P11|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29497|NCT01957202|69649|P10|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29498|NCT01957202|69650|P9|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29499|NCT01957202|69651|P8|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29500|NCT01957202|69652|P7|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29501|NCT01957202|69653|P6|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29502|NCT01957202|69654|P5|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29503|NCT01957202|69655|P4|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29504|NCT01957202|69656|P3|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29505|NCT01957202|69657|P2|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29506|NCT01957202|69658|P1|NOT COMPLETED|Washout Period 1 (14 to 28 Days)||0
29507|NCT01957202|69641|P18|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29508|NCT01957202|69642|P17|COMPLETED|Washout Period 1 (14 to 28 Days)||6
29509|NCT01957202|69643|P16|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29510|NCT01957202|69644|P15|COMPLETED|Washout Period 1 (14 to 28 Days)||6
29511|NCT01957202|69645|P14|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29512|NCT01957202|69646|P13|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29513|NCT01957202|69647|P12|COMPLETED|Washout Period 1 (14 to 28 Days)||6
29514|NCT01957202|69648|P11|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29515|NCT01957202|69649|P10|COMPLETED|Washout Period 1 (14 to 28 Days)||6
29516|NCT01957202|69650|P9|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29517|NCT01957202|69651|P8|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29518|NCT01957202|69652|P7|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29519|NCT01957202|69653|P6|COMPLETED|Washout Period 1 (14 to 28 Days)||2
29520|NCT01957202|69654|P5|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29521|NCT01957202|69655|P4|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29522|NCT01957202|69656|P3|COMPLETED|Washout Period 1 (14 to 28 Days)||6
29523|NCT01957202|69657|P2|COMPLETED|Washout Period 1 (14 to 28 Days)||6
29524|NCT01957202|69658|P1|COMPLETED|Washout Period 1 (14 to 28 Days)||3
29525|NCT01957202|69641|P18|STARTED|Washout Period 1 (14 to 28 Days)||3
29526|NCT01957202|69642|P17|STARTED|Washout Period 1 (14 to 28 Days)||6
29527|NCT01957202|69643|P16|STARTED|Washout Period 1 (14 to 28 Days)||3
29528|NCT01957202|69644|P15|STARTED|Washout Period 1 (14 to 28 Days)||6
29529|NCT01957202|69645|P14|STARTED|Washout Period 1 (14 to 28 Days)||3
29530|NCT01957202|69646|P13|STARTED|Washout Period 1 (14 to 28 Days)||3
29531|NCT01957202|69647|P12|STARTED|Washout Period 1 (14 to 28 Days)||6
29532|NCT01957202|69648|P11|STARTED|Washout Period 1 (14 to 28 Days)||3
29533|NCT01957202|69649|P10|STARTED|Washout Period 1 (14 to 28 Days)||6
29534|NCT01957202|69650|P9|STARTED|Washout Period 1 (14 to 28 Days)||3
29535|NCT01957202|69651|P8|STARTED|Washout Period 1 (14 to 28 Days)||3
29536|NCT01957202|69652|P7|STARTED|Washout Period 1 (14 to 28 Days)||3
29537|NCT01957202|69653|P6|STARTED|Washout Period 1 (14 to 28 Days)||2
29538|NCT01957202|69654|P5|STARTED|Washout Period 1 (14 to 28 Days)||3
29539|NCT01957202|69655|P4|STARTED|Washout Period 1 (14 to 28 Days)||3
29540|NCT01957202|69656|P3|STARTED|Washout Period 1 (14 to 28 Days)||6
29541|NCT01957202|69657|P2|STARTED|Washout Period 1 (14 to 28 Days)||6
29542|NCT01957202|69658|P1|STARTED|Washout Period 1 (14 to 28 Days)||3
29543|NCT01957202|69641|P18|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29544|NCT01957202|69642|P17|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29545|NCT01957202|69643|P16|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29546|NCT01957202|69644|P15|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29547|NCT01957202|69645|P14|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29548|NCT01957202|69646|P13|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29549|NCT01957202|69647|P12|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29550|NCT01957202|69648|P11|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29551|NCT01957202|69649|P10|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29552|NCT01957202|69650|P9|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29553|NCT01957202|69651|P8|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29554|NCT01957202|69652|P7|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29555|NCT01957202|69653|P6|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29556|NCT01957202|69654|P5|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29557|NCT01957202|69655|P4|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29558|NCT01957202|69656|P3|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29559|NCT01957202|69657|P2|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29560|NCT01957202|69658|P1|NOT COMPLETED|Treatment Period 1 (8 Days)||0
29561|NCT01957202|69641|P18|COMPLETED|Treatment Period 1 (8 Days)||3
29562|NCT01957202|69642|P17|COMPLETED|Treatment Period 1 (8 Days)||6
29563|NCT01957202|69643|P16|COMPLETED|Treatment Period 1 (8 Days)||3
29564|NCT01957202|69644|P15|COMPLETED|Treatment Period 1 (8 Days)||6
29565|NCT01957202|69645|P14|COMPLETED|Treatment Period 1 (8 Days)||3
29566|NCT01957202|69646|P13|COMPLETED|Treatment Period 1 (8 Days)||3
29567|NCT01957202|69647|P12|COMPLETED|Treatment Period 1 (8 Days)||6
29568|NCT01957202|69648|P11|COMPLETED|Treatment Period 1 (8 Days)||3
29569|NCT01957202|69649|P10|COMPLETED|Treatment Period 1 (8 Days)||6
29570|NCT01957202|69650|P9|COMPLETED|Treatment Period 1 (8 Days)||3
29571|NCT01957202|69651|P8|COMPLETED|Treatment Period 1 (8 Days)||3
29572|NCT01957202|69652|P7|COMPLETED|Treatment Period 1 (8 Days)||3
29573|NCT01957202|69653|P6|COMPLETED|Treatment Period 1 (8 Days)||2
29574|NCT01957202|69654|P5|COMPLETED|Treatment Period 1 (8 Days)||3
29575|NCT01957202|69655|P4|COMPLETED|Treatment Period 1 (8 Days)||3
29576|NCT01957202|69656|P3|COMPLETED|Treatment Period 1 (8 Days)||6
29577|NCT01957202|69657|P2|COMPLETED|Treatment Period 1 (8 Days)||6
29578|NCT01957202|69658|P1|COMPLETED|Treatment Period 1 (8 Days)||3
29579|NCT01957202|69641|P18|STARTED|Treatment Period 1 (8 Days)||3
29580|NCT01957202|69642|P17|STARTED|Treatment Period 1 (8 Days)||6
29581|NCT01957202|69643|P16|STARTED|Treatment Period 1 (8 Days)||3
29582|NCT01957202|69644|P15|STARTED|Treatment Period 1 (8 Days)||6
29583|NCT01957202|69645|P14|STARTED|Treatment Period 1 (8 Days)||3
29584|NCT01957202|69646|P13|STARTED|Treatment Period 1 (8 Days)||3
29585|NCT01957202|69647|P12|STARTED|Treatment Period 1 (8 Days)||6
29586|NCT01957202|69648|P11|STARTED|Treatment Period 1 (8 Days)||3
29587|NCT01957202|69649|P10|STARTED|Treatment Period 1 (8 Days)||6
29588|NCT01957202|69650|P9|STARTED|Treatment Period 1 (8 Days)||3
29589|NCT01957202|69651|P8|STARTED|Treatment Period 1 (8 Days)||3
29590|NCT01957202|69652|P7|STARTED|Treatment Period 1 (8 Days)||3
29591|NCT01957202|69653|P6|STARTED|Treatment Period 1 (8 Days)||2
29592|NCT01957202|69654|P5|STARTED|Treatment Period 1 (8 Days)||3
29593|NCT01957202|69655|P4|STARTED|Treatment Period 1 (8 Days)||3
29594|NCT01957202|69656|P3|STARTED|Treatment Period 1 (8 Days)||6
29595|NCT01957202|69657|P2|STARTED|Treatment Period 1 (8 Days)||6
29596|NCT01957202|69658|P1|STARTED|Treatment Period 1 (8 Days)||3
29597|NCT01957163|69683|P3|NOT COMPLETED|Overall Study||18
29598|NCT01957163|69684|P2|NOT COMPLETED|Overall Study||11
29599|NCT01957163|69685|P1|NOT COMPLETED|Overall Study||15
29600|NCT01957163|69683|P3|COMPLETED|Overall Study||189
29601|NCT01957163|69684|P2|COMPLETED|Overall Study||195
29602|NCT01957163|69685|P1|COMPLETED|Overall Study||191
29603|NCT01957163|69683|P3|STARTED|Overall Study||207
29604|NCT01957163|69684|P2|STARTED|Overall Study||206
29605|NCT01957163|69685|P1|STARTED|Overall Study||206
29606|NCT01957137|69696|P1|NOT COMPLETED|No Stimulation||0
29607|NCT01957137|69696|P1|COMPLETED|No Stimulation||28
29608|NCT01957137|69696|P1|STARTED|No Stimulation|Following randomized portion, all subjects went through no stimulation for approximately 4 weeks.|28
29609|NCT01957137|69696|P1|NOT COMPLETED|Randomized Portion||2
29610|NCT01957137|69696|P1|COMPLETED|Randomized Portion||28
29611|NCT01957137|69696|P1|Cycling Parameter #3|Randomized Portion|Subjects received Cycling Parameter #3 for approximately 4 weeks.|28
29612|NCT01957137|69696|P1|Cycling Parameter #2|Randomized Portion|Subjects received Cycling Parameter #2 for approximately 4 weeks.|28
29613|NCT01957137|69696|P1|Cycling Parameter #1|Randomized Portion|Subjects received Cycling Parameter #1 for approximately 4 weeks.|30
29614|NCT01957137|69696|P1|Continuous Stimulation|Randomized Portion|Subjects received continuous stimulation for approximately 4 weeks.|29
29615|NCT01957137|69696|P1|STARTED|Randomized Portion||30
29616|NCT01957111|69726|P2|NOT COMPLETED|Overall Study||1
29617|NCT01957111|69727|P1|NOT COMPLETED|Overall Study||1
29618|NCT01957111|69726|P2|COMPLETED|Overall Study||15
29619|NCT01957111|69727|P1|COMPLETED|Overall Study||15
29620|NCT01957111|69726|P2|STARTED|Overall Study||16
29621|NCT01957111|69727|P1|STARTED|Overall Study||16
29622|NCT01956240|69737|P2|NOT COMPLETED|Overall Study||24
29623|NCT01956240|69738|P1|NOT COMPLETED|Overall Study||23
29624|NCT01956240|69737|P2|COMPLETED|Overall Study||25
29625|NCT01956240|69738|P1|COMPLETED|Overall Study||25
29626|NCT01956240|69737|P2|STARTED|Overall Study||49
29627|NCT01956240|69738|P1|STARTED|Overall Study||48
29628|NCT01956097|69749|P3|NOT COMPLETED|Overall Study||0
29629|NCT01956097|69750|P2|NOT COMPLETED|Overall Study||2
29630|NCT01956097|69751|P1|NOT COMPLETED|Overall Study||6
29631|NCT01956097|69749|P3|COMPLETED|Overall Study||15
29632|NCT01956097|69750|P2|COMPLETED|Overall Study||28
29633|NCT01956097|69751|P1|COMPLETED|Overall Study||24
29634|NCT01956097|69749|P3|STARTED|Overall Study||15
29635|NCT01956097|69750|P2|STARTED|Overall Study||30
29636|NCT01956097|69751|P1|STARTED|Overall Study||30
29637|NCT01956032|69768|P1|NOT COMPLETED|Overall Study||0
29638|NCT01956032|69768|P1|COMPLETED|Overall Study||15
29639|NCT01956032|69768|P1|STARTED|Overall Study||15
29640|NCT01955720|69815|P6|NOT COMPLETED|Overall Study||0
29641|NCT01955720|69816|P5|NOT COMPLETED|Overall Study||0
29642|NCT01955720|69817|P4|NOT COMPLETED|Overall Study||0
29643|NCT01955720|69818|P3|NOT COMPLETED|Overall Study||0
29644|NCT01955720|69819|P2|NOT COMPLETED|Overall Study||0
29645|NCT01955720|69820|P1|NOT COMPLETED|Overall Study||0
29646|NCT01955720|69815|P6|COMPLETED|Overall Study||7
29647|NCT01955720|69816|P5|COMPLETED|Overall Study||7
29648|NCT01955720|69817|P4|COMPLETED|Overall Study||3
29649|NCT01955720|69818|P3|COMPLETED|Overall Study||3
29650|NCT01955720|69819|P2|COMPLETED|Overall Study||13
29651|NCT01955720|69820|P1|COMPLETED|Overall Study||13
29652|NCT01955720|69815|P6|Subjects With Moderate Renal Impairment|Overall Study||0
29653|NCT01955720|69816|P5|Subjects With Moderate Renal Impairment|Overall Study||0
29654|NCT01955720|69817|P4|Subjects With Moderate Renal Impairment|Overall Study||0
29655|NCT01955720|69818|P3|Subjects With Moderate Renal Impairment|Overall Study||0
29838|NCT01953328|70420|P3|Received Treatment|Overall Study||50
29656|NCT01955720|69819|P2|Subjects With Moderate Renal Impairment|Overall Study||3
29657|NCT01955720|69820|P1|Subjects With Moderate Renal Impairment|Overall Study||3
29658|NCT01955720|69815|P6|Subjects With Mild Renal Impairment|Overall Study||3
29659|NCT01955720|69816|P5|Subjects With Mild Renal Impairment|Overall Study||3
29660|NCT01955720|69817|P4|Subjects With Mild Renal Impairment|Overall Study||0
29661|NCT01955720|69818|P3|Subjects With Mild Renal Impairment|Overall Study||0
29662|NCT01955720|69819|P2|Subjects With Mild Renal Impairment|Overall Study||3
29663|NCT01955720|69820|P1|Subjects With Mild Renal Impairment|Overall Study||3
29664|NCT01955720|69815|P6|Healthy Subjects Aged 65-80|Overall Study||4
29665|NCT01955720|69816|P5|Healthy Subjects Aged 65-80|Overall Study||4
29666|NCT01955720|69817|P4|Healthy Subjects Aged 65-80|Overall Study||0
29667|NCT01955720|69818|P3|Healthy Subjects Aged 65-80|Overall Study||0
29668|NCT01955720|69819|P2|Healthy Subjects Aged 65-80|Overall Study||4
29669|NCT01955720|69820|P1|Healthy Subjects Aged 65-80|Overall Study||4
29670|NCT01955720|69815|P6|Healthy Subjects Aged 45-64|Overall Study||0
29671|NCT01955720|69816|P5|Healthy Subjects Aged 45-64|Overall Study||0
29672|NCT01955720|69817|P4|Healthy Subjects Aged 45-64|Overall Study||3
29673|NCT01955720|69818|P3|Healthy Subjects Aged 45-64|Overall Study||3
29674|NCT01955720|69819|P2|Healthy Subjects Aged 45-64|Overall Study||3
29675|NCT01955720|69820|P1|Healthy Subjects Aged 45-64|Overall Study||3
29676|NCT01955720|69815|P6|STARTED|Overall Study||7
29677|NCT01955720|69816|P5|STARTED|Overall Study||7
29678|NCT01955720|69817|P4|STARTED|Overall Study||3
29679|NCT01955720|69818|P3|STARTED|Overall Study||3
29680|NCT01955720|69819|P2|STARTED|Overall Study||13
29681|NCT01955720|69820|P1|STARTED|Overall Study||13
29682|NCT01955707|69888|P2|NOT COMPLETED|Overall Study||22
29683|NCT01955707|69889|P1|NOT COMPLETED|Overall Study||20
29684|NCT01955707|69888|P2|COMPLETED|Overall Study||57
29685|NCT01955707|69889|P1|COMPLETED|Overall Study||62
29686|NCT01955707|69888|P2|Received Total Volume of Study Drug|Overall Study||77
29687|NCT01955707|69889|P1|Received Total Volume of Study Drug|Overall Study||82
29688|NCT01955707|69888|P2|Dosed|Overall Study||78
29689|NCT01955707|69889|P1|Dosed|Overall Study||82
29690|NCT01955707|69888|P2|Withdrew Prior to Dosing|Overall Study||1
29691|NCT01955707|69889|P1|Withdrew Prior to Dosing|Overall Study||0
29692|NCT01955707|69888|P2|STARTED|Overall Study||79
29693|NCT01955707|69889|P1|STARTED|Overall Study||82
29694|NCT01955629|69913|P1|NOT COMPLETED|Overall Study||0
29695|NCT01955629|69913|P1|COMPLETED|Overall Study|1 participant with DP and 3 with unacceptable toxicity were considered completed as per protocol.|4
29696|NCT01955629|69913|P1|STARTED|Overall Study||4
29697|NCT01955564|69932|P7|NOT COMPLETED|Overall Study||0
29698|NCT01955564|69933|P6|NOT COMPLETED|Overall Study||0
29699|NCT01955564|69934|P5|NOT COMPLETED|Overall Study||0
29700|NCT01955564|69935|P4|NOT COMPLETED|Overall Study||0
29701|NCT01955564|69936|P3|NOT COMPLETED|Overall Study||0
29702|NCT01955564|69937|P2|NOT COMPLETED|Overall Study||0
29703|NCT01955564|69938|P1|NOT COMPLETED|Overall Study||0
29704|NCT01955564|69932|P7|COMPLETED|Overall Study||6
29705|NCT01955564|69933|P6|COMPLETED|Overall Study||6
29706|NCT01955564|69934|P5|COMPLETED|Overall Study||6
29707|NCT01955564|69935|P4|COMPLETED|Overall Study||6
29708|NCT01955564|69936|P3|COMPLETED|Overall Study||6
29709|NCT01955564|69937|P2|COMPLETED|Overall Study||6
29710|NCT01955564|69938|P1|COMPLETED|Overall Study||18
29711|NCT01955564|69932|P7|STARTED|Overall Study||6
29712|NCT01955564|69933|P6|STARTED|Overall Study||6
29713|NCT01955564|69934|P5|STARTED|Overall Study||6
29714|NCT01955564|69935|P4|STARTED|Overall Study||6
29715|NCT01955564|69936|P3|STARTED|Overall Study||6
29716|NCT01955564|69937|P2|STARTED|Overall Study||6
29717|NCT01955564|69938|P1|STARTED|Overall Study||18
29718|NCT01955473|69971|P5|NOT COMPLETED|Overall Study||0
29719|NCT01955473|69972|P4|NOT COMPLETED|Overall Study||0
29720|NCT01955473|69973|P3|NOT COMPLETED|Overall Study||0
29721|NCT01955473|69974|P2|NOT COMPLETED|Overall Study||0
29722|NCT01955473|69975|P1|NOT COMPLETED|Overall Study||0
29723|NCT01955473|69971|P5|COMPLETED|Overall Study||30
29724|NCT01955473|69972|P4|COMPLETED|Overall Study||6
29725|NCT01955473|69973|P3|COMPLETED|Overall Study||6
29726|NCT01955473|69974|P2|COMPLETED|Overall Study||6
29727|NCT01955473|69975|P1|COMPLETED|Overall Study||3
29728|NCT01955473|69971|P5|STARTED|Overall Study||30
29729|NCT01955473|69972|P4|STARTED|Overall Study||6
29730|NCT01955473|69973|P3|STARTED|Overall Study||6
29731|NCT01955473|69974|P2|STARTED|Overall Study||6
29732|NCT01955473|69975|P1|STARTED|Overall Study||3
29733|NCT01955369|70129|P1|NOT COMPLETED|Overall Study||0
29734|NCT01955369|70129|P1|COMPLETED|Overall Study||200
29735|NCT01955369|70129|P1|STARTED|Overall Study||200
29736|NCT01955122|70137|P2|NOT COMPLETED|Overall Study||5
29737|NCT01955122|70138|P1|NOT COMPLETED|Overall Study||5
29738|NCT01955122|70137|P2|COMPLETED|Overall Study||57
29739|NCT01955122|70138|P1|COMPLETED|Overall Study||59
29740|NCT01955122|70137|P2|No. Patients Completed Double Procedure|Overall Study||57
29741|NCT01955122|70138|P1|No. Patients Completed Double Procedure|Overall Study||59
29742|NCT01955122|70137|P2|No.Patients Enrolled|Overall Study||62
29743|NCT01955122|70138|P1|No.Patients Enrolled|Overall Study||64
29744|NCT01955122|70137|P2|STARTED|Overall Study|"Excluded (n = 5)
Included in analysis (n = 57)"|62
29745|NCT01955122|70138|P1|STARTED|Overall Study|"Excluded (n = 5)
Included in analysis (n = 59)"|64
29746|NCT01955083|70158|P2|NOT COMPLETED|Overall Study||1
29747|NCT01955083|70159|P1|NOT COMPLETED|Overall Study||1
29748|NCT01955083|70158|P2|COMPLETED|Overall Study||14
29749|NCT01955083|70159|P1|COMPLETED|Overall Study||14
29750|NCT01955083|70158|P2|STARTED|Overall Study||15
29751|NCT01955083|70159|P1|STARTED|Overall Study||15
29752|NCT01955044|70192|P3|NOT COMPLETED|Overall Study||0
29753|NCT01955044|70193|P2|NOT COMPLETED|Overall Study||1
29754|NCT01955044|70194|P1|NOT COMPLETED|Overall Study||1
29755|NCT01955044|70192|P3|COMPLETED|Overall Study||10
29756|NCT01955044|70193|P2|COMPLETED|Overall Study||9
29757|NCT01955044|70194|P1|COMPLETED|Overall Study||9
29758|NCT01955044|70192|P3|STARTED|Overall Study||10
29759|NCT01955044|70193|P2|STARTED|Overall Study||10
29760|NCT01955044|70194|P1|STARTED|Overall Study||10
29761|NCT01955005|70207|P2|NOT COMPLETED|Overall Study||5
29762|NCT01955005|70208|P1|NOT COMPLETED|Overall Study||3
29763|NCT01955005|70207|P2|COMPLETED|Overall Study||25
29764|NCT01955005|70208|P1|COMPLETED|Overall Study||27
29765|NCT01955005|70207|P2|STARTED|Overall Study||30
29766|NCT01955005|70208|P1|STARTED|Overall Study||30
29767|NCT01954771|70221|P3|NOT COMPLETED|Overall Study||3
29768|NCT01954771|70222|P2|NOT COMPLETED|Overall Study||3
29769|NCT01954771|70223|P1|NOT COMPLETED|Overall Study||7
29770|NCT01954771|70221|P3|COMPLETED|Overall Study||25
29771|NCT01954771|70222|P2|COMPLETED|Overall Study||29
29772|NCT01954771|70223|P1|COMPLETED|Overall Study||22
29773|NCT01954771|70221|P3|STARTED|Overall Study||28
29774|NCT01954771|70222|P2|STARTED|Overall Study||32
29775|NCT01954771|70223|P1|STARTED|Overall Study||29
29776|NCT01954745|70240|P1|NOT COMPLETED|Overall Study||19
29777|NCT01954745|70240|P1|COMPLETED|Overall Study||0
29778|NCT01954745|70240|P1|STARTED|Overall Study||19
29779|NCT01954628|70249|P2|NOT COMPLETED|Overall Study||27
29780|NCT01954628|70250|P1|NOT COMPLETED|Overall Study||31
29781|NCT01954628|70249|P2|COMPLETED|Overall Study||173
29782|NCT01954628|70250|P1|COMPLETED|Overall Study||169
29783|NCT01954628|70249|P2|US 6 Month Ophthalmology Safety Visit|Overall Study||32
29784|NCT01954628|70250|P1|US 6 Month Ophthalmology Safety Visit|Overall Study||37
29785|NCT01954628|70249|P2|Pharmacokinetic Population|Overall Study||0
29786|NCT01954628|70250|P1|Pharmacokinetic Population|Overall Study||181
29787|NCT01954628|70249|P2|Safety Set|Overall Study||200
29788|NCT01954628|70250|P1|Safety Set|Overall Study||200
29789|NCT01954628|70249|P2|Full Analysis Set (FAS)|Overall Study||198
29790|NCT01954628|70250|P1|Full Analysis Set (FAS)|Overall Study||200
29791|NCT01954628|70249|P2|STARTED|Overall Study||200
29792|NCT01954628|70250|P1|STARTED|Overall Study||200
29793|NCT01954251|70271|P2|NOT COMPLETED|Overall Study||19
29794|NCT01954251|70272|P1|NOT COMPLETED|Overall Study||13
29795|NCT01954251|70271|P2|COMPLETED|Overall Study||396
29796|NCT01954251|70272|P1|COMPLETED|Overall Study||400
29797|NCT01954251|70271|P2|STARTED|Overall Study||415
29798|NCT01954251|70272|P1|STARTED|Overall Study||413
29799|NCT01954160|70308|P2|NOT COMPLETED|Overall Study||0
29800|NCT01954160|70309|P1|NOT COMPLETED|Overall Study||5
29801|NCT01954160|70308|P2|COMPLETED|Overall Study||0
29802|NCT01954160|70309|P1|COMPLETED|Overall Study|Only 4 subjects completed the first early denervation. No subjects completed the late denervation.|0
29803|NCT01954160|70308|P2|STARTED|Overall Study|Not started|0
29804|NCT01954160|70309|P1|STARTED|Overall Study||5
29805|NCT01954121|70369|P2|NOT COMPLETED|Overall Study||91
29806|NCT01954121|70370|P1|NOT COMPLETED|Overall Study||127
29807|NCT01954121|70369|P2|COMPLETED|Overall Study||125
29808|NCT01954121|70370|P1|COMPLETED|Overall Study||93
29809|NCT01954121|70369|P2|STARTED|Overall Study||216
29810|NCT01954121|70370|P1|STARTED|Overall Study||220
29811|NCT01953354|70386|P2|NOT COMPLETED|Overall Study||2
29812|NCT01953354|70387|P1|NOT COMPLETED|Overall Study||1
29813|NCT01953354|70386|P2|COMPLETED|Overall Study||5
29814|NCT01953354|70387|P1|COMPLETED|Overall Study||8
29815|NCT01953354|70386|P2|STARTED|Overall Study||7
29816|NCT01953354|70387|P1|STARTED|Overall Study||9
29817|NCT01953328|70415|P8|NOT COMPLETED|Overall Study||0
29818|NCT01953328|70416|P7|NOT COMPLETED|Overall Study||0
29819|NCT01953328|70417|P6|NOT COMPLETED|Overall Study||0
29820|NCT01953328|70418|P5|NOT COMPLETED|Overall Study||2
29821|NCT01953328|70419|P4|NOT COMPLETED|Overall Study||0
29822|NCT01953328|70420|P3|NOT COMPLETED|Overall Study||0
29823|NCT01953328|70421|P2|NOT COMPLETED|Overall Study||0
29824|NCT01953328|70422|P1|NOT COMPLETED|Overall Study||0
29825|NCT01953328|70415|P8|COMPLETED|Overall Study||51
29826|NCT01953328|70416|P7|COMPLETED|Overall Study||51
29827|NCT01953328|70417|P6|COMPLETED|Overall Study||51
29828|NCT01953328|70418|P5|COMPLETED|Overall Study||50
29829|NCT01953328|70419|P4|COMPLETED|Overall Study||50
29830|NCT01953328|70420|P3|COMPLETED|Overall Study||50
29831|NCT01953328|70421|P2|COMPLETED|Overall Study||50
29832|NCT01953328|70422|P1|COMPLETED|Overall Study||49
29833|NCT01953328|70415|P8|Received Treatment|Overall Study||51
29834|NCT01953328|70416|P7|Received Treatment|Overall Study||51
29835|NCT01953328|70417|P6|Received Treatment|Overall Study||51
29836|NCT01953328|70418|P5|Received Treatment|Overall Study||52
29837|NCT01953328|70419|P4|Received Treatment|Overall Study||50
29839|NCT01953328|70421|P2|Received Treatment|Overall Study||50
29840|NCT01953328|70422|P1|Received Treatment|Overall Study||49
29841|NCT01953328|70415|P8|STARTED|Overall Study||51
29842|NCT01953328|70416|P7|STARTED|Overall Study||51
29843|NCT01953328|70417|P6|STARTED|Overall Study||51
29844|NCT01953328|70418|P5|STARTED|Overall Study||52
29845|NCT01953328|70419|P4|STARTED|Overall Study||50
29846|NCT01953328|70420|P3|STARTED|Overall Study||50
29847|NCT01953328|70421|P2|STARTED|Overall Study||50
29848|NCT01953328|70422|P1|STARTED|Overall Study||49
29849|NCT01953237|70626|P2|NOT COMPLETED|Overall Study||0
29850|NCT01953237|70627|P1|NOT COMPLETED|Overall Study||0
29851|NCT01953237|70626|P2|COMPLETED|Overall Study||21
29852|NCT01953237|70627|P1|COMPLETED|Overall Study||10
29853|NCT01953237|70626|P2|STARTED|Overall Study||21
29854|NCT01953237|70627|P1|STARTED|Overall Study||10
29855|NCT01953081|70635|P2|NOT COMPLETED|Overall Study||3
29856|NCT01953081|70636|P1|NOT COMPLETED|Overall Study||2
29857|NCT01953081|70635|P2|COMPLETED|Overall Study||3
29858|NCT01953081|70636|P1|COMPLETED|Overall Study||5
29859|NCT01953081|70635|P2|STARTED|Overall Study||6
29860|NCT01953081|70636|P1|STARTED|Overall Study||7
29861|NCT01952834|70652|P1|NOT COMPLETED|Overall Study||1
29862|NCT01952834|70652|P1|COMPLETED|Overall Study||20
29863|NCT01952834|70652|P1|STARTED|Overall Study||21
29864|NCT01952691|70659|P1|NOT COMPLETED|Overall Study||2
29865|NCT01952691|70659|P1|COMPLETED|Overall Study||20
29866|NCT01952691|70659|P1|STARTED|Overall Study||22
29867|NCT01952665|70667|P2|NOT COMPLETED|Overall Study||6
29868|NCT01952665|70668|P1|NOT COMPLETED|Overall Study||6
29869|NCT01952665|70667|P2|COMPLETED|Overall Study||20
29870|NCT01952665|70668|P1|COMPLETED|Overall Study||31
29871|NCT01952665|70667|P2|STARTED|Overall Study||26
29872|NCT01952665|70668|P1|STARTED|Overall Study||37
29873|NCT01952600|70809|P3|NOT COMPLETED|Overall Study||7
29874|NCT01952600|70810|P2|NOT COMPLETED|Overall Study||13
29875|NCT01952600|70811|P1|NOT COMPLETED|Overall Study||15
29876|NCT01952600|70809|P3|COMPLETED|Overall Study||38
29877|NCT01952600|70810|P2|COMPLETED|Overall Study||77
29878|NCT01952600|70811|P1|COMPLETED|Overall Study||65
29879|NCT01952600|70809|P3|STARTED|Overall Study||45
29880|NCT01952600|70810|P2|STARTED|Overall Study||90
29881|NCT01952600|70811|P1|STARTED|Overall Study||80
29882|NCT01952418|70821|P2|NOT COMPLETED|Overall Study||0
29883|NCT01952418|70822|P1|NOT COMPLETED|Overall Study||0
29884|NCT01952418|70821|P2|COMPLETED|Overall Study||895
29885|NCT01952418|70822|P1|COMPLETED|Overall Study||910
29886|NCT01952418|70821|P2|STARTED|Overall Study||895
29887|NCT01952418|70822|P1|STARTED|Overall Study||910
29888|NCT01952366|70834|P1|NOT COMPLETED|Overall Study||31
29889|NCT01952366|70834|P1|COMPLETED|Overall Study||138
29890|NCT01952366|70834|P1|STARTED|Overall Study||169
29891|NCT01952301|70840|P1|NOT COMPLETED|Overall Study||0
29892|NCT01952301|70840|P1|COMPLETED|Overall Study||30
29893|NCT01952301|70840|P1|STARTED|Overall Study|We designed and implemented a single-blind, randomized, controlled, split-mouth study of 30 subjects|30
29894|NCT01952145|70848|P2|NOT COMPLETED|Overall Study||14
29895|NCT01952145|70849|P1|NOT COMPLETED|Overall Study||28
29896|NCT01952145|70848|P2|COMPLETED|Overall Study||265
29897|NCT01952145|70849|P1|COMPLETED|Overall Study||250
29898|NCT01952145|70848|P2|STARTED|Overall Study||279
29899|NCT01952145|70849|P1|STARTED|Overall Study||278
29900|NCT01952080|70863|P4|NOT COMPLETED|Overall Study||1
29901|NCT01952080|70864|P3|NOT COMPLETED|Overall Study||0
29902|NCT01952080|70865|P2|NOT COMPLETED|Overall Study||1
29903|NCT01952080|70866|P1|NOT COMPLETED|Overall Study||0
29904|NCT01952080|70863|P4|COMPLETED|Overall Study||14
29905|NCT01952080|70864|P3|COMPLETED|Overall Study||14
29906|NCT01952080|70865|P2|COMPLETED|Overall Study||7
29907|NCT01952080|70866|P1|COMPLETED|Overall Study||5
29908|NCT01952080|70863|P4|Treated|Overall Study||15
29909|NCT01952080|70864|P3|Treated|Overall Study||14
29910|NCT01952080|70865|P2|Treated|Overall Study||8
29911|NCT01952080|70866|P1|Treated|Overall Study||5
29912|NCT01952080|70863|P4|STARTED|Overall Study||15
29913|NCT01952080|70864|P3|STARTED|Overall Study||14
29914|NCT01952080|70865|P2|STARTED|Overall Study||8
29915|NCT01952080|70866|P1|STARTED|Overall Study||5
29916|NCT01951950|70914|P2|NOT COMPLETED|Overall Study||6
29917|NCT01951950|70915|P1|NOT COMPLETED|Overall Study||6
29918|NCT01951950|70914|P2|COMPLETED|Overall Study||20
29919|NCT01951950|70915|P1|COMPLETED|Overall Study||20
29920|NCT01951950|70914|P2|STARTED|Overall Study||26
29921|NCT01951950|70915|P1|STARTED|Overall Study||26
29922|NCT01951820|70923|P2|NOT COMPLETED|Overall Study||0
29923|NCT01951820|70924|P1|NOT COMPLETED|Overall Study||0
29924|NCT01951820|70923|P2|COMPLETED|Overall Study||30
29925|NCT01951820|70924|P1|COMPLETED|Overall Study||34
29926|NCT01951820|70923|P2|STARTED|Overall Study||30
29927|NCT01951820|70924|P1|STARTED|Overall Study||34
29928|NCT01951703|70932|P2|NOT COMPLETED|Second Intervention||2
29929|NCT01951703|70933|P1|NOT COMPLETED|Second Intervention||0
29930|NCT01951703|70932|P2|COMPLETED|Second Intervention||60
29931|NCT01951703|70933|P1|COMPLETED|Second Intervention||61
29932|NCT01951703|70932|P2|STARTED|Second Intervention||62
29933|NCT01951703|70933|P1|STARTED|Second Intervention||61
29934|NCT01951703|70932|P2|NOT COMPLETED|First Intervention||1
29935|NCT01951703|70933|P1|NOT COMPLETED|First Intervention||3
29936|NCT01951703|70932|P2|COMPLETED|First Intervention||62
29937|NCT01951703|70933|P1|COMPLETED|First Intervention||61
29938|NCT01951703|70932|P2|STARTED|First Intervention||63
29939|NCT01951703|70933|P1|STARTED|First Intervention||64
29940|NCT01951651|70943|P2|NOT COMPLETED|Overall Study||2
29941|NCT01951651|70944|P1|NOT COMPLETED|Overall Study||4
29942|NCT01951651|70943|P2|COMPLETED|Overall Study||10
29943|NCT01951651|70944|P1|COMPLETED|Overall Study||8
29944|NCT01951651|70943|P2|STARTED|Overall Study||12
29945|NCT01951651|70944|P1|STARTED|Overall Study||12
29946|NCT01951586|70958|P2|NOT COMPLETED|Overall Study||113
29947|NCT01951586|70959|P1|NOT COMPLETED|Overall Study||59
29948|NCT01951586|70958|P2|COMPLETED|Overall Study||35
29949|NCT01951586|70959|P1|COMPLETED|Overall Study||19
29950|NCT01951586|70958|P2|Received Study Drug|Overall Study||145
29951|NCT01951586|70959|P1|Received Study Drug|Overall Study||76
29952|NCT01951586|70958|P2|STARTED|Overall Study||148
29953|NCT01951586|70959|P1|STARTED|Overall Study||78
29954|NCT01951573|70983|P2|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
29955|NCT01951573|70984|P1|NOT COMPLETED|Period 2, Second 9 Hours of Wear||0
29956|NCT01951573|70983|P2|COMPLETED|Period 2, Second 9 Hours of Wear||16
29957|NCT01951573|70984|P1|COMPLETED|Period 2, Second 9 Hours of Wear||17
29958|NCT01951573|70983|P2|STARTED|Period 2, Second 9 Hours of Wear||16
29959|NCT01951573|70984|P1|STARTED|Period 2, Second 9 Hours of Wear||17
29960|NCT01951573|70983|P2|NOT COMPLETED|Washout Period||1
29961|NCT01951573|70984|P1|NOT COMPLETED|Washout Period||0
29962|NCT01951573|70983|P2|COMPLETED|Washout Period||16
29963|NCT01951573|70984|P1|COMPLETED|Washout Period||17
29964|NCT01951573|70983|P2|STARTED|Washout Period||17
29965|NCT01951573|70984|P1|STARTED|Washout Period||17
29966|NCT01951573|70983|P2|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
29967|NCT01951573|70984|P1|NOT COMPLETED|Period 1, First 9 Hours of Wear||0
29968|NCT01951573|70983|P2|COMPLETED|Period 1, First 9 Hours of Wear||17
29969|NCT01951573|70984|P1|COMPLETED|Period 1, First 9 Hours of Wear||17
29970|NCT01951573|70983|P2|STARTED|Period 1, First 9 Hours of Wear||17
29971|NCT01951573|70984|P1|STARTED|Period 1, First 9 Hours of Wear||17
29972|NCT01951417|70994|P1|NOT COMPLETED|Overall Study||9
29973|NCT01951417|70994|P1|COMPLETED|Overall Study||72
29974|NCT01951417|70994|P1|STARTED|Overall Study||81
29975|NCT01951170|71017|P1|NOT COMPLETED|Overall Study||1
29976|NCT01951170|71017|P1|COMPLETED|Overall Study||51
29977|NCT01951170|71017|P1|STARTED|Overall Study||52
29978|NCT01951092|71040|P1|NOT COMPLETED|Overall Study||12
29979|NCT01951092|71040|P1|COMPLETED|Overall Study||20
29980|NCT01951092|71040|P1|STARTED|Overall Study||32
29981|NCT01951066|71045|P2|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
29982|NCT01951066|71046|P1|NOT COMPLETED|Second Intervention (Week 16 to Week 32)||0
29983|NCT01951066|71045|P2|COMPLETED|Second Intervention (Week 16 to Week 32)||10
29984|NCT01951066|71046|P1|COMPLETED|Second Intervention (Week 16 to Week 32)||10
29985|NCT01951066|71045|P2|STARTED|Second Intervention (Week 16 to Week 32)||10
29986|NCT01951066|71046|P1|STARTED|Second Intervention (Week 16 to Week 32)||10
29987|NCT01951066|71045|P2|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
29988|NCT01951066|71046|P1|NOT COMPLETED|First Intervention (Baseline to Week 16)||0
29989|NCT01951066|71045|P2|COMPLETED|First Intervention (Baseline to Week 16)||10
29990|NCT01951066|71046|P1|COMPLETED|First Intervention (Baseline to Week 16)||10
29991|NCT01951066|71045|P2|STARTED|First Intervention (Baseline to Week 16)||10
29992|NCT01951066|71046|P1|STARTED|First Intervention (Baseline to Week 16)||10
29993|NCT01950741|71051|P1|NOT COMPLETED|Overall Study||3
29994|NCT01950741|71051|P1|COMPLETED|Overall Study||45
29995|NCT01950741|71051|P1|STARTED|Overall Study||48
29996|NCT01950663|71060|P1|NOT COMPLETED|Overall Study||1
29997|NCT01950663|71060|P1|COMPLETED|Overall Study||467
29998|NCT01950663|71060|P1|STARTED|Overall Study||468
29999|NCT01950364|71066|P2|NOT COMPLETED|Overall Study||10
30000|NCT01950364|71067|P1|NOT COMPLETED|Overall Study||10
30001|NCT01950364|71066|P2|COMPLETED|Overall Study||0
30002|NCT01950364|71067|P1|COMPLETED|Overall Study||0
30003|NCT01950364|71066|P2|STARTED|Overall Study||10
30004|NCT01950364|71067|P1|STARTED|Overall Study||10
30005|NCT01950078|71167|P2|NOT COMPLETED|Overall Study||12
30006|NCT01950078|71168|P1|NOT COMPLETED|Overall Study||20
30007|NCT01950078|71167|P2|COMPLETED|Overall Study||496
30008|NCT01950078|71168|P1|COMPLETED|Overall Study||1005
30009|NCT01950078|71167|P2|STARTED|Overall Study||508
30010|NCT01950078|71168|P1|STARTED|Overall Study||1025
30011|NCT01949870|71176|P1|NOT COMPLETED|Overall Study||6
30012|NCT01949870|71176|P1|COMPLETED|Overall Study||0
30013|NCT01949870|71176|P1|Received Treatment|Overall Study||4
30014|NCT01949870|71176|P1|STARTED|Overall Study||6
30015|NCT01949545|71184|P4|NOT COMPLETED|Overall Study||0
30016|NCT01949545|71185|P3|NOT COMPLETED|Overall Study||0
30017|NCT01949545|71186|P2|NOT COMPLETED|Overall Study||0
30018|NCT01949545|71187|P1|NOT COMPLETED|Overall Study||0
30019|NCT01949545|71184|P4|COMPLETED|Overall Study||4
30020|NCT01949545|71185|P3|COMPLETED|Overall Study||14
30021|NCT01949545|71186|P2|COMPLETED|Overall Study||17
30022|NCT01949545|71187|P1|COMPLETED|Overall Study||11
30023|NCT01949545|71184|P4|STARTED|Overall Study||4
30024|NCT01949545|71185|P3|STARTED|Overall Study||14
30025|NCT01949545|71186|P2|STARTED|Overall Study||17
30026|NCT01949545|71187|P1|STARTED|Overall Study||11
30027|NCT01949532|71335|P2|NOT COMPLETED|Overall Study||3
30028|NCT01949532|71336|P1|NOT COMPLETED|Overall Study||3
30029|NCT01949532|71335|P2|COMPLETED|Overall Study||8
30030|NCT01949532|71336|P1|COMPLETED|Overall Study||12
30031|NCT01949532|71335|P2|STARTED|Overall Study||11
30032|NCT01949532|71336|P1|STARTED|Overall Study||15
30033|NCT01949389|71404|P1|NOT COMPLETED|Overall Study||0
30034|NCT01949389|71404|P1|COMPLETED|Overall Study||51
30035|NCT01949389|71404|P1|STARTED|Overall Study||51
30036|NCT01949155|71411|P2|NOT COMPLETED|Overall Study||0
30037|NCT01949155|71412|P1|NOT COMPLETED|Overall Study||2
30038|NCT01949155|71411|P2|COMPLETED|Overall Study||88
30039|NCT01949155|71412|P1|COMPLETED|Overall Study||176
30040|NCT01949155|71411|P2|STARTED|Overall Study||88
30041|NCT01949155|71412|P1|STARTED|Overall Study||178
30042|NCT01949142|71424|P2|NOT COMPLETED|Overall Study||1
30043|NCT01949142|71425|P1|NOT COMPLETED|Overall Study||3
30044|NCT01949142|71424|P2|COMPLETED|Overall Study||86
30045|NCT01949142|71425|P1|COMPLETED|Overall Study||176
30046|NCT01949142|71424|P2|STARTED|Overall Study||87
30047|NCT01949142|71425|P1|STARTED|Overall Study||179
30048|NCT01949051|71435|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||0
30049|NCT01949051|71436|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
30050|NCT01949051|71437|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
30051|NCT01949051|71438|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||0
30052|NCT01949051|71439|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
30053|NCT01949051|71440|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
30054|NCT01949051|71435|P6|COMPLETED|Treatment Period 3 (7 Days)||12
30055|NCT01949051|71436|P5|COMPLETED|Treatment Period 3 (7 Days)||13
30056|NCT01949051|71437|P4|COMPLETED|Treatment Period 3 (7 Days)||12
30057|NCT01949051|71438|P3|COMPLETED|Treatment Period 3 (7 Days)||12
30058|NCT01949051|71439|P2|COMPLETED|Treatment Period 3 (7 Days)||12
30059|NCT01949051|71440|P1|COMPLETED|Treatment Period 3 (7 Days)||11
30060|NCT01949051|71435|P6|STARTED|Treatment Period 3 (7 Days)||12
30061|NCT01949051|71436|P5|STARTED|Treatment Period 3 (7 Days)||13
30062|NCT01949051|71437|P4|STARTED|Treatment Period 3 (7 Days)||12
30063|NCT01949051|71438|P3|STARTED|Treatment Period 3 (7 Days)||12
30064|NCT01949051|71439|P2|STARTED|Treatment Period 3 (7 Days)||12
30065|NCT01949051|71440|P1|STARTED|Treatment Period 3 (7 Days)||11
30066|NCT01949051|71435|P6|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
30067|NCT01949051|71436|P5|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
30068|NCT01949051|71437|P4|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
30069|NCT01949051|71438|P3|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
30070|NCT01949051|71439|P2|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
30071|NCT01949051|71440|P1|NOT COMPLETED|Washout Period 2 (14 to 20 Days)||0
30072|NCT01949051|71435|P6|COMPLETED|Washout Period 2 (14 to 20 Days)||12
30073|NCT01949051|71436|P5|COMPLETED|Washout Period 2 (14 to 20 Days)||13
30074|NCT01949051|71437|P4|COMPLETED|Washout Period 2 (14 to 20 Days)||12
30075|NCT01949051|71438|P3|COMPLETED|Washout Period 2 (14 to 20 Days)||12
30076|NCT01949051|71439|P2|COMPLETED|Washout Period 2 (14 to 20 Days)||12
30077|NCT01949051|71440|P1|COMPLETED|Washout Period 2 (14 to 20 Days)||11
30078|NCT01949051|71435|P6|STARTED|Washout Period 2 (14 to 20 Days)||12
30079|NCT01949051|71436|P5|STARTED|Washout Period 2 (14 to 20 Days)||13
30080|NCT01949051|71437|P4|STARTED|Washout Period 2 (14 to 20 Days)||12
30081|NCT01949051|71438|P3|STARTED|Washout Period 2 (14 to 20 Days)||12
30082|NCT01949051|71439|P2|STARTED|Washout Period 2 (14 to 20 Days)||12
30083|NCT01949051|71440|P1|STARTED|Washout Period 2 (14 to 20 Days)||11
30084|NCT01949051|71435|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||1
30085|NCT01949051|71436|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
30086|NCT01949051|71437|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
30087|NCT01949051|71438|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||1
30088|NCT01949051|71439|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||1
30089|NCT01949051|71440|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
30090|NCT01949051|71435|P6|COMPLETED|Treatment Period 2 (7 Days)||12
30091|NCT01949051|71436|P5|COMPLETED|Treatment Period 2 (7 Days)||13
30092|NCT01949051|71437|P4|COMPLETED|Treatment Period 2 (7 Days)||12
30093|NCT01949051|71438|P3|COMPLETED|Treatment Period 2 (7 Days)||12
30094|NCT01949051|71439|P2|COMPLETED|Treatment Period 2 (7 Days)||12
30095|NCT01949051|71440|P1|COMPLETED|Treatment Period 2 (7 Days)||11
30096|NCT01949051|71435|P6|STARTED|Treatment Period 2 (7 Days)||13
30097|NCT01949051|71436|P5|STARTED|Treatment Period 2 (7 Days)||13
30098|NCT01949051|71437|P4|STARTED|Treatment Period 2 (7 Days)||12
30099|NCT01949051|71438|P3|STARTED|Treatment Period 2 (7 Days)||13
30100|NCT01949051|71439|P2|STARTED|Treatment Period 2 (7 Days)||13
30101|NCT01949051|71440|P1|STARTED|Treatment Period 2 (7 Days)||11
30102|NCT01949051|71435|P6|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
30103|NCT01949051|71436|P5|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
30104|NCT01949051|71437|P4|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
30105|NCT01949051|71438|P3|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
30106|NCT01949051|71439|P2|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
30107|NCT01949051|71440|P1|NOT COMPLETED|Washout Period 1 (14 to 20 Days)||0
30108|NCT01949051|71435|P6|COMPLETED|Washout Period 1 (14 to 20 Days)||13
30109|NCT01949051|71436|P5|COMPLETED|Washout Period 1 (14 to 20 Days)||13
30110|NCT01949051|71437|P4|COMPLETED|Washout Period 1 (14 to 20 Days)||12
30111|NCT01949051|71438|P3|COMPLETED|Washout Period 1 (14 to 20 Days)||13
30112|NCT01949051|71439|P2|COMPLETED|Washout Period 1 (14 to 20 Days)||13
30113|NCT01949051|71440|P1|COMPLETED|Washout Period 1 (14 to 20 Days)||11
30114|NCT01949051|71435|P6|STARTED|Washout Period 1 (14 to 20 Days)||13
30115|NCT01949051|71436|P5|STARTED|Washout Period 1 (14 to 20 Days)||13
30116|NCT01949051|71437|P4|STARTED|Washout Period 1 (14 to 20 Days)||12
30117|NCT01949051|71438|P3|STARTED|Washout Period 1 (14 to 20 Days)||13
30118|NCT01949051|71439|P2|STARTED|Washout Period 1 (14 to 20 Days)||13
30119|NCT01949051|71440|P1|STARTED|Washout Period 1 (14 to 20 Days)||11
30120|NCT01949051|71435|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
30121|NCT01949051|71436|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||0
30122|NCT01949051|71437|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||1
30123|NCT01949051|71438|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
30124|NCT01949051|71439|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||0
30125|NCT01949051|71440|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||2
30126|NCT01949051|71435|P6|COMPLETED|Treatment Period 1 (7 Days)||13
30127|NCT01949051|71436|P5|COMPLETED|Treatment Period 1 (7 Days)||13
30128|NCT01949051|71437|P4|COMPLETED|Treatment Period 1 (7 Days)||12
30129|NCT01949051|71438|P3|COMPLETED|Treatment Period 1 (7 Days)||13
30130|NCT01949051|71439|P2|COMPLETED|Treatment Period 1 (7 Days)||13
30131|NCT01949051|71440|P1|COMPLETED|Treatment Period 1 (7 Days)||11
30132|NCT01949051|71435|P6|STARTED|Treatment Period 1 (7 Days)||13
30133|NCT01949051|71436|P5|STARTED|Treatment Period 1 (7 Days)||13
30134|NCT01949051|71437|P4|STARTED|Treatment Period 1 (7 Days)||13
30135|NCT01949051|71438|P3|STARTED|Treatment Period 1 (7 Days)||13
30136|NCT01949051|71439|P2|STARTED|Treatment Period 1 (7 Days)||13
30137|NCT01949051|71440|P1|STARTED|Treatment Period 1 (7 Days)||13
30138|NCT01948908|71454|P3|NOT COMPLETED|Overall Study||2
30139|NCT01948908|71455|P2|NOT COMPLETED|Overall Study||0
30140|NCT01948908|71456|P1|NOT COMPLETED|Overall Study||1
30141|NCT01948908|71454|P3|COMPLETED|Overall Study||31
30142|NCT01948908|71455|P2|COMPLETED|Overall Study||33
30143|NCT01948908|71456|P1|COMPLETED|Overall Study||32
30144|NCT01948908|71454|P3|STARTED|Overall Study||33
30145|NCT01948908|71455|P2|STARTED|Overall Study||33
30146|NCT01948908|71456|P1|STARTED|Overall Study||33
30147|NCT01948830|71472|P2|NOT COMPLETED|Overall Study||32
30148|NCT01948830|71473|P1|NOT COMPLETED|Overall Study||33
30149|NCT01948830|71472|P2|COMPLETED|Overall Study||295
30150|NCT01948830|71473|P1|COMPLETED|Overall Study||290
30151|NCT01948830|71472|P2|Safety Set|Overall Study||326
30152|NCT01948830|71473|P1|Safety Set|Overall Study||323
30153|NCT01948830|71472|P2|STARTED|Overall Study||327
30154|NCT01948830|71473|P1|STARTED|Overall Study||323
30155|NCT01948791|71505|P1|NOT COMPLETED|Overall Study||71
30156|NCT01948791|71505|P1|COMPLETED|Overall Study||151
30157|NCT01948791|71505|P1|STARTED|Overall Study||222
30158|NCT01948518|71513|P1|NOT COMPLETED|Overall Study||0
30159|NCT01948518|71513|P1|COMPLETED|Overall Study||15
30160|NCT01948518|71513|P1|STARTED|Overall Study||15
30161|NCT01948375|71520|P2|NOT COMPLETED|Overall Study||0
30162|NCT01948375|71521|P1|NOT COMPLETED|Overall Study||0
30163|NCT01948375|71520|P2|COMPLETED|Overall Study||30
30164|NCT01948375|71521|P1|COMPLETED|Overall Study||30
30165|NCT01948375|71520|P2|STARTED|Overall Study||30
30166|NCT01948375|71521|P1|STARTED|Overall Study||30
30167|NCT01948193|71535|P1|NOT COMPLETED|Overall Study||9
30168|NCT01948193|71535|P1|COMPLETED|Overall Study||168
30169|NCT01948193|71535|P1|STARTED|Overall Study||177
30170|NCT01948141|71544|P1|NOT COMPLETED|Overall Study||0
30171|NCT01948141|71544|P1|COMPLETED|Overall Study||6
30172|NCT01948141|71544|P1|STARTED|Overall Study||6
30173|NCT01948076|71557|P2|NOT COMPLETED|Overall Study||1
30174|NCT01948076|71558|P1|NOT COMPLETED|Overall Study||0
30175|NCT01948076|71557|P2|COMPLETED|Overall Study||19
30176|NCT01948076|71558|P1|COMPLETED|Overall Study||20
30177|NCT01948076|71557|P2|STARTED|Overall Study||20
30178|NCT01948076|71558|P1|STARTED|Overall Study||20
30179|NCT01948063|71568|P2|NOT COMPLETED|Overall Study||2
30180|NCT01948063|71569|P1|NOT COMPLETED|Overall Study||1
30181|NCT01948063|71568|P2|COMPLETED|Overall Study||19
30182|NCT01948063|71569|P1|COMPLETED|Overall Study||19
30183|NCT01948063|71568|P2|STARTED|Overall Study||21
30184|NCT01948063|71569|P1|STARTED|Overall Study||20
30185|NCT01948050|71577|P2|NOT COMPLETED|Overall Study||1
30186|NCT01948050|71578|P1|NOT COMPLETED|Overall Study||0
30187|NCT01948050|71577|P2|COMPLETED|Overall Study||7
30188|NCT01948050|71578|P1|COMPLETED|Overall Study||16
30189|NCT01948050|71577|P2|STARTED|Overall Study||8
30190|NCT01948050|71578|P1|STARTED|Overall Study||16
30191|NCT01947946|71587|P3|NOT COMPLETED|Overall Study||5
30192|NCT01947946|71588|P2|NOT COMPLETED|Overall Study||5
30193|NCT01947946|71589|P1|NOT COMPLETED|Overall Study||3
30194|NCT01947946|71587|P3|COMPLETED|Overall Study||0
30195|NCT01947946|71588|P2|COMPLETED|Overall Study||0
30196|NCT01947946|71589|P1|COMPLETED|Overall Study|Study Stopped|0
30197|NCT01947946|71587|P3|STARTED|Overall Study||5
30198|NCT01947946|71588|P2|STARTED|Overall Study||5
30199|NCT01947946|71589|P1|STARTED|Overall Study||3
30200|NCT01947907|71601|P4|NOT COMPLETED|Overall Study||0
30201|NCT01947907|71602|P3|NOT COMPLETED|Overall Study||0
30202|NCT01947907|71603|P2|NOT COMPLETED|Overall Study||0
30203|NCT01947907|71604|P1|NOT COMPLETED|Overall Study||0
30204|NCT01947907|71601|P4|COMPLETED|Overall Study||13
30205|NCT01947907|71602|P3|COMPLETED|Overall Study||14
30206|NCT01947907|71603|P2|COMPLETED|Overall Study||14
30207|NCT01947907|71604|P1|COMPLETED|Overall Study||12
30208|NCT01947907|71601|P4|STARTED|Overall Study||13
30209|NCT01947907|71602|P3|STARTED|Overall Study||14
30210|NCT01947907|71603|P2|STARTED|Overall Study||14
30211|NCT01947907|71604|P1|STARTED|Overall Study||12
30212|NCT01947855|71646|P3|NOT COMPLETED|Overall Study||0
30213|NCT01947855|71647|P2|NOT COMPLETED|Overall Study||0
30214|NCT01947855|71648|P1|NOT COMPLETED|Overall Study||1
30215|NCT01947855|71646|P3|COMPLETED|Overall Study||19
30216|NCT01947855|71647|P2|COMPLETED|Overall Study||20
30217|NCT01947855|71648|P1|COMPLETED|Overall Study||20
30218|NCT01947855|71646|P3|STARTED|Overall Study||19
30219|NCT01947855|71647|P2|STARTED|Overall Study||20
30220|NCT01947855|71648|P1|STARTED|Overall Study||21
30221|NCT01947582|71656|P1|NOT COMPLETED|Overall Study||1
30222|NCT01947582|71656|P1|COMPLETED|Overall Study||1
30223|NCT01947582|71656|P1|STARTED|Overall Study||2
30224|NCT01947517|71665|P2|NOT COMPLETED|Overall Study||1
30225|NCT01947517|71666|P1|NOT COMPLETED|Overall Study||1
30226|NCT01947517|71665|P2|COMPLETED|Overall Study||25
30227|NCT01947517|71666|P1|COMPLETED|Overall Study||25
30228|NCT01947517|71665|P2|STARTED|Overall Study||26
30229|NCT01947517|71666|P1|STARTED|Overall Study||26
30230|NCT01947491|71684|P4|NOT COMPLETED|Overall Study||5
30231|NCT01947491|71685|P3|NOT COMPLETED|Overall Study||2
30232|NCT01947491|71686|P2|NOT COMPLETED|Overall Study||6
30233|NCT01947491|71687|P1|NOT COMPLETED|Overall Study||8
30234|NCT01947491|71684|P4|COMPLETED|Overall Study||38
30235|NCT01947491|71685|P3|COMPLETED|Overall Study||88
30236|NCT01947491|71686|P2|COMPLETED|Overall Study||81
30237|NCT01947491|71687|P1|COMPLETED|Overall Study||166
30238|NCT01947491|71684|P4|STARTED|Overall Study||43
30239|NCT01947491|71685|P3|STARTED|Overall Study||90
30240|NCT01947491|71686|P2|STARTED|Overall Study||87
30241|NCT01947491|71687|P1|STARTED|Overall Study||174
30242|NCT01947335|71699|P2|NOT COMPLETED|Overall Study||0
30243|NCT01947335|71700|P1|NOT COMPLETED|Overall Study||0
30244|NCT01947335|71699|P2|COMPLETED|Overall Study||41
30245|NCT01947335|71700|P1|COMPLETED|Overall Study||42
30246|NCT01947335|71699|P2|STARTED|Overall Study||41
30247|NCT01947335|71700|P1|STARTED|Overall Study||42
30248|NCT01947153|71710|P2|NOT COMPLETED|Test Period 2||0
30249|NCT01947153|71711|P1|NOT COMPLETED|Test Period 2||0
30250|NCT01947153|71710|P2|COMPLETED|Test Period 2||18
30251|NCT01947153|71711|P1|COMPLETED|Test Period 2||18
30252|NCT01947153|71710|P2|STARTED|Test Period 2||18
30253|NCT01947153|71711|P1|STARTED|Test Period 2||18
30254|NCT01947153|71710|P2|NOT COMPLETED|Test Period 1||0
30255|NCT01947153|71711|P1|NOT COMPLETED|Test Period 1||0
30256|NCT01947153|71710|P2|COMPLETED|Test Period 1||18
30257|NCT01947153|71711|P1|COMPLETED|Test Period 1||18
30258|NCT01947153|71710|P2|STARTED|Test Period 1||18
30259|NCT01947153|71711|P1|STARTED|Test Period 1||18
30260|NCT01947127|71731|P2|NOT COMPLETED|Overall Study||43
30261|NCT01947127|71732|P1|NOT COMPLETED|Overall Study||23
30262|NCT01947127|71731|P2|COMPLETED|Overall Study||249
30263|NCT01947127|71732|P1|COMPLETED|Overall Study||143
30264|NCT01947127|71731|P2|STARTED|Overall Study||292
30265|NCT01947127|71732|P1|STARTED|Overall Study||166
30266|NCT01946542|71744|P2|NOT COMPLETED|Testing Visit 2||0
30267|NCT01946542|71745|P1|NOT COMPLETED|Testing Visit 2||0
30268|NCT01946542|71744|P2|COMPLETED|Testing Visit 2||1
30269|NCT01946542|71745|P1|COMPLETED|Testing Visit 2||1
30270|NCT01946542|71744|P2|STARTED|Testing Visit 2||1
30271|NCT01946542|71745|P1|STARTED|Testing Visit 2||1
30272|NCT01946542|71744|P2|NOT COMPLETED|Testing Visit 1||0
30273|NCT01946542|71745|P1|NOT COMPLETED|Testing Visit 1||0
30274|NCT01946542|71744|P2|COMPLETED|Testing Visit 1||1
30275|NCT01946542|71745|P1|COMPLETED|Testing Visit 1||1
30276|NCT01946542|71744|P2|STARTED|Testing Visit 1||1
30277|NCT01946542|71745|P1|STARTED|Testing Visit 1||1
30278|NCT01946529|71756|P3|NOT COMPLETED|Completion of All Therapy||6
30279|NCT01946529|71757|P2|NOT COMPLETED|Completion of All Therapy||16
30280|NCT01946529|71758|P1|NOT COMPLETED|Completion of All Therapy||1
30281|NCT01946529|71756|P3|COMPLETED|Completion of All Therapy||0
30282|NCT01946529|71757|P2|COMPLETED|Completion of All Therapy||0
30283|NCT01946529|71758|P1|COMPLETED|Completion of All Therapy||0
30284|NCT01946529|71756|P3|STARTED|Completion of All Therapy||6
30285|NCT01946529|71757|P2|STARTED|Completion of All Therapy||16
30286|NCT01946529|71758|P1|STARTED|Completion of All Therapy||1
30287|NCT01946529|71756|P3|NOT COMPLETED|End of Window Therapy (2 Courses)||0
30288|NCT01946529|71757|P2|NOT COMPLETED|End of Window Therapy (2 Courses)||1
30289|NCT01946529|71758|P1|NOT COMPLETED|End of Window Therapy (2 Courses)||0
30290|NCT01946529|71756|P3|COMPLETED|End of Window Therapy (2 Courses)||6
30291|NCT01946529|71757|P2|COMPLETED|End of Window Therapy (2 Courses)||16
30292|NCT01946529|71758|P1|COMPLETED|End of Window Therapy (2 Courses)||1
30293|NCT01946529|71756|P3|STARTED|End of Window Therapy (2 Courses)||6
30294|NCT01946529|71757|P2|STARTED|End of Window Therapy (2 Courses)||17
30295|NCT01946529|71758|P1|STARTED|End of Window Therapy (2 Courses)||1
30296|NCT01946438|71769|P4|NOT COMPLETED|Overall Study||1
30297|NCT01946438|71770|P3|NOT COMPLETED|Overall Study||1
30298|NCT01946438|71771|P2|NOT COMPLETED|Overall Study||0
30299|NCT01946438|71772|P1|NOT COMPLETED|Overall Study||2
30300|NCT01946438|71769|P4|COMPLETED|Overall Study||51
30301|NCT01946438|71770|P3|COMPLETED|Overall Study||51
30302|NCT01946438|71771|P2|COMPLETED|Overall Study||52
30303|NCT01946438|71772|P1|COMPLETED|Overall Study||50
30304|NCT01946438|71769|P4|STARTED|Overall Study||52
30305|NCT01946438|71770|P3|STARTED|Overall Study||52
30306|NCT01946438|71771|P2|STARTED|Overall Study||52
30307|NCT01946438|71772|P1|STARTED|Overall Study||52
30308|NCT01946425|71800|P2|NOT COMPLETED|Overall Study||0
30309|NCT01946425|71801|P1|NOT COMPLETED|Overall Study||2
30310|NCT01946425|71800|P2|COMPLETED|Overall Study||30
30311|NCT01946425|71801|P1|COMPLETED|Overall Study||28
30312|NCT01946425|71800|P2|STARTED|Overall Study||30
30313|NCT01946425|71801|P1|STARTED|Overall Study||30
30314|NCT01946412|71815|P1|NOT COMPLETED|Overall Study||5
30315|NCT01946412|71815|P1|COMPLETED|Overall Study||28
30316|NCT01946412|71815|P1|STARTED|Overall Study||33
30317|NCT01946243|71837|P1|NOT COMPLETED|Overall Study||0
30318|NCT01946243|71837|P1|COMPLETED|Overall Study||96
30319|NCT01946243|71837|P1|STARTED|Overall Study||96
30320|NCT01946178|71858|P1|NOT COMPLETED|Overall Study||2
30321|NCT01946178|71858|P1|COMPLETED|Overall Study||71
30322|NCT01946178|71858|P1|STARTED|Overall Study||73
30323|NCT01946126|71868|P2|NOT COMPLETED|Overall Study||0
30324|NCT01946126|71869|P1|NOT COMPLETED|Overall Study||0
30325|NCT01946126|71868|P2|COMPLETED|Overall Study||275
30326|NCT01946126|71869|P1|COMPLETED|Overall Study||184
30327|NCT01946126|71868|P2|STARTED|Overall Study||275
30328|NCT01946126|71869|P1|STARTED|Overall Study||184
30329|NCT01945970|71883|P6|NOT COMPLETED|Overall Study||0
30330|NCT01945970|71884|P5|NOT COMPLETED|Overall Study||0
30331|NCT01945970|71885|P4|NOT COMPLETED|Overall Study||0
30332|NCT01945970|71886|P3|NOT COMPLETED|Overall Study||0
30333|NCT01945970|71887|P2|NOT COMPLETED|Overall Study||0
30334|NCT01945970|71888|P1|NOT COMPLETED|Overall Study||0
30335|NCT01945970|71883|P6|COMPLETED|Overall Study||5
30336|NCT01945970|71884|P5|COMPLETED|Overall Study||5
30337|NCT01945970|71885|P4|COMPLETED|Overall Study||5
30338|NCT01945970|71886|P3|COMPLETED|Overall Study||5
30339|NCT01945970|71887|P2|COMPLETED|Overall Study||5
30340|NCT01945970|71888|P1|COMPLETED|Overall Study||5
30341|NCT01945970|71883|P6|STARTED|Overall Study||5
30342|NCT01945970|71884|P5|STARTED|Overall Study||5
30343|NCT01945970|71885|P4|STARTED|Overall Study||5
30344|NCT01945970|71886|P3|STARTED|Overall Study||5
30345|NCT01945970|71887|P2|STARTED|Overall Study||5
30346|NCT01945970|71888|P1|STARTED|Overall Study||5
30347|NCT01945944|71927|P2|NOT COMPLETED|Overall Study||3
30348|NCT01945944|71928|P1|NOT COMPLETED|Overall Study||1
30349|NCT01945944|71927|P2|COMPLETED|Overall Study||6
30350|NCT01945944|71928|P1|COMPLETED|Overall Study||8
30351|NCT01945944|71927|P2|STARTED|Overall Study||9
30352|NCT01945944|71928|P1|STARTED|Overall Study||9
30353|NCT01945294|71953|P4|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||6
30354|NCT01945294|71954|P3|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||8
30355|NCT01945294|71955|P2|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||5
30356|NCT01945294|71956|P1|NOT COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
30357|NCT01945294|71953|P4|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||23
30358|NCT01945294|71954|P3|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
30359|NCT01945294|71955|P2|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||97
30360|NCT01945294|71956|P1|COMPLETED|Period 2: BOC+ PR Treatment & Follow-up||0
30361|NCT01945294|71953|P4|STARTED|Period 2: BOC+ PR Treatment & Follow-up||29
30362|NCT01945294|71954|P3|STARTED|Period 2: BOC+ PR Treatment & Follow-up||105
30363|NCT01945294|71955|P2|STARTED|Period 2: BOC+ PR Treatment & Follow-up||102
30364|NCT01945294|71956|P1|STARTED|Period 2: BOC+ PR Treatment & Follow-up|Participants were assigned to 1 of the 3 arms after upon the 12-week BOC + PR lead-in.|0
30365|NCT01945294|71953|P4|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
30366|NCT01945294|71954|P3|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
30367|NCT01945294|71955|P2|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
30368|NCT01945294|71956|P1|NOT COMPLETED|Period 1: 12-Week PR + BOC Lead-In||21
30369|NCT01945294|71953|P4|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
30370|NCT01945294|71954|P3|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
30371|NCT01945294|71955|P2|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||0
30372|NCT01945294|71956|P1|COMPLETED|Period 1: 12-Week PR + BOC Lead-In||236
30373|NCT01945294|71953|P4|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
30374|NCT01945294|71954|P3|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
30375|NCT01945294|71955|P2|STARTED|Period 1: 12-Week PR + BOC Lead-In||0
30376|NCT01945294|71956|P1|STARTED|Period 1: 12-Week PR + BOC Lead-In||257
30377|NCT01945242|71987|P2|NOT COMPLETED|Overall Study||3
30378|NCT01945242|71988|P1|NOT COMPLETED|Overall Study||3
30379|NCT01945242|71987|P2|COMPLETED|Overall Study||120
30380|NCT01945242|71988|P1|COMPLETED|Overall Study||1248
30381|NCT01945242|71987|P2|STARTED|Overall Study||123
30382|NCT01945242|71988|P1|STARTED|Overall Study||1251
30383|NCT01945138|72002|P2|NOT COMPLETED|Overall Study||0
30384|NCT01945138|72003|P1|NOT COMPLETED|Overall Study||0
30385|NCT01945138|72002|P2|COMPLETED|Overall Study||7
30386|NCT01945138|72003|P1|COMPLETED|Overall Study||7
30387|NCT01945138|72002|P2|STARTED|Overall Study||7
30388|NCT01945138|72003|P1|STARTED|Overall Study||7
30389|NCT01945112|72037|P2|NOT COMPLETED|Overall Study||0
30390|NCT01945112|72038|P1|NOT COMPLETED|Overall Study||0
30391|NCT01945112|72037|P2|COMPLETED|Overall Study||51
30392|NCT01945112|72038|P1|COMPLETED|Overall Study||77
30393|NCT01945112|72037|P2|STARTED|Overall Study|total number of sites where tape was applied|51
30394|NCT01945112|72038|P1|STARTED|Overall Study|total number of sites where tape was applied|77
30395|NCT01945086|72046|P3|NOT COMPLETED|Overall Study||2
30396|NCT01945086|72047|P2|NOT COMPLETED|Overall Study||0
30397|NCT01945086|72048|P1|NOT COMPLETED|Overall Study||1
30398|NCT01945086|72046|P3|COMPLETED|Overall Study||26
30399|NCT01945086|72047|P2|COMPLETED|Overall Study||24
30400|NCT01945086|72048|P1|COMPLETED|Overall Study||26
30401|NCT01945086|72046|P3|STARTED|Overall Study||28
30402|NCT01945086|72047|P2|STARTED|Overall Study||24
30403|NCT01945086|72048|P1|STARTED|Overall Study||27
30404|NCT01945034|72092|P3|NOT COMPLETED|Overall Study||7
30405|NCT01945034|72093|P2|NOT COMPLETED|Overall Study||5
30406|NCT01945034|72094|P1|NOT COMPLETED|Overall Study||1
30407|NCT01945034|72092|P3|COMPLETED|Overall Study||145
30408|NCT01945034|72093|P2|COMPLETED|Overall Study||80
30409|NCT01945034|72094|P1|COMPLETED|Overall Study||66
30410|NCT01945034|72092|P3|STARTED|Overall Study||152
30411|NCT01945034|72093|P2|STARTED|Overall Study||85
30412|NCT01945034|72094|P1|STARTED|Overall Study||67
30413|NCT01945021|72144|P1|NOT COMPLETED|Overall Study||47
30414|NCT01945021|72144|P1|COMPLETED|Overall Study|Completed is defined as patients who continued crizotinib at the time of final analysis (ongoing)|80
30415|NCT01945021|72144|P1|Patient Reported Outcome -Evaluable|Overall Study|All patients from the safety population who completed a baseline and >/= 1 post-baseline assessment.|123
30416|NCT01945021|72144|P1|Response Evaluable Population|Overall Study|All patients in the safety population who had an adequate baseline tumor assessment|127
30417|NCT01945021|72144|P1|Safety Population|Overall Study|All enrolled patients who received at least 1 dose of study medication.|127
30418|NCT01945021|72144|P1|STARTED|Overall Study|127 pts with ROS1+ & ALK negative tumors were consented and started study (2 more were screen fails)|127
30419|NCT01944969|72158|P1|NOT COMPLETED|Overall Study||26
30420|NCT01944969|72158|P1|COMPLETED|Overall Study||0
30421|NCT01944969|72158|P1|STARTED|Overall Study||26
30422|NCT01944878|72171|P2|NOT COMPLETED|Overall Study||0
30423|NCT01944878|72172|P1|NOT COMPLETED|Overall Study||0
30424|NCT01944878|72171|P2|COMPLETED|Overall Study||328
30425|NCT01944878|72172|P1|COMPLETED|Overall Study||127
30426|NCT01944878|72171|P2|STARTED|Overall Study||328
30427|NCT01944878|72172|P1|STARTED|Overall Study||127
30428|NCT01944774|72183|P3|NOT COMPLETED|Overall Study||8
30429|NCT01944774|72184|P2|NOT COMPLETED|Overall Study||8
30430|NCT01944774|72185|P1|NOT COMPLETED|Overall Study||6
30431|NCT01944774|72183|P3|COMPLETED|Overall Study||62
30432|NCT01944774|72184|P2|COMPLETED|Overall Study||60
30433|NCT01944774|72185|P1|COMPLETED|Overall Study||63
30434|NCT01944774|72183|P3|Received Treatment|Overall Study||70
30435|NCT01944774|72184|P2|Received Treatment|Overall Study||67
30436|NCT01944774|72185|P1|Received Treatment|Overall Study||68
30437|NCT01944774|72183|P3|STARTED|Overall Study||70
30438|NCT01944774|72184|P2|STARTED|Overall Study||68
30439|NCT01944774|72185|P1|STARTED|Overall Study||69
30440|NCT01944670|72226|P1|NOT COMPLETED|Overall Study||2
30441|NCT01944670|72226|P1|COMPLETED|Overall Study||24
30442|NCT01944670|72226|P1|STARTED|Overall Study||26
30443|NCT01944631|72233|P2|NOT COMPLETED|Overall Study||2
30444|NCT01944631|72234|P1|NOT COMPLETED|Overall Study||4
30445|NCT01944631|72233|P2|COMPLETED|Overall Study||98
30446|NCT01944631|72234|P1|COMPLETED|Overall Study||96
30447|NCT01944631|72233|P2|STARTED|Overall Study||100
30448|NCT01944631|72234|P1|STARTED|Overall Study||100
30449|NCT01944345|72250|P1|NOT COMPLETED|Overall Study||0
30450|NCT01944345|72250|P1|COMPLETED|Overall Study||69
30451|NCT01944345|72250|P1|STARTED|Overall Study||69
30452|NCT01944319|72258|P2|NOT COMPLETED|Overall Study||0
30453|NCT01944319|72259|P1|NOT COMPLETED|Overall Study||0
30454|NCT01944319|72258|P2|COMPLETED|Overall Study||39
30455|NCT01944319|72259|P1|COMPLETED|Overall Study||40
30456|NCT01944319|72258|P2|STARTED|Overall Study||39
30457|NCT01944319|72259|P1|STARTED|Overall Study||40
30458|NCT01944059|72269|P1|NOT COMPLETED|Overall Study||7
30459|NCT01944059|72269|P1|COMPLETED|Overall Study||24
30460|NCT01944059|72269|P1|STARTED|Overall Study||31
30461|NCT01943864|72278|P1|NOT COMPLETED|Overall Study||0
30462|NCT01943864|72278|P1|COMPLETED|Overall Study|Death or 1 year from randomization after progression was considered completion; 20 participants died|20
30463|NCT01943864|72278|P1|STARTED|Overall Study||20
30464|NCT01943565|72309|P3|NOT COMPLETED|Overall Study||0
30465|NCT01943565|72310|P2|NOT COMPLETED|Overall Study||0
30466|NCT01943565|72311|P1|NOT COMPLETED|Overall Study||0
30467|NCT01943565|72309|P3|COMPLETED|Overall Study||9
30468|NCT01943565|72310|P2|COMPLETED|Overall Study||9
30469|NCT01943565|72311|P1|COMPLETED|Overall Study||11
30470|NCT01943565|72309|P3|STARTED|Overall Study||9
30471|NCT01943565|72310|P2|STARTED|Overall Study||9
30472|NCT01943565|72311|P1|STARTED|Overall Study||11
30473|NCT01943552|72342|P2|NOT COMPLETED|Overall Study||25
30474|NCT01943552|72343|P1|NOT COMPLETED|Overall Study||25
30475|NCT01943552|72342|P2|COMPLETED|Overall Study||69
30476|NCT01943552|72343|P1|COMPLETED|Overall Study||71
30477|NCT01943552|72342|P2|STARTED|Overall Study||94
30478|NCT01943552|72343|P1|STARTED|Overall Study|One patient was randomised to the placebo group, but received nebulized ipratropium bromide.|96
30479|NCT01943474|72361|P2|NOT COMPLETED|Overall Study||0
30480|NCT01943474|72362|P1|NOT COMPLETED|Overall Study||0
30481|NCT01943474|72361|P2|COMPLETED|Overall Study||125
30482|NCT01943474|72362|P1|COMPLETED|Overall Study||123
30483|NCT01943474|72361|P2|STARTED|Overall Study||125
30484|NCT01943474|72362|P1|STARTED|Overall Study||123
30485|NCT01943435|72386|P3|NOT COMPLETED|6 Month Follow up||15
30486|NCT01943435|72387|P2|NOT COMPLETED|6 Month Follow up||7
30487|NCT01943435|72388|P1|NOT COMPLETED|6 Month Follow up||12
30488|NCT01943435|72386|P3|COMPLETED|6 Month Follow up||65
30489|NCT01943435|72387|P2|COMPLETED|6 Month Follow up||59
30490|NCT01943435|72388|P1|COMPLETED|6 Month Follow up||67
30491|NCT01943435|72386|P3|STARTED|6 Month Follow up||80
30492|NCT01943435|72387|P2|STARTED|6 Month Follow up||66
30493|NCT01943435|72388|P1|STARTED|6 Month Follow up||79
30494|NCT01943435|72386|P3|NOT COMPLETED|2 Month Follow up||0
30495|NCT01943435|72387|P2|NOT COMPLETED|2 Month Follow up||3
30496|NCT01943435|72388|P1|NOT COMPLETED|2 Month Follow up||2
30497|NCT01943435|72386|P3|COMPLETED|2 Month Follow up||80
30498|NCT01943435|72387|P2|COMPLETED|2 Month Follow up||66
30499|NCT01943435|72388|P1|COMPLETED|2 Month Follow up||79
30500|NCT01943435|72386|P3|STARTED|2 Month Follow up||80
30501|NCT01943435|72387|P2|STARTED|2 Month Follow up||69
30502|NCT01943435|72388|P1|STARTED|2 Month Follow up||81
30503|NCT01943435|72386|P3|NOT COMPLETED|Intervention Period||4
30504|NCT01943435|72387|P2|NOT COMPLETED|Intervention Period||3
30505|NCT01943435|72388|P1|NOT COMPLETED|Intervention Period||3
30506|NCT01943435|72386|P3|COMPLETED|Intervention Period||80
30507|NCT01943435|72387|P2|COMPLETED|Intervention Period||69
30508|NCT01943435|72388|P1|COMPLETED|Intervention Period||81
30509|NCT01943435|72386|P3|STARTED|Intervention Period||84
30510|NCT01943435|72387|P2|STARTED|Intervention Period||72
30511|NCT01943435|72388|P1|STARTED|Intervention Period||84
30512|NCT01943344|72402|P1|NOT COMPLETED|Overall Study||3
30513|NCT01943344|72402|P1|COMPLETED|Overall Study||9
30514|NCT01943344|72402|P1|STARTED|Overall Study||12
30515|NCT01943292|72409|P3|NOT COMPLETED|Overall Study||0
30516|NCT01943292|72410|P2|NOT COMPLETED|Overall Study||0
30517|NCT01943292|72411|P1|NOT COMPLETED|Overall Study||1
30518|NCT01943292|72409|P3|COMPLETED|Overall Study||3
30519|NCT01943292|72410|P2|COMPLETED|Overall Study||3
30520|NCT01943292|72411|P1|COMPLETED|Overall Study||2
30521|NCT01943292|72409|P3|Completed Follow-Up|Overall Study||3
30522|NCT01943292|72410|P2|Completed Follow-Up|Overall Study||3
30523|NCT01943292|72411|P1|Completed Follow-Up|Overall Study||2
30524|NCT01943292|72409|P3|Completed Treatment|Overall Study||3
30525|NCT01943292|72410|P2|Completed Treatment|Overall Study||3
30526|NCT01943292|72411|P1|Completed Treatment|Overall Study||3
30527|NCT01943292|72409|P3|Completed Cycle 1|Overall Study||3
30528|NCT01943292|72410|P2|Completed Cycle 1|Overall Study||3
30529|NCT01943292|72411|P1|Completed Cycle 1|Overall Study||3
30530|NCT01943292|72409|P3|STARTED|Overall Study||3
30531|NCT01943292|72410|P2|STARTED|Overall Study||3
30532|NCT01943292|72411|P1|STARTED|Overall Study||3
30533|NCT01943110|72422|P1|NOT COMPLETED|Overall Study||0
30534|NCT01943110|72422|P1|COMPLETED|Overall Study||30
30535|NCT01943110|72422|P1|STARTED|Overall Study||30
30536|NCT01942785|72438|P1|NOT COMPLETED|Overall Study||4
30537|NCT01942785|72438|P1|COMPLETED|Overall Study||50
30538|NCT01942785|72438|P1|STARTED|Overall Study||54
30539|NCT01942733|72467|P1|NOT COMPLETED|Overall Study||3
30540|NCT01942733|72467|P1|COMPLETED|Overall Study||41
30541|NCT01942733|72467|P1|STARTED|Overall Study||44
30542|NCT01942720|72496|P1|NOT COMPLETED|Overall Study||21
30543|NCT01942720|72496|P1|COMPLETED|Overall Study||53
30544|NCT01942720|72496|P1|STARTED|Overall Study||74
30545|NCT01942707|72506|P2|NOT COMPLETED|Overall Study||0
30546|NCT01942707|72507|P1|NOT COMPLETED|Overall Study||0
30547|NCT01942707|72506|P2|COMPLETED|Overall Study||23
30548|NCT01942707|72507|P1|COMPLETED|Overall Study||23
30549|NCT01942707|72506|P2|STARTED|Overall Study||23
30550|NCT01942707|72507|P1|STARTED|Overall Study||23
30551|NCT01942161|72520|P3|NOT COMPLETED|Overall Study||6
30552|NCT01942161|72521|P2|NOT COMPLETED|Overall Study||6
30553|NCT01942161|72522|P1|NOT COMPLETED|Overall Study||8
30554|NCT01942161|72520|P3|COMPLETED|Overall Study||35
30555|NCT01942161|72521|P2|COMPLETED|Overall Study||24
30556|NCT01942161|72522|P1|COMPLETED|Overall Study||27
30557|NCT01942161|72520|P3|STARTED|Overall Study||41
30558|NCT01942161|72521|P2|STARTED|Overall Study||30
30559|NCT01942161|72522|P1|STARTED|Overall Study||35
30560|NCT01942148|72542|P1|NOT COMPLETED|Overall Study||27
30561|NCT01942148|72542|P1|COMPLETED|Overall Study||41
30562|NCT01942148|72542|P1|STARTED|Overall Study||68
30563|NCT01942135|72550|P2|NOT COMPLETED|Overall Study||174
30564|NCT01942135|72551|P1|NOT COMPLETED|Overall Study||347
30565|NCT01942135|72550|P2|COMPLETED|Overall Study||0
30566|NCT01942135|72551|P1|COMPLETED|Overall Study||0
30567|NCT01942135|72550|P2|STARTED|Overall Study||174
30568|NCT01942135|72551|P1|STARTED|Overall Study||347
30569|NCT01941940|72588|P1|NOT COMPLETED|Overall Study||33
30570|NCT01941940|72588|P1|COMPLETED|Overall Study||194
30571|NCT01941940|72588|P1|STARTED|Overall Study||227
30572|NCT01941615|72628|P1|NOT COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
30573|NCT01941615|72628|P1|COMPLETED|Microgynon® Plus Deleobuvir+Faldaprevir||0
30574|NCT01941615|72628|P1|STARTED|Microgynon® Plus Deleobuvir+Faldaprevir||0
30575|NCT01941615|72628|P1|NOT COMPLETED|Reference Treatment: Microgynon®||0
30576|NCT01941615|72628|P1|COMPLETED|Reference Treatment: Microgynon®||0
30577|NCT01941615|72628|P1|STARTED|Reference Treatment: Microgynon®||0
30578|NCT01941615|72628|P1|NOT COMPLETED|Run in Treatment: Microgynon®||0
30579|NCT01941615|72628|P1|COMPLETED|Run in Treatment: Microgynon®||16
30580|NCT01941615|72628|P1|STARTED|Run in Treatment: Microgynon®||16
30581|NCT01941498|72637|P1|NOT COMPLETED|Overall Study||1
30582|NCT01941498|72637|P1|COMPLETED|Overall Study||96
30583|NCT01941498|72637|P1|STARTED|Overall Study||97
30584|NCT01941485|72683|P1|NOT COMPLETED|Overall Study||0
30585|NCT01941485|72683|P1|COMPLETED|Overall Study||59
30586|NCT01941485|72683|P1|STARTED|Overall Study||59
30587|NCT01941472|72749|P1|NOT COMPLETED|Overall Study||0
30588|NCT01941472|72749|P1|COMPLETED|Overall Study||40
30589|NCT01941472|72749|P1|STARTED|Overall Study||40
30590|NCT01941186|72755|P2|NOT COMPLETED|Follow-up||0
30591|NCT01941186|72756|P1|NOT COMPLETED|Follow-up||1
30592|NCT01941186|72755|P2|COMPLETED|Follow-up||33
30593|NCT01941186|72756|P1|COMPLETED|Follow-up||30
30594|NCT01941186|72755|P2|STARTED|Follow-up||33
30595|NCT01941186|72756|P1|STARTED|Follow-up||31
30596|NCT01941186|72755|P2|NOT COMPLETED|Randomization/Allocation to Study Group||0
30597|NCT01941186|72756|P1|NOT COMPLETED|Randomization/Allocation to Study Group||0
30598|NCT01941186|72755|P2|COMPLETED|Randomization/Allocation to Study Group||33
30599|NCT01941186|72756|P1|COMPLETED|Randomization/Allocation to Study Group||31
30600|NCT01941186|72755|P2|STARTED|Randomization/Allocation to Study Group||33
30601|NCT01941186|72756|P1|STARTED|Randomization/Allocation to Study Group||31
30602|NCT01940523|72784|P2|NOT COMPLETED|Overall Study||0
30603|NCT01940523|72785|P1|NOT COMPLETED|Overall Study||0
30604|NCT01940523|72784|P2|COMPLETED|Overall Study||320
30605|NCT01940523|72785|P1|COMPLETED|Overall Study||320
30606|NCT01940523|72784|P2|STARTED|Overall Study||320
30607|NCT01940523|72785|P1|STARTED|Overall Study||320
30608|NCT01940510|72793|P1|NOT COMPLETED|Overall Study||0
30609|NCT01940510|72793|P1|COMPLETED|Overall Study||24
30610|NCT01940510|72793|P1|STARTED|Overall Study||24
30611|NCT01940497|72826|P2|NOT COMPLETED|Overall Study||118
30612|NCT01940497|72827|P1|NOT COMPLETED|Overall Study||120
30613|NCT01940497|72826|P2|COMPLETED|Overall Study||1
30614|NCT01940497|72827|P1|COMPLETED|Overall Study||1
30615|NCT01940497|72826|P2|Treated: Neoadjuvant|Overall Study||21
30616|NCT01940497|72827|P1|Treated: Neoadjuvant|Overall Study||20
30617|NCT01940497|72826|P2|Treated: Adjuvant|Overall Study||92
30618|NCT01940497|72827|P1|Treated: Adjuvant|Overall Study||95
30619|NCT01940497|72826|P2|Treated|Overall Study||113
30620|NCT01940497|72827|P1|Treated|Overall Study||115
30621|NCT01940497|72826|P2|STARTED|Overall Study||119
30622|NCT01940497|72827|P1|STARTED|Overall Study||121
30623|NCT01940484|72866|P1|NOT COMPLETED|Overall Study||10
30624|NCT01940484|72866|P1|COMPLETED|Overall Study||88
30625|NCT01940484|72866|P1|STARTED|Overall Study||98
30626|NCT01940471|72886|P2|NOT COMPLETED|Open-Label Extension||8
30627|NCT01940471|72887|P1|NOT COMPLETED|Open-Label Extension||14
30628|NCT01940471|72886|P2|COMPLETED|Open-Label Extension||0
30629|NCT01940471|72887|P1|COMPLETED|Open-Label Extension||0
30630|NCT01940471|72886|P2|STARTED|Open-Label Extension||8
30631|NCT01940471|72887|P1|STARTED|Open-Label Extension||14
30632|NCT01940471|72886|P2|NOT COMPLETED|Double-Blind Phase||285
30633|NCT01940471|72887|P1|NOT COMPLETED|Double-Blind Phase||568
30634|NCT01940471|72886|P2|COMPLETED|Double-Blind Phase||8
30635|NCT01940471|72887|P1|COMPLETED|Double-Blind Phase||14
30636|NCT01940471|72886|P2|STARTED|Double-Blind Phase||293
30637|NCT01940471|72887|P1|STARTED|Double-Blind Phase||582
30638|NCT01940341|72905|P2|NOT COMPLETED|Open-label Extension Phase||1
30639|NCT01940341|72906|P1|NOT COMPLETED|Open-label Extension Phase||4
30640|NCT01940341|72905|P2|COMPLETED|Open-label Extension Phase||0
30641|NCT01940341|72906|P1|COMPLETED|Open-label Extension Phase||0
30642|NCT01940341|72905|P2|STARTED|Open-label Extension Phase||1
30643|NCT01940341|72906|P1|STARTED|Open-label Extension Phase||4
30644|NCT01940341|72905|P2|NOT COMPLETED|Double-Blind Phase||140
30645|NCT01940341|72906|P1|NOT COMPLETED|Double-Blind Phase||281
30646|NCT01940341|72905|P2|COMPLETED|Double-Blind Phase||1
30647|NCT01940341|72906|P1|COMPLETED|Double-Blind Phase||4
30648|NCT01940341|72905|P2|STARTED|Double-Blind Phase||141
30649|NCT01940341|72906|P1|STARTED|Double-Blind Phase||285
30650|NCT01940146|72924|P4|NOT COMPLETED|Overall Study||2
30651|NCT01940146|72925|P3|NOT COMPLETED|Overall Study||1
30652|NCT01940146|72926|P2|NOT COMPLETED|Overall Study||0
30653|NCT01940146|72927|P1|NOT COMPLETED|Overall Study||1
30654|NCT01940146|72924|P4|COMPLETED|Overall Study||53
30655|NCT01940146|72925|P3|COMPLETED|Overall Study||55
30656|NCT01940146|72926|P2|COMPLETED|Overall Study||55
30657|NCT01940146|72927|P1|COMPLETED|Overall Study||55
30658|NCT01940146|72924|P4|STARTED|Overall Study||55
30659|NCT01940146|72925|P3|STARTED|Overall Study||56
30660|NCT01940146|72926|P2|STARTED|Overall Study||55
30661|NCT01940146|72927|P1|STARTED|Overall Study||56
30662|NCT01940120|72937|P1|NOT COMPLETED|Overall Study||44
30663|NCT01940120|72937|P1|COMPLETED|Overall Study||34
30664|NCT01940120|72937|P1|STARTED|Overall Study||78
30665|NCT01939938|73059|P1|NOT COMPLETED|Overall Study||0
30666|NCT01939938|73059|P1|COMPLETED|Overall Study||10
30667|NCT01939938|73059|P1|STARTED|Overall Study||10
30668|NCT01939548|73067|P3|NOT COMPLETED|Overall Study||30
30669|NCT01939548|73068|P2|NOT COMPLETED|Overall Study||49
30670|NCT01939548|73069|P1|NOT COMPLETED|Overall Study||37
30671|NCT01939548|73067|P3|COMPLETED|Overall Study||50
30672|NCT01939548|73068|P2|COMPLETED|Overall Study||33
30673|NCT01939548|73069|P1|COMPLETED|Overall Study||41
30674|NCT01939548|73067|P3|STARTED|Overall Study||80
30675|NCT01939548|73068|P2|STARTED|Overall Study||82
30676|NCT01939548|73069|P1|STARTED|Overall Study||78
30677|NCT01939496|73143|P3|NOT COMPLETED|Overall Study||2
30678|NCT01939496|73144|P2|NOT COMPLETED|Overall Study||3
30679|NCT01939496|73145|P1|NOT COMPLETED|Overall Study||9
30680|NCT01939496|73143|P3|COMPLETED|Overall Study||54
30681|NCT01939496|73144|P2|COMPLETED|Overall Study||54
30682|NCT01939496|73145|P1|COMPLETED|Overall Study||47
30683|NCT01939496|73143|P3|STARTED|Overall Study||56
30684|NCT01939496|73144|P2|STARTED|Overall Study||57
30685|NCT01939496|73145|P1|STARTED|Overall Study||56
30686|NCT01939314|73197|P2|NOT COMPLETED|Overall Study||8
30687|NCT01939314|73198|P1|NOT COMPLETED|Overall Study||9
30688|NCT01939314|73197|P2|COMPLETED|Overall Study||40
30689|NCT01939314|73198|P1|COMPLETED|Overall Study||36
30690|NCT01939314|73197|P2|24 Hour Endpoint|Overall Study||40
30691|NCT01939314|73198|P1|24 Hour Endpoint|Overall Study||36
30692|NCT01939314|73197|P2|15 Minute Endpoint|Overall Study||46
30693|NCT01939314|73198|P1|15 Minute Endpoint|Overall Study||41
30694|NCT01939314|73197|P2|STARTED|Overall Study||48
30695|NCT01939314|73198|P1|STARTED|Overall Study||45
30696|NCT01939145|73210|P2|NOT COMPLETED|Overall Study||7
30697|NCT01939145|73211|P1|NOT COMPLETED|Overall Study||2
30698|NCT01939145|73210|P2|COMPLETED|Overall Study||44
30699|NCT01939145|73211|P1|COMPLETED|Overall Study||47
30700|NCT01939145|73210|P2|STARTED|Overall Study||51
30701|NCT01939145|73211|P1|STARTED|Overall Study||49
30702|NCT01939002|73221|P2|NOT COMPLETED|Overall Study||18
30703|NCT01939002|73222|P1|NOT COMPLETED|Overall Study||19
30704|NCT01939002|73221|P2|COMPLETED|Overall Study||80
30705|NCT01939002|73222|P1|COMPLETED|Overall Study||84
30706|NCT01939002|73221|P2|STARTED|Overall Study||98
30707|NCT01939002|73222|P1|STARTED|Overall Study||103
30708|NCT01938989|73288|P2|NOT COMPLETED|Overall Study||0
30709|NCT01938989|73289|P1|NOT COMPLETED|Overall Study||0
30710|NCT01938989|73288|P2|COMPLETED|Overall Study||77
30711|NCT01938989|73289|P1|COMPLETED|Overall Study||77
30712|NCT01938989|73288|P2|STARTED|Overall Study||77
30713|NCT01938989|73289|P1|STARTED|Overall Study||77
30714|NCT01938430|73309|P14|NOT COMPLETED|Overall Study||1
30715|NCT01938430|73310|P13|NOT COMPLETED|Overall Study||0
30716|NCT01938430|73311|P12|NOT COMPLETED|Overall Study||1
30717|NCT01938430|73312|P11|NOT COMPLETED|Overall Study||3
30718|NCT01938430|73313|P10|NOT COMPLETED|Overall Study||3
30719|NCT01938430|73314|P9|NOT COMPLETED|Overall Study||4
30720|NCT01938430|73315|P8|NOT COMPLETED|Overall Study||1
30721|NCT01938430|73316|P7|NOT COMPLETED|Overall Study||2
30722|NCT01938430|73317|P6|NOT COMPLETED|Overall Study||1
30723|NCT01938430|73318|P5|NOT COMPLETED|Overall Study||0
30724|NCT01938430|73319|P4|NOT COMPLETED|Overall Study||2
30725|NCT01938430|73320|P3|NOT COMPLETED|Overall Study||5
30726|NCT01938430|73321|P2|NOT COMPLETED|Overall Study||3
30727|NCT01938430|73322|P1|NOT COMPLETED|Overall Study||4
30728|NCT01938430|73309|P14|COMPLETED|Overall Study||2
30729|NCT01938430|73310|P13|COMPLETED|Overall Study||4
30730|NCT01938430|73311|P12|COMPLETED|Overall Study||3
30731|NCT01938430|73312|P11|COMPLETED|Overall Study||3
30732|NCT01938430|73313|P10|COMPLETED|Overall Study||23
30733|NCT01938430|73314|P9|COMPLETED|Overall Study||22
30734|NCT01938430|73315|P8|COMPLETED|Overall Study||24
30735|NCT01938430|73316|P7|COMPLETED|Overall Study||24
30736|NCT01938430|73317|P6|COMPLETED|Overall Study||55
30737|NCT01938430|73318|P5|COMPLETED|Overall Study||55
30738|NCT01938430|73319|P4|COMPLETED|Overall Study||24
30739|NCT01938430|73320|P3|COMPLETED|Overall Study||18
30740|NCT01938430|73321|P2|COMPLETED|Overall Study||26
30741|NCT01938430|73322|P1|COMPLETED|Overall Study||26
30742|NCT01938430|73309|P14|STARTED|Overall Study||3
30743|NCT01938430|73310|P13|STARTED|Overall Study||4
30744|NCT01938430|73311|P12|STARTED|Overall Study||4
30745|NCT01938430|73312|P11|STARTED|Overall Study||6
30746|NCT01938430|73313|P10|STARTED|Overall Study||26
30747|NCT01938430|73314|P9|STARTED|Overall Study||26
30748|NCT01938430|73315|P8|STARTED|Overall Study||25
30749|NCT01938430|73316|P7|STARTED|Overall Study||26
30750|NCT01938430|73317|P6|STARTED|Overall Study||56
30751|NCT01938430|73318|P5|STARTED|Overall Study||55
30752|NCT01938430|73319|P4|STARTED|Overall Study||26
30753|NCT01938430|73320|P3|STARTED|Overall Study||23
30754|NCT01938430|73321|P2|STARTED|Overall Study||29
30755|NCT01938430|73322|P1|STARTED|Overall Study||30
30756|NCT01938391|73647|P1|NOT COMPLETED|12 Month Follow up||2
30757|NCT01938391|73647|P1|COMPLETED|12 Month Follow up||22
30758|NCT01938391|73647|P1|STARTED|12 Month Follow up||24
30759|NCT01938391|73647|P1|NOT COMPLETED|6 Month Follow up||1
30760|NCT01938391|73647|P1|COMPLETED|6 Month Follow up||24
30761|NCT01938391|73647|P1|STARTED|6 Month Follow up||25
30762|NCT01938391|73647|P1|NOT COMPLETED|2 Week Follow up||0
30763|NCT01938391|73647|P1|COMPLETED|2 Week Follow up||25
30764|NCT01938391|73647|P1|STARTED|2 Week Follow up||25
30765|NCT01938391|73647|P1|NOT COMPLETED|Baseline||0
30766|NCT01938391|73647|P1|COMPLETED|Baseline||25
30767|NCT01938391|73647|P1|STARTED|Baseline||25
30768|NCT01938170|73657|P1|NOT COMPLETED|Overall Study||0
30769|NCT01938170|73657|P1|COMPLETED|Overall Study||41
30770|NCT01938170|73657|P1|STARTED|Overall Study||41
30771|NCT01938079|73664|P2|NOT COMPLETED|Overall Study||0
30772|NCT01938079|73665|P1|NOT COMPLETED|Overall Study||0
30773|NCT01938079|73664|P2|COMPLETED|Overall Study||10
30774|NCT01938079|73665|P1|COMPLETED|Overall Study||10
30775|NCT01938079|73664|P2|STARTED|Overall Study||10
30776|NCT01938079|73665|P1|STARTED|Overall Study||10
30777|NCT01938066|73673|P2|NOT COMPLETED|Overall Study||2
30778|NCT01938066|73674|P1|NOT COMPLETED|Overall Study||1
30779|NCT01938066|73673|P2|COMPLETED|Overall Study||13
30780|NCT01938066|73674|P1|COMPLETED|Overall Study||14
30781|NCT01938066|73673|P2|STARTED|Overall Study||15
30782|NCT01938066|73674|P1|STARTED|Overall Study||15
30783|NCT01938040|73684|P2|NOT COMPLETED|Overall Study||0
30784|NCT01938040|73685|P1|NOT COMPLETED|Overall Study||0
30785|NCT01938040|73684|P2|COMPLETED|Overall Study||27
30786|NCT01938040|73685|P1|COMPLETED|Overall Study||28
30787|NCT01938040|73684|P2|Behavior Metrics|Overall Study||27
30788|NCT01938040|73685|P1|Behavior Metrics|Overall Study||28
30789|NCT01938040|73684|P2|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|25
30790|NCT01938040|73685|P1|Plasma Analysis|Overall Study|complete set of blood samples could not be obtained|24
30791|NCT01938040|73684|P2|STARTED|Overall Study||27
30792|NCT01938040|73685|P1|STARTED|Overall Study||28
30793|NCT01937975|73714|P3|NOT COMPLETED|Overall Study||0
30794|NCT01937975|73715|P2|NOT COMPLETED|Overall Study||0
30795|NCT01937975|73716|P1|NOT COMPLETED|Overall Study||0
30796|NCT01937975|73714|P3|COMPLETED|Overall Study||8
30797|NCT01937975|73715|P2|COMPLETED|Overall Study||8
30798|NCT01937975|73716|P1|COMPLETED|Overall Study||8
30799|NCT01937975|73714|P3|STARTED|Overall Study||8
30800|NCT01937975|73715|P2|STARTED|Overall Study||8
30801|NCT01937975|73716|P1|STARTED|Overall Study||8
30802|NCT01937871|73766|P3|NOT COMPLETED|Overall Study||11
30803|NCT01937871|73767|P2|NOT COMPLETED|Overall Study||17
30804|NCT01937871|73768|P1|NOT COMPLETED|Overall Study||24
30805|NCT01937871|73766|P3|COMPLETED|Overall Study||174
30806|NCT01937871|73767|P2|COMPLETED|Overall Study||346
30807|NCT01937871|73768|P1|COMPLETED|Overall Study||337
30808|NCT01937871|73766|P3|Received at Least One Dose of Study Drug|Overall Study||185
30809|NCT01937871|73767|P2|Received at Least One Dose of Study Drug|Overall Study||362
30810|NCT01937871|73768|P1|Received at Least One Dose of Study Drug|Overall Study||361
30811|NCT01937871|73766|P3|STARTED|Overall Study||185
30812|NCT01937871|73767|P2|STARTED|Overall Study||363
30813|NCT01937871|73768|P1|STARTED|Overall Study||361
30814|NCT01937715|73844|P5|NOT COMPLETED|Overall Study||2
30815|NCT01937715|73845|P4|NOT COMPLETED|Overall Study||4
30816|NCT01937715|73846|P3|NOT COMPLETED|Overall Study||0
30817|NCT01937715|73847|P2|NOT COMPLETED|Overall Study||1
30818|NCT01937715|73848|P1|NOT COMPLETED|Overall Study||0
30819|NCT01937715|73844|P5|COMPLETED|Overall Study||1
30820|NCT01937715|73845|P4|COMPLETED|Overall Study||1
30821|NCT01937715|73846|P3|COMPLETED|Overall Study||3
30822|NCT01937715|73847|P2|COMPLETED|Overall Study||3
30823|NCT01937715|73848|P1|COMPLETED|Overall Study||3
30824|NCT01937715|73844|P5|STARTED|Overall Study||3
30825|NCT01937715|73845|P4|STARTED|Overall Study||5
30826|NCT01937715|73846|P3|STARTED|Overall Study||3
30827|NCT01937715|73847|P2|STARTED|Overall Study||4
30828|NCT01937715|73848|P1|STARTED|Overall Study||3
30829|NCT01937598|73970|P2|NOT COMPLETED|Overall Study||0
30830|NCT01937598|73971|P1|NOT COMPLETED|Overall Study||0
30831|NCT01937598|73970|P2|COMPLETED|Overall Study||8
30832|NCT01937598|73971|P1|COMPLETED|Overall Study||8
30833|NCT01937598|73970|P2|STARTED|Overall Study||8
30834|NCT01937598|73971|P1|STARTED|Overall Study||8
30835|NCT01937520|73995|P2|NOT COMPLETED|Overall Study||0
30836|NCT01937520|73996|P1|NOT COMPLETED|Overall Study||0
30837|NCT01937520|73995|P2|COMPLETED|Overall Study||9
30838|NCT01937520|73996|P1|COMPLETED|Overall Study||11
30839|NCT01937520|73995|P2|STARTED|Overall Study||9
30840|NCT01937520|73996|P1|STARTED|Overall Study||11
30841|NCT01937364|74034|P2|NOT COMPLETED|Overall Study||1
30842|NCT01937364|74035|P1|NOT COMPLETED|Overall Study||2
30843|NCT01937364|74034|P2|COMPLETED|Overall Study||7
30844|NCT01937364|74035|P1|COMPLETED|Overall Study||7
30845|NCT01937364|74034|P2|STARTED|Overall Study||8
30846|NCT01937364|74035|P1|STARTED|Overall Study||9
30847|NCT01937351|74047|P2|NOT COMPLETED|Overall Study||2
30848|NCT01937351|74048|P1|NOT COMPLETED|Overall Study||9
30849|NCT01937351|74047|P2|COMPLETED|Overall Study||26
30850|NCT01937351|74048|P1|COMPLETED|Overall Study||125
30851|NCT01937351|74047|P2|6-Month Follow-up|Overall Study||26
30852|NCT01937351|74048|P1|6-Month Follow-up|Overall Study||125
30853|NCT01937351|74047|P2|30-Day Follow-up|Overall Study||27
30854|NCT01937351|74048|P1|30-Day Follow-up|Overall Study||128
30855|NCT01937351|74047|P2|Treated w Study Device|Overall Study||28
30856|NCT01937351|74048|P1|Treated w Study Device|Overall Study||130
30857|NCT01937351|74047|P2|STARTED|Overall Study||28
30858|NCT01937351|74048|P1|STARTED|Overall Study||134
30859|NCT01937312|74056|P2|NOT COMPLETED|Overall Study||3
30860|NCT01937312|74057|P1|NOT COMPLETED|Overall Study||11
30861|NCT01937312|74056|P2|COMPLETED|Overall Study||92
30862|NCT01937312|74057|P1|COMPLETED|Overall Study||83
30863|NCT01937312|74056|P2|Treated|Overall Study||95
30864|NCT01937312|74057|P1|Treated|Overall Study||93
30865|NCT01937312|74056|P2|STARTED|Overall Study||95
30866|NCT01937312|74057|P1|STARTED|Overall Study||94
30867|NCT01937299|74072|P2|NOT COMPLETED|Overall Study||4
30868|NCT01937299|74073|P1|NOT COMPLETED|Overall Study||14
30869|NCT01937299|74072|P2|COMPLETED|Overall Study||112
30870|NCT01937299|74073|P1|COMPLETED|Overall Study||103
30871|NCT01937299|74072|P2|STARTED|Overall Study||116
30872|NCT01937299|74073|P1|STARTED|Overall Study||117
30873|NCT01937260|74086|P2|NOT COMPLETED|Overall Study||0
30874|NCT01937260|74087|P1|NOT COMPLETED|Overall Study||1
30875|NCT01937260|74086|P2|COMPLETED|Overall Study||10
30876|NCT01937260|74087|P1|COMPLETED|Overall Study||20
30877|NCT01937260|74086|P2|STARTED|Overall Study||10
30878|NCT01937260|74087|P1|STARTED|Overall Study||21
30879|NCT01937195|74094|P1|NOT COMPLETED|Overall Study||0
30880|NCT01937195|74094|P1|COMPLETED|Overall Study||95
30881|NCT01937195|74094|P1|STARTED|Overall Study||95
30882|NCT01937130|74108|P4|NOT COMPLETED|Overall Study||2
30883|NCT01937130|74109|P3|NOT COMPLETED|Overall Study||3
30884|NCT01937130|74110|P2|NOT COMPLETED|Overall Study||4
30885|NCT01937130|74111|P1|NOT COMPLETED|Overall Study||5
30886|NCT01937130|74108|P4|COMPLETED|Overall Study||2
30887|NCT01937130|74109|P3|COMPLETED|Overall Study||2
30888|NCT01937130|74110|P2|COMPLETED|Overall Study||3
30889|NCT01937130|74111|P1|COMPLETED|Overall Study||0
30890|NCT01937130|74108|P4|STARTED|Overall Study||4
30891|NCT01937130|74109|P3|STARTED|Overall Study||5
30892|NCT01937130|74110|P2|STARTED|Overall Study||7
30893|NCT01937130|74111|P1|STARTED|Overall Study||5
30894|NCT01937026|74138|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||0
30895|NCT01937026|74138|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day 8)||18
30896|NCT01937026|74138|P1|Received Probenecid on Days 3 Through 7|Period 2 (At Dosing Day 3 Through Day 8)||18
30897|NCT01937026|74138|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day 8)||18
30898|NCT01937026|74138|P1|STARTED|Period 2 (At Dosing Day 3 Through Day 8)||18
30899|NCT01937026|74138|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
30900|NCT01937026|74138|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||18
30901|NCT01937026|74138|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||18
30902|NCT01937026|74138|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||18
30903|NCT01936896|74147|P1|NOT COMPLETED|Overall Study||0
30904|NCT01936896|74147|P1|COMPLETED|Overall Study||10
30905|NCT01936896|74147|P1|STARTED|Overall Study||10
30906|NCT01936870|74152|P1|NOT COMPLETED|Overall Study||189
30907|NCT01936870|74152|P1|COMPLETED|Overall Study||2303
30908|NCT01936870|74152|P1|STARTED|Overall Study||2492
30909|NCT01936844|74167|P2|NOT COMPLETED|Overall Study||7
30910|NCT01936844|74168|P1|NOT COMPLETED|Overall Study||6
30911|NCT01936844|74167|P2|COMPLETED|Overall Study||8
30912|NCT01936844|74168|P1|COMPLETED|Overall Study||9
30913|NCT01936844|74167|P2|STARTED|Overall Study||15
30914|NCT01936844|74168|P1|STARTED|Overall Study||15
30915|NCT01936662|74180|P2|NOT COMPLETED|Overall Study||0
30916|NCT01936662|74181|P1|NOT COMPLETED|Overall Study||0
30917|NCT01936662|74180|P2|COMPLETED|Overall Study||42
30918|NCT01936662|74181|P1|COMPLETED|Overall Study||42
30919|NCT01936662|74180|P2|STARTED|Overall Study||42
30920|NCT01936662|74181|P1|STARTED|Overall Study||42
30921|NCT01936649|74189|P1|NOT COMPLETED|Overall Study||13
30922|NCT01936649|74189|P1|COMPLETED|Overall Study||50
30923|NCT01936649|74189|P1|Treated|Overall Study||51
30924|NCT01936649|74189|P1|STARTED|Overall Study||63
30925|NCT01936623|74196|P2|NOT COMPLETED|Overall Study||5
30926|NCT01936623|74197|P1|NOT COMPLETED|Overall Study||0
30927|NCT01936623|74196|P2|COMPLETED|Overall Study||35
30928|NCT01936623|74197|P1|COMPLETED|Overall Study||40
30929|NCT01936623|74196|P2|STARTED|Overall Study||40
30930|NCT01936623|74197|P1|STARTED|Overall Study||40
30931|NCT01936467|74211|P2|NOT COMPLETED|Overall Study||0
30932|NCT01936467|74212|P1|NOT COMPLETED|Overall Study||0
30933|NCT01936467|74211|P2|COMPLETED|Overall Study||61
30934|NCT01936467|74212|P1|COMPLETED|Overall Study||60
30935|NCT01936467|74211|P2|STARTED|Overall Study||61
30936|NCT01936467|74212|P1|STARTED|Overall Study||60
30937|NCT01936389|74232|P2|NOT COMPLETED|Overall Study||0
30938|NCT01936389|74233|P1|NOT COMPLETED|Overall Study||1
30939|NCT01936389|74232|P2|COMPLETED|Overall Study||5
30940|NCT01936389|74233|P1|COMPLETED|Overall Study||4
30941|NCT01936389|74232|P2|STARTED|Overall Study||5
30942|NCT01936389|74233|P1|STARTED|Overall Study||5
30943|NCT01936363|74241|P2|NOT COMPLETED|Overall Study||5
30944|NCT01936363|74242|P1|NOT COMPLETED|Overall Study||7
30945|NCT01936363|74241|P2|COMPLETED|Overall Study||28
30946|NCT01936363|74242|P1|COMPLETED|Overall Study||25
30947|NCT01936363|74241|P2|STARTED|Overall Study||33
30948|NCT01936363|74242|P1|STARTED|Overall Study||32
30949|NCT01936181|74268|P4|NOT COMPLETED|Transition-extension||5
30950|NCT01936181|74269|P3|NOT COMPLETED|Transition-extension||6
30951|NCT01936181|74270|P2|NOT COMPLETED|Transition-extension||0
30952|NCT01936181|74271|P1|NOT COMPLETED|Transition-extension||15
30953|NCT01936181|74268|P4|COMPLETED|Transition-extension||96
30954|NCT01936181|74269|P3|COMPLETED|Transition-extension||88
30955|NCT01936181|74270|P2|COMPLETED|Transition-extension||0
30956|NCT01936181|74271|P1|COMPLETED|Transition-extension||186
30957|NCT01936181|74268|P4|STARTED|Transition-extension||101
30958|NCT01936181|74269|P3|STARTED|Transition-extension||94
30959|NCT01936181|74270|P2|STARTED|Transition-extension||0
30960|NCT01936181|74271|P1|STARTED|Transition-extension||201
30961|NCT01936181|74268|P4|NOT COMPLETED|Randomised, Double-blind||0
30962|NCT01936181|74269|P3|NOT COMPLETED|Randomised, Double-blind||0
30963|NCT01936181|74270|P2|NOT COMPLETED|Randomised, Double-blind||68
30964|NCT01936181|74271|P1|NOT COMPLETED|Randomised, Double-blind||64
30965|NCT01936181|74268|P4|COMPLETED|Randomised, Double-blind||0
30966|NCT01936181|74269|P3|COMPLETED|Randomised, Double-blind||0
30967|NCT01936181|74270|P2|COMPLETED|Randomised, Double-blind||225
30968|NCT01936181|74271|P1|COMPLETED|Randomised, Double-blind||227
30969|NCT01936181|74268|P4|STARTED|Randomised, Double-blind||0
30970|NCT01936181|74269|P3|STARTED|Randomised, Double-blind||0
30971|NCT01936181|74270|P2|STARTED|Randomised, Double-blind||293
30972|NCT01936181|74271|P1|STARTED|Randomised, Double-blind||291
30973|NCT01935622|74285|P3|NOT COMPLETED|Overall Study||0
30974|NCT01935622|74286|P2|NOT COMPLETED|Overall Study||2
30975|NCT01935622|74287|P1|NOT COMPLETED|Overall Study||2
30976|NCT01935622|74285|P3|COMPLETED|Overall Study||4
30977|NCT01935622|74286|P2|COMPLETED|Overall Study||1
30978|NCT01935622|74287|P1|COMPLETED|Overall Study||1
30979|NCT01935622|74285|P3|STARTED|Overall Study||4
30980|NCT01935622|74286|P2|STARTED|Overall Study||3
30981|NCT01935622|74287|P1|STARTED|Overall Study||3
30982|NCT01935180|74297|P2|NOT COMPLETED|Overall Study||14
30983|NCT01935180|74298|P1|NOT COMPLETED|Overall Study||21
30984|NCT01935180|74297|P2|COMPLETED|Overall Study||561
30985|NCT01935180|74298|P1|COMPLETED|Overall Study||552
30986|NCT01935180|74297|P2|STARTED|Overall Study||575
30987|NCT01935180|74298|P1|STARTED|Overall Study||573
30988|NCT01934894|74318|P2|NOT COMPLETED|Overall Study||5
30989|NCT01934894|74319|P1|NOT COMPLETED|Overall Study||6
30990|NCT01934894|74318|P2|COMPLETED|Overall Study||0
30991|NCT01934894|74319|P1|COMPLETED|Overall Study||0
30992|NCT01934894|74318|P2|STARTED|Overall Study||5
30993|NCT01934894|74319|P1|STARTED|Overall Study||6
30994|NCT01934790|74334|P1|NOT COMPLETED|Overall Study||16
30995|NCT01934790|74334|P1|COMPLETED|Overall Study||29
30996|NCT01934790|74334|P1|Participants Received Study Treatment|Overall Study||44
30997|NCT01934790|74334|P1|STARTED|Overall Study|Eligible for treatment|45
30998|NCT01934582|74354|P1|NOT COMPLETED|Overall Study||0
30999|NCT01934582|74354|P1|COMPLETED|Overall Study||13
31000|NCT01934582|74354|P1|STARTED|Overall Study||13
31001|NCT01934517|74368|P1|NOT COMPLETED|Overall Study||0
31002|NCT01934517|74368|P1|COMPLETED|Overall Study||25
31003|NCT01934517|74368|P1|STARTED|Overall Study||25
31004|NCT01934504|74380|P4|NOT COMPLETED|Overall Study||7
31005|NCT01934504|74381|P3|NOT COMPLETED|Overall Study||5
31006|NCT01934504|74382|P2|NOT COMPLETED|Overall Study||0
31007|NCT01934504|74383|P1|NOT COMPLETED|Overall Study||1
31008|NCT01934504|74380|P4|COMPLETED|Overall Study||1
31009|NCT01934504|74381|P3|COMPLETED|Overall Study||11
31010|NCT01934504|74382|P2|COMPLETED|Overall Study||3
31011|NCT01934504|74383|P1|COMPLETED|Overall Study||5
31012|NCT01934504|74380|P4|STARTED|Overall Study||8
31013|NCT01934504|74381|P3|STARTED|Overall Study||16
31014|NCT01934504|74382|P2|STARTED|Overall Study||3
31015|NCT01934504|74383|P1|STARTED|Overall Study||6
31016|NCT01934231|74405|P1|NOT COMPLETED|Overall Study||0
31017|NCT01934231|74405|P1|COMPLETED|Overall Study||27
31018|NCT01934231|74405|P1|STARTED|Overall Study||27
31019|NCT01934218|74416|P2|NOT COMPLETED|Open-Label Phase||24
31020|NCT01934218|74417|P1|NOT COMPLETED|Open-Label Phase||26
31021|NCT01934218|74416|P2|COMPLETED|Open-Label Phase||304
31022|NCT01934218|74417|P1|COMPLETED|Open-Label Phase||290
31023|NCT01934218|74416|P2|STARTED|Open-Label Phase||328
31024|NCT01934218|74417|P1|STARTED|Open-Label Phase||316
31025|NCT01934218|74416|P2|NOT COMPLETED|Double-blind Phase||54
31026|NCT01934218|74417|P1|NOT COMPLETED|Double-blind Phase||48
31027|NCT01934218|74416|P2|COMPLETED|Double-blind Phase||356
31028|NCT01934218|74417|P1|COMPLETED|Double-blind Phase||356
31029|NCT01934218|74416|P2|Analyzed Participants|Double-blind Phase||407
31030|NCT01934218|74417|P1|Analyzed Participants|Double-blind Phase||402
31031|NCT01934218|74416|P2|STARTED|Double-blind Phase||410
31032|NCT01934218|74417|P1|STARTED|Double-blind Phase||404
31033|NCT01933932|74426|P2|NOT COMPLETED|Overall Study||178
31034|NCT01933932|74427|P1|NOT COMPLETED|Overall Study||184
31035|NCT01933932|74426|P2|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|78
31036|NCT01933932|74427|P1|COMPLETED|Overall Study|These were the number of patients who were still ongoing at data cut-off|70
31037|NCT01933932|74426|P2|STARTED|Overall Study||256
31038|NCT01933932|74427|P1|STARTED|Overall Study||254
31039|NCT01933880|74445|P2|NOT COMPLETED|Overall Study||1
31040|NCT01933880|74446|P1|NOT COMPLETED|Overall Study||30
31041|NCT01933880|74445|P2|COMPLETED|Overall Study||40
31042|NCT01933880|74446|P1|COMPLETED|Overall Study||123
31043|NCT01933880|74445|P2|STARTED|Overall Study||41
31044|NCT01933880|74446|P1|STARTED|Overall Study||153
31045|NCT01933776|74513|P2|NOT COMPLETED|Overall Study||0
31046|NCT01933776|74514|P1|NOT COMPLETED|Overall Study||0
31047|NCT01933776|74513|P2|COMPLETED|Overall Study||20
31048|NCT01933776|74514|P1|COMPLETED|Overall Study||20
31049|NCT01933776|74513|P2|STARTED|Overall Study||20
31050|NCT01933776|74514|P1|STARTED|Overall Study||20
31051|NCT01933672|74522|P7|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
31052|NCT01933672|74523|P6|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
31053|NCT01933672|74524|P5|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
31054|NCT01933672|74525|P4|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
31055|NCT01933672|74526|P3|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
31056|NCT01933672|74527|P2|NOT COMPLETED|Third Intervention Period (12-16 Days)||1
31057|NCT01933672|74528|P1|NOT COMPLETED|Third Intervention Period (12-16 Days)||0
31058|NCT01933672|74522|P7|COMPLETED|Third Intervention Period (12-16 Days)||6
31059|NCT01933672|74523|P6|COMPLETED|Third Intervention Period (12-16 Days)||4
31060|NCT01933672|74524|P5|COMPLETED|Third Intervention Period (12-16 Days)||6
31061|NCT01933672|74525|P4|COMPLETED|Third Intervention Period (12-16 Days)||4
31062|NCT01933672|74526|P3|COMPLETED|Third Intervention Period (12-16 Days)||1
31063|NCT01933672|74527|P2|COMPLETED|Third Intervention Period (12-16 Days)||5
31064|NCT01933672|74528|P1|COMPLETED|Third Intervention Period (12-16 Days)||0
31065|NCT01933672|74522|P7|STARTED|Third Intervention Period (12-16 Days)||6
31066|NCT01933672|74523|P6|STARTED|Third Intervention Period (12-16 Days)||4
31067|NCT01933672|74524|P5|STARTED|Third Intervention Period (12-16 Days)||6
31068|NCT01933672|74525|P4|STARTED|Third Intervention Period (12-16 Days)||5
31069|NCT01933672|74526|P3|STARTED|Third Intervention Period (12-16 Days)||1
31070|NCT01933672|74527|P2|STARTED|Third Intervention Period (12-16 Days)||6
31071|NCT01933672|74528|P1|STARTED|Third Intervention Period (12-16 Days)||0
31072|NCT01933672|74522|P7|NOT COMPLETED|Second Washout Period (7-14 Days)||0
31073|NCT01933672|74523|P6|NOT COMPLETED|Second Washout Period (7-14 Days)||0
31074|NCT01933672|74524|P5|NOT COMPLETED|Second Washout Period (7-14 Days)||0
31075|NCT01933672|74525|P4|NOT COMPLETED|Second Washout Period (7-14 Days)||0
31076|NCT01933672|74526|P3|NOT COMPLETED|Second Washout Period (7-14 Days)||0
31077|NCT01933672|74527|P2|NOT COMPLETED|Second Washout Period (7-14 Days)||0
31078|NCT01933672|74528|P1|NOT COMPLETED|Second Washout Period (7-14 Days)||0
31079|NCT01933672|74522|P7|COMPLETED|Second Washout Period (7-14 Days)||6
31080|NCT01933672|74523|P6|COMPLETED|Second Washout Period (7-14 Days)||4
31081|NCT01933672|74524|P5|COMPLETED|Second Washout Period (7-14 Days)||6
31082|NCT01933672|74525|P4|COMPLETED|Second Washout Period (7-14 Days)||5
31083|NCT01933672|74526|P3|COMPLETED|Second Washout Period (7-14 Days)||1
31084|NCT01933672|74527|P2|COMPLETED|Second Washout Period (7-14 Days)||6
31085|NCT01933672|74528|P1|COMPLETED|Second Washout Period (7-14 Days)||0
31086|NCT01933672|74522|P7|STARTED|Second Washout Period (7-14 Days)||6
31087|NCT01933672|74523|P6|STARTED|Second Washout Period (7-14 Days)||4
31088|NCT01933672|74524|P5|STARTED|Second Washout Period (7-14 Days)||6
31089|NCT01933672|74525|P4|STARTED|Second Washout Period (7-14 Days)||5
31090|NCT01933672|74526|P3|STARTED|Second Washout Period (7-14 Days)||1
31091|NCT01933672|74527|P2|STARTED|Second Washout Period (7-14 Days)||6
31092|NCT01933672|74528|P1|STARTED|Second Washout Period (7-14 Days)||0
31093|NCT01933672|74522|P7|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
31094|NCT01933672|74523|P6|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
31095|NCT01933672|74524|P5|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
31096|NCT01933672|74525|P4|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
31097|NCT01933672|74526|P3|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
31098|NCT01933672|74527|P2|NOT COMPLETED|Second Intervention Period (12-16 Days)||1
31099|NCT01933672|74528|P1|NOT COMPLETED|Second Intervention Period (12-16 Days)||0
31100|NCT01933672|74522|P7|COMPLETED|Second Intervention Period (12-16 Days)||6
31101|NCT01933672|74523|P6|COMPLETED|Second Intervention Period (12-16 Days)||4
31102|NCT01933672|74524|P5|COMPLETED|Second Intervention Period (12-16 Days)||6
31103|NCT01933672|74525|P4|COMPLETED|Second Intervention Period (12-16 Days)||5
31104|NCT01933672|74526|P3|COMPLETED|Second Intervention Period (12-16 Days)||1
31105|NCT01933672|74527|P2|COMPLETED|Second Intervention Period (12-16 Days)||6
31106|NCT01933672|74528|P1|COMPLETED|Second Intervention Period (12-16 Days)||0
31107|NCT01933672|74522|P7|STARTED|Second Intervention Period (12-16 Days)||6
31108|NCT01933672|74523|P6|STARTED|Second Intervention Period (12-16 Days)||4
31109|NCT01933672|74524|P5|STARTED|Second Intervention Period (12-16 Days)||6
31110|NCT01933672|74525|P4|STARTED|Second Intervention Period (12-16 Days)||5
31111|NCT01933672|74526|P3|STARTED|Second Intervention Period (12-16 Days)||2
31112|NCT01933672|74527|P2|STARTED|Second Intervention Period (12-16 Days)||7
31113|NCT01933672|74528|P1|STARTED|Second Intervention Period (12-16 Days)||0
31114|NCT01933672|74522|P7|NOT COMPLETED|First Washout Period (7-14 Days)||0
31115|NCT01933672|74523|P6|NOT COMPLETED|First Washout Period (7-14 Days)||0
31116|NCT01933672|74524|P5|NOT COMPLETED|First Washout Period (7-14 Days)||0
31117|NCT01933672|74525|P4|NOT COMPLETED|First Washout Period (7-14 Days)||0
31118|NCT01933672|74526|P3|NOT COMPLETED|First Washout Period (7-14 Days)||0
31119|NCT01933672|74527|P2|NOT COMPLETED|First Washout Period (7-14 Days)||0
31120|NCT01933672|74528|P1|NOT COMPLETED|First Washout Period (7-14 Days)||0
31121|NCT01933672|74522|P7|COMPLETED|First Washout Period (7-14 Days)||6
31122|NCT01933672|74523|P6|COMPLETED|First Washout Period (7-14 Days)||4
31123|NCT01933672|74524|P5|COMPLETED|First Washout Period (7-14 Days)||6
31124|NCT01933672|74525|P4|COMPLETED|First Washout Period (7-14 Days)||5
31125|NCT01933672|74526|P3|COMPLETED|First Washout Period (7-14 Days)||2
31126|NCT01933672|74527|P2|COMPLETED|First Washout Period (7-14 Days)||7
31127|NCT01933672|74528|P1|COMPLETED|First Washout Period (7-14 Days)||0
31128|NCT01933672|74522|P7|STARTED|First Washout Period (7-14 Days)||6
31129|NCT01933672|74523|P6|STARTED|First Washout Period (7-14 Days)||4
31130|NCT01933672|74524|P5|STARTED|First Washout Period (7-14 Days)||6
31131|NCT01933672|74525|P4|STARTED|First Washout Period (7-14 Days)||5
31132|NCT01933672|74526|P3|STARTED|First Washout Period (7-14 Days)||2
31133|NCT01933672|74527|P2|STARTED|First Washout Period (7-14 Days)||7
31134|NCT01933672|74528|P1|STARTED|First Washout Period (7-14 Days)||0
31135|NCT01933672|74522|P7|NOT COMPLETED|First Intervention Period (12-16 Days)||0
31136|NCT01933672|74523|P6|NOT COMPLETED|First Intervention Period (12-16 Days)||1
31137|NCT01933672|74524|P5|NOT COMPLETED|First Intervention Period (12-16 Days)||1
31138|NCT01933672|74525|P4|NOT COMPLETED|First Intervention Period (12-16 Days)||0
31139|NCT01933672|74526|P3|NOT COMPLETED|First Intervention Period (12-16 Days)||1
31140|NCT01933672|74527|P2|NOT COMPLETED|First Intervention Period (12-16 Days)||0
31141|NCT01933672|74528|P1|NOT COMPLETED|First Intervention Period (12-16 Days)||0
31142|NCT01933672|74522|P7|COMPLETED|First Intervention Period (12-16 Days)||6
31143|NCT01933672|74523|P6|COMPLETED|First Intervention Period (12-16 Days)||4
31144|NCT01933672|74524|P5|COMPLETED|First Intervention Period (12-16 Days)||6
31145|NCT01933672|74525|P4|COMPLETED|First Intervention Period (12-16 Days)||5
31146|NCT01933672|74526|P3|COMPLETED|First Intervention Period (12-16 Days)||2
31147|NCT01933672|74527|P2|COMPLETED|First Intervention Period (12-16 Days)||7
31148|NCT01933672|74528|P1|COMPLETED|First Intervention Period (12-16 Days)||0
31149|NCT01933672|74522|P7|STARTED|First Intervention Period (12-16 Days)||6
31150|NCT01933672|74523|P6|STARTED|First Intervention Period (12-16 Days)||5
31151|NCT01933672|74524|P5|STARTED|First Intervention Period (12-16 Days)||7
31152|NCT01933672|74525|P4|STARTED|First Intervention Period (12-16 Days)||5
31153|NCT01933672|74526|P3|STARTED|First Intervention Period (12-16 Days)||3
31154|NCT01933672|74527|P2|STARTED|First Intervention Period (12-16 Days)||7
31155|NCT01933672|74528|P1|STARTED|First Intervention Period (12-16 Days)||0
31156|NCT01933672|74522|P7|NOT COMPLETED|Metformin Run-in Period||0
31157|NCT01933672|74523|P6|NOT COMPLETED|Metformin Run-in Period||0
31158|NCT01933672|74524|P5|NOT COMPLETED|Metformin Run-in Period||0
31159|NCT01933672|74525|P4|NOT COMPLETED|Metformin Run-in Period||0
31160|NCT01933672|74526|P3|NOT COMPLETED|Metformin Run-in Period||0
31161|NCT01933672|74527|P2|NOT COMPLETED|Metformin Run-in Period||0
31162|NCT01933672|74528|P1|NOT COMPLETED|Metformin Run-in Period||10
31163|NCT01933672|74522|P7|COMPLETED|Metformin Run-in Period||0
31164|NCT01933672|74523|P6|COMPLETED|Metformin Run-in Period||0
31165|NCT01933672|74524|P5|COMPLETED|Metformin Run-in Period||0
31166|NCT01933672|74525|P4|COMPLETED|Metformin Run-in Period||0
31167|NCT01933672|74526|P3|COMPLETED|Metformin Run-in Period||0
31168|NCT01933672|74527|P2|COMPLETED|Metformin Run-in Period||0
31169|NCT01933672|74528|P1|COMPLETED|Metformin Run-in Period||33
31170|NCT01933672|74522|P7|Received Treatment|Metformin Run-in Period||0
31171|NCT01933672|74523|P6|Received Treatment|Metformin Run-in Period||0
31172|NCT01933672|74524|P5|Received Treatment|Metformin Run-in Period||0
31173|NCT01933672|74525|P4|Received Treatment|Metformin Run-in Period||0
31174|NCT01933672|74526|P3|Received Treatment|Metformin Run-in Period||0
31175|NCT01933672|74527|P2|Received Treatment|Metformin Run-in Period||0
31176|NCT01933672|74528|P1|Received Treatment|Metformin Run-in Period||43
31177|NCT01933672|74522|P7|STARTED|Metformin Run-in Period||0
31178|NCT01933672|74523|P6|STARTED|Metformin Run-in Period||0
31179|NCT01933672|74524|P5|STARTED|Metformin Run-in Period||0
31180|NCT01933672|74525|P4|STARTED|Metformin Run-in Period||0
31181|NCT01933672|74526|P3|STARTED|Metformin Run-in Period||0
31182|NCT01933672|74527|P2|STARTED|Metformin Run-in Period||0
31183|NCT01933672|74528|P1|STARTED|Metformin Run-in Period||43
31184|NCT01933425|74574|P2|NOT COMPLETED|Overall Study||0
31185|NCT01933425|74575|P1|NOT COMPLETED|Overall Study||0
31186|NCT01933425|74574|P2|COMPLETED|Overall Study||7
31187|NCT01933425|74575|P1|COMPLETED|Overall Study||7
31188|NCT01933425|74574|P2|STARTED|Overall Study||7
31189|NCT01933425|74575|P1|STARTED|Overall Study||7
31190|NCT01933399|74588|P3|NOT COMPLETED|Overall Study||0
31191|NCT01933399|74589|P2|NOT COMPLETED|Overall Study||0
31192|NCT01933399|74590|P1|NOT COMPLETED|Overall Study||0
31193|NCT01933399|74588|P3|COMPLETED|Overall Study||37
31194|NCT01933399|74589|P2|COMPLETED|Overall Study||32
31195|NCT01933399|74590|P1|COMPLETED|Overall Study||29
31196|NCT01933399|74588|P3|STARTED|Overall Study||37
31197|NCT01933399|74589|P2|STARTED|Overall Study||32
31198|NCT01933399|74590|P1|STARTED|Overall Study||29
31199|NCT01933334|74603|P2|NOT COMPLETED|Overall Study||2
31200|NCT01933334|74604|P1|NOT COMPLETED|Overall Study||5
31201|NCT01933334|74603|P2|COMPLETED|Overall Study||29
31202|NCT01933334|74604|P1|COMPLETED|Overall Study||27
31203|NCT01933334|74603|P2|STARTED|Overall Study||31
31204|NCT01933334|74604|P1|STARTED|Overall Study||32
31205|NCT01933230|74614|P1|NOT COMPLETED|Overall Study||0
31206|NCT01933230|74614|P1|COMPLETED|Overall Study||2
31207|NCT01933230|74614|P1|STARTED|Overall Study||2
31208|NCT01932970|74618|P1|NOT COMPLETED|Overall Study||18
31209|NCT01932970|74618|P1|COMPLETED|Overall Study||140
31210|NCT01932970|74618|P1|Received Treatment|Overall Study|Includes participants who completed the washout period and received etelcalcetide|148
31211|NCT01932970|74618|P1|STARTED|Overall Study|Includes all participants who enrolled into the washout period.|158
31212|NCT01932762|74630|P4|NOT COMPLETED|Overall Study||1
31213|NCT01932762|74631|P3|NOT COMPLETED|Overall Study||0
31214|NCT01932762|74632|P2|NOT COMPLETED|Overall Study||2
31215|NCT01932762|74633|P1|NOT COMPLETED|Overall Study||6
31216|NCT01932762|74630|P4|COMPLETED|Overall Study||18
31217|NCT01932762|74631|P3|COMPLETED|Overall Study||19
31218|NCT01932762|74632|P2|COMPLETED|Overall Study||28
31219|NCT01932762|74633|P1|COMPLETED|Overall Study||24
31220|NCT01932762|74630|P4|STARTED|Overall Study||19
31221|NCT01932762|74631|P3|STARTED|Overall Study||19
31222|NCT01932762|74632|P2|STARTED|Overall Study||30
31223|NCT01932762|74633|P1|STARTED|Overall Study||30
31224|NCT01932606|74669|P2|NOT COMPLETED|Overall Study||0
31225|NCT01932606|74670|P1|NOT COMPLETED|Overall Study||0
31226|NCT01932606|74669|P2|COMPLETED|Overall Study||14
31227|NCT01932606|74670|P1|COMPLETED|Overall Study||14
31228|NCT01932606|74669|P2|STARTED|Overall Study||14
31229|NCT01932606|74670|P1|STARTED|Overall Study||14
31230|NCT01932164|74720|P1|NOT COMPLETED|Overall Study||0
31231|NCT01932164|74720|P1|COMPLETED|Overall Study|In all 5 patients we observed bone formation closing the alveolar cleft after 6 months|5
31232|NCT01932164|74720|P1|Cleft Lip and Palate|Overall Study|The surgeries were performed between december 2013 and june 2014.|5
31233|NCT01932164|74720|P1|Cleft Lip and Palate|Overall Study|Alveolar bone graft surgeries were did using their dental pulp stem cells with biomaterial|5
31234|NCT01932164|74720|P1|Cleft Lip and Palate|Overall Study|Mesenchymal stem cell obtained from dental pulp of 5patients was obtained, caractherized and frozen|5
31235|NCT01932164|74720|P1|Cleft Lip and Palate|Overall Study|Dental pulp was obtained from teeth of 5 different patients (09/2013)|5
31236|NCT01932164|74720|P1|Cleft Lip and Palate|Overall Study|It was performed de extraction of deciduous teeth of 5 cleft lip/palate patients (09/2013)|5
31237|NCT01932164|74720|P1|STARTED|Overall Study|It was performed the selection of 5 patients to participate of these study (08/2013)|5
31238|NCT01932112|74724|P1|NOT COMPLETED|Overall Study||0
31239|NCT01932112|74724|P1|COMPLETED|Overall Study||378
31240|NCT01932112|74724|P1|STARTED|Overall Study||378
31241|NCT01932060|74730|P2|NOT COMPLETED|Overall Study||0
31242|NCT01932060|74731|P1|NOT COMPLETED|Overall Study||0
31243|NCT01932060|74730|P2|COMPLETED|Overall Study||24
31244|NCT01932060|74731|P1|COMPLETED|Overall Study||27
31245|NCT01932060|74730|P2|STARTED|Overall Study||24
31246|NCT01932060|74731|P1|STARTED|Overall Study||27
31247|NCT01931956|74741|P2|NOT COMPLETED|Overall Study||6
31248|NCT01931956|74742|P1|NOT COMPLETED|Overall Study||23
31249|NCT01931956|74741|P2|COMPLETED|Overall Study||1
31250|NCT01931956|74742|P1|COMPLETED|Overall Study||36
31251|NCT01931956|74741|P2|STARTED|Overall Study||7
31252|NCT01931956|74742|P1|STARTED|Overall Study||59
31253|NCT01931878|74788|P2|NOT COMPLETED|Second Intervention (After 3 Months)||2
31254|NCT01931878|74789|P1|NOT COMPLETED|Second Intervention (After 3 Months)||0
31255|NCT01931878|74788|P2|COMPLETED|Second Intervention (After 3 Months)||12
31256|NCT01931878|74789|P1|COMPLETED|Second Intervention (After 3 Months)||9
31257|NCT01931878|74788|P2|STARTED|Second Intervention (After 3 Months)||14
31258|NCT01931878|74789|P1|STARTED|Second Intervention (After 3 Months)||9
31259|NCT01931878|74788|P2|NOT COMPLETED|First Intervention||0
31260|NCT01931878|74789|P1|NOT COMPLETED|First Intervention||1
31261|NCT01931878|74788|P2|COMPLETED|First Intervention||14
31262|NCT01931878|74789|P1|COMPLETED|First Intervention||9
31263|NCT01931878|74788|P2|STARTED|First Intervention||14
31264|NCT01931878|74789|P1|STARTED|First Intervention||10
31265|NCT01931865|74799|P1|NOT COMPLETED|Overall Study||4
31266|NCT01931865|74799|P1|COMPLETED|Overall Study||8
31267|NCT01931865|74799|P1|STARTED|Overall Study||12
31268|NCT01931839|74812|P7|NOT COMPLETED|Overall Study||4
31269|NCT01931839|74813|P6|NOT COMPLETED|Overall Study||5
31270|NCT01931839|74814|P5|NOT COMPLETED|Overall Study||1
31271|NCT01931839|74815|P4|NOT COMPLETED|Overall Study||14
31272|NCT01931839|74816|P3|NOT COMPLETED|Overall Study||39
31273|NCT01931839|74817|P2|NOT COMPLETED|Overall Study||26
31274|NCT01931839|74818|P1|NOT COMPLETED|Overall Study||41
31275|NCT01931839|74812|P7|COMPLETED|Overall Study||56
31276|NCT01931839|74813|P6|COMPLETED|Overall Study||50
31277|NCT01931839|74814|P5|COMPLETED|Overall Study||18
31278|NCT01931839|74815|P4|COMPLETED|Overall Study||162
31279|NCT01931839|74816|P3|COMPLETED|Overall Study||301
31280|NCT01931839|74817|P2|COMPLETED|Overall Study||152
31281|NCT01931839|74818|P1|COMPLETED|Overall Study||294
31282|NCT01931839|74812|P7|Safety Analysis Set (As Dosed)|Overall Study||60
31283|NCT01931839|74813|P6|Safety Analysis Set (As Dosed)|Overall Study||55
31284|NCT01931839|74814|P5|Safety Analysis Set (As Dosed)|Overall Study||19
31285|NCT01931839|74815|P4|Safety Analysis Set (As Dosed)|Overall Study||176
31286|NCT01931839|74816|P3|Safety Analysis Set (As Dosed)|Overall Study||340
31287|NCT01931839|74817|P2|Safety Analysis Set (As Dosed)|Overall Study||178
31288|NCT01931839|74818|P1|Safety Analysis Set (As Dosed)|Overall Study||335
31289|NCT01931839|74812|P7|Full Analysis Set (As Randomized)|Overall Study||60
31290|NCT01931839|74813|P6|Full Analysis Set (As Randomized)|Overall Study||55
31291|NCT01931839|74814|P5|Full Analysis Set (As Randomized)|Overall Study||19
31292|NCT01931839|74815|P4|Full Analysis Set (As Randomized)|Overall Study||176
31293|NCT01931839|74816|P3|Full Analysis Set (As Randomized)|Overall Study||340
31294|NCT01931839|74817|P2|Full Analysis Set (As Randomized)|Overall Study||179
31295|NCT01931839|74818|P1|Full Analysis Set (As Randomized)|Overall Study||334
31296|NCT01931839|74812|P7|STARTED|Overall Study||60
31297|NCT01931839|74813|P6|STARTED|Overall Study||55
31298|NCT01931839|74814|P5|STARTED|Overall Study||19
31299|NCT01931839|74815|P4|STARTED|Overall Study||176
31300|NCT01931839|74816|P3|STARTED|Overall Study||340
31301|NCT01931839|74817|P2|STARTED|Overall Study||178
31302|NCT01931839|74818|P1|STARTED|Overall Study||335
31303|NCT01931709|74886|P1|NOT COMPLETED|Overall Study||0
31304|NCT01931709|74886|P1|COMPLETED|Overall Study||35
31305|NCT01931709|74886|P1|STARTED|Overall Study||35
31306|NCT01931527|74898|P2|NOT COMPLETED|Overall Study||0
31307|NCT01931527|74899|P1|NOT COMPLETED|Overall Study||0
31308|NCT01931527|74898|P2|COMPLETED|Overall Study||15
31309|NCT01931527|74899|P1|COMPLETED|Overall Study||16
31310|NCT01931527|74898|P2|STARTED|Overall Study||15
31311|NCT01931527|74899|P1|STARTED|Overall Study||16
31312|NCT01931475|74909|P2|NOT COMPLETED|Period 2: Extension Treatment Phase||19
31313|NCT01931475|74910|P1|NOT COMPLETED|Period 2: Extension Treatment Phase||4
31314|NCT01931475|74909|P2|COMPLETED|Period 2: Extension Treatment Phase||157
31315|NCT01931475|74910|P1|COMPLETED|Period 2: Extension Treatment Phase||162
31316|NCT01931475|74909|P2|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||175
31317|NCT01931475|74910|P1|Received at Least 1 Dose of Study Drug|Period 2: Extension Treatment Phase||166
31318|NCT01931475|74909|P2|STARTED|Period 2: Extension Treatment Phase||176
31319|NCT01931475|74910|P1|STARTED|Period 2: Extension Treatment Phase||166
31320|NCT01931475|74909|P2|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||26
31321|NCT01931475|74910|P1|NOT COMPLETED|Period 1: Double-Blind Treatment Phase||39
31322|NCT01931475|74909|P2|COMPLETED|Period 1: Double-Blind Treatment Phase||176
31323|NCT01931475|74910|P1|COMPLETED|Period 1: Double-Blind Treatment Phase||166
31324|NCT01931475|74909|P2|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||198
31325|NCT01931475|74910|P1|Received at Least 1 Dose of Study Drug|Period 1: Double-Blind Treatment Phase||199
31326|NCT01931475|74909|P2|STARTED|Period 1: Double-Blind Treatment Phase||202
31327|NCT01931475|74910|P1|STARTED|Period 1: Double-Blind Treatment Phase||205
31328|NCT01931397|74937|P1|NOT COMPLETED|Overall Study||11
31329|NCT01931397|74937|P1|COMPLETED|Overall Study||19
31330|NCT01931397|74937|P1|STARTED|Overall Study||30
31331|NCT01931150|74948|P2|NOT COMPLETED|Overall Study||2
31332|NCT01931150|74949|P1|NOT COMPLETED|Overall Study||1
31333|NCT01931150|74948|P2|COMPLETED|Overall Study||4
31334|NCT01931150|74949|P1|COMPLETED|Overall Study||4
31335|NCT01931150|74948|P2|STARTED|Overall Study||6
31336|NCT01931150|74949|P1|STARTED|Overall Study||5
31337|NCT01930890|74959|P4|NOT COMPLETED|Overall Study||27
31338|NCT01930890|74960|P3|NOT COMPLETED|Overall Study||13
31339|NCT01930890|74961|P2|NOT COMPLETED|Overall Study||33
31340|NCT01930890|74962|P1|NOT COMPLETED|Overall Study||14
31341|NCT01930890|74959|P4|COMPLETED|Overall Study||0
31342|NCT01930890|74960|P3|COMPLETED|Overall Study||0
31343|NCT01930890|74961|P2|COMPLETED|Overall Study||0
31344|NCT01930890|74962|P1|COMPLETED|Overall Study||0
31345|NCT01930890|74959|P4|STARTED|Overall Study||27
31346|NCT01930890|74960|P3|STARTED|Overall Study||13
31347|NCT01930890|74961|P2|STARTED|Overall Study||33
31348|NCT01930890|74962|P1|STARTED|Overall Study||14
31349|NCT01930799|74976|P1|NOT COMPLETED|Overall Study||8
31350|NCT01930799|74976|P1|COMPLETED|Overall Study||112
31351|NCT01930799|74976|P1|STARTED|Overall Study||120
31352|NCT01930487|74981|P2|NOT COMPLETED|Second Intervention (30 Days)||0
31353|NCT01930487|74982|P1|NOT COMPLETED|Second Intervention (30 Days)||0
31354|NCT01930487|74981|P2|COMPLETED|Second Intervention (30 Days)||23
31355|NCT01930487|74982|P1|COMPLETED|Second Intervention (30 Days)||19
31356|NCT01930487|74981|P2|STARTED|Second Intervention (30 Days)||23
31357|NCT01930487|74982|P1|STARTED|Second Intervention (30 Days)||19
31358|NCT01930487|74981|P2|NOT COMPLETED|Washout Period (3 Weeks)||0
31359|NCT01930487|74982|P1|NOT COMPLETED|Washout Period (3 Weeks)||0
31360|NCT01930487|74981|P2|COMPLETED|Washout Period (3 Weeks)||23
31361|NCT01930487|74982|P1|COMPLETED|Washout Period (3 Weeks)||19
31362|NCT01930487|74981|P2|STARTED|Washout Period (3 Weeks)||23
31363|NCT01930487|74982|P1|STARTED|Washout Period (3 Weeks)||19
31364|NCT01930487|74981|P2|NOT COMPLETED|First Intervention (30 Days)||2
31365|NCT01930487|74982|P1|NOT COMPLETED|First Intervention (30 Days)||2
31366|NCT01930487|74981|P2|COMPLETED|First Intervention (30 Days)||23
31367|NCT01930487|74982|P1|COMPLETED|First Intervention (30 Days)||19
31368|NCT01930487|74981|P2|STARTED|First Intervention (30 Days)||25
31369|NCT01930487|74982|P1|STARTED|First Intervention (30 Days)||21
31370|NCT01930435|75076|P1|NOT COMPLETED|Overall Study||0
31371|NCT01930435|75076|P1|COMPLETED|Overall Study||20
31372|NCT01930435|75076|P1|STARTED|Overall Study||20
31373|NCT01930162|75084|P1|NOT COMPLETED|Overall Study||5
31374|NCT01930162|75084|P1|COMPLETED|Overall Study||4
31375|NCT01930162|75084|P1|STARTED|Overall Study||9
31376|NCT01930058|75096|P3|NOT COMPLETED|Overall Study||0
31377|NCT01930058|75097|P2|NOT COMPLETED|Overall Study||0
31378|NCT01930058|75098|P1|NOT COMPLETED|Overall Study||0
31379|NCT01930058|75096|P3|COMPLETED|Overall Study||3
31380|NCT01930058|75097|P2|COMPLETED|Overall Study||3
31381|NCT01930058|75098|P1|COMPLETED|Overall Study||3
31382|NCT01930058|75096|P3|STARTED|Overall Study||3
31383|NCT01930058|75097|P2|STARTED|Overall Study||3
31384|NCT01930058|75098|P1|STARTED|Overall Study||3
31385|NCT01930045|75120|P6|NOT COMPLETED|Part 2 - Period 5||0
31386|NCT01930045|75121|P5|NOT COMPLETED|Part 2 - Period 5||0
31387|NCT01930045|75122|P4|NOT COMPLETED|Part 2 - Period 5||0
31388|NCT01930045|75123|P3|NOT COMPLETED|Part 2 - Period 5||0
31389|NCT01930045|75124|P2|NOT COMPLETED|Part 2 - Period 5||0
31390|NCT01930045|75125|P1|NOT COMPLETED|Part 2 - Period 5||0
31391|NCT01930045|75120|P6|COMPLETED|Part 2 - Period 5||1
31392|NCT01930045|75121|P5|COMPLETED|Part 2 - Period 5||3
31393|NCT01930045|75122|P4|COMPLETED|Part 2 - Period 5||3
31394|NCT01930045|75123|P3|COMPLETED|Part 2 - Period 5||3
31395|NCT01930045|75124|P2|COMPLETED|Part 2 - Period 5||3
31396|NCT01930045|75125|P1|COMPLETED|Part 2 - Period 5||3
31397|NCT01930045|75120|P6|STARTED|Part 2 - Period 5||1
31398|NCT01930045|75121|P5|STARTED|Part 2 - Period 5||3
31399|NCT01930045|75122|P4|STARTED|Part 2 - Period 5||3
31400|NCT01930045|75123|P3|STARTED|Part 2 - Period 5||3
31401|NCT01930045|75124|P2|STARTED|Part 2 - Period 5||3
31402|NCT01930045|75125|P1|STARTED|Part 2 - Period 5||3
31403|NCT01930045|75120|P6|NOT COMPLETED|Part 2 - Period 4||0
31404|NCT01930045|75121|P5|NOT COMPLETED|Part 2 - Period 4||0
31405|NCT01930045|75122|P4|NOT COMPLETED|Part 2 - Period 4||0
31406|NCT01930045|75123|P3|NOT COMPLETED|Part 2 - Period 4||0
31407|NCT01930045|75124|P2|NOT COMPLETED|Part 2 - Period 4||0
31408|NCT01930045|75125|P1|NOT COMPLETED|Part 2 - Period 4||0
31409|NCT01930045|75120|P6|COMPLETED|Part 2 - Period 4||1
31410|NCT01930045|75121|P5|COMPLETED|Part 2 - Period 4||3
31411|NCT01930045|75122|P4|COMPLETED|Part 2 - Period 4||3
31412|NCT01930045|75123|P3|COMPLETED|Part 2 - Period 4||3
31413|NCT01930045|75124|P2|COMPLETED|Part 2 - Period 4||3
31414|NCT01930045|75125|P1|COMPLETED|Part 2 - Period 4||3
31415|NCT01930045|75120|P6|STARTED|Part 2 - Period 4||1
31416|NCT01930045|75121|P5|STARTED|Part 2 - Period 4||3
31417|NCT01930045|75122|P4|STARTED|Part 2 - Period 4||3
31418|NCT01930045|75123|P3|STARTED|Part 2 - Period 4||3
31419|NCT01930045|75124|P2|STARTED|Part 2 - Period 4||3
31420|NCT01930045|75125|P1|STARTED|Part 2 - Period 4||3
31421|NCT01930045|75120|P6|NOT COMPLETED|Pause (up to 37 Days)||2
31422|NCT01930045|75121|P5|NOT COMPLETED|Pause (up to 37 Days)||0
31423|NCT01930045|75122|P4|NOT COMPLETED|Pause (up to 37 Days)||0
31424|NCT01930045|75123|P3|NOT COMPLETED|Pause (up to 37 Days)||0
31425|NCT01930045|75124|P2|NOT COMPLETED|Pause (up to 37 Days)||0
31426|NCT01930045|75125|P1|NOT COMPLETED|Pause (up to 37 Days)||0
31427|NCT01930045|75120|P6|COMPLETED|Pause (up to 37 Days)||1
31428|NCT01930045|75121|P5|COMPLETED|Pause (up to 37 Days)||3
31429|NCT01930045|75122|P4|COMPLETED|Pause (up to 37 Days)||3
31430|NCT01930045|75123|P3|COMPLETED|Pause (up to 37 Days)||3
31431|NCT01930045|75124|P2|COMPLETED|Pause (up to 37 Days)||3
31432|NCT01930045|75125|P1|COMPLETED|Pause (up to 37 Days)||3
31433|NCT01930045|75120|P6|STARTED|Pause (up to 37 Days)||3
31434|NCT01930045|75121|P5|STARTED|Pause (up to 37 Days)||3
31435|NCT01930045|75122|P4|STARTED|Pause (up to 37 Days)||3
31436|NCT01930045|75123|P3|STARTED|Pause (up to 37 Days)|The participant who missed treatment in Period 3, resumed the study|3
31437|NCT01930045|75124|P2|STARTED|Pause (up to 37 Days)||3
31438|NCT01930045|75125|P1|STARTED|Pause (up to 37 Days)||3
31439|NCT01930045|75120|P6|NOT COMPLETED|Part 1 - Period 3||0
31440|NCT01930045|75121|P5|NOT COMPLETED|Part 1 - Period 3||0
31441|NCT01930045|75122|P4|NOT COMPLETED|Part 1 - Period 3||0
31442|NCT01930045|75123|P3|NOT COMPLETED|Part 1 - Period 3||0
31443|NCT01930045|75124|P2|NOT COMPLETED|Part 1 - Period 3||0
31444|NCT01930045|75125|P1|NOT COMPLETED|Part 1 - Period 3||0
31445|NCT01930045|75120|P6|COMPLETED|Part 1 - Period 3||3
31446|NCT01930045|75121|P5|COMPLETED|Part 1 - Period 3||3
31447|NCT01930045|75122|P4|COMPLETED|Part 1 - Period 3||3
31448|NCT01930045|75123|P3|COMPLETED|Part 1 - Period 3||2
31449|NCT01930045|75124|P2|COMPLETED|Part 1 - Period 3||3
31450|NCT01930045|75125|P1|COMPLETED|Part 1 - Period 3||3
31451|NCT01930045|75120|P6|STARTED|Part 1 - Period 3||3
31452|NCT01930045|75121|P5|STARTED|Part 1 - Period 3||3
31453|NCT01930045|75122|P4|STARTED|Part 1 - Period 3||3
31454|NCT01930045|75123|P3|STARTED|Part 1 - Period 3|One participant missed treatment during Period 3 only.|2
31455|NCT01930045|75124|P2|STARTED|Part 1 - Period 3||3
31456|NCT01930045|75125|P1|STARTED|Part 1 - Period 3||3
31457|NCT01930045|75120|P6|NOT COMPLETED|Part 1 - Period 2||0
31458|NCT01930045|75121|P5|NOT COMPLETED|Part 1 - Period 2||0
31459|NCT01930045|75122|P4|NOT COMPLETED|Part 1 - Period 2||0
31460|NCT01930045|75123|P3|NOT COMPLETED|Part 1 - Period 2||0
31461|NCT01930045|75124|P2|NOT COMPLETED|Part 1 - Period 2||0
31462|NCT01930045|75125|P1|NOT COMPLETED|Part 1 - Period 2||0
31463|NCT01930045|75120|P6|COMPLETED|Part 1 - Period 2||3
31464|NCT01930045|75121|P5|COMPLETED|Part 1 - Period 2||3
31465|NCT01930045|75122|P4|COMPLETED|Part 1 - Period 2||3
31466|NCT01930045|75123|P3|COMPLETED|Part 1 - Period 2||3
31467|NCT01930045|75124|P2|COMPLETED|Part 1 - Period 2||3
31468|NCT01930045|75125|P1|COMPLETED|Part 1 - Period 2||3
31469|NCT01930045|75120|P6|STARTED|Part 1 - Period 2||3
31470|NCT01930045|75121|P5|STARTED|Part 1 - Period 2||3
31471|NCT01930045|75122|P4|STARTED|Part 1 - Period 2||3
31472|NCT01930045|75123|P3|STARTED|Part 1 - Period 2||3
31473|NCT01930045|75124|P2|STARTED|Part 1 - Period 2||3
31474|NCT01930045|75125|P1|STARTED|Part 1 - Period 2||3
31475|NCT01930045|75120|P6|NOT COMPLETED|Part 1 - Period 1||0
31476|NCT01930045|75121|P5|NOT COMPLETED|Part 1 - Period 1||0
31477|NCT01930045|75122|P4|NOT COMPLETED|Part 1 - Period 1||0
31478|NCT01930045|75123|P3|NOT COMPLETED|Part 1 - Period 1||0
31479|NCT01930045|75124|P2|NOT COMPLETED|Part 1 - Period 1||0
31480|NCT01930045|75125|P1|NOT COMPLETED|Part 1 - Period 1||0
31481|NCT01930045|75120|P6|COMPLETED|Part 1 - Period 1||3
31482|NCT01930045|75121|P5|COMPLETED|Part 1 - Period 1||3
31483|NCT01930045|75122|P4|COMPLETED|Part 1 - Period 1||3
31484|NCT01930045|75123|P3|COMPLETED|Part 1 - Period 1||3
31485|NCT01930045|75124|P2|COMPLETED|Part 1 - Period 1||3
31486|NCT01930045|75125|P1|COMPLETED|Part 1 - Period 1||3
31487|NCT01930045|75120|P6|STARTED|Part 1 - Period 1||3
31488|NCT01930045|75121|P5|STARTED|Part 1 - Period 1||3
31489|NCT01930045|75122|P4|STARTED|Part 1 - Period 1||3
31490|NCT01930045|75123|P3|STARTED|Part 1 - Period 1||3
31491|NCT01930045|75124|P2|STARTED|Part 1 - Period 1||3
31492|NCT01930045|75125|P1|STARTED|Part 1 - Period 1||3
31493|NCT01929993|75152|P2|NOT COMPLETED|Overall Study||28
31494|NCT01929993|75153|P1|NOT COMPLETED|Overall Study||30
31495|NCT01929993|75152|P2|COMPLETED|Overall Study||54
31496|NCT01929993|75153|P1|COMPLETED|Overall Study||52
31497|NCT01929993|75152|P2|STARTED|Overall Study||82
31498|NCT01929993|75153|P1|STARTED|Overall Study||82
31499|NCT01929980|75159|P1|NOT COMPLETED|Overall Study||1
31500|NCT01929980|75159|P1|COMPLETED|Overall Study||3
31501|NCT01929980|75159|P1|STARTED|Overall Study||4
31502|NCT01929889|75163|P1|NOT COMPLETED|Overall Study||5
31503|NCT01929889|75163|P1|COMPLETED|Overall Study|3 subjects completed the study.|3
31504|NCT01929889|75163|P1|STARTED|Overall Study|Target enrollment goal was 20 completed subjects.|8
31505|NCT01929876|75167|P1|NOT COMPLETED|Period 2||1
31506|NCT01929876|75167|P1|COMPLETED|Period 2||15
31507|NCT01929876|75167|P1|STARTED|Period 2||16
31508|NCT01929876|75167|P1|NOT COMPLETED|Period 1||0
31509|NCT01929876|75167|P1|COMPLETED|Period 1||16
31510|NCT01929876|75167|P1|STARTED|Period 1||16
31511|NCT01929863|75180|P2|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
31512|NCT01929863|75181|P1|NOT COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||6
31513|NCT01929863|75180|P2|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
31514|NCT01929863|75181|P1|COMPLETED|Period 4:Follow-up-Metformin (7-10 Days)||0
31515|NCT01929863|75180|P2|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
31516|NCT01929863|75181|P1|STARTED|Period 4:Follow-up-Metformin (7-10 Days)||6
31517|NCT01929863|75180|P2|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||1
31518|NCT01929863|75181|P1|NOT COMPLETED|Period 3:Intervention Period 2 (7 Days)||0
31519|NCT01929863|75180|P2|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
31520|NCT01929863|75181|P1|COMPLETED|Period 3:Intervention Period 2 (7 Days)||6
31521|NCT01929863|75180|P2|STARTED|Period 3:Intervention Period 2 (7 Days)||7
31522|NCT01929863|75181|P1|STARTED|Period 3:Intervention Period 2 (7 Days)||6
31523|NCT01929863|75180|P2|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
31524|NCT01929863|75181|P1|NOT COMPLETED|Period 2:Washout Period (13-15 Days)||0
31525|NCT01929863|75180|P2|COMPLETED|Period 2:Washout Period (13-15 Days)||7
31526|NCT01929863|75181|P1|COMPLETED|Period 2:Washout Period (13-15 Days)||6
31527|NCT01929863|75180|P2|STARTED|Period 2:Washout Period (13-15 Days)||7
31528|NCT01929863|75181|P1|STARTED|Period 2:Washout Period (13-15 Days)||6
31529|NCT01929863|75180|P2|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
31530|NCT01929863|75181|P1|NOT COMPLETED|Period 1:Intervention Period 1 (7 Days)||1
31531|NCT01929863|75180|P2|COMPLETED|Period 1:Intervention Period 1 (7 Days)||7
31532|NCT01929863|75181|P1|COMPLETED|Period 1:Intervention Period 1 (7 Days)||6
31533|NCT01929863|75180|P2|STARTED|Period 1:Intervention Period 1 (7 Days)||8
31534|NCT01929863|75181|P1|STARTED|Period 1:Intervention Period 1 (7 Days)||7
31535|NCT01929759|75224|P1|NOT COMPLETED|Overall Study||0
31536|NCT01929759|75224|P1|COMPLETED|Overall Study||10
31537|NCT01929759|75224|P1|STARTED|Overall Study||10
31538|NCT01929681|75238|P2|NOT COMPLETED|Overall Study||1
31539|NCT01929681|75239|P1|NOT COMPLETED|Overall Study||2
31540|NCT01929681|75238|P2|COMPLETED|Overall Study||24
31541|NCT01929681|75239|P1|COMPLETED|Overall Study||26
31542|NCT01929681|75238|P2|STARTED|Overall Study||25
31543|NCT01929681|75239|P1|STARTED|Overall Study||28
31544|NCT01929473|75253|P1|NOT COMPLETED|Overall Study||587
31545|NCT01929473|75253|P1|COMPLETED|Overall Study||3243
31546|NCT01929473|75253|P1|365 Day|Overall Study||3589
31547|NCT01929473|75253|P1|STARTED|Overall Study|0 day|3830
31548|NCT01929460|75259|P2|NOT COMPLETED|Overall Study||0
31549|NCT01929460|75260|P1|NOT COMPLETED|Overall Study||0
31550|NCT01929460|75259|P2|COMPLETED|Overall Study||13
31551|NCT01929460|75260|P1|COMPLETED|Overall Study||13
31552|NCT01929460|75259|P2|STARTED|Overall Study||13
31553|NCT01929460|75260|P1|STARTED|Overall Study||13
31554|NCT01929317|75284|P2|NOT COMPLETED|Long-term Phase||4
31555|NCT01929317|75285|P1|NOT COMPLETED|Long-term Phase||19
31556|NCT01929317|75284|P2|COMPLETED|Long-term Phase||14
31557|NCT01929317|75285|P1|COMPLETED|Long-term Phase||25
31558|NCT01929317|75284|P2|STARTED|Long-term Phase||18
31559|NCT01929317|75285|P1|STARTED|Long-term Phase||44
31560|NCT01929317|75284|P2|NOT COMPLETED|Dose Increase Effect Verification Phase||1
31561|NCT01929317|75285|P1|NOT COMPLETED|Dose Increase Effect Verification Phase||9
31562|NCT01929317|75284|P2|COMPLETED|Dose Increase Effect Verification Phase||19
31563|NCT01929317|75285|P1|COMPLETED|Dose Increase Effect Verification Phase||52
31564|NCT01929317|75284|P2|STARTED|Dose Increase Effect Verification Phase||20
31565|NCT01929317|75285|P1|STARTED|Dose Increase Effect Verification Phase||61
31566|NCT01929135|75354|P2|NOT COMPLETED|Overall Study||1
31567|NCT01929135|75355|P1|NOT COMPLETED|Overall Study||1
31568|NCT01929135|75354|P2|COMPLETED|Overall Study||18
31569|NCT01929135|75355|P1|COMPLETED|Overall Study||18
31570|NCT01929135|75354|P2|STARTED|Overall Study||19
31571|NCT01929135|75355|P1|STARTED|Overall Study||19
31572|NCT01929083|75369|P2|NOT COMPLETED|Intervention 2||1
31573|NCT01929083|75370|P1|NOT COMPLETED|Intervention 2||0
31574|NCT01929083|75369|P2|COMPLETED|Intervention 2||8
31575|NCT01929083|75370|P1|COMPLETED|Intervention 2||7
31576|NCT01929083|75369|P2|Returned for 2nd Ibutilide Administratio|Intervention 2||8
31577|NCT01929083|75370|P1|Returned for 2nd Ibutilide Administratio|Intervention 2||7
31578|NCT01929083|75369|P2|STARTED|Intervention 2||9
31579|NCT01929083|75370|P1|STARTED|Intervention 2||7
31580|NCT01929083|75369|P2|NOT COMPLETED|Intervention 1||0
31581|NCT01929083|75370|P1|NOT COMPLETED|Intervention 1||3
31582|NCT01929083|75369|P2|COMPLETED|Intervention 1||9
31583|NCT01929083|75370|P1|COMPLETED|Intervention 1||7
31584|NCT01929083|75369|P2|Returned for 1st Ibutilide Administratio|Intervention 1||9
31585|NCT01929083|75370|P1|Returned for 1st Ibutilide Administratio|Intervention 1||7
31586|NCT01929083|75369|P2|STARTED|Intervention 1||9
31587|NCT01929083|75370|P1|STARTED|Intervention 1|Number of patients randomized to receive progesterone first|10
31588|NCT01929044|75396|P2|NOT COMPLETED|Overall Study||17
31589|NCT01929044|75397|P1|NOT COMPLETED|Overall Study||11
31590|NCT01929044|75396|P2|COMPLETED|Overall Study||129
31591|NCT01929044|75397|P1|COMPLETED|Overall Study||142
31592|NCT01929044|75396|P2|STARTED|Overall Study||146
31593|NCT01929044|75397|P1|STARTED|Overall Study||153
31594|NCT01929031|75419|P6|NOT COMPLETED|Overall Study||1
31595|NCT01929031|75420|P5|NOT COMPLETED|Overall Study||1
31596|NCT01929031|75421|P4|NOT COMPLETED|Overall Study||0
31597|NCT01929031|75422|P3|NOT COMPLETED|Overall Study||1
31598|NCT01929031|75423|P2|NOT COMPLETED|Overall Study||2
31599|NCT01929031|75424|P1|NOT COMPLETED|Overall Study||4
31600|NCT01929031|75419|P6|COMPLETED|Overall Study||35
31601|NCT01929031|75420|P5|COMPLETED|Overall Study||33
31602|NCT01929031|75421|P4|COMPLETED|Overall Study||35
31603|NCT01929031|75422|P3|COMPLETED|Overall Study||34
31604|NCT01929031|75423|P2|COMPLETED|Overall Study||207
31605|NCT01929031|75424|P1|COMPLETED|Overall Study||209
31606|NCT01929031|75419|P6|STARTED|Overall Study||36
31607|NCT01929031|75420|P5|STARTED|Overall Study||34
31608|NCT01929031|75421|P4|STARTED|Overall Study||35
31609|NCT01929031|75422|P3|STARTED|Overall Study||35
31610|NCT01929031|75423|P2|STARTED|Overall Study||209
31611|NCT01929031|75424|P1|STARTED|Overall Study||213
31612|NCT01928940|75448|P2|NOT COMPLETED|Overall Study||1
31613|NCT01928940|75449|P1|NOT COMPLETED|Overall Study||0
31614|NCT01928940|75448|P2|COMPLETED|Overall Study||5
31615|NCT01928940|75449|P1|COMPLETED|Overall Study||6
31616|NCT01928940|75448|P2|STARTED|Overall Study||6
31617|NCT01928940|75449|P1|STARTED|Overall Study||6
31618|NCT01928927|75492|P2|NOT COMPLETED|Overall Study||1
31619|NCT01928927|75493|P1|NOT COMPLETED|Overall Study||2
31620|NCT01928927|75492|P2|COMPLETED|Overall Study||14
31621|NCT01928927|75493|P1|COMPLETED|Overall Study||27
31622|NCT01928927|75492|P2|STARTED|Overall Study||15
31623|NCT01928927|75493|P1|STARTED|Overall Study||29
31624|NCT01928771|75618|P3|NOT COMPLETED|Overall Study||40
31625|NCT01928771|75619|P2|NOT COMPLETED|Overall Study||40
31626|NCT01928771|75620|P1|NOT COMPLETED|Overall Study||46
31627|NCT01928771|75618|P3|COMPLETED|Overall Study||367
31628|NCT01928771|75619|P2|COMPLETED|Overall Study||358
31629|NCT01928771|75620|P1|COMPLETED|Overall Study||354
31630|NCT01928771|75618|P3|Received Treatment|Overall Study||407
31631|NCT01928771|75619|P2|Received Treatment|Overall Study||398
31632|NCT01928771|75620|P1|Received Treatment|Overall Study||399
31633|NCT01928771|75618|P3|STARTED|Overall Study||407
31634|NCT01928771|75619|P2|STARTED|Overall Study||398
31635|NCT01928771|75620|P1|STARTED|Overall Study||400
31636|NCT01928693|75700|P3|NOT COMPLETED|Overall Study||0
31637|NCT01928693|75701|P2|NOT COMPLETED|Overall Study||0
31638|NCT01928693|75702|P1|NOT COMPLETED|Overall Study||0
31639|NCT01928693|75700|P3|COMPLETED|Overall Study||1
31640|NCT01928693|75701|P2|COMPLETED|Overall Study||1
31641|NCT01928693|75702|P1|COMPLETED|Overall Study||0
31642|NCT01928693|75700|P3|STARTED|Overall Study||1
31643|NCT01928693|75701|P2|STARTED|Overall Study||1
31644|NCT01928693|75702|P1|STARTED|Overall Study||0
31645|NCT01928680|75728|P1|NOT COMPLETED|Overall Study||0
31646|NCT01928680|75728|P1|COMPLETED|Overall Study||33
31647|NCT01928680|75728|P1|STARTED|Overall Study||33
31648|NCT01928615|75732|P1|NOT COMPLETED|Overall Study||2
31649|NCT01928615|75732|P1|COMPLETED|Overall Study||0
31650|NCT01928615|75732|P1|STARTED|Overall Study||2
31651|NCT01928472|75751|P4|NOT COMPLETED|Overall Study||2
31652|NCT01928472|75752|P3|NOT COMPLETED|Overall Study||7
31653|NCT01928472|75753|P2|NOT COMPLETED|Overall Study||8
31654|NCT01928472|75754|P1|NOT COMPLETED|Overall Study||8
31655|NCT01928472|75751|P4|COMPLETED|Overall Study||100
31656|NCT01928472|75752|P3|COMPLETED|Overall Study||91
31657|NCT01928472|75753|P2|COMPLETED|Overall Study||96
31658|NCT01928472|75754|P1|COMPLETED|Overall Study||90
31659|NCT01928472|75751|P4|STARTED|Overall Study||102
31660|NCT01928472|75752|P3|STARTED|Overall Study||98
31661|NCT01928472|75753|P2|STARTED|Overall Study||104
31662|NCT01928472|75754|P1|STARTED|Overall Study||98
31663|NCT01928433|75824|P3|NOT COMPLETED|Overall Study||28
31664|NCT01928433|75825|P2|NOT COMPLETED|Overall Study||21
31665|NCT01928433|75826|P1|NOT COMPLETED|Overall Study||20
31666|NCT01928433|75824|P3|COMPLETED|Overall Study||46
31667|NCT01928433|75825|P2|COMPLETED|Overall Study||54
31668|NCT01928433|75826|P1|COMPLETED|Overall Study||56
31669|NCT01928433|75824|P3|STARTED|Overall Study||74
31670|NCT01928433|75825|P2|STARTED|Overall Study||75
31671|NCT01928433|75826|P1|STARTED|Overall Study||76
31672|NCT01928381|75849|P7|NOT COMPLETED|Part 2 - Post Third Intervention||0
31673|NCT01928381|75850|P6|NOT COMPLETED|Part 2 - Post Third Intervention||0
31674|NCT01928381|75851|P5|NOT COMPLETED|Part 2 - Post Third Intervention||0
31675|NCT01928381|75852|P4|NOT COMPLETED|Part 2 - Post Third Intervention||0
31676|NCT01928381|75853|P3|NOT COMPLETED|Part 2 - Post Third Intervention||1
31677|NCT01928381|75854|P2|NOT COMPLETED|Part 2 - Post Third Intervention||0
31678|NCT01928381|75855|P1|NOT COMPLETED|Part 2 - Post Third Intervention||0
31679|NCT01928381|75849|P7|COMPLETED|Part 2 - Post Third Intervention||5
31680|NCT01928381|75850|P6|COMPLETED|Part 2 - Post Third Intervention||5
31681|NCT01928381|75851|P5|COMPLETED|Part 2 - Post Third Intervention||3
31682|NCT01928381|75852|P4|COMPLETED|Part 2 - Post Third Intervention||4
31683|NCT01928381|75853|P3|COMPLETED|Part 2 - Post Third Intervention||3
31684|NCT01928381|75854|P2|COMPLETED|Part 2 - Post Third Intervention||5
31685|NCT01928381|75855|P1|COMPLETED|Part 2 - Post Third Intervention||0
31686|NCT01928381|75849|P7|STARTED|Part 2 - Post Third Intervention||5
31687|NCT01928381|75850|P6|STARTED|Part 2 - Post Third Intervention||5
31688|NCT01928381|75851|P5|STARTED|Part 2 - Post Third Intervention||3
31689|NCT01928381|75852|P4|STARTED|Part 2 - Post Third Intervention||4
31690|NCT01928381|75853|P3|STARTED|Part 2 - Post Third Intervention||4
31691|NCT01928381|75854|P2|STARTED|Part 2 - Post Third Intervention||5
31692|NCT01928381|75855|P1|STARTED|Part 2 - Post Third Intervention||0
31693|NCT01928381|75849|P7|NOT COMPLETED|Part 2 - Third Intervention||0
31694|NCT01928381|75850|P6|NOT COMPLETED|Part 2 - Third Intervention||0
31695|NCT01928381|75851|P5|NOT COMPLETED|Part 2 - Third Intervention||0
31696|NCT01928381|75852|P4|NOT COMPLETED|Part 2 - Third Intervention||0
31697|NCT01928381|75853|P3|NOT COMPLETED|Part 2 - Third Intervention||0
31698|NCT01928381|75854|P2|NOT COMPLETED|Part 2 - Third Intervention||0
31699|NCT01928381|75855|P1|NOT COMPLETED|Part 2 - Third Intervention||0
31700|NCT01928381|75849|P7|COMPLETED|Part 2 - Third Intervention||5
31701|NCT01928381|75850|P6|COMPLETED|Part 2 - Third Intervention||5
31702|NCT01928381|75851|P5|COMPLETED|Part 2 - Third Intervention||3
31703|NCT01928381|75852|P4|COMPLETED|Part 2 - Third Intervention||4
31704|NCT01928381|75853|P3|COMPLETED|Part 2 - Third Intervention||4
31705|NCT01928381|75854|P2|COMPLETED|Part 2 - Third Intervention||5
31706|NCT01928381|75855|P1|COMPLETED|Part 2 - Third Intervention||0
31707|NCT01928381|75849|P7|STARTED|Part 2 - Third Intervention||5
31708|NCT01928381|75850|P6|STARTED|Part 2 - Third Intervention||5
31709|NCT01928381|75851|P5|STARTED|Part 2 - Third Intervention||3
31710|NCT01928381|75852|P4|STARTED|Part 2 - Third Intervention||4
31711|NCT01928381|75853|P3|STARTED|Part 2 - Third Intervention||4
31712|NCT01928381|75854|P2|STARTED|Part 2 - Third Intervention||5
31713|NCT01928381|75855|P1|STARTED|Part 2 - Third Intervention||0
31714|NCT01928381|75849|P7|NOT COMPLETED|Washout Second Intervention||0
31715|NCT01928381|75850|P6|NOT COMPLETED|Washout Second Intervention||0
31716|NCT01928381|75851|P5|NOT COMPLETED|Washout Second Intervention||0
31717|NCT01928381|75852|P4|NOT COMPLETED|Washout Second Intervention||0
31718|NCT01928381|75853|P3|NOT COMPLETED|Washout Second Intervention||0
31719|NCT01928381|75854|P2|NOT COMPLETED|Washout Second Intervention||0
31720|NCT01928381|75855|P1|NOT COMPLETED|Washout Second Intervention||0
31721|NCT01928381|75849|P7|COMPLETED|Washout Second Intervention||5
31722|NCT01928381|75850|P6|COMPLETED|Washout Second Intervention||5
31723|NCT01928381|75851|P5|COMPLETED|Washout Second Intervention||3
31724|NCT01928381|75852|P4|COMPLETED|Washout Second Intervention||4
31725|NCT01928381|75853|P3|COMPLETED|Washout Second Intervention||4
31726|NCT01928381|75854|P2|COMPLETED|Washout Second Intervention||5
31727|NCT01928381|75855|P1|COMPLETED|Washout Second Intervention||0
31728|NCT01928381|75849|P7|STARTED|Washout Second Intervention||5
31729|NCT01928381|75850|P6|STARTED|Washout Second Intervention||5
31730|NCT01928381|75851|P5|STARTED|Washout Second Intervention||3
31731|NCT01928381|75852|P4|STARTED|Washout Second Intervention||4
31732|NCT01928381|75853|P3|STARTED|Washout Second Intervention||4
31733|NCT01928381|75854|P2|STARTED|Washout Second Intervention||5
31734|NCT01928381|75855|P1|STARTED|Washout Second Intervention||0
31735|NCT01928381|75849|P7|NOT COMPLETED|Part 2 - Second Intervention||0
31736|NCT01928381|75850|P6|NOT COMPLETED|Part 2 - Second Intervention||0
31737|NCT01928381|75851|P5|NOT COMPLETED|Part 2 - Second Intervention||0
31738|NCT01928381|75852|P4|NOT COMPLETED|Part 2 - Second Intervention||1
31739|NCT01928381|75853|P3|NOT COMPLETED|Part 2 - Second Intervention||0
31740|NCT01928381|75854|P2|NOT COMPLETED|Part 2 - Second Intervention||1
31741|NCT01928381|75855|P1|NOT COMPLETED|Part 2 - Second Intervention||0
31742|NCT01928381|75849|P7|COMPLETED|Part 2 - Second Intervention||5
31743|NCT01928381|75850|P6|COMPLETED|Part 2 - Second Intervention||5
31744|NCT01928381|75851|P5|COMPLETED|Part 2 - Second Intervention||3
31745|NCT01928381|75852|P4|COMPLETED|Part 2 - Second Intervention||4
31746|NCT01928381|75853|P3|COMPLETED|Part 2 - Second Intervention||4
31747|NCT01928381|75854|P2|COMPLETED|Part 2 - Second Intervention||5
31748|NCT01928381|75855|P1|COMPLETED|Part 2 - Second Intervention||0
31749|NCT01928381|75849|P7|STARTED|Part 2 - Second Intervention||5
31750|NCT01928381|75850|P6|STARTED|Part 2 - Second Intervention||5
31751|NCT01928381|75851|P5|STARTED|Part 2 - Second Intervention||3
31752|NCT01928381|75852|P4|STARTED|Part 2 - Second Intervention||5
31753|NCT01928381|75853|P3|STARTED|Part 2 - Second Intervention||4
31754|NCT01928381|75854|P2|STARTED|Part 2 - Second Intervention||6
31755|NCT01928381|75855|P1|STARTED|Part 2 - Second Intervention||0
31756|NCT01928381|75849|P7|NOT COMPLETED|Washout First Intervention||0
31757|NCT01928381|75850|P6|NOT COMPLETED|Washout First Intervention||0
31758|NCT01928381|75851|P5|NOT COMPLETED|Washout First Intervention||1
31759|NCT01928381|75852|P4|NOT COMPLETED|Washout First Intervention||0
31760|NCT01928381|75853|P3|NOT COMPLETED|Washout First Intervention||0
31761|NCT01928381|75854|P2|NOT COMPLETED|Washout First Intervention||0
31762|NCT01928381|75855|P1|NOT COMPLETED|Washout First Intervention||0
31763|NCT01928381|75849|P7|COMPLETED|Washout First Intervention||5
31764|NCT01928381|75850|P6|COMPLETED|Washout First Intervention||5
31765|NCT01928381|75851|P5|COMPLETED|Washout First Intervention||3
31766|NCT01928381|75852|P4|COMPLETED|Washout First Intervention||5
31767|NCT01928381|75853|P3|COMPLETED|Washout First Intervention||4
31768|NCT01928381|75854|P2|COMPLETED|Washout First Intervention||6
31769|NCT01928381|75855|P1|COMPLETED|Washout First Intervention||0
31770|NCT01928381|75849|P7|STARTED|Washout First Intervention||5
31771|NCT01928381|75850|P6|STARTED|Washout First Intervention||5
31772|NCT01928381|75851|P5|STARTED|Washout First Intervention||4
31773|NCT01928381|75852|P4|STARTED|Washout First Intervention||5
31774|NCT01928381|75853|P3|STARTED|Washout First Intervention||4
31775|NCT01928381|75854|P2|STARTED|Washout First Intervention||6
31776|NCT01928381|75855|P1|STARTED|Washout First Intervention||0
31777|NCT01928381|75849|P7|NOT COMPLETED|Part 2 - First Intervention||1
31778|NCT01928381|75850|P6|NOT COMPLETED|Part 2 - First Intervention||1
31779|NCT01928381|75851|P5|NOT COMPLETED|Part 2 - First Intervention||0
31780|NCT01928381|75852|P4|NOT COMPLETED|Part 2 - First Intervention||1
31781|NCT01928381|75853|P3|NOT COMPLETED|Part 2 - First Intervention||2
31782|NCT01928381|75854|P2|NOT COMPLETED|Part 2 - First Intervention||0
31783|NCT01928381|75855|P1|NOT COMPLETED|Part 2 - First Intervention||0
31784|NCT01928381|75849|P7|COMPLETED|Part 2 - First Intervention||5
31785|NCT01928381|75850|P6|COMPLETED|Part 2 - First Intervention||5
31786|NCT01928381|75851|P5|COMPLETED|Part 2 - First Intervention||4
31787|NCT01928381|75852|P4|COMPLETED|Part 2 - First Intervention||5
31788|NCT01928381|75853|P3|COMPLETED|Part 2 - First Intervention||4
31789|NCT01928381|75854|P2|COMPLETED|Part 2 - First Intervention||6
31790|NCT01928381|75855|P1|COMPLETED|Part 2 - First Intervention||0
31791|NCT01928381|75849|P7|STARTED|Part 2 - First Intervention||6
31792|NCT01928381|75850|P6|STARTED|Part 2 - First Intervention||6
31793|NCT01928381|75851|P5|STARTED|Part 2 - First Intervention||4
31794|NCT01928381|75852|P4|STARTED|Part 2 - First Intervention||6
31795|NCT01928381|75853|P3|STARTED|Part 2 - First Intervention||6
31796|NCT01928381|75854|P2|STARTED|Part 2 - First Intervention||6
31797|NCT01928381|75855|P1|STARTED|Part 2 - First Intervention||0
31798|NCT01928381|75849|P7|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
31799|NCT01928381|75850|P6|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
31800|NCT01928381|75851|P5|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
31801|NCT01928381|75852|P4|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
31802|NCT01928381|75853|P3|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
31803|NCT01928381|75854|P2|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||0
31804|NCT01928381|75855|P1|NOT COMPLETED|Placebo run-in & Part 2 Eligibility||14
31805|NCT01928381|75849|P7|COMPLETED|Placebo run-in & Part 2 Eligibility||0
31806|NCT01928381|75850|P6|COMPLETED|Placebo run-in & Part 2 Eligibility||0
31807|NCT01928381|75851|P5|COMPLETED|Placebo run-in & Part 2 Eligibility||0
31808|NCT01928381|75852|P4|COMPLETED|Placebo run-in & Part 2 Eligibility||0
31809|NCT01928381|75853|P3|COMPLETED|Placebo run-in & Part 2 Eligibility||0
31810|NCT01928381|75854|P2|COMPLETED|Placebo run-in & Part 2 Eligibility||0
31811|NCT01928381|75855|P1|COMPLETED|Placebo run-in & Part 2 Eligibility||34
31812|NCT01928381|75849|P7|STARTED|Placebo run-in & Part 2 Eligibility||0
31813|NCT01928381|75850|P6|STARTED|Placebo run-in & Part 2 Eligibility||0
31814|NCT01928381|75851|P5|STARTED|Placebo run-in & Part 2 Eligibility||0
31815|NCT01928381|75852|P4|STARTED|Placebo run-in & Part 2 Eligibility||0
31816|NCT01928381|75853|P3|STARTED|Placebo run-in & Part 2 Eligibility||0
31817|NCT01928381|75854|P2|STARTED|Placebo run-in & Part 2 Eligibility||0
31818|NCT01928381|75855|P1|STARTED|Placebo run-in & Part 2 Eligibility||48
31819|NCT01928381|75849|P7|NOT COMPLETED|Part 1 - Pain Training||0
31820|NCT01928381|75850|P6|NOT COMPLETED|Part 1 - Pain Training||0
31821|NCT01928381|75851|P5|NOT COMPLETED|Part 1 - Pain Training||0
31822|NCT01928381|75852|P4|NOT COMPLETED|Part 1 - Pain Training||0
31823|NCT01928381|75853|P3|NOT COMPLETED|Part 1 - Pain Training||0
31824|NCT01928381|75854|P2|NOT COMPLETED|Part 1 - Pain Training||0
31825|NCT01928381|75855|P1|NOT COMPLETED|Part 1 - Pain Training||35
31826|NCT01928381|75849|P7|COMPLETED|Part 1 - Pain Training||0
31827|NCT01928381|75850|P6|COMPLETED|Part 1 - Pain Training||0
31828|NCT01928381|75851|P5|COMPLETED|Part 1 - Pain Training||0
31829|NCT01928381|75852|P4|COMPLETED|Part 1 - Pain Training||0
31830|NCT01928381|75853|P3|COMPLETED|Part 1 - Pain Training||0
31831|NCT01928381|75854|P2|COMPLETED|Part 1 - Pain Training||0
31832|NCT01928381|75855|P1|COMPLETED|Part 1 - Pain Training||48
31833|NCT01928381|75849|P7|STARTED|Part 1 - Pain Training||0
31834|NCT01928381|75850|P6|STARTED|Part 1 - Pain Training||0
31835|NCT01928381|75851|P5|STARTED|Part 1 - Pain Training||0
31836|NCT01928381|75852|P4|STARTED|Part 1 - Pain Training||0
31837|NCT01928381|75853|P3|STARTED|Part 1 - Pain Training||0
31838|NCT01928381|75854|P2|STARTED|Part 1 - Pain Training||0
31839|NCT01928381|75855|P1|STARTED|Part 1 - Pain Training||83
31840|NCT01928381|75849|P7|NOT COMPLETED|Screening for Pain Training||0
31841|NCT01928381|75850|P6|NOT COMPLETED|Screening for Pain Training||0
31842|NCT01928381|75851|P5|NOT COMPLETED|Screening for Pain Training||0
31843|NCT01928381|75852|P4|NOT COMPLETED|Screening for Pain Training||0
31844|NCT01928381|75853|P3|NOT COMPLETED|Screening for Pain Training||0
31845|NCT01928381|75854|P2|NOT COMPLETED|Screening for Pain Training||0
31846|NCT01928381|75855|P1|NOT COMPLETED|Screening for Pain Training||60
31847|NCT01928381|75849|P7|COMPLETED|Screening for Pain Training||0
31848|NCT01928381|75850|P6|COMPLETED|Screening for Pain Training||0
31849|NCT01928381|75851|P5|COMPLETED|Screening for Pain Training||0
31850|NCT01928381|75852|P4|COMPLETED|Screening for Pain Training||0
31851|NCT01928381|75853|P3|COMPLETED|Screening for Pain Training||0
31852|NCT01928381|75854|P2|COMPLETED|Screening for Pain Training||0
31853|NCT01928381|75855|P1|COMPLETED|Screening for Pain Training||83
31854|NCT01928381|75849|P7|STARTED|Screening for Pain Training||0
31855|NCT01928381|75850|P6|STARTED|Screening for Pain Training||0
31856|NCT01928381|75851|P5|STARTED|Screening for Pain Training||0
31857|NCT01928381|75852|P4|STARTED|Screening for Pain Training||0
31858|NCT01928381|75853|P3|STARTED|Screening for Pain Training||0
31859|NCT01928381|75854|P2|STARTED|Screening for Pain Training||0
31860|NCT01928381|75855|P1|STARTED|Screening for Pain Training||143
31861|NCT01928030|75868|P3|NOT COMPLETED|Overall Study||0
31862|NCT01928030|75869|P2|NOT COMPLETED|Overall Study||0
31863|NCT01928030|75870|P1|NOT COMPLETED|Overall Study||0
31864|NCT01928030|75868|P3|COMPLETED|Overall Study||0
31865|NCT01928030|75869|P2|COMPLETED|Overall Study||0
31866|NCT01928030|75870|P1|COMPLETED|Overall Study||3
31867|NCT01928030|75868|P3|STARTED|Overall Study||0
31868|NCT01928030|75869|P2|STARTED|Overall Study||0
31869|NCT01928030|75870|P1|STARTED|Overall Study||3
31870|NCT01927887|75877|P1|NOT COMPLETED|Overall Study||0
31871|NCT01927887|75877|P1|COMPLETED|Overall Study||12
31872|NCT01927887|75877|P1|STARTED|Overall Study||12
31873|NCT01927757|75882|P1|NOT COMPLETED|Overall Study||23
31874|NCT01927757|75882|P1|COMPLETED|Overall Study||67
31875|NCT01927757|75882|P1|Received Etanercept|Overall Study||88
31876|NCT01927757|75882|P1|STARTED|Overall Study||90
31877|NCT01927575|75900|P1|NOT COMPLETED|Overall Study||0
31878|NCT01927575|75900|P1|COMPLETED|Overall Study||1
31879|NCT01927575|75900|P1|STARTED|Overall Study||1
31880|NCT01927419|75910|P2|NOT COMPLETED|Overall Study||28
31881|NCT01927419|75911|P1|NOT COMPLETED|Overall Study||70
31882|NCT01927419|75910|P2|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|19
31883|NCT01927419|75911|P1|COMPLETED|Overall Study|All participants who did not discontinue study drug during treatment period (Parts 1 and 2)|25
31884|NCT01927419|75910|P2|Received Treatment|Overall Study||46
31885|NCT01927419|75911|P1|Received Treatment|Overall Study||94
31886|NCT01927419|75910|P2|STARTED|Overall Study||47
31887|NCT01927419|75911|P1|STARTED|Overall Study||95
31888|NCT01927120|75927|P1|NOT COMPLETED|Overall Study||10
31889|NCT01927120|75927|P1|COMPLETED|Overall Study||10
31890|NCT01927120|75927|P1|STARTED|Overall Study||20
31891|NCT01927055|75945|P3|NOT COMPLETED|Double-Blind||13
31892|NCT01927055|75946|P2|NOT COMPLETED|Double-Blind||11
31893|NCT01927055|75947|P1|NOT COMPLETED|Double-Blind||0
31894|NCT01927055|75945|P3|COMPLETED|Double-Blind||10
31895|NCT01927055|75946|P2|COMPLETED|Double-Blind||11
31896|NCT01927055|75947|P1|COMPLETED|Double-Blind||0
31897|NCT01927055|75945|P3|STARTED|Double-Blind||23
31898|NCT01927055|75946|P2|STARTED|Double-Blind||22
31899|NCT01927055|75947|P1|STARTED|Double-Blind||0
31900|NCT01927055|75945|P3|NOT COMPLETED|Open-label||0
31901|NCT01927055|75946|P2|NOT COMPLETED|Open-label||0
31902|NCT01927055|75947|P1|NOT COMPLETED|Open-label||16
31903|NCT01927055|75945|P3|COMPLETED|Open-label||0
31904|NCT01927055|75946|P2|COMPLETED|Open-label||0
31905|NCT01927055|75947|P1|COMPLETED|Open-label||45
31906|NCT01927055|75945|P3|STARTED|Open-label||0
31907|NCT01927055|75946|P2|STARTED|Open-label||0
31908|NCT01927055|75947|P1|STARTED|Open-label||61
31909|NCT01926977|75956|P2|NOT COMPLETED|Overall Study||0
31910|NCT01926977|75957|P1|NOT COMPLETED|Overall Study||0
31911|NCT01926977|75956|P2|COMPLETED|Overall Study||53
31912|NCT01926977|75957|P1|COMPLETED|Overall Study||47
31913|NCT01926977|75956|P2|STARTED|Overall Study||53
31914|NCT01926977|75957|P1|STARTED|Overall Study||47
31915|NCT01926782|75971|P6|NOT COMPLETED|Overall Study||41
31916|NCT01926782|75972|P5|NOT COMPLETED|Overall Study||8
31917|NCT01926782|75973|P4|NOT COMPLETED|Overall Study||20
31918|NCT01926782|75974|P3|NOT COMPLETED|Overall Study||40
31919|NCT01926782|75975|P2|NOT COMPLETED|Overall Study||13
31920|NCT01926782|75976|P1|NOT COMPLETED|Overall Study||28
31921|NCT01926782|75971|P6|COMPLETED|Overall Study||105
31922|NCT01926782|75972|P5|COMPLETED|Overall Study||29
31923|NCT01926782|75973|P4|COMPLETED|Overall Study||53
31924|NCT01926782|75974|P3|COMPLETED|Overall Study||272
31925|NCT01926782|75975|P2|COMPLETED|Overall Study||65
31926|NCT01926782|75976|P1|COMPLETED|Overall Study||129
31927|NCT01926782|75971|P6|Completed 24 Weeks Treatment Period|Overall Study||120
31928|NCT01926782|75972|P5|Completed 24 Weeks Treatment Period|Overall Study||31
31929|NCT01926782|75973|P4|Completed 24 Weeks Treatment Period|Overall Study||58
31930|NCT01926782|75974|P3|Completed 24 Weeks Treatment Period|Overall Study||285
31931|NCT01926782|75975|P2|Completed 24 Weeks Treatment Period|Overall Study||68
31932|NCT01926782|75976|P1|Completed 24 Weeks Treatment Period|Overall Study||137
31933|NCT01926782|75971|P6|Treated|Overall Study||146
31934|NCT01926782|75972|P5|Treated|Overall Study||37
31935|NCT01926782|75973|P4|Treated|Overall Study||72
31936|NCT01926782|75974|P3|Treated|Overall Study||312
31937|NCT01926782|75975|P2|Treated|Overall Study||78
31938|NCT01926782|75976|P1|Treated|Overall Study||157
31939|NCT01926782|75971|P6|STARTED|Overall Study||146
31940|NCT01926782|75972|P5|STARTED|Overall Study||37
31941|NCT01926782|75973|P4|STARTED|Overall Study||73
31942|NCT01926782|75974|P3|STARTED|Overall Study||312
31943|NCT01926782|75975|P2|STARTED|Overall Study||78
31944|NCT01926782|75976|P1|STARTED|Overall Study||157
31945|NCT01926626|76125|P1|NOT COMPLETED|Overall Study||22
31946|NCT01926626|76125|P1|COMPLETED|Overall Study||16
31947|NCT01926626|76125|P1|Received Moclobemide|Overall Study||37
31948|NCT01926626|76125|P1|STARTED|Overall Study||38
31949|NCT01926119|76135|P1|NOT COMPLETED|Overall Study||1
31950|NCT01926119|76135|P1|COMPLETED|Overall Study||3
31951|NCT01926119|76135|P1|STARTED|Overall Study||4
31952|NCT01926015|76147|P2|NOT COMPLETED|Overall Study||1
31953|NCT01926015|76148|P1|NOT COMPLETED|Overall Study||2
31954|NCT01926015|76147|P2|COMPLETED|Overall Study||95
31955|NCT01926015|76148|P1|COMPLETED|Overall Study||94
31956|NCT01926015|76147|P2|Received >=1 Vaccination|Overall Study||96
31957|NCT01926015|76148|P1|Received >=1 Vaccination|Overall Study||94
31958|NCT01926015|76147|P2|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
31959|NCT01926015|76148|P1|STARTED|Overall Study|Participants who passed all entry criteria and who were randomized into the study|96
31960|NCT01925781|76180|P2|NOT COMPLETED|Overall Study||4
31961|NCT01925781|76181|P1|NOT COMPLETED|Overall Study||2
31962|NCT01925781|76180|P2|COMPLETED|Overall Study||1
31963|NCT01925781|76181|P1|COMPLETED|Overall Study||3
31964|NCT01925781|76180|P2|STARTED|Overall Study||5
31965|NCT01925781|76181|P1|STARTED|Overall Study||5
31966|NCT01925768|76191|P2|NOT COMPLETED|Overall Study||23
31967|NCT01925768|76192|P1|NOT COMPLETED|Overall Study||11
31968|NCT01925768|76191|P2|COMPLETED|Overall Study|Completed = participants who completed week 24|87
31969|NCT01925768|76192|P1|COMPLETED|Overall Study|Completed = participants who completed week 24|98
32057|NCT01925144|76374|P1|STARTED|Period 2 (At Dosing Day 3 Through Day12)||30
31970|NCT01925768|76191|P2|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|13
31971|NCT01925768|76192|P1|Escaped Early (EE)|Overall Study|EE= investigator’s discretion plus <10% improvement in both swollen & tender joint counts at Week16|35
31972|NCT01925768|76191|P2|Completed Week 16|Overall Study||91
31973|NCT01925768|76192|P1|Completed Week 16|Overall Study||101
31974|NCT01925768|76191|P2|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
31975|NCT01925768|76192|P1|Safety Population|Overall Study|Safety population = participants who were randomized and received at least one dose of study drug.|109
31976|NCT01925768|76191|P2|Received Treatment|Overall Study||109
31977|NCT01925768|76192|P1|Received Treatment|Overall Study||109
31978|NCT01925768|76191|P2|STARTED|Overall Study||110
31979|NCT01925768|76192|P1|STARTED|Overall Study||109
31980|NCT01925703|76200|P1|NOT COMPLETED|Overall Study||4
31981|NCT01925703|76200|P1|COMPLETED|Overall Study||9
31982|NCT01925703|76200|P1|Follow-up Completed|Overall Study||9
31983|NCT01925703|76200|P1|Full Iron Repletion Achieved|Overall Study||11
31984|NCT01925703|76200|P1|Dosing Regimen Completed|Overall Study||12
31985|NCT01925703|76200|P1|STARTED|Overall Study||13
31986|NCT01925469|76208|P2|NOT COMPLETED|Overall Study||0
31987|NCT01925469|76209|P1|NOT COMPLETED|Overall Study||1
31988|NCT01925469|76208|P2|COMPLETED|Overall Study||15
31989|NCT01925469|76209|P1|COMPLETED|Overall Study||14
31990|NCT01925469|76208|P2|STARTED|Overall Study||15
31991|NCT01925469|76209|P1|STARTED|Overall Study||15
31992|NCT01925417|76219|P1|NOT COMPLETED|Overall Study||3
31993|NCT01925417|76219|P1|COMPLETED|Overall Study||31
31994|NCT01925417|76219|P1|STARTED|Overall Study||34
31995|NCT01925274|76229|P3|NOT COMPLETED|Overall Study||6
31996|NCT01925274|76230|P2|NOT COMPLETED|Overall Study||6
31997|NCT01925274|76231|P1|NOT COMPLETED|Overall Study||7
31998|NCT01925274|76229|P3|COMPLETED|Overall Study||0
31999|NCT01925274|76230|P2|COMPLETED|Overall Study||0
32000|NCT01925274|76231|P1|COMPLETED|Overall Study||0
32001|NCT01925274|76229|P3|STARTED|Overall Study||6
32002|NCT01925274|76230|P2|STARTED|Overall Study||6
32003|NCT01925274|76231|P1|STARTED|Overall Study||7
32004|NCT01925209|76312|P4|NOT COMPLETED|Follow-up||4
32005|NCT01925209|76313|P3|NOT COMPLETED|Follow-up||1
32006|NCT01925209|76314|P2|NOT COMPLETED|Follow-up||6
32007|NCT01925209|76315|P1|NOT COMPLETED|Follow-up||1
32008|NCT01925209|76312|P4|COMPLETED|Follow-up||54
32009|NCT01925209|76313|P3|COMPLETED|Follow-up||55
32010|NCT01925209|76314|P2|COMPLETED|Follow-up||55
32011|NCT01925209|76315|P1|COMPLETED|Follow-up||56
32012|NCT01925209|76312|P4|STARTED|Follow-up||58
32013|NCT01925209|76313|P3|STARTED|Follow-up||56
32014|NCT01925209|76314|P2|STARTED|Follow-up||61
32015|NCT01925209|76315|P1|STARTED|Follow-up||57
32016|NCT01925209|76312|P4|NOT COMPLETED|Maintenance Treatment Epoch||2
32017|NCT01925209|76313|P3|NOT COMPLETED|Maintenance Treatment Epoch||2
32018|NCT01925209|76314|P2|NOT COMPLETED|Maintenance Treatment Epoch||1
32019|NCT01925209|76315|P1|NOT COMPLETED|Maintenance Treatment Epoch||0
32020|NCT01925209|76312|P4|COMPLETED|Maintenance Treatment Epoch||48
32021|NCT01925209|76313|P3|COMPLETED|Maintenance Treatment Epoch||50
32022|NCT01925209|76314|P2|COMPLETED|Maintenance Treatment Epoch||45
32023|NCT01925209|76315|P1|COMPLETED|Maintenance Treatment Epoch||49
32024|NCT01925209|76312|P4|STARTED|Maintenance Treatment Epoch||50
32025|NCT01925209|76313|P3|STARTED|Maintenance Treatment Epoch||52
32026|NCT01925209|76314|P2|STARTED|Maintenance Treatment Epoch||46
32027|NCT01925209|76315|P1|STARTED|Maintenance Treatment Epoch||49
32028|NCT01925209|76312|P4|NOT COMPLETED|Treatment Epoch||5
32029|NCT01925209|76313|P3|NOT COMPLETED|Treatment Epoch||7
32030|NCT01925209|76314|P2|NOT COMPLETED|Treatment Epoch||8
32031|NCT01925209|76315|P1|NOT COMPLETED|Treatment Epoch||9
32032|NCT01925209|76312|P4|COMPLETED|Treatment Epoch||57
32033|NCT01925209|76313|P3|COMPLETED|Treatment Epoch||56
32034|NCT01925209|76314|P2|COMPLETED|Treatment Epoch||55
32035|NCT01925209|76315|P1|COMPLETED|Treatment Epoch||54
32036|NCT01925209|76312|P4|Full Analysis Set|Treatment Epoch||62
32037|NCT01925209|76313|P3|Full Analysis Set|Treatment Epoch||63
32038|NCT01925209|76314|P2|Full Analysis Set|Treatment Epoch||63
32039|NCT01925209|76315|P1|Full Analysis Set|Treatment Epoch||63
32040|NCT01925209|76312|P4|STARTED|Treatment Epoch||62
32041|NCT01925209|76313|P3|STARTED|Treatment Epoch||63
32042|NCT01925209|76314|P2|STARTED|Treatment Epoch||63
32043|NCT01925209|76315|P1|STARTED|Treatment Epoch||63
32044|NCT01925183|76347|P2|NOT COMPLETED|Overall Study||0
32045|NCT01925183|76348|P1|NOT COMPLETED|Overall Study||1
32046|NCT01925183|76347|P2|COMPLETED|Overall Study||3
32047|NCT01925183|76348|P1|COMPLETED|Overall Study||2
32048|NCT01925183|76347|P2|STARTED|Overall Study||3
32049|NCT01925183|76348|P1|STARTED|Overall Study||3
32050|NCT01925170|76356|P1|NOT COMPLETED|Overall Study||53
32051|NCT01925170|76356|P1|COMPLETED|Overall Study||1585
32052|NCT01925170|76356|P1|STARTED|Overall Study||1638
32053|NCT01925144|76374|P1|NOT COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||0
32054|NCT01925144|76374|P1|COMPLETED|Period 2 (At Dosing Day 3 Through Day12)||30
32055|NCT01925144|76374|P1|Received 8 Doses of Omeprazole|Period 2 (At Dosing Day 3 Through Day12)||30
32056|NCT01925144|76374|P1|Received Baricitinib|Period 2 (At Dosing Day 3 Through Day12)||30
32058|NCT01925144|76374|P1|NOT COMPLETED|Period 1 (Day 1 Through Predose Day 3)||0
32059|NCT01925144|76374|P1|COMPLETED|Period 1 (Day 1 Through Predose Day 3)||30
32060|NCT01925144|76374|P1|Received Baricitinib|Period 1 (Day 1 Through Predose Day 3)||30
32061|NCT01925144|76374|P1|STARTED|Period 1 (Day 1 Through Predose Day 3)||30
32062|NCT01924975|76387|P2|NOT COMPLETED|Overall Study||0
32063|NCT01924975|76388|P1|NOT COMPLETED|Overall Study||0
32064|NCT01924975|76387|P2|COMPLETED|Overall Study||51
32065|NCT01924975|76388|P1|COMPLETED|Overall Study||51
32066|NCT01924975|76387|P2|STARTED|Overall Study||51
32067|NCT01924975|76388|P1|STARTED|Overall Study||51
32068|NCT01924949|76394|P1|NOT COMPLETED|Overall Study||0
32069|NCT01924949|76394|P1|COMPLETED|Overall Study||5
32070|NCT01924949|76394|P1|STARTED|Overall Study||5
32071|NCT01924871|76405|P2|NOT COMPLETED|Overall Study||2
32072|NCT01924871|76406|P1|NOT COMPLETED|Overall Study||6
32073|NCT01924871|76405|P2|COMPLETED|Overall Study||29
32074|NCT01924871|76406|P1|COMPLETED|Overall Study||25
32075|NCT01924871|76405|P2|STARTED|Overall Study||31
32076|NCT01924871|76406|P1|STARTED|Overall Study||31
32077|NCT01924767|76417|P5|NOT COMPLETED|Overall Study||0
32078|NCT01924767|76418|P4|NOT COMPLETED|Overall Study||0
32079|NCT01924767|76419|P3|NOT COMPLETED|Overall Study||1
32080|NCT01924767|76420|P2|NOT COMPLETED|Overall Study||0
32081|NCT01924767|76421|P1|NOT COMPLETED|Overall Study||1
32082|NCT01924767|76417|P5|COMPLETED|Overall Study||9
32083|NCT01924767|76418|P4|COMPLETED|Overall Study||9
32084|NCT01924767|76419|P3|COMPLETED|Overall Study||8
32085|NCT01924767|76420|P2|COMPLETED|Overall Study||9
32086|NCT01924767|76421|P1|COMPLETED|Overall Study||11
32087|NCT01924767|76417|P5|STARTED|Overall Study||9
32088|NCT01924767|76418|P4|STARTED|Overall Study||9
32089|NCT01924767|76419|P3|STARTED|Overall Study||9
32090|NCT01924767|76420|P2|STARTED|Overall Study||9
32091|NCT01924767|76421|P1|STARTED|Overall Study||12
32092|NCT01924559|76521|P1|NOT COMPLETED|Overall Study||0
32093|NCT01924559|76521|P1|COMPLETED|Overall Study|The order in which subjects started scenarios (in biohazard gear vs street clothing) was randomized|37
32094|NCT01924559|76521|P1|STARTED|Overall Study|All 37 participants were scored under the same six scenarios, resulting in 222 observations.|37
32095|NCT01924390|76537|P2|NOT COMPLETED|Overall Study||1
32096|NCT01924390|76538|P1|NOT COMPLETED|Overall Study||1
32097|NCT01924390|76537|P2|COMPLETED|Overall Study||21
32098|NCT01924390|76538|P1|COMPLETED|Overall Study||21
32099|NCT01924390|76537|P2|STARTED|Overall Study||22
32100|NCT01924390|76538|P1|STARTED|Overall Study||22
32101|NCT01924299|76550|P2|NOT COMPLETED|Period 2||1
32102|NCT01924299|76551|P1|NOT COMPLETED|Period 2||1
32103|NCT01924299|76550|P2|COMPLETED|Period 2||17
32104|NCT01924299|76551|P1|COMPLETED|Period 2||17
32105|NCT01924299|76550|P2|Received Baricitinib|Period 2||17
32106|NCT01924299|76551|P1|Received Baricitinib|Period 2||17
32107|NCT01924299|76550|P2|Received at Least 1 Dose of Study Drug|Period 2||18
32108|NCT01924299|76551|P1|Received at Least 1 Dose of Study Drug|Period 2||18
32109|NCT01924299|76550|P2|STARTED|Period 2||18
32110|NCT01924299|76551|P1|STARTED|Period 2||18
32111|NCT01924299|76550|P2|NOT COMPLETED|Period 1||0
32112|NCT01924299|76551|P1|NOT COMPLETED|Period 1||0
32113|NCT01924299|76550|P2|COMPLETED|Period 1||18
32114|NCT01924299|76551|P1|COMPLETED|Period 1||18
32115|NCT01924299|76550|P2|Received Baricitinib|Period 1||18
32116|NCT01924299|76551|P1|Received Baricitinib|Period 1||18
32117|NCT01924299|76550|P2|STARTED|Period 1||18
32118|NCT01924299|76551|P1|STARTED|Period 1||18
32119|NCT01924182|76573|P2|NOT COMPLETED|Overall Study||0
32120|NCT01924182|76574|P1|NOT COMPLETED|Overall Study||1
32121|NCT01924182|76573|P2|COMPLETED|Overall Study||0
32122|NCT01924182|76574|P1|COMPLETED|Overall Study||2
32123|NCT01924182|76573|P2|STARTED|Overall Study||0
32124|NCT01924182|76574|P1|STARTED|Overall Study||3
32125|NCT01923896|76582|P2|NOT COMPLETED|Overall Study||0
32126|NCT01923896|76583|P1|NOT COMPLETED|Overall Study||1
32127|NCT01923896|76582|P2|COMPLETED|Overall Study||8
32128|NCT01923896|76583|P1|COMPLETED|Overall Study||7
32129|NCT01923896|76582|P2|STARTED|Overall Study||8
32130|NCT01923896|76583|P1|STARTED|Overall Study||8
32131|NCT01923805|76597|P2|NOT COMPLETED|Overall Study||5
32132|NCT01923805|76598|P1|NOT COMPLETED|Overall Study||3
32133|NCT01923805|76597|P2|COMPLETED|Overall Study||0
32134|NCT01923805|76598|P1|COMPLETED|Overall Study||0
32135|NCT01923805|76597|P2|STARTED|Overall Study|early termination|5
32136|NCT01923805|76598|P1|STARTED|Overall Study|early termination|3
32137|NCT01923480|76607|P6|NOT COMPLETED|Period 2 (Hours 1-7)||0
32138|NCT01923480|76608|P5|NOT COMPLETED|Period 2 (Hours 1-7)||0
32139|NCT01923480|76609|P4|NOT COMPLETED|Period 2 (Hours 1-7)||0
32140|NCT01923480|76610|P3|NOT COMPLETED|Period 2 (Hours 1-7)||0
32141|NCT01923480|76611|P2|NOT COMPLETED|Period 2 (Hours 1-7)||0
32142|NCT01923480|76612|P1|NOT COMPLETED|Period 2 (Hours 1-7)||0
32143|NCT01923480|76607|P6|COMPLETED|Period 2 (Hours 1-7)||2
32144|NCT01923480|76608|P5|COMPLETED|Period 2 (Hours 1-7)||2
32145|NCT01923480|76609|P4|COMPLETED|Period 2 (Hours 1-7)||2
32146|NCT01923480|76610|P3|COMPLETED|Period 2 (Hours 1-7)||2
32147|NCT01923480|76611|P2|COMPLETED|Period 2 (Hours 1-7)||1
32148|NCT01923480|76612|P1|COMPLETED|Period 2 (Hours 1-7)||1
32149|NCT01923480|76607|P6|STARTED|Period 2 (Hours 1-7)||2
32150|NCT01923480|76608|P5|STARTED|Period 2 (Hours 1-7)||2
32151|NCT01923480|76609|P4|STARTED|Period 2 (Hours 1-7)||2
32152|NCT01923480|76610|P3|STARTED|Period 2 (Hours 1-7)||2
32153|NCT01923480|76611|P2|STARTED|Period 2 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|1
32154|NCT01923480|76612|P1|STARTED|Period 2 (Hours 1-7)||1
32155|NCT01923480|76607|P6|NOT COMPLETED|Period 1 (Hours 1-7)||0
32156|NCT01923480|76608|P5|NOT COMPLETED|Period 1 (Hours 1-7)||0
32157|NCT01923480|76609|P4|NOT COMPLETED|Period 1 (Hours 1-7)||0
32158|NCT01923480|76610|P3|NOT COMPLETED|Period 1 (Hours 1-7)||0
32159|NCT01923480|76611|P2|NOT COMPLETED|Period 1 (Hours 1-7)||0
32160|NCT01923480|76612|P1|NOT COMPLETED|Period 1 (Hours 1-7)||0
32161|NCT01923480|76607|P6|COMPLETED|Period 1 (Hours 1-7)||2
32162|NCT01923480|76608|P5|COMPLETED|Period 1 (Hours 1-7)||2
32163|NCT01923480|76609|P4|COMPLETED|Period 1 (Hours 1-7)||2
32164|NCT01923480|76610|P3|COMPLETED|Period 1 (Hours 1-7)||2
32165|NCT01923480|76611|P2|COMPLETED|Period 1 (Hours 1-7)|One subject completed Period 1, but withdrew from the study prior to the start of Period 2.|2
32166|NCT01923480|76612|P1|COMPLETED|Period 1 (Hours 1-7)||1
32167|NCT01923480|76607|P6|STARTED|Period 1 (Hours 1-7)||2
32168|NCT01923480|76608|P5|STARTED|Period 1 (Hours 1-7)||2
32169|NCT01923480|76609|P4|STARTED|Period 1 (Hours 1-7)||2
32170|NCT01923480|76610|P3|STARTED|Period 1 (Hours 1-7)||2
32171|NCT01923480|76611|P2|STARTED|Period 1 (Hours 1-7)||2
32172|NCT01923480|76612|P1|STARTED|Period 1 (Hours 1-7)||1
32173|NCT01923467|76767|P1|NOT COMPLETED|Overall Study||541
32174|NCT01923467|76767|P1|COMPLETED|Overall Study|Completed 3-month follow up survey|226
32175|NCT01923467|76767|P1|Baseline Completed, Enrolled|Overall Study||288
32176|NCT01923467|76767|P1|STARTED|Overall Study|Offered stop smoking program|767
32177|NCT01923389|76773|P2|NOT COMPLETED|Overall Study||0
32178|NCT01923389|76774|P1|NOT COMPLETED|Overall Study||1
32179|NCT01923389|76773|P2|COMPLETED|Overall Study||2
32180|NCT01923389|76774|P1|COMPLETED|Overall Study||1
32181|NCT01923389|76773|P2|STARTED|Overall Study||2
32182|NCT01923389|76774|P1|STARTED|Overall Study||2
32183|NCT01922986|76798|P2|NOT COMPLETED|Overall Study||0
32184|NCT01922986|76799|P1|NOT COMPLETED|Overall Study||0
32185|NCT01922986|76798|P2|COMPLETED|Overall Study||2
32186|NCT01922986|76799|P1|COMPLETED|Overall Study||2
32187|NCT01922986|76798|P2|STARTED|Overall Study||2
32188|NCT01922986|76799|P1|STARTED|Overall Study||2
32189|NCT01922934|76811|P2|NOT COMPLETED|Visit 12 / Final Visits||290
32190|NCT01922934|76812|P1|NOT COMPLETED|Visit 12 / Final Visits||6
32191|NCT01922934|76811|P2|COMPLETED|Visit 12 / Final Visits|290 patients did not have a second weight recorded at one year (+/- 6months) of first weight|2640
32192|NCT01922934|76812|P1|COMPLETED|Visit 12 / Final Visits|6 patients did not return for final visit and weight measure|113
32193|NCT01922934|76811|P2|STARTED|Visit 12 / Final Visits||2930
32194|NCT01922934|76812|P1|STARTED|Visit 12 / Final Visits||119
32195|NCT01922934|76811|P2|NOT COMPLETED|Visit 1- Weight Measured||1284
32196|NCT01922934|76812|P1|NOT COMPLETED|Visit 1- Weight Measured||21
32197|NCT01922934|76811|P2|COMPLETED|Visit 1- Weight Measured|1284 patients did not have any weights recorded in EMR during study timeframe|2930
32198|NCT01922934|76812|P1|COMPLETED|Visit 1- Weight Measured|Patients first received tool and were weighed at Visit 1|119
32199|NCT01922934|76811|P2|STARTED|Visit 1- Weight Measured||4214
32200|NCT01922934|76812|P1|STARTED|Visit 1- Weight Measured|21 patients did not return for Visit 1 to receive tool or have weight measured.|140
32201|NCT01922934|76811|P2|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||0
32202|NCT01922934|76812|P1|NOT COMPLETED|Visit 0 - Patient Contacted & Consented||235
32203|NCT01922934|76811|P2|COMPLETED|Visit 0 - Patient Contacted & Consented||4214
32379|NCT01920282|77422|P3|COMPLETED|Overall Study||15
32204|NCT01922934|76812|P1|COMPLETED|Visit 0 - Patient Contacted & Consented|reflects number of patients that were contacted and agreed to attend Visit 0|140
32205|NCT01922934|76811|P2|STARTED|Visit 0 - Patient Contacted & Consented|Control group patients were not contacted or offered intervention|4214
32206|NCT01922934|76812|P1|STARTED|Visit 0 - Patient Contacted & Consented||375
32207|NCT01922934|76811|P2|NOT COMPLETED|Eligible Patients||88
32208|NCT01922934|76812|P1|NOT COMPLETED|Eligible Patients||53
32209|NCT01922934|76811|P2|COMPLETED|Eligible Patients|81 patients did not meet inclusion criteria as they were 80 years or older. 7 patients had died.|4214
32210|NCT01922934|76812|P1|COMPLETED|Eligible Patients|375 patients determined eligible after original random selection from DHHA data warehouse.|375
32211|NCT01922934|76811|P2|STARTED|Eligible Patients||4302
32212|NCT01922934|76812|P1|STARTED|Eligible Patients||428
32213|NCT01922739|76824|P1|NOT COMPLETED|Open-label Treatment Period||34
32214|NCT01922739|76824|P1|COMPLETED|Open-label Treatment Period||136
32215|NCT01922739|76824|P1|Treatment SAS and FAS|Open-label Treatment Period|SAS = safety analysis set FAS = full analysis set|170
32216|NCT01922739|76824|P1|STARTED|Open-label Treatment Period||170
32217|NCT01922739|76824|P1|NOT COMPLETED|Titration/Adjustment Period||12
32218|NCT01922739|76824|P1|COMPLETED|Titration/Adjustment Period||170
32219|NCT01922739|76824|P1|Safety Analysis Set|Titration/Adjustment Period||182
32220|NCT01922739|76824|P1|STARTED|Titration/Adjustment Period||182
32221|NCT01922349|76853|P4|NOT COMPLETED|Multiple Rising Dose (MRD) Period||1
32222|NCT01922349|76854|P3|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
32223|NCT01922349|76855|P2|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
32224|NCT01922349|76856|P1|NOT COMPLETED|Multiple Rising Dose (MRD) Period||0
32225|NCT01922349|76853|P4|COMPLETED|Multiple Rising Dose (MRD) Period||26
32226|NCT01922349|76854|P3|COMPLETED|Multiple Rising Dose (MRD) Period||18
32227|NCT01922349|76855|P2|COMPLETED|Multiple Rising Dose (MRD) Period||27
32228|NCT01922349|76856|P1|COMPLETED|Multiple Rising Dose (MRD) Period||24
32229|NCT01922349|76853|P4|STARTED|Multiple Rising Dose (MRD) Period||27
32230|NCT01922349|76854|P3|STARTED|Multiple Rising Dose (MRD) Period||18
32231|NCT01922349|76855|P2|STARTED|Multiple Rising Dose (MRD) Period||27
32232|NCT01922349|76856|P1|STARTED|Multiple Rising Dose (MRD) Period|One subject discontinued the trial after the SRD period due to non-compliance with the protocol.|24
32233|NCT01922349|76853|P4|NOT COMPLETED|Single Rising Dose (SRD) Period||0
32234|NCT01922349|76854|P3|NOT COMPLETED|Single Rising Dose (SRD) Period||0
32235|NCT01922349|76855|P2|NOT COMPLETED|Single Rising Dose (SRD) Period||0
32236|NCT01922349|76856|P1|NOT COMPLETED|Single Rising Dose (SRD) Period||0
32237|NCT01922349|76853|P4|COMPLETED|Single Rising Dose (SRD) Period||27
32238|NCT01922349|76854|P3|COMPLETED|Single Rising Dose (SRD) Period||18
32239|NCT01922349|76855|P2|COMPLETED|Single Rising Dose (SRD) Period||27
32240|NCT01922349|76856|P1|COMPLETED|Single Rising Dose (SRD) Period||25
32241|NCT01922349|76853|P4|STARTED|Single Rising Dose (SRD) Period||27
32242|NCT01922349|76854|P3|STARTED|Single Rising Dose (SRD) Period||18
32243|NCT01922349|76855|P2|STARTED|Single Rising Dose (SRD) Period||27
32244|NCT01922349|76856|P1|STARTED|Single Rising Dose (SRD) Period||25
32245|NCT01922271|76963|P2|NOT COMPLETED|PERIOD 2||0
32246|NCT01922271|76964|P1|NOT COMPLETED|PERIOD 2||0
32247|NCT01922271|76963|P2|COMPLETED|PERIOD 2||76
32248|NCT01922271|76964|P1|COMPLETED|PERIOD 2||75
32249|NCT01922271|76963|P2|STARTED|PERIOD 2||76
32250|NCT01922271|76964|P1|STARTED|PERIOD 2||75
32251|NCT01922271|76963|P2|NOT COMPLETED|WASHOUT Period||0
32252|NCT01922271|76964|P1|NOT COMPLETED|WASHOUT Period||1
32253|NCT01922271|76963|P2|COMPLETED|WASHOUT Period||76
32254|NCT01922271|76964|P1|COMPLETED|WASHOUT Period||75
32255|NCT01922271|76963|P2|STARTED|WASHOUT Period||76
32256|NCT01922271|76964|P1|STARTED|WASHOUT Period||76
32257|NCT01922271|76963|P2|NOT COMPLETED|PERIOD 1||0
32258|NCT01922271|76964|P1|NOT COMPLETED|PERIOD 1||0
32259|NCT01922271|76963|P2|COMPLETED|PERIOD 1||76
32260|NCT01922271|76964|P1|COMPLETED|PERIOD 1||76
32261|NCT01922271|76963|P2|STARTED|PERIOD 1||76
32262|NCT01922271|76964|P1|STARTED|PERIOD 1||76
32263|NCT01922219|76982|P1|NOT COMPLETED|Overall Study||6
32264|NCT01922219|76982|P1|COMPLETED|Overall Study||32
32265|NCT01922219|76982|P1|STARTED|Overall Study||38
32266|NCT01922115|76988|P2|NOT COMPLETED|Overall Study||7
32267|NCT01922115|76989|P1|NOT COMPLETED|Overall Study||7
32268|NCT01922115|76988|P2|COMPLETED|Overall Study||24
32269|NCT01922115|76989|P1|COMPLETED|Overall Study||21
32270|NCT01922115|76988|P2|STARTED|Overall Study||31
32271|NCT01922115|76989|P1|STARTED|Overall Study||28
32272|NCT01922089|77003|P2|NOT COMPLETED|Overall Study||30
32273|NCT01922089|77004|P1|NOT COMPLETED|Overall Study||39
32274|NCT01922089|77003|P2|COMPLETED|Overall Study||221
32275|NCT01922089|77004|P1|COMPLETED|Overall Study||208
32276|NCT01922089|77003|P2|Safety Set|Overall Study||251
32277|NCT01922089|77004|P1|Safety Set|Overall Study||246
32278|NCT01922089|77003|P2|STARTED|Overall Study||251
32279|NCT01922089|77004|P1|STARTED|Overall Study||247
32280|NCT01922011|77016|P2|NOT COMPLETED|Overall Study||5
32281|NCT01922011|77017|P1|NOT COMPLETED|Overall Study||6
32282|NCT01922011|77016|P2|COMPLETED|Overall Study||69
32283|NCT01922011|77017|P1|COMPLETED|Overall Study||69
32284|NCT01922011|77016|P2|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|72
32380|NCT01920282|77423|P2|COMPLETED|Overall Study||15
32285|NCT01922011|77017|P1|Treatment Actually Received|Overall Study|One participant intended for treatment with Vancomycin or Nafcillin was treated with Daptomycin|74
32286|NCT01922011|77016|P2|Treated|Overall Study|Treated Participants|73
32287|NCT01922011|77017|P1|Treated|Overall Study|Treated Participants|73
32288|NCT01922011|77016|P2|STARTED|Overall Study|Randomized participants|74
32289|NCT01922011|77017|P1|STARTED|Overall Study|Randomized participants|75
32290|NCT01921894|77060|P3|NOT COMPLETED|Overall Study||0
32291|NCT01921894|77061|P2|NOT COMPLETED|Overall Study||0
32292|NCT01921894|77062|P1|NOT COMPLETED|Overall Study||0
32293|NCT01921894|77060|P3|COMPLETED|Overall Study||8
32294|NCT01921894|77061|P2|COMPLETED|Overall Study||8
32295|NCT01921894|77062|P1|COMPLETED|Overall Study||8
32296|NCT01921894|77060|P3|STARTED|Overall Study||8
32297|NCT01921894|77061|P2|STARTED|Overall Study||8
32298|NCT01921894|77062|P1|STARTED|Overall Study||8
32299|NCT01921829|77084|P2|NOT COMPLETED|Overall Study||1
32300|NCT01921829|77085|P1|NOT COMPLETED|Overall Study||0
32301|NCT01921829|77084|P2|COMPLETED|Overall Study||8
32302|NCT01921829|77085|P1|COMPLETED|Overall Study||10
32303|NCT01921829|77084|P2|STARTED|Overall Study||9
32304|NCT01921829|77085|P1|STARTED|Overall Study||10
32305|NCT01921452|77131|P1|NOT COMPLETED|Overall Study||0
32306|NCT01921452|77131|P1|COMPLETED|Overall Study||283
32307|NCT01921452|77131|P1|STARTED|Overall Study||283
32308|NCT01921348|77138|P2|NOT COMPLETED|Overall Study||2
32309|NCT01921348|77139|P1|NOT COMPLETED|Overall Study||1
32310|NCT01921348|77138|P2|COMPLETED|Overall Study||7
32311|NCT01921348|77139|P1|COMPLETED|Overall Study||8
32312|NCT01921348|77138|P2|STARTED|Overall Study||9
32313|NCT01921348|77139|P1|STARTED|Overall Study||9
32314|NCT01921322|77151|P2|NOT COMPLETED|Overall Study||17
32315|NCT01921322|77152|P1|NOT COMPLETED|Overall Study||15
32316|NCT01921322|77151|P2|COMPLETED|Overall Study||44
32317|NCT01921322|77152|P1|COMPLETED|Overall Study||42
32318|NCT01921322|77151|P2|STARTED|Overall Study||61
32319|NCT01921322|77152|P1|STARTED|Overall Study||57
32320|NCT01921296|77160|P1|NOT COMPLETED|Overall Study||0
32321|NCT01921296|77160|P1|COMPLETED|Overall Study||2
32322|NCT01921296|77160|P1|STARTED|Overall Study||2
32323|NCT01921101|77170|P2|NOT COMPLETED|Overall Study||6
32324|NCT01921101|77171|P1|NOT COMPLETED|Overall Study||16
32325|NCT01921101|77170|P2|COMPLETED|Overall Study||32
32326|NCT01921101|77171|P1|COMPLETED|Overall Study||24
32327|NCT01921101|77170|P2|STARTED|Overall Study||38
32328|NCT01921101|77171|P1|STARTED|Overall Study||40
32329|NCT01920958|77179|P1|NOT COMPLETED|Overall Study||5
32330|NCT01920958|77179|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|228
32331|NCT01920958|77179|P1|STARTED|Overall Study||233
32332|NCT01920893|77197|P2|NOT COMPLETED|Overall Study||2
32333|NCT01920893|77198|P1|NOT COMPLETED|Overall Study||7
32334|NCT01920893|77197|P2|COMPLETED|Overall Study||28
32335|NCT01920893|77198|P1|COMPLETED|Overall Study||23
32336|NCT01920893|77197|P2|Treated (Safety Population)|Overall Study||30
32337|NCT01920893|77198|P1|Treated (Safety Population)|Overall Study||30
32338|NCT01920893|77197|P2|STARTED|Overall Study||30
32339|NCT01920893|77198|P1|STARTED|Overall Study||30
32340|NCT01920854|77231|P7|NOT COMPLETED|Overall Study||1
32341|NCT01920854|77232|P6|NOT COMPLETED|Overall Study||0
32342|NCT01920854|77233|P5|NOT COMPLETED|Overall Study||1
32343|NCT01920854|77234|P4|NOT COMPLETED|Overall Study||0
32344|NCT01920854|77235|P3|NOT COMPLETED|Overall Study||0
32345|NCT01920854|77236|P2|NOT COMPLETED|Overall Study||0
32346|NCT01920854|77237|P1|NOT COMPLETED|Overall Study||1
32347|NCT01920854|77231|P7|COMPLETED|Overall Study||5
32348|NCT01920854|77232|P6|COMPLETED|Overall Study||6
32349|NCT01920854|77233|P5|COMPLETED|Overall Study||5
32350|NCT01920854|77234|P4|COMPLETED|Overall Study||6
32351|NCT01920854|77235|P3|COMPLETED|Overall Study||6
32352|NCT01920854|77236|P2|COMPLETED|Overall Study||6
32353|NCT01920854|77237|P1|COMPLETED|Overall Study||11
32354|NCT01920854|77231|P7|STARTED|Overall Study||6
32355|NCT01920854|77232|P6|STARTED|Overall Study||6
32356|NCT01920854|77233|P5|STARTED|Overall Study||6
32357|NCT01920854|77234|P4|STARTED|Overall Study||6
32358|NCT01920854|77235|P3|STARTED|Overall Study||6
32359|NCT01920854|77236|P2|STARTED|Overall Study||6
32360|NCT01920854|77237|P1|STARTED|Overall Study||12
32361|NCT01920802|77364|P3|NOT COMPLETED|Overall Study||1
32362|NCT01920802|77365|P2|NOT COMPLETED|Overall Study||2
32363|NCT01920802|77366|P1|NOT COMPLETED|Overall Study||4
32364|NCT01920802|77364|P3|COMPLETED|Overall Study||10
32365|NCT01920802|77365|P2|COMPLETED|Overall Study||7
32366|NCT01920802|77366|P1|COMPLETED|Overall Study||7
32367|NCT01920802|77364|P3|STARTED|Overall Study||11
32368|NCT01920802|77365|P2|STARTED|Overall Study||9
32369|NCT01920802|77366|P1|STARTED|Overall Study||11
32370|NCT01920568|77397|P2|NOT COMPLETED|Overall Study||84
32371|NCT01920568|77398|P1|NOT COMPLETED|Overall Study||151
32372|NCT01920568|77397|P2|COMPLETED|Overall Study||75
32373|NCT01920568|77398|P1|COMPLETED|Overall Study||175
32374|NCT01920568|77397|P2|STARTED|Overall Study||159
32375|NCT01920568|77398|P1|STARTED|Overall Study||326
32376|NCT01920282|77422|P3|NOT COMPLETED|Overall Study||0
32377|NCT01920282|77423|P2|NOT COMPLETED|Overall Study||0
32378|NCT01920282|77424|P1|NOT COMPLETED|Overall Study||0
32381|NCT01920282|77424|P1|COMPLETED|Overall Study||15
32382|NCT01920282|77422|P3|STARTED|Overall Study||15
32383|NCT01920282|77423|P2|STARTED|Overall Study||15
32384|NCT01920282|77424|P1|STARTED|Overall Study||15
32385|NCT01920178|77437|P2|NOT COMPLETED|Overall Study||1
32386|NCT01920178|77438|P1|NOT COMPLETED|Overall Study||2
32387|NCT01920178|77437|P2|COMPLETED|Overall Study||1
32388|NCT01920178|77438|P1|COMPLETED|Overall Study||3
32389|NCT01920178|77437|P2|STARTED|Overall Study||2
32390|NCT01920178|77438|P1|STARTED|Overall Study||5
32391|NCT01919996|77448|P1|NOT COMPLETED|Overall Study||0
32392|NCT01919996|77448|P1|COMPLETED|Overall Study||8
32393|NCT01919996|77448|P1|STARTED|Overall Study||8
32394|NCT01919801|77456|P2|NOT COMPLETED|Overall Study||3
32395|NCT01919801|77457|P1|NOT COMPLETED|Overall Study||1
32396|NCT01919801|77456|P2|COMPLETED|Overall Study||57
32397|NCT01919801|77457|P1|COMPLETED|Overall Study||60
32398|NCT01919801|77456|P2|STARTED|Overall Study||60
32399|NCT01919801|77457|P1|STARTED|Overall Study||61
32400|NCT01919723|77482|P2|NOT COMPLETED|Overall Study||2
32401|NCT01919723|77483|P1|NOT COMPLETED|Overall Study||2
32402|NCT01919723|77482|P2|COMPLETED|Overall Study||33
32403|NCT01919723|77483|P1|COMPLETED|Overall Study||33
32404|NCT01919723|77482|P2|STARTED|Overall Study||35
32405|NCT01919723|77483|P1|STARTED|Overall Study||35
32406|NCT01919606|77497|P2|NOT COMPLETED|Overall Study||0
32407|NCT01919606|77498|P1|NOT COMPLETED|Overall Study||0
32408|NCT01919606|77497|P2|COMPLETED|Overall Study||0
32409|NCT01919606|77498|P1|COMPLETED|Overall Study||1
32410|NCT01919606|77497|P2|STARTED|Overall Study||0
32411|NCT01919606|77498|P1|STARTED|Overall Study||1
32412|NCT01919450|77510|P4|NOT COMPLETED|Overall Study||1
32413|NCT01919450|77511|P3|NOT COMPLETED|Overall Study||0
32414|NCT01919450|77512|P2|NOT COMPLETED|Overall Study||0
32415|NCT01919450|77513|P1|NOT COMPLETED|Overall Study||0
32416|NCT01919450|77510|P4|COMPLETED|Overall Study||19
32417|NCT01919450|77511|P3|COMPLETED|Overall Study||20
32418|NCT01919450|77512|P2|COMPLETED|Overall Study||20
32419|NCT01919450|77513|P1|COMPLETED|Overall Study||20
32420|NCT01919450|77510|P4|STARTED|Overall Study||20
32421|NCT01919450|77511|P3|STARTED|Overall Study||20
32422|NCT01919450|77512|P2|STARTED|Overall Study||20
32423|NCT01919450|77513|P1|STARTED|Overall Study||20
32424|NCT01919229|77526|P3|NOT COMPLETED|Overall Study||1
32425|NCT01919229|77527|P2|NOT COMPLETED|Overall Study||0
32426|NCT01919229|77528|P1|NOT COMPLETED|Overall Study||0
32427|NCT01919229|77526|P3|COMPLETED|Overall Study||3
32428|NCT01919229|77527|P2|COMPLETED|Overall Study||6
32429|NCT01919229|77528|P1|COMPLETED|Overall Study||4
32430|NCT01919229|77526|P3|STARTED|Overall Study||4
32431|NCT01919229|77527|P2|STARTED|Overall Study||6
32432|NCT01919229|77528|P1|STARTED|Overall Study||4
32433|NCT01918800|77559|P2|NOT COMPLETED|Overall Study||5
32434|NCT01918800|77560|P1|NOT COMPLETED|Overall Study||9
32435|NCT01918800|77559|P2|COMPLETED|Overall Study||104
32436|NCT01918800|77560|P1|COMPLETED|Overall Study||100
32437|NCT01918800|77559|P2|STARTED|Overall Study||109
32438|NCT01918800|77560|P1|STARTED|Overall Study||109
32439|NCT01918371|77580|P2|NOT COMPLETED|Overall Study||1
32440|NCT01918371|77581|P1|NOT COMPLETED|Overall Study||1
32441|NCT01918371|77580|P2|COMPLETED|Overall Study||156
32442|NCT01918371|77581|P1|COMPLETED|Overall Study||165
32443|NCT01918371|77580|P2|Participants With Complete Data|Overall Study||156
32444|NCT01918371|77581|P1|Participants With Complete Data|Overall Study||165
32445|NCT01918371|77580|P2|STARTED|Overall Study||157
32446|NCT01918371|77581|P1|STARTED|Overall Study||166
32447|NCT01918332|77659|P4|NOT COMPLETED|Overall Study||7
32448|NCT01918332|77660|P3|NOT COMPLETED|Overall Study||9
32449|NCT01918332|77661|P2|NOT COMPLETED|Overall Study||5
32450|NCT01918332|77662|P1|NOT COMPLETED|Overall Study||8
32451|NCT01918332|77659|P4|COMPLETED|Overall Study||38
32452|NCT01918332|77660|P3|COMPLETED|Overall Study||30
32453|NCT01918332|77661|P2|COMPLETED|Overall Study||36
32454|NCT01918332|77662|P1|COMPLETED|Overall Study||35
32455|NCT01918332|77659|P4|STARTED|Overall Study||45
32456|NCT01918332|77660|P3|STARTED|Overall Study||39
32457|NCT01918332|77661|P2|STARTED|Overall Study||41
32458|NCT01918332|77662|P1|STARTED|Overall Study||43
32459|NCT01918306|77674|P4|NOT COMPLETED|Overall Study||3
32460|NCT01918306|77675|P3|NOT COMPLETED|Overall Study||2
32461|NCT01918306|77676|P2|NOT COMPLETED|Overall Study||0
32462|NCT01918306|77677|P1|NOT COMPLETED|Overall Study||6
32463|NCT01918306|77674|P4|COMPLETED|Overall Study||0
32464|NCT01918306|77675|P3|COMPLETED|Overall Study||0
32465|NCT01918306|77676|P2|COMPLETED|Overall Study||0
32466|NCT01918306|77677|P1|COMPLETED|Overall Study||0
32467|NCT01918306|77674|P4|STARTED|Overall Study||3
32468|NCT01918306|77675|P3|STARTED|Overall Study|1 participant Crossed-over to ARM 2|2
32469|NCT01918306|77676|P2|STARTED|Overall Study|No patients enrolled|0
32470|NCT01918306|77677|P1|STARTED|Overall Study||6
32471|NCT01918085|77699|P2|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
32472|NCT01918085|77700|P1|NOT COMPLETED|Test Period 2: Hydrocolloid Strip||0
32473|NCT01918085|77699|P2|COMPLETED|Test Period 2: Hydrocolloid Strip||11
32474|NCT01918085|77700|P1|COMPLETED|Test Period 2: Hydrocolloid Strip||10
32475|NCT01918085|77699|P2|STARTED|Test Period 2: Hydrocolloid Strip||11
32476|NCT01918085|77700|P1|STARTED|Test Period 2: Hydrocolloid Strip||10
32477|NCT01918085|77699|P2|NOT COMPLETED|Test Period 2: Strata Strip||0
32478|NCT01918085|77700|P1|NOT COMPLETED|Test Period 2: Strata Strip||0
32479|NCT01918085|77699|P2|COMPLETED|Test Period 2: Strata Strip||11
32480|NCT01918085|77700|P1|COMPLETED|Test Period 2: Strata Strip||10
32481|NCT01918085|77699|P2|STARTED|Test Period 2: Strata Strip||11
32482|NCT01918085|77700|P1|STARTED|Test Period 2: Strata Strip||10
32483|NCT01918085|77699|P2|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
32484|NCT01918085|77700|P1|NOT COMPLETED|Test Period 1: Hydrocolloid Strip||0
32485|NCT01918085|77699|P2|COMPLETED|Test Period 1: Hydrocolloid Strip||11
32486|NCT01918085|77700|P1|COMPLETED|Test Period 1: Hydrocolloid Strip||10
32487|NCT01918085|77699|P2|STARTED|Test Period 1: Hydrocolloid Strip||11
32488|NCT01918085|77700|P1|STARTED|Test Period 1: Hydrocolloid Strip||10
32489|NCT01918085|77699|P2|NOT COMPLETED|Test Period 1: Strata Strip||1
32490|NCT01918085|77700|P1|NOT COMPLETED|Test Period 1: Strata Strip||0
32491|NCT01918085|77699|P2|COMPLETED|Test Period 1: Strata Strip||11
32492|NCT01918085|77700|P1|COMPLETED|Test Period 1: Strata Strip||10
32493|NCT01918085|77699|P2|STARTED|Test Period 1: Strata Strip||12
32494|NCT01918085|77700|P1|STARTED|Test Period 1: Strata Strip||10
32495|NCT01918033|77711|P3|NOT COMPLETED|Overall Study||3
32496|NCT01918033|77712|P2|NOT COMPLETED|Overall Study||2
32497|NCT01918033|77713|P1|NOT COMPLETED|Overall Study||5
32498|NCT01918033|77711|P3|COMPLETED|Overall Study||199
32499|NCT01918033|77712|P2|COMPLETED|Overall Study||201
32500|NCT01918033|77713|P1|COMPLETED|Overall Study||198
32501|NCT01918033|77711|P3|Treated|Overall Study|One randomized participant did not receive study drug.|201
32502|NCT01918033|77712|P2|Treated|Overall Study||203
32503|NCT01918033|77713|P1|Treated|Overall Study|One randomized participant did not receive study drug.|202
32504|NCT01918033|77711|P3|STARTED|Overall Study||202
32505|NCT01918033|77712|P2|STARTED|Overall Study||203
32506|NCT01918033|77713|P1|STARTED|Overall Study||203
32507|NCT01917812|77754|P3|NOT COMPLETED|Overall Study||0
32508|NCT01917812|77755|P2|NOT COMPLETED|Overall Study||0
32509|NCT01917812|77756|P1|NOT COMPLETED|Overall Study||1
32510|NCT01917812|77754|P3|COMPLETED|Overall Study||16
32511|NCT01917812|77755|P2|COMPLETED|Overall Study||16
32512|NCT01917812|77756|P1|COMPLETED|Overall Study||15
32513|NCT01917812|77754|P3|STARTED|Overall Study||16
32514|NCT01917812|77755|P2|STARTED|Overall Study||16
32515|NCT01917812|77756|P1|STARTED|Overall Study||16
32516|NCT01917773|77776|P1|NOT COMPLETED|Overall Study||0
32517|NCT01917773|77776|P1|COMPLETED|Overall Study||13
32518|NCT01917773|77776|P1|STARTED|Overall Study||13
32519|NCT01917656|77784|P2|NOT COMPLETED|Overall Study||24
32520|NCT01917656|77785|P1|NOT COMPLETED|Overall Study||26
32521|NCT01917656|77784|P2|COMPLETED|Overall Study||147
32522|NCT01917656|77785|P1|COMPLETED|Overall Study||146
32523|NCT01917656|77784|P2|Exposed During Ramadan (Fasting)|Overall Study||163
32524|NCT01917656|77785|P1|Exposed During Ramadan (Fasting)|Overall Study||152
32525|NCT01917656|77784|P2|Exposed|Overall Study|1 subject was withdrawn prior to exposure to first SU dose after randomisation|170
32526|NCT01917656|77785|P1|Exposed|Overall Study|1 subject was withdrawn prior to exposure to trial products|171
32527|NCT01917656|77784|P2|STARTED|Overall Study||171
32528|NCT01917656|77785|P1|STARTED|Overall Study||172
32529|NCT01917526|77811|P2|NOT COMPLETED|Overall Study||1
32530|NCT01917526|77812|P1|NOT COMPLETED|Overall Study||1
32531|NCT01917526|77811|P2|COMPLETED|Overall Study|1 patient in oxygen cannula group receive oxygen mask|249
32532|NCT01917526|77812|P1|COMPLETED|Overall Study|One patient in oxygen mask received oxygen cannula|249
32533|NCT01917526|77811|P2|STARTED|Overall Study||250
32534|NCT01917526|77812|P1|STARTED|Overall Study||250
32535|NCT01917344|77820|P1|NOT COMPLETED|Overall Study||1
32536|NCT01917344|77820|P1|COMPLETED|Overall Study||9
32537|NCT01917344|77820|P1|STARTED|Overall Study||10
32538|NCT01917214|77824|P1|NOT COMPLETED|Overall Study||0
32539|NCT01917214|77824|P1|COMPLETED|Overall Study||212
32540|NCT01917214|77824|P1|STARTED|Overall Study||212
32541|NCT01916980|77835|P2|NOT COMPLETED|Overall Study||4
32542|NCT01916980|77836|P1|NOT COMPLETED|Overall Study||7
32543|NCT01916980|77835|P2|COMPLETED|Overall Study||25
32544|NCT01916980|77836|P1|COMPLETED|Overall Study||58
32545|NCT01916980|77835|P2|STARTED|Overall Study||29
32546|NCT01916980|77836|P1|STARTED|Overall Study||65
32547|NCT01916967|77855|P3|NOT COMPLETED|Overall Study||9
32548|NCT01916967|77856|P2|NOT COMPLETED|Overall Study||1
32549|NCT01916967|77857|P1|NOT COMPLETED|Overall Study||0
32550|NCT01916967|77855|P3|COMPLETED|Overall Study||71
32551|NCT01916967|77856|P2|COMPLETED|Overall Study||78
32552|NCT01916967|77857|P1|COMPLETED|Overall Study||80
32553|NCT01916967|77855|P3|STARTED|Overall Study||80
32554|NCT01916967|77856|P2|STARTED|Overall Study||79
32555|NCT01916967|77857|P1|STARTED|Overall Study||80
32556|NCT01916928|77898|P1|NOT COMPLETED|Overall Study||0
32557|NCT01916928|77898|P1|COMPLETED|Overall Study||50
32558|NCT01916928|77898|P1|STARTED|Overall Study||50
32559|NCT01916681|77906|P4|NOT COMPLETED|Overall Study||0
32560|NCT01916681|77907|P3|NOT COMPLETED|Overall Study||0
32561|NCT01916681|77908|P2|NOT COMPLETED|Overall Study||0
32562|NCT01916681|77909|P1|NOT COMPLETED|Overall Study||0
32563|NCT01916681|77906|P4|COMPLETED|Overall Study||125
32564|NCT01916681|77907|P3|COMPLETED|Overall Study||123
32565|NCT01916681|77908|P2|COMPLETED|Overall Study||120
32566|NCT01916681|77909|P1|COMPLETED|Overall Study||123
32567|NCT01916681|77906|P4|STARTED|Overall Study||125
32568|NCT01916681|77907|P3|STARTED|Overall Study||123
32569|NCT01916681|77908|P2|STARTED|Overall Study||120
32570|NCT01916681|77909|P1|STARTED|Overall Study||123
32571|NCT01916629|77949|P2|NOT COMPLETED|Overall Study||0
32572|NCT01916629|77950|P1|NOT COMPLETED|Overall Study||0
32573|NCT01916629|77949|P2|COMPLETED|Overall Study||5
32574|NCT01916629|77950|P1|COMPLETED|Overall Study||7
32575|NCT01916629|77949|P2|STARTED|Overall Study||5
32576|NCT01916629|77950|P1|STARTED|Overall Study||7
32577|NCT01916590|77958|P2|NOT COMPLETED|Overall Study||0
32578|NCT01916590|77959|P1|NOT COMPLETED|Overall Study||0
32579|NCT01916590|77958|P2|COMPLETED|Overall Study||3
32580|NCT01916590|77959|P1|COMPLETED|Overall Study||4
32581|NCT01916590|77958|P2|STARTED|Overall Study||3
32582|NCT01916590|77959|P1|STARTED|Overall Study||4
32583|NCT01916304|77965|P1|NOT COMPLETED|Overall Study||17
32584|NCT01916304|77965|P1|COMPLETED|Overall Study||84
32585|NCT01916304|77965|P1|Intent-to-Treat Set|Overall Study||84
32586|NCT01916304|77965|P1|Safety Set|Overall Study||101
32587|NCT01916304|77965|P1|STARTED|Overall Study||101
32588|NCT01916226|77977|P4|NOT COMPLETED|Overall Study||4
32589|NCT01916226|77978|P3|NOT COMPLETED|Overall Study||3
32590|NCT01916226|77979|P2|NOT COMPLETED|Overall Study||1
32591|NCT01916226|77980|P1|NOT COMPLETED|Overall Study||1
32592|NCT01916226|77977|P4|COMPLETED|Overall Study||167
32593|NCT01916226|77978|P3|COMPLETED|Overall Study||168
32594|NCT01916226|77979|P2|COMPLETED|Overall Study||169
32595|NCT01916226|77980|P1|COMPLETED|Overall Study||169
32596|NCT01916226|77977|P4|STARTED|Overall Study||171
32597|NCT01916226|77978|P3|STARTED|Overall Study||171
32598|NCT01916226|77979|P2|STARTED|Overall Study||170
32599|NCT01916226|77980|P1|STARTED|Overall Study||170
32600|NCT01916109|78014|P1|NOT COMPLETED|Overall Study||1
32601|NCT01916109|78014|P1|COMPLETED|Overall Study||3
32602|NCT01916109|78014|P1|STARTED|Overall Study||4
32603|NCT01915914|78018|P4|NOT COMPLETED|Follow-up Phase||2
32604|NCT01915914|78019|P3|NOT COMPLETED|Follow-up Phase||0
32605|NCT01915914|78020|P2|NOT COMPLETED|Follow-up Phase||0
32606|NCT01915914|78021|P1|NOT COMPLETED|Follow-up Phase||0
32607|NCT01915914|78018|P4|COMPLETED|Follow-up Phase||64
32608|NCT01915914|78019|P3|COMPLETED|Follow-up Phase||0
32609|NCT01915914|78020|P2|COMPLETED|Follow-up Phase||0
32610|NCT01915914|78021|P1|COMPLETED|Follow-up Phase||0
32611|NCT01915914|78018|P4|STARTED|Follow-up Phase||66
32612|NCT01915914|78019|P3|STARTED|Follow-up Phase||0
32613|NCT01915914|78020|P2|STARTED|Follow-up Phase||0
32614|NCT01915914|78021|P1|STARTED|Follow-up Phase||0
32615|NCT01915914|78018|P4|NOT COMPLETED|Maintenance Phase||0
32616|NCT01915914|78019|P3|NOT COMPLETED|Maintenance Phase||2
32617|NCT01915914|78020|P2|NOT COMPLETED|Maintenance Phase||6
32618|NCT01915914|78021|P1|NOT COMPLETED|Maintenance Phase||0
32619|NCT01915914|78018|P4|COMPLETED|Maintenance Phase||0
32620|NCT01915914|78019|P3|COMPLETED|Maintenance Phase||51
32621|NCT01915914|78020|P2|COMPLETED|Maintenance Phase||48
32622|NCT01915914|78021|P1|COMPLETED|Maintenance Phase||0
32623|NCT01915914|78018|P4|STARTED|Maintenance Phase||0
32624|NCT01915914|78019|P3|STARTED|Maintenance Phase||53
32625|NCT01915914|78020|P2|STARTED|Maintenance Phase||54
32626|NCT01915914|78021|P1|STARTED|Maintenance Phase||0
32627|NCT01915914|78018|P4|NOT COMPLETED|Acute Phase||0
32628|NCT01915914|78019|P3|NOT COMPLETED|Acute Phase||0
32629|NCT01915914|78020|P2|NOT COMPLETED|Acute Phase||0
32630|NCT01915914|78021|P1|NOT COMPLETED|Acute Phase||12
32631|NCT01915914|78018|P4|COMPLETED|Acute Phase||0
32632|NCT01915914|78019|P3|COMPLETED|Acute Phase||0
32633|NCT01915914|78020|P2|COMPLETED|Acute Phase||0
32634|NCT01915914|78021|P1|COMPLETED|Acute Phase||111
32635|NCT01915914|78018|P4|Completed–Not Entered Maintenance Phase|Acute Phase||0
32636|NCT01915914|78019|P3|Completed–Not Entered Maintenance Phase|Acute Phase||0
32637|NCT01915914|78020|P2|Completed–Not Entered Maintenance Phase|Acute Phase||0
32638|NCT01915914|78021|P1|Completed–Not Entered Maintenance Phase|Acute Phase||4
32639|NCT01915914|78018|P4|STARTED|Acute Phase||0
32640|NCT01915914|78019|P3|STARTED|Acute Phase||0
32641|NCT01915914|78020|P2|STARTED|Acute Phase||0
32642|NCT01915914|78021|P1|STARTED|Acute Phase||123
32643|NCT01915849|78053|P4|NOT COMPLETED|Treatment Period 4 (4 Days)||0
32644|NCT01915849|78054|P3|NOT COMPLETED|Treatment Period 4 (4 Days)||0
32645|NCT01915849|78055|P2|NOT COMPLETED|Treatment Period 4 (4 Days)||0
32646|NCT01915849|78056|P1|NOT COMPLETED|Treatment Period 4 (4 Days)||0
32647|NCT01915849|78053|P4|COMPLETED|Treatment Period 4 (4 Days)||3
32648|NCT01915849|78054|P3|COMPLETED|Treatment Period 4 (4 Days)||3
32649|NCT01915849|78055|P2|COMPLETED|Treatment Period 4 (4 Days)||3
32650|NCT01915849|78056|P1|COMPLETED|Treatment Period 4 (4 Days)||3
32651|NCT01915849|78053|P4|STARTED|Treatment Period 4 (4 Days)||3
32652|NCT01915849|78054|P3|STARTED|Treatment Period 4 (4 Days)||3
32653|NCT01915849|78055|P2|STARTED|Treatment Period 4 (4 Days)||3
32654|NCT01915849|78056|P1|STARTED|Treatment Period 4 (4 Days)||3
32655|NCT01915849|78053|P4|NOT COMPLETED|Treatment Period 3 (4 Days)||0
32656|NCT01915849|78054|P3|NOT COMPLETED|Treatment Period 3 (4 Days)||0
32657|NCT01915849|78055|P2|NOT COMPLETED|Treatment Period 3 (4 Days)||0
32658|NCT01915849|78056|P1|NOT COMPLETED|Treatment Period 3 (4 Days)||0
32659|NCT01915849|78053|P4|COMPLETED|Treatment Period 3 (4 Days)||3
32660|NCT01915849|78054|P3|COMPLETED|Treatment Period 3 (4 Days)||3
32661|NCT01915849|78055|P2|COMPLETED|Treatment Period 3 (4 Days)||3
32662|NCT01915849|78056|P1|COMPLETED|Treatment Period 3 (4 Days)||3
32663|NCT01915849|78053|P4|STARTED|Treatment Period 3 (4 Days)||3
32664|NCT01915849|78054|P3|STARTED|Treatment Period 3 (4 Days)||3
32665|NCT01915849|78055|P2|STARTED|Treatment Period 3 (4 Days)||3
32666|NCT01915849|78056|P1|STARTED|Treatment Period 3 (4 Days)||3
32667|NCT01915849|78053|P4|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32668|NCT01915849|78054|P3|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32669|NCT01915849|78055|P2|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32670|NCT01915849|78056|P1|NOT COMPLETED|Treatment Period 2 (4 Days)||0
32671|NCT01915849|78053|P4|COMPLETED|Treatment Period 2 (4 Days)||3
32672|NCT01915849|78054|P3|COMPLETED|Treatment Period 2 (4 Days)||3
32673|NCT01915849|78055|P2|COMPLETED|Treatment Period 2 (4 Days)||3
32674|NCT01915849|78056|P1|COMPLETED|Treatment Period 2 (4 Days)||3
32675|NCT01915849|78053|P4|STARTED|Treatment Period 2 (4 Days)||3
32676|NCT01915849|78054|P3|STARTED|Treatment Period 2 (4 Days)||3
32677|NCT01915849|78055|P2|STARTED|Treatment Period 2 (4 Days)||3
32678|NCT01915849|78056|P1|STARTED|Treatment Period 2 (4 Days)||3
32679|NCT01915849|78053|P4|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32680|NCT01915849|78054|P3|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32681|NCT01915849|78055|P2|NOT COMPLETED|Treatment Period 1 (4 Days)||0
32682|NCT01915849|78056|P1|NOT COMPLETED|Treatment Period 1 (4 Days)||2
32683|NCT01915849|78053|P4|COMPLETED|Treatment Period 1 (4 Days)||3
32684|NCT01915849|78054|P3|COMPLETED|Treatment Period 1 (4 Days)||3
32685|NCT01915849|78055|P2|COMPLETED|Treatment Period 1 (4 Days)||3
32686|NCT01915849|78056|P1|COMPLETED|Treatment Period 1 (4 Days)||3
32687|NCT01915849|78053|P4|STARTED|Treatment Period 1 (4 Days)||3
32688|NCT01915849|78054|P3|STARTED|Treatment Period 1 (4 Days)||3
32689|NCT01915849|78055|P2|STARTED|Treatment Period 1 (4 Days)||3
32690|NCT01915849|78056|P1|STARTED|Treatment Period 1 (4 Days)||5
32691|NCT01915823|78068|P2|NOT COMPLETED|Overall Study||2
32692|NCT01915823|78069|P1|NOT COMPLETED|Overall Study||2
32693|NCT01915823|78068|P2|COMPLETED|Overall Study||173
32694|NCT01915823|78069|P1|COMPLETED|Overall Study||171
32695|NCT01915823|78068|P2|STARTED|Overall Study||175
32696|NCT01915823|78069|P1|STARTED|Overall Study||173
32697|NCT01915732|78081|P2|NOT COMPLETED|Overall Study||71
32698|NCT01915732|78082|P1|NOT COMPLETED|Overall Study||70
32699|NCT01915732|78081|P2|COMPLETED|Overall Study||445
32700|NCT01915732|78082|P1|COMPLETED|Overall Study||430
32701|NCT01915732|78081|P2|STARTED|Overall Study||516
32702|NCT01915732|78082|P1|STARTED|Overall Study||500
32703|NCT01915173|78110|P4|NOT COMPLETED|Overall Study||0
32704|NCT01915173|78111|P3|NOT COMPLETED|Overall Study||0
32705|NCT01915173|78112|P2|NOT COMPLETED|Overall Study||0
32706|NCT01915173|78113|P1|NOT COMPLETED|Overall Study||0
32707|NCT01915173|78110|P4|COMPLETED|Overall Study||6
32708|NCT01915173|78111|P3|COMPLETED|Overall Study||6
32709|NCT01915173|78112|P2|COMPLETED|Overall Study||6
32710|NCT01915173|78113|P1|COMPLETED|Overall Study||6
32711|NCT01915173|78110|P4|STARTED|Overall Study||6
32712|NCT01915173|78111|P3|STARTED|Overall Study||6
32713|NCT01915173|78112|P2|STARTED|Overall Study||6
32714|NCT01915173|78113|P1|STARTED|Overall Study||6
32715|NCT01915108|78135|P4|NOT COMPLETED|Overall Study||2
32716|NCT01915108|78136|P3|NOT COMPLETED|Overall Study||1
32717|NCT01915108|78137|P2|NOT COMPLETED|Overall Study||3
32718|NCT01915108|78138|P1|NOT COMPLETED|Overall Study||2
32719|NCT01915108|78135|P4|COMPLETED|Overall Study|two patients were excluded from the study|30
32720|NCT01915108|78136|P3|COMPLETED|Overall Study|one patients were excluded from the study|31
32721|NCT01915108|78137|P2|COMPLETED|Overall Study|three patients were excluded from the study|29
32722|NCT01915108|78138|P1|COMPLETED|Overall Study|two patients were excluded from the study|30
32723|NCT01915108|78135|P4|STARTED|Overall Study||32
32724|NCT01915108|78136|P3|STARTED|Overall Study||32
32725|NCT01915108|78137|P2|STARTED|Overall Study||32
32726|NCT01915108|78138|P1|STARTED|Overall Study||32
32727|NCT01914926|78150|P2|NOT COMPLETED|Overall Study||1
32728|NCT01914926|78151|P1|NOT COMPLETED|Overall Study||1
32729|NCT01914926|78150|P2|COMPLETED|Overall Study||24
32730|NCT01914926|78151|P1|COMPLETED|Overall Study||28
32731|NCT01914926|78150|P2|STARTED|Overall Study||25
32732|NCT01914926|78151|P1|STARTED|Overall Study||29
32733|NCT01914757|78160|P3|NOT COMPLETED|Overall Study||38
32734|NCT01914757|78161|P2|NOT COMPLETED|Overall Study||51
32735|NCT01914757|78162|P1|NOT COMPLETED|Overall Study||36
32736|NCT01914757|78160|P3|COMPLETED|Overall Study||402
32737|NCT01914757|78161|P2|COMPLETED|Overall Study||390
32738|NCT01914757|78162|P1|COMPLETED|Overall Study||389
32739|NCT01914757|78160|P3|STARTED|Overall Study||440
32740|NCT01914757|78161|P2|STARTED|Overall Study||441
32741|NCT01914757|78162|P1|STARTED|Overall Study||425
32742|NCT01914679|78236|P1|NOT COMPLETED|Overall Study||5
32743|NCT01914679|78236|P1|COMPLETED|Overall Study||12
32744|NCT01914679|78236|P1|Began 12 Week Actual RINCE Treatment|Overall Study||17
32745|NCT01914679|78236|P1|STARTED|Overall Study||17
32746|NCT01914666|78243|P3|NOT COMPLETED|Tapering Period||0
32747|NCT01914666|78244|P2|NOT COMPLETED|Tapering Period||0
32748|NCT01914666|78245|P1|NOT COMPLETED|Tapering Period||0
32749|NCT01914666|78243|P3|COMPLETED|Tapering Period||40
32750|NCT01914666|78244|P2|COMPLETED|Tapering Period||39
32751|NCT01914666|78245|P1|COMPLETED|Tapering Period||59
32752|NCT01914666|78243|P3|STARTED|Tapering Period|7 Pts who discontinued, and 33 Pts who completed Treatment Period entered Tapering Period.|40
32753|NCT01914666|78244|P2|STARTED|Tapering Period|3 Pts who discontinued, and 36 Pts who completed Treatment Period entered Tapering Period.|39
32754|NCT01914666|78245|P1|STARTED|Tapering Period|4 Pts who discontinued, and 55 Pts who completed Treatment Period entered Tapering Period.|59
32755|NCT01914666|78243|P3|NOT COMPLETED|Treatment Period||8
32756|NCT01914666|78244|P2|NOT COMPLETED|Treatment Period||6
32757|NCT01914666|78245|P1|NOT COMPLETED|Treatment Period||13
32758|NCT01914666|78243|P3|COMPLETED|Treatment Period||33
32759|NCT01914666|78244|P2|COMPLETED|Treatment Period||36
32760|NCT01914666|78245|P1|COMPLETED|Treatment Period||55
32761|NCT01914666|78243|P3|Received at Least 1 Dose of Study Drug|Treatment Period||41
32762|NCT01914666|78244|P2|Received at Least 1 Dose of Study Drug|Treatment Period||42
32763|NCT01914666|78245|P1|Received at Least 1 Dose of Study Drug|Treatment Period||68
32764|NCT01914666|78243|P3|STARTED|Treatment Period||41
32765|NCT01914666|78244|P2|STARTED|Treatment Period||42
32766|NCT01914666|78245|P1|STARTED|Treatment Period||68
32767|NCT01914003|78280|P2|NOT COMPLETED|Overall Study||12
32768|NCT01914003|78281|P1|NOT COMPLETED|Overall Study||8
32769|NCT01914003|78280|P2|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|14
32770|NCT01914003|78281|P1|COMPLETED|Overall Study|Number of subjects who completed through study and qualify as evaluable|19
32771|NCT01914003|78280|P2|STARTED|Overall Study||26
32772|NCT01914003|78281|P1|STARTED|Overall Study||27
32773|NCT01913795|78291|P4|NOT COMPLETED|Overall Study||1
32774|NCT01913795|78292|P3|NOT COMPLETED|Overall Study||0
32775|NCT01913795|78293|P2|NOT COMPLETED|Overall Study||3
32776|NCT01913795|78294|P1|NOT COMPLETED|Overall Study||0
32777|NCT01913795|78291|P4|COMPLETED|Overall Study||5
32778|NCT01913795|78292|P3|COMPLETED|Overall Study||9
32779|NCT01913795|78293|P2|COMPLETED|Overall Study||7
32780|NCT01913795|78294|P1|COMPLETED|Overall Study||4
32781|NCT01913795|78291|P4|STARTED|Overall Study||6
32782|NCT01913795|78292|P3|STARTED|Overall Study||9
32783|NCT01913795|78293|P2|STARTED|Overall Study||10
32784|NCT01913795|78294|P1|STARTED|Overall Study||4
32785|NCT01913535|78313|P5|NOT COMPLETED|Phase 2 (Days 3-5)||0
32786|NCT01913535|78314|P4|NOT COMPLETED|Phase 2 (Days 3-5)||0
32787|NCT01913535|78315|P3|NOT COMPLETED|Phase 2 (Days 3-5)||0
32788|NCT01913535|78316|P2|NOT COMPLETED|Phase 2 (Days 3-5)||0
32789|NCT01913535|78317|P1|NOT COMPLETED|Phase 2 (Days 3-5)||0
32790|NCT01913535|78313|P5|COMPLETED|Phase 2 (Days 3-5)||1
32791|NCT01913535|78314|P4|COMPLETED|Phase 2 (Days 3-5)||2
32792|NCT01913535|78315|P3|COMPLETED|Phase 2 (Days 3-5)||1
32793|NCT01913535|78316|P2|COMPLETED|Phase 2 (Days 3-5)||2
32794|NCT01913535|78317|P1|COMPLETED|Phase 2 (Days 3-5)||2
32795|NCT01913535|78313|P5|STARTED|Phase 2 (Days 3-5)||1
32796|NCT01913535|78314|P4|STARTED|Phase 2 (Days 3-5)||2
32797|NCT01913535|78315|P3|STARTED|Phase 2 (Days 3-5)||1
32798|NCT01913535|78316|P2|STARTED|Phase 2 (Days 3-5)||2
32799|NCT01913535|78317|P1|STARTED|Phase 2 (Days 3-5)||2
32800|NCT01913535|78313|P5|NOT COMPLETED|Phase 1 (Days 0-2)||0
32801|NCT01913535|78314|P4|NOT COMPLETED|Phase 1 (Days 0-2)||0
32802|NCT01913535|78315|P3|NOT COMPLETED|Phase 1 (Days 0-2)||0
32803|NCT01913535|78316|P2|NOT COMPLETED|Phase 1 (Days 0-2)||0
32804|NCT01913535|78317|P1|NOT COMPLETED|Phase 1 (Days 0-2)||0
32805|NCT01913535|78313|P5|COMPLETED|Phase 1 (Days 0-2)||1
32806|NCT01913535|78314|P4|COMPLETED|Phase 1 (Days 0-2)||2
32807|NCT01913535|78315|P3|COMPLETED|Phase 1 (Days 0-2)||1
32808|NCT01913535|78316|P2|COMPLETED|Phase 1 (Days 0-2)||2
32809|NCT01913535|78317|P1|COMPLETED|Phase 1 (Days 0-2)||2
32810|NCT01913535|78313|P5|STARTED|Phase 1 (Days 0-2)||1
32811|NCT01913535|78314|P4|STARTED|Phase 1 (Days 0-2)||2
32812|NCT01913535|78315|P3|STARTED|Phase 1 (Days 0-2)||1
32813|NCT01913535|78316|P2|STARTED|Phase 1 (Days 0-2)||2
32814|NCT01913535|78317|P1|STARTED|Phase 1 (Days 0-2)||2
32815|NCT01913483|78350|P2|NOT COMPLETED|Overall Study||22
32816|NCT01913483|78351|P1|NOT COMPLETED|Overall Study||21
32817|NCT01913483|78350|P2|COMPLETED|Overall Study||343
32818|NCT01913483|78351|P1|COMPLETED|Overall Study||346
32819|NCT01913483|78350|P2|Received at Least 1 Dose of Study Drug|Overall Study||321
32820|NCT01913483|78351|P1|Received at Least 1 Dose of Study Drug|Overall Study||335
32821|NCT01913483|78350|P2|STARTED|Overall Study||365
32822|NCT01913483|78351|P1|STARTED|Overall Study||367
32823|NCT01913470|78363|P2|NOT COMPLETED|Overall Study||3
32824|NCT01913470|78364|P1|NOT COMPLETED|Overall Study||0
32825|NCT01913470|78363|P2|COMPLETED|Overall Study||4
32826|NCT01913470|78364|P1|COMPLETED|Overall Study||5
32827|NCT01913470|78363|P2|STARTED|Overall Study||7
32828|NCT01913470|78364|P1|STARTED|Overall Study||5
32829|NCT01913041|78382|P1|NOT COMPLETED|Overall Study||39
32830|NCT01913041|78382|P1|COMPLETED|Overall Study||830
32831|NCT01913041|78382|P1|STARTED|Overall Study||869
32832|NCT01912781|78388|P2|NOT COMPLETED|Overall Study||0
32833|NCT01912781|78389|P1|NOT COMPLETED|Overall Study||2
32834|NCT01912781|78388|P2|COMPLETED|Overall Study||35
32835|NCT01912781|78389|P1|COMPLETED|Overall Study||69
32836|NCT01912781|78388|P2|STARTED|Overall Study||35
32837|NCT01912781|78389|P1|STARTED|Overall Study||71
32838|NCT01912768|78420|P2|NOT COMPLETED|Overall Study||4
32839|NCT01912768|78421|P1|NOT COMPLETED|Overall Study||10
32840|NCT01912768|78420|P2|COMPLETED|Overall Study||109
32841|NCT01912768|78421|P1|COMPLETED|Overall Study||229
32842|NCT01912768|78420|P2|STARTED|Overall Study||113
32843|NCT01912768|78421|P1|STARTED|Overall Study||239
32844|NCT01912599|78452|P2|NOT COMPLETED|Overall Study||1
32845|NCT01912599|78453|P1|NOT COMPLETED|Overall Study||0
32846|NCT01912599|78452|P2|COMPLETED|Overall Study||15
32847|NCT01912599|78453|P1|COMPLETED|Overall Study||20
32848|NCT01912599|78452|P2|STARTED|Overall Study||16
32849|NCT01912599|78453|P1|STARTED|Overall Study||20
32850|NCT01912495|78467|P1|NOT COMPLETED|Overall Study||0
32851|NCT01912495|78467|P1|COMPLETED|Overall Study||57
32852|NCT01912495|78467|P1|STARTED|Overall Study|8 patients had only screening visit, total enrollment: 65|57
32853|NCT01912404|78478|P2|NOT COMPLETED|Overall Study||0
32854|NCT01912404|78479|P1|NOT COMPLETED|Overall Study||1
32855|NCT01912404|78478|P2|COMPLETED|Overall Study||2
32856|NCT01912404|78479|P1|COMPLETED|Overall Study||2
32857|NCT01912404|78478|P2|STARTED|Overall Study||2
32858|NCT01912404|78479|P1|STARTED|Overall Study||3
32859|NCT01912352|78485|P1|NOT COMPLETED|Overall Study||5
32860|NCT01912352|78485|P1|COMPLETED|Overall Study||78
32861|NCT01912352|78485|P1|STARTED|Overall Study||83
32862|NCT01912339|78492|P3|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||53
32863|NCT01912339|78493|P2|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
32864|NCT01912339|78494|P1|NOT COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||133
32865|NCT01912339|78492|P3|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
32866|NCT01912339|78493|P2|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
32867|NCT01912339|78494|P1|COMPLETED|Unblinded (6 Months/Crossover to 5 Yrs)||0
32868|NCT01912339|78492|P3|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|Control subjects that have crossed over.|53
32869|NCT01912339|78493|P2|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)|All subjects for the control group either completed study or crossed over.|0
32870|NCT01912339|78494|P1|STARTED|Unblinded (6 Months/Crossover to 5 Yrs)||133
32871|NCT01912339|78492|P3|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
32872|NCT01912339|78493|P2|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||0
32873|NCT01912339|78494|P1|NOT COMPLETED|Unblinded (3 to 6 Months/Crossover)||1
32874|NCT01912339|78492|P3|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|0
32875|NCT01912339|78493|P2|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Of the 61 subjects, there were 53 crossover subjects and 8 that completed their study participation.|61
32876|NCT01912339|78494|P1|COMPLETED|Unblinded (3 to 6 Months/Crossover)|Still in study|133
32877|NCT01912339|78492|P3|STARTED|Unblinded (3 to 6 Months/Crossover)||0
32878|NCT01912339|78493|P2|STARTED|Unblinded (3 to 6 Months/Crossover)||61
32879|NCT01912339|78494|P1|STARTED|Unblinded (3 to 6 Months/Crossover)||134
32880|NCT01912339|78492|P3|NOT COMPLETED|Blinded (0 to 3 Months)||0
32881|NCT01912339|78493|P2|NOT COMPLETED|Blinded (0 to 3 Months)||0
32882|NCT01912339|78494|P1|NOT COMPLETED|Blinded (0 to 3 Months)||2
32883|NCT01912339|78492|P3|COMPLETED|Blinded (0 to 3 Months)||0
32884|NCT01912339|78493|P2|COMPLETED|Blinded (0 to 3 Months)||61
32885|NCT01912339|78494|P1|COMPLETED|Blinded (0 to 3 Months)||134
32886|NCT01912339|78492|P3|STARTED|Blinded (0 to 3 Months)||0
32887|NCT01912339|78493|P2|STARTED|Blinded (0 to 3 Months)||61
32888|NCT01912339|78494|P1|STARTED|Blinded (0 to 3 Months)||136
32889|NCT01912222|78511|P3|NOT COMPLETED|Part B: Treatment Period||20
32890|NCT01912222|78512|P2|NOT COMPLETED|Part B: Treatment Period||15
32891|NCT01912222|78513|P1|NOT COMPLETED|Part B: Treatment Period||13
32892|NCT01912222|78511|P3|COMPLETED|Part B: Treatment Period||0
32893|NCT01912222|78512|P2|COMPLETED|Part B: Treatment Period||0
32894|NCT01912222|78513|P1|COMPLETED|Part B: Treatment Period||0
32895|NCT01912222|78511|P3|STARTED|Part B: Treatment Period||20
32896|NCT01912222|78512|P2|STARTED|Part B: Treatment Period||15
32897|NCT01912222|78513|P1|STARTED|Part B: Treatment Period||13
32898|NCT01912222|78511|P3|NOT COMPLETED|Part A: Pharmacokinetic Period||2
32899|NCT01912222|78512|P2|NOT COMPLETED|Part A: Pharmacokinetic Period||2
32900|NCT01912222|78513|P1|NOT COMPLETED|Part A: Pharmacokinetic Period||1
32901|NCT01912222|78511|P3|COMPLETED|Part A: Pharmacokinetic Period||18
32902|NCT01912222|78512|P2|COMPLETED|Part A: Pharmacokinetic Period||13
32903|NCT01912222|78513|P1|COMPLETED|Part A: Pharmacokinetic Period||12
32904|NCT01912222|78511|P3|STARTED|Part A: Pharmacokinetic Period||20
32905|NCT01912222|78512|P2|STARTED|Part A: Pharmacokinetic Period||15
32906|NCT01912222|78513|P1|STARTED|Part A: Pharmacokinetic Period||13
32907|NCT01911845|78536|P1|NOT COMPLETED|Overall Study||6
32908|NCT01911845|78536|P1|COMPLETED|Overall Study||32
32909|NCT01911845|78536|P1|Completed Study Drug|Overall Study||37
32910|NCT01911845|78536|P1|STARTED|Overall Study||38
32911|NCT01911793|78552|P2|NOT COMPLETED|Overall Study||5
32912|NCT01911793|78553|P1|NOT COMPLETED|Overall Study||1
32913|NCT01911793|78552|P2|COMPLETED|Overall Study||0
32914|NCT01911793|78553|P1|COMPLETED|Overall Study||0
32915|NCT01911793|78552|P2|STARTED|Overall Study||5
32916|NCT01911793|78553|P1|STARTED|Overall Study||1
32917|NCT01911780|78575|P2|NOT COMPLETED|Extension Period (52 Weeks)||3
32918|NCT01911780|78576|P1|NOT COMPLETED|Extension Period (52 Weeks)||4
32919|NCT01911780|78575|P2|COMPLETED|Extension Period (52 Weeks)||58
32920|NCT01911780|78576|P1|COMPLETED|Extension Period (52 Weeks)||61
32921|NCT01911780|78575|P2|STARTED|Extension Period (52 Weeks)||61
32922|NCT01911780|78576|P1|STARTED|Extension Period (52 Weeks)||65
32923|NCT01911780|78575|P2|NOT COMPLETED|Double-blind Period (8 Weeks)||3
32924|NCT01911780|78576|P1|NOT COMPLETED|Double-blind Period (8 Weeks)||3
32925|NCT01911780|78575|P2|COMPLETED|Double-blind Period (8 Weeks)||61
32926|NCT01911780|78576|P1|COMPLETED|Double-blind Period (8 Weeks)||65
32927|NCT01911780|78575|P2|STARTED|Double-blind Period (8 Weeks)||64
32928|NCT01911780|78576|P1|STARTED|Double-blind Period (8 Weeks)||68
32929|NCT01911689|78596|P2|NOT COMPLETED|Overall Study||0
32930|NCT01911689|78597|P1|NOT COMPLETED|Overall Study||0
32931|NCT01911689|78596|P2|COMPLETED|Overall Study||51
32932|NCT01911689|78597|P1|COMPLETED|Overall Study||117
32933|NCT01911689|78596|P2|STARTED|Overall Study||51
32934|NCT01911689|78597|P1|STARTED|Overall Study||117
32935|NCT01911442|78613|P3|NOT COMPLETED|Overall Study||12
32936|NCT01911442|78614|P2|NOT COMPLETED|Overall Study||4
32937|NCT01911442|78615|P1|NOT COMPLETED|Overall Study||6
32938|NCT01911442|78613|P3|COMPLETED|Overall Study||38
32939|NCT01911442|78614|P2|COMPLETED|Overall Study||47
32940|NCT01911442|78615|P1|COMPLETED|Overall Study||43
32941|NCT01911442|78613|P3|STARTED|Overall Study||50
32942|NCT01911442|78614|P2|STARTED|Overall Study||51
32943|NCT01911442|78615|P1|STARTED|Overall Study||49
32944|NCT01911429|78644|P3|NOT COMPLETED|Overall Study||20
32945|NCT01911429|78645|P2|NOT COMPLETED|Overall Study||10
32946|NCT01911429|78646|P1|NOT COMPLETED|Overall Study||12
32947|NCT01911429|78644|P3|COMPLETED|Overall Study||93
32948|NCT01911429|78645|P2|COMPLETED|Overall Study||96
32949|NCT01911429|78646|P1|COMPLETED|Overall Study||96
32950|NCT01911429|78644|P3|STARTED|Overall Study|one subject randomized to Placebo group was never dosed for study medication, making the total 112|113
32951|NCT01911429|78645|P2|STARTED|Overall Study|Subjects received lurasidone 40/mg day from Days 1-3, and 80mg/day from days 4 to Week 6 visit|106
32952|NCT01911429|78646|P1|STARTED|Overall Study||108
32953|NCT01911403|78680|P2|NOT COMPLETED|Overall Study||3
32954|NCT01911403|78681|P1|NOT COMPLETED|Overall Study||9
32955|NCT01911403|78680|P2|COMPLETED|Overall Study||59
32956|NCT01911403|78681|P1|COMPLETED|Overall Study||52
32957|NCT01911403|78680|P2|STARTED|Overall Study||62
32958|NCT01911403|78681|P1|STARTED|Overall Study||61
32959|NCT01911390|78702|P4|NOT COMPLETED|Overall Study||1
32960|NCT01911390|78703|P3|NOT COMPLETED|Overall Study||1
32961|NCT01911390|78704|P2|NOT COMPLETED|Overall Study||0
32962|NCT01911390|78705|P1|NOT COMPLETED|Overall Study||1
32963|NCT01911390|78702|P4|COMPLETED|Overall Study||10
32964|NCT01911390|78703|P3|COMPLETED|Overall Study||9
32965|NCT01911390|78704|P2|COMPLETED|Overall Study||10
32966|NCT01911390|78705|P1|COMPLETED|Overall Study||9
32967|NCT01911390|78702|P4|STARTED|Overall Study||11
32968|NCT01911390|78703|P3|STARTED|Overall Study||10
32969|NCT01911390|78704|P2|STARTED|Overall Study||10
32970|NCT01911390|78705|P1|STARTED|Overall Study||10
32971|NCT01911351|78721|P2|NOT COMPLETED|Overall Study||0
32972|NCT01911351|78722|P1|NOT COMPLETED|Overall Study||0
32973|NCT01911351|78721|P2|COMPLETED|Overall Study||43
32974|NCT01911351|78722|P1|COMPLETED|Overall Study||39
32975|NCT01911351|78721|P2|STARTED|Overall Study||43
32976|NCT01911351|78722|P1|STARTED|Overall Study||39
32977|NCT01911273|78738|P2|NOT COMPLETED|Overall Study||2
32978|NCT01911273|78739|P1|NOT COMPLETED|Overall Study||1
32979|NCT01911273|78738|P2|COMPLETED|Overall Study||0
32980|NCT01911273|78739|P1|COMPLETED|Overall Study||0
32981|NCT01911273|78738|P2|STARTED|Overall Study||2
32982|NCT01911273|78739|P1|STARTED|Overall Study||1
32983|NCT01911260|78773|P4|NOT COMPLETED|Follow-up Period||12
32984|NCT01911260|78774|P3|NOT COMPLETED|Follow-up Period||15
32985|NCT01911260|78775|P2|NOT COMPLETED|Follow-up Period||20
32986|NCT01911260|78776|P1|NOT COMPLETED|Follow-up Period||13
32987|NCT01911260|78773|P4|COMPLETED|Follow-up Period||30
32988|NCT01911260|78774|P3|COMPLETED|Follow-up Period||24
32989|NCT01911260|78775|P2|COMPLETED|Follow-up Period||18
32990|NCT01911260|78776|P1|COMPLETED|Follow-up Period||27
32991|NCT01911260|78773|P4|STARTED|Follow-up Period||42
32992|NCT01911260|78774|P3|STARTED|Follow-up Period||39
32993|NCT01911260|78775|P2|STARTED|Follow-up Period||38
32994|NCT01911260|78776|P1|STARTED|Follow-up Period||40
32995|NCT01911260|78773|P4|NOT COMPLETED|Supplementation Period||8
32996|NCT01911260|78774|P3|NOT COMPLETED|Supplementation Period||10
32997|NCT01911260|78775|P2|NOT COMPLETED|Supplementation Period||12
32998|NCT01911260|78776|P1|NOT COMPLETED|Supplementation Period||10
32999|NCT01911260|78773|P4|COMPLETED|Supplementation Period||42
33000|NCT01911260|78774|P3|COMPLETED|Supplementation Period||39
33001|NCT01911260|78775|P2|COMPLETED|Supplementation Period||38
33002|NCT01911260|78776|P1|COMPLETED|Supplementation Period||40
33003|NCT01911260|78773|P4|STARTED|Supplementation Period||50
33004|NCT01911260|78774|P3|STARTED|Supplementation Period||49
33005|NCT01911260|78775|P2|STARTED|Supplementation Period||50
33006|NCT01911260|78776|P1|STARTED|Supplementation Period||50
33007|NCT01911221|78786|P1|NOT COMPLETED|Overall Study||0
33008|NCT01911221|78786|P1|COMPLETED|Overall Study||13
33009|NCT01911221|78786|P1|STARTED|Overall Study||13
33010|NCT01911065|78802|P2|NOT COMPLETED|Overall Study||0
33011|NCT01911065|78803|P1|NOT COMPLETED|Overall Study||0
33012|NCT01911065|78802|P2|COMPLETED|Overall Study||9
33013|NCT01911065|78803|P1|COMPLETED|Overall Study||45
33014|NCT01911065|78802|P2|STARTED|Overall Study||9
33015|NCT01911065|78803|P1|STARTED|Overall Study||45
33016|NCT01910831|78811|P1|NOT COMPLETED|Overall Study||1
33017|NCT01910831|78811|P1|COMPLETED|Overall Study||19
33018|NCT01910831|78811|P1|STARTED|Overall Study||20
33019|NCT01910792|78820|P2|NOT COMPLETED|Overall Study||0
33020|NCT01910792|78821|P1|NOT COMPLETED|Overall Study||0
33021|NCT01910792|78820|P2|COMPLETED|Overall Study||10
33022|NCT01910792|78821|P1|COMPLETED|Overall Study||9
33023|NCT01910792|78820|P2|STARTED|Overall Study||10
33024|NCT01910792|78821|P1|STARTED|Overall Study||9
33025|NCT01910688|78827|P1|NOT COMPLETED|Overall Study||5
33026|NCT01910688|78827|P1|COMPLETED|Overall Study||20
33027|NCT01910688|78827|P1|12months|Overall Study||22
33028|NCT01910688|78827|P1|3rd RFA Treatment|Overall Study||18
33029|NCT01910688|78827|P1|7.5months|Overall Study||24
33030|NCT01910688|78827|P1|2nd RFA Treatment|Overall Study||22
33031|NCT01910688|78827|P1|3.5month|Overall Study||25
33032|NCT01910688|78827|P1|STARTED|Overall Study||25
33033|NCT01910636|78836|P2|NOT COMPLETED|Overall Study||0
33034|NCT01910636|78837|P1|NOT COMPLETED|Overall Study||0
33035|NCT01910636|78836|P2|COMPLETED|Overall Study||63
33036|NCT01910636|78837|P1|COMPLETED|Overall Study||90
33037|NCT01910636|78836|P2|STARTED|Overall Study||63
33038|NCT01910636|78837|P1|STARTED|Overall Study||90
33039|NCT01910441|78851|P2|NOT COMPLETED|Overall Study||10
33040|NCT01910441|78852|P1|NOT COMPLETED|Overall Study||7
33041|NCT01910441|78851|P2|COMPLETED|Overall Study||37
33042|NCT01910441|78852|P1|COMPLETED|Overall Study||41
33043|NCT01910441|78851|P2|STARTED|Overall Study||47
33044|NCT01910441|78852|P1|STARTED|Overall Study||48
33045|NCT01910402|78860|P2|NOT COMPLETED|Continuation Phase||0
33046|NCT01910402|78861|P1|NOT COMPLETED|Continuation Phase||90
33047|NCT01910402|78860|P2|COMPLETED|Continuation Phase||0
33048|NCT01910402|78861|P1|COMPLETED|Continuation Phase||30
33049|NCT01910402|78860|P2|STARTED|Continuation Phase||0
33050|NCT01910402|78861|P1|STARTED|Continuation Phase||120
33051|NCT01910402|78860|P2|NOT COMPLETED|Randomized Phase||55
33052|NCT01910402|78861|P1|NOT COMPLETED|Randomized Phase||42
33053|NCT01910402|78860|P2|COMPLETED|Randomized Phase||192
33054|NCT01910402|78861|P1|COMPLETED|Randomized Phase||206
33055|NCT01910402|78860|P2|STARTED|Randomized Phase||247
33056|NCT01910402|78861|P1|STARTED|Randomized Phase||248
33057|NCT01910389|78931|P2|NOT COMPLETED|Overall Study||8
33058|NCT01910389|78932|P1|NOT COMPLETED|Overall Study||15
33059|NCT01910389|78931|P2|COMPLETED|Overall Study||0
33060|NCT01910389|78932|P1|COMPLETED|Overall Study||0
33061|NCT01910389|78931|P2|STARTED|Overall Study||8
33062|NCT01910389|78932|P1|STARTED|Overall Study||15
33063|NCT01910311|78962|P1|NOT COMPLETED|Period 2 (Days 3-32)||0
33064|NCT01910311|78962|P1|COMPLETED|Period 2 (Days 3-32)||18
33065|NCT01910311|78962|P1|Received At Least 1 Dose of Rifampicin|Period 2 (Days 3-32)||18
33066|NCT01910311|78962|P1|Received Baricitinib|Period 2 (Days 3-32)||18
33067|NCT01910311|78962|P1|STARTED|Period 2 (Days 3-32)||18
33068|NCT01910311|78962|P1|NOT COMPLETED|Period 1 (Days 1-2)||0
33069|NCT01910311|78962|P1|COMPLETED|Period 1 (Days 1-2)||18
33070|NCT01910311|78962|P1|Received Baricitinib|Period 1 (Days 1-2)||18
33071|NCT01910311|78962|P1|STARTED|Period 1 (Days 1-2)||18
33072|NCT01910181|78973|P1|NOT COMPLETED|Overall Study||46
33073|NCT01910181|78973|P1|COMPLETED|Overall Study||0
33074|NCT01910181|78973|P1|Expansion Cohort|Overall Study||26
33075|NCT01910181|78973|P1|PK Cohort|Overall Study||20
33076|NCT01910181|78973|P1|STARTED|Overall Study||46
33077|NCT01910116|79000|P2|NOT COMPLETED|Overall Study||16
33078|NCT01910116|79001|P1|NOT COMPLETED|Overall Study||14
33079|NCT01910116|79000|P2|COMPLETED|Overall Study||94
33080|NCT01910116|79001|P1|COMPLETED|Overall Study||96
33081|NCT01910116|79000|P2|Week 16|Overall Study||94
33082|NCT01910116|79001|P1|Week 16|Overall Study||96
33083|NCT01910116|79000|P2|Week 12|Overall Study||96
33084|NCT01910116|79001|P1|Week 12|Overall Study||97
33085|NCT01910116|79000|P2|Week 8|Overall Study||99
33086|NCT01910116|79001|P1|Week 8|Overall Study||98
33087|NCT01910116|79000|P2|Week 4|Overall Study||102
33088|NCT01910116|79001|P1|Week 4|Overall Study||106
33089|NCT01910116|79000|P2|STARTED|Overall Study||110
33090|NCT01910116|79001|P1|STARTED|Overall Study||110
33091|NCT01910064|79077|P1|NOT COMPLETED|Overall Study||45
33092|NCT01910064|79077|P1|COMPLETED|Overall Study||391
33093|NCT01910064|79077|P1|STARTED|Overall Study||436
33094|NCT01909804|79098|P12|NOT COMPLETED|Overall Study||3
33095|NCT01909804|79099|P11|NOT COMPLETED|Overall Study||1
33096|NCT01909804|79100|P10|NOT COMPLETED|Overall Study||1
33097|NCT01909804|79101|P9|NOT COMPLETED|Overall Study||0
33098|NCT01909804|79102|P8|NOT COMPLETED|Overall Study||1
33099|NCT01909804|79103|P7|NOT COMPLETED|Overall Study||2
33100|NCT01909804|79104|P6|NOT COMPLETED|Overall Study||4
33101|NCT01909804|79105|P5|NOT COMPLETED|Overall Study||8
33102|NCT01909804|79106|P4|NOT COMPLETED|Overall Study||0
33103|NCT01909804|79107|P3|NOT COMPLETED|Overall Study||0
33104|NCT01909804|79108|P2|NOT COMPLETED|Overall Study||1
33105|NCT01909804|79109|P1|NOT COMPLETED|Overall Study||4
33106|NCT01909804|79098|P12|COMPLETED|Overall Study||26
33107|NCT01909804|79099|P11|COMPLETED|Overall Study||26
33108|NCT01909804|79100|P10|COMPLETED|Overall Study||28
33109|NCT01909804|79101|P9|COMPLETED|Overall Study||27
33110|NCT01909804|79102|P8|COMPLETED|Overall Study||25
33111|NCT01909804|79103|P7|COMPLETED|Overall Study||25
33112|NCT01909804|79104|P6|COMPLETED|Overall Study||21
33113|NCT01909804|79105|P5|COMPLETED|Overall Study||18
33114|NCT01909804|79106|P4|COMPLETED|Overall Study||26
33115|NCT01909804|79107|P3|COMPLETED|Overall Study||27
33116|NCT01909804|79108|P2|COMPLETED|Overall Study||27
33117|NCT01909804|79109|P1|COMPLETED|Overall Study||22
33118|NCT01909804|79098|P12|STARTED|Overall Study||29
33119|NCT01909804|79099|P11|STARTED|Overall Study||27
33120|NCT01909804|79100|P10|STARTED|Overall Study||29
33121|NCT01909804|79101|P9|STARTED|Overall Study||27
33122|NCT01909804|79102|P8|STARTED|Overall Study||26
33123|NCT01909804|79103|P7|STARTED|Overall Study||27
33124|NCT01909804|79104|P6|STARTED|Overall Study||25
33125|NCT01909804|79105|P5|STARTED|Overall Study||26
33126|NCT01909804|79106|P4|STARTED|Overall Study||26
33127|NCT01909804|79107|P3|STARTED|Overall Study||27
33128|NCT01909804|79108|P2|STARTED|Overall Study||28
33129|NCT01909804|79109|P1|STARTED|Overall Study||26
33130|NCT01909778|79155|P1|NOT COMPLETED|Overall Study||1
33131|NCT01909778|79155|P1|COMPLETED|Overall Study||1
33132|NCT01909778|79155|P1|STARTED|Overall Study||2
33133|NCT01909713|79179|P1|NOT COMPLETED|Overall Study||0
33134|NCT01909713|79179|P1|COMPLETED|Overall Study||35
33135|NCT01909713|79179|P1|STARTED|Overall Study||35
33136|NCT01909674|79234|P2|NOT COMPLETED|Overall Study||2
33137|NCT01909674|79235|P1|NOT COMPLETED|Overall Study||5
33138|NCT01909674|79234|P2|COMPLETED|Overall Study||7
33139|NCT01909674|79235|P1|COMPLETED|Overall Study||7
33140|NCT01909674|79234|P2|STARTED|Overall Study||9
33141|NCT01909674|79235|P1|STARTED|Overall Study||12
33142|NCT01909570|79243|P2|NOT COMPLETED|Overall Study||27
33143|NCT01909570|79244|P1|NOT COMPLETED|Overall Study||27
33144|NCT01909570|79243|P2|COMPLETED|Overall Study||64
33145|NCT01909570|79244|P1|COMPLETED|Overall Study||57
33146|NCT01909570|79243|P2|STARTED|Overall Study||91
33147|NCT01909570|79244|P1|STARTED|Overall Study||84
33148|NCT01909466|79254|P2|NOT COMPLETED|Overall Study||23
33149|NCT01909466|79255|P1|NOT COMPLETED|Overall Study||22
33150|NCT01909466|79254|P2|COMPLETED|Overall Study||50
33151|NCT01909466|79255|P1|COMPLETED|Overall Study||46
33152|NCT01909466|79254|P2|STARTED|Overall Study||73
33153|NCT01909466|79255|P1|STARTED|Overall Study||68
33154|NCT01909336|79278|P3|NOT COMPLETED|Overall Study||3
33155|NCT01909336|79279|P2|NOT COMPLETED|Overall Study||3
33156|NCT01909336|79280|P1|NOT COMPLETED|Overall Study||4
33157|NCT01909336|79278|P3|COMPLETED|Overall Study||52
33158|NCT01909336|79279|P2|COMPLETED|Overall Study||50
33159|NCT01909336|79280|P1|COMPLETED|Overall Study||49
33160|NCT01909336|79278|P3|STARTED|Overall Study||55
33161|NCT01909336|79279|P2|STARTED|Overall Study||53
33162|NCT01909336|79280|P1|STARTED|Overall Study||53
33163|NCT01909180|79294|P1|NOT COMPLETED|Overall Study||0
33164|NCT01909180|79294|P1|COMPLETED|Overall Study||49
33165|NCT01909180|79294|P1|STARTED|Overall Study||49
33166|NCT01909141|79302|P2|NOT COMPLETED|Overall Study||0
33167|NCT01909141|79303|P1|NOT COMPLETED|Overall Study||0
33168|NCT01909141|79302|P2|COMPLETED|Overall Study||50
33169|NCT01909141|79303|P1|COMPLETED|Overall Study||50
33170|NCT01909141|79302|P2|STARTED|Overall Study||50
33171|NCT01909141|79303|P1|STARTED|Overall Study||50
33172|NCT01909011|79319|P2|NOT COMPLETED|Overall Study||0
33173|NCT01909011|79320|P1|NOT COMPLETED|Overall Study||0
33174|NCT01909011|79319|P2|COMPLETED|Overall Study||9
33175|NCT01909011|79320|P1|COMPLETED|Overall Study||7
33176|NCT01909011|79319|P2|STARTED|Overall Study||9
33177|NCT01909011|79320|P1|STARTED|Overall Study||7
33178|NCT01908842|79332|P2|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||17
33179|NCT01908842|79333|P1|NOT COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||25
33180|NCT01908842|79332|P2|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
33181|NCT01908842|79333|P1|COMPLETED|Day 22: Film (Col 1); Tablets (Col 2)||262
33182|NCT01908842|79332|P2|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||279
33183|NCT01908842|79333|P1|STARTED|Day 22: Film (Col 1); Tablets (Col 2)||287
33184|NCT01908842|79332|P2|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||65
33185|NCT01908842|79333|P1|NOT COMPLETED|Switch to Other BNX Formulation (Day 15)||70
33186|NCT01908842|79332|P2|COMPLETED|Switch to Other BNX Formulation (Day 15)||279
33187|NCT01908842|79333|P1|COMPLETED|Switch to Other BNX Formulation (Day 15)||287
33188|NCT01908842|79332|P2|STARTED|Switch to Other BNX Formulation (Day 15)||344
33189|NCT01908842|79333|P1|STARTED|Switch to Other BNX Formulation (Day 15)||357
33190|NCT01908842|79332|P2|NOT COMPLETED|Induction||31
33191|NCT01908842|79333|P1|NOT COMPLETED|Induction||26
33192|NCT01908842|79332|P2|COMPLETED|Induction||344
33193|NCT01908842|79333|P1|COMPLETED|Induction||357
33194|NCT01908842|79332|P2|STARTED|Induction||375
33195|NCT01908842|79333|P1|STARTED|Induction||383
33196|NCT01908803|79353|P2|NOT COMPLETED|Overall Study||1
33197|NCT01908803|79354|P1|NOT COMPLETED|Overall Study||4
33198|NCT01908803|79353|P2|COMPLETED|Overall Study||23
33199|NCT01908803|79354|P1|COMPLETED|Overall Study||42
33200|NCT01908803|79353|P2|Treated|Overall Study||24
33201|NCT01908803|79354|P1|Treated|Overall Study|Two randomized subjects discontinued prior to receiving investigational product.|44
33202|NCT01908803|79353|P2|STARTED|Overall Study||24
33203|NCT01908803|79354|P1|STARTED|Overall Study||46
33204|NCT01908140|79367|P2|NOT COMPLETED|Overall Study||79
33205|NCT01908140|79368|P1|NOT COMPLETED|Overall Study||66
33206|NCT01908140|79367|P2|COMPLETED|Overall Study||386
33207|NCT01908140|79368|P1|COMPLETED|Overall Study||402
33208|NCT01908140|79367|P2|STARTED|Overall Study||465
33209|NCT01908140|79368|P1|STARTED|Overall Study||468
33210|NCT01908127|79378|P2|NOT COMPLETED|Overall Study||0
33211|NCT01908127|79379|P1|NOT COMPLETED|Overall Study||1
33212|NCT01908127|79378|P2|COMPLETED|Overall Study||23
33213|NCT01908127|79379|P1|COMPLETED|Overall Study||22
33214|NCT01908127|79378|P2|STARTED|Overall Study||23
33215|NCT01908127|79379|P1|STARTED|Overall Study||23
33216|NCT01907906|79389|P2|NOT COMPLETED|Overall Study||1
33217|NCT01907906|79390|P1|NOT COMPLETED|Overall Study||4
33218|NCT01907906|79389|P2|COMPLETED|Overall Study||12
33219|NCT01907906|79390|P1|COMPLETED|Overall Study||12
33220|NCT01907906|79389|P2|STARTED|Overall Study||13
33221|NCT01907906|79390|P1|STARTED|Overall Study||16
33222|NCT01907854|79470|P2|NOT COMPLETED|Overall Study||13
33223|NCT01907854|79471|P1|NOT COMPLETED|Overall Study||16
33224|NCT01907854|79470|P2|COMPLETED|Overall Study||191
33225|NCT01907854|79471|P1|COMPLETED|Overall Study||187
33226|NCT01907854|79470|P2|Exposed|Overall Study||204
33227|NCT01907854|79471|P1|Exposed|Overall Study|One subject in lira arm was not exposed (Reason: withdrawal by subject)|202
33228|NCT01907854|79470|P2|STARTED|Overall Study||204
33229|NCT01907854|79471|P1|STARTED|Overall Study||203
33230|NCT01907516|79491|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
33231|NCT01907516|79492|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
33232|NCT01907516|79491|P2|COMPLETED|Second Intervention (3 Weeks)||34
33233|NCT01907516|79492|P1|COMPLETED|Second Intervention (3 Weeks)||40
33234|NCT01907516|79491|P2|STARTED|Second Intervention (3 Weeks)||34
33235|NCT01907516|79492|P1|STARTED|Second Intervention (3 Weeks)||40
33236|NCT01907516|79491|P2|NOT COMPLETED|First Intervention (3 Weeks)||16
33237|NCT01907516|79492|P1|NOT COMPLETED|First Intervention (3 Weeks)||10
33238|NCT01907516|79491|P2|COMPLETED|First Intervention (3 Weeks)||34
33239|NCT01907516|79492|P1|COMPLETED|First Intervention (3 Weeks)||40
33240|NCT01907516|79491|P2|STARTED|First Intervention (3 Weeks)||50
33241|NCT01907516|79492|P1|STARTED|First Intervention (3 Weeks)||50
33242|NCT01907490|79499|P1|NOT COMPLETED|Overall Study||0
33243|NCT01907490|79499|P1|COMPLETED|Overall Study||38
33244|NCT01907490|79499|P1|STARTED|Overall Study||38
33245|NCT01907334|79503|P2|NOT COMPLETED|Overall Study||0
33246|NCT01907334|79504|P1|NOT COMPLETED|Overall Study||0
33247|NCT01907334|79503|P2|COMPLETED|Overall Study||4
33248|NCT01907334|79504|P1|COMPLETED|Overall Study||6
33249|NCT01907334|79503|P2|STARTED|Overall Study||4
33250|NCT01907334|79504|P1|STARTED|Overall Study||6
33251|NCT01907321|79509|P1|NOT COMPLETED|Overall Study||2
33252|NCT01907321|79509|P1|COMPLETED|Overall Study||12
33253|NCT01907321|79509|P1|STARTED|Overall Study||14
33254|NCT01907113|79519|P5|NOT COMPLETED|Overall Study||0
33255|NCT01907113|79520|P4|NOT COMPLETED|Overall Study||0
33256|NCT01907113|79521|P3|NOT COMPLETED|Overall Study||0
33257|NCT01907113|79522|P2|NOT COMPLETED|Overall Study||0
33258|NCT01907113|79523|P1|NOT COMPLETED|Overall Study||0
33259|NCT01907113|79519|P5|COMPLETED|Overall Study||8
33260|NCT01907113|79520|P4|COMPLETED|Overall Study||8
33261|NCT01907113|79521|P3|COMPLETED|Overall Study||7
33262|NCT01907113|79522|P2|COMPLETED|Overall Study||9
33263|NCT01907113|79523|P1|COMPLETED|Overall Study||8
33264|NCT01907113|79519|P5|STARTED|Overall Study||8
33265|NCT01907113|79520|P4|STARTED|Overall Study||8
33266|NCT01907113|79521|P3|STARTED|Overall Study||7
33267|NCT01907113|79522|P2|STARTED|Overall Study||9
33268|NCT01907113|79523|P1|STARTED|Overall Study||8
33269|NCT01906658|79614|P4|NOT COMPLETED|Overall Study||0
33270|NCT01906658|79615|P3|NOT COMPLETED|Overall Study||3
33271|NCT01906658|79616|P2|NOT COMPLETED|Overall Study||1
33272|NCT01906658|79617|P1|NOT COMPLETED|Overall Study||2
33273|NCT01906658|79614|P4|COMPLETED|Overall Study||11
33274|NCT01906658|79615|P3|COMPLETED|Overall Study||7
33275|NCT01906658|79616|P2|COMPLETED|Overall Study||10
33276|NCT01906658|79617|P1|COMPLETED|Overall Study||9
33277|NCT01906658|79614|P4|STARTED|Overall Study||11
33278|NCT01906658|79615|P3|STARTED|Overall Study||10
33279|NCT01906658|79616|P2|STARTED|Overall Study||11
33280|NCT01906658|79617|P1|STARTED|Overall Study||11
33281|NCT01906515|79641|P2|NOT COMPLETED|Overall Study||0
33282|NCT01906515|79642|P1|NOT COMPLETED|Overall Study||0
33283|NCT01906515|79641|P2|COMPLETED|Overall Study||61
33284|NCT01906515|79642|P1|COMPLETED|Overall Study||45
33285|NCT01906515|79641|P2|STARTED|Overall Study||61
33286|NCT01906515|79642|P1|STARTED|Overall Study||45
33287|NCT01906372|79650|P1|NOT COMPLETED|Overall Study||2
33288|NCT01906372|79650|P1|COMPLETED|Overall Study||10
33289|NCT01906372|79650|P1|Visit 10: Follow up Phase Completed|Overall Study||8
33290|NCT01906372|79650|P1|Visit 7: Treatment Phase Completed|Overall Study||10
33291|NCT01906372|79650|P1|STARTED|Overall Study||12
33292|NCT01905956|79657|P2|NOT COMPLETED|Overall Study||11
33293|NCT01905956|79658|P1|NOT COMPLETED|Overall Study||6
33294|NCT01905956|79657|P2|COMPLETED|Overall Study|Per-protocol population|48
33295|NCT01905956|79658|P1|COMPLETED|Overall Study|Per-protocol population|54
33296|NCT01905956|79657|P2|Intention-to-treat Population|Overall Study|Intention-to-treat population|54
33297|NCT01905956|79658|P1|Intention-to-treat Population|Overall Study|Intention-to-treat population|57
33298|NCT01905956|79657|P2|STARTED|Overall Study|Randomized|59
33299|NCT01905956|79658|P1|STARTED|Overall Study|Randomized|60
33300|NCT01905657|79683|P3|NOT COMPLETED|Overall Study||328
33301|NCT01905657|79684|P2|NOT COMPLETED|Overall Study||346
33302|NCT01905657|79685|P1|NOT COMPLETED|Overall Study||345
33303|NCT01905657|79683|P3|COMPLETED|Overall Study||15
33304|NCT01905657|79684|P2|COMPLETED|Overall Study||0
33305|NCT01905657|79685|P1|COMPLETED|Overall Study||0
33306|NCT01905657|79683|P3|Treated|Overall Study||309
33307|NCT01905657|79684|P2|Treated|Overall Study||343
33308|NCT01905657|79685|P1|Treated|Overall Study||339
33309|NCT01905657|79683|P3|STARTED|Overall Study||343
33310|NCT01905657|79684|P2|STARTED|Overall Study||346
33311|NCT01905657|79685|P1|STARTED|Overall Study||345
33312|NCT01905553|79710|P2|NOT COMPLETED|Period 2||0
33313|NCT01905553|79711|P1|NOT COMPLETED|Period 2||1
33314|NCT01905553|79710|P2|COMPLETED|Period 2||4
33315|NCT01905553|79711|P1|COMPLETED|Period 2||4
33316|NCT01905553|79710|P2|STARTED|Period 2||4
33317|NCT01905553|79711|P1|STARTED|Period 2||5
33318|NCT01905553|79710|P2|NOT COMPLETED|Period 1||0
33319|NCT01905553|79711|P1|NOT COMPLETED|Period 1||0
33320|NCT01905553|79710|P2|COMPLETED|Period 1||4
33321|NCT01905553|79711|P1|COMPLETED|Period 1||5
33322|NCT01905553|79710|P2|STARTED|Period 1||4
33323|NCT01905553|79711|P1|STARTED|Period 1||5
33324|NCT01905540|79725|P4|NOT COMPLETED|Period 3||1
33325|NCT01905540|79726|P3|NOT COMPLETED|Period 3||1
33326|NCT01905540|79727|P2|NOT COMPLETED|Period 3||0
33327|NCT01905540|79728|P1|NOT COMPLETED|Period 3||1
33328|NCT01905540|79725|P4|COMPLETED|Period 3||6
33329|NCT01905540|79726|P3|COMPLETED|Period 3||6
33330|NCT01905540|79727|P2|COMPLETED|Period 3||7
33331|NCT01905540|79728|P1|COMPLETED|Period 3||6
33332|NCT01905540|79725|P4|STARTED|Period 3||7
33333|NCT01905540|79726|P3|STARTED|Period 3||7
33334|NCT01905540|79727|P2|STARTED|Period 3||7
33335|NCT01905540|79728|P1|STARTED|Period 3||7
33336|NCT01905540|79725|P4|NOT COMPLETED|Period 2||0
33337|NCT01905540|79726|P3|NOT COMPLETED|Period 2||0
33338|NCT01905540|79727|P2|NOT COMPLETED|Period 2||0
33339|NCT01905540|79728|P1|NOT COMPLETED|Period 2||0
33340|NCT01905540|79725|P4|COMPLETED|Period 2||7
33341|NCT01905540|79726|P3|COMPLETED|Period 2||7
33342|NCT01905540|79727|P2|COMPLETED|Period 2||7
33343|NCT01905540|79728|P1|COMPLETED|Period 2||7
33344|NCT01905540|79725|P4|STARTED|Period 2||7
33345|NCT01905540|79726|P3|STARTED|Period 2||7
33346|NCT01905540|79727|P2|STARTED|Period 2||7
33347|NCT01905540|79728|P1|STARTED|Period 2||7
33348|NCT01905540|79725|P4|NOT COMPLETED|Period 1||0
33349|NCT01905540|79726|P3|NOT COMPLETED|Period 1||0
33350|NCT01905540|79727|P2|NOT COMPLETED|Period 1||0
33351|NCT01905540|79728|P1|NOT COMPLETED|Period 1||0
33352|NCT01905540|79725|P4|COMPLETED|Period 1||7
33353|NCT01905540|79726|P3|COMPLETED|Period 1||7
33354|NCT01905540|79727|P2|COMPLETED|Period 1||7
33355|NCT01905540|79728|P1|COMPLETED|Period 1||7
33356|NCT01905540|79725|P4|STARTED|Period 1||7
33357|NCT01905540|79726|P3|STARTED|Period 1||7
33358|NCT01905540|79727|P2|STARTED|Period 1||7
33359|NCT01905540|79728|P1|STARTED|Period 1||7
33360|NCT01905254|79746|P1|NOT COMPLETED|Overall Study||0
33361|NCT01905254|79746|P1|COMPLETED|Overall Study||34
33362|NCT01905254|79746|P1|STARTED|Overall Study||34
33363|NCT01904773|79750|P9|NOT COMPLETED|Sixth Intervention||0
33364|NCT01904773|79751|P8|NOT COMPLETED|Sixth Intervention||0
33365|NCT01904773|79752|P7|NOT COMPLETED|Sixth Intervention||0
33366|NCT01904773|79753|P6|NOT COMPLETED|Sixth Intervention||0
33367|NCT01904773|79754|P5|NOT COMPLETED|Sixth Intervention||0
33368|NCT01904773|79755|P4|NOT COMPLETED|Sixth Intervention||0
33369|NCT01904773|79756|P3|NOT COMPLETED|Sixth Intervention||0
33370|NCT01904773|79757|P2|NOT COMPLETED|Sixth Intervention||0
33371|NCT01904773|79758|P1|NOT COMPLETED|Sixth Intervention||0
33372|NCT01904773|79750|P9|COMPLETED|Sixth Intervention||4
33373|NCT01904773|79751|P8|COMPLETED|Sixth Intervention||2
33374|NCT01904773|79752|P7|COMPLETED|Sixth Intervention||3
33375|NCT01904773|79753|P6|COMPLETED|Sixth Intervention||4
33376|NCT01904773|79754|P5|COMPLETED|Sixth Intervention||3
33377|NCT01904773|79755|P4|COMPLETED|Sixth Intervention||2
33378|NCT01904773|79756|P3|COMPLETED|Sixth Intervention||1
33379|NCT01904773|79757|P2|COMPLETED|Sixth Intervention||0
33380|NCT01904773|79758|P1|COMPLETED|Sixth Intervention||0
33381|NCT01904773|79750|P9|STARTED|Sixth Intervention||4
33382|NCT01904773|79751|P8|STARTED|Sixth Intervention||2
33383|NCT01904773|79752|P7|STARTED|Sixth Intervention||3
33384|NCT01904773|79753|P6|STARTED|Sixth Intervention||4
33385|NCT01904773|79754|P5|STARTED|Sixth Intervention||3
33386|NCT01904773|79755|P4|STARTED|Sixth Intervention||2
33387|NCT01904773|79756|P3|STARTED|Sixth Intervention||1
33388|NCT01904773|79757|P2|STARTED|Sixth Intervention||0
33389|NCT01904773|79758|P1|STARTED|Sixth Intervention||0
33390|NCT01904773|79750|P9|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33391|NCT01904773|79751|P8|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33392|NCT01904773|79752|P7|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33393|NCT01904773|79753|P6|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33394|NCT01904773|79754|P5|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33395|NCT01904773|79755|P4|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33396|NCT01904773|79756|P3|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33397|NCT01904773|79757|P2|NOT COMPLETED|Placebo Washout Fifth Intervention||1
33398|NCT01904773|79758|P1|NOT COMPLETED|Placebo Washout Fifth Intervention||0
33399|NCT01904773|79750|P9|COMPLETED|Placebo Washout Fifth Intervention||4
33400|NCT01904773|79751|P8|COMPLETED|Placebo Washout Fifth Intervention||2
33401|NCT01904773|79752|P7|COMPLETED|Placebo Washout Fifth Intervention||3
33402|NCT01904773|79753|P6|COMPLETED|Placebo Washout Fifth Intervention||4
33403|NCT01904773|79754|P5|COMPLETED|Placebo Washout Fifth Intervention||3
33404|NCT01904773|79755|P4|COMPLETED|Placebo Washout Fifth Intervention||2
33405|NCT01904773|79756|P3|COMPLETED|Placebo Washout Fifth Intervention||1
33406|NCT01904773|79757|P2|COMPLETED|Placebo Washout Fifth Intervention||0
33407|NCT01904773|79758|P1|COMPLETED|Placebo Washout Fifth Intervention||0
33408|NCT01904773|79750|P9|STARTED|Placebo Washout Fifth Intervention||4
33409|NCT01904773|79751|P8|STARTED|Placebo Washout Fifth Intervention||2
33410|NCT01904773|79752|P7|STARTED|Placebo Washout Fifth Intervention||3
33411|NCT01904773|79753|P6|STARTED|Placebo Washout Fifth Intervention||4
33412|NCT01904773|79754|P5|STARTED|Placebo Washout Fifth Intervention||3
33413|NCT01904773|79755|P4|STARTED|Placebo Washout Fifth Intervention||2
33414|NCT01904773|79756|P3|STARTED|Placebo Washout Fifth Intervention||1
33415|NCT01904773|79757|P2|STARTED|Placebo Washout Fifth Intervention||1
33416|NCT01904773|79758|P1|STARTED|Placebo Washout Fifth Intervention||0
33417|NCT01904773|79750|P9|NOT COMPLETED|Fifth Intervention||0
33418|NCT01904773|79751|P8|NOT COMPLETED|Fifth Intervention||1
33419|NCT01904773|79752|P7|NOT COMPLETED|Fifth Intervention||0
33420|NCT01904773|79753|P6|NOT COMPLETED|Fifth Intervention||0
33421|NCT01904773|79754|P5|NOT COMPLETED|Fifth Intervention||0
33422|NCT01904773|79755|P4|NOT COMPLETED|Fifth Intervention||0
33423|NCT01904773|79756|P3|NOT COMPLETED|Fifth Intervention||0
33424|NCT01904773|79757|P2|NOT COMPLETED|Fifth Intervention||0
33425|NCT01904773|79758|P1|NOT COMPLETED|Fifth Intervention||0
33426|NCT01904773|79750|P9|COMPLETED|Fifth Intervention||4
33427|NCT01904773|79751|P8|COMPLETED|Fifth Intervention||2
33428|NCT01904773|79752|P7|COMPLETED|Fifth Intervention||3
33429|NCT01904773|79753|P6|COMPLETED|Fifth Intervention||4
33430|NCT01904773|79754|P5|COMPLETED|Fifth Intervention||3
33431|NCT01904773|79755|P4|COMPLETED|Fifth Intervention||2
33432|NCT01904773|79756|P3|COMPLETED|Fifth Intervention||1
33433|NCT01904773|79757|P2|COMPLETED|Fifth Intervention||1
33434|NCT01904773|79758|P1|COMPLETED|Fifth Intervention||0
33435|NCT01904773|79750|P9|STARTED|Fifth Intervention||4
33436|NCT01904773|79751|P8|STARTED|Fifth Intervention||3
33437|NCT01904773|79752|P7|STARTED|Fifth Intervention||3
33438|NCT01904773|79753|P6|STARTED|Fifth Intervention||4
33439|NCT01904773|79754|P5|STARTED|Fifth Intervention||3
33440|NCT01904773|79755|P4|STARTED|Fifth Intervention||2
33441|NCT01904773|79756|P3|STARTED|Fifth Intervention||1
33442|NCT01904773|79757|P2|STARTED|Fifth Intervention||1
33443|NCT01904773|79758|P1|STARTED|Fifth Intervention||0
33444|NCT01904773|79750|P9|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33445|NCT01904773|79751|P8|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33446|NCT01904773|79752|P7|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33447|NCT01904773|79753|P6|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33448|NCT01904773|79754|P5|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33449|NCT01904773|79755|P4|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33450|NCT01904773|79756|P3|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33451|NCT01904773|79757|P2|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33452|NCT01904773|79758|P1|NOT COMPLETED|Placebo Washout Fourth Intervention||0
33453|NCT01904773|79750|P9|COMPLETED|Placebo Washout Fourth Intervention||4
33454|NCT01904773|79751|P8|COMPLETED|Placebo Washout Fourth Intervention||3
33455|NCT01904773|79752|P7|COMPLETED|Placebo Washout Fourth Intervention||3
33456|NCT01904773|79753|P6|COMPLETED|Placebo Washout Fourth Intervention||4
33457|NCT01904773|79754|P5|COMPLETED|Placebo Washout Fourth Intervention||3
33458|NCT01904773|79755|P4|COMPLETED|Placebo Washout Fourth Intervention||2
33459|NCT01904773|79756|P3|COMPLETED|Placebo Washout Fourth Intervention||1
33460|NCT01904773|79757|P2|COMPLETED|Placebo Washout Fourth Intervention||1
33461|NCT01904773|79758|P1|COMPLETED|Placebo Washout Fourth Intervention||0
33462|NCT01904773|79750|P9|STARTED|Placebo Washout Fourth Intervention||4
33463|NCT01904773|79751|P8|STARTED|Placebo Washout Fourth Intervention||3
33464|NCT01904773|79752|P7|STARTED|Placebo Washout Fourth Intervention||3
33465|NCT01904773|79753|P6|STARTED|Placebo Washout Fourth Intervention||4
33466|NCT01904773|79754|P5|STARTED|Placebo Washout Fourth Intervention||3
33467|NCT01904773|79755|P4|STARTED|Placebo Washout Fourth Intervention||2
33468|NCT01904773|79756|P3|STARTED|Placebo Washout Fourth Intervention||1
33469|NCT01904773|79757|P2|STARTED|Placebo Washout Fourth Intervention||1
33470|NCT01904773|79758|P1|STARTED|Placebo Washout Fourth Intervention||0
33471|NCT01904773|79750|P9|NOT COMPLETED|Fourth Intervention||0
33472|NCT01904773|79751|P8|NOT COMPLETED|Fourth Intervention||0
33473|NCT01904773|79752|P7|NOT COMPLETED|Fourth Intervention||0
33474|NCT01904773|79753|P6|NOT COMPLETED|Fourth Intervention||0
33475|NCT01904773|79754|P5|NOT COMPLETED|Fourth Intervention||0
33476|NCT01904773|79755|P4|NOT COMPLETED|Fourth Intervention||0
33477|NCT01904773|79756|P3|NOT COMPLETED|Fourth Intervention||0
33478|NCT01904773|79757|P2|NOT COMPLETED|Fourth Intervention||0
33479|NCT01904773|79758|P1|NOT COMPLETED|Fourth Intervention||0
33480|NCT01904773|79750|P9|COMPLETED|Fourth Intervention||4
33481|NCT01904773|79751|P8|COMPLETED|Fourth Intervention||3
33482|NCT01904773|79752|P7|COMPLETED|Fourth Intervention||3
33483|NCT01904773|79753|P6|COMPLETED|Fourth Intervention||4
33484|NCT01904773|79754|P5|COMPLETED|Fourth Intervention||3
33485|NCT01904773|79755|P4|COMPLETED|Fourth Intervention||2
33486|NCT01904773|79756|P3|COMPLETED|Fourth Intervention||1
33487|NCT01904773|79757|P2|COMPLETED|Fourth Intervention||1
33488|NCT01904773|79758|P1|COMPLETED|Fourth Intervention||0
33489|NCT01904773|79750|P9|STARTED|Fourth Intervention||4
33490|NCT01904773|79751|P8|STARTED|Fourth Intervention||3
33491|NCT01904773|79752|P7|STARTED|Fourth Intervention||3
33492|NCT01904773|79753|P6|STARTED|Fourth Intervention||4
33493|NCT01904773|79754|P5|STARTED|Fourth Intervention||3
33494|NCT01904773|79755|P4|STARTED|Fourth Intervention||2
33495|NCT01904773|79756|P3|STARTED|Fourth Intervention||1
33496|NCT01904773|79757|P2|STARTED|Fourth Intervention||1
33497|NCT01904773|79758|P1|STARTED|Fourth Intervention||0
33498|NCT01904773|79750|P9|NOT COMPLETED|Placebo Washout Third Intervention||0
33499|NCT01904773|79751|P8|NOT COMPLETED|Placebo Washout Third Intervention||0
33500|NCT01904773|79752|P7|NOT COMPLETED|Placebo Washout Third Intervention||0
33501|NCT01904773|79753|P6|NOT COMPLETED|Placebo Washout Third Intervention||0
33502|NCT01904773|79754|P5|NOT COMPLETED|Placebo Washout Third Intervention||0
33503|NCT01904773|79755|P4|NOT COMPLETED|Placebo Washout Third Intervention||0
33504|NCT01904773|79756|P3|NOT COMPLETED|Placebo Washout Third Intervention||0
33505|NCT01904773|79757|P2|NOT COMPLETED|Placebo Washout Third Intervention||0
33506|NCT01904773|79758|P1|NOT COMPLETED|Placebo Washout Third Intervention||0
33507|NCT01904773|79750|P9|COMPLETED|Placebo Washout Third Intervention||4
33508|NCT01904773|79751|P8|COMPLETED|Placebo Washout Third Intervention||3
33509|NCT01904773|79752|P7|COMPLETED|Placebo Washout Third Intervention||3
33510|NCT01904773|79753|P6|COMPLETED|Placebo Washout Third Intervention||4
33511|NCT01904773|79754|P5|COMPLETED|Placebo Washout Third Intervention||3
33512|NCT01904773|79755|P4|COMPLETED|Placebo Washout Third Intervention||2
33513|NCT01904773|79756|P3|COMPLETED|Placebo Washout Third Intervention||1
33514|NCT01904773|79757|P2|COMPLETED|Placebo Washout Third Intervention||1
33515|NCT01904773|79758|P1|COMPLETED|Placebo Washout Third Intervention||0
33516|NCT01904773|79750|P9|STARTED|Placebo Washout Third Intervention||4
33517|NCT01904773|79751|P8|STARTED|Placebo Washout Third Intervention||3
33518|NCT01904773|79752|P7|STARTED|Placebo Washout Third Intervention||3
33519|NCT01904773|79753|P6|STARTED|Placebo Washout Third Intervention||4
33520|NCT01904773|79754|P5|STARTED|Placebo Washout Third Intervention||3
33521|NCT01904773|79755|P4|STARTED|Placebo Washout Third Intervention||2
33522|NCT01904773|79756|P3|STARTED|Placebo Washout Third Intervention||1
33523|NCT01904773|79757|P2|STARTED|Placebo Washout Third Intervention||1
33524|NCT01904773|79758|P1|STARTED|Placebo Washout Third Intervention||0
33525|NCT01904773|79750|P9|NOT COMPLETED|Third Intervention||0
33526|NCT01904773|79751|P8|NOT COMPLETED|Third Intervention||0
33527|NCT01904773|79752|P7|NOT COMPLETED|Third Intervention||0
33528|NCT01904773|79753|P6|NOT COMPLETED|Third Intervention||0
33529|NCT01904773|79754|P5|NOT COMPLETED|Third Intervention||0
33530|NCT01904773|79755|P4|NOT COMPLETED|Third Intervention||0
33531|NCT01904773|79756|P3|NOT COMPLETED|Third Intervention||0
33532|NCT01904773|79757|P2|NOT COMPLETED|Third Intervention||0
33533|NCT01904773|79758|P1|NOT COMPLETED|Third Intervention||0
33534|NCT01904773|79750|P9|COMPLETED|Third Intervention||4
33535|NCT01904773|79751|P8|COMPLETED|Third Intervention||3
33536|NCT01904773|79752|P7|COMPLETED|Third Intervention||3
33537|NCT01904773|79753|P6|COMPLETED|Third Intervention||4
33538|NCT01904773|79754|P5|COMPLETED|Third Intervention||3
33539|NCT01904773|79755|P4|COMPLETED|Third Intervention||2
33540|NCT01904773|79756|P3|COMPLETED|Third Intervention||1
33541|NCT01904773|79757|P2|COMPLETED|Third Intervention||1
33542|NCT01904773|79758|P1|COMPLETED|Third Intervention||0
33543|NCT01904773|79750|P9|STARTED|Third Intervention||4
33544|NCT01904773|79751|P8|STARTED|Third Intervention||3
33545|NCT01904773|79752|P7|STARTED|Third Intervention||3
33546|NCT01904773|79753|P6|STARTED|Third Intervention||4
33547|NCT01904773|79754|P5|STARTED|Third Intervention||3
33548|NCT01904773|79755|P4|STARTED|Third Intervention||2
33549|NCT01904773|79756|P3|STARTED|Third Intervention||1
33550|NCT01904773|79757|P2|STARTED|Third Intervention||1
33551|NCT01904773|79758|P1|STARTED|Third Intervention||0
33633|NCT01904773|79750|P9|NOT COMPLETED|First Intervention||0
33552|NCT01904773|79750|P9|NOT COMPLETED|Placebo Washout Second Intervention||0
33553|NCT01904773|79751|P8|NOT COMPLETED|Placebo Washout Second Intervention||0
33554|NCT01904773|79752|P7|NOT COMPLETED|Placebo Washout Second Intervention||0
33555|NCT01904773|79753|P6|NOT COMPLETED|Placebo Washout Second Intervention||0
33556|NCT01904773|79754|P5|NOT COMPLETED|Placebo Washout Second Intervention||0
33557|NCT01904773|79755|P4|NOT COMPLETED|Placebo Washout Second Intervention||0
33558|NCT01904773|79756|P3|NOT COMPLETED|Placebo Washout Second Intervention||0
33559|NCT01904773|79757|P2|NOT COMPLETED|Placebo Washout Second Intervention||0
33560|NCT01904773|79758|P1|NOT COMPLETED|Placebo Washout Second Intervention||0
33561|NCT01904773|79750|P9|COMPLETED|Placebo Washout Second Intervention||4
33562|NCT01904773|79751|P8|COMPLETED|Placebo Washout Second Intervention||3
33563|NCT01904773|79752|P7|COMPLETED|Placebo Washout Second Intervention||3
33564|NCT01904773|79753|P6|COMPLETED|Placebo Washout Second Intervention||4
33565|NCT01904773|79754|P5|COMPLETED|Placebo Washout Second Intervention||3
33566|NCT01904773|79755|P4|COMPLETED|Placebo Washout Second Intervention||2
33567|NCT01904773|79756|P3|COMPLETED|Placebo Washout Second Intervention||1
33568|NCT01904773|79757|P2|COMPLETED|Placebo Washout Second Intervention||1
33569|NCT01904773|79758|P1|COMPLETED|Placebo Washout Second Intervention||0
33570|NCT01904773|79750|P9|STARTED|Placebo Washout Second Intervention||4
33571|NCT01904773|79751|P8|STARTED|Placebo Washout Second Intervention||3
33572|NCT01904773|79752|P7|STARTED|Placebo Washout Second Intervention||3
33573|NCT01904773|79753|P6|STARTED|Placebo Washout Second Intervention||4
33574|NCT01904773|79754|P5|STARTED|Placebo Washout Second Intervention||3
33575|NCT01904773|79755|P4|STARTED|Placebo Washout Second Intervention||2
33576|NCT01904773|79756|P3|STARTED|Placebo Washout Second Intervention||1
33577|NCT01904773|79757|P2|STARTED|Placebo Washout Second Intervention||1
33578|NCT01904773|79758|P1|STARTED|Placebo Washout Second Intervention||0
33579|NCT01904773|79750|P9|NOT COMPLETED|Second Intervention||0
33580|NCT01904773|79751|P8|NOT COMPLETED|Second Intervention||0
33581|NCT01904773|79752|P7|NOT COMPLETED|Second Intervention||0
33582|NCT01904773|79753|P6|NOT COMPLETED|Second Intervention||0
33583|NCT01904773|79754|P5|NOT COMPLETED|Second Intervention||0
33584|NCT01904773|79755|P4|NOT COMPLETED|Second Intervention||0
33585|NCT01904773|79756|P3|NOT COMPLETED|Second Intervention||0
33586|NCT01904773|79757|P2|NOT COMPLETED|Second Intervention||0
33587|NCT01904773|79758|P1|NOT COMPLETED|Second Intervention||0
33588|NCT01904773|79750|P9|COMPLETED|Second Intervention||4
33589|NCT01904773|79751|P8|COMPLETED|Second Intervention||3
33590|NCT01904773|79752|P7|COMPLETED|Second Intervention||3
33591|NCT01904773|79753|P6|COMPLETED|Second Intervention||4
33592|NCT01904773|79754|P5|COMPLETED|Second Intervention||3
33593|NCT01904773|79755|P4|COMPLETED|Second Intervention||2
33594|NCT01904773|79756|P3|COMPLETED|Second Intervention||1
33595|NCT01904773|79757|P2|COMPLETED|Second Intervention||1
33596|NCT01904773|79758|P1|COMPLETED|Second Intervention||0
33597|NCT01904773|79750|P9|STARTED|Second Intervention||4
33598|NCT01904773|79751|P8|STARTED|Second Intervention||3
33599|NCT01904773|79752|P7|STARTED|Second Intervention||3
33600|NCT01904773|79753|P6|STARTED|Second Intervention||4
33601|NCT01904773|79754|P5|STARTED|Second Intervention||3
33602|NCT01904773|79755|P4|STARTED|Second Intervention||2
33603|NCT01904773|79756|P3|STARTED|Second Intervention||1
33604|NCT01904773|79757|P2|STARTED|Second Intervention||1
33605|NCT01904773|79758|P1|STARTED|Second Intervention||0
33606|NCT01904773|79750|P9|NOT COMPLETED|Placebo Washout First Intervention||0
33607|NCT01904773|79751|P8|NOT COMPLETED|Placebo Washout First Intervention||0
33608|NCT01904773|79752|P7|NOT COMPLETED|Placebo Washout First Intervention||0
33609|NCT01904773|79753|P6|NOT COMPLETED|Placebo Washout First Intervention||0
33610|NCT01904773|79754|P5|NOT COMPLETED|Placebo Washout First Intervention||0
33611|NCT01904773|79755|P4|NOT COMPLETED|Placebo Washout First Intervention||0
33612|NCT01904773|79756|P3|NOT COMPLETED|Placebo Washout First Intervention||0
33613|NCT01904773|79757|P2|NOT COMPLETED|Placebo Washout First Intervention||1
33614|NCT01904773|79758|P1|NOT COMPLETED|Placebo Washout First Intervention||0
33615|NCT01904773|79750|P9|COMPLETED|Placebo Washout First Intervention||4
33616|NCT01904773|79751|P8|COMPLETED|Placebo Washout First Intervention||3
33617|NCT01904773|79752|P7|COMPLETED|Placebo Washout First Intervention||3
33618|NCT01904773|79753|P6|COMPLETED|Placebo Washout First Intervention||4
33619|NCT01904773|79754|P5|COMPLETED|Placebo Washout First Intervention||3
33620|NCT01904773|79755|P4|COMPLETED|Placebo Washout First Intervention||2
33621|NCT01904773|79756|P3|COMPLETED|Placebo Washout First Intervention||1
33622|NCT01904773|79757|P2|COMPLETED|Placebo Washout First Intervention||1
33623|NCT01904773|79758|P1|COMPLETED|Placebo Washout First Intervention||0
33624|NCT01904773|79750|P9|STARTED|Placebo Washout First Intervention||4
33625|NCT01904773|79751|P8|STARTED|Placebo Washout First Intervention||3
33626|NCT01904773|79752|P7|STARTED|Placebo Washout First Intervention||3
33627|NCT01904773|79753|P6|STARTED|Placebo Washout First Intervention||4
33628|NCT01904773|79754|P5|STARTED|Placebo Washout First Intervention||3
33629|NCT01904773|79755|P4|STARTED|Placebo Washout First Intervention||2
33630|NCT01904773|79756|P3|STARTED|Placebo Washout First Intervention||1
33631|NCT01904773|79757|P2|STARTED|Placebo Washout First Intervention||2
33632|NCT01904773|79758|P1|STARTED|Placebo Washout First Intervention||0
33634|NCT01904773|79751|P8|NOT COMPLETED|First Intervention||0
33635|NCT01904773|79752|P7|NOT COMPLETED|First Intervention||1
33636|NCT01904773|79753|P6|NOT COMPLETED|First Intervention||0
33637|NCT01904773|79754|P5|NOT COMPLETED|First Intervention||0
33638|NCT01904773|79755|P4|NOT COMPLETED|First Intervention||0
33639|NCT01904773|79756|P3|NOT COMPLETED|First Intervention||0
33640|NCT01904773|79757|P2|NOT COMPLETED|First Intervention||0
33641|NCT01904773|79758|P1|NOT COMPLETED|First Intervention||0
33642|NCT01904773|79750|P9|COMPLETED|First Intervention||4
33643|NCT01904773|79751|P8|COMPLETED|First Intervention||3
33644|NCT01904773|79752|P7|COMPLETED|First Intervention||3
33645|NCT01904773|79753|P6|COMPLETED|First Intervention||4
33646|NCT01904773|79754|P5|COMPLETED|First Intervention||3
33647|NCT01904773|79755|P4|COMPLETED|First Intervention||2
33648|NCT01904773|79756|P3|COMPLETED|First Intervention||1
33649|NCT01904773|79757|P2|COMPLETED|First Intervention||2
33650|NCT01904773|79758|P1|COMPLETED|First Intervention||0
33651|NCT01904773|79750|P9|STARTED|First Intervention||4
33652|NCT01904773|79751|P8|STARTED|First Intervention||3
33653|NCT01904773|79752|P7|STARTED|First Intervention||4
33654|NCT01904773|79753|P6|STARTED|First Intervention||4
33655|NCT01904773|79754|P5|STARTED|First Intervention||3
33656|NCT01904773|79755|P4|STARTED|First Intervention||2
33657|NCT01904773|79756|P3|STARTED|First Intervention||1
33658|NCT01904773|79757|P2|STARTED|First Intervention||2
33659|NCT01904773|79758|P1|STARTED|First Intervention||0
33660|NCT01904773|79750|P9|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33661|NCT01904773|79751|P8|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33662|NCT01904773|79752|P7|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33663|NCT01904773|79753|P6|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33664|NCT01904773|79754|P5|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33665|NCT01904773|79755|P4|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33666|NCT01904773|79756|P3|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33667|NCT01904773|79757|P2|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33668|NCT01904773|79758|P1|NOT COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||1
33669|NCT01904773|79750|P9|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33670|NCT01904773|79751|P8|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33671|NCT01904773|79752|P7|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33672|NCT01904773|79753|P6|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33673|NCT01904773|79754|P5|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33674|NCT01904773|79755|P4|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33675|NCT01904773|79756|P3|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33676|NCT01904773|79757|P2|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33677|NCT01904773|79758|P1|COMPLETED|Part 1 - Multiple Dose AZD5213 2.0 mg||23
33678|NCT01904773|79750|P9|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33679|NCT01904773|79751|P8|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33680|NCT01904773|79752|P7|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33681|NCT01904773|79753|P6|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33682|NCT01904773|79754|P5|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33683|NCT01904773|79755|P4|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33684|NCT01904773|79756|P3|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33685|NCT01904773|79757|P2|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33686|NCT01904773|79758|P1|Did Not Tolerate 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||4
33687|NCT01904773|79750|P9|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33688|NCT01904773|79751|P8|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33689|NCT01904773|79752|P7|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33690|NCT01904773|79753|P6|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33691|NCT01904773|79754|P5|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33692|NCT01904773|79755|P4|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33693|NCT01904773|79756|P3|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33694|NCT01904773|79757|P2|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33695|NCT01904773|79758|P1|Tolerated 2.0 mg in Part 1|Part 1 - Multiple Dose AZD5213 2.0 mg||20
33696|NCT01904773|79750|P9|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33697|NCT01904773|79751|P8|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33698|NCT01904773|79752|P7|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33699|NCT01904773|79753|P6|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33700|NCT01904773|79754|P5|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33701|NCT01904773|79755|P4|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33702|NCT01904773|79756|P3|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33703|NCT01904773|79757|P2|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||0
33704|NCT01904773|79758|P1|STARTED|Part 1 - Multiple Dose AZD5213 2.0 mg||24
33705|NCT01904773|79750|P9|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33706|NCT01904773|79751|P8|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33707|NCT01904773|79752|P7|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33708|NCT01904773|79753|P6|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33709|NCT01904773|79754|P5|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33710|NCT01904773|79755|P4|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33711|NCT01904773|79756|P3|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33712|NCT01904773|79757|P2|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33713|NCT01904773|79758|P1|NOT COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33714|NCT01904773|79750|P9|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33715|NCT01904773|79751|P8|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33716|NCT01904773|79752|P7|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33717|NCT01904773|79753|P6|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33718|NCT01904773|79754|P5|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33719|NCT01904773|79755|P4|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33720|NCT01904773|79756|P3|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33721|NCT01904773|79757|P2|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33722|NCT01904773|79758|P1|COMPLETED|Part 1 - Single Dose- AZD5213 0.5 mg||24
33723|NCT01904773|79750|P9|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33724|NCT01904773|79751|P8|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33725|NCT01904773|79752|P7|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33726|NCT01904773|79753|P6|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33727|NCT01904773|79754|P5|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33728|NCT01904773|79755|P4|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33729|NCT01904773|79756|P3|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33730|NCT01904773|79757|P2|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||0
33731|NCT01904773|79758|P1|STARTED|Part 1 - Single Dose- AZD5213 0.5 mg||24
33732|NCT01904773|79750|P9|NOT COMPLETED|Screen||0
33733|NCT01904773|79751|P8|NOT COMPLETED|Screen||0
33734|NCT01904773|79752|P7|NOT COMPLETED|Screen||0
33735|NCT01904773|79753|P6|NOT COMPLETED|Screen||0
33736|NCT01904773|79754|P5|NOT COMPLETED|Screen||0
33737|NCT01904773|79755|P4|NOT COMPLETED|Screen||0
33738|NCT01904773|79756|P3|NOT COMPLETED|Screen||0
33739|NCT01904773|79757|P2|NOT COMPLETED|Screen||0
33740|NCT01904773|79758|P1|NOT COMPLETED|Screen||4
33741|NCT01904773|79750|P9|COMPLETED|Screen||0
33742|NCT01904773|79751|P8|COMPLETED|Screen||0
33743|NCT01904773|79752|P7|COMPLETED|Screen||0
33744|NCT01904773|79753|P6|COMPLETED|Screen||0
33745|NCT01904773|79754|P5|COMPLETED|Screen||0
33746|NCT01904773|79755|P4|COMPLETED|Screen||0
33747|NCT01904773|79756|P3|COMPLETED|Screen||0
33748|NCT01904773|79757|P2|COMPLETED|Screen||0
33749|NCT01904773|79758|P1|COMPLETED|Screen||24
33750|NCT01904773|79750|P9|STARTED|Screen||0
33751|NCT01904773|79751|P8|STARTED|Screen||0
33752|NCT01904773|79752|P7|STARTED|Screen||0
33753|NCT01904773|79753|P6|STARTED|Screen||0
33754|NCT01904773|79754|P5|STARTED|Screen||0
33755|NCT01904773|79755|P4|STARTED|Screen||0
33756|NCT01904773|79756|P3|STARTED|Screen||0
33757|NCT01904773|79757|P2|STARTED|Screen||0
33758|NCT01904773|79758|P1|STARTED|Screen||28
33759|NCT01904760|79775|P2|NOT COMPLETED|Overall Study||0
33760|NCT01904760|79776|P1|NOT COMPLETED|Overall Study||1
33761|NCT01904760|79775|P2|COMPLETED|Overall Study||40
33762|NCT01904760|79776|P1|COMPLETED|Overall Study||39
33763|NCT01904760|79775|P2|STARTED|Overall Study||40
33764|NCT01904760|79776|P1|STARTED|Overall Study||40
33765|NCT01904721|79791|P7|NOT COMPLETED|Overall Study||7
33766|NCT01904721|79792|P6|NOT COMPLETED|Overall Study||9
33767|NCT01904721|79793|P5|NOT COMPLETED|Overall Study||8
33768|NCT01904721|79794|P4|NOT COMPLETED|Overall Study||1
33769|NCT01904721|79795|P3|NOT COMPLETED|Overall Study||1
33770|NCT01904721|79796|P2|NOT COMPLETED|Overall Study||0
33771|NCT01904721|79797|P1|NOT COMPLETED|Overall Study||0
33772|NCT01904721|79791|P7|COMPLETED|Overall Study||57
33773|NCT01904721|79792|P6|COMPLETED|Overall Study||56
33774|NCT01904721|79793|P5|COMPLETED|Overall Study||57
33775|NCT01904721|79794|P4|COMPLETED|Overall Study||11
33776|NCT01904721|79795|P3|COMPLETED|Overall Study||11
33777|NCT01904721|79796|P2|COMPLETED|Overall Study||13
33778|NCT01904721|79797|P1|COMPLETED|Overall Study||13
33779|NCT01904721|79791|P7|STARTED|Overall Study||64
33780|NCT01904721|79792|P6|STARTED|Overall Study||65
33781|NCT01904721|79793|P5|STARTED|Overall Study||65
33782|NCT01904721|79794|P4|STARTED|Overall Study||12
33783|NCT01904721|79795|P3|STARTED|Overall Study||12
33784|NCT01904721|79796|P2|STARTED|Overall Study||13
33785|NCT01904721|79797|P1|STARTED|Overall Study||13
33786|NCT01904604|79827|P3|NOT COMPLETED|Overall Study||0
33787|NCT01904604|79828|P2|NOT COMPLETED|Overall Study||4
33788|NCT01904604|79829|P1|NOT COMPLETED|Overall Study||3
33789|NCT01904604|79827|P3|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|25
33790|NCT01904604|79828|P2|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|21
33791|NCT01904604|79829|P1|COMPLETED|Overall Study|COMPLETED: Completed the Week 52 Oral Food Challenge (OFC).|22
33792|NCT01904604|79827|P3|STARTED|Overall Study||25
33793|NCT01904604|79828|P2|STARTED|Overall Study||25
33794|NCT01904604|79829|P1|STARTED|Overall Study||25
33795|NCT01904279|79847|P2|NOT COMPLETED|Overall Study||3
33796|NCT01904279|79848|P1|NOT COMPLETED|Overall Study||3
33797|NCT01904279|79847|P2|COMPLETED|Overall Study||22
33798|NCT01904279|79848|P1|COMPLETED|Overall Study||24
33799|NCT01904279|79847|P2|STARTED|Overall Study||25
33800|NCT01904279|79848|P1|STARTED|Overall Study||27
33801|NCT01904149|79874|P6|NOT COMPLETED|Overall Study||3
33802|NCT01904149|79875|P5|NOT COMPLETED|Overall Study||5
33803|NCT01904149|79876|P4|NOT COMPLETED|Overall Study||4
33804|NCT01904149|79877|P3|NOT COMPLETED|Overall Study||2
33805|NCT01904149|79878|P2|NOT COMPLETED|Overall Study||11
33806|NCT01904149|79879|P1|NOT COMPLETED|Overall Study||5
33807|NCT01904149|79874|P6|COMPLETED|Overall Study||48
33808|NCT01904149|79875|P5|COMPLETED|Overall Study||46
33809|NCT01904149|79876|P4|COMPLETED|Overall Study||47
33810|NCT01904149|79877|P3|COMPLETED|Overall Study||148
33811|NCT01904149|79878|P2|COMPLETED|Overall Study||140
33812|NCT01904149|79879|P1|COMPLETED|Overall Study||147
33813|NCT01904149|79874|P6|Multiple-dose Phase|Overall Study||49
33814|NCT01904149|79875|P5|Multiple-dose Phase|Overall Study||48
33815|NCT01904149|79876|P4|Multiple-dose Phase|Overall Study||48
33816|NCT01904149|79877|P3|Multiple-dose Phase|Overall Study||149
33817|NCT01904149|79878|P2|Multiple-dose Phase|Overall Study||146
33818|NCT01904149|79879|P1|Multiple-dose Phase|Overall Study||150
33819|NCT01904149|79874|P6|Single-dose Phase|Overall Study||51
33820|NCT01904149|79875|P5|Single-dose Phase|Overall Study||51
33821|NCT01904149|79876|P4|Single-dose Phase|Overall Study||51
33822|NCT01904149|79877|P3|Single-dose Phase|Overall Study||150
33823|NCT01904149|79878|P2|Single-dose Phase|Overall Study||151
33824|NCT01904149|79879|P1|Single-dose Phase|Overall Study||152
33825|NCT01904149|79874|P6|STARTED|Overall Study||51
33826|NCT01904149|79875|P5|STARTED|Overall Study||51
33827|NCT01904149|79876|P4|STARTED|Overall Study||51
33828|NCT01904149|79877|P3|STARTED|Overall Study||150
33829|NCT01904149|79878|P2|STARTED|Overall Study||151
33830|NCT01904149|79879|P1|STARTED|Overall Study||152
33831|NCT01904071|79904|P3|NOT COMPLETED|Overall Study||0
33832|NCT01904071|79905|P2|NOT COMPLETED|Overall Study||0
33833|NCT01904071|79906|P1|NOT COMPLETED|Overall Study||0
33834|NCT01904071|79904|P3|COMPLETED|Overall Study||20
33835|NCT01904071|79905|P2|COMPLETED|Overall Study||20
33836|NCT01904071|79906|P1|COMPLETED|Overall Study||24
33837|NCT01904071|79904|P3|STARTED|Overall Study||20
33838|NCT01904071|79905|P2|STARTED|Overall Study||20
33839|NCT01904071|79906|P1|STARTED|Overall Study||24
33840|NCT01904058|79930|P4|NOT COMPLETED|Overall Study||1
33841|NCT01904058|79931|P3|NOT COMPLETED|Overall Study||1
33842|NCT01904058|79932|P2|NOT COMPLETED|Overall Study||0
33843|NCT01904058|79933|P1|NOT COMPLETED|Overall Study||3
33844|NCT01904058|79930|P4|COMPLETED|Overall Study||12
33845|NCT01904058|79931|P3|COMPLETED|Overall Study||10
33846|NCT01904058|79932|P2|COMPLETED|Overall Study||21
33847|NCT01904058|79933|P1|COMPLETED|Overall Study||18
33848|NCT01904058|79930|P4|STARTED|Overall Study||13
33849|NCT01904058|79931|P3|STARTED|Overall Study||11
33850|NCT01904058|79932|P2|STARTED|Overall Study||21
33851|NCT01904058|79933|P1|STARTED|Overall Study||21
33852|NCT01903993|79973|P2|NOT COMPLETED|Overall Study||95
33853|NCT01903993|79974|P1|NOT COMPLETED|Overall Study||123
33854|NCT01903993|79973|P2|COMPLETED|Overall Study||49
33855|NCT01903993|79974|P1|COMPLETED|Overall Study||20
33856|NCT01903993|79973|P2|Received Treatment|Overall Study||142
33857|NCT01903993|79974|P1|Received Treatment|Overall Study||135
33858|NCT01903993|79973|P2|STARTED|Overall Study||144
33859|NCT01903993|79974|P1|STARTED|Overall Study||143
33860|NCT01903876|79991|P2|NOT COMPLETED|Six-Month Follow-up Period||145
33861|NCT01903876|79992|P1|NOT COMPLETED|Six-Month Follow-up Period||91
33862|NCT01903876|79991|P2|COMPLETED|Six-Month Follow-up Period||123
33863|NCT01903876|79992|P1|COMPLETED|Six-Month Follow-up Period||92
33864|NCT01903876|79991|P2|STARTED|Six-Month Follow-up Period||268
33865|NCT01903876|79992|P1|STARTED|Six-Month Follow-up Period||183
33866|NCT01903876|79991|P2|NOT COMPLETED|Baseline to Post-Intervention Period||108
33867|NCT01903876|79992|P1|NOT COMPLETED|Baseline to Post-Intervention Period||184
33868|NCT01903876|79991|P2|COMPLETED|Baseline to Post-Intervention Period||268
33869|NCT01903876|79992|P1|COMPLETED|Baseline to Post-Intervention Period||183
33870|NCT01903876|79991|P2|STARTED|Baseline to Post-Intervention Period||376
33871|NCT01903876|79992|P1|STARTED|Baseline to Post-Intervention Period||367
33872|NCT01903863|80002|P2|NOT COMPLETED|Overall Study||0
33873|NCT01903863|80003|P1|NOT COMPLETED|Overall Study||2
33874|NCT01903863|80002|P2|COMPLETED|Overall Study||16
33875|NCT01903863|80003|P1|COMPLETED|Overall Study||13
33876|NCT01903863|80002|P2|STARTED|Overall Study||16
33877|NCT01903863|80003|P1|STARTED|Overall Study||15
33878|NCT01903720|80023|P1|NOT COMPLETED|Overall Study||12
33879|NCT01903720|80023|P1|COMPLETED|Overall Study||59
33880|NCT01903720|80023|P1|STARTED|Overall Study||71
33881|NCT01903460|80042|P4|NOT COMPLETED|Overall Study||1
33882|NCT01903460|80043|P3|NOT COMPLETED|Overall Study||0
33883|NCT01903460|80044|P2|NOT COMPLETED|Overall Study||0
33884|NCT01903460|80045|P1|NOT COMPLETED|Overall Study||0
33885|NCT01903460|80042|P4|COMPLETED|Overall Study||2
33886|NCT01903460|80043|P3|COMPLETED|Overall Study||3
33887|NCT01903460|80044|P2|COMPLETED|Overall Study||8
33888|NCT01903460|80045|P1|COMPLETED|Overall Study||6
33889|NCT01903460|80042|P4|STARTED|Overall Study||3
33890|NCT01903460|80043|P3|STARTED|Overall Study||3
33891|NCT01903460|80044|P2|STARTED|Overall Study||8
33892|NCT01903460|80045|P1|STARTED|Overall Study||6
33893|NCT01903265|80064|P2|NOT COMPLETED|Overall Study||17
33894|NCT01903265|80065|P1|NOT COMPLETED|Overall Study||14
33895|NCT01903265|80064|P2|COMPLETED|Overall Study||85
33896|NCT01903265|80065|P1|COMPLETED|Overall Study||89
33897|NCT01903265|80064|P2|STARTED|Overall Study||102
33898|NCT01903265|80065|P1|STARTED|Overall Study||103
33899|NCT01903187|80081|P2|NOT COMPLETED|12 Month||0
33900|NCT01903187|80082|P1|NOT COMPLETED|12 Month||0
33901|NCT01903187|80081|P2|COMPLETED|12 Month||0
33902|NCT01903187|80082|P1|COMPLETED|12 Month||2
33903|NCT01903187|80081|P2|STARTED|12 Month||0
33904|NCT01903187|80082|P1|STARTED|12 Month||2
33905|NCT01903187|80081|P2|NOT COMPLETED|6 Month||0
33906|NCT01903187|80082|P1|NOT COMPLETED|6 Month||0
33907|NCT01903187|80081|P2|COMPLETED|6 Month||0
33908|NCT01903187|80082|P1|COMPLETED|6 Month||2
33909|NCT01903187|80081|P2|STARTED|6 Month||0
33910|NCT01903187|80082|P1|STARTED|6 Month||2
33911|NCT01903187|80081|P2|NOT COMPLETED|3 Month||0
33912|NCT01903187|80082|P1|NOT COMPLETED|3 Month||0
33913|NCT01903187|80081|P2|COMPLETED|3 Month||0
33914|NCT01903187|80082|P1|COMPLETED|3 Month||2
33915|NCT01903187|80081|P2|STARTED|3 Month||0
33916|NCT01903187|80082|P1|STARTED|3 Month||2
33917|NCT01903187|80081|P2|NOT COMPLETED|1 Month||0
33918|NCT01903187|80082|P1|NOT COMPLETED|1 Month||0
33919|NCT01903187|80081|P2|COMPLETED|1 Month||2
33920|NCT01903187|80082|P1|COMPLETED|1 Month||2
33921|NCT01903187|80081|P2|STARTED|1 Month||2
33922|NCT01903187|80082|P1|STARTED|1 Month||2
33923|NCT01903187|80081|P2|NOT COMPLETED|Procedure||0
33924|NCT01903187|80082|P1|NOT COMPLETED|Procedure||0
33925|NCT01903187|80081|P2|COMPLETED|Procedure||2
33926|NCT01903187|80082|P1|COMPLETED|Procedure||2
33927|NCT01903187|80081|P2|STARTED|Procedure||2
33928|NCT01903187|80082|P1|STARTED|Procedure||2
33929|NCT01903148|80096|P1|NOT COMPLETED|Overall Study||0
33930|NCT01903148|80096|P1|COMPLETED|Overall Study||441
33931|NCT01903148|80096|P1|STARTED|Overall Study||441
33932|NCT01903005|80114|P1|NOT COMPLETED|Overall Study||373
33933|NCT01903005|80114|P1|COMPLETED|Overall Study|Primary study OX219-006 (n=194); Primary study OX219-007 (n=98)|292
33934|NCT01903005|80114|P1|STARTED|Overall Study|Primary study OX219-006 (n=475); Primary study OX219-007 (n=190)|665
33935|NCT01902888|80128|P1|NOT COMPLETED|Overall Study||3
33936|NCT01902888|80128|P1|COMPLETED|Overall Study||0
33937|NCT01902888|80128|P1|STARTED|Overall Study||3
33938|NCT01902758|80135|P2|NOT COMPLETED|Overall Study||0
33939|NCT01902758|80136|P1|NOT COMPLETED|Overall Study||0
33940|NCT01902758|80135|P2|COMPLETED|Overall Study||14
33941|NCT01902758|80136|P1|COMPLETED|Overall Study||14
33942|NCT01902758|80135|P2|STARTED|Overall Study||14
33943|NCT01902758|80136|P1|STARTED|Overall Study||14
33944|NCT01902303|80144|P2|NOT COMPLETED|Overall Study||24
33945|NCT01902303|80145|P1|NOT COMPLETED|Overall Study||23
33946|NCT01902303|80144|P2|COMPLETED|Overall Study|19 not treated /did not use medication as they did not develop a cold sore|57
33947|NCT01902303|80145|P1|COMPLETED|Overall Study|21 not treated - did not use placebo medication as they did not develop cold sore|54
33948|NCT01902303|80144|P2|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|62
33949|NCT01902303|80145|P1|Number of Participants|Overall Study|Number of randomized participants who developed a cold sore and used the assigned treatment.|56
33950|NCT01902303|80144|P2|STARTED|Overall Study|Allocated to active treatment|81
33951|NCT01902303|80145|P1|STARTED|Overall Study|Allocated to placebo|77
33952|NCT01902134|80159|P6|NOT COMPLETED|Overall Study||9
33953|NCT01902134|80160|P5|NOT COMPLETED|Overall Study||7
33954|NCT01902134|80161|P4|NOT COMPLETED|Overall Study||2
33955|NCT01902134|80162|P3|NOT COMPLETED|Overall Study||15
33956|NCT01902134|80163|P2|NOT COMPLETED|Overall Study||11
33957|NCT01902134|80164|P1|NOT COMPLETED|Overall Study||8
33958|NCT01902134|80159|P6|COMPLETED|Overall Study||45
33959|NCT01902134|80160|P5|COMPLETED|Overall Study||46
33960|NCT01902134|80161|P4|COMPLETED|Overall Study||52
33961|NCT01902134|80162|P3|COMPLETED|Overall Study||145
33962|NCT01902134|80163|P2|COMPLETED|Overall Study||150
33963|NCT01902134|80164|P1|COMPLETED|Overall Study||151
33964|NCT01902134|80159|P6|Multiple-dose Phase|Overall Study||52
33965|NCT01902134|80160|P5|Multiple-dose Phase|Overall Study||53
33966|NCT01902134|80161|P4|Multiple-dose Phase|Overall Study||54
33967|NCT01902134|80162|P3|Multiple-dose Phase|Overall Study||160
33968|NCT01902134|80163|P2|Multiple-dose Phase|Overall Study||160
33969|NCT01902134|80164|P1|Multiple-dose Phase|Overall Study||159
33970|NCT01902134|80159|P6|Single-dose Phase|Overall Study||54
33971|NCT01902134|80160|P5|Single-dose Phase|Overall Study||53
33972|NCT01902134|80161|P4|Single-dose Phase|Overall Study||54
33973|NCT01902134|80162|P3|Single-dose Phase|Overall Study||160
33974|NCT01902134|80163|P2|Single-dose Phase|Overall Study||161
33975|NCT01902134|80164|P1|Single-dose Phase|Overall Study||159
33976|NCT01902134|80159|P6|STARTED|Overall Study||54
33977|NCT01902134|80160|P5|STARTED|Overall Study||53
33978|NCT01902134|80161|P4|STARTED|Overall Study||54
33979|NCT01902134|80162|P3|STARTED|Overall Study||160
33980|NCT01902134|80163|P2|STARTED|Overall Study||161
33981|NCT01902134|80164|P1|STARTED|Overall Study||159
33982|NCT01901588|80188|P2|NOT COMPLETED|Overall Study||0
33983|NCT01901588|80189|P1|NOT COMPLETED|Overall Study||0
33984|NCT01901588|80188|P2|COMPLETED|Overall Study||31
33985|NCT01901588|80189|P1|COMPLETED|Overall Study||32
33986|NCT01901588|80188|P2|STARTED|Overall Study||31
33987|NCT01901588|80189|P1|STARTED|Overall Study||32
33988|NCT01901575|80205|P1|NOT COMPLETED|Overall Study||0
33989|NCT01901575|80205|P1|COMPLETED|Overall Study||16
33990|NCT01901575|80205|P1|STARTED|Overall Study|enrolled patients with PVC's present prior to sedation with remifentanil IVPCA|16
33991|NCT01901393|80211|P2|NOT COMPLETED|Overall Study||0
33992|NCT01901393|80212|P1|NOT COMPLETED|Overall Study||1
33993|NCT01901393|80211|P2|COMPLETED|Overall Study||49
33994|NCT01901393|80212|P1|COMPLETED|Overall Study||50
33995|NCT01901393|80211|P2|STARTED|Overall Study||49
33996|NCT01901393|80212|P1|STARTED|Overall Study||51
33997|NCT01901341|80230|P2|NOT COMPLETED|Overall Study||21
33998|NCT01901341|80231|P1|NOT COMPLETED|Overall Study||20
33999|NCT01901341|80230|P2|COMPLETED|Overall Study||1
34000|NCT01901341|80231|P1|COMPLETED|Overall Study||2
34001|NCT01901341|80230|P2|Received at Least 1 Dose of Study Drug|Overall Study||22
34002|NCT01901341|80231|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
34003|NCT01901341|80230|P2|STARTED|Overall Study||22
34004|NCT01901341|80231|P1|STARTED|Overall Study||22
34005|NCT01901328|80245|P2|NOT COMPLETED|Overall Study||21
34006|NCT01901328|80246|P1|NOT COMPLETED|Overall Study||22
34007|NCT01901328|80245|P2|COMPLETED|Overall Study||2
34008|NCT01901328|80246|P1|COMPLETED|Overall Study||4
34009|NCT01901328|80245|P2|Received at Least 1 Dose of Study Drug|Overall Study||23
34010|NCT01901328|80246|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
34011|NCT01901328|80245|P2|STARTED|Overall Study||23
34012|NCT01901328|80246|P1|STARTED|Overall Study||26
34013|NCT01901302|80260|P2|NOT COMPLETED|Overall Study||23
34014|NCT01901302|80261|P1|NOT COMPLETED|Overall Study||27
34015|NCT01901302|80260|P2|COMPLETED|Overall Study||7
34016|NCT01901302|80261|P1|COMPLETED|Overall Study||4
34017|NCT01901302|80260|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
34018|NCT01901302|80261|P1|Received at Least 1 Dose of Study Drug|Overall Study||31
34019|NCT01901302|80260|P2|STARTED|Overall Study||30
34020|NCT01901302|80261|P1|STARTED|Overall Study||31
34021|NCT01901250|80275|P2|NOT COMPLETED|Overall Study||126
34022|NCT01901250|80276|P1|NOT COMPLETED|Overall Study||138
34023|NCT01901250|80275|P2|COMPLETED|Overall Study||139
34024|NCT01901250|80276|P1|COMPLETED|Overall Study||122
34025|NCT01901250|80275|P2|End of 1st Grade|Overall Study||151
34026|NCT01901250|80276|P1|End of 1st Grade|Overall Study||143
34027|NCT01901250|80275|P2|Start of 1st Grade|Overall Study||176
34028|NCT01901250|80276|P1|Start of 1st Grade|Overall Study||173
34029|NCT01901250|80275|P2|End of Kidergarten|Overall Study||212
34030|NCT01901250|80276|P1|End of Kidergarten|Overall Study||215
34031|NCT01901250|80275|P2|STARTED|Overall Study||265
34032|NCT01901250|80276|P1|STARTED|Overall Study||260
34033|NCT01901211|80284|P2|NOT COMPLETED|Second Ten-week Period||0
34034|NCT01901211|80285|P1|NOT COMPLETED|Second Ten-week Period||0
34035|NCT01901211|80284|P2|COMPLETED|Second Ten-week Period||5
34036|NCT01901211|80285|P1|COMPLETED|Second Ten-week Period||6
34037|NCT01901211|80284|P2|STARTED|Second Ten-week Period||5
34038|NCT01901211|80285|P1|STARTED|Second Ten-week Period||6
34039|NCT01901211|80284|P2|NOT COMPLETED|Washout (6 Weeks)||0
34040|NCT01901211|80285|P1|NOT COMPLETED|Washout (6 Weeks)||0
34041|NCT01901211|80284|P2|COMPLETED|Washout (6 Weeks)||5
34042|NCT01901211|80285|P1|COMPLETED|Washout (6 Weeks)||6
34043|NCT01901211|80284|P2|STARTED|Washout (6 Weeks)||5
34044|NCT01901211|80285|P1|STARTED|Washout (6 Weeks)||6
34045|NCT01901211|80284|P2|NOT COMPLETED|First Ten-week Period||0
34046|NCT01901211|80285|P1|NOT COMPLETED|First Ten-week Period||0
34047|NCT01901211|80284|P2|COMPLETED|First Ten-week Period||5
34048|NCT01901211|80285|P1|COMPLETED|First Ten-week Period||6
34049|NCT01901211|80284|P2|STARTED|First Ten-week Period||5
34050|NCT01901211|80285|P1|STARTED|First Ten-week Period||6
34051|NCT01901185|80291|P1|NOT COMPLETED|Overall Study||2
34052|NCT01901185|80291|P1|COMPLETED|Overall Study||75
34053|NCT01901185|80291|P1|Received Etanercept With Autoinjector A|Overall Study||75
34054|NCT01901185|80291|P1|STARTED|Overall Study||77
34055|NCT01900431|80300|P3|NOT COMPLETED|Open-Label Treatment Period (Part C)||8
34056|NCT01900431|80301|P2|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
34057|NCT01900431|80302|P1|NOT COMPLETED|Open-Label Treatment Period (Part C)||0
34058|NCT01900431|80300|P3|COMPLETED|Open-Label Treatment Period (Part C)||13
34059|NCT01900431|80301|P2|COMPLETED|Open-Label Treatment Period (Part C)||0
34060|NCT01900431|80302|P1|COMPLETED|Open-Label Treatment Period (Part C)||0
34061|NCT01900431|80300|P3|STARTED|Open-Label Treatment Period (Part C)|10 non-responders (5 Placebo, 5 Sarilumab) & 11 non-completers (6 Placebo, 5 Sarilumab) from Part A.|21
34062|NCT01900431|80301|P2|STARTED|Open-Label Treatment Period (Part C)||0
34063|NCT01900431|80302|P1|STARTED|Open-Label Treatment Period (Part C)||0
34064|NCT01900431|80300|P3|NOT COMPLETED|Extended Treatment Period (Part B)||0
34065|NCT01900431|80301|P2|NOT COMPLETED|Extended Treatment Period (Part B)||10
34066|NCT01900431|80302|P1|NOT COMPLETED|Extended Treatment Period (Part B)||1
34067|NCT01900431|80300|P3|COMPLETED|Extended Treatment Period (Part B)||0
34068|NCT01900431|80301|P2|COMPLETED|Extended Treatment Period (Part B)||12
34069|NCT01900431|80302|P1|COMPLETED|Extended Treatment Period (Part B)||7
34070|NCT01900431|80300|P3|STARTED|Extended Treatment Period (Part B)||0
34071|NCT01900431|80301|P2|STARTED|Extended Treatment Period (Part B)||22
34072|NCT01900431|80302|P1|STARTED|Extended Treatment Period (Part B)||8
34073|NCT01900431|80300|P3|NOT COMPLETED|Principal Treatment Period (Part A)||0
34074|NCT01900431|80301|P2|NOT COMPLETED|Principal Treatment Period (Part A)||10
34075|NCT01900431|80302|P1|NOT COMPLETED|Principal Treatment Period (Part A)||7
34076|NCT01900431|80300|P3|COMPLETED|Principal Treatment Period (Part A)||0
34077|NCT01900431|80301|P2|COMPLETED|Principal Treatment Period (Part A)|22 responders entered Part B, 5 non-responders entered Part C, 1 discontinued the study.|28
34078|NCT01900431|80302|P1|COMPLETED|Principal Treatment Period (Part A)|8 responders entered Part B and 5 non-responders entered Part C.|13
34079|NCT01900431|80300|P3|STARTED|Principal Treatment Period (Part A)||0
34080|NCT01900431|80301|P2|STARTED|Principal Treatment Period (Part A)||38
34081|NCT01900431|80302|P1|STARTED|Principal Treatment Period (Part A)||20
34082|NCT01900314|80328|P2|NOT COMPLETED|Overall Study||4
34083|NCT01900314|80329|P1|NOT COMPLETED|Overall Study||4
34084|NCT01900314|80328|P2|COMPLETED|Overall Study|1 patient had 4 TMS Tx, but missed too many for protocol requirements,|16
34085|NCT01900314|80329|P1|COMPLETED|Overall Study|1 patient had MRI, then moved away after 5 TMS treatments|16
34086|NCT01900314|80328|P2|Completed MRI#1|Overall Study|2 withdrew consent, 1 patient was unable to tolerate MRI|17
34087|NCT01900314|80329|P1|Completed MRI#1|Overall Study|2 withdrew consent prior to MRI, 1 had MRI technical failure|17
34088|NCT01900314|80328|P2|STARTED|Overall Study||20
34089|NCT01900314|80329|P1|STARTED|Overall Study||20
34090|NCT01900249|80340|P3|NOT COMPLETED|Overall Study||4
34091|NCT01900249|80341|P2|NOT COMPLETED|Overall Study||5
34092|NCT01900249|80342|P1|NOT COMPLETED|Overall Study||3
34093|NCT01900249|80340|P3|COMPLETED|Overall Study||65
34094|NCT01900249|80341|P2|COMPLETED|Overall Study||63
34095|NCT01900249|80342|P1|COMPLETED|Overall Study||64
34096|NCT01900249|80340|P3|STARTED|Overall Study||69
34097|NCT01900249|80341|P2|STARTED|Overall Study||68
34098|NCT01900249|80342|P1|STARTED|Overall Study||67
34099|NCT01900067|80352|P2|NOT COMPLETED|Overall Study||13
34100|NCT01900067|80353|P1|NOT COMPLETED|Overall Study||12
34101|NCT01900067|80352|P2|COMPLETED|Overall Study||124
34102|NCT01900067|80353|P1|COMPLETED|Overall Study||122
34103|NCT01900067|80352|P2|STARTED|Overall Study||137
34104|NCT01900067|80353|P1|STARTED|Overall Study||134
34105|NCT01900054|80359|P1|NOT COMPLETED|Overall Study||2
34106|NCT01900054|80359|P1|COMPLETED|Overall Study||56
34107|NCT01900054|80359|P1|STARTED|Overall Study||58
34108|NCT01899911|80364|P1|NOT COMPLETED|Overall Study||0
34109|NCT01899911|80364|P1|COMPLETED|Overall Study||12
34110|NCT01899911|80364|P1|STARTED|Overall Study||12
34111|NCT01899768|80368|P1|NOT COMPLETED|Part C||0
34112|NCT01899768|80368|P1|COMPLETED|Part C||11
34113|NCT01899768|80368|P1|STARTED|Part C||11
34114|NCT01899768|80368|P1|NOT COMPLETED|Part B||2
34115|NCT01899768|80368|P1|COMPLETED|Part B||11
34116|NCT01899768|80368|P1|STARTED|Part B||13
34117|NCT01899768|80368|P1|NOT COMPLETED|Part A||3
34118|NCT01899768|80368|P1|COMPLETED|Part A||13
34119|NCT01899768|80368|P1|STARTED|Part A||16
34120|NCT01899742|80442|P2|NOT COMPLETED|Overall Study||16
34121|NCT01899742|80443|P1|NOT COMPLETED|Overall Study||17
34122|NCT01899742|80442|P2|COMPLETED|Overall Study||231
34123|NCT01899742|80443|P1|COMPLETED|Overall Study||230
34124|NCT01899742|80442|P2|STARTED|Overall Study||247
34125|NCT01899742|80443|P1|STARTED|Overall Study||247
34126|NCT01899677|80453|P2|NOT COMPLETED|Overall Study||7
34127|NCT01899677|80454|P1|NOT COMPLETED|Overall Study||10
34128|NCT01899677|80453|P2|COMPLETED|Overall Study||28
34129|NCT01899677|80454|P1|COMPLETED|Overall Study||25
34130|NCT01899677|80453|P2|STARTED|Overall Study||35
34131|NCT01899677|80454|P1|STARTED|Overall Study||35
34132|NCT01899144|80482|P1|NOT COMPLETED|Treatment Period 5||1
34133|NCT01899144|80482|P1|COMPLETED|Treatment Period 5|Last treatment taken by the patient who discontinued was ABS Spiromax 180 mcg.|57
34134|NCT01899144|80482|P1|STARTED|Treatment Period 5||58
34135|NCT01899144|80482|P1|NOT COMPLETED|Treatment Period 4||0
34136|NCT01899144|80482|P1|COMPLETED|Treatment Period 4||58
34137|NCT01899144|80482|P1|STARTED|Treatment Period 4||58
34138|NCT01899144|80482|P1|NOT COMPLETED|Treatment Period 3||2
34139|NCT01899144|80482|P1|COMPLETED|Treatment Period 3|Last treatment taken by patients who discontinued were ABS Spiromax 180 mcg and ABS Spiromax 90 mcg.|58
34140|NCT01899144|80482|P1|STARTED|Treatment Period 3||60
34141|NCT01899144|80482|P1|NOT COMPLETED|Treatment Period 2||1
34142|NCT01899144|80482|P1|COMPLETED|Treatment Period 2|Last treatment taken by the patient who discontinued was placebo.|60
34143|NCT01899144|80482|P1|STARTED|Treatment Period 2||61
34144|NCT01899144|80482|P1|NOT COMPLETED|Treatment Period 1||0
34145|NCT01899144|80482|P1|COMPLETED|Treatment Period 1||61
34146|NCT01899144|80482|P1|STARTED|Treatment Period 1||61
34147|NCT01898884|80509|P9|NOT COMPLETED|Multiple Dose Period||1
34148|NCT01898884|80510|P8|NOT COMPLETED|Multiple Dose Period||0
34149|NCT01898884|80511|P7|NOT COMPLETED|Multiple Dose Period||1
34150|NCT01898884|80512|P6|NOT COMPLETED|Multiple Dose Period||0
34151|NCT01898884|80513|P5|NOT COMPLETED|Multiple Dose Period||0
34152|NCT01898884|80514|P4|NOT COMPLETED|Multiple Dose Period||0
34153|NCT01898884|80515|P3|NOT COMPLETED|Multiple Dose Period||0
34154|NCT01898884|80516|P2|NOT COMPLETED|Multiple Dose Period||0
34155|NCT01898884|80517|P1|NOT COMPLETED|Multiple Dose Period||0
34156|NCT01898884|80509|P9|COMPLETED|Multiple Dose Period||5
34157|NCT01898884|80510|P8|COMPLETED|Multiple Dose Period||6
34158|NCT01898884|80511|P7|COMPLETED|Multiple Dose Period||5
34159|NCT01898884|80512|P6|COMPLETED|Multiple Dose Period||6
34160|NCT01898884|80513|P5|COMPLETED|Multiple Dose Period||0
34161|NCT01898884|80514|P4|COMPLETED|Multiple Dose Period||0
34162|NCT01898884|80515|P3|COMPLETED|Multiple Dose Period||0
34163|NCT01898884|80516|P2|COMPLETED|Multiple Dose Period||0
34164|NCT01898884|80517|P1|COMPLETED|Multiple Dose Period||0
34165|NCT01898884|80509|P9|Treated|Multiple Dose Period||5
34166|NCT01898884|80510|P8|Treated|Multiple Dose Period||6
34167|NCT01898884|80511|P7|Treated|Multiple Dose Period||6
34168|NCT01898884|80512|P6|Treated|Multiple Dose Period||6
34169|NCT01898884|80513|P5|Treated|Multiple Dose Period||0
34170|NCT01898884|80514|P4|Treated|Multiple Dose Period||0
34171|NCT01898884|80515|P3|Treated|Multiple Dose Period||0
34172|NCT01898884|80516|P2|Treated|Multiple Dose Period||0
34173|NCT01898884|80517|P1|Treated|Multiple Dose Period||0
34174|NCT01898884|80509|P9|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
34175|NCT01898884|80510|P8|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
34176|NCT01898884|80511|P7|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
34177|NCT01898884|80512|P6|STARTED|Multiple Dose Period|Eligible participants who completed single dose treatment were randomized to multiple dose groups.|6
34178|NCT01898884|80513|P5|STARTED|Multiple Dose Period||0
34179|NCT01898884|80514|P4|STARTED|Multiple Dose Period||0
34180|NCT01898884|80515|P3|STARTED|Multiple Dose Period||0
34181|NCT01898884|80516|P2|STARTED|Multiple Dose Period||0
34182|NCT01898884|80517|P1|STARTED|Multiple Dose Period||0
34183|NCT01898884|80509|P9|NOT COMPLETED|Single Dose Period||0
34184|NCT01898884|80510|P8|NOT COMPLETED|Single Dose Period||0
34185|NCT01898884|80511|P7|NOT COMPLETED|Single Dose Period||0
34186|NCT01898884|80512|P6|NOT COMPLETED|Single Dose Period||0
34187|NCT01898884|80513|P5|NOT COMPLETED|Single Dose Period||0
34188|NCT01898884|80514|P4|NOT COMPLETED|Single Dose Period||0
34189|NCT01898884|80515|P3|NOT COMPLETED|Single Dose Period||0
34190|NCT01898884|80516|P2|NOT COMPLETED|Single Dose Period||0
34191|NCT01898884|80517|P1|NOT COMPLETED|Single Dose Period||0
34192|NCT01898884|80509|P9|COMPLETED|Single Dose Period||0
34193|NCT01898884|80510|P8|COMPLETED|Single Dose Period||0
34194|NCT01898884|80511|P7|COMPLETED|Single Dose Period||0
34195|NCT01898884|80512|P6|COMPLETED|Single Dose Period||0
34196|NCT01898884|80513|P5|COMPLETED|Single Dose Period||6
34197|NCT01898884|80514|P4|COMPLETED|Single Dose Period||6
34198|NCT01898884|80515|P3|COMPLETED|Single Dose Period||6
34199|NCT01898884|80516|P2|COMPLETED|Single Dose Period||6
34200|NCT01898884|80517|P1|COMPLETED|Single Dose Period||8
34201|NCT01898884|80509|P9|STARTED|Single Dose Period||0
34202|NCT01898884|80510|P8|STARTED|Single Dose Period||0
34203|NCT01898884|80511|P7|STARTED|Single Dose Period||0
34204|NCT01898884|80512|P6|STARTED|Single Dose Period||0
34205|NCT01898884|80513|P5|STARTED|Single Dose Period||6
34206|NCT01898884|80514|P4|STARTED|Single Dose Period||6
34207|NCT01898884|80515|P3|STARTED|Single Dose Period||6
34208|NCT01898884|80516|P2|STARTED|Single Dose Period||6
34209|NCT01898884|80517|P1|STARTED|Single Dose Period||8
34210|NCT01898598|80669|P2|NOT COMPLETED|Overall Study||2
34211|NCT01898598|80670|P1|NOT COMPLETED|Overall Study||4
34212|NCT01898598|80669|P2|COMPLETED|Overall Study||4
34213|NCT01898598|80670|P1|COMPLETED|Overall Study||8
34214|NCT01898598|80669|P2|Treated|Overall Study||5
34215|NCT01898598|80670|P1|Treated|Overall Study||11
34216|NCT01898598|80669|P2|STARTED|Overall Study||6
34217|NCT01898598|80670|P1|STARTED|Overall Study||12
34218|NCT01898442|80689|P3|NOT COMPLETED|Overall Study||3
34219|NCT01898442|80690|P2|NOT COMPLETED|Overall Study||2
34220|NCT01898442|80691|P1|NOT COMPLETED|Overall Study||1
34221|NCT01898442|80689|P3|COMPLETED|Overall Study||15
34222|NCT01898442|80690|P2|COMPLETED|Overall Study||15
34223|NCT01898442|80691|P1|COMPLETED|Overall Study||16
34224|NCT01898442|80689|P3|STARTED|Overall Study||18
34225|NCT01898442|80690|P2|STARTED|Overall Study||17
34226|NCT01898442|80691|P1|STARTED|Overall Study||17
34227|NCT01898403|80714|P1|NOT COMPLETED|Overall Study||0
34228|NCT01898403|80714|P1|COMPLETED|Overall Study||50
34229|NCT01898403|80714|P1|STARTED|Overall Study||50
34230|NCT01898286|80720|P1|NOT COMPLETED|Overall Study||3
34231|NCT01898286|80720|P1|COMPLETED|Overall Study|"For this study completed is defined as completing the Early Termination visit"|35
34232|NCT01898286|80720|P1|STARTED|Overall Study||38
34233|NCT01898208|80730|P3|NOT COMPLETED|Overall Study||37
34234|NCT01898208|80731|P2|NOT COMPLETED|Overall Study||49
34235|NCT01898208|80732|P1|NOT COMPLETED|Overall Study||40
34236|NCT01898208|80730|P3|COMPLETED|Overall Study||212
34237|NCT01898208|80731|P2|COMPLETED|Overall Study||198
34238|NCT01898208|80732|P1|COMPLETED|Overall Study||207
34239|NCT01898208|80730|P3|STARTED|Overall Study||249
34240|NCT01898208|80731|P2|STARTED|Overall Study||247
34241|NCT01898208|80732|P1|STARTED|Overall Study||247
34242|NCT01898195|80779|P3|NOT COMPLETED|Smoking Abstinence||36
34243|NCT01898195|80780|P2|NOT COMPLETED|Smoking Abstinence||38
34244|NCT01898195|80781|P1|NOT COMPLETED|Smoking Abstinence||35
34245|NCT01898195|80779|P3|COMPLETED|Smoking Abstinence||15
34246|NCT01898195|80780|P2|COMPLETED|Smoking Abstinence||16
34247|NCT01898195|80781|P1|COMPLETED|Smoking Abstinence||18
34248|NCT01898195|80779|P3|STARTED|Smoking Abstinence||51
34249|NCT01898195|80780|P2|STARTED|Smoking Abstinence||54
34250|NCT01898195|80781|P1|STARTED|Smoking Abstinence||53
34251|NCT01898195|80779|P3|NOT COMPLETED|Varenicline Adherence||36
34252|NCT01898195|80780|P2|NOT COMPLETED|Varenicline Adherence||38
34253|NCT01898195|80781|P1|NOT COMPLETED|Varenicline Adherence||35
34254|NCT01898195|80779|P3|COMPLETED|Varenicline Adherence||15
34255|NCT01898195|80780|P2|COMPLETED|Varenicline Adherence||16
34256|NCT01898195|80781|P1|COMPLETED|Varenicline Adherence||18
34257|NCT01898195|80779|P3|STARTED|Varenicline Adherence||51
34258|NCT01898195|80780|P2|STARTED|Varenicline Adherence||54
34259|NCT01898195|80781|P1|STARTED|Varenicline Adherence||53
34260|NCT01898091|80794|P2|NOT COMPLETED|Overall Study||6
34261|NCT01898091|80795|P1|NOT COMPLETED|Overall Study||2
34262|NCT01898091|80794|P2|COMPLETED|Overall Study||19
34263|NCT01898091|80795|P1|COMPLETED|Overall Study||23
34264|NCT01898091|80794|P2|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
34265|NCT01898091|80795|P1|STARTED|Overall Study|Allocated to intervention. All allocated received intervention.|25
34266|NCT01897792|80803|P2|NOT COMPLETED|Overall Study||0
34267|NCT01897792|80804|P1|NOT COMPLETED|Overall Study||0
34268|NCT01897792|80803|P2|COMPLETED|Overall Study||5
34269|NCT01897792|80804|P1|COMPLETED|Overall Study||6
34270|NCT01897792|80803|P2|STARTED|Overall Study||5
34271|NCT01897792|80804|P1|STARTED|Overall Study||6
34272|NCT01897727|80830|P2|NOT COMPLETED|Overall Study||1
34273|NCT01897727|80831|P1|NOT COMPLETED|Overall Study||0
34274|NCT01897727|80830|P2|COMPLETED|Overall Study||8
34275|NCT01897727|80831|P1|COMPLETED|Overall Study||8
34276|NCT01897727|80830|P2|STARTED|Overall Study||9
34277|NCT01897727|80831|P1|STARTED|Overall Study||8
34278|NCT01897402|80839|P2|NOT COMPLETED|Overall Study||16
34279|NCT01897402|80840|P1|NOT COMPLETED|Overall Study||19
34280|NCT01897402|80839|P2|COMPLETED|Overall Study||244
34281|NCT01897402|80840|P1|COMPLETED|Overall Study||246
34282|NCT01897402|80839|P2|STARTED|Overall Study||260
34283|NCT01897402|80840|P1|STARTED|Overall Study||265
34284|NCT01897285|80852|P1|NOT COMPLETED|Overall Study||0
34285|NCT01897285|80852|P1|COMPLETED|Overall Study||20
34286|NCT01897285|80852|P1|STARTED|Overall Study|All 20 participants received original AND test adhesive dressings on upper arms and lower back.|20
34287|NCT01897233|80860|P1|NOT COMPLETED|Part B (24 Weeks)||4
34288|NCT01897233|80860|P1|COMPLETED|Part B (24 Weeks)||54
34289|NCT01897233|80860|P1|STARTED|Part B (24 Weeks)|6 participants from Part A also participated in Part B of the study.|58
34290|NCT01897233|80860|P1|NOT COMPLETED|Part A (14 Days)||0
34291|NCT01897233|80860|P1|COMPLETED|Part A (14 Days)||10
34292|NCT01897233|80860|P1|Part A Cohort 2 (9 to 11 Years)|Part A (14 Days)||5
34293|NCT01897233|80860|P1|Part A Cohort 1 (6 to 8 Years)|Part A (14 Days)||5
34294|NCT01897233|80860|P1|STARTED|Part A (14 Days)||10
34295|NCT01897025|80884|P2|NOT COMPLETED|Overall Study||0
34296|NCT01897025|80885|P1|NOT COMPLETED|Overall Study||0
34297|NCT01897025|80884|P2|COMPLETED|Overall Study||9
34298|NCT01897025|80885|P1|COMPLETED|Overall Study||10
34299|NCT01897025|80884|P2|STARTED|Overall Study||9
34300|NCT01897025|80885|P1|STARTED|Overall Study||10
34301|NCT01896986|80893|P2|NOT COMPLETED|Overall Study||23
34302|NCT01896986|80894|P1|NOT COMPLETED|Overall Study||14
34303|NCT01896986|80893|P2|COMPLETED|Overall Study||0
34304|NCT01896986|80894|P1|COMPLETED|Overall Study||0
34305|NCT01896986|80893|P2|STARTED|Overall Study||23
34306|NCT01896986|80894|P1|STARTED|Overall Study||14
34307|NCT01896934|80900|P1|NOT COMPLETED|Overall Study||2
34308|NCT01896934|80900|P1|COMPLETED|Overall Study||19
34309|NCT01896934|80900|P1|STARTED|Overall Study||21
34310|NCT01896726|80906|P1|NOT COMPLETED|Treatment Period 2 (Days 23-31)||2
34311|NCT01896726|80906|P1|COMPLETED|Treatment Period 2 (Days 23-31)||18
34312|NCT01896726|80906|P1|Received Microgynon|Treatment Period 2 (Days 23-31)||18
34313|NCT01896726|80906|P1|Received at Least 1 Dose of Baricitinib|Treatment Period 2 (Days 23-31)||20
34314|NCT01896726|80906|P1|STARTED|Treatment Period 2 (Days 23-31)||20
34315|NCT01896726|80906|P1|NOT COMPLETED|Treatment Period 1 (Days 1-22)||0
34316|NCT01896726|80906|P1|COMPLETED|Treatment Period 1 (Days 1-22)||20
34317|NCT01896726|80906|P1|Received Microgynon|Treatment Period 1 (Days 1-22)||20
34318|NCT01896726|80906|P1|STARTED|Treatment Period 1 (Days 1-22)||20
34319|NCT01896687|80921|P2|NOT COMPLETED|Overall Study||0
34320|NCT01896687|80922|P1|NOT COMPLETED|Overall Study||0
34321|NCT01896687|80921|P2|COMPLETED|Overall Study||15
34322|NCT01896687|80922|P1|COMPLETED|Overall Study||15
34323|NCT01896687|80921|P2|STARTED|Overall Study||15
34324|NCT01896687|80922|P1|STARTED|Overall Study||15
34325|NCT01896557|80930|P2|NOT COMPLETED|Clopidogrel + GI Protector||4
34326|NCT01896557|80931|P1|NOT COMPLETED|Clopidogrel + GI Protector||2
34327|NCT01896557|80930|P2|COMPLETED|Clopidogrel + GI Protector||44
34328|NCT01896557|80931|P1|COMPLETED|Clopidogrel + GI Protector||41
34329|NCT01896557|80930|P2|STARTED|Clopidogrel + GI Protector||48
34330|NCT01896557|80931|P1|STARTED|Clopidogrel + GI Protector||43
34331|NCT01896557|80930|P2|NOT COMPLETED|Clopidogrel Alone||0
34332|NCT01896557|80931|P1|NOT COMPLETED|Clopidogrel Alone||1
34333|NCT01896557|80930|P2|COMPLETED|Clopidogrel Alone||48
34334|NCT01896557|80931|P1|COMPLETED|Clopidogrel Alone||43
34335|NCT01896557|80930|P2|STARTED|Clopidogrel Alone||48
34336|NCT01896557|80931|P1|STARTED|Clopidogrel Alone||44
34337|NCT01896544|80942|P3|NOT COMPLETED|Overall Study||0
34338|NCT01896544|80943|P2|NOT COMPLETED|Overall Study||0
34339|NCT01896544|80944|P1|NOT COMPLETED|Overall Study||0
34340|NCT01896544|80942|P3|COMPLETED|Overall Study||10
34341|NCT01896544|80943|P2|COMPLETED|Overall Study||10
34342|NCT01896544|80944|P1|COMPLETED|Overall Study||10
34343|NCT01896544|80942|P3|STARTED|Overall Study||10
34344|NCT01896544|80943|P2|STARTED|Overall Study||10
34345|NCT01896544|80944|P1|STARTED|Overall Study||10
34346|NCT01896297|80964|P1|NOT COMPLETED|Overall Study||1
34347|NCT01896297|80964|P1|COMPLETED|Overall Study||59
34348|NCT01896297|80964|P1|STARTED|Overall Study||60
34349|NCT01896232|80971|P2|NOT COMPLETED|Overall Study||53
34350|NCT01896232|80972|P1|NOT COMPLETED|Overall Study||49
34351|NCT01896232|80971|P2|COMPLETED|Overall Study||287
34352|NCT01896232|80972|P1|COMPLETED|Overall Study||294
34353|NCT01896232|80971|P2|Received Treatment|Overall Study||338
34354|NCT01896232|80972|P1|Received Treatment|Overall Study||341
34355|NCT01896232|80971|P2|STARTED|Overall Study||340
34356|NCT01896232|80972|P1|STARTED|Overall Study||343
34357|NCT01896206|80992|P1|NOT COMPLETED|Overall Study||0
34358|NCT01896206|80992|P1|COMPLETED|Overall Study||21
34359|NCT01896206|80992|P1|STARTED|Overall Study||21
34360|NCT01896193|81000|P2|NOT COMPLETED|Overall Study||12
34361|NCT01896193|81001|P1|NOT COMPLETED|Overall Study||21
34362|NCT01896193|81000|P2|COMPLETED|Overall Study||53
34363|NCT01896193|81001|P1|COMPLETED|Overall Study||41
34364|NCT01896193|81000|P2|STARTED|Overall Study||65
34365|NCT01896193|81001|P1|STARTED|Overall Study||62
34366|NCT01896115|81025|P1|NOT COMPLETED|Overall Study||1
34367|NCT01896115|81025|P1|COMPLETED|Overall Study||15
34368|NCT01896115|81025|P1|Ventral Steering|Overall Study||15
34369|NCT01896115|81025|P1|Dorsal Steering|Overall Study||15
34370|NCT01896115|81025|P1|Conventional PW|Overall Study||15
34371|NCT01896115|81025|P1|Short PW|Overall Study||15
34372|NCT01896115|81025|P1|STARTED|Overall Study||16
34373|NCT01896050|81050|P2|NOT COMPLETED|Overall Study||2
34374|NCT01896050|81051|P1|NOT COMPLETED|Overall Study||38
34375|NCT01896050|81050|P2|COMPLETED|Overall Study||20
34376|NCT01896050|81051|P1|COMPLETED|Overall Study|This includes only patients who remained on the same aromatase inhibitor medication for 12 months|55
34377|NCT01896050|81050|P2|STARTED|Overall Study||22
34378|NCT01896050|81051|P1|STARTED|Overall Study||93
34379|NCT01895946|81063|P2|NOT COMPLETED|Overall Study||0
34380|NCT01895946|81064|P1|NOT COMPLETED|Overall Study||0
34381|NCT01895946|81063|P2|COMPLETED|Overall Study||12
34382|NCT01895946|81064|P1|COMPLETED|Overall Study||18
34383|NCT01895946|81063|P2|STARTED|Overall Study||12
34384|NCT01895946|81064|P1|STARTED|Overall Study||18
34385|NCT01895634|81082|P1|NOT COMPLETED|Overall Study||3
34386|NCT01895634|81082|P1|COMPLETED|Overall Study||46
34387|NCT01895634|81082|P1|STARTED|Overall Study||49
34388|NCT01895608|81094|P4|NOT COMPLETED|Overall Study||0
34389|NCT01895608|81095|P3|NOT COMPLETED|Overall Study||3
34390|NCT01895608|81096|P2|NOT COMPLETED|Overall Study||1
34391|NCT01895608|81097|P1|NOT COMPLETED|Overall Study||0
34392|NCT01895608|81094|P4|COMPLETED|Overall Study||6
34393|NCT01895608|81095|P3|COMPLETED|Overall Study||8
34394|NCT01895608|81096|P2|COMPLETED|Overall Study||6
34395|NCT01895608|81097|P1|COMPLETED|Overall Study||10
34396|NCT01895608|81094|P4|STARTED|Overall Study||6
34397|NCT01895608|81095|P3|STARTED|Overall Study||11
34398|NCT01895608|81096|P2|STARTED|Overall Study||7
34399|NCT01895608|81097|P1|STARTED|Overall Study||10
34400|NCT01895543|81127|P1|NOT COMPLETED|Overall Study||129
34401|NCT01895543|81127|P1|COMPLETED|Overall Study||282
34402|NCT01895543|81127|P1|Per Protocol Analysis Set|Overall Study|Set included all enrolled patients who had no major protocol deviations.|380
34403|NCT01895543|81127|P1|Safety Analysis Set|Overall Study|Set included all enrolled patients who took at least one dose of Investigational Medicinal Product.|409
34404|NCT01895543|81127|P1|STARTED|Overall Study||411
34405|NCT01895452|81143|P2|NOT COMPLETED|Overall Study||28
34406|NCT01895452|81144|P1|NOT COMPLETED|Overall Study||4
34407|NCT01895452|81143|P2|COMPLETED|Overall Study||198
34408|NCT01895452|81144|P1|COMPLETED|Overall Study||61
34409|NCT01895452|81143|P2|STARTED|Overall Study||226
34410|NCT01895452|81144|P1|STARTED|Overall Study||65
34411|NCT01895335|81154|P1|NOT COMPLETED|Overall Study||215
34412|NCT01895335|81154|P1|COMPLETED|Overall Study||786
34413|NCT01895335|81154|P1|Treated|Overall Study||1000
34414|NCT01895335|81154|P1|STARTED|Overall Study||1001
34415|NCT01895322|81171|P1|NOT COMPLETED|Overall Study||13
34416|NCT01895322|81171|P1|COMPLETED|Overall Study||7
34417|NCT01895322|81171|P1|STARTED|Overall Study||20
34418|NCT01895309|81180|P2|NOT COMPLETED|Overall Study||51
34419|NCT01895309|81181|P1|NOT COMPLETED|Overall Study||40
34420|NCT01895309|81180|P2|COMPLETED|Overall Study||246
34421|NCT01895309|81181|P1|COMPLETED|Overall Study||259
34422|NCT01895309|81180|P2|STARTED|Overall Study||297
34423|NCT01895309|81181|P1|STARTED|Overall Study||299
34424|NCT01895270|81195|P2|NOT COMPLETED|Isradipine Taper (W7-8)||2
34425|NCT01895270|81196|P1|NOT COMPLETED|Isradipine Taper (W7-8)||0
34426|NCT01895270|81195|P2|COMPLETED|Isradipine Taper (W7-8)||0
34427|NCT01895270|81196|P1|COMPLETED|Isradipine Taper (W7-8)||2
34428|NCT01895270|81195|P2|STARTED|Isradipine Taper (W7-8)||2
34429|NCT01895270|81196|P1|STARTED|Isradipine Taper (W7-8)||2
34430|NCT01895270|81195|P2|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||5
34431|NCT01895270|81196|P1|NOT COMPLETED|Buprenorphine Taper (W5 to W6D3)||3
34432|NCT01895270|81195|P2|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
34433|NCT01895270|81196|P1|COMPLETED|Buprenorphine Taper (W5 to W6D3)||2
34434|NCT01895270|81195|P2|STARTED|Buprenorphine Taper (W5 to W6D3)|1 subject missed meds prior to bup taper so did not start this phase|7
34435|NCT01895270|81196|P1|STARTED|Buprenorphine Taper (W5 to W6D3)||5
34436|NCT01895270|81195|P2|NOT COMPLETED|Study Medications Induction (W1-4)||6
34437|NCT01895270|81196|P1|NOT COMPLETED|Study Medications Induction (W1-4)||6
34438|NCT01895270|81195|P2|COMPLETED|Study Medications Induction (W1-4)||8
34439|NCT01895270|81196|P1|COMPLETED|Study Medications Induction (W1-4)||5
34440|NCT01895270|81195|P2|STARTED|Study Medications Induction (W1-4)||14
34441|NCT01895270|81196|P1|STARTED|Study Medications Induction (W1-4)||11
34442|NCT01895101|81205|P3|NOT COMPLETED|Overall Study||5
34443|NCT01895101|81206|P2|NOT COMPLETED|Overall Study||5
34444|NCT01895101|81207|P1|NOT COMPLETED|Overall Study||1
34445|NCT01895101|81205|P3|COMPLETED|Overall Study||245
34446|NCT01895101|81206|P2|COMPLETED|Overall Study||245
34447|NCT01895101|81207|P1|COMPLETED|Overall Study||249
34448|NCT01895101|81205|P3|STARTED|Overall Study||250
34449|NCT01895101|81206|P2|STARTED|Overall Study||250
34450|NCT01895101|81207|P1|STARTED|Overall Study||250
34451|NCT01895088|81221|P1|NOT COMPLETED|Overall Study||18
34452|NCT01895088|81221|P1|COMPLETED|Overall Study||253
34453|NCT01895088|81221|P1|STARTED|Overall Study|1 subject consented for monitoring after device removal (not included in cohort), per FDA request.|271
34454|NCT01895062|81227|P2|NOT COMPLETED|Overall Study||0
34455|NCT01895062|81228|P1|NOT COMPLETED|Overall Study||0
34456|NCT01895062|81227|P2|COMPLETED|Overall Study||24
34457|NCT01895062|81228|P1|COMPLETED|Overall Study||30
34458|NCT01895062|81227|P2|STARTED|Overall Study||24
34459|NCT01895062|81228|P1|STARTED|Overall Study||30
34460|NCT01894984|81238|P2|NOT COMPLETED|Overall Study||175
34461|NCT01894984|81239|P1|NOT COMPLETED|Overall Study||314
34462|NCT01894984|81238|P2|COMPLETED|Overall Study||69
34463|NCT01894984|81239|P1|COMPLETED|Overall Study||82
34464|NCT01894984|81238|P2|STARTED|Overall Study||244
34465|NCT01894984|81239|P1|STARTED|Overall Study||396
34466|NCT01894906|81257|P2|NOT COMPLETED|Overall Study||0
34467|NCT01894906|81258|P1|NOT COMPLETED|Overall Study||0
34468|NCT01894906|81257|P2|COMPLETED|Overall Study||6
34469|NCT01894906|81258|P1|COMPLETED|Overall Study||6
34470|NCT01894906|81257|P2|Treatment F|Overall Study||6
34471|NCT01894906|81258|P1|Treatment F|Overall Study||6
34472|NCT01894906|81257|P2|Treatment E|Overall Study||6
34473|NCT01894906|81258|P1|Treatment E|Overall Study||6
34474|NCT01894906|81257|P2|Treatment D|Overall Study||6
34475|NCT01894906|81258|P1|Treatment D|Overall Study||6
34476|NCT01894906|81257|P2|Treatment C|Overall Study||6
34477|NCT01894906|81258|P1|Treatment C|Overall Study||6
34478|NCT01894906|81257|P2|Treatment B|Overall Study||6
34479|NCT01894906|81258|P1|Treatment B|Overall Study||6
34480|NCT01894906|81257|P2|Treatment A|Overall Study||6
34481|NCT01894906|81258|P1|Treatment A|Overall Study||6
34482|NCT01894906|81257|P2|STARTED|Overall Study||6
34483|NCT01894906|81258|P1|STARTED|Overall Study||6
34484|NCT01894672|81288|P1|NOT COMPLETED|Overall Study||0
34485|NCT01894672|81288|P1|COMPLETED|Overall Study||7
34486|NCT01894672|81288|P1|STARTED|Overall Study||7
34487|NCT01894607|81294|P1|NOT COMPLETED|Overall Study||1
34488|NCT01894607|81294|P1|COMPLETED|Overall Study||10
34489|NCT01894607|81294|P1|STARTED|Overall Study||11
34490|NCT01894581|81301|P2|NOT COMPLETED|Overall Study||7
34491|NCT01894581|81302|P1|NOT COMPLETED|Overall Study||5
34492|NCT01894581|81301|P2|COMPLETED|Overall Study||12
34493|NCT01894581|81302|P1|COMPLETED|Overall Study||15
34494|NCT01894581|81301|P2|STARTED|Overall Study||19
34495|NCT01894581|81302|P1|STARTED|Overall Study||20
34496|NCT01894555|81308|P1|NOT COMPLETED|Overall Study||0
34497|NCT01894555|81308|P1|COMPLETED|Overall Study||33
34498|NCT01894555|81308|P1|STARTED|Overall Study||33
34499|NCT01894256|81315|P3|NOT COMPLETED|Part B||14
34500|NCT01894256|81316|P2|NOT COMPLETED|Part B||14
34501|NCT01894256|81317|P1|NOT COMPLETED|Part B||15
34502|NCT01894256|81315|P3|COMPLETED|Part B||0
34503|NCT01894256|81316|P2|COMPLETED|Part B||0
34504|NCT01894256|81317|P1|COMPLETED|Part B||0
34505|NCT01894256|81315|P3|STARTED|Part B||14
34506|NCT01894256|81316|P2|STARTED|Part B||14
34507|NCT01894256|81317|P1|STARTED|Part B||15
34508|NCT01894256|81315|P3|NOT COMPLETED|Part A||0
34509|NCT01894256|81316|P2|NOT COMPLETED|Part A||1
34510|NCT01894256|81317|P1|NOT COMPLETED|Part A||0
34511|NCT01894256|81315|P3|COMPLETED|Part A||14
34512|NCT01894256|81316|P2|COMPLETED|Part A||14
34513|NCT01894256|81317|P1|COMPLETED|Part A||15
34514|NCT01894256|81315|P3|STARTED|Part A||14
34515|NCT01894256|81316|P2|STARTED|Part A||15
34516|NCT01894256|81317|P1|STARTED|Part A||15
34517|NCT01894230|81363|P2|NOT COMPLETED|Overall Study||7
34518|NCT01894230|81364|P1|NOT COMPLETED|Overall Study||7
34519|NCT01894230|81363|P2|COMPLETED|Overall Study||69
34520|NCT01894230|81364|P1|COMPLETED|Overall Study||76
34521|NCT01894230|81363|P2|STARTED|Overall Study||76
34522|NCT01894230|81364|P1|STARTED|Overall Study||83
34523|NCT01894100|81390|P2|NOT COMPLETED|Overall Study||1
34524|NCT01894100|81391|P1|NOT COMPLETED|Overall Study||3
34525|NCT01894100|81390|P2|COMPLETED|Overall Study||14
34526|NCT01894100|81391|P1|COMPLETED|Overall Study||12
34527|NCT01894100|81390|P2|STARTED|Overall Study||15
34528|NCT01894100|81391|P1|STARTED|Overall Study||15
34529|NCT01894022|81401|P2|NOT COMPLETED|Overall Study||10
34530|NCT01894022|81402|P1|NOT COMPLETED|Overall Study||9
34531|NCT01894022|81401|P2|COMPLETED|Overall Study||0
34532|NCT01894022|81402|P1|COMPLETED|Overall Study||0
34533|NCT01894022|81401|P2|STARTED|Overall Study||10
34534|NCT01894022|81402|P1|STARTED|Overall Study||9
34535|NCT01893905|81456|P2|NOT COMPLETED|Overall Study||14
34536|NCT01893905|81457|P1|NOT COMPLETED|Overall Study||25
34537|NCT01893905|81456|P2|COMPLETED|Overall Study||64
34538|NCT01893905|81457|P1|COMPLETED|Overall Study||55
34539|NCT01893905|81456|P2|STARTED|Overall Study||78
34540|NCT01893905|81457|P1|STARTED|Overall Study||80
34541|NCT01893879|81465|P2|NOT COMPLETED|Overall Study||3
34542|NCT01893879|81466|P1|NOT COMPLETED|Overall Study||2
34543|NCT01893879|81465|P2|COMPLETED|Overall Study||4
34544|NCT01893879|81466|P1|COMPLETED|Overall Study||5
34545|NCT01893879|81465|P2|STARTED|Overall Study||7
34546|NCT01893879|81466|P1|STARTED|Overall Study||7
34547|NCT01893567|81472|P1|NOT COMPLETED|Overall Study||0
34548|NCT01893567|81472|P1|COMPLETED|Overall Study||28
34549|NCT01893567|81472|P1|STARTED|Overall Study||28
34550|NCT01893411|81479|P3|NOT COMPLETED|Overall Study||9
34551|NCT01893411|81480|P2|NOT COMPLETED|Overall Study||7
34552|NCT01893411|81481|P1|NOT COMPLETED|Overall Study||17
34553|NCT01893411|81479|P3|COMPLETED|Overall Study||69
34554|NCT01893411|81480|P2|COMPLETED|Overall Study||70
34555|NCT01893411|81481|P1|COMPLETED|Overall Study||139
34556|NCT01893411|81479|P3|STARTED|Overall Study||78
34557|NCT01893411|81480|P2|STARTED|Overall Study||77
34558|NCT01893411|81481|P1|STARTED|Overall Study||156
34559|NCT01893359|81546|P3|NOT COMPLETED|Overall Study||0
34560|NCT01893359|81547|P2|NOT COMPLETED|Overall Study||0
34561|NCT01893359|81548|P1|NOT COMPLETED|Overall Study||0
34562|NCT01893359|81546|P3|COMPLETED|Overall Study||0
34563|NCT01893359|81547|P2|COMPLETED|Overall Study||2
34564|NCT01893359|81548|P1|COMPLETED|Overall Study||0
34565|NCT01893359|81546|P3|STARTED|Overall Study||0
34566|NCT01893359|81547|P2|STARTED|Overall Study||2
34567|NCT01893359|81548|P1|STARTED|Overall Study||0
34568|NCT01893346|81563|P4|NOT COMPLETED|Overall Study||0
34569|NCT01893346|81564|P3|NOT COMPLETED|Overall Study||0
34570|NCT01893346|81565|P2|NOT COMPLETED|Overall Study||1
34571|NCT01893346|81566|P1|NOT COMPLETED|Overall Study||3
34572|NCT01893346|81563|P4|COMPLETED|Overall Study||8
34573|NCT01893346|81564|P3|COMPLETED|Overall Study||8
34574|NCT01893346|81565|P2|COMPLETED|Overall Study||7
34575|NCT01893346|81566|P1|COMPLETED|Overall Study||8
34576|NCT01893346|81563|P4|Patients Who Received Full Infusion|Overall Study||8
34577|NCT01893346|81564|P3|Patients Who Received Full Infusion|Overall Study||8
34578|NCT01893346|81565|P2|Patients Who Received Full Infusion|Overall Study||8
34579|NCT01893346|81566|P1|Patients Who Received Full Infusion|Overall Study||8
34580|NCT01893346|81563|P4|STARTED|Overall Study||8
34581|NCT01893346|81564|P3|STARTED|Overall Study||8
34582|NCT01893346|81565|P2|STARTED|Overall Study||8
34583|NCT01893346|81566|P1|STARTED|Overall Study||11
34584|NCT01893281|81580|P1|NOT COMPLETED|Overall Study||3
34585|NCT01893281|81580|P1|COMPLETED|Overall Study||75
34586|NCT01893281|81580|P1|Received at Least 1 Dose of Study Drug|Overall Study||78
34587|NCT01893281|81580|P1|STARTED|Overall Study||78
34588|NCT01893203|81587|P1|NOT COMPLETED|Overall Study||1
34589|NCT01893203|81587|P1|COMPLETED|Overall Study||13
34590|NCT01893203|81587|P1|STARTED|Overall Study||14
34591|NCT01892657|81594|P1|NOT COMPLETED|Overall Study||18
34592|NCT01892657|81594|P1|COMPLETED|Overall Study||110
34593|NCT01892657|81594|P1|STARTED|Overall Study||128
34594|NCT01892306|81612|P2|NOT COMPLETED|Overall Study||6
34595|NCT01892306|81613|P1|NOT COMPLETED|Overall Study||5
34596|NCT01892306|81612|P2|COMPLETED|Overall Study||10
34597|NCT01892306|81613|P1|COMPLETED|Overall Study||8
34598|NCT01892306|81612|P2|STARTED|Overall Study||16
34599|NCT01892306|81613|P1|STARTED|Overall Study||13
34600|NCT01892267|81635|P2|NOT COMPLETED|Overall Study||0
34601|NCT01892267|81636|P1|NOT COMPLETED|Overall Study||0
34602|NCT01892267|81635|P2|COMPLETED|Overall Study||10
34603|NCT01892267|81636|P1|COMPLETED|Overall Study||9
34604|NCT01892267|81635|P2|STARTED|Overall Study||10
34605|NCT01892267|81636|P1|STARTED|Overall Study||9
34606|NCT01892189|81671|P9|NOT COMPLETED|Third Intervention Period (1 Day)||0
34607|NCT01892189|81672|P8|NOT COMPLETED|Third Intervention Period (1 Day)||0
34608|NCT01892189|81673|P7|NOT COMPLETED|Third Intervention Period (1 Day)||0
34609|NCT01892189|81674|P6|NOT COMPLETED|Third Intervention Period (1 Day)||0
34610|NCT01892189|81675|P5|NOT COMPLETED|Third Intervention Period (1 Day)||0
34611|NCT01892189|81676|P4|NOT COMPLETED|Third Intervention Period (1 Day)||0
34612|NCT01892189|81677|P3|NOT COMPLETED|Third Intervention Period (1 Day)||0
34613|NCT01892189|81678|P2|NOT COMPLETED|Third Intervention Period (1 Day)||0
34614|NCT01892189|81679|P1|NOT COMPLETED|Third Intervention Period (1 Day)||0
34615|NCT01892189|81671|P9|COMPLETED|Third Intervention Period (1 Day)||1
34616|NCT01892189|81672|P8|COMPLETED|Third Intervention Period (1 Day)||3
34617|NCT01892189|81673|P7|COMPLETED|Third Intervention Period (1 Day)||2
34618|NCT01892189|81674|P6|COMPLETED|Third Intervention Period (1 Day)||2
34619|NCT01892189|81675|P5|COMPLETED|Third Intervention Period (1 Day)||3
34620|NCT01892189|81676|P4|COMPLETED|Third Intervention Period (1 Day)||2
34621|NCT01892189|81677|P3|COMPLETED|Third Intervention Period (1 Day)||1
34622|NCT01892189|81678|P2|COMPLETED|Third Intervention Period (1 Day)||3
34623|NCT01892189|81679|P1|COMPLETED|Third Intervention Period (1 Day)||3
34624|NCT01892189|81671|P9|STARTED|Third Intervention Period (1 Day)||1
34625|NCT01892189|81672|P8|STARTED|Third Intervention Period (1 Day)||3
34626|NCT01892189|81673|P7|STARTED|Third Intervention Period (1 Day)||2
34627|NCT01892189|81674|P6|STARTED|Third Intervention Period (1 Day)||2
34628|NCT01892189|81675|P5|STARTED|Third Intervention Period (1 Day)||3
34629|NCT01892189|81676|P4|STARTED|Third Intervention Period (1 Day)||2
34630|NCT01892189|81677|P3|STARTED|Third Intervention Period (1 Day)||1
34631|NCT01892189|81678|P2|STARTED|Third Intervention Period (1 Day)||3
34632|NCT01892189|81679|P1|STARTED|Third Intervention Period (1 Day)||3
34633|NCT01892189|81671|P9|NOT COMPLETED|Washout Period 2 (7 Days)||0
34634|NCT01892189|81672|P8|NOT COMPLETED|Washout Period 2 (7 Days)||0
34635|NCT01892189|81673|P7|NOT COMPLETED|Washout Period 2 (7 Days)||0
34636|NCT01892189|81674|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
34637|NCT01892189|81675|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
34638|NCT01892189|81676|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
34639|NCT01892189|81677|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
34640|NCT01892189|81678|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
34641|NCT01892189|81679|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
34642|NCT01892189|81671|P9|COMPLETED|Washout Period 2 (7 Days)||1
34643|NCT01892189|81672|P8|COMPLETED|Washout Period 2 (7 Days)||3
34644|NCT01892189|81673|P7|COMPLETED|Washout Period 2 (7 Days)||2
34645|NCT01892189|81674|P6|COMPLETED|Washout Period 2 (7 Days)||2
34646|NCT01892189|81675|P5|COMPLETED|Washout Period 2 (7 Days)||3
34647|NCT01892189|81676|P4|COMPLETED|Washout Period 2 (7 Days)||2
34648|NCT01892189|81677|P3|COMPLETED|Washout Period 2 (7 Days)||1
34649|NCT01892189|81678|P2|COMPLETED|Washout Period 2 (7 Days)||3
34650|NCT01892189|81679|P1|COMPLETED|Washout Period 2 (7 Days)||3
34651|NCT01892189|81671|P9|STARTED|Washout Period 2 (7 Days)||1
34652|NCT01892189|81672|P8|STARTED|Washout Period 2 (7 Days)||3
34653|NCT01892189|81673|P7|STARTED|Washout Period 2 (7 Days)||2
34654|NCT01892189|81674|P6|STARTED|Washout Period 2 (7 Days)||2
34655|NCT01892189|81675|P5|STARTED|Washout Period 2 (7 Days)||3
34656|NCT01892189|81676|P4|STARTED|Washout Period 2 (7 Days)||2
34657|NCT01892189|81677|P3|STARTED|Washout Period 2 (7 Days)||1
34658|NCT01892189|81678|P2|STARTED|Washout Period 2 (7 Days)||3
34659|NCT01892189|81679|P1|STARTED|Washout Period 2 (7 Days)||3
34660|NCT01892189|81671|P9|NOT COMPLETED|Second Intervention Period (1 Day)||0
34661|NCT01892189|81672|P8|NOT COMPLETED|Second Intervention Period (1 Day)||0
34662|NCT01892189|81673|P7|NOT COMPLETED|Second Intervention Period (1 Day)||0
34663|NCT01892189|81674|P6|NOT COMPLETED|Second Intervention Period (1 Day)||0
34664|NCT01892189|81675|P5|NOT COMPLETED|Second Intervention Period (1 Day)||0
34665|NCT01892189|81676|P4|NOT COMPLETED|Second Intervention Period (1 Day)||0
34666|NCT01892189|81677|P3|NOT COMPLETED|Second Intervention Period (1 Day)||0
34667|NCT01892189|81678|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
34668|NCT01892189|81679|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
34669|NCT01892189|81671|P9|COMPLETED|Second Intervention Period (1 Day)||1
34670|NCT01892189|81672|P8|COMPLETED|Second Intervention Period (1 Day)||3
34671|NCT01892189|81673|P7|COMPLETED|Second Intervention Period (1 Day)||2
34672|NCT01892189|81674|P6|COMPLETED|Second Intervention Period (1 Day)||2
34673|NCT01892189|81675|P5|COMPLETED|Second Intervention Period (1 Day)||3
34674|NCT01892189|81676|P4|COMPLETED|Second Intervention Period (1 Day)||2
34675|NCT01892189|81677|P3|COMPLETED|Second Intervention Period (1 Day)||1
34676|NCT01892189|81678|P2|COMPLETED|Second Intervention Period (1 Day)||3
34677|NCT01892189|81679|P1|COMPLETED|Second Intervention Period (1 Day)||3
34678|NCT01892189|81671|P9|STARTED|Second Intervention Period (1 Day)||1
34679|NCT01892189|81672|P8|STARTED|Second Intervention Period (1 Day)||3
34680|NCT01892189|81673|P7|STARTED|Second Intervention Period (1 Day)||2
34681|NCT01892189|81674|P6|STARTED|Second Intervention Period (1 Day)||2
34682|NCT01892189|81675|P5|STARTED|Second Intervention Period (1 Day)||3
34683|NCT01892189|81676|P4|STARTED|Second Intervention Period (1 Day)||2
34684|NCT01892189|81677|P3|STARTED|Second Intervention Period (1 Day)||1
34685|NCT01892189|81678|P2|STARTED|Second Intervention Period (1 Day)||3
34686|NCT01892189|81679|P1|STARTED|Second Intervention Period (1 Day)||3
34687|NCT01892189|81671|P9|NOT COMPLETED|Washout Period 1 (7 Days)||2
34688|NCT01892189|81672|P8|NOT COMPLETED|Washout Period 1 (7 Days)||0
34689|NCT01892189|81673|P7|NOT COMPLETED|Washout Period 1 (7 Days)||1
34690|NCT01892189|81674|P6|NOT COMPLETED|Washout Period 1 (7 Days)||1
34691|NCT01892189|81675|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
34692|NCT01892189|81676|P4|NOT COMPLETED|Washout Period 1 (7 Days)||1
34693|NCT01892189|81677|P3|NOT COMPLETED|Washout Period 1 (7 Days)||2
34694|NCT01892189|81678|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
34695|NCT01892189|81679|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
34696|NCT01892189|81671|P9|COMPLETED|Washout Period 1 (7 Days)||1
34697|NCT01892189|81672|P8|COMPLETED|Washout Period 1 (7 Days)||3
34698|NCT01892189|81673|P7|COMPLETED|Washout Period 1 (7 Days)||2
34699|NCT01892189|81674|P6|COMPLETED|Washout Period 1 (7 Days)||2
34700|NCT01892189|81675|P5|COMPLETED|Washout Period 1 (7 Days)||3
34701|NCT01892189|81676|P4|COMPLETED|Washout Period 1 (7 Days)||2
34702|NCT01892189|81677|P3|COMPLETED|Washout Period 1 (7 Days)||1
34703|NCT01892189|81678|P2|COMPLETED|Washout Period 1 (7 Days)||3
34704|NCT01892189|81679|P1|COMPLETED|Washout Period 1 (7 Days)||3
34705|NCT01892189|81671|P9|STARTED|Washout Period 1 (7 Days)||3
34706|NCT01892189|81672|P8|STARTED|Washout Period 1 (7 Days)||3
34707|NCT01892189|81673|P7|STARTED|Washout Period 1 (7 Days)||3
34708|NCT01892189|81674|P6|STARTED|Washout Period 1 (7 Days)||3
34709|NCT01892189|81675|P5|STARTED|Washout Period 1 (7 Days)||3
34710|NCT01892189|81676|P4|STARTED|Washout Period 1 (7 Days)||3
34711|NCT01892189|81677|P3|STARTED|Washout Period 1 (7 Days)||3
34712|NCT01892189|81678|P2|STARTED|Washout Period 1 (7 Days)||3
34713|NCT01892189|81679|P1|STARTED|Washout Period 1 (7 Days)||3
34714|NCT01892189|81671|P9|NOT COMPLETED|First Intervention Period (1 Day)||0
34715|NCT01892189|81672|P8|NOT COMPLETED|First Intervention Period (1 Day)||0
34716|NCT01892189|81673|P7|NOT COMPLETED|First Intervention Period (1 Day)||0
34717|NCT01892189|81674|P6|NOT COMPLETED|First Intervention Period (1 Day)||0
34718|NCT01892189|81675|P5|NOT COMPLETED|First Intervention Period (1 Day)||0
34719|NCT01892189|81676|P4|NOT COMPLETED|First Intervention Period (1 Day)||0
34720|NCT01892189|81677|P3|NOT COMPLETED|First Intervention Period (1 Day)||0
34721|NCT01892189|81678|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
34722|NCT01892189|81679|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
34723|NCT01892189|81671|P9|COMPLETED|First Intervention Period (1 Day)||3
34724|NCT01892189|81672|P8|COMPLETED|First Intervention Period (1 Day)||3
34725|NCT01892189|81673|P7|COMPLETED|First Intervention Period (1 Day)||3
34726|NCT01892189|81674|P6|COMPLETED|First Intervention Period (1 Day)||3
34727|NCT01892189|81675|P5|COMPLETED|First Intervention Period (1 Day)||3
34728|NCT01892189|81676|P4|COMPLETED|First Intervention Period (1 Day)||3
34729|NCT01892189|81677|P3|COMPLETED|First Intervention Period (1 Day)||3
34730|NCT01892189|81678|P2|COMPLETED|First Intervention Period (1 Day)||3
34731|NCT01892189|81679|P1|COMPLETED|First Intervention Period (1 Day)||3
34732|NCT01892189|81671|P9|STARTED|First Intervention Period (1 Day)||3
34733|NCT01892189|81672|P8|STARTED|First Intervention Period (1 Day)||3
34734|NCT01892189|81673|P7|STARTED|First Intervention Period (1 Day)||3
34735|NCT01892189|81674|P6|STARTED|First Intervention Period (1 Day)||3
34736|NCT01892189|81675|P5|STARTED|First Intervention Period (1 Day)||3
34737|NCT01892189|81676|P4|STARTED|First Intervention Period (1 Day)||3
34738|NCT01892189|81677|P3|STARTED|First Intervention Period (1 Day)||3
34739|NCT01892189|81678|P2|STARTED|First Intervention Period (1 Day)||3
34740|NCT01892189|81679|P1|STARTED|First Intervention Period (1 Day)||3
34741|NCT01892163|81721|P2|NOT COMPLETED|Overall Study||1
34742|NCT01892163|81722|P1|NOT COMPLETED|Overall Study||2
34743|NCT01892163|81721|P2|COMPLETED|Overall Study||49
34744|NCT01892163|81722|P1|COMPLETED|Overall Study||48
34745|NCT01892163|81721|P2|STARTED|Overall Study||50
34746|NCT01892163|81722|P1|STARTED|Overall Study||50
34747|NCT01892020|81734|P2|NOT COMPLETED|Period 2||0
34748|NCT01892020|81735|P1|NOT COMPLETED|Period 2||1
34749|NCT01892020|81734|P2|COMPLETED|Period 2||74
34750|NCT01892020|81735|P1|COMPLETED|Period 2||77
34751|NCT01892020|81734|P2|STARTED|Period 2||74
34752|NCT01892020|81735|P1|STARTED|Period 2||78
34753|NCT01892020|81734|P2|NOT COMPLETED|Period 1||6
34754|NCT01892020|81735|P1|NOT COMPLETED|Period 1||3
34755|NCT01892020|81734|P2|COMPLETED|Period 1||74
34756|NCT01892020|81735|P1|COMPLETED|Period 1||78
34757|NCT01892020|81734|P2|STARTED|Period 1||80
34758|NCT01892020|81735|P1|STARTED|Period 1||81
34759|NCT01891864|81755|P6|NOT COMPLETED|Extension Period||0
34760|NCT01891864|81756|P5|NOT COMPLETED|Extension Period||7
34761|NCT01891864|81757|P4|NOT COMPLETED|Extension Period||5
34762|NCT01891864|81758|P3|NOT COMPLETED|Extension Period||8
34763|NCT01891864|81759|P2|NOT COMPLETED|Extension Period||0
34764|NCT01891864|81760|P1|NOT COMPLETED|Extension Period||0
34765|NCT01891864|81755|P6|COMPLETED|Extension Period||90
34766|NCT01891864|81756|P5|COMPLETED|Extension Period||88
34767|NCT01891864|81757|P4|COMPLETED|Extension Period||137
34768|NCT01891864|81758|P3|COMPLETED|Extension Period||132
34769|NCT01891864|81759|P2|COMPLETED|Extension Period||0
34770|NCT01891864|81760|P1|COMPLETED|Extension Period||0
34771|NCT01891864|81755|P6|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to an adverse event|90
34772|NCT01891864|81756|P5|STARTED|Extension Period|1 patient discontinued between Treatment Period 2 and Extension Period due to lack of efficacy|95
34773|NCT01891864|81757|P4|STARTED|Extension Period||142
34774|NCT01891864|81758|P3|STARTED|Extension Period|2 patients withdrew consent 1 patient lost to FU between Treatment Period 2 and the Extension period|140
34775|NCT01891864|81759|P2|STARTED|Extension Period||0
34776|NCT01891864|81760|P1|STARTED|Extension Period||0
34777|NCT01891864|81755|P6|NOT COMPLETED|Treatment Period 2||5
34778|NCT01891864|81756|P5|NOT COMPLETED|Treatment Period 2||4
34779|NCT01891864|81757|P4|NOT COMPLETED|Treatment Period 2||9
34780|NCT01891864|81758|P3|NOT COMPLETED|Treatment Period 2||7
34781|NCT01891864|81759|P2|NOT COMPLETED|Treatment Period 2||0
34782|NCT01891864|81760|P1|NOT COMPLETED|Treatment Period 2||0
34783|NCT01891864|81755|P6|COMPLETED|Treatment Period 2||91
34784|NCT01891864|81756|P5|COMPLETED|Treatment Period 2||96
34785|NCT01891864|81757|P4|COMPLETED|Treatment Period 2||142
34786|NCT01891864|81758|P3|COMPLETED|Treatment Period 2||143
34787|NCT01891864|81759|P2|COMPLETED|Treatment Period 2||0
34788|NCT01891864|81760|P1|COMPLETED|Treatment Period 2||0
34789|NCT01891864|81755|P6|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|96
34790|NCT01891864|81756|P5|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|100
34791|NCT01891864|81757|P4|STARTED|Treatment Period 2|"Part of the patients re-randomized from Enbrel ® Etanercept treatment arm in Treatment Period 1"|151
34876|NCT01890954|82044|P1|COMPLETED|Overall Study||8
34792|NCT01891864|81758|P3|STARTED|Treatment Period 2|"Part of the patients re-randomized from GP2015 Etanercept treatment arm in Treatment Period 1"|150
34793|NCT01891864|81759|P2|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
34794|NCT01891864|81760|P1|STARTED|Treatment Period 2|Treatment arm applicable for Treatment Period 1 only (patients re-randomized in Treatment Period 2)|0
34795|NCT01891864|81755|P6|NOT COMPLETED|Treatment Period 1||0
34796|NCT01891864|81756|P5|NOT COMPLETED|Treatment Period 1||0
34797|NCT01891864|81757|P4|NOT COMPLETED|Treatment Period 1||0
34798|NCT01891864|81758|P3|NOT COMPLETED|Treatment Period 1||0
34799|NCT01891864|81759|P2|NOT COMPLETED|Treatment Period 1||12
34800|NCT01891864|81760|P1|NOT COMPLETED|Treatment Period 1||8
34801|NCT01891864|81755|P6|COMPLETED|Treatment Period 1||0
34802|NCT01891864|81756|P5|COMPLETED|Treatment Period 1||0
34803|NCT01891864|81757|P4|COMPLETED|Treatment Period 1||0
34804|NCT01891864|81758|P3|COMPLETED|Treatment Period 1||0
34805|NCT01891864|81759|P2|COMPLETED|Treatment Period 1|8 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|255
34806|NCT01891864|81760|P1|COMPLETED|Treatment Period 1|6 patients discontinued after completion of Treatment Period 1 and did NOT start Treatment Period 2|256
34807|NCT01891864|81755|P6|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
34808|NCT01891864|81756|P5|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
34809|NCT01891864|81757|P4|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
34810|NCT01891864|81758|P3|STARTED|Treatment Period 1|Treatment arm applicable only in Treatment Period 2 and Extension Period|0
34811|NCT01891864|81759|P2|STARTED|Treatment Period 1||267
34812|NCT01891864|81760|P1|STARTED|Treatment Period 1||264
34813|NCT01891734|81782|P2|NOT COMPLETED|Overall Study||3
34814|NCT01891734|81783|P1|NOT COMPLETED|Overall Study||3
34815|NCT01891734|81782|P2|COMPLETED|Overall Study||13
34816|NCT01891734|81783|P1|COMPLETED|Overall Study||14
34817|NCT01891734|81782|P2|STARTED|Overall Study||16
34818|NCT01891734|81783|P1|STARTED|Overall Study||17
34819|NCT01891669|81803|P10|NOT COMPLETED|Overall Study||2
34820|NCT01891669|81804|P9|NOT COMPLETED|Overall Study||1
34821|NCT01891669|81805|P8|NOT COMPLETED|Overall Study||4
34822|NCT01891669|81806|P7|NOT COMPLETED|Overall Study||1
34823|NCT01891669|81807|P6|NOT COMPLETED|Overall Study||0
34824|NCT01891669|81808|P5|NOT COMPLETED|Overall Study||0
34825|NCT01891669|81809|P4|NOT COMPLETED|Overall Study||0
34826|NCT01891669|81810|P3|NOT COMPLETED|Overall Study||0
34827|NCT01891669|81811|P2|NOT COMPLETED|Overall Study||1
34828|NCT01891669|81812|P1|NOT COMPLETED|Overall Study||2
34829|NCT01891669|81803|P10|COMPLETED|Overall Study||1
34830|NCT01891669|81804|P9|COMPLETED|Overall Study||2
34831|NCT01891669|81805|P8|COMPLETED|Overall Study||2
34832|NCT01891669|81806|P7|COMPLETED|Overall Study||1
34833|NCT01891669|81807|P6|COMPLETED|Overall Study||2
34834|NCT01891669|81808|P5|COMPLETED|Overall Study||2
34835|NCT01891669|81809|P4|COMPLETED|Overall Study||2
34836|NCT01891669|81810|P3|COMPLETED|Overall Study||2
34837|NCT01891669|81811|P2|COMPLETED|Overall Study||1
34838|NCT01891669|81812|P1|COMPLETED|Overall Study||0
34839|NCT01891669|81803|P10|STARTED|Overall Study||3
34840|NCT01891669|81804|P9|STARTED|Overall Study||3
34841|NCT01891669|81805|P8|STARTED|Overall Study||6
34842|NCT01891669|81806|P7|STARTED|Overall Study||2
34843|NCT01891669|81807|P6|STARTED|Overall Study||2
34844|NCT01891669|81808|P5|STARTED|Overall Study||2
34845|NCT01891669|81809|P4|STARTED|Overall Study||2
34846|NCT01891669|81810|P3|STARTED|Overall Study||2
34847|NCT01891669|81811|P2|STARTED|Overall Study||2
34848|NCT01891669|81812|P1|STARTED|Overall Study||2
34849|NCT01890967|81969|P6|NOT COMPLETED|Overall Study||13
34850|NCT01890967|81970|P5|NOT COMPLETED|Overall Study||10
34851|NCT01890967|81971|P4|NOT COMPLETED|Overall Study||11
34852|NCT01890967|81972|P3|NOT COMPLETED|Overall Study||10
34853|NCT01890967|81973|P2|NOT COMPLETED|Overall Study||11
34854|NCT01890967|81974|P1|NOT COMPLETED|Overall Study||10
34855|NCT01890967|81969|P6|COMPLETED|Overall Study||75
34856|NCT01890967|81970|P5|COMPLETED|Overall Study||77
34857|NCT01890967|81971|P4|COMPLETED|Overall Study||77
34858|NCT01890967|81972|P3|COMPLETED|Overall Study||78
34859|NCT01890967|81973|P2|COMPLETED|Overall Study||77
34860|NCT01890967|81974|P1|COMPLETED|Overall Study||78
34861|NCT01890967|81969|P6|Received at Least One Dose of Study Drug|Overall Study||87
34862|NCT01890967|81970|P5|Received at Least One Dose of Study Drug|Overall Study||86
34863|NCT01890967|81971|P4|Received at Least One Dose of Study Drug|Overall Study||86
34864|NCT01890967|81972|P3|Received at Least One Dose of Study Drug|Overall Study||86
34865|NCT01890967|81973|P2|Received at Least One Dose of Study Drug|Overall Study||87
34866|NCT01890967|81974|P1|Received at Least One Dose of Study Drug|Overall Study||87
34867|NCT01890967|81969|P6|STARTED|Overall Study||88
34868|NCT01890967|81970|P5|STARTED|Overall Study||87
34869|NCT01890967|81971|P4|STARTED|Overall Study||88
34870|NCT01890967|81972|P3|STARTED|Overall Study||88
34871|NCT01890967|81973|P2|STARTED|Overall Study||88
34872|NCT01890967|81974|P1|STARTED|Overall Study||88
34873|NCT01890954|82043|P2|NOT COMPLETED|Overall Study||0
34874|NCT01890954|82044|P1|NOT COMPLETED|Overall Study||1
34875|NCT01890954|82043|P2|COMPLETED|Overall Study||8
34877|NCT01890954|82043|P2|STARTED|Overall Study||8
34878|NCT01890954|82044|P1|STARTED|Overall Study||9
34879|NCT01890915|82052|P2|NOT COMPLETED|Overall Study||1
34880|NCT01890915|82053|P1|NOT COMPLETED|Overall Study||3
34881|NCT01890915|82052|P2|COMPLETED|Overall Study||9
34882|NCT01890915|82053|P1|COMPLETED|Overall Study||8
34883|NCT01890915|82052|P2|STARTED|Overall Study||10
34884|NCT01890915|82053|P1|STARTED|Overall Study||11
34885|NCT01890785|82069|P6|NOT COMPLETED|Third Intervention||0
34886|NCT01890785|82070|P5|NOT COMPLETED|Third Intervention||0
34887|NCT01890785|82071|P4|NOT COMPLETED|Third Intervention||0
34888|NCT01890785|82072|P3|NOT COMPLETED|Third Intervention||0
34889|NCT01890785|82073|P2|NOT COMPLETED|Third Intervention||1
34890|NCT01890785|82074|P1|NOT COMPLETED|Third Intervention||0
34891|NCT01890785|82069|P6|COMPLETED|Third Intervention||5
34892|NCT01890785|82070|P5|COMPLETED|Third Intervention||5
34893|NCT01890785|82071|P4|COMPLETED|Third Intervention||5
34894|NCT01890785|82072|P3|COMPLETED|Third Intervention||5
34895|NCT01890785|82073|P2|COMPLETED|Third Intervention||4
34896|NCT01890785|82074|P1|COMPLETED|Third Intervention||5
34897|NCT01890785|82069|P6|STARTED|Third Intervention||5
34898|NCT01890785|82070|P5|STARTED|Third Intervention||5
34899|NCT01890785|82071|P4|STARTED|Third Intervention||5
34900|NCT01890785|82072|P3|STARTED|Third Intervention||5
34901|NCT01890785|82073|P2|STARTED|Third Intervention||5
34902|NCT01890785|82074|P1|STARTED|Third Intervention||5
34903|NCT01890785|82069|P6|NOT COMPLETED|Second Intervention||0
34904|NCT01890785|82070|P5|NOT COMPLETED|Second Intervention||0
34905|NCT01890785|82071|P4|NOT COMPLETED|Second Intervention||0
34906|NCT01890785|82072|P3|NOT COMPLETED|Second Intervention||0
34907|NCT01890785|82073|P2|NOT COMPLETED|Second Intervention||0
34908|NCT01890785|82074|P1|NOT COMPLETED|Second Intervention||0
34909|NCT01890785|82069|P6|COMPLETED|Second Intervention||5
34910|NCT01890785|82070|P5|COMPLETED|Second Intervention||5
34911|NCT01890785|82071|P4|COMPLETED|Second Intervention||5
34912|NCT01890785|82072|P3|COMPLETED|Second Intervention||5
34913|NCT01890785|82073|P2|COMPLETED|Second Intervention||5
34914|NCT01890785|82074|P1|COMPLETED|Second Intervention||5
34915|NCT01890785|82069|P6|STARTED|Second Intervention||5
34916|NCT01890785|82070|P5|STARTED|Second Intervention||5
34917|NCT01890785|82071|P4|STARTED|Second Intervention||5
34918|NCT01890785|82072|P3|STARTED|Second Intervention||5
34919|NCT01890785|82073|P2|STARTED|Second Intervention||5
34920|NCT01890785|82074|P1|STARTED|Second Intervention||5
34921|NCT01890785|82069|P6|NOT COMPLETED|First Intervention||0
34922|NCT01890785|82070|P5|NOT COMPLETED|First Intervention||0
34923|NCT01890785|82071|P4|NOT COMPLETED|First Intervention||0
34924|NCT01890785|82072|P3|NOT COMPLETED|First Intervention||0
34925|NCT01890785|82073|P2|NOT COMPLETED|First Intervention||0
34926|NCT01890785|82074|P1|NOT COMPLETED|First Intervention||0
34927|NCT01890785|82069|P6|COMPLETED|First Intervention||5
34928|NCT01890785|82070|P5|COMPLETED|First Intervention||5
34929|NCT01890785|82071|P4|COMPLETED|First Intervention||5
34930|NCT01890785|82072|P3|COMPLETED|First Intervention||5
34931|NCT01890785|82073|P2|COMPLETED|First Intervention||5
34932|NCT01890785|82074|P1|COMPLETED|First Intervention||5
34933|NCT01890785|82069|P6|STARTED|First Intervention||5
34934|NCT01890785|82070|P5|STARTED|First Intervention||5
34935|NCT01890785|82071|P4|STARTED|First Intervention||5
34936|NCT01890785|82072|P3|STARTED|First Intervention||5
34937|NCT01890785|82073|P2|STARTED|First Intervention||5
34938|NCT01890785|82074|P1|STARTED|First Intervention||5
34939|NCT01890759|82093|P2|NOT COMPLETED|Overall Study||12
34940|NCT01890759|82094|P1|NOT COMPLETED|Overall Study||2
34941|NCT01890759|82093|P2|COMPLETED|Overall Study||188
34942|NCT01890759|82094|P1|COMPLETED|Overall Study||98
34943|NCT01890759|82093|P2|STARTED|Overall Study||200
34944|NCT01890759|82094|P1|STARTED|Overall Study||100
34945|NCT01890746|82128|P2|NOT COMPLETED|Overall Study||74
34946|NCT01890746|82129|P1|NOT COMPLETED|Overall Study||74
34947|NCT01890746|82128|P2|COMPLETED|Overall Study||0
34948|NCT01890746|82129|P1|COMPLETED|Overall Study||0
34949|NCT01890746|82128|P2|STARTED|Overall Study||74
34950|NCT01890746|82129|P1|STARTED|Overall Study||74
34951|NCT01890694|82155|P2|NOT COMPLETED|Overall Study||1
34952|NCT01890694|82156|P1|NOT COMPLETED|Overall Study||1
34953|NCT01890694|82155|P2|COMPLETED|Overall Study||0
34954|NCT01890694|82156|P1|COMPLETED|Overall Study||0
34955|NCT01890694|82155|P2|STARTED|Overall Study||1
34956|NCT01890694|82156|P1|STARTED|Overall Study||1
34957|NCT01890642|82166|P3|NOT COMPLETED|Overall Study||0
34958|NCT01890642|82167|P2|NOT COMPLETED|Overall Study||0
34959|NCT01890642|82168|P1|NOT COMPLETED|Overall Study||0
34960|NCT01890642|82166|P3|COMPLETED|Overall Study||96
34961|NCT01890642|82167|P2|COMPLETED|Overall Study||53
34962|NCT01890642|82168|P1|COMPLETED|Overall Study||56
34963|NCT01890642|82166|P3|STARTED|Overall Study||96
34964|NCT01890642|82167|P2|STARTED|Overall Study||53
34965|NCT01890642|82168|P1|STARTED|Overall Study||56
34966|NCT01890577|82188|P1|NOT COMPLETED|Overall Study||28
34967|NCT01890577|82188|P1|COMPLETED|Overall Study||0
34968|NCT01890577|82188|P1|STARTED|Overall Study||28
34969|NCT01890512|82201|P1|NOT COMPLETED|Overall Study||3
34970|NCT01890512|82201|P1|COMPLETED|Overall Study||17
34971|NCT01890512|82201|P1|STARTED|Overall Study||20
34972|NCT01890473|82207|P2|NOT COMPLETED|Overall Study||0
34973|NCT01890473|82208|P1|NOT COMPLETED|Overall Study||2
34974|NCT01890473|82207|P2|COMPLETED|Overall Study||113
34975|NCT01890473|82208|P1|COMPLETED|Overall Study||109
34976|NCT01890473|82207|P2|STARTED|Overall Study||113
34977|NCT01890473|82208|P1|STARTED|Overall Study||111
34978|NCT01890343|82237|P3|NOT COMPLETED|Overall Study||0
34979|NCT01890343|82238|P2|NOT COMPLETED|Overall Study||0
34980|NCT01890343|82239|P1|NOT COMPLETED|Overall Study||0
34981|NCT01890343|82237|P3|COMPLETED|Overall Study||10
34982|NCT01890343|82238|P2|COMPLETED|Overall Study||10
34983|NCT01890343|82239|P1|COMPLETED|Overall Study||8
34984|NCT01890343|82237|P3|STARTED|Overall Study||10
34985|NCT01890343|82238|P2|STARTED|Overall Study||10
34986|NCT01890343|82239|P1|STARTED|Overall Study||8
34987|NCT01890148|82250|P1|NOT COMPLETED|Overall Study||1
34988|NCT01890148|82250|P1|COMPLETED|Overall Study||4
34989|NCT01890148|82250|P1|STARTED|Overall Study||5
34990|NCT01890122|82270|P4|NOT COMPLETED|Overall Study||59
34991|NCT01890122|82271|P3|NOT COMPLETED|Overall Study||13
34992|NCT01890122|82272|P2|NOT COMPLETED|Overall Study||37
34993|NCT01890122|82273|P1|NOT COMPLETED|Overall Study||27
34994|NCT01890122|82270|P4|COMPLETED|Overall Study||104
34995|NCT01890122|82271|P3|COMPLETED|Overall Study||146
34996|NCT01890122|82272|P2|COMPLETED|Overall Study||126
34997|NCT01890122|82273|P1|COMPLETED|Overall Study||135
34998|NCT01890122|82270|P4|Treated|Overall Study||163
34999|NCT01890122|82271|P3|Treated|Overall Study||159
35000|NCT01890122|82272|P2|Treated|Overall Study||162
35001|NCT01890122|82273|P1|Treated|Overall Study|Treated = Randomized participants who received at least one dose of study drug.|161
35002|NCT01890122|82270|P4|STARTED|Overall Study||163
35003|NCT01890122|82271|P3|STARTED|Overall Study||159
35004|NCT01890122|82272|P2|STARTED|Overall Study||163
35005|NCT01890122|82273|P1|STARTED|Overall Study|Started = Enrolled set which included all participants who signed informed consent.|162
35006|NCT01890031|82340|P5|NOT COMPLETED|Overall Study||0
35007|NCT01890031|82341|P4|NOT COMPLETED|Overall Study||0
35008|NCT01890031|82342|P3|NOT COMPLETED|Overall Study||0
35009|NCT01890031|82343|P2|NOT COMPLETED|Overall Study||0
35010|NCT01890031|82344|P1|NOT COMPLETED|Overall Study||0
35011|NCT01890031|82340|P5|COMPLETED|Overall Study||8
35012|NCT01890031|82341|P4|COMPLETED|Overall Study||11
35013|NCT01890031|82342|P3|COMPLETED|Overall Study||12
35014|NCT01890031|82343|P2|COMPLETED|Overall Study||50
35015|NCT01890031|82344|P1|COMPLETED|Overall Study||50
35016|NCT01890031|82340|P5|STARTED|Overall Study||8
35017|NCT01890031|82341|P4|STARTED|Overall Study||11
35018|NCT01890031|82342|P3|STARTED|Overall Study||12
35019|NCT01890031|82343|P2|STARTED|Overall Study||50
35020|NCT01890031|82344|P1|STARTED|Overall Study||50
35021|NCT01889797|82363|P2|NOT COMPLETED|Overall Study||0
35022|NCT01889797|82364|P1|NOT COMPLETED|Overall Study||0
35023|NCT01889797|82363|P2|COMPLETED|Overall Study||16
35024|NCT01889797|82364|P1|COMPLETED|Overall Study||16
35025|NCT01889797|82363|P2|STARTED|Overall Study||16
35026|NCT01889797|82364|P1|STARTED|Overall Study||16
35027|NCT01889667|82379|P3|NOT COMPLETED|Overall Study||0
35028|NCT01889667|82380|P2|NOT COMPLETED|Overall Study||0
35029|NCT01889667|82381|P1|NOT COMPLETED|Overall Study||0
35030|NCT01889667|82379|P3|COMPLETED|Overall Study||10
35031|NCT01889667|82380|P2|COMPLETED|Overall Study||10
35032|NCT01889667|82381|P1|COMPLETED|Overall Study||10
35033|NCT01889667|82379|P3|STARTED|Overall Study||10
35034|NCT01889667|82380|P2|STARTED|Overall Study||10
35035|NCT01889667|82381|P1|STARTED|Overall Study||10
35036|NCT01889563|82403|P2|NOT COMPLETED|Overall Study||5
35037|NCT01889563|82404|P1|NOT COMPLETED|Overall Study||7
35038|NCT01889563|82403|P2|COMPLETED|Overall Study||10
35039|NCT01889563|82404|P1|COMPLETED|Overall Study||10
35040|NCT01889563|82403|P2|STARTED|Overall Study||15
35041|NCT01889563|82404|P1|STARTED|Overall Study||17
35042|NCT01889420|82412|P1|NOT COMPLETED|Overall Study||0
35043|NCT01889420|82412|P1|COMPLETED|Overall Study||1
35044|NCT01889420|82412|P1|STARTED|Overall Study||1
35045|NCT01889251|82420|P2|NOT COMPLETED|Overall Study||0
35046|NCT01889251|82421|P1|NOT COMPLETED|Overall Study||1
35047|NCT01889251|82420|P2|COMPLETED|Overall Study||57
35048|NCT01889251|82421|P1|COMPLETED|Overall Study||114
35049|NCT01889251|82420|P2|STARTED|Overall Study||57
35050|NCT01889251|82421|P1|STARTED|Overall Study||115
35051|NCT01888965|82427|P1|NOT COMPLETED|Overall Study||9
35052|NCT01888965|82427|P1|COMPLETED|Overall Study||0
35053|NCT01888965|82427|P1|STARTED|Overall Study||9
35054|NCT01888952|82433|P1|NOT COMPLETED|Overall Study||0
35055|NCT01888952|82433|P1|COMPLETED|Overall Study||10
35056|NCT01888952|82433|P1|STARTED|Overall Study||10
35057|NCT01888900|82439|P2|NOT COMPLETED|Overall Study||2
35058|NCT01888900|82440|P1|NOT COMPLETED|Overall Study||0
35059|NCT01888900|82439|P2|COMPLETED|Overall Study||11
35060|NCT01888900|82440|P1|COMPLETED|Overall Study||22
35061|NCT01888900|82439|P2|STARTED|Overall Study||13
35062|NCT01888900|82440|P1|STARTED|Overall Study||22
35063|NCT01888367|82463|P3|NOT COMPLETED|Overall Study||5
35064|NCT01888367|82464|P2|NOT COMPLETED|Overall Study||5
35065|NCT01888367|82465|P1|NOT COMPLETED|Overall Study||8
35066|NCT01888367|82463|P3|COMPLETED|Overall Study||73
35067|NCT01888367|82464|P2|COMPLETED|Overall Study||66
35068|NCT01888367|82465|P1|COMPLETED|Overall Study||288
35069|NCT01888367|82463|P3|STARTED|Overall Study||78
35070|NCT01888367|82464|P2|STARTED|Overall Study||71
35071|NCT01888367|82465|P1|STARTED|Overall Study||296
35072|NCT01888003|82485|P3|NOT COMPLETED|Overall Study||40
35073|NCT01888003|82486|P2|NOT COMPLETED|Overall Study||6
35074|NCT01888003|82487|P1|NOT COMPLETED|Overall Study||5
35075|NCT01888003|82485|P3|COMPLETED|Overall Study||0
35076|NCT01888003|82486|P2|COMPLETED|Overall Study||0
35077|NCT01888003|82487|P1|COMPLETED|Overall Study||0
35078|NCT01888003|82485|P3|STARTED|Overall Study||40
35079|NCT01888003|82486|P2|STARTED|Overall Study||6
35080|NCT01888003|82487|P1|STARTED|Overall Study||5
35081|NCT01887990|82508|P4|NOT COMPLETED|Overall Study||0
35082|NCT01887990|82509|P3|NOT COMPLETED|Overall Study||0
35083|NCT01887990|82510|P2|NOT COMPLETED|Overall Study||0
35084|NCT01887990|82511|P1|NOT COMPLETED|Overall Study||0
35085|NCT01887990|82508|P4|COMPLETED|Overall Study||2
35086|NCT01887990|82509|P3|COMPLETED|Overall Study||2
35087|NCT01887990|82510|P2|COMPLETED|Overall Study||7
35088|NCT01887990|82511|P1|COMPLETED|Overall Study||7
35089|NCT01887990|82508|P4|STARTED|Overall Study||2
35090|NCT01887990|82509|P3|STARTED|Overall Study||2
35091|NCT01887990|82510|P2|STARTED|Overall Study||7
35092|NCT01887990|82511|P1|STARTED|Overall Study||7
35093|NCT01887678|82527|P2|NOT COMPLETED|Overall Study||28
35094|NCT01887678|82528|P1|NOT COMPLETED|Overall Study||17
35095|NCT01887678|82527|P2|COMPLETED|Overall Study||85
35096|NCT01887678|82528|P1|COMPLETED|Overall Study||102
35097|NCT01887678|82527|P2|STARTED|Overall Study||113
35098|NCT01887678|82528|P1|STARTED|Overall Study||119
35099|NCT01887470|82574|P4|NOT COMPLETED|Overall Study||0
35100|NCT01887470|82575|P3|NOT COMPLETED|Overall Study||0
35101|NCT01887470|82576|P2|NOT COMPLETED|Overall Study||0
35102|NCT01887470|82577|P1|NOT COMPLETED|Overall Study||0
35103|NCT01887470|82574|P4|COMPLETED|Overall Study||10
35104|NCT01887470|82575|P3|COMPLETED|Overall Study||10
35105|NCT01887470|82576|P2|COMPLETED|Overall Study||10
35106|NCT01887470|82577|P1|COMPLETED|Overall Study||10
35107|NCT01887470|82574|P4|STARTED|Overall Study||10
35108|NCT01887470|82575|P3|STARTED|Overall Study||10
35109|NCT01887470|82576|P2|STARTED|Overall Study||10
35110|NCT01887470|82577|P1|STARTED|Overall Study||10
35111|NCT01887418|82596|P3|NOT COMPLETED|Overall Study||1
35112|NCT01887418|82597|P2|NOT COMPLETED|Overall Study||0
35113|NCT01887418|82598|P1|NOT COMPLETED|Overall Study||0
35114|NCT01887418|82596|P3|COMPLETED|Overall Study||9
35115|NCT01887418|82597|P2|COMPLETED|Overall Study||14
35116|NCT01887418|82598|P1|COMPLETED|Overall Study||15
35117|NCT01887418|82596|P3|STARTED|Overall Study||10
35118|NCT01887418|82597|P2|STARTED|Overall Study||14
35119|NCT01887418|82598|P1|STARTED|Overall Study||15
35120|NCT01887353|82617|P2|NOT COMPLETED|Overall Study||3
35121|NCT01887353|82618|P1|NOT COMPLETED|Overall Study||4
35122|NCT01887353|82617|P2|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|1
35123|NCT01887353|82618|P1|COMPLETED|Overall Study|Study was stopped early because of difficulty recruiting.|0
35124|NCT01887353|82617|P2|STARTED|Overall Study||4
35125|NCT01887353|82618|P1|STARTED|Overall Study||4
35126|NCT01887171|82626|P2|NOT COMPLETED|Overall Study||0
35127|NCT01887171|82627|P1|NOT COMPLETED|Overall Study||0
35128|NCT01887171|82626|P2|COMPLETED|Overall Study||43
35129|NCT01887171|82627|P1|COMPLETED|Overall Study||43
35130|NCT01887171|82626|P2|STARTED|Overall Study||43
35131|NCT01887171|82627|P1|STARTED|Overall Study||43
35132|NCT01886963|82635|P2|NOT COMPLETED|Overall Study||4
35133|NCT01886963|82636|P1|NOT COMPLETED|Overall Study||5
35134|NCT01886963|82635|P2|COMPLETED|Overall Study||49
35135|NCT01886963|82636|P1|COMPLETED|Overall Study||46
35136|NCT01886963|82635|P2|12 Week Follow Up|Overall Study||22
35137|NCT01886963|82636|P1|12 Week Follow Up|Overall Study||24
35138|NCT01886963|82635|P2|4 Week Follow Up|Overall Study||26
35139|NCT01886963|82636|P1|4 Week Follow Up|Overall Study||24
35140|NCT01886963|82635|P2|2 Week Follow Up|Overall Study||35
35141|NCT01886963|82636|P1|2 Week Follow Up|Overall Study||38
35142|NCT01886963|82635|P2|STARTED|Overall Study||53
35143|NCT01886963|82636|P1|STARTED|Overall Study||51
35144|NCT01886937|82644|P2|NOT COMPLETED|Overall Study||0
35145|NCT01886937|82645|P1|NOT COMPLETED|Overall Study||0
35146|NCT01886937|82644|P2|COMPLETED|Overall Study||6
35147|NCT01886937|82645|P1|COMPLETED|Overall Study||7
35148|NCT01886937|82644|P2|STARTED|Overall Study||6
35149|NCT01886937|82645|P1|STARTED|Overall Study||7
35150|NCT01886807|82654|P3|NOT COMPLETED|Overall Study||10
35151|NCT01886807|82655|P2|NOT COMPLETED|Overall Study||10
35152|NCT01886807|82656|P1|NOT COMPLETED|Overall Study||5
35153|NCT01886807|82654|P3|COMPLETED|Overall Study||153
35154|NCT01886807|82655|P2|COMPLETED|Overall Study||145
35155|NCT01886807|82656|P1|COMPLETED|Overall Study||159
35156|NCT01886807|82654|P3|STARTED|Overall Study||163
35157|NCT01886807|82655|P2|STARTED|Overall Study||155
35158|NCT01886807|82656|P1|STARTED|Overall Study||164
35159|NCT01886781|82666|P2|NOT COMPLETED|Overall Study||2
35160|NCT01886781|82667|P1|NOT COMPLETED|Overall Study||14
35161|NCT01886781|82666|P2|COMPLETED|Overall Study||25
35162|NCT01886781|82667|P1|COMPLETED|Overall Study||40
35163|NCT01886781|82666|P2|STARTED|Overall Study||27
35164|NCT01886781|82667|P1|STARTED|Overall Study||54
35165|NCT01886716|82677|P4|NOT COMPLETED|1-Month Post Follow-Up||0
35166|NCT01886716|82678|P3|NOT COMPLETED|1-Month Post Follow-Up||0
35167|NCT01886716|82679|P2|NOT COMPLETED|1-Month Post Follow-Up||0
35168|NCT01886716|82680|P1|NOT COMPLETED|1-Month Post Follow-Up||0
35169|NCT01886716|82677|P4|COMPLETED|1-Month Post Follow-Up||14
35170|NCT01886716|82678|P3|COMPLETED|1-Month Post Follow-Up||19
35171|NCT01886716|82679|P2|COMPLETED|1-Month Post Follow-Up||17
35172|NCT01886716|82680|P1|COMPLETED|1-Month Post Follow-Up||20
35173|NCT01886716|82677|P4|STARTED|1-Month Post Follow-Up||14
35174|NCT01886716|82678|P3|STARTED|1-Month Post Follow-Up||19
35175|NCT01886716|82679|P2|STARTED|1-Month Post Follow-Up||17
35176|NCT01886716|82680|P1|STARTED|1-Month Post Follow-Up||20
35177|NCT01886716|82677|P4|NOT COMPLETED|1-Week Post Follow-Up||0
35178|NCT01886716|82678|P3|NOT COMPLETED|1-Week Post Follow-Up||0
35179|NCT01886716|82679|P2|NOT COMPLETED|1-Week Post Follow-Up||0
35180|NCT01886716|82680|P1|NOT COMPLETED|1-Week Post Follow-Up||0
35181|NCT01886716|82677|P4|COMPLETED|1-Week Post Follow-Up||14
35182|NCT01886716|82678|P3|COMPLETED|1-Week Post Follow-Up||19
35183|NCT01886716|82679|P2|COMPLETED|1-Week Post Follow-Up||17
35184|NCT01886716|82680|P1|COMPLETED|1-Week Post Follow-Up||20
35185|NCT01886716|82677|P4|STARTED|1-Week Post Follow-Up||14
35186|NCT01886716|82678|P3|STARTED|1-Week Post Follow-Up||19
35187|NCT01886716|82679|P2|STARTED|1-Week Post Follow-Up||17
35188|NCT01886716|82680|P1|STARTED|1-Week Post Follow-Up||20
35189|NCT01886716|82677|P4|NOT COMPLETED|Week 4||0
35190|NCT01886716|82678|P3|NOT COMPLETED|Week 4||0
35191|NCT01886716|82679|P2|NOT COMPLETED|Week 4||0
35192|NCT01886716|82680|P1|NOT COMPLETED|Week 4||0
35193|NCT01886716|82677|P4|COMPLETED|Week 4||14
35194|NCT01886716|82678|P3|COMPLETED|Week 4||19
35195|NCT01886716|82679|P2|COMPLETED|Week 4||17
35196|NCT01886716|82680|P1|COMPLETED|Week 4||20
35197|NCT01886716|82677|P4|STARTED|Week 4||14
35198|NCT01886716|82678|P3|STARTED|Week 4||19
35199|NCT01886716|82679|P2|STARTED|Week 4||17
35200|NCT01886716|82680|P1|STARTED|Week 4||20
35201|NCT01886716|82677|P4|NOT COMPLETED|Week 3||1
35202|NCT01886716|82678|P3|NOT COMPLETED|Week 3||0
35203|NCT01886716|82679|P2|NOT COMPLETED|Week 3||1
35204|NCT01886716|82680|P1|NOT COMPLETED|Week 3||1
35205|NCT01886716|82677|P4|COMPLETED|Week 3||14
35206|NCT01886716|82678|P3|COMPLETED|Week 3||19
35207|NCT01886716|82679|P2|COMPLETED|Week 3||17
35208|NCT01886716|82680|P1|COMPLETED|Week 3||20
35209|NCT01886716|82677|P4|STARTED|Week 3||15
35210|NCT01886716|82678|P3|STARTED|Week 3||19
35211|NCT01886716|82679|P2|STARTED|Week 3||18
35212|NCT01886716|82680|P1|STARTED|Week 3||21
35213|NCT01886716|82677|P4|NOT COMPLETED|Week 2||3
35214|NCT01886716|82678|P3|NOT COMPLETED|Week 2||1
35215|NCT01886716|82679|P2|NOT COMPLETED|Week 2||2
35216|NCT01886716|82680|P1|NOT COMPLETED|Week 2||3
35217|NCT01886716|82677|P4|COMPLETED|Week 2||15
35218|NCT01886716|82678|P3|COMPLETED|Week 2||19
35219|NCT01886716|82679|P2|COMPLETED|Week 2||18
35220|NCT01886716|82680|P1|COMPLETED|Week 2||21
35221|NCT01886716|82677|P4|STARTED|Week 2||18
35222|NCT01886716|82678|P3|STARTED|Week 2||20
35223|NCT01886716|82679|P2|STARTED|Week 2||20
35224|NCT01886716|82680|P1|STARTED|Week 2||24
35225|NCT01886716|82677|P4|NOT COMPLETED|Week 1||2
35226|NCT01886716|82678|P3|NOT COMPLETED|Week 1||2
35227|NCT01886716|82679|P2|NOT COMPLETED|Week 1||0
35228|NCT01886716|82680|P1|NOT COMPLETED|Week 1||0
35229|NCT01886716|82677|P4|COMPLETED|Week 1||18
35230|NCT01886716|82678|P3|COMPLETED|Week 1||20
35231|NCT01886716|82679|P2|COMPLETED|Week 1||20
35232|NCT01886716|82680|P1|COMPLETED|Week 1||24
35233|NCT01886716|82677|P4|STARTED|Week 1||20
35234|NCT01886716|82678|P3|STARTED|Week 1||22
35235|NCT01886716|82679|P2|STARTED|Week 1||20
35236|NCT01886716|82680|P1|STARTED|Week 1||24
35237|NCT01886690|82696|P2|NOT COMPLETED|Overall Study||2
35238|NCT01886690|82697|P1|NOT COMPLETED|Overall Study||0
35239|NCT01886690|82696|P2|COMPLETED|Overall Study||71
35240|NCT01886690|82697|P1|COMPLETED|Overall Study||75
35241|NCT01886690|82696|P2|STARTED|Overall Study||73
35242|NCT01886690|82697|P1|STARTED|Overall Study||75
35243|NCT01886313|82713|P2|NOT COMPLETED|Overall Study||1
35244|NCT01886313|82714|P1|NOT COMPLETED|Overall Study||1
35245|NCT01886313|82713|P2|COMPLETED|Overall Study||4
35246|NCT01886313|82714|P1|COMPLETED|Overall Study||5
35247|NCT01886313|82713|P2|STARTED|Overall Study||5
35248|NCT01886313|82714|P1|STARTED|Overall Study||6
35249|NCT01886300|82720|P1|NOT COMPLETED|Overall Study||16
35250|NCT01886300|82720|P1|COMPLETED|Overall Study||0
35251|NCT01886300|82720|P1|STARTED|Overall Study||16
35252|NCT01886287|82731|P1|NOT COMPLETED|Overall Study||2
35253|NCT01886287|82731|P1|COMPLETED|Overall Study||0
35254|NCT01886287|82731|P1|STARTED|Overall Study||2
35255|NCT01886235|82736|P1|NOT COMPLETED|Overall Study||0
35256|NCT01886235|82736|P1|COMPLETED|Overall Study||10
35257|NCT01886235|82736|P1|STARTED|Overall Study||10
35258|NCT01885910|82747|P1|NOT COMPLETED|Overall Study||8
35259|NCT01885910|82747|P1|COMPLETED|Overall Study||24
35260|NCT01885910|82747|P1|STARTED|Overall Study||32
35261|NCT01885871|82761|P1|NOT COMPLETED|Overall Study||0
35262|NCT01885871|82761|P1|COMPLETED|Overall Study||20
35263|NCT01885871|82761|P1|STARTED|Overall Study||20
35264|NCT01885559|82771|P2|NOT COMPLETED|Overall Study||36
35265|NCT01885559|82772|P1|NOT COMPLETED|Overall Study||24
35266|NCT01885559|82771|P2|COMPLETED|Overall Study||208
35267|NCT01885559|82772|P1|COMPLETED|Overall Study||218
35268|NCT01885559|82771|P2|STARTED|Overall Study||244
35269|NCT01885559|82772|P1|STARTED|Overall Study||242
35270|NCT01885117|82794|P2|NOT COMPLETED|Overall Study||0
35271|NCT01885117|82795|P1|NOT COMPLETED|Overall Study||0
35272|NCT01885117|82794|P2|COMPLETED|Overall Study||64
35273|NCT01885117|82795|P1|COMPLETED|Overall Study||61
35274|NCT01885117|82794|P2|STARTED|Overall Study||64
35275|NCT01885117|82795|P1|STARTED|Overall Study||61
35276|NCT01885104|82817|P2|NOT COMPLETED|Overall Study||1
35277|NCT01885104|82818|P1|NOT COMPLETED|Overall Study||2
35278|NCT01885104|82817|P2|COMPLETED|Overall Study||33
35279|NCT01885104|82818|P1|COMPLETED|Overall Study||29
35280|NCT01885104|82817|P2|STARTED|Overall Study||34
35281|NCT01885104|82818|P1|STARTED|Overall Study||31
35282|NCT01885000|82828|P2|NOT COMPLETED|Overall Study||2
35283|NCT01885000|82829|P1|NOT COMPLETED|Overall Study||2
35284|NCT01885000|82828|P2|COMPLETED|Overall Study||42
35285|NCT01885000|82829|P1|COMPLETED|Overall Study||46
35286|NCT01885000|82828|P2|STARTED|Overall Study||44
35287|NCT01885000|82829|P1|STARTED|Overall Study||48
35288|NCT01884688|82841|P1|NOT COMPLETED|Overall Study||2
35289|NCT01884688|82841|P1|COMPLETED|Overall Study||1
35290|NCT01884688|82841|P1|STARTED|Overall Study||3
35291|NCT01884675|82847|P2|NOT COMPLETED|Overall Study||2
35292|NCT01884675|82848|P1|NOT COMPLETED|Overall Study||3
35293|NCT01884675|82847|P2|COMPLETED|Overall Study||15
35294|NCT01884675|82848|P1|COMPLETED|Overall Study||13
35295|NCT01884675|82847|P2|STARTED|Overall Study||17
35296|NCT01884675|82848|P1|STARTED|Overall Study||16
35297|NCT01884571|82888|P1|NOT COMPLETED|Overall Study||8
35298|NCT01884571|82888|P1|COMPLETED|Overall Study||23
35299|NCT01884571|82888|P1|STARTED|Overall Study||31
35300|NCT01884519|82894|P2|NOT COMPLETED|Overall Study||0
35301|NCT01884519|82895|P1|NOT COMPLETED|Overall Study||0
35302|NCT01884519|82894|P2|COMPLETED|Overall Study||60
35303|NCT01884519|82895|P1|COMPLETED|Overall Study||60
35304|NCT01884519|82894|P2|STARTED|Overall Study||60
35305|NCT01884519|82895|P1|STARTED|Overall Study||60
35306|NCT01884064|82939|P2|NOT COMPLETED|Overall Study||0
35307|NCT01884064|82940|P1|NOT COMPLETED|Overall Study||0
35308|NCT01884064|82939|P2|COMPLETED|Overall Study||5
35309|NCT01884064|82940|P1|COMPLETED|Overall Study||12
35310|NCT01884064|82939|P2|STARTED|Overall Study||5
35311|NCT01884064|82940|P1|STARTED|Overall Study||12
35312|NCT01883999|82946|P1|NOT COMPLETED|Overall Study||3
35313|NCT01883999|82946|P1|COMPLETED|Overall Study||61
35314|NCT01883999|82946|P1|STARTED|Overall Study||64
35315|NCT01883986|82954|P2|NOT COMPLETED|Overall Study||1
35316|NCT01883986|82955|P1|NOT COMPLETED|Overall Study||3
35317|NCT01883986|82954|P2|COMPLETED|Overall Study|Completed study|19
35318|NCT01883986|82955|P1|COMPLETED|Overall Study|Received allocated intervention|17
35319|NCT01883986|82954|P2|Did Not Complete Study|Overall Study|Did not completed study|1
35320|NCT01883986|82955|P1|Did Not Complete Study|Overall Study||3
35321|NCT01883986|82954|P2|STARTED|Overall Study|Allocated to usual care arm|20
35322|NCT01883986|82955|P1|STARTED|Overall Study|Allocated to intervention arm|20
35323|NCT01883908|82969|P2|NOT COMPLETED|Overall Study||0
35324|NCT01883908|82970|P1|NOT COMPLETED|Overall Study||0
35325|NCT01883908|82969|P2|COMPLETED|Overall Study||1
35326|NCT01883908|82970|P1|COMPLETED|Overall Study||3
35327|NCT01883908|82969|P2|STARTED|Overall Study||1
35328|NCT01883908|82970|P1|STARTED|Overall Study||3
35329|NCT01883895|82978|P1|NOT COMPLETED|Overall Study||2
35330|NCT01883895|82978|P1|COMPLETED|Overall Study||32
35331|NCT01883895|82978|P1|STARTED|Overall Study||34
35332|NCT01883635|82985|P2|NOT COMPLETED|Overall Study||0
35333|NCT01883635|82986|P1|NOT COMPLETED|Overall Study||4
35334|NCT01883635|82985|P2|COMPLETED|Overall Study||20
35335|NCT01883635|82986|P1|COMPLETED|Overall Study||20
35336|NCT01883635|82985|P2|STARTED|Overall Study||20
35337|NCT01883635|82986|P1|STARTED|Overall Study||24
35338|NCT01883453|83000|P2|NOT COMPLETED|Overall Study||23
35339|NCT01883453|83001|P1|NOT COMPLETED|Overall Study||25
35340|NCT01883453|83000|P2|COMPLETED|Overall Study||50
35341|NCT01883453|83001|P1|COMPLETED|Overall Study||48
35342|NCT01883453|83000|P2|STARTED|Overall Study||73
35343|NCT01883453|83001|P1|STARTED|Overall Study||73
35344|NCT01883440|83009|P2|NOT COMPLETED|Overall Study||0
35345|NCT01883440|83010|P1|NOT COMPLETED|Overall Study||3
35346|NCT01883440|83009|P2|COMPLETED|Overall Study||45
35347|NCT01883440|83010|P1|COMPLETED|Overall Study||42
35348|NCT01883440|83009|P2|STARTED|Overall Study||45
35349|NCT01883440|83010|P1|STARTED|Overall Study||45
35350|NCT01883427|83020|P2|NOT COMPLETED|Overall Study||0
35351|NCT01883427|83021|P1|NOT COMPLETED|Overall Study||0
35352|NCT01883427|83020|P2|COMPLETED|Overall Study||20
35353|NCT01883427|83021|P1|COMPLETED|Overall Study||20
35354|NCT01883427|83020|P2|STARTED|Overall Study||20
35355|NCT01883427|83021|P1|STARTED|Overall Study||20
35356|NCT01882907|83029|P2|NOT COMPLETED|Overall Study||28
35357|NCT01882907|83030|P1|NOT COMPLETED|Overall Study||14
35358|NCT01882907|83029|P2|COMPLETED|Overall Study||83
35359|NCT01882907|83030|P1|COMPLETED|Overall Study||103
35360|NCT01882907|83029|P2|STARTED|Overall Study||111
35361|NCT01882907|83030|P1|STARTED|Overall Study||117
35362|NCT01882868|83036|P1|NOT COMPLETED|Overall Study||0
35363|NCT01882868|83036|P1|COMPLETED|Overall Study||62
35364|NCT01882868|83036|P1|STARTED|Overall Study||62
35365|NCT01882725|83066|P1|NOT COMPLETED|Overall Study||0
35366|NCT01882725|83066|P1|COMPLETED|Overall Study||14
35367|NCT01882725|83066|P1|STARTED|Overall Study||14
35368|NCT01882647|83073|P2|NOT COMPLETED|Overall Study||6
35369|NCT01882647|83074|P1|NOT COMPLETED|Overall Study||2
35370|NCT01882647|83073|P2|COMPLETED|Overall Study||106
35371|NCT01882647|83074|P1|COMPLETED|Overall Study||108
35372|NCT01882647|83073|P2|STARTED|Overall Study||112
35373|NCT01882647|83074|P1|STARTED|Overall Study||110
35374|NCT01882465|83090|P7|NOT COMPLETED|Period 3||0
35375|NCT01882465|83091|P6|NOT COMPLETED|Period 3||0
35376|NCT01882465|83092|P5|NOT COMPLETED|Period 3||0
35377|NCT01882465|83093|P4|NOT COMPLETED|Period 3||0
35378|NCT01882465|83094|P3|NOT COMPLETED|Period 3||0
35379|NCT01882465|83095|P2|NOT COMPLETED|Period 3||0
35380|NCT01882465|83096|P1|NOT COMPLETED|Period 3||0
35381|NCT01882465|83090|P7|COMPLETED|Period 3||0
35382|NCT01882465|83091|P6|COMPLETED|Period 3||5
35383|NCT01882465|83092|P5|COMPLETED|Period 3||4
35384|NCT01882465|83093|P4|COMPLETED|Period 3||5
35385|NCT01882465|83094|P3|COMPLETED|Period 3||5
35386|NCT01882465|83095|P2|COMPLETED|Period 3||6
35387|NCT01882465|83096|P1|COMPLETED|Period 3||6
35388|NCT01882465|83090|P7|STARTED|Period 3||0
35389|NCT01882465|83091|P6|STARTED|Period 3||5
35390|NCT01882465|83092|P5|STARTED|Period 3||4
35391|NCT01882465|83093|P4|STARTED|Period 3||5
35392|NCT01882465|83094|P3|STARTED|Period 3||5
35393|NCT01882465|83095|P2|STARTED|Period 3||6
35394|NCT01882465|83096|P1|STARTED|Period 3||6
35395|NCT01882465|83090|P7|NOT COMPLETED|Period 2||0
35396|NCT01882465|83091|P6|NOT COMPLETED|Period 2||0
35397|NCT01882465|83092|P5|NOT COMPLETED|Period 2||1
35398|NCT01882465|83093|P4|NOT COMPLETED|Period 2||0
35399|NCT01882465|83094|P3|NOT COMPLETED|Period 2||0
35400|NCT01882465|83095|P2|NOT COMPLETED|Period 2||0
35401|NCT01882465|83096|P1|NOT COMPLETED|Period 2||0
35402|NCT01882465|83090|P7|COMPLETED|Period 2||0
35403|NCT01882465|83091|P6|COMPLETED|Period 2||5
35404|NCT01882465|83092|P5|COMPLETED|Period 2||4
35405|NCT01882465|83093|P4|COMPLETED|Period 2||5
35406|NCT01882465|83094|P3|COMPLETED|Period 2||5
35407|NCT01882465|83095|P2|COMPLETED|Period 2||6
35408|NCT01882465|83096|P1|COMPLETED|Period 2||6
35409|NCT01882465|83090|P7|STARTED|Period 2||0
35410|NCT01882465|83091|P6|STARTED|Period 2||5
35411|NCT01882465|83092|P5|STARTED|Period 2||5
35412|NCT01882465|83093|P4|STARTED|Period 2||5
35413|NCT01882465|83094|P3|STARTED|Period 2||5
35414|NCT01882465|83095|P2|STARTED|Period 2||6
35415|NCT01882465|83096|P1|STARTED|Period 2||6
35416|NCT01882465|83090|P7|NOT COMPLETED|Period 1||1
35417|NCT01882465|83091|P6|NOT COMPLETED|Period 1||0
35418|NCT01882465|83092|P5|NOT COMPLETED|Period 1||0
35419|NCT01882465|83093|P4|NOT COMPLETED|Period 1||1
35420|NCT01882465|83094|P3|NOT COMPLETED|Period 1||0
35421|NCT01882465|83095|P2|NOT COMPLETED|Period 1||0
35422|NCT01882465|83096|P1|NOT COMPLETED|Period 1||0
35423|NCT01882465|83090|P7|COMPLETED|Period 1||0
35424|NCT01882465|83091|P6|COMPLETED|Period 1||5
35425|NCT01882465|83092|P5|COMPLETED|Period 1||5
35426|NCT01882465|83093|P4|COMPLETED|Period 1||5
35427|NCT01882465|83094|P3|COMPLETED|Period 1||5
35428|NCT01882465|83095|P2|COMPLETED|Period 1||6
35429|NCT01882465|83096|P1|COMPLETED|Period 1||6
35430|NCT01882465|83090|P7|STARTED|Period 1||1
35431|NCT01882465|83091|P6|STARTED|Period 1||5
35432|NCT01882465|83092|P5|STARTED|Period 1||5
35433|NCT01882465|83093|P4|STARTED|Period 1||6
35434|NCT01882465|83094|P3|STARTED|Period 1||5
35435|NCT01882465|83095|P2|STARTED|Period 1||6
35436|NCT01882465|83096|P1|STARTED|Period 1||6
35437|NCT01882413|83104|P1|NOT COMPLETED|Overall Study||0
35438|NCT01882413|83104|P1|COMPLETED|Overall Study||204
35439|NCT01882413|83104|P1|STARTED|Overall Study||204
35440|NCT01882257|83121|P3|NOT COMPLETED|Therapy Portion of Study (12 Months)||4
35441|NCT01882257|83122|P2|NOT COMPLETED|Therapy Portion of Study (12 Months)||11
35442|NCT01882257|83123|P1|NOT COMPLETED|Therapy Portion of Study (12 Months)||0
35443|NCT01882257|83121|P3|COMPLETED|Therapy Portion of Study (12 Months)||18
35444|NCT01882257|83122|P2|COMPLETED|Therapy Portion of Study (12 Months)||27
35445|NCT01882257|83123|P1|COMPLETED|Therapy Portion of Study (12 Months)||11
35446|NCT01882257|83121|P3|STARTED|Therapy Portion of Study (12 Months)||22
35447|NCT01882257|83122|P2|STARTED|Therapy Portion of Study (12 Months)||38
35448|NCT01882257|83123|P1|STARTED|Therapy Portion of Study (12 Months)||11
35449|NCT01882257|83121|P3|NOT COMPLETED|Study Origination to Beginning Therapy||1
35450|NCT01882257|83122|P2|NOT COMPLETED|Study Origination to Beginning Therapy||2
35451|NCT01882257|83123|P1|NOT COMPLETED|Study Origination to Beginning Therapy||0
35452|NCT01882257|83121|P3|COMPLETED|Study Origination to Beginning Therapy||22
35453|NCT01882257|83122|P2|COMPLETED|Study Origination to Beginning Therapy||38
35454|NCT01882257|83123|P1|COMPLETED|Study Origination to Beginning Therapy||11
35455|NCT01882257|83121|P3|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 23 who were given the device, 1 chose not to begin the actual therapy|22
35456|NCT01882257|83122|P2|Started Therapy Using Device|Study Origination to Beginning Therapy|Of the 40 who were given the device, 2 chose not to begin the actual therapy|38
35457|NCT01882257|83123|P1|Started Therapy Using Device|Study Origination to Beginning Therapy||11
35458|NCT01882257|83121|P3|STARTED|Study Origination to Beginning Therapy||23
35459|NCT01882257|83122|P2|STARTED|Study Origination to Beginning Therapy||40
35460|NCT01882257|83123|P1|STARTED|Study Origination to Beginning Therapy||11
35461|NCT01882062|83130|P1|NOT COMPLETED|Overall Study||0
35462|NCT01882062|83130|P1|COMPLETED|Overall Study|18th of july 2013|10
35463|NCT01882062|83130|P1|STARTED|Overall Study|16th of may 2013|10
35464|NCT01881984|83134|P1|NOT COMPLETED|Overall Study||0
35465|NCT01881984|83134|P1|COMPLETED|Overall Study||4
35466|NCT01881984|83134|P1|STARTED|Overall Study||4
35467|NCT01881932|83142|P3|NOT COMPLETED|Overall Study||0
35468|NCT01881932|83143|P2|NOT COMPLETED|Overall Study||0
35469|NCT01881932|83144|P1|NOT COMPLETED|Overall Study||0
35470|NCT01881932|83142|P3|COMPLETED|Overall Study||13
35471|NCT01881932|83143|P2|COMPLETED|Overall Study||4
35472|NCT01881932|83144|P1|COMPLETED|Overall Study||2
35473|NCT01881932|83142|P3|STARTED|Overall Study||13
35474|NCT01881932|83143|P2|STARTED|Overall Study||4
35475|NCT01881932|83144|P1|STARTED|Overall Study||2
35476|NCT01881776|83155|P3|NOT COMPLETED|Overall Study||2
35477|NCT01881776|83156|P2|NOT COMPLETED|Overall Study||4
35478|NCT01881776|83157|P1|NOT COMPLETED|Overall Study||1
35479|NCT01881776|83155|P3|COMPLETED|Overall Study||20
35480|NCT01881776|83156|P2|COMPLETED|Overall Study||20
35481|NCT01881776|83157|P1|COMPLETED|Overall Study||23
35482|NCT01881776|83155|P3|STARTED|Overall Study||22
35483|NCT01881776|83156|P2|STARTED|Overall Study||24
35484|NCT01881776|83157|P1|STARTED|Overall Study||24
35485|NCT01881737|83183|P1|NOT COMPLETED|Overall Study||5
35486|NCT01881737|83183|P1|COMPLETED|Overall Study||10
35487|NCT01881737|83183|P1|Number Screened|Overall Study||15
35488|NCT01881737|83183|P1|STARTED|Overall Study|This is a pilot study|15
35489|NCT01881126|83194|P2|NOT COMPLETED|Overall Study||2
35490|NCT01881126|83195|P1|NOT COMPLETED|Overall Study||1
35491|NCT01881126|83194|P2|COMPLETED|Overall Study||44
35492|NCT01881126|83195|P1|COMPLETED|Overall Study||46
35493|NCT01881126|83194|P2|STARTED|Overall Study||46
35494|NCT01881126|83195|P1|STARTED|Overall Study||47
35495|NCT01881087|83204|P3|NOT COMPLETED|Overall Study||2
35496|NCT01881087|83205|P2|NOT COMPLETED|Overall Study||0
35497|NCT01881087|83206|P1|NOT COMPLETED|Overall Study||1
35498|NCT01881087|83204|P3|COMPLETED|Overall Study||60
35499|NCT01881087|83205|P2|COMPLETED|Overall Study||61
35500|NCT01881087|83206|P1|COMPLETED|Overall Study||59
35501|NCT01881087|83204|P3|STARTED|Overall Study||62
35502|NCT01881087|83205|P2|STARTED|Overall Study||61
35503|NCT01881087|83206|P1|STARTED|Overall Study||60
35504|NCT01880840|83219|P2|NOT COMPLETED|Overall Study||5
35505|NCT01880840|83220|P1|NOT COMPLETED|Overall Study||8
35506|NCT01880840|83219|P2|COMPLETED|Overall Study||91
35507|NCT01880840|83220|P1|COMPLETED|Overall Study||87
35508|NCT01880840|83219|P2|STARTED|Overall Study||96
35509|NCT01880840|83220|P1|STARTED|Overall Study||95
35510|NCT01880736|83230|P4|NOT COMPLETED|Overall Study||6
35511|NCT01880736|83231|P3|NOT COMPLETED|Overall Study||1
35512|NCT01880736|83232|P2|NOT COMPLETED|Overall Study||2
35513|NCT01880736|83233|P1|NOT COMPLETED|Overall Study||1
35514|NCT01880736|83230|P4|COMPLETED|Overall Study||108
35515|NCT01880736|83231|P3|COMPLETED|Overall Study||114
35516|NCT01880736|83232|P2|COMPLETED|Overall Study||113
35517|NCT01880736|83233|P1|COMPLETED|Overall Study||113
35518|NCT01880736|83230|P4|STARTED|Overall Study||114
35519|NCT01880736|83231|P3|STARTED|Overall Study||115
35520|NCT01880736|83232|P2|STARTED|Overall Study||115
35521|NCT01880736|83233|P1|STARTED|Overall Study||114
35522|NCT01880723|83277|P2|NOT COMPLETED|Overall Study||0
35523|NCT01880723|83278|P1|NOT COMPLETED|Overall Study||0
35524|NCT01880723|83277|P2|COMPLETED|Overall Study||16
35525|NCT01880723|83278|P1|COMPLETED|Overall Study||16
35526|NCT01880723|83277|P2|STARTED|Overall Study||16
35527|NCT01880723|83278|P1|STARTED|Overall Study||16
35528|NCT01880697|83294|P2|NOT COMPLETED|Overall Study||1
35529|NCT01880697|83295|P1|NOT COMPLETED|Overall Study||0
35530|NCT01880697|83294|P2|COMPLETED|Overall Study||62
35531|NCT01880697|83295|P1|COMPLETED|Overall Study||63
35532|NCT01880697|83294|P2|STARTED|Overall Study||63
35533|NCT01880697|83295|P1|STARTED|Overall Study||63
35534|NCT01880515|83317|P2|NOT COMPLETED|Overall Study||9
35535|NCT01880515|83318|P1|NOT COMPLETED|Overall Study||8
35536|NCT01880515|83317|P2|COMPLETED|Overall Study||45
35537|NCT01880515|83318|P1|COMPLETED|Overall Study||45
35538|NCT01880515|83317|P2|STARTED|Overall Study||54
35539|NCT01880515|83318|P1|STARTED|Overall Study||53
35540|NCT01880437|83329|P3|NOT COMPLETED|Overall Study||19
35541|NCT01880437|83330|P2|NOT COMPLETED|Overall Study||4
35542|NCT01880437|83331|P1|NOT COMPLETED|Overall Study||15
35543|NCT01880437|83329|P3|COMPLETED|Overall Study||0
35544|NCT01880437|83330|P2|COMPLETED|Overall Study||0
35545|NCT01880437|83331|P1|COMPLETED|Overall Study||0
35546|NCT01880437|83329|P3|STARTED|Overall Study||19
35547|NCT01880437|83330|P2|STARTED|Overall Study||4
35548|NCT01880437|83331|P1|STARTED|Overall Study||15
35549|NCT01880424|83357|P2|NOT COMPLETED|Overall Study||55
35550|NCT01880424|83358|P1|NOT COMPLETED|Overall Study||33
35551|NCT01880424|83357|P2|COMPLETED|Overall Study||367
35552|NCT01880424|83358|P1|COMPLETED|Overall Study||384
35553|NCT01880424|83357|P2|STARTED|Overall Study||422
35554|NCT01880424|83358|P1|STARTED|Overall Study||417
35555|NCT01880320|83383|P3|NOT COMPLETED|Overall Study||8
35556|NCT01880320|83384|P2|NOT COMPLETED|Overall Study||25
35557|NCT01880320|83385|P1|NOT COMPLETED|Overall Study||20
35558|NCT01880320|83383|P3|COMPLETED|Overall Study||61
35559|NCT01880320|83384|P2|COMPLETED|Overall Study||192
35560|NCT01880320|83385|P1|COMPLETED|Overall Study||197
35561|NCT01880320|83383|P3|STARTED|Overall Study||69
35562|NCT01880320|83384|P2|STARTED|Overall Study||217
35563|NCT01880320|83385|P1|STARTED|Overall Study||217
35564|NCT01880086|83401|P2|NOT COMPLETED|Overall Study||1
35565|NCT01880086|83402|P1|NOT COMPLETED|Overall Study||1
35566|NCT01880086|83401|P2|COMPLETED|Overall Study||6
35567|NCT01880086|83402|P1|COMPLETED|Overall Study||5
35568|NCT01880086|83401|P2|STARTED|Overall Study||7
35569|NCT01880086|83402|P1|STARTED|Overall Study||6
35570|NCT01879852|83422|P2|NOT COMPLETED|Overall Study||0
35571|NCT01879852|83423|P1|NOT COMPLETED|Overall Study||2
35572|NCT01879852|83422|P2|COMPLETED|Overall Study||13
35573|NCT01879852|83423|P1|COMPLETED|Overall Study||12
35574|NCT01879852|83422|P2|STARTED|Overall Study||13
35575|NCT01879852|83423|P1|STARTED|Overall Study||14
35576|NCT01879800|83437|P2|NOT COMPLETED|Overall Study||4
35577|NCT01879800|83438|P1|NOT COMPLETED|Overall Study||0
35578|NCT01879800|83437|P2|COMPLETED|Overall Study||26
35579|NCT01879800|83438|P1|COMPLETED|Overall Study||14
35580|NCT01879800|83437|P2|STARTED|Overall Study||30
35581|NCT01879800|83438|P1|STARTED|Overall Study||14
35582|NCT01879735|83450|P2|NOT COMPLETED|Overall Study||0
35583|NCT01879735|83451|P1|NOT COMPLETED|Overall Study||0
35584|NCT01879735|83450|P2|COMPLETED|Overall Study||16
35585|NCT01879735|83451|P1|COMPLETED|Overall Study||6
35586|NCT01879735|83450|P2|STARTED|Overall Study||16
35587|NCT01879735|83451|P1|STARTED|Overall Study||6
35588|NCT01879722|83467|P10|NOT COMPLETED|Overall Study||0
35589|NCT01879722|83468|P9|NOT COMPLETED|Overall Study||2
35590|NCT01879722|83469|P8|NOT COMPLETED|Overall Study||1
35591|NCT01879722|83470|P7|NOT COMPLETED|Overall Study||0
35592|NCT01879722|83471|P6|NOT COMPLETED|Overall Study||0
35593|NCT01879722|83472|P5|NOT COMPLETED|Overall Study||1
35594|NCT01879722|83473|P4|NOT COMPLETED|Overall Study||1
35595|NCT01879722|83474|P3|NOT COMPLETED|Overall Study||0
35596|NCT01879722|83475|P2|NOT COMPLETED|Overall Study||1
35597|NCT01879722|83476|P1|NOT COMPLETED|Overall Study||0
35598|NCT01879722|83467|P10|COMPLETED|Overall Study||6
35599|NCT01879722|83468|P9|COMPLETED|Overall Study||6
35600|NCT01879722|83469|P8|COMPLETED|Overall Study||7
35601|NCT01879722|83470|P7|COMPLETED|Overall Study||8
35602|NCT01879722|83471|P6|COMPLETED|Overall Study||9
35603|NCT01879722|83472|P5|COMPLETED|Overall Study||7
35604|NCT01879722|83473|P4|COMPLETED|Overall Study||7
35605|NCT01879722|83474|P3|COMPLETED|Overall Study||7
35606|NCT01879722|83475|P2|COMPLETED|Overall Study||7
35607|NCT01879722|83476|P1|COMPLETED|Overall Study||7
35608|NCT01879722|83467|P10|STARTED|Overall Study||6
35609|NCT01879722|83468|P9|STARTED|Overall Study||8
35610|NCT01879722|83469|P8|STARTED|Overall Study||8
35611|NCT01879722|83470|P7|STARTED|Overall Study||8
35612|NCT01879722|83471|P6|STARTED|Overall Study||9
35613|NCT01879722|83472|P5|STARTED|Overall Study||8
35614|NCT01879722|83473|P4|STARTED|Overall Study||8
35615|NCT01879722|83474|P3|STARTED|Overall Study||7
35616|NCT01879722|83475|P2|STARTED|Overall Study||8
35617|NCT01879722|83476|P1|STARTED|Overall Study||7
35618|NCT01879683|83624|P1|NOT COMPLETED|Overall Study||1
35619|NCT01879683|83624|P1|COMPLETED|Overall Study||9
35620|NCT01879683|83624|P1|STARTED|Overall Study||10
35621|NCT01879618|83631|P1|NOT COMPLETED|Overall Study||21
35622|NCT01879618|83631|P1|COMPLETED|Overall Study||131
35623|NCT01879618|83631|P1|STARTED|Overall Study||152
35624|NCT01879579|83638|P2|NOT COMPLETED|Overall Study||2
35625|NCT01879579|83639|P1|NOT COMPLETED|Overall Study||5
35626|NCT01879579|83638|P2|COMPLETED|Overall Study||26
35627|NCT01879579|83639|P1|COMPLETED|Overall Study||28
35628|NCT01879579|83638|P2|STARTED|Overall Study||28
35629|NCT01879579|83639|P1|STARTED|Overall Study||33
35630|NCT01879553|83669|P2|NOT COMPLETED|Overall Study||0
35631|NCT01879553|83670|P1|NOT COMPLETED|Overall Study||1
35632|NCT01879553|83669|P2|COMPLETED|Overall Study||63
35633|NCT01879553|83670|P1|COMPLETED|Overall Study||62
35634|NCT01879553|83669|P2|STARTED|Overall Study||63
35635|NCT01879553|83670|P1|STARTED|Overall Study||63
35636|NCT01879540|83691|P1|NOT COMPLETED|Overall Study||0
35637|NCT01879540|83691|P1|COMPLETED|Overall Study||63
35638|NCT01879540|83691|P1|STARTED|Overall Study||63
35639|NCT01879410|83704|P2|NOT COMPLETED|Overall Study||38
35640|NCT01879410|83705|P1|NOT COMPLETED|Overall Study||24
35641|NCT01879410|83704|P2|COMPLETED|Overall Study||312
35642|NCT01879410|83705|P1|COMPLETED|Overall Study||326
35643|NCT01879410|83704|P2|Intent-to-Treat Population|Overall Study||348
35644|NCT01879410|83705|P1|Intent-to-Treat Population|Overall Study||349
35645|NCT01879410|83704|P2|STARTED|Overall Study||350
35646|NCT01879410|83705|P1|STARTED|Overall Study||350
35647|NCT01879371|83719|P6|NOT COMPLETED|Overall Study||0
35648|NCT01879371|83720|P5|NOT COMPLETED|Overall Study||0
35649|NCT01879371|83721|P4|NOT COMPLETED|Overall Study||0
35650|NCT01879371|83722|P3|NOT COMPLETED|Overall Study||0
35651|NCT01879371|83723|P2|NOT COMPLETED|Overall Study||0
35652|NCT01879371|83724|P1|NOT COMPLETED|Overall Study||0
35653|NCT01879371|83719|P6|COMPLETED|Overall Study||6
35654|NCT01879371|83720|P5|COMPLETED|Overall Study||6
35655|NCT01879371|83721|P4|COMPLETED|Overall Study||6
35656|NCT01879371|83722|P3|COMPLETED|Overall Study||6
35657|NCT01879371|83723|P2|COMPLETED|Overall Study||6
35658|NCT01879371|83724|P1|COMPLETED|Overall Study||6
35659|NCT01879371|83719|P6|STARTED|Overall Study||6
35660|NCT01879371|83720|P5|STARTED|Overall Study||6
35661|NCT01879371|83721|P4|STARTED|Overall Study||6
35662|NCT01879371|83722|P3|STARTED|Overall Study||6
35663|NCT01879371|83723|P2|STARTED|Overall Study||6
35664|NCT01879371|83724|P1|STARTED|Overall Study||6
35665|NCT01879345|83741|P3|NOT COMPLETED|7-day Multiple-dose Period||0
35666|NCT01879345|83742|P2|NOT COMPLETED|7-day Multiple-dose Period||0
35667|NCT01879345|83743|P1|NOT COMPLETED|7-day Multiple-dose Period||0
35668|NCT01879345|83741|P3|COMPLETED|7-day Multiple-dose Period||6
35669|NCT01879345|83742|P2|COMPLETED|7-day Multiple-dose Period||6
35670|NCT01879345|83743|P1|COMPLETED|7-day Multiple-dose Period||6
35671|NCT01879345|83741|P3|STARTED|7-day Multiple-dose Period||6
35672|NCT01879345|83742|P2|STARTED|7-day Multiple-dose Period||6
35673|NCT01879345|83743|P1|STARTED|7-day Multiple-dose Period||6
35674|NCT01879345|83741|P3|NOT COMPLETED|Single-dose Period||0
35675|NCT01879345|83742|P2|NOT COMPLETED|Single-dose Period||0
35676|NCT01879345|83743|P1|NOT COMPLETED|Single-dose Period||0
35677|NCT01879345|83741|P3|COMPLETED|Single-dose Period||6
35678|NCT01879345|83742|P2|COMPLETED|Single-dose Period||6
35679|NCT01879345|83743|P1|COMPLETED|Single-dose Period||6
35680|NCT01879345|83741|P3|STARTED|Single-dose Period||6
35681|NCT01879345|83742|P2|STARTED|Single-dose Period||6
35682|NCT01879345|83743|P1|STARTED|Single-dose Period||6
35683|NCT01879332|83760|P3|NOT COMPLETED|Overall Study||4
35684|NCT01879332|83761|P2|NOT COMPLETED|Overall Study||6
35685|NCT01879332|83762|P1|NOT COMPLETED|Overall Study||6
35686|NCT01879332|83760|P3|COMPLETED|Overall Study||0
35687|NCT01879332|83761|P2|COMPLETED|Overall Study||0
35688|NCT01879332|83762|P1|COMPLETED|Overall Study||0
35689|NCT01879332|83760|P3|STARTED|Overall Study||4
35690|NCT01879332|83761|P2|STARTED|Overall Study||6
35691|NCT01879332|83762|P1|STARTED|Overall Study||6
35692|NCT01879319|83772|P2|NOT COMPLETED|Overall Study||5
35693|NCT01879319|83773|P1|NOT COMPLETED|Overall Study||2
35694|NCT01879319|83772|P2|COMPLETED|Overall Study||77
35695|NCT01879319|83773|P1|COMPLETED|Overall Study||80
35696|NCT01879319|83772|P2|Received Treatment|Overall Study||82
35697|NCT01879319|83773|P1|Received Treatment|Overall Study||82
35698|NCT01879319|83772|P2|STARTED|Overall Study||82
35699|NCT01879319|83773|P1|STARTED|Overall Study||82
35700|NCT01879176|83783|P2|NOT COMPLETED|Overall Study||6
35701|NCT01879176|83784|P1|NOT COMPLETED|Overall Study||8
35702|NCT01879176|83783|P2|COMPLETED|Overall Study||16
35703|NCT01879176|83784|P1|COMPLETED|Overall Study||16
35704|NCT01879176|83783|P2|STARTED|Overall Study||22
35705|NCT01879176|83784|P1|STARTED|Overall Study||24
35706|NCT01879059|83790|P1|NOT COMPLETED|Overall Study||0
35707|NCT01879059|83790|P1|COMPLETED|Overall Study||13
35708|NCT01879059|83790|P1|STARTED|Overall Study||13
35709|NCT01878825|83796|P2|NOT COMPLETED|Overall Study||0
35710|NCT01878825|83797|P1|NOT COMPLETED|Overall Study||0
35711|NCT01878825|83796|P2|COMPLETED|Overall Study||60
35712|NCT01878825|83797|P1|COMPLETED|Overall Study||60
35713|NCT01878825|83796|P2|STARTED|Overall Study||60
35714|NCT01878825|83797|P1|STARTED|Overall Study||60
35715|NCT01878812|83835|P2|NOT COMPLETED|Overall Study||0
35716|NCT01878812|83836|P1|NOT COMPLETED|Overall Study||0
35717|NCT01878812|83835|P2|COMPLETED|Overall Study||57
35718|NCT01878812|83836|P1|COMPLETED|Overall Study||60
35719|NCT01878812|83835|P2|STARTED|Overall Study||57
35720|NCT01878812|83836|P1|STARTED|Overall Study||60
35721|NCT01878799|83872|P2|NOT COMPLETED|Overall Study||0
35722|NCT01878799|83873|P1|NOT COMPLETED|Overall Study||1
35723|NCT01878799|83872|P2|COMPLETED|Overall Study||13
35724|NCT01878799|83873|P1|COMPLETED|Overall Study||36
35725|NCT01878799|83872|P2|STARTED|Overall Study||13
35726|NCT01878799|83873|P1|STARTED|Overall Study||37
35727|NCT01878656|83881|P2|NOT COMPLETED|Overall Study||0
35728|NCT01878656|83882|P1|NOT COMPLETED|Overall Study||0
35729|NCT01878656|83881|P2|COMPLETED|Overall Study||72
35730|NCT01878656|83882|P1|COMPLETED|Overall Study||72
35731|NCT01878656|83881|P2|STARTED|Overall Study||72
35732|NCT01878656|83882|P1|STARTED|Overall Study||72
35733|NCT01878604|83888|P1|NOT COMPLETED|Overall Study||0
35734|NCT01878604|83888|P1|COMPLETED|Overall Study||5
35735|NCT01878604|83888|P1|STARTED|Overall Study||5
35736|NCT01878526|83895|P2|NOT COMPLETED|Overall Study||2
35737|NCT01878526|83896|P1|NOT COMPLETED|Overall Study||3
35738|NCT01878526|83895|P2|COMPLETED|Overall Study||38
35739|NCT01878526|83896|P1|COMPLETED|Overall Study||37
35740|NCT01878526|83895|P2|STARTED|Overall Study||40
35741|NCT01878526|83896|P1|STARTED|Overall Study||40
35742|NCT01878214|83911|P2|NOT COMPLETED|Overall Study||44
35743|NCT01878214|83912|P1|NOT COMPLETED|Overall Study||53
35744|NCT01878214|83911|P2|COMPLETED|Overall Study||175
35745|NCT01878214|83912|P1|COMPLETED|Overall Study||170
35746|NCT01878214|83911|P2|STARTED|Overall Study||219
35747|NCT01878214|83912|P1|STARTED|Overall Study||223
35748|NCT01878175|83926|P1|NOT COMPLETED|Overall Study||2
35749|NCT01878175|83926|P1|COMPLETED|Overall Study||13
35750|NCT01878175|83926|P1|STARTED|Overall Study||15
35751|NCT01878149|83945|P2|NOT COMPLETED|Overall Study||2
35752|NCT01878149|83946|P1|NOT COMPLETED|Overall Study||2
35753|NCT01878149|83945|P2|COMPLETED|Overall Study||15
35754|NCT01878149|83946|P1|COMPLETED|Overall Study||19
35755|NCT01878149|83945|P2|STARTED|Overall Study||17
35756|NCT01878149|83946|P1|STARTED|Overall Study||21
35757|NCT01878097|83954|P2|NOT COMPLETED|Implementation Year 5||3007
35758|NCT01878097|83955|P1|NOT COMPLETED|Implementation Year 5||3604
35759|NCT01878097|83954|P2|COMPLETED|Implementation Year 5||6607
35760|NCT01878097|83955|P1|COMPLETED|Implementation Year 5||6981
35761|NCT01878097|83954|P2|STARTED|Implementation Year 5||9614
35762|NCT01878097|83955|P1|STARTED|Implementation Year 5||10585
35763|NCT01878097|83954|P2|NOT COMPLETED|Implementation Year 3||2980
35764|NCT01878097|83955|P1|NOT COMPLETED|Implementation Year 3||3494
35765|NCT01878097|83954|P2|COMPLETED|Implementation Year 3||6770
35766|NCT01878097|83955|P1|COMPLETED|Implementation Year 3||7046
35767|NCT01878097|83954|P2|STARTED|Implementation Year 3||9750
35768|NCT01878097|83955|P1|STARTED|Implementation Year 3||10540
35769|NCT01878097|83954|P2|NOT COMPLETED|Implementation Year 2||2841
35770|NCT01878097|83955|P1|NOT COMPLETED|Implementation Year 2||3281
35771|NCT01878097|83954|P2|COMPLETED|Implementation Year 2||6770
35772|NCT01878097|83955|P1|COMPLETED|Implementation Year 2||8286
35773|NCT01878097|83954|P2|STARTED|Implementation Year 2||9611
35774|NCT01878097|83955|P1|STARTED|Implementation Year 2||11567
35775|NCT01878097|83954|P2|NOT COMPLETED|Implementation Year 1||2549
35776|NCT01878097|83955|P1|NOT COMPLETED|Implementation Year 1||3202
35777|NCT01878097|83954|P2|COMPLETED|Implementation Year 1||7317
35778|NCT01878097|83955|P1|COMPLETED|Implementation Year 1||8540
35779|NCT01878097|83954|P2|STARTED|Implementation Year 1||9866
35780|NCT01878097|83955|P1|STARTED|Implementation Year 1||11742
35781|NCT01878097|83954|P2|NOT COMPLETED|Baseline||1800
35782|NCT01878097|83955|P1|NOT COMPLETED|Baseline||2497
35783|NCT01878097|83954|P2|COMPLETED|Baseline|Anonymous surveys; sum of all completed surveys.|8281
35784|NCT01878097|83955|P1|COMPLETED|Baseline|Anonymous surveys so only last year data provided as annual completed.|8228
35785|NCT01878097|83954|P2|STARTED|Baseline|number of students in 13 control schools completing anonymous surveys with non missing data|10081
35786|NCT01878097|83955|P1|STARTED|Baseline|number of students in 13 intervention schools completing anonymous surveys with non missing data|10725
35787|NCT01877941|83965|P1|NOT COMPLETED|Overall Study||0
35788|NCT01877941|83965|P1|COMPLETED|Overall Study||39
35789|NCT01877941|83965|P1|STARTED|Overall Study||39
35790|NCT01877720|83971|P2|NOT COMPLETED|Overall Study||0
35791|NCT01877720|83972|P1|NOT COMPLETED|Overall Study||1
35792|NCT01877720|83971|P2|COMPLETED|Overall Study||8
35793|NCT01877720|83972|P1|COMPLETED|Overall Study||7
35794|NCT01877720|83971|P2|2nd Intervention|Overall Study||8
35795|NCT01877720|83972|P1|2nd Intervention|Overall Study||7
35796|NCT01877720|83971|P2|1st Intervention|Overall Study||8
35797|NCT01877720|83972|P1|1st Intervention|Overall Study||7
35798|NCT01877720|83971|P2|STARTED|Overall Study||8
35799|NCT01877720|83972|P1|STARTED|Overall Study||8
35800|NCT01877668|84001|P5|NOT COMPLETED|Overall Study||10
35801|NCT01877668|84002|P4|NOT COMPLETED|Overall Study||8
35802|NCT01877668|84003|P3|NOT COMPLETED|Overall Study||12
35803|NCT01877668|84004|P2|NOT COMPLETED|Overall Study||8
35804|NCT01877668|84005|P1|NOT COMPLETED|Overall Study||11
35805|NCT01877668|84001|P5|COMPLETED|Overall Study||43
35806|NCT01877668|84002|P4|COMPLETED|Overall Study||44
35807|NCT01877668|84003|P3|COMPLETED|Overall Study||94
35808|NCT01877668|84004|P2|COMPLETED|Overall Study||96
35809|NCT01877668|84005|P1|COMPLETED|Overall Study||96
35810|NCT01877668|84001|P5|STARTED|Overall Study|Received treatment|53
35811|NCT01877668|84002|P4|STARTED|Overall Study|Received treatment|52
35812|NCT01877668|84003|P3|STARTED|Overall Study|Received treatment|106
35813|NCT01877668|84004|P2|STARTED|Overall Study|Received treatment|104
35814|NCT01877668|84005|P1|STARTED|Overall Study|Received treatment|107
35815|NCT01877538|84234|P1|NOT COMPLETED|Overall Study||0
35816|NCT01877538|84234|P1|COMPLETED|Overall Study||7
35817|NCT01877538|84234|P1|STARTED|Overall Study||7
35818|NCT01877408|84241|P2|NOT COMPLETED|Overall Study||2
35819|NCT01877408|84242|P1|NOT COMPLETED|Overall Study||0
35912|NCT01876784|84402|P2|NOT COMPLETED|Overall Study||119
35820|NCT01877408|84241|P2|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|98
35821|NCT01877408|84242|P1|COMPLETED|Overall Study|Completed follow up visit 28 days after procedure|50
35822|NCT01877408|84241|P2|STARTED|Overall Study||100
35823|NCT01877408|84242|P1|STARTED|Overall Study||50
35824|NCT01876368|84261|P2|NOT COMPLETED|Overall Study||13
35825|NCT01876368|84262|P1|NOT COMPLETED|Overall Study||9
35826|NCT01876368|84261|P2|COMPLETED|Overall Study||175
35827|NCT01876368|84262|P1|COMPLETED|Overall Study||179
35828|NCT01876368|84261|P2|Safety Set (SAF)|Overall Study||187
35829|NCT01876368|84262|P1|Safety Set (SAF)|Overall Study||188
35830|NCT01876368|84261|P2|Full Analysis Set (FAS)|Overall Study|One patient was not included in the SAF and FAS due to mis-randomization.|187
35831|NCT01876368|84262|P1|Full Analysis Set (FAS)|Overall Study||188
35832|NCT01876368|84261|P2|STARTED|Overall Study||188
35833|NCT01876368|84262|P1|STARTED|Overall Study||188
35834|NCT01876329|84291|P3|NOT COMPLETED|Overall Study||0
35835|NCT01876329|84292|P2|NOT COMPLETED|Overall Study||0
35836|NCT01876329|84293|P1|NOT COMPLETED|Overall Study||0
35837|NCT01876329|84291|P3|COMPLETED|Overall Study||44
35838|NCT01876329|84292|P2|COMPLETED|Overall Study||36
35839|NCT01876329|84293|P1|COMPLETED|Overall Study||45
35840|NCT01876329|84291|P3|STARTED|Overall Study||44
35841|NCT01876329|84292|P2|STARTED|Overall Study||36
35842|NCT01876329|84293|P1|STARTED|Overall Study||45
35843|NCT01877343|84307|P7|NOT COMPLETED|Overall Study||0
35844|NCT01877343|84308|P6|NOT COMPLETED|Overall Study||0
35845|NCT01877343|84309|P5|NOT COMPLETED|Overall Study||0
35846|NCT01877343|84310|P4|NOT COMPLETED|Overall Study||0
35847|NCT01877343|84311|P3|NOT COMPLETED|Overall Study||0
35848|NCT01877343|84312|P2|NOT COMPLETED|Overall Study||0
35849|NCT01877343|84313|P1|NOT COMPLETED|Overall Study||0
35850|NCT01877343|84307|P7|COMPLETED|Overall Study||0
35851|NCT01877343|84308|P6|COMPLETED|Overall Study||5
35852|NCT01877343|84309|P5|COMPLETED|Overall Study||0
35853|NCT01877343|84310|P4|COMPLETED|Overall Study||0
35854|NCT01877343|84311|P3|COMPLETED|Overall Study||0
35855|NCT01877343|84312|P2|COMPLETED|Overall Study||3
35856|NCT01877343|84313|P1|COMPLETED|Overall Study||2
35857|NCT01877343|84307|P7|STARTED|Overall Study||0
35858|NCT01877343|84308|P6|STARTED|Overall Study||5
35859|NCT01877343|84309|P5|STARTED|Overall Study||0
35860|NCT01877343|84310|P4|STARTED|Overall Study||0
35861|NCT01877343|84311|P3|STARTED|Overall Study||0
35862|NCT01877343|84312|P2|STARTED|Overall Study||3
35863|NCT01877343|84313|P1|STARTED|Overall Study||2
35864|NCT01877278|84320|P2|NOT COMPLETED|Overall Study||3
35865|NCT01877278|84321|P1|NOT COMPLETED|Overall Study||3
35866|NCT01877278|84320|P2|COMPLETED|Overall Study||30
35867|NCT01877278|84321|P1|COMPLETED|Overall Study||30
35868|NCT01877278|84320|P2|STARTED|Overall Study||33
35869|NCT01877278|84321|P1|STARTED|Overall Study||33
35870|NCT01877161|84329|P1|NOT COMPLETED|Third Session of Stimulation||0
35871|NCT01877161|84329|P1|COMPLETED|Third Session of Stimulation||12
35872|NCT01877161|84329|P1|STARTED|Third Session of Stimulation||12
35873|NCT01877161|84329|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
35874|NCT01877161|84329|P1|COMPLETED|Washout (at Least 3 Days)||12
35875|NCT01877161|84329|P1|STARTED|Washout (at Least 3 Days)||12
35876|NCT01877161|84329|P1|NOT COMPLETED|Second Session of Stimulation||0
35877|NCT01877161|84329|P1|COMPLETED|Second Session of Stimulation||12
35878|NCT01877161|84329|P1|STARTED|Second Session of Stimulation||12
35879|NCT01877161|84329|P1|NOT COMPLETED|Washout (at Least 3 Days)||0
35880|NCT01877161|84329|P1|COMPLETED|Washout (at Least 3 Days)||12
35881|NCT01877161|84329|P1|STARTED|Washout (at Least 3 Days)||12
35882|NCT01877161|84329|P1|NOT COMPLETED|First Session of Stimulation||0
35883|NCT01877161|84329|P1|COMPLETED|First Session of Stimulation||12
35884|NCT01877161|84329|P1|STARTED|First Session of Stimulation||12
35885|NCT01877148|84339|P2|NOT COMPLETED|Overall Study||1
35886|NCT01877148|84340|P1|NOT COMPLETED|Overall Study||1
35887|NCT01877148|84339|P2|COMPLETED|Overall Study||5
35888|NCT01877148|84340|P1|COMPLETED|Overall Study||5
35889|NCT01877148|84339|P2|STARTED|Overall Study||6
35890|NCT01877148|84340|P1|STARTED|Overall Study||6
35891|NCT01876992|84354|P2|NOT COMPLETED|Overall Study||0
35892|NCT01876992|84355|P1|NOT COMPLETED|Overall Study||0
35893|NCT01876992|84354|P2|COMPLETED|Overall Study||5
35894|NCT01876992|84355|P1|COMPLETED|Overall Study||5
35895|NCT01876992|84354|P2|STARTED|Overall Study||5
35896|NCT01876992|84355|P1|STARTED|Overall Study||5
35897|NCT01876979|84369|P2|NOT COMPLETED|Overall Study||3
35898|NCT01876979|84370|P1|NOT COMPLETED|Overall Study||2
35899|NCT01876979|84369|P2|COMPLETED|Overall Study||0
35900|NCT01876979|84370|P1|COMPLETED|Overall Study||0
35901|NCT01876979|84369|P2|STARTED|Overall Study||3
35902|NCT01876979|84370|P1|STARTED|Overall Study||2
35903|NCT01876823|84376|P1|NOT COMPLETED|Overall Study||9
35904|NCT01876823|84376|P1|COMPLETED|Overall Study||26
35905|NCT01876823|84376|P1|STARTED|Overall Study||35
35906|NCT01876810|84389|P2|NOT COMPLETED|Overall Study||1
35907|NCT01876810|84390|P1|NOT COMPLETED|Overall Study||0
35908|NCT01876810|84389|P2|COMPLETED|Overall Study||13
35909|NCT01876810|84390|P1|COMPLETED|Overall Study||14
35910|NCT01876810|84389|P2|STARTED|Overall Study||14
35911|NCT01876810|84390|P1|STARTED|Overall Study||14
35913|NCT01876784|84403|P1|NOT COMPLETED|Overall Study||119
35914|NCT01876784|84402|P2|COMPLETED|Overall Study||0
35915|NCT01876784|84403|P1|COMPLETED|Overall Study||0
35916|NCT01876784|84402|P2|Treated|Overall Study||118
35917|NCT01876784|84403|P1|Treated|Overall Study||117
35918|NCT01876784|84402|P2|STARTED|Overall Study||119
35919|NCT01876784|84403|P1|STARTED|Overall Study||119
35920|NCT01876732|84409|P1|NOT COMPLETED|Overall Study||75
35921|NCT01876732|84409|P1|COMPLETED|Overall Study||57
35922|NCT01876732|84409|P1|STARTED|Overall Study||132
35923|NCT01876706|84414|P1|NOT COMPLETED|Overall Study||4
35924|NCT01876706|84414|P1|COMPLETED|Overall Study||47
35925|NCT01876706|84414|P1|12 Months|Overall Study||41
35926|NCT01876706|84414|P1|1 Month|Overall Study||51
35927|NCT01876706|84414|P1|STARTED|Overall Study||51
35928|NCT01875991|84433|P2|NOT COMPLETED|Overall Study||6
35929|NCT01875991|84434|P1|NOT COMPLETED|Overall Study||7
35930|NCT01875991|84433|P2|COMPLETED|Overall Study||103
35931|NCT01875991|84434|P1|COMPLETED|Overall Study||101
35932|NCT01875991|84433|P2|Received Etanercept in Period 2|Overall Study||103
35933|NCT01875991|84434|P1|Received Etanercept in Period 2|Overall Study||102
35934|NCT01875991|84433|P2|Received Etanercept in Period 1|Overall Study||108
35935|NCT01875991|84434|P1|Received Etanercept in Period 1|Overall Study||108
35936|NCT01875991|84433|P2|STARTED|Overall Study||109
35937|NCT01875991|84434|P1|STARTED|Overall Study||108
35938|NCT01875978|84457|P2|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
35939|NCT01875978|84458|P1|NOT COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||0
35940|NCT01875978|84457|P2|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
35941|NCT01875978|84458|P1|COMPLETED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
35942|NCT01875978|84457|P2|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
35943|NCT01875978|84458|P1|STARTED|Washout 2 Weeks ,Crossover Study 4 Weeks||20
35944|NCT01875978|84457|P2|NOT COMPLETED|Study 4weeks||0
35945|NCT01875978|84458|P1|NOT COMPLETED|Study 4weeks||0
35946|NCT01875978|84457|P2|COMPLETED|Study 4weeks||20
35947|NCT01875978|84458|P1|COMPLETED|Study 4weeks||20
35948|NCT01875978|84457|P2|STARTED|Study 4weeks||20
35949|NCT01875978|84458|P1|STARTED|Study 4weeks||20
35950|NCT01875848|84472|P2|NOT COMPLETED|Overall Study||0
35951|NCT01875848|84473|P1|NOT COMPLETED|Overall Study||2
35952|NCT01875848|84472|P2|COMPLETED|Overall Study|4 patients completed the opioid dose escalation arm of the study|4
35953|NCT01875848|84473|P1|COMPLETED|Overall Study|1 patient completed the Buprenorphine arm of the study. 2 patients withdrew|1
35954|NCT01875848|84472|P2|STARTED|Overall Study|4 patients were enrolled in the opioid dose escalation arm of the study|4
35955|NCT01875848|84473|P1|STARTED|Overall Study|3 patients were enrolled in the Buprenorphine arm of the study|3
35956|NCT01875731|84483|P2|NOT COMPLETED|Overall Study||0
35957|NCT01875731|84484|P1|NOT COMPLETED|Overall Study||1
35958|NCT01875731|84483|P2|COMPLETED|Overall Study||32
35959|NCT01875731|84484|P1|COMPLETED|Overall Study||33
35960|NCT01875731|84483|P2|STARTED|Overall Study||32
35961|NCT01875731|84484|P1|STARTED|Overall Study||34
35962|NCT01875510|84494|P2|NOT COMPLETED|Overall Study||0
35963|NCT01875510|84495|P1|NOT COMPLETED|Overall Study||0
35964|NCT01875510|84494|P2|COMPLETED|Overall Study||40
35965|NCT01875510|84495|P1|COMPLETED|Overall Study||40
35966|NCT01875510|84494|P2|STARTED|Overall Study||40
35967|NCT01875510|84495|P1|STARTED|Overall Study||40
35968|NCT01875471|84503|P2|NOT COMPLETED|Overall Study||1
35969|NCT01875471|84504|P1|NOT COMPLETED|Overall Study||1
35970|NCT01875471|84503|P2|COMPLETED|Overall Study||137
35971|NCT01875471|84504|P1|COMPLETED|Overall Study||136
35972|NCT01875471|84503|P2|Completed Per Protocol|Overall Study||123
35973|NCT01875471|84504|P1|Completed Per Protocol|Overall Study||127
35974|NCT01875471|84503|P2|STARTED|Overall Study||138
35975|NCT01875471|84504|P1|STARTED|Overall Study||137
35976|NCT01875445|84512|P2|NOT COMPLETED|Overall Study||0
35977|NCT01875445|84513|P1|NOT COMPLETED|Overall Study||7
35978|NCT01875445|84512|P2|COMPLETED|Overall Study||19
35979|NCT01875445|84513|P1|COMPLETED|Overall Study||12
35980|NCT01875445|84512|P2|STARTED|Overall Study||19
35981|NCT01875445|84513|P1|STARTED|Overall Study||19
35982|NCT01875159|84523|P2|NOT COMPLETED|Overall Study||0
35983|NCT01875159|84524|P1|NOT COMPLETED|Overall Study||3
35984|NCT01875159|84523|P2|COMPLETED|Overall Study||53
35985|NCT01875159|84524|P1|COMPLETED|Overall Study||42
35986|NCT01875159|84523|P2|STARTED|Overall Study||53
35987|NCT01875159|84524|P1|STARTED|Overall Study||45
35988|NCT01874951|84534|P2|NOT COMPLETED|Overall Study||0
35989|NCT01874951|84535|P1|NOT COMPLETED|Overall Study||0
35990|NCT01874951|84534|P2|COMPLETED|Overall Study||6
35991|NCT01874951|84535|P1|COMPLETED|Overall Study||6
35992|NCT01874951|84534|P2|STARTED|Overall Study||6
35993|NCT01874951|84535|P1|STARTED|Overall Study||6
35994|NCT01874665|84557|P2|NOT COMPLETED|Overall Study||2
35995|NCT01874665|84558|P1|NOT COMPLETED|Overall Study||4
35996|NCT01874665|84557|P2|COMPLETED|Overall Study|Completed = off treatment|13
35997|NCT01874665|84558|P1|COMPLETED|Overall Study|Completed = off treatment|26
35998|NCT01874665|84557|P2|STARTED|Overall Study||15
35999|NCT01874665|84558|P1|STARTED|Overall Study||30
36000|NCT01874340|84567|P4|NOT COMPLETED|Overall Study||5
36001|NCT01874340|84568|P3|NOT COMPLETED|Overall Study||8
36002|NCT01874340|84569|P2|NOT COMPLETED|Overall Study||8
36003|NCT01874340|84570|P1|NOT COMPLETED|Overall Study||6
36004|NCT01874340|84567|P4|COMPLETED|Overall Study||1
36005|NCT01874340|84568|P3|COMPLETED|Overall Study||0
36006|NCT01874340|84569|P2|COMPLETED|Overall Study||0
36007|NCT01874340|84570|P1|COMPLETED|Overall Study||0
36008|NCT01874340|84567|P4|STARTED|Overall Study||6
36009|NCT01874340|84568|P3|STARTED|Overall Study||8
36010|NCT01874340|84569|P2|STARTED|Overall Study||8
36011|NCT01874340|84570|P1|STARTED|Overall Study||6
36012|NCT01874275|84598|P2|NOT COMPLETED|Overall Study||0
36013|NCT01874275|84599|P1|NOT COMPLETED|Overall Study||1
36014|NCT01874275|84598|P2|COMPLETED|Overall Study||2
36015|NCT01874275|84599|P1|COMPLETED|Overall Study||3
36016|NCT01874275|84598|P2|STARTED|Overall Study||2
36017|NCT01874275|84599|P1|STARTED|Overall Study||4
36018|NCT01874262|84613|P2|NOT COMPLETED|Overall Study||3
36019|NCT01874262|84614|P1|NOT COMPLETED|Overall Study||5
36020|NCT01874262|84613|P2|COMPLETED|Overall Study||80
36021|NCT01874262|84614|P1|COMPLETED|Overall Study||86
36022|NCT01874262|84613|P2|Not Included Due to Tehnical Issues|Overall Study||3
36023|NCT01874262|84614|P1|Not Included Due to Tehnical Issues|Overall Study||3
36024|NCT01874262|84613|P2|Not Correctly Randomised|Overall Study||0
36025|NCT01874262|84614|P1|Not Correctly Randomised|Overall Study||2
36026|NCT01874262|84613|P2|STARTED|Overall Study||83
36027|NCT01874262|84614|P1|STARTED|Overall Study||91
36028|NCT01874145|84622|P2|NOT COMPLETED|Extension Period||4
36029|NCT01874145|84623|P1|NOT COMPLETED|Extension Period||6
36030|NCT01874145|84622|P2|COMPLETED|Extension Period||97
36031|NCT01874145|84623|P1|COMPLETED|Extension Period||91
36032|NCT01874145|84622|P2|Full Analysis Set|Extension Period||101
36033|NCT01874145|84623|P1|Full Analysis Set|Extension Period||95
36034|NCT01874145|84622|P2|STARTED|Extension Period|Non-Switchers|101
36035|NCT01874145|84623|P1|STARTED|Extension Period|Switchers|97
36036|NCT01874145|84622|P2|NOT COMPLETED|Core Period||7
36037|NCT01874145|84623|P1|NOT COMPLETED|Core Period||3
36038|NCT01874145|84622|P2|COMPLETED|Core Period||101
36039|NCT01874145|84623|P1|COMPLETED|Core Period||98
36040|NCT01874145|84622|P2|Full Analysis Set|Core Period||108
36041|NCT01874145|84623|P1|Full Analysis Set|Core Period||100
36042|NCT01874145|84622|P2|STARTED|Core Period||108
36043|NCT01874145|84623|P1|STARTED|Core Period||101
36044|NCT01874132|84662|P3|NOT COMPLETED|Overall Study||3
36045|NCT01874132|84663|P2|NOT COMPLETED|Overall Study||4
36046|NCT01874132|84664|P1|NOT COMPLETED|Overall Study||4
36047|NCT01874132|84662|P3|COMPLETED|Overall Study||19
36048|NCT01874132|84663|P2|COMPLETED|Overall Study||18
36049|NCT01874132|84664|P1|COMPLETED|Overall Study||18
36050|NCT01874132|84662|P3|STARTED|Overall Study||22
36051|NCT01874132|84663|P2|STARTED|Overall Study||22
36052|NCT01874132|84664|P1|STARTED|Overall Study||22
36053|NCT01874054|84675|P1|NOT COMPLETED|Follow-up Period||49
36054|NCT01874054|84675|P1|COMPLETED|Follow-up Period||2
36055|NCT01874054|84675|P1|STARTED|Follow-up Period|4 patients withdrew consent and did not enter the follow-up period.|51
36056|NCT01874054|84675|P1|NOT COMPLETED|Treatment Period||38
36057|NCT01874054|84675|P1|COMPLETED|Treatment Period||17
36058|NCT01874054|84675|P1|STARTED|Treatment Period||55
36059|NCT01873989|84686|P2|NOT COMPLETED|Overall Study||1
36060|NCT01873989|84687|P1|NOT COMPLETED|Overall Study||1
36061|NCT01873989|84686|P2|COMPLETED|Overall Study||6
36062|NCT01873989|84687|P1|COMPLETED|Overall Study||7
36063|NCT01873989|84686|P2|STARTED|Overall Study||7
36064|NCT01873989|84687|P1|STARTED|Overall Study||8
36065|NCT01873950|84697|P5|NOT COMPLETED|Period 5||0
36066|NCT01873950|84698|P4|NOT COMPLETED|Period 5||1
36067|NCT01873950|84699|P3|NOT COMPLETED|Period 5||0
36068|NCT01873950|84700|P2|NOT COMPLETED|Period 5||0
36069|NCT01873950|84701|P1|NOT COMPLETED|Period 5||0
36070|NCT01873950|84697|P5|COMPLETED|Period 5||4
36071|NCT01873950|84698|P4|COMPLETED|Period 5||3
36072|NCT01873950|84699|P3|COMPLETED|Period 5||4
36073|NCT01873950|84700|P2|COMPLETED|Period 5||5
36074|NCT01873950|84701|P1|COMPLETED|Period 5||4
36075|NCT01873950|84697|P5|STARTED|Period 5||4
36076|NCT01873950|84698|P4|STARTED|Period 5||4
36077|NCT01873950|84699|P3|STARTED|Period 5||4
36078|NCT01873950|84700|P2|STARTED|Period 5||5
36079|NCT01873950|84701|P1|STARTED|Period 5||4
36080|NCT01873950|84697|P5|NOT COMPLETED|Period 4||0
36081|NCT01873950|84698|P4|NOT COMPLETED|Period 4||0
36082|NCT01873950|84699|P3|NOT COMPLETED|Period 4||0
36083|NCT01873950|84700|P2|NOT COMPLETED|Period 4||0
36084|NCT01873950|84701|P1|NOT COMPLETED|Period 4||0
36085|NCT01873950|84697|P5|COMPLETED|Period 4||5
36086|NCT01873950|84698|P4|COMPLETED|Period 4||4
36087|NCT01873950|84699|P3|COMPLETED|Period 4||4
36088|NCT01873950|84700|P2|COMPLETED|Period 4||5
36089|NCT01873950|84701|P1|COMPLETED|Period 4||4
36090|NCT01873950|84697|P5|STARTED|Period 4||5
36091|NCT01873950|84698|P4|STARTED|Period 4||4
36092|NCT01873950|84699|P3|STARTED|Period 4||4
36093|NCT01873950|84700|P2|STARTED|Period 4||5
36094|NCT01873950|84701|P1|STARTED|Period 4||4
36095|NCT01873950|84697|P5|NOT COMPLETED|Period 3||0
36096|NCT01873950|84698|P4|NOT COMPLETED|Period 3||0
36097|NCT01873950|84699|P3|NOT COMPLETED|Period 3||0
36098|NCT01873950|84700|P2|NOT COMPLETED|Period 3||0
36099|NCT01873950|84701|P1|NOT COMPLETED|Period 3||0
36100|NCT01873950|84697|P5|COMPLETED|Period 3||4
36101|NCT01873950|84698|P4|COMPLETED|Period 3||5
36102|NCT01873950|84699|P3|COMPLETED|Period 3||5
36103|NCT01873950|84700|P2|COMPLETED|Period 3||4
36104|NCT01873950|84701|P1|COMPLETED|Period 3||4
36105|NCT01873950|84697|P5|STARTED|Period 3||4
36106|NCT01873950|84698|P4|STARTED|Period 3||5
36107|NCT01873950|84699|P3|STARTED|Period 3||5
36108|NCT01873950|84700|P2|STARTED|Period 3||4
36109|NCT01873950|84701|P1|STARTED|Period 3||4
36110|NCT01873950|84697|P5|NOT COMPLETED|Period 2||0
36111|NCT01873950|84698|P4|NOT COMPLETED|Period 2||0
36112|NCT01873950|84699|P3|NOT COMPLETED|Period 2||0
36113|NCT01873950|84700|P2|NOT COMPLETED|Period 2||0
36114|NCT01873950|84701|P1|NOT COMPLETED|Period 2||0
36115|NCT01873950|84697|P5|COMPLETED|Period 2||5
36116|NCT01873950|84698|P4|COMPLETED|Period 2||4
36117|NCT01873950|84699|P3|COMPLETED|Period 2||4
36118|NCT01873950|84700|P2|COMPLETED|Period 2||4
36119|NCT01873950|84701|P1|COMPLETED|Period 2||5
36120|NCT01873950|84697|P5|STARTED|Period 2||5
36121|NCT01873950|84698|P4|STARTED|Period 2||4
36122|NCT01873950|84699|P3|STARTED|Period 2||4
36123|NCT01873950|84700|P2|STARTED|Period 2||4
36124|NCT01873950|84701|P1|STARTED|Period 2||5
36125|NCT01873950|84697|P5|NOT COMPLETED|Period 1||0
36126|NCT01873950|84698|P4|NOT COMPLETED|Period 1||0
36127|NCT01873950|84699|P3|NOT COMPLETED|Period 1||0
36128|NCT01873950|84700|P2|NOT COMPLETED|Period 1||0
36129|NCT01873950|84701|P1|NOT COMPLETED|Period 1||0
36130|NCT01873950|84697|P5|COMPLETED|Period 1||4
36131|NCT01873950|84698|P4|COMPLETED|Period 1||4
36132|NCT01873950|84699|P3|COMPLETED|Period 1||5
36133|NCT01873950|84700|P2|COMPLETED|Period 1||4
36134|NCT01873950|84701|P1|COMPLETED|Period 1||5
36135|NCT01873950|84697|P5|STARTED|Period 1||4
36136|NCT01873950|84698|P4|STARTED|Period 1||4
36137|NCT01873950|84699|P3|STARTED|Period 1||5
36138|NCT01873950|84700|P2|STARTED|Period 1||4
36139|NCT01873950|84701|P1|STARTED|Period 1||5
36140|NCT01873859|84722|P2|NOT COMPLETED|Overall Study||4
36141|NCT01873859|84723|P1|NOT COMPLETED|Overall Study||0
36142|NCT01873859|84722|P2|COMPLETED|Overall Study||79
36143|NCT01873859|84723|P1|COMPLETED|Overall Study||83
36144|NCT01873859|84722|P2|STARTED|Overall Study||83
36145|NCT01873859|84723|P1|STARTED|Overall Study||83
36146|NCT01873729|84731|P1|NOT COMPLETED|Overall Study||1
36147|NCT01873729|84731|P1|COMPLETED|Overall Study||2
36148|NCT01873729|84731|P1|STARTED|Overall Study||3
36149|NCT01873417|84736|P1|NOT COMPLETED|Overall Study||35
36150|NCT01873417|84736|P1|COMPLETED|Overall Study||202
36151|NCT01873417|84736|P1|Safety Population|Overall Study|Participants who received at least 1 dose of dimethyl fumarate (DMF), recorded in diary data.|233
36152|NCT01873417|84736|P1|STARTED|Overall Study||237
36153|NCT01872819|84747|P1|NOT COMPLETED|Overall Study||2
36154|NCT01872819|84747|P1|COMPLETED|Overall Study||14
36155|NCT01872819|84747|P1|STARTED|Overall Study||16
36156|NCT01872715|84751|P1|NOT COMPLETED|Overall Study||4
36157|NCT01872715|84751|P1|COMPLETED|Overall Study||20
36158|NCT01872715|84751|P1|STARTED|Overall Study||24
36159|NCT01872611|84768|P2|NOT COMPLETED|Overall Study||12
36160|NCT01872611|84769|P1|NOT COMPLETED|Overall Study||24
36161|NCT01872611|84768|P2|COMPLETED|Overall Study||292
36162|NCT01872611|84769|P1|COMPLETED|Overall Study||277
36163|NCT01872611|84768|P2|Full Analysis Set|Overall Study||293
36164|NCT01872611|84769|P1|Full Analysis Set|Overall Study||289
36165|NCT01872611|84768|P2|Treated (Safety Analysis Set)|Overall Study||295
36166|NCT01872611|84769|P1|Treated (Safety Analysis Set)|Overall Study||293
36167|NCT01872611|84768|P2|Randomized|Overall Study||304
36168|NCT01872611|84769|P1|Randomized|Overall Study||301
36169|NCT01872611|84768|P2|STARTED|Overall Study||304
36170|NCT01872611|84769|P1|STARTED|Overall Study||301
36171|NCT01872078|84791|P4|NOT COMPLETED|Overall Study||2
36172|NCT01872078|84792|P3|NOT COMPLETED|Overall Study||3
36173|NCT01872078|84793|P2|NOT COMPLETED|Overall Study||0
36174|NCT01872078|84794|P1|NOT COMPLETED|Overall Study||0
36175|NCT01872078|84791|P4|COMPLETED|Overall Study||15
36176|NCT01872078|84792|P3|COMPLETED|Overall Study||14
36177|NCT01872078|84793|P2|COMPLETED|Overall Study||15
36178|NCT01872078|84794|P1|COMPLETED|Overall Study||16
36179|NCT01872078|84791|P4|STARTED|Overall Study||17
36180|NCT01872078|84792|P3|STARTED|Overall Study||17
36181|NCT01872078|84793|P2|STARTED|Overall Study||15
36182|NCT01872078|84794|P1|STARTED|Overall Study||16
36183|NCT01871870|84804|P1|NOT COMPLETED|Overall Study||9
36184|NCT01871870|84804|P1|COMPLETED|Overall Study||11
36185|NCT01871870|84804|P1|STARTED|Overall Study||20
36186|NCT01871805|84815|P6|NOT COMPLETED|Phase II||87
36187|NCT01871805|84816|P5|NOT COMPLETED|Phase II||0
36188|NCT01871805|84817|P4|NOT COMPLETED|Phase II||0
36189|NCT01871805|84818|P3|NOT COMPLETED|Phase II||0
36190|NCT01871805|84819|P2|NOT COMPLETED|Phase II||0
36191|NCT01871805|84820|P1|NOT COMPLETED|Phase II||0
36192|NCT01871805|84815|P6|COMPLETED|Phase II||0
36193|NCT01871805|84816|P5|COMPLETED|Phase II||0
36194|NCT01871805|84817|P4|COMPLETED|Phase II||0
36195|NCT01871805|84818|P3|COMPLETED|Phase II||0
36196|NCT01871805|84819|P2|COMPLETED|Phase II||0
36197|NCT01871805|84820|P1|COMPLETED|Phase II||0
36198|NCT01871805|84815|P6|STARTED|Phase II||87
36199|NCT01871805|84816|P5|STARTED|Phase II||0
36200|NCT01871805|84817|P4|STARTED|Phase II||0
36201|NCT01871805|84818|P3|STARTED|Phase II||0
36202|NCT01871805|84819|P2|STARTED|Phase II||0
36203|NCT01871805|84820|P1|STARTED|Phase II||0
36204|NCT01871805|84815|P6|NOT COMPLETED|Phase I||0
36205|NCT01871805|84816|P5|NOT COMPLETED|Phase I||13
36206|NCT01871805|84817|P4|NOT COMPLETED|Phase I||7
36207|NCT01871805|84818|P3|NOT COMPLETED|Phase I||13
36208|NCT01871805|84819|P2|NOT COMPLETED|Phase I||7
36209|NCT01871805|84820|P1|NOT COMPLETED|Phase I||7
36210|NCT01871805|84815|P6|COMPLETED|Phase I||0
36211|NCT01871805|84816|P5|COMPLETED|Phase I||0
36212|NCT01871805|84817|P4|COMPLETED|Phase I||0
36213|NCT01871805|84818|P3|COMPLETED|Phase I||0
36214|NCT01871805|84819|P2|COMPLETED|Phase I||0
36215|NCT01871805|84820|P1|COMPLETED|Phase I||0
36216|NCT01871805|84815|P6|STARTED|Phase I||0
36217|NCT01871805|84816|P5|STARTED|Phase I||13
36218|NCT01871805|84817|P4|STARTED|Phase I||7
36219|NCT01871805|84818|P3|STARTED|Phase I||13
36220|NCT01871805|84819|P2|STARTED|Phase I||7
36221|NCT01871805|84820|P1|STARTED|Phase I||7
36222|NCT01871558|84888|P2|NOT COMPLETED|Overall Study||2
36223|NCT01871558|84889|P1|NOT COMPLETED|Overall Study||3
36224|NCT01871558|84888|P2|COMPLETED|Overall Study||19
36225|NCT01871558|84889|P1|COMPLETED|Overall Study||18
36226|NCT01871558|84888|P2|STARTED|Overall Study||21
36227|NCT01871558|84889|P1|STARTED|Overall Study||21
36228|NCT01871532|84909|P2|NOT COMPLETED|Overall Study||2
36229|NCT01871532|84910|P1|NOT COMPLETED|Overall Study||1
36230|NCT01871532|84909|P2|COMPLETED|Overall Study||10
36231|NCT01871532|84910|P1|COMPLETED|Overall Study||11
36232|NCT01871532|84909|P2|Subjects Received hCG Treatment|Overall Study||9
36233|NCT01871532|84910|P1|Subjects Received hCG Treatment|Overall Study||11
36234|NCT01871532|84909|P2|STARTED|Overall Study||12
36235|NCT01871532|84910|P1|STARTED|Overall Study||12
36236|NCT01871519|84944|P1|NOT COMPLETED|Overall Study||90
36237|NCT01871519|84944|P1|COMPLETED|Overall Study||260
36238|NCT01871519|84944|P1|STARTED|Overall Study||350
36239|NCT01871402|84967|P2|NOT COMPLETED|Overall Study||3
36240|NCT01871402|84968|P1|NOT COMPLETED|Overall Study||1
36241|NCT01871402|84967|P2|COMPLETED|Overall Study||108
36242|NCT01871402|84968|P1|COMPLETED|Overall Study||109
36243|NCT01871402|84967|P2|STARTED|Overall Study||111
36244|NCT01871402|84968|P1|STARTED|Overall Study||110
36245|NCT01871285|84986|P4|NOT COMPLETED|Second Intervention (1 Day)||0
36246|NCT01871285|84987|P3|NOT COMPLETED|Second Intervention (1 Day)||0
36247|NCT01871285|84988|P2|NOT COMPLETED|Second Intervention (1 Day)||0
36248|NCT01871285|84989|P1|NOT COMPLETED|Second Intervention (1 Day)||0
36249|NCT01871285|84986|P4|COMPLETED|Second Intervention (1 Day)||2
36250|NCT01871285|84987|P3|COMPLETED|Second Intervention (1 Day)||3
36251|NCT01871285|84988|P2|COMPLETED|Second Intervention (1 Day)||14
36252|NCT01871285|84989|P1|COMPLETED|Second Intervention (1 Day)||17
36253|NCT01871285|84986|P4|STARTED|Second Intervention (1 Day)||2
36254|NCT01871285|84987|P3|STARTED|Second Intervention (1 Day)||3
36255|NCT01871285|84988|P2|STARTED|Second Intervention (1 Day)||14
36256|NCT01871285|84989|P1|STARTED|Second Intervention (1 Day)||17
36257|NCT01871285|84986|P4|NOT COMPLETED|First Intervention (1 Day)||0
36258|NCT01871285|84987|P3|NOT COMPLETED|First Intervention (1 Day)||1
36259|NCT01871285|84988|P2|NOT COMPLETED|First Intervention (1 Day)||1
36260|NCT01871285|84989|P1|NOT COMPLETED|First Intervention (1 Day)||1
36261|NCT01871285|84986|P4|COMPLETED|First Intervention (1 Day)||2
36262|NCT01871285|84987|P3|COMPLETED|First Intervention (1 Day)||3
36263|NCT01871285|84988|P2|COMPLETED|First Intervention (1 Day)||14
36264|NCT01871285|84989|P1|COMPLETED|First Intervention (1 Day)||17
36265|NCT01871285|84986|P4|STARTED|First Intervention (1 Day)||2
36266|NCT01871285|84987|P3|STARTED|First Intervention (1 Day)||4
36267|NCT01871285|84988|P2|STARTED|First Intervention (1 Day)||15
36268|NCT01871285|84989|P1|STARTED|First Intervention (1 Day)||18
36269|NCT01871142|85015|P1|NOT COMPLETED|Overall Study||1
36270|NCT01871142|85015|P1|COMPLETED|Overall Study||11
36271|NCT01871142|85015|P1|Received 3000mg Aes-103 + Hypoxia|Overall Study||12
36272|NCT01871142|85015|P1|Received 1000mg Aes 103+ Hypoxia|Overall Study||11
36273|NCT01871142|85015|P1|Received Placebo + Hypoxia|Overall Study||12
36274|NCT01871142|85015|P1|Received Placebo + Normoixa|Overall Study||11
36275|NCT01871142|85015|P1|STARTED|Overall Study||12
36276|NCT01871090|85031|P2|NOT COMPLETED|Overall Study||23
36277|NCT01871090|85032|P1|NOT COMPLETED|Overall Study||2
36278|NCT01871090|85031|P2|COMPLETED|Overall Study||25
36279|NCT01871090|85032|P1|COMPLETED|Overall Study||33
36280|NCT01871090|85031|P2|STARTED|Overall Study||48
36281|NCT01871090|85032|P1|STARTED|Overall Study||35
36282|NCT01870999|85045|P3|NOT COMPLETED|Overall Study||7
36283|NCT01870999|85046|P2|NOT COMPLETED|Overall Study||8
36284|NCT01870999|85047|P1|NOT COMPLETED|Overall Study||4
36285|NCT01870999|85045|P3|COMPLETED|Overall Study||4
36286|NCT01870999|85046|P2|COMPLETED|Overall Study||8
36287|NCT01870999|85047|P1|COMPLETED|Overall Study||10
36288|NCT01870999|85045|P3|Safety Population; Received Study Drug|Overall Study||10
36725|NCT01863771|85916|P3|STARTED|Maintenance Phase||31
36289|NCT01870999|85046|P2|Safety Population; Received Study Drug|Overall Study||15
36290|NCT01870999|85047|P1|Safety Population; Received Study Drug|Overall Study||14
36291|NCT01870999|85045|P3|STARTED|Overall Study||11
36292|NCT01870999|85046|P2|STARTED|Overall Study||16
36293|NCT01870999|85047|P1|STARTED|Overall Study||14
36294|NCT01870973|85105|P2|NOT COMPLETED|Overall Study||3
36295|NCT01870973|85106|P1|NOT COMPLETED|Overall Study||10
36296|NCT01870973|85105|P2|COMPLETED|Overall Study||49
36297|NCT01870973|85106|P1|COMPLETED|Overall Study||46
36298|NCT01870973|85105|P2|STARTED|Overall Study||52
36299|NCT01870973|85106|P1|STARTED|Overall Study||56
36300|NCT01870921|85112|P1|NOT COMPLETED|Overall Study||90
36301|NCT01870921|85112|P1|COMPLETED|Overall Study||1914
36302|NCT01870921|85112|P1|STARTED|Overall Study||2004
36303|NCT01870856|85120|P2|NOT COMPLETED|Overall Study||0
36304|NCT01870856|85121|P1|NOT COMPLETED|Overall Study||0
36305|NCT01870856|85120|P2|COMPLETED|Overall Study||27
36306|NCT01870856|85121|P1|COMPLETED|Overall Study||25
36307|NCT01870856|85120|P2|STARTED|Overall Study||27
36308|NCT01870856|85121|P1|STARTED|Overall Study||25
36309|NCT01870843|85131|P1|NOT COMPLETED|Overall Study||53
36310|NCT01870843|85131|P1|COMPLETED|Overall Study||208
36311|NCT01870843|85131|P1|STARTED|Overall Study||261
36312|NCT01870739|85146|P2|NOT COMPLETED|Add-on Period (40 Weeks)||2
36313|NCT01870739|85147|P1|NOT COMPLETED|Add-on Period (40 Weeks)||3
36314|NCT01870739|85146|P2|COMPLETED|Add-on Period (40 Weeks)||51
36315|NCT01870739|85147|P1|COMPLETED|Add-on Period (40 Weeks)||51
36316|NCT01870739|85146|P2|STARTED|Add-on Period (40 Weeks)||53
36317|NCT01870739|85147|P1|STARTED|Add-on Period (40 Weeks)||54
36318|NCT01870739|85146|P2|NOT COMPLETED|Single Drug Treatment (12 Weeks)||4
36319|NCT01870739|85147|P1|NOT COMPLETED|Single Drug Treatment (12 Weeks)||3
36320|NCT01870739|85146|P2|COMPLETED|Single Drug Treatment (12 Weeks)||53
36321|NCT01870739|85147|P1|COMPLETED|Single Drug Treatment (12 Weeks)|"Completed indicates maintenance dose complete"|54
36322|NCT01870739|85146|P2|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||56
36323|NCT01870739|85147|P1|Maintenance Dose Started|Single Drug Treatment (12 Weeks)||57
36324|NCT01870739|85146|P2|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||56
36325|NCT01870739|85147|P1|Initiation Dose Completed|Single Drug Treatment (12 Weeks)||57
36326|NCT01870739|85146|P2|STARTED|Single Drug Treatment (12 Weeks)||57
36327|NCT01870739|85147|P1|STARTED|Single Drug Treatment (12 Weeks)|"Start = Safety/Pharmacokinetic/Pharmacodynamic analysis set"|57
36328|NCT01870596|85181|P2|NOT COMPLETED|Overall Study||0
36329|NCT01870596|85182|P1|NOT COMPLETED|Overall Study||0
36330|NCT01870596|85181|P2|COMPLETED|Overall Study||18
36331|NCT01870596|85182|P1|COMPLETED|Overall Study||14
36332|NCT01870596|85181|P2|STARTED|Overall Study||18
36333|NCT01870596|85182|P1|STARTED|Overall Study||14
36334|NCT01870583|85191|P3|NOT COMPLETED|Overall Study||8
36335|NCT01870583|85192|P2|NOT COMPLETED|Overall Study||18
36336|NCT01870583|85193|P1|NOT COMPLETED|Overall Study||11
36337|NCT01870583|85191|P3|COMPLETED|Overall Study||455
36338|NCT01870583|85192|P2|COMPLETED|Overall Study||456
36339|NCT01870583|85193|P1|COMPLETED|Overall Study||456
36340|NCT01870583|85191|P3|STARTED|Overall Study||463
36341|NCT01870583|85192|P2|STARTED|Overall Study||474
36342|NCT01870583|85193|P1|STARTED|Overall Study||467
36343|NCT01870388|85203|P2|NOT COMPLETED|Overall Study||0
36344|NCT01870388|85204|P1|NOT COMPLETED|Overall Study||0
36345|NCT01870388|85203|P2|COMPLETED|Overall Study||8
36346|NCT01870388|85204|P1|COMPLETED|Overall Study||8
36347|NCT01870388|85203|P2|Received 1 Dose of Study Drug|Overall Study||8
36348|NCT01870388|85204|P1|Received 1 Dose of Study Drug|Overall Study||8
36349|NCT01870388|85203|P2|STARTED|Overall Study||8
36350|NCT01870388|85204|P1|STARTED|Overall Study||8
36351|NCT01869959|85216|P5|NOT COMPLETED|Treatment Period||0
36352|NCT01869959|85217|P4|NOT COMPLETED|Treatment Period||2
36353|NCT01869959|85218|P3|NOT COMPLETED|Treatment Period||3
36354|NCT01869959|85219|P2|NOT COMPLETED|Treatment Period||2
36355|NCT01869959|85220|P1|NOT COMPLETED|Treatment Period||1
36356|NCT01869959|85216|P5|COMPLETED|Treatment Period||0
36357|NCT01869959|85217|P4|COMPLETED|Treatment Period||8
36358|NCT01869959|85218|P3|COMPLETED|Treatment Period||12
36359|NCT01869959|85219|P2|COMPLETED|Treatment Period||8
36360|NCT01869959|85220|P1|COMPLETED|Treatment Period||10
36361|NCT01869959|85216|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
36362|NCT01869959|85217|P4|Received at Least 1 Dose of Study Drug|Treatment Period||10
36363|NCT01869959|85218|P3|Received at Least 1 Dose of Study Drug|Treatment Period||15
36364|NCT01869959|85219|P2|Received at Least 1 Dose of Study Drug|Treatment Period||10
36365|NCT01869959|85220|P1|Received at Least 1 Dose of Study Drug|Treatment Period||11
36366|NCT01869959|85216|P5|STARTED|Treatment Period|Participants were randomized to treatment groups for the Treatment Period.|0
36367|NCT01869959|85217|P4|STARTED|Treatment Period||10
36368|NCT01869959|85218|P3|STARTED|Treatment Period||15
36369|NCT01869959|85219|P2|STARTED|Treatment Period||10
36370|NCT01869959|85220|P1|STARTED|Treatment Period||11
36371|NCT01869959|85216|P5|NOT COMPLETED|Randomization Period||1
36372|NCT01869959|85217|P4|NOT COMPLETED|Randomization Period||0
36373|NCT01869959|85218|P3|NOT COMPLETED|Randomization Period||0
36374|NCT01869959|85219|P2|NOT COMPLETED|Randomization Period||0
36375|NCT01869959|85220|P1|NOT COMPLETED|Randomization Period||0
36376|NCT01869959|85216|P5|COMPLETED|Randomization Period|One participant discontinued after randomization but did not receive study drug.|46
36377|NCT01869959|85217|P4|COMPLETED|Randomization Period||0
36378|NCT01869959|85218|P3|COMPLETED|Randomization Period||0
36379|NCT01869959|85219|P2|COMPLETED|Randomization Period||0
36380|NCT01869959|85220|P1|COMPLETED|Randomization Period||0
36381|NCT01869959|85216|P5|STARTED|Randomization Period||47
36382|NCT01869959|85217|P4|STARTED|Randomization Period||0
36383|NCT01869959|85218|P3|STARTED|Randomization Period||0
36384|NCT01869959|85219|P2|STARTED|Randomization Period||0
36385|NCT01869959|85220|P1|STARTED|Randomization Period||0
36386|NCT01869699|85290|P2|NOT COMPLETED|Overall Study||0
36387|NCT01869699|85291|P1|NOT COMPLETED|Overall Study||1
36388|NCT01869699|85290|P2|COMPLETED|Overall Study||20
36389|NCT01869699|85291|P1|COMPLETED|Overall Study||20
36390|NCT01869699|85290|P2|STARTED|Overall Study||20
36391|NCT01869699|85291|P1|STARTED|Overall Study||21
36392|NCT01869686|85309|P1|NOT COMPLETED|Overall Study||0
36393|NCT01869686|85309|P1|COMPLETED|Overall Study||12
36394|NCT01869686|85309|P1|STARTED|Overall Study||12
36395|NCT01869647|85324|P3|NOT COMPLETED|Overall Study||0
36396|NCT01869647|85325|P2|NOT COMPLETED|Overall Study||6
36397|NCT01869647|85326|P1|NOT COMPLETED|Overall Study||1
36398|NCT01869647|85324|P3|COMPLETED|Overall Study||62
36399|NCT01869647|85325|P2|COMPLETED|Overall Study||130
36400|NCT01869647|85326|P1|COMPLETED|Overall Study||65
36401|NCT01869647|85324|P3|STARTED|Overall Study||62
36402|NCT01869647|85325|P2|STARTED|Overall Study||136
36403|NCT01869647|85326|P1|STARTED|Overall Study||66
36404|NCT01869478|85339|P2|NOT COMPLETED|Overall Study||0
36405|NCT01869478|85340|P1|NOT COMPLETED|Overall Study||0
36406|NCT01869478|85339|P2|COMPLETED|Overall Study||1
36407|NCT01869478|85340|P1|COMPLETED|Overall Study||0
36408|NCT01869478|85339|P2|STARTED|Overall Study||1
36409|NCT01869478|85340|P1|STARTED|Overall Study||0
36410|NCT01869075|85354|P6|NOT COMPLETED|Phase 2||0
36411|NCT01869075|85355|P5|NOT COMPLETED|Phase 2||0
36412|NCT01869075|85356|P4|NOT COMPLETED|Phase 2||0
36413|NCT01869075|85357|P3|NOT COMPLETED|Phase 2||0
36414|NCT01869075|85358|P2|NOT COMPLETED|Phase 2||0
36415|NCT01869075|85359|P1|NOT COMPLETED|Phase 2||0
36416|NCT01869075|85354|P6|COMPLETED|Phase 2||45
36417|NCT01869075|85355|P5|COMPLETED|Phase 2||75
36418|NCT01869075|85356|P4|COMPLETED|Phase 2||45
36419|NCT01869075|85357|P3|COMPLETED|Phase 2||75
36420|NCT01869075|85358|P2|COMPLETED|Phase 2||30
36421|NCT01869075|85359|P1|COMPLETED|Phase 2||90
36422|NCT01869075|85354|P6|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
36423|NCT01869075|85355|P5|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
36424|NCT01869075|85356|P4|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|45
36425|NCT01869075|85357|P3|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|75
36426|NCT01869075|85358|P2|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|30
36427|NCT01869075|85359|P1|STARTED|Phase 2|Participants included in phase 2 of the study were not enrolled in phase 1. Each is a unique phase.|90
36428|NCT01869075|85354|P6|NOT COMPLETED|Phase 1||0
36429|NCT01869075|85355|P5|NOT COMPLETED|Phase 1||0
36430|NCT01869075|85356|P4|NOT COMPLETED|Phase 1||0
36431|NCT01869075|85357|P3|NOT COMPLETED|Phase 1||0
36432|NCT01869075|85358|P2|NOT COMPLETED|Phase 1||0
36433|NCT01869075|85359|P1|NOT COMPLETED|Phase 1||0
36434|NCT01869075|85354|P6|COMPLETED|Phase 1||90
36435|NCT01869075|85355|P5|COMPLETED|Phase 1||30
36436|NCT01869075|85356|P4|COMPLETED|Phase 1||75
36437|NCT01869075|85357|P3|COMPLETED|Phase 1||45
36438|NCT01869075|85358|P2|COMPLETED|Phase 1||75
36439|NCT01869075|85359|P1|COMPLETED|Phase 1||45
36440|NCT01869075|85354|P6|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|90
36529|NCT01867710|85505|P4|Treated|Overall Study||42
36441|NCT01869075|85355|P5|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|30
36442|NCT01869075|85356|P4|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
36443|NCT01869075|85357|P3|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
36444|NCT01869075|85358|P2|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|75
36445|NCT01869075|85359|P1|STARTED|Phase 1|Each phase of the study collected data on a unique set of patients.|45
36446|NCT01869075|85354|P6|NOT COMPLETED|Phase 0 (Baseline)||0
36447|NCT01869075|85355|P5|NOT COMPLETED|Phase 0 (Baseline)||0
36448|NCT01869075|85356|P4|NOT COMPLETED|Phase 0 (Baseline)||0
36449|NCT01869075|85357|P3|NOT COMPLETED|Phase 0 (Baseline)||0
36450|NCT01869075|85358|P2|NOT COMPLETED|Phase 0 (Baseline)||0
36451|NCT01869075|85359|P1|NOT COMPLETED|Phase 0 (Baseline)||0
36452|NCT01869075|85354|P6|COMPLETED|Phase 0 (Baseline)||341
36453|NCT01869075|85355|P5|COMPLETED|Phase 0 (Baseline)||0
36454|NCT01869075|85356|P4|COMPLETED|Phase 0 (Baseline)||416
36455|NCT01869075|85357|P3|COMPLETED|Phase 0 (Baseline)||0
36456|NCT01869075|85358|P2|COMPLETED|Phase 0 (Baseline)||418
36457|NCT01869075|85359|P1|COMPLETED|Phase 0 (Baseline)||0
36458|NCT01869075|85354|P6|STARTED|Phase 0 (Baseline)||341
36459|NCT01869075|85355|P5|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
36460|NCT01869075|85356|P4|STARTED|Phase 0 (Baseline)||416
36461|NCT01869075|85357|P3|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
36462|NCT01869075|85358|P2|STARTED|Phase 0 (Baseline)||418
36463|NCT01869075|85359|P1|STARTED|Phase 0 (Baseline)|Phase 0 was the baseline phase. No intervention had been started.|0
36464|NCT01868997|85375|P2|NOT COMPLETED|Overall Study||6
36465|NCT01868997|85376|P1|NOT COMPLETED|Overall Study||5
36466|NCT01868997|85375|P2|COMPLETED|Overall Study|completed treatment to Week 24|37
36467|NCT01868997|85376|P1|COMPLETED|Overall Study|completed treatment to Week 24|39
36468|NCT01868997|85375|P2|STARTED|Overall Study|randomized and treated|43
36469|NCT01868997|85376|P1|STARTED|Overall Study|randomized and treated|44
36470|NCT01868893|85392|P1|NOT COMPLETED|Overall Study||20
36471|NCT01868893|85392|P1|COMPLETED|Overall Study||0
36472|NCT01868893|85392|P1|STARTED|Overall Study||20
36473|NCT01868776|85401|P2|NOT COMPLETED|Overall Study||0
36474|NCT01868776|85402|P1|NOT COMPLETED|Overall Study||0
36475|NCT01868776|85401|P2|COMPLETED|Overall Study||50
36476|NCT01868776|85402|P1|COMPLETED|Overall Study||50
36477|NCT01868776|85401|P2|STARTED|Overall Study||50
36478|NCT01868776|85402|P1|STARTED|Overall Study||50
36479|NCT01868633|85410|P2|NOT COMPLETED|Overall Study||0
36480|NCT01868633|85411|P1|NOT COMPLETED|Overall Study||0
36481|NCT01868633|85410|P2|COMPLETED|Overall Study||26
36482|NCT01868633|85411|P1|COMPLETED|Overall Study||26
36483|NCT01868633|85410|P2|STARTED|Overall Study||26
36484|NCT01868633|85411|P1|STARTED|Overall Study||26
36485|NCT01868542|85423|P2|NOT COMPLETED|Overall Study||2
36486|NCT01868542|85424|P1|NOT COMPLETED|Overall Study||0
36487|NCT01868542|85423|P2|COMPLETED|Overall Study||21
36488|NCT01868542|85424|P1|COMPLETED|Overall Study||23
36489|NCT01868542|85423|P2|STARTED|Overall Study||23
36490|NCT01868542|85424|P1|STARTED|Overall Study||23
36491|NCT01868503|85442|P1|NOT COMPLETED|Overall Study||2
36492|NCT01868503|85442|P1|COMPLETED|Overall Study||5
36493|NCT01868503|85442|P1|STARTED|Overall Study||7
36494|NCT01868243|85452|P2|NOT COMPLETED|Overall Study||1
36495|NCT01868243|85453|P1|NOT COMPLETED|Overall Study||0
36496|NCT01868243|85452|P2|COMPLETED|Overall Study||11
36497|NCT01868243|85453|P1|COMPLETED|Overall Study||15
36498|NCT01868243|85452|P2|STARTED|Overall Study||12
36499|NCT01868243|85453|P1|STARTED|Overall Study||15
36500|NCT01868074|85463|P2|NOT COMPLETED|Overall Study||4
36501|NCT01868074|85464|P1|NOT COMPLETED|Overall Study||7
36502|NCT01868074|85463|P2|COMPLETED|Overall Study||32
36503|NCT01868074|85464|P1|COMPLETED|Overall Study||29
36504|NCT01868074|85463|P2|STARTED|Overall Study||36
36505|NCT01868074|85464|P1|STARTED|Overall Study||36
36506|NCT01868035|85474|P1|NOT COMPLETED|Overall Study||7
36507|NCT01868035|85474|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|8
36508|NCT01868035|85474|P1|STARTED|Overall Study||15
36509|NCT01868009|85490|P2|NOT COMPLETED|Period 2 (5-9 Days)||0
36510|NCT01868009|85491|P1|NOT COMPLETED|Period 2 (5-9 Days)||2
36511|NCT01868009|85490|P2|COMPLETED|Period 2 (5-9 Days)||142
36512|NCT01868009|85491|P1|COMPLETED|Period 2 (5-9 Days)||141
36513|NCT01868009|85490|P2|STARTED|Period 2 (5-9 Days)||142
36514|NCT01868009|85491|P1|STARTED|Period 2 (5-9 Days)||143
36515|NCT01868009|85490|P2|NOT COMPLETED|Period 1 (5-9 Days)||2
36516|NCT01868009|85491|P1|NOT COMPLETED|Period 1 (5-9 Days)||0
36517|NCT01868009|85490|P2|COMPLETED|Period 1 (5-9 Days)||142
36518|NCT01868009|85491|P1|COMPLETED|Period 1 (5-9 Days)||143
36519|NCT01868009|85490|P2|STARTED|Period 1 (5-9 Days)||144
36520|NCT01868009|85491|P1|STARTED|Period 1 (5-9 Days)||143
36521|NCT01867710|85505|P4|NOT COMPLETED|Overall Study||7
36522|NCT01867710|85506|P3|NOT COMPLETED|Overall Study||9
36523|NCT01867710|85507|P2|NOT COMPLETED|Overall Study||7
36524|NCT01867710|85508|P1|NOT COMPLETED|Overall Study||8
36525|NCT01867710|85505|P4|COMPLETED|Overall Study||35
36526|NCT01867710|85506|P3|COMPLETED|Overall Study||31
36527|NCT01867710|85507|P2|COMPLETED|Overall Study||34
36528|NCT01867710|85508|P1|COMPLETED|Overall Study||33
36530|NCT01867710|85506|P3|Treated|Overall Study||39
36531|NCT01867710|85507|P2|Treated|Overall Study||41
36532|NCT01867710|85508|P1|Treated|Overall Study||41
36533|NCT01867710|85505|P4|STARTED|Overall Study||42
36534|NCT01867710|85506|P3|STARTED|Overall Study||40
36535|NCT01867710|85507|P2|STARTED|Overall Study||41
36536|NCT01867710|85508|P1|STARTED|Overall Study||41
36537|NCT01867658|85522|P1|NOT COMPLETED|Overall Study||9
36538|NCT01867658|85522|P1|COMPLETED|Overall Study||103
36539|NCT01867658|85522|P1|STARTED|Overall Study||112
36540|NCT01867632|85535|P2|NOT COMPLETED|Overall Study||0
36541|NCT01867632|85536|P1|NOT COMPLETED|Overall Study||0
36542|NCT01867632|85535|P2|COMPLETED|Overall Study||66
36543|NCT01867632|85536|P1|COMPLETED|Overall Study||65
36544|NCT01867632|85535|P2|STARTED|Overall Study||66
36545|NCT01867632|85536|P1|STARTED|Overall Study||65
36546|NCT01867307|85546|P2|NOT COMPLETED|Overall Study||3
36547|NCT01867307|85547|P1|NOT COMPLETED|Overall Study||3
36548|NCT01867307|85546|P2|COMPLETED|Overall Study||16
36549|NCT01867307|85547|P1|COMPLETED|Overall Study||15
36550|NCT01867307|85546|P2|STARTED|Overall Study|Started are the treated patients|19
36551|NCT01867307|85547|P1|STARTED|Overall Study|Started are the treated patients|18
36552|NCT01867164|85555|P2|NOT COMPLETED|Overall Study||0
36553|NCT01867164|85556|P1|NOT COMPLETED|Overall Study||0
36554|NCT01867164|85555|P2|COMPLETED|Overall Study||79
36555|NCT01867164|85556|P1|COMPLETED|Overall Study||81
36556|NCT01867164|85555|P2|STARTED|Overall Study||79
36557|NCT01867164|85556|P1|STARTED|Overall Study||81
36558|NCT01867021|85572|P2|NOT COMPLETED|Overall Study||10
36559|NCT01867021|85573|P1|NOT COMPLETED|Overall Study||2
36560|NCT01867021|85572|P2|COMPLETED|Overall Study||1440
36561|NCT01867021|85573|P1|COMPLETED|Overall Study||1450
36562|NCT01867021|85572|P2|STARTED|Overall Study||1450
36563|NCT01867021|85573|P1|STARTED|Overall Study||1452
36564|NCT01866709|85594|P2|NOT COMPLETED|Overall Study||0
36565|NCT01866709|85595|P1|NOT COMPLETED|Overall Study||1
36566|NCT01866709|85594|P2|COMPLETED|Overall Study||17
36567|NCT01866709|85595|P1|COMPLETED|Overall Study||14
36568|NCT01866709|85594|P2|STARTED|Overall Study||17
36569|NCT01866709|85595|P1|STARTED|Overall Study||15
36570|NCT01866423|85603|P1|NOT COMPLETED|Overall Study||4
36571|NCT01866423|85603|P1|COMPLETED|Overall Study||0
36572|NCT01866423|85603|P1|STARTED|Overall Study||4
36573|NCT01866319|85616|P3|NOT COMPLETED|Overall Study||277
36574|NCT01866319|85617|P2|NOT COMPLETED|Overall Study||279
36575|NCT01866319|85618|P1|NOT COMPLETED|Overall Study||277
36576|NCT01866319|85616|P3|COMPLETED|Overall Study||0
36577|NCT01866319|85617|P2|COMPLETED|Overall Study||0
36578|NCT01866319|85618|P1|COMPLETED|Overall Study||1
36579|NCT01866319|85616|P3|Treated|Overall Study||277
36580|NCT01866319|85617|P2|Treated|Overall Study||278
36581|NCT01866319|85618|P1|Treated|Overall Study||256
36582|NCT01866319|85616|P3|STARTED|Overall Study||277
36583|NCT01866319|85617|P2|STARTED|Overall Study||279
36584|NCT01866319|85618|P1|STARTED|Overall Study||278
36585|NCT01866306|85639|P7|NOT COMPLETED|Overall Study||0
36586|NCT01866306|85640|P6|NOT COMPLETED|Overall Study||0
36587|NCT01866306|85641|P5|NOT COMPLETED|Overall Study||0
36588|NCT01866306|85642|P4|NOT COMPLETED|Overall Study||0
36589|NCT01866306|85643|P3|NOT COMPLETED|Overall Study||0
36590|NCT01866306|85644|P2|NOT COMPLETED|Overall Study||0
36591|NCT01866306|85645|P1|NOT COMPLETED|Overall Study||0
36592|NCT01866306|85639|P7|COMPLETED|Overall Study||23
36593|NCT01866306|85640|P6|COMPLETED|Overall Study||6
36594|NCT01866306|85641|P5|COMPLETED|Overall Study||6
36595|NCT01866306|85642|P4|COMPLETED|Overall Study||6
36596|NCT01866306|85643|P3|COMPLETED|Overall Study||6
36597|NCT01866306|85644|P2|COMPLETED|Overall Study||6
36598|NCT01866306|85645|P1|COMPLETED|Overall Study||6
36599|NCT01866306|85639|P7|STARTED|Overall Study||23
36600|NCT01866306|85640|P6|STARTED|Overall Study||6
36601|NCT01866306|85641|P5|STARTED|Overall Study||6
36602|NCT01866306|85642|P4|STARTED|Overall Study||6
36603|NCT01866306|85643|P3|STARTED|Overall Study||6
36604|NCT01866306|85644|P2|STARTED|Overall Study||6
36605|NCT01866306|85645|P1|STARTED|Overall Study||6
36606|NCT01866293|85717|P1|NOT COMPLETED|Overall Study||2
36607|NCT01866293|85717|P1|COMPLETED|Overall Study||9
36608|NCT01866293|85717|P1|STARTED|Overall Study||11
36609|NCT01866163|85727|P2|NOT COMPLETED|Overall Study||4
36610|NCT01866163|85728|P1|NOT COMPLETED|Overall Study||10
36611|NCT01866163|85727|P2|COMPLETED|Overall Study||99
36612|NCT01866163|85728|P1|COMPLETED|Overall Study||313
36613|NCT01866163|85727|P2|STARTED|Overall Study||103
36614|NCT01866163|85728|P1|STARTED|Overall Study||323
36615|NCT01866150|85738|P1|NOT COMPLETED|Overall Study||0
36616|NCT01866150|85738|P1|COMPLETED|Overall Study||450
36617|NCT01866150|85738|P1|STARTED|Overall Study||450
36618|NCT01865812|85759|P1|NOT COMPLETED|Overall Study||2
36619|NCT01865812|85759|P1|COMPLETED|Overall Study||24
36620|NCT01865812|85759|P1|STARTED|Overall Study||26
36621|NCT01865747|85767|P2|NOT COMPLETED|Primary Intent to Treat (PITT)||152
36622|NCT01865747|85768|P1|NOT COMPLETED|Primary Intent to Treat (PITT)||131
36623|NCT01865747|85767|P2|COMPLETED|Primary Intent to Treat (PITT)||36
36624|NCT01865747|85768|P1|COMPLETED|Primary Intent to Treat (PITT)||56
36625|NCT01865747|85767|P2|STARTED|Primary Intent to Treat (PITT)|Three subjects in the everolimus arm were randomized but not treated.|188
36626|NCT01865747|85768|P1|STARTED|Primary Intent to Treat (PITT)||187
36627|NCT01865747|85767|P2|NOT COMPLETED|Overall Study (ITT)||255
36628|NCT01865747|85768|P1|NOT COMPLETED|Overall Study (ITT)||198
36629|NCT01865747|85767|P2|COMPLETED|Overall Study (ITT)|Five subjects were randomized but not treated|73
36630|NCT01865747|85768|P1|COMPLETED|Overall Study (ITT)|One subject randomized to everolimus arm received cabozantinib discontd due to clin. deterioration|132
36631|NCT01865747|85767|P2|STARTED|Overall Study (ITT)||328
36632|NCT01865747|85768|P1|STARTED|Overall Study (ITT)||330
36633|NCT01865084|85781|P3|NOT COMPLETED|Open Label Extension (OLE) Period||7
36634|NCT01865084|85782|P2|NOT COMPLETED|Open Label Extension (OLE) Period||11
36635|NCT01865084|85783|P1|NOT COMPLETED|Open Label Extension (OLE) Period||0
36636|NCT01865084|85781|P3|COMPLETED|Open Label Extension (OLE) Period||158
36637|NCT01865084|85782|P2|COMPLETED|Open Label Extension (OLE) Period||139
36638|NCT01865084|85783|P1|COMPLETED|Open Label Extension (OLE) Period||0
36639|NCT01865084|85781|P3|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|165
36640|NCT01865084|85782|P2|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|150
36641|NCT01865084|85783|P1|STARTED|Open Label Extension (OLE) Period|Participants who were on Placebo during the double blind period were assigned tadalafil during OLE.|0
36642|NCT01865084|85781|P3|NOT COMPLETED|Double Blind Period (DB)||6
36643|NCT01865084|85782|P2|NOT COMPLETED|Double Blind Period (DB)||4
36644|NCT01865084|85783|P1|NOT COMPLETED|Double Blind Period (DB)||5
36645|NCT01865084|85781|P3|COMPLETED|Double Blind Period (DB)||107
36646|NCT01865084|85782|P2|COMPLETED|Double Blind Period (DB)|One participant stopped therapy during the DB period but remained in the study for follow-up.|98
36647|NCT01865084|85783|P1|COMPLETED|Double Blind Period (DB)||111
36648|NCT01865084|85781|P3|Received at Least One Dose of Study Drug|Double Blind Period (DB)||112
36649|NCT01865084|85782|P2|Received at Least One Dose of Study Drug|Double Blind Period (DB)||102
36650|NCT01865084|85783|P1|Received at Least One Dose of Study Drug|Double Blind Period (DB)||116
36651|NCT01865084|85781|P3|STARTED|Double Blind Period (DB)||113
36652|NCT01865084|85782|P2|STARTED|Double Blind Period (DB)||102
36653|NCT01865084|85783|P1|STARTED|Double Blind Period (DB)||116
36654|NCT01864538|85809|P1|NOT COMPLETED|Overall Study||11
36655|NCT01864538|85809|P1|COMPLETED|Overall Study||0
36656|NCT01864538|85809|P1|STARTED|Overall Study||11
36657|NCT01864434|85815|P2|NOT COMPLETED|Overall Study||0
36658|NCT01864434|85816|P1|NOT COMPLETED|Overall Study||0
36659|NCT01864434|85815|P2|COMPLETED|Overall Study||25
36660|NCT01864434|85816|P1|COMPLETED|Overall Study||25
36661|NCT01864434|85815|P2|STARTED|Overall Study||25
36662|NCT01864434|85816|P1|STARTED|Overall Study||25
36663|NCT01864174|85828|P2|NOT COMPLETED|Off Treatment Follow-Up||0
36664|NCT01864174|85829|P1|NOT COMPLETED|Off Treatment Follow-Up||3
36665|NCT01864174|85828|P2|COMPLETED|Off Treatment Follow-Up||1
36666|NCT01864174|85829|P1|COMPLETED|Off Treatment Follow-Up||6
36667|NCT01864174|85828|P2|STARTED|Off Treatment Follow-Up||1
36668|NCT01864174|85829|P1|STARTED|Off Treatment Follow-Up||9
36669|NCT01864174|85828|P2|NOT COMPLETED|Double Blind - Compliant Randomized||26
36670|NCT01864174|85829|P1|NOT COMPLETED|Double Blind - Compliant Randomized||23
36671|NCT01864174|85828|P2|COMPLETED|Double Blind - Compliant Randomized||245
36672|NCT01864174|85829|P1|COMPLETED|Double Blind - Compliant Randomized||245
36673|NCT01864174|85828|P2|STARTED|Double Blind - Compliant Randomized||271
36674|NCT01864174|85829|P1|STARTED|Double Blind - Compliant Randomized||268
36675|NCT01864174|85828|P2|NOT COMPLETED|Double Blind Treatment - All Treated||14
36676|NCT01864174|85829|P1|NOT COMPLETED|Double Blind Treatment - All Treated||15
36677|NCT01864174|85828|P2|COMPLETED|Double Blind Treatment - All Treated||271
36678|NCT01864174|85829|P1|COMPLETED|Double Blind Treatment - All Treated||268
36679|NCT01864174|85828|P2|STARTED|Double Blind Treatment - All Treated||285
36680|NCT01864174|85829|P1|STARTED|Double Blind Treatment - All Treated||283
36681|NCT01864148|85848|P5|NOT COMPLETED|Overall Study||23
36682|NCT01864148|85849|P4|NOT COMPLETED|Overall Study||26
36683|NCT01864148|85850|P3|NOT COMPLETED|Overall Study||11
36684|NCT01864148|85851|P2|NOT COMPLETED|Overall Study||5
36685|NCT01864148|85852|P1|NOT COMPLETED|Overall Study||20
36686|NCT01864148|85848|P5|COMPLETED|Overall Study||69
36687|NCT01864148|85849|P4|COMPLETED|Overall Study||68
36688|NCT01864148|85850|P3|COMPLETED|Overall Study||84
36689|NCT01864148|85851|P2|COMPLETED|Overall Study||40
36690|NCT01864148|85852|P1|COMPLETED|Overall Study||73
36691|NCT01864148|85848|P5|Randomized and Dosed|Overall Study||92
36692|NCT01864148|85849|P4|Randomized and Dosed|Overall Study||93
36693|NCT01864148|85850|P3|Randomized and Dosed|Overall Study||95
36694|NCT01864148|85851|P2|Randomized and Dosed|Overall Study||45
36695|NCT01864148|85852|P1|Randomized and Dosed|Overall Study||93
36696|NCT01864148|85848|P5|STARTED|Overall Study||92
36697|NCT01864148|85849|P4|STARTED|Overall Study||94
36698|NCT01864148|85850|P3|STARTED|Overall Study||95
36699|NCT01864148|85851|P2|STARTED|Overall Study||45
36700|NCT01864148|85852|P1|STARTED|Overall Study||93
36701|NCT01864005|85881|P2|NOT COMPLETED|Overall Study||6
36702|NCT01864005|85882|P1|NOT COMPLETED|Overall Study||3
36703|NCT01864005|85881|P2|COMPLETED|Overall Study||25
36704|NCT01864005|85882|P1|COMPLETED|Overall Study||26
36705|NCT01864005|85881|P2|STARTED|Overall Study||31
36706|NCT01864005|85882|P1|STARTED|Overall Study||29
36707|NCT01863953|85899|P3|NOT COMPLETED|Overall Study||1
36708|NCT01863953|85900|P2|NOT COMPLETED|Overall Study||0
36709|NCT01863953|85901|P1|NOT COMPLETED|Overall Study||0
36710|NCT01863953|85899|P3|COMPLETED|Overall Study||37
36711|NCT01863953|85900|P2|COMPLETED|Overall Study||36
36712|NCT01863953|85901|P1|COMPLETED|Overall Study||38
36713|NCT01863953|85899|P3|STARTED|Overall Study||38
36714|NCT01863953|85900|P2|STARTED|Overall Study||36
36715|NCT01863953|85901|P1|STARTED|Overall Study||38
36716|NCT01863771|85915|P4|NOT COMPLETED|Maintenance Phase||43
36717|NCT01863771|85916|P3|NOT COMPLETED|Maintenance Phase||12
36718|NCT01863771|85917|P2|NOT COMPLETED|Maintenance Phase||5
36719|NCT01863771|85918|P1|NOT COMPLETED|Maintenance Phase||0
36720|NCT01863771|85915|P4|COMPLETED|Maintenance Phase||17
36721|NCT01863771|85916|P3|COMPLETED|Maintenance Phase||19
36722|NCT01863771|85917|P2|COMPLETED|Maintenance Phase||27
36723|NCT01863771|85918|P1|COMPLETED|Maintenance Phase||0
36724|NCT01863771|85915|P4|STARTED|Maintenance Phase||60
36726|NCT01863771|85917|P2|STARTED|Maintenance Phase||32
36727|NCT01863771|85918|P1|STARTED|Maintenance Phase||0
36728|NCT01863771|85915|P4|NOT COMPLETED|Induction Phase||0
36729|NCT01863771|85916|P3|NOT COMPLETED|Induction Phase||0
36730|NCT01863771|85917|P2|NOT COMPLETED|Induction Phase||0
36731|NCT01863771|85918|P1|NOT COMPLETED|Induction Phase||21
36732|NCT01863771|85915|P4|COMPLETED|Induction Phase||0
36733|NCT01863771|85916|P3|COMPLETED|Induction Phase||0
36734|NCT01863771|85917|P2|COMPLETED|Induction Phase||0
36735|NCT01863771|85918|P1|COMPLETED|Induction Phase|Same participants who completed the induction phase participated in the maintenance phase.|123
36736|NCT01863771|85915|P4|STARTED|Induction Phase||0
36737|NCT01863771|85916|P3|STARTED|Induction Phase||0
36738|NCT01863771|85917|P2|STARTED|Induction Phase||0
36739|NCT01863771|85918|P1|STARTED|Induction Phase||144
36740|NCT01863680|85930|P1|NOT COMPLETED|Overall Study||57
36741|NCT01863680|85930|P1|COMPLETED|Overall Study||121
36742|NCT01863680|85930|P1|Subjects Who Have Undergone IVF/ET|Overall Study||123
36743|NCT01863680|85930|P1|Subjects Received Study Drug|Overall Study||149
36744|NCT01863680|85930|P1|Subjects Received hCG Injection|Overall Study||162
36745|NCT01863680|85930|P1|Subjects Started COS Treatment|Overall Study||169
36746|NCT01863680|85930|P1|STARTED|Overall Study||178
36747|NCT01863667|85938|P2|NOT COMPLETED|Overall Study||32
36748|NCT01863667|85939|P1|NOT COMPLETED|Overall Study||33
36749|NCT01863667|85938|P2|COMPLETED|Overall Study||0
36750|NCT01863667|85939|P1|COMPLETED|Overall Study||0
36751|NCT01863667|85938|P2|STARTED|Overall Study||32
36752|NCT01863667|85939|P1|STARTED|Overall Study||33
36753|NCT01863433|85959|P1|NOT COMPLETED|Overall Study||1
36754|NCT01863433|85959|P1|COMPLETED|Overall Study|1 subject was withdrawn from the study due to evidence of substance abuse.|119
36755|NCT01863433|85959|P1|STARTED|Overall Study||120
36756|NCT01863368|85969|P2|NOT COMPLETED|Phase II, Day 35 to Day 90||0
36757|NCT01863368|85970|P1|NOT COMPLETED|Phase II, Day 35 to Day 90||2
36758|NCT01863368|85969|P2|COMPLETED|Phase II, Day 35 to Day 90||41
36759|NCT01863368|85970|P1|COMPLETED|Phase II, Day 35 to Day 90||41
36760|NCT01863368|85969|P2|STARTED|Phase II, Day 35 to Day 90||41
36761|NCT01863368|85970|P1|STARTED|Phase II, Day 35 to Day 90||43
36762|NCT01863368|85969|P2|NOT COMPLETED|Phase I, Day 0 to Day 35||7
36763|NCT01863368|85970|P1|NOT COMPLETED|Phase I, Day 0 to Day 35||3
36764|NCT01863368|85969|P2|COMPLETED|Phase I, Day 0 to Day 35||41
36765|NCT01863368|85970|P1|COMPLETED|Phase I, Day 0 to Day 35||43
36766|NCT01863368|85969|P2|Treated|Phase I, Day 0 to Day 35||47
36767|NCT01863368|85970|P1|Treated|Phase I, Day 0 to Day 35||46
36768|NCT01863368|85969|P2|STARTED|Phase I, Day 0 to Day 35||48
36769|NCT01863368|85970|P1|STARTED|Phase I, Day 0 to Day 35||46
36770|NCT01863134|85985|P2|NOT COMPLETED|Overall Study||0
36771|NCT01863134|85986|P1|NOT COMPLETED|Overall Study||0
36772|NCT01863134|85985|P2|COMPLETED|Overall Study||68
36773|NCT01863134|85986|P1|COMPLETED|Overall Study||72
36774|NCT01863134|85985|P2|STARTED|Overall Study||68
36775|NCT01863134|85986|P1|STARTED|Overall Study||72
36776|NCT01862991|85995|P3|NOT COMPLETED|Overall Study||1
36777|NCT01862991|85996|P2|NOT COMPLETED|Overall Study||1
36778|NCT01862991|85997|P1|NOT COMPLETED|Overall Study||3
36779|NCT01862991|85995|P3|COMPLETED|Overall Study||27
36780|NCT01862991|85996|P2|COMPLETED|Overall Study||27
36781|NCT01862991|85997|P1|COMPLETED|Overall Study||21
36782|NCT01862991|85995|P3|STARTED|Overall Study||28
36783|NCT01862991|85996|P2|STARTED|Overall Study||28
36784|NCT01862991|85997|P1|STARTED|Overall Study||24
36785|NCT01862484|86010|P2|NOT COMPLETED|Overall Study||8
36786|NCT01862484|86011|P1|NOT COMPLETED|Overall Study||2
36787|NCT01862484|86010|P2|COMPLETED|Overall Study||6
36788|NCT01862484|86011|P1|COMPLETED|Overall Study||13
36789|NCT01862484|86010|P2|STARTED|Overall Study||14
36790|NCT01862484|86011|P1|STARTED|Overall Study||15
36791|NCT01862419|86019|P2|NOT COMPLETED|Overall Study||0
36792|NCT01862419|86020|P1|NOT COMPLETED|Overall Study||0
36793|NCT01862419|86019|P2|COMPLETED|Overall Study||1192
36794|NCT01862419|86020|P1|COMPLETED|Overall Study||1201
36795|NCT01862419|86019|P2|STARTED|Overall Study||1192
36796|NCT01862419|86020|P1|STARTED|Overall Study||1201
36797|NCT01862159|86030|P1|NOT COMPLETED|Overall Study||0
36798|NCT01862159|86030|P1|COMPLETED|Overall Study||25038
36799|NCT01862159|86030|P1|STARTED|Overall Study||25038
36800|NCT01862133|86037|P2|NOT COMPLETED|Overall Study||0
36801|NCT01862133|86038|P1|NOT COMPLETED|Overall Study||0
36802|NCT01862133|86037|P2|COMPLETED|Overall Study||31
36803|NCT01862133|86038|P1|COMPLETED|Overall Study|All 105 patients recorded preferences; 92 (88%) returned to the study clinic during the 6 mo. study|105
36804|NCT01862133|86037|P2|Returned During 6 mo Study|Overall Study||31
36805|NCT01862133|86038|P1|Returned During 6 mo Study|Overall Study||92
36806|NCT01862133|86037|P2|STARTED|Overall Study||31
36807|NCT01862133|86038|P1|STARTED|Overall Study||105
36808|NCT01861925|86047|P3|NOT COMPLETED|Overall Study||0
36809|NCT01861925|86048|P2|NOT COMPLETED|Overall Study||0
36810|NCT01861925|86049|P1|NOT COMPLETED|Overall Study||0
36811|NCT01861925|86047|P3|COMPLETED|Overall Study||8
36812|NCT01861925|86048|P2|COMPLETED|Overall Study||8
36813|NCT01861925|86049|P1|COMPLETED|Overall Study||34
36814|NCT01861925|86047|P3|STARTED|Overall Study||8
36815|NCT01861925|86048|P2|STARTED|Overall Study||8
36816|NCT01861925|86049|P1|STARTED|Overall Study||34
36817|NCT01861756|86072|P2|NOT COMPLETED|Overall Study||18
36818|NCT01861756|86073|P1|NOT COMPLETED|Overall Study||13
36819|NCT01861756|86072|P2|COMPLETED|Overall Study||85
36820|NCT01861756|86073|P1|COMPLETED|Overall Study||88
36821|NCT01861756|86072|P2|STARTED|Overall Study||103
36822|NCT01861756|86073|P1|STARTED|Overall Study||101
36823|NCT01861704|86081|P2|NOT COMPLETED|Overall Study||3
36824|NCT01861704|86082|P1|NOT COMPLETED|Overall Study||3
36825|NCT01861704|86081|P2|COMPLETED|Overall Study||104
36826|NCT01861704|86082|P1|COMPLETED|Overall Study||67
36827|NCT01861704|86081|P2|STARTED|Overall Study||107
36828|NCT01861704|86082|P1|STARTED|Overall Study||70
36829|NCT01861522|86090|P2|NOT COMPLETED|Overall Study||0
36830|NCT01861522|86091|P1|NOT COMPLETED|Overall Study||3
36831|NCT01861522|86090|P2|COMPLETED|Overall Study||232
36832|NCT01861522|86091|P1|COMPLETED|Overall Study||237
36833|NCT01861522|86090|P2|STARTED|Overall Study|One subject who did not receive any study drug was excluded from the FAS and the Safety Analysis Set|232
36834|NCT01861522|86091|P1|STARTED|Overall Study||240
36835|NCT01861457|86099|P2|NOT COMPLETED|Overall Study||0
36836|NCT01861457|86100|P1|NOT COMPLETED|Overall Study||0
36837|NCT01861457|86099|P2|COMPLETED|Overall Study||19
36838|NCT01861457|86100|P1|COMPLETED|Overall Study||20
36839|NCT01861457|86099|P2|STARTED|Overall Study||19
36840|NCT01861457|86100|P1|STARTED|Overall Study||20
36841|NCT01861301|86108|P1|NOT COMPLETED|Overall Study||0
36842|NCT01861301|86108|P1|COMPLETED|Overall Study||18
36843|NCT01861301|86108|P1|STARTED|Overall Study||18
36844|NCT01860989|86115|P1|NOT COMPLETED|Overall Study||5
36845|NCT01860989|86115|P1|COMPLETED|Overall Study||6
36846|NCT01860989|86115|P1|STARTED|Overall Study||11
36847|NCT01860976|86121|P2|NOT COMPLETED|Long Term Extension||107
36848|NCT01860976|86122|P1|NOT COMPLETED|Long Term Extension||113
36849|NCT01860976|86121|P2|COMPLETED|Long Term Extension||8
36850|NCT01860976|86122|P1|COMPLETED|Long Term Extension||0
36851|NCT01860976|86121|P2|STARTED|Long Term Extension||115
36852|NCT01860976|86122|P1|STARTED|Long Term Extension||113
36853|NCT01860976|86121|P2|NOT COMPLETED|Open-Label||64
36854|NCT01860976|86122|P1|NOT COMPLETED|Open-Label||74
36855|NCT01860976|86121|P2|COMPLETED|Open-Label||121
36856|NCT01860976|86122|P1|COMPLETED|Open-Label||123
36857|NCT01860976|86121|P2|STARTED|Open-Label||185
36858|NCT01860976|86122|P1|STARTED|Open-Label||197
36859|NCT01860976|86121|P2|NOT COMPLETED|Blinded Treatment||113
36860|NCT01860976|86122|P1|NOT COMPLETED|Blinded Treatment||88
36861|NCT01860976|86121|P2|COMPLETED|Blinded Treatment||98
36862|NCT01860976|86122|P1|COMPLETED|Blinded Treatment||125
36863|NCT01860976|86121|P2|STARTED|Blinded Treatment||211
36864|NCT01860976|86122|P1|STARTED|Blinded Treatment||213
36865|NCT01860846|86144|P1|NOT COMPLETED|Overall Study||33
36866|NCT01860846|86144|P1|COMPLETED|Overall Study||73
36867|NCT01860846|86144|P1|Month 12|Overall Study||73
36868|NCT01860846|86144|P1|Month 6|Overall Study||85
36869|NCT01860846|86144|P1|Month 4|Overall Study||82
36870|NCT01860846|86144|P1|Month 2|Overall Study||83
36871|NCT01860846|86144|P1|Month 1|Overall Study||97
36872|NCT01860846|86144|P1|STARTED|Overall Study||106
36873|NCT01860703|86155|P4|NOT COMPLETED|Overall Study||2
36874|NCT01860703|86156|P3|NOT COMPLETED|Overall Study||1
36875|NCT01860703|86157|P2|NOT COMPLETED|Overall Study||5
36876|NCT01860703|86158|P1|NOT COMPLETED|Overall Study||2
36877|NCT01860703|86155|P4|COMPLETED|Overall Study||10
36878|NCT01860703|86156|P3|COMPLETED|Overall Study||11
36879|NCT01860703|86157|P2|COMPLETED|Overall Study||8
36880|NCT01860703|86158|P1|COMPLETED|Overall Study||11
36881|NCT01860703|86155|P4|STARTED|Overall Study||12
36882|NCT01860703|86156|P3|STARTED|Overall Study||12
36883|NCT01860703|86157|P2|STARTED|Overall Study||13
36884|NCT01860703|86158|P1|STARTED|Overall Study||13
36885|NCT01860677|86190|P2|NOT COMPLETED|Second Intervention (1 Day)||0
36886|NCT01860677|86191|P1|NOT COMPLETED|Second Intervention (1 Day)||7
36887|NCT01860677|86190|P2|COMPLETED|Second Intervention (1 Day)||0
36888|NCT01860677|86191|P1|COMPLETED|Second Intervention (1 Day)||1
36889|NCT01860677|86190|P2|STARTED|Second Intervention (1 Day)||0
36890|NCT01860677|86191|P1|STARTED|Second Intervention (1 Day)||8
36891|NCT01860677|86190|P2|NOT COMPLETED|First Intervention (1 Day)||0
36892|NCT01860677|86191|P1|NOT COMPLETED|First Intervention (1 Day)||0
36893|NCT01860677|86190|P2|COMPLETED|First Intervention (1 Day)||0
36894|NCT01860677|86191|P1|COMPLETED|First Intervention (1 Day)||8
36895|NCT01860677|86190|P2|STARTED|First Intervention (1 Day)||0
36896|NCT01860677|86191|P1|STARTED|First Intervention (1 Day)||8
36897|NCT01860586|86200|P1|NOT COMPLETED|Overall Study||0
36898|NCT01860586|86200|P1|COMPLETED|Overall Study||20
36899|NCT01860586|86200|P1|STARTED|Overall Study||20
36900|NCT01860573|86208|P2|NOT COMPLETED|Overall Study||0
36901|NCT01860573|86209|P1|NOT COMPLETED|Overall Study||0
36902|NCT01860573|86208|P2|COMPLETED|Overall Study||85
36903|NCT01860573|86209|P1|COMPLETED|Overall Study||83
36904|NCT01860573|86208|P2|STARTED|Overall Study||85
36905|NCT01860573|86209|P1|STARTED|Overall Study||83
36906|NCT01860534|86229|P2|NOT COMPLETED|ROP #2||0
36907|NCT01860534|86230|P1|NOT COMPLETED|ROP #2||1
36908|NCT01860534|86229|P2|COMPLETED|ROP #2||13
36909|NCT01860534|86230|P1|COMPLETED|ROP #2||13
36910|NCT01860534|86229|P2|STARTED|ROP #2||13
36911|NCT01860534|86230|P1|STARTED|ROP #2||14
36912|NCT01860534|86229|P2|NOT COMPLETED|ROP #1||1
36913|NCT01860534|86230|P1|NOT COMPLETED|ROP #1||0
36914|NCT01860534|86229|P2|COMPLETED|ROP #1||13
36915|NCT01860534|86230|P1|COMPLETED|ROP #1||14
36916|NCT01860534|86229|P2|STARTED|ROP #1||14
36917|NCT01860534|86230|P1|STARTED|ROP #1||14
36918|NCT01860521|86244|P2|NOT COMPLETED|Overall Study||0
36919|NCT01860521|86245|P1|NOT COMPLETED|Overall Study||0
36920|NCT01860521|86244|P2|COMPLETED|Overall Study|June 2013|52
36921|NCT01860521|86245|P1|COMPLETED|Overall Study|June 2013|52
36922|NCT01860521|86244|P2|STARTED|Overall Study|September 2011|52
36923|NCT01860521|86245|P1|STARTED|Overall Study|September 2011|52
36924|NCT01860170|86260|P3|NOT COMPLETED|Overall Study||0
36925|NCT01860170|86261|P2|NOT COMPLETED|Overall Study||0
36926|NCT01860170|86262|P1|NOT COMPLETED|Overall Study||0
36927|NCT01860170|86260|P3|COMPLETED|Overall Study||22
36928|NCT01860170|86261|P2|COMPLETED|Overall Study||3
36929|NCT01860170|86262|P1|COMPLETED|Overall Study||3
36930|NCT01860170|86260|P3|STARTED|Overall Study||22
36931|NCT01860170|86261|P2|STARTED|Overall Study||3
36932|NCT01860170|86262|P1|STARTED|Overall Study||3
36933|NCT01860079|86278|P2|NOT COMPLETED|Overall Study||22
36934|NCT01860079|86279|P1|NOT COMPLETED|Overall Study||14
36935|NCT01860079|86278|P2|COMPLETED|Overall Study||363
36936|NCT01860079|86279|P1|COMPLETED|Overall Study||370
36937|NCT01860079|86278|P2|STARTED|Overall Study||385
36938|NCT01860079|86279|P1|STARTED|Overall Study||384
36939|NCT01859988|86291|P6|NOT COMPLETED|Overall Study||19
36940|NCT01859988|86292|P5|NOT COMPLETED|Overall Study||23
36941|NCT01859988|86293|P4|NOT COMPLETED|Overall Study||10
36942|NCT01859988|86294|P3|NOT COMPLETED|Overall Study||28
36943|NCT01859988|86295|P2|NOT COMPLETED|Overall Study||12
36944|NCT01859988|86296|P1|NOT COMPLETED|Overall Study||11
36945|NCT01859988|86291|P6|COMPLETED|Overall Study||42
36946|NCT01859988|86292|P5|COMPLETED|Overall Study||42
36947|NCT01859988|86293|P4|COMPLETED|Overall Study||55
36948|NCT01859988|86294|P3|COMPLETED|Overall Study||34
36949|NCT01859988|86295|P2|COMPLETED|Overall Study||52
36950|NCT01859988|86296|P1|COMPLETED|Overall Study||52
36951|NCT01859988|86291|P6|Treated|Overall Study||61
36952|NCT01859988|86292|P5|Treated|Overall Study||65
36953|NCT01859988|86293|P4|Treated|Overall Study||65
36954|NCT01859988|86294|P3|Treated|Overall Study||61
36955|NCT01859988|86295|P2|Treated|Overall Study||64
36956|NCT01859988|86296|P1|Treated|Overall Study||63
36957|NCT01859988|86291|P6|STARTED|Overall Study||61
36958|NCT01859988|86292|P5|STARTED|Overall Study||65
36959|NCT01859988|86293|P4|STARTED|Overall Study||65
36960|NCT01859988|86294|P3|STARTED|Overall Study||62
36961|NCT01859988|86295|P2|STARTED|Overall Study||64
36962|NCT01859988|86296|P1|STARTED|Overall Study||63
36963|NCT01859949|86390|P2|NOT COMPLETED|Overall Study||17
36964|NCT01859949|86391|P1|NOT COMPLETED|Overall Study||14
36965|NCT01859949|86390|P2|COMPLETED|Overall Study||15
36966|NCT01859949|86391|P1|COMPLETED|Overall Study||15
36967|NCT01859949|86390|P2|STARTED|Overall Study|Treated participants|32
36968|NCT01859949|86391|P1|STARTED|Overall Study|Treated participants|29
36969|NCT01859793|86409|P2|NOT COMPLETED|2nd Intervention Period||0
36970|NCT01859793|86410|P1|NOT COMPLETED|2nd Intervention Period||0
36971|NCT01859793|86409|P2|COMPLETED|2nd Intervention Period||16
36972|NCT01859793|86410|P1|COMPLETED|2nd Intervention Period||14
36973|NCT01859793|86409|P2|STARTED|2nd Intervention Period||16
36974|NCT01859793|86410|P1|STARTED|2nd Intervention Period||14
36975|NCT01859793|86409|P2|NOT COMPLETED|Washout Period (4 Weeks)||1
36976|NCT01859793|86410|P1|NOT COMPLETED|Washout Period (4 Weeks)||1
36977|NCT01859793|86409|P2|COMPLETED|Washout Period (4 Weeks)||16
36978|NCT01859793|86410|P1|COMPLETED|Washout Period (4 Weeks)||14
36979|NCT01859793|86409|P2|STARTED|Washout Period (4 Weeks)||17
36980|NCT01859793|86410|P1|STARTED|Washout Period (4 Weeks)||15
36981|NCT01859793|86409|P2|NOT COMPLETED|First Intervention (8 Weeks)||1
36982|NCT01859793|86410|P1|NOT COMPLETED|First Intervention (8 Weeks)||5
36983|NCT01859793|86409|P2|COMPLETED|First Intervention (8 Weeks)||17
36984|NCT01859793|86410|P1|COMPLETED|First Intervention (8 Weeks)||15
36985|NCT01859793|86409|P2|STARTED|First Intervention (8 Weeks)||18
36986|NCT01859793|86410|P1|STARTED|First Intervention (8 Weeks)||20
36987|NCT01859715|86423|P3|NOT COMPLETED|Overall Study||23
36988|NCT01859715|86424|P2|NOT COMPLETED|Overall Study||8
36989|NCT01859715|86425|P1|NOT COMPLETED|Overall Study||16
36990|NCT01859715|86423|P3|COMPLETED|Overall Study||93
36991|NCT01859715|86424|P2|COMPLETED|Overall Study||83
36992|NCT01859715|86425|P1|COMPLETED|Overall Study||125
36993|NCT01859715|86423|P3|STARTED|Overall Study||116
36994|NCT01859715|86424|P2|STARTED|Overall Study||91
36995|NCT01859715|86425|P1|STARTED|Overall Study||141
36996|NCT01859702|86436|P1|NOT COMPLETED|Overall Study||5
36997|NCT01859702|86436|P1|COMPLETED|Overall Study||31
36998|NCT01859702|86436|P1|STARTED|Overall Study||36
36999|NCT01859637|86440|P1|NOT COMPLETED|Overall Study||0
37000|NCT01859637|86440|P1|COMPLETED|Overall Study||6
37001|NCT01859637|86440|P1|STARTED|Overall Study||6
37002|NCT01859611|86446|P1|NOT COMPLETED|Overall Study||8
37003|NCT01859611|86446|P1|COMPLETED|Overall Study||43
37004|NCT01859611|86446|P1|STARTED|Overall Study||51
37005|NCT01859598|86450|P1|NOT COMPLETED|Visit 3 at 6 Months||912
37006|NCT01859598|86450|P1|COMPLETED|Visit 3 at 6 Months|Loss to follow-up, N=1517; Come back at visit 3, N=605;|16341
37007|NCT01859598|86450|P1|STARTED|Visit 3 at 6 Months||17253
37008|NCT01859598|86450|P1|NOT COMPLETED|Visit 2 at 3 Months||1742
37009|NCT01859598|86450|P1|COMPLETED|Visit 2 at 3 Months||17253
37010|NCT01859598|86450|P1|STARTED|Visit 2 at 3 Months|At visit 1, patients remained at baseline, N=18995|18995
37011|NCT01859507|86458|P1|NOT COMPLETED|Overall Study||4
37012|NCT01859507|86458|P1|COMPLETED|Overall Study||28
37013|NCT01859507|86458|P1|STARTED|Overall Study||32
37014|NCT01859494|86463|P1|NOT COMPLETED|Overall Study||1
37015|NCT01859494|86463|P1|COMPLETED|Overall Study||218
37016|NCT01859494|86463|P1|STARTED|Overall Study||219
37017|NCT01859390|86474|P2|NOT COMPLETED|Overall Study||7
37018|NCT01859390|86475|P1|NOT COMPLETED|Overall Study||1
37019|NCT01859390|86474|P2|COMPLETED|Overall Study||30
37020|NCT01859390|86475|P1|COMPLETED|Overall Study||35
37021|NCT01859390|86474|P2|Withdrawals|Overall Study||2
37022|NCT01859390|86475|P1|Withdrawals|Overall Study||2
37023|NCT01859390|86474|P2|STARTED|Overall Study||37
37024|NCT01859390|86475|P1|STARTED|Overall Study||36
37025|NCT01859247|86505|P8|NOT COMPLETED|Overall Study||0
37026|NCT01859247|86506|P7|NOT COMPLETED|Overall Study||0
37027|NCT01859247|86507|P6|NOT COMPLETED|Overall Study||0
37028|NCT01859247|86508|P5|NOT COMPLETED|Overall Study||0
37029|NCT01859247|86509|P4|NOT COMPLETED|Overall Study||0
37030|NCT01859247|86510|P3|NOT COMPLETED|Overall Study||0
37031|NCT01859247|86511|P2|NOT COMPLETED|Overall Study||0
37032|NCT01859247|86512|P1|NOT COMPLETED|Overall Study||0
37033|NCT01859247|86505|P8|COMPLETED|Overall Study||1
37034|NCT01859247|86506|P7|COMPLETED|Overall Study||1
37035|NCT01859247|86507|P6|COMPLETED|Overall Study||1
37036|NCT01859247|86508|P5|COMPLETED|Overall Study||1
37037|NCT01859247|86509|P4|COMPLETED|Overall Study||1
37038|NCT01859247|86510|P3|COMPLETED|Overall Study||1
37039|NCT01859247|86511|P2|COMPLETED|Overall Study||1
37040|NCT01859247|86512|P1|COMPLETED|Overall Study||1
37041|NCT01859247|86505|P8|STARTED|Overall Study||1
37042|NCT01859247|86506|P7|STARTED|Overall Study||1
37043|NCT01859247|86507|P6|STARTED|Overall Study||1
37044|NCT01859247|86508|P5|STARTED|Overall Study||1
37045|NCT01859247|86509|P4|STARTED|Overall Study||1
37046|NCT01859247|86510|P3|STARTED|Overall Study||1
37047|NCT01859247|86511|P2|STARTED|Overall Study||1
37048|NCT01859247|86512|P1|STARTED|Overall Study||1
37049|NCT01859143|86539|P2|NOT COMPLETED|Overall Study||0
37050|NCT01859143|86540|P1|NOT COMPLETED|Overall Study||2
37051|NCT01859143|86539|P2|COMPLETED|Overall Study||60
37052|NCT01859143|86540|P1|COMPLETED|Overall Study||238
37053|NCT01859143|86539|P2|STARTED|Overall Study|One participant in this group received trivalent influenza vaccine on Day 1.|60
37054|NCT01859143|86540|P1|STARTED|Overall Study||240
37055|NCT01859078|86554|P1|NOT COMPLETED|Overall Study||0
37056|NCT01859078|86554|P1|COMPLETED|Overall Study||28
37057|NCT01859078|86554|P1|STARTED|Overall Study||28
37058|NCT01859013|86570|P2|NOT COMPLETED|Overall Study||5
37059|NCT01859013|86571|P1|NOT COMPLETED|Overall Study||4
37060|NCT01859013|86570|P2|COMPLETED|Overall Study||9
37061|NCT01859013|86571|P1|COMPLETED|Overall Study||12
37062|NCT01859013|86570|P2|STARTED|Overall Study||14
37063|NCT01859013|86571|P1|STARTED|Overall Study||16
37064|NCT01858766|86596|P19|NOT COMPLETED|Overall Study||4
37065|NCT01858766|86597|P18|NOT COMPLETED|Overall Study||4
37066|NCT01858766|86598|P17|NOT COMPLETED|Overall Study||3
37067|NCT01858766|86599|P16|NOT COMPLETED|Overall Study||6
37068|NCT01858766|86600|P15|NOT COMPLETED|Overall Study||8
37069|NCT01858766|86601|P14|NOT COMPLETED|Overall Study||3
37070|NCT01858766|86602|P13|NOT COMPLETED|Overall Study||5
37071|NCT01858766|86603|P12|NOT COMPLETED|Overall Study||5
37072|NCT01858766|86604|P11|NOT COMPLETED|Overall Study||0
37073|NCT01858766|86605|P10|NOT COMPLETED|Overall Study||0
37074|NCT01858766|86606|P9|NOT COMPLETED|Overall Study||0
37075|NCT01858766|86607|P8|NOT COMPLETED|Overall Study||2
37076|NCT01858766|86608|P7|NOT COMPLETED|Overall Study||0
37077|NCT01858766|86609|P6|NOT COMPLETED|Overall Study||4
37078|NCT01858766|86610|P5|NOT COMPLETED|Overall Study||1
37079|NCT01858766|86611|P4|NOT COMPLETED|Overall Study||0
37080|NCT01858766|86612|P3|NOT COMPLETED|Overall Study||1
37081|NCT01858766|86613|P2|NOT COMPLETED|Overall Study||0
37082|NCT01858766|86614|P1|NOT COMPLETED|Overall Study||1
37083|NCT01858766|86596|P19|COMPLETED|Overall Study||22
37084|NCT01858766|86597|P18|COMPLETED|Overall Study||23
37085|NCT01858766|86598|P17|COMPLETED|Overall Study||22
37086|NCT01858766|86599|P16|COMPLETED|Overall Study||20
37087|NCT01858766|86600|P15|COMPLETED|Overall Study||23
37088|NCT01858766|86601|P14|COMPLETED|Overall Study||26
37089|NCT01858766|86602|P13|COMPLETED|Overall Study||25
37090|NCT01858766|86603|P12|COMPLETED|Overall Study||25
37091|NCT01858766|86604|P11|COMPLETED|Overall Study||5
37092|NCT01858766|86605|P10|COMPLETED|Overall Study||4
37093|NCT01858766|86606|P9|COMPLETED|Overall Study||1
37094|NCT01858766|86607|P8|COMPLETED|Overall Study||5
37095|NCT01858766|86608|P7|COMPLETED|Overall Study||7
37096|NCT01858766|86609|P6|COMPLETED|Overall Study||24
37097|NCT01858766|86610|P5|COMPLETED|Overall Study||26
37098|NCT01858766|86611|P4|COMPLETED|Overall Study||10
37099|NCT01858766|86612|P3|COMPLETED|Overall Study||10
37100|NCT01858766|86613|P2|COMPLETED|Overall Study||28
37101|NCT01858766|86614|P1|COMPLETED|Overall Study||26
37102|NCT01858766|86596|P19|STARTED|Overall Study||26
37103|NCT01858766|86597|P18|STARTED|Overall Study||27
37104|NCT01858766|86598|P17|STARTED|Overall Study||25
37105|NCT01858766|86599|P16|STARTED|Overall Study||26
37106|NCT01858766|86600|P15|STARTED|Overall Study||31
37107|NCT01858766|86601|P14|STARTED|Overall Study||29
37108|NCT01858766|86602|P13|STARTED|Overall Study||30
37109|NCT01858766|86603|P12|STARTED|Overall Study||30
37110|NCT01858766|86604|P11|STARTED|Overall Study||5
37111|NCT01858766|86605|P10|STARTED|Overall Study||4
37112|NCT01858766|86606|P9|STARTED|Overall Study||1
37113|NCT01858766|86607|P8|STARTED|Overall Study||7
37114|NCT01858766|86608|P7|STARTED|Overall Study||7
37115|NCT01858766|86609|P6|STARTED|Overall Study||28
37116|NCT01858766|86610|P5|STARTED|Overall Study||27
37117|NCT01858766|86611|P4|STARTED|Overall Study||10
37118|NCT01858766|86612|P3|STARTED|Overall Study||11
37119|NCT01858766|86613|P2|STARTED|Overall Study||28
37120|NCT01858766|86614|P1|STARTED|Overall Study||27
37121|NCT01858701|86685|P2|NOT COMPLETED|Period 2, Second 30 Days of Wear||1
37122|NCT01858701|86686|P1|NOT COMPLETED|Period 2, Second 30 Days of Wear||0
37123|NCT01858701|86685|P2|COMPLETED|Period 2, Second 30 Days of Wear||16
37124|NCT01858701|86686|P1|COMPLETED|Period 2, Second 30 Days of Wear||18
37125|NCT01858701|86685|P2|STARTED|Period 2, Second 30 Days of Wear||17
37126|NCT01858701|86686|P1|STARTED|Period 2, Second 30 Days of Wear||18
37127|NCT01858701|86685|P2|NOT COMPLETED|Washout Period, 1-13 Days||2
37128|NCT01858701|86686|P1|NOT COMPLETED|Washout Period, 1-13 Days||2
37129|NCT01858701|86685|P2|COMPLETED|Washout Period, 1-13 Days||17
37130|NCT01858701|86686|P1|COMPLETED|Washout Period, 1-13 Days||18
37131|NCT01858701|86685|P2|STARTED|Washout Period, 1-13 Days||19
37132|NCT01858701|86686|P1|STARTED|Washout Period, 1-13 Days||20
37133|NCT01858701|86685|P2|NOT COMPLETED|Period 1, First 30 Days of Wear||1
37134|NCT01858701|86686|P1|NOT COMPLETED|Period 1, First 30 Days of Wear||0
37135|NCT01858701|86685|P2|COMPLETED|Period 1, First 30 Days of Wear||19
37136|NCT01858701|86686|P1|COMPLETED|Period 1, First 30 Days of Wear||20
37137|NCT01858701|86685|P2|STARTED|Period 1, First 30 Days of Wear||20
37138|NCT01858701|86686|P1|STARTED|Period 1, First 30 Days of Wear||20
37139|NCT01858636|86692|P1|NOT COMPLETED|Overall Study||28
37140|NCT01858636|86692|P1|COMPLETED|Overall Study||207
37141|NCT01858636|86692|P1|Device Deployment|Overall Study||211
37142|NCT01858636|86692|P1|STARTED|Overall Study|Subjects consented|235
37143|NCT01858389|86699|P2|NOT COMPLETED|Overall Study||25
37144|NCT01858389|86700|P1|NOT COMPLETED|Overall Study||16
37145|NCT01858389|86699|P2|COMPLETED|Overall Study||0
37146|NCT01858389|86700|P1|COMPLETED|Overall Study||0
37147|NCT01858389|86699|P2|Received Treatment|Overall Study||22
37148|NCT01858389|86700|P1|Received Treatment|Overall Study||16
37149|NCT01858389|86699|P2|STARTED|Overall Study|Enrolled|25
37150|NCT01858389|86700|P1|STARTED|Overall Study|Enrolled|16
37151|NCT01858376|86715|P1|NOT COMPLETED|Overall Study||4
37152|NCT01858376|86715|P1|COMPLETED|Overall Study||20
37153|NCT01858376|86715|P1|STARTED|Overall Study||24
37154|NCT01857986|86723|P2|NOT COMPLETED|Overall Study||7
37155|NCT01857986|86724|P1|NOT COMPLETED|Overall Study||5
37156|NCT01857986|86723|P2|COMPLETED|Overall Study||30
37157|NCT01857986|86724|P1|COMPLETED|Overall Study||34
37158|NCT01857986|86723|P2|STARTED|Overall Study||37
37159|NCT01857986|86724|P1|STARTED|Overall Study||39
37160|NCT01857882|86736|P2|NOT COMPLETED|Overall Study||0
37161|NCT01857882|86737|P1|NOT COMPLETED|Overall Study||0
37162|NCT01857882|86736|P2|COMPLETED|Overall Study||20
37163|NCT01857882|86737|P1|COMPLETED|Overall Study||21
37164|NCT01857882|86736|P2|STARTED|Overall Study||20
37165|NCT01857882|86737|P1|STARTED|Overall Study||21
37166|NCT01857713|86743|P1|NOT COMPLETED|Overall Study||6
37167|NCT01857713|86743|P1|COMPLETED|Overall Study||89
37168|NCT01857713|86743|P1|STARTED|Overall Study||95
37169|NCT01857622|86753|P3|NOT COMPLETED|Overall Study||2
37170|NCT01857622|86754|P2|NOT COMPLETED|Overall Study||1
37171|NCT01857622|86755|P1|NOT COMPLETED|Overall Study||11
37172|NCT01857622|86753|P3|COMPLETED|Overall Study||19
37173|NCT01857622|86754|P2|COMPLETED|Overall Study||21
37174|NCT01857622|86755|P1|COMPLETED|Overall Study||39
37175|NCT01857622|86753|P3|STARTED|Overall Study||21
37176|NCT01857622|86754|P2|STARTED|Overall Study||22
37177|NCT01857622|86755|P1|STARTED|Overall Study||50
37178|NCT01857583|86767|P4|NOT COMPLETED|Overall Study||4
37179|NCT01857583|86768|P3|NOT COMPLETED|Overall Study||3
37180|NCT01857583|86769|P2|NOT COMPLETED|Overall Study||1
37181|NCT01857583|86770|P1|NOT COMPLETED|Overall Study||1
37182|NCT01857583|86767|P4|COMPLETED|Overall Study||17
37183|NCT01857583|86768|P3|COMPLETED|Overall Study||19
37184|NCT01857583|86769|P2|COMPLETED|Overall Study||6
37185|NCT01857583|86770|P1|COMPLETED|Overall Study||29
37186|NCT01857583|86767|P4|Safety Analysis Population|Overall Study||20
37187|NCT01857583|86768|P3|Safety Analysis Population|Overall Study||22
37188|NCT01857583|86769|P2|Safety Analysis Population|Overall Study||7
37189|NCT01857583|86770|P1|Safety Analysis Population|Overall Study||30
37190|NCT01857583|86767|P4|STARTED|Overall Study||21
37191|NCT01857583|86768|P3|STARTED|Overall Study||22
37192|NCT01857583|86769|P2|STARTED|Overall Study||7
37193|NCT01857583|86770|P1|STARTED|Overall Study||30
37194|NCT01857531|86780|P1|NOT COMPLETED|Overall Study||4
37195|NCT01857531|86780|P1|COMPLETED|Overall Study||12
37196|NCT01857531|86780|P1|STARTED|Overall Study||16
37197|NCT01857362|86789|P2|NOT COMPLETED|Overall Study||0
37198|NCT01857362|86790|P1|NOT COMPLETED|Overall Study||0
37199|NCT01857362|86789|P2|COMPLETED|Overall Study||6
37200|NCT01857362|86790|P1|COMPLETED|Overall Study||6
37201|NCT01857362|86789|P2|STARTED|Overall Study||6
37202|NCT01857362|86790|P1|STARTED|Overall Study||6
37203|NCT01857323|86798|P1|NOT COMPLETED|Overall Study||64
37204|NCT01857323|86798|P1|COMPLETED|Overall Study||253
37205|NCT01857323|86798|P1|Safety Population|Overall Study|One enrolled participant was lost to follow-up.|316
37206|NCT01857323|86798|P1|STARTED|Overall Study|36 day treatment cohort: 45 participants 50 day treatment cohort: 272 participants|317
37207|NCT01857297|86809|P2|NOT COMPLETED|Overall Study||0
37208|NCT01857297|86810|P1|NOT COMPLETED|Overall Study||0
37209|NCT01857297|86809|P2|COMPLETED|Overall Study||60
37210|NCT01857297|86810|P1|COMPLETED|Overall Study||60
37211|NCT01857297|86809|P2|STARTED|Overall Study||60
37212|NCT01857297|86810|P1|STARTED|Overall Study||60
37213|NCT01857258|86824|P2|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
37214|NCT01857258|86825|P1|NOT COMPLETED|Second Intervention (3 h Postprandially)||0
37215|NCT01857258|86824|P2|COMPLETED|Second Intervention (3 h Postprandially)||7
37216|NCT01857258|86825|P1|COMPLETED|Second Intervention (3 h Postprandially)||8
37217|NCT01857258|86824|P2|STARTED|Second Intervention (3 h Postprandially)||7
37218|NCT01857258|86825|P1|STARTED|Second Intervention (3 h Postprandially)||8
37219|NCT01857258|86824|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
37220|NCT01857258|86825|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
37221|NCT01857258|86824|P2|COMPLETED|Wash-out Period (7 Days)||7
37222|NCT01857258|86825|P1|COMPLETED|Wash-out Period (7 Days)||8
37223|NCT01857258|86824|P2|STARTED|Wash-out Period (7 Days)||7
37224|NCT01857258|86825|P1|STARTED|Wash-out Period (7 Days)||8
37225|NCT01857258|86824|P2|NOT COMPLETED|First Intervention (3 h Postprandially)||0
37226|NCT01857258|86825|P1|NOT COMPLETED|First Intervention (3 h Postprandially)||0
37227|NCT01857258|86824|P2|COMPLETED|First Intervention (3 h Postprandially)||7
37228|NCT01857258|86825|P1|COMPLETED|First Intervention (3 h Postprandially)||8
37229|NCT01857258|86824|P2|STARTED|First Intervention (3 h Postprandially)||7
37230|NCT01857258|86825|P1|STARTED|First Intervention (3 h Postprandially)||8
37231|NCT01857206|86847|P2|NOT COMPLETED|Overall Study||10
37232|NCT01857206|86848|P1|NOT COMPLETED|Overall Study||13
37233|NCT01857206|86847|P2|COMPLETED|Overall Study||673
37234|NCT01857206|86848|P1|COMPLETED|Overall Study||1359
37235|NCT01857206|86847|P2|STARTED|Overall Study||683
37236|NCT01857206|86848|P1|STARTED|Overall Study||1372
37237|NCT01857102|86866|P2|NOT COMPLETED|Period 2||0
37238|NCT01857102|86867|P1|NOT COMPLETED|Period 2||2
37239|NCT01857102|86866|P2|COMPLETED|Period 2||51
37240|NCT01857102|86867|P1|COMPLETED|Period 2||53
37241|NCT01857102|86866|P2|Neophytes|Period 2||4
37242|NCT01857102|86867|P1|Neophytes|Period 2||7
37243|NCT01857102|86866|P2|Habitual Users|Period 2||47
37244|NCT01857102|86867|P1|Habitual Users|Period 2||48
37245|NCT01857102|86866|P2|STARTED|Period 2||51
37246|NCT01857102|86867|P1|STARTED|Period 2||55
37247|NCT01857102|86866|P2|NOT COMPLETED|Period 1||5
37248|NCT01857102|86867|P1|NOT COMPLETED|Period 1||3
37249|NCT01857102|86866|P2|COMPLETED|Period 1||51
37250|NCT01857102|86867|P1|COMPLETED|Period 1||55
37251|NCT01857102|86866|P2|Neophtyes|Period 1||4
37252|NCT01857102|86867|P1|Neophtyes|Period 1||7
37253|NCT01857102|86866|P2|Habitual Users|Period 1||52
37254|NCT01857102|86867|P1|Habitual Users|Period 1||51
37255|NCT01857102|86866|P2|STARTED|Period 1||56
37256|NCT01857102|86867|P1|STARTED|Period 1||58
37257|NCT01857063|86877|P2|NOT COMPLETED|Period 2 (7 Days)||2
37258|NCT01857063|86878|P1|NOT COMPLETED|Period 2 (7 Days)||4
37259|NCT01857063|86877|P2|COMPLETED|Period 2 (7 Days)||104
37260|NCT01857063|86878|P1|COMPLETED|Period 2 (7 Days)||104
37261|NCT01857063|86877|P2|STARTED|Period 2 (7 Days)||106
37262|NCT01857063|86878|P1|STARTED|Period 2 (7 Days)||108
37263|NCT01857063|86877|P2|NOT COMPLETED|Period 1 (7 Days)||4
37264|NCT01857063|86878|P1|NOT COMPLETED|Period 1 (7 Days)||2
37265|NCT01857063|86877|P2|COMPLETED|Period 1 (7 Days)||106
37266|NCT01857063|86878|P1|COMPLETED|Period 1 (7 Days)||108
37267|NCT01857063|86877|P2|STARTED|Period 1 (7 Days)||110
37268|NCT01857063|86878|P1|STARTED|Period 1 (7 Days)||110
37269|NCT01856933|86904|P1|NOT COMPLETED|Overall Study||0
37270|NCT01856933|86904|P1|COMPLETED|Overall Study||6
37271|NCT01856933|86904|P1|STARTED|Overall Study||6
37272|NCT01856764|86910|P2|NOT COMPLETED|Overall Study||0
37273|NCT01856764|86911|P1|NOT COMPLETED|Overall Study||0
37274|NCT01856764|86910|P2|COMPLETED|Overall Study||20
37275|NCT01856764|86911|P1|COMPLETED|Overall Study||20
37276|NCT01856764|86910|P2|STARTED|Overall Study||20
37277|NCT01856764|86911|P1|STARTED|Overall Study||20
37278|NCT01856686|86923|P2|NOT COMPLETED|Overall Study||11
37279|NCT01856686|86924|P1|NOT COMPLETED|Overall Study||5
37280|NCT01856686|86923|P2|COMPLETED|Overall Study||22
37281|NCT01856686|86924|P1|COMPLETED|Overall Study||26
37282|NCT01856686|86923|P2|STARTED|Overall Study||33
37283|NCT01856686|86924|P1|STARTED|Overall Study||31
37284|NCT01856673|86967|P3|NOT COMPLETED|Overall Study||34
37285|NCT01856673|86968|P2|NOT COMPLETED|Overall Study||85
37286|NCT01856673|86969|P1|NOT COMPLETED|Overall Study||98
37287|NCT01856673|86967|P3|COMPLETED|Overall Study||137
37288|NCT01856673|86968|P2|COMPLETED|Overall Study|A percentage of 80.9% completed the follow-up (exit survey)|90
37289|NCT01856673|86969|P1|COMPLETED|Overall Study|A percentage of 75.1% completed the follow-up (exit survey)|77
37290|NCT01856673|86967|P3|Quibdó Participants|Overall Study||83
37291|NCT01856673|86968|P2|Quibdó Participants|Overall Study||86
37292|NCT01856673|86969|P1|Quibdó Participants|Overall Study||83
37293|NCT01856673|86967|P3|Buenaventura Participants|Overall Study||88
37294|NCT01856673|86968|P2|Buenaventura Participants|Overall Study||89
37295|NCT01856673|86969|P1|Buenaventura Participants|Overall Study||92
37296|NCT01856673|86967|P3|STARTED|Overall Study||171
37297|NCT01856673|86968|P2|STARTED|Overall Study||175
37298|NCT01856673|86969|P1|STARTED|Overall Study||175
37299|NCT01856569|86980|P1|NOT COMPLETED|Overall Study||13
37300|NCT01856569|86980|P1|COMPLETED|Overall Study||139
37301|NCT01856569|86980|P1|Full Analysis Set|Overall Study||144
37302|NCT01856569|86980|P1|STARTED|Overall Study||152
37303|NCT01856530|86991|P2|NOT COMPLETED|Overall Study||0
37304|NCT01856530|86992|P1|NOT COMPLETED|Overall Study||0
37305|NCT01856530|86991|P2|COMPLETED|Overall Study||27
37306|NCT01856530|86992|P1|COMPLETED|Overall Study||27
37307|NCT01856530|86991|P2|STARTED|Overall Study||27
37308|NCT01856530|86992|P1|STARTED|Overall Study||27
37309|NCT01856361|87010|P2|NOT COMPLETED|Overall Study||0
37310|NCT01856361|87011|P1|NOT COMPLETED|Overall Study||0
37311|NCT01856361|87010|P2|COMPLETED|Overall Study||1
37312|NCT01856361|87011|P1|COMPLETED|Overall Study||1
37313|NCT01856361|87010|P2|STARTED|Overall Study||1
37314|NCT01856361|87011|P1|STARTED|Overall Study||1
37315|NCT01856322|87028|P3|NOT COMPLETED|Overall Study||3
37316|NCT01856322|87029|P2|NOT COMPLETED|Overall Study||0
37317|NCT01856322|87030|P1|NOT COMPLETED|Overall Study||0
37318|NCT01856322|87028|P3|COMPLETED|Overall Study||0
37319|NCT01856322|87029|P2|COMPLETED|Overall Study||0
37320|NCT01856322|87030|P1|COMPLETED|Overall Study||0
37321|NCT01856322|87028|P3|STARTED|Overall Study||3
37322|NCT01856322|87029|P2|STARTED|Overall Study||0
37323|NCT01856322|87030|P1|STARTED|Overall Study||0
37324|NCT01856257|87040|P4|NOT COMPLETED|Overall Study||2
37325|NCT01856257|87041|P3|NOT COMPLETED|Overall Study||0
37326|NCT01856257|87042|P2|NOT COMPLETED|Overall Study||1
37327|NCT01856257|87043|P1|NOT COMPLETED|Overall Study||3
37328|NCT01856257|87040|P4|COMPLETED|Overall Study||0
37329|NCT01856257|87041|P3|COMPLETED|Overall Study||11
37330|NCT01856257|87042|P2|COMPLETED|Overall Study||28
37331|NCT01856257|87043|P1|COMPLETED|Overall Study||26
37332|NCT01856257|87040|P4|STARTED|Overall Study||2
37333|NCT01856257|87041|P3|STARTED|Overall Study||11
37334|NCT01856257|87042|P2|STARTED|Overall Study||29
37335|NCT01856257|87043|P1|STARTED|Overall Study||29
37336|NCT01855997|87142|P1|NOT COMPLETED|Overall Study||0
37337|NCT01855997|87142|P1|COMPLETED|Overall Study||1669
37338|NCT01855997|87142|P1|STARTED|Overall Study||1669
37339|NCT01855958|87197|P2|NOT COMPLETED|Overall Study||0
37340|NCT01855958|87198|P1|NOT COMPLETED|Overall Study||1
37341|NCT01855958|87197|P2|COMPLETED|Overall Study||13
37342|NCT01855958|87198|P1|COMPLETED|Overall Study||12
37343|NCT01855958|87197|P2|STARTED|Overall Study||13
37344|NCT01855958|87198|P1|STARTED|Overall Study||13
37345|NCT01855945|87228|P12|NOT COMPLETED|Overall Study||3
37346|NCT01855945|87229|P11|NOT COMPLETED|Overall Study||5
37347|NCT01855945|87230|P10|NOT COMPLETED|Overall Study||2
37348|NCT01855945|87231|P9|NOT COMPLETED|Overall Study||2
37349|NCT01855945|87232|P8|NOT COMPLETED|Overall Study||8
37350|NCT01855945|87233|P7|NOT COMPLETED|Overall Study||10
37351|NCT01855945|87234|P6|NOT COMPLETED|Overall Study||3
37352|NCT01855945|87235|P5|NOT COMPLETED|Overall Study||1
37353|NCT01855945|87236|P4|NOT COMPLETED|Overall Study||4
37354|NCT01855945|87237|P3|NOT COMPLETED|Overall Study||12
37355|NCT01855945|87238|P2|NOT COMPLETED|Overall Study||11
37356|NCT01855945|87239|P1|NOT COMPLETED|Overall Study||16
37357|NCT01855945|87228|P12|COMPLETED|Overall Study||49
37358|NCT01855945|87229|P11|COMPLETED|Overall Study||46
37359|NCT01855945|87230|P10|COMPLETED|Overall Study||49
37360|NCT01855945|87231|P9|COMPLETED|Overall Study||46
37361|NCT01855945|87232|P8|COMPLETED|Overall Study||47
37362|NCT01855945|87233|P7|COMPLETED|Overall Study||43
37363|NCT01855945|87234|P6|COMPLETED|Overall Study||50
37364|NCT01855945|87235|P5|COMPLETED|Overall Study||50
37365|NCT01855945|87236|P4|COMPLETED|Overall Study||49
37366|NCT01855945|87237|P3|COMPLETED|Overall Study||39
37367|NCT01855945|87238|P2|COMPLETED|Overall Study||44
37368|NCT01855945|87239|P1|COMPLETED|Overall Study||38
37369|NCT01855945|87228|P12|STARTED|Overall Study||52
37370|NCT01855945|87229|P11|STARTED|Overall Study||51
37371|NCT01855945|87230|P10|STARTED|Overall Study||51
37372|NCT01855945|87231|P9|STARTED|Overall Study||48
37373|NCT01855945|87232|P8|STARTED|Overall Study||55
37374|NCT01855945|87233|P7|STARTED|Overall Study||53
37375|NCT01855945|87234|P6|STARTED|Overall Study||53
37376|NCT01855945|87235|P5|STARTED|Overall Study||51
37377|NCT01855945|87236|P4|STARTED|Overall Study||53
37378|NCT01855945|87237|P3|STARTED|Overall Study||51
37379|NCT01855945|87238|P2|STARTED|Overall Study||55
37380|NCT01855945|87239|P1|STARTED|Overall Study||54
37381|NCT01855919|87375|P2|NOT COMPLETED|Overall Study||26
37382|NCT01855919|87376|P1|NOT COMPLETED|Overall Study||23
37383|NCT01855919|87375|P2|COMPLETED|Overall Study||200
37384|NCT01855919|87376|P1|COMPLETED|Overall Study||209
37385|NCT01855919|87375|P2|Received at Least 1 Dose of Study Drug|Overall Study||226
37386|NCT01855919|87376|P1|Received at Least 1 Dose of Study Drug|Overall Study||232
37387|NCT01855919|87375|P2|STARTED|Overall Study||226
37388|NCT01855919|87376|P1|STARTED|Overall Study||232
37389|NCT01855074|87408|P1|NOT COMPLETED|Overall Study||14
37390|NCT01855074|87408|P1|COMPLETED|Overall Study||66
37391|NCT01855074|87408|P1|Treated|Overall Study||79
37392|NCT01855074|87408|P1|STARTED|Overall Study||80
37393|NCT01854944|87420|P3|NOT COMPLETED|Overall Study||1
37394|NCT01854944|87421|P2|NOT COMPLETED|Overall Study||0
37395|NCT01854944|87422|P1|NOT COMPLETED|Overall Study||0
37396|NCT01854944|87420|P3|COMPLETED|Overall Study||3
37397|NCT01854944|87421|P2|COMPLETED|Overall Study||4
37398|NCT01854944|87422|P1|COMPLETED|Overall Study||4
37399|NCT01854944|87420|P3|STARTED|Overall Study||4
37400|NCT01854944|87421|P2|STARTED|Overall Study||4
37401|NCT01854944|87422|P1|STARTED|Overall Study||4
37402|NCT01854905|87472|P1|NOT COMPLETED|Overall Study||0
37403|NCT01854905|87472|P1|COMPLETED|Overall Study||400
37404|NCT01854905|87472|P1|STARTED|Overall Study||400
37405|NCT01853839|87476|P1|NOT COMPLETED|Overall Study||429
37406|NCT01853839|87476|P1|COMPLETED|Overall Study||1663
37407|NCT01853839|87476|P1|STARTED|Overall Study||2092
37408|NCT01854697|87501|P5|NOT COMPLETED|Overall Study||2
37409|NCT01854697|87502|P4|NOT COMPLETED|Overall Study||3
37410|NCT01854697|87503|P3|NOT COMPLETED|Overall Study||2
37411|NCT01854697|87504|P2|NOT COMPLETED|Overall Study||3
37412|NCT01854697|87505|P1|NOT COMPLETED|Overall Study||6
37413|NCT01854697|87501|P5|COMPLETED|Overall Study||39
37414|NCT01854697|87502|P4|COMPLETED|Overall Study||80
37415|NCT01854697|87503|P3|COMPLETED|Overall Study||82
37416|NCT01854697|87504|P2|COMPLETED|Overall Study||31
37417|NCT01854697|87505|P1|COMPLETED|Overall Study||63
37418|NCT01854697|87501|P5|STARTED|Overall Study||41
37419|NCT01854697|87502|P4|STARTED|Overall Study||83
37420|NCT01854697|87503|P3|STARTED|Overall Study||84
37421|NCT01854697|87504|P2|STARTED|Overall Study||34
37422|NCT01854697|87505|P1|STARTED|Overall Study||69
37423|NCT01854658|87549|P4|NOT COMPLETED|Overall Study||59
37424|NCT01854658|87550|P3|NOT COMPLETED|Overall Study||80
37425|NCT01854658|87551|P2|NOT COMPLETED|Overall Study||75
37426|NCT01854658|87552|P1|NOT COMPLETED|Overall Study||93
37427|NCT01854658|87549|P4|COMPLETED|Overall Study||165
37428|NCT01854658|87550|P3|COMPLETED|Overall Study||432
37429|NCT01854658|87551|P2|COMPLETED|Overall Study||365
37430|NCT01854658|87552|P1|COMPLETED|Overall Study||346
37431|NCT01854658|87549|P4|STARTED|Overall Study||224
37432|NCT01854658|87550|P3|STARTED|Overall Study||512
37433|NCT01854658|87551|P2|STARTED|Overall Study||440
37434|NCT01854658|87552|P1|STARTED|Overall Study||439
37435|NCT01854645|87587|P5|NOT COMPLETED|Overall Study||60
37436|NCT01854645|87588|P4|NOT COMPLETED|Overall Study||62
37437|NCT01854645|87589|P3|NOT COMPLETED|Overall Study||82
37438|NCT01854645|87590|P2|NOT COMPLETED|Overall Study||106
37439|NCT01854645|87591|P1|NOT COMPLETED|Overall Study||98
37440|NCT01854645|87587|P5|COMPLETED|Overall Study||160
37441|NCT01854645|87588|P4|COMPLETED|Overall Study||391
37442|NCT01854645|87589|P3|COMPLETED|Overall Study||370
37443|NCT01854645|87590|P2|COMPLETED|Overall Study||345
37444|NCT01854645|87591|P1|COMPLETED|Overall Study||429
37445|NCT01854645|87587|P5|STARTED|Overall Study||220
37446|NCT01854645|87588|P4|STARTED|Overall Study||453
37447|NCT01854645|87589|P3|STARTED|Overall Study||452
37448|NCT01854645|87590|P2|STARTED|Overall Study||451
37449|NCT01854645|87591|P1|STARTED|Overall Study||527
37450|NCT01854632|87630|P2|NOT COMPLETED|Overall Study||13
37451|NCT01854632|87631|P1|NOT COMPLETED|Overall Study||26
37452|NCT01854632|87630|P2|COMPLETED|Overall Study||574
37453|NCT01854632|87631|P1|COMPLETED|Overall Study||1148
37454|NCT01854632|87630|P2|STARTED|Overall Study||587
37455|NCT01854632|87631|P1|STARTED|Overall Study||1174
37456|NCT01854593|87639|P2|NOT COMPLETED|Overall Study||1
37457|NCT01854593|87640|P1|NOT COMPLETED|Overall Study||2
37458|NCT01854593|87639|P2|COMPLETED|Overall Study||34
37459|NCT01854593|87640|P1|COMPLETED|Overall Study||32
37460|NCT01854593|87639|P2|STARTED|Overall Study||35
37461|NCT01854593|87640|P1|STARTED|Overall Study||34
37462|NCT01854528|87672|P2|NOT COMPLETED|Overall Study||15
37463|NCT01854528|87673|P1|NOT COMPLETED|Overall Study||0
37464|NCT01854528|87672|P2|COMPLETED|Overall Study||32
37465|NCT01854528|87673|P1|COMPLETED|Overall Study||101
37466|NCT01854528|87672|P2|STARTED|Overall Study||47
37467|NCT01854528|87673|P1|STARTED|Overall Study||101
37468|NCT01854281|87693|P4|NOT COMPLETED|Overall Study||0
37469|NCT01854281|87694|P3|NOT COMPLETED|Overall Study||0
37470|NCT01854281|87695|P2|NOT COMPLETED|Overall Study||0
37471|NCT01854281|87696|P1|NOT COMPLETED|Overall Study||0
37472|NCT01854281|87693|P4|COMPLETED|Overall Study||8
37473|NCT01854281|87694|P3|COMPLETED|Overall Study||5
37474|NCT01854281|87695|P2|COMPLETED|Overall Study||19
37475|NCT01854281|87696|P1|COMPLETED|Overall Study||15
37476|NCT01854281|87693|P4|STARTED|Overall Study||8
37477|NCT01854281|87694|P3|STARTED|Overall Study||5
37478|NCT01854281|87695|P2|STARTED|Overall Study||19
37479|NCT01854281|87696|P1|STARTED|Overall Study||15
37480|NCT01854268|87706|P1|NOT COMPLETED|Overall Study||0
37481|NCT01854268|87706|P1|COMPLETED|Overall Study||25
37482|NCT01854268|87706|P1|STARTED|Overall Study||25
37483|NCT01854242|87712|P1|NOT COMPLETED|Overall Study||0
37484|NCT01854242|87712|P1|COMPLETED|Overall Study||50
37485|NCT01854242|87712|P1|STARTED|Overall Study||50
37486|NCT01854047|87721|P5|NOT COMPLETED|Overall Study||19
37487|NCT01854047|87722|P4|NOT COMPLETED|Overall Study||15
37488|NCT01854047|87723|P3|NOT COMPLETED|Overall Study||13
37489|NCT01854047|87724|P2|NOT COMPLETED|Overall Study||8
37490|NCT01854047|87725|P1|NOT COMPLETED|Overall Study||12
37491|NCT01854047|87721|P5|COMPLETED|Overall Study||135
37492|NCT01854047|87722|P4|COMPLETED|Overall Study||142
37493|NCT01854047|87723|P3|COMPLETED|Overall Study||137
37494|NCT01854047|87724|P2|COMPLETED|Overall Study||149
37495|NCT01854047|87725|P1|COMPLETED|Overall Study||146
37496|NCT01854047|87721|P5|Completed 12-week Study Treatment|Overall Study||143
37497|NCT01854047|87722|P4|Completed 12-week Study Treatment|Overall Study||146
37498|NCT01854047|87723|P3|Completed 12-week Study Treatment|Overall Study||141
37499|NCT01854047|87724|P2|Completed 12-week Study Treatment|Overall Study||149
37500|NCT01854047|87725|P1|Completed 12-week Study Treatment|Overall Study||153
37501|NCT01854047|87721|P5|Treated|Overall Study||150
37502|NCT01854047|87722|P4|Treated|Overall Study||157
37503|NCT01854047|87723|P3|Treated|Overall Study||148
37504|NCT01854047|87724|P2|Treated|Overall Study||156
37505|NCT01854047|87725|P1|Treated|Overall Study||158
37506|NCT01854047|87721|P5|STARTED|Overall Study||154
37507|NCT01854047|87722|P4|STARTED|Overall Study||157
37508|NCT01854047|87723|P3|STARTED|Overall Study||150
37509|NCT01854047|87724|P2|STARTED|Overall Study||157
37510|NCT01854047|87725|P1|STARTED|Overall Study||158
37511|NCT01853982|87849|P2|NOT COMPLETED|Overall Study||1
37512|NCT01853982|87850|P1|NOT COMPLETED|Overall Study||2
37513|NCT01853982|87849|P2|COMPLETED|Overall Study||1
37514|NCT01853982|87850|P1|COMPLETED|Overall Study||0
37515|NCT01853982|87849|P2|Received at Least 1 Dose of Study Drug|Overall Study||2
37516|NCT01853982|87850|P1|Received at Least 1 Dose of Study Drug|Overall Study||2
37517|NCT01853982|87849|P2|STARTED|Overall Study||2
37518|NCT01853982|87850|P1|STARTED|Overall Study||2
37519|NCT01853696|87858|P2|NOT COMPLETED|Overall Study||5
37520|NCT01853696|87859|P1|NOT COMPLETED|Overall Study||6
37521|NCT01853696|87858|P2|COMPLETED|Overall Study||78
37522|NCT01853696|87859|P1|COMPLETED|Overall Study||78
37523|NCT01853696|87858|P2|STARTED|Overall Study||83
37524|NCT01853696|87859|P1|STARTED|Overall Study||84
37525|NCT01853605|87871|P4|NOT COMPLETED|Overall Study||0
37526|NCT01853605|87872|P3|NOT COMPLETED|Overall Study||0
37527|NCT01853605|87873|P2|NOT COMPLETED|Overall Study||0
37528|NCT01853605|87874|P1|NOT COMPLETED|Overall Study||0
37529|NCT01853605|87871|P4|COMPLETED|Overall Study||428
37530|NCT01853605|87872|P3|COMPLETED|Overall Study||751
37531|NCT01853605|87873|P2|COMPLETED|Overall Study||693
37532|NCT01853605|87874|P1|COMPLETED|Overall Study||1939
37533|NCT01853605|87871|P4|STARTED|Overall Study||428
37534|NCT01853605|87872|P3|STARTED|Overall Study||751
37535|NCT01853605|87873|P2|STARTED|Overall Study||693
37536|NCT01853605|87874|P1|STARTED|Overall Study||1939
37537|NCT01853475|87895|P3|NOT COMPLETED|Overall Study||0
37538|NCT01853475|87896|P2|NOT COMPLETED|Overall Study||1
37539|NCT01853475|87897|P1|NOT COMPLETED|Overall Study||0
37540|NCT01853475|87895|P3|COMPLETED|Overall Study||8
37541|NCT01853475|87896|P2|COMPLETED|Overall Study||7
37542|NCT01853475|87897|P1|COMPLETED|Overall Study||8
37543|NCT01853475|87895|P3|STARTED|Overall Study||8
37544|NCT01853475|87896|P2|STARTED|Overall Study||8
37545|NCT01853475|87897|P1|STARTED|Overall Study||8
37546|NCT01853397|87918|P4|NOT COMPLETED|Overall Study||2
37547|NCT01853397|87919|P3|NOT COMPLETED|Overall Study||0
37548|NCT01853397|87920|P2|NOT COMPLETED|Overall Study||0
37549|NCT01853397|87921|P1|NOT COMPLETED|Overall Study||0
37550|NCT01853397|87918|P4|COMPLETED|Overall Study||15
37551|NCT01853397|87919|P3|COMPLETED|Overall Study||17
37552|NCT01853397|87920|P2|COMPLETED|Overall Study||20
37553|NCT01853397|87921|P1|COMPLETED|Overall Study||18
37554|NCT01853397|87918|P4|STARTED|Overall Study||17
37555|NCT01853397|87919|P3|STARTED|Overall Study||17
37556|NCT01853397|87920|P2|STARTED|Overall Study||20
37557|NCT01853397|87921|P1|STARTED|Overall Study||18
37558|NCT01853384|87949|P2|NOT COMPLETED|Completed Follow up Visit 2||3
37559|NCT01853384|87950|P1|NOT COMPLETED|Completed Follow up Visit 2||3
37560|NCT01853384|87949|P2|COMPLETED|Completed Follow up Visit 2||91
37561|NCT01853384|87950|P1|COMPLETED|Completed Follow up Visit 2||93
37562|NCT01853384|87949|P2|STARTED|Completed Follow up Visit 2||94
37563|NCT01853384|87950|P1|STARTED|Completed Follow up Visit 2||96
37564|NCT01853384|87949|P2|NOT COMPLETED|Completed Follow up Visit 1||9
37565|NCT01853384|87950|P1|NOT COMPLETED|Completed Follow up Visit 1||14
37566|NCT01853384|87949|P2|COMPLETED|Completed Follow up Visit 1||85
37567|NCT01853384|87950|P1|COMPLETED|Completed Follow up Visit 1||82
37568|NCT01853384|87949|P2|STARTED|Completed Follow up Visit 1||94
37569|NCT01853384|87950|P1|STARTED|Completed Follow up Visit 1||96
37570|NCT01853384|87949|P2|NOT COMPLETED|Enrolled in Follow up Period||0
37571|NCT01853384|87950|P1|NOT COMPLETED|Enrolled in Follow up Period||0
37572|NCT01853384|87949|P2|COMPLETED|Enrolled in Follow up Period||94
37573|NCT01853384|87950|P1|COMPLETED|Enrolled in Follow up Period||96
37574|NCT01853384|87949|P2|Not Enrolled in Follow-up|Enrolled in Follow up Period||27
37575|NCT01853384|87950|P1|Not Enrolled in Follow-up|Enrolled in Follow up Period||35
37576|NCT01853384|87949|P2|STARTED|Enrolled in Follow up Period||94
37577|NCT01853384|87950|P1|STARTED|Enrolled in Follow up Period||96
37578|NCT01853384|87949|P2|NOT COMPLETED|Randomized||46
37579|NCT01853384|87950|P1|NOT COMPLETED|Randomized||62
37580|NCT01853384|87949|P2|COMPLETED|Randomized||75
37581|NCT01853384|87950|P1|COMPLETED|Randomized||69
37582|NCT01853384|87949|P2|STARTED|Randomized||121
37583|NCT01853384|87950|P1|STARTED|Randomized||131
37584|NCT01853371|87970|P2|NOT COMPLETED|Overall Study||2
37585|NCT01853371|87971|P1|NOT COMPLETED|Overall Study||0
37586|NCT01853371|87970|P2|COMPLETED|Overall Study||8
37587|NCT01853371|87971|P1|COMPLETED|Overall Study||10
37588|NCT01853371|87970|P2|STARTED|Overall Study||10
37589|NCT01853371|87971|P1|STARTED|Overall Study||10
37590|NCT01853332|87979|P1|NOT COMPLETED|Overall Study||59
37591|NCT01853332|87979|P1|COMPLETED|Overall Study||151
37592|NCT01853332|87979|P1|STARTED|Overall Study||210
37593|NCT01853254|87988|P1|NOT COMPLETED|Overall Study||104
37594|NCT01853254|87988|P1|COMPLETED|Overall Study||168
37595|NCT01853254|87988|P1|STARTED|Overall Study||272
37596|NCT01853215|87992|P1|NOT COMPLETED|Overall Study||0
37597|NCT01853215|87992|P1|COMPLETED|Overall Study||24
37598|NCT01853215|87992|P1|STARTED|Overall Study||24
37599|NCT01853176|88005|P2|NOT COMPLETED|Overall Study||0
37600|NCT01853176|88006|P1|NOT COMPLETED|Overall Study||4
37601|NCT01853176|88005|P2|COMPLETED|Overall Study||0
37602|NCT01853176|88006|P1|COMPLETED|Overall Study||0
37603|NCT01853176|88005|P2|STARTED|Overall Study||0
37604|NCT01853176|88006|P1|STARTED|Overall Study||4
37605|NCT01853085|88012|P1|NOT COMPLETED|Overall Study||235
37606|NCT01853085|88012|P1|COMPLETED|Overall Study||1595
37607|NCT01853085|88012|P1|STARTED|Overall Study||1830
37608|NCT01853072|88025|P2|NOT COMPLETED|Overall Study||21
37609|NCT01853072|88026|P1|NOT COMPLETED|Overall Study||12
37610|NCT01853072|88025|P2|COMPLETED|Overall Study||286
37611|NCT01853072|88026|P1|COMPLETED|Overall Study||296
37612|NCT01853072|88025|P2|Full Analysis Set|Overall Study||300
37613|NCT01853072|88026|P1|Full Analysis Set|Overall Study||298
37614|NCT01853072|88025|P2|Treated (Safety Analysis Set)|Overall Study||302
37615|NCT01853072|88026|P1|Treated (Safety Analysis Set)|Overall Study||301
37616|NCT01853072|88025|P2|Randomized|Overall Study||307
37617|NCT01853072|88026|P1|Randomized|Overall Study||308
37618|NCT01853072|88025|P2|STARTED|Overall Study||307
37619|NCT01853072|88026|P1|STARTED|Overall Study||308
37620|NCT01853046|88046|P2|NOT COMPLETED|Overall Study||6
37621|NCT01853046|88047|P1|NOT COMPLETED|Overall Study||18
37622|NCT01853046|88046|P2|COMPLETED|Overall Study||0
37623|NCT01853046|88047|P1|COMPLETED|Overall Study||0
37624|NCT01853046|88046|P2|Received Treatment|Overall Study||6
37625|NCT01853046|88047|P1|Received Treatment|Overall Study||18
37626|NCT01853046|88046|P2|STARTED|Overall Study||6
37627|NCT01853046|88047|P1|STARTED|Overall Study||18
37628|NCT01852955|88101|P2|NOT COMPLETED|Overall Study||3
37629|NCT01852955|88102|P1|NOT COMPLETED|Overall Study||2
37630|NCT01852955|88101|P2|COMPLETED|Overall Study||32
37631|NCT01852955|88102|P1|COMPLETED|Overall Study||33
37632|NCT01852955|88101|P2|STARTED|Overall Study||35
37633|NCT01852955|88102|P1|STARTED|Overall Study||35
37634|NCT01852825|88115|P3|NOT COMPLETED|Overall Study||0
37635|NCT01852825|88116|P2|NOT COMPLETED|Overall Study||0
37636|NCT01852825|88117|P1|NOT COMPLETED|Overall Study||2
37637|NCT01852825|88115|P3|COMPLETED|Overall Study||3
37638|NCT01852825|88116|P2|COMPLETED|Overall Study||7
37639|NCT01852825|88117|P1|COMPLETED|Overall Study||14
37640|NCT01852825|88115|P3|STARTED|Overall Study||3
37641|NCT01852825|88116|P2|STARTED|Overall Study||7
37642|NCT01852825|88117|P1|STARTED|Overall Study||16
37643|NCT01852812|88143|P3|NOT COMPLETED|Overall Study||1
37644|NCT01852812|88144|P2|NOT COMPLETED|Overall Study||1
37645|NCT01852812|88145|P1|NOT COMPLETED|Overall Study||0
37646|NCT01852812|88143|P3|COMPLETED|Overall Study||17
37647|NCT01852812|88144|P2|COMPLETED|Overall Study||17
37648|NCT01852812|88145|P1|COMPLETED|Overall Study||51
37649|NCT01852812|88143|P3|STARTED|Overall Study||18
37650|NCT01852812|88144|P2|STARTED|Overall Study||18
37651|NCT01852812|88145|P1|STARTED|Overall Study||51
37652|NCT01851876|88167|P2|NOT COMPLETED|Overall Study||0
37653|NCT01851876|88168|P1|NOT COMPLETED|Overall Study||0
37654|NCT01851876|88167|P2|COMPLETED|Overall Study||62
37655|NCT01851876|88168|P1|COMPLETED|Overall Study||56
37656|NCT01851876|88167|P2|STARTED|Overall Study||62
37657|NCT01851876|88168|P1|STARTED|Overall Study||56
37658|NCT01851863|88178|P4|NOT COMPLETED|Overall Study||3
37659|NCT01851863|88179|P3|NOT COMPLETED|Overall Study||5
37660|NCT01851863|88180|P2|NOT COMPLETED|Overall Study||9
37661|NCT01851863|88181|P1|NOT COMPLETED|Overall Study||5
37662|NCT01851863|88178|P4|COMPLETED|Overall Study||63
37663|NCT01851863|88179|P3|COMPLETED|Overall Study||60
37664|NCT01851863|88180|P2|COMPLETED|Overall Study||57
37665|NCT01851863|88181|P1|COMPLETED|Overall Study||60
37666|NCT01851863|88178|P4|STARTED|Overall Study||66
37667|NCT01851863|88179|P3|STARTED|Overall Study||65
37668|NCT01851863|88180|P2|STARTED|Overall Study||66
37669|NCT01851863|88181|P1|STARTED|Overall Study||65
37670|NCT01851772|88202|P1|NOT COMPLETED|Overall Study||0
37671|NCT01851772|88202|P1|COMPLETED|Overall Study||3
37672|NCT01851772|88202|P1|STARTED|Overall Study||3
37673|NCT01852669|88210|P2|NOT COMPLETED|Overall Study||1
37674|NCT01852669|88211|P1|NOT COMPLETED|Overall Study||0
37675|NCT01852669|88210|P2|COMPLETED|Overall Study|Randomisation error. Patient has protocol violation which necessitated exclusion from analysis|68
37676|NCT01852669|88211|P1|COMPLETED|Overall Study||71
37677|NCT01852669|88210|P2|STARTED|Overall Study||69
37678|NCT01852669|88211|P1|STARTED|Overall Study||71
37679|NCT01852591|88217|P1|NOT COMPLETED|Overall Study||3
37680|NCT01852591|88217|P1|COMPLETED|Overall Study||5
37681|NCT01852591|88217|P1|STARTED|Overall Study||8
37682|NCT01852383|88224|P1|NOT COMPLETED|Overall Study||11
37683|NCT01852383|88224|P1|COMPLETED|Overall Study||19
37684|NCT01852383|88224|P1|STARTED|Overall Study||30
37685|NCT01852214|88231|P2|NOT COMPLETED|Period 2||0
37686|NCT01852214|88232|P1|NOT COMPLETED|Period 2||0
37687|NCT01852214|88231|P2|COMPLETED|Period 2||20
37688|NCT01852214|88232|P1|COMPLETED|Period 2||25
37689|NCT01852214|88231|P2|STARTED|Period 2||20
37690|NCT01852214|88232|P1|STARTED|Period 2||25
37691|NCT01852214|88231|P2|NOT COMPLETED|Washout Period||1
37692|NCT01852214|88232|P1|NOT COMPLETED|Washout Period||0
37693|NCT01852214|88231|P2|COMPLETED|Washout Period||20
37694|NCT01852214|88232|P1|COMPLETED|Washout Period||25
37695|NCT01852214|88231|P2|STARTED|Washout Period||21
37696|NCT01852214|88232|P1|STARTED|Washout Period||25
37697|NCT01852214|88231|P2|NOT COMPLETED|Period 1||3
37698|NCT01852214|88232|P1|NOT COMPLETED|Period 1||1
37699|NCT01852214|88231|P2|COMPLETED|Period 1||21
37700|NCT01852214|88232|P1|COMPLETED|Period 1||25
37701|NCT01852214|88231|P2|STARTED|Period 1||24
37702|NCT01852214|88232|P1|STARTED|Period 1||26
37703|NCT01852175|88246|P2|NOT COMPLETED|Overall Study||0
37704|NCT01852175|88247|P1|NOT COMPLETED|Overall Study||0
37705|NCT01852175|88246|P2|COMPLETED|Overall Study||55
37706|NCT01852175|88247|P1|COMPLETED|Overall Study||55
37707|NCT01852175|88246|P2|STARTED|Overall Study||55
37708|NCT01852175|88247|P1|STARTED|Overall Study||55
37709|NCT01852162|88259|P2|NOT COMPLETED|Overall Study||1
37710|NCT01852162|88260|P1|NOT COMPLETED|Overall Study||4
37711|NCT01852162|88259|P2|COMPLETED|Overall Study||16
37712|NCT01852162|88260|P1|COMPLETED|Overall Study||14
37713|NCT01852162|88259|P2|STARTED|Overall Study||17
37714|NCT01852162|88260|P1|STARTED|Overall Study||18
37715|NCT01852019|88276|P5|NOT COMPLETED|Day 8||0
37716|NCT01852019|88277|P4|NOT COMPLETED|Day 8||0
37717|NCT01852019|88278|P3|NOT COMPLETED|Day 8||0
37718|NCT01852019|88279|P2|NOT COMPLETED|Day 8||0
37719|NCT01852019|88280|P1|NOT COMPLETED|Day 8||0
37720|NCT01852019|88276|P5|COMPLETED|Day 8||6
37721|NCT01852019|88277|P4|COMPLETED|Day 8||6
37722|NCT01852019|88278|P3|COMPLETED|Day 8||0
37723|NCT01852019|88279|P2|COMPLETED|Day 8||0
37724|NCT01852019|88280|P1|COMPLETED|Day 8||0
37725|NCT01852019|88276|P5|STARTED|Day 8||6
37726|NCT01852019|88277|P4|STARTED|Day 8||6
37727|NCT01852019|88278|P3|STARTED|Day 8||0
37728|NCT01852019|88279|P2|STARTED|Day 8||0
37729|NCT01852019|88280|P1|STARTED|Day 8||0
37730|NCT01852019|88276|P5|NOT COMPLETED|Day 1||0
37731|NCT01852019|88277|P4|NOT COMPLETED|Day 1||0
37732|NCT01852019|88278|P3|NOT COMPLETED|Day 1||0
37733|NCT01852019|88279|P2|NOT COMPLETED|Day 1||0
37734|NCT01852019|88280|P1|NOT COMPLETED|Day 1||0
37735|NCT01852019|88276|P5|COMPLETED|Day 1||0
37736|NCT01852019|88277|P4|COMPLETED|Day 1||0
37737|NCT01852019|88278|P3|COMPLETED|Day 1||6
37738|NCT01852019|88279|P2|COMPLETED|Day 1||3
37739|NCT01852019|88280|P1|COMPLETED|Day 1||3
37740|NCT01852019|88276|P5|STARTED|Day 1||0
37741|NCT01852019|88277|P4|STARTED|Day 1||0
37742|NCT01852019|88278|P3|STARTED|Day 1||6
37743|NCT01852019|88279|P2|STARTED|Day 1||3
37744|NCT01852019|88280|P1|STARTED|Day 1||3
37745|NCT01851720|88301|P2|NOT COMPLETED|Overall Study||1
37746|NCT01851720|88302|P1|NOT COMPLETED|Overall Study||0
37747|NCT01851720|88301|P2|COMPLETED|Overall Study||0
37748|NCT01851720|88302|P1|COMPLETED|Overall Study||0
37749|NCT01851720|88301|P2|STARTED|Overall Study||1
37750|NCT01851720|88302|P1|STARTED|Overall Study||0
37751|NCT01851655|88310|P2|NOT COMPLETED|Overall Study||0
37752|NCT01851655|88311|P1|NOT COMPLETED|Overall Study||0
37753|NCT01851655|88310|P2|COMPLETED|Overall Study||12
37754|NCT01851655|88311|P1|COMPLETED|Overall Study||12
37755|NCT01851655|88310|P2|STARTED|Overall Study||12
37756|NCT01851655|88311|P1|STARTED|Overall Study||12
37757|NCT01851590|88332|P3|NOT COMPLETED|Overall Study||3
37758|NCT01851590|88333|P2|NOT COMPLETED|Overall Study||1
37759|NCT01851590|88334|P1|NOT COMPLETED|Overall Study||0
37760|NCT01851590|88332|P3|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|22
37761|NCT01851590|88333|P2|COMPLETED|Overall Study|All patients (25) were included in the ITT population and final outcome analyses.|24
37762|NCT01851590|88334|P1|COMPLETED|Overall Study|All patients (23) were included in the ITT population and final outcome analyses.|23
37763|NCT01851590|88332|P3|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|22
37764|NCT01851590|88333|P2|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|24
37765|NCT01851590|88334|P1|At 10 Month: Follow-up Visit and Control|Overall Study|Study completed. Clinical response to treatment, toenails samples and lab. exams were controlled.|23
37766|NCT01851590|88332|P3|At 9 Month: End of Topical Treatments|Overall Study|Washout period of the Terbinafine treatment arm continues.|22
37767|NCT01851590|88333|P2|At 9 Month: End of Topical Treatments|Overall Study|End of topical Amorolfine Lacquer treatment. Washout period of the Amorolfine treatment arm begins.|24
37768|NCT01851590|88334|P1|At 9 Month: End of Topical Treatments|Overall Study|End of topical Resin Lacquer treatment. Washout period of the Resin Lacquer treatment arm begins.|23
37769|NCT01851590|88332|P3|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|22
37770|NCT01851590|88333|P2|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|24
37771|NCT01851590|88334|P1|At 4 Month: Follow-up Visit and Control|Overall Study|Clinical response to treatment, toenails samples and laboratory exams were controlled.|23
37772|NCT01851590|88332|P3|At 3 Month: End of Terbinafine Treatment|Overall Study|End of oral Terbinafine treatment. Washout period of the Terbinafine treatment arm begins.|22
37773|NCT01851590|88333|P2|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Amorolfine Lacquer Treatment continues ->|24
37774|NCT01851590|88334|P1|At 3 Month: End of Terbinafine Treatment|Overall Study|Topical Resin Lacquer treatment continues ->|23
37775|NCT01851590|88332|P3|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
37776|NCT01851590|88333|P2|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|25
37777|NCT01851590|88334|P1|STARTED|Overall Study|In addition to clinical control visits, patients were contacted by phone during weeks 6, 13, and 29.|23
37778|NCT01851330|88357|P3|NOT COMPLETED|Overall Study||12
37779|NCT01851330|88358|P2|NOT COMPLETED|Overall Study||16
37780|NCT01851330|88359|P1|NOT COMPLETED|Overall Study||13
37781|NCT01851330|88357|P3|COMPLETED|Overall Study||204
37782|NCT01851330|88358|P2|COMPLETED|Overall Study||200
37783|NCT01851330|88359|P1|COMPLETED|Overall Study||202
37784|NCT01851330|88357|P3|STARTED|Overall Study||216
37785|NCT01851330|88358|P2|STARTED|Overall Study||216
37786|NCT01851330|88359|P1|STARTED|Overall Study||215
37787|NCT01849588|88394|P1|NOT COMPLETED|Overall Study||3
37788|NCT01849588|88394|P1|COMPLETED|Overall Study||0
37789|NCT01849588|88394|P1|STARTED|Overall Study||3
37790|NCT01849562|88404|P3|NOT COMPLETED|Overall Study||0
37791|NCT01849562|88405|P2|NOT COMPLETED|Overall Study||0
37792|NCT01849562|88406|P1|NOT COMPLETED|Overall Study||2
37793|NCT01849562|88404|P3|COMPLETED|Overall Study||10
37794|NCT01849562|88405|P2|COMPLETED|Overall Study||10
37795|NCT01849562|88406|P1|COMPLETED|Overall Study||8
37796|NCT01849562|88404|P3|STARTED|Overall Study||10
37797|NCT01849562|88405|P2|STARTED|Overall Study||10
37798|NCT01849562|88406|P1|STARTED|Overall Study||10
37799|NCT01849497|88419|P2|NOT COMPLETED|Overall Study||4
37800|NCT01849497|88420|P1|NOT COMPLETED|Overall Study||1
37801|NCT01849497|88419|P2|COMPLETED|Overall Study||70
37802|NCT01849497|88420|P1|COMPLETED|Overall Study||74
37803|NCT01849497|88419|P2|Received Treatment|Overall Study||74
37804|NCT01849497|88420|P1|Received Treatment|Overall Study||75
37805|NCT01849497|88419|P2|STARTED|Overall Study||74
37806|NCT01849497|88420|P1|STARTED|Overall Study||75
37807|NCT01850589|88430|P2|NOT COMPLETED|Overall Study||0
37808|NCT01850589|88431|P1|NOT COMPLETED|Overall Study||8
37809|NCT01850589|88430|P2|COMPLETED|Overall Study||22
37810|NCT01850589|88431|P1|COMPLETED|Overall Study||14
37811|NCT01850589|88430|P2|STARTED|Overall Study||22
37812|NCT01850589|88431|P1|STARTED|Overall Study||22
37813|NCT01850550|88439|P2|NOT COMPLETED|Overall Study||3
37814|NCT01850550|88440|P1|NOT COMPLETED|Overall Study||0
37815|NCT01850550|88439|P2|COMPLETED|Overall Study||37
37816|NCT01850550|88440|P1|COMPLETED|Overall Study||40
37817|NCT01850550|88439|P2|STARTED|Overall Study||40
37818|NCT01850550|88440|P1|STARTED|Overall Study||40
37819|NCT01850485|88450|P2|NOT COMPLETED|Overall Study||0
37820|NCT01850485|88451|P1|NOT COMPLETED|Overall Study||0
37821|NCT01850485|88450|P2|COMPLETED|Overall Study||13
37822|NCT01850485|88451|P1|COMPLETED|Overall Study||9
37823|NCT01850485|88450|P2|STARTED|Overall Study||13
37824|NCT01850485|88451|P1|STARTED|Overall Study||9
37825|NCT01850394|88472|P3|NOT COMPLETED|Overall Study||0
37826|NCT01850394|88473|P2|NOT COMPLETED|Overall Study||0
37827|NCT01850394|88474|P1|NOT COMPLETED|Overall Study||0
37828|NCT01850394|88472|P3|COMPLETED|Overall Study||45
37829|NCT01850394|88473|P2|COMPLETED|Overall Study||45
37830|NCT01850394|88474|P1|COMPLETED|Overall Study||45
37831|NCT01850394|88472|P3|STARTED|Overall Study||45
37832|NCT01850394|88473|P2|STARTED|Overall Study||45
37833|NCT01850394|88474|P1|STARTED|Overall Study||45
37834|NCT01849848|88494|P1|NOT COMPLETED|Overall Study||4
37835|NCT01849848|88494|P1|COMPLETED|Overall Study||13
37836|NCT01849848|88494|P1|STARTED|Overall Study||17
37837|NCT01849770|88511|P3|NOT COMPLETED|Overall Study||1
37838|NCT01849770|88512|P2|NOT COMPLETED|Overall Study||4
37839|NCT01849770|88513|P1|NOT COMPLETED|Overall Study||0
37840|NCT01849770|88511|P3|COMPLETED|Overall Study||19
37841|NCT01849770|88512|P2|COMPLETED|Overall Study||15
37842|NCT01849770|88513|P1|COMPLETED|Overall Study||20
37843|NCT01849770|88511|P3|STARTED|Overall Study||20
37844|NCT01849770|88512|P2|STARTED|Overall Study||19
37845|NCT01849770|88513|P1|STARTED|Overall Study||20
37846|NCT01849692|88556|P8|NOT COMPLETED|Overall Study||0
37847|NCT01849692|88557|P7|NOT COMPLETED|Overall Study||0
37848|NCT01849692|88558|P6|NOT COMPLETED|Overall Study||0
37849|NCT01849692|88559|P5|NOT COMPLETED|Overall Study||0
37850|NCT01849692|88560|P4|NOT COMPLETED|Overall Study||0
37851|NCT01849692|88561|P3|NOT COMPLETED|Overall Study||0
37852|NCT01849692|88562|P2|NOT COMPLETED|Overall Study||0
37853|NCT01849692|88563|P1|NOT COMPLETED|Overall Study||0
37854|NCT01849692|88556|P8|COMPLETED|Overall Study||3
37855|NCT01849692|88557|P7|COMPLETED|Overall Study||10
37856|NCT01849692|88558|P6|COMPLETED|Overall Study||3
37857|NCT01849692|88559|P5|COMPLETED|Overall Study||10
37858|NCT01849692|88560|P4|COMPLETED|Overall Study||3
37859|NCT01849692|88561|P3|COMPLETED|Overall Study||10
37860|NCT01849692|88562|P2|COMPLETED|Overall Study||3
37861|NCT01849692|88563|P1|COMPLETED|Overall Study||10
37862|NCT01849692|88556|P8|STARTED|Overall Study||3
37863|NCT01849692|88557|P7|STARTED|Overall Study||10
37864|NCT01849692|88558|P6|STARTED|Overall Study||3
37865|NCT01849692|88559|P5|STARTED|Overall Study||10
37866|NCT01849692|88560|P4|STARTED|Overall Study||3
37867|NCT01849692|88561|P3|STARTED|Overall Study||10
37868|NCT01849692|88562|P2|STARTED|Overall Study||3
37869|NCT01849692|88563|P1|STARTED|Overall Study||10
37870|NCT01849458|88592|P1|NOT COMPLETED|Overall Study||4
37871|NCT01849458|88592|P1|COMPLETED|Overall Study||46
37872|NCT01849458|88592|P1|6 Months Follow-up|Overall Study||50
37873|NCT01849458|88592|P1|STARTED|Overall Study||50
37874|NCT01849419|88602|P1|NOT COMPLETED|Overall Study||0
37875|NCT01849419|88602|P1|COMPLETED|Overall Study||65
37876|NCT01849419|88602|P1|STARTED|Overall Study||65
37877|NCT01849289|88631|P2|NOT COMPLETED|Overall Study||24
37878|NCT01849289|88632|P1|NOT COMPLETED|Overall Study||32
37879|NCT01849289|88631|P2|COMPLETED|Overall Study||254
37880|NCT01849289|88632|P1|COMPLETED|Overall Study||523
37881|NCT01849289|88631|P2|Exposed|Overall Study||278
37882|NCT01849289|88632|P1|Exposed|Overall Study|2 subjects withdrew prior to exposure of trial products|553
37883|NCT01849289|88631|P2|STARTED|Overall Study||278
37884|NCT01849289|88632|P1|STARTED|Overall Study||555
37885|NCT01849068|88650|P2|NOT COMPLETED|Overall Study||0
37886|NCT01849068|88651|P1|NOT COMPLETED|Overall Study||0
37887|NCT01849068|88650|P2|COMPLETED|Overall Study||10
37888|NCT01849068|88651|P1|COMPLETED|Overall Study||10
37889|NCT01849068|88650|P2|STARTED|Overall Study||10
37890|NCT01849068|88651|P1|STARTED|Overall Study||10
37891|NCT01848990|88666|P3|NOT COMPLETED|Overall Study||11
37892|NCT01848990|88667|P2|NOT COMPLETED|Overall Study||9
37893|NCT01848990|88668|P1|NOT COMPLETED|Overall Study||33
37894|NCT01848990|88666|P3|COMPLETED|Overall Study||103
37895|NCT01848990|88667|P2|COMPLETED|Overall Study||106
37896|NCT01848990|88668|P1|COMPLETED|Overall Study||194
37897|NCT01848990|88666|P3|Received at Least 1 Dose of Study Drug|Overall Study||113
37898|NCT01848990|88667|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
37899|NCT01848990|88668|P1|Received at Least 1 Dose of Study Drug|Overall Study||227
37900|NCT01848990|88666|P3|STARTED|Overall Study|One participant was randomized and withdrew consent before start of study treatment.|114
37901|NCT01848990|88667|P2|STARTED|Overall Study||115
37902|NCT01848990|88668|P1|STARTED|Overall Study||227
37903|NCT01848977|88683|P1|NOT COMPLETED|Overall Study||0
37904|NCT01848977|88683|P1|COMPLETED|Overall Study||20
37905|NCT01848977|88683|P1|STARTED|Overall Study||20
37906|NCT01848938|88694|P2|NOT COMPLETED|Overall Study||1
37907|NCT01848938|88695|P1|NOT COMPLETED|Overall Study||1
37908|NCT01848938|88694|P2|COMPLETED|Overall Study||60
37909|NCT01848938|88695|P1|COMPLETED|Overall Study||61
37910|NCT01848938|88694|P2|STARTED|Overall Study||61
37911|NCT01848938|88695|P1|STARTED|Overall Study||62
37912|NCT01848899|88713|P2|NOT COMPLETED|Overall Study||0
37913|NCT01848899|88714|P1|NOT COMPLETED|Overall Study||0
37914|NCT01848899|88713|P2|COMPLETED|Overall Study||50
37915|NCT01848899|88714|P1|COMPLETED|Overall Study||50
37916|NCT01848899|88713|P2|STARTED|Overall Study||50
37917|NCT01848899|88714|P1|STARTED|Overall Study||50
37918|NCT01848847|88730|P2|NOT COMPLETED|Overall Study||3
37919|NCT01848847|88731|P1|NOT COMPLETED|Overall Study||2
37920|NCT01848847|88730|P2|COMPLETED|Overall Study||48
37921|NCT01848847|88731|P1|COMPLETED|Overall Study||49
37922|NCT01848847|88730|P2|STARTED|Overall Study||51
37923|NCT01848847|88731|P1|STARTED|Overall Study||51
37924|NCT01848834|88744|P5|NOT COMPLETED|Overall Study||132
37925|NCT01848834|88745|P4|NOT COMPLETED|Overall Study||37
37926|NCT01848834|88746|P3|NOT COMPLETED|Overall Study||32
37927|NCT01848834|88747|P2|NOT COMPLETED|Overall Study||60
37928|NCT01848834|88748|P1|NOT COMPLETED|Overall Study||30
37929|NCT01848834|88744|P5|COMPLETED|Overall Study|Completed means two-year treatment completed|0
37930|NCT01848834|88745|P4|COMPLETED|Overall Study|Completed means two-year treatment completed|2
37931|NCT01848834|88746|P3|COMPLETED|Overall Study|Completed means two-year treatment completed|1
37932|NCT01848834|88747|P2|COMPLETED|Overall Study|Completed means two-year treatment completed|1
37933|NCT01848834|88748|P1|COMPLETED|Overall Study|Completed means two-year treatment completed|2
37934|NCT01848834|88744|P5|Treated|Overall Study||132
37935|NCT01848834|88745|P4|Treated|Overall Study||39
37936|NCT01848834|88746|P3|Treated|Overall Study||33
37937|NCT01848834|88747|P2|Treated|Overall Study||60
37938|NCT01848834|88748|P1|Treated|Overall Study||32
37939|NCT01848834|88744|P5|STARTED|Overall Study||132
37940|NCT01848834|88745|P4|STARTED|Overall Study||39
37941|NCT01848834|88746|P3|STARTED|Overall Study||33
37942|NCT01848834|88747|P2|STARTED|Overall Study||61
37943|NCT01848834|88748|P1|STARTED|Overall Study||32
37944|NCT01848756|88783|P1|NOT COMPLETED|Overall Study||3
37945|NCT01848756|88783|P1|COMPLETED|Overall Study|Cycle 1|12
37946|NCT01848756|88783|P1|STARTED|Overall Study||15
37947|NCT01848366|88793|P1|NOT COMPLETED|Overall Study||0
37948|NCT01848366|88793|P1|COMPLETED|Overall Study||8
37949|NCT01848366|88793|P1|STARTED|Overall Study||8
37950|NCT01848288|88797|P1|NOT COMPLETED|Overall Study||3
37951|NCT01848288|88797|P1|COMPLETED|Overall Study|Two subjects were discontinued prior to undergoing surgery.|97
37952|NCT01848288|88797|P1|STARTED|Overall Study||100
37953|NCT01848210|88808|P2|NOT COMPLETED|Overall Study||78
37954|NCT01848210|88809|P1|NOT COMPLETED|Overall Study||88
37955|NCT01848210|88808|P2|COMPLETED|Overall Study||340
37956|NCT01848210|88809|P1|COMPLETED|Overall Study||323
37957|NCT01848210|88808|P2|Per Protocol Population|Overall Study||245
37958|NCT01848210|88809|P1|Per Protocol Population|Overall Study||222
37959|NCT01848210|88808|P2|Intent-to-Treat (ITT) Population|Overall Study||388
37960|NCT01848210|88809|P1|Intent-to-Treat (ITT) Population|Overall Study||383
37961|NCT01848210|88808|P2|Safety Population-Received Study Drug|Overall Study||398
37962|NCT01848210|88809|P1|Safety Population-Received Study Drug|Overall Study||394
37963|NCT01848210|88808|P2|STARTED|Overall Study||418
37964|NCT01848210|88809|P1|STARTED|Overall Study||411
37965|NCT01848145|88821|P1|NOT COMPLETED|Subsequent Infusions: Weeks 3-8||10
37966|NCT01848145|88821|P1|COMPLETED|Subsequent Infusions: Weeks 3-8||20
37967|NCT01848145|88821|P1|STARTED|Subsequent Infusions: Weeks 3-8||30
37968|NCT01848145|88821|P1|NOT COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||1
37969|NCT01848145|88821|P1|COMPLETED|Infusion 3: Week 2, Day 1 - 120 Minutes||30
37970|NCT01848145|88821|P1|Completed Within 15min of Infusion Time|Infusion 3: Week 2, Day 1 - 120 Minutes||26
37971|NCT01848145|88821|P1|STARTED|Infusion 3: Week 2, Day 1 - 120 Minutes||31
37972|NCT01848145|88821|P1|NOT COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes||2
37973|NCT01848145|88821|P1|COMPLETED|Infusion 2: Week 1, Day 3 - 167 Minutes|Includes participants that completed Infusion 2 and proceeded to the next infusion, Infusion 3.|31
37974|NCT01848145|88821|P1|Completed Within 15min of Infusion Time|Infusion 2: Week 1, Day 3 - 167 Minutes||24
37975|NCT01848145|88821|P1|STARTED|Infusion 2: Week 1, Day 3 - 167 Minutes||33
37976|NCT01848145|88821|P1|NOT COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes||1
37977|NCT01848145|88821|P1|COMPLETED|Infusion 1: Week 1, Day 1 - 226 Minutes|Includes participants that completed Infusion 1 and proceeded to the next infusion, Infusion 2.|33
37978|NCT01848145|88821|P1|Completed Within 15min of Infusion Time|Infusion 1: Week 1, Day 1 - 226 Minutes|Number of patients who completed within 15 minutes (min) of infusion time.|1
37979|NCT01848145|88821|P1|STARTED|Infusion 1: Week 1, Day 1 - 226 Minutes||34
37980|NCT01848054|88832|P2|NOT COMPLETED|Stabilization/Maintenance||40
37981|NCT01848054|88833|P1|NOT COMPLETED|Stabilization/Maintenance||40
37982|NCT01848054|88832|P2|COMPLETED|Stabilization/Maintenance||107
37983|NCT01848054|88833|P1|COMPLETED|Stabilization/Maintenance||92
37984|NCT01848054|88832|P2|STARTED|Stabilization/Maintenance||147
37985|NCT01848054|88833|P1|STARTED|Stabilization/Maintenance||132
37986|NCT01848054|88832|P2|NOT COMPLETED|Induction Phase||8
37987|NCT01848054|88833|P1|NOT COMPLETED|Induction Phase||23
37988|NCT01848054|88832|P2|COMPLETED|Induction Phase||147
37989|NCT01848054|88833|P1|COMPLETED|Induction Phase||132
37990|NCT01848054|88832|P2|STARTED|Induction Phase||155
37991|NCT01848054|88833|P1|STARTED|Induction Phase||155
37992|NCT01847547|88855|P2|NOT COMPLETED|Overall Study||0
37993|NCT01847547|88856|P1|NOT COMPLETED|Overall Study||0
37994|NCT01847547|88855|P2|COMPLETED|Overall Study||2991
37995|NCT01847547|88856|P1|COMPLETED|Overall Study||2991
37996|NCT01847547|88855|P2|STARTED|Overall Study||2991
37997|NCT01847547|88856|P1|STARTED|Overall Study||2991
37998|NCT01847443|88898|P4|NOT COMPLETED|Study Period 4||0
37999|NCT01847443|88899|P3|NOT COMPLETED|Study Period 4||0
38000|NCT01847443|88900|P2|NOT COMPLETED|Study Period 4||0
38001|NCT01847443|88901|P1|NOT COMPLETED|Study Period 4||0
38002|NCT01847443|88898|P4|COMPLETED|Study Period 4||21
38003|NCT01847443|88899|P3|COMPLETED|Study Period 4||21
38004|NCT01847443|88900|P2|COMPLETED|Study Period 4||19
38005|NCT01847443|88901|P1|COMPLETED|Study Period 4||16
38006|NCT01847443|88898|P4|STARTED|Study Period 4||21
38007|NCT01847443|88899|P3|STARTED|Study Period 4||21
38008|NCT01847443|88900|P2|STARTED|Study Period 4||19
38009|NCT01847443|88901|P1|STARTED|Study Period 4||16
38010|NCT01847443|88898|P4|NOT COMPLETED|Washout Period Before Study Period 4||0
38011|NCT01847443|88899|P3|NOT COMPLETED|Washout Period Before Study Period 4||0
38012|NCT01847443|88900|P2|NOT COMPLETED|Washout Period Before Study Period 4||0
38013|NCT01847443|88901|P1|NOT COMPLETED|Washout Period Before Study Period 4||2
38014|NCT01847443|88898|P4|COMPLETED|Washout Period Before Study Period 4||21
38015|NCT01847443|88899|P3|COMPLETED|Washout Period Before Study Period 4||21
38016|NCT01847443|88900|P2|COMPLETED|Washout Period Before Study Period 4||19
38017|NCT01847443|88901|P1|COMPLETED|Washout Period Before Study Period 4||16
38018|NCT01847443|88898|P4|STARTED|Washout Period Before Study Period 4||21
38019|NCT01847443|88899|P3|STARTED|Washout Period Before Study Period 4||21
38020|NCT01847443|88900|P2|STARTED|Washout Period Before Study Period 4||19
38021|NCT01847443|88901|P1|STARTED|Washout Period Before Study Period 4||18
38022|NCT01847443|88898|P4|NOT COMPLETED|Study Period 3||0
38023|NCT01847443|88899|P3|NOT COMPLETED|Study Period 3||0
38024|NCT01847443|88900|P2|NOT COMPLETED|Study Period 3||0
38025|NCT01847443|88901|P1|NOT COMPLETED|Study Period 3||0
38026|NCT01847443|88898|P4|COMPLETED|Study Period 3||21
38027|NCT01847443|88899|P3|COMPLETED|Study Period 3||21
38028|NCT01847443|88900|P2|COMPLETED|Study Period 3||19
38029|NCT01847443|88901|P1|COMPLETED|Study Period 3||18
38030|NCT01847443|88898|P4|STARTED|Study Period 3||21
38031|NCT01847443|88899|P3|STARTED|Study Period 3||21
38032|NCT01847443|88900|P2|STARTED|Study Period 3||19
38033|NCT01847443|88901|P1|STARTED|Study Period 3||18
38034|NCT01847443|88898|P4|NOT COMPLETED|Washout Period Before Study Period 3||0
38035|NCT01847443|88899|P3|NOT COMPLETED|Washout Period Before Study Period 3||0
38036|NCT01847443|88900|P2|NOT COMPLETED|Washout Period Before Study Period 3||0
38037|NCT01847443|88901|P1|NOT COMPLETED|Washout Period Before Study Period 3||1
38038|NCT01847443|88898|P4|COMPLETED|Washout Period Before Study Period 3||21
38039|NCT01847443|88899|P3|COMPLETED|Washout Period Before Study Period 3||21
38040|NCT01847443|88900|P2|COMPLETED|Washout Period Before Study Period 3||19
38041|NCT01847443|88901|P1|COMPLETED|Washout Period Before Study Period 3||18
38042|NCT01847443|88898|P4|STARTED|Washout Period Before Study Period 3||21
38043|NCT01847443|88899|P3|STARTED|Washout Period Before Study Period 3||21
38044|NCT01847443|88900|P2|STARTED|Washout Period Before Study Period 3||19
38045|NCT01847443|88901|P1|STARTED|Washout Period Before Study Period 3||19
38046|NCT01847443|88898|P4|NOT COMPLETED|Study Period 2||0
38047|NCT01847443|88899|P3|NOT COMPLETED|Study Period 2||0
38048|NCT01847443|88900|P2|NOT COMPLETED|Study Period 2||0
38049|NCT01847443|88901|P1|NOT COMPLETED|Study Period 2||0
38050|NCT01847443|88898|P4|COMPLETED|Study Period 2||21
38051|NCT01847443|88899|P3|COMPLETED|Study Period 2||21
38052|NCT01847443|88900|P2|COMPLETED|Study Period 2||19
38053|NCT01847443|88901|P1|COMPLETED|Study Period 2||19
38054|NCT01847443|88898|P4|STARTED|Study Period 2||21
38055|NCT01847443|88899|P3|STARTED|Study Period 2||21
38056|NCT01847443|88900|P2|STARTED|Study Period 2||19
38057|NCT01847443|88901|P1|STARTED|Study Period 2||19
38058|NCT01847443|88898|P4|NOT COMPLETED|Washout Period Before Study Period 2||0
38059|NCT01847443|88899|P3|NOT COMPLETED|Washout Period Before Study Period 2||0
38060|NCT01847443|88900|P2|NOT COMPLETED|Washout Period Before Study Period 2||1
38061|NCT01847443|88901|P1|NOT COMPLETED|Washout Period Before Study Period 2||2
38062|NCT01847443|88898|P4|COMPLETED|Washout Period Before Study Period 2||21
38063|NCT01847443|88899|P3|COMPLETED|Washout Period Before Study Period 2||21
38064|NCT01847443|88900|P2|COMPLETED|Washout Period Before Study Period 2||19
38065|NCT01847443|88901|P1|COMPLETED|Washout Period Before Study Period 2||19
38066|NCT01847443|88898|P4|STARTED|Washout Period Before Study Period 2||21
38067|NCT01847443|88899|P3|STARTED|Washout Period Before Study Period 2||21
38068|NCT01847443|88900|P2|STARTED|Washout Period Before Study Period 2||20
38069|NCT01847443|88901|P1|STARTED|Washout Period Before Study Period 2||21
38070|NCT01847443|88898|P4|NOT COMPLETED|Study Period 1||0
38071|NCT01847443|88899|P3|NOT COMPLETED|Study Period 1||0
38072|NCT01847443|88900|P2|NOT COMPLETED|Study Period 1||1
38073|NCT01847443|88901|P1|NOT COMPLETED|Study Period 1||0
38074|NCT01847443|88898|P4|COMPLETED|Study Period 1||21
38075|NCT01847443|88899|P3|COMPLETED|Study Period 1||21
38076|NCT01847443|88900|P2|COMPLETED|Study Period 1||20
38077|NCT01847443|88901|P1|COMPLETED|Study Period 1||21
38078|NCT01847443|88898|P4|STARTED|Study Period 1||21
38079|NCT01847443|88899|P3|STARTED|Study Period 1||21
38080|NCT01847443|88900|P2|STARTED|Study Period 1||21
38081|NCT01847443|88901|P1|STARTED|Study Period 1||21
38082|NCT01847430|88931|P1|NOT COMPLETED|Overall Study||0
38083|NCT01847430|88931|P1|COMPLETED|Overall Study||302
38084|NCT01847430|88931|P1|STARTED|Overall Study||302
38085|NCT01847196|88942|P1|NOT COMPLETED|Overall Study||0
38086|NCT01847196|88942|P1|COMPLETED|Overall Study||5
38087|NCT01847196|88942|P1|STARTED|Overall Study|Includes all subjects in which Angel Catheter placement was attempted.|5
38088|NCT01847131|88949|P2|NOT COMPLETED|Overall Study||0
38089|NCT01847131|88950|P1|NOT COMPLETED|Overall Study||0
38090|NCT01847131|88949|P2|COMPLETED|Overall Study||25
38091|NCT01847131|88950|P1|COMPLETED|Overall Study||25
38092|NCT01847131|88949|P2|STARTED|Overall Study||25
38093|NCT01847131|88950|P1|STARTED|Overall Study||25
38094|NCT01846741|88958|P1|NOT COMPLETED|Implantation to 18-Month/End of Study||0
38095|NCT01846741|88958|P1|COMPLETED|Implantation to 18-Month/End of Study||20
38096|NCT01846741|88958|P1|STARTED|Implantation to 18-Month/End of Study||20
38097|NCT01846741|88958|P1|NOT COMPLETED|Baseline Visit||2
38098|NCT01846741|88958|P1|COMPLETED|Baseline Visit||20
38099|NCT01846741|88958|P1|STARTED|Baseline Visit||22
38100|NCT01846455|89019|P5|NOT COMPLETED|Overall Study||0
38101|NCT01846455|89020|P4|NOT COMPLETED|Overall Study||0
38102|NCT01846455|89021|P3|NOT COMPLETED|Overall Study||0
38103|NCT01846455|89022|P2|NOT COMPLETED|Overall Study||0
38104|NCT01846455|89023|P1|NOT COMPLETED|Overall Study||0
38105|NCT01846455|89019|P5|COMPLETED|Overall Study||8
38106|NCT01846455|89020|P4|COMPLETED|Overall Study||10
38107|NCT01846455|89021|P3|COMPLETED|Overall Study||8
38108|NCT01846455|89022|P2|COMPLETED|Overall Study||8
38109|NCT01846455|89023|P1|COMPLETED|Overall Study||9
38110|NCT01846455|89019|P5|PK Population|Overall Study||8
38111|NCT01846455|89020|P4|PK Population|Overall Study||6
38112|NCT01846455|89021|P3|PK Population|Overall Study||6
38113|NCT01846455|89022|P2|PK Population|Overall Study||7
38114|NCT01846455|89023|P1|PK Population|Overall Study||6
38115|NCT01846455|89019|P5|STARTED|Overall Study||8
38116|NCT01846455|89020|P4|STARTED|Overall Study||10
38117|NCT01846455|89021|P3|STARTED|Overall Study||8
38118|NCT01846455|89022|P2|STARTED|Overall Study||8
38119|NCT01846455|89023|P1|STARTED|Overall Study||9
38120|NCT01846442|89084|P4|NOT COMPLETED|Overall Study||3
38121|NCT01846442|89085|P3|NOT COMPLETED|Overall Study||4
38122|NCT01846442|89086|P2|NOT COMPLETED|Overall Study||6
38123|NCT01846442|89087|P1|NOT COMPLETED|Overall Study||6
38124|NCT01846442|89084|P4|COMPLETED|Overall Study||51
38125|NCT01846442|89085|P3|COMPLETED|Overall Study||52
38126|NCT01846442|89086|P2|COMPLETED|Overall Study||48
38127|NCT01846442|89087|P1|COMPLETED|Overall Study||48
38128|NCT01846442|89084|P4|ITT Population|Overall Study||54
38129|NCT01846442|89085|P3|ITT Population|Overall Study||56
38130|NCT01846442|89086|P2|ITT Population|Overall Study||53
38131|NCT01846442|89087|P1|ITT Population|Overall Study||53
38132|NCT01846442|89084|P4|Safety Population|Overall Study||54
38133|NCT01846442|89085|P3|Safety Population|Overall Study||56
38134|NCT01846442|89086|P2|Safety Population|Overall Study||53
38135|NCT01846442|89087|P1|Safety Population|Overall Study||54
38136|NCT01846442|89084|P4|STARTED|Overall Study||54
38137|NCT01846442|89085|P3|STARTED|Overall Study||56
38138|NCT01846442|89086|P2|STARTED|Overall Study||54
38139|NCT01846442|89087|P1|STARTED|Overall Study||54
38140|NCT01846416|89128|P3|NOT COMPLETED|Overall Study||13
38141|NCT01846416|89129|P2|NOT COMPLETED|Overall Study||93
38142|NCT01846416|89130|P1|NOT COMPLETED|Overall Study||31
38143|NCT01846416|89128|P3|COMPLETED|Overall Study||0
38144|NCT01846416|89129|P2|COMPLETED|Overall Study||0
38145|NCT01846416|89130|P1|COMPLETED|Overall Study||0
38146|NCT01846416|89128|P3|STARTED|Overall Study||13
38147|NCT01846416|89129|P2|STARTED|Overall Study||93
38148|NCT01846416|89130|P1|STARTED|Overall Study||31
38149|NCT01846299|89175|P2|NOT COMPLETED|Overall Study||10
38150|NCT01846299|89176|P1|NOT COMPLETED|Overall Study||12
38151|NCT01846299|89175|P2|COMPLETED|Overall Study||50
38152|NCT01846299|89176|P1|COMPLETED|Overall Study||106
38153|NCT01846299|89175|P2|Safety Set|Overall Study||58
38154|NCT01846299|89176|P1|Safety Set|Overall Study|Two participants randomized to sham received ranibizumab at Month 1.|119
38155|NCT01846299|89175|P2|Full Analysis Set|Overall Study||60
38156|NCT01846299|89176|P1|Full Analysis Set|Overall Study|One participant did not receive study treatment prior to discontinuation.|117
38157|NCT01846299|89175|P2|STARTED|Overall Study||60
38158|NCT01846299|89176|P1|STARTED|Overall Study||118
38159|NCT01846104|89212|P1|NOT COMPLETED|Overall Study||1
38160|NCT01846104|89212|P1|COMPLETED|Overall Study||3
38161|NCT01846104|89212|P1|STARTED|Overall Study||4
38162|NCT01846039|89218|P1|NOT COMPLETED|Overall Study||2
38163|NCT01846039|89218|P1|COMPLETED|Overall Study||27
38164|NCT01846039|89218|P1|STARTED|Overall Study||29
38165|NCT01845831|89230|P5|NOT COMPLETED|Outpatient Phase||0
38166|NCT01845831|89231|P4|NOT COMPLETED|Outpatient Phase||0
38167|NCT01845831|89232|P3|NOT COMPLETED|Outpatient Phase||0
38168|NCT01845831|89233|P2|NOT COMPLETED|Outpatient Phase||0
38169|NCT01845831|89234|P1|NOT COMPLETED|Outpatient Phase||0
38170|NCT01845831|89230|P5|COMPLETED|Outpatient Phase||87
38171|NCT01845831|89231|P4|COMPLETED|Outpatient Phase||98
38172|NCT01845831|89232|P3|COMPLETED|Outpatient Phase||68
38173|NCT01845831|89233|P2|COMPLETED|Outpatient Phase||0
38174|NCT01845831|89234|P1|COMPLETED|Outpatient Phase||0
38175|NCT01845831|89230|P5|STARTED|Outpatient Phase||87
38176|NCT01845831|89231|P4|STARTED|Outpatient Phase||98
38177|NCT01845831|89232|P3|STARTED|Outpatient Phase||68
38178|NCT01845831|89233|P2|STARTED|Outpatient Phase||0
38179|NCT01845831|89234|P1|STARTED|Outpatient Phase||0
38180|NCT01845831|89230|P5|NOT COMPLETED|Inpatient Phase||0
38181|NCT01845831|89231|P4|NOT COMPLETED|Inpatient Phase||0
38182|NCT01845831|89232|P3|NOT COMPLETED|Inpatient Phase||0
38183|NCT01845831|89233|P2|NOT COMPLETED|Inpatient Phase||1
38184|NCT01845831|89234|P1|NOT COMPLETED|Inpatient Phase||1
38185|NCT01845831|89230|P5|COMPLETED|Inpatient Phase||0
38186|NCT01845831|89231|P4|COMPLETED|Inpatient Phase||0
38187|NCT01845831|89232|P3|COMPLETED|Inpatient Phase||0
38188|NCT01845831|89233|P2|COMPLETED|Inpatient Phase||138
38189|NCT01845831|89234|P1|COMPLETED|Inpatient Phase||139
38190|NCT01845831|89230|P5|STARTED|Inpatient Phase||0
38191|NCT01845831|89231|P4|STARTED|Inpatient Phase||0
38192|NCT01845831|89232|P3|STARTED|Inpatient Phase||0
38193|NCT01845831|89233|P2|STARTED|Inpatient Phase||139
38194|NCT01845831|89234|P1|STARTED|Inpatient Phase||140
38195|NCT01845155|89263|P2|NOT COMPLETED|Overall Study||0
38196|NCT01845155|89264|P1|NOT COMPLETED|Overall Study||1
38197|NCT01845155|89263|P2|COMPLETED|Overall Study||144
38198|NCT01845155|89264|P1|COMPLETED|Overall Study||145
38199|NCT01845155|89263|P2|STARTED|Overall Study||144
38200|NCT01845155|89264|P1|STARTED|Overall Study||146
38201|NCT01845103|89272|P1|NOT COMPLETED|Overall Study||0
38202|NCT01845103|89272|P1|COMPLETED|Overall Study||1
38203|NCT01845103|89272|P1|STARTED|Overall Study||1
38204|NCT01845077|89280|P6|NOT COMPLETED|Treatment Period 2||0
38205|NCT01845077|89281|P5|NOT COMPLETED|Treatment Period 2||0
38206|NCT01845077|89282|P4|NOT COMPLETED|Treatment Period 2||0
38207|NCT01845077|89283|P3|NOT COMPLETED|Treatment Period 2||0
38208|NCT01845077|89284|P2|NOT COMPLETED|Treatment Period 2||0
38209|NCT01845077|89285|P1|NOT COMPLETED|Treatment Period 2||0
38210|NCT01845077|89280|P6|COMPLETED|Treatment Period 2||11
38211|NCT01845077|89281|P5|COMPLETED|Treatment Period 2||11
38212|NCT01845077|89282|P4|COMPLETED|Treatment Period 2||10
38213|NCT01845077|89283|P3|COMPLETED|Treatment Period 2||11
38214|NCT01845077|89284|P2|COMPLETED|Treatment Period 2||11
38215|NCT01845077|89285|P1|COMPLETED|Treatment Period 2||11
38216|NCT01845077|89280|P6|STARTED|Treatment Period 2||11
38217|NCT01845077|89281|P5|STARTED|Treatment Period 2||11
38218|NCT01845077|89282|P4|STARTED|Treatment Period 2||10
38219|NCT01845077|89283|P3|STARTED|Treatment Period 2||11
38220|NCT01845077|89284|P2|STARTED|Treatment Period 2||11
38221|NCT01845077|89285|P1|STARTED|Treatment Period 2||11
38222|NCT01845077|89280|P6|NOT COMPLETED|Washout Period||1
38223|NCT01845077|89281|P5|NOT COMPLETED|Washout Period||1
38224|NCT01845077|89282|P4|NOT COMPLETED|Washout Period||2
38225|NCT01845077|89283|P3|NOT COMPLETED|Washout Period||1
38226|NCT01845077|89284|P2|NOT COMPLETED|Washout Period||1
38227|NCT01845077|89285|P1|NOT COMPLETED|Washout Period||1
38228|NCT01845077|89280|P6|COMPLETED|Washout Period||11
38229|NCT01845077|89281|P5|COMPLETED|Washout Period||11
38230|NCT01845077|89282|P4|COMPLETED|Washout Period||10
38231|NCT01845077|89283|P3|COMPLETED|Washout Period||11
38232|NCT01845077|89284|P2|COMPLETED|Washout Period||11
38233|NCT01845077|89285|P1|COMPLETED|Washout Period||11
38234|NCT01845077|89280|P6|STARTED|Washout Period||12
38235|NCT01845077|89281|P5|STARTED|Washout Period||12
38236|NCT01845077|89282|P4|STARTED|Washout Period||12
38237|NCT01845077|89283|P3|STARTED|Washout Period||12
38238|NCT01845077|89284|P2|STARTED|Washout Period||12
38239|NCT01845077|89285|P1|STARTED|Washout Period||12
38240|NCT01845077|89280|P6|NOT COMPLETED|Treatment Period 1||0
38241|NCT01845077|89281|P5|NOT COMPLETED|Treatment Period 1||0
38242|NCT01845077|89282|P4|NOT COMPLETED|Treatment Period 1||0
38243|NCT01845077|89283|P3|NOT COMPLETED|Treatment Period 1||0
38244|NCT01845077|89284|P2|NOT COMPLETED|Treatment Period 1||0
38245|NCT01845077|89285|P1|NOT COMPLETED|Treatment Period 1||0
38246|NCT01845077|89280|P6|COMPLETED|Treatment Period 1||12
38247|NCT01845077|89281|P5|COMPLETED|Treatment Period 1||12
38248|NCT01845077|89282|P4|COMPLETED|Treatment Period 1||12
38249|NCT01845077|89283|P3|COMPLETED|Treatment Period 1||12
38250|NCT01845077|89284|P2|COMPLETED|Treatment Period 1||12
38251|NCT01845077|89285|P1|COMPLETED|Treatment Period 1||12
38252|NCT01845077|89280|P6|STARTED|Treatment Period 1||12
38253|NCT01845077|89281|P5|STARTED|Treatment Period 1||12
38254|NCT01845077|89282|P4|STARTED|Treatment Period 1||12
38255|NCT01845077|89283|P3|STARTED|Treatment Period 1||12
38256|NCT01845077|89284|P2|STARTED|Treatment Period 1||12
38257|NCT01845077|89285|P1|STARTED|Treatment Period 1||12
38258|NCT01845025|89331|P2|NOT COMPLETED|Overall Study||77
38259|NCT01845025|89332|P1|NOT COMPLETED|Overall Study||85
38260|NCT01845025|89331|P2|COMPLETED|Overall Study||332
38261|NCT01845025|89332|P1|COMPLETED|Overall Study||326
38262|NCT01845025|89331|P2|STARTED|Overall Study||409
38263|NCT01845025|89332|P1|STARTED|Overall Study||411
38264|NCT01844895|89354|P1|NOT COMPLETED|Day 29 - Day113 - Autoinjector||6
38265|NCT01844895|89354|P1|COMPLETED|Day 29 - Day113 - Autoinjector||111
38266|NCT01844895|89354|P1|STARTED|Day 29 - Day113 - Autoinjector||117
38267|NCT01844895|89354|P1|NOT COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||3
38268|NCT01844895|89354|P1|COMPLETED|Day 1 to Day 28 - Pre-filled Syringe||117
38269|NCT01844895|89354|P1|STARTED|Day 1 to Day 28 - Pre-filled Syringe||120
38270|NCT01844856|89372|P2|NOT COMPLETED|Overall Study||16
38271|NCT01844856|89373|P1|NOT COMPLETED|Overall Study||24
38272|NCT01844856|89372|P2|COMPLETED|Overall Study||255
38273|NCT01844856|89373|P1|COMPLETED|Overall Study||246
38274|NCT01844856|89372|P2|Received at Least 1 Dose of Study Drug|Overall Study||268
38275|NCT01844856|89373|P1|Received at Least 1 Dose of Study Drug|Overall Study||270
38276|NCT01844856|89372|P2|STARTED|Overall Study||271
38277|NCT01844856|89373|P1|STARTED|Overall Study||270
38278|NCT01844830|89385|P2|NOT COMPLETED|Overall Study||0
38279|NCT01844830|89386|P1|NOT COMPLETED|Overall Study||1
38280|NCT01844830|89385|P2|COMPLETED|Overall Study||30
38281|NCT01844830|89386|P1|COMPLETED|Overall Study||59
38282|NCT01844830|89385|P2|400 µL Dose|Overall Study||10
38283|NCT01844830|89386|P1|400 µL Dose|Overall Study||20
38284|NCT01844830|89385|P2|200 µL Dose|Overall Study||12
38285|NCT01844830|89386|P1|200 µL Dose|Overall Study||24
38286|NCT01844830|89385|P2|100 µL Dose|Overall Study||8
38287|NCT01844830|89386|P1|100 µL Dose|Overall Study||16
38288|NCT01844830|89385|P2|STARTED|Overall Study||30
38289|NCT01844830|89386|P1|STARTED|Overall Study||60
38290|NCT01844817|89416|P2|NOT COMPLETED|Treatment||63
38291|NCT01844817|89417|P1|NOT COMPLETED|Treatment||64
38292|NCT01844817|89416|P2|COMPLETED|Treatment||0
38293|NCT01844817|89417|P1|COMPLETED|Treatment||0
38294|NCT01844817|89416|P2|STARTED|Treatment||63
38295|NCT01844817|89417|P1|STARTED|Treatment||64
38296|NCT01844817|89416|P2|NOT COMPLETED|Enrolled and Randomized||3
38297|NCT01844817|89417|P1|NOT COMPLETED|Enrolled and Randomized||2
38298|NCT01844817|89416|P2|COMPLETED|Enrolled and Randomized||63
38299|NCT01844817|89417|P1|COMPLETED|Enrolled and Randomized||64
38300|NCT01844817|89416|P2|STARTED|Enrolled and Randomized||66
38301|NCT01844817|89417|P1|STARTED|Enrolled and Randomized||66
38302|NCT01844778|89430|P3|NOT COMPLETED|Overall Study||4
38303|NCT01844778|89431|P2|NOT COMPLETED|Overall Study||3
38304|NCT01844778|89432|P1|NOT COMPLETED|Overall Study||2
38305|NCT01844778|89430|P3|COMPLETED|Overall Study||14
38306|NCT01844778|89431|P2|COMPLETED|Overall Study||25
38307|NCT01844778|89432|P1|COMPLETED|Overall Study||12
38308|NCT01844778|89430|P3|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||15
38309|NCT01844778|89431|P2|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||25
38310|NCT01844778|89432|P1|Safety Set 2 (at Least 1 Dose, Cycle 2)|Overall Study||12
38311|NCT01844778|89430|P3|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||18
38312|NCT01844778|89431|P2|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||28
38313|NCT01844778|89432|P1|Safety Set 1 (at Least 1 Dose, Cycle 1)|Overall Study||14
38314|NCT01844778|89430|P3|STARTED|Overall Study||18
38315|NCT01844778|89431|P2|STARTED|Overall Study||28
38316|NCT01844778|89432|P1|STARTED|Overall Study||14
38317|NCT01844700|89458|P2|NOT COMPLETED|Overall Study||1
38318|NCT01844700|89459|P1|NOT COMPLETED|Overall Study||3
38319|NCT01844700|89458|P2|COMPLETED|Overall Study||2
38320|NCT01844700|89459|P1|COMPLETED|Overall Study||1
38321|NCT01844700|89458|P2|STARTED|Overall Study||3
38322|NCT01844700|89459|P1|STARTED|Overall Study||4
38323|NCT01844687|89471|P1|NOT COMPLETED|Visit 8||0
38324|NCT01844687|89471|P1|COMPLETED|Visit 8||31
38325|NCT01844687|89471|P1|STARTED|Visit 8||31
38326|NCT01844687|89471|P1|NOT COMPLETED|Visit 7||0
38327|NCT01844687|89471|P1|COMPLETED|Visit 7||31
38328|NCT01844687|89471|P1|STARTED|Visit 7||31
38329|NCT01844687|89471|P1|NOT COMPLETED|Visit 6||0
38330|NCT01844687|89471|P1|COMPLETED|Visit 6||31
38331|NCT01844687|89471|P1|STARTED|Visit 6||31
38332|NCT01844687|89471|P1|NOT COMPLETED|Visit 5||0
38333|NCT01844687|89471|P1|COMPLETED|Visit 5||31
38334|NCT01844687|89471|P1|STARTED|Visit 5||31
38335|NCT01844687|89471|P1|NOT COMPLETED|Visit 4||4
38336|NCT01844687|89471|P1|COMPLETED|Visit 4||31
38337|NCT01844687|89471|P1|STARTED|Visit 4||35
38338|NCT01844687|89471|P1|NOT COMPLETED|Visit 3||5
38339|NCT01844687|89471|P1|COMPLETED|Visit 3||35
38340|NCT01844687|89471|P1|STARTED|Visit 3||40
38341|NCT01844687|89471|P1|NOT COMPLETED|Visit 2||2
38342|NCT01844687|89471|P1|COMPLETED|Visit 2||40
38343|NCT01844687|89471|P1|STARTED|Visit 2||42
38344|NCT01844687|89471|P1|NOT COMPLETED|Visit 1||8
38345|NCT01844687|89471|P1|COMPLETED|Visit 1||42
38346|NCT01844687|89471|P1|STARTED|Visit 1||50
38347|NCT01844531|89534|P4|NOT COMPLETED|Overall Study||0
38348|NCT01844531|89535|P3|NOT COMPLETED|Overall Study||0
38349|NCT01844531|89536|P2|NOT COMPLETED|Overall Study||1
38350|NCT01844531|89537|P1|NOT COMPLETED|Overall Study||0
38351|NCT01844531|89534|P4|COMPLETED|Overall Study||6
38352|NCT01844531|89535|P3|COMPLETED|Overall Study||6
38353|NCT01844531|89536|P2|COMPLETED|Overall Study||5
38354|NCT01844531|89537|P1|COMPLETED|Overall Study||6
38355|NCT01844531|89534|P4|STARTED|Overall Study||6
38356|NCT01844531|89535|P3|STARTED|Overall Study||6
38357|NCT01844531|89536|P2|STARTED|Overall Study||6
38358|NCT01844531|89537|P1|STARTED|Overall Study||6
38359|NCT01844518|89567|P1|NOT COMPLETED|Long-Term Extension||157
38360|NCT01844518|89567|P1|COMPLETED|Long-Term Extension|Study is on-going|0
38361|NCT01844518|89567|P1|STARTED|Long-Term Extension|7 participants completed ST but did not continue in study.|157
38362|NCT01844518|89567|P1|NOT COMPLETED|Short-Term (ST) Period||9
38363|NCT01844518|89567|P1|COMPLETED|Short-Term (ST) Period||164
38364|NCT01844518|89567|P1|STARTED|Short-Term (ST) Period||173
38365|NCT01844479|89581|P2|NOT COMPLETED|Second Intervention up to 30 Minutes||0
38366|NCT01844479|89582|P1|NOT COMPLETED|Second Intervention up to 30 Minutes||0
38367|NCT01844479|89581|P2|COMPLETED|Second Intervention up to 30 Minutes||13
38368|NCT01844479|89582|P1|COMPLETED|Second Intervention up to 30 Minutes||14
38369|NCT01844479|89581|P2|STARTED|Second Intervention up to 30 Minutes||13
38370|NCT01844479|89582|P1|STARTED|Second Intervention up to 30 Minutes||14
38371|NCT01844479|89581|P2|NOT COMPLETED|First Intervention up to 30 Minutes||0
38372|NCT01844479|89582|P1|NOT COMPLETED|First Intervention up to 30 Minutes||0
38373|NCT01844479|89581|P2|COMPLETED|First Intervention up to 30 Minutes||13
38374|NCT01844479|89582|P1|COMPLETED|First Intervention up to 30 Minutes||14
38375|NCT01844479|89581|P2|STARTED|First Intervention up to 30 Minutes||13
38376|NCT01844479|89582|P1|STARTED|First Intervention up to 30 Minutes||14
38377|NCT01844388|89612|P2|NOT COMPLETED|Overall Study||7
38378|NCT01844388|89613|P1|NOT COMPLETED|Overall Study||8
38379|NCT01844388|89612|P2|COMPLETED|Overall Study||114
38380|NCT01844388|89613|P1|COMPLETED|Overall Study||236
38381|NCT01844388|89612|P2|STARTED|Overall Study||121
38382|NCT01844388|89613|P1|STARTED|Overall Study||244
38383|NCT01844206|89625|P2|NOT COMPLETED|Overall Study||1
38384|NCT01844206|89626|P1|NOT COMPLETED|Overall Study||0
38385|NCT01844206|89625|P2|COMPLETED|Overall Study|One patient requested that epidural catheter be removed during the first post-operative day.|2
38386|NCT01844206|89626|P1|COMPLETED|Overall Study||2
38387|NCT01844206|89625|P2|STARTED|Overall Study||3
38388|NCT01844206|89626|P1|STARTED|Overall Study||2
38389|NCT01843972|89642|P10|NOT COMPLETED|Overall Study||0
38390|NCT01843972|89643|P9|NOT COMPLETED|Overall Study||0
38391|NCT01843972|89644|P8|NOT COMPLETED|Overall Study||0
38392|NCT01843972|89645|P7|NOT COMPLETED|Overall Study||0
38393|NCT01843972|89646|P6|NOT COMPLETED|Overall Study||0
38394|NCT01843972|89647|P5|NOT COMPLETED|Overall Study||1
38395|NCT01843972|89648|P4|NOT COMPLETED|Overall Study||0
38396|NCT01843972|89649|P3|NOT COMPLETED|Overall Study||0
38397|NCT01843972|89650|P2|NOT COMPLETED|Overall Study||0
38398|NCT01843972|89651|P1|NOT COMPLETED|Overall Study||0
38399|NCT01843972|89642|P10|COMPLETED|Overall Study||12
38400|NCT01843972|89643|P9|COMPLETED|Overall Study||17
38401|NCT01843972|89644|P8|COMPLETED|Overall Study||5
38402|NCT01843972|89645|P7|COMPLETED|Overall Study||5
38403|NCT01843972|89646|P6|COMPLETED|Overall Study||6
38404|NCT01843972|89647|P5|COMPLETED|Overall Study||5
38405|NCT01843972|89648|P4|COMPLETED|Overall Study||6
38406|NCT01843972|89649|P3|COMPLETED|Overall Study||5
38407|NCT01843972|89650|P2|COMPLETED|Overall Study||6
38408|NCT01843972|89651|P1|COMPLETED|Overall Study||13
38409|NCT01843972|89642|P10|STARTED|Overall Study||12
38410|NCT01843972|89643|P9|STARTED|Overall Study||17
38411|NCT01843972|89644|P8|STARTED|Overall Study||5
38412|NCT01843972|89645|P7|STARTED|Overall Study||5
38413|NCT01843972|89646|P6|STARTED|Overall Study||6
38414|NCT01843972|89647|P5|STARTED|Overall Study||6
38415|NCT01843972|89648|P4|STARTED|Overall Study||6
38416|NCT01843972|89649|P3|STARTED|Overall Study||5
38417|NCT01843972|89650|P2|STARTED|Overall Study||6
38418|NCT01843972|89651|P1|STARTED|Overall Study||13
38419|NCT01843933|89721|P2|NOT COMPLETED|Overall Study||4
38420|NCT01843933|89722|P1|NOT COMPLETED|Overall Study||6
38421|NCT01843933|89721|P2|COMPLETED|Overall Study||103
38422|NCT01843933|89722|P1|COMPLETED|Overall Study||98
38423|NCT01843933|89721|P2|STARTED|Overall Study||107
38424|NCT01843933|89722|P1|STARTED|Overall Study||104
38425|NCT01843920|89730|P2|NOT COMPLETED|Overall Study||0
38426|NCT01843920|89731|P1|NOT COMPLETED|Overall Study||0
38427|NCT01843920|89730|P2|COMPLETED|Overall Study||9
38428|NCT01843920|89731|P1|COMPLETED|Overall Study||12
38429|NCT01843920|89730|P2|STARTED|Overall Study||9
38430|NCT01843920|89731|P1|STARTED|Overall Study||12
38431|NCT01843777|89739|P2|NOT COMPLETED|Overall Study||0
38432|NCT01843777|89740|P1|NOT COMPLETED|Overall Study||1
38433|NCT01843777|89739|P2|COMPLETED|Overall Study|Number of subjects who received the treatment that completed collection of outcome measures|10
38434|NCT01843777|89740|P1|COMPLETED|Overall Study|Final number of standard-of-care participants.|10
38435|NCT01843777|89739|P2|Per Protocol Population|Overall Study|A subject was randomized to treatment but received standard of care and is not in the analyses.|9
38436|NCT01843777|89740|P1|Per Protocol Population|Overall Study||11
38437|NCT01843777|89739|P2|STARTED|Overall Study|Number of participants randomized to treatment.|10
38438|NCT01843777|89740|P1|STARTED|Overall Study|Number of participants randomized to standard-of-care.|11
38439|NCT01843673|89748|P1|NOT COMPLETED|Overall Study||6
38440|NCT01843673|89748|P1|COMPLETED|Overall Study||10
38441|NCT01843673|89748|P1|STARTED|Overall Study||16
38442|NCT01843660|89760|P1|NOT COMPLETED|Overall Study||30
38443|NCT01843660|89760|P1|COMPLETED|Overall Study||1029
38444|NCT01843660|89760|P1|STARTED|Overall Study||1059
38445|NCT01843465|89778|P1|NOT COMPLETED|Overall Study||0
38446|NCT01843465|89778|P1|COMPLETED|Overall Study||34
38447|NCT01843465|89778|P1|STARTED|Overall Study|This study had no follow-up. It focused in the acute setting of cryoballoon ablation.|34
38448|NCT01843374|89784|P2|NOT COMPLETED|Overall Study||321
38449|NCT01843374|89785|P1|NOT COMPLETED|Overall Study||164
38450|NCT01843374|89784|P2|COMPLETED|Overall Study||61
38451|NCT01843374|89785|P1|COMPLETED|Overall Study||25
38452|NCT01843374|89784|P2|RANDOMIZED|Overall Study||382
38453|NCT01843374|89785|P1|RANDOMIZED|Overall Study||189
38454|NCT01843374|89784|P2|STARTED|Overall Study||382
38455|NCT01843374|89785|P1|STARTED|Overall Study||189
38456|NCT01843348|89812|P3|NOT COMPLETED|Overall Study||41
38457|NCT01843348|89813|P2|NOT COMPLETED|Overall Study||40
38458|NCT01843348|89814|P1|NOT COMPLETED|Overall Study||23
38459|NCT01843348|89812|P3|COMPLETED|Overall Study||158
38460|NCT01843348|89813|P2|COMPLETED|Overall Study||168
38461|NCT01843348|89814|P1|COMPLETED|Overall Study||182
38462|NCT01843348|89812|P3|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|80
38463|NCT01843348|89813|P2|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|111
38464|NCT01843348|89814|P1|Per Protocol Set (PPS)|Overall Study|Participants in the FAS without major protocol deviations|147
38465|NCT01843348|89812|P3|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|199
38466|NCT01843348|89813|P2|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|208
38467|NCT01843348|89814|P1|Full Analysis Set (FAS)|Overall Study|Participants in the FAS received at least one dose of study drug|205
38468|NCT01843348|89812|P3|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|198
38469|NCT01843348|89813|P2|Safety Analysis Set (SAS)|Overall Study|Two participants received TAC + Certican in other arms in errorr - analyzed with TAC + Certican arm|210
38470|NCT01843348|89814|P1|Safety Analysis Set (SAS)|Overall Study|One participant received TAC + Certican in error - analyzed with TAC + Certican arm|204
38471|NCT01843348|89812|P3|STARTED|Overall Study||199
38472|NCT01843348|89813|P2|STARTED|Overall Study||208
38473|NCT01843348|89814|P1|STARTED|Overall Study||205
38474|NCT01843192|89857|P3|NOT COMPLETED|Overall Study||2
38475|NCT01843192|89858|P2|NOT COMPLETED|Overall Study||6
38476|NCT01843192|89859|P1|NOT COMPLETED|Overall Study||2
38477|NCT01843192|89857|P3|COMPLETED|Overall Study||9
38478|NCT01843192|89858|P2|COMPLETED|Overall Study||28
38479|NCT01843192|89859|P1|COMPLETED|Overall Study||24
38480|NCT01843192|89857|P3|STARTED|Overall Study||11
38481|NCT01843192|89858|P2|STARTED|Overall Study||34
38482|NCT01843192|89859|P1|STARTED|Overall Study||26
38483|NCT01842906|89890|P2|NOT COMPLETED|Overall Study||0
38484|NCT01842906|89891|P1|NOT COMPLETED|Overall Study||0
38485|NCT01842906|89890|P2|COMPLETED|Overall Study||104
38486|NCT01842906|89891|P1|COMPLETED|Overall Study||115
38487|NCT01842906|89890|P2|STARTED|Overall Study||104
38488|NCT01842906|89891|P1|STARTED|Overall Study||115
38489|NCT01842841|89903|P1|NOT COMPLETED|Overall Study||0
38490|NCT01842841|89903|P1|COMPLETED|Overall Study||5
38491|NCT01842841|89903|P1|STARTED|Overall Study||5
38492|NCT01842789|89924|P2|NOT COMPLETED|Overall Study||0
38493|NCT01842789|89925|P1|NOT COMPLETED|Overall Study||0
38494|NCT01842789|89924|P2|COMPLETED|Overall Study||8
38495|NCT01842789|89925|P1|COMPLETED|Overall Study||10
38496|NCT01842789|89924|P2|STARTED|Overall Study||8
38497|NCT01842789|89925|P1|STARTED|Overall Study||10
38498|NCT01842646|89934|P1|NOT COMPLETED|Overall Study||0
38499|NCT01842646|89934|P1|COMPLETED|Overall Study||35
38500|NCT01842646|89934|P1|STARTED|Overall Study||35
38501|NCT01842633|89943|P3|NOT COMPLETED|Overall Study||0
38502|NCT01842633|89944|P2|NOT COMPLETED|Overall Study||2
38503|NCT01842633|89945|P1|NOT COMPLETED|Overall Study||3
38504|NCT01842633|89943|P3|COMPLETED|Overall Study||34
38505|NCT01842633|89944|P2|COMPLETED|Overall Study||64
38506|NCT01842633|89945|P1|COMPLETED|Overall Study||62
38507|NCT01842633|89943|P3|STARTED|Overall Study||34
38508|NCT01842633|89944|P2|STARTED|Overall Study||66
38509|NCT01842633|89945|P1|STARTED|Overall Study||65
38510|NCT01842607|89992|P1|NOT COMPLETED|Overall Study||66
38511|NCT01842607|89992|P1|COMPLETED|Overall Study||585
38512|NCT01842607|89992|P1|STARTED|Overall Study||651
38513|NCT01842594|90011|P1|NOT COMPLETED|Overall Study||3
38514|NCT01842594|90011|P1|COMPLETED|Overall Study||10
38515|NCT01842594|90011|P1|STARTED|Overall Study||13
38516|NCT01842464|90016|P1|NOT COMPLETED|Overall Study||0
38517|NCT01842464|90016|P1|COMPLETED|Overall Study||44
38518|NCT01842464|90016|P1|STARTED|Overall Study||44
38519|NCT01842438|90024|P2|NOT COMPLETED|T2: 6month Follow-up||4
38520|NCT01842438|90025|P1|NOT COMPLETED|T2: 6month Follow-up||4
38521|NCT01842438|90024|P2|COMPLETED|T2: 6month Follow-up||32
38522|NCT01842438|90025|P1|COMPLETED|T2: 6month Follow-up||32
38523|NCT01842438|90024|P2|STARTED|T2: 6month Follow-up||36
38524|NCT01842438|90025|P1|STARTED|T2: 6month Follow-up||36
38525|NCT01842438|90024|P2|NOT COMPLETED|T1: Immediately After the Intervention||8
38526|NCT01842438|90025|P1|NOT COMPLETED|T1: Immediately After the Intervention||6
38527|NCT01842438|90024|P2|COMPLETED|T1: Immediately After the Intervention||36
38528|NCT01842438|90025|P1|COMPLETED|T1: Immediately After the Intervention||36
38529|NCT01842438|90024|P2|STARTED|T1: Immediately After the Intervention||44
38530|NCT01842438|90025|P1|STARTED|T1: Immediately After the Intervention||42
38531|NCT01841970|90037|P1|NOT COMPLETED|Overall Study||11
38532|NCT01841970|90037|P1|COMPLETED|Overall Study||9
38533|NCT01841970|90037|P1|STARTED|Overall Study||20
38534|NCT01841697|90055|P2|NOT COMPLETED|Overall Study||18
38535|NCT01841697|90056|P1|NOT COMPLETED|Overall Study||20
38536|NCT01841697|90055|P2|COMPLETED|Overall Study||302
38537|NCT01841697|90056|P1|COMPLETED|Overall Study||302
38538|NCT01841697|90055|P2|STARTED|Overall Study||320
38539|NCT01841697|90056|P1|STARTED|Overall Study||322
38540|NCT01841619|90072|P1|NOT COMPLETED|Overall Study||0
38541|NCT01841619|90072|P1|COMPLETED|Overall Study||16
38542|NCT01841619|90072|P1|STARTED|Overall Study||16
38543|NCT01841593|90082|P2|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
38544|NCT01841593|90083|P1|NOT COMPLETED|Third Intervention (Days 15 to 21)||0
38545|NCT01841593|90082|P2|COMPLETED|Third Intervention (Days 15 to 21)||6
38546|NCT01841593|90083|P1|COMPLETED|Third Intervention (Days 15 to 21)||11
38547|NCT01841593|90082|P2|STARTED|Third Intervention (Days 15 to 21)||6
38548|NCT01841593|90083|P1|STARTED|Third Intervention (Days 15 to 21)||11
38549|NCT01841593|90082|P2|NOT COMPLETED|Second Intervention (Days 8 to 14)||0
38550|NCT01841593|90083|P1|NOT COMPLETED|Second Intervention (Days 8 to 14)||1
38551|NCT01841593|90082|P2|COMPLETED|Second Intervention (Days 8 to 14)||6
38552|NCT01841593|90083|P1|COMPLETED|Second Intervention (Days 8 to 14)||11
38553|NCT01841593|90082|P2|STARTED|Second Intervention (Days 8 to 14)||6
38554|NCT01841593|90083|P1|STARTED|Second Intervention (Days 8 to 14)||12
38555|NCT01841593|90082|P2|NOT COMPLETED|First Intervention (Days 1 to 7)||1
38556|NCT01841593|90083|P1|NOT COMPLETED|First Intervention (Days 1 to 7)||0
38557|NCT01841593|90082|P2|COMPLETED|First Intervention (Days 1 to 7)||6
38558|NCT01841593|90083|P1|COMPLETED|First Intervention (Days 1 to 7)||12
38559|NCT01841593|90082|P2|STARTED|First Intervention (Days 1 to 7)||7
38560|NCT01841593|90083|P1|STARTED|First Intervention (Days 1 to 7)||12
38561|NCT01841567|90099|P1|NOT COMPLETED|Overall Study||3
38562|NCT01841567|90099|P1|COMPLETED|Overall Study||57
38563|NCT01841567|90099|P1|STARTED|Overall Study||60
38564|NCT01841216|90106|P2|NOT COMPLETED|Overall Study||0
38565|NCT01841216|90107|P1|NOT COMPLETED|Overall Study||0
38566|NCT01841216|90106|P2|COMPLETED|Overall Study||15
38567|NCT01841216|90107|P1|COMPLETED|Overall Study||15
38568|NCT01841216|90106|P2|STARTED|Overall Study||15
38569|NCT01841216|90107|P1|STARTED|Overall Study||15
38570|NCT01841021|90115|P1|NOT COMPLETED|Overall Study||0
38571|NCT01841021|90115|P1|COMPLETED|Overall Study||1
38572|NCT01841021|90115|P1|STARTED|Overall Study||1
38573|NCT01840943|90127|P2|NOT COMPLETED|Overall Study||12
38574|NCT01840943|90128|P1|NOT COMPLETED|Overall Study||13
38575|NCT01840943|90127|P2|COMPLETED|Overall Study||0
38576|NCT01840943|90128|P1|COMPLETED|Overall Study||1
38577|NCT01840943|90127|P2|STARTED|Overall Study||12
38578|NCT01840943|90128|P1|STARTED|Overall Study||14
38579|NCT01840605|90164|P2|NOT COMPLETED|Overall Study||2
38580|NCT01840605|90165|P1|NOT COMPLETED|Overall Study||2
38581|NCT01840605|90164|P2|COMPLETED|Overall Study||150
38582|NCT01840605|90165|P1|COMPLETED|Overall Study||149
38583|NCT01840605|90164|P2|STARTED|Overall Study||152
38584|NCT01840605|90165|P1|STARTED|Overall Study||151
38585|NCT01840410|90173|P2|NOT COMPLETED|Overall Study||4
38586|NCT01840410|90174|P1|NOT COMPLETED|Overall Study||7
38587|NCT01840410|90173|P2|COMPLETED|Overall Study||55
38588|NCT01840410|90174|P1|COMPLETED|Overall Study||112
38589|NCT01840410|90173|P2|Full Analysis Set|Overall Study||59
38590|NCT01840410|90174|P1|Full Analysis Set|Overall Study||119
38591|NCT01840410|90173|P2|Safety Set|Overall Study|52 received ranibizumab at or after Month 2;7 did not receive ranibizumab any time during the study|59
38592|NCT01840410|90174|P1|Safety Set|Overall Study||119
38593|NCT01840410|90173|P2|STARTED|Overall Study||59
38594|NCT01840410|90174|P1|STARTED|Overall Study||119
38595|NCT01840319|90210|P1|NOT COMPLETED|Overall Study||0
38596|NCT01840319|90210|P1|COMPLETED|Overall Study||156
38597|NCT01840319|90210|P1|STARTED|Overall Study||156
38598|NCT01840072|90216|P2|NOT COMPLETED|Overall Study||47
38599|NCT01840072|90217|P1|NOT COMPLETED|Overall Study||7
38600|NCT01840072|90216|P2|COMPLETED|Overall Study||1986
38601|NCT01840072|90217|P1|COMPLETED|Overall Study||2031
38602|NCT01840072|90216|P2|STARTED|Overall Study||2033
38603|NCT01840072|90217|P1|STARTED|Overall Study||2038
38604|NCT01839695|90239|P1|NOT COMPLETED|Overall Study||0
38605|NCT01839695|90239|P1|COMPLETED|Overall Study||9
38606|NCT01839695|90239|P1|STARTED|Overall Study||9
38607|NCT01839604|90249|P5|NOT COMPLETED|Overall Study||0
38608|NCT01839604|90250|P4|NOT COMPLETED|Overall Study||0
38609|NCT01839604|90251|P3|NOT COMPLETED|Overall Study||0
38610|NCT01839604|90252|P2|NOT COMPLETED|Overall Study||0
38611|NCT01839604|90253|P1|NOT COMPLETED|Overall Study||0
38612|NCT01839604|90249|P5|COMPLETED|Overall Study||15
38613|NCT01839604|90250|P4|COMPLETED|Overall Study||5
38614|NCT01839604|90251|P3|COMPLETED|Overall Study||7
38615|NCT01839604|90252|P2|COMPLETED|Overall Study||6
38616|NCT01839604|90253|P1|COMPLETED|Overall Study||6
38617|NCT01839604|90249|P5|STARTED|Overall Study||15
38618|NCT01839604|90250|P4|STARTED|Overall Study||5
38619|NCT01839604|90251|P3|STARTED|Overall Study||7
38620|NCT01839604|90252|P2|STARTED|Overall Study||6
38621|NCT01839604|90253|P1|STARTED|Overall Study||6
38622|NCT01839318|90280|P6|NOT COMPLETED|Period 3, Third Day of Wear||0
38623|NCT01839318|90281|P5|NOT COMPLETED|Period 3, Third Day of Wear||0
38624|NCT01839318|90282|P4|NOT COMPLETED|Period 3, Third Day of Wear||0
38625|NCT01839318|90283|P3|NOT COMPLETED|Period 3, Third Day of Wear||0
38626|NCT01839318|90284|P2|NOT COMPLETED|Period 3, Third Day of Wear||0
38627|NCT01839318|90285|P1|NOT COMPLETED|Period 3, Third Day of Wear||0
38628|NCT01839318|90280|P6|COMPLETED|Period 3, Third Day of Wear||2
38629|NCT01839318|90281|P5|COMPLETED|Period 3, Third Day of Wear||7
38630|NCT01839318|90282|P4|COMPLETED|Period 3, Third Day of Wear||6
38631|NCT01839318|90283|P3|COMPLETED|Period 3, Third Day of Wear||5
38632|NCT01839318|90284|P2|COMPLETED|Period 3, Third Day of Wear||4
38633|NCT01839318|90285|P1|COMPLETED|Period 3, Third Day of Wear||4
38634|NCT01839318|90280|P6|STARTED|Period 3, Third Day of Wear||2
38635|NCT01839318|90281|P5|STARTED|Period 3, Third Day of Wear||7
38636|NCT01839318|90282|P4|STARTED|Period 3, Third Day of Wear||6
38637|NCT01839318|90283|P3|STARTED|Period 3, Third Day of Wear||5
38638|NCT01839318|90284|P2|STARTED|Period 3, Third Day of Wear||4
38639|NCT01839318|90285|P1|STARTED|Period 3, Third Day of Wear||4
38640|NCT01839318|90280|P6|NOT COMPLETED|Period 2, Second Day of Wear||0
38641|NCT01839318|90281|P5|NOT COMPLETED|Period 2, Second Day of Wear||0
38642|NCT01839318|90282|P4|NOT COMPLETED|Period 2, Second Day of Wear||0
38643|NCT01839318|90283|P3|NOT COMPLETED|Period 2, Second Day of Wear||0
38644|NCT01839318|90284|P2|NOT COMPLETED|Period 2, Second Day of Wear||0
38645|NCT01839318|90285|P1|NOT COMPLETED|Period 2, Second Day of Wear||0
38646|NCT01839318|90280|P6|COMPLETED|Period 2, Second Day of Wear||2
38647|NCT01839318|90281|P5|COMPLETED|Period 2, Second Day of Wear||7
38648|NCT01839318|90282|P4|COMPLETED|Period 2, Second Day of Wear||6
38649|NCT01839318|90283|P3|COMPLETED|Period 2, Second Day of Wear||5
38650|NCT01839318|90284|P2|COMPLETED|Period 2, Second Day of Wear||4
38651|NCT01839318|90285|P1|COMPLETED|Period 2, Second Day of Wear||4
38652|NCT01839318|90280|P6|STARTED|Period 2, Second Day of Wear||2
38653|NCT01839318|90281|P5|STARTED|Period 2, Second Day of Wear||7
38654|NCT01839318|90282|P4|STARTED|Period 2, Second Day of Wear||6
38655|NCT01839318|90283|P3|STARTED|Period 2, Second Day of Wear||5
38656|NCT01839318|90284|P2|STARTED|Period 2, Second Day of Wear||4
38657|NCT01839318|90285|P1|STARTED|Period 2, Second Day of Wear||4
38658|NCT01839318|90280|P6|NOT COMPLETED|Period 1, First Day of Wear||0
38659|NCT01839318|90281|P5|NOT COMPLETED|Period 1, First Day of Wear||0
38660|NCT01839318|90282|P4|NOT COMPLETED|Period 1, First Day of Wear||0
38661|NCT01839318|90283|P3|NOT COMPLETED|Period 1, First Day of Wear||0
38662|NCT01839318|90284|P2|NOT COMPLETED|Period 1, First Day of Wear||0
38663|NCT01839318|90285|P1|NOT COMPLETED|Period 1, First Day of Wear||0
38664|NCT01839318|90280|P6|COMPLETED|Period 1, First Day of Wear||2
38665|NCT01839318|90281|P5|COMPLETED|Period 1, First Day of Wear||7
38666|NCT01839318|90282|P4|COMPLETED|Period 1, First Day of Wear||6
38667|NCT01839318|90283|P3|COMPLETED|Period 1, First Day of Wear||5
38668|NCT01839318|90284|P2|COMPLETED|Period 1, First Day of Wear||4
38669|NCT01839318|90285|P1|COMPLETED|Period 1, First Day of Wear||4
38670|NCT01839318|90280|P6|STARTED|Period 1, First Day of Wear||2
38671|NCT01839318|90281|P5|STARTED|Period 1, First Day of Wear||7
38672|NCT01839318|90282|P4|STARTED|Period 1, First Day of Wear||6
38673|NCT01839318|90283|P3|STARTED|Period 1, First Day of Wear||5
38674|NCT01839318|90284|P2|STARTED|Period 1, First Day of Wear||4
38675|NCT01839318|90285|P1|STARTED|Period 1, First Day of Wear||4
38676|NCT01839279|90299|P3|NOT COMPLETED|Overall Study||2
38677|NCT01839279|90300|P2|NOT COMPLETED|Overall Study||2
38678|NCT01839279|90301|P1|NOT COMPLETED|Overall Study||13
38679|NCT01839279|90299|P3|COMPLETED|Overall Study||30
38680|NCT01839279|90300|P2|COMPLETED|Overall Study||30
38681|NCT01839279|90301|P1|COMPLETED|Overall Study||59
38682|NCT01839279|90299|P3|PK/QTc Analysis Set|Overall Study||0
38683|NCT01839279|90300|P2|PK/QTc Analysis Set|Overall Study||0
38684|NCT01839279|90301|P1|PK/QTc Analysis Set|Overall Study||70
38685|NCT01839279|90299|P3|Moxifloxacin/Placebo Analysis Set|Overall Study||30
38686|NCT01839279|90300|P2|Moxifloxacin/Placebo Analysis Set|Overall Study||31
38687|NCT01839279|90301|P1|Moxifloxacin/Placebo Analysis Set|Overall Study||0
38688|NCT01839279|90299|P3|PK Analysis Set|Overall Study||0
38689|NCT01839279|90300|P2|PK Analysis Set|Overall Study||0
38690|NCT01839279|90301|P1|PK Analysis Set|Overall Study||70
38691|NCT01839279|90299|P3|QT/QTc Analysis Set|Overall Study||32
38692|NCT01839279|90300|P2|QT/QTc Analysis Set|Overall Study||32
38693|NCT01839279|90301|P1|QT/QTc Analysis Set|Overall Study||72
38694|NCT01839279|90299|P3|STARTED|Overall Study||32
38695|NCT01839279|90300|P2|STARTED|Overall Study||32
38696|NCT01839279|90301|P1|STARTED|Overall Study||72
38697|NCT01839058|90322|P2|NOT COMPLETED|Overall Study||3
38698|NCT01839058|90323|P1|NOT COMPLETED|Overall Study||4
38699|NCT01839058|90322|P2|COMPLETED|Overall Study||16
38700|NCT01839058|90323|P1|COMPLETED|Overall Study||17
38701|NCT01839058|90322|P2|STARTED|Overall Study||19
38702|NCT01839058|90323|P1|STARTED|Overall Study||21
38703|NCT01838980|90329|P1|NOT COMPLETED|Overall Study||0
38704|NCT01838980|90329|P1|COMPLETED|Overall Study||15
38705|NCT01838980|90329|P1|STARTED|Overall Study||15
38706|NCT01838941|90333|P1|NOT COMPLETED|Overall Study||2
38707|NCT01838941|90333|P1|COMPLETED|Overall Study||10
38708|NCT01838941|90333|P1|STARTED|Overall Study||12
38709|NCT01838694|90340|P2|NOT COMPLETED|Overall Study||1
38710|NCT01838694|90341|P1|NOT COMPLETED|Overall Study||0
38711|NCT01838694|90340|P2|COMPLETED|Overall Study||21
38712|NCT01838694|90341|P1|COMPLETED|Overall Study||8
38713|NCT01838694|90340|P2|STARTED|Overall Study||22
38714|NCT01838694|90341|P1|STARTED|Overall Study||8
38715|NCT01838681|90350|P4|NOT COMPLETED|Period B/A+||117
38716|NCT01838681|90351|P3|NOT COMPLETED|Period B/A+||95
38717|NCT01838681|90352|P2|NOT COMPLETED|Period B/A+||62
38718|NCT01838681|90353|P1|NOT COMPLETED|Period B/A+||0
38719|NCT01838681|90350|P4|COMPLETED|Period B/A+||653
38720|NCT01838681|90351|P3|COMPLETED|Period B/A+||349
38721|NCT01838681|90352|P2|COMPLETED|Period B/A+||380
38722|NCT01838681|90353|P1|COMPLETED|Period B/A+||0
38723|NCT01838681|90350|P4|STARTED|Period B/A+||770
38724|NCT01838681|90351|P3|STARTED|Period B/A+||444
38725|NCT01838681|90352|P2|STARTED|Period B/A+||442
38726|NCT01838681|90353|P1|STARTED|Period B/A+||0
38727|NCT01838681|90350|P4|NOT COMPLETED|Period A||0
38728|NCT01838681|90351|P3|NOT COMPLETED|Period A||0
38729|NCT01838681|90352|P2|NOT COMPLETED|Period A||0
38730|NCT01838681|90353|P1|NOT COMPLETED|Period A||325
38731|NCT01838681|90350|P4|COMPLETED|Period A||0
38732|NCT01838681|90351|P3|COMPLETED|Period A||0
38733|NCT01838681|90352|P2|COMPLETED|Period A||0
38734|NCT01838681|90353|P1|COMPLETED|Period A||1661
38735|NCT01838681|90350|P4|STARTED|Period A||0
38736|NCT01838681|90351|P3|STARTED|Period A||0
38737|NCT01838681|90352|P2|STARTED|Period A||0
38738|NCT01838681|90353|P1|STARTED|Period A||1986
38739|NCT01838642|90393|P1|NOT COMPLETED|Overall Study||1
38740|NCT01838642|90393|P1|COMPLETED|Overall Study||2
38741|NCT01838642|90393|P1|STARTED|Overall Study||3
38742|NCT01838616|90406|P2|NOT COMPLETED|Pick-up Arm||0
38743|NCT01838616|90407|P1|NOT COMPLETED|Pick-up Arm||15
38744|NCT01838616|90406|P2|COMPLETED|Pick-up Arm||0
38745|NCT01838616|90407|P1|COMPLETED|Pick-up Arm|Participants completed the tapentadol pick-up arm after initially on oxycodone/naloxone PR treatment|35
38746|NCT01838616|90406|P2|Full Analysis Set|Pick-up Arm||0
38747|NCT01838616|90407|P1|Full Analysis Set|Pick-up Arm||49
38748|NCT01838616|90406|P2|STARTED|Pick-up Arm||0
38749|NCT01838616|90407|P1|STARTED|Pick-up Arm|Switch to Tapentadol (PR) after Oxycodone/Naloxone (PR) treatment discontinuation.|50
38750|NCT01838616|90406|P2|NOT COMPLETED|Continuation Period||14
38751|NCT01838616|90407|P1|NOT COMPLETED|Continuation Period||14
38752|NCT01838616|90406|P2|COMPLETED|Continuation Period||48
38753|NCT01838616|90407|P1|COMPLETED|Continuation Period||86
38754|NCT01838616|90406|P2|Switched to Pick-up Arm|Continuation Period||7
38755|NCT01838616|90407|P1|Switched to Pick-up Arm|Continuation Period||0
38756|NCT01838616|90406|P2|STARTED|Continuation Period||62
38757|NCT01838616|90407|P1|STARTED|Continuation Period||100
38758|NCT01838616|90406|P2|NOT COMPLETED|Titration Period||66
38759|NCT01838616|90407|P1|NOT COMPLETED|Titration Period||30
38760|NCT01838616|90406|P2|COMPLETED|Titration Period||62
38761|NCT01838616|90407|P1|COMPLETED|Titration Period||100
38762|NCT01838616|90406|P2|Per Protocol Set|Titration Period||112
38763|NCT01838616|90407|P1|Per Protocol Set|Titration Period||117
38764|NCT01838616|90406|P2|Full Analysis Set|Titration Period||128
38765|NCT01838616|90407|P1|Full Analysis Set|Titration Period||130
38766|NCT01838616|90406|P2|Switched to Pick-up Arm|Titration Period||43
38767|NCT01838616|90407|P1|Switched to Pick-up Arm|Titration Period||0
38768|NCT01838616|90406|P2|Major Protocol Deviations|Titration Period||16
38769|NCT01838616|90407|P1|Major Protocol Deviations|Titration Period||13
38770|NCT01838616|90406|P2|No Post Baseline Pain Intensity Values|Titration Period||2
38771|NCT01838616|90407|P1|No Post Baseline Pain Intensity Values|Titration Period||0
38772|NCT01838616|90406|P2|STARTED|Titration Period||128
38773|NCT01838616|90407|P1|STARTED|Titration Period||130
38774|NCT01838590|90478|P2|NOT COMPLETED|Overall Study||5
38775|NCT01838590|90479|P1|NOT COMPLETED|Overall Study||12
38776|NCT01838590|90478|P2|COMPLETED|Overall Study||46
38777|NCT01838590|90479|P1|COMPLETED|Overall Study||40
38778|NCT01838590|90478|P2|STARTED|Overall Study||51
38779|NCT01838590|90479|P1|STARTED|Overall Study||52
38780|NCT01838499|90503|P2|NOT COMPLETED|Overall Study||17
38781|NCT01838499|90504|P1|NOT COMPLETED|Overall Study||24
38782|NCT01838499|90503|P2|COMPLETED|Overall Study||37
38783|NCT01838499|90504|P1|COMPLETED|Overall Study||31
38784|NCT01838499|90503|P2|STARTED|Overall Study||54
38785|NCT01838499|90504|P1|STARTED|Overall Study||55
38786|NCT01838213|90516|P2|NOT COMPLETED|Overall Study||191
38787|NCT01838213|90517|P1|NOT COMPLETED|Overall Study||166
38788|NCT01838213|90516|P2|COMPLETED|Overall Study||262
38789|NCT01838213|90517|P1|COMPLETED|Overall Study||81
38790|NCT01838213|90516|P2|STARTED|Overall Study||453
38791|NCT01838213|90517|P1|STARTED|Overall Study||247
38792|NCT01838044|90525|P2|NOT COMPLETED|Overall Study||16
38793|NCT01838044|90526|P1|NOT COMPLETED|Overall Study||8
38794|NCT01838044|90525|P2|COMPLETED|Overall Study||75
38795|NCT01838044|90526|P1|COMPLETED|Overall Study||81
38796|NCT01838044|90525|P2|STARTED|Overall Study||91
38797|NCT01838044|90526|P1|STARTED|Overall Study||89
38798|NCT01837966|90559|P2|NOT COMPLETED|Overall Study||1
38799|NCT01837966|90560|P1|NOT COMPLETED|Overall Study||2
38800|NCT01837966|90559|P2|COMPLETED|Overall Study||45
38801|NCT01837966|90560|P1|COMPLETED|Overall Study||45
38802|NCT01837966|90559|P2|STARTED|Overall Study||46
38803|NCT01837966|90560|P1|STARTED|Overall Study||47
38804|NCT01837797|90569|P5|NOT COMPLETED|Period 3||23
38805|NCT01837797|90570|P4|NOT COMPLETED|Period 3||0
38806|NCT01837797|90571|P3|NOT COMPLETED|Period 3||0
38807|NCT01837797|90572|P2|NOT COMPLETED|Period 3||0
38808|NCT01837797|90573|P1|NOT COMPLETED|Period 3||0
38809|NCT01837797|90569|P5|COMPLETED|Period 3||24
38810|NCT01837797|90570|P4|COMPLETED|Period 3||0
38811|NCT01837797|90571|P3|COMPLETED|Period 3||0
38812|NCT01837797|90572|P2|COMPLETED|Period 3||0
38813|NCT01837797|90573|P1|COMPLETED|Period 3||0
38814|NCT01837797|90569|P5|STARTED|Period 3||47
38815|NCT01837797|90570|P4|STARTED|Period 3||0
38816|NCT01837797|90571|P3|STARTED|Period 3||0
38817|NCT01837797|90572|P2|STARTED|Period 3||0
38818|NCT01837797|90573|P1|STARTED|Period 3||0
38819|NCT01837797|90569|P5|NOT COMPLETED|Period 2||0
38820|NCT01837797|90570|P4|NOT COMPLETED|Period 2||5
38821|NCT01837797|90571|P3|NOT COMPLETED|Period 2||2
38822|NCT01837797|90572|P2|NOT COMPLETED|Period 2||5
38823|NCT01837797|90573|P1|NOT COMPLETED|Period 2||0
38824|NCT01837797|90569|P5|COMPLETED|Period 2||0
38825|NCT01837797|90570|P4|COMPLETED|Period 2||1
38826|NCT01837797|90571|P3|COMPLETED|Period 2||1
38827|NCT01837797|90572|P2|COMPLETED|Period 2||1
38828|NCT01837797|90573|P1|COMPLETED|Period 2||0
38829|NCT01837797|90569|P5|STARTED|Period 2||0
38830|NCT01837797|90570|P4|STARTED|Period 2||6
38831|NCT01837797|90571|P3|STARTED|Period 2||3
38832|NCT01837797|90572|P2|STARTED|Period 2||6
38833|NCT01837797|90573|P1|STARTED|Period 2||0
38834|NCT01837797|90569|P5|NOT COMPLETED|Period 1||0
38835|NCT01837797|90570|P4|NOT COMPLETED|Period 1||0
38836|NCT01837797|90571|P3|NOT COMPLETED|Period 1||0
38837|NCT01837797|90572|P2|NOT COMPLETED|Period 1||0
38838|NCT01837797|90573|P1|NOT COMPLETED|Period 1||102
38839|NCT01837797|90569|P5|COMPLETED|Period 1||0
38840|NCT01837797|90570|P4|COMPLETED|Period 1||0
38841|NCT01837797|90571|P3|COMPLETED|Period 1||0
38842|NCT01837797|90572|P2|COMPLETED|Period 1||0
38843|NCT01837797|90573|P1|COMPLETED|Period 1||27
38844|NCT01837797|90569|P5|STARTED|Period 1||0
38845|NCT01837797|90570|P4|STARTED|Period 1||0
38846|NCT01837797|90571|P3|STARTED|Period 1||0
38847|NCT01837797|90572|P2|STARTED|Period 1||0
38848|NCT01837797|90573|P1|STARTED|Period 1||129
38849|NCT01837719|90608|P1|NOT COMPLETED|Period 5: Days 29-31 (Treatment E)||1
38850|NCT01837719|90608|P1|COMPLETED|Period 5: Days 29-31 (Treatment E)||30
38851|NCT01837719|90608|P1|STARTED|Period 5: Days 29-31 (Treatment E)|Reflects the 31 patients remaining after 32 were discharged at the end of Period 4, as per protocol|31
38852|NCT01837719|90608|P1|NOT COMPLETED|Period 4: Days 22-28 (Treatment D or C)||0
38853|NCT01837719|90608|P1|COMPLETED|Period 4: Days 22-28 (Treatment D or C)|Number finishing period; 32 patients were discharged following Period 4, as per protocol|63
38854|NCT01837719|90608|P1|STARTED|Period 4: Days 22-28 (Treatment D or C)||63
38855|NCT01837719|90608|P1|NOT COMPLETED|Period 3: Days 15-21 (Treatment C or D)||0
38856|NCT01837719|90608|P1|COMPLETED|Period 3: Days 15-21 (Treatment C or D)||63
38857|NCT01837719|90608|P1|STARTED|Period 3: Days 15-21 (Treatment C or D)||63
38858|NCT01837719|90608|P1|NOT COMPLETED|Period 2: Days 8-14 (Treatment B or A)||1
38859|NCT01837719|90608|P1|COMPLETED|Period 2: Days 8-14 (Treatment B or A)||63
38860|NCT01837719|90608|P1|STARTED|Period 2: Days 8-14 (Treatment B or A)||64
38861|NCT01837719|90608|P1|NOT COMPLETED|Period 1: Days 1-7 (Treatment A or B)||0
38862|NCT01837719|90608|P1|COMPLETED|Period 1: Days 1-7 (Treatment A or B)||64
38863|NCT01837719|90608|P1|STARTED|Period 1: Days 1-7 (Treatment A or B)|Received treatment|64
38864|NCT01837680|90677|P2|NOT COMPLETED|Overall Study||8
38865|NCT01837680|90678|P1|NOT COMPLETED|Overall Study||10
38866|NCT01837680|90677|P2|COMPLETED|Overall Study||45
38867|NCT01837680|90678|P1|COMPLETED|Overall Study||42
38868|NCT01837680|90677|P2|STARTED|Overall Study||53
38869|NCT01837680|90678|P1|STARTED|Overall Study||52
38870|NCT01837550|90716|P2|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
38871|NCT01837550|90717|P1|NOT COMPLETED|T0-T2, 6 Months Follow-up||0
38872|NCT01837550|90716|P2|COMPLETED|T0-T2, 6 Months Follow-up||37
38873|NCT01837550|90717|P1|COMPLETED|T0-T2, 6 Months Follow-up||37
38874|NCT01837550|90716|P2|STARTED|T0-T2, 6 Months Follow-up||37
38875|NCT01837550|90717|P1|STARTED|T0-T2, 6 Months Follow-up||37
38876|NCT01837550|90716|P2|NOT COMPLETED|T0-T1, 5 Weeks||0
38877|NCT01837550|90717|P1|NOT COMPLETED|T0-T1, 5 Weeks||0
38878|NCT01837550|90716|P2|COMPLETED|T0-T1, 5 Weeks||37
38879|NCT01837550|90717|P1|COMPLETED|T0-T1, 5 Weeks||37
38880|NCT01837550|90716|P2|STARTED|T0-T1, 5 Weeks||37
38881|NCT01837550|90717|P1|STARTED|T0-T1, 5 Weeks||37
38882|NCT01837537|90729|P1|NOT COMPLETED|Overall Study||0
38883|NCT01837537|90729|P1|COMPLETED|Overall Study||90
38884|NCT01837537|90729|P1|STARTED|Overall Study||90
38885|NCT01837524|90736|P2|NOT COMPLETED|Overall Study||2
38886|NCT01837524|90737|P1|NOT COMPLETED|Overall Study||3
38887|NCT01837524|90736|P2|COMPLETED|Overall Study||25
38888|NCT01837524|90737|P1|COMPLETED|Overall Study||25
38889|NCT01837524|90736|P2|STARTED|Overall Study||27
38890|NCT01837524|90737|P1|STARTED|Overall Study||28
38891|NCT01836809|90747|P4|NOT COMPLETED|Overall Study||2
38892|NCT01836809|90748|P3|NOT COMPLETED|Overall Study||0
38893|NCT01836809|90749|P2|NOT COMPLETED|Overall Study||0
38894|NCT01836809|90750|P1|NOT COMPLETED|Overall Study||0
38895|NCT01836809|90747|P4|COMPLETED|Overall Study||0
38896|NCT01836809|90748|P3|COMPLETED|Overall Study||0
38897|NCT01836809|90749|P2|COMPLETED|Overall Study||0
38898|NCT01836809|90750|P1|COMPLETED|Overall Study||0
38899|NCT01836809|90747|P4|STARTED|Overall Study||2
38900|NCT01836809|90748|P3|STARTED|Overall Study||0
38901|NCT01836809|90749|P2|STARTED|Overall Study||0
38902|NCT01836809|90750|P1|STARTED|Overall Study||0
38903|NCT01836523|90784|P4|NOT COMPLETED|Overall Study||74
38904|NCT01836523|90785|P3|NOT COMPLETED|Overall Study||91
38905|NCT01836523|90786|P2|NOT COMPLETED|Overall Study||85
38906|NCT01836523|90787|P1|NOT COMPLETED|Overall Study||51
38907|NCT01836523|90784|P4|COMPLETED|Overall Study||274
38908|NCT01836523|90785|P3|COMPLETED|Overall Study||258
38909|NCT01836523|90786|P2|COMPLETED|Overall Study||265
38910|NCT01836523|90787|P1|COMPLETED|Overall Study||300
38911|NCT01836523|90784|P4|Exposed|Overall Study||348
38912|NCT01836523|90785|P3|Exposed|Overall Study||347
38913|NCT01836523|90786|P2|Exposed|Overall Study||348
38914|NCT01836523|90787|P1|Exposed|Overall Study||350
38915|NCT01836523|90784|P4|STARTED|Overall Study||348
38916|NCT01836523|90785|P3|STARTED|Overall Study||349
38917|NCT01836523|90786|P2|STARTED|Overall Study||350
38918|NCT01836523|90787|P1|STARTED|Overall Study||351
38919|NCT01836471|90814|P5|NOT COMPLETED|Overall Study||5
38920|NCT01836471|90815|P4|NOT COMPLETED|Overall Study||2
38921|NCT01836471|90816|P3|NOT COMPLETED|Overall Study||2
38922|NCT01836471|90817|P2|NOT COMPLETED|Overall Study||9
38923|NCT01836471|90818|P1|NOT COMPLETED|Overall Study||11
38924|NCT01836471|90814|P5|COMPLETED|Overall Study||49
38925|NCT01836471|90815|P4|COMPLETED|Overall Study||40
38926|NCT01836471|90816|P3|COMPLETED|Overall Study||49
38927|NCT01836471|90817|P2|COMPLETED|Overall Study||85
38928|NCT01836471|90818|P1|COMPLETED|Overall Study||82
38929|NCT01836471|90814|P5|STARTED|Overall Study||54
38930|NCT01836471|90815|P4|STARTED|Overall Study||42
38931|NCT01836471|90816|P3|STARTED|Overall Study||51
38932|NCT01836471|90817|P2|STARTED|Overall Study||94
38933|NCT01836471|90818|P1|STARTED|Overall Study||93
38934|NCT01836458|90847|P4|NOT COMPLETED|Overall Study||6
38935|NCT01836458|90848|P3|NOT COMPLETED|Overall Study||5
38936|NCT01836458|90849|P2|NOT COMPLETED|Overall Study||2
38937|NCT01836458|90850|P1|NOT COMPLETED|Overall Study||3
38938|NCT01836458|90847|P4|COMPLETED|Overall Study||1
38939|NCT01836458|90848|P3|COMPLETED|Overall Study||2
38940|NCT01836458|90849|P2|COMPLETED|Overall Study||2
38941|NCT01836458|90850|P1|COMPLETED|Overall Study||4
38942|NCT01836458|90847|P4|STARTED|Overall Study||7
38943|NCT01836458|90848|P3|STARTED|Overall Study||7
38944|NCT01836458|90849|P2|STARTED|Overall Study||4
38945|NCT01836458|90850|P1|STARTED|Overall Study||7
38946|NCT01836133|90872|P1|NOT COMPLETED|Overall Study||0
38947|NCT01836133|90872|P1|COMPLETED|Overall Study||70
38948|NCT01836133|90872|P1|STARTED|Overall Study||70
38949|NCT01836042|90881|P3|NOT COMPLETED|Overall Study||0
38950|NCT01836042|90882|P2|NOT COMPLETED|Overall Study||0
38951|NCT01836042|90883|P1|NOT COMPLETED|Overall Study||0
38952|NCT01836042|90881|P3|COMPLETED|Overall Study||22
38953|NCT01836042|90882|P2|COMPLETED|Overall Study||35
38954|NCT01836042|90883|P1|COMPLETED|Overall Study||51
38955|NCT01836042|90881|P3|STARTED|Overall Study||22
38956|NCT01836042|90882|P2|STARTED|Overall Study||35
38957|NCT01836042|90883|P1|STARTED|Overall Study||51
38958|NCT01835912|90891|P1|NOT COMPLETED|Overall Study||0
38959|NCT01835912|90891|P1|COMPLETED|Overall Study||10
38960|NCT01835912|90891|P1|Chronic Placebo|Overall Study||10
38961|NCT01835912|90891|P1|Chronic|Overall Study||10
38962|NCT01835912|90891|P1|Acute Placebo|Overall Study||10
38963|NCT01835912|90891|P1|Acute|Overall Study||10
38964|NCT01835912|90891|P1|STARTED|Overall Study||10
38965|NCT01835899|90912|P3|NOT COMPLETED|Overall Study||1
38966|NCT01835899|90913|P2|NOT COMPLETED|Overall Study||1
38967|NCT01835899|90914|P1|NOT COMPLETED|Overall Study||0
38968|NCT01835899|90912|P3|COMPLETED|Overall Study||8
38969|NCT01835899|90913|P2|COMPLETED|Overall Study||8
38970|NCT01835899|90914|P1|COMPLETED|Overall Study||6
38971|NCT01835899|90912|P3|STARTED|Overall Study||9
38972|NCT01835899|90913|P2|STARTED|Overall Study||9
38973|NCT01835899|90914|P1|STARTED|Overall Study||6
38974|NCT01835756|90934|P2|NOT COMPLETED|Overall Study||0
38975|NCT01835756|90935|P1|NOT COMPLETED|Overall Study||0
38976|NCT01835756|90934|P2|COMPLETED|Overall Study||31
38977|NCT01835756|90935|P1|COMPLETED|Overall Study||31
38978|NCT01835756|90934|P2|STARTED|Overall Study||31
38979|NCT01835756|90935|P1|STARTED|Overall Study||31
38980|NCT01835743|90947|P2|NOT COMPLETED|Overall Study||0
38981|NCT01835743|90948|P1|NOT COMPLETED|Overall Study||0
38982|NCT01835743|90947|P2|COMPLETED|Overall Study||32
38983|NCT01835743|90948|P1|COMPLETED|Overall Study||37
38984|NCT01835743|90947|P2|STARTED|Overall Study||32
38985|NCT01835743|90948|P1|STARTED|Overall Study||37
38986|NCT01835496|90956|P1|NOT COMPLETED|Overall Study||0
38987|NCT01835496|90956|P1|COMPLETED|Overall Study||8
38988|NCT01835496|90956|P1|STARTED|Overall Study||8
38989|NCT01835470|90965|P1|NOT COMPLETED|Long Term Treatment Period||2
38990|NCT01835470|90965|P1|COMPLETED|Long Term Treatment Period|Completed=Still on Treatment|18
38991|NCT01835470|90965|P1|STARTED|Long Term Treatment Period||20
38992|NCT01835470|90965|P1|NOT COMPLETED|Short Term Treatment Period (to Week 16)||0
38993|NCT01835470|90965|P1|COMPLETED|Short Term Treatment Period (to Week 16)||20
38994|NCT01835470|90965|P1|STARTED|Short Term Treatment Period (to Week 16)||20
38995|NCT01835431|90977|P2|NOT COMPLETED|Overall Study||12
38996|NCT01835431|90978|P1|NOT COMPLETED|Overall Study||8
38997|NCT01835431|90977|P2|COMPLETED|Overall Study||168
38998|NCT01835431|90978|P1|COMPLETED|Overall Study||174
38999|NCT01835431|90977|P2|Exposed|Overall Study|One subject was withdrawn before exposure|179
39000|NCT01835431|90978|P1|Exposed|Overall Study|One subject was withdrawn before exposure.|181
39001|NCT01835431|90977|P2|STARTED|Overall Study||180
39002|NCT01835431|90978|P1|STARTED|Overall Study||182
39003|NCT01835379|90998|P2|NOT COMPLETED|Overall Study||0
39004|NCT01835379|90999|P1|NOT COMPLETED|Overall Study||0
39005|NCT01835379|90998|P2|COMPLETED|Overall Study||41
39006|NCT01835379|90999|P1|COMPLETED|Overall Study||41
39007|NCT01835379|90998|P2|STARTED|Overall Study||41
39008|NCT01835379|90999|P1|STARTED|Overall Study||41
39009|NCT01835262|91009|P2|NOT COMPLETED|Overall Study||0
39010|NCT01835262|91010|P1|NOT COMPLETED|Overall Study||0
39011|NCT01835262|91009|P2|COMPLETED|Overall Study||45
39012|NCT01835262|91010|P1|COMPLETED|Overall Study||45
39013|NCT01835262|91009|P2|STARTED|Overall Study||45
39014|NCT01835262|91010|P1|STARTED|Overall Study||45
39015|NCT01835132|91016|P1|NOT COMPLETED|2nd Extension Phase - As Needed (PRN)||0
39016|NCT01835132|91016|P1|COMPLETED|2nd Extension Phase - As Needed (PRN)||3
39017|NCT01835132|91016|P1|STARTED|2nd Extension Phase - As Needed (PRN)|PRN extension - Participants starting this phase may not equal those who completed the 1st extension|3
39018|NCT01835132|91016|P1|NOT COMPLETED|1st Extension Phase||0
39019|NCT01835132|91016|P1|COMPLETED|1st Extension Phase|Completed 52 Weeks|6
39020|NCT01835132|91016|P1|STARTED|1st Extension Phase||6
39021|NCT01835132|91016|P1|NOT COMPLETED|Initial Phase||2
39022|NCT01835132|91016|P1|COMPLETED|Initial Phase||6
39023|NCT01835132|91016|P1|STARTED|Initial Phase||8
39024|NCT01835015|91060|P5|NOT COMPLETED|Overall Study||0
39025|NCT01835015|91061|P4|NOT COMPLETED|Overall Study||0
39026|NCT01835015|91062|P3|NOT COMPLETED|Overall Study||1
39027|NCT01835015|91063|P2|NOT COMPLETED|Overall Study||0
39028|NCT01835015|91064|P1|NOT COMPLETED|Overall Study||0
39029|NCT01835015|91060|P5|COMPLETED|Overall Study||6
39030|NCT01835015|91061|P4|COMPLETED|Overall Study||6
39031|NCT01835015|91062|P3|COMPLETED|Overall Study||6
39032|NCT01835015|91063|P2|COMPLETED|Overall Study||6
39033|NCT01835015|91064|P1|COMPLETED|Overall Study||6
39034|NCT01835015|91060|P5|STARTED|Overall Study||6
39035|NCT01835015|91061|P4|STARTED|Overall Study||6
39036|NCT01835015|91062|P3|STARTED|Overall Study||7
39037|NCT01835015|91063|P2|STARTED|Overall Study||6
39038|NCT01835015|91064|P1|STARTED|Overall Study||6
39039|NCT01834404|91139|P2|NOT COMPLETED|Overall Study||0
39040|NCT01834404|91140|P1|NOT COMPLETED|Overall Study||0
39041|NCT01834404|91139|P2|COMPLETED|Overall Study||12
39042|NCT01834404|91140|P1|COMPLETED|Overall Study||12
39043|NCT01834404|91139|P2|STARTED|Overall Study||12
39044|NCT01834404|91140|P1|STARTED|Overall Study||12
39045|NCT01834274|91172|P2|NOT COMPLETED|Overall Study||41
39046|NCT01834274|91173|P1|NOT COMPLETED|Overall Study||47
39047|NCT01834274|91172|P2|COMPLETED|Overall Study||5
39048|NCT01834274|91173|P1|COMPLETED|Overall Study||3
39049|NCT01834274|91172|P2|STARTED|Overall Study||46
39050|NCT01834274|91173|P1|STARTED|Overall Study||50
39051|NCT01834261|91185|P2|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
39052|NCT01834261|91186|P1|NOT COMPLETED|MGH Rest + Nueroeconomic Task fMRI||0
39053|NCT01834261|91185|P2|COMPLETED|MGH Rest + Nueroeconomic Task fMRI||10
39054|NCT01834261|91186|P1|COMPLETED|MGH Rest + Nueroeconomic Task fMRI|Enrollment completed in May 2015.|10
39055|NCT01834261|91185|P2|STARTED|MGH Rest + Nueroeconomic Task fMRI||10
39056|NCT01834261|91186|P1|STARTED|MGH Rest + Nueroeconomic Task fMRI|Subjects who dropped out/were excluded (10), did so before they received either Oxytocin or Placebo.|10
39057|NCT01834261|91185|P2|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
39058|NCT01834261|91186|P1|NOT COMPLETED|MIT fMRI and MEG Resting State Study||1
39059|NCT01834261|91185|P2|COMPLETED|MIT fMRI and MEG Resting State Study||9
39060|NCT01834261|91186|P1|COMPLETED|MIT fMRI and MEG Resting State Study|Enrollment completed in March 2014.|10
39061|NCT01834261|91185|P2|STARTED|MIT fMRI and MEG Resting State Study||10
39062|NCT01834261|91186|P1|STARTED|MIT fMRI and MEG Resting State Study||11
39063|NCT01834222|91196|P1|NOT COMPLETED|Overall Study||1
39064|NCT01834222|91196|P1|COMPLETED|Overall Study||658
39065|NCT01834222|91196|P1|Treated|Overall Study||658
39066|NCT01834222|91196|P1|STARTED|Overall Study||659
39067|NCT01834027|91207|P2|NOT COMPLETED|Overall Study||0
39068|NCT01834027|91208|P1|NOT COMPLETED|Overall Study||0
39069|NCT01834027|91207|P2|COMPLETED|Overall Study||28
39070|NCT01834027|91208|P1|COMPLETED|Overall Study||28
39071|NCT01834027|91207|P2|STARTED|Overall Study||28
39072|NCT01834027|91208|P1|STARTED|Overall Study||28
39073|NCT01833988|91218|P2|NOT COMPLETED|Overall Study||0
39074|NCT01833988|91219|P1|NOT COMPLETED|Overall Study||0
39075|NCT01833988|91218|P2|COMPLETED|Overall Study||16
39076|NCT01833988|91219|P1|COMPLETED|Overall Study||16
39077|NCT01833988|91218|P2|STARTED|Overall Study||16
39078|NCT01833988|91219|P1|STARTED|Overall Study||16
39079|NCT01833897|91273|P1|NOT COMPLETED|Overall Study||1
39080|NCT01833897|91273|P1|COMPLETED|Overall Study||7
39081|NCT01833897|91273|P1|STARTED|Overall Study||8
39082|NCT01833845|91281|P1|NOT COMPLETED|Overall Study||0
39083|NCT01833845|91281|P1|COMPLETED|Overall Study||4
39084|NCT01833845|91281|P1|STARTED|Overall Study||4
39085|NCT01833741|91285|P1|NOT COMPLETED|Overall Study||140
39086|NCT01833741|91285|P1|COMPLETED|Overall Study||997
39087|NCT01833741|91285|P1|STARTED|Overall Study||1137
39088|NCT01833533|91300|P2|NOT COMPLETED|Overall Study||21
39089|NCT01833533|91301|P1|NOT COMPLETED|Overall Study||6
39090|NCT01833533|91300|P2|COMPLETED|Overall Study||184
39091|NCT01833533|91301|P1|COMPLETED|Overall Study||94
39092|NCT01833533|91300|P2|STARTED|Overall Study||205
39093|NCT01833533|91301|P1|STARTED|Overall Study||100
39094|NCT01833481|91318|P3|NOT COMPLETED|Overall Study||0
39095|NCT01833481|91319|P2|NOT COMPLETED|Overall Study||0
39096|NCT01833481|91320|P1|NOT COMPLETED|Overall Study||0
39097|NCT01833481|91318|P3|COMPLETED|Overall Study||10
39098|NCT01833481|91319|P2|COMPLETED|Overall Study||10
39099|NCT01833481|91320|P1|COMPLETED|Overall Study||10
39100|NCT01833481|91318|P3|STARTED|Overall Study||10
39101|NCT01833481|91319|P2|STARTED|Overall Study||10
39102|NCT01833481|91320|P1|STARTED|Overall Study||10
39103|NCT01833403|91334|P1|NOT COMPLETED|Overall Study||0
39104|NCT01833403|91334|P1|COMPLETED|Overall Study||4
39105|NCT01833403|91334|P1|STARTED|Overall Study||4
39106|NCT01833247|91339|P1|NOT COMPLETED|Overall Study||0
39107|NCT01833247|91339|P1|COMPLETED|Overall Study||12
39108|NCT01833247|91339|P1|STARTED|Overall Study||12
39109|NCT01833130|91347|P2|NOT COMPLETED|Overall Study||19
39110|NCT01833130|91348|P1|NOT COMPLETED|Overall Study||10
39111|NCT01833130|91347|P2|COMPLETED|Overall Study||8
39112|NCT01833130|91348|P1|COMPLETED|Overall Study||15
39113|NCT01833130|91347|P2|STARTED|Overall Study||27
39114|NCT01833130|91348|P1|STARTED|Overall Study||25
39115|NCT01833117|91386|P2|NOT COMPLETED|Overall Study||0
39116|NCT01833117|91387|P1|NOT COMPLETED|Overall Study||0
39117|NCT01833117|91386|P2|COMPLETED|Overall Study||19
39118|NCT01833117|91387|P1|COMPLETED|Overall Study||43
39119|NCT01833117|91386|P2|STARTED|Overall Study||19
39120|NCT01833117|91387|P1|STARTED|Overall Study||43
39121|NCT01833078|91395|P1|NOT COMPLETED|Overall Study||0
39122|NCT01833078|91395|P1|COMPLETED|Overall Study||5
39123|NCT01833078|91395|P1|STARTED|Overall Study||5
39124|NCT01833065|91403|P5|NOT COMPLETED|Overall Study||36
39125|NCT01833065|91404|P4|NOT COMPLETED|Overall Study||9
39126|NCT01833065|91405|P3|NOT COMPLETED|Overall Study||12
39127|NCT01833065|91406|P2|NOT COMPLETED|Overall Study||13
39128|NCT01833065|91407|P1|NOT COMPLETED|Overall Study||24
39129|NCT01833065|91403|P5|COMPLETED|Overall Study||74
39130|NCT01833065|91404|P4|COMPLETED|Overall Study||41
39131|NCT01833065|91405|P3|COMPLETED|Overall Study||23
39132|NCT01833065|91406|P2|COMPLETED|Overall Study||40
39133|NCT01833065|91407|P1|COMPLETED|Overall Study||41
39134|NCT01833065|91403|P5|Intention-to-treat Analysis Set|Overall Study|Randomized patients|111
39135|NCT01833065|91404|P4|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
39136|NCT01833065|91405|P3|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
39137|NCT01833065|91406|P2|Intention-to-treat Analysis Set|Overall Study|Randomized patients|53
39138|NCT01833065|91407|P1|Intention-to-treat Analysis Set|Overall Study|Randomized patients|50
39139|NCT01833065|91403|P5|STARTED|Overall Study|Randomized patients - As treated|110
39140|NCT01833065|91404|P4|STARTED|Overall Study|Randomized patients - As treated|50
39141|NCT01833065|91405|P3|STARTED|Overall Study|Randomized patients - As treated|35
39142|NCT01833065|91406|P2|STARTED|Overall Study|Randomized patients - As treated|53
39143|NCT01833065|91407|P1|STARTED|Overall Study|Randomized patients - As treated|65
39144|NCT01832766|91438|P2|NOT COMPLETED|Second Intervention||0
39145|NCT01832766|91439|P1|NOT COMPLETED|Second Intervention||0
39146|NCT01832766|91438|P2|COMPLETED|Second Intervention||5
39147|NCT01832766|91439|P1|COMPLETED|Second Intervention||7
39148|NCT01832766|91438|P2|STARTED|Second Intervention||5
39149|NCT01832766|91439|P1|STARTED|Second Intervention||7
39150|NCT01832766|91438|P2|NOT COMPLETED|Washout||1
39151|NCT01832766|91439|P1|NOT COMPLETED|Washout||0
39152|NCT01832766|91438|P2|COMPLETED|Washout||5
39153|NCT01832766|91439|P1|COMPLETED|Washout||7
39154|NCT01832766|91438|P2|STARTED|Washout||6
39155|NCT01832766|91439|P1|STARTED|Washout||7
39156|NCT01832766|91438|P2|NOT COMPLETED|First Intervention||0
39157|NCT01832766|91439|P1|NOT COMPLETED|First Intervention||0
39158|NCT01832766|91438|P2|COMPLETED|First Intervention|one participant did not return for cross over visit|6
39159|NCT01832766|91439|P1|COMPLETED|First Intervention||7
39160|NCT01832766|91438|P2|STARTED|First Intervention||6
39161|NCT01832766|91439|P1|STARTED|First Intervention||7
39162|NCT01832506|91452|P3|NOT COMPLETED|Overall Study||0
39163|NCT01832506|91453|P2|NOT COMPLETED|Overall Study||0
39164|NCT01832506|91454|P1|NOT COMPLETED|Overall Study||0
39165|NCT01832506|91452|P3|COMPLETED|Overall Study||6
39166|NCT01832506|91453|P2|COMPLETED|Overall Study||3
39167|NCT01832506|91454|P1|COMPLETED|Overall Study||3
39168|NCT01832506|91452|P3|STARTED|Overall Study||6
39169|NCT01832506|91453|P2|STARTED|Overall Study||3
39170|NCT01832506|91454|P1|STARTED|Overall Study||3
39171|NCT01832493|91505|P1|NOT COMPLETED|Overall Study||8
39172|NCT01832493|91505|P1|COMPLETED|Overall Study||42
39173|NCT01832493|91505|P1|STARTED|Overall Study||50
39174|NCT01832155|91514|P2|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
39175|NCT01832155|91515|P1|NOT COMPLETED|End of Study: 4 - 8 Weeks||0
39176|NCT01832155|91514|P2|COMPLETED|End of Study: 4 - 8 Weeks||18
39177|NCT01832155|91515|P1|COMPLETED|End of Study: 4 - 8 Weeks||16
39178|NCT01832155|91514|P2|STARTED|End of Study: 4 - 8 Weeks||18
39179|NCT01832155|91515|P1|STARTED|End of Study: 4 - 8 Weeks||16
39180|NCT01832155|91514|P2|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||0
39181|NCT01832155|91515|P1|NOT COMPLETED|Mid-point of Study: 0 - 4 Weeks||1
39182|NCT01832155|91514|P2|COMPLETED|Mid-point of Study: 0 - 4 Weeks||18
39183|NCT01832155|91515|P1|COMPLETED|Mid-point of Study: 0 - 4 Weeks||16
39184|NCT01832155|91514|P2|STARTED|Mid-point of Study: 0 - 4 Weeks||18
39185|NCT01832155|91515|P1|STARTED|Mid-point of Study: 0 - 4 Weeks||17
39186|NCT01832155|91514|P2|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||0
39187|NCT01832155|91515|P1|NOT COMPLETED|Beginning of Study: Baseline at 0 Week||1
39188|NCT01832155|91514|P2|COMPLETED|Beginning of Study: Baseline at 0 Week||18
39189|NCT01832155|91515|P1|COMPLETED|Beginning of Study: Baseline at 0 Week||17
39190|NCT01832155|91514|P2|STARTED|Beginning of Study: Baseline at 0 Week||18
39191|NCT01832155|91515|P1|STARTED|Beginning of Study: Baseline at 0 Week||18
39192|NCT01831934|91538|P2|NOT COMPLETED|Overall Study||0
39193|NCT01831934|91539|P1|NOT COMPLETED|Overall Study||1
39194|NCT01831934|91538|P2|COMPLETED|Overall Study||10
39195|NCT01831934|91539|P1|COMPLETED|Overall Study|Volunteer consented but not enrolled after reporting a prior bad reaction to influenza vaccine.|11
39196|NCT01831934|91538|P2|STARTED|Overall Study||10
39197|NCT01831934|91539|P1|STARTED|Overall Study||12
39198|NCT01831817|91549|P4|NOT COMPLETED|Overall Study||0
39199|NCT01831817|91550|P3|NOT COMPLETED|Overall Study||0
39200|NCT01831817|91551|P2|NOT COMPLETED|Overall Study||0
39201|NCT01831817|91552|P1|NOT COMPLETED|Overall Study||4
39202|NCT01831817|91549|P4|COMPLETED|Overall Study||36
39203|NCT01831817|91550|P3|COMPLETED|Overall Study||35
39204|NCT01831817|91551|P2|COMPLETED|Overall Study||34
39205|NCT01831817|91552|P1|COMPLETED|Overall Study||31
39206|NCT01831817|91549|P4|STARTED|Overall Study||36
39207|NCT01831817|91550|P3|STARTED|Overall Study||35
39208|NCT01831817|91551|P2|STARTED|Overall Study||34
39209|NCT01831817|91552|P1|STARTED|Overall Study||35
39210|NCT01831791|91590|P1|NOT COMPLETED|Overall Study||10
39211|NCT01831791|91590|P1|COMPLETED|Overall Study||110
39212|NCT01831791|91590|P1|STARTED|Overall Study||120
39213|NCT01831726|91616|P1|NOT COMPLETED|Overall Study||80
39214|NCT01831726|91616|P1|COMPLETED|Overall Study||0
39215|NCT01831726|91616|P1|STARTED|Overall Study||80
39216|NCT01831466|91635|P12|NOT COMPLETED|Overall Study||4
39217|NCT01831466|91636|P11|NOT COMPLETED|Overall Study||2
39218|NCT01831466|91637|P10|NOT COMPLETED|Overall Study||5
39219|NCT01831466|91638|P9|NOT COMPLETED|Overall Study||3
39220|NCT01831466|91639|P8|NOT COMPLETED|Overall Study||2
39221|NCT01831466|91640|P7|NOT COMPLETED|Overall Study||1
39222|NCT01831466|91641|P6|NOT COMPLETED|Overall Study||26
39223|NCT01831466|91642|P5|NOT COMPLETED|Overall Study||17
39224|NCT01831466|91643|P4|NOT COMPLETED|Overall Study||19
39225|NCT01831466|91644|P3|NOT COMPLETED|Overall Study||23
39226|NCT01831466|91645|P2|NOT COMPLETED|Overall Study||18
39227|NCT01831466|91646|P1|NOT COMPLETED|Overall Study||16
39228|NCT01831466|91635|P12|COMPLETED|Overall Study||3
39229|NCT01831466|91636|P11|COMPLETED|Overall Study||4
39230|NCT01831466|91637|P10|COMPLETED|Overall Study||2
39231|NCT01831466|91638|P9|COMPLETED|Overall Study||4
39232|NCT01831466|91639|P8|COMPLETED|Overall Study||5
39233|NCT01831466|91640|P7|COMPLETED|Overall Study||6
39234|NCT01831466|91641|P6|COMPLETED|Overall Study||48
39235|NCT01831466|91642|P5|COMPLETED|Overall Study||57
39236|NCT01831466|91643|P4|COMPLETED|Overall Study||51
39237|NCT01831466|91644|P3|COMPLETED|Overall Study||48
39238|NCT01831466|91645|P2|COMPLETED|Overall Study||52
39239|NCT01831466|91646|P1|COMPLETED|Overall Study||55
39240|NCT01831466|91635|P12|STARTED|Overall Study|Treated|7
39241|NCT01831466|91636|P11|STARTED|Overall Study|Treated|6
39242|NCT01831466|91637|P10|STARTED|Overall Study|Treated|7
39243|NCT01831466|91638|P9|STARTED|Overall Study|Treated|7
39244|NCT01831466|91639|P8|STARTED|Overall Study|Treated|7
39245|NCT01831466|91640|P7|STARTED|Overall Study|Treated|7
39246|NCT01831466|91641|P6|STARTED|Overall Study|Treated|74
39247|NCT01831466|91642|P5|STARTED|Overall Study|Treated|74
39248|NCT01831466|91643|P4|STARTED|Overall Study|Treated|70
39249|NCT01831466|91644|P3|STARTED|Overall Study|Treated|71
39250|NCT01831466|91645|P2|STARTED|Overall Study|Treated|70
39251|NCT01831466|91646|P1|STARTED|Overall Study|Treated|71
39252|NCT01831258|91768|P2|NOT COMPLETED|Overall Study||3
39253|NCT01831258|91769|P1|NOT COMPLETED|Overall Study||5
39254|NCT01831258|91768|P2|COMPLETED|Overall Study||32
39255|NCT01831258|91769|P1|COMPLETED|Overall Study||30
39256|NCT01831258|91768|P2|STARTED|Overall Study||35
39257|NCT01831258|91769|P1|STARTED|Overall Study||35
39258|NCT01831219|91797|P2|NOT COMPLETED|Overall Study||24
39259|NCT01831219|91798|P1|NOT COMPLETED|Overall Study||33
39260|NCT01831219|91797|P2|COMPLETED|Overall Study||21
39261|NCT01831219|91798|P1|COMPLETED|Overall Study||40
39262|NCT01831219|91797|P2|STARTED|Overall Study||45
39263|NCT01831219|91798|P1|STARTED|Overall Study||73
39264|NCT01831154|91819|P3|NOT COMPLETED|Overall Study||0
39265|NCT01831154|91820|P2|NOT COMPLETED|Overall Study||0
39266|NCT01831154|91821|P1|NOT COMPLETED|Overall Study||0
39267|NCT01831154|91819|P3|COMPLETED|Overall Study||11
39268|NCT01831154|91820|P2|COMPLETED|Overall Study||11
39269|NCT01831154|91821|P1|COMPLETED|Overall Study||15
39270|NCT01831154|91819|P3|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
39271|NCT01831154|91820|P2|STARTED|Overall Study|Study IRB approval 11-11-2009, first subjects enrolled 6-7-2010|11
39272|NCT01831154|91821|P1|STARTED|Overall Study|Study Institutional Review Board (IRB) approval 11-11-2009, first subjects enrolled 6-7-2010|15
39273|NCT01830933|91846|P2|NOT COMPLETED|Overall Study||232
39274|NCT01830933|91847|P1|NOT COMPLETED|Overall Study||168
39275|NCT01830933|91846|P2|COMPLETED|Overall Study||580
39276|NCT01830933|91847|P1|COMPLETED|Overall Study||655
39277|NCT01830933|91846|P2|Completed Meet-up|Overall Study||603
39278|NCT01830933|91847|P1|Completed Meet-up|Overall Study||675
39279|NCT01830933|91846|P2|STARTED|Overall Study||812
39280|NCT01830933|91847|P1|STARTED|Overall Study||823
39281|NCT01830920|91864|P5|NOT COMPLETED|Overall Study||8
39282|NCT01830920|91865|P4|NOT COMPLETED|Overall Study||16
39283|NCT01830920|91866|P3|NOT COMPLETED|Overall Study||8
39284|NCT01830920|91867|P2|NOT COMPLETED|Overall Study||6
39285|NCT01830920|91868|P1|NOT COMPLETED|Overall Study||21
39286|NCT01830920|91864|P5|COMPLETED|Overall Study||99
39287|NCT01830920|91865|P4|COMPLETED|Overall Study||109
39288|NCT01830920|91866|P3|COMPLETED|Overall Study||40
39289|NCT01830920|91867|P2|COMPLETED|Overall Study||40
39290|NCT01830920|91868|P1|COMPLETED|Overall Study||105
39291|NCT01830920|91864|P5|Received Allocated Drug|Overall Study||105
39292|NCT01830920|91865|P4|Received Allocated Drug|Overall Study||119
39293|NCT01830920|91866|P3|Received Allocated Drug|Overall Study||47
39294|NCT01830920|91867|P2|Received Allocated Drug|Overall Study||45
39295|NCT01830920|91868|P1|Received Allocated Drug|Overall Study||115
39296|NCT01830920|91864|P5|STARTED|Overall Study||107
39297|NCT01830920|91865|P4|STARTED|Overall Study||125
39298|NCT01830920|91866|P3|STARTED|Overall Study||48
39299|NCT01830920|91867|P2|STARTED|Overall Study||46
39300|NCT01830920|91868|P1|STARTED|Overall Study||126
39301|NCT01830881|91907|P2|NOT COMPLETED|Overall Study||1
39302|NCT01830881|91908|P1|NOT COMPLETED|Overall Study||0
39303|NCT01830881|91907|P2|COMPLETED|Overall Study||61
39304|NCT01830881|91908|P1|COMPLETED|Overall Study||62
39305|NCT01830881|91907|P2|STARTED|Overall Study||62
39306|NCT01830881|91908|P1|STARTED|Overall Study||62
39307|NCT01830855|91952|P4|NOT COMPLETED|Overall Study||82
39308|NCT01830855|91953|P3|NOT COMPLETED|Overall Study||66
39309|NCT01830855|91954|P2|NOT COMPLETED|Overall Study||61
39310|NCT01830855|91955|P1|NOT COMPLETED|Overall Study||155
39311|NCT01830855|91952|P4|COMPLETED|Overall Study||815
39312|NCT01830855|91953|P3|COMPLETED|Overall Study||521
39313|NCT01830855|91954|P2|COMPLETED|Overall Study||537
39314|NCT01830855|91955|P1|COMPLETED|Overall Study||1353
39315|NCT01830855|91952|P4|STARTED|Overall Study||897
39316|NCT01830855|91953|P3|STARTED|Overall Study||587
39317|NCT01830855|91954|P2|STARTED|Overall Study||598
39318|NCT01830855|91955|P1|STARTED|Overall Study||1508
39319|NCT01830790|92061|P2|NOT COMPLETED|Overall Study||0
39320|NCT01830790|92062|P1|NOT COMPLETED|Overall Study||0
39321|NCT01830790|92061|P2|COMPLETED|Overall Study||10
39322|NCT01830790|92062|P1|COMPLETED|Overall Study||0
39323|NCT01830790|92061|P2|STARTED|Overall Study||10
39324|NCT01830790|92062|P1|STARTED|Overall Study||0
39325|NCT01830699|92072|P2|NOT COMPLETED|Overall Study||0
39326|NCT01830699|92073|P1|NOT COMPLETED|Overall Study||0
39327|NCT01830699|92072|P2|COMPLETED|Overall Study||20
39328|NCT01830699|92073|P1|COMPLETED|Overall Study||13
39329|NCT01830699|92072|P2|STARTED|Overall Study||20
39330|NCT01830699|92073|P1|STARTED|Overall Study||13
39331|NCT01830543|92086|P3|NOT COMPLETED|Overall Study||214
39332|NCT01830543|92087|P2|NOT COMPLETED|Overall Study||152
39333|NCT01830543|92088|P1|NOT COMPLETED|Overall Study||159
39334|NCT01830543|92086|P3|COMPLETED|Overall Study||492
39335|NCT01830543|92087|P2|COMPLETED|Overall Study||557
39336|NCT01830543|92088|P1|COMPLETED|Overall Study||550
39337|NCT01830543|92086|P3|Treated|Overall Study||697
39338|NCT01830543|92087|P2|Treated|Overall Study||706
39339|NCT01830543|92088|P1|Treated|Overall Study||696
39340|NCT01830543|92086|P3|STARTED|Overall Study||706
39341|NCT01830543|92087|P2|STARTED|Overall Study||709
39342|NCT01830543|92088|P1|STARTED|Overall Study||709
39343|NCT01830205|92124|P4|NOT COMPLETED|Overall Study||0
39344|NCT01830205|92125|P3|NOT COMPLETED|Overall Study||0
39345|NCT01830205|92126|P2|NOT COMPLETED|Overall Study||0
39346|NCT01830205|92127|P1|NOT COMPLETED|Overall Study||0
39347|NCT01830205|92124|P4|COMPLETED|Overall Study||12
39348|NCT01830205|92125|P3|COMPLETED|Overall Study||6
39349|NCT01830205|92126|P2|COMPLETED|Overall Study||6
39350|NCT01830205|92127|P1|COMPLETED|Overall Study||12
39351|NCT01830205|92124|P4|STARTED|Overall Study||12
39352|NCT01830205|92125|P3|STARTED|Overall Study||6
39353|NCT01830205|92126|P2|STARTED|Overall Study||6
39354|NCT01830205|92127|P1|STARTED|Overall Study||12
39355|NCT01830140|92211|P2|NOT COMPLETED|Overall Study||4
39356|NCT01830140|92212|P1|NOT COMPLETED|Overall Study||7
39357|NCT01830140|92211|P2|COMPLETED|Overall Study||229
39358|NCT01830140|92212|P1|COMPLETED|Overall Study||226
39359|NCT01830140|92211|P2|STARTED|Overall Study||233
39360|NCT01830140|92212|P1|STARTED|Overall Study||233
39361|NCT01830127|92220|P2|NOT COMPLETED|Overall Study||9
39362|NCT01830127|92221|P1|NOT COMPLETED|Overall Study||5
39363|NCT01830127|92220|P2|COMPLETED|Overall Study||8
39364|NCT01830127|92221|P1|COMPLETED|Overall Study||13
39365|NCT01830127|92220|P2|STARTED|Overall Study||17
39366|NCT01830127|92221|P1|STARTED|Overall Study||18
39367|NCT01829919|92229|P1|NOT COMPLETED|Overall Study||0
39368|NCT01829919|92229|P1|COMPLETED|Overall Study||24
39369|NCT01829919|92229|P1|STARTED|Overall Study||24
39370|NCT01829516|92245|P2|NOT COMPLETED|2nd Intervention||0
39371|NCT01829516|92246|P1|NOT COMPLETED|2nd Intervention||0
39372|NCT01829516|92245|P2|COMPLETED|2nd Intervention||14
39373|NCT01829516|92246|P1|COMPLETED|2nd Intervention||18
39374|NCT01829516|92245|P2|STARTED|2nd Intervention||14
39375|NCT01829516|92246|P1|STARTED|2nd Intervention||18
39376|NCT01829516|92245|P2|NOT COMPLETED|Washout Period - 1 Week||0
39377|NCT01829516|92246|P1|NOT COMPLETED|Washout Period - 1 Week||0
39378|NCT01829516|92245|P2|COMPLETED|Washout Period - 1 Week||14
39379|NCT01829516|92246|P1|COMPLETED|Washout Period - 1 Week||18
39380|NCT01829516|92245|P2|STARTED|Washout Period - 1 Week||14
39381|NCT01829516|92246|P1|STARTED|Washout Period - 1 Week||18
39382|NCT01829516|92245|P2|NOT COMPLETED|First Intervention||0
39383|NCT01829516|92246|P1|NOT COMPLETED|First Intervention||0
39384|NCT01829516|92245|P2|COMPLETED|First Intervention||14
39385|NCT01829516|92246|P1|COMPLETED|First Intervention||18
39386|NCT01829516|92245|P2|STARTED|First Intervention||14
39387|NCT01829516|92246|P1|STARTED|First Intervention||18
39388|NCT01829477|92256|P2|NOT COMPLETED|Overall Study||15
39389|NCT01829477|92257|P1|NOT COMPLETED|Overall Study||16
39390|NCT01829477|92256|P2|COMPLETED|Overall Study||1
39391|NCT01829477|92257|P1|COMPLETED|Overall Study||1
39392|NCT01829477|92256|P2|STARTED|Overall Study||16
39393|NCT01829477|92257|P1|STARTED|Overall Study||17
39394|NCT01829464|92270|P3|NOT COMPLETED|Overall Study||26
39395|NCT01829464|92271|P2|NOT COMPLETED|Overall Study||29
39396|NCT01829464|92272|P1|NOT COMPLETED|Overall Study||28
39397|NCT01829464|92270|P3|COMPLETED|Overall Study||3
39398|NCT01829464|92271|P2|COMPLETED|Overall Study||2
39399|NCT01829464|92272|P1|COMPLETED|Overall Study||2
39400|NCT01829464|92270|P3|STARTED|Overall Study||29
39401|NCT01829464|92271|P2|STARTED|Overall Study||31
39402|NCT01829464|92272|P1|STARTED|Overall Study||30
39403|NCT01829399|92288|P2|NOT COMPLETED|Visit 2 (One Month Later)||0
39404|NCT01829399|92289|P1|NOT COMPLETED|Visit 2 (One Month Later)||0
39405|NCT01829399|92288|P2|COMPLETED|Visit 2 (One Month Later)||12
39406|NCT01829399|92289|P1|COMPLETED|Visit 2 (One Month Later)||12
39407|NCT01829399|92288|P2|STARTED|Visit 2 (One Month Later)||12
39408|NCT01829399|92289|P1|STARTED|Visit 2 (One Month Later)||12
39409|NCT01829399|92288|P2|NOT COMPLETED|Visit 1||0
39410|NCT01829399|92289|P1|NOT COMPLETED|Visit 1||0
39411|NCT01829399|92288|P2|COMPLETED|Visit 1||12
39412|NCT01829399|92289|P1|COMPLETED|Visit 1||12
39413|NCT01829399|92288|P2|STARTED|Visit 1||12
39414|NCT01829399|92289|P1|STARTED|Visit 1||12
39415|NCT01829243|92297|P2|NOT COMPLETED|Second Intervention||0
39416|NCT01829243|92298|P1|NOT COMPLETED|Second Intervention||0
39417|NCT01829243|92297|P2|COMPLETED|Second Intervention||13
39418|NCT01829243|92298|P1|COMPLETED|Second Intervention||7
39419|NCT01829243|92297|P2|STARTED|Second Intervention||13
39420|NCT01829243|92298|P1|STARTED|Second Intervention||7
39421|NCT01829243|92297|P2|NOT COMPLETED|Washout Period of 1 Week||0
39422|NCT01829243|92298|P1|NOT COMPLETED|Washout Period of 1 Week||0
39423|NCT01829243|92297|P2|COMPLETED|Washout Period of 1 Week||13
39424|NCT01829243|92298|P1|COMPLETED|Washout Period of 1 Week||7
39425|NCT01829243|92297|P2|STARTED|Washout Period of 1 Week||13
39426|NCT01829243|92298|P1|STARTED|Washout Period of 1 Week||7
39427|NCT01829243|92297|P2|NOT COMPLETED|First Intervention||2
39428|NCT01829243|92298|P1|NOT COMPLETED|First Intervention||4
39429|NCT01829243|92297|P2|COMPLETED|First Intervention||13
39430|NCT01829243|92298|P1|COMPLETED|First Intervention||7
39431|NCT01829243|92297|P2|STARTED|First Intervention||15
39432|NCT01829243|92298|P1|STARTED|First Intervention||11
39433|NCT01829230|92312|P2|NOT COMPLETED|Overall Study||4
39434|NCT01829230|92313|P1|NOT COMPLETED|Overall Study||1
39435|NCT01829230|92312|P2|COMPLETED|Overall Study||38
39436|NCT01829230|92313|P1|COMPLETED|Overall Study||39
39437|NCT01829230|92312|P2|STARTED|Overall Study||42
39438|NCT01829230|92313|P1|STARTED|Overall Study||40
39439|NCT01829191|92323|P2|NOT COMPLETED|Overall Study||14
39440|NCT01829191|92324|P1|NOT COMPLETED|Overall Study||7
39441|NCT01829191|92323|P2|COMPLETED|Overall Study||50
39442|NCT01829191|92324|P1|COMPLETED|Overall Study||56
39443|NCT01829191|92323|P2|STARTED|Overall Study||64
39444|NCT01829191|92324|P1|STARTED|Overall Study||63
39445|NCT01828593|92334|P3|NOT COMPLETED|Placebo-Free Phase||6
39446|NCT01828593|92335|P2|NOT COMPLETED|Placebo-Free Phase||6
39447|NCT01828593|92336|P1|NOT COMPLETED|Placebo-Free Phase||0
39448|NCT01828593|92334|P3|COMPLETED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|41
39449|NCT01828593|92335|P2|COMPLETED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|49
39450|NCT01828593|92336|P1|COMPLETED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
39451|NCT01828593|92334|P3|STARTED|Placebo-Free Phase|SBI 5.0 g includes SBI 5.0 plus placebo who started taking SBI at Wk 4|47
39452|NCT01828593|92335|P2|STARTED|Placebo-Free Phase|SBI 2.5 g includes SBI 2.5 plus placebo who started taking SBI at Wk 4|55
39453|NCT01828593|92336|P1|STARTED|Placebo-Free Phase|Placebo subjects took either SBI 2.5 or 5.0 g in the placebo-free phase|0
39454|NCT01828593|92334|P3|NOT COMPLETED|Placebo-Controlled Phase||1
39455|NCT01828593|92335|P2|NOT COMPLETED|Placebo-Controlled Phase||0
39456|NCT01828593|92336|P1|NOT COMPLETED|Placebo-Controlled Phase||0
39457|NCT01828593|92334|P3|COMPLETED|Placebo-Controlled Phase||32
39458|NCT01828593|92335|P2|COMPLETED|Placebo-Controlled Phase||34
39459|NCT01828593|92336|P1|COMPLETED|Placebo-Controlled Phase||36
39460|NCT01828593|92334|P3|STARTED|Placebo-Controlled Phase||33
39461|NCT01828593|92335|P2|STARTED|Placebo-Controlled Phase||34
39462|NCT01828593|92336|P1|STARTED|Placebo-Controlled Phase||36
39463|NCT01828476|92359|P2|NOT COMPLETED|Overall Study||0
39464|NCT01828476|92360|P1|NOT COMPLETED|Overall Study||0
39465|NCT01828476|92359|P2|COMPLETED|Overall Study||0
39466|NCT01828476|92360|P1|COMPLETED|Overall Study||13
39467|NCT01828476|92359|P2|STARTED|Overall Study||0
39468|NCT01828476|92360|P1|STARTED|Overall Study||13
39469|NCT01828281|92382|P2|NOT COMPLETED|Overall Study||0
39470|NCT01828281|92383|P1|NOT COMPLETED|Overall Study||1
39471|NCT01828281|92382|P2|COMPLETED|Overall Study||45
39472|NCT01828281|92383|P1|COMPLETED|Overall Study||44
39473|NCT01828281|92382|P2|STARTED|Overall Study||45
39474|NCT01828281|92383|P1|STARTED|Overall Study||45
39475|NCT01828216|92395|P2|NOT COMPLETED|Overall Study||0
39476|NCT01828216|92396|P1|NOT COMPLETED|Overall Study||0
39477|NCT01828216|92395|P2|COMPLETED|Overall Study||157
39478|NCT01828216|92396|P1|COMPLETED|Overall Study||159
39479|NCT01828216|92395|P2|STARTED|Overall Study||157
39480|NCT01828216|92396|P1|STARTED|Overall Study||159
39481|NCT01828164|92404|P1|NOT COMPLETED|Overall Study||17
39482|NCT01828164|92404|P1|COMPLETED|Overall Study||32
39483|NCT01828164|92404|P1|STARTED|Overall Study|11 out of 60 subjects did not meet inclusion criteria after enrollment.|49
39484|NCT01828112|92416|P2|NOT COMPLETED|Overall Study||108
39485|NCT01828112|92417|P1|NOT COMPLETED|Overall Study||82
39486|NCT01828112|92416|P2|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|8
39487|NCT01828112|92417|P1|COMPLETED|Overall Study|Completed = Ongoing at time of data cut-off of 26-Jan-2016|33
39488|NCT01828112|92416|P2|Treated|Overall Study||113
39489|NCT01828112|92417|P1|Treated|Overall Study||115
39490|NCT01828112|92416|P2|Untreated|Overall Study||3
39491|NCT01828112|92417|P1|Untreated|Overall Study||0
39492|NCT01828112|92416|P2|Untreated Patients|Overall Study|untreated = did not receive study drug|3
39493|NCT01828112|92417|P1|Untreated Patients|Overall Study||0
39494|NCT01828112|92416|P2|Discontinued From Study|Overall Study||10
39495|NCT01828112|92417|P1|Discontinued From Study|Overall Study||14
39496|NCT01828112|92416|P2|Entered Survival Follow-up Phase|Overall Study||19
39497|NCT01828112|92417|P1|Entered Survival Follow-up Phase|Overall Study||61
39498|NCT01828112|92416|P2|Entered Post-treatment Follow-up Phase|Overall Study||5
39499|NCT01828112|92417|P1|Entered Post-treatment Follow-up Phase|Overall Study||7
39500|NCT01828112|92416|P2|Entered Extension Treatment Phase|Overall Study||74
39501|NCT01828112|92417|P1|Entered Extension Treatment Phase|Overall Study||0
39502|NCT01828112|92416|P2|STARTED|Overall Study||116
39503|NCT01828112|92417|P1|STARTED|Overall Study||115
39504|NCT01827839|92423|P1|NOT COMPLETED|Overall Study||3
39505|NCT01827839|92423|P1|COMPLETED|Overall Study||93
39506|NCT01827839|92423|P1|STARTED|Overall Study||96
39507|NCT01827670|92447|P2|NOT COMPLETED|Overall Study||3
39508|NCT01827670|92448|P1|NOT COMPLETED|Overall Study||3
39509|NCT01827670|92447|P2|COMPLETED|Overall Study||56
39510|NCT01827670|92448|P1|COMPLETED|Overall Study||57
39511|NCT01827670|92447|P2|STARTED|Overall Study||59
39512|NCT01827670|92448|P1|STARTED|Overall Study||60
39513|NCT01827592|92467|P3|NOT COMPLETED|Overall Study||76
39514|NCT01827592|92468|P2|NOT COMPLETED|Overall Study||80
39515|NCT01827592|92469|P1|NOT COMPLETED|Overall Study||74
39516|NCT01827592|92467|P3|COMPLETED|Overall Study||48
39517|NCT01827592|92468|P2|COMPLETED|Overall Study||46
39518|NCT01827592|92469|P1|COMPLETED|Overall Study||52
39519|NCT01827592|92467|P3|Safety Analysis Set|Overall Study||124
39520|NCT01827592|92468|P2|Safety Analysis Set|Overall Study||126
39521|NCT01827592|92469|P1|Safety Analysis Set|Overall Study|1 patient withdrew consent before getting the treatment.|125
39522|NCT01827592|92467|P3|STARTED|Overall Study|Randomized patients.|124
39523|NCT01827592|92468|P2|STARTED|Overall Study|Randomized patients.|126
39524|NCT01827592|92469|P1|STARTED|Overall Study|Randomized patients.|126
39525|NCT01827475|92501|P3|NOT COMPLETED|Overall Study||0
39526|NCT01827475|92502|P2|NOT COMPLETED|Overall Study||0
39527|NCT01827475|92503|P1|NOT COMPLETED|Overall Study||0
39528|NCT01827475|92501|P3|COMPLETED|Overall Study||30
39529|NCT01827475|92502|P2|COMPLETED|Overall Study||30
39530|NCT01827475|92503|P1|COMPLETED|Overall Study||30
39531|NCT01827475|92501|P3|STARTED|Overall Study||30
39532|NCT01827475|92502|P2|STARTED|Overall Study||30
39533|NCT01827475|92503|P1|STARTED|Overall Study||30
39534|NCT01827462|92517|P3|NOT COMPLETED|Overall Study||28
39535|NCT01827462|92518|P2|NOT COMPLETED|Overall Study||18
39536|NCT01827462|92519|P1|NOT COMPLETED|Overall Study||41
39537|NCT01827462|92517|P3|COMPLETED|Overall Study||12
39538|NCT01827462|92518|P2|COMPLETED|Overall Study||19
39539|NCT01827462|92519|P1|COMPLETED|Overall Study||18
39540|NCT01827462|92517|P3|STARTED|Overall Study||40
39541|NCT01827462|92518|P2|STARTED|Overall Study||37
39542|NCT01827462|92519|P1|STARTED|Overall Study||59
39543|NCT01827371|92534|P4|NOT COMPLETED|Overall Study||23
39544|NCT01827371|92535|P3|NOT COMPLETED|Overall Study||11
39545|NCT01827371|92536|P2|NOT COMPLETED|Overall Study||7
39546|NCT01827371|92537|P1|NOT COMPLETED|Overall Study||13
39547|NCT01827371|92534|P4|COMPLETED|Overall Study||97
39548|NCT01827371|92535|P3|COMPLETED|Overall Study||93
39549|NCT01827371|92536|P2|COMPLETED|Overall Study||89
39550|NCT01827371|92537|P1|COMPLETED|Overall Study||102
39551|NCT01827371|92534|P4|STARTED|Overall Study||120
39552|NCT01827371|92535|P3|STARTED|Overall Study||104
39553|NCT01827371|92536|P2|STARTED|Overall Study||96
39554|NCT01827371|92537|P1|STARTED|Overall Study||115
39555|NCT01827358|92561|P2|NOT COMPLETED|Overall Study||31
39556|NCT01827358|92562|P1|NOT COMPLETED|Overall Study||35
39557|NCT01827358|92561|P2|COMPLETED|Overall Study||44
39558|NCT01827358|92562|P1|COMPLETED|Overall Study||45
39559|NCT01827358|92561|P2|STARTED|Overall Study||75
39560|NCT01827358|92562|P1|STARTED|Overall Study||80
39561|NCT01827332|92596|P2|NOT COMPLETED|Overall Study||1
39562|NCT01827332|92597|P1|NOT COMPLETED|Overall Study||2
39563|NCT01827332|92596|P2|COMPLETED|Overall Study||7
39564|NCT01827332|92597|P1|COMPLETED|Overall Study||6
39565|NCT01827332|92596|P2|STARTED|Overall Study||8
39566|NCT01827332|92597|P1|STARTED|Overall Study||8
39567|NCT01827319|92605|P1|NOT COMPLETED|Overall Study||3
39568|NCT01827319|92605|P1|COMPLETED|Overall Study||200
39569|NCT01827319|92605|P1|STARTED|Overall Study||203
39570|NCT01827306|92613|P2|NOT COMPLETED|Overall Study||5
39571|NCT01827306|92614|P1|NOT COMPLETED|Overall Study||11
39572|NCT01827306|92613|P2|COMPLETED|Overall Study||8
39573|NCT01827306|92614|P1|COMPLETED|Overall Study||10
39574|NCT01827306|92613|P2|STARTED|Overall Study||13
39575|NCT01827306|92614|P1|STARTED|Overall Study||21
39576|NCT01827254|92626|P1|NOT COMPLETED|Overall Study||59
39577|NCT01827254|92626|P1|COMPLETED|Overall Study||2
39578|NCT01827254|92626|P1|Evaluable Population|Overall Study||52
39579|NCT01827254|92626|P1|STARTED|Overall Study||61
39580|NCT01826981|92651|P15|NOT COMPLETED|Overall Study||0
39581|NCT01826981|92652|P14|NOT COMPLETED|Overall Study||5
39582|NCT01826981|92653|P13|NOT COMPLETED|Overall Study||1
39583|NCT01826981|92654|P12|NOT COMPLETED|Overall Study||2
39584|NCT01826981|92655|P11|NOT COMPLETED|Overall Study||2
39585|NCT01826981|92656|P10|NOT COMPLETED|Overall Study||1
39586|NCT01826981|92657|P9|NOT COMPLETED|Overall Study||7
39587|NCT01826981|92658|P8|NOT COMPLETED|Overall Study||11
39588|NCT01826981|92659|P7|NOT COMPLETED|Overall Study||1
39589|NCT01826981|92660|P6|NOT COMPLETED|Overall Study||1
39590|NCT01826981|92661|P5|NOT COMPLETED|Overall Study||7
39591|NCT01826981|92662|P4|NOT COMPLETED|Overall Study||0
39592|NCT01826981|92663|P3|NOT COMPLETED|Overall Study||0
39593|NCT01826981|92664|P2|NOT COMPLETED|Overall Study||1
39594|NCT01826981|92665|P1|NOT COMPLETED|Overall Study||0
39595|NCT01826981|92651|P15|COMPLETED|Overall Study||8
39596|NCT01826981|92652|P14|COMPLETED|Overall Study||15
39597|NCT01826981|92653|P13|COMPLETED|Overall Study||25
39598|NCT01826981|92654|P12|COMPLETED|Overall Study||25
39599|NCT01826981|92655|P11|COMPLETED|Overall Study||22
39600|NCT01826981|92656|P10|COMPLETED|Overall Study||26
39601|NCT01826981|92657|P9|COMPLETED|Overall Study||13
39602|NCT01826981|92658|P8|COMPLETED|Overall Study||40
39603|NCT01826981|92659|P7|COMPLETED|Overall Study||24
39604|NCT01826981|92660|P6|COMPLETED|Overall Study||25
39605|NCT01826981|92661|P5|COMPLETED|Overall Study||18
39606|NCT01826981|92662|P4|COMPLETED|Overall Study||26
39607|NCT01826981|92663|P3|COMPLETED|Overall Study||25
39608|NCT01826981|92664|P2|COMPLETED|Overall Study||9
39609|NCT01826981|92665|P1|COMPLETED|Overall Study||19
39610|NCT01826981|92651|P15|STARTED|Overall Study||8
39611|NCT01826981|92652|P14|STARTED|Overall Study||20
39612|NCT01826981|92653|P13|STARTED|Overall Study||26
39613|NCT01826981|92654|P12|STARTED|Overall Study||27
39614|NCT01826981|92655|P11|STARTED|Overall Study||24
39615|NCT01826981|92656|P10|STARTED|Overall Study||27
39616|NCT01826981|92657|P9|STARTED|Overall Study||20
39617|NCT01826981|92658|P8|STARTED|Overall Study||51
39618|NCT01826981|92659|P7|STARTED|Overall Study||25
39619|NCT01826981|92660|P6|STARTED|Overall Study||26
39620|NCT01826981|92661|P5|STARTED|Overall Study||25
39621|NCT01826981|92662|P4|STARTED|Overall Study||26
39622|NCT01826981|92663|P3|STARTED|Overall Study||25
39623|NCT01826981|92664|P2|STARTED|Overall Study||10
39624|NCT01826981|92665|P1|STARTED|Overall Study||19
39625|NCT01826812|92813|P2|NOT COMPLETED|Overall Study||1
39626|NCT01826812|92814|P1|NOT COMPLETED|Overall Study||0
39627|NCT01826812|92813|P2|COMPLETED|Overall Study||32
39628|NCT01826812|92814|P1|COMPLETED|Overall Study||167
39629|NCT01826812|92813|P2|STARTED|Overall Study||33
39630|NCT01826812|92814|P1|STARTED|Overall Study||167
39631|NCT01826604|92828|P2|NOT COMPLETED|Overall Study||9
39632|NCT01826604|92829|P1|NOT COMPLETED|Overall Study||8
39633|NCT01826604|92828|P2|COMPLETED|Overall Study||148
39634|NCT01826604|92829|P1|COMPLETED|Overall Study||136
39635|NCT01826604|92828|P2|STARTED|Overall Study||157
39636|NCT01826604|92829|P1|STARTED|Overall Study||144
39637|NCT01826513|92840|P3|NOT COMPLETED|Overall Study||0
39638|NCT01826513|92841|P2|NOT COMPLETED|Overall Study||0
39639|NCT01826513|92842|P1|NOT COMPLETED|Overall Study||0
39640|NCT01826513|92840|P3|COMPLETED|Overall Study||10
39641|NCT01826513|92841|P2|COMPLETED|Overall Study||10
39642|NCT01826513|92842|P1|COMPLETED|Overall Study||5
39643|NCT01826513|92840|P3|STARTED|Overall Study||10
39644|NCT01826513|92841|P2|STARTED|Overall Study||10
39645|NCT01826513|92842|P1|STARTED|Overall Study||5
39646|NCT01826370|92871|P1|NOT COMPLETED|Overall Study||20
39647|NCT01826370|92871|P1|COMPLETED|Overall Study||658
39648|NCT01826370|92871|P1|STARTED|Overall Study||678
39649|NCT01826214|92879|P2|NOT COMPLETED|Overall Study||34
39650|NCT01826214|92880|P1|NOT COMPLETED|Overall Study||35
39651|NCT01826214|92879|P2|COMPLETED|Overall Study||0
39652|NCT01826214|92880|P1|COMPLETED|Overall Study||0
39653|NCT01826214|92879|P2|Treated|Overall Study|Treated = received at least one dose of study drug|34
39654|NCT01826214|92880|P1|Treated|Overall Study|Treated = received at least one dose of study drug|35
39655|NCT01826214|92879|P2|Untreated|Overall Study|Untreated = did not receive study drug|1
39656|NCT01826214|92880|P1|Untreated|Overall Study|Untreated = did not receive study drug|0
39657|NCT01826214|92879|P2|STARTED|Overall Study|35 patients were randomized but only 34 patients received at least one dose of study drug|34
39658|NCT01826214|92880|P1|STARTED|Overall Study||35
39659|NCT01826201|92898|P1|NOT COMPLETED|Overall Study||4
39660|NCT01826201|92898|P1|COMPLETED|Overall Study||17
39661|NCT01826201|92898|P1|STARTED|Overall Study|Subjects in each arm are same|21
39662|NCT01825837|92908|P4|NOT COMPLETED|PART II||0
39663|NCT01825837|92909|P3|NOT COMPLETED|PART II||19
39664|NCT01825837|92910|P2|NOT COMPLETED|PART II||14
39665|NCT01825837|92911|P1|NOT COMPLETED|PART II||19
39666|NCT01825837|92908|P4|COMPLETED|PART II||0
39667|NCT01825837|92909|P3|COMPLETED|PART II||7
39668|NCT01825837|92910|P2|COMPLETED|PART II||12
39669|NCT01825837|92911|P1|COMPLETED|PART II||16
39670|NCT01825837|92908|P4|Per-Protocol Population|PART II||0
39671|NCT01825837|92909|P3|Per-Protocol Population|PART II||24
39672|NCT01825837|92910|P2|Per-Protocol Population|PART II||23
39673|NCT01825837|92911|P1|Per-Protocol Population|PART II||32
39674|NCT01825837|92908|P4|Intent-to-Treat Population|PART II||0
39675|NCT01825837|92909|P3|Intent-to-Treat Population|PART II||26
39676|NCT01825837|92910|P2|Intent-to-Treat Population|PART II||25
39677|NCT01825837|92911|P1|Intent-to-Treat Population|PART II||34
39678|NCT01825837|92908|P4|Safety Population (Double-Blind)|PART II||0
39679|NCT01825837|92909|P3|Safety Population (Double-Blind)|PART II||26
39680|NCT01825837|92910|P2|Safety Population (Double-Blind)|PART II||26
39681|NCT01825837|92911|P1|Safety Population (Double-Blind)|PART II||35
39682|NCT01825837|92908|P4|Randomized Patients|PART II||0
39683|NCT01825837|92909|P3|Randomized Patients|PART II||26
39684|NCT01825837|92910|P2|Randomized Patients|PART II||26
39685|NCT01825837|92911|P1|Randomized Patients|PART II||35
39686|NCT01825837|92908|P4|STARTED|PART II||0
39687|NCT01825837|92909|P3|STARTED|PART II||26
39688|NCT01825837|92910|P2|STARTED|PART II||26
39689|NCT01825837|92911|P1|STARTED|PART II||35
39690|NCT01825837|92908|P4|NOT COMPLETED|PART I||17
39691|NCT01825837|92909|P3|NOT COMPLETED|PART I||0
39692|NCT01825837|92910|P2|NOT COMPLETED|PART I||0
39693|NCT01825837|92911|P1|NOT COMPLETED|PART I||0
39694|NCT01825837|92908|P4|COMPLETED|PART I||87
39695|NCT01825837|92909|P3|COMPLETED|PART I||0
39696|NCT01825837|92910|P2|COMPLETED|PART I||0
39697|NCT01825837|92911|P1|COMPLETED|PART I||0
39698|NCT01825837|92908|P4|Safety Population (Open-Label)|PART I||104
39699|NCT01825837|92909|P3|Safety Population (Open-Label)|PART I||0
39700|NCT01825837|92910|P2|Safety Population (Open-Label)|PART I||0
39701|NCT01825837|92911|P1|Safety Population (Open-Label)|PART I||0
39702|NCT01825837|92908|P4|Enrolled|PART I||104
39703|NCT01825837|92909|P3|Enrolled|PART I||0
39704|NCT01825837|92910|P2|Enrolled|PART I||0
39705|NCT01825837|92911|P1|Enrolled|PART I||0
39706|NCT01825837|92908|P4|STARTED|PART I||104
39707|NCT01825837|92909|P3|STARTED|PART I||0
39708|NCT01825837|92910|P2|STARTED|PART I||0
39709|NCT01825837|92911|P1|STARTED|PART I||0
39710|NCT01825577|92919|P1|NOT COMPLETED|Overall Study||8
39711|NCT01825577|92919|P1|COMPLETED|Overall Study||6
39712|NCT01825577|92919|P1|STARTED|Overall Study||14
39713|NCT01825408|92928|P4|NOT COMPLETED|Overall Study||0
39714|NCT01825408|92929|P3|NOT COMPLETED|Overall Study||0
39715|NCT01825408|92930|P2|NOT COMPLETED|Overall Study||0
39716|NCT01825408|92931|P1|NOT COMPLETED|Overall Study||0
39717|NCT01825408|92928|P4|COMPLETED|Overall Study||12
39718|NCT01825408|92929|P3|COMPLETED|Overall Study||14
39719|NCT01825408|92930|P2|COMPLETED|Overall Study||7
39720|NCT01825408|92931|P1|COMPLETED|Overall Study||7
39721|NCT01825408|92928|P4|STARTED|Overall Study||12
39722|NCT01825408|92929|P3|STARTED|Overall Study||14
39723|NCT01825408|92930|P2|STARTED|Overall Study||7
39724|NCT01825408|92931|P1|STARTED|Overall Study||7
39725|NCT01825200|92943|P2|NOT COMPLETED|Overall Study||7
39726|NCT01825200|92944|P1|NOT COMPLETED|Overall Study||5
39727|NCT01825200|92943|P2|COMPLETED|Overall Study||1314
39728|NCT01825200|92944|P1|COMPLETED|Overall Study||1314
39729|NCT01825200|92943|P2|STARTED|Overall Study||1321
39730|NCT01825200|92944|P1|STARTED|Overall Study||1319
39731|NCT01825122|92958|P2|NOT COMPLETED|Overall Study||19
39732|NCT01825122|92959|P1|NOT COMPLETED|Overall Study||10
39733|NCT01825122|92958|P2|COMPLETED|Overall Study||59
39734|NCT01825122|92959|P1|COMPLETED|Overall Study||67
39735|NCT01825122|92958|P2|STARTED|Overall Study||78
39736|NCT01825122|92959|P1|STARTED|Overall Study||77
39737|NCT01824901|92965|P4|NOT COMPLETED|Overall Study||0
39738|NCT01824901|92966|P3|NOT COMPLETED|Overall Study||0
39739|NCT01824901|92967|P2|NOT COMPLETED|Overall Study||0
39740|NCT01824901|92968|P1|NOT COMPLETED|Overall Study||0
39741|NCT01824901|92965|P4|COMPLETED|Overall Study||0
39742|NCT01824901|92966|P3|COMPLETED|Overall Study||0
39743|NCT01824901|92967|P2|COMPLETED|Overall Study||0
39744|NCT01824901|92968|P1|COMPLETED|Overall Study||2
39745|NCT01824901|92965|P4|STARTED|Overall Study||0
39746|NCT01824901|92966|P3|STARTED|Overall Study||0
39747|NCT01824901|92967|P2|STARTED|Overall Study||0
39748|NCT01824901|92968|P1|STARTED|Overall Study||2
39749|NCT01824823|92974|P2|NOT COMPLETED|Overall Study||1
39750|NCT01824823|92975|P1|NOT COMPLETED|Overall Study||2
39751|NCT01824823|92974|P2|COMPLETED|Overall Study||0
39752|NCT01824823|92975|P1|COMPLETED|Overall Study||0
39753|NCT01824823|92974|P2|STARTED|Overall Study||1
39754|NCT01824823|92975|P1|STARTED|Overall Study||2
39755|NCT01823679|92981|P1|NOT COMPLETED|Overall Study||1
39756|NCT01823679|92981|P1|COMPLETED|Overall Study||1
39757|NCT01823679|92981|P1|STARTED|Overall Study||2
39758|NCT01823653|92989|P1|NOT COMPLETED|Overall Study||0
39759|NCT01823653|92989|P1|COMPLETED|Overall Study||60
39760|NCT01823653|92989|P1|STARTED|Overall Study||60
39761|NCT01823614|93003|P6|NOT COMPLETED|Overall Study||0
39762|NCT01823614|93004|P5|NOT COMPLETED|Overall Study||0
39763|NCT01823614|93005|P4|NOT COMPLETED|Overall Study||0
39764|NCT01823614|93006|P3|NOT COMPLETED|Overall Study||0
39765|NCT01823614|93007|P2|NOT COMPLETED|Overall Study||0
39766|NCT01823614|93008|P1|NOT COMPLETED|Overall Study||0
39767|NCT01823614|93003|P6|COMPLETED|Overall Study||154
39768|NCT01823614|93004|P5|COMPLETED|Overall Study||172
39769|NCT01823614|93005|P4|COMPLETED|Overall Study||122
39770|NCT01823614|93006|P3|COMPLETED|Overall Study||176
39771|NCT01823614|93007|P2|COMPLETED|Overall Study||140
39772|NCT01823614|93008|P1|COMPLETED|Overall Study||179
39773|NCT01823614|93003|P6|STARTED|Overall Study||154
39774|NCT01823614|93004|P5|STARTED|Overall Study||172
39775|NCT01823614|93005|P4|STARTED|Overall Study||122
39776|NCT01823614|93006|P3|STARTED|Overall Study||176
39777|NCT01823614|93007|P2|STARTED|Overall Study||140
39778|NCT01823614|93008|P1|STARTED|Overall Study||179
39779|NCT01824602|93032|P4|NOT COMPLETED|Overall Study||5
39780|NCT01824602|93033|P3|NOT COMPLETED|Overall Study||4
39781|NCT01824602|93034|P2|NOT COMPLETED|Overall Study||0
39782|NCT01824602|93035|P1|NOT COMPLETED|Overall Study||1
39783|NCT01824602|93032|P4|COMPLETED|Overall Study||5
39784|NCT01824602|93033|P3|COMPLETED|Overall Study||5
39785|NCT01824602|93034|P2|COMPLETED|Overall Study||8
39786|NCT01824602|93035|P1|COMPLETED|Overall Study||10
39787|NCT01824602|93032|P4|Intent-to-treat Population|Overall Study||9
39788|NCT01824602|93033|P3|Intent-to-treat Population|Overall Study||9
39789|NCT01824602|93034|P2|Intent-to-treat Population|Overall Study||8
39790|NCT01824602|93035|P1|Intent-to-treat Population|Overall Study||11
39791|NCT01824602|93032|P4|Safety Population|Overall Study||10
39792|NCT01824602|93033|P3|Safety Population|Overall Study||9
39793|NCT01824602|93034|P2|Safety Population|Overall Study||8
39794|NCT01824602|93035|P1|Safety Population|Overall Study||11
39795|NCT01824602|93032|P4|STARTED|Overall Study||10
39796|NCT01824602|93033|P3|STARTED|Overall Study||9
39797|NCT01824602|93034|P2|STARTED|Overall Study||8
39798|NCT01824602|93035|P1|STARTED|Overall Study||11
39799|NCT01824589|93049|P4|NOT COMPLETED|Overall Study||0
39800|NCT01824589|93050|P3|NOT COMPLETED|Overall Study||0
39801|NCT01824589|93051|P2|NOT COMPLETED|Overall Study||0
39802|NCT01824589|93052|P1|NOT COMPLETED|Overall Study||0
39803|NCT01824589|93049|P4|COMPLETED|Overall Study||0
39804|NCT01824589|93050|P3|COMPLETED|Overall Study||0
39805|NCT01824589|93051|P2|COMPLETED|Overall Study||0
39806|NCT01824589|93052|P1|COMPLETED|Overall Study||1
39807|NCT01824589|93049|P4|STARTED|Overall Study||0
39808|NCT01824589|93050|P3|STARTED|Overall Study||0
39809|NCT01824589|93051|P2|STARTED|Overall Study||0
39810|NCT01824589|93052|P1|STARTED|Overall Study||1
39811|NCT01824498|93080|P6|NOT COMPLETED|3rd Intervention (8 Weeks)||0
39812|NCT01824498|93081|P5|NOT COMPLETED|3rd Intervention (8 Weeks)||0
39813|NCT01824498|93082|P4|NOT COMPLETED|3rd Intervention (8 Weeks)||0
39814|NCT01824498|93083|P3|NOT COMPLETED|3rd Intervention (8 Weeks)||0
39815|NCT01824498|93084|P2|NOT COMPLETED|3rd Intervention (8 Weeks)||0
39816|NCT01824498|93085|P1|NOT COMPLETED|3rd Intervention (8 Weeks)||0
39817|NCT01824498|93080|P6|COMPLETED|3rd Intervention (8 Weeks)||4
39818|NCT01824498|93081|P5|COMPLETED|3rd Intervention (8 Weeks)||3
39819|NCT01824498|93082|P4|COMPLETED|3rd Intervention (8 Weeks)||2
39820|NCT01824498|93083|P3|COMPLETED|3rd Intervention (8 Weeks)||4
39821|NCT01824498|93084|P2|COMPLETED|3rd Intervention (8 Weeks)||2
39822|NCT01824498|93085|P1|COMPLETED|3rd Intervention (8 Weeks)||3
39823|NCT01824498|93080|P6|STARTED|3rd Intervention (8 Weeks)||4
39824|NCT01824498|93081|P5|STARTED|3rd Intervention (8 Weeks)||3
39825|NCT01824498|93082|P4|STARTED|3rd Intervention (8 Weeks)||2
39826|NCT01824498|93083|P3|STARTED|3rd Intervention (8 Weeks)||4
39827|NCT01824498|93084|P2|STARTED|3rd Intervention (8 Weeks)||2
39828|NCT01824498|93085|P1|STARTED|3rd Intervention (8 Weeks)||3
39829|NCT01824498|93080|P6|NOT COMPLETED|Washout (8 Weeks)||0
39830|NCT01824498|93081|P5|NOT COMPLETED|Washout (8 Weeks)||0
39831|NCT01824498|93082|P4|NOT COMPLETED|Washout (8 Weeks)||0
39832|NCT01824498|93083|P3|NOT COMPLETED|Washout (8 Weeks)||0
39833|NCT01824498|93084|P2|NOT COMPLETED|Washout (8 Weeks)||0
39834|NCT01824498|93085|P1|NOT COMPLETED|Washout (8 Weeks)||0
39835|NCT01824498|93080|P6|COMPLETED|Washout (8 Weeks)||4
39836|NCT01824498|93081|P5|COMPLETED|Washout (8 Weeks)||3
39837|NCT01824498|93082|P4|COMPLETED|Washout (8 Weeks)||2
39838|NCT01824498|93083|P3|COMPLETED|Washout (8 Weeks)||4
39839|NCT01824498|93084|P2|COMPLETED|Washout (8 Weeks)||2
39840|NCT01824498|93085|P1|COMPLETED|Washout (8 Weeks)||3
39841|NCT01824498|93080|P6|STARTED|Washout (8 Weeks)||4
39842|NCT01824498|93081|P5|STARTED|Washout (8 Weeks)||3
39843|NCT01824498|93082|P4|STARTED|Washout (8 Weeks)||2
39844|NCT01824498|93083|P3|STARTED|Washout (8 Weeks)||4
39845|NCT01824498|93084|P2|STARTED|Washout (8 Weeks)||2
39846|NCT01824498|93085|P1|STARTED|Washout (8 Weeks)||3
39847|NCT01824498|93080|P6|NOT COMPLETED|2nd Intervention (8 Weeks)||0
39848|NCT01824498|93081|P5|NOT COMPLETED|2nd Intervention (8 Weeks)||0
39849|NCT01824498|93082|P4|NOT COMPLETED|2nd Intervention (8 Weeks)||0
39850|NCT01824498|93083|P3|NOT COMPLETED|2nd Intervention (8 Weeks)||0
39851|NCT01824498|93084|P2|NOT COMPLETED|2nd Intervention (8 Weeks)||0
39852|NCT01824498|93085|P1|NOT COMPLETED|2nd Intervention (8 Weeks)||0
39853|NCT01824498|93080|P6|COMPLETED|2nd Intervention (8 Weeks)||4
39854|NCT01824498|93081|P5|COMPLETED|2nd Intervention (8 Weeks)||3
39855|NCT01824498|93082|P4|COMPLETED|2nd Intervention (8 Weeks)||2
39856|NCT01824498|93083|P3|COMPLETED|2nd Intervention (8 Weeks)||4
39857|NCT01824498|93084|P2|COMPLETED|2nd Intervention (8 Weeks)||2
39858|NCT01824498|93085|P1|COMPLETED|2nd Intervention (8 Weeks)||3
39859|NCT01824498|93080|P6|STARTED|2nd Intervention (8 Weeks)||4
39860|NCT01824498|93081|P5|STARTED|2nd Intervention (8 Weeks)||3
39861|NCT01824498|93082|P4|STARTED|2nd Intervention (8 Weeks)||2
39862|NCT01824498|93083|P3|STARTED|2nd Intervention (8 Weeks)||4
39863|NCT01824498|93084|P2|STARTED|2nd Intervention (8 Weeks)||2
39864|NCT01824498|93085|P1|STARTED|2nd Intervention (8 Weeks)||3
39865|NCT01824498|93080|P6|NOT COMPLETED|Washout (8 Weeks)||0
39866|NCT01824498|93081|P5|NOT COMPLETED|Washout (8 Weeks)||1
39867|NCT01824498|93082|P4|NOT COMPLETED|Washout (8 Weeks)||1
39868|NCT01824498|93083|P3|NOT COMPLETED|Washout (8 Weeks)||2
39869|NCT01824498|93084|P2|NOT COMPLETED|Washout (8 Weeks)||0
39870|NCT01824498|93085|P1|NOT COMPLETED|Washout (8 Weeks)||2
39871|NCT01824498|93080|P6|COMPLETED|Washout (8 Weeks)||4
39872|NCT01824498|93081|P5|COMPLETED|Washout (8 Weeks)||3
39873|NCT01824498|93082|P4|COMPLETED|Washout (8 Weeks)||2
39874|NCT01824498|93083|P3|COMPLETED|Washout (8 Weeks)||4
39875|NCT01824498|93084|P2|COMPLETED|Washout (8 Weeks)||2
39876|NCT01824498|93085|P1|COMPLETED|Washout (8 Weeks)||3
39877|NCT01824498|93080|P6|STARTED|Washout (8 Weeks)||4
39878|NCT01824498|93081|P5|STARTED|Washout (8 Weeks)|1 dropped out|4
39879|NCT01824498|93082|P4|STARTED|Washout (8 Weeks)|1 dropped out|3
39880|NCT01824498|93083|P3|STARTED|Washout (8 Weeks)|2 dropped out|6
39881|NCT01824498|93084|P2|STARTED|Washout (8 Weeks)||2
39882|NCT01824498|93085|P1|STARTED|Washout (8 Weeks)|2 dropped out|5
39883|NCT01824498|93080|P6|NOT COMPLETED|1st Intervention (8 Weeks)||0
39884|NCT01824498|93081|P5|NOT COMPLETED|1st Intervention (8 Weeks)||0
39885|NCT01824498|93082|P4|NOT COMPLETED|1st Intervention (8 Weeks)||0
39886|NCT01824498|93083|P3|NOT COMPLETED|1st Intervention (8 Weeks)||0
39887|NCT01824498|93084|P2|NOT COMPLETED|1st Intervention (8 Weeks)||0
39888|NCT01824498|93085|P1|NOT COMPLETED|1st Intervention (8 Weeks)||0
39889|NCT01824498|93080|P6|COMPLETED|1st Intervention (8 Weeks)||4
39890|NCT01824498|93081|P5|COMPLETED|1st Intervention (8 Weeks)||4
39891|NCT01824498|93082|P4|COMPLETED|1st Intervention (8 Weeks)||3
39892|NCT01824498|93083|P3|COMPLETED|1st Intervention (8 Weeks)||6
39893|NCT01824498|93084|P2|COMPLETED|1st Intervention (8 Weeks)||2
39894|NCT01824498|93085|P1|COMPLETED|1st Intervention (8 Weeks)||5
39895|NCT01824498|93080|P6|STARTED|1st Intervention (8 Weeks)||4
39896|NCT01824498|93081|P5|STARTED|1st Intervention (8 Weeks)||4
39897|NCT01824498|93082|P4|STARTED|1st Intervention (8 Weeks)||3
39898|NCT01824498|93083|P3|STARTED|1st Intervention (8 Weeks)||6
39899|NCT01824498|93084|P2|STARTED|1st Intervention (8 Weeks)||2
39900|NCT01824498|93085|P1|STARTED|1st Intervention (8 Weeks)||5
39901|NCT01824446|93093|P1|NOT COMPLETED|Overall Study||0
39902|NCT01824446|93093|P1|COMPLETED|Overall Study||6
39903|NCT01824446|93093|P1|STARTED|Overall Study||6
39904|NCT01824355|93116|P1|NOT COMPLETED|Overall Study||3
39905|NCT01824355|93116|P1|COMPLETED|Overall Study||110
39906|NCT01824355|93116|P1|STARTED|Overall Study||113
39907|NCT01824342|93127|P2|NOT COMPLETED|Overall Study||5
39908|NCT01824342|93128|P1|NOT COMPLETED|Overall Study||9
39909|NCT01824342|93127|P2|COMPLETED|Overall Study||2
39910|NCT01824342|93128|P1|COMPLETED|Overall Study||2
39911|NCT01824342|93127|P2|STARTED|Overall Study||7
39912|NCT01824342|93128|P1|STARTED|Overall Study||11
39913|NCT01824303|93142|P2|NOT COMPLETED|Open Label Extension||0
39914|NCT01824303|93143|P1|NOT COMPLETED|Open Label Extension||0
39915|NCT01824303|93142|P2|COMPLETED|Open Label Extension||11
39916|NCT01824303|93143|P1|COMPLETED|Open Label Extension||12
39917|NCT01824303|93142|P2|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|11
39918|NCT01824303|93143|P1|STARTED|Open Label Extension|2 participants completed the Randomized Study but did not enter the Open Label Extension.|12
39919|NCT01824303|93142|P2|NOT COMPLETED|Randomized Study||1
39920|NCT01824303|93143|P1|NOT COMPLETED|Randomized Study||2
39921|NCT01824303|93142|P2|COMPLETED|Randomized Study||13
39922|NCT01824303|93143|P1|COMPLETED|Randomized Study||14
39923|NCT01824303|93142|P2|STARTED|Randomized Study||14
39924|NCT01824303|93143|P1|STARTED|Randomized Study||16
39925|NCT01824160|93167|P1|NOT COMPLETED|Overall Study||0
39926|NCT01824160|93167|P1|COMPLETED|Overall Study||50
39927|NCT01824160|93167|P1|STARTED|Overall Study||50
39928|NCT01823536|93177|P6|NOT COMPLETED|Overall Study||0
39929|NCT01823536|93178|P5|NOT COMPLETED|Overall Study||2
39930|NCT01823536|93179|P4|NOT COMPLETED|Overall Study||2
39931|NCT01823536|93180|P3|NOT COMPLETED|Overall Study||1
39932|NCT01823536|93181|P2|NOT COMPLETED|Overall Study||2
39933|NCT01823536|93182|P1|NOT COMPLETED|Overall Study||2
39934|NCT01823536|93177|P6|COMPLETED|Overall Study||2
39935|NCT01823536|93178|P5|COMPLETED|Overall Study||99
39936|NCT01823536|93179|P4|COMPLETED|Overall Study||64
39937|NCT01823536|93180|P3|COMPLETED|Overall Study||119
39938|NCT01823536|93181|P2|COMPLETED|Overall Study||101
39939|NCT01823536|93182|P1|COMPLETED|Overall Study||71
39940|NCT01823536|93177|P6|STARTED|Overall Study||2
39941|NCT01823536|93178|P5|STARTED|Overall Study||101
39942|NCT01823536|93179|P4|STARTED|Overall Study||66
39943|NCT01823536|93180|P3|STARTED|Overall Study||120
39944|NCT01823536|93181|P2|STARTED|Overall Study||103
39945|NCT01823536|93182|P1|STARTED|Overall Study||73
39946|NCT01823341|93220|P1|NOT COMPLETED|Overall Study||15
39947|NCT01823341|93220|P1|COMPLETED|Overall Study||82
39948|NCT01823341|93220|P1|STARTED|Overall Study||97
39949|NCT01823289|93263|P1|NOT COMPLETED|Overall Study||24
39950|NCT01823289|93263|P1|COMPLETED|Overall Study||47
39951|NCT01823289|93263|P1|STARTED|Overall Study||71
39952|NCT01823224|93271|P2|NOT COMPLETED|Overall Study||11
39953|NCT01823224|93272|P1|NOT COMPLETED|Overall Study||6
39954|NCT01823224|93271|P2|COMPLETED|Overall Study||22
39955|NCT01823224|93272|P1|COMPLETED|Overall Study||28
39956|NCT01823224|93271|P2|STARTED|Overall Study||33
39957|NCT01823224|93272|P1|STARTED|Overall Study||34
39958|NCT01823146|93282|P2|NOT COMPLETED|Overall Study||2
39959|NCT01823146|93283|P1|NOT COMPLETED|Overall Study||2
39960|NCT01823146|93282|P2|COMPLETED|Overall Study||49
39961|NCT01823146|93283|P1|COMPLETED|Overall Study||53
39962|NCT01823146|93282|P2|STARTED|Overall Study||51
39963|NCT01823146|93283|P1|STARTED|Overall Study||55
39964|NCT01822899|93295|P2|NOT COMPLETED|Overall Study||18
39965|NCT01822899|93296|P1|NOT COMPLETED|Overall Study||24
39966|NCT01822899|93295|P2|COMPLETED|Overall Study||340
39967|NCT01822899|93296|P1|COMPLETED|Overall Study||334
39968|NCT01822899|93295|P2|STARTED|Overall Study||358
39969|NCT01822899|93296|P1|STARTED|Overall Study||358
39970|NCT01822821|93306|P2|NOT COMPLETED|Overall Study||1
39971|NCT01822821|93307|P1|NOT COMPLETED|Overall Study||2
39972|NCT01822821|93306|P2|COMPLETED|Overall Study||74
39973|NCT01822821|93307|P1|COMPLETED|Overall Study||73
39974|NCT01822821|93306|P2|STARTED|Overall Study||75
39975|NCT01822821|93307|P1|STARTED|Overall Study||75
39976|NCT01822756|93336|P5|NOT COMPLETED|Overall Study||7
39977|NCT01822756|93337|P4|NOT COMPLETED|Overall Study||4
39978|NCT01822756|93338|P3|NOT COMPLETED|Overall Study||10
39979|NCT01822756|93339|P2|NOT COMPLETED|Overall Study||4
39980|NCT01822756|93340|P1|NOT COMPLETED|Overall Study||16
39981|NCT01822756|93336|P5|COMPLETED|Overall Study||1
39982|NCT01822756|93337|P4|COMPLETED|Overall Study||0
39983|NCT01822756|93338|P3|COMPLETED|Overall Study||0
39984|NCT01822756|93339|P2|COMPLETED|Overall Study||0
39985|NCT01822756|93340|P1|COMPLETED|Overall Study||0
39986|NCT01822756|93336|P5|Discontinued From the Study|Overall Study||7
39987|NCT01822756|93337|P4|Discontinued From the Study|Overall Study||4
39988|NCT01822756|93338|P3|Discontinued From the Study|Overall Study||10
39989|NCT01822756|93339|P2|Discontinued From the Study|Overall Study||4
39990|NCT01822756|93340|P1|Discontinued From the Study|Overall Study||16
39991|NCT01822756|93336|P5|STARTED|Overall Study||8
39992|NCT01822756|93337|P4|STARTED|Overall Study||4
39993|NCT01822756|93338|P3|STARTED|Overall Study||10
39994|NCT01822756|93339|P2|STARTED|Overall Study||4
39995|NCT01822756|93340|P1|STARTED|Overall Study||16
39996|NCT01822691|93382|P1|NOT COMPLETED|Overall Study||2
39997|NCT01822691|93382|P1|COMPLETED|Overall Study||13
39998|NCT01822691|93382|P1|STARTED|Overall Study||15
39999|NCT01822678|93393|P3|NOT COMPLETED|Overall Study||11
40000|NCT01822678|93394|P2|NOT COMPLETED|Overall Study||15
40001|NCT01822678|93395|P1|NOT COMPLETED|Overall Study||12
40002|NCT01822678|93393|P3|COMPLETED|Overall Study||29
40003|NCT01822678|93394|P2|COMPLETED|Overall Study||49
40004|NCT01822678|93395|P1|COMPLETED|Overall Study||45
40005|NCT01822678|93393|P3|Per Protocol Population|Overall Study||34
40006|NCT01822678|93394|P2|Per Protocol Population|Overall Study||52
40007|NCT01822678|93395|P1|Per Protocol Population|Overall Study||45
40008|NCT01822678|93393|P3|Intention-to-Treat Population (ITT)|Overall Study||40
40009|NCT01822678|93394|P2|Intention-to-Treat Population (ITT)|Overall Study|1 patient was excluded from the ITT population because he did not have post baseline efficacy data|63
40010|NCT01822678|93395|P1|Intention-to-Treat Population (ITT)|Overall Study||57
40011|NCT01822678|93393|P3|Safety Population|Overall Study||40
40012|NCT01822678|93394|P2|Safety Population|Overall Study||64
40013|NCT01822678|93395|P1|Safety Population|Overall Study||57
40014|NCT01822678|93393|P3|Treated|Overall Study||40
40015|NCT01822678|93394|P2|Treated|Overall Study||64
40016|NCT01822678|93395|P1|Treated|Overall Study||57
40017|NCT01822678|93393|P3|STARTED|Overall Study||40
40018|NCT01822678|93394|P2|STARTED|Overall Study||64
40019|NCT01822678|93395|P1|STARTED|Overall Study||57
40020|NCT01822665|93403|P1|NOT COMPLETED|Overall Study||8
40021|NCT01822665|93403|P1|COMPLETED|Overall Study||20
40022|NCT01822665|93403|P1|Received Paracetamol Tablet (1000 mg)|Overall Study||28
40023|NCT01822665|93403|P1|Received Ibuprofen Capsule (400 mg)|Overall Study|Two participants, each in period 3 and period 4 did not complete treatment for 'other reason'.|24
40024|NCT01822665|93403|P1|Received Placebo Tablet|Overall Study|5 participants did not complete; Period 2(1:other reason); Period 4(3:adverse event; 1:other reason)|23
40025|NCT01822665|93403|P1|Received Ibuprofen Tablet (400 mg)|Overall Study|5 participants did not complete; Period 3(2:adverse events;1:other reason); Period 4(2:other reason)|23
40026|NCT01822665|93403|P1|STARTED|Overall Study||28
40027|NCT01822574|93430|P3|NOT COMPLETED|Overall Study||0
40028|NCT01822574|93431|P2|NOT COMPLETED|Overall Study||0
40029|NCT01822574|93432|P1|NOT COMPLETED|Overall Study||0
40030|NCT01822574|93430|P3|COMPLETED|Overall Study||30
40031|NCT01822574|93431|P2|COMPLETED|Overall Study||30
40032|NCT01822574|93432|P1|COMPLETED|Overall Study||30
40033|NCT01822574|93430|P3|STARTED|Overall Study||30
40034|NCT01822574|93431|P2|STARTED|Overall Study||30
40035|NCT01822574|93432|P1|STARTED|Overall Study||30
40036|NCT01822548|93448|P2|NOT COMPLETED|Overall Study||0
40037|NCT01822548|93449|P1|NOT COMPLETED|Overall Study||0
40038|NCT01822548|93448|P2|COMPLETED|Overall Study||24
40039|NCT01822548|93449|P1|COMPLETED|Overall Study||40
40040|NCT01822548|93448|P2|Discontinued Intervention|Overall Study||5
40041|NCT01822548|93449|P1|Discontinued Intervention|Overall Study||0
40042|NCT01822548|93448|P2|STARTED|Overall Study||24
40043|NCT01822548|93449|P1|STARTED|Overall Study|Received allocated intervention n=38 Did not receive allocated intervention (only metformin) n=2|40
40044|NCT01822535|93459|P2|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
40045|NCT01822535|93460|P1|NOT COMPLETED|Visit 2 - Tetraplegia Only - Drug||1
40046|NCT01822535|93459|P2|COMPLETED|Visit 2 - Tetraplegia Only - Drug||0
40047|NCT01822535|93460|P1|COMPLETED|Visit 2 - Tetraplegia Only - Drug||10
40048|NCT01822535|93459|P2|STARTED|Visit 2 - Tetraplegia Only - Drug|Able-bodied subjects were not enrolled for a second visit.|0
40049|NCT01822535|93460|P1|STARTED|Visit 2 - Tetraplegia Only - Drug|These subjects were individuals who completed Visit 1 of testing.|11
40050|NCT01822535|93459|P2|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||2
40051|NCT01822535|93460|P1|NOT COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||6
40052|NCT01822535|93459|P2|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
40053|NCT01822535|93460|P1|COMPLETED|Visit 1 - Tetraplegia and Able-Bodied||11
40054|NCT01822535|93459|P2|STARTED|Visit 1 - Tetraplegia and Able-Bodied||13
40055|NCT01822535|93460|P1|STARTED|Visit 1 - Tetraplegia and Able-Bodied||17
40056|NCT01822301|93472|P1|NOT COMPLETED|Overall Study||0
40057|NCT01822301|93472|P1|COMPLETED|Overall Study||5
40058|NCT01822301|93472|P1|STARTED|Overall Study||5
40059|NCT01822223|93484|P2|NOT COMPLETED|Overall Study||1
40060|NCT01822223|93485|P1|NOT COMPLETED|Overall Study||0
40061|NCT01822223|93484|P2|COMPLETED|Overall Study||9
40062|NCT01822223|93485|P1|COMPLETED|Overall Study||10
40063|NCT01822223|93484|P2|STARTED|Overall Study||10
40064|NCT01822223|93485|P1|STARTED|Overall Study||10
40065|NCT01822197|93501|P1|NOT COMPLETED|Overall Study||0
40066|NCT01822197|93501|P1|COMPLETED|Overall Study||30
40067|NCT01822197|93501|P1|STARTED|Overall Study||30
40068|NCT01822119|93507|P1|NOT COMPLETED|Overall Study||0
40069|NCT01822119|93507|P1|COMPLETED|Overall Study||27
40070|NCT01822119|93507|P1|STARTED|Overall Study||27
40071|NCT01821963|93530|P1|NOT COMPLETED|Overall Study||1
40072|NCT01821963|93530|P1|COMPLETED|Overall Study||0
40073|NCT01821963|93530|P1|STARTED|Overall Study||1
40074|NCT01821937|93536|P2|NOT COMPLETED|Overall Study||3
40075|NCT01821937|93537|P1|NOT COMPLETED|Overall Study||0
40076|NCT01821937|93536|P2|COMPLETED|Overall Study|2 patients discontinued during Single dose period,1 Patient discontinued during Multiple dose period|12
40077|NCT01821937|93537|P1|COMPLETED|Overall Study||10
40078|NCT01821937|93536|P2|STARTED|Overall Study||15
40079|NCT01821937|93537|P1|STARTED|Overall Study||10
40080|NCT01821859|93555|P1|NOT COMPLETED|Overall Study||5
40081|NCT01821859|93555|P1|COMPLETED|Overall Study||0
40082|NCT01821859|93555|P1|STARTED|Overall Study||5
40083|NCT01821807|93561|P2|NOT COMPLETED|Overall Study||1
40084|NCT01821807|93562|P1|NOT COMPLETED|Overall Study||3
40085|NCT01821807|93561|P2|COMPLETED|Overall Study||109
40086|NCT01821807|93562|P1|COMPLETED|Overall Study||147
40087|NCT01821807|93561|P2|STARTED|Overall Study||110
40088|NCT01821807|93562|P1|STARTED|Overall Study||150
40089|NCT01821534|93570|P1|NOT COMPLETED|Overall Study||0
40090|NCT01821534|93570|P1|COMPLETED|Overall Study||201
40091|NCT01821534|93570|P1|STARTED|Overall Study||201
40092|NCT01821417|93579|P2|NOT COMPLETED|Overall Study||0
40093|NCT01821417|93580|P1|NOT COMPLETED|Overall Study||0
40094|NCT01821417|93579|P2|COMPLETED|Overall Study||31
40095|NCT01821417|93580|P1|COMPLETED|Overall Study||37
40096|NCT01821417|93579|P2|STARTED|Overall Study||31
40097|NCT01821417|93580|P1|STARTED|Overall Study||37
40098|NCT01821378|93593|P3|NOT COMPLETED|Overall Study||42
40099|NCT01821378|93594|P2|NOT COMPLETED|Overall Study||54
40100|NCT01821378|93595|P1|NOT COMPLETED|Overall Study||27
40101|NCT01821378|93593|P3|COMPLETED|Overall Study||70
40102|NCT01821378|93594|P2|COMPLETED|Overall Study||145
40103|NCT01821378|93595|P1|COMPLETED|Overall Study||74
40104|NCT01821378|93593|P3|STARTED|Overall Study||112
40105|NCT01821378|93594|P2|STARTED|Overall Study||199
40106|NCT01821378|93595|P1|STARTED|Overall Study||101
40107|NCT01821352|93633|P2|NOT COMPLETED|Overall Study||0
40108|NCT01821352|93634|P1|NOT COMPLETED|Overall Study||0
40109|NCT01821352|93633|P2|COMPLETED|Overall Study||25
40110|NCT01821352|93634|P1|COMPLETED|Overall Study||28
40111|NCT01821352|93633|P2|STARTED|Overall Study||25
40112|NCT01821352|93634|P1|STARTED|Overall Study||28
40113|NCT01821326|93644|P1|NOT COMPLETED|Overall Study||0
40114|NCT01821326|93644|P1|COMPLETED|Overall Study||339
40115|NCT01821326|93644|P1|STARTED|Overall Study||339
40116|NCT01821118|93650|P2|NOT COMPLETED|Overall Study||1
40117|NCT01821118|93651|P1|NOT COMPLETED|Overall Study||0
40118|NCT01821118|93650|P2|COMPLETED|Overall Study||11
40119|NCT01821118|93651|P1|COMPLETED|Overall Study||24
40120|NCT01821118|93650|P2|STARTED|Overall Study||12
40121|NCT01821118|93651|P1|STARTED|Overall Study||24
40122|NCT01821105|93684|P1|NOT COMPLETED|Overall Study||0
40123|NCT01821105|93684|P1|COMPLETED|Overall Study||21
40124|NCT01821105|93684|P1|STARTED|Overall Study||21
40125|NCT01820585|93694|P4|NOT COMPLETED|Overall Study||49
40126|NCT01820585|93695|P3|NOT COMPLETED|Overall Study||34
40127|NCT01820585|93696|P2|NOT COMPLETED|Overall Study||32
40128|NCT01820585|93697|P1|NOT COMPLETED|Overall Study||27
40129|NCT01820585|93694|P4|COMPLETED|Overall Study||83
40130|NCT01820585|93695|P3|COMPLETED|Overall Study||101
40131|NCT01820585|93696|P2|COMPLETED|Overall Study||98
40132|NCT01820585|93697|P1|COMPLETED|Overall Study||104
40133|NCT01820585|93694|P4|Completed Maintenance Period|Overall Study||84
40134|NCT01820585|93695|P3|Completed Maintenance Period|Overall Study||101
40135|NCT01820585|93696|P2|Completed Maintenance Period|Overall Study||98
40136|NCT01820585|93697|P1|Completed Maintenance Period|Overall Study||105
40137|NCT01820585|93694|P4|Entered Maintenance Period|Overall Study||123
40138|NCT01820585|93695|P3|Entered Maintenance Period|Overall Study||131
40139|NCT01820585|93696|P2|Entered Maintenance Period|Overall Study||124
40140|NCT01820585|93697|P1|Entered Maintenance Period|Overall Study||128
40141|NCT01820585|93694|P4|Completed Titration Period|Overall Study||126
40142|NCT01820585|93695|P3|Completed Titration Period|Overall Study||131
40143|NCT01820585|93696|P2|Completed Titration Period|Overall Study||125
40144|NCT01820585|93697|P1|Completed Titration Period|Overall Study||128
40145|NCT01820585|93694|P4|Full Analysis Set|Overall Study||129
40146|NCT01820585|93695|P3|Full Analysis Set|Overall Study||135
40147|NCT01820585|93696|P2|Full Analysis Set|Overall Study||130
40148|NCT01820585|93697|P1|Full Analysis Set|Overall Study||131
40149|NCT01820585|93694|P4|Randomized and Treated|Overall Study||132
40150|NCT01820585|93695|P3|Randomized and Treated|Overall Study||135
40151|NCT01820585|93696|P2|Randomized and Treated|Overall Study||130
40152|NCT01820585|93697|P1|Randomized and Treated|Overall Study||131
40153|NCT01820585|93694|P4|STARTED|Overall Study||132
40154|NCT01820585|93695|P3|STARTED|Overall Study||135
40155|NCT01820585|93696|P2|STARTED|Overall Study||130
40156|NCT01820585|93697|P1|STARTED|Overall Study||131
40157|NCT01820559|93710|P3|NOT COMPLETED|Overall Study||29
40158|NCT01820559|93711|P2|NOT COMPLETED|Overall Study||13
40159|NCT01820559|93712|P1|NOT COMPLETED|Overall Study||14
40160|NCT01820559|93710|P3|COMPLETED|Overall Study||110
40161|NCT01820559|93711|P2|COMPLETED|Overall Study||122
40162|NCT01820559|93712|P1|COMPLETED|Overall Study||122
40163|NCT01820559|93710|P3|Completed Maintenance Period|Overall Study||110
40164|NCT01820559|93711|P2|Completed Maintenance Period|Overall Study||123
40165|NCT01820559|93712|P1|Completed Maintenance Period|Overall Study||122
40166|NCT01820559|93710|P3|Entered Maintenance Period|Overall Study||129
40167|NCT01820559|93711|P2|Entered Maintenance Period|Overall Study||133
40168|NCT01820559|93712|P1|Entered Maintenance Period|Overall Study||129
40169|NCT01820559|93710|P3|Completed Tutration Period|Overall Study||131
40170|NCT01820559|93711|P2|Completed Tutration Period|Overall Study||134
40171|NCT01820559|93712|P1|Completed Tutration Period|Overall Study||130
40172|NCT01820559|93710|P3|Randomized and Treated|Overall Study||139
40173|NCT01820559|93711|P2|Randomized and Treated|Overall Study||135
40174|NCT01820559|93712|P1|Randomized and Treated|Overall Study||136
40175|NCT01820559|93710|P3|STARTED|Overall Study||139
40176|NCT01820559|93711|P2|STARTED|Overall Study||135
40177|NCT01820559|93712|P1|STARTED|Overall Study||136
40178|NCT01820416|93723|P3|NOT COMPLETED|Overall Study||0
40179|NCT01820416|93724|P2|NOT COMPLETED|Overall Study||2
40180|NCT01820416|93725|P1|NOT COMPLETED|Overall Study||3
40181|NCT01820416|93723|P3|COMPLETED|Overall Study||11
40182|NCT01820416|93724|P2|COMPLETED|Overall Study||10
40183|NCT01820416|93725|P1|COMPLETED|Overall Study||9
40184|NCT01820416|93723|P3|STARTED|Overall Study||11
40185|NCT01820416|93724|P2|STARTED|Overall Study||12
40186|NCT01820416|93725|P1|STARTED|Overall Study||12
40187|NCT01820364|93733|P2|NOT COMPLETED|Part II: LGX818 + MEK162||1
40188|NCT01820364|93734|P1|NOT COMPLETED|Part II: LGX818 + MEK162||0
40189|NCT01820364|93733|P2|COMPLETED|Part II: LGX818 + MEK162||0
40190|NCT01820364|93734|P1|COMPLETED|Part II: LGX818 + MEK162||0
40191|NCT01820364|93733|P2|STARTED|Part II: LGX818 + MEK162||1
40192|NCT01820364|93734|P1|STARTED|Part II: LGX818 + MEK162||0
40193|NCT01820364|93733|P2|NOT COMPLETED|Part I: LGX818||0
40194|NCT01820364|93734|P1|NOT COMPLETED|Part I: LGX818||14
40195|NCT01820364|93733|P2|COMPLETED|Part I: LGX818||0
40196|NCT01820364|93734|P1|COMPLETED|Part I: LGX818||1
40197|NCT01820364|93733|P2|STARTED|Part I: LGX818||0
40198|NCT01820364|93734|P1|STARTED|Part I: LGX818||15
40199|NCT01819935|93748|P2|NOT COMPLETED|Overall Study||0
40200|NCT01819935|93749|P1|NOT COMPLETED|Overall Study||0
40201|NCT01819935|93748|P2|COMPLETED|Overall Study||4943
40202|NCT01819935|93749|P1|COMPLETED|Overall Study||328
40203|NCT01819935|93748|P2|STARTED|Overall Study||4943
40204|NCT01819935|93749|P1|STARTED|Overall Study||328
40205|NCT01819922|93769|P2|NOT COMPLETED|Second Intervention Period (1 Day)||0
40206|NCT01819922|93770|P1|NOT COMPLETED|Second Intervention Period (1 Day)||0
40207|NCT01819922|93769|P2|COMPLETED|Second Intervention Period (1 Day)||6
40208|NCT01819922|93770|P1|COMPLETED|Second Intervention Period (1 Day)||6
40209|NCT01819922|93769|P2|STARTED|Second Intervention Period (1 Day)||6
40210|NCT01819922|93770|P1|STARTED|Second Intervention Period (1 Day)||6
40211|NCT01819922|93769|P2|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
40212|NCT01819922|93770|P1|NOT COMPLETED|Washout Period (at Least 7-10 Days)||0
40213|NCT01819922|93769|P2|COMPLETED|Washout Period (at Least 7-10 Days)||6
40214|NCT01819922|93770|P1|COMPLETED|Washout Period (at Least 7-10 Days)||6
40215|NCT01819922|93769|P2|STARTED|Washout Period (at Least 7-10 Days)||6
40216|NCT01819922|93770|P1|STARTED|Washout Period (at Least 7-10 Days)||6
40217|NCT01819922|93769|P2|NOT COMPLETED|First Intervention Period (1 Day)||0
40218|NCT01819922|93770|P1|NOT COMPLETED|First Intervention Period (1 Day)||0
40219|NCT01819922|93769|P2|COMPLETED|First Intervention Period (1 Day)||6
40220|NCT01819922|93770|P1|COMPLETED|First Intervention Period (1 Day)||6
40221|NCT01819922|93769|P2|STARTED|First Intervention Period (1 Day)||6
40222|NCT01819922|93770|P1|STARTED|First Intervention Period (1 Day)||6
40223|NCT01819844|93854|P1|NOT COMPLETED|Overall Study||0
40224|NCT01819844|93854|P1|COMPLETED|Overall Study||12
40225|NCT01819844|93854|P1|STARTED|Overall Study||12
40226|NCT01819415|93871|P4|NOT COMPLETED|Overall Study||2
40227|NCT01819415|93872|P3|NOT COMPLETED|Overall Study||1
40228|NCT01819415|93873|P2|NOT COMPLETED|Overall Study||4
40229|NCT01819415|93874|P1|NOT COMPLETED|Overall Study||3
40230|NCT01819415|93871|P4|COMPLETED|Overall Study||8
40231|NCT01819415|93872|P3|COMPLETED|Overall Study||9
40232|NCT01819415|93873|P2|COMPLETED|Overall Study||6
40233|NCT01819415|93874|P1|COMPLETED|Overall Study||7
40234|NCT01819415|93871|P4|STARTED|Overall Study||10
40235|NCT01819415|93872|P3|STARTED|Overall Study||10
40236|NCT01819415|93873|P2|STARTED|Overall Study||10
40237|NCT01819415|93874|P1|STARTED|Overall Study||10
40238|NCT01819311|93886|P2|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
40239|NCT01819311|93887|P1|NOT COMPLETED|Follow-up Phase (8 Weeks)||7
40240|NCT01819311|93886|P2|COMPLETED|Follow-up Phase (8 Weeks)||23
40241|NCT01819311|93887|P1|COMPLETED|Follow-up Phase (8 Weeks)||24
40242|NCT01819311|93886|P2|STARTED|Follow-up Phase (8 Weeks)||30
40243|NCT01819311|93887|P1|STARTED|Follow-up Phase (8 Weeks)||31
40244|NCT01819311|93886|P2|NOT COMPLETED|Treatment Phase (4 Weeks)||1
40245|NCT01819311|93887|P1|NOT COMPLETED|Treatment Phase (4 Weeks)||2
40246|NCT01819311|93886|P2|COMPLETED|Treatment Phase (4 Weeks)||30
40247|NCT01819311|93887|P1|COMPLETED|Treatment Phase (4 Weeks)||31
40248|NCT01819311|93886|P2|STARTED|Treatment Phase (4 Weeks)||31
40249|NCT01819311|93887|P1|STARTED|Treatment Phase (4 Weeks)||33
40250|NCT01819272|93909|P6|NOT COMPLETED|Overall Study||7
40251|NCT01819272|93910|P5|NOT COMPLETED|Overall Study||4
40252|NCT01819272|93911|P4|NOT COMPLETED|Overall Study||5
40253|NCT01819272|93912|P3|NOT COMPLETED|Overall Study||3
40254|NCT01819272|93913|P2|NOT COMPLETED|Overall Study||3
40255|NCT01819272|93914|P1|NOT COMPLETED|Overall Study||6
40256|NCT01819272|93909|P6|COMPLETED|Overall Study||33
40257|NCT01819272|93910|P5|COMPLETED|Overall Study||36
40258|NCT01819272|93911|P4|COMPLETED|Overall Study||35
40259|NCT01819272|93912|P3|COMPLETED|Overall Study||37
40260|NCT01819272|93913|P2|COMPLETED|Overall Study||36
40261|NCT01819272|93914|P1|COMPLETED|Overall Study||35
40262|NCT01819272|93909|P6|STARTED|Overall Study||40
40263|NCT01819272|93910|P5|STARTED|Overall Study||40
40264|NCT01819272|93911|P4|STARTED|Overall Study||40
40265|NCT01819272|93912|P3|STARTED|Overall Study||40
40266|NCT01819272|93913|P2|STARTED|Overall Study||39
40267|NCT01819272|93914|P1|STARTED|Overall Study||41
40268|NCT01819194|93940|P1|NOT COMPLETED|Overall Study||2
40269|NCT01819194|93940|P1|COMPLETED|Overall Study||60
40270|NCT01819194|93940|P1|STARTED|Overall Study||62
40271|NCT01818752|93947|P2|NOT COMPLETED|Overall Study||198
40272|NCT01818752|93948|P1|NOT COMPLETED|Overall Study||187
40273|NCT01818752|93947|P2|COMPLETED|Overall Study|Completed treatment|280
40274|NCT01818752|93948|P1|COMPLETED|Overall Study|Completed treatment|290
40275|NCT01818752|93947|P2|Received Treatment|Overall Study||474
40276|NCT01818752|93948|P1|Received Treatment|Overall Study||470
40277|NCT01818752|93947|P2|STARTED|Overall Study||478
40278|NCT01818752|93948|P1|STARTED|Overall Study||477
40279|NCT01818700|93966|P1|NOT COMPLETED|Overall Study||104
40280|NCT01818700|93966|P1|COMPLETED|Overall Study|104 subjects dropped out this study prior to study completion.|141
40281|NCT01818700|93966|P1|PP Set|Overall Study|105 subjects excluded from PP set due to various reasons.|105
40282|NCT01818700|93966|P1|FAS Set|Overall Study|31 subjects excluded from FAS due to no assessment of primary efficacy(26) and IC/EC violation(5).|210
40283|NCT01818700|93966|P1|Safety Set|Overall Study|4 subjects were not study drug administered.|241
40284|NCT01818700|93966|P1|STARTED|Overall Study|The No. of enrolled patients|245
40285|NCT01818596|93977|P2|NOT COMPLETED|Overall Study||6
40286|NCT01818596|93978|P1|NOT COMPLETED|Overall Study||246
40287|NCT01818596|93977|P2|COMPLETED|Overall Study||0
40288|NCT01818596|93978|P1|COMPLETED|Overall Study||0
40289|NCT01818596|93977|P2|STARTED|Overall Study||6
40290|NCT01818596|93978|P1|STARTED|Overall Study||246
40291|NCT01818414|94011|P2|NOT COMPLETED|Overall Study||0
40292|NCT01818414|94012|P1|NOT COMPLETED|Overall Study||0
40293|NCT01818414|94011|P2|COMPLETED|Overall Study||15
40294|NCT01818414|94012|P1|COMPLETED|Overall Study||14
40295|NCT01818414|94011|P2|STARTED|Overall Study||15
40296|NCT01818414|94012|P1|STARTED|Overall Study||14
40297|NCT01818336|94026|P2|NOT COMPLETED|Overall Study||12
40298|NCT01818336|94027|P1|NOT COMPLETED|Overall Study||0
40299|NCT01818336|94026|P2|COMPLETED|Overall Study||47
40300|NCT01818336|94027|P1|COMPLETED|Overall Study||391
40301|NCT01818336|94026|P2|STARTED|Overall Study||59
40302|NCT01818336|94027|P1|STARTED|Overall Study||391
40303|NCT01818141|94035|P2|NOT COMPLETED|Overall Study||3
40304|NCT01818141|94036|P1|NOT COMPLETED|Overall Study||3
40305|NCT01818141|94035|P2|COMPLETED|Overall Study||13
40306|NCT01818141|94036|P1|COMPLETED|Overall Study||15
40307|NCT01818141|94035|P2|STARTED|Overall Study||16
40308|NCT01818141|94036|P1|STARTED|Overall Study||18
40309|NCT01817907|94046|P2|NOT COMPLETED|Second Intervention||0
40310|NCT01817907|94047|P1|NOT COMPLETED|Second Intervention||0
40311|NCT01817907|94046|P2|COMPLETED|Second Intervention||7
40312|NCT01817907|94047|P1|COMPLETED|Second Intervention||8
40313|NCT01817907|94046|P2|STARTED|Second Intervention||7
40314|NCT01817907|94047|P1|STARTED|Second Intervention||8
40315|NCT01817907|94046|P2|NOT COMPLETED|Washout Period||0
40316|NCT01817907|94047|P1|NOT COMPLETED|Washout Period||0
40317|NCT01817907|94046|P2|COMPLETED|Washout Period||7
40318|NCT01817907|94047|P1|COMPLETED|Washout Period||8
40319|NCT01817907|94046|P2|STARTED|Washout Period||7
40320|NCT01817907|94047|P1|STARTED|Washout Period||8
40321|NCT01817907|94046|P2|NOT COMPLETED|First Intervention||0
40322|NCT01817907|94047|P1|NOT COMPLETED|First Intervention||0
40323|NCT01817907|94046|P2|COMPLETED|First Intervention||7
40324|NCT01817907|94047|P1|COMPLETED|First Intervention||8
40325|NCT01817907|94046|P2|STARTED|First Intervention||7
40326|NCT01817907|94047|P1|STARTED|First Intervention||8
40327|NCT01817855|94059|P4|NOT COMPLETED|Overall Study||0
40328|NCT01817855|94060|P3|NOT COMPLETED|Overall Study||2
40329|NCT01817855|94061|P2|NOT COMPLETED|Overall Study||2
40330|NCT01817855|94062|P1|NOT COMPLETED|Overall Study||0
40331|NCT01817855|94059|P4|COMPLETED|Overall Study||5
40332|NCT01817855|94060|P3|COMPLETED|Overall Study||9
40333|NCT01817855|94061|P2|COMPLETED|Overall Study||6
40334|NCT01817855|94062|P1|COMPLETED|Overall Study||23
40335|NCT01817855|94059|P4|STARTED|Overall Study||5
40336|NCT01817855|94060|P3|STARTED|Overall Study||11
40337|NCT01817855|94061|P2|STARTED|Overall Study||8
40338|NCT01817855|94062|P1|STARTED|Overall Study||23
40339|NCT01817790|94092|P2|NOT COMPLETED|Overall Study||8
40340|NCT01817790|94093|P1|NOT COMPLETED|Overall Study||4
40341|NCT01817790|94092|P2|COMPLETED|Overall Study||304
40342|NCT01817790|94093|P1|COMPLETED|Overall Study||310
40343|NCT01817790|94092|P2|STARTED|Overall Study||312
40344|NCT01817790|94093|P1|STARTED|Overall Study||314
40345|NCT01817777|94137|P3|NOT COMPLETED|Interventional Phase (20 Weeks)||5
40346|NCT01817777|94138|P2|NOT COMPLETED|Interventional Phase (20 Weeks)||5
40347|NCT01817777|94139|P1|NOT COMPLETED|Interventional Phase (20 Weeks)||0
40348|NCT01817777|94137|P3|COMPLETED|Interventional Phase (20 Weeks)||10
40349|NCT01817777|94138|P2|COMPLETED|Interventional Phase (20 Weeks)||11
40350|NCT01817777|94139|P1|COMPLETED|Interventional Phase (20 Weeks)||0
40351|NCT01817777|94137|P3|STARTED|Interventional Phase (20 Weeks)||15
40352|NCT01817777|94138|P2|STARTED|Interventional Phase (20 Weeks)||16
40353|NCT01817777|94139|P1|STARTED|Interventional Phase (20 Weeks)||0
40354|NCT01817777|94137|P3|NOT COMPLETED|Observational Phase (8 Weeks)||0
40355|NCT01817777|94138|P2|NOT COMPLETED|Observational Phase (8 Weeks)||0
40356|NCT01817777|94139|P1|NOT COMPLETED|Observational Phase (8 Weeks)||5
40357|NCT01817777|94137|P3|COMPLETED|Observational Phase (8 Weeks)||0
40358|NCT01817777|94138|P2|COMPLETED|Observational Phase (8 Weeks)||0
40359|NCT01817777|94139|P1|COMPLETED|Observational Phase (8 Weeks)||31
40360|NCT01817777|94137|P3|STARTED|Observational Phase (8 Weeks)||0
40361|NCT01817777|94138|P2|STARTED|Observational Phase (8 Weeks)||0
40362|NCT01817777|94139|P1|STARTED|Observational Phase (8 Weeks)||36
40363|NCT01817764|94163|P2|NOT COMPLETED|Overall Study||38
40364|NCT01817764|94164|P1|NOT COMPLETED|Overall Study||34
40365|NCT01817764|94163|P2|COMPLETED|Overall Study||315
40366|NCT01817764|94164|P1|COMPLETED|Overall Study||319
40367|NCT01817764|94163|P2|STARTED|Overall Study||353
40368|NCT01817764|94164|P1|STARTED|Overall Study||353
40369|NCT01817725|94172|P1|NOT COMPLETED|Overall Study||1
40370|NCT01817725|94172|P1|COMPLETED|Overall Study||19
40371|NCT01817725|94172|P1|STARTED|Overall Study||20
40372|NCT01816776|94179|P2|NOT COMPLETED|Overall Study||8
40373|NCT01816776|94180|P1|NOT COMPLETED|Overall Study||13
40374|NCT01816776|94179|P2|COMPLETED|Overall Study||70
40375|NCT01816776|94180|P1|COMPLETED|Overall Study||60
40376|NCT01816776|94179|P2|6 Month Primary Effectiveness Assessed|Overall Study||73
40377|NCT01816776|94180|P1|6 Month Primary Effectiveness Assessed|Overall Study||68
40378|NCT01816776|94179|P2|STARTED|Overall Study||78
40379|NCT01816776|94180|P1|STARTED|Overall Study||73
40380|NCT01816685|94202|P2|NOT COMPLETED|Overall Study||11
40381|NCT01816685|94203|P1|NOT COMPLETED|Overall Study||10
40382|NCT01816685|94202|P2|COMPLETED|Overall Study||56
40383|NCT01816685|94203|P1|COMPLETED|Overall Study||58
40384|NCT01816685|94202|P2|STARTED|Overall Study||67
40385|NCT01816685|94203|P1|STARTED|Overall Study||68
40386|NCT01816477|94213|P2|NOT COMPLETED|Overall Study||1
40387|NCT01816477|94214|P1|NOT COMPLETED|Overall Study||16
40388|NCT01816477|94213|P2|COMPLETED|Overall Study||41
40389|NCT01816477|94214|P1|COMPLETED|Overall Study||27
40390|NCT01816477|94213|P2|STARTED|Overall Study||42
40391|NCT01816477|94214|P1|STARTED|Overall Study||43
40392|NCT01816451|94227|P3|NOT COMPLETED|Overall Study||0
40393|NCT01816451|94228|P2|NOT COMPLETED|Overall Study||0
40394|NCT01816451|94229|P1|NOT COMPLETED|Overall Study||0
40395|NCT01816451|94227|P3|COMPLETED|Overall Study||8
40396|NCT01816451|94228|P2|COMPLETED|Overall Study||11
40397|NCT01816451|94229|P1|COMPLETED|Overall Study||13
40398|NCT01816451|94227|P3|STARTED|Overall Study||8
40399|NCT01816451|94228|P2|STARTED|Overall Study||11
40400|NCT01816451|94229|P1|STARTED|Overall Study||13
40401|NCT01816295|94268|P2|NOT COMPLETED|OLE Phase||56
40402|NCT01816295|94269|P1|NOT COMPLETED|OLE Phase||53
40403|NCT01816295|94268|P2|COMPLETED|OLE Phase||227
40404|NCT01816295|94269|P1|COMPLETED|OLE Phase||222
40405|NCT01816295|94268|P2|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|283
40406|NCT01816295|94269|P1|STARTED|OLE Phase|Participants who completed the DBP and still met eligibility criteria had option to enroll in OLE.|275
40407|NCT01816295|94268|P2|NOT COMPLETED|Double Blind Phase||56
40408|NCT01816295|94269|P1|NOT COMPLETED|Double Blind Phase||63
40409|NCT01816295|94268|P2|COMPLETED|Double Blind Phase||302
40410|NCT01816295|94269|P1|COMPLETED|Double Blind Phase||294
40411|NCT01816295|94268|P2|Received Study Drug|Double Blind Phase||354
40412|NCT01816295|94269|P1|Received Study Drug|Double Blind Phase||356
40413|NCT01816295|94268|P2|STARTED|Double Blind Phase||358
40414|NCT01816295|94269|P1|STARTED|Double Blind Phase||357
40415|NCT01816243|94284|P1|NOT COMPLETED|Overall Study||12
40416|NCT01816243|94284|P1|COMPLETED|Overall Study||27
40417|NCT01816243|94284|P1|STARTED|Overall Study||39
40418|NCT01816048|94291|P1|NOT COMPLETED|Overall Study||6
40419|NCT01816048|94291|P1|COMPLETED|Overall Study||2
40420|NCT01816048|94291|P1|STARTED|Overall Study||8
40421|NCT01815918|94306|P2|NOT COMPLETED|Overall Study||19
40422|NCT01815918|94307|P1|NOT COMPLETED|Overall Study||18
40423|NCT01815918|94306|P2|COMPLETED|Overall Study||11
40424|NCT01815918|94307|P1|COMPLETED|Overall Study||12
40425|NCT01815918|94306|P2|STARTED|Overall Study||30
40426|NCT01815918|94307|P1|STARTED|Overall Study||30
40427|NCT01815840|94323|P2|NOT COMPLETED|Overall Study||113
40428|NCT01815840|94324|P1|NOT COMPLETED|Overall Study||116
40429|NCT01815840|94323|P2|COMPLETED|Overall Study||0
40430|NCT01815840|94324|P1|COMPLETED|Overall Study||0
40431|NCT01815840|94323|P2|STARTED|Overall Study||113
40432|NCT01815840|94324|P1|STARTED|Overall Study||116
40433|NCT01815736|94354|P2|NOT COMPLETED|Overall Study||478
40434|NCT01815736|94355|P1|NOT COMPLETED|Overall Study||961
40435|NCT01815736|94354|P2|COMPLETED|Overall Study||2
40436|NCT01815736|94355|P1|COMPLETED|Overall Study||2
40437|NCT01815736|94354|P2|STARTED|Overall Study||480
40438|NCT01815736|94355|P1|STARTED|Overall Study||963
40439|NCT01815671|94371|P2|NOT COMPLETED|Overall Study||0
40440|NCT01815671|94372|P1|NOT COMPLETED|Overall Study||0
40441|NCT01815671|94371|P2|COMPLETED|Overall Study||85
40442|NCT01815671|94372|P1|COMPLETED|Overall Study||88
40443|NCT01815671|94371|P2|STARTED|Overall Study||85
40444|NCT01815671|94372|P1|STARTED|Overall Study||88
40445|NCT01815645|94384|P2|NOT COMPLETED|Overall Study||0
40446|NCT01815645|94385|P1|NOT COMPLETED|Overall Study||0
40447|NCT01815645|94384|P2|COMPLETED|Overall Study||33
40448|NCT01815645|94385|P1|COMPLETED|Overall Study||32
40449|NCT01815645|94384|P2|STARTED|Overall Study||33
40450|NCT01815645|94385|P1|STARTED|Overall Study||32
40451|NCT01815099|94401|P1|NOT COMPLETED|Overall Study||2
40452|NCT01815099|94401|P1|COMPLETED|Overall Study||2
40453|NCT01815099|94401|P1|Began rTMS Treatment|Overall Study||3
40454|NCT01815099|94401|P1|STARTED|Overall Study||4
40455|NCT01815008|94406|P1|NOT COMPLETED|Overall Study||4
40456|NCT01815008|94406|P1|COMPLETED|Overall Study|transcriptomic data was available on 9 participants only|15
40457|NCT01815008|94406|P1|STARTED|Overall Study|Had difficulty in completing enrollment|19
40458|NCT01814878|94415|P2|NOT COMPLETED|Overall Study||30
40459|NCT01814878|94416|P1|NOT COMPLETED|Overall Study||46
40460|NCT01814878|94415|P2|COMPLETED|Overall Study||128
40461|NCT01814878|94416|P1|COMPLETED|Overall Study||116
40462|NCT01814878|94415|P2|STARTED|Overall Study||158
40463|NCT01814878|94416|P1|STARTED|Overall Study||162
40464|NCT01814800|94436|P1|NOT COMPLETED|Overall Study||5
40465|NCT01814800|94436|P1|COMPLETED|Overall Study||54
40466|NCT01814800|94436|P1|STARTED|Overall Study||59
40467|NCT01814787|94475|P2|NOT COMPLETED|Overall Study||0
40468|NCT01814787|94476|P1|NOT COMPLETED|Overall Study||0
40469|NCT01814787|94475|P2|COMPLETED|Overall Study||684
40470|NCT01814787|94476|P1|COMPLETED|Overall Study||685
40471|NCT01814787|94475|P2|STARTED|Overall Study||684
40472|NCT01814787|94476|P1|STARTED|Overall Study||685
40473|NCT01814774|94482|P1|NOT COMPLETED|Overall Study||0
40474|NCT01814774|94482|P1|COMPLETED|Overall Study||48
40475|NCT01814774|94482|P1|STARTED|Overall Study||48
40476|NCT01814761|94496|P2|NOT COMPLETED|Overall Study||30
40477|NCT01814761|94497|P1|NOT COMPLETED|Overall Study||8
40478|NCT01814761|94496|P2|COMPLETED|Overall Study||240
40479|NCT01814761|94497|P1|COMPLETED|Overall Study||34
40480|NCT01814761|94496|P2|STARTED|Overall Study||270
40481|NCT01814761|94497|P1|STARTED|Overall Study||42
40482|NCT01814748|94511|P2|NOT COMPLETED|Overall Study||7
40483|NCT01814748|94512|P1|NOT COMPLETED|Overall Study||8
40484|NCT01814748|94511|P2|COMPLETED|Overall Study||94
40485|NCT01814748|94512|P1|COMPLETED|Overall Study||94
40486|NCT01814748|94511|P2|STARTED|Overall Study||101
40487|NCT01814748|94512|P1|STARTED|Overall Study||102
40488|NCT01814722|94535|P3|NOT COMPLETED|Overall Study||0
40489|NCT01814722|94536|P2|NOT COMPLETED|Overall Study||0
40490|NCT01814722|94537|P1|NOT COMPLETED|Overall Study||0
40491|NCT01814722|94535|P3|COMPLETED|Overall Study||6
40492|NCT01814722|94536|P2|COMPLETED|Overall Study||21
40493|NCT01814722|94537|P1|COMPLETED|Overall Study||36
40494|NCT01814722|94535|P3|STARTED|Overall Study||6
40495|NCT01814722|94536|P2|STARTED|Overall Study||21
40496|NCT01814722|94537|P1|STARTED|Overall Study||36
40497|NCT01814696|94556|P2|NOT COMPLETED|Overall Study||0
40498|NCT01814696|94557|P1|NOT COMPLETED|Overall Study||2
40499|NCT01814696|94556|P2|COMPLETED|Overall Study||11
40500|NCT01814696|94557|P1|COMPLETED|Overall Study||13
40501|NCT01814696|94556|P2|STARTED|Overall Study||11
40502|NCT01814696|94557|P1|STARTED|Overall Study||15
40503|NCT01814670|94575|P1|NOT COMPLETED|Overall Study||12
40504|NCT01814670|94575|P1|COMPLETED|Overall Study||173
40505|NCT01814670|94575|P1|STARTED|Overall Study||185
40506|NCT01814553|94585|P2|NOT COMPLETED|Overall Study||22
40507|NCT01814553|94586|P1|NOT COMPLETED|Overall Study||18
40508|NCT01814553|94585|P2|COMPLETED|Overall Study||0
40509|NCT01814553|94586|P1|COMPLETED|Overall Study||0
40510|NCT01814553|94585|P2|STARTED|Overall Study||22
40511|NCT01814553|94586|P1|STARTED|Overall Study||18
40512|NCT01814397|94600|P1|NOT COMPLETED|Overall Study||14
40513|NCT01814397|94600|P1|COMPLETED|Overall Study||36
40514|NCT01814397|94600|P1|3 Month Evaluation|Overall Study||43
40515|NCT01814397|94600|P1|STARTED|Overall Study||50
40516|NCT01814332|94609|P2|NOT COMPLETED|Overall Study||16
40517|NCT01814332|94610|P1|NOT COMPLETED|Overall Study||16
40518|NCT01814332|94609|P2|COMPLETED|Overall Study||49
40519|NCT01814332|94610|P1|COMPLETED|Overall Study||47
40520|NCT01814332|94609|P2|STARTED|Overall Study||65
40521|NCT01814332|94610|P1|STARTED|Overall Study||63
40522|NCT01814241|94622|P1|NOT COMPLETED|Overall Study||4
40523|NCT01814241|94622|P1|COMPLETED|Overall Study||16
40524|NCT01814241|94622|P1|STARTED|Overall Study||20
40525|NCT01814137|94632|P2|NOT COMPLETED|Overall Study||5
40526|NCT01814137|94633|P1|NOT COMPLETED|Overall Study||5
40527|NCT01814137|94632|P2|COMPLETED|Overall Study||15
40528|NCT01814137|94633|P1|COMPLETED|Overall Study||15
40529|NCT01814137|94632|P2|STARTED|Overall Study||20
40530|NCT01814137|94633|P1|STARTED|Overall Study||20
40531|NCT01814046|94649|P3|NOT COMPLETED|Retreatment||0
40532|NCT01814046|94650|P2|NOT COMPLETED|Retreatment||0
40533|NCT01814046|94651|P1|NOT COMPLETED|Retreatment||0
40534|NCT01814046|94649|P3|COMPLETED|Retreatment||3
40535|NCT01814046|94650|P2|COMPLETED|Retreatment||0
40536|NCT01814046|94651|P1|COMPLETED|Retreatment||0
40537|NCT01814046|94649|P3|STARTED|Retreatment||3
40538|NCT01814046|94650|P2|STARTED|Retreatment||0
40539|NCT01814046|94651|P1|STARTED|Retreatment||0
40540|NCT01814046|94649|P3|NOT COMPLETED|Drug Administration||0
40541|NCT01814046|94650|P2|NOT COMPLETED|Drug Administration||0
40542|NCT01814046|94651|P1|NOT COMPLETED|Drug Administration||1
40543|NCT01814046|94649|P3|COMPLETED|Drug Administration||0
40544|NCT01814046|94650|P2|COMPLETED|Drug Administration||2
40545|NCT01814046|94651|P1|COMPLETED|Drug Administration||21
40546|NCT01814046|94649|P3|STARTED|Drug Administration||0
40547|NCT01814046|94650|P2|STARTED|Drug Administration||2
40548|NCT01814046|94651|P1|STARTED|Drug Administration||22
40549|NCT01813890|94665|P3|NOT COMPLETED|Overall Study||6
40550|NCT01813890|94666|P2|NOT COMPLETED|Overall Study||4
40551|NCT01813890|94667|P1|NOT COMPLETED|Overall Study||9
40552|NCT01813890|94665|P3|COMPLETED|Overall Study||13
40553|NCT01813890|94666|P2|COMPLETED|Overall Study||17
40554|NCT01813890|94667|P1|COMPLETED|Overall Study||11
40555|NCT01813890|94665|P3|STARTED|Overall Study||19
40556|NCT01813890|94666|P2|STARTED|Overall Study||21
40557|NCT01813890|94667|P1|STARTED|Overall Study||20
40558|NCT01813721|94696|P1|NOT COMPLETED|Overall Study||64
40559|NCT01813721|94696|P1|COMPLETED|Overall Study||943
40560|NCT01813721|94696|P1|STARTED|Overall Study|Indicates number of participants enrolled|1007
40561|NCT01813110|94748|P2|NOT COMPLETED|Overall Study||1
40562|NCT01813110|94749|P1|NOT COMPLETED|Overall Study||0
40563|NCT01813110|94748|P2|COMPLETED|Overall Study||10
40564|NCT01813110|94749|P1|COMPLETED|Overall Study||10
40565|NCT01813110|94748|P2|STARTED|Overall Study||11
40566|NCT01813110|94749|P1|STARTED|Overall Study||10
40567|NCT01813019|94757|P2|NOT COMPLETED|Overall Study||6
40568|NCT01813019|94758|P1|NOT COMPLETED|Overall Study||7
40569|NCT01813019|94757|P2|COMPLETED|Overall Study||20
40570|NCT01813019|94758|P1|COMPLETED|Overall Study||17
40571|NCT01813019|94757|P2|STARTED|Overall Study||26
40572|NCT01813019|94758|P1|STARTED|Overall Study||24
40573|NCT01812837|94769|P3|NOT COMPLETED|Overall Study||0
40574|NCT01812837|94770|P2|NOT COMPLETED|Overall Study||1
40575|NCT01812837|94771|P1|NOT COMPLETED|Overall Study||2
40576|NCT01812837|94769|P3|COMPLETED|Overall Study||17
40577|NCT01812837|94770|P2|COMPLETED|Overall Study||16
40578|NCT01812837|94771|P1|COMPLETED|Overall Study||15
40579|NCT01812837|94769|P3|STARTED|Overall Study||17
40580|NCT01812837|94770|P2|STARTED|Overall Study||17
40581|NCT01812837|94771|P1|STARTED|Overall Study||17
40582|NCT01812707|94783|P4|NOT COMPLETED|Overall Study||2
40583|NCT01812707|94784|P3|NOT COMPLETED|Overall Study||0
40584|NCT01812707|94785|P2|NOT COMPLETED|Overall Study||0
40585|NCT01812707|94786|P1|NOT COMPLETED|Overall Study||2
40586|NCT01812707|94783|P4|COMPLETED|Overall Study||23
40587|NCT01812707|94784|P3|COMPLETED|Overall Study||25
40588|NCT01812707|94785|P2|COMPLETED|Overall Study||25
40589|NCT01812707|94786|P1|COMPLETED|Overall Study||23
40590|NCT01812707|94783|P4|Treated|Overall Study||25
40591|NCT01812707|94784|P3|Treated|Overall Study||25
40592|NCT01812707|94785|P2|Treated|Overall Study||25
40593|NCT01812707|94786|P1|Treated|Overall Study||25
40594|NCT01812707|94783|P4|STARTED|Overall Study||25
40595|NCT01812707|94784|P3|STARTED|Overall Study||25
40596|NCT01812707|94785|P2|STARTED|Overall Study||25
40597|NCT01812707|94786|P1|STARTED|Overall Study||25
40598|NCT01812681|94822|P2|NOT COMPLETED|Overall Study||0
40599|NCT01812681|94823|P1|NOT COMPLETED|Overall Study||3
40600|NCT01812681|94822|P2|COMPLETED|Overall Study||24
40601|NCT01812681|94823|P1|COMPLETED|Overall Study||57
40602|NCT01812681|94822|P2|STARTED|Overall Study||24
40603|NCT01812681|94823|P1|STARTED|Overall Study||60
40604|NCT01812655|94834|P3|NOT COMPLETED|Overall Study||0
40605|NCT01812655|94835|P2|NOT COMPLETED|Overall Study||1
40606|NCT01812655|94836|P1|NOT COMPLETED|Overall Study||1
40607|NCT01812655|94834|P3|COMPLETED|Overall Study||10
40608|NCT01812655|94835|P2|COMPLETED|Overall Study||10
40609|NCT01812655|94836|P1|COMPLETED|Overall Study||8
40610|NCT01812655|94834|P3|STARTED|Overall Study|Nurses provided their usual, standard care throughout the entire burn wound care.|10
40611|NCT01812655|94835|P2|STARTED|Overall Study|Passive Distraction-Patients watched a movie during their burn wound care.|11
40612|NCT01812655|94836|P1|STARTED|Overall Study|Virtual Reality-Patients used an interactive VR program during their burn wound care procedure.|9
40613|NCT01812473|94852|P2|NOT COMPLETED|Overall Study||0
40614|NCT01812473|94853|P1|NOT COMPLETED|Overall Study||0
40615|NCT01812473|94852|P2|COMPLETED|Overall Study||13
40616|NCT01812473|94853|P1|COMPLETED|Overall Study||22
40617|NCT01812473|94852|P2|STARTED|Overall Study||13
40618|NCT01812473|94853|P1|STARTED|Overall Study||22
40619|NCT01812057|94861|P2|NOT COMPLETED|Overall Study||0
40620|NCT01812057|94862|P1|NOT COMPLETED|Overall Study||2
40621|NCT01812057|94861|P2|COMPLETED|Overall Study||24
40622|NCT01812057|94862|P1|COMPLETED|Overall Study||23
40623|NCT01812057|94861|P2|STARTED|Overall Study||24
40624|NCT01812057|94862|P1|STARTED|Overall Study||25
40625|NCT01812044|94903|P3|NOT COMPLETED|Overall Study||0
40626|NCT01812044|94904|P2|NOT COMPLETED|Overall Study||0
40627|NCT01812044|94905|P1|NOT COMPLETED|Overall Study||0
40628|NCT01812044|94903|P3|COMPLETED|Overall Study||16
40629|NCT01812044|94904|P2|COMPLETED|Overall Study||17
40630|NCT01812044|94905|P1|COMPLETED|Overall Study||17
40631|NCT01812044|94903|P3|STARTED|Overall Study||16
40632|NCT01812044|94904|P2|STARTED|Overall Study||17
40633|NCT01812044|94905|P1|STARTED|Overall Study||17
40634|NCT01811953|94940|P6|NOT COMPLETED|Overall Study||1
40635|NCT01811953|94941|P5|NOT COMPLETED|Overall Study||1
40636|NCT01811953|94942|P4|NOT COMPLETED|Overall Study||1
40637|NCT01811953|94943|P3|NOT COMPLETED|Overall Study||0
40638|NCT01811953|94944|P2|NOT COMPLETED|Overall Study||0
40639|NCT01811953|94945|P1|NOT COMPLETED|Overall Study||0
40640|NCT01811953|94940|P6|COMPLETED|Overall Study||11
40641|NCT01811953|94941|P5|COMPLETED|Overall Study||11
40642|NCT01811953|94942|P4|COMPLETED|Overall Study||5
40643|NCT01811953|94943|P3|COMPLETED|Overall Study||6
40644|NCT01811953|94944|P2|COMPLETED|Overall Study||6
40645|NCT01811953|94945|P1|COMPLETED|Overall Study||6
40646|NCT01811953|94940|P6|STARTED|Overall Study||12
40647|NCT01811953|94941|P5|STARTED|Overall Study||12
40648|NCT01811953|94942|P4|STARTED|Overall Study||6
40649|NCT01811953|94943|P3|STARTED|Overall Study||6
40650|NCT01811953|94944|P2|STARTED|Overall Study||6
40651|NCT01811953|94945|P1|STARTED|Overall Study||6
40652|NCT01811732|94991|P2|NOT COMPLETED|Overall Study||58
40653|NCT01811732|94992|P1|NOT COMPLETED|Overall Study||55
40654|NCT01811732|94991|P2|COMPLETED|Overall Study||271
40655|NCT01811732|94992|P1|COMPLETED|Overall Study||276
40656|NCT01811732|94991|P2|STARTED|Overall Study||329
40657|NCT01811732|94992|P1|STARTED|Overall Study||331
40658|NCT01811706|95002|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
40659|NCT01811706|95003|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
40660|NCT01811706|95002|P2|COMPLETED|Second Intervention (4 Weeks)||10
40661|NCT01811706|95003|P1|COMPLETED|Second Intervention (4 Weeks)||9
40662|NCT01811706|95002|P2|STARTED|Second Intervention (4 Weeks)||10
40663|NCT01811706|95003|P1|STARTED|Second Intervention (4 Weeks)||9
40664|NCT01811706|95002|P2|NOT COMPLETED|Washout ( 2 Weeks)||0
40665|NCT01811706|95003|P1|NOT COMPLETED|Washout ( 2 Weeks)||0
40666|NCT01811706|95002|P2|COMPLETED|Washout ( 2 Weeks)||10
40667|NCT01811706|95003|P1|COMPLETED|Washout ( 2 Weeks)||9
40668|NCT01811706|95002|P2|STARTED|Washout ( 2 Weeks)||10
40669|NCT01811706|95003|P1|STARTED|Washout ( 2 Weeks)||9
40670|NCT01811706|95002|P2|NOT COMPLETED|First Intervention ( 4 Weeks)||0
40671|NCT01811706|95003|P1|NOT COMPLETED|First Intervention ( 4 Weeks)||1
40672|NCT01811706|95002|P2|COMPLETED|First Intervention ( 4 Weeks)||10
40673|NCT01811706|95003|P1|COMPLETED|First Intervention ( 4 Weeks)||9
40674|NCT01811706|95002|P2|STARTED|First Intervention ( 4 Weeks)||10
40675|NCT01811706|95003|P1|STARTED|First Intervention ( 4 Weeks)||10
40676|NCT01811680|95013|P1|NOT COMPLETED|Overall Study||0
40677|NCT01811680|95013|P1|COMPLETED|Overall Study||10
40678|NCT01811680|95013|P1|STARTED|Overall Study||10
40679|NCT01811563|95020|P2|NOT COMPLETED|Overall Study||3
40680|NCT01811563|95021|P1|NOT COMPLETED|Overall Study||5
40681|NCT01811563|95020|P2|COMPLETED|Overall Study||20
40682|NCT01811563|95021|P1|COMPLETED|Overall Study||20
40683|NCT01811563|95020|P2|STARTED|Overall Study||23
40684|NCT01811563|95021|P1|STARTED|Overall Study||25
40685|NCT01811485|95050|P3|NOT COMPLETED|Overall Study||5
40686|NCT01811485|95051|P2|NOT COMPLETED|Overall Study||4
40687|NCT01811485|95052|P1|NOT COMPLETED|Overall Study||2
40688|NCT01811485|95050|P3|COMPLETED|Overall Study||51
40689|NCT01811485|95051|P2|COMPLETED|Overall Study||55
40690|NCT01811485|95052|P1|COMPLETED|Overall Study||54
40691|NCT01811485|95050|P3|STARTED|Overall Study||56
40692|NCT01811485|95051|P2|STARTED|Overall Study||59
40693|NCT01811485|95052|P1|STARTED|Overall Study|"Started indicates randomized patients"|56
40694|NCT01811472|95072|P3|NOT COMPLETED|Overall Study||5
40695|NCT01811472|95073|P2|NOT COMPLETED|Overall Study||0
40696|NCT01811472|95074|P1|NOT COMPLETED|Overall Study||2
40697|NCT01811472|95072|P3|COMPLETED|Overall Study||16
40698|NCT01811472|95073|P2|COMPLETED|Overall Study||11
40699|NCT01811472|95074|P1|COMPLETED|Overall Study||18
40700|NCT01811472|95072|P3|STARTED|Overall Study||21
40701|NCT01811472|95073|P2|STARTED|Overall Study||11
40702|NCT01811472|95074|P1|STARTED|Overall Study||20
40703|NCT01811355|95119|P2|NOT COMPLETED|Second Dose||0
40704|NCT01811355|95120|P1|NOT COMPLETED|Second Dose||0
40705|NCT01811355|95119|P2|COMPLETED|Second Dose||12
40706|NCT01811355|95120|P1|COMPLETED|Second Dose||9
40707|NCT01811355|95119|P2|STARTED|Second Dose||12
40708|NCT01811355|95120|P1|STARTED|Second Dose||9
40709|NCT01811355|95119|P2|NOT COMPLETED|Washout||0
40710|NCT01811355|95120|P1|NOT COMPLETED|Washout||0
40711|NCT01811355|95119|P2|COMPLETED|Washout||12
40712|NCT01811355|95120|P1|COMPLETED|Washout||9
40713|NCT01811355|95119|P2|STARTED|Washout||12
40714|NCT01811355|95120|P1|STARTED|Washout||9
40715|NCT01811355|95119|P2|NOT COMPLETED|First Dose||0
40716|NCT01811355|95120|P1|NOT COMPLETED|First Dose||2
40717|NCT01811355|95119|P2|COMPLETED|First Dose||12
40718|NCT01811355|95120|P1|COMPLETED|First Dose||9
40719|NCT01811355|95119|P2|STARTED|First Dose||12
40720|NCT01811355|95120|P1|STARTED|First Dose||11
40721|NCT01811303|95128|P4|NOT COMPLETED|Fourth Intervention (1 Day)||0
40722|NCT01811303|95129|P3|NOT COMPLETED|Fourth Intervention (1 Day)||0
40723|NCT01811303|95130|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
40724|NCT01811303|95131|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
40725|NCT01811303|95128|P4|COMPLETED|Fourth Intervention (1 Day)||2
40726|NCT01811303|95129|P3|COMPLETED|Fourth Intervention (1 Day)||4
40727|NCT01811303|95130|P2|COMPLETED|Fourth Intervention (1 Day)||4
40728|NCT01811303|95131|P1|COMPLETED|Fourth Intervention (1 Day)||4
40729|NCT01811303|95128|P4|STARTED|Fourth Intervention (1 Day)||2
40730|NCT01811303|95129|P3|STARTED|Fourth Intervention (1 Day)||4
40731|NCT01811303|95130|P2|STARTED|Fourth Intervention (1 Day)||4
40732|NCT01811303|95131|P1|STARTED|Fourth Intervention (1 Day)||4
40733|NCT01811303|95128|P4|NOT COMPLETED|Washout (2 Days or More)||0
40734|NCT01811303|95129|P3|NOT COMPLETED|Washout (2 Days or More)||0
40735|NCT01811303|95130|P2|NOT COMPLETED|Washout (2 Days or More)||0
40736|NCT01811303|95131|P1|NOT COMPLETED|Washout (2 Days or More)||0
40737|NCT01811303|95128|P4|COMPLETED|Washout (2 Days or More)||2
40738|NCT01811303|95129|P3|COMPLETED|Washout (2 Days or More)||4
40739|NCT01811303|95130|P2|COMPLETED|Washout (2 Days or More)||4
40740|NCT01811303|95131|P1|COMPLETED|Washout (2 Days or More)||4
40741|NCT01811303|95128|P4|STARTED|Washout (2 Days or More)||2
40742|NCT01811303|95129|P3|STARTED|Washout (2 Days or More)||4
40743|NCT01811303|95130|P2|STARTED|Washout (2 Days or More)||4
40744|NCT01811303|95131|P1|STARTED|Washout (2 Days or More)||4
40745|NCT01811303|95128|P4|NOT COMPLETED|Third Intervention (1 Day)||0
40746|NCT01811303|95129|P3|NOT COMPLETED|Third Intervention (1 Day)||0
40747|NCT01811303|95130|P2|NOT COMPLETED|Third Intervention (1 Day)||0
40748|NCT01811303|95131|P1|NOT COMPLETED|Third Intervention (1 Day)||0
40749|NCT01811303|95128|P4|COMPLETED|Third Intervention (1 Day)||2
40750|NCT01811303|95129|P3|COMPLETED|Third Intervention (1 Day)||4
40751|NCT01811303|95130|P2|COMPLETED|Third Intervention (1 Day)||4
40752|NCT01811303|95131|P1|COMPLETED|Third Intervention (1 Day)||4
40753|NCT01811303|95128|P4|STARTED|Third Intervention (1 Day)||2
40754|NCT01811303|95129|P3|STARTED|Third Intervention (1 Day)||4
40755|NCT01811303|95130|P2|STARTED|Third Intervention (1 Day)||4
40756|NCT01811303|95131|P1|STARTED|Third Intervention (1 Day)||4
40757|NCT01811303|95128|P4|NOT COMPLETED|Washout (2 Days or More)||0
40758|NCT01811303|95129|P3|NOT COMPLETED|Washout (2 Days or More)||0
40759|NCT01811303|95130|P2|NOT COMPLETED|Washout (2 Days or More)||0
40760|NCT01811303|95131|P1|NOT COMPLETED|Washout (2 Days or More)||0
40761|NCT01811303|95128|P4|COMPLETED|Washout (2 Days or More)||2
40762|NCT01811303|95129|P3|COMPLETED|Washout (2 Days or More)||4
40763|NCT01811303|95130|P2|COMPLETED|Washout (2 Days or More)||4
40764|NCT01811303|95131|P1|COMPLETED|Washout (2 Days or More)||4
40765|NCT01811303|95128|P4|STARTED|Washout (2 Days or More)||2
40766|NCT01811303|95129|P3|STARTED|Washout (2 Days or More)||4
40767|NCT01811303|95130|P2|STARTED|Washout (2 Days or More)||4
40768|NCT01811303|95131|P1|STARTED|Washout (2 Days or More)||4
40769|NCT01811303|95128|P4|NOT COMPLETED|Second Intervention (1 Day)||0
40770|NCT01811303|95129|P3|NOT COMPLETED|Second Intervention (1 Day)||0
40771|NCT01811303|95130|P2|NOT COMPLETED|Second Intervention (1 Day)||0
40772|NCT01811303|95131|P1|NOT COMPLETED|Second Intervention (1 Day)||0
40773|NCT01811303|95128|P4|COMPLETED|Second Intervention (1 Day)||2
40774|NCT01811303|95129|P3|COMPLETED|Second Intervention (1 Day)||4
40775|NCT01811303|95130|P2|COMPLETED|Second Intervention (1 Day)||4
40776|NCT01811303|95131|P1|COMPLETED|Second Intervention (1 Day)||4
40777|NCT01811303|95128|P4|STARTED|Second Intervention (1 Day)||2
40778|NCT01811303|95129|P3|STARTED|Second Intervention (1 Day)||4
40779|NCT01811303|95130|P2|STARTED|Second Intervention (1 Day)||4
40780|NCT01811303|95131|P1|STARTED|Second Intervention (1 Day)||4
40781|NCT01811303|95128|P4|NOT COMPLETED|Washout (2 Days or More)||0
40782|NCT01811303|95129|P3|NOT COMPLETED|Washout (2 Days or More)||0
40783|NCT01811303|95130|P2|NOT COMPLETED|Washout (2 Days or More)||0
40784|NCT01811303|95131|P1|NOT COMPLETED|Washout (2 Days or More)||0
40785|NCT01811303|95128|P4|COMPLETED|Washout (2 Days or More)||2
40786|NCT01811303|95129|P3|COMPLETED|Washout (2 Days or More)||4
40787|NCT01811303|95130|P2|COMPLETED|Washout (2 Days or More)||4
40788|NCT01811303|95131|P1|COMPLETED|Washout (2 Days or More)||4
40789|NCT01811303|95128|P4|STARTED|Washout (2 Days or More)||2
40790|NCT01811303|95129|P3|STARTED|Washout (2 Days or More)||4
40791|NCT01811303|95130|P2|STARTED|Washout (2 Days or More)||4
40792|NCT01811303|95131|P1|STARTED|Washout (2 Days or More)||4
40793|NCT01811303|95128|P4|NOT COMPLETED|First Intervention (1 Day)||0
40794|NCT01811303|95129|P3|NOT COMPLETED|First Intervention (1 Day)||0
40795|NCT01811303|95130|P2|NOT COMPLETED|First Intervention (1 Day)||0
40796|NCT01811303|95131|P1|NOT COMPLETED|First Intervention (1 Day)||0
40797|NCT01811303|95128|P4|COMPLETED|First Intervention (1 Day)||2
40798|NCT01811303|95129|P3|COMPLETED|First Intervention (1 Day)||4
40799|NCT01811303|95130|P2|COMPLETED|First Intervention (1 Day)||4
40800|NCT01811303|95131|P1|COMPLETED|First Intervention (1 Day)||4
40801|NCT01811303|95128|P4|STARTED|First Intervention (1 Day)||2
40802|NCT01811303|95129|P3|STARTED|First Intervention (1 Day)||4
40803|NCT01811303|95130|P2|STARTED|First Intervention (1 Day)||4
40804|NCT01811303|95131|P1|STARTED|First Intervention (1 Day)||4
40805|NCT01811238|95139|P1|NOT COMPLETED|Overall Study||81
40806|NCT01811238|95139|P1|COMPLETED|Overall Study|159 subjects regardless PP set completed study visit.|159
40807|NCT01811238|95139|P1|PP Set|Overall Study|89 subjects excluded from PP set due to various reasons.|120
40808|NCT01811238|95139|P1|ITT Set|Overall Study|11 subjects excluded from ITT set due to no primary efficacy assessment(5) and IC/EC violation(6).|209
40809|NCT01811238|95139|P1|Safety Set|Overall Study|20 subjects excluded from the safety set due to study drug not administered.|220
40810|NCT01811238|95139|P1|STARTED|Overall Study|First patient was recruited on 26 Sep. 2012.|240
40811|NCT01811186|95150|P2|NOT COMPLETED|Overall Study||62
40812|NCT01811186|95151|P1|NOT COMPLETED|Overall Study||71
40813|NCT01811186|95150|P2|COMPLETED|Overall Study||64
40814|NCT01811186|95151|P1|COMPLETED|Overall Study||61
40815|NCT01811186|95150|P2|STARTED|Overall Study||126
40816|NCT01811186|95151|P1|STARTED|Overall Study||132
40817|NCT01810952|95169|P2|NOT COMPLETED|Overall Study||0
40818|NCT01810952|95170|P1|NOT COMPLETED|Overall Study||0
40819|NCT01810952|95169|P2|COMPLETED|Overall Study||17
40820|NCT01810952|95170|P1|COMPLETED|Overall Study||20
40821|NCT01810952|95169|P2|STARTED|Overall Study||17
40822|NCT01810952|95170|P1|STARTED|Overall Study||20
40823|NCT01810939|95184|P3|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||22
40824|NCT01810939|95185|P2|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||10
40825|NCT01810939|95186|P1|NOT COMPLETED|Part B Placebo-Controlled Withdrawal||0
40826|NCT01810939|95184|P3|COMPLETED|Part B Placebo-Controlled Withdrawal||30
40827|NCT01810939|95185|P2|COMPLETED|Part B Placebo-Controlled Withdrawal||45
40828|NCT01810939|95186|P1|COMPLETED|Part B Placebo-Controlled Withdrawal||0
40829|NCT01810939|95184|P3|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|52
40830|NCT01810939|95185|P2|STARTED|Part B Placebo-Controlled Withdrawal|Part A participants with Part A baseline serum potassium ≥ 5.5 mEq/L who responded to treatment|55
40831|NCT01810939|95186|P1|STARTED|Part B Placebo-Controlled Withdrawal||0
40832|NCT01810939|95184|P3|NOT COMPLETED|Part A Treatment Period||0
40833|NCT01810939|95185|P2|NOT COMPLETED|Part A Treatment Period||0
40834|NCT01810939|95186|P1|NOT COMPLETED|Part A Treatment Period||24
40835|NCT01810939|95184|P3|COMPLETED|Part A Treatment Period||0
40836|NCT01810939|95185|P2|COMPLETED|Part A Treatment Period||0
40837|NCT01810939|95186|P1|COMPLETED|Part A Treatment Period||219
40838|NCT01810939|95184|P3|STARTED|Part A Treatment Period||0
40839|NCT01810939|95185|P2|STARTED|Part A Treatment Period||0
40840|NCT01810939|95186|P1|STARTED|Part A Treatment Period||243
40841|NCT01810783|95199|P1|NOT COMPLETED|Overall Study||109
40842|NCT01810783|95199|P1|COMPLETED|Overall Study||101
40843|NCT01810783|95199|P1|STARTED|Overall Study||210
40844|NCT01810692|95205|P2|NOT COMPLETED|Overall Study||0
40845|NCT01810692|95206|P1|NOT COMPLETED|Overall Study||0
40846|NCT01810692|95205|P2|COMPLETED|Overall Study||77
40847|NCT01810692|95206|P1|COMPLETED|Overall Study||77
40848|NCT01810692|95205|P2|STARTED|Overall Study||77
40849|NCT01810692|95206|P1|STARTED|Overall Study||77
40850|NCT01810666|95218|P1|NOT COMPLETED|Overall Study||0
40851|NCT01810666|95218|P1|COMPLETED|Overall Study||30
40852|NCT01810666|95218|P1|STARTED|Overall Study||30
40853|NCT01810380|95227|P3|NOT COMPLETED|Overall Study||32
40854|NCT01810380|95228|P2|NOT COMPLETED|Overall Study||38
40855|NCT01810380|95229|P1|NOT COMPLETED|Overall Study||55
40856|NCT01810380|95227|P3|COMPLETED|Overall Study||122
40857|NCT01810380|95228|P2|COMPLETED|Overall Study||113
40858|NCT01810380|95229|P1|COMPLETED|Overall Study||108
40859|NCT01810380|95227|P3|Treated|Overall Study||153
40860|NCT01810380|95228|P2|Treated|Overall Study||150
40861|NCT01810380|95229|P1|Treated|Overall Study||161
40862|NCT01810380|95227|P3|STARTED|Overall Study||154
40863|NCT01810380|95228|P2|STARTED|Overall Study||151
40864|NCT01810380|95229|P1|STARTED|Overall Study||163
40865|NCT01810302|95290|P2|NOT COMPLETED|Overall Study||1
40866|NCT01810302|95291|P1|NOT COMPLETED|Overall Study||1
40867|NCT01810302|95290|P2|COMPLETED|Overall Study||0
40868|NCT01810302|95291|P1|COMPLETED|Overall Study||0
40869|NCT01810302|95290|P2|STARTED|Overall Study||1
40870|NCT01810302|95291|P1|STARTED|Overall Study||1
40871|NCT01810289|95301|P2|NOT COMPLETED|Overall Study||0
40872|NCT01810289|95302|P1|NOT COMPLETED|Overall Study||0
40873|NCT01810289|95301|P2|COMPLETED|Overall Study||4747
40874|NCT01810289|95302|P1|COMPLETED|Overall Study||7277
40875|NCT01810289|95301|P2|STARTED|Overall Study||4747
40876|NCT01810289|95302|P1|STARTED|Overall Study||7277
40877|NCT01810263|95310|P2|NOT COMPLETED|Overall Study||7
40878|NCT01810263|95311|P1|NOT COMPLETED|Overall Study||8
40879|NCT01810263|95310|P2|COMPLETED|Overall Study||11
40880|NCT01810263|95311|P1|COMPLETED|Overall Study|2014 July|8
40881|NCT01810263|95310|P2|STARTED|Overall Study||18
40882|NCT01810263|95311|P1|STARTED|Overall Study||16
40883|NCT01810042|95317|P1|NOT COMPLETED|Overall Study||10
40884|NCT01810042|95317|P1|COMPLETED|Overall Study||39
40885|NCT01810042|95317|P1|STARTED|Overall Study||49
40886|NCT01809938|95324|P2|NOT COMPLETED|Second Intervention (170 Minutes)||0
40887|NCT01809938|95325|P1|NOT COMPLETED|Second Intervention (170 Minutes)||0
40888|NCT01809938|95324|P2|COMPLETED|Second Intervention (170 Minutes)||5
40889|NCT01809938|95325|P1|COMPLETED|Second Intervention (170 Minutes)||5
40890|NCT01809938|95324|P2|STARTED|Second Intervention (170 Minutes)||5
40891|NCT01809938|95325|P1|STARTED|Second Intervention (170 Minutes)||5
40892|NCT01809938|95324|P2|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
40893|NCT01809938|95325|P1|NOT COMPLETED|Washout (Not Less Than 24 Hours)||0
40894|NCT01809938|95324|P2|COMPLETED|Washout (Not Less Than 24 Hours)||5
40895|NCT01809938|95325|P1|COMPLETED|Washout (Not Less Than 24 Hours)||5
40896|NCT01809938|95324|P2|STARTED|Washout (Not Less Than 24 Hours)||5
40897|NCT01809938|95325|P1|STARTED|Washout (Not Less Than 24 Hours)||5
40898|NCT01809938|95324|P2|NOT COMPLETED|First Intervention (170 Minutes)||0
40899|NCT01809938|95325|P1|NOT COMPLETED|First Intervention (170 Minutes)||0
40900|NCT01809938|95324|P2|COMPLETED|First Intervention (170 Minutes)||5
40901|NCT01809938|95325|P1|COMPLETED|First Intervention (170 Minutes)||5
40902|NCT01809938|95324|P2|STARTED|First Intervention (170 Minutes)||5
40903|NCT01809938|95325|P1|STARTED|First Intervention (170 Minutes)||5
40904|NCT01809834|95332|P1|NOT COMPLETED|Overall Study||0
40905|NCT01809834|95332|P1|COMPLETED|Overall Study||44
40906|NCT01809834|95332|P1|STARTED|Overall Study||44
40907|NCT01809639|95360|P2|NOT COMPLETED|Overall Study||0
40908|NCT01809639|95361|P1|NOT COMPLETED|Overall Study||0
40909|NCT01809639|95360|P2|COMPLETED|Overall Study||7
40910|NCT01809639|95361|P1|COMPLETED|Overall Study||18
40911|NCT01809639|95360|P2|STARTED|Overall Study||7
40912|NCT01809639|95361|P1|STARTED|Overall Study||18
40913|NCT01809327|95372|P5|NOT COMPLETED|Overall Study||25
40914|NCT01809327|95373|P4|NOT COMPLETED|Overall Study||12
40915|NCT01809327|95374|P3|NOT COMPLETED|Overall Study||22
40916|NCT01809327|95375|P2|NOT COMPLETED|Overall Study||26
40917|NCT01809327|95376|P1|NOT COMPLETED|Overall Study||32
40918|NCT01809327|95372|P5|COMPLETED|Overall Study||212
40919|NCT01809327|95373|P4|COMPLETED|Overall Study||225
40920|NCT01809327|95374|P3|COMPLETED|Overall Study||216
40921|NCT01809327|95375|P2|COMPLETED|Overall Study||211
40922|NCT01809327|95376|P1|COMPLETED|Overall Study||205
40923|NCT01809327|95372|P5|STARTED|Overall Study||237
40924|NCT01809327|95373|P4|STARTED|Overall Study||237
40925|NCT01809327|95374|P3|STARTED|Overall Study||238
40926|NCT01809327|95375|P2|STARTED|Overall Study||237
40927|NCT01809327|95376|P1|STARTED|Overall Study||237
40928|NCT01809314|95418|P1|NOT COMPLETED|Overall Study||745
40929|NCT01809314|95418|P1|COMPLETED|Overall Study||422
40930|NCT01809314|95418|P1|STARTED|Overall Study||1167
40931|NCT01809262|95424|P10|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40932|NCT01809262|95425|P9|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40933|NCT01809262|95426|P8|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40934|NCT01809262|95427|P7|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40935|NCT01809262|95428|P6|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40936|NCT01809262|95429|P5|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40937|NCT01809262|95430|P4|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40938|NCT01809262|95431|P3|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40939|NCT01809262|95432|P2|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40940|NCT01809262|95433|P1|NOT COMPLETED|Period 5 (Fifth Dose + Washout)||0
40941|NCT01809262|95424|P10|COMPLETED|Period 5 (Fifth Dose + Washout)||4
40942|NCT01809262|95425|P9|COMPLETED|Period 5 (Fifth Dose + Washout)||3
40943|NCT01809262|95426|P8|COMPLETED|Period 5 (Fifth Dose + Washout)||4
40944|NCT01809262|95427|P7|COMPLETED|Period 5 (Fifth Dose + Washout)||3
40945|NCT01809262|95428|P6|COMPLETED|Period 5 (Fifth Dose + Washout)||3
40946|NCT01809262|95429|P5|COMPLETED|Period 5 (Fifth Dose + Washout)||3
40947|NCT01809262|95430|P4|COMPLETED|Period 5 (Fifth Dose + Washout)||3
40948|NCT01809262|95431|P3|COMPLETED|Period 5 (Fifth Dose + Washout)||4
40949|NCT01809262|95432|P2|COMPLETED|Period 5 (Fifth Dose + Washout)||3
40950|NCT01809262|95433|P1|COMPLETED|Period 5 (Fifth Dose + Washout)||4
40951|NCT01809262|95424|P10|STARTED|Period 5 (Fifth Dose + Washout)||4
40952|NCT01809262|95425|P9|STARTED|Period 5 (Fifth Dose + Washout)||3
40953|NCT01809262|95426|P8|STARTED|Period 5 (Fifth Dose + Washout)||4
40954|NCT01809262|95427|P7|STARTED|Period 5 (Fifth Dose + Washout)||3
40955|NCT01809262|95428|P6|STARTED|Period 5 (Fifth Dose + Washout)||3
40956|NCT01809262|95429|P5|STARTED|Period 5 (Fifth Dose + Washout)||3
40957|NCT01809262|95430|P4|STARTED|Period 5 (Fifth Dose + Washout)||3
40958|NCT01809262|95431|P3|STARTED|Period 5 (Fifth Dose + Washout)||4
40959|NCT01809262|95432|P2|STARTED|Period 5 (Fifth Dose + Washout)||3
40960|NCT01809262|95433|P1|STARTED|Period 5 (Fifth Dose + Washout)||4
40961|NCT01809262|95424|P10|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40962|NCT01809262|95425|P9|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40963|NCT01809262|95426|P8|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40964|NCT01809262|95427|P7|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40965|NCT01809262|95428|P6|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40966|NCT01809262|95429|P5|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40967|NCT01809262|95430|P4|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40968|NCT01809262|95431|P3|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40969|NCT01809262|95432|P2|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40970|NCT01809262|95433|P1|NOT COMPLETED|Period 4 (Fourth Dose + Washout)||0
40971|NCT01809262|95424|P10|COMPLETED|Period 4 (Fourth Dose + Washout)||4
40972|NCT01809262|95425|P9|COMPLETED|Period 4 (Fourth Dose + Washout)||3
40973|NCT01809262|95426|P8|COMPLETED|Period 4 (Fourth Dose + Washout)||4
40974|NCT01809262|95427|P7|COMPLETED|Period 4 (Fourth Dose + Washout)||3
40975|NCT01809262|95428|P6|COMPLETED|Period 4 (Fourth Dose + Washout)||3
40976|NCT01809262|95429|P5|COMPLETED|Period 4 (Fourth Dose + Washout)||3
40977|NCT01809262|95430|P4|COMPLETED|Period 4 (Fourth Dose + Washout)||3
40978|NCT01809262|95431|P3|COMPLETED|Period 4 (Fourth Dose + Washout)||4
40979|NCT01809262|95432|P2|COMPLETED|Period 4 (Fourth Dose + Washout)||3
40980|NCT01809262|95433|P1|COMPLETED|Period 4 (Fourth Dose + Washout)||4
40981|NCT01809262|95424|P10|STARTED|Period 4 (Fourth Dose + Washout)||4
40982|NCT01809262|95425|P9|STARTED|Period 4 (Fourth Dose + Washout)||3
40983|NCT01809262|95426|P8|STARTED|Period 4 (Fourth Dose + Washout)||4
40984|NCT01809262|95427|P7|STARTED|Period 4 (Fourth Dose + Washout)||3
40985|NCT01809262|95428|P6|STARTED|Period 4 (Fourth Dose + Washout)||3
40986|NCT01809262|95429|P5|STARTED|Period 4 (Fourth Dose + Washout)||3
40987|NCT01809262|95430|P4|STARTED|Period 4 (Fourth Dose + Washout)||3
40988|NCT01809262|95431|P3|STARTED|Period 4 (Fourth Dose + Washout)||4
40989|NCT01809262|95432|P2|STARTED|Period 4 (Fourth Dose + Washout)||3
40990|NCT01809262|95433|P1|STARTED|Period 4 (Fourth Dose + Washout)||4
40991|NCT01809262|95424|P10|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40992|NCT01809262|95425|P9|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40993|NCT01809262|95426|P8|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40994|NCT01809262|95427|P7|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40995|NCT01809262|95428|P6|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40996|NCT01809262|95429|P5|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40997|NCT01809262|95430|P4|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40998|NCT01809262|95431|P3|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
40999|NCT01809262|95432|P2|NOT COMPLETED|Period 3 (Third Dose + Washout)||1
41000|NCT01809262|95433|P1|NOT COMPLETED|Period 3 (Third Dose + Washout)||0
41001|NCT01809262|95424|P10|COMPLETED|Period 3 (Third Dose + Washout)||4
41002|NCT01809262|95425|P9|COMPLETED|Period 3 (Third Dose + Washout)||3
41003|NCT01809262|95426|P8|COMPLETED|Period 3 (Third Dose + Washout)||4
41004|NCT01809262|95427|P7|COMPLETED|Period 3 (Third Dose + Washout)||3
41005|NCT01809262|95428|P6|COMPLETED|Period 3 (Third Dose + Washout)||3
41006|NCT01809262|95429|P5|COMPLETED|Period 3 (Third Dose + Washout)||3
41007|NCT01809262|95430|P4|COMPLETED|Period 3 (Third Dose + Washout)||3
41008|NCT01809262|95431|P3|COMPLETED|Period 3 (Third Dose + Washout)||4
41009|NCT01809262|95432|P2|COMPLETED|Period 3 (Third Dose + Washout)||3
41010|NCT01809262|95433|P1|COMPLETED|Period 3 (Third Dose + Washout)||4
41011|NCT01809262|95424|P10|STARTED|Period 3 (Third Dose + Washout)||4
41012|NCT01809262|95425|P9|STARTED|Period 3 (Third Dose + Washout)||3
41013|NCT01809262|95426|P8|STARTED|Period 3 (Third Dose + Washout)||4
41014|NCT01809262|95427|P7|STARTED|Period 3 (Third Dose + Washout)||3
41015|NCT01809262|95428|P6|STARTED|Period 3 (Third Dose + Washout)||3
41016|NCT01809262|95429|P5|STARTED|Period 3 (Third Dose + Washout)||3
41017|NCT01809262|95430|P4|STARTED|Period 3 (Third Dose + Washout)||3
41018|NCT01809262|95431|P3|STARTED|Period 3 (Third Dose + Washout)||4
41019|NCT01809262|95432|P2|STARTED|Period 3 (Third Dose + Washout)||4
41020|NCT01809262|95433|P1|STARTED|Period 3 (Third Dose + Washout)||4
41021|NCT01809262|95424|P10|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41022|NCT01809262|95425|P9|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41023|NCT01809262|95426|P8|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41024|NCT01809262|95427|P7|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41025|NCT01809262|95428|P6|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41026|NCT01809262|95429|P5|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41027|NCT01809262|95430|P4|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41028|NCT01809262|95431|P3|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41029|NCT01809262|95432|P2|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41030|NCT01809262|95433|P1|NOT COMPLETED|Period 2 (Second Dose + Washout)||0
41031|NCT01809262|95424|P10|COMPLETED|Period 2 (Second Dose + Washout)||4
41032|NCT01809262|95425|P9|COMPLETED|Period 2 (Second Dose + Washout)||3
41033|NCT01809262|95426|P8|COMPLETED|Period 2 (Second Dose + Washout)||4
41034|NCT01809262|95427|P7|COMPLETED|Period 2 (Second Dose + Washout)||3
41035|NCT01809262|95428|P6|COMPLETED|Period 2 (Second Dose + Washout)||3
41036|NCT01809262|95429|P5|COMPLETED|Period 2 (Second Dose + Washout)||3
41037|NCT01809262|95430|P4|COMPLETED|Period 2 (Second Dose + Washout)||3
41038|NCT01809262|95431|P3|COMPLETED|Period 2 (Second Dose + Washout)||4
41039|NCT01809262|95432|P2|COMPLETED|Period 2 (Second Dose + Washout)||4
41040|NCT01809262|95433|P1|COMPLETED|Period 2 (Second Dose + Washout)||4
41041|NCT01809262|95424|P10|STARTED|Period 2 (Second Dose + Washout)||4
41042|NCT01809262|95425|P9|STARTED|Period 2 (Second Dose + Washout)||3
41043|NCT01809262|95426|P8|STARTED|Period 2 (Second Dose + Washout)||4
41044|NCT01809262|95427|P7|STARTED|Period 2 (Second Dose + Washout)||3
41045|NCT01809262|95428|P6|STARTED|Period 2 (Second Dose + Washout)||3
41046|NCT01809262|95429|P5|STARTED|Period 2 (Second Dose + Washout)||3
41047|NCT01809262|95430|P4|STARTED|Period 2 (Second Dose + Washout)||3
41048|NCT01809262|95431|P3|STARTED|Period 2 (Second Dose + Washout)||4
41049|NCT01809262|95432|P2|STARTED|Period 2 (Second Dose + Washout)||4
41050|NCT01809262|95433|P1|STARTED|Period 2 (Second Dose + Washout)||4
41051|NCT01809262|95424|P10|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41052|NCT01809262|95425|P9|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41053|NCT01809262|95426|P8|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41054|NCT01809262|95427|P7|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41055|NCT01809262|95428|P6|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41056|NCT01809262|95429|P5|NOT COMPLETED|Period 1 (First Dose + Washout)||1
41057|NCT01809262|95430|P4|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41058|NCT01809262|95431|P3|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41059|NCT01809262|95432|P2|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41060|NCT01809262|95433|P1|NOT COMPLETED|Period 1 (First Dose + Washout)||0
41061|NCT01809262|95424|P10|COMPLETED|Period 1 (First Dose + Washout)||4
41062|NCT01809262|95425|P9|COMPLETED|Period 1 (First Dose + Washout)||3
41063|NCT01809262|95426|P8|COMPLETED|Period 1 (First Dose + Washout)||4
41064|NCT01809262|95427|P7|COMPLETED|Period 1 (First Dose + Washout)||3
41065|NCT01809262|95428|P6|COMPLETED|Period 1 (First Dose + Washout)||3
41066|NCT01809262|95429|P5|COMPLETED|Period 1 (First Dose + Washout)||3
41067|NCT01809262|95430|P4|COMPLETED|Period 1 (First Dose + Washout)||3
41068|NCT01809262|95431|P3|COMPLETED|Period 1 (First Dose + Washout)||4
41069|NCT01809262|95432|P2|COMPLETED|Period 1 (First Dose + Washout)||4
41070|NCT01809262|95433|P1|COMPLETED|Period 1 (First Dose + Washout)||4
41071|NCT01809262|95424|P10|STARTED|Period 1 (First Dose + Washout)||4
41072|NCT01809262|95425|P9|STARTED|Period 1 (First Dose + Washout)||3
41073|NCT01809262|95426|P8|STARTED|Period 1 (First Dose + Washout)||4
41074|NCT01809262|95427|P7|STARTED|Period 1 (First Dose + Washout)||3
41075|NCT01809262|95428|P6|STARTED|Period 1 (First Dose + Washout)||3
41076|NCT01809262|95429|P5|STARTED|Period 1 (First Dose + Washout)||4
41077|NCT01809262|95430|P4|STARTED|Period 1 (First Dose + Washout)||3
41078|NCT01809262|95431|P3|STARTED|Period 1 (First Dose + Washout)||4
41079|NCT01809262|95432|P2|STARTED|Period 1 (First Dose + Washout)||4
41080|NCT01809262|95433|P1|STARTED|Period 1 (First Dose + Washout)||4
41081|NCT01809197|95502|P2|NOT COMPLETED|Overall Study||8
41082|NCT01809197|95503|P1|NOT COMPLETED|Overall Study||10
41083|NCT01809197|95502|P2|COMPLETED|Overall Study||177
41084|NCT01809197|95503|P1|COMPLETED|Overall Study||177
41085|NCT01809197|95502|P2|STARTED|Overall Study||185
41086|NCT01809197|95503|P1|STARTED|Overall Study||187
41087|NCT01809106|95513|P4|NOT COMPLETED|Overall Study||4
41088|NCT01809106|95514|P3|NOT COMPLETED|Overall Study||3
41089|NCT01809106|95515|P2|NOT COMPLETED|Overall Study||5
41090|NCT01809106|95516|P1|NOT COMPLETED|Overall Study||8
41091|NCT01809106|95513|P4|COMPLETED|Overall Study||124
41092|NCT01809106|95514|P3|COMPLETED|Overall Study||127
41093|NCT01809106|95515|P2|COMPLETED|Overall Study||125
41094|NCT01809106|95516|P1|COMPLETED|Overall Study||122
41095|NCT01809106|95513|P4|STARTED|Overall Study||128
41096|NCT01809106|95514|P3|STARTED|Overall Study||130
41097|NCT01809106|95515|P2|STARTED|Overall Study||130
41098|NCT01809106|95516|P1|STARTED|Overall Study||130
41099|NCT01809054|95536|P2|NOT COMPLETED|Overall Study||0
41100|NCT01809054|95537|P1|NOT COMPLETED|Overall Study||0
41101|NCT01809054|95536|P2|COMPLETED|Overall Study||22
41102|NCT01809054|95537|P1|COMPLETED|Overall Study||27
41103|NCT01809054|95536|P2|STARTED|Overall Study||22
41104|NCT01809054|95537|P1|STARTED|Overall Study||27
41105|NCT01808963|95545|P1|NOT COMPLETED|Overall Study||0
41106|NCT01808963|95545|P1|COMPLETED|Overall Study||13
41107|NCT01808963|95545|P1|STARTED|Overall Study||13
41108|NCT01808950|95552|P3|NOT COMPLETED|Overall Study||0
41109|NCT01808950|95553|P2|NOT COMPLETED|Overall Study||0
41110|NCT01808950|95554|P1|NOT COMPLETED|Overall Study||0
41111|NCT01808950|95552|P3|COMPLETED|Overall Study||0
41112|NCT01808950|95553|P2|COMPLETED|Overall Study||3
41113|NCT01808950|95554|P1|COMPLETED|Overall Study||1
41114|NCT01808950|95552|P3|STARTED|Overall Study||0
41115|NCT01808950|95553|P2|STARTED|Overall Study||3
41116|NCT01808950|95554|P1|STARTED|Overall Study||1
41117|NCT01808755|95565|P2|NOT COMPLETED|Overall Study||0
41118|NCT01808755|95566|P1|NOT COMPLETED|Overall Study||0
41119|NCT01808755|95565|P2|COMPLETED|Overall Study||30
41120|NCT01808755|95566|P1|COMPLETED|Overall Study||30
41121|NCT01808755|95565|P2|STARTED|Overall Study||30
41122|NCT01808755|95566|P1|STARTED|Overall Study||30
41123|NCT01808651|95574|P3|NOT COMPLETED|Study Period 2||0
41124|NCT01808651|95575|P2|NOT COMPLETED|Study Period 2||0
41125|NCT01808651|95576|P1|NOT COMPLETED|Study Period 2||0
41126|NCT01808651|95574|P3|COMPLETED|Study Period 2|3 Pts who DC'd from Study Period 1 and 30 pts who completed Study Period 1 entered Study Period 2.|33
41127|NCT01808651|95575|P2|COMPLETED|Study Period 2|5 Pts who DC'd from Study Period 1 and 47 Pts who completed Study Period 1 entered Study Period 2.|52
41128|NCT01808651|95576|P1|COMPLETED|Study Period 2|9 Pts who DC'd from Study Period 1 and 68 Pts who completed Study Period 1 entered Study Period 2.|77
41129|NCT01808651|95574|P3|STARTED|Study Period 2||33
41130|NCT01808651|95575|P2|STARTED|Study Period 2||52
41131|NCT01808651|95576|P1|STARTED|Study Period 2||77
41132|NCT01808651|95574|P3|NOT COMPLETED|Study Period 1||5
41133|NCT01808651|95575|P2|NOT COMPLETED|Study Period 1||17
41134|NCT01808651|95576|P1|NOT COMPLETED|Study Period 1||26
41135|NCT01808651|95574|P3|COMPLETED|Study Period 1||31
41136|NCT01808651|95575|P2|COMPLETED|Study Period 1||48
41137|NCT01808651|95576|P1|COMPLETED|Study Period 1||73
41138|NCT01808651|95574|P3|Received at Least One Dose of Study Drug|Study Period 1||36
41139|NCT01808651|95575|P2|Received at Least One Dose of Study Drug|Study Period 1||65
41140|NCT01808651|95576|P1|Received at Least One Dose of Study Drug|Study Period 1||98
41141|NCT01808651|95574|P3|STARTED|Study Period 1||36
41142|NCT01808651|95575|P2|STARTED|Study Period 1||65
41143|NCT01808651|95576|P1|STARTED|Study Period 1||99
41144|NCT01808612|95611|P3|NOT COMPLETED|Discontinuation Period||0
41145|NCT01808612|95612|P2|NOT COMPLETED|Discontinuation Period||1
41146|NCT01808612|95613|P1|NOT COMPLETED|Discontinuation Period||2
41147|NCT01808612|95611|P3|COMPLETED|Discontinuation Period||145
41148|NCT01808612|95612|P2|COMPLETED|Discontinuation Period||37
41149|NCT01808612|95613|P1|COMPLETED|Discontinuation Period||85
41150|NCT01808612|95611|P3|STARTED|Discontinuation Period||145
41151|NCT01808612|95612|P2|STARTED|Discontinuation Period||38
41152|NCT01808612|95613|P1|STARTED|Discontinuation Period||87
41153|NCT01808612|95611|P3|NOT COMPLETED|Treatment Period||14
41154|NCT01808612|95612|P2|NOT COMPLETED|Treatment Period||7
41155|NCT01808612|95613|P1|NOT COMPLETED|Treatment Period||15
41156|NCT01808612|95611|P3|COMPLETED|Treatment Period|101 participants who completed the Treatment Period did not enter the Discontinuation Period.|246
41157|NCT01808612|95612|P2|COMPLETED|Treatment Period|39 participants who completed the Treatment Period did not enter the Discontinuation Period.|77
41158|NCT01808612|95613|P1|COMPLETED|Treatment Period|67 participants who completed the Treatment Period did not enter the Discontinuation Period.|154
41159|NCT01808612|95611|P3|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|259
41160|NCT01808612|95612|P2|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|83
41161|NCT01808612|95613|P1|Received at Least 1 Dose of Study Drug|Treatment Period|Only these participants were included in the study analyses (ie, Full Analysis Set).|168
41162|NCT01808612|95611|P3|STARTED|Treatment Period||260
41163|NCT01808612|95612|P2|STARTED|Treatment Period||84
41164|NCT01808612|95613|P1|STARTED|Treatment Period||169
41165|NCT01808547|95644|P2|NOT COMPLETED|Overall Study||46
41166|NCT01808547|95645|P1|NOT COMPLETED|Overall Study||37
41167|NCT01808547|95644|P2|COMPLETED|Overall Study||48
41168|NCT01808547|95645|P1|COMPLETED|Overall Study||137
41169|NCT01808547|95644|P2|mITT Population|Overall Study||85
41170|NCT01808547|95645|P1|mITT Population|Overall Study||168
41171|NCT01808547|95644|P2|Safety Population|Overall Study||85
41172|NCT01808547|95645|P1|Safety Population|Overall Study||170
41173|NCT01808547|95644|P2|STARTED|Overall Study||94
41174|NCT01808547|95645|P1|STARTED|Overall Study||174
41175|NCT01808534|95651|P1|NOT COMPLETED|Overall Study||4
41176|NCT01808534|95651|P1|COMPLETED|Overall Study||1
41177|NCT01808534|95651|P1|STARTED|Overall Study||5
41178|NCT01808508|95662|P3|NOT COMPLETED|Overall Study||0
41179|NCT01808508|95663|P2|NOT COMPLETED|Overall Study||0
41180|NCT01808508|95664|P1|NOT COMPLETED|Overall Study||1
41181|NCT01808508|95662|P3|COMPLETED|Overall Study||3
41182|NCT01808508|95663|P2|COMPLETED|Overall Study||9
41183|NCT01808508|95664|P1|COMPLETED|Overall Study||10
41184|NCT01808508|95662|P3|STARTED|Overall Study||3
41185|NCT01808508|95663|P2|STARTED|Overall Study||9
41186|NCT01808508|95664|P1|STARTED|Overall Study||11
41187|NCT01808339|95681|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||0
41188|NCT01808339|95682|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
41189|NCT01808339|95683|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
41190|NCT01808339|95684|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
41191|NCT01808339|95685|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
41192|NCT01808339|95686|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
41193|NCT01808339|95681|P6|COMPLETED|Treatment Period 3 (14 Days)||5
41194|NCT01808339|95682|P5|COMPLETED|Treatment Period 3 (14 Days)||4
41195|NCT01808339|95683|P4|COMPLETED|Treatment Period 3 (14 Days)||2
41196|NCT01808339|95684|P3|COMPLETED|Treatment Period 3 (14 Days)||3
41197|NCT01808339|95685|P2|COMPLETED|Treatment Period 3 (14 Days)||3
41198|NCT01808339|95686|P1|COMPLETED|Treatment Period 3 (14 Days)||4
41199|NCT01808339|95681|P6|STARTED|Treatment Period 3 (14 Days)||5
41200|NCT01808339|95682|P5|STARTED|Treatment Period 3 (14 Days)||4
41201|NCT01808339|95683|P4|STARTED|Treatment Period 3 (14 Days)||2
41202|NCT01808339|95684|P3|STARTED|Treatment Period 3 (14 Days)||4
41203|NCT01808339|95685|P2|STARTED|Treatment Period 3 (14 Days)||3
41204|NCT01808339|95686|P1|STARTED|Treatment Period 3 (14 Days)||4
41205|NCT01808339|95681|P6|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
41206|NCT01808339|95682|P5|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
41207|NCT01808339|95683|P4|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
41208|NCT01808339|95684|P3|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
41209|NCT01808339|95685|P2|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
41210|NCT01808339|95686|P1|NOT COMPLETED|Washout Period 2 (14-21 Days)||0
41211|NCT01808339|95681|P6|COMPLETED|Washout Period 2 (14-21 Days)||5
41212|NCT01808339|95682|P5|COMPLETED|Washout Period 2 (14-21 Days)||4
41213|NCT01808339|95683|P4|COMPLETED|Washout Period 2 (14-21 Days)||2
41214|NCT01808339|95684|P3|COMPLETED|Washout Period 2 (14-21 Days)||4
41215|NCT01808339|95685|P2|COMPLETED|Washout Period 2 (14-21 Days)||3
41216|NCT01808339|95686|P1|COMPLETED|Washout Period 2 (14-21 Days)||4
41217|NCT01808339|95681|P6|STARTED|Washout Period 2 (14-21 Days)||5
41218|NCT01808339|95682|P5|STARTED|Washout Period 2 (14-21 Days)||4
41219|NCT01808339|95683|P4|STARTED|Washout Period 2 (14-21 Days)||2
41220|NCT01808339|95684|P3|STARTED|Washout Period 2 (14-21 Days)||4
41221|NCT01808339|95685|P2|STARTED|Washout Period 2 (14-21 Days)||3
41222|NCT01808339|95686|P1|STARTED|Washout Period 2 (14-21 Days)||4
41223|NCT01808339|95681|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
41224|NCT01808339|95682|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
41225|NCT01808339|95683|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||0
41226|NCT01808339|95684|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
41227|NCT01808339|95685|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
41228|NCT01808339|95686|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
41229|NCT01808339|95681|P6|COMPLETED|Treatment Period 2 (14 Days)||5
41230|NCT01808339|95682|P5|COMPLETED|Treatment Period 2 (14 Days)||4
41231|NCT01808339|95683|P4|COMPLETED|Treatment Period 2 (14 Days)||2
41232|NCT01808339|95684|P3|COMPLETED|Treatment Period 2 (14 Days)||4
41233|NCT01808339|95685|P2|COMPLETED|Treatment Period 2 (14 Days)||3
41234|NCT01808339|95686|P1|COMPLETED|Treatment Period 2 (14 Days)||4
41235|NCT01808339|95681|P6|STARTED|Treatment Period 2 (14 Days)||5
41236|NCT01808339|95682|P5|STARTED|Treatment Period 2 (14 Days)||4
41237|NCT01808339|95683|P4|STARTED|Treatment Period 2 (14 Days)||2
41238|NCT01808339|95684|P3|STARTED|Treatment Period 2 (14 Days)||4
41239|NCT01808339|95685|P2|STARTED|Treatment Period 2 (14 Days)||3
41240|NCT01808339|95686|P1|STARTED|Treatment Period 2 (14 Days)||4
41241|NCT01808339|95681|P6|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
41242|NCT01808339|95682|P5|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
41243|NCT01808339|95683|P4|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
41244|NCT01808339|95684|P3|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
41245|NCT01808339|95685|P2|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
41246|NCT01808339|95686|P1|NOT COMPLETED|Washout Period 1 (14-21 Days)||0
41247|NCT01808339|95681|P6|COMPLETED|Washout Period 1 (14-21 Days)||5
41248|NCT01808339|95682|P5|COMPLETED|Washout Period 1 (14-21 Days)||4
41249|NCT01808339|95683|P4|COMPLETED|Washout Period 1 (14-21 Days)||2
41250|NCT01808339|95684|P3|COMPLETED|Washout Period 1 (14-21 Days)||4
41251|NCT01808339|95685|P2|COMPLETED|Washout Period 1 (14-21 Days)||3
41252|NCT01808339|95686|P1|COMPLETED|Washout Period 1 (14-21 Days)||4
41253|NCT01808339|95681|P6|STARTED|Washout Period 1 (14-21 Days)||5
41254|NCT01808339|95682|P5|STARTED|Washout Period 1 (14-21 Days)||4
41255|NCT01808339|95683|P4|STARTED|Washout Period 1 (14-21 Days)||2
41256|NCT01808339|95684|P3|STARTED|Washout Period 1 (14-21 Days)||4
41257|NCT01808339|95685|P2|STARTED|Washout Period 1 (14-21 Days)||3
41258|NCT01808339|95686|P1|STARTED|Washout Period 1 (14-21 Days)||4
41259|NCT01808339|95681|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
41260|NCT01808339|95682|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||2
41261|NCT01808339|95683|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||2
41262|NCT01808339|95684|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||0
41263|NCT01808339|95685|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
41264|NCT01808339|95686|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||0
41265|NCT01808339|95681|P6|COMPLETED|Treatment Period 1 (14 Days)||5
41266|NCT01808339|95682|P5|COMPLETED|Treatment Period 1 (14 Days)||4
41267|NCT01808339|95683|P4|COMPLETED|Treatment Period 1 (14 Days)||2
41268|NCT01808339|95684|P3|COMPLETED|Treatment Period 1 (14 Days)||4
41269|NCT01808339|95685|P2|COMPLETED|Treatment Period 1 (14 Days)||3
41270|NCT01808339|95686|P1|COMPLETED|Treatment Period 1 (14 Days)||4
41271|NCT01808339|95681|P6|STARTED|Treatment Period 1 (14 Days)||6
41272|NCT01808339|95682|P5|STARTED|Treatment Period 1 (14 Days)||6
41273|NCT01808339|95683|P4|STARTED|Treatment Period 1 (14 Days)||4
41274|NCT01808339|95684|P3|STARTED|Treatment Period 1 (14 Days)||4
41275|NCT01808339|95685|P2|STARTED|Treatment Period 1 (14 Days)||4
41276|NCT01808339|95686|P1|STARTED|Treatment Period 1 (14 Days)||4
41277|NCT01808326|95703|P1|NOT COMPLETED|Overall Study||0
41278|NCT01808326|95703|P1|COMPLETED|Overall Study||5
41279|NCT01808326|95703|P1|STARTED|Overall Study||5
41280|NCT01808313|95730|P1|NOT COMPLETED|Overall Study||10
41281|NCT01808313|95730|P1|COMPLETED|Overall Study||123
41282|NCT01808313|95730|P1|STARTED|Overall Study||133
41283|NCT01808248|95760|P1|NOT COMPLETED|Overall Study||5
41284|NCT01808248|95760|P1|COMPLETED|Overall Study||42
41285|NCT01808248|95760|P1|Completed Posttreatment Week 12 Visit|Overall Study||45
41286|NCT01808248|95760|P1|STARTED|Overall Study||47
41287|NCT01808209|95774|P2|NOT COMPLETED|Overall Study||1
41288|NCT01808209|95775|P1|NOT COMPLETED|Overall Study||0
41289|NCT01808209|95774|P2|COMPLETED|Overall Study||26
41290|NCT01808209|95775|P1|COMPLETED|Overall Study||33
41291|NCT01808209|95774|P2|STARTED|Overall Study||27
41292|NCT01808209|95775|P1|STARTED|Overall Study||33
41293|NCT01808092|95819|P2|NOT COMPLETED|Overall Study||45
41294|NCT01808092|95820|P1|NOT COMPLETED|Overall Study||54
41295|NCT01808092|95819|P2|COMPLETED|Overall Study||363
41296|NCT01808092|95820|P1|COMPLETED|Overall Study||355
41297|NCT01808092|95819|P2|STARTED|Overall Study||408
41298|NCT01808092|95820|P1|STARTED|Overall Study||409
41299|NCT01808066|95922|P1|NOT COMPLETED|Overall Study||15
41300|NCT01808066|95922|P1|COMPLETED|Overall Study||6
41301|NCT01808066|95922|P1|STARTED|Overall Study||21
41302|NCT01807949|95929|P3|NOT COMPLETED|Overall Study||9
41303|NCT01807949|95930|P2|NOT COMPLETED|Overall Study||7
41304|NCT01807949|95931|P1|NOT COMPLETED|Overall Study||2
41305|NCT01807949|95929|P3|COMPLETED|Overall Study||180
41306|NCT01807949|95930|P2|COMPLETED|Overall Study||180
41307|NCT01807949|95931|P1|COMPLETED|Overall Study||185
41308|NCT01807949|95929|P3|STARTED|Overall Study||189
41309|NCT01807949|95930|P2|STARTED|Overall Study||187
41310|NCT01807949|95931|P1|STARTED|Overall Study||187
41311|NCT01807923|95983|P3|NOT COMPLETED|Overall Study||11
41312|NCT01807923|95984|P2|NOT COMPLETED|Overall Study||6
41313|NCT01807923|95985|P1|NOT COMPLETED|Overall Study||5
41314|NCT01807923|95983|P3|COMPLETED|Overall Study||176
41315|NCT01807923|95984|P2|COMPLETED|Overall Study||179
41316|NCT01807923|95985|P1|COMPLETED|Overall Study||182
41317|NCT01807923|95983|P3|STARTED|Overall Study||187
41318|NCT01807923|95984|P2|STARTED|Overall Study||185
41319|NCT01807923|95985|P1|STARTED|Overall Study||187
41320|NCT01807871|96036|P2|NOT COMPLETED|Overall Study||218
41321|NCT01807871|96037|P1|NOT COMPLETED|Overall Study||178
41322|NCT01807871|96036|P2|COMPLETED|Overall Study||127
41323|NCT01807871|96037|P1|COMPLETED|Overall Study||178
41324|NCT01807871|96036|P2|STARTED|Overall Study||345
41325|NCT01807871|96037|P1|STARTED|Overall Study||356
41326|NCT01807624|96047|P1|NOT COMPLETED|Overall Study||0
41327|NCT01807624|96047|P1|COMPLETED|Overall Study||24
41328|NCT01807624|96047|P1|STARTED|Overall Study||24
41329|NCT01807455|96063|P1|NOT COMPLETED|Overall Study||0
41330|NCT01807455|96063|P1|COMPLETED|Overall Study||12
41331|NCT01807455|96063|P1|STARTED|Overall Study||12
41332|NCT01807234|96077|P6|NOT COMPLETED|Overall Study||4
41333|NCT01807234|96078|P5|NOT COMPLETED|Overall Study||4
41334|NCT01807234|96079|P4|NOT COMPLETED|Overall Study||2
41335|NCT01807234|96080|P3|NOT COMPLETED|Overall Study||2
41336|NCT01807234|96081|P2|NOT COMPLETED|Overall Study||6
41337|NCT01807234|96082|P1|NOT COMPLETED|Overall Study||5
41338|NCT01807234|96077|P6|COMPLETED|Overall Study||8
41339|NCT01807234|96078|P5|COMPLETED|Overall Study||8
41340|NCT01807234|96079|P4|COMPLETED|Overall Study||10
41341|NCT01807234|96080|P3|COMPLETED|Overall Study||10
41342|NCT01807234|96081|P2|COMPLETED|Overall Study||6
41343|NCT01807234|96082|P1|COMPLETED|Overall Study||7
41344|NCT01807234|96077|P6|Completed Only 1 Attack|Overall Study||1
41345|NCT01807234|96078|P5|Completed Only 1 Attack|Overall Study||0
41346|NCT01807234|96079|P4|Completed Only 1 Attack|Overall Study||1
41347|NCT01807234|96080|P3|Completed Only 1 Attack|Overall Study||0
41348|NCT01807234|96081|P2|Completed Only 1 Attack|Overall Study||1
41349|NCT01807234|96082|P1|Completed Only 1 Attack|Overall Study||2
41350|NCT01807234|96077|P6|Randomized, But Did Not Take Drug|Overall Study||3
41351|NCT01807234|96078|P5|Randomized, But Did Not Take Drug|Overall Study||4
41352|NCT01807234|96079|P4|Randomized, But Did Not Take Drug|Overall Study||1
41353|NCT01807234|96080|P3|Randomized, But Did Not Take Drug|Overall Study||2
41354|NCT01807234|96081|P2|Randomized, But Did Not Take Drug|Overall Study||5
41355|NCT01807234|96082|P1|Randomized, But Did Not Take Drug|Overall Study||3
41356|NCT01807234|96077|P6|STARTED|Overall Study||12
41357|NCT01807234|96078|P5|STARTED|Overall Study||12
41358|NCT01807234|96079|P4|STARTED|Overall Study||12
41359|NCT01807234|96080|P3|STARTED|Overall Study||12
41360|NCT01807234|96081|P2|STARTED|Overall Study||12
41361|NCT01807234|96082|P1|STARTED|Overall Study||12
41362|NCT01807156|96117|P1|NOT COMPLETED|Overall Study||1
41363|NCT01807156|96117|P1|COMPLETED|Overall Study||6
41364|NCT01807156|96117|P1|STARTED|Overall Study||7
41365|NCT01807000|96122|P1|NOT COMPLETED|Overall Study||0
41366|NCT01807000|96122|P1|COMPLETED|Overall Study||6
41367|NCT01807000|96122|P1|STARTED|Overall Study||6
41368|NCT01806961|96141|P1|NOT COMPLETED|Overall Study||16
41369|NCT01806961|96141|P1|COMPLETED|Overall Study||0
41370|NCT01806961|96141|P1|STARTED|Overall Study||16
41371|NCT01806857|96145|P2|NOT COMPLETED|Overall Study||0
41372|NCT01806857|96146|P1|NOT COMPLETED|Overall Study||1
41373|NCT01806857|96145|P2|COMPLETED|Overall Study||29
41374|NCT01806857|96146|P1|COMPLETED|Overall Study||30
41375|NCT01806857|96145|P2|STARTED|Overall Study||29
41376|NCT01806857|96146|P1|STARTED|Overall Study||31
41377|NCT01806779|96184|P3|NOT COMPLETED|Overall Study||23
41378|NCT01806779|96185|P2|NOT COMPLETED|Overall Study||44
41379|NCT01806779|96186|P1|NOT COMPLETED|Overall Study||42
41380|NCT01806779|96184|P3|COMPLETED|Overall Study||0
41381|NCT01806779|96185|P2|COMPLETED|Overall Study||40
41382|NCT01806779|96186|P1|COMPLETED|Overall Study||48
41383|NCT01806779|96184|P3|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|0
41384|NCT01806779|96185|P2|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|83
41385|NCT01806779|96186|P1|Completed SE Quest. After Randomization|Overall Study|SE quest. = Side Effects Questionnaire|87
41386|NCT01806779|96184|P3|Randomized at Visit 2|Overall Study||0
41387|NCT01806779|96185|P2|Randomized at Visit 2|Overall Study||84
41388|NCT01806779|96186|P1|Randomized at Visit 2|Overall Study||90
41389|NCT01806779|96184|P3|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|2
41390|NCT01806779|96185|P2|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|84
41391|NCT01806779|96186|P1|Completed SE Quest. After Using Patches|Overall Study|SE quest. = Side Effects Questionnaire|90
41392|NCT01806779|96184|P3|STARTED|Overall Study|All 197 subjects received nicotine patches but 23 dropped before receiving other study drugs.|23
41393|NCT01806779|96185|P2|STARTED|Overall Study||84
41394|NCT01806779|96186|P1|STARTED|Overall Study||90
41395|NCT01806714|96201|P2|NOT COMPLETED|Overall Study||170
41396|NCT01806714|96202|P1|NOT COMPLETED|Overall Study||200
41397|NCT01806714|96201|P2|COMPLETED|Overall Study||1919
41398|NCT01806714|96202|P1|COMPLETED|Overall Study||1893
41399|NCT01806714|96201|P2|STARTED|Overall Study||2089
41400|NCT01806714|96202|P1|STARTED|Overall Study||2093
41401|NCT01806623|96212|P1|NOT COMPLETED|Overall Study||58
41402|NCT01806623|96212|P1|COMPLETED|Overall Study||99
41403|NCT01806623|96212|P1|STARTED|Overall Study||157
41404|NCT01806584|96231|P2|NOT COMPLETED|Overall Study||18
41405|NCT01806584|96232|P1|NOT COMPLETED|Overall Study||14
41406|NCT01806584|96231|P2|COMPLETED|Overall Study||0
41407|NCT01806584|96232|P1|COMPLETED|Overall Study||0
41408|NCT01806584|96231|P2|STARTED|Overall Study||18
41409|NCT01806584|96232|P1|STARTED|Overall Study||14
41410|NCT01806545|96246|P2|NOT COMPLETED|Overall Study||5
41411|NCT01806545|96247|P1|NOT COMPLETED|Overall Study||6
41412|NCT01806545|96246|P2|COMPLETED|Overall Study||30
41413|NCT01806545|96247|P1|COMPLETED|Overall Study||23
41414|NCT01806545|96246|P2|STARTED|Overall Study||35
41415|NCT01806545|96247|P1|STARTED|Overall Study||29
41416|NCT01806389|96269|P1|NOT COMPLETED|Overall Study||4
41417|NCT01806389|96269|P1|COMPLETED|Overall Study||10
41418|NCT01806389|96269|P1|STARTED|Overall Study||14
41419|NCT01806298|96283|P1|NOT COMPLETED|Overall Study||10
41420|NCT01806298|96283|P1|COMPLETED|Overall Study||68
41421|NCT01806298|96283|P1|STARTED|Overall Study||78
41422|NCT01806051|96293|P1|NOT COMPLETED|Overall Study||6
41423|NCT01806051|96293|P1|COMPLETED|Overall Study||0
41424|NCT01806051|96293|P1|STARTED|Overall Study||6
41425|NCT01805882|96308|P9|NOT COMPLETED|Overall Study||1
41426|NCT01805882|96309|P8|NOT COMPLETED|Overall Study||0
41427|NCT01805882|96310|P7|NOT COMPLETED|Overall Study||2
41428|NCT01805882|96311|P6|NOT COMPLETED|Overall Study||1
41429|NCT01805882|96312|P5|NOT COMPLETED|Overall Study||0
41430|NCT01805882|96313|P4|NOT COMPLETED|Overall Study||2
41431|NCT01805882|96314|P3|NOT COMPLETED|Overall Study||1
41432|NCT01805882|96315|P2|NOT COMPLETED|Overall Study||0
41433|NCT01805882|96316|P1|NOT COMPLETED|Overall Study||0
41434|NCT01805882|96308|P9|COMPLETED|Overall Study||24
41435|NCT01805882|96309|P8|COMPLETED|Overall Study||25
41436|NCT01805882|96310|P7|COMPLETED|Overall Study||48
41437|NCT01805882|96311|P6|COMPLETED|Overall Study||20
41438|NCT01805882|96312|P5|COMPLETED|Overall Study||14
41439|NCT01805882|96313|P4|COMPLETED|Overall Study||32
41440|NCT01805882|96314|P3|COMPLETED|Overall Study||19
41441|NCT01805882|96315|P2|COMPLETED|Overall Study||20
41442|NCT01805882|96316|P1|COMPLETED|Overall Study||20
41443|NCT01805882|96308|P9|STARTED|Overall Study||25
41444|NCT01805882|96309|P8|STARTED|Overall Study||25
41445|NCT01805882|96310|P7|STARTED|Overall Study||50
41446|NCT01805882|96311|P6|STARTED|Overall Study||21
41447|NCT01805882|96312|P5|STARTED|Overall Study||14
41448|NCT01805882|96313|P4|STARTED|Overall Study||34
41449|NCT01805882|96314|P3|STARTED|Overall Study||20
41450|NCT01805882|96315|P2|STARTED|Overall Study||20
41451|NCT01805882|96316|P1|STARTED|Overall Study||20
41452|NCT01805687|96336|P1|NOT COMPLETED|Overall Study||0
41453|NCT01805687|96336|P1|COMPLETED|Overall Study||25
41454|NCT01805687|96336|P1|STARTED|Overall Study||25
41455|NCT01805323|96340|P1|NOT COMPLETED|Overall Study||0
41456|NCT01805323|96340|P1|COMPLETED|Overall Study||101
41457|NCT01805323|96340|P1|STARTED|Overall Study||101
41458|NCT01805180|96347|P3|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
41459|NCT01805180|96348|P2|NOT COMPLETED|Pivotal Randomization Through Study Exit||5
41460|NCT01805180|96349|P1|NOT COMPLETED|Pivotal Randomization Through Study Exit||0
41461|NCT01805180|96347|P3|COMPLETED|Pivotal Randomization Through Study Exit||15
41462|NCT01805180|96348|P2|COMPLETED|Pivotal Randomization Through Study Exit||17
41463|NCT01805180|96349|P1|COMPLETED|Pivotal Randomization Through Study Exit||0
41464|NCT01805180|96347|P3|STARTED|Pivotal Randomization Through Study Exit||20
41465|NCT01805180|96348|P2|STARTED|Pivotal Randomization Through Study Exit||22
41466|NCT01805180|96349|P1|STARTED|Pivotal Randomization Through Study Exit|lead-in donors were not randomized and did not participate in this period.|0
41467|NCT01805180|96347|P3|NOT COMPLETED|Lead-in Donor Phase||0
41468|NCT01805180|96348|P2|NOT COMPLETED|Lead-in Donor Phase||0
41469|NCT01805180|96349|P1|NOT COMPLETED|Lead-in Donor Phase||1
41470|NCT01805180|96347|P3|COMPLETED|Lead-in Donor Phase||0
41471|NCT01805180|96348|P2|COMPLETED|Lead-in Donor Phase||0
41472|NCT01805180|96349|P1|COMPLETED|Lead-in Donor Phase||6
41473|NCT01805180|96347|P3|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
41567|NCT01802632|96579|P2|STARTED|Overall Study||31
41474|NCT01805180|96348|P2|STARTED|Lead-in Donor Phase|pivotal trial subjects were not screened or enrolled in this period.|0
41475|NCT01805180|96349|P1|STARTED|Lead-in Donor Phase||7
41476|NCT01805089|96374|P2|NOT COMPLETED|Overall Study||4
41477|NCT01805089|96375|P1|NOT COMPLETED|Overall Study||5
41478|NCT01805089|96374|P2|COMPLETED|Overall Study||43
41479|NCT01805089|96375|P1|COMPLETED|Overall Study||43
41480|NCT01805089|96374|P2|STARTED|Overall Study||47
41481|NCT01805089|96375|P1|STARTED|Overall Study||48
41482|NCT01804946|96387|P2|NOT COMPLETED|Overall Study||4
41483|NCT01804946|96388|P1|NOT COMPLETED|Overall Study||2
41484|NCT01804946|96387|P2|COMPLETED|Overall Study||76
41485|NCT01804946|96388|P1|COMPLETED|Overall Study||79
41486|NCT01804946|96387|P2|STARTED|Overall Study||80
41487|NCT01804946|96388|P1|STARTED|Overall Study||81
41488|NCT01804881|96412|P2|NOT COMPLETED|Overall Study||4
41489|NCT01804881|96413|P1|NOT COMPLETED|Overall Study||5
41490|NCT01804881|96412|P2|COMPLETED|Overall Study||10
41491|NCT01804881|96413|P1|COMPLETED|Overall Study||11
41492|NCT01804881|96412|P2|STARTED|Overall Study||14
41493|NCT01804881|96413|P1|STARTED|Overall Study||16
41494|NCT01804842|96426|P3|NOT COMPLETED|Overall Study||1
41495|NCT01804842|96427|P2|NOT COMPLETED|Overall Study||2
41496|NCT01804842|96428|P1|NOT COMPLETED|Overall Study||3
41497|NCT01804842|96426|P3|COMPLETED|Overall Study||8
41498|NCT01804842|96427|P2|COMPLETED|Overall Study||6
41499|NCT01804842|96428|P1|COMPLETED|Overall Study||6
41500|NCT01804842|96426|P3|Completed Treatment C|Overall Study||9
41501|NCT01804842|96427|P2|Completed Treatment C|Overall Study||7
41502|NCT01804842|96428|P1|Completed Treatment C|Overall Study||7
41503|NCT01804842|96426|P3|Completed Treatment B|Overall Study||8
41504|NCT01804842|96427|P2|Completed Treatment B|Overall Study||8
41505|NCT01804842|96428|P1|Completed Treatment B|Overall Study||8
41506|NCT01804842|96426|P3|Completed Treatment A|Overall Study||8
41507|NCT01804842|96427|P2|Completed Treatment A|Overall Study||6
41508|NCT01804842|96428|P1|Completed Treatment A|Overall Study||9
41509|NCT01804842|96426|P3|STARTED|Overall Study||9
41510|NCT01804842|96427|P2|STARTED|Overall Study||8
41511|NCT01804842|96428|P1|STARTED|Overall Study||9
41512|NCT01804673|96445|P1|NOT COMPLETED|Overall Study||140
41513|NCT01804673|96445|P1|COMPLETED|Overall Study||34
41514|NCT01804673|96445|P1|Completed Hour 72|Overall Study||36
41515|NCT01804673|96445|P1|Completed Hour 48|Overall Study||79
41516|NCT01804673|96445|P1|Completed Hour 24|Overall Study||170
41517|NCT01804673|96445|P1|STARTED|Overall Study||174
41518|NCT01804257|96461|P1|NOT COMPLETED|Overall Study||1
41519|NCT01804257|96461|P1|COMPLETED|Overall Study||27
41520|NCT01804257|96461|P1|STARTED|Overall Study||28
41521|NCT01804140|96465|P1|NOT COMPLETED|Overall Study||114
41522|NCT01804140|96465|P1|COMPLETED|Overall Study|This includes all the participants with mutation results from the sampling or biopsy procedures.|548
41523|NCT01804140|96465|P1|STARTED|Overall Study|This includes all the participants who were enrolled for this study.|662
41524|NCT01804075|96472|P2|NOT COMPLETED|Overall Study||0
41525|NCT01804075|96473|P1|NOT COMPLETED|Overall Study||0
41526|NCT01804075|96472|P2|COMPLETED|Overall Study||16
41527|NCT01804075|96473|P1|COMPLETED|Overall Study||15
41528|NCT01804075|96472|P2|STARTED|Overall Study||16
41529|NCT01804075|96473|P1|STARTED|Overall Study||15
41530|NCT01804062|96481|P1|NOT COMPLETED|Overall Study||0
41531|NCT01804062|96481|P1|COMPLETED|Overall Study||30
41532|NCT01804062|96481|P1|STARTED|Overall Study||30
41533|NCT01804036|96488|P2|NOT COMPLETED|Overall Study||20
41534|NCT01804036|96489|P1|NOT COMPLETED|Overall Study||13
41535|NCT01804036|96488|P2|COMPLETED|Overall Study||21
41536|NCT01804036|96489|P1|COMPLETED|Overall Study||18
41537|NCT01804036|96488|P2|STARTED|Overall Study||41
41538|NCT01804036|96489|P1|STARTED|Overall Study||31
41539|NCT01803737|96523|P2|NOT COMPLETED|Overall Study||3
41540|NCT01803737|96524|P1|NOT COMPLETED|Overall Study||1
41541|NCT01803737|96523|P2|COMPLETED|Overall Study||10
41542|NCT01803737|96524|P1|COMPLETED|Overall Study||12
41543|NCT01803737|96523|P2|STARTED|Overall Study||13
41544|NCT01803737|96524|P1|STARTED|Overall Study||13
41545|NCT01803607|96548|P2|NOT COMPLETED|Overall Study||67
41546|NCT01803607|96549|P1|NOT COMPLETED|Overall Study||68
41547|NCT01803607|96548|P2|COMPLETED|Overall Study||0
41548|NCT01803607|96549|P1|COMPLETED|Overall Study||0
41549|NCT01803607|96548|P2|STARTED|Overall Study||67
41550|NCT01803607|96549|P1|STARTED|Overall Study||68
41551|NCT01802632|96575|P6|NOT COMPLETED|Overall Study||28
41552|NCT01802632|96576|P5|NOT COMPLETED|Overall Study||12
41553|NCT01802632|96577|P4|NOT COMPLETED|Overall Study||60
41554|NCT01802632|96578|P3|NOT COMPLETED|Overall Study||271
41555|NCT01802632|96579|P2|NOT COMPLETED|Overall Study||31
41556|NCT01802632|96580|P1|NOT COMPLETED|Overall Study||201
41557|NCT01802632|96575|P6|COMPLETED|Overall Study||0
41558|NCT01802632|96576|P5|COMPLETED|Overall Study||0
41559|NCT01802632|96577|P4|COMPLETED|Overall Study||0
41560|NCT01802632|96578|P3|COMPLETED|Overall Study||0
41561|NCT01802632|96579|P2|COMPLETED|Overall Study||0
41562|NCT01802632|96580|P1|COMPLETED|Overall Study||0
41563|NCT01802632|96575|P6|STARTED|Overall Study||28
41564|NCT01802632|96576|P5|STARTED|Overall Study||12
41565|NCT01802632|96577|P4|STARTED|Overall Study||60
41566|NCT01802632|96578|P3|STARTED|Overall Study||271
41568|NCT01802632|96580|P1|STARTED|Overall Study||201
41569|NCT01802554|96596|P2|NOT COMPLETED|Overall Study||6
41570|NCT01802554|96597|P1|NOT COMPLETED|Overall Study||8
41571|NCT01802554|96596|P2|COMPLETED|Overall Study||43
41572|NCT01802554|96597|P1|COMPLETED|Overall Study||43
41573|NCT01802554|96596|P2|STARTED|Overall Study||49
41574|NCT01802554|96597|P1|STARTED|Overall Study||51
41575|NCT01802515|96614|P3|NOT COMPLETED|Overall Study||0
41576|NCT01802515|96615|P2|NOT COMPLETED|Overall Study||0
41577|NCT01802515|96616|P1|NOT COMPLETED|Overall Study||3
41578|NCT01802515|96614|P3|COMPLETED|Overall Study||4
41579|NCT01802515|96615|P2|COMPLETED|Overall Study||5
41580|NCT01802515|96616|P1|COMPLETED|Overall Study||2
41581|NCT01802515|96614|P3|STARTED|Overall Study||4
41582|NCT01802515|96615|P2|STARTED|Overall Study||5
41583|NCT01802515|96616|P1|STARTED|Overall Study||5
41584|NCT01802320|96627|P1|NOT COMPLETED|Overall Study||2
41585|NCT01802320|96627|P1|COMPLETED|Overall Study||16
41586|NCT01802320|96627|P1|STARTED|Overall Study||18
41587|NCT01802151|96636|P4|NOT COMPLETED|Overall Study||0
41588|NCT01802151|96637|P3|NOT COMPLETED|Overall Study||2
41589|NCT01802151|96638|P2|NOT COMPLETED|Overall Study||0
41590|NCT01802151|96639|P1|NOT COMPLETED|Overall Study||0
41591|NCT01802151|96636|P4|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
41592|NCT01802151|96637|P3|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
41593|NCT01802151|96638|P2|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|21
41594|NCT01802151|96639|P1|COMPLETED|Overall Study|Participants were enrolled and randomized in five waves. The final wave's data collection ended 9/20|20
41595|NCT01802151|96636|P4|STARTED|Overall Study||20
41596|NCT01802151|96637|P3|STARTED|Overall Study||22
41597|NCT01802151|96638|P2|STARTED|Overall Study||21
41598|NCT01802151|96639|P1|STARTED|Overall Study||20
41599|NCT01801982|96701|P1|NOT COMPLETED|Overall Study||1
41600|NCT01801982|96701|P1|COMPLETED|Overall Study||0
41601|NCT01801982|96701|P1|STARTED|Overall Study||1
41602|NCT01801735|96711|P1|NOT COMPLETED|Overall Study||210
41603|NCT01801735|96711|P1|COMPLETED|Overall Study||390
41604|NCT01801735|96711|P1|STARTED|Overall Study||600
41605|NCT01801475|96718|P5|NOT COMPLETED|Overall Study||1
41606|NCT01801475|96719|P4|NOT COMPLETED|Overall Study||0
41607|NCT01801475|96720|P3|NOT COMPLETED|Overall Study||0
41608|NCT01801475|96721|P2|NOT COMPLETED|Overall Study||0
41609|NCT01801475|96722|P1|NOT COMPLETED|Overall Study||0
41610|NCT01801475|96718|P5|COMPLETED|Overall Study||39
41611|NCT01801475|96719|P4|COMPLETED|Overall Study||10
41612|NCT01801475|96720|P3|COMPLETED|Overall Study||10
41613|NCT01801475|96721|P2|COMPLETED|Overall Study||30
41614|NCT01801475|96722|P1|COMPLETED|Overall Study||10
41615|NCT01801475|96718|P5|STARTED|Overall Study||40
41616|NCT01801475|96719|P4|STARTED|Overall Study||10
41617|NCT01801475|96720|P3|STARTED|Overall Study||10
41618|NCT01801475|96721|P2|STARTED|Overall Study||30
41619|NCT01801475|96722|P1|STARTED|Overall Study||10
41620|NCT01801436|96733|P1|NOT COMPLETED|Overall Study||9
41621|NCT01801436|96733|P1|COMPLETED|Overall Study||5
41622|NCT01801436|96733|P1|STARTED|Overall Study||14
41623|NCT01801358|96771|P6|NOT COMPLETED|Overall Study||8
41624|NCT01801358|96772|P5|NOT COMPLETED|Overall Study||6
41625|NCT01801358|96773|P4|NOT COMPLETED|Overall Study||6
41626|NCT01801358|96774|P3|NOT COMPLETED|Overall Study||6
41627|NCT01801358|96775|P2|NOT COMPLETED|Overall Study||6
41628|NCT01801358|96776|P1|NOT COMPLETED|Overall Study||6
41629|NCT01801358|96771|P6|COMPLETED|Overall Study||0
41630|NCT01801358|96772|P5|COMPLETED|Overall Study||0
41631|NCT01801358|96773|P4|COMPLETED|Overall Study||0
41632|NCT01801358|96774|P3|COMPLETED|Overall Study||0
41633|NCT01801358|96775|P2|COMPLETED|Overall Study||0
41634|NCT01801358|96776|P1|COMPLETED|Overall Study||0
41635|NCT01801358|96771|P6|STARTED|Overall Study||8
41636|NCT01801358|96772|P5|STARTED|Overall Study||6
41637|NCT01801358|96773|P4|STARTED|Overall Study||6
41638|NCT01801358|96774|P3|STARTED|Overall Study||6
41639|NCT01801358|96775|P2|STARTED|Overall Study||6
41640|NCT01801358|96776|P1|STARTED|Overall Study||6
41641|NCT01801280|96898|P4|NOT COMPLETED|Period 4||0
41642|NCT01801280|96899|P3|NOT COMPLETED|Period 4||1
41643|NCT01801280|96900|P2|NOT COMPLETED|Period 4||0
41644|NCT01801280|96901|P1|NOT COMPLETED|Period 4||0
41645|NCT01801280|96898|P4|COMPLETED|Period 4||5
41646|NCT01801280|96899|P3|COMPLETED|Period 4||4
41647|NCT01801280|96900|P2|COMPLETED|Period 4||4
41648|NCT01801280|96901|P1|COMPLETED|Period 4||4
41649|NCT01801280|96898|P4|STARTED|Period 4||5
41650|NCT01801280|96899|P3|STARTED|Period 4||5
41651|NCT01801280|96900|P2|STARTED|Period 4||4
41652|NCT01801280|96901|P1|STARTED|Period 4||4
41653|NCT01801280|96898|P4|NOT COMPLETED|Period 3||0
41654|NCT01801280|96899|P3|NOT COMPLETED|Period 3||0
41655|NCT01801280|96900|P2|NOT COMPLETED|Period 3||0
41656|NCT01801280|96901|P1|NOT COMPLETED|Period 3||0
41657|NCT01801280|96898|P4|COMPLETED|Period 3||5
41658|NCT01801280|96899|P3|COMPLETED|Period 3||5
41659|NCT01801280|96900|P2|COMPLETED|Period 3||4
41660|NCT01801280|96901|P1|COMPLETED|Period 3||4
41661|NCT01801280|96898|P4|STARTED|Period 3||5
41662|NCT01801280|96899|P3|STARTED|Period 3||5
41663|NCT01801280|96900|P2|STARTED|Period 3||4
41664|NCT01801280|96901|P1|STARTED|Period 3||4
41665|NCT01801280|96898|P4|NOT COMPLETED|Period 2||0
41666|NCT01801280|96899|P3|NOT COMPLETED|Period 2||0
41667|NCT01801280|96900|P2|NOT COMPLETED|Period 2||0
41668|NCT01801280|96901|P1|NOT COMPLETED|Period 2||1
41669|NCT01801280|96898|P4|COMPLETED|Period 2||5
41670|NCT01801280|96899|P3|COMPLETED|Period 2||5
41671|NCT01801280|96900|P2|COMPLETED|Period 2||4
41672|NCT01801280|96901|P1|COMPLETED|Period 2||4
41673|NCT01801280|96898|P4|STARTED|Period 2||5
41674|NCT01801280|96899|P3|STARTED|Period 2||5
41675|NCT01801280|96900|P2|STARTED|Period 2||4
41676|NCT01801280|96901|P1|STARTED|Period 2||5
41677|NCT01801280|96898|P4|NOT COMPLETED|Period 1||0
41678|NCT01801280|96899|P3|NOT COMPLETED|Period 1||0
41679|NCT01801280|96900|P2|NOT COMPLETED|Period 1||1
41680|NCT01801280|96901|P1|NOT COMPLETED|Period 1||0
41681|NCT01801280|96898|P4|COMPLETED|Period 1||5
41682|NCT01801280|96899|P3|COMPLETED|Period 1||5
41683|NCT01801280|96900|P2|COMPLETED|Period 1||4
41684|NCT01801280|96901|P1|COMPLETED|Period 1||5
41685|NCT01801280|96898|P4|STARTED|Period 1||5
41686|NCT01801280|96899|P3|STARTED|Period 1||5
41687|NCT01801280|96900|P2|STARTED|Period 1||5
41688|NCT01801280|96901|P1|STARTED|Period 1|Each period lasted 10-14 weeks|5
41689|NCT01801124|96911|P1|NOT COMPLETED|Overall Study||0
41690|NCT01801124|96911|P1|COMPLETED|Overall Study||13
41691|NCT01801124|96911|P1|STARTED|Overall Study||13
41692|NCT01801111|96916|P1|NOT COMPLETED|Overall Study||138
41693|NCT01801111|96916|P1|COMPLETED|Overall Study||0
41694|NCT01801111|96916|P1|STARTED|Overall Study||138
41695|NCT01800968|96941|P2|NOT COMPLETED|Overall Study||32
41696|NCT01800968|96942|P1|NOT COMPLETED|Overall Study||36
41697|NCT01800968|96941|P2|COMPLETED|Overall Study||114
41698|NCT01800968|96942|P1|COMPLETED|Overall Study||118
41699|NCT01800968|96941|P2|STARTED|Overall Study||146
41700|NCT01800968|96942|P1|STARTED|Overall Study||154
41701|NCT01800916|96984|P9|NOT COMPLETED|Test Period 3 (1 Week)||0
41702|NCT01800916|96985|P8|NOT COMPLETED|Test Period 3 (1 Week)||0
41703|NCT01800916|96986|P7|NOT COMPLETED|Test Period 3 (1 Week)||0
41704|NCT01800916|96987|P6|NOT COMPLETED|Test Period 3 (1 Week)||0
41705|NCT01800916|96988|P5|NOT COMPLETED|Test Period 3 (1 Week)||0
41706|NCT01800916|96989|P4|NOT COMPLETED|Test Period 3 (1 Week)||0
41707|NCT01800916|96990|P3|NOT COMPLETED|Test Period 3 (1 Week)||0
41708|NCT01800916|96991|P2|NOT COMPLETED|Test Period 3 (1 Week)||0
41709|NCT01800916|96992|P1|NOT COMPLETED|Test Period 3 (1 Week)||0
41710|NCT01800916|96984|P9|COMPLETED|Test Period 3 (1 Week)||7
41711|NCT01800916|96985|P8|COMPLETED|Test Period 3 (1 Week)||7
41712|NCT01800916|96986|P7|COMPLETED|Test Period 3 (1 Week)||7
41713|NCT01800916|96987|P6|COMPLETED|Test Period 3 (1 Week)||7
41714|NCT01800916|96988|P5|COMPLETED|Test Period 3 (1 Week)||7
41715|NCT01800916|96989|P4|COMPLETED|Test Period 3 (1 Week)||6
41716|NCT01800916|96990|P3|COMPLETED|Test Period 3 (1 Week)||7
41717|NCT01800916|96991|P2|COMPLETED|Test Period 3 (1 Week)||7
41718|NCT01800916|96992|P1|COMPLETED|Test Period 3 (1 Week)||7
41719|NCT01800916|96984|P9|STARTED|Test Period 3 (1 Week)||7
41720|NCT01800916|96985|P8|STARTED|Test Period 3 (1 Week)||7
41721|NCT01800916|96986|P7|STARTED|Test Period 3 (1 Week)||7
41722|NCT01800916|96987|P6|STARTED|Test Period 3 (1 Week)||7
41723|NCT01800916|96988|P5|STARTED|Test Period 3 (1 Week)||7
41724|NCT01800916|96989|P4|STARTED|Test Period 3 (1 Week)||6
41725|NCT01800916|96990|P3|STARTED|Test Period 3 (1 Week)||7
41726|NCT01800916|96991|P2|STARTED|Test Period 3 (1 Week)||7
41727|NCT01800916|96992|P1|STARTED|Test Period 3 (1 Week)||7
41728|NCT01800916|96984|P9|NOT COMPLETED|Test Period 2 (1 Week)||0
41729|NCT01800916|96985|P8|NOT COMPLETED|Test Period 2 (1 Week)||0
41730|NCT01800916|96986|P7|NOT COMPLETED|Test Period 2 (1 Week)||0
41731|NCT01800916|96987|P6|NOT COMPLETED|Test Period 2 (1 Week)||0
41732|NCT01800916|96988|P5|NOT COMPLETED|Test Period 2 (1 Week)||0
41733|NCT01800916|96989|P4|NOT COMPLETED|Test Period 2 (1 Week)||0
41734|NCT01800916|96990|P3|NOT COMPLETED|Test Period 2 (1 Week)||0
41735|NCT01800916|96991|P2|NOT COMPLETED|Test Period 2 (1 Week)||0
41736|NCT01800916|96992|P1|NOT COMPLETED|Test Period 2 (1 Week)||0
41737|NCT01800916|96984|P9|COMPLETED|Test Period 2 (1 Week)||7
41738|NCT01800916|96985|P8|COMPLETED|Test Period 2 (1 Week)||7
41739|NCT01800916|96986|P7|COMPLETED|Test Period 2 (1 Week)||7
41740|NCT01800916|96987|P6|COMPLETED|Test Period 2 (1 Week)||7
41741|NCT01800916|96988|P5|COMPLETED|Test Period 2 (1 Week)||7
41742|NCT01800916|96989|P4|COMPLETED|Test Period 2 (1 Week)||6
41743|NCT01800916|96990|P3|COMPLETED|Test Period 2 (1 Week)||7
41744|NCT01800916|96991|P2|COMPLETED|Test Period 2 (1 Week)||7
41745|NCT01800916|96992|P1|COMPLETED|Test Period 2 (1 Week)||7
41746|NCT01800916|96984|P9|STARTED|Test Period 2 (1 Week)||7
41747|NCT01800916|96985|P8|STARTED|Test Period 2 (1 Week)||7
41748|NCT01800916|96986|P7|STARTED|Test Period 2 (1 Week)||7
41749|NCT01800916|96987|P6|STARTED|Test Period 2 (1 Week)||7
41750|NCT01800916|96988|P5|STARTED|Test Period 2 (1 Week)||7
41751|NCT01800916|96989|P4|STARTED|Test Period 2 (1 Week)||6
41752|NCT01800916|96990|P3|STARTED|Test Period 2 (1 Week)||7
41753|NCT01800916|96991|P2|STARTED|Test Period 2 (1 Week)||7
41754|NCT01800916|96992|P1|STARTED|Test Period 2 (1 Week)||7
41755|NCT01800916|96984|P9|NOT COMPLETED|Test Period 1 (1 Week)||0
41756|NCT01800916|96985|P8|NOT COMPLETED|Test Period 1 (1 Week)||0
41757|NCT01800916|96986|P7|NOT COMPLETED|Test Period 1 (1 Week)||0
41758|NCT01800916|96987|P6|NOT COMPLETED|Test Period 1 (1 Week)||0
41759|NCT01800916|96988|P5|NOT COMPLETED|Test Period 1 (1 Week)||1
41760|NCT01800916|96989|P4|NOT COMPLETED|Test Period 1 (1 Week)||1
41761|NCT01800916|96990|P3|NOT COMPLETED|Test Period 1 (1 Week)||0
41762|NCT01800916|96991|P2|NOT COMPLETED|Test Period 1 (1 Week)||0
41763|NCT01800916|96992|P1|NOT COMPLETED|Test Period 1 (1 Week)||0
41764|NCT01800916|96984|P9|COMPLETED|Test Period 1 (1 Week)||7
41765|NCT01800916|96985|P8|COMPLETED|Test Period 1 (1 Week)||7
41766|NCT01800916|96986|P7|COMPLETED|Test Period 1 (1 Week)||7
41767|NCT01800916|96987|P6|COMPLETED|Test Period 1 (1 Week)||7
41768|NCT01800916|96988|P5|COMPLETED|Test Period 1 (1 Week)||7
41769|NCT01800916|96989|P4|COMPLETED|Test Period 1 (1 Week)||6
41770|NCT01800916|96990|P3|COMPLETED|Test Period 1 (1 Week)||7
41771|NCT01800916|96991|P2|COMPLETED|Test Period 1 (1 Week)||7
41772|NCT01800916|96992|P1|COMPLETED|Test Period 1 (1 Week)||7
41773|NCT01800916|96984|P9|STARTED|Test Period 1 (1 Week)||7
41774|NCT01800916|96985|P8|STARTED|Test Period 1 (1 Week)||7
41775|NCT01800916|96986|P7|STARTED|Test Period 1 (1 Week)||7
41776|NCT01800916|96987|P6|STARTED|Test Period 1 (1 Week)||7
41777|NCT01800916|96988|P5|STARTED|Test Period 1 (1 Week)||8
41778|NCT01800916|96989|P4|STARTED|Test Period 1 (1 Week)||7
41779|NCT01800916|96990|P3|STARTED|Test Period 1 (1 Week)||7
41780|NCT01800916|96991|P2|STARTED|Test Period 1 (1 Week)||7
41781|NCT01800916|96992|P1|STARTED|Test Period 1 (1 Week)||7
41782|NCT01800903|97002|P6|NOT COMPLETED|Third Test Period||0
41783|NCT01800903|97003|P5|NOT COMPLETED|Third Test Period||0
41784|NCT01800903|97004|P4|NOT COMPLETED|Third Test Period||0
41785|NCT01800903|97005|P3|NOT COMPLETED|Third Test Period||0
41786|NCT01800903|97006|P2|NOT COMPLETED|Third Test Period||0
41787|NCT01800903|97007|P1|NOT COMPLETED|Third Test Period||0
41788|NCT01800903|97002|P6|COMPLETED|Third Test Period||6
41789|NCT01800903|97003|P5|COMPLETED|Third Test Period||6
41790|NCT01800903|97004|P4|COMPLETED|Third Test Period||7
41791|NCT01800903|97005|P3|COMPLETED|Third Test Period||4
41792|NCT01800903|97006|P2|COMPLETED|Third Test Period||6
41793|NCT01800903|97007|P1|COMPLETED|Third Test Period||6
41794|NCT01800903|97002|P6|STARTED|Third Test Period||6
41795|NCT01800903|97003|P5|STARTED|Third Test Period||6
41796|NCT01800903|97004|P4|STARTED|Third Test Period||7
41797|NCT01800903|97005|P3|STARTED|Third Test Period||4
41798|NCT01800903|97006|P2|STARTED|Third Test Period||6
41799|NCT01800903|97007|P1|STARTED|Third Test Period||6
41800|NCT01800903|97002|P6|NOT COMPLETED|Second Test Period||0
41801|NCT01800903|97003|P5|NOT COMPLETED|Second Test Period||0
41802|NCT01800903|97004|P4|NOT COMPLETED|Second Test Period||0
41803|NCT01800903|97005|P3|NOT COMPLETED|Second Test Period||0
41804|NCT01800903|97006|P2|NOT COMPLETED|Second Test Period||0
41805|NCT01800903|97007|P1|NOT COMPLETED|Second Test Period||1
41806|NCT01800903|97002|P6|COMPLETED|Second Test Period||6
41807|NCT01800903|97003|P5|COMPLETED|Second Test Period||6
41808|NCT01800903|97004|P4|COMPLETED|Second Test Period||7
41809|NCT01800903|97005|P3|COMPLETED|Second Test Period||4
41810|NCT01800903|97006|P2|COMPLETED|Second Test Period||6
41811|NCT01800903|97007|P1|COMPLETED|Second Test Period||6
41812|NCT01800903|97002|P6|STARTED|Second Test Period||6
41813|NCT01800903|97003|P5|STARTED|Second Test Period||6
41814|NCT01800903|97004|P4|STARTED|Second Test Period||7
41815|NCT01800903|97005|P3|STARTED|Second Test Period||4
41816|NCT01800903|97006|P2|STARTED|Second Test Period||6
41817|NCT01800903|97007|P1|STARTED|Second Test Period||7
41818|NCT01800903|97002|P6|NOT COMPLETED|First Test Period||0
41819|NCT01800903|97003|P5|NOT COMPLETED|First Test Period||0
41820|NCT01800903|97004|P4|NOT COMPLETED|First Test Period||0
41821|NCT01800903|97005|P3|NOT COMPLETED|First Test Period||0
41822|NCT01800903|97006|P2|NOT COMPLETED|First Test Period||0
41823|NCT01800903|97007|P1|NOT COMPLETED|First Test Period||0
41824|NCT01800903|97002|P6|COMPLETED|First Test Period||6
41825|NCT01800903|97003|P5|COMPLETED|First Test Period||6
41826|NCT01800903|97004|P4|COMPLETED|First Test Period||7
41827|NCT01800903|97005|P3|COMPLETED|First Test Period||4
41828|NCT01800903|97006|P2|COMPLETED|First Test Period||6
41829|NCT01800903|97007|P1|COMPLETED|First Test Period||7
41830|NCT01800903|97002|P6|STARTED|First Test Period||6
41831|NCT01800903|97003|P5|STARTED|First Test Period||6
41832|NCT01800903|97004|P4|STARTED|First Test Period||7
41833|NCT01800903|97005|P3|STARTED|First Test Period||4
41834|NCT01800903|97006|P2|STARTED|First Test Period||6
41835|NCT01800903|97007|P1|STARTED|First Test Period||7
41836|NCT01800890|97013|P9|NOT COMPLETED|Test Period 3||0
41837|NCT01800890|97014|P8|NOT COMPLETED|Test Period 3||0
41838|NCT01800890|97015|P7|NOT COMPLETED|Test Period 3||0
41839|NCT01800890|97016|P6|NOT COMPLETED|Test Period 3||0
41840|NCT01800890|97017|P5|NOT COMPLETED|Test Period 3||0
41841|NCT01800890|97018|P4|NOT COMPLETED|Test Period 3||0
41842|NCT01800890|97019|P3|NOT COMPLETED|Test Period 3||0
41843|NCT01800890|97020|P2|NOT COMPLETED|Test Period 3||0
41844|NCT01800890|97021|P1|NOT COMPLETED|Test Period 3||0
41845|NCT01800890|97013|P9|COMPLETED|Test Period 3||3
41846|NCT01800890|97014|P8|COMPLETED|Test Period 3||3
41847|NCT01800890|97015|P7|COMPLETED|Test Period 3||3
41848|NCT01800890|97016|P6|COMPLETED|Test Period 3||4
41849|NCT01800890|97017|P5|COMPLETED|Test Period 3||4
41850|NCT01800890|97018|P4|COMPLETED|Test Period 3||2
41851|NCT01800890|97019|P3|COMPLETED|Test Period 3||3
41852|NCT01800890|97020|P2|COMPLETED|Test Period 3||3
41853|NCT01800890|97021|P1|COMPLETED|Test Period 3||3
41854|NCT01800890|97013|P9|STARTED|Test Period 3||3
41855|NCT01800890|97014|P8|STARTED|Test Period 3||3
41856|NCT01800890|97015|P7|STARTED|Test Period 3||3
41857|NCT01800890|97016|P6|STARTED|Test Period 3||4
41858|NCT01800890|97017|P5|STARTED|Test Period 3||4
41859|NCT01800890|97018|P4|STARTED|Test Period 3||2
41860|NCT01800890|97019|P3|STARTED|Test Period 3||3
41861|NCT01800890|97020|P2|STARTED|Test Period 3||3
41862|NCT01800890|97021|P1|STARTED|Test Period 3||3
41863|NCT01800890|97013|P9|NOT COMPLETED|Test Period 2||0
41864|NCT01800890|97014|P8|NOT COMPLETED|Test Period 2||0
41865|NCT01800890|97015|P7|NOT COMPLETED|Test Period 2||0
41866|NCT01800890|97016|P6|NOT COMPLETED|Test Period 2||0
41867|NCT01800890|97017|P5|NOT COMPLETED|Test Period 2||0
41868|NCT01800890|97018|P4|NOT COMPLETED|Test Period 2||0
41869|NCT01800890|97019|P3|NOT COMPLETED|Test Period 2||0
41870|NCT01800890|97020|P2|NOT COMPLETED|Test Period 2||0
41871|NCT01800890|97021|P1|NOT COMPLETED|Test Period 2||0
41872|NCT01800890|97013|P9|COMPLETED|Test Period 2||3
41873|NCT01800890|97014|P8|COMPLETED|Test Period 2||3
41874|NCT01800890|97015|P7|COMPLETED|Test Period 2||3
41875|NCT01800890|97016|P6|COMPLETED|Test Period 2||4
41876|NCT01800890|97017|P5|COMPLETED|Test Period 2||4
41877|NCT01800890|97018|P4|COMPLETED|Test Period 2||2
41878|NCT01800890|97019|P3|COMPLETED|Test Period 2||3
41879|NCT01800890|97020|P2|COMPLETED|Test Period 2||3
41880|NCT01800890|97021|P1|COMPLETED|Test Period 2||3
41881|NCT01800890|97013|P9|STARTED|Test Period 2||3
41882|NCT01800890|97014|P8|STARTED|Test Period 2||3
41883|NCT01800890|97015|P7|STARTED|Test Period 2||3
41884|NCT01800890|97016|P6|STARTED|Test Period 2||4
41885|NCT01800890|97017|P5|STARTED|Test Period 2||4
41886|NCT01800890|97018|P4|STARTED|Test Period 2||2
41887|NCT01800890|97019|P3|STARTED|Test Period 2||3
41888|NCT01800890|97020|P2|STARTED|Test Period 2||3
41889|NCT01800890|97021|P1|STARTED|Test Period 2||3
41890|NCT01800890|97013|P9|NOT COMPLETED|Test Period 1||0
41891|NCT01800890|97014|P8|NOT COMPLETED|Test Period 1||0
41892|NCT01800890|97015|P7|NOT COMPLETED|Test Period 1||0
41893|NCT01800890|97016|P6|NOT COMPLETED|Test Period 1||0
41894|NCT01800890|97017|P5|NOT COMPLETED|Test Period 1||0
41895|NCT01800890|97018|P4|NOT COMPLETED|Test Period 1||1
41896|NCT01800890|97019|P3|NOT COMPLETED|Test Period 1||0
41897|NCT01800890|97020|P2|NOT COMPLETED|Test Period 1||0
41898|NCT01800890|97021|P1|NOT COMPLETED|Test Period 1||0
41899|NCT01800890|97013|P9|COMPLETED|Test Period 1||3
41900|NCT01800890|97014|P8|COMPLETED|Test Period 1||3
41901|NCT01800890|97015|P7|COMPLETED|Test Period 1||3
41902|NCT01800890|97016|P6|COMPLETED|Test Period 1||4
41903|NCT01800890|97017|P5|COMPLETED|Test Period 1||4
41904|NCT01800890|97018|P4|COMPLETED|Test Period 1||2
41905|NCT01800890|97019|P3|COMPLETED|Test Period 1||3
41906|NCT01800890|97020|P2|COMPLETED|Test Period 1||3
41907|NCT01800890|97021|P1|COMPLETED|Test Period 1||3
41908|NCT01800890|97013|P9|STARTED|Test Period 1||3
41909|NCT01800890|97014|P8|STARTED|Test Period 1||3
41910|NCT01800890|97015|P7|STARTED|Test Period 1||3
41911|NCT01800890|97016|P6|STARTED|Test Period 1||4
41912|NCT01800890|97017|P5|STARTED|Test Period 1||4
41913|NCT01800890|97018|P4|STARTED|Test Period 1||3
41914|NCT01800890|97019|P3|STARTED|Test Period 1||3
41915|NCT01800890|97020|P2|STARTED|Test Period 1||3
41916|NCT01800890|97021|P1|STARTED|Test Period 1||3
41917|NCT01800786|97033|P2|NOT COMPLETED|Overall Study||1
41918|NCT01800786|97034|P1|NOT COMPLETED|Overall Study||2
41919|NCT01800786|97033|P2|COMPLETED|Overall Study||15
41920|NCT01800786|97034|P1|COMPLETED|Overall Study||15
41921|NCT01800786|97033|P2|STARTED|Overall Study||16
41922|NCT01800786|97034|P1|STARTED|Overall Study||17
41923|NCT01800318|97044|P4|NOT COMPLETED|Overall Study||1
41924|NCT01800318|97045|P3|NOT COMPLETED|Overall Study||1
41925|NCT01800318|97046|P2|NOT COMPLETED|Overall Study||5
41926|NCT01800318|97047|P1|NOT COMPLETED|Overall Study||2
41927|NCT01800318|97044|P4|COMPLETED|Overall Study||39
41928|NCT01800318|97045|P3|COMPLETED|Overall Study||40
41929|NCT01800318|97046|P2|COMPLETED|Overall Study||37
41930|NCT01800318|97047|P1|COMPLETED|Overall Study||37
41931|NCT01800318|97044|P4|STARTED|Overall Study||40
41932|NCT01800318|97045|P3|STARTED|Overall Study||41
41933|NCT01800318|97046|P2|STARTED|Overall Study||42
41934|NCT01800318|97047|P1|STARTED|Overall Study||39
41935|NCT01800162|97076|P3|NOT COMPLETED|Overall Study||0
41936|NCT01800162|97077|P2|NOT COMPLETED|Overall Study||0
41937|NCT01800162|97078|P1|NOT COMPLETED|Overall Study||0
41938|NCT01800162|97076|P3|COMPLETED|Overall Study||1
41939|NCT01800162|97077|P2|COMPLETED|Overall Study||0
41940|NCT01800162|97078|P1|COMPLETED|Overall Study||1
41941|NCT01800162|97076|P3|STARTED|Overall Study|1 subject randomized to expectant management on 11/1/2013.|1
41942|NCT01800162|97077|P2|STARTED|Overall Study||0
41943|NCT01800162|97078|P1|STARTED|Overall Study|1 subject was randomized to uterine evacuation on 6/26/2013.|1
41944|NCT01799941|97084|P1|NOT COMPLETED|Overall Study||96
41945|NCT01799941|97084|P1|COMPLETED|Overall Study||271
41946|NCT01799941|97084|P1|STARTED|Overall Study||367
41947|NCT01799720|97141|P3|NOT COMPLETED|Overall Study||1
41948|NCT01799720|97142|P2|NOT COMPLETED|Overall Study||1
41949|NCT01799720|97143|P1|NOT COMPLETED|Overall Study||3
41950|NCT01799720|97141|P3|COMPLETED|Overall Study||18
41951|NCT01799720|97142|P2|COMPLETED|Overall Study||17
41952|NCT01799720|97143|P1|COMPLETED|Overall Study||17
41953|NCT01799720|97141|P3|Began the Treatment and Finished it|Overall Study||18
41954|NCT01799720|97142|P2|Began the Treatment and Finished it|Overall Study||17
41955|NCT01799720|97143|P1|Began the Treatment and Finished it|Overall Study||17
41956|NCT01799720|97141|P3|Began the Treatment|Overall Study||19
41957|NCT01799720|97142|P2|Began the Treatment|Overall Study||18
41958|NCT01799720|97143|P1|Began the Treatment|Overall Study||20
41959|NCT01799720|97141|P3|STARTED|Overall Study||19
41960|NCT01799720|97142|P2|STARTED|Overall Study||18
41961|NCT01799720|97143|P1|STARTED|Overall Study||20
41962|NCT01799590|97181|P3|NOT COMPLETED|Overall Study||14
41963|NCT01799590|97182|P2|NOT COMPLETED|Overall Study||16
41964|NCT01799590|97183|P1|NOT COMPLETED|Overall Study||26
41965|NCT01799590|97181|P3|COMPLETED|Overall Study||77
41966|NCT01799590|97182|P2|COMPLETED|Overall Study||78
41967|NCT01799590|97183|P1|COMPLETED|Overall Study||85
41968|NCT01799590|97181|P3|STARTED|Overall Study||91
41969|NCT01799590|97182|P2|STARTED|Overall Study||94
41970|NCT01799590|97183|P1|STARTED|Overall Study||111
41971|NCT01799239|97218|P2|NOT COMPLETED|Period 2 (7 Days)||1
41972|NCT01799239|97219|P1|NOT COMPLETED|Period 2 (7 Days)||2
41973|NCT01799239|97218|P2|COMPLETED|Period 2 (7 Days)||14
41974|NCT01799239|97219|P1|COMPLETED|Period 2 (7 Days)||11
41975|NCT01799239|97218|P2|STARTED|Period 2 (7 Days)||15
41976|NCT01799239|97219|P1|STARTED|Period 2 (7 Days)||13
41977|NCT01799239|97218|P2|NOT COMPLETED|Period 1 (7 Days)||1
41978|NCT01799239|97219|P1|NOT COMPLETED|Period 1 (7 Days)||3
41979|NCT01799239|97218|P2|COMPLETED|Period 1 (7 Days)||15
41980|NCT01799239|97219|P1|COMPLETED|Period 1 (7 Days)||12
41981|NCT01799239|97218|P2|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|16
41982|NCT01799239|97219|P1|STARTED|Period 1 (7 Days)|It was uncertain in which order the product were tested for 1 subject. Subject is excl from analysis|15
41983|NCT01799226|97227|P2|NOT COMPLETED|Overall Study||0
41984|NCT01799226|97228|P1|NOT COMPLETED|Overall Study||2
41985|NCT01799226|97227|P2|COMPLETED|Overall Study||16
41986|NCT01799226|97228|P1|COMPLETED|Overall Study||14
41987|NCT01799226|97227|P2|Left Stent Side|Overall Study||8
41988|NCT01799226|97228|P1|Left Stent Side|Overall Study||8
41989|NCT01799226|97227|P2|Right Stent Side|Overall Study||8
41990|NCT01799226|97228|P1|Right Stent Side|Overall Study||8
41991|NCT01799226|97227|P2|STARTED|Overall Study||16
41992|NCT01799226|97228|P1|STARTED|Overall Study||16
41993|NCT01798992|97240|P4|NOT COMPLETED|Overall Study||1
41994|NCT01798992|97241|P3|NOT COMPLETED|Overall Study||2
41995|NCT01798992|97242|P2|NOT COMPLETED|Overall Study||2
41996|NCT01798992|97243|P1|NOT COMPLETED|Overall Study||0
41997|NCT01798992|97240|P4|COMPLETED|Overall Study||16
41998|NCT01798992|97241|P3|COMPLETED|Overall Study||14
41999|NCT01798992|97242|P2|COMPLETED|Overall Study||17
42000|NCT01798992|97243|P1|COMPLETED|Overall Study||4
42001|NCT01798992|97240|P4|STARTED|Overall Study||17
42002|NCT01798992|97241|P3|STARTED|Overall Study||16
42003|NCT01798992|97242|P2|STARTED|Overall Study||19
42004|NCT01798992|97243|P1|STARTED|Overall Study||4
42005|NCT01798966|97257|P1|NOT COMPLETED|Overall Study||0
42006|NCT01798966|97257|P1|COMPLETED|Overall Study||10
42007|NCT01798966|97257|P1|STARTED|Overall Study||10
42008|NCT01798927|97263|P1|NOT COMPLETED|Overall Study||1
42009|NCT01798927|97263|P1|COMPLETED|Overall Study||3
42010|NCT01798927|97263|P1|STARTED|Overall Study||4
42011|NCT01798706|97271|P2|NOT COMPLETED|Overall Study||21
42012|NCT01798706|97272|P1|NOT COMPLETED|Overall Study||21
42013|NCT01798706|97271|P2|COMPLETED|Overall Study||153
42014|NCT01798706|97272|P1|COMPLETED|Overall Study||155
42015|NCT01798706|97271|P2|STARTED|Overall Study||174
42016|NCT01798706|97272|P1|STARTED|Overall Study||176
42017|NCT01798485|97300|P2|NOT COMPLETED|Overall Study||290
42018|NCT01798485|97301|P1|NOT COMPLETED|Overall Study||346
42019|NCT01798485|97300|P2|COMPLETED|Overall Study||59
42020|NCT01798485|97301|P1|COMPLETED|Overall Study||1
42021|NCT01798485|97300|P2|Randomized as of 19 October 2015|Overall Study||337
42022|NCT01798485|97301|P1|Randomized as of 19 October 2015|Overall Study||335
42023|NCT01798485|97300|P2|Safety Population as of 23 Dec 2015|Overall Study||342
42024|NCT01798485|97301|P1|Safety Population as of 23 Dec 2015|Overall Study||338
42025|NCT01798485|97300|P2|STARTED|Overall Study||349
42026|NCT01798485|97301|P1|STARTED|Overall Study||347
42027|NCT01798394|97337|P2|NOT COMPLETED|Overall Study||3
42028|NCT01798394|97338|P1|NOT COMPLETED|Overall Study||3
42029|NCT01798394|97337|P2|COMPLETED|Overall Study||19
42030|NCT01798394|97338|P1|COMPLETED|Overall Study||21
42031|NCT01798394|97337|P2|STARTED|Overall Study||22
42032|NCT01798394|97338|P1|STARTED|Overall Study||24
42033|NCT01798316|97358|P2|NOT COMPLETED|Overall Study||0
42034|NCT01798316|97359|P1|NOT COMPLETED|Overall Study||0
42035|NCT01798316|97358|P2|COMPLETED|Overall Study||53
42036|NCT01798316|97359|P1|COMPLETED|Overall Study||52
42037|NCT01798316|97358|P2|STARTED|Overall Study||53
42038|NCT01798316|97359|P1|STARTED|Overall Study||52
42039|NCT01798264|97381|P4|NOT COMPLETED|Overall Study||4
42040|NCT01798264|97382|P3|NOT COMPLETED|Overall Study||0
42041|NCT01798264|97383|P2|NOT COMPLETED|Overall Study||0
42042|NCT01798264|97384|P1|NOT COMPLETED|Overall Study||1
42043|NCT01798264|97381|P4|COMPLETED|Overall Study||7
42044|NCT01798264|97382|P3|COMPLETED|Overall Study||10
42045|NCT01798264|97383|P2|COMPLETED|Overall Study||11
42046|NCT01798264|97384|P1|COMPLETED|Overall Study||11
42047|NCT01798264|97381|P4|STARTED|Overall Study||11
42048|NCT01798264|97382|P3|STARTED|Overall Study||10
42049|NCT01798264|97383|P2|STARTED|Overall Study||11
42050|NCT01798264|97384|P1|STARTED|Overall Study||12
42051|NCT01798186|97410|P4|NOT COMPLETED|Overall Study||0
42052|NCT01798186|97411|P3|NOT COMPLETED|Overall Study||0
42053|NCT01798186|97412|P2|NOT COMPLETED|Overall Study||0
42054|NCT01798186|97413|P1|NOT COMPLETED|Overall Study||0
42055|NCT01798186|97410|P4|COMPLETED|Overall Study||8
42056|NCT01798186|97411|P3|COMPLETED|Overall Study||6
42057|NCT01798186|97412|P2|COMPLETED|Overall Study||6
42058|NCT01798186|97413|P1|COMPLETED|Overall Study||6
42059|NCT01798186|97410|P4|STARTED|Overall Study||8
42060|NCT01798186|97411|P3|STARTED|Overall Study||6
42061|NCT01798186|97412|P2|STARTED|Overall Study||6
42062|NCT01798186|97413|P1|STARTED|Overall Study||6
42063|NCT01798134|97427|P1|NOT COMPLETED|Overall Study||16
42064|NCT01798134|97427|P1|COMPLETED|Overall Study||9
42065|NCT01798134|97427|P1|STARTED|Overall Study||25
42066|NCT01798004|97434|P1|NOT COMPLETED|Overall Study||87
42067|NCT01798004|97434|P1|COMPLETED|Overall Study||63
42068|NCT01798004|97434|P1|STARTED|Overall Study||150
42069|NCT01797783|97440|P2|NOT COMPLETED|Overall Study||1
42070|NCT01797783|97441|P1|NOT COMPLETED|Overall Study||2
42071|NCT01797783|97440|P2|COMPLETED|Overall Study||26
42072|NCT01797783|97441|P1|COMPLETED|Overall Study||50
42073|NCT01797783|97440|P2|STARTED|Overall Study||27
42074|NCT01797783|97441|P1|STARTED|Overall Study||52
42075|NCT01797731|97465|P2|NOT COMPLETED|Overall Study||3
42076|NCT01797731|97466|P1|NOT COMPLETED|Overall Study||3
42077|NCT01797731|97465|P2|COMPLETED|Overall Study|3 excluded due to not having proper radiographs for adequate follow up|47
42078|NCT01797731|97466|P1|COMPLETED|Overall Study|3 were excluded due to not having proper radiographs for adequate follow up|47
42079|NCT01797731|97465|P2|STARTED|Overall Study||50
42080|NCT01797731|97466|P1|STARTED|Overall Study||50
42081|NCT01797705|97474|P1|NOT COMPLETED|Overall Study||5
42082|NCT01797705|97474|P1|COMPLETED|Overall Study||28
42083|NCT01797705|97474|P1|STARTED|Overall Study||33
42084|NCT01797536|97482|P4|NOT COMPLETED|Overall Study||0
42085|NCT01797536|97483|P3|NOT COMPLETED|Overall Study||0
42086|NCT01797536|97484|P2|NOT COMPLETED|Overall Study||1
42087|NCT01797536|97485|P1|NOT COMPLETED|Overall Study||0
42088|NCT01797536|97482|P4|COMPLETED|Overall Study||8
42089|NCT01797536|97483|P3|COMPLETED|Overall Study||7
42090|NCT01797536|97484|P2|COMPLETED|Overall Study||10
42091|NCT01797536|97485|P1|COMPLETED|Overall Study||8
42092|NCT01797536|97482|P4|STARTED|Overall Study||8
42093|NCT01797536|97483|P3|STARTED|Overall Study||7
42094|NCT01797536|97484|P2|STARTED|Overall Study|Includes 3 participants from mild arm who were mistakenly re-enrolled and also dosed in moderate arm|11
42095|NCT01797536|97485|P1|STARTED|Overall Study||8
42096|NCT01797445|97517|P2|NOT COMPLETED|Overall Study||437
42097|NCT01797445|97518|P1|NOT COMPLETED|Overall Study||435
42098|NCT01797445|97517|P2|COMPLETED|Overall Study||0
42099|NCT01797445|97518|P1|COMPLETED|Overall Study||0
42100|NCT01797445|97517|P2|STARTED|Overall Study||437
42101|NCT01797445|97518|P1|STARTED|Overall Study||435
42102|NCT01797380|97558|P2|NOT COMPLETED|Overall Study||2
42103|NCT01797380|97559|P1|NOT COMPLETED|Overall Study||3
42104|NCT01797380|97558|P2|COMPLETED|Overall Study||0
42105|NCT01797380|97559|P1|COMPLETED|Overall Study|Terminated due to lack of enrollment|0
42106|NCT01797380|97558|P2|STARTED|Overall Study||2
42107|NCT01797380|97559|P1|STARTED|Overall Study|Terminated due to lack of enrollment|3
42108|NCT01797328|97567|P2|NOT COMPLETED|Overall Study||0
42109|NCT01797328|97568|P1|NOT COMPLETED|Overall Study||2
42110|NCT01797328|97567|P2|COMPLETED|Overall Study||12
42111|NCT01797328|97568|P1|COMPLETED|Overall Study||14
42112|NCT01797328|97567|P2|STARTED|Overall Study||12
42113|NCT01797328|97568|P1|STARTED|Overall Study||16
42114|NCT01797094|97576|P2|NOT COMPLETED|Overall Study||2
42115|NCT01797094|97577|P1|NOT COMPLETED|Overall Study||6
42116|NCT01797094|97576|P2|COMPLETED|Overall Study||51
42117|NCT01797094|97577|P1|COMPLETED|Overall Study||42
42118|NCT01797094|97576|P2|STARTED|Overall Study||53
42119|NCT01797094|97577|P1|STARTED|Overall Study||48
42120|NCT01797081|97599|P4|NOT COMPLETED|Overall Study||9
42121|NCT01797081|97600|P3|NOT COMPLETED|Overall Study||5
42122|NCT01797081|97601|P2|NOT COMPLETED|Overall Study||4
42123|NCT01797081|97602|P1|NOT COMPLETED|Overall Study||14
42124|NCT01797081|97599|P4|COMPLETED|Overall Study||40
42125|NCT01797081|97600|P3|COMPLETED|Overall Study||43
42126|NCT01797081|97601|P2|COMPLETED|Overall Study||95
42127|NCT01797081|97602|P1|COMPLETED|Overall Study||90
42128|NCT01797081|97599|P4|STARTED|Overall Study||49
42129|NCT01797081|97600|P3|STARTED|Overall Study||48
42130|NCT01797081|97601|P2|STARTED|Overall Study||99
42131|NCT01797081|97602|P1|STARTED|Overall Study||104
42132|NCT01797029|97621|P2|NOT COMPLETED|Overall Study||61
42133|NCT01797029|97622|P1|NOT COMPLETED|Overall Study||159
42134|NCT01797029|97621|P2|COMPLETED|Overall Study||526
42135|NCT01797029|97622|P1|COMPLETED|Overall Study||1015
42136|NCT01797029|97621|P2|STARTED|Overall Study||587
42137|NCT01797029|97622|P1|STARTED|Overall Study||1174
42138|NCT01796977|97630|P1|NOT COMPLETED|Overall Study||0
42139|NCT01796977|97630|P1|COMPLETED|Overall Study||27
42140|NCT01796977|97630|P1|STARTED|Overall Study||27
42141|NCT01796964|97643|P2|NOT COMPLETED|Overall Study||3
42142|NCT01796964|97644|P1|NOT COMPLETED|Overall Study||3
42143|NCT01796964|97643|P2|COMPLETED|Overall Study||42
42144|NCT01796964|97644|P1|COMPLETED|Overall Study||41
42145|NCT01796964|97643|P2|STARTED|Overall Study||45
42146|NCT01796964|97644|P1|STARTED|Overall Study||44
42147|NCT01796860|97666|P1|NOT COMPLETED|Overall Study||3
42148|NCT01796860|97666|P1|COMPLETED|Overall Study||7
42149|NCT01796860|97666|P1|STARTED|Overall Study||10
42150|NCT01796548|97672|P1|NOT COMPLETED|Overall Study||3
42151|NCT01796548|97672|P1|COMPLETED|Overall Study||14
42152|NCT01796548|97672|P1|Treated|Overall Study||15
42153|NCT01796548|97672|P1|STARTED|Overall Study||17
42154|NCT01796236|97686|P2|NOT COMPLETED|Overall Study||2
42155|NCT01796236|97687|P1|NOT COMPLETED|Overall Study||2
42156|NCT01796236|97686|P2|COMPLETED|Overall Study||50
42157|NCT01796236|97687|P1|COMPLETED|Overall Study||49
42158|NCT01796236|97686|P2|STARTED|Overall Study||52
42159|NCT01796236|97687|P1|STARTED|Overall Study||51
42160|NCT01795937|97706|P3|NOT COMPLETED|Overall Study||0
42161|NCT01795937|97707|P2|NOT COMPLETED|Overall Study||1
42162|NCT01795937|97708|P1|NOT COMPLETED|Overall Study||1
42163|NCT01795937|97706|P3|COMPLETED|Overall Study||17
42164|NCT01795937|97707|P2|COMPLETED|Overall Study||15
42165|NCT01795937|97708|P1|COMPLETED|Overall Study||17
42166|NCT01795937|97706|P3|STARTED|Overall Study||17
42167|NCT01795937|97707|P2|STARTED|Overall Study||16
42168|NCT01795937|97708|P1|STARTED|Overall Study||18
42169|NCT01795898|97737|P1|NOT COMPLETED|Overall Study||60
42170|NCT01795898|97737|P1|COMPLETED|Overall Study||177
42171|NCT01795898|97737|P1|STARTED|Overall Study||237
42172|NCT01795859|97747|P2|NOT COMPLETED|Overall Study||2
42173|NCT01795859|97748|P1|NOT COMPLETED|Overall Study||1
42174|NCT01795859|97747|P2|COMPLETED|Overall Study||43
42175|NCT01795859|97748|P1|COMPLETED|Overall Study||44
42176|NCT01795859|97747|P2|STARTED|Overall Study||45
42177|NCT01795859|97748|P1|STARTED|Overall Study||45
42178|NCT01795716|97764|P2|NOT COMPLETED|Second Intervention (13 Days)||0
42179|NCT01795716|97765|P1|NOT COMPLETED|Second Intervention (13 Days)||0
42180|NCT01795716|97764|P2|COMPLETED|Second Intervention (13 Days)||11
42181|NCT01795716|97765|P1|COMPLETED|Second Intervention (13 Days)||10
42182|NCT01795716|97764|P2|STARTED|Second Intervention (13 Days)||11
42183|NCT01795716|97765|P1|STARTED|Second Intervention (13 Days)||10
42184|NCT01795716|97764|P2|NOT COMPLETED|Washout (10 Days)||0
42185|NCT01795716|97765|P1|NOT COMPLETED|Washout (10 Days)||0
42186|NCT01795716|97764|P2|COMPLETED|Washout (10 Days)||11
42187|NCT01795716|97765|P1|COMPLETED|Washout (10 Days)||10
42188|NCT01795716|97764|P2|STARTED|Washout (10 Days)||11
42189|NCT01795716|97765|P1|STARTED|Washout (10 Days)||10
42190|NCT01795716|97764|P2|NOT COMPLETED|First Intervention (13 Days)||0
42191|NCT01795716|97765|P1|NOT COMPLETED|First Intervention (13 Days)||0
42192|NCT01795716|97764|P2|COMPLETED|First Intervention (13 Days)||11
42193|NCT01795716|97765|P1|COMPLETED|First Intervention (13 Days)||10
42194|NCT01795716|97764|P2|STARTED|First Intervention (13 Days)||11
42195|NCT01795716|97765|P1|STARTED|First Intervention (13 Days)||10
42196|NCT01795547|97773|P2|NOT COMPLETED|Overall Study||64
42197|NCT01795547|97774|P1|NOT COMPLETED|Overall Study||48
42198|NCT01795547|97773|P2|COMPLETED|Overall Study||83
42199|NCT01795547|97774|P1|COMPLETED|Overall Study||100
42200|NCT01795547|97773|P2|STARTED|Overall Study||147
42201|NCT01795547|97774|P1|STARTED|Overall Study||148
42202|NCT01795534|97796|P2|NOT COMPLETED|Second Intervention (Second Shot)||0
42203|NCT01795534|97797|P1|NOT COMPLETED|Second Intervention (Second Shot)||0
42204|NCT01795534|97796|P2|COMPLETED|Second Intervention (Second Shot)||5
42205|NCT01795534|97797|P1|COMPLETED|Second Intervention (Second Shot)||5
42206|NCT01795534|97796|P2|STARTED|Second Intervention (Second Shot)||5
42207|NCT01795534|97797|P1|STARTED|Second Intervention (Second Shot)||5
42208|NCT01795534|97796|P2|NOT COMPLETED|Wash Out Period (4 Days)||0
42209|NCT01795534|97797|P1|NOT COMPLETED|Wash Out Period (4 Days)||0
42210|NCT01795534|97796|P2|COMPLETED|Wash Out Period (4 Days)||5
42211|NCT01795534|97797|P1|COMPLETED|Wash Out Period (4 Days)||5
42212|NCT01795534|97796|P2|STARTED|Wash Out Period (4 Days)||5
42213|NCT01795534|97797|P1|STARTED|Wash Out Period (4 Days)||5
42214|NCT01795534|97796|P2|NOT COMPLETED|First Intervention (First Shot)||0
42215|NCT01795534|97797|P1|NOT COMPLETED|First Intervention (First Shot)||0
42216|NCT01795534|97796|P2|COMPLETED|First Intervention (First Shot)||5
42217|NCT01795534|97797|P1|COMPLETED|First Intervention (First Shot)||5
42218|NCT01795534|97796|P2|STARTED|First Intervention (First Shot)||5
42219|NCT01795534|97797|P1|STARTED|First Intervention (First Shot)||5
42220|NCT01794949|97805|P2|NOT COMPLETED|Overall Study||0
42221|NCT01794949|97806|P1|NOT COMPLETED|Overall Study||1
42222|NCT01794949|97805|P2|COMPLETED|Overall Study||1
42223|NCT01794949|97806|P1|COMPLETED|Overall Study||6
42224|NCT01794949|97805|P2|6 Month Follow-up|Overall Study||1
42225|NCT01794949|97806|P1|6 Month Follow-up|Overall Study||6
42226|NCT01794949|97805|P2|STARTED|Overall Study||1
42227|NCT01794949|97806|P1|STARTED|Overall Study||7
42228|NCT01794936|97812|P1|NOT COMPLETED|Overall Study||0
42229|NCT01794936|97812|P1|COMPLETED|Overall Study||9
42230|NCT01794936|97812|P1|STARTED|Overall Study||9
42231|NCT01794845|97817|P1|NOT COMPLETED|Overall Study||1
42232|NCT01794845|97817|P1|COMPLETED|Overall Study||4
42233|NCT01794845|97817|P1|STARTED|Overall Study||5
42234|NCT01794806|97826|P2|NOT COMPLETED|Overall Study||1
42235|NCT01794806|97827|P1|NOT COMPLETED|Overall Study||5
42236|NCT01794806|97826|P2|COMPLETED|Overall Study||27
42237|NCT01794806|97827|P1|COMPLETED|Overall Study||26
42238|NCT01794806|97826|P2|4 Weeks|Overall Study||27
42239|NCT01794806|97827|P1|4 Weeks|Overall Study||26
42240|NCT01794806|97826|P2|1 Week|Overall Study||28
42241|NCT01794806|97827|P1|1 Week|Overall Study||28
42242|NCT01794806|97826|P2|STARTED|Overall Study||28
42243|NCT01794806|97827|P1|STARTED|Overall Study||31
42244|NCT01794741|97839|P2|NOT COMPLETED|Overall Study||9
42245|NCT01794741|97840|P1|NOT COMPLETED|Overall Study||19
42246|NCT01794741|97839|P2|COMPLETED|Overall Study||92
42247|NCT01794741|97840|P1|COMPLETED|Overall Study||285
42248|NCT01794741|97839|P2|STARTED|Overall Study||101
42249|NCT01794741|97840|P1|STARTED|Overall Study||304
42250|NCT01794455|97848|P2|NOT COMPLETED|Overall Study||0
42251|NCT01794455|97849|P1|NOT COMPLETED|Overall Study||0
42252|NCT01794455|97848|P2|COMPLETED|Overall Study||1
42253|NCT01794455|97849|P1|COMPLETED|Overall Study||0
42254|NCT01794455|97848|P2|STARTED|Overall Study||1
42255|NCT01794455|97849|P1|STARTED|Overall Study||0
42256|NCT01794000|97867|P2|NOT COMPLETED|Open-Label Extension Phase (OLE)||0
42257|NCT01794000|97868|P1|NOT COMPLETED|Open-Label Extension Phase (OLE)||3
42258|NCT01794000|97867|P2|COMPLETED|Open-Label Extension Phase (OLE)||0
42259|NCT01794000|97868|P1|COMPLETED|Open-Label Extension Phase (OLE)||0
42260|NCT01794000|97867|P2|STARTED|Open-Label Extension Phase (OLE)|Placebo arm was not applicable to Open-Label Extension Phase|0
42261|NCT01794000|97868|P1|STARTED|Open-Label Extension Phase (OLE)|Pts. who had not permanently discontinued study drug and concluded DBP were eligible to enter OLE|3
42262|NCT01794000|97867|P2|NOT COMPLETED|Double-Blind Phase (DBP)||166
42263|NCT01794000|97868|P1|NOT COMPLETED|Double-Blind Phase (DBP)||169
42264|NCT01794000|97867|P2|COMPLETED|Double-Blind Phase (DBP)||4
42265|NCT01794000|97868|P1|COMPLETED|Double-Blind Phase (DBP)||2
42266|NCT01794000|97867|P2|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||166
42267|NCT01794000|97868|P1|Discontinued During Double Blind Phase|Double-Blind Phase (DBP)||169
42268|NCT01794000|97867|P2|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
42269|NCT01794000|97868|P1|Received at Least One Dose of Drug|Double-Blind Phase (DBP)||170
42270|NCT01794000|97867|P2|STARTED|Double-Blind Phase (DBP)||170
42271|NCT01794000|97868|P1|STARTED|Double-Blind Phase (DBP)||171
42272|NCT01793688|97899|P1|NOT COMPLETED|Overall Study||2
42273|NCT01793688|97899|P1|COMPLETED|Overall Study||980
42274|NCT01793688|97899|P1|STARTED|Overall Study||982
42275|NCT01793285|97906|P1|NOT COMPLETED|Overall Study||0
42276|NCT01793285|97906|P1|COMPLETED|Overall Study||85
42277|NCT01793285|97906|P1|STARTED|Overall Study||85
42278|NCT01792986|97926|P1|NOT COMPLETED|Overall Study||0
42279|NCT01792986|97926|P1|COMPLETED|Overall Study||12
42280|NCT01792986|97926|P1|STARTED|Overall Study||12
42281|NCT01792830|97941|P7|NOT COMPLETED|Overall Study||3
42282|NCT01792830|97942|P6|NOT COMPLETED|Overall Study||0
42283|NCT01792830|97943|P5|NOT COMPLETED|Overall Study||12
42284|NCT01792830|97944|P4|NOT COMPLETED|Overall Study||5
42285|NCT01792830|97945|P3|NOT COMPLETED|Overall Study||0
42286|NCT01792830|97946|P2|NOT COMPLETED|Overall Study||0
42287|NCT01792830|97947|P1|NOT COMPLETED|Overall Study||25
42288|NCT01792830|97941|P7|COMPLETED|Overall Study||9
42289|NCT01792830|97942|P6|COMPLETED|Overall Study||4
42290|NCT01792830|97943|P5|COMPLETED|Overall Study||29
42291|NCT01792830|97944|P4|COMPLETED|Overall Study||22
42292|NCT01792830|97945|P3|COMPLETED|Overall Study||4
42293|NCT01792830|97946|P2|COMPLETED|Overall Study||3
42294|NCT01792830|97947|P1|COMPLETED|Overall Study||59
42295|NCT01792830|97941|P7|STARTED|Overall Study||12
42296|NCT01792830|97942|P6|STARTED|Overall Study||4
42297|NCT01792830|97943|P5|STARTED|Overall Study||41
42298|NCT01792830|97944|P4|STARTED|Overall Study||27
42299|NCT01792830|97945|P3|STARTED|Overall Study||4
42300|NCT01792830|97946|P2|STARTED|Overall Study||3
42301|NCT01792830|97947|P1|STARTED|Overall Study||84
42302|NCT01792635|97978|P3|NOT COMPLETED|Part B||4
42303|NCT01792635|97979|P2|NOT COMPLETED|Part B||4
42304|NCT01792635|97980|P1|NOT COMPLETED|Part B||0
42305|NCT01792635|97978|P3|COMPLETED|Part B||3
42306|NCT01792635|97979|P2|COMPLETED|Part B||2
42307|NCT01792635|97980|P1|COMPLETED|Part B||0
42308|NCT01792635|97978|P3|STARTED|Part B||7
42309|NCT01792635|97979|P2|STARTED|Part B||6
42310|NCT01792635|97980|P1|STARTED|Part B||0
42311|NCT01792635|97978|P3|NOT COMPLETED|Part A||0
42312|NCT01792635|97979|P2|NOT COMPLETED|Part A||0
42313|NCT01792635|97980|P1|NOT COMPLETED|Part A||0
42314|NCT01792635|97978|P3|COMPLETED|Part A||0
42315|NCT01792635|97979|P2|COMPLETED|Part A||0
42316|NCT01792635|97980|P1|COMPLETED|Part A||6
42317|NCT01792635|97978|P3|STARTED|Part A||0
42318|NCT01792635|97979|P2|STARTED|Part A||0
42319|NCT01792635|97980|P1|STARTED|Part A||6
42320|NCT01792518|98008|P2|NOT COMPLETED|Overall Study||7
42321|NCT01792518|98009|P1|NOT COMPLETED|Overall Study||8
42322|NCT01792518|98008|P2|COMPLETED|Overall Study||175
42323|NCT01792518|98009|P1|COMPLETED|Overall Study||170
42324|NCT01792518|98008|P2|STARTED|Overall Study||182
42325|NCT01792518|98009|P1|STARTED|Overall Study||178
42326|NCT01791972|98021|P2|NOT COMPLETED|Overall Study||0
42327|NCT01791972|98022|P1|NOT COMPLETED|Overall Study||0
42328|NCT01791972|98021|P2|COMPLETED|Overall Study||19
42329|NCT01791972|98022|P1|COMPLETED|Overall Study||19
42330|NCT01791972|98021|P2|STARTED|Overall Study||19
42331|NCT01791972|98022|P1|STARTED|Overall Study||19
42332|NCT01791894|98032|P1|NOT COMPLETED|Overall Study||1
42333|NCT01791894|98032|P1|COMPLETED|Overall Study||4
42334|NCT01791894|98032|P1|STARTED|Overall Study||5
42335|NCT01791803|98043|P4|NOT COMPLETED|Overall Study||5
42336|NCT01791803|98044|P3|NOT COMPLETED|Overall Study||2
42337|NCT01791803|98045|P2|NOT COMPLETED|Overall Study||2
42338|NCT01791803|98046|P1|NOT COMPLETED|Overall Study||0
42339|NCT01791803|98043|P4|COMPLETED|Overall Study||37
42340|NCT01791803|98044|P3|COMPLETED|Overall Study||38
42341|NCT01791803|98045|P2|COMPLETED|Overall Study||39
42342|NCT01791803|98046|P1|COMPLETED|Overall Study||41
42343|NCT01791803|98043|P4|STARTED|Overall Study||42
42344|NCT01791803|98044|P3|STARTED|Overall Study||40
42345|NCT01791803|98045|P2|STARTED|Overall Study||41
42346|NCT01791803|98046|P1|STARTED|Overall Study||41
42347|NCT01791725|98064|P3|NOT COMPLETED|Overall Study||0
42348|NCT01791725|98065|P2|NOT COMPLETED|Overall Study||1
42349|NCT01791725|98066|P1|NOT COMPLETED|Overall Study||0
42350|NCT01791725|98064|P3|COMPLETED|Overall Study||6
42351|NCT01791725|98065|P2|COMPLETED|Overall Study||4
42352|NCT01791725|98066|P1|COMPLETED|Overall Study||12
42353|NCT01791725|98064|P3|STARTED|Overall Study||6
42354|NCT01791725|98065|P2|STARTED|Overall Study||5
42355|NCT01791725|98066|P1|STARTED|Overall Study||12
42356|NCT01791491|98086|P1|NOT COMPLETED|Overall Study||0
42357|NCT01791491|98086|P1|COMPLETED|Overall Study||9
42358|NCT01791491|98086|P1|STARTED|Overall Study|Reasons for enrollment and non-treatment: 1 withdrew consent and 6 no longer met study criteria.|9
42359|NCT01791465|98098|P1|NOT COMPLETED|Overall Study||0
42360|NCT01791465|98098|P1|COMPLETED|Overall Study||6
42361|NCT01791465|98098|P1|STARTED|Overall Study||6
42362|NCT01791413|98124|P2|NOT COMPLETED|Overall Study||1
42363|NCT01791413|98125|P1|NOT COMPLETED|Overall Study||5
42364|NCT01791413|98124|P2|COMPLETED|Overall Study||19
42365|NCT01791413|98125|P1|COMPLETED|Overall Study||15
42366|NCT01791413|98124|P2|STARTED|Overall Study||20
42367|NCT01791413|98125|P1|STARTED|Overall Study||20
42368|NCT01791244|98134|P2|NOT COMPLETED|Overall Study||18
42369|NCT01791244|98135|P1|NOT COMPLETED|Overall Study||15
42370|NCT01791244|98134|P2|COMPLETED|Overall Study||29
42371|NCT01791244|98135|P1|COMPLETED|Overall Study||31
42372|NCT01791244|98134|P2|Intent to Treat (ITT)|Overall Study||39
42373|NCT01791244|98135|P1|Intent to Treat (ITT)|Overall Study||38
42374|NCT01791244|98134|P2|STARTED|Overall Study||47
42375|NCT01791244|98135|P1|STARTED|Overall Study||46
42376|NCT01791205|98171|P2|NOT COMPLETED|Phase II||0
42377|NCT01791205|98172|P1|NOT COMPLETED|Phase II||12
42378|NCT01791205|98171|P2|COMPLETED|Phase II||0
42379|NCT01791205|98172|P1|COMPLETED|Phase II||92
42380|NCT01791205|98171|P2|STARTED|Phase II||0
42381|NCT01791205|98172|P1|STARTED|Phase II|Participants who received tocilizumab monotherapy in Phase I was observed in Phase II.|104
42382|NCT01791205|98171|P2|NOT COMPLETED|Phase I||0
42383|NCT01791205|98172|P1|NOT COMPLETED|Phase I||0
42384|NCT01791205|98171|P2|COMPLETED|Phase I||152
42385|NCT01791205|98172|P1|COMPLETED|Phase I||152
42386|NCT01791205|98171|P2|STARTED|Phase I||152
42387|NCT01791205|98172|P1|STARTED|Phase I||152
42388|NCT01791153|98256|P4|NOT COMPLETED|Overall Study||5
42389|NCT01791153|98257|P3|NOT COMPLETED|Overall Study||6
42390|NCT01791153|98258|P2|NOT COMPLETED|Overall Study||8
42391|NCT01791153|98259|P1|NOT COMPLETED|Overall Study||15
42392|NCT01791153|98256|P4|COMPLETED|Overall Study|Completed Study to Week 52|46
42393|NCT01791153|98257|P3|COMPLETED|Overall Study|Completed Study to Week 52|44
42394|NCT01791153|98258|P2|COMPLETED|Overall Study|Completed Study to Week 52|41
42395|NCT01791153|98259|P1|COMPLETED|Overall Study|Completed Study to Week 52|85
42396|NCT01791153|98256|P4|STARTED|Overall Study||51
42397|NCT01791153|98257|P3|STARTED|Overall Study||50
42398|NCT01791153|98258|P2|STARTED|Overall Study||49
42399|NCT01791153|98259|P1|STARTED|Overall Study||100
42400|NCT01790828|98315|P1|NOT COMPLETED|Overall Study||34
42401|NCT01790828|98315|P1|COMPLETED|Overall Study||8
42402|NCT01790828|98315|P1|STARTED|Overall Study||42
42403|NCT01790750|98338|P1|NOT COMPLETED|Overall Study||0
42404|NCT01790750|98338|P1|COMPLETED|Overall Study||50
42405|NCT01790750|98338|P1|STARTED|Overall Study||50
42406|NCT01790685|98345|P2|NOT COMPLETED|Overall Study||0
42407|NCT01790685|98346|P1|NOT COMPLETED|Overall Study||0
42408|NCT01790685|98345|P2|COMPLETED|Overall Study||17
42409|NCT01790685|98346|P1|COMPLETED|Overall Study||23
42410|NCT01790685|98345|P2|STARTED|Overall Study||17
42411|NCT01790685|98346|P1|STARTED|Overall Study||23
42412|NCT01790659|98354|P2|NOT COMPLETED|Overall Study||6
42413|NCT01790659|98355|P1|NOT COMPLETED|Overall Study||6
42414|NCT01790659|98354|P2|COMPLETED|Overall Study||192
42415|NCT01790659|98355|P1|COMPLETED|Overall Study||195
42416|NCT01790659|98354|P2|STARTED|Overall Study||198
42417|NCT01790659|98355|P1|STARTED|Overall Study||201
42418|NCT01790633|98375|P2|NOT COMPLETED|Overall Study||5
42419|NCT01790633|98376|P1|NOT COMPLETED|Overall Study||48
42420|NCT01790633|98375|P2|COMPLETED|Overall Study||159
42421|NCT01790633|98376|P1|COMPLETED|Overall Study||115
42422|NCT01790633|98375|P2|STARTED|Overall Study||164
42423|NCT01790633|98376|P1|STARTED|Overall Study||163
42424|NCT01790581|98389|P2|NOT COMPLETED|Overall Study||0
42425|NCT01790581|98390|P1|NOT COMPLETED|Overall Study||0
42426|NCT01790581|98389|P2|COMPLETED|Overall Study||12
42427|NCT01790581|98390|P1|COMPLETED|Overall Study||12
42428|NCT01790581|98389|P2|STARTED|Overall Study||12
42429|NCT01790581|98390|P1|STARTED|Overall Study||12
42430|NCT01790516|98400|P2|NOT COMPLETED|Overall Study||0
42431|NCT01790516|98401|P1|NOT COMPLETED|Overall Study||1
42432|NCT01790516|98400|P2|COMPLETED|Overall Study||1
42433|NCT01790516|98401|P1|COMPLETED|Overall Study||0
42434|NCT01790516|98400|P2|STARTED|Overall Study||1
42435|NCT01790516|98401|P1|STARTED|Overall Study||1
42436|NCT01790490|98410|P3|NOT COMPLETED|Overall Study||0
42437|NCT01790490|98411|P2|NOT COMPLETED|Overall Study||0
42438|NCT01790490|98412|P1|NOT COMPLETED|Overall Study||0
42439|NCT01790490|98410|P3|COMPLETED|Overall Study||2
42440|NCT01790490|98411|P2|COMPLETED|Overall Study||3
42441|NCT01790490|98412|P1|COMPLETED|Overall Study||3
42442|NCT01790490|98410|P3|STARTED|Overall Study||2
42443|NCT01790490|98411|P2|STARTED|Overall Study||3
42444|NCT01790490|98412|P1|STARTED|Overall Study||3
42445|NCT01790178|98425|P2|NOT COMPLETED|Overall Study||0
42446|NCT01790178|98426|P1|NOT COMPLETED|Overall Study||0
42447|NCT01790178|98425|P2|COMPLETED|Overall Study||24
42448|NCT01790178|98426|P1|COMPLETED|Overall Study||16
42449|NCT01790178|98425|P2|STARTED|Overall Study||24
42450|NCT01790178|98426|P1|STARTED|Overall Study||16
42451|NCT01789970|98442|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||44
42452|NCT01789970|98443|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||50
42453|NCT01789970|98444|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
42454|NCT01789970|98442|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||147
42455|NCT01789970|98443|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||130
42456|NCT01789970|98444|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
42457|NCT01789970|98442|P3|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||191
42458|NCT01789970|98443|P2|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)|One participant was randomized but not treated.|179
42459|NCT01789970|98444|P1|Full Analysis Set and Safety Set|Double-blind Treatment Period (12 Weeks)||0
42460|NCT01789970|98442|P3|STARTED|Double-blind Treatment Period (12 Weeks)||191
42461|NCT01789970|98443|P2|STARTED|Double-blind Treatment Period (12 Weeks)||180
42462|NCT01789970|98444|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
42463|NCT01789970|98442|P3|NOT COMPLETED|Open-label Titration Period||0
42464|NCT01789970|98443|P2|NOT COMPLETED|Open-label Titration Period||0
42465|NCT01789970|98444|P1|NOT COMPLETED|Open-label Titration Period||254
42466|NCT01789970|98442|P3|COMPLETED|Open-label Titration Period||0
42467|NCT01789970|98443|P2|COMPLETED|Open-label Titration Period||0
42468|NCT01789970|98444|P1|COMPLETED|Open-label Titration Period||371
42469|NCT01789970|98442|P3|Safety Analysis Set|Open-label Titration Period||0
42470|NCT01789970|98443|P2|Safety Analysis Set|Open-label Titration Period||0
42471|NCT01789970|98444|P1|Safety Analysis Set|Open-label Titration Period|Two enrolled patients were not treated|623
42472|NCT01789970|98442|P3|STARTED|Open-label Titration Period||0
42473|NCT01789970|98443|P2|STARTED|Open-label Titration Period||0
42474|NCT01789970|98444|P1|STARTED|Open-label Titration Period||625
42475|NCT01789814|98478|P2|NOT COMPLETED|Overall Study||0
42476|NCT01789814|98479|P1|NOT COMPLETED|Overall Study||0
42477|NCT01789814|98478|P2|COMPLETED|Overall Study||12
42478|NCT01789814|98479|P1|COMPLETED|Overall Study||12
42479|NCT01789814|98478|P2|STARTED|Overall Study||12
42480|NCT01789814|98479|P1|STARTED|Overall Study||12
42481|NCT01789775|98487|P2|NOT COMPLETED|Overall Study||7
42482|NCT01789775|98488|P1|NOT COMPLETED|Overall Study||2
42483|NCT01789775|98487|P2|COMPLETED|Overall Study||50
42484|NCT01789775|98488|P1|COMPLETED|Overall Study||53
42485|NCT01789775|98487|P2|STARTED|Overall Study||57
42486|NCT01789775|98488|P1|STARTED|Overall Study||55
42487|NCT01789606|98496|P2|NOT COMPLETED|Overall Study||450
42488|NCT01789606|98497|P1|NOT COMPLETED|Overall Study||23
42489|NCT01789606|98496|P2|COMPLETED|Overall Study||382
42490|NCT01789606|98497|P1|COMPLETED|Overall Study||228
42491|NCT01789606|98496|P2|STARTED|Overall Study||832
42492|NCT01789606|98497|P1|STARTED|Overall Study||251
42493|NCT01789476|98517|P2|NOT COMPLETED|Overall Study||2
42494|NCT01789476|98518|P1|NOT COMPLETED|Overall Study||8
42495|NCT01789476|98517|P2|COMPLETED|Overall Study||15
42496|NCT01789476|98518|P1|COMPLETED|Overall Study||26
42497|NCT01789476|98517|P2|STARTED|Overall Study||17
42498|NCT01789476|98518|P1|STARTED|Overall Study||34
42499|NCT01789255|98528|P1|NOT COMPLETED|Overall Study||0
42500|NCT01789255|98528|P1|COMPLETED|Overall Study||12
42501|NCT01789255|98528|P1|STARTED|Overall Study||12
42502|NCT01789138|98535|P2|NOT COMPLETED|Overall Study||52
42503|NCT01789138|98536|P1|NOT COMPLETED|Overall Study||41
42504|NCT01789138|98535|P2|COMPLETED|Overall Study||206
42505|NCT01789138|98536|P1|COMPLETED|Overall Study||213
42506|NCT01789138|98535|P2|STARTED|Overall Study||258
42507|NCT01789138|98536|P1|STARTED|Overall Study||254
42508|NCT01788566|98544|P1|NOT COMPLETED|Overall Study||8
42509|NCT01788566|98544|P1|COMPLETED|Overall Study||53
42510|NCT01788566|98544|P1|STARTED|Overall Study||61
42511|NCT01788358|98554|P1|NOT COMPLETED|Overall Study||98
42512|NCT01788358|98554|P1|COMPLETED|Overall Study|217 subjects completed the study at Week 28 while the remaining 193 subjects completed at Week 52|410
42513|NCT01788358|98554|P1|Completed Week 52|Overall Study||193
42514|NCT01788358|98554|P1|Entered Extension to Week 52|Overall Study|Only the first 200 subjects who completed Week 28 visit, continued treatment up to 52 weeks.|200
42515|NCT01788358|98554|P1|Completed Week 28|Overall Study||417
42516|NCT01788358|98554|P1|Treated|Overall Study||508
42517|NCT01788358|98554|P1|STARTED|Overall Study||508
42518|NCT01788228|98568|P2|NOT COMPLETED|Overall Study||0
42519|NCT01788228|98569|P1|NOT COMPLETED|Overall Study||1
42520|NCT01788228|98568|P2|COMPLETED|Overall Study||1
42521|NCT01788228|98569|P1|COMPLETED|Overall Study||48
42522|NCT01788228|98568|P2|STARTED|Overall Study||1
42523|NCT01788228|98569|P1|STARTED|Overall Study||49
42524|NCT01788215|98588|P2|NOT COMPLETED|Overall Study||1
42525|NCT01788215|98589|P1|NOT COMPLETED|Overall Study||2
42526|NCT01788215|98588|P2|COMPLETED|Overall Study||4
42527|NCT01788215|98589|P1|COMPLETED|Overall Study||3
42528|NCT01788215|98588|P2|12 Weeks of Doxycycline or Placebo|Overall Study||5
42529|NCT01788215|98589|P1|12 Weeks of Doxycycline or Placebo|Overall Study||5
42530|NCT01788215|98588|P2|STARTED|Overall Study||5
42531|NCT01788215|98589|P1|STARTED|Overall Study||5
42532|NCT01788163|98618|P9|NOT COMPLETED|Overall Study||16
42533|NCT01788163|98619|P8|NOT COMPLETED|Overall Study||48
42534|NCT01788163|98620|P7|NOT COMPLETED|Overall Study||1
42535|NCT01788163|98621|P6|NOT COMPLETED|Overall Study||7
42536|NCT01788163|98622|P5|NOT COMPLETED|Overall Study||0
42537|NCT01788163|98623|P4|NOT COMPLETED|Overall Study||0
42538|NCT01788163|98624|P3|NOT COMPLETED|Overall Study||0
42539|NCT01788163|98625|P2|NOT COMPLETED|Overall Study||0
42540|NCT01788163|98626|P1|NOT COMPLETED|Overall Study||55
42541|NCT01788163|98618|P9|COMPLETED|Overall Study||956
42542|NCT01788163|98619|P8|COMPLETED|Overall Study||254
42543|NCT01788163|98620|P7|COMPLETED|Overall Study||49
42544|NCT01788163|98621|P6|COMPLETED|Overall Study||95
42545|NCT01788163|98622|P5|COMPLETED|Overall Study||94
42546|NCT01788163|98623|P4|COMPLETED|Overall Study||71
42547|NCT01788163|98624|P3|COMPLETED|Overall Study||62
42548|NCT01788163|98625|P2|COMPLETED|Overall Study||271
42549|NCT01788163|98626|P1|COMPLETED|Overall Study||1403
42550|NCT01788163|98618|P9|STARTED|Overall Study||972
42551|NCT01788163|98619|P8|STARTED|Overall Study||302
42552|NCT01788163|98620|P7|STARTED|Overall Study||50
42553|NCT01788163|98621|P6|STARTED|Overall Study||102
42554|NCT01788163|98622|P5|STARTED|Overall Study||94
42555|NCT01788163|98623|P4|STARTED|Overall Study||71
42556|NCT01788163|98624|P3|STARTED|Overall Study||62
42557|NCT01788163|98625|P2|STARTED|Overall Study||271
42558|NCT01788163|98626|P1|STARTED|Overall Study||1458
42559|NCT01788046|98789|P2|NOT COMPLETED|Overall Study||37
42560|NCT01788046|98790|P1|NOT COMPLETED|Overall Study||56
42561|NCT01788046|98789|P2|COMPLETED|Overall Study||218
42562|NCT01788046|98790|P1|COMPLETED|Overall Study||204
42563|NCT01788046|98789|P2|Received Treatment|Overall Study||252
42564|NCT01788046|98790|P1|Received Treatment|Overall Study||259
42565|NCT01788046|98789|P2|STARTED|Overall Study||255
42566|NCT01788046|98790|P1|STARTED|Overall Study||260
42567|NCT01787838|98806|P1|NOT COMPLETED|Overall Study||1413
42568|NCT01787838|98806|P1|COMPLETED|Overall Study|This is the number of patients successfully immunized in a one year period.|1096
42569|NCT01787838|98806|P1|STARTED|Overall Study|This is the number who met Centers for Disease Control and Prevention guidelines for vaccine.|2509
42570|NCT01787825|98810|P2|NOT COMPLETED|Overall Study||1
42571|NCT01787825|98811|P1|NOT COMPLETED|Overall Study||6
42572|NCT01787825|98810|P2|COMPLETED|Overall Study||60
42573|NCT01787825|98811|P1|COMPLETED|Overall Study||54
42574|NCT01787825|98810|P2|STARTED|Overall Study||61
42575|NCT01787825|98811|P1|STARTED|Overall Study||60
42576|NCT01787799|98822|P1|NOT COMPLETED|Overall Study||0
42577|NCT01787799|98822|P1|COMPLETED|Overall Study||100
42578|NCT01787799|98822|P1|STARTED|Overall Study||100
42579|NCT01787760|98829|P3|NOT COMPLETED|Overall Study||5
42580|NCT01787760|98830|P2|NOT COMPLETED|Overall Study||16
42581|NCT01787760|98831|P1|NOT COMPLETED|Overall Study||26
42582|NCT01787760|98829|P3|COMPLETED|Overall Study||46
42583|NCT01787760|98830|P2|COMPLETED|Overall Study||34
42584|NCT01787760|98831|P1|COMPLETED|Overall Study||25
42585|NCT01787760|98829|P3|STARTED|Overall Study||51
42586|NCT01787760|98830|P2|STARTED|Overall Study||50
42587|NCT01787760|98831|P1|STARTED|Overall Study||51
42588|NCT01787591|98845|P4|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
42589|NCT01787591|98846|P3|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
42590|NCT01787591|98847|P2|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
42591|NCT01787591|98848|P1|NOT COMPLETED|Period 4 (Cross-over Arm 4)||0
42592|NCT01787591|98845|P4|COMPLETED|Period 4 (Cross-over Arm 4)||5
42593|NCT01787591|98846|P3|COMPLETED|Period 4 (Cross-over Arm 4)||5
42594|NCT01787591|98847|P2|COMPLETED|Period 4 (Cross-over Arm 4)||5
42595|NCT01787591|98848|P1|COMPLETED|Period 4 (Cross-over Arm 4)||5
42596|NCT01787591|98845|P4|STARTED|Period 4 (Cross-over Arm 4)||5
42597|NCT01787591|98846|P3|STARTED|Period 4 (Cross-over Arm 4)||5
42598|NCT01787591|98847|P2|STARTED|Period 4 (Cross-over Arm 4)||5
42599|NCT01787591|98848|P1|STARTED|Period 4 (Cross-over Arm 4)||5
42600|NCT01787591|98845|P4|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
42601|NCT01787591|98846|P3|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
42602|NCT01787591|98847|P2|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
42603|NCT01787591|98848|P1|NOT COMPLETED|Period 3 (Cross-over Arm 3)||0
42604|NCT01787591|98845|P4|COMPLETED|Period 3 (Cross-over Arm 3)||5
42605|NCT01787591|98846|P3|COMPLETED|Period 3 (Cross-over Arm 3)||5
42606|NCT01787591|98847|P2|COMPLETED|Period 3 (Cross-over Arm 3)||5
42607|NCT01787591|98848|P1|COMPLETED|Period 3 (Cross-over Arm 3)||5
42608|NCT01787591|98845|P4|STARTED|Period 3 (Cross-over Arm 3)||5
42609|NCT01787591|98846|P3|STARTED|Period 3 (Cross-over Arm 3)||5
42610|NCT01787591|98847|P2|STARTED|Period 3 (Cross-over Arm 3)||5
42611|NCT01787591|98848|P1|STARTED|Period 3 (Cross-over Arm 3)||5
42612|NCT01787591|98845|P4|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
42613|NCT01787591|98846|P3|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
42614|NCT01787591|98847|P2|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
42615|NCT01787591|98848|P1|NOT COMPLETED|Period 2 (Cross-over Arm 2)||0
42616|NCT01787591|98845|P4|COMPLETED|Period 2 (Cross-over Arm 2)||5
42617|NCT01787591|98846|P3|COMPLETED|Period 2 (Cross-over Arm 2)||5
42618|NCT01787591|98847|P2|COMPLETED|Period 2 (Cross-over Arm 2)||5
42619|NCT01787591|98848|P1|COMPLETED|Period 2 (Cross-over Arm 2)||5
42620|NCT01787591|98845|P4|STARTED|Period 2 (Cross-over Arm 2)||5
42621|NCT01787591|98846|P3|STARTED|Period 2 (Cross-over Arm 2)||5
42622|NCT01787591|98847|P2|STARTED|Period 2 (Cross-over Arm 2)||5
42623|NCT01787591|98848|P1|STARTED|Period 2 (Cross-over Arm 2)||5
42624|NCT01787591|98845|P4|NOT COMPLETED|Period 1 (Cross-over Arm 1)||1
42625|NCT01787591|98846|P3|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
42626|NCT01787591|98847|P2|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
42627|NCT01787591|98848|P1|NOT COMPLETED|Period 1 (Cross-over Arm 1)||0
42628|NCT01787591|98845|P4|COMPLETED|Period 1 (Cross-over Arm 1)||5
42629|NCT01787591|98846|P3|COMPLETED|Period 1 (Cross-over Arm 1)||5
42630|NCT01787591|98847|P2|COMPLETED|Period 1 (Cross-over Arm 1)||5
42631|NCT01787591|98848|P1|COMPLETED|Period 1 (Cross-over Arm 1)||5
42632|NCT01787591|98845|P4|STARTED|Period 1 (Cross-over Arm 1)||6
42633|NCT01787591|98846|P3|STARTED|Period 1 (Cross-over Arm 1)||5
42634|NCT01787591|98847|P2|STARTED|Period 1 (Cross-over Arm 1)||5
42635|NCT01787591|98848|P1|STARTED|Period 1 (Cross-over Arm 1)||5
42636|NCT01787461|98876|P2|NOT COMPLETED|Overall Study||9
42637|NCT01787461|98877|P1|NOT COMPLETED|Overall Study||14
42638|NCT01787461|98876|P2|COMPLETED|Overall Study||89
42639|NCT01787461|98877|P1|COMPLETED|Overall Study||82
42640|NCT01787461|98876|P2|STARTED|Overall Study||98
42641|NCT01787461|98877|P1|STARTED|Overall Study||96
42642|NCT01787383|98905|P2|NOT COMPLETED|Overall Study||22
42643|NCT01787383|98906|P1|NOT COMPLETED|Overall Study||9
42644|NCT01787383|98905|P2|COMPLETED|Overall Study||76
42645|NCT01787383|98906|P1|COMPLETED|Overall Study||92
42646|NCT01787383|98905|P2|STARTED|Overall Study||98
42647|NCT01787383|98906|P1|STARTED|Overall Study||101
42648|NCT01787279|98926|P1|NOT COMPLETED|Overall Study||3
42649|NCT01787279|98926|P1|COMPLETED|Overall Study||56
42650|NCT01787279|98926|P1|STARTED|Overall Study||59
42651|NCT01787240|98937|P2|NOT COMPLETED|Overall Study||1
42652|NCT01787240|98938|P1|NOT COMPLETED|Overall Study||5
42653|NCT01787240|98937|P2|COMPLETED|Overall Study||4
42654|NCT01787240|98938|P1|COMPLETED|Overall Study||10
42655|NCT01787240|98937|P2|STARTED|Overall Study||5
42656|NCT01787240|98938|P1|STARTED|Overall Study||15
42657|NCT01787188|98952|P3|NOT COMPLETED|Overall Study||18
42658|NCT01787188|98953|P2|NOT COMPLETED|Overall Study||18
42659|NCT01787188|98954|P1|NOT COMPLETED|Overall Study||17
42660|NCT01787188|98952|P3|COMPLETED|Overall Study||116
42661|NCT01787188|98953|P2|COMPLETED|Overall Study||112
42662|NCT01787188|98954|P1|COMPLETED|Overall Study||122
42663|NCT01787188|98952|P3|STARTED|Overall Study||134
42664|NCT01787188|98953|P2|STARTED|Overall Study||130
42665|NCT01787188|98954|P1|STARTED|Overall Study||139
42666|NCT01787175|99009|P2|NOT COMPLETED|Overall Study||0
42667|NCT01787175|99010|P1|NOT COMPLETED|Overall Study||0
42668|NCT01787175|99009|P2|COMPLETED|Overall Study||28
42669|NCT01787175|99010|P1|COMPLETED|Overall Study||30
42670|NCT01787175|99009|P2|STARTED|Overall Study||28
42671|NCT01787175|99010|P1|STARTED|Overall Study||30
42672|NCT01787032|99026|P6|NOT COMPLETED|Overall Study||1
42673|NCT01787032|99027|P5|NOT COMPLETED|Overall Study||1
42674|NCT01787032|99028|P4|NOT COMPLETED|Overall Study||0
42675|NCT01787032|99029|P3|NOT COMPLETED|Overall Study||0
42676|NCT01787032|99030|P2|NOT COMPLETED|Overall Study||0
42677|NCT01787032|99031|P1|NOT COMPLETED|Overall Study||0
42678|NCT01787032|99026|P6|COMPLETED|Overall Study||3
42679|NCT01787032|99027|P5|COMPLETED|Overall Study||3
42680|NCT01787032|99028|P4|COMPLETED|Overall Study||3
42681|NCT01787032|99029|P3|COMPLETED|Overall Study||3
42682|NCT01787032|99030|P2|COMPLETED|Overall Study||3
42683|NCT01787032|99031|P1|COMPLETED|Overall Study||3
42684|NCT01787032|99026|P6|Received T2|Overall Study||4
42685|NCT01787032|99027|P5|Received T2|Overall Study||4
42686|NCT01787032|99028|P4|Received T2|Overall Study||3
42687|NCT01787032|99029|P3|Received T2|Overall Study||3
42688|NCT01787032|99030|P2|Received T2|Overall Study||3
42689|NCT01787032|99031|P1|Received T2|Overall Study||3
42690|NCT01787032|99026|P6|Received T1|Overall Study||4
42691|NCT01787032|99027|P5|Received T1|Overall Study||3
42692|NCT01787032|99028|P4|Received T1|Overall Study||3
42693|NCT01787032|99029|P3|Received T1|Overall Study||3
42694|NCT01787032|99030|P2|Received T1|Overall Study||3
42695|NCT01787032|99031|P1|Received T1|Overall Study||3
42696|NCT01787032|99026|P6|Received R|Overall Study||3
42697|NCT01787032|99027|P5|Received R|Overall Study||4
42698|NCT01787032|99028|P4|Received R|Overall Study||3
42699|NCT01787032|99029|P3|Received R|Overall Study||3
42700|NCT01787032|99030|P2|Received R|Overall Study||3
42701|NCT01787032|99031|P1|Received R|Overall Study||3
42702|NCT01787032|99026|P6|STARTED|Overall Study||4
42703|NCT01787032|99027|P5|STARTED|Overall Study||4
42704|NCT01787032|99028|P4|STARTED|Overall Study||3
42705|NCT01787032|99029|P3|STARTED|Overall Study||3
42706|NCT01787032|99030|P2|STARTED|Overall Study||3
42707|NCT01787032|99031|P1|STARTED|Overall Study||3
42708|NCT01786993|99055|P2|NOT COMPLETED|Overall Study||10
42709|NCT01786993|99056|P1|NOT COMPLETED|Overall Study||12
42710|NCT01786993|99055|P2|COMPLETED|Overall Study||170
42711|NCT01786993|99056|P1|COMPLETED|Overall Study||189
42712|NCT01786993|99055|P2|Per Protocol Population at 9 Months|Overall Study||170
42713|NCT01786993|99056|P1|Per Protocol Population at 9 Months|Overall Study||189
42714|NCT01786993|99055|P2|STARTED|Overall Study||180
42715|NCT01786993|99056|P1|STARTED|Overall Study||201
42716|NCT01786954|99063|P2|NOT COMPLETED|Overall Study||0
42717|NCT01786954|99064|P1|NOT COMPLETED|Overall Study||0
42718|NCT01786954|99063|P2|COMPLETED|Overall Study||34
42719|NCT01786954|99064|P1|COMPLETED|Overall Study||34
42720|NCT01786954|99063|P2|STARTED|Overall Study||34
42721|NCT01786954|99064|P1|STARTED|Overall Study||34
42722|NCT01786902|99076|P2|NOT COMPLETED|Overall Study||3
42723|NCT01786902|99077|P1|NOT COMPLETED|Overall Study||4
42724|NCT01786902|99076|P2|COMPLETED|Overall Study||31
42725|NCT01786902|99077|P1|COMPLETED|Overall Study||32
42726|NCT01786902|99076|P2|STARTED|Overall Study||34
42727|NCT01786902|99077|P1|STARTED|Overall Study||36
42728|NCT01786876|99087|P1|NOT COMPLETED|Overall Study||0
42729|NCT01786876|99087|P1|COMPLETED|Overall Study||6
42730|NCT01786876|99087|P1|STARTED|Overall Study||6
42731|NCT01786707|99106|P2|NOT COMPLETED|Overall Study||1
42732|NCT01786707|99107|P1|NOT COMPLETED|Overall Study||1
42733|NCT01786707|99106|P2|COMPLETED|Overall Study||0
42734|NCT01786707|99107|P1|COMPLETED|Overall Study||0
42735|NCT01786707|99106|P2|STARTED|Overall Study||1
42736|NCT01786707|99107|P1|STARTED|Overall Study||1
42737|NCT01786668|99119|P4|NOT COMPLETED|Overall Study||4
42738|NCT01786668|99120|P3|NOT COMPLETED|Overall Study||5
42739|NCT01786668|99121|P2|NOT COMPLETED|Overall Study||1
42740|NCT01786668|99122|P1|NOT COMPLETED|Overall Study||1
42741|NCT01786668|99119|P4|COMPLETED|Overall Study||47
42742|NCT01786668|99120|P3|COMPLETED|Overall Study||47
42743|NCT01786668|99121|P2|COMPLETED|Overall Study||51
42744|NCT01786668|99122|P1|COMPLETED|Overall Study||51
42745|NCT01786668|99119|P4|STARTED|Overall Study||51
42746|NCT01786668|99120|P3|STARTED|Overall Study||52
42747|NCT01786668|99121|P2|STARTED|Overall Study||52
42748|NCT01786668|99122|P1|STARTED|Overall Study||52
42749|NCT01786629|99222|P2|NOT COMPLETED|Overall Study||5
42750|NCT01786629|99223|P1|NOT COMPLETED|Overall Study||0
42751|NCT01786629|99222|P2|COMPLETED|Overall Study||164
42752|NCT01786629|99223|P1|COMPLETED|Overall Study||169
42753|NCT01786629|99222|P2|STARTED|Overall Study||169
42754|NCT01786629|99223|P1|STARTED|Overall Study||169
42755|NCT01786551|99229|P1|NOT COMPLETED|Overall Study||2
42756|NCT01786551|99229|P1|COMPLETED|Overall Study||14
42757|NCT01786551|99229|P1|STARTED|Overall Study||16
42758|NCT01786330|99237|P2|NOT COMPLETED|Overall Study||3
42759|NCT01786330|99238|P1|NOT COMPLETED|Overall Study||1
42760|NCT01786330|99237|P2|COMPLETED|Overall Study||27
42761|NCT01786330|99238|P1|COMPLETED|Overall Study||29
42762|NCT01786330|99237|P2|STARTED|Overall Study||30
42763|NCT01786330|99238|P1|STARTED|Overall Study||30
42764|NCT01786252|99252|P2|NOT COMPLETED|Overall Study||0
42765|NCT01786252|99253|P1|NOT COMPLETED|Overall Study||0
42766|NCT01786252|99252|P2|COMPLETED|Overall Study||8
42767|NCT01786252|99253|P1|COMPLETED|Overall Study||7
42768|NCT01786252|99252|P2|STARTED|Overall Study||8
42769|NCT01786252|99253|P1|STARTED|Overall Study||7
42770|NCT01786239|99267|P2|NOT COMPLETED|Overall Study||11
42771|NCT01786239|99268|P1|NOT COMPLETED|Overall Study||11
42772|NCT01786239|99267|P2|COMPLETED|Overall Study||14
42773|NCT01786239|99268|P1|COMPLETED|Overall Study||14
42774|NCT01786239|99267|P2|STARTED|Overall Study||25
42775|NCT01786239|99268|P1|STARTED|Overall Study||25
42776|NCT01786174|99276|P2|NOT COMPLETED|Overall Study||0
42777|NCT01786174|99277|P1|NOT COMPLETED|Overall Study||2
42778|NCT01786174|99276|P2|COMPLETED|Overall Study||10
42779|NCT01786174|99277|P1|COMPLETED|Overall Study||16
42780|NCT01786174|99276|P2|Randomized|Overall Study||11
42781|NCT01786174|99277|P1|Randomized|Overall Study||19
42782|NCT01786174|99276|P2|STARTED|Overall Study||10
42783|NCT01786174|99277|P1|STARTED|Overall Study||18
42784|NCT01786161|99293|P2|NOT COMPLETED|Overall Study||0
42785|NCT01786161|99294|P1|NOT COMPLETED|Overall Study||0
42786|NCT01786161|99293|P2|COMPLETED|Overall Study||22
42787|NCT01786161|99294|P1|COMPLETED|Overall Study||22
42788|NCT01786161|99293|P2|STARTED|Overall Study||22
42789|NCT01786161|99294|P1|STARTED|Overall Study||22
42790|NCT01786109|99307|P3|NOT COMPLETED|Overall Study||2
42791|NCT01786109|99308|P2|NOT COMPLETED|Overall Study||0
42792|NCT01786109|99309|P1|NOT COMPLETED|Overall Study||1
42793|NCT01786109|99307|P3|COMPLETED|Overall Study||25
42794|NCT01786109|99308|P2|COMPLETED|Overall Study||24
42795|NCT01786109|99309|P1|COMPLETED|Overall Study||23
42796|NCT01786109|99307|P3|STARTED|Overall Study||27
42797|NCT01786109|99308|P2|STARTED|Overall Study||24
42798|NCT01786109|99309|P1|STARTED|Overall Study||24
42799|NCT01785875|99338|P3|NOT COMPLETED|Overall Study||107
42800|NCT01785875|99339|P2|NOT COMPLETED|Overall Study||289
42801|NCT01785875|99340|P1|NOT COMPLETED|Overall Study||294
42802|NCT01785875|99338|P3|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|16
42803|NCT01785875|99339|P2|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|95
42804|NCT01785875|99340|P1|COMPLETED|Overall Study|Completed etelcalcetide and the 30-day safety follow-up period|90
42805|NCT01785875|99338|P3|Received Etelcalcetide|Overall Study||123
42806|NCT01785875|99339|P2|Received Etelcalcetide|Overall Study||384
42807|NCT01785875|99340|P1|Received Etelcalcetide|Overall Study||383
42808|NCT01785875|99338|P3|STARTED|Overall Study||123
42809|NCT01785875|99339|P2|STARTED|Overall Study||384
42810|NCT01785875|99340|P1|STARTED|Overall Study||384
42811|NCT01785849|99409|P2|NOT COMPLETED|Overall Study||34
42812|NCT01785849|99410|P1|NOT COMPLETED|Overall Study||61
42813|NCT01785849|99409|P2|COMPLETED|Overall Study||220
42814|NCT01785849|99410|P1|COMPLETED|Overall Study||193
42815|NCT01785849|99409|P2|Received Treatment|Overall Study||251
42816|NCT01785849|99410|P1|Received Treatment|Overall Study||254
42817|NCT01785849|99409|P2|STARTED|Overall Study||254
42818|NCT01785849|99410|P1|STARTED|Overall Study||254
42819|NCT01785628|99428|P2|NOT COMPLETED|Overall Study||3
42820|NCT01785628|99429|P1|NOT COMPLETED|Overall Study||2
42821|NCT01785628|99428|P2|COMPLETED|Overall Study||12
42822|NCT01785628|99429|P1|COMPLETED|Overall Study||13
42823|NCT01785628|99428|P2|STARTED|Overall Study||15
42824|NCT01785628|99429|P1|STARTED|Overall Study||15
42825|NCT01785615|99452|P4|NOT COMPLETED|Atorvastatin Phase||0
42826|NCT01785615|99453|P3|NOT COMPLETED|Atorvastatin Phase||0
42827|NCT01785615|99454|P2|NOT COMPLETED|Atorvastatin Phase||0
42828|NCT01785615|99455|P1|NOT COMPLETED|Atorvastatin Phase||0
42829|NCT01785615|99452|P4|COMPLETED|Atorvastatin Phase||0
42830|NCT01785615|99453|P3|COMPLETED|Atorvastatin Phase||0
42831|NCT01785615|99454|P2|COMPLETED|Atorvastatin Phase||44
42832|NCT01785615|99455|P1|COMPLETED|Atorvastatin Phase||44
42833|NCT01785615|99452|P4|STARTED|Atorvastatin Phase||0
42834|NCT01785615|99453|P3|STARTED|Atorvastatin Phase||0
42835|NCT01785615|99454|P2|STARTED|Atorvastatin Phase||44
42836|NCT01785615|99455|P1|STARTED|Atorvastatin Phase||44
42837|NCT01785615|99452|P4|NOT COMPLETED|Dietary Phase||24
42838|NCT01785615|99453|P3|NOT COMPLETED|Dietary Phase||0
42839|NCT01785615|99454|P2|NOT COMPLETED|Dietary Phase||0
42840|NCT01785615|99455|P1|NOT COMPLETED|Dietary Phase||0
42841|NCT01785615|99452|P4|COMPLETED|Dietary Phase||116
42842|NCT01785615|99453|P3|COMPLETED|Dietary Phase||35
42843|NCT01785615|99454|P2|COMPLETED|Dietary Phase||0
42844|NCT01785615|99455|P1|COMPLETED|Dietary Phase||0
42845|NCT01785615|99452|P4|STARTED|Dietary Phase||140
42846|NCT01785615|99453|P3|STARTED|Dietary Phase||35
42847|NCT01785615|99454|P2|STARTED|Dietary Phase||0
42848|NCT01785615|99455|P1|STARTED|Dietary Phase||0
42849|NCT01785602|99527|P2|NOT COMPLETED|Overall Study||9
42850|NCT01785602|99528|P1|NOT COMPLETED|Overall Study||13
42851|NCT01785602|99527|P2|COMPLETED|Overall Study||18
42852|NCT01785602|99528|P1|COMPLETED|Overall Study||63
42853|NCT01785602|99527|P2|STARTED|Overall Study||27
42854|NCT01785602|99528|P1|STARTED|Overall Study||76
42855|NCT01785524|99538|P2|NOT COMPLETED|Overall Study||2
42856|NCT01785524|99539|P1|NOT COMPLETED|Overall Study||2
42857|NCT01785524|99538|P2|COMPLETED|Overall Study||2
42858|NCT01785524|99539|P1|COMPLETED|Overall Study||5
42859|NCT01785524|99538|P2|STARTED|Overall Study||4
42860|NCT01785524|99539|P1|STARTED|Overall Study||7
42861|NCT01785472|99558|P3|NOT COMPLETED|Overall Study||22
42862|NCT01785472|99559|P2|NOT COMPLETED|Overall Study||19
42863|NCT01785472|99560|P1|NOT COMPLETED|Overall Study||24
42864|NCT01785472|99558|P3|COMPLETED|Overall Study||464
42865|NCT01785472|99559|P2|COMPLETED|Overall Study||454
42866|NCT01785472|99560|P1|COMPLETED|Overall Study||455
42867|NCT01785472|99558|P3|Safety Set (SAF)|Overall Study||484
42868|NCT01785472|99559|P2|Safety Set (SAF)|Overall Study||472
42869|NCT01785472|99560|P1|Safety Set (SAF)|Overall Study||478
42870|NCT01785472|99558|P3|Full Analysis Set (FAS)|Overall Study||484
42871|NCT01785472|99559|P2|Full Analysis Set (FAS)|Overall Study||472
42872|NCT01785472|99560|P1|Full Analysis Set (FAS)|Overall Study||479
42873|NCT01785472|99558|P3|STARTED|Overall Study||486
42874|NCT01785472|99559|P2|STARTED|Overall Study||473
42875|NCT01785472|99560|P1|STARTED|Overall Study||479
42876|NCT01785160|99602|P1|NOT COMPLETED|Treatment Period 2: Raltegravir + Faldap||0
42975|NCT01784614|99663|P6|STARTED|Period 2||3
42877|NCT01785160|99602|P1|COMPLETED|Treatment Period 2: Raltegravir + Faldap||23
42878|NCT01785160|99602|P1|STARTED|Treatment Period 2: Raltegravir + Faldap||23
42879|NCT01785160|99602|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
42880|NCT01785160|99602|P1|COMPLETED|Washout Period of at Least 7 Days||23
42881|NCT01785160|99602|P1|STARTED|Washout Period of at Least 7 Days||24
42882|NCT01785160|99602|P1|NOT COMPLETED|Treatment Period 1: Raltegravir||1
42883|NCT01785160|99602|P1|COMPLETED|Treatment Period 1: Raltegravir||24
42884|NCT01785160|99602|P1|STARTED|Treatment Period 1: Raltegravir||25
42885|NCT01785134|99612|P2|NOT COMPLETED|Overall Study||7
42886|NCT01785134|99613|P1|NOT COMPLETED|Overall Study||12
42887|NCT01785134|99612|P2|COMPLETED|Overall Study||33
42888|NCT01785134|99613|P1|COMPLETED|Overall Study||29
42889|NCT01785134|99612|P2|STARTED|Overall Study||40
42890|NCT01785134|99613|P1|STARTED|Overall Study||41
42891|NCT01785095|99627|P1|NOT COMPLETED|Overall Study||3
42892|NCT01785095|99627|P1|COMPLETED|Overall Study||24
42893|NCT01785095|99627|P1|STARTED|Overall Study||27
42894|NCT01784965|99637|P2|NOT COMPLETED|Overall Study||11
42895|NCT01784965|99638|P1|NOT COMPLETED|Overall Study||6
42896|NCT01784965|99637|P2|COMPLETED|Overall Study||24
42897|NCT01784965|99638|P1|COMPLETED|Overall Study||27
42898|NCT01784965|99637|P2|STARTED|Overall Study||35
42899|NCT01784965|99638|P1|STARTED|Overall Study||33
42900|NCT01784666|99651|P3|NOT COMPLETED|Overall Study||0
42901|NCT01784666|99652|P2|NOT COMPLETED|Overall Study||0
42902|NCT01784666|99653|P1|NOT COMPLETED|Overall Study||0
42903|NCT01784666|99651|P3|COMPLETED|Overall Study||1
42904|NCT01784666|99652|P2|COMPLETED|Overall Study||0
42905|NCT01784666|99653|P1|COMPLETED|Overall Study||1
42906|NCT01784666|99651|P3|STARTED|Overall Study||1
42907|NCT01784666|99652|P2|STARTED|Overall Study||0
42908|NCT01784666|99653|P1|STARTED|Overall Study||1
42909|NCT01784614|99661|P8|NOT COMPLETED|Period 4||0
42910|NCT01784614|99662|P7|NOT COMPLETED|Period 4||0
42911|NCT01784614|99663|P6|NOT COMPLETED|Period 4||0
42912|NCT01784614|99664|P5|NOT COMPLETED|Period 4||0
42913|NCT01784614|99665|P4|NOT COMPLETED|Period 4||0
42914|NCT01784614|99666|P3|NOT COMPLETED|Period 4||0
42915|NCT01784614|99667|P2|NOT COMPLETED|Period 4||0
42916|NCT01784614|99668|P1|NOT COMPLETED|Period 4||0
42917|NCT01784614|99661|P8|COMPLETED|Period 4||2
42918|NCT01784614|99662|P7|COMPLETED|Period 4||3
42919|NCT01784614|99663|P6|COMPLETED|Period 4||3
42920|NCT01784614|99664|P5|COMPLETED|Period 4||3
42921|NCT01784614|99665|P4|COMPLETED|Period 4||3
42922|NCT01784614|99666|P3|COMPLETED|Period 4||3
42923|NCT01784614|99667|P2|COMPLETED|Period 4||2
42924|NCT01784614|99668|P1|COMPLETED|Period 4||3
42925|NCT01784614|99661|P8|STARTED|Period 4||2
42926|NCT01784614|99662|P7|STARTED|Period 4||3
42927|NCT01784614|99663|P6|STARTED|Period 4||3
42928|NCT01784614|99664|P5|STARTED|Period 4||3
42929|NCT01784614|99665|P4|STARTED|Period 4||3
42930|NCT01784614|99666|P3|STARTED|Period 4||3
42931|NCT01784614|99667|P2|STARTED|Period 4||2
42932|NCT01784614|99668|P1|STARTED|Period 4||3
42933|NCT01784614|99661|P8|NOT COMPLETED|Period 3||0
42934|NCT01784614|99662|P7|NOT COMPLETED|Period 3||0
42935|NCT01784614|99663|P6|NOT COMPLETED|Period 3||0
42936|NCT01784614|99664|P5|NOT COMPLETED|Period 3||0
42937|NCT01784614|99665|P4|NOT COMPLETED|Period 3||0
42938|NCT01784614|99666|P3|NOT COMPLETED|Period 3||0
42939|NCT01784614|99667|P2|NOT COMPLETED|Period 3||0
42940|NCT01784614|99668|P1|NOT COMPLETED|Period 3||0
42941|NCT01784614|99661|P8|COMPLETED|Period 3||2
42942|NCT01784614|99662|P7|COMPLETED|Period 3||3
42943|NCT01784614|99663|P6|COMPLETED|Period 3||3
42944|NCT01784614|99664|P5|COMPLETED|Period 3||3
42945|NCT01784614|99665|P4|COMPLETED|Period 3||3
42946|NCT01784614|99666|P3|COMPLETED|Period 3||3
42947|NCT01784614|99667|P2|COMPLETED|Period 3||2
42948|NCT01784614|99668|P1|COMPLETED|Period 3||3
42949|NCT01784614|99661|P8|STARTED|Period 3||2
42950|NCT01784614|99662|P7|STARTED|Period 3||3
42951|NCT01784614|99663|P6|STARTED|Period 3||3
42952|NCT01784614|99664|P5|STARTED|Period 3||3
42953|NCT01784614|99665|P4|STARTED|Period 3||3
42954|NCT01784614|99666|P3|STARTED|Period 3||3
42955|NCT01784614|99667|P2|STARTED|Period 3||2
42956|NCT01784614|99668|P1|STARTED|Period 3||3
42957|NCT01784614|99661|P8|NOT COMPLETED|Period 2||0
42958|NCT01784614|99662|P7|NOT COMPLETED|Period 2||0
42959|NCT01784614|99663|P6|NOT COMPLETED|Period 2||0
42960|NCT01784614|99664|P5|NOT COMPLETED|Period 2||0
42961|NCT01784614|99665|P4|NOT COMPLETED|Period 2||0
42962|NCT01784614|99666|P3|NOT COMPLETED|Period 2||0
42963|NCT01784614|99667|P2|NOT COMPLETED|Period 2||0
42964|NCT01784614|99668|P1|NOT COMPLETED|Period 2||0
42965|NCT01784614|99661|P8|COMPLETED|Period 2||2
42966|NCT01784614|99662|P7|COMPLETED|Period 2||3
42967|NCT01784614|99663|P6|COMPLETED|Period 2||3
42968|NCT01784614|99664|P5|COMPLETED|Period 2||3
42969|NCT01784614|99665|P4|COMPLETED|Period 2||3
42970|NCT01784614|99666|P3|COMPLETED|Period 2||3
42971|NCT01784614|99667|P2|COMPLETED|Period 2|One participant withdrew consent after completed Period 2 and did not enter Period 3.|3
42972|NCT01784614|99668|P1|COMPLETED|Period 2||3
42973|NCT01784614|99661|P8|STARTED|Period 2||2
42974|NCT01784614|99662|P7|STARTED|Period 2||3
42976|NCT01784614|99664|P5|STARTED|Period 2||3
42977|NCT01784614|99665|P4|STARTED|Period 2||3
42978|NCT01784614|99666|P3|STARTED|Period 2||3
42979|NCT01784614|99667|P2|STARTED|Period 2||3
42980|NCT01784614|99668|P1|STARTED|Period 2||3
42981|NCT01784614|99661|P8|NOT COMPLETED|Period 1||0
42982|NCT01784614|99662|P7|NOT COMPLETED|Period 1||0
42983|NCT01784614|99663|P6|NOT COMPLETED|Period 1||0
42984|NCT01784614|99664|P5|NOT COMPLETED|Period 1||0
42985|NCT01784614|99665|P4|NOT COMPLETED|Period 1||0
42986|NCT01784614|99666|P3|NOT COMPLETED|Period 1||0
42987|NCT01784614|99667|P2|NOT COMPLETED|Period 1||0
42988|NCT01784614|99668|P1|NOT COMPLETED|Period 1||0
42989|NCT01784614|99661|P8|COMPLETED|Period 1|One participant withdrew consent after completed Period 1 and did not enter Period 2.|3
42990|NCT01784614|99662|P7|COMPLETED|Period 1||3
42991|NCT01784614|99663|P6|COMPLETED|Period 1||3
42992|NCT01784614|99664|P5|COMPLETED|Period 1||3
42993|NCT01784614|99665|P4|COMPLETED|Period 1||3
42994|NCT01784614|99666|P3|COMPLETED|Period 1||3
42995|NCT01784614|99667|P2|COMPLETED|Period 1||3
42996|NCT01784614|99668|P1|COMPLETED|Period 1||3
42997|NCT01784614|99661|P8|Received at Least 1 Dose of Study Drug|Period 1||3
42998|NCT01784614|99662|P7|Received at Least 1 Dose of Study Drug|Period 1||3
42999|NCT01784614|99663|P6|Received at Least 1 Dose of Study Drug|Period 1||3
43000|NCT01784614|99664|P5|Received at Least 1 Dose of Study Drug|Period 1||3
43001|NCT01784614|99665|P4|Received at Least 1 Dose of Study Drug|Period 1||3
43002|NCT01784614|99666|P3|Received at Least 1 Dose of Study Drug|Period 1||3
43003|NCT01784614|99667|P2|Received at Least 1 Dose of Study Drug|Period 1||3
43004|NCT01784614|99668|P1|Received at Least 1 Dose of Study Drug|Period 1||3
43005|NCT01784614|99661|P8|STARTED|Period 1||3
43006|NCT01784614|99662|P7|STARTED|Period 1||3
43007|NCT01784614|99663|P6|STARTED|Period 1||3
43008|NCT01784614|99664|P5|STARTED|Period 1||3
43009|NCT01784614|99665|P4|STARTED|Period 1||3
43010|NCT01784614|99666|P3|STARTED|Period 1||3
43011|NCT01784614|99667|P2|STARTED|Period 1||3
43012|NCT01784614|99668|P1|STARTED|Period 1||3
43013|NCT01783938|99704|P2|NOT COMPLETED|Overall Study||53
43014|NCT01783938|99705|P1|NOT COMPLETED|Overall Study||47
43015|NCT01783938|99704|P2|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|17
43016|NCT01783938|99705|P1|COMPLETED|Overall Study|Completed=continuing treatment; did not permanently discontinue both study drugs in treatment period|21
43017|NCT01783938|99704|P2|STARTED|Overall Study||70
43018|NCT01783938|99705|P1|STARTED|Overall Study||68
43019|NCT01783912|99720|P3|NOT COMPLETED|Overall Study||23
43020|NCT01783912|99721|P2|NOT COMPLETED|Overall Study||46
43021|NCT01783912|99722|P1|NOT COMPLETED|Overall Study||30
43022|NCT01783912|99720|P3|COMPLETED|Overall Study||25
43023|NCT01783912|99721|P2|COMPLETED|Overall Study||58
43024|NCT01783912|99722|P1|COMPLETED|Overall Study||88
43025|NCT01783912|99720|P3|STARTED|Overall Study||48
43026|NCT01783912|99721|P2|STARTED|Overall Study||104
43027|NCT01783912|99722|P1|STARTED|Overall Study||118
43028|NCT01783886|99733|P3|NOT COMPLETED|Overall Study||10
43029|NCT01783886|99734|P2|NOT COMPLETED|Overall Study||11
43030|NCT01783886|99735|P1|NOT COMPLETED|Overall Study||5
43031|NCT01783886|99733|P3|COMPLETED|Overall Study||117
43032|NCT01783886|99734|P2|COMPLETED|Overall Study||116
43033|NCT01783886|99735|P1|COMPLETED|Overall Study||122
43034|NCT01783886|99733|P3|Participants Received Treatment|Overall Study||124
43035|NCT01783886|99734|P2|Participants Received Treatment|Overall Study||127
43036|NCT01783886|99735|P1|Participants Received Treatment|Overall Study||127
43037|NCT01783886|99733|P3|STARTED|Overall Study||127
43038|NCT01783886|99734|P2|STARTED|Overall Study||127
43039|NCT01783886|99735|P1|STARTED|Overall Study||127
43040|NCT01783860|99763|P2|NOT COMPLETED|Overall Study||0
43041|NCT01783860|99764|P1|NOT COMPLETED|Overall Study||0
43042|NCT01783860|99763|P2|COMPLETED|Overall Study||50
43043|NCT01783860|99764|P1|COMPLETED|Overall Study||50
43044|NCT01783860|99763|P2|STARTED|Overall Study||50
43045|NCT01783860|99764|P1|STARTED|Overall Study||50
43046|NCT01783821|99782|P2|NOT COMPLETED|Overall Study||1
43047|NCT01783821|99783|P1|NOT COMPLETED|Overall Study||1
43048|NCT01783821|99782|P2|COMPLETED|Overall Study||30
43049|NCT01783821|99783|P1|COMPLETED|Overall Study||29
43050|NCT01783821|99782|P2|STARTED|Overall Study||31
43051|NCT01783821|99783|P1|STARTED|Overall Study||30
43052|NCT01783730|99799|P1|NOT COMPLETED|Overall Study||6
43053|NCT01783730|99799|P1|COMPLETED|Overall Study||157
43054|NCT01783730|99799|P1|STARTED|Overall Study||163
43055|NCT01783678|99824|P6|NOT COMPLETED|Overall Study||5
43056|NCT01783678|99825|P5|NOT COMPLETED|Overall Study||7
43057|NCT01783678|99826|P4|NOT COMPLETED|Overall Study||8
43058|NCT01783678|99827|P3|NOT COMPLETED|Overall Study||1
43059|NCT01783678|99828|P2|NOT COMPLETED|Overall Study||18
43060|NCT01783678|99829|P1|NOT COMPLETED|Overall Study||2
43061|NCT01783678|99824|P6|COMPLETED|Overall Study||26
43062|NCT01783678|99825|P5|COMPLETED|Overall Study||42
43063|NCT01783678|99826|P4|COMPLETED|Overall Study||50
43064|NCT01783678|99827|P3|COMPLETED|Overall Study||5
43065|NCT01783678|99828|P2|COMPLETED|Overall Study||94
43066|NCT01783678|99829|P1|COMPLETED|Overall Study||17
43067|NCT01783678|99824|P6|STARTED|Overall Study||31
43068|NCT01783678|99825|P5|STARTED|Overall Study||49
43069|NCT01783678|99826|P4|STARTED|Overall Study||58
43070|NCT01783678|99827|P3|STARTED|Overall Study||6
43071|NCT01783678|99828|P2|STARTED|Overall Study||112
43072|NCT01783678|99829|P1|STARTED|Overall Study||19
43073|NCT01783639|99901|P1|NOT COMPLETED|Overall Study||0
43074|NCT01783639|99901|P1|COMPLETED|Overall Study||120
43075|NCT01783639|99901|P1|STARTED|Overall Study||120
43076|NCT01783561|99907|P2|NOT COMPLETED|Overall Study||0
43077|NCT01783561|99908|P1|NOT COMPLETED|Overall Study||0
43078|NCT01783561|99907|P2|COMPLETED|Overall Study||10
43079|NCT01783561|99908|P1|COMPLETED|Overall Study||11
43080|NCT01783561|99907|P2|STARTED|Overall Study||10
43081|NCT01783561|99908|P1|STARTED|Overall Study||11
43082|NCT01783548|99918|P2|NOT COMPLETED|Overall Study||18
43083|NCT01783548|99919|P1|NOT COMPLETED|Overall Study||34
43084|NCT01783548|99918|P2|COMPLETED|Overall Study||167
43085|NCT01783548|99919|P1|COMPLETED|Overall Study||328
43086|NCT01783548|99918|P2|Full Analysis Set (FAS)|Overall Study||184
43087|NCT01783548|99919|P1|Full Analysis Set (FAS)|Overall Study||358
43088|NCT01783548|99918|P2|STARTED|Overall Study|Randomized|185
43089|NCT01783548|99919|P1|STARTED|Overall Study|Randomized|362
43090|NCT01783496|99937|P6|NOT COMPLETED|Overall Study||1
43091|NCT01783496|99938|P5|NOT COMPLETED|Overall Study||0
43092|NCT01783496|99939|P4|NOT COMPLETED|Overall Study||2
43093|NCT01783496|99940|P3|NOT COMPLETED|Overall Study||0
43094|NCT01783496|99941|P2|NOT COMPLETED|Overall Study||0
43095|NCT01783496|99942|P1|NOT COMPLETED|Overall Study||1
43096|NCT01783496|99937|P6|COMPLETED|Overall Study||4
43097|NCT01783496|99938|P5|COMPLETED|Overall Study||5
43098|NCT01783496|99939|P4|COMPLETED|Overall Study||8
43099|NCT01783496|99940|P3|COMPLETED|Overall Study||10
43100|NCT01783496|99941|P2|COMPLETED|Overall Study||10
43101|NCT01783496|99942|P1|COMPLETED|Overall Study||9
43102|NCT01783496|99937|P6|STARTED|Overall Study||5
43103|NCT01783496|99938|P5|STARTED|Overall Study||5
43104|NCT01783496|99939|P4|STARTED|Overall Study||10
43105|NCT01783496|99940|P3|STARTED|Overall Study||10
43106|NCT01783496|99941|P2|STARTED|Overall Study||10
43107|NCT01783496|99942|P1|STARTED|Overall Study||10
43108|NCT01783470|99968|P2|NOT COMPLETED|Overall Study||0
43109|NCT01783470|99969|P1|NOT COMPLETED|Overall Study||0
43110|NCT01783470|99968|P2|COMPLETED|Overall Study||6
43111|NCT01783470|99969|P1|COMPLETED|Overall Study||6
43112|NCT01783470|99968|P2|STARTED|Overall Study|Single-dose|6
43113|NCT01783470|99969|P1|STARTED|Overall Study||6
43114|NCT01783418|99978|P2|NOT COMPLETED|Overall Study||0
43115|NCT01783418|99979|P1|NOT COMPLETED|Overall Study||1
43116|NCT01783418|99978|P2|COMPLETED|Overall Study||6
43117|NCT01783418|99979|P1|COMPLETED|Overall Study||7
43118|NCT01783418|99978|P2|STARTED|Overall Study||6
43119|NCT01783418|99979|P1|STARTED|Overall Study||8
43120|NCT01783236|99999|P2|NOT COMPLETED|Overall Study||0
43121|NCT01783236|100000|P1|NOT COMPLETED|Overall Study||2
43122|NCT01783236|99999|P2|COMPLETED|Overall Study||8
43123|NCT01783236|100000|P1|COMPLETED|Overall Study||6
43124|NCT01783236|99999|P2|STARTED|Overall Study||8
43125|NCT01783236|100000|P1|STARTED|Overall Study||8
43126|NCT01783080|100014|P1|NOT COMPLETED|Overall Study||0
43127|NCT01783080|100014|P1|COMPLETED|Overall Study||16
43128|NCT01783080|100014|P1|STARTED|Overall Study||16
43129|NCT01783054|100021|P1|NOT COMPLETED|Overall Study||0
43130|NCT01783054|100021|P1|COMPLETED|Overall Study||2
43131|NCT01783054|100021|P1|STARTED|Overall Study||2
43132|NCT01783015|100032|P3|NOT COMPLETED|Open Label Treatment||6
43133|NCT01783015|100033|P2|NOT COMPLETED|Open Label Treatment||0
43134|NCT01783015|100034|P1|NOT COMPLETED|Open Label Treatment||0
43135|NCT01783015|100032|P3|COMPLETED|Open Label Treatment||5
43136|NCT01783015|100033|P2|COMPLETED|Open Label Treatment||0
43137|NCT01783015|100034|P1|COMPLETED|Open Label Treatment||0
43138|NCT01783015|100032|P3|STARTED|Open Label Treatment||11
43139|NCT01783015|100033|P2|STARTED|Open Label Treatment||0
43140|NCT01783015|100034|P1|STARTED|Open Label Treatment||0
43141|NCT01783015|100032|P3|NOT COMPLETED|Blinded Treatment||0
43142|NCT01783015|100033|P2|NOT COMPLETED|Blinded Treatment||3
43143|NCT01783015|100034|P1|NOT COMPLETED|Blinded Treatment||2
43144|NCT01783015|100032|P3|COMPLETED|Blinded Treatment||0
43145|NCT01783015|100033|P2|COMPLETED|Blinded Treatment||2
43146|NCT01783015|100034|P1|COMPLETED|Blinded Treatment||9
43147|NCT01783015|100032|P3|Treated|Blinded Treatment||0
43148|NCT01783015|100033|P2|Treated|Blinded Treatment||5
43149|NCT01783015|100034|P1|Treated|Blinded Treatment||11
43150|NCT01783015|100032|P3|STARTED|Blinded Treatment||0
43151|NCT01783015|100033|P2|STARTED|Blinded Treatment||5
43152|NCT01783015|100034|P1|STARTED|Blinded Treatment||11
43153|NCT01782898|100121|P2|NOT COMPLETED|Overall Study||6
43154|NCT01782898|100122|P1|NOT COMPLETED|Overall Study||6
43155|NCT01782898|100121|P2|COMPLETED|Overall Study||29
43156|NCT01782898|100122|P1|COMPLETED|Overall Study||29
43157|NCT01782898|100121|P2|STARTED|Overall Study||35
43158|NCT01782898|100122|P1|STARTED|Overall Study||35
43159|NCT01782885|100134|P2|NOT COMPLETED|Overall Study||6
43160|NCT01782885|100135|P1|NOT COMPLETED|Overall Study||4
43161|NCT01782885|100134|P2|COMPLETED|Overall Study||33
43162|NCT01782885|100135|P1|COMPLETED|Overall Study||32
43163|NCT01782885|100134|P2|STARTED|Overall Study||39
43164|NCT01782885|100135|P1|STARTED|Overall Study||36
43165|NCT01782872|100161|P4|NOT COMPLETED|Overall Study||1
43166|NCT01782872|100162|P3|NOT COMPLETED|Overall Study||0
43167|NCT01782872|100163|P2|NOT COMPLETED|Overall Study||1
43168|NCT01782872|100164|P1|NOT COMPLETED|Overall Study||0
43169|NCT01782872|100161|P4|COMPLETED|Overall Study||19
43170|NCT01782872|100162|P3|COMPLETED|Overall Study||20
43171|NCT01782872|100163|P2|COMPLETED|Overall Study||19
43172|NCT01782872|100164|P1|COMPLETED|Overall Study||20
43173|NCT01782872|100161|P4|STARTED|Overall Study||20
43174|NCT01782872|100162|P3|STARTED|Overall Study||20
43175|NCT01782872|100163|P2|STARTED|Overall Study||20
43176|NCT01782872|100164|P1|STARTED|Overall Study||20
43177|NCT01782859|100188|P2|NOT COMPLETED|Overall Study||7
43178|NCT01782859|100189|P1|NOT COMPLETED|Overall Study||6
43179|NCT01782859|100188|P2|COMPLETED|Overall Study||13
43180|NCT01782859|100189|P1|COMPLETED|Overall Study||14
43181|NCT01782859|100188|P2|STARTED|Overall Study||20
43182|NCT01782859|100189|P1|STARTED|Overall Study||20
43183|NCT01782742|100205|P2|NOT COMPLETED|Open Label Phase||0
43184|NCT01782742|100206|P1|NOT COMPLETED|Open Label Phase||0
43185|NCT01782742|100205|P2|COMPLETED|Open Label Phase||0
43186|NCT01782742|100206|P1|COMPLETED|Open Label Phase||19
43187|NCT01782742|100205|P2|STARTED|Open Label Phase||0
43188|NCT01782742|100206|P1|STARTED|Open Label Phase||19
43189|NCT01782742|100205|P2|NOT COMPLETED|Double-blind Treatment Phase||0
43190|NCT01782742|100206|P1|NOT COMPLETED|Double-blind Treatment Phase||1
43191|NCT01782742|100205|P2|COMPLETED|Double-blind Treatment Phase||4
43192|NCT01782742|100206|P1|COMPLETED|Double-blind Treatment Phase||15
43193|NCT01782742|100205|P2|STARTED|Double-blind Treatment Phase||4
43194|NCT01782742|100206|P1|STARTED|Double-blind Treatment Phase||16
43195|NCT01782664|100245|P6|NOT COMPLETED|Overall Study||0
43196|NCT01782664|100246|P5|NOT COMPLETED|Overall Study||0
43197|NCT01782664|100247|P4|NOT COMPLETED|Overall Study||5
43198|NCT01782664|100248|P3|NOT COMPLETED|Overall Study||4
43199|NCT01782664|100249|P2|NOT COMPLETED|Overall Study||5
43200|NCT01782664|100250|P1|NOT COMPLETED|Overall Study||6
43201|NCT01782664|100245|P6|COMPLETED|Overall Study||2
43202|NCT01782664|100246|P5|COMPLETED|Overall Study||6
43203|NCT01782664|100247|P4|COMPLETED|Overall Study||9
43204|NCT01782664|100248|P3|COMPLETED|Overall Study||12
43205|NCT01782664|100249|P2|COMPLETED|Overall Study||10
43206|NCT01782664|100250|P1|COMPLETED|Overall Study||8
43207|NCT01782664|100245|P6|STARTED|Overall Study||2
43208|NCT01782664|100246|P5|STARTED|Overall Study||6
43209|NCT01782664|100247|P4|STARTED|Overall Study||14
43210|NCT01782664|100248|P3|STARTED|Overall Study||16
43211|NCT01782664|100249|P2|STARTED|Overall Study||15
43212|NCT01782664|100250|P1|STARTED|Overall Study||14
43213|NCT01782482|100398|P2|NOT COMPLETED|Overall Study||10
43214|NCT01782482|100399|P1|NOT COMPLETED|Overall Study||10
43215|NCT01782482|100398|P2|COMPLETED|Overall Study||270
43216|NCT01782482|100399|P1|COMPLETED|Overall Study||271
43217|NCT01782482|100398|P2|STARTED|Overall Study||280
43218|NCT01782482|100399|P1|STARTED|Overall Study||281
43219|NCT01782469|100407|P1|NOT COMPLETED|Overall Study||1
43220|NCT01782469|100407|P1|COMPLETED|Overall Study||15
43221|NCT01782469|100407|P1|STARTED|Overall Study||16
43222|NCT01782326|100417|P2|NOT COMPLETED|Double-blind Treatment||320
43223|NCT01782326|100418|P1|NOT COMPLETED|Double-blind Treatment||278
43224|NCT01782326|100417|P2|COMPLETED|Double-blind Treatment||1360
43225|NCT01782326|100418|P1|COMPLETED|Double-blind Treatment||1400
43226|NCT01782326|100417|P2|STARTED|Double-blind Treatment||1680
43227|NCT01782326|100418|P1|STARTED|Double-blind Treatment||1678
43228|NCT01782326|100417|P2|NOT COMPLETED|Planned Treatment Epoch||208
43229|NCT01782326|100418|P1|NOT COMPLETED|Planned Treatment Epoch||202
43230|NCT01782326|100417|P2|COMPLETED|Planned Treatment Epoch||1474
43231|NCT01782326|100418|P1|COMPLETED|Planned Treatment Epoch||1478
43232|NCT01782326|100417|P2|Urine Cortisol Set|Planned Treatment Epoch||269
43233|NCT01782326|100418|P1|Urine Cortisol Set|Planned Treatment Epoch||266
43234|NCT01782326|100417|P2|Safety Set (SAF)|Planned Treatment Epoch||1680
43235|NCT01782326|100418|P1|Safety Set (SAF)|Planned Treatment Epoch||1678
43236|NCT01782326|100417|P2|Serial Spirometry Set|Planned Treatment Epoch||279
43237|NCT01782326|100418|P1|Serial Spirometry Set|Planned Treatment Epoch||280
43238|NCT01782326|100417|P2|Per-protocol Set (PPS)|Planned Treatment Epoch||1556
43239|NCT01782326|100418|P1|Per-protocol Set (PPS)|Planned Treatment Epoch||1528
43240|NCT01782326|100417|P2|Full Analysis Set (FAS)|Planned Treatment Epoch||1679
43241|NCT01782326|100418|P1|Full Analysis Set (FAS)|Planned Treatment Epoch||1675
43242|NCT01782326|100417|P2|STARTED|Planned Treatment Epoch||1682
43243|NCT01782326|100418|P1|STARTED|Planned Treatment Epoch||1680
43244|NCT01782222|100481|P3|NOT COMPLETED|Overall Study||4
43245|NCT01782222|100482|P2|NOT COMPLETED|Overall Study||11
43246|NCT01782222|100483|P1|NOT COMPLETED|Overall Study||8
43247|NCT01782222|100481|P3|COMPLETED|Overall Study||37
43248|NCT01782222|100482|P2|COMPLETED|Overall Study||30
43249|NCT01782222|100483|P1|COMPLETED|Overall Study||32
43250|NCT01782222|100481|P3|STARTED|Overall Study||41
43251|NCT01782222|100482|P2|STARTED|Overall Study||41
43252|NCT01782222|100483|P1|STARTED|Overall Study||40
43253|NCT01781962|100515|P1|NOT COMPLETED|Overall Study||5
43254|NCT01781962|100515|P1|COMPLETED|Overall Study||201
43255|NCT01781962|100515|P1|STARTED|Overall Study||206
43256|NCT01781637|100523|P2|NOT COMPLETED|Overall Study||6
43257|NCT01781637|100524|P1|NOT COMPLETED|Overall Study||4
43258|NCT01781637|100523|P2|COMPLETED|Overall Study||2
43259|NCT01781637|100524|P1|COMPLETED|Overall Study||24
43260|NCT01781637|100523|P2|STARTED|Overall Study||8
43261|NCT01781637|100524|P1|STARTED|Overall Study||28
43262|NCT01781481|100532|P1|NOT COMPLETED|Overall Study||0
43263|NCT01781481|100532|P1|COMPLETED|Overall Study||148
43264|NCT01781481|100532|P1|STARTED|Overall Study||148
43265|NCT01781403|100591|P3|NOT COMPLETED|Overall Study||0
43266|NCT01781403|100592|P2|NOT COMPLETED|Overall Study||0
43267|NCT01781403|100593|P1|NOT COMPLETED|Overall Study||0
43268|NCT01781403|100591|P3|COMPLETED|Overall Study||18
43269|NCT01781403|100592|P2|COMPLETED|Overall Study||2
43270|NCT01781403|100593|P1|COMPLETED|Overall Study||2
43271|NCT01781403|100591|P3|STARTED|Overall Study||18
43272|NCT01781403|100592|P2|STARTED|Overall Study||2
43273|NCT01781403|100593|P1|STARTED|Overall Study||2
43274|NCT01781299|100611|P2|NOT COMPLETED|Overall Study||1
43275|NCT01781299|100612|P1|NOT COMPLETED|Overall Study||0
43276|NCT01781299|100611|P2|COMPLETED|Overall Study||4
43277|NCT01781299|100612|P1|COMPLETED|Overall Study||4
43278|NCT01781299|100611|P2|STARTED|Overall Study||5
43279|NCT01781299|100612|P1|STARTED|Overall Study||4
43280|NCT01781208|100620|P1|NOT COMPLETED|Overall Study||0
43281|NCT01781208|100620|P1|COMPLETED|Overall Study||62
43282|NCT01781208|100620|P1|Overall Study|Overall Study||62
43283|NCT01781208|100620|P1|STARTED|Overall Study||62
43284|NCT01781169|100627|P2|NOT COMPLETED|Overall Study||0
43285|NCT01781169|100628|P1|NOT COMPLETED|Overall Study||1
43286|NCT01781169|100627|P2|COMPLETED|Overall Study||21
43287|NCT01781169|100628|P1|COMPLETED|Overall Study||21
43288|NCT01781169|100627|P2|STARTED|Overall Study||21
43289|NCT01781169|100628|P1|STARTED|Overall Study||22
43290|NCT01781078|100636|P3|NOT COMPLETED|Overall Study||16
43291|NCT01781078|100637|P2|NOT COMPLETED|Overall Study||5
43292|NCT01781078|100638|P1|NOT COMPLETED|Overall Study||12
43293|NCT01781078|100636|P3|COMPLETED|Overall Study||0
43294|NCT01781078|100637|P2|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|113
43295|NCT01781078|100638|P1|COMPLETED|Overall Study|Patients having completed the MRI + 1 month (Primary endpoint assessment)|217
43296|NCT01781078|100636|P3|STARTED|Overall Study||16
43297|NCT01781078|100637|P2|STARTED|Overall Study|Randomized post implantation|118
43298|NCT01781078|100638|P1|STARTED|Overall Study|Randomized post implantation|229
43299|NCT01781026|100648|P1|NOT COMPLETED|Overall Study||2
43300|NCT01781026|100648|P1|COMPLETED|Overall Study||0
43301|NCT01781026|100648|P1|STARTED|Overall Study||2
43302|NCT01780987|100654|P2|NOT COMPLETED|Overall Study||6
43303|NCT01780987|100655|P1|NOT COMPLETED|Overall Study||3
43304|NCT01780987|100654|P2|COMPLETED|Overall Study||34
43305|NCT01780987|100655|P1|COMPLETED|Overall Study||37
43306|NCT01780987|100654|P2|STARTED|Overall Study|Including one participant who withdrew from the study prior to receiving any study medication.|40
43307|NCT01780987|100655|P1|STARTED|Overall Study||40
43308|NCT01780974|100673|P2|NOT COMPLETED|Overall Study||3
43309|NCT01780974|100674|P1|NOT COMPLETED|Overall Study||2
43310|NCT01780974|100673|P2|COMPLETED|Overall Study||18
43311|NCT01780974|100674|P1|COMPLETED|Overall Study||19
43312|NCT01780974|100673|P2|STARTED|Overall Study||21
43313|NCT01780974|100674|P1|STARTED|Overall Study||21
43314|NCT01780935|100684|P2|NOT COMPLETED|Overall Study||336
43315|NCT01780935|100685|P1|NOT COMPLETED|Overall Study||335
43316|NCT01780935|100684|P2|COMPLETED|Overall Study||0
43317|NCT01780935|100685|P1|COMPLETED|Overall Study||0
43318|NCT01780935|100684|P2|Safety Set|Overall Study||336
43319|NCT01780935|100685|P1|Safety Set|Overall Study||334
43320|NCT01780935|100684|P2|STARTED|Overall Study||336
43321|NCT01780935|100685|P1|STARTED|Overall Study||335
43322|NCT01780922|100715|P6|NOT COMPLETED|Third Intervention (1 Day)||0
43323|NCT01780922|100716|P5|NOT COMPLETED|Third Intervention (1 Day)||0
43324|NCT01780922|100717|P4|NOT COMPLETED|Third Intervention (1 Day)||0
43325|NCT01780922|100718|P3|NOT COMPLETED|Third Intervention (1 Day)||0
43326|NCT01780922|100719|P2|NOT COMPLETED|Third Intervention (1 Day)||0
43327|NCT01780922|100720|P1|NOT COMPLETED|Third Intervention (1 Day)||0
43328|NCT01780922|100715|P6|COMPLETED|Third Intervention (1 Day)||2
43329|NCT01780922|100716|P5|COMPLETED|Third Intervention (1 Day)||2
43330|NCT01780922|100717|P4|COMPLETED|Third Intervention (1 Day)||2
43331|NCT01780922|100718|P3|COMPLETED|Third Intervention (1 Day)||2
43332|NCT01780922|100719|P2|COMPLETED|Third Intervention (1 Day)||2
43333|NCT01780922|100720|P1|COMPLETED|Third Intervention (1 Day)||2
43334|NCT01780922|100715|P6|STARTED|Third Intervention (1 Day)||2
43335|NCT01780922|100716|P5|STARTED|Third Intervention (1 Day)||2
43336|NCT01780922|100717|P4|STARTED|Third Intervention (1 Day)||2
43337|NCT01780922|100718|P3|STARTED|Third Intervention (1 Day)||2
43338|NCT01780922|100719|P2|STARTED|Third Intervention (1 Day)||2
43339|NCT01780922|100720|P1|STARTED|Third Intervention (1 Day)||2
43340|NCT01780922|100715|P6|NOT COMPLETED|Washout (7 Days)||0
43341|NCT01780922|100716|P5|NOT COMPLETED|Washout (7 Days)||0
43342|NCT01780922|100717|P4|NOT COMPLETED|Washout (7 Days)||0
43343|NCT01780922|100718|P3|NOT COMPLETED|Washout (7 Days)||0
43344|NCT01780922|100719|P2|NOT COMPLETED|Washout (7 Days)||0
43345|NCT01780922|100720|P1|NOT COMPLETED|Washout (7 Days)||0
43346|NCT01780922|100715|P6|COMPLETED|Washout (7 Days)||2
43347|NCT01780922|100716|P5|COMPLETED|Washout (7 Days)||2
43348|NCT01780922|100717|P4|COMPLETED|Washout (7 Days)||2
43349|NCT01780922|100718|P3|COMPLETED|Washout (7 Days)||2
43350|NCT01780922|100719|P2|COMPLETED|Washout (7 Days)||2
43351|NCT01780922|100720|P1|COMPLETED|Washout (7 Days)||2
43352|NCT01780922|100715|P6|STARTED|Washout (7 Days)||2
43353|NCT01780922|100716|P5|STARTED|Washout (7 Days)||2
43354|NCT01780922|100717|P4|STARTED|Washout (7 Days)||2
43355|NCT01780922|100718|P3|STARTED|Washout (7 Days)||2
43356|NCT01780922|100719|P2|STARTED|Washout (7 Days)||2
43357|NCT01780922|100720|P1|STARTED|Washout (7 Days)||2
43358|NCT01780922|100715|P6|NOT COMPLETED|Second Intervention (1 Day)||0
43359|NCT01780922|100716|P5|NOT COMPLETED|Second Intervention (1 Day)||0
43360|NCT01780922|100717|P4|NOT COMPLETED|Second Intervention (1 Day)||0
43361|NCT01780922|100718|P3|NOT COMPLETED|Second Intervention (1 Day)||0
43362|NCT01780922|100719|P2|NOT COMPLETED|Second Intervention (1 Day)||0
43363|NCT01780922|100720|P1|NOT COMPLETED|Second Intervention (1 Day)||0
43364|NCT01780922|100715|P6|COMPLETED|Second Intervention (1 Day)||2
43365|NCT01780922|100716|P5|COMPLETED|Second Intervention (1 Day)||2
43366|NCT01780922|100717|P4|COMPLETED|Second Intervention (1 Day)||2
43367|NCT01780922|100718|P3|COMPLETED|Second Intervention (1 Day)||2
43368|NCT01780922|100719|P2|COMPLETED|Second Intervention (1 Day)||2
43369|NCT01780922|100720|P1|COMPLETED|Second Intervention (1 Day)||2
43370|NCT01780922|100715|P6|STARTED|Second Intervention (1 Day)||2
43371|NCT01780922|100716|P5|STARTED|Second Intervention (1 Day)||2
43372|NCT01780922|100717|P4|STARTED|Second Intervention (1 Day)||2
43373|NCT01780922|100718|P3|STARTED|Second Intervention (1 Day)||2
43374|NCT01780922|100719|P2|STARTED|Second Intervention (1 Day)||2
43375|NCT01780922|100720|P1|STARTED|Second Intervention (1 Day)||2
43376|NCT01780922|100715|P6|NOT COMPLETED|Washout (7 Days)||0
43377|NCT01780922|100716|P5|NOT COMPLETED|Washout (7 Days)||0
43378|NCT01780922|100717|P4|NOT COMPLETED|Washout (7 Days)||0
43379|NCT01780922|100718|P3|NOT COMPLETED|Washout (7 Days)||0
43380|NCT01780922|100719|P2|NOT COMPLETED|Washout (7 Days)||0
43381|NCT01780922|100720|P1|NOT COMPLETED|Washout (7 Days)||0
43382|NCT01780922|100715|P6|COMPLETED|Washout (7 Days)||2
43383|NCT01780922|100716|P5|COMPLETED|Washout (7 Days)||2
43384|NCT01780922|100717|P4|COMPLETED|Washout (7 Days)||2
43385|NCT01780922|100718|P3|COMPLETED|Washout (7 Days)||2
43386|NCT01780922|100719|P2|COMPLETED|Washout (7 Days)||2
43387|NCT01780922|100720|P1|COMPLETED|Washout (7 Days)||2
43388|NCT01780922|100715|P6|STARTED|Washout (7 Days)||2
43389|NCT01780922|100716|P5|STARTED|Washout (7 Days)||2
43390|NCT01780922|100717|P4|STARTED|Washout (7 Days)||2
43391|NCT01780922|100718|P3|STARTED|Washout (7 Days)||2
43392|NCT01780922|100719|P2|STARTED|Washout (7 Days)||2
43393|NCT01780922|100720|P1|STARTED|Washout (7 Days)||2
43394|NCT01780922|100715|P6|NOT COMPLETED|First Intervention (1 Day)||0
43395|NCT01780922|100716|P5|NOT COMPLETED|First Intervention (1 Day)||0
43396|NCT01780922|100717|P4|NOT COMPLETED|First Intervention (1 Day)||0
43397|NCT01780922|100718|P3|NOT COMPLETED|First Intervention (1 Day)||0
43398|NCT01780922|100719|P2|NOT COMPLETED|First Intervention (1 Day)||0
43399|NCT01780922|100720|P1|NOT COMPLETED|First Intervention (1 Day)||0
43400|NCT01780922|100715|P6|COMPLETED|First Intervention (1 Day)||2
43401|NCT01780922|100716|P5|COMPLETED|First Intervention (1 Day)||2
43402|NCT01780922|100717|P4|COMPLETED|First Intervention (1 Day)||2
43403|NCT01780922|100718|P3|COMPLETED|First Intervention (1 Day)||2
43404|NCT01780922|100719|P2|COMPLETED|First Intervention (1 Day)||2
43405|NCT01780922|100720|P1|COMPLETED|First Intervention (1 Day)||2
43406|NCT01780922|100715|P6|STARTED|First Intervention (1 Day)||2
43407|NCT01780922|100716|P5|STARTED|First Intervention (1 Day)||2
43408|NCT01780922|100717|P4|STARTED|First Intervention (1 Day)||2
43409|NCT01780922|100718|P3|STARTED|First Intervention (1 Day)||2
43410|NCT01780922|100719|P2|STARTED|First Intervention (1 Day)||2
43411|NCT01780922|100720|P1|STARTED|First Intervention (1 Day)||2
43412|NCT01780870|100775|P2|NOT COMPLETED|Overall Study||0
43413|NCT01780870|100776|P1|NOT COMPLETED|Overall Study||0
43414|NCT01780870|100775|P2|COMPLETED|Overall Study||5
43415|NCT01780870|100776|P1|COMPLETED|Overall Study||0
43416|NCT01780870|100775|P2|STARTED|Overall Study||5
43417|NCT01780870|100776|P1|STARTED|Overall Study||0
43418|NCT01780584|100789|P3|NOT COMPLETED|Overall Study||2
43419|NCT01780584|100790|P2|NOT COMPLETED|Overall Study||1
43420|NCT01780584|100791|P1|NOT COMPLETED|Overall Study||1
43421|NCT01780584|100789|P3|COMPLETED|Overall Study||13
43422|NCT01780584|100790|P2|COMPLETED|Overall Study||14
43423|NCT01780584|100791|P1|COMPLETED|Overall Study||14
43424|NCT01780584|100789|P3|STARTED|Overall Study||15
43425|NCT01780584|100790|P2|STARTED|Overall Study||15
43426|NCT01780584|100791|P1|STARTED|Overall Study||15
43427|NCT01780506|100813|P2|NOT COMPLETED|Overall Study||434
43428|NCT01780506|100814|P1|NOT COMPLETED|Overall Study||438
43429|NCT01780506|100813|P2|COMPLETED|Overall Study||0
43430|NCT01780506|100814|P1|COMPLETED|Overall Study||0
43431|NCT01780506|100813|P2|STARTED|Overall Study||434
43432|NCT01780506|100814|P1|STARTED|Overall Study||438
43433|NCT01780389|100852|P1|NOT COMPLETED|Overall Study||1
43434|NCT01780389|100852|P1|COMPLETED|Overall Study|One patient discontinued due to adverse event.|4
43435|NCT01780389|100852|P1|STARTED|Overall Study||5
43436|NCT01780350|100863|P1|NOT COMPLETED|Overall Study||0
43437|NCT01780350|100863|P1|COMPLETED|Overall Study||200
43438|NCT01780350|100863|P1|STARTED|Overall Study||200
43439|NCT01780337|100870|P2|NOT COMPLETED|Overall Study||0
43440|NCT01780337|100871|P1|NOT COMPLETED|Overall Study||0
43441|NCT01780337|100870|P2|COMPLETED|Overall Study||6
43442|NCT01780337|100871|P1|COMPLETED|Overall Study||6
43443|NCT01780337|100870|P2|STARTED|Overall Study||6
43444|NCT01780337|100871|P1|STARTED|Overall Study||6
43445|NCT01780324|100883|P2|NOT COMPLETED|Overall Study||6
43446|NCT01780324|100884|P1|NOT COMPLETED|Overall Study||1
43447|NCT01780324|100883|P2|COMPLETED|Overall Study||33
43448|NCT01780324|100884|P1|COMPLETED|Overall Study||40
43449|NCT01780324|100883|P2|STARTED|Overall Study||39
43450|NCT01780324|100884|P1|STARTED|Overall Study||41
43451|NCT01779648|100892|P2|NOT COMPLETED|Overall Study||0
43452|NCT01779648|100893|P1|NOT COMPLETED|Overall Study||1
43453|NCT01779648|100892|P2|COMPLETED|Overall Study||27
43454|NCT01779648|100893|P1|COMPLETED|Overall Study||27
43455|NCT01779648|100892|P2|STARTED|Overall Study||27
43456|NCT01779648|100893|P1|STARTED|Overall Study||28
43457|NCT01779219|100923|P2|NOT COMPLETED|Overall Study||0
43458|NCT01779219|100924|P1|NOT COMPLETED|Overall Study||0
43459|NCT01779219|100923|P2|COMPLETED|Overall Study|First interim analysis|21
43460|NCT01779219|100924|P1|COMPLETED|Overall Study|First interim analysis|21
43461|NCT01779219|100923|P2|STARTED|Overall Study|First interim analysis|21
43462|NCT01779219|100924|P1|STARTED|Overall Study|First interim analysis|21
43463|NCT01779167|100936|P1|NOT COMPLETED|Overall Study||1
43464|NCT01779167|100936|P1|COMPLETED|Overall Study||3
43465|NCT01779167|100936|P1|STARTED|Overall Study||4
43466|NCT01778985|100943|P2|NOT COMPLETED|Overall Study||3
43467|NCT01778985|100944|P1|NOT COMPLETED|Overall Study||7
43468|NCT01778985|100943|P2|COMPLETED|Overall Study||12
43469|NCT01778985|100944|P1|COMPLETED|Overall Study||8
43470|NCT01778985|100943|P2|STARTED|Overall Study||15
43471|NCT01778985|100944|P1|STARTED|Overall Study||15
43472|NCT01778855|100990|P2|NOT COMPLETED|Overall Study||1
43473|NCT01778855|100991|P1|NOT COMPLETED|Overall Study||0
43474|NCT01778855|100990|P2|COMPLETED|Overall Study||3
43475|NCT01778855|100991|P1|COMPLETED|Overall Study||2
43476|NCT01778855|100990|P2|STARTED|Overall Study||4
43477|NCT01778855|100991|P1|STARTED|Overall Study||2
43478|NCT01778751|100999|P2|NOT COMPLETED|Overall Study||2
43479|NCT01778751|101000|P1|NOT COMPLETED|Overall Study||2
43480|NCT01778751|100999|P2|COMPLETED|Overall Study||23
43481|NCT01778751|101000|P1|COMPLETED|Overall Study||23
43482|NCT01778751|100999|P2|STARTED|Overall Study||25
43483|NCT01778751|101000|P1|STARTED|Overall Study||25
43484|NCT01778530|101012|P1|NOT COMPLETED|Overall Study||2
43485|NCT01778530|101012|P1|COMPLETED|Overall Study||0
43486|NCT01778530|101012|P1|STARTED|Overall Study||2
43487|NCT01778296|101017|P1|NOT COMPLETED|Overall Study||0
43488|NCT01778296|101017|P1|COMPLETED|Overall Study|No patient was lost to follow-up.|12
43489|NCT01778296|101017|P1|STARTED|Overall Study|There were 12 patients included in the study in the initial stage.|12
43490|NCT01778127|101024|P3|NOT COMPLETED|Overall Study||6
43491|NCT01778127|101025|P2|NOT COMPLETED|Overall Study||2
43492|NCT01778127|101026|P1|NOT COMPLETED|Overall Study||8
43493|NCT01778127|101024|P3|COMPLETED|Overall Study||26
43494|NCT01778127|101025|P2|COMPLETED|Overall Study||31
43495|NCT01778127|101026|P1|COMPLETED|Overall Study||25
43496|NCT01778127|101024|P3|STARTED|Overall Study||32
43497|NCT01778127|101025|P2|STARTED|Overall Study||33
43498|NCT01778127|101026|P1|STARTED|Overall Study||33
43499|NCT01778062|101069|P2|NOT COMPLETED|Overall Study||11
43500|NCT01778062|101070|P1|NOT COMPLETED|Overall Study||6
43501|NCT01778062|101069|P2|COMPLETED|Overall Study||57
43502|NCT01778062|101070|P1|COMPLETED|Overall Study||62
43503|NCT01778062|101069|P2|Intent to Treat (ITT)|Overall Study|One failed to perform primary efficacy evaluation and was excluded, 135 were included in the ITT set|67
43504|NCT01778062|101070|P1|Intent to Treat (ITT)|Overall Study||68
43505|NCT01778062|101069|P2|Safety Set|Overall Study||68
43506|NCT01778062|101070|P1|Safety Set|Overall Study||68
43507|NCT01778062|101069|P2|STARTED|Overall Study||68
43508|NCT01778062|101070|P1|STARTED|Overall Study||68
43509|NCT01778049|101084|P6|NOT COMPLETED|Double Blind Treatment Period||7
43510|NCT01778049|101085|P5|NOT COMPLETED|Double Blind Treatment Period||12
43511|NCT01778049|101086|P4|NOT COMPLETED|Double Blind Treatment Period||12
43512|NCT01778049|101087|P3|NOT COMPLETED|Double Blind Treatment Period||15
43513|NCT01778049|101088|P2|NOT COMPLETED|Double Blind Treatment Period||0
43514|NCT01778049|101089|P1|NOT COMPLETED|Double Blind Treatment Period||0
43515|NCT01778049|101084|P6|COMPLETED|Double Blind Treatment Period||105
43516|NCT01778049|101085|P5|COMPLETED|Double Blind Treatment Period||102
43517|NCT01778049|101086|P4|COMPLETED|Double Blind Treatment Period||118
43518|NCT01778049|101087|P3|COMPLETED|Double Blind Treatment Period||111
43519|NCT01778049|101088|P2|COMPLETED|Double Blind Treatment Period||0
43520|NCT01778049|101089|P1|COMPLETED|Double Blind Treatment Period||0
43521|NCT01778049|101084|P6|STARTED|Double Blind Treatment Period||112
43522|NCT01778049|101085|P5|STARTED|Double Blind Treatment Period||114
43523|NCT01778049|101086|P4|STARTED|Double Blind Treatment Period||130
43524|NCT01778049|101087|P3|STARTED|Double Blind Treatment Period||126
43525|NCT01778049|101088|P2|STARTED|Double Blind Treatment Period||0
43526|NCT01778049|101089|P1|STARTED|Double Blind Treatment Period||0
43527|NCT01778049|101084|P6|NOT COMPLETED|Open Label Treatment Period||0
43528|NCT01778049|101085|P5|NOT COMPLETED|Open Label Treatment Period||0
43529|NCT01778049|101086|P4|NOT COMPLETED|Open Label Treatment Period||0
43530|NCT01778049|101087|P3|NOT COMPLETED|Open Label Treatment Period||0
43531|NCT01778049|101088|P2|NOT COMPLETED|Open Label Treatment Period||129
43532|NCT01778049|101089|P1|NOT COMPLETED|Open Label Treatment Period||98
43533|NCT01778049|101084|P6|COMPLETED|Open Label Treatment Period||0
43534|NCT01778049|101085|P5|COMPLETED|Open Label Treatment Period||0
43535|NCT01778049|101086|P4|COMPLETED|Open Label Treatment Period||0
43536|NCT01778049|101087|P3|COMPLETED|Open Label Treatment Period||0
43537|NCT01778049|101088|P2|COMPLETED|Open Label Treatment Period||226
43538|NCT01778049|101089|P1|COMPLETED|Open Label Treatment Period||256
43539|NCT01778049|101084|P6|STARTED|Open Label Treatment Period||0
43540|NCT01778049|101085|P5|STARTED|Open Label Treatment Period||0
43541|NCT01778049|101086|P4|STARTED|Open Label Treatment Period||0
43542|NCT01778049|101087|P3|STARTED|Open Label Treatment Period||0
43543|NCT01778049|101088|P2|STARTED|Open Label Treatment Period||355
43544|NCT01778049|101089|P1|STARTED|Open Label Treatment Period||354
43545|NCT01778023|101107|P2|NOT COMPLETED|Overall Study||3
43546|NCT01778023|101108|P1|NOT COMPLETED|Overall Study||0
43547|NCT01778023|101107|P2|COMPLETED|Overall Study||15
43548|NCT01778023|101108|P1|COMPLETED|Overall Study||36
43549|NCT01778023|101107|P2|Exposed|Overall Study||15
43550|NCT01778023|101108|P1|Exposed|Overall Study||36
43551|NCT01778023|101107|P2|STARTED|Overall Study||18
43552|NCT01778023|101108|P1|STARTED|Overall Study||36
43553|NCT01777945|101125|P1|NOT COMPLETED|Overall Study||0
43554|NCT01777945|101125|P1|COMPLETED|Overall Study||46
43555|NCT01777945|101125|P1|Evaluable Participants|Overall Study||45
43556|NCT01777945|101125|P1|STARTED|Overall Study||46
43557|NCT01777932|101135|P1|NOT COMPLETED|Overall Study||205
43558|NCT01777932|101135|P1|COMPLETED|Overall Study||15
43559|NCT01777932|101135|P1|STARTED|Overall Study||220
43560|NCT01777776|101153|P4|NOT COMPLETED|Overall Study||4
43561|NCT01777776|101154|P3|NOT COMPLETED|Overall Study||6
43562|NCT01777776|101155|P2|NOT COMPLETED|Overall Study||12
43563|NCT01777776|101156|P1|NOT COMPLETED|Overall Study||6
43564|NCT01777776|101153|P4|COMPLETED|Overall Study||0
43565|NCT01777776|101154|P3|COMPLETED|Overall Study||0
43566|NCT01777776|101155|P2|COMPLETED|Overall Study||0
43567|NCT01777776|101156|P1|COMPLETED|Overall Study||0
43568|NCT01777776|101153|P4|STARTED|Overall Study||4
43569|NCT01777776|101154|P3|STARTED|Overall Study||6
43570|NCT01777776|101155|P2|STARTED|Overall Study||12
43571|NCT01777776|101156|P1|STARTED|Overall Study||6
43572|NCT01777763|101215|P2|NOT COMPLETED|Overall Study||47
43573|NCT01777763|101216|P1|NOT COMPLETED|Overall Study||4
43574|NCT01777763|101215|P2|COMPLETED|Overall Study||163
43575|NCT01777763|101216|P1|COMPLETED|Overall Study||16
43576|NCT01777763|101215|P2|STARTED|Overall Study||210
43577|NCT01777763|101216|P1|STARTED|Overall Study||20
43578|NCT01777620|101240|P2|NOT COMPLETED|Overall Study||0
43579|NCT01777620|101241|P1|NOT COMPLETED|Overall Study||1
43580|NCT01777620|101240|P2|COMPLETED|Overall Study||62
43581|NCT01777620|101241|P1|COMPLETED|Overall Study||62
43582|NCT01777620|101240|P2|STARTED|Overall Study||62
43583|NCT01777620|101241|P1|STARTED|Overall Study||63
43584|NCT01777581|101267|P2|NOT COMPLETED|Overall Study||2
43585|NCT01777581|101268|P1|NOT COMPLETED|Overall Study||3
43586|NCT01777581|101267|P2|COMPLETED|Overall Study||3
43587|NCT01777581|101268|P1|COMPLETED|Overall Study||5
43588|NCT01777581|101267|P2|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|5
43589|NCT01777581|101268|P1|STARTED|Overall Study|Includes one subject screened/consented but not assigned to either arm.|8
43590|NCT01777438|101288|P2|NOT COMPLETED|Overall Study||0
43591|NCT01777438|101289|P1|NOT COMPLETED|Overall Study||0
43592|NCT01777438|101288|P2|COMPLETED|Overall Study||82
43593|NCT01777438|101289|P1|COMPLETED|Overall Study||352
43594|NCT01777438|101288|P2|STARTED|Overall Study||82
43595|NCT01777438|101289|P1|STARTED|Overall Study||352
43596|NCT01777425|101301|P1|NOT COMPLETED|Overall Study||0
43597|NCT01777425|101301|P1|COMPLETED|Overall Study||389
43598|NCT01777425|101301|P1|STARTED|Overall Study||389
43599|NCT01777412|101307|P1|NOT COMPLETED|Overall Study||0
43600|NCT01777412|101307|P1|COMPLETED|Overall Study||10
43601|NCT01777412|101307|P1|STARTED|Overall Study||10
43602|NCT01777334|101315|P2|NOT COMPLETED|Overall Study||63
43603|NCT01777334|101316|P1|NOT COMPLETED|Overall Study||53
43604|NCT01777334|101315|P2|COMPLETED|Overall Study||388
43605|NCT01777334|101316|P1|COMPLETED|Overall Study||401
43606|NCT01777334|101315|P2|STARTED|Overall Study||451
43607|NCT01777334|101316|P1|STARTED|Overall Study||454
43608|NCT01777321|101326|P2|NOT COMPLETED|Overall Study||1
43609|NCT01777321|101327|P1|NOT COMPLETED|Overall Study||0
43610|NCT01777321|101326|P2|COMPLETED|Overall Study||29
43611|NCT01777321|101327|P1|COMPLETED|Overall Study||30
43612|NCT01777321|101326|P2|STARTED|Overall Study||30
43613|NCT01777321|101327|P1|STARTED|Overall Study||30
43614|NCT01777282|101368|P5|NOT COMPLETED|Overall Study||7
43615|NCT01777282|101369|P4|NOT COMPLETED|Overall Study||2
43616|NCT01777282|101370|P3|NOT COMPLETED|Overall Study||6
43617|NCT01777282|101371|P2|NOT COMPLETED|Overall Study||4
43618|NCT01777282|101372|P1|NOT COMPLETED|Overall Study||11
43619|NCT01777282|101368|P5|COMPLETED|Overall Study||54
43620|NCT01777282|101369|P4|COMPLETED|Overall Study||59
43621|NCT01777282|101370|P3|COMPLETED|Overall Study||59
43622|NCT01777282|101371|P2|COMPLETED|Overall Study||63
43623|NCT01777282|101372|P1|COMPLETED|Overall Study||109
43624|NCT01777282|101368|P5|Completing Follow-up Period|Overall Study||54
43625|NCT01777282|101369|P4|Completing Follow-up Period|Overall Study||59
43626|NCT01777282|101370|P3|Completing Follow-up Period|Overall Study||59
43627|NCT01777282|101371|P2|Completing Follow-up Period|Overall Study||63
43628|NCT01777282|101372|P1|Completing Follow-up Period|Overall Study||109
43629|NCT01777282|101368|P5|Completing Treatment Period|Overall Study||54
43630|NCT01777282|101369|P4|Completing Treatment Period|Overall Study||59
43631|NCT01777282|101370|P3|Completing Treatment Period|Overall Study||59
43632|NCT01777282|101371|P2|Completing Treatment Period|Overall Study||63
43633|NCT01777282|101372|P1|Completing Treatment Period|Overall Study||109
43634|NCT01777282|101368|P5|STARTED|Overall Study||61
43635|NCT01777282|101369|P4|STARTED|Overall Study||61
43636|NCT01777282|101370|P3|STARTED|Overall Study||65
43637|NCT01777282|101371|P2|STARTED|Overall Study||67
43638|NCT01777282|101372|P1|STARTED|Overall Study||120
43639|NCT01777269|101416|P2|NOT COMPLETED|Overall Study||59
43640|NCT01777269|101417|P1|NOT COMPLETED|Overall Study||55
43641|NCT01777269|101416|P2|COMPLETED|Overall Study||184
43642|NCT01777269|101417|P1|COMPLETED|Overall Study||191
43643|NCT01777269|101416|P2|STARTED|Overall Study||243
43644|NCT01777269|101417|P1|STARTED|Overall Study||246
43645|NCT01777217|101445|P2|NOT COMPLETED|Overall Study||0
43646|NCT01777217|101446|P1|NOT COMPLETED|Overall Study||0
43647|NCT01777217|101445|P2|COMPLETED|Overall Study||4
43648|NCT01777217|101446|P1|COMPLETED|Overall Study||4
43649|NCT01777217|101445|P2|STARTED|Overall Study||4
43650|NCT01777217|101446|P1|STARTED|Overall Study||4
43651|NCT01777191|101454|P2|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||13
43652|NCT01777191|101455|P1|NOT COMPLETED|Safety Extension Per (Week 12-Week 48)||9
43653|NCT01777191|101454|P2|COMPLETED|Safety Extension Per (Week 12-Week 48)||78
43654|NCT01777191|101455|P1|COMPLETED|Safety Extension Per (Week 12-Week 48)||85
43655|NCT01777191|101454|P2|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|91
43656|NCT01777191|101455|P1|STARTED|Safety Extension Per (Week 12-Week 48)|Participation in the safety extension period was optional.|94
43657|NCT01777191|101454|P2|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||8
43658|NCT01777191|101455|P1|NOT COMPLETED|Treatment Period (Per) (Week 0-Week 12)||6
43659|NCT01777191|101454|P2|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||94
43660|NCT01777191|101455|P1|COMPLETED|Treatment Period (Per) (Week 0-Week 12)||96
43661|NCT01777191|101454|P2|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
43662|NCT01777191|101455|P1|STARTED|Treatment Period (Per) (Week 0-Week 12)||102
43663|NCT01777126|101485|P2|NOT COMPLETED|Overall Study||0
43664|NCT01777126|101486|P1|NOT COMPLETED|Overall Study||0
43665|NCT01777126|101485|P2|COMPLETED|Overall Study||46
43666|NCT01777126|101486|P1|COMPLETED|Overall Study||48
43667|NCT01777126|101485|P2|STARTED|Overall Study||46
43668|NCT01777126|101486|P1|STARTED|Overall Study||48
43669|NCT01776645|101509|P2|NOT COMPLETED|Overall Study||14
43670|NCT01776645|101510|P1|NOT COMPLETED|Overall Study||14
43671|NCT01776645|101509|P2|COMPLETED|Overall Study||14
43672|NCT01776645|101510|P1|COMPLETED|Overall Study||14
43673|NCT01776645|101509|P2|STARTED|Overall Study||28
43674|NCT01776645|101510|P1|STARTED|Overall Study||28
43675|NCT01776554|101518|P2|NOT COMPLETED|Overall Study||23
43676|NCT01776554|101519|P1|NOT COMPLETED|Overall Study||17
43677|NCT01776554|101518|P2|COMPLETED|Overall Study||307
43678|NCT01776554|101519|P1|COMPLETED|Overall Study||315
43679|NCT01776554|101518|P2|STARTED|Overall Study||330
43680|NCT01776554|101519|P1|STARTED|Overall Study||332
43681|NCT01776541|101562|P2|NOT COMPLETED|Overall Study||75
43682|NCT01776541|101563|P1|NOT COMPLETED|Overall Study||56
43683|NCT01776541|101562|P2|COMPLETED|Overall Study||416
43684|NCT01776541|101563|P1|COMPLETED|Overall Study||432
43685|NCT01776541|101562|P2|STARTED|Overall Study||491
43686|NCT01776541|101563|P1|STARTED|Overall Study||488
43687|NCT01776268|101584|P2|NOT COMPLETED|Overall Study||0
43688|NCT01776268|101585|P1|NOT COMPLETED|Overall Study||0
43689|NCT01776268|101584|P2|COMPLETED|Overall Study||51
43690|NCT01776268|101585|P1|COMPLETED|Overall Study||48
43691|NCT01776268|101584|P2|STARTED|Overall Study||51
43692|NCT01776268|101585|P1|STARTED|Overall Study||48
43693|NCT01775995|101595|P2|NOT COMPLETED|Overall Study||1
43694|NCT01775995|101596|P1|NOT COMPLETED|Overall Study||1
43695|NCT01775995|101595|P2|COMPLETED|Overall Study|One control participant was unable to reach at 26 week follow up|13
43696|NCT01775995|101596|P1|COMPLETED|Overall Study|One experimental participant was unable to reach at 26 week follow up|20
43697|NCT01775995|101595|P2|STARTED|Overall Study||14
43698|NCT01775995|101596|P1|STARTED|Overall Study||21
43699|NCT01775852|101658|P2|NOT COMPLETED|Overall Study||1
43700|NCT01775852|101659|P1|NOT COMPLETED|Overall Study||0
43701|NCT01775852|101658|P2|COMPLETED|Overall Study||13
43702|NCT01775852|101659|P1|COMPLETED|Overall Study||31
43703|NCT01775852|101658|P2|STARTED|Overall Study||14
43704|NCT01775852|101659|P1|STARTED|Overall Study||31
43705|NCT01775774|101674|P3|NOT COMPLETED|Overall Study||0
43706|NCT01775774|101675|P2|NOT COMPLETED|Overall Study||0
43707|NCT01775774|101676|P1|NOT COMPLETED|Overall Study||0
43708|NCT01775774|101674|P3|COMPLETED|Overall Study||3
43709|NCT01775774|101675|P2|COMPLETED|Overall Study||3
43710|NCT01775774|101676|P1|COMPLETED|Overall Study||3
43711|NCT01775774|101674|P3|STARTED|Overall Study||3
43712|NCT01775774|101675|P2|STARTED|Overall Study||3
43713|NCT01775774|101676|P1|STARTED|Overall Study||3
43714|NCT01775670|101704|P2|NOT COMPLETED|Overall Study||1
43715|NCT01775670|101705|P1|NOT COMPLETED|Overall Study||1
43716|NCT01775670|101704|P2|COMPLETED|Overall Study||2
43717|NCT01775670|101705|P1|COMPLETED|Overall Study||0
43718|NCT01775670|101704|P2|STARTED|Overall Study||3
43719|NCT01775670|101705|P1|STARTED|Overall Study||1
43720|NCT01775553|101731|P1|NOT COMPLETED|Overall Study||13
43721|NCT01775553|101731|P1|COMPLETED|Overall Study||0
43722|NCT01775553|101731|P1|STARTED|Overall Study||13
43723|NCT01775189|101739|P7|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
43724|NCT01775189|101740|P6|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
43725|NCT01775189|101741|P5|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
43726|NCT01775189|101742|P4|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
43727|NCT01775189|101743|P3|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
43728|NCT01775189|101744|P2|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
43729|NCT01775189|101745|P1|NOT COMPLETED|Treatment Phase: Fourth Intervention||0
43730|NCT01775189|101739|P7|COMPLETED|Treatment Phase: Fourth Intervention||7
43731|NCT01775189|101740|P6|COMPLETED|Treatment Phase: Fourth Intervention||7
43732|NCT01775189|101741|P5|COMPLETED|Treatment Phase: Fourth Intervention||8
43733|NCT01775189|101742|P4|COMPLETED|Treatment Phase: Fourth Intervention||6
43734|NCT01775189|101743|P3|COMPLETED|Treatment Phase: Fourth Intervention||0
43735|NCT01775189|101744|P2|COMPLETED|Treatment Phase: Fourth Intervention||0
43736|NCT01775189|101745|P1|COMPLETED|Treatment Phase: Fourth Intervention||0
43737|NCT01775189|101739|P7|STARTED|Treatment Phase: Fourth Intervention||7
43738|NCT01775189|101740|P6|STARTED|Treatment Phase: Fourth Intervention||7
43739|NCT01775189|101741|P5|STARTED|Treatment Phase: Fourth Intervention||8
43740|NCT01775189|101742|P4|STARTED|Treatment Phase: Fourth Intervention||6
43741|NCT01775189|101743|P3|STARTED|Treatment Phase: Fourth Intervention||0
43742|NCT01775189|101744|P2|STARTED|Treatment Phase: Fourth Intervention||0
43743|NCT01775189|101745|P1|STARTED|Treatment Phase: Fourth Intervention||0
43744|NCT01775189|101739|P7|NOT COMPLETED|Treatment Phase: Washout Period 3||1
43745|NCT01775189|101740|P6|NOT COMPLETED|Treatment Phase: Washout Period 3||0
43746|NCT01775189|101741|P5|NOT COMPLETED|Treatment Phase: Washout Period 3||0
43747|NCT01775189|101742|P4|NOT COMPLETED|Treatment Phase: Washout Period 3||1
43748|NCT01775189|101743|P3|NOT COMPLETED|Treatment Phase: Washout Period 3||0
43749|NCT01775189|101744|P2|NOT COMPLETED|Treatment Phase: Washout Period 3||0
43750|NCT01775189|101745|P1|NOT COMPLETED|Treatment Phase: Washout Period 3||0
43751|NCT01775189|101739|P7|COMPLETED|Treatment Phase: Washout Period 3||7
43752|NCT01775189|101740|P6|COMPLETED|Treatment Phase: Washout Period 3||7
43753|NCT01775189|101741|P5|COMPLETED|Treatment Phase: Washout Period 3||8
43754|NCT01775189|101742|P4|COMPLETED|Treatment Phase: Washout Period 3||6
43755|NCT01775189|101743|P3|COMPLETED|Treatment Phase: Washout Period 3||0
43756|NCT01775189|101744|P2|COMPLETED|Treatment Phase: Washout Period 3||0
43757|NCT01775189|101745|P1|COMPLETED|Treatment Phase: Washout Period 3||0
43758|NCT01775189|101739|P7|STARTED|Treatment Phase: Washout Period 3||8
43759|NCT01775189|101740|P6|STARTED|Treatment Phase: Washout Period 3||7
43760|NCT01775189|101741|P5|STARTED|Treatment Phase: Washout Period 3||8
43761|NCT01775189|101742|P4|STARTED|Treatment Phase: Washout Period 3||7
43762|NCT01775189|101743|P3|STARTED|Treatment Phase: Washout Period 3||0
43763|NCT01775189|101744|P2|STARTED|Treatment Phase: Washout Period 3||0
43764|NCT01775189|101745|P1|STARTED|Treatment Phase: Washout Period 3||0
43765|NCT01775189|101739|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
43766|NCT01775189|101740|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
43767|NCT01775189|101741|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
43768|NCT01775189|101742|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
43769|NCT01775189|101743|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
43770|NCT01775189|101744|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
43771|NCT01775189|101745|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
43772|NCT01775189|101739|P7|COMPLETED|Treatment Phase: Third Intervention||8
43773|NCT01775189|101740|P6|COMPLETED|Treatment Phase: Third Intervention||7
43774|NCT01775189|101741|P5|COMPLETED|Treatment Phase: Third Intervention||8
43775|NCT01775189|101742|P4|COMPLETED|Treatment Phase: Third Intervention||7
43776|NCT01775189|101743|P3|COMPLETED|Treatment Phase: Third Intervention||0
43777|NCT01775189|101744|P2|COMPLETED|Treatment Phase: Third Intervention||0
43778|NCT01775189|101745|P1|COMPLETED|Treatment Phase: Third Intervention||0
43779|NCT01775189|101739|P7|STARTED|Treatment Phase: Third Intervention||8
43780|NCT01775189|101740|P6|STARTED|Treatment Phase: Third Intervention||7
43781|NCT01775189|101741|P5|STARTED|Treatment Phase: Third Intervention||8
43782|NCT01775189|101742|P4|STARTED|Treatment Phase: Third Intervention||7
43783|NCT01775189|101743|P3|STARTED|Treatment Phase: Third Intervention||0
43784|NCT01775189|101744|P2|STARTED|Treatment Phase: Third Intervention||0
43785|NCT01775189|101745|P1|STARTED|Treatment Phase: Third Intervention||0
43786|NCT01775189|101739|P7|NOT COMPLETED|Treatment Phase: Washout Period 2||0
43787|NCT01775189|101740|P6|NOT COMPLETED|Treatment Phase: Washout Period 2||0
43788|NCT01775189|101741|P5|NOT COMPLETED|Treatment Phase: Washout Period 2||0
43789|NCT01775189|101742|P4|NOT COMPLETED|Treatment Phase: Washout Period 2||1
43790|NCT01775189|101743|P3|NOT COMPLETED|Treatment Phase: Washout Period 2||0
43791|NCT01775189|101744|P2|NOT COMPLETED|Treatment Phase: Washout Period 2||0
43792|NCT01775189|101745|P1|NOT COMPLETED|Treatment Phase: Washout Period 2||0
43793|NCT01775189|101739|P7|COMPLETED|Treatment Phase: Washout Period 2||8
43794|NCT01775189|101740|P6|COMPLETED|Treatment Phase: Washout Period 2||7
43795|NCT01775189|101741|P5|COMPLETED|Treatment Phase: Washout Period 2||8
43796|NCT01775189|101742|P4|COMPLETED|Treatment Phase: Washout Period 2||7
43797|NCT01775189|101743|P3|COMPLETED|Treatment Phase: Washout Period 2||0
43798|NCT01775189|101744|P2|COMPLETED|Treatment Phase: Washout Period 2||0
43799|NCT01775189|101745|P1|COMPLETED|Treatment Phase: Washout Period 2||0
43800|NCT01775189|101739|P7|STARTED|Treatment Phase: Washout Period 2||8
43801|NCT01775189|101740|P6|STARTED|Treatment Phase: Washout Period 2||7
43802|NCT01775189|101741|P5|STARTED|Treatment Phase: Washout Period 2||8
43803|NCT01775189|101742|P4|STARTED|Treatment Phase: Washout Period 2||8
43804|NCT01775189|101743|P3|STARTED|Treatment Phase: Washout Period 2||0
43805|NCT01775189|101744|P2|STARTED|Treatment Phase: Washout Period 2||0
43806|NCT01775189|101745|P1|STARTED|Treatment Phase: Washout Period 2||0
43807|NCT01775189|101739|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
43808|NCT01775189|101740|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
43809|NCT01775189|101741|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
43810|NCT01775189|101742|P4|NOT COMPLETED|Treatment Phase: Second Intervention||0
43811|NCT01775189|101743|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
43812|NCT01775189|101744|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
43813|NCT01775189|101745|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
43814|NCT01775189|101739|P7|COMPLETED|Treatment Phase: Second Intervention||8
43815|NCT01775189|101740|P6|COMPLETED|Treatment Phase: Second Intervention||7
43816|NCT01775189|101741|P5|COMPLETED|Treatment Phase: Second Intervention||8
43817|NCT01775189|101742|P4|COMPLETED|Treatment Phase: Second Intervention||8
43818|NCT01775189|101743|P3|COMPLETED|Treatment Phase: Second Intervention||0
43819|NCT01775189|101744|P2|COMPLETED|Treatment Phase: Second Intervention||0
43820|NCT01775189|101745|P1|COMPLETED|Treatment Phase: Second Intervention||0
43821|NCT01775189|101739|P7|STARTED|Treatment Phase: Second Intervention||8
43822|NCT01775189|101740|P6|STARTED|Treatment Phase: Second Intervention||7
43823|NCT01775189|101741|P5|STARTED|Treatment Phase: Second Intervention||8
43824|NCT01775189|101742|P4|STARTED|Treatment Phase: Second Intervention||8
43825|NCT01775189|101743|P3|STARTED|Treatment Phase: Second Intervention||0
43826|NCT01775189|101744|P2|STARTED|Treatment Phase: Second Intervention||0
43827|NCT01775189|101745|P1|STARTED|Treatment Phase: Second Intervention||0
43828|NCT01775189|101739|P7|NOT COMPLETED|Treatment Phase: Washout Period 1||0
43829|NCT01775189|101740|P6|NOT COMPLETED|Treatment Phase: Washout Period 1||1
43830|NCT01775189|101741|P5|NOT COMPLETED|Treatment Phase: Washout Period 1||0
43831|NCT01775189|101742|P4|NOT COMPLETED|Treatment Phase: Washout Period 1||0
43832|NCT01775189|101743|P3|NOT COMPLETED|Treatment Phase: Washout Period 1||0
43833|NCT01775189|101744|P2|NOT COMPLETED|Treatment Phase: Washout Period 1||0
43834|NCT01775189|101745|P1|NOT COMPLETED|Treatment Phase: Washout Period 1||0
43835|NCT01775189|101739|P7|COMPLETED|Treatment Phase: Washout Period 1||8
43836|NCT01775189|101740|P6|COMPLETED|Treatment Phase: Washout Period 1||7
43837|NCT01775189|101741|P5|COMPLETED|Treatment Phase: Washout Period 1||8
43838|NCT01775189|101742|P4|COMPLETED|Treatment Phase: Washout Period 1||8
43839|NCT01775189|101743|P3|COMPLETED|Treatment Phase: Washout Period 1||0
43840|NCT01775189|101744|P2|COMPLETED|Treatment Phase: Washout Period 1||0
43841|NCT01775189|101745|P1|COMPLETED|Treatment Phase: Washout Period 1||0
43842|NCT01775189|101739|P7|STARTED|Treatment Phase: Washout Period 1||8
43843|NCT01775189|101740|P6|STARTED|Treatment Phase: Washout Period 1||8
43844|NCT01775189|101741|P5|STARTED|Treatment Phase: Washout Period 1||8
43845|NCT01775189|101742|P4|STARTED|Treatment Phase: Washout Period 1||8
43846|NCT01775189|101743|P3|STARTED|Treatment Phase: Washout Period 1||0
43847|NCT01775189|101744|P2|STARTED|Treatment Phase: Washout Period 1||0
43848|NCT01775189|101745|P1|STARTED|Treatment Phase: Washout Period 1||0
43849|NCT01775189|101739|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
43850|NCT01775189|101740|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
43851|NCT01775189|101741|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
43852|NCT01775189|101742|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
43853|NCT01775189|101743|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
43854|NCT01775189|101744|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
43855|NCT01775189|101745|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
43856|NCT01775189|101739|P7|COMPLETED|Treatment Phase: First Intervention||8
43857|NCT01775189|101740|P6|COMPLETED|Treatment Phase: First Intervention||8
43858|NCT01775189|101741|P5|COMPLETED|Treatment Phase: First Intervention||8
43859|NCT01775189|101742|P4|COMPLETED|Treatment Phase: First Intervention||8
43860|NCT01775189|101743|P3|COMPLETED|Treatment Phase: First Intervention||0
43861|NCT01775189|101744|P2|COMPLETED|Treatment Phase: First Intervention||0
43862|NCT01775189|101745|P1|COMPLETED|Treatment Phase: First Intervention||0
43863|NCT01775189|101739|P7|STARTED|Treatment Phase: First Intervention||8
43864|NCT01775189|101740|P6|STARTED|Treatment Phase: First Intervention||8
43865|NCT01775189|101741|P5|STARTED|Treatment Phase: First Intervention||8
43866|NCT01775189|101742|P4|STARTED|Treatment Phase: First Intervention||8
43867|NCT01775189|101743|P3|STARTED|Treatment Phase: First Intervention||0
43868|NCT01775189|101744|P2|STARTED|Treatment Phase: First Intervention||0
43869|NCT01775189|101745|P1|STARTED|Treatment Phase: First Intervention||0
43870|NCT01775189|101739|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
43871|NCT01775189|101740|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
43872|NCT01775189|101741|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
43873|NCT01775189|101742|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
43874|NCT01775189|101743|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||7
43875|NCT01775189|101744|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||3
43876|NCT01775189|101745|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
43877|NCT01775189|101739|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
43878|NCT01775189|101740|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
43879|NCT01775189|101741|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
43880|NCT01775189|101742|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
43881|NCT01775189|101743|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
43882|NCT01775189|101744|P2|COMPLETED|Drug Discrimination Phase: Day 2||16
43883|NCT01775189|101745|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
43884|NCT01775189|101739|P7|STARTED|Drug Discrimination Phase: Day 2||0
43885|NCT01775189|101740|P6|STARTED|Drug Discrimination Phase: Day 2||0
43886|NCT01775189|101741|P5|STARTED|Drug Discrimination Phase: Day 2||0
43887|NCT01775189|101742|P4|STARTED|Drug Discrimination Phase: Day 2||0
43888|NCT01775189|101743|P3|STARTED|Drug Discrimination Phase: Day 2||23
43889|NCT01775189|101744|P2|STARTED|Drug Discrimination Phase: Day 2||19
43890|NCT01775189|101745|P1|STARTED|Drug Discrimination Phase: Day 2||0
43891|NCT01775189|101739|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
43892|NCT01775189|101740|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
43893|NCT01775189|101741|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
43894|NCT01775189|101742|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
43895|NCT01775189|101743|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
43896|NCT01775189|101744|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||3
43897|NCT01775189|101745|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
43898|NCT01775189|101739|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
43899|NCT01775189|101740|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
43900|NCT01775189|101741|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
43901|NCT01775189|101742|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
43902|NCT01775189|101743|P3|COMPLETED|Drug Discrimination Phase: Day 1||23
43903|NCT01775189|101744|P2|COMPLETED|Drug Discrimination Phase: Day 1||19
43904|NCT01775189|101745|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
43905|NCT01775189|101739|P7|STARTED|Drug Discrimination Phase: Day 1||0
43906|NCT01775189|101740|P6|STARTED|Drug Discrimination Phase: Day 1||0
43907|NCT01775189|101741|P5|STARTED|Drug Discrimination Phase: Day 1||0
43908|NCT01775189|101742|P4|STARTED|Drug Discrimination Phase: Day 1||0
43909|NCT01775189|101743|P3|STARTED|Drug Discrimination Phase: Day 1||23
43910|NCT01775189|101744|P2|STARTED|Drug Discrimination Phase: Day 1||22
43911|NCT01775189|101745|P1|STARTED|Drug Discrimination Phase: Day 1||0
43912|NCT01775189|101739|P7|NOT COMPLETED|Naloxone Challenge Phase||0
43913|NCT01775189|101740|P6|NOT COMPLETED|Naloxone Challenge Phase||0
43914|NCT01775189|101741|P5|NOT COMPLETED|Naloxone Challenge Phase||0
43915|NCT01775189|101742|P4|NOT COMPLETED|Naloxone Challenge Phase||0
43916|NCT01775189|101743|P3|NOT COMPLETED|Naloxone Challenge Phase||0
43917|NCT01775189|101744|P2|NOT COMPLETED|Naloxone Challenge Phase||0
43918|NCT01775189|101745|P1|NOT COMPLETED|Naloxone Challenge Phase||0
43919|NCT01775189|101739|P7|COMPLETED|Naloxone Challenge Phase||0
43920|NCT01775189|101740|P6|COMPLETED|Naloxone Challenge Phase||0
43921|NCT01775189|101741|P5|COMPLETED|Naloxone Challenge Phase||0
43922|NCT01775189|101742|P4|COMPLETED|Naloxone Challenge Phase||0
43923|NCT01775189|101743|P3|COMPLETED|Naloxone Challenge Phase||0
43924|NCT01775189|101744|P2|COMPLETED|Naloxone Challenge Phase||0
43925|NCT01775189|101745|P1|COMPLETED|Naloxone Challenge Phase||45
43926|NCT01775189|101739|P7|STARTED|Naloxone Challenge Phase||0
43927|NCT01775189|101740|P6|STARTED|Naloxone Challenge Phase||0
43928|NCT01775189|101741|P5|STARTED|Naloxone Challenge Phase||0
43929|NCT01775189|101742|P4|STARTED|Naloxone Challenge Phase||0
43930|NCT01775189|101743|P3|STARTED|Naloxone Challenge Phase||0
43931|NCT01775189|101744|P2|STARTED|Naloxone Challenge Phase||0
43932|NCT01775189|101745|P1|STARTED|Naloxone Challenge Phase||45
43933|NCT01775137|101964|P1|NOT COMPLETED|Overall Study||11
43934|NCT01775137|101964|P1|COMPLETED|Overall Study||34
43935|NCT01775137|101964|P1|STARTED|Overall Study||45
43936|NCT01774981|101997|P8|NOT COMPLETED|Overall Study||1
43937|NCT01774981|101998|P7|NOT COMPLETED|Overall Study||0
43938|NCT01774981|101999|P6|NOT COMPLETED|Overall Study||1
43939|NCT01774981|102000|P5|NOT COMPLETED|Overall Study||1
43940|NCT01774981|102001|P4|NOT COMPLETED|Overall Study||0
43941|NCT01774981|102002|P3|NOT COMPLETED|Overall Study||0
43942|NCT01774981|102003|P2|NOT COMPLETED|Overall Study||0
43943|NCT01774981|102004|P1|NOT COMPLETED|Overall Study||0
43944|NCT01774981|101997|P8|COMPLETED|Overall Study||11
43945|NCT01774981|101998|P7|COMPLETED|Overall Study||13
43946|NCT01774981|101999|P6|COMPLETED|Overall Study||13
43947|NCT01774981|102000|P5|COMPLETED|Overall Study||5
43948|NCT01774981|102001|P4|COMPLETED|Overall Study||4
43949|NCT01774981|102002|P3|COMPLETED|Overall Study||4
43950|NCT01774981|102003|P2|COMPLETED|Overall Study||4
43951|NCT01774981|102004|P1|COMPLETED|Overall Study||3
43952|NCT01774981|101997|P8|Received at Least 1 Dose of Study Drug|Overall Study||12
43953|NCT01774981|101998|P7|Received at Least 1 Dose of Study Drug|Overall Study||13
43954|NCT01774981|101999|P6|Received at Least 1 Dose of Study Drug|Overall Study||14
43955|NCT01774981|102000|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
43956|NCT01774981|102001|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
43957|NCT01774981|102002|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
43958|NCT01774981|102003|P2|Received at Least 1 Dose of Study Drug|Overall Study||4
43959|NCT01774981|102004|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
43960|NCT01774981|101997|P8|STARTED|Overall Study||12
43961|NCT01774981|101998|P7|STARTED|Overall Study||13
43962|NCT01774981|101999|P6|STARTED|Overall Study||14
43963|NCT01774981|102000|P5|STARTED|Overall Study||6
43964|NCT01774981|102001|P4|STARTED|Overall Study||4
43965|NCT01774981|102002|P3|STARTED|Overall Study||4
43966|NCT01774981|102003|P2|STARTED|Overall Study||4
43967|NCT01774981|102004|P1|STARTED|Overall Study||3
43968|NCT01774968|102036|P2|NOT COMPLETED|Overall Study||35
43969|NCT01774968|102037|P1|NOT COMPLETED|Overall Study||30
43970|NCT01774968|102036|P2|COMPLETED|Overall Study||128
43971|NCT01774968|102037|P1|COMPLETED|Overall Study||132
43972|NCT01774968|102036|P2|Received at Least 1 Dose of Study Drug|Overall Study||161
43973|NCT01774968|102037|P1|Received at Least 1 Dose of Study Drug|Overall Study||162
43974|NCT01774968|102036|P2|STARTED|Overall Study||163
43975|NCT01774968|102037|P1|STARTED|Overall Study||162
43976|NCT01774929|102071|P1|NOT COMPLETED|Overall Study||3
43977|NCT01774929|102071|P1|COMPLETED|Overall Study||32
43978|NCT01774929|102071|P1|STARTED|Overall Study||35
43979|NCT01774903|102077|P1|NOT COMPLETED|Overall Study||11
43980|NCT01774903|102077|P1|COMPLETED|Overall Study||34
43981|NCT01774903|102077|P1|STARTED|Overall Study||45
43982|NCT01774851|102086|P2|NOT COMPLETED|Overall Study||0
43983|NCT01774851|102087|P1|NOT COMPLETED|Overall Study||0
43984|NCT01774851|102086|P2|COMPLETED|Overall Study||42
43985|NCT01774851|102087|P1|COMPLETED|Overall Study||42
43986|NCT01774851|102086|P2|STARTED|Overall Study||42
43987|NCT01774851|102087|P1|STARTED|Overall Study||42
43988|NCT01774604|102095|P2|NOT COMPLETED|Overall Study||0
43989|NCT01774604|102096|P1|NOT COMPLETED|Overall Study||0
43990|NCT01774604|102095|P2|COMPLETED|Overall Study||226
43991|NCT01774604|102096|P1|COMPLETED|Overall Study||223
43992|NCT01774604|102095|P2|STARTED|Overall Study||226
43993|NCT01774604|102096|P1|STARTED|Overall Study||223
43994|NCT01774344|102116|P2|NOT COMPLETED|Overall Study||148
43995|NCT01774344|102117|P1|NOT COMPLETED|Overall Study||32
43996|NCT01774344|102116|P2|COMPLETED|Overall Study||231
43997|NCT01774344|102117|P1|COMPLETED|Overall Study||162
43998|NCT01774344|102116|P2|Treated|Overall Study||374
43999|NCT01774344|102117|P1|Treated|Overall Study||193
44000|NCT01774344|102116|P2|STARTED|Overall Study||379
44001|NCT01774344|102117|P1|STARTED|Overall Study||194
44002|NCT01774305|102133|P2|NOT COMPLETED|Overall Study||0
44003|NCT01774305|102134|P1|NOT COMPLETED|Overall Study||1
44004|NCT01774305|102133|P2|COMPLETED|Overall Study||71
44005|NCT01774305|102134|P1|COMPLETED|Overall Study||70
44006|NCT01774305|102133|P2|STARTED|Overall Study||71
44007|NCT01774305|102134|P1|STARTED|Overall Study||71
44008|NCT01774253|102142|P1|NOT COMPLETED|Overall Study||9
44009|NCT01774253|102142|P1|COMPLETED|Overall Study||0
44010|NCT01774253|102142|P1|STARTED|Overall Study||9
44011|NCT01774149|102152|P2|NOT COMPLETED|Overall Study||3
44012|NCT01774149|102153|P1|NOT COMPLETED|Overall Study||1
44013|NCT01774149|102152|P2|COMPLETED|Overall Study||12
44014|NCT01774149|102153|P1|COMPLETED|Overall Study||14
44015|NCT01774149|102152|P2|STARTED|Overall Study||15
44016|NCT01774149|102153|P1|STARTED|Overall Study||15
44017|NCT01774110|102161|P1|NOT COMPLETED|Overall Study||7
44018|NCT01774110|102161|P1|COMPLETED|Overall Study||5
44019|NCT01774110|102161|P1|STARTED|Overall Study||12
44020|NCT01774097|102169|P2|NOT COMPLETED|Overall Study||2
44021|NCT01774097|102170|P1|NOT COMPLETED|Overall Study||2
44022|NCT01774097|102169|P2|COMPLETED|Overall Study||40
44023|NCT01774097|102170|P1|COMPLETED|Overall Study||38
44024|NCT01774097|102169|P2|STARTED|Overall Study||42
44025|NCT01774097|102170|P1|STARTED|Overall Study||40
44026|NCT01774084|102200|P2|NOT COMPLETED|Overall Study||0
44027|NCT01774084|102201|P1|NOT COMPLETED|Overall Study||1
44028|NCT01774084|102200|P2|COMPLETED|Overall Study||12
44029|NCT01774084|102201|P1|COMPLETED|Overall Study||10
44030|NCT01774084|102200|P2|STARTED|Overall Study||12
44031|NCT01774084|102201|P1|STARTED|Overall Study||11
44032|NCT01774045|102211|P2|NOT COMPLETED|Overall Study||0
44033|NCT01774045|102212|P1|NOT COMPLETED|Overall Study||0
44034|NCT01774045|102211|P2|COMPLETED|Overall Study||7
44035|NCT01774045|102212|P1|COMPLETED|Overall Study||23
44036|NCT01774045|102211|P2|STARTED|Overall Study||7
44037|NCT01774045|102212|P1|STARTED|Overall Study||23
44038|NCT01773889|102226|P1|NOT COMPLETED|Overall Study||2
44039|NCT01773889|102226|P1|COMPLETED|Overall Study||0
44040|NCT01773889|102226|P1|STARTED|Overall Study||2
44041|NCT01773473|102232|P2|NOT COMPLETED|Overall Study||19
44042|NCT01773473|102233|P1|NOT COMPLETED|Overall Study||16
44043|NCT01773473|102232|P2|COMPLETED|Overall Study||177
44044|NCT01773473|102233|P1|COMPLETED|Overall Study||191
44045|NCT01773473|102232|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
44046|NCT01773473|102233|P1|Received at Least 1 Dose of Study Drug|Overall Study||207
44047|NCT01773473|102232|P2|STARTED|Overall Study||196
44048|NCT01773473|102233|P1|STARTED|Overall Study||207
44049|NCT01773291|102254|P3|NOT COMPLETED|Overall Study||1
44050|NCT01773291|102255|P2|NOT COMPLETED|Overall Study||0
44051|NCT01773291|102256|P1|NOT COMPLETED|Overall Study||1
44052|NCT01773291|102254|P3|COMPLETED|Overall Study||6
44053|NCT01773291|102255|P2|COMPLETED|Overall Study||9
44054|NCT01773291|102256|P1|COMPLETED|Overall Study||7
44055|NCT01773291|102254|P3|STARTED|Overall Study||7
44056|NCT01773291|102255|P2|STARTED|Overall Study||9
44057|NCT01773291|102256|P1|STARTED|Overall Study||8
44058|NCT01773226|102267|P1|NOT COMPLETED|Overall Study||1
44059|NCT01773226|102267|P1|COMPLETED|Overall Study|Withdrawal of one subject after one-month assessment due to persistent OA symptoms|10
44060|NCT01773226|102267|P1|STARTED|Overall Study||11
44061|NCT01773135|102277|P1|NOT COMPLETED|Overall Study||0
44062|NCT01773135|102277|P1|COMPLETED|Overall Study||262
44063|NCT01773135|102277|P1|STARTED|Overall Study||262
44064|NCT01773122|102286|P4|NOT COMPLETED|Overall Study||1
44065|NCT01773122|102287|P3|NOT COMPLETED|Overall Study||0
44066|NCT01773122|102288|P2|NOT COMPLETED|Overall Study||1
44067|NCT01773122|102289|P1|NOT COMPLETED|Overall Study||3
44068|NCT01773122|102286|P4|COMPLETED|Overall Study||18
44069|NCT01773122|102287|P3|COMPLETED|Overall Study||19
44070|NCT01773122|102288|P2|COMPLETED|Overall Study||18
44071|NCT01773122|102289|P1|COMPLETED|Overall Study||17
44072|NCT01773122|102286|P4|STARTED|Overall Study||19
44073|NCT01773122|102287|P3|STARTED|Overall Study||19
44074|NCT01773122|102288|P2|STARTED|Overall Study||19
44075|NCT01773122|102289|P1|STARTED|Overall Study||20
44076|NCT01772654|102305|P2|NOT COMPLETED|Overall Study||0
44077|NCT01772654|102306|P1|NOT COMPLETED|Overall Study||0
44078|NCT01772654|102305|P2|COMPLETED|Overall Study||15
44079|NCT01772654|102306|P1|COMPLETED|Overall Study||2
44080|NCT01772654|102305|P2|STARTED|Overall Study||15
44081|NCT01772654|102306|P1|STARTED|Overall Study||2
44082|NCT01772576|102312|P1|NOT COMPLETED|Overall Study||34
44083|NCT01772576|102312|P1|COMPLETED|Overall Study||133
44084|NCT01772576|102312|P1|STARTED|Overall Study||167
44085|NCT01772550|102324|P3|NOT COMPLETED|Overall Study||6
44086|NCT01772550|102325|P2|NOT COMPLETED|Overall Study||1
44087|NCT01772550|102326|P1|NOT COMPLETED|Overall Study||1
44088|NCT01772550|102324|P3|COMPLETED|Overall Study||27
44089|NCT01772550|102325|P2|COMPLETED|Overall Study||102
44090|NCT01772550|102326|P1|COMPLETED|Overall Study||101
44091|NCT01772550|102324|P3|CT Cardiac|Overall Study||1
44092|NCT01772550|102325|P2|CT Cardiac|Overall Study||7
44093|NCT01772550|102326|P1|CT Cardiac|Overall Study||7
44094|NCT01772550|102324|P3|CT Kidney|Overall Study||6
44095|NCT01772550|102325|P2|CT Kidney|Overall Study||19
44096|NCT01772550|102326|P1|CT Kidney|Overall Study||12
44097|NCT01772550|102324|P3|CT Liver|Overall Study||8
44098|NCT01772550|102325|P2|CT Liver|Overall Study||14
44099|NCT01772550|102326|P1|CT Liver|Overall Study||18
44100|NCT01772550|102324|P3|CT Angiogram|Overall Study||4
44101|NCT01772550|102325|P2|CT Angiogram|Overall Study||25
44102|NCT01772550|102326|P1|CT Angiogram|Overall Study||24
44103|NCT01772550|102324|P3|CT Pancreas|Overall Study||8
44104|NCT01772550|102325|P2|CT Pancreas|Overall Study||36
44105|NCT01772550|102326|P1|CT Pancreas|Overall Study||40
44106|NCT01772550|102324|P3|STARTED|Overall Study||33
44107|NCT01772550|102325|P2|STARTED|Overall Study||103
44108|NCT01772550|102326|P1|STARTED|Overall Study||102
44109|NCT01772537|102367|P3|NOT COMPLETED|Overall Study||0
44110|NCT01772537|102368|P2|NOT COMPLETED|Overall Study||0
44111|NCT01772537|102369|P1|NOT COMPLETED|Overall Study||1
44112|NCT01772537|102367|P3|COMPLETED|Overall Study||6
44113|NCT01772537|102368|P2|COMPLETED|Overall Study||3
44114|NCT01772537|102369|P1|COMPLETED|Overall Study||4
44115|NCT01772537|102367|P3|STARTED|Overall Study||6
44116|NCT01772537|102368|P2|STARTED|Overall Study||3
44117|NCT01772537|102369|P1|STARTED|Overall Study||5
44118|NCT01772368|102383|P1|NOT COMPLETED|Overall Study||7
44119|NCT01772368|102383|P1|COMPLETED|Overall Study||65
44120|NCT01772368|102383|P1|Received Advair Diskus 100/50 mcg|Overall Study||66
44121|NCT01772368|102383|P1|Received FS MDPI 100/50 mcg|Overall Study||68
44122|NCT01772368|102383|P1|Received FS MDPI 100/25 mcg|Overall Study||67
44123|NCT01772368|102383|P1|Received FS MDPI 100/12.5mcg|Overall Study||69
44124|NCT01772368|102383|P1|Received FS MDPI 100/6.25 mcg|Overall Study||68
44125|NCT01772368|102383|P1|Received Fp MDPI 100 mcg|Overall Study||67
44126|NCT01772368|102383|P1|STARTED|Overall Study||72
44127|NCT01772316|102429|P1|NOT COMPLETED|Overall Study||7
44128|NCT01772316|102429|P1|COMPLETED|Overall Study||40
44129|NCT01772316|102429|P1|STARTED|Overall Study||47
44130|NCT01772147|102450|P3|NOT COMPLETED|Overall Study||18
44131|NCT01772147|102451|P2|NOT COMPLETED|Overall Study||25
44132|NCT01772147|102452|P1|NOT COMPLETED|Overall Study||31
44133|NCT01772147|102450|P3|COMPLETED|Overall Study||184
44134|NCT01772147|102451|P2|COMPLETED|Overall Study||178
44135|NCT01772147|102452|P1|COMPLETED|Overall Study||170
44136|NCT01772147|102450|P3|STARTED|Overall Study||202
44137|NCT01772147|102451|P2|STARTED|Overall Study||203
44138|NCT01772147|102452|P1|STARTED|Overall Study||201
44139|NCT01772134|102472|P3|NOT COMPLETED|Overall Study||22
44140|NCT01772134|102473|P2|NOT COMPLETED|Overall Study||14
44141|NCT01772134|102474|P1|NOT COMPLETED|Overall Study||29
44142|NCT01772134|102472|P3|COMPLETED|Overall Study||184
44143|NCT01772134|102473|P2|COMPLETED|Overall Study||190
44144|NCT01772134|102474|P1|COMPLETED|Overall Study||178
44145|NCT01772134|102472|P3|Received Randomized Study Medication|Overall Study||205
44146|NCT01772134|102473|P2|Received Randomized Study Medication|Overall Study||204
44147|NCT01772134|102474|P1|Received Randomized Study Medication|Overall Study||205
44148|NCT01772134|102472|P3|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|206
44149|NCT01772134|102473|P2|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|204
44150|NCT01772134|102474|P1|STARTED|Overall Study|These participants were randomized but did not all receive study treatment.|207
44151|NCT01771991|102493|P2|NOT COMPLETED|Overall Study||6
44152|NCT01771991|102494|P1|NOT COMPLETED|Overall Study||8
44153|NCT01771991|102493|P2|COMPLETED|Overall Study||30
44154|NCT01771991|102494|P1|COMPLETED|Overall Study||30
44155|NCT01771991|102493|P2|Started Treatment|Overall Study||34
44156|NCT01771991|102494|P1|Started Treatment|Overall Study||37
44157|NCT01771991|102493|P2|STARTED|Overall Study||36
44158|NCT01771991|102494|P1|STARTED|Overall Study||38
44159|NCT01771965|102502|P2|NOT COMPLETED|Overall Study||5
44160|NCT01771965|102503|P1|NOT COMPLETED|Overall Study||3
44161|NCT01771965|102502|P2|COMPLETED|Overall Study||4
44162|NCT01771965|102503|P1|COMPLETED|Overall Study||7
44163|NCT01771965|102502|P2|STARTED|Overall Study||9
44164|NCT01771965|102503|P1|STARTED|Overall Study||10
44165|NCT01771913|102511|P2|NOT COMPLETED|Overall Study||0
44166|NCT01771913|102512|P1|NOT COMPLETED|Overall Study||1
44167|NCT01771913|102511|P2|COMPLETED|Overall Study||11
44168|NCT01771913|102512|P1|COMPLETED|Overall Study||8
44169|NCT01771913|102511|P2|STARTED|Overall Study||11
44170|NCT01771913|102512|P1|STARTED|Overall Study||9
44171|NCT01771172|102522|P1|NOT COMPLETED|Overall Study||2
44172|NCT01771172|102522|P1|COMPLETED|Overall Study||46
44173|NCT01771172|102522|P1|STARTED|Overall Study||48
44174|NCT01770860|102526|P1|NOT COMPLETED|Overall Study||6
44175|NCT01770860|102526|P1|COMPLETED|Overall Study||40
44176|NCT01770860|102526|P1|Randomization|Overall Study|One participant withdrew before randomization|45
44177|NCT01770860|102526|P1|STARTED|Overall Study|Forty-six subjects were enrolled but one subject withdrew before randomization.|46
44178|NCT01770743|102574|P5|NOT COMPLETED|Overall Study||2
44179|NCT01770743|102575|P4|NOT COMPLETED|Overall Study||2
44180|NCT01770743|102576|P3|NOT COMPLETED|Overall Study||1
44181|NCT01770743|102577|P2|NOT COMPLETED|Overall Study||3
44182|NCT01770743|102578|P1|NOT COMPLETED|Overall Study||2
44183|NCT01770743|102574|P5|COMPLETED|Overall Study||21
44184|NCT01770743|102575|P4|COMPLETED|Overall Study||42
44185|NCT01770743|102576|P3|COMPLETED|Overall Study||22
44186|NCT01770743|102577|P2|COMPLETED|Overall Study||31
44187|NCT01770743|102578|P1|COMPLETED|Overall Study||42
44188|NCT01770743|102574|P5|Treated|Overall Study||23
44189|NCT01770743|102575|P4|Treated|Overall Study||44
44190|NCT01770743|102576|P3|Treated|Overall Study||23
44191|NCT01770743|102577|P2|Treated|Overall Study||34
44192|NCT01770743|102578|P1|Treated|Overall Study||44
44193|NCT01770743|102574|P5|STARTED|Overall Study||23
44194|NCT01770743|102575|P4|STARTED|Overall Study||44
44195|NCT01770743|102576|P3|STARTED|Overall Study||23
44196|NCT01770743|102577|P2|STARTED|Overall Study||34
44197|NCT01770743|102578|P1|STARTED|Overall Study||44
44198|NCT01770691|102630|P1|NOT COMPLETED|Overall Study||0
44199|NCT01770691|102630|P1|COMPLETED|Overall Study||7
44200|NCT01770691|102630|P1|STARTED|Overall Study||7
44201|NCT01770652|102641|P4|NOT COMPLETED|Overall Study||0
44202|NCT01770652|102642|P3|NOT COMPLETED|Overall Study||0
44203|NCT01770652|102643|P2|NOT COMPLETED|Overall Study||0
44204|NCT01770652|102644|P1|NOT COMPLETED|Overall Study||0
44205|NCT01770652|102641|P4|COMPLETED|Overall Study||8
44206|NCT01770652|102642|P3|COMPLETED|Overall Study||8
44207|NCT01770652|102643|P2|COMPLETED|Overall Study||8
44208|NCT01770652|102644|P1|COMPLETED|Overall Study||8
44209|NCT01770652|102641|P4|STARTED|Overall Study||8
44210|NCT01770652|102642|P3|STARTED|Overall Study||8
44211|NCT01770652|102643|P2|STARTED|Overall Study||8
44212|NCT01770652|102644|P1|STARTED|Overall Study||8
44213|NCT01770509|102680|P2|NOT COMPLETED|Overall Study||3
44214|NCT01770509|102681|P1|NOT COMPLETED|Overall Study||1
44215|NCT01770509|102680|P2|COMPLETED|Overall Study||14
44216|NCT01770509|102681|P1|COMPLETED|Overall Study||11
44217|NCT01770509|102680|P2|STARTED|Overall Study||17
44218|NCT01770509|102681|P1|STARTED|Overall Study||12
44219|NCT01770483|102697|P2|NOT COMPLETED|Overall Study||0
44220|NCT01770483|102698|P1|NOT COMPLETED|Overall Study||0
44221|NCT01770483|102697|P2|COMPLETED|Overall Study||33
44222|NCT01770483|102698|P1|COMPLETED|Overall Study||33
44223|NCT01770483|102697|P2|STARTED|Overall Study||33
44224|NCT01770483|102698|P1|STARTED|Overall Study||33
44225|NCT01770392|102706|P1|NOT COMPLETED|Nintedanib+ Rifampicin||0
44226|NCT01770392|102706|P1|COMPLETED|Nintedanib+ Rifampicin||25
44227|NCT01770392|102706|P1|STARTED|Nintedanib+ Rifampicin||25
44228|NCT01770392|102706|P1|NOT COMPLETED|Washout Period of at Least 14 Days||1
44229|NCT01770392|102706|P1|COMPLETED|Washout Period of at Least 14 Days||25
44230|NCT01770392|102706|P1|STARTED|Washout Period of at Least 14 Days||26
44231|NCT01770392|102706|P1|NOT COMPLETED|Nintedanib||0
44232|NCT01770392|102706|P1|COMPLETED|Nintedanib||26
44233|NCT01770392|102706|P1|STARTED|Nintedanib||26
44234|NCT01770379|102721|P3|NOT COMPLETED|Overall Study||42
44235|NCT01770379|102722|P2|NOT COMPLETED|Overall Study||44
44236|NCT01770379|102723|P1|NOT COMPLETED|Overall Study||39
44237|NCT01770379|102721|P3|COMPLETED|Overall Study||39
44238|NCT01770379|102722|P2|COMPLETED|Overall Study||37
44239|NCT01770379|102723|P1|COMPLETED|Overall Study||41
44240|NCT01770379|102721|P3|STARTED|Overall Study||81
44241|NCT01770379|102722|P2|STARTED|Overall Study||81
44242|NCT01770379|102723|P1|STARTED|Overall Study||80
44243|NCT01770366|102742|P2|NOT COMPLETED|Overall Study||2
44244|NCT01770366|102743|P1|NOT COMPLETED|Overall Study||2
44245|NCT01770366|102742|P2|COMPLETED|Overall Study||4
44246|NCT01770366|102743|P1|COMPLETED|Overall Study||2
44247|NCT01770366|102742|P2|STARTED|Overall Study||6
44248|NCT01770366|102743|P1|STARTED|Overall Study||4
44249|NCT01770314|102751|P2|NOT COMPLETED|Overall Study||0
44250|NCT01770314|102752|P1|NOT COMPLETED|Overall Study||0
44251|NCT01770314|102751|P2|COMPLETED|Overall Study||90
44252|NCT01770314|102752|P1|COMPLETED|Overall Study||86
44253|NCT01770314|102751|P2|Contributed Data to One-month Follow-up|Overall Study||66
44254|NCT01770314|102752|P1|Contributed Data to One-month Follow-up|Overall Study||61
44255|NCT01770314|102751|P2|Contributed Data to Post-test|Overall Study||67
44256|NCT01770314|102752|P1|Contributed Data to Post-test|Overall Study||65
44257|NCT01770314|102751|P2|Contributed Data to Baseline|Overall Study||72
44258|NCT01770314|102752|P1|Contributed Data to Baseline|Overall Study||68
44259|NCT01770314|102751|P2|STARTED|Overall Study||90
44260|NCT01770314|102752|P1|STARTED|Overall Study||86
44261|NCT01770145|102760|P1|NOT COMPLETED|Treatment||4
44262|NCT01770145|102760|P1|COMPLETED|Treatment||97
44263|NCT01770145|102760|P1|STARTED|Treatment||101
44264|NCT01770145|102760|P1|NOT COMPLETED|Baseline||26
44265|NCT01770145|102760|P1|COMPLETED|Baseline||101
44266|NCT01770145|102760|P1|STARTED|Baseline||127
44267|NCT01769612|102765|P1|NOT COMPLETED|Overall Study||0
44268|NCT01769612|102765|P1|COMPLETED|Overall Study||168
44269|NCT01769612|102765|P1|STARTED|Overall Study||168
44270|NCT01769586|102773|P2|NOT COMPLETED|Overall Study||0
44271|NCT01769586|102774|P1|NOT COMPLETED|Overall Study||0
44272|NCT01769586|102773|P2|COMPLETED|Overall Study||100
44273|NCT01769586|102774|P1|COMPLETED|Overall Study||100
44274|NCT01769586|102773|P2|STARTED|Overall Study||100
44275|NCT01769586|102774|P1|STARTED|Overall Study||100
44276|NCT01769508|102780|P1|NOT COMPLETED|Overall Study||6
44277|NCT01769508|102780|P1|COMPLETED|Overall Study||6
44278|NCT01769508|102780|P1|STARTED|Overall Study||12
44279|NCT01769443|102791|P2|NOT COMPLETED|Overall Study||0
44280|NCT01769443|102792|P1|NOT COMPLETED|Overall Study||1
44281|NCT01769443|102791|P2|COMPLETED|Overall Study||1
44282|NCT01769443|102792|P1|COMPLETED|Overall Study||0
44283|NCT01769443|102791|P2|STARTED|Overall Study||1
44284|NCT01769443|102792|P1|STARTED|Overall Study||1
44285|NCT01769391|102836|P2|NOT COMPLETED|Overall Study||9
44286|NCT01769391|102837|P1|NOT COMPLETED|Overall Study||20
44287|NCT01769391|102836|P2|COMPLETED|Overall Study||48
44288|NCT01769391|102837|P1|COMPLETED|Overall Study||90
44289|NCT01769391|102836|P2|Received at Least One Dose of Study Drug|Overall Study||55
44290|NCT01769391|102837|P1|Received at Least One Dose of Study Drug|Overall Study||106
44291|NCT01769391|102836|P2|STARTED|Overall Study||57
44292|NCT01769391|102837|P1|STARTED|Overall Study||110
44293|NCT01769378|102856|P2|NOT COMPLETED|Overall Study||4
44294|NCT01769378|102857|P1|NOT COMPLETED|Overall Study||25
44295|NCT01769378|102856|P2|COMPLETED|Overall Study|Completed the study on study treatment|56
44296|NCT01769378|102857|P1|COMPLETED|Overall Study|Completed the study on study treatment|215
44390|NCT01768286|103110|P2|NOT COMPLETED|Overall Study||4
44297|NCT01769378|102856|P2|Received at Least 1 Dose of Study Drug|Overall Study||60
44298|NCT01769378|102857|P1|Received at Least 1 Dose of Study Drug|Overall Study||239
44299|NCT01769378|102856|P2|STARTED|Overall Study||60
44300|NCT01769378|102857|P1|STARTED|Overall Study||240
44301|NCT01769365|102895|P3|NOT COMPLETED|Overall Study||2
44302|NCT01769365|102896|P2|NOT COMPLETED|Overall Study||2
44303|NCT01769365|102897|P1|NOT COMPLETED|Overall Study||0
44304|NCT01769365|102895|P3|COMPLETED|Overall Study||101
44305|NCT01769365|102896|P2|COMPLETED|Overall Study||100
44306|NCT01769365|102897|P1|COMPLETED|Overall Study||102
44307|NCT01769365|102895|P3|STARTED|Overall Study||103
44308|NCT01769365|102896|P2|STARTED|Overall Study||102
44309|NCT01769365|102897|P1|STARTED|Overall Study||102
44310|NCT01769339|102905|P1|NOT COMPLETED|Overall Study||43
44311|NCT01769339|102905|P1|COMPLETED|Overall Study||72
44312|NCT01769339|102905|P1|STARTED|Overall Study||115
44313|NCT01769326|102916|P4|NOT COMPLETED|Overall Study||0
44314|NCT01769326|102917|P3|NOT COMPLETED|Overall Study||1
44315|NCT01769326|102918|P2|NOT COMPLETED|Overall Study||4
44316|NCT01769326|102919|P1|NOT COMPLETED|Overall Study||2
44317|NCT01769326|102916|P4|COMPLETED|Overall Study||8
44318|NCT01769326|102917|P3|COMPLETED|Overall Study||8
44319|NCT01769326|102918|P2|COMPLETED|Overall Study||8
44320|NCT01769326|102919|P1|COMPLETED|Overall Study||9
44321|NCT01769326|102916|P4|STARTED|Overall Study||8
44322|NCT01769326|102917|P3|STARTED|Overall Study||9
44323|NCT01769326|102918|P2|STARTED|Overall Study||12
44324|NCT01769326|102919|P1|STARTED|Overall Study||11
44325|NCT01769248|102931|P2|NOT COMPLETED|Overall Study||0
44326|NCT01769248|102932|P1|NOT COMPLETED|Overall Study||0
44327|NCT01769248|102931|P2|COMPLETED|Overall Study||70
44328|NCT01769248|102932|P1|COMPLETED|Overall Study||70
44329|NCT01769248|102931|P2|STARTED|Overall Study||70
44330|NCT01769248|102932|P1|STARTED|Overall Study||70
44331|NCT01769222|102940|P2|NOT COMPLETED|Overall Study||0
44332|NCT01769222|102941|P1|NOT COMPLETED|Overall Study||0
44333|NCT01769222|102940|P2|COMPLETED|Overall Study||0
44334|NCT01769222|102941|P1|COMPLETED|Overall Study||3
44335|NCT01769222|102940|P2|STARTED|Overall Study||0
44336|NCT01769222|102941|P1|STARTED|Overall Study||3
44337|NCT01769196|102957|P2|NOT COMPLETED|Overall Study||272
44338|NCT01769196|102958|P1|NOT COMPLETED|Overall Study||272
44339|NCT01769196|102957|P2|COMPLETED|Overall Study||0
44340|NCT01769196|102958|P1|COMPLETED|Overall Study||0
44341|NCT01769196|102957|P2|STARTED|Overall Study||272
44342|NCT01769196|102958|P1|STARTED|Overall Study||272
44343|NCT01769105|102988|P2|NOT COMPLETED|Cross-over||0
44344|NCT01769105|102989|P1|NOT COMPLETED|Cross-over||5
44345|NCT01769105|102988|P2|COMPLETED|Cross-over|Was not intended by the study protocol|0
44346|NCT01769105|102989|P1|COMPLETED|Cross-over||9
44347|NCT01769105|102988|P2|STARTED|Cross-over|Cross-over was only intended for the Lid margin hygiene group|0
44348|NCT01769105|102989|P1|STARTED|Cross-over||14
44349|NCT01769105|102988|P2|NOT COMPLETED|First Intervention||2
44350|NCT01769105|102989|P1|NOT COMPLETED|First Intervention||2
44351|NCT01769105|102988|P2|COMPLETED|First Intervention||17
44352|NCT01769105|102989|P1|COMPLETED|First Intervention||14
44353|NCT01769105|102988|P2|STARTED|First Intervention||19
44354|NCT01769105|102989|P1|STARTED|First Intervention||16
44355|NCT01768676|103010|P2|NOT COMPLETED|Overall Study||31
44356|NCT01768676|103011|P1|NOT COMPLETED|Overall Study||24
44357|NCT01768676|103010|P2|COMPLETED|Overall Study||60
44358|NCT01768676|103011|P1|COMPLETED|Overall Study||66
44359|NCT01768676|103010|P2|STARTED|Overall Study||91
44360|NCT01768676|103011|P1|STARTED|Overall Study||90
44361|NCT01768572|103028|P3|NOT COMPLETED|Overall Study||6
44362|NCT01768572|103029|P2|NOT COMPLETED|Overall Study||12
44363|NCT01768572|103030|P1|NOT COMPLETED|Overall Study||9
44364|NCT01768572|103028|P3|COMPLETED|Overall Study||96
44365|NCT01768572|103029|P2|COMPLETED|Overall Study||39
44366|NCT01768572|103030|P1|COMPLETED|Overall Study||40
44367|NCT01768572|103028|P3|STARTED|Overall Study||102
44368|NCT01768572|103029|P2|STARTED|Overall Study||51
44369|NCT01768572|103030|P1|STARTED|Overall Study||49
44370|NCT01768559|103041|P3|NOT COMPLETED|Overall Study||13
44371|NCT01768559|103042|P2|NOT COMPLETED|Overall Study||17
44372|NCT01768559|103043|P1|NOT COMPLETED|Overall Study||30
44373|NCT01768559|103041|P3|COMPLETED|Overall Study||285
44374|NCT01768559|103042|P2|COMPLETED|Overall Study||281
44375|NCT01768559|103043|P1|COMPLETED|Overall Study||268
44376|NCT01768559|103041|P3|Treated|Overall Study|4 participants received Insulin Glulisine QD (for more than 50%)|297
44377|NCT01768559|103042|P2|Treated|Overall Study|1 participant received Insulin Glulisine TID (for more than 50%)|298
44378|NCT01768559|103043|P1|Treated|Overall Study||298
44379|NCT01768559|103041|P3|STARTED|Overall Study||298
44380|NCT01768559|103042|P2|STARTED|Overall Study||298
44381|NCT01768559|103043|P1|STARTED|Overall Study||298
44382|NCT01768325|103093|P2|NOT COMPLETED|Overall Study||0
44383|NCT01768325|103094|P1|NOT COMPLETED|Overall Study||0
44384|NCT01768325|103093|P2|COMPLETED|Overall Study||41
44385|NCT01768325|103094|P1|COMPLETED|Overall Study||37
44386|NCT01768325|103093|P2|STARTED|Overall Study||41
44387|NCT01768325|103094|P1|STARTED|Overall Study||37
44388|NCT01768286|103108|P4|NOT COMPLETED|Overall Study||1
44389|NCT01768286|103109|P3|NOT COMPLETED|Overall Study||2
44391|NCT01768286|103111|P1|NOT COMPLETED|Overall Study||7
44392|NCT01768286|103108|P4|COMPLETED|Overall Study||110
44393|NCT01768286|103109|P3|COMPLETED|Overall Study||108
44394|NCT01768286|103110|P2|COMPLETED|Overall Study||107
44395|NCT01768286|103111|P1|COMPLETED|Overall Study||102
44396|NCT01768286|103108|P4|STARTED|Overall Study||111
44397|NCT01768286|103109|P3|STARTED|Overall Study||110
44398|NCT01768286|103110|P2|STARTED|Overall Study||111
44399|NCT01768286|103111|P1|STARTED|Overall Study||109
44400|NCT01768117|103173|P1|NOT COMPLETED|Overall Study||6
44401|NCT01768117|103173|P1|COMPLETED|Overall Study||7
44402|NCT01768117|103173|P1|STARTED|Overall Study||13
44403|NCT01768013|103181|P1|NOT COMPLETED|Overall Study||0
44404|NCT01768013|103181|P1|COMPLETED|Overall Study||13
44405|NCT01768013|103181|P1|STARTED|Overall Study||13
44406|NCT01768000|103214|P4|NOT COMPLETED|Overall Study||2
44407|NCT01768000|103215|P3|NOT COMPLETED|Overall Study||1
44408|NCT01768000|103216|P2|NOT COMPLETED|Overall Study||2
44409|NCT01768000|103217|P1|NOT COMPLETED|Overall Study||1
44410|NCT01768000|103214|P4|COMPLETED|Overall Study||8
44411|NCT01768000|103215|P3|COMPLETED|Overall Study||9
44412|NCT01768000|103216|P2|COMPLETED|Overall Study||8
44413|NCT01768000|103217|P1|COMPLETED|Overall Study||9
44414|NCT01768000|103214|P4|STARTED|Overall Study||10
44415|NCT01768000|103215|P3|STARTED|Overall Study||10
44416|NCT01768000|103216|P2|STARTED|Overall Study||10
44417|NCT01768000|103217|P1|STARTED|Overall Study||10
44418|NCT01767987|103237|P2|NOT COMPLETED|Overall Study||1
44419|NCT01767987|103238|P1|NOT COMPLETED|Overall Study||4
44420|NCT01767987|103237|P2|COMPLETED|Overall Study||1
44421|NCT01767987|103238|P1|COMPLETED|Overall Study||0
44422|NCT01767987|103237|P2|STARTED|Overall Study||2
44423|NCT01767987|103238|P1|STARTED|Overall Study||4
44424|NCT01767701|103260|P1|NOT COMPLETED|Overall Study||0
44425|NCT01767701|103260|P1|COMPLETED|Overall Study||20
44426|NCT01767701|103260|P1|STARTED|Overall Study|All 20 patients who entered the treatment phase completed the six months trial period.|20
44427|NCT01767688|103273|P2|NOT COMPLETED|Overall Study||0
44428|NCT01767688|103274|P1|NOT COMPLETED|Overall Study||0
44429|NCT01767688|103273|P2|COMPLETED|Overall Study||8
44430|NCT01767688|103274|P1|COMPLETED|Overall Study||8
44431|NCT01767688|103273|P2|STARTED|Overall Study||8
44432|NCT01767688|103274|P1|STARTED|Overall Study||8
44433|NCT01767597|103296|P2|NOT COMPLETED|Overall Study||1
44434|NCT01767597|103297|P1|NOT COMPLETED|Overall Study||4
44435|NCT01767597|103296|P2|COMPLETED|Overall Study||499
44436|NCT01767597|103297|P1|COMPLETED|Overall Study||496
44437|NCT01767597|103296|P2|STARTED|Overall Study||500
44438|NCT01767597|103297|P1|STARTED|Overall Study||500
44439|NCT01767519|103306|P3|NOT COMPLETED|Overall Study||5
44440|NCT01767519|103307|P2|NOT COMPLETED|Overall Study||13
44441|NCT01767519|103308|P1|NOT COMPLETED|Overall Study||14
44442|NCT01767519|103306|P3|COMPLETED|Overall Study||55
44443|NCT01767519|103307|P2|COMPLETED|Overall Study||138
44444|NCT01767519|103308|P1|COMPLETED|Overall Study||131
44445|NCT01767519|103306|P3|STARTED|Overall Study||60
44446|NCT01767519|103307|P2|STARTED|Overall Study||151
44447|NCT01767519|103308|P1|STARTED|Overall Study||145
44448|NCT01767467|103336|P2|NOT COMPLETED|Overall Study||20
44449|NCT01767467|103337|P1|NOT COMPLETED|Overall Study||17
44450|NCT01767467|103336|P2|COMPLETED|Overall Study||259
44451|NCT01767467|103337|P1|COMPLETED|Overall Study||266
44452|NCT01767467|103336|P2|STARTED|Overall Study||279
44453|NCT01767467|103337|P1|STARTED|Overall Study||283
44454|NCT01767285|103367|P2|NOT COMPLETED|Overall Study||6
44455|NCT01767285|103368|P1|NOT COMPLETED|Overall Study||7
44456|NCT01767285|103367|P2|COMPLETED|Overall Study||24
44457|NCT01767285|103368|P1|COMPLETED|Overall Study||22
44458|NCT01767285|103367|P2|STARTED|Overall Study||30
44459|NCT01767285|103368|P1|STARTED|Overall Study||29
44460|NCT01767116|103386|P2|NOT COMPLETED|Overall Study||2
44461|NCT01767116|103387|P1|NOT COMPLETED|Overall Study||2
44462|NCT01767116|103386|P2|COMPLETED|Overall Study||207
44463|NCT01767116|103387|P1|COMPLETED|Overall Study||208
44464|NCT01767116|103386|P2|STARTED|Overall Study||209
44465|NCT01767116|103387|P1|STARTED|Overall Study||210
44466|NCT01767103|103406|P3|NOT COMPLETED|Overall Study||0
44467|NCT01767103|103407|P2|NOT COMPLETED|Overall Study||0
44468|NCT01767103|103408|P1|NOT COMPLETED|Overall Study||0
44469|NCT01767103|103406|P3|COMPLETED|Overall Study||7
44470|NCT01767103|103407|P2|COMPLETED|Overall Study||7
44471|NCT01767103|103408|P1|COMPLETED|Overall Study||7
44472|NCT01767103|103406|P3|STARTED|Overall Study||7
44473|NCT01767103|103407|P2|STARTED|Overall Study||7
44474|NCT01767103|103408|P1|STARTED|Overall Study||7
44475|NCT01767064|103436|P2|NOT COMPLETED|Overall Study||0
44476|NCT01767064|103437|P1|NOT COMPLETED|Overall Study||0
44477|NCT01767064|103436|P2|COMPLETED|Overall Study||7
44478|NCT01767064|103437|P1|COMPLETED|Overall Study||7
44479|NCT01767064|103436|P2|STARTED|Overall Study||7
44480|NCT01767064|103437|P1|STARTED|Overall Study||7
44481|NCT01766921|103445|P2|NOT COMPLETED|Overall Study||17
44482|NCT01766921|103446|P1|NOT COMPLETED|Overall Study||24
44483|NCT01766921|103445|P2|COMPLETED|Overall Study||676
44484|NCT01766921|103446|P1|COMPLETED|Overall Study||676
44485|NCT01766921|103445|P2|STARTED|Overall Study||693
44486|NCT01766921|103446|P1|STARTED|Overall Study||700
44487|NCT01766778|103467|P2|NOT COMPLETED|Overall Study||4
44488|NCT01766778|103468|P1|NOT COMPLETED|Overall Study||5
44489|NCT01766778|103467|P2|COMPLETED|Overall Study||57
44490|NCT01766778|103468|P1|COMPLETED|Overall Study||51
44491|NCT01766778|103467|P2|STARTED|Overall Study||61
44492|NCT01766778|103468|P1|STARTED|Overall Study|Intent to treat population|56
44493|NCT01766713|103486|P2|NOT COMPLETED|Overall Study||2
44494|NCT01766713|103487|P1|NOT COMPLETED|Overall Study||2
44495|NCT01766713|103486|P2|COMPLETED|Overall Study||23
44496|NCT01766713|103487|P1|COMPLETED|Overall Study||23
44497|NCT01766713|103486|P2|STARTED|Overall Study||25
44498|NCT01766713|103487|P1|STARTED|Overall Study||25
44499|NCT01766466|103495|P4|NOT COMPLETED|Day 5||0
44500|NCT01766466|103496|P3|NOT COMPLETED|Day 5||0
44501|NCT01766466|103497|P2|NOT COMPLETED|Day 5||0
44502|NCT01766466|103498|P1|NOT COMPLETED|Day 5||0
44503|NCT01766466|103495|P4|COMPLETED|Day 5||6
44504|NCT01766466|103496|P3|COMPLETED|Day 5||0
44505|NCT01766466|103497|P2|COMPLETED|Day 5||6
44506|NCT01766466|103498|P1|COMPLETED|Day 5||0
44507|NCT01766466|103495|P4|STARTED|Day 5||6
44508|NCT01766466|103496|P3|STARTED|Day 5||0
44509|NCT01766466|103497|P2|STARTED|Day 5||6
44510|NCT01766466|103498|P1|STARTED|Day 5||0
44511|NCT01766466|103495|P4|NOT COMPLETED|Day 1||0
44512|NCT01766466|103496|P3|NOT COMPLETED|Day 1||0
44513|NCT01766466|103497|P2|NOT COMPLETED|Day 1||0
44514|NCT01766466|103498|P1|NOT COMPLETED|Day 1||0
44515|NCT01766466|103495|P4|COMPLETED|Day 1||0
44516|NCT01766466|103496|P3|COMPLETED|Day 1||6
44517|NCT01766466|103497|P2|COMPLETED|Day 1||0
44518|NCT01766466|103498|P1|COMPLETED|Day 1||6
44519|NCT01766466|103495|P4|STARTED|Day 1||0
44520|NCT01766466|103496|P3|STARTED|Day 1||6
44521|NCT01766466|103497|P2|STARTED|Day 1||0
44522|NCT01766466|103498|P1|STARTED|Day 1||6
44523|NCT01766440|103511|P1|NOT COMPLETED|Overall Study||1
44524|NCT01766440|103511|P1|COMPLETED|Overall Study||17
44525|NCT01766440|103511|P1|STARTED|Overall Study||18
44526|NCT01766336|103522|P2|NOT COMPLETED|Overall Study||75
44527|NCT01766336|103523|P1|NOT COMPLETED|Overall Study||90
44528|NCT01766336|103522|P2|COMPLETED|Overall Study||71
44529|NCT01766336|103523|P1|COMPLETED|Overall Study||60
44530|NCT01766336|103522|P2|STARTED|Overall Study||146
44531|NCT01766336|103523|P1|STARTED|Overall Study||150
44532|NCT01766310|103531|P2|NOT COMPLETED|Overall Study||3
44533|NCT01766310|103532|P1|NOT COMPLETED|Overall Study||1
44534|NCT01766310|103531|P2|COMPLETED|Overall Study||23
44535|NCT01766310|103532|P1|COMPLETED|Overall Study||23
44536|NCT01766310|103531|P2|STARTED|Overall Study||26
44537|NCT01766310|103532|P1|STARTED|Overall Study||24
44538|NCT01766102|103542|P2|NOT COMPLETED|Overall Study||0
44539|NCT01766102|103543|P1|NOT COMPLETED|Overall Study||0
44540|NCT01766102|103542|P2|COMPLETED|Overall Study||36
44541|NCT01766102|103543|P1|COMPLETED|Overall Study||36
44542|NCT01766102|103542|P2|STARTED|Overall Study||36
44543|NCT01766102|103543|P1|STARTED|Overall Study||36
44544|NCT01766076|103553|P2|NOT COMPLETED|Overall Study||0
44545|NCT01766076|103554|P1|NOT COMPLETED|Overall Study||0
44546|NCT01766076|103553|P2|COMPLETED|Overall Study||15
44547|NCT01766076|103554|P1|COMPLETED|Overall Study||15
44548|NCT01766076|103553|P2|STARTED|Overall Study||15
44549|NCT01766076|103554|P1|STARTED|Overall Study||15
44550|NCT01766050|103560|P1|NOT COMPLETED|Overall Study||4
44551|NCT01766050|103560|P1|COMPLETED|Overall Study||18
44552|NCT01766050|103560|P1|STARTED|Overall Study||22
44553|NCT01766037|103695|P2|NOT COMPLETED|Overall Study||29
44554|NCT01766037|103696|P1|NOT COMPLETED|Overall Study||29
44555|NCT01766037|103695|P2|COMPLETED|Overall Study||31
44556|NCT01766037|103696|P1|COMPLETED|Overall Study||82
44557|NCT01766037|103695|P2|STARTED|Overall Study||60
44558|NCT01766037|103696|P1|STARTED|Overall Study||111
44559|NCT01766024|103733|P2|NOT COMPLETED|Overall Study||0
44560|NCT01766024|103734|P1|NOT COMPLETED|Overall Study||0
44561|NCT01766024|103733|P2|COMPLETED|Overall Study||16
44562|NCT01766024|103734|P1|COMPLETED|Overall Study||16
44563|NCT01766024|103733|P2|STARTED|Overall Study||16
44564|NCT01766024|103734|P1|STARTED|Overall Study||16
44565|NCT01765972|103744|P4|NOT COMPLETED|Overall Study||0
44566|NCT01765972|103745|P3|NOT COMPLETED|Overall Study||0
44567|NCT01765972|103746|P2|NOT COMPLETED|Overall Study||0
44568|NCT01765972|103747|P1|NOT COMPLETED|Overall Study||0
44569|NCT01765972|103744|P4|COMPLETED|Overall Study||6
44570|NCT01765972|103745|P3|COMPLETED|Overall Study||6
44571|NCT01765972|103746|P2|COMPLETED|Overall Study||6
44572|NCT01765972|103747|P1|COMPLETED|Overall Study||6
44573|NCT01765972|103744|P4|STARTED|Overall Study||6
44574|NCT01765972|103745|P3|STARTED|Overall Study||6
44575|NCT01765972|103746|P2|STARTED|Overall Study||6
44576|NCT01765972|103747|P1|STARTED|Overall Study||6
44577|NCT01764841|103761|P4|NOT COMPLETED|Overall Study||19
44578|NCT01764841|103762|P3|NOT COMPLETED|Overall Study||14
44579|NCT01764841|103763|P2|NOT COMPLETED|Overall Study||26
44580|NCT01764841|103764|P1|NOT COMPLETED|Overall Study||23
44581|NCT01764841|103761|P4|COMPLETED|Overall Study||49
44582|NCT01764841|103762|P3|COMPLETED|Overall Study||56
44583|NCT01764841|103763|P2|COMPLETED|Overall Study||111
44584|NCT01764841|103764|P1|COMPLETED|Overall Study||118
44674|NCT01765192|103987|P2|COMPLETED|Treatment Period 2||28
44585|NCT01764841|103761|P4|Participants Received Treatment|Overall Study|safety population|68
44586|NCT01764841|103762|P3|Participants Received Treatment|Overall Study|safety population|69
44587|NCT01764841|103763|P2|Participants Received Treatment|Overall Study|safety population|136
44588|NCT01764841|103764|P1|Participants Received Treatment|Overall Study|safety population|141
44589|NCT01764841|103761|P4|STARTED|Overall Study||68
44590|NCT01764841|103762|P3|STARTED|Overall Study||70
44591|NCT01764841|103763|P2|STARTED|Overall Study||137
44592|NCT01764841|103764|P1|STARTED|Overall Study||141
44593|NCT01764685|103798|P2|NOT COMPLETED|Overall Study||1
44594|NCT01764685|103799|P1|NOT COMPLETED|Overall Study||0
44595|NCT01764685|103798|P2|COMPLETED|Overall Study||3
44596|NCT01764685|103799|P1|COMPLETED|Overall Study||0
44597|NCT01764685|103798|P2|STARTED|Overall Study||4
44598|NCT01764685|103799|P1|STARTED|Overall Study||0
44599|NCT01765803|103805|P1|NOT COMPLETED|Overall Study||0
44600|NCT01765803|103805|P1|COMPLETED|Overall Study||6
44601|NCT01765803|103805|P1|STARTED|Overall Study||6
44602|NCT01765764|103813|P3|NOT COMPLETED|Post-treatment Period||0
44603|NCT01765764|103814|P2|NOT COMPLETED|Post-treatment Period||0
44604|NCT01765764|103815|P1|NOT COMPLETED|Post-treatment Period||0
44605|NCT01765764|103813|P3|COMPLETED|Post-treatment Period||112
44606|NCT01765764|103814|P2|COMPLETED|Post-treatment Period||107
44607|NCT01765764|103815|P1|COMPLETED|Post-treatment Period||114
44608|NCT01765764|103813|P3|STARTED|Post-treatment Period|3 participants did not enter the Post-treatment Period [1 Personal Reasons,2 LFU].|112
44609|NCT01765764|103814|P2|STARTED|Post-treatment Period|2 participants did not enter the Post-treatment Period [2 Lost-to-Follow-up (LFU)]|107
44610|NCT01765764|103815|P1|STARTED|Post-treatment Period|1 participant did not enter the Post-treatment Period. [Personal Reasons]|114
44611|NCT01765764|103813|P3|NOT COMPLETED|Treatment Period||6
44612|NCT01765764|103814|P2|NOT COMPLETED|Treatment Period||9
44613|NCT01765764|103815|P1|NOT COMPLETED|Treatment Period||3
44614|NCT01765764|103813|P3|COMPLETED|Treatment Period||115
44615|NCT01765764|103814|P2|COMPLETED|Treatment Period||109
44616|NCT01765764|103815|P1|COMPLETED|Treatment Period||115
44617|NCT01765764|103813|P3|STARTED|Treatment Period||121
44618|NCT01765764|103814|P2|STARTED|Treatment Period||118
44619|NCT01765764|103815|P1|STARTED|Treatment Period||118
44620|NCT01765569|103832|P1|NOT COMPLETED|Period C||1
44621|NCT01765569|103832|P1|COMPLETED|Period C||27
44622|NCT01765569|103832|P1|STARTED|Period C||28
44623|NCT01765569|103832|P1|NOT COMPLETED|Period B||1
44624|NCT01765569|103832|P1|COMPLETED|Period B||28
44625|NCT01765569|103832|P1|STARTED|Period B||29
44626|NCT01765569|103832|P1|NOT COMPLETED|Period A||0
44627|NCT01765569|103832|P1|COMPLETED|Period A||29
44628|NCT01765569|103832|P1|STARTED|Period A||29
44629|NCT01765543|103853|P1|NOT COMPLETED|Overall Study||3
44630|NCT01765543|103853|P1|COMPLETED|Overall Study||24
44631|NCT01765543|103853|P1|STARTED|Overall Study||27
44632|NCT01765530|103877|P2|NOT COMPLETED|Overall Study||1
44633|NCT01765530|103878|P1|NOT COMPLETED|Overall Study||1
44634|NCT01765530|103877|P2|COMPLETED|Overall Study||36
44635|NCT01765530|103878|P1|COMPLETED|Overall Study||36
44636|NCT01765530|103877|P2|STARTED|Overall Study||37
44637|NCT01765530|103878|P1|STARTED|Overall Study||37
44638|NCT01765465|103888|P2|NOT COMPLETED|Overall Study||4
44639|NCT01765465|103889|P1|NOT COMPLETED|Overall Study||7
44640|NCT01765465|103888|P2|COMPLETED|Overall Study||63
44641|NCT01765465|103889|P1|COMPLETED|Overall Study||64
44642|NCT01765465|103888|P2|STARTED|Overall Study||67
44643|NCT01765465|103889|P1|STARTED|Overall Study||71
44644|NCT01765426|103905|P4|NOT COMPLETED|Overall Study||0
44645|NCT01765426|103906|P3|NOT COMPLETED|Overall Study||0
44646|NCT01765426|103907|P2|NOT COMPLETED|Overall Study||1
44647|NCT01765426|103908|P1|NOT COMPLETED|Overall Study||0
44648|NCT01765426|103905|P4|COMPLETED|Overall Study||15
44649|NCT01765426|103906|P3|COMPLETED|Overall Study||17
44650|NCT01765426|103907|P2|COMPLETED|Overall Study||16
44651|NCT01765426|103908|P1|COMPLETED|Overall Study||18
44652|NCT01765426|103905|P4|Completed All Vaccinations|Overall Study||15
44653|NCT01765426|103906|P3|Completed All Vaccinations|Overall Study||17
44654|NCT01765426|103907|P2|Completed All Vaccinations|Overall Study||16
44655|NCT01765426|103908|P1|Completed All Vaccinations|Overall Study||17
44656|NCT01765426|103905|P4|STARTED|Overall Study||15
44657|NCT01765426|103906|P3|STARTED|Overall Study||17
44658|NCT01765426|103907|P2|STARTED|Overall Study||17
44659|NCT01765426|103908|P1|STARTED|Overall Study||18
44660|NCT01765270|103964|P2|NOT COMPLETED|Overall Study||1
44661|NCT01765270|103965|P1|NOT COMPLETED|Overall Study||1
44662|NCT01765270|103964|P2|COMPLETED|Overall Study||6
44663|NCT01765270|103965|P1|COMPLETED|Overall Study||4
44664|NCT01765270|103964|P2|STARTED|Overall Study||7
44665|NCT01765270|103965|P1|STARTED|Overall Study||5
44666|NCT01765192|103987|P2|NOT COMPLETED|End of Treatment Period 2 to Final Visit||1
44667|NCT01765192|103988|P1|NOT COMPLETED|End of Treatment Period 2 to Final Visit||0
44668|NCT01765192|103987|P2|COMPLETED|End of Treatment Period 2 to Final Visit||27
44669|NCT01765192|103988|P1|COMPLETED|End of Treatment Period 2 to Final Visit||30
44670|NCT01765192|103987|P2|STARTED|End of Treatment Period 2 to Final Visit||28
44671|NCT01765192|103988|P1|STARTED|End of Treatment Period 2 to Final Visit||30
44672|NCT01765192|103987|P2|NOT COMPLETED|Treatment Period 2||2
44673|NCT01765192|103988|P1|NOT COMPLETED|Treatment Period 2||0
44675|NCT01765192|103988|P1|COMPLETED|Treatment Period 2||30
44676|NCT01765192|103987|P2|STARTED|Treatment Period 2||30
44677|NCT01765192|103988|P1|STARTED|Treatment Period 2||30
44678|NCT01765192|103987|P2|NOT COMPLETED|Washout Period||1
44679|NCT01765192|103988|P1|NOT COMPLETED|Washout Period||2
44680|NCT01765192|103987|P2|COMPLETED|Washout Period||30
44681|NCT01765192|103988|P1|COMPLETED|Washout Period||30
44682|NCT01765192|103987|P2|STARTED|Washout Period||31
44683|NCT01765192|103988|P1|STARTED|Washout Period||32
44684|NCT01765192|103987|P2|NOT COMPLETED|Treatment Period 1||1
44685|NCT01765192|103988|P1|NOT COMPLETED|Treatment Period 1||0
44686|NCT01765192|103987|P2|COMPLETED|Treatment Period 1||31
44687|NCT01765192|103988|P1|COMPLETED|Treatment Period 1||32
44688|NCT01765192|103987|P2|STARTED|Treatment Period 1||32
44689|NCT01765192|103988|P1|STARTED|Treatment Period 1||32
44690|NCT01765153|104008|P2|NOT COMPLETED|Rest Phase 2||1
44691|NCT01765153|104009|P1|NOT COMPLETED|Rest Phase 2||2
44692|NCT01765153|104008|P2|COMPLETED|Rest Phase 2||7
44693|NCT01765153|104009|P1|COMPLETED|Rest Phase 2||8
44694|NCT01765153|104008|P2|STARTED|Rest Phase 2||8
44695|NCT01765153|104009|P1|STARTED|Rest Phase 2||10
44696|NCT01765153|104008|P2|NOT COMPLETED|Training Phase 2||1
44697|NCT01765153|104009|P1|NOT COMPLETED|Training Phase 2||0
44698|NCT01765153|104008|P2|COMPLETED|Training Phase 2||8
44699|NCT01765153|104009|P1|COMPLETED|Training Phase 2||10
44700|NCT01765153|104008|P2|STARTED|Training Phase 2||9
44701|NCT01765153|104009|P1|STARTED|Training Phase 2|1st subject didn't use same training(phase 1) as subsequent participants Phase 1 and 2 data removed.|10
44702|NCT01765153|104008|P2|NOT COMPLETED|Rest Phase 1||1
44703|NCT01765153|104009|P1|NOT COMPLETED|Rest Phase 1||0
44704|NCT01765153|104008|P2|COMPLETED|Rest Phase 1||9
44705|NCT01765153|104009|P1|COMPLETED|Rest Phase 1||9
44706|NCT01765153|104008|P2|STARTED|Rest Phase 1||10
44707|NCT01765153|104009|P1|STARTED|Rest Phase 1||9
44708|NCT01765153|104008|P2|NOT COMPLETED|Training Phase 1||1
44709|NCT01765153|104009|P1|NOT COMPLETED|Training Phase 1||1
44710|NCT01765153|104008|P2|COMPLETED|Training Phase 1||10
44711|NCT01765153|104009|P1|COMPLETED|Training Phase 1||9
44712|NCT01765153|104008|P2|STARTED|Training Phase 1||11
44713|NCT01765153|104009|P1|STARTED|Training Phase 1||10
44714|NCT01764997|104116|P5|NOT COMPLETED|Study Drug Treatment Period||36
44715|NCT01764997|104117|P4|NOT COMPLETED|Study Drug Treatment Period||0
44716|NCT01764997|104118|P3|NOT COMPLETED|Study Drug Treatment Period||0
44717|NCT01764997|104119|P2|NOT COMPLETED|Study Drug Treatment Period||1
44718|NCT01764997|104120|P1|NOT COMPLETED|Study Drug Treatment Period||0
44719|NCT01764997|104116|P5|COMPLETED|Study Drug Treatment Period||286
44720|NCT01764997|104117|P4|COMPLETED|Study Drug Treatment Period||13
44721|NCT01764997|104118|P3|COMPLETED|Study Drug Treatment Period||13
44722|NCT01764997|104119|P2|COMPLETED|Study Drug Treatment Period||16
44723|NCT01764997|104120|P1|COMPLETED|Study Drug Treatment Period||0
44724|NCT01764997|104116|P5|STARTED|Study Drug Treatment Period||322
44725|NCT01764997|104117|P4|STARTED|Study Drug Treatment Period||13
44726|NCT01764997|104118|P3|STARTED|Study Drug Treatment Period||13
44727|NCT01764997|104119|P2|STARTED|Study Drug Treatment Period||17
44728|NCT01764997|104120|P1|STARTED|Study Drug Treatment Period||0
44729|NCT01764997|104116|P5|NOT COMPLETED|Run-in Period||0
44730|NCT01764997|104117|P4|NOT COMPLETED|Run-in Period||0
44731|NCT01764997|104118|P3|NOT COMPLETED|Run-in Period||0
44732|NCT01764997|104119|P2|NOT COMPLETED|Run-in Period||0
44733|NCT01764997|104120|P1|NOT COMPLETED|Run-in Period||38
44734|NCT01764997|104116|P5|COMPLETED|Run-in Period||0
44735|NCT01764997|104117|P4|COMPLETED|Run-in Period||0
44736|NCT01764997|104118|P3|COMPLETED|Run-in Period||0
44737|NCT01764997|104119|P2|COMPLETED|Run-in Period||0
44738|NCT01764997|104120|P1|COMPLETED|Run-in Period|43 participants proceeded to randomized treatment and 322 proceeded to open-label sub-study.|738
44739|NCT01764997|104116|P5|STARTED|Run-in Period||0
44740|NCT01764997|104117|P4|STARTED|Run-in Period||0
44741|NCT01764997|104118|P3|STARTED|Run-in Period||0
44742|NCT01764997|104119|P2|STARTED|Run-in Period||0
44743|NCT01764997|104120|P1|STARTED|Run-in Period||776
44744|NCT01764945|104147|P8|NOT COMPLETED|Overall Study||0
44745|NCT01764945|104148|P7|NOT COMPLETED|Overall Study||1
44746|NCT01764945|104149|P6|NOT COMPLETED|Overall Study||0
44747|NCT01764945|104150|P5|NOT COMPLETED|Overall Study||0
44748|NCT01764945|104151|P4|NOT COMPLETED|Overall Study||0
44749|NCT01764945|104152|P3|NOT COMPLETED|Overall Study||0
44750|NCT01764945|104153|P2|NOT COMPLETED|Overall Study||1
44751|NCT01764945|104154|P1|NOT COMPLETED|Overall Study||0
44752|NCT01764945|104147|P8|COMPLETED|Overall Study||9
44753|NCT01764945|104148|P7|COMPLETED|Overall Study||8
44754|NCT01764945|104149|P6|COMPLETED|Overall Study||8
44755|NCT01764945|104150|P5|COMPLETED|Overall Study||10
44756|NCT01764945|104151|P4|COMPLETED|Overall Study||5
44757|NCT01764945|104152|P3|COMPLETED|Overall Study||5
44758|NCT01764945|104153|P2|COMPLETED|Overall Study||4
44759|NCT01764945|104154|P1|COMPLETED|Overall Study||5
44760|NCT01764945|104147|P8|STARTED|Overall Study||9
44761|NCT01764945|104148|P7|STARTED|Overall Study||9
44762|NCT01764945|104149|P6|STARTED|Overall Study||8
44763|NCT01764945|104150|P5|STARTED|Overall Study||10
44764|NCT01764945|104151|P4|STARTED|Overall Study||5
44765|NCT01764945|104152|P3|STARTED|Overall Study||5
44766|NCT01764945|104153|P2|STARTED|Overall Study||5
44767|NCT01764945|104154|P1|STARTED|Overall Study||5
44768|NCT01764919|104188|P1|NOT COMPLETED|Overall Study||0
44769|NCT01764919|104188|P1|COMPLETED|Overall Study||4
44770|NCT01764919|104188|P1|STARTED|Overall Study||4
44771|NCT01764607|104196|P1|NOT COMPLETED|Overall Study||0
44772|NCT01764607|104196|P1|COMPLETED|Overall Study||1
44773|NCT01764607|104196|P1|STARTED|Overall Study||1
44774|NCT01764386|104203|P2|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||53
44775|NCT01764386|104204|P1|NOT COMPLETED|Uncontrolled Treatment Period (UTP)||16
44776|NCT01764386|104203|P2|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|28
44777|NCT01764386|104204|P1|COMPLETED|Uncontrolled Treatment Period (UTP)|Completed the 78-week study.|55
44778|NCT01764386|104203|P2|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||35
44779|NCT01764386|104204|P1|Completed 52 Weeks|Uncontrolled Treatment Period (UTP)||61
44780|NCT01764386|104203|P2|STARTED|Uncontrolled Treatment Period (UTP)|One subject completed the 26-week CTP, but did not continue in the UTP.|81
44781|NCT01764386|104204|P1|STARTED|Uncontrolled Treatment Period (UTP)||71
44782|NCT01764386|104203|P2|NOT COMPLETED|Controlled Treatment Period (CTP)||7
44783|NCT01764386|104204|P1|NOT COMPLETED|Controlled Treatment Period (CTP)||82
44784|NCT01764386|104203|P2|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|82
44785|NCT01764386|104204|P1|COMPLETED|Controlled Treatment Period (CTP)|Completed the 26-week Controlled Treatment Period.|71
44786|NCT01764386|104203|P2|STARTED|Controlled Treatment Period (CTP)||89
44787|NCT01764386|104204|P1|STARTED|Controlled Treatment Period (CTP)||153
44788|NCT01764022|104247|P2|NOT COMPLETED|Overall Study||12
44789|NCT01764022|104248|P1|NOT COMPLETED|Overall Study||21
44790|NCT01764022|104247|P2|COMPLETED|Overall Study||49
44791|NCT01764022|104248|P1|COMPLETED|Overall Study||44
44792|NCT01764022|104247|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
44793|NCT01764022|104248|P1|Received at Least 1 Dose of Study Drug|Overall Study||63
44794|NCT01764022|104247|P2|STARTED|Overall Study||61
44795|NCT01764022|104248|P1|STARTED|Overall Study||65
44796|NCT01763996|104276|P2|NOT COMPLETED|Treatment Period 2||1
44797|NCT01763996|104277|P1|NOT COMPLETED|Treatment Period 2||0
44798|NCT01763996|104276|P2|COMPLETED|Treatment Period 2||14
44799|NCT01763996|104277|P1|COMPLETED|Treatment Period 2||15
44800|NCT01763996|104276|P2|STARTED|Treatment Period 2||15
44801|NCT01763996|104277|P1|STARTED|Treatment Period 2||15
44802|NCT01763996|104276|P2|NOT COMPLETED|Treatment Period 1||0
44803|NCT01763996|104277|P1|NOT COMPLETED|Treatment Period 1||0
44804|NCT01763996|104276|P2|COMPLETED|Treatment Period 1||15
44805|NCT01763996|104277|P1|COMPLETED|Treatment Period 1||15
44806|NCT01763996|104276|P2|STARTED|Treatment Period 1||15
44807|NCT01763996|104277|P1|STARTED|Treatment Period 1||15
44808|NCT01763918|104307|P4|NOT COMPLETED|Overall Study||2
44809|NCT01763918|104308|P3|NOT COMPLETED|Overall Study||10
44810|NCT01763918|104309|P2|NOT COMPLETED|Overall Study||1
44811|NCT01763918|104310|P1|NOT COMPLETED|Overall Study||6
44812|NCT01763918|104307|P4|COMPLETED|Overall Study||108
44813|NCT01763918|104308|P3|COMPLETED|Overall Study||101
44814|NCT01763918|104309|P2|COMPLETED|Overall Study||54
44815|NCT01763918|104310|P1|COMPLETED|Overall Study||49
44816|NCT01763918|104307|P4|Received Treatment|Overall Study||110
44817|NCT01763918|104308|P3|Received Treatment|Overall Study||110
44818|NCT01763918|104309|P2|Received Treatment|Overall Study||55
44819|NCT01763918|104310|P1|Received Treatment|Overall Study||54
44820|NCT01763918|104307|P4|STARTED|Overall Study||110
44821|NCT01763918|104308|P3|STARTED|Overall Study||111
44822|NCT01763918|104309|P2|STARTED|Overall Study||55
44823|NCT01763918|104310|P1|STARTED|Overall Study||55
44824|NCT01763905|104408|P4|NOT COMPLETED|Overall Study||1
44825|NCT01763905|104409|P3|NOT COMPLETED|Overall Study||9
44826|NCT01763905|104410|P2|NOT COMPLETED|Overall Study||1
44827|NCT01763905|104411|P1|NOT COMPLETED|Overall Study||6
44828|NCT01763905|104408|P4|COMPLETED|Overall Study||101
44829|NCT01763905|104409|P3|COMPLETED|Overall Study||94
44830|NCT01763905|104410|P2|COMPLETED|Overall Study||50
44831|NCT01763905|104411|P1|COMPLETED|Overall Study||45
44832|NCT01763905|104408|P4|STARTED|Overall Study||102
44833|NCT01763905|104409|P3|STARTED|Overall Study||103
44834|NCT01763905|104410|P2|STARTED|Overall Study||51
44835|NCT01763905|104411|P1|STARTED|Overall Study||51
44836|NCT01763866|104529|P24|NOT COMPLETED|Overall Study||2
44837|NCT01763866|104530|P23|NOT COMPLETED|Overall Study||3
44838|NCT01763866|104531|P22|NOT COMPLETED|Overall Study||1
44839|NCT01763866|104532|P21|NOT COMPLETED|Overall Study||4
44840|NCT01763866|104533|P20|NOT COMPLETED|Overall Study||2
44841|NCT01763866|104534|P19|NOT COMPLETED|Overall Study||6
44842|NCT01763866|104535|P18|NOT COMPLETED|Overall Study||1
44843|NCT01763866|104536|P17|NOT COMPLETED|Overall Study||1
44844|NCT01763866|104537|P16|NOT COMPLETED|Overall Study||3
44845|NCT01763866|104538|P15|NOT COMPLETED|Overall Study||12
44846|NCT01763866|104539|P14|NOT COMPLETED|Overall Study||0
44847|NCT01763866|104540|P13|NOT COMPLETED|Overall Study||4
44848|NCT01763866|104541|P12|NOT COMPLETED|Overall Study||2
44849|NCT01763866|104542|P11|NOT COMPLETED|Overall Study||8
44850|NCT01763866|104543|P10|NOT COMPLETED|Overall Study||1
44851|NCT01763866|104544|P9|NOT COMPLETED|Overall Study||3
44852|NCT01763866|104545|P8|NOT COMPLETED|Overall Study||0
44853|NCT01763866|104546|P7|NOT COMPLETED|Overall Study||7
44854|NCT01763866|104547|P6|NOT COMPLETED|Overall Study||3
44855|NCT01763866|104548|P5|NOT COMPLETED|Overall Study||2
44856|NCT01763866|104549|P4|NOT COMPLETED|Overall Study||0
44857|NCT01763866|104550|P3|NOT COMPLETED|Overall Study||5
44858|NCT01763866|104551|P2|NOT COMPLETED|Overall Study||1
44859|NCT01763866|104552|P1|NOT COMPLETED|Overall Study||2
44860|NCT01763866|104529|P24|COMPLETED|Overall Study||113
44861|NCT01763866|104530|P23|COMPLETED|Overall Study||109
44862|NCT01763866|104531|P22|COMPLETED|Overall Study||54
44863|NCT01763866|104532|P21|COMPLETED|Overall Study||52
44864|NCT01763866|104533|P20|COMPLETED|Overall Study||110
44865|NCT01763866|104534|P19|COMPLETED|Overall Study||105
44866|NCT01763866|104535|P18|COMPLETED|Overall Study||55
44867|NCT01763866|104536|P17|COMPLETED|Overall Study||55
44868|NCT01763866|104537|P16|COMPLETED|Overall Study||112
44869|NCT01763866|104538|P15|COMPLETED|Overall Study||102
44870|NCT01763866|104539|P14|COMPLETED|Overall Study||57
44871|NCT01763866|104540|P13|COMPLETED|Overall Study||54
44872|NCT01763866|104541|P12|COMPLETED|Overall Study||108
44873|NCT01763866|104542|P11|COMPLETED|Overall Study||102
44874|NCT01763866|104543|P10|COMPLETED|Overall Study||53
44875|NCT01763866|104544|P9|COMPLETED|Overall Study||53
44876|NCT01763866|104545|P8|COMPLETED|Overall Study||55
44877|NCT01763866|104546|P7|COMPLETED|Overall Study||48
44878|NCT01763866|104547|P6|COMPLETED|Overall Study||107
44879|NCT01763866|104548|P5|COMPLETED|Overall Study||108
44880|NCT01763866|104549|P4|COMPLETED|Overall Study||55
44881|NCT01763866|104550|P3|COMPLETED|Overall Study||51
44882|NCT01763866|104551|P2|COMPLETED|Overall Study||54
44883|NCT01763866|104552|P1|COMPLETED|Overall Study||54
44884|NCT01763866|104529|P24|Received Treatment|Overall Study||115
44885|NCT01763866|104530|P23|Received Treatment|Overall Study||112
44886|NCT01763866|104531|P22|Received Treatment|Overall Study||55
44887|NCT01763866|104532|P21|Received Treatment|Overall Study||56
44888|NCT01763866|104533|P20|Received Treatment|Overall Study||112
44889|NCT01763866|104534|P19|Received Treatment|Overall Study||111
44890|NCT01763866|104535|P18|Received Treatment|Overall Study||55
44891|NCT01763866|104536|P17|Received Treatment|Overall Study||56
44892|NCT01763866|104537|P16|Received Treatment|Overall Study||115
44893|NCT01763866|104538|P15|Received Treatment|Overall Study||113
44894|NCT01763866|104539|P14|Received Treatment|Overall Study||57
44895|NCT01763866|104540|P13|Received Treatment|Overall Study||58
44896|NCT01763866|104541|P12|Received Treatment|Overall Study||110
44897|NCT01763866|104542|P11|Received Treatment|Overall Study||109
44898|NCT01763866|104543|P10|Received Treatment|Overall Study||54
44899|NCT01763866|104544|P9|Received Treatment|Overall Study||56
44900|NCT01763866|104545|P8|Received Treatment|Overall Study||55
44901|NCT01763866|104546|P7|Received Treatment|Overall Study||55
44902|NCT01763866|104547|P6|Received Treatment|Overall Study||110
44903|NCT01763866|104548|P5|Received Treatment|Overall Study||110
44904|NCT01763866|104549|P4|Received Treatment|Overall Study||55
44905|NCT01763866|104550|P3|Received Treatment|Overall Study||56
44906|NCT01763866|104551|P2|Received Treatment|Overall Study||55
44907|NCT01763866|104552|P1|Received Treatment|Overall Study||56
44908|NCT01763866|104529|P24|STARTED|Overall Study||115
44909|NCT01763866|104530|P23|STARTED|Overall Study||112
44910|NCT01763866|104531|P22|STARTED|Overall Study||55
44911|NCT01763866|104532|P21|STARTED|Overall Study||56
44912|NCT01763866|104533|P20|STARTED|Overall Study||112
44913|NCT01763866|104534|P19|STARTED|Overall Study||111
44914|NCT01763866|104535|P18|STARTED|Overall Study||56
44915|NCT01763866|104536|P17|STARTED|Overall Study||56
44916|NCT01763866|104537|P16|STARTED|Overall Study||115
44917|NCT01763866|104538|P15|STARTED|Overall Study||114
44918|NCT01763866|104539|P14|STARTED|Overall Study||57
44919|NCT01763866|104540|P13|STARTED|Overall Study||58
44920|NCT01763866|104541|P12|STARTED|Overall Study||110
44921|NCT01763866|104542|P11|STARTED|Overall Study||110
44922|NCT01763866|104543|P10|STARTED|Overall Study||54
44923|NCT01763866|104544|P9|STARTED|Overall Study||56
44924|NCT01763866|104545|P8|STARTED|Overall Study||55
44925|NCT01763866|104546|P7|STARTED|Overall Study||55
44926|NCT01763866|104547|P6|STARTED|Overall Study||110
44927|NCT01763866|104548|P5|STARTED|Overall Study||110
44928|NCT01763866|104549|P4|STARTED|Overall Study||55
44929|NCT01763866|104550|P3|STARTED|Overall Study||56
44930|NCT01763866|104551|P2|STARTED|Overall Study||55
44931|NCT01763866|104552|P1|STARTED|Overall Study||56
44932|NCT01763827|105112|P6|NOT COMPLETED|Overall Study||2
44933|NCT01763827|105113|P5|NOT COMPLETED|Overall Study||6
44934|NCT01763827|105114|P4|NOT COMPLETED|Overall Study||1
44935|NCT01763827|105115|P3|NOT COMPLETED|Overall Study||4
44936|NCT01763827|105116|P2|NOT COMPLETED|Overall Study||1
44937|NCT01763827|105117|P1|NOT COMPLETED|Overall Study||3
44938|NCT01763827|105112|P6|COMPLETED|Overall Study||151
44939|NCT01763827|105113|P5|COMPLETED|Overall Study||147
44940|NCT01763827|105114|P4|COMPLETED|Overall Study||76
44941|NCT01763827|105115|P3|COMPLETED|Overall Study||73
44942|NCT01763827|105116|P2|COMPLETED|Overall Study||77
44943|NCT01763827|105117|P1|COMPLETED|Overall Study||74
44944|NCT01763827|105112|P6|Received at Least 1 Dose of Study Drug|Overall Study||153
44945|NCT01763827|105113|P5|Received at Least 1 Dose of Study Drug|Overall Study||153
45038|NCT01761279|105546|P1|STARTED|Overall Study||84
44946|NCT01763827|105114|P4|Received at Least 1 Dose of Study Drug|Overall Study||77
44947|NCT01763827|105115|P3|Received at Least 1 Dose of Study Drug|Overall Study||77
44948|NCT01763827|105116|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
44949|NCT01763827|105117|P1|Received at Least 1 Dose of Study Drug|Overall Study||76
44950|NCT01763827|105112|P6|STARTED|Overall Study||153
44951|NCT01763827|105113|P5|STARTED|Overall Study||153
44952|NCT01763827|105114|P4|STARTED|Overall Study||77
44953|NCT01763827|105115|P3|STARTED|Overall Study||77
44954|NCT01763827|105116|P2|STARTED|Overall Study||78
44955|NCT01763827|105117|P1|STARTED|Overall Study||77
44956|NCT01763645|105259|P2|NOT COMPLETED|Overall Study||24
44957|NCT01763645|105260|P1|NOT COMPLETED|Overall Study||26
44958|NCT01763645|105259|P2|COMPLETED|Overall Study|Completed the study according the protocol.|45
44959|NCT01763645|105260|P1|COMPLETED|Overall Study|Completed the study according the protocol.|43
44960|NCT01763645|105259|P2|Received at Least 1 Dose of Study Drug|Overall Study||66
44961|NCT01763645|105260|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
44962|NCT01763645|105259|P2|STARTED|Overall Study||69
44963|NCT01763645|105260|P1|STARTED|Overall Study||69
44964|NCT01763567|105278|P1|NOT COMPLETED|Overall Study||0
44965|NCT01763567|105278|P1|COMPLETED|Overall Study||19
44966|NCT01763567|105278|P1|STARTED|Overall Study||19
44967|NCT01763047|105288|P2|NOT COMPLETED|Period 2||5
44968|NCT01763047|105289|P1|NOT COMPLETED|Period 2||4
44969|NCT01763047|105288|P2|COMPLETED|Period 2||121
44970|NCT01763047|105289|P1|COMPLETED|Period 2||126
44971|NCT01763047|105288|P2|Hyperopes|Period 2||54
44972|NCT01763047|105289|P1|Hyperopes|Period 2||56
44973|NCT01763047|105288|P2|Myopes|Period 2||72
44974|NCT01763047|105289|P1|Myopes|Period 2||74
44975|NCT01763047|105288|P2|STARTED|Period 2||126
44976|NCT01763047|105289|P1|STARTED|Period 2||130
44977|NCT01763047|105288|P2|NOT COMPLETED|Period 1||11
44978|NCT01763047|105289|P1|NOT COMPLETED|Period 1||9
44979|NCT01763047|105288|P2|COMPLETED|Period 1||126
44980|NCT01763047|105289|P1|COMPLETED|Period 1||130
44981|NCT01763047|105288|P2|Hyperopes|Period 1||61
44982|NCT01763047|105289|P1|Hyperopes|Period 1||62
44983|NCT01763047|105288|P2|Myopes|Period 1||76
44984|NCT01763047|105289|P1|Myopes|Period 1||77
44985|NCT01763047|105288|P2|STARTED|Period 1||137
44986|NCT01763047|105289|P1|STARTED|Period 1||139
44987|NCT01762982|105305|P1|NOT COMPLETED|Overall Study||0
44988|NCT01762982|105305|P1|COMPLETED|Overall Study||36
44989|NCT01762982|105305|P1|Received Empty Finn Chamber|Overall Study||36
44990|NCT01762982|105305|P1|Received SLS|Overall Study||36
44991|NCT01762982|105305|P1|Received Benzalkonium Chloride|Overall Study||36
44992|NCT01762982|105305|P1|Received Saline Water|Overall Study||36
44993|NCT01762982|105305|P1|STARTED|Overall Study||36
44994|NCT01762904|105326|P1|NOT COMPLETED|Overall Study||0
44995|NCT01762904|105326|P1|COMPLETED|Overall Study|October, 2013|135
44996|NCT01762904|105326|P1|STARTED|Overall Study|January, 2013|135
44997|NCT01762800|105335|P2|NOT COMPLETED|Overall Study||21
44998|NCT01762800|105336|P1|NOT COMPLETED|Overall Study||19
44999|NCT01762800|105335|P2|COMPLETED|Overall Study||183
45000|NCT01762800|105336|P1|COMPLETED|Overall Study||183
45001|NCT01762800|105335|P2|STARTED|Overall Study||204
45002|NCT01762800|105336|P1|STARTED|Overall Study||202
45003|NCT01762761|105410|P2|NOT COMPLETED|Overall Study||4
45004|NCT01762761|105411|P1|NOT COMPLETED|Overall Study||2
45005|NCT01762761|105410|P2|COMPLETED|Overall Study||100
45006|NCT01762761|105411|P1|COMPLETED|Overall Study||49
45007|NCT01762761|105410|P2|STARTED|Overall Study||104
45008|NCT01762761|105411|P1|STARTED|Overall Study||51
45009|NCT01762722|105465|P2|NOT COMPLETED|Overall Study||0
45010|NCT01762722|105466|P1|NOT COMPLETED|Overall Study||0
45011|NCT01762722|105465|P2|COMPLETED|Overall Study||11
45012|NCT01762722|105466|P1|COMPLETED|Overall Study||12
45013|NCT01762722|105465|P2|STARTED|Overall Study||11
45014|NCT01762722|105466|P1|STARTED|Overall Study||12
45015|NCT01762501|105474|P2|NOT COMPLETED|Overall Study||23
45016|NCT01762501|105475|P1|NOT COMPLETED|Overall Study||27
45017|NCT01762501|105474|P2|COMPLETED|Overall Study||336
45018|NCT01762501|105475|P1|COMPLETED|Overall Study||332
45019|NCT01762501|105474|P2|STARTED|Overall Study||359
45020|NCT01762501|105475|P1|STARTED|Overall Study||359
45021|NCT01762345|105489|P1|NOT COMPLETED|Overall Study||7
45022|NCT01762345|105489|P1|COMPLETED|Overall Study||76
45023|NCT01762345|105489|P1|STARTED|Overall Study||83
45024|NCT01762059|105499|P1|NOT COMPLETED|Overall Study||0
45025|NCT01762059|105499|P1|COMPLETED|Overall Study||20
45026|NCT01762059|105499|P1|STARTED|Overall Study||20
45027|NCT01761747|105526|P1|NOT COMPLETED|Overall Study||1
45028|NCT01761747|105526|P1|COMPLETED|Overall Study||2
45029|NCT01761747|105526|P1|STARTED|Overall Study||3
45030|NCT01761565|105537|P1|NOT COMPLETED|40 Consecutive Doses of SUF 15 mcg||1
45031|NCT01761565|105537|P1|COMPLETED|40 Consecutive Doses of SUF 15 mcg||38
45032|NCT01761565|105537|P1|STARTED|40 Consecutive Doses of SUF 15 mcg|Subject was withdrawn from the study prior to the second arm/period due to non-compliance|39
45033|NCT01761565|105537|P1|NOT COMPLETED|Single Dose of SUF NT 15 mcg||0
45034|NCT01761565|105537|P1|COMPLETED|Single Dose of SUF NT 15 mcg||40
45035|NCT01761565|105537|P1|STARTED|Single Dose of SUF NT 15 mcg||40
45036|NCT01761279|105546|P1|NOT COMPLETED|Overall Study||0
45037|NCT01761279|105546|P1|COMPLETED|Overall Study||84
45039|NCT01761175|105561|P2|NOT COMPLETED|Overall Study||0
45040|NCT01761175|105562|P1|NOT COMPLETED|Overall Study||0
45041|NCT01761175|105561|P2|COMPLETED|Overall Study||112
45042|NCT01761175|105562|P1|COMPLETED|Overall Study||112
45043|NCT01761175|105561|P2|STARTED|Overall Study||112
45044|NCT01761175|105562|P1|STARTED|Overall Study||112
45045|NCT01761162|105590|P1|NOT COMPLETED|Overall Study||3
45046|NCT01761162|105590|P1|COMPLETED|Overall Study||226
45047|NCT01761162|105590|P1|STARTED|Overall Study||229
45048|NCT01761019|105598|P1|NOT COMPLETED|Overall Study||0
45049|NCT01761019|105598|P1|COMPLETED|Overall Study||8
45050|NCT01761019|105598|P1|STARTED|Overall Study||8
45051|NCT01760993|105606|P1|NOT COMPLETED|Overall Study||0
45052|NCT01760993|105606|P1|COMPLETED|Overall Study||0
45053|NCT01760993|105606|P1|STARTED|Overall Study||0
45054|NCT01760941|105623|P1|NOT COMPLETED|Overall Study||0
45055|NCT01760941|105623|P1|COMPLETED|Overall Study||1
45056|NCT01760941|105623|P1|STARTED|Overall Study||1
45057|NCT01760889|105633|P3|NOT COMPLETED|Overall Study||0
45058|NCT01760889|105634|P2|NOT COMPLETED|Overall Study||0
45059|NCT01760889|105635|P1|NOT COMPLETED|Overall Study||0
45060|NCT01760889|105633|P3|COMPLETED|Overall Study||0
45061|NCT01760889|105634|P2|COMPLETED|Overall Study||0
45062|NCT01760889|105635|P1|COMPLETED|Overall Study||0
45063|NCT01760889|105633|P3|STARTED|Overall Study||0
45064|NCT01760889|105634|P2|STARTED|Overall Study||0
45065|NCT01760889|105635|P1|STARTED|Overall Study||0
45066|NCT01760876|105682|P1|NOT COMPLETED|Overall Study||6
45067|NCT01760876|105682|P1|COMPLETED|Overall Study|12 months clinical FU of last patient in July 2015.|100
45068|NCT01760876|105682|P1|STARTED|Overall Study||106
45069|NCT01760785|105688|P2|NOT COMPLETED|Overall Study||0
45070|NCT01760785|105689|P1|NOT COMPLETED|Overall Study||0
45071|NCT01760785|105688|P2|COMPLETED|Overall Study||27
45072|NCT01760785|105689|P1|COMPLETED|Overall Study||23
45073|NCT01760785|105688|P2|STARTED|Overall Study||27
45074|NCT01760785|105689|P1|STARTED|Overall Study||23
45075|NCT01760304|105697|P2|NOT COMPLETED|Overall Study||0
45076|NCT01760304|105698|P1|NOT COMPLETED|Overall Study||0
45077|NCT01760304|105697|P2|COMPLETED|Overall Study||3
45078|NCT01760304|105698|P1|COMPLETED|Overall Study||2
45079|NCT01760304|105697|P2|STARTED|Overall Study||3
45080|NCT01760304|105698|P1|STARTED|Overall Study||2
45081|NCT01759602|105708|P1|NOT COMPLETED|Overall Study||0
45082|NCT01759602|105708|P1|COMPLETED|Overall Study||10
45083|NCT01759602|105708|P1|STARTED|Overall Study||10
45084|NCT01759511|105716|P1|NOT COMPLETED|Overall Study||34
45085|NCT01759511|105716|P1|COMPLETED|Overall Study||0
45086|NCT01759511|105716|P1|STARTED|Overall Study||34
45087|NCT01759420|105724|P1|NOT COMPLETED|Overall Study||6
45088|NCT01759420|105724|P1|COMPLETED|Overall Study||22
45089|NCT01759420|105724|P1|STARTED|Overall Study||28
45090|NCT01759381|105731|P2|NOT COMPLETED|Overall Study||0
45091|NCT01759381|105732|P1|NOT COMPLETED|Overall Study||1
45092|NCT01759381|105731|P2|COMPLETED|Overall Study||11
45093|NCT01759381|105732|P1|COMPLETED|Overall Study||7
45094|NCT01759381|105731|P2|STARTED|Overall Study||11
45095|NCT01759381|105732|P1|STARTED|Overall Study||8
45096|NCT01759368|105740|P2|NOT COMPLETED|Overall Study||0
45097|NCT01759368|105741|P1|NOT COMPLETED|Overall Study||1
45098|NCT01759368|105740|P2|COMPLETED|Overall Study||47
45099|NCT01759368|105741|P1|COMPLETED|Overall Study||46
45100|NCT01759368|105740|P2|STARTED|Overall Study||47
45101|NCT01759368|105741|P1|STARTED|Overall Study||47
45102|NCT01759290|105759|P1|NOT COMPLETED|Overall Study||81
45103|NCT01759290|105759|P1|COMPLETED|Overall Study||1719
45104|NCT01759290|105759|P1|STARTED|Overall Study||1800
45105|NCT01759264|105819|P1|NOT COMPLETED|Overall Study||10
45106|NCT01759264|105819|P1|COMPLETED|Overall Study||91
45107|NCT01759264|105819|P1|STARTED|Overall Study||101
45108|NCT01759251|105832|P1|NOT COMPLETED|Follow-up Period||0
45109|NCT01759251|105832|P1|COMPLETED|Follow-up Period||305
45110|NCT01759251|105832|P1|STARTED|Follow-up Period||305
45111|NCT01759251|105832|P1|NOT COMPLETED|60 Days Treatment Period||0
45112|NCT01759251|105832|P1|COMPLETED|60 Days Treatment Period||305
45113|NCT01759251|105832|P1|STARTED|60 Days Treatment Period||305
45114|NCT01759251|105832|P1|NOT COMPLETED|30 Days Treatment Period||4
45115|NCT01759251|105832|P1|COMPLETED|30 Days Treatment Period||305
45116|NCT01759251|105832|P1|STARTED|30 Days Treatment Period||309
45117|NCT01759160|105838|P2|NOT COMPLETED|Overall Study||0
45118|NCT01759160|105839|P1|NOT COMPLETED|Overall Study||0
45119|NCT01759160|105838|P2|COMPLETED|Overall Study||30
45120|NCT01759160|105839|P1|COMPLETED|Overall Study||30
45121|NCT01759160|105838|P2|STARTED|Overall Study||30
45122|NCT01759160|105839|P1|STARTED|Overall Study||30
45123|NCT01758900|105847|P2|NOT COMPLETED|Overall Study||8
45124|NCT01758900|105848|P1|NOT COMPLETED|Overall Study||7
45125|NCT01758900|105847|P2|COMPLETED|Overall Study||100
45126|NCT01758900|105848|P1|COMPLETED|Overall Study||99
45127|NCT01758900|105847|P2|STARTED|Overall Study||108
45128|NCT01758900|105848|P1|STARTED|Overall Study||106
45129|NCT01758289|105866|P1|NOT COMPLETED|Overall Study||53
45130|NCT01758289|105866|P1|COMPLETED|Overall Study||52
45131|NCT01758289|105866|P1|STARTED|Overall Study||105
45132|NCT01757964|105885|P2|NOT COMPLETED|Overall Study||0
45133|NCT01757964|105886|P1|NOT COMPLETED|Overall Study||0
45134|NCT01757964|105885|P2|COMPLETED|Overall Study||4
45135|NCT01757964|105886|P1|COMPLETED|Overall Study||9
45136|NCT01757964|105885|P2|STARTED|Overall Study||4
45137|NCT01757964|105886|P1|STARTED|Overall Study||9
45138|NCT01757847|105892|P2|NOT COMPLETED|Overall Study||4
45139|NCT01757847|105893|P1|NOT COMPLETED|Overall Study||3
45140|NCT01757847|105892|P2|COMPLETED|Overall Study||42
45141|NCT01757847|105893|P1|COMPLETED|Overall Study||41
45142|NCT01757847|105892|P2|STARTED|Overall Study||46
45143|NCT01757847|105893|P1|STARTED|Overall Study||44
45144|NCT01757704|105903|P2|NOT COMPLETED|Overall Study||3
45145|NCT01757704|105904|P1|NOT COMPLETED|Overall Study||1
45146|NCT01757704|105903|P2|COMPLETED|Overall Study||10
45147|NCT01757704|105904|P1|COMPLETED|Overall Study||10
45148|NCT01757704|105903|P2|STARTED|Overall Study|Two patients excluded intraoperatively due to failure to obtain TCD signals and one due to adhesion.|13
45149|NCT01757704|105904|P1|STARTED|Overall Study|One patient was excluded at start of surgery due to opening of the pleurae during sternotomy.|11
45150|NCT01757691|105922|P2|NOT COMPLETED|Overall Study||0
45151|NCT01757691|105923|P1|NOT COMPLETED|Overall Study||2
45152|NCT01757691|105922|P2|COMPLETED|Overall Study||0
45153|NCT01757691|105923|P1|COMPLETED|Overall Study||0
45154|NCT01757691|105922|P2|STARTED|Overall Study||0
45155|NCT01757691|105923|P1|STARTED|Overall Study||2
45156|NCT01757561|105940|P4|NOT COMPLETED|Overall Study||9
45157|NCT01757561|105941|P3|NOT COMPLETED|Overall Study||7
45158|NCT01757561|105942|P2|NOT COMPLETED|Overall Study||6
45159|NCT01757561|105943|P1|NOT COMPLETED|Overall Study||6
45160|NCT01757561|105940|P4|COMPLETED|Overall Study||25
45161|NCT01757561|105941|P3|COMPLETED|Overall Study||31
45162|NCT01757561|105942|P2|COMPLETED|Overall Study||28
45163|NCT01757561|105943|P1|COMPLETED|Overall Study||32
45164|NCT01757561|105940|P4|STARTED|Overall Study||34
45165|NCT01757561|105941|P3|STARTED|Overall Study||38
45166|NCT01757561|105942|P2|STARTED|Overall Study||34
45167|NCT01757561|105943|P1|STARTED|Overall Study||38
45168|NCT01757405|105959|P2|NOT COMPLETED|Overall Study||2
45169|NCT01757405|105960|P1|NOT COMPLETED|Overall Study||1
45170|NCT01757405|105959|P2|COMPLETED|Overall Study||18
45171|NCT01757405|105960|P1|COMPLETED|Overall Study||17
45172|NCT01757405|105959|P2|STARTED|Overall Study||20
45173|NCT01757405|105960|P1|STARTED|Overall Study||18
45174|NCT01757275|105978|P2|NOT COMPLETED|Overall Study||13
45175|NCT01757275|105979|P1|NOT COMPLETED|Overall Study||9
45176|NCT01757275|105978|P2|COMPLETED|Overall Study||98
45177|NCT01757275|105979|P1|COMPLETED|Overall Study||102
45178|NCT01757275|105978|P2|STARTED|Overall Study||111
45179|NCT01757275|105979|P1|STARTED|Overall Study||111
45180|NCT01757184|106003|P2|NOT COMPLETED|Open-Label Period||0
45181|NCT01757184|106004|P1|NOT COMPLETED|Open-Label Period||0
45182|NCT01757184|106003|P2|COMPLETED|Open-Label Period|This period is currently ongoing.|30
45183|NCT01757184|106004|P1|COMPLETED|Open-Label Period|This period is currently ongoing.|35
45184|NCT01757184|106003|P2|STARTED|Open-Label Period||30
45185|NCT01757184|106004|P1|STARTED|Open-Label Period||35
45186|NCT01757184|106003|P2|NOT COMPLETED|Double-Blind Period||0
45187|NCT01757184|106004|P1|NOT COMPLETED|Double-Blind Period||1
45188|NCT01757184|106003|P2|COMPLETED|Double-Blind Period||30
45189|NCT01757184|106004|P1|COMPLETED|Double-Blind Period||35
45190|NCT01757184|106003|P2|STARTED|Double-Blind Period||30
45191|NCT01757184|106004|P1|STARTED|Double-Blind Period||36
45192|NCT01756976|106028|P2|NOT COMPLETED|Overall Study||0
45193|NCT01756976|106029|P1|NOT COMPLETED|Overall Study||3
45194|NCT01756976|106028|P2|COMPLETED|Overall Study||8
45195|NCT01756976|106029|P1|COMPLETED|Overall Study||73
45196|NCT01756976|106028|P2|STARTED|Overall Study||8
45197|NCT01756976|106029|P1|STARTED|Overall Study||76
45198|NCT01756586|106037|P2|NOT COMPLETED|Overall Study||2
45199|NCT01756586|106038|P1|NOT COMPLETED|Overall Study||2
45200|NCT01756586|106037|P2|COMPLETED|Overall Study||0
45201|NCT01756586|106038|P1|COMPLETED|Overall Study||0
45202|NCT01756586|106037|P2|STARTED|Overall Study||2
45203|NCT01756586|106038|P1|STARTED|Overall Study||2
45204|NCT01756391|106044|P1|NOT COMPLETED|Overall Study||32
45205|NCT01756391|106044|P1|COMPLETED|Overall Study||319
45206|NCT01756391|106044|P1|STARTED|Overall Study||351
45207|NCT01756300|106048|P1|NOT COMPLETED|Overall Study||2
45208|NCT01756300|106048|P1|COMPLETED|Overall Study|Subjects with follow up available at 12 months|33
45209|NCT01756300|106048|P1|STARTED|Overall Study|Subjects underwent renal denervation treatment with the study catheter.|35
45210|NCT01756274|106070|P1|NOT COMPLETED|Overall Study||3
45211|NCT01756274|106070|P1|COMPLETED|Overall Study||159
45212|NCT01756274|106070|P1|STARTED|Overall Study||162
45213|NCT01756235|106077|P1|NOT COMPLETED|Overall Study||2
45214|NCT01756235|106077|P1|COMPLETED|Overall Study||460
45215|NCT01756235|106077|P1|STARTED|Overall Study||462
45216|NCT01756157|106098|P2|NOT COMPLETED|Second Intervention Period||0
45217|NCT01756157|106099|P1|NOT COMPLETED|Second Intervention Period||0
45218|NCT01756157|106098|P2|COMPLETED|Second Intervention Period||22
45219|NCT01756157|106099|P1|COMPLETED|Second Intervention Period||22
45220|NCT01756157|106098|P2|STARTED|Second Intervention Period||22
45221|NCT01756157|106099|P1|STARTED|Second Intervention Period||22
45222|NCT01756157|106098|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
45223|NCT01756157|106099|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
45224|NCT01756157|106098|P2|COMPLETED|Washout Period (at Least 7 Days)||22
45225|NCT01756157|106099|P1|COMPLETED|Washout Period (at Least 7 Days)||22
45226|NCT01756157|106098|P2|STARTED|Washout Period (at Least 7 Days)||22
45227|NCT01756157|106099|P1|STARTED|Washout Period (at Least 7 Days)||22
45228|NCT01756157|106098|P2|NOT COMPLETED|First Intervention Period||2
45229|NCT01756157|106099|P1|NOT COMPLETED|First Intervention Period||1
45230|NCT01756157|106098|P2|COMPLETED|First Intervention Period||22
45231|NCT01756157|106099|P1|COMPLETED|First Intervention Period||22
45232|NCT01756157|106098|P2|STARTED|First Intervention Period||24
45233|NCT01756157|106099|P1|STARTED|First Intervention Period||23
45234|NCT01756079|106113|P1|NOT COMPLETED|Treatment / Follow-up: Week 4 to Week 72||35
45235|NCT01756079|106113|P1|COMPLETED|Treatment / Follow-up: Week 4 to Week 72||23
45236|NCT01756079|106113|P1|Treated in Treatment Period|Treatment / Follow-up: Week 4 to Week 72||54
45237|NCT01756079|106113|P1|STARTED|Treatment / Follow-up: Week 4 to Week 72||58
45238|NCT01756079|106113|P1|NOT COMPLETED|Lead-in: Day 0 to Week 4||0
45239|NCT01756079|106113|P1|COMPLETED|Lead-in: Day 0 to Week 4||58
45240|NCT01756079|106113|P1|STARTED|Lead-in: Day 0 to Week 4||58
45241|NCT01756053|106119|P2|NOT COMPLETED|Period 2 (10 Days)||2
45242|NCT01756053|106120|P1|NOT COMPLETED|Period 2 (10 Days)||0
45243|NCT01756053|106119|P2|COMPLETED|Period 2 (10 Days)||6
45244|NCT01756053|106120|P1|COMPLETED|Period 2 (10 Days)||7
45245|NCT01756053|106119|P2|STARTED|Period 2 (10 Days)||8
45246|NCT01756053|106120|P1|STARTED|Period 2 (10 Days)||7
45247|NCT01756053|106119|P2|NOT COMPLETED|Washout Period (~21 Days)||0
45248|NCT01756053|106120|P1|NOT COMPLETED|Washout Period (~21 Days)||0
45249|NCT01756053|106119|P2|COMPLETED|Washout Period (~21 Days)||8
45250|NCT01756053|106120|P1|COMPLETED|Washout Period (~21 Days)||7
45251|NCT01756053|106119|P2|STARTED|Washout Period (~21 Days)||8
45252|NCT01756053|106120|P1|STARTED|Washout Period (~21 Days)||7
45253|NCT01756053|106119|P2|NOT COMPLETED|Period 1 (10 Days)||1
45254|NCT01756053|106120|P1|NOT COMPLETED|Period 1 (10 Days)||1
45255|NCT01756053|106119|P2|COMPLETED|Period 1 (10 Days)||8
45256|NCT01756053|106120|P1|COMPLETED|Period 1 (10 Days)||7
45257|NCT01756053|106119|P2|STARTED|Period 1 (10 Days)||9
45258|NCT01756053|106120|P1|STARTED|Period 1 (10 Days)||8
45259|NCT01755702|106140|P1|NOT COMPLETED|Period III||0
45260|NCT01755702|106140|P1|COMPLETED|Period III||58
45261|NCT01755702|106140|P1|Received Ibuprofen|Period III||18
45262|NCT01755702|106140|P1|Received Paracetamol/Caffeine|Period III||10
45263|NCT01755702|106140|P1|Received Placebo|Period III||13
45264|NCT01755702|106140|P1|Received Paracetamol|Period III||17
45265|NCT01755702|106140|P1|STARTED|Period III||58
45266|NCT01755702|106140|P1|NOT COMPLETED|Washout Period II||5
45267|NCT01755702|106140|P1|COMPLETED|Washout Period II||58
45268|NCT01755702|106140|P1|STARTED|Washout Period II||63
45269|NCT01755702|106140|P1|NOT COMPLETED|Period II||0
45270|NCT01755702|106140|P1|COMPLETED|Period II||63
45271|NCT01755702|106140|P1|Received Paracetamol|Period II||17
45272|NCT01755702|106140|P1|Received Paracetamol/Caffeine|Period II||20
45273|NCT01755702|106140|P1|Received Placebo|Period II||15
45274|NCT01755702|106140|P1|Received Ibuprofen|Period II||11
45275|NCT01755702|106140|P1|STARTED|Period II||63
45276|NCT01755702|106140|P1|NOT COMPLETED|Wash Out Period I||3
45277|NCT01755702|106140|P1|COMPLETED|Wash Out Period I||63
45278|NCT01755702|106140|P1|STARTED|Wash Out Period I||66
45279|NCT01755702|106140|P1|NOT COMPLETED|Period I||0
45280|NCT01755702|106140|P1|COMPLETED|Period I||66
45281|NCT01755702|106140|P1|Received Paracetamol/Caffeine|Period I||17
45282|NCT01755702|106140|P1|Received Ibuprofen|Period I||16
45283|NCT01755702|106140|P1|Received Placebo|Period I||17
45284|NCT01755702|106140|P1|Received Paracetamol|Period I||16
45285|NCT01755702|106140|P1|STARTED|Period I||66
45286|NCT01755637|106182|P2|NOT COMPLETED|Period 2||0
45287|NCT01755637|106183|P1|NOT COMPLETED|Period 2||0
45288|NCT01755637|106182|P2|COMPLETED|Period 2||27
45289|NCT01755637|106183|P1|COMPLETED|Period 2||28
45290|NCT01755637|106182|P2|STARTED|Period 2||27
45291|NCT01755637|106183|P1|STARTED|Period 2||28
45292|NCT01755637|106182|P2|NOT COMPLETED|Period 1||1
45293|NCT01755637|106183|P1|NOT COMPLETED|Period 1||0
45294|NCT01755637|106182|P2|COMPLETED|Period 1||27
45295|NCT01755637|106183|P1|COMPLETED|Period 1||28
45296|NCT01755637|106182|P2|STARTED|Period 1||28
45297|NCT01755637|106183|P1|STARTED|Period 1||28
45298|NCT01755455|106201|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
45299|NCT01755455|106202|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
45300|NCT01755455|106201|P2|COMPLETED|Second Intervention (6 Weeks)||11
45301|NCT01755455|106202|P1|COMPLETED|Second Intervention (6 Weeks)||11
45302|NCT01755455|106201|P2|STARTED|Second Intervention (6 Weeks)||11
45303|NCT01755455|106202|P1|STARTED|Second Intervention (6 Weeks)||11
45304|NCT01755455|106201|P2|NOT COMPLETED|Washout (4 Weeks)||0
45305|NCT01755455|106202|P1|NOT COMPLETED|Washout (4 Weeks)||0
45306|NCT01755455|106201|P2|COMPLETED|Washout (4 Weeks)||11
45307|NCT01755455|106202|P1|COMPLETED|Washout (4 Weeks)||11
45308|NCT01755455|106201|P2|STARTED|Washout (4 Weeks)||11
45309|NCT01755455|106202|P1|STARTED|Washout (4 Weeks)||11
45310|NCT01755455|106201|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
45311|NCT01755455|106202|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
45312|NCT01755455|106201|P2|COMPLETED|First Intervention (6 Weeks)||11
45313|NCT01755455|106202|P1|COMPLETED|First Intervention (6 Weeks)||11
45314|NCT01755455|106201|P2|STARTED|First Intervention (6 Weeks)||11
45315|NCT01755455|106202|P1|STARTED|First Intervention (6 Weeks)||11
45316|NCT01755234|106216|P2|NOT COMPLETED|Overall Study||8
45317|NCT01755234|106217|P1|NOT COMPLETED|Overall Study||15
45318|NCT01755234|106216|P2|COMPLETED|Overall Study||37
45319|NCT01755234|106217|P1|COMPLETED|Overall Study||30
45320|NCT01755234|106216|P2|STARTED|Overall Study||45
45321|NCT01755234|106217|P1|STARTED|Overall Study||45
45322|NCT01755169|106233|P4|NOT COMPLETED|Overall Study||0
45323|NCT01755169|106234|P3|NOT COMPLETED|Overall Study||0
45324|NCT01755169|106235|P2|NOT COMPLETED|Overall Study||0
45325|NCT01755169|106236|P1|NOT COMPLETED|Overall Study||0
45326|NCT01755169|106233|P4|COMPLETED|Overall Study||1
45327|NCT01755169|106234|P3|COMPLETED|Overall Study||0
45328|NCT01755169|106235|P2|COMPLETED|Overall Study||1
45329|NCT01755169|106236|P1|COMPLETED|Overall Study||2
45330|NCT01755169|106233|P4|STARTED|Overall Study||1
45331|NCT01755169|106234|P3|STARTED|Overall Study||0
45332|NCT01755169|106235|P2|STARTED|Overall Study||1
45333|NCT01755169|106236|P1|STARTED|Overall Study||2
45334|NCT01755156|106248|P2|NOT COMPLETED|Phase B (Weeks 24-104)||36
45335|NCT01755156|106249|P1|NOT COMPLETED|Phase B (Weeks 24-104)||39
45336|NCT01755156|106248|P2|COMPLETED|Phase B (Weeks 24-104)||141
45337|NCT01755156|106249|P1|COMPLETED|Phase B (Weeks 24-104)||144
45338|NCT01755156|106248|P2|STARTED|Phase B (Weeks 24-104)||177
45339|NCT01755156|106249|P1|STARTED|Phase B (Weeks 24-104)|1 participant who completed Phase A did not continue to Phase B.|183
45340|NCT01755156|106248|P2|NOT COMPLETED|Phase A (Weeks 0-24)||24
45341|NCT01755156|106249|P1|NOT COMPLETED|Phase A (Weeks 0-24)||17
45342|NCT01755156|106248|P2|COMPLETED|Phase A (Weeks 0-24)||177
45343|NCT01755156|106249|P1|COMPLETED|Phase A (Weeks 0-24)||184
45344|NCT01755156|106248|P2|STARTED|Phase A (Weeks 0-24)||201
45345|NCT01755156|106249|P1|STARTED|Phase A (Weeks 0-24)||201
45346|NCT01755143|106295|P2|NOT COMPLETED|Overall Study||3
45347|NCT01755143|106296|P1|NOT COMPLETED|Overall Study||11
45348|NCT01755143|106295|P2|COMPLETED|Overall Study||86
45349|NCT01755143|106296|P1|COMPLETED|Overall Study||166
45350|NCT01755143|106295|P2|STARTED|Overall Study||89
45351|NCT01755143|106296|P1|STARTED|Overall Study||177
45352|NCT01755026|106312|P2|NOT COMPLETED|Overall Study||1
45353|NCT01755026|106313|P1|NOT COMPLETED|Overall Study||2
45354|NCT01755026|106312|P2|COMPLETED|Overall Study||11
45355|NCT01755026|106313|P1|COMPLETED|Overall Study||9
45356|NCT01755026|106312|P2|STARTED|Overall Study||12
45357|NCT01755026|106313|P1|STARTED|Overall Study||11
45358|NCT01754922|106321|P2|NOT COMPLETED|Overall Study||1
45359|NCT01754922|106322|P1|NOT COMPLETED|Overall Study||0
45360|NCT01754922|106321|P2|COMPLETED|Overall Study||17
45361|NCT01754922|106322|P1|COMPLETED|Overall Study||32
45362|NCT01754922|106321|P2|STARTED|Overall Study||18
45363|NCT01754922|106322|P1|STARTED|Overall Study||32
45364|NCT01754766|106335|P3|NOT COMPLETED|Overall Study||0
45365|NCT01754766|106336|P2|NOT COMPLETED|Overall Study||1
45366|NCT01754766|106337|P1|NOT COMPLETED|Overall Study||1
45367|NCT01754766|106335|P3|COMPLETED|Overall Study||30
45368|NCT01754766|106336|P2|COMPLETED|Overall Study||28
45369|NCT01754766|106337|P1|COMPLETED|Overall Study||30
45370|NCT01754766|106335|P3|STARTED|Overall Study||30
45371|NCT01754766|106336|P2|STARTED|Overall Study||29
45372|NCT01754766|106337|P1|STARTED|Overall Study||31
45373|NCT01754727|106351|P1|NOT COMPLETED|Overall Study||2
45374|NCT01754727|106351|P1|COMPLETED|Overall Study||450
45375|NCT01754727|106351|P1|STARTED|Overall Study||452
45376|NCT01754714|106369|P4|NOT COMPLETED|Overall Study||1
45377|NCT01754714|106370|P3|NOT COMPLETED|Overall Study||2
45378|NCT01754714|106371|P2|NOT COMPLETED|Overall Study||1
45379|NCT01754714|106372|P1|NOT COMPLETED|Overall Study||0
45380|NCT01754714|106369|P4|COMPLETED|Overall Study||27
45381|NCT01754714|106370|P3|COMPLETED|Overall Study||24
45382|NCT01754714|106371|P2|COMPLETED|Overall Study||26
45383|NCT01754714|106372|P1|COMPLETED|Overall Study||27
45384|NCT01754714|106369|P4|STARTED|Overall Study||28
45385|NCT01754714|106370|P3|STARTED|Overall Study||26
45386|NCT01754714|106371|P2|STARTED|Overall Study||27
45387|NCT01754714|106372|P1|STARTED|Overall Study||27
45388|NCT01754623|106462|P1|NOT COMPLETED|Overall Study||0
45389|NCT01754623|106462|P1|COMPLETED|Overall Study||9
45390|NCT01754623|106462|P1|STARTED|Overall Study||9
45391|NCT01754519|106469|P1|NOT COMPLETED|Overall Study||0
45392|NCT01754519|106469|P1|COMPLETED|Overall Study||1
45393|NCT01754519|106469|P1|STARTED|Overall Study||1
45394|NCT01754493|106478|P1|NOT COMPLETED|Overall Study||7
45395|NCT01754493|106478|P1|COMPLETED|Overall Study||10
45396|NCT01754493|106478|P1|STARTED|Overall Study||17
45397|NCT01754480|106488|P2|NOT COMPLETED|Primary Part II||11
45398|NCT01754480|106489|P1|NOT COMPLETED|Primary Part II||15
45399|NCT01754480|106488|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|102
45400|NCT01754480|106489|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6 (not required for pediatric subjects)|96
45401|NCT01754480|106488|P2|Completed Study up to Week 6|Primary Part II||108
45402|NCT01754480|106489|P1|Completed Study up to Week 6|Primary Part II||100
45403|NCT01754480|106488|P2|STARTED|Primary Part II||113
45404|NCT01754480|106489|P1|STARTED|Primary Part II||111
45405|NCT01754480|106488|P2|NOT COMPLETED|Part I + Part II (Overall Study)||23
45406|NCT01754480|106489|P1|NOT COMPLETED|Part I + Part II (Overall Study)||25
45407|NCT01754480|106488|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 3 pediatric subjects)|139
45408|NCT01754480|106489|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6 (not required for 2 pediatric subjects)|138
45409|NCT01754480|106488|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||153
45410|NCT01754480|106489|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||147
45411|NCT01754480|106488|P2|STARTED|Part I + Part II (Overall Study)||162
45412|NCT01754480|106489|P1|STARTED|Part I + Part II (Overall Study)||163
45413|NCT01754467|106503|P1|NOT COMPLETED|Overall Study||1
45414|NCT01754467|106503|P1|COMPLETED|Overall Study||8
45415|NCT01754467|106503|P1|STARTED|Overall Study||9
45416|NCT01754402|106513|P3|NOT COMPLETED|Overall Study||4
45417|NCT01754402|106514|P2|NOT COMPLETED|Overall Study||2
45418|NCT01754402|106515|P1|NOT COMPLETED|Overall Study||2
45419|NCT01754402|106513|P3|COMPLETED|Overall Study||26
45420|NCT01754402|106514|P2|COMPLETED|Overall Study||0
45421|NCT01754402|106515|P1|COMPLETED|Overall Study||4
45422|NCT01754402|106513|P3|STARTED|Overall Study||30
45423|NCT01754402|106514|P2|STARTED|Overall Study||2
45424|NCT01754402|106515|P1|STARTED|Overall Study||6
45425|NCT01754389|106527|P3|NOT COMPLETED|Overall Study||0
45426|NCT01754389|106528|P2|NOT COMPLETED|Overall Study||0
45427|NCT01754389|106529|P1|NOT COMPLETED|Overall Study||0
45428|NCT01754389|106527|P3|COMPLETED|Overall Study||47
45429|NCT01754389|106528|P2|COMPLETED|Overall Study||45
45430|NCT01754389|106529|P1|COMPLETED|Overall Study||46
45431|NCT01754389|106527|P3|STARTED|Overall Study||47
45432|NCT01754389|106528|P2|STARTED|Overall Study||45
45433|NCT01754389|106529|P1|STARTED|Overall Study||46
45434|NCT01754376|106549|P1|NOT COMPLETED|Overall Study||3
45435|NCT01754376|106549|P1|COMPLETED|Overall Study||3
45436|NCT01754376|106549|P1|Completed 2-week Lead in of Vemurafenib|Overall Study||6
45437|NCT01754376|106549|P1|STARTED|Overall Study||6
45438|NCT01754259|106560|P2|NOT COMPLETED|Overall Study||6
45439|NCT01754259|106561|P1|NOT COMPLETED|Overall Study||5
45440|NCT01754259|106560|P2|COMPLETED|Overall Study||18
45441|NCT01754259|106561|P1|COMPLETED|Overall Study||18
45442|NCT01754259|106560|P2|STARTED|Overall Study||24
45443|NCT01754259|106561|P1|STARTED|Overall Study||23
45444|NCT01754194|106571|P2|NOT COMPLETED|Overall Study||27
45445|NCT01754194|106572|P1|NOT COMPLETED|Overall Study||52
45446|NCT01754194|106571|P2|COMPLETED|Overall Study||97
45447|NCT01754194|106572|P1|COMPLETED|Overall Study||117
45448|NCT01754194|106571|P2|STARTED|Overall Study||124
45449|NCT01754194|106572|P1|STARTED|Overall Study||169
45450|NCT01753856|106594|P2|NOT COMPLETED|Overall Study||2
45451|NCT01753856|106595|P1|NOT COMPLETED|Overall Study||3
45452|NCT01753856|106594|P2|COMPLETED|Overall Study||34
45453|NCT01753856|106595|P1|COMPLETED|Overall Study||30
45454|NCT01753856|106594|P2|Completed 3-Month Bone Biopsy|Overall Study||35
45455|NCT01753856|106595|P1|Completed 3-Month Bone Biopsy|Overall Study||31
45456|NCT01753856|106594|P2|Received at Least 1 Dose of Study Drug|Overall Study||36
45457|NCT01753856|106595|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
45458|NCT01753856|106594|P2|STARTED|Overall Study||36
45459|NCT01753856|106595|P1|STARTED|Overall Study||33
45460|NCT01753713|106647|P2|NOT COMPLETED|Overall Study||0
45461|NCT01753713|106648|P1|NOT COMPLETED|Overall Study||0
45462|NCT01753713|106647|P2|COMPLETED|Overall Study||19
45463|NCT01753713|106648|P1|COMPLETED|Overall Study||14
45464|NCT01753713|106647|P2|STARTED|Overall Study||19
45465|NCT01753713|106648|P1|STARTED|Overall Study||14
45466|NCT01753557|106666|P2|NOT COMPLETED|Overall Study||0
45467|NCT01753557|106667|P1|NOT COMPLETED|Overall Study||0
45468|NCT01753557|106666|P2|COMPLETED|Overall Study||19
45469|NCT01753557|106667|P1|COMPLETED|Overall Study||35
45470|NCT01753557|106666|P2|STARTED|Overall Study||19
45471|NCT01753557|106667|P1|STARTED|Overall Study||35
45472|NCT01753518|106685|P2|NOT COMPLETED|Postpartum Follow-up||15
45473|NCT01753518|106686|P1|NOT COMPLETED|Postpartum Follow-up||22
45474|NCT01753518|106685|P2|COMPLETED|Postpartum Follow-up||88
45475|NCT01753518|106686|P1|COMPLETED|Postpartum Follow-up||81
45476|NCT01753518|106685|P2|STARTED|Postpartum Follow-up||103
45477|NCT01753518|106686|P1|STARTED|Postpartum Follow-up||103
45478|NCT01753518|106685|P2|NOT COMPLETED|Intention-to-Treat Analysis||7
45479|NCT01753518|106686|P1|NOT COMPLETED|Intention-to-Treat Analysis||7
45480|NCT01753518|106685|P2|COMPLETED|Intention-to-Treat Analysis||103
45481|NCT01753518|106686|P1|COMPLETED|Intention-to-Treat Analysis||103
45482|NCT01753518|106685|P2|STARTED|Intention-to-Treat Analysis||110
45483|NCT01753518|106686|P1|STARTED|Intention-to-Treat Analysis||110
45484|NCT01753336|106708|P1|NOT COMPLETED|Overall Study||20
45485|NCT01753336|106708|P1|COMPLETED|Overall Study||92
45486|NCT01753336|106708|P1|Cycle 3|Overall Study||93
45487|NCT01753336|106708|P1|Cycle 2|Overall Study||98
45488|NCT01753336|106708|P1|Cycle 1|Overall Study||112
45489|NCT01753336|106708|P1|STARTED|Overall Study||112
45490|NCT01753323|106720|P3|NOT COMPLETED|Overall Study||9
45491|NCT01753323|106721|P2|NOT COMPLETED|Overall Study||0
45492|NCT01753323|106722|P1|NOT COMPLETED|Overall Study||1
45493|NCT01753323|106720|P3|COMPLETED|Overall Study||13
45494|NCT01753323|106721|P2|COMPLETED|Overall Study||10
45495|NCT01753323|106722|P1|COMPLETED|Overall Study||10
45496|NCT01753323|106720|P3|Intent-to-treat Analysis Set|Overall Study||22
45497|NCT01753323|106721|P2|Intent-to-treat Analysis Set|Overall Study||10
45498|NCT01753323|106722|P1|Intent-to-treat Analysis Set|Overall Study||11
45499|NCT01753323|106720|P3|Safety Set|Overall Study||22
45500|NCT01753323|106721|P2|Safety Set|Overall Study||10
45501|NCT01753323|106722|P1|Safety Set|Overall Study||11
45502|NCT01753323|106720|P3|Pharmacokinetic(PK) Set|Overall Study||21
45503|NCT01753323|106721|P2|Pharmacokinetic(PK) Set|Overall Study||10
45504|NCT01753323|106722|P1|Pharmacokinetic(PK) Set|Overall Study||10
45505|NCT01753323|106720|P3|Pharmacodynamic (PD) Set|Overall Study||21
45506|NCT01753323|106721|P2|Pharmacodynamic (PD) Set|Overall Study||10
45507|NCT01753323|106722|P1|Pharmacodynamic (PD) Set|Overall Study||10
45508|NCT01753323|106720|P3|STARTED|Overall Study||22
45509|NCT01753323|106721|P2|STARTED|Overall Study||10
45510|NCT01753323|106722|P1|STARTED|Overall Study||11
45511|NCT01753310|106760|P2|NOT COMPLETED|Overall Study||24
45512|NCT01753310|106761|P1|NOT COMPLETED|Overall Study||32
45513|NCT01753310|106760|P2|COMPLETED|Overall Study||21
45514|NCT01753310|106761|P1|COMPLETED|Overall Study||57
45515|NCT01753310|106760|P2|STARTED|Overall Study||45
45516|NCT01753310|106761|P1|STARTED|Overall Study||89
45517|NCT01753115|106784|P3|NOT COMPLETED|Overall Study||14
45518|NCT01753115|106785|P2|NOT COMPLETED|Overall Study||15
45519|NCT01753115|106786|P1|NOT COMPLETED|Overall Study||12
45520|NCT01753115|106784|P3|COMPLETED|Overall Study||56
45521|NCT01753115|106785|P2|COMPLETED|Overall Study||25
45522|NCT01753115|106786|P1|COMPLETED|Overall Study||32
45523|NCT01753115|106784|P3|Treated|Overall Study||67
45524|NCT01753115|106785|P2|Treated|Overall Study||39
45525|NCT01753115|106786|P1|Treated|Overall Study||38
45526|NCT01753115|106784|P3|STARTED|Overall Study||70
45527|NCT01753115|106785|P2|STARTED|Overall Study||40
45528|NCT01753115|106786|P1|STARTED|Overall Study||44
45529|NCT01753076|106796|P2|NOT COMPLETED|Overall Study||46
45530|NCT01753076|106797|P1|NOT COMPLETED|Overall Study||41
45531|NCT01753076|106796|P2|COMPLETED|Overall Study||106
45532|NCT01753076|106797|P1|COMPLETED|Overall Study||110
45533|NCT01753076|106796|P2|STARTED|Overall Study||152
45534|NCT01753076|106797|P1|STARTED|Overall Study||151
45535|NCT01752907|106823|P2|NOT COMPLETED|Overall Study||20
45536|NCT01752907|106824|P1|NOT COMPLETED|Overall Study||12
45537|NCT01752907|106823|P2|COMPLETED|Overall Study||133
45538|NCT01752907|106824|P1|COMPLETED|Overall Study||139
45539|NCT01752907|106823|P2|Received Pegfilgrastim|Overall Study||151
45540|NCT01752907|106824|P1|Received Pegfilgrastim|Overall Study||149
45541|NCT01752907|106823|P2|STARTED|Overall Study||153
45542|NCT01752907|106824|P1|STARTED|Overall Study||151
45543|NCT01752855|106844|P2|NOT COMPLETED|Overall Study||4
45544|NCT01752855|106845|P1|NOT COMPLETED|Overall Study||1
45545|NCT01752855|106844|P2|COMPLETED|Overall Study||40
45546|NCT01752855|106845|P1|COMPLETED|Overall Study||43
45547|NCT01752855|106844|P2|STARTED|Overall Study||44
45548|NCT01752855|106845|P1|STARTED|Overall Study||44
45549|NCT01752023|106861|P2|NOT COMPLETED|Overall Study||1
45550|NCT01752023|106862|P1|NOT COMPLETED|Overall Study||2
45551|NCT01752023|106861|P2|COMPLETED|Overall Study||0
45552|NCT01752023|106862|P1|COMPLETED|Overall Study||0
45553|NCT01752023|106861|P2|STARTED|Overall Study||1
45554|NCT01752023|106862|P1|STARTED|Overall Study||2
45555|NCT01751867|106880|P2|NOT COMPLETED|Overall Study||99
45556|NCT01751867|106881|P1|NOT COMPLETED|Overall Study||36
45557|NCT01751867|106880|P2|COMPLETED|Overall Study||0
45558|NCT01751867|106881|P1|COMPLETED|Overall Study||0
45559|NCT01751867|106880|P2|Treated|Overall Study||98
45560|NCT01751867|106881|P1|Treated|Overall Study||34
45561|NCT01751867|106880|P2|STARTED|Overall Study||99
45562|NCT01751867|106881|P1|STARTED|Overall Study||36
45563|NCT01751802|106901|P2|NOT COMPLETED|Overall Study||2
45564|NCT01751802|106902|P1|NOT COMPLETED|Overall Study||4
45565|NCT01751802|106901|P2|COMPLETED|Overall Study||2
45566|NCT01751802|106902|P1|COMPLETED|Overall Study||1
45567|NCT01751802|106901|P2|Completed Period 3|Overall Study||1
45568|NCT01751802|106902|P1|Completed Period 3|Overall Study||2
45569|NCT01751802|106901|P2|Completed Period 2|Overall Study||1
45570|NCT01751802|106902|P1|Completed Period 2|Overall Study||2
45571|NCT01751802|106901|P2|Completed Period 1|Overall Study||4
45572|NCT01751802|106902|P1|Completed Period 1|Overall Study||2
45573|NCT01751802|106901|P2|STARTED|Overall Study||4
45574|NCT01751802|106902|P1|STARTED|Overall Study||5
45575|NCT01751724|106916|P2|NOT COMPLETED|Overall Study||2
45576|NCT01751724|106917|P1|NOT COMPLETED|Overall Study||1
45577|NCT01751724|106916|P2|COMPLETED|Overall Study||42
45578|NCT01751724|106917|P1|COMPLETED|Overall Study||41
45579|NCT01751724|106916|P2|STARTED|Overall Study||44
45580|NCT01751724|106917|P1|STARTED|Overall Study||42
45581|NCT01751386|106945|P2|NOT COMPLETED|Overall Study||3
45582|NCT01751386|106946|P1|NOT COMPLETED|Overall Study||2
45583|NCT01751386|106945|P2|COMPLETED|Overall Study||16
45584|NCT01751386|106946|P1|COMPLETED|Overall Study||18
45585|NCT01751386|106945|P2|STARTED|Overall Study||19
45586|NCT01751386|106946|P1|STARTED|Overall Study||20
45587|NCT01751308|106957|P5|NOT COMPLETED|Phase 2||0
45588|NCT01751308|106958|P4|NOT COMPLETED|Phase 2||0
45589|NCT01751308|106959|P3|NOT COMPLETED|Phase 2||0
45590|NCT01751308|106960|P2|NOT COMPLETED|Phase 2||0
45591|NCT01751308|106961|P1|NOT COMPLETED|Phase 2||0
45592|NCT01751308|106957|P5|COMPLETED|Phase 2|DP, AE and death were considered as completed (defined in protocol)|16
45593|NCT01751308|106958|P4|COMPLETED|Phase 2||0
45594|NCT01751308|106959|P3|COMPLETED|Phase 2||0
45595|NCT01751308|106960|P2|COMPLETED|Phase 2||0
45596|NCT01751308|106961|P1|COMPLETED|Phase 2||0
45597|NCT01751308|106957|P5|STARTED|Phase 2|Phase 1 and Phase 2 were separate populations.|16
45598|NCT01751308|106958|P4|STARTED|Phase 2||0
45599|NCT01751308|106959|P3|STARTED|Phase 2||0
45600|NCT01751308|106960|P2|STARTED|Phase 2||0
45601|NCT01751308|106961|P1|STARTED|Phase 2||0
45602|NCT01751308|106957|P5|NOT COMPLETED|Phase 1||0
45603|NCT01751308|106958|P4|NOT COMPLETED|Phase 1||0
45604|NCT01751308|106959|P3|NOT COMPLETED|Phase 1||0
45605|NCT01751308|106960|P2|NOT COMPLETED|Phase 1||0
45606|NCT01751308|106961|P1|NOT COMPLETED|Phase 1||0
45607|NCT01751308|106957|P5|COMPLETED|Phase 1||0
45608|NCT01751308|106958|P4|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
45609|NCT01751308|106959|P3|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|7
45610|NCT01751308|106960|P2|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|3
45611|NCT01751308|106961|P1|COMPLETED|Phase 1|DP, AE and death were considered as completed (defined in protocol)|6
45612|NCT01751308|106957|P5|STARTED|Phase 1|Phase 1 and Phase 2 were separate populations.|0
45613|NCT01751308|106958|P4|STARTED|Phase 1||7
45614|NCT01751308|106959|P3|STARTED|Phase 1||7
45615|NCT01751308|106960|P2|STARTED|Phase 1||3
45616|NCT01751308|106961|P1|STARTED|Phase 1||6
45617|NCT01751178|107001|P3|NOT COMPLETED|Overall Study||2
45618|NCT01751178|107002|P2|NOT COMPLETED|Overall Study||0
45619|NCT01751178|107003|P1|NOT COMPLETED|Overall Study||3
45620|NCT01751178|107001|P3|COMPLETED|Overall Study||105
45621|NCT01751178|107002|P2|COMPLETED|Overall Study||109
45622|NCT01751178|107003|P1|COMPLETED|Overall Study||105
45623|NCT01751178|107001|P3|STARTED|Overall Study||107
45624|NCT01751178|107002|P2|STARTED|Overall Study||109
45625|NCT01751178|107003|P1|STARTED|Overall Study||108
45626|NCT01751165|107023|P3|NOT COMPLETED|Overall Study||3
45627|NCT01751165|107024|P2|NOT COMPLETED|Overall Study||3
45628|NCT01751165|107025|P1|NOT COMPLETED|Overall Study||2
45629|NCT01751165|107023|P3|COMPLETED|Overall Study||113
45630|NCT01751165|107024|P2|COMPLETED|Overall Study||116
45631|NCT01751165|107025|P1|COMPLETED|Overall Study||117
45632|NCT01751165|107023|P3|STARTED|Overall Study||116
45633|NCT01751165|107024|P2|STARTED|Overall Study||119
45634|NCT01751165|107025|P1|STARTED|Overall Study||119
45635|NCT01751113|107065|P6|NOT COMPLETED|Treatment Period 3 (4 Weeks)||1
45636|NCT01751113|107066|P5|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
45637|NCT01751113|107067|P4|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
45638|NCT01751113|107068|P3|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
45639|NCT01751113|107069|P2|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
45640|NCT01751113|107070|P1|NOT COMPLETED|Treatment Period 3 (4 Weeks)||0
45641|NCT01751113|107065|P6|COMPLETED|Treatment Period 3 (4 Weeks)||9
45642|NCT01751113|107066|P5|COMPLETED|Treatment Period 3 (4 Weeks)||8
45643|NCT01751113|107067|P4|COMPLETED|Treatment Period 3 (4 Weeks)||8
45644|NCT01751113|107068|P3|COMPLETED|Treatment Period 3 (4 Weeks)||9
45645|NCT01751113|107069|P2|COMPLETED|Treatment Period 3 (4 Weeks)||8
45646|NCT01751113|107070|P1|COMPLETED|Treatment Period 3 (4 Weeks)||8
45647|NCT01751113|107065|P6|STARTED|Treatment Period 3 (4 Weeks)||10
45648|NCT01751113|107066|P5|STARTED|Treatment Period 3 (4 Weeks)||8
45649|NCT01751113|107067|P4|STARTED|Treatment Period 3 (4 Weeks)||8
45650|NCT01751113|107068|P3|STARTED|Treatment Period 3 (4 Weeks)||9
45651|NCT01751113|107069|P2|STARTED|Treatment Period 3 (4 Weeks)||8
45652|NCT01751113|107070|P1|STARTED|Treatment Period 3 (4 Weeks)||8
45653|NCT01751113|107065|P6|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
45654|NCT01751113|107066|P5|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
45655|NCT01751113|107067|P4|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
45656|NCT01751113|107068|P3|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
45657|NCT01751113|107069|P2|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
45658|NCT01751113|107070|P1|NOT COMPLETED|Washout Period 2 (2 Weeks)||0
45659|NCT01751113|107065|P6|COMPLETED|Washout Period 2 (2 Weeks)||10
45660|NCT01751113|107066|P5|COMPLETED|Washout Period 2 (2 Weeks)||8
45661|NCT01751113|107067|P4|COMPLETED|Washout Period 2 (2 Weeks)||8
45662|NCT01751113|107068|P3|COMPLETED|Washout Period 2 (2 Weeks)||9
45663|NCT01751113|107069|P2|COMPLETED|Washout Period 2 (2 Weeks)||8
45664|NCT01751113|107070|P1|COMPLETED|Washout Period 2 (2 Weeks)||8
45665|NCT01751113|107065|P6|STARTED|Washout Period 2 (2 Weeks)||10
45666|NCT01751113|107066|P5|STARTED|Washout Period 2 (2 Weeks)||8
45667|NCT01751113|107067|P4|STARTED|Washout Period 2 (2 Weeks)||8
45668|NCT01751113|107068|P3|STARTED|Washout Period 2 (2 Weeks)||9
45669|NCT01751113|107069|P2|STARTED|Washout Period 2 (2 Weeks)||8
45670|NCT01751113|107070|P1|STARTED|Washout Period 2 (2 Weeks)||8
45671|NCT01751113|107065|P6|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
45672|NCT01751113|107066|P5|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
45673|NCT01751113|107067|P4|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
45674|NCT01751113|107068|P3|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
45675|NCT01751113|107069|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
45676|NCT01751113|107070|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||0
45677|NCT01751113|107065|P6|COMPLETED|Treatment Period 2 (4 Weeks)||10
45678|NCT01751113|107066|P5|COMPLETED|Treatment Period 2 (4 Weeks)||8
45679|NCT01751113|107067|P4|COMPLETED|Treatment Period 2 (4 Weeks)||8
45680|NCT01751113|107068|P3|COMPLETED|Treatment Period 2 (4 Weeks)||9
45681|NCT01751113|107069|P2|COMPLETED|Treatment Period 2 (4 Weeks)||8
45682|NCT01751113|107070|P1|COMPLETED|Treatment Period 2 (4 Weeks)||8
45683|NCT01751113|107065|P6|STARTED|Treatment Period 2 (4 Weeks)||10
45684|NCT01751113|107066|P5|STARTED|Treatment Period 2 (4 Weeks)||8
45685|NCT01751113|107067|P4|STARTED|Treatment Period 2 (4 Weeks)||8
45686|NCT01751113|107068|P3|STARTED|Treatment Period 2 (4 Weeks)||9
45687|NCT01751113|107069|P2|STARTED|Treatment Period 2 (4 Weeks)||8
45688|NCT01751113|107070|P1|STARTED|Treatment Period 2 (4 Weeks)||8
45689|NCT01751113|107065|P6|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
45690|NCT01751113|107066|P5|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
45691|NCT01751113|107067|P4|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
45692|NCT01751113|107068|P3|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
45693|NCT01751113|107069|P2|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
45694|NCT01751113|107070|P1|NOT COMPLETED|Washout Period 1 (2 Weeks)||0
45695|NCT01751113|107065|P6|COMPLETED|Washout Period 1 (2 Weeks)||10
45696|NCT01751113|107066|P5|COMPLETED|Washout Period 1 (2 Weeks)||8
45697|NCT01751113|107067|P4|COMPLETED|Washout Period 1 (2 Weeks)||8
45698|NCT01751113|107068|P3|COMPLETED|Washout Period 1 (2 Weeks)||9
45699|NCT01751113|107069|P2|COMPLETED|Washout Period 1 (2 Weeks)||8
45700|NCT01751113|107070|P1|COMPLETED|Washout Period 1 (2 Weeks)||8
45701|NCT01751113|107065|P6|STARTED|Washout Period 1 (2 Weeks)||10
45702|NCT01751113|107066|P5|STARTED|Washout Period 1 (2 Weeks)||8
45703|NCT01751113|107067|P4|STARTED|Washout Period 1 (2 Weeks)||8
45704|NCT01751113|107068|P3|STARTED|Washout Period 1 (2 Weeks)||9
45705|NCT01751113|107069|P2|STARTED|Washout Period 1 (2 Weeks)||8
45706|NCT01751113|107070|P1|STARTED|Washout Period 1 (2 Weeks)||8
45707|NCT01751113|107065|P6|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
45708|NCT01751113|107066|P5|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
45709|NCT01751113|107067|P4|NOT COMPLETED|Treatment Period 1 (4 Weeks)||1
45710|NCT01751113|107068|P3|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
45711|NCT01751113|107069|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
45712|NCT01751113|107070|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||0
45713|NCT01751113|107065|P6|COMPLETED|Treatment Period 1 (4 Weeks)||10
45714|NCT01751113|107066|P5|COMPLETED|Treatment Period 1 (4 Weeks)||8
45715|NCT01751113|107067|P4|COMPLETED|Treatment Period 1 (4 Weeks)||8
45716|NCT01751113|107068|P3|COMPLETED|Treatment Period 1 (4 Weeks)||9
45717|NCT01751113|107069|P2|COMPLETED|Treatment Period 1 (4 Weeks)||8
45718|NCT01751113|107070|P1|COMPLETED|Treatment Period 1 (4 Weeks)||8
45719|NCT01751113|107065|P6|STARTED|Treatment Period 1 (4 Weeks)||10
45720|NCT01751113|107066|P5|STARTED|Treatment Period 1 (4 Weeks)||9
45721|NCT01751113|107067|P4|STARTED|Treatment Period 1 (4 Weeks)||9
45722|NCT01751113|107068|P3|STARTED|Treatment Period 1 (4 Weeks)||9
45723|NCT01751113|107069|P2|STARTED|Treatment Period 1 (4 Weeks)||8
45724|NCT01751113|107070|P1|STARTED|Treatment Period 1 (4 Weeks)||8
45725|NCT01751087|107111|P3|NOT COMPLETED|Overall Study||1
45726|NCT01751087|107112|P2|NOT COMPLETED|Overall Study||0
45727|NCT01751087|107113|P1|NOT COMPLETED|Overall Study||1
45728|NCT01751087|107111|P3|COMPLETED|Overall Study||99
45729|NCT01751087|107112|P2|COMPLETED|Overall Study||100
45730|NCT01751087|107113|P1|COMPLETED|Overall Study||99
45731|NCT01751087|107111|P3|STARTED|Overall Study||100
45732|NCT01751087|107112|P2|STARTED|Overall Study||100
45733|NCT01751087|107113|P1|STARTED|Overall Study||100
45734|NCT01751022|107148|P3|NOT COMPLETED|Overall Study||27
45735|NCT01751022|107149|P2|NOT COMPLETED|Overall Study||44
45736|NCT01751022|107150|P1|NOT COMPLETED|Overall Study||56
45737|NCT01751022|107148|P3|COMPLETED|Overall Study|6 month visit|273
45738|NCT01751022|107149|P2|COMPLETED|Overall Study|6 month visit|282
45739|NCT01751022|107150|P1|COMPLETED|Overall Study|6 month visit|443
45740|NCT01751022|107148|P3|STARTED|Overall Study||300
45741|NCT01751022|107149|P2|STARTED|Overall Study||326
45742|NCT01751022|107150|P1|STARTED|Overall Study||499
45743|NCT01750931|107182|P2|NOT COMPLETED|Period 2||0
45744|NCT01750931|107183|P1|NOT COMPLETED|Period 2||0
45745|NCT01750931|107182|P2|COMPLETED|Period 2||14
45746|NCT01750931|107183|P1|COMPLETED|Period 2||14
45747|NCT01750931|107182|P2|STARTED|Period 2||14
45748|NCT01750931|107183|P1|STARTED|Period 2||14
45749|NCT01750931|107182|P2|NOT COMPLETED|Wash Out||0
45750|NCT01750931|107183|P1|NOT COMPLETED|Wash Out||0
45751|NCT01750931|107182|P2|COMPLETED|Wash Out||14
45752|NCT01750931|107183|P1|COMPLETED|Wash Out||14
45753|NCT01750931|107182|P2|STARTED|Wash Out||14
45754|NCT01750931|107183|P1|STARTED|Wash Out||14
45755|NCT01750931|107182|P2|NOT COMPLETED|Period 1||0
45756|NCT01750931|107183|P1|NOT COMPLETED|Period 1||0
45757|NCT01750931|107182|P2|COMPLETED|Period 1||14
45758|NCT01750931|107183|P1|COMPLETED|Period 1||14
45759|NCT01750931|107182|P2|STARTED|Period 1||14
45760|NCT01750931|107183|P1|STARTED|Period 1||14
45761|NCT01750840|107201|P1|NOT COMPLETED|Overall Study||4
45762|NCT01750840|107201|P1|COMPLETED|Overall Study||4
45763|NCT01750840|107201|P1|STARTED|Overall Study||8
45764|NCT01750684|107208|P2|NOT COMPLETED|Overall Study||2
45765|NCT01750684|107209|P1|NOT COMPLETED|Overall Study||2
45766|NCT01750684|107208|P2|COMPLETED|Overall Study||5
45767|NCT01750684|107209|P1|COMPLETED|Overall Study||4
45768|NCT01750684|107208|P2|STARTED|Overall Study||7
45769|NCT01750684|107209|P1|STARTED|Overall Study||6
45770|NCT01750502|107217|P2|NOT COMPLETED|Overall Study||0
45771|NCT01750502|107218|P1|NOT COMPLETED|Overall Study||0
45772|NCT01750502|107217|P2|COMPLETED|Overall Study||186
45773|NCT01750502|107218|P1|COMPLETED|Overall Study||70
45774|NCT01750502|107217|P2|STARTED|Overall Study||186
45775|NCT01750502|107218|P1|STARTED|Overall Study||70
45776|NCT01750398|107231|P1|NOT COMPLETED|Bipolar Androgen Thearpy Phase||3
45777|NCT01750398|107231|P1|COMPLETED|Bipolar Androgen Thearpy Phase||26
45778|NCT01750398|107231|P1|STARTED|Bipolar Androgen Thearpy Phase||29
45779|NCT01750398|107231|P1|NOT COMPLETED|ADT Lead In Phase||4
45780|NCT01750398|107231|P1|COMPLETED|ADT Lead In Phase||29
45781|NCT01750398|107231|P1|STARTED|ADT Lead In Phase||33
45782|NCT01750346|107244|P3|NOT COMPLETED|Overall Study||0
45783|NCT01750346|107245|P2|NOT COMPLETED|Overall Study||0
45784|NCT01750346|107246|P1|NOT COMPLETED|Overall Study||1
45785|NCT01750346|107244|P3|COMPLETED|Overall Study||3
45786|NCT01750346|107245|P2|COMPLETED|Overall Study||2
45787|NCT01750346|107246|P1|COMPLETED|Overall Study||2
45788|NCT01750346|107244|P3|STARTED|Overall Study||3
45789|NCT01750346|107245|P2|STARTED|Overall Study||2
45790|NCT01750346|107246|P1|STARTED|Overall Study||3
45791|NCT01750294|107272|P1|NOT COMPLETED|Overall Study||2
45792|NCT01750294|107272|P1|COMPLETED|Overall Study||12
45793|NCT01750294|107272|P1|STARTED|Overall Study||14
45794|NCT01750281|107279|P3|NOT COMPLETED|Overall Study||84
45795|NCT01750281|107280|P2|NOT COMPLETED|Overall Study||85
45796|NCT01750281|107281|P1|NOT COMPLETED|Overall Study||43
45797|NCT01750281|107279|P3|COMPLETED|Overall Study||0
45798|NCT01750281|107280|P2|COMPLETED|Overall Study||0
45799|NCT01750281|107281|P1|COMPLETED|Overall Study||0
45800|NCT01750281|107279|P3|Did Not Receive Treatment|Overall Study||0
45801|NCT01750281|107280|P2|Did Not Receive Treatment|Overall Study||1
45802|NCT01750281|107281|P1|Did Not Receive Treatment|Overall Study||0
45803|NCT01750281|107279|P3|Received Treatment|Overall Study||84
45804|NCT01750281|107280|P2|Received Treatment|Overall Study||84
45805|NCT01750281|107281|P1|Received Treatment|Overall Study||43
45806|NCT01750281|107279|P3|STARTED|Overall Study||84
45807|NCT01750281|107280|P2|STARTED|Overall Study||85
45808|NCT01750281|107281|P1|STARTED|Overall Study||43
45809|NCT01750255|107294|P2|NOT COMPLETED|Overall Study||5
45810|NCT01750255|107295|P1|NOT COMPLETED|Overall Study||6
45811|NCT01750255|107294|P2|COMPLETED|Overall Study||38
45812|NCT01750255|107295|P1|COMPLETED|Overall Study||43
45813|NCT01750255|107294|P2|STARTED|Overall Study||43
45814|NCT01750255|107295|P1|STARTED|Overall Study||49
45815|NCT01750242|107311|P1|NOT COMPLETED|Overall Study||3
45816|NCT01750242|107311|P1|COMPLETED|Overall Study||20
45817|NCT01750242|107311|P1|Readable Images|Overall Study|Subjects with readable images were analyzed and there were 3 subjects with unreadable images.|20
45818|NCT01750242|107311|P1|STARTED|Overall Study||23
45819|NCT01750086|107318|P2|NOT COMPLETED|Overall Study||1
45820|NCT01750086|107319|P1|NOT COMPLETED|Overall Study||1
45821|NCT01750086|107318|P2|COMPLETED|Overall Study||13
45822|NCT01750086|107319|P1|COMPLETED|Overall Study||12
45823|NCT01750086|107318|P2|STARTED|Overall Study||14
45824|NCT01750086|107319|P1|STARTED|Overall Study||13
45825|NCT01749982|107329|P4|NOT COMPLETED|Overall Study||3
45826|NCT01749982|107330|P3|NOT COMPLETED|Overall Study||0
45827|NCT01749982|107331|P2|NOT COMPLETED|Overall Study||0
45828|NCT01749982|107332|P1|NOT COMPLETED|Overall Study||0
45829|NCT01749982|107329|P4|COMPLETED|Overall Study||12
45830|NCT01749982|107330|P3|COMPLETED|Overall Study||15
45831|NCT01749982|107331|P2|COMPLETED|Overall Study||15
45832|NCT01749982|107332|P1|COMPLETED|Overall Study||15
45833|NCT01749982|107329|P4|STARTED|Overall Study||15
45834|NCT01749982|107330|P3|STARTED|Overall Study||15
45835|NCT01749982|107331|P2|STARTED|Overall Study||15
45836|NCT01749982|107332|P1|STARTED|Overall Study||15
45837|NCT01749956|107350|P1|NOT COMPLETED|Overall Study||15
45838|NCT01749956|107350|P1|COMPLETED|Overall Study||24
45839|NCT01749956|107350|P1|STARTED|Overall Study||39
45840|NCT01748799|107368|P8|NOT COMPLETED|Overall Study||0
45841|NCT01748799|107369|P7|NOT COMPLETED|Overall Study||1
45842|NCT01748799|107370|P6|NOT COMPLETED|Overall Study||1
45843|NCT01748799|107371|P5|NOT COMPLETED|Overall Study||0
45844|NCT01748799|107372|P4|NOT COMPLETED|Overall Study||0
45845|NCT01748799|107373|P3|NOT COMPLETED|Overall Study||0
45846|NCT01748799|107374|P2|NOT COMPLETED|Overall Study||0
45847|NCT01748799|107375|P1|NOT COMPLETED|Overall Study||5
45848|NCT01748799|107368|P8|COMPLETED|Overall Study||1
45849|NCT01748799|107369|P7|COMPLETED|Overall Study||1
45850|NCT01748799|107370|P6|COMPLETED|Overall Study||1
45851|NCT01748799|107371|P5|COMPLETED|Overall Study||1
45852|NCT01748799|107372|P4|COMPLETED|Overall Study||2
45853|NCT01748799|107373|P3|COMPLETED|Overall Study||1
45854|NCT01748799|107374|P2|COMPLETED|Overall Study||1
45855|NCT01748799|107375|P1|COMPLETED|Overall Study||1
45856|NCT01748799|107368|P8|Completed Self-titrated Sativex|Overall Study||1
45857|NCT01748799|107369|P7|Completed Self-titrated Sativex|Overall Study||1
45858|NCT01748799|107370|P6|Completed Self-titrated Sativex|Overall Study||1
45859|NCT01748799|107371|P5|Completed Self-titrated Sativex|Overall Study||1
45860|NCT01748799|107372|P4|Completed Self-titrated Sativex|Overall Study||2
45861|NCT01748799|107373|P3|Completed Self-titrated Sativex|Overall Study||1
45862|NCT01748799|107374|P2|Completed Self-titrated Sativex|Overall Study||1
45863|NCT01748799|107375|P1|Completed Self-titrated Sativex|Overall Study||1
45864|NCT01748799|107368|P8|Completed SAU of Self-titrated Sativex|Overall Study||1
45865|NCT01748799|107369|P7|Completed SAU of Self-titrated Sativex|Overall Study||1
45866|NCT01748799|107370|P6|Completed SAU of Self-titrated Sativex|Overall Study||2
45947|NCT01749735|107433|P2|STARTED|Overall Study||0
45867|NCT01748799|107371|P5|Completed SAU of Self-titrated Sativex|Overall Study||1
45868|NCT01748799|107372|P4|Completed SAU of Self-titrated Sativex|Overall Study||2
45869|NCT01748799|107373|P3|Completed SAU of Self-titrated Sativex|Overall Study||1
45870|NCT01748799|107374|P2|Completed SAU of Self-titrated Sativex|Overall Study||1
45871|NCT01748799|107375|P1|Completed SAU of Self-titrated Sativex|Overall Study||2
45872|NCT01748799|107368|P8|Completed Self-titrated Placebo|Overall Study||1
45873|NCT01748799|107369|P7|Completed Self-titrated Placebo|Overall Study||1
45874|NCT01748799|107370|P6|Completed Self-titrated Placebo|Overall Study||2
45875|NCT01748799|107371|P5|Completed Self-titrated Placebo|Overall Study||1
45876|NCT01748799|107372|P4|Completed Self-titrated Placebo|Overall Study||2
45877|NCT01748799|107373|P3|Completed Self-titrated Placebo|Overall Study||1
45878|NCT01748799|107374|P2|Completed Self-titrated Placebo|Overall Study||1
45879|NCT01748799|107375|P1|Completed Self-titrated Placebo|Overall Study||4
45880|NCT01748799|107368|P8|Completed SAU of Self-titrated Placebo|Overall Study||1
45881|NCT01748799|107369|P7|Completed SAU of Self-titrated Placebo|Overall Study||1
45882|NCT01748799|107370|P6|Completed SAU of Self-titrated Placebo|Overall Study||2
45883|NCT01748799|107371|P5|Completed SAU of Self-titrated Placebo|Overall Study||1
45884|NCT01748799|107372|P4|Completed SAU of Self-titrated Placebo|Overall Study||2
45885|NCT01748799|107373|P3|Completed SAU of Self-titrated Placebo|Overall Study||1
45886|NCT01748799|107374|P2|Completed SAU of Self-titrated Placebo|Overall Study||1
45887|NCT01748799|107375|P1|Completed SAU of Self-titrated Placebo|Overall Study||5
45888|NCT01748799|107368|P8|Completed Fixed Dose Sativex|Overall Study||1
45889|NCT01748799|107369|P7|Completed Fixed Dose Sativex|Overall Study||1
45890|NCT01748799|107370|P6|Completed Fixed Dose Sativex|Overall Study||1
45891|NCT01748799|107371|P5|Completed Fixed Dose Sativex|Overall Study||1
45892|NCT01748799|107372|P4|Completed Fixed Dose Sativex|Overall Study||2
45893|NCT01748799|107373|P3|Completed Fixed Dose Sativex|Overall Study||1
45894|NCT01748799|107374|P2|Completed Fixed Dose Sativex|Overall Study||1
45895|NCT01748799|107375|P1|Completed Fixed Dose Sativex|Overall Study||1
45896|NCT01748799|107368|P8|Completed SAU of Fixed Dose Sativex|Overall Study||1
45897|NCT01748799|107369|P7|Completed SAU of Fixed Dose Sativex|Overall Study||1
45898|NCT01748799|107370|P6|Completed SAU of Fixed Dose Sativex|Overall Study||1
45899|NCT01748799|107371|P5|Completed SAU of Fixed Dose Sativex|Overall Study||1
45900|NCT01748799|107372|P4|Completed SAU of Fixed Dose Sativex|Overall Study||2
45901|NCT01748799|107373|P3|Completed SAU of Fixed Dose Sativex|Overall Study||1
45902|NCT01748799|107374|P2|Completed SAU of Fixed Dose Sativex|Overall Study||1
45903|NCT01748799|107375|P1|Completed SAU of Fixed Dose Sativex|Overall Study||1
45904|NCT01748799|107368|P8|Completed Fixed Dose Placebo|Overall Study||1
45905|NCT01748799|107369|P7|Completed Fixed Dose Placebo|Overall Study||1
45906|NCT01748799|107370|P6|Completed Fixed Dose Placebo|Overall Study||1
45907|NCT01748799|107371|P5|Completed Fixed Dose Placebo|Overall Study||1
45908|NCT01748799|107372|P4|Completed Fixed Dose Placebo|Overall Study||2
45909|NCT01748799|107373|P3|Completed Fixed Dose Placebo|Overall Study||1
45910|NCT01748799|107374|P2|Completed Fixed Dose Placebo|Overall Study||1
45911|NCT01748799|107375|P1|Completed Fixed Dose Placebo|Overall Study||2
45912|NCT01748799|107368|P8|Completed SAU of Fixed Dose Placebo|Overall Study||1
45913|NCT01748799|107369|P7|Completed SAU of Fixed Dose Placebo|Overall Study||1
45914|NCT01748799|107370|P6|Completed SAU of Fixed Dose Placebo|Overall Study||1
45915|NCT01748799|107371|P5|Completed SAU of Fixed Dose Placebo|Overall Study||1
45916|NCT01748799|107372|P4|Completed SAU of Fixed Dose Placebo|Overall Study||2
45917|NCT01748799|107373|P3|Completed SAU of Fixed Dose Placebo|Overall Study||1
45918|NCT01748799|107374|P2|Completed SAU of Fixed Dose Placebo|Overall Study||1
45919|NCT01748799|107375|P1|Completed SAU of Fixed Dose Placebo|Overall Study||2
45920|NCT01748799|107368|P8|STARTED|Overall Study||1
45921|NCT01748799|107369|P7|STARTED|Overall Study||2
45922|NCT01748799|107370|P6|STARTED|Overall Study||2
45923|NCT01748799|107371|P5|STARTED|Overall Study||1
45924|NCT01748799|107372|P4|STARTED|Overall Study||2
45925|NCT01748799|107373|P3|STARTED|Overall Study||1
45926|NCT01748799|107374|P2|STARTED|Overall Study||1
45927|NCT01748799|107375|P1|STARTED|Overall Study||6
45928|NCT01748760|107411|P2|NOT COMPLETED|Overall Study||2
45929|NCT01748760|107412|P1|NOT COMPLETED|Overall Study||6
45930|NCT01748760|107411|P2|COMPLETED|Overall Study||23
45931|NCT01748760|107412|P1|COMPLETED|Overall Study||19
45932|NCT01748760|107411|P2|STARTED|Overall Study||25
45933|NCT01748760|107412|P1|STARTED|Overall Study||25
45934|NCT01749800|107421|P3|NOT COMPLETED|Overall Study||0
45935|NCT01749800|107422|P2|NOT COMPLETED|Overall Study||1
45936|NCT01749800|107423|P1|NOT COMPLETED|Overall Study||3
45937|NCT01749800|107421|P3|COMPLETED|Overall Study||0
45938|NCT01749800|107422|P2|COMPLETED|Overall Study||0
45939|NCT01749800|107423|P1|COMPLETED|Overall Study||3
45940|NCT01749800|107421|P3|STARTED|Overall Study||0
45941|NCT01749800|107422|P2|STARTED|Overall Study|1 subject showed significant motor impairments but decided to undergo therapy (exclusion criterion)|1
45942|NCT01749800|107423|P1|STARTED|Overall Study|3 subjects did not show significant attention span deficit (required inclusion criterion)|6
45943|NCT01749735|107433|P2|NOT COMPLETED|Overall Study||0
45944|NCT01749735|107434|P1|NOT COMPLETED|Overall Study||1
45945|NCT01749735|107433|P2|COMPLETED|Overall Study||0
45946|NCT01749735|107434|P1|COMPLETED|Overall Study||1
45948|NCT01749735|107434|P1|STARTED|Overall Study||2
45949|NCT01749631|107442|P1|NOT COMPLETED|Overall Study||0
45950|NCT01749631|107442|P1|COMPLETED|Overall Study||97
45951|NCT01749631|107442|P1|STARTED|Overall Study||97
45952|NCT01749605|107454|P2|NOT COMPLETED|Overall Study||3
45953|NCT01749605|107455|P1|NOT COMPLETED|Overall Study||4
45954|NCT01749605|107454|P2|COMPLETED|Overall Study||14
45955|NCT01749605|107455|P1|COMPLETED|Overall Study||14
45956|NCT01749605|107454|P2|STARTED|Overall Study||17
45957|NCT01749605|107455|P1|STARTED|Overall Study||18
45958|NCT01749501|107463|P2|NOT COMPLETED|Overall Study||0
45959|NCT01749501|107464|P1|NOT COMPLETED|Overall Study||0
45960|NCT01749501|107463|P2|COMPLETED|Overall Study||23
45961|NCT01749501|107464|P1|COMPLETED|Overall Study||22
45962|NCT01749501|107463|P2|STARTED|Overall Study||23
45963|NCT01749501|107464|P1|STARTED|Overall Study||22
45964|NCT01749410|107472|P1|NOT COMPLETED|Overall Study||0
45965|NCT01749410|107472|P1|COMPLETED|Overall Study||33
45966|NCT01749410|107472|P1|STARTED|Overall Study||33
45967|NCT01748955|107478|P2|NOT COMPLETED|Overall Study||5
45968|NCT01748955|107479|P1|NOT COMPLETED|Overall Study||3
45969|NCT01748955|107478|P2|COMPLETED|Overall Study||4
45970|NCT01748955|107479|P1|COMPLETED|Overall Study||3
45971|NCT01748955|107478|P2|STARTED|Overall Study||9
45972|NCT01748955|107479|P1|STARTED|Overall Study||6
45973|NCT01748916|107487|P6|NOT COMPLETED|Overall Study||0
45974|NCT01748916|107488|P5|NOT COMPLETED|Overall Study||0
45975|NCT01748916|107489|P4|NOT COMPLETED|Overall Study||0
45976|NCT01748916|107490|P3|NOT COMPLETED|Overall Study||0
45977|NCT01748916|107491|P2|NOT COMPLETED|Overall Study||0
45978|NCT01748916|107492|P1|NOT COMPLETED|Overall Study||0
45979|NCT01748916|107487|P6|COMPLETED|Overall Study||3
45980|NCT01748916|107488|P5|COMPLETED|Overall Study||3
45981|NCT01748916|107489|P4|COMPLETED|Overall Study||3
45982|NCT01748916|107490|P3|COMPLETED|Overall Study||2
45983|NCT01748916|107491|P2|COMPLETED|Overall Study||3
45984|NCT01748916|107492|P1|COMPLETED|Overall Study||2
45985|NCT01748916|107487|P6|STARTED|Overall Study||3
45986|NCT01748916|107488|P5|STARTED|Overall Study||3
45987|NCT01748916|107489|P4|STARTED|Overall Study||3
45988|NCT01748916|107490|P3|STARTED|Overall Study||2
45989|NCT01748916|107491|P2|STARTED|Overall Study||3
45990|NCT01748916|107492|P1|STARTED|Overall Study||2
45991|NCT01748890|107500|P1|NOT COMPLETED|Overall Study||4
45992|NCT01748890|107500|P1|COMPLETED|Overall Study|Insufficient recruitment for analysis|0
45993|NCT01748890|107500|P1|STARTED|Overall Study||4
45994|NCT01748695|107504|P2|NOT COMPLETED|Second Intervention (4 Weeks)||0
45995|NCT01748695|107505|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
45996|NCT01748695|107504|P2|COMPLETED|Second Intervention (4 Weeks)||11
45997|NCT01748695|107505|P1|COMPLETED|Second Intervention (4 Weeks)||14
45998|NCT01748695|107504|P2|STARTED|Second Intervention (4 Weeks)||11
45999|NCT01748695|107505|P1|STARTED|Second Intervention (4 Weeks)||14
46000|NCT01748695|107504|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
46001|NCT01748695|107505|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
46002|NCT01748695|107504|P2|COMPLETED|First Intervention (4 Weeks)||11
46003|NCT01748695|107505|P1|COMPLETED|First Intervention (4 Weeks)||14
46004|NCT01748695|107504|P2|STARTED|First Intervention (4 Weeks)||11
46005|NCT01748695|107505|P1|STARTED|First Intervention (4 Weeks)||14
46006|NCT01748643|107515|P2|NOT COMPLETED|Overall Study||0
46007|NCT01748643|107516|P1|NOT COMPLETED|Overall Study||0
46008|NCT01748643|107515|P2|COMPLETED|Overall Study||30
46009|NCT01748643|107516|P1|COMPLETED|Overall Study||30
46010|NCT01748643|107515|P2|STARTED|Overall Study||30
46011|NCT01748643|107516|P1|STARTED|Overall Study||30
46012|NCT01748227|107532|P1|NOT COMPLETED|Overall Study||3
46013|NCT01748227|107532|P1|COMPLETED|Overall Study||17
46014|NCT01748227|107532|P1|STARTED|Overall Study||20
46015|NCT01748071|107543|P3|NOT COMPLETED|Overall Study||0
46016|NCT01748071|107544|P2|NOT COMPLETED|Overall Study||2
46017|NCT01748071|107545|P1|NOT COMPLETED|Overall Study||2
46018|NCT01748071|107543|P3|COMPLETED|Overall Study||40
46019|NCT01748071|107544|P2|COMPLETED|Overall Study||38
46020|NCT01748071|107545|P1|COMPLETED|Overall Study||38
46021|NCT01748071|107543|P3|STARTED|Overall Study||40
46022|NCT01748071|107544|P2|STARTED|Overall Study||40
46023|NCT01748071|107545|P1|STARTED|Overall Study||40
46024|NCT01748045|107567|P2|NOT COMPLETED|Overall Study||0
46025|NCT01748045|107568|P1|NOT COMPLETED|Overall Study||0
46026|NCT01748045|107567|P2|COMPLETED|Overall Study||1
46027|NCT01748045|107568|P1|COMPLETED|Overall Study||2
46028|NCT01748045|107567|P2|STARTED|Overall Study||1
46029|NCT01748045|107568|P1|STARTED|Overall Study||2
46030|NCT01747928|107594|P8|NOT COMPLETED|Overall Study||0
46031|NCT01747928|107595|P7|NOT COMPLETED|Overall Study||0
46032|NCT01747928|107596|P6|NOT COMPLETED|Overall Study||0
46033|NCT01747928|107597|P5|NOT COMPLETED|Overall Study||0
46034|NCT01747928|107598|P4|NOT COMPLETED|Overall Study||0
46035|NCT01747928|107599|P3|NOT COMPLETED|Overall Study||0
46036|NCT01747928|107600|P2|NOT COMPLETED|Overall Study||0
46037|NCT01747928|107601|P1|NOT COMPLETED|Overall Study||0
46038|NCT01747928|107594|P8|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46039|NCT01747928|107595|P7|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46040|NCT01747928|107596|P6|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46041|NCT01747928|107597|P5|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46042|NCT01747928|107598|P4|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46043|NCT01747928|107599|P3|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46044|NCT01747928|107600|P2|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46045|NCT01747928|107601|P1|COMPLETED|Overall Study|Participants carried on assessment to a point where Observer could determine success/failure.|6
46046|NCT01747928|107594|P8|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46047|NCT01747928|107595|P7|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46048|NCT01747928|107596|P6|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46049|NCT01747928|107597|P5|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46050|NCT01747928|107598|P4|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46051|NCT01747928|107599|P3|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46052|NCT01747928|107600|P2|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46053|NCT01747928|107601|P1|STARTED|Overall Study|Participants initiated the attempt to perform the injection task.|6
46054|NCT01747811|107807|P2|NOT COMPLETED|Overall Study||4
46055|NCT01747811|107808|P1|NOT COMPLETED|Overall Study||2
46056|NCT01747811|107807|P2|COMPLETED|Overall Study||12
46057|NCT01747811|107808|P1|COMPLETED|Overall Study||14
46058|NCT01747811|107807|P2|STARTED|Overall Study||16
46059|NCT01747811|107808|P1|STARTED|Overall Study||16
46060|NCT01747772|107824|P1|NOT COMPLETED|Overall Study||9
46061|NCT01747772|107824|P1|COMPLETED|Overall Study||171
46062|NCT01747772|107824|P1|Analysis Population|Overall Study|All participants who completed the study and had adequate SWE and liver biopsy data.|164
46063|NCT01747772|107824|P1|STARTED|Overall Study||180
46064|NCT01747655|107832|P2|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
46065|NCT01747655|107833|P1|NOT COMPLETED|PEG-J Period (Continued Treatment)||0
46066|NCT01747655|107832|P2|COMPLETED|PEG-J Period (Continued Treatment)||15
46067|NCT01747655|107833|P1|COMPLETED|PEG-J Period (Continued Treatment)||41
46068|NCT01747655|107832|P2|STARTED|PEG-J Period (Continued Treatment)|SoC MAS: 6 SoC participants plus 9 participants who received Duodopa via PEG-J then returned to SoC|15
46069|NCT01747655|107833|P1|STARTED|PEG-J Period (Continued Treatment)||41
46070|NCT01747655|107832|P2|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||0
46071|NCT01747655|107833|P1|NOT COMPLETED|PEG-J Period (Duodopa Treatment)||14
46072|NCT01747655|107832|P2|COMPLETED|PEG-J Period (Duodopa Treatment)||6
46073|NCT01747655|107833|P1|COMPLETED|PEG-J Period (Duodopa Treatment)||44
46074|NCT01747655|107832|P2|STARTED|PEG-J Period (Duodopa Treatment)|Participants in the MAS that returned to SoC (no PEG-J introduced; did not meet selection criteria)|6
46075|NCT01747655|107833|P1|STARTED|PEG-J Period (Duodopa Treatment)|Dudopa MAS: Participants in the MAS that received Duodopa via PEG-J.|58
46076|NCT01747655|107832|P2|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
46077|NCT01747655|107833|P1|NOT COMPLETED|Temporary Naso-jejunal Tube Period||0
46078|NCT01747655|107832|P2|COMPLETED|Temporary Naso-jejunal Tube Period||0
46079|NCT01747655|107833|P1|COMPLETED|Temporary Naso-jejunal Tube Period||64
46080|NCT01747655|107832|P2|STARTED|Temporary Naso-jejunal Tube Period||0
46081|NCT01747655|107833|P1|STARTED|Temporary Naso-jejunal Tube Period|Main Analysis Set (MAS): participants with baseline and 1 further visit and ≥ 1 Duodopa treatment|64
46082|NCT01747629|107863|P2|NOT COMPLETED|Overall Study||6
46083|NCT01747629|107864|P1|NOT COMPLETED|Overall Study||8
46084|NCT01747629|107863|P2|COMPLETED|Overall Study||69
46085|NCT01747629|107864|P1|COMPLETED|Overall Study||77
46086|NCT01747629|107863|P2|Treated|Overall Study|Safety set and full analysis set|75
46087|NCT01747629|107864|P1|Treated|Overall Study|Safety set and full analysis set|84
46088|NCT01747629|107863|P2|STARTED|Overall Study||75
46089|NCT01747629|107864|P1|STARTED|Overall Study||85
46090|NCT01747343|107896|P1|NOT COMPLETED|Underwear/Differential Reinforcement||0
46091|NCT01747343|107896|P1|COMPLETED|Underwear/Differential Reinforcement||4
46092|NCT01747343|107896|P1|STARTED|Underwear/Differential Reinforcement||4
46093|NCT01747343|107896|P1|NOT COMPLETED|Underwear||0
46094|NCT01747343|107896|P1|COMPLETED|Underwear||4
46095|NCT01747343|107896|P1|STARTED|Underwear||4
46096|NCT01747343|107896|P1|NOT COMPLETED|Baseline||0
46097|NCT01747343|107896|P1|COMPLETED|Baseline||4
46098|NCT01747343|107896|P1|STARTED|Baseline||4
46099|NCT01747330|107902|P1|NOT COMPLETED|Overall Study||0
46100|NCT01747330|107902|P1|COMPLETED|Overall Study||40
46101|NCT01747330|107902|P1|STARTED|Overall Study||40
46102|NCT01746940|107918|P4|NOT COMPLETED|Safety Second Phase||0
46103|NCT01746940|107919|P3|NOT COMPLETED|Safety Second Phase||0
46104|NCT01746940|107920|P2|NOT COMPLETED|Safety Second Phase||0
46105|NCT01746940|107921|P1|NOT COMPLETED|Safety Second Phase||0
46106|NCT01746940|107918|P4|COMPLETED|Safety Second Phase||0
46107|NCT01746940|107919|P3|COMPLETED|Safety Second Phase||0
46108|NCT01746940|107920|P2|COMPLETED|Safety Second Phase||18
46109|NCT01746940|107921|P1|COMPLETED|Safety Second Phase||18
46110|NCT01746940|107918|P4|STARTED|Safety Second Phase||0
46111|NCT01746940|107919|P3|STARTED|Safety Second Phase||0
46112|NCT01746940|107920|P2|STARTED|Safety Second Phase||18
46113|NCT01746940|107921|P1|STARTED|Safety Second Phase||18
46114|NCT01746940|107918|P4|NOT COMPLETED|Safety and Efficacy First Phase||3
46115|NCT01746940|107919|P3|NOT COMPLETED|Safety and Efficacy First Phase||0
46116|NCT01746940|107920|P2|NOT COMPLETED|Safety and Efficacy First Phase||0
46117|NCT01746940|107921|P1|NOT COMPLETED|Safety and Efficacy First Phase||0
46118|NCT01746940|107918|P4|COMPLETED|Safety and Efficacy First Phase||0
46119|NCT01746940|107919|P3|COMPLETED|Safety and Efficacy First Phase||40
46120|NCT01746940|107920|P2|COMPLETED|Safety and Efficacy First Phase||41
46121|NCT01746940|107921|P1|COMPLETED|Safety and Efficacy First Phase||39
46122|NCT01746940|107918|P4|STARTED|Safety and Efficacy First Phase||3
46123|NCT01746940|107919|P3|STARTED|Safety and Efficacy First Phase||40
46124|NCT01746940|107920|P2|STARTED|Safety and Efficacy First Phase||41
46125|NCT01746940|107921|P1|STARTED|Safety and Efficacy First Phase||39
46126|NCT01746862|107931|P2|NOT COMPLETED|Overall Study||3
46127|NCT01746862|107932|P1|NOT COMPLETED|Overall Study||8
46128|NCT01746862|107931|P2|COMPLETED|Overall Study||27
46129|NCT01746862|107932|P1|COMPLETED|Overall Study||52
46130|NCT01746862|107931|P2|Treated|Overall Study||30
46131|NCT01746862|107932|P1|Treated|Overall Study||59
46132|NCT01746862|107931|P2|STARTED|Overall Study||30
46133|NCT01746862|107932|P1|STARTED|Overall Study||60
46134|NCT01746784|107957|P5|NOT COMPLETED|Overall Study||0
46135|NCT01746784|107958|P4|NOT COMPLETED|Overall Study||0
46136|NCT01746784|107959|P3|NOT COMPLETED|Overall Study||0
46137|NCT01746784|107960|P2|NOT COMPLETED|Overall Study||0
46138|NCT01746784|107961|P1|NOT COMPLETED|Overall Study||0
46139|NCT01746784|107957|P5|COMPLETED|Overall Study||19
46140|NCT01746784|107958|P4|COMPLETED|Overall Study||9
46141|NCT01746784|107959|P3|COMPLETED|Overall Study||9
46142|NCT01746784|107960|P2|COMPLETED|Overall Study||10
46143|NCT01746784|107961|P1|COMPLETED|Overall Study||19
46144|NCT01746784|107957|P5|Enrolled|Overall Study||19
46145|NCT01746784|107958|P4|Enrolled|Overall Study||9
46146|NCT01746784|107959|P3|Enrolled|Overall Study||9
46147|NCT01746784|107960|P2|Enrolled|Overall Study||10
46148|NCT01746784|107961|P1|Enrolled|Overall Study||19
46149|NCT01746784|107957|P5|STARTED|Overall Study||19
46150|NCT01746784|107958|P4|STARTED|Overall Study||9
46151|NCT01746784|107959|P3|STARTED|Overall Study||9
46152|NCT01746784|107960|P2|STARTED|Overall Study||10
46153|NCT01746784|107961|P1|STARTED|Overall Study||19
46154|NCT01746511|107985|P2|NOT COMPLETED|Overall Study||0
46155|NCT01746511|107986|P1|NOT COMPLETED|Overall Study||0
46156|NCT01746511|107985|P2|COMPLETED|Overall Study||39
46157|NCT01746511|107986|P1|COMPLETED|Overall Study||40
46158|NCT01746511|107985|P2|STARTED|Overall Study||39
46159|NCT01746511|107986|P1|STARTED|Overall Study||40
46160|NCT01746368|108002|P2|NOT COMPLETED|Overall Study||1
46161|NCT01746368|108003|P1|NOT COMPLETED|Overall Study||2
46162|NCT01746368|108002|P2|COMPLETED|Overall Study||16
46163|NCT01746368|108003|P1|COMPLETED|Overall Study||31
46164|NCT01746368|108002|P2|Analyzed for Satisfaction|Overall Study||16
46165|NCT01746368|108003|P1|Analyzed for Satisfaction|Overall Study||30
46166|NCT01746368|108002|P2|Analyzed for AD Completion Rate|Overall Study||17
46167|NCT01746368|108003|P1|Analyzed for AD Completion Rate|Overall Study||32
46168|NCT01746368|108002|P2|Assessment Completed|Overall Study||16
46169|NCT01746368|108003|P1|Assessment Completed|Overall Study||31
46170|NCT01746368|108002|P2|Recieved Allocated Intervention|Overall Study||8
46171|NCT01746368|108003|P1|Recieved Allocated Intervention|Overall Study||31
46172|NCT01746368|108002|P2|STARTED|Overall Study||17
46173|NCT01746368|108003|P1|STARTED|Overall Study||33
46174|NCT01746264|108011|P1|NOT COMPLETED|Overall Study||0
46175|NCT01746264|108011|P1|COMPLETED|Overall Study||19
46176|NCT01746264|108011|P1|STARTED|Overall Study||19
46177|NCT01746173|108030|P1|NOT COMPLETED|Overall Study||2
46178|NCT01746173|108030|P1|COMPLETED|Overall Study||3
46179|NCT01746173|108030|P1|STARTED|Overall Study||5
46180|NCT01746108|108038|P3|NOT COMPLETED|Overall Study||0
46181|NCT01746108|108039|P2|NOT COMPLETED|Overall Study||4
46182|NCT01746108|108040|P1|NOT COMPLETED|Overall Study||0
46183|NCT01746108|108038|P3|COMPLETED|Overall Study||6
46184|NCT01746108|108039|P2|COMPLETED|Overall Study||24
46185|NCT01746108|108040|P1|COMPLETED|Overall Study||18
46186|NCT01746108|108038|P3|STARTED|Overall Study||6
46187|NCT01746108|108039|P2|STARTED|Overall Study||28
46188|NCT01746108|108040|P1|STARTED|Overall Study||18
46189|NCT01745952|108076|P3|NOT COMPLETED|Overall Study||0
46190|NCT01745952|108077|P2|NOT COMPLETED|Overall Study||1
46191|NCT01745952|108078|P1|NOT COMPLETED|Overall Study||1
46192|NCT01745952|108076|P3|COMPLETED|Overall Study||3
46193|NCT01745952|108077|P2|COMPLETED|Overall Study|data of one patient not used due to no seizure diary entries on multiple occasions|3
46194|NCT01745952|108078|P1|COMPLETED|Overall Study||3
46195|NCT01745952|108076|P3|STARTED|Overall Study||3
46196|NCT01745952|108077|P2|STARTED|Overall Study||4
46197|NCT01745952|108078|P1|STARTED|Overall Study||4
46198|NCT01745913|108104|P2|NOT COMPLETED|Overall Study||1
46199|NCT01745913|108105|P1|NOT COMPLETED|Overall Study||1
46200|NCT01745913|108104|P2|COMPLETED|Overall Study||0
46201|NCT01745913|108105|P1|COMPLETED|Overall Study||0
46202|NCT01745913|108104|P2|STARTED|Overall Study||1
46203|NCT01745913|108105|P1|STARTED|Overall Study||1
46204|NCT01745848|108113|P1|NOT COMPLETED|Overall Study||6
46205|NCT01745848|108113|P1|COMPLETED|Overall Study||20
46206|NCT01745848|108113|P1|STARTED|Overall Study||26
46207|NCT01745380|108120|P2|NOT COMPLETED|Overall Study||1
46208|NCT01745380|108121|P1|NOT COMPLETED|Overall Study||1
46209|NCT01745380|108120|P2|COMPLETED|Overall Study||49
46210|NCT01745380|108121|P1|COMPLETED|Overall Study||99
46211|NCT01745380|108120|P2|STARTED|Overall Study||50
46212|NCT01745380|108121|P1|STARTED|Overall Study||100
46213|NCT01745133|108160|P3|NOT COMPLETED|Overall Study||4
46214|NCT01745133|108161|P2|NOT COMPLETED|Overall Study||4
46215|NCT01745133|108162|P1|NOT COMPLETED|Overall Study||6
46216|NCT01745133|108160|P3|COMPLETED|Overall Study||15
46217|NCT01745133|108161|P2|COMPLETED|Overall Study||16
46218|NCT01745133|108162|P1|COMPLETED|Overall Study||13
46219|NCT01745133|108160|P3|STARTED|Overall Study||19
46220|NCT01745133|108161|P2|STARTED|Overall Study||20
46221|NCT01745133|108162|P1|STARTED|Overall Study||19
46222|NCT01745055|108170|P1|NOT COMPLETED|Overall Study||0
46223|NCT01745055|108170|P1|COMPLETED|Overall Study||12
46224|NCT01745055|108170|P1|STARTED|Overall Study||12
46225|NCT01744977|108205|P2|NOT COMPLETED|Overall Study||5
46226|NCT01744977|108206|P1|NOT COMPLETED|Overall Study||11
46227|NCT01744977|108205|P2|COMPLETED|Overall Study||115
46228|NCT01744977|108206|P1|COMPLETED|Overall Study||109
46229|NCT01744977|108205|P2|6 Month Completed|Overall Study||115
46230|NCT01744977|108206|P1|6 Month Completed|Overall Study||113
46231|NCT01744977|108205|P2|STARTED|Overall Study||120
46232|NCT01744977|108206|P1|STARTED|Overall Study||120
46233|NCT01744860|108214|P1|NOT COMPLETED|Overall Study||0
46234|NCT01744860|108214|P1|COMPLETED|Overall Study||420
46235|NCT01744860|108214|P1|STARTED|Overall Study||420
46236|NCT01744821|108252|P4|NOT COMPLETED|Overall Study||0
46237|NCT01744821|108253|P3|NOT COMPLETED|Overall Study||0
46238|NCT01744821|108254|P2|NOT COMPLETED|Overall Study||0
46239|NCT01744821|108255|P1|NOT COMPLETED|Overall Study||0
46240|NCT01744821|108252|P4|COMPLETED|Overall Study||1
46241|NCT01744821|108253|P3|COMPLETED|Overall Study||2
46242|NCT01744821|108254|P2|COMPLETED|Overall Study||3
46243|NCT01744821|108255|P1|COMPLETED|Overall Study||1
46244|NCT01744821|108252|P4|STARTED|Overall Study||1
46245|NCT01744821|108253|P3|STARTED|Overall Study||2
46246|NCT01744821|108254|P2|STARTED|Overall Study||3
46247|NCT01744821|108255|P1|STARTED|Overall Study||1
46248|NCT01744730|108282|P5|NOT COMPLETED|Overall Study||0
46249|NCT01744730|108283|P4|NOT COMPLETED|Overall Study||0
46250|NCT01744730|108284|P3|NOT COMPLETED|Overall Study||0
46251|NCT01744730|108285|P2|NOT COMPLETED|Overall Study||0
46252|NCT01744730|108286|P1|NOT COMPLETED|Overall Study||0
46253|NCT01744730|108282|P5|COMPLETED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
46254|NCT01744730|108283|P4|COMPLETED|Overall Study||11
46255|NCT01744730|108284|P3|COMPLETED|Overall Study||4
46256|NCT01744730|108285|P2|COMPLETED|Overall Study||3
46257|NCT01744730|108286|P1|COMPLETED|Overall Study||4
46258|NCT01744730|108282|P5|STARTED|Overall Study|Please note this study (NCT01431326) is ongoing and data only represents a subset of this study.|178
46259|NCT01744730|108283|P4|STARTED|Overall Study||11
46260|NCT01744730|108284|P3|STARTED|Overall Study||4
46261|NCT01744730|108285|P2|STARTED|Overall Study||3
46262|NCT01744730|108286|P1|STARTED|Overall Study||4
46263|NCT01744691|108329|P1|NOT COMPLETED|Overall Study||43
46264|NCT01744691|108329|P1|COMPLETED|Overall Study|Participants who were on study treatment at the time of the primary analysis|101
46265|NCT01744691|108329|P1|STARTED|Overall Study|Participants who received study treatment|144
46266|NCT01744496|108336|P2|NOT COMPLETED|Maintenance Period||4
46267|NCT01744496|108337|P1|NOT COMPLETED|Maintenance Period||4
46268|NCT01744496|108336|P2|COMPLETED|Maintenance Period||29
46269|NCT01744496|108337|P1|COMPLETED|Maintenance Period||27
46270|NCT01744496|108336|P2|STARTED|Maintenance Period||33
46271|NCT01744496|108337|P1|STARTED|Maintenance Period||31
46272|NCT01744496|108336|P2|NOT COMPLETED|Titration Period||2
46273|NCT01744496|108337|P1|NOT COMPLETED|Titration Period||2
46274|NCT01744496|108336|P2|COMPLETED|Titration Period||33
46275|NCT01744496|108337|P1|COMPLETED|Titration Period||31
46276|NCT01744496|108336|P2|STARTED|Titration Period||35
46277|NCT01744496|108337|P1|STARTED|Titration Period||33
46278|NCT01744483|108358|P3|NOT COMPLETED|Overall Study||28
46279|NCT01744483|108359|P2|NOT COMPLETED|Overall Study||22
46280|NCT01744483|108360|P1|NOT COMPLETED|Overall Study||29
46281|NCT01744483|108358|P3|COMPLETED|Overall Study||10
46282|NCT01744483|108359|P2|COMPLETED|Overall Study||13
46283|NCT01744483|108360|P1|COMPLETED|Overall Study||15
46284|NCT01744483|108358|P3|STARTED|Overall Study||38
46285|NCT01744483|108359|P2|STARTED|Overall Study||35
46286|NCT01744483|108360|P1|STARTED|Overall Study||44
46287|NCT01744392|108368|P1|NOT COMPLETED|Overall Study||1
46288|NCT01744392|108368|P1|COMPLETED|Overall Study||22
46289|NCT01744392|108368|P1|STARTED|Overall Study||23
46290|NCT01744353|108384|P3|NOT COMPLETED|Overall Study||0
46291|NCT01744353|108385|P2|NOT COMPLETED|Overall Study||0
46292|NCT01744353|108386|P1|NOT COMPLETED|Overall Study||0
46293|NCT01744353|108384|P3|COMPLETED|Overall Study||3
46294|NCT01744353|108385|P2|COMPLETED|Overall Study||26
46295|NCT01744353|108386|P1|COMPLETED|Overall Study||6
46296|NCT01744353|108384|P3|STARTED|Overall Study||3
46297|NCT01744353|108385|P2|STARTED|Overall Study||26
46298|NCT01744353|108386|P1|STARTED|Overall Study||6
46299|NCT01744340|108397|P2|NOT COMPLETED|Overall Study||0
46300|NCT01744340|108398|P1|NOT COMPLETED|Overall Study||0
46301|NCT01744340|108397|P2|COMPLETED|Overall Study||15
46302|NCT01744340|108398|P1|COMPLETED|Overall Study||8
46303|NCT01744340|108397|P2|STARTED|Overall Study||15
46304|NCT01744340|108398|P1|STARTED|Overall Study||8
46305|NCT01744197|108408|P2|NOT COMPLETED|Overall Study||3
46306|NCT01744197|108409|P1|NOT COMPLETED|Overall Study||4
46307|NCT01744197|108408|P2|COMPLETED|Overall Study||26
46308|NCT01744197|108409|P1|COMPLETED|Overall Study||28
46309|NCT01744197|108408|P2|STARTED|Overall Study||29
46310|NCT01744197|108409|P1|STARTED|Overall Study||32
46311|NCT01743963|108421|P2|NOT COMPLETED|Overall Study||0
46312|NCT01743963|108422|P1|NOT COMPLETED|Overall Study||0
46313|NCT01743963|108421|P2|COMPLETED|Overall Study||17
46314|NCT01743963|108422|P1|COMPLETED|Overall Study||21
46315|NCT01743963|108421|P2|STARTED|Overall Study||17
46316|NCT01743963|108422|P1|STARTED|Overall Study||21
46317|NCT01743729|108430|P2|NOT COMPLETED|Overall Study||12
46318|NCT01743729|108431|P1|NOT COMPLETED|Overall Study||37
46319|NCT01743729|108430|P2|COMPLETED|Overall Study||348
46320|NCT01743729|108431|P1|COMPLETED|Overall Study||321
46321|NCT01743729|108430|P2|STARTED|Overall Study|One placebo participant was considered for Lifitegrast arm; Placebo safety analysis set (N= 359).|360
46322|NCT01743729|108431|P1|STARTED|Overall Study|One participant from placebo arm included in Lifitegrast arm for safety analysis set (N=359).|358
46323|NCT01743521|108443|P4|NOT COMPLETED|Overall Study||0
46324|NCT01743521|108444|P3|NOT COMPLETED|Overall Study||0
46325|NCT01743521|108445|P2|NOT COMPLETED|Overall Study||0
46326|NCT01743521|108446|P1|NOT COMPLETED|Overall Study||0
46327|NCT01743521|108443|P4|COMPLETED|Overall Study||2
46328|NCT01743521|108444|P3|COMPLETED|Overall Study||2
46329|NCT01743521|108445|P2|COMPLETED|Overall Study||3
46330|NCT01743521|108446|P1|COMPLETED|Overall Study||7
46331|NCT01743521|108443|P4|STARTED|Overall Study||2
46332|NCT01743521|108444|P3|STARTED|Overall Study||2
46333|NCT01743521|108445|P2|STARTED|Overall Study||3
46334|NCT01743521|108446|P1|STARTED|Overall Study||7
46335|NCT01743092|108498|P2|NOT COMPLETED|Overall Study||15
46336|NCT01743092|108499|P1|NOT COMPLETED|Overall Study||14
46337|NCT01743092|108498|P2|COMPLETED|Overall Study||11
46338|NCT01743092|108499|P1|COMPLETED|Overall Study||19
46339|NCT01743092|108498|P2|STARTED|Overall Study||26
46340|NCT01743092|108499|P1|STARTED|Overall Study||33
46341|NCT01743027|108511|P4|NOT COMPLETED|Overall Study||1
46342|NCT01743027|108512|P3|NOT COMPLETED|Overall Study||9
46343|NCT01743027|108513|P2|NOT COMPLETED|Overall Study||5
46344|NCT01743027|108514|P1|NOT COMPLETED|Overall Study||5
46345|NCT01743027|108511|P4|COMPLETED|Overall Study||48
46346|NCT01743027|108512|P3|COMPLETED|Overall Study||90
46347|NCT01743027|108513|P2|COMPLETED|Overall Study||94
46348|NCT01743027|108514|P1|COMPLETED|Overall Study||93
46349|NCT01743027|108511|P4|STARTED|Overall Study||49
46350|NCT01743027|108512|P3|STARTED|Overall Study||99
46351|NCT01743027|108513|P2|STARTED|Overall Study||99
46352|NCT01743027|108514|P1|STARTED|Overall Study||98
46353|NCT01742936|108554|P2|NOT COMPLETED|Overall Study||0
46354|NCT01742936|108555|P1|NOT COMPLETED|Overall Study||0
46355|NCT01742936|108554|P2|COMPLETED|Overall Study||50
46356|NCT01742936|108555|P1|COMPLETED|Overall Study||50
46357|NCT01742936|108554|P2|STARTED|Overall Study||50
46358|NCT01742936|108555|P1|STARTED|Overall Study||50
46359|NCT01742897|108563|P1|NOT COMPLETED|Overall Study||5
46360|NCT01742897|108563|P1|COMPLETED|Overall Study||30
46361|NCT01742897|108563|P1|Treated|Overall Study||33
46362|NCT01742897|108563|P1|STARTED|Overall Study||35
46363|NCT01742832|108569|P2|NOT COMPLETED|Overall Study||5
46364|NCT01742832|108570|P1|NOT COMPLETED|Overall Study||1
46365|NCT01742832|108569|P2|COMPLETED|Overall Study||23
46366|NCT01742832|108570|P1|COMPLETED|Overall Study||19
46367|NCT01742832|108569|P2|STARTED|Overall Study||28
46368|NCT01742832|108570|P1|STARTED|Overall Study||20
46369|NCT01742364|108580|P4|NOT COMPLETED|Overall Study||0
46370|NCT01742364|108581|P3|NOT COMPLETED|Overall Study||0
46371|NCT01742364|108582|P2|NOT COMPLETED|Overall Study||0
46372|NCT01742364|108583|P1|NOT COMPLETED|Overall Study||0
46373|NCT01742364|108580|P4|COMPLETED|Overall Study||15
46374|NCT01742364|108581|P3|COMPLETED|Overall Study||15
46375|NCT01742364|108582|P2|COMPLETED|Overall Study||33
46376|NCT01742364|108583|P1|COMPLETED|Overall Study||33
46377|NCT01742364|108580|P4|STARTED|Overall Study||15
46378|NCT01742364|108581|P3|STARTED|Overall Study||15
46379|NCT01742364|108582|P2|STARTED|Overall Study||33
46380|NCT01742364|108583|P1|STARTED|Overall Study||33
46381|NCT01741792|108612|P3|NOT COMPLETED|Overall Study||12
46382|NCT01741792|108613|P2|NOT COMPLETED|Overall Study||1
46383|NCT01741792|108614|P1|NOT COMPLETED|Overall Study||6
46384|NCT01741792|108612|P3|COMPLETED|Overall Study||2
46385|NCT01741792|108613|P2|COMPLETED|Overall Study||1
46386|NCT01741792|108614|P1|COMPLETED|Overall Study||3
46387|NCT01741792|108612|P3|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|13
46388|NCT01741792|108613|P2|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|1
46389|NCT01741792|108614|P1|Efficacy Set|Overall Study|Completed > 7 days of infusion on the highest intended dose level or discontinued due to progression|7
46390|NCT01741792|108612|P3|STARTED|Overall Study||14
46391|NCT01741792|108613|P2|STARTED|Overall Study|Cohort 2 was closed to enrollment on recommendation of the data monitoring committee|2
46392|NCT01741792|108614|P1|STARTED|Overall Study|3 participants were not considered evaluable and were replaced as specified in the protocol.|9
46393|NCT01741701|108681|P2|NOT COMPLETED|Overall Study||2
46394|NCT01741701|108682|P1|NOT COMPLETED|Overall Study||5
46395|NCT01741701|108681|P2|COMPLETED|Overall Study||13
46396|NCT01741701|108682|P1|COMPLETED|Overall Study||13
46397|NCT01741701|108681|P2|STARTED|Overall Study||15
46398|NCT01741701|108682|P1|STARTED|Overall Study||18
46399|NCT01741688|108698|P1|NOT COMPLETED|Overall Study||3
46400|NCT01741688|108698|P1|COMPLETED|Overall Study||13
46401|NCT01741688|108698|P1|STARTED|Overall Study||16
46402|NCT01741350|108717|P2|NOT COMPLETED|12-Month Follow-up Assessment||2
46403|NCT01741350|108718|P1|NOT COMPLETED|12-Month Follow-up Assessment||3
46404|NCT01741350|108717|P2|COMPLETED|12-Month Follow-up Assessment||109
46405|NCT01741350|108718|P1|COMPLETED|12-Month Follow-up Assessment||111
46406|NCT01741350|108717|P2|STARTED|12-Month Follow-up Assessment||111
46407|NCT01741350|108718|P1|STARTED|12-Month Follow-up Assessment||114
46408|NCT01741350|108717|P2|NOT COMPLETED|6-Month Follow-up Assessment||8
46409|NCT01741350|108718|P1|NOT COMPLETED|6-Month Follow-up Assessment||15
46410|NCT01741350|108717|P2|COMPLETED|6-Month Follow-up Assessment||111
46411|NCT01741350|108718|P1|COMPLETED|6-Month Follow-up Assessment||114
46412|NCT01741350|108717|P2|STARTED|6-Month Follow-up Assessment||119
46413|NCT01741350|108718|P1|STARTED|6-Month Follow-up Assessment||129
46414|NCT01741350|108717|P2|NOT COMPLETED|3-Month Follow-up Assessment||22
46415|NCT01741350|108718|P1|NOT COMPLETED|3-Month Follow-up Assessment||6
46416|NCT01741350|108717|P2|COMPLETED|3-Month Follow-up Assessment||119
46417|NCT01741350|108718|P1|COMPLETED|3-Month Follow-up Assessment||129
46418|NCT01741350|108717|P2|STARTED|3-Month Follow-up Assessment||141
46419|NCT01741350|108718|P1|STARTED|3-Month Follow-up Assessment||135
46420|NCT01741350|108717|P2|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
46421|NCT01741350|108718|P1|NOT COMPLETED|Post Intervention Assessment (at Week 4)||14
46422|NCT01741350|108717|P2|COMPLETED|Post Intervention Assessment (at Week 4)||141
46423|NCT01741350|108718|P1|COMPLETED|Post Intervention Assessment (at Week 4)||135
46424|NCT01741350|108717|P2|STARTED|Post Intervention Assessment (at Week 4)||155
46425|NCT01741350|108718|P1|STARTED|Post Intervention Assessment (at Week 4)||149
46426|NCT01741350|108717|P2|NOT COMPLETED|Study Intervention||0
46427|NCT01741350|108718|P1|NOT COMPLETED|Study Intervention||0
46428|NCT01741350|108717|P2|COMPLETED|Study Intervention||155
46429|NCT01741350|108718|P1|COMPLETED|Study Intervention||149
46430|NCT01741350|108717|P2|STARTED|Study Intervention||155
46431|NCT01741350|108718|P1|STARTED|Study Intervention||149
46432|NCT01741272|108854|P2|NOT COMPLETED|Overall Study||0
46433|NCT01741272|108855|P1|NOT COMPLETED|Overall Study||0
46434|NCT01741272|108854|P2|COMPLETED|Overall Study||97
46435|NCT01741272|108855|P1|COMPLETED|Overall Study||92
46436|NCT01741272|108854|P2|STARTED|Overall Study||97
46437|NCT01741272|108855|P1|STARTED|Overall Study||92
46438|NCT01740817|108869|P2|NOT COMPLETED|Second Intervention (48 h)||0
46439|NCT01740817|108870|P1|NOT COMPLETED|Second Intervention (48 h)||0
46440|NCT01740817|108869|P2|COMPLETED|Second Intervention (48 h)||4
46441|NCT01740817|108870|P1|COMPLETED|Second Intervention (48 h)||8
46442|NCT01740817|108869|P2|STARTED|Second Intervention (48 h)||4
46443|NCT01740817|108870|P1|STARTED|Second Intervention (48 h)||8
46444|NCT01740817|108869|P2|NOT COMPLETED|Washout (4-6 Weeks)||0
46445|NCT01740817|108870|P1|NOT COMPLETED|Washout (4-6 Weeks)||0
46446|NCT01740817|108869|P2|COMPLETED|Washout (4-6 Weeks)||4
46447|NCT01740817|108870|P1|COMPLETED|Washout (4-6 Weeks)||8
46448|NCT01740817|108869|P2|STARTED|Washout (4-6 Weeks)||4
46449|NCT01740817|108870|P1|STARTED|Washout (4-6 Weeks)||8
46450|NCT01740817|108869|P2|NOT COMPLETED|First Intervention (48 h)||0
46451|NCT01740817|108870|P1|NOT COMPLETED|First Intervention (48 h)||0
46452|NCT01740817|108869|P2|COMPLETED|First Intervention (48 h)||4
46453|NCT01740817|108870|P1|COMPLETED|First Intervention (48 h)||8
46454|NCT01740817|108869|P2|STARTED|First Intervention (48 h)||4
46455|NCT01740817|108870|P1|STARTED|First Intervention (48 h)||8
46456|NCT01740726|108882|P2|NOT COMPLETED|Overall Study||0
46457|NCT01740726|108883|P1|NOT COMPLETED|Overall Study||0
46458|NCT01740726|108882|P2|COMPLETED|Overall Study||1
46459|NCT01740726|108883|P1|COMPLETED|Overall Study||0
46460|NCT01740726|108882|P2|STARTED|Overall Study||1
46461|NCT01740726|108883|P1|STARTED|Overall Study||0
46462|NCT01740713|108892|P3|NOT COMPLETED|Overall Study||1
46463|NCT01740713|108893|P2|NOT COMPLETED|Overall Study||2
46464|NCT01740713|108894|P1|NOT COMPLETED|Overall Study||0
46465|NCT01740713|108892|P3|COMPLETED|Overall Study||6
46466|NCT01740713|108893|P2|COMPLETED|Overall Study||6
46467|NCT01740713|108894|P1|COMPLETED|Overall Study||6
46468|NCT01740713|108892|P3|STARTED|Overall Study||7
46469|NCT01740713|108893|P2|STARTED|Overall Study||8
46470|NCT01740713|108894|P1|STARTED|Overall Study||6
46471|NCT01740440|108918|P1|NOT COMPLETED|Overall Study||3
46472|NCT01740440|108918|P1|COMPLETED|Overall Study||27
46473|NCT01740440|108918|P1|STARTED|Overall Study||30
46474|NCT01740427|108926|P2|NOT COMPLETED|Overall Study||222
46475|NCT01740427|108927|P1|NOT COMPLETED|Overall Study||444
46476|NCT01740427|108926|P2|COMPLETED|Overall Study||0
46477|NCT01740427|108927|P1|COMPLETED|Overall Study||0
46478|NCT01740427|108926|P2|STARTED|Overall Study||222
46479|NCT01740427|108927|P1|STARTED|Overall Study||444
46480|NCT01740414|108956|P2|NOT COMPLETED|Overall Study||8
46481|NCT01740414|108957|P1|NOT COMPLETED|Overall Study||9
46482|NCT01740414|108956|P2|COMPLETED|Overall Study||8
46483|NCT01740414|108957|P1|COMPLETED|Overall Study||3
46484|NCT01740414|108956|P2|STARTED|Overall Study||16
46485|NCT01740414|108957|P1|STARTED|Overall Study||12
46486|NCT01740401|108979|P1|NOT COMPLETED|Overall Study||10
46487|NCT01740401|108979|P1|COMPLETED|Overall Study||0
46488|NCT01740401|108979|P1|STARTED|Overall Study||10
46489|NCT01740388|108988|P2|NOT COMPLETED|Overall Study||44
46490|NCT01740388|108989|P1|NOT COMPLETED|Overall Study||46
46491|NCT01740388|108988|P2|COMPLETED|Overall Study||28
46492|NCT01740388|108989|P1|COMPLETED|Overall Study||18
46493|NCT01740388|108988|P2|STARTED|Overall Study||72
46494|NCT01740388|108989|P1|STARTED|Overall Study||64
46495|NCT01740362|109009|P4|NOT COMPLETED|Overall Study||0
46496|NCT01740362|109010|P3|NOT COMPLETED|Overall Study||0
46497|NCT01740362|109011|P2|NOT COMPLETED|Overall Study||0
46498|NCT01740362|109012|P1|NOT COMPLETED|Overall Study||0
46499|NCT01740362|109009|P4|COMPLETED|Overall Study||6
46500|NCT01740362|109010|P3|COMPLETED|Overall Study||6
46501|NCT01740362|109011|P2|COMPLETED|Overall Study||6
46502|NCT01740362|109012|P1|COMPLETED|Overall Study||6
46503|NCT01740362|109009|P4|STARTED|Overall Study||6
46504|NCT01740362|109010|P3|STARTED|Overall Study||6
46505|NCT01740362|109011|P2|STARTED|Overall Study||6
46506|NCT01740362|109012|P1|STARTED|Overall Study||6
46507|NCT01740089|109041|P3|NOT COMPLETED|After 12 Weeks||11
46508|NCT01740089|109042|P2|NOT COMPLETED|After 12 Weeks||3
46509|NCT01740089|109043|P1|NOT COMPLETED|After 12 Weeks||7
46510|NCT01740089|109041|P3|COMPLETED|After 12 Weeks|"Withdrawn due to:
No EVR (n=4) AE (n=5) Non-attendance of visit (n=1) Withdrawn consent (n=1)"|37
46511|NCT01740089|109042|P2|COMPLETED|After 12 Weeks|"Withdrawn due to:
Withdrawn consent (n=1) No EVR (n=1) Non-compliance (n=1)"|45
46512|NCT01740089|109043|P1|COMPLETED|After 12 Weeks|"Withdrawn due to:
No EVR (n=3) AE (n=2) No EOT (n=1) Non-compliance (n=1)"|43
46513|NCT01740089|109041|P3|STARTED|After 12 Weeks||48
46514|NCT01740089|109042|P2|STARTED|After 12 Weeks||48
46515|NCT01740089|109043|P1|STARTED|After 12 Weeks||50
46516|NCT01740089|109041|P3|NOT COMPLETED|First 12 Weeks of Treatment||2
46517|NCT01740089|109042|P2|NOT COMPLETED|First 12 Weeks of Treatment||2
46518|NCT01740089|109043|P1|NOT COMPLETED|First 12 Weeks of Treatment||0
46519|NCT01740089|109041|P3|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
AE before W12 (n=2)"|48
46520|NCT01740089|109042|P2|COMPLETED|First 12 Weeks of Treatment|"Withdrawn due to:
AE before W12 (n=1) Withdrew consent before W12 (n=1)"|48
46521|NCT01740089|109043|P1|COMPLETED|First 12 Weeks of Treatment||50
46522|NCT01740089|109041|P3|STARTED|First 12 Weeks of Treatment||50
46523|NCT01740089|109042|P2|STARTED|First 12 Weeks of Treatment||50
46524|NCT01740089|109043|P1|STARTED|First 12 Weeks of Treatment||50
46525|NCT01739803|109061|P2|NOT COMPLETED|Overall Study||6
46526|NCT01739803|109062|P1|NOT COMPLETED|Overall Study||9
46527|NCT01739803|109061|P2|COMPLETED|Overall Study||68
46528|NCT01739803|109062|P1|COMPLETED|Overall Study||67
46529|NCT01739803|109061|P2|STARTED|Overall Study||74
46530|NCT01739803|109062|P1|STARTED|Overall Study||76
46531|NCT01739595|109075|P3|NOT COMPLETED|Overall Study||2
46532|NCT01739595|109076|P2|NOT COMPLETED|Overall Study||1
46533|NCT01739595|109077|P1|NOT COMPLETED|Overall Study||13
46534|NCT01739595|109075|P3|COMPLETED|Overall Study||45
46535|NCT01739595|109076|P2|COMPLETED|Overall Study||21
46536|NCT01739595|109077|P1|COMPLETED|Overall Study||99
46537|NCT01739595|109075|P3|STARTED|Overall Study||47
46538|NCT01739595|109076|P2|STARTED|Overall Study||22
46539|NCT01739595|109077|P1|STARTED|Overall Study||112
46540|NCT01739361|109087|P2|NOT COMPLETED|Overall Study||1
46541|NCT01739361|109088|P1|NOT COMPLETED|Overall Study||3
46542|NCT01739361|109087|P2|COMPLETED|Overall Study||22
46543|NCT01739361|109088|P1|COMPLETED|Overall Study||18
46544|NCT01739361|109087|P2|STARTED|Overall Study||23
46545|NCT01739361|109088|P1|STARTED|Overall Study||21
46546|NCT01738984|109096|P2|NOT COMPLETED|Overall Study||39
46547|NCT01738984|109097|P1|NOT COMPLETED|Overall Study||64
46548|NCT01738984|109096|P2|COMPLETED|Overall Study||210
46549|NCT01738984|109097|P1|COMPLETED|Overall Study||186
46550|NCT01738984|109096|P2|STARTED|Overall Study||249
46551|NCT01738984|109097|P1|STARTED|Overall Study||250
46552|NCT01738971|109110|P3|NOT COMPLETED|Overall Study||17
46553|NCT01738971|109111|P2|NOT COMPLETED|Overall Study||30
46554|NCT01738971|109112|P1|NOT COMPLETED|Overall Study||19
46555|NCT01738971|109110|P3|COMPLETED|Overall Study|39 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|39
46556|NCT01738971|109111|P2|COMPLETED|Overall Study|28 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|28
46557|NCT01738971|109112|P1|COMPLETED|Overall Study|35 participants successfully contacted to complete telephone follow-up at 6-8 weeks.|35
46558|NCT01738971|109110|P3|STARTED|Overall Study|56 participants recruited to this arm|56
46650|NCT01737879|109398|P1|Transitioned to Epoetin Alfa|Overall Study||0
46559|NCT01738971|109111|P2|STARTED|Overall Study|58 participants recruited to this arm|58
46560|NCT01738971|109112|P1|STARTED|Overall Study|54 participants recruited to this arm|54
46561|NCT01738919|109128|P2|NOT COMPLETED|Overall Study||3
46562|NCT01738919|109129|P1|NOT COMPLETED|Overall Study||1
46563|NCT01738919|109128|P2|COMPLETED|Overall Study||14
46564|NCT01738919|109129|P1|COMPLETED|Overall Study||14
46565|NCT01738919|109128|P2|STARTED|Overall Study||17
46566|NCT01738919|109129|P1|STARTED|Overall Study||15
46567|NCT01738750|109147|P2|NOT COMPLETED|Overall Study||0
46568|NCT01738750|109148|P1|NOT COMPLETED|Overall Study||0
46569|NCT01738750|109147|P2|COMPLETED|Overall Study||51
46570|NCT01738750|109148|P1|COMPLETED|Overall Study||49
46571|NCT01738750|109147|P2|STARTED|Overall Study||51
46572|NCT01738750|109148|P1|STARTED|Overall Study||49
46573|NCT01738737|109161|P5|NOT COMPLETED|Overall Study||4
46574|NCT01738737|109162|P4|NOT COMPLETED|Overall Study||4
46575|NCT01738737|109163|P3|NOT COMPLETED|Overall Study||4
46576|NCT01738737|109164|P2|NOT COMPLETED|Overall Study||4
46577|NCT01738737|109165|P1|NOT COMPLETED|Overall Study||4
46578|NCT01738737|109161|P5|COMPLETED|Overall Study||25
46579|NCT01738737|109162|P4|COMPLETED|Overall Study||25
46580|NCT01738737|109163|P3|COMPLETED|Overall Study||25
46581|NCT01738737|109164|P2|COMPLETED|Overall Study||25
46582|NCT01738737|109165|P1|COMPLETED|Overall Study||25
46583|NCT01738737|109161|P5|STARTED|Overall Study||29
46584|NCT01738737|109162|P4|STARTED|Overall Study||29
46585|NCT01738737|109163|P3|STARTED|Overall Study||29
46586|NCT01738737|109164|P2|STARTED|Overall Study||29
46587|NCT01738737|109165|P1|STARTED|Overall Study||29
46588|NCT01738698|109201|P4|NOT COMPLETED|Overall Study||0
46589|NCT01738698|109202|P3|NOT COMPLETED|Overall Study||0
46590|NCT01738698|109203|P2|NOT COMPLETED|Overall Study||0
46591|NCT01738698|109204|P1|NOT COMPLETED|Overall Study||0
46592|NCT01738698|109201|P4|COMPLETED|Overall Study||0
46593|NCT01738698|109202|P3|COMPLETED|Overall Study||0
46594|NCT01738698|109203|P2|COMPLETED|Overall Study||0
46595|NCT01738698|109204|P1|COMPLETED|Overall Study||0
46596|NCT01738698|109201|P4|STARTED|Overall Study||0
46597|NCT01738698|109202|P3|STARTED|Overall Study||0
46598|NCT01738698|109203|P2|STARTED|Overall Study||0
46599|NCT01738698|109204|P1|STARTED|Overall Study||0
46600|NCT01738646|109270|P1|NOT COMPLETED|Overall Study||2
46601|NCT01738646|109270|P1|COMPLETED|Overall Study|Participants who discontinued study drug for any reason.|38
46602|NCT01738646|109270|P1|STARTED|Overall Study||40
46603|NCT01738581|109280|P2|NOT COMPLETED|Overall Study||0
46604|NCT01738581|109281|P1|NOT COMPLETED|Overall Study||1
46605|NCT01738581|109280|P2|COMPLETED|Overall Study||4
46606|NCT01738581|109281|P1|COMPLETED|Overall Study||4
46607|NCT01738581|109280|P2|STARTED|Overall Study||4
46608|NCT01738581|109281|P1|STARTED|Overall Study||5
46609|NCT01738438|109299|P1|NOT COMPLETED|Overall Study||35
46610|NCT01738438|109299|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
46611|NCT01738438|109299|P1|STARTED|Overall Study||35
46612|NCT01738321|109307|P2|NOT COMPLETED|Overall Study||0
46613|NCT01738321|109308|P1|NOT COMPLETED|Overall Study||0
46614|NCT01738321|109307|P2|COMPLETED|Overall Study||30
46615|NCT01738321|109308|P1|COMPLETED|Overall Study||33
46616|NCT01738321|109307|P2|STARTED|Overall Study||30
46617|NCT01738321|109308|P1|STARTED|Overall Study||33
46618|NCT01737996|109317|P3|NOT COMPLETED|Overall Study||2
46619|NCT01737996|109318|P2|NOT COMPLETED|Overall Study||1
46620|NCT01737996|109319|P1|NOT COMPLETED|Overall Study||0
46621|NCT01737996|109317|P3|COMPLETED|Overall Study|One patient withdrew consent after the first dose due to private reasons.|14
46622|NCT01737996|109318|P2|COMPLETED|Overall Study||7
46623|NCT01737996|109319|P1|COMPLETED|Overall Study||8
46624|NCT01737996|109317|P3|STARTED|Overall Study||16
46625|NCT01737996|109318|P2|STARTED|Overall Study||8
46626|NCT01737996|109319|P1|STARTED|Overall Study||8
46627|NCT01737944|109360|P4|NOT COMPLETED|Overall Study||0
46628|NCT01737944|109361|P3|NOT COMPLETED|Overall Study||0
46629|NCT01737944|109362|P2|NOT COMPLETED|Overall Study||0
46630|NCT01737944|109363|P1|NOT COMPLETED|Overall Study||0
46631|NCT01737944|109360|P4|COMPLETED|Overall Study||9
46632|NCT01737944|109361|P3|COMPLETED|Overall Study||9
46633|NCT01737944|109362|P2|COMPLETED|Overall Study||9
46634|NCT01737944|109363|P1|COMPLETED|Overall Study||9
46635|NCT01737944|109360|P4|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
46728|NCT01736696|109594|P3|STARTED|Overall Study||10
46636|NCT01737944|109361|P3|STARTED|Overall Study|10 patients randomized, one patient discontinued before first study drug dose|9
46637|NCT01737944|109362|P2|STARTED|Overall Study||9
46638|NCT01737944|109363|P1|STARTED|Overall Study||9
46639|NCT01737931|109381|P3|NOT COMPLETED|Overall Study||1
46640|NCT01737931|109382|P2|NOT COMPLETED|Overall Study||2
46641|NCT01737931|109383|P1|NOT COMPLETED|Overall Study||0
46642|NCT01737931|109381|P3|COMPLETED|Overall Study||38
46643|NCT01737931|109382|P2|COMPLETED|Overall Study||38
46644|NCT01737931|109383|P1|COMPLETED|Overall Study||38
46645|NCT01737931|109381|P3|STARTED|Overall Study||39
46646|NCT01737931|109382|P2|STARTED|Overall Study||40
46647|NCT01737931|109383|P1|STARTED|Overall Study||38
46648|NCT01737879|109398|P1|NOT COMPLETED|Overall Study||41
46649|NCT01737879|109398|P1|COMPLETED|Overall Study||0
46651|NCT01737879|109398|P1|Received Peginesatide|Overall Study||34
46652|NCT01737879|109398|P1|STARTED|Overall Study||41
46653|NCT01737840|109407|P2|NOT COMPLETED|Overall Study||2
46654|NCT01737840|109408|P1|NOT COMPLETED|Overall Study||2
46655|NCT01737840|109407|P2|COMPLETED|Overall Study||33
46656|NCT01737840|109408|P1|COMPLETED|Overall Study||33
46657|NCT01737840|109407|P2|STARTED|Overall Study||35
46658|NCT01737840|109408|P1|STARTED|Overall Study||35
46659|NCT01737762|109418|P2|NOT COMPLETED|Overall Study||17
46660|NCT01737762|109419|P1|NOT COMPLETED|Overall Study||20
46661|NCT01737762|109418|P2|COMPLETED|Overall Study||61
46662|NCT01737762|109419|P1|COMPLETED|Overall Study||57
46663|NCT01737762|109418|P2|STARTED|Overall Study||78
46664|NCT01737762|109419|P1|STARTED|Overall Study||77
46665|NCT01737710|109432|P5|NOT COMPLETED|Overall Study||0
46666|NCT01737710|109433|P4|NOT COMPLETED|Overall Study||0
46667|NCT01737710|109434|P3|NOT COMPLETED|Overall Study||3
46668|NCT01737710|109435|P2|NOT COMPLETED|Overall Study||4
46669|NCT01737710|109436|P1|NOT COMPLETED|Overall Study||2
46670|NCT01737710|109432|P5|COMPLETED|Overall Study||21
46671|NCT01737710|109433|P4|COMPLETED|Overall Study||23
46672|NCT01737710|109434|P3|COMPLETED|Overall Study||102
46673|NCT01737710|109435|P2|COMPLETED|Overall Study||101
46674|NCT01737710|109436|P1|COMPLETED|Overall Study||112
46675|NCT01737710|109432|P5|STARTED|Overall Study||21
46676|NCT01737710|109433|P4|STARTED|Overall Study||23
46677|NCT01737710|109434|P3|STARTED|Overall Study||105
46678|NCT01737710|109435|P2|STARTED|Overall Study||105
46679|NCT01737710|109436|P1|STARTED|Overall Study||114
46680|NCT01737684|109475|P3|NOT COMPLETED|Overall Study||0
46681|NCT01737684|109476|P2|NOT COMPLETED|Overall Study||0
46682|NCT01737684|109477|P1|NOT COMPLETED|Overall Study||0
46683|NCT01737684|109475|P3|COMPLETED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
46684|NCT01737684|109476|P2|COMPLETED|Overall Study||8
46685|NCT01737684|109477|P1|COMPLETED|Overall Study||8
46686|NCT01737684|109475|P3|STARTED|Overall Study|Participants with mild hepatic insufficiency were not enrolled in study.|0
46687|NCT01737684|109476|P2|STARTED|Overall Study||8
46688|NCT01737684|109477|P1|STARTED|Overall Study||8
46689|NCT01737593|109496|P3|NOT COMPLETED|Overall Study||0
46690|NCT01737593|109497|P2|NOT COMPLETED|Overall Study||0
46691|NCT01737593|109498|P1|NOT COMPLETED|Overall Study||0
46692|NCT01737593|109496|P3|COMPLETED|Overall Study||39
46693|NCT01737593|109497|P2|COMPLETED|Overall Study||32
46694|NCT01737593|109498|P1|COMPLETED|Overall Study||37
46695|NCT01737593|109496|P3|STARTED|Overall Study||39
46696|NCT01737593|109497|P2|STARTED|Overall Study||32
46697|NCT01737593|109498|P1|STARTED|Overall Study||37
46698|NCT01737021|109529|P2|NOT COMPLETED|Overall Study||3
46699|NCT01737021|109530|P1|NOT COMPLETED|Overall Study||5
46700|NCT01737021|109529|P2|COMPLETED|Overall Study||6
46701|NCT01737021|109530|P1|COMPLETED|Overall Study||17
46702|NCT01737021|109529|P2|STARTED|Overall Study||9
46703|NCT01737021|109530|P1|STARTED|Overall Study||22
46704|NCT01736930|109536|P1|NOT COMPLETED|Overall Study||1
46705|NCT01736930|109536|P1|COMPLETED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|19
46706|NCT01736930|109536|P1|STARTED|Overall Study|Each night randomized to have either Predictive Low Glucose suspend or inactive (control).|20
46707|NCT01736917|109576|P1|NOT COMPLETED|Overall Study||11
46708|NCT01736917|109576|P1|COMPLETED|Overall Study||54
46709|NCT01736917|109576|P1|STARTED|Overall Study||65
46710|NCT01736696|109590|P7|NOT COMPLETED|Overall Study||0
46711|NCT01736696|109591|P6|NOT COMPLETED|Overall Study||0
46712|NCT01736696|109592|P5|NOT COMPLETED|Overall Study||0
46713|NCT01736696|109593|P4|NOT COMPLETED|Overall Study||0
46714|NCT01736696|109594|P3|NOT COMPLETED|Overall Study||1
46715|NCT01736696|109595|P2|NOT COMPLETED|Overall Study||0
46716|NCT01736696|109596|P1|NOT COMPLETED|Overall Study||0
46717|NCT01736696|109590|P7|COMPLETED|Overall Study||13
46718|NCT01736696|109591|P6|COMPLETED|Overall Study||8
46719|NCT01736696|109592|P5|COMPLETED|Overall Study||9
46720|NCT01736696|109593|P4|COMPLETED|Overall Study||9
46721|NCT01736696|109594|P3|COMPLETED|Overall Study||9
46722|NCT01736696|109595|P2|COMPLETED|Overall Study||5
46723|NCT01736696|109596|P1|COMPLETED|Overall Study||5
46724|NCT01736696|109590|P7|STARTED|Overall Study||13
46725|NCT01736696|109591|P6|STARTED|Overall Study||8
46726|NCT01736696|109592|P5|STARTED|Overall Study||9
46727|NCT01736696|109593|P4|STARTED|Overall Study||9
46729|NCT01736696|109595|P2|STARTED|Overall Study||5
46730|NCT01736696|109596|P1|STARTED|Overall Study||5
46731|NCT01736657|109913|P1|NOT COMPLETED|Overall Study||1
46732|NCT01736657|109913|P1|COMPLETED|Overall Study||72
46733|NCT01736657|109913|P1|STARTED|Overall Study||73
46734|NCT01736579|109922|P2|NOT COMPLETED|Overall Study||2
46735|NCT01736579|109923|P1|NOT COMPLETED|Overall Study||2
46736|NCT01736579|109922|P2|COMPLETED|Overall Study||0
46737|NCT01736579|109923|P1|COMPLETED|Overall Study||0
46738|NCT01736579|109922|P2|STARTED|Overall Study||2
46739|NCT01736579|109923|P1|STARTED|Overall Study||2
46740|NCT01736540|109957|P1|NOT COMPLETED|Overall Study||15
46741|NCT01736540|109957|P1|COMPLETED|Overall Study||228
46742|NCT01736540|109957|P1|STARTED|Overall Study||243
46743|NCT01736527|110014|P1|NOT COMPLETED|Overall Study||0
46744|NCT01736527|110014|P1|COMPLETED|Overall Study||12
46745|NCT01736527|110014|P1|STARTED|Overall Study||12
46746|NCT01736475|110023|P2|NOT COMPLETED|Overall Study||0
46747|NCT01736475|110024|P1|NOT COMPLETED|Overall Study||12
46748|NCT01736475|110023|P2|COMPLETED|Overall Study||17
46749|NCT01736475|110024|P1|COMPLETED|Overall Study||109
46750|NCT01736475|110023|P2|STARTED|Overall Study||17
46751|NCT01736475|110024|P1|STARTED|Overall Study||121
46752|NCT01736215|110077|P1|NOT COMPLETED|Overall Study||14
46753|NCT01736215|110077|P1|COMPLETED|Overall Study||19
46754|NCT01736215|110077|P1|Treated|Overall Study||25
46755|NCT01736215|110077|P1|STARTED|Overall Study||33
46756|NCT01736176|110089|P1|NOT COMPLETED|Overall Study||11
46757|NCT01736176|110089|P1|COMPLETED|Overall Study||28
46758|NCT01736176|110089|P1|Received LCIG|Overall Study||38
46759|NCT01736176|110089|P1|STARTED|Overall Study|Enrolled participants who underwent the PEG-J placement procedure|39
46760|NCT01735916|110136|P3|NOT COMPLETED|Overall Study||7
46761|NCT01735916|110137|P2|NOT COMPLETED|Overall Study||19
46762|NCT01735916|110138|P1|NOT COMPLETED|Overall Study||18
46763|NCT01735916|110136|P3|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
46764|NCT01735916|110137|P2|COMPLETED|Overall Study|Study was cancelled before any subjects completed 24 months of follow-up or met any study endpoints.|0
46765|NCT01735916|110138|P1|COMPLETED|Overall Study||0
46766|NCT01735916|110136|P3|STARTED|Overall Study||7
46767|NCT01735916|110137|P2|STARTED|Overall Study||19
46768|NCT01735916|110138|P1|STARTED|Overall Study||18
46769|NCT01735877|110159|P2|NOT COMPLETED|Overall Study||0
46770|NCT01735877|110160|P1|NOT COMPLETED|Overall Study||1
46771|NCT01735877|110159|P2|COMPLETED|Overall Study||21
46772|NCT01735877|110160|P1|COMPLETED|Overall Study||26
46773|NCT01735877|110159|P2|STARTED|Overall Study||21
46774|NCT01735877|110160|P1|STARTED|Overall Study||27
46775|NCT01735630|110176|P2|NOT COMPLETED|Overall Study||18
46776|NCT01735630|110177|P1|NOT COMPLETED|Overall Study||18
46777|NCT01735630|110176|P2|COMPLETED|Overall Study||157
46778|NCT01735630|110177|P1|COMPLETED|Overall Study||157
46779|NCT01735630|110176|P2|STARTED|Overall Study||175
46780|NCT01735630|110177|P1|STARTED|Overall Study||175
46781|NCT01735617|110191|P1|NOT COMPLETED|Overall Study||0
46782|NCT01735617|110191|P1|COMPLETED|Overall Study||16
46783|NCT01735617|110191|P1|STARTED|Overall Study||16
46784|NCT01735396|110204|P1|NOT COMPLETED|Overall Study||1
46785|NCT01735396|110204|P1|COMPLETED|Overall Study||10
46786|NCT01735396|110204|P1|STARTED|Overall Study||11
46787|NCT01735214|110213|P1|NOT COMPLETED|Overall Study||0
46788|NCT01735214|110213|P1|COMPLETED|Overall Study||358
46789|NCT01735214|110213|P1|STARTED|Overall Study||358
46790|NCT01735201|110233|P8|NOT COMPLETED|Overall Study||2
46791|NCT01735201|110234|P7|NOT COMPLETED|Overall Study||3
46792|NCT01735201|110235|P6|NOT COMPLETED|Overall Study||5
46793|NCT01735201|110236|P5|NOT COMPLETED|Overall Study||1
46794|NCT01735201|110237|P4|NOT COMPLETED|Overall Study||2
46795|NCT01735201|110238|P3|NOT COMPLETED|Overall Study||0
46796|NCT01735201|110239|P2|NOT COMPLETED|Overall Study||1
46797|NCT01735201|110240|P1|NOT COMPLETED|Overall Study||3
46798|NCT01735201|110233|P8|COMPLETED|Overall Study||42
46799|NCT01735201|110234|P7|COMPLETED|Overall Study||42
46800|NCT01735201|110235|P6|COMPLETED|Overall Study||40
46801|NCT01735201|110236|P5|COMPLETED|Overall Study||44
46802|NCT01735201|110237|P4|COMPLETED|Overall Study||42
46803|NCT01735201|110238|P3|COMPLETED|Overall Study||44
46804|NCT01735201|110239|P2|COMPLETED|Overall Study||43
46805|NCT01735201|110240|P1|COMPLETED|Overall Study||42
46806|NCT01735201|110233|P8|STARTED|Overall Study||44
46807|NCT01735201|110234|P7|STARTED|Overall Study||45
46808|NCT01735201|110235|P6|STARTED|Overall Study||45
46809|NCT01735201|110236|P5|STARTED|Overall Study||45
46810|NCT01735201|110237|P4|STARTED|Overall Study||44
46811|NCT01735201|110238|P3|STARTED|Overall Study||44
46812|NCT01735201|110239|P2|STARTED|Overall Study||44
46813|NCT01735201|110240|P1|STARTED|Overall Study||45
46814|NCT01735175|110276|P2|NOT COMPLETED|Overall Study||13
46815|NCT01735175|110277|P1|NOT COMPLETED|Overall Study||29
46816|NCT01735175|110276|P2|COMPLETED|Overall Study||144
46817|NCT01735175|110277|P1|COMPLETED|Overall Study||130
46818|NCT01735175|110276|P2|Completed the 6-month SFU Visit|Overall Study||138
46819|NCT01735175|110277|P1|Completed the 6-month SFU Visit|Overall Study||120
46820|NCT01735175|110276|P2|Completed All Treatments as Planned|Overall Study||150
46821|NCT01735175|110277|P1|Completed All Treatments as Planned|Overall Study||140
46822|NCT01735175|110276|P2|Completed All Cycles|Overall Study||150
46823|NCT01735175|110277|P1|Completed All Cycles|Overall Study||141
46824|NCT01735175|110276|P2|STARTED|Overall Study||157
46825|NCT01735175|110277|P1|STARTED|Overall Study||159
46826|NCT01734993|110297|P1|NOT COMPLETED|Overall Study||2
46827|NCT01734993|110297|P1|COMPLETED|Overall Study||9
46828|NCT01734993|110297|P1|STARTED|Overall Study||11
46829|NCT01734889|110323|P1|NOT COMPLETED|Overall Study||0
46830|NCT01734889|110323|P1|COMPLETED|Overall Study||18
46831|NCT01734889|110323|P1|STARTED|Overall Study||18
46832|NCT01734785|110334|P4|NOT COMPLETED|Double−Blind Period||0
46833|NCT01734785|110335|P3|NOT COMPLETED|Double−Blind Period||5
46834|NCT01734785|110336|P2|NOT COMPLETED|Double−Blind Period||9
46835|NCT01734785|110337|P1|NOT COMPLETED|Double−Blind Period||5
46836|NCT01734785|110334|P4|COMPLETED|Double−Blind Period||0
46837|NCT01734785|110335|P3|COMPLETED|Double−Blind Period||105
46838|NCT01734785|110336|P2|COMPLETED|Double−Blind Period||103
46839|NCT01734785|110337|P1|COMPLETED|Double−Blind Period||106
46840|NCT01734785|110334|P4|STARTED|Double−Blind Period||0
46841|NCT01734785|110335|P3|STARTED|Double−Blind Period||110
46842|NCT01734785|110336|P2|STARTED|Double−Blind Period||112
46843|NCT01734785|110337|P1|STARTED|Double−Blind Period||111
46844|NCT01734785|110334|P4|NOT COMPLETED|Open−Label Period||273
46845|NCT01734785|110335|P3|NOT COMPLETED|Open−Label Period||0
46846|NCT01734785|110336|P2|NOT COMPLETED|Open−Label Period||0
46847|NCT01734785|110337|P1|NOT COMPLETED|Open−Label Period||0
46848|NCT01734785|110334|P4|COMPLETED|Open−Label Period||333
46849|NCT01734785|110335|P3|COMPLETED|Open−Label Period||0
46850|NCT01734785|110336|P2|COMPLETED|Open−Label Period||0
46851|NCT01734785|110337|P1|COMPLETED|Open−Label Period||0
46852|NCT01734785|110334|P4|STARTED|Open−Label Period||606
46853|NCT01734785|110335|P3|STARTED|Open−Label Period||0
46854|NCT01734785|110336|P2|STARTED|Open−Label Period||0
46855|NCT01734785|110337|P1|STARTED|Open−Label Period||0
46856|NCT01734772|110354|P2|NOT COMPLETED|Overall Study||3
46857|NCT01734772|110355|P1|NOT COMPLETED|Overall Study||1
46858|NCT01734772|110354|P2|COMPLETED|Overall Study||21
46859|NCT01734772|110355|P1|COMPLETED|Overall Study||23
46860|NCT01734772|110354|P2|STARTED|Overall Study||24
46861|NCT01734772|110355|P1|STARTED|Overall Study||24
46862|NCT01734655|110372|P1|NOT COMPLETED|Overall Study||0
46863|NCT01734655|110372|P1|COMPLETED|Overall Study||40
46864|NCT01734655|110372|P1|STARTED|Overall Study||40
46865|NCT01734395|110381|P1|NOT COMPLETED|Overall Study||410
46866|NCT01734395|110381|P1|COMPLETED|Overall Study||1472
46867|NCT01734395|110381|P1|STARTED|Overall Study||1882
46868|NCT01734317|110387|P1|NOT COMPLETED|Overall Study||0
46869|NCT01734317|110387|P1|COMPLETED|Overall Study||10
46870|NCT01734317|110387|P1|STARTED|Overall Study||10
46871|NCT01734239|110393|P2|NOT COMPLETED|Overall Study||0
46872|NCT01734239|110394|P1|NOT COMPLETED|Overall Study||0
46873|NCT01734239|110393|P2|COMPLETED|Overall Study||50
46874|NCT01734239|110394|P1|COMPLETED|Overall Study||52
46875|NCT01734239|110393|P2|STARTED|Overall Study||50
46876|NCT01734239|110394|P1|STARTED|Overall Study||52
46877|NCT01734161|110409|P2|NOT COMPLETED|Overall Study||8
46878|NCT01734161|110410|P1|NOT COMPLETED|Overall Study||6
46879|NCT01734161|110409|P2|COMPLETED|Overall Study||53
46880|NCT01734161|110410|P1|COMPLETED|Overall Study||55
46881|NCT01734161|110409|P2|STARTED|Overall Study||61
46882|NCT01734161|110410|P1|STARTED|Overall Study||61
46883|NCT01733953|110418|P2|NOT COMPLETED|Overall Study||7
46884|NCT01733953|110419|P1|NOT COMPLETED|Overall Study||5
46885|NCT01733953|110418|P2|COMPLETED|Overall Study||6
46886|NCT01733953|110419|P1|COMPLETED|Overall Study||9
46887|NCT01733953|110418|P2|STARTED|Overall Study||13
46888|NCT01733953|110419|P1|STARTED|Overall Study||14
46889|NCT01733758|110439|P4|NOT COMPLETED|Overall Study||8
46890|NCT01733758|110440|P3|NOT COMPLETED|Overall Study||15
46891|NCT01733758|110441|P2|NOT COMPLETED|Overall Study||12
46892|NCT01733758|110442|P1|NOT COMPLETED|Overall Study||15
46893|NCT01733758|110439|P4|COMPLETED|Overall Study||95
46894|NCT01733758|110440|P3|COMPLETED|Overall Study||135
46895|NCT01733758|110441|P2|COMPLETED|Overall Study||148
46896|NCT01733758|110442|P1|COMPLETED|Overall Study||62
46897|NCT01733758|110439|P4|STARTED|Overall Study||103
46898|NCT01733758|110440|P3|STARTED|Overall Study||150
46899|NCT01733758|110441|P2|STARTED|Overall Study||160
46900|NCT01733758|110442|P1|STARTED|Overall Study||77
46901|NCT01733745|110495|P2|NOT COMPLETED|Overall Study||0
46902|NCT01733745|110496|P1|NOT COMPLETED|Overall Study||0
46903|NCT01733745|110495|P2|COMPLETED|Overall Study||13
46904|NCT01733745|110496|P1|COMPLETED|Overall Study||13
46905|NCT01733745|110495|P2|STARTED|Overall Study||13
46906|NCT01733745|110496|P1|STARTED|Overall Study||13
46907|NCT01733732|110508|P2|NOT COMPLETED|Overall Study||0
46908|NCT01733732|110509|P1|NOT COMPLETED|Overall Study||2
46909|NCT01733732|110508|P2|COMPLETED|Overall Study||27
46910|NCT01733732|110509|P1|COMPLETED|Overall Study||25
46911|NCT01733732|110508|P2|STARTED|Overall Study||27
46912|NCT01733732|110509|P1|STARTED|Overall Study||27
46913|NCT01733329|110545|P2|NOT COMPLETED|Overall Study||1
46914|NCT01733329|110546|P1|NOT COMPLETED|Overall Study||2
46915|NCT01733329|110545|P2|COMPLETED|Overall Study||60
46916|NCT01733329|110546|P1|COMPLETED|Overall Study||60
46917|NCT01733329|110545|P2|STARTED|Overall Study||61
46918|NCT01733329|110546|P1|STARTED|Overall Study||62
46919|NCT01733316|110558|P1|NOT COMPLETED|Overall Study||2
46920|NCT01733316|110558|P1|COMPLETED|Overall Study||39
46921|NCT01733316|110558|P1|STARTED|Overall Study||41
46922|NCT01733277|110582|P2|NOT COMPLETED|Overall Study||0
46923|NCT01733277|110583|P1|NOT COMPLETED|Overall Study||0
46924|NCT01733277|110582|P2|COMPLETED|Overall Study||25
46925|NCT01733277|110583|P1|COMPLETED|Overall Study||25
46926|NCT01733277|110582|P2|STARTED|Overall Study||25
46927|NCT01733277|110583|P1|STARTED|Overall Study||25
46928|NCT01732263|110595|P2|NOT COMPLETED|Overall Study||0
46929|NCT01732263|110596|P1|NOT COMPLETED|Overall Study||0
46930|NCT01732263|110595|P2|COMPLETED|Overall Study||20
46931|NCT01732263|110596|P1|COMPLETED|Overall Study||23
46932|NCT01732263|110595|P2|STARTED|Overall Study||20
46933|NCT01732263|110596|P1|STARTED|Overall Study||23
46934|NCT01733121|110638|P2|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
46935|NCT01733121|110639|P1|NOT COMPLETED|Follow-Up Period (Week 6 to 8)||0
46936|NCT01733121|110638|P2|COMPLETED|Follow-Up Period (Week 6 to 8)||46
46937|NCT01733121|110639|P1|COMPLETED|Follow-Up Period (Week 6 to 8)||44
46938|NCT01733121|110638|P2|STARTED|Follow-Up Period (Week 6 to 8)||46
46939|NCT01733121|110639|P1|STARTED|Follow-Up Period (Week 6 to 8)||44
46940|NCT01733121|110638|P2|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||5
46941|NCT01733121|110639|P1|NOT COMPLETED|Double-Blind Period (Week 0 to 6)||7
46942|NCT01733121|110638|P2|COMPLETED|Double-Blind Period (Week 0 to 6)||46
46943|NCT01733121|110639|P1|COMPLETED|Double-Blind Period (Week 0 to 6)||44
46944|NCT01733121|110638|P2|STARTED|Double-Blind Period (Week 0 to 6)||51
46945|NCT01733121|110639|P1|STARTED|Double-Blind Period (Week 0 to 6)||51
46946|NCT01733069|110653|P2|NOT COMPLETED|Overall Study||0
46947|NCT01733069|110654|P1|NOT COMPLETED|Overall Study||0
46948|NCT01733069|110653|P2|COMPLETED|Overall Study||1598
46949|NCT01733069|110654|P1|COMPLETED|Overall Study||264
46950|NCT01733069|110653|P2|STARTED|Overall Study||1598
46951|NCT01733069|110654|P1|STARTED|Overall Study||264
46952|NCT01733056|110663|P3|NOT COMPLETED|Overall Study||0
46953|NCT01733056|110664|P2|NOT COMPLETED|Overall Study||0
46954|NCT01733056|110665|P1|NOT COMPLETED|Overall Study||0
46955|NCT01733056|110663|P3|COMPLETED|Overall Study||12
46956|NCT01733056|110664|P2|COMPLETED|Overall Study||10
46957|NCT01733056|110665|P1|COMPLETED|Overall Study||21
46958|NCT01733056|110663|P3|STARTED|Overall Study||12
46959|NCT01733056|110664|P2|STARTED|Overall Study||10
46960|NCT01733056|110665|P1|STARTED|Overall Study||21
46961|NCT01732926|110681|P2|NOT COMPLETED|Overall Study||110
46962|NCT01732926|110682|P1|NOT COMPLETED|Overall Study||267
46963|NCT01732926|110681|P2|COMPLETED|Overall Study||45
46964|NCT01732926|110682|P1|COMPLETED|Overall Study||53
46965|NCT01732926|110681|P2|STARTED|Overall Study||155
46966|NCT01732926|110682|P1|STARTED|Overall Study||320
46967|NCT01732913|110698|P2|NOT COMPLETED|Overall Study||69
46968|NCT01732913|110699|P1|NOT COMPLETED|Overall Study||156
46969|NCT01732913|110698|P2|COMPLETED|Overall Study||28
46970|NCT01732913|110699|P1|COMPLETED|Overall Study||42
46971|NCT01732913|110698|P2|STARTED|Overall Study||97
46972|NCT01732913|110699|P1|STARTED|Overall Study||198
46973|NCT01732835|110713|P1|NOT COMPLETED|2-year Extended Follow-up||5
46974|NCT01732835|110713|P1|COMPLETED|2-year Extended Follow-up||39
46975|NCT01732835|110713|P1|STARTED|2-year Extended Follow-up||44
46976|NCT01732835|110713|P1|NOT COMPLETED|6-month Primary Endpoint||24
46977|NCT01732835|110713|P1|COMPLETED|6-month Primary Endpoint||44
46978|NCT01732835|110713|P1|STARTED|6-month Primary Endpoint||68
46979|NCT01732796|110747|P3|NOT COMPLETED|Overall Study||13
46980|NCT01732796|110748|P2|NOT COMPLETED|Overall Study||42
46981|NCT01732796|110749|P1|NOT COMPLETED|Overall Study||46
46982|NCT01732796|110747|P3|COMPLETED|Overall Study||38
46983|NCT01732796|110748|P2|COMPLETED|Overall Study||169
46984|NCT01732796|110749|P1|COMPLETED|Overall Study||162
46985|NCT01732796|110747|P3|STARTED|Overall Study||51
46986|NCT01732796|110748|P2|STARTED|Overall Study||211
46987|NCT01732796|110749|P1|STARTED|Overall Study||208
46988|NCT01732770|110767|P2|NOT COMPLETED|Overall Study||8
46989|NCT01732770|110768|P1|NOT COMPLETED|Overall Study||10
46990|NCT01732770|110767|P2|COMPLETED|Overall Study||313
46991|NCT01732770|110768|P1|COMPLETED|Overall Study||312
46992|NCT01732770|110767|P2|Received Study Treatment|Overall Study||320
46993|NCT01732770|110768|P1|Received Study Treatment|Overall Study||320
46994|NCT01732770|110767|P2|STARTED|Overall Study||321
46995|NCT01732770|110768|P1|STARTED|Overall Study||322
46996|NCT01732757|110783|P3|NOT COMPLETED|Overall Study||0
46997|NCT01732757|110784|P2|NOT COMPLETED|Overall Study||0
46998|NCT01732757|110785|P1|NOT COMPLETED|Overall Study||1
46999|NCT01732757|110783|P3|COMPLETED|Overall Study||52
47000|NCT01732757|110784|P2|COMPLETED|Overall Study||52
47001|NCT01732757|110785|P1|COMPLETED|Overall Study||52
47002|NCT01732757|110783|P3|STARTED|Overall Study||52
47003|NCT01732757|110784|P2|STARTED|Overall Study||52
47004|NCT01732757|110785|P1|STARTED|Overall Study||53
47005|NCT01732692|110825|P2|NOT COMPLETED|Overall Study||1
47006|NCT01732692|110826|P1|NOT COMPLETED|Overall Study||0
47007|NCT01732692|110825|P2|COMPLETED|Overall Study||69
47008|NCT01732692|110826|P1|COMPLETED|Overall Study||70
47009|NCT01732692|110825|P2|STARTED|Overall Study||70
47010|NCT01732692|110826|P1|STARTED|Overall Study||70
47011|NCT01732588|110843|P3|NOT COMPLETED|Third Intervention (7 Days)||0
47012|NCT01732588|110844|P2|NOT COMPLETED|Third Intervention (7 Days)||0
47013|NCT01732588|110845|P1|NOT COMPLETED|Third Intervention (7 Days)||0
47014|NCT01732588|110843|P3|COMPLETED|Third Intervention (7 Days)||4
47015|NCT01732588|110844|P2|COMPLETED|Third Intervention (7 Days)||2
47016|NCT01732588|110845|P1|COMPLETED|Third Intervention (7 Days)||4
47017|NCT01732588|110843|P3|STARTED|Third Intervention (7 Days)||4
47018|NCT01732588|110844|P2|STARTED|Third Intervention (7 Days)||2
47019|NCT01732588|110845|P1|STARTED|Third Intervention (7 Days)||4
47020|NCT01732588|110843|P3|NOT COMPLETED|Second Intervention (7 Days)||0
47021|NCT01732588|110844|P2|NOT COMPLETED|Second Intervention (7 Days)||0
47022|NCT01732588|110845|P1|NOT COMPLETED|Second Intervention (7 Days)||0
47023|NCT01732588|110843|P3|COMPLETED|Second Intervention (7 Days)||4
47024|NCT01732588|110844|P2|COMPLETED|Second Intervention (7 Days)||2
47025|NCT01732588|110845|P1|COMPLETED|Second Intervention (7 Days)||4
47026|NCT01732588|110843|P3|STARTED|Second Intervention (7 Days)||4
47027|NCT01732588|110844|P2|STARTED|Second Intervention (7 Days)||2
47028|NCT01732588|110845|P1|STARTED|Second Intervention (7 Days)||4
47029|NCT01732588|110843|P3|NOT COMPLETED|First Intervention (7 Days)||0
47030|NCT01732588|110844|P2|NOT COMPLETED|First Intervention (7 Days)||1
47031|NCT01732588|110845|P1|NOT COMPLETED|First Intervention (7 Days)||0
47032|NCT01732588|110843|P3|COMPLETED|First Intervention (7 Days)||4
47033|NCT01732588|110844|P2|COMPLETED|First Intervention (7 Days)||2
47034|NCT01732588|110845|P1|COMPLETED|First Intervention (7 Days)||4
47035|NCT01732588|110843|P3|STARTED|First Intervention (7 Days)||4
47036|NCT01732588|110844|P2|STARTED|First Intervention (7 Days)||3
47037|NCT01732588|110845|P1|STARTED|First Intervention (7 Days)||4
47038|NCT01732549|110861|P2|NOT COMPLETED|Overall Study||73
47039|NCT01732549|110862|P1|NOT COMPLETED|Overall Study||71
47040|NCT01732549|110861|P2|COMPLETED|Overall Study||0
47041|NCT01732549|110862|P1|COMPLETED|Overall Study||0
47042|NCT01732549|110861|P2|Withdrawn During Treatment:Final Analysi|Overall Study||73
47043|NCT01732549|110862|P1|Withdrawn During Treatment:Final Analysi|Overall Study||71
47044|NCT01732549|110861|P2|Ongoing Treatment Period:Final Analysis|Overall Study||0
47045|NCT01732549|110862|P1|Ongoing Treatment Period:Final Analysis|Overall Study||0
47046|NCT01732549|110861|P2|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 61 (AE 3, Consent withdrawn 6, Disease progression 46, Other 6)|61
47047|NCT01732549|110862|P1|Withdrawn During Treatment:Data Cut-off|Overall Study|Withdrawn during treatment period 59 (AE 13, Consent withdrawn 13, Disease progression 31, Other 2)|59
47048|NCT01732549|110861|P2|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
47049|NCT01732549|110862|P1|Ongoing in Treatment Period:Data Cut-off|Overall Study||12
47050|NCT01732549|110861|P2|STARTED|Overall Study||73
47051|NCT01732549|110862|P1|STARTED|Overall Study||71
47052|NCT01732510|110889|P7|NOT COMPLETED|Overall Study||8
47053|NCT01732510|110890|P6|NOT COMPLETED|Overall Study||13
47054|NCT01732510|110891|P5|NOT COMPLETED|Overall Study||5
47055|NCT01732510|110892|P4|NOT COMPLETED|Overall Study||5
47056|NCT01732510|110893|P3|NOT COMPLETED|Overall Study||4
47057|NCT01732510|110894|P2|NOT COMPLETED|Overall Study||5
47058|NCT01732510|110895|P1|NOT COMPLETED|Overall Study||1
47059|NCT01732510|110889|P7|COMPLETED|Overall Study||0
47060|NCT01732510|110890|P6|COMPLETED|Overall Study||0
47061|NCT01732510|110891|P5|COMPLETED|Overall Study||3
47062|NCT01732510|110892|P4|COMPLETED|Overall Study||5
47063|NCT01732510|110893|P3|COMPLETED|Overall Study||4
47064|NCT01732510|110894|P2|COMPLETED|Overall Study||4
47065|NCT01732510|110895|P1|COMPLETED|Overall Study||8
47066|NCT01732510|110889|P7|STARTED|Overall Study||8
47067|NCT01732510|110890|P6|STARTED|Overall Study||13
47068|NCT01732510|110891|P5|STARTED|Overall Study||8
47069|NCT01732510|110892|P4|STARTED|Overall Study||10
47070|NCT01732510|110893|P3|STARTED|Overall Study||8
47071|NCT01732510|110894|P2|STARTED|Overall Study||9
47072|NCT01732510|110895|P1|STARTED|Overall Study||9
47073|NCT01732484|110974|P1|NOT COMPLETED|Overall Study||26
47074|NCT01732484|110974|P1|COMPLETED|Overall Study||74
47075|NCT01732484|110974|P1|Allocation|Overall Study||100
47076|NCT01732484|110974|P1|Randomized|Overall Study|Randomized implantation SN60WF IOL in on eye and iMics NY-60 in the other eye.|100
47077|NCT01732484|110974|P1|STARTED|Overall Study||100
47078|NCT01732471|110982|P1|NOT COMPLETED|Overall Study||1
47079|NCT01732471|110982|P1|COMPLETED|Overall Study||89
47080|NCT01732471|110982|P1|STARTED|Overall Study||90
47081|NCT01731990|110991|P2|NOT COMPLETED|Overall Study||8
47082|NCT01731990|110992|P1|NOT COMPLETED|Overall Study||4
47083|NCT01731990|110991|P2|COMPLETED|Overall Study||12
47084|NCT01731990|110992|P1|COMPLETED|Overall Study||14
47085|NCT01731990|110991|P2|STARTED|Overall Study||20
47086|NCT01731990|110992|P1|STARTED|Overall Study|"Started indicates Safety and Pharmacodynamics set ."|18
47087|NCT01731938|111008|P2|NOT COMPLETED|Primary Part II||13
47088|NCT01731938|111009|P1|NOT COMPLETED|Primary Part II||13
47089|NCT01731938|111008|P2|COMPLETED|Primary Part II||95
47090|NCT01731938|111009|P1|COMPLETED|Primary Part II||103
47091|NCT01731938|111008|P2|STARTED|Primary Part II|Subjects from Preliminary Part I were not carried over to Primary Part II to assess safety/efficacy.|108
47092|NCT01731938|111009|P1|STARTED|Primary Part II|Preliminary Part I was for study team familiarization with FS Grifols application.|116
47093|NCT01731938|111008|P2|NOT COMPLETED|Preliminary Part I||8
47094|NCT01731938|111009|P1|NOT COMPLETED|Preliminary Part I||3
47095|NCT01731938|111008|P2|COMPLETED|Preliminary Part I||44
47096|NCT01731938|111009|P1|COMPLETED|Preliminary Part I||48
47097|NCT01731938|111008|P2|STARTED|Preliminary Part I||52
47098|NCT01731938|111009|P1|STARTED|Preliminary Part I||51
47099|NCT01731470|111021|P1|NOT COMPLETED|Overall Study||2
47100|NCT01731470|111021|P1|COMPLETED|Overall Study|Number of patients enrolled in the study|14
47101|NCT01731470|111021|P1|STARTED|Overall Study|Number of patients consented to participate in the study|16
47102|NCT01731119|111026|P1|NOT COMPLETED|Overall Study||2
47103|NCT01731119|111026|P1|COMPLETED|Overall Study||7
47104|NCT01731119|111026|P1|STARTED|Overall Study||9
47105|NCT01731041|111036|P2|NOT COMPLETED|Overall Study||0
47106|NCT01731041|111037|P1|NOT COMPLETED|Overall Study||0
47107|NCT01731041|111036|P2|COMPLETED|Overall Study||30
47108|NCT01731041|111037|P1|COMPLETED|Overall Study||30
47109|NCT01731041|111036|P2|STARTED|Overall Study||30
47110|NCT01731041|111037|P1|STARTED|Overall Study||30
47111|NCT01730378|111047|P2|NOT COMPLETED|Overall Study||0
47112|NCT01730378|111048|P1|NOT COMPLETED|Overall Study||1
47113|NCT01730378|111047|P2|COMPLETED|Overall Study||47
47114|NCT01730378|111048|P1|COMPLETED|Overall Study||83
47115|NCT01730378|111047|P2|STARTED|Overall Study||47
47116|NCT01730378|111048|P1|STARTED|Overall Study||84
47117|NCT01730339|111079|P2|NOT COMPLETED|Overall Study||3
47118|NCT01730339|111080|P1|NOT COMPLETED|Overall Study||5
47119|NCT01730339|111079|P2|COMPLETED|Overall Study||52
47120|NCT01730339|111080|P1|COMPLETED|Overall Study||40
47121|NCT01730339|111079|P2|STARTED|Overall Study||55
47122|NCT01730339|111080|P1|STARTED|Overall Study||45
47123|NCT01730053|111120|P6|NOT COMPLETED|Overall Study||13
47124|NCT01730053|111121|P5|NOT COMPLETED|Overall Study||9
47125|NCT01730053|111122|P4|NOT COMPLETED|Overall Study||8
47126|NCT01730053|111123|P3|NOT COMPLETED|Overall Study||11
47127|NCT01730053|111124|P2|NOT COMPLETED|Overall Study||14
47128|NCT01730053|111125|P1|NOT COMPLETED|Overall Study||5
47129|NCT01730053|111120|P6|COMPLETED|Overall Study||41
47130|NCT01730053|111121|P5|COMPLETED|Overall Study||44
47131|NCT01730053|111122|P4|COMPLETED|Overall Study||45
47132|NCT01730053|111123|P3|COMPLETED|Overall Study||38
47133|NCT01730053|111124|P2|COMPLETED|Overall Study||34
47134|NCT01730053|111125|P1|COMPLETED|Overall Study||43
47135|NCT01730053|111120|P6|Treated|Overall Study||54
47136|NCT01730053|111121|P5|Treated|Overall Study||53
47137|NCT01730053|111122|P4|Treated|Overall Study||53
47138|NCT01730053|111123|P3|Treated|Overall Study||49
47139|NCT01730053|111124|P2|Treated|Overall Study||48
47140|NCT01730053|111125|P1|Treated|Overall Study||48
47141|NCT01730053|111120|P6|STARTED|Overall Study||54
47142|NCT01730053|111121|P5|STARTED|Overall Study||53
47143|NCT01730053|111122|P4|STARTED|Overall Study||53
47144|NCT01730053|111123|P3|STARTED|Overall Study||49
47145|NCT01730053|111124|P2|STARTED|Overall Study||48
47146|NCT01730053|111125|P1|STARTED|Overall Study||48
47147|NCT01730040|111284|P7|NOT COMPLETED|Overall Study||9
47148|NCT01730040|111285|P6|NOT COMPLETED|Overall Study||7
47149|NCT01730040|111286|P5|NOT COMPLETED|Overall Study||6
47150|NCT01730040|111287|P4|NOT COMPLETED|Overall Study||8
47151|NCT01730040|111288|P3|NOT COMPLETED|Overall Study||11
47152|NCT01730040|111289|P2|NOT COMPLETED|Overall Study||15
47153|NCT01730040|111290|P1|NOT COMPLETED|Overall Study||13
47154|NCT01730040|111284|P7|COMPLETED|Overall Study||38
47155|NCT01730040|111285|P6|COMPLETED|Overall Study||40
47156|NCT01730040|111286|P5|COMPLETED|Overall Study||39
47157|NCT01730040|111287|P4|COMPLETED|Overall Study||39
47158|NCT01730040|111288|P3|COMPLETED|Overall Study||46
47159|NCT01730040|111289|P2|COMPLETED|Overall Study||40
47160|NCT01730040|111290|P1|COMPLETED|Overall Study||44
47161|NCT01730040|111284|P7|Treated|Overall Study||47
47162|NCT01730040|111285|P6|Treated|Overall Study||46
47163|NCT01730040|111286|P5|Treated|Overall Study||45
47164|NCT01730040|111287|P4|Treated|Overall Study||47
47165|NCT01730040|111288|P3|Treated|Overall Study||57
47166|NCT01730040|111289|P2|Treated|Overall Study||55
47167|NCT01730040|111290|P1|Treated|Overall Study||57
47168|NCT01730040|111284|P7|STARTED|Overall Study||47
47169|NCT01730040|111285|P6|STARTED|Overall Study||47
47170|NCT01730040|111286|P5|STARTED|Overall Study||45
47171|NCT01730040|111287|P4|STARTED|Overall Study||47
47172|NCT01730040|111288|P3|STARTED|Overall Study||57
47173|NCT01730040|111289|P2|STARTED|Overall Study||55
47174|NCT01730040|111290|P1|STARTED|Overall Study||57
47175|NCT01729871|111469|P2|NOT COMPLETED|Overall Study||23
47176|NCT01729871|111470|P1|NOT COMPLETED|Overall Study||12
47177|NCT01729871|111469|P2|COMPLETED|Overall Study||101
47178|NCT01729871|111470|P1|COMPLETED|Overall Study||112
47179|NCT01729871|111469|P2|STARTED|Overall Study||124
47180|NCT01729871|111470|P1|STARTED|Overall Study||124
47181|NCT01729728|111489|P3|NOT COMPLETED|Overall Study||1
47182|NCT01729728|111490|P2|NOT COMPLETED|Overall Study||6
47183|NCT01729728|111491|P1|NOT COMPLETED|Overall Study||1
47184|NCT01729728|111489|P3|COMPLETED|Overall Study||16
47185|NCT01729728|111490|P2|COMPLETED|Overall Study||22
47186|NCT01729728|111491|P1|COMPLETED|Overall Study||20
47187|NCT01729728|111489|P3|STARTED|Overall Study||17
47188|NCT01729728|111490|P2|STARTED|Overall Study||28
47189|NCT01729728|111491|P1|STARTED|Overall Study||21
47190|NCT01729559|111624|P2|NOT COMPLETED|Overall Study||28
47191|NCT01729559|111625|P1|NOT COMPLETED|Overall Study||31
47192|NCT01729559|111624|P2|COMPLETED|Overall Study||216
47193|NCT01729559|111625|P1|COMPLETED|Overall Study||220
47194|NCT01729559|111624|P2|STARTED|Overall Study||244
47195|NCT01729559|111625|P1|STARTED|Overall Study||251
47196|NCT01729338|111637|P1|NOT COMPLETED|Overall Study||2
47197|NCT01729338|111637|P1|COMPLETED|Overall Study||14
47198|NCT01729338|111637|P1|STARTED|Overall Study||16
47199|NCT01729247|111652|P1|NOT COMPLETED|Overall Study||0
47200|NCT01729247|111652|P1|COMPLETED|Overall Study||50
47201|NCT01729247|111652|P1|STARTED|Overall Study||50
47202|NCT01729026|111668|P2|NOT COMPLETED|3-month to 6-month (Final) Follow-up||2
47203|NCT01729026|111669|P1|NOT COMPLETED|3-month to 6-month (Final) Follow-up||1
47204|NCT01729026|111668|P2|COMPLETED|3-month to 6-month (Final) Follow-up||6
47205|NCT01729026|111669|P1|COMPLETED|3-month to 6-month (Final) Follow-up||6
47206|NCT01729026|111668|P2|STARTED|3-month to 6-month (Final) Follow-up||8
47207|NCT01729026|111669|P1|STARTED|3-month to 6-month (Final) Follow-up||7
47208|NCT01729026|111668|P2|NOT COMPLETED|Randomization to 3-month Follow-up||2
47209|NCT01729026|111669|P1|NOT COMPLETED|Randomization to 3-month Follow-up||2
47210|NCT01729026|111668|P2|COMPLETED|Randomization to 3-month Follow-up||8
47211|NCT01729026|111669|P1|COMPLETED|Randomization to 3-month Follow-up||7
47212|NCT01729026|111668|P2|STARTED|Randomization to 3-month Follow-up||10
47213|NCT01729026|111669|P1|STARTED|Randomization to 3-month Follow-up||9
47214|NCT01728792|111680|P5|NOT COMPLETED|Overall Study||0
47215|NCT01728792|111681|P4|NOT COMPLETED|Overall Study||3
47216|NCT01728792|111682|P3|NOT COMPLETED|Overall Study||4
47217|NCT01728792|111683|P2|NOT COMPLETED|Overall Study||2
47218|NCT01728792|111684|P1|NOT COMPLETED|Overall Study||3
47219|NCT01728792|111680|P5|COMPLETED|Overall Study||16
47220|NCT01728792|111681|P4|COMPLETED|Overall Study||14
47221|NCT01728792|111682|P3|COMPLETED|Overall Study||13
47222|NCT01728792|111683|P2|COMPLETED|Overall Study||14
47223|NCT01728792|111684|P1|COMPLETED|Overall Study||11
47224|NCT01728792|111680|P5|STARTED|Overall Study||16
47225|NCT01728792|111681|P4|STARTED|Overall Study||17
47226|NCT01728792|111682|P3|STARTED|Overall Study||17
47227|NCT01728792|111683|P2|STARTED|Overall Study||16
47228|NCT01728792|111684|P1|STARTED|Overall Study||14
47229|NCT01728584|111735|P4|NOT COMPLETED|Overall Study||1
47230|NCT01728584|111736|P3|NOT COMPLETED|Overall Study||1
47231|NCT01728584|111737|P2|NOT COMPLETED|Overall Study||0
47232|NCT01728584|111738|P1|NOT COMPLETED|Overall Study||8
47233|NCT01728584|111735|P4|COMPLETED|Overall Study||29
47234|NCT01728584|111736|P3|COMPLETED|Overall Study||30
47235|NCT01728584|111737|P2|COMPLETED|Overall Study||30
47236|NCT01728584|111738|P1|COMPLETED|Overall Study||28
47237|NCT01728584|111735|P4|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 5 (all to Deep/Std)|30
47238|NCT01728584|111736|P3|STARTED|Overall Study|Randomized|31
47239|NCT01728584|111737|P2|STARTED|Overall Study|Randomized - NMB/pressure conditions were changed in 7 (2 to Std/Std, 4 to Deep/Std, 1 to Deep/Low)|30
47240|NCT01728584|111738|P1|STARTED|Overall Study|Randomized|36
47241|NCT01728376|111796|P6|NOT COMPLETED|Overall Study||2
47242|NCT01728376|111797|P5|NOT COMPLETED|Overall Study||2
47243|NCT01728376|111798|P4|NOT COMPLETED|Overall Study||2
47244|NCT01728376|111799|P3|NOT COMPLETED|Overall Study||2
47245|NCT01728376|111800|P2|NOT COMPLETED|Overall Study||2
47246|NCT01728376|111801|P1|NOT COMPLETED|Overall Study||4
47247|NCT01728376|111796|P6|COMPLETED|Overall Study||5
47248|NCT01728376|111797|P5|COMPLETED|Overall Study||12
47249|NCT01728376|111798|P4|COMPLETED|Overall Study||7
47250|NCT01728376|111799|P3|COMPLETED|Overall Study||17
47251|NCT01728376|111800|P2|COMPLETED|Overall Study||9
47252|NCT01728376|111801|P1|COMPLETED|Overall Study||18
47253|NCT01728376|111796|P6|Treated|Overall Study||7
47254|NCT01728376|111797|P5|Treated|Overall Study||14
47255|NCT01728376|111798|P4|Treated|Overall Study||9
47256|NCT01728376|111799|P3|Treated|Overall Study||19
47257|NCT01728376|111800|P2|Treated|Overall Study||10
47258|NCT01728376|111801|P1|Treated|Overall Study||22
47259|NCT01728376|111796|P6|STARTED|Overall Study||7
47260|NCT01728376|111797|P5|STARTED|Overall Study||14
47261|NCT01728376|111798|P4|STARTED|Overall Study||9
47262|NCT01728376|111799|P3|STARTED|Overall Study||19
47263|NCT01728376|111800|P2|STARTED|Overall Study||11
47264|NCT01728376|111801|P1|STARTED|Overall Study||22
47265|NCT01728337|111863|P1|NOT COMPLETED|Overall Study||0
47266|NCT01728337|111863|P1|COMPLETED|Overall Study||80
47267|NCT01728337|111863|P1|STARTED|Overall Study||80
47268|NCT01728324|111874|P3|NOT COMPLETED|Termination of RBV||15
47269|NCT01728324|111875|P2|NOT COMPLETED|Termination of RBV||37
47270|NCT01728324|111876|P1|NOT COMPLETED|Termination of RBV||39
47271|NCT01728324|111874|P3|COMPLETED|Termination of RBV||57
47272|NCT01728324|111875|P2|COMPLETED|Termination of RBV||176
47273|NCT01728324|111876|P1|COMPLETED|Termination of RBV||172
47274|NCT01728324|111874|P3|STARTED|Termination of RBV||72
47275|NCT01728324|111875|P2|STARTED|Termination of RBV||213
47276|NCT01728324|111876|P1|STARTED|Termination of RBV||211
47277|NCT01728324|111874|P3|NOT COMPLETED|Termination of FDV||14
47278|NCT01728324|111875|P2|NOT COMPLETED|Termination of FDV||36
47279|NCT01728324|111876|P1|NOT COMPLETED|Termination of FDV||38
47280|NCT01728324|111874|P3|COMPLETED|Termination of FDV||58
47281|NCT01728324|111875|P2|COMPLETED|Termination of FDV||177
47282|NCT01728324|111876|P1|COMPLETED|Termination of FDV||173
47283|NCT01728324|111874|P3|STARTED|Termination of FDV||72
47284|NCT01728324|111875|P2|STARTED|Termination of FDV||213
47285|NCT01728324|111876|P1|STARTED|Termination of FDV||211
47286|NCT01728324|111874|P3|NOT COMPLETED|Termination of DBV||14
47287|NCT01728324|111875|P2|NOT COMPLETED|Termination of DBV||36
47288|NCT01728324|111876|P1|NOT COMPLETED|Termination of DBV||38
47289|NCT01728324|111874|P3|COMPLETED|Termination of DBV||58
47290|NCT01728324|111875|P2|COMPLETED|Termination of DBV||177
47291|NCT01728324|111876|P1|COMPLETED|Termination of DBV||173
47292|NCT01728324|111874|P3|STARTED|Termination of DBV||72
47293|NCT01728324|111875|P2|STARTED|Termination of DBV||213
47294|NCT01728324|111876|P1|STARTED|Termination of DBV||211
47295|NCT01728246|111897|P2|NOT COMPLETED|Overall Study||36
47296|NCT01728246|111898|P1|NOT COMPLETED|Overall Study||36
47297|NCT01728246|111897|P2|COMPLETED|Overall Study||195
47298|NCT01728246|111898|P1|COMPLETED|Overall Study||206
47299|NCT01728246|111897|P2|STARTED|Overall Study||231
47300|NCT01728246|111898|P1|STARTED|Overall Study||242
47301|NCT01728116|111916|P2|NOT COMPLETED|Overall Study||47
47302|NCT01728116|111917|P1|NOT COMPLETED|Overall Study||161
47303|NCT01728116|111916|P2|COMPLETED|Overall Study|Completed to Week 52|60
47304|NCT01728116|111917|P1|COMPLETED|Overall Study|Completed to Week 78|52
47305|NCT01728116|111916|P2|STARTED|Overall Study|Sham mITT subjects|107
47306|NCT01728116|111917|P1|STARTED|Overall Study|EndoBarrier mITT Subjects|213
47307|NCT01728077|111942|P2|NOT COMPLETED|Overall Study||5
47308|NCT01728077|111943|P1|NOT COMPLETED|Overall Study||8
47309|NCT01728077|111942|P2|COMPLETED|Overall Study||2
47310|NCT01728077|111943|P1|COMPLETED|Overall Study||11
47311|NCT01728077|111942|P2|STARTED|Overall Study||7
47312|NCT01728077|111943|P1|STARTED|Overall Study||19
47313|NCT01727895|111958|P2|NOT COMPLETED|Overall Study||0
47314|NCT01727895|111959|P1|NOT COMPLETED|Overall Study||0
47315|NCT01727895|111958|P2|COMPLETED|Overall Study||5
47316|NCT01727895|111959|P1|COMPLETED|Overall Study||10
47317|NCT01727895|111958|P2|STARTED|Overall Study||5
47318|NCT01727895|111959|P1|STARTED|Overall Study||10
47319|NCT01727791|111965|P1|NOT COMPLETED|Overall Study||0
47320|NCT01727791|111965|P1|COMPLETED|Overall Study||10
47321|NCT01727791|111965|P1|STARTED|Overall Study||10
47322|NCT01727713|111995|P1|NOT COMPLETED|Overall Study||35
47323|NCT01727713|111995|P1|COMPLETED|Overall Study||75
47324|NCT01727713|111995|P1|STARTED|Overall Study||110
47325|NCT01727700|112022|P3|NOT COMPLETED|Overall Study||2
47326|NCT01727700|112023|P2|NOT COMPLETED|Overall Study||10
47327|NCT01727700|112024|P1|NOT COMPLETED|Overall Study||2
47328|NCT01727700|112022|P3|COMPLETED|Overall Study||42
47329|NCT01727700|112023|P2|COMPLETED|Overall Study||35
47330|NCT01727700|112024|P1|COMPLETED|Overall Study||42
47331|NCT01727700|112022|P3|STARTED|Overall Study||44
47332|NCT01727700|112023|P2|STARTED|Overall Study||45
47333|NCT01727700|112024|P1|STARTED|Overall Study||44
47334|NCT01727505|112047|P2|NOT COMPLETED|Second 24 Hours||1
47335|NCT01727505|112048|P1|NOT COMPLETED|Second 24 Hours||0
47336|NCT01727505|112047|P2|COMPLETED|Second 24 Hours||10
47337|NCT01727505|112048|P1|COMPLETED|Second 24 Hours||14
47338|NCT01727505|112047|P2|STARTED|Second 24 Hours||11
47339|NCT01727505|112048|P1|STARTED|Second 24 Hours||14
47340|NCT01727505|112047|P2|NOT COMPLETED|First 24 Hours||1
47341|NCT01727505|112048|P1|NOT COMPLETED|First 24 Hours||0
47342|NCT01727505|112047|P2|COMPLETED|First 24 Hours||11
47343|NCT01727505|112048|P1|COMPLETED|First 24 Hours||14
47344|NCT01727505|112047|P2|STARTED|First 24 Hours||12
47345|NCT01727505|112048|P1|STARTED|First 24 Hours||14
47346|NCT01727414|112066|P2|NOT COMPLETED|Overall Study||0
47347|NCT01727414|112067|P1|NOT COMPLETED|Overall Study||3
47348|NCT01727414|112066|P2|COMPLETED|Overall Study||45
47349|NCT01727414|112067|P1|COMPLETED|Overall Study||123
47350|NCT01727414|112066|P2|STARTED|Overall Study||45
47351|NCT01727414|112067|P1|STARTED|Overall Study||126
47352|NCT01727258|112076|P3|NOT COMPLETED|Overall Study||1
47353|NCT01727258|112077|P2|NOT COMPLETED|Overall Study||3
47354|NCT01727258|112078|P1|NOT COMPLETED|Overall Study||2
47355|NCT01727258|112076|P3|COMPLETED|Overall Study||50
47356|NCT01727258|112077|P2|COMPLETED|Overall Study||48
47357|NCT01727258|112078|P1|COMPLETED|Overall Study||49
47358|NCT01727258|112076|P3|STARTED|Overall Study||51
47359|NCT01727258|112077|P2|STARTED|Overall Study||51
47360|NCT01727258|112078|P1|STARTED|Overall Study||51
47361|NCT01727180|112101|P1|NOT COMPLETED|Overall Study||0
47362|NCT01727180|112101|P1|COMPLETED|Overall Study||108
47363|NCT01727180|112101|P1|STARTED|Overall Study||108
47364|NCT01727167|112107|P2|NOT COMPLETED|Overall Study||0
47365|NCT01727167|112108|P1|NOT COMPLETED|Overall Study||0
47366|NCT01727167|112107|P2|COMPLETED|Overall Study||0
47367|NCT01727167|112108|P1|COMPLETED|Overall Study||1
47368|NCT01727167|112107|P2|STARTED|Overall Study||0
47369|NCT01727167|112108|P1|STARTED|Overall Study||1
47370|NCT01727141|112120|P4|NOT COMPLETED|Overall Study||15
47371|NCT01727141|112121|P3|NOT COMPLETED|Overall Study||3
47372|NCT01727141|112122|P2|NOT COMPLETED|Overall Study||9
47373|NCT01727141|112123|P1|NOT COMPLETED|Overall Study||5
47374|NCT01727141|112120|P4|COMPLETED|Overall Study||246
47375|NCT01727141|112121|P3|COMPLETED|Overall Study||258
47376|NCT01727141|112122|P2|COMPLETED|Overall Study||251
47377|NCT01727141|112123|P1|COMPLETED|Overall Study||255
47378|NCT01727141|112120|P4|Full Analysis Set|Overall Study||261
47379|NCT01727141|112121|P3|Full Analysis Set|Overall Study||261
47380|NCT01727141|112122|P2|Full Analysis Set|Overall Study||260
47381|NCT01727141|112123|P1|Full Analysis Set|Overall Study||258
47382|NCT01727141|112120|P4|Safety Set|Overall Study||260
47383|NCT01727141|112121|P3|Safety Set|Overall Study||262
47384|NCT01727141|112122|P2|Safety Set|Overall Study||260
47385|NCT01727141|112123|P1|Safety Set|Overall Study||258
47386|NCT01727141|112120|P4|STARTED|Overall Study||261
47387|NCT01727141|112121|P3|STARTED|Overall Study||261
47388|NCT01727141|112122|P2|STARTED|Overall Study||260
47389|NCT01727141|112123|P1|STARTED|Overall Study||260
47390|NCT01727024|112173|P2|NOT COMPLETED|Period 2||0
47391|NCT01727024|112174|P1|NOT COMPLETED|Period 2||0
47392|NCT01727024|112173|P2|COMPLETED|Period 2||64
47393|NCT01727024|112174|P1|COMPLETED|Period 2||68
47394|NCT01727024|112173|P2|STARTED|Period 2||64
47395|NCT01727024|112174|P1|STARTED|Period 2||68
47396|NCT01727024|112173|P2|NOT COMPLETED|Period 1||4
47397|NCT01727024|112174|P1|NOT COMPLETED|Period 1||3
47398|NCT01727024|112173|P2|COMPLETED|Period 1||64
47399|NCT01727024|112174|P1|COMPLETED|Period 1||68
47400|NCT01727024|112173|P2|STARTED|Period 1||68
47401|NCT01727024|112174|P1|STARTED|Period 1||71
47402|NCT01726621|112187|P1|NOT COMPLETED|Overall Study||4
47403|NCT01726621|112187|P1|COMPLETED|Overall Study||51
47404|NCT01726621|112187|P1|STARTED|Overall Study||55
47405|NCT01726517|112196|P5|NOT COMPLETED|Overall Study||0
47406|NCT01726517|112197|P4|NOT COMPLETED|Overall Study||0
47407|NCT01726517|112198|P3|NOT COMPLETED|Overall Study||1
47408|NCT01726517|112199|P2|NOT COMPLETED|Overall Study||0
47409|NCT01726517|112200|P1|NOT COMPLETED|Overall Study||0
47410|NCT01726517|112196|P5|COMPLETED|Overall Study||21
47411|NCT01726517|112197|P4|COMPLETED|Overall Study||19
47412|NCT01726517|112198|P3|COMPLETED|Overall Study||18
47413|NCT01726517|112199|P2|COMPLETED|Overall Study||21
47414|NCT01726517|112200|P1|COMPLETED|Overall Study||20
47415|NCT01726517|112196|P5|STARTED|Overall Study||21
47416|NCT01726517|112197|P4|STARTED|Overall Study||19
47417|NCT01726517|112198|P3|STARTED|Overall Study||19
47418|NCT01726517|112199|P2|STARTED|Overall Study||21
47419|NCT01726517|112200|P1|STARTED|Overall Study||20
47420|NCT01726504|112229|P2|NOT COMPLETED|Overall Study||28
47421|NCT01726504|112230|P1|NOT COMPLETED|Overall Study||12
47422|NCT01726504|112229|P2|COMPLETED|Overall Study||511
47423|NCT01726504|112230|P1|COMPLETED|Overall Study||524
47424|NCT01726504|112229|P2|STARTED|Overall Study||539
47425|NCT01726504|112230|P1|STARTED|Overall Study||536
47426|NCT01726335|112256|P1|NOT COMPLETED|Overall Study||24
47427|NCT01726335|112256|P1|COMPLETED|Overall Study||29
47428|NCT01726335|112256|P1|STARTED|Overall Study||53
47429|NCT01726049|112274|P2|NOT COMPLETED|Overall Study||4
47430|NCT01726049|112275|P1|NOT COMPLETED|Overall Study||5
47431|NCT01726049|112274|P2|COMPLETED|Overall Study||22
47432|NCT01726049|112275|P1|COMPLETED|Overall Study||21
47433|NCT01726049|112274|P2|STARTED|Overall Study||26
47434|NCT01726049|112275|P1|STARTED|Overall Study||26
47435|NCT01726023|112289|P2|NOT COMPLETED|Overall Study||26
47436|NCT01726023|112290|P1|NOT COMPLETED|Overall Study||29
47437|NCT01726023|112289|P2|COMPLETED|Overall Study||196
47438|NCT01726023|112290|P1|COMPLETED|Overall Study||190
47439|NCT01726023|112289|P2|STARTED|Overall Study||222
47440|NCT01726023|112290|P1|STARTED|Overall Study||219
47441|NCT01725984|112382|P2|NOT COMPLETED|Overall Study||0
47442|NCT01725984|112383|P1|NOT COMPLETED|Overall Study||0
47443|NCT01725984|112382|P2|COMPLETED|Overall Study||41
47444|NCT01725984|112383|P1|COMPLETED|Overall Study||39
47445|NCT01725984|112382|P2|STARTED|Overall Study||41
47446|NCT01725984|112383|P1|STARTED|Overall Study||39
47447|NCT01725529|112410|P3|NOT COMPLETED|Overall Study||10
47448|NCT01725529|112411|P2|NOT COMPLETED|Overall Study||16
47449|NCT01725529|112412|P1|NOT COMPLETED|Overall Study||15
47450|NCT01725529|112410|P3|COMPLETED|Overall Study||142
47451|NCT01725529|112411|P2|COMPLETED|Overall Study||137
47452|NCT01725529|112412|P1|COMPLETED|Overall Study||137
47453|NCT01725529|112410|P3|STARTED|Overall Study||152
47454|NCT01725529|112411|P2|STARTED|Overall Study||153
47455|NCT01725529|112412|P1|STARTED|Overall Study||152
47456|NCT01725451|112438|P4|NOT COMPLETED|Period 6||0
47457|NCT01725451|112439|P3|NOT COMPLETED|Period 6||0
47458|NCT01725451|112440|P2|NOT COMPLETED|Period 6||0
47459|NCT01725451|112441|P1|NOT COMPLETED|Period 6||0
47460|NCT01725451|112438|P4|COMPLETED|Period 6||7
47461|NCT01725451|112439|P3|COMPLETED|Period 6||6
47462|NCT01725451|112440|P2|COMPLETED|Period 6||6
47463|NCT01725451|112441|P1|COMPLETED|Period 6||7
47464|NCT01725451|112438|P4|STARTED|Period 6||7
47465|NCT01725451|112439|P3|STARTED|Period 6||6
47466|NCT01725451|112440|P2|STARTED|Period 6||6
47467|NCT01725451|112441|P1|STARTED|Period 6||7
47468|NCT01725451|112438|P4|NOT COMPLETED|Washout From Period 5||0
47469|NCT01725451|112439|P3|NOT COMPLETED|Washout From Period 5||0
47470|NCT01725451|112440|P2|NOT COMPLETED|Washout From Period 5||0
47471|NCT01725451|112441|P1|NOT COMPLETED|Washout From Period 5||0
47472|NCT01725451|112438|P4|COMPLETED|Washout From Period 5||7
47473|NCT01725451|112439|P3|COMPLETED|Washout From Period 5||6
47474|NCT01725451|112440|P2|COMPLETED|Washout From Period 5||6
47475|NCT01725451|112441|P1|COMPLETED|Washout From Period 5||7
47476|NCT01725451|112438|P4|STARTED|Washout From Period 5||7
47477|NCT01725451|112439|P3|STARTED|Washout From Period 5||6
47478|NCT01725451|112440|P2|STARTED|Washout From Period 5||6
47479|NCT01725451|112441|P1|STARTED|Washout From Period 5||7
47480|NCT01725451|112438|P4|NOT COMPLETED|Period 5||0
47481|NCT01725451|112439|P3|NOT COMPLETED|Period 5||0
47482|NCT01725451|112440|P2|NOT COMPLETED|Period 5||0
47483|NCT01725451|112441|P1|NOT COMPLETED|Period 5||0
47484|NCT01725451|112438|P4|COMPLETED|Period 5||7
47485|NCT01725451|112439|P3|COMPLETED|Period 5||6
47486|NCT01725451|112440|P2|COMPLETED|Period 5||6
47487|NCT01725451|112441|P1|COMPLETED|Period 5||7
47488|NCT01725451|112438|P4|STARTED|Period 5||7
47489|NCT01725451|112439|P3|STARTED|Period 5||6
47490|NCT01725451|112440|P2|STARTED|Period 5||6
47491|NCT01725451|112441|P1|STARTED|Period 5||7
47492|NCT01725451|112438|P4|NOT COMPLETED|Washout From Period 4||0
47493|NCT01725451|112439|P3|NOT COMPLETED|Washout From Period 4||0
47494|NCT01725451|112440|P2|NOT COMPLETED|Washout From Period 4||0
47495|NCT01725451|112441|P1|NOT COMPLETED|Washout From Period 4||0
47496|NCT01725451|112438|P4|COMPLETED|Washout From Period 4||7
47497|NCT01725451|112439|P3|COMPLETED|Washout From Period 4||6
47498|NCT01725451|112440|P2|COMPLETED|Washout From Period 4||6
47499|NCT01725451|112441|P1|COMPLETED|Washout From Period 4||7
47500|NCT01725451|112438|P4|STARTED|Washout From Period 4||7
47501|NCT01725451|112439|P3|STARTED|Washout From Period 4||6
47502|NCT01725451|112440|P2|STARTED|Washout From Period 4||6
47503|NCT01725451|112441|P1|STARTED|Washout From Period 4||7
47504|NCT01725451|112438|P4|NOT COMPLETED|Period 4||0
47505|NCT01725451|112439|P3|NOT COMPLETED|Period 4||1
47506|NCT01725451|112440|P2|NOT COMPLETED|Period 4||0
47507|NCT01725451|112441|P1|NOT COMPLETED|Period 4||0
47508|NCT01725451|112438|P4|COMPLETED|Period 4||7
47509|NCT01725451|112439|P3|COMPLETED|Period 4||6
47510|NCT01725451|112440|P2|COMPLETED|Period 4||6
47511|NCT01725451|112441|P1|COMPLETED|Period 4||7
47512|NCT01725451|112438|P4|STARTED|Period 4||7
47513|NCT01725451|112439|P3|STARTED|Period 4||7
47514|NCT01725451|112440|P2|STARTED|Period 4||6
47515|NCT01725451|112441|P1|STARTED|Period 4||7
47516|NCT01725451|112438|P4|NOT COMPLETED|Washout From Period 3||0
47517|NCT01725451|112439|P3|NOT COMPLETED|Washout From Period 3||1
47518|NCT01725451|112440|P2|NOT COMPLETED|Washout From Period 3||1
47519|NCT01725451|112441|P1|NOT COMPLETED|Washout From Period 3||0
47520|NCT01725451|112438|P4|COMPLETED|Washout From Period 3||7
47521|NCT01725451|112439|P3|COMPLETED|Washout From Period 3||7
47522|NCT01725451|112440|P2|COMPLETED|Washout From Period 3||6
47523|NCT01725451|112441|P1|COMPLETED|Washout From Period 3||7
47524|NCT01725451|112438|P4|STARTED|Washout From Period 3||7
47525|NCT01725451|112439|P3|STARTED|Washout From Period 3||8
47526|NCT01725451|112440|P2|STARTED|Washout From Period 3||7
47527|NCT01725451|112441|P1|STARTED|Washout From Period 3||7
47528|NCT01725451|112438|P4|NOT COMPLETED|Period 3||0
47529|NCT01725451|112439|P3|NOT COMPLETED|Period 3||0
47530|NCT01725451|112440|P2|NOT COMPLETED|Period 3||0
47531|NCT01725451|112441|P1|NOT COMPLETED|Period 3||0
47532|NCT01725451|112438|P4|COMPLETED|Period 3||7
47533|NCT01725451|112439|P3|COMPLETED|Period 3||8
47534|NCT01725451|112440|P2|COMPLETED|Period 3||7
47535|NCT01725451|112441|P1|COMPLETED|Period 3||7
47536|NCT01725451|112438|P4|STARTED|Period 3||7
47537|NCT01725451|112439|P3|STARTED|Period 3||8
47538|NCT01725451|112440|P2|STARTED|Period 3||7
47539|NCT01725451|112441|P1|STARTED|Period 3||7
47540|NCT01725451|112438|P4|NOT COMPLETED|Washout From Period 2||0
47541|NCT01725451|112439|P3|NOT COMPLETED|Washout From Period 2||0
47542|NCT01725451|112440|P2|NOT COMPLETED|Washout From Period 2||0
47543|NCT01725451|112441|P1|NOT COMPLETED|Washout From Period 2||0
47544|NCT01725451|112438|P4|COMPLETED|Washout From Period 2||7
47545|NCT01725451|112439|P3|COMPLETED|Washout From Period 2||8
47546|NCT01725451|112440|P2|COMPLETED|Washout From Period 2||7
47547|NCT01725451|112441|P1|COMPLETED|Washout From Period 2||7
47548|NCT01725451|112438|P4|STARTED|Washout From Period 2||7
47549|NCT01725451|112439|P3|STARTED|Washout From Period 2||8
47550|NCT01725451|112440|P2|STARTED|Washout From Period 2||7
47551|NCT01725451|112441|P1|STARTED|Washout From Period 2||7
47552|NCT01725451|112438|P4|NOT COMPLETED|Period 2||0
47553|NCT01725451|112439|P3|NOT COMPLETED|Period 2||0
47554|NCT01725451|112440|P2|NOT COMPLETED|Period 2||0
47555|NCT01725451|112441|P1|NOT COMPLETED|Period 2||0
47556|NCT01725451|112438|P4|COMPLETED|Period 2||7
47557|NCT01725451|112439|P3|COMPLETED|Period 2||8
47558|NCT01725451|112440|P2|COMPLETED|Period 2||7
47559|NCT01725451|112441|P1|COMPLETED|Period 2||7
47560|NCT01725451|112438|P4|STARTED|Period 2||7
47561|NCT01725451|112439|P3|STARTED|Period 2||8
47562|NCT01725451|112440|P2|STARTED|Period 2||7
47563|NCT01725451|112441|P1|STARTED|Period 2||7
47564|NCT01725451|112438|P4|NOT COMPLETED|Washout From Period 1||0
47565|NCT01725451|112439|P3|NOT COMPLETED|Washout From Period 1||0
47566|NCT01725451|112440|P2|NOT COMPLETED|Washout From Period 1||0
47567|NCT01725451|112441|P1|NOT COMPLETED|Washout From Period 1||0
47568|NCT01725451|112438|P4|COMPLETED|Washout From Period 1||7
47569|NCT01725451|112439|P3|COMPLETED|Washout From Period 1||8
47570|NCT01725451|112440|P2|COMPLETED|Washout From Period 1||7
47571|NCT01725451|112441|P1|COMPLETED|Washout From Period 1||7
47572|NCT01725451|112438|P4|STARTED|Washout From Period 1||7
47573|NCT01725451|112439|P3|STARTED|Washout From Period 1||8
47574|NCT01725451|112440|P2|STARTED|Washout From Period 1||7
47575|NCT01725451|112441|P1|STARTED|Washout From Period 1||7
47576|NCT01725451|112438|P4|NOT COMPLETED|Period 1||0
47577|NCT01725451|112439|P3|NOT COMPLETED|Period 1||0
47578|NCT01725451|112440|P2|NOT COMPLETED|Period 1||0
47579|NCT01725451|112441|P1|NOT COMPLETED|Period 1||1
47580|NCT01725451|112438|P4|COMPLETED|Period 1||7
47581|NCT01725451|112439|P3|COMPLETED|Period 1||8
47582|NCT01725451|112440|P2|COMPLETED|Period 1||7
47583|NCT01725451|112441|P1|COMPLETED|Period 1||7
47584|NCT01725451|112438|P4|STARTED|Period 1||7
47585|NCT01725451|112439|P3|STARTED|Period 1||8
47586|NCT01725451|112440|P2|STARTED|Period 1||7
47587|NCT01725451|112441|P1|STARTED|Period 1||8
47588|NCT01725386|112463|P2|NOT COMPLETED|Overall Study||46
47589|NCT01725386|112464|P1|NOT COMPLETED|Overall Study||175
47590|NCT01725386|112463|P2|COMPLETED|Overall Study||17
47591|NCT01725386|112464|P1|COMPLETED|Overall Study||13
47592|NCT01725386|112463|P2|STARTED|Overall Study||63
47593|NCT01725386|112464|P1|STARTED|Overall Study||188
47594|NCT01725308|112483|P3|NOT COMPLETED|Overall Study||41
47595|NCT01725308|112484|P2|NOT COMPLETED|Overall Study||14
47596|NCT01725308|112485|P1|NOT COMPLETED|Overall Study||44
47597|NCT01725308|112483|P3|COMPLETED|Overall Study||138
47598|NCT01725308|112484|P2|COMPLETED|Overall Study||60
47599|NCT01725308|112485|P1|COMPLETED|Overall Study||134
47600|NCT01725308|112483|P3|Treated|Overall Study||179
47601|NCT01725308|112484|P2|Treated|Overall Study||74
47602|NCT01725308|112485|P1|Treated|Overall Study||177
47603|NCT01725308|112483|P3|STARTED|Overall Study||179
47604|NCT01725308|112484|P2|STARTED|Overall Study||74
47605|NCT01725308|112485|P1|STARTED|Overall Study||178
47606|NCT01725282|112539|P4|NOT COMPLETED|Overall Study||7
47607|NCT01725282|112540|P3|NOT COMPLETED|Overall Study||8
47608|NCT01725282|112541|P2|NOT COMPLETED|Overall Study||5
47609|NCT01725282|112542|P1|NOT COMPLETED|Overall Study||2
47610|NCT01725282|112539|P4|COMPLETED|Overall Study||36
47611|NCT01725282|112540|P3|COMPLETED|Overall Study||33
47612|NCT01725282|112541|P2|COMPLETED|Overall Study||39
47613|NCT01725282|112542|P1|COMPLETED|Overall Study||42
47614|NCT01725282|112539|P4|STARTED|Overall Study||43
47615|NCT01725282|112540|P3|STARTED|Overall Study||41
47616|NCT01725282|112541|P2|STARTED|Overall Study||44
47617|NCT01725282|112542|P1|STARTED|Overall Study||44
47618|NCT01725217|112575|P3|NOT COMPLETED|Overall Study||0
47619|NCT01725217|112576|P2|NOT COMPLETED|Overall Study||0
47620|NCT01725217|112577|P1|NOT COMPLETED|Overall Study||1
47621|NCT01725217|112575|P3|COMPLETED|Overall Study||66
47622|NCT01725217|112576|P2|COMPLETED|Overall Study||66
47623|NCT01725217|112577|P1|COMPLETED|Overall Study||65
47624|NCT01725217|112575|P3|STARTED|Overall Study||66
47625|NCT01725217|112576|P2|STARTED|Overall Study||66
47626|NCT01725217|112577|P1|STARTED|Overall Study||66
47627|NCT01724528|112607|P2|NOT COMPLETED|Overall Study||3
47628|NCT01724528|112608|P1|NOT COMPLETED|Overall Study||4
47629|NCT01724528|112607|P2|COMPLETED|Overall Study||170
47630|NCT01724528|112608|P1|COMPLETED|Overall Study||169
47631|NCT01724528|112607|P2|STARTED|Overall Study||173
47632|NCT01724528|112608|P1|STARTED|Overall Study||173
47633|NCT01724359|112622|P1|NOT COMPLETED|Overall Study||31
47634|NCT01724359|112622|P1|COMPLETED|Overall Study||64
47635|NCT01724359|112622|P1|STARTED|Overall Study||95
47636|NCT01724216|112635|P1|NOT COMPLETED|Overall Study||1
47637|NCT01724216|112635|P1|COMPLETED|Overall Study||10
47638|NCT01724216|112635|P1|STARTED|Overall Study||11
47639|NCT01724177|112639|P1|NOT COMPLETED|Overall Study||21
47640|NCT01724177|112639|P1|COMPLETED|Overall Study|Completed includes participants who continue receiving oral lenalidomide|5
47641|NCT01724177|112639|P1|Safety Population|Overall Study|Safety Population includes participants who received at least one dose of lenalidomide|26
47642|NCT01724177|112639|P1|STARTED|Overall Study||26
47643|NCT01724021|112651|P2|NOT COMPLETED|Overall Study||60
47644|NCT01724021|112652|P1|NOT COMPLETED|Overall Study||48
47645|NCT01724021|112651|P2|COMPLETED|Overall Study||309
47646|NCT01724021|112652|P1|COMPLETED|Overall Study||323
47647|NCT01724021|112651|P2|STARTED|Overall Study||369
47648|NCT01724021|112652|P1|STARTED|Overall Study||371
47649|NCT01723904|112684|P1|NOT COMPLETED|Overall Study||11
47650|NCT01723904|112684|P1|COMPLETED|Overall Study||79
47651|NCT01723904|112684|P1|STARTED|Overall Study||90
47652|NCT01723722|112696|P2|NOT COMPLETED|Overall Study||0
47653|NCT01723722|112697|P1|NOT COMPLETED|Overall Study||0
47654|NCT01723722|112696|P2|COMPLETED|Overall Study||20
47655|NCT01723722|112697|P1|COMPLETED|Overall Study||20
47656|NCT01723722|112696|P2|STARTED|Overall Study||20
47657|NCT01723722|112697|P1|STARTED|Overall Study||20
47658|NCT01723397|112705|P2|NOT COMPLETED|Study Period 2||1
47659|NCT01723397|112706|P1|NOT COMPLETED|Study Period 2||0
47660|NCT01723397|112705|P2|COMPLETED|Study Period 2||5
47661|NCT01723397|112706|P1|COMPLETED|Study Period 2||7
47662|NCT01723397|112705|P2|STARTED|Study Period 2||6
47663|NCT01723397|112706|P1|STARTED|Study Period 2||7
47664|NCT01723397|112705|P2|NOT COMPLETED|Washout||0
47665|NCT01723397|112706|P1|NOT COMPLETED|Washout||0
47666|NCT01723397|112705|P2|COMPLETED|Washout||6
47667|NCT01723397|112706|P1|COMPLETED|Washout||7
47668|NCT01723397|112705|P2|STARTED|Washout||6
47669|NCT01723397|112706|P1|STARTED|Washout||7
47670|NCT01723397|112705|P2|NOT COMPLETED|Study Period 1||1
47671|NCT01723397|112706|P1|NOT COMPLETED|Study Period 1||0
47672|NCT01723397|112705|P2|COMPLETED|Study Period 1||6
47673|NCT01723397|112706|P1|COMPLETED|Study Period 1||7
47674|NCT01723397|112705|P2|STARTED|Study Period 1||7
47675|NCT01723397|112706|P1|STARTED|Study Period 1||7
47676|NCT01723254|112720|P8|NOT COMPLETED|Overall Study||3
47677|NCT01723254|112721|P7|NOT COMPLETED|Overall Study||1
47678|NCT01723254|112722|P6|NOT COMPLETED|Overall Study||2
47679|NCT01723254|112723|P5|NOT COMPLETED|Overall Study||2
47680|NCT01723254|112724|P4|NOT COMPLETED|Overall Study||2
47681|NCT01723254|112725|P3|NOT COMPLETED|Overall Study||3
47682|NCT01723254|112726|P2|NOT COMPLETED|Overall Study||3
47683|NCT01723254|112727|P1|NOT COMPLETED|Overall Study||1
47684|NCT01723254|112720|P8|COMPLETED|Overall Study||60
47685|NCT01723254|112721|P7|COMPLETED|Overall Study||19
47686|NCT01723254|112722|P6|COMPLETED|Overall Study||18
47687|NCT01723254|112723|P5|COMPLETED|Overall Study||18
47688|NCT01723254|112724|P4|COMPLETED|Overall Study||18
47689|NCT01723254|112725|P3|COMPLETED|Overall Study||17
47690|NCT01723254|112726|P2|COMPLETED|Overall Study||18
47691|NCT01723254|112727|P1|COMPLETED|Overall Study||5
47692|NCT01723254|112720|P8|STARTED|Overall Study||63
47693|NCT01723254|112721|P7|STARTED|Overall Study||20
47694|NCT01723254|112722|P6|STARTED|Overall Study||20
47695|NCT01723254|112723|P5|STARTED|Overall Study||20
47696|NCT01723254|112724|P4|STARTED|Overall Study||20
47697|NCT01723254|112725|P3|STARTED|Overall Study||20
47698|NCT01723254|112726|P2|STARTED|Overall Study||21
47699|NCT01723254|112727|P1|STARTED|Overall Study||6
47700|NCT01723228|112779|P2|NOT COMPLETED|Overall Study||11
47701|NCT01723228|112780|P1|NOT COMPLETED|Overall Study||8
47702|NCT01723228|112779|P2|COMPLETED|Overall Study||73
47703|NCT01723228|112780|P1|COMPLETED|Overall Study||78
47704|NCT01723228|112779|P2|STARTED|Overall Study||84
47705|NCT01723228|112780|P1|STARTED|Overall Study||86
47706|NCT01722994|112798|P2|NOT COMPLETED|Overall Study||17
47707|NCT01722994|112799|P1|NOT COMPLETED|Overall Study||25
47708|NCT01722994|112798|P2|COMPLETED|Overall Study||31
47709|NCT01722994|112799|P1|COMPLETED|Overall Study||24
47710|NCT01722994|112798|P2|STARTED|Overall Study||48
47711|NCT01722994|112799|P1|STARTED|Overall Study||49
47712|NCT01722877|112813|P1|NOT COMPLETED|Overall Study||2
47713|NCT01722877|112813|P1|COMPLETED|Overall Study||27
47714|NCT01722877|112813|P1|STARTED|Overall Study||29
47715|NCT01722734|112823|P3|NOT COMPLETED|Overall Study||2
47716|NCT01722734|112824|P2|NOT COMPLETED|Overall Study||1
47717|NCT01722734|112825|P1|NOT COMPLETED|Overall Study||2
47718|NCT01722734|112823|P3|COMPLETED|Overall Study||307
47719|NCT01722734|112824|P2|COMPLETED|Overall Study||276
47720|NCT01722734|112825|P1|COMPLETED|Overall Study||552
47721|NCT01722734|112823|P3|STARTED|Overall Study||309
47722|NCT01722734|112824|P2|STARTED|Overall Study||277
47723|NCT01722734|112825|P1|STARTED|Overall Study||554
47724|NCT01722552|112833|P1|NOT COMPLETED|Overall Study||4
47725|NCT01722552|112833|P1|COMPLETED|Overall Study|Number of subjects who completed the intervention|116
47726|NCT01722552|112833|P1|STARTED|Overall Study|Number of subjects enrolled|120
47727|NCT01722487|112843|P2|NOT COMPLETED|Overall Study||7
47728|NCT01722487|112844|P1|NOT COMPLETED|Overall Study||2
47729|NCT01722487|112843|P2|COMPLETED|Overall Study|Participants who were still on study or died at study closure|126
47730|NCT01722487|112844|P1|COMPLETED|Overall Study|Participants who were still on study or died at study closure|134
47731|NCT01722487|112843|P2|STARTED|Overall Study||133
47732|NCT01722487|112844|P1|STARTED|Overall Study||136
47733|NCT01722435|112862|P1|NOT COMPLETED|Overall Study||0
47734|NCT01722435|112862|P1|COMPLETED|Overall Study||78
47735|NCT01722435|112862|P1|STARTED|Overall Study||78
47736|NCT01722266|112874|P4|NOT COMPLETED|Overall Study||0
47737|NCT01722266|112875|P3|NOT COMPLETED|Overall Study||5
47738|NCT01722266|112876|P2|NOT COMPLETED|Overall Study||3
47739|NCT01722266|112877|P1|NOT COMPLETED|Overall Study||1
47740|NCT01722266|112874|P4|COMPLETED|Overall Study|3 subjects randomized to 1.2 mg group and 1 to 1.8 mg group tolerated only 0.6 mg|18
47741|NCT01722266|112875|P3|COMPLETED|Overall Study||13
47742|NCT01722266|112876|P2|COMPLETED|Overall Study||15
47743|NCT01722266|112877|P1|COMPLETED|Overall Study||17
47744|NCT01722266|112874|P4|STARTED|Overall Study|3 withdrew consent; 1 dropped out due to nausea|18
47745|NCT01722266|112875|P3|STARTED|Overall Study||18
47746|NCT01722266|112876|P2|STARTED|Overall Study||18
47747|NCT01722266|112877|P1|STARTED|Overall Study||18
47748|NCT01722162|112905|P2|NOT COMPLETED|Overall Study||6
47749|NCT01722162|112906|P1|NOT COMPLETED|Overall Study||5
47750|NCT01722162|112905|P2|COMPLETED|Overall Study||18
47751|NCT01722162|112906|P1|COMPLETED|Overall Study||18
47752|NCT01722162|112905|P2|STARTED|Overall Study||24
47753|NCT01722162|112906|P1|STARTED|Overall Study||23
47754|NCT01722097|112916|P2|NOT COMPLETED|Overall Study||5
47755|NCT01722097|112917|P1|NOT COMPLETED|Overall Study||6
47756|NCT01722097|112916|P2|COMPLETED|Overall Study||50
47757|NCT01722097|112917|P1|COMPLETED|Overall Study||49
47758|NCT01722097|112916|P2|STARTED|Overall Study||55
47759|NCT01722097|112917|P1|STARTED|Overall Study||55
47760|NCT01722071|112925|P2|NOT COMPLETED|Overall Study||0
47761|NCT01722071|112926|P1|NOT COMPLETED|Overall Study||1
47762|NCT01722071|112925|P2|COMPLETED|Overall Study||10
47763|NCT01722071|112926|P1|COMPLETED|Overall Study||9
47764|NCT01722071|112925|P2|STARTED|Overall Study||10
47765|NCT01722071|112926|P1|STARTED|Overall Study||10
47766|NCT01721967|112932|P1|NOT COMPLETED|Overall Study||3
47767|NCT01721967|112932|P1|COMPLETED|Overall Study||11
47768|NCT01721967|112932|P1|STARTED|Overall Study||14
47769|NCT01721837|112941|P1|NOT COMPLETED|Overall Study||0
47770|NCT01721837|112941|P1|COMPLETED|Overall Study||2120
47771|NCT01721837|112941|P1|STARTED|Overall Study||2120
47772|NCT01721772|112947|P2|NOT COMPLETED|Overall Study||192
47773|NCT01721772|112948|P1|NOT COMPLETED|Overall Study||111
47774|NCT01721772|112947|P2|COMPLETED|Overall Study|Continuing in treatment period|13
47775|NCT01721772|112948|P1|COMPLETED|Overall Study|Continuing in treatment period|95
47776|NCT01721772|112947|P2|STARTED|Overall Study||205
47777|NCT01721772|112948|P1|STARTED|Overall Study||206
47778|NCT01721759|112968|P1|NOT COMPLETED|Overall Study||102
47779|NCT01721759|112968|P1|COMPLETED|Overall Study|Completed=continuing to receive treatment|15
47780|NCT01721759|112968|P1|STARTED|Overall Study||117
47781|NCT01721746|112976|P3|NOT COMPLETED|Follow-Up Period||0
47782|NCT01721746|112977|P2|NOT COMPLETED|Follow-Up Period||0
47783|NCT01721746|112978|P1|NOT COMPLETED|Follow-Up Period||0
47784|NCT01721746|112976|P3|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|19
47785|NCT01721746|112977|P2|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|11
47786|NCT01721746|112978|P1|COMPLETED|Follow-Up Period|Completed=Continuing in Follow-up Period; Study on-going|92
47787|NCT01721746|112976|P3|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|19
47788|NCT01721746|112977|P2|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|11
47789|NCT01721746|112978|P1|STARTED|Follow-Up Period|Participants could enter follow-up after discontinuing treatment for safety assessments|92
47790|NCT01721746|112976|P3|NOT COMPLETED|Treatment Period||57
47791|NCT01721746|112977|P2|NOT COMPLETED|Treatment Period||45
47792|NCT01721746|112978|P1|NOT COMPLETED|Treatment Period||233
47793|NCT01721746|112976|P3|COMPLETED|Treatment Period||0
47794|NCT01721746|112977|P2|COMPLETED|Treatment Period||0
47795|NCT01721746|112978|P1|COMPLETED|Treatment Period|Completed=Continuing in Treatment Period|35
47796|NCT01721746|112976|P3|STARTED|Treatment Period||57
47797|NCT01721746|112977|P2|STARTED|Treatment Period||45
47798|NCT01721746|112978|P1|STARTED|Treatment Period||268
47799|NCT01721564|112994|P1|NOT COMPLETED|Overall Study||0
47800|NCT01721564|112994|P1|COMPLETED|Overall Study||8
47801|NCT01721564|112994|P1|STARTED|Overall Study||8
47802|NCT01721486|113001|P2|NOT COMPLETED|Overall Study||1
47803|NCT01721486|113002|P1|NOT COMPLETED|Overall Study||1
47804|NCT01721486|113001|P2|COMPLETED|Overall Study||19
47805|NCT01721486|113002|P1|COMPLETED|Overall Study||20
47806|NCT01721486|113001|P2|STARTED|Overall Study||20
47807|NCT01721486|113002|P1|STARTED|Overall Study||21
47808|NCT01721330|113016|P2|NOT COMPLETED|Overall Study||1
47809|NCT01721330|113017|P1|NOT COMPLETED|Overall Study||0
47810|NCT01721330|113016|P2|COMPLETED|Overall Study||1
47811|NCT01721330|113017|P1|COMPLETED|Overall Study||1
47812|NCT01721330|113016|P2|STARTED|Overall Study||2
47813|NCT01721330|113017|P1|STARTED|Overall Study||1
47814|NCT01721317|113025|P2|NOT COMPLETED|Overall Study||4
47815|NCT01721317|113026|P1|NOT COMPLETED|Overall Study||2
47816|NCT01721317|113025|P2|COMPLETED|Overall Study||0
47817|NCT01721317|113026|P1|COMPLETED|Overall Study||0
47818|NCT01721317|113025|P2|STARTED|Overall Study||4
47819|NCT01721317|113026|P1|STARTED|Overall Study||2
47820|NCT01721226|113094|P2|NOT COMPLETED|Overall Study||7
47821|NCT01721226|113095|P1|NOT COMPLETED|Overall Study||5
47822|NCT01721226|113094|P2|COMPLETED|Overall Study||50
47823|NCT01721226|113095|P1|COMPLETED|Overall Study||50
47824|NCT01721226|113094|P2|Week 24|Overall Study||50
47825|NCT01721226|113095|P1|Week 24|Overall Study||50
47826|NCT01721226|113094|P2|Week 12|Overall Study||53
47827|NCT01721226|113095|P1|Week 12|Overall Study||48
47828|NCT01721226|113094|P2|Baseline|Overall Study||57
47829|NCT01721226|113095|P1|Baseline|Overall Study||53
47830|NCT01721226|113094|P2|STARTED|Overall Study||57
47831|NCT01721226|113095|P1|STARTED|Overall Study||55
47832|NCT01721161|113105|P2|NOT COMPLETED|Overall Study||7
47833|NCT01721161|113106|P1|NOT COMPLETED|Overall Study||4
47834|NCT01721161|113105|P2|COMPLETED|Overall Study||34
47835|NCT01721161|113106|P1|COMPLETED|Overall Study||37
47836|NCT01721161|113105|P2|STARTED|Overall Study||41
47837|NCT01721161|113106|P1|STARTED|Overall Study||41
47838|NCT01721109|113129|P1|NOT COMPLETED|Extension Phase||37
47839|NCT01721109|113129|P1|COMPLETED|Extension Phase|Participants turned 18 years old or the study drug became commercially available in their country.|3
47840|NCT01721109|113129|P1|STARTED|Extension Phase|Only 40 participants entered the optional extension phase.|40
47841|NCT01721109|113129|P1|NOT COMPLETED|Main Phase||1
47842|NCT01721109|113129|P1|COMPLETED|Main Phase||49
47843|NCT01721109|113129|P1|STARTED|Main Phase||50
47844|NCT01721096|113144|P2|NOT COMPLETED|Follow-up Completed at 3 Year||204
47845|NCT01721096|113145|P1|NOT COMPLETED|Follow-up Completed at 3 Year||302
47846|NCT01721096|113144|P2|COMPLETED|Follow-up Completed at 3 Year||2
47847|NCT01721096|113145|P1|COMPLETED|Follow-up Completed at 3 Year||5
47848|NCT01721096|113144|P2|STARTED|Follow-up Completed at 3 Year||206
47849|NCT01721096|113145|P1|STARTED|Follow-up Completed at 3 Year||307
47850|NCT01721096|113144|P2|NOT COMPLETED|Follow-up Completed at 2 Year||1
47851|NCT01721096|113145|P1|NOT COMPLETED|Follow-up Completed at 2 Year||8
47852|NCT01721096|113144|P2|COMPLETED|Follow-up Completed at 2 Year||206
47853|NCT01721096|113145|P1|COMPLETED|Follow-up Completed at 2 Year||307
47854|NCT01721096|113144|P2|STARTED|Follow-up Completed at 2 Year||207
47855|NCT01721096|113145|P1|STARTED|Follow-up Completed at 2 Year||315
47856|NCT01721096|113144|P2|NOT COMPLETED|Follow-up Completed at 1 Year||1
47857|NCT01721096|113145|P1|NOT COMPLETED|Follow-up Completed at 1 Year||4
47858|NCT01721096|113144|P2|COMPLETED|Follow-up Completed at 1 Year||207
47859|NCT01721096|113145|P1|COMPLETED|Follow-up Completed at 1 Year||315
47860|NCT01721096|113144|P2|STARTED|Follow-up Completed at 1 Year||208
47861|NCT01721096|113145|P1|STARTED|Follow-up Completed at 1 Year||319
47862|NCT01721096|113144|P2|NOT COMPLETED|Follow-up Completed at 8 Months||5
47863|NCT01721096|113145|P1|NOT COMPLETED|Follow-up Completed at 8 Months||4
47864|NCT01721096|113144|P2|COMPLETED|Follow-up Completed at 8 Months||208
47865|NCT01721096|113145|P1|COMPLETED|Follow-up Completed at 8 Months||319
47866|NCT01721096|113144|P2|STARTED|Follow-up Completed at 8 Months||213
47867|NCT01721096|113145|P1|STARTED|Follow-up Completed at 8 Months||323
47868|NCT01721070|113235|P1|NOT COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||1
47869|NCT01721070|113235|P1|COMPLETED|Ketoconazole 400 mg and SUF NT 15 mcg||18
47870|NCT01721070|113235|P1|STARTED|Ketoconazole 400 mg and SUF NT 15 mcg||19
47871|NCT01721070|113235|P1|NOT COMPLETED|SUF NT 15 mcg||0
47872|NCT01721070|113235|P1|COMPLETED|SUF NT 15 mcg||19
47873|NCT01721070|113235|P1|STARTED|SUF NT 15 mcg||19
47874|NCT01721057|113246|P7|NOT COMPLETED|Follow Up||0
47875|NCT01721057|113247|P6|NOT COMPLETED|Follow Up||0
47876|NCT01721057|113248|P5|NOT COMPLETED|Follow Up||0
47877|NCT01721057|113249|P4|NOT COMPLETED|Follow Up||0
47878|NCT01721057|113250|P3|NOT COMPLETED|Follow Up||0
47879|NCT01721057|113251|P2|NOT COMPLETED|Follow Up||0
47880|NCT01721057|113252|P1|NOT COMPLETED|Follow Up||0
47881|NCT01721057|113246|P7|COMPLETED|Follow Up||22
47882|NCT01721057|113247|P6|COMPLETED|Follow Up||19
47883|NCT01721057|113248|P5|COMPLETED|Follow Up||17
47884|NCT01721057|113249|P4|COMPLETED|Follow Up||0
47885|NCT01721057|113250|P3|COMPLETED|Follow Up||0
47886|NCT01721057|113251|P2|COMPLETED|Follow Up||0
47887|NCT01721057|113252|P1|COMPLETED|Follow Up||0
47888|NCT01721057|113246|P7|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|22
47889|NCT01721057|113247|P6|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|19
47890|NCT01721057|113248|P5|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|17
47891|NCT01721057|113249|P4|STARTED|Follow Up|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4 mg FollowUp|0
47892|NCT01721057|113250|P3|STARTED|Follow Up||0
47893|NCT01721057|113251|P2|STARTED|Follow Up||0
47894|NCT01721057|113252|P1|STARTED|Follow Up||0
47895|NCT01721057|113246|P7|NOT COMPLETED|Rescue Period||0
47896|NCT01721057|113247|P6|NOT COMPLETED|Rescue Period||0
47897|NCT01721057|113248|P5|NOT COMPLETED|Rescue Period||0
47898|NCT01721057|113249|P4|NOT COMPLETED|Rescue Period||3
47899|NCT01721057|113250|P3|NOT COMPLETED|Rescue Period||0
47900|NCT01721057|113251|P2|NOT COMPLETED|Rescue Period||0
47901|NCT01721057|113252|P1|NOT COMPLETED|Rescue Period||0
47902|NCT01721057|113246|P7|COMPLETED|Rescue Period||0
47903|NCT01721057|113247|P6|COMPLETED|Rescue Period||0
47904|NCT01721057|113248|P5|COMPLETED|Rescue Period||0
47905|NCT01721057|113249|P4|COMPLETED|Rescue Period||88
47906|NCT01721057|113250|P3|COMPLETED|Rescue Period||0
47907|NCT01721057|113251|P2|COMPLETED|Rescue Period||0
47908|NCT01721057|113252|P1|COMPLETED|Rescue Period||0
47909|NCT01721057|113246|P7|STARTED|Rescue Period||0
47910|NCT01721057|113247|P6|STARTED|Rescue Period||0
47911|NCT01721057|113248|P5|STARTED|Rescue Period||0
47912|NCT01721057|113249|P4|STARTED|Rescue Period|Participants who were determined to be nonresponders based on tender/swollen joint count.|91
47913|NCT01721057|113250|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
47914|NCT01721057|113251|P2|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
47915|NCT01721057|113252|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
47916|NCT01721057|113246|P7|NOT COMPLETED|Treatment Period||0
47917|NCT01721057|113247|P6|NOT COMPLETED|Treatment Period||0
47918|NCT01721057|113248|P5|NOT COMPLETED|Treatment Period||0
47919|NCT01721057|113249|P4|NOT COMPLETED|Treatment Period||0
47920|NCT01721057|113250|P3|NOT COMPLETED|Treatment Period||23
47921|NCT01721057|113251|P2|NOT COMPLETED|Treatment Period||19
47922|NCT01721057|113252|P1|NOT COMPLETED|Treatment Period||28
47923|NCT01721057|113246|P7|COMPLETED|Treatment Period||0
47924|NCT01721057|113247|P6|COMPLETED|Treatment Period||0
47925|NCT01721057|113248|P5|COMPLETED|Treatment Period||0
47926|NCT01721057|113249|P4|COMPLETED|Treatment Period||0
47927|NCT01721057|113250|P3|COMPLETED|Treatment Period|"Completers include rescued participants."|204
47928|NCT01721057|113251|P2|COMPLETED|Treatment Period|"Completers include rescued participants."|210
47929|NCT01721057|113252|P1|COMPLETED|Treatment Period|"Completers include rescued participants."|200
47930|NCT01721057|113246|P7|Rescued|Treatment Period||0
47931|NCT01721057|113247|P6|Rescued|Treatment Period||0
47932|NCT01721057|113248|P5|Rescued|Treatment Period||0
47933|NCT01721057|113249|P4|Rescued|Treatment Period||0
47934|NCT01721057|113250|P3|Rescued|Treatment Period||15
47935|NCT01721057|113251|P2|Rescued|Treatment Period||21
47936|NCT01721057|113252|P1|Rescued|Treatment Period||55
47937|NCT01721057|113246|P7|Received at Least 1 Dose of Study Drug|Treatment Period||0
47938|NCT01721057|113247|P6|Received at Least 1 Dose of Study Drug|Treatment Period||0
47939|NCT01721057|113248|P5|Received at Least 1 Dose of Study Drug|Treatment Period||0
47940|NCT01721057|113249|P4|Received at Least 1 Dose of Study Drug|Treatment Period||0
47941|NCT01721057|113250|P3|Received at Least 1 Dose of Study Drug|Treatment Period||227
47942|NCT01721057|113251|P2|Received at Least 1 Dose of Study Drug|Treatment Period||229
47943|NCT01721057|113252|P1|Received at Least 1 Dose of Study Drug|Treatment Period||228
47944|NCT01721057|113246|P7|STARTED|Treatment Period||0
47945|NCT01721057|113247|P6|STARTED|Treatment Period||0
47946|NCT01721057|113248|P5|STARTED|Treatment Period||0
47947|NCT01721057|113249|P4|STARTED|Treatment Period||0
47948|NCT01721057|113250|P3|STARTED|Treatment Period||227
47949|NCT01721057|113251|P2|STARTED|Treatment Period||229
47950|NCT01721057|113252|P1|STARTED|Treatment Period||228
47951|NCT01720797|113324|P2|NOT COMPLETED|Overall Study||0
47952|NCT01720797|113325|P1|NOT COMPLETED|Overall Study||3
47953|NCT01720797|113324|P2|COMPLETED|Overall Study||9
47954|NCT01720797|113325|P1|COMPLETED|Overall Study||9
47955|NCT01720797|113324|P2|STARTED|Overall Study||9
47956|NCT01720797|113325|P1|STARTED|Overall Study||12
47957|NCT01720602|113331|P1|NOT COMPLETED|Overall Study||5
47958|NCT01720602|113331|P1|COMPLETED|Overall Study||10
47959|NCT01720602|113331|P1|STARTED|Overall Study||15
47960|NCT01720316|113339|P2|NOT COMPLETED|Open-label Glycine||0
47961|NCT01720316|113340|P1|NOT COMPLETED|Open-label Glycine||0
47962|NCT01720316|113339|P2|COMPLETED|Open-label Glycine||1
47963|NCT01720316|113340|P1|COMPLETED|Open-label Glycine||1
47964|NCT01720316|113339|P2|STARTED|Open-label Glycine||1
47965|NCT01720316|113340|P1|STARTED|Open-label Glycine||1
47966|NCT01720316|113339|P2|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
47967|NCT01720316|113340|P1|NOT COMPLETED|Double-Blind Glycine Placebo Crossover||0
47968|NCT01720316|113339|P2|COMPLETED|Double-Blind Glycine Placebo Crossover||1
47969|NCT01720316|113340|P1|COMPLETED|Double-Blind Glycine Placebo Crossover||1
47970|NCT01720316|113339|P2|STARTED|Double-Blind Glycine Placebo Crossover||1
47971|NCT01720316|113340|P1|STARTED|Double-Blind Glycine Placebo Crossover||1
47972|NCT01720251|113389|P3|NOT COMPLETED|Overall Study||0
47973|NCT01720251|113390|P2|NOT COMPLETED|Overall Study||2
47974|NCT01720251|113391|P1|NOT COMPLETED|Overall Study||1
47975|NCT01720251|113389|P3|COMPLETED|Overall Study||82
47976|NCT01720251|113390|P2|COMPLETED|Overall Study||77
47977|NCT01720251|113391|P1|COMPLETED|Overall Study||78
47978|NCT01720251|113389|P3|STARTED|Overall Study||82
47979|NCT01720251|113390|P2|STARTED|Overall Study||79
47980|NCT01720251|113391|P1|STARTED|Overall Study||79
47981|NCT01720043|113399|P1|NOT COMPLETED|Overall Study||1
47982|NCT01720043|113399|P1|COMPLETED|Overall Study||7
47983|NCT01720043|113399|P1|STARTED|Overall Study||8
47984|NCT01719861|113403|P1|NOT COMPLETED|Cycle 2||1
47985|NCT01719861|113403|P1|COMPLETED|Cycle 2||1
47986|NCT01719861|113403|P1|STARTED|Cycle 2||2
47987|NCT01719861|113403|P1|NOT COMPLETED|Cycle 1||4
47988|NCT01719861|113403|P1|COMPLETED|Cycle 1||2
47989|NCT01719861|113403|P1|STARTED|Cycle 1||6
47990|NCT01719757|113411|P1|NOT COMPLETED|Overall Study||101
47991|NCT01719757|113411|P1|COMPLETED|Overall Study||258
47992|NCT01719757|113411|P1|STARTED|Overall Study||359
47993|NCT01719653|113424|P5|NOT COMPLETED|Overall Study||21
47994|NCT01719653|113425|P4|NOT COMPLETED|Overall Study||18
47995|NCT01719653|113426|P3|NOT COMPLETED|Overall Study||18
47996|NCT01719653|113427|P2|NOT COMPLETED|Overall Study||13
47997|NCT01719653|113428|P1|NOT COMPLETED|Overall Study||9
47998|NCT01719653|113424|P5|COMPLETED|Overall Study||200
47999|NCT01719653|113425|P4|COMPLETED|Overall Study||200
48000|NCT01719653|113426|P3|COMPLETED|Overall Study||200
48001|NCT01719653|113427|P2|COMPLETED|Overall Study||200
48002|NCT01719653|113428|P1|COMPLETED|Overall Study||200
48003|NCT01719653|113424|P5|STARTED|Overall Study||221
48004|NCT01719653|113425|P4|STARTED|Overall Study||218
48005|NCT01719653|113426|P3|STARTED|Overall Study||218
48006|NCT01719653|113427|P2|STARTED|Overall Study||213
48007|NCT01719653|113428|P1|STARTED|Overall Study||209
48008|NCT01719172|113450|P1|NOT COMPLETED|Overall Study||2
48009|NCT01719172|113450|P1|COMPLETED|Overall Study||28
48010|NCT01719172|113450|P1|STARTED|Overall Study||30
48011|NCT01719003|113464|P9|NOT COMPLETED|Overall Study||4
48012|NCT01719003|113465|P8|NOT COMPLETED|Overall Study||20
48013|NCT01719003|113466|P7|NOT COMPLETED|Overall Study||20
48014|NCT01719003|113467|P6|NOT COMPLETED|Overall Study||12
48015|NCT01719003|113468|P5|NOT COMPLETED|Overall Study||17
48016|NCT01719003|113469|P4|NOT COMPLETED|Overall Study||13
48017|NCT01719003|113470|P3|NOT COMPLETED|Overall Study||17
48018|NCT01719003|113471|P2|NOT COMPLETED|Overall Study||17
48019|NCT01719003|113472|P1|NOT COMPLETED|Overall Study||9
48020|NCT01719003|113464|P9|COMPLETED|Overall Study||49
48021|NCT01719003|113465|P8|COMPLETED|Overall Study||151
48022|NCT01719003|113466|P7|COMPLETED|Overall Study||150
48023|NCT01719003|113467|P6|COMPLETED|Overall Study||160
48024|NCT01719003|113468|P5|COMPLETED|Overall Study||150
48025|NCT01719003|113469|P4|COMPLETED|Overall Study||156
48026|NCT01719003|113470|P3|COMPLETED|Overall Study||154
48027|NCT01719003|113471|P2|COMPLETED|Overall Study||153
48028|NCT01719003|113472|P1|COMPLETED|Overall Study||161
48029|NCT01719003|113464|P9|STARTED|Overall Study||53
48030|NCT01719003|113465|P8|STARTED|Overall Study||171
48031|NCT01719003|113466|P7|STARTED|Overall Study||170
48032|NCT01719003|113467|P6|STARTED|Overall Study||172
48033|NCT01719003|113468|P5|STARTED|Overall Study||167
48034|NCT01719003|113469|P4|STARTED|Overall Study||169
48035|NCT01719003|113470|P3|STARTED|Overall Study||171
48036|NCT01719003|113471|P2|STARTED|Overall Study||170
48037|NCT01719003|113472|P1|STARTED|Overall Study||170
48038|NCT01718691|113509|P2|NOT COMPLETED|Overall Study||1
48039|NCT01718691|113510|P1|NOT COMPLETED|Overall Study||18
48040|NCT01718691|113509|P2|COMPLETED|Overall Study||9
48041|NCT01718691|113510|P1|COMPLETED|Overall Study||42
48042|NCT01718691|113509|P2|STARTED|Overall Study||10
48043|NCT01718691|113510|P1|STARTED|Overall Study||60
48044|NCT01718535|113553|P10|NOT COMPLETED|Overall Study||0
48045|NCT01718535|113554|P9|NOT COMPLETED|Overall Study||0
48046|NCT01718535|113555|P8|NOT COMPLETED|Overall Study||0
48047|NCT01718535|113556|P7|NOT COMPLETED|Overall Study||0
48048|NCT01718535|113557|P6|NOT COMPLETED|Overall Study||0
48049|NCT01718535|113558|P5|NOT COMPLETED|Overall Study||0
48050|NCT01718535|113559|P4|NOT COMPLETED|Overall Study||1
48051|NCT01718535|113560|P3|NOT COMPLETED|Overall Study||0
48052|NCT01718535|113561|P2|NOT COMPLETED|Overall Study||0
48053|NCT01718535|113562|P1|NOT COMPLETED|Overall Study||1
48054|NCT01718535|113553|P10|COMPLETED|Overall Study||1
48055|NCT01718535|113554|P9|COMPLETED|Overall Study||15
48056|NCT01718535|113555|P8|COMPLETED|Overall Study||6
48057|NCT01718535|113556|P7|COMPLETED|Overall Study||11
48058|NCT01718535|113557|P6|COMPLETED|Overall Study||40
48059|NCT01718535|113558|P5|COMPLETED|Overall Study||1
48060|NCT01718535|113559|P4|COMPLETED|Overall Study||7
48061|NCT01718535|113560|P3|COMPLETED|Overall Study||19
48062|NCT01718535|113561|P2|COMPLETED|Overall Study||95
48063|NCT01718535|113562|P1|COMPLETED|Overall Study||130
48064|NCT01718535|113553|P10|First Pass|Overall Study||1
48065|NCT01718535|113554|P9|First Pass|Overall Study||15
48066|NCT01718535|113555|P8|First Pass|Overall Study||6
48067|NCT01718535|113556|P7|First Pass|Overall Study||11
48068|NCT01718535|113557|P6|First Pass|Overall Study||39
48069|NCT01718535|113558|P5|First Pass|Overall Study||1
48070|NCT01718535|113559|P4|First Pass|Overall Study||7
48071|NCT01718535|113560|P3|First Pass|Overall Study||19
48072|NCT01718535|113561|P2|First Pass|Overall Study||94
48073|NCT01718535|113562|P1|First Pass|Overall Study||128
48074|NCT01718535|113553|P10|STARTED|Overall Study||1
48075|NCT01718535|113554|P9|STARTED|Overall Study||15
48076|NCT01718535|113555|P8|STARTED|Overall Study||6
48077|NCT01718535|113556|P7|STARTED|Overall Study||11
48078|NCT01718535|113557|P6|STARTED|Overall Study||40
48079|NCT01718535|113558|P5|STARTED|Overall Study||1
48080|NCT01718535|113559|P4|STARTED|Overall Study||8
48081|NCT01718535|113560|P3|STARTED|Overall Study||19
48082|NCT01718535|113561|P2|STARTED|Overall Study||95
48083|NCT01718535|113562|P1|STARTED|Overall Study||131
48084|NCT01718509|113586|P2|NOT COMPLETED|Overall Study||48
48085|NCT01718509|113587|P1|NOT COMPLETED|Overall Study||48
48086|NCT01718509|113586|P2|COMPLETED|Overall Study||147
48087|NCT01718509|113587|P1|COMPLETED|Overall Study||147
48088|NCT01718509|113586|P2|STARTED|Overall Study||195
48089|NCT01718509|113587|P1|STARTED|Overall Study||195
48090|NCT01718483|113633|P2|NOT COMPLETED|Overall Study||34
48091|NCT01718483|113634|P1|NOT COMPLETED|Overall Study||34
48092|NCT01718483|113633|P2|COMPLETED|Overall Study||158
48093|NCT01718483|113634|P1|COMPLETED|Overall Study||157
48094|NCT01718483|113633|P2|Treated|Overall Study||192
48095|NCT01718483|113634|P1|Treated|Overall Study||187
48096|NCT01718483|113633|P2|STARTED|Overall Study||192
48097|NCT01718483|113634|P1|STARTED|Overall Study||191
48098|NCT01718028|113680|P2|NOT COMPLETED|Overall Study||0
48099|NCT01718028|113681|P1|NOT COMPLETED|Overall Study||0
48100|NCT01718028|113680|P2|COMPLETED|Overall Study||24
48101|NCT01718028|113681|P1|COMPLETED|Overall Study||25
48102|NCT01718028|113680|P2|STARTED|Overall Study||24
48103|NCT01718028|113681|P1|STARTED|Overall Study||25
48104|NCT01717989|113693|P1|NOT COMPLETED|Overall Study||1066
48105|NCT01717989|113693|P1|COMPLETED|Overall Study||1182
48106|NCT01717989|113693|P1|STARTED|Overall Study||2248
48107|NCT01717976|113761|P2|NOT COMPLETED|Overall Study||1
48108|NCT01717976|113762|P1|NOT COMPLETED|Overall Study||0
48109|NCT01717976|113761|P2|COMPLETED|Overall Study||256
48110|NCT01717976|113762|P1|COMPLETED|Overall Study||257
48111|NCT01717976|113761|P2|STARTED|Overall Study||257
48112|NCT01717976|113762|P1|STARTED|Overall Study||257
48113|NCT01717872|113778|P2|NOT COMPLETED|Overall Study||0
48114|NCT01717872|113779|P1|NOT COMPLETED|Overall Study||0
48115|NCT01717872|113778|P2|COMPLETED|Overall Study||25
48116|NCT01717872|113779|P1|COMPLETED|Overall Study||25
48117|NCT01717872|113778|P2|STARTED|Overall Study||25
48118|NCT01717872|113779|P1|STARTED|Overall Study||25
48119|NCT01717768|113799|P12|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48120|NCT01717768|113800|P11|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48121|NCT01717768|113801|P10|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||1
48122|NCT01717768|113802|P9|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48123|NCT01717768|113803|P8|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||2
48124|NCT01717768|113804|P7|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48125|NCT01717768|113805|P6|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48126|NCT01717768|113806|P5|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48127|NCT01717768|113807|P4|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48128|NCT01717768|113808|P3|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48129|NCT01717768|113809|P2|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48130|NCT01717768|113810|P1|NOT COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48131|NCT01717768|113799|P12|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48132|NCT01717768|113800|P11|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48133|NCT01717768|113801|P10|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
48134|NCT01717768|113802|P9|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48135|NCT01717768|113803|P8|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||15
48136|NCT01717768|113804|P7|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48137|NCT01717768|113805|P6|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48138|NCT01717768|113806|P5|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48139|NCT01717768|113807|P4|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48140|NCT01717768|113808|P3|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48141|NCT01717768|113809|P2|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48142|NCT01717768|113810|P1|COMPLETED|Part 4-Treatment 2 (Duration of 15 Days)||0
48143|NCT01717768|113799|P12|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48144|NCT01717768|113800|P11|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48145|NCT01717768|113801|P10|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||16
48146|NCT01717768|113802|P9|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48147|NCT01717768|113803|P8|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||17
48148|NCT01717768|113804|P7|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48149|NCT01717768|113805|P6|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48150|NCT01717768|113806|P5|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48151|NCT01717768|113807|P4|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48152|NCT01717768|113808|P3|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48153|NCT01717768|113809|P2|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48154|NCT01717768|113810|P1|STARTED|Part 4-Treatment 2 (Duration of 15 Days)||0
48155|NCT01717768|113799|P12|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||1
48156|NCT01717768|113800|P11|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48157|NCT01717768|113801|P10|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48158|NCT01717768|113802|P9|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48159|NCT01717768|113803|P8|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48160|NCT01717768|113804|P7|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48161|NCT01717768|113805|P6|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48162|NCT01717768|113806|P5|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48163|NCT01717768|113807|P4|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48164|NCT01717768|113808|P3|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48165|NCT01717768|113809|P2|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48166|NCT01717768|113810|P1|NOT COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48167|NCT01717768|113799|P12|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||15
48168|NCT01717768|113800|P11|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
48169|NCT01717768|113801|P10|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48170|NCT01717768|113802|P9|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||16
48171|NCT01717768|113803|P8|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48172|NCT01717768|113804|P7|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||17
48173|NCT01717768|113805|P6|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48174|NCT01717768|113806|P5|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48175|NCT01717768|113807|P4|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48176|NCT01717768|113808|P3|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48177|NCT01717768|113809|P2|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48178|NCT01717768|113810|P1|COMPLETED|Part 4-Treatment 1 (Duration of 15 Days)||0
48179|NCT01717768|113799|P12|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
48180|NCT01717768|113800|P11|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
48181|NCT01717768|113801|P10|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48182|NCT01717768|113802|P9|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||16
48183|NCT01717768|113803|P8|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48184|NCT01717768|113804|P7|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||17
48185|NCT01717768|113805|P6|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48186|NCT01717768|113806|P5|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48187|NCT01717768|113807|P4|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48188|NCT01717768|113808|P3|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48189|NCT01717768|113809|P2|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48190|NCT01717768|113810|P1|STARTED|Part 4-Treatment 1 (Duration of 15 Days)||0
48191|NCT01717768|113799|P12|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48192|NCT01717768|113800|P11|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48193|NCT01717768|113801|P10|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48194|NCT01717768|113802|P9|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48195|NCT01717768|113803|P8|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48196|NCT01717768|113804|P7|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48197|NCT01717768|113805|P6|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48198|NCT01717768|113806|P5|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48199|NCT01717768|113807|P4|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48200|NCT01717768|113808|P3|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48201|NCT01717768|113809|P2|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48202|NCT01717768|113810|P1|NOT COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48203|NCT01717768|113799|P12|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48204|NCT01717768|113800|P11|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48205|NCT01717768|113801|P10|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48206|NCT01717768|113802|P9|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48207|NCT01717768|113803|P8|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48208|NCT01717768|113804|P7|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48209|NCT01717768|113805|P6|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
48210|NCT01717768|113806|P5|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||5
48211|NCT01717768|113807|P4|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||4
48212|NCT01717768|113808|P3|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48213|NCT01717768|113809|P2|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48214|NCT01717768|113810|P1|COMPLETED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48215|NCT01717768|113799|P12|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48216|NCT01717768|113800|P11|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48217|NCT01717768|113801|P10|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48218|NCT01717768|113802|P9|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48219|NCT01717768|113803|P8|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48220|NCT01717768|113804|P7|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48221|NCT01717768|113805|P6|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
48222|NCT01717768|113806|P5|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||5
48223|NCT01717768|113807|P4|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||4
48224|NCT01717768|113808|P3|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48225|NCT01717768|113809|P2|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48226|NCT01717768|113810|P1|STARTED|Part 3 - Treatment 3 (Duration of 1 Day)||0
48227|NCT01717768|113799|P12|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48228|NCT01717768|113800|P11|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48229|NCT01717768|113801|P10|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48230|NCT01717768|113802|P9|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48231|NCT01717768|113803|P8|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48232|NCT01717768|113804|P7|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48233|NCT01717768|113805|P6|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48234|NCT01717768|113806|P5|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48235|NCT01717768|113807|P4|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48236|NCT01717768|113808|P3|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48237|NCT01717768|113809|P2|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48238|NCT01717768|113810|P1|NOT COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48239|NCT01717768|113799|P12|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48240|NCT01717768|113800|P11|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48241|NCT01717768|113801|P10|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48242|NCT01717768|113802|P9|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48243|NCT01717768|113803|P8|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48244|NCT01717768|113804|P7|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48245|NCT01717768|113805|P6|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
48246|NCT01717768|113806|P5|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||5
48247|NCT01717768|113807|P4|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||4
48248|NCT01717768|113808|P3|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48249|NCT01717768|113809|P2|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48250|NCT01717768|113810|P1|COMPLETED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48251|NCT01717768|113799|P12|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48252|NCT01717768|113800|P11|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48253|NCT01717768|113801|P10|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48254|NCT01717768|113802|P9|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48255|NCT01717768|113803|P8|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48256|NCT01717768|113804|P7|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48257|NCT01717768|113805|P6|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
48258|NCT01717768|113806|P5|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||5
48259|NCT01717768|113807|P4|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||4
48260|NCT01717768|113808|P3|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48261|NCT01717768|113809|P2|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48262|NCT01717768|113810|P1|STARTED|Part 3 - Treatment 2 (Duration of 1 Day)||0
48263|NCT01717768|113799|P12|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48264|NCT01717768|113800|P11|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48265|NCT01717768|113801|P10|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48266|NCT01717768|113802|P9|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48267|NCT01717768|113803|P8|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48268|NCT01717768|113804|P7|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48269|NCT01717768|113805|P6|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48270|NCT01717768|113806|P5|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48271|NCT01717768|113807|P4|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48272|NCT01717768|113808|P3|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48273|NCT01717768|113809|P2|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48274|NCT01717768|113810|P1|NOT COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48275|NCT01717768|113799|P12|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48276|NCT01717768|113800|P11|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48277|NCT01717768|113801|P10|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48278|NCT01717768|113802|P9|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48279|NCT01717768|113803|P8|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48280|NCT01717768|113804|P7|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48281|NCT01717768|113805|P6|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
48282|NCT01717768|113806|P5|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||5
48283|NCT01717768|113807|P4|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||4
48284|NCT01717768|113808|P3|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48285|NCT01717768|113809|P2|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48286|NCT01717768|113810|P1|COMPLETED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48287|NCT01717768|113799|P12|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48288|NCT01717768|113800|P11|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48289|NCT01717768|113801|P10|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48290|NCT01717768|113802|P9|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48291|NCT01717768|113803|P8|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48292|NCT01717768|113804|P7|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48293|NCT01717768|113805|P6|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
48294|NCT01717768|113806|P5|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||5
48295|NCT01717768|113807|P4|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||4
48296|NCT01717768|113808|P3|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48297|NCT01717768|113809|P2|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48298|NCT01717768|113810|P1|STARTED|Part 3 - Treatment 1 (Duration of 1 Day)||0
48299|NCT01717768|113799|P12|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48300|NCT01717768|113800|P11|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48301|NCT01717768|113801|P10|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48302|NCT01717768|113802|P9|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48303|NCT01717768|113803|P8|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48304|NCT01717768|113804|P7|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48305|NCT01717768|113805|P6|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48306|NCT01717768|113806|P5|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48307|NCT01717768|113807|P4|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48308|NCT01717768|113808|P3|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48309|NCT01717768|113809|P2|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48310|NCT01717768|113810|P1|NOT COMPLETED|Part 2 (Duration of 15 Days)||0
48311|NCT01717768|113799|P12|COMPLETED|Part 2 (Duration of 15 Days)||0
48312|NCT01717768|113800|P11|COMPLETED|Part 2 (Duration of 15 Days)||0
48313|NCT01717768|113801|P10|COMPLETED|Part 2 (Duration of 15 Days)||0
48314|NCT01717768|113802|P9|COMPLETED|Part 2 (Duration of 15 Days)||0
48315|NCT01717768|113803|P8|COMPLETED|Part 2 (Duration of 15 Days)||0
48316|NCT01717768|113804|P7|COMPLETED|Part 2 (Duration of 15 Days)||0
48317|NCT01717768|113805|P6|COMPLETED|Part 2 (Duration of 15 Days)||0
48318|NCT01717768|113806|P5|COMPLETED|Part 2 (Duration of 15 Days)||0
48319|NCT01717768|113807|P4|COMPLETED|Part 2 (Duration of 15 Days)||0
48320|NCT01717768|113808|P3|COMPLETED|Part 2 (Duration of 15 Days)||17
48321|NCT01717768|113809|P2|COMPLETED|Part 2 (Duration of 15 Days)||0
48322|NCT01717768|113810|P1|COMPLETED|Part 2 (Duration of 15 Days)||0
48323|NCT01717768|113799|P12|STARTED|Part 2 (Duration of 15 Days)||0
48324|NCT01717768|113800|P11|STARTED|Part 2 (Duration of 15 Days)||0
48325|NCT01717768|113801|P10|STARTED|Part 2 (Duration of 15 Days)||0
48326|NCT01717768|113802|P9|STARTED|Part 2 (Duration of 15 Days)||0
48327|NCT01717768|113803|P8|STARTED|Part 2 (Duration of 15 Days)||0
48328|NCT01717768|113804|P7|STARTED|Part 2 (Duration of 15 Days)||0
48329|NCT01717768|113805|P6|STARTED|Part 2 (Duration of 15 Days)||0
48330|NCT01717768|113806|P5|STARTED|Part 2 (Duration of 15 Days)||0
48331|NCT01717768|113807|P4|STARTED|Part 2 (Duration of 15 Days)||0
48332|NCT01717768|113808|P3|STARTED|Part 2 (Duration of 15 Days)||17
48333|NCT01717768|113809|P2|STARTED|Part 2 (Duration of 15 Days)||0
48334|NCT01717768|113810|P1|STARTED|Part 2 (Duration of 15 Days)||0
48335|NCT01717768|113799|P12|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48336|NCT01717768|113800|P11|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48337|NCT01717768|113801|P10|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48338|NCT01717768|113802|P9|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48339|NCT01717768|113803|P8|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48340|NCT01717768|113804|P7|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48341|NCT01717768|113805|P6|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48342|NCT01717768|113806|P5|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48343|NCT01717768|113807|P4|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48344|NCT01717768|113808|P3|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48345|NCT01717768|113809|P2|NOT COMPLETED|Part 1 (Duration of 15 Days)||1
48346|NCT01717768|113810|P1|NOT COMPLETED|Part 1 (Duration of 15 Days)||0
48347|NCT01717768|113799|P12|COMPLETED|Part 1 (Duration of 15 Days)||0
48348|NCT01717768|113800|P11|COMPLETED|Part 1 (Duration of 15 Days)||0
48349|NCT01717768|113801|P10|COMPLETED|Part 1 (Duration of 15 Days)||0
48350|NCT01717768|113802|P9|COMPLETED|Part 1 (Duration of 15 Days)||0
48351|NCT01717768|113803|P8|COMPLETED|Part 1 (Duration of 15 Days)||0
48352|NCT01717768|113804|P7|COMPLETED|Part 1 (Duration of 15 Days)||0
48353|NCT01717768|113805|P6|COMPLETED|Part 1 (Duration of 15 Days)||0
48354|NCT01717768|113806|P5|COMPLETED|Part 1 (Duration of 15 Days)||0
48355|NCT01717768|113807|P4|COMPLETED|Part 1 (Duration of 15 Days)||0
48356|NCT01717768|113808|P3|COMPLETED|Part 1 (Duration of 15 Days)||0
48357|NCT01717768|113809|P2|COMPLETED|Part 1 (Duration of 15 Days)||16
48358|NCT01717768|113810|P1|COMPLETED|Part 1 (Duration of 15 Days)||17
48359|NCT01717768|113799|P12|STARTED|Part 1 (Duration of 15 Days)||0
48360|NCT01717768|113800|P11|STARTED|Part 1 (Duration of 15 Days)||0
48361|NCT01717768|113801|P10|STARTED|Part 1 (Duration of 15 Days)||0
48362|NCT01717768|113802|P9|STARTED|Part 1 (Duration of 15 Days)||0
48363|NCT01717768|113803|P8|STARTED|Part 1 (Duration of 15 Days)||0
48364|NCT01717768|113804|P7|STARTED|Part 1 (Duration of 15 Days)||0
48365|NCT01717768|113805|P6|STARTED|Part 1 (Duration of 15 Days)||0
48366|NCT01717768|113806|P5|STARTED|Part 1 (Duration of 15 Days)||0
48367|NCT01717768|113807|P4|STARTED|Part 1 (Duration of 15 Days)||0
48368|NCT01717768|113808|P3|STARTED|Part 1 (Duration of 15 Days)||0
48369|NCT01717768|113809|P2|STARTED|Part 1 (Duration of 15 Days)||17
48370|NCT01717768|113810|P1|STARTED|Part 1 (Duration of 15 Days)||17
48371|NCT01717638|113861|P13|NOT COMPLETED|Overall Study||19
48372|NCT01717638|113862|P12|NOT COMPLETED|Overall Study||0
48373|NCT01717638|113863|P11|NOT COMPLETED|Overall Study||0
48374|NCT01717638|113864|P10|NOT COMPLETED|Overall Study||1
48375|NCT01717638|113865|P9|NOT COMPLETED|Overall Study||2
48376|NCT01717638|113866|P8|NOT COMPLETED|Overall Study||1
48377|NCT01717638|113867|P7|NOT COMPLETED|Overall Study||2
48378|NCT01717638|113868|P6|NOT COMPLETED|Overall Study||1
48379|NCT01717638|113869|P5|NOT COMPLETED|Overall Study||1
48380|NCT01717638|113870|P4|NOT COMPLETED|Overall Study||0
48381|NCT01717638|113871|P3|NOT COMPLETED|Overall Study||1
48382|NCT01717638|113872|P2|NOT COMPLETED|Overall Study||1
48383|NCT01717638|113873|P1|NOT COMPLETED|Overall Study||0
48384|NCT01717638|113861|P13|COMPLETED|Overall Study||190
48385|NCT01717638|113862|P12|COMPLETED|Overall Study||12
48386|NCT01717638|113863|P11|COMPLETED|Overall Study||11
48387|NCT01717638|113864|P10|COMPLETED|Overall Study||99
48388|NCT01717638|113865|P9|COMPLETED|Overall Study||26
48389|NCT01717638|113866|P8|COMPLETED|Overall Study||28
48390|NCT01717638|113867|P7|COMPLETED|Overall Study||41
48391|NCT01717638|113868|P6|COMPLETED|Overall Study||54
48392|NCT01717638|113869|P5|COMPLETED|Overall Study||63
48393|NCT01717638|113870|P4|COMPLETED|Overall Study||66
48394|NCT01717638|113871|P3|COMPLETED|Overall Study||59
48395|NCT01717638|113872|P2|COMPLETED|Overall Study||60
48396|NCT01717638|113873|P1|COMPLETED|Overall Study||67
48397|NCT01717638|113861|P13|STARTED|Overall Study||209
48398|NCT01717638|113862|P12|STARTED|Overall Study||12
48399|NCT01717638|113863|P11|STARTED|Overall Study||11
48400|NCT01717638|113864|P10|STARTED|Overall Study||100
48401|NCT01717638|113865|P9|STARTED|Overall Study||28
48402|NCT01717638|113866|P8|STARTED|Overall Study||29
48403|NCT01717638|113867|P7|STARTED|Overall Study||43
48404|NCT01717638|113868|P6|STARTED|Overall Study||55
48405|NCT01717638|113869|P5|STARTED|Overall Study||64
48406|NCT01717638|113870|P4|STARTED|Overall Study||66
48407|NCT01717638|113871|P3|STARTED|Overall Study||60
48408|NCT01717638|113872|P2|STARTED|Overall Study||61
48409|NCT01717638|113873|P1|STARTED|Overall Study||67
48410|NCT01717456|114017|P2|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
48411|NCT01717456|114018|P1|NOT COMPLETED|Follow-Up 6 Months After End of Tx||4
48412|NCT01717456|114017|P2|COMPLETED|Follow-Up 6 Months After End of Tx||2
48413|NCT01717456|114018|P1|COMPLETED|Follow-Up 6 Months After End of Tx||7
48414|NCT01717456|114017|P2|STARTED|Follow-Up 6 Months After End of Tx||6
48415|NCT01717456|114018|P1|STARTED|Follow-Up 6 Months After End of Tx||11
48416|NCT01717456|114017|P2|NOT COMPLETED|End of Treatment||2
48417|NCT01717456|114018|P1|NOT COMPLETED|End of Treatment||0
48418|NCT01717456|114017|P2|COMPLETED|End of Treatment||6
48419|NCT01717456|114018|P1|COMPLETED|End of Treatment||11
48420|NCT01717456|114017|P2|STARTED|End of Treatment||8
48421|NCT01717456|114018|P1|STARTED|End of Treatment||11
48422|NCT01717326|114106|P20|NOT COMPLETED|Overall Study||6
48423|NCT01717326|114107|P19|NOT COMPLETED|Overall Study||4
48424|NCT01717326|114108|P18|NOT COMPLETED|Overall Study||0
48425|NCT01717326|114109|P17|NOT COMPLETED|Overall Study||1
48426|NCT01717326|114110|P16|NOT COMPLETED|Overall Study||3
48427|NCT01717326|114111|P15|NOT COMPLETED|Overall Study||0
48428|NCT01717326|114112|P14|NOT COMPLETED|Overall Study||0
48429|NCT01717326|114113|P13|NOT COMPLETED|Overall Study||1
48430|NCT01717326|114114|P12|NOT COMPLETED|Overall Study||0
48431|NCT01717326|114115|P11|NOT COMPLETED|Overall Study||2
48432|NCT01717326|114116|P10|NOT COMPLETED|Overall Study||2
48433|NCT01717326|114117|P9|NOT COMPLETED|Overall Study||0
48434|NCT01717326|114118|P8|NOT COMPLETED|Overall Study||0
48435|NCT01717326|114119|P7|NOT COMPLETED|Overall Study||1
48436|NCT01717326|114120|P6|NOT COMPLETED|Overall Study||0
48437|NCT01717326|114121|P5|NOT COMPLETED|Overall Study||2
48438|NCT01717326|114122|P4|NOT COMPLETED|Overall Study||2
48439|NCT01717326|114123|P3|NOT COMPLETED|Overall Study||0
48440|NCT01717326|114124|P2|NOT COMPLETED|Overall Study||1
48441|NCT01717326|114125|P1|NOT COMPLETED|Overall Study||3
48442|NCT01717326|114106|P20|COMPLETED|Overall Study||15
48443|NCT01717326|114107|P19|COMPLETED|Overall Study||16
48444|NCT01717326|114108|P18|COMPLETED|Overall Study||31
48445|NCT01717326|114109|P17|COMPLETED|Overall Study||29
48446|NCT01717326|114110|P16|COMPLETED|Overall Study||27
48447|NCT01717326|114111|P15|COMPLETED|Overall Study||29
48448|NCT01717326|114112|P14|COMPLETED|Overall Study||32
48449|NCT01717326|114113|P13|COMPLETED|Overall Study||32
48450|NCT01717326|114114|P12|COMPLETED|Overall Study||33
48451|NCT01717326|114115|P11|COMPLETED|Overall Study||30
48452|NCT01717326|114116|P10|COMPLETED|Overall Study||29
48453|NCT01717326|114117|P9|COMPLETED|Overall Study||32
48454|NCT01717326|114118|P8|COMPLETED|Overall Study||29
48455|NCT01717326|114119|P7|COMPLETED|Overall Study||30
48456|NCT01717326|114120|P6|COMPLETED|Overall Study||31
48457|NCT01717326|114121|P5|COMPLETED|Overall Study||31
48458|NCT01717326|114122|P4|COMPLETED|Overall Study||28
48459|NCT01717326|114123|P3|COMPLETED|Overall Study||13
48460|NCT01717326|114124|P2|COMPLETED|Overall Study||26
48461|NCT01717326|114125|P1|COMPLETED|Overall Study||22
48462|NCT01717326|114106|P20|Treated|Overall Study||21
48463|NCT01717326|114107|P19|Treated|Overall Study||20
48464|NCT01717326|114108|P18|Treated|Overall Study||31
48465|NCT01717326|114109|P17|Treated|Overall Study||30
48466|NCT01717326|114110|P16|Treated|Overall Study||30
48467|NCT01717326|114111|P15|Treated|Overall Study||29
48468|NCT01717326|114112|P14|Treated|Overall Study||32
48469|NCT01717326|114113|P13|Treated|Overall Study||33
48470|NCT01717326|114114|P12|Treated|Overall Study||33
48471|NCT01717326|114115|P11|Treated|Overall Study||32
48472|NCT01717326|114116|P10|Treated|Overall Study||31
48473|NCT01717326|114117|P9|Treated|Overall Study||32
48474|NCT01717326|114118|P8|Treated|Overall Study||29
48475|NCT01717326|114119|P7|Treated|Overall Study||31
48476|NCT01717326|114120|P6|Treated|Overall Study||31
48477|NCT01717326|114121|P5|Treated|Overall Study||33
48478|NCT01717326|114122|P4|Treated|Overall Study||30
48479|NCT01717326|114123|P3|Treated|Overall Study|Number excludes 1 participant randomized to A3 but treated on Arm A2|12
48480|NCT01717326|114124|P2|Treated|Overall Study|Number includes 1 additional participant randomized to A3 but treated on A2|28
48481|NCT01717326|114125|P1|Treated|Overall Study||25
48482|NCT01717326|114106|P20|STARTED|Overall Study||21
48483|NCT01717326|114107|P19|STARTED|Overall Study||20
48484|NCT01717326|114108|P18|STARTED|Overall Study||31
48485|NCT01717326|114109|P17|STARTED|Overall Study||30
48486|NCT01717326|114110|P16|STARTED|Overall Study||30
48487|NCT01717326|114111|P15|STARTED|Overall Study||29
48488|NCT01717326|114112|P14|STARTED|Overall Study||32
48489|NCT01717326|114113|P13|STARTED|Overall Study||33
48490|NCT01717326|114114|P12|STARTED|Overall Study||33
48491|NCT01717326|114115|P11|STARTED|Overall Study||32
48492|NCT01717326|114116|P10|STARTED|Overall Study||31
48493|NCT01717326|114117|P9|STARTED|Overall Study||32
48494|NCT01717326|114118|P8|STARTED|Overall Study||29
48495|NCT01717326|114119|P7|STARTED|Overall Study||31
48496|NCT01717326|114120|P6|STARTED|Overall Study||31
48497|NCT01717326|114121|P5|STARTED|Overall Study||33
48498|NCT01717326|114122|P4|STARTED|Overall Study||30
48499|NCT01717326|114123|P3|STARTED|Overall Study||13
48500|NCT01717326|114124|P2|STARTED|Overall Study||27
48501|NCT01717326|114125|P1|STARTED|Overall Study||25
48502|NCT01717313|114389|P2|NOT COMPLETED|Phase B (Weeks 24 to 54)||16
48503|NCT01717313|114390|P1|NOT COMPLETED|Phase B (Weeks 24 to 54)||12
48504|NCT01717313|114389|P2|COMPLETED|Phase B (Weeks 24 to 54)||135
48505|NCT01717313|114390|P1|COMPLETED|Phase B (Weeks 24 to 54)||134
48506|NCT01717313|114389|P2|STARTED|Phase B (Weeks 24 to 54)||151
48507|NCT01717313|114390|P1|STARTED|Phase B (Weeks 24 to 54)||146
48508|NCT01717313|114389|P2|NOT COMPLETED|Interphase||0
48509|NCT01717313|114390|P1|NOT COMPLETED|Interphase||1
48510|NCT01717313|114389|P2|COMPLETED|Interphase||151
48511|NCT01717313|114390|P1|COMPLETED|Interphase||146
48512|NCT01717313|114389|P2|STARTED|Interphase||151
48513|NCT01717313|114390|P1|STARTED|Interphase||147
48514|NCT01717313|114389|P2|NOT COMPLETED|Phase A (Weeks 0 to 24)||13
48515|NCT01717313|114390|P1|NOT COMPLETED|Phase A (Weeks 0 to 24)||18
48516|NCT01717313|114389|P2|COMPLETED|Phase A (Weeks 0 to 24)||151
48517|NCT01717313|114390|P1|COMPLETED|Phase A (Weeks 0 to 24)||147
48518|NCT01717313|114389|P2|STARTED|Phase A (Weeks 0 to 24)||164
48519|NCT01717313|114390|P1|STARTED|Phase A (Weeks 0 to 24)||165
48520|NCT01717287|114428|P2|NOT COMPLETED|Overall Study||3
48521|NCT01717287|114429|P1|NOT COMPLETED|Overall Study||0
48522|NCT01717287|114428|P2|COMPLETED|Overall Study||25
48523|NCT01717287|114429|P1|COMPLETED|Overall Study||4
48524|NCT01717287|114428|P2|STARTED|Overall Study||28
48525|NCT01717287|114429|P1|STARTED|Overall Study||4
48526|NCT01717040|114453|P2|NOT COMPLETED|Overall Study||5
48527|NCT01717040|114454|P1|NOT COMPLETED|Overall Study||5
48528|NCT01717040|114453|P2|COMPLETED|Overall Study||15
48529|NCT01717040|114454|P1|COMPLETED|Overall Study||12
48530|NCT01717040|114453|P2|STARTED|Overall Study||20
48531|NCT01717040|114454|P1|STARTED|Overall Study||17
48532|NCT01717014|114460|P1|NOT COMPLETED|Overall Study||0
48533|NCT01717014|114460|P1|COMPLETED|Overall Study||8
48534|NCT01717014|114460|P1|STARTED|Overall Study||8
48535|NCT01716754|114472|P4|NOT COMPLETED|Overall Study||8
48536|NCT01716754|114473|P3|NOT COMPLETED|Overall Study||14
48537|NCT01716754|114474|P2|NOT COMPLETED|Overall Study||4
48538|NCT01716754|114475|P1|NOT COMPLETED|Overall Study||11
48539|NCT01716754|114472|P4|COMPLETED|Overall Study||89
48540|NCT01716754|114473|P3|COMPLETED|Overall Study||121
48541|NCT01716754|114474|P2|COMPLETED|Overall Study||36
48542|NCT01716754|114475|P1|COMPLETED|Overall Study||188
48543|NCT01716754|114472|P4|Safety Set|Overall Study||96
48544|NCT01716754|114473|P3|Safety Set|Overall Study||131
48545|NCT01716754|114474|P2|Safety Set|Overall Study||40
48546|NCT01716754|114475|P1|Safety Set|Overall Study||199
48547|NCT01716754|114472|P4|FAS|Overall Study||96
48548|NCT01716754|114473|P3|FAS|Overall Study||131
48549|NCT01716754|114474|P2|FAS|Overall Study||40
48550|NCT01716754|114475|P1|FAS|Overall Study||199
48551|NCT01716754|114472|P4|STARTED|Overall Study||97
48552|NCT01716754|114473|P3|STARTED|Overall Study||135
48553|NCT01716754|114474|P2|STARTED|Overall Study||40
48554|NCT01716754|114475|P1|STARTED|Overall Study||199
48555|NCT01716663|114496|P1|NOT COMPLETED|Overall Study||6
48556|NCT01716663|114496|P1|COMPLETED|Overall Study|Effectiveness population = enrolled and treated (study device inserted and RF energy applied)|228
48557|NCT01716663|114496|P1|Safety|Overall Study|Enrolled patients who had a study device inserted.|230
48558|NCT01716663|114496|P1|STARTED|Overall Study|Enrolled = signed informed consent and met eligibility requirements|234
48559|NCT01716585|114506|P2|NOT COMPLETED|Open-label Treatment||7
48560|NCT01716585|114507|P1|NOT COMPLETED|Open-label Treatment||0
48561|NCT01716585|114506|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|150
48562|NCT01716585|114507|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
48563|NCT01716585|114506|P2|STARTED|Open-label Treatment||157
48564|NCT01716585|114507|P1|STARTED|Open-label Treatment|not applicable to this arm|0
48565|NCT01716585|114506|P2|NOT COMPLETED|Double-blind Treatment||2
48566|NCT01716585|114507|P1|NOT COMPLETED|Double-blind Treatment||13
48567|NCT01716585|114506|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|157
48568|NCT01716585|114507|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|464
48569|NCT01716585|114506|P2|Randomized But Not Treated|Double-blind Treatment||1
48570|NCT01716585|114507|P1|Randomized But Not Treated|Double-blind Treatment||4
48571|NCT01716585|114506|P2|STARTED|Double-blind Treatment||159
48572|NCT01716585|114507|P1|STARTED|Double-blind Treatment||477
48573|NCT01716559|114519|P1|NOT COMPLETED|Overall Study||111
48574|NCT01716559|114519|P1|COMPLETED|Overall Study||49
48575|NCT01716559|114519|P1|STARTED|Overall Study||160
48576|NCT01716520|114527|P6|NOT COMPLETED|Treatment Period 3 (14 Days)||2
48577|NCT01716520|114528|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||0
48578|NCT01716520|114529|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
48579|NCT01716520|114530|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||1
48580|NCT01716520|114531|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||0
48581|NCT01716520|114532|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
48582|NCT01716520|114527|P6|COMPLETED|Treatment Period 3 (14 Days)||23
48583|NCT01716520|114528|P5|COMPLETED|Treatment Period 3 (14 Days)||29
48584|NCT01716520|114529|P4|COMPLETED|Treatment Period 3 (14 Days)||28
48585|NCT01716520|114530|P3|COMPLETED|Treatment Period 3 (14 Days)||25
48586|NCT01716520|114531|P2|COMPLETED|Treatment Period 3 (14 Days)||27
48587|NCT01716520|114532|P1|COMPLETED|Treatment Period 3 (14 Days)||27
48588|NCT01716520|114527|P6|STARTED|Treatment Period 3 (14 Days)||25
48589|NCT01716520|114528|P5|STARTED|Treatment Period 3 (14 Days)||29
48590|NCT01716520|114529|P4|STARTED|Treatment Period 3 (14 Days)||28
48591|NCT01716520|114530|P3|STARTED|Treatment Period 3 (14 Days)||26
48592|NCT01716520|114531|P2|STARTED|Treatment Period 3 (14 Days)||27
48593|NCT01716520|114532|P1|STARTED|Treatment Period 3 (14 Days)||27
48594|NCT01716520|114527|P6|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
48595|NCT01716520|114528|P5|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
48596|NCT01716520|114529|P4|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||0
48597|NCT01716520|114530|P3|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
48598|NCT01716520|114531|P2|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||1
48599|NCT01716520|114532|P1|NOT COMPLETED|Washout Period 2 (10 to 14 Days)||2
48600|NCT01716520|114527|P6|COMPLETED|Washout Period 2 (10 to 14 Days)||25
48601|NCT01716520|114528|P5|COMPLETED|Washout Period 2 (10 to 14 Days)||29
48602|NCT01716520|114529|P4|COMPLETED|Washout Period 2 (10 to 14 Days)||28
48603|NCT01716520|114530|P3|COMPLETED|Washout Period 2 (10 to 14 Days)||26
48604|NCT01716520|114531|P2|COMPLETED|Washout Period 2 (10 to 14 Days)||27
48605|NCT01716520|114532|P1|COMPLETED|Washout Period 2 (10 to 14 Days)||27
48606|NCT01716520|114527|P6|STARTED|Washout Period 2 (10 to 14 Days)||27
48607|NCT01716520|114528|P5|STARTED|Washout Period 2 (10 to 14 Days)||29
48608|NCT01716520|114529|P4|STARTED|Washout Period 2 (10 to 14 Days)||28
48609|NCT01716520|114530|P3|STARTED|Washout Period 2 (10 to 14 Days)||27
48610|NCT01716520|114531|P2|STARTED|Washout Period 2 (10 to 14 Days)||28
48611|NCT01716520|114532|P1|STARTED|Washout Period 2 (10 to 14 Days)||29
48612|NCT01716520|114527|P6|NOT COMPLETED|Treatment Period 2 (14 Days)||0
48613|NCT01716520|114528|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||2
48614|NCT01716520|114529|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
48615|NCT01716520|114530|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||0
48616|NCT01716520|114531|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||0
48617|NCT01716520|114532|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
48618|NCT01716520|114527|P6|COMPLETED|Treatment Period 2 (14 Days)||27
48619|NCT01716520|114528|P5|COMPLETED|Treatment Period 2 (14 Days)||29
48620|NCT01716520|114529|P4|COMPLETED|Treatment Period 2 (14 Days)||28
48621|NCT01716520|114530|P3|COMPLETED|Treatment Period 2 (14 Days)||27
48622|NCT01716520|114531|P2|COMPLETED|Treatment Period 2 (14 Days)||28
48623|NCT01716520|114532|P1|COMPLETED|Treatment Period 2 (14 Days)||29
48624|NCT01716520|114527|P6|STARTED|Treatment Period 2 (14 Days)||27
48625|NCT01716520|114528|P5|STARTED|Treatment Period 2 (14 Days)||31
48626|NCT01716520|114529|P4|STARTED|Treatment Period 2 (14 Days)||29
48627|NCT01716520|114530|P3|STARTED|Treatment Period 2 (14 Days)||27
48628|NCT01716520|114531|P2|STARTED|Treatment Period 2 (14 Days)||28
48629|NCT01716520|114532|P1|STARTED|Treatment Period 2 (14 Days)||29
48630|NCT01716520|114527|P6|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||2
48631|NCT01716520|114528|P5|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
48632|NCT01716520|114529|P4|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
48633|NCT01716520|114530|P3|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
48634|NCT01716520|114531|P2|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||1
48635|NCT01716520|114532|P1|NOT COMPLETED|Washout Period 1 (10 to 14 Days)||0
48636|NCT01716520|114527|P6|COMPLETED|Washout Period 1 (10 to 14 Days)||27
48637|NCT01716520|114528|P5|COMPLETED|Washout Period 1 (10 to 14 Days)||31
48638|NCT01716520|114529|P4|COMPLETED|Washout Period 1 (10 to 14 Days)||29
48639|NCT01716520|114530|P3|COMPLETED|Washout Period 1 (10 to 14 Days)||27
48640|NCT01716520|114531|P2|COMPLETED|Washout Period 1 (10 to 14 Days)||28
48641|NCT01716520|114532|P1|COMPLETED|Washout Period 1 (10 to 14 Days)||29
48642|NCT01716520|114527|P6|STARTED|Washout Period 1 (10 to 14 Days)||29
48643|NCT01716520|114528|P5|STARTED|Washout Period 1 (10 to 14 Days)||31
48644|NCT01716520|114529|P4|STARTED|Washout Period 1 (10 to 14 Days)||29
48645|NCT01716520|114530|P3|STARTED|Washout Period 1 (10 to 14 Days)||28
48646|NCT01716520|114531|P2|STARTED|Washout Period 1 (10 to 14 Days)||29
48647|NCT01716520|114532|P1|STARTED|Washout Period 1 (10 to 14 Days)||29
48648|NCT01716520|114527|P6|NOT COMPLETED|Treatment Period 1 (14 Days)||1
48649|NCT01716520|114528|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
48650|NCT01716520|114529|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||1
48651|NCT01716520|114530|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||2
48652|NCT01716520|114531|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
48653|NCT01716520|114532|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
48654|NCT01716520|114527|P6|COMPLETED|Treatment Period 1 (14 Days)||29
48655|NCT01716520|114528|P5|COMPLETED|Treatment Period 1 (14 Days)||31
48656|NCT01716520|114529|P4|COMPLETED|Treatment Period 1 (14 Days)||29
48657|NCT01716520|114530|P3|COMPLETED|Treatment Period 1 (14 Days)||28
48658|NCT01716520|114531|P2|COMPLETED|Treatment Period 1 (14 Days)||29
48659|NCT01716520|114532|P1|COMPLETED|Treatment Period 1 (14 Days)||29
48660|NCT01716520|114527|P6|STARTED|Treatment Period 1 (14 Days)||30
48661|NCT01716520|114528|P5|STARTED|Treatment Period 1 (14 Days)||31
48662|NCT01716520|114529|P4|STARTED|Treatment Period 1 (14 Days)||30
48663|NCT01716520|114530|P3|STARTED|Treatment Period 1 (14 Days)||30
48664|NCT01716520|114531|P2|STARTED|Treatment Period 1 (14 Days)||30
48665|NCT01716520|114532|P1|STARTED|Treatment Period 1 (14 Days)||31
48666|NCT01716468|114548|P1|NOT COMPLETED|Overall Study||6
48667|NCT01716468|114548|P1|COMPLETED|Overall Study||11
48668|NCT01716468|114548|P1|STARTED|Overall Study||17
48669|NCT01716455|114558|P6|NOT COMPLETED|Overall Study||0
48670|NCT01716455|114559|P5|NOT COMPLETED|Overall Study||0
48671|NCT01716455|114560|P4|NOT COMPLETED|Overall Study||0
48672|NCT01716455|114561|P3|NOT COMPLETED|Overall Study||0
48673|NCT01716455|114562|P2|NOT COMPLETED|Overall Study||0
48674|NCT01716455|114563|P1|NOT COMPLETED|Overall Study||0
48675|NCT01716455|114558|P6|COMPLETED|Overall Study||8
48676|NCT01716455|114559|P5|COMPLETED|Overall Study||26
48677|NCT01716455|114560|P4|COMPLETED|Overall Study||8
48678|NCT01716455|114561|P3|COMPLETED|Overall Study||8
48679|NCT01716455|114562|P2|COMPLETED|Overall Study||8
48680|NCT01716455|114563|P1|COMPLETED|Overall Study||8
48681|NCT01716455|114558|P6|STARTED|Overall Study||8
48682|NCT01716455|114559|P5|STARTED|Overall Study||26
48683|NCT01716455|114560|P4|STARTED|Overall Study||8
48684|NCT01716455|114561|P3|STARTED|Overall Study||8
48685|NCT01716455|114562|P2|STARTED|Overall Study||8
48686|NCT01716455|114563|P1|STARTED|Overall Study||8
48687|NCT01716234|114587|P7|NOT COMPLETED|Overall Study||0
48688|NCT01716234|114588|P6|NOT COMPLETED|Overall Study||14
48689|NCT01716234|114589|P5|NOT COMPLETED|Overall Study||5
48690|NCT01716234|114590|P4|NOT COMPLETED|Overall Study||12
48691|NCT01716234|114591|P3|NOT COMPLETED|Overall Study||5
48692|NCT01716234|114592|P2|NOT COMPLETED|Overall Study||10
48693|NCT01716234|114593|P1|NOT COMPLETED|Overall Study||10
48694|NCT01716234|114587|P7|COMPLETED|Overall Study||1
48695|NCT01716234|114588|P6|COMPLETED|Overall Study||18
48696|NCT01716234|114589|P5|COMPLETED|Overall Study||10
48697|NCT01716234|114590|P4|COMPLETED|Overall Study||16
48698|NCT01716234|114591|P3|COMPLETED|Overall Study||15
48699|NCT01716234|114592|P2|COMPLETED|Overall Study||12
48700|NCT01716234|114593|P1|COMPLETED|Overall Study||14
48701|NCT01716234|114587|P7|Treated|Overall Study||1
48702|NCT01716234|114588|P6|Treated|Overall Study||30
48703|NCT01716234|114589|P5|Treated|Overall Study||15
48704|NCT01716234|114590|P4|Treated|Overall Study||28
48705|NCT01716234|114591|P3|Treated|Overall Study||19
48706|NCT01716234|114592|P2|Treated|Overall Study||21
48707|NCT01716234|114593|P1|Treated|Overall Study||22
48708|NCT01716234|114587|P7|STARTED|Overall Study||1
48709|NCT01716234|114588|P6|STARTED|Overall Study||32
48710|NCT01716234|114589|P5|STARTED|Overall Study||15
48711|NCT01716234|114590|P4|STARTED|Overall Study||28
48712|NCT01716234|114591|P3|STARTED|Overall Study||20
48713|NCT01716234|114592|P2|STARTED|Overall Study||22
48714|NCT01716234|114593|P1|STARTED|Overall Study||24
48715|NCT01716221|114630|P1|NOT COMPLETED|Overall Study||0
48716|NCT01716221|114630|P1|COMPLETED|Overall Study||1
48717|NCT01716221|114630|P1|STARTED|Overall Study||1
48718|NCT01716169|114656|P1|NOT COMPLETED|Overall Study||4
48719|NCT01716169|114656|P1|COMPLETED|Overall Study||6
48720|NCT01716169|114656|P1|Standard of Care Dressings Used|Overall Study||7
48721|NCT01716169|114656|P1|STARTED|Overall Study||10
48722|NCT01716156|114665|P3|NOT COMPLETED|Overall Study||2
48723|NCT01716156|114666|P2|NOT COMPLETED|Overall Study||1
48724|NCT01716156|114667|P1|NOT COMPLETED|Overall Study||2
48725|NCT01716156|114665|P3|COMPLETED|Overall Study||11
48726|NCT01716156|114666|P2|COMPLETED|Overall Study||3
48727|NCT01716156|114667|P1|COMPLETED|Overall Study||7
48728|NCT01716156|114665|P3|STARTED|Overall Study||13
48729|NCT01716156|114666|P2|STARTED|Overall Study||4
48730|NCT01716156|114667|P1|STARTED|Overall Study||9
48731|NCT01716052|114693|P2|NOT COMPLETED|Overall Study||1
48732|NCT01716052|114694|P1|NOT COMPLETED|Overall Study||1
48733|NCT01716052|114693|P2|COMPLETED|Overall Study||0
48734|NCT01716052|114694|P1|COMPLETED|Overall Study||0
48735|NCT01716052|114693|P2|STARTED|Overall Study||1
48736|NCT01716052|114694|P1|STARTED|Overall Study||1
48737|NCT01716013|114702|P2|NOT COMPLETED|Overall Study||0
48738|NCT01716013|114703|P1|NOT COMPLETED|Overall Study||3
48739|NCT01716013|114702|P2|COMPLETED|Overall Study||54
48740|NCT01716013|114703|P1|COMPLETED|Overall Study||105
48741|NCT01716013|114702|P2|STARTED|Overall Study||54
48742|NCT01716013|114703|P1|STARTED|Overall Study||108
48743|NCT01715948|114715|P1|NOT COMPLETED|Overall Study||1
48744|NCT01715948|114715|P1|COMPLETED|Overall Study||8
48745|NCT01715948|114715|P1|STARTED|Overall Study||9
48746|NCT01715896|114736|P2|NOT COMPLETED|Overall Study||11
48747|NCT01715896|114737|P1|NOT COMPLETED|Overall Study||3
48748|NCT01715896|114736|P2|COMPLETED|Overall Study||59
48749|NCT01715896|114737|P1|COMPLETED|Overall Study||65
48750|NCT01715896|114736|P2|STARTED|Overall Study||70
48751|NCT01715896|114737|P1|STARTED|Overall Study||68
48752|NCT01715857|114800|P1|NOT COMPLETED|Overall Study||96
48753|NCT01715857|114800|P1|COMPLETED|Overall Study||4004
48754|NCT01715857|114800|P1|STARTED|Overall Study||4100
48755|NCT01715831|114810|P1|NOT COMPLETED|Overall Study||1
48756|NCT01715831|114810|P1|COMPLETED|Overall Study||25
48757|NCT01715831|114810|P1|STARTED|Overall Study||26
48758|NCT01715415|114828|P2|NOT COMPLETED|Open-label Treatment||2
48759|NCT01715415|114829|P1|NOT COMPLETED|Open-label Treatment||0
48760|NCT01715415|114828|P2|COMPLETED|Open-label Treatment|The number of participants who completed open-label study drug.|94
48761|NCT01715415|114829|P1|COMPLETED|Open-label Treatment|not applicable to this arm|0
48762|NCT01715415|114828|P2|STARTED|Open-label Treatment||96
48763|NCT01715415|114829|P1|STARTED|Open-label Treatment|not applicable to this arm|0
48764|NCT01715415|114828|P2|NOT COMPLETED|Double-blind Treatment||2
48765|NCT01715415|114829|P1|NOT COMPLETED|Double-blind Treatment||5
48766|NCT01715415|114828|P2|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|96
48767|NCT01715415|114829|P1|COMPLETED|Double-blind Treatment|The number of participants who completed double-blind study drug.|292
48768|NCT01715415|114828|P2|Randomized But Not Treated|Double-blind Treatment||1
48769|NCT01715415|114829|P1|Randomized But Not Treated|Double-blind Treatment||0
48770|NCT01715415|114828|P2|STARTED|Double-blind Treatment||98
48771|NCT01715415|114829|P1|STARTED|Double-blind Treatment||297
48772|NCT01715298|114843|P2|NOT COMPLETED|Overall Study||11
48773|NCT01715298|114844|P1|NOT COMPLETED|Overall Study||7
48774|NCT01715298|114843|P2|COMPLETED|Overall Study||205
48775|NCT01715298|114844|P1|COMPLETED|Overall Study||209
48776|NCT01715298|114843|P2|Full Analysis Set (FAS)|Overall Study||214
48777|NCT01715298|114844|P1|Full Analysis Set (FAS)|Overall Study|patients were analyzed according to the treatment to which they were randomized|215
48778|NCT01715298|114843|P2|STARTED|Overall Study||216
48779|NCT01715298|114844|P1|STARTED|Overall Study||216
48780|NCT01715207|114882|P2|NOT COMPLETED|Overall Study||1
48781|NCT01715207|114883|P1|NOT COMPLETED|Overall Study||1
48782|NCT01715207|114882|P2|COMPLETED|Overall Study||14
48783|NCT01715207|114883|P1|COMPLETED|Overall Study||14
48784|NCT01715207|114882|P2|STARTED|Overall Study||15
48785|NCT01715207|114883|P1|STARTED|Overall Study||15
48786|NCT01715129|114891|P1|NOT COMPLETED|Overall Study||9
48787|NCT01715129|114891|P1|COMPLETED|Overall Study||117
48788|NCT01715129|114891|P1|STARTED|Overall Study||126
48789|NCT01715064|114910|P2|NOT COMPLETED|Overall Study||0
48790|NCT01715064|114911|P1|NOT COMPLETED|Overall Study||0
48791|NCT01715064|114910|P2|COMPLETED|Overall Study||18
48792|NCT01715064|114911|P1|COMPLETED|Overall Study||18
48793|NCT01715064|114910|P2|STARTED|Overall Study||18
48794|NCT01715064|114911|P1|STARTED|Overall Study||18
48795|NCT01714635|114920|P3|NOT COMPLETED|Overall Study||2
48796|NCT01714635|114921|P2|NOT COMPLETED|Overall Study||0
48797|NCT01714635|114922|P1|NOT COMPLETED|Overall Study||2
48798|NCT01714635|114920|P3|COMPLETED|Overall Study||146
48799|NCT01714635|114921|P2|COMPLETED|Overall Study||150
48800|NCT01714635|114922|P1|COMPLETED|Overall Study||145
48801|NCT01714635|114920|P3|STARTED|Overall Study||148
48802|NCT01714635|114921|P2|STARTED|Overall Study||150
48803|NCT01714635|114922|P1|STARTED|Overall Study||147
48804|NCT01714609|114938|P2|NOT COMPLETED|Overall Study||0
48805|NCT01714609|114939|P1|NOT COMPLETED|Overall Study||1
48806|NCT01714609|114938|P2|COMPLETED|Overall Study||5
48807|NCT01714609|114939|P1|COMPLETED|Overall Study||4
48808|NCT01714609|114938|P2|STARTED|Overall Study||5
48809|NCT01714609|114939|P1|STARTED|Overall Study||5
48810|NCT01714544|114945|P1|NOT COMPLETED|Overall Study||3
48811|NCT01714544|114945|P1|COMPLETED|Overall Study||57
48812|NCT01714544|114945|P1|STARTED|Overall Study||60
48813|NCT01714505|114949|P2|NOT COMPLETED|Admission 2 (40 Hours)||0
48814|NCT01714505|114950|P1|NOT COMPLETED|Admission 2 (40 Hours)||0
48815|NCT01714505|114949|P2|COMPLETED|Admission 2 (40 Hours)||9
48816|NCT01714505|114950|P1|COMPLETED|Admission 2 (40 Hours)||9
48817|NCT01714505|114949|P2|STARTED|Admission 2 (40 Hours)||9
48818|NCT01714505|114950|P1|STARTED|Admission 2 (40 Hours)||9
48819|NCT01714505|114949|P2|NOT COMPLETED|Admission 1 (40 Hours)||1
48820|NCT01714505|114950|P1|NOT COMPLETED|Admission 1 (40 Hours)||1
48821|NCT01714505|114949|P2|COMPLETED|Admission 1 (40 Hours)||9
48822|NCT01714505|114950|P1|COMPLETED|Admission 1 (40 Hours)||9
48823|NCT01714505|114949|P2|STARTED|Admission 1 (40 Hours)||10
48824|NCT01714505|114950|P1|STARTED|Admission 1 (40 Hours)||10
48825|NCT01714492|114960|P1|NOT COMPLETED|Overall Study||0
48826|NCT01714492|114960|P1|COMPLETED|Overall Study||8
48827|NCT01714492|114960|P1|STARTED|Overall Study||8
48828|NCT01714336|114971|P2|NOT COMPLETED|Overall Study||0
48829|NCT01714336|114972|P1|NOT COMPLETED|Overall Study||0
48830|NCT01714336|114971|P2|COMPLETED|Overall Study||69
48831|NCT01714336|114972|P1|COMPLETED|Overall Study||69
48832|NCT01714336|114971|P2|STARTED|Overall Study||69
48833|NCT01714336|114972|P1|STARTED|Overall Study||69
48834|NCT01714232|114992|P1|NOT COMPLETED|Overall Study||0
48835|NCT01714232|114992|P1|COMPLETED|Overall Study||106
48836|NCT01714232|114992|P1|STARTED|Overall Study||106
48837|NCT01714024|115001|P3|NOT COMPLETED|Overall Study||3
48838|NCT01714024|115002|P2|NOT COMPLETED|Overall Study||6
48839|NCT01714024|115003|P1|NOT COMPLETED|Overall Study||1
48840|NCT01714024|115001|P3|COMPLETED|Overall Study||8
48841|NCT01714024|115002|P2|COMPLETED|Overall Study||12
48842|NCT01714024|115003|P1|COMPLETED|Overall Study||12
48843|NCT01714024|115001|P3|STARTED|Overall Study||11
48844|NCT01714024|115002|P2|STARTED|Overall Study||18
48845|NCT01714024|115003|P1|STARTED|Overall Study||13
48846|NCT01713998|115017|P3|NOT COMPLETED|Overall Study||2
48847|NCT01713998|115018|P2|NOT COMPLETED|Overall Study||0
48848|NCT01713998|115019|P1|NOT COMPLETED|Overall Study||3
48849|NCT01713998|115017|P3|COMPLETED|Overall Study||14
48850|NCT01713998|115018|P2|COMPLETED|Overall Study||15
48851|NCT01713998|115019|P1|COMPLETED|Overall Study||13
48852|NCT01713998|115017|P3|STARTED|Overall Study||16
48853|NCT01713998|115018|P2|STARTED|Overall Study||15
48854|NCT01713998|115019|P1|STARTED|Overall Study||16
48855|NCT01713933|115037|P1|NOT COMPLETED|Overall Study||6
48856|NCT01713933|115037|P1|COMPLETED|Overall Study||31
48857|NCT01713933|115037|P1|STARTED|Overall Study||37
48858|NCT01713686|115049|P1|NOT COMPLETED|Overall Study||15
48859|NCT01713686|115049|P1|COMPLETED|Overall Study||110
48860|NCT01713686|115049|P1|STARTED|Overall Study|129 enrolled, 125 treated. 2 withdrew consent prior to treatment; 2 excluded after enrollment.|125
48861|NCT01713660|115058|P1|NOT COMPLETED|Overall Study||0
48862|NCT01713660|115058|P1|COMPLETED|Overall Study||37
48863|NCT01713660|115058|P1|STARTED|Overall Study||37
48864|NCT01713621|115066|P2|NOT COMPLETED|Overall Study||16
48865|NCT01713621|115067|P1|NOT COMPLETED|Overall Study||7
48866|NCT01713621|115066|P2|COMPLETED|Overall Study||1
48867|NCT01713621|115067|P1|COMPLETED|Overall Study||1
48868|NCT01713621|115066|P2|STARTED|Overall Study||17
48869|NCT01713621|115067|P1|STARTED|Overall Study||8
48870|NCT01713608|115077|P4|NOT COMPLETED|Overall Study||0
48871|NCT01713608|115078|P3|NOT COMPLETED|Overall Study||0
48872|NCT01713608|115079|P2|NOT COMPLETED|Overall Study||0
48873|NCT01713608|115080|P1|NOT COMPLETED|Overall Study||0
48874|NCT01713608|115077|P4|COMPLETED|Overall Study||12
48875|NCT01713608|115078|P3|COMPLETED|Overall Study||8
48876|NCT01713608|115079|P2|COMPLETED|Overall Study||6
48877|NCT01713608|115080|P1|COMPLETED|Overall Study||8
48878|NCT01713608|115077|P4|STARTED|Overall Study||12
48879|NCT01713608|115078|P3|STARTED|Overall Study||8
48880|NCT01713608|115079|P2|STARTED|Overall Study||6
48881|NCT01713608|115080|P1|STARTED|Overall Study||8
48882|NCT01713530|115100|P2|NOT COMPLETED|Overall Study||19
48883|NCT01713530|115101|P1|NOT COMPLETED|Overall Study||25
48884|NCT01713530|115100|P2|COMPLETED|Overall Study||117
48885|NCT01713530|115101|P1|COMPLETED|Overall Study||113
48886|NCT01713530|115100|P2|Exposed|Overall Study|One (1) subject was withdrawn by the investigator|135
48887|NCT01713530|115101|P1|Exposed|Overall Study|One (1) subject was randomised in error and 1 subject withdrew consent|136
48888|NCT01713530|115100|P2|STARTED|Overall Study||136
48889|NCT01713530|115101|P1|STARTED|Overall Study||138
48890|NCT01713400|115119|P2|NOT COMPLETED|Overall Study||0
48891|NCT01713400|115120|P1|NOT COMPLETED|Overall Study||0
48892|NCT01713400|115119|P2|COMPLETED|Overall Study||15
48893|NCT01713400|115120|P1|COMPLETED|Overall Study||15
48894|NCT01713400|115119|P2|STARTED|Overall Study||15
48895|NCT01713400|115120|P1|STARTED|Overall Study||15
48896|NCT01713348|115132|P4|NOT COMPLETED|Overall Study||0
48897|NCT01713348|115133|P3|NOT COMPLETED|Overall Study||2
48898|NCT01713348|115134|P2|NOT COMPLETED|Overall Study||2
48899|NCT01713348|115135|P1|NOT COMPLETED|Overall Study||4
48900|NCT01713348|115132|P4|COMPLETED|Overall Study||15
48901|NCT01713348|115133|P3|COMPLETED|Overall Study||28
48902|NCT01713348|115134|P2|COMPLETED|Overall Study||11
48903|NCT01713348|115135|P1|COMPLETED|Overall Study||25
48904|NCT01713348|115132|P4|STARTED|Overall Study||15
48905|NCT01713348|115133|P3|STARTED|Overall Study||30
48906|NCT01713348|115134|P2|STARTED|Overall Study||13
48907|NCT01713348|115135|P1|STARTED|Overall Study||29
48908|NCT01713283|115165|P2|NOT COMPLETED|Overall Study||3
48909|NCT01713283|115166|P1|NOT COMPLETED|Overall Study||11
48910|NCT01713283|115165|P2|COMPLETED|Overall Study||26
48911|NCT01713283|115166|P1|COMPLETED|Overall Study||20
48912|NCT01713283|115165|P2|STARTED|Overall Study||29
48913|NCT01713283|115166|P1|STARTED|Overall Study||31
48914|NCT01713036|115188|P1|NOT COMPLETED|Overall Study||1
48915|NCT01713036|115188|P1|COMPLETED|Overall Study||5
48916|NCT01713036|115188|P1|STARTED|Overall Study||6
48917|NCT01712984|115228|P3|NOT COMPLETED|Overall Study||10
48918|NCT01712984|115229|P2|NOT COMPLETED|Overall Study||16
48919|NCT01712984|115230|P1|NOT COMPLETED|Overall Study||16
48920|NCT01712984|115228|P3|COMPLETED|Overall Study||836
48921|NCT01712984|115229|P2|COMPLETED|Overall Study||821
48922|NCT01712984|115230|P1|COMPLETED|Overall Study||1656
48923|NCT01712984|115228|P3|STARTED|Overall Study||846
48924|NCT01712984|115229|P2|STARTED|Overall Study||837
48925|NCT01712984|115230|P1|STARTED|Overall Study||1672
48926|NCT01712854|115250|P1|NOT COMPLETED|Overall Study||1
48927|NCT01712854|115250|P1|COMPLETED|Overall Study||8
48928|NCT01712854|115250|P1|STARTED|Overall Study||9
48929|NCT01712776|115257|P2|NOT COMPLETED|Overall Study||0
48930|NCT01712776|115258|P1|NOT COMPLETED|Overall Study||0
48931|NCT01712776|115257|P2|COMPLETED|Overall Study||50
48932|NCT01712776|115258|P1|COMPLETED|Overall Study|trial to enroll 50 in each group for total of 100|50
48933|NCT01712776|115257|P2|STARTED|Overall Study||50
48934|NCT01712776|115258|P1|STARTED|Overall Study||50
48935|NCT01712711|115266|P2|NOT COMPLETED|Overall Study||0
48936|NCT01712711|115267|P1|NOT COMPLETED|Overall Study||0
48937|NCT01712711|115266|P2|COMPLETED|Overall Study||20
48938|NCT01712711|115267|P1|COMPLETED|Overall Study||20
48939|NCT01712711|115266|P2|STARTED|Overall Study||20
48940|NCT01712711|115267|P1|STARTED|Overall Study||20
48941|NCT01712685|115273|P1|NOT COMPLETED|Overall Study||1
48942|NCT01712685|115273|P1|COMPLETED|Overall Study||11
48943|NCT01712685|115273|P1|STARTED|Overall Study||12
48944|NCT01712516|115289|P4|NOT COMPLETED|Overall Study||13
48945|NCT01712516|115290|P3|NOT COMPLETED|Overall Study||6
48946|NCT01712516|115291|P2|NOT COMPLETED|Overall Study||10
48947|NCT01712516|115292|P1|NOT COMPLETED|Overall Study||6
48948|NCT01712516|115289|P4|COMPLETED|Overall Study||236
48949|NCT01712516|115290|P3|COMPLETED|Overall Study||245
48950|NCT01712516|115291|P2|COMPLETED|Overall Study||241
48951|NCT01712516|115292|P1|COMPLETED|Overall Study||244
48952|NCT01712516|115289|P4|Full Analysis Set|Overall Study||247
48953|NCT01712516|115290|P3|Full Analysis Set|Overall Study||250
48954|NCT01712516|115291|P2|Full Analysis Set|Overall Study||251
48955|NCT01712516|115292|P1|Full Analysis Set|Overall Study||250
48956|NCT01712516|115289|P4|Safety Set|Overall Study||248
48957|NCT01712516|115290|P3|Safety Set|Overall Study||251
48958|NCT01712516|115291|P2|Safety Set|Overall Study||251
48959|NCT01712516|115292|P1|Safety Set|Overall Study||250
48960|NCT01712516|115289|P4|STARTED|Overall Study||249
48961|NCT01712516|115290|P3|STARTED|Overall Study||251
48962|NCT01712516|115291|P2|STARTED|Overall Study||251
48963|NCT01712516|115292|P1|STARTED|Overall Study||250
48964|NCT01712399|115342|P1|NOT COMPLETED|Overall Study||397
48965|NCT01712399|115342|P1|COMPLETED|Overall Study||0
48966|NCT01712399|115342|P1|STARTED|Overall Study||397
48967|NCT01712360|115359|P4|NOT COMPLETED|Overall Study||2
48968|NCT01712360|115360|P3|NOT COMPLETED|Overall Study||0
48969|NCT01712360|115361|P2|NOT COMPLETED|Overall Study||1
48970|NCT01712360|115362|P1|NOT COMPLETED|Overall Study||0
48971|NCT01712360|115359|P4|COMPLETED|Overall Study||4
48972|NCT01712360|115360|P3|COMPLETED|Overall Study||6
48973|NCT01712360|115361|P2|COMPLETED|Overall Study||21
48974|NCT01712360|115362|P1|COMPLETED|Overall Study||22
48975|NCT01712360|115359|P4|STARTED|Overall Study||6
48976|NCT01712360|115360|P3|STARTED|Overall Study||6
48977|NCT01712360|115361|P2|STARTED|Overall Study||22
48978|NCT01712360|115362|P1|STARTED|Overall Study||22
48979|NCT01712334|115388|P2|NOT COMPLETED|Treatment Period 2||0
48980|NCT01712334|115389|P1|NOT COMPLETED|Treatment Period 2||0
48981|NCT01712334|115388|P2|COMPLETED|Treatment Period 2||41
48982|NCT01712334|115389|P1|COMPLETED|Treatment Period 2||44
48983|NCT01712334|115388|P2|STARTED|Treatment Period 2||41
48984|NCT01712334|115389|P1|STARTED|Treatment Period 2||44
48985|NCT01712334|115388|P2|NOT COMPLETED|Treatment Period 1||2
48986|NCT01712334|115389|P1|NOT COMPLETED|Treatment Period 1||0
48987|NCT01712334|115388|P2|COMPLETED|Treatment Period 1||41
48988|NCT01712334|115389|P1|COMPLETED|Treatment Period 1||44
48989|NCT01712334|115388|P2|Received Treatment|Treatment Period 1||41
48990|NCT01712334|115389|P1|Received Treatment|Treatment Period 1||44
48991|NCT01712334|115388|P2|STARTED|Treatment Period 1||43
48992|NCT01712334|115389|P1|STARTED|Treatment Period 1||44
48993|NCT01712256|115397|P1|NOT COMPLETED|Overall Study||1
48994|NCT01712256|115397|P1|COMPLETED|Overall Study||32
48995|NCT01712256|115397|P1|STARTED|Overall Study||33
48996|NCT01712204|115408|P2|NOT COMPLETED|Overall Study||5
48997|NCT01712204|115409|P1|NOT COMPLETED|Overall Study||8
48998|NCT01712204|115408|P2|COMPLETED|Overall Study||36
48999|NCT01712204|115409|P1|COMPLETED|Overall Study||33
49000|NCT01712204|115408|P2|STARTED|Overall Study||41
49001|NCT01712204|115409|P1|STARTED|Overall Study||41
49002|NCT01712178|115417|P2|NOT COMPLETED|Overall Study||3
49003|NCT01712178|115418|P1|NOT COMPLETED|Overall Study||1
49004|NCT01712178|115417|P2|COMPLETED|Overall Study||47
49005|NCT01712178|115418|P1|COMPLETED|Overall Study||49
49006|NCT01712178|115417|P2|STARTED|Overall Study||50
49007|NCT01712178|115418|P1|STARTED|Overall Study||50
49008|NCT01712074|115443|P3|NOT COMPLETED|Double Blind Period||8
49009|NCT01712074|115444|P2|NOT COMPLETED|Double Blind Period||14
49010|NCT01712074|115445|P1|NOT COMPLETED|Double Blind Period||0
49011|NCT01712074|115443|P3|COMPLETED|Double Blind Period||86
49012|NCT01712074|115444|P2|COMPLETED|Double Blind Period||77
49013|NCT01712074|115445|P1|COMPLETED|Double Blind Period||0
49014|NCT01712074|115443|P3|STARTED|Double Blind Period||94
49015|NCT01712074|115444|P2|STARTED|Double Blind Period||91
49016|NCT01712074|115445|P1|STARTED|Double Blind Period||0
49017|NCT01712074|115443|P3|NOT COMPLETED|Placebo Run-in Period||0
49018|NCT01712074|115444|P2|NOT COMPLETED|Placebo Run-in Period||0
49019|NCT01712074|115445|P1|NOT COMPLETED|Placebo Run-in Period||10
49020|NCT01712074|115443|P3|COMPLETED|Placebo Run-in Period||0
49021|NCT01712074|115444|P2|COMPLETED|Placebo Run-in Period||0
49022|NCT01712074|115445|P1|COMPLETED|Placebo Run-in Period||185
49023|NCT01712074|115443|P3|STARTED|Placebo Run-in Period||0
49024|NCT01712074|115444|P2|STARTED|Placebo Run-in Period||0
49025|NCT01712074|115445|P1|STARTED|Placebo Run-in Period||195
49026|NCT01712061|115501|P3|NOT COMPLETED|Overall Study||11
49027|NCT01712061|115502|P2|NOT COMPLETED|Overall Study||26
49028|NCT01712061|115503|P1|NOT COMPLETED|Overall Study||10
49029|NCT01712061|115501|P3|COMPLETED|Overall Study||45
49030|NCT01712061|115502|P2|COMPLETED|Overall Study||114
49031|NCT01712061|115503|P1|COMPLETED|Overall Study||20
49032|NCT01712061|115501|P3|STARTED|Overall Study||56
49033|NCT01712061|115502|P2|STARTED|Overall Study||140
49034|NCT01712061|115503|P1|STARTED|Overall Study||30
49035|NCT01712009|115543|P3|NOT COMPLETED|Overall Study||21
49036|NCT01712009|115544|P2|NOT COMPLETED|Overall Study||29
49037|NCT01712009|115545|P1|NOT COMPLETED|Overall Study||38
49038|NCT01712009|115543|P3|COMPLETED|Overall Study||181
49039|NCT01712009|115544|P2|COMPLETED|Overall Study||171
49040|NCT01712009|115545|P1|COMPLETED|Overall Study||160
49041|NCT01712009|115543|P3|Received Naproxen / Loratadine|Overall Study||198
49042|NCT01712009|115544|P2|Received Naproxen / Loratadine|Overall Study||193
49043|NCT01712009|115545|P1|Received Naproxen / Loratadine|Overall Study||0
49044|NCT01712009|115543|P3|Received Pegfilgrastim|Overall Study||200
49045|NCT01712009|115544|P2|Received Pegfilgrastim|Overall Study||196
49046|NCT01712009|115545|P1|Received Pegfilgrastim|Overall Study||191
49047|NCT01712009|115543|P3|STARTED|Overall Study||202
49048|NCT01712009|115544|P2|STARTED|Overall Study||200
49049|NCT01712009|115545|P1|STARTED|Overall Study||198
49050|NCT01711918|115571|P1|NOT COMPLETED|Overall Study||2
49051|NCT01711918|115571|P1|COMPLETED|Overall Study||7
49052|NCT01711918|115571|P1|STARTED|Overall Study||9
49053|NCT01711866|115579|P1|NOT COMPLETED|Overall Study||8
49054|NCT01711866|115579|P1|COMPLETED|Overall Study||79
49055|NCT01711866|115579|P1|STARTED|Overall Study||87
49056|NCT01711853|115584|P1|NOT COMPLETED|Overall Study||3
49057|NCT01711853|115584|P1|COMPLETED|Overall Study||16
49058|NCT01711853|115584|P1|STARTED|Overall Study||19
49059|NCT01711736|115591|P2|NOT COMPLETED|Overall Study||8
49060|NCT01711736|115592|P1|NOT COMPLETED|Overall Study||12
49061|NCT01711736|115591|P2|COMPLETED|Overall Study|Up to Day 180|294
49062|NCT01711736|115592|P1|COMPLETED|Overall Study|Up to Day 180|287
49063|NCT01711736|115591|P2|STARTED|Overall Study||302
49064|NCT01711736|115592|P1|STARTED|Overall Study||299
49065|NCT01711645|115620|P1|NOT COMPLETED|Overall Study||19
49066|NCT01711645|115620|P1|COMPLETED|Overall Study||36
49067|NCT01711645|115620|P1|STARTED|Overall Study||55
49068|NCT01711424|115655|P1|NOT COMPLETED|Overall Study||0
49069|NCT01711424|115655|P1|COMPLETED|Overall Study||1209
49070|NCT01711424|115655|P1|STARTED|Overall Study||1209
49071|NCT01711359|115665|P3|NOT COMPLETED|Follow Up||28
49072|NCT01711359|115666|P2|NOT COMPLETED|Follow Up||15
49073|NCT01711359|115667|P1|NOT COMPLETED|Follow Up||25
49074|NCT01711359|115665|P3|COMPLETED|Follow Up||0
49075|NCT01711359|115666|P2|COMPLETED|Follow Up||0
49076|NCT01711359|115667|P1|COMPLETED|Follow Up||0
49077|NCT01711359|115665|P3|STARTED|Follow Up|Participants from treatment and rescue who entered the post-treatment follow-up period.|28
49078|NCT01711359|115666|P2|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|15
49079|NCT01711359|115667|P1|STARTED|Follow Up|Participants from treatment who entered the post-treatment follow-up period.|25
49080|NCT01711359|115665|P3|NOT COMPLETED|Treatment Period||42
49081|NCT01711359|115666|P2|NOT COMPLETED|Treatment Period||24
49082|NCT01711359|115667|P1|NOT COMPLETED|Treatment Period||52
49083|NCT01711359|115665|P3|COMPLETED|Treatment Period||173
49084|NCT01711359|115666|P2|COMPLETED|Treatment Period||136
49085|NCT01711359|115667|P1|COMPLETED|Treatment Period||161
49086|NCT01711359|115665|P3|Rescued|Treatment Period||6
49087|NCT01711359|115666|P2|Rescued|Treatment Period||7
49088|NCT01711359|115667|P1|Rescued|Treatment Period||26
49089|NCT01711359|115665|P3|Received at Least One Dose of Study Drug|Treatment Period||215
49090|NCT01711359|115666|P2|Received at Least One Dose of Study Drug|Treatment Period||159
49091|NCT01711359|115667|P1|Received at Least One Dose of Study Drug|Treatment Period||210
49092|NCT01711359|115665|P3|STARTED|Treatment Period||215
49093|NCT01711359|115666|P2|STARTED|Treatment Period||160
49094|NCT01711359|115667|P1|STARTED|Treatment Period||213
49095|NCT01711216|115738|P1|NOT COMPLETED|Overall Study||217
49096|NCT01711216|115738|P1|COMPLETED|Overall Study||782
49097|NCT01711216|115738|P1|STARTED|Overall Study||999
49098|NCT01711177|115762|P3|NOT COMPLETED|Overall Study||0
49099|NCT01711177|115763|P2|NOT COMPLETED|Overall Study||0
49100|NCT01711177|115764|P1|NOT COMPLETED|Overall Study||0
49101|NCT01711177|115762|P3|COMPLETED|Overall Study||3
49102|NCT01711177|115763|P2|COMPLETED|Overall Study||3
49103|NCT01711177|115764|P1|COMPLETED|Overall Study||10
49104|NCT01711177|115762|P3|STARTED|Overall Study||3
49105|NCT01711177|115763|P2|STARTED|Overall Study||3
49106|NCT01711177|115764|P1|STARTED|Overall Study||10
49107|NCT01710839|115774|P2|NOT COMPLETED|Overall Study||6
49108|NCT01710839|115775|P1|NOT COMPLETED|Overall Study||1
49109|NCT01710839|115774|P2|COMPLETED|Overall Study||0
49110|NCT01710839|115775|P1|COMPLETED|Overall Study||23
49111|NCT01710839|115774|P2|STARTED|Overall Study||6
49112|NCT01710839|115775|P1|STARTED|Overall Study||24
49113|NCT01710800|115791|P1|NOT COMPLETED|Overall Study||22
49114|NCT01710800|115791|P1|COMPLETED|Overall Study|22 drop outs(consented but did not participate, refused 2nd intervention)|41
49115|NCT01710800|115791|P1|Received Placebo Intervention|Overall Study||45
49116|NCT01710800|115791|P1|Received PPI Intervention|Overall Study||44
49117|NCT01710800|115791|P1|STARTED|Overall Study|63 patients consented to be part of the study|63
49118|NCT01710787|115800|P3|NOT COMPLETED|Overall Study||0
49119|NCT01710787|115801|P2|NOT COMPLETED|Overall Study||0
49120|NCT01710787|115802|P1|NOT COMPLETED|Overall Study||0
49121|NCT01710787|115800|P3|COMPLETED|Overall Study||22
49122|NCT01710787|115801|P2|COMPLETED|Overall Study||44
49123|NCT01710787|115802|P1|COMPLETED|Overall Study||44
49124|NCT01710787|115800|P3|STARTED|Overall Study||22
49125|NCT01710787|115801|P2|STARTED|Overall Study||44
49126|NCT01710787|115802|P1|STARTED|Overall Study||44
49127|NCT01710657|115858|P3|NOT COMPLETED|Overall Study||32
49128|NCT01710657|115859|P2|NOT COMPLETED|Overall Study||12
49129|NCT01710657|115860|P1|NOT COMPLETED|Overall Study||18
49130|NCT01710657|115858|P3|COMPLETED|Overall Study||148
49131|NCT01710657|115859|P2|COMPLETED|Overall Study||171
49132|NCT01710657|115860|P1|COMPLETED|Overall Study||166
49133|NCT01710657|115858|P3|Maintenance Period (12 Weeks)|Overall Study||168
49134|NCT01710657|115859|P2|Maintenance Period (12 Weeks)|Overall Study||175
49135|NCT01710657|115860|P1|Maintenance Period (12 Weeks)|Overall Study||176
49136|NCT01710657|115858|P3|Titration Period (4 Weeks)|Overall Study||180
49137|NCT01710657|115859|P2|Titration Period (4 Weeks)|Overall Study||183
49138|NCT01710657|115860|P1|Titration Period (4 Weeks)|Overall Study||184
49139|NCT01710657|115858|P3|STARTED|Overall Study||180
49140|NCT01710657|115859|P2|STARTED|Overall Study||183
49141|NCT01710657|115860|P1|STARTED|Overall Study||184
49142|NCT01710527|115877|P2|NOT COMPLETED|Period 3: Intervention Period 2||0
49143|NCT01710527|115878|P1|NOT COMPLETED|Period 3: Intervention Period 2||0
49144|NCT01710527|115877|P2|COMPLETED|Period 3: Intervention Period 2||15
49145|NCT01710527|115878|P1|COMPLETED|Period 3: Intervention Period 2||16
49146|NCT01710527|115877|P2|STARTED|Period 3: Intervention Period 2||15
49147|NCT01710527|115878|P1|STARTED|Period 3: Intervention Period 2||16
49148|NCT01710527|115877|P2|NOT COMPLETED|Period 2: Washout Period (7 Days)||1
49149|NCT01710527|115878|P1|NOT COMPLETED|Period 2: Washout Period (7 Days)||0
49150|NCT01710527|115877|P2|COMPLETED|Period 2: Washout Period (7 Days)||15
49151|NCT01710527|115878|P1|COMPLETED|Period 2: Washout Period (7 Days)||16
49152|NCT01710527|115877|P2|STARTED|Period 2: Washout Period (7 Days)||16
49153|NCT01710527|115878|P1|STARTED|Period 2: Washout Period (7 Days)||16
49154|NCT01710527|115877|P2|NOT COMPLETED|Period 1: Intervention Period 1||0
49155|NCT01710527|115878|P1|NOT COMPLETED|Period 1: Intervention Period 1||0
49156|NCT01710527|115877|P2|COMPLETED|Period 1: Intervention Period 1||16
49157|NCT01710527|115878|P1|COMPLETED|Period 1: Intervention Period 1||16
49158|NCT01710527|115877|P2|STARTED|Period 1: Intervention Period 1||16
49159|NCT01710527|115878|P1|STARTED|Period 1: Intervention Period 1||16
49160|NCT01710514|115904|P2|NOT COMPLETED|Overall Study||7
49161|NCT01710514|115905|P1|NOT COMPLETED|Overall Study||7
49162|NCT01710514|115904|P2|COMPLETED|Overall Study||47
49163|NCT01710514|115905|P1|COMPLETED|Overall Study||47
49164|NCT01710514|115904|P2|Safety Analysis Set|Overall Study|All subjects received at least one dose of IMP.|54
49165|NCT01710514|115905|P1|Safety Analysis Set|Overall Study|All subjects received at least one dose of Investigational Medicinal Product (IMP).|54
49166|NCT01710514|115904|P2|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|47
49167|NCT01710514|115905|P1|FAS With Embryo Transfer (ET)|Overall Study|Data on pregnancy was reported for the subjects with embryo transfer.|43
49168|NCT01710514|115904|P2|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|48
49169|NCT01710514|115905|P1|Full Analysis Set (FAS)|Overall Study|All randomised and exposed subjects with at least one completed primary efficacy assessment.|46
49170|NCT01710514|115904|P2|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the ITT analysis set.|54
49171|NCT01710514|115905|P1|Intent-To-Treat (ITT) Analysis Set|Overall Study|All randomised subjects were included in the Intent-To-Treat (ITT) analysis set.|54
49172|NCT01710514|115904|P2|STARTED|Overall Study||54
49173|NCT01710514|115905|P1|STARTED|Overall Study||54
49174|NCT01710501|115926|P3|NOT COMPLETED|Overall Study||0
49175|NCT01710501|115927|P2|NOT COMPLETED|Overall Study||0
49176|NCT01710501|115928|P1|NOT COMPLETED|Overall Study||2
49177|NCT01710501|115926|P3|COMPLETED|Overall Study||30
49178|NCT01710501|115927|P2|COMPLETED|Overall Study||28
49179|NCT01710501|115928|P1|COMPLETED|Overall Study||27
49180|NCT01710501|115926|P3|STARTED|Overall Study||30
49181|NCT01710501|115927|P2|STARTED|Overall Study||28
49182|NCT01710501|115928|P1|STARTED|Overall Study||29
49183|NCT01710358|115960|P3|NOT COMPLETED|Follow-up Period||0
49184|NCT01710358|115961|P2|NOT COMPLETED|Follow-up Period||0
49185|NCT01710358|115962|P1|NOT COMPLETED|Follow-up Period||0
49186|NCT01710358|115960|P3|COMPLETED|Follow-up Period||20
49187|NCT01710358|115961|P2|COMPLETED|Follow-up Period||76
49188|NCT01710358|115962|P1|COMPLETED|Follow-up Period||33
49189|NCT01710358|115960|P3|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|20
49190|NCT01710358|115961|P2|STARTED|Follow-up Period|Rescued participants who entered post-treatment follow-up are included in Baricitinib 4mg follow up.|76
49191|NCT01710358|115962|P1|STARTED|Follow-up Period|Participants from treatment who entered the post-treatment follow-up period.|33
49192|NCT01710358|115960|P3|NOT COMPLETED|Rescue Period||0
49193|NCT01710358|115961|P2|NOT COMPLETED|Rescue Period||31
49194|NCT01710358|115962|P1|NOT COMPLETED|Rescue Period||0
49195|NCT01710358|115960|P3|COMPLETED|Rescue Period||0
49196|NCT01710358|115961|P2|COMPLETED|Rescue Period||196
49197|NCT01710358|115962|P1|COMPLETED|Rescue Period||0
49198|NCT01710358|115960|P3|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
49199|NCT01710358|115961|P2|STARTED|Rescue Period|Baricitinib 4 mg administered PO QD through Week 52. Participants continued background MTX therapy.|227
49200|NCT01710358|115962|P1|STARTED|Rescue Period|Participants who were nonresponders based on tender/swollen joint count entered into rescue group.|0
49201|NCT01710358|115960|P3|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||15
49202|NCT01710358|115961|P2|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||22
49203|NCT01710358|115962|P1|NOT COMPLETED|Treatment Period Part B (Weeks 24 to 52)||16
49204|NCT01710358|115960|P3|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|252
49205|NCT01710358|115961|P2|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|402
49206|NCT01710358|115962|P1|COMPLETED|Treatment Period Part B (Weeks 24 to 52)|Includes all participants rescued during Part B.|294
49207|NCT01710358|115960|P3|Rescued|Treatment Period Part B (Weeks 24 to 52)||11
49208|NCT01710358|115961|P2|Rescued|Treatment Period Part B (Weeks 24 to 52)||8
49209|NCT01710358|115962|P1|Rescued|Treatment Period Part B (Weeks 24 to 52)||5
49210|NCT01710358|115960|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||267
49211|NCT01710358|115961|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)||424
49212|NCT01710358|115962|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part B (Weeks 24 to 52)|Participants originally randomized to placebo received baricitinib during Part B.|306
49213|NCT01710358|115960|P3|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|267
49214|NCT01710358|115961|P2|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|424
49215|NCT01710358|115962|P1|STARTED|Treatment Period Part B (Weeks 24 to 52)|Excludes participants rescued during Part A.|310
49216|NCT01710358|115960|P3|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||23
49217|NCT01710358|115961|P2|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||29
49218|NCT01710358|115962|P1|NOT COMPLETED|Treatment Period Part A (Weeks 0 to 24)||51
49219|NCT01710358|115960|P3|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|307
49220|NCT01710358|115961|P2|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|459
49221|NCT01710358|115962|P1|COMPLETED|Treatment Period Part A (Weeks 0 to 24)|Includes all participants rescued during Part A.|438
49222|NCT01710358|115960|P3|Rescued|Treatment Period Part A (Weeks 0 to 24)||40
49223|NCT01710358|115961|P2|Rescued|Treatment Period Part A (Weeks 0 to 24)||35
49224|NCT01710358|115962|P1|Rescued|Treatment Period Part A (Weeks 0 to 24)||128
49225|NCT01710358|115960|P3|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||330
49226|NCT01710358|115961|P2|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||487
49227|NCT01710358|115962|P1|Received at Least 1 Dose of Study Drug|Treatment Period Part A (Weeks 0 to 24)||488
49228|NCT01710358|115960|P3|STARTED|Treatment Period Part A (Weeks 0 to 24)||330
49229|NCT01710358|115961|P2|STARTED|Treatment Period Part A (Weeks 0 to 24)||488
49230|NCT01710358|115962|P1|STARTED|Treatment Period Part A (Weeks 0 to 24)||489
49231|NCT01710345|116033|P3|NOT COMPLETED|Overall Study||1
49232|NCT01710345|116034|P2|NOT COMPLETED|Overall Study||5
49233|NCT01710345|116035|P1|NOT COMPLETED|Overall Study||3
49234|NCT01710345|116033|P3|COMPLETED|Overall Study||19
49235|NCT01710345|116034|P2|COMPLETED|Overall Study||35
49236|NCT01710345|116035|P1|COMPLETED|Overall Study||37
49237|NCT01710345|116033|P3|STARTED|Overall Study||20
49238|NCT01710345|116034|P2|STARTED|Overall Study||40
49239|NCT01710345|116035|P1|STARTED|Overall Study|41 patients were randomized to sufentanil 20 mcg, one patient not dosed due to damaged medication.|40
49240|NCT01710332|116045|P2|NOT COMPLETED|Overall Study||0
49241|NCT01710332|116046|P1|NOT COMPLETED|Overall Study||0
49242|NCT01710332|116045|P2|COMPLETED|Overall Study||6
49243|NCT01710332|116046|P1|COMPLETED|Overall Study||6
49244|NCT01710332|116045|P2|STARTED|Overall Study||6
49245|NCT01710332|116046|P1|STARTED|Overall Study||6
49246|NCT01710046|116056|P2|NOT COMPLETED|Overall Study||0
49247|NCT01710046|116057|P1|NOT COMPLETED|Overall Study||1
49248|NCT01710046|116056|P2|COMPLETED|Overall Study||3
49249|NCT01710046|116057|P1|COMPLETED|Overall Study||8
49250|NCT01710046|116056|P2|STARTED|Overall Study||3
49251|NCT01710046|116057|P1|STARTED|Overall Study||9
49252|NCT01710033|116097|P5|NOT COMPLETED|Stage 2||1
49253|NCT01710033|116098|P4|NOT COMPLETED|Stage 2||0
49254|NCT01710033|116099|P3|NOT COMPLETED|Stage 2||0
49255|NCT01710033|116100|P2|NOT COMPLETED|Stage 2||0
49256|NCT01710033|116101|P1|NOT COMPLETED|Stage 2||0
49257|NCT01710033|116097|P5|COMPLETED|Stage 2||3
49258|NCT01710033|116098|P4|COMPLETED|Stage 2||0
49259|NCT01710033|116099|P3|COMPLETED|Stage 2||0
49260|NCT01710033|116100|P2|COMPLETED|Stage 2||0
49261|NCT01710033|116101|P1|COMPLETED|Stage 2||0
49262|NCT01710033|116097|P5|STARTED|Stage 2||4
49263|NCT01710033|116098|P4|STARTED|Stage 2||0
49264|NCT01710033|116099|P3|STARTED|Stage 2||0
49265|NCT01710033|116100|P2|STARTED|Stage 2||0
49266|NCT01710033|116101|P1|STARTED|Stage 2||0
49267|NCT01710033|116097|P5|NOT COMPLETED|Stage 1||0
49268|NCT01710033|116098|P4|NOT COMPLETED|Stage 1||0
49269|NCT01710033|116099|P3|NOT COMPLETED|Stage 1||0
49270|NCT01710033|116100|P2|NOT COMPLETED|Stage 1||0
49271|NCT01710033|116101|P1|NOT COMPLETED|Stage 1||0
49272|NCT01710033|116097|P5|COMPLETED|Stage 1||0
49273|NCT01710033|116098|P4|COMPLETED|Stage 1||6
49274|NCT01710033|116099|P3|COMPLETED|Stage 1||6
49275|NCT01710033|116100|P2|COMPLETED|Stage 1||6
49276|NCT01710033|116101|P1|COMPLETED|Stage 1||6
49277|NCT01710033|116097|P5|STARTED|Stage 1||0
49278|NCT01710033|116098|P4|STARTED|Stage 1||6
49279|NCT01710033|116099|P3|STARTED|Stage 1||6
49280|NCT01710033|116100|P2|STARTED|Stage 1||6
49281|NCT01710033|116101|P1|STARTED|Stage 1||6
49282|NCT01710020|116182|P1|NOT COMPLETED|Period 2||0
49283|NCT01710020|116182|P1|COMPLETED|Period 2||11
49284|NCT01710020|116182|P1|STARTED|Period 2||11
49285|NCT01710020|116182|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
49286|NCT01710020|116182|P1|COMPLETED|Washout Period (at Least 14 Days)||11
49287|NCT01710020|116182|P1|STARTED|Washout Period (at Least 14 Days)||11
49288|NCT01710020|116182|P1|NOT COMPLETED|Period 1||1
49289|NCT01710020|116182|P1|COMPLETED|Period 1||11
49290|NCT01710020|116182|P1|STARTED|Period 1||12
49291|NCT01709903|116201|P2|NOT COMPLETED|Overall Study||39
49292|NCT01709903|116202|P1|NOT COMPLETED|Overall Study||29
49293|NCT01709903|116201|P2|COMPLETED|Overall Study||333
49294|NCT01709903|116202|P1|COMPLETED|Overall Study||343
49295|NCT01709903|116201|P2|STARTED|Overall Study|Randomized set|372
49296|NCT01709903|116202|P1|STARTED|Overall Study|Randomized set|372
49297|NCT01709864|116226|P2|NOT COMPLETED|Overall Study||11
49298|NCT01709864|116227|P1|NOT COMPLETED|Overall Study||7
49299|NCT01709864|116226|P2|COMPLETED|Overall Study||208
49300|NCT01709864|116227|P1|COMPLETED|Overall Study||215
49301|NCT01709864|116226|P2|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|201
49302|NCT01709864|116227|P1|Per Protocol Set (PPS)|Overall Study|PPS included all patients in the FAS who did not have any major protocol deviations.|204
49303|NCT01709864|116226|P2|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|216
49304|NCT01709864|116227|P1|Full Analysis Set (FAS)|Overall Study|FAS included all randomized patients who received at least one dose of trial drug.|222
49305|NCT01709864|116226|P2|STARTED|Overall Study||219
49306|NCT01709864|116227|P1|STARTED|Overall Study||222
49307|NCT01709799|116264|P3|NOT COMPLETED|Overall Study||3
49308|NCT01709799|116265|P2|NOT COMPLETED|Overall Study||3
49309|NCT01709799|116266|P1|NOT COMPLETED|Overall Study||3
49310|NCT01709799|116264|P3|COMPLETED|Overall Study||15
49311|NCT01709799|116265|P2|COMPLETED|Overall Study||18
49312|NCT01709799|116266|P1|COMPLETED|Overall Study||22
49313|NCT01709799|116264|P3|STARTED|Overall Study||18
49314|NCT01709799|116265|P2|STARTED|Overall Study||21
49315|NCT01709799|116266|P1|STARTED|Overall Study||25
49316|NCT01709786|116289|P1|NOT COMPLETED|Overall Study||0
49317|NCT01709786|116289|P1|COMPLETED|Overall Study||88
49318|NCT01709786|116289|P1|STARTED|Overall Study||88
49319|NCT01709708|116298|P2|NOT COMPLETED|Overall Study||2
49320|NCT01709708|116299|P1|NOT COMPLETED|Overall Study||1
49321|NCT01709708|116298|P2|COMPLETED|Overall Study||12
49322|NCT01709708|116299|P1|COMPLETED|Overall Study||26
49323|NCT01709708|116298|P2|STARTED|Overall Study||14
49324|NCT01709708|116299|P1|STARTED|Overall Study||27
49325|NCT01709578|116308|P3|NOT COMPLETED|Overall Study||51
49326|NCT01709578|116309|P2|NOT COMPLETED|Overall Study||56
49327|NCT01709578|116310|P1|NOT COMPLETED|Overall Study||80
49328|NCT01709578|116308|P3|COMPLETED|Overall Study||133
49329|NCT01709578|116309|P2|COMPLETED|Overall Study||125
49330|NCT01709578|116310|P1|COMPLETED|Overall Study||101
49331|NCT01709578|116308|P3|STARTED|Overall Study||184
49332|NCT01709578|116309|P2|STARTED|Overall Study||181
49333|NCT01709578|116310|P1|STARTED|Overall Study||181
49334|NCT01709513|116441|P3|NOT COMPLETED|Overall Study||30
49335|NCT01709513|116442|P2|NOT COMPLETED|Overall Study||43
49336|NCT01709513|116443|P1|NOT COMPLETED|Overall Study||21
49337|NCT01709513|116441|P3|COMPLETED|Overall Study||96
49338|NCT01709513|116442|P2|COMPLETED|Overall Study||82
49339|NCT01709513|116443|P1|COMPLETED|Overall Study||42
49340|NCT01709513|116441|P3|Treated|Overall Study||126
49341|NCT01709513|116442|P2|Treated|Overall Study||124
49342|NCT01709513|116443|P1|Treated|Overall Study||63
49343|NCT01709513|116441|P3|STARTED|Overall Study||126
49344|NCT01709513|116442|P2|STARTED|Overall Study||125
49345|NCT01709513|116443|P1|STARTED|Overall Study||63
49346|NCT01709500|116504|P2|NOT COMPLETED|Overall Study||82
49347|NCT01709500|116505|P1|NOT COMPLETED|Overall Study||167
49348|NCT01709500|116504|P2|COMPLETED|Overall Study||0
49349|NCT01709500|116505|P1|COMPLETED|Overall Study||0
49350|NCT01709500|116504|P2|Treated|Overall Study||81
49351|NCT01709500|116505|P1|Treated|Overall Study||167
49352|NCT01709500|116504|P2|STARTED|Overall Study||82
49353|NCT01709500|116505|P1|STARTED|Overall Study||167
49354|NCT01709474|116561|P2|NOT COMPLETED|Overall Study||0
49355|NCT01709474|116562|P1|NOT COMPLETED|Overall Study||0
49356|NCT01709474|116561|P2|COMPLETED|Overall Study||4
49357|NCT01709474|116562|P1|COMPLETED|Overall Study||3
49358|NCT01709474|116561|P2|STARTED|Overall Study||4
49359|NCT01709474|116562|P1|STARTED|Overall Study||3
49360|NCT01709422|116572|P2|NOT COMPLETED|Overall Study||0
49361|NCT01709422|116573|P1|NOT COMPLETED|Overall Study||0
49362|NCT01709422|116572|P2|COMPLETED|Overall Study||70
49363|NCT01709422|116573|P1|COMPLETED|Overall Study||70
49364|NCT01709422|116572|P2|STARTED|Overall Study||70
49365|NCT01709422|116573|P1|STARTED|Overall Study||70
49366|NCT01709383|116583|P2|NOT COMPLETED|Overall Study||0
49367|NCT01709383|116584|P1|NOT COMPLETED|Overall Study||1
49368|NCT01709383|116583|P2|COMPLETED|Overall Study||14
49369|NCT01709383|116584|P1|COMPLETED|Overall Study||23
49370|NCT01709383|116583|P2|Included in Analysis|Overall Study||13
49371|NCT01709383|116584|P1|Included in Analysis|Overall Study||22
49372|NCT01709383|116583|P2|Completed Follow-ups|Overall Study||14
49373|NCT01709383|116584|P1|Completed Follow-ups|Overall Study||23
49374|NCT01709383|116583|P2|Completed Treatment|Overall Study||14
49375|NCT01709383|116584|P1|Completed Treatment|Overall Study||24
49376|NCT01709383|116583|P2|STARTED|Overall Study||14
49377|NCT01709383|116584|P1|STARTED|Overall Study||24
49378|NCT01709331|116602|P1|NOT COMPLETED|Overall Study||1
49379|NCT01709331|116602|P1|COMPLETED|Overall Study||17
49380|NCT01709331|116602|P1|STARTED|Overall Study||18
49381|NCT01709305|116608|P5|NOT COMPLETED|Phase 2||47
49382|NCT01709305|116609|P4|NOT COMPLETED|Phase 2||48
49383|NCT01709305|116610|P3|NOT COMPLETED|Phase 2||45
49384|NCT01709305|116611|P2|NOT COMPLETED|Phase 2||52
49385|NCT01709305|116612|P1|NOT COMPLETED|Phase 2||0
49386|NCT01709305|116608|P5|COMPLETED|Phase 2||507
49387|NCT01709305|116609|P4|COMPLETED|Phase 2||508
49388|NCT01709305|116610|P3|COMPLETED|Phase 2||505
49389|NCT01709305|116611|P2|COMPLETED|Phase 2||500
49390|NCT01709305|116612|P1|COMPLETED|Phase 2||0
49391|NCT01709305|116608|P5|STARTED|Phase 2||554
49392|NCT01709305|116609|P4|STARTED|Phase 2||556
49393|NCT01709305|116610|P3|STARTED|Phase 2||550
49394|NCT01709305|116611|P2|STARTED|Phase 2||552
49395|NCT01709305|116612|P1|STARTED|Phase 2||0
49396|NCT01709305|116608|P5|NOT COMPLETED|Phase 1||0
49397|NCT01709305|116609|P4|NOT COMPLETED|Phase 1||0
49398|NCT01709305|116610|P3|NOT COMPLETED|Phase 1||0
49399|NCT01709305|116611|P2|NOT COMPLETED|Phase 1||0
49400|NCT01709305|116612|P1|NOT COMPLETED|Phase 1||637
49401|NCT01709305|116608|P5|COMPLETED|Phase 1||0
49402|NCT01709305|116609|P4|COMPLETED|Phase 1||0
49403|NCT01709305|116610|P3|COMPLETED|Phase 1||0
49404|NCT01709305|116611|P2|COMPLETED|Phase 1||0
49405|NCT01709305|116612|P1|COMPLETED|Phase 1||4933
49406|NCT01709305|116608|P5|STARTED|Phase 1||0
49407|NCT01709305|116609|P4|STARTED|Phase 1||0
49408|NCT01709305|116610|P3|STARTED|Phase 1||0
49409|NCT01709305|116611|P2|STARTED|Phase 1||0
49410|NCT01709305|116612|P1|STARTED|Phase 1||5570
49411|NCT01709227|116649|P2|NOT COMPLETED|Overall Study||9
49412|NCT01709227|116650|P1|NOT COMPLETED|Overall Study||1
49413|NCT01709227|116649|P2|COMPLETED|Overall Study||32
49414|NCT01709227|116650|P1|COMPLETED|Overall Study||31
49415|NCT01709227|116649|P2|STARTED|Overall Study||41
49416|NCT01709227|116650|P1|STARTED|Overall Study||32
49417|NCT01709162|116676|P2|NOT COMPLETED|Overall Study||5
49418|NCT01709162|116677|P1|NOT COMPLETED|Overall Study||6
49419|NCT01709162|116676|P2|COMPLETED|Overall Study|Completed treatment as per protocol|0
49420|NCT01709162|116677|P1|COMPLETED|Overall Study|Completed treatment as per protocol|12
49421|NCT01709162|116676|P2|Still Receiving Treatment|Overall Study||0
49422|NCT01709162|116677|P1|Still Receiving Treatment|Overall Study||0
49423|NCT01709162|116676|P2|Received Treatment|Overall Study||4
49424|NCT01709162|116677|P1|Received Treatment|Overall Study||18
49425|NCT01709162|116676|P2|STARTED|Overall Study|Randomized|5
49426|NCT01709162|116677|P1|STARTED|Overall Study|Randomized|18
49427|NCT01709136|116689|P1|NOT COMPLETED|Overall Study||0
49428|NCT01709136|116689|P1|COMPLETED|Overall Study||3
49429|NCT01709136|116689|P1|STARTED|Overall Study||3
49430|NCT01709084|116698|P2|NOT COMPLETED|Overall Study||15
49431|NCT01709084|116699|P1|NOT COMPLETED|Overall Study||16
49432|NCT01709084|116698|P2|COMPLETED|Overall Study||198
49433|NCT01709084|116699|P1|COMPLETED|Overall Study||197
49434|NCT01709084|116698|P2|Treated|Overall Study||211
49435|NCT01709084|116699|P1|Treated|Overall Study||213
49436|NCT01709084|116698|P2|STARTED|Overall Study||213
49437|NCT01709084|116699|P1|STARTED|Overall Study||213
49438|NCT01708967|116717|P2|NOT COMPLETED|Overall Study||7
49439|NCT01708967|116718|P1|NOT COMPLETED|Overall Study||0
49440|NCT01708967|116717|P2|COMPLETED|Overall Study||43
49441|NCT01708967|116718|P1|COMPLETED|Overall Study||50
49442|NCT01708967|116717|P2|STARTED|Overall Study||50
49443|NCT01708967|116718|P1|STARTED|Overall Study||50
49444|NCT01708954|116727|P3|NOT COMPLETED|Step 2||0
49445|NCT01708954|116728|P2|NOT COMPLETED|Step 2||7
49446|NCT01708954|116729|P1|NOT COMPLETED|Step 2||13
49447|NCT01708954|116727|P3|COMPLETED|Step 2||0
49448|NCT01708954|116728|P2|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
49449|NCT01708954|116729|P1|COMPLETED|Step 2|Treatment continued until progressive disease or unacceptable toxicity.|0
49450|NCT01708954|116727|P3|STARTED|Step 2|Only patients with disease progression on Arms A and B were allowed to register to Step 2.|0
49451|NCT01708954|116728|P2|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|7
49452|NCT01708954|116729|P1|STARTED|Step 2|Only patients with disease progression in Step 1 are eligible to register to Step 2.|13
49453|NCT01708954|116727|P3|NOT COMPLETED|Step 1||43
49454|NCT01708954|116728|P2|NOT COMPLETED|Step 1||40
49455|NCT01708954|116729|P1|NOT COMPLETED|Step 1||42
49456|NCT01708954|116727|P3|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
49457|NCT01708954|116728|P2|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
49458|NCT01708954|116729|P1|COMPLETED|Step 1|Treatment continued until progressive disease or unacceptable toxicity.|0
49459|NCT01708954|116727|P3|Patients With MET Status Data Available|Step 1||24
49460|NCT01708954|116728|P2|Patients With MET Status Data Available|Step 1||32
49461|NCT01708954|116729|P1|Patients With MET Status Data Available|Step 1||30
49462|NCT01708954|116727|P3|Eligible and Treated|Step 1||35
49463|NCT01708954|116728|P2|Eligible and Treated|Step 1||38
49464|NCT01708954|116729|P1|Eligible and Treated|Step 1||38
49465|NCT01708954|116727|P3|Started Protocol Therapy|Step 1||39
49466|NCT01708954|116728|P2|Started Protocol Therapy|Step 1||40
49467|NCT01708954|116729|P1|Started Protocol Therapy|Step 1||40
49468|NCT01708954|116727|P3|STARTED|Step 1||43
49469|NCT01708954|116728|P2|STARTED|Step 1||40
49470|NCT01708954|116729|P1|STARTED|Step 1||42
49471|NCT01708915|116754|P4|NOT COMPLETED|Overall Study||33
49472|NCT01708915|116755|P3|NOT COMPLETED|Overall Study||46
49473|NCT01708915|116756|P2|NOT COMPLETED|Overall Study||62
49474|NCT01708915|116757|P1|NOT COMPLETED|Overall Study||86
49475|NCT01708915|116754|P4|COMPLETED|Overall Study||169
49476|NCT01708915|116755|P3|COMPLETED|Overall Study||152
49477|NCT01708915|116756|P2|COMPLETED|Overall Study||139
49478|NCT01708915|116757|P1|COMPLETED|Overall Study||118
49479|NCT01708915|116754|P4|STARTED|Overall Study||202
49480|NCT01708915|116755|P3|STARTED|Overall Study||198
49481|NCT01708915|116756|P2|STARTED|Overall Study||201
49482|NCT01708915|116757|P1|STARTED|Overall Study||204
49483|NCT01708902|116786|P7|NOT COMPLETED|Overall Study||7
49484|NCT01708902|116787|P6|NOT COMPLETED|Overall Study||7
49485|NCT01708902|116788|P5|NOT COMPLETED|Overall Study||16
49486|NCT01708902|116789|P4|NOT COMPLETED|Overall Study||10
49487|NCT01708902|116790|P3|NOT COMPLETED|Overall Study||17
49488|NCT01708902|116791|P2|NOT COMPLETED|Overall Study||8
49489|NCT01708902|116792|P1|NOT COMPLETED|Overall Study||17
49490|NCT01708902|116786|P7|COMPLETED|Overall Study||65
49491|NCT01708902|116787|P6|COMPLETED|Overall Study||64
49492|NCT01708902|116788|P5|COMPLETED|Overall Study||131
49493|NCT01708902|116789|P4|COMPLETED|Overall Study||137
49494|NCT01708902|116790|P3|COMPLETED|Overall Study||127
49495|NCT01708902|116791|P2|COMPLETED|Overall Study||137
49496|NCT01708902|116792|P1|COMPLETED|Overall Study||130
49497|NCT01708902|116786|P7|STARTED|Overall Study||72
49498|NCT01708902|116787|P6|STARTED|Overall Study||71
49499|NCT01708902|116788|P5|STARTED|Overall Study||147
49500|NCT01708902|116789|P4|STARTED|Overall Study||147
49501|NCT01708902|116790|P3|STARTED|Overall Study||144
49502|NCT01708902|116791|P2|STARTED|Overall Study||145
49503|NCT01708902|116792|P1|STARTED|Overall Study||147
49504|NCT01708525|116851|P1|NOT COMPLETED|Overall Study||0
49505|NCT01708525|116851|P1|COMPLETED|Overall Study||2
49506|NCT01708525|116851|P1|STARTED|Overall Study||2
49507|NCT01708317|116856|P1|NOT COMPLETED|Final Education Period||0
49508|NCT01708317|116856|P1|COMPLETED|Final Education Period||909
49509|NCT01708317|116856|P1|STARTED|Final Education Period|# of ED patients eligible for ACASI, had it been available, in final education period|909
49510|NCT01708317|116856|P1|NOT COMPLETED|ACASI + Education Period||0
49511|NCT01708317|116856|P1|COMPLETED|ACASI + Education Period||2601
49512|NCT01708317|116856|P1|STARTED|ACASI + Education Period|# of ED patients eligible for ACASI in the period the ACASI was actually available.|2601
49513|NCT01708317|116856|P1|NOT COMPLETED|Initial Education Period||0
49514|NCT01708317|116856|P1|COMPLETED|Initial Education Period||982
49515|NCT01708317|116856|P1|STARTED|Initial Education Period|# of ED patients eligible for ACASI, had it been available, in initial education period|982
49516|NCT01708317|116856|P1|NOT COMPLETED|2010 Control Period||0
49517|NCT01708317|116856|P1|COMPLETED|2010 Control Period||3929
49518|NCT01708317|116856|P1|STARTED|2010 Control Period|# of ED patients eligible for ACASI, had it been available, in control period|3929
49519|NCT01708291|116865|P2|NOT COMPLETED|Overall Study||1
49520|NCT01708291|116866|P1|NOT COMPLETED|Overall Study||2
49521|NCT01708291|116865|P2|COMPLETED|Overall Study||20
49522|NCT01708291|116866|P1|COMPLETED|Overall Study||19
49523|NCT01708291|116865|P2|STARTED|Overall Study||21
49524|NCT01708291|116866|P1|STARTED|Overall Study||21
49525|NCT01708278|116878|P6|NOT COMPLETED|Overall Study||0
49526|NCT01708278|116879|P5|NOT COMPLETED|Overall Study||0
49527|NCT01708278|116880|P4|NOT COMPLETED|Overall Study||0
49528|NCT01708278|116881|P3|NOT COMPLETED|Overall Study||0
49529|NCT01708278|116882|P2|NOT COMPLETED|Overall Study||0
49530|NCT01708278|116883|P1|NOT COMPLETED|Overall Study||0
49531|NCT01708278|116878|P6|COMPLETED|Overall Study||1
49532|NCT01708278|116879|P5|COMPLETED|Overall Study||1
49533|NCT01708278|116880|P4|COMPLETED|Overall Study||2
49534|NCT01708278|116881|P3|COMPLETED|Overall Study||2
49535|NCT01708278|116882|P2|COMPLETED|Overall Study||2
49536|NCT01708278|116883|P1|COMPLETED|Overall Study||1
49537|NCT01708278|116878|P6|STARTED|Overall Study||1
49538|NCT01708278|116879|P5|STARTED|Overall Study||1
49539|NCT01708278|116880|P4|STARTED|Overall Study||2
49540|NCT01708278|116881|P3|STARTED|Overall Study||2
49541|NCT01708278|116882|P2|STARTED|Overall Study||2
49542|NCT01708278|116883|P1|STARTED|Overall Study||1
49543|NCT01708213|116897|P1|NOT COMPLETED|Overall Study||1
49544|NCT01708213|116897|P1|COMPLETED|Overall Study||71
49545|NCT01708213|116897|P1|STARTED|Overall Study||72
49546|NCT01708187|116905|P2|NOT COMPLETED|Overall Study||1
49547|NCT01708187|116906|P1|NOT COMPLETED|Overall Study||0
49548|NCT01708187|116905|P2|COMPLETED|Overall Study||0
49549|NCT01708187|116906|P1|COMPLETED|Overall Study||1
49550|NCT01708187|116905|P2|STARTED|Overall Study||1
49551|NCT01708187|116906|P1|STARTED|Overall Study||1
49552|NCT01708174|116915|P3|NOT COMPLETED|Survival Follow-up||0
49553|NCT01708174|116916|P2|NOT COMPLETED|Survival Follow-up||0
49554|NCT01708174|116917|P1|NOT COMPLETED|Survival Follow-up||0
49555|NCT01708174|116915|P3|COMPLETED|Survival Follow-up||0
49556|NCT01708174|116916|P2|COMPLETED|Survival Follow-up||10
49557|NCT01708174|116917|P1|COMPLETED|Survival Follow-up||1
49558|NCT01708174|116915|P3|STARTED|Survival Follow-up||0
49559|NCT01708174|116916|P2|STARTED|Survival Follow-up||10
49560|NCT01708174|116917|P1|STARTED|Survival Follow-up||1
49561|NCT01708174|116915|P3|NOT COMPLETED|Treatment Period||1
49562|NCT01708174|116916|P2|NOT COMPLETED|Treatment Period||2
49563|NCT01708174|116917|P1|NOT COMPLETED|Treatment Period||1
49564|NCT01708174|116915|P3|COMPLETED|Treatment Period||3
49565|NCT01708174|116916|P2|COMPLETED|Treatment Period||14
49566|NCT01708174|116917|P1|COMPLETED|Treatment Period||1
49567|NCT01708174|116915|P3|Pharmacokinetic Analysis Set|Treatment Period||0
49568|NCT01708174|116916|P2|Pharmacokinetic Analysis Set|Treatment Period||13
49569|NCT01708174|116917|P1|Pharmacokinetic Analysis Set|Treatment Period||2
49570|NCT01708174|116915|P3|STARTED|Treatment Period||4
49571|NCT01708174|116916|P2|STARTED|Treatment Period||16
49572|NCT01708174|116917|P1|STARTED|Treatment Period||2
49573|NCT01708122|116945|P2|NOT COMPLETED|Overall Study||0
49574|NCT01708122|116946|P1|NOT COMPLETED|Overall Study||0
49575|NCT01708122|116945|P2|COMPLETED|Overall Study||26
49576|NCT01708122|116946|P1|COMPLETED|Overall Study||27
49577|NCT01708122|116945|P2|STARTED|Overall Study||26
49578|NCT01708122|116946|P1|STARTED|Overall Study||27
49579|NCT01708057|116954|P3|NOT COMPLETED|Overall Study||1
49580|NCT01708057|116955|P2|NOT COMPLETED|Overall Study||1
49581|NCT01708057|116956|P1|NOT COMPLETED|Overall Study||1
49582|NCT01708057|116954|P3|COMPLETED|Overall Study||0
49583|NCT01708057|116955|P2|COMPLETED|Overall Study||0
49584|NCT01708057|116956|P1|COMPLETED|Overall Study||0
49585|NCT01708057|116954|P3|STARTED|Overall Study||1
49586|NCT01708057|116955|P2|STARTED|Overall Study||1
49587|NCT01708057|116956|P1|STARTED|Overall Study||1
49588|NCT01707667|117014|P2|NOT COMPLETED|Period 2||0
49589|NCT01707667|117015|P1|NOT COMPLETED|Period 2||0
49590|NCT01707667|117014|P2|COMPLETED|Period 2||6
49591|NCT01707667|117015|P1|COMPLETED|Period 2||6
49592|NCT01707667|117014|P2|STARTED|Period 2||6
49593|NCT01707667|117015|P1|STARTED|Period 2||6
49594|NCT01707667|117014|P2|NOT COMPLETED|Period 1||0
49595|NCT01707667|117015|P1|NOT COMPLETED|Period 1||1
49596|NCT01707667|117014|P2|COMPLETED|Period 1||6
49597|NCT01707667|117015|P1|COMPLETED|Period 1||6
49598|NCT01707667|117014|P2|STARTED|Period 1||6
49599|NCT01707667|117015|P1|STARTED|Period 1||7
49600|NCT01707654|117033|P1|NOT COMPLETED|Overall Study||0
49601|NCT01707654|117033|P1|COMPLETED|Overall Study||9
49602|NCT01707654|117033|P1|STARTED|Overall Study||9
49603|NCT01707290|117039|P2|NOT COMPLETED|Overall Study||1
49604|NCT01707290|117040|P1|NOT COMPLETED|Overall Study||86
49605|NCT01707290|117039|P2|COMPLETED|Overall Study||3
49606|NCT01707290|117040|P1|COMPLETED|Overall Study||35
49607|NCT01707290|117039|P2|STARTED|Overall Study||4
49608|NCT01707290|117040|P1|STARTED|Overall Study||121
49609|NCT01707238|117063|P2|NOT COMPLETED|Overall Study||0
49610|NCT01707238|117064|P1|NOT COMPLETED|Overall Study||0
49611|NCT01707238|117063|P2|COMPLETED|Overall Study||52
49612|NCT01707238|117064|P1|COMPLETED|Overall Study||48
49613|NCT01707238|117063|P2|STARTED|Overall Study||52
49614|NCT01707238|117064|P1|STARTED|Overall Study||48
49615|NCT01707225|117080|P1|NOT COMPLETED|Overall Study||0
49616|NCT01707225|117080|P1|COMPLETED|Overall Study||10
49617|NCT01707225|117080|P1|STARTED|Overall Study||10
49618|NCT01707095|117087|P2|NOT COMPLETED|Overall Study||0
49619|NCT01707095|117088|P1|NOT COMPLETED|Overall Study||0
49620|NCT01707095|117087|P2|COMPLETED|Overall Study||42
49621|NCT01707095|117088|P1|COMPLETED|Overall Study||42
49622|NCT01707095|117087|P2|STARTED|Overall Study||42
49623|NCT01707095|117088|P1|STARTED|Overall Study||42
49624|NCT01707043|117098|P2|NOT COMPLETED|Overall Study||0
49625|NCT01707043|117099|P1|NOT COMPLETED|Overall Study||0
49626|NCT01707043|117098|P2|COMPLETED|Overall Study||10
49627|NCT01707043|117099|P1|COMPLETED|Overall Study||10
49628|NCT01707043|117098|P2|STARTED|Overall Study||10
49629|NCT01707043|117099|P1|STARTED|Overall Study||10
49630|NCT01706952|117107|P1|NOT COMPLETED|Overall Study||8
49631|NCT01706952|117107|P1|COMPLETED|Overall Study||37
49632|NCT01706952|117107|P1|STARTED|Overall Study||45
49633|NCT01706926|117123|P4|NOT COMPLETED|Overall Study||5
49634|NCT01706926|117124|P3|NOT COMPLETED|Overall Study||6
49635|NCT01706926|117125|P2|NOT COMPLETED|Overall Study||4
49636|NCT01706926|117126|P1|NOT COMPLETED|Overall Study||6
49637|NCT01706926|117123|P4|COMPLETED|Overall Study||74
49638|NCT01706926|117124|P3|COMPLETED|Overall Study||79
49639|NCT01706926|117125|P2|COMPLETED|Overall Study||77
49640|NCT01706926|117126|P1|COMPLETED|Overall Study||75
49641|NCT01706926|117123|P4|STARTED|Overall Study||79
49642|NCT01706926|117124|P3|STARTED|Overall Study||85
49643|NCT01706926|117125|P2|STARTED|Overall Study||81
49644|NCT01706926|117126|P1|STARTED|Overall Study||81
49645|NCT01706822|117235|P1|NOT COMPLETED|Overall Study||0
49646|NCT01706822|117235|P1|COMPLETED|Overall Study||8
49647|NCT01706822|117235|P1|STARTED|Overall Study||8
49648|NCT01706770|117245|P2|NOT COMPLETED|Overall Study||0
49649|NCT01706770|117246|P1|NOT COMPLETED|Overall Study||2
49650|NCT01706770|117245|P2|COMPLETED|Overall Study||17
49651|NCT01706770|117246|P1|COMPLETED|Overall Study||31
49652|NCT01706770|117245|P2|STARTED|Overall Study||17
49653|NCT01706770|117246|P1|STARTED|Overall Study||33
49654|NCT01706666|117257|P3|NOT COMPLETED|Overall Study||0
49655|NCT01706666|117258|P2|NOT COMPLETED|Overall Study||0
49656|NCT01706666|117259|P1|NOT COMPLETED|Overall Study||0
49657|NCT01706666|117257|P3|COMPLETED|Overall Study||1
49658|NCT01706666|117258|P2|COMPLETED|Overall Study||1
49659|NCT01706666|117259|P1|COMPLETED|Overall Study||1
49660|NCT01706666|117257|P3|STARTED|Overall Study||1
49661|NCT01706666|117258|P2|STARTED|Overall Study||1
49662|NCT01706666|117259|P1|STARTED|Overall Study||1
49663|NCT01706588|117278|P5|NOT COMPLETED|Overall Study||0
49664|NCT01706588|117279|P4|NOT COMPLETED|Overall Study||0
49665|NCT01706588|117280|P3|NOT COMPLETED|Overall Study||0
49666|NCT01706588|117281|P2|NOT COMPLETED|Overall Study||0
49667|NCT01706588|117282|P1|NOT COMPLETED|Overall Study||0
49668|NCT01706588|117278|P5|COMPLETED|Overall Study||16
49669|NCT01706588|117279|P4|COMPLETED|Overall Study||14
49670|NCT01706588|117280|P3|COMPLETED|Overall Study||15
49671|NCT01706588|117281|P2|COMPLETED|Overall Study||15
49672|NCT01706588|117282|P1|COMPLETED|Overall Study||15
49673|NCT01706588|117278|P5|STARTED|Overall Study||16
49674|NCT01706588|117279|P4|STARTED|Overall Study||14
49675|NCT01706588|117280|P3|STARTED|Overall Study||15
49676|NCT01706588|117281|P2|STARTED|Overall Study||15
49677|NCT01706588|117282|P1|STARTED|Overall Study||15
49678|NCT01706575|117294|P1|NOT COMPLETED|Overall Study||12
49679|NCT01706575|117294|P1|COMPLETED|Overall Study||64
49680|NCT01706575|117294|P1|Treated|Overall Study||70
49681|NCT01706575|117294|P1|STARTED|Overall Study||76
49682|NCT01706549|117305|P1|NOT COMPLETED|Overall Study||0
49683|NCT01706549|117305|P1|COMPLETED|Overall Study||16
49684|NCT01706549|117305|P1|STARTED|Overall Study||16
49685|NCT01706328|117312|P3|NOT COMPLETED|12-week Double-blind Treatment Period||45
49686|NCT01706328|117313|P2|NOT COMPLETED|12-week Double-blind Treatment Period||46
49687|NCT01706328|117314|P1|NOT COMPLETED|12-week Double-blind Treatment Period||0
49688|NCT01706328|117312|P3|COMPLETED|12-week Double-blind Treatment Period||371
49689|NCT01706328|117313|P2|COMPLETED|12-week Double-blind Treatment Period||366
49690|NCT01706328|117314|P1|COMPLETED|12-week Double-blind Treatment Period||0
49691|NCT01706328|117312|P3|STARTED|12-week Double-blind Treatment Period||416
49692|NCT01706328|117313|P2|STARTED|12-week Double-blind Treatment Period||412
49693|NCT01706328|117314|P1|STARTED|12-week Double-blind Treatment Period||0
49694|NCT01706328|117312|P3|NOT COMPLETED|2-week Run-in Period||0
49695|NCT01706328|117313|P2|NOT COMPLETED|2-week Run-in Period||0
49696|NCT01706328|117314|P1|NOT COMPLETED|2-week Run-in Period||165
49697|NCT01706328|117312|P3|COMPLETED|2-week Run-in Period||0
49698|NCT01706328|117313|P2|COMPLETED|2-week Run-in Period||0
49699|NCT01706328|117314|P1|COMPLETED|2-week Run-in Period||828
49700|NCT01706328|117312|P3|STARTED|2-week Run-in Period||0
49701|NCT01706328|117313|P2|STARTED|2-week Run-in Period||0
49702|NCT01706328|117314|P1|STARTED|2-week Run-in Period||993
49703|NCT01706250|117324|P1|NOT COMPLETED|Overall Study||2
49704|NCT01706250|117324|P1|COMPLETED|Overall Study||18
49705|NCT01706250|117324|P1|STARTED|Overall Study||20
49706|NCT01706159|117355|P2|NOT COMPLETED|Overall Study||2
49707|NCT01706159|117356|P1|NOT COMPLETED|Overall Study||8
49708|NCT01706159|117355|P2|COMPLETED|Overall Study||4
49709|NCT01706159|117356|P1|COMPLETED|Overall Study||6
49710|NCT01706159|117355|P2|Completers (With Baron Score at Week 8)|Overall Study||3
49711|NCT01706159|117356|P1|Completers (With Baron Score at Week 8)|Overall Study||6
49712|NCT01706159|117355|P2|Exposed|Overall Study|One subject was not exposed to placebo.|5
49713|NCT01706159|117356|P1|Exposed|Overall Study|One subject was not exposed to rFXIII.|13
49714|NCT01706159|117355|P2|STARTED|Overall Study||6
49715|NCT01706159|117356|P1|STARTED|Overall Study||14
49716|NCT01706146|117370|P1|NOT COMPLETED|Overall Study||6
49717|NCT01706146|117370|P1|COMPLETED|Overall Study|1 pt developed permanent AF; 1 pt needed dual antiplatelet therapy; 3 possible TIA; 1 withdraw|53
49718|NCT01706146|117370|P1|STARTED|Overall Study||59
49719|NCT01705717|117377|P2|NOT COMPLETED|Overall Study||5
49720|NCT01705717|117378|P1|NOT COMPLETED|Overall Study||2
49721|NCT01705717|117377|P2|COMPLETED|Overall Study||7
49722|NCT01705717|117378|P1|COMPLETED|Overall Study||35
49723|NCT01705717|117377|P2|STARTED|Overall Study||12
49724|NCT01705717|117378|P1|STARTED|Overall Study||37
49725|NCT01705652|117395|P2|NOT COMPLETED|Overall Study||3
49726|NCT01705652|117396|P1|NOT COMPLETED|Overall Study||3
49727|NCT01705652|117395|P2|COMPLETED|Overall Study||9
49728|NCT01705652|117396|P1|COMPLETED|Overall Study||6
49729|NCT01705652|117395|P2|STARTED|Overall Study||12
49730|NCT01705652|117396|P1|STARTED|Overall Study||9
49731|NCT01705574|117404|P2|NOT COMPLETED|Overall Study||163
49732|NCT01705574|117405|P1|NOT COMPLETED|Overall Study||167
49733|NCT01705574|117404|P2|COMPLETED|Overall Study||127
49734|NCT01705574|117405|P1|COMPLETED|Overall Study||126
49735|NCT01705574|117404|P2|STARTED|Overall Study||290
49736|NCT01705574|117405|P1|STARTED|Overall Study||293
49737|NCT01705496|117413|P1|NOT COMPLETED|Overall Study||4
49738|NCT01705496|117413|P1|COMPLETED|Overall Study||19
49739|NCT01705496|117413|P1|STARTED|Overall Study||23
49740|NCT01705145|117423|P1|NOT COMPLETED|Part B||1
49741|NCT01705145|117423|P1|COMPLETED|Part B||33
49742|NCT01705145|117423|P1|STARTED|Part B|Eight participants from Part A continued in Part B of the study.|34
49743|NCT01705145|117423|P1|NOT COMPLETED|Part A||0
49744|NCT01705145|117423|P1|COMPLETED|Part A||9
49745|NCT01705145|117423|P1|STARTED|Part A||9
49746|NCT01704976|117453|P2|NOT COMPLETED|Overall Study||2
49747|NCT01704976|117454|P1|NOT COMPLETED|Overall Study||1
49748|NCT01704976|117453|P2|COMPLETED|Overall Study|2 participants completed < 11 SR-WBV sessions, they were excluded from statistical analysis|11
49749|NCT01704976|117454|P1|COMPLETED|Overall Study|One participant completed < 11 SR-WBV sessions and was excluded from the statistical analysis|13
49750|NCT01704976|117453|P2|STARTED|Overall Study||13
49751|NCT01704976|117454|P1|STARTED|Overall Study||14
49752|NCT01704846|117470|P2|NOT COMPLETED|Treatment Period 4||0
49753|NCT01704846|117471|P1|NOT COMPLETED|Treatment Period 4||0
49754|NCT01704846|117470|P2|COMPLETED|Treatment Period 4||29
49755|NCT01704846|117471|P1|COMPLETED|Treatment Period 4||30
49756|NCT01704846|117470|P2|STARTED|Treatment Period 4||29
49757|NCT01704846|117471|P1|STARTED|Treatment Period 4||30
49758|NCT01704846|117470|P2|NOT COMPLETED|Treatment Period 3||0
49759|NCT01704846|117471|P1|NOT COMPLETED|Treatment Period 3||0
49760|NCT01704846|117470|P2|COMPLETED|Treatment Period 3||29
49761|NCT01704846|117471|P1|COMPLETED|Treatment Period 3||30
49762|NCT01704846|117470|P2|STARTED|Treatment Period 3||29
49763|NCT01704846|117471|P1|STARTED|Treatment Period 3||30
49764|NCT01704846|117470|P2|NOT COMPLETED|Treatment Period 2||1
49765|NCT01704846|117471|P1|NOT COMPLETED|Treatment Period 2||0
49766|NCT01704846|117470|P2|COMPLETED|Treatment Period 2||29
49767|NCT01704846|117471|P1|COMPLETED|Treatment Period 2||30
49768|NCT01704846|117470|P2|STARTED|Treatment Period 2||30
49769|NCT01704846|117471|P1|STARTED|Treatment Period 2||30
49770|NCT01704846|117470|P2|NOT COMPLETED|Treatment Period 1||0
49771|NCT01704846|117471|P1|NOT COMPLETED|Treatment Period 1||0
49772|NCT01704846|117470|P2|COMPLETED|Treatment Period 1||30
49773|NCT01704846|117471|P1|COMPLETED|Treatment Period 1||30
49774|NCT01704846|117470|P2|STARTED|Treatment Period 1||30
49775|NCT01704846|117471|P1|STARTED|Treatment Period 1||30
49776|NCT01704781|117494|P5|NOT COMPLETED|Overall Study||0
49777|NCT01704781|117495|P4|NOT COMPLETED|Overall Study||0
49778|NCT01704781|117496|P3|NOT COMPLETED|Overall Study||0
49779|NCT01704781|117497|P2|NOT COMPLETED|Overall Study||0
49780|NCT01704781|117498|P1|NOT COMPLETED|Overall Study||0
49781|NCT01704781|117494|P5|COMPLETED|Overall Study||12
49782|NCT01704781|117495|P4|COMPLETED|Overall Study||12
49783|NCT01704781|117496|P3|COMPLETED|Overall Study||6
49784|NCT01704781|117497|P2|COMPLETED|Overall Study||3
49785|NCT01704781|117498|P1|COMPLETED|Overall Study||3
49786|NCT01704781|117494|P5|STARTED|Overall Study||12
49787|NCT01704781|117495|P4|STARTED|Overall Study||12
49788|NCT01704781|117496|P3|STARTED|Overall Study||6
49789|NCT01704781|117497|P2|STARTED|Overall Study||3
49790|NCT01704781|117498|P1|STARTED|Overall Study||3
49791|NCT01704755|117526|P2|NOT COMPLETED|Overall Study||7
49792|NCT01704755|117527|P1|NOT COMPLETED|Overall Study||12
49793|NCT01704755|117526|P2|COMPLETED|Overall Study||165
49794|NCT01704755|117527|P1|COMPLETED|Overall Study||196
49795|NCT01704755|117526|P2|Completed Study Drug|Overall Study||163
49796|NCT01704755|117527|P1|Completed Study Drug|Overall Study||204
49797|NCT01704755|117526|P2|STARTED|Overall Study||172
49798|NCT01704755|117527|P1|STARTED|Overall Study||208
49799|NCT01704651|117541|P2|NOT COMPLETED|Overall Study||7
49800|NCT01704651|117542|P1|NOT COMPLETED|Overall Study||5
49801|NCT01704651|117541|P2|COMPLETED|Overall Study||68
49802|NCT01704651|117542|P1|COMPLETED|Overall Study||66
49803|NCT01704651|117541|P2|STARTED|Overall Study||75
49804|NCT01704651|117542|P1|STARTED|Overall Study||71
49805|NCT01704599|117550|P1|NOT COMPLETED|Overall Study||1
49806|NCT01704599|117550|P1|COMPLETED|Overall Study|11 screened 8 entered study 1 terminated.|7
49807|NCT01704599|117550|P1|STARTED|Overall Study|Study was started January 22, 2010|8
49808|NCT01704521|117579|P2|NOT COMPLETED|Overall Study||0
49809|NCT01704521|117580|P1|NOT COMPLETED|Overall Study||0
49810|NCT01704521|117579|P2|COMPLETED|Overall Study||2
49811|NCT01704521|117580|P1|COMPLETED|Overall Study||3
49812|NCT01704521|117579|P2|STARTED|Overall Study||2
49813|NCT01704521|117580|P1|STARTED|Overall Study||3
49814|NCT01704495|117590|P4|NOT COMPLETED|Optional Safety Extension||31
49815|NCT01704495|117591|P3|NOT COMPLETED|Optional Safety Extension||31
49816|NCT01704495|117592|P2|NOT COMPLETED|Optional Safety Extension||33
49817|NCT01704495|117593|P1|NOT COMPLETED|Optional Safety Extension||29
49818|NCT01704495|117590|P4|COMPLETED|Optional Safety Extension||85
49819|NCT01704495|117591|P3|COMPLETED|Optional Safety Extension||83
49820|NCT01704495|117592|P2|COMPLETED|Optional Safety Extension||88
49821|NCT01704495|117593|P1|COMPLETED|Optional Safety Extension||87
49822|NCT01704495|117590|P4|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
49823|NCT01704495|117591|P3|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|114
49824|NCT01704495|117592|P2|STARTED|Optional Safety Extension|35 subjects did not enter safety extension|121
49825|NCT01704495|117593|P1|STARTED|Optional Safety Extension|46 subjects did not enter safety extension|116
49826|NCT01704495|117590|P4|NOT COMPLETED|Subjects Randomized||17
49827|NCT01704495|117591|P3|NOT COMPLETED|Subjects Randomized||16
49828|NCT01704495|117592|P2|NOT COMPLETED|Subjects Randomized||15
49829|NCT01704495|117593|P1|NOT COMPLETED|Subjects Randomized||22
49830|NCT01704495|117590|P4|COMPLETED|Subjects Randomized||145
49831|NCT01704495|117591|P3|COMPLETED|Subjects Randomized||144
49832|NCT01704495|117592|P2|COMPLETED|Subjects Randomized||141
49833|NCT01704495|117593|P1|COMPLETED|Subjects Randomized||140
49834|NCT01704495|117590|P4|STARTED|Subjects Randomized||162
49835|NCT01704495|117591|P3|STARTED|Subjects Randomized||160
49836|NCT01704495|117592|P2|STARTED|Subjects Randomized||156
49837|NCT01704495|117593|P1|STARTED|Subjects Randomized||162
49838|NCT01704404|117767|P6|NOT COMPLETED|Overall Study||0
49839|NCT01704404|117768|P5|NOT COMPLETED|Overall Study||1
49840|NCT01704404|117769|P4|NOT COMPLETED|Overall Study||3
49841|NCT01704404|117770|P3|NOT COMPLETED|Overall Study||1
49842|NCT01704404|117771|P2|NOT COMPLETED|Overall Study||1
49843|NCT01704404|117772|P1|NOT COMPLETED|Overall Study||1
49844|NCT01704404|117767|P6|COMPLETED|Overall Study||9
49845|NCT01704404|117768|P5|COMPLETED|Overall Study||10
49846|NCT01704404|117769|P4|COMPLETED|Overall Study||8
49847|NCT01704404|117770|P3|COMPLETED|Overall Study||9
49848|NCT01704404|117771|P2|COMPLETED|Overall Study||9
49849|NCT01704404|117772|P1|COMPLETED|Overall Study||10
49850|NCT01704404|117767|P6|STARTED|Overall Study||9
49851|NCT01704404|117768|P5|STARTED|Overall Study||11
49852|NCT01704404|117769|P4|STARTED|Overall Study||11
49853|NCT01704404|117770|P3|STARTED|Overall Study||10
49854|NCT01704404|117771|P2|STARTED|Overall Study||10
49855|NCT01704404|117772|P1|STARTED|Overall Study||11
49856|NCT01704287|117809|P5|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||45
49857|NCT01704287|117810|P4|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||53
49858|NCT01704287|117811|P3|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
49859|NCT01704287|117812|P2|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
49860|NCT01704287|117813|P1|NOT COMPLETED|Switch to Pembrolizumab Treatment Period||0
49861|NCT01704287|117809|P5|COMPLETED|Switch to Pembrolizumab Treatment Period||0
49862|NCT01704287|117810|P4|COMPLETED|Switch to Pembrolizumab Treatment Period||0
49863|NCT01704287|117811|P3|COMPLETED|Switch to Pembrolizumab Treatment Period||0
49864|NCT01704287|117812|P2|COMPLETED|Switch to Pembrolizumab Treatment Period||0
49865|NCT01704287|117813|P1|COMPLETED|Switch to Pembrolizumab Treatment Period||0
49866|NCT01704287|117809|P5|STARTED|Switch to Pembrolizumab Treatment Period||45
49867|NCT01704287|117810|P4|STARTED|Switch to Pembrolizumab Treatment Period||53
49868|NCT01704287|117811|P3|STARTED|Switch to Pembrolizumab Treatment Period||0
49869|NCT01704287|117812|P2|STARTED|Switch to Pembrolizumab Treatment Period||0
49870|NCT01704287|117813|P1|STARTED|Switch to Pembrolizumab Treatment Period||0
49871|NCT01704287|117809|P5|NOT COMPLETED|Initial Treatment Period||0
49872|NCT01704287|117810|P4|NOT COMPLETED|Initial Treatment Period||0
49873|NCT01704287|117811|P3|NOT COMPLETED|Initial Treatment Period||179
49874|NCT01704287|117812|P2|NOT COMPLETED|Initial Treatment Period||181
49875|NCT01704287|117813|P1|NOT COMPLETED|Initial Treatment Period||180
49876|NCT01704287|117809|P5|COMPLETED|Initial Treatment Period||0
49877|NCT01704287|117810|P4|COMPLETED|Initial Treatment Period||0
49878|NCT01704287|117811|P3|COMPLETED|Initial Treatment Period||0
49879|NCT01704287|117812|P2|COMPLETED|Initial Treatment Period||0
49880|NCT01704287|117813|P1|COMPLETED|Initial Treatment Period||0
49881|NCT01704287|117809|P5|Treated|Initial Treatment Period||0
49882|NCT01704287|117810|P4|Treated|Initial Treatment Period||0
49883|NCT01704287|117811|P3|Treated|Initial Treatment Period||171
49884|NCT01704287|117812|P2|Treated|Initial Treatment Period||179
49885|NCT01704287|117813|P1|Treated|Initial Treatment Period||178
49886|NCT01704287|117809|P5|STARTED|Initial Treatment Period||0
49887|NCT01704287|117810|P4|STARTED|Initial Treatment Period||0
49888|NCT01704287|117811|P3|STARTED|Initial Treatment Period||179
49889|NCT01704287|117812|P2|STARTED|Initial Treatment Period||181
49890|NCT01704287|117813|P1|STARTED|Initial Treatment Period||180
49891|NCT01704261|117848|P2|NOT COMPLETED|Overall Study||15
49892|NCT01704261|117849|P1|NOT COMPLETED|Overall Study||13
49893|NCT01704261|117848|P2|COMPLETED|Overall Study||138
49894|NCT01704261|117849|P1|COMPLETED|Overall Study||141
49895|NCT01704261|117848|P2|STARTED|Overall Study||153
49896|NCT01704261|117849|P1|STARTED|Overall Study||154
49897|NCT01704196|117865|P2|NOT COMPLETED|Overall Study||24
49898|NCT01704196|117866|P1|NOT COMPLETED|Overall Study||19
49899|NCT01704196|117865|P2|COMPLETED|Overall Study||65
49900|NCT01704196|117866|P1|COMPLETED|Overall Study||71
49901|NCT01704196|117865|P2|STARTED|Overall Study||89
49902|NCT01704196|117866|P1|STARTED|Overall Study||90
49903|NCT01704079|117876|P2|NOT COMPLETED|Overall Study||23
49904|NCT01704079|117877|P1|NOT COMPLETED|Overall Study||14
49905|NCT01704079|117876|P2|COMPLETED|Overall Study||121
49906|NCT01704079|117877|P1|COMPLETED|Overall Study||58
49907|NCT01704079|117876|P2|Entered Extension Study|Overall Study||102
49908|NCT01704079|117877|P1|Entered Extension Study|Overall Study||53
49909|NCT01704079|117876|P2|STARTED|Overall Study||144
49910|NCT01704079|117877|P1|STARTED|Overall Study||72
49911|NCT01703988|117893|P4|NOT COMPLETED|Overall Study||1
49912|NCT01703988|117894|P3|NOT COMPLETED|Overall Study||0
49913|NCT01703988|117895|P2|NOT COMPLETED|Overall Study||0
49914|NCT01703988|117896|P1|NOT COMPLETED|Overall Study||0
49915|NCT01703988|117893|P4|COMPLETED|Overall Study||8
49916|NCT01703988|117894|P3|COMPLETED|Overall Study||9
49917|NCT01703988|117895|P2|COMPLETED|Overall Study||8
49918|NCT01703988|117896|P1|COMPLETED|Overall Study||8
49919|NCT01703988|117893|P4|STARTED|Overall Study||9
49920|NCT01703988|117894|P3|STARTED|Overall Study||9
49921|NCT01703988|117895|P2|STARTED|Overall Study||8
49922|NCT01703988|117896|P1|STARTED|Overall Study||8
49923|NCT01703858|117926|P3|NOT COMPLETED|Overall Study||0
49924|NCT01703858|117927|P2|NOT COMPLETED|Overall Study||1
49925|NCT01703858|117928|P1|NOT COMPLETED|Overall Study||0
49926|NCT01703858|117926|P3|COMPLETED|Overall Study||5
49927|NCT01703858|117927|P2|COMPLETED|Overall Study||4
49928|NCT01703858|117928|P1|COMPLETED|Overall Study||5
49929|NCT01703858|117926|P3|STARTED|Overall Study||5
49930|NCT01703858|117927|P2|STARTED|Overall Study||5
49931|NCT01703858|117928|P1|STARTED|Overall Study||5
49932|NCT01703845|117953|P2|NOT COMPLETED|Overall Study||0
49933|NCT01703845|117954|P1|NOT COMPLETED|Overall Study||3
49934|NCT01703845|117953|P2|COMPLETED|Overall Study||16
49935|NCT01703845|117954|P1|COMPLETED|Overall Study||13
49936|NCT01703845|117953|P2|STARTED|Overall Study|started are actually the randomized|16
49937|NCT01703845|117954|P1|STARTED|Overall Study|started are actually the randomized|16
49938|NCT01703832|117991|P2|NOT COMPLETED|Overall Study||0
49939|NCT01703832|117992|P1|NOT COMPLETED|Overall Study||1
49940|NCT01703832|117991|P2|COMPLETED|Overall Study||32
49941|NCT01703832|117992|P1|COMPLETED|Overall Study||32
49942|NCT01703832|117991|P2|STARTED|Overall Study||32
49943|NCT01703832|117992|P1|STARTED|Overall Study||33
49944|NCT01703819|118024|P2|NOT COMPLETED|Overall Study||2
49945|NCT01703819|118025|P1|NOT COMPLETED|Overall Study||0
49946|NCT01703819|118024|P2|COMPLETED|Overall Study||30
49947|NCT01703819|118025|P1|COMPLETED|Overall Study||34
49948|NCT01703819|118024|P2|STARTED|Overall Study||32
49949|NCT01703819|118025|P1|STARTED|Overall Study||34
49950|NCT01703702|118057|P2|NOT COMPLETED|Overall Study||22
49951|NCT01703702|118058|P1|NOT COMPLETED|Overall Study||36
49952|NCT01703702|118057|P2|COMPLETED|Overall Study||288
49953|NCT01703702|118058|P1|COMPLETED|Overall Study||272
49954|NCT01703702|118057|P2|STARTED|Overall Study||310
49955|NCT01703702|118058|P1|STARTED|Overall Study||308
49956|NCT01703663|118075|P2|NOT COMPLETED|Second Treatment Period||0
49957|NCT01703663|118076|P1|NOT COMPLETED|Second Treatment Period||0
49958|NCT01703663|118075|P2|COMPLETED|Second Treatment Period||8
49959|NCT01703663|118076|P1|COMPLETED|Second Treatment Period||11
49960|NCT01703663|118075|P2|STARTED|Second Treatment Period||8
49961|NCT01703663|118076|P1|STARTED|Second Treatment Period||11
49962|NCT01703663|118075|P2|NOT COMPLETED|First Treatment Period||0
49963|NCT01703663|118076|P1|NOT COMPLETED|First Treatment Period||0
49964|NCT01703663|118075|P2|COMPLETED|First Treatment Period||20
49965|NCT01703663|118076|P1|COMPLETED|First Treatment Period||20
49966|NCT01703663|118075|P2|STARTED|First Treatment Period||20
49967|NCT01703663|118076|P1|STARTED|First Treatment Period||20
49968|NCT01703286|118082|P6|NOT COMPLETED|Period 3 Including Washout||0
49969|NCT01703286|118083|P5|NOT COMPLETED|Period 3 Including Washout||0
49970|NCT01703286|118084|P4|NOT COMPLETED|Period 3 Including Washout||0
49971|NCT01703286|118085|P3|NOT COMPLETED|Period 3 Including Washout||0
49972|NCT01703286|118086|P2|NOT COMPLETED|Period 3 Including Washout||0
49973|NCT01703286|118087|P1|NOT COMPLETED|Period 3 Including Washout||0
49974|NCT01703286|118082|P6|COMPLETED|Period 3 Including Washout||6
49975|NCT01703286|118083|P5|COMPLETED|Period 3 Including Washout||7
49976|NCT01703286|118084|P4|COMPLETED|Period 3 Including Washout||5
49977|NCT01703286|118085|P3|COMPLETED|Period 3 Including Washout||7
49978|NCT01703286|118086|P2|COMPLETED|Period 3 Including Washout||7
49979|NCT01703286|118087|P1|COMPLETED|Period 3 Including Washout||7
49980|NCT01703286|118082|P6|STARTED|Period 3 Including Washout||6
49981|NCT01703286|118083|P5|STARTED|Period 3 Including Washout||7
49982|NCT01703286|118084|P4|STARTED|Period 3 Including Washout||5
49983|NCT01703286|118085|P3|STARTED|Period 3 Including Washout||7
49984|NCT01703286|118086|P2|STARTED|Period 3 Including Washout||7
49985|NCT01703286|118087|P1|STARTED|Period 3 Including Washout||7
49986|NCT01703286|118082|P6|NOT COMPLETED|Period 2 Including Washout||0
49987|NCT01703286|118083|P5|NOT COMPLETED|Period 2 Including Washout||0
49988|NCT01703286|118084|P4|NOT COMPLETED|Period 2 Including Washout||1
49989|NCT01703286|118085|P3|NOT COMPLETED|Period 2 Including Washout||0
49990|NCT01703286|118086|P2|NOT COMPLETED|Period 2 Including Washout||0
49991|NCT01703286|118087|P1|NOT COMPLETED|Period 2 Including Washout||0
49992|NCT01703286|118082|P6|COMPLETED|Period 2 Including Washout||6
49993|NCT01703286|118083|P5|COMPLETED|Period 2 Including Washout||7
49994|NCT01703286|118084|P4|COMPLETED|Period 2 Including Washout||5
49995|NCT01703286|118085|P3|COMPLETED|Period 2 Including Washout||7
49996|NCT01703286|118086|P2|COMPLETED|Period 2 Including Washout||7
49997|NCT01703286|118087|P1|COMPLETED|Period 2 Including Washout||7
49998|NCT01703286|118082|P6|STARTED|Period 2 Including Washout||6
49999|NCT01703286|118083|P5|STARTED|Period 2 Including Washout||7
50000|NCT01703286|118084|P4|STARTED|Period 2 Including Washout||6
50001|NCT01703286|118085|P3|STARTED|Period 2 Including Washout||7
50002|NCT01703286|118086|P2|STARTED|Period 2 Including Washout||7
50003|NCT01703286|118087|P1|STARTED|Period 2 Including Washout||7
50004|NCT01703286|118082|P6|NOT COMPLETED|Period 1 Including Washout||1
50005|NCT01703286|118083|P5|NOT COMPLETED|Period 1 Including Washout||0
50006|NCT01703286|118084|P4|NOT COMPLETED|Period 1 Including Washout||1
50007|NCT01703286|118085|P3|NOT COMPLETED|Period 1 Including Washout||0
50008|NCT01703286|118086|P2|NOT COMPLETED|Period 1 Including Washout||0
50009|NCT01703286|118087|P1|NOT COMPLETED|Period 1 Including Washout||0
50010|NCT01703286|118082|P6|COMPLETED|Period 1 Including Washout||6
50011|NCT01703286|118083|P5|COMPLETED|Period 1 Including Washout||7
50012|NCT01703286|118084|P4|COMPLETED|Period 1 Including Washout||6
50013|NCT01703286|118085|P3|COMPLETED|Period 1 Including Washout||7
50014|NCT01703286|118086|P2|COMPLETED|Period 1 Including Washout||7
50015|NCT01703286|118087|P1|COMPLETED|Period 1 Including Washout||7
50016|NCT01703286|118082|P6|STARTED|Period 1 Including Washout||7
50017|NCT01703286|118083|P5|STARTED|Period 1 Including Washout||7
50018|NCT01703286|118084|P4|STARTED|Period 1 Including Washout||7
50019|NCT01703286|118085|P3|STARTED|Period 1 Including Washout||7
50020|NCT01703286|118086|P2|STARTED|Period 1 Including Washout||7
50021|NCT01703286|118087|P1|STARTED|Period 1 Including Washout||7
50022|NCT01703260|118110|P3|NOT COMPLETED|Overall Study||3
50023|NCT01703260|118111|P2|NOT COMPLETED|Overall Study||4
50024|NCT01703260|118112|P1|NOT COMPLETED|Overall Study||3
50025|NCT01703260|118110|P3|COMPLETED|Overall Study||3
50026|NCT01703260|118111|P2|COMPLETED|Overall Study||3
50027|NCT01703260|118112|P1|COMPLETED|Overall Study||4
50028|NCT01703260|118110|P3|STARTED|Overall Study||6
50029|NCT01703260|118111|P2|STARTED|Overall Study||7
50030|NCT01703260|118112|P1|STARTED|Overall Study||7
50031|NCT01703221|118138|P3|NOT COMPLETED|Phase B - (Week 25 to 52)||5
50032|NCT01703221|118139|P2|NOT COMPLETED|Phase B - (Week 25 to 52)||14
50033|NCT01703221|118140|P1|NOT COMPLETED|Phase B - (Week 25 to 52)||16
50034|NCT01703221|118138|P3|COMPLETED|Phase B - (Week 25 to 52)||75
50035|NCT01703221|118139|P2|COMPLETED|Phase B - (Week 25 to 52)||147
50036|NCT01703221|118140|P1|COMPLETED|Phase B - (Week 25 to 52)||143
50037|NCT01703221|118138|P3|STARTED|Phase B - (Week 25 to 52)||80
50038|NCT01703221|118139|P2|STARTED|Phase B - (Week 25 to 52)||161
50039|NCT01703221|118140|P1|STARTED|Phase B - (Week 25 to 52)||159
50040|NCT01703221|118138|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
50041|NCT01703221|118139|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||4
50042|NCT01703221|118140|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||7
50043|NCT01703221|118138|P3|COMPLETED|Phase A (Up to 24 Weeks)||80
50044|NCT01703221|118139|P2|COMPLETED|Phase A (Up to 24 Weeks)||161
50045|NCT01703221|118140|P1|COMPLETED|Phase A (Up to 24 Weeks)||159
50046|NCT01703221|118138|P3|STARTED|Phase A (Up to 24 Weeks)||83
50047|NCT01703221|118139|P2|STARTED|Phase A (Up to 24 Weeks)||165
50048|NCT01703221|118140|P1|STARTED|Phase A (Up to 24 Weeks)||166
50049|NCT01703091|118171|P2|NOT COMPLETED|Overall Study||4
50050|NCT01703091|118172|P1|NOT COMPLETED|Overall Study||9
50051|NCT01703091|118171|P2|COMPLETED|Overall Study||95
50052|NCT01703091|118172|P1|COMPLETED|Overall Study||89
50053|NCT01703091|118171|P2|Received at Least One Dose of Study Drug|Overall Study||98
50054|NCT01703091|118172|P1|Received at Least One Dose of Study Drug|Overall Study||94
50055|NCT01703091|118171|P2|STARTED|Overall Study||99
50056|NCT01703091|118172|P1|STARTED|Overall Study||98
50057|NCT01703000|118188|P1|NOT COMPLETED|Overall Study||1
50058|NCT01703000|118188|P1|COMPLETED|Overall Study||99
50059|NCT01703000|118188|P1|STARTED|Overall Study||100
50060|NCT01702987|118221|P2|NOT COMPLETED|Overall Study||0
50061|NCT01702987|118222|P1|NOT COMPLETED|Overall Study||1
50062|NCT01702987|118221|P2|COMPLETED|Overall Study||12
50063|NCT01702987|118222|P1|COMPLETED|Overall Study||9
50064|NCT01702987|118221|P2|STARTED|Overall Study||12
50065|NCT01702987|118222|P1|STARTED|Overall Study||10
50066|NCT01702961|118228|P1|NOT COMPLETED|Overall Study||47
50067|NCT01702961|118228|P1|COMPLETED|Overall Study||28
50068|NCT01702961|118228|P1|STARTED|Overall Study||75
50069|NCT01702532|118236|P2|NOT COMPLETED|Overall Study||1
50070|NCT01702532|118237|P1|NOT COMPLETED|Overall Study||0
50071|NCT01702532|118236|P2|COMPLETED|Overall Study||160
50072|NCT01702532|118237|P1|COMPLETED|Overall Study||161
50073|NCT01702532|118236|P2|Safety Population|Overall Study|One subject randomized but did not receive the study treatment.|160
50074|NCT01702532|118237|P1|Safety Population|Overall Study||161
50075|NCT01702532|118236|P2|STARTED|Overall Study||161
50076|NCT01702532|118237|P1|STARTED|Overall Study||161
50077|NCT01702519|118247|P2|NOT COMPLETED|Period 2||0
50078|NCT01702519|118248|P1|NOT COMPLETED|Period 2||0
50079|NCT01702519|118247|P2|COMPLETED|Period 2||18
50080|NCT01702519|118248|P1|COMPLETED|Period 2||19
50081|NCT01702519|118247|P2|STARTED|Period 2||18
50082|NCT01702519|118248|P1|STARTED|Period 2||19
50083|NCT01702519|118247|P2|NOT COMPLETED|Washout Period||2
50084|NCT01702519|118248|P1|NOT COMPLETED|Washout Period||1
50085|NCT01702519|118247|P2|COMPLETED|Washout Period||18
50086|NCT01702519|118248|P1|COMPLETED|Washout Period||19
50087|NCT01702519|118247|P2|STARTED|Washout Period||20
50088|NCT01702519|118248|P1|STARTED|Washout Period||20
50089|NCT01702519|118247|P2|NOT COMPLETED|Period 1||0
50090|NCT01702519|118248|P1|NOT COMPLETED|Period 1||0
50091|NCT01702519|118247|P2|COMPLETED|Period 1||20
50092|NCT01702519|118248|P1|COMPLETED|Period 1||20
50093|NCT01702519|118247|P2|STARTED|Period 1||20
50094|NCT01702519|118248|P1|STARTED|Period 1||20
50095|NCT01702454|118266|P2|NOT COMPLETED|Overall Study||8
50096|NCT01702454|118267|P1|NOT COMPLETED|Overall Study||3
50097|NCT01702454|118266|P2|COMPLETED|Overall Study||221
50098|NCT01702454|118267|P1|COMPLETED|Overall Study||238
50099|NCT01702454|118266|P2|STARTED|Overall Study||229
50100|NCT01702454|118267|P1|STARTED|Overall Study||241
50101|NCT01702363|118345|P1|NOT COMPLETED|Overall Study||20
50102|NCT01702363|118345|P1|COMPLETED|Overall Study||111
50103|NCT01702363|118345|P1|STARTED|Overall Study||131
50104|NCT01702311|118362|P2|NOT COMPLETED|Overall Study||13
50105|NCT01702311|118363|P1|NOT COMPLETED|Overall Study||16
50106|NCT01702311|118362|P2|COMPLETED|Overall Study||100
50107|NCT01702311|118363|P1|COMPLETED|Overall Study||106
50108|NCT01702311|118362|P2|STARTED|Overall Study||113
50109|NCT01702311|118363|P1|STARTED|Overall Study||122
50110|NCT01702298|118369|P1|NOT COMPLETED|Overall Study||1
50111|NCT01702298|118369|P1|COMPLETED|Overall Study||41
50112|NCT01702298|118369|P1|STARTED|Overall Study||42
50113|NCT01702259|118382|P2|NOT COMPLETED|Overall Study||0
50114|NCT01702259|118383|P1|NOT COMPLETED|Overall Study||0
50115|NCT01702259|118382|P2|COMPLETED|Overall Study||34
50116|NCT01702259|118383|P1|COMPLETED|Overall Study||34
50117|NCT01702259|118382|P2|STARTED|Overall Study||34
50118|NCT01702259|118383|P1|STARTED|Overall Study||34
50119|NCT01702246|118397|P1|NOT COMPLETED|Overall Study||5
50120|NCT01702246|118397|P1|COMPLETED|Overall Study||19
50121|NCT01702246|118397|P1|STARTED|Overall Study||24
50122|NCT01702233|118409|P3|NOT COMPLETED|Overall Study||5
50123|NCT01702233|118410|P2|NOT COMPLETED|Overall Study||3
50124|NCT01702233|118411|P1|NOT COMPLETED|Overall Study||6
50125|NCT01702233|118409|P3|COMPLETED|Overall Study||31
50126|NCT01702233|118410|P2|COMPLETED|Overall Study|One of these Patient completed the Trial but had no valid outcome measure after enrolment|64
50127|NCT01702233|118411|P1|COMPLETED|Overall Study||66
50128|NCT01702233|118409|P3|Per Protocol Set|Overall Study||27
50129|NCT01702233|118410|P2|Per Protocol Set|Overall Study||58
50130|NCT01702233|118411|P1|Per Protocol Set|Overall Study||58
50131|NCT01702233|118409|P3|Full Analysis Set (ITT)|Overall Study||31
50132|NCT01702233|118410|P2|Full Analysis Set (ITT)|Overall Study||63
50133|NCT01702233|118411|P1|Full Analysis Set (ITT)|Overall Study||66
50134|NCT01702233|118409|P3|STARTED|Overall Study||36
50135|NCT01702233|118410|P2|STARTED|Overall Study||67
50136|NCT01702233|118411|P1|STARTED|Overall Study||72
50137|NCT01702025|118451|P4|NOT COMPLETED|Overall Study||0
50138|NCT01702025|118452|P3|NOT COMPLETED|Overall Study||1
50139|NCT01702025|118453|P2|NOT COMPLETED|Overall Study||1
50140|NCT01702025|118454|P1|NOT COMPLETED|Overall Study||2
50141|NCT01702025|118451|P4|COMPLETED|Overall Study||10
50142|NCT01702025|118452|P3|COMPLETED|Overall Study||9
50143|NCT01702025|118453|P2|COMPLETED|Overall Study||9
50144|NCT01702025|118454|P1|COMPLETED|Overall Study||9
50145|NCT01702025|118451|P4|STARTED|Overall Study||10
50146|NCT01702025|118452|P3|STARTED|Overall Study||10
50147|NCT01702025|118453|P2|STARTED|Overall Study||10
50148|NCT01702025|118454|P1|STARTED|Overall Study||11
50149|NCT01701999|118470|P2|NOT COMPLETED|Overall Study||0
50150|NCT01701999|118471|P1|NOT COMPLETED|Overall Study||0
50151|NCT01701999|118470|P2|COMPLETED|Overall Study||37
50152|NCT01701999|118471|P1|COMPLETED|Overall Study||8
50153|NCT01701999|118470|P2|STARTED|Overall Study||37
50154|NCT01701999|118471|P1|STARTED|Overall Study||8
50155|NCT01701674|118483|P1|NOT COMPLETED|Overall Study||1
50156|NCT01701674|118483|P1|COMPLETED|Overall Study||12
50157|NCT01701674|118483|P1|STARTED|Overall Study||13
50158|NCT01701622|118488|P1|NOT COMPLETED|Overall Study||0
50159|NCT01701622|118488|P1|COMPLETED|Overall Study||1
50160|NCT01701622|118488|P1|STARTED|Overall Study||1
50161|NCT01701505|118499|P6|NOT COMPLETED|Overall Study||0
50162|NCT01701505|118500|P5|NOT COMPLETED|Overall Study||0
50163|NCT01701505|118501|P4|NOT COMPLETED|Overall Study||0
50164|NCT01701505|118502|P3|NOT COMPLETED|Overall Study||0
50165|NCT01701505|118503|P2|NOT COMPLETED|Overall Study||0
50166|NCT01701505|118504|P1|NOT COMPLETED|Overall Study||0
50167|NCT01701505|118499|P6|COMPLETED|Overall Study||8
50168|NCT01701505|118500|P5|COMPLETED|Overall Study||8
50169|NCT01701505|118501|P4|COMPLETED|Overall Study||8
50170|NCT01701505|118502|P3|COMPLETED|Overall Study||8
50171|NCT01701505|118503|P2|COMPLETED|Overall Study||8
50172|NCT01701505|118504|P1|COMPLETED|Overall Study||8
50173|NCT01701505|118499|P6|STARTED|Overall Study||8
50174|NCT01701505|118500|P5|STARTED|Overall Study||8
50175|NCT01701505|118501|P4|STARTED|Overall Study||8
50176|NCT01701505|118502|P3|STARTED|Overall Study||8
50177|NCT01701505|118503|P2|STARTED|Overall Study||8
50178|NCT01701505|118504|P1|STARTED|Overall Study||8
50179|NCT01701414|118556|P2|NOT COMPLETED|Overall Study||1
50180|NCT01701414|118557|P1|NOT COMPLETED|Overall Study||1
50181|NCT01701414|118556|P2|COMPLETED|Overall Study||18
50182|NCT01701414|118557|P1|COMPLETED|Overall Study||18
50183|NCT01701414|118556|P2|STARTED|Overall Study||19
50184|NCT01701414|118557|P1|STARTED|Overall Study||19
50185|NCT01701401|118567|P4|NOT COMPLETED|Overall Study||6
50186|NCT01701401|118568|P3|NOT COMPLETED|Overall Study||5
50187|NCT01701401|118569|P2|NOT COMPLETED|Overall Study||9
50188|NCT01701401|118570|P1|NOT COMPLETED|Overall Study||10
50189|NCT01701401|118567|P4|COMPLETED|Overall Study||212
50190|NCT01701401|118568|P3|COMPLETED|Overall Study||212
50191|NCT01701401|118569|P2|COMPLETED|Overall Study||209
50192|NCT01701401|118570|P1|COMPLETED|Overall Study||207
50193|NCT01701401|118567|P4|STARTED|Overall Study||218
50194|NCT01701401|118568|P3|STARTED|Overall Study||217
50195|NCT01701401|118569|P2|STARTED|Overall Study||218
50196|NCT01701401|118570|P1|STARTED|Overall Study||217
50197|NCT01701375|118616|P1|NOT COMPLETED|Overall Study||0
50198|NCT01701375|118616|P1|COMPLETED|Overall Study||2
50199|NCT01701375|118616|P1|STARTED|Overall Study||2
50200|NCT01701362|118622|P2|NOT COMPLETED|Overall Study||56
50201|NCT01701362|118623|P1|NOT COMPLETED|Overall Study||42
50202|NCT01701362|118622|P2|COMPLETED|Overall Study||211
50203|NCT01701362|118623|P1|COMPLETED|Overall Study||233
50204|NCT01701362|118622|P2|TREATED|Overall Study||265
50205|NCT01701362|118623|P1|TREATED|Overall Study||274
50206|NCT01701362|118622|P2|STARTED|Overall Study||267
50207|NCT01701362|118623|P1|STARTED|Overall Study||275
50208|NCT01701271|118651|P1|NOT COMPLETED|Overall Study||0
50209|NCT01701271|118651|P1|COMPLETED|Overall Study||20
50210|NCT01701271|118651|P1|STARTED|Overall Study||20
50211|NCT01701245|118659|P2|NOT COMPLETED|Overall Study||15
50212|NCT01701245|118660|P1|NOT COMPLETED|Overall Study||12
50213|NCT01701245|118659|P2|COMPLETED|Overall Study||33
50214|NCT01701245|118660|P1|COMPLETED|Overall Study||37
50215|NCT01701245|118659|P2|FAS Matched Data|Overall Study||32
50216|NCT01701245|118660|P1|FAS Matched Data|Overall Study||42
50217|NCT01701245|118659|P2|FAS Unmatched Data|Overall Study|3 patients protocol violation|45
50218|NCT01701245|118660|P1|FAS Unmatched Data|Overall Study|1 patient protocol violation|48
50219|NCT01701245|118659|P2|STARTED|Overall Study||48
50220|NCT01701245|118660|P1|STARTED|Overall Study||49
50221|NCT01701102|118676|P4|NOT COMPLETED|Overall Study||0
50222|NCT01701102|118677|P3|NOT COMPLETED|Overall Study||0
50223|NCT01701102|118678|P2|NOT COMPLETED|Overall Study||0
50224|NCT01701102|118679|P1|NOT COMPLETED|Overall Study||0
50225|NCT01701102|118676|P4|COMPLETED|Overall Study||18
50226|NCT01701102|118677|P3|COMPLETED|Overall Study||10
50227|NCT01701102|118678|P2|COMPLETED|Overall Study||6
50228|NCT01701102|118679|P1|COMPLETED|Overall Study||22
50229|NCT01701102|118676|P4|STARTED|Overall Study||18
50230|NCT01701102|118677|P3|STARTED|Overall Study||10
50231|NCT01701102|118678|P2|STARTED|Overall Study||6
50232|NCT01701102|118679|P1|STARTED|Overall Study||22
50233|NCT01701063|118692|P3|NOT COMPLETED|Overall Study||2
50234|NCT01701063|118693|P2|NOT COMPLETED|Overall Study||1
50235|NCT01701063|118694|P1|NOT COMPLETED|Overall Study||0
50236|NCT01701063|118692|P3|COMPLETED|Overall Study||8
50237|NCT01701063|118693|P2|COMPLETED|Overall Study||18
50238|NCT01701063|118694|P1|COMPLETED|Overall Study||13
50239|NCT01701063|118692|P3|STARTED|Overall Study||10
50240|NCT01701063|118693|P2|STARTED|Overall Study||19
50241|NCT01701063|118694|P1|STARTED|Overall Study||13
50242|NCT01701037|118736|P1|NOT COMPLETED|Overall Study||0
50243|NCT01701037|118736|P1|COMPLETED|Overall Study||13
50244|NCT01701037|118736|P1|STARTED|Overall Study||13
50245|NCT01701024|118747|P2|NOT COMPLETED|Overall Study||9
50246|NCT01701024|118748|P1|NOT COMPLETED|Overall Study||10
50247|NCT01701024|118747|P2|COMPLETED|Overall Study||236
50248|NCT01701024|118748|P1|COMPLETED|Overall Study||243
50249|NCT01701024|118747|P2|STARTED|Overall Study||245
50250|NCT01701024|118748|P1|STARTED|Overall Study||253
50251|NCT01701011|118763|P3|NOT COMPLETED|Overall Study||34
50252|NCT01701011|118764|P2|NOT COMPLETED|Overall Study||24
50253|NCT01701011|118765|P1|NOT COMPLETED|Overall Study||35
50254|NCT01701011|118763|P3|COMPLETED|Overall Study||90
50255|NCT01701011|118764|P2|COMPLETED|Overall Study||102
50256|NCT01701011|118765|P1|COMPLETED|Overall Study||92
50257|NCT01701011|118763|P3|STARTED|Overall Study||124
50258|NCT01701011|118764|P2|STARTED|Overall Study||126
50259|NCT01701011|118765|P1|STARTED|Overall Study||127
50260|NCT01700907|118778|P2|NOT COMPLETED|Overall Study||0
50261|NCT01700907|118779|P1|NOT COMPLETED|Overall Study||0
50262|NCT01700907|118778|P2|COMPLETED|Overall Study||10
50263|NCT01700907|118779|P1|COMPLETED|Overall Study||10
50264|NCT01700907|118778|P2|STARTED|Overall Study||10
50265|NCT01700907|118779|P1|STARTED|Overall Study||10
50266|NCT01700816|118795|P2|NOT COMPLETED|Overall Study||0
50267|NCT01700816|118796|P1|NOT COMPLETED|Overall Study||0
50268|NCT01700816|118795|P2|COMPLETED|Overall Study||19
50269|NCT01700816|118796|P1|COMPLETED|Overall Study||21
50270|NCT01700816|118795|P2|STARTED|Overall Study||19
50271|NCT01700816|118796|P1|STARTED|Overall Study||21
50272|NCT01699698|118824|P2|NOT COMPLETED|Overall Study||5
50273|NCT01699698|118825|P1|NOT COMPLETED|Overall Study||2
50274|NCT01699698|118824|P2|COMPLETED|Overall Study||56
50275|NCT01699698|118825|P1|COMPLETED|Overall Study||42
50276|NCT01699698|118824|P2|STARTED|Overall Study||61
50277|NCT01699698|118825|P1|STARTED|Overall Study||44
50278|NCT01700530|118836|P3|NOT COMPLETED|Overall Study||1
50279|NCT01700530|118837|P2|NOT COMPLETED|Overall Study||3
50280|NCT01700530|118838|P1|NOT COMPLETED|Overall Study||0
50281|NCT01700530|118836|P3|COMPLETED|Overall Study||19
50282|NCT01700530|118837|P2|COMPLETED|Overall Study||18
50283|NCT01700530|118838|P1|COMPLETED|Overall Study||9
50284|NCT01700530|118836|P3|STARTED|Overall Study||20
50285|NCT01700530|118837|P2|STARTED|Overall Study||21
50286|NCT01700530|118838|P1|STARTED|Overall Study||9
50287|NCT01700517|118852|P3|NOT COMPLETED|Overall Study||0
50288|NCT01700517|118853|P2|NOT COMPLETED|Overall Study||0
50289|NCT01700517|118854|P1|NOT COMPLETED|Overall Study||0
50290|NCT01700517|118852|P3|COMPLETED|Overall Study||40
50291|NCT01700517|118853|P2|COMPLETED|Overall Study||40
50292|NCT01700517|118854|P1|COMPLETED|Overall Study||40
50293|NCT01700517|118852|P3|STARTED|Overall Study||40
50294|NCT01700517|118853|P2|STARTED|Overall Study||40
50295|NCT01700517|118854|P1|STARTED|Overall Study||40
50296|NCT01700387|118864|P2|NOT COMPLETED|Overall Study||4
50297|NCT01700387|118865|P1|NOT COMPLETED|Overall Study||4
50298|NCT01700387|118864|P2|COMPLETED|Overall Study||6
50299|NCT01700387|118865|P1|COMPLETED|Overall Study||6
50300|NCT01700387|118864|P2|STARTED|Overall Study||10
50301|NCT01700387|118865|P1|STARTED|Overall Study||10
50302|NCT01700348|118875|P1|NOT COMPLETED|Overall Study||23
50303|NCT01700348|118875|P1|COMPLETED|Overall Study||93
50304|NCT01700348|118875|P1|STARTED|Overall Study||116
50305|NCT01700335|118879|P2|NOT COMPLETED|Overall Study||4
50306|NCT01700335|118880|P1|NOT COMPLETED|Overall Study||1
50307|NCT01700335|118879|P2|COMPLETED|Overall Study||2
50308|NCT01700335|118880|P1|COMPLETED|Overall Study||2
50309|NCT01700335|118879|P2|STARTED|Overall Study||6
50310|NCT01700335|118880|P1|STARTED|Overall Study||3
50311|NCT01700192|118893|P2|NOT COMPLETED|Overall Study||128
50312|NCT01700192|118894|P1|NOT COMPLETED|Overall Study||180
50313|NCT01700192|118893|P2|COMPLETED|Overall Study||613
50314|NCT01700192|118894|P1|COMPLETED|Overall Study||561
50315|NCT01700192|118893|P2|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|738
50316|NCT01700192|118894|P1|All Participants as Treated (APaT)|Overall Study|Three participants randomized to receive placebo were given MK-8237 12 DU.|743
50317|NCT01700192|118893|P2|Treated|Overall Study||741
50318|NCT01700192|118894|P1|Treated|Overall Study||740
50319|NCT01700192|118893|P2|STARTED|Overall Study||741
50320|NCT01700192|118894|P1|STARTED|Overall Study||741
50321|NCT01700179|118912|P1|NOT COMPLETED|Overall Study||2
50322|NCT01700179|118912|P1|COMPLETED|Overall Study||6
50323|NCT01700179|118912|P1|STARTED|Overall Study||8
50324|NCT01700140|118919|P3|NOT COMPLETED|Overall Study||1
50325|NCT01700140|118920|P2|NOT COMPLETED|Overall Study||9
50326|NCT01700140|118921|P1|NOT COMPLETED|Overall Study||6
50327|NCT01700140|118919|P3|COMPLETED|Overall Study||61
50328|NCT01700140|118920|P2|COMPLETED|Overall Study||57
50329|NCT01700140|118921|P1|COMPLETED|Overall Study||55
50330|NCT01700140|118919|P3|STARTED|Overall Study||62
50331|NCT01700140|118920|P2|STARTED|Overall Study||66
50332|NCT01700140|118921|P1|STARTED|Overall Study||61
50333|NCT01699867|118953|P1|NOT COMPLETED|Overall Study||3
50334|NCT01699867|118953|P1|COMPLETED|Overall Study||47
50335|NCT01699867|118953|P1|STARTED|Overall Study||50
50336|NCT01699815|118960|P2|NOT COMPLETED|Overall Study||8
50337|NCT01699815|118961|P1|NOT COMPLETED|Overall Study||5
50338|NCT01699815|118960|P2|COMPLETED|Overall Study||56
50339|NCT01699815|118961|P1|COMPLETED|Overall Study||57
50340|NCT01699815|118960|P2|STARTED|Overall Study||64
50341|NCT01699815|118961|P1|STARTED|Overall Study||62
50342|NCT01699789|118973|P2|NOT COMPLETED|Overall Study||126
50343|NCT01699789|118974|P1|NOT COMPLETED|Overall Study||102
50344|NCT01699789|118973|P2|COMPLETED|Overall Study|Clients in 46 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|514
50345|NCT01699789|118974|P1|COMPLETED|Overall Study|Clients in 44 programs with complete or partially complete data at baseline, 6 and 12 mo FU analyzed|504
50346|NCT01699789|118973|P2|12-Month Follow-Up|Overall Study||369
50347|NCT01699789|118974|P1|12-Month Follow-Up|Overall Study||364
50348|NCT01699789|118973|P2|6-Month Follow-Up|Overall Study||379
50349|NCT01699789|118974|P1|6-Month Follow-Up|Overall Study||380
50350|NCT01699789|118973|P2|Baseline|Overall Study||488
50351|NCT01699789|118974|P1|Baseline|Overall Study||492
50352|NCT01699789|118973|P2|STARTED|Overall Study|640 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in CEP arm|640
50353|NCT01699789|118974|P1|STARTED|Overall Study|606 eligible clients enrolled and contacted by telephone for baseline or follow-up survey in RS arm|606
50354|NCT01699763|119036|P1|NOT COMPLETED|Overall Study||0
50355|NCT01699763|119036|P1|COMPLETED|Overall Study||112
50356|NCT01699763|119036|P1|STARTED|Overall Study||112
50357|NCT01699750|119044|P2|NOT COMPLETED|Overall Study||3
50358|NCT01699750|119045|P1|NOT COMPLETED|Overall Study||0
50359|NCT01699750|119044|P2|COMPLETED|Overall Study||33
50360|NCT01699750|119045|P1|COMPLETED|Overall Study||34
50361|NCT01699750|119044|P2|STARTED|Overall Study||36
50362|NCT01699750|119045|P1|STARTED|Overall Study||34
50363|NCT01699685|119069|P2|NOT COMPLETED|Period 2||0
50364|NCT01699685|119070|P1|NOT COMPLETED|Period 2||1
50365|NCT01699685|119069|P2|COMPLETED|Period 2||36
50366|NCT01699685|119070|P1|COMPLETED|Period 2||35
50367|NCT01699685|119069|P2|STARTED|Period 2||36
50368|NCT01699685|119070|P1|STARTED|Period 2||36
50369|NCT01699685|119069|P2|NOT COMPLETED|Period 1||3
50370|NCT01699685|119070|P1|NOT COMPLETED|Period 1||3
50371|NCT01699685|119069|P2|COMPLETED|Period 1||36
50372|NCT01699685|119070|P1|COMPLETED|Period 1||36
50373|NCT01699685|119069|P2|Full Analysis Population (FAS)|Period 1||38
50374|NCT01699685|119070|P1|Full Analysis Population (FAS)|Period 1||38
50375|NCT01699685|119069|P2|Safety Population|Period 1||38
50376|NCT01699685|119070|P1|Safety Population|Period 1||39
50377|NCT01699685|119069|P2|STARTED|Period 1||39
50378|NCT01699685|119070|P1|STARTED|Period 1||39
50379|NCT01699607|119088|P2|NOT COMPLETED|Overall Study||0
50380|NCT01699607|119089|P1|NOT COMPLETED|Overall Study||0
50381|NCT01699607|119088|P2|COMPLETED|Overall Study||4
50382|NCT01699607|119089|P1|COMPLETED|Overall Study||6
50383|NCT01699607|119088|P2|STARTED|Overall Study||4
50384|NCT01699607|119089|P1|STARTED|Overall Study||6
50385|NCT01699373|119096|P2|NOT COMPLETED|Overall Study||0
50386|NCT01699373|119097|P1|NOT COMPLETED|Overall Study||0
50387|NCT01699373|119096|P2|COMPLETED|Overall Study||85
50388|NCT01699373|119097|P1|COMPLETED|Overall Study||85
50389|NCT01699373|119096|P2|STARTED|Overall Study||85
50390|NCT01699373|119097|P1|STARTED|Overall Study||85
50391|NCT01699087|119103|P1|NOT COMPLETED|Overall Study||24
50392|NCT01699087|119103|P1|COMPLETED|Overall Study||152
50393|NCT01699087|119103|P1|Treated|Overall Study||161
50394|NCT01699087|119103|P1|STARTED|Overall Study||176
50395|NCT01699022|119117|P1|NOT COMPLETED|Overall Study||3
50396|NCT01699022|119117|P1|COMPLETED|Overall Study||14
50397|NCT01699022|119117|P1|STARTED|Overall Study||17
50398|NCT01698814|119132|P2|NOT COMPLETED|Overall Study||3
50399|NCT01698814|119133|P1|NOT COMPLETED|Overall Study||2
50400|NCT01698814|119132|P2|COMPLETED|Overall Study||166
50401|NCT01698814|119133|P1|COMPLETED|Overall Study||329
50402|NCT01698814|119132|P2|STARTED|Overall Study||169
50403|NCT01698814|119133|P1|STARTED|Overall Study||331
50404|NCT01698801|119139|P1|NOT COMPLETED|Follow Up Phase||5
50405|NCT01698801|119139|P1|COMPLETED|Follow Up Phase|Completed includes participants who remain in follow-up for up to 5 years from start of treatment|6
50406|NCT01698801|119139|P1|STARTED|Follow Up Phase|11 participants did not complete the study and moved into the follow up phase lasting up to 5 years.|11
50407|NCT01698801|119139|P1|NOT COMPLETED|Treatment Phase||11
50497|NCT01697956|119278|P2|NOT COMPLETED|Overall Study||1
50408|NCT01698801|119139|P1|COMPLETED|Treatment Phase|Completed includes participants who continued to receive study medication and treatment is ongoing.|15
50409|NCT01698801|119139|P1|STARTED|Treatment Phase||26
50410|NCT01698775|119150|P2|NOT COMPLETED|Phase B||11
50411|NCT01698775|119151|P1|NOT COMPLETED|Phase B||14
50412|NCT01698775|119150|P2|COMPLETED|Phase B||86
50413|NCT01698775|119151|P1|COMPLETED|Phase B||84
50414|NCT01698775|119150|P2|STARTED|Phase B||97
50415|NCT01698775|119151|P1|STARTED|Phase B||98
50416|NCT01698775|119150|P2|NOT COMPLETED|Phase A||9
50417|NCT01698775|119151|P1|NOT COMPLETED|Phase A||9
50418|NCT01698775|119150|P2|COMPLETED|Phase A||97
50419|NCT01698775|119151|P1|COMPLETED|Phase A||98
50420|NCT01698775|119150|P2|STARTED|Phase A||106
50421|NCT01698775|119151|P1|STARTED|Phase A||107
50422|NCT01698710|119177|P1|NOT COMPLETED|Overall Study||0
50423|NCT01698710|119177|P1|COMPLETED|Overall Study||5
50424|NCT01698710|119177|P1|STARTED|Overall Study||5
50425|NCT01698684|119186|P3|NOT COMPLETED|Overall Study||21
50426|NCT01698684|119187|P2|NOT COMPLETED|Overall Study||23
50427|NCT01698684|119188|P1|NOT COMPLETED|Overall Study||29
50428|NCT01698684|119186|P3|COMPLETED|Overall Study||127
50429|NCT01698684|119187|P2|COMPLETED|Overall Study||124
50430|NCT01698684|119188|P1|COMPLETED|Overall Study||116
50431|NCT01698684|119186|P3|Safety Population|Overall Study||146
50432|NCT01698684|119187|P2|Safety Population|Overall Study||146
50433|NCT01698684|119188|P1|Safety Population|Overall Study||143
50434|NCT01698684|119186|P3|ITT Population|Overall Study||139
50435|NCT01698684|119187|P2|ITT Population|Overall Study||139
50436|NCT01698684|119188|P1|ITT Population|Overall Study||136
50437|NCT01698684|119186|P3|STARTED|Overall Study||148
50438|NCT01698684|119187|P2|STARTED|Overall Study||147
50439|NCT01698684|119188|P1|STARTED|Overall Study||145
50440|NCT01698554|119200|P4|NOT COMPLETED|Overall Study||2
50441|NCT01698554|119201|P3|NOT COMPLETED|Overall Study||2
50442|NCT01698554|119202|P2|NOT COMPLETED|Overall Study||10
50443|NCT01698554|119203|P1|NOT COMPLETED|Overall Study||6
50444|NCT01698554|119200|P4|COMPLETED|Overall Study||77
50445|NCT01698554|119201|P3|COMPLETED|Overall Study||73
50446|NCT01698554|119202|P2|COMPLETED|Overall Study||147
50447|NCT01698554|119203|P1|COMPLETED|Overall Study||147
50448|NCT01698554|119200|P4|STARTED|Overall Study||79
50449|NCT01698554|119201|P3|STARTED|Overall Study||75
50450|NCT01698554|119202|P2|STARTED|Overall Study||157
50451|NCT01698554|119203|P1|STARTED|Overall Study||153
50452|NCT01698502|119231|P2|NOT COMPLETED|Overall Study||0
50453|NCT01698502|119232|P1|NOT COMPLETED|Overall Study||0
50454|NCT01698502|119231|P2|COMPLETED|Overall Study||10
50455|NCT01698502|119232|P1|COMPLETED|Overall Study||11
50456|NCT01698502|119231|P2|STARTED|Overall Study||10
50457|NCT01698502|119232|P1|STARTED|Overall Study||11
50458|NCT01698320|119242|P3|NOT COMPLETED|40-Week Open-Label Period||10
50459|NCT01698320|119243|P2|NOT COMPLETED|40-Week Open-Label Period||19
50460|NCT01698320|119244|P1|NOT COMPLETED|40-Week Open-Label Period||0
50461|NCT01698320|119242|P3|COMPLETED|40-Week Open-Label Period||146
50462|NCT01698320|119243|P2|COMPLETED|40-Week Open-Label Period||146
50463|NCT01698320|119244|P1|COMPLETED|40-Week Open-Label Period||0
50464|NCT01698320|119242|P3|STARTED|40-Week Open-Label Period||156
50465|NCT01698320|119243|P2|STARTED|40-Week Open-Label Period||165
50466|NCT01698320|119244|P1|STARTED|40-Week Open-Label Period||0
50467|NCT01698320|119242|P3|NOT COMPLETED|12-Week Double-Blind Period||12
50468|NCT01698320|119243|P2|NOT COMPLETED|12-Week Double-Blind Period||4
50469|NCT01698320|119244|P1|NOT COMPLETED|12-Week Double-Blind Period||0
50470|NCT01698320|119242|P3|COMPLETED|12-Week Double-Blind Period||156
50471|NCT01698320|119243|P2|COMPLETED|12-Week Double-Blind Period||165
50472|NCT01698320|119244|P1|COMPLETED|12-Week Double-Blind Period||0
50473|NCT01698320|119242|P3|Safety Population|12-Week Double-Blind Period||168
50474|NCT01698320|119243|P2|Safety Population|12-Week Double-Blind Period|One participant took both placebo and albuterol so is counted in both treatment groups for safety.|170
50475|NCT01698320|119244|P1|Safety Population|12-Week Double-Blind Period||0
50476|NCT01698320|119242|P3|STARTED|12-Week Double-Blind Period||168
50477|NCT01698320|119243|P2|STARTED|12-Week Double-Blind Period||169
50478|NCT01698320|119244|P1|STARTED|12-Week Double-Blind Period||0
50479|NCT01698320|119242|P3|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
50480|NCT01698320|119243|P2|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||0
50481|NCT01698320|119244|P1|NOT COMPLETED|Run-In Period (Week -1 to Day 0)||27
50482|NCT01698320|119242|P3|COMPLETED|Run-In Period (Week -1 to Day 0)||0
50483|NCT01698320|119243|P2|COMPLETED|Run-In Period (Week -1 to Day 0)||0
50484|NCT01698320|119244|P1|COMPLETED|Run-In Period (Week -1 to Day 0)||337
50485|NCT01698320|119242|P3|STARTED|Run-In Period (Week -1 to Day 0)||0
50486|NCT01698320|119243|P2|STARTED|Run-In Period (Week -1 to Day 0)||0
50487|NCT01698320|119244|P1|STARTED|Run-In Period (Week -1 to Day 0)||364
50488|NCT01698268|119264|P2|NOT COMPLETED|Overall Study||1
50489|NCT01698268|119265|P1|NOT COMPLETED|Overall Study||2
50490|NCT01698268|119264|P2|COMPLETED|Overall Study||24
50491|NCT01698268|119265|P1|COMPLETED|Overall Study||23
50492|NCT01698268|119264|P2|STARTED|Overall Study||25
50493|NCT01698268|119265|P1|STARTED|Overall Study||25
50494|NCT01697969|119271|P1|NOT COMPLETED|Overall Study||3
50495|NCT01697969|119271|P1|COMPLETED|Overall Study||10
50496|NCT01697969|119271|P1|STARTED|Overall Study||13
50498|NCT01697956|119279|P1|NOT COMPLETED|Overall Study||1
50499|NCT01697956|119278|P2|COMPLETED|Overall Study||31
50500|NCT01697956|119279|P1|COMPLETED|Overall Study||66
50501|NCT01697956|119278|P2|Per Protocol Population|Overall Study||31
50502|NCT01697956|119279|P1|Per Protocol Population|Overall Study||66
50503|NCT01697956|119278|P2|STARTED|Overall Study|enrolled and randomized|32
50504|NCT01697956|119279|P1|STARTED|Overall Study|enrolled and randomized|67
50505|NCT01697696|119309|P2|NOT COMPLETED|Overall Study||47
50506|NCT01697696|119310|P1|NOT COMPLETED|Overall Study||47
50507|NCT01697696|119309|P2|COMPLETED|Overall Study||210
50508|NCT01697696|119310|P1|COMPLETED|Overall Study||207
50509|NCT01697696|119309|P2|Full Analysis Set (FAS)|Overall Study||255
50510|NCT01697696|119310|P1|Full Analysis Set (FAS)|Overall Study||251
50511|NCT01697696|119309|P2|Safety Set|Overall Study|Safety set included a patient that was treated, but not randomized|256
50512|NCT01697696|119310|P1|Safety Set|Overall Study||251
50513|NCT01697696|119309|P2|STARTED|Overall Study||257
50514|NCT01697696|119310|P1|STARTED|Overall Study||254
50515|NCT01697592|119342|P10|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
50516|NCT01697592|119343|P9|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
50517|NCT01697592|119344|P8|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
50518|NCT01697592|119345|P7|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
50519|NCT01697592|119346|P6|NOT COMPLETED|Phase B (Week 25 to Week 52)||2
50520|NCT01697592|119347|P5|NOT COMPLETED|Phase B (Week 25 to Week 52)||0
50521|NCT01697592|119348|P4|NOT COMPLETED|Phase B (Week 25 to Week 52)||3
50522|NCT01697592|119349|P3|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
50523|NCT01697592|119350|P2|NOT COMPLETED|Phase B (Week 25 to Week 52)||1
50524|NCT01697592|119351|P1|NOT COMPLETED|Phase B (Week 25 to Week 52)||5
50525|NCT01697592|119342|P10|COMPLETED|Phase B (Week 25 to Week 52)||30
50526|NCT01697592|119343|P9|COMPLETED|Phase B (Week 25 to Week 52)||32
50527|NCT01697592|119344|P8|COMPLETED|Phase B (Week 25 to Week 52)||32
50528|NCT01697592|119345|P7|COMPLETED|Phase B (Week 25 to Week 52)||31
50529|NCT01697592|119346|P6|COMPLETED|Phase B (Week 25 to Week 52)||60
50530|NCT01697592|119347|P5|COMPLETED|Phase B (Week 25 to Week 52)||67
50531|NCT01697592|119348|P4|COMPLETED|Phase B (Week 25 to Week 52)||60
50532|NCT01697592|119349|P3|COMPLETED|Phase B (Week 25 to Week 52)||64
50533|NCT01697592|119350|P2|COMPLETED|Phase B (Week 25 to Week 52)||61
50534|NCT01697592|119351|P1|COMPLETED|Phase B (Week 25 to Week 52)||118
50535|NCT01697592|119342|P10|STARTED|Phase B (Week 25 to Week 52)||30
50536|NCT01697592|119343|P9|STARTED|Phase B (Week 25 to Week 52)||34
50537|NCT01697592|119344|P8|STARTED|Phase B (Week 25 to Week 52)||33
50538|NCT01697592|119345|P7|STARTED|Phase B (Week 25 to Week 52)||32
50539|NCT01697592|119346|P6|STARTED|Phase B (Week 25 to Week 52)||62
50540|NCT01697592|119347|P5|STARTED|Phase B (Week 25 to Week 52)||67
50541|NCT01697592|119348|P4|STARTED|Phase B (Week 25 to Week 52)||63
50542|NCT01697592|119349|P3|STARTED|Phase B (Week 25 to Week 52)||65
50543|NCT01697592|119350|P2|STARTED|Phase B (Week 25 to Week 52)||62
50544|NCT01697592|119351|P1|STARTED|Phase B (Week 25 to Week 52)||123
50545|NCT01697592|119342|P10|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
50546|NCT01697592|119343|P9|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
50547|NCT01697592|119344|P8|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
50548|NCT01697592|119345|P7|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
50549|NCT01697592|119346|P6|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
50550|NCT01697592|119347|P5|NOT COMPLETED|Phase A (Up to 24 Weeks)||0
50551|NCT01697592|119348|P4|NOT COMPLETED|Phase A (Up to 24 Weeks)||2
50552|NCT01697592|119349|P3|NOT COMPLETED|Phase A (Up to 24 Weeks)||1
50553|NCT01697592|119350|P2|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
50554|NCT01697592|119351|P1|NOT COMPLETED|Phase A (Up to 24 Weeks)||3
50555|NCT01697592|119342|P10|COMPLETED|Phase A (Up to 24 Weeks)||30
50556|NCT01697592|119343|P9|COMPLETED|Phase A (Up to 24 Weeks)||34
50557|NCT01697592|119344|P8|COMPLETED|Phase A (Up to 24 Weeks)||33
50558|NCT01697592|119345|P7|COMPLETED|Phase A (Up to 24 Weeks)||32
50559|NCT01697592|119346|P6|COMPLETED|Phase A (Up to 24 Weeks)||62
50560|NCT01697592|119347|P5|COMPLETED|Phase A (Up to 24 Weeks)||67
50561|NCT01697592|119348|P4|COMPLETED|Phase A (Up to 24 Weeks)||63
50562|NCT01697592|119349|P3|COMPLETED|Phase A (Up to 24 Weeks)||65
50563|NCT01697592|119350|P2|COMPLETED|Phase A (Up to 24 Weeks)||62
50564|NCT01697592|119351|P1|COMPLETED|Phase A (Up to 24 Weeks)||123
50565|NCT01697592|119342|P10|STARTED|Phase A (Up to 24 Weeks)||32
50566|NCT01697592|119343|P9|STARTED|Phase A (Up to 24 Weeks)||34
50567|NCT01697592|119344|P8|STARTED|Phase A (Up to 24 Weeks)||33
50568|NCT01697592|119345|P7|STARTED|Phase A (Up to 24 Weeks)||34
50569|NCT01697592|119346|P6|STARTED|Phase A (Up to 24 Weeks)||63
50570|NCT01697592|119347|P5|STARTED|Phase A (Up to 24 Weeks)||67
50571|NCT01697592|119348|P4|STARTED|Phase A (Up to 24 Weeks)||65
50572|NCT01697592|119349|P3|STARTED|Phase A (Up to 24 Weeks)||66
50573|NCT01697592|119350|P2|STARTED|Phase A (Up to 24 Weeks)||65
50574|NCT01697592|119351|P1|STARTED|Phase A (Up to 24 Weeks)||126
50575|NCT01697501|119415|P1|NOT COMPLETED|Overall Study||2
50576|NCT01697501|119415|P1|COMPLETED|Overall Study||86
50577|NCT01697501|119415|P1|STARTED|Overall Study||88
50578|NCT01697462|119458|P1|NOT COMPLETED|Overall Study||77
50579|NCT01697462|119458|P1|COMPLETED|Overall Study||181
50580|NCT01697462|119458|P1|STARTED|Overall Study||258
50581|NCT01697449|119465|P1|NOT COMPLETED|Overall Study||90
50582|NCT01697449|119465|P1|COMPLETED|Overall Study||101
50583|NCT01697449|119465|P1|STARTED|Overall Study||191
50584|NCT01697358|119476|P2|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||55
50585|NCT01697358|119477|P1|NOT COMPLETED|Period II: 6-24M Long-term Follow-up||49
50586|NCT01697358|119476|P2|COMPLETED|Period II: 6-24M Long-term Follow-up||52
50587|NCT01697358|119477|P1|COMPLETED|Period II: 6-24M Long-term Follow-up||48
50588|NCT01697358|119476|P2|STARTED|Period II: 6-24M Long-term Follow-up||107
50589|NCT01697358|119477|P1|STARTED|Period II: 6-24M Long-term Follow-up||97
50590|NCT01697358|119476|P2|NOT COMPLETED|Period I: Randomization to 6 Months||1
50591|NCT01697358|119477|P1|NOT COMPLETED|Period I: Randomization to 6 Months||13
50592|NCT01697358|119476|P2|COMPLETED|Period I: Randomization to 6 Months||107
50593|NCT01697358|119477|P1|COMPLETED|Period I: Randomization to 6 Months||97
50594|NCT01697358|119476|P2|STARTED|Period I: Randomization to 6 Months||108
50595|NCT01697358|119477|P1|STARTED|Period I: Randomization to 6 Months||110
50596|NCT01697345|119493|P1|NOT COMPLETED|Overall Study||1
50597|NCT01697345|119493|P1|COMPLETED|Overall Study|One patient withdrew due to symptoms of recurrent Gardnerella vaginalis.|12
50598|NCT01697345|119493|P1|STARTED|Overall Study||13
50599|NCT01697319|119512|P1|NOT COMPLETED|Extension Phase||15
50600|NCT01697319|119512|P1|COMPLETED|Extension Phase||0
50601|NCT01697319|119512|P1|STARTED|Extension Phase||15
50602|NCT01697319|119512|P1|NOT COMPLETED|Primary Phase||1
50603|NCT01697319|119512|P1|COMPLETED|Primary Phase||15
50604|NCT01697319|119512|P1|STARTED|Primary Phase|One subject enrolled but did not receive a single dose of study drug|16
50605|NCT01696994|119521|P2|NOT COMPLETED|Overall Study||8437
50606|NCT01696994|119522|P1|NOT COMPLETED|Overall Study||5192
50607|NCT01696994|119521|P2|COMPLETED|Overall Study||30668
50608|NCT01696994|119522|P1|COMPLETED|Overall Study||33919
50609|NCT01696994|119521|P2|STARTED|Overall Study||39105
50610|NCT01696994|119522|P1|STARTED|Overall Study||39111
50611|NCT01696981|119550|P2|NOT COMPLETED|Overall Study||10374
50612|NCT01696981|119551|P1|NOT COMPLETED|Overall Study||1201
50613|NCT01696981|119550|P2|COMPLETED|Overall Study||67071
50614|NCT01696981|119551|P1|COMPLETED|Overall Study||76254
50615|NCT01696981|119550|P2|STARTED|Overall Study||77445
50616|NCT01696981|119551|P1|STARTED|Overall Study||77455
50617|NCT01696968|119571|P2|NOT COMPLETED|Overall Study||6812
50618|NCT01696968|119572|P1|NOT COMPLETED|Overall Study||1201
50619|NCT01696968|119571|P2|COMPLETED|Overall Study||70633
50620|NCT01696968|119572|P1|COMPLETED|Overall Study||76255
50621|NCT01696968|119571|P2|STARTED|Overall Study||77445
50622|NCT01696968|119572|P1|STARTED|Overall Study||77456
50623|NCT01696929|119592|P1|NOT COMPLETED|Overall Study||1
50624|NCT01696929|119592|P1|COMPLETED|Overall Study||5
50625|NCT01696929|119592|P1|STARTED|Overall Study||6
50626|NCT01696773|119599|P2|NOT COMPLETED|Day 28, Second Intervention||0
50627|NCT01696773|119600|P1|NOT COMPLETED|Day 28, Second Intervention||0
50628|NCT01696773|119599|P2|COMPLETED|Day 28, Second Intervention||6
50629|NCT01696773|119600|P1|COMPLETED|Day 28, Second Intervention||5
50630|NCT01696773|119599|P2|STARTED|Day 28, Second Intervention||6
50631|NCT01696773|119600|P1|STARTED|Day 28, Second Intervention||5
50632|NCT01696773|119599|P2|NOT COMPLETED|Days 15-27, Washout||0
50633|NCT01696773|119600|P1|NOT COMPLETED|Days 15-27, Washout||1
50634|NCT01696773|119599|P2|COMPLETED|Days 15-27, Washout||6
50635|NCT01696773|119600|P1|COMPLETED|Days 15-27, Washout||5
50636|NCT01696773|119599|P2|STARTED|Days 15-27, Washout||6
50637|NCT01696773|119600|P1|STARTED|Days 15-27, Washout||6
50638|NCT01696773|119599|P2|NOT COMPLETED|Day 14, First Intervention||0
50639|NCT01696773|119600|P1|NOT COMPLETED|Day 14, First Intervention||0
50640|NCT01696773|119599|P2|COMPLETED|Day 14, First Intervention||6
50641|NCT01696773|119600|P1|COMPLETED|Day 14, First Intervention||6
50642|NCT01696773|119599|P2|STARTED|Day 14, First Intervention||6
50643|NCT01696773|119600|P1|STARTED|Day 14, First Intervention||6
50644|NCT01696773|119599|P2|NOT COMPLETED|Days 1-13, Washout||0
50645|NCT01696773|119600|P1|NOT COMPLETED|Days 1-13, Washout||0
50646|NCT01696773|119599|P2|COMPLETED|Days 1-13, Washout||6
50647|NCT01696773|119600|P1|COMPLETED|Days 1-13, Washout||6
50648|NCT01696773|119599|P2|STARTED|Days 1-13, Washout||6
50649|NCT01696773|119600|P1|STARTED|Days 1-13, Washout||6
50650|NCT01696760|119608|P2|NOT COMPLETED|Overall Study||0
50651|NCT01696760|119609|P1|NOT COMPLETED|Overall Study||0
50652|NCT01696760|119608|P2|COMPLETED|Overall Study||3
50653|NCT01696760|119609|P1|COMPLETED|Overall Study||9
50654|NCT01696760|119608|P2|STARTED|Overall Study||3
50655|NCT01696760|119609|P1|STARTED|Overall Study||9
50656|NCT01696695|119627|P1|NOT COMPLETED|Overall Study||882
50657|NCT01696695|119627|P1|COMPLETED|Overall Study||0
50658|NCT01696695|119627|P1|STARTED|Overall Study||882
50659|NCT01696643|119639|P2|NOT COMPLETED|Overall Study||535
50660|NCT01696643|119640|P1|NOT COMPLETED|Overall Study||529
50661|NCT01696643|119639|P2|COMPLETED|Overall Study||169
50662|NCT01696643|119640|P1|COMPLETED|Overall Study||174
50663|NCT01696643|119639|P2|Received at Least 1 Dose of Study Drug|Overall Study|2 participants randomized to placebo took CB-5945. Their results are included in the CB-5945 group.|702
50664|NCT01696643|119640|P1|Received at Least 1 Dose of Study Drug|Overall Study||701
50665|NCT01696643|119639|P2|STARTED|Overall Study||704
50666|NCT01696643|119640|P1|STARTED|Overall Study||703
50667|NCT01696357|119657|P2|NOT COMPLETED|Overall Study||1
50668|NCT01696357|119658|P1|NOT COMPLETED|Overall Study||2
50669|NCT01696357|119657|P2|COMPLETED|Overall Study||41
50670|NCT01696357|119658|P1|COMPLETED|Overall Study||40
50671|NCT01696357|119657|P2|STARTED|Overall Study||42
50672|NCT01696357|119658|P1|STARTED|Overall Study||42
50673|NCT01696214|119668|P4|NOT COMPLETED|Overall Study||0
50674|NCT01696214|119669|P3|NOT COMPLETED|Overall Study||0
50675|NCT01696214|119670|P2|NOT COMPLETED|Overall Study||1
50676|NCT01696214|119671|P1|NOT COMPLETED|Overall Study||0
50677|NCT01696214|119668|P4|COMPLETED|Overall Study||5
50678|NCT01696214|119669|P3|COMPLETED|Overall Study||5
50679|NCT01696214|119670|P2|COMPLETED|Overall Study||4
50680|NCT01696214|119671|P1|COMPLETED|Overall Study||5
50681|NCT01696214|119668|P4|STARTED|Overall Study||5
50682|NCT01696214|119669|P3|STARTED|Overall Study||5
50683|NCT01696214|119670|P2|STARTED|Overall Study||5
50684|NCT01696214|119671|P1|STARTED|Overall Study||5
50685|NCT01696188|119683|P2|NOT COMPLETED|Overall Study||1
50686|NCT01696188|119684|P1|NOT COMPLETED|Overall Study||1
50687|NCT01696188|119683|P2|COMPLETED|Overall Study||42
50688|NCT01696188|119684|P1|COMPLETED|Overall Study||40
50689|NCT01696188|119683|P2|STARTED|Overall Study||43
50690|NCT01696188|119684|P1|STARTED|Overall Study||41
50691|NCT01696071|119696|P2|NOT COMPLETED|Treatment Period 2: 4 Weeks||0
50692|NCT01696071|119697|P1|NOT COMPLETED|Treatment Period 2: 4 Weeks||1
50693|NCT01696071|119696|P2|COMPLETED|Treatment Period 2: 4 Weeks||47
50694|NCT01696071|119697|P1|COMPLETED|Treatment Period 2: 4 Weeks||50
50695|NCT01696071|119696|P2|STARTED|Treatment Period 2: 4 Weeks||47
50696|NCT01696071|119697|P1|STARTED|Treatment Period 2: 4 Weeks||51
50697|NCT01696071|119696|P2|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
50698|NCT01696071|119697|P1|NOT COMPLETED|Treatment Period 1: 4 Weeks||0
50699|NCT01696071|119696|P2|COMPLETED|Treatment Period 1: 4 Weeks||47
50700|NCT01696071|119697|P1|COMPLETED|Treatment Period 1: 4 Weeks||51
50701|NCT01696071|119696|P2|STARTED|Treatment Period 1: 4 Weeks||47
50702|NCT01696071|119697|P1|STARTED|Treatment Period 1: 4 Weeks||51
50703|NCT01696058|119725|P2|NOT COMPLETED|Overall Study||31
50704|NCT01696058|119726|P1|NOT COMPLETED|Overall Study||43
50705|NCT01696058|119725|P2|COMPLETED|Overall Study||538
50706|NCT01696058|119726|P1|COMPLETED|Overall Study||523
50707|NCT01696058|119725|P2|STARTED|Overall Study||569
50708|NCT01696058|119726|P1|STARTED|Overall Study||566
50709|NCT01696045|119754|P2|NOT COMPLETED|Overall Study||7
50710|NCT01696045|119755|P1|NOT COMPLETED|Overall Study||3
50711|NCT01696045|119754|P2|COMPLETED|Overall Study||1
50712|NCT01696045|119755|P1|COMPLETED|Overall Study||1
50713|NCT01696045|119754|P2|STARTED|Overall Study||8
50714|NCT01696045|119755|P1|STARTED|Overall Study||4
50715|NCT01695772|119771|P1|NOT COMPLETED|Overall Study||38
50716|NCT01695772|119771|P1|COMPLETED|Overall Study||12
50717|NCT01695772|119771|P1|STARTED|Overall Study||50
50718|NCT01695746|119783|P1|NOT COMPLETED|Overall Study||12
50719|NCT01695746|119783|P1|COMPLETED|Overall Study||96
50720|NCT01695746|119783|P1|STARTED|Overall Study||108
50721|NCT01695668|119799|P2|NOT COMPLETED|Overall Study||17
50722|NCT01695668|119800|P1|NOT COMPLETED|Overall Study||15
50723|NCT01695668|119799|P2|COMPLETED|Overall Study||20
50724|NCT01695668|119800|P1|COMPLETED|Overall Study||23
50725|NCT01695668|119799|P2|STARTED|Overall Study||37
50726|NCT01695668|119800|P1|STARTED|Overall Study||38
50727|NCT01695369|119806|P1|NOT COMPLETED|Overall Study||0
50728|NCT01695369|119806|P1|COMPLETED|Overall Study||61
50729|NCT01695369|119806|P1|STARTED|Overall Study||61
50730|NCT01695330|119812|P2|NOT COMPLETED|Overall Study||0
50731|NCT01695330|119813|P1|NOT COMPLETED|Overall Study||47
50732|NCT01695330|119812|P2|COMPLETED|Overall Study||0
50733|NCT01695330|119813|P1|COMPLETED|Overall Study||5
50734|NCT01695330|119812|P2|STARTED|Overall Study||0
50735|NCT01695330|119813|P1|STARTED|Overall Study||52
50736|NCT01695304|119819|P2|NOT COMPLETED|Overall Study||0
50737|NCT01695304|119820|P1|NOT COMPLETED|Overall Study||0
50738|NCT01695304|119819|P2|COMPLETED|Overall Study|3 deaths & 2 drop out in the intervention group, contributed some information over the 26 weeks|120
50739|NCT01695304|119820|P1|COMPLETED|Overall Study|2 deaths & 1 drop out in the intervention group, contributed some information over the 26 weeks|120
50740|NCT01695304|119819|P2|STARTED|Overall Study||120
50741|NCT01695304|119820|P1|STARTED|Overall Study||120
50742|NCT01695239|119832|P4|NOT COMPLETED|Overall Study||6
50743|NCT01695239|119833|P3|NOT COMPLETED|Overall Study||10
50744|NCT01695239|119834|P2|NOT COMPLETED|Overall Study||4
50745|NCT01695239|119835|P1|NOT COMPLETED|Overall Study||15
50746|NCT01695239|119832|P4|COMPLETED|Overall Study||97
50747|NCT01695239|119833|P3|COMPLETED|Overall Study||97
50748|NCT01695239|119834|P2|COMPLETED|Overall Study||97
50749|NCT01695239|119835|P1|COMPLETED|Overall Study||91
50750|NCT01695239|119832|P4|Classified as Inadequate Responder (IR)|Overall Study||10
50751|NCT01695239|119833|P3|Classified as Inadequate Responder (IR)|Overall Study||11
50752|NCT01695239|119834|P2|Classified as Inadequate Responder (IR)|Overall Study||9
50753|NCT01695239|119835|P1|Classified as Inadequate Responder (IR)|Overall Study||27
50754|NCT01695239|119832|P4|Received at Least 1 Dose of Study Drug|Overall Study||102
50755|NCT01695239|119833|P3|Received at Least 1 Dose of Study Drug|Overall Study||107
50756|NCT01695239|119834|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
50757|NCT01695239|119835|P1|Received at Least 1 Dose of Study Drug|Overall Study||106
50758|NCT01695239|119832|P4|STARTED|Overall Study||103
50759|NCT01695239|119833|P3|STARTED|Overall Study||107
50760|NCT01695239|119834|P2|STARTED|Overall Study||101
50761|NCT01695239|119835|P1|STARTED|Overall Study||106
50762|NCT01695044|119926|P1|NOT COMPLETED|Overall Study||102
50763|NCT01695044|119926|P1|COMPLETED|Overall Study||17
50764|NCT01695044|119926|P1|STARTED|Overall Study||119
50765|NCT01694771|119938|P2|NOT COMPLETED|Overall Study||40
50766|NCT01694771|119939|P1|NOT COMPLETED|Overall Study||40
50767|NCT01694771|119938|P2|COMPLETED|Overall Study||525
50768|NCT01694771|119939|P1|COMPLETED|Overall Study||527
50769|NCT01694771|119938|P2|STARTED|Overall Study||565
50770|NCT01694771|119939|P1|STARTED|Overall Study||567
50771|NCT01694706|119963|P3|NOT COMPLETED|Overall Study||0
50772|NCT01694706|119964|P2|NOT COMPLETED|Overall Study||1
50773|NCT01694706|119965|P1|NOT COMPLETED|Overall Study||1
50774|NCT01694706|119963|P3|COMPLETED|Overall Study||5
50775|NCT01694706|119964|P2|COMPLETED|Overall Study||4
50776|NCT01694706|119965|P1|COMPLETED|Overall Study||4
50777|NCT01694706|119963|P3|Received Faldaprevir Fed|Overall Study||5
50778|NCT01694706|119964|P2|Received Faldaprevir Fed|Overall Study||5
50779|NCT01694706|119965|P1|Received Faldaprevir Fed|Overall Study||4
50780|NCT01694706|119963|P3|Received Faldaprevir +OMP|Overall Study||5
50781|NCT01694706|119964|P2|Received Faldaprevir +OMP|Overall Study||5
50782|NCT01694706|119965|P1|Received Faldaprevir +OMP|Overall Study||5
50783|NCT01694706|119963|P3|Received Faldaprevir|Overall Study||5
50784|NCT01694706|119964|P2|Received Faldaprevir|Overall Study||5
50785|NCT01694706|119965|P1|Received Faldaprevir|Overall Study||5
50786|NCT01694706|119963|P3|STARTED|Overall Study||5
50787|NCT01694706|119964|P2|STARTED|Overall Study||5
50788|NCT01694706|119965|P1|STARTED|Overall Study||5
50789|NCT01694667|119982|P2|NOT COMPLETED|Overall Study||0
50790|NCT01694667|119983|P1|NOT COMPLETED|Overall Study||0
50791|NCT01694667|119982|P2|COMPLETED|Overall Study||28
50792|NCT01694667|119983|P1|COMPLETED|Overall Study||29
50793|NCT01694667|119982|P2|STARTED|Overall Study||28
50794|NCT01694667|119983|P1|STARTED|Overall Study||29
50795|NCT01694641|120001|P2|NOT COMPLETED|Overall Study||10
50796|NCT01694641|120002|P1|NOT COMPLETED|Overall Study||12
50797|NCT01694641|120001|P2|COMPLETED|Overall Study||71
50798|NCT01694641|120002|P1|COMPLETED|Overall Study||68
50799|NCT01694641|120001|P2|STARTED|Overall Study||81
50800|NCT01694641|120002|P1|STARTED|Overall Study||80
50801|NCT01694420|120008|P1|NOT COMPLETED|Overall Study||3
50802|NCT01694420|120008|P1|COMPLETED|Overall Study||30
50803|NCT01694420|120008|P1|STARTED|Overall Study||33
50804|NCT01694199|120019|P2|NOT COMPLETED|Overall Study||0
50805|NCT01694199|120020|P1|NOT COMPLETED|Overall Study||0
50806|NCT01694199|120019|P2|COMPLETED|Overall Study||68
50807|NCT01694199|120020|P1|COMPLETED|Overall Study||71
50808|NCT01694199|120019|P2|STARTED|Overall Study||68
50809|NCT01694199|120020|P1|STARTED|Overall Study||71
50810|NCT01694108|120036|P2|NOT COMPLETED|Overall Study||0
50811|NCT01694108|120037|P1|NOT COMPLETED|Overall Study||0
50812|NCT01694108|120036|P2|COMPLETED|Overall Study|100% follow-up|2133
50813|NCT01694108|120037|P1|COMPLETED|Overall Study|100% follow-up|2129
50814|NCT01694108|120036|P2|STARTED|Overall Study||2133
50815|NCT01694108|120037|P1|STARTED|Overall Study||2129
50816|NCT01693900|120093|P2|NOT COMPLETED|Overall Study||0
50817|NCT01693900|120094|P1|NOT COMPLETED|Overall Study||0
50818|NCT01693900|120093|P2|COMPLETED|Overall Study||25
50819|NCT01693900|120094|P1|COMPLETED|Overall Study||25
50820|NCT01693900|120093|P2|STARTED|Overall Study||25
50821|NCT01693900|120094|P1|STARTED|Overall Study||25
50822|NCT01693653|120108|P2|NOT COMPLETED|Overall Study||0
50823|NCT01693653|120109|P1|NOT COMPLETED|Overall Study||0
50824|NCT01693653|120108|P2|COMPLETED|Overall Study||0
50825|NCT01693653|120109|P1|COMPLETED|Overall Study||1
50826|NCT01693653|120108|P2|STARTED|Overall Study||0
50827|NCT01693653|120109|P1|STARTED|Overall Study||1
50828|NCT01693484|120115|P1|NOT COMPLETED|Overall Study||13
50829|NCT01693484|120115|P1|COMPLETED|Overall Study|Study closed by PI|0
50830|NCT01693484|120115|P1|STARTED|Overall Study||13
50831|NCT01693367|120121|P2|NOT COMPLETED|Overall Study||2
50832|NCT01693367|120122|P1|NOT COMPLETED|Overall Study||1
50833|NCT01693367|120121|P2|COMPLETED|Overall Study||1
50834|NCT01693367|120122|P1|COMPLETED|Overall Study||1
50835|NCT01693367|120121|P2|STARTED|Overall Study||3
50836|NCT01693367|120122|P1|STARTED|Overall Study||2
50837|NCT01693185|120140|P2|NOT COMPLETED|Overall Study||6
50838|NCT01693185|120141|P1|NOT COMPLETED|Overall Study||0
50839|NCT01693185|120140|P2|COMPLETED|Overall Study||27
50840|NCT01693185|120141|P1|COMPLETED|Overall Study||27
50841|NCT01693185|120140|P2|STARTED|Overall Study||33
50842|NCT01693185|120141|P1|STARTED|Overall Study||27
50843|NCT01693029|120159|P2|NOT COMPLETED|Overall Study||57
50844|NCT01693029|120160|P1|NOT COMPLETED|Overall Study||44
50845|NCT01693029|120159|P2|COMPLETED|Overall Study||161
50846|NCT01693029|120160|P1|COMPLETED|Overall Study||173
50847|NCT01693029|120159|P2|STARTED|Overall Study||218
50848|NCT01693029|120160|P1|STARTED|Overall Study||217
50849|NCT01691885|120172|P2|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
50850|NCT01691885|120173|P1|NOT COMPLETED|Treatment Period 2 (7-14 Days)||0
50851|NCT01691885|120172|P2|COMPLETED|Treatment Period 2 (7-14 Days)||21
50852|NCT01691885|120173|P1|COMPLETED|Treatment Period 2 (7-14 Days)||21
50853|NCT01691885|120172|P2|STARTED|Treatment Period 2 (7-14 Days)||21
50854|NCT01691885|120173|P1|STARTED|Treatment Period 2 (7-14 Days)||21
50855|NCT01691885|120172|P2|NOT COMPLETED|Washout Period (7-9 Days)||1
50856|NCT01691885|120173|P1|NOT COMPLETED|Washout Period (7-9 Days)||0
50857|NCT01691885|120172|P2|COMPLETED|Washout Period (7-9 Days)||21
50858|NCT01691885|120173|P1|COMPLETED|Washout Period (7-9 Days)||21
50859|NCT01691885|120172|P2|STARTED|Washout Period (7-9 Days)||22
50860|NCT01691885|120173|P1|STARTED|Washout Period (7-9 Days)||21
50861|NCT01691885|120172|P2|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
50862|NCT01691885|120173|P1|NOT COMPLETED|Treatment Period 1(7-14 Days)||1
50863|NCT01691885|120172|P2|COMPLETED|Treatment Period 1(7-14 Days)||22
50864|NCT01691885|120173|P1|COMPLETED|Treatment Period 1(7-14 Days)||21
50865|NCT01691885|120172|P2|STARTED|Treatment Period 1(7-14 Days)||23
50866|NCT01691885|120173|P1|STARTED|Treatment Period 1(7-14 Days)||22
50867|NCT01692951|120183|P4|NOT COMPLETED|Overall Study||0
50868|NCT01692951|120184|P3|NOT COMPLETED|Overall Study||0
50869|NCT01692951|120185|P2|NOT COMPLETED|Overall Study||0
50870|NCT01692951|120186|P1|NOT COMPLETED|Overall Study||0
50871|NCT01692951|120183|P4|COMPLETED|Overall Study||54
50872|NCT01692951|120184|P3|COMPLETED|Overall Study||18
50873|NCT01692951|120185|P2|COMPLETED|Overall Study||111
50874|NCT01692951|120186|P1|COMPLETED|Overall Study||37
50875|NCT01692951|120183|P4|STARTED|Overall Study||54
50876|NCT01692951|120184|P3|STARTED|Overall Study||18
50877|NCT01692951|120185|P2|STARTED|Overall Study||111
50878|NCT01692951|120186|P1|STARTED|Overall Study||37
50879|NCT01692938|120198|P2|NOT COMPLETED|Overall Study||4
50880|NCT01692938|120199|P1|NOT COMPLETED|Overall Study||4
50881|NCT01692938|120198|P2|COMPLETED|Overall Study||12
50882|NCT01692938|120199|P1|COMPLETED|Overall Study||12
50883|NCT01692938|120198|P2|STARTED|Overall Study||16
50884|NCT01692938|120199|P1|STARTED|Overall Study||16
50885|NCT01692782|120210|P3|NOT COMPLETED|Overall Study||10
50886|NCT01692782|120211|P2|NOT COMPLETED|Overall Study||56
50887|NCT01692782|120212|P1|NOT COMPLETED|Overall Study||20
50888|NCT01692782|120210|P3|COMPLETED|Overall Study||100
50889|NCT01692782|120211|P2|COMPLETED|Overall Study||59
50890|NCT01692782|120212|P1|COMPLETED|Overall Study||96
50891|NCT01692782|120210|P3|STARTED|Overall Study||110
50892|NCT01692782|120211|P2|STARTED|Overall Study||115
50893|NCT01692782|120212|P1|STARTED|Overall Study||116
50894|NCT01692691|120235|P1|NOT COMPLETED|Overall Study||0
50895|NCT01692691|120235|P1|COMPLETED|Overall Study||1
50896|NCT01692691|120235|P1|STARTED|Overall Study||1
50897|NCT01692626|120240|P2|NOT COMPLETED|Overall Study||6
50898|NCT01692626|120241|P1|NOT COMPLETED|Overall Study||4
50899|NCT01692626|120240|P2|COMPLETED|Overall Study||1
50900|NCT01692626|120241|P1|COMPLETED|Overall Study||2
50901|NCT01692626|120240|P2|STARTED|Overall Study||7
50902|NCT01692626|120241|P1|STARTED|Overall Study||6
50903|NCT01692340|120249|P3|NOT COMPLETED|Overall Study||0
50904|NCT01692340|120250|P2|NOT COMPLETED|Overall Study||0
50905|NCT01692340|120251|P1|NOT COMPLETED|Overall Study||0
50906|NCT01692340|120249|P3|COMPLETED|Overall Study||0
50907|NCT01692340|120250|P2|COMPLETED|Overall Study||4
50908|NCT01692340|120251|P1|COMPLETED|Overall Study||8
50909|NCT01692340|120249|P3|STARTED|Overall Study||0
50910|NCT01692340|120250|P2|STARTED|Overall Study||4
50911|NCT01692340|120251|P1|STARTED|Overall Study||8
50912|NCT01692301|120270|P2|NOT COMPLETED|Overall Study||42
50913|NCT01692301|120271|P1|NOT COMPLETED|Overall Study||45
50914|NCT01692301|120270|P2|COMPLETED|Overall Study||183
50915|NCT01692301|120271|P1|COMPLETED|Overall Study||184
50916|NCT01692301|120270|P2|STARTED|Overall Study||225
50917|NCT01692301|120271|P1|STARTED|Overall Study|"Started indicates patients in randomized, full analysis and safety set"|229
50918|NCT01691794|120300|P3|NOT COMPLETED|Overall Study||3
50919|NCT01691794|120301|P2|NOT COMPLETED|Overall Study||3
50920|NCT01691794|120302|P1|NOT COMPLETED|Overall Study||0
50921|NCT01691794|120300|P3|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|20
50922|NCT01691794|120301|P2|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|30
50923|NCT01691794|120302|P1|COMPLETED|Overall Study|Completed Phase 1 (to Week 24)|3
50924|NCT01691794|120300|P3|STARTED|Overall Study||23
50925|NCT01691794|120301|P2|STARTED|Overall Study||33
50926|NCT01691794|120302|P1|STARTED|Overall Study||3
50927|NCT01691781|120318|P2|NOT COMPLETED|Overall Study||7
50928|NCT01691781|120319|P1|NOT COMPLETED|Overall Study||7
50929|NCT01691781|120318|P2|COMPLETED|Overall Study||15
50930|NCT01691781|120319|P1|COMPLETED|Overall Study||12
50931|NCT01691781|120318|P2|STARTED|Overall Study||22
50932|NCT01691781|120319|P1|STARTED|Overall Study||19
50933|NCT01691690|120331|P2|NOT COMPLETED|Overall Study||4
50934|NCT01691690|120332|P1|NOT COMPLETED|Overall Study||7
50935|NCT01691690|120331|P2|COMPLETED|Overall Study||121
50936|NCT01691690|120332|P1|COMPLETED|Overall Study||118
50937|NCT01691690|120331|P2|STARTED|Overall Study||125
50938|NCT01691690|120332|P1|STARTED|Overall Study||125
50939|NCT01691612|120342|P1|NOT COMPLETED|Overall Study||7
50940|NCT01691612|120342|P1|COMPLETED|Overall Study||7
50941|NCT01691612|120342|P1|Second Visit (Bronchoscopy)|Overall Study||7
50942|NCT01691612|120342|P1|First Visit (Allergen Challenge)|Overall Study||8
50943|NCT01691612|120342|P1|STARTED|Overall Study||14
50944|NCT01691560|120353|P4|NOT COMPLETED|Overall Study||0
50945|NCT01691560|120354|P3|NOT COMPLETED|Overall Study||0
50946|NCT01691560|120355|P2|NOT COMPLETED|Overall Study||0
50947|NCT01691560|120356|P1|NOT COMPLETED|Overall Study||0
50948|NCT01691560|120353|P4|COMPLETED|Overall Study||33
50949|NCT01691560|120354|P3|COMPLETED|Overall Study||34
50950|NCT01691560|120355|P2|COMPLETED|Overall Study||33
50951|NCT01691560|120356|P1|COMPLETED|Overall Study||34
50952|NCT01691560|120353|P4|STARTED|Overall Study||33
50953|NCT01691560|120354|P3|STARTED|Overall Study||34
50954|NCT01691560|120355|P2|STARTED|Overall Study||33
50955|NCT01691560|120356|P1|STARTED|Overall Study||34
50956|NCT01691534|120393|P7|NOT COMPLETED|Overall Study||1
50957|NCT01691534|120394|P6|NOT COMPLETED|Overall Study||1
50958|NCT01691534|120395|P5|NOT COMPLETED|Overall Study||0
50959|NCT01691534|120396|P4|NOT COMPLETED|Overall Study||1
50960|NCT01691534|120397|P3|NOT COMPLETED|Overall Study||1
50961|NCT01691534|120398|P2|NOT COMPLETED|Overall Study||1
50962|NCT01691534|120399|P1|NOT COMPLETED|Overall Study||0
50963|NCT01691534|120393|P7|COMPLETED|Overall Study||14
50964|NCT01691534|120394|P6|COMPLETED|Overall Study||14
50965|NCT01691534|120395|P5|COMPLETED|Overall Study||15
50966|NCT01691534|120396|P4|COMPLETED|Overall Study||14
50967|NCT01691534|120397|P3|COMPLETED|Overall Study||14
50968|NCT01691534|120398|P2|COMPLETED|Overall Study||14
50969|NCT01691534|120399|P1|COMPLETED|Overall Study||15
50970|NCT01691534|120393|P7|STARTED|Overall Study||15
50971|NCT01691534|120394|P6|STARTED|Overall Study||15
50972|NCT01691534|120395|P5|STARTED|Overall Study||15
50973|NCT01691534|120396|P4|STARTED|Overall Study||15
50974|NCT01691534|120397|P3|STARTED|Overall Study||15
50975|NCT01691534|120398|P2|STARTED|Overall Study||15
50976|NCT01691534|120399|P1|STARTED|Overall Study||15
50977|NCT01691521|120453|P3|NOT COMPLETED|Overall Study||9
50978|NCT01691521|120454|P2|NOT COMPLETED|Overall Study||16
50979|NCT01691521|120455|P1|NOT COMPLETED|Overall Study||12
50980|NCT01691521|120453|P3|COMPLETED|Overall Study||185
50981|NCT01691521|120454|P2|COMPLETED|Overall Study||175
50982|NCT01691521|120455|P1|COMPLETED|Overall Study||179
50983|NCT01691521|120453|P3|STARTED|Overall Study||194
50984|NCT01691521|120454|P2|STARTED|Overall Study||191
50985|NCT01691521|120455|P1|STARTED|Overall Study||191
50986|NCT01691508|120477|P2|NOT COMPLETED|Overall Study||3
50987|NCT01691508|120478|P1|NOT COMPLETED|Overall Study||4
50988|NCT01691508|120477|P2|COMPLETED|Overall Study||66
50989|NCT01691508|120478|P1|COMPLETED|Overall Study||62
50990|NCT01691508|120477|P2|STARTED|Overall Study||69
50991|NCT01691508|120478|P1|STARTED|Overall Study||66
50992|NCT01691482|120492|P2|NOT COMPLETED|Treatment Period 2||2
50993|NCT01691482|120493|P1|NOT COMPLETED|Treatment Period 2||1
50994|NCT01691482|120492|P2|COMPLETED|Treatment Period 2||26
50995|NCT01691482|120493|P1|COMPLETED|Treatment Period 2||27
50996|NCT01691482|120492|P2|STARTED|Treatment Period 2||28
50997|NCT01691482|120493|P1|STARTED|Treatment Period 2||28
50998|NCT01691482|120492|P2|NOT COMPLETED|Treatment Period 1||0
50999|NCT01691482|120493|P1|NOT COMPLETED|Treatment Period 1||0
51000|NCT01691482|120492|P2|COMPLETED|Treatment Period 1||28
51001|NCT01691482|120493|P1|COMPLETED|Treatment Period 1||28
51002|NCT01691482|120492|P2|STARTED|Treatment Period 1||28
51003|NCT01691482|120493|P1|STARTED|Treatment Period 1||28
51004|NCT01691339|120513|P4|NOT COMPLETED|Overall Study||0
51005|NCT01691339|120514|P3|NOT COMPLETED|Overall Study||0
51006|NCT01691339|120515|P2|NOT COMPLETED|Overall Study||0
51007|NCT01691339|120516|P1|NOT COMPLETED|Overall Study||0
51008|NCT01691339|120513|P4|COMPLETED|Overall Study||49
51009|NCT01691339|120514|P3|COMPLETED|Overall Study||51
51010|NCT01691339|120515|P2|COMPLETED|Overall Study||50
51011|NCT01691339|120516|P1|COMPLETED|Overall Study||50
51012|NCT01691339|120513|P4|STARTED|Overall Study||49
51013|NCT01691339|120514|P3|STARTED|Overall Study||51
51014|NCT01691339|120515|P2|STARTED|Overall Study||50
51015|NCT01691339|120516|P1|STARTED|Overall Study||50
51016|NCT01691326|120544|P2|NOT COMPLETED|Overall Study||0
51017|NCT01691326|120545|P1|NOT COMPLETED|Overall Study||0
51018|NCT01691326|120544|P2|COMPLETED|Overall Study||30
51019|NCT01691326|120545|P1|COMPLETED|Overall Study||30
51020|NCT01691326|120544|P2|STARTED|Overall Study||30
51021|NCT01691326|120545|P1|STARTED|Overall Study||30
51022|NCT01691313|120563|P4|NOT COMPLETED|Overall Study||0
51023|NCT01691313|120564|P3|NOT COMPLETED|Overall Study||0
51024|NCT01691313|120565|P2|NOT COMPLETED|Overall Study||0
51025|NCT01691313|120566|P1|NOT COMPLETED|Overall Study||0
51026|NCT01691313|120563|P4|COMPLETED|Overall Study||25
51027|NCT01691313|120564|P3|COMPLETED|Overall Study||25
51028|NCT01691313|120565|P2|COMPLETED|Overall Study||32
51029|NCT01691313|120566|P1|COMPLETED|Overall Study||22
51030|NCT01691313|120563|P4|STARTED|Overall Study||25
51031|NCT01691313|120564|P3|STARTED|Overall Study||25
51032|NCT01691313|120565|P2|STARTED|Overall Study||32
51033|NCT01691313|120566|P1|STARTED|Overall Study||22
51034|NCT01691248|120582|P2|NOT COMPLETED|Overall Study||114
51035|NCT01691248|120583|P1|NOT COMPLETED|Overall Study||111
51036|NCT01691248|120582|P2|COMPLETED|Overall Study||192
51037|NCT01691248|120583|P1|COMPLETED|Overall Study||194
51038|NCT01691248|120582|P2|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
51039|NCT01691248|120583|P1|Safety Analysis Set|Overall Study|A participant randomized to Fidaxomicin, received placebo instead.|300
51040|NCT01691248|120582|P2|Treated|Overall Study|Received at least 1 dose of study drug|299
51041|NCT01691248|120583|P1|Treated|Overall Study|Received at least 1 dose of study drug|301
51042|NCT01691248|120582|P2|STARTED|Overall Study|Randomized|306
51043|NCT01691248|120583|P1|STARTED|Overall Study|Randomized|305
51044|NCT01691092|120593|P1|NOT COMPLETED|Overall Study||41
51045|NCT01691092|120593|P1|COMPLETED|Overall Study||38
51046|NCT01691092|120593|P1|STARTED|Overall Study||79
51047|NCT01691014|120601|P4|NOT COMPLETED|Overall Study||5
51048|NCT01691014|120602|P3|NOT COMPLETED|Overall Study||11
51049|NCT01691014|120603|P2|NOT COMPLETED|Overall Study||15
51050|NCT01691014|120604|P1|NOT COMPLETED|Overall Study||3
51051|NCT01691014|120601|P4|COMPLETED|Overall Study||4
51052|NCT01691014|120602|P3|COMPLETED|Overall Study||25
51053|NCT01691014|120603|P2|COMPLETED|Overall Study||11
51054|NCT01691014|120604|P1|COMPLETED|Overall Study||5
51055|NCT01691014|120601|P4|STARTED|Overall Study||9
51056|NCT01691014|120602|P3|STARTED|Overall Study||36
51057|NCT01691014|120603|P2|STARTED|Overall Study||26
51058|NCT01691014|120604|P1|STARTED|Overall Study||8
51059|NCT01690923|120646|P2|NOT COMPLETED|Overall Study||1
51060|NCT01690923|120647|P1|NOT COMPLETED|Overall Study||0
51061|NCT01690923|120646|P2|COMPLETED|Overall Study||10
51062|NCT01690923|120647|P1|COMPLETED|Overall Study||10
51063|NCT01690923|120646|P2|STARTED|Overall Study|1 participant was withdrawn and excluded due to poor fit with the pillows mask|11
51064|NCT01690923|120647|P1|STARTED|Overall Study||10
51065|NCT01690663|120656|P4|NOT COMPLETED|Overall Study||4
51066|NCT01690663|120657|P3|NOT COMPLETED|Overall Study||3
51067|NCT01690663|120658|P2|NOT COMPLETED|Overall Study||3
51068|NCT01690663|120659|P1|NOT COMPLETED|Overall Study||3
51069|NCT01690663|120656|P4|COMPLETED|Overall Study||20
51070|NCT01690663|120657|P3|COMPLETED|Overall Study||19
51071|NCT01690663|120658|P2|COMPLETED|Overall Study||17
51072|NCT01690663|120659|P1|COMPLETED|Overall Study||20
51073|NCT01690663|120656|P4|STARTED|Overall Study||24
51074|NCT01690663|120657|P3|STARTED|Overall Study||22
51075|NCT01690663|120658|P2|STARTED|Overall Study||20
51076|NCT01690663|120659|P1|STARTED|Overall Study||23
51077|NCT01690546|120673|P1|NOT COMPLETED|Overall Study||9
51078|NCT01690546|120673|P1|COMPLETED|Overall Study||26
51079|NCT01690546|120673|P1|Extended Release Injectable NTX|Overall Study||27
51080|NCT01690546|120673|P1|STARTED|Overall Study||35
51081|NCT01690299|120689|P6|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||30
51082|NCT01690299|120690|P5|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||33
51083|NCT01690299|120691|P4|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||26
51084|NCT01690299|120692|P3|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
51085|NCT01690299|120693|P2|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
51086|NCT01690299|120694|P1|NOT COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
51087|NCT01690299|120689|P6|COMPLETED|Apremilast Extension Phase (Weeks16-104)||50
51088|NCT01690299|120690|P5|COMPLETED|Apremilast Extension Phase (Weeks16-104)||41
51089|NCT01690299|120691|P4|COMPLETED|Apremilast Extension Phase (Weeks16-104)||47
51090|NCT01690299|120692|P3|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
51091|NCT01690299|120693|P2|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
51092|NCT01690299|120694|P1|COMPLETED|Apremilast Extension Phase (Weeks16-104)||0
51093|NCT01690299|120689|P6|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|79
51094|NCT01690299|120690|P5|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|74
51095|NCT01690299|120691|P4|Safety Population|Apremilast Extension Phase (Weeks16-104)|Safety population includes all participants who received at least one dose of study drug.|73
51096|NCT01690299|120692|P3|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
51097|NCT01690299|120693|P2|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
51098|NCT01690299|120694|P1|Safety Population|Apremilast Extension Phase (Weeks16-104)||0
51099|NCT01690299|120689|P6|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|80
51100|NCT01690299|120690|P5|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|74
51101|NCT01690299|120691|P4|STARTED|Apremilast Extension Phase (Weeks16-104)|There are fewer participants in this period because some stopped the study at or prior to Week 16.|73
51102|NCT01690299|120692|P3|STARTED|Apremilast Extension Phase (Weeks16-104)||0
51103|NCT01690299|120693|P2|STARTED|Apremilast Extension Phase (Weeks16-104)||0
51104|NCT01690299|120694|P1|STARTED|Apremilast Extension Phase (Weeks16-104)||0
51105|NCT01690299|120689|P6|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
51106|NCT01690299|120690|P5|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
51107|NCT01690299|120691|P4|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
51108|NCT01690299|120692|P3|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||2
51109|NCT01690299|120693|P2|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||6
51110|NCT01690299|120694|P1|NOT COMPLETED|Placebo-controlled Phase (Weeks 0-16)||9
51111|NCT01690299|120689|P6|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
51112|NCT01690299|120690|P5|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
51113|NCT01690299|120691|P4|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||0
51114|NCT01690299|120692|P3|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||81
51115|NCT01690299|120693|P2|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||77
51116|NCT01690299|120694|P1|COMPLETED|Placebo-controlled Phase (Weeks 0-16)||75
51117|NCT01690299|120689|P6|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
51118|NCT01690299|120690|P5|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
51119|NCT01690299|120691|P4|Safety Population|Placebo-controlled Phase (Weeks 0-16)||0
51120|NCT01690299|120692|P3|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
51121|NCT01690299|120693|P2|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|83
51122|NCT01690299|120694|P1|Safety Population|Placebo-controlled Phase (Weeks 0-16)|Safety population includes all participants who received at least one dose of study drug.|84
51123|NCT01690299|120689|P6|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
51124|NCT01690299|120690|P5|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
51125|NCT01690299|120691|P4|STARTED|Placebo-controlled Phase (Weeks 0-16)||0
51126|NCT01690299|120692|P3|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
51127|NCT01690299|120693|P2|STARTED|Placebo-controlled Phase (Weeks 0-16)||83
51128|NCT01690299|120694|P1|STARTED|Placebo-controlled Phase (Weeks 0-16)||84
51129|NCT01690273|120739|P3|NOT COMPLETED|Overall Study||0
51130|NCT01690273|120740|P2|NOT COMPLETED|Overall Study||0
51131|NCT01690273|120741|P1|NOT COMPLETED|Overall Study||0
51132|NCT01690273|120739|P3|COMPLETED|Overall Study||20
51133|NCT01690273|120740|P2|COMPLETED|Overall Study||17
51134|NCT01690273|120741|P1|COMPLETED|Overall Study||18
51135|NCT01690273|120739|P3|STARTED|Overall Study||20
51136|NCT01690273|120740|P2|STARTED|Overall Study||17
51137|NCT01690273|120741|P1|STARTED|Overall Study||18
51138|NCT01690117|120793|P2|NOT COMPLETED|Overall Study||14
51139|NCT01690117|120794|P1|NOT COMPLETED|Overall Study||16
51140|NCT01690117|120793|P2|COMPLETED|Overall Study||31
51141|NCT01690117|120794|P1|COMPLETED|Overall Study||31
51142|NCT01690117|120793|P2|Post-Measurement|Overall Study||40
51143|NCT01690117|120794|P1|Post-Measurement|Overall Study||41
51144|NCT01690117|120793|P2|STARTED|Overall Study||45
51145|NCT01690117|120794|P1|STARTED|Overall Study||47
51146|NCT01690052|120830|P2|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
51147|NCT01690052|120831|P1|NOT COMPLETED|SECOND INTERVENTION: 4 WEEKS||0
51148|NCT01690052|120830|P2|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
51149|NCT01690052|120831|P1|COMPLETED|SECOND INTERVENTION: 4 WEEKS||6
51150|NCT01690052|120830|P2|STARTED|SECOND INTERVENTION: 4 WEEKS||6
51151|NCT01690052|120831|P1|STARTED|SECOND INTERVENTION: 4 WEEKS||6
51152|NCT01690052|120830|P2|NOT COMPLETED|Washout Period of 1 Week||0
51153|NCT01690052|120831|P1|NOT COMPLETED|Washout Period of 1 Week||0
51154|NCT01690052|120830|P2|COMPLETED|Washout Period of 1 Week||6
51155|NCT01690052|120831|P1|COMPLETED|Washout Period of 1 Week||6
51156|NCT01690052|120830|P2|STARTED|Washout Period of 1 Week||6
51157|NCT01690052|120831|P1|STARTED|Washout Period of 1 Week||6
51158|NCT01690052|120830|P2|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||2
51159|NCT01690052|120831|P1|NOT COMPLETED|FIRST INTERVENTION: 4 WEEKS||1
51160|NCT01690052|120830|P2|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
51161|NCT01690052|120831|P1|COMPLETED|FIRST INTERVENTION: 4 WEEKS||6
51162|NCT01690052|120830|P2|STARTED|FIRST INTERVENTION: 4 WEEKS||8
51163|NCT01690052|120831|P1|STARTED|FIRST INTERVENTION: 4 WEEKS||7
51164|NCT01690000|120839|P2|NOT COMPLETED|Overall Study||6
51165|NCT01690000|120840|P1|NOT COMPLETED|Overall Study||3
51166|NCT01690000|120839|P2|COMPLETED|Overall Study||35
51167|NCT01690000|120840|P1|COMPLETED|Overall Study||37
51168|NCT01690000|120839|P2|STARTED|Overall Study||41
51169|NCT01690000|120840|P1|STARTED|Overall Study||40
51170|NCT01689857|120848|P2|NOT COMPLETED|Overall Study||2
51171|NCT01689857|120849|P1|NOT COMPLETED|Overall Study||5
51172|NCT01689857|120848|P2|COMPLETED|Overall Study||18
51173|NCT01689857|120849|P1|COMPLETED|Overall Study||15
51174|NCT01689857|120848|P2|STARTED|Overall Study||20
51175|NCT01689857|120849|P1|STARTED|Overall Study||20
51176|NCT01689649|120855|P1|NOT COMPLETED|Overall Study||22
51177|NCT01689649|120855|P1|COMPLETED|Overall Study||117
51178|NCT01689649|120855|P1|STARTED|Overall Study||139
51179|NCT01689532|120867|P2|NOT COMPLETED|Overall Study||9
51180|NCT01689532|120868|P1|NOT COMPLETED|Overall Study||14
51181|NCT01689532|120867|P2|COMPLETED|Overall Study||52
51182|NCT01689532|120868|P1|COMPLETED|Overall Study||47
51183|NCT01689532|120867|P2|STARTED|Overall Study||61
51184|NCT01689532|120868|P1|STARTED|Overall Study||61
51185|NCT01689519|120932|P2|NOT COMPLETED|Overall Study||138
51186|NCT01689519|120933|P1|NOT COMPLETED|Overall Study||166
51187|NCT01689519|120932|P2|COMPLETED|Overall Study||109
51188|NCT01689519|120933|P1|COMPLETED|Overall Study||82
51189|NCT01689519|120932|P2|Received Treatment|Overall Study||246
51190|NCT01689519|120933|P1|Received Treatment|Overall Study||247
51191|NCT01689519|120932|P2|STARTED|Overall Study||247
51192|NCT01689519|120933|P1|STARTED|Overall Study||248
51193|NCT01689441|120949|P2|NOT COMPLETED|Overall Study||0
51194|NCT01689441|120950|P1|NOT COMPLETED|Overall Study||0
51195|NCT01689441|120949|P2|COMPLETED|Overall Study||31
51196|NCT01689441|120950|P1|COMPLETED|Overall Study||36
51197|NCT01689441|120949|P2|STARTED|Overall Study||31
51198|NCT01689441|120950|P1|STARTED|Overall Study||36
51199|NCT01689363|120960|P8|NOT COMPLETED|Overall Study||0
51200|NCT01689363|120961|P7|NOT COMPLETED|Overall Study||0
51201|NCT01689363|120962|P6|NOT COMPLETED|Overall Study||0
51202|NCT01689363|120963|P5|NOT COMPLETED|Overall Study||0
51203|NCT01689363|120964|P4|NOT COMPLETED|Overall Study||0
51204|NCT01689363|120965|P3|NOT COMPLETED|Overall Study||0
51205|NCT01689363|120966|P2|NOT COMPLETED|Overall Study||1
51206|NCT01689363|120967|P1|NOT COMPLETED|Overall Study||0
51207|NCT01689363|120960|P8|COMPLETED|Overall Study||32
51208|NCT01689363|120961|P7|COMPLETED|Overall Study||32
51209|NCT01689363|120962|P6|COMPLETED|Overall Study||31
51210|NCT01689363|120963|P5|COMPLETED|Overall Study||31
51211|NCT01689363|120964|P4|COMPLETED|Overall Study||31
51212|NCT01689363|120965|P3|COMPLETED|Overall Study||32
51213|NCT01689363|120966|P2|COMPLETED|Overall Study||31
51214|NCT01689363|120967|P1|COMPLETED|Overall Study||32
51215|NCT01689363|120960|P8|STARTED|Overall Study||32
51216|NCT01689363|120961|P7|STARTED|Overall Study||32
51217|NCT01689363|120962|P6|STARTED|Overall Study||31
51218|NCT01689363|120963|P5|STARTED|Overall Study||31
51219|NCT01689363|120964|P4|STARTED|Overall Study||31
51220|NCT01689363|120965|P3|STARTED|Overall Study||32
51221|NCT01689363|120966|P2|STARTED|Overall Study||32
51222|NCT01689363|120967|P1|STARTED|Overall Study||32
51223|NCT01689350|121013|P2|NOT COMPLETED|Overall Study||0
51224|NCT01689350|121014|P1|NOT COMPLETED|Overall Study||0
51225|NCT01689350|121013|P2|COMPLETED|Overall Study||45
51226|NCT01689350|121014|P1|COMPLETED|Overall Study||47
51227|NCT01689350|121013|P2|STARTED|Overall Study||45
51228|NCT01689350|121014|P1|STARTED|Overall Study||47
51229|NCT01689337|121022|P1|NOT COMPLETED|Overall Study||1
51230|NCT01689337|121022|P1|COMPLETED|Overall Study||0
51231|NCT01689337|121022|P1|STARTED|Overall Study||1
51232|NCT01689324|121037|P1|NOT COMPLETED|Overall Study||0
51233|NCT01689324|121037|P1|COMPLETED|Overall Study||43
51234|NCT01689324|121037|P1|STARTED|Overall Study||43
51235|NCT01689207|121061|P11|NOT COMPLETED|Overall Study||0
51236|NCT01689207|121062|P10|NOT COMPLETED|Overall Study||0
51237|NCT01689207|121063|P9|NOT COMPLETED|Overall Study||1
51238|NCT01689207|121064|P8|NOT COMPLETED|Overall Study||0
51239|NCT01689207|121065|P7|NOT COMPLETED|Overall Study||0
51240|NCT01689207|121066|P6|NOT COMPLETED|Overall Study||1
51241|NCT01689207|121067|P5|NOT COMPLETED|Overall Study||2
51242|NCT01689207|121068|P4|NOT COMPLETED|Overall Study||0
51243|NCT01689207|121069|P3|NOT COMPLETED|Overall Study||0
51244|NCT01689207|121070|P2|NOT COMPLETED|Overall Study||1
51245|NCT01689207|121071|P1|NOT COMPLETED|Overall Study||0
51246|NCT01689207|121061|P11|COMPLETED|Overall Study|Subjects completed study|8
51247|NCT01689207|121062|P10|COMPLETED|Overall Study|Subjects completed study|10
51248|NCT01689207|121063|P9|COMPLETED|Overall Study|Subjects completed study|5
51249|NCT01689207|121064|P8|COMPLETED|Overall Study|Subjects completed study|10
51250|NCT01689207|121065|P7|COMPLETED|Overall Study|Subjects completed study|10
51251|NCT01689207|121066|P6|COMPLETED|Overall Study|Subjects completed study|7
51252|NCT01689207|121067|P5|COMPLETED|Overall Study|Subjects completed study|2
51253|NCT01689207|121068|P4|COMPLETED|Overall Study|Subjects completed study|8
51254|NCT01689207|121069|P3|COMPLETED|Overall Study|Subjects completed study|16
51255|NCT01689207|121070|P2|COMPLETED|Overall Study|Subjects completed study|7
51256|NCT01689207|121071|P1|COMPLETED|Overall Study|Subjects completed study|4
51257|NCT01689207|121061|P11|STARTED|Overall Study|Subjects randomised|8
51258|NCT01689207|121062|P10|STARTED|Overall Study|Subjects randomised|10
51259|NCT01689207|121063|P9|STARTED|Overall Study|Subjects randomised|6
51260|NCT01689207|121064|P8|STARTED|Overall Study|Subjects randomised|10
51261|NCT01689207|121065|P7|STARTED|Overall Study|Subjects randomised|10
51262|NCT01689207|121066|P6|STARTED|Overall Study|Subjects randomised|8
51263|NCT01689207|121067|P5|STARTED|Overall Study|Subjects randomised|4
51264|NCT01689207|121068|P4|STARTED|Overall Study|Subjects randomised|8
51265|NCT01689207|121069|P3|STARTED|Overall Study|Subjects randomised|16
51266|NCT01689207|121070|P2|STARTED|Overall Study|Subjects randomised|8
51267|NCT01689207|121071|P1|STARTED|Overall Study|Subjects randomised|4
51268|NCT01689155|121167|P1|NOT COMPLETED|Overall Study||0
51269|NCT01689155|121167|P1|COMPLETED|Overall Study||116
51270|NCT01689155|121167|P1|STARTED|Overall Study||116
51271|NCT01688921|121178|P2|NOT COMPLETED|Overall Study||15
51272|NCT01688921|121179|P1|NOT COMPLETED|Overall Study||16
51273|NCT01688921|121178|P2|COMPLETED|Overall Study||608
51274|NCT01688921|121179|P1|COMPLETED|Overall Study||611
51275|NCT01688921|121178|P2|STARTED|Overall Study||623
51276|NCT01688921|121179|P1|STARTED|Overall Study||627
51277|NCT01688882|121204|P2|NOT COMPLETED|Overall Study||1
51278|NCT01688882|121205|P1|NOT COMPLETED|Overall Study||3
51279|NCT01688882|121204|P2|COMPLETED|Overall Study|The one patient that discontinued was already switched to open-label QGE031 treatment.|6
51280|NCT01688882|121205|P1|COMPLETED|Overall Study||10
51281|NCT01688882|121204|P2|Safety Follow-up|Overall Study||5
51282|NCT01688882|121205|P1|Safety Follow-up|Overall Study||11
51283|NCT01688882|121204|P2|STARTED|Overall Study|4 patients who completed 12 weeks of placebo changed to open-label QGE031 treatment.|7
51284|NCT01688882|121205|P1|STARTED|Overall Study||13
51285|NCT01688830|121240|P21|NOT COMPLETED|Overall Study||0
51286|NCT01688830|121241|P20|NOT COMPLETED|Overall Study||0
51287|NCT01688830|121242|P19|NOT COMPLETED|Overall Study||0
51288|NCT01688830|121243|P18|NOT COMPLETED|Overall Study||0
51289|NCT01688830|121244|P17|NOT COMPLETED|Overall Study||0
51290|NCT01688830|121245|P16|NOT COMPLETED|Overall Study||0
51291|NCT01688830|121246|P15|NOT COMPLETED|Overall Study||0
51292|NCT01688830|121247|P14|NOT COMPLETED|Overall Study||0
51293|NCT01688830|121248|P13|NOT COMPLETED|Overall Study||0
51294|NCT01688830|121249|P12|NOT COMPLETED|Overall Study||0
51295|NCT01688830|121250|P11|NOT COMPLETED|Overall Study||1
51296|NCT01688830|121251|P10|NOT COMPLETED|Overall Study||0
51297|NCT01688830|121252|P9|NOT COMPLETED|Overall Study||0
51298|NCT01688830|121253|P8|NOT COMPLETED|Overall Study||0
51299|NCT01688830|121254|P7|NOT COMPLETED|Overall Study||0
51300|NCT01688830|121255|P6|NOT COMPLETED|Overall Study||0
51301|NCT01688830|121256|P5|NOT COMPLETED|Overall Study||0
51302|NCT01688830|121257|P4|NOT COMPLETED|Overall Study||0
51303|NCT01688830|121258|P3|NOT COMPLETED|Overall Study||0
51304|NCT01688830|121259|P2|NOT COMPLETED|Overall Study||0
51305|NCT01688830|121260|P1|NOT COMPLETED|Overall Study||0
51306|NCT01688830|121240|P21|COMPLETED|Overall Study||9
51307|NCT01688830|121241|P20|COMPLETED|Overall Study||3
51308|NCT01688830|121242|P19|COMPLETED|Overall Study||8
51309|NCT01688830|121243|P18|COMPLETED|Overall Study||9
51310|NCT01688830|121244|P17|COMPLETED|Overall Study||9
51311|NCT01688830|121245|P16|COMPLETED|Overall Study||9
51312|NCT01688830|121246|P15|COMPLETED|Overall Study||6
51313|NCT01688830|121247|P14|COMPLETED|Overall Study||6
51314|NCT01688830|121248|P13|COMPLETED|Overall Study||6
51315|NCT01688830|121249|P12|COMPLETED|Overall Study||6
51316|NCT01688830|121250|P11|COMPLETED|Overall Study||5
51317|NCT01688830|121251|P10|COMPLETED|Overall Study||6
51318|NCT01688830|121252|P9|COMPLETED|Overall Study||6
51319|NCT01688830|121253|P8|COMPLETED|Overall Study||6
51320|NCT01688830|121254|P7|COMPLETED|Overall Study||12
51321|NCT01688830|121255|P6|COMPLETED|Overall Study||6
51322|NCT01688830|121256|P5|COMPLETED|Overall Study||5
51323|NCT01688830|121257|P4|COMPLETED|Overall Study||6
51324|NCT01688830|121258|P3|COMPLETED|Overall Study||6
51325|NCT01688830|121259|P2|COMPLETED|Overall Study||6
51326|NCT01688830|121260|P1|COMPLETED|Overall Study||21
51327|NCT01688830|121240|P21|STARTED|Overall Study||9
51328|NCT01688830|121241|P20|STARTED|Overall Study||3
51329|NCT01688830|121242|P19|STARTED|Overall Study||8
51330|NCT01688830|121243|P18|STARTED|Overall Study||9
51331|NCT01688830|121244|P17|STARTED|Overall Study||9
51332|NCT01688830|121245|P16|STARTED|Overall Study||9
51333|NCT01688830|121246|P15|STARTED|Overall Study||6
51334|NCT01688830|121247|P14|STARTED|Overall Study||6
51335|NCT01688830|121248|P13|STARTED|Overall Study||6
51336|NCT01688830|121249|P12|STARTED|Overall Study||6
51337|NCT01688830|121250|P11|STARTED|Overall Study||6
51338|NCT01688830|121251|P10|STARTED|Overall Study||6
51339|NCT01688830|121252|P9|STARTED|Overall Study||6
51340|NCT01688830|121253|P8|STARTED|Overall Study||6
51341|NCT01688830|121254|P7|STARTED|Overall Study||12
51342|NCT01688830|121255|P6|STARTED|Overall Study||6
51343|NCT01688830|121256|P5|STARTED|Overall Study||5
51344|NCT01688830|121257|P4|STARTED|Overall Study||6
51345|NCT01688830|121258|P3|STARTED|Overall Study||6
51346|NCT01688830|121259|P2|STARTED|Overall Study||6
51347|NCT01688830|121260|P1|STARTED|Overall Study||21
51348|NCT01688726|121406|P2|NOT COMPLETED|Overall Study||1
51349|NCT01688726|121407|P1|NOT COMPLETED|Overall Study||1
51350|NCT01688726|121406|P2|COMPLETED|Overall Study||44
51351|NCT01688726|121407|P1|COMPLETED|Overall Study||45
51352|NCT01688726|121406|P2|STARTED|Overall Study||45
51353|NCT01688726|121407|P1|STARTED|Overall Study||46
51354|NCT01688635|121419|P2|NOT COMPLETED|Period 4||0
51355|NCT01688635|121420|P1|NOT COMPLETED|Period 4||0
51356|NCT01688635|121419|P2|COMPLETED|Period 4||42
51357|NCT01688635|121420|P1|COMPLETED|Period 4||40
51358|NCT01688635|121419|P2|STARTED|Period 4||42
51359|NCT01688635|121420|P1|STARTED|Period 4||40
51360|NCT01688635|121419|P2|NOT COMPLETED|Washout 3||0
51361|NCT01688635|121420|P1|NOT COMPLETED|Washout 3||1
51362|NCT01688635|121419|P2|COMPLETED|Washout 3||42
51363|NCT01688635|121420|P1|COMPLETED|Washout 3||40
51364|NCT01688635|121419|P2|STARTED|Washout 3||42
51365|NCT01688635|121420|P1|STARTED|Washout 3||41
51366|NCT01688635|121419|P2|NOT COMPLETED|Period 3||0
51367|NCT01688635|121420|P1|NOT COMPLETED|Period 3||0
51368|NCT01688635|121419|P2|COMPLETED|Period 3||42
51369|NCT01688635|121420|P1|COMPLETED|Period 3||41
51370|NCT01688635|121419|P2|STARTED|Period 3||42
51371|NCT01688635|121420|P1|STARTED|Period 3||41
51372|NCT01688635|121419|P2|NOT COMPLETED|Washout 2||2
51373|NCT01688635|121420|P1|NOT COMPLETED|Washout 2||3
51374|NCT01688635|121419|P2|COMPLETED|Washout 2||42
51375|NCT01688635|121420|P1|COMPLETED|Washout 2||41
51376|NCT01688635|121419|P2|STARTED|Washout 2||44
51377|NCT01688635|121420|P1|STARTED|Washout 2||44
51378|NCT01688635|121419|P2|NOT COMPLETED|Period 2||0
51379|NCT01688635|121420|P1|NOT COMPLETED|Period 2||0
51380|NCT01688635|121419|P2|COMPLETED|Period 2||44
51381|NCT01688635|121420|P1|COMPLETED|Period 2||44
51382|NCT01688635|121419|P2|STARTED|Period 2||44
51383|NCT01688635|121420|P1|STARTED|Period 2||44
51384|NCT01688635|121419|P2|NOT COMPLETED|Washout 1||2
51385|NCT01688635|121420|P1|NOT COMPLETED|Washout 1||1
51386|NCT01688635|121419|P2|COMPLETED|Washout 1||44
51387|NCT01688635|121420|P1|COMPLETED|Washout 1||44
51388|NCT01688635|121419|P2|STARTED|Washout 1||46
51389|NCT01688635|121420|P1|STARTED|Washout 1||45
51390|NCT01688635|121419|P2|NOT COMPLETED|Period 1||0
51391|NCT01688635|121420|P1|NOT COMPLETED|Period 1||0
51392|NCT01688635|121419|P2|COMPLETED|Period 1||46
51393|NCT01688635|121420|P1|COMPLETED|Period 1||45
51394|NCT01688635|121419|P2|Received at Least 1 Dose of Study Drug|Period 1||46
51395|NCT01688635|121420|P1|Received at Least 1 Dose of Study Drug|Period 1||45
51396|NCT01688635|121419|P2|STARTED|Period 1||46
51397|NCT01688635|121420|P1|STARTED|Period 1||45
51398|NCT01688336|121432|P1|NOT COMPLETED|Overall Study||0
51399|NCT01688336|121432|P1|COMPLETED|Overall Study||9
51400|NCT01688336|121432|P1|STARTED|Overall Study||9
51401|NCT01688310|121443|P2|NOT COMPLETED|Overall Study||0
51402|NCT01688310|121444|P1|NOT COMPLETED|Overall Study||0
51403|NCT01688310|121443|P2|COMPLETED|Overall Study||100
51404|NCT01688310|121444|P1|COMPLETED|Overall Study||100
51405|NCT01688310|121443|P2|STARTED|Overall Study||100
51406|NCT01688310|121444|P1|STARTED|Overall Study||100
51407|NCT01688102|121464|P2|NOT COMPLETED|Overall Study||18
51408|NCT01688102|121465|P1|NOT COMPLETED|Overall Study||16
51409|NCT01688102|121464|P2|COMPLETED|Overall Study||40
51410|NCT01688102|121465|P1|COMPLETED|Overall Study||44
51411|NCT01688102|121464|P2|STARTED|Overall Study||58
51412|NCT01688102|121465|P1|STARTED|Overall Study||60
51413|NCT01688050|121471|P1|NOT COMPLETED|Overall Study||50
51414|NCT01688050|121471|P1|COMPLETED|Overall Study||0
51415|NCT01688050|121471|P1|30 Days|Overall Study||50
51416|NCT01688050|121471|P1|STARTED|Overall Study||50
51417|NCT01687790|121477|P1|NOT COMPLETED|Overall Study||0
51418|NCT01687790|121477|P1|COMPLETED|Overall Study||60
51419|NCT01687790|121477|P1|STARTED|Overall Study||60
51420|NCT01687478|121484|P2|NOT COMPLETED|Overall Study||39
51421|NCT01687478|121485|P1|NOT COMPLETED|Overall Study||32
51422|NCT01687478|121484|P2|COMPLETED|Overall Study||49
51423|NCT01687478|121485|P1|COMPLETED|Overall Study||56
51424|NCT01687478|121484|P2|Safety Analysis Set|Overall Study||87
51425|NCT01687478|121485|P1|Safety Analysis Set|Overall Study||88
51426|NCT01687478|121484|P2|STARTED|Overall Study||88
51427|NCT01687478|121485|P1|STARTED|Overall Study||88
51428|NCT01687283|121509|P2|NOT COMPLETED|Overall Study||27
51429|NCT01687283|121510|P1|NOT COMPLETED|Overall Study||35
51430|NCT01687283|121509|P2|COMPLETED|Overall Study||130
51431|NCT01687283|121510|P1|COMPLETED|Overall Study||123
51432|NCT01687283|121509|P2|STARTED|Overall Study||157
51433|NCT01687283|121510|P1|STARTED|Overall Study||158
51434|NCT01687270|121533|P1|NOT COMPLETED|Overall Study||12
51435|NCT01687270|121533|P1|COMPLETED|Overall Study||28
51436|NCT01687270|121533|P1|STARTED|Overall Study||40
51437|NCT01687257|121544|P3|NOT COMPLETED|Overall Study||6
51438|NCT01687257|121545|P2|NOT COMPLETED|Overall Study||4
51439|NCT01687257|121546|P1|NOT COMPLETED|Overall Study||8
51440|NCT01687257|121544|P3|COMPLETED|Overall Study||15
51441|NCT01687257|121545|P2|COMPLETED|Overall Study||0
51442|NCT01687257|121546|P1|COMPLETED|Overall Study||17
51443|NCT01687257|121544|P3|STARTED|Overall Study||21
51444|NCT01687257|121545|P2|STARTED|Overall Study||4
51445|NCT01687257|121546|P1|STARTED|Overall Study||25
51446|NCT01687244|121574|P2|NOT COMPLETED|Overall Study||0
51447|NCT01687244|121575|P1|NOT COMPLETED|Overall Study||0
51448|NCT01687244|121574|P2|COMPLETED|Overall Study||19
51449|NCT01687244|121575|P1|COMPLETED|Overall Study||21
51450|NCT01687244|121574|P2|STARTED|Overall Study||19
51451|NCT01687244|121575|P1|STARTED|Overall Study||21
51452|NCT01687218|121611|P6|NOT COMPLETED|Overall Study||0
51453|NCT01687218|121612|P5|NOT COMPLETED|Overall Study||1
51454|NCT01687218|121613|P4|NOT COMPLETED|Overall Study||2
51455|NCT01687218|121614|P3|NOT COMPLETED|Overall Study||1
51456|NCT01687218|121615|P2|NOT COMPLETED|Overall Study||3
51457|NCT01687218|121616|P1|NOT COMPLETED|Overall Study||3
51458|NCT01687218|121611|P6|COMPLETED|Overall Study||32
51459|NCT01687218|121612|P5|COMPLETED|Overall Study||32
51460|NCT01687218|121613|P4|COMPLETED|Overall Study||32
51461|NCT01687218|121614|P3|COMPLETED|Overall Study||30
51462|NCT01687218|121615|P2|COMPLETED|Overall Study||29
51463|NCT01687218|121616|P1|COMPLETED|Overall Study||30
51464|NCT01687218|121611|P6|STARTED|Overall Study||32
51465|NCT01687218|121612|P5|STARTED|Overall Study||33
51466|NCT01687218|121613|P4|STARTED|Overall Study||34
51467|NCT01687218|121614|P3|STARTED|Overall Study||31
51468|NCT01687218|121615|P2|STARTED|Overall Study||32
51469|NCT01687218|121616|P1|STARTED|Overall Study||33
51470|NCT01687114|121636|P1|NOT COMPLETED|Overall Study||0
51471|NCT01687114|121636|P1|COMPLETED|Overall Study||5
51472|NCT01687114|121636|P1|STARTED|Overall Study||5
51473|NCT01687101|121640|P1|NOT COMPLETED|Overall Study||7
51474|NCT01687101|121640|P1|COMPLETED|Overall Study||25
51475|NCT01687101|121640|P1|STARTED|Overall Study||32
51476|NCT01687088|121646|P2|NOT COMPLETED|Overall Study||0
51477|NCT01687088|121647|P1|NOT COMPLETED|Overall Study||0
51478|NCT01687088|121646|P2|COMPLETED|Overall Study||50
51479|NCT01687088|121647|P1|COMPLETED|Overall Study||50
51480|NCT01687088|121646|P2|STARTED|Overall Study||50
51481|NCT01687088|121647|P1|STARTED|Overall Study||50
51482|NCT01687036|121653|P1|NOT COMPLETED|Overall Study||0
51483|NCT01687036|121653|P1|COMPLETED|Overall Study||10
51484|NCT01687036|121653|P1|STARTED|Overall Study||10
51485|NCT01686932|121667|P2|NOT COMPLETED|Period 2||0
51486|NCT01686932|121668|P1|NOT COMPLETED|Period 2||0
51487|NCT01686932|121667|P2|COMPLETED|Period 2||25
51488|NCT01686932|121668|P1|COMPLETED|Period 2||24
51489|NCT01686932|121667|P2|STARTED|Period 2||25
51490|NCT01686932|121668|P1|STARTED|Period 2||24
51491|NCT01686932|121667|P2|NOT COMPLETED|Period 1||1
51492|NCT01686932|121668|P1|NOT COMPLETED|Period 1||1
51493|NCT01686932|121667|P2|COMPLETED|Period 1||25
51494|NCT01686932|121668|P1|COMPLETED|Period 1||24
51495|NCT01686932|121667|P2|STARTED|Period 1||26
51496|NCT01686932|121668|P1|STARTED|Period 1||25
51497|NCT01686828|121698|P4|NOT COMPLETED|Overall Study||0
51498|NCT01686828|121699|P3|NOT COMPLETED|Overall Study||1
51499|NCT01686828|121700|P2|NOT COMPLETED|Overall Study||1
51500|NCT01686828|121701|P1|NOT COMPLETED|Overall Study||1
51501|NCT01686828|121698|P4|COMPLETED|Overall Study||13
51502|NCT01686828|121699|P3|COMPLETED|Overall Study||12
51503|NCT01686828|121700|P2|COMPLETED|Overall Study||13
51504|NCT01686828|121701|P1|COMPLETED|Overall Study||12
51505|NCT01686828|121698|P4|STARTED|Overall Study||13
51506|NCT01686828|121699|P3|STARTED|Overall Study||13
51507|NCT01686828|121700|P2|STARTED|Overall Study||14
51508|NCT01686828|121701|P1|STARTED|Overall Study||13
51509|NCT01686646|121723|P4|NOT COMPLETED|Overall Study||0
51510|NCT01686646|121724|P3|NOT COMPLETED|Overall Study||0
51511|NCT01686646|121725|P2|NOT COMPLETED|Overall Study||0
51512|NCT01686646|121726|P1|NOT COMPLETED|Overall Study||0
51513|NCT01686646|121723|P4|COMPLETED|Overall Study||75
51514|NCT01686646|121724|P3|COMPLETED|Overall Study||75
51515|NCT01686646|121725|P2|COMPLETED|Overall Study||45
51516|NCT01686646|121726|P1|COMPLETED|Overall Study||45
51517|NCT01686646|121723|P4|Safety Population|Overall Study||75
51518|NCT01686646|121724|P3|Safety Population|Overall Study||74
51519|NCT01686646|121725|P2|Safety Population|Overall Study||45
51520|NCT01686646|121726|P1|Safety Population|Overall Study|One subject randomized to Paracetamol+Caffeine (500/65) group but received 1000/130 combination.|46
51521|NCT01686646|121723|P4|Intent to Treat Population|Overall Study||75
51522|NCT01686646|121724|P3|Intent to Treat Population|Overall Study||75
51523|NCT01686646|121725|P2|Intent to Treat Population|Overall Study||45
51524|NCT01686646|121726|P1|Intent to Treat Population|Overall Study||45
51525|NCT01686646|121723|P4|STARTED|Overall Study||75
51526|NCT01686646|121724|P3|STARTED|Overall Study||75
51527|NCT01686646|121725|P2|STARTED|Overall Study||45
51528|NCT01686646|121726|P1|STARTED|Overall Study||45
51529|NCT01686633|121775|P3|NOT COMPLETED|Overall Study||25
51530|NCT01686633|121776|P2|NOT COMPLETED|Overall Study||32
51531|NCT01686633|121777|P1|NOT COMPLETED|Overall Study||51
51532|NCT01686633|121775|P3|COMPLETED|Overall Study||321
51533|NCT01686633|121776|P2|COMPLETED|Overall Study||314
51534|NCT01686633|121777|P1|COMPLETED|Overall Study||296
51535|NCT01686633|121775|P3|STARTED|Overall Study||346
51536|NCT01686633|121776|P2|STARTED|Overall Study||346
51537|NCT01686633|121777|P1|STARTED|Overall Study||347
51538|NCT01686568|121802|P2|NOT COMPLETED|Sub-Study||2
51539|NCT01686568|121803|P1|NOT COMPLETED|Sub-Study||2
51540|NCT01686568|121802|P2|COMPLETED|Sub-Study||9
51541|NCT01686568|121803|P1|COMPLETED|Sub-Study||12
51542|NCT01686568|121802|P2|STARTED|Sub-Study||11
51543|NCT01686568|121803|P1|STARTED|Sub-Study||14
51544|NCT01686568|121802|P2|NOT COMPLETED|Main Study||4
51545|NCT01686568|121803|P1|NOT COMPLETED|Main Study||2
51546|NCT01686568|121802|P2|COMPLETED|Main Study||11
51547|NCT01686568|121803|P1|COMPLETED|Main Study||14
51548|NCT01686568|121802|P2|STARTED|Main Study||15
51549|NCT01686568|121803|P1|STARTED|Main Study||16
51550|NCT01686503|121829|P4|NOT COMPLETED|Overall Study||1
51551|NCT01686503|121830|P3|NOT COMPLETED|Overall Study||2
51552|NCT01686503|121831|P2|NOT COMPLETED|Overall Study||3
51553|NCT01686503|121832|P1|NOT COMPLETED|Overall Study||1
51554|NCT01686503|121829|P4|COMPLETED|Overall Study||32
51555|NCT01686503|121830|P3|COMPLETED|Overall Study||64
51556|NCT01686503|121831|P2|COMPLETED|Overall Study||63
51557|NCT01686503|121832|P1|COMPLETED|Overall Study||65
51558|NCT01686503|121829|P4|STARTED|Overall Study||33
51559|NCT01686503|121830|P3|STARTED|Overall Study||66
51560|NCT01686503|121831|P2|STARTED|Overall Study||66
51561|NCT01686503|121832|P1|STARTED|Overall Study||66
51562|NCT01686451|121848|P2|NOT COMPLETED|Overall Study||0
51563|NCT01686451|121849|P1|NOT COMPLETED|Overall Study||0
51564|NCT01686451|121848|P2|COMPLETED|Overall Study||27
51565|NCT01686451|121849|P1|COMPLETED|Overall Study||33
51566|NCT01686451|121848|P2|STARTED|Overall Study||27
51567|NCT01686451|121849|P1|STARTED|Overall Study||33
51568|NCT01685996|121879|P2|NOT COMPLETED|Overall Study||13
51569|NCT01685996|121880|P1|NOT COMPLETED|Overall Study||16
51570|NCT01685996|121879|P2|COMPLETED|Overall Study||27
51571|NCT01685996|121880|P1|COMPLETED|Overall Study||18
51572|NCT01685996|121879|P2|STARTED|Overall Study||40
51573|NCT01685996|121880|P1|STARTED|Overall Study||34
51574|NCT01685983|121888|P1|NOT COMPLETED|Overall Study||82
51575|NCT01685983|121888|P1|COMPLETED|Overall Study||0
51576|NCT01685983|121888|P1|STARTED|Overall Study||82
51577|NCT01685801|121902|P4|NOT COMPLETED|Open-label Period (8 Weeks)||0
51578|NCT01685801|121903|P3|NOT COMPLETED|Open-label Period (8 Weeks)||0
51579|NCT01685801|121904|P2|NOT COMPLETED|Open-label Period (8 Weeks)||0
51580|NCT01685801|121905|P1|NOT COMPLETED|Open-label Period (8 Weeks)||0
51581|NCT01685801|121902|P4|COMPLETED|Open-label Period (8 Weeks)||4
51582|NCT01685801|121903|P3|COMPLETED|Open-label Period (8 Weeks)||7
51583|NCT01685801|121904|P2|COMPLETED|Open-label Period (8 Weeks)||5
51584|NCT01685801|121905|P1|COMPLETED|Open-label Period (8 Weeks)||5
51585|NCT01685801|121902|P4|STARTED|Open-label Period (8 Weeks)||4
51586|NCT01685801|121903|P3|STARTED|Open-label Period (8 Weeks)||7
51587|NCT01685801|121904|P2|STARTED|Open-label Period (8 Weeks)||5
51588|NCT01685801|121905|P1|STARTED|Open-label Period (8 Weeks)||5
51589|NCT01685801|121902|P4|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
51590|NCT01685801|121903|P3|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
51591|NCT01685801|121904|P2|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
51592|NCT01685801|121905|P1|NOT COMPLETED|Washout Period 2 (4 Weeks)||0
51593|NCT01685801|121902|P4|COMPLETED|Washout Period 2 (4 Weeks)||4
51594|NCT01685801|121903|P3|COMPLETED|Washout Period 2 (4 Weeks)||7
51595|NCT01685801|121904|P2|COMPLETED|Washout Period 2 (4 Weeks)||5
51596|NCT01685801|121905|P1|COMPLETED|Washout Period 2 (4 Weeks)||5
51597|NCT01685801|121902|P4|STARTED|Washout Period 2 (4 Weeks)||4
51598|NCT01685801|121903|P3|STARTED|Washout Period 2 (4 Weeks)||7
51599|NCT01685801|121904|P2|STARTED|Washout Period 2 (4 Weeks)||5
51600|NCT01685801|121905|P1|STARTED|Washout Period 2 (4 Weeks)||5
51601|NCT01685801|121902|P4|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
51602|NCT01685801|121903|P3|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
51603|NCT01685801|121904|P2|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||1
51604|NCT01685801|121905|P1|NOT COMPLETED|Cycle 2 Period 2 (2 Weeks)||0
51605|NCT01685801|121902|P4|COMPLETED|Cycle 2 Period 2 (2 Weeks)||4
51606|NCT01685801|121903|P3|COMPLETED|Cycle 2 Period 2 (2 Weeks)||7
51607|NCT01685801|121904|P2|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
51608|NCT01685801|121905|P1|COMPLETED|Cycle 2 Period 2 (2 Weeks)||5
51609|NCT01685801|121902|P4|STARTED|Cycle 2 Period 2 (2 Weeks)||5
51610|NCT01685801|121903|P3|STARTED|Cycle 2 Period 2 (2 Weeks)||7
51611|NCT01685801|121904|P2|STARTED|Cycle 2 Period 2 (2 Weeks)||6
51612|NCT01685801|121905|P1|STARTED|Cycle 2 Period 2 (2 Weeks)||5
51613|NCT01685801|121902|P4|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
51614|NCT01685801|121903|P3|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
51615|NCT01685801|121904|P2|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
51616|NCT01685801|121905|P1|NOT COMPLETED|Cycle 2 Period 1 (2 Weeks)||0
51617|NCT01685801|121902|P4|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
51618|NCT01685801|121903|P3|COMPLETED|Cycle 2 Period 1 (2 Weeks)||7
51619|NCT01685801|121904|P2|COMPLETED|Cycle 2 Period 1 (2 Weeks)||6
51620|NCT01685801|121905|P1|COMPLETED|Cycle 2 Period 1 (2 Weeks)||5
51621|NCT01685801|121902|P4|STARTED|Cycle 2 Period 1 (2 Weeks)||5
51622|NCT01685801|121903|P3|STARTED|Cycle 2 Period 1 (2 Weeks)||7
51623|NCT01685801|121904|P2|STARTED|Cycle 2 Period 1 (2 Weeks)||6
51624|NCT01685801|121905|P1|STARTED|Cycle 2 Period 1 (2 Weeks)||5
51625|NCT01685801|121902|P4|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
51626|NCT01685801|121903|P3|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
51627|NCT01685801|121904|P2|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
51628|NCT01685801|121905|P1|NOT COMPLETED|Washout Period 1 (4 Weeks)||0
51629|NCT01685801|121902|P4|COMPLETED|Washout Period 1 (4 Weeks)||5
51630|NCT01685801|121903|P3|COMPLETED|Washout Period 1 (4 Weeks)||7
51631|NCT01685801|121904|P2|COMPLETED|Washout Period 1 (4 Weeks)||6
51632|NCT01685801|121905|P1|COMPLETED|Washout Period 1 (4 Weeks)||5
51633|NCT01685801|121902|P4|STARTED|Washout Period 1 (4 Weeks)||5
51634|NCT01685801|121903|P3|STARTED|Washout Period 1 (4 Weeks)||7
51635|NCT01685801|121904|P2|STARTED|Washout Period 1 (4 Weeks)||6
51636|NCT01685801|121905|P1|STARTED|Washout Period 1 (4 Weeks)||5
51637|NCT01685801|121902|P4|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||1
51638|NCT01685801|121903|P3|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
51639|NCT01685801|121904|P2|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
51640|NCT01685801|121905|P1|NOT COMPLETED|Cycle 1 Period 2 (2 Weeks)||0
51641|NCT01685801|121902|P4|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
51642|NCT01685801|121903|P3|COMPLETED|Cycle 1 Period 2 (2 Weeks)||7
51643|NCT01685801|121904|P2|COMPLETED|Cycle 1 Period 2 (2 Weeks)||6
51644|NCT01685801|121905|P1|COMPLETED|Cycle 1 Period 2 (2 Weeks)||5
51645|NCT01685801|121902|P4|STARTED|Cycle 1 Period 2 (2 Weeks)||6
51646|NCT01685801|121903|P3|STARTED|Cycle 1 Period 2 (2 Weeks)||7
51647|NCT01685801|121904|P2|STARTED|Cycle 1 Period 2 (2 Weeks)||6
51648|NCT01685801|121905|P1|STARTED|Cycle 1 Period 2 (2 Weeks)||5
51649|NCT01685801|121902|P4|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
51650|NCT01685801|121903|P3|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
51651|NCT01685801|121904|P2|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
51652|NCT01685801|121905|P1|NOT COMPLETED|Cycle 1 Period 1 (2 Weeks)||0
51653|NCT01685801|121902|P4|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
51654|NCT01685801|121903|P3|COMPLETED|Cycle 1 Period 1 (2 Weeks)||7
51655|NCT01685801|121904|P2|COMPLETED|Cycle 1 Period 1 (2 Weeks)||6
51656|NCT01685801|121905|P1|COMPLETED|Cycle 1 Period 1 (2 Weeks)||5
51657|NCT01685801|121902|P4|STARTED|Cycle 1 Period 1 (2 Weeks)||6
51658|NCT01685801|121903|P3|STARTED|Cycle 1 Period 1 (2 Weeks)||7
51659|NCT01685801|121904|P2|STARTED|Cycle 1 Period 1 (2 Weeks)||6
51660|NCT01685801|121905|P1|STARTED|Cycle 1 Period 1 (2 Weeks)||5
51661|NCT01685684|121927|P3|NOT COMPLETED|Double-blind Maintenance Phase||96
51662|NCT01685684|121928|P2|NOT COMPLETED|Double-blind Maintenance Phase||71
51663|NCT01685684|121929|P1|NOT COMPLETED|Double-blind Maintenance Phase||0
51664|NCT01685684|121927|P3|COMPLETED|Double-blind Maintenance Phase||100
51665|NCT01685684|121928|P2|COMPLETED|Double-blind Maintenance Phase||122
51666|NCT01685684|121929|P1|COMPLETED|Double-blind Maintenance Phase||0
51667|NCT01685684|121927|P3|STARTED|Double-blind Maintenance Phase||196
51668|NCT01685684|121928|P2|STARTED|Double-blind Maintenance Phase||193
51669|NCT01685684|121929|P1|STARTED|Double-blind Maintenance Phase||0
51670|NCT01685684|121927|P3|NOT COMPLETED|Titration Phase||0
51671|NCT01685684|121928|P2|NOT COMPLETED|Titration Phase||0
51672|NCT01685684|121929|P1|NOT COMPLETED|Titration Phase||351
51673|NCT01685684|121927|P3|COMPLETED|Titration Phase||0
51674|NCT01685684|121928|P2|COMPLETED|Titration Phase||0
51675|NCT01685684|121929|P1|COMPLETED|Titration Phase||389
51676|NCT01685684|121927|P3|STARTED|Titration Phase||0
51677|NCT01685684|121928|P2|STARTED|Titration Phase||0
51678|NCT01685684|121929|P1|STARTED|Titration Phase||740
51679|NCT01685606|121953|P1|NOT COMPLETED|Overall Study||1
51680|NCT01685606|121953|P1|COMPLETED|Overall Study||5
51681|NCT01685606|121953|P1|STARTED|Overall Study||6
51682|NCT01685567|121958|P1|NOT COMPLETED|Overall Study||0
51683|NCT01685567|121958|P1|COMPLETED|Overall Study||219
51684|NCT01685567|121958|P1|STARTED|Overall Study||219
51685|NCT01685437|121966|P1|NOT COMPLETED|Overall Study||31
51686|NCT01685437|121966|P1|COMPLETED|Overall Study||158
51687|NCT01685437|121966|P1|STARTED|Overall Study||189
51688|NCT01685320|121980|P2|NOT COMPLETED|Overall Study||0
51689|NCT01685320|121981|P1|NOT COMPLETED|Overall Study||0
51690|NCT01685320|121980|P2|COMPLETED|Overall Study||15
51691|NCT01685320|121981|P1|COMPLETED|Overall Study||15
51692|NCT01685320|121980|P2|STARTED|Overall Study||15
51693|NCT01685320|121981|P1|STARTED|Overall Study||15
51694|NCT01685216|121989|P1|NOT COMPLETED|Overall Study||1
51695|NCT01685216|121989|P1|COMPLETED|Overall Study||6
51696|NCT01685216|121989|P1|STARTED|Overall Study||7
51697|NCT01685203|122006|P7|NOT COMPLETED|Overall Study||0
51698|NCT01685203|122007|P6|NOT COMPLETED|Overall Study||3
51699|NCT01685203|122008|P5|NOT COMPLETED|Overall Study||0
51700|NCT01685203|122009|P4|NOT COMPLETED|Overall Study||1
51701|NCT01685203|122010|P3|NOT COMPLETED|Overall Study||0
51702|NCT01685203|122011|P2|NOT COMPLETED|Overall Study||3
51703|NCT01685203|122012|P1|NOT COMPLETED|Overall Study||4
51704|NCT01685203|122006|P7|COMPLETED|Overall Study||52
51705|NCT01685203|122007|P6|COMPLETED|Overall Study||44
51706|NCT01685203|122008|P5|COMPLETED|Overall Study||49
51707|NCT01685203|122009|P4|COMPLETED|Overall Study||41
51708|NCT01685203|122010|P3|COMPLETED|Overall Study||40
51709|NCT01685203|122011|P2|COMPLETED|Overall Study||39
51710|NCT01685203|122012|P1|COMPLETED|Overall Study||40
51711|NCT01685203|122006|P7|Completed Study Drug|Overall Study||52
51712|NCT01685203|122007|P6|Completed Study Drug|Overall Study||43
51713|NCT01685203|122008|P5|Completed Study Drug|Overall Study||49
51714|NCT01685203|122009|P4|Completed Study Drug|Overall Study||42
51715|NCT01685203|122010|P3|Completed Study Drug|Overall Study||39
51716|NCT01685203|122011|P2|Completed Study Drug|Overall Study||40
51717|NCT01685203|122012|P1|Completed Study Drug|Overall Study||42
51718|NCT01685203|122006|P7|STARTED|Overall Study||52
51719|NCT01685203|122007|P6|STARTED|Overall Study||47
51720|NCT01685203|122008|P5|STARTED|Overall Study||49
51721|NCT01685203|122009|P4|STARTED|Overall Study||42
51722|NCT01685203|122010|P3|STARTED|Overall Study||40
51723|NCT01685203|122011|P2|STARTED|Overall Study||42
51724|NCT01685203|122012|P1|STARTED|Overall Study||44
51725|NCT01685060|122056|P1|NOT COMPLETED|Overall Study||140
51726|NCT01685060|122056|P1|COMPLETED|Overall Study||0
51727|NCT01685060|122056|P1|Discontinued From Study|Overall Study||35
51728|NCT01685060|122056|P1|Entered Survival Follow up|Overall Study||98
51729|NCT01685060|122056|P1|Entered Post-treatment Efficacy f/u|Overall Study||7
51730|NCT01685060|122056|P1|STARTED|Overall Study||140
51731|NCT01684930|122073|P2|NOT COMPLETED|Overall Study||1
51732|NCT01684930|122074|P1|NOT COMPLETED|Overall Study||3
51733|NCT01684930|122073|P2|COMPLETED|Overall Study||13
51734|NCT01684930|122074|P1|COMPLETED|Overall Study||9
51735|NCT01684930|122073|P2|STARTED|Overall Study||14
51736|NCT01684930|122074|P1|STARTED|Overall Study||12
51737|NCT01684878|122094|P4|NOT COMPLETED|Part 2: Randomized Phase||78
51738|NCT01684878|122095|P3|NOT COMPLETED|Part 2: Randomized Phase||78
51739|NCT01684878|122096|P2|NOT COMPLETED|Part 2: Randomized Phase||0
51740|NCT01684878|122097|P1|NOT COMPLETED|Part 2: Randomized Phase||0
51741|NCT01684878|122094|P4|COMPLETED|Part 2: Randomized Phase||0
51742|NCT01684878|122095|P3|COMPLETED|Part 2: Randomized Phase||0
51743|NCT01684878|122096|P2|COMPLETED|Part 2: Randomized Phase||0
51744|NCT01684878|122097|P1|COMPLETED|Part 2: Randomized Phase||0
51745|NCT01684878|122094|P4|Participants Mis-randomized|Part 2: Randomized Phase||0
51746|NCT01684878|122095|P3|Participants Mis-randomized|Part 2: Randomized Phase||2
51747|NCT01684878|122096|P2|Participants Mis-randomized|Part 2: Randomized Phase||0
51748|NCT01684878|122097|P1|Participants Mis-randomized|Part 2: Randomized Phase||0
51749|NCT01684878|122094|P4|Participants Randomized But Not Treated|Part 2: Randomized Phase||2
51750|NCT01684878|122095|P3|Participants Randomized But Not Treated|Part 2: Randomized Phase||1
51751|NCT01684878|122096|P2|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
51752|NCT01684878|122097|P1|Participants Randomized But Not Treated|Part 2: Randomized Phase||0
51753|NCT01684878|122094|P4|STARTED|Part 2: Randomized Phase||78
51754|NCT01684878|122095|P3|STARTED|Part 2: Randomized Phase||78
51755|NCT01684878|122096|P2|STARTED|Part 2: Randomized Phase||0
51756|NCT01684878|122097|P1|STARTED|Part 2: Randomized Phase||0
51757|NCT01684878|122094|P4|NOT COMPLETED|Part 1: Safety Run in Phase||0
51758|NCT01684878|122095|P3|NOT COMPLETED|Part 1: Safety Run in Phase||0
51759|NCT01684878|122096|P2|NOT COMPLETED|Part 1: Safety Run in Phase||23
51760|NCT01684878|122097|P1|NOT COMPLETED|Part 1: Safety Run in Phase||16
51761|NCT01684878|122094|P4|COMPLETED|Part 1: Safety Run in Phase||0
51762|NCT01684878|122095|P3|COMPLETED|Part 1: Safety Run in Phase||0
51763|NCT01684878|122096|P2|COMPLETED|Part 1: Safety Run in Phase||5
51764|NCT01684878|122097|P1|COMPLETED|Part 1: Safety Run in Phase||6
51765|NCT01684878|122094|P4|STARTED|Part 1: Safety Run in Phase||0
51766|NCT01684878|122095|P3|STARTED|Part 1: Safety Run in Phase||0
51767|NCT01684878|122096|P2|STARTED|Part 1: Safety Run in Phase||28
51768|NCT01684878|122097|P1|STARTED|Part 1: Safety Run in Phase||22
51769|NCT01684839|122121|P1|NOT COMPLETED|Overall Study||0
51770|NCT01684839|122121|P1|COMPLETED|Overall Study||9
51771|NCT01684839|122121|P1|STARTED|Overall Study||9
51772|NCT01684826|122125|P1|NOT COMPLETED|Overall Study||10
51773|NCT01684826|122125|P1|COMPLETED|Overall Study||39
51774|NCT01684826|122125|P1|Collected Dose and Image Information|Overall Study||39
51775|NCT01684826|122125|P1|STARTED|Overall Study||49
51776|NCT01684748|122133|P2|NOT COMPLETED|Second Intervention - 8 Weeks||0
51777|NCT01684748|122134|P1|NOT COMPLETED|Second Intervention - 8 Weeks||0
51778|NCT01684748|122133|P2|COMPLETED|Second Intervention - 8 Weeks||8
51779|NCT01684748|122134|P1|COMPLETED|Second Intervention - 8 Weeks||8
51780|NCT01684748|122133|P2|STARTED|Second Intervention - 8 Weeks||8
51781|NCT01684748|122134|P1|STARTED|Second Intervention - 8 Weeks||8
51782|NCT01684748|122133|P2|NOT COMPLETED|First Intervention - 8 Weeks||2
51783|NCT01684748|122134|P1|NOT COMPLETED|First Intervention - 8 Weeks||2
51784|NCT01684748|122133|P2|COMPLETED|First Intervention - 8 Weeks||8
51785|NCT01684748|122134|P1|COMPLETED|First Intervention - 8 Weeks||8
51786|NCT01684748|122133|P2|STARTED|First Intervention - 8 Weeks||10
51787|NCT01684748|122134|P1|STARTED|First Intervention - 8 Weeks||10
51788|NCT01684566|122142|P2|NOT COMPLETED|Overall Study||7
51789|NCT01684566|122143|P1|NOT COMPLETED|Overall Study||16
51790|NCT01684566|122142|P2|COMPLETED|Overall Study||49
51791|NCT01684566|122143|P1|COMPLETED|Overall Study||44
51792|NCT01684566|122142|P2|Treated (ITT)|Overall Study||52
51793|NCT01684566|122143|P1|Treated (ITT)|Overall Study||57
51794|NCT01684566|122142|P2|STARTED|Overall Study||56
51795|NCT01684566|122143|P1|STARTED|Overall Study||60
51796|NCT01684436|122165|P1|NOT COMPLETED|Overall Study||1
51797|NCT01684436|122165|P1|COMPLETED|Overall Study||29
51798|NCT01684436|122165|P1|STARTED|Overall Study||30
51799|NCT01684410|122177|P3|NOT COMPLETED|Overall Study||0
51800|NCT01684410|122178|P2|NOT COMPLETED|Overall Study||0
51801|NCT01684410|122179|P1|NOT COMPLETED|Overall Study||0
51802|NCT01684410|122177|P3|COMPLETED|Overall Study||10
51803|NCT01684410|122178|P2|COMPLETED|Overall Study||10
51804|NCT01684410|122179|P1|COMPLETED|Overall Study||10
51805|NCT01684410|122177|P3|STARTED|Overall Study||10
51806|NCT01684410|122178|P2|STARTED|Overall Study||10
51807|NCT01684410|122179|P1|STARTED|Overall Study||10
51808|NCT01684215|122197|P4|NOT COMPLETED|Overall Study||43
51809|NCT01684215|122198|P3|NOT COMPLETED|Overall Study||6
51810|NCT01684215|122199|P2|NOT COMPLETED|Overall Study||6
51811|NCT01684215|122200|P1|NOT COMPLETED|Overall Study||6
51812|NCT01684215|122197|P4|COMPLETED|Overall Study||0
51813|NCT01684215|122198|P3|COMPLETED|Overall Study||0
51814|NCT01684215|122199|P2|COMPLETED|Overall Study||0
51815|NCT01684215|122200|P1|COMPLETED|Overall Study||0
51816|NCT01684215|122197|P4|Treated|Overall Study||42
51817|NCT01684215|122198|P3|Treated|Overall Study||6
51818|NCT01684215|122199|P2|Treated|Overall Study||6
51819|NCT01684215|122200|P1|Treated|Overall Study||6
51820|NCT01684215|122197|P4|STARTED|Overall Study||43
51821|NCT01684215|122198|P3|STARTED|Overall Study||6
51822|NCT01684215|122199|P2|STARTED|Overall Study||6
51823|NCT01684215|122200|P1|STARTED|Overall Study||6
51824|NCT01684046|122274|P2|NOT COMPLETED|Period 2, Second 30 Days||0
51825|NCT01684046|122275|P1|NOT COMPLETED|Period 2, Second 30 Days||0
51826|NCT01684046|122274|P2|COMPLETED|Period 2, Second 30 Days||93
51827|NCT01684046|122275|P1|COMPLETED|Period 2, Second 30 Days||97
51828|NCT01684046|122274|P2|STARTED|Period 2, Second 30 Days||93
51829|NCT01684046|122275|P1|STARTED|Period 2, Second 30 Days||97
51830|NCT01684046|122274|P2|NOT COMPLETED|Period 1, First 30 Days||2
51831|NCT01684046|122275|P1|NOT COMPLETED|Period 1, First 30 Days||0
51832|NCT01684046|122274|P2|COMPLETED|Period 1, First 30 Days||93
51833|NCT01684046|122275|P1|COMPLETED|Period 1, First 30 Days||97
51834|NCT01684046|122274|P2|STARTED|Period 1, First 30 Days||95
51835|NCT01684046|122275|P1|STARTED|Period 1, First 30 Days||97
51836|NCT01684033|122281|P2|NOT COMPLETED|Period 2, Second 30 Days||0
51837|NCT01684033|122282|P1|NOT COMPLETED|Period 2, Second 30 Days||1
51838|NCT01684033|122281|P2|COMPLETED|Period 2, Second 30 Days||98
51839|NCT01684033|122282|P1|COMPLETED|Period 2, Second 30 Days||94
51840|NCT01684033|122281|P2|STARTED|Period 2, Second 30 Days||98
51841|NCT01684033|122282|P1|STARTED|Period 2, Second 30 Days||95
51842|NCT01684033|122281|P2|NOT COMPLETED|Period 1, First 30 Days||1
51843|NCT01684033|122282|P1|NOT COMPLETED|Period 1, First 30 Days||4
51844|NCT01684033|122281|P2|COMPLETED|Period 1, First 30 Days||98
51845|NCT01684033|122282|P1|COMPLETED|Period 1, First 30 Days||95
51846|NCT01684033|122281|P2|STARTED|Period 1, First 30 Days||99
51847|NCT01684033|122282|P1|STARTED|Period 1, First 30 Days||99
51848|NCT01684007|122292|P2|NOT COMPLETED|Overall Study||0
51849|NCT01684007|122293|P1|NOT COMPLETED|Overall Study||0
51850|NCT01684007|122292|P2|COMPLETED|Overall Study||50
51851|NCT01684007|122293|P1|COMPLETED|Overall Study||53
51852|NCT01684007|122292|P2|STARTED|Overall Study||50
51853|NCT01684007|122293|P1|STARTED|Overall Study||53
51854|NCT01682954|122303|P2|NOT COMPLETED|Overall Study||5
51855|NCT01682954|122304|P1|NOT COMPLETED|Overall Study||5
51856|NCT01682954|122303|P2|COMPLETED|Overall Study||33
51857|NCT01682954|122304|P1|COMPLETED|Overall Study||35
51858|NCT01682954|122303|P2|STARTED|Overall Study||38
51859|NCT01682954|122304|P1|STARTED|Overall Study||40
51860|NCT01682876|122316|P4|NOT COMPLETED|Overall Study||19
51861|NCT01682876|122317|P3|NOT COMPLETED|Overall Study||11
51862|NCT01682876|122318|P2|NOT COMPLETED|Overall Study||20
51863|NCT01682876|122319|P1|NOT COMPLETED|Overall Study||21
51864|NCT01682876|122316|P4|COMPLETED|Overall Study||157
51865|NCT01682876|122317|P3|COMPLETED|Overall Study||169
51866|NCT01682876|122318|P2|COMPLETED|Overall Study||163
51867|NCT01682876|122319|P1|COMPLETED|Overall Study||155
51868|NCT01682876|122316|P4|STARTED|Overall Study||176
51869|NCT01682876|122317|P3|STARTED|Overall Study||180
51870|NCT01682876|122318|P2|STARTED|Overall Study||183
51871|NCT01682876|122319|P1|STARTED|Overall Study||176
51872|NCT01682863|122365|P3|NOT COMPLETED|Overall Study||24
51873|NCT01682863|122366|P2|NOT COMPLETED|Overall Study||17
51874|NCT01682863|122367|P1|NOT COMPLETED|Overall Study||27
51875|NCT01682863|122365|P3|COMPLETED|Overall Study||183
51876|NCT01682863|122366|P2|COMPLETED|Overall Study||187
51877|NCT01682863|122367|P1|COMPLETED|Overall Study||177
51878|NCT01682863|122365|P3|Randomized Set|Overall Study|1 randomized patient was not treated; experienced an AE prior to receiving any study drug|207
51879|NCT01682863|122366|P2|Randomized Set|Overall Study||204
51880|NCT01682863|122367|P1|Randomized Set|Overall Study||204
51881|NCT01682863|122365|P3|Full Analysis Set (FAS)|Overall Study||206
51882|NCT01682863|122366|P2|Full Analysis Set (FAS)|Overall Study||204
51883|NCT01682863|122367|P1|Full Analysis Set (FAS)|Overall Study|included all randomized patients who received at least one dose of study medication|204
51884|NCT01682863|122365|P3|Safety Set|Overall Study||206
51885|NCT01682863|122366|P2|Safety Set|Overall Study||204
51886|NCT01682863|122367|P1|Safety Set|Overall Study||204
51887|NCT01682863|122365|P3|STARTED|Overall Study||207
51888|NCT01682863|122366|P2|STARTED|Overall Study||204
51889|NCT01682863|122367|P1|STARTED|Overall Study||204
51890|NCT01683838|122398|P2|NOT COMPLETED|Overall Study||12
51891|NCT01683838|122399|P1|NOT COMPLETED|Overall Study||26
51892|NCT01683838|122398|P2|COMPLETED|Overall Study||88
51893|NCT01683838|122399|P1|COMPLETED|Overall Study||78
51894|NCT01683838|122398|P2|Efficacy Population|Overall Study||93
51895|NCT01683838|122399|P1|Efficacy Population|Overall Study||89
51896|NCT01683838|122398|P2|Safety Population|Overall Study||100
51897|NCT01683838|122399|P1|Safety Population|Overall Study||103
51898|NCT01683838|122398|P2|Intent to Treat (ITT) Population|Overall Study||100
51899|NCT01683838|122399|P1|Intent to Treat (ITT) Population|Overall Study||103
51900|NCT01683838|122398|P2|STARTED|Overall Study||100
51901|NCT01683838|122399|P1|STARTED|Overall Study||104
51902|NCT01683812|122421|P1|NOT COMPLETED|Overall Study||0
51903|NCT01683812|122421|P1|COMPLETED|Overall Study||23
51904|NCT01683812|122421|P1|STARTED|Overall Study||23
51905|NCT01683630|122428|P2|NOT COMPLETED|Overall Study||0
51906|NCT01683630|122429|P1|NOT COMPLETED|Overall Study||0
51907|NCT01683630|122428|P2|COMPLETED|Overall Study||445
51908|NCT01683630|122429|P1|COMPLETED|Overall Study||1404
51909|NCT01683630|122428|P2|STARTED|Overall Study||445
51910|NCT01683630|122429|P1|STARTED|Overall Study||1404
51911|NCT01683604|122439|P1|NOT COMPLETED|Overall Study||5
51912|NCT01683604|122439|P1|COMPLETED|Overall Study||32
51913|NCT01683604|122439|P1|STARTED|Overall Study||37
51914|NCT01683526|122604|P2|NOT COMPLETED|Overall Study||0
51915|NCT01683526|122605|P1|NOT COMPLETED|Overall Study||0
51916|NCT01683526|122604|P2|COMPLETED|Overall Study||57
51917|NCT01683526|122605|P1|COMPLETED|Overall Study||60
51918|NCT01683526|122604|P2|STARTED|Overall Study||57
51919|NCT01683526|122605|P1|STARTED|Overall Study||60
51920|NCT01683409|122624|P5|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||3
51921|NCT01683409|122625|P4|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
51922|NCT01683409|122626|P3|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||1
51923|NCT01683409|122627|P2|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
51924|NCT01683409|122628|P1|NOT COMPLETED|Washout Period 2 (Weeks 29-32)||0
51925|NCT01683409|122624|P5|COMPLETED|Washout Period 2 (Weeks 29-32)||9
51926|NCT01683409|122625|P4|COMPLETED|Washout Period 2 (Weeks 29-32)||6
51927|NCT01683409|122626|P3|COMPLETED|Washout Period 2 (Weeks 29-32)||7
51928|NCT01683409|122627|P2|COMPLETED|Washout Period 2 (Weeks 29-32)||6
51929|NCT01683409|122628|P1|COMPLETED|Washout Period 2 (Weeks 29-32)||6
52008|NCT01682837|122758|P1|Received KCl|Third Intervention (4 Weeks)||7
51930|NCT01683409|122624|P5|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 8 participants.|12
51931|NCT01683409|122625|P4|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 16 participants.|6
51932|NCT01683409|122626|P3|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 17 participants.|8
51933|NCT01683409|122627|P2|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 11 participants.|6
51934|NCT01683409|122628|P1|STARTED|Washout Period 2 (Weeks 29-32)|Study was completed at Week 28 for 18 participants.|6
51935|NCT01683409|122624|P5|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
51936|NCT01683409|122625|P4|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||2
51937|NCT01683409|122626|P3|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||1
51938|NCT01683409|122627|P2|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||4
51939|NCT01683409|122628|P1|NOT COMPLETED|Washout Period 1 (Weeks 25-28)||3
51940|NCT01683409|122624|P5|COMPLETED|Washout Period 1 (Weeks 25-28)||20
51941|NCT01683409|122625|P4|COMPLETED|Washout Period 1 (Weeks 25-28)||22
51942|NCT01683409|122626|P3|COMPLETED|Washout Period 1 (Weeks 25-28)||25
51943|NCT01683409|122627|P2|COMPLETED|Washout Period 1 (Weeks 25-28)||17
51944|NCT01683409|122628|P1|COMPLETED|Washout Period 1 (Weeks 25-28)||24
51945|NCT01683409|122624|P5|STARTED|Washout Period 1 (Weeks 25-28)||23
51946|NCT01683409|122625|P4|STARTED|Washout Period 1 (Weeks 25-28)||24
51947|NCT01683409|122626|P3|STARTED|Washout Period 1 (Weeks 25-28)||26
51948|NCT01683409|122627|P2|STARTED|Washout Period 1 (Weeks 25-28)||21
51949|NCT01683409|122628|P1|STARTED|Washout Period 1 (Weeks 25-28)||27
51950|NCT01683409|122624|P5|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
51951|NCT01683409|122625|P4|NOT COMPLETED|Treatment Period (Weeks 1-24)||2
51952|NCT01683409|122626|P3|NOT COMPLETED|Treatment Period (Weeks 1-24)||1
51953|NCT01683409|122627|P2|NOT COMPLETED|Treatment Period (Weeks 1-24)||4
51954|NCT01683409|122628|P1|NOT COMPLETED|Treatment Period (Weeks 1-24)||0
51955|NCT01683409|122624|P5|COMPLETED|Treatment Period (Weeks 1-24)||23
51956|NCT01683409|122625|P4|COMPLETED|Treatment Period (Weeks 1-24)||24
51957|NCT01683409|122626|P3|COMPLETED|Treatment Period (Weeks 1-24)||26
51958|NCT01683409|122627|P2|COMPLETED|Treatment Period (Weeks 1-24)||21
51959|NCT01683409|122628|P1|COMPLETED|Treatment Period (Weeks 1-24)||27
51960|NCT01683409|122624|P5|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
51961|NCT01683409|122625|P4|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
51962|NCT01683409|122626|P3|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||26
51963|NCT01683409|122627|P2|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||25
51964|NCT01683409|122628|P1|Received at Least One Dose of Study Drug|Treatment Period (Weeks 1-24)||27
51965|NCT01683409|122624|P5|STARTED|Treatment Period (Weeks 1-24)||25
51966|NCT01683409|122625|P4|STARTED|Treatment Period (Weeks 1-24)||26
51967|NCT01683409|122626|P3|STARTED|Treatment Period (Weeks 1-24)||27
51968|NCT01683409|122627|P2|STARTED|Treatment Period (Weeks 1-24)||25
51969|NCT01683409|122628|P1|STARTED|Treatment Period (Weeks 1-24)||27
51970|NCT01683383|122671|P2|NOT COMPLETED|Overall Study||0
51971|NCT01683383|122672|P1|NOT COMPLETED|Overall Study||1
51972|NCT01683383|122671|P2|COMPLETED|Overall Study||51
51973|NCT01683383|122672|P1|COMPLETED|Overall Study||49
51974|NCT01683383|122671|P2|Transported and Treated|Overall Study||51
51975|NCT01683383|122672|P1|Transported and Treated|Overall Study||49
51976|NCT01683383|122671|P2|STARTED|Overall Study||51
51977|NCT01683383|122672|P1|STARTED|Overall Study||50
51978|NCT01683266|122688|P2|NOT COMPLETED|Overall Study||50
51979|NCT01683266|122689|P1|NOT COMPLETED|Overall Study||55
51980|NCT01683266|122688|P2|COMPLETED|Overall Study||225
51981|NCT01683266|122689|P1|COMPLETED|Overall Study||219
51982|NCT01683266|122688|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
51983|NCT01683266|122689|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|273
51984|NCT01683266|122688|P2|STARTED|Overall Study||275
51985|NCT01683266|122689|P1|STARTED|Overall Study||274
51986|NCT01683058|122717|P1|NOT COMPLETED|Overall Study||29
51987|NCT01683058|122717|P1|COMPLETED|Overall Study||45
51988|NCT01683058|122717|P1|STARTED|Overall Study||74
51989|NCT01683019|122748|P3|NOT COMPLETED|Overall Study||4
51990|NCT01683019|122749|P2|NOT COMPLETED|Overall Study||1
51991|NCT01683019|122750|P1|NOT COMPLETED|Overall Study||2
51992|NCT01683019|122748|P3|COMPLETED|Overall Study||15
51993|NCT01683019|122749|P2|COMPLETED|Overall Study||14
51994|NCT01683019|122750|P1|COMPLETED|Overall Study||16
51995|NCT01683019|122748|P3|STARTED|Overall Study||19
51996|NCT01683019|122749|P2|STARTED|Overall Study||15
51997|NCT01683019|122750|P1|STARTED|Overall Study||18
51998|NCT01682837|122758|P1|NOT COMPLETED|Fourth Intervention (4 Weeks)||0
51999|NCT01682837|122758|P1|COMPLETED|Fourth Intervention (4 Weeks)||30
52000|NCT01682837|122758|P1|Received Placebo|Fourth Intervention (4 Weeks)||7
52001|NCT01682837|122758|P1|Received KCl|Fourth Intervention (4 Weeks)||8
52002|NCT01682837|122758|P1|Received KCit|Fourth Intervention (4 Weeks)||9
52003|NCT01682837|122758|P1|Received KMgCit|Fourth Intervention (4 Weeks)||6
52004|NCT01682837|122758|P1|STARTED|Fourth Intervention (4 Weeks)||30
52005|NCT01682837|122758|P1|NOT COMPLETED|Third Intervention (4 Weeks)||0
52006|NCT01682837|122758|P1|COMPLETED|Third Intervention (4 Weeks)||30
52007|NCT01682837|122758|P1|Received Placebo|Third Intervention (4 Weeks)||7
52009|NCT01682837|122758|P1|Received KCit|Third Intervention (4 Weeks)||7
52010|NCT01682837|122758|P1|Received KMgCit|Third Intervention (4 Weeks)||9
52011|NCT01682837|122758|P1|STARTED|Third Intervention (4 Weeks)||30
52012|NCT01682837|122758|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
52013|NCT01682837|122758|P1|COMPLETED|Second Intervention (4 Weeks)||30
52014|NCT01682837|122758|P1|Received Placebo|Second Intervention (4 Weeks)||9
52015|NCT01682837|122758|P1|Received KCl|Second Intervention (4 Weeks)||8
52016|NCT01682837|122758|P1|Received KCit|Second Intervention (4 Weeks)||6
52017|NCT01682837|122758|P1|Received KMgCit|Second Intervention (4 Weeks)||7
52018|NCT01682837|122758|P1|STARTED|Second Intervention (4 Weeks)||30
52019|NCT01682837|122758|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
52020|NCT01682837|122758|P1|COMPLETED|First Intervention (4 Weeks)||30
52021|NCT01682837|122758|P1|Received Placebo|First Intervention (4 Weeks)||7
52022|NCT01682837|122758|P1|Received KCl|First Intervention (4 Weeks)||7
52023|NCT01682837|122758|P1|Received KCit|First Intervention (4 Weeks)||8
52024|NCT01682837|122758|P1|Received KMgCit|First Intervention (4 Weeks)||8
52025|NCT01682837|122758|P1|STARTED|First Intervention (4 Weeks)||30
52026|NCT01682837|122758|P1|NOT COMPLETED|Baseline||5
52027|NCT01682837|122758|P1|COMPLETED|Baseline||30
52028|NCT01682837|122758|P1|STARTED|Baseline||35
52029|NCT01682759|122802|P2|NOT COMPLETED|Overall Study||70
52030|NCT01682759|122803|P1|NOT COMPLETED|Overall Study||69
52031|NCT01682759|122802|P2|COMPLETED|Overall Study||305
52032|NCT01682759|122803|P1|COMPLETED|Overall Study||307
52033|NCT01682759|122802|P2|Treated|Overall Study||375
52034|NCT01682759|122803|P1|Treated|Overall Study||375
52035|NCT01682759|122802|P2|STARTED|Overall Study||375
52036|NCT01682759|122803|P1|STARTED|Overall Study||376
52037|NCT01682720|122827|P4|NOT COMPLETED|Overall Study||39
52038|NCT01682720|122828|P3|NOT COMPLETED|Overall Study||7
52039|NCT01682720|122829|P2|NOT COMPLETED|Overall Study||5
52040|NCT01682720|122830|P1|NOT COMPLETED|Overall Study||85
52041|NCT01682720|122827|P4|COMPLETED|Overall Study||211
52042|NCT01682720|122828|P3|COMPLETED|Overall Study||5
52043|NCT01682720|122829|P2|COMPLETED|Overall Study||69
52044|NCT01682720|122830|P1|COMPLETED|Overall Study||0
52045|NCT01682720|122827|P4|Included in Full Analysis Set|Overall Study||250
52046|NCT01682720|122828|P3|Included in Full Analysis Set|Overall Study||11
52047|NCT01682720|122829|P2|Included in Full Analysis Set|Overall Study||73
52048|NCT01682720|122830|P1|Included in Full Analysis Set|Overall Study||0
52049|NCT01682720|122827|P4|STARTED|Overall Study||250
52050|NCT01682720|122828|P3|STARTED|Overall Study||12
52051|NCT01682720|122829|P2|STARTED|Overall Study||74
52052|NCT01682720|122830|P1|STARTED|Overall Study||85
52053|NCT01682681|122847|P1|NOT COMPLETED|Overall Study||332
52054|NCT01682681|122847|P1|COMPLETED|Overall Study||902
52055|NCT01682681|122847|P1|Treated|Overall Study|2 Participants were not compliant with eligibility criteria|1232
52056|NCT01682681|122847|P1|STARTED|Overall Study||1234
52057|NCT01682642|122857|P2|NOT COMPLETED|Overall Study||1
52058|NCT01682642|122858|P1|NOT COMPLETED|Overall Study||0
52059|NCT01682642|122857|P2|COMPLETED|Overall Study||58
52060|NCT01682642|122858|P1|COMPLETED|Overall Study||61
52061|NCT01682642|122857|P2|STARTED|Overall Study||59
52062|NCT01682642|122858|P1|STARTED|Overall Study||61
52063|NCT01682603|122876|P1|NOT COMPLETED|Overall Study||3
52064|NCT01682603|122876|P1|COMPLETED|Overall Study||34
52065|NCT01682603|122876|P1|STARTED|Overall Study||37
52066|NCT01682538|122890|P1|NOT COMPLETED|Overall Study||0
52067|NCT01682538|122890|P1|COMPLETED|Overall Study||12
52068|NCT01682538|122890|P1|STARTED|Overall Study||12
52069|NCT01682460|122918|P1|NOT COMPLETED|Overall Study||4
52070|NCT01682460|122918|P1|COMPLETED|Overall Study||11
52071|NCT01682460|122918|P1|STARTED|Overall Study||15
52072|NCT01682135|122936|P3|NOT COMPLETED|Overall Study||0
52073|NCT01682135|122937|P2|NOT COMPLETED|Overall Study||0
52074|NCT01682135|122938|P1|NOT COMPLETED|Overall Study||0
52075|NCT01682135|122936|P3|COMPLETED|Overall Study||12
52076|NCT01682135|122937|P2|COMPLETED|Overall Study||10
52077|NCT01682135|122938|P1|COMPLETED|Overall Study||6
52078|NCT01682135|122936|P3|Received at Least 1 Dose of Study Drug|Overall Study||12
52079|NCT01682135|122937|P2|Received at Least 1 Dose of Study Drug|Overall Study||10
52080|NCT01682135|122938|P1|Received at Least 1 Dose of Study Drug|Overall Study||6
52081|NCT01682135|122936|P3|STARTED|Overall Study||12
52082|NCT01682135|122937|P2|STARTED|Overall Study||10
52083|NCT01682135|122938|P1|STARTED|Overall Study||6
52084|NCT01682031|122972|P2|NOT COMPLETED|Overall Study||5
52085|NCT01682031|122973|P1|NOT COMPLETED|Overall Study||1
52086|NCT01682031|122972|P2|COMPLETED|Overall Study||5
52087|NCT01682031|122973|P1|COMPLETED|Overall Study||7
52088|NCT01682031|122972|P2|STARTED|Overall Study||10
52089|NCT01682031|122973|P1|STARTED|Overall Study||8
52090|NCT01681849|122996|P3|NOT COMPLETED|Overall Study||39
52091|NCT01681849|122997|P2|NOT COMPLETED|Overall Study||7
52092|NCT01681849|122998|P1|NOT COMPLETED|Overall Study||8
52093|NCT01681849|122996|P3|COMPLETED|Overall Study||17
52094|NCT01681849|122997|P2|COMPLETED|Overall Study||6
52095|NCT01681849|122998|P1|COMPLETED|Overall Study||7
52096|NCT01681849|122996|P3|STARTED|Overall Study||56
52097|NCT01681849|122997|P2|STARTED|Overall Study||13
52098|NCT01681849|122998|P1|STARTED|Overall Study||15
52099|NCT01681628|123009|P2|NOT COMPLETED|19 Months Follow-up||43
52100|NCT01681628|123010|P1|NOT COMPLETED|19 Months Follow-up||62
52101|NCT01681628|123009|P2|COMPLETED|19 Months Follow-up||64
52102|NCT01681628|123010|P1|COMPLETED|19 Months Follow-up||52
52103|NCT01681628|123009|P2|STARTED|19 Months Follow-up||107
52104|NCT01681628|123010|P1|STARTED|19 Months Follow-up||114
52105|NCT01681628|123009|P2|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||15
52106|NCT01681628|123010|P1|NOT COMPLETED|Time 2 to Time 3 (One Week Later).||0
52107|NCT01681628|123009|P2|COMPLETED|Time 2 to Time 3 (One Week Later).||107
52108|NCT01681628|123010|P1|COMPLETED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
52109|NCT01681628|123009|P2|STARTED|Time 2 to Time 3 (One Week Later).||122
52110|NCT01681628|123010|P1|STARTED|Time 2 to Time 3 (One Week Later).|Only wait list group studied in this period.|0
52111|NCT01681628|123009|P2|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||6
52112|NCT01681628|123010|P1|NOT COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||14
52113|NCT01681628|123009|P2|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||122
52114|NCT01681628|123010|P1|COMPLETED|Time 1 (Entry) to Time 2 One Week Later.||114
52115|NCT01681628|123009|P2|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
52116|NCT01681628|123010|P1|STARTED|Time 1 (Entry) to Time 2 One Week Later.||128
52117|NCT01681576|123023|P2|NOT COMPLETED|Period 2||1
52118|NCT01681576|123024|P1|NOT COMPLETED|Period 2||4
52119|NCT01681576|123023|P2|COMPLETED|Period 2||35
52120|NCT01681576|123024|P1|COMPLETED|Period 2||30
52121|NCT01681576|123023|P2|STARTED|Period 2|Period 2: LCZ696 400mg|36
52122|NCT01681576|123024|P1|STARTED|Period 2|Period 2: Valsartan 320mg|34
52123|NCT01681576|123023|P2|NOT COMPLETED|Period 1||0
52124|NCT01681576|123024|P1|NOT COMPLETED|Period 1||2
52125|NCT01681576|123023|P2|COMPLETED|Period 1||36
52126|NCT01681576|123024|P1|COMPLETED|Period 1||34
52127|NCT01681576|123023|P2|STARTED|Period 1||36
52128|NCT01681576|123024|P1|STARTED|Period 1||36
52129|NCT01681511|123040|P2|NOT COMPLETED|Overall Study||14
52130|NCT01681511|123041|P1|NOT COMPLETED|Overall Study||18
52131|NCT01681511|123040|P2|COMPLETED|Overall Study||35
52132|NCT01681511|123041|P1|COMPLETED|Overall Study||28
52133|NCT01681511|123040|P2|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the TIC arm of this population.|14
52134|NCT01681511|123041|P1|Evaluable Population|Overall Study|Subjects w/ positive urine culture results also removed from the Lubri-Sil arm of this population.|16
52135|NCT01681511|123040|P2|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the TIC treatment after randomization.|46
52136|NCT01681511|123041|P1|Intent to Treat (ITT) Population|Overall Study|Any subject receiving the Lubri-Sil treatment after randomization.|45
52137|NCT01681511|123040|P2|STARTED|Overall Study|All randomized subjects in the TIC arm.|49
52138|NCT01681511|123041|P1|STARTED|Overall Study|All randomized subjects in the Lubri-Sil arm.|46
52139|NCT01681472|123059|P4|NOT COMPLETED|Overall Study||0
52140|NCT01681472|123060|P3|NOT COMPLETED|Overall Study||0
52141|NCT01681472|123061|P2|NOT COMPLETED|Overall Study||1
52142|NCT01681472|123062|P1|NOT COMPLETED|Overall Study||0
52143|NCT01681472|123059|P4|COMPLETED|Overall Study||8
52144|NCT01681472|123060|P3|COMPLETED|Overall Study||8
52145|NCT01681472|123061|P2|COMPLETED|Overall Study||7
52146|NCT01681472|123062|P1|COMPLETED|Overall Study||8
52147|NCT01681472|123059|P4|STARTED|Overall Study||8
52148|NCT01681472|123060|P3|STARTED|Overall Study||8
52149|NCT01681472|123061|P2|STARTED|Overall Study||8
52150|NCT01681472|123062|P1|STARTED|Overall Study||8
52151|NCT01681368|123072|P1|NOT COMPLETED|Overall Study||2
52152|NCT01681368|123072|P1|COMPLETED|Overall Study||9
52153|NCT01681368|123072|P1|STARTED|Overall Study||11
52154|NCT01681277|123089|P5|NOT COMPLETED|Overall Study||0
52155|NCT01681277|123090|P4|NOT COMPLETED|Overall Study||0
52156|NCT01681277|123091|P3|NOT COMPLETED|Overall Study||0
52157|NCT01681277|123092|P2|NOT COMPLETED|Overall Study||0
52158|NCT01681277|123093|P1|NOT COMPLETED|Overall Study||1
52159|NCT01681277|123089|P5|COMPLETED|Overall Study||9
52160|NCT01681277|123090|P4|COMPLETED|Overall Study||9
52161|NCT01681277|123091|P3|COMPLETED|Overall Study||9
52162|NCT01681277|123092|P2|COMPLETED|Overall Study||9
52163|NCT01681277|123093|P1|COMPLETED|Overall Study||11
52164|NCT01681277|123089|P5|STARTED|Overall Study||9
52165|NCT01681277|123090|P4|STARTED|Overall Study||9
52166|NCT01681277|123091|P3|STARTED|Overall Study||9
52167|NCT01681277|123092|P2|STARTED|Overall Study||9
52168|NCT01681277|123093|P1|STARTED|Overall Study||12
52169|NCT01681212|123134|P1|NOT COMPLETED|Overall Study||6
52170|NCT01681212|123134|P1|COMPLETED|Overall Study|Completed=patients who received treatment; not completed=patients who did not receive treatment|15
52171|NCT01681212|123134|P1|Received Treatment|Overall Study||15
52172|NCT01681212|123134|P1|STARTED|Overall Study|Enrolled|21
52173|NCT01681121|123142|P2|NOT COMPLETED|Overall Study||11
52174|NCT01681121|123143|P1|NOT COMPLETED|Overall Study||8
52175|NCT01681121|123142|P2|COMPLETED|Overall Study||38
52176|NCT01681121|123143|P1|COMPLETED|Overall Study||36
52177|NCT01681121|123142|P2|STARTED|Overall Study||49
52178|NCT01681121|123143|P1|STARTED|Overall Study||44
52179|NCT01681095|123151|P2|NOT COMPLETED|Overall Study||0
52180|NCT01681095|123152|P1|NOT COMPLETED|Overall Study||0
52181|NCT01681095|123151|P2|COMPLETED|Overall Study||55
52182|NCT01681095|123152|P1|COMPLETED|Overall Study||55
52183|NCT01681095|123151|P2|STARTED|Overall Study||55
52184|NCT01681095|123152|P1|STARTED|Overall Study||55
52185|NCT01681069|123192|P2|NOT COMPLETED|Overall Study||7
52186|NCT01681069|123193|P1|NOT COMPLETED|Overall Study||5
52187|NCT01681069|123192|P2|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|53
52188|NCT01681069|123193|P1|COMPLETED|Overall Study|Valid Case Analysis Set (VAS)|55
52189|NCT01681069|123192|P2|Full Analysis Set (FAS)|Overall Study||60
52190|NCT01681069|123193|P1|Full Analysis Set (FAS)|Overall Study||57
52191|NCT01681069|123192|P2|STARTED|Overall Study||60
52192|NCT01681069|123193|P1|STARTED|Overall Study||60
52193|NCT01681004|123205|P2|NOT COMPLETED|Study Completion||8
52194|NCT01681004|123206|P1|NOT COMPLETED|Study Completion||12
52195|NCT01681004|123205|P2|COMPLETED|Study Completion||36
52196|NCT01681004|123206|P1|COMPLETED|Study Completion||89
52197|NCT01681004|123205|P2|STARTED|Study Completion||44
52198|NCT01681004|123206|P1|STARTED|Study Completion||101
52199|NCT01681004|123205|P2|NOT COMPLETED|Primary Endpoint: 6 Months||2
52200|NCT01681004|123206|P1|NOT COMPLETED|Primary Endpoint: 6 Months||1
52201|NCT01681004|123205|P2|COMPLETED|Primary Endpoint: 6 Months||44
52202|NCT01681004|123206|P1|COMPLETED|Primary Endpoint: 6 Months||101
52203|NCT01681004|123205|P2|Crossover to Surgical Treatment|Primary Endpoint: 6 Months|Crossover to surgical treatment allowed per study protocol after the 6-month visit was complete.|39
52204|NCT01681004|123206|P1|Crossover to Surgical Treatment|Primary Endpoint: 6 Months||0
52205|NCT01681004|123205|P2|STARTED|Primary Endpoint: 6 Months||46
52206|NCT01681004|123206|P1|STARTED|Primary Endpoint: 6 Months||102
52207|NCT01680991|123263|P3|NOT COMPLETED|Overall Study||4
52208|NCT01680991|123264|P2|NOT COMPLETED|Overall Study||19
52209|NCT01680991|123265|P1|NOT COMPLETED|Overall Study||8
52210|NCT01680991|123263|P3|COMPLETED|Overall Study||9
52211|NCT01680991|123264|P2|COMPLETED|Overall Study||4
52212|NCT01680991|123265|P1|COMPLETED|Overall Study||4
52213|NCT01680991|123263|P3|STARTED|Overall Study||13
52214|NCT01680991|123264|P2|STARTED|Overall Study||23
52215|NCT01680991|123265|P1|STARTED|Overall Study||12
52216|NCT01680900|123326|P2|NOT COMPLETED|Overall Study||1
52217|NCT01680900|123327|P1|NOT COMPLETED|Overall Study||4
52218|NCT01680900|123326|P2|COMPLETED|Overall Study||11
52219|NCT01680900|123327|P1|COMPLETED|Overall Study||20
52220|NCT01680900|123326|P2|STARTED|Overall Study||12
52221|NCT01680900|123327|P1|STARTED|Overall Study||24
52222|NCT01680861|123345|P2|NOT COMPLETED|First 12 Months Post-transplant||0
52223|NCT01680861|123346|P1|NOT COMPLETED|First 12 Months Post-transplant||0
52224|NCT01680861|123345|P2|COMPLETED|First 12 Months Post-transplant||15
52225|NCT01680861|123346|P1|COMPLETED|First 12 Months Post-transplant||15
52226|NCT01680861|123345|P2|STARTED|First 12 Months Post-transplant||15
52227|NCT01680861|123346|P1|STARTED|First 12 Months Post-transplant||15
52228|NCT01680861|123345|P2|NOT COMPLETED|Early Post-transplant Period||1
52229|NCT01680861|123346|P1|NOT COMPLETED|Early Post-transplant Period||1
52230|NCT01680861|123345|P2|COMPLETED|Early Post-transplant Period||15
52231|NCT01680861|123346|P1|COMPLETED|Early Post-transplant Period||15
52232|NCT01680861|123345|P2|STARTED|Early Post-transplant Period|One patient developed immediate DGF (delayed graft function) and was therefore ineligible.|16
52233|NCT01680861|123346|P1|STARTED|Early Post-transplant Period|One patient didn't produce sufficient urine during first 24hr post-transplant (ineligible).|16
52234|NCT01680848|123364|P1|NOT COMPLETED|Overall Study||93
52235|NCT01680848|123364|P1|COMPLETED|Overall Study||189
52236|NCT01680848|123364|P1|STARTED|Overall Study||282
52237|NCT01680783|123370|P2|NOT COMPLETED|Overall Study||0
52238|NCT01680783|123371|P1|NOT COMPLETED|Overall Study||0
52239|NCT01680783|123370|P2|COMPLETED|Overall Study||44
52240|NCT01680783|123371|P1|COMPLETED|Overall Study||39
52241|NCT01680783|123370|P2|STARTED|Overall Study||44
52242|NCT01680783|123371|P1|STARTED|Overall Study||39
52243|NCT01680666|123379|P2|NOT COMPLETED|Overall Study||0
52244|NCT01680666|123380|P1|NOT COMPLETED|Overall Study||0
52245|NCT01680666|123379|P2|COMPLETED|Overall Study||66
52246|NCT01680666|123380|P1|COMPLETED|Overall Study||84
52247|NCT01680666|123379|P2|STARTED|Overall Study||66
52248|NCT01680666|123380|P1|STARTED|Overall Study||84
52249|NCT01680549|123388|P2|NOT COMPLETED|Overall Study||8
52250|NCT01680549|123389|P1|NOT COMPLETED|Overall Study||5
52251|NCT01680549|123388|P2|COMPLETED|Overall Study||17
52252|NCT01680549|123389|P1|COMPLETED|Overall Study||20
52253|NCT01680549|123388|P2|STARTED|Overall Study||25
52254|NCT01680549|123389|P1|STARTED|Overall Study||25
52255|NCT01680497|123401|P1|NOT COMPLETED|Overall Study||2
52256|NCT01680497|123401|P1|COMPLETED|Overall Study||68
52257|NCT01680497|123401|P1|STARTED|Overall Study||70
52258|NCT01680458|123411|P1|NOT COMPLETED|Overall Study||3
52259|NCT01680458|123411|P1|COMPLETED|Overall Study||27
52260|NCT01680458|123411|P1|STARTED|Overall Study||30
52261|NCT01680341|123422|P2|NOT COMPLETED|Overall Study||17
52262|NCT01680341|123423|P1|NOT COMPLETED|Overall Study||21
52263|NCT01680341|123422|P2|COMPLETED|Overall Study||119
52264|NCT01680341|123423|P1|COMPLETED|Overall Study||115
52265|NCT01680341|123422|P2|Exposed|Overall Study|Two (2) subjects withdrew consent prior to exposure to trial product.|134
52266|NCT01680341|123423|P1|Exposed|Overall Study|One (1) subject withdrew consent prior to exposure to trial product.|135
52267|NCT01680341|123422|P2|STARTED|Overall Study||136
52268|NCT01680341|123423|P1|STARTED|Overall Study||136
52269|NCT01680328|123443|P1|NOT COMPLETED|Overall Study||2
52270|NCT01680328|123443|P1|COMPLETED|Overall Study||80
52271|NCT01680328|123443|P1|Subjects Missing Injections|Overall Study|One missed the [1600 μL, 450 μL/s; thighs]; one missed the [400 μL, 300 μL/s; abdomen]|2
52272|NCT01680328|123443|P1|STARTED|Overall Study||82
52273|NCT01680172|123481|P2|NOT COMPLETED|Overall Study||0
52274|NCT01680172|123482|P1|NOT COMPLETED|Overall Study||0
52275|NCT01680172|123481|P2|COMPLETED|Overall Study||2
52276|NCT01680172|123482|P1|COMPLETED|Overall Study||3
52277|NCT01680172|123481|P2|STARTED|Overall Study||2
52278|NCT01680172|123482|P1|STARTED|Overall Study||3
52279|NCT01680159|123494|P1|NOT COMPLETED|Increased Dose Period||8
52280|NCT01680159|123494|P1|COMPLETED|Increased Dose Period||43
52281|NCT01680159|123494|P1|STARTED|Increased Dose Period||51
52282|NCT01680159|123494|P1|NOT COMPLETED|Screening Period||7
52283|NCT01680159|123494|P1|COMPLETED|Screening Period||39
52284|NCT01680159|123494|P1|STARTED|Screening Period||46
52285|NCT01680016|123521|P4|NOT COMPLETED|Overall Study||5
52286|NCT01680016|123522|P3|NOT COMPLETED|Overall Study||5
52287|NCT01680016|123523|P2|NOT COMPLETED|Overall Study||8
52288|NCT01680016|123524|P1|NOT COMPLETED|Overall Study||6
52289|NCT01680016|123521|P4|COMPLETED|Overall Study||195
52290|NCT01680016|123522|P3|COMPLETED|Overall Study||196
52291|NCT01680016|123523|P2|COMPLETED|Overall Study||114
52292|NCT01680016|123524|P1|COMPLETED|Overall Study||115
52293|NCT01680016|123521|P4|STARTED|Overall Study||200
52294|NCT01680016|123522|P3|STARTED|Overall Study||201
52295|NCT01680016|123523|P2|STARTED|Overall Study||122
52296|NCT01680016|123524|P1|STARTED|Overall Study||121
52297|NCT01679613|123586|P4|NOT COMPLETED|Overall Study||2
52298|NCT01679613|123587|P3|NOT COMPLETED|Overall Study||2
52299|NCT01679613|123588|P2|NOT COMPLETED|Overall Study||1
52300|NCT01679613|123589|P1|NOT COMPLETED|Overall Study||0
52301|NCT01679613|123586|P4|COMPLETED|Overall Study||11
52302|NCT01679613|123587|P3|COMPLETED|Overall Study||11
52303|NCT01679613|123588|P2|COMPLETED|Overall Study||3
52304|NCT01679613|123589|P1|COMPLETED|Overall Study||4
52305|NCT01679613|123586|P4|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
52306|NCT01679613|123587|P3|Received Nintedanib+Ketoconazole (Main)|Overall Study|Two subjects received only ketoconazole not nintedanib|13
52307|NCT01679613|123588|P2|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
52308|NCT01679613|123589|P1|Received Nintedanib+Ketoconazole (Main)|Overall Study||0
52309|NCT01679613|123586|P4|Received Nintedanib (Main)|Overall Study||11
52310|NCT01679613|123587|P3|Received Nintedanib (Main)|Overall Study||13
52311|NCT01679613|123588|P2|Received Nintedanib (Main)|Overall Study||0
52312|NCT01679613|123589|P1|Received Nintedanib (Main)|Overall Study||0
52313|NCT01679613|123586|P4|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
52314|NCT01679613|123587|P3|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||0
52315|NCT01679613|123588|P2|Received Nintedanib+Ketoconazole (Pilot)|Overall Study|One subject received only ketoconazole not nintedanib|4
52316|NCT01679613|123589|P1|Received Nintedanib+Ketoconazole (Pilot)|Overall Study||4
52317|NCT01679613|123586|P4|Received Nintedanib (Pilot)|Overall Study||0
52318|NCT01679613|123587|P3|Received Nintedanib (Pilot)|Overall Study||0
52319|NCT01679613|123588|P2|Received Nintedanib (Pilot)|Overall Study||3
52320|NCT01679613|123589|P1|Received Nintedanib (Pilot)|Overall Study||4
52321|NCT01679613|123586|P4|STARTED|Overall Study||13
52322|NCT01679613|123587|P3|STARTED|Overall Study||13
52323|NCT01679613|123588|P2|STARTED|Overall Study||4
52324|NCT01679613|123589|P1|STARTED|Overall Study||4
52325|NCT01679600|123602|P2|NOT COMPLETED|Overall Study||0
52326|NCT01679600|123603|P1|NOT COMPLETED|Overall Study||0
52327|NCT01679600|123602|P2|COMPLETED|Overall Study||7
52328|NCT01679600|123603|P1|COMPLETED|Overall Study||7
52329|NCT01679600|123602|P2|STARTED|Overall Study||7
52330|NCT01679600|123603|P1|STARTED|Overall Study||7
52331|NCT01679314|123611|P2|NOT COMPLETED|Overall Study||0
52332|NCT01679314|123612|P1|NOT COMPLETED|Overall Study||2
52333|NCT01679314|123611|P2|COMPLETED|Overall Study||28
52334|NCT01679314|123612|P1|COMPLETED|Overall Study||24
52335|NCT01679314|123611|P2|STARTED|Overall Study||28
52336|NCT01679314|123612|P1|STARTED|Overall Study||26
52337|NCT01679236|123632|P2|NOT COMPLETED|Overall Study||15
52338|NCT01679236|123633|P1|NOT COMPLETED|Overall Study||15
52339|NCT01679236|123632|P2|COMPLETED|Overall Study||10
52340|NCT01679236|123633|P1|COMPLETED|Overall Study||15
52341|NCT01679236|123632|P2|STARTED|Overall Study||25
52342|NCT01679236|123633|P1|STARTED|Overall Study||30
52343|NCT01679197|123639|P1|NOT COMPLETED|Overall Study||4
52344|NCT01679197|123639|P1|COMPLETED|Overall Study||19
52345|NCT01679197|123639|P1|STARTED|Overall Study||23
52346|NCT01679028|123658|P6|NOT COMPLETED|Overall Study||0
52347|NCT01679028|123659|P5|NOT COMPLETED|Overall Study||0
52348|NCT01679028|123660|P4|NOT COMPLETED|Overall Study||0
52349|NCT01679028|123661|P3|NOT COMPLETED|Overall Study||0
52350|NCT01679028|123662|P2|NOT COMPLETED|Overall Study||0
52351|NCT01679028|123663|P1|NOT COMPLETED|Overall Study||0
52352|NCT01679028|123658|P6|COMPLETED|Overall Study||6
52353|NCT01679028|123659|P5|COMPLETED|Overall Study||2
52354|NCT01679028|123660|P4|COMPLETED|Overall Study||4
52355|NCT01679028|123661|P3|COMPLETED|Overall Study||2
52356|NCT01679028|123662|P2|COMPLETED|Overall Study||4
52357|NCT01679028|123663|P1|COMPLETED|Overall Study||2
52358|NCT01679028|123658|P6|STARTED|Overall Study||6
52359|NCT01679028|123659|P5|STARTED|Overall Study||2
52360|NCT01679028|123660|P4|STARTED|Overall Study||4
52361|NCT01679028|123661|P3|STARTED|Overall Study||2
52362|NCT01679028|123662|P2|STARTED|Overall Study||4
52363|NCT01679028|123663|P1|STARTED|Overall Study||2
52364|NCT01679002|123680|P3|NOT COMPLETED|Overall Study||0
52365|NCT01679002|123681|P2|NOT COMPLETED|Overall Study||1
52366|NCT01679002|123682|P1|NOT COMPLETED|Overall Study||1
52367|NCT01679002|123680|P3|COMPLETED|Overall Study||4
52368|NCT01679002|123681|P2|COMPLETED|Overall Study||3
52369|NCT01679002|123682|P1|COMPLETED|Overall Study||3
52370|NCT01679002|123680|P3|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
52371|NCT01679002|123681|P2|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||4
52372|NCT01679002|123682|P1|Oxcarbazepine 450 mg Twice-daily Period|Overall Study||3
52373|NCT01679002|123680|P3|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
52374|NCT01679002|123681|P2|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
52375|NCT01679002|123682|P1|BIA 2-093 450 mg Twice-daily Period|Overall Study||4
52376|NCT01679002|123680|P3|BIA 2-093 900 mg Once-daily Period|Overall Study||4
52377|NCT01679002|123681|P2|BIA 2-093 900 mg Once-daily Period|Overall Study||3
52378|NCT01679002|123682|P1|BIA 2-093 900 mg Once-daily Period|Overall Study||4
52379|NCT01679002|123680|P3|STARTED|Overall Study||4
52380|NCT01679002|123681|P2|STARTED|Overall Study||4
52381|NCT01679002|123682|P1|STARTED|Overall Study||4
52382|NCT01678976|123698|P2|NOT COMPLETED|Second Period||0
52383|NCT01678976|123699|P1|NOT COMPLETED|Second Period||0
52384|NCT01678976|123698|P2|COMPLETED|Second Period||6
52385|NCT01678976|123699|P1|COMPLETED|Second Period||6
52386|NCT01678976|123698|P2|STARTED|Second Period||6
52387|NCT01678976|123699|P1|STARTED|Second Period||6
52388|NCT01678976|123698|P2|NOT COMPLETED|First Period||1
52389|NCT01678976|123699|P1|NOT COMPLETED|First Period||0
52390|NCT01678976|123698|P2|COMPLETED|First Period||6
52391|NCT01678976|123699|P1|COMPLETED|First Period||6
52392|NCT01678976|123698|P2|STARTED|First Period||7
52393|NCT01678976|123699|P1|STARTED|First Period||6
52394|NCT01678911|123709|P2|NOT COMPLETED|Second Intervention||0
52395|NCT01678911|123710|P1|NOT COMPLETED|Second Intervention||2
52396|NCT01678911|123709|P2|COMPLETED|Second Intervention||1
52397|NCT01678911|123710|P1|COMPLETED|Second Intervention||2
52398|NCT01678911|123709|P2|STARTED|Second Intervention||1
52399|NCT01678911|123710|P1|STARTED|Second Intervention||4
52400|NCT01678911|123709|P2|NOT COMPLETED|First Intervention||0
52401|NCT01678911|123710|P1|NOT COMPLETED|First Intervention||0
52402|NCT01678911|123709|P2|COMPLETED|First Intervention||1
52403|NCT01678911|123710|P1|COMPLETED|First Intervention||4
52404|NCT01678911|123709|P2|Cross Over|First Intervention||1
52405|NCT01678911|123710|P1|Cross Over|First Intervention||4
52406|NCT01678911|123709|P2|STARTED|First Intervention||1
52407|NCT01678911|123710|P1|STARTED|First Intervention||4
52408|NCT01678885|123726|P5|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||17
52409|NCT01678885|123727|P4|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52410|NCT01678885|123728|P3|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52411|NCT01678885|123729|P2|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52412|NCT01678885|123730|P1|NOT COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52413|NCT01678885|123726|P5|COMPLETED|Phase II; 8 Week Low Calorie Diet||70
52414|NCT01678885|123727|P4|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52415|NCT01678885|123728|P3|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52416|NCT01678885|123729|P2|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52417|NCT01678885|123730|P1|COMPLETED|Phase II; 8 Week Low Calorie Diet||0
52418|NCT01678885|123726|P5|STARTED|Phase II; 8 Week Low Calorie Diet||87
52419|NCT01678885|123727|P4|STARTED|Phase II; 8 Week Low Calorie Diet||0
52420|NCT01678885|123728|P3|STARTED|Phase II; 8 Week Low Calorie Diet||0
52421|NCT01678885|123729|P2|STARTED|Phase II; 8 Week Low Calorie Diet||0
52422|NCT01678885|123730|P1|STARTED|Phase II; 8 Week Low Calorie Diet||0
52423|NCT01678885|123726|P5|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
52424|NCT01678885|123727|P4|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
52425|NCT01678885|123728|P3|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||1
52426|NCT01678885|123729|P2|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||3
52427|NCT01678885|123730|P1|NOT COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
52428|NCT01678885|123726|P5|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||0
52429|NCT01678885|123727|P4|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||21
52430|NCT01678885|123728|P3|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
52431|NCT01678885|123729|P2|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||15
52432|NCT01678885|123730|P1|COMPLETED|Phase I; 2 Wks Duration, Both Sub-study||22
52433|NCT01678885|123726|P5|STARTED|Phase I; 2 Wks Duration, Both Sub-study||0
52434|NCT01678885|123727|P4|STARTED|Phase I; 2 Wks Duration, Both Sub-study||24
52435|NCT01678885|123728|P3|STARTED|Phase I; 2 Wks Duration, Both Sub-study||23
52436|NCT01678885|123729|P2|STARTED|Phase I; 2 Wks Duration, Both Sub-study||18
52437|NCT01678885|123730|P1|STARTED|Phase I; 2 Wks Duration, Both Sub-study||22
52438|NCT01678846|123740|P2|NOT COMPLETED|Overall Study||0
52439|NCT01678846|123741|P1|NOT COMPLETED|Overall Study||0
52440|NCT01678846|123740|P2|COMPLETED|Overall Study||1899
52441|NCT01678846|123741|P1|COMPLETED|Overall Study||1921
52442|NCT01678846|123740|P2|STARTED|Overall Study||1899
52443|NCT01678846|123741|P1|STARTED|Overall Study|Whole school implementation. Started and completed shows number of students in the end-line survey.|1921
52444|NCT01678820|123756|P3|NOT COMPLETED|Overall Study||57
52445|NCT01678820|123757|P2|NOT COMPLETED|Overall Study||63
52446|NCT01678820|123758|P1|NOT COMPLETED|Overall Study||62
52447|NCT01678820|123756|P3|COMPLETED|Overall Study||43
52448|NCT01678820|123757|P2|COMPLETED|Overall Study||36
52449|NCT01678820|123758|P1|COMPLETED|Overall Study||38
52450|NCT01678820|123756|P3|Treated With Double-blind Study Drug|Overall Study||98
52451|NCT01678820|123757|P2|Treated With Double-blind Study Drug|Overall Study||97
52452|NCT01678820|123758|P1|Treated With Double-blind Study Drug|Overall Study||100
52453|NCT01678820|123756|P3|STARTED|Overall Study||100
52454|NCT01678820|123757|P2|STARTED|Overall Study||99
52455|NCT01678820|123758|P1|STARTED|Overall Study||100
52456|NCT01678807|123803|P3|NOT COMPLETED|Overall Study||0
52457|NCT01678807|123804|P2|NOT COMPLETED|Overall Study||5
52458|NCT01678807|123805|P1|NOT COMPLETED|Overall Study||4
52459|NCT01678807|123803|P3|COMPLETED|Overall Study||65
52460|NCT01678807|123804|P2|COMPLETED|Overall Study||60
52461|NCT01678807|123805|P1|COMPLETED|Overall Study||61
52462|NCT01678807|123803|P3|STARTED|Overall Study||65
52463|NCT01678807|123804|P2|STARTED|Overall Study||65
52464|NCT01678807|123805|P1|STARTED|Overall Study||65
52465|NCT01678313|123818|P2|NOT COMPLETED|Prostate Biopsy at 3 Months||12
52466|NCT01678313|123819|P1|NOT COMPLETED|Prostate Biopsy at 3 Months||11
52467|NCT01678313|123818|P2|COMPLETED|Prostate Biopsy at 3 Months||37
52468|NCT01678313|123819|P1|COMPLETED|Prostate Biopsy at 3 Months||45
52469|NCT01678313|123818|P2|STARTED|Prostate Biopsy at 3 Months||49
52470|NCT01678313|123819|P1|STARTED|Prostate Biopsy at 3 Months||56
52471|NCT01678313|123818|P2|NOT COMPLETED|PSA >4 ng/dL at 3 Months||9
52472|NCT01678313|123819|P1|NOT COMPLETED|PSA >4 ng/dL at 3 Months||8
52473|NCT01678313|123818|P2|COMPLETED|PSA >4 ng/dL at 3 Months||49
52474|NCT01678313|123819|P1|COMPLETED|PSA >4 ng/dL at 3 Months||56
52475|NCT01678313|123818|P2|STARTED|PSA >4 ng/dL at 3 Months||58
52476|NCT01678313|123819|P1|STARTED|PSA >4 ng/dL at 3 Months||64
52477|NCT01678313|123818|P2|NOT COMPLETED|Completed the 3-month Therapy||12
52478|NCT01678313|123819|P1|NOT COMPLETED|Completed the 3-month Therapy||6
52479|NCT01678313|123818|P2|COMPLETED|Completed the 3-month Therapy||58
52480|NCT01678313|123819|P1|COMPLETED|Completed the 3-month Therapy||64
52481|NCT01678313|123818|P2|STARTED|Completed the 3-month Therapy||70
52482|NCT01678313|123819|P1|STARTED|Completed the 3-month Therapy||70
52483|NCT01678196|123837|P2|NOT COMPLETED|Overall Study||0
52484|NCT01678196|123838|P1|NOT COMPLETED|Overall Study||0
52485|NCT01678196|123837|P2|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|32
52486|NCT01678196|123838|P1|COMPLETED|Overall Study|Primary outcome data was from the electronic medical record and was available for all participants.|34
52487|NCT01678196|123837|P2|STARTED|Overall Study||32
52488|NCT01678196|123838|P1|STARTED|Overall Study||34
52489|NCT01678131|123853|P3|NOT COMPLETED|Overall Study||2
52490|NCT01678131|123854|P2|NOT COMPLETED|Overall Study||1
52491|NCT01678131|123855|P1|NOT COMPLETED|Overall Study||0
52492|NCT01678131|123853|P3|COMPLETED|Overall Study||9
52493|NCT01678131|123854|P2|COMPLETED|Overall Study||9
52494|NCT01678131|123855|P1|COMPLETED|Overall Study||10
52495|NCT01678131|123853|P3|STARTED|Overall Study||11
52496|NCT01678131|123854|P2|STARTED|Overall Study||10
52497|NCT01678131|123855|P1|STARTED|Overall Study||10
52498|NCT01677988|123863|P1|NOT COMPLETED|Overall Study||2
52499|NCT01677988|123863|P1|COMPLETED|Overall Study||1
52500|NCT01677988|123863|P1|STARTED|Overall Study||3
52501|NCT01677936|123876|P2|NOT COMPLETED|Overall Study||5
52502|NCT01677936|123877|P1|NOT COMPLETED|Overall Study||9
52503|NCT01677936|123876|P2|COMPLETED|Overall Study|Full analysis dataset completers|15
52504|NCT01677936|123877|P1|COMPLETED|Overall Study|Full analysis dataset completers|22
52505|NCT01677936|123876|P2|STARTED|Overall Study|20 randomized to snacks; 1 excluded due to lack of post-baseline evaluation; 19 = full dataset|20
52506|NCT01677936|123877|P1|STARTED|Overall Study|31 randomized to raisins; 4 excluded due to lack of post-baseline evaluation; 27 = full dataset|31
52507|NCT01677858|123890|P5|NOT COMPLETED|Overall Study||85
52508|NCT01677858|123891|P4|NOT COMPLETED|Overall Study||6
52509|NCT01677858|123892|P3|NOT COMPLETED|Overall Study||14
52510|NCT01677858|123893|P2|NOT COMPLETED|Overall Study||2
52511|NCT01677858|123894|P1|NOT COMPLETED|Overall Study||3
52512|NCT01677858|123890|P5|COMPLETED|Overall Study|Completed indicates participants ongoing in study|4
52513|NCT01677858|123891|P4|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
52514|NCT01677858|123892|P3|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
52515|NCT01677858|123893|P2|COMPLETED|Overall Study|Completed indicates participants ongoing in study|1
52516|NCT01677858|123894|P1|COMPLETED|Overall Study|Completed indicates participants ongoing in study|0
52517|NCT01677858|123890|P5|STARTED|Overall Study||89
52518|NCT01677858|123891|P4|STARTED|Overall Study||6
52519|NCT01677858|123892|P3|STARTED|Overall Study||15
52520|NCT01677858|123893|P2|STARTED|Overall Study||3
52521|NCT01677858|123894|P1|STARTED|Overall Study||3
52522|NCT01677767|123967|P1|NOT COMPLETED|Overall Study||22
52523|NCT01677767|123967|P1|COMPLETED|Overall Study||102
52524|NCT01677767|123967|P1|STARTED|Overall Study||124
52525|NCT01677624|123981|P1|NOT COMPLETED|Overall Study||1
52526|NCT01677624|123981|P1|COMPLETED|Overall Study||27
52527|NCT01677624|123981|P1|STARTED|Overall Study||28
52528|NCT01677299|123990|P4|NOT COMPLETED|Overall Study||1
52529|NCT01677299|123991|P3|NOT COMPLETED|Overall Study||1
52530|NCT01677299|123992|P2|NOT COMPLETED|Overall Study||3
52531|NCT01677299|123993|P1|NOT COMPLETED|Overall Study||0
52532|NCT01677299|123990|P4|COMPLETED|Overall Study||5
52533|NCT01677299|123991|P3|COMPLETED|Overall Study||5
52534|NCT01677299|123992|P2|COMPLETED|Overall Study||3
52535|NCT01677299|123993|P1|COMPLETED|Overall Study||6
52536|NCT01677299|123990|P4|STARTED|Overall Study||6
52537|NCT01677299|123991|P3|STARTED|Overall Study||6
52538|NCT01677299|123992|P2|STARTED|Overall Study||6
52539|NCT01677299|123993|P1|STARTED|Overall Study||6
52540|NCT01677286|124015|P1|NOT COMPLETED|Overall Study||11
52541|NCT01677286|124015|P1|COMPLETED|Overall Study||14
52542|NCT01677286|124015|P1|STARTED|Overall Study||25
52543|NCT01677195|124025|P3|NOT COMPLETED|Overall Study||30
52544|NCT01677195|124026|P2|NOT COMPLETED|Overall Study||32
52545|NCT01677195|124027|P1|NOT COMPLETED|Overall Study||29
52546|NCT01677195|124025|P3|COMPLETED|Overall Study||50
52547|NCT01677195|124026|P2|COMPLETED|Overall Study||51
52548|NCT01677195|124027|P1|COMPLETED|Overall Study||42
52549|NCT01677195|124025|P3|STARTED|Overall Study||80
52550|NCT01677195|124026|P2|STARTED|Overall Study||83
52551|NCT01677195|124027|P1|STARTED|Overall Study||71
52552|NCT01677182|124038|P3|NOT COMPLETED|Overall Study||39
52553|NCT01677182|124039|P2|NOT COMPLETED|Overall Study||28
52554|NCT01677182|124040|P1|NOT COMPLETED|Overall Study||34
52555|NCT01677182|124038|P3|COMPLETED|Overall Study||143
52556|NCT01677182|124039|P2|COMPLETED|Overall Study||141
52557|NCT01677182|124040|P1|COMPLETED|Overall Study||150
52558|NCT01677182|124038|P3|STARTED|Overall Study||182
52559|NCT01677182|124039|P2|STARTED|Overall Study||169
52560|NCT01677182|124040|P1|STARTED|Overall Study||184
52561|NCT01676896|124075|P3|NOT COMPLETED|Overall Study||19
52562|NCT01676896|124076|P2|NOT COMPLETED|Overall Study||7
52563|NCT01676896|124077|P1|NOT COMPLETED|Overall Study||12
52564|NCT01676896|124075|P3|COMPLETED|Overall Study||81
52565|NCT01676896|124076|P2|COMPLETED|Overall Study||89
52566|NCT01676896|124077|P1|COMPLETED|Overall Study||84
52567|NCT01676896|124075|P3|STARTED|Overall Study||100
52568|NCT01676896|124076|P2|STARTED|Overall Study||96
52569|NCT01676896|124077|P1|STARTED|Overall Study||96
52570|NCT01676714|124172|P1|NOT COMPLETED|Overall Study||0
52571|NCT01676714|124172|P1|COMPLETED|Overall Study||10
52572|NCT01676714|124172|P1|STARTED|Overall Study||10
52573|NCT01676532|124179|P1|NOT COMPLETED|Overall Study||0
52574|NCT01676532|124179|P1|COMPLETED|Overall Study||127
52575|NCT01676532|124179|P1|STARTED|Overall Study||127
52576|NCT01676415|124190|P2|NOT COMPLETED|Overall Study||0
52577|NCT01676415|124191|P1|NOT COMPLETED|Overall Study||0
52578|NCT01676415|124190|P2|COMPLETED|Overall Study||5
52579|NCT01676415|124191|P1|COMPLETED|Overall Study||4
52580|NCT01676415|124190|P2|STARTED|Overall Study||5
52581|NCT01676415|124191|P1|STARTED|Overall Study||4
52582|NCT01676298|124211|P8|NOT COMPLETED|Overall Study||0
52583|NCT01676298|124212|P7|NOT COMPLETED|Overall Study||0
52584|NCT01676298|124213|P6|NOT COMPLETED|Overall Study||0
52585|NCT01676298|124214|P5|NOT COMPLETED|Overall Study||0
52586|NCT01676298|124215|P4|NOT COMPLETED|Overall Study||0
52587|NCT01676298|124216|P3|NOT COMPLETED|Overall Study||0
52588|NCT01676298|124217|P2|NOT COMPLETED|Overall Study||0
52589|NCT01676298|124218|P1|NOT COMPLETED|Overall Study||0
52590|NCT01676298|124211|P8|COMPLETED|Overall Study||1
52591|NCT01676298|124212|P7|COMPLETED|Overall Study||1
52592|NCT01676298|124213|P6|COMPLETED|Overall Study||1
52593|NCT01676298|124214|P5|COMPLETED|Overall Study||1
52594|NCT01676298|124215|P4|COMPLETED|Overall Study||1
52595|NCT01676298|124216|P3|COMPLETED|Overall Study||1
52596|NCT01676298|124217|P2|COMPLETED|Overall Study||1
52597|NCT01676298|124218|P1|COMPLETED|Overall Study||1
52598|NCT01676298|124211|P8|Participated in All Tests|Overall Study||1
52599|NCT01676298|124212|P7|Participated in All Tests|Overall Study||1
52600|NCT01676298|124213|P6|Participated in All Tests|Overall Study||1
52601|NCT01676298|124214|P5|Participated in All Tests|Overall Study||1
52602|NCT01676298|124215|P4|Participated in All Tests|Overall Study||1
52603|NCT01676298|124216|P3|Participated in All Tests|Overall Study||1
52604|NCT01676298|124217|P2|Participated in All Tests|Overall Study||1
52605|NCT01676298|124218|P1|Participated in All Tests|Overall Study||1
52606|NCT01676298|124211|P8|All Genotypes Confirmed With Reference|Overall Study||1
52607|NCT01676298|124212|P7|All Genotypes Confirmed With Reference|Overall Study||1
52608|NCT01676298|124213|P6|All Genotypes Confirmed With Reference|Overall Study||1
52609|NCT01676298|124214|P5|All Genotypes Confirmed With Reference|Overall Study||1
52610|NCT01676298|124215|P4|All Genotypes Confirmed With Reference|Overall Study||1
52611|NCT01676298|124216|P3|All Genotypes Confirmed With Reference|Overall Study||1
52612|NCT01676298|124217|P2|All Genotypes Confirmed With Reference|Overall Study||1
52613|NCT01676298|124218|P1|All Genotypes Confirmed With Reference|Overall Study||1
52614|NCT01676298|124211|P8|STARTED|Overall Study||1
52615|NCT01676298|124212|P7|STARTED|Overall Study||1
52616|NCT01676298|124213|P6|STARTED|Overall Study||1
52617|NCT01676298|124214|P5|STARTED|Overall Study||1
52618|NCT01676298|124215|P4|STARTED|Overall Study||1
52619|NCT01676298|124216|P3|STARTED|Overall Study||1
52620|NCT01676298|124217|P2|STARTED|Overall Study||1
52621|NCT01676298|124218|P1|STARTED|Overall Study||1
52622|NCT01676220|124238|P2|NOT COMPLETED|Overall Study||125
52623|NCT01676220|124239|P1|NOT COMPLETED|Overall Study||102
52624|NCT01676220|124238|P2|COMPLETED|Overall Study||314
52625|NCT01676220|124239|P1|COMPLETED|Overall Study||337
52626|NCT01676220|124238|P2|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|430
52627|NCT01676220|124239|P1|Modified Intent-To-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post­baseline data|432
52628|NCT01676220|124238|P2|Treated|Overall Study||438
52629|NCT01676220|124239|P1|Treated|Overall Study||435
52630|NCT01676220|124238|P2|STARTED|Overall Study||439
52631|NCT01676220|124239|P1|STARTED|Overall Study||439
52632|NCT01676012|124269|P1|NOT COMPLETED|Overall Study||3
52633|NCT01676012|124269|P1|COMPLETED|Overall Study||29
52634|NCT01676012|124269|P1|STARTED|Overall Study||32
52635|NCT01675830|124273|P1|NOT COMPLETED|Overall Study||0
52636|NCT01675830|124273|P1|COMPLETED|Overall Study||10
52637|NCT01675830|124273|P1|STARTED|Overall Study||10
52638|NCT01675661|124280|P2|NOT COMPLETED|Overall Study||46
52639|NCT01675661|124281|P1|NOT COMPLETED|Overall Study||40
52640|NCT01675661|124280|P2|COMPLETED|Overall Study||103
52641|NCT01675661|124281|P1|COMPLETED|Overall Study||113
52642|NCT01675661|124280|P2|STARTED|Overall Study||149
52643|NCT01675661|124281|P1|STARTED|Overall Study||153
52644|NCT01675544|124293|P1|NOT COMPLETED|Overall Study||2
52645|NCT01675544|124293|P1|COMPLETED|Overall Study||44
52646|NCT01675544|124293|P1|STARTED|Overall Study||46
52647|NCT01675531|124298|P1|NOT COMPLETED|Overall Study||25
52648|NCT01675531|124298|P1|COMPLETED|Overall Study||41
52649|NCT01675531|124298|P1|STARTED|Overall Study||66
52650|NCT01675492|124305|P1|NOT COMPLETED|Overall Study||42
52651|NCT01675492|124305|P1|COMPLETED|Overall Study||42
52652|NCT01675492|124305|P1|STARTED|Overall Study||84
52653|NCT01675453|124312|P2|NOT COMPLETED|Overall Study||0
52654|NCT01675453|124313|P1|NOT COMPLETED|Overall Study||0
52655|NCT01675453|124312|P2|COMPLETED|Overall Study||20
52656|NCT01675453|124313|P1|COMPLETED|Overall Study||20
52657|NCT01675453|124312|P2|STARTED|Overall Study||20
52658|NCT01675453|124313|P1|STARTED|Overall Study||20
52659|NCT01675427|124319|P1|NOT COMPLETED|Overall Study||34
52660|NCT01675427|124319|P1|COMPLETED|Overall Study||4732
52661|NCT01675427|124319|P1|STARTED|Overall Study||4766
52662|NCT01675167|124606|P3|NOT COMPLETED|Double-blind Treatment Phase||110
52663|NCT01675167|124607|P2|NOT COMPLETED|Double-blind Treatment Phase||48
52664|NCT01675167|124608|P1|NOT COMPLETED|Double-blind Treatment Phase||0
52665|NCT01675167|124606|P3|COMPLETED|Double-blind Treatment Phase||147
52666|NCT01675167|124607|P2|COMPLETED|Double-blind Treatment Phase||206
52667|NCT01675167|124608|P1|COMPLETED|Double-blind Treatment Phase||0
52668|NCT01675167|124606|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|257
52669|NCT01675167|124607|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|254
52670|NCT01675167|124608|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
52671|NCT01675167|124606|P3|NOT COMPLETED|Open-label Titration Phase||0
52672|NCT01675167|124607|P2|NOT COMPLETED|Open-label Titration Phase||0
52673|NCT01675167|124608|P1|NOT COMPLETED|Open-label Titration Phase||304
52674|NCT01675167|124606|P3|COMPLETED|Open-label Titration Phase||0
52675|NCT01675167|124607|P2|COMPLETED|Open-label Titration Phase||0
52676|NCT01675167|124608|P1|COMPLETED|Open-label Titration Phase||511
52677|NCT01675167|124606|P3|STARTED|Open-label Titration Phase||0
52678|NCT01675167|124607|P2|STARTED|Open-label Titration Phase||0
52679|NCT01675167|124608|P1|STARTED|Open-label Titration Phase||815
52680|NCT01675141|124630|P1|NOT COMPLETED|Overall Study||11
52681|NCT01675141|124630|P1|COMPLETED|Overall Study||0
52682|NCT01675141|124630|P1|STARTED|Overall Study||11
52683|NCT01675128|124643|P3|NOT COMPLETED|Overall Study||1
52684|NCT01675128|124644|P2|NOT COMPLETED|Overall Study||2
52685|NCT01675128|124645|P1|NOT COMPLETED|Overall Study||2
52686|NCT01675128|124643|P3|COMPLETED|Overall Study||9
52687|NCT01675128|124644|P2|COMPLETED|Overall Study||8
52688|NCT01675128|124645|P1|COMPLETED|Overall Study||2
52689|NCT01675128|124643|P3|STARTED|Overall Study||10
52690|NCT01675128|124644|P2|STARTED|Overall Study||10
52691|NCT01675128|124645|P1|STARTED|Overall Study||4
52692|NCT01675063|124667|P1|NOT COMPLETED|Overall Study||0
52693|NCT01675063|124667|P1|COMPLETED|Overall Study||77
52694|NCT01675063|124667|P1|STARTED|Overall Study||77
52695|NCT01675050|124673|P2|NOT COMPLETED|Second Period Treatment||0
52696|NCT01675050|124674|P1|NOT COMPLETED|Second Period Treatment||0
52697|NCT01675050|124673|P2|COMPLETED|Second Period Treatment||2
52698|NCT01675050|124674|P1|COMPLETED|Second Period Treatment||1
52699|NCT01675050|124673|P2|STARTED|Second Period Treatment||2
52700|NCT01675050|124674|P1|STARTED|Second Period Treatment||1
52701|NCT01675050|124673|P2|NOT COMPLETED|Wash Out Period||0
52702|NCT01675050|124674|P1|NOT COMPLETED|Wash Out Period||0
52703|NCT01675050|124673|P2|COMPLETED|Wash Out Period||2
52704|NCT01675050|124674|P1|COMPLETED|Wash Out Period||1
52705|NCT01675050|124673|P2|STARTED|Wash Out Period||2
52706|NCT01675050|124674|P1|STARTED|Wash Out Period||1
52707|NCT01675050|124673|P2|NOT COMPLETED|Period One Treatment||0
52708|NCT01675050|124674|P1|NOT COMPLETED|Period One Treatment||1
52709|NCT01675050|124673|P2|COMPLETED|Period One Treatment||2
52710|NCT01675050|124674|P1|COMPLETED|Period One Treatment||1
52711|NCT01675050|124673|P2|STARTED|Period One Treatment||2
52712|NCT01675050|124674|P1|STARTED|Period One Treatment||2
52713|NCT01675011|124684|P2|NOT COMPLETED|Overall Study||1
52714|NCT01675011|124685|P1|NOT COMPLETED|Overall Study||3
52715|NCT01675011|124684|P2|COMPLETED|Overall Study||0
52716|NCT01675011|124685|P1|COMPLETED|Overall Study||0
52717|NCT01675011|124684|P2|STARTED|Overall Study||1
52718|NCT01675011|124685|P1|STARTED|Overall Study||3
52719|NCT01674725|124693|P2|NOT COMPLETED|Overall Study||1
52720|NCT01674725|124694|P1|NOT COMPLETED|Overall Study||3
52721|NCT01674725|124693|P2|COMPLETED|Overall Study||94
52722|NCT01674725|124694|P1|COMPLETED|Overall Study||89
52723|NCT01674725|124693|P2|STARTED|Overall Study||95
52724|NCT01674725|124694|P1|STARTED|Overall Study||92
52725|NCT01674712|124713|P5|NOT COMPLETED|Overall Study||11
52726|NCT01674712|124714|P4|NOT COMPLETED|Overall Study||8
52727|NCT01674712|124715|P3|NOT COMPLETED|Overall Study||9
52728|NCT01674712|124716|P2|NOT COMPLETED|Overall Study||9
52729|NCT01674712|124717|P1|NOT COMPLETED|Overall Study||10
52730|NCT01674712|124713|P5|COMPLETED|Overall Study||102
52731|NCT01674712|124714|P4|COMPLETED|Overall Study||108
52732|NCT01674712|124715|P3|COMPLETED|Overall Study||106
52733|NCT01674712|124716|P2|COMPLETED|Overall Study||108
52734|NCT01674712|124717|P1|COMPLETED|Overall Study||104
52735|NCT01674712|124713|P5|Safety Subject Sample|Overall Study||112
52736|NCT01674712|124714|P4|Safety Subject Sample|Overall Study||115
52737|NCT01674712|124715|P3|Safety Subject Sample|Overall Study||113
52738|NCT01674712|124716|P2|Safety Subject Sample|Overall Study||117
52739|NCT01674712|124717|P1|Safety Subject Sample|Overall Study||111
52740|NCT01674712|124713|P5|Full Analysis Subject Sample|Overall Study||111
52741|NCT01674712|124714|P4|Full Analysis Subject Sample|Overall Study||112
52742|NCT01674712|124715|P3|Full Analysis Subject Sample|Overall Study||110
52743|NCT01674712|124716|P2|Full Analysis Subject Sample|Overall Study||114
52744|NCT01674712|124717|P1|Full Analysis Subject Sample|Overall Study||109
52745|NCT01674712|124713|P5|STARTED|Overall Study||113
52746|NCT01674712|124714|P4|STARTED|Overall Study||116
52747|NCT01674712|124715|P3|STARTED|Overall Study||115
52748|NCT01674712|124716|P2|STARTED|Overall Study||117
52749|NCT01674712|124717|P1|STARTED|Overall Study||114
52750|NCT01674647|124741|P2|NOT COMPLETED|30-day Safety Follow-up Period||41
52751|NCT01674647|124742|P1|NOT COMPLETED|30-day Safety Follow-up Period||58
52752|NCT01674647|124741|P2|COMPLETED|30-day Safety Follow-up Period||446
52753|NCT01674647|124742|P1|COMPLETED|30-day Safety Follow-up Period||924
52754|NCT01674647|124741|P2|STARTED|30-day Safety Follow-up Period||487
52755|NCT01674647|124742|P1|STARTED|30-day Safety Follow-up Period||982
52756|NCT01674647|124741|P2|NOT COMPLETED|Treatment Period||102
52757|NCT01674647|124742|P1|NOT COMPLETED|Treatment Period||156
52758|NCT01674647|124741|P2|COMPLETED|Treatment Period||400
52759|NCT01674647|124742|P1|COMPLETED|Treatment Period||846
52760|NCT01674647|124741|P2|Subjects Received Treatment|Treatment Period||499
52761|NCT01674647|124742|P1|Subjects Received Treatment|Treatment Period||988
52762|NCT01674647|124741|P2|STARTED|Treatment Period||502
52763|NCT01674647|124742|P1|STARTED|Treatment Period||1002
52764|NCT01674634|124768|P1|NOT COMPLETED|Overall Study||6
52765|NCT01674634|124768|P1|COMPLETED|Overall Study||709
52766|NCT01674634|124768|P1|STARTED|Overall Study||715
52767|NCT01674621|124788|P5|NOT COMPLETED|Overall Study||6
52768|NCT01674621|124789|P4|NOT COMPLETED|Overall Study||7
52769|NCT01674621|124790|P3|NOT COMPLETED|Overall Study||8
52770|NCT01674621|124791|P2|NOT COMPLETED|Overall Study||5
52771|NCT01674621|124792|P1|NOT COMPLETED|Overall Study||6
52772|NCT01674621|124788|P5|COMPLETED|Overall Study||45
52773|NCT01674621|124789|P4|COMPLETED|Overall Study||41
52774|NCT01674621|124790|P3|COMPLETED|Overall Study||43
52775|NCT01674621|124791|P2|COMPLETED|Overall Study||45
52776|NCT01674621|124792|P1|COMPLETED|Overall Study||44
52777|NCT01674621|124788|P5|STARTED|Overall Study||51
52778|NCT01674621|124789|P4|STARTED|Overall Study||48
52779|NCT01674621|124790|P3|STARTED|Overall Study||51
52780|NCT01674621|124791|P2|STARTED|Overall Study||50
52781|NCT01674621|124792|P1|STARTED|Overall Study||50
52782|NCT01674062|124816|P2|NOT COMPLETED|Overall Study||29
52783|NCT01674062|124817|P1|NOT COMPLETED|Overall Study||66
52784|NCT01674062|124816|P2|COMPLETED|Overall Study||0
52785|NCT01674062|124817|P1|COMPLETED|Overall Study||0
52786|NCT01674062|124816|P2|STARTED|Overall Study||29
52787|NCT01674062|124817|P1|STARTED|Overall Study||66
52788|NCT01674010|124832|P3|NOT COMPLETED|Randomization Phase 2||61
52789|NCT01674010|124833|P2|NOT COMPLETED|Randomization Phase 2||62
52790|NCT01674010|124834|P1|NOT COMPLETED|Randomization Phase 2||0
52791|NCT01674010|124832|P3|COMPLETED|Randomization Phase 2||3
52792|NCT01674010|124833|P2|COMPLETED|Randomization Phase 2||3
52793|NCT01674010|124834|P1|COMPLETED|Randomization Phase 2||0
52794|NCT01674010|124832|P3|STARTED|Randomization Phase 2||64
52795|NCT01674010|124833|P2|STARTED|Randomization Phase 2||65
52796|NCT01674010|124834|P1|STARTED|Randomization Phase 2||0
52797|NCT01674010|124832|P3|NOT COMPLETED|Open Treatment Phase 1||0
52798|NCT01674010|124833|P2|NOT COMPLETED|Open Treatment Phase 1||0
52799|NCT01674010|124834|P1|NOT COMPLETED|Open Treatment Phase 1||180
52800|NCT01674010|124832|P3|COMPLETED|Open Treatment Phase 1||0
52801|NCT01674010|124833|P2|COMPLETED|Open Treatment Phase 1||0
52802|NCT01674010|124834|P1|COMPLETED|Open Treatment Phase 1||129
52803|NCT01674010|124832|P3|STARTED|Open Treatment Phase 1||0
52804|NCT01674010|124833|P2|STARTED|Open Treatment Phase 1||0
52805|NCT01674010|124834|P1|STARTED|Open Treatment Phase 1||309
52806|NCT01673984|124853|P2|NOT COMPLETED|Overall Study||6
52807|NCT01673984|124854|P1|NOT COMPLETED|Overall Study||10
52808|NCT01673984|124853|P2|COMPLETED|Overall Study||1
52809|NCT01673984|124854|P1|COMPLETED|Overall Study||4
52810|NCT01673984|124853|P2|STARTED|Overall Study||7
52811|NCT01673984|124854|P1|STARTED|Overall Study||14
52812|NCT01673919|124872|P1|NOT COMPLETED|Overall Study||0
52813|NCT01673919|124872|P1|COMPLETED|Overall Study||7
52814|NCT01673919|124872|P1|STARTED|Overall Study||7
52815|NCT01673867|124896|P2|NOT COMPLETED|Treatment||268
52816|NCT01673867|124897|P1|NOT COMPLETED|Treatment||244
52817|NCT01673867|124896|P2|COMPLETED|Treatment||0
52818|NCT01673867|124897|P1|COMPLETED|Treatment||43
52819|NCT01673867|124896|P2|STARTED|Treatment||268
52820|NCT01673867|124897|P1|STARTED|Treatment||287
52821|NCT01673867|124896|P2|NOT COMPLETED|Randomization||22
52822|NCT01673867|124897|P1|NOT COMPLETED|Randomization||5
52823|NCT01673867|124896|P2|COMPLETED|Randomization||268
52824|NCT01673867|124897|P1|COMPLETED|Randomization||287
52825|NCT01673867|124896|P2|STARTED|Randomization||290
52826|NCT01673867|124897|P1|STARTED|Randomization||292
52827|NCT01673854|124923|P1|NOT COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||19
52828|NCT01673854|124923|P1|COMPLETED|Vem 2 Phase (Vemurafenib Retreatment)||0
52829|NCT01673854|124923|P1|STARTED|Vem 2 Phase (Vemurafenib Retreatment)||19
52830|NCT01673854|124923|P1|NOT COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||27
52831|NCT01673854|124923|P1|COMPLETED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||19
52832|NCT01673854|124923|P1|STARTED|Ipilimumab Phase (Ipilimumab, 10 mg/kg)||46
52833|NCT01673854|124923|P1|NOT COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||0
52834|NCT01673854|124923|P1|COMPLETED|Vem 1 Phase (Vemurafenib, 960 mg)||46
52835|NCT01673854|124923|P1|STARTED|Vem 1 Phase (Vemurafenib, 960 mg)||46
52836|NCT01673828|124933|P2|NOT COMPLETED|Overall Study||0
52837|NCT01673828|124934|P1|NOT COMPLETED|Overall Study||0
52838|NCT01673828|124933|P2|COMPLETED|Overall Study||6
52839|NCT01673828|124934|P1|COMPLETED|Overall Study||7
52840|NCT01673828|124933|P2|STARTED|Overall Study||6
52841|NCT01673828|124934|P1|STARTED|Overall Study||7
52842|NCT01673802|124940|P1|NOT COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||0
52843|NCT01673802|124940|P1|COMPLETED|Gadoxetate Double Dose 0.050 mmol/kg||10
52844|NCT01673802|124940|P1|STARTED|Gadoxetate Double Dose 0.050 mmol/kg||10
52845|NCT01673802|124940|P1|NOT COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||0
52846|NCT01673802|124940|P1|COMPLETED|Gadoxetate Standard Dose 0.025 mmol/kg||8
52847|NCT01673802|124940|P1|STARTED|Gadoxetate Standard Dose 0.025 mmol/kg||8
52848|NCT01673698|124946|P2|NOT COMPLETED|Overall Study||13
52849|NCT01673698|124947|P1|NOT COMPLETED|Overall Study||51
52850|NCT01673698|124946|P2|COMPLETED|Overall Study||126
52851|NCT01673698|124947|P1|COMPLETED|Overall Study||136
52852|NCT01673698|124946|P2|STARTED|Overall Study||139
52853|NCT01673698|124947|P1|STARTED|Overall Study||187
52854|NCT01673620|124957|P2|NOT COMPLETED|Overall Study||0
52855|NCT01673620|124958|P1|NOT COMPLETED|Overall Study||1
52856|NCT01673620|124957|P2|COMPLETED|Overall Study||22
52857|NCT01673620|124958|P1|COMPLETED|Overall Study||46
52858|NCT01673620|124957|P2|STARTED|Overall Study||22
52859|NCT01673620|124958|P1|STARTED|Overall Study||47
52860|NCT01673594|124968|P2|NOT COMPLETED|Overall Study||6
52861|NCT01673594|124969|P1|NOT COMPLETED|Overall Study||6
52862|NCT01673594|124968|P2|COMPLETED|Overall Study||13
52863|NCT01673594|124969|P1|COMPLETED|Overall Study||12
52864|NCT01673594|124968|P2|STARTED|Overall Study||19
52865|NCT01673594|124969|P1|STARTED|Overall Study||18
52866|NCT01673568|124979|P2|NOT COMPLETED|Overall Study||0
52867|NCT01673568|124980|P1|NOT COMPLETED|Overall Study||0
52868|NCT01673568|124979|P2|COMPLETED|Overall Study||28
52869|NCT01673568|124980|P1|COMPLETED|Overall Study||28
52870|NCT01673568|124979|P2|STARTED|Overall Study||28
52871|NCT01673568|124980|P1|STARTED|Overall Study||28
52872|NCT01673490|124988|P1|NOT COMPLETED|Overall Study||7
52873|NCT01673490|124988|P1|COMPLETED|Overall Study||52
52874|NCT01673490|124988|P1|STARTED|Overall Study||59
52875|NCT01673425|125001|P1|NOT COMPLETED|Overall Study||1
52876|NCT01673425|125001|P1|COMPLETED|Overall Study||4
52877|NCT01673425|125001|P1|STARTED|Overall Study||5
52878|NCT01673347|125005|P1|NOT COMPLETED|Overall Study||7
52879|NCT01673347|125005|P1|COMPLETED|Overall Study||17
52880|NCT01673347|125005|P1|STARTED|Overall Study||24
52881|NCT01673282|125014|P2|NOT COMPLETED|Overall Study||26
52882|NCT01673282|125015|P1|NOT COMPLETED|Overall Study||33
52883|NCT01673282|125014|P2|COMPLETED|Overall Study||132
52884|NCT01673282|125015|P1|COMPLETED|Overall Study||120
52885|NCT01673282|125014|P2|STARTED|Overall Study||158
52886|NCT01673282|125015|P1|STARTED|Overall Study||153
52887|NCT01673256|125021|P1|NOT COMPLETED|Overall Study||0
52888|NCT01673256|125021|P1|COMPLETED|Overall Study||90
52889|NCT01673256|125021|P1|STARTED|Overall Study||90
52890|NCT01673191|125027|P2|NOT COMPLETED|Overall Study||0
52891|NCT01673191|125028|P1|NOT COMPLETED|Overall Study||0
52892|NCT01673191|125027|P2|COMPLETED|Overall Study||11
52893|NCT01673191|125028|P1|COMPLETED|Overall Study||26
52894|NCT01673191|125027|P2|STARTED|Overall Study||11
52895|NCT01673191|125028|P1|STARTED|Overall Study||26
52896|NCT01673178|125051|P5|NOT COMPLETED|Overall Study||2
52897|NCT01673178|125052|P4|NOT COMPLETED|Overall Study||8
52898|NCT01673178|125053|P3|NOT COMPLETED|Overall Study||3
52899|NCT01673178|125054|P2|NOT COMPLETED|Overall Study||2
52900|NCT01673178|125055|P1|NOT COMPLETED|Overall Study||3
52901|NCT01673178|125051|P5|COMPLETED|Overall Study||19
52902|NCT01673178|125052|P4|COMPLETED|Overall Study||14
52903|NCT01673178|125053|P3|COMPLETED|Overall Study||18
52904|NCT01673178|125054|P2|COMPLETED|Overall Study||19
52905|NCT01673178|125055|P1|COMPLETED|Overall Study||19
52906|NCT01673178|125051|P5|STARTED|Overall Study||21
52907|NCT01673178|125052|P4|STARTED|Overall Study||22
52908|NCT01673178|125053|P3|STARTED|Overall Study||21
52909|NCT01673178|125054|P2|STARTED|Overall Study||21
52910|NCT01673178|125055|P1|STARTED|Overall Study||22
52911|NCT01673126|125294|P2|NOT COMPLETED|Overall Study||3
52912|NCT01673126|125295|P1|NOT COMPLETED|Overall Study||4
52913|NCT01673126|125294|P2|COMPLETED|Overall Study||23
52914|NCT01673126|125295|P1|COMPLETED|Overall Study||32
52915|NCT01673126|125294|P2|STARTED|Overall Study|First stimulation (20 minutes) Washout (2days) Second stimulation (20 minutes)|26
52916|NCT01673126|125295|P1|STARTED|Overall Study|First stimulation (20 minutes) Washout (2 days) Second stimulation (20 minutes)|36
52917|NCT01673113|125303|P2|NOT COMPLETED|Overall Study||0
52918|NCT01673113|125304|P1|NOT COMPLETED|Overall Study||0
52919|NCT01673113|125303|P2|COMPLETED|Overall Study||11
52920|NCT01673113|125304|P1|COMPLETED|Overall Study||11
52921|NCT01673113|125303|P2|STARTED|Overall Study||11
52922|NCT01673113|125304|P1|STARTED|Overall Study||11
52923|NCT01673009|125311|P1|NOT COMPLETED|Overall Study||13
52924|NCT01673009|125311|P1|COMPLETED|Overall Study||23
52925|NCT01673009|125311|P1|STARTED|Overall Study||36
52926|NCT01672996|125323|P3|NOT COMPLETED|Overall Study||0
52927|NCT01672996|125324|P2|NOT COMPLETED|Overall Study||0
52928|NCT01672996|125325|P1|NOT COMPLETED|Overall Study||0
52929|NCT01672996|125323|P3|COMPLETED|Overall Study||6
52930|NCT01672996|125324|P2|COMPLETED|Overall Study||30
52931|NCT01672996|125325|P1|COMPLETED|Overall Study||30
52932|NCT01672996|125323|P3|STARTED|Overall Study||6
52933|NCT01672996|125324|P2|STARTED|Overall Study||30
52934|NCT01672996|125325|P1|STARTED|Overall Study||30
52935|NCT01672983|125361|P6|NOT COMPLETED|Overall Study||0
52936|NCT01672983|125362|P5|NOT COMPLETED|Overall Study||0
52937|NCT01672983|125363|P4|NOT COMPLETED|Overall Study||0
52938|NCT01672983|125364|P3|NOT COMPLETED|Overall Study||0
52939|NCT01672983|125365|P2|NOT COMPLETED|Overall Study||0
52940|NCT01672983|125366|P1|NOT COMPLETED|Overall Study||0
52941|NCT01672983|125361|P6|COMPLETED|Overall Study||18
52942|NCT01672983|125362|P5|COMPLETED|Overall Study||19
52943|NCT01672983|125363|P4|COMPLETED|Overall Study||18
52944|NCT01672983|125364|P3|COMPLETED|Overall Study||19
52945|NCT01672983|125365|P2|COMPLETED|Overall Study||18
52946|NCT01672983|125366|P1|COMPLETED|Overall Study||18
52947|NCT01672983|125361|P6|Completed Study Drug|Overall Study||17
52948|NCT01672983|125362|P5|Completed Study Drug|Overall Study||12
52949|NCT01672983|125363|P4|Completed Study Drug|Overall Study||18
52950|NCT01672983|125364|P3|Completed Study Drug|Overall Study||18
52951|NCT01672983|125365|P2|Completed Study Drug|Overall Study||17
52952|NCT01672983|125366|P1|Completed Study Drug|Overall Study||18
52953|NCT01672983|125361|P6|STARTED|Overall Study||18
52954|NCT01672983|125362|P5|STARTED|Overall Study||19
52955|NCT01672983|125363|P4|STARTED|Overall Study||18
52956|NCT01672983|125364|P3|STARTED|Overall Study||19
52957|NCT01672983|125365|P2|STARTED|Overall Study||18
52958|NCT01672983|125366|P1|STARTED|Overall Study||18
52959|NCT01672970|125396|P1|NOT COMPLETED|Overall Study||47
52960|NCT01672970|125396|P1|COMPLETED|Overall Study||244
52961|NCT01672970|125396|P1|Treated|Overall Study||290
52962|NCT01672970|125396|P1|STARTED|Overall Study||291
52963|NCT01672957|125432|P1|NOT COMPLETED|Overall Study||55
52964|NCT01672957|125432|P1|COMPLETED|Overall Study||73
52965|NCT01672957|125432|P1|Intent-to-treat (ITT) Population|Overall Study|All enrolled participants who had no major protocol violation.|123
52966|NCT01672957|125432|P1|STARTED|Overall Study||128
52967|NCT01672827|125445|P1|NOT COMPLETED|Overall Study||0
52968|NCT01672827|125445|P1|COMPLETED|Overall Study||276
52969|NCT01672827|125445|P1|STARTED|Overall Study||276
52970|NCT01672788|125451|P4|NOT COMPLETED|Treatment Period 4 (3 Days)||0
52971|NCT01672788|125452|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
52972|NCT01672788|125453|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
52973|NCT01672788|125454|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
52974|NCT01672788|125451|P4|COMPLETED|Treatment Period 4 (3 Days)||8
52975|NCT01672788|125452|P3|COMPLETED|Treatment Period 4 (3 Days)||9
52976|NCT01672788|125453|P2|COMPLETED|Treatment Period 4 (3 Days)||9
52977|NCT01672788|125454|P1|COMPLETED|Treatment Period 4 (3 Days)||9
52978|NCT01672788|125451|P4|STARTED|Treatment Period 4 (3 Days)||8
52979|NCT01672788|125452|P3|STARTED|Treatment Period 4 (3 Days)||9
52980|NCT01672788|125453|P2|STARTED|Treatment Period 4 (3 Days)||9
52981|NCT01672788|125454|P1|STARTED|Treatment Period 4 (3 Days)||9
52982|NCT01672788|125451|P4|NOT COMPLETED|Washout Period 3 (7 Days)||0
52983|NCT01672788|125452|P3|NOT COMPLETED|Washout Period 3 (7 Days)||0
52984|NCT01672788|125453|P2|NOT COMPLETED|Washout Period 3 (7 Days)||0
52985|NCT01672788|125454|P1|NOT COMPLETED|Washout Period 3 (7 Days)||0
52986|NCT01672788|125451|P4|COMPLETED|Washout Period 3 (7 Days)||8
52987|NCT01672788|125452|P3|COMPLETED|Washout Period 3 (7 Days)||9
52988|NCT01672788|125453|P2|COMPLETED|Washout Period 3 (7 Days)||9
52989|NCT01672788|125454|P1|COMPLETED|Washout Period 3 (7 Days)||9
52990|NCT01672788|125451|P4|STARTED|Washout Period 3 (7 Days)||8
52991|NCT01672788|125452|P3|STARTED|Washout Period 3 (7 Days)||9
52992|NCT01672788|125453|P2|STARTED|Washout Period 3 (7 Days)||9
52993|NCT01672788|125454|P1|STARTED|Washout Period 3 (7 Days)||9
52994|NCT01672788|125451|P4|NOT COMPLETED|Treatment Period 3 (3 Days)||0
52995|NCT01672788|125452|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
52996|NCT01672788|125453|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
52997|NCT01672788|125454|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
52998|NCT01672788|125451|P4|COMPLETED|Treatment Period 3 (3 Days)||8
52999|NCT01672788|125452|P3|COMPLETED|Treatment Period 3 (3 Days)||9
53000|NCT01672788|125453|P2|COMPLETED|Treatment Period 3 (3 Days)||9
53001|NCT01672788|125454|P1|COMPLETED|Treatment Period 3 (3 Days)||9
53002|NCT01672788|125451|P4|STARTED|Treatment Period 3 (3 Days)||8
53003|NCT01672788|125452|P3|STARTED|Treatment Period 3 (3 Days)||9
53004|NCT01672788|125453|P2|STARTED|Treatment Period 3 (3 Days)||9
53005|NCT01672788|125454|P1|STARTED|Treatment Period 3 (3 Days)||9
53006|NCT01672788|125451|P4|NOT COMPLETED|Washout Period 2 (7 Days)||1
53007|NCT01672788|125452|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
53008|NCT01672788|125453|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
53009|NCT01672788|125454|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
53010|NCT01672788|125451|P4|COMPLETED|Washout Period 2 (7 Days)||8
53011|NCT01672788|125452|P3|COMPLETED|Washout Period 2 (7 Days)||9
53012|NCT01672788|125453|P2|COMPLETED|Washout Period 2 (7 Days)||9
53013|NCT01672788|125454|P1|COMPLETED|Washout Period 2 (7 Days)||9
53014|NCT01672788|125451|P4|STARTED|Washout Period 2 (7 Days)||9
53015|NCT01672788|125452|P3|STARTED|Washout Period 2 (7 Days)||9
53016|NCT01672788|125453|P2|STARTED|Washout Period 2 (7 Days)||9
53017|NCT01672788|125454|P1|STARTED|Washout Period 2 (7 Days)||9
53018|NCT01672788|125451|P4|NOT COMPLETED|Treatment Period 2 (3 Days)||0
53019|NCT01672788|125452|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
53020|NCT01672788|125453|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||0
53021|NCT01672788|125454|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
53022|NCT01672788|125451|P4|COMPLETED|Treatment Period 2 (3 Days)||9
53023|NCT01672788|125452|P3|COMPLETED|Treatment Period 2 (3 Days)||9
53024|NCT01672788|125453|P2|COMPLETED|Treatment Period 2 (3 Days)||9
53025|NCT01672788|125454|P1|COMPLETED|Treatment Period 2 (3 Days)||9
53026|NCT01672788|125451|P4|STARTED|Treatment Period 2 (3 Days)||9
53027|NCT01672788|125452|P3|STARTED|Treatment Period 2 (3 Days)||9
53028|NCT01672788|125453|P2|STARTED|Treatment Period 2 (3 Days)||9
53029|NCT01672788|125454|P1|STARTED|Treatment Period 2 (3 Days)||9
53030|NCT01672788|125451|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
53031|NCT01672788|125452|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
53032|NCT01672788|125453|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
53033|NCT01672788|125454|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
53034|NCT01672788|125451|P4|COMPLETED|Washout Period 1 (7 Days)||9
53035|NCT01672788|125452|P3|COMPLETED|Washout Period 1 (7 Days)||9
53036|NCT01672788|125453|P2|COMPLETED|Washout Period 1 (7 Days)||9
53037|NCT01672788|125454|P1|COMPLETED|Washout Period 1 (7 Days)||9
53038|NCT01672788|125451|P4|STARTED|Washout Period 1 (7 Days)||9
53039|NCT01672788|125452|P3|STARTED|Washout Period 1 (7 Days)||9
53040|NCT01672788|125453|P2|STARTED|Washout Period 1 (7 Days)||9
53041|NCT01672788|125454|P1|STARTED|Washout Period 1 (7 Days)||9
53042|NCT01672788|125451|P4|NOT COMPLETED|Treatment Period 1 (3 Days)||0
53043|NCT01672788|125452|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
53044|NCT01672788|125453|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
53045|NCT01672788|125454|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
53046|NCT01672788|125451|P4|COMPLETED|Treatment Period 1 (3 Days)||9
53047|NCT01672788|125452|P3|COMPLETED|Treatment Period 1 (3 Days)||9
53048|NCT01672788|125453|P2|COMPLETED|Treatment Period 1 (3 Days)||9
53049|NCT01672788|125454|P1|COMPLETED|Treatment Period 1 (3 Days)||9
53050|NCT01672788|125451|P4|STARTED|Treatment Period 1 (3 Days)||9
53051|NCT01672788|125452|P3|STARTED|Treatment Period 1 (3 Days)||9
53052|NCT01672788|125453|P2|STARTED|Treatment Period 1 (3 Days)||9
53053|NCT01672788|125454|P1|STARTED|Treatment Period 1 (3 Days)||9
53054|NCT01672723|125484|P2|NOT COMPLETED|Second Intervention||0
53055|NCT01672723|125485|P1|NOT COMPLETED|Second Intervention||0
53056|NCT01672723|125484|P2|COMPLETED|Second Intervention||15
53057|NCT01672723|125485|P1|COMPLETED|Second Intervention||16
53058|NCT01672723|125484|P2|STARTED|Second Intervention||15
53059|NCT01672723|125485|P1|STARTED|Second Intervention||16
53060|NCT01672723|125484|P2|NOT COMPLETED|Washout Period of 10 Days||0
53061|NCT01672723|125485|P1|NOT COMPLETED|Washout Period of 10 Days||0
53062|NCT01672723|125484|P2|COMPLETED|Washout Period of 10 Days||15
53063|NCT01672723|125485|P1|COMPLETED|Washout Period of 10 Days||16
53064|NCT01672723|125484|P2|STARTED|Washout Period of 10 Days||15
53065|NCT01672723|125485|P1|STARTED|Washout Period of 10 Days||16
53066|NCT01672723|125484|P2|NOT COMPLETED|First Intervention||0
53067|NCT01672723|125485|P1|NOT COMPLETED|First Intervention||3
53068|NCT01672723|125484|P2|COMPLETED|First Intervention||15
53069|NCT01672723|125485|P1|COMPLETED|First Intervention||16
53070|NCT01672723|125484|P2|STARTED|First Intervention||15
53071|NCT01672723|125485|P1|STARTED|First Intervention||19
53072|NCT01672658|125497|P2|NOT COMPLETED|Overall Study||1
53073|NCT01672658|125498|P1|NOT COMPLETED|Overall Study||0
53074|NCT01672658|125497|P2|COMPLETED|Overall Study||14
53075|NCT01672658|125498|P1|COMPLETED|Overall Study||16
53076|NCT01672658|125497|P2|STARTED|Overall Study||15
53077|NCT01672658|125498|P1|STARTED|Overall Study||16
53078|NCT01672294|125522|P4|NOT COMPLETED|Overall Study||13
53079|NCT01672294|125523|P3|NOT COMPLETED|Overall Study||11
53080|NCT01672294|125524|P2|NOT COMPLETED|Overall Study||21
53081|NCT01672294|125525|P1|NOT COMPLETED|Overall Study||6
53082|NCT01672294|125522|P4|COMPLETED|Overall Study||59
53083|NCT01672294|125523|P3|COMPLETED|Overall Study||61
53084|NCT01672294|125524|P2|COMPLETED|Overall Study||50
53085|NCT01672294|125525|P1|COMPLETED|Overall Study||65
53086|NCT01672294|125522|P4|STARTED|Overall Study||72
53087|NCT01672294|125523|P3|STARTED|Overall Study||72
53088|NCT01672294|125524|P2|STARTED|Overall Study||71
53089|NCT01672294|125525|P1|STARTED|Overall Study||71
53090|NCT01671839|125547|P1|NOT COMPLETED|Overall Study||5
53091|NCT01671839|125547|P1|COMPLETED|Overall Study||50
53092|NCT01671839|125547|P1|STARTED|Overall Study||55
53093|NCT01671748|125558|P2|NOT COMPLETED|12 Week Treatment Phase||0
53094|NCT01671748|125559|P1|NOT COMPLETED|12 Week Treatment Phase||0
53095|NCT01671748|125558|P2|COMPLETED|12 Week Treatment Phase||17
53096|NCT01671748|125559|P1|COMPLETED|12 Week Treatment Phase||19
53097|NCT01671748|125558|P2|STARTED|12 Week Treatment Phase||17
53098|NCT01671748|125559|P1|STARTED|12 Week Treatment Phase||19
53099|NCT01671748|125558|P2|NOT COMPLETED|4 Week run-in Phase||0
53100|NCT01671748|125559|P1|NOT COMPLETED|4 Week run-in Phase||11
53101|NCT01671748|125558|P2|COMPLETED|4 Week run-in Phase||0
53102|NCT01671748|125559|P1|COMPLETED|4 Week run-in Phase||36
53103|NCT01671748|125558|P2|STARTED|4 Week run-in Phase||0
53104|NCT01671748|125559|P1|STARTED|4 Week run-in Phase||47
53105|NCT01671605|125579|P2|NOT COMPLETED|Overall Study||0
53106|NCT01671605|125580|P1|NOT COMPLETED|Overall Study||0
53107|NCT01671605|125579|P2|COMPLETED|Overall Study||31
53108|NCT01671605|125580|P1|COMPLETED|Overall Study||72
53109|NCT01671605|125579|P2|STARTED|Overall Study||31
53110|NCT01671605|125580|P1|STARTED|Overall Study||72
53111|NCT01671488|125586|P1|NOT COMPLETED|Overall Study||1
53112|NCT01671488|125586|P1|COMPLETED|Overall Study||10
53113|NCT01671488|125586|P1|STARTED|Overall Study||11
53114|NCT01671293|125594|P2|NOT COMPLETED|Overall Study||2
53115|NCT01671293|125595|P1|NOT COMPLETED|Overall Study||3
53116|NCT01671293|125594|P2|COMPLETED|Overall Study||32
53117|NCT01671293|125595|P1|COMPLETED|Overall Study||33
53118|NCT01671293|125594|P2|STARTED|Overall Study||34
53119|NCT01671293|125595|P1|STARTED|Overall Study||36
53120|NCT01671280|125601|P1|NOT COMPLETED|Overall Study||2
53121|NCT01671280|125601|P1|COMPLETED|Overall Study||401
53122|NCT01671280|125601|P1|STARTED|Overall Study|The number is enrollment.|403
53123|NCT01671111|125607|P1|NOT COMPLETED|Overall Study||30
53124|NCT01671111|125607|P1|COMPLETED|Overall Study||0
53125|NCT01671111|125607|P1|STARTED|Overall Study||30
53126|NCT01671059|125617|P1|NOT COMPLETED|Overall Study||5
53127|NCT01671059|125617|P1|COMPLETED|Overall Study||75
53128|NCT01671059|125617|P1|STARTED|Overall Study||80
53129|NCT01670825|125642|P2|NOT COMPLETED|Overall Study||0
53130|NCT01670825|125643|P1|NOT COMPLETED|Overall Study||0
53131|NCT01670825|125642|P2|COMPLETED|Overall Study||39
53132|NCT01670825|125643|P1|COMPLETED|Overall Study||42
53133|NCT01670825|125642|P2|STARTED|Overall Study||39
53134|NCT01670825|125643|P1|STARTED|Overall Study||42
53135|NCT01670721|125709|P1|NOT COMPLETED|Overall Study||53
53136|NCT01670721|125709|P1|COMPLETED|Overall Study|81 participants with DP and 41 with adverse events were considered as completed.|122
53137|NCT01670721|125709|P1|STARTED|Overall Study||175
53138|NCT01670656|125721|P5|NOT COMPLETED|Overall Study||11
53139|NCT01670656|125722|P4|NOT COMPLETED|Overall Study||6
53140|NCT01670656|125723|P3|NOT COMPLETED|Overall Study||8
53141|NCT01670656|125724|P2|NOT COMPLETED|Overall Study||7
53142|NCT01670656|125725|P1|NOT COMPLETED|Overall Study||3
53143|NCT01670656|125721|P5|COMPLETED|Overall Study||79
53144|NCT01670656|125722|P4|COMPLETED|Overall Study||79
53145|NCT01670656|125723|P3|COMPLETED|Overall Study||79
53146|NCT01670656|125724|P2|COMPLETED|Overall Study||84
53147|NCT01670656|125725|P1|COMPLETED|Overall Study||83
53148|NCT01670656|125721|P5|Treated|Overall Study||90
53149|NCT01670656|125722|P4|Treated|Overall Study||85
53150|NCT01670656|125723|P3|Treated|Overall Study||86
53151|NCT01670656|125724|P2|Treated|Overall Study||91
53152|NCT01670656|125725|P1|Treated|Overall Study||86
53153|NCT01670656|125721|P5|STARTED|Overall Study||90
53154|NCT01670656|125722|P4|STARTED|Overall Study||85
53155|NCT01670656|125723|P3|STARTED|Overall Study||87
53156|NCT01670656|125724|P2|STARTED|Overall Study||91
53157|NCT01670656|125725|P1|STARTED|Overall Study||86
53158|NCT01670526|125754|P2|NOT COMPLETED|Overall Study||6
53159|NCT01670526|125755|P1|NOT COMPLETED|Overall Study||12
53160|NCT01670526|125754|P2|COMPLETED|Overall Study||39
53161|NCT01670526|125755|P1|COMPLETED|Overall Study||37
53162|NCT01670526|125754|P2|STARTED|Overall Study||45
53163|NCT01670526|125755|P1|STARTED|Overall Study||49
53164|NCT01670487|125769|P2|NOT COMPLETED|Overall Study||0
53165|NCT01670487|125770|P1|NOT COMPLETED|Overall Study||0
53166|NCT01670487|125769|P2|COMPLETED|Overall Study||150
53167|NCT01670487|125770|P1|COMPLETED|Overall Study||150
53168|NCT01670487|125769|P2|STARTED|Overall Study||150
53169|NCT01670487|125770|P1|STARTED|Overall Study||150
53170|NCT01670279|125779|P4|NOT COMPLETED|Overall Study||1
53171|NCT01670279|125780|P3|NOT COMPLETED|Overall Study||0
53172|NCT01670279|125781|P2|NOT COMPLETED|Overall Study||2
53173|NCT01670279|125782|P1|NOT COMPLETED|Overall Study||0
53174|NCT01670279|125779|P4|COMPLETED|Overall Study||4
53175|NCT01670279|125780|P3|COMPLETED|Overall Study||0
53176|NCT01670279|125781|P2|COMPLETED|Overall Study||5
53177|NCT01670279|125782|P1|COMPLETED|Overall Study||6
53178|NCT01670279|125779|P4|STARTED|Overall Study||5
53179|NCT01670279|125780|P3|STARTED|Overall Study||0
53180|NCT01670279|125781|P2|STARTED|Overall Study||7
53181|NCT01670279|125782|P1|STARTED|Overall Study||6
53182|NCT01670201|125817|P1|NOT COMPLETED|Overall Study||0
53183|NCT01670201|125817|P1|COMPLETED|Overall Study||8
53184|NCT01670201|125817|P1|STARTED|Overall Study||8
53185|NCT01670045|125822|P1|NOT COMPLETED|Overall Study||16
53186|NCT01670045|125822|P1|COMPLETED|Overall Study||27
53187|NCT01670045|125822|P1|STARTED|Overall Study||43
53188|NCT01670019|125840|P2|NOT COMPLETED|Overall Study||0
53189|NCT01670019|125841|P1|NOT COMPLETED|Overall Study||9
53190|NCT01670019|125840|P2|COMPLETED|Overall Study||23
53191|NCT01670019|125841|P1|COMPLETED|Overall Study||14
53192|NCT01670019|125840|P2|STARTED|Overall Study||23
53193|NCT01670019|125841|P1|STARTED|Overall Study||23
53194|NCT01669902|125855|P1|NOT COMPLETED|Overall Study||29
53195|NCT01669902|125855|P1|COMPLETED|Overall Study||78
53196|NCT01669902|125855|P1|STARTED|Overall Study||107
53197|NCT01669863|125882|P1|NOT COMPLETED|Overall Study||0
53198|NCT01669863|125882|P1|COMPLETED|Overall Study||6
53199|NCT01669863|125882|P1|STARTED|Overall Study||6
53200|NCT01669811|125890|P2|NOT COMPLETED|Overall Study||11
53201|NCT01669811|125891|P1|NOT COMPLETED|Overall Study||3
53202|NCT01669811|125890|P2|COMPLETED|Overall Study||131
53203|NCT01669811|125891|P1|COMPLETED|Overall Study||142
53204|NCT01669811|125890|P2|STARTED|Overall Study||142
53205|NCT01669811|125891|P1|STARTED|Overall Study||145
53206|NCT01669785|125912|P3|NOT COMPLETED|Overall Study||0
53207|NCT01669785|125913|P2|NOT COMPLETED|Overall Study||0
53208|NCT01669785|125914|P1|NOT COMPLETED|Overall Study||0
53209|NCT01669785|125912|P3|COMPLETED|Overall Study||46
53210|NCT01669785|125913|P2|COMPLETED|Overall Study||48
53211|NCT01669785|125914|P1|COMPLETED|Overall Study||45
53212|NCT01669785|125912|P3|STARTED|Overall Study||46
53213|NCT01669785|125913|P2|STARTED|Overall Study||48
53214|NCT01669785|125914|P1|STARTED|Overall Study||45
53215|NCT01669720|125951|P2|NOT COMPLETED|Overall Study||0
53216|NCT01669720|125952|P1|NOT COMPLETED|Overall Study||0
53217|NCT01669720|125951|P2|COMPLETED|Overall Study||3
53218|NCT01669720|125952|P1|COMPLETED|Overall Study||7
53219|NCT01669720|125951|P2|STARTED|Overall Study||3
53220|NCT01669720|125952|P1|STARTED|Overall Study||7
53221|NCT01669629|125958|P2|NOT COMPLETED|Period 2||0
53222|NCT01669629|125959|P1|NOT COMPLETED|Period 2||0
53223|NCT01669629|125958|P2|COMPLETED|Period 2||89
53224|NCT01669629|125959|P1|COMPLETED|Period 2||91
53225|NCT01669629|125958|P2|STARTED|Period 2||89
53226|NCT01669629|125959|P1|STARTED|Period 2||91
53227|NCT01669629|125958|P2|NOT COMPLETED|Period 1||2
53228|NCT01669629|125959|P1|NOT COMPLETED|Period 1||1
53229|NCT01669629|125958|P2|COMPLETED|Period 1||89
53230|NCT01669629|125959|P1|COMPLETED|Period 1||91
53231|NCT01669629|125958|P2|STARTED|Period 1||91
53232|NCT01669629|125959|P1|STARTED|Period 1||92
53233|NCT01669603|125975|P2|NOT COMPLETED|Overall Study||38
53234|NCT01669603|125976|P1|NOT COMPLETED|Overall Study||37
53235|NCT01669603|125975|P2|COMPLETED|Overall Study||57
53236|NCT01669603|125976|P1|COMPLETED|Overall Study||58
53237|NCT01669603|125975|P2|STARTED|Overall Study||95
53238|NCT01669603|125976|P1|STARTED|Overall Study||95
53239|NCT01669577|125982|P1|NOT COMPLETED|Overall Study||134
53240|NCT01669577|125982|P1|COMPLETED|Overall Study|complete case analysis (data missing completely at random)|200
53241|NCT01669577|125982|P1|STARTED|Overall Study|calculated ISS<16, no informed consent, not enough data(complete case analysis), were excluded|334
53242|NCT01669174|125988|P2|NOT COMPLETED|Overall Study||6
53243|NCT01669174|125989|P1|NOT COMPLETED|Overall Study||6
53244|NCT01669174|125988|P2|COMPLETED|Overall Study||28
53245|NCT01669174|125989|P1|COMPLETED|Overall Study||27
53246|NCT01669174|125988|P2|STARTED|Overall Study||34
53247|NCT01669174|125989|P1|STARTED|Overall Study||33
53248|NCT01669148|126000|P1|NOT COMPLETED|Overall Study||70
53249|NCT01669148|126000|P1|COMPLETED|Overall Study||426
53250|NCT01669148|126000|P1|STARTED|Overall Study||496
53251|NCT01669122|126005|P1|NOT COMPLETED|Period IV||0
53252|NCT01669122|126005|P1|COMPLETED|Period IV||37
53253|NCT01669122|126005|P1|STARTED|Period IV|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=9, Reference Lozenge=9|37
53254|NCT01669122|126005|P1|NOT COMPLETED|Period III||0
53255|NCT01669122|126005|P1|COMPLETED|Period III||37
53256|NCT01669122|126005|P1|STARTED|Period III|Participants who received Lozenge A=10, Lozenge B=8, Lozenge C=10, Reference Lozenge=9|37
53257|NCT01669122|126005|P1|NOT COMPLETED|Washout Period III||0
53258|NCT01669122|126005|P1|COMPLETED|Washout Period III||37
53259|NCT01669122|126005|P1|STARTED|Washout Period III||37
53260|NCT01669122|126005|P1|NOT COMPLETED|Washout Period II||2
53261|NCT01669122|126005|P1|COMPLETED|Washout Period II||37
53262|NCT01669122|126005|P1|STARTED|Washout Period II||39
53263|NCT01669122|126005|P1|NOT COMPLETED|Period II||0
53264|NCT01669122|126005|P1|COMPLETED|Period II||39
53265|NCT01669122|126005|P1|STARTED|Period II|Participants who received Lozenge A=9, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|39
53266|NCT01669122|126005|P1|NOT COMPLETED|Washout Period I||0
53267|NCT01669122|126005|P1|COMPLETED|Washout Period I||39
53268|NCT01669122|126005|P1|STARTED|Washout Period I||39
53269|NCT01669122|126005|P1|NOT COMPLETED|Period I||1
53270|NCT01669122|126005|P1|COMPLETED|Period I||39
53271|NCT01669122|126005|P1|Safety Population|Period I||39
53272|NCT01669122|126005|P1|STARTED|Period I|Participants who received Lozenge A=10, Lozenge B=10, Lozenge C=10, Reference Lozenge=10|40
53273|NCT01668836|126039|P4|NOT COMPLETED|Overall Study||0
53274|NCT01668836|126040|P3|NOT COMPLETED|Overall Study||0
53275|NCT01668836|126041|P2|NOT COMPLETED|Overall Study||0
53276|NCT01668836|126042|P1|NOT COMPLETED|Overall Study||0
53277|NCT01668836|126039|P4|COMPLETED|Overall Study||12
53278|NCT01668836|126040|P3|COMPLETED|Overall Study||12
53279|NCT01668836|126041|P2|COMPLETED|Overall Study||12
53280|NCT01668836|126042|P1|COMPLETED|Overall Study||12
53281|NCT01668836|126039|P4|STARTED|Overall Study||12
53282|NCT01668836|126040|P3|STARTED|Overall Study||12
53283|NCT01668836|126041|P2|STARTED|Overall Study||12
53284|NCT01668836|126042|P1|STARTED|Overall Study||12
53285|NCT01668797|126098|P4|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||96
53286|NCT01668797|126099|P3|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||83
53287|NCT01668797|126100|P2|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
53288|NCT01668797|126101|P1|NOT COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
53289|NCT01668797|126098|P4|COMPLETED|Phase C (Double-Blind Maintenance Phase)||9
53290|NCT01668797|126099|P3|COMPLETED|Phase C (Double-Blind Maintenance Phase)||14
53291|NCT01668797|126100|P2|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
53292|NCT01668797|126101|P1|COMPLETED|Phase C (Double-Blind Maintenance Phase)||0
53293|NCT01668797|126098|P4|STARTED|Phase C (Double-Blind Maintenance Phase)||105
53294|NCT01668797|126099|P3|STARTED|Phase C (Double-Blind Maintenance Phase)|N= 202 rolled over from Phase B|97
53295|NCT01668797|126100|P2|STARTED|Phase C (Double-Blind Maintenance Phase)||0
53296|NCT01668797|126101|P1|STARTED|Phase C (Double-Blind Maintenance Phase)||0
53297|NCT01668797|126098|P4|NOT COMPLETED|Phase B (Stabilization Phase)||0
53298|NCT01668797|126099|P3|NOT COMPLETED|Phase B (Stabilization Phase)||0
53299|NCT01668797|126100|P2|NOT COMPLETED|Phase B (Stabilization Phase)||262
53300|NCT01668797|126101|P1|NOT COMPLETED|Phase B (Stabilization Phase)||0
53301|NCT01668797|126098|P4|COMPLETED|Phase B (Stabilization Phase)||0
53302|NCT01668797|126099|P3|COMPLETED|Phase B (Stabilization Phase)||0
53303|NCT01668797|126100|P2|COMPLETED|Phase B (Stabilization Phase)||202
53304|NCT01668797|126101|P1|COMPLETED|Phase B (Stabilization Phase)||0
53305|NCT01668797|126098|P4|STARTED|Phase B (Stabilization Phase)||0
53306|NCT01668797|126099|P3|STARTED|Phase B (Stabilization Phase)||0
53307|NCT01668797|126100|P2|STARTED|Phase B (Stabilization Phase)|N= 464; 346 rolled over from Phase A and 118 entered directly into Phase B|464
53308|NCT01668797|126101|P1|STARTED|Phase B (Stabilization Phase)||0
53309|NCT01668797|126098|P4|NOT COMPLETED|Phase A (Conversion Phase)||0
53310|NCT01668797|126099|P3|NOT COMPLETED|Phase A (Conversion Phase)||0
53311|NCT01668797|126100|P2|NOT COMPLETED|Phase A (Conversion Phase)||0
53312|NCT01668797|126101|P1|NOT COMPLETED|Phase A (Conversion Phase)||60
53313|NCT01668797|126098|P4|COMPLETED|Phase A (Conversion Phase)||0
53314|NCT01668797|126099|P3|COMPLETED|Phase A (Conversion Phase)||0
53315|NCT01668797|126100|P2|COMPLETED|Phase A (Conversion Phase)||0
53316|NCT01668797|126101|P1|COMPLETED|Phase A (Conversion Phase)||346
53317|NCT01668797|126098|P4|STARTED|Phase A (Conversion Phase)||0
53318|NCT01668797|126099|P3|STARTED|Phase A (Conversion Phase)||0
53319|NCT01668797|126100|P2|STARTED|Phase A (Conversion Phase)||0
53320|NCT01668797|126101|P1|STARTED|Phase A (Conversion Phase)||406
53321|NCT01668784|126166|P2|NOT COMPLETED|Treated (Overall)||369
53322|NCT01668784|126167|P1|NOT COMPLETED|Treated (Overall)||339
53323|NCT01668784|126166|P2|COMPLETED|Treated (Overall)||28
53324|NCT01668784|126167|P1|COMPLETED|Treated (Overall)||67
53325|NCT01668784|126166|P2|STARTED|Treated (Overall)||397
53326|NCT01668784|126167|P1|STARTED|Treated (Overall)||406
53327|NCT01668784|126166|P2|NOT COMPLETED|Randomized (Pre-treatment)||14
53328|NCT01668784|126167|P1|NOT COMPLETED|Randomized (Pre-treatment)||4
53329|NCT01668784|126166|P2|COMPLETED|Randomized (Pre-treatment)||397
53330|NCT01668784|126167|P1|COMPLETED|Randomized (Pre-treatment)||406
53331|NCT01668784|126166|P2|STARTED|Randomized (Pre-treatment)||411
53332|NCT01668784|126167|P1|STARTED|Randomized (Pre-treatment)||410
53333|NCT01668667|126195|P4|NOT COMPLETED|Overall Study||23
53334|NCT01668667|126196|P3|NOT COMPLETED|Overall Study||31
53335|NCT01668667|126197|P2|NOT COMPLETED|Overall Study||26
53336|NCT01668667|126198|P1|NOT COMPLETED|Overall Study||31
53337|NCT01668667|126195|P4|COMPLETED|Overall Study||102
53338|NCT01668667|126196|P3|COMPLETED|Overall Study||94
53339|NCT01668667|126197|P2|COMPLETED|Overall Study||99
53340|NCT01668667|126198|P1|COMPLETED|Overall Study||95
53341|NCT01668667|126195|P4|STARTED|Overall Study||125
53342|NCT01668667|126196|P3|STARTED|Overall Study||125
53343|NCT01668667|126197|P2|STARTED|Overall Study||125
53344|NCT01668667|126198|P1|STARTED|Overall Study||126
53345|NCT01668654|126220|P1|NOT COMPLETED|Overall Study||4
53346|NCT01668654|126220|P1|COMPLETED|Overall Study||0
53347|NCT01668654|126220|P1|STARTED|Overall Study||4
53348|NCT01668628|126263|P3|NOT COMPLETED|Overall Study||0
53349|NCT01668628|126264|P2|NOT COMPLETED|Overall Study||0
53350|NCT01668628|126265|P1|NOT COMPLETED|Overall Study||2
53351|NCT01668628|126263|P3|COMPLETED|Overall Study||367
53352|NCT01668628|126264|P2|COMPLETED|Overall Study||359
53353|NCT01668628|126265|P1|COMPLETED|Overall Study||347
53354|NCT01668628|126263|P3|STARTED|Overall Study|2 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|367
53355|NCT01668628|126264|P2|STARTED|Overall Study||359
53356|NCT01668628|126265|P1|STARTED|Overall Study|5 subjects had been excluded due to protocol violation and then data of the rest were anlayzed.|349
53357|NCT01668589|126281|P4|NOT COMPLETED|Overall Study||35
53358|NCT01668589|126282|P3|NOT COMPLETED|Overall Study||35
53359|NCT01668589|126283|P2|NOT COMPLETED|Overall Study||58
53360|NCT01668589|126284|P1|NOT COMPLETED|Overall Study||139
53361|NCT01668589|126281|P4|COMPLETED|Overall Study||266
53362|NCT01668589|126282|P3|COMPLETED|Overall Study||265
53363|NCT01668589|126283|P2|COMPLETED|Overall Study||242
53364|NCT01668589|126284|P1|COMPLETED|Overall Study||461
53365|NCT01668589|126281|P4|Received Denosumab|Overall Study||301
53366|NCT01668589|126282|P3|Received Denosumab|Overall Study||300
53367|NCT01668589|126283|P2|Received Denosumab|Overall Study||300
53368|NCT01668589|126284|P1|Received Denosumab|Overall Study||599
53369|NCT01668589|126281|P4|STARTED|Overall Study||301
53370|NCT01668589|126282|P3|STARTED|Overall Study||300
53371|NCT01668589|126283|P2|STARTED|Overall Study||300
53372|NCT01668589|126284|P1|STARTED|Overall Study||600
53373|NCT01668173|126322|P1|NOT COMPLETED|Overall Study||7
53374|NCT01668173|126322|P1|COMPLETED|Overall Study||0
53375|NCT01668173|126322|P1|STARTED|Overall Study||7
53376|NCT01668030|126326|P2|NOT COMPLETED|Overall Study||0
53377|NCT01668030|126327|P1|NOT COMPLETED|Overall Study||0
53378|NCT01668030|126326|P2|COMPLETED|Overall Study||10
53379|NCT01668030|126327|P1|COMPLETED|Overall Study||10
53380|NCT01668030|126326|P2|STARTED|Overall Study||10
53381|NCT01668030|126327|P1|STARTED|Overall Study||10
53382|NCT01668017|126337|P5|NOT COMPLETED|Overall Study||0
53383|NCT01668017|126338|P4|NOT COMPLETED|Overall Study||0
53384|NCT01668017|126339|P3|NOT COMPLETED|Overall Study||0
53385|NCT01668017|126340|P2|NOT COMPLETED|Overall Study||0
53386|NCT01668017|126341|P1|NOT COMPLETED|Overall Study||0
53387|NCT01668017|126337|P5|COMPLETED|Overall Study||2
53388|NCT01668017|126338|P4|COMPLETED|Overall Study||5
53389|NCT01668017|126339|P3|COMPLETED|Overall Study||6
53390|NCT01668017|126340|P2|COMPLETED|Overall Study||9
53391|NCT01668017|126341|P1|COMPLETED|Overall Study||4
53392|NCT01668017|126337|P5|STARTED|Overall Study||2
53393|NCT01668017|126338|P4|STARTED|Overall Study||5
53394|NCT01668017|126339|P3|STARTED|Overall Study||6
53395|NCT01668017|126340|P2|STARTED|Overall Study||9
53396|NCT01668017|126341|P1|STARTED|Overall Study||4
53397|NCT01668004|126448|P1|NOT COMPLETED|Overall Study||25
53398|NCT01668004|126448|P1|COMPLETED|Overall Study||76
53399|NCT01668004|126448|P1|Treated|Overall Study||101
53400|NCT01668004|126448|P1|STARTED|Overall Study||101
53401|NCT01667978|126461|P2|NOT COMPLETED|Overall Study||0
53402|NCT01667978|126462|P1|NOT COMPLETED|Overall Study||2
53403|NCT01667978|126461|P2|COMPLETED|Overall Study||17
53404|NCT01667978|126462|P1|COMPLETED|Overall Study||16
53405|NCT01667978|126461|P2|STARTED|Overall Study||17
53406|NCT01667978|126462|P1|STARTED|Overall Study||18
53407|NCT01667926|126470|P3|NOT COMPLETED|Overall Study||11
53408|NCT01667926|126471|P2|NOT COMPLETED|Overall Study||4
53409|NCT01667926|126472|P1|NOT COMPLETED|Overall Study||5
53410|NCT01667926|126470|P3|COMPLETED|Overall Study|Participants in the screen fail group were not randomized in the study.|0
53411|NCT01667926|126471|P2|COMPLETED|Overall Study||9
53412|NCT01667926|126472|P1|COMPLETED|Overall Study||8
53413|NCT01667926|126470|P3|STARTED|Overall Study||11
53414|NCT01667926|126471|P2|STARTED|Overall Study||13
53415|NCT01667926|126472|P1|STARTED|Overall Study||13
53416|NCT01667900|126485|P20|NOT COMPLETED|Part B||0
53417|NCT01667900|126486|P19|NOT COMPLETED|Part B||0
53418|NCT01667900|126487|P18|NOT COMPLETED|Part B||0
53419|NCT01667900|126488|P17|NOT COMPLETED|Part B||1
53420|NCT01667900|126489|P16|NOT COMPLETED|Part B||0
53421|NCT01667900|126490|P15|NOT COMPLETED|Part B||0
53422|NCT01667900|126491|P14|NOT COMPLETED|Part B||0
53423|NCT01667900|126492|P13|NOT COMPLETED|Part B||0
53424|NCT01667900|126493|P12|NOT COMPLETED|Part B||0
53425|NCT01667900|126494|P11|NOT COMPLETED|Part B||0
53426|NCT01667900|126495|P10|NOT COMPLETED|Part B||0
53427|NCT01667900|126496|P9|NOT COMPLETED|Part B||0
53428|NCT01667900|126497|P8|NOT COMPLETED|Part B||0
53429|NCT01667900|126498|P7|NOT COMPLETED|Part B||0
53430|NCT01667900|126499|P6|NOT COMPLETED|Part B||0
53431|NCT01667900|126500|P5|NOT COMPLETED|Part B||0
53432|NCT01667900|126501|P4|NOT COMPLETED|Part B||0
53433|NCT01667900|126502|P3|NOT COMPLETED|Part B||0
53434|NCT01667900|126503|P2|NOT COMPLETED|Part B||0
53435|NCT01667900|126504|P1|NOT COMPLETED|Part B||0
53436|NCT01667900|126485|P20|COMPLETED|Part B||10
53437|NCT01667900|126486|P19|COMPLETED|Part B||10
53438|NCT01667900|126487|P18|COMPLETED|Part B||11
53439|NCT01667900|126488|P17|COMPLETED|Part B||10
53440|NCT01667900|126489|P16|COMPLETED|Part B||0
53441|NCT01667900|126490|P15|COMPLETED|Part B||0
53442|NCT01667900|126491|P14|COMPLETED|Part B||0
53443|NCT01667900|126492|P13|COMPLETED|Part B||0
53444|NCT01667900|126493|P12|COMPLETED|Part B||0
53445|NCT01667900|126494|P11|COMPLETED|Part B||0
53446|NCT01667900|126495|P10|COMPLETED|Part B||0
53447|NCT01667900|126496|P9|COMPLETED|Part B||0
53448|NCT01667900|126497|P8|COMPLETED|Part B||0
53449|NCT01667900|126498|P7|COMPLETED|Part B||0
53450|NCT01667900|126499|P6|COMPLETED|Part B||0
53451|NCT01667900|126500|P5|COMPLETED|Part B||0
53452|NCT01667900|126501|P4|COMPLETED|Part B||0
53453|NCT01667900|126502|P3|COMPLETED|Part B||0
53454|NCT01667900|126503|P2|COMPLETED|Part B||0
53455|NCT01667900|126504|P1|COMPLETED|Part B||0
53456|NCT01667900|126485|P20|STARTED|Part B||10
53457|NCT01667900|126486|P19|STARTED|Part B||10
53458|NCT01667900|126487|P18|STARTED|Part B||11
53459|NCT01667900|126488|P17|STARTED|Part B||11
53460|NCT01667900|126489|P16|STARTED|Part B|Part A participants did not participate in Part B.|0
53461|NCT01667900|126490|P15|STARTED|Part B|Part A participants did not participate in Part B.|0
53462|NCT01667900|126491|P14|STARTED|Part B|Part A participants did not participate in Part B.|0
53463|NCT01667900|126492|P13|STARTED|Part B|Part A participants did not participate in Part B.|0
53464|NCT01667900|126493|P12|STARTED|Part B|Part A participants did not participate in Part B.|0
53465|NCT01667900|126494|P11|STARTED|Part B|Part A participants did not participate in Part B.|0
53466|NCT01667900|126495|P10|STARTED|Part B|Part A participants did not participate in Part B.|0
53467|NCT01667900|126496|P9|STARTED|Part B|Part A participants did not participate in Part B.|0
53468|NCT01667900|126497|P8|STARTED|Part B|Part A participants did not participate in Part B.|0
53469|NCT01667900|126498|P7|STARTED|Part B|Part A participants did not participate in Part B.|0
53470|NCT01667900|126499|P6|STARTED|Part B|Part A participants did not participate in Part B.|0
53471|NCT01667900|126500|P5|STARTED|Part B|Part A participants did not participate in Part B.|0
53472|NCT01667900|126501|P4|STARTED|Part B|Part A participants did not participate in Part B.|0
53473|NCT01667900|126502|P3|STARTED|Part B|Part A participants did not participate in Part B.|0
53474|NCT01667900|126503|P2|STARTED|Part B|Part A participants did not participate in Part B.|0
53475|NCT01667900|126504|P1|STARTED|Part B|Part A participants did not participate in Part B.|0
53476|NCT01667900|126485|P20|NOT COMPLETED|Part A, Period 3||0
53477|NCT01667900|126486|P19|NOT COMPLETED|Part A, Period 3||0
53478|NCT01667900|126487|P18|NOT COMPLETED|Part A, Period 3||0
53479|NCT01667900|126488|P17|NOT COMPLETED|Part A, Period 3||0
53480|NCT01667900|126489|P16|NOT COMPLETED|Part A, Period 3||0
53481|NCT01667900|126490|P15|NOT COMPLETED|Part A, Period 3||0
53482|NCT01667900|126491|P14|NOT COMPLETED|Part A, Period 3||0
53483|NCT01667900|126492|P13|NOT COMPLETED|Part A, Period 3||0
53484|NCT01667900|126493|P12|NOT COMPLETED|Part A, Period 3||0
53485|NCT01667900|126494|P11|NOT COMPLETED|Part A, Period 3||0
53486|NCT01667900|126495|P10|NOT COMPLETED|Part A, Period 3||0
53487|NCT01667900|126496|P9|NOT COMPLETED|Part A, Period 3||0
53488|NCT01667900|126497|P8|NOT COMPLETED|Part A, Period 3||0
53489|NCT01667900|126498|P7|NOT COMPLETED|Part A, Period 3||0
53490|NCT01667900|126499|P6|NOT COMPLETED|Part A, Period 3||0
53491|NCT01667900|126500|P5|NOT COMPLETED|Part A, Period 3||0
53492|NCT01667900|126501|P4|NOT COMPLETED|Part A, Period 3||0
53493|NCT01667900|126502|P3|NOT COMPLETED|Part A, Period 3||0
53494|NCT01667900|126503|P2|NOT COMPLETED|Part A, Period 3||0
53495|NCT01667900|126504|P1|NOT COMPLETED|Part A, Period 3||0
53496|NCT01667900|126485|P20|COMPLETED|Part A, Period 3||0
53497|NCT01667900|126486|P19|COMPLETED|Part A, Period 3||0
53498|NCT01667900|126487|P18|COMPLETED|Part A, Period 3||0
53499|NCT01667900|126488|P17|COMPLETED|Part A, Period 3||0
53500|NCT01667900|126489|P16|COMPLETED|Part A, Period 3||1
53501|NCT01667900|126490|P15|COMPLETED|Part A, Period 3||1
53502|NCT01667900|126491|P14|COMPLETED|Part A, Period 3||1
53503|NCT01667900|126492|P13|COMPLETED|Part A, Period 3||1
53504|NCT01667900|126493|P12|COMPLETED|Part A, Period 3||1
53505|NCT01667900|126494|P11|COMPLETED|Part A, Period 3||1
53506|NCT01667900|126495|P10|COMPLETED|Part A, Period 3||1
53507|NCT01667900|126496|P9|COMPLETED|Part A, Period 3||1
53508|NCT01667900|126497|P8|COMPLETED|Part A, Period 3||1
53509|NCT01667900|126498|P7|COMPLETED|Part A, Period 3||1
53510|NCT01667900|126499|P6|COMPLETED|Part A, Period 3||1
53511|NCT01667900|126500|P5|COMPLETED|Part A, Period 3||1
53512|NCT01667900|126501|P4|COMPLETED|Part A, Period 3||1
53513|NCT01667900|126502|P3|COMPLETED|Part A, Period 3||1
53514|NCT01667900|126503|P2|COMPLETED|Part A, Period 3||1
53515|NCT01667900|126504|P1|COMPLETED|Part A, Period 3||1
53516|NCT01667900|126485|P20|STARTED|Part A, Period 3||0
53517|NCT01667900|126486|P19|STARTED|Part A, Period 3||0
53518|NCT01667900|126487|P18|STARTED|Part A, Period 3||0
53519|NCT01667900|126488|P17|STARTED|Part A, Period 3||0
53520|NCT01667900|126489|P16|STARTED|Part A, Period 3||1
53521|NCT01667900|126490|P15|STARTED|Part A, Period 3||1
53522|NCT01667900|126491|P14|STARTED|Part A, Period 3||1
53523|NCT01667900|126492|P13|STARTED|Part A, Period 3||1
53524|NCT01667900|126493|P12|STARTED|Part A, Period 3||1
53525|NCT01667900|126494|P11|STARTED|Part A, Period 3||1
53526|NCT01667900|126495|P10|STARTED|Part A, Period 3||1
53527|NCT01667900|126496|P9|STARTED|Part A, Period 3||1
53528|NCT01667900|126497|P8|STARTED|Part A, Period 3||1
53529|NCT01667900|126498|P7|STARTED|Part A, Period 3||1
53530|NCT01667900|126499|P6|STARTED|Part A, Period 3||1
53531|NCT01667900|126500|P5|STARTED|Part A, Period 3||1
53532|NCT01667900|126501|P4|STARTED|Part A, Period 3||1
53533|NCT01667900|126502|P3|STARTED|Part A, Period 3||1
53534|NCT01667900|126503|P2|STARTED|Part A, Period 3||1
53535|NCT01667900|126504|P1|STARTED|Part A, Period 3||1
53536|NCT01667900|126485|P20|NOT COMPLETED|Part A, Washout 2||0
53537|NCT01667900|126486|P19|NOT COMPLETED|Part A, Washout 2||0
53538|NCT01667900|126487|P18|NOT COMPLETED|Part A, Washout 2||0
53539|NCT01667900|126488|P17|NOT COMPLETED|Part A, Washout 2||0
53540|NCT01667900|126489|P16|NOT COMPLETED|Part A, Washout 2||0
53541|NCT01667900|126490|P15|NOT COMPLETED|Part A, Washout 2||0
53542|NCT01667900|126491|P14|NOT COMPLETED|Part A, Washout 2||0
53543|NCT01667900|126492|P13|NOT COMPLETED|Part A, Washout 2||0
53544|NCT01667900|126493|P12|NOT COMPLETED|Part A, Washout 2||0
53545|NCT01667900|126494|P11|NOT COMPLETED|Part A, Washout 2||0
53546|NCT01667900|126495|P10|NOT COMPLETED|Part A, Washout 2||0
53547|NCT01667900|126496|P9|NOT COMPLETED|Part A, Washout 2||0
53548|NCT01667900|126497|P8|NOT COMPLETED|Part A, Washout 2||0
53549|NCT01667900|126498|P7|NOT COMPLETED|Part A, Washout 2||0
53550|NCT01667900|126499|P6|NOT COMPLETED|Part A, Washout 2||0
53551|NCT01667900|126500|P5|NOT COMPLETED|Part A, Washout 2||0
53552|NCT01667900|126501|P4|NOT COMPLETED|Part A, Washout 2||0
53553|NCT01667900|126502|P3|NOT COMPLETED|Part A, Washout 2||0
53554|NCT01667900|126503|P2|NOT COMPLETED|Part A, Washout 2||0
53555|NCT01667900|126504|P1|NOT COMPLETED|Part A, Washout 2||0
53556|NCT01667900|126485|P20|COMPLETED|Part A, Washout 2||0
53557|NCT01667900|126486|P19|COMPLETED|Part A, Washout 2||0
53558|NCT01667900|126487|P18|COMPLETED|Part A, Washout 2||0
53559|NCT01667900|126488|P17|COMPLETED|Part A, Washout 2||0
53560|NCT01667900|126489|P16|COMPLETED|Part A, Washout 2||1
53561|NCT01667900|126490|P15|COMPLETED|Part A, Washout 2||1
53562|NCT01667900|126491|P14|COMPLETED|Part A, Washout 2||1
53563|NCT01667900|126492|P13|COMPLETED|Part A, Washout 2||1
53564|NCT01667900|126493|P12|COMPLETED|Part A, Washout 2||1
53565|NCT01667900|126494|P11|COMPLETED|Part A, Washout 2||1
53566|NCT01667900|126495|P10|COMPLETED|Part A, Washout 2||1
53567|NCT01667900|126496|P9|COMPLETED|Part A, Washout 2||1
53568|NCT01667900|126497|P8|COMPLETED|Part A, Washout 2||1
53569|NCT01667900|126498|P7|COMPLETED|Part A, Washout 2||1
53570|NCT01667900|126499|P6|COMPLETED|Part A, Washout 2||1
53571|NCT01667900|126500|P5|COMPLETED|Part A, Washout 2||1
53572|NCT01667900|126501|P4|COMPLETED|Part A, Washout 2||1
53573|NCT01667900|126502|P3|COMPLETED|Part A, Washout 2||1
53574|NCT01667900|126503|P2|COMPLETED|Part A, Washout 2||1
53575|NCT01667900|126504|P1|COMPLETED|Part A, Washout 2||1
53576|NCT01667900|126485|P20|STARTED|Part A, Washout 2||0
53577|NCT01667900|126486|P19|STARTED|Part A, Washout 2||0
53578|NCT01667900|126487|P18|STARTED|Part A, Washout 2||0
53579|NCT01667900|126488|P17|STARTED|Part A, Washout 2||0
53580|NCT01667900|126489|P16|STARTED|Part A, Washout 2||1
53581|NCT01667900|126490|P15|STARTED|Part A, Washout 2||1
53582|NCT01667900|126491|P14|STARTED|Part A, Washout 2||1
53583|NCT01667900|126492|P13|STARTED|Part A, Washout 2||1
53584|NCT01667900|126493|P12|STARTED|Part A, Washout 2||1
53585|NCT01667900|126494|P11|STARTED|Part A, Washout 2||1
53586|NCT01667900|126495|P10|STARTED|Part A, Washout 2||1
53587|NCT01667900|126496|P9|STARTED|Part A, Washout 2||1
53588|NCT01667900|126497|P8|STARTED|Part A, Washout 2||1
53589|NCT01667900|126498|P7|STARTED|Part A, Washout 2||1
53590|NCT01667900|126499|P6|STARTED|Part A, Washout 2||1
53591|NCT01667900|126500|P5|STARTED|Part A, Washout 2||1
53592|NCT01667900|126501|P4|STARTED|Part A, Washout 2||1
53593|NCT01667900|126502|P3|STARTED|Part A, Washout 2||1
53594|NCT01667900|126503|P2|STARTED|Part A, Washout 2||1
53595|NCT01667900|126504|P1|STARTED|Part A, Washout 2||1
53596|NCT01667900|126485|P20|NOT COMPLETED|Part A, Period 2||0
53597|NCT01667900|126486|P19|NOT COMPLETED|Part A, Period 2||0
53598|NCT01667900|126487|P18|NOT COMPLETED|Part A, Period 2||0
53599|NCT01667900|126488|P17|NOT COMPLETED|Part A, Period 2||0
53600|NCT01667900|126489|P16|NOT COMPLETED|Part A, Period 2||0
53601|NCT01667900|126490|P15|NOT COMPLETED|Part A, Period 2||0
53602|NCT01667900|126491|P14|NOT COMPLETED|Part A, Period 2||0
53603|NCT01667900|126492|P13|NOT COMPLETED|Part A, Period 2||0
53604|NCT01667900|126493|P12|NOT COMPLETED|Part A, Period 2||0
53605|NCT01667900|126494|P11|NOT COMPLETED|Part A, Period 2||0
53606|NCT01667900|126495|P10|NOT COMPLETED|Part A, Period 2||0
53607|NCT01667900|126496|P9|NOT COMPLETED|Part A, Period 2||0
53608|NCT01667900|126497|P8|NOT COMPLETED|Part A, Period 2||0
53609|NCT01667900|126498|P7|NOT COMPLETED|Part A, Period 2||0
53610|NCT01667900|126499|P6|NOT COMPLETED|Part A, Period 2||0
53611|NCT01667900|126500|P5|NOT COMPLETED|Part A, Period 2||0
53612|NCT01667900|126501|P4|NOT COMPLETED|Part A, Period 2||0
53613|NCT01667900|126502|P3|NOT COMPLETED|Part A, Period 2||0
53614|NCT01667900|126503|P2|NOT COMPLETED|Part A, Period 2||0
53615|NCT01667900|126504|P1|NOT COMPLETED|Part A, Period 2||0
53616|NCT01667900|126485|P20|COMPLETED|Part A, Period 2||0
53617|NCT01667900|126486|P19|COMPLETED|Part A, Period 2||0
53618|NCT01667900|126487|P18|COMPLETED|Part A, Period 2||0
53619|NCT01667900|126488|P17|COMPLETED|Part A, Period 2||0
53620|NCT01667900|126489|P16|COMPLETED|Part A, Period 2||1
53621|NCT01667900|126490|P15|COMPLETED|Part A, Period 2||1
53622|NCT01667900|126491|P14|COMPLETED|Part A, Period 2||1
53623|NCT01667900|126492|P13|COMPLETED|Part A, Period 2||1
53624|NCT01667900|126493|P12|COMPLETED|Part A, Period 2||1
53625|NCT01667900|126494|P11|COMPLETED|Part A, Period 2||1
53626|NCT01667900|126495|P10|COMPLETED|Part A, Period 2||1
53627|NCT01667900|126496|P9|COMPLETED|Part A, Period 2||1
53628|NCT01667900|126497|P8|COMPLETED|Part A, Period 2||1
53629|NCT01667900|126498|P7|COMPLETED|Part A, Period 2||1
53630|NCT01667900|126499|P6|COMPLETED|Part A, Period 2||1
53631|NCT01667900|126500|P5|COMPLETED|Part A, Period 2||1
53632|NCT01667900|126501|P4|COMPLETED|Part A, Period 2||1
53633|NCT01667900|126502|P3|COMPLETED|Part A, Period 2||1
53634|NCT01667900|126503|P2|COMPLETED|Part A, Period 2||1
53635|NCT01667900|126504|P1|COMPLETED|Part A, Period 2||1
53636|NCT01667900|126485|P20|STARTED|Part A, Period 2||0
53637|NCT01667900|126486|P19|STARTED|Part A, Period 2||0
53638|NCT01667900|126487|P18|STARTED|Part A, Period 2||0
53639|NCT01667900|126488|P17|STARTED|Part A, Period 2||0
53640|NCT01667900|126489|P16|STARTED|Part A, Period 2||1
53641|NCT01667900|126490|P15|STARTED|Part A, Period 2||1
53642|NCT01667900|126491|P14|STARTED|Part A, Period 2||1
53643|NCT01667900|126492|P13|STARTED|Part A, Period 2||1
53644|NCT01667900|126493|P12|STARTED|Part A, Period 2||1
53645|NCT01667900|126494|P11|STARTED|Part A, Period 2||1
53646|NCT01667900|126495|P10|STARTED|Part A, Period 2||1
53647|NCT01667900|126496|P9|STARTED|Part A, Period 2||1
53648|NCT01667900|126497|P8|STARTED|Part A, Period 2||1
53649|NCT01667900|126498|P7|STARTED|Part A, Period 2||1
53650|NCT01667900|126499|P6|STARTED|Part A, Period 2||1
53651|NCT01667900|126500|P5|STARTED|Part A, Period 2||1
53652|NCT01667900|126501|P4|STARTED|Part A, Period 2||1
53653|NCT01667900|126502|P3|STARTED|Part A, Period 2||1
53654|NCT01667900|126503|P2|STARTED|Part A, Period 2||1
53655|NCT01667900|126504|P1|STARTED|Part A, Period 2||1
53656|NCT01667900|126485|P20|NOT COMPLETED|Part A, Washout 1||0
53657|NCT01667900|126486|P19|NOT COMPLETED|Part A, Washout 1||0
53658|NCT01667900|126487|P18|NOT COMPLETED|Part A, Washout 1||0
53659|NCT01667900|126488|P17|NOT COMPLETED|Part A, Washout 1||0
53660|NCT01667900|126489|P16|NOT COMPLETED|Part A, Washout 1||0
53661|NCT01667900|126490|P15|NOT COMPLETED|Part A, Washout 1||0
53662|NCT01667900|126491|P14|NOT COMPLETED|Part A, Washout 1||0
53663|NCT01667900|126492|P13|NOT COMPLETED|Part A, Washout 1||0
53664|NCT01667900|126493|P12|NOT COMPLETED|Part A, Washout 1||0
53665|NCT01667900|126494|P11|NOT COMPLETED|Part A, Washout 1||0
53666|NCT01667900|126495|P10|NOT COMPLETED|Part A, Washout 1||0
53667|NCT01667900|126496|P9|NOT COMPLETED|Part A, Washout 1||0
53668|NCT01667900|126497|P8|NOT COMPLETED|Part A, Washout 1||0
53669|NCT01667900|126498|P7|NOT COMPLETED|Part A, Washout 1||0
53670|NCT01667900|126499|P6|NOT COMPLETED|Part A, Washout 1||0
53671|NCT01667900|126500|P5|NOT COMPLETED|Part A, Washout 1||0
53672|NCT01667900|126501|P4|NOT COMPLETED|Part A, Washout 1||0
53673|NCT01667900|126502|P3|NOT COMPLETED|Part A, Washout 1||0
53674|NCT01667900|126503|P2|NOT COMPLETED|Part A, Washout 1||0
53675|NCT01667900|126504|P1|NOT COMPLETED|Part A, Washout 1||0
53676|NCT01667900|126485|P20|COMPLETED|Part A, Washout 1||0
53677|NCT01667900|126486|P19|COMPLETED|Part A, Washout 1||0
53678|NCT01667900|126487|P18|COMPLETED|Part A, Washout 1||0
53679|NCT01667900|126488|P17|COMPLETED|Part A, Washout 1||0
53680|NCT01667900|126489|P16|COMPLETED|Part A, Washout 1||1
53681|NCT01667900|126490|P15|COMPLETED|Part A, Washout 1||1
53682|NCT01667900|126491|P14|COMPLETED|Part A, Washout 1||1
53683|NCT01667900|126492|P13|COMPLETED|Part A, Washout 1||1
53684|NCT01667900|126493|P12|COMPLETED|Part A, Washout 1||1
53685|NCT01667900|126494|P11|COMPLETED|Part A, Washout 1||1
53686|NCT01667900|126495|P10|COMPLETED|Part A, Washout 1||1
53687|NCT01667900|126496|P9|COMPLETED|Part A, Washout 1||1
53688|NCT01667900|126497|P8|COMPLETED|Part A, Washout 1||1
53689|NCT01667900|126498|P7|COMPLETED|Part A, Washout 1||1
53690|NCT01667900|126499|P6|COMPLETED|Part A, Washout 1||1
53691|NCT01667900|126500|P5|COMPLETED|Part A, Washout 1||1
53692|NCT01667900|126501|P4|COMPLETED|Part A, Washout 1||1
53693|NCT01667900|126502|P3|COMPLETED|Part A, Washout 1||1
53694|NCT01667900|126503|P2|COMPLETED|Part A, Washout 1||1
53695|NCT01667900|126504|P1|COMPLETED|Part A, Washout 1||1
53696|NCT01667900|126485|P20|STARTED|Part A, Washout 1||0
53697|NCT01667900|126486|P19|STARTED|Part A, Washout 1||0
53698|NCT01667900|126487|P18|STARTED|Part A, Washout 1||0
53699|NCT01667900|126488|P17|STARTED|Part A, Washout 1||0
53700|NCT01667900|126489|P16|STARTED|Part A, Washout 1||1
53701|NCT01667900|126490|P15|STARTED|Part A, Washout 1||1
53702|NCT01667900|126491|P14|STARTED|Part A, Washout 1||1
53703|NCT01667900|126492|P13|STARTED|Part A, Washout 1||1
53704|NCT01667900|126493|P12|STARTED|Part A, Washout 1||1
53705|NCT01667900|126494|P11|STARTED|Part A, Washout 1||1
53706|NCT01667900|126495|P10|STARTED|Part A, Washout 1||1
53707|NCT01667900|126496|P9|STARTED|Part A, Washout 1||1
53708|NCT01667900|126497|P8|STARTED|Part A, Washout 1||1
53709|NCT01667900|126498|P7|STARTED|Part A, Washout 1||1
53710|NCT01667900|126499|P6|STARTED|Part A, Washout 1||1
53711|NCT01667900|126500|P5|STARTED|Part A, Washout 1||1
53712|NCT01667900|126501|P4|STARTED|Part A, Washout 1||1
53713|NCT01667900|126502|P3|STARTED|Part A, Washout 1||1
53714|NCT01667900|126503|P2|STARTED|Part A, Washout 1||1
53715|NCT01667900|126504|P1|STARTED|Part A, Washout 1||1
53716|NCT01667900|126485|P20|NOT COMPLETED|Part A, Period 1||0
53717|NCT01667900|126486|P19|NOT COMPLETED|Part A, Period 1||0
53718|NCT01667900|126487|P18|NOT COMPLETED|Part A, Period 1||0
53719|NCT01667900|126488|P17|NOT COMPLETED|Part A, Period 1||0
53720|NCT01667900|126489|P16|NOT COMPLETED|Part A, Period 1||0
53721|NCT01667900|126490|P15|NOT COMPLETED|Part A, Period 1||0
53722|NCT01667900|126491|P14|NOT COMPLETED|Part A, Period 1||0
53723|NCT01667900|126492|P13|NOT COMPLETED|Part A, Period 1||0
53724|NCT01667900|126493|P12|NOT COMPLETED|Part A, Period 1||0
53725|NCT01667900|126494|P11|NOT COMPLETED|Part A, Period 1||0
53726|NCT01667900|126495|P10|NOT COMPLETED|Part A, Period 1||0
53727|NCT01667900|126496|P9|NOT COMPLETED|Part A, Period 1||0
53728|NCT01667900|126497|P8|NOT COMPLETED|Part A, Period 1||0
53729|NCT01667900|126498|P7|NOT COMPLETED|Part A, Period 1||0
53730|NCT01667900|126499|P6|NOT COMPLETED|Part A, Period 1||0
53731|NCT01667900|126500|P5|NOT COMPLETED|Part A, Period 1||0
53732|NCT01667900|126501|P4|NOT COMPLETED|Part A, Period 1||0
53733|NCT01667900|126502|P3|NOT COMPLETED|Part A, Period 1||0
53734|NCT01667900|126503|P2|NOT COMPLETED|Part A, Period 1||0
53735|NCT01667900|126504|P1|NOT COMPLETED|Part A, Period 1||0
53736|NCT01667900|126485|P20|COMPLETED|Part A, Period 1||0
53737|NCT01667900|126486|P19|COMPLETED|Part A, Period 1||0
53738|NCT01667900|126487|P18|COMPLETED|Part A, Period 1||0
53739|NCT01667900|126488|P17|COMPLETED|Part A, Period 1||0
53740|NCT01667900|126489|P16|COMPLETED|Part A, Period 1||1
53741|NCT01667900|126490|P15|COMPLETED|Part A, Period 1||1
53742|NCT01667900|126491|P14|COMPLETED|Part A, Period 1||1
53743|NCT01667900|126492|P13|COMPLETED|Part A, Period 1||1
53744|NCT01667900|126493|P12|COMPLETED|Part A, Period 1||1
53745|NCT01667900|126494|P11|COMPLETED|Part A, Period 1||1
53746|NCT01667900|126495|P10|COMPLETED|Part A, Period 1||1
53747|NCT01667900|126496|P9|COMPLETED|Part A, Period 1||1
53748|NCT01667900|126497|P8|COMPLETED|Part A, Period 1||1
53749|NCT01667900|126498|P7|COMPLETED|Part A, Period 1||1
53750|NCT01667900|126499|P6|COMPLETED|Part A, Period 1||1
53751|NCT01667900|126500|P5|COMPLETED|Part A, Period 1||1
53752|NCT01667900|126501|P4|COMPLETED|Part A, Period 1||1
53753|NCT01667900|126502|P3|COMPLETED|Part A, Period 1||1
53754|NCT01667900|126503|P2|COMPLETED|Part A, Period 1||1
53755|NCT01667900|126504|P1|COMPLETED|Part A, Period 1||1
53756|NCT01667900|126485|P20|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
53757|NCT01667900|126486|P19|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
53758|NCT01667900|126487|P18|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
53759|NCT01667900|126488|P17|STARTED|Part A, Period 1|Part B participants did not participate in Part A.|0
53760|NCT01667900|126489|P16|STARTED|Part A, Period 1||1
53761|NCT01667900|126490|P15|STARTED|Part A, Period 1||1
53762|NCT01667900|126491|P14|STARTED|Part A, Period 1||1
53763|NCT01667900|126492|P13|STARTED|Part A, Period 1||1
53764|NCT01667900|126493|P12|STARTED|Part A, Period 1||1
53765|NCT01667900|126494|P11|STARTED|Part A, Period 1||1
53766|NCT01667900|126495|P10|STARTED|Part A, Period 1||1
53767|NCT01667900|126496|P9|STARTED|Part A, Period 1||1
53768|NCT01667900|126497|P8|STARTED|Part A, Period 1||1
53769|NCT01667900|126498|P7|STARTED|Part A, Period 1||1
53770|NCT01667900|126499|P6|STARTED|Part A, Period 1||1
53771|NCT01667900|126500|P5|STARTED|Part A, Period 1||1
53772|NCT01667900|126501|P4|STARTED|Part A, Period 1||1
53773|NCT01667900|126502|P3|STARTED|Part A, Period 1||1
53774|NCT01667900|126503|P2|STARTED|Part A, Period 1||1
53775|NCT01667900|126504|P1|STARTED|Part A, Period 1||1
53776|NCT01667848|126544|P2|NOT COMPLETED|Overall Study||0
53777|NCT01667848|126545|P1|NOT COMPLETED|Overall Study||0
53778|NCT01667848|126544|P2|COMPLETED|Overall Study||81
53779|NCT01667848|126545|P1|COMPLETED|Overall Study||67
53780|NCT01667848|126544|P2|STARTED|Overall Study||81
53781|NCT01667848|126545|P1|STARTED|Overall Study||67
53782|NCT01667796|126555|P2|NOT COMPLETED|Overall Study||1
53783|NCT01667796|126556|P1|NOT COMPLETED|Overall Study||3
53784|NCT01667796|126555|P2|COMPLETED|Overall Study||29
53785|NCT01667796|126556|P1|COMPLETED|Overall Study||24
53786|NCT01667796|126555|P2|STARTED|Overall Study||30
53787|NCT01667796|126556|P1|STARTED|Overall Study||27
53788|NCT01667731|126567|P5|NOT COMPLETED|Overall Study||28
53789|NCT01667731|126568|P4|NOT COMPLETED|Overall Study||2
53790|NCT01667731|126569|P3|NOT COMPLETED|Overall Study||2
53791|NCT01667731|126570|P2|NOT COMPLETED|Overall Study||16
53792|NCT01667731|126571|P1|NOT COMPLETED|Overall Study||5
53793|NCT01667731|126567|P5|COMPLETED|Overall Study||87
53794|NCT01667731|126568|P4|COMPLETED|Overall Study||15
53795|NCT01667731|126569|P3|COMPLETED|Overall Study||22
53796|NCT01667731|126570|P2|COMPLETED|Overall Study||26
53797|NCT01667731|126571|P1|COMPLETED|Overall Study||21
53798|NCT01667731|126567|P5|STARTED|Overall Study||115
53799|NCT01667731|126568|P4|STARTED|Overall Study||17
53800|NCT01667731|126569|P3|STARTED|Overall Study||24
53801|NCT01667731|126570|P2|STARTED|Overall Study||42
53802|NCT01667731|126571|P1|STARTED|Overall Study||26
53803|NCT01667679|126626|P2|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
53804|NCT01667679|126627|P1|NOT COMPLETED|Treatment Period 2 (<=12 Weeks)||22
53805|NCT01667679|126626|P2|COMPLETED|Treatment Period 2 (<=12 Weeks)||85
53806|NCT01667679|126627|P1|COMPLETED|Treatment Period 2 (<=12 Weeks)||100
53807|NCT01667679|126626|P2|STARTED|Treatment Period 2 (<=12 Weeks)||107
53808|NCT01667679|126627|P1|STARTED|Treatment Period 2 (<=12 Weeks)||122
53809|NCT01667679|126626|P2|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||30
53810|NCT01667679|126627|P1|NOT COMPLETED|Treatment Period 1 (<=12 Weeks)||16
53811|NCT01667679|126626|P2|COMPLETED|Treatment Period 1 (<=12 Weeks)||107
53812|NCT01667679|126627|P1|COMPLETED|Treatment Period 1 (<=12 Weeks)||122
53813|NCT01667679|126626|P2|STARTED|Treatment Period 1 (<=12 Weeks)||137
53814|NCT01667679|126627|P1|STARTED|Treatment Period 1 (<=12 Weeks)||138
53815|NCT01667536|126685|P1|NOT COMPLETED|Overall Study||0
53816|NCT01667536|126685|P1|COMPLETED|Overall Study|105 subjects comprised the safety popn, defined as all subjects who received an MIP-1404 injection.|105
53817|NCT01667536|126685|P1|STARTED|Overall Study||105
53818|NCT01667471|126696|P1|NOT COMPLETED|Overall Study||0
53819|NCT01667471|126696|P1|COMPLETED|Overall Study||7
53820|NCT01667471|126696|P1|STARTED|Overall Study||7
53821|NCT01667432|126712|P1|NOT COMPLETED|Overall Study||57
53822|NCT01667432|126712|P1|COMPLETED|Overall Study||84
53823|NCT01667432|126712|P1|STARTED|Overall Study||141
53824|NCT01667224|126719|P2|NOT COMPLETED|Overall Study||2
53825|NCT01667224|126720|P1|NOT COMPLETED|Overall Study||4
53826|NCT01667224|126719|P2|COMPLETED|Overall Study||38
53827|NCT01667224|126720|P1|COMPLETED|Overall Study||36
53828|NCT01667224|126719|P2|STARTED|Overall Study||40
53829|NCT01667224|126720|P1|STARTED|Overall Study||40
53830|NCT01667107|126734|P2|NOT COMPLETED|Overall Study||7
53831|NCT01667107|126735|P1|NOT COMPLETED|Overall Study||4
53832|NCT01667107|126734|P2|COMPLETED|Overall Study||11
53833|NCT01667107|126735|P1|COMPLETED|Overall Study||4
53834|NCT01667107|126734|P2|STARTED|Overall Study||18
53835|NCT01667107|126735|P1|STARTED|Overall Study||8
53836|NCT01666951|126753|P2|NOT COMPLETED|Overall Study||1
53837|NCT01666951|126754|P1|NOT COMPLETED|Overall Study||1
53838|NCT01666951|126753|P2|COMPLETED|Overall Study||17
53839|NCT01666951|126754|P1|COMPLETED|Overall Study||17
53840|NCT01666951|126753|P2|STARTED|Overall Study||18
53841|NCT01666951|126754|P1|STARTED|Overall Study||18
53842|NCT01666912|126792|P2|NOT COMPLETED|Overall Study||11
53843|NCT01666912|126793|P1|NOT COMPLETED|Overall Study||21
53844|NCT01666912|126792|P2|COMPLETED|Overall Study||37
53845|NCT01666912|126793|P1|COMPLETED|Overall Study||27
53846|NCT01666912|126792|P2|STARTED|Overall Study||48
53847|NCT01666912|126793|P1|STARTED|Overall Study||48
53848|NCT01666782|126805|P2|NOT COMPLETED|Overall Study||1
53849|NCT01666782|126806|P1|NOT COMPLETED|Overall Study||4
53850|NCT01666782|126805|P2|COMPLETED|Overall Study||50
53851|NCT01666782|126806|P1|COMPLETED|Overall Study||50
53852|NCT01666782|126805|P2|STARTED|Overall Study||51
53853|NCT01666782|126806|P1|STARTED|Overall Study||54
53854|NCT01666210|126824|P2|NOT COMPLETED|Overall Study||1
53855|NCT01666210|126825|P1|NOT COMPLETED|Overall Study||2
53856|NCT01666210|126824|P2|COMPLETED|Overall Study||29
53857|NCT01666210|126825|P1|COMPLETED|Overall Study||28
53858|NCT01666210|126824|P2|STARTED|Overall Study||30
53859|NCT01666210|126825|P1|STARTED|Overall Study||30
53860|NCT01666197|126837|P2|NOT COMPLETED|Overall Study||0
53861|NCT01666197|126838|P1|NOT COMPLETED|Overall Study||0
53862|NCT01666197|126837|P2|COMPLETED|Overall Study||50
53863|NCT01666197|126838|P1|COMPLETED|Overall Study||50
53864|NCT01666197|126837|P2|STARTED|Overall Study||50
53865|NCT01666197|126838|P1|STARTED|Overall Study||50
53866|NCT01666119|126844|P1|NOT COMPLETED|Overall Study||52
53867|NCT01666119|126844|P1|COMPLETED|Overall Study||197
53868|NCT01666119|126844|P1|STARTED|Overall Study||249
53869|NCT01666002|126851|P2|NOT COMPLETED|Overall Study||0
53870|NCT01666002|126852|P1|NOT COMPLETED|Overall Study||5
53871|NCT01666002|126851|P2|COMPLETED|Overall Study||10
53872|NCT01666002|126852|P1|COMPLETED|Overall Study||12
53873|NCT01666002|126851|P2|STARTED|Overall Study||10
53874|NCT01666002|126852|P1|STARTED|Overall Study||17
53875|NCT01665950|126863|P3|NOT COMPLETED|Overall Study||1
53876|NCT01665950|126864|P2|NOT COMPLETED|Overall Study||0
53877|NCT01665950|126865|P1|NOT COMPLETED|Overall Study||1
53878|NCT01665950|126863|P3|COMPLETED|Overall Study||1
53879|NCT01665950|126864|P2|COMPLETED|Overall Study||0
53880|NCT01665950|126865|P1|COMPLETED|Overall Study||1
53881|NCT01665950|126863|P3|STARTED|Overall Study||2
53882|NCT01665950|126864|P2|STARTED|Overall Study||0
53883|NCT01665950|126865|P1|STARTED|Overall Study||2
53884|NCT01665911|126873|P1|NOT COMPLETED|Overall Study||6
53885|NCT01665911|126873|P1|COMPLETED|Overall Study||22
53886|NCT01665911|126873|P1|3.0 mg Sodium Fluoride in 200 ml Milk|Overall Study||22
53887|NCT01665911|126873|P1|3.0 mg Sodium Fluoride in 100 ml Milk|Overall Study||22
53888|NCT01665911|126873|P1|1.5 mg Sodium Fluoride in 200 ml Milk|Overall Study||25
53889|NCT01665911|126873|P1|1.5 mg Sodium Fluoride in 100 ml Milk|Overall Study||23
53890|NCT01665911|126873|P1|0 mg Fluoride in 200 ml Milk|Overall Study||22
53891|NCT01665911|126873|P1|STARTED|Overall Study||28
53892|NCT01665807|126882|P3|NOT COMPLETED|Overall Study||1
53893|NCT01665807|126883|P2|NOT COMPLETED|Overall Study||0
53894|NCT01665807|126884|P1|NOT COMPLETED|Overall Study||2
53895|NCT01665807|126882|P3|COMPLETED|Overall Study||401
53896|NCT01665807|126883|P2|COMPLETED|Overall Study||58
53897|NCT01665807|126884|P1|COMPLETED|Overall Study||409
53898|NCT01665807|126882|P3|STARTED|Overall Study||402
53899|NCT01665807|126883|P2|STARTED|Overall Study||58
53900|NCT01665807|126884|P1|STARTED|Overall Study||411
53901|NCT01665508|126895|P1|NOT COMPLETED|Overall Study||5
53902|NCT01665508|126895|P1|COMPLETED|Overall Study||7
53903|NCT01665508|126895|P1|STARTED|Overall Study||12
53904|NCT01665170|126913|P2|NOT COMPLETED|Overall Study||0
53905|NCT01665170|126914|P1|NOT COMPLETED|Overall Study||0
53906|NCT01665170|126913|P2|COMPLETED|Overall Study||30
53907|NCT01665170|126914|P1|COMPLETED|Overall Study|Last TSST/ last patient out|30
53908|NCT01665170|126913|P2|After TSST|Overall Study||30
53909|NCT01665170|126914|P1|After TSST|Overall Study||30
53910|NCT01665170|126913|P2|During TSST|Overall Study||30
53911|NCT01665170|126914|P1|During TSST|Overall Study||30
53912|NCT01665170|126913|P2|Bevore TSST|Overall Study||30
53913|NCT01665170|126914|P1|Bevore TSST|Overall Study||30
53914|NCT01665170|126913|P2|STARTED|Overall Study||30
53915|NCT01665170|126914|P1|STARTED|Overall Study|First patient in|30
53916|NCT01665157|126965|P3|NOT COMPLETED|Overall Study||0
53917|NCT01665157|126966|P2|NOT COMPLETED|Overall Study||0
53918|NCT01665157|126967|P1|NOT COMPLETED|Overall Study||0
53919|NCT01665157|126965|P3|COMPLETED|Overall Study||60
53920|NCT01665157|126966|P2|COMPLETED|Overall Study||60
53921|NCT01665157|126967|P1|COMPLETED|Overall Study||60
53922|NCT01665157|126965|P3|STARTED|Overall Study||60
53923|NCT01665157|126966|P2|STARTED|Overall Study||60
53924|NCT01665157|126967|P1|STARTED|Overall Study||60
53925|NCT01665053|126995|P2|NOT COMPLETED|Overall Study||15
53926|NCT01665053|126996|P1|NOT COMPLETED|Overall Study||32
53927|NCT01665053|126995|P2|COMPLETED|Overall Study||831
53928|NCT01665053|126996|P1|COMPLETED|Overall Study||806
53929|NCT01665053|126995|P2|Death With No 12-month Clinical FU|Overall Study||9
53930|NCT01665053|126996|P1|Death With No 12-month Clinical FU|Overall Study||9
53931|NCT01665053|126995|P2|No 12-Month F/U|Overall Study||15
53932|NCT01665053|126996|P1|No 12-Month F/U|Overall Study||32
53933|NCT01665053|126995|P2|Completed 12-Month Clinical F/U|Overall Study||822
53934|NCT01665053|126996|P1|Completed 12-Month Clinical F/U|Overall Study||797
53935|NCT01665053|126995|P2|STARTED|Overall Study||846
53936|NCT01665053|126996|P1|STARTED|Overall Study||838
53937|NCT01664975|127036|P2|NOT COMPLETED|Overall Study||3
53938|NCT01664975|127037|P1|NOT COMPLETED|Overall Study||5
53939|NCT01664975|127036|P2|COMPLETED|Overall Study||51
53940|NCT01664975|127037|P1|COMPLETED|Overall Study||52
53941|NCT01664975|127036|P2|STARTED|Overall Study||54
53942|NCT01664975|127037|P1|STARTED|Overall Study||57
53943|NCT01664949|127045|P2|NOT COMPLETED|Overall Study||25
53944|NCT01664949|127046|P1|NOT COMPLETED|Overall Study||24
53945|NCT01664949|127045|P2|COMPLETED|Overall Study||211
53946|NCT01664949|127046|P1|COMPLETED|Overall Study||200
53947|NCT01664949|127045|P2|STARTED|Overall Study||236
53948|NCT01664949|127046|P1|STARTED|Overall Study||224
53949|NCT01664923|127062|P2|NOT COMPLETED|Overall Study||158
53950|NCT01664923|127063|P1|NOT COMPLETED|Overall Study||93
53951|NCT01664923|127062|P2|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|40
53952|NCT01664923|127063|P1|COMPLETED|Overall Study|Indicates participants continuing to receive treatment as of 09 February 2015.|105
53953|NCT01664923|127062|P2|Received Study Treatment|Overall Study||198
53954|NCT01664923|127063|P1|Received Study Treatment|Overall Study||197
53955|NCT01664923|127062|P2|STARTED|Overall Study||198
53956|NCT01664923|127063|P1|STARTED|Overall Study||198
53957|NCT01664806|127083|P2|NOT COMPLETED|Overall Study||0
53958|NCT01664806|127084|P1|NOT COMPLETED|Overall Study||0
53959|NCT01664806|127083|P2|COMPLETED|Overall Study||20
53960|NCT01664806|127084|P1|COMPLETED|Overall Study||20
53961|NCT01664806|127083|P2|STARTED|Overall Study||20
53962|NCT01664806|127084|P1|STARTED|Overall Study||20
53963|NCT01664793|127094|P2|NOT COMPLETED|Overall Study||0
53964|NCT01664793|127095|P1|NOT COMPLETED|Overall Study||0
53965|NCT01664793|127094|P2|COMPLETED|Overall Study||38626
53966|NCT01664793|127095|P1|COMPLETED|Overall Study||49039
53967|NCT01664793|127094|P2|STARTED|Overall Study||38626
53968|NCT01664793|127095|P1|STARTED|Overall Study||49039
53969|NCT01664624|127107|P4|NOT COMPLETED|Overall Study||0
53970|NCT01664624|127108|P3|NOT COMPLETED|Overall Study||0
53971|NCT01664624|127109|P2|NOT COMPLETED|Overall Study||1
53972|NCT01664624|127110|P1|NOT COMPLETED|Overall Study||0
53973|NCT01664624|127107|P4|COMPLETED|Overall Study||9
53974|NCT01664624|127108|P3|COMPLETED|Overall Study||10
53975|NCT01664624|127109|P2|COMPLETED|Overall Study||10
53976|NCT01664624|127110|P1|COMPLETED|Overall Study||10
53977|NCT01664624|127107|P4|STARTED|Overall Study||9
53978|NCT01664624|127108|P3|STARTED|Overall Study||10
53979|NCT01664624|127109|P2|STARTED|Overall Study||11
53980|NCT01664624|127110|P1|STARTED|Overall Study||10
53981|NCT01664559|127142|P2|NOT COMPLETED|Overall Study||0
53982|NCT01664559|127143|P1|NOT COMPLETED|Overall Study||0
53983|NCT01664559|127142|P2|COMPLETED|Overall Study||33
53984|NCT01664559|127143|P1|COMPLETED|Overall Study||34
53985|NCT01664559|127142|P2|STARTED|Overall Study||33
53986|NCT01664559|127143|P1|STARTED|Overall Study||34
53987|NCT01664533|127157|P1|NOT COMPLETED|Overall Study||57
53988|NCT01664533|127157|P1|COMPLETED|Overall Study||0
53989|NCT01664533|127157|P1|STARTED|Overall Study||57
53990|NCT01664494|127165|P1|NOT COMPLETED|Overall Study||193
53991|NCT01664494|127165|P1|COMPLETED|Overall Study||370
53992|NCT01664494|127165|P1|STARTED|Overall Study||563
53993|NCT01664247|127172|P2|NOT COMPLETED|Overall Study||41
53994|NCT01664247|127173|P1|NOT COMPLETED|Overall Study||14
53995|NCT01664247|127172|P2|COMPLETED|Overall Study||131
53996|NCT01664247|127173|P1|COMPLETED|Overall Study||160
53997|NCT01664247|127172|P2|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|170
53998|NCT01664247|127173|P1|Exposed|Overall Study|1 subject was randomised in error and withdrew before exposure to the drug|173
53999|NCT01664247|127172|P2|STARTED|Overall Study||172
54000|NCT01664247|127173|P1|STARTED|Overall Study||174
54001|NCT01664117|127195|P1|NOT COMPLETED|Overall Study||0
54002|NCT01664117|127195|P1|COMPLETED|Overall Study||209
54003|NCT01664117|127195|P1|STARTED|Overall Study||209
54004|NCT01664104|127250|P1|NOT COMPLETED|Overall Study||16
54005|NCT01664104|127250|P1|COMPLETED|Overall Study||120
54006|NCT01664104|127250|P1|STARTED|Overall Study||136
54007|NCT01664052|127319|P2|NOT COMPLETED|Phase 2||4
54008|NCT01664052|127320|P1|NOT COMPLETED|Phase 2||0
54009|NCT01664052|127319|P2|COMPLETED|Phase 2||31
54010|NCT01664052|127320|P1|COMPLETED|Phase 2||0
54011|NCT01664052|127319|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 2||10
54012|NCT01664052|127320|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 2||0
54013|NCT01664052|127319|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 2||10
54014|NCT01664052|127320|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 2||0
54015|NCT01664052|127319|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 2||10
54016|NCT01664052|127320|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 2||0
54017|NCT01664052|127319|P2|HSG 1 Hour Post Placement|Phase 2||31
54018|NCT01664052|127320|P1|HSG 1 Hour Post Placement|Phase 2||0
54019|NCT01664052|127319|P2|Insert Placed|Phase 2||31
54020|NCT01664052|127320|P1|Insert Placed|Phase 2||0
54021|NCT01664052|127319|P2|STARTED|Phase 2||35
54022|NCT01664052|127320|P1|STARTED|Phase 2|Screened and enrolled|0
54023|NCT01664052|127319|P2|NOT COMPLETED|Phase 1||0
54024|NCT01664052|127320|P1|NOT COMPLETED|Phase 1||7
54025|NCT01664052|127319|P2|COMPLETED|Phase 1||0
54026|NCT01664052|127320|P1|COMPLETED|Phase 1||24
54027|NCT01664052|127319|P2|Repeat HSG and Hysterectomy at 90 Days|Phase 1||0
54028|NCT01664052|127320|P1|Repeat HSG and Hysterectomy at 90 Days|Phase 1||7
54029|NCT01664052|127319|P2|Repeat HSG and Hysterectomy at 60 Days|Phase 1||0
54030|NCT01664052|127320|P1|Repeat HSG and Hysterectomy at 60 Days|Phase 1||8
54031|NCT01664052|127319|P2|Repeat HSG and Hysterectomy at 30 Days|Phase 1||0
54032|NCT01664052|127320|P1|Repeat HSG and Hysterectomy at 30 Days|Phase 1||9
54033|NCT01664052|127319|P2|HSG 1 Hour Post Placement|Phase 1||0
54034|NCT01664052|127320|P1|HSG 1 Hour Post Placement|Phase 1||24
54035|NCT01664052|127319|P2|Insert Placed in at Least One Tube|Phase 1||0
54036|NCT01664052|127320|P1|Insert Placed in at Least One Tube|Phase 1||25
54037|NCT01664052|127319|P2|STARTED|Phase 1||0
54038|NCT01664052|127320|P1|STARTED|Phase 1|Screening and enrollment|31
54039|NCT01664039|127338|P2|NOT COMPLETED|Overall Study||9
54040|NCT01664039|127339|P1|NOT COMPLETED|Overall Study||6
54041|NCT01664039|127338|P2|COMPLETED|Overall Study||43
54042|NCT01664039|127339|P1|COMPLETED|Overall Study||46
54043|NCT01664039|127338|P2|STARTED|Overall Study||52
54044|NCT01664039|127339|P1|STARTED|Overall Study||52
54045|NCT01663987|127361|P2|NOT COMPLETED|Overall Study||6
54046|NCT01663987|127362|P1|NOT COMPLETED|Overall Study||13
54047|NCT01663987|127361|P2|COMPLETED|Overall Study||34
54048|NCT01663987|127362|P1|COMPLETED|Overall Study||26
54049|NCT01663987|127361|P2|STARTED|Overall Study||40
54050|NCT01663987|127362|P1|STARTED|Overall Study||39
54051|NCT01663922|127388|P2|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
54052|NCT01663922|127389|P1|NOT COMPLETED|Third Intervention (14 Days or 5 Days)||0
54053|NCT01663922|127388|P2|COMPLETED|Third Intervention (14 Days or 5 Days)||9
54054|NCT01663922|127389|P1|COMPLETED|Third Intervention (14 Days or 5 Days)||8
54055|NCT01663922|127388|P2|STARTED|Third Intervention (14 Days or 5 Days)||9
54056|NCT01663922|127389|P1|STARTED|Third Intervention (14 Days or 5 Days)||8
54057|NCT01663922|127388|P2|NOT COMPLETED|Washout (7 Days)||0
54058|NCT01663922|127389|P1|NOT COMPLETED|Washout (7 Days)||0
54059|NCT01663922|127388|P2|COMPLETED|Washout (7 Days)||9
54060|NCT01663922|127389|P1|COMPLETED|Washout (7 Days)||8
54061|NCT01663922|127388|P2|STARTED|Washout (7 Days)||9
54062|NCT01663922|127389|P1|STARTED|Washout (7 Days)||8
54063|NCT01663922|127388|P2|NOT COMPLETED|Second Intervention (14 Days)||0
54064|NCT01663922|127389|P1|NOT COMPLETED|Second Intervention (14 Days)||0
54065|NCT01663922|127388|P2|COMPLETED|Second Intervention (14 Days)||9
54066|NCT01663922|127389|P1|COMPLETED|Second Intervention (14 Days)||8
54067|NCT01663922|127388|P2|STARTED|Second Intervention (14 Days)||9
54068|NCT01663922|127389|P1|STARTED|Second Intervention (14 Days)||8
54069|NCT01663922|127388|P2|NOT COMPLETED|Washout (7 Days)||0
54070|NCT01663922|127389|P1|NOT COMPLETED|Washout (7 Days)||0
54071|NCT01663922|127388|P2|COMPLETED|Washout (7 Days)||9
54072|NCT01663922|127389|P1|COMPLETED|Washout (7 Days)||8
54073|NCT01663922|127388|P2|STARTED|Washout (7 Days)||9
54074|NCT01663922|127389|P1|STARTED|Washout (7 Days)||8
54075|NCT01663922|127388|P2|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
54076|NCT01663922|127389|P1|NOT COMPLETED|First Intervention (14 Days or 5 Days)||0
54077|NCT01663922|127388|P2|COMPLETED|First Intervention (14 Days or 5 Days)||9
54078|NCT01663922|127389|P1|COMPLETED|First Intervention (14 Days or 5 Days)||8
54079|NCT01663922|127388|P2|STARTED|First Intervention (14 Days or 5 Days)||9
54080|NCT01663922|127389|P1|STARTED|First Intervention (14 Days or 5 Days)||8
54081|NCT01663779|127396|P2|NOT COMPLETED|Overall Study||0
54082|NCT01663779|127397|P1|NOT COMPLETED|Overall Study||0
54083|NCT01663779|127396|P2|COMPLETED|Overall Study||23
54084|NCT01663779|127397|P1|COMPLETED|Overall Study||27
54085|NCT01663779|127396|P2|STARTED|Overall Study||23
54086|NCT01663779|127397|P1|STARTED|Overall Study||27
54087|NCT01663727|127405|P2|NOT COMPLETED|Overall Study||239
54088|NCT01663727|127406|P1|NOT COMPLETED|Overall Study||242
54089|NCT01663727|127405|P2|COMPLETED|Overall Study||0
54090|NCT01663727|127406|P1|COMPLETED|Overall Study||0
54091|NCT01663727|127405|P2|STARTED|Overall Study||239
54092|NCT01663727|127406|P1|STARTED|Overall Study||242
54093|NCT01663714|127434|P1|NOT COMPLETED|Long-Term Follow-Up||6
54094|NCT01663714|127434|P1|COMPLETED|Long-Term Follow-Up||16
54095|NCT01663714|127434|P1|STARTED|Long-Term Follow-Up|22 of the30 participants withdrawing from Study BEX104514 enrolled in the LTFU study.|22
54096|NCT01663714|127434|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||30
54097|NCT01663714|127434|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
54098|NCT01663714|127434|P1|STARTED|Dosimetric and Therapeutic Treatment||30
54099|NCT01663532|127463|P2|NOT COMPLETED|Overall Study||107
54100|NCT01663532|127464|P1|NOT COMPLETED|Overall Study||74
54101|NCT01663532|127463|P2|COMPLETED|Overall Study||65
54102|NCT01663532|127464|P1|COMPLETED|Overall Study||94
54103|NCT01663532|127463|P2|STARTED|Overall Study||172
54104|NCT01663532|127464|P1|STARTED|Overall Study||168
54105|NCT01663506|127482|P1|NOT COMPLETED|Overall Study||8
54106|NCT01663506|127482|P1|COMPLETED|Overall Study||15
54107|NCT01663506|127482|P1|STARTED|Overall Study||23
54108|NCT01663363|127511|P1|NOT COMPLETED|Overall Study||0
54109|NCT01663363|127511|P1|COMPLETED|Overall Study|334 Eyes were treated among 170 participants|170
54110|NCT01663363|127511|P1|STARTED|Overall Study|334 Eyes were treated among 170 participants|170
54111|NCT01663285|127516|P1|NOT COMPLETED|Overall Study||0
54112|NCT01663285|127516|P1|COMPLETED|Overall Study||1
54113|NCT01663285|127516|P1|STARTED|Overall Study||1
54114|NCT01663233|127524|P2|NOT COMPLETED|Overall Study||7
54115|NCT01663233|127525|P1|NOT COMPLETED|Overall Study||4
54116|NCT01663233|127524|P2|COMPLETED|Overall Study||129
54117|NCT01663233|127525|P1|COMPLETED|Overall Study||126
54118|NCT01663233|127524|P2|STARTED|Overall Study||136
54119|NCT01663233|127525|P1|STARTED|Overall Study||130
54120|NCT01663103|127549|P2|NOT COMPLETED|Overall Study||2
54121|NCT01663103|127550|P1|NOT COMPLETED|Overall Study||3
54122|NCT01663103|127549|P2|COMPLETED|Overall Study||19
54123|NCT01663103|127550|P1|COMPLETED|Overall Study||18
54124|NCT01663103|127549|P2|STARTED|Overall Study||21
54125|NCT01663103|127550|P1|STARTED|Overall Study||21
54126|NCT01663012|127566|P1|NOT COMPLETED|Overall Study||0
54127|NCT01663012|127566|P1|COMPLETED|Overall Study||20
54128|NCT01663012|127566|P1|STARTED|Overall Study||20
54129|NCT01662999|127578|P6|NOT COMPLETED|Period 3||0
54130|NCT01662999|127579|P5|NOT COMPLETED|Period 3||0
54131|NCT01662999|127580|P4|NOT COMPLETED|Period 3||0
54132|NCT01662999|127581|P3|NOT COMPLETED|Period 3||0
54133|NCT01662999|127582|P2|NOT COMPLETED|Period 3||1
54134|NCT01662999|127583|P1|NOT COMPLETED|Period 3||0
54135|NCT01662999|127578|P6|COMPLETED|Period 3||7
54136|NCT01662999|127579|P5|COMPLETED|Period 3||7
54137|NCT01662999|127580|P4|COMPLETED|Period 3||7
54138|NCT01662999|127581|P3|COMPLETED|Period 3||7
54139|NCT01662999|127582|P2|COMPLETED|Period 3|Participant did not provide 36, 48, or 60 hour samples in this period for Treatment B.|6
54140|NCT01662999|127583|P1|COMPLETED|Period 3||7
54141|NCT01662999|127578|P6|STARTED|Period 3||7
54142|NCT01662999|127579|P5|STARTED|Period 3||7
54143|NCT01662999|127580|P4|STARTED|Period 3||7
54144|NCT01662999|127581|P3|STARTED|Period 3||7
54145|NCT01662999|127582|P2|STARTED|Period 3||7
54146|NCT01662999|127583|P1|STARTED|Period 3||7
54147|NCT01662999|127578|P6|NOT COMPLETED|Period 2||0
54148|NCT01662999|127579|P5|NOT COMPLETED|Period 2||0
54149|NCT01662999|127580|P4|NOT COMPLETED|Period 2||0
54150|NCT01662999|127581|P3|NOT COMPLETED|Period 2||0
54151|NCT01662999|127582|P2|NOT COMPLETED|Period 2||0
54152|NCT01662999|127583|P1|NOT COMPLETED|Period 2||0
54153|NCT01662999|127578|P6|COMPLETED|Period 2||7
54154|NCT01662999|127579|P5|COMPLETED|Period 2||7
54155|NCT01662999|127580|P4|COMPLETED|Period 2||7
54156|NCT01662999|127581|P3|COMPLETED|Period 2||7
54157|NCT01662999|127582|P2|COMPLETED|Period 2||7
54158|NCT01662999|127583|P1|COMPLETED|Period 2||7
54159|NCT01662999|127578|P6|STARTED|Period 2||7
54160|NCT01662999|127579|P5|STARTED|Period 2||7
54161|NCT01662999|127580|P4|STARTED|Period 2||7
54162|NCT01662999|127581|P3|STARTED|Period 2||7
54163|NCT01662999|127582|P2|STARTED|Period 2||7
54164|NCT01662999|127583|P1|STARTED|Period 2||7
54165|NCT01662999|127578|P6|NOT COMPLETED|Period 1||0
54166|NCT01662999|127579|P5|NOT COMPLETED|Period 1||0
54167|NCT01662999|127580|P4|NOT COMPLETED|Period 1||0
54168|NCT01662999|127581|P3|NOT COMPLETED|Period 1||0
54169|NCT01662999|127582|P2|NOT COMPLETED|Period 1||0
54170|NCT01662999|127583|P1|NOT COMPLETED|Period 1||0
54171|NCT01662999|127578|P6|COMPLETED|Period 1||7
54172|NCT01662999|127579|P5|COMPLETED|Period 1||7
54173|NCT01662999|127580|P4|COMPLETED|Period 1||7
54174|NCT01662999|127581|P3|COMPLETED|Period 1||7
54175|NCT01662999|127582|P2|COMPLETED|Period 1||7
54176|NCT01662999|127583|P1|COMPLETED|Period 1||7
54177|NCT01662999|127578|P6|STARTED|Period 1||7
54178|NCT01662999|127579|P5|STARTED|Period 1||7
54179|NCT01662999|127580|P4|STARTED|Period 1||7
54180|NCT01662999|127581|P3|STARTED|Period 1||7
54181|NCT01662999|127582|P2|STARTED|Period 1||7
54182|NCT01662999|127583|P1|STARTED|Period 1||7
54183|NCT01662986|127654|P2|NOT COMPLETED|Overall Study||13
54184|NCT01662986|127655|P1|NOT COMPLETED|Overall Study||18
54185|NCT01662986|127654|P2|COMPLETED|Overall Study||26
54186|NCT01662986|127655|P1|COMPLETED|Overall Study||22
54187|NCT01662986|127654|P2|STARTED|Overall Study||39
54188|NCT01662986|127655|P1|STARTED|Overall Study||40
54189|NCT01662908|127687|P2|NOT COMPLETED|Overall Study||5
54190|NCT01662908|127688|P1|NOT COMPLETED|Overall Study||6
54191|NCT01662908|127687|P2|COMPLETED|Overall Study||23
54192|NCT01662908|127688|P1|COMPLETED|Overall Study||50
54193|NCT01662908|127687|P2|STARTED|Overall Study||28
54194|NCT01662908|127688|P1|STARTED|Overall Study||56
54195|NCT01662882|127705|P3|NOT COMPLETED|Overall Study||0
54196|NCT01662882|127706|P2|NOT COMPLETED|Overall Study||0
54197|NCT01662882|127707|P1|NOT COMPLETED|Overall Study||0
54198|NCT01662882|127705|P3|COMPLETED|Overall Study||15
54199|NCT01662882|127706|P2|COMPLETED|Overall Study||18
54200|NCT01662882|127707|P1|COMPLETED|Overall Study||15
54201|NCT01662882|127705|P3|STARTED|Overall Study||15
54202|NCT01662882|127706|P2|STARTED|Overall Study||18
54203|NCT01662882|127707|P1|STARTED|Overall Study||15
54204|NCT01662856|127720|P2|NOT COMPLETED|Primary Part II||2
54205|NCT01662856|127721|P1|NOT COMPLETED|Primary Part II||10
54206|NCT01662856|127720|P2|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|55
54207|NCT01662856|127721|P1|COMPLETED|Primary Part II|Completed Virology follow-up visit at Month 3 or Month 6|99
54208|NCT01662856|127720|P2|Completed Study up to Week 6|Primary Part II||56
54209|NCT01662856|127721|P1|Completed Study up to Week 6|Primary Part II||106
54210|NCT01662856|127720|P2|STARTED|Primary Part II||57
54211|NCT01662856|127721|P1|STARTED|Primary Part II||109
54212|NCT01662856|127720|P2|NOT COMPLETED|Part I + Part II (Overall Study)||2
54213|NCT01662856|127721|P1|NOT COMPLETED|Part I + Part II (Overall Study)||16
54214|NCT01662856|127720|P2|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|55
54215|NCT01662856|127721|P1|COMPLETED|Part I + Part II (Overall Study)|Completed Virology follow-up visit at Month 3 or Month 6|152
54216|NCT01662856|127720|P2|Completed Study up to Week 6|Part I + Part II (Overall Study)||56
54217|NCT01662856|127721|P1|Completed Study up to Week 6|Part I + Part II (Overall Study)||164
54218|NCT01662856|127720|P2|STARTED|Part I + Part II (Overall Study)||57
54219|NCT01662856|127721|P1|STARTED|Part I + Part II (Overall Study)||168
54220|NCT01662791|127735|P2|NOT COMPLETED|Part 2 - Interventional||0
54221|NCT01662791|127736|P1|NOT COMPLETED|Part 2 - Interventional||0
54222|NCT01662791|127735|P2|COMPLETED|Part 2 - Interventional||0
54223|NCT01662791|127736|P1|COMPLETED|Part 2 - Interventional||8
54224|NCT01662791|127735|P2|STARTED|Part 2 - Interventional|The Control Group did not take part in the second part of the study.|0
54225|NCT01662791|127736|P1|STARTED|Part 2 - Interventional||8
54226|NCT01662791|127735|P2|NOT COMPLETED|Part 1 - Observational||0
54227|NCT01662791|127736|P1|NOT COMPLETED|Part 1 - Observational||0
54228|NCT01662791|127735|P2|COMPLETED|Part 1 - Observational||41
54229|NCT01662791|127736|P1|COMPLETED|Part 1 - Observational||8
54230|NCT01662791|127735|P2|STARTED|Part 1 - Observational||41
54231|NCT01662791|127736|P1|STARTED|Part 1 - Observational||8
54232|NCT01662765|127760|P2|NOT COMPLETED|Overall Study||2
54233|NCT01662765|127761|P1|NOT COMPLETED|Overall Study||1
54234|NCT01662765|127760|P2|COMPLETED|Overall Study||40
54235|NCT01662765|127761|P1|COMPLETED|Overall Study||41
54236|NCT01662765|127760|P2|STARTED|Overall Study||42
54237|NCT01662765|127761|P1|STARTED|Overall Study||42
54238|NCT01662648|127775|P2|NOT COMPLETED|Overall Study||178
54239|NCT01662648|127776|P1|NOT COMPLETED|Overall Study||147
54240|NCT01662648|127775|P2|COMPLETED|Overall Study||419
54241|NCT01662648|127776|P1|COMPLETED|Overall Study||373
54242|NCT01662648|127775|P2|STARTED|Overall Study||597
54243|NCT01662648|127776|P1|STARTED|Overall Study||520
54244|NCT01662635|127798|P1|NOT COMPLETED|Overall Study||30
54245|NCT01662635|127798|P1|COMPLETED|Overall Study||200
54246|NCT01662635|127798|P1|STARTED|Overall Study||230
54247|NCT01662583|127807|P3|NOT COMPLETED|Overall Study||0
54248|NCT01662583|127808|P2|NOT COMPLETED|Overall Study||0
54249|NCT01662583|127809|P1|NOT COMPLETED|Overall Study||0
54250|NCT01662583|127807|P3|COMPLETED|Overall Study||219
54251|NCT01662583|127808|P2|COMPLETED|Overall Study||225
54252|NCT01662583|127809|P1|COMPLETED|Overall Study||216
54253|NCT01662583|127807|P3|STARTED|Overall Study||219
54254|NCT01662583|127808|P2|STARTED|Overall Study||225
54255|NCT01662583|127809|P1|STARTED|Overall Study||216
54256|NCT01662531|127822|P1|NOT COMPLETED|Overall Study||0
54257|NCT01662531|127822|P1|COMPLETED|Overall Study||27
54258|NCT01662531|127822|P1|STARTED|Overall Study||27
54259|NCT01662440|127850|P4|NOT COMPLETED|Overall Study||4
54260|NCT01662440|127851|P3|NOT COMPLETED|Overall Study||6
54261|NCT01662440|127852|P2|NOT COMPLETED|Overall Study||6
54262|NCT01662440|127853|P1|NOT COMPLETED|Overall Study||9
54263|NCT01662440|127850|P4|COMPLETED|Overall Study||52
54264|NCT01662440|127851|P3|COMPLETED|Overall Study||215
54265|NCT01662440|127852|P2|COMPLETED|Overall Study||211
54266|NCT01662440|127853|P1|COMPLETED|Overall Study||158
54267|NCT01662440|127850|P4|STARTED|Overall Study||56
54268|NCT01662440|127851|P3|STARTED|Overall Study||221
54269|NCT01662440|127852|P2|STARTED|Overall Study||217
54270|NCT01662440|127853|P1|STARTED|Overall Study||167
54271|NCT01662362|127901|P1|NOT COMPLETED|Overall Study||38
54272|NCT01662362|127901|P1|COMPLETED|Overall Study||25
54273|NCT01662362|127901|P1|STARTED|Overall Study||63
54274|NCT01662310|127906|P5|NOT COMPLETED|Open-Label Extension Phase||10
54275|NCT01662310|127907|P4|NOT COMPLETED|Open-Label Extension Phase||11
54276|NCT01662310|127908|P3|NOT COMPLETED|Open-Label Extension Phase||0
54277|NCT01662310|127909|P2|NOT COMPLETED|Open-Label Extension Phase||0
54278|NCT01662310|127910|P1|NOT COMPLETED|Open-Label Extension Phase||0
54279|NCT01662310|127906|P5|COMPLETED|Open-Label Extension Phase||49
54280|NCT01662310|127907|P4|COMPLETED|Open-Label Extension Phase||36
54281|NCT01662310|127908|P3|COMPLETED|Open-Label Extension Phase||0
54282|NCT01662310|127909|P2|COMPLETED|Open-Label Extension Phase||0
54283|NCT01662310|127910|P1|COMPLETED|Open-Label Extension Phase||0
54284|NCT01662310|127906|P5|STARTED|Open-Label Extension Phase||59
54285|NCT01662310|127907|P4|STARTED|Open-Label Extension Phase||47
54286|NCT01662310|127908|P3|STARTED|Open-Label Extension Phase||0
54287|NCT01662310|127909|P2|STARTED|Open-Label Extension Phase||0
54288|NCT01662310|127910|P1|STARTED|Open-Label Extension Phase||0
54289|NCT01662310|127906|P5|NOT COMPLETED|Double-Blind Phase||0
54290|NCT01662310|127907|P4|NOT COMPLETED|Double-Blind Phase||0
54291|NCT01662310|127908|P3|NOT COMPLETED|Double-Blind Phase||5
54292|NCT01662310|127909|P2|NOT COMPLETED|Double-Blind Phase||15
54293|NCT01662310|127910|P1|NOT COMPLETED|Double-Blind Phase||0
54294|NCT01662310|127906|P5|COMPLETED|Double-Blind Phase||0
54295|NCT01662310|127907|P4|COMPLETED|Double-Blind Phase||0
54296|NCT01662310|127908|P3|COMPLETED|Double-Blind Phase||66
54297|NCT01662310|127909|P2|COMPLETED|Double-Blind Phase||50
54298|NCT01662310|127910|P1|COMPLETED|Double-Blind Phase||0
54299|NCT01662310|127906|P5|Treated|Double-Blind Phase||0
54300|NCT01662310|127907|P4|Treated|Double-Blind Phase||0
54301|NCT01662310|127908|P3|Treated|Double-Blind Phase||71
54302|NCT01662310|127909|P2|Treated|Double-Blind Phase||64
54303|NCT01662310|127910|P1|Treated|Double-Blind Phase||0
54304|NCT01662310|127906|P5|STARTED|Double-Blind Phase||0
54305|NCT01662310|127907|P4|STARTED|Double-Blind Phase||0
54306|NCT01662310|127908|P3|STARTED|Double-Blind Phase||71
54307|NCT01662310|127909|P2|STARTED|Double-Blind Phase||65
54308|NCT01662310|127910|P1|STARTED|Double-Blind Phase||0
54309|NCT01662310|127906|P5|NOT COMPLETED|Run-In or Stabilization Phase||0
54310|NCT01662310|127907|P4|NOT COMPLETED|Run-In or Stabilization Phase||0
54311|NCT01662310|127908|P3|NOT COMPLETED|Run-In or Stabilization Phase||0
54312|NCT01662310|127909|P2|NOT COMPLETED|Run-In or Stabilization Phase||0
54313|NCT01662310|127910|P1|NOT COMPLETED|Run-In or Stabilization Phase||65
54314|NCT01662310|127906|P5|COMPLETED|Run-In or Stabilization Phase||0
54315|NCT01662310|127907|P4|COMPLETED|Run-In or Stabilization Phase||0
54316|NCT01662310|127908|P3|COMPLETED|Run-In or Stabilization Phase||0
54317|NCT01662310|127909|P2|COMPLETED|Run-In or Stabilization Phase||0
54318|NCT01662310|127910|P1|COMPLETED|Run-In or Stabilization Phase||136
54319|NCT01662310|127906|P5|STARTED|Run-In or Stabilization Phase||0
54320|NCT01662310|127907|P4|STARTED|Run-In or Stabilization Phase||0
54321|NCT01662310|127908|P3|STARTED|Run-In or Stabilization Phase||0
54322|NCT01662310|127909|P2|STARTED|Run-In or Stabilization Phase||0
54323|NCT01662310|127910|P1|STARTED|Run-In or Stabilization Phase||201
54324|NCT01662115|127945|P3|NOT COMPLETED|Overall Study||0
54325|NCT01662115|127946|P2|NOT COMPLETED|Overall Study||0
54326|NCT01662115|127947|P1|NOT COMPLETED|Overall Study||0
54327|NCT01662115|127945|P3|COMPLETED|Overall Study||0
54328|NCT01662115|127946|P2|COMPLETED|Overall Study||2
54329|NCT01662115|127947|P1|COMPLETED|Overall Study||2
54330|NCT01662115|127945|P3|STARTED|Overall Study||0
54331|NCT01662115|127946|P2|STARTED|Overall Study||2
54332|NCT01662115|127947|P1|STARTED|Overall Study||2
54333|NCT01662102|127966|P2|NOT COMPLETED|Overall Study||0
54334|NCT01662102|127967|P1|NOT COMPLETED|Overall Study||1
54335|NCT01662102|127966|P2|COMPLETED|Overall Study||0
54336|NCT01662102|127967|P1|COMPLETED|Overall Study||0
54337|NCT01662102|127966|P2|STARTED|Overall Study||0
54338|NCT01662102|127967|P1|STARTED|Overall Study||1
54339|NCT01662063|127975|P3|NOT COMPLETED|Overall Study||1
54340|NCT01662063|127976|P2|NOT COMPLETED|Overall Study||29
54341|NCT01662063|127977|P1|NOT COMPLETED|Overall Study||5
54342|NCT01662063|127975|P3|COMPLETED|Overall Study||0
54343|NCT01662063|127976|P2|COMPLETED|Overall Study||144
54344|NCT01662063|127977|P1|COMPLETED|Overall Study||39
54345|NCT01662063|127975|P3|STARTED|Overall Study||1
54346|NCT01662063|127976|P2|STARTED|Overall Study||173
54347|NCT01662063|127977|P1|STARTED|Overall Study||44
54348|NCT01662024|128056|P1|NOT COMPLETED|Overall Study||5
54349|NCT01662024|128056|P1|COMPLETED|Overall Study||15
54350|NCT01662024|128056|P1|STARTED|Overall Study||20
54351|NCT01661972|128068|P2|NOT COMPLETED|Overall Study||4
54352|NCT01661972|128069|P1|NOT COMPLETED|Overall Study||2
54353|NCT01661972|128068|P2|COMPLETED|Overall Study||46
54354|NCT01661972|128069|P1|COMPLETED|Overall Study||11
54355|NCT01661972|128068|P2|STARTED|Overall Study||50
54356|NCT01661972|128069|P1|STARTED|Overall Study||13
54357|NCT01661933|128079|P1|NOT COMPLETED|High-dose Gluten Challenge||2
54358|NCT01661933|128079|P1|COMPLETED|High-dose Gluten Challenge||8
54359|NCT01661933|128079|P1|STARTED|High-dose Gluten Challenge|2 of 10 available after post-GC-1g did not enroll for reasons unrelated to gluten.|10
54360|NCT01661933|128079|P1|NOT COMPLETED|Low-dose Gluten Challenge||2
54361|NCT01661933|128079|P1|COMPLETED|Low-dose Gluten Challenge|Two had challenge interrupted for 1-2 weeks. All completed challenge.|10
54362|NCT01661933|128079|P1|STARTED|Low-dose Gluten Challenge|One was symptomatically intolerant to gluten >25 mg. One had active CeD pre- & post-micro-challenge|12
54363|NCT01661933|128079|P1|NOT COMPLETED|Gluten Micro-challenge||0
54364|NCT01661933|128079|P1|COMPLETED|Gluten Micro-challenge|Two gluten intolerant participants did not proceed to the low-dose challenge.|12
54365|NCT01661933|128079|P1|STARTED|Gluten Micro-challenge|All 12 enrolled completed hookworm inoculation and gluten micro-challenge.|12
54366|NCT01661881|128086|P1|NOT COMPLETED|Overall Study||0
54367|NCT01661881|128086|P1|COMPLETED|Overall Study||23
54368|NCT01661881|128086|P1|STARTED|Overall Study||23
54369|NCT01661790|128094|P2|NOT COMPLETED|Overall Study||2
54370|NCT01661790|128095|P1|NOT COMPLETED|Overall Study||0
54371|NCT01661790|128094|P2|COMPLETED|Overall Study||34
54372|NCT01661790|128095|P1|COMPLETED|Overall Study||36
54373|NCT01661790|128094|P2|STARTED|Overall Study||36
54374|NCT01661790|128095|P1|STARTED|Overall Study||36
54375|NCT01661621|128103|P2|NOT COMPLETED|Overall Study||0
54376|NCT01661621|128104|P1|NOT COMPLETED|Overall Study||0
54377|NCT01661621|128103|P2|COMPLETED|Overall Study||279
54378|NCT01661621|128104|P1|COMPLETED|Overall Study||116
54379|NCT01661621|128103|P2|STARTED|Overall Study||279
54380|NCT01661621|128104|P1|STARTED|Overall Study||116
54381|NCT01661270|128126|P2|NOT COMPLETED|Overall Study||0
54382|NCT01661270|128127|P1|NOT COMPLETED|Overall Study||0
54383|NCT01661270|128126|P2|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|223
54384|NCT01661270|128127|P1|COMPLETED|Overall Study|Treatment until disease progression/death, toxicity, consent withdrawal or Investigator's decision.|109
54385|NCT01661270|128126|P2|Other Reasons|Overall Study||2
54386|NCT01661270|128127|P1|Other Reasons|Overall Study||0
54387|NCT01661270|128126|P2|Participant’s Request|Overall Study|Met EOT criteria|48
54388|NCT01661270|128127|P1|Participant’s Request|Overall Study|Met EOT criteria|15
54389|NCT01661270|128126|P2|Physician Decision|Overall Study|Met EOT criteria|8
54390|NCT01661270|128127|P1|Physician Decision|Overall Study|Met EOT criteria|1
54391|NCT01661270|128126|P2|Disease Progression|Overall Study|Met EOT criteria|118
54392|NCT01661270|128127|P1|Disease Progression|Overall Study|Met EOT criteria|67
54393|NCT01661270|128126|P2|Adverse Event|Overall Study|Met EOT criteria|47
54394|NCT01661270|128127|P1|Adverse Event|Overall Study|Met end of treatment (EOT) criteria.|26
54395|NCT01661270|128126|P2|STARTED|Overall Study||223
54396|NCT01661270|128127|P1|STARTED|Overall Study||109
54397|NCT01661205|128138|P1|NOT COMPLETED|Overall Study||2
54398|NCT01661205|128138|P1|COMPLETED|Overall Study||24
54399|NCT01661205|128138|P1|STARTED|Overall Study||26
54400|NCT01661179|128149|P1|NOT COMPLETED|Overall Study||6
54401|NCT01661179|128149|P1|COMPLETED|Overall Study||8
54402|NCT01661179|128149|P1|STARTED|Overall Study||14
54403|NCT01661140|128153|P3|NOT COMPLETED|Double-Blind Period||50
54404|NCT01661140|128154|P2|NOT COMPLETED|Double-Blind Period||41
54405|NCT01661140|128155|P1|NOT COMPLETED|Double-Blind Period||0
54406|NCT01661140|128153|P3|COMPLETED|Double-Blind Period||86
54407|NCT01661140|128154|P2|COMPLETED|Double-Blind Period||95
54408|NCT01661140|128155|P1|COMPLETED|Double-Blind Period||0
54409|NCT01661140|128153|P3|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
54410|NCT01661140|128154|P2|STARTED|Double-Blind Period|Only those with a good/moderate disease response in the initial phase were randomized.|136
54411|NCT01661140|128155|P1|STARTED|Double-Blind Period|Those with a good/moderate disease response in the initial phase were randomized to the MTX arms.|0
54412|NCT01661140|128153|P3|NOT COMPLETED|Open-Label Period||0
54413|NCT01661140|128154|P2|NOT COMPLETED|Open-Label Period||0
54414|NCT01661140|128155|P1|NOT COMPLETED|Open-Label Period||76
54415|NCT01661140|128153|P3|COMPLETED|Open-Label Period||0
54416|NCT01661140|128154|P2|COMPLETED|Open-Label Period||0
54417|NCT01661140|128155|P1|COMPLETED|Open-Label Period||351
54418|NCT01661140|128153|P3|STARTED|Open-Label Period||0
54419|NCT01661140|128154|P2|STARTED|Open-Label Period||0
54420|NCT01661140|128155|P1|STARTED|Open-Label Period|All participants entered the study in the initial phase for 24 weeks of open label treatment.|427
54421|NCT01661114|128196|P1|NOT COMPLETED|Overall Study||0
54422|NCT01661114|128196|P1|COMPLETED|Overall Study||39
54423|NCT01661114|128196|P1|STARTED|Overall Study||39
54424|NCT01661062|128201|P1|NOT COMPLETED|Overall Study||5
54425|NCT01661062|128201|P1|COMPLETED|Overall Study||18
54426|NCT01661062|128201|P1|STARTED|Overall Study||23
54427|NCT01660906|128206|P1|NOT COMPLETED|Overall Study||3
54428|NCT01660906|128206|P1|COMPLETED|Overall Study||36
54429|NCT01660906|128206|P1|STARTED|Overall Study||39
54430|NCT01660815|128215|P1|NOT COMPLETED|Overall Study||0
54431|NCT01660815|128215|P1|COMPLETED|Overall Study||7
54432|NCT01660815|128215|P1|STARTED|Overall Study||7
54433|NCT01660802|128222|P2|NOT COMPLETED|Overall Study||11
54434|NCT01660802|128223|P1|NOT COMPLETED|Overall Study||4
54435|NCT01660802|128222|P2|COMPLETED|Overall Study||121
54436|NCT01660802|128223|P1|COMPLETED|Overall Study||126
54437|NCT01660802|128222|P2|STARTED|Overall Study||132
54438|NCT01660802|128223|P1|STARTED|Overall Study||130
54439|NCT01660763|128237|P2|NOT COMPLETED|Overall Study||61
54440|NCT01660763|128238|P1|NOT COMPLETED|Overall Study||100
54441|NCT01660763|128237|P2|COMPLETED|Overall Study||43
54442|NCT01660763|128238|P1|COMPLETED|Overall Study||215
54443|NCT01660763|128237|P2|STARTED|Overall Study||104
54444|NCT01660763|128238|P1|STARTED|Overall Study||315
54445|NCT01660737|128244|P1|NOT COMPLETED|Overall Study||0
54446|NCT01660737|128244|P1|COMPLETED|Overall Study||123
54447|NCT01660737|128244|P1|STARTED|Overall Study||123
54448|NCT01660698|128261|P2|NOT COMPLETED|Overall Study||0
54449|NCT01660698|128262|P1|NOT COMPLETED|Overall Study||0
54450|NCT01660698|128261|P2|COMPLETED|Overall Study||10
54451|NCT01660698|128262|P1|COMPLETED|Overall Study||10
54452|NCT01660698|128261|P2|STARTED|Overall Study||10
54453|NCT01660698|128262|P1|STARTED|Overall Study||10
54454|NCT01660672|128272|P1|NOT COMPLETED|Overall Study||0
54455|NCT01660672|128272|P1|COMPLETED|Overall Study||7
54456|NCT01660672|128272|P1|STARTED|Overall Study||7
54457|NCT01659736|128285|P2|NOT COMPLETED|3-month Follow-up||1
54458|NCT01659736|128286|P1|NOT COMPLETED|3-month Follow-up||0
54459|NCT01659736|128285|P2|COMPLETED|3-month Follow-up||9
54460|NCT01659736|128286|P1|COMPLETED|3-month Follow-up||9
54461|NCT01659736|128285|P2|STARTED|3-month Follow-up||10
54462|NCT01659736|128286|P1|STARTED|3-month Follow-up||9
54463|NCT01659736|128285|P2|NOT COMPLETED|Treatment Period||2
54464|NCT01659736|128286|P1|NOT COMPLETED|Treatment Period||5
54465|NCT01659736|128285|P2|COMPLETED|Treatment Period||10
54466|NCT01659736|128286|P1|COMPLETED|Treatment Period|n = 10, but data from one completer was excluded from all analyses due to protocol violation.|9
54467|NCT01659736|128285|P2|STARTED|Treatment Period||12
54468|NCT01659736|128286|P1|STARTED|Treatment Period||14
54469|NCT01660334|128300|P1|NOT COMPLETED|Overall Study||1
54470|NCT01660334|128300|P1|COMPLETED|Overall Study||12
54471|NCT01660334|128300|P1|STARTED|Overall Study||13
54472|NCT01660321|128305|P1|NOT COMPLETED|Overall Study||0
54473|NCT01660321|128305|P1|COMPLETED|Overall Study||26
54474|NCT01660321|128305|P1|STARTED|Overall Study||26
54475|NCT01660230|128329|P12|NOT COMPLETED|Overall Study||0
54476|NCT01660230|128330|P11|NOT COMPLETED|Overall Study||0
54477|NCT01660230|128331|P10|NOT COMPLETED|Overall Study||0
54478|NCT01660230|128332|P9|NOT COMPLETED|Overall Study||0
54479|NCT01660230|128333|P8|NOT COMPLETED|Overall Study||0
54480|NCT01660230|128334|P7|NOT COMPLETED|Overall Study||0
54481|NCT01660230|128335|P6|NOT COMPLETED|Overall Study||0
54482|NCT01660230|128336|P5|NOT COMPLETED|Overall Study||0
54483|NCT01660230|128337|P4|NOT COMPLETED|Overall Study||0
54484|NCT01660230|128338|P3|NOT COMPLETED|Overall Study||0
54485|NCT01660230|128339|P2|NOT COMPLETED|Overall Study||0
54486|NCT01660230|128340|P1|NOT COMPLETED|Overall Study||0
54487|NCT01660230|128329|P12|COMPLETED|Overall Study||14
54488|NCT01660230|128330|P11|COMPLETED|Overall Study||6
54489|NCT01660230|128331|P10|COMPLETED|Overall Study||6
54490|NCT01660230|128332|P9|COMPLETED|Overall Study||6
54491|NCT01660230|128333|P8|COMPLETED|Overall Study||6
54492|NCT01660230|128334|P7|COMPLETED|Overall Study||4
54493|NCT01660230|128335|P6|COMPLETED|Overall Study||2
54494|NCT01660230|128336|P5|COMPLETED|Overall Study||4
54495|NCT01660230|128337|P4|COMPLETED|Overall Study||4
54496|NCT01660230|128338|P3|COMPLETED|Overall Study||4
54497|NCT01660230|128339|P2|COMPLETED|Overall Study||4
54498|NCT01660230|128340|P1|COMPLETED|Overall Study||4
54499|NCT01660230|128329|P12|STARTED|Overall Study||14
54500|NCT01660230|128330|P11|STARTED|Overall Study||6
54501|NCT01660230|128331|P10|STARTED|Overall Study||6
54502|NCT01660230|128332|P9|STARTED|Overall Study||6
54503|NCT01660230|128333|P8|STARTED|Overall Study||6
54504|NCT01660230|128334|P7|STARTED|Overall Study||4
54505|NCT01660230|128335|P6|STARTED|Overall Study||2
54506|NCT01660230|128336|P5|STARTED|Overall Study||4
54507|NCT01660230|128337|P4|STARTED|Overall Study||4
54508|NCT01660230|128338|P3|STARTED|Overall Study||4
54509|NCT01660230|128339|P2|STARTED|Overall Study||4
54510|NCT01660230|128340|P1|STARTED|Overall Study||4
54511|NCT01660191|128512|P3|NOT COMPLETED|End of Treatment||1
54512|NCT01660191|128513|P2|NOT COMPLETED|End of Treatment||6
54513|NCT01660191|128514|P1|NOT COMPLETED|End of Treatment||1
54514|NCT01660191|128512|P3|COMPLETED|End of Treatment||43
54515|NCT01660191|128513|P2|COMPLETED|End of Treatment||39
54516|NCT01660191|128514|P1|COMPLETED|End of Treatment||44
54517|NCT01660191|128512|P3|STARTED|End of Treatment||44
54518|NCT01660191|128513|P2|STARTED|End of Treatment||45
54519|NCT01660191|128514|P1|STARTED|End of Treatment||45
54520|NCT01660191|128512|P3|NOT COMPLETED|Randomization||0
54521|NCT01660191|128513|P2|NOT COMPLETED|Randomization||0
54522|NCT01660191|128514|P1|NOT COMPLETED|Randomization||0
54523|NCT01660191|128512|P3|COMPLETED|Randomization||44
54524|NCT01660191|128513|P2|COMPLETED|Randomization||45
54525|NCT01660191|128514|P1|COMPLETED|Randomization||45
54526|NCT01660191|128512|P3|STARTED|Randomization||44
54527|NCT01660191|128513|P2|STARTED|Randomization||45
54528|NCT01660191|128514|P1|STARTED|Randomization||45
54529|NCT01660191|128512|P3|NOT COMPLETED|Enrollment and Washout||0
54530|NCT01660191|128513|P2|NOT COMPLETED|Enrollment and Washout||0
54531|NCT01660191|128514|P1|NOT COMPLETED|Enrollment and Washout||0
54532|NCT01660191|128512|P3|COMPLETED|Enrollment and Washout||44
54533|NCT01660191|128513|P2|COMPLETED|Enrollment and Washout||45
54534|NCT01660191|128514|P1|COMPLETED|Enrollment and Washout||45
54535|NCT01660191|128512|P3|STARTED|Enrollment and Washout||44
54536|NCT01660191|128513|P2|STARTED|Enrollment and Washout||45
54537|NCT01660191|128514|P1|STARTED|Enrollment and Washout||45
54538|NCT01660022|128543|P6|NOT COMPLETED|Second Sequence (42 Days)||0
54539|NCT01660022|128544|P5|NOT COMPLETED|Second Sequence (42 Days)||0
54540|NCT01660022|128545|P4|NOT COMPLETED|Second Sequence (42 Days)||0
54541|NCT01660022|128546|P3|NOT COMPLETED|Second Sequence (42 Days)||0
54542|NCT01660022|128547|P2|NOT COMPLETED|Second Sequence (42 Days)||0
54543|NCT01660022|128548|P1|NOT COMPLETED|Second Sequence (42 Days)||0
54544|NCT01660022|128543|P6|COMPLETED|Second Sequence (42 Days)||16
54545|NCT01660022|128544|P5|COMPLETED|Second Sequence (42 Days)||6
54546|NCT01660022|128545|P4|COMPLETED|Second Sequence (42 Days)||7
54547|NCT01660022|128546|P3|COMPLETED|Second Sequence (42 Days)||8
54548|NCT01660022|128547|P2|COMPLETED|Second Sequence (42 Days)||7
54549|NCT01660022|128548|P1|COMPLETED|Second Sequence (42 Days)||8
54550|NCT01660022|128543|P6|STARTED|Second Sequence (42 Days)||16
54551|NCT01660022|128544|P5|STARTED|Second Sequence (42 Days)||6
54552|NCT01660022|128545|P4|STARTED|Second Sequence (42 Days)||7
54553|NCT01660022|128546|P3|STARTED|Second Sequence (42 Days)||8
54554|NCT01660022|128547|P2|STARTED|Second Sequence (42 Days)||7
54555|NCT01660022|128548|P1|STARTED|Second Sequence (42 Days)||8
54556|NCT01660022|128543|P6|NOT COMPLETED|First Sequence (7 Days)||4
54557|NCT01660022|128544|P5|NOT COMPLETED|First Sequence (7 Days)||1
54558|NCT01660022|128545|P4|NOT COMPLETED|First Sequence (7 Days)||1
54559|NCT01660022|128546|P3|NOT COMPLETED|First Sequence (7 Days)||0
54560|NCT01660022|128547|P2|NOT COMPLETED|First Sequence (7 Days)||1
54561|NCT01660022|128548|P1|NOT COMPLETED|First Sequence (7 Days)||0
54562|NCT01660022|128543|P6|COMPLETED|First Sequence (7 Days)||16
54563|NCT01660022|128544|P5|COMPLETED|First Sequence (7 Days)||6
54564|NCT01660022|128545|P4|COMPLETED|First Sequence (7 Days)||7
54565|NCT01660022|128546|P3|COMPLETED|First Sequence (7 Days)||8
54566|NCT01660022|128547|P2|COMPLETED|First Sequence (7 Days)||7
54567|NCT01660022|128548|P1|COMPLETED|First Sequence (7 Days)||8
54568|NCT01660022|128543|P6|STARTED|First Sequence (7 Days)||20
54569|NCT01660022|128544|P5|STARTED|First Sequence (7 Days)||7
54570|NCT01660022|128545|P4|STARTED|First Sequence (7 Days)||8
54571|NCT01660022|128546|P3|STARTED|First Sequence (7 Days)||8
54572|NCT01660022|128547|P2|STARTED|First Sequence (7 Days)||8
54573|NCT01660022|128548|P1|STARTED|First Sequence (7 Days)||8
54574|NCT01659996|128607|P3|NOT COMPLETED|Overall Study||11
54575|NCT01659996|128608|P2|NOT COMPLETED|Overall Study||7
54576|NCT01659996|128609|P1|NOT COMPLETED|Overall Study||8
54577|NCT01659996|128607|P3|COMPLETED|Overall Study||461
54578|NCT01659996|128608|P2|COMPLETED|Overall Study||388
54579|NCT01659996|128609|P1|COMPLETED|Overall Study||413
54580|NCT01659996|128607|P3|STARTED|Overall Study||472
54581|NCT01659996|128608|P2|STARTED|Overall Study||395
54582|NCT01659996|128609|P1|STARTED|Overall Study||421
54583|NCT01659853|128641|P2|NOT COMPLETED|Treatment Period 2||0
54584|NCT01659853|128642|P1|NOT COMPLETED|Treatment Period 2||0
54585|NCT01659853|128641|P2|COMPLETED|Treatment Period 2||35
54586|NCT01659853|128642|P1|COMPLETED|Treatment Period 2||33
54587|NCT01659853|128641|P2|STARTED|Treatment Period 2||35
54588|NCT01659853|128642|P1|STARTED|Treatment Period 2||33
54589|NCT01659853|128641|P2|NOT COMPLETED|Washout , 3 to 7 Days||0
54590|NCT01659853|128642|P1|NOT COMPLETED|Washout , 3 to 7 Days||2
54591|NCT01659853|128641|P2|COMPLETED|Washout , 3 to 7 Days||35
54592|NCT01659853|128642|P1|COMPLETED|Washout , 3 to 7 Days||33
54593|NCT01659853|128641|P2|STARTED|Washout , 3 to 7 Days||35
54594|NCT01659853|128642|P1|STARTED|Washout , 3 to 7 Days||35
54595|NCT01659853|128641|P2|NOT COMPLETED|Treatment Period 1||0
54596|NCT01659853|128642|P1|NOT COMPLETED|Treatment Period 1||0
54597|NCT01659853|128641|P2|COMPLETED|Treatment Period 1||35
54598|NCT01659853|128642|P1|COMPLETED|Treatment Period 1||35
54599|NCT01659853|128641|P2|STARTED|Treatment Period 1||35
54600|NCT01659853|128642|P1|STARTED|Treatment Period 1||35
54601|NCT01659554|128650|P1|NOT COMPLETED|Overall Study||4
54602|NCT01659554|128650|P1|COMPLETED|Overall Study||0
54696|NCT01658514|128834|P1|NOT COMPLETED|Overall Study||1
54603|NCT01659554|128650|P1|STARTED|Overall Study|4 subjects enrolled; 4 subjects treated and 4 did not complete protocol schema|4
54604|NCT01659320|128657|P1|NOT COMPLETED|Overall Study||3
54605|NCT01659320|128657|P1|COMPLETED|Overall Study||13
54606|NCT01659320|128657|P1|STARTED|Overall Study||16
54607|NCT01659268|128663|P2|NOT COMPLETED|Overall Study||0
54608|NCT01659268|128664|P1|NOT COMPLETED|Overall Study||0
54609|NCT01659268|128663|P2|COMPLETED|Overall Study||8
54610|NCT01659268|128664|P1|COMPLETED|Overall Study||9
54611|NCT01659268|128663|P2|STARTED|Overall Study||8
54612|NCT01659268|128664|P1|STARTED|Overall Study||9
54613|NCT01659125|128676|P1|NOT COMPLETED|Overall Study||14
54614|NCT01659125|128676|P1|COMPLETED|Overall Study||12
54615|NCT01659125|128676|P1|Completed 6-month Follow-up|Overall Study||12
54616|NCT01659125|128676|P1|Completed 3-month Follow-up|Overall Study||16
54617|NCT01659125|128676|P1|Completed the Posttreatment Assessment|Overall Study||17
54618|NCT01659125|128676|P1|Initiated Treatment|Overall Study||24
54619|NCT01659125|128676|P1|STARTED|Overall Study||26
54620|NCT01659021|128683|P2|NOT COMPLETED|Overall Study||37
54621|NCT01659021|128684|P1|NOT COMPLETED|Overall Study||88
54622|NCT01659021|128683|P2|COMPLETED|Overall Study||50
54623|NCT01659021|128684|P1|COMPLETED|Overall Study||86
54624|NCT01659021|128683|P2|Randomized and Treated|Overall Study||86
54625|NCT01659021|128684|P1|Randomized and Treated|Overall Study||173
54626|NCT01659021|128683|P2|STARTED|Overall Study||87
54627|NCT01659021|128684|P1|STARTED|Overall Study||174
54628|NCT01658943|128702|P2|NOT COMPLETED|Overall Study||67
54629|NCT01658943|128703|P1|NOT COMPLETED|Overall Study||70
54630|NCT01658943|128702|P2|COMPLETED|Overall Study||0
54631|NCT01658943|128703|P1|COMPLETED|Overall Study||0
54632|NCT01658943|128702|P2|Eligible and Began Protocol Therapy|Overall Study||58
54633|NCT01658943|128703|P1|Eligible and Began Protocol Therapy|Overall Study||62
54634|NCT01658943|128702|P2|Eligible|Overall Study||58
54635|NCT01658943|128703|P1|Eligible|Overall Study||63
54636|NCT01658943|128702|P2|STARTED|Overall Study||67
54637|NCT01658943|128703|P1|STARTED|Overall Study||70
54638|NCT01658904|128718|P3|NOT COMPLETED|Overall Study||0
54639|NCT01658904|128719|P2|NOT COMPLETED|Overall Study||0
54640|NCT01658904|128720|P1|NOT COMPLETED|Overall Study||2
54641|NCT01658904|128718|P3|COMPLETED|Overall Study||0
54642|NCT01658904|128719|P2|COMPLETED|Overall Study||0
54643|NCT01658904|128720|P1|COMPLETED|Overall Study||1
54644|NCT01658904|128718|P3|STARTED|Overall Study||0
54645|NCT01658904|128719|P2|STARTED|Overall Study||0
54646|NCT01658904|128720|P1|STARTED|Overall Study||3
54647|NCT01658839|128737|P1|NOT COMPLETED|Overall Study||0
54648|NCT01658839|128737|P1|COMPLETED|Overall Study||25
54649|NCT01658839|128737|P1|STARTED|Overall Study||25
54650|NCT01658813|128746|P1|NOT COMPLETED|Overall Study||3
54651|NCT01658813|128746|P1|COMPLETED|Overall Study||15
54652|NCT01658813|128746|P1|Treated|Overall Study||18
54653|NCT01658813|128746|P1|Eligible|Overall Study||18
54654|NCT01658813|128746|P1|STARTED|Overall Study||18
54655|NCT01658735|128757|P3|NOT COMPLETED|Overall Study||4
54656|NCT01658735|128758|P2|NOT COMPLETED|Overall Study||7
54657|NCT01658735|128759|P1|NOT COMPLETED|Overall Study||5
54658|NCT01658735|128757|P3|COMPLETED|Overall Study||34
54659|NCT01658735|128758|P2|COMPLETED|Overall Study||29
54660|NCT01658735|128759|P1|COMPLETED|Overall Study||34
54661|NCT01658735|128757|P3|STARTED|Overall Study||38
54662|NCT01658735|128758|P2|STARTED|Overall Study||36
54663|NCT01658735|128759|P1|STARTED|Overall Study||39
54664|NCT01658657|128790|P2|NOT COMPLETED|Overall Study||3
54665|NCT01658657|128791|P1|NOT COMPLETED|Overall Study||3
54666|NCT01658657|128790|P2|COMPLETED|Overall Study||7
54667|NCT01658657|128791|P1|COMPLETED|Overall Study||4
54668|NCT01658657|128790|P2|STARTED|Overall Study||10
54669|NCT01658657|128791|P1|STARTED|Overall Study||7
54670|NCT01658579|128801|P4|NOT COMPLETED|Treatment Period B||1
54671|NCT01658579|128802|P3|NOT COMPLETED|Treatment Period B||0
54672|NCT01658579|128803|P2|NOT COMPLETED|Treatment Period B||0
54673|NCT01658579|128804|P1|NOT COMPLETED|Treatment Period B||0
54674|NCT01658579|128801|P4|COMPLETED|Treatment Period B||12
54675|NCT01658579|128802|P3|COMPLETED|Treatment Period B||14
54676|NCT01658579|128803|P2|COMPLETED|Treatment Period B||15
54677|NCT01658579|128804|P1|COMPLETED|Treatment Period B||14
54678|NCT01658579|128801|P4|STARTED|Treatment Period B||13
54679|NCT01658579|128802|P3|STARTED|Treatment Period B||14
54680|NCT01658579|128803|P2|STARTED|Treatment Period B||15
54681|NCT01658579|128804|P1|STARTED|Treatment Period B||14
54682|NCT01658579|128801|P4|NOT COMPLETED|Treatment Period A||1
54683|NCT01658579|128802|P3|NOT COMPLETED|Treatment Period A||1
54684|NCT01658579|128803|P2|NOT COMPLETED|Treatment Period A||0
54685|NCT01658579|128804|P1|NOT COMPLETED|Treatment Period A||1
54686|NCT01658579|128801|P4|COMPLETED|Treatment Period A||13
54687|NCT01658579|128802|P3|COMPLETED|Treatment Period A||14
54688|NCT01658579|128803|P2|COMPLETED|Treatment Period A||15
54689|NCT01658579|128804|P1|COMPLETED|Treatment Period A||14
54690|NCT01658579|128801|P4|STARTED|Treatment Period A||14
54691|NCT01658579|128802|P3|STARTED|Treatment Period A||15
54692|NCT01658579|128803|P2|STARTED|Treatment Period A||15
54693|NCT01658579|128804|P1|STARTED|Treatment Period A||15
54694|NCT01658514|128832|P3|NOT COMPLETED|Overall Study||2
54695|NCT01658514|128833|P2|NOT COMPLETED|Overall Study||0
54697|NCT01658514|128832|P3|COMPLETED|Overall Study||12
54698|NCT01658514|128833|P2|COMPLETED|Overall Study||11
54699|NCT01658514|128834|P1|COMPLETED|Overall Study||13
54700|NCT01658514|128832|P3|Completed - Severe RI Cohort Only|Overall Study||3
54701|NCT01658514|128833|P2|Completed - Severe RI Cohort Only|Overall Study||2
54702|NCT01658514|128834|P1|Completed - Severe RI Cohort Only|Overall Study||3
54703|NCT01658514|128832|P3|Started - Severe RI Cohort Only|Overall Study||3
54704|NCT01658514|128833|P2|Started - Severe RI Cohort Only|Overall Study||2
54705|NCT01658514|128834|P1|Started - Severe RI Cohort Only|Overall Study||3
54706|NCT01658514|128832|P3|Completed - Moderate RI Cohort Only|Overall Study||2
54707|NCT01658514|128833|P2|Completed - Moderate RI Cohort Only|Overall Study||4
54708|NCT01658514|128834|P1|Completed - Moderate RI Cohort Only|Overall Study||3
54709|NCT01658514|128832|P3|Started - Moderate RI Cohort Only|Overall Study||4
54710|NCT01658514|128833|P2|Started - Moderate RI Cohort Only|Overall Study||4
54711|NCT01658514|128834|P1|Started - Moderate RI Cohort Only|Overall Study||4
54712|NCT01658514|128832|P3|Completed - Mild RI Cohort Only|Overall Study||4
54713|NCT01658514|128833|P2|Completed - Mild RI Cohort Only|Overall Study||3
54714|NCT01658514|128834|P1|Completed - Mild RI Cohort Only|Overall Study||4
54715|NCT01658514|128832|P3|Started - Mild RI Cohort Only|Overall Study||4
54716|NCT01658514|128833|P2|Started - Mild RI Cohort Only|Overall Study||3
54717|NCT01658514|128834|P1|Started - Mild RI Cohort Only|Overall Study||4
54718|NCT01658514|128832|P3|Completed - Normal RF Cohort Only|Overall Study||3
54719|NCT01658514|128833|P2|Completed - Normal RF Cohort Only|Overall Study||2
54720|NCT01658514|128834|P1|Completed - Normal RF Cohort Only|Overall Study||3
54721|NCT01658514|128832|P3|Started - Normal RF Cohort Only|Overall Study||3
54722|NCT01658514|128833|P2|Started - Normal RF Cohort Only|Overall Study||2
54723|NCT01658514|128834|P1|Started - Normal RF Cohort Only|Overall Study||3
54724|NCT01658514|128832|P3|Completed Treatment C|Overall Study||12
54725|NCT01658514|128833|P2|Completed Treatment C|Overall Study||11
54726|NCT01658514|128834|P1|Completed Treatment C|Overall Study||13
54727|NCT01658514|128832|P3|Completed Treatment B|Overall Study||14
54728|NCT01658514|128833|P2|Completed Treatment B|Overall Study||11
54729|NCT01658514|128834|P1|Completed Treatment B|Overall Study||13
54730|NCT01658514|128832|P3|Completed Treatment A|Overall Study||12
54731|NCT01658514|128833|P2|Completed Treatment A|Overall Study||11
54732|NCT01658514|128834|P1|Completed Treatment A|Overall Study||14
54733|NCT01658514|128832|P3|STARTED|Overall Study||14
54734|NCT01658514|128833|P2|STARTED|Overall Study||11
54735|NCT01658514|128834|P1|STARTED|Overall Study||14
54736|NCT01658436|128845|P2|NOT COMPLETED|Overall Study||11
54737|NCT01658436|128846|P1|NOT COMPLETED|Overall Study||20
54738|NCT01658436|128845|P2|COMPLETED|Overall Study||0
54739|NCT01658436|128846|P1|COMPLETED|Overall Study||0
54740|NCT01658436|128845|P2|STARTED|Overall Study||11
54741|NCT01658436|128846|P1|STARTED|Overall Study||20
54742|NCT01658072|128855|P2|NOT COMPLETED|Overall Study||2
54743|NCT01658072|128856|P1|NOT COMPLETED|Overall Study||4
54744|NCT01658072|128855|P2|COMPLETED|Overall Study||43
54745|NCT01658072|128856|P1|COMPLETED|Overall Study||41
54746|NCT01658072|128855|P2|STARTED|Overall Study||45
54747|NCT01658072|128856|P1|STARTED|Overall Study||45
54748|NCT01658020|128864|P2|NOT COMPLETED|Overall Study||9
54749|NCT01658020|128865|P1|NOT COMPLETED|Overall Study||8
54750|NCT01658020|128864|P2|COMPLETED|Overall Study||158
54751|NCT01658020|128865|P1|COMPLETED|Overall Study||167
54752|NCT01658020|128864|P2|STARTED|Overall Study||167
54753|NCT01658020|128865|P1|STARTED|Overall Study||175
54754|NCT01657903|128881|P1|NOT COMPLETED|Overall Study||2
54755|NCT01657903|128881|P1|COMPLETED|Overall Study||54
54756|NCT01657903|128881|P1|Received NaF/KNO3 Toothpaste 2|Overall Study||55
54757|NCT01657903|128881|P1|Received NaF/KNO3 Toothpaste 3|Overall Study||54
54758|NCT01657903|128881|P1|Received NaF/KNO3 Toothpaste 1|Overall Study|One participant withdrew consent in study period 3|55
54759|NCT01657903|128881|P1|Received Placebo (No NaF/KNO3)Toothpaste|Overall Study|One participant was lost to follow up in study period 1|56
54760|NCT01657903|128881|P1|STARTED|Overall Study||56
54761|NCT01657877|128903|P1|NOT COMPLETED|Overall Study||14
54762|NCT01657877|128903|P1|COMPLETED|Overall Study||65
54763|NCT01657877|128903|P1|Received 1500ppm Fluoride as SMFP+0% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and 1 withdrawal of consent and AE in P3|71
54764|NCT01657877|128903|P1|Received 0ppm Fluoride+ 0% CSP|Overall Study|Discontinuation: 1 in P4 due to other reasons|69
54765|NCT01657877|128903|P1|Received 0ppm Fluoride+ 5% CSP|Overall Study|Discontinuations: 1 protocol violation in P1 and P2 each and 1 withdrawal of consent in P1.|71
54766|NCT01657877|128903|P1|Received 1500ppm Fluoride as SMFP+5% CSP|Overall Study|Discontinuations:2 withdrawal of consent in period (P) 1; 1 AE in P2;1 protocol violation in P3 & P4|75
54767|NCT01657877|128903|P1|Received 500ppm Fluoride as SMFP+ 0% CSP|Overall Study|Discontinuations: 1 due to other reason in P2 and 1 protocol violation in P4|70
54768|NCT01657877|128903|P1|STARTED|Overall Study||79
54769|NCT01657461|128922|P2|NOT COMPLETED|Overall Study||20
54770|NCT01657461|128923|P1|NOT COMPLETED|Overall Study||10
54771|NCT01657461|128922|P2|COMPLETED|Overall Study||78
54772|NCT01657461|128923|P1|COMPLETED|Overall Study||88
54773|NCT01657461|128922|P2|STARTED|Overall Study||98
54774|NCT01657461|128923|P1|STARTED|Overall Study||98
54775|NCT01657370|128953|P6|NOT COMPLETED|Overall Study||4
54776|NCT01657370|128954|P5|NOT COMPLETED|Overall Study||7
54777|NCT01657370|128955|P4|NOT COMPLETED|Overall Study||5
54778|NCT01657370|128956|P3|NOT COMPLETED|Overall Study||7
54779|NCT01657370|128957|P2|NOT COMPLETED|Overall Study||4
54780|NCT01657370|128958|P1|NOT COMPLETED|Overall Study||6
54781|NCT01657370|128953|P6|COMPLETED|Overall Study||27
54782|NCT01657370|128954|P5|COMPLETED|Overall Study||27
54783|NCT01657370|128955|P4|COMPLETED|Overall Study||28
54784|NCT01657370|128956|P3|COMPLETED|Overall Study||25
54785|NCT01657370|128957|P2|COMPLETED|Overall Study||28
54786|NCT01657370|128958|P1|COMPLETED|Overall Study||27
54787|NCT01657370|128953|P6|STARTED|Overall Study||31
54788|NCT01657370|128954|P5|STARTED|Overall Study||34
54789|NCT01657370|128955|P4|STARTED|Overall Study||33
54790|NCT01657370|128956|P3|STARTED|Overall Study||32
54791|NCT01657370|128957|P2|STARTED|Overall Study||32
54792|NCT01657370|128958|P1|STARTED|Overall Study||33
54793|NCT01657292|129040|P1|NOT COMPLETED|Overall Study||10
54794|NCT01657292|129040|P1|COMPLETED|Overall Study||51
54795|NCT01657292|129040|P1|STARTED|Overall Study||61
54796|NCT01657032|129049|P2|NOT COMPLETED|Overall Study||7
54797|NCT01657032|129050|P1|NOT COMPLETED|Overall Study||0
54798|NCT01657032|129049|P2|COMPLETED|Overall Study||37
54799|NCT01657032|129050|P1|COMPLETED|Overall Study||44
54800|NCT01657032|129049|P2|STARTED|Overall Study||44
54801|NCT01657032|129050|P1|STARTED|Overall Study||44
54802|NCT01657019|129076|P1|NOT COMPLETED|Overall Study||235
54803|NCT01657019|129076|P1|COMPLETED|Overall Study||369
54804|NCT01657019|129076|P1|STARTED|Overall Study||604
54805|NCT01656967|129090|P2|NOT COMPLETED|Overall Study||2
54806|NCT01656967|129091|P1|NOT COMPLETED|Overall Study||4
54807|NCT01656967|129090|P2|COMPLETED|Overall Study||31
54808|NCT01656967|129091|P1|COMPLETED|Overall Study||29
54809|NCT01656967|129090|P2|ETT Insertion|Overall Study||31
54810|NCT01656967|129091|P1|ETT Insertion|Overall Study||29
54811|NCT01656967|129090|P2|SGA Placement|Overall Study||33
54812|NCT01656967|129091|P1|SGA Placement|Overall Study||32
54813|NCT01656967|129090|P2|STARTED|Overall Study||33
54814|NCT01656967|129091|P1|STARTED|Overall Study||33
54815|NCT01656889|129113|P2|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||9
54816|NCT01656889|129114|P1|NOT COMPLETED|Post Treatment Follow-Up, 3 Months||4
54817|NCT01656889|129113|P2|COMPLETED|Post Treatment Follow-Up, 3 Months||204
54818|NCT01656889|129114|P1|COMPLETED|Post Treatment Follow-Up, 3 Months||206
54819|NCT01656889|129113|P2|STARTED|Post Treatment Follow-Up, 3 Months||213
54820|NCT01656889|129114|P1|STARTED|Post Treatment Follow-Up, 3 Months||210
54821|NCT01656889|129113|P2|NOT COMPLETED|Treatment Period, 12 Weeks||11
54822|NCT01656889|129114|P1|NOT COMPLETED|Treatment Period, 12 Weeks||12
54823|NCT01656889|129113|P2|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|214
54824|NCT01656889|129114|P1|COMPLETED|Treatment Period, 12 Weeks|Completed treatment|210
54825|NCT01656889|129113|P2|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|225
54826|NCT01656889|129114|P1|STARTED|Treatment Period, 12 Weeks|Randomized (Met all I/E criteria at completion of run-in)|222
54827|NCT01656850|129134|P2|NOT COMPLETED|Second Intervention (3 Months)||0
54828|NCT01656850|129135|P1|NOT COMPLETED|Second Intervention (3 Months)||0
54829|NCT01656850|129134|P2|COMPLETED|Second Intervention (3 Months)||16
54830|NCT01656850|129135|P1|COMPLETED|Second Intervention (3 Months)||17
54831|NCT01656850|129134|P2|STARTED|Second Intervention (3 Months)||16
54832|NCT01656850|129135|P1|STARTED|Second Intervention (3 Months)||17
54833|NCT01656850|129134|P2|NOT COMPLETED|Washout (2 Weeks)||0
54834|NCT01656850|129135|P1|NOT COMPLETED|Washout (2 Weeks)||0
54835|NCT01656850|129134|P2|COMPLETED|Washout (2 Weeks)||16
54836|NCT01656850|129135|P1|COMPLETED|Washout (2 Weeks)||17
54837|NCT01656850|129134|P2|STARTED|Washout (2 Weeks)||16
54838|NCT01656850|129135|P1|STARTED|Washout (2 Weeks)||17
54839|NCT01656850|129134|P2|NOT COMPLETED|First Intervention (3 Months)||4
54840|NCT01656850|129135|P1|NOT COMPLETED|First Intervention (3 Months)||3
54841|NCT01656850|129134|P2|COMPLETED|First Intervention (3 Months)||16
54842|NCT01656850|129135|P1|COMPLETED|First Intervention (3 Months)||17
54843|NCT01656850|129134|P2|STARTED|First Intervention (3 Months)||20
54844|NCT01656850|129135|P1|STARTED|First Intervention (3 Months)||20
54845|NCT01656772|129215|P2|NOT COMPLETED|Overall Study||0
54846|NCT01656772|129216|P1|NOT COMPLETED|Overall Study||0
54847|NCT01656772|129215|P2|COMPLETED|Overall Study||77
54848|NCT01656772|129216|P1|COMPLETED|Overall Study||43
54849|NCT01656772|129215|P2|STARTED|Overall Study||77
54850|NCT01656772|129216|P1|STARTED|Overall Study||43
54851|NCT01656759|129226|P2|NOT COMPLETED|Overall Study||3
54852|NCT01656759|129227|P1|NOT COMPLETED|Overall Study||2
54853|NCT01656759|129226|P2|COMPLETED|Overall Study||22
54854|NCT01656759|129227|P1|COMPLETED|Overall Study||25
54855|NCT01656759|129226|P2|STARTED|Overall Study||25
54856|NCT01656759|129227|P1|STARTED|Overall Study||27
54857|NCT01656486|129239|P1|NOT COMPLETED|Overall Study||0
54858|NCT01656486|129239|P1|COMPLETED|Overall Study||1
54859|NCT01656486|129239|P1|STARTED|Overall Study||1
54860|NCT01656460|129243|P4|NOT COMPLETED|Overall Study||0
54861|NCT01656460|129244|P3|NOT COMPLETED|Overall Study||0
54862|NCT01656460|129245|P2|NOT COMPLETED|Overall Study||0
54863|NCT01656460|129246|P1|NOT COMPLETED|Overall Study||0
54864|NCT01656460|129243|P4|COMPLETED|Overall Study||3
54865|NCT01656460|129244|P3|COMPLETED|Overall Study||3
54866|NCT01656460|129245|P2|COMPLETED|Overall Study||3
54867|NCT01656460|129246|P1|COMPLETED|Overall Study||3
54868|NCT01656460|129243|P4|STARTED|Overall Study||3
54869|NCT01656460|129244|P3|STARTED|Overall Study||3
54870|NCT01656460|129245|P2|STARTED|Overall Study||3
54871|NCT01656460|129246|P1|STARTED|Overall Study||3
54872|NCT01656434|129258|P2|NOT COMPLETED|Overall Study||580
54873|NCT01656434|129259|P1|NOT COMPLETED|Overall Study||2401
54874|NCT01656434|129258|P2|COMPLETED|Overall Study||40
54875|NCT01656434|129259|P1|COMPLETED|Overall Study||152
54876|NCT01656434|129258|P2|Treated|Overall Study||604
54877|NCT01656434|129259|P1|Treated|Overall Study|One treated participant had incomplete data and was not included in the Safety Analyses.|2466
54878|NCT01656434|129258|P2|STARTED|Overall Study||620
54879|NCT01656434|129259|P1|STARTED|Overall Study||2553
54880|NCT01656408|129285|P10|NOT COMPLETED|Overall Study||3
54881|NCT01656408|129286|P9|NOT COMPLETED|Overall Study||2
54882|NCT01656408|129287|P8|NOT COMPLETED|Overall Study||1
54883|NCT01656408|129288|P7|NOT COMPLETED|Overall Study||1
54884|NCT01656408|129289|P6|NOT COMPLETED|Overall Study||2
54885|NCT01656408|129290|P5|NOT COMPLETED|Overall Study||1
54886|NCT01656408|129291|P4|NOT COMPLETED|Overall Study||0
54887|NCT01656408|129292|P3|NOT COMPLETED|Overall Study||2
54888|NCT01656408|129293|P2|NOT COMPLETED|Overall Study||0
54889|NCT01656408|129294|P1|NOT COMPLETED|Overall Study||1
54890|NCT01656408|129285|P10|COMPLETED|Overall Study||15
54891|NCT01656408|129286|P9|COMPLETED|Overall Study||16
54892|NCT01656408|129287|P8|COMPLETED|Overall Study||7
54893|NCT01656408|129288|P7|COMPLETED|Overall Study||9
54894|NCT01656408|129289|P6|COMPLETED|Overall Study||7
54895|NCT01656408|129290|P5|COMPLETED|Overall Study||8
54896|NCT01656408|129291|P4|COMPLETED|Overall Study||7
54897|NCT01656408|129292|P3|COMPLETED|Overall Study||6
54898|NCT01656408|129293|P2|COMPLETED|Overall Study||8
54899|NCT01656408|129294|P1|COMPLETED|Overall Study||7
54900|NCT01656408|129285|P10|STARTED|Overall Study||18
54901|NCT01656408|129286|P9|STARTED|Overall Study||18
54902|NCT01656408|129287|P8|STARTED|Overall Study||8
54903|NCT01656408|129288|P7|STARTED|Overall Study||10
54904|NCT01656408|129289|P6|STARTED|Overall Study||9
54905|NCT01656408|129290|P5|STARTED|Overall Study||9
54906|NCT01656408|129291|P4|STARTED|Overall Study||7
54907|NCT01656408|129292|P3|STARTED|Overall Study||8
54908|NCT01656408|129293|P2|STARTED|Overall Study||8
54909|NCT01656408|129294|P1|STARTED|Overall Study||8
54910|NCT01656304|129483|P1|NOT COMPLETED|Overall Study||1
54911|NCT01656304|129483|P1|COMPLETED|Overall Study||15
54912|NCT01656304|129483|P1|STARTED|Overall Study||16
54913|NCT01656252|129489|P1|NOT COMPLETED|Phase II||0
54914|NCT01656252|129489|P1|COMPLETED|Phase II||0
54915|NCT01656252|129489|P1|STARTED|Phase II||0
54916|NCT01656252|129489|P1|NOT COMPLETED|Phase I||0
54917|NCT01656252|129489|P1|COMPLETED|Phase I||14
54918|NCT01656252|129489|P1|STARTED|Phase I||14
54919|NCT01656161|129521|P1|NOT COMPLETED|Overall Study||7
54920|NCT01656161|129521|P1|COMPLETED|Overall Study|Per protocol analysis set|113
54921|NCT01656161|129521|P1|Received Triptorelin at Day 169|Overall Study||115
54922|NCT01656161|129521|P1|Received Triptorelin at Day 1|Overall Study|Safety analysis set|120
54923|NCT01656161|129521|P1|STARTED|Overall Study|Intention to treat analysis set|120
54924|NCT01656031|129535|P1|NOT COMPLETED|Overall Study||0
54925|NCT01656031|129535|P1|COMPLETED|Overall Study||39
54926|NCT01656031|129535|P1|STARTED|Overall Study||39
54927|NCT01655498|129539|P1|NOT COMPLETED|Overall Study||5
54928|NCT01655498|129539|P1|COMPLETED|Overall Study||56
54929|NCT01655498|129539|P1|STARTED|Overall Study||61
54930|NCT01655381|129546|P1|NOT COMPLETED|Overall Study||3
54931|NCT01655381|129546|P1|COMPLETED|Overall Study||12
54932|NCT01655381|129546|P1|STARTED|Overall Study||15
54933|NCT01655329|129566|P1|NOT COMPLETED|Overall Study||0
54934|NCT01655329|129566|P1|COMPLETED|Overall Study||10
54935|NCT01655329|129566|P1|STARTED|Overall Study|The same 10 radiologists are interpreting images in both arms.|10
54936|NCT01655043|129582|P1|NOT COMPLETED|Overall Study||0
54937|NCT01655043|129582|P1|COMPLETED|Overall Study||20
54938|NCT01655043|129582|P1|STARTED|Overall Study||20
54939|NCT01654887|129588|P2|NOT COMPLETED|Overall Study||0
54940|NCT01654887|129589|P1|NOT COMPLETED|Overall Study||0
54941|NCT01654887|129588|P2|COMPLETED|Overall Study||88
54942|NCT01654887|129589|P1|COMPLETED|Overall Study||103
54943|NCT01654887|129588|P2|STARTED|Overall Study||88
54944|NCT01654887|129589|P1|STARTED|Overall Study||103
54945|NCT01654861|129605|P1|NOT COMPLETED|Overall Study||0
54946|NCT01654861|129605|P1|COMPLETED|Overall Study||3
54947|NCT01654861|129605|P1|STARTED|Overall Study||3
54948|NCT01654796|129613|P3|NOT COMPLETED|Overall Study||1
54949|NCT01654796|129614|P2|NOT COMPLETED|Overall Study||3
54950|NCT01654796|129615|P1|NOT COMPLETED|Overall Study||2
54951|NCT01654796|129613|P3|COMPLETED|Overall Study||28
54952|NCT01654796|129614|P2|COMPLETED|Overall Study||26
54953|NCT01654796|129615|P1|COMPLETED|Overall Study||25
54954|NCT01654796|129613|P3|STARTED|Overall Study||29
54955|NCT01654796|129614|P2|STARTED|Overall Study||29
54956|NCT01654796|129615|P1|STARTED|Overall Study||27
54957|NCT01654666|129627|P3|NOT COMPLETED|Overall Study||14
54958|NCT01654666|129628|P2|NOT COMPLETED|Overall Study||13
54959|NCT01654666|129629|P1|NOT COMPLETED|Overall Study||15
54960|NCT01654666|129627|P3|COMPLETED|Overall Study||49
54961|NCT01654666|129628|P2|COMPLETED|Overall Study||50
54962|NCT01654666|129629|P1|COMPLETED|Overall Study||48
54963|NCT01654666|129627|P3|Primary Analysis|Overall Study||54
54964|NCT01654666|129628|P2|Primary Analysis|Overall Study||56
54965|NCT01654666|129629|P1|Primary Analysis|Overall Study||52
54966|NCT01654666|129627|P3|STARTED|Overall Study||63
54967|NCT01654666|129628|P2|STARTED|Overall Study||63
54968|NCT01654666|129629|P1|STARTED|Overall Study||63
54969|NCT01654601|129654|P2|NOT COMPLETED|2nd Administration||1
54970|NCT01654601|129655|P1|NOT COMPLETED|2nd Administration||1
54971|NCT01654601|129654|P2|COMPLETED|2nd Administration||11
54972|NCT01654601|129655|P1|COMPLETED|2nd Administration||11
54973|NCT01654601|129654|P2|STARTED|2nd Administration||12
54974|NCT01654601|129655|P1|STARTED|2nd Administration||12
54975|NCT01654601|129654|P2|NOT COMPLETED|1st Administration||2
54976|NCT01654601|129655|P1|NOT COMPLETED|1st Administration||2
54977|NCT01654601|129654|P2|COMPLETED|1st Administration||12
54978|NCT01654601|129655|P1|COMPLETED|1st Administration||12
54979|NCT01654601|129654|P2|STARTED|1st Administration||14
54980|NCT01654601|129655|P1|STARTED|1st Administration||14
54981|NCT01654549|129669|P2|NOT COMPLETED|Overall Study||1
54982|NCT01654549|129670|P1|NOT COMPLETED|Overall Study||0
54983|NCT01654549|129669|P2|COMPLETED|Overall Study||19
54984|NCT01654549|129670|P1|COMPLETED|Overall Study||20
54985|NCT01654549|129669|P2|STARTED|Overall Study||20
54986|NCT01654549|129670|P1|STARTED|Overall Study||20
54987|NCT01654536|129682|P2|NOT COMPLETED|Overall Study||38
54988|NCT01654536|129683|P1|NOT COMPLETED|Overall Study||44
54989|NCT01654536|129682|P2|COMPLETED|Overall Study||331
54990|NCT01654536|129683|P1|COMPLETED|Overall Study||324
54991|NCT01654536|129682|P2|STARTED|Overall Study||369
54992|NCT01654536|129683|P1|STARTED|Overall Study||368
54993|NCT01654523|129719|P1|NOT COMPLETED|Overall Study||1
54994|NCT01654523|129719|P1|COMPLETED|Overall Study||19
54995|NCT01654523|129719|P1|STARTED|Overall Study||20
54996|NCT01654302|129725|P2|NOT COMPLETED|Second Intervention (Day 7)||1
54997|NCT01654302|129726|P1|NOT COMPLETED|Second Intervention (Day 7)||1
54998|NCT01654302|129725|P2|COMPLETED|Second Intervention (Day 7)||19
54999|NCT01654302|129726|P1|COMPLETED|Second Intervention (Day 7)||19
55000|NCT01654302|129725|P2|STARTED|Second Intervention (Day 7)||20
55001|NCT01654302|129726|P1|STARTED|Second Intervention (Day 7)||20
55002|NCT01654302|129725|P2|NOT COMPLETED|First Intervention (Day 1)||0
55003|NCT01654302|129726|P1|NOT COMPLETED|First Intervention (Day 1)||0
55004|NCT01654302|129725|P2|COMPLETED|First Intervention (Day 1)||20
55005|NCT01654302|129726|P1|COMPLETED|First Intervention (Day 1)||20
55006|NCT01654302|129725|P2|STARTED|First Intervention (Day 1)||20
55007|NCT01654302|129726|P1|STARTED|First Intervention (Day 1)||20
55008|NCT01654276|129732|P1|NOT COMPLETED|Overall Study||6
55009|NCT01654276|129732|P1|COMPLETED|Overall Study||18
55010|NCT01654276|129732|P1|Visit 4 (6months)|Overall Study||18
55011|NCT01654276|129732|P1|Visit 3 (4 Months)|Overall Study||18
55012|NCT01654276|129732|P1|Visit 2 (2 Months)|Overall Study||19
55013|NCT01654276|129732|P1|STARTED|Overall Study||24
55014|NCT01654263|129756|P6|NOT COMPLETED|Overall Study||1
55015|NCT01654263|129757|P5|NOT COMPLETED|Overall Study||1
55016|NCT01654263|129758|P4|NOT COMPLETED|Overall Study||1
55017|NCT01654263|129759|P3|NOT COMPLETED|Overall Study||2
55018|NCT01654263|129760|P2|NOT COMPLETED|Overall Study||0
55019|NCT01654263|129761|P1|NOT COMPLETED|Overall Study||0
55020|NCT01654263|129756|P6|COMPLETED|Overall Study||148
55021|NCT01654263|129757|P5|COMPLETED|Overall Study||139
55022|NCT01654263|129758|P4|COMPLETED|Overall Study||144
55023|NCT01654263|129759|P3|COMPLETED|Overall Study||137
55024|NCT01654263|129760|P2|COMPLETED|Overall Study||147
55025|NCT01654263|129761|P1|COMPLETED|Overall Study||164
55026|NCT01654263|129756|P6|STARTED|Overall Study||149
55027|NCT01654263|129757|P5|STARTED|Overall Study||140
55028|NCT01654263|129758|P4|STARTED|Overall Study||145
55029|NCT01654263|129759|P3|STARTED|Overall Study||139
55030|NCT01654263|129760|P2|STARTED|Overall Study||147
55031|NCT01654263|129761|P1|STARTED|Overall Study||164
55032|NCT01654250|129786|P2|NOT COMPLETED|Overall Study||0
55033|NCT01654250|129787|P1|NOT COMPLETED|Overall Study||1
55034|NCT01654250|129786|P2|COMPLETED|Overall Study||42
55035|NCT01654250|129787|P1|COMPLETED|Overall Study||43
55036|NCT01654250|129786|P2|STARTED|Overall Study||42
55037|NCT01654250|129787|P1|STARTED|Overall Study||44
55038|NCT01654224|129804|P2|NOT COMPLETED|Overall Study||12
55039|NCT01654224|129805|P1|NOT COMPLETED|Overall Study||6
55040|NCT01654224|129804|P2|COMPLETED|Overall Study||98
55041|NCT01654224|129805|P1|COMPLETED|Overall Study||89
55042|NCT01654224|129804|P2|STARTED|Overall Study||110
55043|NCT01654224|129805|P1|STARTED|Overall Study||95
55044|NCT01654107|129817|P2|NOT COMPLETED|Overall Study||8
55045|NCT01654107|129818|P1|NOT COMPLETED|Overall Study||3
55046|NCT01654107|129817|P2|COMPLETED|Overall Study||22
55047|NCT01654107|129818|P1|COMPLETED|Overall Study||25
55048|NCT01654107|129817|P2|STARTED|Overall Study||30
55049|NCT01654107|129818|P1|STARTED|Overall Study||28
55050|NCT01653782|129827|P3|NOT COMPLETED|Overall Study||6
55051|NCT01653782|129828|P2|NOT COMPLETED|Overall Study||18
55052|NCT01653782|129829|P1|NOT COMPLETED|Overall Study||16
55053|NCT01653782|129827|P3|COMPLETED|Overall Study||46
55054|NCT01653782|129828|P2|COMPLETED|Overall Study||37
55055|NCT01653782|129829|P1|COMPLETED|Overall Study||36
55056|NCT01653782|129827|P3|STARTED|Overall Study||52
55057|NCT01653782|129828|P2|STARTED|Overall Study||55
55058|NCT01653782|129829|P1|STARTED|Overall Study||52
55059|NCT01653743|129839|P2|NOT COMPLETED|Overall Study||0
55060|NCT01653743|129840|P1|NOT COMPLETED|Overall Study||4
55061|NCT01653743|129839|P2|COMPLETED|Overall Study||27
55062|NCT01653743|129840|P1|COMPLETED|Overall Study||50
55063|NCT01653743|129839|P2|STARTED|Overall Study||27
55064|NCT01653743|129840|P1|STARTED|Overall Study||54
55065|NCT01653509|129856|P2|NOT COMPLETED|Overall Study||0
55066|NCT01653509|129857|P1|NOT COMPLETED|Overall Study||0
55067|NCT01653509|129856|P2|COMPLETED|Overall Study||13
55068|NCT01653509|129857|P1|COMPLETED|Overall Study||12
55069|NCT01653509|129856|P2|STARTED|Overall Study||13
55070|NCT01653509|129857|P1|STARTED|Overall Study||12
55071|NCT01653418|129875|P1|NOT COMPLETED|Overall Study||0
55072|NCT01653418|129875|P1|COMPLETED|Overall Study||10
55073|NCT01653418|129875|P1|STARTED|Overall Study||10
55074|NCT01653262|129887|P1|NOT COMPLETED|Overall Study||3
55075|NCT01653262|129887|P1|COMPLETED|Overall Study||26
55076|NCT01653262|129887|P1|STARTED|Overall Study||29
55077|NCT01653158|129900|P8|NOT COMPLETED|Overall Study||15
55078|NCT01653158|129901|P7|NOT COMPLETED|Overall Study||2
55079|NCT01653158|129902|P6|NOT COMPLETED|Overall Study||1
55080|NCT01653158|129903|P5|NOT COMPLETED|Overall Study||1
55081|NCT01653158|129904|P4|NOT COMPLETED|Overall Study||2
55082|NCT01653158|129905|P3|NOT COMPLETED|Overall Study||0
55083|NCT01653158|129906|P2|NOT COMPLETED|Overall Study||0
55084|NCT01653158|129907|P1|NOT COMPLETED|Overall Study||1
55085|NCT01653158|129900|P8|COMPLETED|Overall Study||4
55086|NCT01653158|129901|P7|COMPLETED|Overall Study||7
55087|NCT01653158|129902|P6|COMPLETED|Overall Study||2
55088|NCT01653158|129903|P5|COMPLETED|Overall Study||2
55089|NCT01653158|129904|P4|COMPLETED|Overall Study||1
55090|NCT01653158|129905|P3|COMPLETED|Overall Study||3
55091|NCT01653158|129906|P2|COMPLETED|Overall Study||3
55092|NCT01653158|129907|P1|COMPLETED|Overall Study||2
55093|NCT01653158|129900|P8|STARTED|Overall Study|Six (6) and 13 participants were enrolled in dose escalation and expansion cohorts, respectively.|19
55094|NCT01653158|129901|P7|STARTED|Overall Study||9
55095|NCT01653158|129902|P6|STARTED|Overall Study||3
55096|NCT01653158|129903|P5|STARTED|Overall Study||3
55097|NCT01653158|129904|P4|STARTED|Overall Study||3
55098|NCT01653158|129905|P3|STARTED|Overall Study||3
55099|NCT01653158|129906|P2|STARTED|Overall Study||3
55100|NCT01653158|129907|P1|STARTED|Overall Study||3
55101|NCT01653132|130179|P2|NOT COMPLETED|Second Intervention||0
55102|NCT01653132|130180|P1|NOT COMPLETED|Second Intervention||0
55103|NCT01653132|130179|P2|COMPLETED|Second Intervention||5
55104|NCT01653132|130180|P1|COMPLETED|Second Intervention||4
55105|NCT01653132|130179|P2|STARTED|Second Intervention||5
55106|NCT01653132|130180|P1|STARTED|Second Intervention||4
55107|NCT01653132|130179|P2|NOT COMPLETED|Washout 1-2 Months||0
55108|NCT01653132|130180|P1|NOT COMPLETED|Washout 1-2 Months||0
55109|NCT01653132|130179|P2|COMPLETED|Washout 1-2 Months||5
55110|NCT01653132|130180|P1|COMPLETED|Washout 1-2 Months||4
55111|NCT01653132|130179|P2|STARTED|Washout 1-2 Months||5
55112|NCT01653132|130180|P1|STARTED|Washout 1-2 Months||4
55113|NCT01653132|130179|P2|NOT COMPLETED|First Intervention||0
55114|NCT01653132|130180|P1|NOT COMPLETED|First Intervention||1
55115|NCT01653132|130179|P2|COMPLETED|First Intervention||5
55116|NCT01653132|130180|P1|COMPLETED|First Intervention|one dropped out: wanted to start anticholinergic drug for tremor that could affect saliva volume|4
55117|NCT01653132|130179|P2|STARTED|First Intervention||5
55118|NCT01653132|130180|P1|STARTED|First Intervention||5
55119|NCT01653028|130199|P5|NOT COMPLETED|Overall Study||0
55120|NCT01653028|130200|P4|NOT COMPLETED|Overall Study||0
55121|NCT01653028|130201|P3|NOT COMPLETED|Overall Study||0
55122|NCT01653028|130202|P2|NOT COMPLETED|Overall Study||0
55123|NCT01653028|130203|P1|NOT COMPLETED|Overall Study||0
55124|NCT01653028|130199|P5|COMPLETED|Overall Study||29
55125|NCT01653028|130200|P4|COMPLETED|Overall Study||10
55126|NCT01653028|130201|P3|COMPLETED|Overall Study||11
55127|NCT01653028|130202|P2|COMPLETED|Overall Study||10
55128|NCT01653028|130203|P1|COMPLETED|Overall Study||12
55129|NCT01653028|130199|P5|STARTED|Overall Study||29
55130|NCT01653028|130200|P4|STARTED|Overall Study||10
55131|NCT01653028|130201|P3|STARTED|Overall Study||11
55132|NCT01653028|130202|P2|STARTED|Overall Study||10
55133|NCT01653028|130203|P1|STARTED|Overall Study||12
55134|NCT01652885|130230|P1|NOT COMPLETED|Overall Study||1
55135|NCT01652885|130230|P1|COMPLETED|Overall Study||22
55136|NCT01652885|130230|P1|STARTED|Overall Study||23
55137|NCT01652729|130258|P3|NOT COMPLETED|Overall Study||14
55138|NCT01652729|130259|P2|NOT COMPLETED|Overall Study||13
55139|NCT01652729|130260|P1|NOT COMPLETED|Overall Study||27
55140|NCT01652729|130258|P3|COMPLETED|Overall Study||47
55141|NCT01652729|130259|P2|COMPLETED|Overall Study||109
55142|NCT01652729|130260|P1|COMPLETED|Overall Study|The double-enrolled subject’s reasons for withdrawal were LTFU and PV. Only PV is shown below.|155
55143|NCT01652729|130258|P3|Meal Test Evaluable|Overall Study||15
55144|NCT01652729|130259|P2|Meal Test Evaluable|Overall Study||31
55145|NCT01652729|130260|P1|Meal Test Evaluable|Overall Study|ITT subjects who ate >=75% of meal and did not miss 2-hour postprandial glucose measures at V3 and 8|44
55146|NCT01652729|130258|P3|Meal Test Subjects|Overall Study||20
55147|NCT01652729|130259|P2|Meal Test Subjects|Overall Study||41
55148|NCT01652729|130260|P1|Meal Test Subjects|Overall Study||60
55149|NCT01652729|130258|P3|Evaluable|Overall Study||43
55150|NCT01652729|130259|P2|Evaluable|Overall Study||91
55151|NCT01652729|130260|P1|Evaluable|Overall Study|Subjects who completed study procedures to Week 24 or beyond and had adequate study drug exposure|143
55152|NCT01652729|130258|P3|Treated|Overall Study||61
55153|NCT01652729|130259|P2|Treated|Overall Study||122
55154|NCT01652729|130260|P1|Treated|Overall Study|All subjects who received at least one dose of study medication even if not randomized.|181
55155|NCT01652729|130258|P3|Modified Intent-to-Treat|Overall Study||61
55156|NCT01652729|130259|P2|Modified Intent-to-Treat|Overall Study||122
55157|NCT01652729|130260|P1|Modified Intent-to-Treat|Overall Study|All randomized subjects who received at least one dose of study drug.|181
55158|NCT01652729|130258|P3|STARTED|Overall Study||61
55159|NCT01652729|130259|P2|STARTED|Overall Study||122
55160|NCT01652729|130260|P1|STARTED|Overall Study|One subject was enrolled twice at different sites. He was randomized to exenatide at both sites.|182
55161|NCT01652716|130282|P2|NOT COMPLETED|Overall Study||46
55162|NCT01652716|130283|P1|NOT COMPLETED|Overall Study||56
55163|NCT01652716|130282|P2|COMPLETED|Overall Study|* completed study|102
55164|NCT01652716|130283|P1|COMPLETED|Overall Study|* completed study|173
55165|NCT01652716|130282|P2|Completed 28-week|Overall Study||118
55166|NCT01652716|130283|P1|Completed 28-week|Overall Study||197
55167|NCT01652716|130282|P2|STARTED|Overall Study|Two subjects in the exenatide BID group withdrew from the study before receiving study drug.|148
55168|NCT01652716|130283|P1|STARTED|Overall Study||229
55169|NCT01652703|130303|P6|NOT COMPLETED|Overall Study||2
55170|NCT01652703|130304|P5|NOT COMPLETED|Overall Study||1
55171|NCT01652703|130305|P4|NOT COMPLETED|Overall Study||2
55172|NCT01652703|130306|P3|NOT COMPLETED|Overall Study||3
55173|NCT01652703|130307|P2|NOT COMPLETED|Overall Study||1
55174|NCT01652703|130308|P1|NOT COMPLETED|Overall Study||0
55175|NCT01652703|130303|P6|COMPLETED|Overall Study||51
55176|NCT01652703|130304|P5|COMPLETED|Overall Study||51
55177|NCT01652703|130305|P4|COMPLETED|Overall Study||50
55178|NCT01652703|130306|P3|COMPLETED|Overall Study||47
55179|NCT01652703|130307|P2|COMPLETED|Overall Study||50
55180|NCT01652703|130308|P1|COMPLETED|Overall Study||52
55181|NCT01652703|130303|P6|Received Treatment|Overall Study||53
55182|NCT01652703|130304|P5|Received Treatment|Overall Study||51
55183|NCT01652703|130305|P4|Received Treatment|Overall Study||52
55184|NCT01652703|130306|P3|Received Treatment|Overall Study||49
55185|NCT01652703|130307|P2|Received Treatment|Overall Study||50
55186|NCT01652703|130308|P1|Received Treatment|Overall Study||52
55187|NCT01652703|130303|P6|STARTED|Overall Study||53
55188|NCT01652703|130304|P5|STARTED|Overall Study||52
55189|NCT01652703|130305|P4|STARTED|Overall Study||52
55190|NCT01652703|130306|P3|STARTED|Overall Study||50
55191|NCT01652703|130307|P2|STARTED|Overall Study||51
55192|NCT01652703|130308|P1|STARTED|Overall Study||52
55193|NCT01652690|130366|P2|NOT COMPLETED|Overall Study||21
55194|NCT01652690|130367|P1|NOT COMPLETED|Overall Study||35
55195|NCT01652690|130366|P2|COMPLETED|Overall Study||279
55196|NCT01652690|130367|P1|COMPLETED|Overall Study||265
55197|NCT01652690|130366|P2|STARTED|Overall Study||300
55198|NCT01652690|130367|P1|STARTED|Overall Study||300
55199|NCT01652664|130401|P2|NOT COMPLETED|Overall Study||1
55200|NCT01652664|130402|P1|NOT COMPLETED|Overall Study||6
55201|NCT01652664|130401|P2|COMPLETED|Overall Study||74
55202|NCT01652664|130402|P1|COMPLETED|Overall Study||71
55203|NCT01652664|130401|P2|STARTED|Overall Study||75
55204|NCT01652664|130402|P1|STARTED|Overall Study||77
55205|NCT01652573|130411|P2|NOT COMPLETED|Overall Study||1
55206|NCT01652573|130412|P1|NOT COMPLETED|Overall Study||0
55207|NCT01652573|130411|P2|COMPLETED|Overall Study||10
55208|NCT01652573|130412|P1|COMPLETED|Overall Study||10
55209|NCT01652573|130411|P2|STARTED|Overall Study||11
55210|NCT01652573|130412|P1|STARTED|Overall Study||10
55211|NCT01652495|130454|P2|NOT COMPLETED|Overall Study||2
55212|NCT01652495|130455|P1|NOT COMPLETED|Overall Study||2
55213|NCT01652495|130454|P2|COMPLETED|Overall Study||20
55214|NCT01652495|130455|P1|COMPLETED|Overall Study||20
55215|NCT01652495|130454|P2|STARTED|Overall Study||22
55216|NCT01652495|130455|P1|STARTED|Overall Study||22
55217|NCT01652287|130467|P2|NOT COMPLETED|Overall Study||0
55218|NCT01652287|130468|P1|NOT COMPLETED|Overall Study||2
55219|NCT01652287|130467|P2|COMPLETED|Overall Study||31
55220|NCT01652287|130468|P1|COMPLETED|Overall Study|• Did not receive allocated intervention (withdrew consent) (n=2)|29
55221|NCT01652287|130467|P2|STARTED|Overall Study||31
55222|NCT01652287|130468|P1|STARTED|Overall Study||31
55223|NCT01652001|130476|P2|NOT COMPLETED|Overall Study||6
55224|NCT01652001|130477|P1|NOT COMPLETED|Overall Study||9
55225|NCT01652001|130476|P2|COMPLETED|Overall Study||79
55226|NCT01652001|130477|P1|COMPLETED|Overall Study||91
55227|NCT01652001|130476|P2|STARTED|Overall Study||85
55228|NCT01652001|130477|P1|STARTED|Overall Study||100
55229|NCT01651949|130488|P3|NOT COMPLETED|Overall Study||31
55230|NCT01651949|130489|P2|NOT COMPLETED|Overall Study||86
55231|NCT01651949|130490|P1|NOT COMPLETED|Overall Study||53
55232|NCT01651949|130488|P3|COMPLETED|Overall Study||282
55233|NCT01651949|130489|P2|COMPLETED|Overall Study||1015
55234|NCT01651949|130490|P1|COMPLETED|Overall Study||1053
55235|NCT01651949|130488|P3|Vaccination 3|Overall Study||291
55236|NCT01651949|130489|P2|Vaccination 3|Overall Study||1037
55237|NCT01651949|130490|P1|Vaccination 3|Overall Study||1067
55238|NCT01651949|130488|P3|Vaccination 2|Overall Study||298
55239|NCT01651949|130489|P2|Vaccination 2|Overall Study||1069
55240|NCT01651949|130490|P1|Vaccination 2|Overall Study||1089
55241|NCT01651949|130488|P3|Vaccination 1|Overall Study||313
55242|NCT01651949|130489|P2|Vaccination 1|Overall Study||1099
55243|NCT01651949|130490|P1|Vaccination 1|Overall Study||1103
55244|NCT01651949|130488|P3|STARTED|Overall Study||313
55245|NCT01651949|130489|P2|STARTED|Overall Study||1101
55246|NCT01651949|130490|P1|STARTED|Overall Study||1106
55247|NCT01651936|130510|P3|NOT COMPLETED|Extension Study||14
55248|NCT01651936|130511|P2|NOT COMPLETED|Extension Study||0
55249|NCT01651936|130512|P1|NOT COMPLETED|Extension Study||0
55250|NCT01651936|130510|P3|COMPLETED|Extension Study||0
55251|NCT01651936|130511|P2|COMPLETED|Extension Study||0
55252|NCT01651936|130512|P1|COMPLETED|Extension Study||0
55253|NCT01651936|130510|P3|STARTED|Extension Study|Includes completers and early escapees from the Base Study|14
55254|NCT01651936|130511|P2|STARTED|Extension Study||0
55255|NCT01651936|130512|P1|STARTED|Extension Study||0
55256|NCT01651936|130510|P3|NOT COMPLETED|Base Study||0
55257|NCT01651936|130511|P2|NOT COMPLETED|Base Study||25
55258|NCT01651936|130512|P1|NOT COMPLETED|Base Study||27
55259|NCT01651936|130510|P3|COMPLETED|Base Study||0
55260|NCT01651936|130511|P2|COMPLETED|Base Study||1
55261|NCT01651936|130512|P1|COMPLETED|Base Study||3
55262|NCT01651936|130510|P3|STARTED|Base Study||0
55263|NCT01651936|130511|P2|STARTED|Base Study||26
55264|NCT01651936|130512|P1|STARTED|Base Study||30
55265|NCT01651780|130535|P2|NOT COMPLETED|Overall Study||10
55266|NCT01651780|130536|P1|NOT COMPLETED|Overall Study||11
55267|NCT01651780|130535|P2|COMPLETED|Overall Study||388
55268|NCT01651780|130536|P1|COMPLETED|Overall Study||394
55269|NCT01651780|130535|P2|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|0
55270|NCT01651780|130536|P1|BRAVO 2 Feasibility Cohort|Overall Study|1st 2 participants/site made up the bivalirudin feasibility cohort (BRAVO2) and analyzed separately.|65
55271|NCT01651780|130535|P2|Received at Least 1 Dose of Study Drug|Overall Study||394
55272|NCT01651780|130536|P1|Received at Least 1 Dose of Study Drug|Overall Study|All but 1 participant in the bivalirudin group (withdrew consent) comprised the ITT population.|393
55273|NCT01651780|130535|P2|Intent-To-Treat (ITT) Population|Overall Study||398
55274|NCT01651780|130536|P1|Intent-To-Treat (ITT) Population|Overall Study||404
55275|NCT01651780|130535|P2|STARTED|Overall Study||398
55276|NCT01651780|130536|P1|STARTED|Overall Study||405
55277|NCT01651351|130568|P2|NOT COMPLETED|Overall Study||0
55278|NCT01651351|130569|P1|NOT COMPLETED|Overall Study||0
55279|NCT01651351|130568|P2|COMPLETED|Overall Study||15
55280|NCT01651351|130569|P1|COMPLETED|Overall Study||15
55281|NCT01651351|130568|P2|STARTED|Overall Study||15
55282|NCT01651351|130569|P1|STARTED|Overall Study||15
55283|NCT01651260|130586|P1|NOT COMPLETED|Overall Study||3
55284|NCT01651260|130586|P1|COMPLETED|Overall Study||62
55285|NCT01651260|130586|P1|STARTED|Overall Study||65
55286|NCT01651208|130593|P2|NOT COMPLETED|Overall Study||16
55287|NCT01651208|130594|P1|NOT COMPLETED|Overall Study||14
55288|NCT01651208|130593|P2|COMPLETED|Overall Study|16 subjects had no pharmacy claims data to analyze primary outcome|209
55289|NCT01651208|130594|P1|COMPLETED|Overall Study|14 patients had no pharmacy claims data to analyze primary outcome|213
55290|NCT01651208|130593|P2|STARTED|Overall Study||225
55291|NCT01651208|130594|P1|STARTED|Overall Study||227
55292|NCT01651104|130602|P1|NOT COMPLETED|Overall Study||0
55293|NCT01651104|130602|P1|COMPLETED|Overall Study||63
55294|NCT01651104|130602|P1|STARTED|Overall Study||63
55295|NCT01651000|130611|P2|NOT COMPLETED|Overall Study||28
55296|NCT01651000|130612|P1|NOT COMPLETED|Overall Study||10
55297|NCT01651000|130611|P2|COMPLETED|Overall Study||113
55298|NCT01651000|130612|P1|COMPLETED|Overall Study||62
55299|NCT01651000|130611|P2|Entered Extension Study|Overall Study||93
55300|NCT01651000|130612|P1|Entered Extension Study|Overall Study||50
55301|NCT01651000|130611|P2|STARTED|Overall Study||141
55302|NCT01651000|130612|P1|STARTED|Overall Study||72
55303|NCT01650831|130624|P1|NOT COMPLETED|Overall Study||1
55304|NCT01650831|130624|P1|COMPLETED|Overall Study||112
55305|NCT01650831|130624|P1|STARTED|Overall Study||113
55306|NCT01650805|130634|P2|NOT COMPLETED|Overall Study||0
55307|NCT01650805|130635|P1|NOT COMPLETED|Overall Study||1
55308|NCT01650805|130634|P2|COMPLETED|Overall Study||152
55309|NCT01650805|130635|P1|COMPLETED|Overall Study|Completed means patient initiated and discontinued study treatment.|154
55310|NCT01650805|130634|P2|STARTED|Overall Study||152
55311|NCT01650805|130635|P1|STARTED|Overall Study|Started means patient has been randomized.|155
55312|NCT01650779|130645|P1|NOT COMPLETED|Overall Study||1
55313|NCT01650779|130645|P1|COMPLETED|Overall Study||14
55314|NCT01650779|130645|P1|STARTED|Overall Study||15
55315|NCT01650519|130654|P2|NOT COMPLETED|Overall Study||0
55316|NCT01650519|130655|P1|NOT COMPLETED|Overall Study||1
55317|NCT01650519|130654|P2|COMPLETED|Overall Study||31
55318|NCT01650519|130655|P1|COMPLETED|Overall Study||19
55319|NCT01650519|130654|P2|STARTED|Overall Study||31
55320|NCT01650519|130655|P1|STARTED|Overall Study||20
55321|NCT01650350|130673|P1|NOT COMPLETED|Overall Study||0
55322|NCT01650350|130673|P1|COMPLETED|Overall Study||7
55323|NCT01650350|130673|P1|STARTED|Overall Study||7
55324|NCT01650324|130682|P5|NOT COMPLETED|Overall Study||0
55325|NCT01650324|130683|P4|NOT COMPLETED|Overall Study||0
55326|NCT01650324|130684|P3|NOT COMPLETED|Overall Study||0
55327|NCT01650324|130685|P2|NOT COMPLETED|Overall Study||0
55328|NCT01650324|130686|P1|NOT COMPLETED|Overall Study||0
55329|NCT01650324|130682|P5|COMPLETED|Overall Study||6
55330|NCT01650324|130683|P4|COMPLETED|Overall Study||6
55331|NCT01650324|130684|P3|COMPLETED|Overall Study||6
55332|NCT01650324|130685|P2|COMPLETED|Overall Study||6
55333|NCT01650324|130686|P1|COMPLETED|Overall Study||8
55334|NCT01650324|130682|P5|STARTED|Overall Study||6
55335|NCT01650324|130683|P4|STARTED|Overall Study||6
55336|NCT01650324|130684|P3|STARTED|Overall Study||6
55337|NCT01650324|130685|P2|STARTED|Overall Study||6
55338|NCT01650324|130686|P1|STARTED|Overall Study||8
55339|NCT01650285|130715|P1|NOT COMPLETED|Overall Study||1
55340|NCT01650285|130715|P1|COMPLETED|Overall Study||4
55341|NCT01650285|130715|P1|STARTED|Overall Study||5
55342|NCT01650246|130719|P1|NOT COMPLETED|Overall Study||143
55343|NCT01650246|130719|P1|COMPLETED|Overall Study||0
55344|NCT01650246|130719|P1|STARTED|Overall Study||143
55345|NCT01649856|130726|P2|NOT COMPLETED|Overall Study||203
55346|NCT01649856|130727|P1|NOT COMPLETED|Overall Study||369
55347|NCT01649856|130726|P2|COMPLETED|Overall Study||0
55348|NCT01649856|130727|P1|COMPLETED|Overall Study||0
55349|NCT01649856|130726|P2|STARTED|Overall Study||203
55350|NCT01649856|130727|P1|STARTED|Overall Study||369
55351|NCT01649804|130759|P1|NOT COMPLETED|Overall Study||8
55352|NCT01649804|130759|P1|COMPLETED|Overall Study||4
55353|NCT01649804|130759|P1|STARTED|Overall Study||12
55354|NCT01649791|130771|P1|NOT COMPLETED|Overall Study||3
55355|NCT01649791|130771|P1|COMPLETED|Overall Study||5
55356|NCT01649791|130771|P1|STARTED|Overall Study||8
55357|NCT01649557|130781|P3|NOT COMPLETED|Overall Study||9
55358|NCT01649557|130782|P2|NOT COMPLETED|Overall Study||14
55359|NCT01649557|130783|P1|NOT COMPLETED|Overall Study||44
55360|NCT01649557|130781|P3|COMPLETED|Overall Study||15
55361|NCT01649557|130782|P2|COMPLETED|Overall Study||27
55362|NCT01649557|130783|P1|COMPLETED|Overall Study||135
55363|NCT01649557|130781|P3|52-week Enrollers|Overall Study||2
55364|NCT01649557|130782|P2|52-week Enrollers|Overall Study||6
55365|NCT01649557|130783|P1|52-week Enrollers|Overall Study||20
55366|NCT01649557|130781|P3|6-week Enrollers|Overall Study||22
55367|NCT01649557|130782|P2|6-week Enrollers|Overall Study||35
55368|NCT01649557|130783|P1|6-week Enrollers|Overall Study||159
55369|NCT01649557|130781|P3|STARTED|Overall Study||24
55370|NCT01649557|130782|P2|STARTED|Overall Study||41
55371|NCT01649557|130783|P1|STARTED|Overall Study||179
55372|NCT01649505|130820|P2|NOT COMPLETED|Overall Study||1
55373|NCT01649505|130821|P1|NOT COMPLETED|Overall Study||1
55374|NCT01649505|130820|P2|COMPLETED|Overall Study||0
55375|NCT01649505|130821|P1|COMPLETED|Overall Study||0
55376|NCT01649505|130820|P2|STARTED|Overall Study||1
55377|NCT01649505|130821|P1|STARTED|Overall Study||1
55378|NCT01649362|130829|P2|NOT COMPLETED|Overall Study||14
55379|NCT01649362|130830|P1|NOT COMPLETED|Overall Study||1
55380|NCT01649362|130829|P2|COMPLETED|Overall Study||40
55381|NCT01649362|130830|P1|COMPLETED|Overall Study||46
55382|NCT01649362|130829|P2|STARTED|Overall Study||54
55383|NCT01649362|130830|P1|STARTED|Overall Study||47
55384|NCT01649297|130845|P5|NOT COMPLETED|Overall Study||4
55385|NCT01649297|130846|P4|NOT COMPLETED|Overall Study||19
55386|NCT01649297|130847|P3|NOT COMPLETED|Overall Study||17
55387|NCT01649297|130848|P2|NOT COMPLETED|Overall Study||13
55388|NCT01649297|130849|P1|NOT COMPLETED|Overall Study||14
55389|NCT01649297|130845|P5|COMPLETED|Overall Study||103
55390|NCT01649297|130846|P4|COMPLETED|Overall Study||201
55391|NCT01649297|130847|P3|COMPLETED|Overall Study||202
55392|NCT01649297|130848|P2|COMPLETED|Overall Study||205
55393|NCT01649297|130849|P1|COMPLETED|Overall Study||205
55394|NCT01649297|130845|P5|STARTED|Overall Study|randomised|107
55395|NCT01649297|130846|P4|STARTED|Overall Study|randomised|220
55396|NCT01649297|130847|P3|STARTED|Overall Study|randomised|219
55397|NCT01649297|130848|P2|STARTED|Overall Study|randomised|218
55398|NCT01649297|130849|P1|STARTED|Overall Study|randomised|219
55399|NCT01649232|130868|P2|NOT COMPLETED|Overall Study||0
55400|NCT01649232|130869|P1|NOT COMPLETED|Overall Study||2
55401|NCT01649232|130868|P2|COMPLETED|Overall Study||30
55402|NCT01649232|130869|P1|COMPLETED|Overall Study|technical problems or excessive artifacts, two data sets were excluded from further analysis.|28
55403|NCT01649232|130868|P2|STARTED|Overall Study||30
55404|NCT01649232|130869|P1|STARTED|Overall Study||30
55405|NCT01649180|130889|P1|NOT COMPLETED|Overall Study||0
55406|NCT01649180|130889|P1|COMPLETED|Overall Study||3
55407|NCT01649180|130889|P1|STARTED|Overall Study||3
55408|NCT01648920|130897|P1|NOT COMPLETED|Overall Study||0
55409|NCT01648920|130897|P1|COMPLETED|Overall Study||50
55410|NCT01648920|130897|P1|STARTED|Overall Study||50
55411|NCT01648790|130921|P5|NOT COMPLETED|Treatment 5||0
55412|NCT01648790|130922|P4|NOT COMPLETED|Treatment 5||0
55413|NCT01648790|130923|P3|NOT COMPLETED|Treatment 5||0
55414|NCT01648790|130924|P2|NOT COMPLETED|Treatment 5||0
55415|NCT01648790|130925|P1|NOT COMPLETED|Treatment 5||0
55416|NCT01648790|130921|P5|COMPLETED|Treatment 5||4
55417|NCT01648790|130922|P4|COMPLETED|Treatment 5||3
55418|NCT01648790|130923|P3|COMPLETED|Treatment 5||4
55419|NCT01648790|130924|P2|COMPLETED|Treatment 5||4
55420|NCT01648790|130925|P1|COMPLETED|Treatment 5||4
55421|NCT01648790|130921|P5|STARTED|Treatment 5||4
55422|NCT01648790|130922|P4|STARTED|Treatment 5||3
55423|NCT01648790|130923|P3|STARTED|Treatment 5||4
55424|NCT01648790|130924|P2|STARTED|Treatment 5||4
55425|NCT01648790|130925|P1|STARTED|Treatment 5||4
55426|NCT01648790|130921|P5|NOT COMPLETED|Treatment 4||0
55427|NCT01648790|130922|P4|NOT COMPLETED|Treatment 4||0
55428|NCT01648790|130923|P3|NOT COMPLETED|Treatment 4||0
55429|NCT01648790|130924|P2|NOT COMPLETED|Treatment 4||0
55430|NCT01648790|130925|P1|NOT COMPLETED|Treatment 4||0
55431|NCT01648790|130921|P5|COMPLETED|Treatment 4||4
55432|NCT01648790|130922|P4|COMPLETED|Treatment 4||3
55433|NCT01648790|130923|P3|COMPLETED|Treatment 4||4
55434|NCT01648790|130924|P2|COMPLETED|Treatment 4||4
55435|NCT01648790|130925|P1|COMPLETED|Treatment 4||4
55436|NCT01648790|130921|P5|STARTED|Treatment 4||4
55437|NCT01648790|130922|P4|STARTED|Treatment 4||3
55438|NCT01648790|130923|P3|STARTED|Treatment 4||4
55439|NCT01648790|130924|P2|STARTED|Treatment 4||4
55440|NCT01648790|130925|P1|STARTED|Treatment 4||4
55441|NCT01648790|130921|P5|NOT COMPLETED|Treatment 3||0
55442|NCT01648790|130922|P4|NOT COMPLETED|Treatment 3||1
55443|NCT01648790|130923|P3|NOT COMPLETED|Treatment 3||0
55444|NCT01648790|130924|P2|NOT COMPLETED|Treatment 3||0
55445|NCT01648790|130925|P1|NOT COMPLETED|Treatment 3||0
55446|NCT01648790|130921|P5|COMPLETED|Treatment 3||4
55447|NCT01648790|130922|P4|COMPLETED|Treatment 3||3
55448|NCT01648790|130923|P3|COMPLETED|Treatment 3||4
55449|NCT01648790|130924|P2|COMPLETED|Treatment 3||4
55450|NCT01648790|130925|P1|COMPLETED|Treatment 3||4
55451|NCT01648790|130921|P5|STARTED|Treatment 3||4
55452|NCT01648790|130922|P4|STARTED|Treatment 3|Withdrew consent prior to dosing on this treatment day.|4
55453|NCT01648790|130923|P3|STARTED|Treatment 3||4
55454|NCT01648790|130924|P2|STARTED|Treatment 3||4
55455|NCT01648790|130925|P1|STARTED|Treatment 3||4
55456|NCT01648790|130921|P5|NOT COMPLETED|Treatment 2||0
55457|NCT01648790|130922|P4|NOT COMPLETED|Treatment 2||0
55458|NCT01648790|130923|P3|NOT COMPLETED|Treatment 2||0
55459|NCT01648790|130924|P2|NOT COMPLETED|Treatment 2||0
55460|NCT01648790|130925|P1|NOT COMPLETED|Treatment 2||0
55461|NCT01648790|130921|P5|COMPLETED|Treatment 2||4
55462|NCT01648790|130922|P4|COMPLETED|Treatment 2||4
55463|NCT01648790|130923|P3|COMPLETED|Treatment 2||4
55464|NCT01648790|130924|P2|COMPLETED|Treatment 2||4
55465|NCT01648790|130925|P1|COMPLETED|Treatment 2||4
55466|NCT01648790|130921|P5|STARTED|Treatment 2||4
55467|NCT01648790|130922|P4|STARTED|Treatment 2||4
55468|NCT01648790|130923|P3|STARTED|Treatment 2||4
55469|NCT01648790|130924|P2|STARTED|Treatment 2||4
55470|NCT01648790|130925|P1|STARTED|Treatment 2||4
55471|NCT01648790|130921|P5|NOT COMPLETED|Treatment 1||0
55472|NCT01648790|130922|P4|NOT COMPLETED|Treatment 1||0
55473|NCT01648790|130923|P3|NOT COMPLETED|Treatment 1||0
55474|NCT01648790|130924|P2|NOT COMPLETED|Treatment 1||0
55475|NCT01648790|130925|P1|NOT COMPLETED|Treatment 1||0
55476|NCT01648790|130921|P5|COMPLETED|Treatment 1||4
55477|NCT01648790|130922|P4|COMPLETED|Treatment 1||4
55478|NCT01648790|130923|P3|COMPLETED|Treatment 1||4
55479|NCT01648790|130924|P2|COMPLETED|Treatment 1||4
55480|NCT01648790|130925|P1|COMPLETED|Treatment 1||4
55481|NCT01648790|130921|P5|Received at Least 1 Dose of Study Drug|Treatment 1||4
55482|NCT01648790|130922|P4|Received at Least 1 Dose of Study Drug|Treatment 1||4
55483|NCT01648790|130923|P3|Received at Least 1 Dose of Study Drug|Treatment 1||4
55484|NCT01648790|130924|P2|Received at Least 1 Dose of Study Drug|Treatment 1||4
55485|NCT01648790|130925|P1|Received at Least 1 Dose of Study Drug|Treatment 1||4
55486|NCT01648790|130921|P5|STARTED|Treatment 1||4
55487|NCT01648790|130922|P4|STARTED|Treatment 1||4
55488|NCT01648790|130923|P3|STARTED|Treatment 1||4
55489|NCT01648790|130924|P2|STARTED|Treatment 1||4
55490|NCT01648790|130925|P1|STARTED|Treatment 1||4
55491|NCT01648699|130946|P1|NOT COMPLETED|Overall Study||5
55492|NCT01648699|130946|P1|COMPLETED|Overall Study||15
55493|NCT01648699|130946|P1|STARTED|Overall Study||20
55494|NCT01647542|130975|P3|NOT COMPLETED|Overall Study||72
55495|NCT01647542|130976|P2|NOT COMPLETED|Overall Study||73
55496|NCT01647542|130977|P1|NOT COMPLETED|Overall Study||76
55497|NCT01647542|130975|P3|COMPLETED|Overall Study||59
55498|NCT01647542|130976|P2|COMPLETED|Overall Study||58
55499|NCT01647542|130977|P1|COMPLETED|Overall Study||55
55500|NCT01647542|130975|P3|STARTED|Overall Study||131
55501|NCT01647542|130976|P2|STARTED|Overall Study||131
55502|NCT01647542|130977|P1|STARTED|Overall Study||131
55503|NCT01648582|130997|P3|NOT COMPLETED|Overall Study||32
55504|NCT01648582|130998|P2|NOT COMPLETED|Overall Study||38
55505|NCT01648582|130999|P1|NOT COMPLETED|Overall Study||32
55506|NCT01648582|130997|P3|COMPLETED|Overall Study||227
55507|NCT01648582|130998|P2|COMPLETED|Overall Study||219
55508|NCT01648582|130999|P1|COMPLETED|Overall Study||226
55509|NCT01648582|130997|P3|Modified Intent-to-Treat Population|Overall Study||250
55510|NCT01648582|130998|P2|Modified Intent-to-Treat Population|Overall Study||252
55511|NCT01648582|130999|P1|Modified Intent-to-Treat Population|Overall Study||253
55512|NCT01648582|130997|P3|Received at Least One Dose of Study Drug|Overall Study||259
55513|NCT01648582|130998|P2|Received at Least One Dose of Study Drug|Overall Study||257
55514|NCT01648582|130999|P1|Received at Least One Dose of Study Drug|Overall Study||258
55515|NCT01648582|130997|P3|STARTED|Overall Study||259
55516|NCT01648582|130998|P2|STARTED|Overall Study||257
55517|NCT01648582|130999|P1|STARTED|Overall Study||258
55518|NCT01648530|131068|P1|NOT COMPLETED|Overall Study||10874
55519|NCT01648530|131068|P1|COMPLETED|Overall Study||5915
55520|NCT01648530|131068|P1|STARTED|Overall Study||16789
55521|NCT01648491|131074|P1|NOT COMPLETED|Overall Study||0
55522|NCT01648491|131074|P1|COMPLETED|Overall Study||1
55523|NCT01648491|131074|P1|STARTED|Overall Study||1
55524|NCT01648452|131081|P1|NOT COMPLETED|Overall Study||0
55525|NCT01648452|131081|P1|COMPLETED|Overall Study|One participant was explanted due to an adverse event. Remainder kept implant at study completion.|5
55526|NCT01648452|131081|P1|STARTED|Overall Study||5
55527|NCT01648140|131103|P4|NOT COMPLETED|Overall Study||2
55528|NCT01648140|131104|P3|NOT COMPLETED|Overall Study||8
55529|NCT01648140|131105|P2|NOT COMPLETED|Overall Study||12
55530|NCT01648140|131106|P1|NOT COMPLETED|Overall Study||12
55531|NCT01648140|131103|P4|COMPLETED|Overall Study||11
55532|NCT01648140|131104|P3|COMPLETED|Overall Study||9
55533|NCT01648140|131105|P2|COMPLETED|Overall Study||28
55534|NCT01648140|131106|P1|COMPLETED|Overall Study||29
55535|NCT01648140|131103|P4|STARTED|Overall Study||13
55536|NCT01648140|131104|P3|STARTED|Overall Study||17
55537|NCT01648140|131105|P2|STARTED|Overall Study||40
55538|NCT01648140|131106|P1|STARTED|Overall Study||41
55539|NCT01648101|131271|P3|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
55540|NCT01648101|131272|P2|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
55541|NCT01648101|131273|P1|NOT COMPLETED|Taper/Follow-up Phase (4 Weeks)||0
55542|NCT01648101|131271|P3|COMPLETED|Taper/Follow-up Phase (4 Weeks)||3
55543|NCT01648101|131272|P2|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
55544|NCT01648101|131273|P1|COMPLETED|Taper/Follow-up Phase (4 Weeks)||1
55545|NCT01648101|131271|P3|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|3
55546|NCT01648101|131272|P2|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|2
55547|NCT01648101|131273|P1|STARTED|Taper/Follow-up Phase (4 Weeks)|Includes only those par. who completed the Titration + MN phase, but opted not to enroll in the OLE|1
55548|NCT01648101|131271|P3|NOT COMPLETED|Transition Phase (4 Weeks)||4
55549|NCT01648101|131272|P2|NOT COMPLETED|Transition Phase (4 Weeks)||5
55550|NCT01648101|131273|P1|NOT COMPLETED|Transition Phase (4 Weeks)||5
55551|NCT01648101|131271|P3|COMPLETED|Transition Phase (4 Weeks)||5
55552|NCT01648101|131272|P2|COMPLETED|Transition Phase (4 Weeks)||13
55553|NCT01648101|131273|P1|COMPLETED|Transition Phase (4 Weeks)||12
55554|NCT01648101|131271|P3|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|9
55555|NCT01648101|131272|P2|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|18
55556|NCT01648101|131273|P1|STARTED|Transition Phase (4 Weeks)|After completing the MP, only those par. that chose to enter the OLE study started the TnP|17
55557|NCT01648101|131271|P3|NOT COMPLETED|Maintenance Phase (12 Weeks)||6
55558|NCT01648101|131272|P2|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
55559|NCT01648101|131273|P1|NOT COMPLETED|Maintenance Phase (12 Weeks)||3
55560|NCT01648101|131271|P3|COMPLETED|Maintenance Phase (12 Weeks)||12
55561|NCT01648101|131272|P2|COMPLETED|Maintenance Phase (12 Weeks)||20
55562|NCT01648101|131273|P1|COMPLETED|Maintenance Phase (12 Weeks)||20
55563|NCT01648101|131271|P3|STARTED|Maintenance Phase (12 Weeks)||18
55564|NCT01648101|131272|P2|STARTED|Maintenance Phase (12 Weeks)||23
55565|NCT01648101|131273|P1|STARTED|Maintenance Phase (12 Weeks)||23
55566|NCT01648101|131271|P3|NOT COMPLETED|Titration Phase (4 Weeks)||6
55567|NCT01648101|131272|P2|NOT COMPLETED|Titration Phase (4 Weeks)||3
55568|NCT01648101|131273|P1|NOT COMPLETED|Titration Phase (4 Weeks)||2
55569|NCT01648101|131271|P3|COMPLETED|Titration Phase (4 Weeks)||18
55570|NCT01648101|131272|P2|COMPLETED|Titration Phase (4 Weeks)||23
55571|NCT01648101|131273|P1|COMPLETED|Titration Phase (4 Weeks)||23
55572|NCT01648101|131271|P3|STARTED|Titration Phase (4 Weeks)||24
55573|NCT01648101|131272|P2|STARTED|Titration Phase (4 Weeks)||26
55574|NCT01648101|131273|P1|STARTED|Titration Phase (4 Weeks)||25
55575|NCT01647945|131325|P4|NOT COMPLETED|Overall Study||1
55576|NCT01647945|131326|P3|NOT COMPLETED|Overall Study||2
55577|NCT01647945|131327|P2|NOT COMPLETED|Overall Study||0
55578|NCT01647945|131328|P1|NOT COMPLETED|Overall Study||0
55579|NCT01647945|131325|P4|COMPLETED|Overall Study||5
55580|NCT01647945|131326|P3|COMPLETED|Overall Study||3
55581|NCT01647945|131327|P2|COMPLETED|Overall Study||6
55582|NCT01647945|131328|P1|COMPLETED|Overall Study||6
55583|NCT01647945|131325|P4|STARTED|Overall Study||6
55584|NCT01647945|131326|P3|STARTED|Overall Study||5
55585|NCT01647945|131327|P2|STARTED|Overall Study||6
55586|NCT01647945|131328|P1|STARTED|Overall Study||6
55587|NCT01647737|131348|P2|NOT COMPLETED|Overall Study||5
55588|NCT01647737|131349|P1|NOT COMPLETED|Overall Study||4
55589|NCT01647737|131348|P2|COMPLETED|Overall Study||25
55590|NCT01647737|131349|P1|COMPLETED|Overall Study||26
55591|NCT01647737|131348|P2|STARTED|Overall Study||30
55592|NCT01647737|131349|P1|STARTED|Overall Study||30
55593|NCT01647711|131360|P5|NOT COMPLETED|Overall Study||6
55594|NCT01647711|131361|P4|NOT COMPLETED|Overall Study||11
55595|NCT01647711|131362|P3|NOT COMPLETED|Overall Study||9
55596|NCT01647711|131363|P2|NOT COMPLETED|Overall Study||3
55597|NCT01647711|131364|P1|NOT COMPLETED|Overall Study||6
55598|NCT01647711|131360|P5|COMPLETED|Overall Study||0
55599|NCT01647711|131361|P4|COMPLETED|Overall Study||0
55600|NCT01647711|131362|P3|COMPLETED|Overall Study||0
55601|NCT01647711|131363|P2|COMPLETED|Overall Study||0
55602|NCT01647711|131364|P1|COMPLETED|Overall Study||0
55603|NCT01647711|131360|P5|STARTED|Overall Study||6
55604|NCT01647711|131361|P4|STARTED|Overall Study||11
55605|NCT01647711|131362|P3|STARTED|Overall Study||9
55606|NCT01647711|131363|P2|STARTED|Overall Study||3
55607|NCT01647711|131364|P1|STARTED|Overall Study||6
55608|NCT01647464|131389|P1|NOT COMPLETED|Overall Study||0
55609|NCT01647464|131389|P1|COMPLETED|Overall Study||10
55610|NCT01647464|131389|P1|STARTED|Overall Study||10
55611|NCT01647438|131395|P2|NOT COMPLETED|Overall Study||0
55612|NCT01647438|131396|P1|NOT COMPLETED|Overall Study||0
55613|NCT01647438|131395|P2|COMPLETED|Overall Study||31
55614|NCT01647438|131396|P1|COMPLETED|Overall Study||32
55615|NCT01647438|131395|P2|STARTED|Overall Study||31
55616|NCT01647438|131396|P1|STARTED|Overall Study||32
55617|NCT01647217|131406|P2|NOT COMPLETED|Overall Study||1
55618|NCT01647217|131407|P1|NOT COMPLETED|Overall Study||1
55619|NCT01647217|131406|P2|COMPLETED|Overall Study||8
55620|NCT01647217|131407|P1|COMPLETED|Overall Study||7
55621|NCT01647217|131406|P2|STARTED|Overall Study||9
55622|NCT01647217|131407|P1|STARTED|Overall Study||8
55623|NCT01646827|131417|P2|NOT COMPLETED|Overall Study||5
55624|NCT01646827|131418|P1|NOT COMPLETED|Overall Study||2
55625|NCT01646827|131417|P2|COMPLETED|Overall Study||14
55626|NCT01646827|131418|P1|COMPLETED|Overall Study||16
55627|NCT01646827|131417|P2|STARTED|Overall Study||19
55628|NCT01646827|131418|P1|STARTED|Overall Study||18
55629|NCT01646814|131448|P2|NOT COMPLETED|Overall Study||6
55630|NCT01646814|131449|P1|NOT COMPLETED|Overall Study||11
55631|NCT01646814|131448|P2|COMPLETED|Overall Study||120
55632|NCT01646814|131449|P1|COMPLETED|Overall Study||110
55633|NCT01646814|131448|P2|STARTED|Overall Study||126
55634|NCT01646814|131449|P1|STARTED|Overall Study||121
55635|NCT01646671|131458|P3|NOT COMPLETED|Overall Study||0
55636|NCT01646671|131459|P2|NOT COMPLETED|Overall Study||0
55637|NCT01646671|131460|P1|NOT COMPLETED|Overall Study||0
55638|NCT01646671|131458|P3|COMPLETED|Overall Study||21
55639|NCT01646671|131459|P2|COMPLETED|Overall Study||11
55640|NCT01646671|131460|P1|COMPLETED|Overall Study||3
55641|NCT01646671|131458|P3|STARTED|Overall Study||21
55642|NCT01646671|131459|P2|STARTED|Overall Study||11
55643|NCT01646671|131460|P1|STARTED|Overall Study||3
55644|NCT01646398|131496|P2|NOT COMPLETED|Overall Study||0
55645|NCT01646398|131497|P1|NOT COMPLETED|Overall Study||1
55646|NCT01646398|131496|P2|COMPLETED|Overall Study||382
55647|NCT01646398|131497|P1|COMPLETED|Overall Study||381
55648|NCT01646398|131496|P2|STARTED|Overall Study||382
55649|NCT01646398|131497|P1|STARTED|Overall Study||382
55650|NCT01646385|131513|P2|NOT COMPLETED|Overall Study||871
55651|NCT01646385|131514|P1|NOT COMPLETED|Overall Study||838
55652|NCT01646385|131513|P2|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|1993
55653|NCT01646385|131514|P1|COMPLETED|Overall Study|Completed refers to participants who continued up to last follow-up.|2691
55654|NCT01646385|131513|P2|STARTED|Overall Study||2864
55655|NCT01646385|131514|P1|STARTED|Overall Study||3529
55656|NCT01646320|131547|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||7
55657|NCT01646320|131548|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 52)||6
55658|NCT01646320|131547|P2|COMPLETED|Long-term Period (Weeks 24 to 52)||140
55659|NCT01646320|131548|P1|COMPLETED|Long-term Period (Weeks 24 to 52)||141
55660|NCT01646320|131547|P2|STARTED|Long-term Period (Weeks 24 to 52)||147
55661|NCT01646320|131548|P1|STARTED|Long-term Period (Weeks 24 to 52)||147
55662|NCT01646320|131547|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||7
55663|NCT01646320|131548|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||12
55664|NCT01646320|131547|P2|COMPLETED|Short-term Period (Day 1 to Week 24)||153
55665|NCT01646320|131548|P1|COMPLETED|Short-term Period (Day 1 to Week 24)||148
55666|NCT01646320|131547|P2|STARTED|Short-term Period (Day 1 to Week 24)||160
55667|NCT01646320|131548|P1|STARTED|Short-term Period (Day 1 to Week 24)||160
55668|NCT01646268|131564|P2|NOT COMPLETED|Overall Study||16
55669|NCT01646268|131565|P1|NOT COMPLETED|Overall Study||11
55670|NCT01646268|131564|P2|COMPLETED|Overall Study||107
55671|NCT01646268|131565|P1|COMPLETED|Overall Study||113
55672|NCT01646268|131564|P2|STARTED|Overall Study||123
55673|NCT01646268|131565|P1|STARTED|Overall Study||124
55674|NCT01646255|131579|P2|NOT COMPLETED|Overall Study||14
55675|NCT01646255|131580|P1|NOT COMPLETED|Overall Study||21
55676|NCT01646255|131579|P2|COMPLETED|Overall Study||160
55677|NCT01646255|131580|P1|COMPLETED|Overall Study||151
55678|NCT01646255|131579|P2|STARTED|Overall Study||174
55679|NCT01646255|131580|P1|STARTED|Overall Study||172
55680|NCT01646177|131614|P4|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
55681|NCT01646177|131615|P3|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
55682|NCT01646177|131616|P2|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
55683|NCT01646177|131617|P1|NOT COMPLETED|Long-Term Extension Period (Week 12-264)||0
55684|NCT01646177|131614|P4|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55770|NCT01645280|131874|P5|STARTED|Overall Study||55
55685|NCT01646177|131615|P3|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55686|NCT01646177|131616|P2|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55687|NCT01646177|131617|P1|COMPLETED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55688|NCT01646177|131614|P4|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55689|NCT01646177|131615|P3|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55690|NCT01646177|131616|P2|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55691|NCT01646177|131617|P1|STARTED|Long-Term Extension Period (Week 12-264)|Data for this period is not yet available.|0
55692|NCT01646177|131614|P4|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||22
55693|NCT01646177|131615|P3|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||26
55694|NCT01646177|131616|P2|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||13
55695|NCT01646177|131617|P1|NOT COMPLETED|Blinded Induction Dosing (Week 0-12)||10
55696|NCT01646177|131614|P4|COMPLETED|Blinded Induction Dosing (Week 0-12)||363
55697|NCT01646177|131615|P3|COMPLETED|Blinded Induction Dosing (Week 0-12)||360
55698|NCT01646177|131616|P2|COMPLETED|Blinded Induction Dosing (Week 0-12)||369
55699|NCT01646177|131617|P1|COMPLETED|Blinded Induction Dosing (Week 0-12)||183
55700|NCT01646177|131614|P4|STARTED|Blinded Induction Dosing (Week 0-12)||385
55701|NCT01646177|131615|P3|STARTED|Blinded Induction Dosing (Week 0-12)||386
55702|NCT01646177|131616|P2|STARTED|Blinded Induction Dosing (Week 0-12)||382
55703|NCT01646177|131617|P1|STARTED|Blinded Induction Dosing (Week 0-12)||193
55704|NCT01646151|131695|P1|NOT COMPLETED|Overall Study||170
55705|NCT01646151|131695|P1|COMPLETED|Overall Study||2410
55706|NCT01646151|131695|P1|STARTED|Overall Study||2580
55707|NCT01646138|131711|P5|NOT COMPLETED|Overall Study||2
55708|NCT01646138|131712|P4|NOT COMPLETED|Overall Study||0
55709|NCT01646138|131713|P3|NOT COMPLETED|Overall Study||0
55710|NCT01646138|131714|P2|NOT COMPLETED|Overall Study||0
55711|NCT01646138|131715|P1|NOT COMPLETED|Overall Study||0
55712|NCT01646138|131711|P5|COMPLETED|Overall Study||13
55713|NCT01646138|131712|P4|COMPLETED|Overall Study||19
55714|NCT01646138|131713|P3|COMPLETED|Overall Study||5
55715|NCT01646138|131714|P2|COMPLETED|Overall Study||4
55716|NCT01646138|131715|P1|COMPLETED|Overall Study||5
55717|NCT01646138|131711|P5|STARTED|Overall Study||15
55718|NCT01646138|131712|P4|STARTED|Overall Study||19
55719|NCT01646138|131713|P3|STARTED|Overall Study||5
55720|NCT01646138|131714|P2|STARTED|Overall Study||4
55721|NCT01646138|131715|P1|STARTED|Overall Study||5
55722|NCT01646125|131729|P2|NOT COMPLETED|Overall Study||28
55723|NCT01646125|131730|P1|NOT COMPLETED|Overall Study||31
55724|NCT01646125|131729|P2|COMPLETED|Overall Study||0
55725|NCT01646125|131730|P1|COMPLETED|Overall Study||0
55726|NCT01646125|131729|P2|STARTED|Overall Study||28
55727|NCT01646125|131730|P1|STARTED|Overall Study||31
55728|NCT01646073|131755|P2|NOT COMPLETED|Period B (12 Weeks)||13
55729|NCT01646073|131756|P1|NOT COMPLETED|Period B (12 Weeks)||1
55730|NCT01646073|131755|P2|COMPLETED|Period B (12 Weeks)||320
55731|NCT01646073|131756|P1|COMPLETED|Period B (12 Weeks)||84
55732|NCT01646073|131755|P2|STARTED|Period B (12 Weeks)||333
55733|NCT01646073|131756|P1|STARTED|Period B (12 Weeks)||85
55734|NCT01646073|131755|P2|NOT COMPLETED|Period A (12 Weeks)||5
55735|NCT01646073|131756|P1|NOT COMPLETED|Period A (12 Weeks)||2
55736|NCT01646073|131755|P2|COMPLETED|Period A (12 Weeks)||333
55737|NCT01646073|131756|P1|COMPLETED|Period A (12 Weeks)||85
55738|NCT01646073|131755|P2|STARTED|Period A (12 Weeks)||338
55739|NCT01646073|131756|P1|STARTED|Period A (12 Weeks)||87
55740|NCT01646021|131797|P2|NOT COMPLETED|Overall Study||78
55741|NCT01646021|131798|P1|NOT COMPLETED|Overall Study||66
55742|NCT01646021|131797|P2|COMPLETED|Overall Study||63
55743|NCT01646021|131798|P1|COMPLETED|Overall Study||73
55744|NCT01646021|131797|P2|Received Treatment|Overall Study||139
55745|NCT01646021|131798|P1|Received Treatment|Overall Study||139
55746|NCT01646021|131797|P2|STARTED|Overall Study||141
55747|NCT01646021|131798|P1|STARTED|Overall Study||139
55748|NCT01645735|131831|P2|NOT COMPLETED|Overall Study||1
55749|NCT01645735|131832|P1|NOT COMPLETED|Overall Study||4
55750|NCT01645735|131831|P2|COMPLETED|Overall Study||16
55751|NCT01645735|131832|P1|COMPLETED|Overall Study||28
55752|NCT01645735|131831|P2|STARTED|Overall Study||17
55753|NCT01645735|131832|P1|STARTED|Overall Study||32
55754|NCT01645709|131846|P2|NOT COMPLETED|Overall Study||0
55755|NCT01645709|131847|P1|NOT COMPLETED|Overall Study||0
55756|NCT01645709|131846|P2|COMPLETED|Overall Study|Study was terminated; not made unblind|0
55757|NCT01645709|131847|P1|COMPLETED|Overall Study|Study was terminated; not made unblind|0
55758|NCT01645709|131846|P2|STARTED|Overall Study|Study was terminated; not made unblind|0
55759|NCT01645709|131847|P1|STARTED|Overall Study|Study was terminated; not made unblind|0
55760|NCT01645280|131874|P5|NOT COMPLETED|Overall Study||8
55761|NCT01645280|131875|P4|NOT COMPLETED|Overall Study||6
55762|NCT01645280|131876|P3|NOT COMPLETED|Overall Study||6
55763|NCT01645280|131877|P2|NOT COMPLETED|Overall Study||3
55764|NCT01645280|131878|P1|NOT COMPLETED|Overall Study||6
55765|NCT01645280|131874|P5|COMPLETED|Overall Study||47
55766|NCT01645280|131875|P4|COMPLETED|Overall Study||48
55767|NCT01645280|131876|P3|COMPLETED|Overall Study||49
55768|NCT01645280|131877|P2|COMPLETED|Overall Study||51
55769|NCT01645280|131878|P1|COMPLETED|Overall Study||49
55771|NCT01645280|131875|P4|STARTED|Overall Study||54
55772|NCT01645280|131876|P3|STARTED|Overall Study||55
55773|NCT01645280|131877|P2|STARTED|Overall Study||54
55774|NCT01645280|131878|P1|STARTED|Overall Study|16 participants in placebo group early escaped to receive Ustekinmab; included in safety population.|55
55775|NCT01645176|131906|P1|NOT COMPLETED|Overall Study||5
55776|NCT01645176|131906|P1|COMPLETED|Overall Study||16
55777|NCT01645176|131906|P1|STARTED|Overall Study||21
55778|NCT01645111|131910|P1|NOT COMPLETED|Overall Study||15
55779|NCT01645111|131910|P1|COMPLETED|Overall Study||35
55780|NCT01645111|131910|P1|STARTED|Overall Study||50
55781|NCT01645098|131916|P2|NOT COMPLETED|Overall Study||0
55782|NCT01645098|131917|P1|NOT COMPLETED|Overall Study||0
55783|NCT01645098|131916|P2|COMPLETED|Overall Study||29
55784|NCT01645098|131917|P1|COMPLETED|Overall Study||24
55785|NCT01645098|131916|P2|STARTED|Overall Study||29
55786|NCT01645098|131917|P1|STARTED|Overall Study||24
55787|NCT01645059|131931|P1|NOT COMPLETED|Overall Study||0
55788|NCT01645059|131931|P1|COMPLETED|Overall Study||129
55789|NCT01645059|131931|P1|STARTED|Overall Study||129
55790|NCT01644734|131949|P1|NOT COMPLETED|Overall Study||266
55791|NCT01644734|131949|P1|COMPLETED|Overall Study||1016
55792|NCT01644734|131949|P1|STARTED|Overall Study|Patients with documentation of treatment.|1282
55793|NCT01644695|131954|P1|NOT COMPLETED|Overall Study||0
55794|NCT01644695|131954|P1|COMPLETED|Overall Study||85
55795|NCT01644695|131954|P1|STARTED|Overall Study||85
55796|NCT01644643|131963|P4|NOT COMPLETED|Overall Study||10
55797|NCT01644643|131964|P3|NOT COMPLETED|Overall Study||5
55798|NCT01644643|131965|P2|NOT COMPLETED|Overall Study||0
55799|NCT01644643|131966|P1|NOT COMPLETED|Overall Study||2
55800|NCT01644643|131963|P4|COMPLETED|Overall Study||143
55801|NCT01644643|131964|P3|COMPLETED|Overall Study||148
55802|NCT01644643|131965|P2|COMPLETED|Overall Study||12
55803|NCT01644643|131966|P1|COMPLETED|Overall Study||13
55804|NCT01644643|131963|P4|STARTED|Overall Study||153
55805|NCT01644643|131964|P3|STARTED|Overall Study||153
55806|NCT01644643|131965|P2|STARTED|Overall Study||12
55807|NCT01644643|131966|P1|STARTED|Overall Study||15
55808|NCT01644617|132131|P3|NOT COMPLETED|Overall Study||7
55809|NCT01644617|132132|P2|NOT COMPLETED|Overall Study||5
55810|NCT01644617|132133|P1|NOT COMPLETED|Overall Study||6
55811|NCT01644617|132131|P3|COMPLETED|Overall Study||34
55812|NCT01644617|132132|P2|COMPLETED|Overall Study||36
55813|NCT01644617|132133|P1|COMPLETED|Overall Study||36
55814|NCT01644617|132131|P3|STARTED|Overall Study||41
55815|NCT01644617|132132|P2|STARTED|Overall Study||41
55816|NCT01644617|132133|P1|STARTED|Overall Study||42
55817|NCT01643525|132183|P1|NOT COMPLETED|Overall Study||0
55818|NCT01643525|132183|P1|COMPLETED|Overall Study||29
55819|NCT01643525|132183|P1|STARTED|Overall Study||29
55820|NCT01644500|132190|P3|NOT COMPLETED|Overall Study||18
55821|NCT01644500|132191|P2|NOT COMPLETED|Overall Study||28
55822|NCT01644500|132192|P1|NOT COMPLETED|Overall Study||24
55823|NCT01644500|132190|P3|COMPLETED|Overall Study||253
55824|NCT01644500|132191|P2|COMPLETED|Overall Study||240
55825|NCT01644500|132192|P1|COMPLETED|Overall Study||244
55826|NCT01644500|132190|P3|Modified Intent-to-treat Population|Overall Study||268
55827|NCT01644500|132191|P2|Modified Intent-to-treat Population|Overall Study||259
55828|NCT01644500|132192|P1|Modified Intent-to-treat Population|Overall Study||263
55829|NCT01644500|132190|P3|Received at Least One Dose of Study Drug|Overall Study||269
55830|NCT01644500|132191|P2|Received at Least One Dose of Study Drug|Overall Study||268
55831|NCT01644500|132192|P1|Received at Least One Dose of Study Drug|Overall Study||268
55832|NCT01644500|132190|P3|STARTED|Overall Study||271
55833|NCT01644500|132191|P2|STARTED|Overall Study||268
55834|NCT01644500|132192|P1|STARTED|Overall Study||268
55835|NCT01644474|132262|P2|NOT COMPLETED|Overall Study||8
55836|NCT01644474|132263|P1|NOT COMPLETED|Overall Study||7
55837|NCT01644474|132262|P2|COMPLETED|Overall Study||44
55838|NCT01644474|132263|P1|COMPLETED|Overall Study||44
55839|NCT01644474|132262|P2|Treated|Overall Study||52
55840|NCT01644474|132263|P1|Treated|Overall Study||51
55841|NCT01644474|132262|P2|STARTED|Overall Study|Randomized|52
55842|NCT01644474|132263|P1|STARTED|Overall Study|Randomized|51
55843|NCT01644396|132303|P1|NOT COMPLETED|Overall Study||0
55844|NCT01644396|132303|P1|COMPLETED|Overall Study||50
55845|NCT01644396|132303|P1|STARTED|Overall Study||50
55846|NCT01644331|132347|P2|NOT COMPLETED|Overall Study||10
55847|NCT01644331|132348|P1|NOT COMPLETED|Overall Study||11
55848|NCT01644331|132347|P2|COMPLETED|Overall Study||118
55849|NCT01644331|132348|P1|COMPLETED|Overall Study||118
55850|NCT01644331|132347|P2|STARTED|Overall Study||128
55851|NCT01644331|132348|P1|STARTED|Overall Study||129
55852|NCT01644292|132380|P1|NOT COMPLETED|Overall Study||0
55853|NCT01644292|132380|P1|COMPLETED|Overall Study||2
55854|NCT01644292|132380|P1|STARTED|Overall Study||2
55855|NCT01644240|132387|P3|NOT COMPLETED|Overall Study||0
55856|NCT01644240|132388|P2|NOT COMPLETED|Overall Study||0
55857|NCT01644240|132389|P1|NOT COMPLETED|Overall Study||0
55858|NCT01644240|132387|P3|COMPLETED|Overall Study||6
55859|NCT01644240|132388|P2|COMPLETED|Overall Study||4
55860|NCT01644240|132389|P1|COMPLETED|Overall Study||6
55861|NCT01644240|132387|P3|STARTED|Overall Study||6
55862|NCT01644240|132388|P2|STARTED|Overall Study||4
55863|NCT01644240|132389|P1|STARTED|Overall Study||6
55864|NCT01644188|132447|P2|NOT COMPLETED|Overall Study||75
55865|NCT01644188|132448|P1|NOT COMPLETED|Overall Study||122
55866|NCT01644188|132447|P2|COMPLETED|Overall Study||166
55867|NCT01644188|132448|P1|COMPLETED|Overall Study||357
55868|NCT01644188|132447|P2|Treated|Overall Study||241
55869|NCT01644188|132448|P1|Treated|Overall Study||479
55870|NCT01644188|132447|P2|STARTED|Overall Study|Randomized|241
55871|NCT01644188|132448|P1|STARTED|Overall Study|Randomized|479
55872|NCT01644175|132506|P2|NOT COMPLETED|Overall Study||53
55873|NCT01644175|132507|P1|NOT COMPLETED|Overall Study||32
55874|NCT01644175|132506|P2|COMPLETED|Overall Study||156
55875|NCT01644175|132507|P1|COMPLETED|Overall Study||75
55876|NCT01644175|132506|P2|Treated|Overall Study||207
55877|NCT01644175|132507|P1|Treated|Overall Study||107
55878|NCT01644175|132506|P2|STARTED|Overall Study|Randomized|209
55879|NCT01644175|132507|P1|STARTED|Overall Study|Randomized|107
55880|NCT01644058|132557|P1|NOT COMPLETED|Overall Study||0
55881|NCT01644058|132557|P1|COMPLETED|Overall Study||18
55882|NCT01644058|132557|P1|STARTED|Overall Study||18
55883|NCT01643928|132567|P5|NOT COMPLETED|Overall Study||2
55884|NCT01643928|132568|P4|NOT COMPLETED|Overall Study||3
55885|NCT01643928|132569|P3|NOT COMPLETED|Overall Study||3
55886|NCT01643928|132570|P2|NOT COMPLETED|Overall Study||2
55887|NCT01643928|132571|P1|NOT COMPLETED|Overall Study||10
55888|NCT01643928|132567|P5|COMPLETED|Overall Study||28
55889|NCT01643928|132568|P4|COMPLETED|Overall Study||27
55890|NCT01643928|132569|P3|COMPLETED|Overall Study||30
55891|NCT01643928|132570|P2|COMPLETED|Overall Study||30
55892|NCT01643928|132571|P1|COMPLETED|Overall Study||48
55893|NCT01643928|132567|P5|STARTED|Overall Study||30
55894|NCT01643928|132568|P4|STARTED|Overall Study||30
55895|NCT01643928|132569|P3|STARTED|Overall Study||33
55896|NCT01643928|132570|P2|STARTED|Overall Study||32
55897|NCT01643928|132571|P1|STARTED|Overall Study||58
55898|NCT01643902|132856|P1|NOT COMPLETED|Overall Study||0
55899|NCT01643902|132856|P1|COMPLETED|Overall Study||20
55900|NCT01643902|132856|P1|STARTED|Overall Study||20
55901|NCT01643876|132861|P1|NOT COMPLETED|Overall Study||0
55902|NCT01643876|132861|P1|COMPLETED|Overall Study||48
55903|NCT01643876|132861|P1|STARTED|Overall Study||48
55904|NCT01643798|132866|P2|NOT COMPLETED|Pretreatment 2 and Stimulation||0
55905|NCT01643798|132867|P1|NOT COMPLETED|Pretreatment 2 and Stimulation||0
55906|NCT01643798|132866|P2|COMPLETED|Pretreatment 2 and Stimulation||8
55907|NCT01643798|132867|P1|COMPLETED|Pretreatment 2 and Stimulation||6
55908|NCT01643798|132866|P2|STARTED|Pretreatment 2 and Stimulation||8
55909|NCT01643798|132867|P1|STARTED|Pretreatment 2 and Stimulation||6
55910|NCT01643798|132866|P2|NOT COMPLETED|Pretreatment 1 and Stimulation||0
55911|NCT01643798|132867|P1|NOT COMPLETED|Pretreatment 1 and Stimulation||1
55912|NCT01643798|132866|P2|COMPLETED|Pretreatment 1 and Stimulation||8
55913|NCT01643798|132867|P1|COMPLETED|Pretreatment 1 and Stimulation||6
55914|NCT01643798|132866|P2|STARTED|Pretreatment 1 and Stimulation||8
55915|NCT01643798|132867|P1|STARTED|Pretreatment 1 and Stimulation||7
55916|NCT01643668|132878|P1|NOT COMPLETED|Overall Study||1
55917|NCT01643668|132878|P1|COMPLETED|Overall Study||33
55918|NCT01643668|132878|P1|STARTED|Overall Study||34
55919|NCT01643616|132892|P2|NOT COMPLETED|Overall Study||0
55920|NCT01643616|132893|P1|NOT COMPLETED|Overall Study||0
55921|NCT01643616|132892|P2|COMPLETED|Overall Study||125
55922|NCT01643616|132893|P1|COMPLETED|Overall Study||125
55923|NCT01643616|132892|P2|STARTED|Overall Study||125
55924|NCT01643616|132893|P1|STARTED|Overall Study||125
55925|NCT01643213|132905|P2|NOT COMPLETED|Overall Study||0
55926|NCT01643213|132906|P1|NOT COMPLETED|Overall Study||1
55927|NCT01643213|132905|P2|COMPLETED|Overall Study||14
55928|NCT01643213|132906|P1|COMPLETED|Overall Study||12
55929|NCT01643213|132905|P2|STARTED|Overall Study||14
55930|NCT01643213|132906|P1|STARTED|Overall Study||13
55931|NCT01643044|132914|P2|NOT COMPLETED|Overall Study||5
55932|NCT01643044|132915|P1|NOT COMPLETED|Overall Study||4
55933|NCT01643044|132914|P2|COMPLETED|Overall Study||19
55934|NCT01643044|132915|P1|COMPLETED|Overall Study||20
55935|NCT01643044|132914|P2|STARTED|Overall Study||24
55936|NCT01643044|132915|P1|STARTED|Overall Study||24
55937|NCT01642914|132924|P3|NOT COMPLETED|Overall Study||40
55938|NCT01642914|132925|P2|NOT COMPLETED|Overall Study||32
55939|NCT01642914|132926|P1|NOT COMPLETED|Overall Study||46
55940|NCT01642914|132924|P3|COMPLETED|Overall Study||120
55941|NCT01642914|132925|P2|COMPLETED|Overall Study||122
55942|NCT01642914|132926|P1|COMPLETED|Overall Study||127
55943|NCT01642914|132924|P3|STARTED|Overall Study||160
55944|NCT01642914|132925|P2|STARTED|Overall Study||154
55945|NCT01642914|132926|P1|STARTED|Overall Study||173
55946|NCT01642732|133001|P1|NOT COMPLETED|Overall Study||1
55947|NCT01642732|133001|P1|COMPLETED|Overall Study||0
55948|NCT01642732|133001|P1|STARTED|Overall Study||1
55949|NCT01642615|133006|P3|NOT COMPLETED|Double Blind Maintenance Phase||6
55950|NCT01642615|133007|P2|NOT COMPLETED|Double Blind Maintenance Phase||7
55951|NCT01642615|133008|P1|NOT COMPLETED|Double Blind Maintenance Phase||0
55952|NCT01642615|133006|P3|COMPLETED|Double Blind Maintenance Phase||20
55953|NCT01642615|133007|P2|COMPLETED|Double Blind Maintenance Phase||18
55954|NCT01642615|133008|P1|COMPLETED|Double Blind Maintenance Phase||0
55955|NCT01642615|133006|P3|STARTED|Double Blind Maintenance Phase||26
55956|NCT01642615|133007|P2|STARTED|Double Blind Maintenance Phase||25
55957|NCT01642615|133008|P1|STARTED|Double Blind Maintenance Phase||0
55958|NCT01642615|133006|P3|NOT COMPLETED|Open Label Maintenance Phase||0
55959|NCT01642615|133007|P2|NOT COMPLETED|Open Label Maintenance Phase||0
55960|NCT01642615|133008|P1|NOT COMPLETED|Open Label Maintenance Phase||5
55961|NCT01642615|133006|P3|COMPLETED|Open Label Maintenance Phase||0
55962|NCT01642615|133007|P2|COMPLETED|Open Label Maintenance Phase||0
55963|NCT01642615|133008|P1|COMPLETED|Open Label Maintenance Phase||58
55964|NCT01642615|133006|P3|Safety Analysis Set|Open Label Maintenance Phase||0
55965|NCT01642615|133007|P2|Safety Analysis Set|Open Label Maintenance Phase||0
55966|NCT01642615|133008|P1|Safety Analysis Set|Open Label Maintenance Phase||62
55967|NCT01642615|133006|P3|STARTED|Open Label Maintenance Phase||0
55968|NCT01642615|133007|P2|STARTED|Open Label Maintenance Phase||0
55969|NCT01642615|133008|P1|STARTED|Open Label Maintenance Phase||63
55970|NCT01642602|133022|P1|NOT COMPLETED|Overall Study||2
55971|NCT01642602|133022|P1|COMPLETED|Overall Study||102
55972|NCT01642602|133022|P1|STARTED|Overall Study||104
55973|NCT01642589|133029|P2|NOT COMPLETED|Overall Study||1
55974|NCT01642589|133030|P1|NOT COMPLETED|Overall Study||1
55975|NCT01642589|133029|P2|COMPLETED|Overall Study||99
55976|NCT01642589|133030|P1|COMPLETED|Overall Study||199
55977|NCT01642589|133029|P2|STARTED|Overall Study||100
55978|NCT01642589|133030|P1|STARTED|Overall Study||200
55979|NCT01642485|133044|P8|NOT COMPLETED|Period 2, Day 3||0
55980|NCT01642485|133045|P7|NOT COMPLETED|Period 2, Day 3||0
55981|NCT01642485|133046|P6|NOT COMPLETED|Period 2, Day 3||0
55982|NCT01642485|133047|P5|NOT COMPLETED|Period 2, Day 3||0
55983|NCT01642485|133048|P4|NOT COMPLETED|Period 2, Day 3||0
55984|NCT01642485|133049|P3|NOT COMPLETED|Period 2, Day 3||0
55985|NCT01642485|133050|P2|NOT COMPLETED|Period 2, Day 3||0
55986|NCT01642485|133051|P1|NOT COMPLETED|Period 2, Day 3||0
55987|NCT01642485|133044|P8|COMPLETED|Period 2, Day 3||4
55988|NCT01642485|133045|P7|COMPLETED|Period 2, Day 3||4
55989|NCT01642485|133046|P6|COMPLETED|Period 2, Day 3||4
55990|NCT01642485|133047|P5|COMPLETED|Period 2, Day 3||4
55991|NCT01642485|133048|P4|COMPLETED|Period 2, Day 3||4
55992|NCT01642485|133049|P3|COMPLETED|Period 2, Day 3||4
55993|NCT01642485|133050|P2|COMPLETED|Period 2, Day 3||4
55994|NCT01642485|133051|P1|COMPLETED|Period 2, Day 3||4
55995|NCT01642485|133044|P8|STARTED|Period 2, Day 3||4
55996|NCT01642485|133045|P7|STARTED|Period 2, Day 3||4
55997|NCT01642485|133046|P6|STARTED|Period 2, Day 3||4
55998|NCT01642485|133047|P5|STARTED|Period 2, Day 3||4
55999|NCT01642485|133048|P4|STARTED|Period 2, Day 3||4
56000|NCT01642485|133049|P3|STARTED|Period 2, Day 3||4
56001|NCT01642485|133050|P2|STARTED|Period 2, Day 3||4
56002|NCT01642485|133051|P1|STARTED|Period 2, Day 3||4
56003|NCT01642485|133044|P8|NOT COMPLETED|Period 2, Day 2||0
56004|NCT01642485|133045|P7|NOT COMPLETED|Period 2, Day 2||0
56005|NCT01642485|133046|P6|NOT COMPLETED|Period 2, Day 2||0
56006|NCT01642485|133047|P5|NOT COMPLETED|Period 2, Day 2||0
56007|NCT01642485|133048|P4|NOT COMPLETED|Period 2, Day 2||0
56008|NCT01642485|133049|P3|NOT COMPLETED|Period 2, Day 2||0
56009|NCT01642485|133050|P2|NOT COMPLETED|Period 2, Day 2||0
56010|NCT01642485|133051|P1|NOT COMPLETED|Period 2, Day 2||0
56011|NCT01642485|133044|P8|COMPLETED|Period 2, Day 2||4
56012|NCT01642485|133045|P7|COMPLETED|Period 2, Day 2||4
56013|NCT01642485|133046|P6|COMPLETED|Period 2, Day 2||4
56014|NCT01642485|133047|P5|COMPLETED|Period 2, Day 2||4
56015|NCT01642485|133048|P4|COMPLETED|Period 2, Day 2||4
56016|NCT01642485|133049|P3|COMPLETED|Period 2, Day 2||4
56017|NCT01642485|133050|P2|COMPLETED|Period 2, Day 2||4
56018|NCT01642485|133051|P1|COMPLETED|Period 2, Day 2||4
56019|NCT01642485|133044|P8|STARTED|Period 2, Day 2||4
56020|NCT01642485|133045|P7|STARTED|Period 2, Day 2||4
56021|NCT01642485|133046|P6|STARTED|Period 2, Day 2||4
56022|NCT01642485|133047|P5|STARTED|Period 2, Day 2||4
56023|NCT01642485|133048|P4|STARTED|Period 2, Day 2||4
56024|NCT01642485|133049|P3|STARTED|Period 2, Day 2||4
56025|NCT01642485|133050|P2|STARTED|Period 2, Day 2||4
56026|NCT01642485|133051|P1|STARTED|Period 2, Day 2||4
56027|NCT01642485|133044|P8|NOT COMPLETED|Period 2, Day 1||0
56028|NCT01642485|133045|P7|NOT COMPLETED|Period 2, Day 1||0
56029|NCT01642485|133046|P6|NOT COMPLETED|Period 2, Day 1||0
56030|NCT01642485|133047|P5|NOT COMPLETED|Period 2, Day 1||0
56031|NCT01642485|133048|P4|NOT COMPLETED|Period 2, Day 1||0
56032|NCT01642485|133049|P3|NOT COMPLETED|Period 2, Day 1||0
56033|NCT01642485|133050|P2|NOT COMPLETED|Period 2, Day 1||0
56034|NCT01642485|133051|P1|NOT COMPLETED|Period 2, Day 1||0
56035|NCT01642485|133044|P8|COMPLETED|Period 2, Day 1||4
56036|NCT01642485|133045|P7|COMPLETED|Period 2, Day 1||4
56037|NCT01642485|133046|P6|COMPLETED|Period 2, Day 1||4
56038|NCT01642485|133047|P5|COMPLETED|Period 2, Day 1||4
56039|NCT01642485|133048|P4|COMPLETED|Period 2, Day 1||4
56040|NCT01642485|133049|P3|COMPLETED|Period 2, Day 1||4
56041|NCT01642485|133050|P2|COMPLETED|Period 2, Day 1||4
56042|NCT01642485|133051|P1|COMPLETED|Period 2, Day 1||4
56043|NCT01642485|133044|P8|STARTED|Period 2, Day 1||4
56044|NCT01642485|133045|P7|STARTED|Period 2, Day 1||4
56045|NCT01642485|133046|P6|STARTED|Period 2, Day 1||4
56046|NCT01642485|133047|P5|STARTED|Period 2, Day 1||4
56047|NCT01642485|133048|P4|STARTED|Period 2, Day 1||4
56048|NCT01642485|133049|P3|STARTED|Period 2, Day 1||4
56049|NCT01642485|133050|P2|STARTED|Period 2, Day 1||4
56050|NCT01642485|133051|P1|STARTED|Period 2, Day 1||4
56051|NCT01642485|133044|P8|NOT COMPLETED|Period 1, Day 3||0
56052|NCT01642485|133045|P7|NOT COMPLETED|Period 1, Day 3||0
56053|NCT01642485|133046|P6|NOT COMPLETED|Period 1, Day 3||0
56054|NCT01642485|133047|P5|NOT COMPLETED|Period 1, Day 3||0
56055|NCT01642485|133048|P4|NOT COMPLETED|Period 1, Day 3||0
56056|NCT01642485|133049|P3|NOT COMPLETED|Period 1, Day 3||0
56057|NCT01642485|133050|P2|NOT COMPLETED|Period 1, Day 3||0
56058|NCT01642485|133051|P1|NOT COMPLETED|Period 1, Day 3||0
56059|NCT01642485|133044|P8|COMPLETED|Period 1, Day 3||4
56060|NCT01642485|133045|P7|COMPLETED|Period 1, Day 3||4
56061|NCT01642485|133046|P6|COMPLETED|Period 1, Day 3||4
56062|NCT01642485|133047|P5|COMPLETED|Period 1, Day 3||4
56063|NCT01642485|133048|P4|COMPLETED|Period 1, Day 3||4
56064|NCT01642485|133049|P3|COMPLETED|Period 1, Day 3||4
56065|NCT01642485|133050|P2|COMPLETED|Period 1, Day 3||4
56066|NCT01642485|133051|P1|COMPLETED|Period 1, Day 3||4
56067|NCT01642485|133044|P8|STARTED|Period 1, Day 3||4
56068|NCT01642485|133045|P7|STARTED|Period 1, Day 3||4
56069|NCT01642485|133046|P6|STARTED|Period 1, Day 3||4
56070|NCT01642485|133047|P5|STARTED|Period 1, Day 3||4
56071|NCT01642485|133048|P4|STARTED|Period 1, Day 3||4
56072|NCT01642485|133049|P3|STARTED|Period 1, Day 3||4
56073|NCT01642485|133050|P2|STARTED|Period 1, Day 3||4
56074|NCT01642485|133051|P1|STARTED|Period 1, Day 3||4
56075|NCT01642485|133044|P8|NOT COMPLETED|Period 1, Day 2||0
56076|NCT01642485|133045|P7|NOT COMPLETED|Period 1, Day 2||0
56077|NCT01642485|133046|P6|NOT COMPLETED|Period 1, Day 2||0
56078|NCT01642485|133047|P5|NOT COMPLETED|Period 1, Day 2||0
56079|NCT01642485|133048|P4|NOT COMPLETED|Period 1, Day 2||0
56080|NCT01642485|133049|P3|NOT COMPLETED|Period 1, Day 2||0
56081|NCT01642485|133050|P2|NOT COMPLETED|Period 1, Day 2||0
56082|NCT01642485|133051|P1|NOT COMPLETED|Period 1, Day 2||0
56083|NCT01642485|133044|P8|COMPLETED|Period 1, Day 2||4
56084|NCT01642485|133045|P7|COMPLETED|Period 1, Day 2||4
56085|NCT01642485|133046|P6|COMPLETED|Period 1, Day 2||4
56086|NCT01642485|133047|P5|COMPLETED|Period 1, Day 2||4
56087|NCT01642485|133048|P4|COMPLETED|Period 1, Day 2||4
56088|NCT01642485|133049|P3|COMPLETED|Period 1, Day 2||4
56089|NCT01642485|133050|P2|COMPLETED|Period 1, Day 2||4
56090|NCT01642485|133051|P1|COMPLETED|Period 1, Day 2||4
56091|NCT01642485|133044|P8|STARTED|Period 1, Day 2||4
56092|NCT01642485|133045|P7|STARTED|Period 1, Day 2||4
56093|NCT01642485|133046|P6|STARTED|Period 1, Day 2||4
56094|NCT01642485|133047|P5|STARTED|Period 1, Day 2||4
56095|NCT01642485|133048|P4|STARTED|Period 1, Day 2||4
56096|NCT01642485|133049|P3|STARTED|Period 1, Day 2||4
56097|NCT01642485|133050|P2|STARTED|Period 1, Day 2||4
56098|NCT01642485|133051|P1|STARTED|Period 1, Day 2||4
56099|NCT01642485|133044|P8|NOT COMPLETED|Period 1, Day 1||0
56100|NCT01642485|133045|P7|NOT COMPLETED|Period 1, Day 1||0
56101|NCT01642485|133046|P6|NOT COMPLETED|Period 1, Day 1||0
56102|NCT01642485|133047|P5|NOT COMPLETED|Period 1, Day 1||0
56103|NCT01642485|133048|P4|NOT COMPLETED|Period 1, Day 1||0
56104|NCT01642485|133049|P3|NOT COMPLETED|Period 1, Day 1||0
56105|NCT01642485|133050|P2|NOT COMPLETED|Period 1, Day 1||0
56106|NCT01642485|133051|P1|NOT COMPLETED|Period 1, Day 1||0
56107|NCT01642485|133044|P8|COMPLETED|Period 1, Day 1||4
56108|NCT01642485|133045|P7|COMPLETED|Period 1, Day 1||4
56109|NCT01642485|133046|P6|COMPLETED|Period 1, Day 1||4
56110|NCT01642485|133047|P5|COMPLETED|Period 1, Day 1||4
56111|NCT01642485|133048|P4|COMPLETED|Period 1, Day 1||4
56112|NCT01642485|133049|P3|COMPLETED|Period 1, Day 1||4
56113|NCT01642485|133050|P2|COMPLETED|Period 1, Day 1||4
56114|NCT01642485|133051|P1|COMPLETED|Period 1, Day 1||4
56115|NCT01642485|133044|P8|STARTED|Period 1, Day 1||4
56116|NCT01642485|133045|P7|STARTED|Period 1, Day 1||4
56117|NCT01642485|133046|P6|STARTED|Period 1, Day 1||4
56118|NCT01642485|133047|P5|STARTED|Period 1, Day 1||4
56119|NCT01642485|133048|P4|STARTED|Period 1, Day 1||4
56120|NCT01642485|133049|P3|STARTED|Period 1, Day 1||4
56121|NCT01642485|133050|P2|STARTED|Period 1, Day 1||4
56122|NCT01642485|133051|P1|STARTED|Period 1, Day 1|crossover so all subjects had this treatment|4
56123|NCT01642407|133069|P1|NOT COMPLETED|Overall Study||2
56124|NCT01642407|133069|P1|COMPLETED|Overall Study||4
56125|NCT01642407|133069|P1|STARTED|Overall Study||6
56126|NCT01642277|133113|P2|NOT COMPLETED|Overall Study||0
56127|NCT01642277|133114|P1|NOT COMPLETED|Overall Study||24
56128|NCT01642277|133113|P2|COMPLETED|Overall Study||60
56129|NCT01642277|133114|P1|COMPLETED|Overall Study||50
56130|NCT01642277|133113|P2|STARTED|Overall Study||60
56131|NCT01642277|133114|P1|STARTED|Overall Study||74
56132|NCT01642238|133123|P2|NOT COMPLETED|Second Intervention (1 Day)||0
56133|NCT01642238|133124|P1|NOT COMPLETED|Second Intervention (1 Day)||0
56134|NCT01642238|133123|P2|COMPLETED|Second Intervention (1 Day)||8
56135|NCT01642238|133124|P1|COMPLETED|Second Intervention (1 Day)||7
56136|NCT01642238|133123|P2|STARTED|Second Intervention (1 Day)||8
56137|NCT01642238|133124|P1|STARTED|Second Intervention (1 Day)||7
56138|NCT01642238|133123|P2|NOT COMPLETED|Washout (1-2 Weeks)||0
56139|NCT01642238|133124|P1|NOT COMPLETED|Washout (1-2 Weeks)||0
56140|NCT01642238|133123|P2|COMPLETED|Washout (1-2 Weeks)||8
56141|NCT01642238|133124|P1|COMPLETED|Washout (1-2 Weeks)||7
56142|NCT01642238|133123|P2|STARTED|Washout (1-2 Weeks)||8
56143|NCT01642238|133124|P1|STARTED|Washout (1-2 Weeks)||7
56144|NCT01642238|133123|P2|NOT COMPLETED|First Intervention (1 Day)||0
56145|NCT01642238|133124|P1|NOT COMPLETED|First Intervention (1 Day)||0
56146|NCT01642238|133123|P2|COMPLETED|First Intervention (1 Day)||8
56147|NCT01642238|133124|P1|COMPLETED|First Intervention (1 Day)||7
56148|NCT01642238|133123|P2|STARTED|First Intervention (1 Day)||8
56149|NCT01642238|133124|P1|STARTED|First Intervention (1 Day)||7
56150|NCT01642212|133146|P5|NOT COMPLETED|Open-label Extension||8
56151|NCT01642212|133147|P4|NOT COMPLETED|Open-label Extension||10
56152|NCT01642212|133148|P3|NOT COMPLETED|Open-label Extension||0
56153|NCT01642212|133149|P2|NOT COMPLETED|Open-label Extension||0
56154|NCT01642212|133150|P1|NOT COMPLETED|Open-label Extension||0
56155|NCT01642212|133146|P5|COMPLETED|Open-label Extension||37
56156|NCT01642212|133147|P4|COMPLETED|Open-label Extension||27
56157|NCT01642212|133148|P3|COMPLETED|Open-label Extension||0
56158|NCT01642212|133149|P2|COMPLETED|Open-label Extension||0
56159|NCT01642212|133150|P1|COMPLETED|Open-label Extension||0
56160|NCT01642212|133146|P5|STARTED|Open-label Extension|Four participants completed double-blind treatment but did not enter the open-label extension.|45
56161|NCT01642212|133147|P4|STARTED|Open-label Extension|Two participants completed double-blind treatment but did not enter the open-label extension.|37
56162|NCT01642212|133148|P3|STARTED|Open-label Extension||0
56163|NCT01642212|133149|P2|STARTED|Open-label Extension||0
56164|NCT01642212|133150|P1|STARTED|Open-label Extension||0
56165|NCT01642212|133146|P5|NOT COMPLETED|Double-blind Treatment||0
56166|NCT01642212|133147|P4|NOT COMPLETED|Double-blind Treatment||0
56167|NCT01642212|133148|P3|NOT COMPLETED|Double-blind Treatment||2
56168|NCT01642212|133149|P2|NOT COMPLETED|Double-blind Treatment||3
56169|NCT01642212|133150|P1|NOT COMPLETED|Double-blind Treatment||0
56170|NCT01642212|133146|P5|COMPLETED|Double-blind Treatment||0
56171|NCT01642212|133147|P4|COMPLETED|Double-blind Treatment||0
56172|NCT01642212|133148|P3|COMPLETED|Double-blind Treatment||49
56173|NCT01642212|133149|P2|COMPLETED|Double-blind Treatment||39
56174|NCT01642212|133150|P1|COMPLETED|Double-blind Treatment||0
56175|NCT01642212|133146|P5|STARTED|Double-blind Treatment||0
56176|NCT01642212|133147|P4|STARTED|Double-blind Treatment||0
56177|NCT01642212|133148|P3|STARTED|Double-blind Treatment||51
56178|NCT01642212|133149|P2|STARTED|Double-blind Treatment||42
56179|NCT01642212|133150|P1|STARTED|Double-blind Treatment||0
56180|NCT01642212|133146|P5|NOT COMPLETED|Single-blind Baseline||0
56181|NCT01642212|133147|P4|NOT COMPLETED|Single-blind Baseline||0
56182|NCT01642212|133148|P3|NOT COMPLETED|Single-blind Baseline||0
56183|NCT01642212|133149|P2|NOT COMPLETED|Single-blind Baseline||0
56184|NCT01642212|133150|P1|NOT COMPLETED|Single-blind Baseline||26
56185|NCT01642212|133146|P5|COMPLETED|Single-blind Baseline||0
56186|NCT01642212|133147|P4|COMPLETED|Single-blind Baseline||0
56187|NCT01642212|133148|P3|COMPLETED|Single-blind Baseline||0
56188|NCT01642212|133149|P2|COMPLETED|Single-blind Baseline||0
56189|NCT01642212|133150|P1|COMPLETED|Single-blind Baseline||93
56190|NCT01642212|133146|P5|STARTED|Single-blind Baseline||0
56191|NCT01642212|133147|P4|STARTED|Single-blind Baseline||0
56192|NCT01642212|133148|P3|STARTED|Single-blind Baseline||0
56193|NCT01642212|133149|P2|STARTED|Single-blind Baseline||0
56194|NCT01642212|133150|P1|STARTED|Single-blind Baseline||119
56195|NCT01642147|133200|P2|NOT COMPLETED|Overall Study||0
56196|NCT01642147|133201|P1|NOT COMPLETED|Overall Study||0
56197|NCT01642147|133200|P2|COMPLETED|Overall Study||30
56198|NCT01642147|133201|P1|COMPLETED|Overall Study||30
56199|NCT01642147|133200|P2|STARTED|Overall Study||30
56200|NCT01642147|133201|P1|STARTED|Overall Study||30
56201|NCT01642082|133229|P1|NOT COMPLETED|Overall Study||0
56202|NCT01642082|133229|P1|COMPLETED|Overall Study||28
56203|NCT01642082|133229|P1|STARTED|Overall Study||28
56204|NCT01642004|133239|P2|NOT COMPLETED|Treatment||127
56205|NCT01642004|133240|P1|NOT COMPLETED|Treatment||110
56206|NCT01642004|133239|P2|COMPLETED|Treatment||2
56207|NCT01642004|133240|P1|COMPLETED|Treatment||21
56208|NCT01642004|133239|P2|STARTED|Treatment||129
56209|NCT01642004|133240|P1|STARTED|Treatment||131
56210|NCT01642004|133239|P2|NOT COMPLETED|Randomization||8
56211|NCT01642004|133240|P1|NOT COMPLETED|Randomization||4
56212|NCT01642004|133239|P2|COMPLETED|Randomization||129
56213|NCT01642004|133240|P1|COMPLETED|Randomization||131
56214|NCT01642004|133239|P2|STARTED|Randomization||137
56215|NCT01642004|133240|P1|STARTED|Randomization||135
56216|NCT01641991|133274|P4|NOT COMPLETED|Overall Study||16
56217|NCT01641991|133275|P3|NOT COMPLETED|Overall Study||17
56218|NCT01641991|133276|P2|NOT COMPLETED|Overall Study||8
56219|NCT01641991|133277|P1|NOT COMPLETED|Overall Study||9
56220|NCT01641991|133274|P4|COMPLETED|Overall Study||66
56221|NCT01641991|133275|P3|COMPLETED|Overall Study||65
56222|NCT01641991|133276|P2|COMPLETED|Overall Study||74
56223|NCT01641991|133277|P1|COMPLETED|Overall Study||73
56224|NCT01641991|133274|P4|STARTED|Overall Study||82
56225|NCT01641991|133275|P3|STARTED|Overall Study||82
56226|NCT01641991|133276|P2|STARTED|Overall Study||82
56227|NCT01641991|133277|P1|STARTED|Overall Study||82
56228|NCT01641978|133353|P1|NOT COMPLETED|Overall Study||0
56229|NCT01641978|133353|P1|COMPLETED|Overall Study||125
56230|NCT01641978|133353|P1|STARTED|Overall Study||125
56231|NCT01641952|133361|P1|NOT COMPLETED|Overall Study||34
56232|NCT01641952|133361|P1|COMPLETED|Overall Study||471
56233|NCT01641952|133361|P1|Treated|Overall Study||504
56234|NCT01641952|133361|P1|STARTED|Overall Study||505
56235|NCT01641939|133377|P3|NOT COMPLETED|Overall Study||70
56236|NCT01641939|133378|P2|NOT COMPLETED|Overall Study||228
56237|NCT01641939|133379|P1|NOT COMPLETED|Overall Study||117
56238|NCT01641939|133377|P3|COMPLETED|Overall Study||0
56239|NCT01641939|133378|P2|COMPLETED|Overall Study||0
56240|NCT01641939|133379|P1|COMPLETED|Overall Study||0
56241|NCT01641939|133377|P3|Stage 2|Overall Study||0
56242|NCT01641939|133378|P2|Stage 2|Overall Study||153
56243|NCT01641939|133379|P1|Stage 2|Overall Study||80
56244|NCT01641939|133377|P3|Stage 1|Overall Study||70
56245|NCT01641939|133378|P2|Stage 1|Overall Study||75
56246|NCT01641939|133379|P1|Stage 1|Overall Study||37
56247|NCT01641939|133377|P3|STARTED|Overall Study||70
56248|NCT01641939|133378|P2|STARTED|Overall Study||228
56249|NCT01641939|133379|P1|STARTED|Overall Study||117
56250|NCT01641926|133422|P4|NOT COMPLETED|Overall Study||4
56251|NCT01641926|133423|P3|NOT COMPLETED|Overall Study||11
56252|NCT01641926|133424|P2|NOT COMPLETED|Overall Study||15
56253|NCT01641926|133425|P1|NOT COMPLETED|Overall Study||28
56254|NCT01641926|133422|P4|COMPLETED|Overall Study||53
56255|NCT01641926|133423|P3|COMPLETED|Overall Study||46
56256|NCT01641926|133424|P2|COMPLETED|Overall Study||130
56257|NCT01641926|133425|P1|COMPLETED|Overall Study||115
56258|NCT01641926|133422|P4|Treated (All Participants as Treated)|Overall Study||57
56259|NCT01641926|133423|P3|Treated (All Participants as Treated)|Overall Study||56
56260|NCT01641926|133424|P2|Treated (All Participants as Treated)|Overall Study||144
56261|NCT01641926|133425|P1|Treated (All Participants as Treated)|Overall Study||142
56262|NCT01641926|133422|P4|STARTED|Overall Study||57
56263|NCT01641926|133423|P3|STARTED|Overall Study||57
56264|NCT01641926|133424|P2|STARTED|Overall Study||145
56265|NCT01641926|133425|P1|STARTED|Overall Study||143
56266|NCT01641900|133453|P2|NOT COMPLETED|Overall Study||2
56267|NCT01641900|133454|P1|NOT COMPLETED|Overall Study||2
56268|NCT01641900|133453|P2|COMPLETED|Overall Study||29
56269|NCT01641900|133454|P1|COMPLETED|Overall Study||26
56270|NCT01641900|133453|P2|Completed Drug Intervention|Overall Study||29
56271|NCT01641900|133454|P1|Completed Drug Intervention|Overall Study|n=1,assigned to drug intervention first, completed the session and dropped out of the study.|26
56272|NCT01641900|133453|P2|Completed Placebo Intervention|Overall Study|n=2,both assigned to placebo intervention first, completed the session and dropped out of the study.|29
56273|NCT01641900|133454|P1|Completed Placebo Intervention|Overall Study|n=1,assigned to placebo intervention first, completed the session and dropped out of the study.|27
56274|NCT01641900|133453|P2|STARTED|Overall Study||31
56275|NCT01641900|133454|P1|STARTED|Overall Study||28
56276|NCT01641861|133466|P2|NOT COMPLETED|Overall Study||25
56277|NCT01641861|133467|P1|NOT COMPLETED|Overall Study||35
56278|NCT01641861|133466|P2|COMPLETED|Overall Study||217
56279|NCT01641861|133467|P1|COMPLETED|Overall Study||211
56280|NCT01641861|133466|P2|STARTED|Overall Study||242
56281|NCT01641861|133467|P1|STARTED|Overall Study||246
56282|NCT01641835|133481|P1|NOT COMPLETED|Overall Study||0
56283|NCT01641835|133481|P1|COMPLETED|Overall Study||303
56284|NCT01641835|133481|P1|STARTED|Overall Study||303
56285|NCT01641822|133488|P3|NOT COMPLETED|Comparative Phase||10
56286|NCT01641822|133489|P2|NOT COMPLETED|Comparative Phase||6
56287|NCT01641822|133490|P1|NOT COMPLETED|Comparative Phase||0
56288|NCT01641822|133488|P3|COMPLETED|Comparative Phase||37
56289|NCT01641822|133489|P2|COMPLETED|Comparative Phase||37
56290|NCT01641822|133490|P1|COMPLETED|Comparative Phase||0
56291|NCT01641822|133488|P3|Received Randomized Study Drug Treatment|Comparative Phase||46
56292|NCT01641822|133489|P2|Received Randomized Study Drug Treatment|Comparative Phase||42
56293|NCT01641822|133490|P1|Received Randomized Study Drug Treatment|Comparative Phase||0
56294|NCT01641822|133488|P3|STARTED|Comparative Phase||47
56295|NCT01641822|133489|P2|STARTED|Comparative Phase||43
56296|NCT01641822|133490|P1|STARTED|Comparative Phase|Participants continuing into the Comparative Phase were randomized to the AZLI or Placebo group.|0
56297|NCT01641822|133488|P3|NOT COMPLETED|Run-in Phase||0
56298|NCT01641822|133489|P2|NOT COMPLETED|Run-in Phase||0
56299|NCT01641822|133490|P1|NOT COMPLETED|Run-in Phase||14
56300|NCT01641822|133488|P3|COMPLETED|Run-in Phase||0
56301|NCT01641822|133489|P2|COMPLETED|Run-in Phase||0
56302|NCT01641822|133490|P1|COMPLETED|Run-in Phase|3 participants who completed the TIS Run-In Phase did not continue to the Comparative Phase.|93
56303|NCT01641822|133488|P3|STARTED|Run-in Phase||0
56304|NCT01641822|133489|P2|STARTED|Run-in Phase||0
56305|NCT01641822|133490|P1|STARTED|Run-in Phase||107
56306|NCT01641692|133507|P8|NOT COMPLETED|Washout Period 3 or Follow-up||0
56307|NCT01641692|133508|P7|NOT COMPLETED|Washout Period 3 or Follow-up||1
56308|NCT01641692|133509|P6|NOT COMPLETED|Washout Period 3 or Follow-up||2
56309|NCT01641692|133510|P5|NOT COMPLETED|Washout Period 3 or Follow-up||0
56310|NCT01641692|133511|P4|NOT COMPLETED|Washout Period 3 or Follow-up||1
56311|NCT01641692|133512|P3|NOT COMPLETED|Washout Period 3 or Follow-up||1
56312|NCT01641692|133513|P2|NOT COMPLETED|Washout Period 3 or Follow-up||0
56313|NCT01641692|133514|P1|NOT COMPLETED|Washout Period 3 or Follow-up||1
56314|NCT01641692|133507|P8|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|38
56315|NCT01641692|133508|P7|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
56316|NCT01641692|133509|P6|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|37
56383|NCT01641692|133512|P3|NOT COMPLETED|Treatment Period 2||0
56317|NCT01641692|133510|P5|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|40
56318|NCT01641692|133511|P4|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|41
56319|NCT01641692|133512|P3|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|36
56320|NCT01641692|133513|P2|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|32
56321|NCT01641692|133514|P1|COMPLETED|Washout Period 3 or Follow-up|Participants withdrawing during washout are counted under the last treatment taken.|42
56322|NCT01641692|133507|P8|STARTED|Washout Period 3 or Follow-up||38
56323|NCT01641692|133508|P7|STARTED|Washout Period 3 or Follow-up||33
56324|NCT01641692|133509|P6|STARTED|Washout Period 3 or Follow-up||39
56325|NCT01641692|133510|P5|STARTED|Washout Period 3 or Follow-up||40
56326|NCT01641692|133511|P4|STARTED|Washout Period 3 or Follow-up||42
56327|NCT01641692|133512|P3|STARTED|Washout Period 3 or Follow-up||37
56328|NCT01641692|133513|P2|STARTED|Washout Period 3 or Follow-up||32
56329|NCT01641692|133514|P1|STARTED|Washout Period 3 or Follow-up||43
56330|NCT01641692|133507|P8|NOT COMPLETED|Treatment Period 3||0
56331|NCT01641692|133508|P7|NOT COMPLETED|Treatment Period 3||2
56332|NCT01641692|133509|P6|NOT COMPLETED|Treatment Period 3||0
56333|NCT01641692|133510|P5|NOT COMPLETED|Treatment Period 3||0
56334|NCT01641692|133511|P4|NOT COMPLETED|Treatment Period 3||0
56335|NCT01641692|133512|P3|NOT COMPLETED|Treatment Period 3||1
56336|NCT01641692|133513|P2|NOT COMPLETED|Treatment Period 3||1
56337|NCT01641692|133514|P1|NOT COMPLETED|Treatment Period 3||0
56338|NCT01641692|133507|P8|COMPLETED|Treatment Period 3||38
56339|NCT01641692|133508|P7|COMPLETED|Treatment Period 3||33
56340|NCT01641692|133509|P6|COMPLETED|Treatment Period 3||39
56341|NCT01641692|133510|P5|COMPLETED|Treatment Period 3||40
56342|NCT01641692|133511|P4|COMPLETED|Treatment Period 3||42
56343|NCT01641692|133512|P3|COMPLETED|Treatment Period 3||37
56344|NCT01641692|133513|P2|COMPLETED|Treatment Period 3||32
56345|NCT01641692|133514|P1|COMPLETED|Treatment Period 3||43
56346|NCT01641692|133507|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
56347|NCT01641692|133508|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|35
56348|NCT01641692|133509|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|39
56349|NCT01641692|133510|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|40
56350|NCT01641692|133511|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|42
56351|NCT01641692|133512|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|38
56352|NCT01641692|133513|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|33
56353|NCT01641692|133514|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|43
56354|NCT01641692|133507|P8|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
56355|NCT01641692|133508|P7|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
56356|NCT01641692|133509|P6|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
56357|NCT01641692|133510|P5|NOT COMPLETED|Washout Period 2 (12-14 Days)||3
56358|NCT01641692|133511|P4|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
56359|NCT01641692|133512|P3|NOT COMPLETED|Washout Period 2 (12-14 Days)||1
56360|NCT01641692|133513|P2|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
56361|NCT01641692|133514|P1|NOT COMPLETED|Washout Period 2 (12-14 Days)||0
56362|NCT01641692|133507|P8|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
56363|NCT01641692|133508|P7|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
56364|NCT01641692|133509|P6|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|42
56365|NCT01641692|133510|P5|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|34
56366|NCT01641692|133511|P4|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|41
56367|NCT01641692|133512|P3|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
56368|NCT01641692|133513|P2|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|46
56369|NCT01641692|133514|P1|COMPLETED|Washout Period 2 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|30
56370|NCT01641692|133507|P8|STARTED|Washout Period 2 (12-14 Days)||35
56371|NCT01641692|133508|P7|STARTED|Washout Period 2 (12-14 Days)||43
56372|NCT01641692|133509|P6|STARTED|Washout Period 2 (12-14 Days)||43
56373|NCT01641692|133510|P5|STARTED|Washout Period 2 (12-14 Days)||37
56374|NCT01641692|133511|P4|STARTED|Washout Period 2 (12-14 Days)||41
56375|NCT01641692|133512|P3|STARTED|Washout Period 2 (12-14 Days)||40
56376|NCT01641692|133513|P2|STARTED|Washout Period 2 (12-14 Days)||46
56377|NCT01641692|133514|P1|STARTED|Washout Period 2 (12-14 Days)||30
56378|NCT01641692|133507|P8|NOT COMPLETED|Treatment Period 2||1
56379|NCT01641692|133508|P7|NOT COMPLETED|Treatment Period 2||0
56380|NCT01641692|133509|P6|NOT COMPLETED|Treatment Period 2||2
56381|NCT01641692|133510|P5|NOT COMPLETED|Treatment Period 2||0
56382|NCT01641692|133511|P4|NOT COMPLETED|Treatment Period 2||0
56384|NCT01641692|133513|P2|NOT COMPLETED|Treatment Period 2||0
56385|NCT01641692|133514|P1|NOT COMPLETED|Treatment Period 2||3
56386|NCT01641692|133507|P8|COMPLETED|Treatment Period 2||35
56387|NCT01641692|133508|P7|COMPLETED|Treatment Period 2||43
56388|NCT01641692|133509|P6|COMPLETED|Treatment Period 2||43
56389|NCT01641692|133510|P5|COMPLETED|Treatment Period 2||37
56390|NCT01641692|133511|P4|COMPLETED|Treatment Period 2||41
56391|NCT01641692|133512|P3|COMPLETED|Treatment Period 2||40
56392|NCT01641692|133513|P2|COMPLETED|Treatment Period 2||46
56393|NCT01641692|133514|P1|COMPLETED|Treatment Period 2||30
56394|NCT01641692|133507|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|36
56395|NCT01641692|133508|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|43
56396|NCT01641692|133509|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|45
56397|NCT01641692|133510|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|37
56398|NCT01641692|133511|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|41
56399|NCT01641692|133512|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|40
56400|NCT01641692|133513|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|46
56401|NCT01641692|133514|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|33
56402|NCT01641692|133507|P8|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
56403|NCT01641692|133508|P7|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
56404|NCT01641692|133509|P6|NOT COMPLETED|Washout Period 1 (12-14 Days)||0
56405|NCT01641692|133510|P5|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
56406|NCT01641692|133511|P4|NOT COMPLETED|Washout Period 1 (12-14 Days)||2
56407|NCT01641692|133512|P3|NOT COMPLETED|Washout Period 1 (12-14 Days)||3
56408|NCT01641692|133513|P2|NOT COMPLETED|Washout Period 1 (12-14 Days)||1
56409|NCT01641692|133514|P1|NOT COMPLETED|Washout Period 1 (12-14 Days)||4
56410|NCT01641692|133507|P8|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
56411|NCT01641692|133508|P7|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
56412|NCT01641692|133509|P6|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|37
56413|NCT01641692|133510|P5|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|35
56414|NCT01641692|133511|P4|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|39
56415|NCT01641692|133512|P3|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|47
56416|NCT01641692|133513|P2|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|44
56417|NCT01641692|133514|P1|COMPLETED|Washout Period 1 (12-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|36
56418|NCT01641692|133507|P8|STARTED|Washout Period 1 (12-14 Days)||48
56419|NCT01641692|133508|P7|STARTED|Washout Period 1 (12-14 Days)||38
56420|NCT01641692|133509|P6|STARTED|Washout Period 1 (12-14 Days)||37
56421|NCT01641692|133510|P5|STARTED|Washout Period 1 (12-14 Days)||39
56422|NCT01641692|133511|P4|STARTED|Washout Period 1 (12-14 Days)||41
56423|NCT01641692|133512|P3|STARTED|Washout Period 1 (12-14 Days)||50
56424|NCT01641692|133513|P2|STARTED|Washout Period 1 (12-14 Days)||45
56425|NCT01641692|133514|P1|STARTED|Washout Period 1 (12-14 Days)||40
56426|NCT01641692|133507|P8|NOT COMPLETED|Treatment Period 1||3
56427|NCT01641692|133508|P7|NOT COMPLETED|Treatment Period 1||0
56428|NCT01641692|133509|P6|NOT COMPLETED|Treatment Period 1||2
56429|NCT01641692|133510|P5|NOT COMPLETED|Treatment Period 1||4
56430|NCT01641692|133511|P4|NOT COMPLETED|Treatment Period 1||0
56431|NCT01641692|133512|P3|NOT COMPLETED|Treatment Period 1||1
56432|NCT01641692|133513|P2|NOT COMPLETED|Treatment Period 1||0
56433|NCT01641692|133514|P1|NOT COMPLETED|Treatment Period 1||2
56434|NCT01641692|133507|P8|COMPLETED|Treatment Period 1||48
56435|NCT01641692|133508|P7|COMPLETED|Treatment Period 1||38
56436|NCT01641692|133509|P6|COMPLETED|Treatment Period 1||37
56437|NCT01641692|133510|P5|COMPLETED|Treatment Period 1||39
56438|NCT01641692|133511|P4|COMPLETED|Treatment Period 1||41
56439|NCT01641692|133512|P3|COMPLETED|Treatment Period 1||50
56440|NCT01641692|133513|P2|COMPLETED|Treatment Period 1||45
56441|NCT01641692|133514|P1|COMPLETED|Treatment Period 1||40
56442|NCT01641692|133507|P8|STARTED|Treatment Period 1||51
56443|NCT01641692|133508|P7|STARTED|Treatment Period 1||38
56444|NCT01641692|133509|P6|STARTED|Treatment Period 1||39
56445|NCT01641692|133510|P5|STARTED|Treatment Period 1||43
56446|NCT01641692|133511|P4|STARTED|Treatment Period 1||41
56447|NCT01641692|133512|P3|STARTED|Treatment Period 1||51
56448|NCT01641692|133513|P2|STARTED|Treatment Period 1||45
56449|NCT01641692|133514|P1|STARTED|Treatment Period 1||42
56450|NCT01641653|133703|P2|NOT COMPLETED|Overall Study||0
56451|NCT01641653|133704|P1|NOT COMPLETED|Overall Study||0
56452|NCT01641653|133703|P2|COMPLETED|Overall Study||30
56453|NCT01641653|133704|P1|COMPLETED|Overall Study||30
56454|NCT01641653|133703|P2|STARTED|Overall Study||30
56455|NCT01641653|133704|P1|STARTED|Overall Study||30
56456|NCT01641640|133714|P1|NOT COMPLETED|Overall Study||36
56457|NCT01641640|133714|P1|COMPLETED|Overall Study||292
56458|NCT01641640|133714|P1|Enrolled and Treated|Overall Study||327
56459|NCT01641640|133714|P1|STARTED|Overall Study||328
56460|NCT01641471|133725|P2|NOT COMPLETED|Overall Study||27
56461|NCT01641471|133726|P1|NOT COMPLETED|Overall Study||23
56462|NCT01641471|133725|P2|COMPLETED|Overall Study||31
56463|NCT01641471|133726|P1|COMPLETED|Overall Study||35
56464|NCT01641471|133725|P2|STARTED|Overall Study||58
56465|NCT01641471|133726|P1|STARTED|Overall Study||58
56466|NCT01641237|133732|P4|NOT COMPLETED|Period IV||0
56467|NCT01641237|133733|P3|NOT COMPLETED|Period IV||0
56468|NCT01641237|133734|P2|NOT COMPLETED|Period IV||0
56469|NCT01641237|133735|P1|NOT COMPLETED|Period IV||0
56470|NCT01641237|133732|P4|COMPLETED|Period IV||15
56471|NCT01641237|133733|P3|COMPLETED|Period IV||15
56472|NCT01641237|133734|P2|COMPLETED|Period IV||15
56473|NCT01641237|133735|P1|COMPLETED|Period IV||15
56474|NCT01641237|133732|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
56475|NCT01641237|133733|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
56476|NCT01641237|133734|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
56477|NCT01641237|133735|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|15
56478|NCT01641237|133732|P4|NOT COMPLETED|Period III||0
56479|NCT01641237|133733|P3|NOT COMPLETED|Period III||0
56480|NCT01641237|133734|P2|NOT COMPLETED|Period III||0
56481|NCT01641237|133735|P1|NOT COMPLETED|Period III||1
56482|NCT01641237|133732|P4|COMPLETED|Period III||16
56483|NCT01641237|133733|P3|COMPLETED|Period III||15
56484|NCT01641237|133734|P2|COMPLETED|Period III||14
56485|NCT01641237|133735|P1|COMPLETED|Period III||15
56486|NCT01641237|133732|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
56487|NCT01641237|133733|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|15
56488|NCT01641237|133734|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
56489|NCT01641237|133735|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|16
56490|NCT01641237|133732|P4|NOT COMPLETED|Period II||0
56491|NCT01641237|133733|P3|NOT COMPLETED|Period II||0
56492|NCT01641237|133734|P2|NOT COMPLETED|Period II||0
56493|NCT01641237|133735|P1|NOT COMPLETED|Period II||1
56494|NCT01641237|133732|P4|COMPLETED|Period II||15
56495|NCT01641237|133733|P3|COMPLETED|Period II||16
56496|NCT01641237|133734|P2|COMPLETED|Period II||16
56497|NCT01641237|133735|P1|COMPLETED|Period II||14
56498|NCT01641237|133732|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
56499|NCT01641237|133733|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
56500|NCT01641237|133734|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|16
56501|NCT01641237|133735|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|15
56502|NCT01641237|133732|P4|NOT COMPLETED|Period I||0
56503|NCT01641237|133733|P3|NOT COMPLETED|Period I||0
56504|NCT01641237|133734|P2|NOT COMPLETED|Period I||0
56505|NCT01641237|133735|P1|NOT COMPLETED|Period I||0
56506|NCT01641237|133732|P4|COMPLETED|Period I||15
56507|NCT01641237|133733|P3|COMPLETED|Period I||15
56508|NCT01641237|133734|P2|COMPLETED|Period I||16
56509|NCT01641237|133735|P1|COMPLETED|Period I||16
56510|NCT01641237|133732|P4|STARTED|Period I||15
56511|NCT01641237|133733|P3|STARTED|Period I||15
56512|NCT01641237|133734|P2|STARTED|Period I||16
56513|NCT01641237|133735|P1|STARTED|Period I||16
56514|NCT01641159|133759|P2|NOT COMPLETED|Overall Study||2
56515|NCT01641159|133760|P1|NOT COMPLETED|Overall Study||2
56516|NCT01641159|133759|P2|COMPLETED|Overall Study||25
56517|NCT01641159|133760|P1|COMPLETED|Overall Study||33
56518|NCT01641159|133759|P2|STARTED|Overall Study||27
56519|NCT01641159|133760|P1|STARTED|Overall Study||35
56520|NCT01641133|133771|P3|NOT COMPLETED|Overall Study||8
56521|NCT01641133|133772|P2|NOT COMPLETED|Overall Study||9
56522|NCT01641133|133773|P1|NOT COMPLETED|Overall Study||10
56523|NCT01641133|133771|P3|COMPLETED|Overall Study||90
56524|NCT01641133|133772|P2|COMPLETED|Overall Study||90
56525|NCT01641133|133773|P1|COMPLETED|Overall Study||87
56526|NCT01641133|133771|P3|STARTED|Overall Study||98
56527|NCT01641133|133772|P2|STARTED|Overall Study||99
56528|NCT01641133|133773|P1|STARTED|Overall Study||97
56529|NCT01641120|133811|P1|NOT COMPLETED|30 Gauge Needle Weeks 2 and 3||0
56530|NCT01641120|133811|P1|COMPLETED|30 Gauge Needle Weeks 2 and 3||20
56531|NCT01641120|133811|P1|STARTED|30 Gauge Needle Weeks 2 and 3||20
56532|NCT01641120|133811|P1|NOT COMPLETED|25 Gauge Needle Weeks 1, 4, 5||0
56533|NCT01641120|133811|P1|COMPLETED|25 Gauge Needle Weeks 1, 4, 5||20
56534|NCT01641120|133811|P1|STARTED|25 Gauge Needle Weeks 1, 4, 5||20
56535|NCT01641081|133823|P10|NOT COMPLETED|Period 5||0
56536|NCT01641081|133824|P9|NOT COMPLETED|Period 5||0
56537|NCT01641081|133825|P8|NOT COMPLETED|Period 5||0
56538|NCT01641081|133826|P7|NOT COMPLETED|Period 5||0
56539|NCT01641081|133827|P6|NOT COMPLETED|Period 5||0
56540|NCT01641081|133828|P5|NOT COMPLETED|Period 5||0
56541|NCT01641081|133829|P4|NOT COMPLETED|Period 5||0
56542|NCT01641081|133830|P3|NOT COMPLETED|Period 5||2
56543|NCT01641081|133831|P2|NOT COMPLETED|Period 5||0
56544|NCT01641081|133832|P1|NOT COMPLETED|Period 5||0
56545|NCT01641081|133823|P10|COMPLETED|Period 5||14
56546|NCT01641081|133824|P9|COMPLETED|Period 5||14
56547|NCT01641081|133825|P8|COMPLETED|Period 5||14
56548|NCT01641081|133826|P7|COMPLETED|Period 5||16
56549|NCT01641081|133827|P6|COMPLETED|Period 5||18
56550|NCT01641081|133828|P5|COMPLETED|Period 5||16
56551|NCT01641081|133829|P4|COMPLETED|Period 5||20
56552|NCT01641081|133830|P3|COMPLETED|Period 5||12
56553|NCT01641081|133831|P2|COMPLETED|Period 5||17
56554|NCT01641081|133832|P1|COMPLETED|Period 5||16
56555|NCT01641081|133823|P10|STARTED|Period 5||14
56556|NCT01641081|133824|P9|STARTED|Period 5||14
56557|NCT01641081|133825|P8|STARTED|Period 5||14
56558|NCT01641081|133826|P7|STARTED|Period 5||16
56559|NCT01641081|133827|P6|STARTED|Period 5||18
56560|NCT01641081|133828|P5|STARTED|Period 5||16
56561|NCT01641081|133829|P4|STARTED|Period 5||20
56562|NCT01641081|133830|P3|STARTED|Period 5||14
56563|NCT01641081|133831|P2|STARTED|Period 5||17
56564|NCT01641081|133832|P1|STARTED|Period 5||16
56565|NCT01641081|133823|P10|NOT COMPLETED|Period 4||0
56566|NCT01641081|133824|P9|NOT COMPLETED|Period 4||0
56567|NCT01641081|133825|P8|NOT COMPLETED|Period 4||0
56568|NCT01641081|133826|P7|NOT COMPLETED|Period 4||0
56569|NCT01641081|133827|P6|NOT COMPLETED|Period 4||0
56570|NCT01641081|133828|P5|NOT COMPLETED|Period 4||0
56571|NCT01641081|133829|P4|NOT COMPLETED|Period 4||1
56572|NCT01641081|133830|P3|NOT COMPLETED|Period 4||0
56573|NCT01641081|133831|P2|NOT COMPLETED|Period 4||1
56574|NCT01641081|133832|P1|NOT COMPLETED|Period 4||0
56575|NCT01641081|133823|P10|COMPLETED|Period 4||14
56576|NCT01641081|133824|P9|COMPLETED|Period 4||14
56577|NCT01641081|133825|P8|COMPLETED|Period 4||14
56578|NCT01641081|133826|P7|COMPLETED|Period 4||16
56579|NCT01641081|133827|P6|COMPLETED|Period 4||18
56580|NCT01641081|133828|P5|COMPLETED|Period 4||16
56581|NCT01641081|133829|P4|COMPLETED|Period 4||20
56582|NCT01641081|133830|P3|COMPLETED|Period 4||14
56583|NCT01641081|133831|P2|COMPLETED|Period 4||17
56584|NCT01641081|133832|P1|COMPLETED|Period 4||16
56585|NCT01641081|133823|P10|STARTED|Period 4||14
56586|NCT01641081|133824|P9|STARTED|Period 4||14
56587|NCT01641081|133825|P8|STARTED|Period 4||14
56588|NCT01641081|133826|P7|STARTED|Period 4||16
56589|NCT01641081|133827|P6|STARTED|Period 4||18
56590|NCT01641081|133828|P5|STARTED|Period 4||16
56591|NCT01641081|133829|P4|STARTED|Period 4||21
56592|NCT01641081|133830|P3|STARTED|Period 4||14
56593|NCT01641081|133831|P2|STARTED|Period 4||18
56594|NCT01641081|133832|P1|STARTED|Period 4||16
56595|NCT01641081|133823|P10|NOT COMPLETED|Period 3||0
56596|NCT01641081|133824|P9|NOT COMPLETED|Period 3||1
56597|NCT01641081|133825|P8|NOT COMPLETED|Period 3||0
56598|NCT01641081|133826|P7|NOT COMPLETED|Period 3||0
56599|NCT01641081|133827|P6|NOT COMPLETED|Period 3||0
56600|NCT01641081|133828|P5|NOT COMPLETED|Period 3||0
56601|NCT01641081|133829|P4|NOT COMPLETED|Period 3||0
56602|NCT01641081|133830|P3|NOT COMPLETED|Period 3||1
56603|NCT01641081|133831|P2|NOT COMPLETED|Period 3||0
56604|NCT01641081|133832|P1|NOT COMPLETED|Period 3||0
56605|NCT01641081|133823|P10|COMPLETED|Period 3||14
56606|NCT01641081|133824|P9|COMPLETED|Period 3||14
56607|NCT01641081|133825|P8|COMPLETED|Period 3||14
56608|NCT01641081|133826|P7|COMPLETED|Period 3||16
56609|NCT01641081|133827|P6|COMPLETED|Period 3||18
56610|NCT01641081|133828|P5|COMPLETED|Period 3||16
56611|NCT01641081|133829|P4|COMPLETED|Period 3||21
56612|NCT01641081|133830|P3|COMPLETED|Period 3||14
56613|NCT01641081|133831|P2|COMPLETED|Period 3||18
56614|NCT01641081|133832|P1|COMPLETED|Period 3||16
56615|NCT01641081|133823|P10|STARTED|Period 3||14
56616|NCT01641081|133824|P9|STARTED|Period 3||15
56617|NCT01641081|133825|P8|STARTED|Period 3||14
56618|NCT01641081|133826|P7|STARTED|Period 3||16
56619|NCT01641081|133827|P6|STARTED|Period 3||18
56620|NCT01641081|133828|P5|STARTED|Period 3||16
56621|NCT01641081|133829|P4|STARTED|Period 3||21
56622|NCT01641081|133830|P3|STARTED|Period 3||15
56623|NCT01641081|133831|P2|STARTED|Period 3||18
56624|NCT01641081|133832|P1|STARTED|Period 3||16
56625|NCT01641081|133823|P10|NOT COMPLETED|Period 2||0
56626|NCT01641081|133824|P9|NOT COMPLETED|Period 2||0
56627|NCT01641081|133825|P8|NOT COMPLETED|Period 2||0
56628|NCT01641081|133826|P7|NOT COMPLETED|Period 2||2
56629|NCT01641081|133827|P6|NOT COMPLETED|Period 2||1
56630|NCT01641081|133828|P5|NOT COMPLETED|Period 2||0
56631|NCT01641081|133829|P4|NOT COMPLETED|Period 2||1
56632|NCT01641081|133830|P3|NOT COMPLETED|Period 2||0
56633|NCT01641081|133831|P2|NOT COMPLETED|Period 2||0
56634|NCT01641081|133832|P1|NOT COMPLETED|Period 2||1
56635|NCT01641081|133823|P10|COMPLETED|Period 2||14
56636|NCT01641081|133824|P9|COMPLETED|Period 2||15
56637|NCT01641081|133825|P8|COMPLETED|Period 2||14
56638|NCT01641081|133826|P7|COMPLETED|Period 2||16
56639|NCT01641081|133827|P6|COMPLETED|Period 2||18
56640|NCT01641081|133828|P5|COMPLETED|Period 2||16
56641|NCT01641081|133829|P4|COMPLETED|Period 2||21
56642|NCT01641081|133830|P3|COMPLETED|Period 2||15
56643|NCT01641081|133831|P2|COMPLETED|Period 2||18
56644|NCT01641081|133832|P1|COMPLETED|Period 2||16
56645|NCT01641081|133823|P10|STARTED|Period 2||14
56646|NCT01641081|133824|P9|STARTED|Period 2||15
56647|NCT01641081|133825|P8|STARTED|Period 2||14
56648|NCT01641081|133826|P7|STARTED|Period 2||18
56649|NCT01641081|133827|P6|STARTED|Period 2||19
56650|NCT01641081|133828|P5|STARTED|Period 2||16
56651|NCT01641081|133829|P4|STARTED|Period 2||22
56652|NCT01641081|133830|P3|STARTED|Period 2||15
56653|NCT01641081|133831|P2|STARTED|Period 2||18
56654|NCT01641081|133832|P1|STARTED|Period 2||17
56655|NCT01641081|133823|P10|NOT COMPLETED|Period 1||0
56656|NCT01641081|133824|P9|NOT COMPLETED|Period 1||0
56657|NCT01641081|133825|P8|NOT COMPLETED|Period 1||3
56658|NCT01641081|133826|P7|NOT COMPLETED|Period 1||1
56659|NCT01641081|133827|P6|NOT COMPLETED|Period 1||0
56660|NCT01641081|133828|P5|NOT COMPLETED|Period 1||1
56661|NCT01641081|133829|P4|NOT COMPLETED|Period 1||0
56662|NCT01641081|133830|P3|NOT COMPLETED|Period 1||0
56663|NCT01641081|133831|P2|NOT COMPLETED|Period 1||0
56664|NCT01641081|133832|P1|NOT COMPLETED|Period 1||1
56665|NCT01641081|133823|P10|COMPLETED|Period 1||14
56666|NCT01641081|133824|P9|COMPLETED|Period 1||15
56667|NCT01641081|133825|P8|COMPLETED|Period 1||14
56668|NCT01641081|133826|P7|COMPLETED|Period 1||18
56669|NCT01641081|133827|P6|COMPLETED|Period 1||19
56670|NCT01641081|133828|P5|COMPLETED|Period 1||16
56671|NCT01641081|133829|P4|COMPLETED|Period 1||22
56672|NCT01641081|133830|P3|COMPLETED|Period 1||15
56673|NCT01641081|133831|P2|COMPLETED|Period 1||18
56674|NCT01641081|133832|P1|COMPLETED|Period 1||17
56675|NCT01641081|133823|P10|STARTED|Period 1||14
56676|NCT01641081|133824|P9|STARTED|Period 1||15
56677|NCT01641081|133825|P8|STARTED|Period 1||17
56678|NCT01641081|133826|P7|STARTED|Period 1||19
56679|NCT01641081|133827|P6|STARTED|Period 1||19
56680|NCT01641081|133828|P5|STARTED|Period 1||17
56681|NCT01641081|133829|P4|STARTED|Period 1||22
56682|NCT01641081|133830|P3|STARTED|Period 1||15
56683|NCT01641081|133831|P2|STARTED|Period 1||18
56684|NCT01641081|133832|P1|STARTED|Period 1||18
56685|NCT01640964|133852|P3|NOT COMPLETED|Overall Study||3
56686|NCT01640964|133853|P2|NOT COMPLETED|Overall Study||1
56687|NCT01640964|133854|P1|NOT COMPLETED|Overall Study||1
56688|NCT01640964|133852|P3|COMPLETED|Overall Study||3
56689|NCT01640964|133853|P2|COMPLETED|Overall Study||19
56690|NCT01640964|133854|P1|COMPLETED|Overall Study||19
56691|NCT01640964|133852|P3|STARTED|Overall Study||6
56692|NCT01640964|133853|P2|STARTED|Overall Study||20
56693|NCT01640964|133854|P1|STARTED|Overall Study||20
56694|NCT01640925|133871|P2|NOT COMPLETED|Overall Study||11
56695|NCT01640925|133872|P1|NOT COMPLETED|Overall Study||14
56696|NCT01640925|133871|P2|COMPLETED|Overall Study||164
56697|NCT01640925|133872|P1|COMPLETED|Overall Study||161
56698|NCT01640925|133871|P2|STARTED|Overall Study||175
56699|NCT01640925|133872|P1|STARTED|Overall Study||175
56700|NCT01640548|133878|P1|NOT COMPLETED|Overall Study||0
56701|NCT01640548|133878|P1|COMPLETED|Overall Study||309
56702|NCT01640548|133878|P1|STARTED|Overall Study||309
56703|NCT01640353|133892|P1|NOT COMPLETED|Overall Study||45
56704|NCT01640353|133892|P1|COMPLETED|Overall Study||149
56705|NCT01640353|133892|P1|Month 18|Overall Study||150
56706|NCT01640353|133892|P1|Month 12|Overall Study||160
56707|NCT01640353|133892|P1|Month 6|Overall Study||168
56708|NCT01640353|133892|P1|Month 3|Overall Study||169
56709|NCT01640353|133892|P1|Month 1|Overall Study||171
56710|NCT01640353|133892|P1|Treated|Overall Study||172
56711|NCT01640353|133892|P1|STARTED|Overall Study||194
56712|NCT01640340|133904|P2|NOT COMPLETED|Overall Study||0
56713|NCT01640340|133905|P1|NOT COMPLETED|Overall Study||0
56714|NCT01640340|133904|P2|COMPLETED|Overall Study||20
56715|NCT01640340|133905|P1|COMPLETED|Overall Study||20
56716|NCT01640340|133904|P2|Overall Complete Response Rate|Overall Study||20
56717|NCT01640340|133905|P1|Overall Complete Response Rate|Overall Study||20
56718|NCT01640340|133904|P2|STARTED|Overall Study||20
56719|NCT01640340|133905|P1|STARTED|Overall Study||20
56720|NCT01640327|133925|P2|NOT COMPLETED|Overall Study||0
56721|NCT01640327|133926|P1|NOT COMPLETED|Overall Study||0
56722|NCT01640327|133925|P2|COMPLETED|Overall Study||63
56723|NCT01640327|133926|P1|COMPLETED|Overall Study||63
56724|NCT01640327|133925|P2|STARTED|Overall Study||63
56725|NCT01640327|133926|P1|STARTED|Overall Study||63
56726|NCT01640314|133940|P2|NOT COMPLETED|Overall Study||1
56727|NCT01640314|133941|P1|NOT COMPLETED|Overall Study||0
56728|NCT01640314|133940|P2|COMPLETED|Overall Study||62
56729|NCT01640314|133941|P1|COMPLETED|Overall Study||63
56730|NCT01640314|133940|P2|STARTED|Overall Study||63
56731|NCT01640314|133941|P1|STARTED|Overall Study||63
56732|NCT01640197|133957|P2|NOT COMPLETED|Overall Study||0
56733|NCT01640197|133958|P1|NOT COMPLETED|Overall Study||0
56734|NCT01640197|133957|P2|COMPLETED|Overall Study||30
56735|NCT01640197|133958|P1|COMPLETED|Overall Study||30
56736|NCT01640197|133957|P2|STARTED|Overall Study||30
56737|NCT01640197|133958|P1|STARTED|Overall Study||30
56738|NCT01640184|133979|P3|NOT COMPLETED|Overall Study||2
56739|NCT01640184|133980|P2|NOT COMPLETED|Overall Study||2
56740|NCT01640184|133981|P1|NOT COMPLETED|Overall Study||8
56741|NCT01640184|133979|P3|COMPLETED|Overall Study||20
56742|NCT01640184|133980|P2|COMPLETED|Overall Study||21
56743|NCT01640184|133981|P1|COMPLETED|Overall Study||26
56744|NCT01640184|133979|P3|STARTED|Overall Study||22
56745|NCT01640184|133980|P2|STARTED|Overall Study||23
56746|NCT01640184|133981|P1|STARTED|Overall Study||34
56747|NCT01640171|134003|P1|NOT COMPLETED|Overall Study||0
56748|NCT01640171|134003|P1|COMPLETED|Overall Study||57
56749|NCT01640171|134003|P1|STARTED|Overall Study||57
56750|NCT01640054|134010|P1|NOT COMPLETED|Overall Study||6
56751|NCT01640054|134010|P1|COMPLETED|Overall Study|Number of patients on treatment when the study was stopped.|109
56752|NCT01640054|134010|P1|Did Not Receive Treatment|Overall Study||0
56753|NCT01640054|134010|P1|STARTED|Overall Study|Patients who received treatment|115
56754|NCT01639833|134020|P2|NOT COMPLETED|Overall Study||4
56755|NCT01639833|134021|P1|NOT COMPLETED|Overall Study||6
56756|NCT01639833|134020|P2|COMPLETED|Overall Study||41
56757|NCT01639833|134021|P1|COMPLETED|Overall Study||39
56758|NCT01639833|134020|P2|STARTED|Overall Study||45
56759|NCT01639833|134021|P1|STARTED|Overall Study||45
56760|NCT01639755|134029|P1|NOT COMPLETED|Overall Study||19
56761|NCT01639755|134029|P1|COMPLETED|Overall Study||0
56762|NCT01639755|134029|P1|STARTED|Overall Study||19
56763|NCT01639742|134037|P1|NOT COMPLETED|Overall Study||18
56764|NCT01639742|134037|P1|COMPLETED|Overall Study||0
56765|NCT01639742|134037|P1|STARTED|Overall Study||18
56766|NCT01639729|134045|P6|NOT COMPLETED|Overall Study||0
56767|NCT01639729|134046|P5|NOT COMPLETED|Overall Study||0
56768|NCT01639729|134047|P4|NOT COMPLETED|Overall Study||1
56769|NCT01639729|134048|P3|NOT COMPLETED|Overall Study||1
56770|NCT01639729|134049|P2|NOT COMPLETED|Overall Study||0
56771|NCT01639729|134050|P1|NOT COMPLETED|Overall Study||1
56772|NCT01639729|134045|P6|COMPLETED|Overall Study||4
56773|NCT01639729|134046|P5|COMPLETED|Overall Study||4
56774|NCT01639729|134047|P4|COMPLETED|Overall Study||4
56775|NCT01639729|134048|P3|COMPLETED|Overall Study||3
56776|NCT01639729|134049|P2|COMPLETED|Overall Study||4
56777|NCT01639729|134050|P1|COMPLETED|Overall Study||3
56778|NCT01639729|134045|P6|STARTED|Overall Study||4
56779|NCT01639729|134046|P5|STARTED|Overall Study||4
56780|NCT01639729|134047|P4|STARTED|Overall Study||5
56781|NCT01639729|134048|P3|STARTED|Overall Study||4
56782|NCT01639729|134049|P2|STARTED|Overall Study||4
56783|NCT01639729|134050|P1|STARTED|Overall Study||4
56784|NCT01639703|134072|P1|NOT COMPLETED|Overall Study||12
56785|NCT01639703|134072|P1|COMPLETED|Overall Study||84
56786|NCT01639703|134072|P1|STARTED|Overall Study||96
56787|NCT01639560|134115|P2|NOT COMPLETED|Overall Study||29
56788|NCT01639560|134116|P1|NOT COMPLETED|Overall Study||19
56789|NCT01639560|134115|P2|COMPLETED|Overall Study||19
56790|NCT01639560|134116|P1|COMPLETED|Overall Study||26
56791|NCT01639560|134115|P2|End of Treatment|Overall Study||20
56792|NCT01639560|134116|P1|End of Treatment|Overall Study||28
56793|NCT01639560|134115|P2|STARTED|Overall Study||48
56794|NCT01639560|134116|P1|STARTED|Overall Study||45
56795|NCT01639469|134130|P2|NOT COMPLETED|Overall Study||3
56796|NCT01639469|134131|P1|NOT COMPLETED|Overall Study||5
56797|NCT01639469|134130|P2|COMPLETED|Overall Study||77
56798|NCT01639469|134131|P1|COMPLETED|Overall Study||84
56799|NCT01639469|134130|P2|STARTED|Overall Study||80
56800|NCT01639469|134131|P1|STARTED|Overall Study||89
56801|NCT01639443|134139|P2|NOT COMPLETED|Overall Study||0
56802|NCT01639443|134140|P1|NOT COMPLETED|Overall Study||0
56803|NCT01639443|134139|P2|COMPLETED|Overall Study|These individuals all booked appointments using typical booking.|4855
56804|NCT01639443|134140|P1|COMPLETED|Overall Study|Intervention is limited to appointment booking, and all completed.|180
56805|NCT01639443|134139|P2|STARTED|Overall Study|These individuals opted to not participate in Fast-tracked group, and were not consented.|4855
56806|NCT01639443|134140|P1|STARTED|Overall Study|These individuals opted into Fast-tracked group and were consented.|180
56807|NCT01639352|134156|P1|NOT COMPLETED|Overall Study||0
56808|NCT01639352|134156|P1|COMPLETED|Overall Study||20
56809|NCT01639352|134156|P1|STARTED|Overall Study||20
56810|NCT01639222|134165|P1|NOT COMPLETED|Overall Study||0
56811|NCT01639222|134165|P1|COMPLETED|Overall Study||55
56812|NCT01639222|134165|P1|STARTED|Overall Study||55
56813|NCT01639157|134175|P2|NOT COMPLETED|Overall Study||0
56814|NCT01639157|134176|P1|NOT COMPLETED|Overall Study||0
56815|NCT01639157|134175|P2|COMPLETED|Overall Study||5
56816|NCT01639157|134176|P1|COMPLETED|Overall Study||4
56817|NCT01639157|134175|P2|STARTED|Overall Study||5
56818|NCT01639157|134176|P1|STARTED|Overall Study||4
56819|NCT01639144|134236|P2|NOT COMPLETED|Overall Study||5
56820|NCT01639144|134237|P1|NOT COMPLETED|Overall Study||10
56821|NCT01639144|134236|P2|COMPLETED|Overall Study||250
56822|NCT01639144|134237|P1|COMPLETED|Overall Study||250
56823|NCT01639144|134236|P2|STARTED|Overall Study||255
56824|NCT01639144|134237|P1|STARTED|Overall Study||260
56825|NCT01639001|134245|P2|NOT COMPLETED|Overall Study||103
56826|NCT01639001|134246|P1|NOT COMPLETED|Overall Study||104
56827|NCT01639001|134245|P2|COMPLETED|Overall Study||0
56828|NCT01639001|134246|P1|COMPLETED|Overall Study||0
56829|NCT01639001|134245|P2|Treated|Overall Study||101
56830|NCT01639001|134246|P1|Treated|Overall Study||104
56831|NCT01639001|134245|P2|STARTED|Overall Study||103
56832|NCT01639001|134246|P1|STARTED|Overall Study||104
56833|NCT01638559|134290|P1|NOT COMPLETED|Overall Study||0
56834|NCT01638559|134290|P1|COMPLETED|Overall Study|Completion through the time of the primary endpoint.|88
56835|NCT01638559|134290|P1|STARTED|Overall Study||88
56836|NCT01638507|134294|P1|NOT COMPLETED|Overall Study||6
56837|NCT01638507|134294|P1|COMPLETED|Overall Study||224
56838|NCT01638507|134294|P1|STARTED|Overall Study||230
56839|NCT01638468|134307|P1|NOT COMPLETED|Overall Study||0
56840|NCT01638468|134307|P1|COMPLETED|Overall Study||7
56841|NCT01638468|134307|P1|STARTED|Overall Study||7
56842|NCT01638312|134323|P2|NOT COMPLETED|Overall Study||0
56843|NCT01638312|134324|P1|NOT COMPLETED|Overall Study||0
56844|NCT01638312|134323|P2|COMPLETED|Overall Study||30
56845|NCT01638312|134324|P1|COMPLETED|Overall Study||20
56846|NCT01638312|134323|P2|STARTED|Overall Study||30
56847|NCT01638312|134324|P1|STARTED|Overall Study||20
56848|NCT01638000|134332|P2|NOT COMPLETED|Overall Study||71
56849|NCT01638000|134333|P1|NOT COMPLETED|Overall Study||60
56850|NCT01638000|134332|P2|COMPLETED|Overall Study||873
56851|NCT01638000|134333|P1|COMPLETED|Overall Study||883
56852|NCT01638000|134332|P2|Received at Least 1 Double-Blind Dose|Overall Study||934
56853|NCT01638000|134333|P1|Received at Least 1 Double-Blind Dose|Overall Study||936
56854|NCT01638000|134332|P2|STARTED|Overall Study||944
56855|NCT01638000|134333|P1|STARTED|Overall Study||943
56856|NCT01637961|134431|P1|NOT COMPLETED|Overall Study||2
56857|NCT01637961|134431|P1|COMPLETED|Overall Study|Eligible and treated patients.|21
56858|NCT01637961|134431|P1|STARTED|Overall Study||23
56859|NCT01637935|134439|P2|NOT COMPLETED|Overall Study||0
56860|NCT01637935|134440|P1|NOT COMPLETED|Overall Study||0
56861|NCT01637935|134439|P2|COMPLETED|Overall Study||158918
56862|NCT01637935|134440|P1|COMPLETED|Overall Study||34181
56863|NCT01637935|134439|P2|STARTED|Overall Study||158918
56864|NCT01637935|134440|P1|STARTED|Overall Study||34181
56865|NCT01637922|134456|P2|NOT COMPLETED|Overall Study||5
56866|NCT01637922|134457|P1|NOT COMPLETED|Overall Study||2
56867|NCT01637922|134456|P2|COMPLETED|Overall Study||14
56868|NCT01637922|134457|P1|COMPLETED|Overall Study||13
56869|NCT01637922|134456|P2|STARTED|Overall Study||19
56870|NCT01637922|134457|P1|STARTED|Overall Study||15
56871|NCT01637584|134482|P2|NOT COMPLETED|Overall Study||3
56872|NCT01637584|134483|P1|NOT COMPLETED|Overall Study||1
56873|NCT01637584|134482|P2|COMPLETED|Overall Study||17
56874|NCT01637584|134483|P1|COMPLETED|Overall Study||19
56875|NCT01637584|134482|P2|STARTED|Overall Study||20
56876|NCT01637584|134483|P1|STARTED|Overall Study||20
56877|NCT01637272|134490|P1|NOT COMPLETED|Overall Study||20
56878|NCT01637272|134490|P1|COMPLETED|Overall Study||23
56879|NCT01637272|134490|P1|Completed Core But Did no Enter Ext..|Overall Study||4
56880|NCT01637272|134490|P1|Entered Extension Phase|Overall Study||27
56881|NCT01637272|134490|P1|Completed Core Phase (sc + LAR)|Overall Study||31
56882|NCT01637272|134490|P1|Completed sc Phase|Overall Study||33
56883|NCT01637272|134490|P1|STARTED|Overall Study||43
56884|NCT01637246|134552|P1|NOT COMPLETED|Overall Study||2139
56885|NCT01637246|134552|P1|COMPLETED|Overall Study||2246
56886|NCT01637246|134552|P1|STARTED|Overall Study||4385
56887|NCT01637090|134560|P1|NOT COMPLETED|Overall Study||3
56888|NCT01637090|134560|P1|COMPLETED|Overall Study||0
56889|NCT01637090|134560|P1|STARTED|Overall Study||3
56890|NCT01636986|134570|P2|NOT COMPLETED|Overall Study||2
56891|NCT01636986|134571|P1|NOT COMPLETED|Overall Study||0
56892|NCT01636986|134570|P2|COMPLETED|Overall Study||30
56893|NCT01636986|134571|P1|COMPLETED|Overall Study||30
56894|NCT01636986|134570|P2|STARTED|Overall Study||32
56895|NCT01636986|134571|P1|STARTED|Overall Study||30
56896|NCT01636960|134577|P1|NOT COMPLETED|Maintenance Phase||7
56897|NCT01636960|134577|P1|COMPLETED|Maintenance Phase||0
56898|NCT01636960|134577|P1|STARTED|Maintenance Phase||7
56899|NCT01636960|134577|P1|NOT COMPLETED|Induction Phase||2
56900|NCT01636960|134577|P1|COMPLETED|Induction Phase|Participants continuing into Maintenance Phase|7
56901|NCT01636960|134577|P1|STARTED|Induction Phase||9
56902|NCT01636947|134585|P2|NOT COMPLETED|Overall Study||11
56903|NCT01636947|134586|P1|NOT COMPLETED|Overall Study||12
56904|NCT01636947|134585|P2|COMPLETED|Overall Study||239
56905|NCT01636947|134586|P1|COMPLETED|Overall Study||232
56906|NCT01636947|134585|P2|Treated|Overall Study||248
56907|NCT01636947|134586|P1|Treated|Overall Study||242
56908|NCT01636947|134585|P2|STARTED|Overall Study||250
56909|NCT01636947|134586|P1|STARTED|Overall Study||244
56910|NCT01636778|134606|P3|NOT COMPLETED|Follow-up Period After Part 2||4
56911|NCT01636778|134607|P2|NOT COMPLETED|Follow-up Period After Part 2||0
56912|NCT01636778|134608|P1|NOT COMPLETED|Follow-up Period After Part 2||0
56913|NCT01636778|134606|P3|COMPLETED|Follow-up Period After Part 2||37
56914|NCT01636778|134607|P2|COMPLETED|Follow-up Period After Part 2||0
56915|NCT01636778|134608|P1|COMPLETED|Follow-up Period After Part 2||0
56916|NCT01636778|134606|P3|STARTED|Follow-up Period After Part 2||41
56917|NCT01636778|134607|P2|STARTED|Follow-up Period After Part 2||0
56918|NCT01636778|134608|P1|STARTED|Follow-up Period After Part 2||0
56919|NCT01636778|134606|P3|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
56920|NCT01636778|134607|P2|NOT COMPLETED|Antiviral Treatment Period (Part 2)||10
56921|NCT01636778|134608|P1|NOT COMPLETED|Antiviral Treatment Period (Part 2)||0
56922|NCT01636778|134606|P3|COMPLETED|Antiviral Treatment Period (Part 2)||0
57016|NCT01635881|134874|P1|COMPLETED|Overall Study||60
56923|NCT01636778|134607|P2|COMPLETED|Antiviral Treatment Period (Part 2)||31
56924|NCT01636778|134608|P1|COMPLETED|Antiviral Treatment Period (Part 2)||0
56925|NCT01636778|134606|P3|STARTED|Antiviral Treatment Period (Part 2)||0
56926|NCT01636778|134607|P2|STARTED|Antiviral Treatment Period (Part 2)||41
56927|NCT01636778|134608|P1|STARTED|Antiviral Treatment Period (Part 2)||0
56928|NCT01636778|134606|P3|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
56929|NCT01636778|134607|P2|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
56930|NCT01636778|134608|P1|NOT COMPLETED|Pre-Antiviral Treatment Period (Part 1)||4
56931|NCT01636778|134606|P3|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
56932|NCT01636778|134607|P2|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||0
56933|NCT01636778|134608|P1|COMPLETED|Pre-Antiviral Treatment Period (Part 1)||41
56934|NCT01636778|134606|P3|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
56935|NCT01636778|134607|P2|STARTED|Pre-Antiviral Treatment Period (Part 1)||0
56936|NCT01636778|134608|P1|STARTED|Pre-Antiviral Treatment Period (Part 1)||45
56937|NCT01636765|134671|P1|NOT COMPLETED|Overall Study||0
56938|NCT01636765|134671|P1|COMPLETED|Overall Study||104
56939|NCT01636765|134671|P1|STARTED|Overall Study||104
56940|NCT01636713|134679|P3|NOT COMPLETED|Overall Study||23
56941|NCT01636713|134680|P2|NOT COMPLETED|Overall Study||28
56942|NCT01636713|134681|P1|NOT COMPLETED|Overall Study||32
56943|NCT01636713|134679|P3|COMPLETED|Overall Study||170
56944|NCT01636713|134680|P2|COMPLETED|Overall Study||166
56945|NCT01636713|134681|P1|COMPLETED|Overall Study||161
56946|NCT01636713|134679|P3|STARTED|Overall Study||193
56947|NCT01636713|134680|P2|STARTED|Overall Study||194
56948|NCT01636713|134681|P1|STARTED|Overall Study||193
56949|NCT01636661|134697|P2|NOT COMPLETED|Overall Study||0
56950|NCT01636661|134698|P1|NOT COMPLETED|Overall Study||0
56951|NCT01636661|134697|P2|COMPLETED|Overall Study||6
56952|NCT01636661|134698|P1|COMPLETED|Overall Study||5
56953|NCT01636661|134697|P2|STARTED|Overall Study||6
56954|NCT01636661|134698|P1|STARTED|Overall Study||5
56955|NCT01636466|134708|P2|NOT COMPLETED|Overall Study||0
56956|NCT01636466|134709|P1|NOT COMPLETED|Overall Study||1
56957|NCT01636466|134708|P2|COMPLETED|Overall Study||0
56958|NCT01636466|134709|P1|COMPLETED|Overall Study||0
56959|NCT01636466|134708|P2|STARTED|Overall Study||0
56960|NCT01636466|134709|P1|STARTED|Overall Study||1
56961|NCT01636414|134718|P3|NOT COMPLETED|Overall Study||9
56962|NCT01636414|134719|P2|NOT COMPLETED|Overall Study||6
56963|NCT01636414|134720|P1|NOT COMPLETED|Overall Study||3
56964|NCT01636414|134718|P3|COMPLETED|Overall Study||65
56965|NCT01636414|134719|P2|COMPLETED|Overall Study||60
56966|NCT01636414|134720|P1|COMPLETED|Overall Study||61
56967|NCT01636414|134718|P3|STARTED|Overall Study||74
56968|NCT01636414|134719|P2|STARTED|Overall Study||66
56969|NCT01636414|134720|P1|STARTED|Overall Study||64
56970|NCT01636362|134731|P1|NOT COMPLETED|Overall Study||8
56971|NCT01636362|134731|P1|COMPLETED|Overall Study||37
56972|NCT01636362|134731|P1|STARTED|Overall Study||45
56973|NCT01636258|134739|P2|NOT COMPLETED|Overall Study||0
56974|NCT01636258|134740|P1|NOT COMPLETED|Overall Study||1
56975|NCT01636258|134739|P2|COMPLETED|Overall Study||14
56976|NCT01636258|134740|P1|COMPLETED|Overall Study||12
56977|NCT01636258|134739|P2|STARTED|Overall Study||14
56978|NCT01636258|134740|P1|STARTED|Overall Study||13
56979|NCT01636206|134756|P2|NOT COMPLETED|Overall Study||51
56980|NCT01636206|134757|P1|NOT COMPLETED|Overall Study||19
56981|NCT01636206|134756|P2|COMPLETED|Overall Study||170
56982|NCT01636206|134757|P1|COMPLETED|Overall Study||92
56983|NCT01636206|134756|P2|STARTED|Overall Study||221
56984|NCT01636206|134757|P1|STARTED|Overall Study||111
56985|NCT01636102|134765|P2|NOT COMPLETED|Overall Study||0
56986|NCT01636102|134766|P1|NOT COMPLETED|Overall Study||0
56987|NCT01636102|134765|P2|COMPLETED|Overall Study||63
56988|NCT01636102|134766|P1|COMPLETED|Overall Study||63
56989|NCT01636102|134765|P2|STARTED|Overall Study||63
56990|NCT01636102|134766|P1|STARTED|Overall Study||63
56991|NCT01636076|134780|P2|NOT COMPLETED|Overall Study||25
56992|NCT01636076|134781|P1|NOT COMPLETED|Overall Study||17
56993|NCT01636076|134780|P2|COMPLETED|Overall Study||288
56994|NCT01636076|134781|P1|COMPLETED|Overall Study||299
56995|NCT01636076|134780|P2|STARTED|Overall Study||313
56996|NCT01636076|134781|P1|STARTED|Overall Study||316
56997|NCT01636063|134843|P2|NOT COMPLETED|Overall Study||0
56998|NCT01636063|134844|P1|NOT COMPLETED|Overall Study||0
56999|NCT01636063|134843|P2|COMPLETED|Overall Study||21
57000|NCT01636063|134844|P1|COMPLETED|Overall Study||21
57001|NCT01636063|134843|P2|STARTED|Overall Study||21
57002|NCT01636063|134844|P1|STARTED|Overall Study||21
57003|NCT01635933|134852|P2|NOT COMPLETED|Overall Study||8
57004|NCT01635933|134853|P1|NOT COMPLETED|Overall Study||2
57005|NCT01635933|134852|P2|COMPLETED|Overall Study||177
57006|NCT01635933|134853|P1|COMPLETED|Overall Study||176
57007|NCT01635933|134852|P2|STARTED|Overall Study||185
57008|NCT01635933|134853|P1|STARTED|Overall Study||178
57009|NCT01635920|134865|P2|NOT COMPLETED|Overall Study||1
57010|NCT01635920|134866|P1|NOT COMPLETED|Overall Study||3
57011|NCT01635920|134865|P2|COMPLETED|Overall Study||125
57012|NCT01635920|134866|P1|COMPLETED|Overall Study||122
57013|NCT01635920|134865|P2|STARTED|Overall Study||126
57014|NCT01635920|134866|P1|STARTED|Overall Study||125
57015|NCT01635881|134874|P1|NOT COMPLETED|Overall Study||0
57017|NCT01635881|134874|P1|STARTED|Overall Study||60
57018|NCT01635855|134879|P1|NOT COMPLETED|Overall Study||4
57019|NCT01635855|134879|P1|COMPLETED|Overall Study||113
57020|NCT01635855|134879|P1|STARTED|Overall Study||117
57021|NCT01635504|134883|P1|NOT COMPLETED|Overall Study||0
57022|NCT01635504|134883|P1|COMPLETED|Overall Study||5
57023|NCT01635504|134883|P1|STARTED|Overall Study||5
57024|NCT01635439|134890|P2|NOT COMPLETED|Overall Study||0
57025|NCT01635439|134891|P1|NOT COMPLETED|Overall Study||0
57026|NCT01635439|134890|P2|COMPLETED|Overall Study||100
57027|NCT01635439|134891|P1|COMPLETED|Overall Study||100
57028|NCT01635439|134890|P2|STARTED|Overall Study||100
57029|NCT01635439|134891|P1|STARTED|Overall Study||100
57030|NCT01635244|134908|P3|NOT COMPLETED|Overall Study||2
57031|NCT01635244|134909|P2|NOT COMPLETED|Overall Study||1
57032|NCT01635244|134910|P1|NOT COMPLETED|Overall Study||1
57033|NCT01635244|134908|P3|COMPLETED|Overall Study||18
57034|NCT01635244|134909|P2|COMPLETED|Overall Study||21
57035|NCT01635244|134910|P1|COMPLETED|Overall Study||17
57036|NCT01635244|134908|P3|STARTED|Overall Study||20
57037|NCT01635244|134909|P2|STARTED|Overall Study||22
57038|NCT01635244|134910|P1|STARTED|Overall Study||18
57039|NCT01635218|134921|P3|NOT COMPLETED|Overall Study||6
57040|NCT01635218|134922|P2|NOT COMPLETED|Overall Study||7
57041|NCT01635218|134923|P1|NOT COMPLETED|Overall Study||3
57042|NCT01635218|134921|P3|COMPLETED|Overall Study||37
57043|NCT01635218|134922|P2|COMPLETED|Overall Study||39
57044|NCT01635218|134923|P1|COMPLETED|Overall Study||41
57045|NCT01635218|134921|P3|STARTED|Overall Study||43
57046|NCT01635218|134922|P2|STARTED|Overall Study||46
57047|NCT01635218|134923|P1|STARTED|Overall Study||44
57048|NCT01635062|134945|P2|NOT COMPLETED|Overall Study||0
57049|NCT01635062|134946|P1|NOT COMPLETED|Overall Study||0
57050|NCT01635062|134945|P2|COMPLETED|Overall Study||9
57051|NCT01635062|134946|P1|COMPLETED|Overall Study||9
57052|NCT01635062|134945|P2|Post-Randomization Sodium Loaded|Overall Study||9
57053|NCT01635062|134946|P1|Post-Randomization Sodium Loaded|Overall Study||9
57054|NCT01635062|134945|P2|Post-randomization Sodium Restriction|Overall Study||9
57055|NCT01635062|134946|P1|Post-randomization Sodium Restriction|Overall Study||9
57056|NCT01635062|134945|P2|Sodium Loading Baseline Visit|Overall Study||9
57057|NCT01635062|134946|P1|Sodium Loading Baseline Visit|Overall Study||9
57058|NCT01635062|134945|P2|Sodium Restriction Baseline Visit|Overall Study||9
57059|NCT01635062|134946|P1|Sodium Restriction Baseline Visit|Overall Study||9
57060|NCT01635062|134945|P2|STARTED|Overall Study||9
57061|NCT01635062|134946|P1|STARTED|Overall Study||9
57062|NCT01634854|134958|P2|NOT COMPLETED|Overall Study||7
57063|NCT01634854|134959|P1|NOT COMPLETED|Overall Study||2
57064|NCT01634854|134958|P2|COMPLETED|Overall Study||59
57065|NCT01634854|134959|P1|COMPLETED|Overall Study||62
57066|NCT01634854|134958|P2|STARTED|Overall Study||66
57067|NCT01634854|134959|P1|STARTED|Overall Study||64
57068|NCT01634659|134979|P2|NOT COMPLETED|Period 2 - Second 8 Days of Wear||0
57069|NCT01634659|134980|P1|NOT COMPLETED|Period 2 - Second 8 Days of Wear||3
57070|NCT01634659|134979|P2|COMPLETED|Period 2 - Second 8 Days of Wear||158
57071|NCT01634659|134980|P1|COMPLETED|Period 2 - Second 8 Days of Wear||152
57072|NCT01634659|134979|P2|STARTED|Period 2 - Second 8 Days of Wear||158
57073|NCT01634659|134980|P1|STARTED|Period 2 - Second 8 Days of Wear||155
57074|NCT01634659|134979|P2|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
57075|NCT01634659|134980|P1|NOT COMPLETED|Period 1 - First 8 Days of Wear||0
57076|NCT01634659|134979|P2|COMPLETED|Period 1 - First 8 Days of Wear||158
57077|NCT01634659|134980|P1|COMPLETED|Period 1 - First 8 Days of Wear||155
57078|NCT01634659|134979|P2|STARTED|Period 1 - First 8 Days of Wear||158
57079|NCT01634659|134980|P1|STARTED|Period 1 - First 8 Days of Wear||155
57080|NCT01634620|134990|P1|NOT COMPLETED|Overall Study||0
57081|NCT01634620|134990|P1|COMPLETED|Overall Study||200
57082|NCT01634620|134990|P1|STARTED|Overall Study||200
57083|NCT01634555|135010|P1|NOT COMPLETED|Overall Study||17
57084|NCT01634555|135010|P1|COMPLETED|Overall Study|Completed the required treatment and assessment.|12
57085|NCT01634555|135010|P1|Drug-Drug Interaction (DDI) Population|Overall Study|Completed the required treatment in Cycle 1, Day 1 and Cycle 2, Day 1.|25
57086|NCT01634555|135010|P1|Received at Least 1 Dose of Study Drug|Overall Study||29
57087|NCT01634555|135010|P1|STARTED|Overall Study||29
57088|NCT01634360|135020|P2|NOT COMPLETED|Overall Study||136
57089|NCT01634360|135021|P1|NOT COMPLETED|Overall Study||49
57090|NCT01634360|135020|P2|COMPLETED|Overall Study||0
57091|NCT01634360|135021|P1|COMPLETED|Overall Study||0
57092|NCT01634360|135020|P2|STARTED|Overall Study||136
57093|NCT01634360|135021|P1|STARTED|Overall Study||49
57094|NCT01634256|135033|P2|NOT COMPLETED|Overall Study||8
57095|NCT01634256|135034|P1|NOT COMPLETED|Overall Study||4
57096|NCT01634256|135033|P2|COMPLETED|Overall Study||22
57097|NCT01634256|135034|P1|COMPLETED|Overall Study||26
57098|NCT01634256|135033|P2|STARTED|Overall Study||30
57099|NCT01634256|135034|P1|STARTED|Overall Study||30
57100|NCT01634243|135050|P2|NOT COMPLETED|Overall Study||5
57101|NCT01634243|135051|P1|NOT COMPLETED|Overall Study||6
57102|NCT01634243|135050|P2|COMPLETED|Overall Study||38
57103|NCT01634243|135051|P1|COMPLETED|Overall Study||15
57104|NCT01634243|135050|P2|STARTED|Overall Study||43
57105|NCT01634243|135051|P1|STARTED|Overall Study||21
57106|NCT01634165|135077|P4|NOT COMPLETED|Period 4||0
57107|NCT01634165|135078|P3|NOT COMPLETED|Period 4||0
57108|NCT01634165|135079|P2|NOT COMPLETED|Period 4||0
57109|NCT01634165|135080|P1|NOT COMPLETED|Period 4||0
57110|NCT01634165|135077|P4|COMPLETED|Period 4||6
57111|NCT01634165|135078|P3|COMPLETED|Period 4||6
57112|NCT01634165|135079|P2|COMPLETED|Period 4||5
57113|NCT01634165|135080|P1|COMPLETED|Period 4||6
57114|NCT01634165|135077|P4|STARTED|Period 4||6
57115|NCT01634165|135078|P3|STARTED|Period 4||6
57116|NCT01634165|135079|P2|STARTED|Period 4||5
57117|NCT01634165|135080|P1|STARTED|Period 4||6
57118|NCT01634165|135077|P4|NOT COMPLETED|Period 3||0
57119|NCT01634165|135078|P3|NOT COMPLETED|Period 3||0
57120|NCT01634165|135079|P2|NOT COMPLETED|Period 3||0
57121|NCT01634165|135080|P1|NOT COMPLETED|Period 3||0
57122|NCT01634165|135077|P4|COMPLETED|Period 3||6
57123|NCT01634165|135078|P3|COMPLETED|Period 3||6
57124|NCT01634165|135079|P2|COMPLETED|Period 3||5
57125|NCT01634165|135080|P1|COMPLETED|Period 3||6
57126|NCT01634165|135077|P4|STARTED|Period 3||6
57127|NCT01634165|135078|P3|STARTED|Period 3||6
57128|NCT01634165|135079|P2|STARTED|Period 3||5
57129|NCT01634165|135080|P1|STARTED|Period 3||6
57130|NCT01634165|135077|P4|NOT COMPLETED|Period 2||0
57131|NCT01634165|135078|P3|NOT COMPLETED|Period 2||0
57132|NCT01634165|135079|P2|NOT COMPLETED|Period 2||1
57133|NCT01634165|135080|P1|NOT COMPLETED|Period 2||0
57134|NCT01634165|135077|P4|COMPLETED|Period 2||6
57135|NCT01634165|135078|P3|COMPLETED|Period 2||6
57136|NCT01634165|135079|P2|COMPLETED|Period 2||5
57137|NCT01634165|135080|P1|COMPLETED|Period 2||6
57138|NCT01634165|135077|P4|STARTED|Period 2||6
57139|NCT01634165|135078|P3|STARTED|Period 2||6
57140|NCT01634165|135079|P2|STARTED|Period 2||6
57141|NCT01634165|135080|P1|STARTED|Period 2||6
57142|NCT01634165|135077|P4|NOT COMPLETED|Period 1||0
57143|NCT01634165|135078|P3|NOT COMPLETED|Period 1||0
57144|NCT01634165|135079|P2|NOT COMPLETED|Period 1||0
57145|NCT01634165|135080|P1|NOT COMPLETED|Period 1||0
57146|NCT01634165|135077|P4|COMPLETED|Period 1||6
57147|NCT01634165|135078|P3|COMPLETED|Period 1||6
57148|NCT01634165|135079|P2|COMPLETED|Period 1||6
57149|NCT01634165|135080|P1|COMPLETED|Period 1||6
57150|NCT01634165|135077|P4|Received at Least 1 Dose of Study Drug|Period 1||6
57151|NCT01634165|135078|P3|Received at Least 1 Dose of Study Drug|Period 1||6
57152|NCT01634165|135079|P2|Received at Least 1 Dose of Study Drug|Period 1||6
57153|NCT01634165|135080|P1|Received at Least 1 Dose of Study Drug|Period 1||6
57154|NCT01634165|135077|P4|STARTED|Period 1||6
57155|NCT01634165|135078|P3|STARTED|Period 1||6
57156|NCT01634165|135079|P2|STARTED|Period 1||6
57157|NCT01634165|135080|P1|STARTED|Period 1||6
57158|NCT01634152|135113|P3|NOT COMPLETED|Overall Study||4
57159|NCT01634152|135114|P2|NOT COMPLETED|Overall Study||1
57160|NCT01634152|135115|P1|NOT COMPLETED|Overall Study||4
57161|NCT01634152|135113|P3|COMPLETED|Overall Study||126
57162|NCT01634152|135114|P2|COMPLETED|Overall Study||136
57163|NCT01634152|135115|P1|COMPLETED|Overall Study||130
57164|NCT01634152|135113|P3|STARTED|Overall Study||130
57165|NCT01634152|135114|P2|STARTED|Overall Study||137
57166|NCT01634152|135115|P1|STARTED|Overall Study||134
57167|NCT01634139|135198|P3|NOT COMPLETED|Overall Study||5
57168|NCT01634139|135199|P2|NOT COMPLETED|Overall Study||6
57169|NCT01634139|135200|P1|NOT COMPLETED|Overall Study||10
57170|NCT01634139|135198|P3|COMPLETED|Overall Study||130
57171|NCT01634139|135199|P2|COMPLETED|Overall Study||130
57172|NCT01634139|135200|P1|COMPLETED|Overall Study||122
57173|NCT01634139|135198|P3|STARTED|Overall Study||135
57174|NCT01634139|135199|P2|STARTED|Overall Study||136
57175|NCT01634139|135200|P1|STARTED|Overall Study||132
57176|NCT01634113|135301|P3|NOT COMPLETED|Overall Study||1
57177|NCT01634113|135302|P2|NOT COMPLETED|Overall Study||0
57178|NCT01634113|135303|P1|NOT COMPLETED|Overall Study||0
57179|NCT01634113|135301|P3|COMPLETED|Overall Study||31
57180|NCT01634113|135302|P2|COMPLETED|Overall Study||36
57181|NCT01634113|135303|P1|COMPLETED|Overall Study||34
57182|NCT01634113|135301|P3|STARTED|Overall Study||32
57183|NCT01634113|135302|P2|STARTED|Overall Study||36
57184|NCT01634113|135303|P1|STARTED|Overall Study||34
57185|NCT01634100|135347|P6|NOT COMPLETED|Overall Study||0
57186|NCT01634100|135348|P5|NOT COMPLETED|Overall Study||0
57187|NCT01634100|135349|P4|NOT COMPLETED|Overall Study||0
57188|NCT01634100|135350|P3|NOT COMPLETED|Overall Study||1
57189|NCT01634100|135351|P2|NOT COMPLETED|Overall Study||0
57190|NCT01634100|135352|P1|NOT COMPLETED|Overall Study||1
57191|NCT01634100|135347|P6|COMPLETED|Overall Study||3
57192|NCT01634100|135348|P5|COMPLETED|Overall Study||3
57193|NCT01634100|135349|P4|COMPLETED|Overall Study||3
57194|NCT01634100|135350|P3|COMPLETED|Overall Study||2
57195|NCT01634100|135351|P2|COMPLETED|Overall Study||3
57196|NCT01634100|135352|P1|COMPLETED|Overall Study||2
57197|NCT01634100|135347|P6|Received Empa + Probenecid|Overall Study||3
57198|NCT01634100|135348|P5|Received Empa + Probenecid|Overall Study||3
57199|NCT01634100|135349|P4|Received Empa + Probenecid|Overall Study||3
57200|NCT01634100|135350|P3|Received Empa + Probenecid|Overall Study||2
57201|NCT01634100|135351|P2|Received Empa + Probenecid|Overall Study||3
57202|NCT01634100|135352|P1|Received Empa + Probenecid|Overall Study||2
57203|NCT01634100|135347|P6|Received Empa + Rifampicin|Overall Study||3
57204|NCT01634100|135348|P5|Received Empa + Rifampicin|Overall Study||3
57205|NCT01634100|135349|P4|Received Empa + Rifampicin|Overall Study||3
57206|NCT01634100|135350|P3|Received Empa + Rifampicin|Overall Study||3
57207|NCT01634100|135351|P2|Received Empa + Rifampicin|Overall Study||3
57208|NCT01634100|135352|P1|Received Empa + Rifampicin|Overall Study||3
57209|NCT01634100|135347|P6|Received Empa Alone|Overall Study||3
57210|NCT01634100|135348|P5|Received Empa Alone|Overall Study||3
57211|NCT01634100|135349|P4|Received Empa Alone|Overall Study||3
57212|NCT01634100|135350|P3|Received Empa Alone|Overall Study||3
57213|NCT01634100|135351|P2|Received Empa Alone|Overall Study||3
57214|NCT01634100|135352|P1|Received Empa Alone|Overall Study||3
57215|NCT01634100|135347|P6|STARTED|Overall Study||3
57216|NCT01634100|135348|P5|STARTED|Overall Study||3
57217|NCT01634100|135349|P4|STARTED|Overall Study||3
57218|NCT01634100|135350|P3|STARTED|Overall Study||3
57219|NCT01634100|135351|P2|STARTED|Overall Study||3
57220|NCT01634100|135352|P1|STARTED|Overall Study||3
57221|NCT01633944|135368|P3|NOT COMPLETED|Double-blind Treatment Phase||58
57222|NCT01633944|135369|P2|NOT COMPLETED|Double-blind Treatment Phase||54
57223|NCT01633944|135370|P1|NOT COMPLETED|Double-blind Treatment Phase||0
57224|NCT01633944|135368|P3|COMPLETED|Double-blind Treatment Phase||174
57225|NCT01633944|135369|P2|COMPLETED|Double-blind Treatment Phase||176
57226|NCT01633944|135370|P1|COMPLETED|Double-blind Treatment Phase||0
57227|NCT01633944|135368|P3|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|232
57228|NCT01633944|135369|P2|STARTED|Double-blind Treatment Phase|Subjects were randomized to DB treatment after completing OL titration in the previous period.|230
57229|NCT01633944|135370|P1|STARTED|Double-blind Treatment Phase|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
57230|NCT01633944|135368|P3|NOT COMPLETED|Open-label Titration Phase||0
57231|NCT01633944|135369|P2|NOT COMPLETED|Open-label Titration Phase||0
57232|NCT01633944|135370|P1|NOT COMPLETED|Open-label Titration Phase||290
57233|NCT01633944|135368|P3|COMPLETED|Open-label Titration Phase||0
57234|NCT01633944|135369|P2|COMPLETED|Open-label Titration Phase||0
57235|NCT01633944|135370|P1|COMPLETED|Open-label Titration Phase||462
57236|NCT01633944|135368|P3|STARTED|Open-label Titration Phase||0
57237|NCT01633944|135369|P2|STARTED|Open-label Titration Phase||0
57238|NCT01633944|135370|P1|STARTED|Open-label Titration Phase||752
57239|NCT01633892|135390|P1|NOT COMPLETED|Overall Study||0
57240|NCT01633892|135390|P1|COMPLETED|Overall Study||5
57241|NCT01633892|135390|P1|STARTED|Overall Study||5
57242|NCT01633853|135400|P2|NOT COMPLETED|Overall Study||0
57243|NCT01633853|135401|P1|NOT COMPLETED|Overall Study||0
57244|NCT01633853|135400|P2|COMPLETED|Overall Study||100
57245|NCT01633853|135401|P1|COMPLETED|Overall Study||104
57246|NCT01633853|135400|P2|STARTED|Overall Study||100
57247|NCT01633853|135401|P1|STARTED|Overall Study||104
57248|NCT01633827|135415|P2|NOT COMPLETED|Second Intervention||0
57249|NCT01633827|135416|P1|NOT COMPLETED|Second Intervention||0
57250|NCT01633827|135415|P2|COMPLETED|Second Intervention||11
57251|NCT01633827|135416|P1|COMPLETED|Second Intervention||11
57252|NCT01633827|135415|P2|STARTED|Second Intervention||11
57253|NCT01633827|135416|P1|STARTED|Second Intervention||11
57254|NCT01633827|135415|P2|NOT COMPLETED|Washout Period||0
57255|NCT01633827|135416|P1|NOT COMPLETED|Washout Period||0
57256|NCT01633827|135415|P2|COMPLETED|Washout Period||11
57257|NCT01633827|135416|P1|COMPLETED|Washout Period||11
57258|NCT01633827|135415|P2|STARTED|Washout Period||11
57259|NCT01633827|135416|P1|STARTED|Washout Period||11
57260|NCT01633827|135415|P2|NOT COMPLETED|First Intervention||0
57261|NCT01633827|135416|P1|NOT COMPLETED|First Intervention||0
57262|NCT01633827|135415|P2|COMPLETED|First Intervention||11
57263|NCT01633827|135416|P1|COMPLETED|First Intervention||11
57264|NCT01633827|135415|P2|STARTED|First Intervention||11
57265|NCT01633827|135416|P1|STARTED|First Intervention||11
57266|NCT01633814|135429|P1|NOT COMPLETED|Overall Study||0
57267|NCT01633814|135429|P1|COMPLETED|Overall Study||4
57268|NCT01633814|135429|P1|STARTED|Overall Study||4
57269|NCT01633320|135436|P2|NOT COMPLETED|Overall Study||0
57270|NCT01633320|135437|P1|NOT COMPLETED|Overall Study||0
57271|NCT01633320|135436|P2|COMPLETED|Overall Study||68
57272|NCT01633320|135437|P1|COMPLETED|Overall Study||132
57273|NCT01633320|135436|P2|STARTED|Overall Study||68
57274|NCT01633320|135437|P1|STARTED|Overall Study||132
57275|NCT01632995|135445|P1|NOT COMPLETED|Main Study Follow-up Period||120
57276|NCT01632995|135445|P1|COMPLETED|Main Study Follow-up Period||437
57277|NCT01632995|135445|P1|STARTED|Main Study Follow-up Period||557
57278|NCT01632995|135445|P1|NOT COMPLETED|Pre-screening to Enrollment Period||512
57279|NCT01632995|135445|P1|COMPLETED|Pre-screening to Enrollment Period||557
57280|NCT01632995|135445|P1|STARTED|Pre-screening to Enrollment Period||1069
57281|NCT01632904|135460|P2|NOT COMPLETED|Overall Study||6
57282|NCT01632904|135461|P1|NOT COMPLETED|Overall Study||7
57283|NCT01632904|135460|P2|COMPLETED|Overall Study|Patients still in the study as of 27MAR2014, including those who crossed over to ruxolitinib|50
57284|NCT01632904|135461|P1|COMPLETED|Overall Study|Patients still in the study as of data cutoff, 27MAR2014.|47
57285|NCT01632904|135460|P2|STARTED|Overall Study||56
57286|NCT01632904|135461|P1|STARTED|Overall Study||54
57287|NCT01632878|135471|P1|NOT COMPLETED|Treatment||158
57288|NCT01632878|135471|P1|COMPLETED|Treatment||1105
57289|NCT01632878|135471|P1|STARTED|Treatment||1263
57290|NCT01632878|135471|P1|NOT COMPLETED|Screening||268
57291|NCT01632878|135471|P1|COMPLETED|Screening||1263
57292|NCT01632878|135471|P1|STARTED|Screening||1531
57293|NCT01632800|135475|P1|NOT COMPLETED|Overall Study||1
57294|NCT01632800|135475|P1|COMPLETED|Overall Study||25
57295|NCT01632800|135475|P1|STARTED|Overall Study||26
57296|NCT01632735|135481|P2|NOT COMPLETED|Overall Study||3
57297|NCT01632735|135482|P1|NOT COMPLETED|Overall Study||4
57298|NCT01632735|135481|P2|COMPLETED|Overall Study||37
57299|NCT01632735|135482|P1|COMPLETED|Overall Study||36
57300|NCT01632735|135481|P2|STARTED|Overall Study||40
57301|NCT01632735|135482|P1|STARTED|Overall Study||40
57302|NCT01632709|135498|P4|NOT COMPLETED|Overall Study||1
57303|NCT01632709|135499|P3|NOT COMPLETED|Overall Study||0
57304|NCT01632709|135500|P2|NOT COMPLETED|Overall Study||1
57305|NCT01632709|135501|P1|NOT COMPLETED|Overall Study||2
57306|NCT01632709|135498|P4|COMPLETED|Overall Study||3
57307|NCT01632709|135499|P3|COMPLETED|Overall Study||5
57308|NCT01632709|135500|P2|COMPLETED|Overall Study||2
57309|NCT01632709|135501|P1|COMPLETED|Overall Study||2
57310|NCT01632709|135498|P4|Completed Visit 2 (Received Injection)|Overall Study||3
57311|NCT01632709|135499|P3|Completed Visit 2 (Received Injection)|Overall Study||5
57312|NCT01632709|135500|P2|Completed Visit 2 (Received Injection)|Overall Study||2
57313|NCT01632709|135501|P1|Completed Visit 2 (Received Injection)|Overall Study||4
57314|NCT01632709|135498|P4|STARTED|Overall Study||4
57315|NCT01632709|135499|P3|STARTED|Overall Study||5
57316|NCT01632709|135500|P2|STARTED|Overall Study||3
57317|NCT01632709|135501|P1|STARTED|Overall Study||4
57318|NCT01632683|135527|P2|NOT COMPLETED|Overall Study||0
57319|NCT01632683|135528|P1|NOT COMPLETED|Overall Study||0
57320|NCT01632683|135527|P2|COMPLETED|Overall Study||552
57321|NCT01632683|135528|P1|COMPLETED|Overall Study||548
57322|NCT01632683|135527|P2|STARTED|Overall Study||552
57323|NCT01632683|135528|P1|STARTED|Overall Study||548
57324|NCT01632423|135534|P1|NOT COMPLETED|Overall Study||246
57325|NCT01632423|135534|P1|COMPLETED|Overall Study||10091
57326|NCT01632423|135534|P1|STARTED|Overall Study||10337
57327|NCT01632267|135542|P1|NOT COMPLETED|Overall Study||7
57328|NCT01632267|135542|P1|COMPLETED|Overall Study||97
57329|NCT01632267|135542|P1|STARTED|Overall Study||104
57330|NCT01632215|135548|P2|NOT COMPLETED|Overall Study||1
57331|NCT01632215|135549|P1|NOT COMPLETED|Overall Study||2
57332|NCT01632215|135548|P2|COMPLETED|Overall Study||19
57333|NCT01632215|135549|P1|COMPLETED|Overall Study||18
57334|NCT01632215|135548|P2|STARTED|Overall Study||20
57335|NCT01632215|135549|P1|STARTED|Overall Study||20
57336|NCT01632150|135555|P1|NOT COMPLETED|Overall Study||40
57337|NCT01632150|135555|P1|COMPLETED|Overall Study|Completed=still receiving treatment|0
57338|NCT01632150|135555|P1|Received Cyclophosphamide|Overall Study||11
57339|NCT01632150|135555|P1|STARTED|Overall Study||40
57340|NCT01632020|135564|P2|NOT COMPLETED|Overall Study||0
57341|NCT01632020|135565|P1|NOT COMPLETED|Overall Study||2
57342|NCT01632020|135564|P2|COMPLETED|Overall Study||3
57343|NCT01632020|135565|P1|COMPLETED|Overall Study||2
57344|NCT01632020|135564|P2|STARTED|Overall Study||3
57345|NCT01632020|135565|P1|STARTED|Overall Study||4
57346|NCT01631929|135575|P2|NOT COMPLETED|Overall Study||0
57347|NCT01631929|135576|P1|NOT COMPLETED|Overall Study||0
57348|NCT01631929|135575|P2|COMPLETED|Overall Study||6
57349|NCT01631929|135576|P1|COMPLETED|Overall Study||6
57350|NCT01631929|135575|P2|STARTED|Overall Study||6
57351|NCT01631929|135576|P1|STARTED|Overall Study||6
57352|NCT01631864|135584|P2|NOT COMPLETED|Overall Study||4
57353|NCT01631864|135585|P1|NOT COMPLETED|Overall Study||2
57354|NCT01631864|135584|P2|COMPLETED|Overall Study||44
57355|NCT01631864|135585|P1|COMPLETED|Overall Study||48
57356|NCT01631864|135584|P2|STARTED|Overall Study||48
57357|NCT01631864|135585|P1|STARTED|Overall Study||50
57358|NCT01631825|135597|P1|NOT COMPLETED|Overall Study||65
57359|NCT01631825|135597|P1|COMPLETED|Overall Study||256
57360|NCT01631825|135597|P1|STARTED|Overall Study||321
57361|NCT01631812|135617|P1|NOT COMPLETED|Overall Study||37
57362|NCT01631812|135617|P1|COMPLETED|Overall Study||93
57363|NCT01631812|135617|P1|STARTED|Overall Study||130
57364|NCT01631682|135629|P4|NOT COMPLETED|Overall Study||2
57365|NCT01631682|135630|P3|NOT COMPLETED|Overall Study||31
57366|NCT01631682|135631|P2|NOT COMPLETED|Overall Study||45
57367|NCT01631682|135632|P1|NOT COMPLETED|Overall Study||31
57368|NCT01631682|135629|P4|COMPLETED|Overall Study||5
57369|NCT01631682|135630|P3|COMPLETED|Overall Study||13
57370|NCT01631682|135631|P2|COMPLETED|Overall Study||21
57371|NCT01631682|135632|P1|COMPLETED|Overall Study||24
57372|NCT01631682|135629|P4|STARTED|Overall Study||7
57373|NCT01631682|135630|P3|STARTED|Overall Study||44
57374|NCT01631682|135631|P2|STARTED|Overall Study||66
57375|NCT01631682|135632|P1|STARTED|Overall Study||55
57376|NCT01631630|135644|P2|NOT COMPLETED|Overall Study||0
57377|NCT01631630|135645|P1|NOT COMPLETED|Overall Study||3
57378|NCT01631630|135644|P2|COMPLETED|Overall Study||8
57379|NCT01631630|135645|P1|COMPLETED|Overall Study||5
57380|NCT01631630|135644|P2|STARTED|Overall Study||8
57381|NCT01631630|135645|P1|STARTED|Overall Study||8
57382|NCT01631435|135755|P1|NOT COMPLETED|Overall Study||9
57383|NCT01631435|135755|P1|COMPLETED|Overall Study||66
57384|NCT01631435|135755|P1|STARTED|Overall Study||75
57385|NCT01631227|135762|P2|NOT COMPLETED|Overall Study||22
57386|NCT01631227|135763|P1|NOT COMPLETED|Overall Study||30
57387|NCT01631227|135762|P2|COMPLETED|Overall Study||310
57388|NCT01631227|135763|P1|COMPLETED|Overall Study||303
57389|NCT01631227|135762|P2|Full Analysis Set Population|Overall Study|1 patient not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|331
57390|NCT01631227|135763|P1|Full Analysis Set Population|Overall Study|2 patients not eligible for the Full Analysis Set due to missing post-baseline efficacy measurement|330
57391|NCT01631227|135762|P2|Safety Subject Sample|Overall Study||332
57392|NCT01631227|135763|P1|Safety Subject Sample|Overall Study|1 patient was randomized by mistake and never received study medication.|332
57393|NCT01631227|135762|P2|STARTED|Overall Study||332
57394|NCT01631227|135763|P1|STARTED|Overall Study||333
57395|NCT01631149|135771|P2|NOT COMPLETED|Overall Study||0
57396|NCT01631149|135772|P1|NOT COMPLETED|Overall Study||0
57397|NCT01631149|135771|P2|COMPLETED|Overall Study||12
57398|NCT01631149|135772|P1|COMPLETED|Overall Study||12
57399|NCT01631149|135771|P2|STARTED|Overall Study||12
57400|NCT01631149|135772|P1|STARTED|Overall Study||12
57401|NCT01631110|135788|P2|NOT COMPLETED|Overall Study||0
57402|NCT01631110|135789|P1|NOT COMPLETED|Overall Study||0
57403|NCT01631110|135788|P2|COMPLETED|Overall Study||55
57404|NCT01631110|135789|P1|COMPLETED|Overall Study||55
57405|NCT01631110|135788|P2|STARTED|Overall Study||55
57406|NCT01631110|135789|P1|STARTED|Overall Study||55
57407|NCT01631071|135803|P2|NOT COMPLETED|Overall Study||0
57408|NCT01631071|135804|P1|NOT COMPLETED|Overall Study||0
57409|NCT01631071|135803|P2|COMPLETED|Overall Study||55
57410|NCT01631071|135804|P1|COMPLETED|Overall Study||55
57411|NCT01631071|135803|P2|STARTED|Overall Study||55
57412|NCT01631071|135804|P1|STARTED|Overall Study||55
57413|NCT01630694|135818|P2|NOT COMPLETED|Overall Study||0
57414|NCT01630694|135819|P1|NOT COMPLETED|Overall Study||0
57415|NCT01630694|135818|P2|COMPLETED|Overall Study||16
57416|NCT01630694|135819|P1|COMPLETED|Overall Study||12
57417|NCT01630694|135818|P2|STARTED|Overall Study||16
57418|NCT01630694|135819|P1|STARTED|Overall Study||12
57419|NCT01630135|135829|P2|NOT COMPLETED|Overall Study||2
57420|NCT01630135|135830|P1|NOT COMPLETED|Overall Study||0
57421|NCT01630135|135829|P2|COMPLETED|Overall Study||128
57422|NCT01630135|135830|P1|COMPLETED|Overall Study||131
57423|NCT01630135|135829|P2|STARTED|Overall Study||130
57424|NCT01630135|135830|P1|STARTED|Overall Study||131
57425|NCT01630109|135869|P3|NOT COMPLETED|Overall Study||0
57426|NCT01630109|135870|P2|NOT COMPLETED|Overall Study||0
57427|NCT01630109|135871|P1|NOT COMPLETED|Overall Study||0
57428|NCT01630109|135869|P3|COMPLETED|Overall Study||3
57429|NCT01630109|135870|P2|COMPLETED|Overall Study||1
57430|NCT01630109|135871|P1|COMPLETED|Overall Study||1
57431|NCT01630109|135869|P3|STARTED|Overall Study||3
57432|NCT01630109|135870|P2|STARTED|Overall Study||1
57433|NCT01630109|135871|P1|STARTED|Overall Study||1
57434|NCT01629823|135894|P3|NOT COMPLETED|Washout Period||0
57435|NCT01629823|135895|P2|NOT COMPLETED|Washout Period||6
57436|NCT01629823|135896|P1|NOT COMPLETED|Washout Period||3
57437|NCT01629823|135894|P3|COMPLETED|Washout Period||50
57438|NCT01629823|135895|P2|COMPLETED|Washout Period||51
57439|NCT01629823|135896|P1|COMPLETED|Washout Period||51
57440|NCT01629823|135894|P3|STARTED|Washout Period||50
57441|NCT01629823|135895|P2|STARTED|Washout Period||57
57442|NCT01629823|135896|P1|STARTED|Washout Period||54
57443|NCT01629823|135894|P3|NOT COMPLETED|Trial Period||10
57444|NCT01629823|135895|P2|NOT COMPLETED|Trial Period||13
57445|NCT01629823|135896|P1|NOT COMPLETED|Trial Period||13
57446|NCT01629823|135894|P3|COMPLETED|Trial Period||49
57447|NCT01629823|135895|P2|COMPLETED|Trial Period||56
57448|NCT01629823|135896|P1|COMPLETED|Trial Period||53
57449|NCT01629823|135894|P3|STARTED|Trial Period||59
57450|NCT01629823|135895|P2|STARTED|Trial Period||69
57451|NCT01629823|135896|P1|STARTED|Trial Period||66
57452|NCT01629797|135904|P1|NOT COMPLETED|Overall Study||18
57453|NCT01629797|135904|P1|COMPLETED|Overall Study||82
57454|NCT01629797|135904|P1|STARTED|Overall Study||100
57455|NCT01629784|135911|P1|NOT COMPLETED|Overall Study||6
57456|NCT01629784|135911|P1|COMPLETED|Overall Study||25
57457|NCT01629784|135911|P1|STARTED|Overall Study||31
57458|NCT01629771|135920|P2|NOT COMPLETED|Overall Study||0
57459|NCT01629771|135921|P1|NOT COMPLETED|Overall Study||0
57460|NCT01629771|135920|P2|COMPLETED|Overall Study||36
57461|NCT01629771|135921|P1|COMPLETED|Overall Study||36
57462|NCT01629771|135920|P2|STARTED|Overall Study||36
57463|NCT01629771|135921|P1|STARTED|Overall Study||36
57464|NCT01629706|135931|P1|NOT COMPLETED|Phase 2 Habitual||10
57465|NCT01629706|135931|P1|COMPLETED|Phase 2 Habitual||48
57466|NCT01629706|135931|P1|STARTED|Phase 2 Habitual|Phase 2 enrolled 48 new participants, plus 10 participants from Phase 1|58
57467|NCT01629706|135931|P1|NOT COMPLETED|Phase 1 PureVision||9
57468|NCT01629706|135931|P1|COMPLETED|Phase 1 PureVision||35
57469|NCT01629706|135931|P1|STARTED|Phase 1 PureVision||44
57470|NCT01629693|135959|P2|NOT COMPLETED|Overall Study||10
57471|NCT01629693|135960|P1|NOT COMPLETED|Overall Study||5
57472|NCT01629693|135959|P2|COMPLETED|Overall Study||178
57473|NCT01629693|135960|P1|COMPLETED|Overall Study||188
57474|NCT01629693|135959|P2|STARTED|Overall Study||188
57475|NCT01629693|135960|P1|STARTED|Overall Study||193
57476|NCT01629667|135969|P3|NOT COMPLETED|Overall Study||45
57477|NCT01629667|135970|P2|NOT COMPLETED|Overall Study||41
57478|NCT01629667|135971|P1|NOT COMPLETED|Overall Study||47
57479|NCT01629667|135969|P3|COMPLETED|Overall Study||14
57480|NCT01629667|135970|P2|COMPLETED|Overall Study||17
57481|NCT01629667|135971|P1|COMPLETED|Overall Study||12
57482|NCT01629667|135969|P3|Randomized and Treated|Overall Study||59
57483|NCT01629667|135970|P2|Randomized and Treated|Overall Study||57
57484|NCT01629667|135971|P1|Randomized and Treated|Overall Study||57
57485|NCT01629667|135969|P3|STARTED|Overall Study||59
57486|NCT01629667|135970|P2|STARTED|Overall Study||58
57487|NCT01629667|135971|P1|STARTED|Overall Study||59
57488|NCT01629589|136055|P2|NOT COMPLETED|Overall Study||7
57489|NCT01629589|136056|P1|NOT COMPLETED|Overall Study||8
57490|NCT01629589|136055|P2|COMPLETED|Overall Study||204
57491|NCT01629589|136056|P1|COMPLETED|Overall Study|A participant received the Boostrix vaccine. Study data reported for the Boostrix vaccine group.|204
57492|NCT01629589|136055|P2|STARTED|Overall Study||211
57493|NCT01629589|136056|P1|STARTED|Overall Study||212
57494|NCT01629290|136072|P1|NOT COMPLETED|Overall Study||0
57495|NCT01629290|136072|P1|COMPLETED|Overall Study||15
57496|NCT01629290|136072|P1|STARTED|Overall Study||15
57497|NCT01629134|136082|P1|NOT COMPLETED|Overall Study||0
57498|NCT01629134|136082|P1|COMPLETED|Overall Study||62
57499|NCT01629134|136082|P1|STARTED|Overall Study||62
57500|NCT01628965|136095|P1|NOT COMPLETED|Overall Study||49
57501|NCT01628965|136095|P1|COMPLETED|Overall Study||94
57502|NCT01628965|136095|P1|STARTED|Overall Study||143
57503|NCT01628926|136104|P3|NOT COMPLETED|Overall Study||17
57504|NCT01628926|136105|P2|NOT COMPLETED|Overall Study||23
57505|NCT01628926|136106|P1|NOT COMPLETED|Overall Study||26
57506|NCT01628926|136104|P3|COMPLETED|Overall Study||68
57507|NCT01628926|136105|P2|COMPLETED|Overall Study||144
57508|NCT01628926|136106|P1|COMPLETED|Overall Study||142
57509|NCT01628926|136104|P3|STARTED|Overall Study||85
57510|NCT01628926|136105|P2|STARTED|Overall Study||167
57511|NCT01628926|136106|P1|STARTED|Overall Study||168
57512|NCT01628913|136155|P2|NOT COMPLETED|Overall Study||31
57513|NCT01628913|136156|P1|NOT COMPLETED|Overall Study||31
57514|NCT01628913|136155|P2|COMPLETED|Overall Study||0
57515|NCT01628913|136156|P1|COMPLETED|Overall Study||0
57516|NCT01628913|136155|P2|STARTED|Overall Study||31
57517|NCT01628913|136156|P1|STARTED|Overall Study||31
57518|NCT01628848|136170|P2|NOT COMPLETED|Overall Study||14
57519|NCT01628848|136171|P1|NOT COMPLETED|Overall Study||12
57520|NCT01628848|136170|P2|COMPLETED|Overall Study||73
57521|NCT01628848|136171|P1|COMPLETED|Overall Study||75
57522|NCT01628848|136170|P2|STARTED|Overall Study||87
57523|NCT01628848|136171|P1|STARTED|Overall Study||87
57524|NCT01628692|136205|P6|NOT COMPLETED|Overall Study||9
57525|NCT01628692|136206|P5|NOT COMPLETED|Overall Study||4
57526|NCT01628692|136207|P4|NOT COMPLETED|Overall Study||1
57527|NCT01628692|136208|P3|NOT COMPLETED|Overall Study||8
57528|NCT01628692|136209|P2|NOT COMPLETED|Overall Study||6
57529|NCT01628692|136210|P1|NOT COMPLETED|Overall Study||7
57530|NCT01628692|136205|P6|COMPLETED|Overall Study||0
57531|NCT01628692|136206|P5|COMPLETED|Overall Study||8
57532|NCT01628692|136207|P4|COMPLETED|Overall Study||19
57533|NCT01628692|136208|P3|COMPLETED|Overall Study||43
57534|NCT01628692|136209|P2|COMPLETED|Overall Study||17
57535|NCT01628692|136210|P1|COMPLETED|Overall Study||46
57536|NCT01628692|136205|P6|STARTED|Overall Study||9
57537|NCT01628692|136206|P5|STARTED|Overall Study||12
57538|NCT01628692|136207|P4|STARTED|Overall Study||20
57539|NCT01628692|136208|P3|STARTED|Overall Study||51
57540|NCT01628692|136209|P2|STARTED|Overall Study||23
57541|NCT01628692|136210|P1|STARTED|Overall Study||53
57542|NCT01628614|136254|P1|NOT COMPLETED|Overall Study||1775
57543|NCT01628614|136254|P1|COMPLETED|Overall Study||3037
57544|NCT01628614|136254|P1|STARTED|Overall Study||4812
57545|NCT01628601|136260|P1|NOT COMPLETED|Overall Study||41
57546|NCT01628601|136260|P1|COMPLETED|Overall Study||351
57547|NCT01628601|136260|P1|STARTED|Overall Study||392
57548|NCT01628588|136268|P1|NOT COMPLETED|Overall Study||16
57549|NCT01628588|136268|P1|COMPLETED|Overall Study||838
57550|NCT01628588|136268|P1|STARTED|Overall Study||854
57551|NCT01628510|136278|P2|NOT COMPLETED|Overall Study||5
57552|NCT01628510|136279|P1|NOT COMPLETED|Overall Study||3
57553|NCT01628510|136278|P2|COMPLETED|Overall Study||44
57554|NCT01628510|136279|P1|COMPLETED|Overall Study||48
57555|NCT01628510|136278|P2|STARTED|Overall Study||49
57556|NCT01628510|136279|P1|STARTED|Overall Study||51
57557|NCT01628367|136287|P2|NOT COMPLETED|Overall Study||0
57558|NCT01628367|136288|P1|NOT COMPLETED|Overall Study||1
57559|NCT01628367|136287|P2|COMPLETED|Overall Study||16
57560|NCT01628367|136288|P1|COMPLETED|Overall Study||15
57561|NCT01628367|136287|P2|STARTED|Overall Study||16
57562|NCT01628367|136288|P1|STARTED|Overall Study||16
57563|NCT01628250|136300|P2|NOT COMPLETED|Overall Study||0
57564|NCT01628250|136301|P1|NOT COMPLETED|Overall Study||0
57565|NCT01628250|136300|P2|COMPLETED|Overall Study||50
57566|NCT01628250|136301|P1|COMPLETED|Overall Study||49
57567|NCT01628250|136300|P2|STARTED|Overall Study||50
57568|NCT01628250|136301|P1|STARTED|Overall Study||49
57569|NCT01628042|136311|P4|NOT COMPLETED|Overall Study||0
57570|NCT01628042|136312|P3|NOT COMPLETED|Overall Study||0
57571|NCT01628042|136313|P2|NOT COMPLETED|Overall Study||0
57572|NCT01628042|136314|P1|NOT COMPLETED|Overall Study||0
57573|NCT01628042|136311|P4|COMPLETED|Overall Study||8
57574|NCT01628042|136312|P3|COMPLETED|Overall Study||8
57575|NCT01628042|136313|P2|COMPLETED|Overall Study||8
57576|NCT01628042|136314|P1|COMPLETED|Overall Study||8
57577|NCT01628042|136311|P4|STARTED|Overall Study||8
57578|NCT01628042|136312|P3|STARTED|Overall Study||8
57579|NCT01628042|136313|P2|STARTED|Overall Study||8
57580|NCT01628042|136314|P1|STARTED|Overall Study||8
57581|NCT01627860|136334|P2|NOT COMPLETED|Overall Study||6
57582|NCT01627860|136335|P1|NOT COMPLETED|Overall Study||12
57583|NCT01627860|136334|P2|COMPLETED|Overall Study||14
57584|NCT01627860|136335|P1|COMPLETED|Overall Study||23
57585|NCT01627860|136334|P2|STARTED|Overall Study||20
57586|NCT01627860|136335|P1|STARTED|Overall Study||35
57587|NCT01627782|136349|P4|NOT COMPLETED|Overall Study||6
57588|NCT01627782|136350|P3|NOT COMPLETED|Overall Study||15
57589|NCT01627782|136351|P2|NOT COMPLETED|Overall Study||6
57590|NCT01627782|136352|P1|NOT COMPLETED|Overall Study||16
57591|NCT01627782|136349|P4|COMPLETED|Overall Study||11
57592|NCT01627782|136350|P3|COMPLETED|Overall Study||1
57593|NCT01627782|136351|P2|COMPLETED|Overall Study||12
57594|NCT01627782|136352|P1|COMPLETED|Overall Study||1
57595|NCT01627782|136349|P4|Treated|Overall Study||17
57596|NCT01627782|136350|P3|Treated|Overall Study||16
57597|NCT01627782|136351|P2|Treated|Overall Study||18
57598|NCT01627782|136352|P1|Treated|Overall Study||16
57599|NCT01627782|136349|P4|STARTED|Overall Study||17
57600|NCT01627782|136350|P3|STARTED|Overall Study||16
57601|NCT01627782|136351|P2|STARTED|Overall Study||18
57602|NCT01627782|136352|P1|STARTED|Overall Study||17
57603|NCT01627561|136410|P2|NOT COMPLETED|Overall Study||3
57604|NCT01627561|136411|P1|NOT COMPLETED|Overall Study||0
57605|NCT01627561|136410|P2|COMPLETED|Overall Study||71
57606|NCT01627561|136411|P1|COMPLETED|Overall Study||74
57607|NCT01627561|136410|P2|STARTED|Overall Study||74
57608|NCT01627561|136411|P1|STARTED|Overall Study||74
57609|NCT01627340|136459|P2|NOT COMPLETED|Overall Study||4
57610|NCT01627340|136460|P1|NOT COMPLETED|Overall Study||12
57611|NCT01627340|136459|P2|COMPLETED|Overall Study||254
57612|NCT01627340|136460|P1|COMPLETED|Overall Study||404
57613|NCT01627340|136459|P2|STARTED|Overall Study||258
57614|NCT01627340|136460|P1|STARTED|Overall Study||416
57615|NCT01627327|136478|P2|NOT COMPLETED|Overall Study||39
57616|NCT01627327|136479|P1|NOT COMPLETED|Overall Study||19
57617|NCT01627327|136478|P2|COMPLETED|Overall Study||274
57618|NCT01627327|136479|P1|COMPLETED|Overall Study||291
57619|NCT01627327|136478|P2|STARTED|Overall Study||313
57620|NCT01627327|136479|P1|STARTED|Overall Study||310
57621|NCT01627249|136492|P3|NOT COMPLETED|Overall Study||12
57622|NCT01627249|136493|P2|NOT COMPLETED|Overall Study||12
57623|NCT01627249|136494|P1|NOT COMPLETED|Overall Study||16
57624|NCT01627249|136492|P3|COMPLETED|Overall Study||206
57625|NCT01627249|136493|P2|COMPLETED|Overall Study||206
57626|NCT01627249|136494|P1|COMPLETED|Overall Study||208
57627|NCT01627249|136492|P3|STARTED|Overall Study||218
57628|NCT01627249|136493|P2|STARTED|Overall Study||218
57629|NCT01627249|136494|P1|STARTED|Overall Study||224
57630|NCT01627002|136531|P9|NOT COMPLETED|Overall Study||0
57631|NCT01627002|136532|P8|NOT COMPLETED|Overall Study||0
57632|NCT01627002|136533|P7|NOT COMPLETED|Overall Study||0
57633|NCT01627002|136534|P6|NOT COMPLETED|Overall Study||0
57634|NCT01627002|136535|P5|NOT COMPLETED|Overall Study||0
57635|NCT01627002|136536|P4|NOT COMPLETED|Overall Study||0
57636|NCT01627002|136537|P3|NOT COMPLETED|Overall Study||0
57637|NCT01627002|136538|P2|NOT COMPLETED|Overall Study||0
57638|NCT01627002|136539|P1|NOT COMPLETED|Overall Study||0
57639|NCT01627002|136531|P9|COMPLETED|Overall Study||7
57640|NCT01627002|136532|P8|COMPLETED|Overall Study||5
57641|NCT01627002|136533|P7|COMPLETED|Overall Study||10
57642|NCT01627002|136534|P6|COMPLETED|Overall Study||9
57643|NCT01627002|136535|P5|COMPLETED|Overall Study||2
57644|NCT01627002|136536|P4|COMPLETED|Overall Study||4
57645|NCT01627002|136537|P3|COMPLETED|Overall Study||4
57646|NCT01627002|136538|P2|COMPLETED|Overall Study||4
57647|NCT01627002|136539|P1|COMPLETED|Overall Study||4
57648|NCT01627002|136531|P9|STARTED|Overall Study||7
57649|NCT01627002|136532|P8|STARTED|Overall Study||5
57650|NCT01627002|136533|P7|STARTED|Overall Study||10
57651|NCT01627002|136534|P6|STARTED|Overall Study||9
57652|NCT01627002|136535|P5|STARTED|Overall Study||2
57653|NCT01627002|136536|P4|STARTED|Overall Study||4
57654|NCT01627002|136537|P3|STARTED|Overall Study||4
57655|NCT01627002|136538|P2|STARTED|Overall Study||4
57656|NCT01627002|136539|P1|STARTED|Overall Study||4
57657|NCT01626820|136592|P2|NOT COMPLETED|Overall Study||0
57658|NCT01626820|136593|P1|NOT COMPLETED|Overall Study||0
57659|NCT01626820|136592|P2|COMPLETED|Overall Study||57
57660|NCT01626820|136593|P1|COMPLETED|Overall Study||56
57661|NCT01626820|136592|P2|STARTED|Overall Study||57
57662|NCT01626820|136593|P1|STARTED|Overall Study||56
57663|NCT01626690|136615|P2|NOT COMPLETED|Overall Study||0
57664|NCT01626690|136616|P1|NOT COMPLETED|Overall Study||2
57665|NCT01626690|136615|P2|COMPLETED|Overall Study||51
57666|NCT01626690|136616|P1|COMPLETED|Overall Study||47
57667|NCT01626690|136615|P2|STARTED|Overall Study||51
57668|NCT01626690|136616|P1|STARTED|Overall Study||49
57669|NCT01626456|136638|P2|NOT COMPLETED|Overall Study||117
57670|NCT01626456|136639|P1|NOT COMPLETED|Overall Study||35
57671|NCT01626456|136638|P2|COMPLETED|Overall Study||251
57672|NCT01626456|136639|P1|COMPLETED|Overall Study||75
57673|NCT01626456|136638|P2|STARTED|Overall Study||368
57674|NCT01626456|136639|P1|STARTED|Overall Study||110
57675|NCT01626391|136669|P2|NOT COMPLETED|Overall Study||0
57676|NCT01626391|136670|P1|NOT COMPLETED|Overall Study||2
57677|NCT01626391|136669|P2|COMPLETED|Overall Study||4
57678|NCT01626391|136670|P1|COMPLETED|Overall Study||3
57679|NCT01626391|136669|P2|STARTED|Overall Study||4
57680|NCT01626391|136670|P1|STARTED|Overall Study||5
57681|NCT01626118|136680|P4|NOT COMPLETED|Overall Study||3
57682|NCT01626118|136681|P3|NOT COMPLETED|Overall Study||2
57683|NCT01626118|136682|P2|NOT COMPLETED|Overall Study||2
57684|NCT01626118|136683|P1|NOT COMPLETED|Overall Study||2
57685|NCT01626118|136680|P4|COMPLETED|Overall Study||91
57686|NCT01626118|136681|P3|COMPLETED|Overall Study||90
57687|NCT01626118|136682|P2|COMPLETED|Overall Study||91
57688|NCT01626118|136683|P1|COMPLETED|Overall Study||92
57689|NCT01626118|136680|P4|STARTED|Overall Study||94
57690|NCT01626118|136681|P3|STARTED|Overall Study||92
57691|NCT01626118|136682|P2|STARTED|Overall Study||93
57692|NCT01626118|136683|P1|STARTED|Overall Study||94
57693|NCT01626092|136721|P1|NOT COMPLETED|Overall Study||0
57694|NCT01626092|136721|P1|COMPLETED|Overall Study||3
57695|NCT01626092|136721|P1|STARTED|Overall Study||3
57696|NCT01625910|136729|P2|NOT COMPLETED|Overall Study||4
57697|NCT01625910|136730|P1|NOT COMPLETED|Overall Study||3
57698|NCT01625910|136729|P2|COMPLETED|Overall Study||33
57699|NCT01625910|136730|P1|COMPLETED|Overall Study||32
57700|NCT01625910|136729|P2|STARTED|Overall Study||37
57701|NCT01625910|136730|P1|STARTED|Overall Study||35
57702|NCT01625845|136740|P2|NOT COMPLETED|Overall Study||3
57703|NCT01625845|136741|P1|NOT COMPLETED|Overall Study||5
57704|NCT01625845|136740|P2|COMPLETED|Overall Study||3
57705|NCT01625845|136741|P1|COMPLETED|Overall Study||5
57706|NCT01625845|136740|P2|STARTED|Overall Study||6
57707|NCT01625845|136741|P1|STARTED|Overall Study||10
57708|NCT01625689|136761|P2|NOT COMPLETED|Overall Study||1
57709|NCT01625689|136762|P1|NOT COMPLETED|Overall Study||2
57710|NCT01625689|136761|P2|COMPLETED|Overall Study||149
57711|NCT01625689|136762|P1|COMPLETED|Overall Study||148
57712|NCT01625689|136761|P2|STARTED|Overall Study||150
57713|NCT01625689|136762|P1|STARTED|Overall Study||150
57714|NCT01625507|136772|P1|NOT COMPLETED|Overall Study||10
57715|NCT01625507|136772|P1|COMPLETED|Overall Study||63
57716|NCT01625507|136772|P1|STARTED|Overall Study||73
57717|NCT01625455|136787|P2|NOT COMPLETED|Overall Study||0
57718|NCT01625455|136788|P1|NOT COMPLETED|Overall Study||0
57719|NCT01625455|136787|P2|COMPLETED|Overall Study||3
57720|NCT01625455|136788|P1|COMPLETED|Overall Study||2
57721|NCT01625455|136787|P2|STARTED|Overall Study||3
57722|NCT01625455|136788|P1|STARTED|Overall Study||2
57723|NCT01625377|136798|P2|NOT COMPLETED|Overall Study||22
57724|NCT01625377|136799|P1|NOT COMPLETED|Overall Study||7
57725|NCT01625377|136798|P2|COMPLETED|Overall Study||71
57726|NCT01625377|136799|P1|COMPLETED|Overall Study||88
57727|NCT01625377|136798|P2|Intent to Treat Population|Overall Study||90
57728|NCT01625377|136799|P1|Intent to Treat Population|Overall Study||93
57729|NCT01625377|136798|P2|Safety Set of Population|Overall Study||90
57730|NCT01625377|136799|P1|Safety Set of Population|Overall Study||94
57731|NCT01625377|136798|P2|STARTED|Overall Study||93
57732|NCT01625377|136799|P1|STARTED|Overall Study|"Started indicates randomized patients."|95
57733|NCT01625338|136832|P3|NOT COMPLETED|Overall Study||39
57734|NCT01625338|136833|P2|NOT COMPLETED|Overall Study||44
57735|NCT01625338|136834|P1|NOT COMPLETED|Overall Study||32
57736|NCT01625338|136832|P3|COMPLETED|Overall Study||181
57737|NCT01625338|136833|P2|COMPLETED|Overall Study||156
57738|NCT01625338|136834|P1|COMPLETED|Overall Study||82
57739|NCT01625338|136832|P3|STARTED|Overall Study||220
57740|NCT01625338|136833|P2|STARTED|Overall Study||200
57741|NCT01625338|136834|P1|STARTED|Overall Study||114
57742|NCT01625221|136854|P1|NOT COMPLETED|Overall Study||7
57743|NCT01625221|136854|P1|COMPLETED|Overall Study||28
57744|NCT01625221|136854|P1|STARTED|Overall Study||35
57745|NCT01625169|136858|P1|NOT COMPLETED|Overall Study||0
57746|NCT01625169|136858|P1|COMPLETED|Overall Study||9
57747|NCT01625169|136858|P1|STARTED|Overall Study||9
57748|NCT01625091|136873|P2|NOT COMPLETED|Post-intervention||2
57749|NCT01625091|136874|P1|NOT COMPLETED|Post-intervention||4
57750|NCT01625091|136873|P2|COMPLETED|Post-intervention||85
57751|NCT01625091|136874|P1|COMPLETED|Post-intervention||81
57752|NCT01625091|136873|P2|7 Months|Post-intervention||85
57753|NCT01625091|136874|P1|7 Months|Post-intervention||81
57754|NCT01625091|136873|P2|STARTED|Post-intervention||87
57755|NCT01625091|136874|P1|STARTED|Post-intervention||85
57756|NCT01625091|136873|P2|NOT COMPLETED|Intervention||11
57757|NCT01625091|136874|P1|NOT COMPLETED|Intervention||11
57758|NCT01625091|136873|P2|COMPLETED|Intervention||87
57759|NCT01625091|136874|P1|COMPLETED|Intervention||85
57760|NCT01625091|136873|P2|4 Months|Intervention||87
57761|NCT01625091|136874|P1|4 Months|Intervention||85
57762|NCT01625091|136873|P2|2 Months|Intervention||93
57763|NCT01625091|136874|P1|2 Months|Intervention||90
57764|NCT01625091|136873|P2|STARTED|Intervention||98
57765|NCT01625091|136874|P1|STARTED|Intervention||96
57766|NCT01624948|136888|P2|NOT COMPLETED|Overall Study||0
57767|NCT01624948|136889|P1|NOT COMPLETED|Overall Study||0
57768|NCT01624948|136888|P2|COMPLETED|Overall Study||20
57769|NCT01624948|136889|P1|COMPLETED|Overall Study||20
57770|NCT01624948|136888|P2|STARTED|Overall Study||20
57771|NCT01624948|136889|P1|STARTED|Overall Study||20
57772|NCT01624740|136907|P2|NOT COMPLETED|Second Intervention (3-4 Days)||0
57773|NCT01624740|136908|P1|NOT COMPLETED|Second Intervention (3-4 Days)||1
57774|NCT01624740|136907|P2|COMPLETED|Second Intervention (3-4 Days)||9
57775|NCT01624740|136908|P1|COMPLETED|Second Intervention (3-4 Days)||8
57776|NCT01624740|136907|P2|STARTED|Second Intervention (3-4 Days)||9
57777|NCT01624740|136908|P1|STARTED|Second Intervention (3-4 Days)||9
57778|NCT01624740|136907|P2|NOT COMPLETED|Washout (1 Hour)||0
57779|NCT01624740|136908|P1|NOT COMPLETED|Washout (1 Hour)||0
57780|NCT01624740|136907|P2|COMPLETED|Washout (1 Hour)||9
57781|NCT01624740|136908|P1|COMPLETED|Washout (1 Hour)||9
57782|NCT01624740|136907|P2|STARTED|Washout (1 Hour)||9
57783|NCT01624740|136908|P1|STARTED|Washout (1 Hour)||9
57784|NCT01624740|136907|P2|NOT COMPLETED|First Intervention (3-4 Days)||0
57785|NCT01624740|136908|P1|NOT COMPLETED|First Intervention (3-4 Days)||0
57786|NCT01624740|136907|P2|COMPLETED|First Intervention (3-4 Days)||9
57787|NCT01624740|136908|P1|COMPLETED|First Intervention (3-4 Days)||9
57788|NCT01624740|136907|P2|STARTED|First Intervention (3-4 Days)||9
57789|NCT01624740|136908|P1|STARTED|First Intervention (3-4 Days)||9
57790|NCT01624467|136915|P1|NOT COMPLETED|Overall Study||31
57791|NCT01624467|136915|P1|COMPLETED|Overall Study||44
57792|NCT01624467|136915|P1|Received at Least One Dose of Study Drug|Overall Study||75
57793|NCT01624467|136915|P1|STARTED|Overall Study||75
57794|NCT01624363|136928|P1|NOT COMPLETED|Overall Study||0
57795|NCT01624363|136928|P1|COMPLETED|Overall Study||341
57796|NCT01624363|136928|P1|STARTED|Overall Study||341
57797|NCT01624350|136932|P1|NOT COMPLETED|Overall Study||25
57798|NCT01624350|136932|P1|COMPLETED|Overall Study||75
57799|NCT01624350|136932|P1|STARTED|Overall Study||100
57800|NCT01624259|136954|P2|NOT COMPLETED|Overall Study||31
57801|NCT01624259|136955|P1|NOT COMPLETED|Overall Study||30
57802|NCT01624259|136954|P2|COMPLETED|Overall Study|Completed the study on study treatment|269
57803|NCT01624259|136955|P1|COMPLETED|Overall Study|Completed the study on study treatment|269
57804|NCT01624259|136954|P2|Received at Least One Dose of Study Drug|Overall Study||300
57805|NCT01624259|136955|P1|Received at Least One Dose of Study Drug|Overall Study||299
57806|NCT01624259|136954|P2|STARTED|Overall Study||300
57807|NCT01624259|136955|P1|STARTED|Overall Study||299
57808|NCT01624233|137004|P1|NOT COMPLETED|Period 3 - Maintenance||7
57809|NCT01624233|137004|P1|COMPLETED|Period 3 - Maintenance||83
57810|NCT01624233|137004|P1|Received at Least 1 Dose of Study Drug|Period 3 - Maintenance||90
57811|NCT01624233|137004|P1|STARTED|Period 3 - Maintenance||90
57812|NCT01624233|137004|P1|NOT COMPLETED|Period 2 - Induction||1
57813|NCT01624233|137004|P1|COMPLETED|Period 2 - Induction||90
57814|NCT01624233|137004|P1|Plaque Ps|Period 2 - Induction||78
57815|NCT01624233|137004|P1|Pustular Ps|Period 2 - Induction||5
57816|NCT01624233|137004|P1|Erythrodermic Psoriasis (Ps)|Period 2 - Induction||8
57817|NCT01624233|137004|P1|Received at Least 1 Dose of Study Drug|Period 2 - Induction||91
57818|NCT01624233|137004|P1|STARTED|Period 2 - Induction||91
57819|NCT01624168|137024|P3|NOT COMPLETED|Overall Study||6
57820|NCT01624168|137025|P2|NOT COMPLETED|Overall Study||12
57821|NCT01624168|137026|P1|NOT COMPLETED|Overall Study||4
57822|NCT01624168|137024|P3|COMPLETED|Overall Study||22
57823|NCT01624168|137025|P2|COMPLETED|Overall Study||16
57824|NCT01624168|137026|P1|COMPLETED|Overall Study||15
57825|NCT01624168|137024|P3|STARTED|Overall Study||28
57826|NCT01624168|137025|P2|STARTED|Overall Study||28
57827|NCT01624168|137026|P1|STARTED|Overall Study||19
57828|NCT01623869|137049|P1|NOT COMPLETED|Overall Study||0
57829|NCT01623869|137049|P1|COMPLETED|Overall Study||16
57830|NCT01623869|137049|P1|STARTED|Overall Study||16
57831|NCT01623830|137057|P2|NOT COMPLETED|Overall Study||9
57832|NCT01623830|137058|P1|NOT COMPLETED|Overall Study||7
57833|NCT01623830|137057|P2|COMPLETED|Overall Study||35
57834|NCT01623830|137058|P1|COMPLETED|Overall Study||38
57835|NCT01623830|137057|P2|STARTED|Overall Study||44
57836|NCT01623830|137058|P1|STARTED|Overall Study||45
57837|NCT01623479|137072|P1|NOT COMPLETED|Overall Study||0
57838|NCT01623479|137072|P1|COMPLETED|Overall Study||585
57839|NCT01623479|137072|P1|STARTED|Overall Study||585
57840|NCT01623466|137080|P2|NOT COMPLETED|Overall Study||0
57841|NCT01623466|137081|P1|NOT COMPLETED|Overall Study||1
57842|NCT01623466|137080|P2|COMPLETED|Overall Study||18
57843|NCT01623466|137081|P1|COMPLETED|Overall Study||17
57844|NCT01623466|137080|P2|STARTED|Overall Study||18
57845|NCT01623466|137081|P1|STARTED|Overall Study||18
57846|NCT01623323|137095|P1|NOT COMPLETED|Overall Study||104
57847|NCT01623323|137095|P1|COMPLETED|Overall Study||601
57848|NCT01623323|137095|P1|STARTED|Overall Study||705
57849|NCT01623271|137099|P1|NOT COMPLETED|Overall Study||2
57850|NCT01623271|137099|P1|COMPLETED|Overall Study||3
57851|NCT01623271|137099|P1|STARTED|Overall Study||5
57852|NCT01623154|137103|P1|NOT COMPLETED|Overall Study||4
57853|NCT01623154|137103|P1|COMPLETED|Overall Study||95
57854|NCT01623154|137103|P1|Available for Analysis|Overall Study||95
57855|NCT01623154|137103|P1|STARTED|Overall Study||99
57856|NCT01623115|137111|P2|NOT COMPLETED|Overall Study||77
57857|NCT01623115|137112|P1|NOT COMPLETED|Overall Study||33
57858|NCT01623115|137111|P2|COMPLETED|Overall Study||246
57859|NCT01623115|137112|P1|COMPLETED|Overall Study||130
57860|NCT01623115|137111|P2|Treated|Overall Study||322
57861|NCT01623115|137112|P1|Treated|Overall Study||163
57862|NCT01623115|137111|P2|STARTED|Overall Study|Randomized|323
57863|NCT01623115|137112|P1|STARTED|Overall Study|Randomized|163
57864|NCT01623050|137172|P1|NOT COMPLETED|Overall Study||9
57865|NCT01623050|137172|P1|COMPLETED|Overall Study||27
57866|NCT01623050|137172|P1|Treated|Overall Study||34
57867|NCT01623050|137172|P1|STARTED|Overall Study||36
57868|NCT01622673|137186|P6|NOT COMPLETED|Treatment Period 5||0
57869|NCT01622673|137187|P5|NOT COMPLETED|Treatment Period 5||0
57870|NCT01622673|137188|P4|NOT COMPLETED|Treatment Period 5||0
57871|NCT01622673|137189|P3|NOT COMPLETED|Treatment Period 5||0
57872|NCT01622673|137190|P2|NOT COMPLETED|Treatment Period 5||0
57873|NCT01622673|137191|P1|NOT COMPLETED|Treatment Period 5||0
57874|NCT01622673|137186|P6|COMPLETED|Treatment Period 5||4
57875|NCT01622673|137187|P5|COMPLETED|Treatment Period 5||4
57876|NCT01622673|137188|P4|COMPLETED|Treatment Period 5||4
57877|NCT01622673|137189|P3|COMPLETED|Treatment Period 5||4
57878|NCT01622673|137190|P2|COMPLETED|Treatment Period 5||3
57879|NCT01622673|137191|P1|COMPLETED|Treatment Period 5||4
57880|NCT01622673|137186|P6|STARTED|Treatment Period 5||4
57881|NCT01622673|137187|P5|STARTED|Treatment Period 5||4
57882|NCT01622673|137188|P4|STARTED|Treatment Period 5||4
57883|NCT01622673|137189|P3|STARTED|Treatment Period 5||4
57884|NCT01622673|137190|P2|STARTED|Treatment Period 5||3
57885|NCT01622673|137191|P1|STARTED|Treatment Period 5||4
57886|NCT01622673|137186|P6|NOT COMPLETED|Treatment Period 4||0
57887|NCT01622673|137187|P5|NOT COMPLETED|Treatment Period 4||0
57888|NCT01622673|137188|P4|NOT COMPLETED|Treatment Period 4||0
57889|NCT01622673|137189|P3|NOT COMPLETED|Treatment Period 4||0
57890|NCT01622673|137190|P2|NOT COMPLETED|Treatment Period 4||0
57891|NCT01622673|137191|P1|NOT COMPLETED|Treatment Period 4||0
57892|NCT01622673|137186|P6|COMPLETED|Treatment Period 4||4
57893|NCT01622673|137187|P5|COMPLETED|Treatment Period 4||4
57894|NCT01622673|137188|P4|COMPLETED|Treatment Period 4||4
57895|NCT01622673|137189|P3|COMPLETED|Treatment Period 4||4
57896|NCT01622673|137190|P2|COMPLETED|Treatment Period 4||3
57897|NCT01622673|137191|P1|COMPLETED|Treatment Period 4||4
57898|NCT01622673|137186|P6|STARTED|Treatment Period 4||4
57899|NCT01622673|137187|P5|STARTED|Treatment Period 4||4
57900|NCT01622673|137188|P4|STARTED|Treatment Period 4||4
57901|NCT01622673|137189|P3|STARTED|Treatment Period 4||4
57902|NCT01622673|137190|P2|STARTED|Treatment Period 4||3
57903|NCT01622673|137191|P1|STARTED|Treatment Period 4||4
57904|NCT01622673|137186|P6|NOT COMPLETED|Treatment Period 3||0
57905|NCT01622673|137187|P5|NOT COMPLETED|Treatment Period 3||0
57906|NCT01622673|137188|P4|NOT COMPLETED|Treatment Period 3||0
57907|NCT01622673|137189|P3|NOT COMPLETED|Treatment Period 3||0
57908|NCT01622673|137190|P2|NOT COMPLETED|Treatment Period 3||1
57909|NCT01622673|137191|P1|NOT COMPLETED|Treatment Period 3||0
57910|NCT01622673|137186|P6|COMPLETED|Treatment Period 3||4
57911|NCT01622673|137187|P5|COMPLETED|Treatment Period 3||4
57912|NCT01622673|137188|P4|COMPLETED|Treatment Period 3||4
57913|NCT01622673|137189|P3|COMPLETED|Treatment Period 3||4
57914|NCT01622673|137190|P2|COMPLETED|Treatment Period 3||3
57915|NCT01622673|137191|P1|COMPLETED|Treatment Period 3||4
57916|NCT01622673|137186|P6|STARTED|Treatment Period 3||4
57917|NCT01622673|137187|P5|STARTED|Treatment Period 3||4
57918|NCT01622673|137188|P4|STARTED|Treatment Period 3||4
57919|NCT01622673|137189|P3|STARTED|Treatment Period 3||4
57920|NCT01622673|137190|P2|STARTED|Treatment Period 3||4
57921|NCT01622673|137191|P1|STARTED|Treatment Period 3||4
57922|NCT01622673|137186|P6|NOT COMPLETED|Treatment Period 2||0
57923|NCT01622673|137187|P5|NOT COMPLETED|Treatment Period 2||0
57924|NCT01622673|137188|P4|NOT COMPLETED|Treatment Period 2||1
57925|NCT01622673|137189|P3|NOT COMPLETED|Treatment Period 2||0
57926|NCT01622673|137190|P2|NOT COMPLETED|Treatment Period 2||0
57927|NCT01622673|137191|P1|NOT COMPLETED|Treatment Period 2||0
57928|NCT01622673|137186|P6|COMPLETED|Treatment Period 2||4
57929|NCT01622673|137187|P5|COMPLETED|Treatment Period 2||4
57930|NCT01622673|137188|P4|COMPLETED|Treatment Period 2||4
57931|NCT01622673|137189|P3|COMPLETED|Treatment Period 2||4
57932|NCT01622673|137190|P2|COMPLETED|Treatment Period 2||4
57933|NCT01622673|137191|P1|COMPLETED|Treatment Period 2||4
57934|NCT01622673|137186|P6|STARTED|Treatment Period 2||4
57935|NCT01622673|137187|P5|STARTED|Treatment Period 2||4
57936|NCT01622673|137188|P4|STARTED|Treatment Period 2||5
57937|NCT01622673|137189|P3|STARTED|Treatment Period 2||4
57938|NCT01622673|137190|P2|STARTED|Treatment Period 2||4
57939|NCT01622673|137191|P1|STARTED|Treatment Period 2||4
57940|NCT01622673|137186|P6|NOT COMPLETED|Treatment Period 1||0
57941|NCT01622673|137187|P5|NOT COMPLETED|Treatment Period 1||0
57942|NCT01622673|137188|P4|NOT COMPLETED|Treatment Period 1||1
57943|NCT01622673|137189|P3|NOT COMPLETED|Treatment Period 1||0
57944|NCT01622673|137190|P2|NOT COMPLETED|Treatment Period 1||1
57945|NCT01622673|137191|P1|NOT COMPLETED|Treatment Period 1||0
57946|NCT01622673|137186|P6|COMPLETED|Treatment Period 1||4
57947|NCT01622673|137187|P5|COMPLETED|Treatment Period 1||4
57948|NCT01622673|137188|P4|COMPLETED|Treatment Period 1||5
57949|NCT01622673|137189|P3|COMPLETED|Treatment Period 1||4
57950|NCT01622673|137190|P2|COMPLETED|Treatment Period 1||4
57951|NCT01622673|137191|P1|COMPLETED|Treatment Period 1||4
57952|NCT01622673|137186|P6|STARTED|Treatment Period 1||4
57953|NCT01622673|137187|P5|STARTED|Treatment Period 1||4
57954|NCT01622673|137188|P4|STARTED|Treatment Period 1||6
57955|NCT01622673|137189|P3|STARTED|Treatment Period 1||4
57956|NCT01622673|137190|P2|STARTED|Treatment Period 1||5
57957|NCT01622673|137191|P1|STARTED|Treatment Period 1||4
57958|NCT01622660|137226|P1|NOT COMPLETED|Overall Study||1
57959|NCT01622660|137226|P1|COMPLETED|Overall Study||1
57960|NCT01622660|137226|P1|STARTED|Overall Study||2
57961|NCT01622296|137230|P2|NOT COMPLETED|Second Intervention||0
57962|NCT01622296|137231|P1|NOT COMPLETED|Second Intervention||0
57963|NCT01622296|137230|P2|COMPLETED|Second Intervention||10
57964|NCT01622296|137231|P1|COMPLETED|Second Intervention||10
57965|NCT01622296|137230|P2|STARTED|Second Intervention||10
57966|NCT01622296|137231|P1|STARTED|Second Intervention||10
57967|NCT01622296|137230|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
57968|NCT01622296|137231|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
57969|NCT01622296|137230|P2|COMPLETED|Washout Period of at Least 1 Week||10
57970|NCT01622296|137231|P1|COMPLETED|Washout Period of at Least 1 Week||10
57971|NCT01622296|137230|P2|STARTED|Washout Period of at Least 1 Week||10
57972|NCT01622296|137231|P1|STARTED|Washout Period of at Least 1 Week||10
57973|NCT01622296|137230|P2|NOT COMPLETED|First Intervention||0
57974|NCT01622296|137231|P1|NOT COMPLETED|First Intervention||0
57975|NCT01622296|137230|P2|COMPLETED|First Intervention||10
57976|NCT01622296|137231|P1|COMPLETED|First Intervention||10
57977|NCT01622296|137230|P2|STARTED|First Intervention||10
57978|NCT01622296|137231|P1|STARTED|First Intervention||10
57979|NCT01622257|137239|P3|NOT COMPLETED|Overall Study||0
57980|NCT01622257|137240|P2|NOT COMPLETED|Overall Study||0
57981|NCT01622257|137241|P1|NOT COMPLETED|Overall Study||0
57982|NCT01622257|137239|P3|COMPLETED|Overall Study||66
57983|NCT01622257|137240|P2|COMPLETED|Overall Study||66
57984|NCT01622257|137241|P1|COMPLETED|Overall Study||66
57985|NCT01622257|137239|P3|STARTED|Overall Study||66
57986|NCT01622257|137240|P2|STARTED|Overall Study||66
57987|NCT01622257|137241|P1|STARTED|Overall Study||66
57988|NCT01622231|137261|P1|NOT COMPLETED|Overall Study||2
57989|NCT01622231|137261|P1|COMPLETED|Overall Study||59
57990|NCT01622231|137261|P1|STARTED|Overall Study||61
57991|NCT01621776|137292|P3|NOT COMPLETED|Overall Study||0
57992|NCT01621776|137293|P2|NOT COMPLETED|Overall Study||0
57993|NCT01621776|137294|P1|NOT COMPLETED|Overall Study||0
57994|NCT01621776|137292|P3|COMPLETED|Overall Study||18
57995|NCT01621776|137293|P2|COMPLETED|Overall Study||40
57996|NCT01621776|137294|P1|COMPLETED|Overall Study||41
57997|NCT01621776|137292|P3|STARTED|Overall Study||18
57998|NCT01621776|137293|P2|STARTED|Overall Study||40
57999|NCT01621776|137294|P1|STARTED|Overall Study||41
58000|NCT01621672|137310|P2|NOT COMPLETED|Overall Study||0
58001|NCT01621672|137311|P1|NOT COMPLETED|Overall Study||0
58002|NCT01621672|137310|P2|COMPLETED|Overall Study||17
58003|NCT01621672|137311|P1|COMPLETED|Overall Study||25
58004|NCT01621672|137310|P2|STARTED|Overall Study||17
58005|NCT01621672|137311|P1|STARTED|Overall Study||25
58006|NCT01621633|137321|P4|NOT COMPLETED|Overall Study||0
58007|NCT01621633|137322|P3|NOT COMPLETED|Overall Study||0
58008|NCT01621633|137323|P2|NOT COMPLETED|Overall Study||0
58009|NCT01621633|137324|P1|NOT COMPLETED|Overall Study||0
58010|NCT01621633|137321|P4|COMPLETED|Overall Study||8
58011|NCT01621633|137322|P3|COMPLETED|Overall Study||8
58012|NCT01621633|137323|P2|COMPLETED|Overall Study||8
58013|NCT01621633|137324|P1|COMPLETED|Overall Study||8
58014|NCT01621633|137321|P4|STARTED|Overall Study||8
58015|NCT01621633|137322|P3|STARTED|Overall Study||8
58016|NCT01621633|137323|P2|STARTED|Overall Study||8
58017|NCT01621633|137324|P1|STARTED|Overall Study||8
58018|NCT01621477|137346|P1|NOT COMPLETED|Overall Study||0
58019|NCT01621477|137346|P1|COMPLETED|Overall Study||17
58020|NCT01621477|137346|P1|STARTED|Overall Study||17
58021|NCT01621191|137356|P1|NOT COMPLETED|Overall Study||25
58022|NCT01621191|137356|P1|COMPLETED|Overall Study||124
58023|NCT01621191|137356|P1|Had at Least 1 Post-Baseline Observation|Overall Study||148
58024|NCT01621191|137356|P1|Received at Least 1 Dose of Study Drug|Overall Study||149
58025|NCT01621191|137356|P1|STARTED|Overall Study||149
58026|NCT01621178|137370|P3|NOT COMPLETED|Overall Study||31
58027|NCT01621178|137371|P2|NOT COMPLETED|Overall Study||22
58028|NCT01621178|137372|P1|NOT COMPLETED|Overall Study||15
58029|NCT01621178|137370|P3|COMPLETED|Overall Study||162
58030|NCT01621178|137371|P2|COMPLETED|Overall Study||168
58031|NCT01621178|137372|P1|COMPLETED|Overall Study||179
58032|NCT01621178|137370|P3|Received at Least One Dose of Study Drug|Overall Study||192
58033|NCT01621178|137371|P2|Received at Least One Dose of Study Drug|Overall Study||190
58034|NCT01621178|137372|P1|Received at Least One Dose of Study Drug|Overall Study||194
58035|NCT01621178|137370|P3|STARTED|Overall Study||193
58036|NCT01621178|137371|P2|STARTED|Overall Study||190
58037|NCT01621178|137372|P1|STARTED|Overall Study||194
58038|NCT01621126|137419|P1|NOT COMPLETED|Overall Study||6
58039|NCT01621126|137419|P1|COMPLETED|Overall Study||34
58040|NCT01621126|137419|P1|STARTED|Overall Study||40
58041|NCT01621009|137427|P4|NOT COMPLETED|Overall Study||53
58042|NCT01621009|137428|P3|NOT COMPLETED|Overall Study||63
58043|NCT01621009|137429|P2|NOT COMPLETED|Overall Study||51
58044|NCT01621009|137430|P1|NOT COMPLETED|Overall Study||43
58045|NCT01621009|137427|P4|COMPLETED|Overall Study||60
58046|NCT01621009|137428|P3|COMPLETED|Overall Study||58
58047|NCT01621009|137429|P2|COMPLETED|Overall Study||65
58048|NCT01621009|137430|P1|COMPLETED|Overall Study||70
58049|NCT01621009|137427|P4|STARTED|Overall Study||113
58050|NCT01621009|137428|P3|STARTED|Overall Study||121
58051|NCT01621009|137429|P2|STARTED|Overall Study||116
58052|NCT01621009|137430|P1|STARTED|Overall Study||113
58053|NCT01620489|137440|P2|NOT COMPLETED|Overall Study||34
58054|NCT01620489|137441|P1|NOT COMPLETED|Overall Study||35
58055|NCT01620489|137440|P2|COMPLETED|Overall Study|2 subjects did not take trial product|105
58056|NCT01620489|137441|P1|COMPLETED|Overall Study||105
58057|NCT01620489|137440|P2|Exposed|Overall Study|2 subjects did not take trial product|137
58058|NCT01620489|137441|P1|Exposed|Overall Study||140
58059|NCT01620489|137440|P2|STARTED|Overall Study||139
58060|NCT01620489|137441|P1|STARTED|Overall Study||140
58061|NCT01620255|137462|P5|NOT COMPLETED|Overall Study||6
58062|NCT01620255|137463|P4|NOT COMPLETED|Overall Study||3
58063|NCT01620255|137464|P3|NOT COMPLETED|Overall Study||2
58064|NCT01620255|137465|P2|NOT COMPLETED|Overall Study||6
58065|NCT01620255|137466|P1|NOT COMPLETED|Overall Study||4
58066|NCT01620255|137462|P5|COMPLETED|Overall Study||64
58067|NCT01620255|137463|P4|COMPLETED|Overall Study||70
58068|NCT01620255|137464|P3|COMPLETED|Overall Study||68
58069|NCT01620255|137465|P2|COMPLETED|Overall Study||65
58070|NCT01620255|137466|P1|COMPLETED|Overall Study||69
58071|NCT01620255|137462|P5|Treated|Overall Study||70
58072|NCT01620255|137463|P4|Treated|Overall Study||73
58073|NCT01620255|137464|P3|Treated|Overall Study||70
58074|NCT01620255|137465|P2|Treated|Overall Study||71
58075|NCT01620255|137466|P1|Treated|Overall Study||73
58076|NCT01620255|137462|P5|STARTED|Overall Study||70
58077|NCT01620255|137463|P4|STARTED|Overall Study||73
58078|NCT01620255|137464|P3|STARTED|Overall Study||70
58079|NCT01620255|137465|P2|STARTED|Overall Study||71
58080|NCT01620255|137466|P1|STARTED|Overall Study||73
58081|NCT01620177|137543|P1|NOT COMPLETED|Overall Study||79
58082|NCT01620177|137543|P1|COMPLETED|Overall Study||19
58083|NCT01620177|137543|P1|STARTED|Overall Study||98
58084|NCT01620138|137568|P2|NOT COMPLETED|Overall Study||0
58085|NCT01620138|137569|P1|NOT COMPLETED|Overall Study||6
58086|NCT01620138|137568|P2|COMPLETED|Overall Study||9
58087|NCT01620138|137569|P1|COMPLETED|Overall Study||6
58088|NCT01620138|137568|P2|STARTED|Overall Study||9
58089|NCT01620138|137569|P1|STARTED|Overall Study||12
58090|NCT01620086|137577|P3|NOT COMPLETED|Overall Study||0
58091|NCT01620086|137578|P2|NOT COMPLETED|Overall Study||7
58092|NCT01620086|137579|P1|NOT COMPLETED|Overall Study||5
58093|NCT01620086|137577|P3|COMPLETED|Overall Study||2
58094|NCT01620086|137578|P2|COMPLETED|Overall Study||4
58095|NCT01620086|137579|P1|COMPLETED|Overall Study||8
58096|NCT01620086|137577|P3|STARTED|Overall Study||2
58097|NCT01620086|137578|P2|STARTED|Overall Study||11
58098|NCT01620086|137579|P1|STARTED|Overall Study||13
58099|NCT01620060|137598|P1|NOT COMPLETED|Overall Study||15
58100|NCT01620060|137598|P1|COMPLETED|Overall Study||90
58101|NCT01620060|137598|P1|STARTED|Overall Study||105
58102|NCT01620047|137607|P3|NOT COMPLETED|Overall Study||0
58103|NCT01620047|137608|P2|NOT COMPLETED|Overall Study||0
58104|NCT01620047|137609|P1|NOT COMPLETED|Overall Study||0
58105|NCT01620047|137607|P3|COMPLETED|Overall Study||20
58106|NCT01620047|137608|P2|COMPLETED|Overall Study||20
58107|NCT01620047|137609|P1|COMPLETED|Overall Study||20
58108|NCT01620047|137607|P3|STARTED|Overall Study||20
58109|NCT01620047|137608|P2|STARTED|Overall Study||20
58110|NCT01620047|137609|P1|STARTED|Overall Study||20
58111|NCT01619878|137617|P1|NOT COMPLETED|Follow-up at 12 Months of Age||3
58112|NCT01619878|137617|P1|COMPLETED|Follow-up at 12 Months of Age||17
58113|NCT01619878|137617|P1|STARTED|Follow-up at 12 Months of Age||20
58114|NCT01619878|137617|P1|NOT COMPLETED|6 Week Follow-up Phase||1
58115|NCT01619878|137617|P1|COMPLETED|6 Week Follow-up Phase||19
58116|NCT01619878|137617|P1|STARTED|6 Week Follow-up Phase||20
58117|NCT01619800|137631|P2|NOT COMPLETED|Overall Study||0
58118|NCT01619800|137632|P1|NOT COMPLETED|Overall Study||2
58119|NCT01619800|137631|P2|COMPLETED|Overall Study||0
58120|NCT01619800|137632|P1|COMPLETED|Overall Study||0
58121|NCT01619800|137631|P2|STARTED|Overall Study||0
58122|NCT01619800|137632|P1|STARTED|Overall Study||2
58123|NCT01619787|137640|P1|NOT COMPLETED|Overall Study||5
58124|NCT01619787|137640|P1|COMPLETED|Overall Study||212
58125|NCT01619787|137640|P1|STARTED|Overall Study||217
58126|NCT01619774|137649|P1|NOT COMPLETED|Overall Study||0
58127|NCT01619774|137649|P1|COMPLETED|Overall Study||23
58128|NCT01619774|137649|P1|STARTED|Overall Study||23
58129|NCT01619579|137657|P2|NOT COMPLETED|Overall Study||3
58130|NCT01619579|137658|P1|NOT COMPLETED|Overall Study||0
58131|NCT01619579|137657|P2|COMPLETED|Overall Study||14
58132|NCT01619579|137658|P1|COMPLETED|Overall Study||5
58133|NCT01619579|137657|P2|STARTED|Overall Study||17
58134|NCT01619579|137658|P1|STARTED|Overall Study||5
58135|NCT01619059|137670|P2|NOT COMPLETED|Long-Term (LT) Treatment Period||9
58136|NCT01619059|137671|P1|NOT COMPLETED|Long-Term (LT) Treatment Period||8
58137|NCT01619059|137670|P2|COMPLETED|Long-Term (LT) Treatment Period||133
58138|NCT01619059|137671|P1|COMPLETED|Long-Term (LT) Treatment Period||147
58139|NCT01619059|137670|P2|STARTED|Long-Term (LT) Treatment Period||142
58140|NCT01619059|137671|P1|STARTED|Long-Term (LT) Treatment Period||155
58141|NCT01619059|137670|P2|NOT COMPLETED|Short-Term (ST) Treatment Period||11
58142|NCT01619059|137671|P1|NOT COMPLETED|Short-Term (ST) Treatment Period||6
58143|NCT01619059|137670|P2|COMPLETED|Short-Term (ST) Treatment Period||142
58144|NCT01619059|137671|P1|COMPLETED|Short-Term (ST) Treatment Period||156
58145|NCT01619059|137670|P2|STARTED|Short-Term (ST) Treatment Period||153
58146|NCT01619059|137671|P1|STARTED|Short-Term (ST) Treatment Period||162
58147|NCT01618968|137687|P4|NOT COMPLETED|Overall Study||1
58148|NCT01618968|137688|P3|NOT COMPLETED|Overall Study||0
58149|NCT01618968|137689|P2|NOT COMPLETED|Overall Study||0
58150|NCT01618968|137690|P1|NOT COMPLETED|Overall Study||1
58151|NCT01618968|137687|P4|COMPLETED|Overall Study||11
58152|NCT01618968|137688|P3|COMPLETED|Overall Study||12
58153|NCT01618968|137689|P2|COMPLETED|Overall Study||12
58154|NCT01618968|137690|P1|COMPLETED|Overall Study||12
58155|NCT01618968|137687|P4|Received Treatment C|Overall Study||11
58156|NCT01618968|137688|P3|Received Treatment C|Overall Study||12
58157|NCT01618968|137689|P2|Received Treatment C|Overall Study||12
58158|NCT01618968|137690|P1|Received Treatment C|Overall Study||12
58159|NCT01618968|137687|P4|Received Treatment B|Overall Study||12
58160|NCT01618968|137688|P3|Received Treatment B|Overall Study||12
58161|NCT01618968|137689|P2|Received Treatment B|Overall Study||12
58162|NCT01618968|137690|P1|Received Treatment B|Overall Study||13
58163|NCT01618968|137687|P4|Received Treatment A|Overall Study||11
58164|NCT01618968|137688|P3|Received Treatment A|Overall Study||12
58165|NCT01618968|137689|P2|Received Treatment A|Overall Study||12
58166|NCT01618968|137690|P1|Received Treatment A|Overall Study||12
58167|NCT01618968|137687|P4|STARTED|Overall Study||12
58168|NCT01618968|137688|P3|STARTED|Overall Study||12
58169|NCT01618968|137689|P2|STARTED|Overall Study||12
58170|NCT01618968|137690|P1|STARTED|Overall Study||13
58171|NCT01618955|137709|P4|NOT COMPLETED|Overall Study||0
58172|NCT01618955|137710|P3|NOT COMPLETED|Overall Study||0
58173|NCT01618955|137711|P2|NOT COMPLETED|Overall Study||0
58174|NCT01618955|137712|P1|NOT COMPLETED|Overall Study||0
58175|NCT01618955|137709|P4|COMPLETED|Overall Study||20
58176|NCT01618955|137710|P3|COMPLETED|Overall Study||31
58177|NCT01618955|137711|P2|COMPLETED|Overall Study||30
58178|NCT01618955|137712|P1|COMPLETED|Overall Study||20
58179|NCT01618955|137709|P4|STARTED|Overall Study||20
58180|NCT01618955|137710|P3|STARTED|Overall Study||31
58181|NCT01618955|137711|P2|STARTED|Overall Study||30
58182|NCT01618955|137712|P1|STARTED|Overall Study||20
58183|NCT01618942|137736|P2|NOT COMPLETED|Overall Study||0
58184|NCT01618942|137737|P1|NOT COMPLETED|Overall Study||0
58185|NCT01618942|137736|P2|COMPLETED|Overall Study||50
58186|NCT01618942|137737|P1|COMPLETED|Overall Study||50
58187|NCT01618942|137736|P2|STARTED|Overall Study||50
58188|NCT01618942|137737|P1|STARTED|Overall Study||50
58189|NCT01618864|137757|P1|NOT COMPLETED|Overall Study||4
58190|NCT01618864|137757|P1|COMPLETED|Overall Study|Completed 4 weeks and 8 weeks of treatment|19
58191|NCT01618864|137757|P1|Completed 2 Weeks|Overall Study||19
58192|NCT01618864|137757|P1|STARTED|Overall Study||23
58193|NCT01618838|137766|P1|NOT COMPLETED|Overall Study||4
58194|NCT01618838|137766|P1|COMPLETED|Overall Study||0
58195|NCT01618838|137766|P1|STARTED|Overall Study||4
58196|NCT01618708|137772|P2|NOT COMPLETED|Overall Study||46
58197|NCT01618708|137773|P1|NOT COMPLETED|Overall Study||44
58198|NCT01618708|137772|P2|COMPLETED|Overall Study||136
58199|NCT01618708|137773|P1|COMPLETED|Overall Study||131
58200|NCT01618708|137772|P2|Treated|Overall Study||180
58201|NCT01618708|137773|P1|Treated|Overall Study||172
58202|NCT01618708|137772|P2|STARTED|Overall Study||182
58203|NCT01618708|137773|P1|STARTED|Overall Study||175
58204|NCT01618669|137787|P2|NOT COMPLETED|Overall Study||23
58205|NCT01618669|137788|P1|NOT COMPLETED|Overall Study||34
58206|NCT01618669|137787|P2|COMPLETED|Overall Study||546
58207|NCT01618669|137788|P1|COMPLETED|Overall Study||544
58208|NCT01618669|137787|P2|Received Treatment|Overall Study||567
58209|NCT01618669|137788|P1|Received Treatment|Overall Study||575
58210|NCT01618669|137787|P2|STARTED|Overall Study||569
58211|NCT01618669|137788|P1|STARTED|Overall Study||578
58212|NCT01618422|137834|P2|NOT COMPLETED|Overall Study||0
58213|NCT01618422|137835|P1|NOT COMPLETED|Overall Study||0
58214|NCT01618422|137834|P2|COMPLETED|Overall Study||111
58215|NCT01618422|137835|P1|COMPLETED|Overall Study||114
58216|NCT01618422|137834|P2|STARTED|Overall Study||111
58217|NCT01618422|137835|P1|STARTED|Overall Study||114
58218|NCT01618266|137841|P1|NOT COMPLETED|Overall Study||96
58219|NCT01618266|137841|P1|COMPLETED|Overall Study||279
58220|NCT01618266|137841|P1|STARTED|Overall Study||375
58221|NCT01618240|137856|P1|NOT COMPLETED|Overall Study||0
58222|NCT01618240|137856|P1|COMPLETED|Overall Study||30
58223|NCT01618240|137856|P1|STARTED|Overall Study||30
58224|NCT01618227|137863|P2|NOT COMPLETED|Overall Study||2
58225|NCT01618227|137864|P1|NOT COMPLETED|Overall Study||0
58226|NCT01618227|137863|P2|COMPLETED|Overall Study||0
58227|NCT01618227|137864|P1|COMPLETED|Overall Study||2
58228|NCT01618227|137863|P2|STARTED|Overall Study||2
58229|NCT01618227|137864|P1|STARTED|Overall Study||2
58230|NCT01618214|137878|P2|NOT COMPLETED|Overall Study||13
58231|NCT01618214|137879|P1|NOT COMPLETED|Overall Study||10
58232|NCT01618214|137878|P2|COMPLETED|Overall Study||159
58233|NCT01618214|137879|P1|COMPLETED|Overall Study||162
58234|NCT01618214|137878|P2|Exposed|Overall Study||172
58235|NCT01618214|137879|P1|Exposed|Overall Study||172
58236|NCT01618214|137878|P2|STARTED|Overall Study||172
58237|NCT01618214|137879|P1|STARTED|Overall Study||172
58238|NCT01618162|137895|P2|NOT COMPLETED|Overall Study||35
58239|NCT01618162|137896|P1|NOT COMPLETED|Overall Study||38
58240|NCT01618162|137895|P2|COMPLETED|Overall Study||111
58241|NCT01618162|137896|P1|COMPLETED|Overall Study||251
58242|NCT01618162|137895|P2|Exposed|Overall Study||146
58243|NCT01618162|137896|P1|Exposed|Overall Study||288
58244|NCT01618162|137895|P2|STARTED|Overall Study||146
58245|NCT01618162|137896|P1|STARTED|Overall Study||289
58246|NCT01618019|137916|P2|NOT COMPLETED|Overall Study||14
58247|NCT01618019|137917|P1|NOT COMPLETED|Overall Study||14
58248|NCT01618019|137916|P2|COMPLETED|Overall Study||40
58249|NCT01618019|137917|P1|COMPLETED|Overall Study||41
58250|NCT01618019|137916|P2|STARTED|Overall Study||54
58251|NCT01618019|137917|P1|STARTED|Overall Study||55
58252|NCT01617668|137939|P4|NOT COMPLETED|Overall Study||15
58253|NCT01617668|137940|P3|NOT COMPLETED|Overall Study||23
58254|NCT01617668|137941|P2|NOT COMPLETED|Overall Study||9
58255|NCT01617668|137942|P1|NOT COMPLETED|Overall Study||13
58256|NCT01617668|137939|P4|COMPLETED|Overall Study||38
58257|NCT01617668|137940|P3|COMPLETED|Overall Study||32
58258|NCT01617668|137941|P2|COMPLETED|Overall Study||41
58259|NCT01617668|137942|P1|COMPLETED|Overall Study||38
58260|NCT01617668|137939|P4|Randomized Patients|Overall Study||55
58261|NCT01617668|137940|P3|Randomized Patients|Overall Study||55
58262|NCT01617668|137941|P2|Randomized Patients|Overall Study||54
58263|NCT01617668|137942|P1|Randomized Patients|Overall Study||51
58264|NCT01617668|137939|P4|STARTED|Overall Study|55 patients were randomized and only 53 received study treatment.|53
58265|NCT01617668|137940|P3|STARTED|Overall Study||55
58266|NCT01617668|137941|P2|STARTED|Overall Study|54 patients were randomized and only 50 received study treatment.|50
58267|NCT01617668|137942|P1|STARTED|Overall Study||51
58268|NCT01617655|137983|P2|NOT COMPLETED|Overall Study||29
58269|NCT01617655|137984|P1|NOT COMPLETED|Overall Study||9
58270|NCT01617655|137983|P2|COMPLETED|Overall Study||43
58271|NCT01617655|137984|P1|COMPLETED|Overall Study||26
58272|NCT01617655|137983|P2|Treated|Overall Study||72
58273|NCT01617655|137984|P1|Treated|Overall Study||35
58274|NCT01617655|137983|P2|STARTED|Overall Study|Randomized|72
58275|NCT01617655|137984|P1|STARTED|Overall Study|Randomized|35
58276|NCT01617603|138047|P3|NOT COMPLETED|Overall Study||1
58277|NCT01617603|138048|P2|NOT COMPLETED|Overall Study||2
58278|NCT01617603|138049|P1|NOT COMPLETED|Overall Study||3
58279|NCT01617603|138047|P3|COMPLETED|Overall Study||20
58280|NCT01617603|138048|P2|COMPLETED|Overall Study||19
58281|NCT01617603|138049|P1|COMPLETED|Overall Study||17
58282|NCT01617603|138047|P3|STARTED|Overall Study||21
58283|NCT01617603|138048|P2|STARTED|Overall Study||21
58284|NCT01617603|138049|P1|STARTED|Overall Study||20
58285|NCT01617577|138059|P2|NOT COMPLETED|Overall Study||0
58286|NCT01617577|138060|P1|NOT COMPLETED|Overall Study||0
58287|NCT01617577|138059|P2|COMPLETED|Overall Study||3
58288|NCT01617577|138060|P1|COMPLETED|Overall Study||5
58289|NCT01617577|138059|P2|STARTED|Overall Study||3
58290|NCT01617577|138060|P1|STARTED|Overall Study||5
58291|NCT01617447|138069|P2|NOT COMPLETED|Overall Study||3
58292|NCT01617447|138070|P1|NOT COMPLETED|Overall Study||0
58293|NCT01617447|138069|P2|COMPLETED|Overall Study||42
58294|NCT01617447|138070|P1|COMPLETED|Overall Study||47
58295|NCT01617447|138069|P2|STARTED|Overall Study||45
58296|NCT01617447|138070|P1|STARTED|Overall Study||47
58297|NCT01617434|138078|P2|NOT COMPLETED|Overall Study||51
58298|NCT01617434|138079|P1|NOT COMPLETED|Overall Study||35
58299|NCT01617434|138078|P2|COMPLETED|Overall Study||174
58300|NCT01617434|138079|P1|COMPLETED|Overall Study||191
58301|NCT01617434|138078|P2|Exposed|Overall Study||225
58302|NCT01617434|138079|P1|Exposed|Overall Study||225
58303|NCT01617434|138078|P2|STARTED|Overall Study||225
58304|NCT01617434|138079|P1|STARTED|Overall Study||226
58305|NCT01617369|138101|P1|NOT COMPLETED|Overall Study||0
58306|NCT01617369|138101|P1|COMPLETED|Overall Study||12
58307|NCT01617369|138101|P1|STARTED|Overall Study||12
58308|NCT01617187|138111|P4|NOT COMPLETED|Treatment Through Study Completion||10
58309|NCT01617187|138112|P3|NOT COMPLETED|Treatment Through Study Completion||5
58310|NCT01617187|138113|P2|NOT COMPLETED|Treatment Through Study Completion||11
58311|NCT01617187|138114|P1|NOT COMPLETED|Treatment Through Study Completion||11
58312|NCT01617187|138111|P4|COMPLETED|Treatment Through Study Completion||91
58313|NCT01617187|138112|P3|COMPLETED|Treatment Through Study Completion||41
58314|NCT01617187|138113|P2|COMPLETED|Treatment Through Study Completion||102
58315|NCT01617187|138114|P1|COMPLETED|Treatment Through Study Completion|Excludes the participant who did not receive study drug but completed study in database|86
58316|NCT01617187|138111|P4|STARTED|Treatment Through Study Completion|Treated|101
58317|NCT01617187|138112|P3|STARTED|Treatment Through Study Completion|Treated|46
58318|NCT01617187|138113|P2|STARTED|Treatment Through Study Completion|Treated|113
58319|NCT01617187|138114|P1|STARTED|Treatment Through Study Completion|Treated|97
58320|NCT01617187|138111|P4|NOT COMPLETED|Randomization Through Start Treatment||2
58321|NCT01617187|138112|P3|NOT COMPLETED|Randomization Through Start Treatment||0
58322|NCT01617187|138113|P2|NOT COMPLETED|Randomization Through Start Treatment||0
58323|NCT01617187|138114|P1|NOT COMPLETED|Randomization Through Start Treatment||1
58324|NCT01617187|138111|P4|COMPLETED|Randomization Through Start Treatment||101
58325|NCT01617187|138112|P3|COMPLETED|Randomization Through Start Treatment||46
58326|NCT01617187|138113|P2|COMPLETED|Randomization Through Start Treatment||113
58327|NCT01617187|138114|P1|COMPLETED|Randomization Through Start Treatment||97
58328|NCT01617187|138111|P4|STARTED|Randomization Through Start Treatment|Randomized|103
58329|NCT01617187|138112|P3|STARTED|Randomization Through Start Treatment|Randomized|46
58330|NCT01617187|138113|P2|STARTED|Randomization Through Start Treatment|Randomized|113
58331|NCT01617187|138114|P1|STARTED|Randomization Through Start Treatment|Randomized|98
58332|NCT01617070|138184|P1|NOT COMPLETED|BH4 and LNAA (4 Weeks)||1
58333|NCT01617070|138184|P1|COMPLETED|BH4 and LNAA (4 Weeks)||9
58334|NCT01617070|138184|P1|STARTED|BH4 and LNAA (4 Weeks)||10
58335|NCT01617070|138184|P1|NOT COMPLETED|BH4 Therapy (4 Weeks)||0
58336|NCT01617070|138184|P1|COMPLETED|BH4 Therapy (4 Weeks)||10
58337|NCT01617070|138184|P1|STARTED|BH4 Therapy (4 Weeks)||10
58338|NCT01617070|138184|P1|NOT COMPLETED|Washout (4 Weeks)||0
58339|NCT01617070|138184|P1|COMPLETED|Washout (4 Weeks)||10
58340|NCT01617070|138184|P1|STARTED|Washout (4 Weeks)||10
58341|NCT01617070|138184|P1|NOT COMPLETED|LNAA (4 Weeks)||0
58342|NCT01617070|138184|P1|COMPLETED|LNAA (4 Weeks)||10
58343|NCT01617070|138184|P1|STARTED|LNAA (4 Weeks)||10
58344|NCT01617005|138202|P1|NOT COMPLETED|Overall Study||2
58345|NCT01617005|138202|P1|COMPLETED|Overall Study||48
58346|NCT01617005|138202|P1|STARTED|Overall Study||50
58347|NCT01616953|138211|P2|NOT COMPLETED|Overall Study||0
58348|NCT01616953|138212|P1|NOT COMPLETED|Overall Study||2
58349|NCT01616953|138211|P2|COMPLETED|Overall Study||8
58350|NCT01616953|138212|P1|COMPLETED|Overall Study||8
58351|NCT01616953|138211|P2|6 Months Post-loading|Overall Study||8
58352|NCT01616953|138212|P1|6 Months Post-loading|Overall Study||8
58353|NCT01616953|138211|P2|Implant Uncovery|Overall Study||8
58354|NCT01616953|138212|P1|Implant Uncovery|Overall Study||8
58355|NCT01616953|138211|P2|Implant Placement Surgery|Overall Study||8
58356|NCT01616953|138212|P1|Implant Placement Surgery|Overall Study||9
58357|NCT01616953|138211|P2|STARTED|Overall Study||8
58358|NCT01616953|138212|P1|STARTED|Overall Study||10
58359|NCT01616771|138220|P1|NOT COMPLETED|Smaller Sized GVL for 5 Sec||4
58360|NCT01616771|138220|P1|COMPLETED|Smaller Sized GVL for 5 Sec||19
58361|NCT01616771|138220|P1|STARTED|Smaller Sized GVL for 5 Sec|Four of 23 patients could not be evaluated by smaller sized GVL, because there was no smaller one.|23
58362|NCT01616771|138220|P1|NOT COMPLETED|GVL Selected by Weight for 5 Sec||0
58363|NCT01616771|138220|P1|COMPLETED|GVL Selected by Weight for 5 Sec||23
58364|NCT01616771|138220|P1|STARTED|GVL Selected by Weight for 5 Sec||23
58365|NCT01616771|138220|P1|NOT COMPLETED|Macintosh Laryngoscopy for 5 Sec||0
58366|NCT01616771|138220|P1|COMPLETED|Macintosh Laryngoscopy for 5 Sec||23
58367|NCT01616771|138220|P1|STARTED|Macintosh Laryngoscopy for 5 Sec||23
58368|NCT01616576|138231|P2|NOT COMPLETED|Overall Study||0
58369|NCT01616576|138232|P1|NOT COMPLETED|Overall Study||0
58370|NCT01616576|138231|P2|COMPLETED|Overall Study||18
58371|NCT01616576|138232|P1|COMPLETED|Overall Study||18
58372|NCT01616576|138231|P2|STARTED|Overall Study||18
58373|NCT01616576|138232|P1|STARTED|Overall Study||18
58374|NCT01616459|138245|P4|NOT COMPLETED|Overall Study||8
58375|NCT01616459|138246|P3|NOT COMPLETED|Overall Study||10
58376|NCT01616459|138247|P2|NOT COMPLETED|Overall Study||17
58377|NCT01616459|138248|P1|NOT COMPLETED|Overall Study||4
58378|NCT01616459|138245|P4|COMPLETED|Overall Study||233
58379|NCT01616459|138246|P3|COMPLETED|Overall Study||220
58380|NCT01616459|138247|P2|COMPLETED|Overall Study||223
58381|NCT01616459|138248|P1|COMPLETED|Overall Study||236
58382|NCT01616459|138245|P4|STARTED|Overall Study||241
58383|NCT01616459|138246|P3|STARTED|Overall Study||230
58384|NCT01616459|138247|P2|STARTED|Overall Study||240
58385|NCT01616459|138248|P1|STARTED|Overall Study||240
58386|NCT01616173|138337|P3|NOT COMPLETED|Overall Study||0
58387|NCT01616173|138338|P2|NOT COMPLETED|Overall Study||2
58388|NCT01616173|138339|P1|NOT COMPLETED|Overall Study||0
58389|NCT01616173|138337|P3|COMPLETED|Overall Study||27
58390|NCT01616173|138338|P2|COMPLETED|Overall Study||24
58391|NCT01616173|138339|P1|COMPLETED|Overall Study||27
58392|NCT01616173|138337|P3|STARTED|Overall Study||27
58393|NCT01616173|138338|P2|STARTED|Overall Study||26
58394|NCT01616173|138339|P1|STARTED|Overall Study||27
58395|NCT01616056|138353|P1|NOT COMPLETED|Overall Study||1
58396|NCT01616056|138353|P1|COMPLETED|Overall Study||19
58397|NCT01616056|138353|P1|STARTED|Overall Study||20
58398|NCT01615939|138367|P2|NOT COMPLETED|Overall Study||0
58399|NCT01615939|138368|P1|NOT COMPLETED|Overall Study||5
58400|NCT01615939|138367|P2|COMPLETED|Overall Study||4
58401|NCT01615939|138368|P1|COMPLETED|Overall Study||8
58402|NCT01615939|138367|P2|STARTED|Overall Study||4
58403|NCT01615939|138368|P1|STARTED|Overall Study||13
58404|NCT01615822|138381|P3|NOT COMPLETED|Period 2||2
58405|NCT01615822|138382|P2|NOT COMPLETED|Period 2||1
58406|NCT01615822|138383|P1|NOT COMPLETED|Period 2||0
58407|NCT01615822|138381|P3|COMPLETED|Period 2||4
58408|NCT01615822|138382|P2|COMPLETED|Period 2||8
58409|NCT01615822|138383|P1|COMPLETED|Period 2||7
58410|NCT01615822|138381|P3|STARTED|Period 2||6
58411|NCT01615822|138382|P2|STARTED|Period 2||9
58412|NCT01615822|138383|P1|STARTED|Period 2||7
58413|NCT01615822|138381|P3|NOT COMPLETED|Period 1||0
58414|NCT01615822|138382|P2|NOT COMPLETED|Period 1||2
58415|NCT01615822|138383|P1|NOT COMPLETED|Period 1||1
58416|NCT01615822|138381|P3|COMPLETED|Period 1||6
58417|NCT01615822|138382|P2|COMPLETED|Period 1||9
58418|NCT01615822|138383|P1|COMPLETED|Period 1||7
58419|NCT01615822|138381|P3|STARTED|Period 1||6
58420|NCT01615822|138382|P2|STARTED|Period 1||11
58421|NCT01615822|138383|P1|STARTED|Period 1||8
58422|NCT01615809|138400|P1|NOT COMPLETED|Overall Study||10
58423|NCT01615809|138400|P1|COMPLETED|Overall Study||22
58424|NCT01615809|138400|P1|STARTED|Overall Study|basal visit|32
58425|NCT01615731|138408|P2|NOT COMPLETED|Overall Study||2
58426|NCT01615731|138409|P1|NOT COMPLETED|Overall Study||3
58427|NCT01615731|138408|P2|COMPLETED|Overall Study||24
58428|NCT01615731|138409|P1|COMPLETED|Overall Study||21
58429|NCT01615731|138408|P2|STARTED|Overall Study||26
58430|NCT01615731|138409|P1|STARTED|Overall Study||24
58431|NCT01615328|138429|P2|NOT COMPLETED|Overall Study||5
58432|NCT01615328|138430|P1|NOT COMPLETED|Overall Study||3
58433|NCT01615328|138429|P2|COMPLETED|Overall Study||38
58434|NCT01615328|138430|P1|COMPLETED|Overall Study||39
58435|NCT01615328|138429|P2|STARTED|Overall Study||43
58436|NCT01615328|138430|P1|STARTED|Overall Study||42
58437|NCT01615263|138442|P2|NOT COMPLETED|Overall Study||2
58438|NCT01615263|138443|P1|NOT COMPLETED|Overall Study||0
58439|NCT01615263|138442|P2|COMPLETED|Overall Study||18
58440|NCT01615263|138443|P1|COMPLETED|Overall Study||20
58441|NCT01615263|138442|P2|STARTED|Overall Study||20
58442|NCT01615263|138443|P1|STARTED|Overall Study||20
58443|NCT01615198|138457|P2|NOT COMPLETED|Overall Study||19
58444|NCT01615198|138458|P1|NOT COMPLETED|Overall Study||24
58445|NCT01615198|138457|P2|COMPLETED|Overall Study||273
58446|NCT01615198|138458|P1|COMPLETED|Overall Study||272
58447|NCT01615198|138457|P2|ABPM Dipper Status Subset|Overall Study||84
58448|NCT01615198|138458|P1|ABPM Dipper Status Subset|Overall Study||82
58449|NCT01615198|138457|P2|Safety Set|Overall Study||292
58450|NCT01615198|138458|P1|Safety Set|Overall Study||296
58451|NCT01615198|138457|P2|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||157
58452|NCT01615198|138458|P1|Ambulatory BP Monitoring (ABPM) Subset|Overall Study||154
58453|NCT01615198|138457|P2|Full Analysis Set|Overall Study||292
58454|NCT01615198|138458|P1|Full Analysis Set|Overall Study||296
58455|NCT01615198|138457|P2|STARTED|Overall Study||292
58456|NCT01615198|138458|P1|STARTED|Overall Study||296
58457|NCT01615029|138491|P5|NOT COMPLETED|Overall Study||32
58458|NCT01615029|138492|P4|NOT COMPLETED|Overall Study||3
58459|NCT01615029|138493|P3|NOT COMPLETED|Overall Study||4
58460|NCT01615029|138494|P2|NOT COMPLETED|Overall Study||3
58461|NCT01615029|138495|P1|NOT COMPLETED|Overall Study||3
58462|NCT01615029|138491|P5|COMPLETED|Overall Study||0
58463|NCT01615029|138492|P4|COMPLETED|Overall Study||0
58464|NCT01615029|138493|P3|COMPLETED|Overall Study||0
58465|NCT01615029|138494|P2|COMPLETED|Overall Study||0
58466|NCT01615029|138495|P1|COMPLETED|Overall Study||0
58467|NCT01615029|138491|P5|STARTED|Overall Study||32
58468|NCT01615029|138492|P4|STARTED|Overall Study||3
58469|NCT01615029|138493|P3|STARTED|Overall Study||4
58470|NCT01615029|138494|P2|STARTED|Overall Study||3
58471|NCT01615029|138495|P1|STARTED|Overall Study||3
58472|NCT01614886|138518|P2|NOT COMPLETED|Overall Study||26
58473|NCT01614886|138519|P1|NOT COMPLETED|Overall Study||20
58474|NCT01614886|138518|P2|COMPLETED|Overall Study||83
58475|NCT01614886|138519|P1|COMPLETED|Overall Study||87
58476|NCT01614886|138518|P2|Full Analysis Set (FAS)|Overall Study||105
58477|NCT01614886|138519|P1|Full Analysis Set (FAS)|Overall Study||104
58478|NCT01614886|138518|P2|Safety Population (SAF)|Overall Study||108
58479|NCT01614886|138519|P1|Safety Population (SAF)|Overall Study||107
58480|NCT01614886|138518|P2|STARTED|Overall Study||109
58481|NCT01614886|138519|P1|STARTED|Overall Study||107
58482|NCT01614795|138537|P4|NOT COMPLETED|Overall Study||12
58483|NCT01614795|138538|P3|NOT COMPLETED|Overall Study||11
58484|NCT01614795|138539|P2|NOT COMPLETED|Overall Study||12
58485|NCT01614795|138540|P1|NOT COMPLETED|Overall Study||11
58486|NCT01614795|138537|P4|COMPLETED|Overall Study||0
58487|NCT01614795|138538|P3|COMPLETED|Overall Study||0
58488|NCT01614795|138539|P2|COMPLETED|Overall Study||0
58489|NCT01614795|138540|P1|COMPLETED|Overall Study||0
58490|NCT01614795|138537|P4|STARTED|Overall Study||12
58491|NCT01614795|138538|P3|STARTED|Overall Study||11
58492|NCT01614795|138539|P2|STARTED|Overall Study||12
58493|NCT01614795|138540|P1|STARTED|Overall Study||11
58494|NCT01614769|138550|P6|NOT COMPLETED|Period 3||0
58495|NCT01614769|138551|P5|NOT COMPLETED|Period 3||0
58496|NCT01614769|138552|P4|NOT COMPLETED|Period 3||0
58497|NCT01614769|138553|P3|NOT COMPLETED|Period 3||1
58498|NCT01614769|138554|P2|NOT COMPLETED|Period 3||0
58499|NCT01614769|138555|P1|NOT COMPLETED|Period 3||0
58500|NCT01614769|138550|P6|COMPLETED|Period 3||1
58501|NCT01614769|138551|P5|COMPLETED|Period 3||1
58502|NCT01614769|138552|P4|COMPLETED|Period 3||0
58503|NCT01614769|138553|P3|COMPLETED|Period 3||1
58504|NCT01614769|138554|P2|COMPLETED|Period 3||1
58505|NCT01614769|138555|P1|COMPLETED|Period 3||1
58506|NCT01614769|138550|P6|STARTED|Period 3||1
58507|NCT01614769|138551|P5|STARTED|Period 3||1
58508|NCT01614769|138552|P4|STARTED|Period 3||0
58509|NCT01614769|138553|P3|STARTED|Period 3||2
58510|NCT01614769|138554|P2|STARTED|Period 3||1
58511|NCT01614769|138555|P1|STARTED|Period 3||1
58512|NCT01614769|138550|P6|NOT COMPLETED|7-Day Washout||0
58513|NCT01614769|138551|P5|NOT COMPLETED|7-Day Washout||0
58514|NCT01614769|138552|P4|NOT COMPLETED|7-Day Washout||0
58515|NCT01614769|138553|P3|NOT COMPLETED|7-Day Washout||0
58516|NCT01614769|138554|P2|NOT COMPLETED|7-Day Washout||0
58517|NCT01614769|138555|P1|NOT COMPLETED|7-Day Washout||0
58518|NCT01614769|138550|P6|COMPLETED|7-Day Washout||1
58519|NCT01614769|138551|P5|COMPLETED|7-Day Washout||1
58520|NCT01614769|138552|P4|COMPLETED|7-Day Washout||0
58521|NCT01614769|138553|P3|COMPLETED|7-Day Washout||2
58522|NCT01614769|138554|P2|COMPLETED|7-Day Washout||1
58523|NCT01614769|138555|P1|COMPLETED|7-Day Washout||1
58524|NCT01614769|138550|P6|STARTED|7-Day Washout||1
58525|NCT01614769|138551|P5|STARTED|7-Day Washout||1
58526|NCT01614769|138552|P4|STARTED|7-Day Washout||0
58527|NCT01614769|138553|P3|STARTED|7-Day Washout||2
58528|NCT01614769|138554|P2|STARTED|7-Day Washout||1
58529|NCT01614769|138555|P1|STARTED|7-Day Washout||1
58530|NCT01614769|138550|P6|NOT COMPLETED|Period 2||0
58531|NCT01614769|138551|P5|NOT COMPLETED|Period 2||0
58532|NCT01614769|138552|P4|NOT COMPLETED|Period 2||0
58533|NCT01614769|138553|P3|NOT COMPLETED|Period 2||0
58534|NCT01614769|138554|P2|NOT COMPLETED|Period 2||0
58535|NCT01614769|138555|P1|NOT COMPLETED|Period 2||0
58536|NCT01614769|138550|P6|COMPLETED|Period 2||1
58537|NCT01614769|138551|P5|COMPLETED|Period 2||1
58538|NCT01614769|138552|P4|COMPLETED|Period 2||0
58539|NCT01614769|138553|P3|COMPLETED|Period 2||2
58540|NCT01614769|138554|P2|COMPLETED|Period 2||1
58541|NCT01614769|138555|P1|COMPLETED|Period 2||1
58542|NCT01614769|138550|P6|STARTED|Period 2||1
58543|NCT01614769|138551|P5|STARTED|Period 2||1
58544|NCT01614769|138552|P4|STARTED|Period 2||0
58545|NCT01614769|138553|P3|STARTED|Period 2||2
58546|NCT01614769|138554|P2|STARTED|Period 2||1
58547|NCT01614769|138555|P1|STARTED|Period 2||1
58548|NCT01614769|138550|P6|NOT COMPLETED|7-Day Washout||0
58549|NCT01614769|138551|P5|NOT COMPLETED|7-Day Washout||0
58550|NCT01614769|138552|P4|NOT COMPLETED|7-Day Washout||0
58551|NCT01614769|138553|P3|NOT COMPLETED|7-Day Washout||0
58552|NCT01614769|138554|P2|NOT COMPLETED|7-Day Washout||0
58553|NCT01614769|138555|P1|NOT COMPLETED|7-Day Washout||0
58554|NCT01614769|138550|P6|COMPLETED|7-Day Washout||1
58555|NCT01614769|138551|P5|COMPLETED|7-Day Washout||1
58556|NCT01614769|138552|P4|COMPLETED|7-Day Washout||0
58557|NCT01614769|138553|P3|COMPLETED|7-Day Washout||2
58558|NCT01614769|138554|P2|COMPLETED|7-Day Washout||1
58559|NCT01614769|138555|P1|COMPLETED|7-Day Washout||1
58560|NCT01614769|138550|P6|STARTED|7-Day Washout||1
58561|NCT01614769|138551|P5|STARTED|7-Day Washout||1
58562|NCT01614769|138552|P4|STARTED|7-Day Washout||0
58563|NCT01614769|138553|P3|STARTED|7-Day Washout||2
58564|NCT01614769|138554|P2|STARTED|7-Day Washout||1
58565|NCT01614769|138555|P1|STARTED|7-Day Washout||1
58566|NCT01614769|138550|P6|NOT COMPLETED|Period 1||1
58567|NCT01614769|138551|P5|NOT COMPLETED|Period 1||0
58568|NCT01614769|138552|P4|NOT COMPLETED|Period 1||2
58569|NCT01614769|138553|P3|NOT COMPLETED|Period 1||0
58570|NCT01614769|138554|P2|NOT COMPLETED|Period 1||0
58571|NCT01614769|138555|P1|NOT COMPLETED|Period 1||1
58572|NCT01614769|138550|P6|COMPLETED|Period 1||1
58573|NCT01614769|138551|P5|COMPLETED|Period 1||1
58574|NCT01614769|138552|P4|COMPLETED|Period 1||0
58575|NCT01614769|138553|P3|COMPLETED|Period 1||2
58576|NCT01614769|138554|P2|COMPLETED|Period 1||1
58577|NCT01614769|138555|P1|COMPLETED|Period 1||1
58578|NCT01614769|138550|P6|STARTED|Period 1||2
58579|NCT01614769|138551|P5|STARTED|Period 1||1
58580|NCT01614769|138552|P4|STARTED|Period 1||2
58581|NCT01614769|138553|P3|STARTED|Period 1||2
58582|NCT01614769|138554|P2|STARTED|Period 1||1
58583|NCT01614769|138555|P1|STARTED|Period 1||2
58584|NCT01614613|138569|P1|NOT COMPLETED|Overall Study||0
58585|NCT01614613|138569|P1|COMPLETED|Overall Study||146
58586|NCT01614613|138569|P1|STARTED|Overall Study||146
58587|NCT01614600|138577|P1|NOT COMPLETED|Overall Study||4
58588|NCT01614600|138577|P1|COMPLETED|Overall Study||84
58589|NCT01614600|138577|P1|STARTED|Overall Study||88
58590|NCT01614574|138581|P1|NOT COMPLETED|Overall Study||0
58591|NCT01614574|138581|P1|COMPLETED|Overall Study||6
58592|NCT01614574|138581|P1|STARTED|Overall Study||6
58593|NCT01614509|138597|P2|NOT COMPLETED|Overall Study||3
58594|NCT01614509|138598|P1|NOT COMPLETED|Overall Study||1
58595|NCT01614509|138597|P2|COMPLETED|Overall Study||18
58596|NCT01614509|138598|P1|COMPLETED|Overall Study||23
58597|NCT01614509|138597|P2|STARTED|Overall Study||21
58598|NCT01614509|138598|P1|STARTED|Overall Study||24
58599|NCT01614470|138608|P3|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
58600|NCT01614470|138609|P2|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
58601|NCT01614470|138610|P1|NOT COMPLETED|Part 2: Open-label Period (16 Weeks)||0
58602|NCT01614470|138608|P3|COMPLETED|Part 2: Open-label Period (16 Weeks)||36
58603|NCT01614470|138609|P2|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
58604|NCT01614470|138610|P1|COMPLETED|Part 2: Open-label Period (16 Weeks)||0
58605|NCT01614470|138608|P3|STARTED|Part 2: Open-label Period (16 Weeks)||36
58606|NCT01614470|138609|P2|STARTED|Part 2: Open-label Period (16 Weeks)||0
58607|NCT01614470|138610|P1|STARTED|Part 2: Open-label Period (16 Weeks)||0
58608|NCT01614470|138608|P3|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
58609|NCT01614470|138609|P2|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
58610|NCT01614470|138610|P1|NOT COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
58611|NCT01614470|138608|P3|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||0
58612|NCT01614470|138609|P2|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
58613|NCT01614470|138610|P1|COMPLETED|Part 1: Treatment Period 2 (8 Weeks)||18
58614|NCT01614470|138608|P3|STARTED|Part 1: Treatment Period 2 (8 Weeks)||0
58615|NCT01614470|138609|P2|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
58616|NCT01614470|138610|P1|STARTED|Part 1: Treatment Period 2 (8 Weeks)||18
58617|NCT01614470|138608|P3|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
58618|NCT01614470|138609|P2|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
58619|NCT01614470|138610|P1|NOT COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
58620|NCT01614470|138608|P3|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||0
58621|NCT01614470|138609|P2|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
58622|NCT01614470|138610|P1|COMPLETED|Part 1: Washout Period (4 to 8 Weeks)||18
58623|NCT01614470|138608|P3|STARTED|Part 1: Washout Period (4 to 8 Weeks)||0
58624|NCT01614470|138609|P2|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
58625|NCT01614470|138610|P1|STARTED|Part 1: Washout Period (4 to 8 Weeks)||18
58626|NCT01614470|138608|P3|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
58627|NCT01614470|138609|P2|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||1
58628|NCT01614470|138610|P1|NOT COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||2
58629|NCT01614470|138608|P3|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||0
58630|NCT01614470|138609|P2|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
58631|NCT01614470|138610|P1|COMPLETED|Part 1: Treatment Period 1 (8 Weeks)||18
58632|NCT01614470|138608|P3|STARTED|Part 1: Treatment Period 1 (8 Weeks)||0
58633|NCT01614470|138609|P2|STARTED|Part 1: Treatment Period 1 (8 Weeks)||19
58634|NCT01614470|138610|P1|STARTED|Part 1: Treatment Period 1 (8 Weeks)||20
58635|NCT01614457|138632|P2|NOT COMPLETED|Overall Study||0
58636|NCT01614457|138633|P1|NOT COMPLETED|Overall Study||2
58637|NCT01614457|138632|P2|COMPLETED|Overall Study||35
58638|NCT01614457|138633|P1|COMPLETED|Overall Study||32
58639|NCT01614457|138632|P2|STARTED|Overall Study||35
58640|NCT01614457|138633|P1|STARTED|Overall Study||34
58641|NCT01614249|138651|P2|NOT COMPLETED|Overall Study||23
58642|NCT01614249|138652|P1|NOT COMPLETED|Overall Study||11
58643|NCT01614249|138651|P2|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|86
58644|NCT01614249|138652|P1|COMPLETED|Overall Study|End of study data analyzed for only participants who completed the 8-week trial period.|96
58645|NCT01614249|138651|P2|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|86
58646|NCT01614249|138652|P1|At Week-8 (End of Study Period)|Overall Study|End of study data collected for all participants who completed the 8-week trial period.|96
58647|NCT01614249|138651|P2|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|92
58648|NCT01614249|138652|P1|At Week-4|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|98
58649|NCT01614249|138651|P2|STARTED|Overall Study|Participants received every two-week supply and monitored regularly on cell-phone and face-to-face.|109
58650|NCT01614249|138652|P1|STARTED|Overall Study|Participants received every two-weeks supply and monitored regularly on cell-phone and face-to-face.|107
58651|NCT01613599|138658|P1|NOT COMPLETED|Overall Study||97
58652|NCT01613599|138658|P1|COMPLETED|Overall Study||0
58653|NCT01613599|138658|P1|STARTED|Overall Study||97
58654|NCT01613417|138673|P2|NOT COMPLETED|Second Injection||0
58655|NCT01613417|138674|P1|NOT COMPLETED|Second Injection||0
58656|NCT01613417|138673|P2|COMPLETED|Second Injection||109
58657|NCT01613417|138674|P1|COMPLETED|Second Injection||100
58658|NCT01613417|138673|P2|STARTED|Second Injection||109
58659|NCT01613417|138674|P1|STARTED|Second Injection||100
58660|NCT01613417|138673|P2|NOT COMPLETED|Washout (no Second Injection/MRI)||7
58661|NCT01613417|138674|P1|NOT COMPLETED|Washout (no Second Injection/MRI)||13
58662|NCT01613417|138673|P2|COMPLETED|Washout (no Second Injection/MRI)||109
58663|NCT01613417|138674|P1|COMPLETED|Washout (no Second Injection/MRI)||100
58664|NCT01613417|138673|P2|STARTED|Washout (no Second Injection/MRI)||116
58665|NCT01613417|138674|P1|STARTED|Washout (no Second Injection/MRI)||113
58666|NCT01613417|138673|P2|NOT COMPLETED|First Injection||0
58667|NCT01613417|138674|P1|NOT COMPLETED|First Injection||0
58668|NCT01613417|138673|P2|COMPLETED|First Injection||116
58669|NCT01613417|138674|P1|COMPLETED|First Injection||113
58670|NCT01613417|138673|P2|STARTED|First Injection||116
58671|NCT01613417|138674|P1|STARTED|First Injection||113
58672|NCT01613378|138711|P1|NOT COMPLETED|Overall Study||39
58673|NCT01613378|138711|P1|COMPLETED|Overall Study||161
58674|NCT01613378|138711|P1|STARTED|Overall Study||200
58675|NCT01613339|138729|P2|NOT COMPLETED|Overall Study||1
58676|NCT01613339|138730|P1|NOT COMPLETED|Overall Study||3
58677|NCT01613339|138729|P2|COMPLETED|Overall Study||21
58678|NCT01613339|138730|P1|COMPLETED|Overall Study||21
58679|NCT01613339|138729|P2|STARTED|Overall Study||22
58680|NCT01613339|138730|P1|STARTED|Overall Study||24
58681|NCT01613326|138741|P2|NOT COMPLETED|Overall Study||14
58682|NCT01613326|138742|P1|NOT COMPLETED|Overall Study||13
58683|NCT01613326|138741|P2|COMPLETED|Overall Study||316
58684|NCT01613326|138742|P1|COMPLETED|Overall Study||314
58685|NCT01613326|138741|P2|STARTED|Overall Study||330
58686|NCT01613326|138742|P1|STARTED|Overall Study||327
58687|NCT01613313|138776|P4|NOT COMPLETED|Overall Study||0
58688|NCT01613313|138777|P3|NOT COMPLETED|Overall Study||0
58689|NCT01613313|138778|P2|NOT COMPLETED|Overall Study||0
58690|NCT01613313|138779|P1|NOT COMPLETED|Overall Study||0
58691|NCT01613313|138776|P4|COMPLETED|Overall Study||4
58692|NCT01613313|138777|P3|COMPLETED|Overall Study||4
58693|NCT01613313|138778|P2|COMPLETED|Overall Study||4
58694|NCT01613313|138779|P1|COMPLETED|Overall Study||2
58695|NCT01613313|138776|P4|STARTED|Overall Study||4
58696|NCT01613313|138777|P3|STARTED|Overall Study||4
58697|NCT01613313|138778|P2|STARTED|Overall Study||4
58698|NCT01613313|138779|P1|STARTED|Overall Study||2
58699|NCT01613248|138799|P6|NOT COMPLETED|Overall Study||38
58700|NCT01613248|138800|P5|NOT COMPLETED|Overall Study||35
58701|NCT01613248|138801|P4|NOT COMPLETED|Overall Study||38
58702|NCT01613248|138802|P3|NOT COMPLETED|Overall Study||33
58703|NCT01613248|138803|P2|NOT COMPLETED|Overall Study||34
58704|NCT01613248|138804|P1|NOT COMPLETED|Overall Study||29
58705|NCT01613248|138799|P6|COMPLETED|Overall Study||102
58706|NCT01613248|138800|P5|COMPLETED|Overall Study||104
58707|NCT01613248|138801|P4|COMPLETED|Overall Study||101
58708|NCT01613248|138802|P3|COMPLETED|Overall Study||106
58709|NCT01613248|138803|P2|COMPLETED|Overall Study||104
58710|NCT01613248|138804|P1|COMPLETED|Overall Study||110
58711|NCT01613248|138799|P6|STARTED|Overall Study||140
58712|NCT01613248|138800|P5|STARTED|Overall Study||139
58713|NCT01613248|138801|P4|STARTED|Overall Study||139
58714|NCT01613248|138802|P3|STARTED|Overall Study||139
58715|NCT01613248|138803|P2|STARTED|Overall Study||138
58716|NCT01613248|138804|P1|STARTED|Overall Study||139
58717|NCT01613131|138904|P2|NOT COMPLETED|Overall Study||5
58718|NCT01613131|138905|P1|NOT COMPLETED|Overall Study||3
58719|NCT01613131|138904|P2|COMPLETED|Overall Study||13
58720|NCT01613131|138905|P1|COMPLETED|Overall Study||17
58721|NCT01613131|138904|P2|STARTED|Overall Study||18
58722|NCT01613131|138905|P1|STARTED|Overall Study||20
58723|NCT01613027|138933|P1|NOT COMPLETED|Overall Study||8
58724|NCT01613027|138933|P1|COMPLETED|Overall Study||127
58725|NCT01613027|138933|P1|STARTED|Overall Study||135
58726|NCT01613014|138954|P2|NOT COMPLETED|Overall Study||12
58727|NCT01613014|138955|P1|NOT COMPLETED|Overall Study||18
58728|NCT01613014|138954|P2|COMPLETED|Overall Study||63
58729|NCT01613014|138955|P1|COMPLETED|Overall Study||57
58730|NCT01613014|138954|P2|STARTED|Overall Study||75
58731|NCT01613014|138955|P1|STARTED|Overall Study||75
58732|NCT01612858|138963|P2|NOT COMPLETED|Overall Study||1
58733|NCT01612858|138964|P1|NOT COMPLETED|Overall Study||5
58734|NCT01612858|138963|P2|COMPLETED|Overall Study||3
58735|NCT01612858|138964|P1|COMPLETED|Overall Study||11
58736|NCT01612858|138963|P2|STARTED|Overall Study||4
58737|NCT01612858|138964|P1|STARTED|Overall Study||16
58738|NCT01612767|138972|P1|NOT COMPLETED|Overall Study||9
58739|NCT01612767|138972|P1|COMPLETED|Overall Study||320
58740|NCT01612767|138972|P1|STARTED|Overall Study||329
58741|NCT01612702|139001|P2|NOT COMPLETED|Overall Study||11
58742|NCT01612702|139002|P1|NOT COMPLETED|Overall Study||11
58743|NCT01612702|139001|P2|COMPLETED|Overall Study||134
58744|NCT01612702|139002|P1|COMPLETED|Overall Study||135
58745|NCT01612702|139001|P2|STARTED|Overall Study||145
58746|NCT01612702|139002|P1|STARTED|Overall Study||146
58747|NCT01612676|139016|P4|NOT COMPLETED|Overall Study||3
58748|NCT01612676|139017|P3|NOT COMPLETED|Overall Study||1
58749|NCT01612676|139018|P2|NOT COMPLETED|Overall Study||4
58750|NCT01612676|139019|P1|NOT COMPLETED|Overall Study||2
58751|NCT01612676|139016|P4|COMPLETED|Overall Study||10
58752|NCT01612676|139017|P3|COMPLETED|Overall Study||4
58753|NCT01612676|139018|P2|COMPLETED|Overall Study||3
58754|NCT01612676|139019|P1|COMPLETED|Overall Study||4
58755|NCT01612676|139016|P4|Dosed|Overall Study||13
58756|NCT01612676|139017|P3|Dosed|Overall Study||5
58757|NCT01612676|139018|P2|Dosed|Overall Study||7
58758|NCT01612676|139019|P1|Dosed|Overall Study||5
58759|NCT01612676|139016|P4|STARTED|Overall Study||13
58760|NCT01612676|139017|P3|STARTED|Overall Study||5
58761|NCT01612676|139018|P2|STARTED|Overall Study||7
58762|NCT01612676|139019|P1|STARTED|Overall Study||6
58763|NCT01612494|139077|P2|NOT COMPLETED|Overall Study||0
58764|NCT01612494|139078|P1|NOT COMPLETED|Overall Study||0
58765|NCT01612494|139077|P2|COMPLETED|Overall Study||23
58766|NCT01612494|139078|P1|COMPLETED|Overall Study||21
58767|NCT01612494|139077|P2|STARTED|Overall Study||23
58768|NCT01612494|139078|P1|STARTED|Overall Study||21
58769|NCT01612221|139086|P2|NOT COMPLETED|Overall Study||0
58770|NCT01612221|139087|P1|NOT COMPLETED|Overall Study||0
58771|NCT01612221|139086|P2|COMPLETED|Overall Study||50
58772|NCT01612221|139087|P1|COMPLETED|Overall Study||50
58773|NCT01612221|139086|P2|STARTED|Overall Study||50
58774|NCT01612221|139087|P1|STARTED|Overall Study||50
58775|NCT01612156|139097|P2|NOT COMPLETED|Overall Study||0
58776|NCT01612156|139098|P1|NOT COMPLETED|Overall Study||2
58777|NCT01612156|139097|P2|COMPLETED|Overall Study||48
58778|NCT01612156|139098|P1|COMPLETED|Overall Study|Contraindication to urodynamics (urinary tract infection) diagnosed after randomization|40
58779|NCT01612156|139097|P2|STARTED|Overall Study||48
58780|NCT01612156|139098|P1|STARTED|Overall Study||42
58781|NCT01612000|139110|P4|NOT COMPLETED|Overall Study||10
58782|NCT01612000|139111|P3|NOT COMPLETED|Overall Study||7
58783|NCT01612000|139112|P2|NOT COMPLETED|Overall Study||5
58784|NCT01612000|139113|P1|NOT COMPLETED|Overall Study||9
58785|NCT01612000|139110|P4|COMPLETED|Overall Study||76
58786|NCT01612000|139111|P3|COMPLETED|Overall Study||78
58787|NCT01612000|139112|P2|COMPLETED|Overall Study||81
58788|NCT01612000|139113|P1|COMPLETED|Overall Study||75
58789|NCT01612000|139110|P4|STARTED|Overall Study||86
58790|NCT01612000|139111|P3|STARTED|Overall Study||85
58791|NCT01612000|139112|P2|STARTED|Overall Study||86
58792|NCT01612000|139113|P1|STARTED|Overall Study||84
58793|NCT01611974|139138|P3|NOT COMPLETED|Overall Study||16
58794|NCT01611974|139139|P2|NOT COMPLETED|Overall Study||15
58795|NCT01611974|139140|P1|NOT COMPLETED|Overall Study||15
58796|NCT01611974|139138|P3|COMPLETED|Overall Study||24
58797|NCT01611974|139139|P2|COMPLETED|Overall Study||25
58798|NCT01611974|139140|P1|COMPLETED|Overall Study||25
58799|NCT01611974|139138|P3|STARTED|Overall Study||40
58800|NCT01611974|139139|P2|STARTED|Overall Study||40
58801|NCT01611974|139140|P1|STARTED|Overall Study||40
58802|NCT01611948|139177|P2|NOT COMPLETED|Overall Study||12
58803|NCT01611948|139178|P1|NOT COMPLETED|Overall Study||14
58804|NCT01611948|139177|P2|COMPLETED|Overall Study||26
58805|NCT01611948|139178|P1|COMPLETED|Overall Study||18
58806|NCT01611948|139177|P2|STARTED|Overall Study||38
58807|NCT01611948|139178|P1|STARTED|Overall Study||32
58808|NCT01611883|139186|P2|NOT COMPLETED|Overall Study||1
58809|NCT01611883|139187|P1|NOT COMPLETED|Overall Study||1
58810|NCT01611883|139186|P2|COMPLETED|Overall Study||76
58811|NCT01611883|139187|P1|COMPLETED|Overall Study||74
58812|NCT01611883|139186|P2|STARTED|Overall Study||77
58813|NCT01611883|139187|P1|STARTED|Overall Study||75
58814|NCT01611857|139213|P2|NOT COMPLETED|Overall Study||2
58815|NCT01611857|139214|P1|NOT COMPLETED|Overall Study||0
58816|NCT01611857|139213|P2|COMPLETED|Overall Study||32
58817|NCT01611857|139214|P1|COMPLETED|Overall Study||15
58818|NCT01611857|139213|P2|Tivantinib 360 mg|Overall Study|Two participants withdrew prior to receiving drug.|32
58819|NCT01611857|139214|P1|Tivantinib 360 mg|Overall Study||7
58820|NCT01611857|139213|P2|Tivantinib 240 mg|Overall Study||0
58821|NCT01611857|139214|P1|Tivantinib 240 mg|Overall Study||3
58822|NCT01611857|139213|P2|Tivantinib 120 mg|Overall Study||0
58823|NCT01611857|139214|P1|Tivantinib 120 mg|Overall Study||5
58824|NCT01611857|139213|P2|STARTED|Overall Study||34
58825|NCT01611857|139214|P1|STARTED|Overall Study|Three dose levels of tivantinib (120 mg, 240 mg, and 360 mg) were evaluated to determine the MTD.|15
58826|NCT01611792|139226|P2|NOT COMPLETED|Followup: at 6 Months||13
58827|NCT01611792|139227|P1|NOT COMPLETED|Followup: at 6 Months||6
58828|NCT01611792|139226|P2|COMPLETED|Followup: at 6 Months||7
58829|NCT01611792|139227|P1|COMPLETED|Followup: at 6 Months||11
58830|NCT01611792|139226|P2|STARTED|Followup: at 6 Months||20
58831|NCT01611792|139227|P1|STARTED|Followup: at 6 Months||17
58832|NCT01611792|139226|P2|NOT COMPLETED|Follow-up: at 11 Weeks||0
58833|NCT01611792|139227|P1|NOT COMPLETED|Follow-up: at 11 Weeks||0
58834|NCT01611792|139226|P2|COMPLETED|Follow-up: at 11 Weeks||20
58835|NCT01611792|139227|P1|COMPLETED|Follow-up: at 11 Weeks||17
58836|NCT01611792|139226|P2|STARTED|Follow-up: at 11 Weeks||20
58837|NCT01611792|139227|P1|STARTED|Follow-up: at 11 Weeks||17
58838|NCT01611792|139226|P2|NOT COMPLETED|Initial Period: Time 0||9
58839|NCT01611792|139227|P1|NOT COMPLETED|Initial Period: Time 0||12
58840|NCT01611792|139226|P2|COMPLETED|Initial Period: Time 0||20
58841|NCT01611792|139227|P1|COMPLETED|Initial Period: Time 0||17
58842|NCT01611792|139226|P2|STARTED|Initial Period: Time 0||29
58843|NCT01611792|139227|P1|STARTED|Initial Period: Time 0||29
58844|NCT01611779|139243|P1|NOT COMPLETED|Overall Study||0
58845|NCT01611779|139243|P1|COMPLETED|Overall Study||5
58846|NCT01611779|139243|P1|STARTED|Overall Study||5
58847|NCT01611662|139252|P1|NOT COMPLETED|Overall Study||1
58848|NCT01611662|139252|P1|COMPLETED|Overall Study||31
58849|NCT01611662|139252|P1|STARTED|Overall Study||32
58850|NCT01611571|139259|P3|NOT COMPLETED|Overall Study||1
58851|NCT01611571|139260|P2|NOT COMPLETED|Overall Study||0
58852|NCT01611571|139261|P1|NOT COMPLETED|Overall Study||1
58853|NCT01611571|139259|P3|COMPLETED|Overall Study||9
58854|NCT01611571|139260|P2|COMPLETED|Overall Study||10
58855|NCT01611571|139261|P1|COMPLETED|Overall Study||10
58856|NCT01611571|139259|P3|STARTED|Overall Study||10
58857|NCT01611571|139260|P2|STARTED|Overall Study||10
58858|NCT01611571|139261|P1|STARTED|Overall Study||11
58859|NCT01611558|139281|P1|NOT COMPLETED|Maintenance Phase||2
58860|NCT01611558|139281|P1|COMPLETED|Maintenance Phase||0
58861|NCT01611558|139281|P1|STARTED|Maintenance Phase||2
58862|NCT01611558|139281|P1|NOT COMPLETED|Induction Phase||38
58863|NCT01611558|139281|P1|COMPLETED|Induction Phase||2
58864|NCT01611558|139281|P1|STARTED|Induction Phase||40
58865|NCT01610791|139287|P1|NOT COMPLETED|Overall Study||21
58866|NCT01610791|139287|P1|COMPLETED|Overall Study||100
58867|NCT01610791|139287|P1|STARTED|Overall Study||121
58868|NCT01610713|139310|P2|NOT COMPLETED|Overall Study||1
58869|NCT01610713|139311|P1|NOT COMPLETED|Overall Study||6
58870|NCT01610713|139310|P2|COMPLETED|Overall Study||76
58871|NCT01610713|139311|P1|COMPLETED|Overall Study||71
58872|NCT01610713|139310|P2|STARTED|Overall Study||77
58873|NCT01610713|139311|P1|STARTED|Overall Study||77
58874|NCT01610700|139369|P2|NOT COMPLETED|Overall Study||3
58875|NCT01610700|139370|P1|NOT COMPLETED|Overall Study||3
58876|NCT01610700|139369|P2|COMPLETED|Overall Study||77
58877|NCT01610700|139370|P1|COMPLETED|Overall Study||77
58878|NCT01610700|139369|P2|STARTED|Overall Study||80
58879|NCT01610700|139370|P1|STARTED|Overall Study||80
58880|NCT01610687|139424|P1|NOT COMPLETED|Overall Study||67
58881|NCT01610687|139424|P1|COMPLETED|Overall Study||70
58882|NCT01610687|139424|P1|STARTED|Overall Study||137
58883|NCT01610596|139437|P2|NOT COMPLETED|Overall Study||1
58884|NCT01610596|139438|P1|NOT COMPLETED|Overall Study||0
58885|NCT01610596|139437|P2|COMPLETED|Overall Study||35
58886|NCT01610596|139438|P1|COMPLETED|Overall Study||36
58887|NCT01610596|139437|P2|STARTED|Overall Study||36
58888|NCT01610596|139438|P1|STARTED|Overall Study||36
58889|NCT01610570|139454|P4|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58890|NCT01610570|139455|P3|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58891|NCT01610570|139456|P2|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58892|NCT01610570|139457|P1|NOT COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58893|NCT01610570|139454|P4|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58894|NCT01610570|139455|P3|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58895|NCT01610570|139456|P2|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58896|NCT01610570|139457|P1|COMPLETED|Ph II >/= 12 mo. & </=17yrs||0
58897|NCT01610570|139454|P4|STARTED|Ph II >/= 12 mo. & </=17yrs||0
58898|NCT01610570|139455|P3|STARTED|Ph II >/= 12 mo. & </=17yrs||0
58899|NCT01610570|139456|P2|STARTED|Ph II >/= 12 mo. & </=17yrs||0
58900|NCT01610570|139457|P1|STARTED|Ph II >/= 12 mo. & </=17yrs||0
58901|NCT01610570|139454|P4|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
58902|NCT01610570|139455|P3|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
58903|NCT01610570|139456|P2|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
58904|NCT01610570|139457|P1|NOT COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
58905|NCT01610570|139454|P4|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||6
58906|NCT01610570|139455|P3|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
58907|NCT01610570|139456|P2|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
58908|NCT01610570|139457|P1|COMPLETED|Ph II >/= 18yrs of Age at Enrollment||0
58909|NCT01610570|139454|P4|STARTED|Ph II >/= 18yrs of Age at Enrollment||6
58910|NCT01610570|139455|P3|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
58911|NCT01610570|139456|P2|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
58912|NCT01610570|139457|P1|STARTED|Ph II >/= 18yrs of Age at Enrollment||0
58913|NCT01610570|139454|P4|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
58914|NCT01610570|139455|P3|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
58915|NCT01610570|139456|P2|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
58916|NCT01610570|139457|P1|NOT COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
58917|NCT01610570|139454|P4|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
58918|NCT01610570|139455|P3|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
58919|NCT01610570|139456|P2|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||2
58920|NCT01610570|139457|P1|COMPLETED|Ph I >/= 12 mo. Children & Adolescents||0
58921|NCT01610570|139454|P4|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
58922|NCT01610570|139455|P3|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
58923|NCT01610570|139456|P2|STARTED|Ph I >/= 12 mo. Children & Adolescents||2
58924|NCT01610570|139457|P1|STARTED|Ph I >/= 12 mo. Children & Adolescents||0
58925|NCT01610557|139475|P5|NOT COMPLETED|Post-36-Week Extension Phase||3
58926|NCT01610557|139476|P4|NOT COMPLETED|Post-36-Week Extension Phase||0
58927|NCT01610557|139477|P3|NOT COMPLETED|Post-36-Week Extension Phase||0
58928|NCT01610557|139478|P2|NOT COMPLETED|Post-36-Week Extension Phase||0
58929|NCT01610557|139479|P1|NOT COMPLETED|Post-36-Week Extension Phase||0
58930|NCT01610557|139475|P5|COMPLETED|Post-36-Week Extension Phase|2 bilateral participants withdrew before their first post-36-week extension visit|52
58931|NCT01610557|139476|P4|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
58932|NCT01610557|139477|P3|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
58933|NCT01610557|139478|P2|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
58934|NCT01610557|139479|P1|COMPLETED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
58935|NCT01610557|139475|P5|STARTED|Post-36-Week Extension Phase||55
58936|NCT01610557|139476|P4|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
58937|NCT01610557|139477|P3|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
58938|NCT01610557|139478|P2|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
59020|NCT01610011|139635|P2|NOT COMPLETED|Overall Study||0
58939|NCT01610557|139479|P1|STARTED|Post-36-Week Extension Phase|Not applicable for the post-36-week extension phase|0
58940|NCT01610557|139475|P5|NOT COMPLETED|36-Week Randomized Crossover Phase||0
58941|NCT01610557|139476|P4|NOT COMPLETED|36-Week Randomized Crossover Phase||0
58942|NCT01610557|139477|P3|NOT COMPLETED|36-Week Randomized Crossover Phase||0
58943|NCT01610557|139478|P2|NOT COMPLETED|36-Week Randomized Crossover Phase||1
58944|NCT01610557|139479|P1|NOT COMPLETED|36-Week Randomized Crossover Phase||0
58945|NCT01610557|139475|P5|COMPLETED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
58946|NCT01610557|139476|P4|COMPLETED|36-Week Randomized Crossover Phase||13
58947|NCT01610557|139477|P3|COMPLETED|36-Week Randomized Crossover Phase||14
58948|NCT01610557|139478|P2|COMPLETED|36-Week Randomized Crossover Phase|Unilateral participant unable to return for visits after Wk 4 due to recovery from an adverse event|12
58949|NCT01610557|139479|P1|COMPLETED|36-Week Randomized Crossover Phase||16
58950|NCT01610557|139475|P5|STARTED|36-Week Randomized Crossover Phase|Not applicable for 36-week double-masked randomized crossover phase|0
58951|NCT01610557|139476|P4|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 4: 11 unilateral and 2 bilateral (left eye assigned to Grp 2)|13
58952|NCT01610557|139477|P3|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 3: 13 unilateral and 1 bilateral (left eye assigned to Grp 1)|14
58953|NCT01610557|139478|P2|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 2: 12 unilateral and 1 bilateral (left eye assigned to Grp 4)|13
58954|NCT01610557|139479|P1|STARTED|36-Week Randomized Crossover Phase|Participants randomly assigned to Grp 1: 14 unilateral and 2 bilateral (left eye assigned to Grp 3)|16
58955|NCT01610492|139492|P1|NOT COMPLETED|Overall Study||3
58956|NCT01610492|139492|P1|COMPLETED|Overall Study||11
58957|NCT01610492|139492|P1|STARTED|Overall Study||14
58958|NCT01610453|139499|P1|NOT COMPLETED|Overall Study||0
58959|NCT01610453|139499|P1|COMPLETED|Overall Study||150
58960|NCT01610453|139499|P1|STARTED|Overall Study||150
58961|NCT01610297|139504|P1|NOT COMPLETED|Overall Study||1
58962|NCT01610297|139504|P1|COMPLETED|Overall Study||26
58963|NCT01610297|139504|P1|STARTED|Overall Study||27
58964|NCT01610167|139515|P3|NOT COMPLETED|Overall Study||2
58965|NCT01610167|139516|P2|NOT COMPLETED|Overall Study||0
58966|NCT01610167|139517|P1|NOT COMPLETED|Overall Study||0
58967|NCT01610167|139515|P3|COMPLETED|Overall Study||48
58968|NCT01610167|139516|P2|COMPLETED|Overall Study||49
58969|NCT01610167|139517|P1|COMPLETED|Overall Study||52
58970|NCT01610167|139515|P3|STARTED|Overall Study||50
58971|NCT01610167|139516|P2|STARTED|Overall Study||49
58972|NCT01610167|139517|P1|STARTED|Overall Study||52
58973|NCT01610154|139537|P1|NOT COMPLETED|Overall Study||1
58974|NCT01610154|139537|P1|COMPLETED|Overall Study||84
58975|NCT01610154|139537|P1|STARTED|Overall Study||85
58976|NCT01610076|139554|P2|NOT COMPLETED|Overall Study||5
58977|NCT01610076|139555|P1|NOT COMPLETED|Overall Study||3
58978|NCT01610076|139554|P2|COMPLETED|Overall Study||100
58979|NCT01610076|139555|P1|COMPLETED|Overall Study||100
58980|NCT01610076|139554|P2|STARTED|Overall Study||105
58981|NCT01610076|139555|P1|STARTED|Overall Study||103
58982|NCT01610063|139566|P2|NOT COMPLETED|Overall Study||20
58983|NCT01610063|139567|P1|NOT COMPLETED|Overall Study||42
58984|NCT01610063|139566|P2|COMPLETED|Overall Study||93
58985|NCT01610063|139567|P1|COMPLETED|Overall Study||72
58986|NCT01610063|139566|P2|Completed 8-week|Overall Study||93
58987|NCT01610063|139567|P1|Completed 8-week|Overall Study||72
58988|NCT01610063|139566|P2|Completed 4-week|Overall Study||98
58989|NCT01610063|139567|P1|Completed 4-week|Overall Study||86
58990|NCT01610063|139566|P2|Completed 2-week|Overall Study||105
58991|NCT01610063|139567|P1|Completed 2-week|Overall Study||97
58992|NCT01610063|139566|P2|Baseline|Overall Study||113
58993|NCT01610063|139567|P1|Baseline|Overall Study||114
58994|NCT01610063|139566|P2|STARTED|Overall Study||113
58995|NCT01610063|139567|P1|STARTED|Overall Study||114
58996|NCT01610037|139590|P3|NOT COMPLETED|Treatment and Follow up Period||26
58997|NCT01610037|139591|P2|NOT COMPLETED|Treatment and Follow up Period||28
58998|NCT01610037|139592|P1|NOT COMPLETED|Treatment and Follow up Period||25
58999|NCT01610037|139590|P3|COMPLETED|Treatment and Follow up Period||378
59000|NCT01610037|139591|P2|COMPLETED|Treatment and Follow up Period||377
59001|NCT01610037|139592|P1|COMPLETED|Treatment and Follow up Period||382
59002|NCT01610037|139590|P3|STARTED|Treatment and Follow up Period||404
59003|NCT01610037|139591|P2|STARTED|Treatment and Follow up Period||405
59004|NCT01610037|139592|P1|STARTED|Treatment and Follow up Period||407
59005|NCT01610037|139590|P3|NOT COMPLETED|All Patients||84
59006|NCT01610037|139591|P2|NOT COMPLETED|All Patients||51
59007|NCT01610037|139592|P1|NOT COMPLETED|All Patients||59
59008|NCT01610037|139590|P3|COMPLETED|All Patients||320
59009|NCT01610037|139591|P2|COMPLETED|All Patients||354
59010|NCT01610037|139592|P1|COMPLETED|All Patients||348
59011|NCT01610037|139590|P3|Full Analysis Set (FAS)|All Patients||403
59012|NCT01610037|139591|P2|Full Analysis Set (FAS)|All Patients||405
59013|NCT01610037|139592|P1|Full Analysis Set (FAS)|All Patients||407
59014|NCT01610037|139590|P3|Randomized Set (RAN)|All Patients||404
59015|NCT01610037|139591|P2|Randomized Set (RAN)|All Patients||405
59016|NCT01610037|139592|P1|Randomized Set (RAN)|All Patients||407
59017|NCT01610037|139590|P3|STARTED|All Patients||404
59018|NCT01610037|139591|P2|STARTED|All Patients||405
59019|NCT01610037|139592|P1|STARTED|All Patients||407
59021|NCT01610011|139636|P1|NOT COMPLETED|Overall Study||10
59022|NCT01610011|139635|P2|COMPLETED|Overall Study||2
59023|NCT01610011|139636|P1|COMPLETED|Overall Study||9
59024|NCT01610011|139635|P2|STARTED|Overall Study||2
59025|NCT01610011|139636|P1|STARTED|Overall Study||19
59026|NCT01609790|139645|P3|NOT COMPLETED|Overall Study||8
59027|NCT01609790|139646|P2|NOT COMPLETED|Overall Study||7
59028|NCT01609790|139647|P1|NOT COMPLETED|Overall Study||1
59029|NCT01609790|139645|P3|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|57
59030|NCT01609790|139646|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
59031|NCT01609790|139647|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|6
59032|NCT01609790|139645|P3|STARTED|Overall Study||65
59033|NCT01609790|139646|P2|STARTED|Overall Study||65
59034|NCT01609790|139647|P1|STARTED|Overall Study||7
59035|NCT01609582|139665|P2|NOT COMPLETED|Overall Study||1604
59036|NCT01609582|139666|P1|NOT COMPLETED|Overall Study||1603
59037|NCT01609582|139665|P2|COMPLETED|Overall Study||0
59038|NCT01609582|139666|P1|COMPLETED|Overall Study||0
59039|NCT01609582|139665|P2|Treated|Overall Study||1601
59040|NCT01609582|139666|P1|Treated|Overall Study||1603
59041|NCT01609582|139665|P2|STARTED|Overall Study||1604
59042|NCT01609582|139666|P1|STARTED|Overall Study||1603
59043|NCT01609543|139674|P1|NOT COMPLETED|Overall Study||42
59044|NCT01609543|139674|P1|COMPLETED|Overall Study||20
59045|NCT01609543|139674|P1|STARTED|Overall Study||62
59046|NCT01609478|139683|P3|NOT COMPLETED|Overall Study||9
59047|NCT01609478|139684|P2|NOT COMPLETED|Overall Study||2
59048|NCT01609478|139685|P1|NOT COMPLETED|Overall Study||7
59049|NCT01609478|139683|P3|COMPLETED|Overall Study||107
59050|NCT01609478|139684|P2|COMPLETED|Overall Study||106
59051|NCT01609478|139685|P1|COMPLETED|Overall Study||104
59052|NCT01609478|139683|P3|Full Analysis Set (FAS)|Overall Study||115
59053|NCT01609478|139684|P2|Full Analysis Set (FAS)|Overall Study||108
59054|NCT01609478|139685|P1|Full Analysis Set (FAS)|Overall Study||110
59055|NCT01609478|139683|P3|STARTED|Overall Study||116
59056|NCT01609478|139684|P2|STARTED|Overall Study||108
59057|NCT01609478|139685|P1|STARTED|Overall Study||111
59058|NCT01609257|139751|P2|NOT COMPLETED|Overall Study||8
59059|NCT01609257|139752|P1|NOT COMPLETED|Overall Study||6
59060|NCT01609257|139751|P2|COMPLETED|Overall Study||57
59061|NCT01609257|139752|P1|COMPLETED|Overall Study||61
59062|NCT01609257|139751|P2|Received Challenge Product|Overall Study||53
59063|NCT01609257|139752|P1|Received Challenge Product|Overall Study||56
59064|NCT01609257|139751|P2|Received 2 Doses|Overall Study||64
59065|NCT01609257|139752|P1|Received 2 Doses|Overall Study||63
59066|NCT01609257|139751|P2|STARTED|Overall Study||65
59067|NCT01609257|139752|P1|STARTED|Overall Study||67
59068|NCT01609062|139824|P2|NOT COMPLETED|Extension Phase||10
59069|NCT01609062|139825|P1|NOT COMPLETED|Extension Phase||15
59070|NCT01609062|139824|P2|COMPLETED|Extension Phase|EAP = Expanded Access Program|0
59071|NCT01609062|139825|P1|COMPLETED|Extension Phase||0
59072|NCT01609062|139824|P2|STARTED|Extension Phase||10
59073|NCT01609062|139825|P1|STARTED|Extension Phase||15
59074|NCT01609062|139824|P2|NOT COMPLETED|Primary Phase||0
59075|NCT01609062|139825|P1|NOT COMPLETED|Primary Phase||0
59076|NCT01609062|139824|P2|COMPLETED|Primary Phase||10
59077|NCT01609062|139825|P1|COMPLETED|Primary Phase||15
59078|NCT01609062|139824|P2|STARTED|Primary Phase||10
59079|NCT01609062|139825|P1|STARTED|Primary Phase||15
59080|NCT01609023|139868|P1|NOT COMPLETED|Overall Study||33
59081|NCT01609023|139868|P1|COMPLETED|Overall Study||34
59082|NCT01609023|139868|P1|STARTED|Overall Study||67
59083|NCT01609010|139880|P2|NOT COMPLETED|Overall Study||37
59084|NCT01609010|139881|P1|NOT COMPLETED|Overall Study||43
59085|NCT01609010|139880|P2|COMPLETED|Overall Study||120
59086|NCT01609010|139881|P1|COMPLETED|Overall Study||113
59087|NCT01609010|139880|P2|Entering Cycle 2|Overall Study||124
59088|NCT01609010|139881|P1|Entering Cycle 2|Overall Study||120
59089|NCT01609010|139880|P2|STARTED|Overall Study||157
59090|NCT01609010|139881|P1|STARTED|Overall Study||156
59091|NCT01608971|139907|P2|NOT COMPLETED|Overall Study||0
59092|NCT01608971|139908|P1|NOT COMPLETED|Overall Study||0
59093|NCT01608971|139907|P2|COMPLETED|Overall Study||15
59094|NCT01608971|139908|P1|COMPLETED|Overall Study||15
59095|NCT01608971|139907|P2|STARTED|Overall Study||15
59096|NCT01608971|139908|P1|STARTED|Overall Study||15
59097|NCT01608815|139923|P3|NOT COMPLETED|Overall Study||0
59098|NCT01608815|139924|P2|NOT COMPLETED|Overall Study||0
59099|NCT01608815|139925|P1|NOT COMPLETED|Overall Study||0
59100|NCT01608815|139923|P3|COMPLETED|Overall Study||5
59101|NCT01608815|139924|P2|COMPLETED|Overall Study||7
59102|NCT01608815|139925|P1|COMPLETED|Overall Study||188
59103|NCT01608815|139923|P3|STARTED|Overall Study||5
59104|NCT01608815|139924|P2|STARTED|Overall Study||7
59105|NCT01608815|139925|P1|STARTED|Overall Study||188
59106|NCT01608724|139942|P1|NOT COMPLETED|Overall Study||243
59107|NCT01608724|139942|P1|COMPLETED|Overall Study||1180
59108|NCT01608724|139942|P1|Treated|Overall Study||1361
59109|NCT01608724|139942|P1|STARTED|Overall Study|One patient was excluded because the Informed Consent Form was destroyed by site staff by mistake.|1423
59110|NCT01608672|139949|P1|NOT COMPLETED|Overall Study||0
59111|NCT01608672|139949|P1|COMPLETED|Overall Study||207
59112|NCT01608672|139949|P1|STARTED|Overall Study||207
59113|NCT01608659|139955|P1|NOT COMPLETED|Overall Study||16
59114|NCT01608659|139955|P1|COMPLETED|Overall Study||94
59115|NCT01608659|139955|P1|STARTED|Overall Study||110
59116|NCT01608490|139963|P2|NOT COMPLETED|Overall Study||0
59117|NCT01608490|139964|P1|NOT COMPLETED|Overall Study||0
59118|NCT01608490|139963|P2|COMPLETED|Overall Study||157
59119|NCT01608490|139964|P1|COMPLETED|Overall Study||158
59120|NCT01608490|139963|P2|STARTED|Overall Study||157
59121|NCT01608490|139964|P1|STARTED|Overall Study||158
59122|NCT01608321|139974|P2|NOT COMPLETED|Overall Study||0
59123|NCT01608321|139975|P1|NOT COMPLETED|Overall Study||1
59124|NCT01608321|139974|P2|COMPLETED|Overall Study||4
59125|NCT01608321|139975|P1|COMPLETED|Overall Study||12
59126|NCT01608321|139974|P2|STARTED|Overall Study||4
59127|NCT01608321|139975|P1|STARTED|Overall Study||13
59128|NCT01608308|139983|P2|NOT COMPLETED|Overall Study||2
59129|NCT01608308|139984|P1|NOT COMPLETED|Overall Study||0
59130|NCT01608308|139983|P2|COMPLETED|Overall Study||29
59131|NCT01608308|139984|P1|COMPLETED|Overall Study||31
59132|NCT01608308|139983|P2|STARTED|Overall Study||31
59133|NCT01608308|139984|P1|STARTED|Overall Study||31
59134|NCT01608295|140008|P2|NOT COMPLETED|Overall Study||5
59135|NCT01608295|140009|P1|NOT COMPLETED|Overall Study||6
59136|NCT01608295|140008|P2|COMPLETED|Overall Study||25
59137|NCT01608295|140009|P1|COMPLETED|Overall Study||20
59138|NCT01608295|140008|P2|STARTED|Overall Study||30
59139|NCT01608295|140009|P1|STARTED|Overall Study||26
59140|NCT01608100|140019|P1|NOT COMPLETED|Overall Study||0
59141|NCT01608100|140019|P1|COMPLETED|Overall Study||1101
59142|NCT01608100|140019|P1|STARTED|Overall Study||1101
59143|NCT01607853|140043|P1|NOT COMPLETED|Overall Study||0
59144|NCT01607853|140043|P1|COMPLETED|Overall Study||24
59145|NCT01607853|140043|P1|STARTED|Overall Study||24
59146|NCT01607645|140152|P2|NOT COMPLETED|Overall Study||0
59147|NCT01607645|140153|P1|NOT COMPLETED|Overall Study||0
59148|NCT01607645|140152|P2|COMPLETED|Overall Study||3
59149|NCT01607645|140153|P1|COMPLETED|Overall Study||4
59150|NCT01607645|140152|P2|STARTED|Overall Study||3
59151|NCT01607645|140153|P1|STARTED|Overall Study||4
59152|NCT01607593|140183|P1|NOT COMPLETED|Overall Study||93
59153|NCT01607593|140183|P1|COMPLETED|Overall Study||29
59154|NCT01607593|140183|P1|STARTED|Overall Study||122
59155|NCT01607476|140192|P3|NOT COMPLETED|Overall Study||3
59156|NCT01607476|140193|P2|NOT COMPLETED|Overall Study||0
59157|NCT01607476|140194|P1|NOT COMPLETED|Overall Study||1
59158|NCT01607476|140192|P3|COMPLETED|Overall Study||30
59159|NCT01607476|140193|P2|COMPLETED|Overall Study||30
59160|NCT01607476|140194|P1|COMPLETED|Overall Study||24
59161|NCT01607476|140192|P3|STARTED|Overall Study||33
59162|NCT01607476|140193|P2|STARTED|Overall Study||30
59163|NCT01607476|140194|P1|STARTED|Overall Study||25
59164|NCT01607450|140212|P7|NOT COMPLETED|Overall Study||0
59165|NCT01607450|140213|P6|NOT COMPLETED|Overall Study||0
59166|NCT01607450|140214|P5|NOT COMPLETED|Overall Study||0
59167|NCT01607450|140215|P4|NOT COMPLETED|Overall Study||0
59168|NCT01607450|140216|P3|NOT COMPLETED|Overall Study||0
59169|NCT01607450|140217|P2|NOT COMPLETED|Overall Study||0
59170|NCT01607450|140218|P1|NOT COMPLETED|Overall Study||0
59171|NCT01607450|140212|P7|COMPLETED|Overall Study||0
59172|NCT01607450|140213|P6|COMPLETED|Overall Study||0
59173|NCT01607450|140214|P5|COMPLETED|Overall Study||1
59174|NCT01607450|140215|P4|COMPLETED|Overall Study||11
59175|NCT01607450|140216|P3|COMPLETED|Overall Study||7
59176|NCT01607450|140217|P2|COMPLETED|Overall Study||8
59177|NCT01607450|140218|P1|COMPLETED|Overall Study||6
59178|NCT01607450|140212|P7|STARTED|Overall Study||0
59179|NCT01607450|140213|P6|STARTED|Overall Study||0
59180|NCT01607450|140214|P5|STARTED|Overall Study||1
59181|NCT01607450|140215|P4|STARTED|Overall Study||11
59182|NCT01607450|140216|P3|STARTED|Overall Study||7
59183|NCT01607450|140217|P2|STARTED|Overall Study||8
59184|NCT01607450|140218|P1|STARTED|Overall Study||6
59185|NCT01607411|140262|P4|NOT COMPLETED|Period IV||0
59186|NCT01607411|140263|P3|NOT COMPLETED|Period IV||0
59187|NCT01607411|140264|P2|NOT COMPLETED|Period IV||0
59188|NCT01607411|140265|P1|NOT COMPLETED|Period IV||0
59189|NCT01607411|140262|P4|COMPLETED|Period IV||14
59190|NCT01607411|140263|P3|COMPLETED|Period IV||14
59191|NCT01607411|140264|P2|COMPLETED|Period IV||14
59192|NCT01607411|140265|P1|COMPLETED|Period IV||13
59193|NCT01607411|140262|P4|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
59194|NCT01607411|140263|P3|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
59195|NCT01607411|140264|P2|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|14
59196|NCT01607411|140265|P1|STARTED|Period IV|Due to crossover design, different set of participants entered Period 4|13
59197|NCT01607411|140262|P4|NOT COMPLETED|Period III||0
59198|NCT01607411|140263|P3|NOT COMPLETED|Period III||0
59199|NCT01607411|140264|P2|NOT COMPLETED|Period III||0
59200|NCT01607411|140265|P1|NOT COMPLETED|Period III||0
59201|NCT01607411|140262|P4|COMPLETED|Period III||13
59202|NCT01607411|140263|P3|COMPLETED|Period III||14
59203|NCT01607411|140264|P2|COMPLETED|Period III||14
59204|NCT01607411|140265|P1|COMPLETED|Period III||14
59292|NCT01606319|140452|P1|STARTED|Overall Study||150
59205|NCT01607411|140262|P4|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|13
59206|NCT01607411|140263|P3|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
59207|NCT01607411|140264|P2|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
59208|NCT01607411|140265|P1|STARTED|Period III|Due to crossover design, different set of participants entered Period 3|14
59209|NCT01607411|140262|P4|NOT COMPLETED|Period II||0
59210|NCT01607411|140263|P3|NOT COMPLETED|Period II||0
59211|NCT01607411|140264|P2|NOT COMPLETED|Period II||0
59212|NCT01607411|140265|P1|NOT COMPLETED|Period II||0
59213|NCT01607411|140262|P4|COMPLETED|Period II||14
59214|NCT01607411|140263|P3|COMPLETED|Period II||13
59215|NCT01607411|140264|P2|COMPLETED|Period II||14
59216|NCT01607411|140265|P1|COMPLETED|Period II||14
59217|NCT01607411|140262|P4|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
59218|NCT01607411|140263|P3|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|13
59219|NCT01607411|140264|P2|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
59220|NCT01607411|140265|P1|STARTED|Period II|Due to crossover design, different set of participants entered Period 2|14
59221|NCT01607411|140262|P4|NOT COMPLETED|Period I||0
59222|NCT01607411|140263|P3|NOT COMPLETED|Period I||0
59223|NCT01607411|140264|P2|NOT COMPLETED|Period I||0
59224|NCT01607411|140265|P1|NOT COMPLETED|Period I||0
59225|NCT01607411|140262|P4|COMPLETED|Period I||14
59226|NCT01607411|140263|P3|COMPLETED|Period I||14
59227|NCT01607411|140264|P2|COMPLETED|Period I||13
59228|NCT01607411|140265|P1|COMPLETED|Period I||14
59229|NCT01607411|140262|P4|STARTED|Period I||14
59230|NCT01607411|140263|P3|STARTED|Period I||14
59231|NCT01607411|140264|P2|STARTED|Period I||13
59232|NCT01607411|140265|P1|STARTED|Period I||14
59233|NCT01607398|140288|P2|NOT COMPLETED|Overall Study||2
59234|NCT01607398|140289|P1|NOT COMPLETED|Overall Study||2
59235|NCT01607398|140288|P2|COMPLETED|Overall Study||26
59236|NCT01607398|140289|P1|COMPLETED|Overall Study||26
59237|NCT01607398|140288|P2|STARTED|Overall Study||28
59238|NCT01607398|140289|P1|STARTED|Overall Study||28
59239|NCT01607320|140333|P2|NOT COMPLETED|Overall Study||0
59240|NCT01607320|140334|P1|NOT COMPLETED|Overall Study||0
59241|NCT01607320|140333|P2|COMPLETED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
59242|NCT01607320|140334|P1|COMPLETED|Overall Study|The study was randomized between the 2 treatments and was never unblinded,so unknown.|0
59243|NCT01607320|140333|P2|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
59244|NCT01607320|140334|P1|STARTED|Overall Study|The study was randomized between the two treatments and was never unblinded,therefore unknown.|0
59245|NCT01607203|140340|P2|NOT COMPLETED|Overall Study||0
59246|NCT01607203|140341|P1|NOT COMPLETED|Overall Study||0
59247|NCT01607203|140340|P2|COMPLETED|Overall Study||61
59248|NCT01607203|140341|P1|COMPLETED|Overall Study||59
59249|NCT01607203|140340|P2|STARTED|Overall Study||61
59250|NCT01607203|140341|P1|STARTED|Overall Study||59
59251|NCT01607112|140353|P2|NOT COMPLETED|Overall Study||0
59252|NCT01607112|140354|P1|NOT COMPLETED|Overall Study||0
59253|NCT01607112|140353|P2|COMPLETED|Overall Study||59
59254|NCT01607112|140354|P1|COMPLETED|Overall Study||60
59255|NCT01607112|140353|P2|STARTED|Overall Study||59
59256|NCT01607112|140354|P1|STARTED|Overall Study||60
59257|NCT01606800|140390|P2|NOT COMPLETED|Overall Study||2
59258|NCT01606800|140391|P1|NOT COMPLETED|Overall Study||5
59259|NCT01606800|140390|P2|COMPLETED|Overall Study||21
59260|NCT01606800|140391|P1|COMPLETED|Overall Study||17
59261|NCT01606800|140390|P2|Treated|Overall Study||23
59262|NCT01606800|140391|P1|Treated|Overall Study||22
59263|NCT01606800|140390|P2|STARTED|Overall Study||23
59264|NCT01606800|140391|P1|STARTED|Overall Study||22
59265|NCT01606748|140399|P2|NOT COMPLETED|Overall Study||0
59266|NCT01606748|140400|P1|NOT COMPLETED|Overall Study||3
59267|NCT01606748|140399|P2|COMPLETED|Overall Study||17
59268|NCT01606748|140400|P1|COMPLETED|Overall Study||15
59269|NCT01606748|140399|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
59270|NCT01606748|140400|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
59271|NCT01606748|140399|P2|STARTED|Overall Study||17
59272|NCT01606748|140400|P1|STARTED|Overall Study||18
59273|NCT01606735|140431|P3|NOT COMPLETED|Overall Study||0
59274|NCT01606735|140432|P2|NOT COMPLETED|Overall Study||0
59275|NCT01606735|140433|P1|NOT COMPLETED|Overall Study||0
59276|NCT01606735|140431|P3|COMPLETED|Overall Study||58
59277|NCT01606735|140432|P2|COMPLETED|Overall Study||56
59278|NCT01606735|140433|P1|COMPLETED|Overall Study||58
59279|NCT01606735|140431|P3|STARTED|Overall Study||58
59280|NCT01606735|140432|P2|STARTED|Overall Study||56
59281|NCT01606735|140433|P1|STARTED|Overall Study||58
59282|NCT01606670|140441|P1|NOT COMPLETED|Overall Study||16
59283|NCT01606670|140441|P1|COMPLETED|Overall Study||77
59284|NCT01606670|140441|P1|Full Analysis Set|Overall Study||70
59285|NCT01606670|140441|P1|Safety Set|Overall Study||93
59286|NCT01606670|140441|P1|STARTED|Overall Study||93
59287|NCT01606319|140451|P2|NOT COMPLETED|Overall Study||40
59288|NCT01606319|140452|P1|NOT COMPLETED|Overall Study||34
59289|NCT01606319|140451|P2|COMPLETED|Overall Study||110
59290|NCT01606319|140452|P1|COMPLETED|Overall Study||116
59291|NCT01606319|140451|P2|STARTED|Overall Study||150
59293|NCT01606306|140470|P6|NOT COMPLETED|Overall Study||11
59294|NCT01606306|140471|P5|NOT COMPLETED|Overall Study||11
59295|NCT01606306|140472|P4|NOT COMPLETED|Overall Study||13
59296|NCT01606306|140473|P3|NOT COMPLETED|Overall Study||14
59297|NCT01606306|140474|P2|NOT COMPLETED|Overall Study||10
59298|NCT01606306|140475|P1|NOT COMPLETED|Overall Study||15
59299|NCT01606306|140470|P6|COMPLETED|Overall Study||36
59300|NCT01606306|140471|P5|COMPLETED|Overall Study||41
59301|NCT01606306|140472|P4|COMPLETED|Overall Study||38
59302|NCT01606306|140473|P3|COMPLETED|Overall Study||37
59303|NCT01606306|140474|P2|COMPLETED|Overall Study||39
59304|NCT01606306|140475|P1|COMPLETED|Overall Study||35
59305|NCT01606306|140470|P6|Completed Third Treatment Period|Overall Study||36
59306|NCT01606306|140471|P5|Completed Third Treatment Period|Overall Study||41
59307|NCT01606306|140472|P4|Completed Third Treatment Period|Overall Study||38
59308|NCT01606306|140473|P3|Completed Third Treatment Period|Overall Study||37
59309|NCT01606306|140474|P2|Completed Third Treatment Period|Overall Study||39
59310|NCT01606306|140475|P1|Completed Third Treatment Period|Overall Study||35
59311|NCT01606306|140470|P6|Completed Second Treatment Period|Overall Study||41
59312|NCT01606306|140471|P5|Completed Second Treatment Period|Overall Study||46
59313|NCT01606306|140472|P4|Completed Second Treatment Period|Overall Study||44
59314|NCT01606306|140473|P3|Completed Second Treatment Period|Overall Study||43
59315|NCT01606306|140474|P2|Completed Second Treatment Period|Overall Study||38
59316|NCT01606306|140475|P1|Completed Second Treatment Period|Overall Study||41
59317|NCT01606306|140470|P6|Completed First Treatment Period|Overall Study||44
59318|NCT01606306|140471|P5|Completed First Treatment Period|Overall Study||47
59319|NCT01606306|140472|P4|Completed First Treatment Period|Overall Study||45
59320|NCT01606306|140473|P3|Completed First Treatment Period|Overall Study||47
59321|NCT01606306|140474|P2|Completed First Treatment Period|Overall Study||47
59322|NCT01606306|140475|P1|Completed First Treatment Period|Overall Study||43
59323|NCT01606306|140470|P6|STARTED|Overall Study||47
59324|NCT01606306|140471|P5|STARTED|Overall Study||52
59325|NCT01606306|140472|P4|STARTED|Overall Study||51
59326|NCT01606306|140473|P3|STARTED|Overall Study||51
59327|NCT01606306|140474|P2|STARTED|Overall Study||49
59328|NCT01606306|140475|P1|STARTED|Overall Study||50
59329|NCT01606254|140485|P4|NOT COMPLETED|Overall Study||3
59330|NCT01606254|140486|P3|NOT COMPLETED|Overall Study||0
59331|NCT01606254|140487|P2|NOT COMPLETED|Overall Study||4
59332|NCT01606254|140488|P1|NOT COMPLETED|Overall Study||2
59333|NCT01606254|140485|P4|COMPLETED|Overall Study||11
59334|NCT01606254|140486|P3|COMPLETED|Overall Study||14
59335|NCT01606254|140487|P2|COMPLETED|Overall Study||10
59336|NCT01606254|140488|P1|COMPLETED|Overall Study||12
59337|NCT01606254|140485|P4|STARTED|Overall Study||14
59338|NCT01606254|140486|P3|STARTED|Overall Study||14
59339|NCT01606254|140487|P2|STARTED|Overall Study||14
59340|NCT01606254|140488|P1|STARTED|Overall Study||14
59341|NCT01606228|140570|P1|NOT COMPLETED|Overall Study||29
59342|NCT01606228|140570|P1|COMPLETED|Overall Study||159
59343|NCT01606228|140570|P1|STARTED|Overall Study||188
59344|NCT01606202|140587|P2|NOT COMPLETED|Overall Study||3
59345|NCT01606202|140588|P1|NOT COMPLETED|Overall Study||7
59346|NCT01606202|140587|P2|COMPLETED|Overall Study||57
59347|NCT01606202|140588|P1|COMPLETED|Overall Study||49
59348|NCT01606202|140587|P2|STARTED|Overall Study||60
59349|NCT01606202|140588|P1|STARTED|Overall Study||56
59350|NCT01606189|140620|P6|NOT COMPLETED|Third Intenvention (14-20 Days)||1
59351|NCT01606189|140621|P5|NOT COMPLETED|Third Intenvention (14-20 Days)||0
59352|NCT01606189|140622|P4|NOT COMPLETED|Third Intenvention (14-20 Days)||0
59353|NCT01606189|140623|P3|NOT COMPLETED|Third Intenvention (14-20 Days)||0
59354|NCT01606189|140624|P2|NOT COMPLETED|Third Intenvention (14-20 Days)||0
59355|NCT01606189|140625|P1|NOT COMPLETED|Third Intenvention (14-20 Days)||0
59356|NCT01606189|140620|P6|COMPLETED|Third Intenvention (14-20 Days)||6
59357|NCT01606189|140621|P5|COMPLETED|Third Intenvention (14-20 Days)||8
59358|NCT01606189|140622|P4|COMPLETED|Third Intenvention (14-20 Days)||8
59359|NCT01606189|140623|P3|COMPLETED|Third Intenvention (14-20 Days)||8
59360|NCT01606189|140624|P2|COMPLETED|Third Intenvention (14-20 Days)||8
59361|NCT01606189|140625|P1|COMPLETED|Third Intenvention (14-20 Days)||8
59362|NCT01606189|140620|P6|STARTED|Third Intenvention (14-20 Days)||7
59363|NCT01606189|140621|P5|STARTED|Third Intenvention (14-20 Days)||8
59364|NCT01606189|140622|P4|STARTED|Third Intenvention (14-20 Days)||8
59365|NCT01606189|140623|P3|STARTED|Third Intenvention (14-20 Days)||8
59366|NCT01606189|140624|P2|STARTED|Third Intenvention (14-20 Days)||8
59367|NCT01606189|140625|P1|STARTED|Third Intenvention (14-20 Days)||8
59368|NCT01606189|140620|P6|NOT COMPLETED|Second Intenvention (14-20 Days)||1
59369|NCT01606189|140621|P5|NOT COMPLETED|Second Intenvention (14-20 Days)||0
59370|NCT01606189|140622|P4|NOT COMPLETED|Second Intenvention (14-20 Days)||0
59371|NCT01606189|140623|P3|NOT COMPLETED|Second Intenvention (14-20 Days)||0
59372|NCT01606189|140624|P2|NOT COMPLETED|Second Intenvention (14-20 Days)||0
59373|NCT01606189|140625|P1|NOT COMPLETED|Second Intenvention (14-20 Days)||0
59374|NCT01606189|140620|P6|COMPLETED|Second Intenvention (14-20 Days)||7
59375|NCT01606189|140621|P5|COMPLETED|Second Intenvention (14-20 Days)||8
59376|NCT01606189|140622|P4|COMPLETED|Second Intenvention (14-20 Days)||8
59377|NCT01606189|140623|P3|COMPLETED|Second Intenvention (14-20 Days)||8
59378|NCT01606189|140624|P2|COMPLETED|Second Intenvention (14-20 Days)||8
59379|NCT01606189|140625|P1|COMPLETED|Second Intenvention (14-20 Days)||8
59380|NCT01606189|140620|P6|STARTED|Second Intenvention (14-20 Days)||8
59381|NCT01606189|140621|P5|STARTED|Second Intenvention (14-20 Days)||8
59382|NCT01606189|140622|P4|STARTED|Second Intenvention (14-20 Days)||8
59383|NCT01606189|140623|P3|STARTED|Second Intenvention (14-20 Days)||8
59384|NCT01606189|140624|P2|STARTED|Second Intenvention (14-20 Days)||8
59385|NCT01606189|140625|P1|STARTED|Second Intenvention (14-20 Days)||8
59386|NCT01606189|140620|P6|NOT COMPLETED|First Intenvention (14-20 Days)||0
59387|NCT01606189|140621|P5|NOT COMPLETED|First Intenvention (14-20 Days)||0
59388|NCT01606189|140622|P4|NOT COMPLETED|First Intenvention (14-20 Days)||0
59389|NCT01606189|140623|P3|NOT COMPLETED|First Intenvention (14-20 Days)||0
59390|NCT01606189|140624|P2|NOT COMPLETED|First Intenvention (14-20 Days)||0
59391|NCT01606189|140625|P1|NOT COMPLETED|First Intenvention (14-20 Days)||0
59392|NCT01606189|140620|P6|COMPLETED|First Intenvention (14-20 Days)||8
59393|NCT01606189|140621|P5|COMPLETED|First Intenvention (14-20 Days)||8
59394|NCT01606189|140622|P4|COMPLETED|First Intenvention (14-20 Days)||8
59395|NCT01606189|140623|P3|COMPLETED|First Intenvention (14-20 Days)||8
59396|NCT01606189|140624|P2|COMPLETED|First Intenvention (14-20 Days)||8
59397|NCT01606189|140625|P1|COMPLETED|First Intenvention (14-20 Days)||8
59398|NCT01606189|140620|P6|STARTED|First Intenvention (14-20 Days)||8
59399|NCT01606189|140621|P5|STARTED|First Intenvention (14-20 Days)||8
59400|NCT01606189|140622|P4|STARTED|First Intenvention (14-20 Days)||8
59401|NCT01606189|140623|P3|STARTED|First Intenvention (14-20 Days)||8
59402|NCT01606189|140624|P2|STARTED|First Intenvention (14-20 Days)||8
59403|NCT01606189|140625|P1|STARTED|First Intenvention (14-20 Days)||8
59404|NCT01606176|140659|P2|NOT COMPLETED|Overall Study||3
59405|NCT01606176|140660|P1|NOT COMPLETED|Overall Study||4
59406|NCT01606176|140659|P2|COMPLETED|Overall Study||31
59407|NCT01606176|140660|P1|COMPLETED|Overall Study||32
59408|NCT01606176|140659|P2|STARTED|Overall Study||34
59409|NCT01606176|140660|P1|STARTED|Overall Study||36
59410|NCT01606150|140696|P2|NOT COMPLETED|Overall Study||0
59411|NCT01606150|140697|P1|NOT COMPLETED|Overall Study||0
59412|NCT01606150|140696|P2|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
59413|NCT01606150|140697|P1|COMPLETED|Overall Study|Enrollment was only for two months in 2012 due to technical and enrollment problems|0
59414|NCT01606150|140696|P2|STARTED|Overall Study||0
59415|NCT01606150|140697|P1|STARTED|Overall Study||0
59416|NCT01606137|140705|P1|NOT COMPLETED|Overall Study||262
59417|NCT01606137|140705|P1|COMPLETED|Overall Study||245
59418|NCT01606137|140705|P1|STARTED|Overall Study||507
59419|NCT01606007|140728|P3|NOT COMPLETED|Overall Study||10
59420|NCT01606007|140729|P2|NOT COMPLETED|Overall Study||19
59421|NCT01606007|140730|P1|NOT COMPLETED|Overall Study||15
59422|NCT01606007|140728|P3|COMPLETED|Overall Study||169
59423|NCT01606007|140729|P2|COMPLETED|Overall Study||160
59424|NCT01606007|140730|P1|COMPLETED|Overall Study||161
59425|NCT01606007|140728|P3|STARTED|Overall Study||179
59426|NCT01606007|140729|P2|STARTED|Overall Study||179
59427|NCT01606007|140730|P1|STARTED|Overall Study||176
59428|NCT01605942|140752|P2|NOT COMPLETED|Overall Study||0
59429|NCT01605942|140753|P1|NOT COMPLETED|Overall Study||0
59430|NCT01605942|140752|P2|COMPLETED|Overall Study||2
59431|NCT01605942|140753|P1|COMPLETED|Overall Study||6
59432|NCT01605942|140752|P2|STARTED|Overall Study||2
59433|NCT01605942|140753|P1|STARTED|Overall Study||6
59434|NCT01605916|140765|P5|NOT COMPLETED|Overall Study||6
59435|NCT01605916|140766|P4|NOT COMPLETED|Overall Study||6
59436|NCT01605916|140767|P3|NOT COMPLETED|Overall Study||3
59437|NCT01605916|140768|P2|NOT COMPLETED|Overall Study||4
59438|NCT01605916|140769|P1|NOT COMPLETED|Overall Study||4
59439|NCT01605916|140765|P5|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
59440|NCT01605916|140766|P4|COMPLETED|Overall Study||0
59441|NCT01605916|140767|P3|COMPLETED|Overall Study|Subject ongoing the study at data cut off|1
59442|NCT01605916|140768|P2|COMPLETED|Overall Study||0
59443|NCT01605916|140769|P1|COMPLETED|Overall Study||0
59444|NCT01605916|140765|P5|STARTED|Overall Study||7
59445|NCT01605916|140766|P4|STARTED|Overall Study||6
59446|NCT01605916|140767|P3|STARTED|Overall Study||4
59447|NCT01605916|140768|P2|STARTED|Overall Study||4
59448|NCT01605916|140769|P1|STARTED|Overall Study||4
59449|NCT01605877|140842|P1|NOT COMPLETED|Overall Study||1
59450|NCT01605877|140842|P1|COMPLETED|Overall Study||63
59451|NCT01605877|140842|P1|STARTED|Overall Study||64
59452|NCT01605825|140906|P2|NOT COMPLETED|Overall Study||3
59453|NCT01605825|140907|P1|NOT COMPLETED|Overall Study||10
59454|NCT01605825|140906|P2|COMPLETED|Overall Study||25
59455|NCT01605825|140907|P1|COMPLETED|Overall Study||45
59456|NCT01605825|140906|P2|STARTED|Overall Study||28
59457|NCT01605825|140907|P1|STARTED|Overall Study||55
59458|NCT01605799|140915|P2|NOT COMPLETED|Overall Study||1
59459|NCT01605799|140916|P1|NOT COMPLETED|Overall Study||2
59460|NCT01605799|140915|P2|COMPLETED|Overall Study||15
59461|NCT01605799|140916|P1|COMPLETED|Overall Study||15
59462|NCT01605799|140915|P2|STARTED|Overall Study||16
59463|NCT01605799|140916|P1|STARTED|Overall Study||17
59464|NCT01605669|140924|P1|NOT COMPLETED|Overall Study||0
59465|NCT01605669|140924|P1|COMPLETED|Overall Study||50
59466|NCT01605669|140924|P1|STARTED|Overall Study||50
59467|NCT01605617|140931|P2|NOT COMPLETED|Second Intervention||0
59468|NCT01605617|140932|P1|NOT COMPLETED|Second Intervention||0
59469|NCT01605617|140931|P2|COMPLETED|Second Intervention||0
59470|NCT01605617|140932|P1|COMPLETED|Second Intervention||0
59471|NCT01605617|140931|P2|STARTED|Second Intervention||0
59472|NCT01605617|140932|P1|STARTED|Second Intervention||0
59473|NCT01605617|140931|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
59474|NCT01605617|140932|P1|NOT COMPLETED|Washout Period of 4 Weeks||2
59475|NCT01605617|140931|P2|COMPLETED|Washout Period of 4 Weeks||0
59476|NCT01605617|140932|P1|COMPLETED|Washout Period of 4 Weeks||0
59477|NCT01605617|140931|P2|STARTED|Washout Period of 4 Weeks||1
59478|NCT01605617|140932|P1|STARTED|Washout Period of 4 Weeks||2
59479|NCT01605617|140931|P2|NOT COMPLETED|First Intervention||1
59480|NCT01605617|140932|P1|NOT COMPLETED|First Intervention||0
59481|NCT01605617|140931|P2|COMPLETED|First Intervention||1
59482|NCT01605617|140932|P1|COMPLETED|First Intervention||2
59483|NCT01605617|140931|P2|STARTED|First Intervention||2
59484|NCT01605617|140932|P1|STARTED|First Intervention||2
59485|NCT01605552|140952|P2|NOT COMPLETED|Overall Study||2
59486|NCT01605552|140953|P1|NOT COMPLETED|Overall Study||6
59487|NCT01605552|140952|P2|COMPLETED|Overall Study||14
59488|NCT01605552|140953|P1|COMPLETED|Overall Study|4 dropped out before the first BtB visit; it is unlikely that the treatment was the cause of dropout|7
59489|NCT01605552|140952|P2|STARTED|Overall Study||16
59490|NCT01605552|140953|P1|STARTED|Overall Study||13
59491|NCT01605539|140967|P3|NOT COMPLETED|Overall Study||0
59492|NCT01605539|140968|P2|NOT COMPLETED|Overall Study||1
59493|NCT01605539|140969|P1|NOT COMPLETED|Overall Study||0
59494|NCT01605539|140967|P3|COMPLETED|Overall Study||4
59495|NCT01605539|140968|P2|COMPLETED|Overall Study||2
59496|NCT01605539|140969|P1|COMPLETED|Overall Study||3
59497|NCT01605539|140967|P3|STARTED|Overall Study||4
59498|NCT01605539|140968|P2|STARTED|Overall Study||3
59499|NCT01605539|140969|P1|STARTED|Overall Study||3
59500|NCT01605461|140991|P1|NOT COMPLETED|Overall Study||4
59501|NCT01605461|140991|P1|COMPLETED|Overall Study||8
59502|NCT01605461|140991|P1|STARTED|Overall Study||12
59503|NCT01605370|141002|P2|NOT COMPLETED|Overall Study||0
59504|NCT01605370|141003|P1|NOT COMPLETED|Overall Study||1
59505|NCT01605370|141002|P2|COMPLETED|Overall Study||0
59506|NCT01605370|141003|P1|COMPLETED|Overall Study||0
59507|NCT01605370|141002|P2|STARTED|Overall Study||0
59508|NCT01605370|141003|P1|STARTED|Overall Study||1
59509|NCT01605292|141011|P2|NOT COMPLETED|Overall Study||0
59510|NCT01605292|141012|P1|NOT COMPLETED|Overall Study||0
59511|NCT01605292|141011|P2|COMPLETED|Overall Study||347
59512|NCT01605292|141012|P1|COMPLETED|Overall Study||351
59513|NCT01605292|141011|P2|STARTED|Overall Study||347
59514|NCT01605292|141012|P1|STARTED|Overall Study||351
59515|NCT01604941|141038|P6|NOT COMPLETED|Overall Study||7
59516|NCT01604941|141039|P5|NOT COMPLETED|Overall Study||1
59517|NCT01604941|141040|P4|NOT COMPLETED|Overall Study||3
59518|NCT01604941|141041|P3|NOT COMPLETED|Overall Study||3
59519|NCT01604941|141042|P2|NOT COMPLETED|Overall Study||4
59520|NCT01604941|141043|P1|NOT COMPLETED|Overall Study||11
59521|NCT01604941|141038|P6|COMPLETED|Overall Study||0
59522|NCT01604941|141039|P5|COMPLETED|Overall Study||3
59523|NCT01604941|141040|P4|COMPLETED|Overall Study||0
59524|NCT01604941|141041|P3|COMPLETED|Overall Study||0
59525|NCT01604941|141042|P2|COMPLETED|Overall Study||0
59526|NCT01604941|141043|P1|COMPLETED|Overall Study||0
59527|NCT01604941|141038|P6|STARTED|Overall Study||7
59528|NCT01604941|141039|P5|STARTED|Overall Study||4
59529|NCT01604941|141040|P4|STARTED|Overall Study||3
59530|NCT01604941|141041|P3|STARTED|Overall Study||3
59531|NCT01604941|141042|P2|STARTED|Overall Study||4
59532|NCT01604941|141043|P1|STARTED|Overall Study||11
59533|NCT01604850|141071|P2|NOT COMPLETED|Overall Study||30
59534|NCT01604850|141072|P1|NOT COMPLETED|Overall Study||52
59535|NCT01604850|141071|P2|COMPLETED|Overall Study||69
59536|NCT01604850|141072|P1|COMPLETED|Overall Study||51
59537|NCT01604850|141071|P2|Enrolled and Treated|Overall Study||98
59538|NCT01604850|141072|P1|Enrolled and Treated|Overall Study||103
59539|NCT01604850|141071|P2|STARTED|Overall Study||99
59540|NCT01604850|141072|P1|STARTED|Overall Study||103
59541|NCT01604772|141088|P1|NOT COMPLETED|Overall Study||0
59542|NCT01604772|141088|P1|COMPLETED|Overall Study||16
59543|NCT01604772|141088|P1|STARTED|Overall Study||16
59544|NCT01604278|141096|P2|NOT COMPLETED|Overall Study||13
59545|NCT01604278|141097|P1|NOT COMPLETED|Overall Study||14
59546|NCT01604278|141096|P2|COMPLETED|Overall Study||210
59547|NCT01604278|141097|P1|COMPLETED|Overall Study||212
59548|NCT01604278|141096|P2|Full Analysis Set|Overall Study|Three randomized participants excluded: 2 who did not receive study drug; 1 with a major deviation.|220
59549|NCT01604278|141097|P1|Full Analysis Set|Overall Study||226
59550|NCT01604278|141096|P2|Safety Set|Overall Study|Two randomized participants who did not receive study drug were excluded from this set.|221
59551|NCT01604278|141097|P1|Safety Set|Overall Study||226
59552|NCT01604278|141096|P2|STARTED|Overall Study||223
59553|NCT01604278|141097|P1|STARTED|Overall Study||226
59554|NCT01604265|141123|P2|NOT COMPLETED|Overall Study||0
59555|NCT01604265|141124|P1|NOT COMPLETED|Overall Study||2
59556|NCT01604265|141123|P2|COMPLETED|Overall Study||32
59557|NCT01604265|141124|P1|COMPLETED|Overall Study||32
59558|NCT01604265|141123|P2|STARTED|Overall Study||32
59559|NCT01604265|141124|P1|STARTED|Overall Study||34
59560|NCT01604122|141160|P2|NOT COMPLETED|Overall Study||0
59561|NCT01604122|141161|P1|NOT COMPLETED|Overall Study||0
59562|NCT01604122|141160|P2|COMPLETED|Overall Study||32
59563|NCT01604122|141161|P1|COMPLETED|Overall Study||60
59564|NCT01604122|141160|P2|STARTED|Overall Study||32
59565|NCT01604122|141161|P1|STARTED|Overall Study||60
59566|NCT01604109|141208|P2|NOT COMPLETED|Overall Study||34
59567|NCT01604109|141209|P1|NOT COMPLETED|Overall Study||33
59568|NCT01604109|141208|P2|COMPLETED|Overall Study||112
59569|NCT01604109|141209|P1|COMPLETED|Overall Study||117
59570|NCT01604109|141208|P2|STARTED|Overall Study||146
59571|NCT01604109|141209|P1|STARTED|Overall Study||150
59572|NCT01603940|141217|P2|NOT COMPLETED|Overall Study||0
59573|NCT01603940|141218|P1|NOT COMPLETED|Overall Study||0
59574|NCT01603940|141217|P2|COMPLETED|Overall Study||14
59575|NCT01603940|141218|P1|COMPLETED|Overall Study||16
59576|NCT01603940|141217|P2|STARTED|Overall Study||14
59577|NCT01603940|141218|P1|STARTED|Overall Study||16
59578|NCT01603875|141235|P3|NOT COMPLETED|Overall Study||9
59579|NCT01603875|141236|P2|NOT COMPLETED|Overall Study||8
59580|NCT01603875|141237|P1|NOT COMPLETED|Overall Study||7
59581|NCT01603875|141235|P3|COMPLETED|Overall Study||26
59582|NCT01603875|141236|P2|COMPLETED|Overall Study||27
59583|NCT01603875|141237|P1|COMPLETED|Overall Study||28
59584|NCT01603875|141235|P3|STARTED|Overall Study||35
59585|NCT01603875|141236|P2|STARTED|Overall Study||35
59586|NCT01603875|141237|P1|STARTED|Overall Study||35
59587|NCT01603459|141257|P1|NOT COMPLETED|Overall Study||18
59588|NCT01603459|141257|P1|COMPLETED|Overall Study||137
59589|NCT01603459|141257|P1|STARTED|Overall Study||155
59590|NCT01603420|141379|P2|NOT COMPLETED|Overall Study||0
59591|NCT01603420|141380|P1|NOT COMPLETED|Overall Study||0
59592|NCT01603420|141379|P2|COMPLETED|Overall Study||1
59593|NCT01603420|141380|P1|COMPLETED|Overall Study||1
59594|NCT01603420|141379|P2|STARTED|Overall Study||1
59595|NCT01603420|141380|P1|STARTED|Overall Study||1
59596|NCT01603394|141408|P1|NOT COMPLETED|Overall Study||1
59597|NCT01603394|141408|P1|COMPLETED|Overall Study||8
59598|NCT01603394|141408|P1|STARTED|Overall Study||9
59599|NCT01603277|141425|P2|NOT COMPLETED|Overall Study||18
59600|NCT01603277|141426|P1|NOT COMPLETED|Overall Study||14
59601|NCT01603277|141425|P2|COMPLETED|Overall Study||64
59602|NCT01603277|141426|P1|COMPLETED|Overall Study||64
59603|NCT01603277|141425|P2|STARTED|Overall Study||82
59604|NCT01603277|141426|P1|STARTED|Overall Study||78
59605|NCT01603121|141432|P2|NOT COMPLETED|Second Intervention, 10 Hours||0
59606|NCT01603121|141433|P1|NOT COMPLETED|Second Intervention, 10 Hours||1
59607|NCT01603121|141432|P2|COMPLETED|Second Intervention, 10 Hours||0
59608|NCT01603121|141433|P1|COMPLETED|Second Intervention, 10 Hours||0
59609|NCT01603121|141432|P2|STARTED|Second Intervention, 10 Hours||0
59610|NCT01603121|141433|P1|STARTED|Second Intervention, 10 Hours||1
59611|NCT01603121|141432|P2|NOT COMPLETED|First Intervention, 10 Hours||0
59612|NCT01603121|141433|P1|NOT COMPLETED|First Intervention, 10 Hours||0
59613|NCT01603121|141432|P2|COMPLETED|First Intervention, 10 Hours||0
59614|NCT01603121|141433|P1|COMPLETED|First Intervention, 10 Hours||1
59615|NCT01603121|141432|P2|STARTED|First Intervention, 10 Hours||0
59616|NCT01603121|141433|P1|STARTED|First Intervention, 10 Hours||1
59617|NCT01603082|141445|P2|NOT COMPLETED|Overall Study||1
59618|NCT01603082|141446|P1|NOT COMPLETED|Overall Study||2
59619|NCT01603082|141445|P2|COMPLETED|Overall Study|Completed the study|48
59620|NCT01603082|141446|P1|COMPLETED|Overall Study|Completed the study.|49
59621|NCT01603082|141445|P2|STARTED|Overall Study|Randomized|49
59622|NCT01603082|141446|P1|STARTED|Overall Study|Randomized|51
59623|NCT01603056|141456|P2|NOT COMPLETED|Overall Study||14
59624|NCT01603056|141457|P1|NOT COMPLETED|Overall Study||34
59625|NCT01603056|141456|P2|COMPLETED|Overall Study||190
59626|NCT01603056|141457|P1|COMPLETED|Overall Study||379
59627|NCT01603056|141456|P2|STARTED|Overall Study||204
59628|NCT01603056|141457|P1|STARTED|Overall Study||413
59629|NCT01603043|141487|P2|NOT COMPLETED|Overall Study||3
59630|NCT01603043|141488|P1|NOT COMPLETED|Overall Study||7
59631|NCT01603043|141487|P2|COMPLETED|Overall Study||0
59632|NCT01603043|141488|P1|COMPLETED|Overall Study||0
59633|NCT01603043|141487|P2|STARTED|Overall Study||3
59634|NCT01603043|141488|P1|STARTED|Overall Study||7
59635|NCT01602965|141500|P2|NOT COMPLETED|Overall Study||2
59636|NCT01602965|141501|P1|NOT COMPLETED|Overall Study||4
59637|NCT01602965|141500|P2|COMPLETED|Overall Study||18
59638|NCT01602965|141501|P1|COMPLETED|Overall Study||16
59639|NCT01602965|141500|P2|STARTED|Overall Study||20
59640|NCT01602965|141501|P1|STARTED|Overall Study||20
59641|NCT01602744|141509|P2|NOT COMPLETED|Overall Study||23
59642|NCT01602744|141510|P1|NOT COMPLETED|Overall Study||30
59643|NCT01602744|141509|P2|COMPLETED|Overall Study||160
59644|NCT01602744|141510|P1|COMPLETED|Overall Study||146
59645|NCT01602744|141509|P2|STARTED|Overall Study||183
59646|NCT01602744|141510|P1|STARTED|Overall Study||176
59647|NCT01602731|141526|P1|NOT COMPLETED|Overall Study||30
59648|NCT01602731|141526|P1|COMPLETED|Overall Study||15
59649|NCT01602731|141526|P1|Poor Medication Adherence|Overall Study|24 out of 35 patients who completed 1-month pill counts had medication adherence <88%.|24
59650|NCT01602731|141526|P1|Cognitive Impairment|Overall Study|After repeat cognitive testing, additional 1 patient had no cognitive impairment and did not proceed|44
59651|NCT01602731|141526|P1|STARTED|Overall Study||45
59652|NCT01602562|141534|P2|NOT COMPLETED|Overall Study||3
59653|NCT01602562|141535|P1|NOT COMPLETED|Overall Study||5
59654|NCT01602562|141534|P2|COMPLETED|Overall Study||16
59655|NCT01602562|141535|P1|COMPLETED|Overall Study||16
59656|NCT01602562|141534|P2|STARTED|Overall Study||19
59657|NCT01602562|141535|P1|STARTED|Overall Study||21
59658|NCT01602549|141571|P2|NOT COMPLETED|Overall Study||1
59659|NCT01602549|141572|P1|NOT COMPLETED|Overall Study||1
59660|NCT01602549|141571|P2|COMPLETED|Overall Study||37
59661|NCT01602549|141572|P1|COMPLETED|Overall Study||18
59662|NCT01602549|141571|P2|STARTED|Overall Study||38
59663|NCT01602549|141572|P1|STARTED|Overall Study||19
59664|NCT01602510|141651|P3|NOT COMPLETED|Randomized Phase||73
59665|NCT01602510|141652|P2|NOT COMPLETED|Randomized Phase||74
59666|NCT01602510|141653|P1|NOT COMPLETED|Randomized Phase||0
59667|NCT01602510|141651|P3|COMPLETED|Randomized Phase||58
59668|NCT01602510|141652|P2|COMPLETED|Randomized Phase||59
59669|NCT01602510|141653|P1|COMPLETED|Randomized Phase||0
59670|NCT01602510|141651|P3|STARTED|Randomized Phase||131
59671|NCT01602510|141652|P2|STARTED|Randomized Phase||133
59672|NCT01602510|141653|P1|STARTED|Randomized Phase||0
59673|NCT01602510|141651|P3|NOT COMPLETED|Open Label Phase||0
59674|NCT01602510|141652|P2|NOT COMPLETED|Open Label Phase||0
59675|NCT01602510|141653|P1|NOT COMPLETED|Open Label Phase||303
59676|NCT01602510|141651|P3|COMPLETED|Open Label Phase||0
59677|NCT01602510|141652|P2|COMPLETED|Open Label Phase||0
59678|NCT01602510|141653|P1|COMPLETED|Open Label Phase||117
59679|NCT01602510|141651|P3|STARTED|Open Label Phase||0
59680|NCT01602510|141652|P2|STARTED|Open Label Phase||0
59681|NCT01602510|141653|P1|STARTED|Open Label Phase||420
59682|NCT01602484|141679|P2|NOT COMPLETED|Overall Study||1
59683|NCT01602484|141680|P1|NOT COMPLETED|Overall Study||0
59684|NCT01602484|141679|P2|COMPLETED|Overall Study||24
59685|NCT01602484|141680|P1|COMPLETED|Overall Study||25
59686|NCT01602484|141679|P2|STARTED|Overall Study||25
59687|NCT01602484|141680|P1|STARTED|Overall Study||25
59688|NCT01602471|141692|P1|NOT COMPLETED|Overall Study||0
59689|NCT01602471|141692|P1|COMPLETED|Overall Study||4
59690|NCT01602471|141692|P1|STARTED|Overall Study||4
59691|NCT01602380|141698|P2|NOT COMPLETED|Overall Study||101
59692|NCT01602380|141699|P1|NOT COMPLETED|Overall Study||93
59693|NCT01602380|141698|P2|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|131
59694|NCT01602380|141699|P1|COMPLETED|Overall Study|Completed: number of patients ongoing in the study at data cut-off for the primary analysis|137
59695|NCT01602380|141698|P2|STARTED|Overall Study||232
59696|NCT01602380|141699|P1|STARTED|Overall Study||230
59697|NCT01602341|141723|P2|NOT COMPLETED|Overall Study||1
59698|NCT01602341|141724|P1|NOT COMPLETED|Overall Study||0
59699|NCT01602341|141723|P2|COMPLETED|Overall Study||41
59700|NCT01602341|141724|P1|COMPLETED|Overall Study||44
59701|NCT01602341|141723|P2|STARTED|Overall Study||42
59702|NCT01602341|141724|P1|STARTED|Overall Study||44
59703|NCT01602198|141760|P2|NOT COMPLETED|Overall Study||0
59704|NCT01602198|141761|P1|NOT COMPLETED|Overall Study||0
59705|NCT01602198|141760|P2|COMPLETED|Overall Study||1
59706|NCT01602198|141761|P1|COMPLETED|Overall Study||0
59707|NCT01602198|141760|P2|STARTED|Overall Study||1
59708|NCT01602198|141761|P1|STARTED|Overall Study||0
59709|NCT01602016|141767|P1|NOT COMPLETED|Overall Study||0
59710|NCT01602016|141767|P1|COMPLETED|Overall Study||0
59711|NCT01602016|141767|P1|STARTED|Overall Study||0
59712|NCT01601977|141771|P1|NOT COMPLETED|Overall Study||0
59713|NCT01601977|141771|P1|COMPLETED|Overall Study||10
59714|NCT01601977|141771|P1|STARTED|Overall Study|5 patients consented for study participation but did not attend for study assessments.|10
59715|NCT01601821|141791|P2|NOT COMPLETED|Overall Study||29
59716|NCT01601821|141792|P1|NOT COMPLETED|Overall Study||29
59717|NCT01601821|141791|P2|COMPLETED|Overall Study||91
59718|NCT01601821|141792|P1|COMPLETED|Overall Study||96
59719|NCT01601821|141791|P2|STARTED|Overall Study||120
59720|NCT01601821|141792|P1|STARTED|Overall Study||125
59721|NCT01601782|141822|P1|NOT COMPLETED|Overall Study||0
59722|NCT01601782|141822|P1|COMPLETED|Overall Study||16
59723|NCT01601782|141822|P1|STARTED|Overall Study||16
59724|NCT01601704|141828|P2|NOT COMPLETED|Overall Study||4
59725|NCT01601704|141829|P1|NOT COMPLETED|Overall Study||1
59726|NCT01601704|141828|P2|COMPLETED|Overall Study||4450
59727|NCT01601704|141829|P1|COMPLETED|Overall Study||4455
59728|NCT01601704|141828|P2|Treated|Overall Study||4450
59729|NCT01601704|141829|P1|Treated|Overall Study||4455
59730|NCT01601704|141828|P2|STARTED|Overall Study||4454
59731|NCT01601704|141829|P1|STARTED|Overall Study||4456
59732|NCT01601691|141843|P1|NOT COMPLETED|Overall Study||0
59733|NCT01601691|141843|P1|COMPLETED|Overall Study||10
59734|NCT01601691|141843|P1|STARTED|Overall Study||10
59735|NCT01601470|141847|P1|NOT COMPLETED|Period 3 - LCZ696+Sildenafil||0
59736|NCT01601470|141847|P1|COMPLETED|Period 3 - LCZ696+Sildenafil||27
59737|NCT01601470|141847|P1|Safety Set|Period 3 - LCZ696+Sildenafil||27
59738|NCT01601470|141847|P1|PK Analysis Set|Period 3 - LCZ696+Sildenafil||27
59739|NCT01601470|141847|P1|STARTED|Period 3 - LCZ696+Sildenafil||27
59740|NCT01601470|141847|P1|NOT COMPLETED|Period 2 - LCZ696||1
59741|NCT01601470|141847|P1|COMPLETED|Period 2 - LCZ696||27
59742|NCT01601470|141847|P1|Safety Set|Period 2 - LCZ696||27
59743|NCT01601470|141847|P1|PK Analysis Set|Period 2 - LCZ696||27
59744|NCT01601470|141847|P1|STARTED|Period 2 - LCZ696||28
59745|NCT01601470|141847|P1|NOT COMPLETED|Period 1 - Sildenafil||0
59746|NCT01601470|141847|P1|COMPLETED|Period 1 - Sildenafil||28
59747|NCT01601470|141847|P1|Safety Set|Period 1 - Sildenafil||28
59748|NCT01601470|141847|P1|PK Analysis Set|Period 1 - Sildenafil||28
59749|NCT01601470|141847|P1|STARTED|Period 1 - Sildenafil||28
59750|NCT01601236|141868|P6|NOT COMPLETED|Overall Study||1
59751|NCT01601236|141869|P5|NOT COMPLETED|Overall Study||3
59752|NCT01601236|141870|P4|NOT COMPLETED|Overall Study||2
59753|NCT01601236|141871|P3|NOT COMPLETED|Overall Study||6
59754|NCT01601236|141872|P2|NOT COMPLETED|Overall Study||1
59755|NCT01601236|141873|P1|NOT COMPLETED|Overall Study||5
59756|NCT01601236|141868|P6|COMPLETED|Overall Study||0
59757|NCT01601236|141869|P5|COMPLETED|Overall Study||0
59758|NCT01601236|141870|P4|COMPLETED|Overall Study||4
59759|NCT01601236|141871|P3|COMPLETED|Overall Study||8
59760|NCT01601236|141872|P2|COMPLETED|Overall Study||2
59761|NCT01601236|141873|P1|COMPLETED|Overall Study||2
59762|NCT01601236|141868|P6|STARTED|Overall Study||1
59763|NCT01601236|141869|P5|STARTED|Overall Study||3
59764|NCT01601236|141870|P4|STARTED|Overall Study||6
59765|NCT01601236|141871|P3|STARTED|Overall Study||14
59766|NCT01601236|141872|P2|STARTED|Overall Study||3
59767|NCT01601236|141873|P1|STARTED|Overall Study||7
59768|NCT01601132|141909|P1|NOT COMPLETED|Overall Study||2
59769|NCT01601132|141909|P1|COMPLETED|Overall Study||28
59770|NCT01601132|141909|P1|STARTED|Overall Study||30
59771|NCT01600950|141926|P2|NOT COMPLETED|Period 2||0
59772|NCT01600950|141927|P1|NOT COMPLETED|Period 2||0
59773|NCT01600950|141926|P2|COMPLETED|Period 2||10
59774|NCT01600950|141927|P1|COMPLETED|Period 2||10
59775|NCT01600950|141926|P2|STARTED|Period 2||10
59776|NCT01600950|141927|P1|STARTED|Period 2||10
59777|NCT01600950|141926|P2|NOT COMPLETED|Period 1||0
59778|NCT01600950|141927|P1|NOT COMPLETED|Period 1||0
59779|NCT01600950|141926|P2|COMPLETED|Period 1||10
59780|NCT01600950|141927|P1|COMPLETED|Period 1||10
59781|NCT01600950|141926|P2|STARTED|Period 1||10
59782|NCT01600950|141927|P1|STARTED|Period 1||10
59783|NCT01600885|141943|P2|NOT COMPLETED|Second Period||0
59784|NCT01600885|141944|P1|NOT COMPLETED|Second Period||0
59785|NCT01600885|141943|P2|COMPLETED|Second Period||8
59786|NCT01600885|141944|P1|COMPLETED|Second Period||8
59787|NCT01600885|141943|P2|STARTED|Second Period||8
59788|NCT01600885|141944|P1|STARTED|Second Period||8
59789|NCT01600885|141943|P2|NOT COMPLETED|Wash Out Period||0
59790|NCT01600885|141944|P1|NOT COMPLETED|Wash Out Period||0
59791|NCT01600885|141943|P2|COMPLETED|Wash Out Period||8
59792|NCT01600885|141944|P1|COMPLETED|Wash Out Period||8
59793|NCT01600885|141943|P2|STARTED|Wash Out Period||8
59794|NCT01600885|141944|P1|STARTED|Wash Out Period||8
59795|NCT01600885|141943|P2|NOT COMPLETED|First Period||1
59796|NCT01600885|141944|P1|NOT COMPLETED|First Period||2
59797|NCT01600885|141943|P2|COMPLETED|First Period||8
59798|NCT01600885|141944|P1|COMPLETED|First Period||8
59799|NCT01600885|141943|P2|STARTED|First Period||9
59800|NCT01600885|141944|P1|STARTED|First Period||10
59801|NCT01600729|141954|P1|NOT COMPLETED|Overall Study||1
59802|NCT01600729|141954|P1|COMPLETED|Overall Study||65
59803|NCT01600729|141954|P1|STARTED|Overall Study||66
59804|NCT01600716|141961|P2|NOT COMPLETED|Overall Study||7
59805|NCT01600716|141962|P1|NOT COMPLETED|Overall Study||7
59806|NCT01600716|141961|P2|COMPLETED|Overall Study||71
59807|NCT01600716|141962|P1|COMPLETED|Overall Study||59
59808|NCT01600716|141961|P2|STARTED|Overall Study||78
59809|NCT01600716|141962|P1|STARTED|Overall Study||66
59810|NCT01600703|141978|P2|NOT COMPLETED|Second Intervention||0
59811|NCT01600703|141979|P1|NOT COMPLETED|Second Intervention||0
59812|NCT01600703|141978|P2|COMPLETED|Second Intervention||8
59813|NCT01600703|141979|P1|COMPLETED|Second Intervention||7
59814|NCT01600703|141978|P2|STARTED|Second Intervention||8
59815|NCT01600703|141979|P1|STARTED|Second Intervention||7
59816|NCT01600703|141978|P2|NOT COMPLETED|First Intervention||0
59817|NCT01600703|141979|P1|NOT COMPLETED|First Intervention||0
59818|NCT01600703|141978|P2|COMPLETED|First Intervention||8
59819|NCT01600703|141979|P1|COMPLETED|First Intervention||7
59820|NCT01600703|141978|P2|STARTED|First Intervention||8
59821|NCT01600703|141979|P1|STARTED|First Intervention||7
59822|NCT01600677|141989|P2|NOT COMPLETED|Overall Study||0
59823|NCT01600677|141990|P1|NOT COMPLETED|Overall Study||0
59824|NCT01600677|141989|P2|COMPLETED|Overall Study||4
59825|NCT01600677|141990|P1|COMPLETED|Overall Study||7
59826|NCT01600677|141989|P2|STARTED|Overall Study||4
59827|NCT01600677|141990|P1|STARTED|Overall Study||7
59828|NCT01600495|142002|P2|NOT COMPLETED|Overall Study||0
59829|NCT01600495|142003|P1|NOT COMPLETED|Overall Study||0
59830|NCT01600495|142002|P2|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
59831|NCT01600495|142003|P1|COMPLETED|Overall Study|We finished the job with 23 patients for each group (treated and control)|23
59832|NCT01600495|142002|P2|STARTED|Overall Study|We start with the prediction of collecting 20 control patients|23
59833|NCT01600495|142003|P1|STARTED|Overall Study|We start with the prediction of collecting 20 patients in the treated group|23
59834|NCT01600482|142017|P2|NOT COMPLETED|Overall Study||0
59835|NCT01600482|142018|P1|NOT COMPLETED|Overall Study||0
59836|NCT01600482|142017|P2|COMPLETED|Overall Study||59
59922|NCT01599585|142388|P2|NOT COMPLETED|Overall Study||17
59837|NCT01600482|142018|P1|COMPLETED|Overall Study|Last 26 patients allocated to CELT ACD|148
59838|NCT01600482|142017|P2|STARTED|Overall Study|Last 26 patients allocated to CELT ACD|59
59839|NCT01600482|142018|P1|STARTED|Overall Study||148
59840|NCT01600326|142038|P2|NOT COMPLETED|Overall Study||1
59841|NCT01600326|142039|P1|NOT COMPLETED|Overall Study||1
59842|NCT01600326|142038|P2|COMPLETED|Overall Study||14
59843|NCT01600326|142039|P1|COMPLETED|Overall Study||14
59844|NCT01600326|142038|P2|Primary Outcome Measure Data Collection|Overall Study||15
59845|NCT01600326|142039|P1|Primary Outcome Measure Data Collection|Overall Study||15
59846|NCT01600326|142038|P2|STARTED|Overall Study||15
59847|NCT01600326|142039|P1|STARTED|Overall Study||15
59848|NCT01600287|142049|P2|NOT COMPLETED|Overall Study||0
59849|NCT01600287|142050|P1|NOT COMPLETED|Overall Study||0
59850|NCT01600287|142049|P2|COMPLETED|Overall Study||20
59851|NCT01600287|142050|P1|COMPLETED|Overall Study||20
59852|NCT01600287|142049|P2|STARTED|Overall Study||20
59853|NCT01600287|142050|P1|STARTED|Overall Study||20
59854|NCT01600222|142090|P1|NOT COMPLETED|Overall Study||2
59855|NCT01600222|142090|P1|COMPLETED|Overall Study||35
59856|NCT01600222|142090|P1|STARTED|Overall Study||37
59857|NCT01600092|142115|P2|NOT COMPLETED|Overall Study||16
59858|NCT01600092|142116|P1|NOT COMPLETED|Overall Study||18
59859|NCT01600092|142115|P2|COMPLETED|Overall Study||491
59860|NCT01600092|142116|P1|COMPLETED|Overall Study||495
59861|NCT01600092|142115|P2|Received All 3 Vaccinations|Overall Study||494
59862|NCT01600092|142116|P1|Received All 3 Vaccinations|Overall Study||500
59863|NCT01600092|142115|P2|Received at Least 1 Vaccination|Overall Study||504
59864|NCT01600092|142116|P1|Received at Least 1 Vaccination|Overall Study|1 participant received RotaTeq™ existing formulation as their first vaccination|510
59865|NCT01600092|142115|P2|STARTED|Overall Study||507
59866|NCT01600092|142116|P1|STARTED|Overall Study||513
59867|NCT01600053|142130|P1|NOT COMPLETED|Overall Study||11
59868|NCT01600053|142130|P1|COMPLETED|Overall Study||0
59869|NCT01600053|142130|P1|STARTED|Overall Study||11
59870|NCT01600014|142135|P2|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||0
59871|NCT01600014|142136|P1|NOT COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||3
59872|NCT01600014|142135|P2|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||20
59873|NCT01600014|142136|P1|COMPLETED|2. Cycl Recurrent Subgroup W26/44 to W52||39
59874|NCT01600014|142135|P2|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||20
59875|NCT01600014|142136|P1|STARTED|2. Cycl Recurrent Subgroup W26/44 to W52||42
59876|NCT01600014|142135|P2|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||10
59877|NCT01600014|142136|P1|NOT COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||12
59878|NCT01600014|142135|P2|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||39
59879|NCT01600014|142136|P1|COMPLETED|2. Cycle Recalcitrant Subgroup W8 to W52||80
59880|NCT01600014|142135|P2|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||49
59881|NCT01600014|142136|P1|STARTED|2. Cycle Recalcitrant Subgroup W8 to W52||92
59882|NCT01600014|142135|P2|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||0
59883|NCT01600014|142136|P1|NOT COMPLETED|1. Cycle & Observation Period D1 to W52||288
59884|NCT01600014|142135|P2|COMPLETED|1. Cycle & Observation Period D1 to W52||0
59885|NCT01600014|142136|P1|COMPLETED|1. Cycle & Observation Period D1 to W52||162
59886|NCT01600014|142135|P2|STARTED|1. Cycle & Observation Period D1 to W52||0
59887|NCT01600014|142136|P1|STARTED|1. Cycle & Observation Period D1 to W52|Subjects completing W52 without having been administered a 2nd cycle are counted as completers.|450
59888|NCT01599832|142154|P1|NOT COMPLETED|Overall Study||0
59889|NCT01599832|142154|P1|COMPLETED|Overall Study||20
59890|NCT01599832|142154|P1|STARTED|Overall Study||20
59891|NCT01599806|142164|P2|NOT COMPLETED|Overall Study||41
59892|NCT01599806|142165|P1|NOT COMPLETED|Overall Study||43
59893|NCT01599806|142164|P2|COMPLETED|Overall Study||476
59894|NCT01599806|142165|P1|COMPLETED|Overall Study||473
59895|NCT01599806|142164|P2|STARTED|Overall Study||517
59896|NCT01599806|142165|P1|STARTED|Overall Study||516
59897|NCT01599741|142289|P1|NOT COMPLETED|Overall Study||3
59898|NCT01599741|142289|P1|COMPLETED|Overall Study||48
59899|NCT01599741|142289|P1|Collected Dose and Image Information|Overall Study||48
59900|NCT01599741|142289|P1|STARTED|Overall Study||51
59901|NCT01599650|142298|P3|NOT COMPLETED|Overall Study||27
59902|NCT01599650|142299|P2|NOT COMPLETED|Overall Study||26
59903|NCT01599650|142300|P1|NOT COMPLETED|Overall Study||22
59904|NCT01599650|142298|P3|COMPLETED|Overall Study||65
59905|NCT01599650|142299|P2|COMPLETED|Overall Study||154
59906|NCT01599650|142300|P1|COMPLETED|Overall Study||161
59907|NCT01599650|142298|P3|Completed 6 Mos|Overall Study||80
59908|NCT01599650|142299|P2|Completed 6 Mos|Overall Study||170
59909|NCT01599650|142300|P1|Completed 6 Mos|Overall Study||174
59910|NCT01599650|142298|P3|STARTED|Overall Study||92
59911|NCT01599650|142299|P2|STARTED|Overall Study||180
59912|NCT01599650|142300|P1|STARTED|Overall Study||183
59913|NCT01599637|142339|P3|NOT COMPLETED|Overall Study||0
59914|NCT01599637|142340|P2|NOT COMPLETED|Overall Study||2
59915|NCT01599637|142341|P1|NOT COMPLETED|Overall Study||1
59916|NCT01599637|142339|P3|COMPLETED|Overall Study||10
59917|NCT01599637|142340|P2|COMPLETED|Overall Study||8
59918|NCT01599637|142341|P1|COMPLETED|Overall Study||19
59919|NCT01599637|142339|P3|STARTED|Overall Study||10
59920|NCT01599637|142340|P2|STARTED|Overall Study||10
59921|NCT01599637|142341|P1|STARTED|Overall Study|" started indicates randomized safety, pharmacodynamics and pharmocokinetics set"|20
59923|NCT01599585|142389|P1|NOT COMPLETED|Overall Study||22
59924|NCT01599585|142388|P2|COMPLETED|Overall Study||42
59925|NCT01599585|142389|P1|COMPLETED|Overall Study||40
59926|NCT01599585|142388|P2|STARTED|Overall Study||59
59927|NCT01599585|142389|P1|STARTED|Overall Study||62
59928|NCT01599325|142427|P1|NOT COMPLETED|Overall Study||57
59929|NCT01599325|142427|P1|COMPLETED|Overall Study|Participants still on study treatment at time of study closure|15
59930|NCT01599325|142427|P1|Pharmacokinetic (PK) Population|Overall Study|Includes all participants with evaluable azacitidine plasma PK profiles.|12
59931|NCT01599325|142427|P1|Intent to Treat (ITT) Population|Overall Study|Includes all participants who were enrolled into the study|72
59932|NCT01599325|142427|P1|STARTED|Overall Study||72
59933|NCT01599234|142449|P2|NOT COMPLETED|Overall Study||15
59934|NCT01599234|142450|P1|NOT COMPLETED|Overall Study||17
59935|NCT01599234|142449|P2|COMPLETED|Overall Study||155
59936|NCT01599234|142450|P1|COMPLETED|Overall Study||150
59937|NCT01599234|142449|P2|STARTED|Overall Study||170
59938|NCT01599234|142450|P1|STARTED|Overall Study||167
59939|NCT01599104|142475|P3|NOT COMPLETED|Overall Study||26
59940|NCT01599104|142476|P2|NOT COMPLETED|Overall Study||14
59941|NCT01599104|142477|P1|NOT COMPLETED|Overall Study||16
59942|NCT01599104|142475|P3|COMPLETED|Overall Study||363
59943|NCT01599104|142476|P2|COMPLETED|Overall Study||371
59944|NCT01599104|142477|P1|COMPLETED|Overall Study||371
59945|NCT01599104|142475|P3|STARTED|Overall Study||389
59946|NCT01599104|142476|P2|STARTED|Overall Study||385
59947|NCT01599104|142477|P1|STARTED|Overall Study||387
59948|NCT01598987|142515|P1|NOT COMPLETED|Baseline to 24 Month||8
59949|NCT01598987|142515|P1|COMPLETED|Baseline to 24 Month||48
59950|NCT01598987|142515|P1|STARTED|Baseline to 24 Month||56
59951|NCT01598987|142515|P1|NOT COMPLETED|Baseline to Month 12||6
59952|NCT01598987|142515|P1|COMPLETED|Baseline to Month 12||50
59953|NCT01598987|142515|P1|STARTED|Baseline to Month 12||56
59954|NCT01598779|142549|P1|NOT COMPLETED|Overall Study||0
59955|NCT01598779|142549|P1|COMPLETED|Overall Study||150
59956|NCT01598779|142549|P1|STARTED|Overall Study||150
59957|NCT01598740|142555|P2|NOT COMPLETED|Period 2||0
59958|NCT01598740|142556|P1|NOT COMPLETED|Period 2||1
59959|NCT01598740|142555|P2|COMPLETED|Period 2||9
59960|NCT01598740|142556|P1|COMPLETED|Period 2||7
59961|NCT01598740|142555|P2|STARTED|Period 2||9
59962|NCT01598740|142556|P1|STARTED|Period 2|1 subject discontinued during the washout period prior to starting treatment period 2.|8
59963|NCT01598740|142555|P2|NOT COMPLETED|Period 1||0
59964|NCT01598740|142556|P1|NOT COMPLETED|Period 1||0
59965|NCT01598740|142555|P2|COMPLETED|Period 1||9
59966|NCT01598740|142556|P1|COMPLETED|Period 1||9
59967|NCT01598740|142555|P2|STARTED|Period 1||9
59968|NCT01598740|142556|P1|STARTED|Period 1||9
59969|NCT01598610|142564|P1|NOT COMPLETED|Overall Study||1
59970|NCT01598610|142564|P1|COMPLETED|Overall Study||219
59971|NCT01598610|142564|P1|STARTED|Overall Study||220
59972|NCT01598545|142573|P1|NOT COMPLETED|Overall Study||0
59973|NCT01598545|142573|P1|COMPLETED|Overall Study||20
59974|NCT01598545|142573|P1|STARTED|Overall Study||20
59975|NCT01598532|142581|P1|NOT COMPLETED|Overall Study||11
59976|NCT01598532|142581|P1|COMPLETED|Overall Study||11
59977|NCT01598532|142581|P1|STARTED|Overall Study||22
59978|NCT01598506|142590|P1|NOT COMPLETED|Overall Study||2
59979|NCT01598506|142590|P1|COMPLETED|Overall Study||20
59980|NCT01598506|142590|P1|STARTED|Overall Study||22
59981|NCT01598428|142596|P1|NOT COMPLETED|Overall Study||0
59982|NCT01598428|142596|P1|COMPLETED|Overall Study||20
59983|NCT01598428|142596|P1|STARTED|Overall Study||20
59984|NCT01598350|142605|P1|NOT COMPLETED|Overall Study||0
59985|NCT01598350|142605|P1|COMPLETED|Overall Study||6
59986|NCT01598350|142605|P1|STARTED|Overall Study||6
59987|NCT01598207|142611|P2|NOT COMPLETED|Overall Study||0
59988|NCT01598207|142612|P1|NOT COMPLETED|Overall Study||1
59989|NCT01598207|142611|P2|COMPLETED|Overall Study||6
59990|NCT01598207|142612|P1|COMPLETED|Overall Study||6
59991|NCT01598207|142611|P2|STARTED|Overall Study||6
59992|NCT01598207|142612|P1|STARTED|Overall Study||7
59993|NCT01598129|142630|P1|NOT COMPLETED|Overall Study||9
59994|NCT01598129|142630|P1|COMPLETED|Overall Study||3
59995|NCT01598129|142630|P1|STARTED|Overall Study||12
59996|NCT01598064|142641|P2|NOT COMPLETED|Overall Study||0
59997|NCT01598064|142642|P1|NOT COMPLETED|Overall Study||0
59998|NCT01598064|142641|P2|COMPLETED|Overall Study||24
59999|NCT01598064|142642|P1|COMPLETED|Overall Study||25
60000|NCT01598064|142641|P2|STARTED|Overall Study||24
60001|NCT01598064|142642|P1|STARTED|Overall Study||25
60002|NCT01597908|142652|P2|NOT COMPLETED|Overall Study||352
60003|NCT01597908|142653|P1|NOT COMPLETED|Overall Study||352
60004|NCT01597908|142652|P2|COMPLETED|Overall Study||0
60005|NCT01597908|142653|P1|COMPLETED|Overall Study||0
60006|NCT01597908|142652|P2|Ongoing|Overall Study||202
60007|NCT01597908|142653|P1|Ongoing|Overall Study||236
60008|NCT01597908|142652|P2|STARTED|Overall Study||352
60009|NCT01597908|142653|P1|STARTED|Overall Study||352
60010|NCT01597843|142668|P3|NOT COMPLETED|Overall Study||0
60011|NCT01597843|142669|P2|NOT COMPLETED|Overall Study||0
60012|NCT01597843|142670|P1|NOT COMPLETED|Overall Study||0
60013|NCT01597843|142668|P3|COMPLETED|Overall Study||81
60014|NCT01597843|142669|P2|COMPLETED|Overall Study||122
60015|NCT01597843|142670|P1|COMPLETED|Overall Study||79
60016|NCT01597843|142668|P3|Survey 3 Responses|Overall Study||76
60017|NCT01597843|142669|P2|Survey 3 Responses|Overall Study||56
60018|NCT01597843|142670|P1|Survey 3 Responses|Overall Study||65
60019|NCT01597843|142668|P3|Survey 2 Responses|Overall Study||58
60020|NCT01597843|142669|P2|Survey 2 Responses|Overall Study||42
60021|NCT01597843|142670|P1|Survey 2 Responses|Overall Study||52
60022|NCT01597843|142668|P3|Survey 1 Responses|Overall Study||59
60023|NCT01597843|142669|P2|Survey 1 Responses|Overall Study||71
60024|NCT01597843|142670|P1|Survey 1 Responses|Overall Study||45
60025|NCT01597843|142668|P3|STARTED|Overall Study||81
60026|NCT01597843|142669|P2|STARTED|Overall Study||122
60027|NCT01597843|142670|P1|STARTED|Overall Study||79
60028|NCT01597596|142680|P2|NOT COMPLETED|Overall Study||1
60029|NCT01597596|142681|P1|NOT COMPLETED|Overall Study||1
60030|NCT01597596|142680|P2|COMPLETED|Overall Study||2
60031|NCT01597596|142681|P1|COMPLETED|Overall Study||0
60032|NCT01597596|142680|P2|STARTED|Overall Study||3
60033|NCT01597596|142681|P1|STARTED|Overall Study||1
60034|NCT01597492|142695|P2|NOT COMPLETED|Overall Study||4
60035|NCT01597492|142696|P1|NOT COMPLETED|Overall Study||6
60036|NCT01597492|142695|P2|COMPLETED|Overall Study||41
60037|NCT01597492|142696|P1|COMPLETED|Overall Study||28
60038|NCT01597492|142695|P2|STARTED|Overall Study||45
60039|NCT01597492|142696|P1|STARTED|Overall Study||34
60040|NCT01597479|142704|P2|NOT COMPLETED|Overall Study||0
60041|NCT01597479|142705|P1|NOT COMPLETED|Overall Study||2
60042|NCT01597479|142704|P2|COMPLETED|Overall Study||26
60043|NCT01597479|142705|P1|COMPLETED|Overall Study||24
60044|NCT01597479|142704|P2|STARTED|Overall Study||26
60045|NCT01597479|142705|P1|STARTED|Overall Study||26
60046|NCT01597440|142714|P2|NOT COMPLETED|Overall Study||0
60047|NCT01597440|142715|P1|NOT COMPLETED|Overall Study||0
60048|NCT01597440|142714|P2|COMPLETED|Overall Study||0
60049|NCT01597440|142715|P1|COMPLETED|Overall Study||1
60050|NCT01597440|142714|P2|STARTED|Overall Study||0
60051|NCT01597440|142715|P1|STARTED|Overall Study||1
60052|NCT01597245|142727|P13|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||12
60053|NCT01597245|142728|P12|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||19
60054|NCT01597245|142729|P11|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||22
60055|NCT01597245|142730|P10|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||118
60056|NCT01597245|142731|P9|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||20
60057|NCT01597245|142732|P8|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||3
60058|NCT01597245|142733|P7|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||37
60059|NCT01597245|142734|P6|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||89
60060|NCT01597245|142735|P5|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||159
60061|NCT01597245|142736|P4|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60062|NCT01597245|142737|P3|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60063|NCT01597245|142738|P2|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60064|NCT01597245|142739|P1|NOT COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60065|NCT01597245|142727|P13|COMPLETED|Maintenance Period (Week 12 to Week 60)||37
60066|NCT01597245|142728|P12|COMPLETED|Maintenance Period (Week 12 to Week 60)||56
60067|NCT01597245|142729|P11|COMPLETED|Maintenance Period (Week 12 to Week 60)||178
60068|NCT01597245|142730|P10|COMPLETED|Maintenance Period (Week 12 to Week 60)||14
60069|NCT01597245|142731|P9|COMPLETED|Maintenance Period (Week 12 to Week 60)||135
60070|NCT01597245|142732|P8|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60071|NCT01597245|142733|P7|COMPLETED|Maintenance Period (Week 12 to Week 60)||150
60072|NCT01597245|142734|P6|COMPLETED|Maintenance Period (Week 12 to Week 60)||92
60073|NCT01597245|142735|P5|COMPLETED|Maintenance Period (Week 12 to Week 60)||17
60074|NCT01597245|142736|P4|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60075|NCT01597245|142737|P3|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60076|NCT01597245|142738|P2|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60077|NCT01597245|142739|P1|COMPLETED|Maintenance Period (Week 12 to Week 60)||0
60078|NCT01597245|142727|P13|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||49
60079|NCT01597245|142728|P12|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||75
60080|NCT01597245|142729|P11|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||200
60081|NCT01597245|142730|P10|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||132
60082|NCT01597245|142731|P9|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||155
60083|NCT01597245|142732|P8|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||3
60084|NCT01597245|142733|P7|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||187
60085|NCT01597245|142734|P6|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||181
60086|NCT01597245|142735|P5|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||176
60087|NCT01597245|142736|P4|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
60088|NCT01597245|142737|P3|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
60089|NCT01597245|142738|P2|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
60090|NCT01597245|142739|P1|Participants Received One Dose|Maintenance Period (Week 12 to Week 60)||0
60091|NCT01597245|142727|P13|STARTED|Maintenance Period (Week 12 to Week 60)||49
60092|NCT01597245|142728|P12|STARTED|Maintenance Period (Week 12 to Week 60)||75
60093|NCT01597245|142729|P11|STARTED|Maintenance Period (Week 12 to Week 60)||200
60094|NCT01597245|142730|P10|STARTED|Maintenance Period (Week 12 to Week 60)||132
60095|NCT01597245|142731|P9|STARTED|Maintenance Period (Week 12 to Week 60)||155
60096|NCT01597245|142732|P8|STARTED|Maintenance Period (Week 12 to Week 60)||3
60097|NCT01597245|142733|P7|STARTED|Maintenance Period (Week 12 to Week 60)||187
60098|NCT01597245|142734|P6|STARTED|Maintenance Period (Week 12 to Week 60)||181
60099|NCT01597245|142735|P5|STARTED|Maintenance Period (Week 12 to Week 60)||176
60100|NCT01597245|142736|P4|STARTED|Maintenance Period (Week 12 to Week 60)||0
60101|NCT01597245|142737|P3|STARTED|Maintenance Period (Week 12 to Week 60)||0
60102|NCT01597245|142738|P2|STARTED|Maintenance Period (Week 12 to Week 60)||0
60103|NCT01597245|142739|P1|STARTED|Maintenance Period (Week 12 to Week 60)||0
60104|NCT01597245|142727|P13|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60105|NCT01597245|142728|P12|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60106|NCT01597245|142729|P11|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60107|NCT01597245|142730|P10|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60108|NCT01597245|142731|P9|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60109|NCT01597245|142732|P8|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60110|NCT01597245|142733|P7|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60111|NCT01597245|142734|P6|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60112|NCT01597245|142735|P5|NOT COMPLETED|Induction Period (Week 0 - Week 12)||0
60113|NCT01597245|142736|P4|NOT COMPLETED|Induction Period (Week 0 - Week 12)||9
60114|NCT01597245|142737|P3|NOT COMPLETED|Induction Period (Week 0 - Week 12)||19
60115|NCT01597245|142738|P2|NOT COMPLETED|Induction Period (Week 0 - Week 12)||25
60116|NCT01597245|142739|P1|NOT COMPLETED|Induction Period (Week 0 - Week 12)||10
60117|NCT01597245|142727|P13|COMPLETED|Induction Period (Week 0 - Week 12)||0
60118|NCT01597245|142728|P12|COMPLETED|Induction Period (Week 0 - Week 12)||0
60119|NCT01597245|142729|P11|COMPLETED|Induction Period (Week 0 - Week 12)||0
60120|NCT01597245|142730|P10|COMPLETED|Induction Period (Week 0 - Week 12)||0
60121|NCT01597245|142731|P9|COMPLETED|Induction Period (Week 0 - Week 12)||0
60122|NCT01597245|142732|P8|COMPLETED|Induction Period (Week 0 - Week 12)||0
60123|NCT01597245|142733|P7|COMPLETED|Induction Period (Week 0 - Week 12)||0
60124|NCT01597245|142734|P6|COMPLETED|Induction Period (Week 0 - Week 12)||0
60125|NCT01597245|142735|P5|COMPLETED|Induction Period (Week 0 - Week 12)||0
60126|NCT01597245|142736|P4|COMPLETED|Induction Period (Week 0 - Week 12)|2 participants discontinued after IND completion and prior to randomizing into maintenance period.|342
60127|NCT01597245|142737|P3|COMPLETED|Induction Period (Week 0 - Week 12)||328
60128|NCT01597245|142738|P2|COMPLETED|Induction Period (Week 0 - Week 12)|1 participant randomized to maintenance period but did not receive a dose in the maintenance period.|333
60129|NCT01597245|142739|P1|COMPLETED|Induction Period (Week 0 - Week 12)||158
60130|NCT01597245|142727|P13|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60131|NCT01597245|142728|P12|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60132|NCT01597245|142729|P11|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60133|NCT01597245|142730|P10|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60134|NCT01597245|142731|P9|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60135|NCT01597245|142732|P8|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60136|NCT01597245|142733|P7|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60137|NCT01597245|142734|P6|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60138|NCT01597245|142735|P5|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||0
60139|NCT01597245|142736|P4|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||350
60140|NCT01597245|142737|P3|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||347
60141|NCT01597245|142738|P2|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||357
60142|NCT01597245|142739|P1|Received at Least 1 Dose of Study Drug|Induction Period (Week 0 - Week 12)||167
60143|NCT01597245|142727|P13|STARTED|Induction Period (Week 0 - Week 12)||0
60144|NCT01597245|142728|P12|STARTED|Induction Period (Week 0 - Week 12)||0
60145|NCT01597245|142729|P11|STARTED|Induction Period (Week 0 - Week 12)||0
60146|NCT01597245|142730|P10|STARTED|Induction Period (Week 0 - Week 12)||0
60147|NCT01597245|142731|P9|STARTED|Induction Period (Week 0 - Week 12)||0
60148|NCT01597245|142732|P8|STARTED|Induction Period (Week 0 - Week 12)||0
60149|NCT01597245|142733|P7|STARTED|Induction Period (Week 0 - Week 12)||0
60150|NCT01597245|142734|P6|STARTED|Induction Period (Week 0 - Week 12)||0
60151|NCT01597245|142735|P5|STARTED|Induction Period (Week 0 - Week 12)||0
60152|NCT01597245|142736|P4|STARTED|Induction Period (Week 0 - Week 12)||351
60153|NCT01597245|142737|P3|STARTED|Induction Period (Week 0 - Week 12)||347
60154|NCT01597245|142738|P2|STARTED|Induction Period (Week 0 - Week 12)||358
60155|NCT01597245|142739|P1|STARTED|Induction Period (Week 0 - Week 12)||168
60156|NCT01597141|142824|P2|NOT COMPLETED|Overall Study||0
60157|NCT01597141|142825|P1|NOT COMPLETED|Overall Study||0
60158|NCT01597141|142824|P2|COMPLETED|Overall Study||50
60159|NCT01597141|142825|P1|COMPLETED|Overall Study||50
60160|NCT01597141|142824|P2|STARTED|Overall Study||50
60161|NCT01597141|142825|P1|STARTED|Overall Study||50
60162|NCT01597128|142835|P2|NOT COMPLETED|Overall Study||0
60163|NCT01597128|142836|P1|NOT COMPLETED|Overall Study||0
60164|NCT01597128|142835|P2|COMPLETED|Overall Study||17
60165|NCT01597128|142836|P1|COMPLETED|Overall Study||18
60166|NCT01597128|142835|P2|STARTED|Overall Study||17
60167|NCT01597128|142836|P1|STARTED|Overall Study||18
60168|NCT01597050|142862|P2|NOT COMPLETED|Overall Study||0
60169|NCT01597050|142863|P1|NOT COMPLETED|Overall Study||1
60170|NCT01597050|142862|P2|COMPLETED|Overall Study||18
60171|NCT01597050|142863|P1|COMPLETED|Overall Study||35
60172|NCT01597050|142862|P2|STARTED|Overall Study||18
60173|NCT01597050|142863|P1|STARTED|Overall Study||36
60174|NCT01596972|142871|P2|NOT COMPLETED|Overall Study||14
60175|NCT01596972|142872|P1|NOT COMPLETED|Overall Study||1
60176|NCT01596972|142871|P2|COMPLETED|Overall Study||12
60177|NCT01596972|142872|P1|COMPLETED|Overall Study||24
60178|NCT01596972|142871|P2|STARTED|Overall Study||26
60179|NCT01596972|142872|P1|STARTED|Overall Study||25
60180|NCT01596842|142884|P2|NOT COMPLETED|Overall Study||0
60181|NCT01596842|142885|P1|NOT COMPLETED|Overall Study||2
60182|NCT01596842|142884|P2|COMPLETED|Overall Study||7
60183|NCT01596842|142885|P1|COMPLETED|Overall Study||8
60184|NCT01596842|142884|P2|STARTED|Overall Study||7
60185|NCT01596842|142885|P1|STARTED|Overall Study||10
60186|NCT01596582|142895|P2|NOT COMPLETED|Overall Study||7
60187|NCT01596582|142896|P1|NOT COMPLETED|Overall Study||4
60188|NCT01596582|142895|P2|COMPLETED|Overall Study||173
60189|NCT01596582|142896|P1|COMPLETED|Overall Study||168
60190|NCT01596582|142895|P2|STARTED|Overall Study||180
60191|NCT01596582|142896|P1|STARTED|Overall Study||172
60192|NCT01596504|142923|P3|NOT COMPLETED|Overall Study||1
60193|NCT01596504|142924|P2|NOT COMPLETED|Overall Study||3
60194|NCT01596504|142925|P1|NOT COMPLETED|Overall Study||2
60195|NCT01596504|142923|P3|COMPLETED|Overall Study||46
60196|NCT01596504|142924|P2|COMPLETED|Overall Study||44
60197|NCT01596504|142925|P1|COMPLETED|Overall Study||46
60198|NCT01596504|142923|P3|STARTED|Overall Study||47
60199|NCT01596504|142924|P2|STARTED|Overall Study||47
60200|NCT01596504|142925|P1|STARTED|Overall Study||48
60201|NCT01596231|142983|P2|NOT COMPLETED|Overall Study||0
60202|NCT01596231|142984|P1|NOT COMPLETED|Overall Study||0
60203|NCT01596231|142983|P2|COMPLETED|Overall Study||10
60204|NCT01596231|142984|P1|COMPLETED|Overall Study||10
60205|NCT01596231|142983|P2|STARTED|Overall Study||10
60206|NCT01596231|142984|P1|STARTED|Overall Study||10
60207|NCT01596088|142990|P1|NOT COMPLETED|Overall Study||0
60208|NCT01596088|142990|P1|COMPLETED|Overall Study||2
60209|NCT01596088|142990|P1|STARTED|Overall Study||2
60210|NCT01596062|142997|P3|NOT COMPLETED|Overall Study||3
60211|NCT01596062|142998|P2|NOT COMPLETED|Overall Study||0
60212|NCT01596062|142999|P1|NOT COMPLETED|Overall Study||1
60213|NCT01596062|142997|P3|COMPLETED|Overall Study||4
60214|NCT01596062|142998|P2|COMPLETED|Overall Study||6
60215|NCT01596062|142999|P1|COMPLETED|Overall Study||2
60216|NCT01596062|142997|P3|STARTED|Overall Study||7
60217|NCT01596062|142998|P2|STARTED|Overall Study||6
60218|NCT01596062|142999|P1|STARTED|Overall Study||3
60219|NCT01595854|143036|P5|NOT COMPLETED|Overall Study||0
60220|NCT01595854|143037|P4|NOT COMPLETED|Overall Study||0
60221|NCT01595854|143038|P3|NOT COMPLETED|Overall Study||0
60222|NCT01595854|143039|P2|NOT COMPLETED|Overall Study||0
60223|NCT01595854|143040|P1|NOT COMPLETED|Overall Study||0
60224|NCT01595854|143036|P5|COMPLETED|Overall Study||12
60225|NCT01595854|143037|P4|COMPLETED|Overall Study||4
60226|NCT01595854|143038|P3|COMPLETED|Overall Study||8
60227|NCT01595854|143039|P2|COMPLETED|Overall Study||4
60228|NCT01595854|143040|P1|COMPLETED|Overall Study||8
60229|NCT01595854|143036|P5|STARTED|Overall Study||12
60230|NCT01595854|143037|P4|STARTED|Overall Study||4
60231|NCT01595854|143038|P3|STARTED|Overall Study||8
60232|NCT01595854|143039|P2|STARTED|Overall Study||4
60233|NCT01595854|143040|P1|STARTED|Overall Study||8
60234|NCT01595438|143062|P2|NOT COMPLETED|Overall Study||41
60235|NCT01595438|143063|P1|NOT COMPLETED|Overall Study||43
60236|NCT01595438|143062|P2|COMPLETED|Overall Study||476
60237|NCT01595438|143063|P1|COMPLETED|Overall Study||473
60238|NCT01595438|143062|P2|STARTED|Overall Study||517
60239|NCT01595438|143063|P1|STARTED|Overall Study||516
60240|NCT01595386|143189|P2|NOT COMPLETED|Overall Study||0
60241|NCT01595386|143190|P1|NOT COMPLETED|Overall Study||0
60242|NCT01595386|143189|P2|COMPLETED|Overall Study||19
60243|NCT01595386|143190|P1|COMPLETED|Overall Study||21
60244|NCT01595386|143189|P2|STARTED|Overall Study||19
60245|NCT01595386|143190|P1|STARTED|Overall Study||21
60246|NCT01595282|143218|P2|NOT COMPLETED|Overall Study||0
60247|NCT01595282|143219|P1|NOT COMPLETED|Overall Study||0
60248|NCT01595282|143218|P2|COMPLETED|Overall Study||47
60249|NCT01595282|143219|P1|COMPLETED|Overall Study||47
60250|NCT01595282|143218|P2|STARTED|Overall Study||47
60251|NCT01595282|143219|P1|STARTED|Overall Study||47
60252|NCT01594970|143232|P3|NOT COMPLETED|Overall Study||66
60253|NCT01594970|143233|P2|NOT COMPLETED|Overall Study||82
60254|NCT01594970|143234|P1|NOT COMPLETED|Overall Study||75
60255|NCT01594970|143232|P3|COMPLETED|Overall Study||191
60256|NCT01594970|143233|P2|COMPLETED|Overall Study||166
60257|NCT01594970|143234|P1|COMPLETED|Overall Study||220
60258|NCT01594970|143232|P3|STARTED|Overall Study||257
60259|NCT01594970|143233|P2|STARTED|Overall Study||248
60260|NCT01594970|143234|P1|STARTED|Overall Study||295
60261|NCT01594762|143253|P2|NOT COMPLETED|Overall Study||10
60262|NCT01594762|143254|P1|NOT COMPLETED|Overall Study||11
60263|NCT01594762|143253|P2|COMPLETED|Overall Study||93
60264|NCT01594762|143254|P1|COMPLETED|Overall Study||86
60265|NCT01594762|143253|P2|STARTED|Overall Study||103
60266|NCT01594762|143254|P1|STARTED|Overall Study||97
60267|NCT01594749|143266|P2|NOT COMPLETED|Overall Study||18
60268|NCT01594749|143267|P1|NOT COMPLETED|Overall Study||22
60269|NCT01594749|143266|P2|COMPLETED|Overall Study||490
60270|NCT01594749|143267|P1|COMPLETED|Overall Study||485
60271|NCT01594749|143266|P2|Treated|Overall Study||498
60272|NCT01594749|143267|P1|Treated|Overall Study||503
60273|NCT01594749|143266|P2|STARTED|Overall Study||508
60274|NCT01594749|143267|P1|STARTED|Overall Study||507
60275|NCT01594515|143293|P10|NOT COMPLETED|Overall Study||0
60276|NCT01594515|143294|P9|NOT COMPLETED|Overall Study||0
60277|NCT01594515|143295|P8|NOT COMPLETED|Overall Study||0
60278|NCT01594515|143296|P7|NOT COMPLETED|Overall Study||0
60279|NCT01594515|143297|P6|NOT COMPLETED|Overall Study||0
60280|NCT01594515|143298|P5|NOT COMPLETED|Overall Study||0
60281|NCT01594515|143299|P4|NOT COMPLETED|Overall Study||0
60282|NCT01594515|143300|P3|NOT COMPLETED|Overall Study||0
60283|NCT01594515|143301|P2|NOT COMPLETED|Overall Study||0
60284|NCT01594515|143302|P1|NOT COMPLETED|Overall Study||0
60285|NCT01594515|143293|P10|COMPLETED|Overall Study||16
60286|NCT01594515|143294|P9|COMPLETED|Overall Study||6
60287|NCT01594515|143295|P8|COMPLETED|Overall Study||6
60288|NCT01594515|143296|P7|COMPLETED|Overall Study||6
60289|NCT01594515|143297|P6|COMPLETED|Overall Study||6
60290|NCT01594515|143298|P5|COMPLETED|Overall Study||6
60291|NCT01594515|143299|P4|COMPLETED|Overall Study||6
60292|NCT01594515|143300|P3|COMPLETED|Overall Study||6
60293|NCT01594515|143301|P2|COMPLETED|Overall Study||6
60294|NCT01594515|143302|P1|COMPLETED|Overall Study||6
60295|NCT01594515|143293|P10|STARTED|Overall Study||16
60296|NCT01594515|143294|P9|STARTED|Overall Study||6
60297|NCT01594515|143295|P8|STARTED|Overall Study||6
60298|NCT01594515|143296|P7|STARTED|Overall Study||6
60299|NCT01594515|143297|P6|STARTED|Overall Study||6
60300|NCT01594515|143298|P5|STARTED|Overall Study||6
60301|NCT01594515|143299|P4|STARTED|Overall Study||6
60302|NCT01594515|143300|P3|STARTED|Overall Study||6
60303|NCT01594515|143301|P2|STARTED|Overall Study||6
60304|NCT01594515|143302|P1|STARTED|Overall Study||6
60305|NCT01594424|143392|P1|NOT COMPLETED|Overall Study||2
60306|NCT01594424|143392|P1|COMPLETED|Overall Study||8
60307|NCT01594424|143392|P1|STARTED|Overall Study||10
60308|NCT01594411|143396|P1|NOT COMPLETED|Overall Study||2
60309|NCT01594411|143396|P1|COMPLETED|Overall Study||249
60310|NCT01594411|143396|P1|STARTED|Overall Study||251
60311|NCT01594385|143405|P2|NOT COMPLETED|Overall Study||0
60312|NCT01594385|143406|P1|NOT COMPLETED|Overall Study||0
60313|NCT01594385|143405|P2|COMPLETED|Overall Study||13
60314|NCT01594385|143406|P1|COMPLETED|Overall Study||17
60315|NCT01594385|143405|P2|STARTED|Overall Study||13
60316|NCT01594385|143406|P1|STARTED|Overall Study||17
60317|NCT01594294|143414|P2|NOT COMPLETED|Overall Study||4
60318|NCT01594294|143415|P1|NOT COMPLETED|Overall Study||3
60319|NCT01594294|143414|P2|COMPLETED|Overall Study||36
60320|NCT01594294|143415|P1|COMPLETED|Overall Study||36
60321|NCT01594294|143414|P2|STARTED|Overall Study||40
60322|NCT01594294|143415|P1|STARTED|Overall Study||39
60323|NCT01594125|143434|P5|NOT COMPLETED|Overall Study||7
60324|NCT01594125|143435|P4|NOT COMPLETED|Overall Study||4
60325|NCT01594125|143436|P3|NOT COMPLETED|Overall Study||3
60326|NCT01594125|143437|P2|NOT COMPLETED|Overall Study||12
60327|NCT01594125|143438|P1|NOT COMPLETED|Overall Study||4
60328|NCT01594125|143434|P5|COMPLETED|Overall Study||0
60329|NCT01594125|143435|P4|COMPLETED|Overall Study||0
60330|NCT01594125|143436|P3|COMPLETED|Overall Study||0
60331|NCT01594125|143437|P2|COMPLETED|Overall Study||0
60332|NCT01594125|143438|P1|COMPLETED|Overall Study||0
60333|NCT01594125|143434|P5|STARTED|Overall Study||7
60334|NCT01594125|143435|P4|STARTED|Overall Study||4
60335|NCT01594125|143436|P3|STARTED|Overall Study||3
60336|NCT01594125|143437|P2|STARTED|Overall Study||12
60337|NCT01594125|143438|P1|STARTED|Overall Study||4
60338|NCT01593852|143472|P2|NOT COMPLETED|Overall Study||0
60339|NCT01593852|143473|P1|NOT COMPLETED|Overall Study||0
60340|NCT01593852|143472|P2|COMPLETED|Overall Study||68
60341|NCT01593852|143473|P1|COMPLETED|Overall Study||68
60342|NCT01593852|143472|P2|STARTED|Overall Study||68
60343|NCT01593852|143473|P1|STARTED|Overall Study||68
60344|NCT01593787|143498|P3|NOT COMPLETED|Overall Study||0
60345|NCT01593787|143499|P2|NOT COMPLETED|Overall Study||0
60346|NCT01593787|143500|P1|NOT COMPLETED|Overall Study||1
60347|NCT01593787|143498|P3|COMPLETED|Overall Study||18
60348|NCT01593787|143499|P2|COMPLETED|Overall Study||8
60349|NCT01593787|143500|P1|COMPLETED|Overall Study||5
60350|NCT01593787|143498|P3|STARTED|Overall Study||18
60351|NCT01593787|143499|P2|STARTED|Overall Study||8
60352|NCT01593787|143500|P1|STARTED|Overall Study||6
60353|NCT01593722|143540|P2|NOT COMPLETED|Overall Study||0
60354|NCT01593722|143541|P1|NOT COMPLETED|Overall Study||0
60355|NCT01593722|143540|P2|COMPLETED|Overall Study||6
60356|NCT01593722|143541|P1|COMPLETED|Overall Study||6
60357|NCT01593722|143540|P2|STARTED|Overall Study||6
60358|NCT01593722|143541|P1|STARTED|Overall Study||6
60359|NCT01593670|143555|P1|NOT COMPLETED|Overall Study||0
60360|NCT01593670|143555|P1|COMPLETED|Overall Study||9
60361|NCT01593670|143555|P1|STARTED|Overall Study||9
60362|NCT01593592|143565|P2|NOT COMPLETED|Overall Study||0
60363|NCT01593592|143566|P1|NOT COMPLETED|Overall Study||0
60364|NCT01593592|143565|P2|COMPLETED|Overall Study||35
60365|NCT01593592|143566|P1|COMPLETED|Overall Study||35
60366|NCT01593592|143565|P2|STARTED|Overall Study||35
60367|NCT01593592|143566|P1|STARTED|Overall Study||35
60368|NCT01593215|143578|P2|NOT COMPLETED|Overall Study||0
60369|NCT01593215|143579|P1|NOT COMPLETED|Overall Study||1
60370|NCT01593215|143578|P2|COMPLETED|Overall Study||25
60371|NCT01593215|143579|P1|COMPLETED|Overall Study||24
60372|NCT01593215|143578|P2|STARTED|Overall Study||25
60373|NCT01593215|143579|P1|STARTED|Overall Study||25
60374|NCT01592864|143587|P2|NOT COMPLETED|Overall Study||1
60375|NCT01592864|143588|P1|NOT COMPLETED|Overall Study||0
60376|NCT01592864|143587|P2|COMPLETED|Overall Study||57
60377|NCT01592864|143588|P1|COMPLETED|Overall Study||60
60378|NCT01592864|143587|P2|STARTED|Overall Study||58
60379|NCT01592864|143588|P1|STARTED|Overall Study||60
60380|NCT01592851|143602|P2|NOT COMPLETED|Overall Study||0
60381|NCT01592851|143603|P1|NOT COMPLETED|Overall Study||0
60382|NCT01592851|143602|P2|COMPLETED|Overall Study||57
60383|NCT01592851|143603|P1|COMPLETED|Overall Study||56
60384|NCT01592851|143602|P2|STARTED|Overall Study||57
60385|NCT01592851|143603|P1|STARTED|Overall Study||56
60386|NCT01592786|143619|P1|NOT COMPLETED|Overall Study||138
60387|NCT01592786|143619|P1|COMPLETED|Overall Study||765
60388|NCT01592786|143619|P1|STARTED|Overall Study|Participants in the Safety Population are being presented.|903
60389|NCT01592773|143623|P1|NOT COMPLETED|Overall Study||666
60390|NCT01592773|143623|P1|COMPLETED|Overall Study||81
60391|NCT01592773|143623|P1|STARTED|Overall Study|All enrolled patients received at least 1 dose of investigational product (Safety Population).|747
60392|NCT01592760|143630|P3|NOT COMPLETED|24-hour Follow-Up||2
60393|NCT01592760|143631|P2|NOT COMPLETED|24-hour Follow-Up||3
60394|NCT01592760|143632|P1|NOT COMPLETED|24-hour Follow-Up||4
60395|NCT01592760|143630|P3|COMPLETED|24-hour Follow-Up||43
60396|NCT01592760|143631|P2|COMPLETED|24-hour Follow-Up||87
60397|NCT01592760|143632|P1|COMPLETED|24-hour Follow-Up||86
60398|NCT01592760|143630|P3|STARTED|24-hour Follow-Up||45
60399|NCT01592760|143631|P2|STARTED|24-hour Follow-Up||90
60400|NCT01592760|143632|P1|STARTED|24-hour Follow-Up||90
60401|NCT01592760|143630|P3|NOT COMPLETED|Perioperative to Discharge||0
60402|NCT01592760|143631|P2|NOT COMPLETED|Perioperative to Discharge||0
60403|NCT01592760|143632|P1|NOT COMPLETED|Perioperative to Discharge||0
60404|NCT01592760|143630|P3|COMPLETED|Perioperative to Discharge||45
60405|NCT01592760|143631|P2|COMPLETED|Perioperative to Discharge||90
60406|NCT01592760|143632|P1|COMPLETED|Perioperative to Discharge||90
60407|NCT01592760|143630|P3|STARTED|Perioperative to Discharge||45
60408|NCT01592760|143631|P2|STARTED|Perioperative to Discharge||90
60409|NCT01592760|143632|P1|STARTED|Perioperative to Discharge||90
60410|NCT01592708|143675|P2|NOT COMPLETED|Overall Study||0
60411|NCT01592708|143676|P1|NOT COMPLETED|Overall Study||3
60412|NCT01592708|143675|P2|COMPLETED|Overall Study||137
60413|NCT01592708|143676|P1|COMPLETED|Overall Study||93
60414|NCT01592708|143675|P2|STARTED|Overall Study||137
60415|NCT01592708|143676|P1|STARTED|Overall Study||96
60416|NCT01592695|143692|P2|NOT COMPLETED|Overall Study||4
60417|NCT01592695|143693|P1|NOT COMPLETED|Overall Study||8
60418|NCT01592695|143692|P2|COMPLETED|Overall Study||28
60419|NCT01592695|143693|P1|COMPLETED|Overall Study||23
60420|NCT01592695|143692|P2|STARTED|Overall Study||32
60421|NCT01592695|143693|P1|STARTED|Overall Study||31
60422|NCT01592435|143711|P1|NOT COMPLETED|Overall Study||0
60423|NCT01592435|143711|P1|COMPLETED|Overall Study||76
60424|NCT01592435|143711|P1|STARTED|Overall Study||76
60425|NCT01592396|143719|P2|NOT COMPLETED|Overall Study||0
60426|NCT01592396|143720|P1|NOT COMPLETED|Overall Study||0
60427|NCT01592396|143719|P2|COMPLETED|Overall Study||10
60428|NCT01592396|143720|P1|COMPLETED|Overall Study||10
60429|NCT01592396|143719|P2|STARTED|Overall Study||10
60430|NCT01592396|143720|P1|STARTED|Overall Study||10
60431|NCT01592344|143737|P2|NOT COMPLETED|Overall Study||5
60432|NCT01592344|143738|P1|NOT COMPLETED|Overall Study||4
60433|NCT01592344|143737|P2|COMPLETED|Overall Study||44
60434|NCT01592344|143738|P1|COMPLETED|Overall Study||41
60435|NCT01592344|143737|P2|STARTED|Overall Study||49
60436|NCT01592344|143738|P1|STARTED|Overall Study||45
60437|NCT01592292|143752|P4|NOT COMPLETED|Overall Study||1
60438|NCT01592292|143753|P3|NOT COMPLETED|Overall Study||3
60439|NCT01592292|143754|P2|NOT COMPLETED|Overall Study||5
60440|NCT01592292|143755|P1|NOT COMPLETED|Overall Study||6
60441|NCT01592292|143752|P4|COMPLETED|Overall Study||10
60442|NCT01592292|143753|P3|COMPLETED|Overall Study||10
60443|NCT01592292|143754|P2|COMPLETED|Overall Study||15
60444|NCT01592292|143755|P1|COMPLETED|Overall Study|Participants who completed 12 months visit.|40
60445|NCT01592292|143752|P4|Standard Population Set (SPS)|Overall Study||7
60446|NCT01592292|143753|P3|Standard Population Set (SPS)|Overall Study||7
60447|NCT01592292|143754|P2|Standard Population Set (SPS)|Overall Study||10
60448|NCT01592292|143755|P1|Standard Population Set (SPS)|Overall Study|Excluding participants with change of administration drug or suspension of drug administration.|31
60449|NCT01592292|143752|P4|Intention to Treat (ITT) Set|Overall Study||8
60450|NCT01592292|143753|P3|Intention to Treat (ITT) Set|Overall Study||10
60451|NCT01592292|143754|P2|Intention to Treat (ITT) Set|Overall Study||13
60452|NCT01592292|143755|P1|Intention to Treat (ITT) Set|Overall Study|Excluding primary effect evaluation omission.|34
60453|NCT01592292|143752|P4|STARTED|Overall Study||11
60454|NCT01592292|143753|P3|STARTED|Overall Study||13
60455|NCT01592292|143754|P2|STARTED|Overall Study||20
60456|NCT01592292|143755|P1|STARTED|Overall Study||46
60457|NCT01592071|143787|P1|NOT COMPLETED|Overall Study||0
60458|NCT01592071|143787|P1|COMPLETED|Overall Study||120
60459|NCT01592071|143787|P1|STARTED|Overall Study||120
60460|NCT01592045|143800|P2|NOT COMPLETED|Overall Study||2
60461|NCT01592045|143801|P1|NOT COMPLETED|Overall Study||5
60462|NCT01592045|143800|P2|COMPLETED|Overall Study||12
60463|NCT01592045|143801|P1|COMPLETED|Overall Study||9
60464|NCT01592045|143800|P2|Completed Course 5|Overall Study||12
60465|NCT01592045|143801|P1|Completed Course 5|Overall Study||9
60466|NCT01592045|143800|P2|Completed Course 4|Overall Study||12
60467|NCT01592045|143801|P1|Completed Course 4|Overall Study||11
60468|NCT01592045|143800|P2|Completed Course 3|Overall Study||13
60469|NCT01592045|143801|P1|Completed Course 3|Overall Study||11
60470|NCT01592045|143800|P2|Completed Course 2|Overall Study||13
60471|NCT01592045|143801|P1|Completed Course 2|Overall Study||13
60472|NCT01592045|143800|P2|Completed Course 1|Overall Study||14
60473|NCT01592045|143801|P1|Completed Course 1|Overall Study||13
60474|NCT01592045|143800|P2|STARTED|Overall Study||14
60475|NCT01592045|143801|P1|STARTED|Overall Study||14
60476|NCT01592006|143809|P1|NOT COMPLETED|Overall Study||0
60477|NCT01592006|143809|P1|COMPLETED|Overall Study||3
60478|NCT01592006|143809|P1|STARTED|Overall Study||3
60479|NCT01591954|143814|P1|NOT COMPLETED|Overall Study||0
60480|NCT01591954|143814|P1|COMPLETED|Overall Study||1
60481|NCT01591954|143814|P1|STARTED|Overall Study||1
60482|NCT01591863|143819|P1|NOT COMPLETED|Overall Study||14
60483|NCT01591863|143819|P1|COMPLETED|Overall Study||24
60484|NCT01591863|143819|P1|STARTED|Overall Study||38
60485|NCT01591837|143831|P2|NOT COMPLETED|Overall Study||0
60486|NCT01591837|143832|P1|NOT COMPLETED|Overall Study||0
60487|NCT01591837|143831|P2|COMPLETED|Overall Study||60
60488|NCT01591837|143832|P1|COMPLETED|Overall Study||60
60489|NCT01591837|143831|P2|STARTED|Overall Study||60
60490|NCT01591837|143832|P1|STARTED|Overall Study||60
60491|NCT01591681|143846|P1|NOT COMPLETED|Overall Study||4
60492|NCT01591681|143846|P1|COMPLETED|Overall Study||45
60493|NCT01591681|143846|P1|STARTED|Overall Study||49
60494|NCT01591616|143872|P1|NOT COMPLETED|Overall Study||1
60495|NCT01591616|143872|P1|COMPLETED|Overall Study||15
60496|NCT01591616|143872|P1|STARTED|Overall Study||16
60497|NCT01591499|144013|P4|NOT COMPLETED|Second Intervention (up to 24 Days)||3
60498|NCT01591499|144014|P3|NOT COMPLETED|Second Intervention (up to 24 Days)||3
60499|NCT01591499|144015|P2|NOT COMPLETED|Second Intervention (up to 24 Days)||3
60500|NCT01591499|144016|P1|NOT COMPLETED|Second Intervention (up to 24 Days)||6
60501|NCT01591499|144013|P4|COMPLETED|Second Intervention (up to 24 Days)||34
60502|NCT01591499|144014|P3|COMPLETED|Second Intervention (up to 24 Days)||28
60503|NCT01591499|144015|P2|COMPLETED|Second Intervention (up to 24 Days)||34
60504|NCT01591499|144016|P1|COMPLETED|Second Intervention (up to 24 Days)||27
60505|NCT01591499|144013|P4|STARTED|Second Intervention (up to 24 Days)||37
60506|NCT01591499|144014|P3|STARTED|Second Intervention (up to 24 Days)||31
60507|NCT01591499|144015|P2|STARTED|Second Intervention (up to 24 Days)||37
60508|NCT01591499|144016|P1|STARTED|Second Intervention (up to 24 Days)||33
60509|NCT01591499|144013|P4|NOT COMPLETED|First Intervention (up to 24 Days)||0
60510|NCT01591499|144014|P3|NOT COMPLETED|First Intervention (up to 24 Days)||0
60511|NCT01591499|144015|P2|NOT COMPLETED|First Intervention (up to 24 Days)||0
60512|NCT01591499|144016|P1|NOT COMPLETED|First Intervention (up to 24 Days)||0
60513|NCT01591499|144013|P4|COMPLETED|First Intervention (up to 24 Days)||37
60514|NCT01591499|144014|P3|COMPLETED|First Intervention (up to 24 Days)||31
60515|NCT01591499|144015|P2|COMPLETED|First Intervention (up to 24 Days)||37
60516|NCT01591499|144016|P1|COMPLETED|First Intervention (up to 24 Days)||33
60517|NCT01591499|144013|P4|STARTED|First Intervention (up to 24 Days)||37
60518|NCT01591499|144014|P3|STARTED|First Intervention (up to 24 Days)||31
60519|NCT01591499|144015|P2|STARTED|First Intervention (up to 24 Days)||37
60520|NCT01591499|144016|P1|STARTED|First Intervention (up to 24 Days)||33
60521|NCT01591499|144013|P4|NOT COMPLETED|Baseline Visit||2
60522|NCT01591499|144014|P3|NOT COMPLETED|Baseline Visit||0
60523|NCT01591499|144015|P2|NOT COMPLETED|Baseline Visit||2
60524|NCT01591499|144016|P1|NOT COMPLETED|Baseline Visit||0
60525|NCT01591499|144013|P4|COMPLETED|Baseline Visit||37
60526|NCT01591499|144014|P3|COMPLETED|Baseline Visit||31
60527|NCT01591499|144015|P2|COMPLETED|Baseline Visit||37
60528|NCT01591499|144016|P1|COMPLETED|Baseline Visit||33
60529|NCT01591499|144013|P4|STARTED|Baseline Visit||39
60530|NCT01591499|144014|P3|STARTED|Baseline Visit||31
60531|NCT01591499|144015|P2|STARTED|Baseline Visit||39
60532|NCT01591499|144016|P1|STARTED|Baseline Visit||33
60533|NCT01591460|144082|P1|NOT COMPLETED|Overall Study||26
60534|NCT01591460|144082|P1|COMPLETED|Overall Study|The number who completed PEG-IFN, as scheduled according to response-guided treatment, is presented.|139
60535|NCT01591460|144082|P1|STARTED|Overall Study|Those with elevated (Week 12) or detectable (Week 24) virus discontinued due to the Futility Rule.|165
60536|NCT01591408|144164|P2|NOT COMPLETED|Overall Study||8
60537|NCT01591408|144165|P1|NOT COMPLETED|Overall Study||12
60538|NCT01591408|144164|P2|COMPLETED|Overall Study||24
60539|NCT01591408|144165|P1|COMPLETED|Overall Study||24
60540|NCT01591408|144164|P2|STARTED|Overall Study||32
60541|NCT01591408|144165|P1|STARTED|Overall Study||36
60542|NCT01591382|144173|P2|NOT COMPLETED|Overall Study||2
60543|NCT01591382|144174|P1|NOT COMPLETED|Overall Study||3
60544|NCT01591382|144173|P2|COMPLETED|Overall Study||30
60545|NCT01591382|144174|P1|COMPLETED|Overall Study||29
60546|NCT01591382|144173|P2|STARTED|Overall Study||32
60547|NCT01591382|144174|P1|STARTED|Overall Study||32
60548|NCT01591317|144191|P3|NOT COMPLETED|Overall Study||0
60549|NCT01591317|144192|P2|NOT COMPLETED|Overall Study||0
60550|NCT01591317|144193|P1|NOT COMPLETED|Overall Study||0
60551|NCT01591317|144191|P3|COMPLETED|Overall Study||10
60552|NCT01591317|144192|P2|COMPLETED|Overall Study||10
60553|NCT01591317|144193|P1|COMPLETED|Overall Study||10
60554|NCT01591317|144191|P3|STARTED|Overall Study||10
60555|NCT01591317|144192|P2|STARTED|Overall Study||10
60556|NCT01591317|144193|P1|STARTED|Overall Study||10
60557|NCT01591044|144222|P3|NOT COMPLETED|Overall Study||4
60558|NCT01591044|144223|P2|NOT COMPLETED|Overall Study||9
60559|NCT01591044|144224|P1|NOT COMPLETED|Overall Study||7
60560|NCT01591044|144222|P3|COMPLETED|Overall Study||96
60561|NCT01591044|144223|P2|COMPLETED|Overall Study||91
60562|NCT01591044|144224|P1|COMPLETED|Overall Study||94
60563|NCT01591044|144222|P3|STARTED|Overall Study||100
60564|NCT01591044|144223|P2|STARTED|Overall Study||100
60565|NCT01591044|144224|P1|STARTED|Overall Study||101
60566|NCT01591018|144234|P2|NOT COMPLETED|Overall Study||0
60567|NCT01591018|144235|P1|NOT COMPLETED|Overall Study||0
60568|NCT01591018|144234|P2|COMPLETED|Overall Study||60
60569|NCT01591018|144235|P1|COMPLETED|Overall Study||60
60570|NCT01591018|144234|P2|STARTED|Overall Study||60
60571|NCT01591018|144235|P1|STARTED|Overall Study||60
60572|NCT01591005|144249|P4|NOT COMPLETED|Overall Study||0
60573|NCT01591005|144250|P3|NOT COMPLETED|Overall Study||0
60574|NCT01591005|144251|P2|NOT COMPLETED|Overall Study||0
60575|NCT01591005|144252|P1|NOT COMPLETED|Overall Study||0
60576|NCT01591005|144249|P4|COMPLETED|Overall Study||68
60577|NCT01591005|144250|P3|COMPLETED|Overall Study||68
60578|NCT01591005|144251|P2|COMPLETED|Overall Study||53
60579|NCT01591005|144252|P1|COMPLETED|Overall Study||53
60580|NCT01591005|144249|P4|STARTED|Overall Study||68
60581|NCT01591005|144250|P3|STARTED|Overall Study||68
60582|NCT01591005|144251|P2|STARTED|Overall Study||53
60583|NCT01591005|144252|P1|STARTED|Overall Study||53
60584|NCT01590979|144288|P2|NOT COMPLETED|Overall Study||0
60585|NCT01590979|144289|P1|NOT COMPLETED|Overall Study||0
60586|NCT01590979|144288|P2|COMPLETED|Overall Study||27
60587|NCT01590979|144289|P1|COMPLETED|Overall Study||27
60588|NCT01590979|144288|P2|STARTED|Overall Study||27
60589|NCT01590979|144289|P1|STARTED|Overall Study||27
60590|NCT01590888|144298|P3|NOT COMPLETED|Overall Study||1
60591|NCT01590888|144299|P2|NOT COMPLETED|Overall Study||0
60592|NCT01590888|144300|P1|NOT COMPLETED|Overall Study||4
60593|NCT01590888|144298|P3|COMPLETED|Overall Study||34
60594|NCT01590888|144299|P2|COMPLETED|Overall Study||38
60595|NCT01590888|144300|P1|COMPLETED|Overall Study||32
60596|NCT01590888|144298|P3|STARTED|Overall Study||35
60597|NCT01590888|144299|P2|STARTED|Overall Study||38
60598|NCT01590888|144300|P1|STARTED|Overall Study||36
60599|NCT01590875|144346|P2|NOT COMPLETED|Overall Study||0
60600|NCT01590875|144347|P1|NOT COMPLETED|Overall Study||0
60601|NCT01590875|144346|P2|COMPLETED|Overall Study||10
60602|NCT01590875|144347|P1|COMPLETED|Overall Study||10
60603|NCT01590875|144346|P2|STARTED|Overall Study||10
60604|NCT01590875|144347|P1|STARTED|Overall Study||10
60605|NCT01590810|144364|P5|NOT COMPLETED|Overall Study||0
60606|NCT01590810|144365|P4|NOT COMPLETED|Overall Study||0
60607|NCT01590810|144366|P3|NOT COMPLETED|Overall Study||1
60608|NCT01590810|144367|P2|NOT COMPLETED|Overall Study||1
60609|NCT01590810|144368|P1|NOT COMPLETED|Overall Study||0
60610|NCT01590810|144364|P5|COMPLETED|Overall Study||2
60611|NCT01590810|144365|P4|COMPLETED|Overall Study||8
60612|NCT01590810|144366|P3|COMPLETED|Overall Study||7
60613|NCT01590810|144367|P2|COMPLETED|Overall Study||7
60614|NCT01590810|144368|P1|COMPLETED|Overall Study||8
60615|NCT01590810|144364|P5|STARTED|Overall Study||2
60616|NCT01590810|144365|P4|STARTED|Overall Study||8
60617|NCT01590810|144366|P3|STARTED|Overall Study||8
60618|NCT01590810|144367|P2|STARTED|Overall Study||8
60619|NCT01590810|144368|P1|STARTED|Overall Study||8
60620|NCT01590797|144513|P2|NOT COMPLETED|Overall Study||16
60621|NCT01590797|144514|P1|NOT COMPLETED|Overall Study||17
60622|NCT01590797|144513|P2|COMPLETED|Overall Study||217
60623|NCT01590797|144514|P1|COMPLETED|Overall Study||217
60624|NCT01590797|144513|P2|STARTED|Overall Study||233
60625|NCT01590797|144514|P1|STARTED|Overall Study||234
60626|NCT01590771|144530|P2|NOT COMPLETED|Overall Study||39
60627|NCT01590771|144531|P1|NOT COMPLETED|Overall Study||19
60628|NCT01590771|144530|P2|COMPLETED|Overall Study||210
60629|NCT01590771|144531|P1|COMPLETED|Overall Study||230
60630|NCT01590771|144530|P2|STARTED|Overall Study||249
60631|NCT01590771|144531|P1|STARTED|Overall Study||249
60632|NCT01590758|144559|P2|NOT COMPLETED|Overall Study||7
60633|NCT01590758|144560|P1|NOT COMPLETED|Overall Study||5
60634|NCT01590758|144559|P2|COMPLETED|Overall Study||97
60635|NCT01590758|144560|P1|COMPLETED|Overall Study||80
60636|NCT01590758|144559|P2|STARTED|Overall Study||104
60637|NCT01590758|144560|P1|STARTED|Overall Study||85
60638|NCT01590563|144570|P1|NOT COMPLETED|Overall Study||1
60639|NCT01590563|144570|P1|COMPLETED|Overall Study||14
60640|NCT01590563|144570|P1|STARTED|Overall Study||15
60641|NCT01590550|144576|P1|NOT COMPLETED|Overall Study||0
60642|NCT01590550|144576|P1|COMPLETED|Overall Study||18
60643|NCT01590550|144576|P1|STARTED|Overall Study||18
60644|NCT01590264|144582|P1|NOT COMPLETED|Overall Study||0
60645|NCT01590264|144582|P1|COMPLETED|Overall Study||5
60646|NCT01590264|144582|P1|STARTED|Overall Study||5
60647|NCT01590238|144587|P1|NOT COMPLETED|Overall Study||2
60648|NCT01590238|144587|P1|COMPLETED|Overall Study||13
60649|NCT01590238|144587|P1|STARTED|Overall Study||15
60650|NCT01590212|144594|P3|NOT COMPLETED|Overall Study||5
60651|NCT01590212|144595|P2|NOT COMPLETED|Overall Study||4
60652|NCT01590212|144596|P1|NOT COMPLETED|Overall Study||3
60653|NCT01590212|144594|P3|COMPLETED|Overall Study||9
60654|NCT01590212|144595|P2|COMPLETED|Overall Study||5
60655|NCT01590212|144596|P1|COMPLETED|Overall Study|Includes 2 contacted who failed contact at post-intervention data collection point|9
60656|NCT01590212|144594|P3|Post-intervention|Overall Study|failed contact=1|10
60657|NCT01590212|144595|P2|Post-intervention|Overall Study|failed contact=2; withdrew=1|6
60658|NCT01590212|144596|P1|Post-intervention|Overall Study|failed contact=3|7
60659|NCT01590212|144594|P3|Baseline (Pre-intervention)|Overall Study|failed contact=2|12
60660|NCT01590212|144595|P2|Baseline (Pre-intervention)|Overall Study||9
60661|NCT01590212|144596|P1|Baseline (Pre-intervention)|Overall Study|withdrew=2|10
60662|NCT01590212|144594|P3|STARTED|Overall Study||14
60663|NCT01590212|144595|P2|STARTED|Overall Study||9
60664|NCT01590212|144596|P1|STARTED|Overall Study||12
60665|NCT01589978|144613|P1|NOT COMPLETED|Overall Study||0
60666|NCT01589978|144613|P1|COMPLETED|Overall Study||2681
60667|NCT01589978|144613|P1|STARTED|Overall Study||2681
60668|NCT01589822|144640|P3|NOT COMPLETED|Overall Study||1
60669|NCT01589822|144641|P2|NOT COMPLETED|Overall Study||3
60670|NCT01589822|144642|P1|NOT COMPLETED|Overall Study||4
60671|NCT01589822|144640|P3|COMPLETED|Overall Study||40
60672|NCT01589822|144641|P2|COMPLETED|Overall Study||86
60673|NCT01589822|144642|P1|COMPLETED|Overall Study||80
60674|NCT01589822|144640|P3|STARTED|Overall Study||41
60675|NCT01589822|144641|P2|STARTED|Overall Study||89
60676|NCT01589822|144642|P1|STARTED|Overall Study||84
60677|NCT01589653|144661|P2|NOT COMPLETED|Overall Study||11
60678|NCT01589653|144662|P1|NOT COMPLETED|Overall Study||7
60679|NCT01589653|144661|P2|COMPLETED|Overall Study||68
60680|NCT01589653|144662|P1|COMPLETED|Overall Study||69
60681|NCT01589653|144661|P2|Exposed|Overall Study||78
60682|NCT01589653|144662|P1|Exposed|Overall Study||76
60683|NCT01589653|144661|P2|STARTED|Overall Study||79
60684|NCT01589653|144662|P1|STARTED|Overall Study||76
60685|NCT01589601|144678|P2|NOT COMPLETED|Overall Study||49
60686|NCT01589601|144679|P1|NOT COMPLETED|Overall Study||47
60687|NCT01589601|144678|P2|COMPLETED|Overall Study||26
60688|NCT01589601|144679|P1|COMPLETED|Overall Study||28
60689|NCT01589601|144678|P2|STARTED|Overall Study||75
60690|NCT01589601|144679|P1|STARTED|Overall Study||75
60691|NCT01589510|144695|P1|NOT COMPLETED|Overall Study||33
60692|NCT01589510|144695|P1|COMPLETED|Overall Study||386
60693|NCT01589510|144695|P1|STARTED|Overall Study||419
60694|NCT01589497|144710|P4|NOT COMPLETED|Overall Study||1
60695|NCT01589497|144711|P3|NOT COMPLETED|Overall Study||1
60696|NCT01589497|144712|P2|NOT COMPLETED|Overall Study||1
60697|NCT01589497|144713|P1|NOT COMPLETED|Overall Study||1
60698|NCT01589497|144710|P4|COMPLETED|Overall Study||17
60699|NCT01589497|144711|P3|COMPLETED|Overall Study||15
60700|NCT01589497|144712|P2|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|16
60701|NCT01589497|144713|P1|COMPLETED|Overall Study|1 participant who completed study but had insufficient sputum volume was excluded from the analyses|17
60702|NCT01589497|144710|P4|STARTED|Overall Study||18
60703|NCT01589497|144711|P3|STARTED|Overall Study||16
60704|NCT01589497|144712|P2|STARTED|Overall Study||17
60705|NCT01589497|144713|P1|STARTED|Overall Study||18
60706|NCT01589484|144746|P1|NOT COMPLETED|Overall Study||4
60707|NCT01589484|144746|P1|COMPLETED|Overall Study||100
60708|NCT01589484|144746|P1|STARTED|Overall Study||104
60709|NCT01589445|144751|P1|NOT COMPLETED|002 (Metformin)-3 Months||9
60710|NCT01589445|144751|P1|COMPLETED|002 (Metformin)-3 Months|61 patients completed the drug 002.9 patients dropped out.|61
60711|NCT01589445|144751|P1|STARTED|002 (Metformin)-3 Months|70 patients participated for trial of drug 002.|70
60712|NCT01589445|144751|P1|NOT COMPLETED|001 (Pioglitazone) -3 Months||7
60713|NCT01589445|144751|P1|COMPLETED|001 (Pioglitazone) -3 Months|dropped out 7 patients|70
60714|NCT01589445|144751|P1|STARTED|001 (Pioglitazone) -3 Months||77
60715|NCT01589237|144771|P4|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
60716|NCT01589237|144772|P3|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||4
60717|NCT01589237|144773|P2|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||6
60718|NCT01589237|144774|P1|NOT COMPLETED|Part B (Planned for 78 Week-terminated)||5
60719|NCT01589237|144771|P4|COMPLETED|Part B (Planned for 78 Week-terminated)||0
60720|NCT01589237|144772|P3|COMPLETED|Part B (Planned for 78 Week-terminated)||0
60721|NCT01589237|144773|P2|COMPLETED|Part B (Planned for 78 Week-terminated)||0
60722|NCT01589237|144774|P1|COMPLETED|Part B (Planned for 78 Week-terminated)||0
60723|NCT01589237|144771|P4|STARTED|Part B (Planned for 78 Week-terminated)||4
60724|NCT01589237|144772|P3|STARTED|Part B (Planned for 78 Week-terminated)||4
60725|NCT01589237|144773|P2|STARTED|Part B (Planned for 78 Week-terminated)||6
60726|NCT01589237|144774|P1|STARTED|Part B (Planned for 78 Week-terminated)||5
60727|NCT01589237|144771|P4|NOT COMPLETED|Part A (52 Weeks)||0
60728|NCT01589237|144772|P3|NOT COMPLETED|Part A (52 Weeks)||2
60729|NCT01589237|144773|P2|NOT COMPLETED|Part A (52 Weeks)||3
60730|NCT01589237|144774|P1|NOT COMPLETED|Part A (52 Weeks)||2
60731|NCT01589237|144771|P4|COMPLETED|Part A (52 Weeks)||5
60732|NCT01589237|144772|P3|COMPLETED|Part A (52 Weeks)||8
60733|NCT01589237|144773|P2|COMPLETED|Part A (52 Weeks)||9
60734|NCT01589237|144774|P1|COMPLETED|Part A (52 Weeks)||9
60735|NCT01589237|144771|P4|STARTED|Part A (52 Weeks)||5
60736|NCT01589237|144772|P3|STARTED|Part A (52 Weeks)||10
60737|NCT01589237|144773|P2|STARTED|Part A (52 Weeks)||12
60738|NCT01589237|144774|P1|STARTED|Part A (52 Weeks)|"Started = Full analysis set/safety set"|11
60739|NCT01588951|144823|P3|NOT COMPLETED|Overall Study||1
60740|NCT01588951|144824|P2|NOT COMPLETED|Overall Study||0
60741|NCT01588951|144825|P1|NOT COMPLETED|Overall Study||0
60742|NCT01588951|144823|P3|COMPLETED|Overall Study||5
60743|NCT01588951|144824|P2|COMPLETED|Overall Study||2
60744|NCT01588951|144825|P1|COMPLETED|Overall Study||2
60745|NCT01588951|144823|P3|STARTED|Overall Study||6
60746|NCT01588951|144824|P2|STARTED|Overall Study||2
60747|NCT01588951|144825|P1|STARTED|Overall Study||2
60748|NCT01588561|144833|P2|NOT COMPLETED|Overall Study||0
60749|NCT01588561|144834|P1|NOT COMPLETED|Overall Study||0
60750|NCT01588561|144833|P2|COMPLETED|Overall Study||1
60751|NCT01588561|144834|P1|COMPLETED|Overall Study||14
60752|NCT01588561|144833|P2|Second Injection (Visit 2)|Overall Study||1
60753|NCT01588561|144834|P1|Second Injection (Visit 2)|Overall Study||14
60754|NCT01588561|144833|P2|Rest Period|Overall Study||1
60755|NCT01588561|144834|P1|Rest Period|Overall Study||14
60756|NCT01588561|144833|P2|First Injection (Visit 1)|Overall Study||1
60757|NCT01588561|144834|P1|First Injection (Visit 1)|Overall Study||14
60758|NCT01588561|144833|P2|STARTED|Overall Study||1
60759|NCT01588561|144834|P1|STARTED|Overall Study||14
60760|NCT01588548|144851|P6|NOT COMPLETED|Overall Study||6
60761|NCT01588548|144852|P5|NOT COMPLETED|Overall Study||6
60762|NCT01588548|144853|P4|NOT COMPLETED|Overall Study||7
60763|NCT01588548|144854|P3|NOT COMPLETED|Overall Study||6
60764|NCT01588548|144855|P2|NOT COMPLETED|Overall Study||7
60765|NCT01588548|144856|P1|NOT COMPLETED|Overall Study||3
60766|NCT01588548|144851|P6|COMPLETED|Overall Study||0
60767|NCT01588548|144852|P5|COMPLETED|Overall Study||0
60768|NCT01588548|144853|P4|COMPLETED|Overall Study||0
60769|NCT01588548|144854|P3|COMPLETED|Overall Study||0
60770|NCT01588548|144855|P2|COMPLETED|Overall Study||0
60771|NCT01588548|144856|P1|COMPLETED|Overall Study||0
60772|NCT01588548|144851|P6|Cycle 1 Day 21|Overall Study||3
60773|NCT01588548|144852|P5|Cycle 1 Day 21|Overall Study||3
60774|NCT01588548|144853|P4|Cycle 1 Day 21|Overall Study||5
60775|NCT01588548|144854|P3|Cycle 1 Day 21|Overall Study||2
60776|NCT01588548|144855|P2|Cycle 1 Day 21|Overall Study||5
60777|NCT01588548|144856|P1|Cycle 1 Day 21|Overall Study||3
60778|NCT01588548|144851|P6|STARTED|Overall Study||6
60779|NCT01588548|144852|P5|STARTED|Overall Study||6
60780|NCT01588548|144853|P4|STARTED|Overall Study||7
60781|NCT01588548|144854|P3|STARTED|Overall Study||6
60782|NCT01588548|144855|P2|STARTED|Overall Study||7
60783|NCT01588548|144856|P1|STARTED|Overall Study||3
60784|NCT01588496|144873|P3|NOT COMPLETED|Overall Study||0
60785|NCT01588496|144874|P2|NOT COMPLETED|Overall Study||1
60786|NCT01588496|144875|P1|NOT COMPLETED|Overall Study||0
60787|NCT01588496|144873|P3|COMPLETED|Overall Study||33
60788|NCT01588496|144874|P2|COMPLETED|Overall Study||16
60789|NCT01588496|144875|P1|COMPLETED|Overall Study||8
60790|NCT01588496|144873|P3|Received Treatment|Overall Study||33
60791|NCT01588496|144874|P2|Received Treatment|Overall Study||16
60792|NCT01588496|144875|P1|Received Treatment|Overall Study||8
60793|NCT01588496|144873|P3|STARTED|Overall Study||33
60794|NCT01588496|144874|P2|STARTED|Overall Study||17
60795|NCT01588496|144875|P1|STARTED|Overall Study||8
60796|NCT01588444|144902|P2|NOT COMPLETED|Overall Study||0
60797|NCT01588444|144903|P1|NOT COMPLETED|Overall Study||0
60798|NCT01588444|144902|P2|COMPLETED|Overall Study||20
60799|NCT01588444|144903|P1|COMPLETED|Overall Study||20
60800|NCT01588444|144902|P2|STARTED|Overall Study||20
60801|NCT01588444|144903|P1|STARTED|Overall Study||20
60802|NCT01588418|144909|P2|NOT COMPLETED|Overall Study||0
60803|NCT01588418|144910|P1|NOT COMPLETED|Overall Study||0
60804|NCT01588418|144909|P2|COMPLETED|Overall Study||4
60805|NCT01588418|144910|P1|COMPLETED|Overall Study||11
60806|NCT01588418|144909|P2|STARTED|Overall Study||4
60807|NCT01588418|144910|P1|STARTED|Overall Study||11
60808|NCT01588405|144914|P1|NOT COMPLETED|Overall Study||2
60809|NCT01588405|144914|P1|COMPLETED|Overall Study||31
60810|NCT01588405|144914|P1|STARTED|Overall Study||33
60811|NCT01588353|144941|P3|NOT COMPLETED|Step3||2
60812|NCT01588353|144942|P2|NOT COMPLETED|Step3||0
60813|NCT01588353|144943|P1|NOT COMPLETED|Step3||0
60814|NCT01588353|144941|P3|COMPLETED|Step3||23
60815|NCT01588353|144942|P2|COMPLETED|Step3||0
60816|NCT01588353|144943|P1|COMPLETED|Step3||0
60817|NCT01588353|144941|P3|STARTED|Step3||25
60818|NCT01588353|144942|P2|STARTED|Step3||0
60819|NCT01588353|144943|P1|STARTED|Step3||0
60820|NCT01588353|144941|P3|NOT COMPLETED|Step2||0
60821|NCT01588353|144942|P2|NOT COMPLETED|Step2||1
60822|NCT01588353|144943|P1|NOT COMPLETED|Step2||0
60823|NCT01588353|144941|P3|COMPLETED|Step2||0
60824|NCT01588353|144942|P2|COMPLETED|Step2||70
60825|NCT01588353|144943|P1|COMPLETED|Step2||0
60826|NCT01588353|144941|P3|STARTED|Step2||0
60827|NCT01588353|144942|P2|STARTED|Step2||71
60828|NCT01588353|144943|P1|STARTED|Step2||0
60829|NCT01588353|144941|P3|NOT COMPLETED|Step1||0
60830|NCT01588353|144942|P2|NOT COMPLETED|Step1||0
60831|NCT01588353|144943|P1|NOT COMPLETED|Step1||0
60832|NCT01588353|144941|P3|COMPLETED|Step1||0
60833|NCT01588353|144942|P2|COMPLETED|Step1||0
60834|NCT01588353|144943|P1|COMPLETED|Step1||6
60835|NCT01588353|144941|P3|STARTED|Step1||0
60836|NCT01588353|144942|P2|STARTED|Step1||0
60837|NCT01588353|144943|P1|STARTED|Step1||6
60838|NCT01588158|144961|P2|NOT COMPLETED|Overall Study||0
60839|NCT01588158|144962|P1|NOT COMPLETED|Overall Study||0
60840|NCT01588158|144961|P2|COMPLETED|Overall Study||3
60841|NCT01588158|144962|P1|COMPLETED|Overall Study||4
60842|NCT01588158|144961|P2|STARTED|Overall Study||3
60843|NCT01588158|144962|P1|STARTED|Overall Study||4
60844|NCT01588106|144986|P2|NOT COMPLETED|Overall Study||4
60845|NCT01588106|144987|P1|NOT COMPLETED|Overall Study||5
60846|NCT01588106|144986|P2|COMPLETED|Overall Study||72
60847|NCT01588106|144987|P1|COMPLETED|Overall Study||73
60848|NCT01588106|144986|P2|STARTED|Overall Study||76
60849|NCT01588106|144987|P1|STARTED|Overall Study||78
60850|NCT01587989|144995|P3|NOT COMPLETED|Randomized Study Treatment||1
60851|NCT01587989|144996|P2|NOT COMPLETED|Randomized Study Treatment||2
60852|NCT01587989|144997|P1|NOT COMPLETED|Randomized Study Treatment||0
60853|NCT01587989|144995|P3|COMPLETED|Randomized Study Treatment||32
60854|NCT01587989|144996|P2|COMPLETED|Randomized Study Treatment||30
60855|NCT01587989|144997|P1|COMPLETED|Randomized Study Treatment||0
60856|NCT01587989|144995|P3|STARTED|Randomized Study Treatment||33
60857|NCT01587989|144996|P2|STARTED|Randomized Study Treatment||32
60858|NCT01587989|144997|P1|STARTED|Randomized Study Treatment||0
60859|NCT01587989|144995|P3|NOT COMPLETED|12-Week Open-Label Run-In Period||0
60860|NCT01587989|144996|P2|NOT COMPLETED|12-Week Open-Label Run-In Period||0
60861|NCT01587989|144997|P1|NOT COMPLETED|12-Week Open-Label Run-In Period||12
60862|NCT01587989|144995|P3|COMPLETED|12-Week Open-Label Run-In Period||0
60863|NCT01587989|144996|P2|COMPLETED|12-Week Open-Label Run-In Period||0
60864|NCT01587989|144997|P1|COMPLETED|12-Week Open-Label Run-In Period||65
60865|NCT01587989|144995|P3|STARTED|12-Week Open-Label Run-In Period||0
60866|NCT01587989|144996|P2|STARTED|12-Week Open-Label Run-In Period||0
60867|NCT01587989|144997|P1|STARTED|12-Week Open-Label Run-In Period||77
60868|NCT01587963|145021|P2|NOT COMPLETED|Overall Study||0
60869|NCT01587963|145022|P1|NOT COMPLETED|Overall Study||1
60870|NCT01587963|145021|P2|COMPLETED|Overall Study||4
60871|NCT01587963|145022|P1|COMPLETED|Overall Study||6
60872|NCT01587963|145021|P2|STARTED|Overall Study||4
60873|NCT01587963|145022|P1|STARTED|Overall Study||7
60874|NCT01587950|145028|P1|NOT COMPLETED|Period 3||0
60875|NCT01587950|145028|P1|COMPLETED|Period 3||12
60876|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 3||5
60877|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 3||3
60878|NCT01587950|145028|P1|Received 5% KNO3 Solution (2 Minutes)|Period 3||3
60879|NCT01587950|145028|P1|Received 5% KNO3 Solution (5 Minutes)|Period 3||5
60880|NCT01587950|145028|P1|Received Sterile Water (5 Minutes)|Period 3||5
60881|NCT01587950|145028|P1|Received 5% KNO3 Solution (10 Minutes)|Period 3||4
60882|NCT01587950|145028|P1|Received Sterile Water (2 Minutes)|Period 3||2
60883|NCT01587950|145028|P1|Received Sterile Water (10 Minutes)|Period 3||5
60884|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 3||4
60885|NCT01587950|145028|P1|STARTED|Period 3||12
60886|NCT01587950|145028|P1|NOT COMPLETED|Washout 2||0
60887|NCT01587950|145028|P1|COMPLETED|Washout 2||12
60888|NCT01587950|145028|P1|STARTED|Washout 2||12
60889|NCT01587950|145028|P1|NOT COMPLETED|Period 2||0
60890|NCT01587950|145028|P1|COMPLETED|Period 2||12
60891|NCT01587950|145028|P1|Received 5% KNO3 Solution (5 Minutes)|Period 2||2
60892|NCT01587950|145028|P1|Received Sterile Water (10 Minutes)|Period 2||2
60893|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 2||4
60894|NCT01587950|145028|P1|Received Sterile Water (5 Minutes)|Period 2||2
60895|NCT01587950|145028|P1|Received 5% KNO3 Solution (2 Minutes)|Period 2||6
60896|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 2||6
60897|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 2||2
60898|NCT01587950|145028|P1|Received 5% KNO3 Solution (10 Minutes)|Period 2||4
60899|NCT01587950|145028|P1|Received Sterile Water (2 Minutes)|Period 2||8
60900|NCT01587950|145028|P1|STARTED|Period 2||12
60901|NCT01587950|145028|P1|NOT COMPLETED|Washout 1||0
60902|NCT01587950|145028|P1|COMPLETED|Washout 1||12
60903|NCT01587950|145028|P1|STARTED|Washout 1||12
60904|NCT01587950|145028|P1|NOT COMPLETED|Period 1||0
60905|NCT01587950|145028|P1|COMPLETED|Period 1||12
60906|NCT01587950|145028|P1|Received Sterile Water (5 Minutes)|Period 1||5
60907|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (5 Minutes)|Period 1||5
60908|NCT01587950|145028|P1|Received Sterile Water (10 Minutes)|Period 1||5
60909|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (10 Minutes)|Period 1||3
60910|NCT01587950|145028|P1|Received 2.5% KNO3 Solution (2 Minutes)|Period 1||4
60911|NCT01587950|145028|P1|Received 5% KNO3 Solution (10 Minutes)|Period 1||4
60912|NCT01587950|145028|P1|Received Sterile Water (2 Minutes)|Period 1||2
60913|NCT01587950|145028|P1|Received 5% KNO3 Solution (2 Minutes)|Period 1||3
60914|NCT01587950|145028|P1|Received 5% KNO3 Solution (5 Minutes)|Period 1||5
60915|NCT01587950|145028|P1|STARTED|Period 1||12
60916|NCT01587885|145058|P2|NOT COMPLETED|Treatment Period 2||0
60917|NCT01587885|145059|P1|NOT COMPLETED|Treatment Period 2||0
60918|NCT01587885|145058|P2|COMPLETED|Treatment Period 2||19
60919|NCT01587885|145059|P1|COMPLETED|Treatment Period 2||26
60920|NCT01587885|145058|P2|STARTED|Treatment Period 2||19
60921|NCT01587885|145059|P1|STARTED|Treatment Period 2||26
60922|NCT01587885|145058|P2|NOT COMPLETED|Treatment Period 1||3
60923|NCT01587885|145059|P1|NOT COMPLETED|Treatment Period 1||0
60924|NCT01587885|145058|P2|COMPLETED|Treatment Period 1||19
60925|NCT01587885|145059|P1|COMPLETED|Treatment Period 1||26
60926|NCT01587885|145058|P2|STARTED|Treatment Period 1||22
60927|NCT01587885|145059|P1|STARTED|Treatment Period 1||26
60928|NCT01587651|145075|P3|NOT COMPLETED|Overall Study||1
60929|NCT01587651|145076|P2|NOT COMPLETED|Overall Study||3
60930|NCT01587651|145077|P1|NOT COMPLETED|Overall Study||0
60931|NCT01587651|145075|P3|COMPLETED|Overall Study||34
60932|NCT01587651|145076|P2|COMPLETED|Overall Study||38
60933|NCT01587651|145077|P1|COMPLETED|Overall Study||34
60934|NCT01587651|145075|P3|STARTED|Overall Study||35
60935|NCT01587651|145076|P2|STARTED|Overall Study||41
60936|NCT01587651|145077|P1|STARTED|Overall Study||34
60937|NCT01587118|145104|P1|NOT COMPLETED|Overall Study||7
60938|NCT01587118|145104|P1|COMPLETED|Overall Study||11
60939|NCT01587118|145104|P1|STARTED|Overall Study|31 signed consent and 18 were deemed eligible and initiated treatment with adjunctive asenapine.|18
60940|NCT01587105|145111|P2|NOT COMPLETED|Overall Study||43
60941|NCT01587105|145112|P1|NOT COMPLETED|Overall Study||6
60942|NCT01587105|145111|P2|COMPLETED|Overall Study||138
60943|NCT01587105|145112|P1|COMPLETED|Overall Study||144
60944|NCT01587105|145111|P2|STARTED|Overall Study||181
60945|NCT01587105|145112|P1|STARTED|Overall Study||150
60946|NCT01587079|145128|P1|NOT COMPLETED|Overall Study||39
60947|NCT01587079|145128|P1|COMPLETED|Overall Study||120
60948|NCT01587079|145128|P1|STARTED|Overall Study||159
60949|NCT01587027|145252|P2|NOT COMPLETED|Discharge (1 Day)||0
60950|NCT01587027|145253|P1|NOT COMPLETED|Discharge (1 Day)||0
60951|NCT01587027|145252|P2|COMPLETED|Discharge (1 Day)||8
60952|NCT01587027|145253|P1|COMPLETED|Discharge (1 Day)||8
60953|NCT01587027|145252|P2|STARTED|Discharge (1 Day)||8
60954|NCT01587027|145253|P1|STARTED|Discharge (1 Day)||8
60955|NCT01587027|145252|P2|NOT COMPLETED|Third Intervention (1 Day)||0
60956|NCT01587027|145253|P1|NOT COMPLETED|Third Intervention (1 Day)||0
60957|NCT01587027|145252|P2|COMPLETED|Third Intervention (1 Day)||8
60958|NCT01587027|145253|P1|COMPLETED|Third Intervention (1 Day)||8
60959|NCT01587027|145252|P2|STARTED|Third Intervention (1 Day)||8
60960|NCT01587027|145253|P1|STARTED|Third Intervention (1 Day)||8
60961|NCT01587027|145252|P2|NOT COMPLETED|Washout (1 Day)||0
60962|NCT01587027|145253|P1|NOT COMPLETED|Washout (1 Day)||0
60963|NCT01587027|145252|P2|COMPLETED|Washout (1 Day)||8
60964|NCT01587027|145253|P1|COMPLETED|Washout (1 Day)||8
60965|NCT01587027|145252|P2|STARTED|Washout (1 Day)||8
60966|NCT01587027|145253|P1|STARTED|Washout (1 Day)||8
60967|NCT01587027|145252|P2|NOT COMPLETED|Second Intervention (1 Day)||0
60968|NCT01587027|145253|P1|NOT COMPLETED|Second Intervention (1 Day)||0
60969|NCT01587027|145252|P2|COMPLETED|Second Intervention (1 Day)||8
60970|NCT01587027|145253|P1|COMPLETED|Second Intervention (1 Day)||8
60971|NCT01587027|145252|P2|STARTED|Second Intervention (1 Day)||8
60972|NCT01587027|145253|P1|STARTED|Second Intervention (1 Day)||8
60973|NCT01587027|145252|P2|NOT COMPLETED|Washout (1 Day)||0
60974|NCT01587027|145253|P1|NOT COMPLETED|Washout (1 Day)||0
60975|NCT01587027|145252|P2|COMPLETED|Washout (1 Day)||8
60976|NCT01587027|145253|P1|COMPLETED|Washout (1 Day)||8
60977|NCT01587027|145252|P2|STARTED|Washout (1 Day)||8
60978|NCT01587027|145253|P1|STARTED|Washout (1 Day)||8
60979|NCT01587027|145252|P2|NOT COMPLETED|First Intervention (1 Day)||0
60980|NCT01587027|145253|P1|NOT COMPLETED|First Intervention (1 Day)||0
60981|NCT01587027|145252|P2|COMPLETED|First Intervention (1 Day)||8
60982|NCT01587027|145253|P1|COMPLETED|First Intervention (1 Day)||8
60983|NCT01587027|145252|P2|STARTED|First Intervention (1 Day)||8
60984|NCT01587027|145253|P1|STARTED|First Intervention (1 Day)||8
60985|NCT01587014|145259|P1|NOT COMPLETED|Overall Study||2
60986|NCT01587014|145259|P1|COMPLETED|Overall Study||24
60987|NCT01587014|145259|P1|STARTED|Overall Study||26
60988|NCT01587001|145266|P2|NOT COMPLETED|Overall Study||1
60989|NCT01587001|145267|P1|NOT COMPLETED|Overall Study||6
60990|NCT01587001|145266|P2|COMPLETED|Overall Study||2
60991|NCT01587001|145267|P1|COMPLETED|Overall Study||8
60992|NCT01587001|145266|P2|STARTED|Overall Study||3
60993|NCT01587001|145267|P1|STARTED|Overall Study||14
60994|NCT01586975|145278|P3|NOT COMPLETED|Overall Study||0
60995|NCT01586975|145279|P2|NOT COMPLETED|Overall Study||0
60996|NCT01586975|145280|P1|NOT COMPLETED|Overall Study||0
60997|NCT01586975|145278|P3|COMPLETED|Overall Study||46
60998|NCT01586975|145279|P2|COMPLETED|Overall Study||32
60999|NCT01586975|145280|P1|COMPLETED|Overall Study||15
61000|NCT01586975|145278|P3|STARTED|Overall Study||46
61001|NCT01586975|145279|P2|STARTED|Overall Study||32
61002|NCT01586975|145280|P1|STARTED|Overall Study||15
61003|NCT01586962|145288|P1|NOT COMPLETED|Overall Study||0
61004|NCT01586962|145288|P1|COMPLETED|Overall Study||56
61005|NCT01586962|145288|P1|STARTED|Overall Study||56
61006|NCT01586897|145296|P2|NOT COMPLETED|Overall Study||0
61007|NCT01586897|145297|P1|NOT COMPLETED|Overall Study||0
61008|NCT01586897|145296|P2|COMPLETED|Overall Study||26
61009|NCT01586897|145297|P1|COMPLETED|Overall Study||26
61010|NCT01586897|145296|P2|STARTED|Overall Study||26
61011|NCT01586897|145297|P1|STARTED|Overall Study||26
61012|NCT01586806|145316|P3|NOT COMPLETED|Overall Study||2
61013|NCT01586806|145317|P2|NOT COMPLETED|Overall Study||4
61014|NCT01586806|145318|P1|NOT COMPLETED|Overall Study||3
61015|NCT01586806|145316|P3|COMPLETED|Overall Study||63
61016|NCT01586806|145317|P2|COMPLETED|Overall Study||61
61017|NCT01586806|145318|P1|COMPLETED|Overall Study||62
61018|NCT01586806|145316|P3|STARTED|Overall Study||65
61019|NCT01586806|145317|P2|STARTED|Overall Study||65
61020|NCT01586806|145318|P1|STARTED|Overall Study||65
61021|NCT01586364|145338|P1|NOT COMPLETED|Overall Study||117
61022|NCT01586364|145338|P1|COMPLETED|Overall Study||184
61023|NCT01586364|145338|P1|STARTED|Overall Study||301
61024|NCT01586338|145391|P1|NOT COMPLETED|Overall Study||8
61025|NCT01586338|145391|P1|COMPLETED|Overall Study||229
61026|NCT01586338|145391|P1|STARTED|Overall Study||237
61027|NCT01586312|145403|P2|NOT COMPLETED|Overall Study||0
61028|NCT01586312|145404|P1|NOT COMPLETED|Overall Study||0
61029|NCT01586312|145403|P2|COMPLETED|Overall Study||15
61030|NCT01586312|145404|P1|COMPLETED|Overall Study||15
61031|NCT01586312|145403|P2|STARTED|Overall Study||15
61032|NCT01586312|145404|P1|STARTED|Overall Study||15
61033|NCT01586195|145414|P1|NOT COMPLETED|Overall Study||26
61034|NCT01586195|145414|P1|COMPLETED|Overall Study||5
61035|NCT01586195|145414|P1|STARTED|Overall Study||31
61036|NCT01586026|145425|P3|NOT COMPLETED|Overall Study||0
61037|NCT01586026|145426|P2|NOT COMPLETED|Overall Study||0
61038|NCT01586026|145427|P1|NOT COMPLETED|Overall Study||0
61039|NCT01586026|145425|P3|COMPLETED|Overall Study||271
61040|NCT01586026|145426|P2|COMPLETED|Overall Study||414
61041|NCT01586026|145427|P1|COMPLETED|Overall Study||350
61042|NCT01586026|145425|P3|STARTED|Overall Study||271
61043|NCT01586026|145426|P2|STARTED|Overall Study||414
61044|NCT01586026|145427|P1|STARTED|Overall Study||350
61045|NCT01585987|145437|P2|NOT COMPLETED|Treated||49
61046|NCT01585987|145438|P1|NOT COMPLETED|Treated||54
61047|NCT01585987|145437|P2|COMPLETED|Treated||2
61048|NCT01585987|145438|P1|COMPLETED|Treated||3
61049|NCT01585987|145437|P2|STARTED|Treated||51
61050|NCT01585987|145438|P1|STARTED|Treated||57
61051|NCT01585987|145437|P2|NOT COMPLETED|Randomized||6
61052|NCT01585987|145438|P1|NOT COMPLETED|Randomized||0
61053|NCT01585987|145437|P2|COMPLETED|Randomized||51
61054|NCT01585987|145438|P1|COMPLETED|Randomized||57
61055|NCT01585987|145437|P2|STARTED|Randomized||57
61056|NCT01585987|145438|P1|STARTED|Randomized||57
61057|NCT01585961|145453|P1|NOT COMPLETED|Overall Study||33
61058|NCT01585961|145453|P1|COMPLETED|Overall Study||478
61059|NCT01585961|145453|P1|Safety|Overall Study|Patients ablated with study catheter|508
61060|NCT01585961|145453|P1|STARTED|Overall Study||511
61061|NCT01585779|145470|P2|NOT COMPLETED|Overall Study||7
61062|NCT01585779|145471|P1|NOT COMPLETED|Overall Study||10
61063|NCT01585779|145470|P2|COMPLETED|Overall Study||21
61064|NCT01585779|145471|P1|COMPLETED|Overall Study||26
61065|NCT01585779|145470|P2|STARTED|Overall Study||28
61066|NCT01585779|145471|P1|STARTED|Overall Study||36
61067|NCT01585597|145525|P1|NOT COMPLETED|Overall Study||0
61068|NCT01585597|145525|P1|COMPLETED|Overall Study||20
61069|NCT01585597|145525|P1|STARTED|Overall Study||20
61070|NCT01585584|145530|P1|NOT COMPLETED|Overall Study||4
61071|NCT01585584|145530|P1|COMPLETED|Overall Study||6
61072|NCT01585584|145530|P1|STARTED|Overall Study||10
61073|NCT01585558|145537|P3|NOT COMPLETED|Overall Study||15
61074|NCT01585558|145538|P2|NOT COMPLETED|Overall Study||12
61075|NCT01585558|145539|P1|NOT COMPLETED|Overall Study||13
61076|NCT01585558|145537|P3|COMPLETED|Overall Study||34
61077|NCT01585558|145538|P2|COMPLETED|Overall Study||57
61078|NCT01585558|145539|P1|COMPLETED|Overall Study||49
61079|NCT01585558|145537|P3|STARTED|Overall Study||49
61080|NCT01585558|145538|P2|STARTED|Overall Study||69
61081|NCT01585558|145539|P1|STARTED|Overall Study||62
61082|NCT01585441|145720|P2|NOT COMPLETED|Overall Study||0
61083|NCT01585441|145721|P1|NOT COMPLETED|Overall Study||0
61084|NCT01585441|145720|P2|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
61085|NCT01585441|145721|P1|COMPLETED|Overall Study|Defined as completing the Month 3 masked phase of the study and/or the final safety visit|3
61086|NCT01585441|145720|P2|Final Study Safety Visit|Overall Study|A final study visit was not required for the placebo participant who completed the study at Month 3.|2
61087|NCT01585441|145721|P1|Final Study Safety Visit|Overall Study||3
61088|NCT01585441|145720|P2|Received Finasteride at Month 3|Overall Study||2
61089|NCT01585441|145721|P1|Received Finasteride at Month 3|Overall Study||2
61090|NCT01585441|145720|P2|Month 3|Overall Study||3
61091|NCT01585441|145721|P1|Month 3|Overall Study|One participant was not evaluated at Month 3 but at the final visit due to study terminating early.|2
61092|NCT01585441|145720|P2|STARTED|Overall Study||3
61093|NCT01585441|145721|P1|STARTED|Overall Study||3
61094|NCT01585428|145773|P2|NOT COMPLETED|Overall Study||0
61095|NCT01585428|145774|P1|NOT COMPLETED|Overall Study||1
61096|NCT01585428|145773|P2|COMPLETED|Overall Study||11
61097|NCT01585428|145774|P1|COMPLETED|Overall Study||17
61098|NCT01585428|145773|P2|STARTED|Overall Study||11
61099|NCT01585428|145774|P1|STARTED|Overall Study||18
61100|NCT01585324|145782|P1|NOT COMPLETED|Overall Study||0
61101|NCT01585324|145782|P1|COMPLETED|Overall Study||30
61102|NCT01585324|145782|P1|STARTED|Overall Study||30
61103|NCT01585272|145798|P1|NOT COMPLETED|Overall Study||39
61104|NCT01585272|145798|P1|COMPLETED|Overall Study||82
61105|NCT01585272|145798|P1|Exelon Patch 10 cm2|Overall Study||96
61106|NCT01585272|145798|P1|Exelon Patch 5 cm2|Overall Study||114
61107|NCT01585272|145798|P1|Safety Set|Overall Study|Subjects received 3 mg bid Exelon caps for more than 4 weeks & used at least 1 dose of Exelon patch.|102
61108|NCT01585272|145798|P1|STARTED|Overall Study||121
61109|NCT01585246|145811|P5|NOT COMPLETED|Overall Study||2
61110|NCT01585246|145812|P4|NOT COMPLETED|Overall Study||4
61111|NCT01585246|145813|P3|NOT COMPLETED|Overall Study||4
61112|NCT01585246|145814|P2|NOT COMPLETED|Overall Study||1
61113|NCT01585246|145815|P1|NOT COMPLETED|Overall Study||0
61114|NCT01585246|145811|P5|COMPLETED|Overall Study||9
61115|NCT01585246|145812|P4|COMPLETED|Overall Study||6
61116|NCT01585246|145813|P3|COMPLETED|Overall Study||16
61117|NCT01585246|145814|P2|COMPLETED|Overall Study||3
61118|NCT01585246|145815|P1|COMPLETED|Overall Study||3
61119|NCT01585246|145811|P5|STARTED|Overall Study||11
61120|NCT01585246|145812|P4|STARTED|Overall Study||10
61121|NCT01585246|145813|P3|STARTED|Overall Study||20
61122|NCT01585246|145814|P2|STARTED|Overall Study||4
61123|NCT01585246|145815|P1|STARTED|Overall Study||3
61124|NCT01585038|145832|P2|NOT COMPLETED|Overall Study||2
61125|NCT01585038|145833|P1|NOT COMPLETED|Overall Study||2
61126|NCT01585038|145832|P2|COMPLETED|Overall Study||18
61127|NCT01585038|145833|P1|COMPLETED|Overall Study||18
61128|NCT01585038|145832|P2|STARTED|Overall Study||20
61129|NCT01585038|145833|P1|STARTED|Overall Study||20
61130|NCT01584843|145849|P6|NOT COMPLETED|Second Treatment Period||1
61131|NCT01584843|145850|P5|NOT COMPLETED|Second Treatment Period||0
61132|NCT01584843|145851|P4|NOT COMPLETED|Second Treatment Period||0
61133|NCT01584843|145852|P3|NOT COMPLETED|Second Treatment Period||0
61134|NCT01584843|145853|P2|NOT COMPLETED|Second Treatment Period||0
61135|NCT01584843|145854|P1|NOT COMPLETED|Second Treatment Period||0
61136|NCT01584843|145849|P6|COMPLETED|Second Treatment Period||0
61137|NCT01584843|145850|P5|COMPLETED|Second Treatment Period||3
61138|NCT01584843|145851|P4|COMPLETED|Second Treatment Period||6
61139|NCT01584843|145852|P3|COMPLETED|Second Treatment Period||2
61140|NCT01584843|145853|P2|COMPLETED|Second Treatment Period||1
61141|NCT01584843|145854|P1|COMPLETED|Second Treatment Period||2
61142|NCT01584843|145849|P6|STARTED|Second Treatment Period||1
61143|NCT01584843|145850|P5|STARTED|Second Treatment Period||3
61144|NCT01584843|145851|P4|STARTED|Second Treatment Period||6
61145|NCT01584843|145852|P3|STARTED|Second Treatment Period||2
61146|NCT01584843|145853|P2|STARTED|Second Treatment Period||1
61147|NCT01584843|145854|P1|STARTED|Second Treatment Period||2
61148|NCT01584843|145849|P6|NOT COMPLETED|First Treatment Period||2
61149|NCT01584843|145850|P5|NOT COMPLETED|First Treatment Period||0
61150|NCT01584843|145851|P4|NOT COMPLETED|First Treatment Period||0
61151|NCT01584843|145852|P3|NOT COMPLETED|First Treatment Period||1
61152|NCT01584843|145853|P2|NOT COMPLETED|First Treatment Period||0
61153|NCT01584843|145854|P1|NOT COMPLETED|First Treatment Period||0
61154|NCT01584843|145849|P6|COMPLETED|First Treatment Period||9
61155|NCT01584843|145850|P5|COMPLETED|First Treatment Period||10
61156|NCT01584843|145851|P4|COMPLETED|First Treatment Period||10
61157|NCT01584843|145852|P3|COMPLETED|First Treatment Period||2
61158|NCT01584843|145853|P2|COMPLETED|First Treatment Period||4
61159|NCT01584843|145854|P1|COMPLETED|First Treatment Period||3
61160|NCT01584843|145849|P6|STARTED|First Treatment Period||11
61161|NCT01584843|145850|P5|STARTED|First Treatment Period||10
61162|NCT01584843|145851|P4|STARTED|First Treatment Period||10
61163|NCT01584843|145852|P3|STARTED|First Treatment Period||3
61164|NCT01584843|145853|P2|STARTED|First Treatment Period||4
61165|NCT01584843|145854|P1|STARTED|First Treatment Period||3
61166|NCT01584648|145965|P2|NOT COMPLETED|Overall Study||212
61167|NCT01584648|145966|P1|NOT COMPLETED|Overall Study||211
61168|NCT01584648|145965|P2|COMPLETED|Overall Study||0
61169|NCT01584648|145966|P1|COMPLETED|Overall Study||0
61170|NCT01584648|145965|P2|Ongoing|Overall Study||147
61171|NCT01584648|145966|P1|Ongoing|Overall Study||154
61172|NCT01584648|145965|P2|STARTED|Overall Study||212
61173|NCT01584648|145966|P1|STARTED|Overall Study||211
61174|NCT01584544|146009|P5|NOT COMPLETED|Overall Study||0
61175|NCT01584544|146010|P4|NOT COMPLETED|Overall Study||0
61176|NCT01584544|146011|P3|NOT COMPLETED|Overall Study||0
61177|NCT01584544|146012|P2|NOT COMPLETED|Overall Study||0
61178|NCT01584544|146013|P1|NOT COMPLETED|Overall Study||0
61179|NCT01584544|146009|P5|COMPLETED|Overall Study||6
61180|NCT01584544|146010|P4|COMPLETED|Overall Study||3
61181|NCT01584544|146011|P3|COMPLETED|Overall Study||6
61182|NCT01584544|146012|P2|COMPLETED|Overall Study||6
61183|NCT01584544|146013|P1|COMPLETED|Overall Study||3
61184|NCT01584544|146009|P5|STARTED|Overall Study||6
61185|NCT01584544|146010|P4|STARTED|Overall Study||3
61186|NCT01584544|146011|P3|STARTED|Overall Study||6
61187|NCT01584544|146012|P2|STARTED|Overall Study||6
61188|NCT01584544|146013|P1|STARTED|Overall Study||3
61189|NCT01584518|146027|P2|NOT COMPLETED|Overall Study||0
61190|NCT01584518|146028|P1|NOT COMPLETED|Overall Study||0
61191|NCT01584518|146027|P2|COMPLETED|Overall Study||25
61192|NCT01584518|146028|P1|COMPLETED|Overall Study||25
61193|NCT01584518|146027|P2|STARTED|Overall Study||25
61194|NCT01584518|146028|P1|STARTED|Overall Study||25
61195|NCT01584479|146038|P4|NOT COMPLETED|Overall Study||0
61196|NCT01584479|146039|P3|NOT COMPLETED|Overall Study||0
61197|NCT01584479|146040|P2|NOT COMPLETED|Overall Study||0
61198|NCT01584479|146041|P1|NOT COMPLETED|Overall Study||0
61199|NCT01584479|146038|P4|COMPLETED|Overall Study||1847
61200|NCT01584479|146039|P3|COMPLETED|Overall Study||852
61201|NCT01584479|146040|P2|COMPLETED|Overall Study||1686
61202|NCT01584479|146041|P1|COMPLETED|Overall Study||732
61203|NCT01584479|146038|P4|STARTED|Overall Study||1847
61204|NCT01584479|146039|P3|STARTED|Overall Study||852
61205|NCT01584479|146040|P2|STARTED|Overall Study||1686
61206|NCT01584479|146041|P1|STARTED|Overall Study||732
61207|NCT01584388|146051|P1|NOT COMPLETED|Overall Study||0
61208|NCT01584388|146051|P1|COMPLETED|Overall Study||30
61209|NCT01584388|146051|P1|STARTED|Overall Study||30
61210|NCT01584232|146071|P2|NOT COMPLETED|Overall Study||3
61211|NCT01584232|146072|P1|NOT COMPLETED|Overall Study||8
61212|NCT01584232|146071|P2|COMPLETED|Overall Study||177
61213|NCT01584232|146072|P1|COMPLETED|Overall Study||173
61214|NCT01584232|146071|P2|Received at Least 1 Dose of Study Drug|Overall Study||180
61215|NCT01584232|146072|P1|Received at Least 1 Dose of Study Drug|Overall Study||181
61216|NCT01584232|146071|P2|STARTED|Overall Study||180
61217|NCT01584232|146072|P1|STARTED|Overall Study||181
61218|NCT01583894|146088|P1|NOT COMPLETED|Overall Study||15
61219|NCT01583894|146088|P1|COMPLETED|Overall Study||813
61220|NCT01583894|146088|P1|STARTED|Overall Study||828
61221|NCT01582789|146092|P2|NOT COMPLETED|Second Intervention (14 Days)||0
61222|NCT01582789|146093|P1|NOT COMPLETED|Second Intervention (14 Days)||1
61223|NCT01582789|146092|P2|COMPLETED|Second Intervention (14 Days)||27
61224|NCT01582789|146093|P1|COMPLETED|Second Intervention (14 Days)||33
61225|NCT01582789|146092|P2|STARTED|Second Intervention (14 Days)||27
61226|NCT01582789|146093|P1|STARTED|Second Intervention (14 Days)||34
61227|NCT01582789|146092|P2|NOT COMPLETED|First Intervention (14 Days)||0
61228|NCT01582789|146093|P1|NOT COMPLETED|First Intervention (14 Days)||0
61229|NCT01582789|146092|P2|COMPLETED|First Intervention (14 Days)||27
61230|NCT01582789|146093|P1|COMPLETED|First Intervention (14 Days)||34
61231|NCT01582789|146092|P2|STARTED|First Intervention (14 Days)||27
61232|NCT01582789|146093|P1|STARTED|First Intervention (14 Days)||34
61233|NCT01583647|146109|P2|NOT COMPLETED|Overall Study||0
61234|NCT01583647|146110|P1|NOT COMPLETED|Overall Study||0
61235|NCT01583647|146109|P2|COMPLETED|Overall Study||0
61236|NCT01583647|146110|P1|COMPLETED|Overall Study||10
61237|NCT01583647|146109|P2|STARTED|Overall Study|Study terminated prior to Panel B being conducted.|0
61238|NCT01583647|146110|P1|STARTED|Overall Study||10
61239|NCT01583543|146122|P1|NOT COMPLETED|Overall Study||0
61240|NCT01583543|146122|P1|COMPLETED|Overall Study||12
61241|NCT01583543|146122|P1|STARTED|Overall Study||12
61242|NCT01583530|146135|P6|NOT COMPLETED|Overall Study||3
61243|NCT01583530|146136|P5|NOT COMPLETED|Overall Study||5
61244|NCT01583530|146137|P4|NOT COMPLETED|Overall Study||1
61245|NCT01583530|146138|P3|NOT COMPLETED|Overall Study||0
61246|NCT01583530|146139|P2|NOT COMPLETED|Overall Study||3
61247|NCT01583530|146140|P1|NOT COMPLETED|Overall Study||0
61248|NCT01583530|146135|P6|COMPLETED|Overall Study||17
61249|NCT01583530|146136|P5|COMPLETED|Overall Study||15
61250|NCT01583530|146137|P4|COMPLETED|Overall Study||18
61251|NCT01583530|146138|P3|COMPLETED|Overall Study||20
61252|NCT01583530|146139|P2|COMPLETED|Overall Study||17
61253|NCT01583530|146140|P1|COMPLETED|Overall Study||19
61254|NCT01583530|146135|P6|STARTED|Overall Study||20
61255|NCT01583530|146136|P5|STARTED|Overall Study||20
61256|NCT01583530|146137|P4|STARTED|Overall Study||19
61257|NCT01583530|146138|P3|STARTED|Overall Study||20
61258|NCT01583530|146139|P2|STARTED|Overall Study||20
61259|NCT01583530|146140|P1|STARTED|Overall Study||19
61260|NCT01583452|146186|P2|NOT COMPLETED|Overall Study||0
61261|NCT01583452|146187|P1|NOT COMPLETED|Overall Study||0
61262|NCT01583452|146186|P2|COMPLETED|Overall Study||20
61263|NCT01583452|146187|P1|COMPLETED|Overall Study||21
61264|NCT01583452|146186|P2|STARTED|Overall Study||20
61265|NCT01583452|146187|P1|STARTED|Overall Study||21
61266|NCT01583374|146202|P3|NOT COMPLETED|Overall Study||25
61267|NCT01583374|146203|P2|NOT COMPLETED|Overall Study||16
61268|NCT01583374|146204|P1|NOT COMPLETED|Overall Study||19
61269|NCT01583374|146202|P3|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|138
61270|NCT01583374|146203|P2|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|147
61362|NCT01582308|146316|P2|COMPLETED|10-day Washout Following Period 4||2
61271|NCT01583374|146204|P1|COMPLETED|Overall Study|Completed = those who completed the Placebo-controlled Treatment Phase – Weeks 0 to 24|145
61272|NCT01583374|146202|P3|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|49
61273|NCT01583374|146203|P2|Early Escape at Week 16|Overall Study||49
61274|NCT01583374|146204|P1|Early Escape at Week 16|Overall Study|One participant who escaped early did not complete Week 24|51
61275|NCT01583374|146202|P3|Completed Week 16|Overall Study||144
61276|NCT01583374|146203|P2|Completed Week 16|Overall Study||151
61277|NCT01583374|146204|P1|Completed Week 16|Overall Study||150
61278|NCT01583374|146202|P3|Received Treatment|Overall Study||163
61279|NCT01583374|146203|P2|Received Treatment|Overall Study||163
61280|NCT01583374|146204|P1|Received Treatment|Overall Study||164
61281|NCT01583374|146202|P3|STARTED|Overall Study||163
61282|NCT01583374|146203|P2|STARTED|Overall Study||163
61283|NCT01583374|146204|P1|STARTED|Overall Study||164
61284|NCT01583101|146216|P2|NOT COMPLETED|Overall Study||0
61285|NCT01583101|146217|P1|NOT COMPLETED|Overall Study||0
61286|NCT01583101|146216|P2|COMPLETED|Overall Study||1161
61287|NCT01583101|146217|P1|COMPLETED|Overall Study||1076
61288|NCT01583101|146216|P2|STARTED|Overall Study||1161
61289|NCT01583101|146217|P1|STARTED|Overall Study||1076
61290|NCT01582945|146223|P1|NOT COMPLETED|Overall Study||2
61291|NCT01582945|146223|P1|COMPLETED|Overall Study||12
61292|NCT01582945|146223|P1|STARTED|Overall Study||14
61293|NCT01582880|146227|P1|NOT COMPLETED|Overall Study||0
61294|NCT01582880|146227|P1|COMPLETED|Overall Study||1
61295|NCT01582880|146227|P1|STARTED|Overall Study||1
61296|NCT01582854|146237|P2|NOT COMPLETED|Overall Study||34
61297|NCT01582854|146238|P1|NOT COMPLETED|Overall Study||36
61298|NCT01582854|146237|P2|COMPLETED|Overall Study||221
61299|NCT01582854|146238|P1|COMPLETED|Overall Study||212
61300|NCT01582854|146237|P2|STARTED|Overall Study||255
61301|NCT01582854|146238|P1|STARTED|Overall Study||248
61302|NCT01582490|146268|P2|NOT COMPLETED|Overall Study||1
61303|NCT01582490|146269|P1|NOT COMPLETED|Overall Study||1
61304|NCT01582490|146268|P2|COMPLETED|Overall Study||9
61305|NCT01582490|146269|P1|COMPLETED|Overall Study||8
61306|NCT01582490|146268|P2|STARTED|Overall Study||10
61307|NCT01582490|146269|P1|STARTED|Overall Study||9
61308|NCT01582477|146291|P2|NOT COMPLETED|Overall Study||0
61309|NCT01582477|146292|P1|NOT COMPLETED|Overall Study||0
61310|NCT01582477|146291|P2|COMPLETED|Overall Study||12
61311|NCT01582477|146292|P1|COMPLETED|Overall Study||12
61312|NCT01582477|146291|P2|STARTED|Overall Study||12
61313|NCT01582477|146292|P1|STARTED|Overall Study||12
61314|NCT01582308|146308|P10|NOT COMPLETED|Period 5||0
61315|NCT01582308|146309|P9|NOT COMPLETED|Period 5||0
61316|NCT01582308|146310|P8|NOT COMPLETED|Period 5||0
61317|NCT01582308|146311|P7|NOT COMPLETED|Period 5||0
61318|NCT01582308|146312|P6|NOT COMPLETED|Period 5||0
61319|NCT01582308|146313|P5|NOT COMPLETED|Period 5||0
61320|NCT01582308|146314|P4|NOT COMPLETED|Period 5||0
61321|NCT01582308|146315|P3|NOT COMPLETED|Period 5||0
61322|NCT01582308|146316|P2|NOT COMPLETED|Period 5||0
61323|NCT01582308|146317|P1|NOT COMPLETED|Period 5||0
61324|NCT01582308|146308|P10|COMPLETED|Period 5||1
61325|NCT01582308|146309|P9|COMPLETED|Period 5||2
61326|NCT01582308|146310|P8|COMPLETED|Period 5||2
61327|NCT01582308|146311|P7|COMPLETED|Period 5||2
61328|NCT01582308|146312|P6|COMPLETED|Period 5||1
61329|NCT01582308|146313|P5|COMPLETED|Period 5||2
61330|NCT01582308|146314|P4|COMPLETED|Period 5||2
61331|NCT01582308|146315|P3|COMPLETED|Period 5||2
61332|NCT01582308|146316|P2|COMPLETED|Period 5||2
61333|NCT01582308|146317|P1|COMPLETED|Period 5||1
61334|NCT01582308|146308|P10|STARTED|Period 5||1
61335|NCT01582308|146309|P9|STARTED|Period 5||2
61336|NCT01582308|146310|P8|STARTED|Period 5||2
61337|NCT01582308|146311|P7|STARTED|Period 5||2
61338|NCT01582308|146312|P6|STARTED|Period 5||1
61339|NCT01582308|146313|P5|STARTED|Period 5||2
61340|NCT01582308|146314|P4|STARTED|Period 5||2
61341|NCT01582308|146315|P3|STARTED|Period 5||2
61342|NCT01582308|146316|P2|STARTED|Period 5||2
61343|NCT01582308|146317|P1|STARTED|Period 5||1
61344|NCT01582308|146308|P10|NOT COMPLETED|10-day Washout Following Period 4||0
61345|NCT01582308|146309|P9|NOT COMPLETED|10-day Washout Following Period 4||0
61346|NCT01582308|146310|P8|NOT COMPLETED|10-day Washout Following Period 4||0
61347|NCT01582308|146311|P7|NOT COMPLETED|10-day Washout Following Period 4||0
61348|NCT01582308|146312|P6|NOT COMPLETED|10-day Washout Following Period 4||0
61349|NCT01582308|146313|P5|NOT COMPLETED|10-day Washout Following Period 4||0
61350|NCT01582308|146314|P4|NOT COMPLETED|10-day Washout Following Period 4||0
61351|NCT01582308|146315|P3|NOT COMPLETED|10-day Washout Following Period 4||0
61352|NCT01582308|146316|P2|NOT COMPLETED|10-day Washout Following Period 4||0
61353|NCT01582308|146317|P1|NOT COMPLETED|10-day Washout Following Period 4||0
61354|NCT01582308|146308|P10|COMPLETED|10-day Washout Following Period 4||1
61355|NCT01582308|146309|P9|COMPLETED|10-day Washout Following Period 4||2
61356|NCT01582308|146310|P8|COMPLETED|10-day Washout Following Period 4||2
61357|NCT01582308|146311|P7|COMPLETED|10-day Washout Following Period 4||2
61358|NCT01582308|146312|P6|COMPLETED|10-day Washout Following Period 4||1
61359|NCT01582308|146313|P5|COMPLETED|10-day Washout Following Period 4||2
61360|NCT01582308|146314|P4|COMPLETED|10-day Washout Following Period 4||2
61361|NCT01582308|146315|P3|COMPLETED|10-day Washout Following Period 4||2
61363|NCT01582308|146317|P1|COMPLETED|10-day Washout Following Period 4||1
61364|NCT01582308|146308|P10|STARTED|10-day Washout Following Period 4||1
61365|NCT01582308|146309|P9|STARTED|10-day Washout Following Period 4||2
61366|NCT01582308|146310|P8|STARTED|10-day Washout Following Period 4||2
61367|NCT01582308|146311|P7|STARTED|10-day Washout Following Period 4||2
61368|NCT01582308|146312|P6|STARTED|10-day Washout Following Period 4||1
61369|NCT01582308|146313|P5|STARTED|10-day Washout Following Period 4||2
61370|NCT01582308|146314|P4|STARTED|10-day Washout Following Period 4||2
61371|NCT01582308|146315|P3|STARTED|10-day Washout Following Period 4||2
61372|NCT01582308|146316|P2|STARTED|10-day Washout Following Period 4||2
61373|NCT01582308|146317|P1|STARTED|10-day Washout Following Period 4||1
61374|NCT01582308|146308|P10|NOT COMPLETED|Period 4||1
61375|NCT01582308|146309|P9|NOT COMPLETED|Period 4||0
61376|NCT01582308|146310|P8|NOT COMPLETED|Period 4||0
61377|NCT01582308|146311|P7|NOT COMPLETED|Period 4||0
61378|NCT01582308|146312|P6|NOT COMPLETED|Period 4||1
61379|NCT01582308|146313|P5|NOT COMPLETED|Period 4||0
61380|NCT01582308|146314|P4|NOT COMPLETED|Period 4||0
61381|NCT01582308|146315|P3|NOT COMPLETED|Period 4||0
61382|NCT01582308|146316|P2|NOT COMPLETED|Period 4||0
61383|NCT01582308|146317|P1|NOT COMPLETED|Period 4||1
61384|NCT01582308|146308|P10|COMPLETED|Period 4||1
61385|NCT01582308|146309|P9|COMPLETED|Period 4||2
61386|NCT01582308|146310|P8|COMPLETED|Period 4||2
61387|NCT01582308|146311|P7|COMPLETED|Period 4||2
61388|NCT01582308|146312|P6|COMPLETED|Period 4||1
61389|NCT01582308|146313|P5|COMPLETED|Period 4||2
61390|NCT01582308|146314|P4|COMPLETED|Period 4||2
61391|NCT01582308|146315|P3|COMPLETED|Period 4||2
61392|NCT01582308|146316|P2|COMPLETED|Period 4||2
61393|NCT01582308|146317|P1|COMPLETED|Period 4||1
61394|NCT01582308|146308|P10|STARTED|Period 4||2
61395|NCT01582308|146309|P9|STARTED|Period 4||2
61396|NCT01582308|146310|P8|STARTED|Period 4||2
61397|NCT01582308|146311|P7|STARTED|Period 4||2
61398|NCT01582308|146312|P6|STARTED|Period 4||2
61399|NCT01582308|146313|P5|STARTED|Period 4||2
61400|NCT01582308|146314|P4|STARTED|Period 4||2
61401|NCT01582308|146315|P3|STARTED|Period 4||2
61402|NCT01582308|146316|P2|STARTED|Period 4||2
61403|NCT01582308|146317|P1|STARTED|Period 4||2
61404|NCT01582308|146308|P10|NOT COMPLETED|10-day Washout Following Period 3||0
61405|NCT01582308|146309|P9|NOT COMPLETED|10-day Washout Following Period 3||0
61406|NCT01582308|146310|P8|NOT COMPLETED|10-day Washout Following Period 3||0
61407|NCT01582308|146311|P7|NOT COMPLETED|10-day Washout Following Period 3||0
61408|NCT01582308|146312|P6|NOT COMPLETED|10-day Washout Following Period 3||0
61409|NCT01582308|146313|P5|NOT COMPLETED|10-day Washout Following Period 3||0
61410|NCT01582308|146314|P4|NOT COMPLETED|10-day Washout Following Period 3||0
61411|NCT01582308|146315|P3|NOT COMPLETED|10-day Washout Following Period 3||0
61412|NCT01582308|146316|P2|NOT COMPLETED|10-day Washout Following Period 3||0
61413|NCT01582308|146317|P1|NOT COMPLETED|10-day Washout Following Period 3||0
61414|NCT01582308|146308|P10|COMPLETED|10-day Washout Following Period 3||2
61415|NCT01582308|146309|P9|COMPLETED|10-day Washout Following Period 3||2
61416|NCT01582308|146310|P8|COMPLETED|10-day Washout Following Period 3||2
61417|NCT01582308|146311|P7|COMPLETED|10-day Washout Following Period 3||2
61418|NCT01582308|146312|P6|COMPLETED|10-day Washout Following Period 3||2
61419|NCT01582308|146313|P5|COMPLETED|10-day Washout Following Period 3||2
61420|NCT01582308|146314|P4|COMPLETED|10-day Washout Following Period 3||2
61421|NCT01582308|146315|P3|COMPLETED|10-day Washout Following Period 3||2
61422|NCT01582308|146316|P2|COMPLETED|10-day Washout Following Period 3||2
61423|NCT01582308|146317|P1|COMPLETED|10-day Washout Following Period 3||2
61424|NCT01582308|146308|P10|STARTED|10-day Washout Following Period 3||2
61425|NCT01582308|146309|P9|STARTED|10-day Washout Following Period 3||2
61426|NCT01582308|146310|P8|STARTED|10-day Washout Following Period 3||2
61427|NCT01582308|146311|P7|STARTED|10-day Washout Following Period 3||2
61428|NCT01582308|146312|P6|STARTED|10-day Washout Following Period 3||2
61429|NCT01582308|146313|P5|STARTED|10-day Washout Following Period 3||2
61430|NCT01582308|146314|P4|STARTED|10-day Washout Following Period 3||2
61431|NCT01582308|146315|P3|STARTED|10-day Washout Following Period 3||2
61432|NCT01582308|146316|P2|STARTED|10-day Washout Following Period 3||2
61433|NCT01582308|146317|P1|STARTED|10-day Washout Following Period 3||2
61434|NCT01582308|146308|P10|NOT COMPLETED|Period 3||0
61435|NCT01582308|146309|P9|NOT COMPLETED|Period 3||0
61436|NCT01582308|146310|P8|NOT COMPLETED|Period 3||0
61437|NCT01582308|146311|P7|NOT COMPLETED|Period 3||0
61438|NCT01582308|146312|P6|NOT COMPLETED|Period 3||0
61439|NCT01582308|146313|P5|NOT COMPLETED|Period 3||0
61440|NCT01582308|146314|P4|NOT COMPLETED|Period 3||0
61441|NCT01582308|146315|P3|NOT COMPLETED|Period 3||0
61442|NCT01582308|146316|P2|NOT COMPLETED|Period 3||0
61443|NCT01582308|146317|P1|NOT COMPLETED|Period 3||0
61444|NCT01582308|146308|P10|COMPLETED|Period 3||2
61445|NCT01582308|146309|P9|COMPLETED|Period 3||2
61446|NCT01582308|146310|P8|COMPLETED|Period 3||2
61447|NCT01582308|146311|P7|COMPLETED|Period 3||2
61448|NCT01582308|146312|P6|COMPLETED|Period 3||2
61449|NCT01582308|146313|P5|COMPLETED|Period 3||2
61450|NCT01582308|146314|P4|COMPLETED|Period 3||2
61451|NCT01582308|146315|P3|COMPLETED|Period 3||2
61452|NCT01582308|146316|P2|COMPLETED|Period 3||2
61453|NCT01582308|146317|P1|COMPLETED|Period 3||2
61454|NCT01582308|146308|P10|STARTED|Period 3||2
61455|NCT01582308|146309|P9|STARTED|Period 3||2
61456|NCT01582308|146310|P8|STARTED|Period 3||2
61457|NCT01582308|146311|P7|STARTED|Period 3||2
61458|NCT01582308|146312|P6|STARTED|Period 3||2
61459|NCT01582308|146313|P5|STARTED|Period 3||2
61460|NCT01582308|146314|P4|STARTED|Period 3||2
61461|NCT01582308|146315|P3|STARTED|Period 3||2
61462|NCT01582308|146316|P2|STARTED|Period 3||2
61463|NCT01582308|146317|P1|STARTED|Period 3||2
61464|NCT01582308|146308|P10|NOT COMPLETED|10-day Washout Following Period 2||0
61465|NCT01582308|146309|P9|NOT COMPLETED|10-day Washout Following Period 2||0
61466|NCT01582308|146310|P8|NOT COMPLETED|10-day Washout Following Period 2||0
61467|NCT01582308|146311|P7|NOT COMPLETED|10-day Washout Following Period 2||0
61468|NCT01582308|146312|P6|NOT COMPLETED|10-day Washout Following Period 2||0
61469|NCT01582308|146313|P5|NOT COMPLETED|10-day Washout Following Period 2||0
61470|NCT01582308|146314|P4|NOT COMPLETED|10-day Washout Following Period 2||0
61471|NCT01582308|146315|P3|NOT COMPLETED|10-day Washout Following Period 2||0
61472|NCT01582308|146316|P2|NOT COMPLETED|10-day Washout Following Period 2||0
61473|NCT01582308|146317|P1|NOT COMPLETED|10-day Washout Following Period 2||0
61474|NCT01582308|146308|P10|COMPLETED|10-day Washout Following Period 2||2
61475|NCT01582308|146309|P9|COMPLETED|10-day Washout Following Period 2||2
61476|NCT01582308|146310|P8|COMPLETED|10-day Washout Following Period 2||2
61477|NCT01582308|146311|P7|COMPLETED|10-day Washout Following Period 2||2
61478|NCT01582308|146312|P6|COMPLETED|10-day Washout Following Period 2||2
61479|NCT01582308|146313|P5|COMPLETED|10-day Washout Following Period 2||2
61480|NCT01582308|146314|P4|COMPLETED|10-day Washout Following Period 2||2
61481|NCT01582308|146315|P3|COMPLETED|10-day Washout Following Period 2||2
61482|NCT01582308|146316|P2|COMPLETED|10-day Washout Following Period 2||2
61483|NCT01582308|146317|P1|COMPLETED|10-day Washout Following Period 2||2
61484|NCT01582308|146308|P10|STARTED|10-day Washout Following Period 2||2
61485|NCT01582308|146309|P9|STARTED|10-day Washout Following Period 2||2
61486|NCT01582308|146310|P8|STARTED|10-day Washout Following Period 2||2
61487|NCT01582308|146311|P7|STARTED|10-day Washout Following Period 2||2
61488|NCT01582308|146312|P6|STARTED|10-day Washout Following Period 2||2
61489|NCT01582308|146313|P5|STARTED|10-day Washout Following Period 2||2
61490|NCT01582308|146314|P4|STARTED|10-day Washout Following Period 2||2
61491|NCT01582308|146315|P3|STARTED|10-day Washout Following Period 2||2
61492|NCT01582308|146316|P2|STARTED|10-day Washout Following Period 2||2
61493|NCT01582308|146317|P1|STARTED|10-day Washout Following Period 2||2
61494|NCT01582308|146308|P10|NOT COMPLETED|Period 2||0
61495|NCT01582308|146309|P9|NOT COMPLETED|Period 2||0
61496|NCT01582308|146310|P8|NOT COMPLETED|Period 2||0
61497|NCT01582308|146311|P7|NOT COMPLETED|Period 2||0
61498|NCT01582308|146312|P6|NOT COMPLETED|Period 2||0
61499|NCT01582308|146313|P5|NOT COMPLETED|Period 2||0
61500|NCT01582308|146314|P4|NOT COMPLETED|Period 2||0
61501|NCT01582308|146315|P3|NOT COMPLETED|Period 2||0
61502|NCT01582308|146316|P2|NOT COMPLETED|Period 2||0
61503|NCT01582308|146317|P1|NOT COMPLETED|Period 2||0
61504|NCT01582308|146308|P10|COMPLETED|Period 2||2
61505|NCT01582308|146309|P9|COMPLETED|Period 2||2
61506|NCT01582308|146310|P8|COMPLETED|Period 2||2
61507|NCT01582308|146311|P7|COMPLETED|Period 2||2
61508|NCT01582308|146312|P6|COMPLETED|Period 2||2
61509|NCT01582308|146313|P5|COMPLETED|Period 2||2
61510|NCT01582308|146314|P4|COMPLETED|Period 2||2
61511|NCT01582308|146315|P3|COMPLETED|Period 2||2
61512|NCT01582308|146316|P2|COMPLETED|Period 2||2
61513|NCT01582308|146317|P1|COMPLETED|Period 2||2
61514|NCT01582308|146308|P10|STARTED|Period 2||2
61515|NCT01582308|146309|P9|STARTED|Period 2||2
61516|NCT01582308|146310|P8|STARTED|Period 2||2
61517|NCT01582308|146311|P7|STARTED|Period 2||2
61518|NCT01582308|146312|P6|STARTED|Period 2||2
61519|NCT01582308|146313|P5|STARTED|Period 2||2
61520|NCT01582308|146314|P4|STARTED|Period 2||2
61521|NCT01582308|146315|P3|STARTED|Period 2||2
61522|NCT01582308|146316|P2|STARTED|Period 2||2
61523|NCT01582308|146317|P1|STARTED|Period 2||2
61524|NCT01582308|146308|P10|NOT COMPLETED|10-day Washout Following Period 1||0
61525|NCT01582308|146309|P9|NOT COMPLETED|10-day Washout Following Period 1||0
61526|NCT01582308|146310|P8|NOT COMPLETED|10-day Washout Following Period 1||0
61527|NCT01582308|146311|P7|NOT COMPLETED|10-day Washout Following Period 1||0
61528|NCT01582308|146312|P6|NOT COMPLETED|10-day Washout Following Period 1||0
61529|NCT01582308|146313|P5|NOT COMPLETED|10-day Washout Following Period 1||1
61530|NCT01582308|146314|P4|NOT COMPLETED|10-day Washout Following Period 1||0
61531|NCT01582308|146315|P3|NOT COMPLETED|10-day Washout Following Period 1||0
61532|NCT01582308|146316|P2|NOT COMPLETED|10-day Washout Following Period 1||0
61533|NCT01582308|146317|P1|NOT COMPLETED|10-day Washout Following Period 1||0
61534|NCT01582308|146308|P10|COMPLETED|10-day Washout Following Period 1||2
61535|NCT01582308|146309|P9|COMPLETED|10-day Washout Following Period 1||2
61536|NCT01582308|146310|P8|COMPLETED|10-day Washout Following Period 1||2
61537|NCT01582308|146311|P7|COMPLETED|10-day Washout Following Period 1||2
61538|NCT01582308|146312|P6|COMPLETED|10-day Washout Following Period 1||2
61539|NCT01582308|146313|P5|COMPLETED|10-day Washout Following Period 1||2
61540|NCT01582308|146314|P4|COMPLETED|10-day Washout Following Period 1||2
61541|NCT01582308|146315|P3|COMPLETED|10-day Washout Following Period 1||2
61542|NCT01582308|146316|P2|COMPLETED|10-day Washout Following Period 1||2
61543|NCT01582308|146317|P1|COMPLETED|10-day Washout Following Period 1||2
61544|NCT01582308|146308|P10|STARTED|10-day Washout Following Period 1||2
61545|NCT01582308|146309|P9|STARTED|10-day Washout Following Period 1||2
61546|NCT01582308|146310|P8|STARTED|10-day Washout Following Period 1||2
61547|NCT01582308|146311|P7|STARTED|10-day Washout Following Period 1||2
61548|NCT01582308|146312|P6|STARTED|10-day Washout Following Period 1||2
61549|NCT01582308|146313|P5|STARTED|10-day Washout Following Period 1||3
61550|NCT01582308|146314|P4|STARTED|10-day Washout Following Period 1||2
61551|NCT01582308|146315|P3|STARTED|10-day Washout Following Period 1||2
61552|NCT01582308|146316|P2|STARTED|10-day Washout Following Period 1||2
61553|NCT01582308|146317|P1|STARTED|10-day Washout Following Period 1||2
61554|NCT01582308|146308|P10|NOT COMPLETED|Period 1||0
61555|NCT01582308|146309|P9|NOT COMPLETED|Period 1||0
61556|NCT01582308|146310|P8|NOT COMPLETED|Period 1||0
61557|NCT01582308|146311|P7|NOT COMPLETED|Period 1||1
61558|NCT01582308|146312|P6|NOT COMPLETED|Period 1||0
61559|NCT01582308|146313|P5|NOT COMPLETED|Period 1||0
61560|NCT01582308|146314|P4|NOT COMPLETED|Period 1||0
61561|NCT01582308|146315|P3|NOT COMPLETED|Period 1||0
61562|NCT01582308|146316|P2|NOT COMPLETED|Period 1||0
61563|NCT01582308|146317|P1|NOT COMPLETED|Period 1||0
61564|NCT01582308|146308|P10|COMPLETED|Period 1||2
61565|NCT01582308|146309|P9|COMPLETED|Period 1||2
61566|NCT01582308|146310|P8|COMPLETED|Period 1||2
61567|NCT01582308|146311|P7|COMPLETED|Period 1||2
61568|NCT01582308|146312|P6|COMPLETED|Period 1||2
61569|NCT01582308|146313|P5|COMPLETED|Period 1||3
61570|NCT01582308|146314|P4|COMPLETED|Period 1||2
61571|NCT01582308|146315|P3|COMPLETED|Period 1||2
61572|NCT01582308|146316|P2|COMPLETED|Period 1||2
61573|NCT01582308|146317|P1|COMPLETED|Period 1||2
61574|NCT01582308|146308|P10|STARTED|Period 1||2
61575|NCT01582308|146309|P9|STARTED|Period 1||2
61576|NCT01582308|146310|P8|STARTED|Period 1||2
61577|NCT01582308|146311|P7|STARTED|Period 1|Includes replacement for a participant who discontinued during period 1|3
61578|NCT01582308|146312|P6|STARTED|Period 1||2
61579|NCT01582308|146313|P5|STARTED|Period 1|Includes replacement for a participant who discontinued after period 1|3
61580|NCT01582308|146314|P4|STARTED|Period 1||2
61581|NCT01582308|146315|P3|STARTED|Period 1||2
61582|NCT01582308|146316|P2|STARTED|Period 1||2
61583|NCT01582308|146317|P1|STARTED|Period 1||2
61584|NCT01582282|146345|P3|NOT COMPLETED|Overall Study||0
61585|NCT01582282|146346|P2|NOT COMPLETED|Overall Study||2
61586|NCT01582282|146347|P1|NOT COMPLETED|Overall Study||2
61587|NCT01582282|146345|P3|COMPLETED|Overall Study||8
61588|NCT01582282|146346|P2|COMPLETED|Overall Study||12
61589|NCT01582282|146347|P1|COMPLETED|Overall Study||13
61590|NCT01582282|146345|P3|STARTED|Overall Study||8
61591|NCT01582282|146346|P2|STARTED|Overall Study||14
61592|NCT01582282|146347|P1|STARTED|Overall Study||15
61593|NCT01582243|146370|P1|NOT COMPLETED|Overall Study||3
61594|NCT01582243|146370|P1|COMPLETED|Overall Study||37
61595|NCT01582243|146370|P1|STARTED|Overall Study||40
61596|NCT01582178|146381|P2|NOT COMPLETED|Overall Study||5
61597|NCT01582178|146382|P1|NOT COMPLETED|Overall Study||6
61598|NCT01582178|146381|P2|COMPLETED|Overall Study||101
61599|NCT01582178|146382|P1|COMPLETED|Overall Study||100
61600|NCT01582178|146381|P2|STARTED|Overall Study||106
61601|NCT01582178|146382|P1|STARTED|Overall Study||106
61602|NCT01582139|146390|P2|NOT COMPLETED|Overall Study||0
61603|NCT01582139|146391|P1|NOT COMPLETED|Overall Study||0
61604|NCT01582139|146390|P2|COMPLETED|Overall Study||6
61605|NCT01582139|146391|P1|COMPLETED|Overall Study||6
61606|NCT01582139|146390|P2|STARTED|Overall Study||6
61607|NCT01582139|146391|P1|STARTED|Overall Study||6
61608|NCT01582100|146403|P1|NOT COMPLETED|Overall Study||2
61609|NCT01582100|146403|P1|COMPLETED|Overall Study||0
61610|NCT01582100|146403|P1|STARTED|Overall Study||2
61611|NCT01582009|146407|P1|NOT COMPLETED|Overall Study||2
61612|NCT01582009|146407|P1|COMPLETED|Overall Study||24
61613|NCT01582009|146407|P1|STARTED|Overall Study||26
61614|NCT01581931|146415|P2|NOT COMPLETED|Second Period||0
61615|NCT01581931|146416|P1|NOT COMPLETED|Second Period||0
61616|NCT01581931|146415|P2|COMPLETED|Second Period||15
61617|NCT01581931|146416|P1|COMPLETED|Second Period||16
61618|NCT01581931|146415|P2|STARTED|Second Period||15
61619|NCT01581931|146416|P1|STARTED|Second Period||16
61620|NCT01581931|146415|P2|NOT COMPLETED|Washout||1
61621|NCT01581931|146416|P1|NOT COMPLETED|Washout||0
61622|NCT01581931|146415|P2|COMPLETED|Washout||15
61623|NCT01581931|146416|P1|COMPLETED|Washout||16
61624|NCT01581931|146415|P2|STARTED|Washout||16
61625|NCT01581931|146416|P1|STARTED|Washout||16
61626|NCT01581931|146415|P2|NOT COMPLETED|First Period||0
61627|NCT01581931|146416|P1|NOT COMPLETED|First Period||0
61628|NCT01581931|146415|P2|COMPLETED|First Period||16
61629|NCT01581931|146416|P1|COMPLETED|First Period||16
61630|NCT01581931|146415|P2|STARTED|First Period||16
61631|NCT01581931|146416|P1|STARTED|First Period||16
61632|NCT01581684|146440|P10|NOT COMPLETED|Overall Study||0
61633|NCT01581684|146441|P9|NOT COMPLETED|Overall Study||1
61634|NCT01581684|146442|P8|NOT COMPLETED|Overall Study||0
61635|NCT01581684|146443|P7|NOT COMPLETED|Overall Study||0
61636|NCT01581684|146444|P6|NOT COMPLETED|Overall Study||0
61637|NCT01581684|146445|P5|NOT COMPLETED|Overall Study||0
61638|NCT01581684|146446|P4|NOT COMPLETED|Overall Study||0
61639|NCT01581684|146447|P3|NOT COMPLETED|Overall Study||0
61640|NCT01581684|146448|P2|NOT COMPLETED|Overall Study||0
61641|NCT01581684|146449|P1|NOT COMPLETED|Overall Study||0
61642|NCT01581684|146440|P10|COMPLETED|Overall Study||5
61643|NCT01581684|146441|P9|COMPLETED|Overall Study||0
61644|NCT01581684|146442|P8|COMPLETED|Overall Study||6
61645|NCT01581684|146443|P7|COMPLETED|Overall Study||6
61646|NCT01581684|146444|P6|COMPLETED|Overall Study||6
61647|NCT01581684|146445|P5|COMPLETED|Overall Study||6
61648|NCT01581684|146446|P4|COMPLETED|Overall Study||6
61649|NCT01581684|146447|P3|COMPLETED|Overall Study||6
61650|NCT01581684|146448|P2|COMPLETED|Overall Study||6
61651|NCT01581684|146449|P1|COMPLETED|Overall Study||14
61652|NCT01581684|146440|P10|STARTED|Overall Study||5
61653|NCT01581684|146441|P9|STARTED|Overall Study||1
61654|NCT01581684|146442|P8|STARTED|Overall Study||6
61655|NCT01581684|146443|P7|STARTED|Overall Study||6
61656|NCT01581684|146444|P6|STARTED|Overall Study||6
61657|NCT01581684|146445|P5|STARTED|Overall Study||6
61658|NCT01581684|146446|P4|STARTED|Overall Study||6
61659|NCT01581684|146447|P3|STARTED|Overall Study||6
61660|NCT01581684|146448|P2|STARTED|Overall Study||6
61661|NCT01581684|146449|P1|STARTED|Overall Study||14
61662|NCT01581658|146524|P4|NOT COMPLETED|Overall Study||0
61663|NCT01581658|146525|P3|NOT COMPLETED|Overall Study||0
61664|NCT01581658|146526|P2|NOT COMPLETED|Overall Study||0
61665|NCT01581658|146527|P1|NOT COMPLETED|Overall Study||0
61666|NCT01581658|146524|P4|COMPLETED|Overall Study||8
61667|NCT01581658|146525|P3|COMPLETED|Overall Study||8
61668|NCT01581658|146526|P2|COMPLETED|Overall Study||8
61669|NCT01581658|146527|P1|COMPLETED|Overall Study||8
61670|NCT01581658|146524|P4|STARTED|Overall Study||8
61671|NCT01581658|146525|P3|STARTED|Overall Study||8
61672|NCT01581658|146526|P2|STARTED|Overall Study||8
61673|NCT01581658|146527|P1|STARTED|Overall Study||8
61674|NCT01581437|146545|P1|NOT COMPLETED|Overall Study||0
61675|NCT01581437|146545|P1|COMPLETED|Overall Study||78
61676|NCT01581437|146545|P1|STARTED|Overall Study||78
61677|NCT01581307|146556|P1|NOT COMPLETED|Overall Study||1
61678|NCT01581307|146556|P1|COMPLETED|Overall Study||8
61679|NCT01581307|146556|P1|STARTED|Overall Study||9
61680|NCT01581281|146565|P3|NOT COMPLETED|Overall Study||12
61681|NCT01581281|146566|P2|NOT COMPLETED|Overall Study||6
61682|NCT01581281|146567|P1|NOT COMPLETED|Overall Study||15
61683|NCT01581281|146565|P3|COMPLETED|Overall Study||132
61684|NCT01581281|146566|P2|COMPLETED|Overall Study||66
61685|NCT01581281|146567|P1|COMPLETED|Overall Study||130
61686|NCT01581281|146565|P3|STARTED|Overall Study||144
61687|NCT01581281|146566|P2|STARTED|Overall Study||72
61688|NCT01581281|146567|P1|STARTED|Overall Study||145
61689|NCT01581021|146589|P2|NOT COMPLETED|Overall Study||11
61690|NCT01581021|146590|P1|NOT COMPLETED|Overall Study||10
61691|NCT01581021|146589|P2|COMPLETED|Overall Study||18
61692|NCT01581021|146590|P1|COMPLETED|Overall Study||19
61693|NCT01581021|146589|P2|STARTED|Overall Study||29
61694|NCT01581021|146590|P1|STARTED|Overall Study||29
61695|NCT01581008|146604|P2|NOT COMPLETED|Overall Study||6
61696|NCT01581008|146605|P1|NOT COMPLETED|Overall Study||1
61697|NCT01581008|146604|P2|COMPLETED|Overall Study||7
61698|NCT01581008|146605|P1|COMPLETED|Overall Study||16
61699|NCT01581008|146604|P2|STARTED|Overall Study||13
61700|NCT01581008|146605|P1|STARTED|Overall Study||17
61701|NCT01580995|146616|P2|NOT COMPLETED|Overall Study||2
61702|NCT01580995|146617|P1|NOT COMPLETED|Overall Study||2
61703|NCT01580995|146616|P2|COMPLETED|Overall Study||7
61704|NCT01580995|146617|P1|COMPLETED|Overall Study||8
61705|NCT01580995|146616|P2|STARTED|Overall Study||9
61706|NCT01580995|146617|P1|STARTED|Overall Study||10
61707|NCT01580904|146625|P2|NOT COMPLETED|Overall Study||7
61708|NCT01580904|146626|P1|NOT COMPLETED|Overall Study||4
61709|NCT01580904|146625|P2|COMPLETED|Overall Study||42
61710|NCT01580904|146626|P1|COMPLETED|Overall Study||47
61711|NCT01580904|146625|P2|STARTED|Overall Study||49
61712|NCT01580904|146626|P1|STARTED|Overall Study||51
61713|NCT01580618|146640|P2|NOT COMPLETED|Overall Study||0
61714|NCT01580618|146641|P1|NOT COMPLETED|Overall Study||1
61715|NCT01580618|146640|P2|COMPLETED|Overall Study||12
61716|NCT01580618|146641|P1|COMPLETED|Overall Study|One patient was switched from the normal saline to TNKase arm at attending physician request.|7
61717|NCT01580618|146640|P2|STARTED|Overall Study||12
61718|NCT01580618|146641|P1|STARTED|Overall Study||8
61719|NCT01580592|146657|P3|NOT COMPLETED|Overall Study||0
61720|NCT01580592|146658|P2|NOT COMPLETED|Overall Study||0
61721|NCT01580592|146659|P1|NOT COMPLETED|Overall Study||0
61722|NCT01580592|146657|P3|COMPLETED|Overall Study||12
61723|NCT01580592|146658|P2|COMPLETED|Overall Study||9
61724|NCT01580592|146659|P1|COMPLETED|Overall Study||10
61725|NCT01580592|146657|P3|STARTED|Overall Study||12
61726|NCT01580592|146658|P2|STARTED|Overall Study||9
61727|NCT01580592|146659|P1|STARTED|Overall Study||10
61728|NCT01580488|146670|P1|NOT COMPLETED|Overall Study||1
61729|NCT01580488|146670|P1|COMPLETED|Overall Study||23
61730|NCT01580488|146670|P1|STARTED|Overall Study||24
61731|NCT01580423|146714|P2|NOT COMPLETED|Second Intervention||0
61732|NCT01580423|146715|P1|NOT COMPLETED|Second Intervention||0
61733|NCT01580423|146714|P2|COMPLETED|Second Intervention||8
61734|NCT01580423|146715|P1|COMPLETED|Second Intervention||8
61735|NCT01580423|146714|P2|STARTED|Second Intervention||8
61736|NCT01580423|146715|P1|STARTED|Second Intervention||8
61737|NCT01580423|146714|P2|NOT COMPLETED|First Intervention||0
61738|NCT01580423|146715|P1|NOT COMPLETED|First Intervention||0
61739|NCT01580423|146714|P2|COMPLETED|First Intervention||8
61740|NCT01580423|146715|P1|COMPLETED|First Intervention||8
61741|NCT01580423|146714|P2|STARTED|First Intervention||8
61742|NCT01580423|146715|P1|STARTED|First Intervention||8
61743|NCT01580306|146729|P4|NOT COMPLETED|Overall Study||0
61744|NCT01580306|146730|P3|NOT COMPLETED|Overall Study||0
61745|NCT01580306|146731|P2|NOT COMPLETED|Overall Study||0
61746|NCT01580306|146732|P1|NOT COMPLETED|Overall Study||0
61747|NCT01580306|146729|P4|COMPLETED|Overall Study||8
61748|NCT01580306|146730|P3|COMPLETED|Overall Study||8
61749|NCT01580306|146731|P2|COMPLETED|Overall Study||8
61750|NCT01580306|146732|P1|COMPLETED|Overall Study||8
61751|NCT01580306|146729|P4|STARTED|Overall Study||8
61752|NCT01580306|146730|P3|STARTED|Overall Study||8
61753|NCT01580306|146731|P2|STARTED|Overall Study||8
61754|NCT01580306|146732|P1|STARTED|Overall Study||8
61755|NCT01580098|146756|P3|NOT COMPLETED|Overall Study||3
61756|NCT01580098|146757|P2|NOT COMPLETED|Overall Study||13
61757|NCT01580098|146758|P1|NOT COMPLETED|Overall Study||15
61758|NCT01580098|146756|P3|COMPLETED|Overall Study|Due to high age and bad health conditions no patients finished (nursing)|0
61759|NCT01580098|146757|P2|COMPLETED|Overall Study||101
61760|NCT01580098|146758|P1|COMPLETED|Overall Study||61
61761|NCT01580098|146756|P3|STARTED|Overall Study||3
61762|NCT01580098|146757|P2|STARTED|Overall Study||114
61763|NCT01580098|146758|P1|STARTED|Overall Study||76
61764|NCT01580072|146781|P3|NOT COMPLETED|Overall Study||0
61765|NCT01580072|146782|P2|NOT COMPLETED|Overall Study||9
61766|NCT01580072|146783|P1|NOT COMPLETED|Overall Study||12
61767|NCT01580072|146781|P3|COMPLETED|Overall Study||0
61768|NCT01580072|146782|P2|COMPLETED|Overall Study||28
61769|NCT01580072|146783|P1|COMPLETED|Overall Study||16
61770|NCT01580072|146781|P3|STARTED|Overall Study||0
61771|NCT01580072|146782|P2|STARTED|Overall Study||37
61772|NCT01580072|146783|P1|STARTED|Overall Study||28
61773|NCT01580020|146811|P4|NOT COMPLETED|Overall Study||2
61774|NCT01580020|146812|P3|NOT COMPLETED|Overall Study||4
61775|NCT01580020|146813|P2|NOT COMPLETED|Overall Study||7
61776|NCT01580020|146814|P1|NOT COMPLETED|Overall Study||1
61777|NCT01580020|146811|P4|COMPLETED|Overall Study||20
61778|NCT01580020|146812|P3|COMPLETED|Overall Study||57
61779|NCT01580020|146813|P2|COMPLETED|Overall Study||33
61780|NCT01580020|146814|P1|COMPLETED|Overall Study||51
61781|NCT01580020|146811|P4|STARTED|Overall Study||22
61782|NCT01580020|146812|P3|STARTED|Overall Study||61
61783|NCT01580020|146813|P2|STARTED|Overall Study||40
61784|NCT01580020|146814|P1|STARTED|Overall Study||52
61785|NCT01579916|146858|P2|NOT COMPLETED|Overall Study||2
61786|NCT01579916|146859|P1|NOT COMPLETED|Overall Study||8
61787|NCT01579916|146858|P2|COMPLETED|Overall Study||59
61788|NCT01579916|146859|P1|COMPLETED|Overall Study||234
61789|NCT01579916|146858|P2|STARTED|Overall Study||61
61790|NCT01579916|146859|P1|STARTED|Overall Study||242
61791|NCT01579747|146887|P2|NOT COMPLETED|Overall Study||0
61792|NCT01579747|146888|P1|NOT COMPLETED|Overall Study||0
61793|NCT01579747|146887|P2|COMPLETED|Overall Study||12
61794|NCT01579747|146888|P1|COMPLETED|Overall Study||12
61795|NCT01579747|146887|P2|STARTED|Overall Study||12
61796|NCT01579747|146888|P1|STARTED|Overall Study||12
61797|NCT01579669|146898|P2|NOT COMPLETED|Overall Study||0
61798|NCT01579669|146899|P1|NOT COMPLETED|Overall Study||36
61799|NCT01579669|146898|P2|COMPLETED|Overall Study||41
61800|NCT01579669|146899|P1|COMPLETED|Overall Study||134
61801|NCT01579669|146898|P2|STARTED|Overall Study||41
61802|NCT01579669|146899|P1|STARTED|Overall Study||170
61803|NCT01579578|146911|P2|NOT COMPLETED|Overall Study||12
61804|NCT01579578|146912|P1|NOT COMPLETED|Overall Study||13
61805|NCT01579578|146911|P2|COMPLETED|Overall Study||0
61806|NCT01579578|146912|P1|COMPLETED|Overall Study||0
61807|NCT01579578|146911|P2|Ongoing|Overall Study||0
61808|NCT01579578|146912|P1|Ongoing|Overall Study||3
61809|NCT01579578|146911|P2|STARTED|Overall Study||12
61810|NCT01579578|146912|P1|STARTED|Overall Study||13
61811|NCT01579565|146924|P2|NOT COMPLETED|Treated||3
61812|NCT01579565|146925|P1|NOT COMPLETED|Treated||2
61813|NCT01579565|146924|P2|COMPLETED|Treated||201
61814|NCT01579565|146925|P1|COMPLETED|Treated||200
61815|NCT01579565|146924|P2|STARTED|Treated||204
61816|NCT01579565|146925|P1|STARTED|Treated||202
61817|NCT01579565|146924|P2|NOT COMPLETED|Randomized||5
61818|NCT01579565|146925|P1|NOT COMPLETED|Randomized||5
61819|NCT01579565|146924|P2|COMPLETED|Randomized||204
61820|NCT01579565|146925|P1|COMPLETED|Randomized||202
61821|NCT01579565|146924|P2|STARTED|Randomized||209
61822|NCT01579565|146925|P1|STARTED|Randomized||207
61823|NCT01579474|146959|P6|NOT COMPLETED|Overall Study||1
61824|NCT01579474|146960|P5|NOT COMPLETED|Overall Study||1
61825|NCT01579474|146961|P4|NOT COMPLETED|Overall Study||0
61826|NCT01579474|146962|P3|NOT COMPLETED|Overall Study||2
61827|NCT01579474|146963|P2|NOT COMPLETED|Overall Study||13
61828|NCT01579474|146964|P1|NOT COMPLETED|Overall Study||3
61829|NCT01579474|146959|P6|COMPLETED|Overall Study||1
61830|NCT01579474|146960|P5|COMPLETED|Overall Study||9
61831|NCT01579474|146961|P4|COMPLETED|Overall Study||3
61832|NCT01579474|146962|P3|COMPLETED|Overall Study||27
61833|NCT01579474|146963|P2|COMPLETED|Overall Study||30
61834|NCT01579474|146964|P1|COMPLETED|Overall Study||41
61835|NCT01579474|146959|P6|STARTED|Overall Study||2
61836|NCT01579474|146960|P5|STARTED|Overall Study||10
61837|NCT01579474|146961|P4|STARTED|Overall Study||3
61838|NCT01579474|146962|P3|STARTED|Overall Study||29
61839|NCT01579474|146963|P2|STARTED|Overall Study||43
61840|NCT01579474|146964|P1|STARTED|Overall Study||44
61841|NCT01579305|147040|P2|NOT COMPLETED|Overall Study||27
61842|NCT01579305|147041|P1|NOT COMPLETED|Overall Study||21
61843|NCT01579305|147040|P2|COMPLETED|Overall Study||115
61844|NCT01579305|147041|P1|COMPLETED|Overall Study||118
61845|NCT01579305|147040|P2|Continued After Treatment|Overall Study||141
61846|NCT01579305|147041|P1|Continued After Treatment|Overall Study||139
61847|NCT01579305|147040|P2|Discontinued Before Treatment|Overall Study||1
61848|NCT01579305|147041|P1|Discontinued Before Treatment|Overall Study||0
61849|NCT01579305|147040|P2|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|142
61850|NCT01579305|147041|P1|STARTED|Overall Study|Subjects that signed Informed Consent, passed screening criteria, and were randomized.|139
61851|NCT01579084|147057|P10|NOT COMPLETED|Overall Study||0
61852|NCT01579084|147058|P9|NOT COMPLETED|Overall Study||0
61853|NCT01579084|147059|P8|NOT COMPLETED|Overall Study||0
61854|NCT01579084|147060|P7|NOT COMPLETED|Overall Study||0
61855|NCT01579084|147061|P6|NOT COMPLETED|Overall Study||0
61856|NCT01579084|147062|P5|NOT COMPLETED|Overall Study||0
61857|NCT01579084|147063|P4|NOT COMPLETED|Overall Study||0
61858|NCT01579084|147064|P3|NOT COMPLETED|Overall Study||0
61859|NCT01579084|147065|P2|NOT COMPLETED|Overall Study||0
61860|NCT01579084|147066|P1|NOT COMPLETED|Overall Study||0
61861|NCT01579084|147057|P10|COMPLETED|Overall Study||4
61862|NCT01579084|147058|P9|COMPLETED|Overall Study||4
61863|NCT01579084|147059|P8|COMPLETED|Overall Study||4
61864|NCT01579084|147060|P7|COMPLETED|Overall Study||4
61865|NCT01579084|147061|P6|COMPLETED|Overall Study||8
61866|NCT01579084|147062|P5|COMPLETED|Overall Study||8
61867|NCT01579084|147063|P4|COMPLETED|Overall Study||8
61868|NCT01579084|147064|P3|COMPLETED|Overall Study||8
61869|NCT01579084|147065|P2|COMPLETED|Overall Study||8
61870|NCT01579084|147066|P1|COMPLETED|Overall Study||8
61871|NCT01579084|147057|P10|STARTED|Overall Study||4
61872|NCT01579084|147058|P9|STARTED|Overall Study||4
61873|NCT01579084|147059|P8|STARTED|Overall Study||4
61874|NCT01579084|147060|P7|STARTED|Overall Study||4
61875|NCT01579084|147061|P6|STARTED|Overall Study||8
61876|NCT01579084|147062|P5|STARTED|Overall Study||8
61877|NCT01579084|147063|P4|STARTED|Overall Study||8
61878|NCT01579084|147064|P3|STARTED|Overall Study||8
61879|NCT01579084|147065|P2|STARTED|Overall Study||8
61880|NCT01579084|147066|P1|STARTED|Overall Study||8
61881|NCT01579045|147094|P1|NOT COMPLETED|Overall Study||0
61882|NCT01579045|147094|P1|COMPLETED|Overall Study||24
61883|NCT01579045|147094|P1|STARTED|Overall Study||24
61884|NCT01579006|147111|P1|NOT COMPLETED|Overall Study||33
61885|NCT01579006|147111|P1|COMPLETED|Overall Study||151
61886|NCT01579006|147111|P1|STARTED|Overall Study||184
61887|NCT01578993|147150|P1|NOT COMPLETED|Overall Study||0
61888|NCT01578993|147150|P1|COMPLETED|Overall Study||101
61889|NCT01578993|147150|P1|STARTED|Overall Study||101
61890|NCT01578980|147154|P1|NOT COMPLETED|Overall Study||0
61891|NCT01578980|147154|P1|COMPLETED|Overall Study||20
61892|NCT01578980|147154|P1|STARTED|Overall Study||20
61893|NCT01578850|147161|P3|NOT COMPLETED|Period 2||14
61894|NCT01578850|147162|P2|NOT COMPLETED|Period 2||13
61895|NCT01578850|147163|P1|NOT COMPLETED|Period 2||0
61896|NCT01578850|147161|P3|COMPLETED|Period 2||162
61897|NCT01578850|147162|P2|COMPLETED|Period 2||154
61898|NCT01578850|147163|P1|COMPLETED|Period 2||0
61899|NCT01578850|147161|P3|STARTED|Period 2|One participants in PBO did not receive treatment.|176
61900|NCT01578850|147162|P2|STARTED|Period 2|Two participants in ETN did not receive treatment.|167
61901|NCT01578850|147163|P1|STARTED|Period 2||0
61902|NCT01578850|147161|P3|NOT COMPLETED|Period 1||0
61903|NCT01578850|147162|P2|NOT COMPLETED|Period 1||0
61904|NCT01578850|147163|P1|NOT COMPLETED|Period 1||37
61905|NCT01578850|147161|P3|COMPLETED|Period 1||0
61906|NCT01578850|147162|P2|COMPLETED|Period 1||0
61907|NCT01578850|147163|P1|COMPLETED|Period 1||452
61908|NCT01578850|147161|P3|STARTED|Period 1||0
61909|NCT01578850|147162|P2|STARTED|Period 1||0
61910|NCT01578850|147163|P1|STARTED|Period 1|491 participants were enrolled in open-label treatment but 2 did not receive study medication.|489
61911|NCT01578785|147215|P2|NOT COMPLETED|Overall Study||119
61912|NCT01578785|147216|P1|NOT COMPLETED|Overall Study||59
61913|NCT01578785|147215|P2|COMPLETED|Overall Study||0
61914|NCT01578785|147216|P1|COMPLETED|Overall Study||0
61915|NCT01578785|147215|P2|STARTED|Overall Study||119
61916|NCT01578785|147216|P1|STARTED|Overall Study||59
61917|NCT01578772|147228|P1|NOT COMPLETED|Overall Study||0
61918|NCT01578772|147228|P1|COMPLETED|Overall Study||17
61919|NCT01578772|147228|P1|STARTED|Overall Study||17
61920|NCT01578707|147237|P2|NOT COMPLETED|Overall Study||0
61921|NCT01578707|147238|P1|NOT COMPLETED|Overall Study||0
61922|NCT01578707|147237|P2|COMPLETED|Overall Study||195
61923|NCT01578707|147238|P1|COMPLETED|Overall Study||196
61924|NCT01578707|147237|P2|STARTED|Overall Study||195
61925|NCT01578707|147238|P1|STARTED|Overall Study||196
61926|NCT01578330|147246|P1|NOT COMPLETED|Overall Study||7
61927|NCT01578330|147246|P1|COMPLETED|Overall Study||35
61928|NCT01578330|147246|P1|Per Protocol Population|Overall Study||35
61929|NCT01578330|147246|P1|STARTED|Overall Study||42
61930|NCT01578187|147253|P1|NOT COMPLETED|Usability Phase||1
61931|NCT01578187|147253|P1|COMPLETED|Usability Phase||47
61932|NCT01578187|147253|P1|STARTED|Usability Phase||48
61933|NCT01578187|147253|P1|NOT COMPLETED|Label Comprehension Phase||0
61934|NCT01578187|147253|P1|COMPLETED|Label Comprehension Phase||63
61935|NCT01578187|147253|P1|STARTED|Label Comprehension Phase||63
61936|NCT01578044|147261|P2|NOT COMPLETED|Overall Study||0
61937|NCT01578044|147262|P1|NOT COMPLETED|Overall Study||0
61938|NCT01578044|147261|P2|COMPLETED|Overall Study||6
61939|NCT01578044|147262|P1|COMPLETED|Overall Study||6
61940|NCT01578044|147261|P2|STARTED|Overall Study||6
61941|NCT01578044|147262|P1|STARTED|Overall Study||6
61942|NCT01578031|147272|P4|NOT COMPLETED|Overall Study||0
61943|NCT01578031|147273|P3|NOT COMPLETED|Overall Study||0
61944|NCT01578031|147274|P2|NOT COMPLETED|Overall Study||34
61945|NCT01578031|147275|P1|NOT COMPLETED|Overall Study||62
61946|NCT01578031|147272|P4|COMPLETED|Overall Study|Only baseline data collected|30
61947|NCT01578031|147273|P3|COMPLETED|Overall Study|Only baseline data collected|12
61948|NCT01578031|147274|P2|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|35
61949|NCT01578031|147275|P1|COMPLETED|Overall Study|Follow-up obtained only in subjects with average PAP use at least 4 hr/day|67
61950|NCT01578031|147272|P4|STARTED|Overall Study||30
61951|NCT01578031|147273|P3|STARTED|Overall Study||12
61952|NCT01578031|147274|P2|STARTED|Overall Study||69
61953|NCT01578031|147275|P1|STARTED|Overall Study||129
61954|NCT01577966|147283|P1|NOT COMPLETED|Overall Study||0
61955|NCT01577966|147283|P1|COMPLETED|Overall Study||9
61956|NCT01577966|147283|P1|STARTED|Overall Study||9
61957|NCT01577758|147287|P8|NOT COMPLETED|mCRC Expansion Phase||25
61958|NCT01577758|147288|P7|NOT COMPLETED|mCRC Expansion Phase||0
61959|NCT01577758|147289|P6|NOT COMPLETED|mCRC Expansion Phase||0
61960|NCT01577758|147290|P5|NOT COMPLETED|mCRC Expansion Phase||0
61961|NCT01577758|147291|P4|NOT COMPLETED|mCRC Expansion Phase||0
61962|NCT01577758|147292|P3|NOT COMPLETED|mCRC Expansion Phase||0
61963|NCT01577758|147293|P2|NOT COMPLETED|mCRC Expansion Phase||0
61964|NCT01577758|147294|P1|NOT COMPLETED|mCRC Expansion Phase||0
61965|NCT01577758|147287|P8|COMPLETED|mCRC Expansion Phase||0
61966|NCT01577758|147288|P7|COMPLETED|mCRC Expansion Phase||0
61967|NCT01577758|147289|P6|COMPLETED|mCRC Expansion Phase||0
61968|NCT01577758|147290|P5|COMPLETED|mCRC Expansion Phase||0
61969|NCT01577758|147291|P4|COMPLETED|mCRC Expansion Phase||0
61970|NCT01577758|147292|P3|COMPLETED|mCRC Expansion Phase||0
61971|NCT01577758|147293|P2|COMPLETED|mCRC Expansion Phase||0
61972|NCT01577758|147294|P1|COMPLETED|mCRC Expansion Phase||0
61973|NCT01577758|147287|P8|STARTED|mCRC Expansion Phase||25
61974|NCT01577758|147288|P7|STARTED|mCRC Expansion Phase||0
61975|NCT01577758|147289|P6|STARTED|mCRC Expansion Phase||0
61976|NCT01577758|147290|P5|STARTED|mCRC Expansion Phase||0
61977|NCT01577758|147291|P4|STARTED|mCRC Expansion Phase||0
61978|NCT01577758|147292|P3|STARTED|mCRC Expansion Phase||0
61979|NCT01577758|147293|P2|STARTED|mCRC Expansion Phase||0
61980|NCT01577758|147294|P1|STARTED|mCRC Expansion Phase||0
61981|NCT01577758|147287|P8|NOT COMPLETED|Dose Escalation Phase||0
61982|NCT01577758|147288|P7|NOT COMPLETED|Dose Escalation Phase||1
61983|NCT01577758|147289|P6|NOT COMPLETED|Dose Escalation Phase||4
61984|NCT01577758|147290|P5|NOT COMPLETED|Dose Escalation Phase||6
61985|NCT01577758|147291|P4|NOT COMPLETED|Dose Escalation Phase||2
61986|NCT01577758|147292|P3|NOT COMPLETED|Dose Escalation Phase||2
61987|NCT01577758|147293|P2|NOT COMPLETED|Dose Escalation Phase||2
61988|NCT01577758|147294|P1|NOT COMPLETED|Dose Escalation Phase||2
61989|NCT01577758|147287|P8|COMPLETED|Dose Escalation Phase||0
61990|NCT01577758|147288|P7|COMPLETED|Dose Escalation Phase||0
61991|NCT01577758|147289|P6|COMPLETED|Dose Escalation Phase||0
61992|NCT01577758|147290|P5|COMPLETED|Dose Escalation Phase||0
61993|NCT01577758|147291|P4|COMPLETED|Dose Escalation Phase||0
61994|NCT01577758|147292|P3|COMPLETED|Dose Escalation Phase||0
61995|NCT01577758|147293|P2|COMPLETED|Dose Escalation Phase||0
61996|NCT01577758|147294|P1|COMPLETED|Dose Escalation Phase||0
61997|NCT01577758|147287|P8|STARTED|Dose Escalation Phase||0
61998|NCT01577758|147288|P7|STARTED|Dose Escalation Phase||1
61999|NCT01577758|147289|P6|STARTED|Dose Escalation Phase||4
62000|NCT01577758|147290|P5|STARTED|Dose Escalation Phase||6
62001|NCT01577758|147291|P4|STARTED|Dose Escalation Phase||2
62002|NCT01577758|147292|P3|STARTED|Dose Escalation Phase||2
62003|NCT01577758|147293|P2|STARTED|Dose Escalation Phase||2
62004|NCT01577758|147294|P1|STARTED|Dose Escalation Phase||2
62005|NCT01577745|147333|P6|NOT COMPLETED|Overall Study||4
62006|NCT01577745|147334|P5|NOT COMPLETED|Overall Study||5
62007|NCT01577745|147335|P4|NOT COMPLETED|Overall Study||6
62008|NCT01577745|147336|P3|NOT COMPLETED|Overall Study||2
62009|NCT01577745|147337|P2|NOT COMPLETED|Overall Study||3
62010|NCT01577745|147338|P1|NOT COMPLETED|Overall Study||3
62011|NCT01577745|147333|P6|COMPLETED|Overall Study||1
62012|NCT01577745|147334|P5|COMPLETED|Overall Study||0
62013|NCT01577745|147335|P4|COMPLETED|Overall Study||0
62014|NCT01577745|147336|P3|COMPLETED|Overall Study||1
62015|NCT01577745|147337|P2|COMPLETED|Overall Study||0
62016|NCT01577745|147338|P1|COMPLETED|Overall Study||0
62017|NCT01577745|147333|P6|STARTED|Overall Study||5
62018|NCT01577745|147334|P5|STARTED|Overall Study||5
62019|NCT01577745|147335|P4|STARTED|Overall Study||6
62020|NCT01577745|147336|P3|STARTED|Overall Study||3
62021|NCT01577745|147337|P2|STARTED|Overall Study||3
62022|NCT01577745|147338|P1|STARTED|Overall Study||3
62023|NCT01577732|147455|P1|NOT COMPLETED|Overall Study||0
62024|NCT01577732|147455|P1|COMPLETED|Overall Study||300
62025|NCT01577732|147455|P1|STARTED|Overall Study||300
62026|NCT01577706|147462|P3|NOT COMPLETED|Third Intervention (1 Day)||0
62027|NCT01577706|147463|P2|NOT COMPLETED|Third Intervention (1 Day)||0
62028|NCT01577706|147464|P1|NOT COMPLETED|Third Intervention (1 Day)||0
62029|NCT01577706|147462|P3|COMPLETED|Third Intervention (1 Day)||3
62030|NCT01577706|147463|P2|COMPLETED|Third Intervention (1 Day)||1
62031|NCT01577706|147464|P1|COMPLETED|Third Intervention (1 Day)||3
62032|NCT01577706|147462|P3|STARTED|Third Intervention (1 Day)||3
62033|NCT01577706|147463|P2|STARTED|Third Intervention (1 Day)||1
62034|NCT01577706|147464|P1|STARTED|Third Intervention (1 Day)||3
62035|NCT01577706|147462|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
62036|NCT01577706|147463|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
62037|NCT01577706|147464|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
62038|NCT01577706|147462|P3|COMPLETED|Washout (at Least 1 Week)||3
62039|NCT01577706|147463|P2|COMPLETED|Washout (at Least 1 Week)||1
62040|NCT01577706|147464|P1|COMPLETED|Washout (at Least 1 Week)||3
62041|NCT01577706|147462|P3|STARTED|Washout (at Least 1 Week)||3
62042|NCT01577706|147463|P2|STARTED|Washout (at Least 1 Week)||1
62043|NCT01577706|147464|P1|STARTED|Washout (at Least 1 Week)||3
62044|NCT01577706|147462|P3|NOT COMPLETED|Second Intervention (1 Day)||0
62045|NCT01577706|147463|P2|NOT COMPLETED|Second Intervention (1 Day)||0
62046|NCT01577706|147464|P1|NOT COMPLETED|Second Intervention (1 Day)||0
62047|NCT01577706|147462|P3|COMPLETED|Second Intervention (1 Day)||3
62048|NCT01577706|147463|P2|COMPLETED|Second Intervention (1 Day)||1
62049|NCT01577706|147464|P1|COMPLETED|Second Intervention (1 Day)||3
62050|NCT01577706|147462|P3|STARTED|Second Intervention (1 Day)||3
62051|NCT01577706|147463|P2|STARTED|Second Intervention (1 Day)||1
62052|NCT01577706|147464|P1|STARTED|Second Intervention (1 Day)||3
62053|NCT01577706|147462|P3|NOT COMPLETED|Washout (at Least 1 Week)||0
62054|NCT01577706|147463|P2|NOT COMPLETED|Washout (at Least 1 Week)||0
62055|NCT01577706|147464|P1|NOT COMPLETED|Washout (at Least 1 Week)||0
62056|NCT01577706|147462|P3|COMPLETED|Washout (at Least 1 Week)||3
62057|NCT01577706|147463|P2|COMPLETED|Washout (at Least 1 Week)||1
62058|NCT01577706|147464|P1|COMPLETED|Washout (at Least 1 Week)||3
62059|NCT01577706|147462|P3|STARTED|Washout (at Least 1 Week)||3
62060|NCT01577706|147463|P2|STARTED|Washout (at Least 1 Week)||1
62061|NCT01577706|147464|P1|STARTED|Washout (at Least 1 Week)||3
62062|NCT01577706|147462|P3|NOT COMPLETED|First Intervention (1 Day)||0
62063|NCT01577706|147463|P2|NOT COMPLETED|First Intervention (1 Day)||0
62064|NCT01577706|147464|P1|NOT COMPLETED|First Intervention (1 Day)||0
62065|NCT01577706|147462|P3|COMPLETED|First Intervention (1 Day)||3
62066|NCT01577706|147463|P2|COMPLETED|First Intervention (1 Day)||1
62067|NCT01577706|147464|P1|COMPLETED|First Intervention (1 Day)||3
62068|NCT01577706|147462|P3|STARTED|First Intervention (1 Day)||3
62069|NCT01577706|147463|P2|STARTED|First Intervention (1 Day)||1
62070|NCT01577706|147464|P1|STARTED|First Intervention (1 Day)||3
62071|NCT01577628|147492|P3|NOT COMPLETED|Overall Study||2
62072|NCT01577628|147493|P2|NOT COMPLETED|Overall Study||0
62073|NCT01577628|147494|P1|NOT COMPLETED|Overall Study||0
62074|NCT01577628|147492|P3|COMPLETED|Overall Study||0
62075|NCT01577628|147493|P2|COMPLETED|Overall Study||0
62076|NCT01577628|147494|P1|COMPLETED|Overall Study||0
62077|NCT01577628|147492|P3|STARTED|Overall Study||2
62078|NCT01577628|147493|P2|STARTED|Overall Study||0
62079|NCT01577628|147494|P1|STARTED|Overall Study||0
62080|NCT01577381|147522|P4|NOT COMPLETED|Overall Study||2
62081|NCT01577381|147523|P3|NOT COMPLETED|Overall Study||3
62082|NCT01577381|147524|P2|NOT COMPLETED|Overall Study||3
62083|NCT01577381|147525|P1|NOT COMPLETED|Overall Study||2
62084|NCT01577381|147522|P4|COMPLETED|Overall Study||0
62085|NCT01577381|147523|P3|COMPLETED|Overall Study||0
62086|NCT01577381|147524|P2|COMPLETED|Overall Study||0
62087|NCT01577381|147525|P1|COMPLETED|Overall Study||0
62088|NCT01577381|147522|P4|STARTED|Overall Study||2
62089|NCT01577381|147523|P3|STARTED|Overall Study||3
62090|NCT01577381|147524|P2|STARTED|Overall Study||3
62091|NCT01577381|147525|P1|STARTED|Overall Study||2
62092|NCT01577329|147656|P2|NOT COMPLETED|Overall Study||0
62093|NCT01577329|147657|P1|NOT COMPLETED|Overall Study||3
62094|NCT01577329|147656|P2|COMPLETED|Overall Study||22
62095|NCT01577329|147657|P1|COMPLETED|Overall Study||16
62096|NCT01577329|147656|P2|STARTED|Overall Study||22
62097|NCT01577329|147657|P1|STARTED|Overall Study||19
62098|NCT01577186|147663|P1|NOT COMPLETED|Overall Study||130
62099|NCT01577186|147663|P1|COMPLETED|Overall Study||350
62100|NCT01577186|147663|P1|STARTED|Overall Study||480
62101|NCT01577160|147671|P1|NOT COMPLETED|Overall Study||98
62102|NCT01577160|147671|P1|COMPLETED|Overall Study||255
62103|NCT01577160|147671|P1|STARTED|Overall Study||353
62104|NCT01577108|147681|P2|NOT COMPLETED|Overall Study||6
62105|NCT01577108|147682|P1|NOT COMPLETED|Overall Study||5
62106|NCT01577108|147681|P2|COMPLETED|Overall Study||50
62107|NCT01577108|147682|P1|COMPLETED|Overall Study||49
62108|NCT01577108|147681|P2|STARTED|Overall Study||56
62109|NCT01577108|147682|P1|STARTED|Overall Study||54
62110|NCT01576952|147690|P2|NOT COMPLETED|Overall Study||55
62111|NCT01576952|147691|P1|NOT COMPLETED|Overall Study||41
62112|NCT01576952|147690|P2|COMPLETED|Overall Study||33
62113|NCT01576952|147691|P1|COMPLETED|Overall Study||139
62114|NCT01576952|147690|P2|mITT Population|Overall Study||85
62115|NCT01576952|147691|P1|mITT Population|Overall Study||168
62116|NCT01576952|147690|P2|Safety Population|Overall Study||85
62117|NCT01576952|147691|P1|Safety Population|Overall Study||169
62118|NCT01576952|147690|P2|STARTED|Overall Study||88
62119|NCT01576952|147691|P1|STARTED|Overall Study||180
62120|NCT01576939|147697|P1|NOT COMPLETED|Overall Study||0
62121|NCT01576939|147697|P1|COMPLETED|Overall Study||30
62122|NCT01576939|147697|P1|STARTED|Overall Study||30
62123|NCT01576809|147705|P1|NOT COMPLETED|Overall Study||0
62124|NCT01576809|147705|P1|COMPLETED|Overall Study||51
62125|NCT01576809|147705|P1|STARTED|Overall Study||51
62126|NCT01576718|147717|P7|NOT COMPLETED|Treatment Period||30
62127|NCT01576718|147718|P6|NOT COMPLETED|Treatment Period||48
62128|NCT01576718|147719|P5|NOT COMPLETED|Treatment Period||27
62129|NCT01576718|147720|P4|NOT COMPLETED|Treatment Period||31
62130|NCT01576718|147721|P3|NOT COMPLETED|Treatment Period||20
62131|NCT01576718|147722|P2|NOT COMPLETED|Treatment Period||25
62132|NCT01576718|147723|P1|NOT COMPLETED|Treatment Period||0
62133|NCT01576718|147717|P7|COMPLETED|Treatment Period||77
62134|NCT01576718|147718|P6|COMPLETED|Treatment Period||58
62135|NCT01576718|147719|P5|COMPLETED|Treatment Period||80
62136|NCT01576718|147720|P4|COMPLETED|Treatment Period||75
62137|NCT01576718|147721|P3|COMPLETED|Treatment Period||87
62138|NCT01576718|147722|P2|COMPLETED|Treatment Period||82
62139|NCT01576718|147723|P1|COMPLETED|Treatment Period||0
62140|NCT01576718|147717|P7|Efficacy Population (Full Analysis Set)|Treatment Period||103
62141|NCT01576718|147718|P6|Efficacy Population (Full Analysis Set)|Treatment Period||105
62142|NCT01576718|147719|P5|Efficacy Population (Full Analysis Set)|Treatment Period||107
62143|NCT01576718|147720|P4|Efficacy Population (Full Analysis Set)|Treatment Period||102
62144|NCT01576718|147721|P3|Efficacy Population (Full Analysis Set)|Treatment Period||106
62145|NCT01576718|147722|P2|Efficacy Population (Full Analysis Set)|Treatment Period||107
62146|NCT01576718|147723|P1|Efficacy Population (Full Analysis Set)|Treatment Period||0
62147|NCT01576718|147717|P7|Safety Population|Treatment Period||106
62148|NCT01576718|147718|P6|Safety Population|Treatment Period||106
62149|NCT01576718|147719|P5|Safety Population|Treatment Period||107
62150|NCT01576718|147720|P4|Safety Population|Treatment Period||106
62151|NCT01576718|147721|P3|Safety Population|Treatment Period||107
62152|NCT01576718|147722|P2|Safety Population|Treatment Period||107
62153|NCT01576718|147723|P1|Safety Population|Treatment Period||0
62154|NCT01576718|147717|P7|STARTED|Treatment Period||107
62155|NCT01576718|147718|P6|STARTED|Treatment Period||106
62156|NCT01576718|147719|P5|STARTED|Treatment Period||107
62157|NCT01576718|147720|P4|STARTED|Treatment Period||106
62158|NCT01576718|147721|P3|STARTED|Treatment Period||107
62159|NCT01576718|147722|P2|STARTED|Treatment Period||107
62160|NCT01576718|147723|P1|STARTED|Treatment Period||0
62161|NCT01576718|147717|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62162|NCT01576718|147718|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62163|NCT01576718|147719|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62164|NCT01576718|147720|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62165|NCT01576718|147721|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62166|NCT01576718|147722|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62167|NCT01576718|147723|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||249
62168|NCT01576718|147717|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62169|NCT01576718|147718|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62170|NCT01576718|147719|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62171|NCT01576718|147720|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62172|NCT01576718|147721|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62173|NCT01576718|147722|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
62174|NCT01576718|147723|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)|Participants randomized into the Treatment Period|640
62175|NCT01576718|147717|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
62176|NCT01576718|147718|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
62177|NCT01576718|147719|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
62178|NCT01576718|147720|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
62179|NCT01576718|147721|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
62273|NCT01575197|148014|P1|NOT COMPLETED|Overall Study||3
62180|NCT01576718|147722|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
62181|NCT01576718|147723|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||889
62182|NCT01576471|147817|P2|NOT COMPLETED|Overall Study||9
62183|NCT01576471|147818|P1|NOT COMPLETED|Overall Study||8
62184|NCT01576471|147817|P2|COMPLETED|Overall Study||116
62185|NCT01576471|147818|P1|COMPLETED|Overall Study||117
62186|NCT01576471|147817|P2|STARTED|Overall Study||125
62187|NCT01576471|147818|P1|STARTED|Overall Study||125
62188|NCT01576367|147824|P1|NOT COMPLETED|Overall Study||3
62189|NCT01576367|147824|P1|COMPLETED|Overall Study||14
62190|NCT01576367|147824|P1|STARTED|Overall Study||17
62191|NCT01576341|147832|P1|NOT COMPLETED|Overall Study||93
62192|NCT01576341|147832|P1|COMPLETED|Overall Study||324
62193|NCT01576341|147832|P1|STARTED|Overall Study||417
62194|NCT01576159|147843|P4|NOT COMPLETED|Overall Study||1
62195|NCT01576159|147844|P3|NOT COMPLETED|Overall Study||1
62196|NCT01576159|147845|P2|NOT COMPLETED|Overall Study||1
62197|NCT01576159|147846|P1|NOT COMPLETED|Overall Study||1
62198|NCT01576159|147843|P4|COMPLETED|Overall Study||11
62199|NCT01576159|147844|P3|COMPLETED|Overall Study||11
62200|NCT01576159|147845|P2|COMPLETED|Overall Study||11
62201|NCT01576159|147846|P1|COMPLETED|Overall Study||11
62202|NCT01576159|147843|P4|STARTED|Overall Study||12
62203|NCT01576159|147844|P3|STARTED|Overall Study||12
62204|NCT01576159|147845|P2|STARTED|Overall Study||12
62205|NCT01576159|147846|P1|STARTED|Overall Study||12
62206|NCT01576146|147864|P1|NOT COMPLETED|Extension Period 2||17
62207|NCT01576146|147864|P1|COMPLETED|Extension Period 2||0
62208|NCT01576146|147864|P1|STARTED|Extension Period 2|Three participants who completed Extension Period 1 did not enroll in Period 2|17
62209|NCT01576146|147864|P1|NOT COMPLETED|Extension Period 1||10
62210|NCT01576146|147864|P1|COMPLETED|Extension Period 1||20
62211|NCT01576146|147864|P1|STARTED|Extension Period 1||30
62212|NCT01576120|147873|P2|NOT COMPLETED|Overall Study||0
62213|NCT01576120|147874|P1|NOT COMPLETED|Overall Study||0
62214|NCT01576120|147873|P2|COMPLETED|Overall Study||19
62215|NCT01576120|147874|P1|COMPLETED|Overall Study||21
62216|NCT01576120|147873|P2|STARTED|Overall Study||19
62217|NCT01576120|147874|P1|STARTED|Overall Study||21
62218|NCT01576055|147882|P2|NOT COMPLETED|Overall Study||6
62219|NCT01576055|147883|P1|NOT COMPLETED|Overall Study||19
62220|NCT01576055|147882|P2|COMPLETED|Overall Study||64
62221|NCT01576055|147883|P1|COMPLETED|Overall Study||178
62222|NCT01576055|147882|P2|STARTED|Overall Study||70
62223|NCT01576055|147883|P1|STARTED|Overall Study||197
62224|NCT01576042|147897|P2|NOT COMPLETED|Overall Study||0
62225|NCT01576042|147898|P1|NOT COMPLETED|Overall Study||2
62226|NCT01576042|147897|P2|COMPLETED|Overall Study||14
62227|NCT01576042|147898|P1|COMPLETED|Overall Study||11
62228|NCT01576042|147897|P2|Switched to the Other Arm|Overall Study||1
62229|NCT01576042|147898|P1|Switched to the Other Arm|Overall Study||5
62230|NCT01576042|147897|P2|STARTED|Overall Study||14
62231|NCT01576042|147898|P1|STARTED|Overall Study||13
62232|NCT01575912|147921|P3|NOT COMPLETED|Overall Study||0
62233|NCT01575912|147922|P2|NOT COMPLETED|Overall Study||0
62234|NCT01575912|147923|P1|NOT COMPLETED|Overall Study||0
62235|NCT01575912|147921|P3|COMPLETED|Overall Study||30
62236|NCT01575912|147922|P2|COMPLETED|Overall Study||32
62237|NCT01575912|147923|P1|COMPLETED|Overall Study||30
62238|NCT01575912|147921|P3|STARTED|Overall Study||30
62239|NCT01575912|147922|P2|STARTED|Overall Study||32
62240|NCT01575912|147923|P1|STARTED|Overall Study||30
62241|NCT01575899|147934|P3|NOT COMPLETED|Overall Study||2
62242|NCT01575899|147935|P2|NOT COMPLETED|Overall Study||5
62243|NCT01575899|147936|P1|NOT COMPLETED|Overall Study||5
62244|NCT01575899|147934|P3|COMPLETED|Overall Study||60
62245|NCT01575899|147935|P2|COMPLETED|Overall Study||68
62246|NCT01575899|147936|P1|COMPLETED|Overall Study||68
62247|NCT01575899|147934|P3|STARTED|Overall Study|Included patients still with Hp infection after previous therapy without levofloxacin and Augmentin.|62
62248|NCT01575899|147935|P2|STARTED|Overall Study||73
62249|NCT01575899|147936|P1|STARTED|Overall Study||73
62250|NCT01575769|147946|P1|NOT COMPLETED|Overall Study||41
62251|NCT01575769|147946|P1|COMPLETED|Overall Study||0
62252|NCT01575769|147946|P1|STARTED|Overall Study||41
62253|NCT01575756|147972|P2|NOT COMPLETED|Treatment Period 2||0
62254|NCT01575756|147973|P1|NOT COMPLETED|Treatment Period 2||0
62255|NCT01575756|147972|P2|COMPLETED|Treatment Period 2||11
62256|NCT01575756|147973|P1|COMPLETED|Treatment Period 2||11
62257|NCT01575756|147972|P2|STARTED|Treatment Period 2||11
62258|NCT01575756|147973|P1|STARTED|Treatment Period 2||11
62259|NCT01575756|147972|P2|NOT COMPLETED|Treatment Period 1||0
62260|NCT01575756|147973|P1|NOT COMPLETED|Treatment Period 1||0
62261|NCT01575756|147972|P2|COMPLETED|Treatment Period 1||11
62262|NCT01575756|147973|P1|COMPLETED|Treatment Period 1||11
62263|NCT01575756|147972|P2|STARTED|Treatment Period 1||11
62264|NCT01575756|147973|P1|STARTED|Treatment Period 1||11
62265|NCT01575561|147989|P1|NOT COMPLETED|Overall Study||39
62266|NCT01575561|147989|P1|COMPLETED|Overall Study||338
62267|NCT01575561|147989|P1|STARTED|Overall Study||377
62268|NCT01575522|148001|P1|NOT COMPLETED|Overall Study||0
62269|NCT01575522|148001|P1|COMPLETED|Overall Study||22
62270|NCT01575522|148001|P1|STARTED|Overall Study||22
62271|NCT01575197|148012|P3|NOT COMPLETED|Overall Study||6
62272|NCT01575197|148013|P2|NOT COMPLETED|Overall Study||9
62274|NCT01575197|148012|P3|COMPLETED|Overall Study||146
62275|NCT01575197|148013|P2|COMPLETED|Overall Study||143
62276|NCT01575197|148014|P1|COMPLETED|Overall Study||149
62277|NCT01575197|148012|P3|STARTED|Overall Study||152
62278|NCT01575197|148013|P2|STARTED|Overall Study||152
62279|NCT01575197|148014|P1|STARTED|Overall Study||152
62280|NCT01575080|148027|P1|NOT COMPLETED|Overall Study||0
62281|NCT01575080|148027|P1|COMPLETED|Overall Study||102
62282|NCT01575080|148027|P1|STARTED|Overall Study||102
62283|NCT01573910|148036|P2|NOT COMPLETED|Overall Study||17
62284|NCT01573910|148037|P1|NOT COMPLETED|Overall Study||20
62285|NCT01573910|148036|P2|COMPLETED|Overall Study||476
62286|NCT01573910|148037|P1|COMPLETED|Overall Study||469
62287|NCT01573910|148036|P2|STARTED|Overall Study||493
62288|NCT01573910|148037|P1|STARTED|Overall Study||489
62289|NCT01575054|148047|P2|NOT COMPLETED|Overall Study||26
62290|NCT01575054|148048|P1|NOT COMPLETED|Overall Study||29
62291|NCT01575054|148047|P2|COMPLETED|Overall Study||209
62292|NCT01575054|148048|P1|COMPLETED|Overall Study||204
62293|NCT01575054|148047|P2|STARTED|Overall Study||235
62294|NCT01575054|148048|P1|STARTED|Overall Study||233
62295|NCT01575028|148064|P2|NOT COMPLETED|Overall Study||1
62296|NCT01575028|148065|P1|NOT COMPLETED|Overall Study||0
62297|NCT01575028|148064|P2|COMPLETED|Overall Study||0
62298|NCT01575028|148065|P1|COMPLETED|Overall Study||2
62299|NCT01575028|148064|P2|STARTED|Overall Study||1
62300|NCT01575028|148065|P1|STARTED|Overall Study||2
62301|NCT01574703|148075|P4|NOT COMPLETED|Overall Study||114
62302|NCT01574703|148076|P3|NOT COMPLETED|Overall Study||105
62303|NCT01574703|148077|P2|NOT COMPLETED|Overall Study||112
62304|NCT01574703|148078|P1|NOT COMPLETED|Overall Study||125
62305|NCT01574703|148075|P4|COMPLETED|Overall Study||1007
62306|NCT01574703|148076|P3|COMPLETED|Overall Study||1011
62307|NCT01574703|148077|P2|COMPLETED|Overall Study||1054
62308|NCT01574703|148078|P1|COMPLETED|Overall Study||1067
62309|NCT01574703|148075|P4|STARTED|Overall Study||1121
62310|NCT01574703|148076|P3|STARTED|Overall Study||1116
62311|NCT01574703|148077|P2|STARTED|Overall Study||1166
62312|NCT01574703|148078|P1|STARTED|Overall Study||1192
62313|NCT01574651|148122|P2|NOT COMPLETED|Overall Study||52
62314|NCT01574651|148123|P1|NOT COMPLETED|Overall Study||61
62315|NCT01574651|148122|P2|COMPLETED|Overall Study||406
62316|NCT01574651|148123|P1|COMPLETED|Overall Study||415
62317|NCT01574651|148122|P2|Per Protocol Set (PPS)|Overall Study||374
62318|NCT01574651|148123|P1|Per Protocol Set (PPS)|Overall Study||373
62319|NCT01574651|148122|P2|Full Analysis Set (FAS)|Overall Study||458
62320|NCT01574651|148123|P1|Full Analysis Set (FAS)|Overall Study||476
62321|NCT01574651|148122|P2|STARTED|Overall Study||458
62322|NCT01574651|148123|P1|STARTED|Overall Study||476
62323|NCT01574612|148145|P1|NOT COMPLETED|Overall Study||8
62324|NCT01574612|148145|P1|COMPLETED|Overall Study||46
62325|NCT01574612|148145|P1|STARTED|Overall Study|patients who were identified as having the appropriate medical history of herpes labialis|54
62326|NCT01574326|148151|P2|NOT COMPLETED|Overall Study||19
62327|NCT01574326|148152|P1|NOT COMPLETED|Overall Study||16
62328|NCT01574326|148151|P2|COMPLETED|Overall Study||31
62329|NCT01574326|148152|P1|COMPLETED|Overall Study||35
62330|NCT01574326|148151|P2|Treated|Overall Study||49
62331|NCT01574326|148152|P1|Treated|Overall Study||51
62332|NCT01574326|148151|P2|STARTED|Overall Study||50
62333|NCT01574326|148152|P1|STARTED|Overall Study||51
62334|NCT01574248|148165|P2|NOT COMPLETED|Overall Study||0
62335|NCT01574248|148166|P1|NOT COMPLETED|Overall Study||3
62336|NCT01574248|148165|P2|COMPLETED|Overall Study||18
62337|NCT01574248|148166|P1|COMPLETED|Overall Study||12
62338|NCT01574248|148165|P2|STARTED|Overall Study||18
62339|NCT01574248|148166|P1|STARTED|Overall Study||15
62340|NCT01574183|148186|P2|NOT COMPLETED|Overall Study||18
62341|NCT01574183|148187|P1|NOT COMPLETED|Overall Study||27
62342|NCT01574183|148186|P2|COMPLETED|Overall Study||17
62343|NCT01574183|148187|P1|COMPLETED|Overall Study||14
62344|NCT01574183|148186|P2|STARTED|Overall Study||35
62345|NCT01574183|148187|P1|STARTED|Overall Study||41
62346|NCT01574105|148199|P2|NOT COMPLETED|Overall Study||0
62347|NCT01574105|148200|P1|NOT COMPLETED|Overall Study||0
62348|NCT01574105|148199|P2|COMPLETED|Overall Study||37
62349|NCT01574105|148200|P1|COMPLETED|Overall Study||29
62350|NCT01574105|148199|P2|STARTED|Overall Study||37
62351|NCT01574105|148200|P1|STARTED|Overall Study||29
62352|NCT01574079|148210|P2|NOT COMPLETED|Overall Study||2
62353|NCT01574079|148211|P1|NOT COMPLETED|Overall Study||1
62354|NCT01574079|148210|P2|COMPLETED|Overall Study||13
62355|NCT01574079|148211|P1|COMPLETED|Overall Study||17
62356|NCT01574079|148210|P2|STARTED|Overall Study||15
62357|NCT01574079|148211|P1|STARTED|Overall Study||18
62358|NCT01573767|148225|P4|NOT COMPLETED|Overall Study||24
62359|NCT01573767|148226|P3|NOT COMPLETED|Overall Study||14
62360|NCT01573767|148227|P2|NOT COMPLETED|Overall Study||21
62361|NCT01573767|148228|P1|NOT COMPLETED|Overall Study||22
62362|NCT01573767|148225|P4|COMPLETED|Overall Study||90
62363|NCT01573767|148226|P3|COMPLETED|Overall Study||99
62364|NCT01573767|148227|P2|COMPLETED|Overall Study||93
62365|NCT01573767|148228|P1|COMPLETED|Overall Study||93
62366|NCT01573767|148225|P4|STARTED|Overall Study||114
62367|NCT01573767|148226|P3|STARTED|Overall Study||113
62368|NCT01573767|148227|P2|STARTED|Overall Study||114
62369|NCT01573767|148228|P1|STARTED|Overall Study||115
62370|NCT01573624|148262|P7|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
62371|NCT01573624|148263|P6|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
62372|NCT01573624|148264|P5|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||2
62373|NCT01573624|148265|P4|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
62374|NCT01573624|148266|P3|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
62375|NCT01573624|148267|P2|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||0
62376|NCT01573624|148268|P1|NOT COMPLETED|Period 6 : Follow-up Period (7 Days)||1
62377|NCT01573624|148262|P7|COMPLETED|Period 6 : Follow-up Period (7 Days)||48
62378|NCT01573624|148263|P6|COMPLETED|Period 6 : Follow-up Period (7 Days)||38
62379|NCT01573624|148264|P5|COMPLETED|Period 6 : Follow-up Period (7 Days)||49
62380|NCT01573624|148265|P4|COMPLETED|Period 6 : Follow-up Period (7 Days)||53
62381|NCT01573624|148266|P3|COMPLETED|Period 6 : Follow-up Period (7 Days)||43
62382|NCT01573624|148267|P2|COMPLETED|Period 6 : Follow-up Period (7 Days)||47
62383|NCT01573624|148268|P1|COMPLETED|Period 6 : Follow-up Period (7 Days)||45
62384|NCT01573624|148262|P7|STARTED|Period 6 : Follow-up Period (7 Days)||48
62385|NCT01573624|148263|P6|STARTED|Period 6 : Follow-up Period (7 Days)||39
62386|NCT01573624|148264|P5|STARTED|Period 6 : Follow-up Period (7 Days)||51
62387|NCT01573624|148265|P4|STARTED|Period 6 : Follow-up Period (7 Days)||53
62388|NCT01573624|148266|P3|STARTED|Period 6 : Follow-up Period (7 Days)||43
62389|NCT01573624|148267|P2|STARTED|Period 6 : Follow-up Period (7 Days)||47
62390|NCT01573624|148268|P1|STARTED|Period 6 : Follow-up Period (7 Days)||46
62391|NCT01573624|148262|P7|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||4
62392|NCT01573624|148263|P6|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||2
62393|NCT01573624|148264|P5|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
62394|NCT01573624|148265|P4|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
62395|NCT01573624|148266|P3|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||0
62396|NCT01573624|148267|P2|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||1
62397|NCT01573624|148268|P1|NOT COMPLETED|Period 5 : Treatment Period 3 (14 Days)||3
62398|NCT01573624|148262|P7|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||48
62399|NCT01573624|148263|P6|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||39
62400|NCT01573624|148264|P5|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||51
62401|NCT01573624|148265|P4|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||53
62402|NCT01573624|148266|P3|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||43
62403|NCT01573624|148267|P2|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||47
62404|NCT01573624|148268|P1|COMPLETED|Period 5 : Treatment Period 3 (14 Days)||46
62405|NCT01573624|148262|P7|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
62406|NCT01573624|148263|P6|STARTED|Period 5 : Treatment Period 3 (14 Days)||41
62407|NCT01573624|148264|P5|STARTED|Period 5 : Treatment Period 3 (14 Days)||52
62408|NCT01573624|148265|P4|STARTED|Period 5 : Treatment Period 3 (14 Days)||53
62409|NCT01573624|148266|P3|STARTED|Period 5 : Treatment Period 3 (14 Days)||43
62410|NCT01573624|148267|P2|STARTED|Period 5 : Treatment Period 3 (14 Days)||48
62411|NCT01573624|148268|P1|STARTED|Period 5 : Treatment Period 3 (14 Days)||49
62412|NCT01573624|148262|P7|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||3
62413|NCT01573624|148263|P6|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
62414|NCT01573624|148264|P5|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
62415|NCT01573624|148265|P4|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
62416|NCT01573624|148266|P3|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||2
62417|NCT01573624|148267|P2|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||4
62418|NCT01573624|148268|P1|NOT COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||1
62419|NCT01573624|148262|P7|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
62420|NCT01573624|148263|P6|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||41
62421|NCT01573624|148264|P5|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||52
62422|NCT01573624|148265|P4|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||53
62423|NCT01573624|148266|P3|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||43
62424|NCT01573624|148267|P2|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||48
62425|NCT01573624|148268|P1|COMPLETED|Period 4 : Washout Period 2 (12-14 Days)||49
62426|NCT01573624|148262|P7|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
62427|NCT01573624|148263|P6|STARTED|Period 4 : Washout Period 2 (12-14 Days)||43
62428|NCT01573624|148264|P5|STARTED|Period 4 : Washout Period 2 (12-14 Days)||53
62429|NCT01573624|148265|P4|STARTED|Period 4 : Washout Period 2 (12-14 Days)||55
62430|NCT01573624|148266|P3|STARTED|Period 4 : Washout Period 2 (12-14 Days)||45
62431|NCT01573624|148267|P2|STARTED|Period 4 : Washout Period 2 (12-14 Days)||52
62432|NCT01573624|148268|P1|STARTED|Period 4 : Washout Period 2 (12-14 Days)||50
62433|NCT01573624|148262|P7|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||0
62434|NCT01573624|148263|P6|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||5
62435|NCT01573624|148264|P5|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
62436|NCT01573624|148265|P4|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||1
62437|NCT01573624|148266|P3|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||3
62438|NCT01573624|148267|P2|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||6
62439|NCT01573624|148268|P1|NOT COMPLETED|Period 3 : Treatment Period 2 (14 Days)||7
62440|NCT01573624|148262|P7|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
62441|NCT01573624|148263|P6|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||43
62442|NCT01573624|148264|P5|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||53
62443|NCT01573624|148265|P4|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||55
62444|NCT01573624|148266|P3|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||45
62445|NCT01573624|148267|P2|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||52
62446|NCT01573624|148268|P1|COMPLETED|Period 3 : Treatment Period 2 (14 Days)||50
62447|NCT01573624|148262|P7|STARTED|Period 3 : Treatment Period 2 (14 Days)||55
62448|NCT01573624|148263|P6|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
62449|NCT01573624|148264|P5|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
62450|NCT01573624|148265|P4|STARTED|Period 3 : Treatment Period 2 (14 Days)||56
62451|NCT01573624|148266|P3|STARTED|Period 3 : Treatment Period 2 (14 Days)||48
62452|NCT01573624|148267|P2|STARTED|Period 3 : Treatment Period 2 (14 Days)||58
62453|NCT01573624|148268|P1|STARTED|Period 3 : Treatment Period 2 (14 Days)||57
62454|NCT01573624|148262|P7|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||2
62455|NCT01573624|148263|P6|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
62456|NCT01573624|148264|P5|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||0
62457|NCT01573624|148265|P4|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||5
62458|NCT01573624|148266|P3|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||3
62459|NCT01573624|148267|P2|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
62460|NCT01573624|148268|P1|NOT COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||1
62461|NCT01573624|148262|P7|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||55
62462|NCT01573624|148263|P6|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
62463|NCT01573624|148264|P5|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
62464|NCT01573624|148265|P4|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||56
62465|NCT01573624|148266|P3|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||48
62466|NCT01573624|148267|P2|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||58
62467|NCT01573624|148268|P1|COMPLETED|Period 2 : Washout Period 1 (12-14 Days)||57
62468|NCT01573624|148262|P7|STARTED|Period 2 : Washout Period 1 (12-14 Days)||57
62469|NCT01573624|148263|P6|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
62470|NCT01573624|148264|P5|STARTED|Period 2 : Washout Period 1 (12-14 Days)||56
62471|NCT01573624|148265|P4|STARTED|Period 2 : Washout Period 1 (12-14 Days)||61
62472|NCT01573624|148266|P3|STARTED|Period 2 : Washout Period 1 (12-14 Days)||51
62473|NCT01573624|148267|P2|STARTED|Period 2 : Washout Period 1 (12-14 Days)||59
62474|NCT01573624|148268|P1|STARTED|Period 2 : Washout Period 1 (12-14 Days)||58
62475|NCT01573624|148262|P7|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
62476|NCT01573624|148263|P6|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||4
62477|NCT01573624|148264|P5|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
62478|NCT01573624|148265|P4|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||2
62479|NCT01573624|148266|P3|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||9
62480|NCT01573624|148267|P2|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||3
62481|NCT01573624|148268|P1|NOT COMPLETED|Period 1 : Treatment Period 1 (14 Days)||6
62482|NCT01573624|148262|P7|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||57
62483|NCT01573624|148263|P6|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
62484|NCT01573624|148264|P5|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||56
62485|NCT01573624|148265|P4|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||61
62486|NCT01573624|148266|P3|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||51
62487|NCT01573624|148267|P2|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||59
62488|NCT01573624|148268|P1|COMPLETED|Period 1 : Treatment Period 1 (14 Days)||58
62489|NCT01573624|148262|P7|STARTED|Period 1 : Treatment Period 1 (14 Days)||59
62490|NCT01573624|148263|P6|STARTED|Period 1 : Treatment Period 1 (14 Days)||55
62491|NCT01573624|148264|P5|STARTED|Period 1 : Treatment Period 1 (14 Days)||58
62492|NCT01573624|148265|P4|STARTED|Period 1 : Treatment Period 1 (14 Days)||63
62493|NCT01573624|148266|P3|STARTED|Period 1 : Treatment Period 1 (14 Days)||60
62494|NCT01573624|148267|P2|STARTED|Period 1 : Treatment Period 1 (14 Days)||62
62495|NCT01573624|148268|P1|STARTED|Period 1 : Treatment Period 1 (14 Days)||64
62496|NCT01573325|148315|P1|NOT COMPLETED|Overall Study||0
62497|NCT01573325|148315|P1|COMPLETED|Overall Study||50
62498|NCT01573325|148315|P1|STARTED|Overall Study||50
62499|NCT01573260|148322|P2|NOT COMPLETED|Overall Study||0
62500|NCT01573260|148323|P1|NOT COMPLETED|Overall Study||0
62501|NCT01573260|148322|P2|COMPLETED|Overall Study||15
62502|NCT01573260|148323|P1|COMPLETED|Overall Study||18
62503|NCT01573260|148322|P2|STARTED|Overall Study||15
62504|NCT01573260|148323|P1|STARTED|Overall Study||18
62505|NCT01573000|148357|P2|NOT COMPLETED|Long-Term Follow-Up||1
62506|NCT01573000|148358|P1|NOT COMPLETED|Long-Term Follow-Up||3
62507|NCT01573000|148357|P2|COMPLETED|Long-Term Follow-Up|One participant who received crossover treatment was lost to follow up.|4
62508|NCT01573000|148358|P1|COMPLETED|Long-Term Follow-Up||11
62509|NCT01573000|148357|P2|STARTED|Long-Term Follow-Up|5 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|5
62510|NCT01573000|148358|P1|STARTED|Long-Term Follow-Up|14 of the 35 participants withdrawing from Study BEX104515 enrolled in long-term follow-up study.|14
62511|NCT01573000|148357|P2|NOT COMPLETED|Crossover Phase||18
62512|NCT01573000|148358|P1|NOT COMPLETED|Crossover Phase||0
62513|NCT01573000|148357|P2|COMPLETED|Crossover Phase|This participant completed 2 years of follow up and enrolled in BEX104526.|1
62514|NCT01573000|148358|P1|COMPLETED|Crossover Phase||0
62515|NCT01573000|148357|P2|STARTED|Crossover Phase|19 of 36 par. randomized to receive Unlabeled TST crossed over to receive TST and Iodine I 131 TST.|19
62516|NCT01573000|148358|P1|STARTED|Crossover Phase||0
62517|NCT01573000|148357|P2|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
62518|NCT01573000|148358|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||35
62519|NCT01573000|148357|P2|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|1
62520|NCT01573000|148358|P1|COMPLETED|Dosimetric and Therapeutic Treatment|These participants completed 2 years of follow up and enrolled in BEX104526.|7
62521|NCT01573000|148357|P2|STARTED|Dosimetric and Therapeutic Treatment||36
62522|NCT01573000|148358|P1|STARTED|Dosimetric and Therapeutic Treatment||42
62523|NCT01572948|148454|P2|NOT COMPLETED|Overall Study||1
62524|NCT01572948|148455|P1|NOT COMPLETED|Overall Study||1
62525|NCT01572948|148454|P2|COMPLETED|Overall Study||15
62526|NCT01572948|148455|P1|COMPLETED|Overall Study||10
62527|NCT01572948|148454|P2|STARTED|Overall Study||16
62528|NCT01572948|148455|P1|STARTED|Overall Study||11
62529|NCT01572792|148476|P5|NOT COMPLETED|Extension Study||32
62530|NCT01572792|148477|P4|NOT COMPLETED|Extension Study||29
62531|NCT01572792|148478|P3|NOT COMPLETED|Extension Study||26
62532|NCT01572792|148479|P2|NOT COMPLETED|Extension Study||29
62533|NCT01572792|148480|P1|NOT COMPLETED|Extension Study||25
62534|NCT01572792|148476|P5|COMPLETED|Extension Study||160
62535|NCT01572792|148477|P4|COMPLETED|Extension Study||165
62536|NCT01572792|148478|P3|COMPLETED|Extension Study||179
62537|NCT01572792|148479|P2|COMPLETED|Extension Study||155
62538|NCT01572792|148480|P1|COMPLETED|Extension Study||121
62539|NCT01572792|148476|P5|STARTED|Extension Study||192
62540|NCT01572792|148477|P4|STARTED|Extension Study||194
62541|NCT01572792|148478|P3|STARTED|Extension Study||205
62542|NCT01572792|148479|P2|STARTED|Extension Study||184
62543|NCT01572792|148480|P1|STARTED|Extension Study||146
62544|NCT01572792|148476|P5|NOT COMPLETED|Lead-in Study||69
62545|NCT01572792|148477|P4|NOT COMPLETED|Lead-in Study||72
62546|NCT01572792|148478|P3|NOT COMPLETED|Lead-in Study||62
62547|NCT01572792|148479|P2|NOT COMPLETED|Lead-in Study||66
62548|NCT01572792|148480|P1|NOT COMPLETED|Lead-in Study||101
62549|NCT01572792|148476|P5|COMPLETED|Lead-in Study||270
62550|NCT01572792|148477|P4|COMPLETED|Lead-in Study||268
62551|NCT01572792|148478|P3|COMPLETED|Lead-in Study||276
62552|NCT01572792|148479|P2|COMPLETED|Lead-in Study||272
62553|NCT01572792|148480|P1|COMPLETED|Lead-in Study||236
62554|NCT01572792|148476|P5|STARTED|Lead-in Study||339
62555|NCT01572792|148477|P4|STARTED|Lead-in Study||340
62556|NCT01572792|148478|P3|STARTED|Lead-in Study||338
62557|NCT01572792|148479|P2|STARTED|Lead-in Study||338
62558|NCT01572792|148480|P1|STARTED|Lead-in Study||337
62559|NCT01572740|148529|P2|NOT COMPLETED|Overall Study||5
62560|NCT01572740|148530|P1|NOT COMPLETED|Overall Study||6
62561|NCT01572740|148529|P2|COMPLETED|Overall Study||125
62562|NCT01572740|148530|P1|COMPLETED|Overall Study||121
62563|NCT01572740|148529|P2|STARTED|Overall Study||130
62564|NCT01572740|148530|P1|STARTED|Overall Study||127
62565|NCT01572727|148560|P2|NOT COMPLETED|Overall Study||209
62566|NCT01572727|148561|P1|NOT COMPLETED|Overall Study||207
62567|NCT01572727|148560|P2|COMPLETED|Overall Study||0
62568|NCT01572727|148561|P1|COMPLETED|Overall Study||0
62569|NCT01572727|148560|P2|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|201
62570|NCT01572727|148561|P1|Pts With Treatment + Safety Assessment|Overall Study|patients who received study treatment and had at least one post-baseline safety assessment|202
62571|NCT01572727|148560|P2|STARTED|Overall Study||209
62572|NCT01572727|148561|P1|STARTED|Overall Study||207
62573|NCT01572675|148583|P2|NOT COMPLETED|Overall Study||223
62574|NCT01572675|148584|P1|NOT COMPLETED|Overall Study||237
62575|NCT01572675|148583|P2|COMPLETED|Overall Study||56
62576|NCT01572675|148584|P1|COMPLETED|Overall Study||31
62577|NCT01572675|148583|P2|STARTED|Overall Study||279
62578|NCT01572675|148584|P1|STARTED|Overall Study||268
62579|NCT01572298|148683|P2|NOT COMPLETED|Overall Study||1
62580|NCT01572298|148684|P1|NOT COMPLETED|Overall Study||2
62581|NCT01572298|148683|P2|COMPLETED|Overall Study||12
62582|NCT01572298|148684|P1|COMPLETED|Overall Study||12
62583|NCT01572298|148683|P2|STARTED|Overall Study||13
62584|NCT01572298|148684|P1|STARTED|Overall Study||14
62585|NCT01572207|148692|P2|NOT COMPLETED|Overall Study||3
62586|NCT01572207|148693|P1|NOT COMPLETED|Overall Study||2
62587|NCT01572207|148692|P2|COMPLETED|Overall Study||13
62588|NCT01572207|148693|P1|COMPLETED|Overall Study||12
62589|NCT01572207|148692|P2|STARTED|Overall Study||16
62590|NCT01572207|148693|P1|STARTED|Overall Study||14
62591|NCT01571557|148703|P1|NOT COMPLETED|Overall Study||0
62592|NCT01571557|148703|P1|COMPLETED|Overall Study||573
62593|NCT01571557|148703|P1|STARTED|Overall Study||573
62594|NCT01571453|148712|P2|NOT COMPLETED|Overall Study||62
62595|NCT01571453|148713|P1|NOT COMPLETED|Overall Study||38
62596|NCT01571453|148712|P2|COMPLETED|Overall Study||164
62597|NCT01571453|148713|P1|COMPLETED|Overall Study||173
62598|NCT01571453|148712|P2|STARTED|Overall Study||226
62599|NCT01571453|148713|P1|STARTED|Overall Study||211
62600|NCT01571362|148729|P3|NOT COMPLETED|Double-Blind Treatment Period||39
62601|NCT01571362|148730|P2|NOT COMPLETED|Double-Blind Treatment Period||53
62602|NCT01571362|148731|P1|NOT COMPLETED|Double-Blind Treatment Period||0
62603|NCT01571362|148729|P3|COMPLETED|Double-Blind Treatment Period||107
62604|NCT01571362|148730|P2|COMPLETED|Double-Blind Treatment Period||81
62691|NCT01569815|149058|P4|NOT COMPLETED|Overall Study||0
62605|NCT01571362|148731|P1|COMPLETED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
62606|NCT01571362|148729|P3|STARTED|Double-Blind Treatment Period||146
62607|NCT01571362|148730|P2|STARTED|Double-Blind Treatment Period||134
62608|NCT01571362|148731|P1|STARTED|Double-Blind Treatment Period|This phase preceded the Double-Blind Treatment Period.|0
62609|NCT01571362|148729|P3|NOT COMPLETED|Open-Label Conversion + Titration Period||0
62610|NCT01571362|148730|P2|NOT COMPLETED|Open-Label Conversion + Titration Period||0
62611|NCT01571362|148731|P1|NOT COMPLETED|Open-Label Conversion + Titration Period||129
62612|NCT01571362|148729|P3|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
62613|NCT01571362|148730|P2|COMPLETED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
62614|NCT01571362|148731|P1|COMPLETED|Open-Label Conversion + Titration Period||281
62615|NCT01571362|148729|P3|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
62616|NCT01571362|148730|P2|STARTED|Open-Label Conversion + Titration Period|This phase commenced after the Open-Label Period.|0
62617|NCT01571362|148731|P1|STARTED|Open-Label Conversion + Titration Period||410
62618|NCT01571232|148903|P2|NOT COMPLETED|Overall Study||1
62619|NCT01571232|148904|P1|NOT COMPLETED|Overall Study||1
62620|NCT01571232|148903|P2|COMPLETED|Overall Study||9
62621|NCT01571232|148904|P1|COMPLETED|Overall Study||9
62622|NCT01571232|148903|P2|STARTED|Overall Study||10
62623|NCT01571232|148904|P1|STARTED|Overall Study||10
62624|NCT01570751|148916|P2|NOT COMPLETED|Period B (16 Weeks)||1
62625|NCT01570751|148917|P1|NOT COMPLETED|Period B (16 Weeks)||1
62626|NCT01570751|148916|P2|COMPLETED|Period B (16 Weeks)||66
62627|NCT01570751|148917|P1|COMPLETED|Period B (16 Weeks)||69
62628|NCT01570751|148916|P2|Exposed|Period B (16 Weeks)||67
62629|NCT01570751|148917|P1|Exposed|Period B (16 Weeks)||70
62630|NCT01570751|148916|P2|STARTED|Period B (16 Weeks)||67
62631|NCT01570751|148917|P1|STARTED|Period B (16 Weeks)||70
62632|NCT01570751|148916|P2|NOT COMPLETED|Period A (16 Weeks)||5
62633|NCT01570751|148917|P1|NOT COMPLETED|Period A (16 Weeks)||3
62634|NCT01570751|148916|P2|COMPLETED|Period A (16 Weeks)||67
62635|NCT01570751|148917|P1|COMPLETED|Period A (16 Weeks)||70
62636|NCT01570751|148916|P2|Exposed|Period A (16 Weeks)||72
62637|NCT01570751|148917|P1|Exposed|Period A (16 Weeks)||73
62638|NCT01570751|148916|P2|STARTED|Period A (16 Weeks)||72
62639|NCT01570751|148917|P1|STARTED|Period A (16 Weeks)||73
62640|NCT01570686|148935|P2|NOT COMPLETED|Overall Study||16
62641|NCT01570686|148936|P1|NOT COMPLETED|Overall Study||22
62642|NCT01570686|148935|P2|COMPLETED|Overall Study||278
62643|NCT01570686|148936|P1|COMPLETED|Overall Study||274
62644|NCT01570686|148935|P2|Safety and Full Analysis Set (FAS)|Overall Study||294
62645|NCT01570686|148936|P1|Safety and Full Analysis Set (FAS)|Overall Study|One patient was mis-randomized and never received study drug. Hence not included in Safety or FAS.|295
62646|NCT01570686|148935|P2|STARTED|Overall Study||294
62647|NCT01570686|148936|P1|STARTED|Overall Study||296
62648|NCT01570634|148962|P1|NOT COMPLETED|Overall Study||0
62649|NCT01570634|148962|P1|COMPLETED|Overall Study||2
62650|NCT01570634|148962|P1|STARTED|Overall Study||2
62651|NCT01570309|148972|P2|NOT COMPLETED|Overall Study||3
62652|NCT01570309|148973|P1|NOT COMPLETED|Overall Study||3
62653|NCT01570309|148972|P2|COMPLETED|Overall Study||45
62654|NCT01570309|148973|P1|COMPLETED|Overall Study||45
62655|NCT01570309|148972|P2|STARTED|Overall Study||48
62656|NCT01570309|148973|P1|STARTED|Overall Study||48
62657|NCT01570244|148987|P1|NOT COMPLETED|Microgynon+Faldaprevir||1
62658|NCT01570244|148987|P1|COMPLETED|Microgynon+Faldaprevir||15
62659|NCT01570244|148987|P1|STARTED|Microgynon+Faldaprevir||16
62660|NCT01570244|148987|P1|NOT COMPLETED|Microgynon||0
62661|NCT01570244|148987|P1|COMPLETED|Microgynon||16
62662|NCT01570244|148987|P1|STARTED|Microgynon||16
62663|NCT01570192|149009|P2|NOT COMPLETED|Overall Study||13
62664|NCT01570192|149010|P1|NOT COMPLETED|Overall Study||7
62665|NCT01570192|149009|P2|COMPLETED|Overall Study||17
62666|NCT01570192|149010|P1|COMPLETED|Overall Study||6
62667|NCT01570192|149009|P2|STARTED|Overall Study||30
62668|NCT01570192|149010|P1|STARTED|Overall Study||13
62669|NCT01569841|149016|P2|NOT COMPLETED|Period B (6 Weeks)||0
62670|NCT01569841|149017|P1|NOT COMPLETED|Period B (6 Weeks)||0
62671|NCT01569841|149016|P2|COMPLETED|Period B (6 Weeks)||11
62672|NCT01569841|149017|P1|COMPLETED|Period B (6 Weeks)||12
62673|NCT01569841|149016|P2|Exposed|Period B (6 Weeks)||11
62674|NCT01569841|149017|P1|Exposed|Period B (6 Weeks)||12
62675|NCT01569841|149016|P2|STARTED|Period B (6 Weeks)||11
62676|NCT01569841|149017|P1|STARTED|Period B (6 Weeks)||12
62677|NCT01569841|149016|P2|NOT COMPLETED|Period A (6 Weeks)||1
62678|NCT01569841|149017|P1|NOT COMPLETED|Period A (6 Weeks)||0
62679|NCT01569841|149016|P2|COMPLETED|Period A (6 Weeks)||11
62680|NCT01569841|149017|P1|COMPLETED|Period A (6 Weeks)||12
62681|NCT01569841|149016|P2|Exposed|Period A (6 Weeks)||12
62682|NCT01569841|149017|P1|Exposed|Period A (6 Weeks)||12
62683|NCT01569841|149016|P2|STARTED|Period A (6 Weeks)||12
62684|NCT01569841|149017|P1|STARTED|Period A (6 Weeks)||12
62685|NCT01569828|149035|P2|NOT COMPLETED|Overall Study||0
62686|NCT01569828|149036|P1|NOT COMPLETED|Overall Study||0
62687|NCT01569828|149035|P2|COMPLETED|Overall Study||6
62688|NCT01569828|149036|P1|COMPLETED|Overall Study||6
62689|NCT01569828|149035|P2|STARTED|Overall Study||6
62690|NCT01569828|149036|P1|STARTED|Overall Study||6
62692|NCT01569815|149059|P3|NOT COMPLETED|Overall Study||0
62693|NCT01569815|149060|P2|NOT COMPLETED|Overall Study||0
62694|NCT01569815|149061|P1|NOT COMPLETED|Overall Study||0
62695|NCT01569815|149058|P4|COMPLETED|Overall Study||8
62696|NCT01569815|149059|P3|COMPLETED|Overall Study||8
62697|NCT01569815|149060|P2|COMPLETED|Overall Study||8
62698|NCT01569815|149061|P1|COMPLETED|Overall Study||8
62699|NCT01569815|149058|P4|STARTED|Overall Study||8
62700|NCT01569815|149059|P3|STARTED|Overall Study||8
62701|NCT01569815|149060|P2|STARTED|Overall Study||8
62702|NCT01569815|149061|P1|STARTED|Overall Study||8
62703|NCT01569763|149106|P2|NOT COMPLETED|Overall Study||7
62704|NCT01569763|149107|P1|NOT COMPLETED|Overall Study||3
62705|NCT01569763|149106|P2|COMPLETED|Overall Study|Completed 12 Months of Follow-up|44
62706|NCT01569763|149107|P1|COMPLETED|Overall Study|Completed 12 Months of Follow-up|99
62707|NCT01569763|149106|P2|Treated|Overall Study||51
62708|NCT01569763|149107|P1|Treated|Overall Study||102
62709|NCT01569763|149106|P2|STARTED|Overall Study||51
62710|NCT01569763|149107|P1|STARTED|Overall Study||102
62711|NCT01569568|149119|P2|NOT COMPLETED|Overall Study||2
62712|NCT01569568|149120|P1|NOT COMPLETED|Overall Study||0
62713|NCT01569568|149119|P2|COMPLETED|Overall Study||27
62714|NCT01569568|149120|P1|COMPLETED|Overall Study||20
62715|NCT01569568|149119|P2|STARTED|Overall Study||29
62716|NCT01569568|149120|P1|STARTED|Overall Study||20
62717|NCT01569529|149134|P2|NOT COMPLETED|Overall Study||0
62718|NCT01569529|149135|P1|NOT COMPLETED|Overall Study||0
62719|NCT01569529|149134|P2|COMPLETED|Overall Study||394
62720|NCT01569529|149135|P1|COMPLETED|Overall Study||2676
62721|NCT01569529|149134|P2|STARTED|Overall Study||394
62722|NCT01569529|149135|P1|STARTED|Overall Study||2676
62723|NCT01569464|149143|P2|NOT COMPLETED|Overall Study||5
62724|NCT01569464|149144|P1|NOT COMPLETED|Overall Study||10
62725|NCT01569464|149143|P2|COMPLETED|Overall Study||44
62726|NCT01569464|149144|P1|COMPLETED|Overall Study||91
62727|NCT01569464|149143|P2|STARTED|Overall Study||49
62728|NCT01569464|149144|P1|STARTED|Overall Study||101
62729|NCT01569438|149182|P2|NOT COMPLETED|Overall Study||9
62730|NCT01569438|149183|P1|NOT COMPLETED|Overall Study||2
62731|NCT01569438|149182|P2|COMPLETED|Overall Study||27
62732|NCT01569438|149183|P1|COMPLETED|Overall Study||36
62733|NCT01569438|149182|P2|STARTED|Overall Study||36
62734|NCT01569438|149183|P1|STARTED|Overall Study||38
62735|NCT01569152|149197|P3|NOT COMPLETED|Safety Extension, Period 3||55
62736|NCT01569152|149198|P2|NOT COMPLETED|Safety Extension, Period 3||0
62737|NCT01569152|149199|P1|NOT COMPLETED|Safety Extension, Period 3||0
62738|NCT01569152|149197|P3|COMPLETED|Safety Extension, Period 3||0
62739|NCT01569152|149198|P2|COMPLETED|Safety Extension, Period 3||0
62740|NCT01569152|149199|P1|COMPLETED|Safety Extension, Period 3||0
62741|NCT01569152|149197|P3|STARTED|Safety Extension, Period 3|Includes 29 completers and 26 early escapees from Base Study Phase IIa|55
62742|NCT01569152|149198|P2|STARTED|Safety Extension, Period 3||0
62743|NCT01569152|149199|P1|STARTED|Safety Extension, Period 3||0
62744|NCT01569152|149197|P3|NOT COMPLETED|Phase IIa, Period 1||0
62745|NCT01569152|149198|P2|NOT COMPLETED|Phase IIa, Period 1||32
62746|NCT01569152|149199|P1|NOT COMPLETED|Phase IIa, Period 1||21
62747|NCT01569152|149197|P3|COMPLETED|Phase IIa, Period 1||0
62748|NCT01569152|149198|P2|COMPLETED|Phase IIa, Period 1||9
62749|NCT01569152|149199|P1|COMPLETED|Phase IIa, Period 1||20
62750|NCT01569152|149197|P3|STARTED|Phase IIa, Period 1||0
62751|NCT01569152|149198|P2|STARTED|Phase IIa, Period 1||41
62752|NCT01569152|149199|P1|STARTED|Phase IIa, Period 1||41
62753|NCT01569126|149262|P6|NOT COMPLETED|Overall Study||0
62754|NCT01569126|149263|P5|NOT COMPLETED|Overall Study||0
62755|NCT01569126|149264|P4|NOT COMPLETED|Overall Study||0
62756|NCT01569126|149265|P3|NOT COMPLETED|Overall Study||0
62757|NCT01569126|149266|P2|NOT COMPLETED|Overall Study||0
62758|NCT01569126|149267|P1|NOT COMPLETED|Overall Study||0
62759|NCT01569126|149262|P6|COMPLETED|Overall Study||12
62760|NCT01569126|149263|P5|COMPLETED|Overall Study||12
62761|NCT01569126|149264|P4|COMPLETED|Overall Study||8
62762|NCT01569126|149265|P3|COMPLETED|Overall Study||8
62763|NCT01569126|149266|P2|COMPLETED|Overall Study||8
62764|NCT01569126|149267|P1|COMPLETED|Overall Study||8
62765|NCT01569126|149262|P6|Received at Least 1 Dose of Study Drug|Overall Study||12
62766|NCT01569126|149263|P5|Received at Least 1 Dose of Study Drug|Overall Study||12
62767|NCT01569126|149264|P4|Received at Least 1 Dose of Study Drug|Overall Study||8
62768|NCT01569126|149265|P3|Received at Least 1 Dose of Study Drug|Overall Study||8
62769|NCT01569126|149266|P2|Received at Least 1 Dose of Study Drug|Overall Study||8
62770|NCT01569126|149267|P1|Received at Least 1 Dose of Study Drug|Overall Study||8
62771|NCT01569126|149262|P6|STARTED|Overall Study||12
62772|NCT01569126|149263|P5|STARTED|Overall Study||12
62773|NCT01569126|149264|P4|STARTED|Overall Study||8
62774|NCT01569126|149265|P3|STARTED|Overall Study||8
62775|NCT01569126|149266|P2|STARTED|Overall Study||8
62776|NCT01569126|149267|P1|STARTED|Overall Study||8
62777|NCT01569087|149305|P3|NOT COMPLETED|Overall Study||1
62778|NCT01569087|149306|P2|NOT COMPLETED|Overall Study||0
62779|NCT01569087|149307|P1|NOT COMPLETED|Overall Study||1
62780|NCT01569087|149305|P3|COMPLETED|Overall Study||18
62781|NCT01569087|149306|P2|COMPLETED|Overall Study||20
62782|NCT01569087|149307|P1|COMPLETED|Overall Study||20
62783|NCT01569087|149305|P3|STARTED|Overall Study||19
62784|NCT01569087|149306|P2|STARTED|Overall Study||20
62785|NCT01569087|149307|P1|STARTED|Overall Study||21
62786|NCT01569074|149335|P5|NOT COMPLETED|Overall Study||8
62787|NCT01569074|149336|P4|NOT COMPLETED|Overall Study||8
62788|NCT01569074|149337|P3|NOT COMPLETED|Overall Study||12
62789|NCT01569074|149338|P2|NOT COMPLETED|Overall Study||9
62790|NCT01569074|149339|P1|NOT COMPLETED|Overall Study||7
62791|NCT01569074|149335|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
62792|NCT01569074|149336|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|25
62793|NCT01569074|149337|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|21
62794|NCT01569074|149338|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
62795|NCT01569074|149339|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|24
62796|NCT01569074|149335|P5|Randomised But Did Not Receive Treatment|Overall Study||0
62797|NCT01569074|149336|P4|Randomised But Did Not Receive Treatment|Overall Study||0
62798|NCT01569074|149337|P3|Randomised But Did Not Receive Treatment|Overall Study||0
62799|NCT01569074|149338|P2|Randomised But Did Not Receive Treatment|Overall Study||0
62800|NCT01569074|149339|P1|Randomised But Did Not Receive Treatment|Overall Study||0
62801|NCT01569074|149335|P5|STARTED|Overall Study|Patients who received treatment|33
62802|NCT01569074|149336|P4|STARTED|Overall Study|Patients who received treatment|33
62803|NCT01569074|149337|P3|STARTED|Overall Study|Patients who received treatment|33
62804|NCT01569074|149338|P2|STARTED|Overall Study|Patients who received treatment|33
62805|NCT01569074|149339|P1|STARTED|Overall Study|Patients who received treatment|31
62806|NCT01568905|149398|P3|NOT COMPLETED|Overall Study||0
62807|NCT01568905|149399|P2|NOT COMPLETED|Overall Study||0
62808|NCT01568905|149400|P1|NOT COMPLETED|Overall Study||1
62809|NCT01568905|149398|P3|COMPLETED|Overall Study||12
62810|NCT01568905|149399|P2|COMPLETED|Overall Study||11
62811|NCT01568905|149400|P1|COMPLETED|Overall Study||12
62812|NCT01568905|149398|P3|STARTED|Overall Study||12
62813|NCT01568905|149399|P2|STARTED|Overall Study||11
62814|NCT01568905|149400|P1|STARTED|Overall Study||13
62815|NCT01568892|149419|P2|NOT COMPLETED|Open-label Phase||16
62816|NCT01568892|149420|P1|NOT COMPLETED|Open-label Phase||13
62817|NCT01568892|149419|P2|COMPLETED|Open-label Phase||0
62818|NCT01568892|149420|P1|COMPLETED|Open-label Phase||0
62819|NCT01568892|149419|P2|Ongoing|Open-label Phase||15
62820|NCT01568892|149420|P1|Ongoing|Open-label Phase||12
62821|NCT01568892|149419|P2|STARTED|Open-label Phase||16
62822|NCT01568892|149420|P1|STARTED|Open-label Phase|One participant completing the DB Phase withdrew on Day 8 and did not enter the Open-label Phase.|13
62823|NCT01568892|149419|P2|NOT COMPLETED|Double-blind Phase||0
62824|NCT01568892|149420|P1|NOT COMPLETED|Double-blind Phase||0
62825|NCT01568892|149419|P2|COMPLETED|Double-blind Phase||16
62826|NCT01568892|149420|P1|COMPLETED|Double-blind Phase||14
62827|NCT01568892|149419|P2|STARTED|Double-blind Phase||16
62828|NCT01568892|149420|P1|STARTED|Double-blind Phase||14
62829|NCT01568866|149458|P2|NOT COMPLETED|Overall Study||264
62830|NCT01568866|149459|P1|NOT COMPLETED|Overall Study||360
62831|NCT01568866|149458|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment|200
62832|NCT01568866|149459|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment|105
62833|NCT01568866|149458|P2|Received Treatment|Overall Study||463
62834|NCT01568866|149459|P1|Received Treatment|Overall Study||456
62835|NCT01568866|149458|P2|STARTED|Overall Study||464
62836|NCT01568866|149459|P1|STARTED|Overall Study||465
62837|NCT01568827|149481|P2|NOT COMPLETED|Intervention 2 (5 Days)||0
62838|NCT01568827|149482|P1|NOT COMPLETED|Intervention 2 (5 Days)||0
62839|NCT01568827|149481|P2|COMPLETED|Intervention 2 (5 Days)||5
62840|NCT01568827|149482|P1|COMPLETED|Intervention 2 (5 Days)||5
62841|NCT01568827|149481|P2|STARTED|Intervention 2 (5 Days)||5
62842|NCT01568827|149482|P1|STARTED|Intervention 2 (5 Days)||5
62843|NCT01568827|149481|P2|NOT COMPLETED|Washout (2 Days)||0
62844|NCT01568827|149482|P1|NOT COMPLETED|Washout (2 Days)||0
62845|NCT01568827|149481|P2|COMPLETED|Washout (2 Days)||5
62846|NCT01568827|149482|P1|COMPLETED|Washout (2 Days)||5
62847|NCT01568827|149481|P2|STARTED|Washout (2 Days)||5
62848|NCT01568827|149482|P1|STARTED|Washout (2 Days)||5
62849|NCT01568827|149481|P2|NOT COMPLETED|First Intervention (6 Days)||0
62850|NCT01568827|149482|P1|NOT COMPLETED|First Intervention (6 Days)||0
62851|NCT01568827|149481|P2|COMPLETED|First Intervention (6 Days)||5
62852|NCT01568827|149482|P1|COMPLETED|First Intervention (6 Days)||5
62853|NCT01568827|149481|P2|STARTED|First Intervention (6 Days)||5
62854|NCT01568827|149482|P1|STARTED|First Intervention (6 Days)||5
62855|NCT01568593|149490|P2|NOT COMPLETED|Overall Study||3
62856|NCT01568593|149491|P1|NOT COMPLETED|Overall Study||7
62857|NCT01568593|149490|P2|COMPLETED|Overall Study||42
62858|NCT01568593|149491|P1|COMPLETED|Overall Study||41
62859|NCT01568593|149490|P2|STARTED|Overall Study||45
62860|NCT01568593|149491|P1|STARTED|Overall Study||48
62861|NCT01568424|149497|P1|NOT COMPLETED|Overall Study||0
62862|NCT01568424|149497|P1|COMPLETED|Overall Study||25
62863|NCT01568424|149497|P1|STARTED|Overall Study||25
62864|NCT01568112|149511|P4|NOT COMPLETED|Overall Study||12
62865|NCT01568112|149512|P3|NOT COMPLETED|Overall Study||7
62866|NCT01568112|149513|P2|NOT COMPLETED|Overall Study||8
62867|NCT01568112|149514|P1|NOT COMPLETED|Overall Study||5
62868|NCT01568112|149511|P4|COMPLETED|Overall Study||30
62869|NCT01568112|149512|P3|COMPLETED|Overall Study||36
62870|NCT01568112|149513|P2|COMPLETED|Overall Study||36
62871|NCT01568112|149514|P1|COMPLETED|Overall Study||39
62872|NCT01568112|149511|P4|STARTED|Overall Study||42
62873|NCT01568112|149512|P3|STARTED|Overall Study||43
62874|NCT01568112|149513|P2|STARTED|Overall Study||44
62875|NCT01568112|149514|P1|STARTED|Overall Study||44
62876|NCT01568073|149637|P5|NOT COMPLETED|Overall Study||9
62877|NCT01568073|149638|P4|NOT COMPLETED|Overall Study||11
62878|NCT01568073|149639|P3|NOT COMPLETED|Overall Study||12
62879|NCT01568073|149640|P2|NOT COMPLETED|Overall Study||15
62880|NCT01568073|149641|P1|NOT COMPLETED|Overall Study||11
62881|NCT01568073|149637|P5|COMPLETED|Overall Study||107
62882|NCT01568073|149638|P4|COMPLETED|Overall Study||108
62883|NCT01568073|149639|P3|COMPLETED|Overall Study||110
62884|NCT01568073|149640|P2|COMPLETED|Overall Study||107
62885|NCT01568073|149641|P1|COMPLETED|Overall Study||110
62886|NCT01568073|149637|P5|STARTED|Overall Study||116
62887|NCT01568073|149638|P4|STARTED|Overall Study||119
62888|NCT01568073|149639|P3|STARTED|Overall Study||122
62889|NCT01568073|149640|P2|STARTED|Overall Study||122
62890|NCT01568073|149641|P1|STARTED|Overall Study||121
62891|NCT01568047|149672|P4|NOT COMPLETED|Overall Study||1
62892|NCT01568047|149673|P3|NOT COMPLETED|Overall Study||1
62893|NCT01568047|149674|P2|NOT COMPLETED|Overall Study||1
62894|NCT01568047|149675|P1|NOT COMPLETED|Overall Study||1
62895|NCT01568047|149672|P4|COMPLETED|Overall Study||9
62896|NCT01568047|149673|P3|COMPLETED|Overall Study||9
62897|NCT01568047|149674|P2|COMPLETED|Overall Study||9
62898|NCT01568047|149675|P1|COMPLETED|Overall Study||9
62899|NCT01568047|149672|P4|STARTED|Overall Study||10
62900|NCT01568047|149673|P3|STARTED|Overall Study||10
62901|NCT01568047|149674|P2|STARTED|Overall Study||10
62902|NCT01568047|149675|P1|STARTED|Overall Study||10
62903|NCT01568034|149693|P4|NOT COMPLETED|Overall Study||0
62904|NCT01568034|149694|P3|NOT COMPLETED|Overall Study||0
62905|NCT01568034|149695|P2|NOT COMPLETED|Overall Study||0
62906|NCT01568034|149696|P1|NOT COMPLETED|Overall Study||1
62907|NCT01568034|149693|P4|COMPLETED|Overall Study||3
62908|NCT01568034|149694|P3|COMPLETED|Overall Study||3
62909|NCT01568034|149695|P2|COMPLETED|Overall Study||2
62910|NCT01568034|149696|P1|COMPLETED|Overall Study||1
62911|NCT01568034|149693|P4|Placebo|Overall Study||3
62912|NCT01568034|149694|P3|Placebo|Overall Study||3
62913|NCT01568034|149695|P2|Placebo|Overall Study||2
62914|NCT01568034|149696|P1|Placebo|Overall Study||1
62915|NCT01568034|149693|P4|100 mg BIA 9-1067|Overall Study||3
62916|NCT01568034|149694|P3|100 mg BIA 9-1067|Overall Study||3
62917|NCT01568034|149695|P2|100 mg BIA 9-1067|Overall Study||2
62918|NCT01568034|149696|P1|100 mg BIA 9-1067|Overall Study||2
62919|NCT01568034|149693|P4|50 mg BIA 9-1067|Overall Study||3
62920|NCT01568034|149694|P3|50 mg BIA 9-1067|Overall Study||3
62921|NCT01568034|149695|P2|50 mg BIA 9-1067|Overall Study||2
62922|NCT01568034|149696|P1|50 mg BIA 9-1067|Overall Study||2
62923|NCT01568034|149693|P4|25 mg BIA 9-1067|Overall Study||3
62924|NCT01568034|149694|P3|25 mg BIA 9-1067|Overall Study||3
62925|NCT01568034|149695|P2|25 mg BIA 9-1067|Overall Study||2
62926|NCT01568034|149696|P1|25 mg BIA 9-1067|Overall Study||2
62927|NCT01568034|149693|P4|STARTED|Overall Study||3
62928|NCT01568034|149694|P3|STARTED|Overall Study||3
62929|NCT01568034|149695|P2|STARTED|Overall Study||2
62930|NCT01568034|149696|P1|STARTED|Overall Study||2
62931|NCT01568021|149714|P1|NOT COMPLETED|Overall Study||16
62932|NCT01568021|149714|P1|COMPLETED|Overall Study||83
62933|NCT01568021|149714|P1|STARTED|Overall Study||99
62934|NCT01568008|149720|P1|NOT COMPLETED|Overall Study||234
62935|NCT01568008|149720|P1|COMPLETED|Overall Study||699
62936|NCT01568008|149720|P1|STARTED|Overall Study||933
62937|NCT01567943|149731|P3|NOT COMPLETED|Overall Study||0
62938|NCT01567943|149732|P2|NOT COMPLETED|Overall Study||10
62939|NCT01567943|149733|P1|NOT COMPLETED|Overall Study||14
62940|NCT01567943|149731|P3|COMPLETED|Overall Study||44
62941|NCT01567943|149732|P2|COMPLETED|Overall Study||29
62942|NCT01567943|149733|P1|COMPLETED|Overall Study||26
62943|NCT01567943|149731|P3|STARTED|Overall Study||44
62944|NCT01567943|149732|P2|STARTED|Overall Study||39
62945|NCT01567943|149733|P1|STARTED|Overall Study||40
62946|NCT01567852|149743|P2|NOT COMPLETED|Overall Study||7
62947|NCT01567852|149744|P1|NOT COMPLETED|Overall Study||4
62948|NCT01567852|149743|P2|COMPLETED|Overall Study||5
62949|NCT01567852|149744|P1|COMPLETED|Overall Study||4
62950|NCT01567852|149743|P2|STARTED|Overall Study||12
62951|NCT01567852|149744|P1|STARTED|Overall Study||8
62952|NCT01567839|149752|P1|NOT COMPLETED|Overall Study||0
62953|NCT01567839|149752|P1|COMPLETED|Overall Study||60
62954|NCT01567839|149752|P1|STARTED|Overall Study||60
62955|NCT01567826|149762|P2|NOT COMPLETED|Overall Study||2
62956|NCT01567826|149763|P1|NOT COMPLETED|Overall Study||3
62957|NCT01567826|149762|P2|COMPLETED|Overall Study||42
62958|NCT01567826|149763|P1|COMPLETED|Overall Study||40
62959|NCT01567826|149762|P2|STARTED|Overall Study||44
62960|NCT01567826|149763|P1|STARTED|Overall Study||43
62961|NCT01567371|149787|P1|NOT COMPLETED|Overall Study||0
62962|NCT01567371|149787|P1|COMPLETED|Overall Study||30
62963|NCT01567371|149787|P1|STARTED|Overall Study||30
62964|NCT01567163|149792|P1|NOT COMPLETED|Overall Study||4
62965|NCT01567163|149792|P1|COMPLETED|Overall Study||18
62966|NCT01567163|149792|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1, Day 1 and Cycle 2, Day 1 treatment with required assessments.|18
62967|NCT01567163|149792|P1|Received at Least 1 Dose of Study Drug|Overall Study||22
62968|NCT01567163|149792|P1|STARTED|Overall Study||22
62969|NCT01567150|149804|P2|NOT COMPLETED|Overall Study||2
62970|NCT01567150|149805|P1|NOT COMPLETED|Overall Study||2
62971|NCT01567150|149804|P2|COMPLETED|Overall Study||16
62972|NCT01567150|149805|P1|COMPLETED|Overall Study||19
62973|NCT01567150|149804|P2|STARTED|Overall Study||18
62974|NCT01567150|149805|P1|STARTED|Overall Study||21
62975|NCT01567020|149817|P4|NOT COMPLETED|Overall Study||1
62976|NCT01567020|149818|P3|NOT COMPLETED|Overall Study||2
62977|NCT01567020|149819|P2|NOT COMPLETED|Overall Study||5
62978|NCT01567020|149820|P1|NOT COMPLETED|Overall Study||7
62979|NCT01567020|149817|P4|COMPLETED|Overall Study||10
62980|NCT01567020|149818|P3|COMPLETED|Overall Study||18
62981|NCT01567020|149819|P2|COMPLETED|Overall Study||41
62982|NCT01567020|149820|P1|COMPLETED|Overall Study||21
62983|NCT01567020|149817|P4|STARTED|Overall Study||11
62984|NCT01567020|149818|P3|STARTED|Overall Study||20
62985|NCT01567020|149819|P2|STARTED|Overall Study||46
62986|NCT01567020|149820|P1|STARTED|Overall Study||28
62987|NCT01566981|149832|P2|NOT COMPLETED|Overall Study||8
62988|NCT01566981|149833|P1|NOT COMPLETED|Overall Study||5
62989|NCT01566981|149832|P2|COMPLETED|Overall Study||54
62990|NCT01566981|149833|P1|COMPLETED|Overall Study||53
62991|NCT01566981|149832|P2|STARTED|Overall Study||62
62992|NCT01566981|149833|P1|STARTED|Overall Study||58
62993|NCT01566838|149845|P2|NOT COMPLETED|Overall Study||0
62994|NCT01566838|149846|P1|NOT COMPLETED|Overall Study||3
62995|NCT01566838|149845|P2|COMPLETED|Overall Study||42
62996|NCT01566838|149846|P1|COMPLETED|Overall Study||38
62997|NCT01566838|149845|P2|STARTED|Overall Study||42
62998|NCT01566838|149846|P1|STARTED|Overall Study||41
62999|NCT01566721|149864|P2|NOT COMPLETED|Overall Study||710
63000|NCT01566721|149865|P1|NOT COMPLETED|Overall Study||1867
63001|NCT01566721|149864|P2|COMPLETED|Overall Study||0
63002|NCT01566721|149865|P1|COMPLETED|Overall Study||0
63003|NCT01566721|149864|P2|Received Treatment|Overall Study||709
63004|NCT01566721|149865|P1|Received Treatment|Overall Study||1864
63005|NCT01566721|149864|P2|STARTED|Overall Study||710
63006|NCT01566721|149865|P1|STARTED|Overall Study||1867
63007|NCT01566630|149890|P2|NOT COMPLETED|Overall Study||0
63008|NCT01566630|149891|P1|NOT COMPLETED|Overall Study||0
63009|NCT01566630|149890|P2|COMPLETED|Overall Study||1
63010|NCT01566630|149891|P1|COMPLETED|Overall Study||2
63011|NCT01566630|149890|P2|STARTED|Overall Study||1
63012|NCT01566630|149891|P1|STARTED|Overall Study||2
63013|NCT01566604|149947|P2|NOT COMPLETED|Overall Study||11
63014|NCT01566604|149948|P1|NOT COMPLETED|Overall Study||24
63015|NCT01566604|149947|P2|COMPLETED|Overall Study||143
63016|NCT01566604|149948|P1|COMPLETED|Overall Study||282
63017|NCT01566604|149947|P2|FAS, Serial Spirometry Subgroup|Overall Study||58
63018|NCT01566604|149948|P1|FAS, Serial Spirometry Subgroup|Overall Study||134
63019|NCT01566604|149947|P2|Full Analysis Set (FAS)|Overall Study||154
63020|NCT01566604|149948|P1|Full Analysis Set (FAS)|Overall Study||305
63021|NCT01566604|149947|P2|Safety Set|Overall Study||154
63022|NCT01566604|149948|P1|Safety Set|Overall Study||305
63023|NCT01566604|149947|P2|STARTED|Overall Study||154
63024|NCT01566604|149948|P1|STARTED|Overall Study||306
63025|NCT01566526|149974|P1|NOT COMPLETED|Overall Study||0
63026|NCT01566526|149974|P1|COMPLETED|Overall Study||26
63027|NCT01566526|149974|P1|STARTED|Overall Study||26
63028|NCT01566500|149984|P1|NOT COMPLETED|Overall Study||0
63029|NCT01566500|149984|P1|COMPLETED|Overall Study||140
63030|NCT01566500|149984|P1|STARTED|Overall Study||140
63031|NCT01566461|149990|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
63032|NCT01566461|149991|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
63033|NCT01566461|149990|P2|COMPLETED|IN.PACT SFA II Phase||55
63034|NCT01566461|149991|P1|COMPLETED|IN.PACT SFA II Phase||109
63035|NCT01566461|149990|P2|STARTED|IN.PACT SFA II Phase||60
63036|NCT01566461|149991|P1|STARTED|IN.PACT SFA II Phase||121
63037|NCT01566461|149990|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
63038|NCT01566461|149991|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
63039|NCT01566461|149990|P2|COMPLETED|IN.PACT SFA I Phase||49
63040|NCT01566461|149991|P1|COMPLETED|IN.PACT SFA I Phase||88
63041|NCT01566461|149990|P2|STARTED|IN.PACT SFA I Phase||51
63042|NCT01566461|149991|P1|STARTED|IN.PACT SFA I Phase||99
63043|NCT01566435|150035|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cetuximab||0
63044|NCT01566435|150035|P1|COMPLETED|ACF Definitive Chemoradiation-cetuximab||2
63045|NCT01566435|150035|P1|STARTED|ACF Definitive Chemoradiation-cetuximab||2
63046|NCT01566435|150035|P1|NOT COMPLETED|ACF Definitive Chemoradiation-cisplatin||1
63047|NCT01566435|150035|P1|COMPLETED|ACF Definitive Chemoradiation-cisplatin||27
63048|NCT01566435|150035|P1|STARTED|ACF Definitive Chemoradiation-cisplatin||28
63049|NCT01566435|150035|P1|NOT COMPLETED|ACF Induction Therapy||0
63050|NCT01566435|150035|P1|COMPLETED|ACF Induction Therapy||30
63051|NCT01566435|150035|P1|STARTED|ACF Induction Therapy||30
63052|NCT01566409|150051|P2|NOT COMPLETED|Overall Study||5
63053|NCT01566409|150052|P1|NOT COMPLETED|Overall Study||2
63054|NCT01566409|150051|P2|COMPLETED|Overall Study||48
63055|NCT01566409|150052|P1|COMPLETED|Overall Study||47
63056|NCT01566409|150051|P2|STARTED|Overall Study||53
63057|NCT01566409|150052|P1|STARTED|Overall Study||49
63058|NCT01566370|150060|P2|NOT COMPLETED|Overall Study||1
63059|NCT01566370|150061|P1|NOT COMPLETED|Overall Study||2
63060|NCT01566370|150060|P2|COMPLETED|Overall Study||0
63061|NCT01566370|150061|P1|COMPLETED|Overall Study||0
63062|NCT01566370|150060|P2|STARTED|Overall Study||1
63063|NCT01566370|150061|P1|STARTED|Overall Study||2
63064|NCT01566331|150087|P2|NOT COMPLETED|Overall Study||0
63065|NCT01566331|150088|P1|NOT COMPLETED|Overall Study||0
63066|NCT01566331|150087|P2|COMPLETED|Overall Study||40
63067|NCT01566331|150088|P1|COMPLETED|Overall Study||40
63068|NCT01566331|150087|P2|STARTED|Overall Study||40
63069|NCT01566331|150088|P1|STARTED|Overall Study||40
63070|NCT01566162|150094|P1|NOT COMPLETED|Overall Study||36
63071|NCT01566162|150094|P1|COMPLETED|Overall Study||155
63072|NCT01566162|150094|P1|STARTED|Overall Study||191
63073|NCT01566149|150108|P2|NOT COMPLETED|Overall Study||2
63074|NCT01566149|150109|P1|NOT COMPLETED|Overall Study||3
63075|NCT01566149|150108|P2|COMPLETED|Overall Study||23
63076|NCT01566149|150109|P1|COMPLETED|Overall Study||21
63077|NCT01566149|150108|P2|STARTED|Overall Study||25
63078|NCT01566149|150109|P1|STARTED|Overall Study||24
63079|NCT01566084|150125|P2|NOT COMPLETED|Overall Study||0
63080|NCT01566084|150126|P1|NOT COMPLETED|Overall Study||0
63081|NCT01566084|150125|P2|COMPLETED|Overall Study||10
63082|NCT01566084|150126|P1|COMPLETED|Overall Study||7
63083|NCT01566084|150125|P2|STARTED|Overall Study||10
63084|NCT01566084|150126|P1|STARTED|Overall Study||7
63085|NCT01565993|150142|P2|NOT COMPLETED|Overall Study||3
63086|NCT01565993|150143|P1|NOT COMPLETED|Overall Study||0
63087|NCT01565993|150142|P2|COMPLETED|Overall Study||39
63088|NCT01565993|150143|P1|COMPLETED|Overall Study|A total of 105 polypectomies were performed on 98 patients|66
63089|NCT01565993|150142|P2|STARTED|Overall Study|3 patients were excluded for failing to meet the inclusion criteria|42
63090|NCT01565993|150143|P1|STARTED|Overall Study||66
63091|NCT01565980|150151|P2|NOT COMPLETED|Overall Study||4
63092|NCT01565980|150152|P1|NOT COMPLETED|Overall Study||4
63093|NCT01565980|150151|P2|COMPLETED|Overall Study||16
63094|NCT01565980|150152|P1|COMPLETED|Overall Study||16
63095|NCT01565980|150151|P2|STARTED|Overall Study|Three patients had started the intervention protocol at the time of study withdrawal.|20
63096|NCT01565980|150152|P1|STARTED|Overall Study||20
63097|NCT01565902|150174|P4|NOT COMPLETED|Overall Study||0
63098|NCT01565902|150175|P3|NOT COMPLETED|Overall Study||0
63099|NCT01565902|150176|P2|NOT COMPLETED|Overall Study||0
63100|NCT01565902|150177|P1|NOT COMPLETED|Overall Study||0
63101|NCT01565902|150174|P4|COMPLETED|Overall Study||16
63102|NCT01565902|150175|P3|COMPLETED|Overall Study||8
63103|NCT01565902|150176|P2|COMPLETED|Overall Study||8
63104|NCT01565902|150177|P1|COMPLETED|Overall Study||8
63105|NCT01565902|150174|P4|STARTED|Overall Study||16
63106|NCT01565902|150175|P3|STARTED|Overall Study||8
63107|NCT01565902|150176|P2|STARTED|Overall Study||8
63108|NCT01565902|150177|P1|STARTED|Overall Study||8
63109|NCT01565889|150211|P6|NOT COMPLETED|Part B||4
63110|NCT01565889|150212|P5|NOT COMPLETED|Part B||0
63111|NCT01565889|150213|P4|NOT COMPLETED|Part B||0
63112|NCT01565889|150214|P3|NOT COMPLETED|Part B||0
63113|NCT01565889|150215|P2|NOT COMPLETED|Part B||0
63114|NCT01565889|150216|P1|NOT COMPLETED|Part B||0
63115|NCT01565889|150211|P6|COMPLETED|Part B||19
63116|NCT01565889|150212|P5|COMPLETED|Part B||0
63117|NCT01565889|150213|P4|COMPLETED|Part B||0
63118|NCT01565889|150214|P3|COMPLETED|Part B||0
63119|NCT01565889|150215|P2|COMPLETED|Part B||0
63120|NCT01565889|150216|P1|COMPLETED|Part B||0
63121|NCT01565889|150211|P6|STARTED|Part B|9 participants in this group transferred from a Part A cohort, and 14 participants joined the study.|23
63122|NCT01565889|150212|P5|STARTED|Part B||0
63123|NCT01565889|150213|P4|STARTED|Part B||0
63124|NCT01565889|150214|P3|STARTED|Part B||0
63125|NCT01565889|150215|P2|STARTED|Part B||0
63126|NCT01565889|150216|P1|STARTED|Part B||0
63127|NCT01565889|150211|P6|NOT COMPLETED|Part A||0
63128|NCT01565889|150212|P5|NOT COMPLETED|Part A||0
63129|NCT01565889|150213|P4|NOT COMPLETED|Part A||0
63130|NCT01565889|150214|P3|NOT COMPLETED|Part A||0
63131|NCT01565889|150215|P2|NOT COMPLETED|Part A||0
63132|NCT01565889|150216|P1|NOT COMPLETED|Part A||1
63133|NCT01565889|150211|P6|COMPLETED|Part A||0
63134|NCT01565889|150212|P5|COMPLETED|Part A|1 participant from this group continued in the Part B: SOF+PEG+RBV group.|7
63135|NCT01565889|150213|P4|COMPLETED|Part A|2 participants from this group continued in the Part B: SOF+PEG+RBV group.|7
63136|NCT01565889|150214|P3|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|8
63137|NCT01565889|150215|P2|COMPLETED|Part A|No participants from this group continued in the Part B: SOF+PEG+RBV group.|4
63138|NCT01565889|150216|P1|COMPLETED|Part A|3 participants from this group continued in the Part B: SOF+PEG+RBV group.|11
63139|NCT01565889|150211|P6|STARTED|Part A||0
63140|NCT01565889|150212|P5|STARTED|Part A||7
63141|NCT01565889|150213|P4|STARTED|Part A||7
63142|NCT01565889|150214|P3|STARTED|Part A||8
63143|NCT01565889|150215|P2|STARTED|Part A||4
63144|NCT01565889|150216|P1|STARTED|Part A||12
63145|NCT01565850|150247|P2|NOT COMPLETED|Overall Study||8
63146|NCT01565850|150248|P1|NOT COMPLETED|Overall Study||20
63147|NCT01565850|150247|P2|COMPLETED|Overall Study||42
63148|NCT01565850|150248|P1|COMPLETED|Overall Study||83
63149|NCT01565850|150247|P2|STARTED|Overall Study||50
63150|NCT01565850|150248|P1|STARTED|Overall Study||103
63151|NCT01565707|150268|P4|NOT COMPLETED|Overall Study||5
63152|NCT01565707|150269|P3|NOT COMPLETED|Overall Study||3
63153|NCT01565707|150270|P2|NOT COMPLETED|Overall Study||8
63154|NCT01565707|150271|P1|NOT COMPLETED|Overall Study||9
63155|NCT01565707|150268|P4|COMPLETED|Overall Study||17
63156|NCT01565707|150269|P3|COMPLETED|Overall Study||16
63157|NCT01565707|150270|P2|COMPLETED|Overall Study||65
63158|NCT01565707|150271|P1|COMPLETED|Overall Study||66
63159|NCT01565707|150268|P4|Treated|Overall Study||22
63160|NCT01565707|150269|P3|Treated|Overall Study||19
63161|NCT01565707|150270|P2|Treated|Overall Study||73
63162|NCT01565707|150271|P1|Treated|Overall Study||73
63163|NCT01565707|150268|P4|STARTED|Overall Study||22
63164|NCT01565707|150269|P3|STARTED|Overall Study||19
63165|NCT01565707|150270|P2|STARTED|Overall Study||73
63166|NCT01565707|150271|P1|STARTED|Overall Study||75
63167|NCT01565564|150364|P2|NOT COMPLETED|Overall Study||1
63168|NCT01565564|150365|P1|NOT COMPLETED|Overall Study||5
63169|NCT01565564|150364|P2|COMPLETED|Overall Study||361
63170|NCT01565564|150365|P1|COMPLETED|Overall Study||339
63171|NCT01565564|150364|P2|STARTED|Overall Study||362
63172|NCT01565564|150365|P1|STARTED|Overall Study||344
63173|NCT01565551|150375|P2|NOT COMPLETED|Overall Study||0
63174|NCT01565551|150376|P1|NOT COMPLETED|Overall Study||0
63175|NCT01565551|150375|P2|COMPLETED|Overall Study||51
63176|NCT01565551|150376|P1|COMPLETED|Overall Study||586
63177|NCT01565551|150375|P2|6-Month Outcomes|Overall Study||30
63178|NCT01565551|150376|P1|6-Month Outcomes|Overall Study||412
63179|NCT01565551|150375|P2|Neuroimaging|Overall Study||25
63180|NCT01565551|150376|P1|Neuroimaging|Overall Study||233
63181|NCT01565551|150375|P2|Biospecimens/Biomarkers|Overall Study||22
63182|NCT01565551|150376|P1|Biospecimens/Biomarkers|Overall Study||479
63183|NCT01565551|150375|P2|Clinical/Demographics|Overall Study||51
63184|NCT01565551|150376|P1|Clinical/Demographics|Overall Study||586
63185|NCT01565551|150375|P2|STARTED|Overall Study||51
63186|NCT01565551|150376|P1|STARTED|Overall Study||586
63187|NCT01565538|150384|P2|NOT COMPLETED|Overall Study||0
63188|NCT01565538|150385|P1|NOT COMPLETED|Overall Study||0
63189|NCT01565538|150384|P2|COMPLETED|Overall Study||62
63190|NCT01565538|150385|P1|COMPLETED|Overall Study||61
63191|NCT01565538|150384|P2|STARTED|Overall Study||62
63192|NCT01565538|150385|P1|STARTED|Overall Study||61
63193|NCT01563406|150399|P4|NOT COMPLETED|Overall Study||0
63194|NCT01563406|150400|P3|NOT COMPLETED|Overall Study||0
63195|NCT01563406|150401|P2|NOT COMPLETED|Overall Study||0
63196|NCT01563406|150402|P1|NOT COMPLETED|Overall Study||0
63197|NCT01563406|150399|P4|COMPLETED|Overall Study|112 hubs|29
63198|NCT01563406|150400|P3|COMPLETED|Overall Study|101 hubs|30
63199|NCT01563406|150401|P2|COMPLETED|Overall Study|102 hubs|30
63200|NCT01563406|150402|P1|COMPLETED|Overall Study|194 hubs|60
63201|NCT01563406|150399|P4|STARTED|Overall Study|112 hubs|29
63202|NCT01563406|150400|P3|STARTED|Overall Study|101 hubs|30
63203|NCT01563406|150401|P2|STARTED|Overall Study|102 hubs|30
63204|NCT01563406|150402|P1|STARTED|Overall Study|194 hubs|60
63205|NCT01565382|150420|P2|NOT COMPLETED|Overall Study||0
63206|NCT01565382|150421|P1|NOT COMPLETED|Overall Study||0
63207|NCT01565382|150420|P2|COMPLETED|Overall Study||7
63208|NCT01565382|150421|P1|COMPLETED|Overall Study||40
63209|NCT01565382|150420|P2|STARTED|Overall Study||7
63210|NCT01565382|150421|P1|STARTED|Overall Study||40
63211|NCT01565369|150426|P1|NOT COMPLETED|Overall Study||0
63212|NCT01565369|150426|P1|COMPLETED|Overall Study||35
63213|NCT01565369|150426|P1|STARTED|Overall Study||35
63214|NCT01565356|150432|P1|NOT COMPLETED|Overall Study||0
63215|NCT01565356|150432|P1|COMPLETED|Overall Study||41
63216|NCT01565356|150432|P1|STARTED|Overall Study||41
63217|NCT01565343|150440|P3|NOT COMPLETED|Overall Study||0
63218|NCT01565343|150441|P2|NOT COMPLETED|Overall Study||0
63219|NCT01565343|150442|P1|NOT COMPLETED|Overall Study||1
63220|NCT01565343|150440|P3|COMPLETED|Overall Study||10
63221|NCT01565343|150441|P2|COMPLETED|Overall Study||4
63222|NCT01565343|150442|P1|COMPLETED|Overall Study||10
63223|NCT01565343|150440|P3|STARTED|Overall Study||10
63224|NCT01565343|150441|P2|STARTED|Overall Study||4
63225|NCT01565343|150442|P1|STARTED|Overall Study||11
63226|NCT01565330|150453|P4|NOT COMPLETED|Overall Study||0
63227|NCT01565330|150454|P3|NOT COMPLETED|Overall Study||0
63228|NCT01565330|150455|P2|NOT COMPLETED|Overall Study||0
63229|NCT01565330|150456|P1|NOT COMPLETED|Overall Study||0
63230|NCT01565330|150453|P4|COMPLETED|Overall Study||7
63231|NCT01565330|150454|P3|COMPLETED|Overall Study||4
63232|NCT01565330|150455|P2|COMPLETED|Overall Study||4
63233|NCT01565330|150456|P1|COMPLETED|Overall Study||5
63234|NCT01565330|150453|P4|STARTED|Overall Study||7
63235|NCT01565330|150454|P3|STARTED|Overall Study||4
63236|NCT01565330|150455|P2|STARTED|Overall Study||4
63237|NCT01565330|150456|P1|STARTED|Overall Study||5
63238|NCT01565291|150472|P2|NOT COMPLETED|Overall Study||0
63239|NCT01565291|150473|P1|NOT COMPLETED|Overall Study||1
63240|NCT01565291|150472|P2|COMPLETED|Overall Study||16
63241|NCT01565291|150473|P1|COMPLETED|Overall Study||15
63242|NCT01565291|150472|P2|STARTED|Overall Study||16
63243|NCT01565291|150473|P1|STARTED|Overall Study||16
63244|NCT01565148|150485|P4|NOT COMPLETED|Overall Study||13
63245|NCT01565148|150486|P3|NOT COMPLETED|Overall Study||7
63246|NCT01565148|150487|P2|NOT COMPLETED|Overall Study||15
63247|NCT01565148|150488|P1|NOT COMPLETED|Overall Study||15
63248|NCT01565148|150485|P4|COMPLETED|Overall Study||32
63249|NCT01565148|150486|P3|COMPLETED|Overall Study||40
63250|NCT01565148|150487|P2|COMPLETED|Overall Study||31
63251|NCT01565148|150488|P1|COMPLETED|Overall Study||32
63252|NCT01565148|150485|P4|STARTED|Overall Study||45
63253|NCT01565148|150486|P3|STARTED|Overall Study||47
63254|NCT01565148|150487|P2|STARTED|Overall Study||46
63255|NCT01565148|150488|P1|STARTED|Overall Study||47
63256|NCT01565083|150524|P2|NOT COMPLETED|Overall Study||39
63257|NCT01565083|150525|P1|NOT COMPLETED|Overall Study||33
63258|NCT01565083|150524|P2|COMPLETED|Overall Study||68
63259|NCT01565083|150525|P1|COMPLETED|Overall Study||73
63260|NCT01565083|150524|P2|STARTED|Overall Study||107
63261|NCT01565083|150525|P1|STARTED|Overall Study||106
63262|NCT01564953|150551|P1|NOT COMPLETED|Overall Study||0
63263|NCT01564953|150551|P1|COMPLETED|Overall Study||143
63264|NCT01564953|150551|P1|STARTED|Overall Study||143
63265|NCT01564862|150562|P3|NOT COMPLETED|Overall Study||30
63266|NCT01564862|150563|P2|NOT COMPLETED|Overall Study||34
63267|NCT01564862|150564|P1|NOT COMPLETED|Overall Study||30
63268|NCT01564862|150562|P3|COMPLETED|Overall Study||164
63269|NCT01564862|150563|P2|COMPLETED|Overall Study||176
63270|NCT01564862|150564|P1|COMPLETED|Overall Study||168
63271|NCT01564862|150562|P3|Received Treatment|Overall Study||191
63272|NCT01564862|150563|P2|Received Treatment|Overall Study||207
63273|NCT01564862|150564|P1|Received Treatment|Overall Study||196
63274|NCT01564862|150562|P3|STARTED|Overall Study||194
63275|NCT01564862|150563|P2|STARTED|Overall Study||210
63276|NCT01564862|150564|P1|STARTED|Overall Study||198
63277|NCT01564758|150613|P1|NOT COMPLETED|Overall Study||14
63278|NCT01564758|150613|P1|COMPLETED|Overall Study||85
63279|NCT01564758|150613|P1|STARTED|Overall Study||99
63280|NCT01564732|150620|P2|NOT COMPLETED|Overall Study||5
63281|NCT01564732|150621|P1|NOT COMPLETED|Overall Study||6
63282|NCT01564732|150620|P2|COMPLETED|Overall Study||0
63283|NCT01564732|150621|P1|COMPLETED|Overall Study||0
63284|NCT01564732|150620|P2|STARTED|Overall Study||5
63285|NCT01564732|150621|P1|STARTED|Overall Study||6
63286|NCT01564706|150637|P1|NOT COMPLETED|Overall Study||0
63287|NCT01564706|150637|P1|COMPLETED|Overall Study||9
63288|NCT01564706|150637|P1|STARTED|Overall Study||9
63289|NCT01564693|150644|P3|NOT COMPLETED|Overall Study||0
63290|NCT01564693|150645|P2|NOT COMPLETED|Overall Study||0
63291|NCT01564693|150646|P1|NOT COMPLETED|Overall Study||0
63292|NCT01564693|150644|P3|COMPLETED|Overall Study||2
63293|NCT01564693|150645|P2|COMPLETED|Overall Study||4
63294|NCT01564693|150646|P1|COMPLETED|Overall Study||9
63295|NCT01564693|150644|P3|STARTED|Overall Study|Only 2 patients were found necessary to give statistical relevance to the patients' results.|2
63296|NCT01564693|150645|P2|STARTED|Overall Study||4
63297|NCT01564693|150646|P1|STARTED|Overall Study|Originally we planned to study 4 patients. We expanded to 9 to improve consistency of the results.|9
63298|NCT01564537|150656|P2|NOT COMPLETED|Overall Study||6
63299|NCT01564537|150657|P1|NOT COMPLETED|Overall Study||6
63300|NCT01564537|150656|P2|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|356
63301|NCT01564537|150657|P1|COMPLETED|Overall Study|Completed=Participants who are ongoing as of 30 October 2014 or who have died on study.|354
63302|NCT01564537|150656|P2|Safety Population: Received Study Drug|Overall Study||360
63303|NCT01564537|150657|P1|Safety Population: Received Study Drug|Overall Study||360
63304|NCT01564537|150656|P2|STARTED|Overall Study||362
63305|NCT01564537|150657|P1|STARTED|Overall Study||360
63306|NCT01564459|150680|P3|NOT COMPLETED|Double-blind Treatment||1
63307|NCT01564459|150681|P2|NOT COMPLETED|Double-blind Treatment||0
63308|NCT01564459|150682|P1|NOT COMPLETED|Double-blind Treatment||0
63309|NCT01564459|150680|P3|COMPLETED|Double-blind Treatment||82
63310|NCT01564459|150681|P2|COMPLETED|Double-blind Treatment||87
63311|NCT01564459|150682|P1|COMPLETED|Double-blind Treatment||0
63312|NCT01564459|150680|P3|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|83
63313|NCT01564459|150681|P2|STARTED|Double-blind Treatment|1 participant randomized to placebo arm received MK-6096 10 mg|87
63314|NCT01564459|150682|P1|STARTED|Double-blind Treatment||0
63315|NCT01564459|150680|P3|NOT COMPLETED|Run-In||0
63316|NCT01564459|150681|P2|NOT COMPLETED|Run-In||0
63317|NCT01564459|150682|P1|NOT COMPLETED|Run-In||12
63318|NCT01564459|150680|P3|COMPLETED|Run-In||83
63319|NCT01564459|150681|P2|COMPLETED|Run-In||87
63320|NCT01564459|150682|P1|COMPLETED|Run-In||0
63321|NCT01564459|150680|P3|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|83
63322|NCT01564459|150681|P2|STARTED|Run-In|1 participant randomized to placebo arm received MK-6096 10 mg|87
63323|NCT01564459|150682|P1|STARTED|Run-In||12
63324|NCT01564407|150706|P5|NOT COMPLETED|Overall Study||0
63325|NCT01564407|150707|P4|NOT COMPLETED|Overall Study||1
63326|NCT01564407|150708|P3|NOT COMPLETED|Overall Study||0
63327|NCT01564407|150709|P2|NOT COMPLETED|Overall Study||2
63328|NCT01564407|150710|P1|NOT COMPLETED|Overall Study||0
63329|NCT01564407|150706|P5|COMPLETED|Overall Study||0
63330|NCT01564407|150707|P4|COMPLETED|Overall Study||1
63331|NCT01564407|150708|P3|COMPLETED|Overall Study||4
63332|NCT01564407|150709|P2|COMPLETED|Overall Study||3
63333|NCT01564407|150710|P1|COMPLETED|Overall Study||4
63334|NCT01564407|150706|P5|STARTED|Overall Study||0
63335|NCT01564407|150707|P4|STARTED|Overall Study||2
63336|NCT01564407|150708|P3|STARTED|Overall Study||4
63337|NCT01564407|150709|P2|STARTED|Overall Study||5
63338|NCT01564407|150710|P1|STARTED|Overall Study||4
63339|NCT01564394|150751|P2|NOT COMPLETED|Overall Study||10
63340|NCT01564394|150752|P1|NOT COMPLETED|Overall Study||6
63341|NCT01564394|150751|P2|COMPLETED|Overall Study|Prostate cancer survivors n=13, family n=7.|20
63342|NCT01564394|150752|P1|COMPLETED|Overall Study|Prostate cancer survivors n=16, family n=8.|24
63343|NCT01564394|150751|P2|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
63344|NCT01564394|150752|P1|STARTED|Overall Study|Prostate cancer survivors n=20, family n=10. Only survivors were randomized.|30
63345|NCT01563978|150766|P2|NOT COMPLETED|Overall Study||2
63346|NCT01563978|150767|P1|NOT COMPLETED|Overall Study||4
63347|NCT01563978|150766|P2|COMPLETED|Overall Study||65
63348|NCT01563978|150767|P1|COMPLETED|Overall Study||64
63349|NCT01563978|150766|P2|Randomised But Did Not Receive Treatment|Overall Study||0
63350|NCT01563978|150767|P1|Randomised But Did Not Receive Treatment|Overall Study||0
63351|NCT01563978|150766|P2|STARTED|Overall Study|Patients who received treatment.|67
63352|NCT01563978|150767|P1|STARTED|Overall Study|Patients who received treatment.|68
63353|NCT01563536|150793|P2|NOT COMPLETED|Overall Study||2
63354|NCT01563536|150794|P1|NOT COMPLETED|Overall Study||1
63355|NCT01563536|150793|P2|COMPLETED|Overall Study||4
63356|NCT01563536|150794|P1|COMPLETED|Overall Study||5
63357|NCT01563536|150793|P2|STARTED|Overall Study||6
63358|NCT01563536|150794|P1|STARTED|Overall Study||6
63359|NCT01563198|150822|P1|NOT COMPLETED|After Training||0
63360|NCT01563198|150822|P1|COMPLETED|After Training||47979
63361|NCT01563198|150822|P1|STARTED|After Training||47979
63362|NCT01563198|150822|P1|NOT COMPLETED|Baseline||0
63363|NCT01563198|150822|P1|COMPLETED|Baseline||49733
63364|NCT01563198|150822|P1|STARTED|Baseline||49733
63365|NCT01563185|150828|P1|NOT COMPLETED|Overall Study||2
63366|NCT01563185|150828|P1|COMPLETED|Overall Study||10
63367|NCT01563185|150828|P1|STARTED|Overall Study||12
63368|NCT01563172|150842|P1|NOT COMPLETED|Overall Study||13
63369|NCT01563172|150842|P1|COMPLETED|Overall Study||52
63370|NCT01563172|150842|P1|Control Dentifrice|Overall Study||60
63371|NCT01563172|150842|P1|Experimental Dentifrice 1.5g/ 45 Sec|Overall Study||58
63372|NCT01563172|150842|P1|Experimental Dentifrice 1.5g/ 2min|Overall Study||58
63373|NCT01563172|150842|P1|Experimental Dentifrice 0.5g/45 Sec|Overall Study||59
63374|NCT01563172|150842|P1|Experimental Dentifrice 0.5g/2 Min|Overall Study||59
63375|NCT01563172|150842|P1|STARTED|Overall Study||65
63376|NCT01563081|150871|P2|NOT COMPLETED|Overall Study||0
63377|NCT01563081|150872|P1|NOT COMPLETED|Overall Study||0
63378|NCT01563081|150871|P2|COMPLETED|Overall Study||30
63379|NCT01563081|150872|P1|COMPLETED|Overall Study||30
63380|NCT01563081|150871|P2|STARTED|Overall Study||30
63381|NCT01563081|150872|P1|STARTED|Overall Study||30
63382|NCT01563055|150885|P1|NOT COMPLETED|Overall Study||0
63383|NCT01563055|150885|P1|COMPLETED|Overall Study||10
63384|NCT01563055|150885|P1|STARTED|Overall Study||10
63385|NCT01563029|150948|P5|NOT COMPLETED|Overall Study||29
63386|NCT01563029|150949|P4|NOT COMPLETED|Overall Study||33
63387|NCT01563029|150950|P3|NOT COMPLETED|Overall Study||33
63388|NCT01563029|150951|P2|NOT COMPLETED|Overall Study||24
63389|NCT01563029|150952|P1|NOT COMPLETED|Overall Study||53
63390|NCT01563029|150948|P5|COMPLETED|Overall Study||89
63391|NCT01563029|150949|P4|COMPLETED|Overall Study||85
63392|NCT01563029|150950|P3|COMPLETED|Overall Study||87
63393|NCT01563029|150951|P2|COMPLETED|Overall Study||94
63394|NCT01563029|150952|P1|COMPLETED|Overall Study||66
63395|NCT01563029|150948|P5|STARTED|Overall Study||118
63396|NCT01563029|150949|P4|STARTED|Overall Study||118
63397|NCT01563029|150950|P3|STARTED|Overall Study||120
63398|NCT01563029|150951|P2|STARTED|Overall Study||118
63399|NCT01563029|150952|P1|STARTED|Overall Study||119
63400|NCT01563003|151002|P2|NOT COMPLETED|Overall Study||0
63401|NCT01563003|151003|P1|NOT COMPLETED|Overall Study||0
63402|NCT01563003|151002|P2|COMPLETED|Overall Study||15
63403|NCT01563003|151003|P1|COMPLETED|Overall Study||16
63404|NCT01563003|151002|P2|STARTED|Overall Study||15
63405|NCT01563003|151003|P1|STARTED|Overall Study||16
63406|NCT01562886|151013|P1|NOT COMPLETED|Overall Study||1
63407|NCT01562886|151013|P1|COMPLETED|Overall Study||13
63408|NCT01562886|151013|P1|STARTED|Overall Study||14
63409|NCT01562873|151018|P2|NOT COMPLETED|Overall Study||0
63410|NCT01562873|151019|P1|NOT COMPLETED|Overall Study||21
63411|NCT01562873|151018|P2|COMPLETED|Overall Study||0
63412|NCT01562873|151019|P1|COMPLETED|Overall Study||0
63413|NCT01562873|151018|P2|STARTED|Overall Study|The observed number of objective responses in Cohort A was not sufficient for Cohort B to open.|0
63414|NCT01562873|151019|P1|STARTED|Overall Study||21
63415|NCT01562756|151026|P1|NOT COMPLETED|Overall Study||0
63416|NCT01562756|151026|P1|COMPLETED|Overall Study||6
63417|NCT01562756|151026|P1|STARTED|Overall Study||6
63418|NCT01562743|151031|P1|NOT COMPLETED|Overall Study||52
63419|NCT01562743|151031|P1|COMPLETED|Overall Study||133
63420|NCT01562743|151031|P1|STARTED|Overall Study||185
63421|NCT01562678|151043|P2|NOT COMPLETED|Overall Study||2
63422|NCT01562678|151044|P1|NOT COMPLETED|Overall Study||6
63423|NCT01562678|151043|P2|COMPLETED|Overall Study||12
63424|NCT01562678|151044|P1|COMPLETED|Overall Study||8
63425|NCT01562678|151043|P2|STARTED|Overall Study||14
63426|NCT01562678|151044|P1|STARTED|Overall Study||14
63427|NCT01562613|151050|P1|NOT COMPLETED|Overall Study||4
63428|NCT01562613|151050|P1|COMPLETED|Overall Study||529
63429|NCT01562613|151050|P1|STARTED|Overall Study||533
63430|NCT01562548|151060|P4|NOT COMPLETED|Overall Study||0
63431|NCT01562548|151061|P3|NOT COMPLETED|Overall Study||1
63432|NCT01562548|151062|P2|NOT COMPLETED|Overall Study||0
63433|NCT01562548|151063|P1|NOT COMPLETED|Overall Study||0
63434|NCT01562548|151060|P4|COMPLETED|Overall Study||14
63435|NCT01562548|151061|P3|COMPLETED|Overall Study||24
63436|NCT01562548|151062|P2|COMPLETED|Overall Study||15
63437|NCT01562548|151063|P1|COMPLETED|Overall Study||25
63438|NCT01562548|151060|P4|STARTED|Overall Study||14
63439|NCT01562548|151061|P3|STARTED|Overall Study||25
63440|NCT01562548|151062|P2|STARTED|Overall Study||15
63441|NCT01562548|151063|P1|STARTED|Overall Study||25
63442|NCT01562327|151113|P1|NOT COMPLETED|Overall Study||8
63443|NCT01562327|151113|P1|COMPLETED|Overall Study||42
63444|NCT01562327|151113|P1|STARTED|Overall Study||50
63445|NCT01562314|151143|P2|NOT COMPLETED|Overall Study||8
63446|NCT01562314|151144|P1|NOT COMPLETED|Overall Study||13
63447|NCT01562314|151143|P2|COMPLETED|Overall Study||23
63448|NCT01562314|151144|P1|COMPLETED|Overall Study||16
63449|NCT01562314|151143|P2|STARTED|Overall Study||31
63450|NCT01562314|151144|P1|STARTED|Overall Study||29
63451|NCT01562275|151231|P13|NOT COMPLETED|Stage 2||5
63452|NCT01562275|151232|P12|NOT COMPLETED|Stage 2||14
63453|NCT01562275|151233|P11|NOT COMPLETED|Stage 2||0
63454|NCT01562275|151234|P10|NOT COMPLETED|Stage 2||0
63455|NCT01562275|151235|P9|NOT COMPLETED|Stage 2||0
63456|NCT01562275|151236|P8|NOT COMPLETED|Stage 2||0
63457|NCT01562275|151237|P7|NOT COMPLETED|Stage 2||0
63458|NCT01562275|151238|P6|NOT COMPLETED|Stage 2||0
63459|NCT01562275|151239|P5|NOT COMPLETED|Stage 2||0
63460|NCT01562275|151240|P4|NOT COMPLETED|Stage 2||0
63461|NCT01562275|151241|P3|NOT COMPLETED|Stage 2||0
63462|NCT01562275|151242|P2|NOT COMPLETED|Stage 2||0
63463|NCT01562275|151243|P1|NOT COMPLETED|Stage 2||0
63464|NCT01562275|151231|P13|COMPLETED|Stage 2||0
63465|NCT01562275|151232|P12|COMPLETED|Stage 2||0
63466|NCT01562275|151233|P11|COMPLETED|Stage 2||0
63467|NCT01562275|151234|P10|COMPLETED|Stage 2||0
63468|NCT01562275|151235|P9|COMPLETED|Stage 2||0
63469|NCT01562275|151236|P8|COMPLETED|Stage 2||0
63470|NCT01562275|151237|P7|COMPLETED|Stage 2||0
63471|NCT01562275|151238|P6|COMPLETED|Stage 2||0
63472|NCT01562275|151239|P5|COMPLETED|Stage 2||0
63473|NCT01562275|151240|P4|COMPLETED|Stage 2||0
63474|NCT01562275|151241|P3|COMPLETED|Stage 2||0
63475|NCT01562275|151242|P2|COMPLETED|Stage 2||0
63476|NCT01562275|151243|P1|COMPLETED|Stage 2||0
63477|NCT01562275|151231|P13|STARTED|Stage 2||5
63478|NCT01562275|151232|P12|STARTED|Stage 2||14
63479|NCT01562275|151233|P11|STARTED|Stage 2||0
63480|NCT01562275|151234|P10|STARTED|Stage 2||0
63481|NCT01562275|151235|P9|STARTED|Stage 2||0
63482|NCT01562275|151236|P8|STARTED|Stage 2||0
63483|NCT01562275|151237|P7|STARTED|Stage 2||0
63484|NCT01562275|151238|P6|STARTED|Stage 2||0
63485|NCT01562275|151239|P5|STARTED|Stage 2||0
63486|NCT01562275|151240|P4|STARTED|Stage 2||0
63487|NCT01562275|151241|P3|STARTED|Stage 2||0
63488|NCT01562275|151242|P2|STARTED|Stage 2||0
63489|NCT01562275|151243|P1|STARTED|Stage 2||0
63490|NCT01562275|151231|P13|NOT COMPLETED|Stage 1||0
63491|NCT01562275|151232|P12|NOT COMPLETED|Stage 1||0
63492|NCT01562275|151233|P11|NOT COMPLETED|Stage 1||3
63493|NCT01562275|151234|P10|NOT COMPLETED|Stage 1||7
63494|NCT01562275|151235|P9|NOT COMPLETED|Stage 1||3
63495|NCT01562275|151236|P8|NOT COMPLETED|Stage 1||7
63496|NCT01562275|151237|P7|NOT COMPLETED|Stage 1||3
63497|NCT01562275|151238|P6|NOT COMPLETED|Stage 1||4
63498|NCT01562275|151239|P5|NOT COMPLETED|Stage 1||4
63499|NCT01562275|151240|P4|NOT COMPLETED|Stage 1||4
63500|NCT01562275|151241|P3|NOT COMPLETED|Stage 1||3
63501|NCT01562275|151242|P2|NOT COMPLETED|Stage 1||7
63502|NCT01562275|151243|P1|NOT COMPLETED|Stage 1||3
63503|NCT01562275|151231|P13|COMPLETED|Stage 1||0
63504|NCT01562275|151232|P12|COMPLETED|Stage 1||0
63505|NCT01562275|151233|P11|COMPLETED|Stage 1||0
63506|NCT01562275|151234|P10|COMPLETED|Stage 1||0
63507|NCT01562275|151235|P9|COMPLETED|Stage 1||0
63508|NCT01562275|151236|P8|COMPLETED|Stage 1||0
63509|NCT01562275|151237|P7|COMPLETED|Stage 1||0
63510|NCT01562275|151238|P6|COMPLETED|Stage 1||0
63511|NCT01562275|151239|P5|COMPLETED|Stage 1||0
63512|NCT01562275|151240|P4|COMPLETED|Stage 1||0
63513|NCT01562275|151241|P3|COMPLETED|Stage 1||0
63514|NCT01562275|151242|P2|COMPLETED|Stage 1||0
63515|NCT01562275|151243|P1|COMPLETED|Stage 1||0
63516|NCT01562275|151231|P13|STARTED|Stage 1||0
63517|NCT01562275|151232|P12|STARTED|Stage 1||0
63518|NCT01562275|151233|P11|STARTED|Stage 1||3
63519|NCT01562275|151234|P10|STARTED|Stage 1||7
63520|NCT01562275|151235|P9|STARTED|Stage 1||3
63521|NCT01562275|151236|P8|STARTED|Stage 1||7
63522|NCT01562275|151237|P7|STARTED|Stage 1||3
63523|NCT01562275|151238|P6|STARTED|Stage 1||4
63524|NCT01562275|151239|P5|STARTED|Stage 1||4
63525|NCT01562275|151240|P4|STARTED|Stage 1||4
63526|NCT01562275|151241|P3|STARTED|Stage 1||3
63527|NCT01562275|151242|P2|STARTED|Stage 1||7
63528|NCT01562275|151243|P1|STARTED|Stage 1||3
63529|NCT01562132|151375|P2|NOT COMPLETED|Overall Study||0
63530|NCT01562132|151376|P1|NOT COMPLETED|Overall Study||0
63531|NCT01562132|151375|P2|COMPLETED|Overall Study||3
63532|NCT01562132|151376|P1|COMPLETED|Overall Study||3
63533|NCT01562132|151375|P2|STARTED|Overall Study||3
63534|NCT01562132|151376|P1|STARTED|Overall Study||3
63535|NCT01561898|151386|P4|NOT COMPLETED|Overall Study||20
63536|NCT01561898|151387|P3|NOT COMPLETED|Overall Study||44
63537|NCT01561898|151388|P2|NOT COMPLETED|Overall Study||41
63538|NCT01561898|151389|P1|NOT COMPLETED|Overall Study||2
63539|NCT01561898|151386|P4|COMPLETED|Overall Study||12
63540|NCT01561898|151387|P3|COMPLETED|Overall Study||53
63541|NCT01561898|151388|P2|COMPLETED|Overall Study||51
63542|NCT01561898|151389|P1|COMPLETED|Overall Study||5
63543|NCT01561898|151386|P4|STARTED|Overall Study||32
63544|NCT01561898|151387|P3|STARTED|Overall Study||97
63545|NCT01561898|151388|P2|STARTED|Overall Study||92
63546|NCT01561898|151389|P1|STARTED|Overall Study||7
63547|NCT01561716|151407|P6|NOT COMPLETED|Overall Study||0
63548|NCT01561716|151408|P5|NOT COMPLETED|Overall Study||0
63549|NCT01561716|151409|P4|NOT COMPLETED|Overall Study||0
63550|NCT01561716|151410|P3|NOT COMPLETED|Overall Study||0
63551|NCT01561716|151411|P2|NOT COMPLETED|Overall Study||0
63552|NCT01561716|151412|P1|NOT COMPLETED|Overall Study||0
63553|NCT01561716|151407|P6|COMPLETED|Overall Study||5
63554|NCT01561716|151408|P5|COMPLETED|Overall Study||5
63555|NCT01561716|151409|P4|COMPLETED|Overall Study||5
63556|NCT01561716|151410|P3|COMPLETED|Overall Study||5
63557|NCT01561716|151411|P2|COMPLETED|Overall Study||5
63558|NCT01561716|151412|P1|COMPLETED|Overall Study||5
63559|NCT01561716|151407|P6|STARTED|Overall Study||5
63560|NCT01561716|151408|P5|STARTED|Overall Study||5
63561|NCT01561716|151409|P4|STARTED|Overall Study||5
63562|NCT01561716|151410|P3|STARTED|Overall Study||5
63563|NCT01561716|151411|P2|STARTED|Overall Study||5
63564|NCT01561716|151412|P1|STARTED|Overall Study||5
63565|NCT01561703|151428|P2|NOT COMPLETED|Overall Study||6
63566|NCT01561703|151429|P1|NOT COMPLETED|Overall Study||8
63567|NCT01561703|151428|P2|COMPLETED|Overall Study||24
63568|NCT01561703|151429|P1|COMPLETED|Overall Study||20
63569|NCT01561703|151428|P2|STARTED|Overall Study||30
63570|NCT01561703|151429|P1|STARTED|Overall Study||28
63571|NCT01561560|151435|P2|NOT COMPLETED|Second Two Weeks of Wear||1
63572|NCT01561560|151436|P1|NOT COMPLETED|Second Two Weeks of Wear||0
63573|NCT01561560|151435|P2|COMPLETED|Second Two Weeks of Wear||58
63574|NCT01561560|151436|P1|COMPLETED|Second Two Weeks of Wear||60
63575|NCT01561560|151435|P2|STARTED|Second Two Weeks of Wear||59
63576|NCT01561560|151436|P1|STARTED|Second Two Weeks of Wear||60
63577|NCT01561560|151435|P2|NOT COMPLETED|First Two Weeks of Wear||2
63578|NCT01561560|151436|P1|NOT COMPLETED|First Two Weeks of Wear||0
63579|NCT01561560|151435|P2|COMPLETED|First Two Weeks of Wear||59
63580|NCT01561560|151436|P1|COMPLETED|First Two Weeks of Wear||60
63581|NCT01561560|151435|P2|STARTED|First Two Weeks of Wear||61
63582|NCT01561560|151436|P1|STARTED|First Two Weeks of Wear||60
63583|NCT01561469|151444|P2|NOT COMPLETED|Overall Study||0
63584|NCT01561469|151445|P1|NOT COMPLETED|Overall Study||0
63585|NCT01561469|151444|P2|COMPLETED|Overall Study||87
63586|NCT01561469|151445|P1|COMPLETED|Overall Study||101
63587|NCT01561469|151444|P2|STARTED|Overall Study||87
63588|NCT01561469|151445|P1|STARTED|Overall Study||101
63589|NCT01561313|151465|P2|NOT COMPLETED|Overall Study||0
63590|NCT01561313|151466|P1|NOT COMPLETED|Overall Study||2
63591|NCT01561313|151465|P2|COMPLETED|Overall Study||31
63592|NCT01561313|151466|P1|COMPLETED|Overall Study||31
63593|NCT01561313|151465|P2|STARTED|Overall Study||31
63594|NCT01561313|151466|P1|STARTED|Overall Study||33
63595|NCT01561300|151484|P2|NOT COMPLETED|Second Intervention||0
63596|NCT01561300|151485|P1|NOT COMPLETED|Second Intervention||0
63597|NCT01561300|151484|P2|COMPLETED|Second Intervention||15
63598|NCT01561300|151485|P1|COMPLETED|Second Intervention||14
63599|NCT01561300|151484|P2|STARTED|Second Intervention||15
63600|NCT01561300|151485|P1|STARTED|Second Intervention||14
63601|NCT01561300|151484|P2|NOT COMPLETED|Washout on Placebo||0
63602|NCT01561300|151485|P1|NOT COMPLETED|Washout on Placebo||0
63603|NCT01561300|151484|P2|COMPLETED|Washout on Placebo||15
63604|NCT01561300|151485|P1|COMPLETED|Washout on Placebo||14
63605|NCT01561300|151484|P2|STARTED|Washout on Placebo||15
63606|NCT01561300|151485|P1|STARTED|Washout on Placebo||14
63607|NCT01561300|151484|P2|NOT COMPLETED|First Intervention||0
63608|NCT01561300|151485|P1|NOT COMPLETED|First Intervention||0
63609|NCT01561300|151484|P2|COMPLETED|First Intervention||15
63610|NCT01561300|151485|P1|COMPLETED|First Intervention||14
63611|NCT01561300|151484|P2|STARTED|First Intervention||15
63612|NCT01561300|151485|P1|STARTED|First Intervention||14
63613|NCT01561300|151484|P2|NOT COMPLETED|Run in on Placebo||0
63614|NCT01561300|151485|P1|NOT COMPLETED|Run in on Placebo||1
63615|NCT01561300|151484|P2|COMPLETED|Run in on Placebo||15
63616|NCT01561300|151485|P1|COMPLETED|Run in on Placebo||14
63617|NCT01561300|151484|P2|STARTED|Run in on Placebo||15
63618|NCT01561300|151485|P1|STARTED|Run in on Placebo||15
63619|NCT01561079|151496|P1|NOT COMPLETED|Overall Study||78
63620|NCT01561079|151496|P1|COMPLETED|Overall Study||49
63621|NCT01561079|151496|P1|STARTED|Overall Study||127
63622|NCT01560988|151539|P2|NOT COMPLETED|Second Intervention (Six Weeks)||2
63623|NCT01560988|151540|P1|NOT COMPLETED|Second Intervention (Six Weeks)||2
63624|NCT01560988|151539|P2|COMPLETED|Second Intervention (Six Weeks)||22
63625|NCT01560988|151540|P1|COMPLETED|Second Intervention (Six Weeks)||18
63626|NCT01560988|151539|P2|STARTED|Second Intervention (Six Weeks)||24
63627|NCT01560988|151540|P1|STARTED|Second Intervention (Six Weeks)||20
63628|NCT01560988|151539|P2|NOT COMPLETED|Washout (Six Weeks)||2
63629|NCT01560988|151540|P1|NOT COMPLETED|Washout (Six Weeks)||2
63630|NCT01560988|151539|P2|COMPLETED|Washout (Six Weeks)||24
63631|NCT01560988|151540|P1|COMPLETED|Washout (Six Weeks)||20
63632|NCT01560988|151539|P2|STARTED|Washout (Six Weeks)||26
63633|NCT01560988|151540|P1|STARTED|Washout (Six Weeks)||22
63634|NCT01560988|151539|P2|NOT COMPLETED|First Intervention (Six Weeks)||4
63635|NCT01560988|151540|P1|NOT COMPLETED|First Intervention (Six Weeks)||10
63636|NCT01560988|151539|P2|COMPLETED|First Intervention (Six Weeks)||26
63637|NCT01560988|151540|P1|COMPLETED|First Intervention (Six Weeks)||22
63638|NCT01560988|151539|P2|STARTED|First Intervention (Six Weeks)||30
63639|NCT01560988|151540|P1|STARTED|First Intervention (Six Weeks)||32
63640|NCT01560975|151558|P1|NOT COMPLETED|Overall Study||0
63641|NCT01560975|151558|P1|COMPLETED|Overall Study||10
63642|NCT01560975|151558|P1|STARTED|Overall Study||10
63643|NCT01560819|151573|P2|NOT COMPLETED|Overall Study||0
63644|NCT01560819|151574|P1|NOT COMPLETED|Overall Study||1
63645|NCT01560819|151573|P2|COMPLETED|Overall Study||10
63646|NCT01560819|151574|P1|COMPLETED|Overall Study||9
63647|NCT01560819|151573|P2|STARTED|Overall Study||10
63648|NCT01560819|151574|P1|STARTED|Overall Study||10
63649|NCT01560507|151581|P3|NOT COMPLETED|Overall Study||2
63650|NCT01560507|151582|P2|NOT COMPLETED|Overall Study||2
63651|NCT01560507|151583|P1|NOT COMPLETED|Overall Study||4
63652|NCT01560507|151581|P3|COMPLETED|Overall Study||0
63653|NCT01560507|151582|P2|COMPLETED|Overall Study||0
63654|NCT01560507|151583|P1|COMPLETED|Overall Study||1
63655|NCT01560507|151581|P3|STARTED|Overall Study||2
63656|NCT01560507|151582|P2|STARTED|Overall Study||2
63657|NCT01560507|151583|P1|STARTED|Overall Study||5
63658|NCT01560429|151596|P2|NOT COMPLETED|Overall Study||6
63659|NCT01560429|151597|P1|NOT COMPLETED|Overall Study||3
63660|NCT01560429|151596|P2|COMPLETED|Overall Study||20
63661|NCT01560429|151597|P1|COMPLETED|Overall Study||23
63662|NCT01560429|151596|P2|STARTED|Overall Study||26
63663|NCT01560429|151597|P1|STARTED|Overall Study||26
63664|NCT01560403|151607|P2|NOT COMPLETED|Overall Study||1
63665|NCT01560403|151608|P1|NOT COMPLETED|Overall Study||0
63666|NCT01560403|151607|P2|COMPLETED|Overall Study||8
63667|NCT01560403|151608|P1|COMPLETED|Overall Study||5
63668|NCT01560403|151607|P2|STARTED|Overall Study||9
63669|NCT01560403|151608|P1|STARTED|Overall Study||5
63670|NCT01560260|151614|P1|NOT COMPLETED|Overall Study||0
63671|NCT01560260|151614|P1|COMPLETED|Overall Study||20
63672|NCT01560260|151614|P1|STARTED|Overall Study||20
63673|NCT01560234|151626|P8|NOT COMPLETED|Overall Study||2
63674|NCT01560234|151627|P7|NOT COMPLETED|Overall Study||0
63675|NCT01560234|151628|P6|NOT COMPLETED|Overall Study||2
63676|NCT01560234|151629|P5|NOT COMPLETED|Overall Study||0
63677|NCT01560234|151630|P4|NOT COMPLETED|Overall Study||0
63678|NCT01560234|151631|P3|NOT COMPLETED|Overall Study||1
63679|NCT01560234|151632|P2|NOT COMPLETED|Overall Study||0
63680|NCT01560234|151633|P1|NOT COMPLETED|Overall Study||3
63681|NCT01560234|151626|P8|COMPLETED|Overall Study||6
63682|NCT01560234|151627|P7|COMPLETED|Overall Study||4
63683|NCT01560234|151628|P6|COMPLETED|Overall Study||2
63684|NCT01560234|151629|P5|COMPLETED|Overall Study||4
63685|NCT01560234|151630|P4|COMPLETED|Overall Study||3
63686|NCT01560234|151631|P3|COMPLETED|Overall Study||3
63687|NCT01560234|151632|P2|COMPLETED|Overall Study||4
63688|NCT01560234|151633|P1|COMPLETED|Overall Study||13
63689|NCT01560234|151626|P8|STARTED|Overall Study||8
63690|NCT01560234|151627|P7|STARTED|Overall Study||4
63691|NCT01560234|151628|P6|STARTED|Overall Study||4
63692|NCT01560234|151629|P5|STARTED|Overall Study||4
63693|NCT01560234|151630|P4|STARTED|Overall Study||3
63694|NCT01560234|151631|P3|STARTED|Overall Study||4
63695|NCT01560234|151632|P2|STARTED|Overall Study||4
63696|NCT01560234|151633|P1|STARTED|Overall Study||16
63697|NCT01560143|151707|P1|NOT COMPLETED|Overall Study||0
63698|NCT01560143|151707|P1|COMPLETED|Overall Study||12
63699|NCT01560143|151707|P1|STARTED|Overall Study||12
63700|NCT01559935|151711|P1|NOT COMPLETED|Maintenance Phase||54
63701|NCT01559935|151711|P1|COMPLETED|Maintenance Phase||0
63702|NCT01559935|151711|P1|STARTED|Maintenance Phase||54
63703|NCT01559935|151711|P1|NOT COMPLETED|BiRD Phase||4
63704|NCT01559935|151711|P1|COMPLETED|BiRD Phase||54
63705|NCT01559935|151711|P1|STARTED|BiRD Phase||58
63706|NCT01559935|151711|P1|NOT COMPLETED|Car Phase||14
63707|NCT01559935|151711|P1|COMPLETED|Car Phase||58
63708|NCT01559935|151711|P1|STARTED|Car Phase||72
63709|NCT01559922|151721|P2|NOT COMPLETED|Overall Study||10
63710|NCT01559922|151722|P1|NOT COMPLETED|Overall Study||4
63711|NCT01559922|151721|P2|COMPLETED|Overall Study||87
63712|NCT01559922|151722|P1|COMPLETED|Overall Study||46
63713|NCT01559922|151721|P2|STARTED|Overall Study||97
63714|NCT01559922|151722|P1|STARTED|Overall Study||50
63715|NCT01559857|151730|P2|NOT COMPLETED|Overall Study||0
63716|NCT01559857|151731|P1|NOT COMPLETED|Overall Study||0
63717|NCT01559857|151730|P2|COMPLETED|Overall Study||18
63718|NCT01559857|151731|P1|COMPLETED|Overall Study||19
63719|NCT01559857|151730|P2|STARTED|Overall Study||18
63720|NCT01559857|151731|P1|STARTED|Overall Study||19
63721|NCT01559844|151747|P1|NOT COMPLETED|Overall Study||25
63722|NCT01559844|151747|P1|COMPLETED|Overall Study||36
63723|NCT01559844|151747|P1|STARTED|Overall Study||61
63724|NCT01559675|151760|P2|NOT COMPLETED|Overall Study||14
63725|NCT01559675|151761|P1|NOT COMPLETED|Overall Study||15
63726|NCT01559675|151760|P2|COMPLETED|Overall Study||49
63727|NCT01559675|151761|P1|COMPLETED|Overall Study||43
63728|NCT01559675|151760|P2|STARTED|Overall Study||63
63729|NCT01559675|151761|P1|STARTED|Overall Study||58
63730|NCT01559649|151769|P2|NOT COMPLETED|Overall Study||6
63731|NCT01559649|151770|P1|NOT COMPLETED|Overall Study||19
63732|NCT01559649|151769|P2|COMPLETED|Overall Study||9
63733|NCT01559649|151770|P1|COMPLETED|Overall Study|Screening not completed in 11, VFSS not completed in 2, 6 excluded from analysis. N=250 analyzed|250
63734|NCT01559649|151769|P2|STARTED|Overall Study|Started with 10 nurses. As an RN dropped out due to scheduling, etc, RN replaced with another RN|15
63735|NCT01559649|151770|P1|STARTED|Overall Study||269
63736|NCT01559506|151783|P2|NOT COMPLETED|Overall Study||3
63737|NCT01559506|151784|P1|NOT COMPLETED|Overall Study||0
63738|NCT01559506|151783|P2|COMPLETED|Overall Study||18
63739|NCT01559506|151784|P1|COMPLETED|Overall Study||20
63740|NCT01559506|151783|P2|STARTED|Overall Study||21
63741|NCT01559506|151784|P1|STARTED|Overall Study||20
63742|NCT01559454|151792|P2|NOT COMPLETED|Overall Study||6
63743|NCT01559454|151793|P1|NOT COMPLETED|Overall Study||3
63744|NCT01559454|151792|P2|COMPLETED|Overall Study||4
63745|NCT01559454|151793|P1|COMPLETED|Overall Study||6
63746|NCT01559454|151792|P2|STARTED|Overall Study||10
63747|NCT01559454|151793|P1|STARTED|Overall Study||9
63748|NCT01559311|151812|P3|NOT COMPLETED|Overall Study||8
63749|NCT01559311|151813|P2|NOT COMPLETED|Overall Study||6
63750|NCT01559311|151814|P1|NOT COMPLETED|Overall Study||3
63751|NCT01559311|151812|P3|COMPLETED|Overall Study|12-Month|26
63752|NCT01559311|151813|P2|COMPLETED|Overall Study|12-Month|28
63753|NCT01559311|151814|P1|COMPLETED|Overall Study|12-Month|27
63754|NCT01559311|151812|P3|6-Month|Overall Study||28
63755|NCT01559311|151813|P2|6-Month|Overall Study||33
63756|NCT01559311|151814|P1|6-Month|Overall Study||27
63757|NCT01559311|151812|P3|3-Month|Overall Study||29
63758|NCT01559311|151813|P2|3-Month|Overall Study||34
63759|NCT01559311|151814|P1|3-Month|Overall Study||27
63760|NCT01559311|151812|P3|1-Month|Overall Study||29
63761|NCT01559311|151813|P2|1-Month|Overall Study||34
63762|NCT01559311|151814|P1|1-Month|Overall Study||27
63763|NCT01559311|151812|P3|Implant|Overall Study||32
63764|NCT01559311|151813|P2|Implant|Overall Study||34
63765|NCT01559311|151814|P1|Implant|Overall Study||28
63766|NCT01559311|151812|P3|STARTED|Overall Study|Enrollment & Baseline|34
63767|NCT01559311|151813|P2|STARTED|Overall Study|Enrollment & Baseline|34
63768|NCT01559311|151814|P1|STARTED|Overall Study|Enrollment & Baseline|30
63769|NCT01559116|151825|P1|NOT COMPLETED|Overall Study||26
63770|NCT01559116|151825|P1|COMPLETED|Overall Study|Completed all 4 treatment periods|193
63771|NCT01559116|151825|P1|STARTED|Overall Study|Randomised|219
63772|NCT01559064|151896|P3|NOT COMPLETED|Overall Study||2
63773|NCT01559064|151897|P2|NOT COMPLETED|Overall Study||1
63774|NCT01559064|151898|P1|NOT COMPLETED|Overall Study||1
63775|NCT01559064|151896|P3|COMPLETED|Overall Study||57
63776|NCT01559064|151897|P2|COMPLETED|Overall Study||39
63777|NCT01559064|151898|P1|COMPLETED|Overall Study||15
63778|NCT01559064|151896|P3|STARTED|Overall Study||59
63779|NCT01559064|151897|P2|STARTED|Overall Study||40
63780|NCT01559064|151898|P1|STARTED|Overall Study||16
63781|NCT01559012|151908|P2|NOT COMPLETED|Overall Study||1
63782|NCT01559012|151909|P1|NOT COMPLETED|Overall Study||0
63783|NCT01559012|151908|P2|COMPLETED|Overall Study|Patient N. 2 withdrew from study for alleged side effects at day 1 of placebo cycle.|6
63784|NCT01559012|151909|P1|COMPLETED|Overall Study||6
63785|NCT01559012|151908|P2|STARTED|Overall Study|1 more patient added to randomization list to reach the pre-assignment number of treated patients|7
63786|NCT01559012|151909|P1|STARTED|Overall Study||6
63787|NCT01558791|151934|P2|NOT COMPLETED|Overall Study||0
63788|NCT01558791|151935|P1|NOT COMPLETED|Overall Study||0
63789|NCT01558791|151934|P2|COMPLETED|Overall Study||629
63790|NCT01558791|151935|P1|COMPLETED|Overall Study||607
63791|NCT01558791|151934|P2|STARTED|Overall Study||629
63792|NCT01558791|151935|P1|STARTED|Overall Study||607
63793|NCT01558739|151945|P1|NOT COMPLETED|Overall Study||17
63794|NCT01558739|151945|P1|COMPLETED|Overall Study||31
63795|NCT01558739|151945|P1|STARTED|Overall Study||48
63796|NCT01558700|151959|P2|NOT COMPLETED|Overall Study||0
63797|NCT01558700|151960|P1|NOT COMPLETED|Overall Study||0
63798|NCT01558700|151959|P2|COMPLETED|Overall Study||21
63799|NCT01558700|151960|P1|COMPLETED|Overall Study||19
63800|NCT01558700|151959|P2|STARTED|Overall Study||21
63801|NCT01558700|151960|P1|STARTED|Overall Study||19
63802|NCT01558674|151970|P2|NOT COMPLETED|Part 2||0
63803|NCT01558674|151971|P1|NOT COMPLETED|Part 2||0
63804|NCT01558674|151970|P2|COMPLETED|Part 2||0
63805|NCT01558674|151971|P1|COMPLETED|Part 2||0
63806|NCT01558674|151970|P2|STARTED|Part 2||0
63807|NCT01558674|151971|P1|STARTED|Part 2||0
63808|NCT01558674|151970|P2|NOT COMPLETED|Part 1||0
63809|NCT01558674|151971|P1|NOT COMPLETED|Part 1||11
63810|NCT01558674|151970|P2|COMPLETED|Part 1||0
63811|NCT01558674|151971|P1|COMPLETED|Part 1||0
63812|NCT01558674|151970|P2|STARTED|Part 1||0
63813|NCT01558674|151971|P1|STARTED|Part 1||11
63814|NCT01555567|152019|P4|NOT COMPLETED|Return to Activity||1
63815|NCT01555567|152020|P3|NOT COMPLETED|Return to Activity||0
63816|NCT01555567|152021|P2|NOT COMPLETED|Return to Activity||2
63817|NCT01555567|152022|P1|NOT COMPLETED|Return to Activity||1
63818|NCT01555567|152019|P4|COMPLETED|Return to Activity||8
63819|NCT01555567|152020|P3|COMPLETED|Return to Activity||8
63820|NCT01555567|152021|P2|COMPLETED|Return to Activity||10
63821|NCT01555567|152022|P1|COMPLETED|Return to Activity||10
63822|NCT01555567|152019|P4|STARTED|Return to Activity||9
63823|NCT01555567|152020|P3|STARTED|Return to Activity||8
63824|NCT01555567|152021|P2|STARTED|Return to Activity||12
63825|NCT01555567|152022|P1|STARTED|Return to Activity||11
63826|NCT01555567|152019|P4|NOT COMPLETED|12 Week||0
63827|NCT01555567|152020|P3|NOT COMPLETED|12 Week||1
63828|NCT01555567|152021|P2|NOT COMPLETED|12 Week||1
63829|NCT01555567|152022|P1|NOT COMPLETED|12 Week||1
63830|NCT01555567|152019|P4|COMPLETED|12 Week||9
63831|NCT01555567|152020|P3|COMPLETED|12 Week||8
63832|NCT01555567|152021|P2|COMPLETED|12 Week||12
63833|NCT01555567|152022|P1|COMPLETED|12 Week||11
63834|NCT01555567|152019|P4|STARTED|12 Week||9
63835|NCT01555567|152020|P3|STARTED|12 Week||9
63836|NCT01555567|152021|P2|STARTED|12 Week||13
63837|NCT01555567|152022|P1|STARTED|12 Week||12
63838|NCT01558596|152038|P2|NOT COMPLETED|Overall Study||1
63839|NCT01558596|152039|P1|NOT COMPLETED|Overall Study||3
63840|NCT01558596|152038|P2|COMPLETED|Overall Study||100
63841|NCT01558596|152039|P1|COMPLETED|Overall Study||101
63842|NCT01558596|152038|P2|STARTED|Overall Study||101
63843|NCT01558596|152039|P1|STARTED|Overall Study||104
63844|NCT01558492|152045|P1|NOT COMPLETED|Overall Study||0
63845|NCT01558492|152045|P1|COMPLETED|Overall Study||3
63846|NCT01558492|152045|P1|STARTED|Overall Study||3
63847|NCT01558297|152054|P3|NOT COMPLETED|Overall Study||1
63848|NCT01558297|152055|P2|NOT COMPLETED|Overall Study||2
63849|NCT01558297|152056|P1|NOT COMPLETED|Overall Study||2
63850|NCT01558297|152054|P3|COMPLETED|Overall Study||29
63851|NCT01558297|152055|P2|COMPLETED|Overall Study||27
63852|NCT01558297|152056|P1|COMPLETED|Overall Study||28
63853|NCT01558297|152054|P3|STARTED|Overall Study||30
63854|NCT01558297|152055|P2|STARTED|Overall Study||29
63855|NCT01558297|152056|P1|STARTED|Overall Study||30
63856|NCT01558271|152073|P3|NOT COMPLETED|Overall Study||17
63857|NCT01558271|152074|P2|NOT COMPLETED|Overall Study||11
63858|NCT01558271|152075|P1|NOT COMPLETED|Overall Study||18
63859|NCT01558271|152073|P3|COMPLETED|Overall Study||124
63860|NCT01558271|152074|P2|COMPLETED|Overall Study||59
63861|NCT01558271|152075|P1|COMPLETED|Overall Study||263
63862|NCT01558271|152073|P3|Completed 26 Weeks|Overall Study||128
63863|NCT01558271|152074|P2|Completed 26 Weeks|Overall Study||63
63864|NCT01558271|152075|P1|Completed 26 Weeks|Overall Study||271
63865|NCT01558271|152073|P3|Received at Least 1 Dose of Study Drug|Overall Study||137
63866|NCT01558271|152074|P2|Received at Least 1 Dose of Study Drug|Overall Study||70
63867|NCT01558271|152075|P1|Received at Least 1 Dose of Study Drug|Overall Study||280
63868|NCT01558271|152073|P3|STARTED|Overall Study||141
63869|NCT01558271|152074|P2|STARTED|Overall Study||70
63870|NCT01558271|152075|P1|STARTED|Overall Study||281
63871|NCT01558128|152137|P1|NOT COMPLETED|Overall Study||0
63872|NCT01558128|152137|P1|COMPLETED|Overall Study||1
63873|NCT01558128|152137|P1|STARTED|Overall Study||1
63874|NCT01558089|152141|P1|NOT COMPLETED|Overall Study||13
63875|NCT01558089|152141|P1|COMPLETED|Overall Study||63
63876|NCT01558089|152141|P1|STARTED|Overall Study||76
63877|NCT01557959|152152|P1|NOT COMPLETED|Overall Study||0
63878|NCT01557959|152152|P1|COMPLETED|Overall Study||45
63879|NCT01557959|152152|P1|STARTED|Overall Study||45
63880|NCT01557920|152156|P2|NOT COMPLETED|Overall Study||3
63881|NCT01557920|152157|P1|NOT COMPLETED|Overall Study||3
63882|NCT01557920|152156|P2|COMPLETED|Overall Study||6
63883|NCT01557920|152157|P1|COMPLETED|Overall Study||6
63884|NCT01557920|152156|P2|STARTED|Overall Study||9
63885|NCT01557920|152157|P1|STARTED|Overall Study||9
63886|NCT01557894|152192|P2|NOT COMPLETED|Overall Study||5
63887|NCT01557894|152193|P1|NOT COMPLETED|Overall Study||3
63888|NCT01557894|152192|P2|COMPLETED|Overall Study||33
63889|NCT01557894|152193|P1|COMPLETED|Overall Study||35
63890|NCT01557894|152192|P2|STARTED|Overall Study||38
63891|NCT01557894|152193|P1|STARTED|Overall Study||38
63892|NCT01557868|152209|P2|NOT COMPLETED|Overall Study||30
63893|NCT01557868|152210|P1|NOT COMPLETED|Overall Study||27
63894|NCT01557868|152209|P2|COMPLETED|Overall Study||65
63895|NCT01557868|152210|P1|COMPLETED|Overall Study||76
63896|NCT01557868|152209|P2|STARTED|Overall Study||95
63897|NCT01557868|152210|P1|STARTED|Overall Study||103
63898|NCT01557842|152220|P2|NOT COMPLETED|Overall Study||6
63899|NCT01557842|152221|P1|NOT COMPLETED|Overall Study||9
63900|NCT01557842|152220|P2|COMPLETED|Overall Study||0
63901|NCT01557842|152221|P1|COMPLETED|Overall Study||0
63902|NCT01557842|152220|P2|STARTED|Overall Study||6
63903|NCT01557842|152221|P1|STARTED|Overall Study||9
63904|NCT01557699|152232|P3|NOT COMPLETED|Overall Study||0
63905|NCT01557699|152233|P2|NOT COMPLETED|Overall Study||0
63906|NCT01557699|152234|P1|NOT COMPLETED|Overall Study||0
63907|NCT01557699|152232|P3|COMPLETED|Overall Study||20
63908|NCT01557699|152233|P2|COMPLETED|Overall Study||20
63909|NCT01557699|152234|P1|COMPLETED|Overall Study||20
63910|NCT01557699|152232|P3|STARTED|Overall Study||20
63911|NCT01557699|152233|P2|STARTED|Overall Study||20
63912|NCT01557699|152234|P1|STARTED|Overall Study||20
63913|NCT01555463|152268|P2|NOT COMPLETED|Follow up||45
63914|NCT01555463|152269|P1|NOT COMPLETED|Follow up||38
63915|NCT01555463|152268|P2|COMPLETED|Follow up||394
63916|NCT01555463|152269|P1|COMPLETED|Follow up||409
63917|NCT01555463|152268|P2|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|439
63918|NCT01555463|152269|P1|STARTED|Follow up|Treatment completers and non-completers were asked to participate in the follow-up phase.|447
63919|NCT01555463|152268|P2|NOT COMPLETED|Treatment||79
63920|NCT01555463|152269|P1|NOT COMPLETED|Treatment||64
63921|NCT01555463|152268|P2|COMPLETED|Treatment||399
63922|NCT01555463|152269|P1|COMPLETED|Treatment||419
63923|NCT01555463|152268|P2|STARTED|Treatment||478
63924|NCT01555463|152269|P1|STARTED|Treatment||483
63925|NCT01557595|152309|P1|NOT COMPLETED|Overall Study||8
63926|NCT01557595|152309|P1|COMPLETED|Overall Study||14
63927|NCT01557595|152309|P1|STARTED|Overall Study||22
63928|NCT01557582|152313|P1|NOT COMPLETED|Overall Study||6
63929|NCT01557582|152313|P1|COMPLETED|Overall Study||97
63930|NCT01557582|152313|P1|STARTED|Overall Study||103
63931|NCT01557569|152321|P2|NOT COMPLETED|Overall Study||7
63932|NCT01557569|152322|P1|NOT COMPLETED|Overall Study||5
63933|NCT01557569|152321|P2|COMPLETED|Overall Study||0
63934|NCT01557569|152322|P1|COMPLETED|Overall Study||1
63935|NCT01557569|152321|P2|Completed 2-wk Residential Stay|Overall Study||1
63936|NCT01557569|152322|P1|Completed 2-wk Residential Stay|Overall Study||3
63937|NCT01557569|152321|P2|STARTED|Overall Study|Those who received at least one dose of medication|7
63938|NCT01557569|152322|P1|STARTED|Overall Study|Those who received at least one dose of medication|6
63939|NCT01557504|152330|P2|NOT COMPLETED|Overall Study||0
63940|NCT01557504|152331|P1|NOT COMPLETED|Overall Study||1
63941|NCT01557504|152330|P2|COMPLETED|Overall Study||12
63942|NCT01557504|152331|P1|COMPLETED|Overall Study||12
63943|NCT01557504|152330|P2|STARTED|Overall Study||12
63944|NCT01557504|152331|P1|STARTED|Overall Study||13
63945|NCT01557348|152356|P2|NOT COMPLETED|Overall Study||90
63946|NCT01557348|152357|P1|NOT COMPLETED|Overall Study||80
63947|NCT01557348|152356|P2|COMPLETED|Overall Study||417
63948|NCT01557348|152357|P1|COMPLETED|Overall Study||524
63949|NCT01557348|152356|P2|Safety Population|Overall Study||507
63950|NCT01557348|152357|P1|Safety Population|Overall Study||604
63951|NCT01557348|152356|P2|STARTED|Overall Study||507
63952|NCT01557348|152357|P1|STARTED|Overall Study||604
63953|NCT01557322|152399|P2|NOT COMPLETED|Overall Study||0
63954|NCT01557322|152400|P1|NOT COMPLETED|Overall Study||0
63955|NCT01557322|152399|P2|COMPLETED|Overall Study||1543
63956|NCT01557322|152400|P1|COMPLETED|Overall Study||211
63957|NCT01557322|152399|P2|STARTED|Overall Study||1543
63958|NCT01557322|152400|P1|STARTED|Overall Study||211
63959|NCT01557283|152474|P1|NOT COMPLETED|Overall Study||44
63960|NCT01557283|152474|P1|COMPLETED|Overall Study||96
63961|NCT01557283|152474|P1|STARTED|Overall Study||140
63962|NCT01557166|152486|P2|NOT COMPLETED|Overall Study||37
63963|NCT01557166|152487|P1|NOT COMPLETED|Overall Study||46
63964|NCT01557166|152486|P2|COMPLETED|Overall Study||142
63965|NCT01557166|152487|P1|COMPLETED|Overall Study||134
63966|NCT01557166|152486|P2|Exposed|Overall Study||179
63967|NCT01557166|152487|P1|Exposed|Overall Study||176
63968|NCT01557166|152486|P2|STARTED|Overall Study||179
63969|NCT01557166|152487|P1|STARTED|Overall Study||180
63970|NCT01556997|152502|P3|NOT COMPLETED|Overall Study||32
63971|NCT01556997|152503|P2|NOT COMPLETED|Overall Study||28
63972|NCT01556997|152504|P1|NOT COMPLETED|Overall Study||26
63973|NCT01556997|152502|P3|COMPLETED|Overall Study||246
63974|NCT01556997|152503|P2|COMPLETED|Overall Study||252
63975|NCT01556997|152504|P1|COMPLETED|Overall Study||253
63976|NCT01556997|152502|P3|STARTED|Overall Study||278
63977|NCT01556997|152503|P2|STARTED|Overall Study||280
63978|NCT01556997|152504|P1|STARTED|Overall Study||279
63979|NCT01556932|152515|P2|NOT COMPLETED|Second Treament||0
63980|NCT01556932|152516|P1|NOT COMPLETED|Second Treament||0
63981|NCT01556932|152515|P2|COMPLETED|Second Treament||8
63982|NCT01556932|152516|P1|COMPLETED|Second Treament||12
63983|NCT01556932|152515|P2|Recieved|Second Treament||8
63984|NCT01556932|152516|P1|Recieved|Second Treament||12
63985|NCT01556932|152515|P2|STARTED|Second Treament||8
63986|NCT01556932|152516|P1|STARTED|Second Treament||12
63987|NCT01556932|152515|P2|NOT COMPLETED|Time Point 60 Minutes||1
63988|NCT01556932|152516|P1|NOT COMPLETED|Time Point 60 Minutes||1
63989|NCT01556932|152515|P2|COMPLETED|Time Point 60 Minutes||8
63990|NCT01556932|152516|P1|COMPLETED|Time Point 60 Minutes||12
63991|NCT01556932|152515|P2|Recieved|Time Point 60 Minutes||8
63992|NCT01556932|152516|P1|Recieved|Time Point 60 Minutes||12
63993|NCT01556932|152515|P2|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|9
63994|NCT01556932|152516|P1|STARTED|Time Point 60 Minutes|1 subject withdrew and never started second treatment.|13
63995|NCT01556932|152515|P2|NOT COMPLETED|Baseline First Treatment||0
63996|NCT01556932|152516|P1|NOT COMPLETED|Baseline First Treatment||0
63997|NCT01556932|152515|P2|COMPLETED|Baseline First Treatment||9
63998|NCT01556932|152516|P1|COMPLETED|Baseline First Treatment||13
63999|NCT01556932|152515|P2|Recieved|Baseline First Treatment||9
64000|NCT01556932|152516|P1|Recieved|Baseline First Treatment||13
64001|NCT01556932|152515|P2|STARTED|Baseline First Treatment||9
64002|NCT01556932|152516|P1|STARTED|Baseline First Treatment||13
64003|NCT01556906|152521|P1|NOT COMPLETED|Overall Study||0
64004|NCT01556906|152521|P1|COMPLETED|Overall Study||6
64005|NCT01556906|152521|P1|STARTED|Overall Study||6
64006|NCT01556763|152542|P3|NOT COMPLETED|Overall Study||0
64007|NCT01556763|152543|P2|NOT COMPLETED|Overall Study||1
64008|NCT01556763|152544|P1|NOT COMPLETED|Overall Study||0
64009|NCT01556763|152542|P3|COMPLETED|Overall Study||8
64010|NCT01556763|152543|P2|COMPLETED|Overall Study||8
64011|NCT01556763|152544|P1|COMPLETED|Overall Study||4
64012|NCT01556763|152542|P3|STARTED|Overall Study||8
64013|NCT01556763|152543|P2|STARTED|Overall Study||9
64014|NCT01556763|152544|P1|STARTED|Overall Study||4
64015|NCT01556724|152582|P2|NOT COMPLETED|Overall Study||0
64016|NCT01556724|152583|P1|NOT COMPLETED|Overall Study||0
64017|NCT01556724|152582|P2|COMPLETED|Overall Study||15
64018|NCT01556724|152583|P1|COMPLETED|Overall Study||15
64019|NCT01556724|152582|P2|STARTED|Overall Study||15
64020|NCT01556724|152583|P1|STARTED|Overall Study||15
64021|NCT01556633|152591|P2|NOT COMPLETED|Overall Study||0
64022|NCT01556633|152592|P1|NOT COMPLETED|Overall Study||0
64023|NCT01556633|152591|P2|COMPLETED|Overall Study||6
64024|NCT01556633|152592|P1|COMPLETED|Overall Study||10
64025|NCT01556633|152591|P2|STARTED|Overall Study||6
64026|NCT01556633|152592|P1|STARTED|Overall Study||10
64027|NCT01556594|152617|P3|NOT COMPLETED|Overall Study||0
64028|NCT01556594|152618|P2|NOT COMPLETED|Overall Study||0
64029|NCT01556594|152619|P1|NOT COMPLETED|Overall Study||0
64030|NCT01556594|152617|P3|COMPLETED|Overall Study||6
64031|NCT01556594|152618|P2|COMPLETED|Overall Study||2
64032|NCT01556594|152619|P1|COMPLETED|Overall Study||10
64033|NCT01556594|152617|P3|STARTED|Overall Study||6
64034|NCT01556594|152618|P2|STARTED|Overall Study||2
64035|NCT01556594|152619|P1|STARTED|Overall Study||10
64036|NCT01556451|152637|P1|NOT COMPLETED|Overall Study||0
64037|NCT01556451|152637|P1|COMPLETED|Overall Study||180
64038|NCT01556451|152637|P1|STARTED|Overall Study||180
64039|NCT01556204|152646|P2|NOT COMPLETED|Overall Study||0
64040|NCT01556204|152647|P1|NOT COMPLETED|Overall Study||0
64041|NCT01556204|152646|P2|COMPLETED|Overall Study||38
64042|NCT01556204|152647|P1|COMPLETED|Overall Study||35
64043|NCT01556204|152646|P2|STARTED|Overall Study||38
64044|NCT01556204|152647|P1|STARTED|Overall Study||35
64045|NCT01556165|152657|P2|NOT COMPLETED|Overall Study||7
64046|NCT01556165|152658|P1|NOT COMPLETED|Overall Study||12
64047|NCT01556165|152657|P2|COMPLETED|Overall Study||58
64048|NCT01556165|152658|P1|COMPLETED|Overall Study||53
64049|NCT01556165|152657|P2|STARTED|Overall Study||65
64050|NCT01556165|152658|P1|STARTED|Overall Study||65
64051|NCT01556061|152672|P2|NOT COMPLETED|Overall Study||0
64052|NCT01556061|152673|P1|NOT COMPLETED|Overall Study||0
64053|NCT01556061|152672|P2|COMPLETED|Overall Study||25
64054|NCT01556061|152673|P1|COMPLETED|Overall Study||25
64055|NCT01556061|152672|P2|STARTED|Overall Study||25
64056|NCT01556061|152673|P1|STARTED|Overall Study||25
64057|NCT01555983|152683|P6|NOT COMPLETED|Overall Study||1
64058|NCT01555983|152684|P5|NOT COMPLETED|Overall Study||1
64059|NCT01555983|152685|P4|NOT COMPLETED|Overall Study||0
64060|NCT01555983|152686|P3|NOT COMPLETED|Overall Study||0
64061|NCT01555983|152687|P2|NOT COMPLETED|Overall Study||0
64062|NCT01555983|152688|P1|NOT COMPLETED|Overall Study||1
64063|NCT01555983|152683|P6|COMPLETED|Overall Study|One subject completed the 6.7%THC session, then dropped out.|6
64064|NCT01555983|152684|P5|COMPLETED|Overall Study|One subject complete 6.7%THC and placebo sessions, then dropped out|4
64065|NCT01555983|152685|P4|COMPLETED|Overall Study||7
64066|NCT01555983|152686|P3|COMPLETED|Overall Study||7
64067|NCT01555983|152687|P2|COMPLETED|Overall Study||7
64068|NCT01555983|152688|P1|COMPLETED|Overall Study|One subject only finished the placebo session, then dropped out of study|8
64069|NCT01555983|152683|P6|STARTED|Overall Study||7
64070|NCT01555983|152684|P5|STARTED|Overall Study||5
64071|NCT01555983|152685|P4|STARTED|Overall Study||7
64072|NCT01555983|152686|P3|STARTED|Overall Study||7
64073|NCT01555983|152687|P2|STARTED|Overall Study||7
64074|NCT01555983|152688|P1|STARTED|Overall Study||9
64075|NCT01555931|152698|P2|NOT COMPLETED|Overall Study||5
64076|NCT01555931|152699|P1|NOT COMPLETED|Overall Study||2
64077|NCT01555931|152698|P2|COMPLETED|Overall Study||13
64078|NCT01555931|152699|P1|COMPLETED|Overall Study||15
64079|NCT01555931|152698|P2|STARTED|Overall Study||18
64080|NCT01555931|152699|P1|STARTED|Overall Study||17
64081|NCT01555164|152709|P2|NOT COMPLETED|Overall Study||35
64082|NCT01555164|152710|P1|NOT COMPLETED|Overall Study||40
64083|NCT01555164|152709|P2|COMPLETED|Overall Study||185
64084|NCT01555164|152710|P1|COMPLETED|Overall Study||182
64085|NCT01555164|152709|P2|STARTED|Overall Study||220
64086|NCT01555164|152710|P1|STARTED|Overall Study||222
64087|NCT01555151|152724|P4|NOT COMPLETED|Overall Study||10
64088|NCT01555151|152725|P3|NOT COMPLETED|Overall Study||6
64089|NCT01555151|152726|P2|NOT COMPLETED|Overall Study||8
64090|NCT01555151|152727|P1|NOT COMPLETED|Overall Study||13
64091|NCT01555151|152724|P4|COMPLETED|Overall Study||176
64092|NCT01555151|152725|P3|COMPLETED|Overall Study||178
64093|NCT01555151|152726|P2|COMPLETED|Overall Study||173
64094|NCT01555151|152727|P1|COMPLETED|Overall Study||175
64095|NCT01555151|152724|P4|Safety Set (SAF)|Overall Study||186
64096|NCT01555151|152725|P3|Safety Set (SAF)|Overall Study||183
64097|NCT01555151|152726|P2|Safety Set (SAF)|Overall Study||180
64098|NCT01555151|152727|P1|Safety Set (SAF)|Overall Study||186
64099|NCT01555151|152724|P4|STARTED|Overall Study||186
64100|NCT01555151|152725|P3|STARTED|Overall Study||184
64101|NCT01555151|152726|P2|STARTED|Overall Study||181
64102|NCT01555151|152727|P1|STARTED|Overall Study||188
64103|NCT01555138|152780|P2|NOT COMPLETED|Overall Study||38
64104|NCT01555138|152781|P1|NOT COMPLETED|Overall Study||47
64105|NCT01555138|152780|P2|COMPLETED|Overall Study||250
64106|NCT01555138|152781|P1|COMPLETED|Overall Study||246
64107|NCT01555138|152780|P2|STARTED|Overall Study||288
64108|NCT01555138|152781|P1|STARTED|Overall Study||293
64109|NCT01555073|152811|P4|NOT COMPLETED|Overall Study||5
64110|NCT01555073|152812|P3|NOT COMPLETED|Overall Study||0
64111|NCT01555073|152813|P2|NOT COMPLETED|Overall Study||2
64112|NCT01555073|152814|P1|NOT COMPLETED|Overall Study||1
64113|NCT01555073|152811|P4|COMPLETED|Overall Study||1
64114|NCT01555073|152812|P3|COMPLETED|Overall Study||7
64115|NCT01555073|152813|P2|COMPLETED|Overall Study||1
64116|NCT01555073|152814|P1|COMPLETED|Overall Study||6
64117|NCT01555073|152811|P4|STARTED|Overall Study||6
64118|NCT01555073|152812|P3|STARTED|Overall Study||7
64119|NCT01555073|152813|P2|STARTED|Overall Study||3
64120|NCT01555073|152814|P1|STARTED|Overall Study||7
64121|NCT01554982|152828|P1|NOT COMPLETED|Overall Study||43
64122|NCT01554982|152828|P1|COMPLETED|Overall Study||125
64123|NCT01554982|152828|P1|Received Drug|Overall Study||166
64124|NCT01554982|152828|P1|STARTED|Overall Study||168
64125|NCT01554904|152841|P1|NOT COMPLETED|Overall Study||4
64126|NCT01554904|152841|P1|COMPLETED|Overall Study||14
64127|NCT01554904|152841|P1|Home Sleep Study 2|Overall Study||14
64128|NCT01554904|152841|P1|Complete 6 Weeks of Facial Training|Overall Study|3 subjects withdrew during training|14
64129|NCT01554904|152841|P1|Start 6 Weeks of Facial Training|Overall Study|1 participant was found to have obstructive sleep apnea on the home sleep study #1|17
64130|NCT01554904|152841|P1|Home Sleep Study 1|Overall Study|After informed consent signed.|18
64131|NCT01554904|152841|P1|STARTED|Overall Study||18
64132|NCT01554891|152849|P3|NOT COMPLETED|Overall Study||2
64133|NCT01554891|152850|P2|NOT COMPLETED|Overall Study||5
64134|NCT01554891|152851|P1|NOT COMPLETED|Overall Study||7
64135|NCT01554891|152849|P3|COMPLETED|Overall Study||55
64136|NCT01554891|152850|P2|COMPLETED|Overall Study||115
64137|NCT01554891|152851|P1|COMPLETED|Overall Study||98
64138|NCT01554891|152849|P3|STARTED|Overall Study||57
64139|NCT01554891|152850|P2|STARTED|Overall Study||120
64140|NCT01554891|152851|P1|STARTED|Overall Study||105
64141|NCT01554579|152861|P2|NOT COMPLETED|Overall Study||27
64142|NCT01554579|152862|P1|NOT COMPLETED|Overall Study||10
64143|NCT01554579|152861|P2|COMPLETED|Overall Study||58
64144|NCT01554579|152862|P1|COMPLETED|Overall Study||76
64145|NCT01554579|152861|P2|STARTED|Overall Study||85
64146|NCT01554579|152862|P1|STARTED|Overall Study||86
64147|NCT01554241|152876|P4|NOT COMPLETED|Overall Study||1
64148|NCT01554241|152877|P3|NOT COMPLETED|Overall Study||4
64149|NCT01554241|152878|P2|NOT COMPLETED|Overall Study||1
64150|NCT01554241|152879|P1|NOT COMPLETED|Overall Study||3
64151|NCT01554241|152876|P4|COMPLETED|Overall Study||13
64152|NCT01554241|152877|P3|COMPLETED|Overall Study||20
64153|NCT01554241|152878|P2|COMPLETED|Overall Study||19
64154|NCT01554241|152879|P1|COMPLETED|Overall Study||20
64155|NCT01554241|152876|P4|STARTED|Overall Study||14
64156|NCT01554241|152877|P3|STARTED|Overall Study||24
64157|NCT01554241|152878|P2|STARTED|Overall Study||20
64158|NCT01554241|152879|P1|STARTED|Overall Study||23
64159|NCT01554176|152895|P5|NOT COMPLETED|Run-out Phase||0
64160|NCT01554176|152896|P4|NOT COMPLETED|Run-out Phase||1
64161|NCT01554176|152897|P3|NOT COMPLETED|Run-out Phase||0
64162|NCT01554176|152898|P2|NOT COMPLETED|Run-out Phase||0
64163|NCT01554176|152899|P1|NOT COMPLETED|Run-out Phase||0
64164|NCT01554176|152895|P5|COMPLETED|Run-out Phase||59
64165|NCT01554176|152896|P4|COMPLETED|Run-out Phase||27
64166|NCT01554176|152897|P3|COMPLETED|Run-out Phase||29
64167|NCT01554176|152898|P2|COMPLETED|Run-out Phase||0
64168|NCT01554176|152899|P1|COMPLETED|Run-out Phase||0
64169|NCT01554176|152895|P5|Treated|Run-out Phase||59
64170|NCT01554176|152896|P4|Treated|Run-out Phase||28
64171|NCT01554176|152897|P3|Treated|Run-out Phase||29
64172|NCT01554176|152898|P2|Treated|Run-out Phase||0
64173|NCT01554176|152899|P1|Treated|Run-out Phase||0
64174|NCT01554176|152895|P5|STARTED|Run-out Phase||59
64175|NCT01554176|152896|P4|STARTED|Run-out Phase||28
64176|NCT01554176|152897|P3|STARTED|Run-out Phase||29
64177|NCT01554176|152898|P2|STARTED|Run-out Phase||0
64178|NCT01554176|152899|P1|STARTED|Run-out Phase||0
64179|NCT01554176|152895|P5|NOT COMPLETED|Treatment Phase||0
64180|NCT01554176|152896|P4|NOT COMPLETED|Treatment Phase||0
64181|NCT01554176|152897|P3|NOT COMPLETED|Treatment Phase||0
64182|NCT01554176|152898|P2|NOT COMPLETED|Treatment Phase||5
64183|NCT01554176|152899|P1|NOT COMPLETED|Treatment Phase||8
64184|NCT01554176|152895|P5|COMPLETED|Treatment Phase||0
64185|NCT01554176|152896|P4|COMPLETED|Treatment Phase||0
64186|NCT01554176|152897|P3|COMPLETED|Treatment Phase||0
64187|NCT01554176|152898|P2|COMPLETED|Treatment Phase||59
64188|NCT01554176|152899|P1|COMPLETED|Treatment Phase||57
64189|NCT01554176|152895|P5|Treated|Treatment Phase||0
64190|NCT01554176|152896|P4|Treated|Treatment Phase||0
64191|NCT01554176|152897|P3|Treated|Treatment Phase||0
64192|NCT01554176|152898|P2|Treated|Treatment Phase||64
64193|NCT01554176|152899|P1|Treated|Treatment Phase||64
64194|NCT01554176|152895|P5|STARTED|Treatment Phase||0
64195|NCT01554176|152896|P4|STARTED|Treatment Phase||0
64196|NCT01554176|152897|P3|STARTED|Treatment Phase||0
64197|NCT01554176|152898|P2|STARTED|Treatment Phase||64
64198|NCT01554176|152899|P1|STARTED|Treatment Phase||65
64199|NCT01554163|152926|P2|NOT COMPLETED|Overall Study||10
64200|NCT01554163|152927|P1|NOT COMPLETED|Overall Study||8
64201|NCT01554163|152926|P2|COMPLETED|Overall Study||109
64202|NCT01554163|152927|P1|COMPLETED|Overall Study||112
64203|NCT01554163|152926|P2|Number Treated|Overall Study||119
64204|NCT01554163|152927|P1|Number Treated|Overall Study||119
64205|NCT01554163|152926|P2|STARTED|Overall Study||119
64206|NCT01554163|152927|P1|STARTED|Overall Study||120
64207|NCT01553851|152945|P1|NOT COMPLETED|Overall Study||3
64208|NCT01553851|152945|P1|COMPLETED|Overall Study||17
64209|NCT01553851|152945|P1|STARTED|Overall Study||20
64210|NCT01553708|152959|P2|NOT COMPLETED|Overall Study||0
64211|NCT01553708|152960|P1|NOT COMPLETED|Overall Study||0
64212|NCT01553708|152959|P2|COMPLETED|Overall Study||17
64213|NCT01553708|152960|P1|COMPLETED|Overall Study||17
64214|NCT01553708|152959|P2|STARTED|Overall Study||17
64215|NCT01553708|152960|P1|STARTED|Overall Study||17
64216|NCT01553539|152966|P1|NOT COMPLETED|Overall Study||0
64217|NCT01553539|152966|P1|COMPLETED|Overall Study||20
64218|NCT01553539|152966|P1|STARTED|Overall Study||20
64219|NCT01553318|152973|P2|NOT COMPLETED|Overall Study||2
64220|NCT01553318|152974|P1|NOT COMPLETED|Overall Study||3
64221|NCT01553318|152973|P2|COMPLETED|Overall Study||25
64222|NCT01553318|152974|P1|COMPLETED|Overall Study||21
64223|NCT01553318|152973|P2|STARTED|Overall Study||27
64224|NCT01553318|152974|P1|STARTED|Overall Study||24
64225|NCT01553292|152986|P1|NOT COMPLETED|Overall Study||0
64226|NCT01553292|152986|P1|COMPLETED|Overall Study||21
64227|NCT01553292|152986|P1|STARTED|Overall Study||21
64228|NCT01553240|153002|P1|NOT COMPLETED|Overall Study||0
64229|NCT01553240|153002|P1|COMPLETED|Overall Study||0
64230|NCT01553240|153002|P1|STARTED|Overall Study||0
64231|NCT01552954|153009|P2|NOT COMPLETED|Overall Study||6
64232|NCT01552954|153010|P1|NOT COMPLETED|Overall Study||5
64233|NCT01552954|153009|P2|COMPLETED|Overall Study||119
64234|NCT01552954|153010|P1|COMPLETED|Overall Study||126
64235|NCT01552954|153009|P2|STARTED|Overall Study||125
64236|NCT01552954|153010|P1|STARTED|Overall Study|A total of 13 patients were withdrawn from 269 patients. The remained 256 patients were randomized.|131
64237|NCT01552928|153026|P4|NOT COMPLETED|Period 4||0
64238|NCT01552928|153027|P3|NOT COMPLETED|Period 4||0
64239|NCT01552928|153028|P2|NOT COMPLETED|Period 4||0
64240|NCT01552928|153029|P1|NOT COMPLETED|Period 4||0
64241|NCT01552928|153026|P4|COMPLETED|Period 4||16
64242|NCT01552928|153027|P3|COMPLETED|Period 4||14
64243|NCT01552928|153028|P2|COMPLETED|Period 4||15
64244|NCT01552928|153029|P1|COMPLETED|Period 4||14
64245|NCT01552928|153026|P4|STARTED|Period 4||16
64246|NCT01552928|153027|P3|STARTED|Period 4||14
64247|NCT01552928|153028|P2|STARTED|Period 4||15
64248|NCT01552928|153029|P1|STARTED|Period 4||14
64249|NCT01552928|153026|P4|NOT COMPLETED|Period 3||0
64250|NCT01552928|153027|P3|NOT COMPLETED|Period 3||1
64251|NCT01552928|153028|P2|NOT COMPLETED|Period 3||0
64252|NCT01552928|153029|P1|NOT COMPLETED|Period 3||0
64253|NCT01552928|153026|P4|COMPLETED|Period 3||16
64254|NCT01552928|153027|P3|COMPLETED|Period 3||14
64255|NCT01552928|153028|P2|COMPLETED|Period 3||15
64256|NCT01552928|153029|P1|COMPLETED|Period 3||14
64257|NCT01552928|153026|P4|STARTED|Period 3||16
64258|NCT01552928|153027|P3|STARTED|Period 3||15
64259|NCT01552928|153028|P2|STARTED|Period 3||15
64260|NCT01552928|153029|P1|STARTED|Period 3||14
64261|NCT01552928|153026|P4|NOT COMPLETED|Period 2||0
64262|NCT01552928|153027|P3|NOT COMPLETED|Period 2||0
64263|NCT01552928|153028|P2|NOT COMPLETED|Period 2||0
64264|NCT01552928|153029|P1|NOT COMPLETED|Period 2||0
64265|NCT01552928|153026|P4|COMPLETED|Period 2||16
64266|NCT01552928|153027|P3|COMPLETED|Period 2||15
64267|NCT01552928|153028|P2|COMPLETED|Period 2||15
64268|NCT01552928|153029|P1|COMPLETED|Period 2||14
64269|NCT01552928|153026|P4|STARTED|Period 2||16
64270|NCT01552928|153027|P3|STARTED|Period 2||15
64271|NCT01552928|153028|P2|STARTED|Period 2||15
64272|NCT01552928|153029|P1|STARTED|Period 2||14
64273|NCT01552928|153026|P4|NOT COMPLETED|Period 1||0
64274|NCT01552928|153027|P3|NOT COMPLETED|Period 1||0
64275|NCT01552928|153028|P2|NOT COMPLETED|Period 1||0
64276|NCT01552928|153029|P1|NOT COMPLETED|Period 1||0
64277|NCT01552928|153026|P4|COMPLETED|Period 1||16
64278|NCT01552928|153027|P3|COMPLETED|Period 1||15
64279|NCT01552928|153028|P2|COMPLETED|Period 1||15
64280|NCT01552928|153029|P1|COMPLETED|Period 1||14
64281|NCT01552928|153026|P4|STARTED|Period 1||16
64282|NCT01552928|153027|P3|STARTED|Period 1||15
64283|NCT01552928|153028|P2|STARTED|Period 1||15
64284|NCT01552928|153029|P1|STARTED|Period 1||14
64285|NCT01552915|153076|P3|NOT COMPLETED|Overall Study||27
64286|NCT01552915|153077|P2|NOT COMPLETED|Overall Study||29
64287|NCT01552915|153078|P1|NOT COMPLETED|Overall Study||23
64288|NCT01552915|153076|P3|COMPLETED|Overall Study||157
64289|NCT01552915|153077|P2|COMPLETED|Overall Study||155
64290|NCT01552915|153078|P1|COMPLETED|Overall Study||68
64291|NCT01552915|153076|P3|STARTED|Overall Study|This population is from the Safety Set. One randomized subject was not dosed and was excluded.|184
64292|NCT01552915|153077|P2|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|184
64293|NCT01552915|153078|P1|STARTED|Overall Study|This population is from the Safety Set. Two randomized subjects were not dosed and were excluded.|91
64294|NCT01552902|153101|P3|NOT COMPLETED|Overall Study||33
64295|NCT01552902|153102|P2|NOT COMPLETED|Overall Study||37
64296|NCT01552902|153103|P1|NOT COMPLETED|Overall Study||13
64297|NCT01552902|153101|P3|COMPLETED|Overall Study||186
64298|NCT01552902|153102|P2|COMPLETED|Overall Study||181
64299|NCT01552902|153103|P1|COMPLETED|Overall Study||97
64300|NCT01552902|153101|P3|STARTED|Overall Study||219
64301|NCT01552902|153102|P2|STARTED|Overall Study||218
64302|NCT01552902|153103|P1|STARTED|Overall Study||110
64303|NCT01552889|153125|P2|NOT COMPLETED|Overall Study||5
64304|NCT01552889|153126|P1|NOT COMPLETED|Overall Study||11
64305|NCT01552889|153125|P2|COMPLETED|Overall Study||95
64306|NCT01552889|153126|P1|COMPLETED|Overall Study||90
64307|NCT01552889|153125|P2|STARTED|Overall Study||100
64308|NCT01552889|153126|P1|STARTED|Overall Study||101
64309|NCT01552876|153136|P2|NOT COMPLETED|Overall Study||0
64310|NCT01552876|153137|P1|NOT COMPLETED|Overall Study||0
64311|NCT01552876|153136|P2|COMPLETED|Overall Study||20
64312|NCT01552876|153137|P1|COMPLETED|Overall Study||20
64313|NCT01552876|153136|P2|STARTED|Overall Study||20
64314|NCT01552876|153137|P1|STARTED|Overall Study||20
64315|NCT01552772|153153|P1|NOT COMPLETED|Overall Study||4
64316|NCT01552772|153153|P1|COMPLETED|Overall Study|Participants who completed the Day 28 visit were defined as completers for the trial.|56
64317|NCT01552772|153153|P1|STARTED|Overall Study||60
64318|NCT01552694|153169|P2|NOT COMPLETED|Overall Study||2
64319|NCT01552694|153170|P1|NOT COMPLETED|Overall Study||0
64320|NCT01552694|153169|P2|COMPLETED|Overall Study||18
64321|NCT01552694|153170|P1|COMPLETED|Overall Study||18
64322|NCT01552694|153169|P2|STARTED|Overall Study||20
64323|NCT01552694|153170|P1|STARTED|Overall Study||18
64324|NCT01552681|153182|P2|NOT COMPLETED|Overall Study||1
64325|NCT01552681|153183|P1|NOT COMPLETED|Overall Study||5
64326|NCT01552681|153182|P2|COMPLETED|Overall Study||18
64327|NCT01552681|153183|P1|COMPLETED|Overall Study||28
64328|NCT01552681|153182|P2|STARTED|Overall Study||19
64329|NCT01552681|153183|P1|STARTED|Overall Study||33
64330|NCT01552603|153231|P1|NOT COMPLETED|Overall Study||1
64331|NCT01552603|153231|P1|COMPLETED|Overall Study||13
64332|NCT01552603|153231|P1|STARTED|Overall Study||14
64333|NCT01552343|153238|P2|NOT COMPLETED|Overall Study||0
64334|NCT01552343|153239|P1|NOT COMPLETED|Overall Study||0
64335|NCT01552343|153238|P2|COMPLETED|Overall Study||27
64336|NCT01552343|153239|P1|COMPLETED|Overall Study||29
64337|NCT01552343|153238|P2|STARTED|Overall Study||27
64338|NCT01552343|153239|P1|STARTED|Overall Study||29
64339|NCT01552057|153262|P2|NOT COMPLETED|Overall Study||48
64340|NCT01552057|153263|P1|NOT COMPLETED|Overall Study||30
64341|NCT01552057|153262|P2|COMPLETED|Overall Study||149
64342|NCT01552057|153263|P1|COMPLETED|Overall Study||166
64343|NCT01552057|153262|P2|Received at Least 1 Dose of Study Drug|Overall Study||196
64344|NCT01552057|153263|P1|Received at Least 1 Dose of Study Drug|Overall Study||194
64345|NCT01552057|153262|P2|STARTED|Overall Study||197
64346|NCT01552057|153263|P1|STARTED|Overall Study||196
64347|NCT01551979|153297|P2|NOT COMPLETED|Overall Study||2
64348|NCT01551979|153298|P1|NOT COMPLETED|Overall Study||2
64349|NCT01551979|153297|P2|COMPLETED|Overall Study||6
64350|NCT01551979|153298|P1|COMPLETED|Overall Study||7
64351|NCT01551979|153297|P2|1 Week Post Treatment|Overall Study||7
64352|NCT01551979|153298|P1|1 Week Post Treatment|Overall Study||9
64353|NCT01551979|153297|P2|Last Day of Treatment (After 5 Days of t|Overall Study||8
64354|NCT01551979|153298|P1|Last Day of Treatment (After 5 Days of t|Overall Study||9
64355|NCT01551979|153297|P2|STARTED|Overall Study||8
64356|NCT01551979|153298|P1|STARTED|Overall Study||9
64357|NCT01551888|153314|P2|NOT COMPLETED|Period 2||0
64358|NCT01551888|153315|P1|NOT COMPLETED|Period 2||0
64359|NCT01551888|153314|P2|COMPLETED|Period 2||12
64360|NCT01551888|153315|P1|COMPLETED|Period 2||12
64361|NCT01551888|153314|P2|STARTED|Period 2||12
64362|NCT01551888|153315|P1|STARTED|Period 2||12
64363|NCT01551888|153314|P2|NOT COMPLETED|Period 1||0
64364|NCT01551888|153315|P1|NOT COMPLETED|Period 1||0
64365|NCT01551888|153314|P2|COMPLETED|Period 1||12
64366|NCT01551888|153315|P1|COMPLETED|Period 1||12
64367|NCT01551888|153314|P2|STARTED|Period 1||12
64368|NCT01551888|153315|P1|STARTED|Period 1||12
64369|NCT01551758|153329|P2|NOT COMPLETED|Overall Study||105
64370|NCT01551758|153330|P1|NOT COMPLETED|Overall Study||94
64371|NCT01551758|153329|P2|COMPLETED|Overall Study||1291
64372|NCT01551758|153330|P1|COMPLETED|Overall Study||1309
64373|NCT01551758|153329|P2|STARTED|Overall Study||1396
64374|NCT01551758|153330|P1|STARTED|Overall Study||1403
64375|NCT01551693|153370|P2|NOT COMPLETED|Overall Study||2
64376|NCT01551693|153371|P1|NOT COMPLETED|Overall Study||1
64377|NCT01551693|153370|P2|COMPLETED|Overall Study||0
64378|NCT01551693|153371|P1|COMPLETED|Overall Study||0
64379|NCT01551693|153370|P2|STARTED|Overall Study||2
64380|NCT01551693|153371|P1|STARTED|Overall Study||1
64381|NCT01551355|153387|P6|NOT COMPLETED|Overall Study||6
64382|NCT01551355|153388|P5|NOT COMPLETED|Overall Study||9
64383|NCT01551355|153389|P4|NOT COMPLETED|Overall Study||24
64384|NCT01551355|153390|P3|NOT COMPLETED|Overall Study||34
64385|NCT01551355|153391|P2|NOT COMPLETED|Overall Study||49
64386|NCT01551355|153392|P1|NOT COMPLETED|Overall Study||51
64387|NCT01551355|153387|P6|COMPLETED|Overall Study||65
64388|NCT01551355|153388|P5|COMPLETED|Overall Study||55
64389|NCT01551355|153389|P4|COMPLETED|Overall Study||411
64390|NCT01551355|153390|P3|COMPLETED|Overall Study||459
64391|NCT01551355|153391|P2|COMPLETED|Overall Study||545
64392|NCT01551355|153392|P1|COMPLETED|Overall Study||571
64393|NCT01551355|153387|P6|STARTED|Overall Study||71
64394|NCT01551355|153388|P5|STARTED|Overall Study||64
64395|NCT01551355|153389|P4|STARTED|Overall Study||435
64396|NCT01551355|153390|P3|STARTED|Overall Study||493
64397|NCT01551355|153391|P2|STARTED|Overall Study||594
64398|NCT01551355|153392|P1|STARTED|Overall Study||622
64399|NCT01551303|153406|P2|NOT COMPLETED|Overall Study||7
64400|NCT01551303|153407|P1|NOT COMPLETED|Overall Study||4
64401|NCT01551303|153406|P2|COMPLETED|Overall Study||15
64402|NCT01551303|153407|P1|COMPLETED|Overall Study||21
64403|NCT01551303|153406|P2|STARTED|Overall Study||22
64404|NCT01551303|153407|P1|STARTED|Overall Study||25
64405|NCT01551199|153413|P1|NOT COMPLETED|Overall Study||5
64406|NCT01551199|153413|P1|COMPLETED|Overall Study||2
64407|NCT01551199|153413|P1|STARTED|Overall Study||7
64408|NCT01551173|153421|P2|NOT COMPLETED|Overall Study||32
64409|NCT01551173|153422|P1|NOT COMPLETED|Overall Study||28
64410|NCT01551173|153421|P2|COMPLETED|Overall Study||186
64411|NCT01551173|153422|P1|COMPLETED|Overall Study||190
64412|NCT01551173|153421|P2|Full Analysis Set (FAS)|Overall Study||214
64413|NCT01551173|153422|P1|Full Analysis Set (FAS)|Overall Study|Patients took at least 1 dose of study drug & had at least 1 post-randomization efficacy parameter|210
64414|NCT01551173|153421|P2|STARTED|Overall Study||218
64415|NCT01551173|153422|P1|STARTED|Overall Study|"Started indicates randomized"|218
64416|NCT01551095|153433|P1|NOT COMPLETED|Overall Study||0
64417|NCT01551095|153433|P1|COMPLETED|Overall Study||7
64418|NCT01551095|153433|P1|STARTED|Overall Study||7
64419|NCT01551082|153438|P1|NOT COMPLETED|Overall Study||0
64420|NCT01551082|153438|P1|COMPLETED|Overall Study||12
64421|NCT01551082|153438|P1|STARTED|Overall Study||12
64422|NCT01550965|153442|P1|NOT COMPLETED|Overall Study||110
64423|NCT01550965|153442|P1|COMPLETED|Overall Study||353
64424|NCT01550965|153442|P1|STARTED|Overall Study||463
64425|NCT01550952|153461|P1|NOT COMPLETED|Overall Study||0
64426|NCT01550952|153461|P1|COMPLETED|Overall Study||10
64427|NCT01550952|153461|P1|STARTED|Overall Study||10
64428|NCT01550809|153471|P2|NOT COMPLETED|Overall Study||0
64429|NCT01550809|153472|P1|NOT COMPLETED|Overall Study||0
64430|NCT01550809|153471|P2|COMPLETED|Overall Study||6
64431|NCT01550809|153472|P1|COMPLETED|Overall Study||6
64432|NCT01550809|153471|P2|STARTED|Overall Study|Six patients started with the iBolus, the others with the tBolus, according to a crossover design.|6
64433|NCT01550809|153472|P1|STARTED|Overall Study|Six patients started with the tBolus, the others with the iBolus, according to a crossover design.|6
64434|NCT01550744|153482|P3|NOT COMPLETED|Double-Blind||67
64435|NCT01550744|153483|P2|NOT COMPLETED|Double-Blind||17
64436|NCT01550744|153484|P1|NOT COMPLETED|Double-Blind||0
64437|NCT01550744|153482|P3|COMPLETED|Double-Blind||235
64438|NCT01550744|153483|P2|COMPLETED|Double-Blind||59
64439|NCT01550744|153484|P1|COMPLETED|Double-Blind||0
64440|NCT01550744|153482|P3|STARTED|Double-Blind||302
64441|NCT01550744|153483|P2|STARTED|Double-Blind||76
64442|NCT01550744|153484|P1|STARTED|Double-Blind||0
64443|NCT01550744|153482|P3|NOT COMPLETED|Open-Label||0
64444|NCT01550744|153483|P2|NOT COMPLETED|Open-Label||0
64445|NCT01550744|153484|P1|NOT COMPLETED|Open-Label||100
64446|NCT01550744|153482|P3|COMPLETED|Open-Label||0
64447|NCT01550744|153483|P2|COMPLETED|Open-Label||0
64448|NCT01550744|153484|P1|COMPLETED|Open-Label||378
64449|NCT01550744|153482|P3|STARTED|Open-Label||0
64450|NCT01550744|153483|P2|STARTED|Open-Label||0
64451|NCT01550744|153484|P1|STARTED|Open-Label||478
64452|NCT01550705|153497|P1|NOT COMPLETED|Overall Study||1
64453|NCT01550705|153497|P1|COMPLETED|Overall Study||10
64454|NCT01550705|153497|P1|STARTED|Overall Study||11
64455|NCT01550549|153502|P1|NOT COMPLETED|Overall Study||0
64456|NCT01550549|153502|P1|COMPLETED|Overall Study||151
64457|NCT01550549|153502|P1|STARTED|Overall Study||151
64458|NCT01550302|153516|P2|NOT COMPLETED|Overall Study||0
64459|NCT01550302|153517|P1|NOT COMPLETED|Overall Study||0
64460|NCT01550302|153516|P2|COMPLETED|Overall Study||5
64461|NCT01550302|153517|P1|COMPLETED|Overall Study||5
64462|NCT01550302|153516|P2|STARTED|Overall Study||5
64463|NCT01550302|153517|P1|STARTED|Overall Study||5
64464|NCT01550289|153537|P2|NOT COMPLETED|Overall Study||4
64465|NCT01550289|153538|P1|NOT COMPLETED|Overall Study||13
64466|NCT01550289|153537|P2|COMPLETED|Overall Study||57
64467|NCT01550289|153538|P1|COMPLETED|Overall Study||115
64468|NCT01550289|153537|P2|STARTED|Overall Study||61
64469|NCT01550289|153538|P1|STARTED|Overall Study||128
64470|NCT01549977|153570|P2|NOT COMPLETED|Overall Study||0
64471|NCT01549977|153571|P1|NOT COMPLETED|Overall Study||0
64472|NCT01549977|153570|P2|COMPLETED|Overall Study||0
64473|NCT01549977|153571|P1|COMPLETED|Overall Study||1
64474|NCT01549977|153570|P2|STARTED|Overall Study||0
64475|NCT01549977|153571|P1|STARTED|Overall Study||1
64476|NCT01549964|153589|P4|NOT COMPLETED|80-Week Extension Period||137
64477|NCT01549964|153590|P3|NOT COMPLETED|80-Week Extension Period||140
64478|NCT01549964|153591|P2|NOT COMPLETED|80-Week Extension Period||138
64479|NCT01549964|153592|P1|NOT COMPLETED|80-Week Extension Period||66
64480|NCT01549964|153589|P4|COMPLETED|80-Week Extension Period||0
64481|NCT01549964|153590|P3|COMPLETED|80-Week Extension Period||0
64482|NCT01549964|153591|P2|COMPLETED|80-Week Extension Period||0
64483|NCT01549964|153592|P1|COMPLETED|80-Week Extension Period||0
64484|NCT01549964|153589|P4|STARTED|80-Week Extension Period||137
64485|NCT01549964|153590|P3|STARTED|80-Week Extension Period||140
64486|NCT01549964|153591|P2|STARTED|80-Week Extension Period||138
64487|NCT01549964|153592|P1|STARTED|80-Week Extension Period||66
64488|NCT01549964|153589|P4|NOT COMPLETED|24-Week Treatment Period||121
64489|NCT01549964|153590|P3|NOT COMPLETED|24-Week Treatment Period||116
64490|NCT01549964|153591|P2|NOT COMPLETED|24-Week Treatment Period||111
64491|NCT01549964|153592|P1|NOT COMPLETED|24-Week Treatment Period||61
64492|NCT01549964|153589|P4|COMPLETED|24-Week Treatment Period||140
64493|NCT01549964|153590|P3|COMPLETED|24-Week Treatment Period||147
64494|NCT01549964|153591|P2|COMPLETED|24-Week Treatment Period||149
64495|NCT01549964|153592|P1|COMPLETED|24-Week Treatment Period||71
64496|NCT01549964|153589|P4|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
64497|NCT01549964|153590|P3|Safety Analysis Set=Received Treatment|24-Week Treatment Period||263
64498|NCT01549964|153591|P2|Safety Analysis Set=Received Treatment|24-Week Treatment Period||260
64499|NCT01549964|153592|P1|Safety Analysis Set=Received Treatment|24-Week Treatment Period||132
64500|NCT01549964|153589|P4|STARTED|24-Week Treatment Period||261
64501|NCT01549964|153590|P3|STARTED|24-Week Treatment Period||263
64502|NCT01549964|153591|P2|STARTED|24-Week Treatment Period||260
64503|NCT01549964|153592|P1|STARTED|24-Week Treatment Period||132
64504|NCT01549951|153610|P1|NOT COMPLETED|Overall Study||50
64505|NCT01549951|153610|P1|COMPLETED|Overall Study||0
64506|NCT01549951|153610|P1|Primary Reason Off Study Treatment|Overall Study||50
64507|NCT01549951|153610|P1|STARTED|Overall Study||50
64508|NCT01549925|153628|P2|NOT COMPLETED|Overall Study||0
64509|NCT01549925|153629|P1|NOT COMPLETED|Overall Study||0
64510|NCT01549925|153628|P2|COMPLETED|Overall Study||25
64511|NCT01549925|153629|P1|COMPLETED|Overall Study||25
64512|NCT01549925|153628|P2|STARTED|Overall Study||25
64513|NCT01549925|153629|P1|STARTED|Overall Study||25
64514|NCT01549873|153637|P2|NOT COMPLETED|Overall Study||1
64515|NCT01549873|153638|P1|NOT COMPLETED|Overall Study||0
64516|NCT01549873|153637|P2|COMPLETED|Overall Study||14
64517|NCT01549873|153638|P1|COMPLETED|Overall Study||15
64518|NCT01549873|153637|P2|STARTED|Overall Study||15
64519|NCT01549873|153638|P1|STARTED|Overall Study||15
64520|NCT01549860|153650|P2|NOT COMPLETED|Overall Study||1
64521|NCT01549860|153651|P1|NOT COMPLETED|Overall Study||2
64522|NCT01549860|153650|P2|COMPLETED|Overall Study||40
64523|NCT01549860|153651|P1|COMPLETED|Overall Study||38
64524|NCT01549860|153650|P2|STARTED|Overall Study||41
64525|NCT01549860|153651|P1|STARTED|Overall Study||40
64526|NCT01549613|153663|P2|NOT COMPLETED|Overall Study||11
64527|NCT01549613|153664|P1|NOT COMPLETED|Overall Study||11
64528|NCT01549613|153663|P2|COMPLETED|Overall Study||39
64529|NCT01549613|153664|P1|COMPLETED|Overall Study||39
64530|NCT01549613|153663|P2|STARTED|Overall Study||50
64531|NCT01549613|153664|P1|STARTED|Overall Study||50
64532|NCT01549405|153672|P2|NOT COMPLETED|Overall Study||0
64533|NCT01549405|153673|P1|NOT COMPLETED|Overall Study||0
64534|NCT01549405|153672|P2|COMPLETED|Overall Study||20
64535|NCT01549405|153673|P1|COMPLETED|Overall Study||20
64536|NCT01549405|153672|P2|STARTED|Overall Study||20
64537|NCT01549405|153673|P1|STARTED|Overall Study||20
64538|NCT01549392|153683|P2|NOT COMPLETED|Overall Study||0
64539|NCT01549392|153684|P1|NOT COMPLETED|Overall Study||1
64540|NCT01549392|153683|P2|COMPLETED|Overall Study||0
64541|NCT01549392|153684|P1|COMPLETED|Overall Study||2
64542|NCT01549392|153683|P2|STARTED|Overall Study||0
64543|NCT01549392|153684|P1|STARTED|Overall Study||3
64544|NCT01549340|153690|P1|NOT COMPLETED|Overall Study||8405
64545|NCT01549340|153690|P1|COMPLETED|Overall Study|Completed 5 years of AIT|385
64546|NCT01549340|153690|P1|Started AIT|Overall Study||3182
64547|NCT01549340|153690|P1|STARTED|Overall Study|Advised to receive AIT|8790
64548|NCT01549275|153703|P2|NOT COMPLETED|Overall Study||0
64549|NCT01549275|153704|P1|NOT COMPLETED|Overall Study||1
64550|NCT01549275|153703|P2|COMPLETED|Overall Study||29
64551|NCT01549275|153704|P1|COMPLETED|Overall Study||75
64552|NCT01549275|153703|P2|STARTED|Overall Study||29
64553|NCT01549275|153704|P1|STARTED|Overall Study||76
64554|NCT01549223|153716|P2|NOT COMPLETED|Overall Study||0
64555|NCT01549223|153717|P1|NOT COMPLETED|Overall Study||0
64556|NCT01549223|153716|P2|COMPLETED|Overall Study||30
64557|NCT01549223|153717|P1|COMPLETED|Overall Study||30
64558|NCT01549223|153716|P2|STARTED|Overall Study||30
64559|NCT01549223|153717|P1|STARTED|Overall Study||30
64560|NCT01549041|153727|P2|NOT COMPLETED|Overall Study||8
64561|NCT01549041|153728|P1|NOT COMPLETED|Overall Study||2
64562|NCT01549041|153727|P2|COMPLETED|Overall Study||10
64563|NCT01549041|153728|P1|COMPLETED|Overall Study||10
64564|NCT01549041|153727|P2|STARTED|Overall Study||18
64565|NCT01549041|153728|P1|STARTED|Overall Study||12
64566|NCT01549002|153738|P2|NOT COMPLETED|Overall Study||4
64567|NCT01549002|153739|P1|NOT COMPLETED|Overall Study||0
64568|NCT01549002|153738|P2|COMPLETED|Overall Study||6
64569|NCT01549002|153739|P1|COMPLETED|Overall Study||10
64570|NCT01549002|153738|P2|STARTED|Overall Study||10
64571|NCT01549002|153739|P1|STARTED|Overall Study||10
64572|NCT01548885|153745|P1|NOT COMPLETED|Overall Study||0
64573|NCT01548885|153745|P1|COMPLETED|Overall Study||146
64574|NCT01548885|153745|P1|STARTED|Overall Study||146
64575|NCT01548833|153750|P1|NOT COMPLETED|Overall Study||0
64576|NCT01548833|153750|P1|COMPLETED|Overall Study||39
64577|NCT01548833|153750|P1|STARTED|Overall Study||39
64578|NCT01548742|153760|P2|NOT COMPLETED|Overall Study||4
64579|NCT01548742|153761|P1|NOT COMPLETED|Overall Study||13
64580|NCT01548742|153760|P2|COMPLETED|Overall Study||54
64581|NCT01548742|153761|P1|COMPLETED|Overall Study||45
64582|NCT01548742|153760|P2|STARTED|Overall Study||58
64583|NCT01548742|153761|P1|STARTED|Overall Study||58
64584|NCT01548638|153775|P1|NOT COMPLETED|Overall Study||4
64585|NCT01548638|153775|P1|COMPLETED|Overall Study||9
64586|NCT01548638|153775|P1|STARTED|Overall Study||13
64587|NCT01548573|153782|P1|NOT COMPLETED|Overall Study||5
64588|NCT01548573|153782|P1|COMPLETED|Overall Study||14
64589|NCT01548573|153782|P1|STARTED|Overall Study||19
64590|NCT01548417|153791|P2|NOT COMPLETED|Overall Study||2
64591|NCT01548417|153792|P1|NOT COMPLETED|Overall Study||0
64592|NCT01548417|153791|P2|COMPLETED|Overall Study||26
64593|NCT01548417|153792|P1|COMPLETED|Overall Study||28
64594|NCT01548417|153791|P2|STARTED|Overall Study||28
64595|NCT01548417|153792|P1|STARTED|Overall Study||28
64596|NCT01548287|153804|P5|NOT COMPLETED|Randomized Period||0
64597|NCT01548287|153805|P4|NOT COMPLETED|Randomized Period||0
64598|NCT01548287|153806|P3|NOT COMPLETED|Randomized Period||7
64599|NCT01548287|153807|P2|NOT COMPLETED|Randomized Period||2
64600|NCT01548287|153808|P1|NOT COMPLETED|Randomized Period||0
64601|NCT01548287|153804|P5|COMPLETED|Randomized Period||0
64602|NCT01548287|153805|P4|COMPLETED|Randomized Period||20
64603|NCT01548287|153806|P3|COMPLETED|Randomized Period||13
64604|NCT01548287|153807|P2|COMPLETED|Randomized Period||20
64605|NCT01548287|153808|P1|COMPLETED|Randomized Period||19
64606|NCT01548287|153804|P5|STARTED|Randomized Period||0
64607|NCT01548287|153805|P4|STARTED|Randomized Period||20
64608|NCT01548287|153806|P3|STARTED|Randomized Period||20
64609|NCT01548287|153807|P2|STARTED|Randomized Period||22
64610|NCT01548287|153808|P1|STARTED|Randomized Period||19
64611|NCT01548287|153804|P5|NOT COMPLETED|Screening||83
64612|NCT01548287|153805|P4|NOT COMPLETED|Screening||0
64613|NCT01548287|153806|P3|NOT COMPLETED|Screening||0
64614|NCT01548287|153807|P2|NOT COMPLETED|Screening||0
64615|NCT01548287|153808|P1|NOT COMPLETED|Screening||0
64616|NCT01548287|153804|P5|COMPLETED|Screening||0
64617|NCT01548287|153805|P4|COMPLETED|Screening||20
64618|NCT01548287|153806|P3|COMPLETED|Screening||20
64619|NCT01548287|153807|P2|COMPLETED|Screening||22
64620|NCT01548287|153808|P1|COMPLETED|Screening||19
64621|NCT01548287|153804|P5|STARTED|Screening||83
64622|NCT01548287|153805|P4|STARTED|Screening||20
64623|NCT01548287|153806|P3|STARTED|Screening||20
64624|NCT01548287|153807|P2|STARTED|Screening||22
64625|NCT01548287|153808|P1|STARTED|Screening||19
64626|NCT01547806|153838|P1|NOT COMPLETED|Overall Study||0
64627|NCT01547806|153838|P1|COMPLETED|Overall Study||49
64628|NCT01547806|153838|P1|STARTED|Overall Study||49
64629|NCT01547728|153854|P1|NOT COMPLETED|Overall Study||41
64630|NCT01547728|153854|P1|COMPLETED|Overall Study||1
64631|NCT01547728|153854|P1|STARTED|Overall Study||42
64632|NCT01547715|153861|P3|NOT COMPLETED|Overall Study||0
64633|NCT01547715|153862|P2|NOT COMPLETED|Overall Study||0
64634|NCT01547715|153863|P1|NOT COMPLETED|Overall Study||0
64635|NCT01547715|153861|P3|COMPLETED|Overall Study||60
64636|NCT01547715|153862|P2|COMPLETED|Overall Study||60
64637|NCT01547715|153863|P1|COMPLETED|Overall Study||60
64638|NCT01547715|153861|P3|STARTED|Overall Study||60
64639|NCT01547715|153862|P2|STARTED|Overall Study||60
64640|NCT01547715|153863|P1|STARTED|Overall Study||60
64641|NCT01547598|153963|P2|NOT COMPLETED|Overall Study||5
64642|NCT01547598|153964|P1|NOT COMPLETED|Overall Study||6
64643|NCT01547598|153963|P2|COMPLETED|Overall Study||63
64644|NCT01547598|153964|P1|COMPLETED|Overall Study||61
64645|NCT01547598|153963|P2|STARTED|Overall Study||68
64646|NCT01547598|153964|P1|STARTED|Overall Study||67
64647|NCT01547299|153981|P2|NOT COMPLETED|Overall Study||2
64648|NCT01547299|153982|P1|NOT COMPLETED|Overall Study||2
64649|NCT01547299|153981|P2|COMPLETED|Overall Study||25
64650|NCT01547299|153982|P1|COMPLETED|Overall Study||23
64651|NCT01547299|153981|P2|STARTED|Overall Study||27
64652|NCT01547299|153982|P1|STARTED|Overall Study||25
64653|NCT01547286|154042|P1|NOT COMPLETED|Overall Study||2
64654|NCT01547286|154042|P1|COMPLETED|Overall Study||5
64655|NCT01547286|154042|P1|STARTED|Overall Study||7
64656|NCT01547247|154049|P2|NOT COMPLETED|Overall Study||6
64657|NCT01547247|154050|P1|NOT COMPLETED|Overall Study||6
64658|NCT01547247|154049|P2|COMPLETED|Overall Study||98
64659|NCT01547247|154050|P1|COMPLETED|Overall Study||98
64660|NCT01547247|154049|P2|STARTED|Overall Study||104
64661|NCT01547247|154050|P1|STARTED|Overall Study||104
64662|NCT01547130|154060|P2|NOT COMPLETED|Overall Study||5
64663|NCT01547130|154061|P1|NOT COMPLETED|Overall Study||9
64664|NCT01547130|154060|P2|COMPLETED|Overall Study||68
64665|NCT01547130|154061|P1|COMPLETED|Overall Study||65
64666|NCT01547130|154060|P2|STARTED|Overall Study||73
64667|NCT01547130|154061|P1|STARTED|Overall Study||74
64668|NCT01546922|154075|P2|NOT COMPLETED|Second Period of 10 Weeks||3
64669|NCT01546922|154076|P1|NOT COMPLETED|Second Period of 10 Weeks||3
64670|NCT01546922|154075|P2|COMPLETED|Second Period of 10 Weeks||25
64671|NCT01546922|154076|P1|COMPLETED|Second Period of 10 Weeks||22
64672|NCT01546922|154075|P2|STARTED|Second Period of 10 Weeks||28
64673|NCT01546922|154076|P1|STARTED|Second Period of 10 Weeks||25
64674|NCT01546922|154075|P2|NOT COMPLETED|First Period of 10 Weeks||2
64675|NCT01546922|154076|P1|NOT COMPLETED|First Period of 10 Weeks||5
64676|NCT01546922|154075|P2|COMPLETED|First Period of 10 Weeks||28
64677|NCT01546922|154076|P1|COMPLETED|First Period of 10 Weeks||25
64678|NCT01546922|154075|P2|STARTED|First Period of 10 Weeks||30
64679|NCT01546922|154076|P1|STARTED|First Period of 10 Weeks||30
64680|NCT01546883|154082|P1|NOT COMPLETED|Overall Study||12
64681|NCT01546883|154082|P1|COMPLETED|Overall Study||2
64682|NCT01546883|154082|P1|STARTED|Overall Study||14
64683|NCT01546688|154088|P2|NOT COMPLETED|Overall Study||5
64684|NCT01546688|154089|P1|NOT COMPLETED|Overall Study||3
64685|NCT01546688|154088|P2|COMPLETED|Overall Study||28
64686|NCT01546688|154089|P1|COMPLETED|Overall Study||15
64687|NCT01546688|154088|P2|STARTED|Overall Study||33
64688|NCT01546688|154089|P1|STARTED|Overall Study||18
64689|NCT01546675|154103|P2|NOT COMPLETED|Overall Study||0
64690|NCT01546675|154104|P1|NOT COMPLETED|Overall Study||0
64691|NCT01546675|154103|P2|COMPLETED|Overall Study||1
64692|NCT01546675|154104|P1|COMPLETED|Overall Study||1
64693|NCT01546675|154103|P2|STARTED|Overall Study||1
64694|NCT01546675|154104|P1|STARTED|Overall Study||1
64695|NCT01546649|154121|P2|NOT COMPLETED|Overall Study||9
64696|NCT01546649|154122|P1|NOT COMPLETED|Overall Study||8
64697|NCT01546649|154121|P2|COMPLETED|Overall Study||75
64698|NCT01546649|154122|P1|COMPLETED|Overall Study||75
64699|NCT01546649|154121|P2|STARTED|Overall Study||84
64700|NCT01546649|154122|P1|STARTED|Overall Study||83
64701|NCT01546636|154144|P2|NOT COMPLETED|Overall Study||0
64702|NCT01546636|154145|P1|NOT COMPLETED|Overall Study||0
64703|NCT01546636|154144|P2|COMPLETED|Overall Study||34
64704|NCT01546636|154145|P1|COMPLETED|Overall Study||36
64705|NCT01546636|154144|P2|STARTED|Overall Study||34
64706|NCT01546636|154145|P1|STARTED|Overall Study||36
64707|NCT01546623|154157|P2|NOT COMPLETED|Overall Study||6
64708|NCT01546623|154158|P1|NOT COMPLETED|Overall Study||6
64709|NCT01546623|154157|P2|COMPLETED|Overall Study||74
64710|NCT01546623|154158|P1|COMPLETED|Overall Study||76
64711|NCT01546623|154157|P2|Received Study Drug|Overall Study||79
64712|NCT01546623|154158|P1|Received Study Drug|Overall Study||81
64713|NCT01546623|154157|P2|STARTED|Overall Study||80
64714|NCT01546623|154158|P1|STARTED|Overall Study||82
64715|NCT01546519|154188|P4|NOT COMPLETED|Overall Study||6
64716|NCT01546519|154189|P3|NOT COMPLETED|Overall Study||8
64717|NCT01546519|154190|P2|NOT COMPLETED|Overall Study||8
64718|NCT01546519|154191|P1|NOT COMPLETED|Overall Study||9
64719|NCT01546519|154188|P4|COMPLETED|Overall Study||0
64720|NCT01546519|154189|P3|COMPLETED|Overall Study||0
64721|NCT01546519|154190|P2|COMPLETED|Overall Study||0
64722|NCT01546519|154191|P1|COMPLETED|Overall Study||0
64723|NCT01546519|154188|P4|Safety-Evaluable Participants|Overall Study||6
64724|NCT01546519|154189|P3|Safety-Evaluable Participants|Overall Study||8
64725|NCT01546519|154190|P2|Safety-Evaluable Participants|Overall Study||8
64726|NCT01546519|154191|P1|Safety-Evaluable Participants|Overall Study||9
64727|NCT01546519|154188|P4|STARTED|Overall Study||6
64728|NCT01546519|154189|P3|STARTED|Overall Study||8
64729|NCT01546519|154190|P2|STARTED|Overall Study||8
64730|NCT01546519|154191|P1|STARTED|Overall Study||9
64731|NCT01546454|154233|P1|NOT COMPLETED|Estrogen/Progesterone Replacement Cycle||0
64732|NCT01546454|154233|P1|COMPLETED|Estrogen/Progesterone Replacement Cycle||4
64733|NCT01546454|154233|P1|STARTED|Estrogen/Progesterone Replacement Cycle||4
64734|NCT01546454|154233|P1|NOT COMPLETED|Eligard Treatment||0
64735|NCT01546454|154233|P1|COMPLETED|Eligard Treatment||4
64736|NCT01546454|154233|P1|STARTED|Eligard Treatment||4
64737|NCT01546454|154233|P1|NOT COMPLETED|Oral Contraceptive Cycle||0
64738|NCT01546454|154233|P1|COMPLETED|Oral Contraceptive Cycle||4
64739|NCT01546454|154233|P1|STARTED|Oral Contraceptive Cycle||4
64740|NCT01546454|154233|P1|NOT COMPLETED|Natural Menstrual Cycle||0
64741|NCT01546454|154233|P1|COMPLETED|Natural Menstrual Cycle||4
64742|NCT01546454|154233|P1|STARTED|Natural Menstrual Cycle||4
64743|NCT01546402|154241|P2|NOT COMPLETED|Overall Study||0
64744|NCT01546402|154242|P1|NOT COMPLETED|Overall Study||0
64745|NCT01546402|154241|P2|COMPLETED|Overall Study||10
64746|NCT01546402|154242|P1|COMPLETED|Overall Study||10
64747|NCT01546402|154241|P2|STARTED|Overall Study||10
64748|NCT01546402|154242|P1|STARTED|Overall Study||10
64749|NCT01546285|154250|P1|NOT COMPLETED|Overall Study||0
64750|NCT01546285|154250|P1|COMPLETED|Overall Study||66
64751|NCT01546285|154250|P1|STARTED|Overall Study||66
64752|NCT01546207|154256|P1|NOT COMPLETED|Overall Study||1
64753|NCT01546207|154256|P1|COMPLETED|Overall Study||3
64754|NCT01546207|154256|P1|STARTED|Overall Study||4
64755|NCT01546194|154262|P2|NOT COMPLETED|Overall Study||35
64756|NCT01546194|154263|P1|NOT COMPLETED|Overall Study||36
64757|NCT01546194|154262|P2|COMPLETED|Overall Study||65
64758|NCT01546194|154263|P1|COMPLETED|Overall Study||64
64759|NCT01546194|154262|P2|STARTED|Overall Study||100
64760|NCT01546194|154263|P1|STARTED|Overall Study||100
64761|NCT01546155|154269|P1|NOT COMPLETED|Overall Study||3
64762|NCT01546155|154269|P1|COMPLETED|Overall Study||8
64763|NCT01546155|154269|P1|STARTED|Overall Study||11
64764|NCT01546142|154275|P2|NOT COMPLETED|Overall Study||34
64765|NCT01546142|154276|P1|NOT COMPLETED|Overall Study||44
64766|NCT01546142|154275|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|224
64767|NCT01546142|154276|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|214
64768|NCT01546142|154275|P2|Received Treatment|Overall Study||257
64769|NCT01546142|154276|P1|Received Treatment|Overall Study||257
64770|NCT01546142|154275|P2|STARTED|Overall Study||258
64771|NCT01546142|154276|P1|STARTED|Overall Study||258
64772|NCT01545843|154291|P3|NOT COMPLETED|Overall Study||4
64773|NCT01545843|154292|P2|NOT COMPLETED|Overall Study||7
64774|NCT01545843|154293|P1|NOT COMPLETED|Overall Study||3
64775|NCT01545843|154291|P3|COMPLETED|Overall Study||21
64776|NCT01545843|154292|P2|COMPLETED|Overall Study||17
64777|NCT01545843|154293|P1|COMPLETED|Overall Study||16
64778|NCT01545843|154291|P3|STARTED|Overall Study||25
64779|NCT01545843|154292|P2|STARTED|Overall Study||24
64780|NCT01545843|154293|P1|STARTED|Overall Study||19
64781|NCT01545765|154304|P1|NOT COMPLETED|Overall Study||0
64782|NCT01545765|154304|P1|COMPLETED|Overall Study||31
64783|NCT01545765|154304|P1|STARTED|Overall Study||31
64784|NCT01545700|154321|P6|NOT COMPLETED|Overall Study||0
64785|NCT01545700|154322|P5|NOT COMPLETED|Overall Study||1
64786|NCT01545700|154323|P4|NOT COMPLETED|Overall Study||0
64787|NCT01545700|154324|P3|NOT COMPLETED|Overall Study||2
64788|NCT01545700|154325|P2|NOT COMPLETED|Overall Study||1
64789|NCT01545700|154326|P1|NOT COMPLETED|Overall Study||1
64790|NCT01545700|154321|P6|COMPLETED|Overall Study||33
64791|NCT01545700|154322|P5|COMPLETED|Overall Study||32
64792|NCT01545700|154323|P4|COMPLETED|Overall Study||34
64793|NCT01545700|154324|P3|COMPLETED|Overall Study||31
64794|NCT01545700|154325|P2|COMPLETED|Overall Study||32
64795|NCT01545700|154326|P1|COMPLETED|Overall Study||33
64796|NCT01545700|154321|P6|STARTED|Overall Study||33
64797|NCT01545700|154322|P5|STARTED|Overall Study||33
64798|NCT01545700|154323|P4|STARTED|Overall Study||34
64799|NCT01545700|154324|P3|STARTED|Overall Study||33
64800|NCT01545700|154325|P2|STARTED|Overall Study||33
64801|NCT01545700|154326|P1|STARTED|Overall Study||34
64802|NCT01545518|154360|P1|NOT COMPLETED|Overall Study||0
64803|NCT01545518|154360|P1|COMPLETED|Overall Study||20
64804|NCT01545518|154360|P1|STARTED|Overall Study||20
64805|NCT01545388|154367|P3|NOT COMPLETED|Overall Study||8
64806|NCT01545388|154368|P2|NOT COMPLETED|Overall Study||11
64807|NCT01545388|154369|P1|NOT COMPLETED|Overall Study||8
64808|NCT01545388|154367|P3|COMPLETED|Overall Study||58
64809|NCT01545388|154368|P2|COMPLETED|Overall Study||122
64810|NCT01545388|154369|P1|COMPLETED|Overall Study||130
64811|NCT01545388|154367|P3|STARTED|Overall Study||66
64812|NCT01545388|154368|P2|STARTED|Overall Study||133
64813|NCT01545388|154369|P1|STARTED|Overall Study||138
64814|NCT01545336|154388|P2|NOT COMPLETED|Overall Study||0
64815|NCT01545336|154389|P1|NOT COMPLETED|Overall Study||0
64816|NCT01545336|154388|P2|COMPLETED|Overall Study||6
64817|NCT01545336|154389|P1|COMPLETED|Overall Study||12
64818|NCT01545336|154388|P2|STARTED|Overall Study||6
64819|NCT01545336|154389|P1|STARTED|Overall Study||12
64820|NCT01545232|154401|P2|NOT COMPLETED|Overall Study||0
64821|NCT01545232|154402|P1|NOT COMPLETED|Overall Study||0
64822|NCT01545232|154401|P2|COMPLETED|Overall Study||342
64823|NCT01545232|154402|P1|COMPLETED|Overall Study||338
64824|NCT01545232|154401|P2|STARTED|Overall Study||342
64825|NCT01545232|154402|P1|STARTED|Overall Study||338
64826|NCT01545193|154432|P2|NOT COMPLETED|Overall Study||1
64827|NCT01545193|154433|P1|NOT COMPLETED|Overall Study||0
64828|NCT01545193|154432|P2|COMPLETED|Overall Study||149
64829|NCT01545193|154433|P1|COMPLETED|Overall Study||150
64830|NCT01545193|154432|P2|STARTED|Overall Study||150
64831|NCT01545193|154433|P1|STARTED|Overall Study||150
64832|NCT01544153|154449|P4|NOT COMPLETED|Overall Study||0
64833|NCT01544153|154450|P3|NOT COMPLETED|Overall Study||1
64834|NCT01544153|154451|P2|NOT COMPLETED|Overall Study||1
64835|NCT01544153|154452|P1|NOT COMPLETED|Overall Study||0
64836|NCT01544153|154449|P4|COMPLETED|Overall Study||1317
64837|NCT01544153|154450|P3|COMPLETED|Overall Study||1313
64838|NCT01544153|154451|P2|COMPLETED|Overall Study||1323
64839|NCT01544153|154452|P1|COMPLETED|Overall Study||1337
64840|NCT01544153|154449|P4|STARTED|Overall Study||1317
64841|NCT01544153|154450|P3|STARTED|Overall Study||1314
64842|NCT01544153|154451|P2|STARTED|Overall Study||1324
64843|NCT01544153|154452|P1|STARTED|Overall Study||1337
64844|NCT01544062|154468|P2|NOT COMPLETED|Overall Study||0
64845|NCT01544062|154469|P1|NOT COMPLETED|Overall Study||0
64846|NCT01544062|154468|P2|COMPLETED|Overall Study||35
64847|NCT01544062|154469|P1|COMPLETED|Overall Study||33
64848|NCT01544062|154468|P2|STARTED|Overall Study||35
64849|NCT01544062|154469|P1|STARTED|Overall Study||33
64850|NCT01544023|154515|P1|NOT COMPLETED|Overall Study||0
64851|NCT01544023|154515|P1|COMPLETED|Overall Study||207
64852|NCT01544023|154515|P1|STARTED|Overall Study|retrospective|207
64853|NCT01543958|154520|P1|NOT COMPLETED|Overall Study||4
64854|NCT01543958|154520|P1|COMPLETED|Overall Study||36
64855|NCT01543958|154520|P1|STARTED|Overall Study||40
64856|NCT01544998|154573|P2|NOT COMPLETED|Second Intervention (3 Hours)||0
64857|NCT01544998|154574|P1|NOT COMPLETED|Second Intervention (3 Hours)||0
64858|NCT01544998|154573|P2|COMPLETED|Second Intervention (3 Hours)||15
64859|NCT01544998|154574|P1|COMPLETED|Second Intervention (3 Hours)||26
64860|NCT01544998|154573|P2|STARTED|Second Intervention (3 Hours)||15
64861|NCT01544998|154574|P1|STARTED|Second Intervention (3 Hours)||26
64862|NCT01544998|154573|P2|NOT COMPLETED|Washout (1 Week)||0
64863|NCT01544998|154574|P1|NOT COMPLETED|Washout (1 Week)||0
64864|NCT01544998|154573|P2|COMPLETED|Washout (1 Week)||15
64865|NCT01544998|154574|P1|COMPLETED|Washout (1 Week)||26
64866|NCT01544998|154573|P2|STARTED|Washout (1 Week)||15
64867|NCT01544998|154574|P1|STARTED|Washout (1 Week)||26
64868|NCT01544998|154573|P2|NOT COMPLETED|First Intervention (3 Hours)||0
64869|NCT01544998|154574|P1|NOT COMPLETED|First Intervention (3 Hours)||0
64870|NCT01544998|154573|P2|COMPLETED|First Intervention (3 Hours)||15
64871|NCT01544998|154574|P1|COMPLETED|First Intervention (3 Hours)||26
64872|NCT01544998|154573|P2|STARTED|First Intervention (3 Hours)||15
64873|NCT01544998|154574|P1|STARTED|First Intervention (3 Hours)||26
64874|NCT01544920|154586|P2|NOT COMPLETED|Overall Study||23
64875|NCT01544920|154587|P1|NOT COMPLETED|Overall Study||19
64876|NCT01544920|154586|P2|COMPLETED|Overall Study||346
64877|NCT01544920|154587|P1|COMPLETED|Overall Study||349
64878|NCT01544920|154586|P2|STARTED|Overall Study||369
64879|NCT01544920|154587|P1|STARTED|Overall Study||368
64880|NCT01544582|154598|P4|NOT COMPLETED|Analysis Population||39
64881|NCT01544582|154599|P3|NOT COMPLETED|Analysis Population||102
64882|NCT01544582|154600|P2|NOT COMPLETED|Analysis Population||118
64883|NCT01544582|154601|P1|NOT COMPLETED|Analysis Population||0
64884|NCT01544582|154598|P4|COMPLETED|Analysis Population||35
64885|NCT01544582|154599|P3|COMPLETED|Analysis Population||205
64886|NCT01544582|154600|P2|COMPLETED|Analysis Population||180
64887|NCT01544582|154601|P1|COMPLETED|Analysis Population||0
64888|NCT01544582|154598|P4|STARTED|Analysis Population||74
64889|NCT01544582|154599|P3|STARTED|Analysis Population||307
64890|NCT01544582|154600|P2|STARTED|Analysis Population||298
64891|NCT01544582|154601|P1|STARTED|Analysis Population|Analysis Population was grouped into Boceprevir+PR, Telaprevir+PR, or PR Alone|0
64892|NCT01544582|154598|P4|NOT COMPLETED|Screening/Eligibility||0
64893|NCT01544582|154599|P3|NOT COMPLETED|Screening/Eligibility||0
64894|NCT01544582|154600|P2|NOT COMPLETED|Screening/Eligibility||0
64895|NCT01544582|154601|P1|NOT COMPLETED|Screening/Eligibility||34
64896|NCT01544582|154598|P4|COMPLETED|Screening/Eligibility||0
64897|NCT01544582|154599|P3|COMPLETED|Screening/Eligibility||0
64898|NCT01544582|154600|P2|COMPLETED|Screening/Eligibility||0
64899|NCT01544582|154601|P1|COMPLETED|Screening/Eligibility|Completed means met criteria for Analysis Population|679
64900|NCT01544582|154598|P4|Analysis Population|Screening/Eligibility||0
64901|NCT01544582|154599|P3|Analysis Population|Screening/Eligibility||0
64902|NCT01544582|154600|P2|Analysis Population|Screening/Eligibility||0
64903|NCT01544582|154601|P1|Analysis Population|Screening/Eligibility||679
64904|NCT01544582|154598|P4|STARTED|Screening/Eligibility||0
64905|NCT01544582|154599|P3|STARTED|Screening/Eligibility||0
64906|NCT01544582|154600|P2|STARTED|Screening/Eligibility||0
64907|NCT01544582|154601|P1|STARTED|Screening/Eligibility||713
64908|NCT01544478|154659|P1|NOT COMPLETED|Overall Study||118
64909|NCT01544478|154659|P1|COMPLETED|Overall Study||912
64910|NCT01544478|154659|P1|Vaccination 3|Overall Study||1019
64911|NCT01544478|154659|P1|Vaccination 2|Overall Study||1026
64912|NCT01544478|154659|P1|Vaccination 1|Overall Study||1030
64913|NCT01544478|154659|P1|STARTED|Overall Study||1030
64914|NCT01544361|154668|P5|NOT COMPLETED|Overall Study||0
64915|NCT01544361|154669|P4|NOT COMPLETED|Overall Study||0
64916|NCT01544361|154670|P3|NOT COMPLETED|Overall Study||0
64917|NCT01544361|154671|P2|NOT COMPLETED|Overall Study||0
64918|NCT01544361|154672|P1|NOT COMPLETED|Overall Study||0
64919|NCT01544361|154668|P5|COMPLETED|Overall Study||6
64920|NCT01544361|154669|P4|COMPLETED|Overall Study||6
64921|NCT01544361|154670|P3|COMPLETED|Overall Study||6
64922|NCT01544361|154671|P2|COMPLETED|Overall Study||6
64923|NCT01544361|154672|P1|COMPLETED|Overall Study||8
64924|NCT01544361|154668|P5|STARTED|Overall Study||6
64925|NCT01544361|154669|P4|STARTED|Overall Study||6
64926|NCT01544361|154670|P3|STARTED|Overall Study||6
64927|NCT01544361|154671|P2|STARTED|Overall Study||6
64928|NCT01544361|154672|P1|STARTED|Overall Study||8
64929|NCT01544348|154702|P8|NOT COMPLETED|Overall Study||0
64930|NCT01544348|154703|P7|NOT COMPLETED|Overall Study||2
64931|NCT01544348|154704|P6|NOT COMPLETED|Overall Study||3
64932|NCT01544348|154705|P5|NOT COMPLETED|Overall Study||1
64933|NCT01544348|154706|P4|NOT COMPLETED|Overall Study||0
64934|NCT01544348|154707|P3|NOT COMPLETED|Overall Study||0
64935|NCT01544348|154708|P2|NOT COMPLETED|Overall Study||0
64936|NCT01544348|154709|P1|NOT COMPLETED|Overall Study||2
64937|NCT01544348|154702|P8|COMPLETED|Overall Study||8
64938|NCT01544348|154703|P7|COMPLETED|Overall Study||12
64939|NCT01544348|154704|P6|COMPLETED|Overall Study||16
64940|NCT01544348|154705|P5|COMPLETED|Overall Study||15
64941|NCT01544348|154706|P4|COMPLETED|Overall Study||3
64942|NCT01544348|154707|P3|COMPLETED|Overall Study||3
64943|NCT01544348|154708|P2|COMPLETED|Overall Study||6
64944|NCT01544348|154709|P1|COMPLETED|Overall Study||15
64945|NCT01544348|154702|P8|Treated|Overall Study||8
64946|NCT01544348|154703|P7|Treated|Overall Study||14
64947|NCT01544348|154704|P6|Treated|Overall Study||18
64948|NCT01544348|154705|P5|Treated|Overall Study||15
64949|NCT01544348|154706|P4|Treated|Overall Study||3
64950|NCT01544348|154707|P3|Treated|Overall Study||3
64951|NCT01544348|154708|P2|Treated|Overall Study||6
64952|NCT01544348|154709|P1|Treated|Overall Study||17
64953|NCT01544348|154702|P8|STARTED|Overall Study||8
64954|NCT01544348|154703|P7|STARTED|Overall Study||14
64955|NCT01544348|154704|P6|STARTED|Overall Study||19
64956|NCT01544348|154705|P5|STARTED|Overall Study||16
64957|NCT01544348|154706|P4|STARTED|Overall Study||3
64958|NCT01544348|154707|P3|STARTED|Overall Study||3
64959|NCT01544348|154708|P2|STARTED|Overall Study||6
64960|NCT01544348|154709|P1|STARTED|Overall Study||17
64961|NCT01544309|154751|P2|NOT COMPLETED|Overall Study||11
64962|NCT01544309|154752|P1|NOT COMPLETED|Overall Study||20
64963|NCT01544309|154751|P2|COMPLETED|Overall Study||514
64964|NCT01544309|154752|P1|COMPLETED|Overall Study||504
64965|NCT01544309|154751|P2|STARTED|Overall Study||525
64966|NCT01544309|154752|P1|STARTED|Overall Study||524
64967|NCT01544179|154790|P2|NOT COMPLETED|Overall Study||46
64968|NCT01544179|154791|P1|NOT COMPLETED|Overall Study||63
64969|NCT01544179|154790|P2|COMPLETED|Overall Study|Patients are ongoing in the study|86
64970|NCT01544179|154791|P1|COMPLETED|Overall Study|Patients are ongoing in the study|70
64971|NCT01544179|154790|P2|Did Not Receive Treatment|Overall Study||0
64972|NCT01544179|154791|P1|Did Not Receive Treatment|Overall Study||1
64973|NCT01544179|154790|P2|Received Treatment|Overall Study||132
64974|NCT01544179|154791|P1|Received Treatment|Overall Study||132
64975|NCT01544179|154790|P2|STARTED|Overall Study||132
64976|NCT01544179|154791|P1|STARTED|Overall Study||133
64977|NCT01544166|154819|P1|NOT COMPLETED|Overall Study||0
64978|NCT01544166|154819|P1|COMPLETED|Overall Study||44
64979|NCT01544166|154819|P1|STARTED|Overall Study||44
64980|NCT01543828|154882|P2|NOT COMPLETED|Treatment 2||0
64981|NCT01543828|154883|P1|NOT COMPLETED|Treatment 2||1
64982|NCT01543828|154882|P2|COMPLETED|Treatment 2||19
64983|NCT01543828|154883|P1|COMPLETED|Treatment 2||19
64984|NCT01543828|154882|P2|STARTED|Treatment 2|1 participant completed treatment 1, had an adverse event, and did not receive treatment 2.|19
64985|NCT01543828|154883|P1|STARTED|Treatment 2||20
64986|NCT01543828|154882|P2|NOT COMPLETED|Treatment 1||0
64987|NCT01543828|154883|P1|NOT COMPLETED|Treatment 1||0
64988|NCT01543828|154882|P2|COMPLETED|Treatment 1||20
64989|NCT01543828|154883|P1|COMPLETED|Treatment 1||20
64990|NCT01543828|154882|P2|STARTED|Treatment 1||20
64991|NCT01543828|154883|P1|STARTED|Treatment 1||20
64992|NCT01543685|154896|P5|NOT COMPLETED|Overall Study||4
64993|NCT01543685|154897|P4|NOT COMPLETED|Overall Study||0
64994|NCT01543685|154898|P3|NOT COMPLETED|Overall Study||2
64995|NCT01543685|154899|P2|NOT COMPLETED|Overall Study||3
64996|NCT01543685|154900|P1|NOT COMPLETED|Overall Study||3
64997|NCT01543685|154896|P5|COMPLETED|Overall Study||90
64998|NCT01543685|154897|P4|COMPLETED|Overall Study||93
64999|NCT01543685|154898|P3|COMPLETED|Overall Study||89
65000|NCT01543685|154899|P2|COMPLETED|Overall Study||88
65001|NCT01543685|154900|P1|COMPLETED|Overall Study||90
65002|NCT01543685|154896|P5|STARTED|Overall Study||94
65003|NCT01543685|154897|P4|STARTED|Overall Study||93
65004|NCT01543685|154898|P3|STARTED|Overall Study||91
65005|NCT01543685|154899|P2|STARTED|Overall Study||91
65006|NCT01543685|154900|P1|STARTED|Overall Study||93
65007|NCT01543607|154947|P1|NOT COMPLETED|Overall Study||0
65008|NCT01543607|154947|P1|COMPLETED|Overall Study||1
65009|NCT01543607|154947|P1|STARTED|Overall Study||1
65010|NCT01543581|154953|P2|NOT COMPLETED|Overall Study||0
65011|NCT01543581|154954|P1|NOT COMPLETED|Overall Study||0
65012|NCT01543581|154953|P2|COMPLETED|Overall Study||0
65013|NCT01543581|154954|P1|COMPLETED|Overall Study||1
65014|NCT01543581|154953|P2|STARTED|Overall Study||0
65015|NCT01543581|154954|P1|STARTED|Overall Study||1
65016|NCT01543568|154960|P1|NOT COMPLETED|Overall Study||1
65017|NCT01543568|154960|P1|COMPLETED|Overall Study||45
65018|NCT01543568|154960|P1|STARTED|Overall Study||46
65019|NCT01543503|154972|P2|NOT COMPLETED|Overall Study||87
65020|NCT01543503|154973|P1|NOT COMPLETED|Overall Study||76
65021|NCT01543503|154972|P2|COMPLETED|Overall Study||711
65022|NCT01543503|154973|P1|COMPLETED|Overall Study||350
65023|NCT01543503|154972|P2|STARTED|Overall Study||798
65024|NCT01543503|154973|P1|STARTED|Overall Study||426
65025|NCT01543204|155017|P1|NOT COMPLETED|Overall Study||8
65026|NCT01543204|155017|P1|COMPLETED|Overall Study||56
65027|NCT01543204|155017|P1|STARTED|Overall Study||64
65028|NCT01543178|155064|P3|NOT COMPLETED|Double-blind Period||37
65029|NCT01543178|155065|P2|NOT COMPLETED|Double-blind Period||44
65030|NCT01543178|155066|P1|NOT COMPLETED|Double-blind Period||0
65031|NCT01543178|155064|P3|COMPLETED|Double-blind Period|283 completed 1st double-blind retreatment and 271 completed 2nd double-blind retreatment.|271
65032|NCT01543178|155065|P2|COMPLETED|Double-blind Period|295 completed 1st double-blind retreatment and 284 completed 2nd double-blind retreatment.|284
65033|NCT01543178|155066|P1|COMPLETED|Double-blind Period||0
65034|NCT01543178|155064|P3|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 308 randomized to placebo.|308
65035|NCT01543178|155065|P2|STARTED|Double-blind Period|636 subjects had recurrence in open-label period; 328 randomized to rifaximin.|328
65036|NCT01543178|155066|P1|STARTED|Double-blind Period|The open-label rifaximin arm/group is not applicable to the double-blind period.|0
65037|NCT01543178|155064|P3|NOT COMPLETED|Open-label Period||0
65038|NCT01543178|155065|P2|NOT COMPLETED|Open-label Period||0
65039|NCT01543178|155066|P1|NOT COMPLETED|Open-label Period||1947
65040|NCT01543178|155064|P3|COMPLETED|Open-label Period||0
65041|NCT01543178|155065|P2|COMPLETED|Open-label Period||0
65042|NCT01543178|155066|P1|COMPLETED|Open-label Period||636
65043|NCT01543178|155064|P3|STARTED|Open-label Period|The double-blind placebo arm/group is not applicable to the open-label period.|0
65044|NCT01543178|155065|P2|STARTED|Open-label Period|The double-blind rifaximin arm/group is not applicable to the open-label period.|0
65045|NCT01543178|155066|P1|STARTED|Open-label Period|2583 subjects entered the open-label period, but 4 received no rifaximin; 2579 received rifaximin.|2583
65046|NCT01543074|155077|P4|NOT COMPLETED|Overall Study||0
65047|NCT01543074|155078|P3|NOT COMPLETED|Overall Study||0
65048|NCT01543074|155079|P2|NOT COMPLETED|Overall Study||0
65049|NCT01543074|155080|P1|NOT COMPLETED|Overall Study||0
65050|NCT01543074|155077|P4|COMPLETED|Overall Study||6
65051|NCT01543074|155078|P3|COMPLETED|Overall Study||5
65052|NCT01543074|155079|P2|COMPLETED|Overall Study||7
65053|NCT01543074|155080|P1|COMPLETED|Overall Study||5
65054|NCT01543074|155077|P4|STARTED|Overall Study||6
65055|NCT01543074|155078|P3|STARTED|Overall Study||5
65056|NCT01543074|155079|P2|STARTED|Overall Study||7
65057|NCT01543074|155080|P1|STARTED|Overall Study||5
65058|NCT01542957|155096|P2|NOT COMPLETED|12-month Follow-up||13
65059|NCT01542957|155097|P1|NOT COMPLETED|12-month Follow-up||16
65060|NCT01542957|155096|P2|COMPLETED|12-month Follow-up||40
65061|NCT01542957|155097|P1|COMPLETED|12-month Follow-up||37
65062|NCT01542957|155096|P2|STARTED|12-month Follow-up||53
65063|NCT01542957|155097|P1|STARTED|12-month Follow-up||53
65064|NCT01542957|155096|P2|NOT COMPLETED|3-month Follow-up||8
65065|NCT01542957|155097|P1|NOT COMPLETED|3-month Follow-up||3
65066|NCT01542957|155096|P2|COMPLETED|3-month Follow-up||45
65067|NCT01542957|155097|P1|COMPLETED|3-month Follow-up||50
65068|NCT01542957|155096|P2|STARTED|3-month Follow-up||53
65069|NCT01542957|155097|P1|STARTED|3-month Follow-up||53
65070|NCT01542957|155096|P2|NOT COMPLETED|End of Therapy||10
65071|NCT01542957|155097|P1|NOT COMPLETED|End of Therapy||12
65072|NCT01542957|155096|P2|COMPLETED|End of Therapy||53
65073|NCT01542957|155097|P1|COMPLETED|End of Therapy||53
65074|NCT01542957|155096|P2|STARTED|End of Therapy||63
65075|NCT01542957|155097|P1|STARTED|End of Therapy||65
65076|NCT01542788|155109|P2|NOT COMPLETED|Overall Study||71
65077|NCT01542788|155110|P1|NOT COMPLETED|Overall Study||55
65078|NCT01542788|155109|P2|COMPLETED|Overall Study||0
65079|NCT01542788|155110|P1|COMPLETED|Overall Study||154
65080|NCT01542788|155109|P2|Randomized and Treated|Overall Study||71
65081|NCT01542788|155110|P1|Randomized and Treated|Overall Study||207
65082|NCT01542788|155109|P2|STARTED|Overall Study||71
65083|NCT01542788|155110|P1|STARTED|Overall Study||209
65084|NCT01542684|155126|P1|NOT COMPLETED|Overall Study||0
65085|NCT01542684|155126|P1|COMPLETED|Overall Study||8
65086|NCT01542684|155126|P1|STARTED|Overall Study||8
65087|NCT01542645|155132|P2|NOT COMPLETED|Overall Study||3
65088|NCT01542645|155133|P1|NOT COMPLETED|Overall Study||5
65089|NCT01542645|155132|P2|COMPLETED|Overall Study||79
65090|NCT01542645|155133|P1|COMPLETED|Overall Study||77
65091|NCT01542645|155132|P2|STARTED|Overall Study||82
65092|NCT01542645|155133|P1|STARTED|Overall Study||82
65093|NCT01542632|155149|P6|NOT COMPLETED|Overall Study||0
65094|NCT01542632|155150|P5|NOT COMPLETED|Overall Study||4
65095|NCT01542632|155151|P4|NOT COMPLETED|Overall Study||2
65096|NCT01542632|155152|P3|NOT COMPLETED|Overall Study||1
65097|NCT01542632|155153|P2|NOT COMPLETED|Overall Study||1
65098|NCT01542632|155154|P1|NOT COMPLETED|Overall Study||0
65099|NCT01542632|155149|P6|COMPLETED|Overall Study||24
65100|NCT01542632|155150|P5|COMPLETED|Overall Study||17
65101|NCT01542632|155151|P4|COMPLETED|Overall Study||19
65102|NCT01542632|155152|P3|COMPLETED|Overall Study||23
65103|NCT01542632|155153|P2|COMPLETED|Overall Study||24
65104|NCT01542632|155154|P1|COMPLETED|Overall Study||25
65105|NCT01542632|155149|P6|STARTED|Overall Study||24
65106|NCT01542632|155150|P5|STARTED|Overall Study||21
65107|NCT01542632|155151|P4|STARTED|Overall Study||21
65108|NCT01542632|155152|P3|STARTED|Overall Study||24
65109|NCT01542632|155153|P2|STARTED|Overall Study||25
65110|NCT01542632|155154|P1|STARTED|Overall Study||25
65111|NCT01542541|155200|P2|NOT COMPLETED|Overall Study||0
65112|NCT01542541|155201|P1|NOT COMPLETED|Overall Study||8
65113|NCT01542541|155200|P2|COMPLETED|Overall Study||30
65114|NCT01542541|155201|P1|COMPLETED|Overall Study||30
65115|NCT01542541|155200|P2|STARTED|Overall Study||30
65116|NCT01542541|155201|P1|STARTED|Overall Study||38
65117|NCT01542502|155207|P2|NOT COMPLETED|Overall Study||0
65118|NCT01542502|155208|P1|NOT COMPLETED|Overall Study||0
65119|NCT01542502|155207|P2|COMPLETED|Overall Study||6
65120|NCT01542502|155208|P1|COMPLETED|Overall Study||6
65121|NCT01542502|155207|P2|STARTED|Overall Study||6
65122|NCT01542502|155208|P1|STARTED|Overall Study||6
65123|NCT01542372|155216|P2|NOT COMPLETED|Overall Study||0
65124|NCT01542372|155217|P1|NOT COMPLETED|Overall Study||0
65125|NCT01542372|155216|P2|COMPLETED|Overall Study||11
65126|NCT01542372|155217|P1|COMPLETED|Overall Study||11
65127|NCT01542372|155216|P2|STARTED|Overall Study||11
65128|NCT01542372|155217|P1|STARTED|Overall Study||11
65129|NCT01542307|155232|P2|NOT COMPLETED|Overall Study||0
65130|NCT01542307|155233|P1|NOT COMPLETED|Overall Study||0
65131|NCT01542307|155232|P2|COMPLETED|Overall Study||22
65132|NCT01542307|155233|P1|COMPLETED|Overall Study||22
65133|NCT01542307|155232|P2|STARTED|Overall Study|Each subject inhaled Medical Air for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
65134|NCT01542307|155233|P1|STARTED|Overall Study|Each subject inhaled Oxygen for 30 minutes in blinded fashion for 2 of the 4 migraine attacks|22
65135|NCT01542255|155253|P1|NOT COMPLETED|Overall Study||0
65136|NCT01542255|155253|P1|COMPLETED|Overall Study||7
65137|NCT01542255|155253|P1|Analyzed for Time to Progression|Overall Study||7
65138|NCT01542255|155253|P1|STARTED|Overall Study||7
65139|NCT01542125|155259|P2|NOT COMPLETED|Overall Study||0
65140|NCT01542125|155260|P1|NOT COMPLETED|Overall Study||0
65141|NCT01542125|155259|P2|COMPLETED|Overall Study||141
65142|NCT01542125|155260|P1|COMPLETED|Overall Study||140
65143|NCT01542125|155259|P2|STARTED|Overall Study||141
65144|NCT01542125|155260|P1|STARTED|Overall Study||140
65145|NCT01542034|155268|P2|NOT COMPLETED|Overall Study||23
65146|NCT01542034|155269|P1|NOT COMPLETED|Overall Study||30
65147|NCT01542034|155268|P2|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|227
65148|NCT01542034|155269|P1|COMPLETED|Overall Study|Participants who completed long-term follow-up 24 weeks after the last treatment|226
65149|NCT01542034|155268|P2|Received Treatment|Overall Study||249
65150|NCT01542034|155269|P1|Received Treatment|Overall Study||256
65151|NCT01542034|155268|P2|STARTED|Overall Study||250
65152|NCT01542034|155269|P1|STARTED|Overall Study||256
65153|NCT01541969|155283|P2|NOT COMPLETED|Open Label Extension (12-36 Weeks)||13
65154|NCT01541969|155284|P1|NOT COMPLETED|Open Label Extension (12-36 Weeks)||11
65155|NCT01541969|155283|P2|COMPLETED|Open Label Extension (12-36 Weeks)||35
65156|NCT01541969|155284|P1|COMPLETED|Open Label Extension (12-36 Weeks)||33
65157|NCT01541969|155283|P2|STARTED|Open Label Extension (12-36 Weeks)||48
65158|NCT01541969|155284|P1|STARTED|Open Label Extension (12-36 Weeks)||44
65159|NCT01541969|155283|P2|NOT COMPLETED|Double-blind (0-12 Weeks)||2
65160|NCT01541969|155284|P1|NOT COMPLETED|Double-blind (0-12 Weeks)||6
65161|NCT01541969|155283|P2|COMPLETED|Double-blind (0-12 Weeks)||48
65162|NCT01541969|155284|P1|COMPLETED|Double-blind (0-12 Weeks)||44
65163|NCT01541969|155283|P2|STARTED|Double-blind (0-12 Weeks)||50
65164|NCT01541969|155284|P1|STARTED|Double-blind (0-12 Weeks)||50
65165|NCT01541930|155300|P1|NOT COMPLETED|Overall Study||1
65166|NCT01541930|155300|P1|COMPLETED|Overall Study||20
65167|NCT01541930|155300|P1|STARTED|Overall Study||21
65168|NCT01541917|155322|P2|NOT COMPLETED|Overall Study||9
65169|NCT01541917|155323|P1|NOT COMPLETED|Overall Study||15
65170|NCT01541917|155322|P2|COMPLETED|Overall Study||136
65171|NCT01541917|155323|P1|COMPLETED|Overall Study||129
65172|NCT01541917|155322|P2|STARTED|Overall Study||145
65173|NCT01541917|155323|P1|STARTED|Overall Study||144
65174|NCT01541865|155339|P1|NOT COMPLETED|Overall Study||22
65175|NCT01541865|155339|P1|COMPLETED|Overall Study||124
65176|NCT01541865|155339|P1|STARTED|Overall Study||146
65177|NCT01541826|155357|P3|NOT COMPLETED|Overall Study||0
65178|NCT01541826|155358|P2|NOT COMPLETED|Overall Study||3
65179|NCT01541826|155359|P1|NOT COMPLETED|Overall Study||4
65180|NCT01541826|155357|P3|COMPLETED|Overall Study||6
65181|NCT01541826|155358|P2|COMPLETED|Overall Study||25
65182|NCT01541826|155359|P1|COMPLETED|Overall Study||24
65183|NCT01541826|155357|P3|STARTED|Overall Study||6
65184|NCT01541826|155358|P2|STARTED|Overall Study||28
65185|NCT01541826|155359|P1|STARTED|Overall Study||28
65186|NCT01541735|155428|P2|NOT COMPLETED|Overall Study||0
65187|NCT01541735|155429|P1|NOT COMPLETED|Overall Study||0
65188|NCT01541735|155428|P2|COMPLETED|Overall Study||7
65189|NCT01541735|155429|P1|COMPLETED|Overall Study||7
65190|NCT01541735|155428|P2|STARTED|Overall Study||7
65191|NCT01541735|155429|P1|STARTED|Overall Study||7
65192|NCT01541644|155441|P1|NOT COMPLETED|Overall Study||3
65193|NCT01541644|155441|P1|COMPLETED|Overall Study||24
65194|NCT01541644|155441|P1|STARTED|Overall Study||27
65195|NCT01541553|155447|P2|NOT COMPLETED|Overall Study||14
65196|NCT01541553|155448|P1|NOT COMPLETED|Overall Study||12
65197|NCT01541553|155447|P2|COMPLETED|Overall Study||148
65198|NCT01541553|155448|P1|COMPLETED|Overall Study||155
65199|NCT01541553|155447|P2|STARTED|Overall Study||162
65200|NCT01541553|155448|P1|STARTED|Overall Study||167
65201|NCT01541397|155460|P2|NOT COMPLETED|Overall Study||2
65202|NCT01541397|155461|P1|NOT COMPLETED|Overall Study||4
65203|NCT01541397|155460|P2|COMPLETED|Overall Study||0
65204|NCT01541397|155461|P1|COMPLETED|Overall Study||0
65205|NCT01541397|155460|P2|STARTED|Overall Study||2
65206|NCT01541397|155461|P1|STARTED|Overall Study||4
65207|NCT01541384|155476|P3|NOT COMPLETED|Overall Study||2
65208|NCT01541384|155477|P2|NOT COMPLETED|Overall Study||1
65209|NCT01541384|155478|P1|NOT COMPLETED|Overall Study||0
65210|NCT01541384|155476|P3|COMPLETED|Overall Study||38
65211|NCT01541384|155477|P2|COMPLETED|Overall Study||39
65212|NCT01541384|155478|P1|COMPLETED|Overall Study||40
65213|NCT01541384|155476|P3|STARTED|Overall Study||40
65214|NCT01541384|155477|P2|STARTED|Overall Study||40
65215|NCT01541384|155478|P1|STARTED|Overall Study||40
65216|NCT01541371|155486|P1|NOT COMPLETED|Overall Study||77
65217|NCT01541371|155486|P1|COMPLETED|Overall Study||326
65218|NCT01541371|155486|P1|Full Analysis Set|Overall Study||394
65219|NCT01541371|155486|P1|STARTED|Overall Study||403
65220|NCT01541358|155509|P1|NOT COMPLETED|Overall Study||0
65221|NCT01541358|155509|P1|COMPLETED|Overall Study||2
65222|NCT01541358|155509|P1|STARTED|Overall Study||2
65223|NCT01541254|155515|P1|NOT COMPLETED|Overall Study||6
65224|NCT01541254|155515|P1|COMPLETED|Overall Study||30
65225|NCT01541254|155515|P1|STARTED|Overall Study||36
65226|NCT01540981|155522|P2|NOT COMPLETED|Overall Study||0
65227|NCT01540981|155523|P1|NOT COMPLETED|Overall Study||1
65228|NCT01540981|155522|P2|COMPLETED|Overall Study||6
65229|NCT01540981|155523|P1|COMPLETED|Overall Study||5
65230|NCT01540981|155522|P2|STARTED|Overall Study||6
65231|NCT01540981|155523|P1|STARTED|Overall Study||6
65232|NCT01540851|155533|P2|NOT COMPLETED|Overall Study||18
65233|NCT01540851|155534|P1|NOT COMPLETED|Overall Study||21
65234|NCT01540851|155533|P2|COMPLETED|Overall Study||136
65235|NCT01540851|155534|P1|COMPLETED|Overall Study||133
65236|NCT01540851|155533|P2|STARTED|Overall Study||154
65237|NCT01540851|155534|P1|STARTED|Overall Study||154
65238|NCT01540825|155555|P11|NOT COMPLETED|Overall Study||0
65239|NCT01540825|155556|P10|NOT COMPLETED|Overall Study||0
65240|NCT01540825|155557|P9|NOT COMPLETED|Overall Study||0
65241|NCT01540825|155558|P8|NOT COMPLETED|Overall Study||0
65242|NCT01540825|155559|P7|NOT COMPLETED|Overall Study||0
65243|NCT01540825|155560|P6|NOT COMPLETED|Overall Study||0
65244|NCT01540825|155561|P5|NOT COMPLETED|Overall Study||0
65245|NCT01540825|155562|P4|NOT COMPLETED|Overall Study||0
65246|NCT01540825|155563|P3|NOT COMPLETED|Overall Study||0
65247|NCT01540825|155564|P2|NOT COMPLETED|Overall Study||0
65248|NCT01540825|155565|P1|NOT COMPLETED|Overall Study||0
65249|NCT01540825|155555|P11|COMPLETED|Overall Study||6
65250|NCT01540825|155556|P10|COMPLETED|Overall Study||6
65251|NCT01540825|155557|P9|COMPLETED|Overall Study||6
65252|NCT01540825|155558|P8|COMPLETED|Overall Study||6
65253|NCT01540825|155559|P7|COMPLETED|Overall Study||6
65254|NCT01540825|155560|P6|COMPLETED|Overall Study||6
65255|NCT01540825|155561|P5|COMPLETED|Overall Study||6
65256|NCT01540825|155562|P4|COMPLETED|Overall Study||6
65257|NCT01540825|155563|P3|COMPLETED|Overall Study||6
65258|NCT01540825|155564|P2|COMPLETED|Overall Study||6
65259|NCT01540825|155565|P1|COMPLETED|Overall Study||20
65260|NCT01540825|155555|P11|STARTED|Overall Study||6
65261|NCT01540825|155556|P10|STARTED|Overall Study||6
65262|NCT01540825|155557|P9|STARTED|Overall Study||6
65263|NCT01540825|155558|P8|STARTED|Overall Study||6
65264|NCT01540825|155559|P7|STARTED|Overall Study||6
65265|NCT01540825|155560|P6|STARTED|Overall Study||6
65266|NCT01540825|155561|P5|STARTED|Overall Study||6
65267|NCT01540825|155562|P4|STARTED|Overall Study||6
65268|NCT01540825|155563|P3|STARTED|Overall Study||6
65269|NCT01540825|155564|P2|STARTED|Overall Study||6
65270|NCT01540825|155565|P1|STARTED|Overall Study||20
65271|NCT01540773|155661|P2|NOT COMPLETED|Second Intervention||0
65272|NCT01540773|155662|P1|NOT COMPLETED|Second Intervention||0
65273|NCT01540773|155661|P2|COMPLETED|Second Intervention||8
65274|NCT01540773|155662|P1|COMPLETED|Second Intervention||8
65275|NCT01540773|155661|P2|STARTED|Second Intervention||8
65276|NCT01540773|155662|P1|STARTED|Second Intervention||8
65277|NCT01540773|155661|P2|NOT COMPLETED|Wash Out Period of 1 Week||0
65278|NCT01540773|155662|P1|NOT COMPLETED|Wash Out Period of 1 Week||0
65279|NCT01540773|155661|P2|COMPLETED|Wash Out Period of 1 Week||8
65280|NCT01540773|155662|P1|COMPLETED|Wash Out Period of 1 Week||8
65281|NCT01540773|155661|P2|STARTED|Wash Out Period of 1 Week||8
65282|NCT01540773|155662|P1|STARTED|Wash Out Period of 1 Week||8
65283|NCT01540773|155661|P2|NOT COMPLETED|First Intervention||0
65284|NCT01540773|155662|P1|NOT COMPLETED|First Intervention||0
65285|NCT01540773|155661|P2|COMPLETED|First Intervention||8
65286|NCT01540773|155662|P1|COMPLETED|First Intervention||8
65287|NCT01540773|155661|P2|STARTED|First Intervention||8
65288|NCT01540773|155662|P1|STARTED|First Intervention||8
65289|NCT01540487|155674|P2|NOT COMPLETED|Overall Study||0
65290|NCT01540487|155675|P1|NOT COMPLETED|Overall Study||1
65291|NCT01540487|155674|P2|COMPLETED|Overall Study||24
65292|NCT01540487|155675|P1|COMPLETED|Overall Study||23
65293|NCT01540487|155674|P2|STARTED|Overall Study||24
65294|NCT01540487|155675|P1|STARTED|Overall Study||24
65295|NCT01540370|155709|P1|NOT COMPLETED|Overall Study||2
65296|NCT01540370|155709|P1|COMPLETED|Overall Study||100
65297|NCT01540370|155709|P1|STARTED|Overall Study||102
65298|NCT01540266|155720|P6|NOT COMPLETED|Overall Study||0
65299|NCT01540266|155721|P5|NOT COMPLETED|Overall Study||0
65300|NCT01540266|155722|P4|NOT COMPLETED|Overall Study||0
65301|NCT01540266|155723|P3|NOT COMPLETED|Overall Study||1
65302|NCT01540266|155724|P2|NOT COMPLETED|Overall Study||1
65303|NCT01540266|155725|P1|NOT COMPLETED|Overall Study||6
65304|NCT01540266|155720|P6|COMPLETED|Overall Study||19
65305|NCT01540266|155721|P5|COMPLETED|Overall Study||20
65306|NCT01540266|155722|P4|COMPLETED|Overall Study||38
65307|NCT01540266|155723|P3|COMPLETED|Overall Study||59
65308|NCT01540266|155724|P2|COMPLETED|Overall Study||41
65309|NCT01540266|155725|P1|COMPLETED|Overall Study||57
65310|NCT01540266|155720|P6|STARTED|Overall Study||19
65311|NCT01540266|155721|P5|STARTED|Overall Study||20
65312|NCT01540266|155722|P4|STARTED|Overall Study||38
65313|NCT01540266|155723|P3|STARTED|Overall Study||60
65314|NCT01540266|155724|P2|STARTED|Overall Study||42
65315|NCT01540266|155725|P1|STARTED|Overall Study||63
65316|NCT01540162|155741|P2|NOT COMPLETED|Overall Study||0
65317|NCT01540162|155742|P1|NOT COMPLETED|Overall Study||0
65318|NCT01540162|155741|P2|COMPLETED|Overall Study||32
65319|NCT01540162|155742|P1|COMPLETED|Overall Study||30
65320|NCT01540162|155741|P2|STARTED|Overall Study||32
65321|NCT01540162|155742|P1|STARTED|Overall Study||30
65322|NCT01540045|155752|P1|NOT COMPLETED|Overall Study||0
65323|NCT01540045|155752|P1|COMPLETED|Overall Study||40
65324|NCT01540045|155752|P1|STARTED|Overall Study||40
65325|NCT01539980|155791|P1|NOT COMPLETED|Overall Study||0
65326|NCT01539980|155791|P1|COMPLETED|Overall Study||30
65327|NCT01539980|155791|P1|STARTED|Overall Study||30
65328|NCT01539811|155801|P2|NOT COMPLETED|Overall Study||0
65329|NCT01539811|155802|P1|NOT COMPLETED|Overall Study||0
65330|NCT01539811|155801|P2|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
65331|NCT01539811|155802|P1|COMPLETED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
65332|NCT01539811|155801|P2|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
65333|NCT01539811|155802|P1|STARTED|Overall Study|Antibiotics never given. Study closed prior to initiating treatment.|0
65334|NCT01539759|155810|P2|NOT COMPLETED|Overall Study||8
65335|NCT01539759|155811|P1|NOT COMPLETED|Overall Study||6
65336|NCT01539759|155810|P2|COMPLETED|Overall Study||48
65337|NCT01539759|155811|P1|COMPLETED|Overall Study||50
65338|NCT01539759|155810|P2|IUD in Place at 6 Months Posptartum|Overall Study||40
65339|NCT01539759|155811|P1|IUD in Place at 6 Months Posptartum|Overall Study||32
65340|NCT01539759|155810|P2|IUD Removal|Overall Study||7
65341|NCT01539759|155811|P1|IUD Removal|Overall Study||2
65342|NCT01539759|155810|P2|IUD Expulsion|Overall Study||4
65343|NCT01539759|155811|P1|IUD Expulsion|Overall Study||1
65344|NCT01539759|155810|P2|Had Successful IUD Placement|Overall Study||53
65345|NCT01539759|155811|P1|Had Successful IUD Placement|Overall Study||34
65346|NCT01539759|155810|P2|STARTED|Overall Study||56
65347|NCT01539759|155811|P1|STARTED|Overall Study||56
65348|NCT01539642|155821|P2|NOT COMPLETED|Overall Study||31
65349|NCT01539642|155822|P1|NOT COMPLETED|Overall Study||36
65350|NCT01539642|155821|P2|COMPLETED|Overall Study||27
65351|NCT01539642|155822|P1|COMPLETED|Overall Study||78
65352|NCT01539642|155821|P2|STARTED|Overall Study||58
65353|NCT01539642|155822|P1|STARTED|Overall Study||114
65354|NCT01539590|155830|P2|NOT COMPLETED|Overall Study||0
65355|NCT01539590|155831|P1|NOT COMPLETED|Overall Study||3
65356|NCT01539590|155830|P2|COMPLETED|Overall Study||2
65357|NCT01539590|155831|P1|COMPLETED|Overall Study||0
65358|NCT01539590|155830|P2|Complete Study Treatment|Overall Study||2
65359|NCT01539590|155831|P1|Complete Study Treatment|Overall Study||1
65360|NCT01539590|155830|P2|STARTED|Overall Study||2
65361|NCT01539590|155831|P1|STARTED|Overall Study||3
65362|NCT01539538|155839|P2|NOT COMPLETED|Overall Study||44
65363|NCT01539538|155840|P1|NOT COMPLETED|Overall Study||31
65364|NCT01539538|155839|P2|COMPLETED|Overall Study||136
65365|NCT01539538|155840|P1|COMPLETED|Overall Study||146
65366|NCT01539538|155839|P2|STARTED|Overall Study||180
65367|NCT01539538|155840|P1|STARTED|Overall Study||177
65368|NCT01539525|155849|P3|NOT COMPLETED|Overall Study||17
65369|NCT01539525|155850|P2|NOT COMPLETED|Overall Study||16
65370|NCT01539525|155851|P1|NOT COMPLETED|Overall Study||20
65371|NCT01539525|155849|P3|COMPLETED|Overall Study||134
65372|NCT01539525|155850|P2|COMPLETED|Overall Study||127
65373|NCT01539525|155851|P1|COMPLETED|Overall Study||125
65374|NCT01539525|155849|P3|STARTED|Overall Study||151
65375|NCT01539525|155850|P2|STARTED|Overall Study||143
65376|NCT01539525|155851|P1|STARTED|Overall Study||145
65377|NCT01539512|155870|P2|NOT COMPLETED|Overall Study||13
65378|NCT01539512|155871|P1|NOT COMPLETED|Overall Study||23
65379|NCT01539512|155870|P2|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|97
65380|NCT01539512|155871|P1|COMPLETED|Overall Study|Completed=reached primary efficacy endpoint (progressive disease or death) or finished study period.|87
65381|NCT01539512|155870|P2|STARTED|Overall Study||110
65382|NCT01539512|155871|P1|STARTED|Overall Study||110
65383|NCT01539317|155887|P2|NOT COMPLETED|Overall Study||0
65384|NCT01539317|155888|P1|NOT COMPLETED|Overall Study||1
65385|NCT01539317|155887|P2|COMPLETED|Overall Study||25
65386|NCT01539317|155888|P1|COMPLETED|Overall Study||24
65387|NCT01539317|155887|P2|STARTED|Overall Study||25
65388|NCT01539317|155888|P1|STARTED|Overall Study||25
65389|NCT01539135|155905|P2|NOT COMPLETED|Overall Study||0
65390|NCT01539135|155906|P1|NOT COMPLETED|Overall Study||0
65391|NCT01539135|155905|P2|COMPLETED|Overall Study||37
65392|NCT01539135|155906|P1|COMPLETED|Overall Study||43
65393|NCT01539135|155905|P2|STARTED|Overall Study||37
65394|NCT01539135|155906|P1|STARTED|Overall Study||43
65395|NCT01539083|155918|P3|NOT COMPLETED|After Randomization (TP and VTP)||11
65396|NCT01539083|155919|P2|NOT COMPLETED|After Randomization (TP and VTP)||13
65397|NCT01539083|155920|P1|NOT COMPLETED|After Randomization (TP and VTP)||0
65398|NCT01539083|155918|P3|COMPLETED|After Randomization (TP and VTP)||92
65399|NCT01539083|155919|P2|COMPLETED|After Randomization (TP and VTP)||87
65400|NCT01539083|155920|P1|COMPLETED|After Randomization (TP and VTP)||0
65401|NCT01539083|155918|P3|Safety Population|After Randomization (TP and VTP)||103
65402|NCT01539083|155919|P2|Safety Population|After Randomization (TP and VTP)|One participant was randomized but not treated. Hence, was not included in safety population.|99
65403|NCT01539083|155920|P1|Safety Population|After Randomization (TP and VTP)||0
65404|NCT01539083|155918|P3|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|103
65405|NCT01539083|155919|P2|STARTED|After Randomization (TP and VTP)|Participants who completed induction phase were randomized for the consolidated treatment.|100
65406|NCT01539083|155920|P1|STARTED|After Randomization (TP and VTP)||0
65407|NCT01539083|155918|P3|NOT COMPLETED|Before Randomization (VCD Induction)||0
65408|NCT01539083|155919|P2|NOT COMPLETED|Before Randomization (VCD Induction)||0
65409|NCT01539083|155920|P1|NOT COMPLETED|Before Randomization (VCD Induction)||53
65410|NCT01539083|155918|P3|COMPLETED|Before Randomization (VCD Induction)||0
65411|NCT01539083|155919|P2|COMPLETED|Before Randomization (VCD Induction)||0
65412|NCT01539083|155920|P1|COMPLETED|Before Randomization (VCD Induction)||203
65413|NCT01539083|155918|P3|Treated|Before Randomization (VCD Induction)||0
65414|NCT01539083|155919|P2|Treated|Before Randomization (VCD Induction)||0
65415|NCT01539083|155920|P1|Treated|Before Randomization (VCD Induction)||254
65416|NCT01539083|155918|P3|STARTED|Before Randomization (VCD Induction)||0
65417|NCT01539083|155919|P2|STARTED|Before Randomization (VCD Induction)||0
65418|NCT01539083|155920|P1|STARTED|Before Randomization (VCD Induction)||256
65419|NCT01539070|155943|P2|NOT COMPLETED|Overall Study||39
65420|NCT01539070|155944|P1|NOT COMPLETED|Overall Study||59
65421|NCT01539070|155943|P2|COMPLETED|Overall Study||99
65422|NCT01539070|155944|P1|COMPLETED|Overall Study||109
65423|NCT01539070|155943|P2|STARTED|Overall Study||138
65424|NCT01539070|155944|P1|STARTED|Overall Study||168
65425|NCT01538862|155956|P1|NOT COMPLETED|Overall Study||0
65426|NCT01538862|155956|P1|COMPLETED|Overall Study||7
65427|NCT01538862|155956|P1|STARTED|Overall Study||7
65428|NCT01538472|155962|P1|NOT COMPLETED|Overall Study||4
65429|NCT01538472|155962|P1|COMPLETED|Overall Study||36
65430|NCT01538472|155962|P1|STARTED|Overall Study||40
65431|NCT01537900|155967|P1|NOT COMPLETED|Overall Study||0
65432|NCT01537900|155967|P1|COMPLETED|Overall Study||4
65433|NCT01537900|155967|P1|STARTED|Overall Study||4
65434|NCT01537835|155981|P3|NOT COMPLETED|Overall Study||0
65435|NCT01537835|155982|P2|NOT COMPLETED|Overall Study||0
65436|NCT01537835|155983|P1|NOT COMPLETED|Overall Study||0
65437|NCT01537835|155981|P3|COMPLETED|Overall Study||35
65438|NCT01537835|155982|P2|COMPLETED|Overall Study||37
65439|NCT01537835|155983|P1|COMPLETED|Overall Study||37
65440|NCT01537835|155981|P3|STARTED|Overall Study||35
65441|NCT01537835|155982|P2|STARTED|Overall Study||37
65442|NCT01537835|155983|P1|STARTED|Overall Study||37
65443|NCT01537783|155996|P2|NOT COMPLETED|Overall Study||2
65444|NCT01537783|155997|P1|NOT COMPLETED|Overall Study||11
65445|NCT01537783|155996|P2|COMPLETED|Overall Study||23
65446|NCT01537783|155997|P1|COMPLETED|Overall Study||14
65447|NCT01537783|155996|P2|STARTED|Overall Study||25
65448|NCT01537783|155997|P1|STARTED|Overall Study||25
65449|NCT01537666|156007|P4|NOT COMPLETED|Overall Study||0
65450|NCT01537666|156008|P3|NOT COMPLETED|Overall Study||0
65451|NCT01537666|156009|P2|NOT COMPLETED|Overall Study||0
65452|NCT01537666|156010|P1|NOT COMPLETED|Overall Study||0
65453|NCT01537666|156007|P4|COMPLETED|Overall Study|1 patient withdrew after a 32 mg dose and was replaced by a patient who only received an 80 mg dose.|7
65454|NCT01537666|156008|P3|COMPLETED|Overall Study||6
65455|NCT01537666|156009|P2|COMPLETED|Overall Study||6
65456|NCT01537666|156010|P1|COMPLETED|Overall Study||6
65457|NCT01537666|156007|P4|STARTED|Overall Study|5 of 7 patients received a 32 mg dose of AeroVanc followed by a dose of 80 mg at least 1 week later.|7
65458|NCT01537666|156008|P3|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
65549|NCT01536951|156216|P8|NOT COMPLETED|Third Intervention||0
65459|NCT01537666|156009|P2|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
65460|NCT01537666|156010|P1|STARTED|Overall Study|2 of these 6 also received a single 250 mg IV dose of vancomycin at least 72 hours after AeroVanc.|6
65461|NCT01537549|156048|P1|NOT COMPLETED|Overall Study||3
65462|NCT01537549|156048|P1|COMPLETED|Overall Study||8
65463|NCT01537549|156048|P1|STARTED|Overall Study||11
65464|NCT01537432|156056|P2|NOT COMPLETED|Overall Study||2
65465|NCT01537432|156057|P1|NOT COMPLETED|Overall Study||6
65466|NCT01537432|156056|P2|COMPLETED|Overall Study||10
65467|NCT01537432|156057|P1|COMPLETED|Overall Study||18
65468|NCT01537432|156056|P2|STARTED|Overall Study||12
65469|NCT01537432|156057|P1|STARTED|Overall Study||24
65470|NCT01537367|156068|P3|NOT COMPLETED|Overall Study||0
65471|NCT01537367|156069|P2|NOT COMPLETED|Overall Study||0
65472|NCT01537367|156070|P1|NOT COMPLETED|Overall Study||0
65473|NCT01537367|156068|P3|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|613
65474|NCT01537367|156069|P2|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|610
65475|NCT01537367|156070|P1|COMPLETED|Overall Study|All participants who were enrolled were followed for routine HIV clinic attendance via clinic EMR.|615
65476|NCT01537367|156068|P3|STARTED|Overall Study||613
65477|NCT01537367|156069|P2|STARTED|Overall Study||610
65478|NCT01537367|156070|P1|STARTED|Overall Study||615
65479|NCT01537315|156086|P2|NOT COMPLETED|Overall Study||0
65480|NCT01537315|156087|P1|NOT COMPLETED|Overall Study||0
65481|NCT01537315|156086|P2|COMPLETED|Overall Study||7
65482|NCT01537315|156087|P1|COMPLETED|Overall Study||1
65483|NCT01537315|156086|P2|STARTED|Overall Study||7
65484|NCT01537315|156087|P1|STARTED|Overall Study||1
65485|NCT01537302|156093|P1|NOT COMPLETED|Overall Study||2
65486|NCT01537302|156093|P1|COMPLETED|Overall Study||199
65487|NCT01537302|156093|P1|STARTED|Overall Study||201
65488|NCT01537198|156100|P1|NOT COMPLETED|Overall Study||154
65489|NCT01537198|156100|P1|COMPLETED|Overall Study||463
65490|NCT01537198|156100|P1|STARTED|Overall Study||617
65491|NCT01537185|156108|P4|NOT COMPLETED|Overall Study||2
65492|NCT01537185|156109|P3|NOT COMPLETED|Overall Study||6
65493|NCT01537185|156110|P2|NOT COMPLETED|Overall Study||6
65494|NCT01537185|156111|P1|NOT COMPLETED|Overall Study||3
65495|NCT01537185|156108|P4|COMPLETED|Overall Study||8
65496|NCT01537185|156109|P3|COMPLETED|Overall Study||4
65497|NCT01537185|156110|P2|COMPLETED|Overall Study||6
65498|NCT01537185|156111|P1|COMPLETED|Overall Study||7
65499|NCT01537185|156108|P4|STARTED|Overall Study||10
65500|NCT01537185|156109|P3|STARTED|Overall Study||10
65501|NCT01537185|156110|P2|STARTED|Overall Study||12
65502|NCT01537185|156111|P1|STARTED|Overall Study||10
65503|NCT01537133|156129|P4|NOT COMPLETED|Overall Study||0
65504|NCT01537133|156130|P3|NOT COMPLETED|Overall Study||0
65505|NCT01537133|156131|P2|NOT COMPLETED|Overall Study||0
65506|NCT01537133|156132|P1|NOT COMPLETED|Overall Study||3
65507|NCT01537133|156129|P4|COMPLETED|Overall Study||21
65508|NCT01537133|156130|P3|COMPLETED|Overall Study||21
65509|NCT01537133|156131|P2|COMPLETED|Overall Study||14
65510|NCT01537133|156132|P1|COMPLETED|Overall Study||25
65511|NCT01537133|156129|P4|STARTED|Overall Study||21
65512|NCT01537133|156130|P3|STARTED|Overall Study||21
65513|NCT01537133|156131|P2|STARTED|Overall Study||14
65514|NCT01537133|156132|P1|STARTED|Overall Study||28
65515|NCT01537120|156148|P1|NOT COMPLETED|12 Weeks Vildagliptin||0
65516|NCT01537120|156148|P1|COMPLETED|12 Weeks Vildagliptin||23
65517|NCT01537120|156148|P1|STARTED|12 Weeks Vildagliptin||23
65518|NCT01537120|156148|P1|NOT COMPLETED|3 Weeks Placebo||1
65519|NCT01537120|156148|P1|COMPLETED|3 Weeks Placebo||23
65520|NCT01537120|156148|P1|STARTED|3 Weeks Placebo||24
65521|NCT01537120|156148|P1|NOT COMPLETED|8 Weeks Washout||1
65522|NCT01537120|156148|P1|COMPLETED|8 Weeks Washout||24
65523|NCT01537120|156148|P1|STARTED|8 Weeks Washout||25
65524|NCT01537120|156148|P1|NOT COMPLETED|Enrolled||0
65525|NCT01537120|156148|P1|COMPLETED|Enrolled||25
65526|NCT01537120|156148|P1|STARTED|Enrolled||25
65527|NCT01537081|156161|P3|NOT COMPLETED|Overall Study||16
65528|NCT01537081|156162|P2|NOT COMPLETED|Overall Study||38
65529|NCT01537081|156163|P1|NOT COMPLETED|Overall Study||39
65530|NCT01537081|156161|P3|COMPLETED|Overall Study||547
65531|NCT01537081|156162|P2|COMPLETED|Overall Study||1086
65532|NCT01537081|156163|P1|COMPLETED|Overall Study||1084
65533|NCT01537081|156161|P3|Modified Intent to Treat Population|Overall Study||556
65534|NCT01537081|156162|P2|Modified Intent to Treat Population|Overall Study||1109
65535|NCT01537081|156163|P1|Modified Intent to Treat Population|Overall Study||1106
65536|NCT01537081|156161|P3|Safety Population|Overall Study||561
65537|NCT01537081|156162|P2|Safety Population|Overall Study||1122
65538|NCT01537081|156163|P1|Safety Population|Overall Study||1122
65539|NCT01537081|156161|P3|STARTED|Overall Study||563
65540|NCT01537081|156162|P2|STARTED|Overall Study||1124
65541|NCT01537081|156163|P1|STARTED|Overall Study||1123
65542|NCT01537042|156176|P2|NOT COMPLETED|Overall Study||5
65543|NCT01537042|156177|P1|NOT COMPLETED|Overall Study||0
65544|NCT01537042|156176|P2|COMPLETED|Overall Study||15
65545|NCT01537042|156177|P1|COMPLETED|Overall Study||10
65546|NCT01537042|156176|P2|STARTED|Overall Study||20
65547|NCT01537042|156177|P1|STARTED|Overall Study||10
65548|NCT01536951|156215|P9|NOT COMPLETED|Third Intervention||0
65550|NCT01536951|156217|P7|NOT COMPLETED|Third Intervention||0
65551|NCT01536951|156218|P6|NOT COMPLETED|Third Intervention||0
65552|NCT01536951|156219|P5|NOT COMPLETED|Third Intervention||0
65553|NCT01536951|156220|P4|NOT COMPLETED|Third Intervention||0
65554|NCT01536951|156221|P3|NOT COMPLETED|Third Intervention||0
65555|NCT01536951|156222|P2|NOT COMPLETED|Third Intervention||0
65556|NCT01536951|156223|P1|NOT COMPLETED|Third Intervention||0
65557|NCT01536951|156215|P9|COMPLETED|Third Intervention||9
65558|NCT01536951|156216|P8|COMPLETED|Third Intervention||8
65559|NCT01536951|156217|P7|COMPLETED|Third Intervention||9
65560|NCT01536951|156218|P6|COMPLETED|Third Intervention||9
65561|NCT01536951|156219|P5|COMPLETED|Third Intervention||9
65562|NCT01536951|156220|P4|COMPLETED|Third Intervention||8
65563|NCT01536951|156221|P3|COMPLETED|Third Intervention||2
65564|NCT01536951|156222|P2|COMPLETED|Third Intervention||3
65565|NCT01536951|156223|P1|COMPLETED|Third Intervention||3
65566|NCT01536951|156215|P9|STARTED|Third Intervention||9
65567|NCT01536951|156216|P8|STARTED|Third Intervention||8
65568|NCT01536951|156217|P7|STARTED|Third Intervention||9
65569|NCT01536951|156218|P6|STARTED|Third Intervention||9
65570|NCT01536951|156219|P5|STARTED|Third Intervention||9
65571|NCT01536951|156220|P4|STARTED|Third Intervention||8
65572|NCT01536951|156221|P3|STARTED|Third Intervention||2
65573|NCT01536951|156222|P2|STARTED|Third Intervention||3
65574|NCT01536951|156223|P1|STARTED|Third Intervention||3
65575|NCT01536951|156215|P9|NOT COMPLETED|Second Intervention and Washout Period 2||0
65576|NCT01536951|156216|P8|NOT COMPLETED|Second Intervention and Washout Period 2||1
65577|NCT01536951|156217|P7|NOT COMPLETED|Second Intervention and Washout Period 2||0
65578|NCT01536951|156218|P6|NOT COMPLETED|Second Intervention and Washout Period 2||0
65579|NCT01536951|156219|P5|NOT COMPLETED|Second Intervention and Washout Period 2||0
65580|NCT01536951|156220|P4|NOT COMPLETED|Second Intervention and Washout Period 2||0
65581|NCT01536951|156221|P3|NOT COMPLETED|Second Intervention and Washout Period 2||0
65582|NCT01536951|156222|P2|NOT COMPLETED|Second Intervention and Washout Period 2||0
65583|NCT01536951|156223|P1|NOT COMPLETED|Second Intervention and Washout Period 2||0
65584|NCT01536951|156215|P9|COMPLETED|Second Intervention and Washout Period 2||9
65585|NCT01536951|156216|P8|COMPLETED|Second Intervention and Washout Period 2||8
65586|NCT01536951|156217|P7|COMPLETED|Second Intervention and Washout Period 2||9
65587|NCT01536951|156218|P6|COMPLETED|Second Intervention and Washout Period 2||9
65588|NCT01536951|156219|P5|COMPLETED|Second Intervention and Washout Period 2||9
65589|NCT01536951|156220|P4|COMPLETED|Second Intervention and Washout Period 2||8
65590|NCT01536951|156221|P3|COMPLETED|Second Intervention and Washout Period 2||2
65591|NCT01536951|156222|P2|COMPLETED|Second Intervention and Washout Period 2||3
65592|NCT01536951|156223|P1|COMPLETED|Second Intervention and Washout Period 2||3
65593|NCT01536951|156215|P9|STARTED|Second Intervention and Washout Period 2||9
65594|NCT01536951|156216|P8|STARTED|Second Intervention and Washout Period 2||9
65595|NCT01536951|156217|P7|STARTED|Second Intervention and Washout Period 2||9
65596|NCT01536951|156218|P6|STARTED|Second Intervention and Washout Period 2||9
65597|NCT01536951|156219|P5|STARTED|Second Intervention and Washout Period 2||9
65598|NCT01536951|156220|P4|STARTED|Second Intervention and Washout Period 2||8
65599|NCT01536951|156221|P3|STARTED|Second Intervention and Washout Period 2||2
65600|NCT01536951|156222|P2|STARTED|Second Intervention and Washout Period 2||3
65601|NCT01536951|156223|P1|STARTED|Second Intervention and Washout Period 2||3
65602|NCT01536951|156215|P9|NOT COMPLETED|First Intervention and Washout Period 1||0
65603|NCT01536951|156216|P8|NOT COMPLETED|First Intervention and Washout Period 1||0
65604|NCT01536951|156217|P7|NOT COMPLETED|First Intervention and Washout Period 1||0
65605|NCT01536951|156218|P6|NOT COMPLETED|First Intervention and Washout Period 1||0
65606|NCT01536951|156219|P5|NOT COMPLETED|First Intervention and Washout Period 1||0
65607|NCT01536951|156220|P4|NOT COMPLETED|First Intervention and Washout Period 1||0
65608|NCT01536951|156221|P3|NOT COMPLETED|First Intervention and Washout Period 1||1
65609|NCT01536951|156222|P2|NOT COMPLETED|First Intervention and Washout Period 1||0
65610|NCT01536951|156223|P1|NOT COMPLETED|First Intervention and Washout Period 1||0
65611|NCT01536951|156215|P9|COMPLETED|First Intervention and Washout Period 1||9
65612|NCT01536951|156216|P8|COMPLETED|First Intervention and Washout Period 1||9
65613|NCT01536951|156217|P7|COMPLETED|First Intervention and Washout Period 1||9
65614|NCT01536951|156218|P6|COMPLETED|First Intervention and Washout Period 1||9
65615|NCT01536951|156219|P5|COMPLETED|First Intervention and Washout Period 1||9
65616|NCT01536951|156220|P4|COMPLETED|First Intervention and Washout Period 1||8
65617|NCT01536951|156221|P3|COMPLETED|First Intervention and Washout Period 1||2
65618|NCT01536951|156222|P2|COMPLETED|First Intervention and Washout Period 1||3
65619|NCT01536951|156223|P1|COMPLETED|First Intervention and Washout Period 1||3
65620|NCT01536951|156215|P9|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
65621|NCT01536951|156216|P8|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
65622|NCT01536951|156217|P7|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
65623|NCT01536951|156218|P6|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
65624|NCT01536951|156219|P5|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||9
65625|NCT01536951|156220|P4|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||8
65626|NCT01536951|156221|P3|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
65627|NCT01536951|156222|P2|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1||3
65628|NCT01536951|156223|P1|Received at Least 1 Dose of Study Drug|First Intervention and Washout Period 1|Across all reporting groups, study drug is LY3009104, moxifloxacin, or placebo.|3
65629|NCT01536951|156215|P9|STARTED|First Intervention and Washout Period 1||9
65630|NCT01536951|156216|P8|STARTED|First Intervention and Washout Period 1||9
65631|NCT01536951|156217|P7|STARTED|First Intervention and Washout Period 1||9
65632|NCT01536951|156218|P6|STARTED|First Intervention and Washout Period 1||9
65633|NCT01536951|156219|P5|STARTED|First Intervention and Washout Period 1||9
65634|NCT01536951|156220|P4|STARTED|First Intervention and Washout Period 1||8
65635|NCT01536951|156221|P3|STARTED|First Intervention and Washout Period 1||3
65636|NCT01536951|156222|P2|STARTED|First Intervention and Washout Period 1||3
65637|NCT01536951|156223|P1|STARTED|First Intervention and Washout Period 1||3
65638|NCT01536938|156253|P3|NOT COMPLETED|Overall Study||8
65639|NCT01536938|156254|P2|NOT COMPLETED|Overall Study||7
65640|NCT01536938|156255|P1|NOT COMPLETED|Overall Study||6
65641|NCT01536938|156253|P3|COMPLETED|Overall Study||93
65642|NCT01536938|156254|P2|COMPLETED|Overall Study||94
65643|NCT01536938|156255|P1|COMPLETED|Overall Study||94
65644|NCT01536938|156253|P3|STARTED|Overall Study||101
65645|NCT01536938|156254|P2|STARTED|Overall Study||101
65646|NCT01536938|156255|P1|STARTED|Overall Study||100
65647|NCT01536886|156267|P4|NOT COMPLETED|Overall Study||3
65648|NCT01536886|156268|P3|NOT COMPLETED|Overall Study||2
65649|NCT01536886|156269|P2|NOT COMPLETED|Overall Study||8
65650|NCT01536886|156270|P1|NOT COMPLETED|Overall Study||5
65651|NCT01536886|156267|P4|COMPLETED|Overall Study||48
65652|NCT01536886|156268|P3|COMPLETED|Overall Study||47
65653|NCT01536886|156269|P2|COMPLETED|Overall Study||127
65654|NCT01536886|156270|P1|COMPLETED|Overall Study||136
65655|NCT01536886|156267|P4|STARTED|Overall Study||51
65656|NCT01536886|156268|P3|STARTED|Overall Study||49
65657|NCT01536886|156269|P2|STARTED|Overall Study||135
65658|NCT01536886|156270|P1|STARTED|Overall Study||141
65659|NCT01536860|156280|P3|NOT COMPLETED|Third Intervention (1 Day)||0
65660|NCT01536860|156281|P2|NOT COMPLETED|Third Intervention (1 Day)||0
65661|NCT01536860|156282|P1|NOT COMPLETED|Third Intervention (1 Day)||0
65662|NCT01536860|156280|P3|COMPLETED|Third Intervention (1 Day)||4
65663|NCT01536860|156281|P2|COMPLETED|Third Intervention (1 Day)||4
65664|NCT01536860|156282|P1|COMPLETED|Third Intervention (1 Day)||3
65665|NCT01536860|156280|P3|STARTED|Third Intervention (1 Day)||4
65666|NCT01536860|156281|P2|STARTED|Third Intervention (1 Day)||4
65667|NCT01536860|156282|P1|STARTED|Third Intervention (1 Day)||3
65668|NCT01536860|156280|P3|NOT COMPLETED|Washout Period (3 Days)||0
65669|NCT01536860|156281|P2|NOT COMPLETED|Washout Period (3 Days)||0
65670|NCT01536860|156282|P1|NOT COMPLETED|Washout Period (3 Days)||1
65671|NCT01536860|156280|P3|COMPLETED|Washout Period (3 Days)||4
65672|NCT01536860|156281|P2|COMPLETED|Washout Period (3 Days)||4
65673|NCT01536860|156282|P1|COMPLETED|Washout Period (3 Days)||3
65674|NCT01536860|156280|P3|STARTED|Washout Period (3 Days)||4
65675|NCT01536860|156281|P2|STARTED|Washout Period (3 Days)||4
65676|NCT01536860|156282|P1|STARTED|Washout Period (3 Days)||4
65677|NCT01536860|156280|P3|NOT COMPLETED|Second Intervention (1 Day)||0
65678|NCT01536860|156281|P2|NOT COMPLETED|Second Intervention (1 Day)||0
65679|NCT01536860|156282|P1|NOT COMPLETED|Second Intervention (1 Day)||0
65680|NCT01536860|156280|P3|COMPLETED|Second Intervention (1 Day)||4
65681|NCT01536860|156281|P2|COMPLETED|Second Intervention (1 Day)||4
65682|NCT01536860|156282|P1|COMPLETED|Second Intervention (1 Day)||4
65683|NCT01536860|156280|P3|STARTED|Second Intervention (1 Day)||4
65684|NCT01536860|156281|P2|STARTED|Second Intervention (1 Day)||4
65685|NCT01536860|156282|P1|STARTED|Second Intervention (1 Day)||4
65686|NCT01536860|156280|P3|NOT COMPLETED|Washout Period (3 Days)||0
65687|NCT01536860|156281|P2|NOT COMPLETED|Washout Period (3 Days)||0
65688|NCT01536860|156282|P1|NOT COMPLETED|Washout Period (3 Days)||0
65689|NCT01536860|156280|P3|COMPLETED|Washout Period (3 Days)||4
65690|NCT01536860|156281|P2|COMPLETED|Washout Period (3 Days)||4
65691|NCT01536860|156282|P1|COMPLETED|Washout Period (3 Days)||4
65692|NCT01536860|156280|P3|STARTED|Washout Period (3 Days)||4
65693|NCT01536860|156281|P2|STARTED|Washout Period (3 Days)||4
65694|NCT01536860|156282|P1|STARTED|Washout Period (3 Days)||4
65695|NCT01536860|156280|P3|NOT COMPLETED|First Intervention (1 Day)||0
65696|NCT01536860|156281|P2|NOT COMPLETED|First Intervention (1 Day)||0
65697|NCT01536860|156282|P1|NOT COMPLETED|First Intervention (1 Day)||0
65698|NCT01536860|156280|P3|COMPLETED|First Intervention (1 Day)||4
65699|NCT01536860|156281|P2|COMPLETED|First Intervention (1 Day)||4
65700|NCT01536860|156282|P1|COMPLETED|First Intervention (1 Day)||4
65701|NCT01536860|156280|P3|STARTED|First Intervention (1 Day)||4
65702|NCT01536860|156281|P2|STARTED|First Intervention (1 Day)||4
65703|NCT01536860|156282|P1|STARTED|First Intervention (1 Day)||4
65704|NCT01536704|156290|P4|NOT COMPLETED|Period 4||0
65705|NCT01536704|156291|P3|NOT COMPLETED|Period 4||0
65706|NCT01536704|156292|P2|NOT COMPLETED|Period 4||0
65707|NCT01536704|156293|P1|NOT COMPLETED|Period 4||0
65708|NCT01536704|156290|P4|COMPLETED|Period 4||10
65709|NCT01536704|156291|P3|COMPLETED|Period 4||10
65710|NCT01536704|156292|P2|COMPLETED|Period 4||11
65711|NCT01536704|156293|P1|COMPLETED|Period 4||12
65712|NCT01536704|156290|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
65713|NCT01536704|156291|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
65714|NCT01536704|156292|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
65715|NCT01536704|156293|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3|12
65716|NCT01536704|156290|P4|NOT COMPLETED|Washout Period 3||0
65717|NCT01536704|156291|P3|NOT COMPLETED|Washout Period 3||1
65718|NCT01536704|156292|P2|NOT COMPLETED|Washout Period 3||0
65719|NCT01536704|156293|P1|NOT COMPLETED|Washout Period 3||0
65720|NCT01536704|156290|P4|COMPLETED|Washout Period 3||10
65721|NCT01536704|156291|P3|COMPLETED|Washout Period 3||11
65722|NCT01536704|156292|P2|COMPLETED|Washout Period 3||12
65723|NCT01536704|156293|P1|COMPLETED|Washout Period 3||10
65724|NCT01536704|156290|P4|STARTED|Washout Period 3||10
65725|NCT01536704|156291|P3|STARTED|Washout Period 3||12
65726|NCT01536704|156292|P2|STARTED|Washout Period 3||12
65727|NCT01536704|156293|P1|STARTED|Washout Period 3||10
65728|NCT01536704|156290|P4|NOT COMPLETED|Period 3||1
65729|NCT01536704|156291|P3|NOT COMPLETED|Period 3||0
65730|NCT01536704|156292|P2|NOT COMPLETED|Period 3||0
65731|NCT01536704|156293|P1|NOT COMPLETED|Period 3||0
65732|NCT01536704|156290|P4|COMPLETED|Period 3||10
65733|NCT01536704|156291|P3|COMPLETED|Period 3||12
65734|NCT01536704|156292|P2|COMPLETED|Period 3||12
65735|NCT01536704|156293|P1|COMPLETED|Period 3||10
65736|NCT01536704|156290|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|11
65737|NCT01536704|156291|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
65738|NCT01536704|156292|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
65739|NCT01536704|156293|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2|10
65740|NCT01536704|156290|P4|NOT COMPLETED|Washout Period 2||1
65741|NCT01536704|156291|P3|NOT COMPLETED|Washout Period 2||0
65742|NCT01536704|156292|P2|NOT COMPLETED|Washout Period 2||0
65743|NCT01536704|156293|P1|NOT COMPLETED|Washout Period 2||1
65744|NCT01536704|156290|P4|COMPLETED|Washout Period 2||12
65745|NCT01536704|156291|P3|COMPLETED|Washout Period 2||10
65746|NCT01536704|156292|P2|COMPLETED|Washout Period 2||11
65747|NCT01536704|156293|P1|COMPLETED|Washout Period 2||12
65748|NCT01536704|156290|P4|STARTED|Washout Period 2||13
65749|NCT01536704|156291|P3|STARTED|Washout Period 2||10
65750|NCT01536704|156292|P2|STARTED|Washout Period 2||11
65751|NCT01536704|156293|P1|STARTED|Washout Period 2||13
65752|NCT01536704|156290|P4|NOT COMPLETED|Period 2||0
65753|NCT01536704|156291|P3|NOT COMPLETED|Period 2||0
65754|NCT01536704|156292|P2|NOT COMPLETED|Period 2||0
65755|NCT01536704|156293|P1|NOT COMPLETED|Period 2||0
65756|NCT01536704|156290|P4|COMPLETED|Period 2||13
65757|NCT01536704|156291|P3|COMPLETED|Period 2||10
65758|NCT01536704|156292|P2|COMPLETED|Period 2||11
65759|NCT01536704|156293|P1|COMPLETED|Period 2||13
65760|NCT01536704|156290|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
65761|NCT01536704|156291|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|10
65762|NCT01536704|156292|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
65763|NCT01536704|156293|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
65764|NCT01536704|156290|P4|NOT COMPLETED|Washout Period 1||0
65765|NCT01536704|156291|P3|NOT COMPLETED|Washout Period 1||0
65766|NCT01536704|156292|P2|NOT COMPLETED|Washout Period 1||2
65767|NCT01536704|156293|P1|NOT COMPLETED|Washout Period 1||1
65768|NCT01536704|156290|P4|COMPLETED|Washout Period 1||13
65769|NCT01536704|156291|P3|COMPLETED|Washout Period 1||13
65770|NCT01536704|156292|P2|COMPLETED|Washout Period 1||10
65771|NCT01536704|156293|P1|COMPLETED|Washout Period 1||11
65772|NCT01536704|156290|P4|STARTED|Washout Period 1||13
65773|NCT01536704|156291|P3|STARTED|Washout Period 1||13
65774|NCT01536704|156292|P2|STARTED|Washout Period 1||12
65775|NCT01536704|156293|P1|STARTED|Washout Period 1||12
65776|NCT01536704|156290|P4|NOT COMPLETED|Period 1||0
65777|NCT01536704|156291|P3|NOT COMPLETED|Period 1||0
65778|NCT01536704|156292|P2|NOT COMPLETED|Period 1||0
65779|NCT01536704|156293|P1|NOT COMPLETED|Period 1||0
65780|NCT01536704|156290|P4|COMPLETED|Period 1||13
65781|NCT01536704|156291|P3|COMPLETED|Period 1||13
65782|NCT01536704|156292|P2|COMPLETED|Period 1||12
65783|NCT01536704|156293|P1|COMPLETED|Period 1||12
65784|NCT01536704|156290|P4|STARTED|Period 1||13
65785|NCT01536704|156291|P3|STARTED|Period 1||13
65786|NCT01536704|156292|P2|STARTED|Period 1||12
65787|NCT01536704|156293|P1|STARTED|Period 1||12
65788|NCT01536587|156323|P1|NOT COMPLETED|Overall Study||2
65789|NCT01536587|156323|P1|COMPLETED|Overall Study||30
65790|NCT01536587|156323|P1|STARTED|Overall Study||32
65791|NCT01536574|156362|P2|NOT COMPLETED|Overall Study||7
65792|NCT01536574|156363|P1|NOT COMPLETED|Overall Study||6
65793|NCT01536574|156362|P2|COMPLETED|Overall Study||126
65794|NCT01536574|156363|P1|COMPLETED|Overall Study||156
65795|NCT01536574|156362|P2|STARTED|Overall Study||133
65796|NCT01536574|156363|P1|STARTED|Overall Study||162
65797|NCT01536561|156381|P1|NOT COMPLETED|Long-Term Follow-Up||0
65798|NCT01536561|156381|P1|COMPLETED|Long-Term Follow-Up||13
65799|NCT01536561|156381|P1|STARTED|Long-Term Follow-Up||13
65800|NCT01536561|156381|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||59
65801|NCT01536561|156381|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
65802|NCT01536561|156381|P1|STARTED|Dosimetric and Therapeutic Treatment||59
65803|NCT01536496|156421|P2|NOT COMPLETED|Overall Study||1
65804|NCT01536496|156422|P1|NOT COMPLETED|Overall Study||2
65805|NCT01536496|156421|P2|COMPLETED|Overall Study||56
65806|NCT01536496|156422|P1|COMPLETED|Overall Study||55
65807|NCT01536496|156421|P2|STARTED|Overall Study||57
65808|NCT01536496|156422|P1|STARTED|Overall Study||57
65809|NCT01536418|156458|P2|NOT COMPLETED|Overall Study||66
65810|NCT01536418|156459|P1|NOT COMPLETED|Overall Study||69
65811|NCT01536418|156458|P2|COMPLETED|Overall Study||60
65812|NCT01536418|156459|P1|COMPLETED|Overall Study||58
65813|NCT01536418|156458|P2|STARTED|Overall Study||126
65814|NCT01536418|156459|P1|STARTED|Overall Study||127
65815|NCT01536405|156479|P2|NOT COMPLETED|Visit 4 to Extended Study Follow-up||23
65816|NCT01536405|156480|P1|NOT COMPLETED|Visit 4 to Extended Study Follow-up||20
65817|NCT01536405|156479|P2|COMPLETED|Visit 4 to Extended Study Follow-up||595
65818|NCT01536405|156480|P1|COMPLETED|Visit 4 to Extended Study Follow-up||595
65819|NCT01536405|156479|P2|STARTED|Visit 4 to Extended Study Follow-up||618
65820|NCT01536405|156480|P1|STARTED|Visit 4 to Extended Study Follow-up||615
65821|NCT01536405|156479|P2|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||16
65822|NCT01536405|156480|P1|NOT COMPLETED|Visit 3 (Vaccination 2) to Visit 4||20
65823|NCT01536405|156479|P2|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||618
65824|NCT01536405|156480|P1|COMPLETED|Visit 3 (Vaccination 2) to Visit 4||615
65825|NCT01536405|156479|P2|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||632
65826|NCT01536405|156480|P1|Received Vaccination 2|Visit 3 (Vaccination 2) to Visit 4||634
65827|NCT01536405|156479|P2|STARTED|Visit 3 (Vaccination 2) to Visit 4||634
65828|NCT01536405|156480|P1|STARTED|Visit 3 (Vaccination 2) to Visit 4||635
65829|NCT01536405|156479|P2|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||28
65830|NCT01536405|156480|P1|NOT COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||31
65831|NCT01536405|156479|P2|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||634
65832|NCT01536405|156480|P1|COMPLETED|Visit 2 to Visit 3 (Vaccination 2)||635
65833|NCT01536405|156479|P2|STARTED|Visit 2 to Visit 3 (Vaccination 2)||662
65834|NCT01536405|156480|P1|STARTED|Visit 2 to Visit 3 (Vaccination 2)||666
65835|NCT01536405|156479|P2|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||40
65836|NCT01536405|156480|P1|NOT COMPLETED|Visit 1 (Vaccination 1) to Visit 2||32
65837|NCT01536405|156479|P2|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||662
65838|NCT01536405|156480|P1|COMPLETED|Visit 1 (Vaccination 1) to Visit 2||666
65839|NCT01536405|156479|P2|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||702
65840|NCT01536405|156480|P1|Received Vaccination 1|Visit 1 (Vaccination 1) to Visit 2||698
65841|NCT01536405|156479|P2|STARTED|Visit 1 (Vaccination 1) to Visit 2||702
65842|NCT01536405|156480|P1|STARTED|Visit 1 (Vaccination 1) to Visit 2||698
65843|NCT01536405|156479|P2|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||4
65844|NCT01536405|156480|P1|NOT COMPLETED|Randomization to Visit 1 (Vaccination 1)||8
65845|NCT01536405|156479|P2|COMPLETED|Randomization to Visit 1 (Vaccination 1)||702
65846|NCT01536405|156480|P1|COMPLETED|Randomization to Visit 1 (Vaccination 1)||698
65847|NCT01536405|156479|P2|STARTED|Randomization to Visit 1 (Vaccination 1)||706
65848|NCT01536405|156480|P1|STARTED|Randomization to Visit 1 (Vaccination 1)||706
65849|NCT01536379|156518|P2|NOT COMPLETED|Overall Study||3
65850|NCT01536379|156519|P1|NOT COMPLETED|Overall Study||2
65851|NCT01536379|156518|P2|COMPLETED|Overall Study||9
65852|NCT01536379|156519|P1|COMPLETED|Overall Study||11
65853|NCT01536379|156518|P2|STARTED|Overall Study||12
65854|NCT01536379|156519|P1|STARTED|Overall Study||13
65855|NCT01536366|156595|P2|NOT COMPLETED|Overall Study||4
65856|NCT01536366|156596|P1|NOT COMPLETED|Overall Study||13
65857|NCT01536366|156595|P2|COMPLETED|Overall Study||9
65858|NCT01536366|156596|P1|COMPLETED|Overall Study||1
65859|NCT01536366|156595|P2|Follow-up|Overall Study||9
65860|NCT01536366|156596|P1|Follow-up|Overall Study||13
65861|NCT01536366|156595|P2|Repaglinide|Overall Study||13
65862|NCT01536366|156596|P1|Repaglinide|Overall Study||14
65863|NCT01536366|156595|P2|BIA 9-1067 + Repaglinide|Overall Study||10
65864|NCT01536366|156596|P1|BIA 9-1067 + Repaglinide|Overall Study||14
65865|NCT01536366|156595|P2|STARTED|Overall Study||13
65866|NCT01536366|156596|P1|STARTED|Overall Study||14
65867|NCT01536262|156611|P3|NOT COMPLETED|Overall Study||2
65868|NCT01536262|156612|P2|NOT COMPLETED|Overall Study||2
65869|NCT01536262|156613|P1|NOT COMPLETED|Overall Study||8
65870|NCT01536262|156611|P3|COMPLETED|Overall Study||39
65871|NCT01536262|156612|P2|COMPLETED|Overall Study||38
65872|NCT01536262|156613|P1|COMPLETED|Overall Study||33
65873|NCT01536262|156611|P3|STARTED|Overall Study||41
65874|NCT01536262|156612|P2|STARTED|Overall Study||40
65875|NCT01536262|156613|P1|STARTED|Overall Study||41
65876|NCT01536197|156629|P2|NOT COMPLETED|Overall Study||0
65877|NCT01536197|156630|P1|NOT COMPLETED|Overall Study||0
65878|NCT01536197|156629|P2|COMPLETED|Overall Study||10
65879|NCT01536197|156630|P1|COMPLETED|Overall Study||17
65880|NCT01536197|156629|P2|STARTED|Overall Study||10
65881|NCT01536197|156630|P1|STARTED|Overall Study||17
65882|NCT01536184|156640|P2|NOT COMPLETED|Overall Study||0
65883|NCT01536184|156641|P1|NOT COMPLETED|Overall Study||0
65884|NCT01536184|156640|P2|COMPLETED|Overall Study||4
65885|NCT01536184|156641|P1|COMPLETED|Overall Study||8
65886|NCT01536184|156640|P2|STARTED|Overall Study||4
65887|NCT01536184|156641|P1|STARTED|Overall Study||8
65888|NCT01536171|156655|P1|NOT COMPLETED|Overall Study||1
65889|NCT01536171|156655|P1|COMPLETED|Overall Study||21
65890|NCT01536171|156655|P1|STARTED|Overall Study||22
65891|NCT01536145|156660|P11|NOT COMPLETED|Overall Study||10
65892|NCT01536145|156661|P10|NOT COMPLETED|Overall Study||6
65893|NCT01536145|156662|P9|NOT COMPLETED|Overall Study||3
65894|NCT01536145|156663|P8|NOT COMPLETED|Overall Study||4
65895|NCT01536145|156664|P7|NOT COMPLETED|Overall Study||2
65896|NCT01536145|156665|P6|NOT COMPLETED|Overall Study||3
65897|NCT01536145|156666|P5|NOT COMPLETED|Overall Study||2
65898|NCT01536145|156667|P4|NOT COMPLETED|Overall Study||2
65899|NCT01536145|156668|P3|NOT COMPLETED|Overall Study||2
65900|NCT01536145|156669|P2|NOT COMPLETED|Overall Study||4
65901|NCT01536145|156670|P1|NOT COMPLETED|Overall Study||3
65902|NCT01536145|156660|P11|COMPLETED|Overall Study||0
65903|NCT01536145|156661|P10|COMPLETED|Overall Study||1
65904|NCT01536145|156662|P9|COMPLETED|Overall Study||0
65905|NCT01536145|156663|P8|COMPLETED|Overall Study||0
65906|NCT01536145|156664|P7|COMPLETED|Overall Study||1
65907|NCT01536145|156665|P6|COMPLETED|Overall Study||0
65908|NCT01536145|156666|P5|COMPLETED|Overall Study||2
65909|NCT01536145|156667|P4|COMPLETED|Overall Study||1
65910|NCT01536145|156668|P3|COMPLETED|Overall Study||1
65911|NCT01536145|156669|P2|COMPLETED|Overall Study||0
65912|NCT01536145|156670|P1|COMPLETED|Overall Study||0
65913|NCT01536145|156660|P11|STARTED|Overall Study||10
65914|NCT01536145|156661|P10|STARTED|Overall Study||7
65915|NCT01536145|156662|P9|STARTED|Overall Study||3
65916|NCT01536145|156663|P8|STARTED|Overall Study||4
65917|NCT01536145|156664|P7|STARTED|Overall Study||3
65918|NCT01536145|156665|P6|STARTED|Overall Study||3
65919|NCT01536145|156666|P5|STARTED|Overall Study||4
65920|NCT01536145|156667|P4|STARTED|Overall Study||3
65921|NCT01536145|156668|P3|STARTED|Overall Study||3
65922|NCT01536145|156669|P2|STARTED|Overall Study||4
65923|NCT01536145|156670|P1|STARTED|Overall Study||3
65924|NCT01536119|156777|P2|NOT COMPLETED|Overall Study||14
65925|NCT01536119|156778|P1|NOT COMPLETED|Overall Study||17
65926|NCT01536119|156777|P2|COMPLETED|Overall Study|105 mothers + 95 fathers = 200 participants 2 mothers + 12 fathers = 14 did not complete the study|200
65927|NCT01536119|156778|P1|COMPLETED|Overall Study|104 Mothers + 93 fathers = 197 participants 3 mothers + 14 fathers = 17 did not complete the study|197
65928|NCT01536119|156777|P2|STARTED|Overall Study|(107*2=214) (107 mothers and 107 fathers)|214
65929|NCT01536119|156778|P1|STARTED|Overall Study|(107*2= 214) (107 mothers and 107 fathers)|214
65930|NCT01536093|156804|P2|NOT COMPLETED|Overall Study||3
65931|NCT01536093|156805|P1|NOT COMPLETED|Overall Study||3
65932|NCT01536093|156804|P2|COMPLETED|Overall Study||21
65933|NCT01536093|156805|P1|COMPLETED|Overall Study||21
65934|NCT01536093|156804|P2|STARTED|Overall Study||24
65935|NCT01536093|156805|P1|STARTED|Overall Study||24
65936|NCT01536067|156821|P1|NOT COMPLETED|Overall Study||1
65937|NCT01536067|156821|P1|COMPLETED|Overall Study||2
65938|NCT01536067|156821|P1|STARTED|Overall Study||3
65939|NCT01536015|156834|P2|NOT COMPLETED|Overall Study||10
65940|NCT01536015|156835|P1|NOT COMPLETED|Overall Study||8
65941|NCT01536015|156834|P2|COMPLETED|Overall Study||3
65942|NCT01536015|156835|P1|COMPLETED|Overall Study||4
65943|NCT01536015|156834|P2|STARTED|Overall Study||13
65944|NCT01536015|156835|P1|STARTED|Overall Study||12
65945|NCT01535976|156853|P2|NOT COMPLETED|Overall Study||1
65946|NCT01535976|156854|P1|NOT COMPLETED|Overall Study||1
65947|NCT01535976|156853|P2|COMPLETED|Overall Study||26
65948|NCT01535976|156854|P1|COMPLETED|Overall Study||26
65949|NCT01535976|156853|P2|STARTED|Overall Study||27
65950|NCT01535976|156854|P1|STARTED|Overall Study||27
65951|NCT01535807|156862|P2|NOT COMPLETED|Overall Study||2
65952|NCT01535807|156863|P1|NOT COMPLETED|Overall Study||2
65953|NCT01535807|156862|P2|COMPLETED|Overall Study||20
65954|NCT01535807|156863|P1|COMPLETED|Overall Study||20
65955|NCT01535807|156862|P2|STARTED|Overall Study||22
65956|NCT01535807|156863|P1|STARTED|Overall Study||22
65957|NCT01535729|156869|P1|NOT COMPLETED|Overall Study||416
65958|NCT01535729|156869|P1|COMPLETED|Overall Study||49
65959|NCT01535729|156869|P1|Treated|Overall Study||385
65960|NCT01535729|156869|P1|STARTED|Overall Study||465
65961|NCT01535664|156896|P1|NOT COMPLETED|Overall Study||0
65962|NCT01535664|156896|P1|COMPLETED|Overall Study||20
65963|NCT01535664|156896|P1|STARTED|Overall Study||20
65964|NCT01535638|156910|P6|NOT COMPLETED|Treatment 3 (Single Dose)||0
65965|NCT01535638|156911|P5|NOT COMPLETED|Treatment 3 (Single Dose)||0
65966|NCT01535638|156912|P4|NOT COMPLETED|Treatment 3 (Single Dose)||1
65967|NCT01535638|156913|P3|NOT COMPLETED|Treatment 3 (Single Dose)||0
65968|NCT01535638|156914|P2|NOT COMPLETED|Treatment 3 (Single Dose)||0
65969|NCT01535638|156915|P1|NOT COMPLETED|Treatment 3 (Single Dose)||0
65970|NCT01535638|156910|P6|COMPLETED|Treatment 3 (Single Dose)||2
65971|NCT01535638|156911|P5|COMPLETED|Treatment 3 (Single Dose)||3
65972|NCT01535638|156912|P4|COMPLETED|Treatment 3 (Single Dose)||2
65973|NCT01535638|156913|P3|COMPLETED|Treatment 3 (Single Dose)||3
65974|NCT01535638|156914|P2|COMPLETED|Treatment 3 (Single Dose)||3
65975|NCT01535638|156915|P1|COMPLETED|Treatment 3 (Single Dose)||3
65976|NCT01535638|156910|P6|STARTED|Treatment 3 (Single Dose)||2
65977|NCT01535638|156911|P5|STARTED|Treatment 3 (Single Dose)||3
65978|NCT01535638|156912|P4|STARTED|Treatment 3 (Single Dose)||3
65979|NCT01535638|156913|P3|STARTED|Treatment 3 (Single Dose)||3
65980|NCT01535638|156914|P2|STARTED|Treatment 3 (Single Dose)||3
65981|NCT01535638|156915|P1|STARTED|Treatment 3 (Single Dose)||3
65982|NCT01535638|156910|P6|NOT COMPLETED|Treatment 2 (Single Dose)||0
65983|NCT01535638|156911|P5|NOT COMPLETED|Treatment 2 (Single Dose)||0
65984|NCT01535638|156912|P4|NOT COMPLETED|Treatment 2 (Single Dose)||0
65985|NCT01535638|156913|P3|NOT COMPLETED|Treatment 2 (Single Dose)||0
65986|NCT01535638|156914|P2|NOT COMPLETED|Treatment 2 (Single Dose)||0
65987|NCT01535638|156915|P1|NOT COMPLETED|Treatment 2 (Single Dose)||0
65988|NCT01535638|156910|P6|COMPLETED|Treatment 2 (Single Dose)||2
65989|NCT01535638|156911|P5|COMPLETED|Treatment 2 (Single Dose)||3
65990|NCT01535638|156912|P4|COMPLETED|Treatment 2 (Single Dose)||3
65991|NCT01535638|156913|P3|COMPLETED|Treatment 2 (Single Dose)||3
65992|NCT01535638|156914|P2|COMPLETED|Treatment 2 (Single Dose)||3
65993|NCT01535638|156915|P1|COMPLETED|Treatment 2 (Single Dose)||3
65994|NCT01535638|156910|P6|STARTED|Treatment 2 (Single Dose)||2
65995|NCT01535638|156911|P5|STARTED|Treatment 2 (Single Dose)||3
65996|NCT01535638|156912|P4|STARTED|Treatment 2 (Single Dose)||3
65997|NCT01535638|156913|P3|STARTED|Treatment 2 (Single Dose)||3
65998|NCT01535638|156914|P2|STARTED|Treatment 2 (Single Dose)||3
65999|NCT01535638|156915|P1|STARTED|Treatment 2 (Single Dose)||3
66000|NCT01535638|156910|P6|NOT COMPLETED|Treatment 1 (Single Dose)||1
66001|NCT01535638|156911|P5|NOT COMPLETED|Treatment 1 (Single Dose)||0
66002|NCT01535638|156912|P4|NOT COMPLETED|Treatment 1 (Single Dose)||0
66003|NCT01535638|156913|P3|NOT COMPLETED|Treatment 1 (Single Dose)||0
66004|NCT01535638|156914|P2|NOT COMPLETED|Treatment 1 (Single Dose)||0
66005|NCT01535638|156915|P1|NOT COMPLETED|Treatment 1 (Single Dose)||0
66006|NCT01535638|156910|P6|COMPLETED|Treatment 1 (Single Dose)||2
66007|NCT01535638|156911|P5|COMPLETED|Treatment 1 (Single Dose)||3
66008|NCT01535638|156912|P4|COMPLETED|Treatment 1 (Single Dose)||3
66009|NCT01535638|156913|P3|COMPLETED|Treatment 1 (Single Dose)||3
66010|NCT01535638|156914|P2|COMPLETED|Treatment 1 (Single Dose)||3
66011|NCT01535638|156915|P1|COMPLETED|Treatment 1 (Single Dose)||3
66012|NCT01535638|156910|P6|STARTED|Treatment 1 (Single Dose)||3
66013|NCT01535638|156911|P5|STARTED|Treatment 1 (Single Dose)||3
66014|NCT01535638|156912|P4|STARTED|Treatment 1 (Single Dose)||3
66015|NCT01535638|156913|P3|STARTED|Treatment 1 (Single Dose)||3
66016|NCT01535638|156914|P2|STARTED|Treatment 1 (Single Dose)||3
66017|NCT01535638|156915|P1|STARTED|Treatment 1 (Single Dose)||3
66018|NCT01535599|156929|P2|NOT COMPLETED|Overall Study||96
66019|NCT01535599|156930|P1|NOT COMPLETED|Overall Study||50
66020|NCT01535599|156929|P2|COMPLETED|Overall Study||250
66021|NCT01535599|156930|P1|COMPLETED|Overall Study||297
66022|NCT01535599|156929|P2|STARTED|Overall Study||346
66023|NCT01535599|156930|P1|STARTED|Overall Study||347
66024|NCT01535560|156942|P2|NOT COMPLETED|Overall Study||96
66025|NCT01535560|156943|P1|NOT COMPLETED|Overall Study||37
66026|NCT01535560|156942|P2|COMPLETED|Overall Study||179
66027|NCT01535560|156943|P1|COMPLETED|Overall Study||237
66028|NCT01535560|156942|P2|STARTED|Overall Study||275
66029|NCT01535560|156943|P1|STARTED|Overall Study||274
66030|NCT01535365|156955|P2|NOT COMPLETED|Overall Study||0
66031|NCT01535365|156956|P1|NOT COMPLETED|Overall Study||0
66032|NCT01535365|156955|P2|COMPLETED|Overall Study||29
66033|NCT01535365|156956|P1|COMPLETED|Overall Study||31
66034|NCT01535365|156955|P2|STARTED|Overall Study||29
66035|NCT01535365|156956|P1|STARTED|Overall Study||31
66036|NCT01535326|156967|P3|NOT COMPLETED|Overall Study||0
66037|NCT01535326|156968|P2|NOT COMPLETED|Overall Study||0
66038|NCT01535326|156969|P1|NOT COMPLETED|Overall Study||0
66039|NCT01535326|156967|P3|COMPLETED|Overall Study||90
66040|NCT01535326|156968|P2|COMPLETED|Overall Study||90
66041|NCT01535326|156969|P1|COMPLETED|Overall Study||90
66042|NCT01535326|156967|P3|STARTED|Overall Study||90
66043|NCT01535326|156968|P2|STARTED|Overall Study||90
66044|NCT01535326|156969|P1|STARTED|Overall Study||90
66045|NCT01535261|156986|P1|NOT COMPLETED|Overall Study||50
66046|NCT01535261|156986|P1|COMPLETED|Overall Study||307
66047|NCT01535261|156986|P1|STARTED|Overall Study||357
66048|NCT01535235|156999|P2|NOT COMPLETED|Overall Study||0
66049|NCT01535235|157000|P1|NOT COMPLETED|Overall Study||1
66050|NCT01535235|156999|P2|COMPLETED|Overall Study||15
66051|NCT01535235|157000|P1|COMPLETED|Overall Study||15
66052|NCT01535235|156999|P2|STARTED|Overall Study||15
66053|NCT01535235|157000|P1|STARTED|Overall Study||16
66054|NCT01535222|157014|P6|NOT COMPLETED|Overall Study||0
66055|NCT01535222|157015|P5|NOT COMPLETED|Overall Study||0
66056|NCT01535222|157016|P4|NOT COMPLETED|Overall Study||0
66057|NCT01535222|157017|P3|NOT COMPLETED|Overall Study||1
66058|NCT01535222|157018|P2|NOT COMPLETED|Overall Study||0
66059|NCT01535222|157019|P1|NOT COMPLETED|Overall Study||0
66060|NCT01535222|157014|P6|COMPLETED|Overall Study||8
66061|NCT01535222|157015|P5|COMPLETED|Overall Study||6
66062|NCT01535222|157016|P4|COMPLETED|Overall Study||6
66063|NCT01535222|157017|P3|COMPLETED|Overall Study||6
66064|NCT01535222|157018|P2|COMPLETED|Overall Study||3
66065|NCT01535222|157019|P1|COMPLETED|Overall Study||3
66066|NCT01535222|157014|P6|STARTED|Overall Study||8
66067|NCT01535222|157015|P5|STARTED|Overall Study||6
66068|NCT01535222|157016|P4|STARTED|Overall Study||6
66069|NCT01535222|157017|P3|STARTED|Overall Study|Patient randomized but did not meet inclusion/exclusion criteria and did not receive study drug|7
66070|NCT01535222|157018|P2|STARTED|Overall Study||3
66071|NCT01535222|157019|P1|STARTED|Overall Study||3
66072|NCT01535118|157039|P1|NOT COMPLETED|Overall Study||0
66073|NCT01535118|157039|P1|COMPLETED|Overall Study||2765
66074|NCT01535118|157039|P1|STARTED|Overall Study||2765
66075|NCT01535040|157050|P2|NOT COMPLETED|Overall Study||21
66076|NCT01535040|157051|P1|NOT COMPLETED|Overall Study||30
66077|NCT01535040|157050|P2|COMPLETED|Overall Study||44
66078|NCT01535040|157051|P1|COMPLETED|Overall Study||35
66079|NCT01535040|157050|P2|STARTED|Overall Study||65
66080|NCT01535040|157051|P1|STARTED|Overall Study||65
66081|NCT01535001|157065|P2|NOT COMPLETED|Overall Study||6
66082|NCT01535001|157066|P1|NOT COMPLETED|Overall Study||3
66083|NCT01535001|157065|P2|COMPLETED|Overall Study||44
66084|NCT01535001|157066|P1|COMPLETED|Overall Study||47
66085|NCT01535001|157065|P2|STARTED|Overall Study||50
66086|NCT01535001|157066|P1|STARTED|Overall Study||50
66087|NCT01534962|157092|P4|NOT COMPLETED|Overall Study||32
66088|NCT01534962|157093|P3|NOT COMPLETED|Overall Study||24
66089|NCT01534962|157094|P2|NOT COMPLETED|Overall Study||26
66090|NCT01534962|157095|P1|NOT COMPLETED|Overall Study||37
66091|NCT01534962|157092|P4|COMPLETED|Overall Study||24
66092|NCT01534962|157093|P3|COMPLETED|Overall Study||34
66093|NCT01534962|157094|P2|COMPLETED|Overall Study||34
66094|NCT01534962|157095|P1|COMPLETED|Overall Study||30
66095|NCT01534962|157092|P4|STARTED|Overall Study||56
66096|NCT01534962|157093|P3|STARTED|Overall Study||58
66097|NCT01534962|157094|P2|STARTED|Overall Study||60
66098|NCT01534962|157095|P1|STARTED|Overall Study||67
66099|NCT01534910|157127|P2|NOT COMPLETED|Overall Study||4
66100|NCT01534910|157128|P1|NOT COMPLETED|Overall Study||4
66101|NCT01534910|157127|P2|COMPLETED|Overall Study||28
66102|NCT01534910|157128|P1|COMPLETED|Overall Study||29
66103|NCT01534910|157127|P2|STARTED|Overall Study||32
66104|NCT01534910|157128|P1|STARTED|Overall Study||33
66105|NCT01534897|157136|P1|NOT COMPLETED|Overall Study||0
66106|NCT01534897|157136|P1|COMPLETED|Overall Study||10
66107|NCT01534897|157136|P1|Day 37 Iodine-131 Treatment|Overall Study||6
66108|NCT01534897|157136|P1|Day 25 Iodine-131 Scan|Overall Study||10
66109|NCT01534897|157136|P1|STARTED|Overall Study||10
66110|NCT01534689|157144|P1|NOT COMPLETED|Overall Study||0
66111|NCT01534689|157144|P1|COMPLETED|Overall Study||105
66112|NCT01534689|157144|P1|STARTED|Overall Study||105
66113|NCT01534676|157152|P2|NOT COMPLETED|Overall Study||1
66114|NCT01534676|157153|P1|NOT COMPLETED|Overall Study||2
66115|NCT01534676|157152|P2|COMPLETED|Overall Study||0
66116|NCT01534676|157153|P1|COMPLETED|Overall Study||0
66117|NCT01534676|157152|P2|STARTED|Overall Study||1
66118|NCT01534676|157153|P1|STARTED|Overall Study||2
66119|NCT01534637|157159|P1|NOT COMPLETED|Overall Study||9
66120|NCT01534637|157159|P1|COMPLETED|Overall Study||13
66121|NCT01534637|157159|P1|STARTED|Overall Study||22
66122|NCT01534533|157169|P4|NOT COMPLETED|Overall Study||4
66123|NCT01534533|157170|P3|NOT COMPLETED|Overall Study||8
66124|NCT01534533|157171|P2|NOT COMPLETED|Overall Study||3
66125|NCT01534533|157172|P1|NOT COMPLETED|Overall Study||8
66126|NCT01534533|157169|P4|COMPLETED|Overall Study||44
66127|NCT01534533|157170|P3|COMPLETED|Overall Study||40
66128|NCT01534533|157171|P2|COMPLETED|Overall Study||45
66129|NCT01534533|157172|P1|COMPLETED|Overall Study||40
66130|NCT01534533|157169|P4|STARTED|Overall Study||48
66131|NCT01534533|157170|P3|STARTED|Overall Study||48
66132|NCT01534533|157171|P2|STARTED|Overall Study||48
66133|NCT01534533|157172|P1|STARTED|Overall Study||48
66134|NCT01534520|157200|P2|NOT COMPLETED|Overall Study||1
66135|NCT01534520|157201|P1|NOT COMPLETED|Overall Study||0
66136|NCT01534520|157200|P2|COMPLETED|Overall Study|1 subject withdrew consent at time of uterine sound attempt due to intolerable pain|28
66137|NCT01534520|157201|P1|COMPLETED|Overall Study||30
66138|NCT01534520|157200|P2|STARTED|Overall Study||29
66139|NCT01534520|157201|P1|STARTED|Overall Study||30
66140|NCT01534351|157216|P3|NOT COMPLETED|Overall Study||0
66141|NCT01534351|157217|P2|NOT COMPLETED|Overall Study||0
66142|NCT01534351|157218|P1|NOT COMPLETED|Overall Study||1
66143|NCT01534351|157216|P3|COMPLETED|Overall Study||0
66144|NCT01534351|157217|P2|COMPLETED|Overall Study||0
66145|NCT01534351|157218|P1|COMPLETED|Overall Study||0
66146|NCT01534351|157216|P3|STARTED|Overall Study||0
66147|NCT01534351|157217|P2|STARTED|Overall Study||0
66148|NCT01534351|157218|P1|STARTED|Overall Study||1
66149|NCT01534208|157237|P2|NOT COMPLETED|Overall Study||49
66150|NCT01534208|157238|P1|NOT COMPLETED|Overall Study||57
66151|NCT01534208|157237|P2|COMPLETED|Overall Study||234
66152|NCT01534208|157238|P1|COMPLETED|Overall Study||159
66153|NCT01534208|157237|P2|STARTED|Overall Study||283
66154|NCT01534208|157238|P1|STARTED|Overall Study||216
66155|NCT01534182|157256|P2|NOT COMPLETED|Overall Study||10
66156|NCT01534182|157257|P1|NOT COMPLETED|Overall Study||12
66157|NCT01534182|157256|P2|COMPLETED|Overall Study||58
66158|NCT01534182|157257|P1|COMPLETED|Overall Study||218
66159|NCT01534182|157256|P2|Full Analysis Set|Overall Study||62
66160|NCT01534182|157257|P1|Full Analysis Set|Overall Study||229
66161|NCT01534182|157256|P2|Safety Set|Overall Study||64
66162|NCT01534182|157257|P1|Safety Set|Overall Study||230
66163|NCT01534182|157256|P2|STARTED|Overall Study||68
66164|NCT01534182|157257|P1|STARTED|Overall Study||230
66165|NCT01534143|157272|P1|NOT COMPLETED|Overall Study||0
66166|NCT01534143|157272|P1|COMPLETED|Overall Study||1
66167|NCT01534143|157272|P1|STARTED|Overall Study||1
66168|NCT01534078|157288|P1|NOT COMPLETED|Overall Study||2
66169|NCT01534078|157288|P1|COMPLETED|Overall Study||32
66170|NCT01534078|157288|P1|STARTED|Overall Study||34
66171|NCT01533974|157297|P2|NOT COMPLETED|Overall Study||50
66172|NCT01533974|157298|P1|NOT COMPLETED|Overall Study||51
66173|NCT01533974|157297|P2|COMPLETED|Overall Study||176
66174|NCT01533974|157298|P1|COMPLETED|Overall Study||173
66175|NCT01533974|157297|P2|STARTED|Overall Study||226
66176|NCT01533974|157298|P1|STARTED|Overall Study||224
66177|NCT01533935|157304|P5|NOT COMPLETED|Overall Study||8
66178|NCT01533935|157305|P4|NOT COMPLETED|Overall Study||7
66179|NCT01533935|157306|P3|NOT COMPLETED|Overall Study||8
66180|NCT01533935|157307|P2|NOT COMPLETED|Overall Study||13
66181|NCT01533935|157308|P1|NOT COMPLETED|Overall Study||6
66182|NCT01533935|157304|P5|COMPLETED|Overall Study|All treatment periods|50
66183|NCT01533935|157305|P4|COMPLETED|Overall Study|All treatment periods|52
66184|NCT01533935|157306|P3|COMPLETED|Overall Study|All treatment periods|50
66185|NCT01533935|157307|P2|COMPLETED|Overall Study|All treatment periods|45
66186|NCT01533935|157308|P1|COMPLETED|Overall Study|All treatment periods|52
66187|NCT01533935|157304|P5|Received Tio+Olo 5/5|Overall Study||55
66188|NCT01533935|157305|P4|Received Tio+Olo 5/5|Overall Study||54
66189|NCT01533935|157306|P3|Received Tio+Olo 5/5|Overall Study|One patient received Tio+Olo 5/5 instead of Tio+Olo 2.5/5 by mistake.|1
66190|NCT01533935|157307|P2|Received Tio+Olo 5/5|Overall Study||58
66191|NCT01533935|157308|P1|Received Tio+Olo 5/5|Overall Study||56
66192|NCT01533935|157304|P5|Received Tio+Olo 2.5/5|Overall Study||56
66193|NCT01533935|157305|P4|Received Tio+Olo 2.5/5|Overall Study||56
66194|NCT01533935|157306|P3|Received Tio+Olo 2.5/5|Overall Study||49
66195|NCT01533935|157307|P2|Received Tio+Olo 2.5/5|Overall Study||0
66196|NCT01533935|157308|P1|Received Tio+Olo 2.5/5|Overall Study||58
66197|NCT01533935|157304|P5|Received Tio 5|Overall Study||52
66198|NCT01533935|157305|P4|Received Tio 5|Overall Study||0
66199|NCT01533935|157306|P3|Received Tio 5|Overall Study||58
66200|NCT01533935|157307|P2|Received Tio 5|Overall Study||54
66201|NCT01533935|157308|P1|Received Tio 5|Overall Study||54
66202|NCT01533935|157304|P5|Received Olo 5|Overall Study||0
66203|NCT01533935|157305|P4|Received Olo 5|Overall Study||59
66204|NCT01533935|157306|P3|Received Olo 5|Overall Study||55
66205|NCT01533935|157307|P2|Received Olo 5|Overall Study||52
66206|NCT01533935|157308|P1|Received Olo 5|Overall Study||52
66207|NCT01533935|157304|P5|Received Placebo|Overall Study||58
66208|NCT01533935|157305|P4|Received Placebo|Overall Study||57
66209|NCT01533935|157306|P3|Received Placebo|Overall Study||52
66210|NCT01533935|157307|P2|Received Placebo|Overall Study||47
66211|NCT01533935|157308|P1|Received Placebo|Overall Study||0
66212|NCT01533935|157304|P5|STARTED|Overall Study||58
66213|NCT01533935|157305|P4|STARTED|Overall Study||59
66214|NCT01533935|157306|P3|STARTED|Overall Study||58
66215|NCT01533935|157307|P2|STARTED|Overall Study||58
66216|NCT01533935|157308|P1|STARTED|Overall Study||58
66217|NCT01533922|157335|P5|NOT COMPLETED|Overall Study||6
66218|NCT01533922|157336|P4|NOT COMPLETED|Overall Study||5
66219|NCT01533922|157337|P3|NOT COMPLETED|Overall Study||10
66220|NCT01533922|157338|P2|NOT COMPLETED|Overall Study||12
66221|NCT01533922|157339|P1|NOT COMPLETED|Overall Study||10
66222|NCT01533922|157335|P5|COMPLETED|Overall Study|Completed all treatment arms|53
66223|NCT01533922|157336|P4|COMPLETED|Overall Study|Completed all treatment arms|53
66224|NCT01533922|157337|P3|COMPLETED|Overall Study|Completed all treatment arms|50
66225|NCT01533922|157338|P2|COMPLETED|Overall Study|Completed all treatment arms|47
66226|NCT01533922|157339|P1|COMPLETED|Overall Study|Completed all treatment arms|49
66227|NCT01533922|157335|P5|Received Tio+Olo 5/5|Overall Study||56
66228|NCT01533922|157336|P4|Received Tio+Olo 5/5|Overall Study||53
66229|NCT01533922|157337|P3|Received Tio+Olo 5/5|Overall Study||0
66230|NCT01533922|157338|P2|Received Tio+Olo 5/5|Overall Study||59
66231|NCT01533922|157339|P1|Received Tio+Olo 5/5|Overall Study||58
66232|NCT01533922|157335|P5|Received Tio+Olo 2.5/5|Overall Study||56
66233|NCT01533922|157336|P4|Received Tio+Olo 2.5/5|Overall Study||55
66234|NCT01533922|157337|P3|Received Tio+Olo 2.5/5|Overall Study||52
66235|NCT01533922|157338|P2|Received Tio+Olo 2.5/5|Overall Study||0
66236|NCT01533922|157339|P1|Received Tio+Olo 2.5/5|Overall Study||59
66237|NCT01533922|157335|P5|Received Tio 5|Overall Study||54
66238|NCT01533922|157336|P4|Received Tio 5|Overall Study|One patient received Tio 5 instead of Olo 5 by mistake.|1
66239|NCT01533922|157337|P3|Received Tio 5|Overall Study||59
66240|NCT01533922|157338|P2|Received Tio 5|Overall Study||58
66241|NCT01533922|157339|P1|Received Tio 5|Overall Study||54
66242|NCT01533922|157335|P5|Received Olo 5|Overall Study||0
66243|NCT01533922|157336|P4|Received Olo 5|Overall Study||57
66244|NCT01533922|157337|P3|Received Olo 5|Overall Study||57
66245|NCT01533922|157338|P2|Received Olo 5|Overall Study||52
66246|NCT01533922|157339|P1|Received Olo 5|Overall Study||51
66247|NCT01533922|157335|P5|Received Placebo|Overall Study||59
66248|NCT01533922|157336|P4|Received Placebo|Overall Study||57
66249|NCT01533922|157337|P3|Received Placebo|Overall Study||57
66250|NCT01533922|157338|P2|Received Placebo|Overall Study||49
66251|NCT01533922|157339|P1|Received Placebo|Overall Study||0
66252|NCT01533922|157335|P5|STARTED|Overall Study||59
66253|NCT01533922|157336|P4|STARTED|Overall Study||58
66254|NCT01533922|157337|P3|STARTED|Overall Study||60
66255|NCT01533922|157338|P2|STARTED|Overall Study||59
66256|NCT01533922|157339|P1|STARTED|Overall Study||59
66257|NCT01533753|157368|P2|NOT COMPLETED|Overall Study||0
66258|NCT01533753|157369|P1|NOT COMPLETED|Overall Study||0
66259|NCT01533753|157368|P2|COMPLETED|Overall Study||3
66260|NCT01533753|157369|P1|COMPLETED|Overall Study||2
66261|NCT01533753|157368|P2|STARTED|Overall Study||3
66262|NCT01533753|157369|P1|STARTED|Overall Study||2
66263|NCT01533597|157383|P2|NOT COMPLETED|Overall Study||10
66264|NCT01533597|157384|P1|NOT COMPLETED|Overall Study||6
66265|NCT01533597|157383|P2|COMPLETED|Overall Study||25
66266|NCT01533597|157384|P1|COMPLETED|Overall Study||29
66267|NCT01533597|157383|P2|STARTED|Overall Study||35
66268|NCT01533597|157384|P1|STARTED|Overall Study||35
66269|NCT01533493|157402|P2|NOT COMPLETED|Overall Study||3
66270|NCT01533493|157403|P1|NOT COMPLETED|Overall Study||5
66271|NCT01533493|157402|P2|COMPLETED|Overall Study||11
66272|NCT01533493|157403|P1|COMPLETED|Overall Study||7
66273|NCT01533493|157402|P2|STARTED|Overall Study||14
66274|NCT01533493|157403|P1|STARTED|Overall Study||12
66275|NCT01533428|157411|P2|NOT COMPLETED|Overall Study||8
66276|NCT01533428|157412|P1|NOT COMPLETED|Overall Study||9
66277|NCT01533428|157411|P2|COMPLETED|Overall Study||175
66278|NCT01533428|157412|P1|COMPLETED|Overall Study||177
66279|NCT01533428|157411|P2|STARTED|Overall Study||183
66280|NCT01533428|157412|P1|STARTED|Overall Study||186
66281|NCT01533259|157452|P1|NOT COMPLETED|Overall Study||0
66282|NCT01533259|157452|P1|COMPLETED|Overall Study||48
66283|NCT01533259|157452|P1|STARTED|Overall Study||48
66284|NCT01533246|157458|P1|NOT COMPLETED|Overall Study||2
66285|NCT01533246|157458|P1|COMPLETED|Overall Study||15
66286|NCT01533246|157458|P1|STARTED|Overall Study||17
66287|NCT01533181|157469|P2|NOT COMPLETED|Overall Study||1
66288|NCT01533181|157470|P1|NOT COMPLETED|Overall Study||1
66289|NCT01533181|157469|P2|COMPLETED|Overall Study||28
66290|NCT01533181|157470|P1|COMPLETED|Overall Study||14
66291|NCT01533181|157469|P2|STARTED|Overall Study||29
66292|NCT01533181|157470|P1|STARTED|Overall Study||15
66293|NCT01533116|157486|P4|NOT COMPLETED|Overall Study||0
66294|NCT01533116|157487|P3|NOT COMPLETED|Overall Study||1
66295|NCT01533116|157488|P2|NOT COMPLETED|Overall Study||1
66296|NCT01533116|157489|P1|NOT COMPLETED|Overall Study||2
66297|NCT01533116|157486|P4|COMPLETED|Overall Study||12
66298|NCT01533116|157487|P3|COMPLETED|Overall Study||12
66299|NCT01533116|157488|P2|COMPLETED|Overall Study||12
66300|NCT01533116|157489|P1|COMPLETED|Overall Study||12
66301|NCT01533116|157486|P4|STARTED|Overall Study||12
66302|NCT01533116|157487|P3|STARTED|Overall Study||13
66303|NCT01533116|157488|P2|STARTED|Overall Study||13
66304|NCT01533116|157489|P1|STARTED|Overall Study||14
66305|NCT01533077|157519|P4|NOT COMPLETED|Overall Study||0
66306|NCT01533077|157520|P3|NOT COMPLETED|Overall Study||0
66307|NCT01533077|157521|P2|NOT COMPLETED|Overall Study||1
66308|NCT01533077|157522|P1|NOT COMPLETED|Overall Study||1
66309|NCT01533077|157519|P4|COMPLETED|Overall Study||4
66310|NCT01533077|157520|P3|COMPLETED|Overall Study||4
66311|NCT01533077|157521|P2|COMPLETED|Overall Study||4
66312|NCT01533077|157522|P1|COMPLETED|Overall Study||4
66313|NCT01533077|157519|P4|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
66314|NCT01533077|157520|P3|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||4
66315|NCT01533077|157521|P2|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
66316|NCT01533077|157522|P1|Sinemet® 100/25 1 h After the BIA 9-1067|Overall Study||5
66317|NCT01533077|157519|P4|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
66318|NCT01533077|157520|P3|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
66319|NCT01533077|157521|P2|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
66320|NCT01533077|157522|P1|BIA 9-1067 50 mg + Sinemet® 100/25|Overall Study||4
66321|NCT01533077|157519|P4|Sinemet® 100/25|Overall Study||4
66322|NCT01533077|157520|P3|Sinemet® 100/25|Overall Study||4
66323|NCT01533077|157521|P2|Sinemet® 100/25|Overall Study||5
66324|NCT01533077|157522|P1|Sinemet® 100/25|Overall Study||4
66325|NCT01533077|157519|P4|BIA 9-1067 50 mg|Overall Study||4
66326|NCT01533077|157520|P3|BIA 9-1067 50 mg|Overall Study||4
66327|NCT01533077|157521|P2|BIA 9-1067 50 mg|Overall Study||5
66328|NCT01533077|157522|P1|BIA 9-1067 50 mg|Overall Study||5
66329|NCT01533077|157519|P4|STARTED|Overall Study||4
66330|NCT01533077|157520|P3|STARTED|Overall Study||4
66331|NCT01533077|157521|P2|STARTED|Overall Study||5
66332|NCT01533077|157522|P1|STARTED|Overall Study||5
66333|NCT01533038|157578|P2|NOT COMPLETED|Overall Study||1
66334|NCT01533038|157579|P1|NOT COMPLETED|Overall Study||0
66335|NCT01533038|157578|P2|COMPLETED|Overall Study||34
66336|NCT01533038|157579|P1|COMPLETED|Overall Study||45
66337|NCT01533038|157578|P2|STARTED|Overall Study||35
66338|NCT01533038|157579|P1|STARTED|Overall Study||45
66339|NCT01532999|157587|P2|NOT COMPLETED|Overall Study||18
66340|NCT01532999|157588|P1|NOT COMPLETED|Overall Study||31
66341|NCT01532999|157587|P2|COMPLETED|Overall Study||77
66342|NCT01532999|157588|P1|COMPLETED|Overall Study||65
66343|NCT01532999|157587|P2|STARTED|Overall Study||95
66344|NCT01532999|157588|P1|STARTED|Overall Study||96
66345|NCT01532973|157619|P10|NOT COMPLETED|Part 3||0
66346|NCT01532973|157620|P9|NOT COMPLETED|Part 3||0
66347|NCT01532973|157621|P8|NOT COMPLETED|Part 3||0
66348|NCT01532973|157622|P7|NOT COMPLETED|Part 3||0
66349|NCT01532973|157623|P6|NOT COMPLETED|Part 3||0
66350|NCT01532973|157624|P5|NOT COMPLETED|Part 3||0
66351|NCT01532973|157625|P4|NOT COMPLETED|Part 3||0
66352|NCT01532973|157626|P3|NOT COMPLETED|Part 3||0
66353|NCT01532973|157627|P2|NOT COMPLETED|Part 3||0
66354|NCT01532973|157628|P1|NOT COMPLETED|Part 3||0
66355|NCT01532973|157619|P10|COMPLETED|Part 3||6
66356|NCT01532973|157620|P9|COMPLETED|Part 3||6
66357|NCT01532973|157621|P8|COMPLETED|Part 3||0
66358|NCT01532973|157622|P7|COMPLETED|Part 3||0
66359|NCT01532973|157623|P6|COMPLETED|Part 3||0
66360|NCT01532973|157624|P5|COMPLETED|Part 3||0
66361|NCT01532973|157625|P4|COMPLETED|Part 3||0
66362|NCT01532973|157626|P3|COMPLETED|Part 3||0
66363|NCT01532973|157627|P2|COMPLETED|Part 3||0
66364|NCT01532973|157628|P1|COMPLETED|Part 3||0
66365|NCT01532973|157619|P10|STARTED|Part 3||6
66366|NCT01532973|157620|P9|STARTED|Part 3||6
66367|NCT01532973|157621|P8|STARTED|Part 3||0
66368|NCT01532973|157622|P7|STARTED|Part 3||0
66369|NCT01532973|157623|P6|STARTED|Part 3||0
66370|NCT01532973|157624|P5|STARTED|Part 3||0
66371|NCT01532973|157625|P4|STARTED|Part 3||0
66372|NCT01532973|157626|P3|STARTED|Part 3||0
66373|NCT01532973|157627|P2|STARTED|Part 3||0
66374|NCT01532973|157628|P1|STARTED|Part 3||0
66375|NCT01532973|157619|P10|NOT COMPLETED|Part 2||0
66376|NCT01532973|157620|P9|NOT COMPLETED|Part 2||0
66377|NCT01532973|157621|P8|NOT COMPLETED|Part 2||0
66378|NCT01532973|157622|P7|NOT COMPLETED|Part 2||0
66379|NCT01532973|157623|P6|NOT COMPLETED|Part 2||0
66380|NCT01532973|157624|P5|NOT COMPLETED|Part 2||0
66381|NCT01532973|157625|P4|NOT COMPLETED|Part 2||0
66382|NCT01532973|157626|P3|NOT COMPLETED|Part 2||0
66383|NCT01532973|157627|P2|NOT COMPLETED|Part 2||0
66384|NCT01532973|157628|P1|NOT COMPLETED|Part 2||0
66385|NCT01532973|157619|P10|COMPLETED|Part 2||0
66386|NCT01532973|157620|P9|COMPLETED|Part 2||0
66387|NCT01532973|157621|P8|COMPLETED|Part 2||0
66388|NCT01532973|157622|P7|COMPLETED|Part 2||6
66389|NCT01532973|157623|P6|COMPLETED|Part 2||6
66390|NCT01532973|157624|P5|COMPLETED|Part 2||6
66391|NCT01532973|157625|P4|COMPLETED|Part 2||0
66392|NCT01532973|157626|P3|COMPLETED|Part 2||0
66393|NCT01532973|157627|P2|COMPLETED|Part 2||0
66394|NCT01532973|157628|P1|COMPLETED|Part 2||0
66395|NCT01532973|157619|P10|STARTED|Part 2||0
66396|NCT01532973|157620|P9|STARTED|Part 2||0
66397|NCT01532973|157621|P8|STARTED|Part 2|Planned panel not performed. No participants were enrolled.|0
66398|NCT01532973|157622|P7|STARTED|Part 2||6
66399|NCT01532973|157623|P6|STARTED|Part 2||6
66400|NCT01532973|157624|P5|STARTED|Part 2||6
66401|NCT01532973|157625|P4|STARTED|Part 2||0
66402|NCT01532973|157626|P3|STARTED|Part 2||0
66403|NCT01532973|157627|P2|STARTED|Part 2||0
66404|NCT01532973|157628|P1|STARTED|Part 2||0
66405|NCT01532973|157619|P10|NOT COMPLETED|Part 1||0
66406|NCT01532973|157620|P9|NOT COMPLETED|Part 1||0
66407|NCT01532973|157621|P8|NOT COMPLETED|Part 1||0
66408|NCT01532973|157622|P7|NOT COMPLETED|Part 1||0
66409|NCT01532973|157623|P6|NOT COMPLETED|Part 1||0
66410|NCT01532973|157624|P5|NOT COMPLETED|Part 1||0
66411|NCT01532973|157625|P4|NOT COMPLETED|Part 1||0
66412|NCT01532973|157626|P3|NOT COMPLETED|Part 1||0
66413|NCT01532973|157627|P2|NOT COMPLETED|Part 1||0
66414|NCT01532973|157628|P1|NOT COMPLETED|Part 1||0
66415|NCT01532973|157619|P10|COMPLETED|Part 1||0
66416|NCT01532973|157620|P9|COMPLETED|Part 1||0
66417|NCT01532973|157621|P8|COMPLETED|Part 1||0
66418|NCT01532973|157622|P7|COMPLETED|Part 1||0
66419|NCT01532973|157623|P6|COMPLETED|Part 1||0
66420|NCT01532973|157624|P5|COMPLETED|Part 1||0
66421|NCT01532973|157625|P4|COMPLETED|Part 1||0
66422|NCT01532973|157626|P3|COMPLETED|Part 1||6
66423|NCT01532973|157627|P2|COMPLETED|Part 1||6
66424|NCT01532973|157628|P1|COMPLETED|Part 1||6
66425|NCT01532973|157619|P10|STARTED|Part 1||0
66426|NCT01532973|157620|P9|STARTED|Part 1||0
66427|NCT01532973|157621|P8|STARTED|Part 1||0
66428|NCT01532973|157622|P7|STARTED|Part 1||0
66429|NCT01532973|157623|P6|STARTED|Part 1||0
66430|NCT01532973|157624|P5|STARTED|Part 1||0
66431|NCT01532973|157625|P4|STARTED|Part 1|Planned panel not performed. No participants were enrolled.|0
66432|NCT01532973|157626|P3|STARTED|Part 1||6
66433|NCT01532973|157627|P2|STARTED|Part 1||6
66434|NCT01532973|157628|P1|STARTED|Part 1||6
66435|NCT01532934|157670|P2|NOT COMPLETED|Overall Study||13
66436|NCT01532934|157671|P1|NOT COMPLETED|Overall Study||14
66437|NCT01532934|157670|P2|COMPLETED|Overall Study||39
66438|NCT01532934|157671|P1|COMPLETED|Overall Study||39
66439|NCT01532934|157670|P2|STARTED|Overall Study||52
66440|NCT01532934|157671|P1|STARTED|Overall Study||53
66441|NCT01532869|157683|P2|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||3
66526|NCT01532128|157837|P2|STARTED|Overall Study||8
66442|NCT01532869|157684|P1|NOT COMPLETED|Open-label Period (Week 48 to Week 96)||7
66443|NCT01532869|157683|P2|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|27
66444|NCT01532869|157684|P1|COMPLETED|Open-label Period (Week 48 to Week 96)|Number of participants who completed study to Week 96.|24
66445|NCT01532869|157683|P2|STARTED|Open-label Period (Week 48 to Week 96)||30
66446|NCT01532869|157684|P1|STARTED|Open-label Period (Week 48 to Week 96)|Two participants did not start the open label extension period.|31
66447|NCT01532869|157683|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||13
66448|NCT01532869|157684|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 48)||11
66449|NCT01532869|157683|P2|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|30
66450|NCT01532869|157684|P1|COMPLETED|Blinded-Treatment Period (Up to Week 48)|Number of participants who completed 48 weeks of blinded-treatment period.|33
66451|NCT01532869|157683|P2|STARTED|Blinded-Treatment Period (Up to Week 48)||43
66452|NCT01532869|157684|P1|STARTED|Blinded-Treatment Period (Up to Week 48)||44
66453|NCT01532869|157683|P2|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
66454|NCT01532869|157684|P1|NOT COMPLETED|Blinded-Treatment Period (Up to Week 24)||8
66455|NCT01532869|157683|P2|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|35
66456|NCT01532869|157684|P1|COMPLETED|Blinded-Treatment Period (Up to Week 24)|Number of participants who completed the first 24 weeks of full 48 weeks blinded-treatment period.|36
66457|NCT01532869|157683|P2|STARTED|Blinded-Treatment Period (Up to Week 24)||43
66458|NCT01532869|157684|P1|STARTED|Blinded-Treatment Period (Up to Week 24)||44
66459|NCT01532635|157721|P1|NOT COMPLETED|Overall Study||0
66460|NCT01532635|157721|P1|COMPLETED|Overall Study||4
66461|NCT01532635|157721|P1|STARTED|Overall Study||4
66462|NCT01532570|157737|P4|NOT COMPLETED|Overall Study||0
66463|NCT01532570|157738|P3|NOT COMPLETED|Overall Study||0
66464|NCT01532570|157739|P2|NOT COMPLETED|Overall Study||1
66465|NCT01532570|157740|P1|NOT COMPLETED|Overall Study||1
66466|NCT01532570|157737|P4|COMPLETED|Overall Study||4
66467|NCT01532570|157738|P3|COMPLETED|Overall Study||1
66468|NCT01532570|157739|P2|COMPLETED|Overall Study||1
66469|NCT01532570|157740|P1|COMPLETED|Overall Study||10
66470|NCT01532570|157737|P4|STARTED|Overall Study||4
66471|NCT01532570|157738|P3|STARTED|Overall Study||1
66472|NCT01532570|157739|P2|STARTED|Overall Study||2
66473|NCT01532570|157740|P1|STARTED|Overall Study||11
66474|NCT01532453|157773|P2|NOT COMPLETED|Overall Study||70
66475|NCT01532453|157774|P1|NOT COMPLETED|Overall Study||27
66476|NCT01532453|157773|P2|COMPLETED|Overall Study||90
66477|NCT01532453|157774|P1|COMPLETED|Overall Study||54
66478|NCT01532453|157773|P2|STARTED|Overall Study||160
66479|NCT01532453|157774|P1|STARTED|Overall Study||81
66480|NCT01532414|157785|P3|NOT COMPLETED|Overall Study||3
66481|NCT01532414|157786|P2|NOT COMPLETED|Overall Study||2
66482|NCT01532414|157787|P1|NOT COMPLETED|Overall Study||7
66483|NCT01532414|157785|P3|COMPLETED|Overall Study||35
66484|NCT01532414|157786|P2|COMPLETED|Overall Study||19
66485|NCT01532414|157787|P1|COMPLETED|Overall Study||85
66486|NCT01532414|157785|P3|STARTED|Overall Study||38
66487|NCT01532414|157786|P2|STARTED|Overall Study|Up-titrated at 6 weeks from a starting dose of 12.5 mg due to morning testosterone <300 ng/dL|21
66488|NCT01532414|157787|P1|STARTED|Overall Study||92
66489|NCT01532362|157797|P2|NOT COMPLETED|Overall Study||0
66490|NCT01532362|157798|P1|NOT COMPLETED|Overall Study||0
66491|NCT01532362|157797|P2|COMPLETED|Overall Study||0
66492|NCT01532362|157798|P1|COMPLETED|Overall Study||1
66493|NCT01532362|157797|P2|STARTED|Overall Study||0
66494|NCT01532362|157798|P1|STARTED|Overall Study||1
66495|NCT01532349|157806|P2|NOT COMPLETED|Overall Study||5
66496|NCT01532349|157807|P1|NOT COMPLETED|Overall Study||2
66497|NCT01532349|157806|P2|COMPLETED|Overall Study||12
66498|NCT01532349|157807|P1|COMPLETED|Overall Study||15
66499|NCT01532349|157806|P2|STARTED|Overall Study||17
66500|NCT01532349|157807|P1|STARTED|Overall Study||17
66501|NCT01532141|157816|P3|NOT COMPLETED|Overall Study||0
66502|NCT01532141|157817|P2|NOT COMPLETED|Overall Study||0
66503|NCT01532141|157818|P1|NOT COMPLETED|Overall Study||1
66504|NCT01532141|157816|P3|COMPLETED|Overall Study||8
66505|NCT01532141|157817|P2|COMPLETED|Overall Study||8
66506|NCT01532141|157818|P1|COMPLETED|Overall Study||8
66507|NCT01532141|157816|P3|Period 3|Overall Study||8
66508|NCT01532141|157817|P2|Period 3|Overall Study||8
66509|NCT01532141|157818|P1|Period 3|Overall Study||8
66510|NCT01532141|157816|P3|Period 2|Overall Study||8
66511|NCT01532141|157817|P2|Period 2|Overall Study||8
66512|NCT01532141|157818|P1|Period 2|Overall Study||8
66513|NCT01532141|157816|P3|Period 1|Overall Study||8
66514|NCT01532141|157817|P2|Period 1|Overall Study||8
66515|NCT01532141|157818|P1|Period 1|Overall Study||9
66516|NCT01532141|157816|P3|STARTED|Overall Study||8
66517|NCT01532141|157817|P2|STARTED|Overall Study||8
66518|NCT01532141|157818|P1|STARTED|Overall Study||9
66519|NCT01532128|157836|P3|NOT COMPLETED|Overall Study||0
66520|NCT01532128|157837|P2|NOT COMPLETED|Overall Study||0
66521|NCT01532128|157838|P1|NOT COMPLETED|Overall Study||0
66522|NCT01532128|157836|P3|COMPLETED|Overall Study||8
66523|NCT01532128|157837|P2|COMPLETED|Overall Study||8
66524|NCT01532128|157838|P1|COMPLETED|Overall Study||8
66525|NCT01532128|157836|P3|STARTED|Overall Study||8
66527|NCT01532128|157838|P1|STARTED|Overall Study||8
66528|NCT01531998|157853|P1|NOT COMPLETED|Overall Study||3
66529|NCT01531998|157853|P1|COMPLETED|Overall Study||8
66530|NCT01531998|157853|P1|STARTED|Overall Study||11
66531|NCT01531725|157858|P1|NOT COMPLETED|Overall Study||5
66532|NCT01531725|157858|P1|COMPLETED|Overall Study||197
66533|NCT01531725|157858|P1|STARTED|Overall Study|5 patients with protocol violation were excluded.|202
66534|NCT01531387|157865|P2|NOT COMPLETED|Overall Study||11
66535|NCT01531387|157866|P1|NOT COMPLETED|Overall Study||11
66536|NCT01531387|157865|P2|COMPLETED|Overall Study||0
66537|NCT01531387|157866|P1|COMPLETED|Overall Study||0
66538|NCT01531387|157865|P2|STARTED|Overall Study||11
66539|NCT01531387|157866|P1|STARTED|Overall Study||11
66540|NCT01531374|157883|P3|NOT COMPLETED|Overall Study||283
66541|NCT01531374|157884|P2|NOT COMPLETED|Overall Study||142
66542|NCT01531374|157885|P1|NOT COMPLETED|Overall Study||364
66543|NCT01531374|157883|P3|COMPLETED|Overall Study||836
66544|NCT01531374|157884|P2|COMPLETED|Overall Study||231
66545|NCT01531374|157885|P1|COMPLETED|Overall Study||921
66546|NCT01531374|157883|P3|STARTED|Overall Study||1119
66547|NCT01531374|157884|P2|STARTED|Overall Study||373
66548|NCT01531374|157885|P1|STARTED|Overall Study||1285
66549|NCT01531335|157949|P2|NOT COMPLETED|Overall Study||0
66550|NCT01531335|157950|P1|NOT COMPLETED|Overall Study||0
66551|NCT01531335|157949|P2|COMPLETED|Overall Study||40
66552|NCT01531335|157950|P1|COMPLETED|Overall Study||40
66553|NCT01531335|157949|P2|STARTED|Overall Study||40
66554|NCT01531335|157950|P1|STARTED|Overall Study||40
66555|NCT01531205|157958|P1|NOT COMPLETED|Overall Study||1
66556|NCT01531205|157958|P1|COMPLETED|Overall Study||1
66557|NCT01531205|157958|P1|STARTED|Overall Study||2
66558|NCT01530997|157967|P1|NOT COMPLETED|Overall Study||2
66559|NCT01530997|157967|P1|COMPLETED|Overall Study||43
66560|NCT01530997|157967|P1|STARTED|Overall Study||45
66561|NCT01530880|157987|P1|NOT COMPLETED|Overall Study||0
66562|NCT01530880|157987|P1|COMPLETED|Overall Study||35
66563|NCT01530880|157987|P1|STARTED|Overall Study||35
66564|NCT01530477|158001|P3|NOT COMPLETED|Overall Study||0
66565|NCT01530477|158002|P2|NOT COMPLETED|Overall Study||0
66566|NCT01530477|158003|P1|NOT COMPLETED|Overall Study||0
66567|NCT01530477|158001|P3|COMPLETED|Overall Study|53 subjects completed the imaging in both the Skeletal and Body Composition cohorts.|53
66568|NCT01530477|158002|P2|COMPLETED|Overall Study|12 subjects completed imaging in the Body Composition cohort only.|12
66569|NCT01530477|158003|P1|COMPLETED|Overall Study|17 subjects completed imaging in the Skeletal cohort only.|17
66570|NCT01530477|158001|P3|STARTED|Overall Study|53 subjects consented to both the Skeletal and body Composition cohorts.|53
66571|NCT01530477|158002|P2|STARTED|Overall Study|12 subjects consented to the Body Composition cohort only.|12
66572|NCT01530477|158003|P1|STARTED|Overall Study|17 subjects consented to the Skeletal cohort only.|17
66573|NCT01530464|158011|P2|NOT COMPLETED|Washout (24h)||1
66574|NCT01530464|158012|P1|NOT COMPLETED|Washout (24h)||0
66575|NCT01530464|158011|P2|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|7
66576|NCT01530464|158012|P1|COMPLETED|Washout (24h)||9
66577|NCT01530464|158011|P2|STARTED|Washout (24h)||8
66578|NCT01530464|158012|P1|STARTED|Washout (24h)||9
66579|NCT01530464|158011|P2|NOT COMPLETED|Third Intervention (24h)||0
66580|NCT01530464|158012|P1|NOT COMPLETED|Third Intervention (24h)||0
66581|NCT01530464|158011|P2|COMPLETED|Third Intervention (24h)||8
66582|NCT01530464|158012|P1|COMPLETED|Third Intervention (24h)||9
66583|NCT01530464|158011|P2|STARTED|Third Intervention (24h)||8
66584|NCT01530464|158012|P1|STARTED|Third Intervention (24h)||9
66585|NCT01530464|158011|P2|NOT COMPLETED|Washout (24h)||0
66586|NCT01530464|158012|P1|NOT COMPLETED|Washout (24h)||1
66587|NCT01530464|158011|P2|COMPLETED|Washout (24h)||8
66588|NCT01530464|158012|P1|COMPLETED|Washout (24h)|1 subject withdrew consent and left due to family emergencies|9
66589|NCT01530464|158011|P2|STARTED|Washout (24h)||8
66590|NCT01530464|158012|P1|STARTED|Washout (24h)||10
66591|NCT01530464|158011|P2|NOT COMPLETED|Second Intervention (24h)||0
66592|NCT01530464|158012|P1|NOT COMPLETED|Second Intervention (24h)||0
66593|NCT01530464|158011|P2|COMPLETED|Second Intervention (24h)||8
66594|NCT01530464|158012|P1|COMPLETED|Second Intervention (24h)||10
66595|NCT01530464|158011|P2|STARTED|Second Intervention (24h)||8
66596|NCT01530464|158012|P1|STARTED|Second Intervention (24h)||10
66597|NCT01530464|158011|P2|NOT COMPLETED|Washout (24h)||0
66598|NCT01530464|158012|P1|NOT COMPLETED|Washout (24h)||0
66599|NCT01530464|158011|P2|COMPLETED|Washout (24h)||8
66600|NCT01530464|158012|P1|COMPLETED|Washout (24h)||10
66601|NCT01530464|158011|P2|STARTED|Washout (24h)||8
66602|NCT01530464|158012|P1|STARTED|Washout (24h)||10
66603|NCT01530464|158011|P2|NOT COMPLETED|First Intervention (24h)||0
66604|NCT01530464|158012|P1|NOT COMPLETED|First Intervention (24h)||0
66605|NCT01530464|158011|P2|COMPLETED|First Intervention (24h)||8
66606|NCT01530464|158012|P1|COMPLETED|First Intervention (24h)||10
66607|NCT01530464|158011|P2|STARTED|First Intervention (24h)||8
66608|NCT01530464|158012|P1|STARTED|First Intervention (24h)||10
66609|NCT01530399|158045|P6|NOT COMPLETED|Overall Study||1
66610|NCT01530399|158046|P5|NOT COMPLETED|Overall Study||0
66611|NCT01530399|158047|P4|NOT COMPLETED|Overall Study||0
66612|NCT01530399|158048|P3|NOT COMPLETED|Overall Study||1
66613|NCT01530399|158049|P2|NOT COMPLETED|Overall Study||2
66614|NCT01530399|158050|P1|NOT COMPLETED|Overall Study||1
66615|NCT01530399|158045|P6|COMPLETED|Overall Study||6
66616|NCT01530399|158046|P5|COMPLETED|Overall Study||6
66617|NCT01530399|158047|P4|COMPLETED|Overall Study||10
66618|NCT01530399|158048|P3|COMPLETED|Overall Study||7
66619|NCT01530399|158049|P2|COMPLETED|Overall Study||8
66620|NCT01530399|158050|P1|COMPLETED|Overall Study||7
66621|NCT01530399|158045|P6|STARTED|Overall Study||7
66622|NCT01530399|158046|P5|STARTED|Overall Study||6
66623|NCT01530399|158047|P4|STARTED|Overall Study||10
66624|NCT01530399|158048|P3|STARTED|Overall Study||8
66625|NCT01530399|158049|P2|STARTED|Overall Study||10
66626|NCT01530399|158050|P1|STARTED|Overall Study||8
66627|NCT01530334|158064|P1|NOT COMPLETED|Overall Study||51
66628|NCT01530334|158064|P1|COMPLETED|Overall Study||10
66629|NCT01530334|158064|P1|STARTED|Overall Study||61
66630|NCT01530243|158077|P4|NOT COMPLETED|Overall Study||2
66631|NCT01530243|158078|P3|NOT COMPLETED|Overall Study||3
66632|NCT01530243|158079|P2|NOT COMPLETED|Overall Study||3
66633|NCT01530243|158080|P1|NOT COMPLETED|Overall Study||2
66634|NCT01530243|158077|P4|COMPLETED|Overall Study||24
66635|NCT01530243|158078|P3|COMPLETED|Overall Study||23
66636|NCT01530243|158079|P2|COMPLETED|Overall Study||23
66637|NCT01530243|158080|P1|COMPLETED|Overall Study||24
66638|NCT01530243|158077|P4|STARTED|Overall Study||26
66639|NCT01530243|158078|P3|STARTED|Overall Study||26
66640|NCT01530243|158079|P2|STARTED|Overall Study||26
66641|NCT01530243|158080|P1|STARTED|Overall Study||26
66642|NCT01530087|158098|P1|NOT COMPLETED|Overall Study||2
66643|NCT01530087|158098|P1|COMPLETED|Overall Study||1
66644|NCT01530087|158098|P1|STARTED|Overall Study||3
66645|NCT01529827|158103|P1|NOT COMPLETED|Overall Study||0
66646|NCT01529827|158103|P1|COMPLETED|Overall Study||94
66647|NCT01529827|158103|P1|STARTED|Overall Study||94
66648|NCT01529645|158120|P10|NOT COMPLETED|Overall Study||0
66649|NCT01529645|158121|P9|NOT COMPLETED|Overall Study||1
66650|NCT01529645|158122|P8|NOT COMPLETED|Overall Study||0
66651|NCT01529645|158123|P7|NOT COMPLETED|Overall Study||2
66652|NCT01529645|158124|P6|NOT COMPLETED|Overall Study||1
66653|NCT01529645|158125|P5|NOT COMPLETED|Overall Study||2
66654|NCT01529645|158126|P4|NOT COMPLETED|Overall Study||2
66655|NCT01529645|158127|P3|NOT COMPLETED|Overall Study||2
66656|NCT01529645|158128|P2|NOT COMPLETED|Overall Study||1
66657|NCT01529645|158129|P1|NOT COMPLETED|Overall Study||2
66658|NCT01529645|158120|P10|COMPLETED|Overall Study||42
66659|NCT01529645|158121|P9|COMPLETED|Overall Study||41
66660|NCT01529645|158122|P8|COMPLETED|Overall Study||42
66661|NCT01529645|158123|P7|COMPLETED|Overall Study||40
66662|NCT01529645|158124|P6|COMPLETED|Overall Study||41
66663|NCT01529645|158125|P5|COMPLETED|Overall Study||40
66664|NCT01529645|158126|P4|COMPLETED|Overall Study||40
66665|NCT01529645|158127|P3|COMPLETED|Overall Study||40
66666|NCT01529645|158128|P2|COMPLETED|Overall Study||41
66667|NCT01529645|158129|P1|COMPLETED|Overall Study||40
66668|NCT01529645|158120|P10|STARTED|Overall Study||42
66669|NCT01529645|158121|P9|STARTED|Overall Study||42
66670|NCT01529645|158122|P8|STARTED|Overall Study||42
66671|NCT01529645|158123|P7|STARTED|Overall Study||42
66672|NCT01529645|158124|P6|STARTED|Overall Study||42
66673|NCT01529645|158125|P5|STARTED|Overall Study||42
66674|NCT01529645|158126|P4|STARTED|Overall Study||42
66675|NCT01529645|158127|P3|STARTED|Overall Study||42
66676|NCT01529645|158128|P2|STARTED|Overall Study||42
66677|NCT01529645|158129|P1|STARTED|Overall Study||42
66678|NCT01529632|158227|P2|NOT COMPLETED|Overall Study||3
66679|NCT01529632|158228|P1|NOT COMPLETED|Overall Study||3
66680|NCT01529632|158227|P2|COMPLETED|Overall Study||100
66681|NCT01529632|158228|P1|COMPLETED|Overall Study||87
66682|NCT01529632|158227|P2|STARTED|Overall Study||103
66683|NCT01529632|158228|P1|STARTED|Overall Study||90
66684|NCT01529515|158248|P4|NOT COMPLETED|DOUBLE BLIND PHASE||12
66685|NCT01529515|158249|P3|NOT COMPLETED|DOUBLE BLIND PHASE||23
66686|NCT01529515|158250|P2|NOT COMPLETED|DOUBLE BLIND PHASE||0
66687|NCT01529515|158251|P1|NOT COMPLETED|DOUBLE BLIND PHASE||0
66688|NCT01529515|158248|P4|COMPLETED|DOUBLE BLIND PHASE||148
66689|NCT01529515|158249|P3|COMPLETED|DOUBLE BLIND PHASE||122
66690|NCT01529515|158250|P2|COMPLETED|DOUBLE BLIND PHASE||0
66691|NCT01529515|158251|P1|COMPLETED|DOUBLE BLIND PHASE||0
66692|NCT01529515|158248|P4|STARTED|DOUBLE BLIND PHASE||160
66693|NCT01529515|158249|P3|STARTED|DOUBLE BLIND PHASE||145
66694|NCT01529515|158250|P2|STARTED|DOUBLE BLIND PHASE||0
66695|NCT01529515|158251|P1|STARTED|DOUBLE BLIND PHASE||0
66696|NCT01529515|158248|P4|NOT COMPLETED|MAINTENANCE PHASE||0
66697|NCT01529515|158249|P3|NOT COMPLETED|MAINTENANCE PHASE||0
66698|NCT01529515|158250|P2|NOT COMPLETED|MAINTENANCE PHASE||74
66699|NCT01529515|158251|P1|NOT COMPLETED|MAINTENANCE PHASE||0
66700|NCT01529515|158248|P4|COMPLETED|MAINTENANCE PHASE||0
66701|NCT01529515|158249|P3|COMPLETED|MAINTENANCE PHASE||0
66702|NCT01529515|158250|P2|COMPLETED|MAINTENANCE PHASE||305
66703|NCT01529515|158251|P1|COMPLETED|MAINTENANCE PHASE||0
66704|NCT01529515|158248|P4|STARTED|MAINTENANCE PHASE||0
66705|NCT01529515|158249|P3|STARTED|MAINTENANCE PHASE||0
66706|NCT01529515|158250|P2|STARTED|MAINTENANCE PHASE||379
66707|NCT01529515|158251|P1|STARTED|MAINTENANCE PHASE||0
66708|NCT01529515|158248|P4|NOT COMPLETED|TRANSITION PHASE||0
66709|NCT01529515|158249|P3|NOT COMPLETED|TRANSITION PHASE||0
66710|NCT01529515|158250|P2|NOT COMPLETED|TRANSITION PHASE||0
66711|NCT01529515|158251|P1|NOT COMPLETED|TRANSITION PHASE||127
66712|NCT01529515|158248|P4|COMPLETED|TRANSITION PHASE||0
66713|NCT01529515|158249|P3|COMPLETED|TRANSITION PHASE||0
66714|NCT01529515|158250|P2|COMPLETED|TRANSITION PHASE||0
66715|NCT01529515|158251|P1|COMPLETED|TRANSITION PHASE||379
66716|NCT01529515|158248|P4|STARTED|TRANSITION PHASE||0
66717|NCT01529515|158249|P3|STARTED|TRANSITION PHASE||0
66718|NCT01529515|158250|P2|STARTED|TRANSITION PHASE||0
66719|NCT01529515|158251|P1|STARTED|TRANSITION PHASE||506
66720|NCT01529502|158270|P6|NOT COMPLETED|Overall Study||0
66721|NCT01529502|158271|P5|NOT COMPLETED|Overall Study||0
66722|NCT01529502|158272|P4|NOT COMPLETED|Overall Study||2
66723|NCT01529502|158273|P3|NOT COMPLETED|Overall Study||0
66724|NCT01529502|158274|P2|NOT COMPLETED|Overall Study||0
66725|NCT01529502|158275|P1|NOT COMPLETED|Overall Study||0
66726|NCT01529502|158270|P6|COMPLETED|Overall Study||2
66727|NCT01529502|158271|P5|COMPLETED|Overall Study||2
66728|NCT01529502|158272|P4|COMPLETED|Overall Study||1
66729|NCT01529502|158273|P3|COMPLETED|Overall Study||2
66730|NCT01529502|158274|P2|COMPLETED|Overall Study||3
66731|NCT01529502|158275|P1|COMPLETED|Overall Study||2
66732|NCT01529502|158270|P6|STARTED|Overall Study||2
66733|NCT01529502|158271|P5|STARTED|Overall Study||2
66734|NCT01529502|158272|P4|STARTED|Overall Study||3
66735|NCT01529502|158273|P3|STARTED|Overall Study||2
66736|NCT01529502|158274|P2|STARTED|Overall Study||3
66737|NCT01529502|158275|P1|STARTED|Overall Study||2
66738|NCT01529450|158288|P2|NOT COMPLETED|Overall Study||2
66739|NCT01529450|158289|P1|NOT COMPLETED|Overall Study||0
66740|NCT01529450|158288|P2|COMPLETED|Overall Study||6
66741|NCT01529450|158289|P1|COMPLETED|Overall Study||3
66742|NCT01529450|158288|P2|STARTED|Overall Study||8
66743|NCT01529450|158289|P1|STARTED|Overall Study||3
66744|NCT01529385|158298|P2|NOT COMPLETED|Overall Study||1
66745|NCT01529385|158299|P1|NOT COMPLETED|Overall Study||2
66746|NCT01529385|158298|P2|COMPLETED|Overall Study||39
66747|NCT01529385|158299|P1|COMPLETED|Overall Study||38
66748|NCT01529385|158298|P2|Received Intervention|Overall Study||40
66749|NCT01529385|158299|P1|Received Intervention|Overall Study|1 participant failed to show up to treatment allocation visit and was subsequently lost to follow up|39
66750|NCT01529385|158298|P2|STARTED|Overall Study||40
66751|NCT01529385|158299|P1|STARTED|Overall Study||40
66752|NCT01529203|158323|P1|NOT COMPLETED|Overall Study||3
66753|NCT01529203|158323|P1|COMPLETED|Overall Study||57
66754|NCT01529203|158323|P1|STARTED|Overall Study||60
66755|NCT01529112|158331|P2|NOT COMPLETED|Overall Study||41
66756|NCT01529112|158332|P1|NOT COMPLETED|Overall Study||69
66757|NCT01529112|158331|P2|COMPLETED|Overall Study|Discontinued treatment-continued follow-up=5 (data cut-off date 21 January 2014)|5
66758|NCT01529112|158332|P1|COMPLETED|Overall Study|On treatment=2, Discontinued treatment-continued follow-up=18 (data cut-off date 21 January 2014)|20
66759|NCT01529112|158331|P2|STARTED|Overall Study||46
66760|NCT01529112|158332|P1|STARTED|Overall Study||89
66761|NCT01528969|158359|P2|NOT COMPLETED|Overall Study||0
66762|NCT01528969|158360|P1|NOT COMPLETED|Overall Study||2
66763|NCT01528969|158359|P2|COMPLETED|Overall Study||38
66764|NCT01528969|158360|P1|COMPLETED|Overall Study||35
66765|NCT01528969|158359|P2|STARTED|Overall Study||38
66766|NCT01528969|158360|P1|STARTED|Overall Study||37
66767|NCT01528891|158368|P2|NOT COMPLETED|Overall Study||0
66768|NCT01528891|158369|P1|NOT COMPLETED|Overall Study||0
66769|NCT01528891|158368|P2|COMPLETED|Overall Study||200
66770|NCT01528891|158369|P1|COMPLETED|Overall Study||200
66771|NCT01528891|158368|P2|STARTED|Overall Study||200
66772|NCT01528891|158369|P1|STARTED|Overall Study||200
66773|NCT01528735|158383|P2|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||0
66774|NCT01528735|158384|P1|NOT COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||1
66775|NCT01528735|158383|P2|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||12
66776|NCT01528735|158384|P1|COMPLETED|Treatment Period 2: Faldap/PegIFN/RBV||10
66777|NCT01528735|158383|P2|STARTED|Treatment Period 2: Faldap/PegIFN/RBV|One patient was treated with only PegIFN/RBV, as faldaprevir was discontinued due to adverse events|12
66778|NCT01528735|158384|P1|STARTED|Treatment Period 2: Faldap/PegIFN/RBV||11
66779|NCT01528735|158383|P2|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
66780|NCT01528735|158384|P1|NOT COMPLETED|Treatment Period 1: Faldap/Del/RBV||1
66781|NCT01528735|158383|P2|COMPLETED|Treatment Period 1: Faldap/Del/RBV||12
66782|NCT01528735|158384|P1|COMPLETED|Treatment Period 1: Faldap/Del/RBV||11
66783|NCT01528735|158383|P2|STARTED|Treatment Period 1: Faldap/Del/RBV||13
66784|NCT01528735|158384|P1|STARTED|Treatment Period 1: Faldap/Del/RBV||12
66785|NCT01528696|158486|P2|NOT COMPLETED|Overall Study||19
66786|NCT01528696|158487|P1|NOT COMPLETED|Overall Study||18
66787|NCT01528696|158486|P2|COMPLETED|Overall Study||0
66788|NCT01528696|158487|P1|COMPLETED|Overall Study||0
66789|NCT01528696|158486|P2|Hospital Stay (2-5 Days)|Overall Study||19
66790|NCT01528696|158487|P1|Hospital Stay (2-5 Days)|Overall Study||18
66791|NCT01528696|158486|P2|STARTED|Overall Study||19
66792|NCT01528696|158487|P1|STARTED|Overall Study||18
66793|NCT01528605|158503|P6|NOT COMPLETED|Overall Study||0
66794|NCT01528605|158504|P5|NOT COMPLETED|Overall Study||0
66795|NCT01528605|158505|P4|NOT COMPLETED|Overall Study||1
66796|NCT01528605|158506|P3|NOT COMPLETED|Overall Study||1
66797|NCT01528605|158507|P2|NOT COMPLETED|Overall Study||0
66798|NCT01528605|158508|P1|NOT COMPLETED|Overall Study||2
66799|NCT01528605|158503|P6|COMPLETED|Overall Study||28
66800|NCT01528605|158504|P5|COMPLETED|Overall Study||28
66801|NCT01528605|158505|P4|COMPLETED|Overall Study||27
66802|NCT01528605|158506|P3|COMPLETED|Overall Study||27
66803|NCT01528605|158507|P2|COMPLETED|Overall Study||28
66804|NCT01528605|158508|P1|COMPLETED|Overall Study||26
66805|NCT01528605|158503|P6|STARTED|Overall Study||28
66806|NCT01528605|158504|P5|STARTED|Overall Study||28
66807|NCT01528605|158505|P4|STARTED|Overall Study||28
66808|NCT01528605|158506|P3|STARTED|Overall Study||28
66809|NCT01528605|158507|P2|STARTED|Overall Study||28
66810|NCT01528605|158508|P1|STARTED|Overall Study||28
66811|NCT01528592|158532|P1|NOT COMPLETED|Overall Study||0
66812|NCT01528592|158532|P1|COMPLETED|Overall Study||18
66813|NCT01528592|158532|P1|STARTED|Overall Study||18
66814|NCT01528345|158538|P2|NOT COMPLETED|Overall Study||50
66815|NCT01528345|158539|P1|NOT COMPLETED|Overall Study||47
66816|NCT01528345|158538|P2|COMPLETED|Overall Study||0
66817|NCT01528345|158539|P1|COMPLETED|Overall Study||0
66818|NCT01528345|158538|P2|STARTED|Overall Study||50
66819|NCT01528345|158539|P1|STARTED|Overall Study||47
66820|NCT01528332|158557|P2|NOT COMPLETED|Overall Study||2
66821|NCT01528332|158558|P1|NOT COMPLETED|Overall Study||4
66822|NCT01528332|158557|P2|COMPLETED|Overall Study||84
66823|NCT01528332|158558|P1|COMPLETED|Overall Study||81
66824|NCT01528332|158557|P2|STARTED|Overall Study||86
66825|NCT01528332|158558|P1|STARTED|Overall Study||85
66826|NCT01528319|158564|P1|NOT COMPLETED|Overall Study||1
66827|NCT01528319|158564|P1|COMPLETED|Overall Study||23
66828|NCT01528319|158564|P1|12 Weeks After Surgery|Overall Study||24
66829|NCT01528319|158564|P1|STARTED|Overall Study||24
66830|NCT01528293|158575|P2|NOT COMPLETED|Overall Study||0
66831|NCT01528293|158576|P1|NOT COMPLETED|Overall Study||1
66832|NCT01528293|158575|P2|COMPLETED|Overall Study||1
66833|NCT01528293|158576|P1|COMPLETED|Overall Study||0
66834|NCT01528293|158575|P2|STARTED|Overall Study||1
66835|NCT01528293|158576|P1|STARTED|Overall Study||1
66836|NCT01528215|158590|P2|NOT COMPLETED|Overall Study||1
66837|NCT01528215|158591|P1|NOT COMPLETED|Overall Study||4
66838|NCT01528215|158590|P2|COMPLETED|Overall Study||60
66839|NCT01528215|158591|P1|COMPLETED|Overall Study||55
66840|NCT01528215|158590|P2|STARTED|Overall Study||61
66841|NCT01528215|158591|P1|STARTED|Overall Study||59
66842|NCT01528150|158597|P1|NOT COMPLETED|Overall Study||44
66843|NCT01528150|158597|P1|COMPLETED|Overall Study||422
66844|NCT01528150|158597|P1|STARTED|Overall Study||466
66845|NCT01527942|158603|P2|NOT COMPLETED|Overall Study||0
66846|NCT01527942|158604|P1|NOT COMPLETED|Overall Study||0
66847|NCT01527942|158603|P2|COMPLETED|Overall Study||18
66848|NCT01527942|158604|P1|COMPLETED|Overall Study||16
66849|NCT01527942|158603|P2|STARTED|Overall Study||18
66850|NCT01527942|158604|P1|STARTED|Overall Study||16
66851|NCT01527513|158616|P2|NOT COMPLETED|Eligible for 1-Year Open Label Period||17
66852|NCT01527513|158617|P1|NOT COMPLETED|Eligible for 1-Year Open Label Period||0
66853|NCT01527513|158616|P2|COMPLETED|Eligible for 1-Year Open Label Period||95
66854|NCT01527513|158617|P1|COMPLETED|Eligible for 1-Year Open Label Period||0
66855|NCT01527513|158616|P2|STARTED|Eligible for 1-Year Open Label Period|Participants that were eligible to participate in for 1-Year Open Label Period - Part II|112
66856|NCT01527513|158617|P1|STARTED|Eligible for 1-Year Open Label Period||0
66857|NCT01527513|158616|P2|NOT COMPLETED|Double Blind Period (DB) - Part I||8
66858|NCT01527513|158617|P1|NOT COMPLETED|Double Blind Period (DB) - Part I||3
66859|NCT01527513|158616|P2|COMPLETED|Double Blind Period (DB) - Part I||75
66860|NCT01527513|158617|P1|COMPLETED|Double Blind Period (DB) - Part I||37
66861|NCT01527513|158616|P2|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||66
66862|NCT01527513|158617|P1|Per-protocol (PP) Population|Double Blind Period (DB) - Part I||36
66863|NCT01527513|158616|P2|Efficacy PP Population|Double Blind Period (DB) - Part I||67
66864|NCT01527513|158617|P1|Efficacy PP Population|Double Blind Period (DB) - Part I||37
66865|NCT01527513|158616|P2|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||75
66866|NCT01527513|158617|P1|Eligible for Open Label Period (OL)|Double Blind Period (DB) - Part I||37
66867|NCT01527513|158616|P2|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||75
66868|NCT01527513|158617|P1|Completed the Double Blind (DB)- Part I|Double Blind Period (DB) - Part I||37
66869|NCT01527513|158616|P2|Entered Maintenance Period|Double Blind Period (DB) - Part I||76
66870|NCT01527513|158617|P1|Entered Maintenance Period|Double Blind Period (DB) - Part I||40
66871|NCT01527513|158616|P2|Safety Population|Double Blind Period (DB) - Part I||83
66872|NCT01527513|158617|P1|Safety Population|Double Blind Period (DB) - Part I||40
66873|NCT01527513|158616|P2|Randomized|Double Blind Period (DB) - Part I||83
66874|NCT01527513|158617|P1|Randomized|Double Blind Period (DB) - Part I||40
66875|NCT01527513|158616|P2|STARTED|Double Blind Period (DB) - Part I||83
66876|NCT01527513|158617|P1|STARTED|Double Blind Period (DB) - Part I||40
66877|NCT01527487|158629|P2|NOT COMPLETED|Overall Study||7
66878|NCT01527487|158630|P1|NOT COMPLETED|Overall Study||8
66879|NCT01527487|158629|P2|COMPLETED|Overall Study||15
66880|NCT01527487|158630|P1|COMPLETED|Overall Study|Patients who completed 6 cycles plus surgery.|46
66881|NCT01527487|158629|P2|STARTED|Overall Study||22
66882|NCT01527487|158630|P1|STARTED|Overall Study|Includes 10 patients from safety lead-in.|54
66883|NCT01527370|158642|P1|NOT COMPLETED|Overall Study||6
66884|NCT01527370|158642|P1|COMPLETED|Overall Study||244
66885|NCT01527370|158642|P1|STARTED|Overall Study||250
66886|NCT01527162|158648|P2|NOT COMPLETED|Overall Study||0
66887|NCT01527162|158649|P1|NOT COMPLETED|Overall Study||0
66888|NCT01527162|158648|P2|COMPLETED|Overall Study||5
66889|NCT01527162|158649|P1|COMPLETED|Overall Study||6
66890|NCT01527162|158648|P2|STARTED|Overall Study||5
66891|NCT01527162|158649|P1|STARTED|Overall Study||6
66892|NCT01527006|158661|P2|NOT COMPLETED|Extension Phase||8
66893|NCT01527006|158662|P1|NOT COMPLETED|Extension Phase||6
66894|NCT01527006|158661|P2|COMPLETED|Extension Phase||14
66895|NCT01527006|158662|P1|COMPLETED|Extension Phase||13
66896|NCT01527006|158661|P2|STARTED|Extension Phase||22
66897|NCT01527006|158662|P1|STARTED|Extension Phase|Of the 20 subjects who completed the Core Study, 19 subjects continued into the Extension Phase.|19
66898|NCT01527006|158661|P2|NOT COMPLETED|Core Study||6
66899|NCT01527006|158662|P1|NOT COMPLETED|Core Study||2
66900|NCT01527006|158661|P2|COMPLETED|Core Study||22
66901|NCT01527006|158662|P1|COMPLETED|Core Study||20
66902|NCT01527006|158661|P2|STARTED|Core Study||28
66903|NCT01527006|158662|P1|STARTED|Core Study||22
66904|NCT01526902|158712|P2|NOT COMPLETED|Overall Study||0
66905|NCT01526902|158713|P1|NOT COMPLETED|Overall Study||0
66906|NCT01526902|158712|P2|COMPLETED|Overall Study||24
66907|NCT01526902|158713|P1|COMPLETED|Overall Study||25
66908|NCT01526902|158712|P2|STARTED|Overall Study||24
66909|NCT01526902|158713|P1|STARTED|Overall Study||25
66910|NCT01526785|158729|P1|NOT COMPLETED|Overall Study||13
66911|NCT01526785|158729|P1|COMPLETED|Overall Study||100
66912|NCT01526785|158729|P1|STARTED|Overall Study||113
66913|NCT01526733|158739|P2|NOT COMPLETED|Phase 2||0
66914|NCT01526733|158740|P1|NOT COMPLETED|Phase 2||0
66915|NCT01526733|158739|P2|COMPLETED|Phase 2||12
66916|NCT01526733|158740|P1|COMPLETED|Phase 2||10
66917|NCT01526733|158739|P2|STARTED|Phase 2||12
66918|NCT01526733|158740|P1|STARTED|Phase 2||10
66919|NCT01526733|158739|P2|NOT COMPLETED|Washout Period of 5 to 21 Days||0
66920|NCT01526733|158740|P1|NOT COMPLETED|Washout Period of 5 to 21 Days||0
66921|NCT01526733|158739|P2|COMPLETED|Washout Period of 5 to 21 Days||12
66922|NCT01526733|158740|P1|COMPLETED|Washout Period of 5 to 21 Days||10
66923|NCT01526733|158739|P2|STARTED|Washout Period of 5 to 21 Days||12
66924|NCT01526733|158740|P1|STARTED|Washout Period of 5 to 21 Days||10
66925|NCT01526733|158739|P2|NOT COMPLETED|Phase 1||1
66926|NCT01526733|158740|P1|NOT COMPLETED|Phase 1||2
66927|NCT01526733|158739|P2|COMPLETED|Phase 1||12
66928|NCT01526733|158740|P1|COMPLETED|Phase 1||10
66929|NCT01526733|158739|P2|Received at Least 1 Dose of Study Drug|Phase 1||13
66930|NCT01526733|158740|P1|Received at Least 1 Dose of Study Drug|Phase 1||12
66931|NCT01526733|158739|P2|STARTED|Phase 1|One participant discontinued after receiving insulin-sham and before receiving insulin-rHuPH20.|13
66932|NCT01526733|158740|P1|STARTED|Phase 1||12
66933|NCT01526629|158758|P1|NOT COMPLETED|Overall Study||46
66934|NCT01526629|158758|P1|COMPLETED|Overall Study||308
66935|NCT01526629|158758|P1|STARTED|Overall Study||354
66936|NCT01526551|158762|P1|NOT COMPLETED|Overall Study||424
66937|NCT01526551|158762|P1|COMPLETED|Overall Study||511
66938|NCT01526551|158762|P1|STARTED|Overall Study||935
66939|NCT01526538|158769|P2|NOT COMPLETED|Overall Study||4
66940|NCT01526538|158770|P1|NOT COMPLETED|Overall Study||9
66941|NCT01526538|158769|P2|COMPLETED|Overall Study||18
66942|NCT01526538|158770|P1|COMPLETED|Overall Study||21
66943|NCT01526538|158769|P2|STARTED|Overall Study||22
66944|NCT01526538|158770|P1|STARTED|Overall Study||30
66945|NCT01526343|158780|P1|NOT COMPLETED|Overall Study||0
66946|NCT01526343|158780|P1|COMPLETED|Overall Study||47
66947|NCT01526343|158780|P1|STARTED|Overall Study||47
66948|NCT01526213|158791|P6|NOT COMPLETED|Period 3 (5 Days)||0
66949|NCT01526213|158792|P5|NOT COMPLETED|Period 3 (5 Days)||0
66950|NCT01526213|158793|P4|NOT COMPLETED|Period 3 (5 Days)||0
66951|NCT01526213|158794|P3|NOT COMPLETED|Period 3 (5 Days)||0
66952|NCT01526213|158795|P2|NOT COMPLETED|Period 3 (5 Days)||0
66953|NCT01526213|158796|P1|NOT COMPLETED|Period 3 (5 Days)||0
66954|NCT01526213|158791|P6|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66955|NCT01526213|158792|P5|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66956|NCT01526213|158793|P4|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66957|NCT01526213|158794|P3|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66958|NCT01526213|158795|P2|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66959|NCT01526213|158796|P1|COMPLETED|Period 3 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66960|NCT01526213|158791|P6|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66961|NCT01526213|158792|P5|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66962|NCT01526213|158793|P4|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66963|NCT01526213|158794|P3|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67125|NCT01525238|159117|P3|COMPLETED|Overall Study||8
66964|NCT01526213|158795|P2|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66965|NCT01526213|158796|P1|STARTED|Period 3 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66966|NCT01526213|158791|P6|NOT COMPLETED|Washout 2 (10 Days)||0
66967|NCT01526213|158792|P5|NOT COMPLETED|Washout 2 (10 Days)||0
66968|NCT01526213|158793|P4|NOT COMPLETED|Washout 2 (10 Days)||0
66969|NCT01526213|158794|P3|NOT COMPLETED|Washout 2 (10 Days)||0
66970|NCT01526213|158795|P2|NOT COMPLETED|Washout 2 (10 Days)||0
66971|NCT01526213|158796|P1|NOT COMPLETED|Washout 2 (10 Days)||0
66972|NCT01526213|158791|P6|COMPLETED|Washout 2 (10 Days)||3
66973|NCT01526213|158792|P5|COMPLETED|Washout 2 (10 Days)||3
66974|NCT01526213|158793|P4|COMPLETED|Washout 2 (10 Days)||3
66975|NCT01526213|158794|P3|COMPLETED|Washout 2 (10 Days)||3
66976|NCT01526213|158795|P2|COMPLETED|Washout 2 (10 Days)||3
66977|NCT01526213|158796|P1|COMPLETED|Washout 2 (10 Days)||3
66978|NCT01526213|158791|P6|STARTED|Washout 2 (10 Days)||3
66979|NCT01526213|158792|P5|STARTED|Washout 2 (10 Days)||3
66980|NCT01526213|158793|P4|STARTED|Washout 2 (10 Days)||3
66981|NCT01526213|158794|P3|STARTED|Washout 2 (10 Days)||3
66982|NCT01526213|158795|P2|STARTED|Washout 2 (10 Days)||3
66983|NCT01526213|158796|P1|STARTED|Washout 2 (10 Days)||3
66984|NCT01526213|158791|P6|NOT COMPLETED|Period 2 (5 Days)||0
66985|NCT01526213|158792|P5|NOT COMPLETED|Period 2 (5 Days)||0
66986|NCT01526213|158793|P4|NOT COMPLETED|Period 2 (5 Days)||0
66987|NCT01526213|158794|P3|NOT COMPLETED|Period 2 (5 Days)||0
66988|NCT01526213|158795|P2|NOT COMPLETED|Period 2 (5 Days)||0
66989|NCT01526213|158796|P1|NOT COMPLETED|Period 2 (5 Days)||0
66990|NCT01526213|158791|P6|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
66991|NCT01526213|158792|P5|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
66992|NCT01526213|158793|P4|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
66993|NCT01526213|158794|P3|COMPLETED|Period 2 (5 Days)|3-way crossover study. Each subject was his/her own control and underwent all 3 treatments.|3
66994|NCT01526213|158795|P2|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66995|NCT01526213|158796|P1|COMPLETED|Period 2 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
66996|NCT01526213|158791|P6|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66997|NCT01526213|158792|P5|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66998|NCT01526213|158793|P4|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
66999|NCT01526213|158794|P3|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67000|NCT01526213|158795|P2|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67001|NCT01526213|158796|P1|STARTED|Period 2 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67002|NCT01526213|158791|P6|NOT COMPLETED|Washout 1 (10 Days)||0
67003|NCT01526213|158792|P5|NOT COMPLETED|Washout 1 (10 Days)||0
67004|NCT01526213|158793|P4|NOT COMPLETED|Washout 1 (10 Days)||0
67005|NCT01526213|158794|P3|NOT COMPLETED|Washout 1 (10 Days)||0
67006|NCT01526213|158795|P2|NOT COMPLETED|Washout 1 (10 Days)||0
67007|NCT01526213|158796|P1|NOT COMPLETED|Washout 1 (10 Days)||0
67008|NCT01526213|158791|P6|COMPLETED|Washout 1 (10 Days)||3
67009|NCT01526213|158792|P5|COMPLETED|Washout 1 (10 Days)||3
67010|NCT01526213|158793|P4|COMPLETED|Washout 1 (10 Days)||3
67011|NCT01526213|158794|P3|COMPLETED|Washout 1 (10 Days)||3
67012|NCT01526213|158795|P2|COMPLETED|Washout 1 (10 Days)||3
67013|NCT01526213|158796|P1|COMPLETED|Washout 1 (10 Days)||3
67014|NCT01526213|158791|P6|STARTED|Washout 1 (10 Days)||3
67015|NCT01526213|158792|P5|STARTED|Washout 1 (10 Days)||3
67016|NCT01526213|158793|P4|STARTED|Washout 1 (10 Days)||3
67017|NCT01526213|158794|P3|STARTED|Washout 1 (10 Days)||3
67018|NCT01526213|158795|P2|STARTED|Washout 1 (10 Days)||3
67019|NCT01526213|158796|P1|STARTED|Washout 1 (10 Days)||3
67020|NCT01526213|158791|P6|NOT COMPLETED|Period 1 (5 Days)||0
67021|NCT01526213|158792|P5|NOT COMPLETED|Period 1 (5 Days)||0
67022|NCT01526213|158793|P4|NOT COMPLETED|Period 1 (5 Days)||0
67023|NCT01526213|158794|P3|NOT COMPLETED|Period 1 (5 Days)||0
67024|NCT01526213|158795|P2|NOT COMPLETED|Period 1 (5 Days)||0
67025|NCT01526213|158796|P1|NOT COMPLETED|Period 1 (5 Days)||0
67026|NCT01526213|158791|P6|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
67027|NCT01526213|158792|P5|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
67028|NCT01526213|158793|P4|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
67029|NCT01526213|158794|P3|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
67030|NCT01526213|158795|P2|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
67031|NCT01526213|158796|P1|COMPLETED|Period 1 (5 Days)|Each subject served as his/her own control and completed assigned sequence.|3
67032|NCT01526213|158791|P6|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to (and completed) one of six sequences.|3
67033|NCT01526213|158792|P5|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67034|NCT01526213|158793|P4|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67035|NCT01526213|158794|P3|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67036|NCT01526213|158795|P2|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67037|NCT01526213|158796|P1|STARTED|Period 1 (5 Days)|3-way crossover study. Each subject was assigned to one of six sequences.|3
67038|NCT01526148|158809|P2|NOT COMPLETED|Overall Study||13
67039|NCT01526148|158810|P1|NOT COMPLETED|Overall Study||14
67040|NCT01526148|158809|P2|COMPLETED|Overall Study||11
67041|NCT01526148|158810|P1|COMPLETED|Overall Study||4
67042|NCT01526148|158809|P2|STARTED|Overall Study||24
67043|NCT01526148|158810|P1|STARTED|Overall Study||18
67044|NCT01525927|158820|P1|NOT COMPLETED|Overall Study||0
67045|NCT01525927|158820|P1|COMPLETED|Overall Study||0
67046|NCT01525927|158820|P1|STARTED|Overall Study||0
67047|NCT01525849|158827|P2|NOT COMPLETED|Overall Study||16
67048|NCT01525849|158828|P1|NOT COMPLETED|Overall Study||5
67049|NCT01525849|158827|P2|COMPLETED|Overall Study||59
67050|NCT01525849|158828|P1|COMPLETED|Overall Study||71
67051|NCT01525849|158827|P2|6-Months|Overall Study||60
67052|NCT01525849|158828|P1|6-Months|Overall Study||73
67053|NCT01525849|158827|P2|Treated|Overall Study|14 withdrew before treatment: 8 didn't want FESS, 1 too busy, 2 medical issues, 3 excl. criteria.|61
67054|NCT01525849|158828|P1|Treated|Overall Study|2 withdrew before treatment: 1 didn't want balloon dilation, 1 unrelated medical issue.|74
67055|NCT01525849|158827|P2|STARTED|Overall Study||75
67056|NCT01525849|158828|P1|STARTED|Overall Study||76
67057|NCT01525745|158844|P2|NOT COMPLETED|Overall Study||1
67058|NCT01525745|158845|P1|NOT COMPLETED|Overall Study||1
67059|NCT01525745|158844|P2|COMPLETED|Overall Study||1
67060|NCT01525745|158845|P1|COMPLETED|Overall Study||3
67061|NCT01525745|158844|P2|STARTED|Overall Study||2
67062|NCT01525745|158845|P1|STARTED|Overall Study||4
67063|NCT01525667|158862|P3|NOT COMPLETED|Overall Study||0
67064|NCT01525667|158863|P2|NOT COMPLETED|Overall Study||0
67065|NCT01525667|158864|P1|NOT COMPLETED|Overall Study||0
67066|NCT01525667|158862|P3|COMPLETED|Overall Study||7
67067|NCT01525667|158863|P2|COMPLETED|Overall Study||6
67068|NCT01525667|158864|P1|COMPLETED|Overall Study||7
67069|NCT01525667|158862|P3|STARTED|Overall Study||7
67070|NCT01525667|158863|P2|STARTED|Overall Study||6
67071|NCT01525667|158864|P1|STARTED|Overall Study||7
67072|NCT01525641|158884|P1|NOT COMPLETED|Overall Study||180
67073|NCT01525641|158884|P1|COMPLETED|Overall Study||435
67074|NCT01525641|158884|P1|STARTED|Overall Study||615
67075|NCT01525628|158898|P5|NOT COMPLETED|Overall Study||3
67076|NCT01525628|158899|P4|NOT COMPLETED|Overall Study||4
67077|NCT01525628|158900|P3|NOT COMPLETED|Overall Study||5
67078|NCT01525628|158901|P2|NOT COMPLETED|Overall Study||5
67079|NCT01525628|158902|P1|NOT COMPLETED|Overall Study||2
67080|NCT01525628|158898|P5|COMPLETED|Overall Study||4
67081|NCT01525628|158899|P4|COMPLETED|Overall Study||10
67082|NCT01525628|158900|P3|COMPLETED|Overall Study||11
67083|NCT01525628|158901|P2|COMPLETED|Overall Study||14
67084|NCT01525628|158902|P1|COMPLETED|Overall Study||14
67085|NCT01525628|158898|P5|STARTED|Overall Study||7
67086|NCT01525628|158899|P4|STARTED|Overall Study||14
67087|NCT01525628|158900|P3|STARTED|Overall Study||16
67088|NCT01525628|158901|P2|STARTED|Overall Study||19
67089|NCT01525628|158902|P1|STARTED|Overall Study||16
67090|NCT01525615|158969|P3|NOT COMPLETED|Overall Study||6
67091|NCT01525615|158970|P2|NOT COMPLETED|Overall Study||7
67092|NCT01525615|158971|P1|NOT COMPLETED|Overall Study||14
67093|NCT01525615|158969|P3|COMPLETED|Overall Study||133
67094|NCT01525615|158970|P2|COMPLETED|Overall Study||126
67095|NCT01525615|158971|P1|COMPLETED|Overall Study||118
67096|NCT01525615|158969|P3|STARTED|Overall Study||139
67097|NCT01525615|158970|P2|STARTED|Overall Study||133
67098|NCT01525615|158971|P1|STARTED|Overall Study||132
67099|NCT01525563|159015|P1|NOT COMPLETED|Overall Study||212
67100|NCT01525563|159015|P1|COMPLETED|Overall Study|6 Months Follow-up|788
67101|NCT01525563|159015|P1|3 Months Follow-up|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|838
67102|NCT01525563|159015|P1|End of Treatment|Overall Study|Only patients who had cycle regularization at end of treatment were allowed to continue.|910
67103|NCT01525563|159015|P1|STARTED|Overall Study||1000
67104|NCT01525550|159027|P2|NOT COMPLETED|Overall Study||45
67105|NCT01525550|159028|P1|NOT COMPLETED|Overall Study||61
67106|NCT01525550|159027|P2|COMPLETED|Overall Study||0
67107|NCT01525550|159028|P1|COMPLETED|Overall Study||0
67108|NCT01525550|159027|P2|STARTED|Overall Study||45
67109|NCT01525550|159028|P1|STARTED|Overall Study||61
67110|NCT01525420|159090|P2|NOT COMPLETED|Overall Study||24
67111|NCT01525420|159091|P1|NOT COMPLETED|Overall Study||16
67112|NCT01525420|159090|P2|COMPLETED|Overall Study||38
67113|NCT01525420|159091|P1|COMPLETED|Overall Study||43
67114|NCT01525420|159090|P2|STARTED|Overall Study||62
67115|NCT01525420|159091|P1|STARTED|Overall Study||59
67116|NCT01525407|159099|P2|NOT COMPLETED|Overall Study||4
67117|NCT01525407|159100|P1|NOT COMPLETED|Overall Study||3
67118|NCT01525407|159099|P2|COMPLETED|Overall Study||38
67119|NCT01525407|159100|P1|COMPLETED|Overall Study||38
67120|NCT01525407|159099|P2|STARTED|Overall Study||42
67121|NCT01525407|159100|P1|STARTED|Overall Study||41
67122|NCT01525238|159117|P3|NOT COMPLETED|Overall Study||0
67123|NCT01525238|159118|P2|NOT COMPLETED|Overall Study||0
67124|NCT01525238|159119|P1|NOT COMPLETED|Overall Study||1
67126|NCT01525238|159118|P2|COMPLETED|Overall Study||8
67127|NCT01525238|159119|P1|COMPLETED|Overall Study||7
67128|NCT01525238|159117|P3|STARTED|Overall Study||8
67129|NCT01525238|159118|P2|STARTED|Overall Study||8
67130|NCT01525238|159119|P1|STARTED|Overall Study||8
67131|NCT01525225|159184|P1|NOT COMPLETED|Treated||0
67132|NCT01525225|159184|P1|COMPLETED|Treated||2
67133|NCT01525225|159184|P1|STARTED|Treated||2
67134|NCT01525225|159184|P1|NOT COMPLETED|Enrollment||2
67135|NCT01525225|159184|P1|COMPLETED|Enrollment||2
67136|NCT01525225|159184|P1|STARTED|Enrollment||4
67137|NCT01525173|159191|P2|NOT COMPLETED|Overall Study||5
67138|NCT01525173|159192|P1|NOT COMPLETED|Overall Study||7
67139|NCT01525173|159191|P2|COMPLETED|Overall Study||62
67140|NCT01525173|159192|P1|COMPLETED|Overall Study||63
67141|NCT01525173|159191|P2|STARTED|Overall Study||67
67142|NCT01525173|159192|P1|STARTED|Overall Study||70
67143|NCT01524913|159201|P3|NOT COMPLETED|Overall Study||0
67144|NCT01524913|159202|P2|NOT COMPLETED|Overall Study||0
67145|NCT01524913|159203|P1|NOT COMPLETED|Overall Study||4
67146|NCT01524913|159201|P3|COMPLETED|Overall Study||31
67147|NCT01524913|159202|P2|COMPLETED|Overall Study||36
67148|NCT01524913|159203|P1|COMPLETED|Overall Study||31
67149|NCT01524913|159201|P3|STARTED|Overall Study||31
67150|NCT01524913|159202|P2|STARTED|Overall Study||36
67151|NCT01524913|159203|P1|STARTED|Overall Study||35
67152|NCT01524900|159225|P5|NOT COMPLETED|Overall Study||0
67153|NCT01524900|159226|P4|NOT COMPLETED|Overall Study||1
67154|NCT01524900|159227|P3|NOT COMPLETED|Overall Study||1
67155|NCT01524900|159228|P2|NOT COMPLETED|Overall Study||14
67156|NCT01524900|159229|P1|NOT COMPLETED|Overall Study||6
67157|NCT01524900|159225|P5|COMPLETED|Overall Study||40
67158|NCT01524900|159226|P4|COMPLETED|Overall Study||21
67159|NCT01524900|159227|P3|COMPLETED|Overall Study||29
67160|NCT01524900|159228|P2|COMPLETED|Overall Study||232
67161|NCT01524900|159229|P1|COMPLETED|Overall Study||43
67162|NCT01524900|159225|P5|STARTED|Overall Study||40
67163|NCT01524900|159226|P4|STARTED|Overall Study||22
67164|NCT01524900|159227|P3|STARTED|Overall Study||30
67165|NCT01524900|159228|P2|STARTED|Overall Study||246
67166|NCT01524900|159229|P1|STARTED|Overall Study||49
67167|NCT01524887|159274|P3|NOT COMPLETED|Overall Study||86
67168|NCT01524887|159275|P2|NOT COMPLETED|Overall Study||90
67169|NCT01524887|159276|P1|NOT COMPLETED|Overall Study||85
67170|NCT01524887|159274|P3|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
67171|NCT01524887|159275|P2|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
67172|NCT01524887|159276|P1|COMPLETED|Overall Study|No subject completed the study as Baxter Healthcare terminated the study early.|0
67173|NCT01524887|159274|P3|Received Treatment|Overall Study||83
67174|NCT01524887|159275|P2|Received Treatment|Overall Study||85
67175|NCT01524887|159276|P1|Received Treatment|Overall Study||83
67176|NCT01524887|159274|P3|STARTED|Overall Study||86
67177|NCT01524887|159275|P2|STARTED|Overall Study||90
67178|NCT01524887|159276|P1|STARTED|Overall Study||85
67179|NCT01524796|159320|P1|NOT COMPLETED|Overall Study||28
67180|NCT01524796|159320|P1|COMPLETED|Overall Study||100
67181|NCT01524796|159320|P1|STARTED|Overall Study||128
67182|NCT01524783|159335|P2|NOT COMPLETED|Randomized and Treated||84
67183|NCT01524783|159336|P1|NOT COMPLETED|Randomized and Treated||155
67184|NCT01524783|159335|P2|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|13
67185|NCT01524783|159336|P1|COMPLETED|Randomized and Treated|Completed = Patients with ongoing treatment at the time of data cut-off of 28-Nov-2014.|48
67186|NCT01524783|159335|P2|STARTED|Randomized and Treated||97
67187|NCT01524783|159336|P1|STARTED|Randomized and Treated||203
67188|NCT01524783|159335|P2|NOT COMPLETED|Randomized But Not Treated||0
67189|NCT01524783|159336|P1|NOT COMPLETED|Randomized But Not Treated||2
67190|NCT01524783|159335|P2|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|97
67191|NCT01524783|159336|P1|COMPLETED|Randomized But Not Treated|Completed = Participants randomized and treated with study drug|203
67192|NCT01524783|159335|P2|STARTED|Randomized But Not Treated||97
67193|NCT01524783|159336|P1|STARTED|Randomized But Not Treated||205
67194|NCT01524770|159358|P2|NOT COMPLETED|Second Intervention||0
67195|NCT01524770|159359|P1|NOT COMPLETED|Second Intervention||0
67196|NCT01524770|159358|P2|COMPLETED|Second Intervention||23
67197|NCT01524770|159359|P1|COMPLETED|Second Intervention||23
67198|NCT01524770|159358|P2|STARTED|Second Intervention||23
67199|NCT01524770|159359|P1|STARTED|Second Intervention||23
67200|NCT01524770|159358|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
67201|NCT01524770|159359|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
67202|NCT01524770|159358|P2|COMPLETED|Washout Period of at Least 28 Days||23
67203|NCT01524770|159359|P1|COMPLETED|Washout Period of at Least 28 Days||23
67204|NCT01524770|159358|P2|STARTED|Washout Period of at Least 28 Days||23
67205|NCT01524770|159359|P1|STARTED|Washout Period of at Least 28 Days||23
67206|NCT01524770|159358|P2|NOT COMPLETED|First Intervention||1
67207|NCT01524770|159359|P1|NOT COMPLETED|First Intervention||3
67208|NCT01524770|159358|P2|COMPLETED|First Intervention||23
67209|NCT01524770|159359|P1|COMPLETED|First Intervention||23
67210|NCT01524770|159358|P2|Received at Least 1 Dose of Study Drug|First Intervention||24
67211|NCT01524770|159359|P1|Received at Least 1 Dose of Study Drug|First Intervention||26
67212|NCT01524770|159358|P2|STARTED|First Intervention||24
67213|NCT01524770|159359|P1|STARTED|First Intervention||26
67214|NCT01524627|159371|P2|NOT COMPLETED|Overall Study||2
67215|NCT01524627|159372|P1|NOT COMPLETED|Overall Study||1
67216|NCT01524627|159371|P2|COMPLETED|Overall Study||19
67217|NCT01524627|159372|P1|COMPLETED|Overall Study||21
67218|NCT01524627|159371|P2|STARTED|Overall Study||21
67219|NCT01524627|159372|P1|STARTED|Overall Study||22
67220|NCT01524302|159380|P2|NOT COMPLETED|Overall Study||0
67221|NCT01524302|159381|P1|NOT COMPLETED|Overall Study||0
67222|NCT01524302|159380|P2|COMPLETED|Overall Study||6
67223|NCT01524302|159381|P1|COMPLETED|Overall Study||6
67224|NCT01524302|159380|P2|STARTED|Overall Study||6
67225|NCT01524302|159381|P1|STARTED|Overall Study||6
67226|NCT01524198|159399|P2|NOT COMPLETED|Overall Study||16
67227|NCT01524198|159400|P1|NOT COMPLETED|Overall Study||23
67228|NCT01524198|159399|P2|COMPLETED|Overall Study||458
67229|NCT01524198|159400|P1|COMPLETED|Overall Study||448
67230|NCT01524198|159399|P2|STARTED|Overall Study||474
67231|NCT01524198|159400|P1|STARTED|Overall Study||471
67232|NCT01523964|159412|P4|NOT COMPLETED|Overall Study||0
67233|NCT01523964|159413|P3|NOT COMPLETED|Overall Study||0
67234|NCT01523964|159414|P2|NOT COMPLETED|Overall Study||0
67235|NCT01523964|159415|P1|NOT COMPLETED|Overall Study||0
67236|NCT01523964|159412|P4|COMPLETED|Overall Study||15
67237|NCT01523964|159413|P3|COMPLETED|Overall Study||16
67238|NCT01523964|159414|P2|COMPLETED|Overall Study||30
67239|NCT01523964|159415|P1|COMPLETED|Overall Study||31
67240|NCT01523964|159412|P4|STARTED|Overall Study||15
67241|NCT01523964|159413|P3|STARTED|Overall Study||16
67242|NCT01523964|159414|P2|STARTED|Overall Study||30
67243|NCT01523964|159415|P1|STARTED|Overall Study||31
67244|NCT01523886|159427|P2|NOT COMPLETED|Overall Study||1
67245|NCT01523886|159428|P1|NOT COMPLETED|Overall Study||0
67246|NCT01523886|159427|P2|COMPLETED|Overall Study||23
67247|NCT01523886|159428|P1|COMPLETED|Overall Study||25
67248|NCT01523886|159427|P2|STARTED|Overall Study||24
67249|NCT01523886|159428|P1|STARTED|Overall Study||25
67250|NCT01523873|159434|P1|NOT COMPLETED|Overall Study||422
67251|NCT01523873|159434|P1|COMPLETED|Overall Study||35499
67252|NCT01523873|159434|P1|Administered With Dotarem|Overall Study||35474
67253|NCT01523873|159434|P1|STARTED|Overall Study||35921
67254|NCT01523756|159441|P2|NOT COMPLETED|Test Period 2||1
67255|NCT01523756|159442|P1|NOT COMPLETED|Test Period 2||0
67256|NCT01523756|159441|P2|COMPLETED|Test Period 2||7
67257|NCT01523756|159442|P1|COMPLETED|Test Period 2||10
67258|NCT01523756|159441|P2|STARTED|Test Period 2||8
67259|NCT01523756|159442|P1|STARTED|Test Period 2||10
67260|NCT01523756|159441|P2|NOT COMPLETED|Test Period 1||0
67261|NCT01523756|159442|P1|NOT COMPLETED|Test Period 1||1
67262|NCT01523756|159441|P2|COMPLETED|Test Period 1||8
67263|NCT01523756|159442|P1|COMPLETED|Test Period 1||10
67264|NCT01523756|159441|P2|STARTED|Test Period 1||8
67265|NCT01523756|159442|P1|STARTED|Test Period 1||11
67266|NCT01523756|159441|P2|NOT COMPLETED|Baseline Period||1
67267|NCT01523756|159442|P1|NOT COMPLETED|Baseline Period||0
67268|NCT01523756|159441|P2|COMPLETED|Baseline Period||8
67269|NCT01523756|159442|P1|COMPLETED|Baseline Period||11
67270|NCT01523756|159441|P2|STARTED|Baseline Period||9
67271|NCT01523756|159442|P1|STARTED|Baseline Period||11
67272|NCT01523743|159450|P2|NOT COMPLETED|Period 2||2
67273|NCT01523743|159451|P1|NOT COMPLETED|Period 2||1
67274|NCT01523743|159450|P2|COMPLETED|Period 2||58
67275|NCT01523743|159451|P1|COMPLETED|Period 2||52
67276|NCT01523743|159450|P2|STARTED|Period 2||60
67277|NCT01523743|159451|P1|STARTED|Period 2||53
67278|NCT01523743|159450|P2|NOT COMPLETED|Period 1||2
67279|NCT01523743|159451|P1|NOT COMPLETED|Period 1||10
67280|NCT01523743|159450|P2|COMPLETED|Period 1||60
67281|NCT01523743|159451|P1|COMPLETED|Period 1||53
67282|NCT01523743|159450|P2|STARTED|Period 1||62
67283|NCT01523743|159451|P1|STARTED|Period 1||63
67284|NCT01523587|159459|P2|NOT COMPLETED|Overall Study||54
67285|NCT01523587|159460|P1|NOT COMPLETED|Overall Study||87
67286|NCT01523587|159459|P2|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|280
67287|NCT01523587|159460|P1|COMPLETED|Overall Study|Pts that withdrew due to PD (RECIST 1.1), PD (non RECIST1.1) and ongoing were considered Completed.|248
67288|NCT01523587|159459|P2|STARTED|Overall Study||334
67289|NCT01523587|159460|P1|STARTED|Overall Study||335
67290|NCT01523457|159480|P2|NOT COMPLETED|Overall Study||2
67291|NCT01523457|159481|P1|NOT COMPLETED|Overall Study||7
67292|NCT01523457|159480|P2|COMPLETED|Overall Study||29
67293|NCT01523457|159481|P1|COMPLETED|Overall Study||37
67294|NCT01523457|159480|P2|STARTED|Overall Study||31
67295|NCT01523457|159481|P1|STARTED|Overall Study||44
67296|NCT01523392|159499|P2|NOT COMPLETED|Treatment Period 2||0
67297|NCT01523392|159500|P1|NOT COMPLETED|Treatment Period 2||0
67298|NCT01523392|159499|P2|COMPLETED|Treatment Period 2||14
67299|NCT01523392|159500|P1|COMPLETED|Treatment Period 2||17
67300|NCT01523392|159499|P2|STARTED|Treatment Period 2||14
67301|NCT01523392|159500|P1|STARTED|Treatment Period 2||17
67302|NCT01523392|159499|P2|NOT COMPLETED|Washout Period - 10 to 14 Days||0
67303|NCT01523392|159500|P1|NOT COMPLETED|Washout Period - 10 to 14 Days||1
67304|NCT01523392|159499|P2|COMPLETED|Washout Period - 10 to 14 Days||14
67305|NCT01523392|159500|P1|COMPLETED|Washout Period - 10 to 14 Days||17
67306|NCT01523392|159499|P2|STARTED|Washout Period - 10 to 14 Days||14
67307|NCT01523392|159500|P1|STARTED|Washout Period - 10 to 14 Days|1 patient did not complete 7-9 days of Period 1 treatment but continued in the Washout and Period 2|18
67308|NCT01523392|159499|P2|NOT COMPLETED|Treatment Period 1||0
67309|NCT01523392|159500|P1|NOT COMPLETED|Treatment Period 1||3
67310|NCT01523392|159499|P2|COMPLETED|Treatment Period 1||14
67311|NCT01523392|159500|P1|COMPLETED|Treatment Period 1||17
67312|NCT01523392|159499|P2|STARTED|Treatment Period 1||14
67313|NCT01523392|159500|P1|STARTED|Treatment Period 1||20
67314|NCT01523366|159516|P2|NOT COMPLETED|Treatment Period 2||0
67315|NCT01523366|159517|P1|NOT COMPLETED|Treatment Period 2||1
67316|NCT01523366|159516|P2|COMPLETED|Treatment Period 2||20
67317|NCT01523366|159517|P1|COMPLETED|Treatment Period 2||18
67318|NCT01523366|159516|P2|STARTED|Treatment Period 2||20
67319|NCT01523366|159517|P1|STARTED|Treatment Period 2||19
67320|NCT01523366|159516|P2|NOT COMPLETED|Washout Period - 10-14 Days||0
67321|NCT01523366|159517|P1|NOT COMPLETED|Washout Period - 10-14 Days||0
67322|NCT01523366|159516|P2|COMPLETED|Washout Period - 10-14 Days||20
67323|NCT01523366|159517|P1|COMPLETED|Washout Period - 10-14 Days||19
67324|NCT01523366|159516|P2|STARTED|Washout Period - 10-14 Days||20
67325|NCT01523366|159517|P1|STARTED|Washout Period - 10-14 Days||19
67326|NCT01523366|159516|P2|NOT COMPLETED|Treatment Period 1||0
67327|NCT01523366|159517|P1|NOT COMPLETED|Treatment Period 1||1
67328|NCT01523366|159516|P2|COMPLETED|Treatment Period 1||20
67329|NCT01523366|159517|P1|COMPLETED|Treatment Period 1||19
67330|NCT01523366|159516|P2|STARTED|Treatment Period 1||20
67331|NCT01523366|159517|P1|STARTED|Treatment Period 1||20
67332|NCT01523301|159533|P2|NOT COMPLETED|Overall Study||32
67333|NCT01523301|159534|P1|NOT COMPLETED|Overall Study||35
67334|NCT01523301|159533|P2|COMPLETED|Overall Study||164
67335|NCT01523301|159534|P1|COMPLETED|Overall Study||149
67336|NCT01523301|159533|P2|STARTED|Overall Study||196
67337|NCT01523301|159534|P1|STARTED|Overall Study||184
67338|NCT01522976|159555|P3|NOT COMPLETED|Overall Study||93
67339|NCT01522976|159556|P2|NOT COMPLETED|Overall Study||92
67340|NCT01522976|159557|P1|NOT COMPLETED|Overall Study||97
67341|NCT01522976|159555|P3|COMPLETED|Overall Study||0
67342|NCT01522976|159556|P2|COMPLETED|Overall Study||0
67343|NCT01522976|159557|P1|COMPLETED|Overall Study||0
67344|NCT01522976|159555|P3|STARTED|Overall Study||93
67345|NCT01522976|159556|P2|STARTED|Overall Study||92
67346|NCT01522976|159557|P1|STARTED|Overall Study||97
67347|NCT01522963|159581|P4|NOT COMPLETED|Overall Study||6
67348|NCT01522963|159582|P3|NOT COMPLETED|Overall Study||3
67349|NCT01522963|159583|P2|NOT COMPLETED|Overall Study||3
67350|NCT01522963|159584|P1|NOT COMPLETED|Overall Study||2
67351|NCT01522963|159581|P4|COMPLETED|Overall Study||18
67352|NCT01522963|159582|P3|COMPLETED|Overall Study||22
67353|NCT01522963|159583|P2|COMPLETED|Overall Study||22
67354|NCT01522963|159584|P1|COMPLETED|Overall Study||22
67355|NCT01522963|159581|P4|STARTED|Overall Study||24
67356|NCT01522963|159582|P3|STARTED|Overall Study||25
67357|NCT01522963|159583|P2|STARTED|Overall Study||25
67358|NCT01522963|159584|P1|STARTED|Overall Study||24
67359|NCT01522937|159596|P1|NOT COMPLETED|Overall Study||0
67360|NCT01522937|159596|P1|COMPLETED|Overall Study||146
67361|NCT01522937|159596|P1|STARTED|Overall Study||146
67362|NCT01522924|159606|P2|NOT COMPLETED|Overall Study||0
67363|NCT01522924|159607|P1|NOT COMPLETED|Overall Study||0
67364|NCT01522924|159606|P2|COMPLETED|Overall Study|There were 52 dental students who completed the second survey after the lecture.|52
67365|NCT01522924|159607|P1|COMPLETED|Overall Study|There were 42 dental students who completed the second survey after the intervention.|42
67366|NCT01522924|159606|P2|STARTED|Overall Study|There were 52 dental students in the control group.|52
67367|NCT01522924|159607|P1|STARTED|Overall Study|There were 42 dental students in the intervention group.|42
67368|NCT01522703|159627|P2|NOT COMPLETED|Overall Study||6
67369|NCT01522703|159628|P1|NOT COMPLETED|Overall Study||5
67370|NCT01522703|159627|P2|COMPLETED|Overall Study||20
67371|NCT01522703|159628|P1|COMPLETED|Overall Study||20
67372|NCT01522703|159627|P2|STARTED|Overall Study||26
67373|NCT01522703|159628|P1|STARTED|Overall Study||25
67374|NCT01522456|159634|P1|NOT COMPLETED|Overall Study||8
67375|NCT01522456|159634|P1|COMPLETED|Overall Study||65
67376|NCT01522456|159634|P1|STARTED|Overall Study||73
67377|NCT01522339|159695|P1|NOT COMPLETED|Overall Study||0
67378|NCT01522339|159695|P1|COMPLETED|Overall Study||15
67379|NCT01522339|159695|P1|STARTED|Overall Study||15
67380|NCT01522235|159702|P2|NOT COMPLETED|Overall Study||1
67381|NCT01522235|159703|P1|NOT COMPLETED|Overall Study||1
67382|NCT01522235|159702|P2|COMPLETED|Overall Study||2
67383|NCT01522235|159703|P1|COMPLETED|Overall Study||2
67384|NCT01522235|159702|P2|Randomized|Overall Study||3
67385|NCT01522235|159703|P1|Randomized|Overall Study||2
67386|NCT01522235|159702|P2|STARTED|Overall Study||3
67387|NCT01522235|159703|P1|STARTED|Overall Study||3
67388|NCT01522131|159721|P2|NOT COMPLETED|Overall Study||0
67389|NCT01522131|159722|P1|NOT COMPLETED|Overall Study||2
67390|NCT01522131|159721|P2|COMPLETED|Overall Study||17
67391|NCT01522131|159722|P1|COMPLETED|Overall Study||14
67392|NCT01522131|159721|P2|STARTED|Overall Study||17
67393|NCT01522131|159722|P1|STARTED|Overall Study||16
67394|NCT01521923|159734|P4|NOT COMPLETED|Overall Study||13
67395|NCT01521923|159735|P3|NOT COMPLETED|Overall Study||15
67396|NCT01521923|159736|P2|NOT COMPLETED|Overall Study||9
67397|NCT01521923|159737|P1|NOT COMPLETED|Overall Study||7
67398|NCT01521923|159734|P4|COMPLETED|Overall Study||70
67399|NCT01521923|159735|P3|COMPLETED|Overall Study||112
67400|NCT01521923|159736|P2|COMPLETED|Overall Study||72
67401|NCT01521923|159737|P1|COMPLETED|Overall Study||59
67402|NCT01521923|159734|P4|STARTED|Overall Study||83
67403|NCT01521923|159735|P3|STARTED|Overall Study||127
67404|NCT01521923|159736|P2|STARTED|Overall Study||81
67405|NCT01521923|159737|P1|STARTED|Overall Study||66
67406|NCT01521897|159857|P1|NOT COMPLETED|Overall Study||23
67407|NCT01521897|159857|P1|COMPLETED|Overall Study||1120
67408|NCT01521897|159857|P1|STARTED|Overall Study||1143
67409|NCT01521884|159869|P1|NOT COMPLETED|Overall Study||27
67410|NCT01521884|159869|P1|COMPLETED|Overall Study||35
67411|NCT01521884|159869|P1|STARTED|Overall Study||62
67412|NCT01521871|159888|P2|NOT COMPLETED|Overall Study||0
67413|NCT01521871|159889|P1|NOT COMPLETED|Overall Study||0
67414|NCT01521871|159888|P2|COMPLETED|Overall Study||32
67415|NCT01521871|159889|P1|COMPLETED|Overall Study||32
67416|NCT01521871|159888|P2|STARTED|Overall Study||32
67417|NCT01521871|159889|P1|STARTED|Overall Study||32
67418|NCT01521845|159929|P2|NOT COMPLETED|Overall Study||5
67419|NCT01521845|159930|P1|NOT COMPLETED|Overall Study||9
67420|NCT01521845|159929|P2|COMPLETED|Overall Study||47
67421|NCT01521845|159930|P1|COMPLETED|Overall Study||43
67422|NCT01521845|159929|P2|STARTED|Overall Study||52
67423|NCT01521845|159930|P1|STARTED|Overall Study||52
67424|NCT01521780|159940|P3|NOT COMPLETED|Overall Study||0
67425|NCT01521780|159941|P2|NOT COMPLETED|Overall Study||0
67426|NCT01521780|159942|P1|NOT COMPLETED|Overall Study||0
67427|NCT01521780|159940|P3|COMPLETED|Overall Study||2
67428|NCT01521780|159941|P2|COMPLETED|Overall Study||1
67429|NCT01521780|159942|P1|COMPLETED|Overall Study||9
67430|NCT01521780|159940|P3|STARTED|Overall Study||2
67431|NCT01521780|159941|P2|STARTED|Overall Study||1
67432|NCT01521780|159942|P1|STARTED|Overall Study||9
67433|NCT01521559|159966|P2|NOT COMPLETED|Overall Study||18
67434|NCT01521559|159967|P1|NOT COMPLETED|Overall Study||15
67435|NCT01521559|159966|P2|COMPLETED|Overall Study||73
67436|NCT01521559|159967|P1|COMPLETED|Overall Study||77
67437|NCT01521559|159966|P2|Completed Week 52|Overall Study||73
67438|NCT01521559|159967|P1|Completed Week 52|Overall Study||77
67439|NCT01521559|159966|P2|Completed Week 24|Overall Study||85
67440|NCT01521559|159967|P1|Completed Week 24|Overall Study||83
67441|NCT01521559|159966|P2|STARTED|Overall Study||91
67442|NCT01521559|159967|P1|STARTED|Overall Study||92
67443|NCT01521546|159981|P2|NOT COMPLETED|Overall Study||0
67444|NCT01521546|159982|P1|NOT COMPLETED|Overall Study||2
67445|NCT01521546|159981|P2|COMPLETED|Overall Study||20
67446|NCT01521546|159982|P1|COMPLETED|Overall Study||20
67447|NCT01521546|159981|P2|STARTED|Overall Study||20
67448|NCT01521546|159982|P1|STARTED|Overall Study||22
67449|NCT01521507|159990|P2|NOT COMPLETED|Stage 2: Observational Design||2
67450|NCT01521507|159991|P1|NOT COMPLETED|Stage 2: Observational Design||4
67451|NCT01521507|159990|P2|COMPLETED|Stage 2: Observational Design||92
67452|NCT01521507|159991|P1|COMPLETED|Stage 2: Observational Design||94
67453|NCT01521507|159990|P2|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||1
67454|NCT01521507|159991|P1|Received 2nd LipiFlow Tx at 12 Mo|Stage 2: Observational Design||2
67455|NCT01521507|159990|P2|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||9
67456|NCT01521507|159991|P1|Received Other MGD Treatment at 12 Mo|Stage 2: Observational Design||11
67457|NCT01521507|159990|P2|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||82
67458|NCT01521507|159991|P1|Received Only One LipiFlow Tx at 12 Mo|Stage 2: Observational Design||81
67459|NCT01521507|159990|P2|Received Crossover LipiFlow Tx|Stage 2: Observational Design||93
67460|NCT01521507|159991|P1|Received Crossover LipiFlow Tx|Stage 2: Observational Design||0
67461|NCT01521507|159990|P2|STARTED|Stage 2: Observational Design||94
67462|NCT01521507|159991|P1|STARTED|Stage 2: Observational Design||98
67463|NCT01521507|159990|P2|NOT COMPLETED|Stage 1: Randomized Design||5
67464|NCT01521507|159991|P1|NOT COMPLETED|Stage 1: Randomized Design||3
67465|NCT01521507|159990|P2|COMPLETED|Stage 1: Randomized Design||94
67466|NCT01521507|159991|P1|COMPLETED|Stage 1: Randomized Design||98
67467|NCT01521507|159990|P2|Received Initial Treatment (Tx)|Stage 1: Randomized Design||98
67468|NCT01521507|159991|P1|Received Initial Treatment (Tx)|Stage 1: Randomized Design||99
67469|NCT01521507|159990|P2|STARTED|Stage 1: Randomized Design||99
67470|NCT01521507|159991|P1|STARTED|Stage 1: Randomized Design||101
67471|NCT01521364|160008|P1|NOT COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||1
67472|NCT01521364|160008|P1|COMPLETED|Linezolid + 500mg Claritromycin (wk 4&5)||5
67473|NCT01521364|160008|P1|STARTED|Linezolid + 500mg Claritromycin (wk 4&5)||6
67474|NCT01521364|160008|P1|NOT COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||1
67475|NCT01521364|160008|P1|COMPLETED|Linezolid + 250mg Claritromycin (wk 2&3)||6
67476|NCT01521364|160008|P1|STARTED|Linezolid + 250mg Claritromycin (wk 2&3)||7
67477|NCT01521364|160008|P1|NOT COMPLETED|Linezolid Without Clarithromycin (1 wk)||0
67478|NCT01521364|160008|P1|COMPLETED|Linezolid Without Clarithromycin (1 wk)||7
67479|NCT01521364|160008|P1|STARTED|Linezolid Without Clarithromycin (1 wk)||7
67480|NCT01521260|160021|P2|NOT COMPLETED|Overall Study||0
67481|NCT01521260|160022|P1|NOT COMPLETED|Overall Study||0
67482|NCT01521260|160021|P2|COMPLETED|Overall Study||15
67483|NCT01521260|160022|P1|COMPLETED|Overall Study||15
67484|NCT01521260|160021|P2|STARTED|Overall Study||15
67485|NCT01521260|160022|P1|STARTED|Overall Study||15
67486|NCT01521143|160032|P4|NOT COMPLETED|Overall Study||7
67487|NCT01521143|160033|P3|NOT COMPLETED|Overall Study||8
67488|NCT01521143|160034|P2|NOT COMPLETED|Overall Study||26
67489|NCT01521143|160035|P1|NOT COMPLETED|Overall Study||29
67490|NCT01521143|160032|P4|COMPLETED|Overall Study||0
67491|NCT01521143|160033|P3|COMPLETED|Overall Study||0
67492|NCT01521143|160034|P2|COMPLETED|Overall Study||10
67493|NCT01521143|160035|P1|COMPLETED|Overall Study||11
67494|NCT01521143|160032|P4|Received Treatment|Overall Study||4
67495|NCT01521143|160033|P3|Received Treatment|Overall Study||3
67496|NCT01521143|160034|P2|Received Treatment|Overall Study||20
67497|NCT01521143|160035|P1|Received Treatment|Overall Study||20
67498|NCT01521143|160032|P4|STARTED|Overall Study||7
67499|NCT01521143|160033|P3|STARTED|Overall Study||8
67500|NCT01521143|160034|P2|STARTED|Overall Study||36
67501|NCT01521143|160035|P1|STARTED|Overall Study||40
67502|NCT01521026|160067|P2|NOT COMPLETED|Overall Study||3
67503|NCT01521026|160068|P1|NOT COMPLETED|Overall Study||15
67504|NCT01521026|160067|P2|COMPLETED|Overall Study||28
67505|NCT01521026|160068|P1|COMPLETED|Overall Study||23
67506|NCT01521026|160067|P2|STARTED|Overall Study||31
67507|NCT01521026|160068|P1|STARTED|Overall Study||38
67508|NCT01520987|160084|P8|NOT COMPLETED|Overall Study||0
67509|NCT01520987|160085|P7|NOT COMPLETED|Overall Study||0
67510|NCT01520987|160086|P6|NOT COMPLETED|Overall Study||1
67511|NCT01520987|160087|P5|NOT COMPLETED|Overall Study||0
67512|NCT01520987|160088|P4|NOT COMPLETED|Overall Study||0
67513|NCT01520987|160089|P3|NOT COMPLETED|Overall Study||0
67514|NCT01520987|160090|P2|NOT COMPLETED|Overall Study||0
67515|NCT01520987|160091|P1|NOT COMPLETED|Overall Study||1
67516|NCT01520987|160084|P8|COMPLETED|Overall Study||14
67517|NCT01520987|160085|P7|COMPLETED|Overall Study||12
67518|NCT01520987|160086|P6|COMPLETED|Overall Study||13
67519|NCT01520987|160087|P5|COMPLETED|Overall Study||14
67520|NCT01520987|160088|P4|COMPLETED|Overall Study||15
67521|NCT01520987|160089|P3|COMPLETED|Overall Study||11
67522|NCT01520987|160090|P2|COMPLETED|Overall Study||12
67523|NCT01520987|160091|P1|COMPLETED|Overall Study||12
67524|NCT01520987|160084|P8|Dosed|Overall Study||14
67525|NCT01520987|160085|P7|Dosed|Overall Study||12
67526|NCT01520987|160086|P6|Dosed|Overall Study||14
67527|NCT01520987|160087|P5|Dosed|Overall Study||14
67528|NCT01520987|160088|P4|Dosed|Overall Study||15
67529|NCT01520987|160089|P3|Dosed|Overall Study||11
67530|NCT01520987|160090|P2|Dosed|Overall Study||12
67531|NCT01520987|160091|P1|Dosed|Overall Study||13
67532|NCT01520987|160084|P8|STARTED|Overall Study||14
67533|NCT01520987|160085|P7|STARTED|Overall Study||12
67534|NCT01520987|160086|P6|STARTED|Overall Study||14
67535|NCT01520987|160087|P5|STARTED|Overall Study||14
67536|NCT01520987|160088|P4|STARTED|Overall Study||15
67537|NCT01520987|160089|P3|STARTED|Overall Study||11
67538|NCT01520987|160090|P2|STARTED|Overall Study||12
67539|NCT01520987|160091|P1|STARTED|Overall Study||13
67540|NCT01520922|160151|P2|NOT COMPLETED|Survival Follow-up||0
67541|NCT01520922|160152|P1|NOT COMPLETED|Survival Follow-up||1
67542|NCT01520922|160151|P2|COMPLETED|Survival Follow-up||40
67543|NCT01520922|160152|P1|COMPLETED|Survival Follow-up||20
67544|NCT01520922|160151|P2|STARTED|Survival Follow-up||40
67545|NCT01520922|160152|P1|STARTED|Survival Follow-up||21
67546|NCT01520922|160151|P2|NOT COMPLETED|Follow up||1
67547|NCT01520922|160152|P1|NOT COMPLETED|Follow up||0
67548|NCT01520922|160151|P2|COMPLETED|Follow up||44
67549|NCT01520922|160152|P1|COMPLETED|Follow up||44
67550|NCT01520922|160151|P2|STARTED|Follow up||45
67551|NCT01520922|160152|P1|STARTED|Follow up||44
67552|NCT01520922|160151|P2|NOT COMPLETED|Treatment Phase||8
67553|NCT01520922|160152|P1|NOT COMPLETED|Treatment Phase||5
67554|NCT01520922|160151|P2|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|45
67555|NCT01520922|160152|P1|COMPLETED|Treatment Phase|Completed 6 Cycles of Study Treatment|39
67556|NCT01520922|160151|P2|STARTED|Treatment Phase||53
67557|NCT01520922|160152|P1|STARTED|Treatment Phase||44
67558|NCT01520909|160214|P3|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||7
67559|NCT01520909|160215|P2|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
67560|NCT01520909|160216|P1|NOT COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
67561|NCT01520909|160214|P3|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||80
67562|NCT01520909|160215|P2|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
67563|NCT01520909|160216|P1|COMPLETED|Part 2 (Open-Label Period)-Eltrombopag||0
67564|NCT01520909|160214|P3|STARTED|Part 2 (Open-Label Period)-Eltrombopag|Two participants that completed Part 1 did not start Part 2 because of lack of efficacy.|87
67565|NCT01520909|160215|P2|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
67566|NCT01520909|160216|P1|STARTED|Part 2 (Open-Label Period)-Eltrombopag||0
67567|NCT01520909|160214|P3|NOT COMPLETED|Part 1 (Randomized Period)||0
67568|NCT01520909|160215|P2|NOT COMPLETED|Part 1 (Randomized Period)||2
67569|NCT01520909|160216|P1|NOT COMPLETED|Part 1 (Randomized Period)||1
67570|NCT01520909|160214|P3|COMPLETED|Part 1 (Randomized Period)||0
67571|NCT01520909|160215|P2|COMPLETED|Part 1 (Randomized Period)||61
67572|NCT01520909|160216|P1|COMPLETED|Part 1 (Randomized Period)||28
67573|NCT01520909|160214|P3|STARTED|Part 1 (Randomized Period)||0
67574|NCT01520909|160215|P2|STARTED|Part 1 (Randomized Period)||63
67575|NCT01520909|160216|P1|STARTED|Part 1 (Randomized Period)||29
67576|NCT01520727|160287|P9|NOT COMPLETED|Overall Study||0
67577|NCT01520727|160288|P8|NOT COMPLETED|Overall Study||0
67578|NCT01520727|160289|P7|NOT COMPLETED|Overall Study||0
67579|NCT01520727|160290|P6|NOT COMPLETED|Overall Study||0
67580|NCT01520727|160291|P5|NOT COMPLETED|Overall Study||0
67581|NCT01520727|160292|P4|NOT COMPLETED|Overall Study||0
67582|NCT01520727|160293|P3|NOT COMPLETED|Overall Study||0
67583|NCT01520727|160294|P2|NOT COMPLETED|Overall Study||0
67584|NCT01520727|160295|P1|NOT COMPLETED|Overall Study||0
67585|NCT01520727|160287|P9|COMPLETED|Overall Study||16
67586|NCT01520727|160288|P8|COMPLETED|Overall Study||6
67587|NCT01520727|160289|P7|COMPLETED|Overall Study||6
67588|NCT01520727|160290|P6|COMPLETED|Overall Study||6
67589|NCT01520727|160291|P5|COMPLETED|Overall Study||6
67590|NCT01520727|160292|P4|COMPLETED|Overall Study||6
67591|NCT01520727|160293|P3|COMPLETED|Overall Study||6
67592|NCT01520727|160294|P2|COMPLETED|Overall Study||6
67593|NCT01520727|160295|P1|COMPLETED|Overall Study||6
67594|NCT01520727|160287|P9|STARTED|Overall Study||16
67595|NCT01520727|160288|P8|STARTED|Overall Study||6
67596|NCT01520727|160289|P7|STARTED|Overall Study||6
67597|NCT01520727|160290|P6|STARTED|Overall Study||6
67598|NCT01520727|160291|P5|STARTED|Overall Study||6
67599|NCT01520727|160292|P4|STARTED|Overall Study||6
67600|NCT01520727|160293|P3|STARTED|Overall Study||6
67601|NCT01520727|160294|P2|STARTED|Overall Study||6
67602|NCT01520727|160295|P1|STARTED|Overall Study||6
67603|NCT01520714|160333|P2|NOT COMPLETED|Overall Study||6
67604|NCT01520714|160334|P1|NOT COMPLETED|Overall Study||0
67605|NCT01520714|160333|P2|COMPLETED|Overall Study||5
67606|NCT01520714|160334|P1|COMPLETED|Overall Study||0
67607|NCT01520714|160333|P2|STARTED|Overall Study||11
67608|NCT01520714|160334|P1|STARTED|Overall Study||0
67609|NCT01520558|160343|P3|NOT COMPLETED|Overall Study||3
67610|NCT01520558|160344|P2|NOT COMPLETED|Overall Study||2
67611|NCT01520558|160345|P1|NOT COMPLETED|Overall Study||2
67612|NCT01520558|160343|P3|COMPLETED|Overall Study||3
67613|NCT01520558|160344|P2|COMPLETED|Overall Study||1
67614|NCT01520558|160345|P1|COMPLETED|Overall Study||1
67615|NCT01520558|160343|P3|STARTED|Overall Study||6
67616|NCT01520558|160344|P2|STARTED|Overall Study||3
67617|NCT01520558|160345|P1|STARTED|Overall Study||3
67618|NCT01520532|160353|P1|NOT COMPLETED|Overall Study||0
67619|NCT01520532|160353|P1|COMPLETED|Overall Study||60
67620|NCT01520532|160353|P1|STARTED|Overall Study|Subjects who underwent an ablation and had post-procedure MRI|60
67621|NCT01520506|160359|P1|NOT COMPLETED|Overall Study||6
67622|NCT01520506|160359|P1|COMPLETED|Overall Study||44
67623|NCT01520506|160359|P1|STARTED|Overall Study||50
67624|NCT01520454|160369|P4|NOT COMPLETED|Overall Study||0
67625|NCT01520454|160370|P3|NOT COMPLETED|Overall Study||0
67626|NCT01520454|160371|P2|NOT COMPLETED|Overall Study||0
67627|NCT01520454|160372|P1|NOT COMPLETED|Overall Study||0
67628|NCT01520454|160369|P4|COMPLETED|Overall Study||6
67629|NCT01520454|160370|P3|COMPLETED|Overall Study||5
67630|NCT01520454|160371|P2|COMPLETED|Overall Study||6
67631|NCT01520454|160372|P1|COMPLETED|Overall Study||9
67632|NCT01520454|160369|P4|STARTED|Overall Study||6
67633|NCT01520454|160370|P3|STARTED|Overall Study||5
67634|NCT01520454|160371|P2|STARTED|Overall Study||6
67635|NCT01520454|160372|P1|STARTED|Overall Study||9
67636|NCT01520402|160410|P1|NOT COMPLETED|Overall Study||5
67637|NCT01520402|160410|P1|COMPLETED|Overall Study||30
67638|NCT01520402|160410|P1|STARTED|Overall Study||35
67639|NCT01519960|160424|P3|NOT COMPLETED|Overall Study||10
67640|NCT01519960|160425|P2|NOT COMPLETED|Overall Study||50
67641|NCT01519960|160426|P1|NOT COMPLETED|Overall Study||101
67642|NCT01519960|160424|P3|COMPLETED|Overall Study||0
67643|NCT01519960|160425|P2|COMPLETED|Overall Study||0
67644|NCT01519960|160426|P1|COMPLETED|Overall Study||0
67645|NCT01519960|160424|P3|Completed FU Week 24|Overall Study||10
67646|NCT01519960|160425|P2|Completed FU Week 24|Overall Study||15
67647|NCT01519960|160426|P1|Completed FU Week 24|Overall Study||101
67648|NCT01519960|160424|P3|Completed Follow-Up (FU) Week 12|Overall Study||10
67649|NCT01519960|160425|P2|Completed Follow-Up (FU) Week 12|Overall Study||26
67650|NCT01519960|160426|P1|Completed Follow-Up (FU) Week 12|Overall Study||101
67651|NCT01519960|160424|P3|Completed Week 48|Overall Study||10
67652|NCT01519960|160425|P2|Completed Week 48|Overall Study||47
67653|NCT01519960|160426|P1|Completed Week 48|Overall Study||99
67654|NCT01519960|160424|P3|STARTED|Overall Study||10
67655|NCT01519960|160425|P2|STARTED|Overall Study||50
67656|NCT01519960|160426|P1|STARTED|Overall Study||101
67657|NCT01519934|160532|P1|NOT COMPLETED|Overall Study||3
67658|NCT01519934|160532|P1|COMPLETED|Overall Study||45
67659|NCT01519934|160532|P1|STARTED|Overall Study||48
67660|NCT01519921|160541|P2|NOT COMPLETED|Overall Study||15
67661|NCT01519921|160542|P1|NOT COMPLETED|Overall Study||21
67662|NCT01519921|160541|P2|COMPLETED|Overall Study||49
67663|NCT01519921|160542|P1|COMPLETED|Overall Study||65
67664|NCT01519921|160541|P2|STARTED|Overall Study||64
67665|NCT01519921|160542|P1|STARTED|Overall Study||86
67666|NCT01519882|160566|P2|NOT COMPLETED|Overall Study||0
67667|NCT01519882|160567|P1|NOT COMPLETED|Overall Study||0
67668|NCT01519882|160566|P2|COMPLETED|Overall Study||0
67669|NCT01519882|160567|P1|COMPLETED|Overall Study||1
67670|NCT01519882|160566|P2|STARTED|Overall Study||0
67671|NCT01519882|160567|P1|STARTED|Overall Study||1
67672|NCT01519817|160591|P4|NOT COMPLETED|Overall Study||1
67673|NCT01519817|160592|P3|NOT COMPLETED|Overall Study||0
67674|NCT01519817|160593|P2|NOT COMPLETED|Overall Study||0
67675|NCT01519817|160594|P1|NOT COMPLETED|Overall Study||1
67676|NCT01519817|160591|P4|COMPLETED|Overall Study||10
67677|NCT01519817|160592|P3|COMPLETED|Overall Study||16
67678|NCT01519817|160593|P2|COMPLETED|Overall Study||3
67679|NCT01519817|160594|P1|COMPLETED|Overall Study||3
67680|NCT01519817|160591|P4|STARTED|Overall Study||11
67681|NCT01519817|160592|P3|STARTED|Overall Study||16
67682|NCT01519817|160593|P2|STARTED|Overall Study||3
67683|NCT01519817|160594|P1|STARTED|Overall Study||4
67684|NCT01519791|160634|P2|NOT COMPLETED|Overall Study||368
67685|NCT01519791|160635|P1|NOT COMPLETED|Overall Study||152
67686|NCT01519791|160634|P2|COMPLETED|Overall Study||292
67687|NCT01519791|160635|P1|COMPLETED|Overall Study||67
67688|NCT01519791|160634|P2|Completed Week 52|Overall Study||500
67689|NCT01519791|160635|P1|Completed Week 52|Overall Study||143
67690|NCT01519791|160634|P2|STARTED|Overall Study||660
67691|NCT01519791|160635|P1|STARTED|Overall Study||219
67692|NCT01519778|160699|P1|NOT COMPLETED|Overall Study||14
67693|NCT01519778|160699|P1|COMPLETED|Overall Study||186
67694|NCT01519778|160699|P1|STARTED|Overall Study||200
67695|NCT01519765|160705|P2|NOT COMPLETED|Overall Study||2
67696|NCT01519765|160706|P1|NOT COMPLETED|Overall Study||3
67697|NCT01519765|160705|P2|COMPLETED|Overall Study||34
67698|NCT01519765|160706|P1|COMPLETED|Overall Study||34
67699|NCT01519765|160705|P2|STARTED|Overall Study||36
67700|NCT01519765|160706|P1|STARTED|Overall Study||37
67701|NCT01519713|160755|P3|NOT COMPLETED|Overall Study||0
67702|NCT01519713|160756|P2|NOT COMPLETED|Overall Study||0
67703|NCT01519713|160757|P1|NOT COMPLETED|Overall Study||0
67704|NCT01519713|160755|P3|COMPLETED|Overall Study||4
67705|NCT01519713|160756|P2|COMPLETED|Overall Study||2
67706|NCT01519713|160757|P1|COMPLETED|Overall Study||194
67707|NCT01519713|160755|P3|STARTED|Overall Study||4
67708|NCT01519713|160756|P2|STARTED|Overall Study||2
67709|NCT01519713|160757|P1|STARTED|Overall Study||194
67710|NCT01519700|160784|P4|NOT COMPLETED|Overall Study||7
67711|NCT01519700|160785|P3|NOT COMPLETED|Overall Study||7
67712|NCT01519700|160786|P2|NOT COMPLETED|Overall Study||6
67713|NCT01519700|160787|P1|NOT COMPLETED|Overall Study||9
67714|NCT01519700|160784|P4|COMPLETED|Overall Study||47
67715|NCT01519700|160785|P3|COMPLETED|Overall Study||48
67716|NCT01519700|160786|P2|COMPLETED|Overall Study||49
67717|NCT01519700|160787|P1|COMPLETED|Overall Study||45
67718|NCT01519700|160784|P4|Treated Cycle 6 Neupogen|Overall Study||49
67719|NCT01519700|160785|P3|Treated Cycle 6 Neupogen|Overall Study||0
67720|NCT01519700|160786|P2|Treated Cycle 6 Neupogen|Overall Study||49
67721|NCT01519700|160787|P1|Treated Cycle 6 Neupogen|Overall Study||0
67722|NCT01519700|160784|P4|Treated Cycle 6 EP2006|Overall Study||0
67723|NCT01519700|160785|P3|Treated Cycle 6 EP2006|Overall Study||48
67724|NCT01519700|160786|P2|Treated Cycle 6 EP2006|Overall Study||0
67725|NCT01519700|160787|P1|Treated Cycle 6 EP2006|Overall Study||45
67726|NCT01519700|160784|P4|Treated Cycle 5 Neupogen|Overall Study||50
67727|NCT01519700|160785|P3|Treated Cycle 5 Neupogen|Overall Study||48
67728|NCT01519700|160786|P2|Treated Cycle 5 Neupogen|Overall Study||0
67729|NCT01519700|160787|P1|Treated Cycle 5 Neupogen|Overall Study||0
67730|NCT01519700|160784|P4|Treated Cycle 5 EP2006|Overall Study||0
67731|NCT01519700|160785|P3|Treated Cycle 5 EP2006|Overall Study||0
67732|NCT01519700|160786|P2|Treated Cycle 5 EP2006|Overall Study||49
67733|NCT01519700|160787|P1|Treated Cycle 5 EP2006|Overall Study||46
67734|NCT01519700|160784|P4|Treated Cycle 4 Neupogen|Overall Study||50
67735|NCT01519700|160785|P3|Treated Cycle 4 Neupogen|Overall Study||0
67736|NCT01519700|160786|P2|Treated Cycle 4 Neupogen|Overall Study||51
67737|NCT01519700|160787|P1|Treated Cycle 4 Neupogen|Overall Study||0
67738|NCT01519700|160784|P4|Treated Cycle 4 EP2006|Overall Study||0
67739|NCT01519700|160785|P3|Treated Cycle 4 EP2006|Overall Study||50
67740|NCT01519700|160786|P2|Treated Cycle 4 EP2006|Overall Study||0
67741|NCT01519700|160787|P1|Treated Cycle 4 EP2006|Overall Study||51
67742|NCT01519700|160784|P4|Treated Cycle 3 Neupogen|Overall Study||51
67743|NCT01519700|160785|P3|Treated Cycle 3 Neupogen|Overall Study||54
67744|NCT01519700|160786|P2|Treated Cycle 3 Neupogen|Overall Study||0
67745|NCT01519700|160787|P1|Treated Cycle 3 Neupogen|Overall Study||0
67746|NCT01519700|160784|P4|Treated Cycle 3 EP2006|Overall Study||0
67747|NCT01519700|160785|P3|Treated Cycle 3 EP2006|Overall Study||0
67748|NCT01519700|160786|P2|Treated Cycle 3 EP2006|Overall Study||51
67749|NCT01519700|160787|P1|Treated Cycle 3 EP2006|Overall Study||51
67750|NCT01519700|160784|P4|Treated Cycle 2 Neupogen|Overall Study||51
67751|NCT01519700|160785|P3|Treated Cycle 2 Neupogen|Overall Study||0
67752|NCT01519700|160786|P2|Treated Cycle 2 Neupogen|Overall Study||52
67753|NCT01519700|160787|P1|Treated Cycle 2 Neupogen|Overall Study||0
67754|NCT01519700|160784|P4|Treated Cycle 2 EP2006|Overall Study||0
67755|NCT01519700|160785|P3|Treated Cycle 2 EP2006|Overall Study||55
67756|NCT01519700|160786|P2|Treated Cycle 2 EP2006|Overall Study||0
67757|NCT01519700|160787|P1|Treated Cycle 2 EP2006|Overall Study||52
67758|NCT01519700|160784|P4|Treated Cycle 1 Neupogen|Overall Study||52
67759|NCT01519700|160785|P3|Treated Cycle 1 Neupogen|Overall Study||55
67760|NCT01519700|160786|P2|Treated Cycle 1 Neupogen|Overall Study||0
67761|NCT01519700|160787|P1|Treated Cycle 1 Neupogen|Overall Study||0
67762|NCT01519700|160784|P4|Treated Cycle 1 EP2006|Overall Study||0
67763|NCT01519700|160785|P3|Treated Cycle 1 EP2006|Overall Study||0
67764|NCT01519700|160786|P2|Treated Cycle 1 EP2006|Overall Study||54
67765|NCT01519700|160787|P1|Treated Cycle 1 EP2006|Overall Study||53
67766|NCT01519700|160784|P4|STARTED|Overall Study||54
67767|NCT01519700|160785|P3|STARTED|Overall Study||55
67768|NCT01519700|160786|P2|STARTED|Overall Study||55
67769|NCT01519700|160787|P1|STARTED|Overall Study||54
67770|NCT01519674|160822|P3|NOT COMPLETED|Overall Study||12
67771|NCT01519674|160823|P2|NOT COMPLETED|Overall Study||13
67772|NCT01519674|160824|P1|NOT COMPLETED|Overall Study||21
67773|NCT01519674|160822|P3|COMPLETED|Overall Study||181
67774|NCT01519674|160823|P2|COMPLETED|Overall Study||182
67775|NCT01519674|160824|P1|COMPLETED|Overall Study||173
67776|NCT01519674|160822|P3|Exposed|Overall Study||190
67777|NCT01519674|160823|P2|Exposed|Overall Study||193
67778|NCT01519674|160824|P1|Exposed|Overall Study||192
67779|NCT01519674|160822|P3|STARTED|Overall Study||193
67780|NCT01519674|160823|P2|STARTED|Overall Study||195
67781|NCT01519674|160824|P1|STARTED|Overall Study||194
67782|NCT01519661|160862|P1|NOT COMPLETED|Overall Study||61
67783|NCT01519661|160862|P1|COMPLETED|Overall Study||96
67784|NCT01519661|160862|P1|STARTED|Overall Study||157
67785|NCT01519648|160879|P2|NOT COMPLETED|Overall Study||0
67786|NCT01519648|160880|P1|NOT COMPLETED|Overall Study||0
67787|NCT01519648|160879|P2|COMPLETED|Overall Study||306
67788|NCT01519648|160880|P1|COMPLETED|Overall Study||502
67789|NCT01519648|160879|P2|STARTED|Overall Study||306
67790|NCT01519648|160880|P1|STARTED|Overall Study||502
67791|NCT01519518|160888|P2|NOT COMPLETED|Overall Study||10
67792|NCT01519518|160889|P1|NOT COMPLETED|Overall Study||7
67793|NCT01519518|160888|P2|COMPLETED|Overall Study||905
67794|NCT01519518|160889|P1|COMPLETED|Overall Study||907
67795|NCT01519518|160888|P2|STARTED|Overall Study||915
67796|NCT01519518|160889|P1|STARTED|Overall Study||914
67797|NCT01519466|160903|P2|NOT COMPLETED|Overall Study||0
67798|NCT01519466|160904|P1|NOT COMPLETED|Overall Study||0
67799|NCT01519466|160903|P2|COMPLETED|Overall Study||16
67800|NCT01519466|160904|P1|COMPLETED|Overall Study||33
67801|NCT01519466|160903|P2|STARTED|Overall Study||16
67802|NCT01519466|160904|P1|STARTED|Overall Study||33
67803|NCT01519427|160914|P1|NOT COMPLETED|Overall Study||2
67804|NCT01519427|160914|P1|COMPLETED|Overall Study||0
67805|NCT01519427|160914|P1|STARTED|Overall Study||2
67806|NCT01519323|160921|P2|NOT COMPLETED|Overall Study||3
67807|NCT01519323|160922|P1|NOT COMPLETED|Overall Study||3
67808|NCT01519323|160921|P2|COMPLETED|Overall Study||0
67809|NCT01519323|160922|P1|COMPLETED|Overall Study||0
67810|NCT01519323|160921|P2|STARTED|Overall Study||3
67811|NCT01519323|160922|P1|STARTED|Overall Study||3
67812|NCT01519284|160938|P5|NOT COMPLETED|Overall Study||0
67813|NCT01519284|160939|P4|NOT COMPLETED|Overall Study||0
67814|NCT01519284|160940|P3|NOT COMPLETED|Overall Study||2
67815|NCT01519284|160941|P2|NOT COMPLETED|Overall Study||0
67816|NCT01519284|160942|P1|NOT COMPLETED|Overall Study||0
67817|NCT01519284|160938|P5|COMPLETED|Overall Study||16
67818|NCT01519284|160939|P4|COMPLETED|Overall Study||16
67819|NCT01519284|160940|P3|COMPLETED|Overall Study||16
67820|NCT01519284|160941|P2|COMPLETED|Overall Study||16
67821|NCT01519284|160942|P1|COMPLETED|Overall Study||16
67822|NCT01519284|160938|P5|STARTED|Overall Study||16
67823|NCT01519284|160939|P4|STARTED|Overall Study||16
67824|NCT01519284|160940|P3|STARTED|Overall Study||18
67825|NCT01519284|160941|P2|STARTED|Overall Study||16
67826|NCT01519284|160942|P1|STARTED|Overall Study||16
67827|NCT01519271|160971|P2|NOT COMPLETED|Phase 2||0
67828|NCT01519271|160972|P1|NOT COMPLETED|Phase 2||0
67829|NCT01519271|160971|P2|COMPLETED|Phase 2||14
67830|NCT01519271|160972|P1|COMPLETED|Phase 2||12
67831|NCT01519271|160971|P2|STARTED|Phase 2||14
67832|NCT01519271|160972|P1|STARTED|Phase 2|2 participants discontinued after Phase 1|12
67833|NCT01519271|160971|P2|NOT COMPLETED|Phase 1||1
67834|NCT01519271|160972|P1|NOT COMPLETED|Phase 1||0
67835|NCT01519271|160971|P2|COMPLETED|Phase 1|1 participant discontinued participation in the middle of phase 1.|13
67836|NCT01519271|160972|P1|COMPLETED|Phase 1||14
67837|NCT01519271|160971|P2|STARTED|Phase 1||14
67838|NCT01519271|160972|P1|STARTED|Phase 1||14
67839|NCT01519245|160982|P2|NOT COMPLETED|Overall Study||2
67840|NCT01519245|160983|P1|NOT COMPLETED|Overall Study||1
67841|NCT01519245|160982|P2|COMPLETED|Overall Study||18
67842|NCT01519245|160983|P1|COMPLETED|Overall Study||23
67843|NCT01519245|160982|P2|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|2
67844|NCT01519245|160983|P1|Received Post-pump IV TXA|Overall Study|A break in protocol, dosing was given in the operating room at the surgeon's preference.|6
67845|NCT01519245|160982|P2|Received Pre-pump IV TXA|Overall Study|All patients meeting inclusion criteria received appropriate dosing, as per protocol.|18
67846|NCT01519245|160983|P1|Received Pre-pump IV TXA|Overall Study|Two patients included in in the final analysis did not receive pre-pump IV TXA.|21
67847|NCT01519245|160982|P2|STARTED|Overall Study||20
67848|NCT01519245|160983|P1|STARTED|Overall Study||24
67849|NCT01519206|160995|P1|NOT COMPLETED|Overall Study||5
67850|NCT01519206|160995|P1|COMPLETED|Overall Study||27
67851|NCT01519206|160995|P1|STARTED|Overall Study||32
67852|NCT01519167|161009|P2|NOT COMPLETED|Overall Study||8
67853|NCT01519167|161010|P1|NOT COMPLETED|Overall Study||0
67854|NCT01519167|161009|P2|COMPLETED|Overall Study||81
67855|NCT01519167|161010|P1|COMPLETED|Overall Study||1
67856|NCT01519167|161009|P2|STARTED|Overall Study||89
67857|NCT01519167|161010|P1|STARTED|Overall Study||1
67858|NCT01519089|161036|P2|NOT COMPLETED|Overall Study||15
67859|NCT01519089|161037|P1|NOT COMPLETED|Overall Study||7
67860|NCT01519089|161036|P2|COMPLETED|Overall Study||33
67861|NCT01519089|161037|P1|COMPLETED|Overall Study||40
67862|NCT01519089|161036|P2|Received Treatment|Overall Study||47
67863|NCT01519089|161037|P1|Received Treatment|Overall Study||47
67864|NCT01519089|161036|P2|STARTED|Overall Study||48
67865|NCT01519089|161037|P1|STARTED|Overall Study||47
67866|NCT01518946|161158|P3|NOT COMPLETED|Randomized Phase (Second Intervention)||0
67867|NCT01518946|161159|P2|NOT COMPLETED|Randomized Phase (Second Intervention)||0
67868|NCT01518946|161160|P1|NOT COMPLETED|Randomized Phase (Second Intervention)||0
67869|NCT01518946|161158|P3|COMPLETED|Randomized Phase (Second Intervention)||10
67870|NCT01518946|161159|P2|COMPLETED|Randomized Phase (Second Intervention)||9
67871|NCT01518946|161160|P1|COMPLETED|Randomized Phase (Second Intervention)||0
67872|NCT01518946|161158|P3|STARTED|Randomized Phase (Second Intervention)||10
67873|NCT01518946|161159|P2|STARTED|Randomized Phase (Second Intervention)||9
67874|NCT01518946|161160|P1|STARTED|Randomized Phase (Second Intervention)||0
67875|NCT01518946|161158|P3|NOT COMPLETED|Randomized Phase (First Intervention)||0
67876|NCT01518946|161159|P2|NOT COMPLETED|Randomized Phase (First Intervention)||1
67877|NCT01518946|161160|P1|NOT COMPLETED|Randomized Phase (First Intervention)||0
67878|NCT01518946|161158|P3|COMPLETED|Randomized Phase (First Intervention)||10
67879|NCT01518946|161159|P2|COMPLETED|Randomized Phase (First Intervention)||9
67880|NCT01518946|161160|P1|COMPLETED|Randomized Phase (First Intervention)||0
67881|NCT01518946|161158|P3|STARTED|Randomized Phase (First Intervention)||10
67882|NCT01518946|161159|P2|STARTED|Randomized Phase (First Intervention)||10
67883|NCT01518946|161160|P1|STARTED|Randomized Phase (First Intervention)||0
67884|NCT01518946|161158|P3|NOT COMPLETED|Open-label Phase||0
67885|NCT01518946|161159|P2|NOT COMPLETED|Open-label Phase||0
67886|NCT01518946|161160|P1|NOT COMPLETED|Open-label Phase||4
67887|NCT01518946|161158|P3|COMPLETED|Open-label Phase||0
67888|NCT01518946|161159|P2|COMPLETED|Open-label Phase||0
67889|NCT01518946|161160|P1|COMPLETED|Open-label Phase||20
67890|NCT01518946|161158|P3|STARTED|Open-label Phase||0
67891|NCT01518946|161159|P2|STARTED|Open-label Phase||0
67892|NCT01518946|161160|P1|STARTED|Open-label Phase||24
67893|NCT01518530|161167|P1|NOT COMPLETED|Post-Treatment Follow-up||0
67894|NCT01518530|161167|P1|COMPLETED|Post-Treatment Follow-up||9
67895|NCT01518530|161167|P1|STARTED|Post-Treatment Follow-up||9
67896|NCT01518530|161167|P1|NOT COMPLETED|Active Treatment Period||1
67897|NCT01518530|161167|P1|COMPLETED|Active Treatment Period||9
67898|NCT01518530|161167|P1|STARTED|Active Treatment Period||10
67899|NCT01518322|161171|P1|NOT COMPLETED|Overall Study||13
67900|NCT01518322|161171|P1|COMPLETED|Overall Study||222
67901|NCT01518322|161171|P1|STARTED|Overall Study||235
67902|NCT01518270|161184|P1|NOT COMPLETED|Overall Study||0
67903|NCT01518270|161184|P1|COMPLETED|Overall Study||179
67904|NCT01518270|161184|P1|STARTED|Overall Study||179
67905|NCT01518257|161192|P2|NOT COMPLETED|Overall Study||0
67906|NCT01518257|161193|P1|NOT COMPLETED|Overall Study||2
67907|NCT01518257|161192|P2|COMPLETED|Overall Study||60
67908|NCT01518257|161193|P1|COMPLETED|Overall Study||59
67909|NCT01518257|161192|P2|STARTED|Overall Study||60
67910|NCT01518257|161193|P1|STARTED|Overall Study||61
67911|NCT01518244|161215|P1|NOT COMPLETED|Overall Study||3
67912|NCT01518244|161215|P1|COMPLETED|Overall Study||47
67913|NCT01518244|161215|P1|STARTED|Overall Study||50
67914|NCT01518192|161223|P3|NOT COMPLETED|Overall Study||35
67915|NCT01518192|161224|P2|NOT COMPLETED|Overall Study||26
67916|NCT01518192|161225|P1|NOT COMPLETED|Overall Study||29
67917|NCT01518192|161223|P3|COMPLETED|Overall Study||224
67918|NCT01518192|161224|P2|COMPLETED|Overall Study||114
67919|NCT01518192|161225|P1|COMPLETED|Overall Study||116
67920|NCT01518192|161223|P3|STARTED|Overall Study||259
67921|NCT01518192|161224|P2|STARTED|Overall Study||140
67922|NCT01518192|161225|P1|STARTED|Overall Study||145
67923|NCT01518153|161246|P3|NOT COMPLETED|Donor Lymphocyte Infusion||1
67924|NCT01518153|161247|P2|NOT COMPLETED|Donor Lymphocyte Infusion||2
67925|NCT01518153|161248|P1|NOT COMPLETED|Donor Lymphocyte Infusion||0
67926|NCT01518153|161246|P3|COMPLETED|Donor Lymphocyte Infusion||3
67927|NCT01518153|161247|P2|COMPLETED|Donor Lymphocyte Infusion||1
67928|NCT01518153|161248|P1|COMPLETED|Donor Lymphocyte Infusion||0
67929|NCT01518153|161246|P3|STARTED|Donor Lymphocyte Infusion||4
67930|NCT01518153|161247|P2|STARTED|Donor Lymphocyte Infusion||3
67931|NCT01518153|161248|P1|STARTED|Donor Lymphocyte Infusion||0
67932|NCT01518153|161246|P3|NOT COMPLETED|Stem Cell Transplant||0
67933|NCT01518153|161247|P2|NOT COMPLETED|Stem Cell Transplant||0
67934|NCT01518153|161248|P1|NOT COMPLETED|Stem Cell Transplant||9
67935|NCT01518153|161246|P3|COMPLETED|Stem Cell Transplant||0
67936|NCT01518153|161247|P2|COMPLETED|Stem Cell Transplant||0
67937|NCT01518153|161248|P1|COMPLETED|Stem Cell Transplant||7
67938|NCT01518153|161246|P3|STARTED|Stem Cell Transplant||0
67939|NCT01518153|161247|P2|STARTED|Stem Cell Transplant||0
67940|NCT01518153|161248|P1|STARTED|Stem Cell Transplant||16
67941|NCT01517984|161259|P4|NOT COMPLETED|Overall Study||1
67942|NCT01517984|161260|P3|NOT COMPLETED|Overall Study||4
67943|NCT01517984|161261|P2|NOT COMPLETED|Overall Study||23
67944|NCT01517984|161262|P1|NOT COMPLETED|Overall Study||5
67945|NCT01517984|161259|P4|COMPLETED|Overall Study||6
67946|NCT01517984|161260|P3|COMPLETED|Overall Study||10
67947|NCT01517984|161261|P2|COMPLETED|Overall Study||3
67948|NCT01517984|161262|P1|COMPLETED|Overall Study||0
67949|NCT01517984|161259|P4|STARTED|Overall Study||7
67950|NCT01517984|161260|P3|STARTED|Overall Study||14
67951|NCT01517984|161261|P2|STARTED|Overall Study||26
67952|NCT01517984|161262|P1|STARTED|Overall Study||5
67953|NCT01517893|161288|P2|NOT COMPLETED|Overall Study||1
67954|NCT01517893|161289|P1|NOT COMPLETED|Overall Study||2
67955|NCT01517893|161288|P2|COMPLETED|Overall Study||6
67956|NCT01517893|161289|P1|COMPLETED|Overall Study||6
67957|NCT01517893|161288|P2|STARTED|Overall Study||7
67958|NCT01517893|161289|P1|STARTED|Overall Study||8
67959|NCT01517750|161299|P4|NOT COMPLETED|Overall Study||1
67960|NCT01517750|161300|P3|NOT COMPLETED|Overall Study||4
67961|NCT01517750|161301|P2|NOT COMPLETED|Overall Study||2
67962|NCT01517750|161302|P1|NOT COMPLETED|Overall Study||1
67963|NCT01517750|161299|P4|COMPLETED|Overall Study||18
67964|NCT01517750|161300|P3|COMPLETED|Overall Study||17
67965|NCT01517750|161301|P2|COMPLETED|Overall Study||17
67966|NCT01517750|161302|P1|COMPLETED|Overall Study||20
67967|NCT01517750|161299|P4|STARTED|Overall Study||19
67968|NCT01517750|161300|P3|STARTED|Overall Study||21
67969|NCT01517750|161301|P2|STARTED|Overall Study||19
67970|NCT01517750|161302|P1|STARTED|Overall Study||21
67971|NCT01517529|161332|P1|NOT COMPLETED|Overall Study||0
67972|NCT01517529|161332|P1|COMPLETED|Overall Study||10
67973|NCT01517529|161332|P1|STARTED|Overall Study||10
67974|NCT01517412|161339|P2|NOT COMPLETED|Overall Study||24
67975|NCT01517412|161340|P1|NOT COMPLETED|Overall Study||36
67976|NCT01517412|161339|P2|COMPLETED|Overall Study||202
67977|NCT01517412|161340|P1|COMPLETED|Overall Study||189
67978|NCT01517412|161339|P2|STARTED|Overall Study||226
67979|NCT01517412|161340|P1|STARTED|Overall Study||225
67980|NCT01517373|161369|P6|NOT COMPLETED|Treatment Period||7
67981|NCT01517373|161370|P5|NOT COMPLETED|Treatment Period||6
67982|NCT01517373|161371|P4|NOT COMPLETED|Treatment Period||7
67983|NCT01517373|161372|P3|NOT COMPLETED|Treatment Period||6
67984|NCT01517373|161373|P2|NOT COMPLETED|Treatment Period||4
67985|NCT01517373|161374|P1|NOT COMPLETED|Treatment Period||0
67986|NCT01517373|161369|P6|COMPLETED|Treatment Period||54
67987|NCT01517373|161370|P5|COMPLETED|Treatment Period||55
67988|NCT01517373|161371|P4|COMPLETED|Treatment Period||54
67989|NCT01517373|161372|P3|COMPLETED|Treatment Period||54
67990|NCT01517373|161373|P2|COMPLETED|Treatment Period||57
67991|NCT01517373|161374|P1|COMPLETED|Treatment Period||0
67992|NCT01517373|161369|P6|STARTED|Treatment Period||61
67993|NCT01517373|161370|P5|STARTED|Treatment Period||61
67994|NCT01517373|161371|P4|STARTED|Treatment Period||61
67995|NCT01517373|161372|P3|STARTED|Treatment Period||60
67996|NCT01517373|161373|P2|STARTED|Treatment Period||61
67997|NCT01517373|161374|P1|STARTED|Treatment Period||0
67998|NCT01517373|161369|P6|NOT COMPLETED|Run-in Period||0
67999|NCT01517373|161370|P5|NOT COMPLETED|Run-in Period||0
68000|NCT01517373|161371|P4|NOT COMPLETED|Run-in Period||0
68001|NCT01517373|161372|P3|NOT COMPLETED|Run-in Period||0
68002|NCT01517373|161373|P2|NOT COMPLETED|Run-in Period||0
68003|NCT01517373|161374|P1|NOT COMPLETED|Run-in Period||57
68004|NCT01517373|161369|P6|COMPLETED|Run-in Period||0
68005|NCT01517373|161370|P5|COMPLETED|Run-in Period||0
68006|NCT01517373|161371|P4|COMPLETED|Run-in Period||0
68007|NCT01517373|161372|P3|COMPLETED|Run-in Period||0
68008|NCT01517373|161373|P2|COMPLETED|Run-in Period||0
68009|NCT01517373|161374|P1|COMPLETED|Run-in Period||304
68010|NCT01517373|161369|P6|STARTED|Run-in Period||0
68011|NCT01517373|161370|P5|STARTED|Run-in Period||0
68012|NCT01517373|161371|P4|STARTED|Run-in Period||0
68013|NCT01517373|161372|P3|STARTED|Run-in Period||0
68014|NCT01517373|161373|P2|STARTED|Run-in Period||0
68015|NCT01517373|161374|P1|STARTED|Run-in Period||361
68016|NCT01517295|161444|P2|NOT COMPLETED|Overall Study||0
68017|NCT01517295|161445|P1|NOT COMPLETED|Overall Study||1
68018|NCT01517295|161444|P2|COMPLETED|Overall Study||14
68019|NCT01517295|161445|P1|COMPLETED|Overall Study||15
68020|NCT01517295|161444|P2|STARTED|Overall Study||14
68021|NCT01517295|161445|P1|STARTED|Overall Study||16
68022|NCT01517282|161459|P4|NOT COMPLETED|Overall Study||1
68023|NCT01517282|161460|P3|NOT COMPLETED|Overall Study||1
68024|NCT01517282|161461|P2|NOT COMPLETED|Overall Study||1
68025|NCT01517282|161462|P1|NOT COMPLETED|Overall Study||1
68026|NCT01517282|161459|P4|COMPLETED|Overall Study||5
68027|NCT01517282|161460|P3|COMPLETED|Overall Study||8
68028|NCT01517282|161461|P2|COMPLETED|Overall Study||7
68029|NCT01517282|161462|P1|COMPLETED|Overall Study||8
68030|NCT01517282|161459|P4|STARTED|Overall Study||6
68124|NCT01515943|161736|P2|STARTED|Overall Study||85
68031|NCT01517282|161460|P3|STARTED|Overall Study|1 patient completed the trial, but received only 4 doses of medication and 2 MRIs due to pregnancy|9
68032|NCT01517282|161461|P2|STARTED|Overall Study||8
68033|NCT01517282|161462|P1|STARTED|Overall Study|One patient was randomized but did not receive study medication based on the investigator's decision|9
68034|NCT01517178|161496|P2|NOT COMPLETED|Period 2||2
68035|NCT01517178|161497|P1|NOT COMPLETED|Period 2||6
68036|NCT01517178|161496|P2|COMPLETED|Period 2||4
68037|NCT01517178|161497|P1|COMPLETED|Period 2||5
68038|NCT01517178|161496|P2|STARTED|Period 2||6
68039|NCT01517178|161497|P1|STARTED|Period 2|One subject discontinued during run-in and did not start period 2.|11
68040|NCT01517178|161496|P2|NOT COMPLETED|Period 1||5
68041|NCT01517178|161497|P1|NOT COMPLETED|Period 1||4
68042|NCT01517178|161496|P2|COMPLETED|Period 1||6
68043|NCT01517178|161497|P1|COMPLETED|Period 1||12
68044|NCT01517178|161496|P2|STARTED|Period 1||11
68045|NCT01517178|161497|P1|STARTED|Period 1|One subject (who discontinued due to an adverse event) actually used New ostomy base plate.|16
68046|NCT01517074|161503|P1|NOT COMPLETED|Overall Study||0
68047|NCT01517074|161503|P1|COMPLETED|Overall Study||5
68048|NCT01517074|161503|P1|STARTED|Overall Study||5
68049|NCT01516970|161516|P2|NOT COMPLETED|Overall Study||21
68050|NCT01516970|161517|P1|NOT COMPLETED|Overall Study||18
68051|NCT01516970|161516|P2|COMPLETED|Overall Study||132
68052|NCT01516970|161517|P1|COMPLETED|Overall Study||141
68053|NCT01516970|161516|P2|STARTED|Overall Study||153
68054|NCT01516970|161517|P1|STARTED|Overall Study||159
68055|NCT01516892|161529|P1|NOT COMPLETED|Overall Study||343
68056|NCT01516892|161529|P1|COMPLETED|Overall Study||373
68057|NCT01516892|161529|P1|STARTED|Overall Study||716
68058|NCT01516879|161537|P2|NOT COMPLETED|Overall Study||34
68059|NCT01516879|161538|P1|NOT COMPLETED|Overall Study||16
68060|NCT01516879|161537|P2|COMPLETED|Overall Study||568
68061|NCT01516879|161538|P1|COMPLETED|Overall Study||287
68062|NCT01516879|161537|P2|Received Treatment|Overall Study||599
68063|NCT01516879|161538|P1|Received Treatment|Overall Study||302
68064|NCT01516879|161537|P2|STARTED|Overall Study||602
68065|NCT01516879|161538|P1|STARTED|Overall Study||303
68066|NCT01516749|161572|P1|NOT COMPLETED|Follow-up Off Therapy||1
68067|NCT01516749|161572|P1|COMPLETED|Follow-up Off Therapy||4
68068|NCT01516749|161572|P1|STARTED|Follow-up Off Therapy||5
68069|NCT01516749|161572|P1|NOT COMPLETED|Active Therapy||1
68070|NCT01516749|161572|P1|COMPLETED|Active Therapy||5
68071|NCT01516749|161572|P1|STARTED|Active Therapy||6
68072|NCT01516736|161581|P2|NOT COMPLETED|Overall Study||13
68073|NCT01516736|161582|P1|NOT COMPLETED|Overall Study||20
68074|NCT01516736|161581|P2|COMPLETED|Overall Study||140
68075|NCT01516736|161582|P1|COMPLETED|Overall Study||135
68076|NCT01516736|161581|P2|STARTED|Overall Study||153
68077|NCT01516736|161582|P1|STARTED|Overall Study||155
68078|NCT01516632|161604|P2|NOT COMPLETED|Overall Study||15
68079|NCT01516632|161605|P1|NOT COMPLETED|Overall Study||24
68080|NCT01516632|161604|P2|COMPLETED|Overall Study||48
68081|NCT01516632|161605|P1|COMPLETED|Overall Study||77
68082|NCT01516632|161604|P2|STARTED|Overall Study||63
68083|NCT01516632|161605|P1|STARTED|Overall Study||101
68084|NCT01516437|161619|P4|NOT COMPLETED|Overall Study||1
68085|NCT01516437|161620|P3|NOT COMPLETED|Overall Study||1
68086|NCT01516437|161621|P2|NOT COMPLETED|Overall Study||0
68087|NCT01516437|161622|P1|NOT COMPLETED|Overall Study||0
68088|NCT01516437|161619|P4|COMPLETED|Overall Study||6
68089|NCT01516437|161620|P3|COMPLETED|Overall Study||14
68090|NCT01516437|161621|P2|COMPLETED|Overall Study||24
68091|NCT01516437|161622|P1|COMPLETED|Overall Study||24
68092|NCT01516437|161619|P4|STARTED|Overall Study||7
68093|NCT01516437|161620|P3|STARTED|Overall Study||15
68094|NCT01516437|161621|P2|STARTED|Overall Study||24
68095|NCT01516437|161622|P1|STARTED|Overall Study||24
68096|NCT01516268|161678|P2|NOT COMPLETED|Overall Study||0
68097|NCT01516268|161679|P1|NOT COMPLETED|Overall Study||0
68098|NCT01516268|161678|P2|COMPLETED|Overall Study||25
68099|NCT01516268|161679|P1|COMPLETED|Overall Study||25
68100|NCT01516268|161678|P2|STARTED|Overall Study||25
68101|NCT01516268|161679|P1|STARTED|Overall Study||25
68102|NCT01516034|161685|P1|NOT COMPLETED|Overall Study||8
68103|NCT01516034|161685|P1|COMPLETED|Overall Study||0
68104|NCT01516034|161685|P1|STARTED|Overall Study||8
68105|NCT01516008|161692|P3|NOT COMPLETED|Overall Study||18
68106|NCT01516008|161693|P2|NOT COMPLETED|Overall Study||16
68107|NCT01516008|161694|P1|NOT COMPLETED|Overall Study||45
68108|NCT01516008|161692|P3|COMPLETED|Overall Study||99
68109|NCT01516008|161693|P2|COMPLETED|Overall Study||105
68110|NCT01516008|161694|P1|COMPLETED|Overall Study||69
68111|NCT01516008|161692|P3|STARTED|Overall Study||117
68112|NCT01516008|161693|P2|STARTED|Overall Study||121
68113|NCT01516008|161694|P1|STARTED|Overall Study||114
68114|NCT01515956|161726|P1|NOT COMPLETED|Overall Study||0
68115|NCT01515956|161726|P1|COMPLETED|Overall Study||15
68116|NCT01515956|161726|P1|STARTED|Overall Study||15
68117|NCT01515943|161735|P3|NOT COMPLETED|Overall Study||13
68118|NCT01515943|161736|P2|NOT COMPLETED|Overall Study||16
68119|NCT01515943|161737|P1|NOT COMPLETED|Overall Study||6
68120|NCT01515943|161735|P3|COMPLETED|Overall Study||31
68121|NCT01515943|161736|P2|COMPLETED|Overall Study||69
68122|NCT01515943|161737|P1|COMPLETED|Overall Study||69
68123|NCT01515943|161735|P3|STARTED|Overall Study||44
68125|NCT01515943|161737|P1|STARTED|Overall Study||75
68126|NCT01515891|161783|P1|NOT COMPLETED|Overall Study||0
68127|NCT01515891|161783|P1|COMPLETED|Overall Study||4
68128|NCT01515891|161783|P1|STARTED|Overall Study||4
68129|NCT01515865|161790|P3|NOT COMPLETED|Part C (Randomized)||0
68130|NCT01515865|161791|P2|NOT COMPLETED|Part C (Randomized)||0
68131|NCT01515865|161792|P1|NOT COMPLETED|Part C (Randomized)||0
68132|NCT01515865|161790|P3|COMPLETED|Part C (Randomized)||34
68133|NCT01515865|161791|P2|COMPLETED|Part C (Randomized)||33
68134|NCT01515865|161792|P1|COMPLETED|Part C (Randomized)||0
68135|NCT01515865|161790|P3|STARTED|Part C (Randomized)||34
68136|NCT01515865|161791|P2|STARTED|Part C (Randomized)|A total of two subjects from Part B did not meet the criteria required to be enrolled into Part C.|33
68137|NCT01515865|161792|P1|STARTED|Part C (Randomized)||0
68138|NCT01515865|161790|P3|NOT COMPLETED|Part B (Open-label)||0
68139|NCT01515865|161791|P2|NOT COMPLETED|Part B (Open-label)||0
68140|NCT01515865|161792|P1|NOT COMPLETED|Part B (Open-label)||2
68141|NCT01515865|161790|P3|COMPLETED|Part B (Open-label)||0
68142|NCT01515865|161791|P2|COMPLETED|Part B (Open-label)||0
68143|NCT01515865|161792|P1|COMPLETED|Part B (Open-label)||69
68144|NCT01515865|161790|P3|STARTED|Part B (Open-label)||0
68145|NCT01515865|161791|P2|STARTED|Part B (Open-label)||0
68146|NCT01515865|161792|P1|STARTED|Part B (Open-label)|Twenty-four subjects from Part A did not meet the criteria required to be enrolled into Part B.|71
68147|NCT01515865|161790|P3|NOT COMPLETED|Part A (Open-label)||0
68148|NCT01515865|161791|P2|NOT COMPLETED|Part A (Open-label)||0
68149|NCT01515865|161792|P1|NOT COMPLETED|Part A (Open-label)||3
68150|NCT01515865|161790|P3|COMPLETED|Part A (Open-label)||0
68151|NCT01515865|161791|P2|COMPLETED|Part A (Open-label)||0
68152|NCT01515865|161792|P1|COMPLETED|Part A (Open-label)||95
68153|NCT01515865|161790|P3|STARTED|Part A (Open-label)||0
68154|NCT01515865|161791|P2|STARTED|Part A (Open-label)||0
68155|NCT01515865|161792|P1|STARTED|Part A (Open-label)||98
68156|NCT01515696|161802|P2|NOT COMPLETED|Overall Study||10
68157|NCT01515696|161803|P1|NOT COMPLETED|Overall Study||8
68158|NCT01515696|161802|P2|COMPLETED|Overall Study||39
68159|NCT01515696|161803|P1|COMPLETED|Overall Study||39
68160|NCT01515696|161802|P2|STARTED|Overall Study||49
68161|NCT01515696|161803|P1|STARTED|Overall Study||47
68162|NCT01515657|161813|P3|NOT COMPLETED|Third Intervention||0
68163|NCT01515657|161814|P2|NOT COMPLETED|Third Intervention||0
68164|NCT01515657|161815|P1|NOT COMPLETED|Third Intervention||1
68165|NCT01515657|161813|P3|COMPLETED|Third Intervention||13
68166|NCT01515657|161814|P2|COMPLETED|Third Intervention||11
68167|NCT01515657|161815|P1|COMPLETED|Third Intervention||13
68168|NCT01515657|161813|P3|STARTED|Third Intervention||13
68169|NCT01515657|161814|P2|STARTED|Third Intervention||11
68170|NCT01515657|161815|P1|STARTED|Third Intervention||14
68171|NCT01515657|161813|P3|NOT COMPLETED|Second Intervention||0
68172|NCT01515657|161814|P2|NOT COMPLETED|Second Intervention||1
68173|NCT01515657|161815|P1|NOT COMPLETED|Second Intervention||0
68174|NCT01515657|161813|P3|COMPLETED|Second Intervention||13
68175|NCT01515657|161814|P2|COMPLETED|Second Intervention||11
68176|NCT01515657|161815|P1|COMPLETED|Second Intervention||14
68177|NCT01515657|161813|P3|STARTED|Second Intervention||13
68178|NCT01515657|161814|P2|STARTED|Second Intervention||12
68179|NCT01515657|161815|P1|STARTED|Second Intervention||14
68180|NCT01515657|161813|P3|NOT COMPLETED|First Intervention||0
68181|NCT01515657|161814|P2|NOT COMPLETED|First Intervention||1
68182|NCT01515657|161815|P1|NOT COMPLETED|First Intervention||0
68183|NCT01515657|161813|P3|COMPLETED|First Intervention||13
68184|NCT01515657|161814|P2|COMPLETED|First Intervention||12
68185|NCT01515657|161815|P1|COMPLETED|First Intervention||14
68186|NCT01515657|161813|P3|STARTED|First Intervention||13
68187|NCT01515657|161814|P2|STARTED|First Intervention||13
68188|NCT01515657|161815|P1|STARTED|First Intervention||14
68189|NCT01515566|161825|P2|NOT COMPLETED|Overall Study||0
68190|NCT01515566|161826|P1|NOT COMPLETED|Overall Study||0
68191|NCT01515566|161825|P2|COMPLETED|Overall Study||10
68192|NCT01515566|161826|P1|COMPLETED|Overall Study||10
68193|NCT01515566|161825|P2|STARTED|Overall Study||10
68194|NCT01515566|161826|P1|STARTED|Overall Study||10
68195|NCT01515540|161838|P2|NOT COMPLETED|Overall Study||3
68196|NCT01515540|161839|P1|NOT COMPLETED|Overall Study||5
68197|NCT01515540|161838|P2|COMPLETED|Overall Study||15
68198|NCT01515540|161839|P1|COMPLETED|Overall Study||15
68199|NCT01515540|161838|P2|STARTED|Overall Study||18
68200|NCT01515540|161839|P1|STARTED|Overall Study||20
68201|NCT01515488|161847|P2|NOT COMPLETED|Overall Study||0
68202|NCT01515488|161848|P1|NOT COMPLETED|Overall Study||0
68203|NCT01515488|161847|P2|COMPLETED|Overall Study||200
68204|NCT01515488|161848|P1|COMPLETED|Overall Study||200
68205|NCT01515488|161847|P2|STARTED|Overall Study||200
68206|NCT01515488|161848|P1|STARTED|Overall Study||200
68207|NCT01515423|161860|P3|NOT COMPLETED|DOUBLE BLIND||92
68208|NCT01515423|161861|P2|NOT COMPLETED|DOUBLE BLIND||82
68209|NCT01515423|161862|P1|NOT COMPLETED|DOUBLE BLIND||0
68210|NCT01515423|161860|P3|COMPLETED|DOUBLE BLIND||420
68211|NCT01515423|161861|P2|COMPLETED|DOUBLE BLIND||422
68212|NCT01515423|161862|P1|COMPLETED|DOUBLE BLIND||0
68213|NCT01515423|161860|P3|STARTED|DOUBLE BLIND||512
68214|NCT01515423|161861|P2|STARTED|DOUBLE BLIND||504
68215|NCT01515423|161862|P1|STARTED|DOUBLE BLIND||0
68216|NCT01515423|161860|P3|NOT COMPLETED|Open Label Phase||0
68217|NCT01515423|161861|P2|NOT COMPLETED|Open Label Phase||0
68218|NCT01515423|161862|P1|NOT COMPLETED|Open Label Phase||413
68219|NCT01515423|161860|P3|COMPLETED|Open Label Phase||0
68220|NCT01515423|161861|P2|COMPLETED|Open Label Phase||0
68221|NCT01515423|161862|P1|COMPLETED|Open Label Phase||1016
68222|NCT01515423|161860|P3|STARTED|Open Label Phase||0
68223|NCT01515423|161861|P2|STARTED|Open Label Phase||0
68224|NCT01515423|161862|P1|STARTED|Open Label Phase||1429
68225|NCT01515410|161881|P2|NOT COMPLETED|Overall Study||0
68226|NCT01515410|161882|P1|NOT COMPLETED|Overall Study||0
68227|NCT01515410|161881|P2|COMPLETED|Overall Study||15
68228|NCT01515410|161882|P1|COMPLETED|Overall Study||19
68229|NCT01515410|161881|P2|STARTED|Overall Study||15
68230|NCT01515410|161882|P1|STARTED|Overall Study||19
68231|NCT01515345|161890|P2|NOT COMPLETED|Overall Study||0
68232|NCT01515345|161891|P1|NOT COMPLETED|Overall Study||1
68233|NCT01515345|161890|P2|COMPLETED|Overall Study||343
68234|NCT01515345|161891|P1|COMPLETED|Overall Study||664
68235|NCT01515345|161890|P2|STARTED|Overall Study||343
68236|NCT01515345|161891|P1|STARTED|Overall Study||665
68237|NCT01515306|161903|P2|NOT COMPLETED|Overall Study||14
68238|NCT01515306|161904|P1|NOT COMPLETED|Overall Study||12
68239|NCT01515306|161903|P2|COMPLETED|Overall Study||2
68240|NCT01515306|161904|P1|COMPLETED|Overall Study|Completed the required treatment in Cycle 1 Day 1 and Cycle 2 Day 1 and assessment.|12
68241|NCT01515306|161903|P2|Drug-Drug Interaction Population|Overall Study|Drug-drug interaction was only assessed in Part A.|0
68242|NCT01515306|161904|P1|Drug-Drug Interaction Population|Overall Study|Completed Cycle 1 Day 1 and Cycle 2 Day 1 treatment.|21
68243|NCT01515306|161903|P2|Received at Least 1 Dose of Study Drug|Overall Study||16
68244|NCT01515306|161904|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
68245|NCT01515306|161903|P2|STARTED|Overall Study||16
68246|NCT01515306|161904|P1|STARTED|Overall Study||24
68247|NCT01515189|161917|P2|NOT COMPLETED|First Re-Induction Phase||15
68248|NCT01515189|161918|P1|NOT COMPLETED|First Re-Induction Phase||14
68249|NCT01515189|161917|P2|COMPLETED|First Re-Induction Phase||17
68250|NCT01515189|161918|P1|COMPLETED|First Re-Induction Phase||9
68251|NCT01515189|161917|P2|STARTED|First Re-Induction Phase||32
68252|NCT01515189|161918|P1|STARTED|First Re-Induction Phase||23
68253|NCT01515189|161917|P2|NOT COMPLETED|Induction||232
68254|NCT01515189|161918|P1|NOT COMPLETED|Induction||237
68255|NCT01515189|161917|P2|COMPLETED|Induction||130
68256|NCT01515189|161918|P1|COMPLETED|Induction||128
68257|NCT01515189|161917|P2|STARTED|Induction||362
68258|NCT01515189|161918|P1|STARTED|Induction|Includes 1 subject who was randomized but not treated due to an Adverse Event before treatment|365
68259|NCT01515072|161940|P2|NOT COMPLETED|Overall Study||0
68260|NCT01515072|161941|P1|NOT COMPLETED|Overall Study||0
68261|NCT01515072|161940|P2|COMPLETED|Overall Study|There were 513 total organs transplanted and 235 kidneys transplanted in the RIPC group|155
68262|NCT01515072|161941|P1|COMPLETED|Overall Study|There were 566 total organs transplanted and 248 kidneys transplanted in the No RIPC group.|166
68263|NCT01515072|161940|P2|STARTED|Overall Study||155
68264|NCT01515072|161941|P1|STARTED|Overall Study||166
68265|NCT01515046|161981|P1|NOT COMPLETED|Overall Study||0
68266|NCT01515046|161981|P1|COMPLETED|Overall Study||1
68267|NCT01515046|161981|P1|STARTED|Overall Study||1
68268|NCT01514864|161991|P2|NOT COMPLETED|Overall Study||5
68269|NCT01514864|161992|P1|NOT COMPLETED|Overall Study||9
68270|NCT01514864|161991|P2|COMPLETED|Overall Study||0
68271|NCT01514864|161992|P1|COMPLETED|Overall Study|Study was terminated; no patients completed study treatment|0
68272|NCT01514864|161991|P2|STARTED|Overall Study||5
68273|NCT01514864|161992|P1|STARTED|Overall Study||9
68274|NCT01514760|162008|P1|NOT COMPLETED|Overall Study||2
68275|NCT01514760|162008|P1|COMPLETED|Overall Study||20
68276|NCT01514760|162008|P1|STARTED|Overall Study||22
68277|NCT01514734|162015|P1|NOT COMPLETED|Overall Study||0
68278|NCT01514734|162015|P1|COMPLETED|Overall Study||9
68279|NCT01514734|162015|P1|STARTED|Overall Study||9
68280|NCT01514630|162019|P1|NOT COMPLETED|Overall Study||3
68281|NCT01514630|162019|P1|COMPLETED|Overall Study||11
68282|NCT01514630|162019|P1|STARTED|Overall Study||14
68283|NCT01514513|162025|P2|NOT COMPLETED|Overall Study||1
68284|NCT01514513|162026|P1|NOT COMPLETED|Overall Study||1
68285|NCT01514513|162025|P2|COMPLETED|Overall Study||20
68286|NCT01514513|162026|P1|COMPLETED|Overall Study||20
68287|NCT01514513|162025|P2|STARTED|Overall Study||21
68288|NCT01514513|162026|P1|STARTED|Overall Study||21
68289|NCT01514461|162037|P3|NOT COMPLETED|Overall Study||4
68290|NCT01514461|162038|P2|NOT COMPLETED|Overall Study||3
68291|NCT01514461|162039|P1|NOT COMPLETED|Overall Study||5
68292|NCT01514461|162037|P3|COMPLETED|Overall Study||11
68293|NCT01514461|162038|P2|COMPLETED|Overall Study||12
68294|NCT01514461|162039|P1|COMPLETED|Overall Study||10
68295|NCT01514461|162037|P3|STARTED|Overall Study||15
68296|NCT01514461|162038|P2|STARTED|Overall Study||15
68297|NCT01514461|162039|P1|STARTED|Overall Study||15
68298|NCT01514448|162078|P2|NOT COMPLETED|Overall Study||8
68299|NCT01514448|162079|P1|NOT COMPLETED|Overall Study||12
68300|NCT01514448|162078|P2|COMPLETED|Overall Study||5
68301|NCT01514448|162079|P1|COMPLETED|Overall Study||4
68302|NCT01514448|162078|P2|Full Analysis Set (FAS)|Overall Study||13
68303|NCT01514448|162079|P1|Full Analysis Set (FAS)|Overall Study||12
68304|NCT01514448|162078|P2|STARTED|Overall Study||13
68305|NCT01514448|162079|P1|STARTED|Overall Study||16
68306|NCT01514422|162094|P1|NOT COMPLETED|Overall Study||1
68307|NCT01514422|162094|P1|COMPLETED|Overall Study||19
68308|NCT01514422|162094|P1|STARTED|Overall Study||20
68309|NCT01514318|162100|P1|NOT COMPLETED|Overall Study||0
68310|NCT01514318|162100|P1|COMPLETED|Overall Study||8
68311|NCT01514318|162100|P1|STARTED|Overall Study||8
68312|NCT01514292|162106|P1|NOT COMPLETED|Overall Study||0
68313|NCT01514292|162106|P1|COMPLETED|Overall Study||72
68314|NCT01514292|162106|P1|STARTED|Overall Study||72
68315|NCT01514240|162112|P2|NOT COMPLETED|Overall Study||11
68316|NCT01514240|162113|P1|NOT COMPLETED|Overall Study||6
68317|NCT01514240|162112|P2|COMPLETED|Overall Study||45
68318|NCT01514240|162113|P1|COMPLETED|Overall Study||50
68319|NCT01514240|162112|P2|STARTED|Overall Study||56
68320|NCT01514240|162113|P1|STARTED|Overall Study||56
68321|NCT01514162|162187|P1|NOT COMPLETED|Overall Study||85
68322|NCT01514162|162187|P1|COMPLETED|Overall Study||160
68323|NCT01514162|162187|P1|STARTED|Overall Study||245
68324|NCT01514149|162198|P5|NOT COMPLETED|Overall Study||1
68325|NCT01514149|162199|P4|NOT COMPLETED|Overall Study||1
68326|NCT01514149|162200|P3|NOT COMPLETED|Overall Study||3
68327|NCT01514149|162201|P2|NOT COMPLETED|Overall Study||1
68328|NCT01514149|162202|P1|NOT COMPLETED|Overall Study||3
68329|NCT01514149|162198|P5|COMPLETED|Overall Study||14
68330|NCT01514149|162199|P4|COMPLETED|Overall Study||13
68331|NCT01514149|162200|P3|COMPLETED|Overall Study||11
68332|NCT01514149|162201|P2|COMPLETED|Overall Study||14
68333|NCT01514149|162202|P1|COMPLETED|Overall Study||12
68334|NCT01514149|162198|P5|STARTED|Overall Study||15
68335|NCT01514149|162199|P4|STARTED|Overall Study||14
68336|NCT01514149|162200|P3|STARTED|Overall Study||14
68337|NCT01514149|162201|P2|STARTED|Overall Study||15
68338|NCT01514149|162202|P1|STARTED|Overall Study||15
68339|NCT01514136|162226|P8|NOT COMPLETED|Test Period; Test D*||0
68340|NCT01514136|162227|P7|NOT COMPLETED|Test Period; Test D*||0
68341|NCT01514136|162228|P6|NOT COMPLETED|Test Period; Test D*||0
68342|NCT01514136|162229|P5|NOT COMPLETED|Test Period; Test D*||0
68343|NCT01514136|162230|P4|NOT COMPLETED|Test Period; Test D*||0
68344|NCT01514136|162231|P3|NOT COMPLETED|Test Period; Test D*||0
68345|NCT01514136|162232|P2|NOT COMPLETED|Test Period; Test D*||0
68346|NCT01514136|162233|P1|NOT COMPLETED|Test Period; Test D*||0
68347|NCT01514136|162226|P8|COMPLETED|Test Period; Test D*||23
68348|NCT01514136|162227|P7|COMPLETED|Test Period; Test D*||0
68349|NCT01514136|162228|P6|COMPLETED|Test Period; Test D*||0
68350|NCT01514136|162229|P5|COMPLETED|Test Period; Test D*||0
68351|NCT01514136|162230|P4|COMPLETED|Test Period; Test D*||0
68352|NCT01514136|162231|P3|COMPLETED|Test Period; Test D*||0
68353|NCT01514136|162232|P2|COMPLETED|Test Period; Test D*||0
68354|NCT01514136|162233|P1|COMPLETED|Test Period; Test D*||0
68355|NCT01514136|162226|P8|STARTED|Test Period; Test D*||23
68356|NCT01514136|162227|P7|STARTED|Test Period; Test D*||0
68357|NCT01514136|162228|P6|STARTED|Test Period; Test D*||0
68358|NCT01514136|162229|P5|STARTED|Test Period; Test D*||0
68359|NCT01514136|162230|P4|STARTED|Test Period; Test D*||0
68360|NCT01514136|162231|P3|STARTED|Test Period; Test D*||0
68361|NCT01514136|162232|P2|STARTED|Test Period; Test D*||0
68362|NCT01514136|162233|P1|STARTED|Test Period; Test D*||0
68363|NCT01514136|162226|P8|NOT COMPLETED|Test Period 2; Test C*||0
68364|NCT01514136|162227|P7|NOT COMPLETED|Test Period 2; Test C*||3
68365|NCT01514136|162228|P6|NOT COMPLETED|Test Period 2; Test C*||0
68366|NCT01514136|162229|P5|NOT COMPLETED|Test Period 2; Test C*||0
68367|NCT01514136|162230|P4|NOT COMPLETED|Test Period 2; Test C*||0
68368|NCT01514136|162231|P3|NOT COMPLETED|Test Period 2; Test C*||0
68369|NCT01514136|162232|P2|NOT COMPLETED|Test Period 2; Test C*||0
68370|NCT01514136|162233|P1|NOT COMPLETED|Test Period 2; Test C*||0
68371|NCT01514136|162226|P8|COMPLETED|Test Period 2; Test C*||0
68372|NCT01514136|162227|P7|COMPLETED|Test Period 2; Test C*||23
68373|NCT01514136|162228|P6|COMPLETED|Test Period 2; Test C*||0
68374|NCT01514136|162229|P5|COMPLETED|Test Period 2; Test C*||0
68375|NCT01514136|162230|P4|COMPLETED|Test Period 2; Test C*||0
68376|NCT01514136|162231|P3|COMPLETED|Test Period 2; Test C*||0
68377|NCT01514136|162232|P2|COMPLETED|Test Period 2; Test C*||0
68378|NCT01514136|162233|P1|COMPLETED|Test Period 2; Test C*||0
68379|NCT01514136|162226|P8|STARTED|Test Period 2; Test C*||0
68380|NCT01514136|162227|P7|STARTED|Test Period 2; Test C*||26
68381|NCT01514136|162228|P6|STARTED|Test Period 2; Test C*||0
68382|NCT01514136|162229|P5|STARTED|Test Period 2; Test C*||0
68383|NCT01514136|162230|P4|STARTED|Test Period 2; Test C*||0
68384|NCT01514136|162231|P3|STARTED|Test Period 2; Test C*||0
68385|NCT01514136|162232|P2|STARTED|Test Period 2; Test C*||0
68386|NCT01514136|162233|P1|STARTED|Test Period 2; Test C*||0
68387|NCT01514136|162226|P8|NOT COMPLETED|Test Period 2; Test B*||0
68388|NCT01514136|162227|P7|NOT COMPLETED|Test Period 2; Test B*||0
68389|NCT01514136|162228|P6|NOT COMPLETED|Test Period 2; Test B*||2
68390|NCT01514136|162229|P5|NOT COMPLETED|Test Period 2; Test B*||0
68391|NCT01514136|162230|P4|NOT COMPLETED|Test Period 2; Test B*||0
68392|NCT01514136|162231|P3|NOT COMPLETED|Test Period 2; Test B*||0
68393|NCT01514136|162232|P2|NOT COMPLETED|Test Period 2; Test B*||0
68394|NCT01514136|162233|P1|NOT COMPLETED|Test Period 2; Test B*||0
68395|NCT01514136|162226|P8|COMPLETED|Test Period 2; Test B*||0
68396|NCT01514136|162227|P7|COMPLETED|Test Period 2; Test B*||0
68397|NCT01514136|162228|P6|COMPLETED|Test Period 2; Test B*||26
68398|NCT01514136|162229|P5|COMPLETED|Test Period 2; Test B*||0
68399|NCT01514136|162230|P4|COMPLETED|Test Period 2; Test B*||0
68400|NCT01514136|162231|P3|COMPLETED|Test Period 2; Test B*||0
68401|NCT01514136|162232|P2|COMPLETED|Test Period 2; Test B*||0
68402|NCT01514136|162233|P1|COMPLETED|Test Period 2; Test B*||0
68403|NCT01514136|162226|P8|STARTED|Test Period 2; Test B*||0
68404|NCT01514136|162227|P7|STARTED|Test Period 2; Test B*||0
68405|NCT01514136|162228|P6|STARTED|Test Period 2; Test B*|Two subjects did not test test A*, but had a break and continued again on Test B*|28
68406|NCT01514136|162229|P5|STARTED|Test Period 2; Test B*||0
68407|NCT01514136|162230|P4|STARTED|Test Period 2; Test B*||0
68408|NCT01514136|162231|P3|STARTED|Test Period 2; Test B*||0
68409|NCT01514136|162232|P2|STARTED|Test Period 2; Test B*||0
68410|NCT01514136|162233|P1|STARTED|Test Period 2; Test B*||0
68411|NCT01514136|162226|P8|NOT COMPLETED|Test Period 2; Test A*||0
68412|NCT01514136|162227|P7|NOT COMPLETED|Test Period 2; Test A*||0
68413|NCT01514136|162228|P6|NOT COMPLETED|Test Period 2; Test A*||0
68414|NCT01514136|162229|P5|NOT COMPLETED|Test Period 2; Test A*||2
68415|NCT01514136|162230|P4|NOT COMPLETED|Test Period 2; Test A*||0
68416|NCT01514136|162231|P3|NOT COMPLETED|Test Period 2; Test A*||0
68417|NCT01514136|162232|P2|NOT COMPLETED|Test Period 2; Test A*||0
68418|NCT01514136|162233|P1|NOT COMPLETED|Test Period 2; Test A*||0
68419|NCT01514136|162226|P8|COMPLETED|Test Period 2; Test A*||0
68420|NCT01514136|162227|P7|COMPLETED|Test Period 2; Test A*||0
68421|NCT01514136|162228|P6|COMPLETED|Test Period 2; Test A*||0
68422|NCT01514136|162229|P5|COMPLETED|Test Period 2; Test A*||26
68423|NCT01514136|162230|P4|COMPLETED|Test Period 2; Test A*||0
68424|NCT01514136|162231|P3|COMPLETED|Test Period 2; Test A*||0
68425|NCT01514136|162232|P2|COMPLETED|Test Period 2; Test A*||0
68426|NCT01514136|162233|P1|COMPLETED|Test Period 2; Test A*||0
68427|NCT01514136|162226|P8|STARTED|Test Period 2; Test A*||0
68428|NCT01514136|162227|P7|STARTED|Test Period 2; Test A*||0
68429|NCT01514136|162228|P6|STARTED|Test Period 2; Test A*||0
68430|NCT01514136|162229|P5|STARTED|Test Period 2; Test A*|4 new subjects were included in the investigation|28
68431|NCT01514136|162230|P4|STARTED|Test Period 2; Test A*||0
68432|NCT01514136|162231|P3|STARTED|Test Period 2; Test A*||0
68433|NCT01514136|162232|P2|STARTED|Test Period 2; Test A*||0
68434|NCT01514136|162233|P1|STARTED|Test Period 2; Test A*||0
68435|NCT01514136|162226|P8|NOT COMPLETED|Test Period 1; Test D||0
68436|NCT01514136|162227|P7|NOT COMPLETED|Test Period 1; Test D||0
68437|NCT01514136|162228|P6|NOT COMPLETED|Test Period 1; Test D||0
68438|NCT01514136|162229|P5|NOT COMPLETED|Test Period 1; Test D||0
68439|NCT01514136|162230|P4|NOT COMPLETED|Test Period 1; Test D||2
68440|NCT01514136|162231|P3|NOT COMPLETED|Test Period 1; Test D||0
68441|NCT01514136|162232|P2|NOT COMPLETED|Test Period 1; Test D||0
68442|NCT01514136|162233|P1|NOT COMPLETED|Test Period 1; Test D||0
68443|NCT01514136|162226|P8|COMPLETED|Test Period 1; Test D||0
68444|NCT01514136|162227|P7|COMPLETED|Test Period 1; Test D||0
68445|NCT01514136|162228|P6|COMPLETED|Test Period 1; Test D||0
68446|NCT01514136|162229|P5|COMPLETED|Test Period 1; Test D||0
68447|NCT01514136|162230|P4|COMPLETED|Test Period 1; Test D||24
68448|NCT01514136|162231|P3|COMPLETED|Test Period 1; Test D||0
68449|NCT01514136|162232|P2|COMPLETED|Test Period 1; Test D||0
68450|NCT01514136|162233|P1|COMPLETED|Test Period 1; Test D||0
68451|NCT01514136|162226|P8|STARTED|Test Period 1; Test D||0
68452|NCT01514136|162227|P7|STARTED|Test Period 1; Test D||0
68453|NCT01514136|162228|P6|STARTED|Test Period 1; Test D||0
68454|NCT01514136|162229|P5|STARTED|Test Period 1; Test D||0
68455|NCT01514136|162230|P4|STARTED|Test Period 1; Test D|The two subject that were on holiday after test A re-entered the investigation|26
68456|NCT01514136|162231|P3|STARTED|Test Period 1; Test D||0
68457|NCT01514136|162232|P2|STARTED|Test Period 1; Test D||0
68458|NCT01514136|162233|P1|STARTED|Test Period 1; Test D||0
68459|NCT01514136|162226|P8|NOT COMPLETED|Test Period 1; Test C||0
68460|NCT01514136|162227|P7|NOT COMPLETED|Test Period 1; Test C||0
68461|NCT01514136|162228|P6|NOT COMPLETED|Test Period 1; Test C||0
68462|NCT01514136|162229|P5|NOT COMPLETED|Test Period 1; Test C||0
68463|NCT01514136|162230|P4|NOT COMPLETED|Test Period 1; Test C||0
68464|NCT01514136|162231|P3|NOT COMPLETED|Test Period 1; Test C||0
68465|NCT01514136|162232|P2|NOT COMPLETED|Test Period 1; Test C||0
68466|NCT01514136|162233|P1|NOT COMPLETED|Test Period 1; Test C||0
68467|NCT01514136|162226|P8|COMPLETED|Test Period 1; Test C||0
68468|NCT01514136|162227|P7|COMPLETED|Test Period 1; Test C||0
68469|NCT01514136|162228|P6|COMPLETED|Test Period 1; Test C||0
68470|NCT01514136|162229|P5|COMPLETED|Test Period 1; Test C||0
68471|NCT01514136|162230|P4|COMPLETED|Test Period 1; Test C||0
68472|NCT01514136|162231|P3|COMPLETED|Test Period 1; Test C||24
68473|NCT01514136|162232|P2|COMPLETED|Test Period 1; Test C||0
68474|NCT01514136|162233|P1|COMPLETED|Test Period 1; Test C||0
68475|NCT01514136|162226|P8|STARTED|Test Period 1; Test C||0
68476|NCT01514136|162227|P7|STARTED|Test Period 1; Test C||0
68477|NCT01514136|162228|P6|STARTED|Test Period 1; Test C||0
68478|NCT01514136|162229|P5|STARTED|Test Period 1; Test C||0
68479|NCT01514136|162230|P4|STARTED|Test Period 1; Test C||0
68480|NCT01514136|162231|P3|STARTED|Test Period 1; Test C|1 new subject was included in the investigation|24
68481|NCT01514136|162232|P2|STARTED|Test Period 1; Test C||0
68482|NCT01514136|162233|P1|STARTED|Test Period 1; Test C||0
68483|NCT01514136|162226|P8|NOT COMPLETED|Test Period 1; Test B||0
68484|NCT01514136|162227|P7|NOT COMPLETED|Test Period 1; Test B||0
68485|NCT01514136|162228|P6|NOT COMPLETED|Test Period 1; Test B||0
68486|NCT01514136|162229|P5|NOT COMPLETED|Test Period 1; Test B||0
68487|NCT01514136|162230|P4|NOT COMPLETED|Test Period 1; Test B||0
68488|NCT01514136|162231|P3|NOT COMPLETED|Test Period 1; Test B||0
68489|NCT01514136|162232|P2|NOT COMPLETED|Test Period 1; Test B||1
68490|NCT01514136|162233|P1|NOT COMPLETED|Test Period 1; Test B||0
68491|NCT01514136|162226|P8|COMPLETED|Test Period 1; Test B||0
68492|NCT01514136|162227|P7|COMPLETED|Test Period 1; Test B||0
68493|NCT01514136|162228|P6|COMPLETED|Test Period 1; Test B||0
68494|NCT01514136|162229|P5|COMPLETED|Test Period 1; Test B||0
68495|NCT01514136|162230|P4|COMPLETED|Test Period 1; Test B||0
68496|NCT01514136|162231|P3|COMPLETED|Test Period 1; Test B||0
68497|NCT01514136|162232|P2|COMPLETED|Test Period 1; Test B||23
68498|NCT01514136|162233|P1|COMPLETED|Test Period 1; Test B||0
68499|NCT01514136|162226|P8|STARTED|Test Period 1; Test B||0
68500|NCT01514136|162227|P7|STARTED|Test Period 1; Test B||0
68501|NCT01514136|162228|P6|STARTED|Test Period 1; Test B||0
68502|NCT01514136|162229|P5|STARTED|Test Period 1; Test B||0
68503|NCT01514136|162230|P4|STARTED|Test Period 1; Test B||0
68504|NCT01514136|162231|P3|STARTED|Test Period 1; Test B||0
68505|NCT01514136|162232|P2|STARTED|Test Period 1; Test B|2 new subjects were entered the investigation|24
68506|NCT01514136|162233|P1|STARTED|Test Period 1; Test B||0
68507|NCT01514136|162226|P8|NOT COMPLETED|Test Period 1; Test A||0
68508|NCT01514136|162227|P7|NOT COMPLETED|Test Period 1; Test A||0
68509|NCT01514136|162228|P6|NOT COMPLETED|Test Period 1; Test A||0
68510|NCT01514136|162229|P5|NOT COMPLETED|Test Period 1; Test A||0
68511|NCT01514136|162230|P4|NOT COMPLETED|Test Period 1; Test A||0
68512|NCT01514136|162231|P3|NOT COMPLETED|Test Period 1; Test A||0
68513|NCT01514136|162232|P2|NOT COMPLETED|Test Period 1; Test A||0
68514|NCT01514136|162233|P1|NOT COMPLETED|Test Period 1; Test A||3
68515|NCT01514136|162226|P8|COMPLETED|Test Period 1; Test A||0
68516|NCT01514136|162227|P7|COMPLETED|Test Period 1; Test A||0
68517|NCT01514136|162228|P6|COMPLETED|Test Period 1; Test A||0
68518|NCT01514136|162229|P5|COMPLETED|Test Period 1; Test A||0
68519|NCT01514136|162230|P4|COMPLETED|Test Period 1; Test A||0
68520|NCT01514136|162231|P3|COMPLETED|Test Period 1; Test A||0
68521|NCT01514136|162232|P2|COMPLETED|Test Period 1; Test A||0
68522|NCT01514136|162233|P1|COMPLETED|Test Period 1; Test A||22
68523|NCT01514136|162226|P8|STARTED|Test Period 1; Test A||0
68524|NCT01514136|162227|P7|STARTED|Test Period 1; Test A||0
68525|NCT01514136|162228|P6|STARTED|Test Period 1; Test A||0
68526|NCT01514136|162229|P5|STARTED|Test Period 1; Test A||0
68527|NCT01514136|162230|P4|STARTED|Test Period 1; Test A||0
68528|NCT01514136|162231|P3|STARTED|Test Period 1; Test A||0
68529|NCT01514136|162232|P2|STARTED|Test Period 1; Test A||0
68530|NCT01514136|162233|P1|STARTED|Test Period 1; Test A|26 subjects tested Test A|25
68531|NCT01513902|162262|P3|NOT COMPLETED|Overall Study||0
68532|NCT01513902|162263|P2|NOT COMPLETED|Overall Study||0
68533|NCT01513902|162264|P1|NOT COMPLETED|Overall Study||0
68534|NCT01513902|162262|P3|COMPLETED|Overall Study||9
68535|NCT01513902|162263|P2|COMPLETED|Overall Study||9
68536|NCT01513902|162264|P1|COMPLETED|Overall Study||8
68537|NCT01513902|162262|P3|STARTED|Overall Study||9
68538|NCT01513902|162263|P2|STARTED|Overall Study||9
68539|NCT01513902|162264|P1|STARTED|Overall Study||8
68540|NCT01513590|162301|P2|NOT COMPLETED|Overall Study||13
68541|NCT01513590|162302|P1|NOT COMPLETED|Overall Study||10
68542|NCT01513590|162301|P2|COMPLETED|Overall Study||184
68543|NCT01513590|162302|P1|COMPLETED|Overall Study||187
68544|NCT01513590|162301|P2|Exposed|Overall Study|"Two (2) subjects were withdrawn prior to exposure due to withdrawal of consent"|195
68545|NCT01513590|162302|P1|Exposed|Overall Study|One (1) subject was withdrawn prior to exposure due to “non fulfilment of inclusion criteria”|196
68546|NCT01513590|162301|P2|STARTED|Overall Study||197
68547|NCT01513590|162302|P1|STARTED|Overall Study||197
68548|NCT01513473|162322|P2|NOT COMPLETED|Extension Trial (26 Weeks)||6
68549|NCT01513473|162323|P1|NOT COMPLETED|Extension Trial (26 Weeks)||1
68550|NCT01513473|162322|P2|COMPLETED|Extension Trial (26 Weeks)||122
68551|NCT01513473|162323|P1|COMPLETED|Extension Trial (26 Weeks)||151
68552|NCT01513473|162322|P2|STARTED|Extension Trial (26 Weeks)|37 subjects did not consent to participate in the extension trial.|128
68553|NCT01513473|162323|P1|STARTED|Extension Trial (26 Weeks)|18 subjects did not consent to participate in the extension trial.|152
68554|NCT01513473|162322|P2|NOT COMPLETED|Main Trial (26 Weeks)||11
68555|NCT01513473|162323|P1|NOT COMPLETED|Main Trial (26 Weeks)||4
68556|NCT01513473|162322|P2|COMPLETED|Main Trial (26 Weeks)||165
68557|NCT01513473|162323|P1|COMPLETED|Main Trial (26 Weeks)||170
68558|NCT01513473|162322|P2|Exposed|Main Trial (26 Weeks)||175
68559|NCT01513473|162323|P1|Exposed|Main Trial (26 Weeks)||174
68560|NCT01513473|162322|P2|STARTED|Main Trial (26 Weeks)|1 subject was randomised but withdrew before the drug exposure.|176
68561|NCT01513473|162323|P1|STARTED|Main Trial (26 Weeks)||174
68562|NCT01513460|162350|P3|NOT COMPLETED|Overall Study||56
68563|NCT01513460|162351|P2|NOT COMPLETED|Overall Study||32
68564|NCT01513460|162352|P1|NOT COMPLETED|Overall Study||29
68565|NCT01513460|162350|P3|COMPLETED|Overall Study||201
68566|NCT01513460|162351|P2|COMPLETED|Overall Study||226
68567|NCT01513460|162352|P1|COMPLETED|Overall Study||229
68568|NCT01513460|162350|P3|Per-protocol Set|Overall Study||166
68569|NCT01513460|162351|P2|Per-protocol Set|Overall Study||186
68570|NCT01513460|162352|P1|Per-protocol Set|Overall Study||196
68571|NCT01513460|162350|P3|Full Analysis Set|Overall Study||257
68572|NCT01513460|162351|P2|Full Analysis Set|Overall Study||258
68573|NCT01513460|162352|P1|Full Analysis Set|Overall Study||257
68574|NCT01513460|162350|P3|STARTED|Overall Study||257
68575|NCT01513460|162351|P2|STARTED|Overall Study||258
68576|NCT01513460|162352|P1|STARTED|Overall Study||258
68577|NCT01513447|162378|P2|NOT COMPLETED|Overall Study||0
68578|NCT01513447|162379|P1|NOT COMPLETED|Overall Study||0
68579|NCT01513447|162378|P2|COMPLETED|Overall Study||5
68580|NCT01513447|162379|P1|COMPLETED|Overall Study||3
68581|NCT01513447|162378|P2|STARTED|Overall Study||5
68582|NCT01513447|162379|P1|STARTED|Overall Study||3
68583|NCT01513330|162387|P2|NOT COMPLETED|Standard Care First,||4
68584|NCT01513330|162388|P1|NOT COMPLETED|Standard Care First,||4
68585|NCT01513330|162387|P2|COMPLETED|Standard Care First,||52
68586|NCT01513330|162388|P1|COMPLETED|Standard Care First,||56
68587|NCT01513330|162387|P2|STARTED|Standard Care First,||56
68588|NCT01513330|162388|P1|STARTED|Standard Care First,||60
68589|NCT01513330|162387|P2|NOT COMPLETED|SenSura Mio First,||2
68590|NCT01513330|162388|P1|NOT COMPLETED|SenSura Mio First,||4
68591|NCT01513330|162387|P2|COMPLETED|SenSura Mio First,||56
68592|NCT01513330|162388|P1|COMPLETED|SenSura Mio First,||60
68593|NCT01513330|162387|P2|STARTED|SenSura Mio First,||58
68594|NCT01513330|162388|P1|STARTED|SenSura Mio First,||64
68595|NCT01513317|162396|P2|NOT COMPLETED|Overall Study||24
68596|NCT01513317|162397|P1|NOT COMPLETED|Overall Study||34
68597|NCT01513317|162396|P2|COMPLETED|Overall Study||2
68598|NCT01513317|162397|P1|COMPLETED|Overall Study||16
68599|NCT01513317|162396|P2|STARTED|Overall Study||26
68600|NCT01513317|162397|P1|STARTED|Overall Study||50
68601|NCT01513291|162415|P5|NOT COMPLETED|Run-out Period||0
68602|NCT01513291|162416|P4|NOT COMPLETED|Run-out Period||2
68603|NCT01513291|162417|P3|NOT COMPLETED|Run-out Period||0
68604|NCT01513291|162418|P2|NOT COMPLETED|Run-out Period||0
68605|NCT01513291|162419|P1|NOT COMPLETED|Run-out Period||0
68606|NCT01513291|162415|P5|COMPLETED|Run-out Period||101
68607|NCT01513291|162416|P4|COMPLETED|Run-out Period||45
68608|NCT01513291|162417|P3|COMPLETED|Run-out Period||50
68609|NCT01513291|162418|P2|COMPLETED|Run-out Period||0
68610|NCT01513291|162419|P1|COMPLETED|Run-out Period||0
68611|NCT01513291|162415|P5|STARTED|Run-out Period|These participants were completers from the Treatment Period: Placebo group|101
68612|NCT01513291|162416|P4|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|47
68613|NCT01513291|162417|P3|STARTED|Run-out Period|These participants were pre-randomized from participants in the Treatment Period: MK-6096 group|50
68614|NCT01513291|162418|P2|STARTED|Run-out Period||0
68615|NCT01513291|162419|P1|STARTED|Run-out Period||0
68616|NCT01513291|162415|P5|NOT COMPLETED|Treatment Period||0
68617|NCT01513291|162416|P4|NOT COMPLETED|Treatment Period||0
68618|NCT01513291|162417|P3|NOT COMPLETED|Treatment Period||0
68619|NCT01513291|162418|P2|NOT COMPLETED|Treatment Period||16
68620|NCT01513291|162419|P1|NOT COMPLETED|Treatment Period||23
68621|NCT01513291|162415|P5|COMPLETED|Treatment Period||0
68622|NCT01513291|162416|P4|COMPLETED|Treatment Period||0
68623|NCT01513291|162417|P3|COMPLETED|Treatment Period||0
68624|NCT01513291|162418|P2|COMPLETED|Treatment Period||101
68625|NCT01513291|162419|P1|COMPLETED|Treatment Period||97
68626|NCT01513291|162415|P5|Treated|Treatment Period||0
68627|NCT01513291|162416|P4|Treated|Treatment Period||0
68628|NCT01513291|162417|P3|Treated|Treatment Period||0
68629|NCT01513291|162418|P2|Treated|Treatment Period||115
68630|NCT01513291|162419|P1|Treated|Treatment Period||120
68631|NCT01513291|162415|P5|STARTED|Treatment Period||0
68632|NCT01513291|162416|P4|STARTED|Treatment Period||0
68633|NCT01513291|162417|P3|STARTED|Treatment Period||0
68634|NCT01513291|162418|P2|STARTED|Treatment Period||117
68635|NCT01513291|162419|P1|STARTED|Treatment Period||120
68636|NCT01513239|162447|P3|NOT COMPLETED|Overall Study||88
68637|NCT01513239|162448|P2|NOT COMPLETED|Overall Study||70
68638|NCT01513239|162449|P1|NOT COMPLETED|Overall Study||75
68639|NCT01513239|162447|P3|COMPLETED|Overall Study||311
68640|NCT01513239|162448|P2|COMPLETED|Overall Study||337
68641|NCT01513239|162449|P1|COMPLETED|Overall Study||322
68642|NCT01513239|162447|P3|All Participants as Treated|Overall Study|Treatment actually received|381
68643|NCT01513239|162448|P2|All Participants as Treated|Overall Study|Treatment actually received|396
68644|NCT01513239|162449|P1|All Participants as Treated|Overall Study|One participant randomized to receive MK-3415A (MK-3415 plus MK-6072) received only MK-3415|390
68645|NCT01513239|162447|P3|Treated|Overall Study|Treated participants|381
68646|NCT01513239|162448|P2|Treated|Overall Study|Treated participants|396
68647|NCT01513239|162449|P1|Treated|Overall Study|Treated participants|391
68648|NCT01513239|162447|P3|STARTED|Overall Study|Randomized participants|399
68649|NCT01513239|162448|P2|STARTED|Overall Study|Randomized participants|407
68650|NCT01513239|162449|P1|STARTED|Overall Study|Randomized participants|397
68651|NCT01513148|162499|P2|NOT COMPLETED|Overall Study||2
68652|NCT01513148|162500|P1|NOT COMPLETED|Overall Study||2
68653|NCT01513148|162499|P2|COMPLETED|Overall Study||14
68654|NCT01513148|162500|P1|COMPLETED|Overall Study||14
68655|NCT01513148|162499|P2|STARTED|Overall Study||16
68656|NCT01513148|162500|P1|STARTED|Overall Study||16
68657|NCT01513122|162548|P2|NOT COMPLETED|Overall Study||3
68658|NCT01513122|162549|P1|NOT COMPLETED|Overall Study||11
68659|NCT01513122|162548|P2|COMPLETED|Overall Study||105
68660|NCT01513122|162549|P1|COMPLETED|Overall Study||91
68661|NCT01513122|162548|P2|STARTED|Overall Study||108
68662|NCT01513122|162549|P1|STARTED|Overall Study||102
68663|NCT01512979|162567|P2|NOT COMPLETED|Overall Study||22
68664|NCT01512979|162568|P1|NOT COMPLETED|Overall Study||19
68665|NCT01512979|162567|P2|COMPLETED|Overall Study||135
68666|NCT01512979|162568|P1|COMPLETED|Overall Study||140
68667|NCT01512979|162567|P2|STARTED|Overall Study|Randomised and treated|157
68668|NCT01512979|162568|P1|STARTED|Overall Study|Randomised and treated|159
68669|NCT01512849|162588|P4|NOT COMPLETED|Crossover Period 2||0
68670|NCT01512849|162589|P3|NOT COMPLETED|Crossover Period 2||0
68671|NCT01512849|162590|P2|NOT COMPLETED|Crossover Period 2||0
68672|NCT01512849|162591|P1|NOT COMPLETED|Crossover Period 2||0
68673|NCT01512849|162588|P4|COMPLETED|Crossover Period 2||6
68674|NCT01512849|162589|P3|COMPLETED|Crossover Period 2||6
68675|NCT01512849|162590|P2|COMPLETED|Crossover Period 2||6
68676|NCT01512849|162591|P1|COMPLETED|Crossover Period 2||6
68677|NCT01512849|162588|P4|STARTED|Crossover Period 2||6
68678|NCT01512849|162589|P3|STARTED|Crossover Period 2||6
68679|NCT01512849|162590|P2|STARTED|Crossover Period 2||6
68680|NCT01512849|162591|P1|STARTED|Crossover Period 2||6
68681|NCT01512849|162588|P4|NOT COMPLETED|Crossover Period 1||0
68682|NCT01512849|162589|P3|NOT COMPLETED|Crossover Period 1||0
68683|NCT01512849|162590|P2|NOT COMPLETED|Crossover Period 1||0
68684|NCT01512849|162591|P1|NOT COMPLETED|Crossover Period 1||0
68685|NCT01512849|162588|P4|COMPLETED|Crossover Period 1||6
68686|NCT01512849|162589|P3|COMPLETED|Crossover Period 1||6
68687|NCT01512849|162590|P2|COMPLETED|Crossover Period 1||6
68688|NCT01512849|162591|P1|COMPLETED|Crossover Period 1||6
68689|NCT01512849|162588|P4|STARTED|Crossover Period 1||6
68690|NCT01512849|162589|P3|STARTED|Crossover Period 1||6
68691|NCT01512849|162590|P2|STARTED|Crossover Period 1||6
68692|NCT01512849|162591|P1|STARTED|Crossover Period 1||6
68693|NCT01512745|162615|P2|NOT COMPLETED|Overall Study||20
68694|NCT01512745|162616|P1|NOT COMPLETED|Overall Study||40
68695|NCT01512745|162615|P2|COMPLETED|Overall Study||71
68696|NCT01512745|162616|P1|COMPLETED|Overall Study||136
68697|NCT01512745|162615|P2|STARTED|Overall Study||91
68698|NCT01512745|162616|P1|STARTED|Overall Study||176
68699|NCT01512368|162630|P1|NOT COMPLETED|Overall Study||3
68700|NCT01512368|162630|P1|COMPLETED|Overall Study||60
68701|NCT01512368|162630|P1|STARTED|Overall Study||63
68702|NCT01512225|162641|P2|NOT COMPLETED|Overall Study||0
68703|NCT01512225|162642|P1|NOT COMPLETED|Overall Study||0
68704|NCT01512225|162641|P2|COMPLETED|Overall Study||45
68705|NCT01512225|162642|P1|COMPLETED|Overall Study||45
68706|NCT01512225|162641|P2|Provided Day 14 Volume|Overall Study||40
68707|NCT01512225|162642|P1|Provided Day 14 Volume|Overall Study||45
68708|NCT01512225|162641|P2|STARTED|Overall Study||45
68709|NCT01512225|162642|P1|STARTED|Overall Study||45
68710|NCT01512160|162666|P4|NOT COMPLETED|Overall Study||1
68711|NCT01512160|162667|P3|NOT COMPLETED|Overall Study||0
68712|NCT01512160|162668|P2|NOT COMPLETED|Overall Study||0
68713|NCT01512160|162669|P1|NOT COMPLETED|Overall Study||2
68714|NCT01512160|162666|P4|COMPLETED|Overall Study||22
68715|NCT01512160|162667|P3|COMPLETED|Overall Study||22
68716|NCT01512160|162668|P2|COMPLETED|Overall Study||23
68717|NCT01512160|162669|P1|COMPLETED|Overall Study||20
68718|NCT01512160|162666|P4|STARTED|Overall Study||23
68719|NCT01512160|162667|P3|STARTED|Overall Study||22
68720|NCT01512160|162668|P2|STARTED|Overall Study||23
68721|NCT01512160|162669|P1|STARTED|Overall Study||22
68722|NCT01512108|162761|P2|NOT COMPLETED|Overall Study||9
68723|NCT01512108|162762|P1|NOT COMPLETED|Overall Study||22
68724|NCT01512108|162761|P2|COMPLETED|Overall Study||111
68725|NCT01512108|162762|P1|COMPLETED|Overall Study||221
68726|NCT01512108|162761|P2|Exposed|Overall Study||120
68727|NCT01512108|162762|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|240
68728|NCT01512108|162761|P2|STARTED|Overall Study||120
68729|NCT01512108|162762|P1|STARTED|Overall Study||243
68730|NCT01511978|162776|P2|NOT COMPLETED|Overall Study||0
68731|NCT01511978|162777|P1|NOT COMPLETED|Overall Study||0
68732|NCT01511978|162776|P2|COMPLETED|Overall Study||18
68733|NCT01511978|162777|P1|COMPLETED|Overall Study||14
68734|NCT01511978|162776|P2|STARTED|Overall Study||18
68735|NCT01511978|162777|P1|STARTED|Overall Study||14
68736|NCT01511939|162788|P3|NOT COMPLETED|Overall Study||0
68737|NCT01511939|162789|P2|NOT COMPLETED|Overall Study||1
68738|NCT01511939|162790|P1|NOT COMPLETED|Overall Study||2
68739|NCT01511939|162788|P3|COMPLETED|Overall Study||8
68740|NCT01511939|162789|P2|COMPLETED|Overall Study||4
68741|NCT01511939|162790|P1|COMPLETED|Overall Study||7
68742|NCT01511939|162788|P3|STARTED|Overall Study||8
68743|NCT01511939|162789|P2|STARTED|Overall Study|Includes one patient who was also taking aspirin.|5
68744|NCT01511939|162790|P1|STARTED|Overall Study|Includes 1 subject who was also taking aspirin.|9
68745|NCT01511809|162809|P2|NOT COMPLETED|Overall Study||7
68746|NCT01511809|162810|P1|NOT COMPLETED|Overall Study||7
68747|NCT01511809|162809|P2|COMPLETED|Overall Study||52
68748|NCT01511809|162810|P1|COMPLETED|Overall Study||51
68749|NCT01511809|162809|P2|STARTED|Overall Study||59
68750|NCT01511809|162810|P1|STARTED|Overall Study||58
68751|NCT01511536|162819|P3|NOT COMPLETED|Phase 2||9
68752|NCT01511536|162820|P2|NOT COMPLETED|Phase 2||0
68753|NCT01511536|162821|P1|NOT COMPLETED|Phase 2||0
68754|NCT01511536|162819|P3|COMPLETED|Phase 2|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|18
68755|NCT01511536|162820|P2|COMPLETED|Phase 2||0
68756|NCT01511536|162821|P1|COMPLETED|Phase 2||0
68757|NCT01511536|162819|P3|STARTED|Phase 2||27
68758|NCT01511536|162820|P2|STARTED|Phase 2||0
68759|NCT01511536|162821|P1|STARTED|Phase 2||0
68760|NCT01511536|162819|P3|NOT COMPLETED|Phase 1||0
68761|NCT01511536|162820|P2|NOT COMPLETED|Phase 1||1
68762|NCT01511536|162821|P1|NOT COMPLETED|Phase 1||0
68763|NCT01511536|162819|P3|COMPLETED|Phase 1||0
68764|NCT01511536|162820|P2|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|6
68765|NCT01511536|162821|P1|COMPLETED|Phase 1|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|3
68766|NCT01511536|162819|P3|STARTED|Phase 1|Phase 1 and phase 2 are separate populations.|0
68767|NCT01511536|162820|P2|STARTED|Phase 1||7
68768|NCT01511536|162821|P1|STARTED|Phase 1||3
68769|NCT01511445|162843|P2|NOT COMPLETED|Overall Study||4
68770|NCT01511445|162844|P1|NOT COMPLETED|Overall Study||5
68771|NCT01511445|162843|P2|COMPLETED|Overall Study|Data analysis was completed in February, 2016|47
68772|NCT01511445|162844|P1|COMPLETED|Overall Study|Data analysis was completed in February, 2016|48
68773|NCT01511445|162843|P2|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|47
68774|NCT01511445|162844|P1|Follow-up Completion|Overall Study|Two year follow-up was completed in November, 2015|48
68775|NCT01511445|162843|P2|Primary Completion October, 2014|Overall Study|3 protocol violations. 1 lost to follow-up.|47
68776|NCT01511445|162844|P1|Primary Completion October, 2014|Overall Study|1 was excluded Bechterew's disease. 1 protocol violation. 3 were lost to follow-up.|48
68777|NCT01511445|162843|P2|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|51
68778|NCT01511445|162844|P1|Surgeries Completed|Overall Study|All surgeries were completed by October, 2013.|53
68779|NCT01511445|162843|P2|STARTED|Overall Study|Patient enrollment started in December, 2011.|51
68780|NCT01511445|162844|P1|STARTED|Overall Study|Patient enrollment started in December, 2011.|53
68781|NCT01511315|162852|P1|NOT COMPLETED|Overall Study||4
68782|NCT01511315|162852|P1|COMPLETED|Overall Study||32
68783|NCT01511315|162852|P1|STARTED|Overall Study||36
68784|NCT01511107|162864|P2|NOT COMPLETED|Overall Study||41
68785|NCT01511107|162865|P1|NOT COMPLETED|Overall Study||22
68786|NCT01511107|162864|P2|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|219
68787|NCT01511107|162865|P1|COMPLETED|Overall Study|Completed - Assessed at a final visit in Sep or at the end of the respiratory season in Apr or May.|238
68788|NCT01511107|162864|P2|STARTED|Overall Study|Randomized to the treatment group.|260
68789|NCT01511107|162865|P1|STARTED|Overall Study|Randomized to the treatment group.|260
68790|NCT01511016|162915|P2|NOT COMPLETED|Overall Study||2
68791|NCT01511016|162916|P1|NOT COMPLETED|Overall Study||2
68792|NCT01511016|162915|P2|COMPLETED|Overall Study||7
68793|NCT01511016|162916|P1|COMPLETED|Overall Study||6
68794|NCT01511016|162915|P2|STARTED|Overall Study||9
68795|NCT01511016|162916|P1|STARTED|Overall Study||8
68796|NCT01510912|162932|P1|NOT COMPLETED|Overall Study||242
68797|NCT01510912|162932|P1|COMPLETED|Overall Study||360
68798|NCT01510912|162932|P1|STARTED|Overall Study||602
68799|NCT01510834|162938|P1|NOT COMPLETED|Overall Study||33
68800|NCT01510834|162938|P1|COMPLETED|Overall Study||57
68801|NCT01510834|162938|P1|STARTED|Overall Study||90
68802|NCT01510769|162948|P3|NOT COMPLETED|Overall Study||22
68803|NCT01510769|162949|P2|NOT COMPLETED|Overall Study||25
68804|NCT01510769|162950|P1|NOT COMPLETED|Overall Study||27
68805|NCT01510769|162948|P3|COMPLETED|Overall Study||87
68806|NCT01510769|162949|P2|COMPLETED|Overall Study||84
68807|NCT01510769|162950|P1|COMPLETED|Overall Study||79
68808|NCT01510769|162948|P3|STARTED|Overall Study||109
68809|NCT01510769|162949|P2|STARTED|Overall Study||109
68810|NCT01510769|162950|P1|STARTED|Overall Study||106
68811|NCT01510756|162967|P1|NOT COMPLETED|Overall Study||4
68812|NCT01510756|162967|P1|COMPLETED|Overall Study||0
68813|NCT01510756|162967|P1|STARTED|Overall Study||4
68814|NCT01510717|162975|P2|NOT COMPLETED|Overall Study||5
68815|NCT01510717|162976|P1|NOT COMPLETED|Overall Study||2
68816|NCT01510717|162975|P2|COMPLETED|Overall Study||160
68817|NCT01510717|162976|P1|COMPLETED|Overall Study||153
68818|NCT01510717|162975|P2|STARTED|Overall Study||165
68819|NCT01510717|162976|P1|STARTED|Overall Study||155
68820|NCT01510704|163004|P4|NOT COMPLETED|Overall Study||0
68821|NCT01510704|163005|P3|NOT COMPLETED|Overall Study||0
68822|NCT01510704|163006|P2|NOT COMPLETED|Overall Study||0
68823|NCT01510704|163007|P1|NOT COMPLETED|Overall Study||0
68824|NCT01510704|163004|P4|COMPLETED|Overall Study||53
68825|NCT01510704|163005|P3|COMPLETED|Overall Study||50
68826|NCT01510704|163006|P2|COMPLETED|Overall Study||58
68827|NCT01510704|163007|P1|COMPLETED|Overall Study||54
68828|NCT01510704|163004|P4|STARTED|Overall Study||53
68829|NCT01510704|163005|P3|STARTED|Overall Study||50
68830|NCT01510704|163006|P2|STARTED|Overall Study||58
68831|NCT01510704|163007|P1|STARTED|Overall Study||54
68832|NCT01510652|163019|P2|NOT COMPLETED|Overall Study||67
68833|NCT01510652|163020|P1|NOT COMPLETED|Overall Study||92
68834|NCT01510652|163019|P2|COMPLETED|Overall Study||288
68835|NCT01510652|163020|P1|COMPLETED|Overall Study||627
68836|NCT01510652|163019|P2|Baseline|Overall Study||348
68837|NCT01510652|163020|P1|Baseline|Overall Study||718
68838|NCT01510652|163019|P2|STARTED|Overall Study||355
68839|NCT01510652|163020|P1|STARTED|Overall Study||719
68840|NCT01510457|163032|P2|NOT COMPLETED|Overall Study||3
68841|NCT01510457|163033|P1|NOT COMPLETED|Overall Study||5
68842|NCT01510457|163032|P2|COMPLETED|Overall Study||26
68843|NCT01510457|163033|P1|COMPLETED|Overall Study||12
68844|NCT01510457|163032|P2|STARTED|Overall Study||29
68845|NCT01510457|163033|P1|STARTED|Overall Study||17
68846|NCT01510379|163053|P2|NOT COMPLETED|Overall Study||0
68847|NCT01510379|163054|P1|NOT COMPLETED|Overall Study||0
68848|NCT01510379|163053|P2|COMPLETED|Overall Study||51
68849|NCT01510379|163054|P1|COMPLETED|Overall Study||49
68850|NCT01510379|163053|P2|STARTED|Overall Study||51
68851|NCT01510379|163054|P1|STARTED|Overall Study||49
68852|NCT01510327|163062|P1|NOT COMPLETED|Overall Study||0
68853|NCT01510327|163062|P1|COMPLETED|Overall Study||22
68854|NCT01510327|163062|P1|STARTED|Overall Study||22
68855|NCT01510158|163096|P3|NOT COMPLETED|Overall Study||50
68856|NCT01510158|163097|P2|NOT COMPLETED|Overall Study||53
68857|NCT01510158|163098|P1|NOT COMPLETED|Overall Study||51
68858|NCT01510158|163096|P3|COMPLETED|Overall Study||152
68859|NCT01510158|163097|P2|COMPLETED|Overall Study||150
68860|NCT01510158|163098|P1|COMPLETED|Overall Study||151
68861|NCT01510158|163096|P3|STARTED|Overall Study||202
68862|NCT01510158|163097|P2|STARTED|Overall Study||203
68863|NCT01510158|163098|P1|STARTED|Overall Study||202
68864|NCT01510145|163112|P1|NOT COMPLETED|Overall Study||18
68865|NCT01510145|163112|P1|COMPLETED|Overall Study||173
68866|NCT01510145|163112|P1|STARTED|Overall Study||191
68867|NCT01509807|163119|P2|NOT COMPLETED|Overall Study||1
68868|NCT01509807|163120|P1|NOT COMPLETED|Overall Study||1
68869|NCT01509807|163119|P2|COMPLETED|Overall Study||16
68870|NCT01509807|163120|P1|COMPLETED|Overall Study||15
68871|NCT01509807|163119|P2|STARTED|Overall Study||17
68872|NCT01509807|163120|P1|STARTED|Overall Study||16
68873|NCT01509664|163146|P2|NOT COMPLETED|Overall Study||21
68874|NCT01509664|163147|P1|NOT COMPLETED|Overall Study||15
68875|NCT01509664|163146|P2|COMPLETED|Overall Study||28
68876|NCT01509664|163147|P1|COMPLETED|Overall Study||34
68877|NCT01509664|163146|P2|T3 Follow-up|Overall Study||33
68878|NCT01509664|163147|P1|T3 Follow-up|Overall Study||40
68879|NCT01509664|163146|P2|T2 Follow-up|Overall Study||38
68880|NCT01509664|163147|P1|T2 Follow-up|Overall Study||45
68881|NCT01509664|163146|P2|STARTED|Overall Study||49
68882|NCT01509664|163147|P1|STARTED|Overall Study||49
68883|NCT01509638|163155|P2|NOT COMPLETED|Overall Study||2
68884|NCT01509638|163156|P1|NOT COMPLETED|Overall Study||3
68885|NCT01509638|163155|P2|COMPLETED|Overall Study||24
68886|NCT01509638|163156|P1|COMPLETED|Overall Study||20
68887|NCT01509638|163155|P2|STARTED|Overall Study||26
68888|NCT01509638|163156|P1|STARTED|Overall Study||23
68889|NCT01509625|163180|P1|NOT COMPLETED|Overall Study||9
68890|NCT01509625|163180|P1|COMPLETED|Overall Study||263
68891|NCT01509625|163180|P1|STARTED|Overall Study||272
68892|NCT01509586|163198|P2|NOT COMPLETED|Overall Study||0
68893|NCT01509586|163199|P1|NOT COMPLETED|Overall Study||0
68894|NCT01509586|163198|P2|COMPLETED|Overall Study|final intent to treat sample|610
68895|NCT01509586|163199|P1|COMPLETED|Overall Study|final intent to treat sample|626
68896|NCT01509586|163198|P2|Week 58 (Month 12)|Overall Study||499
68897|NCT01509586|163199|P1|Week 58 (Month 12)|Overall Study||492
68898|NCT01509586|163198|P2|Week 46|Overall Study||494
68899|NCT01509586|163199|P1|Week 46|Overall Study||483
68900|NCT01509586|163198|P2|Week 32 (Month 6)|Overall Study||523
68901|NCT01509586|163199|P1|Week 32 (Month 6)|Overall Study||504
68902|NCT01509586|163198|P2|Week18|Overall Study||555
68903|NCT01509586|163199|P1|Week18|Overall Study||529
68904|NCT01509586|163198|P2|Week 14|Overall Study||566
68905|NCT01509586|163199|P1|Week 14|Overall Study||528
68906|NCT01509586|163198|P2|Week 10|Overall Study||574
68907|NCT01509586|163199|P1|Week 10|Overall Study||537
68908|NCT01509586|163198|P2|Week 6|Overall Study||585
68909|NCT01509586|163199|P1|Week 6|Overall Study||551
68910|NCT01509586|163198|P2|Week 3|Overall Study||585
68911|NCT01509586|163199|P1|Week 3|Overall Study||574
68912|NCT01509586|163198|P2|STARTED|Overall Study|Week 0|610
68913|NCT01509586|163199|P1|STARTED|Overall Study|Week 0|626
68914|NCT01509105|163205|P1|NOT COMPLETED|Overall Study||0
68915|NCT01509105|163205|P1|COMPLETED|Overall Study||649
68916|NCT01509105|163205|P1|STARTED|Overall Study||649
68917|NCT01509079|163222|P2|NOT COMPLETED|Overall Study||3
68918|NCT01509079|163223|P1|NOT COMPLETED|Overall Study||0
68919|NCT01509079|163222|P2|COMPLETED|Overall Study||56
68920|NCT01509079|163223|P1|COMPLETED|Overall Study||57
68921|NCT01509079|163222|P2|STARTED|Overall Study||59
68922|NCT01509079|163223|P1|STARTED|Overall Study||57
68923|NCT01509053|163239|P1|NOT COMPLETED|Aripiprazole IM Depot Extension Phase(C)||3
68924|NCT01509053|163239|P1|COMPLETED|Aripiprazole IM Depot Extension Phase(C)||0
68925|NCT01509053|163239|P1|STARTED|Aripiprazole IM Depot Extension Phase(C)||3
68926|NCT01509053|163239|P1|NOT COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||16
68927|NCT01509053|163239|P1|COMPLETED|Aripiprazole IM Depot Treatment Phase(B)||3
68928|NCT01509053|163239|P1|STARTED|Aripiprazole IM Depot Treatment Phase(B)|Includes 8 patients from Phase A + 11 patients who entered directly into Phase B.|19
68929|NCT01509053|163239|P1|NOT COMPLETED|Oral Aripirazole (Phase A)||11
68930|NCT01509053|163239|P1|COMPLETED|Oral Aripirazole (Phase A)||8
68931|NCT01509053|163239|P1|STARTED|Oral Aripirazole (Phase A)||19
68932|NCT01509040|163253|P3|NOT COMPLETED|Overall Study||0
68933|NCT01509040|163254|P2|NOT COMPLETED|Overall Study||1
68934|NCT01509040|163255|P1|NOT COMPLETED|Overall Study||0
68935|NCT01509040|163253|P3|COMPLETED|Overall Study||0
68936|NCT01509040|163254|P2|COMPLETED|Overall Study||1
68937|NCT01509040|163255|P1|COMPLETED|Overall Study||0
68938|NCT01509040|163253|P3|STARTED|Overall Study||0
68939|NCT01509040|163254|P2|STARTED|Overall Study||2
68940|NCT01509040|163255|P1|STARTED|Overall Study||0
68941|NCT01508936|163301|P2|NOT COMPLETED|Overall Study||79
68942|NCT01508936|163302|P1|NOT COMPLETED|Overall Study||23
68943|NCT01508936|163301|P2|COMPLETED|Overall Study||330
68944|NCT01508936|163302|P1|COMPLETED|Overall Study||79
68945|NCT01508936|163301|P2|FEV1 Subpopulation Analysis Set|Overall Study||346
68946|NCT01508936|163302|P1|FEV1 Subpopulation Analysis Set|Overall Study||91
68947|NCT01508936|163301|P2|Full Analysis Set|Overall Study||395
68948|NCT01508936|163302|P1|Full Analysis Set|Overall Study||97
68949|NCT01508936|163301|P2|Safety Analysis Set|Overall Study||395
68950|NCT01508936|163302|P1|Safety Analysis Set|Overall Study||97
68951|NCT01508936|163301|P2|Randomized, Not Treated|Overall Study||3
68952|NCT01508936|163302|P1|Randomized, Not Treated|Overall Study||1
68953|NCT01508936|163301|P2|Randomized|Overall Study||398
68954|NCT01508936|163302|P1|Randomized|Overall Study||98
68955|NCT01508936|163301|P2|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|11
68956|NCT01508936|163302|P1|Randomized, Not Analyzed|Overall Study|Participants from two centers were omitted from all analyses.|4
68957|NCT01508936|163301|P2|STARTED|Overall Study||409
68958|NCT01508936|163302|P1|STARTED|Overall Study||102
68959|NCT01508910|163341|P4|NOT COMPLETED|Treatment||3
68960|NCT01508910|163342|P3|NOT COMPLETED|Treatment||10
68961|NCT01508910|163343|P2|NOT COMPLETED|Treatment||4
68962|NCT01508910|163344|P1|NOT COMPLETED|Treatment||2
68963|NCT01508910|163341|P4|COMPLETED|Treatment||3
68964|NCT01508910|163342|P3|COMPLETED|Treatment||18
68965|NCT01508910|163343|P2|COMPLETED|Treatment||24
68966|NCT01508910|163344|P1|COMPLETED|Treatment||48
68967|NCT01508910|163341|P4|STARTED|Treatment|3 moved from Treatment (Tx) to Active Control (AC) Arm; 6 in Not injected Arm(4 from Tx ; 2 from AC)|6
68968|NCT01508910|163342|P3|STARTED|Treatment||28
68969|NCT01508910|163343|P2|STARTED|Treatment||28
68970|NCT01508910|163344|P1|STARTED|Treatment||50
68971|NCT01508910|163341|P4|NOT COMPLETED|Randomization||0
68972|NCT01508910|163342|P3|NOT COMPLETED|Randomization||0
68973|NCT01508910|163343|P2|NOT COMPLETED|Randomization||0
68974|NCT01508910|163344|P1|NOT COMPLETED|Randomization||0
68975|NCT01508910|163341|P4|COMPLETED|Randomization||0
68976|NCT01508910|163342|P3|COMPLETED|Randomization||28
68977|NCT01508910|163343|P2|COMPLETED|Randomization||27
68978|NCT01508910|163344|P1|COMPLETED|Randomization||57
68979|NCT01508910|163341|P4|STARTED|Randomization|Participants not randomized into Not Injected arm, but some were re-assigned here during treatment.|0
68980|NCT01508910|163342|P3|STARTED|Randomization||28
68981|NCT01508910|163343|P2|STARTED|Randomization||27
68982|NCT01508910|163344|P1|STARTED|Randomization||57
68983|NCT01508832|163368|P2|NOT COMPLETED|Overall Study||0
68984|NCT01508832|163369|P1|NOT COMPLETED|Overall Study||0
68985|NCT01508832|163368|P2|COMPLETED|Overall Study||6
68986|NCT01508832|163369|P1|COMPLETED|Overall Study||6
68987|NCT01508832|163368|P2|STARTED|Overall Study||6
68988|NCT01508832|163369|P1|STARTED|Overall Study||6
68989|NCT01508702|163377|P2|NOT COMPLETED|Overall Study||13
68990|NCT01508702|163378|P1|NOT COMPLETED|Overall Study||23
68991|NCT01508702|163377|P2|COMPLETED|Overall Study||94
68992|NCT01508702|163378|P1|COMPLETED|Overall Study||84
68993|NCT01508702|163377|P2|STARTED|Overall Study||107
68994|NCT01508702|163378|P1|STARTED|Overall Study||107
68995|NCT01508676|163386|P2|NOT COMPLETED|Phase II (2 Weeks)||1
68996|NCT01508676|163387|P1|NOT COMPLETED|Phase II (2 Weeks)||1
68997|NCT01508676|163386|P2|COMPLETED|Phase II (2 Weeks)||13
68998|NCT01508676|163387|P1|COMPLETED|Phase II (2 Weeks)||15
68999|NCT01508676|163386|P2|STARTED|Phase II (2 Weeks)||14
69000|NCT01508676|163387|P1|STARTED|Phase II (2 Weeks)||16
69001|NCT01508676|163386|P2|NOT COMPLETED|Washout Period (1 Week)||0
69002|NCT01508676|163387|P1|NOT COMPLETED|Washout Period (1 Week)||0
69003|NCT01508676|163386|P2|COMPLETED|Washout Period (1 Week)||14
69004|NCT01508676|163387|P1|COMPLETED|Washout Period (1 Week)||16
69005|NCT01508676|163386|P2|STARTED|Washout Period (1 Week)||14
69006|NCT01508676|163387|P1|STARTED|Washout Period (1 Week)||16
69007|NCT01508676|163386|P2|NOT COMPLETED|Phase I (2 Weeks)||3
69008|NCT01508676|163387|P1|NOT COMPLETED|Phase I (2 Weeks)||2
69009|NCT01508676|163386|P2|COMPLETED|Phase I (2 Weeks)||14
69010|NCT01508676|163387|P1|COMPLETED|Phase I (2 Weeks)||16
69011|NCT01508676|163386|P2|STARTED|Phase I (2 Weeks)||17
69012|NCT01508676|163387|P1|STARTED|Phase I (2 Weeks)||18
69013|NCT01508455|163397|P1|NOT COMPLETED|Overall Study||0
69014|NCT01508455|163397|P1|COMPLETED|Overall Study||6
69015|NCT01508455|163397|P1|STARTED|Overall Study||6
69016|NCT01508325|163408|P2|NOT COMPLETED|Overall Study||21
69017|NCT01508325|163409|P1|NOT COMPLETED|Overall Study||18
69018|NCT01508325|163408|P2|COMPLETED|Overall Study||72
69019|NCT01508325|163409|P1|COMPLETED|Overall Study||75
69020|NCT01508325|163408|P2|STARTED|Overall Study||93
69021|NCT01508325|163409|P1|STARTED|Overall Study||93
69022|NCT01508169|163439|P2|NOT COMPLETED|Overall Study||2
69023|NCT01508169|163440|P1|NOT COMPLETED|Overall Study||3
69024|NCT01508169|163439|P2|COMPLETED|Overall Study||45
69025|NCT01508169|163440|P1|COMPLETED|Overall Study||44
69026|NCT01508169|163439|P2|STARTED|Overall Study||47
69027|NCT01508169|163440|P1|STARTED|Overall Study||47
69028|NCT01508130|163454|P2|NOT COMPLETED|Overall Study||69
69029|NCT01508130|163455|P1|NOT COMPLETED|Overall Study||227
69030|NCT01508130|163454|P2|COMPLETED|Overall Study||73
69031|NCT01508130|163455|P1|COMPLETED|Overall Study||266
69032|NCT01508130|163454|P2|mTRT|Overall Study||142
69033|NCT01508130|163455|P1|mTRT|Overall Study||493
69034|NCT01508130|163454|P2|STARTED|Overall Study||142
69035|NCT01508130|163455|P1|STARTED|Overall Study||493
69036|NCT01508052|163499|P2|NOT COMPLETED|Overall Study||0
69037|NCT01508052|163500|P1|NOT COMPLETED|Overall Study||0
69038|NCT01508052|163499|P2|COMPLETED|Overall Study||20
69039|NCT01508052|163500|P1|COMPLETED|Overall Study||20
69040|NCT01508052|163499|P2|STARTED|Overall Study||20
69041|NCT01508052|163500|P1|STARTED|Overall Study||20
69042|NCT01508013|163508|P2|NOT COMPLETED|Overall Study||23
69043|NCT01508013|163509|P1|NOT COMPLETED|Overall Study||32
69044|NCT01508013|163508|P2|COMPLETED|Overall Study||206
69045|NCT01508013|163509|P1|COMPLETED|Overall Study||182
69046|NCT01508013|163508|P2|STARTED|Overall Study||229
69047|NCT01508013|163509|P1|STARTED|Overall Study||214
69048|NCT01507896|163519|P1|NOT COMPLETED|Overall Study||2
69049|NCT01507896|163519|P1|COMPLETED|Overall Study|28 unique participants had 38 surgeries (participants could have multiple surgeries).|28
69050|NCT01507896|163519|P1|STARTED|Overall Study|30 unique participants had 40 surgeries planned (participants could have multiple surgeries).|30
69051|NCT01507831|163562|P2|NOT COMPLETED|Overall Study||440
69052|NCT01507831|163563|P1|NOT COMPLETED|Overall Study||193
69053|NCT01507831|163562|P2|COMPLETED|Overall Study||1113
69054|NCT01507831|163563|P1|COMPLETED|Overall Study||595
69055|NCT01507831|163562|P2|Treated|Overall Study||1550
69056|NCT01507831|163563|P1|Treated|Overall Study||788
69057|NCT01507831|163562|P2|STARTED|Overall Study|Randomized|1553
69058|NCT01507831|163563|P1|STARTED|Overall Study|Randomized|788
69059|NCT01507662|163633|P2|NOT COMPLETED|Overall Study||831
69060|NCT01507662|163634|P1|NOT COMPLETED|Overall Study||816
69061|NCT01507662|163633|P2|COMPLETED|Overall Study||3020
69062|NCT01507662|163634|P1|COMPLETED|Overall Study||3082
69063|NCT01507662|163633|P2|STARTED|Overall Study||3851
69064|NCT01507662|163634|P1|STARTED|Overall Study||3898
69065|NCT01507493|163642|P2|NOT COMPLETED|Overall Study||0
69066|NCT01507493|163643|P1|NOT COMPLETED|Overall Study||0
69067|NCT01507493|163642|P2|COMPLETED|Overall Study||178
69068|NCT01507493|163643|P1|COMPLETED|Overall Study||22
69069|NCT01507493|163642|P2|STARTED|Overall Study||178
69070|NCT01507493|163643|P1|STARTED|Overall Study||22
69071|NCT01507246|163659|P2|NOT COMPLETED|Overall Study||1
69072|NCT01507246|163660|P1|NOT COMPLETED|Overall Study||2
69073|NCT01507246|163659|P2|COMPLETED|Overall Study||21
69074|NCT01507246|163660|P1|COMPLETED|Overall Study||18
69075|NCT01507246|163659|P2|STARTED|Overall Study||22
69076|NCT01507246|163660|P1|STARTED|Overall Study||20
69077|NCT01507233|163674|P2|NOT COMPLETED|Overall Study||0
69078|NCT01507233|163675|P1|NOT COMPLETED|Overall Study||0
69079|NCT01507233|163674|P2|COMPLETED|Overall Study||0
69080|NCT01507233|163675|P1|COMPLETED|Overall Study||5
69081|NCT01507233|163674|P2|STARTED|Overall Study||0
69082|NCT01507233|163675|P1|STARTED|Overall Study||5
69083|NCT01507220|163687|P2|NOT COMPLETED|Overall Study||0
69084|NCT01507220|163688|P1|NOT COMPLETED|Overall Study||0
69085|NCT01507220|163687|P2|COMPLETED|Overall Study||0
69086|NCT01507220|163688|P1|COMPLETED|Overall Study||2
69087|NCT01507220|163687|P2|STARTED|Overall Study||0
69088|NCT01507220|163688|P1|STARTED|Overall Study||2
69089|NCT01507181|163702|P2|NOT COMPLETED|Overall Study||0
69090|NCT01507181|163703|P1|NOT COMPLETED|Overall Study||0
69091|NCT01507181|163702|P2|COMPLETED|Overall Study||12
69092|NCT01507181|163703|P1|COMPLETED|Overall Study||12
69093|NCT01507181|163702|P2|STARTED|Overall Study||12
69094|NCT01507181|163703|P1|STARTED|Overall Study||12
69095|NCT01507155|163723|P2|NOT COMPLETED|Overall Study||0
69096|NCT01507155|163724|P1|NOT COMPLETED|Overall Study||0
69097|NCT01507155|163723|P2|COMPLETED|Overall Study||60
69098|NCT01507155|163724|P1|COMPLETED|Overall Study||625
69099|NCT01507155|163723|P2|STARTED|Overall Study||60
69100|NCT01507155|163724|P1|STARTED|Overall Study||625
69101|NCT01507103|163733|P3|NOT COMPLETED|Overall Study||0
69102|NCT01507103|163734|P2|NOT COMPLETED|Overall Study||0
69103|NCT01507103|163735|P1|NOT COMPLETED|Overall Study||0
69104|NCT01507103|163733|P3|COMPLETED|Overall Study||42
69105|NCT01507103|163734|P2|COMPLETED|Overall Study||41
69106|NCT01507103|163735|P1|COMPLETED|Overall Study||41
69107|NCT01507103|163733|P3|STARTED|Overall Study||42
69108|NCT01507103|163734|P2|STARTED|Overall Study||41
69109|NCT01507103|163735|P1|STARTED|Overall Study||41
69110|NCT01507090|163758|P1|NOT COMPLETED|Overall Study||18
69111|NCT01507090|163758|P1|COMPLETED|Overall Study||624
69112|NCT01507090|163758|P1|STARTED|Overall Study||642
69113|NCT01507051|163797|P4|NOT COMPLETED|Overall Study||7
69114|NCT01507051|163798|P3|NOT COMPLETED|Overall Study||1
69115|NCT01507051|163799|P2|NOT COMPLETED|Overall Study||3
69116|NCT01507051|163800|P1|NOT COMPLETED|Overall Study||2
69117|NCT01507051|163797|P4|COMPLETED|Overall Study||0
69118|NCT01507051|163798|P3|COMPLETED|Overall Study||28
69119|NCT01507051|163799|P2|COMPLETED|Overall Study||28
69120|NCT01507051|163800|P1|COMPLETED|Overall Study||27
69121|NCT01507051|163797|P4|Received Placebo or Rivaroxaban|Overall Study||0
69122|NCT01507051|163798|P3|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG3|28
69123|NCT01507051|163799|P2|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG2 and in RG4|28
69124|NCT01507051|163800|P1|Received Placebo or Rivaroxaban|Overall Study|Safety Population: in RG1 and in RG4 (RG = Reporting Group for Safety Data)|28
69125|NCT01507051|163797|P4|Warfarin run-in Phase|Overall Study|Safety Population: in RG4|7
69126|NCT01507051|163798|P3|Warfarin run-in Phase|Overall Study||0
69127|NCT01507051|163799|P2|Warfarin run-in Phase|Overall Study||28
69128|NCT01507051|163800|P1|Warfarin run-in Phase|Overall Study||28
69129|NCT01507051|163797|P4|STARTED|Overall Study||7
69130|NCT01507051|163798|P3|STARTED|Overall Study||29
69131|NCT01507051|163799|P2|STARTED|Overall Study||31
69132|NCT01507051|163800|P1|STARTED|Overall Study||29
69133|NCT01506960|163918|P1|NOT COMPLETED|Overall Study||47
69134|NCT01506960|163918|P1|COMPLETED|Overall Study||17
69135|NCT01506960|163918|P1|STARTED|Overall Study||64
69136|NCT01506947|163924|P1|NOT COMPLETED|Overall Study||16
69137|NCT01506947|163924|P1|COMPLETED|Overall Study||49
69138|NCT01506947|163924|P1|STARTED|Overall Study||65
69139|NCT01506908|163942|P2|NOT COMPLETED|Overall Study||0
69140|NCT01506908|163943|P1|NOT COMPLETED|Overall Study||1
69141|NCT01506908|163942|P2|COMPLETED|Overall Study||161
69142|NCT01506908|163943|P1|COMPLETED|Overall Study||161
69143|NCT01506908|163942|P2|STARTED|Overall Study||161
69144|NCT01506908|163943|P1|STARTED|Overall Study||162
69145|NCT01506882|163961|P2|NOT COMPLETED|Overall Study||7
69146|NCT01506882|163962|P1|NOT COMPLETED|Overall Study||22
69147|NCT01506882|163961|P2|COMPLETED|Overall Study||3
69148|NCT01506882|163962|P1|COMPLETED|Overall Study||39
69149|NCT01506882|163961|P2|STARTED|Overall Study||10
69150|NCT01506882|163962|P1|STARTED|Overall Study||61
69151|NCT01506726|163976|P2|NOT COMPLETED|Overall Study||2
69152|NCT01506726|163977|P1|NOT COMPLETED|Overall Study||1
69153|NCT01506726|163976|P2|COMPLETED|Overall Study||3
69154|NCT01506726|163977|P1|COMPLETED|Overall Study||5
69155|NCT01506726|163976|P2|STARTED|Overall Study||5
69156|NCT01506726|163977|P1|STARTED|Overall Study||6
69157|NCT01506596|164017|P1|NOT COMPLETED|Overall Study||1
69158|NCT01506596|164017|P1|COMPLETED|Overall Study|One enrolled patient had ineligible pathology after starting treatment; was removed from treatment.|41
69159|NCT01506596|164017|P1|STARTED|Overall Study||42
69160|NCT01506362|164025|P1|NOT COMPLETED|Overall Study||6
69161|NCT01506362|164025|P1|COMPLETED|Overall Study||16
69162|NCT01506362|164025|P1|STARTED|Overall Study||22
69163|NCT01506323|164031|P2|NOT COMPLETED|Overall Study||13
69164|NCT01506323|164032|P1|NOT COMPLETED|Overall Study||24
69165|NCT01506323|164031|P2|COMPLETED|Overall Study||71
69166|NCT01506323|164032|P1|COMPLETED|Overall Study||65
69167|NCT01506323|164031|P2|Post-treatment Completed CAPS|Overall Study||72
69168|NCT01506323|164032|P1|Post-treatment Completed CAPS|Overall Study||68
69169|NCT01506323|164031|P2|Post-treatment Completers|Overall Study||72
69170|NCT01506323|164032|P1|Post-treatment Completers|Overall Study||69
69171|NCT01506323|164031|P2|STARTED|Overall Study||84
69172|NCT01506323|164032|P1|STARTED|Overall Study||89
69173|NCT01506193|164061|P3|NOT COMPLETED|Overall Study||14
69174|NCT01506193|164062|P2|NOT COMPLETED|Overall Study||4
69175|NCT01506193|164063|P1|NOT COMPLETED|Overall Study||14
69176|NCT01506193|164061|P3|COMPLETED|Overall Study||168
69177|NCT01506193|164062|P2|COMPLETED|Overall Study||179
69178|NCT01506193|164063|P1|COMPLETED|Overall Study||337
69179|NCT01506193|164061|P3|STARTED|Overall Study||182
69180|NCT01506193|164062|P2|STARTED|Overall Study||183
69181|NCT01506193|164063|P1|STARTED|Overall Study||351
69182|NCT01505881|164096|P2|NOT COMPLETED|Overall Study||1
69183|NCT01505881|164097|P1|NOT COMPLETED|Overall Study||4
69184|NCT01505881|164096|P2|COMPLETED|Overall Study||58
69185|NCT01505881|164097|P1|COMPLETED|Overall Study||95
69186|NCT01505881|164096|P2|STARTED|Overall Study||59
69187|NCT01505881|164097|P1|STARTED|Overall Study||99
69188|NCT01505764|164111|P2|NOT COMPLETED|Overall Study||1
69189|NCT01505764|164112|P1|NOT COMPLETED|Overall Study||3
69190|NCT01505764|164111|P2|COMPLETED|Overall Study||2
69191|NCT01505764|164112|P1|COMPLETED|Overall Study||3
69192|NCT01505764|164111|P2|STARTED|Overall Study||3
69193|NCT01505764|164112|P1|STARTED|Overall Study||6
69194|NCT01505647|164120|P2|NOT COMPLETED|Day 43 Through Day 182 Follow-up||3
69195|NCT01505647|164121|P1|NOT COMPLETED|Day 43 Through Day 182 Follow-up||1
69196|NCT01505647|164120|P2|COMPLETED|Day 43 Through Day 182 Follow-up||163
69197|NCT01505647|164121|P1|COMPLETED|Day 43 Through Day 182 Follow-up||328
69198|NCT01505647|164120|P2|STARTED|Day 43 Through Day 182 Follow-up||166
69199|NCT01505647|164121|P1|STARTED|Day 43 Through Day 182 Follow-up||329
69200|NCT01505647|164120|P2|NOT COMPLETED|Day 1 Through Day 42 Follow-up||0
69201|NCT01505647|164121|P1|NOT COMPLETED|Day 1 Through Day 42 Follow-up||3
69202|NCT01505647|164120|P2|COMPLETED|Day 1 Through Day 42 Follow-up||166
69203|NCT01505647|164121|P1|COMPLETED|Day 1 Through Day 42 Follow-up||329
69204|NCT01505647|164120|P2|Vaccinated|Day 1 Through Day 42 Follow-up||166
69205|NCT01505647|164121|P1|Vaccinated|Day 1 Through Day 42 Follow-up||331
69206|NCT01505647|164120|P2|STARTED|Day 1 Through Day 42 Follow-up||166
69207|NCT01505647|164121|P1|STARTED|Day 1 Through Day 42 Follow-up||332
69208|NCT01505608|164137|P2|NOT COMPLETED|Phase II||2
69209|NCT01505608|164138|P1|NOT COMPLETED|Phase II||2
69210|NCT01505608|164137|P2|COMPLETED|Phase II||2
69211|NCT01505608|164138|P1|COMPLETED|Phase II||0
69212|NCT01505608|164137|P2|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|4
69213|NCT01505608|164138|P1|STARTED|Phase II|Phase 2 was new enrollment, not the same patients from Phase 1.|2
69214|NCT01505608|164137|P2|NOT COMPLETED|Phase I||6
69215|NCT01505608|164138|P1|NOT COMPLETED|Phase I||0
69216|NCT01505608|164137|P2|COMPLETED|Phase I||2
69217|NCT01505608|164138|P1|COMPLETED|Phase I||0
69218|NCT01505608|164137|P2|STARTED|Phase I||8
69219|NCT01505608|164138|P1|STARTED|Phase I|Randomization to Arm A began in Phase 2. All patients in Phase I were enrolled to receive TPI 287.|0
69220|NCT01505465|164156|P2|NOT COMPLETED|Overall Study||7
69221|NCT01505465|164157|P1|NOT COMPLETED|Overall Study||6
69222|NCT01505465|164156|P2|COMPLETED|Overall Study||18
69223|NCT01505465|164157|P1|COMPLETED|Overall Study||19
69224|NCT01505465|164156|P2|STARTED|Overall Study||25
69225|NCT01505465|164157|P1|STARTED|Overall Study||25
69226|NCT01505387|164173|P2|NOT COMPLETED|Overall Study||1
69227|NCT01505387|164174|P1|NOT COMPLETED|Overall Study||2
69228|NCT01505387|164173|P2|COMPLETED|Overall Study||24
69229|NCT01505387|164174|P1|COMPLETED|Overall Study|1 subject not included in intention to treat population as violated inclusion criteria|23
69230|NCT01505387|164173|P2|Treated|Overall Study||24
69231|NCT01505387|164174|P1|Treated|Overall Study||24
69232|NCT01505387|164173|P2|STARTED|Overall Study||25
69233|NCT01505387|164174|P1|STARTED|Overall Study||25
69234|NCT01505374|164180|P2|NOT COMPLETED|Overall Study||0
69235|NCT01505374|164181|P1|NOT COMPLETED|Overall Study||1
69236|NCT01505374|164180|P2|COMPLETED|Overall Study||30
69237|NCT01505374|164181|P1|COMPLETED|Overall Study||29
69238|NCT01505374|164180|P2|STARTED|Overall Study||30
69239|NCT01505374|164181|P1|STARTED|Overall Study||30
69240|NCT01505114|164199|P4|NOT COMPLETED|Overall Study||23
69241|NCT01505114|164200|P3|NOT COMPLETED|Overall Study||18
69242|NCT01505114|164201|P2|NOT COMPLETED|Overall Study||13
69243|NCT01505114|164202|P1|NOT COMPLETED|Overall Study||25
69244|NCT01505114|164199|P4|COMPLETED|Overall Study||128
69245|NCT01505114|164200|P3|COMPLETED|Overall Study||129
69246|NCT01505114|164201|P2|COMPLETED|Overall Study||135
69247|NCT01505114|164202|P1|COMPLETED|Overall Study||123
69248|NCT01505114|164199|P4|STARTED|Overall Study||151
69249|NCT01505114|164200|P3|STARTED|Overall Study||147
69250|NCT01505114|164201|P2|STARTED|Overall Study||148
69251|NCT01505114|164202|P1|STARTED|Overall Study||148
69252|NCT01504997|164212|P1|NOT COMPLETED|Overall Study||0
69253|NCT01504997|164212|P1|COMPLETED|Overall Study||18
69254|NCT01504997|164212|P1|STARTED|Overall Study||18
69255|NCT01504971|164216|P1|NOT COMPLETED|Overall Study||13
69256|NCT01504971|164216|P1|COMPLETED|Overall Study||82
69257|NCT01504971|164216|P1|STARTED|Overall Study||95
69258|NCT01504958|164227|P3|NOT COMPLETED|Overall Study||0
69259|NCT01504958|164228|P2|NOT COMPLETED|Overall Study||0
69260|NCT01504958|164229|P1|NOT COMPLETED|Overall Study||0
69261|NCT01504958|164227|P3|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
69262|NCT01504958|164228|P2|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|6
69263|NCT01504958|164229|P1|COMPLETED|Overall Study|1 Month Post-Treatment Follow Up|10
69264|NCT01504958|164227|P3|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
69265|NCT01504958|164228|P2|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|6
69266|NCT01504958|164229|P1|STARTED|Overall Study|Baseline clinical, cognitive, and behavioral assessments: TMS-EMG measures, MRI scan, randomization.|10
69267|NCT01504867|164245|P2|NOT COMPLETED|Overall Study||3
69268|NCT01504867|164246|P1|NOT COMPLETED|Overall Study||7
69269|NCT01504867|164245|P2|COMPLETED|Overall Study||195
69270|NCT01504867|164246|P1|COMPLETED|Overall Study||195
69271|NCT01504867|164245|P2|STARTED|Overall Study||198
69272|NCT01504867|164246|P1|STARTED|Overall Study||202
69273|NCT01504854|164266|P2|NOT COMPLETED|Overall Study||7
69274|NCT01504854|164267|P1|NOT COMPLETED|Overall Study||8
69275|NCT01504854|164266|P2|COMPLETED|Overall Study||48
69276|NCT01504854|164267|P1|COMPLETED|Overall Study||56
69277|NCT01504854|164266|P2|STARTED|Overall Study||55
69278|NCT01504854|164267|P1|STARTED|Overall Study||64
69279|NCT01503749|164284|P3|NOT COMPLETED|Overall Study||0
69280|NCT01503749|164285|P2|NOT COMPLETED|Overall Study||0
69281|NCT01503749|164286|P1|NOT COMPLETED|Overall Study||0
69282|NCT01503749|164284|P3|COMPLETED|Overall Study||3
69283|NCT01503749|164285|P2|COMPLETED|Overall Study||3
69284|NCT01503749|164286|P1|COMPLETED|Overall Study||3
69285|NCT01503749|164284|P3|STARTED|Overall Study||3
69286|NCT01503749|164285|P2|STARTED|Overall Study||3
69287|NCT01503749|164286|P1|STARTED|Overall Study||3
69288|NCT01503021|164299|P2|NOT COMPLETED|Overall Study||26
69289|NCT01503021|164300|P1|NOT COMPLETED|Overall Study||27
69290|NCT01503021|164299|P2|COMPLETED|Overall Study||332
69291|NCT01503021|164300|P1|COMPLETED|Overall Study||333
69292|NCT01503021|164299|P2|Completed Treatment|Overall Study|One patient completed the treatment period but discontinued prior to completing the follow-up visit.|333
69293|NCT01503021|164300|P1|Completed Treatment|Overall Study||333
69294|NCT01503021|164299|P2|Dosed|Overall Study||352
69295|NCT01503021|164300|P1|Dosed|Overall Study||351
69296|NCT01503021|164299|P2|STARTED|Overall Study||358
69297|NCT01503021|164300|P1|STARTED|Overall Study||360
69298|NCT01502787|164347|P2|NOT COMPLETED|Overall Study||0
69299|NCT01502787|164348|P1|NOT COMPLETED|Overall Study||0
69300|NCT01502787|164347|P2|COMPLETED|Overall Study||10
69301|NCT01502787|164348|P1|COMPLETED|Overall Study||11
69302|NCT01502787|164347|P2|STARTED|Overall Study||10
69303|NCT01502787|164348|P1|STARTED|Overall Study||11
69304|NCT01502761|164358|P4|NOT COMPLETED|Overall Study||0
69305|NCT01502761|164359|P3|NOT COMPLETED|Overall Study||0
69306|NCT01502761|164360|P2|NOT COMPLETED|Overall Study||0
69307|NCT01502761|164361|P1|NOT COMPLETED|Overall Study||0
69308|NCT01502761|164358|P4|COMPLETED|Overall Study||0
69309|NCT01502761|164359|P3|COMPLETED|Overall Study||0
69310|NCT01502761|164360|P2|COMPLETED|Overall Study||0
69311|NCT01502761|164361|P1|COMPLETED|Overall Study||4
69312|NCT01502761|164358|P4|STARTED|Overall Study||0
69313|NCT01502761|164359|P3|STARTED|Overall Study||0
69314|NCT01502761|164360|P2|STARTED|Overall Study||0
69315|NCT01502761|164361|P1|STARTED|Overall Study||4
69316|NCT01502709|164377|P2|NOT COMPLETED|Overall Study||0
69317|NCT01502709|164378|P1|NOT COMPLETED|Overall Study||4
69318|NCT01502709|164377|P2|COMPLETED|Overall Study||0
69319|NCT01502709|164378|P1|COMPLETED|Overall Study||1
69320|NCT01502709|164377|P2|STARTED|Overall Study||0
69321|NCT01502709|164378|P1|STARTED|Overall Study||5
69322|NCT01502644|164391|P4|NOT COMPLETED|Assigned to NA Groups||8
69323|NCT01502644|164392|P3|NOT COMPLETED|Assigned to NA Groups||3
69324|NCT01502644|164393|P2|NOT COMPLETED|Assigned to NA Groups||6
69325|NCT01502644|164394|P1|NOT COMPLETED|Assigned to NA Groups||0
69326|NCT01502644|164391|P4|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
69327|NCT01502644|164392|P3|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|7
69328|NCT01502644|164393|P2|COMPLETED|Assigned to NA Groups|Completed = completed at least 50% of the opioid treatment period (at least 10 weeks of treatment)|24
69329|NCT01502644|164394|P1|COMPLETED|Assigned to NA Groups||0
69330|NCT01502644|164391|P4|STARTED|Assigned to NA Groups||32
69331|NCT01502644|164392|P3|STARTED|Assigned to NA Groups||10
69332|NCT01502644|164393|P2|STARTED|Assigned to NA Groups||30
69333|NCT01502644|164394|P1|STARTED|Assigned to NA Groups||0
69334|NCT01502644|164391|P4|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
69335|NCT01502644|164392|P3|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
69336|NCT01502644|164393|P2|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||0
69337|NCT01502644|164394|P1|NOT COMPLETED|Enrolled at Visit 1 After Pre-screening||9
69338|NCT01502644|164391|P4|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
69339|NCT01502644|164392|P3|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
69340|NCT01502644|164393|P2|COMPLETED|Enrolled at Visit 1 After Pre-screening||0
69341|NCT01502644|164394|P1|COMPLETED|Enrolled at Visit 1 After Pre-screening|Participants who completed Visit 1 were assigned to 1 of the 3 NA groups for remainder of the trial|72
69342|NCT01502644|164391|P4|STARTED|Enrolled at Visit 1 After Pre-screening||0
69343|NCT01502644|164392|P3|STARTED|Enrolled at Visit 1 After Pre-screening||0
69344|NCT01502644|164393|P2|STARTED|Enrolled at Visit 1 After Pre-screening||0
69345|NCT01502644|164394|P1|STARTED|Enrolled at Visit 1 After Pre-screening||81
69346|NCT01502423|164404|P2|NOT COMPLETED|Overall Study||1
69347|NCT01502423|164405|P1|NOT COMPLETED|Overall Study||0
69348|NCT01502423|164404|P2|COMPLETED|Overall Study||29
69349|NCT01502423|164405|P1|COMPLETED|Overall Study||31
69350|NCT01502423|164404|P2|STARTED|Overall Study||30
69351|NCT01502423|164405|P1|STARTED|Overall Study||31
69352|NCT01502410|164427|P4|NOT COMPLETED|Overall Study||0
69353|NCT01502410|164428|P3|NOT COMPLETED|Overall Study||0
69354|NCT01502410|164429|P2|NOT COMPLETED|Overall Study||10
69355|NCT01502410|164430|P1|NOT COMPLETED|Overall Study||10
69356|NCT01502410|164427|P4|COMPLETED|Overall Study||0
69357|NCT01502410|164428|P3|COMPLETED|Overall Study||0
69358|NCT01502410|164429|P2|COMPLETED|Overall Study||0
69359|NCT01502410|164430|P1|COMPLETED|Overall Study||0
69360|NCT01502410|164427|P4|STARTED|Overall Study||0
69361|NCT01502410|164428|P3|STARTED|Overall Study||0
69362|NCT01502410|164429|P2|STARTED|Overall Study||10
69363|NCT01502410|164430|P1|STARTED|Overall Study||10
69364|NCT01502371|164443|P5|NOT COMPLETED|Overall Study||52
69365|NCT01502371|164444|P4|NOT COMPLETED|Overall Study||37
69366|NCT01502371|164445|P3|NOT COMPLETED|Overall Study||25
69367|NCT01502371|164446|P2|NOT COMPLETED|Overall Study||32
69368|NCT01502371|164447|P1|NOT COMPLETED|Overall Study||41
69369|NCT01502371|164443|P5|COMPLETED|Overall Study||60
69370|NCT01502371|164444|P4|COMPLETED|Overall Study||88
69371|NCT01502371|164445|P3|COMPLETED|Overall Study||83
69372|NCT01502371|164446|P2|COMPLETED|Overall Study||81
69373|NCT01502371|164447|P1|COMPLETED|Overall Study||79
69374|NCT01502371|164443|P5|STARTED|Overall Study||112
69375|NCT01502371|164444|P4|STARTED|Overall Study||125
69376|NCT01502371|164445|P3|STARTED|Overall Study||108
69377|NCT01502371|164446|P2|STARTED|Overall Study||113
69378|NCT01502371|164447|P1|STARTED|Overall Study||120
69379|NCT01502332|164472|P2|NOT COMPLETED|Overall Study||0
69380|NCT01502332|164473|P1|NOT COMPLETED|Overall Study||0
69381|NCT01502332|164472|P2|COMPLETED|Overall Study||163
69382|NCT01502332|164473|P1|COMPLETED|Overall Study||157
69383|NCT01502332|164472|P2|STARTED|Overall Study||163
69384|NCT01502332|164473|P1|STARTED|Overall Study||157
69385|NCT01502228|164487|P1|NOT COMPLETED|Overall Study||1
69386|NCT01502228|164487|P1|COMPLETED|Overall Study||13
69387|NCT01502228|164487|P1|STARTED|Overall Study||14
69388|NCT01502033|164492|P1|NOT COMPLETED|Overall Study||3
69389|NCT01502033|164492|P1|COMPLETED|Overall Study|Milestone (10 participants) met|7
69390|NCT01502033|164492|P1|STARTED|Overall Study|Milestone (10 participants) met.|10
69391|NCT01501162|164500|P2|NOT COMPLETED|Overall Study||5
69392|NCT01501162|164501|P1|NOT COMPLETED|Overall Study||8
69393|NCT01501162|164500|P2|COMPLETED|Overall Study||60
69394|NCT01501162|164501|P1|COMPLETED|Overall Study||57
69395|NCT01501162|164500|P2|STARTED|Overall Study||65
69396|NCT01501162|164501|P1|STARTED|Overall Study||65
69397|NCT01501110|164511|P2|NOT COMPLETED|Overall Study||1
69398|NCT01501110|164512|P1|NOT COMPLETED|Overall Study||0
69399|NCT01501110|164511|P2|COMPLETED|Overall Study||33
69400|NCT01501110|164512|P1|COMPLETED|Overall Study||34
69401|NCT01501110|164511|P2|STARTED|Overall Study||34
69402|NCT01501110|164512|P1|STARTED|Overall Study||34
69403|NCT01500772|164518|P1|NOT COMPLETED|Overall Study||6
69404|NCT01500772|164518|P1|COMPLETED|Overall Study||0
69405|NCT01500772|164518|P1|STARTED|Overall Study||6
69406|NCT01500746|164527|P2|NOT COMPLETED|Overall Study||0
69407|NCT01500746|164528|P1|NOT COMPLETED|Overall Study||0
69408|NCT01500746|164527|P2|COMPLETED|Overall Study||4
69409|NCT01500746|164528|P1|COMPLETED|Overall Study||4
69410|NCT01500746|164527|P2|STARTED|Overall Study||4
69411|NCT01500746|164528|P1|STARTED|Overall Study||4
69412|NCT01500720|164536|P2|NOT COMPLETED|Overall Study||9
69413|NCT01500720|164537|P1|NOT COMPLETED|Overall Study||5
69414|NCT01500720|164536|P2|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|80
69415|NCT01500720|164537|P1|COMPLETED|Overall Study|Cancer progression,adverse event,consent withdrawal are considered as completed(defined in protocol)|85
69416|NCT01500720|164536|P2|Treated|Overall Study||88
69417|NCT01500720|164537|P1|Treated|Overall Study||89
69418|NCT01500720|164536|P2|STARTED|Overall Study|Randomized|89
69419|NCT01500720|164537|P1|STARTED|Overall Study|Randomized|90
69420|NCT01500694|164551|P2|NOT COMPLETED|Overall Study||29
69421|NCT01500694|164552|P1|NOT COMPLETED|Overall Study||52
69422|NCT01500694|164551|P2|COMPLETED|Overall Study||54
69423|NCT01500694|164552|P1|COMPLETED|Overall Study||79
69424|NCT01500694|164551|P2|STARTED|Overall Study|Participants who received treatment were reported as Started.|83
69425|NCT01500694|164552|P1|STARTED|Overall Study||131
69426|NCT01500629|164578|P2|NOT COMPLETED|Period 2 (Single Dose)||0
69427|NCT01500629|164579|P1|NOT COMPLETED|Period 2 (Single Dose)||0
69428|NCT01500629|164578|P2|COMPLETED|Period 2 (Single Dose)||10
69429|NCT01500629|164579|P1|COMPLETED|Period 2 (Single Dose)||10
69430|NCT01500629|164578|P2|STARTED|Period 2 (Single Dose)||10
69431|NCT01500629|164579|P1|STARTED|Period 2 (Single Dose)||10
69432|NCT01500629|164578|P2|NOT COMPLETED|Washout Period of 14 to 30 Days||0
69433|NCT01500629|164579|P1|NOT COMPLETED|Washout Period of 14 to 30 Days||1
69434|NCT01500629|164578|P2|COMPLETED|Washout Period of 14 to 30 Days||10
69435|NCT01500629|164579|P1|COMPLETED|Washout Period of 14 to 30 Days||10
69436|NCT01500629|164578|P2|STARTED|Washout Period of 14 to 30 Days||10
69437|NCT01500629|164579|P1|STARTED|Washout Period of 14 to 30 Days||11
69438|NCT01500629|164578|P2|NOT COMPLETED|Period 1 (Single Dose)||0
69439|NCT01500629|164579|P1|NOT COMPLETED|Period 1 (Single Dose)||0
69440|NCT01500629|164578|P2|COMPLETED|Period 1 (Single Dose)||10
69441|NCT01500629|164579|P1|COMPLETED|Period 1 (Single Dose)||11
69442|NCT01500629|164578|P2|STARTED|Period 1 (Single Dose)||10
69443|NCT01500629|164579|P1|STARTED|Period 1 (Single Dose)||11
69444|NCT01500434|164663|P1|NOT COMPLETED|Overall Study||7
69445|NCT01500434|164663|P1|COMPLETED|Overall Study||95
69446|NCT01500434|164663|P1|STARTED|Overall Study||102
69447|NCT01500382|164696|P4|NOT COMPLETED|Treatment Period 2||0
69448|NCT01500382|164697|P3|NOT COMPLETED|Treatment Period 2||0
69449|NCT01500382|164698|P2|NOT COMPLETED|Treatment Period 2||0
69450|NCT01500382|164699|P1|NOT COMPLETED|Treatment Period 2||0
69451|NCT01500382|164696|P4|COMPLETED|Treatment Period 2||1
69452|NCT01500382|164697|P3|COMPLETED|Treatment Period 2||0
69453|NCT01500382|164698|P2|COMPLETED|Treatment Period 2||1
69454|NCT01500382|164699|P1|COMPLETED|Treatment Period 2||1
69455|NCT01500382|164696|P4|STARTED|Treatment Period 2||1
69456|NCT01500382|164697|P3|STARTED|Treatment Period 2||0
69457|NCT01500382|164698|P2|STARTED|Treatment Period 2||1
69458|NCT01500382|164699|P1|STARTED|Treatment Period 2||1
69459|NCT01500382|164696|P4|NOT COMPLETED|Washout Period||0
69460|NCT01500382|164697|P3|NOT COMPLETED|Washout Period||1
69461|NCT01500382|164698|P2|NOT COMPLETED|Washout Period||0
69462|NCT01500382|164699|P1|NOT COMPLETED|Washout Period||0
69463|NCT01500382|164696|P4|COMPLETED|Washout Period||1
69464|NCT01500382|164697|P3|COMPLETED|Washout Period||0
69465|NCT01500382|164698|P2|COMPLETED|Washout Period||1
69466|NCT01500382|164699|P1|COMPLETED|Washout Period||1
69467|NCT01500382|164696|P4|STARTED|Washout Period||1
69468|NCT01500382|164697|P3|STARTED|Washout Period||1
69469|NCT01500382|164698|P2|STARTED|Washout Period||1
69470|NCT01500382|164699|P1|STARTED|Washout Period||1
69471|NCT01500382|164696|P4|NOT COMPLETED|Treatment Period 1||0
69472|NCT01500382|164697|P3|NOT COMPLETED|Treatment Period 1||0
69473|NCT01500382|164698|P2|NOT COMPLETED|Treatment Period 1||0
69474|NCT01500382|164699|P1|NOT COMPLETED|Treatment Period 1||0
69475|NCT01500382|164696|P4|COMPLETED|Treatment Period 1||1
69476|NCT01500382|164697|P3|COMPLETED|Treatment Period 1||1
69477|NCT01500382|164698|P2|COMPLETED|Treatment Period 1||1
69478|NCT01500382|164699|P1|COMPLETED|Treatment Period 1||1
69479|NCT01500382|164696|P4|STARTED|Treatment Period 1||1
69480|NCT01500382|164697|P3|STARTED|Treatment Period 1||1
69481|NCT01500382|164698|P2|STARTED|Treatment Period 1||1
69482|NCT01500382|164699|P1|STARTED|Treatment Period 1||1
69483|NCT01500317|164724|P3|NOT COMPLETED|Overall Study||0
69484|NCT01500317|164725|P2|NOT COMPLETED|Overall Study||2
69485|NCT01500317|164726|P1|NOT COMPLETED|Overall Study||3
69486|NCT01500317|164724|P3|COMPLETED|Overall Study||13
69487|NCT01500317|164725|P2|COMPLETED|Overall Study||10
69488|NCT01500317|164726|P1|COMPLETED|Overall Study||10
69489|NCT01500317|164724|P3|STARTED|Overall Study||13
69490|NCT01500317|164725|P2|STARTED|Overall Study||12
69491|NCT01500317|164726|P1|STARTED|Overall Study||13
69492|NCT01500278|164748|P2|NOT COMPLETED|Week 13 - Week 104||126
69493|NCT01500278|164749|P1|NOT COMPLETED|Week 13 - Week 104||139
69494|NCT01500278|164748|P2|COMPLETED|Week 13 - Week 104||302
69495|NCT01500278|164749|P1|COMPLETED|Week 13 - Week 104||287
69496|NCT01500278|164748|P2|STARTED|Week 13 - Week 104||428
69497|NCT01500278|164749|P1|STARTED|Week 13 - Week 104||426
69498|NCT01500278|164748|P2|NOT COMPLETED|Week 0 - Week 12||30
69499|NCT01500278|164749|P1|NOT COMPLETED|Week 0 - Week 12||31
69500|NCT01500278|164748|P2|COMPLETED|Week 0 - Week 12||428
69501|NCT01500278|164749|P1|COMPLETED|Week 0 - Week 12||426
69502|NCT01500278|164748|P2|STARTED|Week 0 - Week 12||458
69503|NCT01500278|164749|P1|STARTED|Week 0 - Week 12||457
69504|NCT01500252|164773|P2|NOT COMPLETED|Overall Study||6
69505|NCT01500252|164774|P1|NOT COMPLETED|Overall Study||9
69506|NCT01500252|164773|P2|COMPLETED|Overall Study|2 participant deceased by 5 years; no further deaths between 5 & 10 years for a total of 2 deaths|11
69507|NCT01500252|164774|P1|COMPLETED|Overall Study|2 participants died within 5 years; 2 participants died between 5 & 10 years for a total of 4 deaths|12
69508|NCT01500252|164773|P2|Ten Years|Overall Study||11
69509|NCT01500252|164774|P1|Ten Years|Overall Study||12
69510|NCT01500252|164773|P2|Five Years|Overall Study||13
69511|NCT01500252|164774|P1|Five Years|Overall Study||17
69512|NCT01500252|164773|P2|One Years|Overall Study||16
69513|NCT01500252|164774|P1|One Years|Overall Study||20
69514|NCT01500252|164773|P2|STARTED|Overall Study||17
69515|NCT01500252|164774|P1|STARTED|Overall Study||21
69516|NCT01500226|164800|P2|NOT COMPLETED|Overall Study||494
69517|NCT01500226|164801|P1|NOT COMPLETED|Overall Study||499
69518|NCT01500226|164800|P2|COMPLETED|Overall Study||191
69519|NCT01500226|164801|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|185
69520|NCT01500226|164800|P2|STARTED|Overall Study||685
69521|NCT01500226|164801|P1|STARTED|Overall Study|Number of randomized patients|684
69522|NCT01500213|164813|P2|NOT COMPLETED|Overall Study||224
69523|NCT01500213|164814|P1|NOT COMPLETED|Overall Study||217
69524|NCT01500213|164813|P2|COMPLETED|Overall Study||53
69525|NCT01500213|164814|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|61
69526|NCT01500213|164813|P2|STARTED|Overall Study||277
69527|NCT01500213|164814|P1|STARTED|Overall Study|Number of randomized patients|278
69528|NCT01500135|164826|P2|NOT COMPLETED|Overall Study||11
69529|NCT01500135|164827|P1|NOT COMPLETED|Overall Study||17
69530|NCT01500135|164826|P2|COMPLETED|Overall Study||39
69531|NCT01500135|164827|P1|COMPLETED|Overall Study||83
69532|NCT01500135|164826|P2|STARTED|Overall Study||50
69533|NCT01500135|164827|P1|STARTED|Overall Study||100
69534|NCT01500109|164840|P3|NOT COMPLETED|Overall Study||0
69535|NCT01500109|164841|P2|NOT COMPLETED|Overall Study||0
69536|NCT01500109|164842|P1|NOT COMPLETED|Overall Study||0
69537|NCT01500109|164840|P3|COMPLETED|Overall Study||16
69538|NCT01500109|164841|P2|COMPLETED|Overall Study||14
69539|NCT01500109|164842|P1|COMPLETED|Overall Study||15
69540|NCT01500109|164840|P3|STARTED|Overall Study||16
69541|NCT01500109|164841|P2|STARTED|Overall Study||14
69542|NCT01500109|164842|P1|STARTED|Overall Study||15
69543|NCT01500083|164852|P2|NOT COMPLETED|Overall Study||43
69544|NCT01500083|164853|P1|NOT COMPLETED|Overall Study||12
69545|NCT01500083|164852|P2|COMPLETED|Overall Study||31
69546|NCT01500083|164853|P1|COMPLETED|Overall Study||4
69547|NCT01500083|164852|P2|STARTED|Overall Study||74
69548|NCT01500083|164853|P1|STARTED|Overall Study||16
69549|NCT01500031|164859|P1|NOT COMPLETED|Overall Study||5
69550|NCT01500031|164859|P1|COMPLETED|Overall Study||87
69551|NCT01500031|164859|P1|STARTED|Overall Study||92
69552|NCT01499862|164874|P1|NOT COMPLETED|Overall Study||0
69553|NCT01499862|164874|P1|COMPLETED|Overall Study||3
69554|NCT01499862|164874|P1|STARTED|Overall Study||3
69555|NCT01499849|164894|P2|NOT COMPLETED|Overall Study||226
69556|NCT01499849|164895|P1|NOT COMPLETED|Overall Study||224
69557|NCT01499849|164894|P2|COMPLETED|Overall Study||40
69558|NCT01499849|164895|P1|COMPLETED|Overall Study|Number of patients who completed 6 cycles|42
69559|NCT01499849|164894|P2|STARTED|Overall Study||266
69560|NCT01499849|164895|P1|STARTED|Overall Study|Number of randomized patients|266
69561|NCT01499810|164905|P1|NOT COMPLETED|Overall Study||12
69562|NCT01499810|164905|P1|COMPLETED|Overall Study||41
69563|NCT01499810|164905|P1|STARTED|Overall Study||53
69564|NCT01499667|164955|P3|NOT COMPLETED|Overall Study||10
69565|NCT01499667|164956|P2|NOT COMPLETED|Overall Study||11
69566|NCT01499667|164957|P1|NOT COMPLETED|Overall Study||9
69567|NCT01499667|164955|P3|COMPLETED|Overall Study||40
69568|NCT01499667|164956|P2|COMPLETED|Overall Study||31
69569|NCT01499667|164957|P1|COMPLETED|Overall Study||41
69570|NCT01499667|164955|P3|Modified Full Analysis Set|Overall Study||39
69571|NCT01499667|164956|P2|Modified Full Analysis Set|Overall Study||29
69572|NCT01499667|164957|P1|Modified Full Analysis Set|Overall Study|mFAS included all FAS patients who completed 8 wks of fingolimod treatment with MRI scan|41
69573|NCT01499667|164955|P3|Full Analysis Set (FAS)|Overall Study||50
69574|NCT01499667|164956|P2|Full Analysis Set (FAS)|Overall Study||42
69575|NCT01499667|164957|P1|Full Analysis Set (FAS)|Overall Study|One randomized patient did not receive natalizumub at screening, which was a requirement for FAS.|49
69576|NCT01499667|164955|P3|STARTED|Overall Study||50
69577|NCT01499667|164956|P2|STARTED|Overall Study||42
69578|NCT01499667|164957|P1|STARTED|Overall Study|Started” indicates randomized as well as safety population.|50
69579|NCT01499654|164986|P1|NOT COMPLETED|Overall Study||0
69580|NCT01499654|164986|P1|COMPLETED|Overall Study||64
69581|NCT01499654|164986|P1|STARTED|Overall Study||64
69582|NCT01499576|165005|P1|NOT COMPLETED|Overall Study||21
69583|NCT01499576|165005|P1|COMPLETED|Overall Study||105
69584|NCT01499576|165005|P1|STARTED|Overall Study||126
69585|NCT01499498|165011|P1|NOT COMPLETED|Overall Study||0
69586|NCT01499498|165011|P1|COMPLETED|Overall Study||13
69587|NCT01499498|165011|P1|STARTED|Overall Study||13
69588|NCT01499355|165019|P4|NOT COMPLETED|Double-Blind Period||23
69589|NCT01499355|165020|P3|NOT COMPLETED|Double-Blind Period||25
69590|NCT01499355|165021|P2|NOT COMPLETED|Double-Blind Period||23
69591|NCT01499355|165022|P1|NOT COMPLETED|Double-Blind Period||0
69592|NCT01499355|165019|P4|COMPLETED|Double-Blind Period||39
69593|NCT01499355|165020|P3|COMPLETED|Double-Blind Period||38
69594|NCT01499355|165021|P2|COMPLETED|Double-Blind Period||40
69595|NCT01499355|165022|P1|COMPLETED|Double-Blind Period||0
69596|NCT01499355|165019|P4|STARTED|Double-Blind Period||62
69597|NCT01499355|165020|P3|STARTED|Double-Blind Period||63
69598|NCT01499355|165021|P2|STARTED|Double-Blind Period||63
69599|NCT01499355|165022|P1|STARTED|Double-Blind Period||0
69600|NCT01499355|165019|P4|NOT COMPLETED|Run-In Period||0
69601|NCT01499355|165020|P3|NOT COMPLETED|Run-In Period||0
69602|NCT01499355|165021|P2|NOT COMPLETED|Run-In Period||0
69603|NCT01499355|165022|P1|NOT COMPLETED|Run-In Period||31
69604|NCT01499355|165019|P4|COMPLETED|Run-In Period||0
69605|NCT01499355|165020|P3|COMPLETED|Run-In Period||0
69606|NCT01499355|165021|P2|COMPLETED|Run-In Period||0
69607|NCT01499355|165022|P1|COMPLETED|Run-In Period||245
69608|NCT01499355|165019|P4|STARTED|Run-In Period||0
69609|NCT01499355|165020|P3|STARTED|Run-In Period||0
69610|NCT01499355|165021|P2|STARTED|Run-In Period||0
69611|NCT01499355|165022|P1|STARTED|Run-In Period||276
69612|NCT01499303|165055|P2|NOT COMPLETED|Overall Study||7
69613|NCT01499303|165056|P1|NOT COMPLETED|Overall Study||3
69614|NCT01499303|165055|P2|COMPLETED|Overall Study||40
69615|NCT01499303|165056|P1|COMPLETED|Overall Study||18
69616|NCT01499303|165055|P2|STARTED|Overall Study||47
69617|NCT01499303|165056|P1|STARTED|Overall Study||21
69618|NCT01499290|165064|P2|NOT COMPLETED|Overall Study||35
69619|NCT01499290|165065|P1|NOT COMPLETED|Overall Study||55
69620|NCT01499290|165064|P2|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|494
69621|NCT01499290|165065|P1|COMPLETED|Overall Study|(Numbers indicate patients who completed treatment)|474
69622|NCT01499290|165064|P2|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
69623|NCT01499290|165065|P1|STARTED|Overall Study|Patients dosed in pooled protocols D4280C00001/D4280C00005 (NCT01499290/NCT01500239) agreed with FDA|529
69624|NCT01499277|165115|P2|NOT COMPLETED|Overall Study||32
69625|NCT01499277|165116|P1|NOT COMPLETED|Overall Study||47
69626|NCT01499277|165115|P2|COMPLETED|Overall Study||223
69627|NCT01499277|165116|P1|COMPLETED|Overall Study||459
69628|NCT01499277|165115|P2|STARTED|Overall Study||255
69629|NCT01499277|165116|P1|STARTED|Overall Study||506
69630|NCT01499199|165138|P1|NOT COMPLETED|Overall Study||2
69631|NCT01499199|165138|P1|COMPLETED|Overall Study||11
69632|NCT01499199|165138|P1|STARTED|Overall Study||13
69633|NCT01499147|165159|P2|NOT COMPLETED|Overall Study||5
69634|NCT01499147|165160|P1|NOT COMPLETED|Overall Study||15
69635|NCT01499147|165159|P2|COMPLETED|Overall Study||12
69636|NCT01499147|165160|P1|COMPLETED|Overall Study||18
69637|NCT01499147|165159|P2|STARTED|Overall Study||17
69638|NCT01499147|165160|P1|STARTED|Overall Study||33
69639|NCT01499134|165175|P2|NOT COMPLETED|Overall Study||1
69640|NCT01499134|165176|P1|NOT COMPLETED|Overall Study||0
69641|NCT01499134|165175|P2|COMPLETED|Overall Study||7
69642|NCT01499134|165176|P1|COMPLETED|Overall Study||9
69643|NCT01499134|165175|P2|STARTED|Overall Study||8
69644|NCT01499134|165176|P1|STARTED|Overall Study||9
69645|NCT01499095|165198|P2|NOT COMPLETED|Overall Study||93
69646|NCT01499095|165199|P1|NOT COMPLETED|Overall Study||89
69647|NCT01499095|165198|P2|COMPLETED|Overall Study||314
69648|NCT01499095|165199|P1|COMPLETED|Overall Study||315
69649|NCT01499095|165198|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|405
69650|NCT01499095|165199|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|403
69651|NCT01499095|165198|P2|Participated in Substudy|Overall Study||0
69652|NCT01499095|165199|P1|Participated in Substudy|Overall Study|45 participants received adaptable dosing regimen and 44 participants received fixed dosing regimen|89
69653|NCT01499095|165198|P2|Treated|Overall Study||406
69654|NCT01499095|165199|P1|Treated|Overall Study||403
69655|NCT01499095|165198|P2|STARTED|Overall Study||407
69656|NCT01499095|165199|P1|STARTED|Overall Study||404
69657|NCT01499082|165229|P2|NOT COMPLETED|Overall Study||48
69658|NCT01499082|165230|P1|NOT COMPLETED|Overall Study||45
69659|NCT01499082|165229|P2|COMPLETED|Overall Study||355
69660|NCT01499082|165230|P1|COMPLETED|Overall Study||359
69661|NCT01499082|165229|P2|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|400
69662|NCT01499082|165230|P1|Modified Intent-to-Treat Population|Overall Study|Participants who received at least 1 dose of drug, had both baseline, at least 1 post-baseline data|404
69663|NCT01499082|165229|P2|Participated in Substudy|Overall Study||0
69664|NCT01499082|165230|P1|Participated in Substudy|Overall Study|56 participants received adaptable dosing regimen and 53 participants received fixed dosing regimen|109
69665|NCT01499082|165229|P2|Treated|Overall Study||402
69666|NCT01499082|165230|P1|Treated|Overall Study||404
69667|NCT01499082|165229|P2|STARTED|Overall Study||403
69668|NCT01499082|165230|P1|STARTED|Overall Study||404
69669|NCT01498822|165260|P2|NOT COMPLETED|Overall Study||56
69670|NCT01498822|165261|P1|NOT COMPLETED|Overall Study||54
69671|NCT01498822|165260|P2|COMPLETED|Overall Study||122
69672|NCT01498822|165261|P1|COMPLETED|Overall Study||121
69673|NCT01498822|165260|P2|STARTED|Overall Study||178
69674|NCT01498822|165261|P1|STARTED|Overall Study||175
69675|NCT01498744|165275|P2|NOT COMPLETED|Overall Study||0
69676|NCT01498744|165276|P1|NOT COMPLETED|Overall Study||0
69677|NCT01498744|165275|P2|COMPLETED|Overall Study||31
69678|NCT01498744|165276|P1|COMPLETED|Overall Study||22
69679|NCT01498744|165275|P2|STARTED|Overall Study||31
69680|NCT01498744|165276|P1|STARTED|Overall Study||22
69681|NCT01498692|165288|P1|NOT COMPLETED|Overall Study||8
69682|NCT01498692|165288|P1|COMPLETED|Overall Study||86
69683|NCT01498692|165288|P1|STARTED|Overall Study||94
69684|NCT01498679|165319|P2|NOT COMPLETED|Overall Study||22
69685|NCT01498679|165320|P1|NOT COMPLETED|Overall Study||89
69686|NCT01498679|165319|P2|COMPLETED|Overall Study||131
69687|NCT01498679|165320|P1|COMPLETED|Overall Study||65
69688|NCT01498679|165319|P2|STARTED|Overall Study||153
69689|NCT01498679|165320|P1|STARTED|Overall Study||154
69690|NCT01498653|165336|P2|NOT COMPLETED|Overall Study||35
69691|NCT01498653|165337|P1|NOT COMPLETED|Overall Study||19
69692|NCT01498653|165336|P2|COMPLETED|Overall Study||119
69693|NCT01498653|165337|P1|COMPLETED|Overall Study||136
69694|NCT01498653|165336|P2|STARTED|Overall Study||154
69695|NCT01498653|165337|P1|STARTED|Overall Study||155
69696|NCT01498640|165351|P1|NOT COMPLETED|Overall Study||5
69697|NCT01498640|165351|P1|COMPLETED|Overall Study||47
69698|NCT01498640|165351|P1|STARTED|Overall Study||52
69699|NCT01498601|165367|P2|NOT COMPLETED|Overall Study||0
69700|NCT01498601|165368|P1|NOT COMPLETED|Overall Study||0
69701|NCT01498601|165367|P2|COMPLETED|Overall Study||32
69702|NCT01498601|165368|P1|COMPLETED|Overall Study||51
69703|NCT01498601|165367|P2|STARTED|Overall Study||32
69704|NCT01498601|165368|P1|STARTED|Overall Study||51
69705|NCT01498588|165374|P1|NOT COMPLETED|Overall Study||0
69706|NCT01498588|165374|P1|COMPLETED|Overall Study||7
69707|NCT01498588|165374|P1|STARTED|Overall Study||7
69708|NCT01498575|165381|P2|NOT COMPLETED|On the Road Driving Assessment (ODA)||24
69709|NCT01498575|165382|P1|NOT COMPLETED|On the Road Driving Assessment (ODA)||42
69710|NCT01498575|165381|P2|COMPLETED|On the Road Driving Assessment (ODA)||65
69711|NCT01498575|165382|P1|COMPLETED|On the Road Driving Assessment (ODA)||86
69712|NCT01498575|165381|P2|STARTED|On the Road Driving Assessment (ODA)||89
69713|NCT01498575|165382|P1|STARTED|On the Road Driving Assessment (ODA)||128
69714|NCT01498575|165381|P2|NOT COMPLETED|Overall Sample||14
69715|NCT01498575|165382|P1|NOT COMPLETED|Overall Sample||60
69716|NCT01498575|165381|P2|COMPLETED|Overall Sample||400
69717|NCT01498575|165382|P1|COMPLETED|Overall Sample||550
69718|NCT01498575|165381|P2|STARTED|Overall Sample||414
69719|NCT01498575|165382|P1|STARTED|Overall Sample||610
69720|NCT01498549|165388|P1|NOT COMPLETED|Overall Study||4
69721|NCT01498549|165388|P1|COMPLETED|Overall Study||35
69722|NCT01498549|165388|P1|Sugar Pill 0 mg|Overall Study||36
69723|NCT01498549|165388|P1|Atomoxetine 80 mg|Overall Study||37
69724|NCT01498549|165388|P1|Atomoxetine 40 mg|Overall Study||39
69725|NCT01498549|165388|P1|STARTED|Overall Study||39
69726|NCT01498458|165399|P1|NOT COMPLETED|Overall Study||7
69727|NCT01498458|165399|P1|COMPLETED|Overall Study|only 1 patient was in the study at the end. 7 left due to Adverse Events or Investigators Decision.|1
69728|NCT01498458|165399|P1|STARTED|Overall Study|9 patients took part in the study of which 8 received pazopanib.|8
69729|NCT01498419|165412|P4|NOT COMPLETED|Overall Study||19
69730|NCT01498419|165413|P3|NOT COMPLETED|Overall Study||18
69731|NCT01498419|165414|P2|NOT COMPLETED|Overall Study||23
69732|NCT01498419|165415|P1|NOT COMPLETED|Overall Study||18
69733|NCT01498419|165412|P4|COMPLETED|Overall Study||7
69734|NCT01498419|165413|P3|COMPLETED|Overall Study||41
69735|NCT01498419|165414|P2|COMPLETED|Overall Study||39
69736|NCT01498419|165415|P1|COMPLETED|Overall Study||42
69737|NCT01498419|165412|P4|STARTED|Overall Study||26
69738|NCT01498419|165413|P3|STARTED|Overall Study||59
69739|NCT01498419|165414|P2|STARTED|Overall Study||62
69740|NCT01498419|165415|P1|STARTED|Overall Study||60
69741|NCT01498185|165454|P5|NOT COMPLETED|Overall Study||3
69742|NCT01498185|165455|P4|NOT COMPLETED|Overall Study||3
69743|NCT01498185|165456|P3|NOT COMPLETED|Overall Study||0
69744|NCT01498185|165457|P2|NOT COMPLETED|Overall Study||1
69745|NCT01498185|165458|P1|NOT COMPLETED|Overall Study||1
69746|NCT01498185|165454|P5|COMPLETED|Overall Study||12
69747|NCT01498185|165455|P4|COMPLETED|Overall Study||11
69748|NCT01498185|165456|P3|COMPLETED|Overall Study||15
69749|NCT01498185|165457|P2|COMPLETED|Overall Study||12
69750|NCT01498185|165458|P1|COMPLETED|Overall Study||12
69751|NCT01498185|165454|P5|STARTED|Overall Study||15
69752|NCT01498185|165455|P4|STARTED|Overall Study||14
69753|NCT01498185|165456|P3|STARTED|Overall Study||15
69754|NCT01498185|165457|P2|STARTED|Overall Study||13
69755|NCT01498185|165458|P1|STARTED|Overall Study||13
69756|NCT01498120|165498|P1|NOT COMPLETED|Overall Study||13
69757|NCT01498120|165498|P1|COMPLETED|Overall Study||1
69758|NCT01498120|165498|P1|STARTED|Overall Study||14
69759|NCT01498068|165505|P2|NOT COMPLETED|Overall Study||1
69760|NCT01498068|165506|P1|NOT COMPLETED|Overall Study||1
69761|NCT01498068|165505|P2|COMPLETED|Overall Study||19
69762|NCT01498068|165506|P1|COMPLETED|Overall Study||15
69763|NCT01498068|165505|P2|STARTED|Overall Study||20
69764|NCT01498068|165506|P1|STARTED|Overall Study||16
69765|NCT01497938|165524|P2|NOT COMPLETED|Overall Study||2
69766|NCT01497938|165525|P1|NOT COMPLETED|Overall Study||5
69767|NCT01497938|165524|P2|COMPLETED|Overall Study||124
69768|NCT01497938|165525|P1|COMPLETED|Overall Study||116
69769|NCT01497938|165524|P2|STARTED|Overall Study||126
69770|NCT01497938|165525|P1|STARTED|Overall Study||121
69771|NCT01497899|165537|P4|NOT COMPLETED|Open-Label Extension Phase||38
69772|NCT01497899|165538|P3|NOT COMPLETED|Open-Label Extension Phase||70
69773|NCT01497899|165539|P2|NOT COMPLETED|Open-Label Extension Phase||53
69774|NCT01497899|165540|P1|NOT COMPLETED|Open-Label Extension Phase||105
69775|NCT01497899|165537|P4|COMPLETED|Open-Label Extension Phase||0
69776|NCT01497899|165538|P3|COMPLETED|Open-Label Extension Phase||0
69777|NCT01497899|165539|P2|COMPLETED|Open-Label Extension Phase||0
69778|NCT01497899|165540|P1|COMPLETED|Open-Label Extension Phase||0
69779|NCT01497899|165537|P4|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored studies.|38
69780|NCT01497899|165538|P3|STARTED|Open-Label Extension Phase|Participants enrolled from other Gilead-sponsored studies.|70
69781|NCT01497899|165539|P2|STARTED|Open-Label Extension Phase||53
69782|NCT01497899|165540|P1|STARTED|Open-Label Extension Phase|2 participants completed the Double-Blind Phase, but did not continue in the Open-Label Extension.|105
69783|NCT01497899|165537|P4|NOT COMPLETED|Double-Blind Phase||0
69784|NCT01497899|165538|P3|NOT COMPLETED|Double-Blind Phase||0
69785|NCT01497899|165539|P2|NOT COMPLETED|Double-Blind Phase||5
69786|NCT01497899|165540|P1|NOT COMPLETED|Double-Blind Phase||6
69787|NCT01497899|165537|P4|COMPLETED|Double-Blind Phase||0
69788|NCT01497899|165538|P3|COMPLETED|Double-Blind Phase||0
69789|NCT01497899|165539|P2|COMPLETED|Double-Blind Phase||53
69790|NCT01497899|165540|P1|COMPLETED|Double-Blind Phase||107
69791|NCT01497899|165537|P4|STARTED|Double-Blind Phase||0
69792|NCT01497899|165538|P3|STARTED|Double-Blind Phase||0
69793|NCT01497899|165539|P2|STARTED|Double-Blind Phase||58
69794|NCT01497899|165540|P1|STARTED|Double-Blind Phase||113
69795|NCT01497756|165553|P1|NOT COMPLETED|Overall Study||0
69796|NCT01497756|165553|P1|COMPLETED|Overall Study||10
69797|NCT01497756|165553|P1|STARTED|Overall Study||10
69798|NCT01497665|165558|P1|NOT COMPLETED|Overall Study||0
69799|NCT01497665|165558|P1|COMPLETED|Overall Study||16
69800|NCT01497665|165558|P1|Completed Effifcacy Assessment|Overall Study|Number of patients who completed efficacy assessment with CNS lesions per Overall RECIST 1.1.|10
69801|NCT01497665|165558|P1|STARTED|Overall Study||16
69802|NCT01497366|165568|P2|NOT COMPLETED|Overall Study||88
69803|NCT01497366|165569|P1|NOT COMPLETED|Overall Study||39
69804|NCT01497366|165568|P2|COMPLETED|Overall Study||176
69805|NCT01497366|165569|P1|COMPLETED|Overall Study||224
69806|NCT01497366|165568|P2|Randomized But Not Treated|Overall Study||21
69807|NCT01497366|165569|P1|Randomized But Not Treated|Overall Study||7
69808|NCT01497366|165568|P2|STARTED|Overall Study||264
69809|NCT01497366|165569|P1|STARTED|Overall Study||263
69810|NCT01497275|165587|P1|NOT COMPLETED|Overall Study||2
69811|NCT01497275|165587|P1|COMPLETED|Overall Study||3
69812|NCT01497275|165587|P1|STARTED|Overall Study||5
69813|NCT01497262|165594|P1|NOT COMPLETED|Overall Study||11
69814|NCT01497262|165594|P1|COMPLETED|Overall Study||151
69815|NCT01497262|165594|P1|STARTED|Overall Study||162
69816|NCT01497197|165601|P2|NOT COMPLETED|Overall Study||15
69817|NCT01497197|165602|P1|NOT COMPLETED|Overall Study||17
69818|NCT01497197|165601|P2|COMPLETED|Overall Study||70
69819|NCT01497197|165602|P1|COMPLETED|Overall Study||72
69820|NCT01497197|165601|P2|STARTED|Overall Study||85
69821|NCT01497197|165602|P1|STARTED|Overall Study||89
69822|NCT01497171|165630|P2|NOT COMPLETED|Overall Study||0
69823|NCT01497171|165631|P1|NOT COMPLETED|Overall Study||0
69824|NCT01497171|165630|P2|COMPLETED|Overall Study||3
69825|NCT01497171|165631|P1|COMPLETED|Overall Study||2
69826|NCT01497171|165630|P2|STARTED|Overall Study||3
69827|NCT01497171|165631|P1|STARTED|Overall Study||2
69828|NCT01496807|165637|P1|NOT COMPLETED|Overall Study||30
69829|NCT01496807|165637|P1|COMPLETED|Overall Study||1
69830|NCT01496807|165637|P1|STARTED|Overall Study||31
69831|NCT01496469|165649|P2|NOT COMPLETED|Overall Study||8
69832|NCT01496469|165650|P1|NOT COMPLETED|Overall Study||10
69833|NCT01496469|165649|P2|COMPLETED|Overall Study||53
69834|NCT01496469|165650|P1|COMPLETED|Overall Study||50
69835|NCT01496469|165649|P2|STARTED|Overall Study||61
69836|NCT01496469|165650|P1|STARTED|Overall Study||60
69837|NCT01496456|165660|P1|NOT COMPLETED|Overall Study||8
69838|NCT01496456|165660|P1|COMPLETED|Overall Study||9
69839|NCT01496456|165660|P1|3-yr Final Recall|Overall Study||9
69840|NCT01496456|165660|P1|2-yr Recall|Overall Study||10
69841|NCT01496456|165660|P1|1-yr Recall|Overall Study||12
69842|NCT01496456|165660|P1|Baseline|Overall Study|Baseline group started with 16 patients.|16
69843|NCT01496456|165660|P1|STARTED|Overall Study||17
69844|NCT01496430|165673|P3|NOT COMPLETED|Overall Study||10
69845|NCT01496430|165674|P2|NOT COMPLETED|Overall Study||5
69846|NCT01496430|165675|P1|NOT COMPLETED|Overall Study||6
69847|NCT01496430|165673|P3|COMPLETED|Overall Study||25
69848|NCT01496430|165674|P2|COMPLETED|Overall Study||30
69849|NCT01496430|165675|P1|COMPLETED|Overall Study||29
69850|NCT01496430|165673|P3|STARTED|Overall Study||35
69851|NCT01496430|165674|P2|STARTED|Overall Study||35
69852|NCT01496430|165675|P1|STARTED|Overall Study||35
69853|NCT01496352|165751|P2|NOT COMPLETED|Overall Study||0
69854|NCT01496352|165752|P1|NOT COMPLETED|Overall Study||0
69855|NCT01496352|165751|P2|COMPLETED|Overall Study||6
69856|NCT01496352|165752|P1|COMPLETED|Overall Study||24
69857|NCT01496352|165751|P2|STARTED|Overall Study||6
69858|NCT01496352|165752|P1|STARTED|Overall Study||24
69859|NCT01496313|165770|P2|NOT COMPLETED|Overall Study||15
69860|NCT01496313|165771|P1|NOT COMPLETED|Overall Study||5
69861|NCT01496313|165770|P2|COMPLETED|Overall Study||26
69862|NCT01496313|165771|P1|COMPLETED|Overall Study||35
69863|NCT01496313|165770|P2|STARTED|Overall Study||41
69864|NCT01496313|165771|P1|STARTED|Overall Study||40
69865|NCT01496287|165787|P1|NOT COMPLETED|Overall Study||6
69866|NCT01496287|165787|P1|COMPLETED|Overall Study||64
69867|NCT01496287|165787|P1|STARTED|Overall Study||70
69868|NCT01496274|165797|P2|NOT COMPLETED|Overall Study||5
69869|NCT01496274|165798|P1|NOT COMPLETED|Overall Study||3
69870|NCT01496274|165797|P2|COMPLETED|Overall Study||18
69871|NCT01496274|165798|P1|COMPLETED|Overall Study||37
69872|NCT01496274|165797|P2|STARTED|Overall Study||23
69873|NCT01496274|165798|P1|STARTED|Overall Study||40
69874|NCT01496248|165830|P1|NOT COMPLETED|Overall Study||10
69875|NCT01496248|165830|P1|COMPLETED|Overall Study||25
69876|NCT01496248|165830|P1|STARTED|Overall Study||35
69877|NCT01496183|165843|P2|NOT COMPLETED|Overall Study||2
69878|NCT01496183|165844|P1|NOT COMPLETED|Overall Study||3
69879|NCT01496183|165843|P2|COMPLETED|Overall Study||13
69880|NCT01496183|165844|P1|COMPLETED|Overall Study||6
69881|NCT01496183|165843|P2|STARTED|Overall Study||15
69882|NCT01496183|165844|P1|STARTED|Overall Study||9
69883|NCT01495988|165854|P4|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69884|NCT01495988|165855|P3|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69885|NCT01495988|165856|P2|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69886|NCT01495988|165857|P1|NOT COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69887|NCT01495988|165854|P4|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69888|NCT01495988|165855|P3|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69889|NCT01495988|165856|P2|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||2
69890|NCT01495988|165857|P1|COMPLETED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69891|NCT01495988|165854|P4|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69892|NCT01495988|165855|P3|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69893|NCT01495988|165856|P2|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||2
69894|NCT01495988|165857|P1|STARTED|Vem/Cobi +/- Bev (Protocol v4.0)||0
69895|NCT01495988|165854|P4|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
69896|NCT01495988|165855|P3|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
69897|NCT01495988|165856|P2|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
69898|NCT01495988|165857|P1|NOT COMPLETED|Vem +/- Bev (Protocol v2.0)||0
69899|NCT01495988|165854|P4|COMPLETED|Vem +/- Bev (Protocol v2.0)||3
69900|NCT01495988|165855|P3|COMPLETED|Vem +/- Bev (Protocol v2.0)||5
69901|NCT01495988|165856|P2|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
69902|NCT01495988|165857|P1|COMPLETED|Vem +/- Bev (Protocol v2.0)||0
69903|NCT01495988|165854|P4|STARTED|Vem +/- Bev (Protocol v2.0)||3
69904|NCT01495988|165855|P3|STARTED|Vem +/- Bev (Protocol v2.0)||5
69905|NCT01495988|165856|P2|STARTED|Vem +/- Bev (Protocol v2.0)||0
69906|NCT01495988|165857|P1|STARTED|Vem +/- Bev (Protocol v2.0)||0
69907|NCT01495975|165893|P2|NOT COMPLETED|Overall Study||0
69908|NCT01495975|165894|P1|NOT COMPLETED|Overall Study||1
69909|NCT01495975|165893|P2|COMPLETED|Overall Study||14
69910|NCT01495975|165894|P1|COMPLETED|Overall Study||14
69911|NCT01495975|165893|P2|STARTED|Overall Study||14
69912|NCT01495975|165894|P1|STARTED|Overall Study||15
69913|NCT01495923|165902|P2|NOT COMPLETED|Overall Study||0
69914|NCT01495923|165903|P1|NOT COMPLETED|Overall Study||0
69915|NCT01495923|165902|P2|COMPLETED|Overall Study||72
69916|NCT01495923|165903|P1|COMPLETED|Overall Study||73
69917|NCT01495923|165902|P2|STARTED|Overall Study||72
69918|NCT01495923|165903|P1|STARTED|Overall Study||73
69919|NCT01495858|165936|P3|NOT COMPLETED|Overall Study||0
69920|NCT01495858|165937|P2|NOT COMPLETED|Overall Study||0
69921|NCT01495858|165938|P1|NOT COMPLETED|Overall Study||0
69922|NCT01495858|165936|P3|COMPLETED|Overall Study||54
69923|NCT01495858|165937|P2|COMPLETED|Overall Study||106
69924|NCT01495858|165938|P1|COMPLETED|Overall Study||107
69925|NCT01495858|165936|P3|STARTED|Overall Study||54
69926|NCT01495858|165937|P2|STARTED|Overall Study||106
69927|NCT01495858|165938|P1|STARTED|Overall Study||107
69928|NCT01495793|166018|P1|NOT COMPLETED|Overall Study||2
69929|NCT01495793|166018|P1|COMPLETED|Overall Study||22
69930|NCT01495793|166018|P1|STARTED|Overall Study||24
69931|NCT01495702|166031|P2|NOT COMPLETED|Extension Phase||0
69932|NCT01495702|166032|P1|NOT COMPLETED|Extension Phase||0
69933|NCT01495702|166031|P2|COMPLETED|Extension Phase||2
69934|NCT01495702|166032|P1|COMPLETED|Extension Phase||26
69935|NCT01495702|166031|P2|STARTED|Extension Phase||2
69936|NCT01495702|166032|P1|STARTED|Extension Phase||26
69937|NCT01495702|166031|P2|NOT COMPLETED|Randomized Phase||28
69938|NCT01495702|166032|P1|NOT COMPLETED|Randomized Phase||26
69939|NCT01495702|166031|P2|COMPLETED|Randomized Phase||119
69940|NCT01495702|166032|P1|COMPLETED|Randomized Phase||266
69941|NCT01495702|166031|P2|STARTED|Randomized Phase||147
69942|NCT01495702|166032|P1|STARTED|Randomized Phase||292
69943|NCT01495689|166047|P2|NOT COMPLETED|Overall Study||7
69944|NCT01495689|166048|P1|NOT COMPLETED|Overall Study||10
69945|NCT01495689|166047|P2|COMPLETED|Overall Study||16
69946|NCT01495689|166048|P1|COMPLETED|Overall Study||16
69947|NCT01495689|166047|P2|STARTED|Overall Study||23
69948|NCT01495689|166048|P1|STARTED|Overall Study||26
69949|NCT01495585|166057|P3|NOT COMPLETED|Overall Study||0
69950|NCT01495585|166058|P2|NOT COMPLETED|Overall Study||0
69951|NCT01495585|166059|P1|NOT COMPLETED|Overall Study||0
69952|NCT01495585|166057|P3|COMPLETED|Overall Study||4
69953|NCT01495585|166058|P2|COMPLETED|Overall Study||6
69954|NCT01495585|166059|P1|COMPLETED|Overall Study||4
69955|NCT01495585|166057|P3|Open Label Lonafarnib 200 mg|Overall Study||0
69956|NCT01495585|166058|P2|Open Label Lonafarnib 200 mg|Overall Study||0
69957|NCT01495585|166059|P1|Open Label Lonafarnib 200 mg|Overall Study||2
69958|NCT01495585|166057|P3|STARTED|Overall Study||4
69959|NCT01495585|166058|P2|STARTED|Overall Study||6
69960|NCT01495585|166059|P1|STARTED|Overall Study||4
69961|NCT01495572|166072|P2|NOT COMPLETED|Overall Study||0
69962|NCT01495572|166073|P1|NOT COMPLETED|Overall Study||0
69963|NCT01495572|166072|P2|COMPLETED|Overall Study||5
69964|NCT01495572|166073|P1|COMPLETED|Overall Study||0
69965|NCT01495572|166072|P2|STARTED|Overall Study||5
69966|NCT01495572|166073|P1|STARTED|Overall Study||0
69967|NCT01495481|166081|P1|NOT COMPLETED|Dexmedetomidine||0
69968|NCT01495481|166081|P1|COMPLETED|Dexmedetomidine||22
69969|NCT01495481|166081|P1|STARTED|Dexmedetomidine||22
69970|NCT01495481|166081|P1|NOT COMPLETED|Washout||0
69971|NCT01495481|166081|P1|COMPLETED|Washout||22
69972|NCT01495481|166081|P1|STARTED|Washout||22
69973|NCT01495481|166081|P1|NOT COMPLETED|Adenosine||0
69974|NCT01495481|166081|P1|COMPLETED|Adenosine||22
69975|NCT01495481|166081|P1|STARTED|Adenosine|Patients first received adenosine and then dexmedetomidine.|22
69976|NCT01495286|166093|P1|NOT COMPLETED|Overall Study||0
69977|NCT01495286|166093|P1|COMPLETED|Overall Study||30
69978|NCT01495286|166093|P1|STARTED|Overall Study||30
69979|NCT01495000|166103|P2|NOT COMPLETED|Overall Study||12
69980|NCT01495000|166104|P1|NOT COMPLETED|Overall Study||13
69981|NCT01495000|166103|P2|COMPLETED|Overall Study||114
69982|NCT01495000|166104|P1|COMPLETED|Overall Study||111
69983|NCT01495000|166103|P2|STARTED|Overall Study||126
69984|NCT01495000|166104|P1|STARTED|Overall Study||124
69985|NCT01494987|166146|P2|NOT COMPLETED|Overall Study||28
69986|NCT01494987|166147|P1|NOT COMPLETED|Overall Study||28
69987|NCT01494987|166146|P2|COMPLETED|Overall Study||187
69988|NCT01494987|166147|P1|COMPLETED|Overall Study||188
69989|NCT01494987|166146|P2|STARTED|Overall Study||215
69990|NCT01494987|166147|P1|STARTED|Overall Study||216
69991|NCT01494818|166161|P2|NOT COMPLETED|Overall Study||2
69992|NCT01494818|166162|P1|NOT COMPLETED|Overall Study||2
69993|NCT01494818|166161|P2|COMPLETED|Overall Study||37
69994|NCT01494818|166162|P1|COMPLETED|Overall Study||37
69995|NCT01494818|166161|P2|STARTED|Overall Study||39
69996|NCT01494818|166162|P1|STARTED|Overall Study||39
69997|NCT01494753|166184|P2|NOT COMPLETED|Day42-Day84||0
69998|NCT01494753|166185|P1|NOT COMPLETED|Day42-Day84||0
69999|NCT01494753|166184|P2|COMPLETED|Day42-Day84||15
70000|NCT01494753|166185|P1|COMPLETED|Day42-Day84||15
70001|NCT01494753|166184|P2|STARTED|Day42-Day84||15
70002|NCT01494753|166185|P1|STARTED|Day42-Day84||15
70003|NCT01494753|166184|P2|NOT COMPLETED|Day0-Day42||0
70004|NCT01494753|166185|P1|NOT COMPLETED|Day0-Day42||0
70005|NCT01494753|166184|P2|COMPLETED|Day0-Day42||15
70006|NCT01494753|166185|P1|COMPLETED|Day0-Day42||15
70007|NCT01494753|166184|P2|STARTED|Day0-Day42||15
70008|NCT01494753|166185|P1|STARTED|Day0-Day42||15
70009|NCT01494649|166193|P2|NOT COMPLETED|Overall Study||1
70010|NCT01494649|166194|P1|NOT COMPLETED|Overall Study||0
70011|NCT01494649|166193|P2|COMPLETED|Overall Study||58
70012|NCT01494649|166194|P1|COMPLETED|Overall Study||59
70013|NCT01494649|166193|P2|STARTED|Overall Study||59
70014|NCT01494649|166194|P1|STARTED|Overall Study||59
70015|NCT01494610|166210|P2|NOT COMPLETED|Period 4||0
70016|NCT01494610|166211|P1|NOT COMPLETED|Period 4||1
70017|NCT01494610|166210|P2|COMPLETED|Period 4||28
70018|NCT01494610|166211|P1|COMPLETED|Period 4||27
70019|NCT01494610|166210|P2|STARTED|Period 4||28
70020|NCT01494610|166211|P1|STARTED|Period 4||28
70021|NCT01494610|166210|P2|NOT COMPLETED|Period 3||0
70022|NCT01494610|166211|P1|NOT COMPLETED|Period 3||2
70023|NCT01494610|166210|P2|COMPLETED|Period 3||28
70024|NCT01494610|166211|P1|COMPLETED|Period 3||28
70025|NCT01494610|166210|P2|STARTED|Period 3||28
70026|NCT01494610|166211|P1|STARTED|Period 3||30
70027|NCT01494610|166210|P2|NOT COMPLETED|Period 2||0
70028|NCT01494610|166211|P1|NOT COMPLETED|Period 2||0
70029|NCT01494610|166210|P2|COMPLETED|Period 2||28
70030|NCT01494610|166211|P1|COMPLETED|Period 2||30
70031|NCT01494610|166210|P2|STARTED|Period 2||28
70032|NCT01494610|166211|P1|STARTED|Period 2||30
70033|NCT01494610|166210|P2|NOT COMPLETED|Period 1||1
70034|NCT01494610|166211|P1|NOT COMPLETED|Period 1||1
70035|NCT01494610|166210|P2|COMPLETED|Period 1||28
70036|NCT01494610|166211|P1|COMPLETED|Period 1||30
70037|NCT01494610|166210|P2|STARTED|Period 1||29
70038|NCT01494610|166211|P1|STARTED|Period 1||31
70039|NCT01494584|166279|P1|NOT COMPLETED|Overall Study||1
70040|NCT01494584|166279|P1|COMPLETED|Overall Study||4
70041|NCT01494584|166279|P1|STARTED|Overall Study||5
70042|NCT01494545|166368|P1|NOT COMPLETED|Overall Study||10
70043|NCT01494545|166368|P1|COMPLETED|Overall Study||92
70044|NCT01494545|166368|P1|STARTED|Overall Study||102
70045|NCT01494532|166411|P6|NOT COMPLETED|Overall Study||0
70046|NCT01494532|166412|P5|NOT COMPLETED|Overall Study||12
70047|NCT01494532|166413|P4|NOT COMPLETED|Overall Study||15
70048|NCT01494532|166414|P3|NOT COMPLETED|Overall Study||17
70049|NCT01494532|166415|P2|NOT COMPLETED|Overall Study||4
70050|NCT01494532|166416|P1|NOT COMPLETED|Overall Study||10
70051|NCT01494532|166411|P6|COMPLETED|Overall Study||25
70052|NCT01494532|166412|P5|COMPLETED|Overall Study||64
70053|NCT01494532|166413|P4|COMPLETED|Overall Study||60
70054|NCT01494532|166414|P3|COMPLETED|Overall Study||59
70055|NCT01494532|166415|P2|COMPLETED|Overall Study||21
70056|NCT01494532|166416|P1|COMPLETED|Overall Study||65
70057|NCT01494532|166411|P6|STARTED|Overall Study||25
70058|NCT01494532|166412|P5|STARTED|Overall Study||76
70059|NCT01494532|166413|P4|STARTED|Overall Study||75
70060|NCT01494532|166414|P3|STARTED|Overall Study||76
70061|NCT01494532|166415|P2|STARTED|Overall Study||25
70062|NCT01494532|166416|P1|STARTED|Overall Study||75
70063|NCT01494506|166571|P3|NOT COMPLETED|Overall Study||103
70064|NCT01494506|166572|P2|NOT COMPLETED|Overall Study||143
70065|NCT01494506|166573|P1|NOT COMPLETED|Overall Study||148
70066|NCT01494506|166571|P3|COMPLETED|Overall Study||14
70067|NCT01494506|166572|P2|COMPLETED|Overall Study||6
70068|NCT01494506|166573|P1|COMPLETED|Overall Study|Completed = Subjects remaining on treatment at the time of the primary analysis data cut off.|3
70069|NCT01494506|166571|P3|Treated Population|Overall Study|2 randomized Arm C patients did not receive study drug. 1 patient each in A and B received Arm C.|117
70070|NCT01494506|166572|P2|Treated Population|Overall Study||134
70071|NCT01494506|166573|P1|Treated Population|Overall Study|Treated population: Patients who received at least 1 dose of study drug.|147
70072|NCT01494506|166571|P3|STARTED|Overall Study||117
70073|NCT01494506|166572|P2|STARTED|Overall Study||149
70074|NCT01494506|166573|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|151
70075|NCT01494467|166610|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
70076|NCT01494467|166611|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
70077|NCT01494467|166610|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||159
70078|NCT01494467|166611|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||353
70079|NCT01494467|166610|P2|STARTED|Part C Safety Follow up (4 Weeks)||159
70080|NCT01494467|166611|P1|STARTED|Part C Safety Follow up (4 Weeks)||353
70081|NCT01494467|166610|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||49
70082|NCT01494467|166611|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||75
70083|NCT01494467|166610|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||159
70084|NCT01494467|166611|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||353
70085|NCT01494467|166610|P2|STARTED|Part B Long Term Active Control 40 Weeks||208
70086|NCT01494467|166611|P1|STARTED|Part B Long Term Active Control 40 Weeks|429 completed Part A. Subsequently, one subject discontinued so only 428 entered Part B|428
70087|NCT01494467|166610|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||21
70088|NCT01494467|166611|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||30
70089|NCT01494467|166610|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||208
70090|NCT01494467|166611|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||429
70091|NCT01494467|166610|P2|STARTED|Part A Vehicle Control (12 Weeks)||229
70092|NCT01494467|166611|P1|STARTED|Part A Vehicle Control (12 Weeks)||459
70093|NCT01494350|166627|P1|NOT COMPLETED|Overall Study||1
70094|NCT01494350|166627|P1|COMPLETED|Overall Study||49
70095|NCT01494350|166627|P1|STARTED|Overall Study||50
70096|NCT01494298|166637|P2|NOT COMPLETED|Overall Study||8
70097|NCT01494298|166638|P1|NOT COMPLETED|Overall Study||2
70098|NCT01494298|166637|P2|COMPLETED|Overall Study||47
70099|NCT01494298|166638|P1|COMPLETED|Overall Study||54
70100|NCT01494298|166637|P2|STARTED|Overall Study||55
70101|NCT01494298|166638|P1|STARTED|Overall Study||56
70102|NCT01493947|166650|P2|NOT COMPLETED|Period B Extension Period||32
70103|NCT01493947|166651|P1|NOT COMPLETED|Period B Extension Period||33
70104|NCT01493947|166650|P2|COMPLETED|Period B Extension Period||326
70105|NCT01493947|166651|P1|COMPLETED|Period B Extension Period||366
70106|NCT01493947|166650|P2|STARTED|Period B Extension Period|358 / 456 subjects were eligible to enter in Period B (i.e IGA =0 or 1 at end of Period A).|358
70107|NCT01493947|166651|P1|STARTED|Period B Extension Period|Only 399 /446 subjects were eligible to enter in Period B (i.e IGA=0 or1 at end of Period A).|399
70108|NCT01493947|166650|P2|NOT COMPLETED|Period A Efficacy and Safety Data||28
70109|NCT01493947|166651|P1|NOT COMPLETED|Period A Efficacy and Safety Data||32
70110|NCT01493947|166650|P2|COMPLETED|Period A Efficacy and Safety Data||456
70111|NCT01493947|166651|P1|COMPLETED|Period A Efficacy and Safety Data||446
70112|NCT01493947|166650|P2|STARTED|Period A Efficacy and Safety Data||484
70113|NCT01493947|166651|P1|STARTED|Period A Efficacy and Safety Data||478
70114|NCT01493687|166663|P2|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||1
70115|NCT01493687|166664|P1|NOT COMPLETED|Part C Safety Follow up (4 Weeks)||0
70116|NCT01493687|166663|P2|COMPLETED|Part C Safety Follow up (4 Weeks)||174
70117|NCT01493687|166664|P1|COMPLETED|Part C Safety Follow up (4 Weeks)||350
70118|NCT01493687|166663|P2|STARTED|Part C Safety Follow up (4 Weeks)||175
70119|NCT01493687|166664|P1|STARTED|Part C Safety Follow up (4 Weeks)|351 completed Part B. Then 1 discontinued (subject request) prior to Part C.|350
70120|NCT01493687|166663|P2|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||35
70121|NCT01493687|166664|P1|NOT COMPLETED|Part B Long Term Active Control 40 Weeks||61
70122|NCT01493687|166663|P2|COMPLETED|Part B Long Term Active Control 40 Weeks||175
70123|NCT01493687|166664|P1|COMPLETED|Part B Long Term Active Control 40 Weeks||351
70124|NCT01493687|166663|P2|STARTED|Part B Long Term Active Control 40 Weeks||210
70125|NCT01493687|166664|P1|STARTED|Part B Long Term Active Control 40 Weeks|414 completed Part A. Then 2 discontinued (lack of efficacy, subject request) prior to Part B.|412
70126|NCT01493687|166663|P2|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||22
70127|NCT01493687|166664|P1|NOT COMPLETED|Part A Vehicle Control (12 Weeks)||37
70128|NCT01493687|166663|P2|COMPLETED|Part A Vehicle Control (12 Weeks)||210
70129|NCT01493687|166664|P1|COMPLETED|Part A Vehicle Control (12 Weeks)||414
70130|NCT01493687|166663|P2|STARTED|Part A Vehicle Control (12 Weeks)||232
70131|NCT01493687|166664|P1|STARTED|Part A Vehicle Control (12 Weeks)||451
70132|NCT01493557|166683|P3|NOT COMPLETED|Adding the Second Strategy||0
70133|NCT01493557|166684|P2|NOT COMPLETED|Adding the Second Strategy||4
70134|NCT01493557|166685|P1|NOT COMPLETED|Adding the Second Strategy||2
70135|NCT01493557|166683|P3|COMPLETED|Adding the Second Strategy||0
70136|NCT01493557|166684|P2|COMPLETED|Adding the Second Strategy||11
70137|NCT01493557|166685|P1|COMPLETED|Adding the Second Strategy||12
70138|NCT01493557|166683|P3|STARTED|Adding the Second Strategy||0
70139|NCT01493557|166684|P2|STARTED|Adding the Second Strategy||15
70140|NCT01493557|166685|P1|STARTED|Adding the Second Strategy||14
70141|NCT01493557|166683|P3|NOT COMPLETED|Randomized to Management Strategies||0
70142|NCT01493557|166684|P2|NOT COMPLETED|Randomized to Management Strategies||11
70143|NCT01493557|166685|P1|NOT COMPLETED|Randomized to Management Strategies||15
70144|NCT01493557|166683|P3|COMPLETED|Randomized to Management Strategies||0
70145|NCT01493557|166684|P2|COMPLETED|Randomized to Management Strategies||47
70146|NCT01493557|166685|P1|COMPLETED|Randomized to Management Strategies||44
70147|NCT01493557|166683|P3|STARTED|Randomized to Management Strategies||0
70148|NCT01493557|166684|P2|STARTED|Randomized to Management Strategies||58
70149|NCT01493557|166685|P1|STARTED|Randomized to Management Strategies||59
70150|NCT01493557|166683|P3|NOT COMPLETED|Not Randomized to Management Strategies||134
70151|NCT01493557|166684|P2|NOT COMPLETED|Not Randomized to Management Strategies||0
70152|NCT01493557|166685|P1|NOT COMPLETED|Not Randomized to Management Strategies||0
70153|NCT01493557|166683|P3|COMPLETED|Not Randomized to Management Strategies||816
70154|NCT01493557|166684|P2|COMPLETED|Not Randomized to Management Strategies||0
70155|NCT01493557|166685|P1|COMPLETED|Not Randomized to Management Strategies||0
70156|NCT01493557|166683|P3|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies|26 patients completed (GIS resolved ) and 4 patients completed (GIS not resolved ) the trial.|48
70157|NCT01493557|166684|P2|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
70158|NCT01493557|166685|P1|Reported GIS Only at EOT Visit|Not Randomized to Management Strategies||0
70159|NCT01493557|166683|P3|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies|32 patients completed the trial.|48
70160|NCT01493557|166684|P2|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
70161|NCT01493557|166685|P1|Reported GIS Prior to EOT Visit|Not Randomized to Management Strategies||0
70162|NCT01493557|166683|P3|Without Experiencing GIS|Not Randomized to Management Strategies|754 patients completed the trial.|854
70163|NCT01493557|166684|P2|Without Experiencing GIS|Not Randomized to Management Strategies||0
70164|NCT01493557|166685|P1|Without Experiencing GIS|Not Randomized to Management Strategies||0
70165|NCT01493557|166683|P3|STARTED|Not Randomized to Management Strategies||950
70166|NCT01493557|166684|P2|STARTED|Not Randomized to Management Strategies||0
70167|NCT01493557|166685|P1|STARTED|Not Randomized to Management Strategies||0
70168|NCT01493531|166713|P3|NOT COMPLETED|Overall Study||48
70169|NCT01493531|166714|P2|NOT COMPLETED|Overall Study||50
70170|NCT01493531|166715|P1|NOT COMPLETED|Overall Study||41
70171|NCT01493531|166713|P3|COMPLETED|Overall Study||158
70172|NCT01493531|166714|P2|COMPLETED|Overall Study||150
70173|NCT01493531|166715|P1|COMPLETED|Overall Study||163
70174|NCT01493531|166713|P3|STARTED|Overall Study||206
70175|NCT01493531|166714|P2|STARTED|Overall Study||200
70176|NCT01493531|166715|P1|STARTED|Overall Study||204
70177|NCT01493427|166729|P1|NOT COMPLETED|Overall Study||20
70178|NCT01493427|166729|P1|COMPLETED|Overall Study||179
70179|NCT01493427|166729|P1|STARTED|Overall Study||199
70180|NCT01493180|166736|P2|NOT COMPLETED|Overall Study||2
70181|NCT01493180|166737|P1|NOT COMPLETED|Overall Study||3
70182|NCT01493180|166736|P2|COMPLETED|Overall Study||49
70183|NCT01493180|166737|P1|COMPLETED|Overall Study||48
70184|NCT01493180|166736|P2|STARTED|Overall Study||51
70185|NCT01493180|166737|P1|STARTED|Overall Study||51
70186|NCT01493167|166743|P1|NOT COMPLETED|Overall Study||0
70187|NCT01493167|166743|P1|COMPLETED|Overall Study||97
70188|NCT01493167|166743|P1|STARTED|Overall Study||97
70189|NCT01493089|166749|P2|NOT COMPLETED|Overall Study||3
70190|NCT01493089|166750|P1|NOT COMPLETED|Overall Study||3
70191|NCT01493089|166749|P2|COMPLETED|Overall Study||114
70192|NCT01493089|166750|P1|COMPLETED|Overall Study||119
70193|NCT01493089|166749|P2|STARTED|Overall Study||117
70194|NCT01493089|166750|P1|STARTED|Overall Study||122
70195|NCT01492439|166768|P2|NOT COMPLETED|Overall Study||9
70196|NCT01492439|166769|P1|NOT COMPLETED|Overall Study||4
70197|NCT01492439|166768|P2|COMPLETED|Overall Study||9
70198|NCT01492439|166769|P1|COMPLETED|Overall Study||15
70199|NCT01492439|166768|P2|Post-intervention|Overall Study||13
70200|NCT01492439|166769|P1|Post-intervention|Overall Study||18
70201|NCT01492439|166768|P2|STARTED|Overall Study||18
70202|NCT01492439|166769|P1|STARTED|Overall Study||19
70203|NCT01492426|166817|P2|NOT COMPLETED|Follow-Up||10
70204|NCT01492426|166818|P1|NOT COMPLETED|Follow-Up||25
70205|NCT01492426|166817|P2|COMPLETED|Follow-Up||181
70206|NCT01492426|166818|P1|COMPLETED|Follow-Up||359
70207|NCT01492426|166817|P2|STARTED|Follow-Up|This total number includes 160 who completed treatment plus 31 who rejoined for follow-up.|191
70208|NCT01492426|166818|P1|STARTED|Follow-Up|This total number includes 319 who completed treatment plus 65 who rejoined for follow-up.|384
70209|NCT01492426|166817|P2|NOT COMPLETED|Treatment||40
70210|NCT01492426|166818|P1|NOT COMPLETED|Treatment||83
70211|NCT01492426|166817|P2|COMPLETED|Treatment||160
70212|NCT01492426|166818|P1|COMPLETED|Treatment||319
70213|NCT01492426|166817|P2|STARTED|Treatment||200
70214|NCT01492426|166818|P1|STARTED|Treatment||402
70215|NCT01492400|166836|P2|NOT COMPLETED|Overall Study||16
70216|NCT01492400|166837|P1|NOT COMPLETED|Overall Study||16
70217|NCT01492400|166836|P2|COMPLETED|Overall Study||166
70218|NCT01492400|166837|P1|COMPLETED|Overall Study||165
70219|NCT01492400|166836|P2|STARTED|Overall Study||182
70220|NCT01492400|166837|P1|STARTED|Overall Study||181
70221|NCT01492088|166850|P3|NOT COMPLETED|Overall Study||13
70222|NCT01492088|166851|P2|NOT COMPLETED|Overall Study||14
70223|NCT01492088|166852|P1|NOT COMPLETED|Overall Study||3
70224|NCT01492088|166850|P3|COMPLETED|Overall Study||4
70225|NCT01492088|166851|P2|COMPLETED|Overall Study||2
70226|NCT01492088|166852|P1|COMPLETED|Overall Study||0
70227|NCT01492088|166850|P3|STARTED|Overall Study||17
70228|NCT01492088|166851|P2|STARTED|Overall Study||16
70229|NCT01492088|166852|P1|STARTED|Overall Study||3
70230|NCT01491984|166912|P2|NOT COMPLETED|Overall Study||1
70231|NCT01491984|166913|P1|NOT COMPLETED|Overall Study||2
70232|NCT01491984|166912|P2|COMPLETED|Overall Study||44
70233|NCT01491984|166913|P1|COMPLETED|Overall Study||47
70234|NCT01491984|166912|P2|STARTED|Overall Study||45
70235|NCT01491984|166913|P1|STARTED|Overall Study||49
70236|NCT01491919|166922|P3|NOT COMPLETED|Overall Study||1
70237|NCT01491919|166923|P2|NOT COMPLETED|Overall Study||2
70238|NCT01491919|166924|P1|NOT COMPLETED|Overall Study||1
70239|NCT01491919|166922|P3|COMPLETED|Overall Study||2
70240|NCT01491919|166923|P2|COMPLETED|Overall Study||8
70241|NCT01491919|166924|P1|COMPLETED|Overall Study||12
70242|NCT01491919|166922|P3|STARTED|Overall Study||3
70243|NCT01491919|166923|P2|STARTED|Overall Study||10
70244|NCT01491919|166924|P1|STARTED|Overall Study||13
70245|NCT01491802|166970|P2|NOT COMPLETED|Overall Study||2
70246|NCT01491802|166971|P1|NOT COMPLETED|Overall Study||1
70247|NCT01491802|166970|P2|COMPLETED|Overall Study||6
70248|NCT01491802|166971|P1|COMPLETED|Overall Study||8
70249|NCT01491802|166970|P2|STARTED|Overall Study||8
70250|NCT01491802|166971|P1|STARTED|Overall Study||9
70251|NCT01491737|166998|P2|NOT COMPLETED|Overall Study||50
70252|NCT01491737|166999|P1|NOT COMPLETED|Overall Study||49
70253|NCT01491737|166998|P2|COMPLETED|Overall Study||79
70254|NCT01491737|166999|P1|COMPLETED|Overall Study||80
70255|NCT01491737|166998|P2|STARTED|Overall Study||129
70256|NCT01491737|166999|P1|STARTED|Overall Study||129
70257|NCT01491672|167022|P3|NOT COMPLETED|Overall Study||11
70258|NCT01491672|167023|P2|NOT COMPLETED|Overall Study||60
70259|NCT01491672|167024|P1|NOT COMPLETED|Overall Study||56
70260|NCT01491672|167022|P3|COMPLETED|Overall Study||3
70261|NCT01491672|167023|P2|COMPLETED|Overall Study||2
70262|NCT01491672|167024|P1|COMPLETED|Overall Study||2
70263|NCT01491672|167022|P3|Safety Set|Overall Study||14
70264|NCT01491672|167023|P2|Safety Set|Overall Study||61
70265|NCT01491672|167024|P1|Safety Set|Overall Study||58
70266|NCT01491672|167022|P3|STARTED|Overall Study||14
70267|NCT01491672|167023|P2|STARTED|Overall Study|1 participant died prior to treatment initiation.|62
70268|NCT01491672|167024|P1|STARTED|Overall Study||58
70269|NCT01491633|167049|P1|NOT COMPLETED|Overall Study||5
70270|NCT01491633|167049|P1|COMPLETED|Overall Study||0
70271|NCT01491633|167049|P1|STARTED|Overall Study||5
70272|NCT01491607|167061|P1|NOT COMPLETED|Overall Study||10
70273|NCT01491607|167061|P1|COMPLETED|Overall Study||190
70274|NCT01491607|167061|P1|STARTED|Overall Study||200
70275|NCT01491490|167159|P2|NOT COMPLETED|Overall Study||0
70276|NCT01491490|167160|P1|NOT COMPLETED|Overall Study||0
70277|NCT01491490|167159|P2|COMPLETED|Overall Study||1
70278|NCT01491490|167160|P1|COMPLETED|Overall Study||1
70279|NCT01491490|167159|P2|STARTED|Overall Study||1
70280|NCT01491490|167160|P1|STARTED|Overall Study||1
70281|NCT01491113|167171|P5|NOT COMPLETED|Overall Study||0
70282|NCT01491113|167172|P4|NOT COMPLETED|Overall Study||0
70283|NCT01491113|167173|P3|NOT COMPLETED|Overall Study||0
70284|NCT01491113|167174|P2|NOT COMPLETED|Overall Study||0
70285|NCT01491113|167175|P1|NOT COMPLETED|Overall Study||0
70286|NCT01491113|167171|P5|COMPLETED|Overall Study||6
70287|NCT01491113|167172|P4|COMPLETED|Overall Study||6
70288|NCT01491113|167173|P3|COMPLETED|Overall Study||6
70289|NCT01491113|167174|P2|COMPLETED|Overall Study||6
70290|NCT01491113|167175|P1|COMPLETED|Overall Study||6
70291|NCT01491113|167171|P5|STARTED|Overall Study||6
70292|NCT01491113|167172|P4|STARTED|Overall Study||6
70293|NCT01491113|167173|P3|STARTED|Overall Study||6
70294|NCT01491113|167174|P2|STARTED|Overall Study||6
70295|NCT01491113|167175|P1|STARTED|Overall Study||6
70296|NCT01491035|167270|P8|NOT COMPLETED|Overall Study||0
70297|NCT01491035|167271|P7|NOT COMPLETED|Overall Study||0
70298|NCT01491035|167272|P6|NOT COMPLETED|Overall Study||0
70299|NCT01491035|167273|P5|NOT COMPLETED|Overall Study||1
70300|NCT01491035|167274|P4|NOT COMPLETED|Overall Study||0
70301|NCT01491035|167275|P3|NOT COMPLETED|Overall Study||0
70302|NCT01491035|167276|P2|NOT COMPLETED|Overall Study||0
70303|NCT01491035|167277|P1|NOT COMPLETED|Overall Study||0
70304|NCT01491035|167270|P8|COMPLETED|Overall Study||6
70305|NCT01491035|167271|P7|COMPLETED|Overall Study||6
70306|NCT01491035|167272|P6|COMPLETED|Overall Study||6
70307|NCT01491035|167273|P5|COMPLETED|Overall Study||5
70308|NCT01491035|167274|P4|COMPLETED|Overall Study||6
70309|NCT01491035|167275|P3|COMPLETED|Overall Study||6
70310|NCT01491035|167276|P2|COMPLETED|Overall Study||6
70311|NCT01491035|167277|P1|COMPLETED|Overall Study||6
70312|NCT01491035|167270|P8|STARTED|Overall Study||6
70313|NCT01491035|167271|P7|STARTED|Overall Study||6
70314|NCT01491035|167272|P6|STARTED|Overall Study||6
70315|NCT01491035|167273|P5|STARTED|Overall Study||6
70316|NCT01491035|167274|P4|STARTED|Overall Study||6
70317|NCT01491035|167275|P3|STARTED|Overall Study||6
70318|NCT01491035|167276|P2|STARTED|Overall Study||6
70319|NCT01491035|167277|P1|STARTED|Overall Study||6
70320|NCT01491022|167345|P2|NOT COMPLETED|Intervention 2||0
70321|NCT01491022|167346|P1|NOT COMPLETED|Intervention 2||1
70322|NCT01491022|167345|P2|COMPLETED|Intervention 2||11
70323|NCT01491022|167346|P1|COMPLETED|Intervention 2||8
70324|NCT01491022|167345|P2|STARTED|Intervention 2||11
70325|NCT01491022|167346|P1|STARTED|Intervention 2||9
70326|NCT01491022|167345|P2|NOT COMPLETED|2 Week Washout||0
70327|NCT01491022|167346|P1|NOT COMPLETED|2 Week Washout||0
70328|NCT01491022|167345|P2|COMPLETED|2 Week Washout||11
70329|NCT01491022|167346|P1|COMPLETED|2 Week Washout||9
70330|NCT01491022|167345|P2|STARTED|2 Week Washout||11
70331|NCT01491022|167346|P1|STARTED|2 Week Washout||9
70332|NCT01491022|167345|P2|NOT COMPLETED|Intervention 1||1
70333|NCT01491022|167346|P1|NOT COMPLETED|Intervention 1||1
70334|NCT01491022|167345|P2|COMPLETED|Intervention 1||11
70335|NCT01491022|167346|P1|COMPLETED|Intervention 1||9
70336|NCT01491022|167345|P2|STARTED|Intervention 1||12
70337|NCT01491022|167346|P1|STARTED|Intervention 1||10
70338|NCT01490931|167362|P1|NOT COMPLETED|Overall Study||0
70339|NCT01490931|167362|P1|COMPLETED|Overall Study||25
70340|NCT01490931|167362|P1|STARTED|Overall Study||25
70341|NCT01490866|167378|P1|NOT COMPLETED|Axitinib Maintenance Therapy||49
70342|NCT01490866|167378|P1|COMPLETED|Axitinib Maintenance Therapy|No protocol defined endpoint to Axitinib maintenance treatment.|0
70343|NCT01490866|167378|P1|STARTED|Axitinib Maintenance Therapy||49
70344|NCT01490866|167378|P1|NOT COMPLETED|FOLFOX/Bevacizumab Treatment||21
70345|NCT01490866|167378|P1|COMPLETED|FOLFOX/Bevacizumab Treatment||49
70346|NCT01490866|167378|P1|STARTED|FOLFOX/Bevacizumab Treatment||70
70347|NCT01490840|167389|P2|NOT COMPLETED|Phase 2||6
70348|NCT01490840|167390|P1|NOT COMPLETED|Phase 2||6
70349|NCT01490840|167389|P2|COMPLETED|Phase 2||68
70350|NCT01490840|167390|P1|COMPLETED|Phase 2||75
70351|NCT01490840|167389|P2|STARTED|Phase 2|4 participants discontinued between phase 1 and phase 2|74
70352|NCT01490840|167390|P1|STARTED|Phase 2|3 participants discontinued between phase 1 and phase 2|81
70353|NCT01490840|167389|P2|NOT COMPLETED|Phase 1||6
70354|NCT01490840|167390|P1|NOT COMPLETED|Phase 1||10
70355|NCT01490840|167389|P2|COMPLETED|Phase 1||78
70356|NCT01490840|167390|P1|COMPLETED|Phase 1||84
70357|NCT01490840|167389|P2|Modified Full Analysis Set|Phase 1||83
70358|NCT01490840|167390|P1|Modified Full Analysis Set|Phase 1||56
70359|NCT01490840|167389|P2|STARTED|Phase 1||84
70360|NCT01490840|167390|P1|STARTED|Phase 1||94
70361|NCT01490697|167414|P2|NOT COMPLETED|Overall Study||2
70362|NCT01490697|167415|P1|NOT COMPLETED|Overall Study||1
70363|NCT01490697|167414|P2|COMPLETED|Overall Study||16
70364|NCT01490697|167415|P1|COMPLETED|Overall Study||15
70365|NCT01490697|167414|P2|STARTED|Overall Study||18
70366|NCT01490697|167415|P1|STARTED|Overall Study||16
70367|NCT01490632|167428|P20|NOT COMPLETED|Part D: Re-Treatment Period||7
70368|NCT01490632|167429|P19|NOT COMPLETED|Part D: Re-Treatment Period||7
70369|NCT01490632|167430|P18|NOT COMPLETED|Part D: Re-Treatment Period||5
70370|NCT01490632|167431|P17|NOT COMPLETED|Part D: Re-Treatment Period||0
70371|NCT01490632|167432|P16|NOT COMPLETED|Part D: Re-Treatment Period||0
70372|NCT01490632|167433|P15|NOT COMPLETED|Part D: Re-Treatment Period||0
70373|NCT01490632|167434|P14|NOT COMPLETED|Part D: Re-Treatment Period||0
70374|NCT01490632|167435|P13|NOT COMPLETED|Part D: Re-Treatment Period||0
70375|NCT01490632|167436|P12|NOT COMPLETED|Part D: Re-Treatment Period||0
70376|NCT01490632|167437|P11|NOT COMPLETED|Part D: Re-Treatment Period||0
70377|NCT01490632|167438|P10|NOT COMPLETED|Part D: Re-Treatment Period||0
70378|NCT01490632|167439|P9|NOT COMPLETED|Part D: Re-Treatment Period||0
70379|NCT01490632|167440|P8|NOT COMPLETED|Part D: Re-Treatment Period||0
70380|NCT01490632|167441|P7|NOT COMPLETED|Part D: Re-Treatment Period||0
70381|NCT01490632|167442|P6|NOT COMPLETED|Part D: Re-Treatment Period||0
70382|NCT01490632|167443|P5|NOT COMPLETED|Part D: Re-Treatment Period||0
70383|NCT01490632|167444|P4|NOT COMPLETED|Part D: Re-Treatment Period||0
70384|NCT01490632|167445|P3|NOT COMPLETED|Part D: Re-Treatment Period||0
70385|NCT01490632|167446|P2|NOT COMPLETED|Part D: Re-Treatment Period||0
70386|NCT01490632|167447|P1|NOT COMPLETED|Part D: Re-Treatment Period||0
70387|NCT01490632|167428|P20|COMPLETED|Part D: Re-Treatment Period||30
70388|NCT01490632|167429|P19|COMPLETED|Part D: Re-Treatment Period||12
70389|NCT01490632|167430|P18|COMPLETED|Part D: Re-Treatment Period||8
70390|NCT01490632|167431|P17|COMPLETED|Part D: Re-Treatment Period||3
70391|NCT01490632|167432|P16|COMPLETED|Part D: Re-Treatment Period||0
70392|NCT01490632|167433|P15|COMPLETED|Part D: Re-Treatment Period||0
70393|NCT01490632|167434|P14|COMPLETED|Part D: Re-Treatment Period||0
70394|NCT01490632|167435|P13|COMPLETED|Part D: Re-Treatment Period||0
70395|NCT01490632|167436|P12|COMPLETED|Part D: Re-Treatment Period||0
70396|NCT01490632|167437|P11|COMPLETED|Part D: Re-Treatment Period||0
70397|NCT01490632|167438|P10|COMPLETED|Part D: Re-Treatment Period||0
70398|NCT01490632|167439|P9|COMPLETED|Part D: Re-Treatment Period||0
70399|NCT01490632|167440|P8|COMPLETED|Part D: Re-Treatment Period||0
70400|NCT01490632|167441|P7|COMPLETED|Part D: Re-Treatment Period||0
70401|NCT01490632|167442|P6|COMPLETED|Part D: Re-Treatment Period||0
70402|NCT01490632|167443|P5|COMPLETED|Part D: Re-Treatment Period||0
70403|NCT01490632|167444|P4|COMPLETED|Part D: Re-Treatment Period||0
70404|NCT01490632|167445|P3|COMPLETED|Part D: Re-Treatment Period||0
70405|NCT01490632|167446|P2|COMPLETED|Part D: Re-Treatment Period||0
70406|NCT01490632|167447|P1|COMPLETED|Part D: Re-Treatment Period||0
70407|NCT01490632|167428|P20|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 10 mg.|37
70408|NCT01490632|167429|P19|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 8 mg.|19
70409|NCT01490632|167430|P18|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 4 mg.|13
70410|NCT01490632|167431|P17|STARTED|Part D: Re-Treatment Period|Responders who experienced a relapse or flare proceeded for retreatment with 2 mg.|3
70411|NCT01490632|167432|P16|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|0
70412|NCT01490632|167433|P15|STARTED|Part D: Re-Treatment Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|0
70413|NCT01490632|167434|P14|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|0
70414|NCT01490632|167435|P13|STARTED|Part D: Re-Treatment Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|0
70415|NCT01490632|167436|P12|STARTED|Part D: Re-Treatment Period||0
70416|NCT01490632|167437|P11|STARTED|Part D: Re-Treatment Period||0
70417|NCT01490632|167438|P10|STARTED|Part D: Re-Treatment Period||0
70418|NCT01490632|167439|P9|STARTED|Part D: Re-Treatment Period||0
70419|NCT01490632|167440|P8|STARTED|Part D: Re-Treatment Period||0
70420|NCT01490632|167441|P7|STARTED|Part D: Re-Treatment Period||0
70421|NCT01490632|167442|P6|STARTED|Part D: Re-Treatment Period||0
70422|NCT01490632|167443|P5|STARTED|Part D: Re-Treatment Period||0
70423|NCT01490632|167444|P4|STARTED|Part D: Re-Treatment Period||0
70424|NCT01490632|167445|P3|STARTED|Part D: Re-Treatment Period||0
70425|NCT01490632|167446|P2|STARTED|Part D: Re-Treatment Period||0
70426|NCT01490632|167447|P1|STARTED|Part D: Re-Treatment Period||0
70427|NCT01490632|167428|P20|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70428|NCT01490632|167429|P19|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70429|NCT01490632|167430|P18|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70430|NCT01490632|167431|P17|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70431|NCT01490632|167432|P16|NOT COMPLETED|Part C: Washout or Step-Down Period||37
70432|NCT01490632|167433|P15|NOT COMPLETED|Part C: Washout or Step-Down Period||18
70433|NCT01490632|167434|P14|NOT COMPLETED|Part C: Washout or Step-Down Period||10
70434|NCT01490632|167435|P13|NOT COMPLETED|Part C: Washout or Step-Down Period||5
70435|NCT01490632|167436|P12|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70436|NCT01490632|167437|P11|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70437|NCT01490632|167438|P10|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70438|NCT01490632|167439|P9|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70439|NCT01490632|167440|P8|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70440|NCT01490632|167441|P7|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70441|NCT01490632|167442|P6|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70442|NCT01490632|167443|P5|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70443|NCT01490632|167444|P4|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70444|NCT01490632|167445|P3|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70445|NCT01490632|167446|P2|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70446|NCT01490632|167447|P1|NOT COMPLETED|Part C: Washout or Step-Down Period||0
70447|NCT01490632|167428|P20|COMPLETED|Part C: Washout or Step-Down Period||0
70448|NCT01490632|167429|P19|COMPLETED|Part C: Washout or Step-Down Period||0
70449|NCT01490632|167430|P18|COMPLETED|Part C: Washout or Step-Down Period||0
70450|NCT01490632|167431|P17|COMPLETED|Part C: Washout or Step-Down Period||0
70451|NCT01490632|167432|P16|COMPLETED|Part C: Washout or Step-Down Period||18
70452|NCT01490632|167433|P15|COMPLETED|Part C: Washout or Step-Down Period||37
70453|NCT01490632|167434|P14|COMPLETED|Part C: Washout or Step-Down Period||6
70454|NCT01490632|167435|P13|COMPLETED|Part C: Washout or Step-Down Period||10
70455|NCT01490632|167436|P12|COMPLETED|Part C: Washout or Step-Down Period||0
70456|NCT01490632|167437|P11|COMPLETED|Part C: Washout or Step-Down Period||0
70457|NCT01490632|167438|P10|COMPLETED|Part C: Washout or Step-Down Period||0
70458|NCT01490632|167439|P9|COMPLETED|Part C: Washout or Step-Down Period||0
70459|NCT01490632|167440|P8|COMPLETED|Part C: Washout or Step-Down Period||0
70460|NCT01490632|167441|P7|COMPLETED|Part C: Washout or Step-Down Period||0
70461|NCT01490632|167442|P6|COMPLETED|Part C: Washout or Step-Down Period||0
70462|NCT01490632|167443|P5|COMPLETED|Part C: Washout or Step-Down Period||0
70463|NCT01490632|167444|P4|COMPLETED|Part C: Washout or Step-Down Period||0
70464|NCT01490632|167445|P3|COMPLETED|Part C: Washout or Step-Down Period||0
70465|NCT01490632|167446|P2|COMPLETED|Part C: Washout or Step-Down Period||0
70466|NCT01490632|167447|P1|COMPLETED|Part C: Washout or Step-Down Period||0
70467|NCT01490632|167428|P20|STARTED|Part C: Washout or Step-Down Period||0
70468|NCT01490632|167429|P19|STARTED|Part C: Washout or Step-Down Period||0
70469|NCT01490632|167430|P18|STARTED|Part C: Washout or Step-Down Period||0
70470|NCT01490632|167431|P17|STARTED|Part C: Washout or Step-Down Period||0
70471|NCT01490632|167432|P16|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive 4 mg.|55
70472|NCT01490632|167433|P15|STARTED|Part C: Washout or Step-Down Period|Responders receiving 8 or 10 mg were re-randomized to receive placebo.|55
70473|NCT01490632|167434|P14|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive half of the dose from Part B.|16
70474|NCT01490632|167435|P13|STARTED|Part C: Washout or Step-Down Period|Responders receiving 2 or 4 mg were re-randomized to receive placebo.|15
70475|NCT01490632|167436|P12|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to Placebo remained on Placebo.|0
70476|NCT01490632|167437|P11|STARTED|Part C: Washout or Step-Down Period|Part A 10 mg non-responders were discontinued from the study.|0
70477|NCT01490632|167438|P10|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|0
70478|NCT01490632|167439|P9|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|0
70479|NCT01490632|167440|P8|STARTED|Part C: Washout or Step-Down Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|0
70480|NCT01490632|167441|P7|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|0
70481|NCT01490632|167442|P6|STARTED|Part C: Washout or Step-Down Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|0
70482|NCT01490632|167443|P5|STARTED|Part C: Washout or Step-Down Period|One participant completed Part B but discontinued without receiving a Part C treatment assignment.|0
70483|NCT01490632|167444|P4|STARTED|Part C: Washout or Step-Down Period||0
70484|NCT01490632|167445|P3|STARTED|Part C: Washout or Step-Down Period||0
70485|NCT01490632|167446|P2|STARTED|Part C: Washout or Step-Down Period||0
70486|NCT01490632|167447|P1|STARTED|Part C: Washout or Step-Down Period||0
70487|NCT01490632|167428|P20|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70488|NCT01490632|167429|P19|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70489|NCT01490632|167430|P18|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70490|NCT01490632|167431|P17|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70491|NCT01490632|167432|P16|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70492|NCT01490632|167433|P15|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70493|NCT01490632|167434|P14|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70494|NCT01490632|167435|P13|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70495|NCT01490632|167436|P12|NOT COMPLETED|Part B: Extension or Step-Up Period||8
70496|NCT01490632|167437|P11|NOT COMPLETED|Part B: Extension or Step-Up Period||21
70497|NCT01490632|167438|P10|NOT COMPLETED|Part B: Extension or Step-Up Period||25
70498|NCT01490632|167439|P9|NOT COMPLETED|Part B: Extension or Step-Up Period||10
70499|NCT01490632|167440|P8|NOT COMPLETED|Part B: Extension or Step-Up Period||6
70500|NCT01490632|167441|P7|NOT COMPLETED|Part B: Extension or Step-Up Period||13
70501|NCT01490632|167442|P6|NOT COMPLETED|Part B: Extension or Step-Up Period||4
70502|NCT01490632|167443|P5|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70503|NCT01490632|167444|P4|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70504|NCT01490632|167445|P3|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70505|NCT01490632|167446|P2|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70506|NCT01490632|167447|P1|NOT COMPLETED|Part B: Extension or Step-Up Period||0
70507|NCT01490632|167428|P20|COMPLETED|Part B: Extension or Step-Up Period||0
70508|NCT01490632|167429|P19|COMPLETED|Part B: Extension or Step-Up Period||0
70509|NCT01490632|167430|P18|COMPLETED|Part B: Extension or Step-Up Period||0
70510|NCT01490632|167431|P17|COMPLETED|Part B: Extension or Step-Up Period||0
70511|NCT01490632|167432|P16|COMPLETED|Part B: Extension or Step-Up Period||0
70512|NCT01490632|167433|P15|COMPLETED|Part B: Extension or Step-Up Period||0
70513|NCT01490632|167434|P14|COMPLETED|Part B: Extension or Step-Up Period||0
70514|NCT01490632|167435|P13|COMPLETED|Part B: Extension or Step-Up Period||0
70515|NCT01490632|167436|P12|COMPLETED|Part B: Extension or Step-Up Period||0
70516|NCT01490632|167437|P11|COMPLETED|Part B: Extension or Step-Up Period||22
70517|NCT01490632|167438|P10|COMPLETED|Part B: Extension or Step-Up Period||25
70518|NCT01490632|167439|P9|COMPLETED|Part B: Extension or Step-Up Period||6
70519|NCT01490632|167440|P8|COMPLETED|Part B: Extension or Step-Up Period||13
70520|NCT01490632|167441|P7|COMPLETED|Part B: Extension or Step-Up Period||51
70521|NCT01490632|167442|P6|COMPLETED|Part B: Extension or Step-Up Period||25
70522|NCT01490632|167443|P5|COMPLETED|Part B: Extension or Step-Up Period||0
70523|NCT01490632|167444|P4|COMPLETED|Part B: Extension or Step-Up Period||0
70524|NCT01490632|167445|P3|COMPLETED|Part B: Extension or Step-Up Period||0
70525|NCT01490632|167446|P2|COMPLETED|Part B: Extension or Step-Up Period||0
70526|NCT01490632|167447|P1|COMPLETED|Part B: Extension or Step-Up Period||0
70527|NCT01490632|167428|P20|STARTED|Part B: Extension or Step-Up Period||0
70528|NCT01490632|167429|P19|STARTED|Part B: Extension or Step-Up Period||0
70529|NCT01490632|167430|P18|STARTED|Part B: Extension or Step-Up Period||0
70530|NCT01490632|167431|P17|STARTED|Part B: Extension or Step-Up Period||0
70531|NCT01490632|167432|P16|STARTED|Part B: Extension or Step-Up Period||0
70532|NCT01490632|167433|P15|STARTED|Part B: Extension or Step-Up Period||0
70533|NCT01490632|167434|P14|STARTED|Part B: Extension or Step-Up Period||0
70534|NCT01490632|167435|P13|STARTED|Part B: Extension or Step-Up Period||0
70535|NCT01490632|167436|P12|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to Placebo remained on Placebo.|8
70536|NCT01490632|167437|P11|STARTED|Part B: Extension or Step-Up Period|Part A 10 mg non-responders were discontinued from the study.|43
70537|NCT01490632|167438|P10|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI <50 were re-randomized to 8 mg or 10 mg.|50
70538|NCT01490632|167439|P9|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥50 to <75 remained on 2 mg or 4 mg.|16
70539|NCT01490632|167440|P8|STARTED|Part B: Extension or Step-Up Period|Placebo participants in Part A with a PASI <75 were re-randomized to 8 mg or 10 mg.|19
70540|NCT01490632|167441|P7|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 8 mg or 10 mg with a PASI ≥75 remained on 8 mg or 10 mg.|64
70541|NCT01490632|167442|P6|STARTED|Part B: Extension or Step-Up Period|Part A participants randomized to 2 mg or 4 mg with a PASI ≥75 remained on 2 mg or 4 mg.|29
70542|NCT01490632|167443|P5|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
70543|NCT01490632|167444|P4|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
70544|NCT01490632|167445|P3|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
70545|NCT01490632|167446|P2|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
70546|NCT01490632|167447|P1|STARTED|Part B: Extension or Step-Up Period|See Recruitment Details for explanation of Part B participant assignment.|0
70547|NCT01490632|167428|P20|NOT COMPLETED|Part A: Initial Treatment Period||0
70548|NCT01490632|167429|P19|NOT COMPLETED|Part A: Initial Treatment Period||0
70549|NCT01490632|167430|P18|NOT COMPLETED|Part A: Initial Treatment Period||0
70550|NCT01490632|167431|P17|NOT COMPLETED|Part A: Initial Treatment Period||0
70551|NCT01490632|167432|P16|NOT COMPLETED|Part A: Initial Treatment Period||0
70552|NCT01490632|167433|P15|NOT COMPLETED|Part A: Initial Treatment Period||0
70553|NCT01490632|167434|P14|NOT COMPLETED|Part A: Initial Treatment Period||0
70554|NCT01490632|167435|P13|NOT COMPLETED|Part A: Initial Treatment Period||0
70555|NCT01490632|167436|P12|NOT COMPLETED|Part A: Initial Treatment Period||0
70556|NCT01490632|167437|P11|NOT COMPLETED|Part A: Initial Treatment Period||0
70557|NCT01490632|167438|P10|NOT COMPLETED|Part A: Initial Treatment Period||0
70558|NCT01490632|167439|P9|NOT COMPLETED|Part A: Initial Treatment Period||0
70559|NCT01490632|167440|P8|NOT COMPLETED|Part A: Initial Treatment Period||0
70560|NCT01490632|167441|P7|NOT COMPLETED|Part A: Initial Treatment Period||0
70561|NCT01490632|167442|P6|NOT COMPLETED|Part A: Initial Treatment Period||0
70562|NCT01490632|167443|P5|NOT COMPLETED|Part A: Initial Treatment Period||17
70563|NCT01490632|167444|P4|NOT COMPLETED|Part A: Initial Treatment Period||9
70564|NCT01490632|167445|P3|NOT COMPLETED|Part A: Initial Treatment Period||5
70565|NCT01490632|167446|P2|NOT COMPLETED|Part A: Initial Treatment Period||4
70566|NCT01490632|167447|P1|NOT COMPLETED|Part A: Initial Treatment Period||7
70567|NCT01490632|167428|P20|COMPLETED|Part A: Initial Treatment Period||0
70568|NCT01490632|167429|P19|COMPLETED|Part A: Initial Treatment Period||0
70569|NCT01490632|167430|P18|COMPLETED|Part A: Initial Treatment Period||0
70570|NCT01490632|167431|P17|COMPLETED|Part A: Initial Treatment Period||0
70571|NCT01490632|167432|P16|COMPLETED|Part A: Initial Treatment Period||0
70572|NCT01490632|167433|P15|COMPLETED|Part A: Initial Treatment Period||0
70573|NCT01490632|167434|P14|COMPLETED|Part A: Initial Treatment Period||0
70574|NCT01490632|167435|P13|COMPLETED|Part A: Initial Treatment Period||0
70575|NCT01490632|167436|P12|COMPLETED|Part A: Initial Treatment Period||0
70576|NCT01490632|167437|P11|COMPLETED|Part A: Initial Treatment Period||0
70577|NCT01490632|167438|P10|COMPLETED|Part A: Initial Treatment Period||0
70578|NCT01490632|167439|P9|COMPLETED|Part A: Initial Treatment Period||0
70579|NCT01490632|167440|P8|COMPLETED|Part A: Initial Treatment Period||0
70580|NCT01490632|167441|P7|COMPLETED|Part A: Initial Treatment Period||0
70581|NCT01490632|167442|P6|COMPLETED|Part A: Initial Treatment Period||0
70582|NCT01490632|167443|P5|COMPLETED|Part A: Initial Treatment Period|Includes participants who completed Part A, but discontinued per protocol using Part A PASI score.|52
70583|NCT01490632|167444|P4|COMPLETED|Part A: Initial Treatment Period||55
70584|NCT01490632|167445|P3|COMPLETED|Part A: Initial Treatment Period||67
70585|NCT01490632|167446|P2|COMPLETED|Part A: Initial Treatment Period||28
70586|NCT01490632|167447|P1|COMPLETED|Part A: Initial Treatment Period||27
70587|NCT01490632|167428|P20|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70588|NCT01490632|167429|P19|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70589|NCT01490632|167430|P18|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70590|NCT01490632|167431|P17|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70591|NCT01490632|167432|P16|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70592|NCT01490632|167433|P15|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70593|NCT01490632|167434|P14|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70594|NCT01490632|167435|P13|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70595|NCT01490632|167436|P12|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70596|NCT01490632|167437|P11|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70597|NCT01490632|167438|P10|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70598|NCT01490632|167439|P9|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70599|NCT01490632|167440|P8|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70600|NCT01490632|167441|P7|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70601|NCT01490632|167442|P6|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||0
70602|NCT01490632|167443|P5|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||69
70603|NCT01490632|167444|P4|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||64
70604|NCT01490632|167445|P3|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||72
70605|NCT01490632|167446|P2|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||32
70606|NCT01490632|167447|P1|Received at Least One Dose of Study Drug|Part A: Initial Treatment Period||34
70607|NCT01490632|167428|P20|STARTED|Part A: Initial Treatment Period||0
70608|NCT01490632|167429|P19|STARTED|Part A: Initial Treatment Period||0
70609|NCT01490632|167430|P18|STARTED|Part A: Initial Treatment Period||0
70610|NCT01490632|167431|P17|STARTED|Part A: Initial Treatment Period||0
70611|NCT01490632|167432|P16|STARTED|Part A: Initial Treatment Period||0
70612|NCT01490632|167433|P15|STARTED|Part A: Initial Treatment Period||0
70613|NCT01490632|167434|P14|STARTED|Part A: Initial Treatment Period||0
70614|NCT01490632|167435|P13|STARTED|Part A: Initial Treatment Period||0
70615|NCT01490632|167436|P12|STARTED|Part A: Initial Treatment Period||0
70616|NCT01490632|167437|P11|STARTED|Part A: Initial Treatment Period||0
70617|NCT01490632|167438|P10|STARTED|Part A: Initial Treatment Period||0
70618|NCT01490632|167439|P9|STARTED|Part A: Initial Treatment Period||0
70619|NCT01490632|167440|P8|STARTED|Part A: Initial Treatment Period||0
70620|NCT01490632|167441|P7|STARTED|Part A: Initial Treatment Period||0
70621|NCT01490632|167442|P6|STARTED|Part A: Initial Treatment Period||0
70622|NCT01490632|167443|P5|STARTED|Part A: Initial Treatment Period||69
70623|NCT01490632|167444|P4|STARTED|Part A: Initial Treatment Period||64
70624|NCT01490632|167445|P3|STARTED|Part A: Initial Treatment Period||72
70625|NCT01490632|167446|P2|STARTED|Part A: Initial Treatment Period||32
70626|NCT01490632|167447|P1|STARTED|Part A: Initial Treatment Period||34
70627|NCT01490294|167579|P4|NOT COMPLETED|Overall Study||1
70628|NCT01490294|167580|P3|NOT COMPLETED|Overall Study||1
70629|NCT01490294|167581|P2|NOT COMPLETED|Overall Study||0
70630|NCT01490294|167582|P1|NOT COMPLETED|Overall Study||5
70631|NCT01490294|167579|P4|COMPLETED|Overall Study||54
70632|NCT01490294|167580|P3|COMPLETED|Overall Study||58
70633|NCT01490294|167581|P2|COMPLETED|Overall Study||60
70634|NCT01490294|167582|P1|COMPLETED|Overall Study||53
70635|NCT01490294|167579|P4|Participant Received Treatment|Overall Study||54
70636|NCT01490294|167580|P3|Participant Received Treatment|Overall Study||58
70637|NCT01490294|167581|P2|Participant Received Treatment|Overall Study||60
70638|NCT01490294|167582|P1|Participant Received Treatment|Overall Study||54
70639|NCT01490294|167579|P4|STARTED|Overall Study||55
70640|NCT01490294|167580|P3|STARTED|Overall Study||59
70641|NCT01490294|167581|P2|STARTED|Overall Study||60
70642|NCT01490294|167582|P1|STARTED|Overall Study||58
70643|NCT01490190|167816|P1|NOT COMPLETED|Overall Study||48
70644|NCT01490190|167816|P1|COMPLETED|Overall Study||204
70645|NCT01490190|167816|P1|STARTED|Overall Study||252
70646|NCT01490125|167837|P6|NOT COMPLETED|Period III||0
70647|NCT01490125|167838|P5|NOT COMPLETED|Period III||1
70648|NCT01490125|167839|P4|NOT COMPLETED|Period III||2
70649|NCT01490125|167840|P3|NOT COMPLETED|Period III||0
70650|NCT01490125|167841|P2|NOT COMPLETED|Period III||1
70651|NCT01490125|167842|P1|NOT COMPLETED|Period III||3
70652|NCT01490125|167837|P6|COMPLETED|Period III||35
70653|NCT01490125|167838|P5|COMPLETED|Period III||31
70654|NCT01490125|167839|P4|COMPLETED|Period III||28
70655|NCT01490125|167840|P3|COMPLETED|Period III||34
70656|NCT01490125|167841|P2|COMPLETED|Period III||32
70657|NCT01490125|167842|P1|COMPLETED|Period III||31
70658|NCT01490125|167837|P6|STARTED|Period III||35
70659|NCT01490125|167838|P5|STARTED|Period III||32
70660|NCT01490125|167839|P4|STARTED|Period III||30
70661|NCT01490125|167840|P3|STARTED|Period III||34
70662|NCT01490125|167841|P2|STARTED|Period III||33
70663|NCT01490125|167842|P1|STARTED|Period III||34
70664|NCT01490125|167837|P6|NOT COMPLETED|Period II||2
70665|NCT01490125|167838|P5|NOT COMPLETED|Period II||4
70666|NCT01490125|167839|P4|NOT COMPLETED|Period II||3
70667|NCT01490125|167840|P3|NOT COMPLETED|Period II||3
70668|NCT01490125|167841|P2|NOT COMPLETED|Period II||4
70669|NCT01490125|167842|P1|NOT COMPLETED|Period II||3
70670|NCT01490125|167837|P6|COMPLETED|Period II||35
70671|NCT01490125|167838|P5|COMPLETED|Period II||32
70672|NCT01490125|167839|P4|COMPLETED|Period II||30
70673|NCT01490125|167840|P3|COMPLETED|Period II||34
70674|NCT01490125|167841|P2|COMPLETED|Period II||33
70675|NCT01490125|167842|P1|COMPLETED|Period II||34
70676|NCT01490125|167837|P6|STARTED|Period II||37
70677|NCT01490125|167838|P5|STARTED|Period II||36
70678|NCT01490125|167839|P4|STARTED|Period II||33
70679|NCT01490125|167840|P3|STARTED|Period II||37
70680|NCT01490125|167841|P2|STARTED|Period II||37
70681|NCT01490125|167842|P1|STARTED|Period II||37
70682|NCT01490125|167837|P6|NOT COMPLETED|Period I||5
70683|NCT01490125|167838|P5|NOT COMPLETED|Period I||4
70684|NCT01490125|167839|P4|NOT COMPLETED|Period I||5
70685|NCT01490125|167840|P3|NOT COMPLETED|Period I||4
70686|NCT01490125|167841|P2|NOT COMPLETED|Period I||5
70687|NCT01490125|167842|P1|NOT COMPLETED|Period I||6
70688|NCT01490125|167837|P6|COMPLETED|Period I||37
70689|NCT01490125|167838|P5|COMPLETED|Period I||36
70690|NCT01490125|167839|P4|COMPLETED|Period I||33
70691|NCT01490125|167840|P3|COMPLETED|Period I||37
70692|NCT01490125|167841|P2|COMPLETED|Period I||37
70693|NCT01490125|167842|P1|COMPLETED|Period I||37
70694|NCT01490125|167837|P6|STARTED|Period I||42
70695|NCT01490125|167838|P5|STARTED|Period I||40
70696|NCT01490125|167839|P4|STARTED|Period I||38
70697|NCT01490125|167840|P3|STARTED|Period I||41
70698|NCT01490125|167841|P2|STARTED|Period I||42
70699|NCT01490125|167842|P1|STARTED|Period I||43
70700|NCT01490086|167870|P5|NOT COMPLETED|Overall Study||11
70701|NCT01490086|167871|P4|NOT COMPLETED|Overall Study||7
70702|NCT01490086|167872|P3|NOT COMPLETED|Overall Study||7
70703|NCT01490086|167873|P2|NOT COMPLETED|Overall Study||15
70704|NCT01490086|167874|P1|NOT COMPLETED|Overall Study||8
70705|NCT01490086|167870|P5|COMPLETED|Overall Study||28
70706|NCT01490086|167871|P4|COMPLETED|Overall Study||13
70707|NCT01490086|167872|P3|COMPLETED|Overall Study||51
70708|NCT01490086|167873|P2|COMPLETED|Overall Study||44
70709|NCT01490086|167874|P1|COMPLETED|Overall Study||50
70710|NCT01490086|167870|P5|STARTED|Overall Study||39
70711|NCT01490086|167871|P4|STARTED|Overall Study||20
70712|NCT01490086|167872|P3|STARTED|Overall Study||58
70713|NCT01490086|167873|P2|STARTED|Overall Study||59
70714|NCT01490086|167874|P1|STARTED|Overall Study||58
70715|NCT01490060|167908|P4|NOT COMPLETED|Cycle 2||0
70716|NCT01490060|167909|P3|NOT COMPLETED|Cycle 2||1
70717|NCT01490060|167910|P2|NOT COMPLETED|Cycle 2||1
70718|NCT01490060|167911|P1|NOT COMPLETED|Cycle 2||2
70719|NCT01490060|167908|P4|COMPLETED|Cycle 2||8
70720|NCT01490060|167909|P3|COMPLETED|Cycle 2||8
70721|NCT01490060|167910|P2|COMPLETED|Cycle 2||11
70722|NCT01490060|167911|P1|COMPLETED|Cycle 2||9
70723|NCT01490060|167908|P4|STARTED|Cycle 2||8
70724|NCT01490060|167909|P3|STARTED|Cycle 2||9
70725|NCT01490060|167910|P2|STARTED|Cycle 2||12
70726|NCT01490060|167911|P1|STARTED|Cycle 2||11
70727|NCT01490060|167908|P4|NOT COMPLETED|Cycle 1||3
70728|NCT01490060|167909|P3|NOT COMPLETED|Cycle 1||3
70729|NCT01490060|167910|P2|NOT COMPLETED|Cycle 1||1
70730|NCT01490060|167911|P1|NOT COMPLETED|Cycle 1||0
70731|NCT01490060|167908|P4|COMPLETED|Cycle 1||8
70732|NCT01490060|167909|P3|COMPLETED|Cycle 1||9
70733|NCT01490060|167910|P2|COMPLETED|Cycle 1||12
70734|NCT01490060|167911|P1|COMPLETED|Cycle 1||11
70735|NCT01490060|167908|P4|STARTED|Cycle 1||11
70736|NCT01490060|167909|P3|STARTED|Cycle 1||12
70737|NCT01490060|167910|P2|STARTED|Cycle 1||13
70738|NCT01490060|167911|P1|STARTED|Cycle 1||11
70739|NCT01489956|167921|P3|NOT COMPLETED|Overall Study||1
70740|NCT01489956|167922|P2|NOT COMPLETED|Overall Study||0
70741|NCT01489956|167923|P1|NOT COMPLETED|Overall Study||1
70742|NCT01489956|167921|P3|COMPLETED|Overall Study||5
70743|NCT01489956|167922|P2|COMPLETED|Overall Study||0
70744|NCT01489956|167923|P1|COMPLETED|Overall Study||12
70745|NCT01489956|167921|P3|STARTED|Overall Study|These 6 subjects had Immucothel alone since Montanide was not needed for the 10 participants dosed.|6
70746|NCT01489956|167922|P2|STARTED|Overall Study|Nine of the 10 participants receiving Immucothel alone had a response, so Montanide was not used.|0
70747|NCT01489956|167923|P1|STARTED|Overall Study|Ten of the 13 participants were considered evaluable.|13
70748|NCT01489891|167960|P2|NOT COMPLETED|Overall Study||0
70749|NCT01489891|167961|P1|NOT COMPLETED|Overall Study||1
70750|NCT01489891|167960|P2|COMPLETED|Overall Study||60
70751|NCT01489891|167961|P1|COMPLETED|Overall Study||59
70752|NCT01489891|167960|P2|STARTED|Overall Study||60
70753|NCT01489891|167961|P1|STARTED|Overall Study||60
70754|NCT01489826|167982|P9|NOT COMPLETED|Overall Study||0
70755|NCT01489826|167983|P8|NOT COMPLETED|Overall Study||0
70756|NCT01489826|167984|P7|NOT COMPLETED|Overall Study||0
70757|NCT01489826|167985|P6|NOT COMPLETED|Overall Study||0
70758|NCT01489826|167986|P5|NOT COMPLETED|Overall Study||0
70759|NCT01489826|167987|P4|NOT COMPLETED|Overall Study||0
70760|NCT01489826|167988|P3|NOT COMPLETED|Overall Study||0
70761|NCT01489826|167989|P2|NOT COMPLETED|Overall Study||0
70762|NCT01489826|167990|P1|NOT COMPLETED|Overall Study||0
70763|NCT01489826|167982|P9|COMPLETED|Overall Study||6
70764|NCT01489826|167983|P8|COMPLETED|Overall Study||3
70765|NCT01489826|167984|P7|COMPLETED|Overall Study||9
70766|NCT01489826|167985|P6|COMPLETED|Overall Study||3
70767|NCT01489826|167986|P5|COMPLETED|Overall Study||3
70768|NCT01489826|167987|P4|COMPLETED|Overall Study||7
70769|NCT01489826|167988|P3|COMPLETED|Overall Study||3
70770|NCT01489826|167989|P2|COMPLETED|Overall Study||3
70771|NCT01489826|167990|P1|COMPLETED|Overall Study||3
70772|NCT01489826|167982|P9|STARTED|Overall Study||6
70773|NCT01489826|167983|P8|STARTED|Overall Study||3
70774|NCT01489826|167984|P7|STARTED|Overall Study||9
70775|NCT01489826|167985|P6|STARTED|Overall Study||3
70776|NCT01489826|167986|P5|STARTED|Overall Study||3
70777|NCT01489826|167987|P4|STARTED|Overall Study||7
70778|NCT01489826|167988|P3|STARTED|Overall Study||3
70779|NCT01489826|167989|P2|STARTED|Overall Study||3
70780|NCT01489826|167990|P1|STARTED|Overall Study||3
70781|NCT01489670|168087|P1|NOT COMPLETED|Overall Study||53
70782|NCT01489670|168087|P1|COMPLETED|Overall Study||334
70783|NCT01489670|168087|P1|STARTED|Overall Study||387
70784|NCT01489527|168099|P2|NOT COMPLETED|Overall Study||26
70785|NCT01489527|168100|P1|NOT COMPLETED|Overall Study||22
70786|NCT01489527|168099|P2|COMPLETED|Overall Study||175
70787|NCT01489527|168100|P1|COMPLETED|Overall Study||183
70788|NCT01489527|168099|P2|STARTED|Overall Study||201
70789|NCT01489527|168100|P1|STARTED|Overall Study||205
70790|NCT01489358|168117|P3|NOT COMPLETED|Overall Study||2
70791|NCT01489358|168118|P2|NOT COMPLETED|Overall Study||0
70792|NCT01489358|168119|P1|NOT COMPLETED|Overall Study||0
70793|NCT01489358|168117|P3|COMPLETED|Overall Study||8
70794|NCT01489358|168118|P2|COMPLETED|Overall Study||10
70795|NCT01489358|168119|P1|COMPLETED|Overall Study||5
70796|NCT01489358|168117|P3|STARTED|Overall Study||10
70797|NCT01489358|168118|P2|STARTED|Overall Study||10
70798|NCT01489358|168119|P1|STARTED|Overall Study||5
70799|NCT01489254|168169|P4|NOT COMPLETED|Open-label Extension Part||58
70800|NCT01489254|168170|P3|NOT COMPLETED|Open-label Extension Part||0
70801|NCT01489254|168171|P2|NOT COMPLETED|Open-label Extension Part||0
70802|NCT01489254|168172|P1|NOT COMPLETED|Open-label Extension Part||0
70803|NCT01489254|168169|P4|COMPLETED|Open-label Extension Part||670
70804|NCT01489254|168170|P3|COMPLETED|Open-label Extension Part||0
70805|NCT01489254|168171|P2|COMPLETED|Open-label Extension Part||0
70806|NCT01489254|168172|P1|COMPLETED|Open-label Extension Part||0
70807|NCT01489254|168169|P4|STARTED|Open-label Extension Part|735 completed the DB part, 729 were eligible to continue in the OL part, 1 opted not to continue|728
70808|NCT01489254|168170|P3|STARTED|Open-label Extension Part||0
70809|NCT01489254|168171|P2|STARTED|Open-label Extension Part||0
70810|NCT01489254|168172|P1|STARTED|Open-label Extension Part||0
70811|NCT01489254|168169|P4|NOT COMPLETED|Double-blind Part||0
70812|NCT01489254|168170|P3|NOT COMPLETED|Double-blind Part||3
70813|NCT01489254|168171|P2|NOT COMPLETED|Double-blind Part||33
70814|NCT01489254|168172|P1|NOT COMPLETED|Double-blind Part||25
70815|NCT01489254|168169|P4|COMPLETED|Double-blind Part||0
70816|NCT01489254|168170|P3|COMPLETED|Double-blind Part||81
70817|NCT01489254|168171|P2|COMPLETED|Double-blind Part||324
70818|NCT01489254|168172|P1|COMPLETED|Double-blind Part||330
70819|NCT01489254|168169|P4|STARTED|Double-blind Part||0
70820|NCT01489254|168170|P3|STARTED|Double-blind Part||84
70821|NCT01489254|168171|P2|STARTED|Double-blind Part||357
70822|NCT01489254|168172|P1|STARTED|Double-blind Part||355
70823|NCT01489189|168183|P2|NOT COMPLETED|Overall Study||35
70824|NCT01489189|168184|P1|NOT COMPLETED|Overall Study||31
70825|NCT01489189|168183|P2|COMPLETED|Overall Study|Number of Eyes|168
70826|NCT01489189|168184|P1|COMPLETED|Overall Study|Number of Eyes|160
70827|NCT01489189|168183|P2|STARTED|Overall Study|Number of Eyes|203
70828|NCT01489189|168184|P1|STARTED|Overall Study|Number of Eyes|191
70829|NCT01488994|168211|P2|NOT COMPLETED|Overall Study||1
70830|NCT01488994|168212|P1|NOT COMPLETED|Overall Study||0
70831|NCT01488994|168211|P2|COMPLETED|Overall Study||11
70832|NCT01488994|168212|P1|COMPLETED|Overall Study||11
70833|NCT01488994|168211|P2|STARTED|Overall Study||12
70834|NCT01488994|168212|P1|STARTED|Overall Study||11
70835|NCT01488877|168299|P3|NOT COMPLETED|Re-randomization||0
70836|NCT01488877|168300|P2|NOT COMPLETED|Re-randomization||0
70837|NCT01488877|168301|P1|NOT COMPLETED|Re-randomization||0
70838|NCT01488877|168299|P3|COMPLETED|Re-randomization||3
70839|NCT01488877|168300|P2|COMPLETED|Re-randomization||0
70840|NCT01488877|168301|P1|COMPLETED|Re-randomization||0
70841|NCT01488877|168299|P3|STARTED|Re-randomization|Three participants were re-randomized from PF-03882845 3 mg arm.|3
70842|NCT01488877|168300|P2|STARTED|Re-randomization||0
70843|NCT01488877|168301|P1|STARTED|Re-randomization||0
70844|NCT01488877|168299|P3|NOT COMPLETED|Initial Randomization||0
70845|NCT01488877|168300|P2|NOT COMPLETED|Initial Randomization||0
70846|NCT01488877|168301|P1|NOT COMPLETED|Initial Randomization||0
70847|NCT01488877|168299|P3|COMPLETED|Initial Randomization||0
70848|NCT01488877|168300|P2|COMPLETED|Initial Randomization||5
70849|NCT01488877|168301|P1|COMPLETED|Initial Randomization||1
70850|NCT01488877|168299|P3|STARTED|Initial Randomization||0
70851|NCT01488877|168300|P2|STARTED|Initial Randomization||5
70852|NCT01488877|168301|P1|STARTED|Initial Randomization||1
70853|NCT01488578|168316|P1|NOT COMPLETED|Overall Study||1836
70854|NCT01488578|168316|P1|COMPLETED|Overall Study||9321
70855|NCT01488578|168316|P1|STARTED|Overall Study||11157
70856|NCT01488487|168350|P1|NOT COMPLETED|Overall Study||9
70857|NCT01488487|168350|P1|COMPLETED|Overall Study||15
70858|NCT01488487|168350|P1|Received Treatment|Overall Study||24
70859|NCT01488487|168350|P1|STARTED|Overall Study||24
70860|NCT01488448|168359|P2|NOT COMPLETED|Overall Study||17
70861|NCT01488448|168360|P1|NOT COMPLETED|Overall Study||20
70862|NCT01488448|168359|P2|COMPLETED|Overall Study||97
70863|NCT01488448|168360|P1|COMPLETED|Overall Study||93
70864|NCT01488448|168359|P2|STARTED|Overall Study||114
70865|NCT01488448|168360|P1|STARTED|Overall Study||113
70866|NCT01488409|168384|P2|NOT COMPLETED|Overall Study||4
70867|NCT01488409|168385|P1|NOT COMPLETED|Overall Study||4
70868|NCT01488409|168384|P2|COMPLETED|Overall Study||15
70869|NCT01488409|168385|P1|COMPLETED|Overall Study||16
70870|NCT01488409|168384|P2|STARTED|Overall Study||19
70871|NCT01488409|168385|P1|STARTED|Overall Study||20
70872|NCT01488370|168402|P3|NOT COMPLETED|Overall Study||1
70873|NCT01488370|168403|P2|NOT COMPLETED|Overall Study||1
70874|NCT01488370|168404|P1|NOT COMPLETED|Overall Study||0
70875|NCT01488370|168402|P3|COMPLETED|Overall Study||19
70876|NCT01488370|168403|P2|COMPLETED|Overall Study||22
70877|NCT01488370|168404|P1|COMPLETED|Overall Study||22
70878|NCT01488370|168402|P3|STARTED|Overall Study||20
70879|NCT01488370|168403|P2|STARTED|Overall Study||23
70880|NCT01488370|168404|P1|STARTED|Overall Study||22
70881|NCT01488188|168426|P2|NOT COMPLETED|Overall Study||0
70882|NCT01488188|168427|P1|NOT COMPLETED|Overall Study||0
70883|NCT01488188|168426|P2|COMPLETED|Overall Study||20
70884|NCT01488188|168427|P1|COMPLETED|Overall Study||20
70885|NCT01488188|168426|P2|STARTED|Overall Study||20
70886|NCT01488188|168427|P1|STARTED|Overall Study||20
70887|NCT01488097|168439|P1|NOT COMPLETED|Long-term Treatment (Beyond Week 104)||6
70888|NCT01488097|168439|P1|COMPLETED|Long-term Treatment (Beyond Week 104)|This period is ongoing.|2
70889|NCT01488097|168439|P1|STARTED|Long-term Treatment (Beyond Week 104)||8
70890|NCT01488097|168439|P1|NOT COMPLETED|Long-term Treatment (up to Week 104)||0
70891|NCT01488097|168439|P1|COMPLETED|Long-term Treatment (up to Week 104)||8
70892|NCT01488097|168439|P1|STARTED|Long-term Treatment (up to Week 104)||8
70893|NCT01488071|168451|P2|NOT COMPLETED|Overall Study||63
70894|NCT01488071|168452|P1|NOT COMPLETED|Overall Study||53
70895|NCT01488071|168451|P2|COMPLETED|Overall Study||179
70896|NCT01488071|168452|P1|COMPLETED|Overall Study||200
70897|NCT01488071|168451|P2|STARTED|Overall Study|APTS|242
70898|NCT01488071|168452|P1|STARTED|Overall Study|all-patients-treated set (APTS)|253
70899|NCT01488019|168486|P2|NOT COMPLETED|Overall Study||304
70900|NCT01488019|168487|P1|NOT COMPLETED|Overall Study||247
70901|NCT01488019|168486|P2|COMPLETED|Overall Study||226
70902|NCT01488019|168487|P1|COMPLETED|Overall Study||294
70903|NCT01488019|168486|P2|STARTED|Overall Study||530
70904|NCT01488019|168487|P1|STARTED|Overall Study||541
70905|NCT01487954|168521|P2|NOT COMPLETED|Overall Study||0
70906|NCT01487954|168522|P1|NOT COMPLETED|Overall Study||0
70907|NCT01487954|168521|P2|COMPLETED|Overall Study||16
70908|NCT01487954|168522|P1|COMPLETED|Overall Study||29
70909|NCT01487954|168521|P2|Safety lead-in|Overall Study|Only the first 10 patients in the alkaline group were analyzed, as that was the experimental group.|0
70910|NCT01487954|168522|P1|Safety lead-in|Overall Study||10
70911|NCT01487954|168521|P2|STARTED|Overall Study||16
70912|NCT01487954|168522|P1|STARTED|Overall Study||29
70913|NCT01487863|168532|P2|NOT COMPLETED|Overall Study||19
70914|NCT01487863|168533|P1|NOT COMPLETED|Overall Study||19
70915|NCT01487863|168532|P2|COMPLETED|Overall Study||15
70916|NCT01487863|168533|P1|COMPLETED|Overall Study||16
70917|NCT01487863|168532|P2|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||34
70918|NCT01487863|168533|P1|Rcvd ≥1 Leukapheresis (Safety Analysis)|Overall Study||35
70919|NCT01487863|168532|P2|Subjects Randomized (Efficacy Analysis)|Overall Study||34
70920|NCT01487863|168533|P1|Subjects Randomized (Efficacy Analysis)|Overall Study||35
70921|NCT01487863|168532|P2|STARTED|Overall Study||34
70922|NCT01487863|168533|P1|STARTED|Overall Study||35
70923|NCT01487668|168541|P2|NOT COMPLETED|Overall Study||17
70924|NCT01487668|168542|P1|NOT COMPLETED|Overall Study||25
70925|NCT01487668|168541|P2|COMPLETED|Overall Study||124
70926|NCT01487668|168542|P1|COMPLETED|Overall Study||121
70927|NCT01487668|168541|P2|STARTED|Overall Study||141
70928|NCT01487668|168542|P1|STARTED|Overall Study||146
70929|NCT01487577|168550|P1|NOT COMPLETED|Overall Study||1
70930|NCT01487577|168550|P1|COMPLETED|Overall Study|One participant became ineligible after signing consent, but before receiving protocol therapy.|18
70931|NCT01487577|168550|P1|STARTED|Overall Study||19
70932|NCT01487525|168564|P2|NOT COMPLETED|Overall Study||1
70933|NCT01487525|168565|P1|NOT COMPLETED|Overall Study||0
70934|NCT01487525|168564|P2|COMPLETED|Overall Study||19
70935|NCT01487525|168565|P1|COMPLETED|Overall Study||22
70936|NCT01487525|168564|P2|STARTED|Overall Study||20
70937|NCT01487525|168565|P1|STARTED|Overall Study||22
70938|NCT01487499|168575|P1|NOT COMPLETED|Overall Study||0
70939|NCT01487499|168575|P1|COMPLETED|Overall Study||4
70940|NCT01487499|168575|P1|STARTED|Overall Study||4
70941|NCT01486966|168583|P2|NOT COMPLETED|Overall Study||2
70942|NCT01486966|168584|P1|NOT COMPLETED|Overall Study||0
70943|NCT01486966|168583|P2|COMPLETED|Overall Study||27
70944|NCT01486966|168584|P1|COMPLETED|Overall Study||29
70945|NCT01486966|168583|P2|STARTED|Overall Study||29
70946|NCT01486966|168584|P1|STARTED|Overall Study||29
70947|NCT01486927|168608|P1|NOT COMPLETED|Overall Study||13
70948|NCT01486927|168608|P1|COMPLETED|Overall Study||161
70949|NCT01486927|168608|P1|STARTED|Overall Study||174
70950|NCT01486758|168641|P2|NOT COMPLETED|Overall Study||1
70951|NCT01486758|168642|P1|NOT COMPLETED|Overall Study||0
70952|NCT01486758|168641|P2|COMPLETED|Overall Study||19
70953|NCT01486758|168642|P1|COMPLETED|Overall Study||20
70954|NCT01486758|168641|P2|STARTED|Overall Study||20
70955|NCT01486758|168642|P1|STARTED|Overall Study||20
70956|NCT01486615|168666|P4|NOT COMPLETED|Overall Study||2
70957|NCT01486615|168667|P3|NOT COMPLETED|Overall Study||2
70958|NCT01486615|168668|P2|NOT COMPLETED|Overall Study||1
70959|NCT01486615|168669|P1|NOT COMPLETED|Overall Study||0
70960|NCT01486615|168666|P4|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
70961|NCT01486615|168667|P3|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|18
70962|NCT01486615|168668|P2|COMPLETED|Overall Study|observed till 2 hrs after premedication, not available after 24 hours as surgery was postponed|19
70963|NCT01486615|168669|P1|COMPLETED|Overall Study||20
70964|NCT01486615|168666|P4|STARTED|Overall Study||20
70965|NCT01486615|168667|P3|STARTED|Overall Study||20
70966|NCT01486615|168668|P2|STARTED|Overall Study||20
70967|NCT01486615|168669|P1|STARTED|Overall Study||20
70968|NCT01486446|168709|P2|NOT COMPLETED|Overall Study||0
70969|NCT01486446|168710|P1|NOT COMPLETED|Overall Study||1
70970|NCT01486446|168709|P2|COMPLETED|Overall Study||1
70971|NCT01486446|168710|P1|COMPLETED|Overall Study||6
70972|NCT01486446|168709|P2|STARTED|Overall Study||1
70973|NCT01486446|168710|P1|STARTED|Overall Study||7
70974|NCT01486238|168732|P2|NOT COMPLETED|Overall Study||6
70975|NCT01486238|168733|P1|NOT COMPLETED|Overall Study||2
70976|NCT01486238|168732|P2|COMPLETED|Overall Study||43
70977|NCT01486238|168733|P1|COMPLETED|Overall Study||21
70978|NCT01486238|168732|P2|STARTED|Overall Study||49
70979|NCT01486238|168733|P1|STARTED|Overall Study||23
70980|NCT01486043|168739|P1|NOT COMPLETED|Overall Study||2
70981|NCT01486043|168739|P1|COMPLETED|Overall Study|Study terminated due to insufficient recruitment|2
70982|NCT01486043|168739|P1|STARTED|Overall Study||4
70983|NCT01485991|168747|P2|NOT COMPLETED|Overall Study||36
70984|NCT01485991|168748|P1|NOT COMPLETED|Overall Study||32
70985|NCT01485991|168747|P2|COMPLETED|Overall Study||350
70986|NCT01485991|168748|P1|COMPLETED|Overall Study||353
70987|NCT01485991|168747|P2|Treated|Overall Study||384
70988|NCT01485991|168748|P1|Treated|Overall Study||379
70989|NCT01485991|168747|P2|STARTED|Overall Study||386
70990|NCT01485991|168748|P1|STARTED|Overall Study||385
70991|NCT01485887|168758|P1|NOT COMPLETED|Overall Study||12
70992|NCT01485887|168758|P1|COMPLETED|Overall Study||38
70993|NCT01485887|168758|P1|STARTED|Overall Study||50
70994|NCT01485796|168770|P1|NOT COMPLETED|Overall Trial (Incl. Safety Follow-up)||12
70995|NCT01485796|168770|P1|COMPLETED|Overall Trial (Incl. Safety Follow-up)|1 subject who completed Epoch 2 + 24 subjects who completed the safety follow-up|25
70996|NCT01485796|168770|P1|Completed Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||24
71090|NCT01484561|169025|P1|COMPLETED|Overall Study||88
70997|NCT01485796|168770|P1|Switch to Safety Follow-up|Overall Trial (Incl. Safety Follow-up)||26
70998|NCT01485796|168770|P1|Completed Epoch 2|Overall Trial (Incl. Safety Follow-up)||1
70999|NCT01485796|168770|P1|Treated in Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
71000|NCT01485796|168770|P1|Started Epoch 2|Overall Trial (Incl. Safety Follow-up)||36
71001|NCT01485796|168770|P1|Completed Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||36
71002|NCT01485796|168770|P1|Treated in Epoch 1 (Ramp-up)|Overall Trial (Incl. Safety Follow-up)||37
71003|NCT01485796|168770|P1|STARTED|Overall Trial (Incl. Safety Follow-up)||37
71004|NCT01485796|168770|P1|NOT COMPLETED|Period 2: Epoch 2||35
71005|NCT01485796|168770|P1|COMPLETED|Period 2: Epoch 2||1
71006|NCT01485796|168770|P1|Treated in Epoch 2|Period 2: Epoch 2||36
71007|NCT01485796|168770|P1|STARTED|Period 2: Epoch 2||36
71008|NCT01485796|168770|P1|NOT COMPLETED|Period 1: Epoch 1 (Ramp-up)||1
71009|NCT01485796|168770|P1|COMPLETED|Period 1: Epoch 1 (Ramp-up)||36
71010|NCT01485796|168770|P1|Treated in Epoch 1|Period 1: Epoch 1 (Ramp-up)||37
71011|NCT01485796|168770|P1|STARTED|Period 1: Epoch 1 (Ramp-up)||37
71012|NCT01485640|168792|P1|NOT COMPLETED|Overall Study||122
71013|NCT01485640|168792|P1|COMPLETED|Overall Study||40
71014|NCT01485640|168792|P1|STARTED|Overall Study||162
71015|NCT01485536|168797|P1|NOT COMPLETED|Overall Study||4
71016|NCT01485536|168797|P1|COMPLETED|Overall Study||17
71017|NCT01485536|168797|P1|STARTED|Overall Study||21
71018|NCT01485380|168802|P1|NOT COMPLETED|Overall Study||3
71019|NCT01485380|168802|P1|COMPLETED|Overall Study||17
71020|NCT01485380|168802|P1|STARTED|Overall Study||20
71021|NCT01485354|168806|P1|NOT COMPLETED|Overall Study||5
71022|NCT01485354|168806|P1|COMPLETED|Overall Study||12
71023|NCT01485354|168806|P1|STARTED|Overall Study||17
71024|NCT01485172|168820|P6|NOT COMPLETED|Overall Study||4
71025|NCT01485172|168821|P5|NOT COMPLETED|Overall Study||5
71026|NCT01485172|168822|P4|NOT COMPLETED|Overall Study||8
71027|NCT01485172|168823|P3|NOT COMPLETED|Overall Study||7
71028|NCT01485172|168824|P2|NOT COMPLETED|Overall Study||1
71029|NCT01485172|168825|P1|NOT COMPLETED|Overall Study||7
71030|NCT01485172|168820|P6|COMPLETED|Overall Study||9
71031|NCT01485172|168821|P5|COMPLETED|Overall Study||34
71032|NCT01485172|168822|P4|COMPLETED|Overall Study||32
71033|NCT01485172|168823|P3|COMPLETED|Overall Study||34
71034|NCT01485172|168824|P2|COMPLETED|Overall Study||12
71035|NCT01485172|168825|P1|COMPLETED|Overall Study||33
71036|NCT01485172|168820|P6|STARTED|Overall Study||13
71037|NCT01485172|168821|P5|STARTED|Overall Study||39
71038|NCT01485172|168822|P4|STARTED|Overall Study||40
71039|NCT01485172|168823|P3|STARTED|Overall Study||41
71040|NCT01485172|168824|P2|STARTED|Overall Study||13
71041|NCT01485172|168825|P1|STARTED|Overall Study||40
71042|NCT01485094|168902|P3|NOT COMPLETED|Overall Study||1
71043|NCT01485094|168903|P2|NOT COMPLETED|Overall Study||2
71044|NCT01485094|168904|P1|NOT COMPLETED|Overall Study||3
71045|NCT01485094|168902|P3|COMPLETED|Overall Study||18
71046|NCT01485094|168903|P2|COMPLETED|Overall Study||18
71047|NCT01485094|168904|P1|COMPLETED|Overall Study||17
71048|NCT01485094|168902|P3|STARTED|Overall Study||19
71049|NCT01485094|168903|P2|STARTED|Overall Study||20
71050|NCT01485094|168904|P1|STARTED|Overall Study||20
71051|NCT01484977|168945|P1|NOT COMPLETED|Overall Study||27
71052|NCT01484977|168945|P1|COMPLETED|Overall Study||93
71053|NCT01484977|168945|P1|STARTED|Overall Study||120
71054|NCT01484951|168949|P1|NOT COMPLETED|Overall Study||5
71055|NCT01484951|168949|P1|COMPLETED|Overall Study||69
71056|NCT01484951|168949|P1|STARTED|Overall Study||74
71057|NCT01484938|168954|P1|NOT COMPLETED|Overall Study||4
71058|NCT01484938|168954|P1|COMPLETED|Overall Study||171
71059|NCT01484938|168954|P1|STARTED|Overall Study||175
71060|NCT01484912|168961|P2|NOT COMPLETED|Overall Study||1
71061|NCT01484912|168962|P1|NOT COMPLETED|Overall Study||1
71062|NCT01484912|168961|P2|COMPLETED|Overall Study||39
71063|NCT01484912|168962|P1|COMPLETED|Overall Study||38
71064|NCT01484912|168961|P2|STARTED|Overall Study||40
71065|NCT01484912|168962|P1|STARTED|Overall Study||39
71066|NCT01484873|168972|P1|NOT COMPLETED|Overall Study||2
71067|NCT01484873|168972|P1|COMPLETED|Overall Study||8
71068|NCT01484873|168972|P1|STARTED|Overall Study||10
71069|NCT01484834|168984|P4|NOT COMPLETED|Overall Study||4
71070|NCT01484834|168985|P3|NOT COMPLETED|Overall Study||1
71071|NCT01484834|168986|P2|NOT COMPLETED|Overall Study||8
71072|NCT01484834|168987|P1|NOT COMPLETED|Overall Study||5
71073|NCT01484834|168984|P4|COMPLETED|Overall Study||20
71074|NCT01484834|168985|P3|COMPLETED|Overall Study||38
71075|NCT01484834|168986|P2|COMPLETED|Overall Study||54
71076|NCT01484834|168987|P1|COMPLETED|Overall Study||60
71077|NCT01484834|168984|P4|STARTED|Overall Study||24
71078|NCT01484834|168985|P3|STARTED|Overall Study||39
71079|NCT01484834|168986|P2|STARTED|Overall Study||62
71080|NCT01484834|168987|P1|STARTED|Overall Study||65
71081|NCT01484652|169015|P2|NOT COMPLETED|Overall Study||21
71082|NCT01484652|169016|P1|NOT COMPLETED|Overall Study||15
71083|NCT01484652|169015|P2|COMPLETED|Overall Study||142
71084|NCT01484652|169016|P1|COMPLETED|Overall Study||151
71085|NCT01484652|169015|P2|STARTED|Overall Study||163
71086|NCT01484652|169016|P1|STARTED|Overall Study||166
71087|NCT01484561|169024|P2|NOT COMPLETED|Overall Study||6
71088|NCT01484561|169025|P1|NOT COMPLETED|Overall Study||9
71089|NCT01484561|169024|P2|COMPLETED|Overall Study||45
71091|NCT01484561|169024|P2|STARTED|Overall Study||51
71092|NCT01484561|169025|P1|STARTED|Overall Study||97
71093|NCT01484496|169115|P4|NOT COMPLETED|Period 2||22
71094|NCT01484496|169116|P3|NOT COMPLETED|Period 2||15
71095|NCT01484496|169117|P2|NOT COMPLETED|Period 2||0
71096|NCT01484496|169118|P1|NOT COMPLETED|Period 2||0
71097|NCT01484496|169115|P4|COMPLETED|Period 2||434
71098|NCT01484496|169116|P3|COMPLETED|Period 2||191
71099|NCT01484496|169117|P2|COMPLETED|Period 2||0
71100|NCT01484496|169118|P1|COMPLETED|Period 2||0
71101|NCT01484496|169115|P4|STARTED|Period 2||456
71102|NCT01484496|169116|P3|STARTED|Period 2||206
71103|NCT01484496|169117|P2|STARTED|Period 2||0
71104|NCT01484496|169118|P1|STARTED|Period 2||0
71105|NCT01484496|169115|P4|NOT COMPLETED|Period 1||0
71106|NCT01484496|169116|P3|NOT COMPLETED|Period 1||0
71107|NCT01484496|169117|P2|NOT COMPLETED|Period 1||93
71108|NCT01484496|169118|P1|NOT COMPLETED|Period 1||66
71109|NCT01484496|169115|P4|COMPLETED|Period 1||0
71110|NCT01484496|169116|P3|COMPLETED|Period 1||0
71111|NCT01484496|169117|P2|COMPLETED|Period 1||463
71112|NCT01484496|169118|P1|COMPLETED|Period 1||214
71113|NCT01484496|169115|P4|STARTED|Period 1||0
71114|NCT01484496|169116|P3|STARTED|Period 1||0
71115|NCT01484496|169117|P2|STARTED|Period 1||556
71116|NCT01484496|169118|P1|STARTED|Period 1||280
71117|NCT01484314|169130|P1|NOT COMPLETED|Overall Study||0
71118|NCT01484314|169130|P1|COMPLETED|Overall Study||1
71119|NCT01484314|169130|P1|STARTED|Overall Study||1
71120|NCT01484197|169136|P4|NOT COMPLETED|Treatment Period 4||0
71121|NCT01484197|169137|P3|NOT COMPLETED|Treatment Period 4||0
71122|NCT01484197|169138|P2|NOT COMPLETED|Treatment Period 4||0
71123|NCT01484197|169139|P1|NOT COMPLETED|Treatment Period 4||0
71124|NCT01484197|169136|P4|COMPLETED|Treatment Period 4||6
71125|NCT01484197|169137|P3|COMPLETED|Treatment Period 4||9
71126|NCT01484197|169138|P2|COMPLETED|Treatment Period 4||8
71127|NCT01484197|169139|P1|COMPLETED|Treatment Period 4||7
71128|NCT01484197|169136|P4|STARTED|Treatment Period 4|2 patients completed Period 3 but did not enter Period 4 due to a Protocol deviation and an AE.|6
71129|NCT01484197|169137|P3|STARTED|Treatment Period 4||9
71130|NCT01484197|169138|P2|STARTED|Treatment Period 4||8
71131|NCT01484197|169139|P1|STARTED|Treatment Period 4||7
71132|NCT01484197|169136|P4|NOT COMPLETED|Treatment Period 3||0
71133|NCT01484197|169137|P3|NOT COMPLETED|Treatment Period 3||0
71134|NCT01484197|169138|P2|NOT COMPLETED|Treatment Period 3||0
71135|NCT01484197|169139|P1|NOT COMPLETED|Treatment Period 3||0
71136|NCT01484197|169136|P4|COMPLETED|Treatment Period 3||8
71137|NCT01484197|169137|P3|COMPLETED|Treatment Period 3||9
71138|NCT01484197|169138|P2|COMPLETED|Treatment Period 3||8
71139|NCT01484197|169139|P1|COMPLETED|Treatment Period 3||7
71140|NCT01484197|169136|P4|STARTED|Treatment Period 3||8
71141|NCT01484197|169137|P3|STARTED|Treatment Period 3||9
71142|NCT01484197|169138|P2|STARTED|Treatment Period 3||8
71143|NCT01484197|169139|P1|STARTED|Treatment Period 3||7
71144|NCT01484197|169136|P4|NOT COMPLETED|Treatment Period 2||1
71145|NCT01484197|169137|P3|NOT COMPLETED|Treatment Period 2||0
71146|NCT01484197|169138|P2|NOT COMPLETED|Treatment Period 2||0
71147|NCT01484197|169139|P1|NOT COMPLETED|Treatment Period 2||0
71148|NCT01484197|169136|P4|COMPLETED|Treatment Period 2||8
71149|NCT01484197|169137|P3|COMPLETED|Treatment Period 2||9
71150|NCT01484197|169138|P2|COMPLETED|Treatment Period 2||8
71151|NCT01484197|169139|P1|COMPLETED|Treatment Period 2||7
71152|NCT01484197|169136|P4|STARTED|Treatment Period 2||9
71153|NCT01484197|169137|P3|STARTED|Treatment Period 2||9
71154|NCT01484197|169138|P2|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to an Adverse event (AE).|8
71155|NCT01484197|169139|P1|STARTED|Treatment Period 2|1 patient completed Period 1 but did not enter Period 2 due to a Protocol deviation.|7
71156|NCT01484197|169136|P4|NOT COMPLETED|Treatment Period 1||0
71157|NCT01484197|169137|P3|NOT COMPLETED|Treatment Period 1||0
71158|NCT01484197|169138|P2|NOT COMPLETED|Treatment Period 1||0
71159|NCT01484197|169139|P1|NOT COMPLETED|Treatment Period 1||1
71160|NCT01484197|169136|P4|COMPLETED|Treatment Period 1||9
71161|NCT01484197|169137|P3|COMPLETED|Treatment Period 1||9
71162|NCT01484197|169138|P2|COMPLETED|Treatment Period 1||9
71163|NCT01484197|169139|P1|COMPLETED|Treatment Period 1||8
71164|NCT01484197|169136|P4|STARTED|Treatment Period 1||9
71165|NCT01484197|169137|P3|STARTED|Treatment Period 1||9
71166|NCT01484197|169138|P2|STARTED|Treatment Period 1||9
71167|NCT01484197|169139|P1|STARTED|Treatment Period 1||9
71168|NCT01484132|169222|P1|NOT COMPLETED|Overall Study||22
71169|NCT01484132|169222|P1|COMPLETED|Overall Study|91 subjects had at least one pre-treatment and at least one post-treatment urine sample.|91
71170|NCT01484132|169222|P1|Pre-treatment Urine Sample|Overall Study|Urine samples were collected twice pre-treatment. 101 subjects completed at least one urine sample.|101
71171|NCT01484132|169222|P1|STARTED|Overall Study||113
71172|NCT01484054|169230|P2|NOT COMPLETED|Period 2||0
71173|NCT01484054|169231|P1|NOT COMPLETED|Period 2||0
71174|NCT01484054|169230|P2|COMPLETED|Period 2||49
71175|NCT01484054|169231|P1|COMPLETED|Period 2||50
71176|NCT01484054|169230|P2|STARTED|Period 2||49
71177|NCT01484054|169231|P1|STARTED|Period 2||50
71178|NCT01484054|169230|P2|NOT COMPLETED|Period 1||1
71179|NCT01484054|169231|P1|NOT COMPLETED|Period 1||0
71180|NCT01484054|169230|P2|COMPLETED|Period 1||49
71181|NCT01484054|169231|P1|COMPLETED|Period 1||50
71182|NCT01484054|169230|P2|STARTED|Period 1||50
71183|NCT01484054|169231|P1|STARTED|Period 1||50
71184|NCT01484041|169241|P1|NOT COMPLETED|Overall Study||0
71185|NCT01484041|169241|P1|COMPLETED|Overall Study||12
71186|NCT01484041|169241|P1|STARTED|Overall Study||12
71187|NCT01484028|169249|P4|NOT COMPLETED|Period 2||0
71188|NCT01484028|169250|P3|NOT COMPLETED|Period 2||0
71189|NCT01484028|169251|P2|NOT COMPLETED|Period 2||0
71190|NCT01484028|169252|P1|NOT COMPLETED|Period 2||0
71191|NCT01484028|169249|P4|COMPLETED|Period 2||66
71192|NCT01484028|169250|P3|COMPLETED|Period 2||64
71193|NCT01484028|169251|P2|COMPLETED|Period 2||67
71194|NCT01484028|169252|P1|COMPLETED|Period 2||66
71195|NCT01484028|169249|P4|STARTED|Period 2||66
71196|NCT01484028|169250|P3|STARTED|Period 2||64
71197|NCT01484028|169251|P2|STARTED|Period 2||67
71198|NCT01484028|169252|P1|STARTED|Period 2||66
71199|NCT01484028|169249|P4|NOT COMPLETED|Period 1||1
71200|NCT01484028|169250|P3|NOT COMPLETED|Period 1||0
71201|NCT01484028|169251|P2|NOT COMPLETED|Period 1||3
71202|NCT01484028|169252|P1|NOT COMPLETED|Period 1||0
71203|NCT01484028|169249|P4|COMPLETED|Period 1||66
71204|NCT01484028|169250|P3|COMPLETED|Period 1||64
71205|NCT01484028|169251|P2|COMPLETED|Period 1||67
71206|NCT01484028|169252|P1|COMPLETED|Period 1||66
71207|NCT01484028|169249|P4|STARTED|Period 1||67
71208|NCT01484028|169250|P3|STARTED|Period 1||64
71209|NCT01484028|169251|P2|STARTED|Period 1||70
71210|NCT01484028|169252|P1|STARTED|Period 1||66
71211|NCT01483963|169267|P5|NOT COMPLETED|Overall Study||0
71212|NCT01483963|169268|P4|NOT COMPLETED|Overall Study||0
71213|NCT01483963|169269|P3|NOT COMPLETED|Overall Study||0
71214|NCT01483963|169270|P2|NOT COMPLETED|Overall Study||0
71215|NCT01483963|169271|P1|NOT COMPLETED|Overall Study||0
71216|NCT01483963|169267|P5|COMPLETED|Overall Study||10
71217|NCT01483963|169268|P4|COMPLETED|Overall Study||10
71218|NCT01483963|169269|P3|COMPLETED|Overall Study||10
71219|NCT01483963|169270|P2|COMPLETED|Overall Study||10
71220|NCT01483963|169271|P1|COMPLETED|Overall Study||10
71221|NCT01483963|169267|P5|STARTED|Overall Study||10
71222|NCT01483963|169268|P4|STARTED|Overall Study||10
71223|NCT01483963|169269|P3|STARTED|Overall Study||10
71224|NCT01483963|169270|P2|STARTED|Overall Study||10
71225|NCT01483963|169271|P1|STARTED|Overall Study||10
71226|NCT01483937|169345|P2|NOT COMPLETED|Overall Study||3
71227|NCT01483937|169346|P1|NOT COMPLETED|Overall Study||4
71228|NCT01483937|169345|P2|COMPLETED|Overall Study||14
71229|NCT01483937|169346|P1|COMPLETED|Overall Study||11
71230|NCT01483937|169345|P2|STARTED|Overall Study||17
71231|NCT01483937|169346|P1|STARTED|Overall Study||15
71232|NCT01483924|169373|P5|NOT COMPLETED|Overall Study||2
71233|NCT01483924|169374|P4|NOT COMPLETED|Overall Study||4
71234|NCT01483924|169375|P3|NOT COMPLETED|Overall Study||1
71235|NCT01483924|169376|P2|NOT COMPLETED|Overall Study||0
71236|NCT01483924|169377|P1|NOT COMPLETED|Overall Study||2
71237|NCT01483924|169373|P5|COMPLETED|Overall Study||10
71238|NCT01483924|169374|P4|COMPLETED|Overall Study||8
71239|NCT01483924|169375|P3|COMPLETED|Overall Study||11
71240|NCT01483924|169376|P2|COMPLETED|Overall Study||12
71241|NCT01483924|169377|P1|COMPLETED|Overall Study||10
71242|NCT01483924|169373|P5|STARTED|Overall Study||12
71243|NCT01483924|169374|P4|STARTED|Overall Study||12
71244|NCT01483924|169375|P3|STARTED|Overall Study||12
71245|NCT01483924|169376|P2|STARTED|Overall Study||12
71246|NCT01483924|169377|P1|STARTED|Overall Study||12
71247|NCT01483820|169425|P1|NOT COMPLETED|Overall Study||8
71248|NCT01483820|169425|P1|COMPLETED|Overall Study||0
71249|NCT01483820|169425|P1|STARTED|Overall Study||8
71250|NCT01483651|169434|P6|NOT COMPLETED|Overall Study||1
71251|NCT01483651|169435|P5|NOT COMPLETED|Overall Study||0
71252|NCT01483651|169436|P4|NOT COMPLETED|Overall Study||0
71253|NCT01483651|169437|P3|NOT COMPLETED|Overall Study||1
71254|NCT01483651|169438|P2|NOT COMPLETED|Overall Study||1
71255|NCT01483651|169439|P1|NOT COMPLETED|Overall Study||0
71256|NCT01483651|169434|P6|COMPLETED|Overall Study||1
71257|NCT01483651|169435|P5|COMPLETED|Overall Study||2
71258|NCT01483651|169436|P4|COMPLETED|Overall Study||1
71259|NCT01483651|169437|P3|COMPLETED|Overall Study||1
71260|NCT01483651|169438|P2|COMPLETED|Overall Study||2
71261|NCT01483651|169439|P1|COMPLETED|Overall Study||1
71262|NCT01483651|169434|P6|STARTED|Overall Study||2
71263|NCT01483651|169435|P5|STARTED|Overall Study||2
71264|NCT01483651|169436|P4|STARTED|Overall Study||1
71265|NCT01483651|169437|P3|STARTED|Overall Study||2
71266|NCT01483651|169438|P2|STARTED|Overall Study||3
71267|NCT01483651|169439|P1|STARTED|Overall Study||1
71268|NCT01483625|169449|P2|NOT COMPLETED|Overall Study||2
71269|NCT01483625|169450|P1|NOT COMPLETED|Overall Study||4
71270|NCT01483625|169449|P2|COMPLETED|Overall Study||66
71271|NCT01483625|169450|P1|COMPLETED|Overall Study||68
71272|NCT01483625|169449|P2|STARTED|Overall Study||68
71273|NCT01483625|169450|P1|STARTED|Overall Study||72
71274|NCT01483599|169473|P14|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||7
71275|NCT01483599|169474|P13|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||3
71276|NCT01483599|169475|P12|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||1
71277|NCT01483599|169476|P11|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
71278|NCT01483599|169477|P10|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||4
71279|NCT01483599|169478|P9|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||9
71280|NCT01483599|169479|P8|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||2
71281|NCT01483599|169480|P7|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
71282|NCT01483599|169481|P6|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
71283|NCT01483599|169482|P5|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
71284|NCT01483599|169483|P4|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
71285|NCT01483599|169484|P3|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
71286|NCT01483599|169485|P2|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
71287|NCT01483599|169486|P1|NOT COMPLETED|After Controlled Period(Week 16-Week 40)||0
71288|NCT01483599|169473|P14|COMPLETED|After Controlled Period(Week 16-Week 40)||32
71289|NCT01483599|169474|P13|COMPLETED|After Controlled Period(Week 16-Week 40)||35
71290|NCT01483599|169475|P12|COMPLETED|After Controlled Period(Week 16-Week 40)||39
71291|NCT01483599|169476|P11|COMPLETED|After Controlled Period(Week 16-Week 40)||37
71292|NCT01483599|169477|P10|COMPLETED|After Controlled Period(Week 16-Week 40)||37
71293|NCT01483599|169478|P9|COMPLETED|After Controlled Period(Week 16-Week 40)||29
71294|NCT01483599|169479|P8|COMPLETED|After Controlled Period(Week 16-Week 40)||37
71295|NCT01483599|169480|P7|COMPLETED|After Controlled Period(Week 16-Week 40)||0
71296|NCT01483599|169481|P6|COMPLETED|After Controlled Period(Week 16-Week 40)||0
71297|NCT01483599|169482|P5|COMPLETED|After Controlled Period(Week 16-Week 40)||0
71298|NCT01483599|169483|P4|COMPLETED|After Controlled Period(Week 16-Week 40)||0
71299|NCT01483599|169484|P3|COMPLETED|After Controlled Period(Week 16-Week 40)||0
71300|NCT01483599|169485|P2|COMPLETED|After Controlled Period(Week 16-Week 40)||0
71301|NCT01483599|169486|P1|COMPLETED|After Controlled Period(Week 16-Week 40)||0
71302|NCT01483599|169473|P14|STARTED|After Controlled Period(Week 16-Week 40)||39
71303|NCT01483599|169474|P13|STARTED|After Controlled Period(Week 16-Week 40)||38
71304|NCT01483599|169475|P12|STARTED|After Controlled Period(Week 16-Week 40)||40
71305|NCT01483599|169476|P11|STARTED|After Controlled Period(Week 16-Week 40)||39
71306|NCT01483599|169477|P10|STARTED|After Controlled Period(Week 16-Week 40)||41
71307|NCT01483599|169478|P9|STARTED|After Controlled Period(Week 16-Week 40)||38
71308|NCT01483599|169479|P8|STARTED|After Controlled Period(Week 16-Week 40)||39
71309|NCT01483599|169480|P7|STARTED|After Controlled Period(Week 16-Week 40)||0
71310|NCT01483599|169481|P6|STARTED|After Controlled Period(Week 16-Week 40)||0
71311|NCT01483599|169482|P5|STARTED|After Controlled Period(Week 16-Week 40)||0
71312|NCT01483599|169483|P4|STARTED|After Controlled Period(Week 16-Week 40)||0
71313|NCT01483599|169484|P3|STARTED|After Controlled Period(Week 16-Week 40)||0
71314|NCT01483599|169485|P2|STARTED|After Controlled Period(Week 16-Week 40)||0
71315|NCT01483599|169486|P1|STARTED|After Controlled Period(Week 16-Week 40)||0
71316|NCT01483599|169473|P14|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71317|NCT01483599|169474|P13|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71318|NCT01483599|169475|P12|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71319|NCT01483599|169476|P11|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71320|NCT01483599|169477|P10|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71321|NCT01483599|169478|P9|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71322|NCT01483599|169479|P8|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71323|NCT01483599|169480|P7|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
71324|NCT01483599|169481|P6|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||4
71325|NCT01483599|169482|P5|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||2
71326|NCT01483599|169483|P4|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
71327|NCT01483599|169484|P3|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||0
71328|NCT01483599|169485|P2|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
71329|NCT01483599|169486|P1|NOT COMPLETED|Controlled Period (CP) (up to Week 16)||3
71330|NCT01483599|169473|P14|COMPLETED|Controlled Period (CP) (up to Week 16)||0
71331|NCT01483599|169474|P13|COMPLETED|Controlled Period (CP) (up to Week 16)||0
71332|NCT01483599|169475|P12|COMPLETED|Controlled Period (CP) (up to Week 16)||0
71333|NCT01483599|169476|P11|COMPLETED|Controlled Period (CP) (up to Week 16)||0
71334|NCT01483599|169477|P10|COMPLETED|Controlled Period (CP) (up to Week 16)||0
71335|NCT01483599|169478|P9|COMPLETED|Controlled Period (CP) (up to Week 16)||0
71336|NCT01483599|169479|P8|COMPLETED|Controlled Period (CP) (up to Week 16)||0
71337|NCT01483599|169480|P7|COMPLETED|Controlled Period (CP) (up to Week 16)||39
71338|NCT01483599|169481|P6|COMPLETED|Controlled Period (CP) (up to Week 16)||38
71339|NCT01483599|169482|P5|COMPLETED|Controlled Period (CP) (up to Week 16)||40
71340|NCT01483599|169483|P4|COMPLETED|Controlled Period (CP) (up to Week 16)||39
71341|NCT01483599|169484|P3|COMPLETED|Controlled Period (CP) (up to Week 16)||41
71342|NCT01483599|169485|P2|COMPLETED|Controlled Period (CP) (up to Week 16)||38
71343|NCT01483599|169486|P1|COMPLETED|Controlled Period (CP) (up to Week 16)||39
71344|NCT01483599|169473|P14|Treated|Controlled Period (CP) (up to Week 16)||0
71345|NCT01483599|169474|P13|Treated|Controlled Period (CP) (up to Week 16)||0
71346|NCT01483599|169475|P12|Treated|Controlled Period (CP) (up to Week 16)||0
71347|NCT01483599|169476|P11|Treated|Controlled Period (CP) (up to Week 16)||0
71348|NCT01483599|169477|P10|Treated|Controlled Period (CP) (up to Week 16)||0
71349|NCT01483599|169478|P9|Treated|Controlled Period (CP) (up to Week 16)||0
71350|NCT01483599|169479|P8|Treated|Controlled Period (CP) (up to Week 16)||0
71351|NCT01483599|169480|P7|Treated|Controlled Period (CP) (up to Week 16)||43
71352|NCT01483599|169481|P6|Treated|Controlled Period (CP) (up to Week 16)||41
71353|NCT01483599|169482|P5|Treated|Controlled Period (CP) (up to Week 16)||42
71354|NCT01483599|169483|P4|Treated|Controlled Period (CP) (up to Week 16)||42
71355|NCT01483599|169484|P3|Treated|Controlled Period (CP) (up to Week 16)||41
71356|NCT01483599|169485|P2|Treated|Controlled Period (CP) (up to Week 16)||41
71357|NCT01483599|169486|P1|Treated|Controlled Period (CP) (up to Week 16)||42
71358|NCT01483599|169473|P14|STARTED|Controlled Period (CP) (up to Week 16)||0
71359|NCT01483599|169474|P13|STARTED|Controlled Period (CP) (up to Week 16)||0
71360|NCT01483599|169475|P12|STARTED|Controlled Period (CP) (up to Week 16)||0
71361|NCT01483599|169476|P11|STARTED|Controlled Period (CP) (up to Week 16)||0
71362|NCT01483599|169477|P10|STARTED|Controlled Period (CP) (up to Week 16)||0
71363|NCT01483599|169478|P9|STARTED|Controlled Period (CP) (up to Week 16)||0
71364|NCT01483599|169479|P8|STARTED|Controlled Period (CP) (up to Week 16)||0
71365|NCT01483599|169480|P7|STARTED|Controlled Period (CP) (up to Week 16)||43
71366|NCT01483599|169481|P6|STARTED|Controlled Period (CP) (up to Week 16)||42
71367|NCT01483599|169482|P5|STARTED|Controlled Period (CP) (up to Week 16)||42
71368|NCT01483599|169483|P4|STARTED|Controlled Period (CP) (up to Week 16)||42
71369|NCT01483599|169484|P3|STARTED|Controlled Period (CP) (up to Week 16)||41
71370|NCT01483599|169485|P2|STARTED|Controlled Period (CP) (up to Week 16)||41
71371|NCT01483599|169486|P1|STARTED|Controlled Period (CP) (up to Week 16)||42
71372|NCT01483378|169535|P2|NOT COMPLETED|Overall Study||0
71373|NCT01483378|169536|P1|NOT COMPLETED|Overall Study||0
71374|NCT01483378|169535|P2|COMPLETED|Overall Study||66
71375|NCT01483378|169536|P1|COMPLETED|Overall Study||100
71376|NCT01483378|169535|P2|STARTED|Overall Study||66
71377|NCT01483378|169536|P1|STARTED|Overall Study||100
71378|NCT01483352|169542|P1|NOT COMPLETED|Overall Study||0
71379|NCT01483352|169542|P1|COMPLETED|Overall Study||12
71380|NCT01483352|169542|P1|STARTED|Overall Study||12
71381|NCT01483209|169561|P1|NOT COMPLETED|Overall Study||1
71382|NCT01483209|169561|P1|COMPLETED|Overall Study||1
71383|NCT01483209|169561|P1|STARTED|Overall Study||2
71384|NCT01483183|169576|P10|NOT COMPLETED|Overall Study||1
71385|NCT01483183|169577|P9|NOT COMPLETED|Overall Study||0
71386|NCT01483183|169578|P8|NOT COMPLETED|Overall Study||0
71387|NCT01483183|169579|P7|NOT COMPLETED|Overall Study||2
71388|NCT01483183|169580|P6|NOT COMPLETED|Overall Study||0
71389|NCT01483183|169581|P5|NOT COMPLETED|Overall Study||0
71390|NCT01483183|169582|P4|NOT COMPLETED|Overall Study||0
71391|NCT01483183|169583|P3|NOT COMPLETED|Overall Study||0
71392|NCT01483183|169584|P2|NOT COMPLETED|Overall Study||0
71393|NCT01483183|169585|P1|NOT COMPLETED|Overall Study||0
71394|NCT01483183|169576|P10|COMPLETED|Overall Study||4
71395|NCT01483183|169577|P9|COMPLETED|Overall Study||4
71396|NCT01483183|169578|P8|COMPLETED|Overall Study||4
71397|NCT01483183|169579|P7|COMPLETED|Overall Study||4
71398|NCT01483183|169580|P6|COMPLETED|Overall Study||4
71399|NCT01483183|169581|P5|COMPLETED|Overall Study||4
71400|NCT01483183|169582|P4|COMPLETED|Overall Study||3
71401|NCT01483183|169583|P3|COMPLETED|Overall Study||5
71402|NCT01483183|169584|P2|COMPLETED|Overall Study||1
71403|NCT01483183|169585|P1|COMPLETED|Overall Study||4
71404|NCT01483183|169576|P10|STARTED|Overall Study||5
71405|NCT01483183|169577|P9|STARTED|Overall Study||4
71406|NCT01483183|169578|P8|STARTED|Overall Study||4
71407|NCT01483183|169579|P7|STARTED|Overall Study||6
71408|NCT01483183|169580|P6|STARTED|Overall Study||4
71409|NCT01483183|169581|P5|STARTED|Overall Study||4
71410|NCT01483183|169582|P4|STARTED|Overall Study||3
71411|NCT01483183|169583|P3|STARTED|Overall Study||5
71412|NCT01483183|169584|P2|STARTED|Overall Study||1
71413|NCT01483183|169585|P1|STARTED|Overall Study||4
71414|NCT01483118|169655|P2|NOT COMPLETED|Overall Study||16
71415|NCT01483118|169656|P1|NOT COMPLETED|Overall Study||12
71416|NCT01483118|169655|P2|COMPLETED|Overall Study||6
71417|NCT01483118|169656|P1|COMPLETED|Overall Study||11
71418|NCT01483118|169655|P2|Completed 3 Months|Overall Study||11
71419|NCT01483118|169656|P1|Completed 3 Months|Overall Study||15
71420|NCT01483118|169655|P2|STARTED|Overall Study||22
71421|NCT01483118|169656|P1|STARTED|Overall Study||23
71422|NCT01482910|169668|P2|NOT COMPLETED|Overall Study||9
71423|NCT01482910|169669|P1|NOT COMPLETED|Overall Study||15
71424|NCT01482910|169668|P2|COMPLETED|Overall Study||67
71425|NCT01482910|169669|P1|COMPLETED|Overall Study||213
71426|NCT01482910|169668|P2|Completed Week 28|Overall Study||71
71427|NCT01482910|169669|P1|Completed Week 28|Overall Study||216
71428|NCT01482910|169668|P2|STARTED|Overall Study||76
71429|NCT01482910|169669|P1|STARTED|Overall Study||228
71430|NCT01482884|169681|P2|NOT COMPLETED|Overall Study||18
71431|NCT01482884|169682|P1|NOT COMPLETED|Overall Study||13
71432|NCT01482884|169681|P2|COMPLETED|Overall Study||37
71433|NCT01482884|169682|P1|COMPLETED|Overall Study||43
71434|NCT01482884|169681|P2|STARTED|Overall Study||55
71435|NCT01482884|169682|P1|STARTED|Overall Study|One participant did not receive study treatment|56
71436|NCT01482819|169708|P1|NOT COMPLETED|Overall Study||2
71437|NCT01482819|169708|P1|COMPLETED|Overall Study||19
71438|NCT01482819|169708|P1|STARTED|Overall Study||21
71439|NCT01482767|169728|P2|NOT COMPLETED|Overall Study||49
71440|NCT01482767|169729|P1|NOT COMPLETED|Overall Study||54
71441|NCT01482767|169728|P2|COMPLETED|Overall Study||78
71442|NCT01482767|169729|P1|COMPLETED|Overall Study||81
71443|NCT01482767|169728|P2|STARTED|Overall Study||127
71444|NCT01482767|169729|P1|STARTED|Overall Study||135
71445|NCT01482429|169751|P2|NOT COMPLETED|Protocol||0
71446|NCT01482429|169752|P1|NOT COMPLETED|Protocol||275
71447|NCT01482429|169751|P2|COMPLETED|Protocol||0
71448|NCT01482429|169752|P1|COMPLETED|Protocol||139
71449|NCT01482429|169751|P2|STARTED|Protocol||0
71450|NCT01482429|169752|P1|STARTED|Protocol||414
71451|NCT01482429|169751|P2|NOT COMPLETED|Care Usual||173
71452|NCT01482429|169752|P1|NOT COMPLETED|Care Usual||0
71453|NCT01482429|169751|P2|COMPLETED|Care Usual||96
71454|NCT01482429|169752|P1|COMPLETED|Care Usual||0
71455|NCT01482429|169751|P2|STARTED|Care Usual||269
71456|NCT01482429|169752|P1|STARTED|Care Usual||0
71457|NCT01482325|169760|P1|NOT COMPLETED|Overall Study||0
71458|NCT01482325|169760|P1|COMPLETED|Overall Study||31
71459|NCT01482325|169760|P1|STARTED|Overall Study||31
71460|NCT01482312|169764|P3|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
71461|NCT01482312|169765|P2|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
71462|NCT01482312|169766|P1|NOT COMPLETED|Period 3, 90 Minutes of Wear||0
71463|NCT01482312|169764|P3|COMPLETED|Period 3, 90 Minutes of Wear||9
71464|NCT01482312|169765|P2|COMPLETED|Period 3, 90 Minutes of Wear||9
71465|NCT01482312|169766|P1|COMPLETED|Period 3, 90 Minutes of Wear||8
71466|NCT01482312|169764|P3|STARTED|Period 3, 90 Minutes of Wear||9
71467|NCT01482312|169765|P2|STARTED|Period 3, 90 Minutes of Wear||9
71468|NCT01482312|169766|P1|STARTED|Period 3, 90 Minutes of Wear||8
71469|NCT01482312|169764|P3|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
71470|NCT01482312|169765|P2|NOT COMPLETED|Period 2, 90 Minutes of Wear||0
71471|NCT01482312|169766|P1|NOT COMPLETED|Period 2, 90 Minutes of Wear||1
71472|NCT01482312|169764|P3|COMPLETED|Period 2, 90 Minutes of Wear||9
71473|NCT01482312|169765|P2|COMPLETED|Period 2, 90 Minutes of Wear||9
71474|NCT01482312|169766|P1|COMPLETED|Period 2, 90 Minutes of Wear||8
71475|NCT01482312|169764|P3|STARTED|Period 2, 90 Minutes of Wear|One participant discontinued between Period 1 and Period 2|9
71476|NCT01482312|169765|P2|STARTED|Period 2, 90 Minutes of Wear||9
71477|NCT01482312|169766|P1|STARTED|Period 2, 90 Minutes of Wear||9
71478|NCT01482312|169764|P3|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
71479|NCT01482312|169765|P2|NOT COMPLETED|Period 1, 90 Minutes of Wear||0
71480|NCT01482312|169766|P1|NOT COMPLETED|Period 1, 90 Minutes of Wear||1
71481|NCT01482312|169764|P3|COMPLETED|Period 1, 90 Minutes of Wear||10
71482|NCT01482312|169765|P2|COMPLETED|Period 1, 90 Minutes of Wear||9
71483|NCT01482312|169766|P1|COMPLETED|Period 1, 90 Minutes of Wear||9
71484|NCT01482312|169764|P3|STARTED|Period 1, 90 Minutes of Wear||10
71485|NCT01482312|169765|P2|STARTED|Period 1, 90 Minutes of Wear||9
71486|NCT01482312|169766|P1|STARTED|Period 1, 90 Minutes of Wear||10
71487|NCT01482221|169780|P3|NOT COMPLETED|Overall Study||23
71488|NCT01482221|169781|P2|NOT COMPLETED|Overall Study||20
71489|NCT01482221|169782|P1|NOT COMPLETED|Overall Study||21
71490|NCT01482221|169780|P3|COMPLETED|Overall Study||77
71491|NCT01482221|169781|P2|COMPLETED|Overall Study||81
71492|NCT01482221|169782|P1|COMPLETED|Overall Study||80
71493|NCT01482221|169780|P3|STARTED|Overall Study||100
71494|NCT01482221|169781|P2|STARTED|Overall Study||101
71495|NCT01482221|169782|P1|STARTED|Overall Study||101
71496|NCT01482091|169825|P2|NOT COMPLETED|Overall Study||0
71497|NCT01482091|169826|P1|NOT COMPLETED|Overall Study||0
71498|NCT01482091|169825|P2|COMPLETED|Overall Study||24
71499|NCT01482091|169826|P1|COMPLETED|Overall Study||25
71500|NCT01482091|169825|P2|STARTED|Overall Study||24
71501|NCT01482091|169826|P1|STARTED|Overall Study||25
71502|NCT01482065|169858|P2|NOT COMPLETED|Overall Study||1
71503|NCT01482065|169859|P1|NOT COMPLETED|Overall Study||0
71504|NCT01482065|169858|P2|COMPLETED|Overall Study||4
71505|NCT01482065|169859|P1|COMPLETED|Overall Study||4
71506|NCT01482065|169858|P2|STARTED|Overall Study||5
71507|NCT01482065|169859|P1|STARTED|Overall Study||4
71508|NCT01481935|169873|P2|NOT COMPLETED|Overall Study||0
71509|NCT01481935|169874|P1|NOT COMPLETED|Overall Study||0
71510|NCT01481935|169873|P2|COMPLETED|Overall Study||93
71511|NCT01481935|169874|P1|COMPLETED|Overall Study||97
71512|NCT01481935|169873|P2|STARTED|Overall Study||93
71513|NCT01481935|169874|P1|STARTED|Overall Study||97
71514|NCT01481896|169880|P1|NOT COMPLETED|Overall Study||12
71515|NCT01481896|169880|P1|COMPLETED|Overall Study|The 114 participants includes 5 participants with bilateral hip replacements for a total of 119 THAs|114
71516|NCT01481896|169880|P1|Min 4.75 yr Follow-up, Revised or Dead|Overall Study|114 participants with 119 THAs had at least 4.75 year follow-up or were known revised or deceased|114
71517|NCT01481896|169880|P1|STARTED|Overall Study|The 126 participants includes 5 participants with bilateral hip replacements for a total of 131 THAs|126
71518|NCT01481740|169896|P2|NOT COMPLETED|Overall Study||7
71519|NCT01481740|169897|P1|NOT COMPLETED|Overall Study||11
71520|NCT01481740|169896|P2|COMPLETED|Overall Study||81
71521|NCT01481740|169897|P1|COMPLETED|Overall Study||79
71522|NCT01481740|169896|P2|STARTED|Overall Study||88
71523|NCT01481740|169897|P1|STARTED|Overall Study||90
71524|NCT01481558|169915|P2|NOT COMPLETED|Overall Study||0
71525|NCT01481558|169916|P1|NOT COMPLETED|Overall Study||0
71526|NCT01481558|169915|P2|COMPLETED|Overall Study||20
71527|NCT01481558|169916|P1|COMPLETED|Overall Study||20
71528|NCT01481558|169915|P2|STARTED|Overall Study||20
71529|NCT01481558|169916|P1|STARTED|Overall Study||20
71530|NCT01481376|169922|P1|NOT COMPLETED|Overall Study||31
71531|NCT01481376|169922|P1|COMPLETED|Overall Study||169
71532|NCT01481376|169922|P1|STARTED|Overall Study||200
71533|NCT01481324|169933|P3|NOT COMPLETED|Overall Study||2
71534|NCT01481324|169934|P2|NOT COMPLETED|Overall Study||2
71535|NCT01481324|169935|P1|NOT COMPLETED|Overall Study||0
71536|NCT01481324|169933|P3|COMPLETED|Overall Study||20
71537|NCT01481324|169934|P2|COMPLETED|Overall Study||22
71538|NCT01481324|169935|P1|COMPLETED|Overall Study||21
71539|NCT01481324|169933|P3|Month 3-Wear Rate Data|Overall Study||6
71540|NCT01481324|169934|P2|Month 3-Wear Rate Data|Overall Study||11
71541|NCT01481324|169935|P1|Month 3-Wear Rate Data|Overall Study||7
71542|NCT01481324|169933|P3|Month 2-Wear Rate Data|Overall Study||7
71543|NCT01481324|169934|P2|Month 2-Wear Rate Data|Overall Study||13
71544|NCT01481324|169935|P1|Month 2-Wear Rate Data|Overall Study||9
71545|NCT01481324|169933|P3|Month 1-Wear Rate Data|Overall Study||8
71546|NCT01481324|169934|P2|Month 1-Wear Rate Data|Overall Study||16
71547|NCT01481324|169935|P1|Month 1-Wear Rate Data|Overall Study||15
71548|NCT01481324|169933|P3|STARTED|Overall Study||22
71549|NCT01481324|169934|P2|STARTED|Overall Study||24
71550|NCT01481324|169935|P1|STARTED|Overall Study||21
71551|NCT01481129|169943|P1|NOT COMPLETED|Overall Study||0
71552|NCT01481129|169943|P1|COMPLETED|Overall Study||22
71553|NCT01481129|169943|P1|STARTED|Overall Study||22
71554|NCT01481116|169954|P3|NOT COMPLETED|Overall Study||813
71555|NCT01481116|169955|P2|NOT COMPLETED|Overall Study||817
71556|NCT01481116|169956|P1|NOT COMPLETED|Overall Study||824
71557|NCT01481116|169954|P3|COMPLETED|Overall Study||0
71558|NCT01481116|169955|P2|COMPLETED|Overall Study||0
71559|NCT01481116|169956|P1|COMPLETED|Overall Study||0
71560|NCT01481116|169954|P3|Treated|Overall Study||813
71561|NCT01481116|169955|P2|Treated|Overall Study||816
71562|NCT01481116|169956|P1|Treated|Overall Study||822
71563|NCT01481116|169954|P3|STARTED|Overall Study||813
71564|NCT01481116|169955|P2|STARTED|Overall Study||817
71565|NCT01481116|169956|P1|STARTED|Overall Study||824
71566|NCT01480674|169982|P1|NOT COMPLETED|Overall Study||35
71567|NCT01480674|169982|P1|COMPLETED|Overall Study||125
71568|NCT01480674|169982|P1|Analysed Set|Overall Study||128
71569|NCT01480674|169982|P1|Safety Set|Overall Study||154
71570|NCT01480674|169982|P1|STARTED|Overall Study||160
71571|NCT01480596|169996|P2|NOT COMPLETED|Overall Study||2
71572|NCT01480596|169997|P1|NOT COMPLETED|Overall Study||5
71573|NCT01480596|169996|P2|COMPLETED|Overall Study||16
71574|NCT01480596|169997|P1|COMPLETED|Overall Study||17
71575|NCT01480596|169996|P2|STARTED|Overall Study||18
71576|NCT01480596|169997|P1|STARTED|Overall Study||22
71577|NCT01480297|170039|P1|NOT COMPLETED|Overall Study||0
71578|NCT01480297|170039|P1|COMPLETED|Overall Study||8
71579|NCT01480297|170039|P1|STARTED|Overall Study||8
71580|NCT01480284|170045|P2|NOT COMPLETED|Overall Study||0
71581|NCT01480284|170046|P1|NOT COMPLETED|Overall Study||8
71582|NCT01480284|170045|P2|COMPLETED|Overall Study||56
71583|NCT01480284|170046|P1|COMPLETED|Overall Study||102
71584|NCT01480284|170045|P2|STARTED|Overall Study||56
71585|NCT01480284|170046|P1|STARTED|Overall Study||110
71586|NCT01480232|170078|P4|NOT COMPLETED|Overall Study||19
71587|NCT01480232|170079|P3|NOT COMPLETED|Overall Study||17
71588|NCT01480232|170080|P2|NOT COMPLETED|Overall Study||22
71589|NCT01480232|170081|P1|NOT COMPLETED|Overall Study||18
71590|NCT01480232|170078|P4|COMPLETED|Overall Study||22
71591|NCT01480232|170079|P3|COMPLETED|Overall Study||21
71592|NCT01480232|170080|P2|COMPLETED|Overall Study||19
71593|NCT01480232|170081|P1|COMPLETED|Overall Study||22
71594|NCT01480232|170078|P4|STARTED|Overall Study||41
71595|NCT01480232|170079|P3|STARTED|Overall Study||38
71596|NCT01480232|170080|P2|STARTED|Overall Study||41
71597|NCT01480232|170081|P1|STARTED|Overall Study||40
71598|NCT01480219|170109|P2|NOT COMPLETED|Overall Study||0
71599|NCT01480219|170110|P1|NOT COMPLETED|Overall Study||0
71600|NCT01480219|170109|P2|COMPLETED|Overall Study||142
71601|NCT01480219|170110|P1|COMPLETED|Overall Study||325
71602|NCT01480219|170109|P2|STARTED|Overall Study||142
71603|NCT01480219|170110|P1|STARTED|Overall Study||325
71604|NCT01480089|170118|P2|NOT COMPLETED|Overall Study||0
71605|NCT01480089|170119|P1|NOT COMPLETED|Overall Study||0
71606|NCT01480089|170118|P2|COMPLETED|Overall Study||30
71607|NCT01480089|170119|P1|COMPLETED|Overall Study||25
71608|NCT01480089|170118|P2|STARTED|Overall Study||30
71609|NCT01480089|170119|P1|STARTED|Overall Study||25
71610|NCT01480076|170129|P1|NOT COMPLETED|Overall Study||290
71611|NCT01480076|170129|P1|COMPLETED|Overall Study||611
71612|NCT01480076|170129|P1|Intent to Treat Population|Overall Study|Received ≥1 dose of study drug & provided ≥1 efficacy assessment at Baseline & the 3-month visit.|835
71613|NCT01480076|170129|P1|STARTED|Overall Study|enrolled and started run-in treatment|901
71614|NCT01479868|170248|P1|NOT COMPLETED|Overall Study||9
71615|NCT01479868|170248|P1|COMPLETED|Overall Study||97
71616|NCT01479868|170248|P1|STARTED|Overall Study|Restricted to subject who received at least one dose of treatment (TMC435/RBV/PegIFN).|106
71617|NCT01479777|170263|P1|NOT COMPLETED|Overall Study||2
71618|NCT01479777|170263|P1|COMPLETED|Overall Study||10
71619|NCT01479777|170263|P1|STARTED|Overall Study||12
71620|NCT01479764|170275|P2|NOT COMPLETED|Treated||2
71621|NCT01479764|170276|P1|NOT COMPLETED|Treated||0
71622|NCT01479764|170275|P2|COMPLETED|Treated||75
71623|NCT01479764|170276|P1|COMPLETED|Treated||74
71624|NCT01479764|170275|P2|STARTED|Treated||77
71625|NCT01479764|170276|P1|STARTED|Treated||74
71626|NCT01479764|170275|P2|NOT COMPLETED|Randomized||1
71627|NCT01479764|170276|P1|NOT COMPLETED|Randomized||2
71628|NCT01479764|170275|P2|COMPLETED|Randomized|1 randomized participant did not receive study drug|77
71629|NCT01479764|170276|P1|COMPLETED|Randomized|2 randomized participants did not receive study drug|74
71630|NCT01479764|170275|P2|STARTED|Randomized||78
71631|NCT01479764|170276|P1|STARTED|Randomized||76
71632|NCT01479725|170286|P2|NOT COMPLETED|Overall Study||1
71633|NCT01479725|170287|P1|NOT COMPLETED|Overall Study||2
71634|NCT01479725|170286|P2|COMPLETED|Overall Study||1
71635|NCT01479725|170287|P1|COMPLETED|Overall Study||4
71636|NCT01479725|170286|P2|STARTED|Overall Study||2
71637|NCT01479725|170287|P1|STARTED|Overall Study||6
71638|NCT01479621|170299|P7|NOT COMPLETED|Treatment Period||20
71639|NCT01479621|170300|P6|NOT COMPLETED|Treatment Period||41
71640|NCT01479621|170301|P5|NOT COMPLETED|Treatment Period||21
71641|NCT01479621|170302|P4|NOT COMPLETED|Treatment Period||12
71642|NCT01479621|170303|P3|NOT COMPLETED|Treatment Period||21
71643|NCT01479621|170304|P2|NOT COMPLETED|Treatment Period||24
71644|NCT01479621|170305|P1|NOT COMPLETED|Treatment Period||0
71645|NCT01479621|170299|P7|COMPLETED|Treatment Period||84
71646|NCT01479621|170300|P6|COMPLETED|Treatment Period||63
71647|NCT01479621|170301|P5|COMPLETED|Treatment Period||82
71648|NCT01479621|170302|P4|COMPLETED|Treatment Period||92
71649|NCT01479621|170303|P3|COMPLETED|Treatment Period||83
71650|NCT01479621|170304|P2|COMPLETED|Treatment Period||79
71651|NCT01479621|170305|P1|COMPLETED|Treatment Period||0
71652|NCT01479621|170299|P7|Full Analysis Set|Treatment Period||102
71653|NCT01479621|170300|P6|Full Analysis Set|Treatment Period||102
71654|NCT01479621|170301|P5|Full Analysis Set|Treatment Period||102
71655|NCT01479621|170302|P4|Full Analysis Set|Treatment Period||102
71656|NCT01479621|170303|P3|Full Analysis Set|Treatment Period||101
71657|NCT01479621|170304|P2|Full Analysis Set|Treatment Period||102
71658|NCT01479621|170305|P1|Full Analysis Set|Treatment Period||0
71659|NCT01479621|170299|P7|Safety Population|Treatment Period||104
71660|NCT01479621|170300|P6|Safety Population|Treatment Period||104
71661|NCT01479621|170301|P5|Safety Population|Treatment Period||103
71662|NCT01479621|170302|P4|Safety Population|Treatment Period||104
71663|NCT01479621|170303|P3|Safety Population|Treatment Period||104
71664|NCT01479621|170304|P2|Safety Population|Treatment Period||103
71665|NCT01479621|170305|P1|Safety Population|Treatment Period||0
71666|NCT01479621|170299|P7|STARTED|Treatment Period||104
71667|NCT01479621|170300|P6|STARTED|Treatment Period||104
71668|NCT01479621|170301|P5|STARTED|Treatment Period||103
71669|NCT01479621|170302|P4|STARTED|Treatment Period||104
71670|NCT01479621|170303|P3|STARTED|Treatment Period||104
71671|NCT01479621|170304|P2|STARTED|Treatment Period||103
71672|NCT01479621|170305|P1|STARTED|Treatment Period||0
71673|NCT01479621|170299|P7|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71674|NCT01479621|170300|P6|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71675|NCT01479621|170301|P5|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71676|NCT01479621|170302|P4|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71677|NCT01479621|170303|P3|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71678|NCT01479621|170304|P2|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71679|NCT01479621|170305|P1|NOT COMPLETED|Pre-Assignment Period (Run-In Placebo)||287
71680|NCT01479621|170299|P7|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71681|NCT01479621|170300|P6|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71682|NCT01479621|170301|P5|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71683|NCT01479621|170302|P4|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71684|NCT01479621|170303|P3|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71685|NCT01479621|170304|P2|COMPLETED|Pre-Assignment Period (Run-In Placebo)||0
71686|NCT01479621|170305|P1|COMPLETED|Pre-Assignment Period (Run-In Placebo)||622
71687|NCT01479621|170299|P7|STARTED|Pre-Assignment Period (Run-In Placebo)||0
71688|NCT01479621|170300|P6|STARTED|Pre-Assignment Period (Run-In Placebo)||0
71689|NCT01479621|170301|P5|STARTED|Pre-Assignment Period (Run-In Placebo)||0
71690|NCT01479621|170302|P4|STARTED|Pre-Assignment Period (Run-In Placebo)||0
71691|NCT01479621|170303|P3|STARTED|Pre-Assignment Period (Run-In Placebo)||0
71692|NCT01479621|170304|P2|STARTED|Pre-Assignment Period (Run-In Placebo)||0
71693|NCT01479621|170305|P1|STARTED|Pre-Assignment Period (Run-In Placebo)||909
71694|NCT01479595|170393|P2|NOT COMPLETED|Overall Study||2
71695|NCT01479595|170394|P1|NOT COMPLETED|Overall Study||2
71696|NCT01479595|170393|P2|COMPLETED|Overall Study||19
71697|NCT01479595|170394|P1|COMPLETED|Overall Study||42
71698|NCT01479595|170393|P2|Per Protocol Analysis Set|Overall Study||20
71699|NCT01479595|170394|P1|Per Protocol Analysis Set|Overall Study||41
71700|NCT01479595|170393|P2|PK Analysis Set|Overall Study||0
71701|NCT01479595|170394|P1|PK Analysis Set|Overall Study||42
71702|NCT01479595|170393|P2|STARTED|Overall Study||21
71703|NCT01479595|170394|P1|STARTED|Overall Study||44
71704|NCT01479543|170421|P5|NOT COMPLETED|Overall Study||1
71705|NCT01479543|170422|P4|NOT COMPLETED|Overall Study||0
71706|NCT01479543|170423|P3|NOT COMPLETED|Overall Study||1
71707|NCT01479543|170424|P2|NOT COMPLETED|Overall Study||0
71708|NCT01479543|170425|P1|NOT COMPLETED|Overall Study||1
71709|NCT01479543|170421|P5|COMPLETED|Overall Study||20
71710|NCT01479543|170422|P4|COMPLETED|Overall Study||20
71711|NCT01479543|170423|P3|COMPLETED|Overall Study||20
71712|NCT01479543|170424|P2|COMPLETED|Overall Study||20
71713|NCT01479543|170425|P1|COMPLETED|Overall Study||20
71714|NCT01479543|170421|P5|STARTED|Overall Study||21
71715|NCT01479543|170422|P4|STARTED|Overall Study||20
71716|NCT01479543|170423|P3|STARTED|Overall Study||21
71717|NCT01479543|170424|P2|STARTED|Overall Study||20
71718|NCT01479543|170425|P1|STARTED|Overall Study||21
71719|NCT01479530|170439|P2|NOT COMPLETED|Overall Study||12
71720|NCT01479530|170440|P1|NOT COMPLETED|Overall Study||10
71721|NCT01479530|170439|P2|COMPLETED|Overall Study||151
71722|NCT01479530|170440|P1|COMPLETED|Overall Study||148
71723|NCT01479530|170439|P2|STARTED|Overall Study||163
71724|NCT01479530|170440|P1|STARTED|Overall Study||158
71725|NCT01479517|170455|P3|NOT COMPLETED|Overall Study||0
71726|NCT01479517|170456|P2|NOT COMPLETED|Overall Study||0
71727|NCT01479517|170457|P1|NOT COMPLETED|Overall Study||0
71728|NCT01479517|170455|P3|COMPLETED|Overall Study||10
71729|NCT01479517|170456|P2|COMPLETED|Overall Study||10
71730|NCT01479517|170457|P1|COMPLETED|Overall Study||10
71731|NCT01479517|170455|P3|STARTED|Overall Study||10
71732|NCT01479517|170456|P2|STARTED|Overall Study||10
71733|NCT01479517|170457|P1|STARTED|Overall Study||10
71734|NCT01479374|170477|P3|NOT COMPLETED|Overall Study||5
71735|NCT01479374|170478|P2|NOT COMPLETED|Overall Study||8
71736|NCT01479374|170479|P1|NOT COMPLETED|Overall Study||3
71737|NCT01479374|170477|P3|COMPLETED|Overall Study||63
71738|NCT01479374|170478|P2|COMPLETED|Overall Study||60
71739|NCT01479374|170479|P1|COMPLETED|Overall Study||63
71740|NCT01479374|170477|P3|STARTED|Overall Study||68
71741|NCT01479374|170478|P2|STARTED|Overall Study||68
71742|NCT01479374|170479|P1|STARTED|Overall Study||66
71743|NCT01479127|170505|P1|NOT COMPLETED|Overall Study||3
71744|NCT01479127|170505|P1|COMPLETED|Overall Study||5
71745|NCT01479127|170505|P1|Started LCIG|Overall Study||6
71746|NCT01479127|170505|P1|STARTED|Overall Study|started oral study drug (full safety sample)|8
71747|NCT01479010|170539|P1|NOT COMPLETED|Overall Study||1
71748|NCT01479010|170539|P1|COMPLETED|Overall Study||1
71749|NCT01479010|170539|P1|STARTED|Overall Study||2
71750|NCT01478971|170544|P1|NOT COMPLETED|Peginesatide Treatment Period||14
71751|NCT01478971|170544|P1|COMPLETED|Peginesatide Treatment Period||143
71752|NCT01478971|170544|P1|STARTED|Peginesatide Treatment Period|2 participants terminated the study before transitioning to peginesatide for unknown reasons|157
71753|NCT01478971|170544|P1|NOT COMPLETED|Standard of Care Period||25
71754|NCT01478971|170544|P1|COMPLETED|Standard of Care Period||159
71755|NCT01478971|170544|P1|Received Treatment|Standard of Care Period||178
71756|NCT01478971|170544|P1|STARTED|Standard of Care Period||184
71757|NCT01478958|170561|P3|NOT COMPLETED|Overall Study||3
71758|NCT01478958|170562|P2|NOT COMPLETED|Overall Study||2
71759|NCT01478958|170563|P1|NOT COMPLETED|Overall Study||2
71760|NCT01478958|170561|P3|COMPLETED|Overall Study||66
71761|NCT01478958|170562|P2|COMPLETED|Overall Study||64
71762|NCT01478958|170563|P1|COMPLETED|Overall Study||65
71763|NCT01478958|170561|P3|STARTED|Overall Study||69
71764|NCT01478958|170562|P2|STARTED|Overall Study||66
71765|NCT01478958|170563|P1|STARTED|Overall Study||67
71766|NCT01478828|170571|P1|NOT COMPLETED|Overall Study||1
71767|NCT01478828|170571|P1|COMPLETED|Overall Study||1
71768|NCT01478828|170571|P1|STARTED|Overall Study||2
71769|NCT01478620|170576|P1|NOT COMPLETED|Overall Study||6
71770|NCT01478620|170576|P1|COMPLETED|Overall Study||119
71771|NCT01478620|170576|P1|STARTED|Overall Study||125
71772|NCT01478594|170582|P2|NOT COMPLETED|Overall Study||28
71773|NCT01478594|170583|P1|NOT COMPLETED|Overall Study||65
71774|NCT01478594|170582|P2|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|60
71775|NCT01478594|170583|P1|COMPLETED|Overall Study|Participants still on study as of 28 February 2014|112
71776|NCT01478594|170582|P2|Treated|Overall Study||87
71777|NCT01478594|170583|P1|Treated|Overall Study||177
71778|NCT01478594|170582|P2|STARTED|Overall Study||88
71779|NCT01478594|170583|P1|STARTED|Overall Study||177
71780|NCT01478373|170655|P1|NOT COMPLETED|Survival Phase||38
71781|NCT01478373|170655|P1|COMPLETED|Survival Phase||0
71782|NCT01478373|170655|P1|STARTED|Survival Phase||38
71783|NCT01478373|170655|P1|NOT COMPLETED|Treatment Phase||1
71784|NCT01478373|170655|P1|COMPLETED|Treatment Phase||38
71785|NCT01478373|170655|P1|STARTED|Treatment Phase||39
71786|NCT01478360|170668|P2|NOT COMPLETED|Overall Study||3
71787|NCT01478360|170669|P1|NOT COMPLETED|Overall Study||2
71788|NCT01478360|170668|P2|COMPLETED|Overall Study||12
71789|NCT01478360|170669|P1|COMPLETED|Overall Study||29
71790|NCT01478360|170668|P2|PK (Pharmacokinetics) Analysis Set|Overall Study||0
71791|NCT01478360|170669|P1|PK (Pharmacokinetics) Analysis Set|Overall Study|Serum samples were collected during the study and analyzed only for the AIN457 group|31
71792|NCT01478360|170668|P2|PD (Pharmacodynamic) Analysis Set|Overall Study||15
71793|NCT01478360|170669|P1|PD (Pharmacodynamic) Analysis Set|Overall Study||31
71794|NCT01478360|170668|P2|STARTED|Overall Study||15
71795|NCT01478360|170669|P1|STARTED|Overall Study||31
71796|NCT01478347|170675|P1|NOT COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||8
71797|NCT01478347|170675|P1|COMPLETED|Visit 4-Visit 7 (Day 151-331) - Part II||4
71798|NCT01478347|170675|P1|STARTED|Visit 4-Visit 7 (Day 151-331) - Part II||12
71799|NCT01478347|170675|P1|NOT COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||1
71800|NCT01478347|170675|P1|COMPLETED|Visit 1-Visit 3 (Day 0-91) - Part I||17
71801|NCT01478347|170675|P1|STARTED|Visit 1-Visit 3 (Day 0-91) - Part I||18
71802|NCT01478256|170682|P2|NOT COMPLETED|Overall Study||0
71803|NCT01478256|170683|P1|NOT COMPLETED|Overall Study||0
71804|NCT01478256|170682|P2|COMPLETED|Overall Study||15
71805|NCT01478256|170683|P1|COMPLETED|Overall Study||15
71806|NCT01478256|170682|P2|STARTED|Overall Study||15
71807|NCT01478256|170683|P1|STARTED|Overall Study||15
71808|NCT01478113|170693|P2|NOT COMPLETED|Overall Study||1
71809|NCT01478113|170694|P1|NOT COMPLETED|Overall Study||1
71810|NCT01478113|170693|P2|COMPLETED|Overall Study||1
71811|NCT01478113|170694|P1|COMPLETED|Overall Study||1
71812|NCT01478113|170693|P2|STARTED|Overall Study||2
71813|NCT01478113|170694|P1|STARTED|Overall Study||2
71814|NCT01478087|170712|P1|NOT COMPLETED|Overall Study||1
71815|NCT01478087|170712|P1|COMPLETED|Overall Study||2
71816|NCT01478087|170712|P1|STARTED|Overall Study||3
71817|NCT01478048|170719|P2|NOT COMPLETED|Overall Study||68
71818|NCT01478048|170720|P1|NOT COMPLETED|Overall Study||63
71819|NCT01478048|170719|P2|COMPLETED|Overall Study|completed=treatment on-going|7
71820|NCT01478048|170720|P1|COMPLETED|Overall Study|completed=treatment on-going|14
71821|NCT01478048|170719|P2|Received Treatment|Overall Study||75
71822|NCT01478048|170720|P1|Received Treatment|Overall Study||75
71823|NCT01478048|170719|P2|STARTED|Overall Study||75
71824|NCT01478048|170720|P1|STARTED|Overall Study||77
71825|NCT01478009|170738|P2|NOT COMPLETED|Overall Study||1
71826|NCT01478009|170739|P1|NOT COMPLETED|Overall Study||1
71827|NCT01478009|170738|P2|COMPLETED|Overall Study||49
71828|NCT01478009|170739|P1|COMPLETED|Overall Study||49
71829|NCT01478009|170738|P2|STARTED|Overall Study||50
71830|NCT01478009|170739|P1|STARTED|Overall Study||50
71831|NCT01477892|170749|P2|NOT COMPLETED|Overall Study||2
71832|NCT01477892|170750|P1|NOT COMPLETED|Overall Study||0
71833|NCT01477892|170749|P2|COMPLETED|Overall Study||5
71834|NCT01477892|170750|P1|COMPLETED|Overall Study||7
71835|NCT01477892|170749|P2|STARTED|Overall Study||7
71836|NCT01477892|170750|P1|STARTED|Overall Study||7
71837|NCT01477853|170761|P3|NOT COMPLETED|Phase B||11
71838|NCT01477853|170762|P2|NOT COMPLETED|Phase B||11
71839|NCT01477853|170763|P1|NOT COMPLETED|Phase B||12
71840|NCT01477853|170761|P3|COMPLETED|Phase B||0
71841|NCT01477853|170762|P2|COMPLETED|Phase B||0
71842|NCT01477853|170763|P1|COMPLETED|Phase B||0
71843|NCT01477853|170761|P3|STARTED|Phase B||11
71844|NCT01477853|170762|P2|STARTED|Phase B||11
71845|NCT01477853|170763|P1|STARTED|Phase B||12
71846|NCT01477853|170761|P3|NOT COMPLETED|Phase A||44
71847|NCT01477853|170762|P2|NOT COMPLETED|Phase A||45
71848|NCT01477853|170763|P1|NOT COMPLETED|Phase A||43
71849|NCT01477853|170761|P3|COMPLETED|Phase A||11
71850|NCT01477853|170762|P2|COMPLETED|Phase A||11
71851|NCT01477853|170763|P1|COMPLETED|Phase A||12
71852|NCT01477853|170761|P3|STARTED|Phase A||55
71853|NCT01477853|170762|P2|STARTED|Phase A||56
71854|NCT01477853|170763|P1|STARTED|Phase A||55
71855|NCT01477762|170805|P4|NOT COMPLETED|Overall Study||2
71856|NCT01477762|170806|P3|NOT COMPLETED|Overall Study||4
71857|NCT01477762|170807|P2|NOT COMPLETED|Overall Study||13
71858|NCT01477762|170808|P1|NOT COMPLETED|Overall Study||9
71859|NCT01477762|170805|P4|COMPLETED|Overall Study||11
71860|NCT01477762|170806|P3|COMPLETED|Overall Study||16
71861|NCT01477762|170807|P2|COMPLETED|Overall Study||20
71862|NCT01477762|170808|P1|COMPLETED|Overall Study||16
71863|NCT01477762|170805|P4|STARTED|Overall Study||13
71864|NCT01477762|170806|P3|STARTED|Overall Study||20
71865|NCT01477762|170807|P2|STARTED|Overall Study||33
71866|NCT01477762|170808|P1|STARTED|Overall Study||25
71867|NCT01477749|170830|P1|NOT COMPLETED|Overall Study||4
71868|NCT01477749|170830|P1|COMPLETED|Overall Study||43
71869|NCT01477749|170830|P1|STARTED|Overall Study||47
71870|NCT01477710|170837|P1|NOT COMPLETED|Overall Study||0
71871|NCT01477710|170837|P1|COMPLETED|Overall Study||30
71872|NCT01477710|170837|P1|STARTED|Overall Study||30
71873|NCT01477567|170852|P7|NOT COMPLETED|Overall Study||0
71874|NCT01477567|170853|P6|NOT COMPLETED|Overall Study||0
71875|NCT01477567|170854|P5|NOT COMPLETED|Overall Study||0
71876|NCT01477567|170855|P4|NOT COMPLETED|Overall Study||0
71877|NCT01477567|170856|P3|NOT COMPLETED|Overall Study||0
71878|NCT01477567|170857|P2|NOT COMPLETED|Overall Study||0
71879|NCT01477567|170858|P1|NOT COMPLETED|Overall Study||0
71880|NCT01477567|170852|P7|COMPLETED|Overall Study||6
71881|NCT01477567|170853|P6|COMPLETED|Overall Study||5
71882|NCT01477567|170854|P5|COMPLETED|Overall Study||6
71883|NCT01477567|170855|P4|COMPLETED|Overall Study||6
71884|NCT01477567|170856|P3|COMPLETED|Overall Study||6
71885|NCT01477567|170857|P2|COMPLETED|Overall Study||6
71886|NCT01477567|170858|P1|COMPLETED|Overall Study||5
71887|NCT01477567|170852|P7|Received at Least 1 Dose of Study Drug|Overall Study||6
71888|NCT01477567|170853|P6|Received at Least 1 Dose of Study Drug|Overall Study||5
71889|NCT01477567|170854|P5|Received at Least 1 Dose of Study Drug|Overall Study||6
71890|NCT01477567|170855|P4|Received at Least 1 Dose of Study Drug|Overall Study||6
71891|NCT01477567|170856|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
71892|NCT01477567|170857|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
71893|NCT01477567|170858|P1|Received at Least 1 Dose of Study Drug|Overall Study||5
71894|NCT01477567|170852|P7|STARTED|Overall Study||6
71895|NCT01477567|170853|P6|STARTED|Overall Study||5
71896|NCT01477567|170854|P5|STARTED|Overall Study||6
71897|NCT01477567|170855|P4|STARTED|Overall Study||6
71898|NCT01477567|170856|P3|STARTED|Overall Study||6
71899|NCT01477567|170857|P2|STARTED|Overall Study||6
71900|NCT01477567|170858|P1|STARTED|Overall Study||5
71901|NCT01477463|170914|P2|NOT COMPLETED|Overall Study||0
71902|NCT01477463|170915|P1|NOT COMPLETED|Overall Study||0
71903|NCT01477463|170914|P2|COMPLETED|Overall Study||6
71904|NCT01477463|170915|P1|COMPLETED|Overall Study||18
71905|NCT01477463|170914|P2|STARTED|Overall Study||6
71906|NCT01477463|170915|P1|STARTED|Overall Study||18
71907|NCT01477450|170928|P3|NOT COMPLETED|Overall Study||0
71908|NCT01477450|170929|P2|NOT COMPLETED|Overall Study||0
71909|NCT01477450|170930|P1|NOT COMPLETED|Overall Study||0
71910|NCT01477450|170928|P3|COMPLETED|Overall Study||10
71911|NCT01477450|170929|P2|COMPLETED|Overall Study||10
71912|NCT01477450|170930|P1|COMPLETED|Overall Study||10
71913|NCT01477450|170928|P3|STARTED|Overall Study||10
71914|NCT01477450|170929|P2|STARTED|Overall Study||10
71915|NCT01477450|170930|P1|STARTED|Overall Study||10
71916|NCT01477333|170938|P1|NOT COMPLETED|Overall Study||3
71917|NCT01477333|170938|P1|COMPLETED|Overall Study||15
71918|NCT01477333|170938|P1|STARTED|Overall Study||18
71919|NCT01475734|170956|P2|NOT COMPLETED|Overall Study||1
71920|NCT01475734|170957|P1|NOT COMPLETED|Overall Study||2
71921|NCT01475734|170956|P2|COMPLETED|Overall Study||21
71922|NCT01475734|170957|P1|COMPLETED|Overall Study||20
71923|NCT01475734|170956|P2|STARTED|Overall Study||22
71924|NCT01475734|170957|P1|STARTED|Overall Study||22
71925|NCT01475721|170985|P2|NOT COMPLETED|Overall Study||14
71926|NCT01475721|170986|P1|NOT COMPLETED|Overall Study||11
71927|NCT01475721|170985|P2|COMPLETED|Overall Study||5831
71928|NCT01475721|170986|P1|COMPLETED|Overall Study||5823
71929|NCT01475721|170985|P2|STARTED|Overall Study||5845
71930|NCT01475721|170986|P1|STARTED|Overall Study||5834
71931|NCT01476748|171003|P3|NOT COMPLETED|Overall Study||0
71932|NCT01476748|171004|P2|NOT COMPLETED|Overall Study||0
71933|NCT01476748|171005|P1|NOT COMPLETED|Overall Study||0
71934|NCT01476748|171003|P3|COMPLETED|Overall Study||5
71935|NCT01476748|171004|P2|COMPLETED|Overall Study||5
71936|NCT01476748|171005|P1|COMPLETED|Overall Study||5
71937|NCT01476748|171003|P3|STARTED|Overall Study||5
71938|NCT01476748|171004|P2|STARTED|Overall Study||5
71939|NCT01476748|171005|P1|STARTED|Overall Study||5
71940|NCT01476722|171016|P1|NOT COMPLETED|Overall Study||1
71941|NCT01476722|171016|P1|COMPLETED|Overall Study||124
71942|NCT01476722|171016|P1|STARTED|Overall Study||125
71943|NCT01476696|171023|P3|NOT COMPLETED|Overall Study||0
71944|NCT01476696|171024|P2|NOT COMPLETED|Overall Study||1
71945|NCT01476696|171025|P1|NOT COMPLETED|Overall Study||3
71946|NCT01476696|171023|P3|COMPLETED|Overall Study||9
71947|NCT01476696|171024|P2|COMPLETED|Overall Study||8
71948|NCT01476696|171025|P1|COMPLETED|Overall Study||12
71949|NCT01476696|171023|P3|Received at Least 1 Dose of Study Drug|Overall Study||9
71950|NCT01476696|171024|P2|Received at Least 1 Dose of Study Drug|Overall Study||9
71951|NCT01476696|171025|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
71952|NCT01476696|171023|P3|STARTED|Overall Study||9
71953|NCT01476696|171024|P2|STARTED|Overall Study||9
71954|NCT01476696|171025|P1|STARTED|Overall Study||15
71955|NCT01476475|171041|P2|NOT COMPLETED|Overall Study||3
71956|NCT01476475|171042|P1|NOT COMPLETED|Overall Study||11
71957|NCT01476475|171041|P2|COMPLETED|Overall Study||159
71958|NCT01476475|171042|P1|COMPLETED|Overall Study||150
71959|NCT01476475|171041|P2|STARTED|Overall Study||162
71960|NCT01476475|171042|P1|STARTED|Overall Study||161
71961|NCT01476345|171074|P2|NOT COMPLETED|Period 4||0
71962|NCT01476345|171075|P1|NOT COMPLETED|Period 4||0
71963|NCT01476345|171074|P2|COMPLETED|Period 4||39
71964|NCT01476345|171075|P1|COMPLETED|Period 4||39
71965|NCT01476345|171074|P2|STARTED|Period 4||39
71966|NCT01476345|171075|P1|STARTED|Period 4||39
71967|NCT01476345|171074|P2|NOT COMPLETED|Period 3||0
71968|NCT01476345|171075|P1|NOT COMPLETED|Period 3||0
71969|NCT01476345|171074|P2|COMPLETED|Period 3||39
71970|NCT01476345|171075|P1|COMPLETED|Period 3||39
71971|NCT01476345|171074|P2|STARTED|Period 3||39
71972|NCT01476345|171075|P1|STARTED|Period 3||39
71973|NCT01476345|171074|P2|NOT COMPLETED|Period 2||0
71974|NCT01476345|171075|P1|NOT COMPLETED|Period 2||0
71975|NCT01476345|171074|P2|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
71976|NCT01476345|171075|P1|COMPLETED|Period 2|1 did not enter Period 3 due to participant's decision.|40
71977|NCT01476345|171074|P2|STARTED|Period 2||40
71978|NCT01476345|171075|P1|STARTED|Period 2||40
71979|NCT01476345|171074|P2|NOT COMPLETED|Period 1||0
71980|NCT01476345|171075|P1|NOT COMPLETED|Period 1||0
71981|NCT01476345|171074|P2|COMPLETED|Period 1||40
71982|NCT01476345|171075|P1|COMPLETED|Period 1||40
71983|NCT01476345|171074|P2|Received at Least 1 Dose of Study Drug|Period 1||40
71984|NCT01476345|171075|P1|Received at Least 1 Dose of Study Drug|Period 1||40
71985|NCT01476345|171074|P2|STARTED|Period 1||40
71986|NCT01476345|171075|P1|STARTED|Period 1||40
71987|NCT01476202|171090|P3|NOT COMPLETED|Overall Study||0
71988|NCT01476202|171091|P2|NOT COMPLETED|Overall Study||0
71989|NCT01476202|171092|P1|NOT COMPLETED|Overall Study||0
71990|NCT01476202|171090|P3|COMPLETED|Overall Study||40
71991|NCT01476202|171091|P2|COMPLETED|Overall Study||40
71992|NCT01476202|171092|P1|COMPLETED|Overall Study||40
71993|NCT01476202|171090|P3|STARTED|Overall Study||40
71994|NCT01476202|171091|P2|STARTED|Overall Study||40
71995|NCT01476202|171092|P1|STARTED|Overall Study||40
71996|NCT01475955|171108|P5|NOT COMPLETED|Overall Study||0
71997|NCT01475955|171109|P4|NOT COMPLETED|Overall Study||0
71998|NCT01475955|171110|P3|NOT COMPLETED|Overall Study||3
71999|NCT01475955|171111|P2|NOT COMPLETED|Overall Study||0
72000|NCT01475955|171112|P1|NOT COMPLETED|Overall Study||1
72001|NCT01475955|171108|P5|COMPLETED|Overall Study||46
72002|NCT01475955|171109|P4|COMPLETED|Overall Study||46
72003|NCT01475955|171110|P3|COMPLETED|Overall Study||44
72004|NCT01475955|171111|P2|COMPLETED|Overall Study||48
72005|NCT01475955|171112|P1|COMPLETED|Overall Study||47
72006|NCT01475955|171108|P5|STARTED|Overall Study||46
72007|NCT01475955|171109|P4|STARTED|Overall Study||46
72008|NCT01475955|171110|P3|STARTED|Overall Study||47
72009|NCT01475955|171111|P2|STARTED|Overall Study||48
72010|NCT01475955|171112|P1|STARTED|Overall Study||48
72011|NCT01475851|171471|P2|NOT COMPLETED|Overall Study||0
72012|NCT01475851|171472|P1|NOT COMPLETED|Overall Study||1
72013|NCT01475851|171471|P2|COMPLETED|Overall Study||21
72014|NCT01475851|171472|P1|COMPLETED|Overall Study||12
72015|NCT01475851|171471|P2|STARTED|Overall Study||21
72016|NCT01475851|171472|P1|STARTED|Overall Study||13
72017|NCT01475838|171500|P2|NOT COMPLETED|Extension Phase||0
72018|NCT01475838|171501|P1|NOT COMPLETED|Extension Phase||1
72019|NCT01475838|171500|P2|COMPLETED|Extension Phase||20
72020|NCT01475838|171501|P1|COMPLETED|Extension Phase||41
72021|NCT01475838|171500|P2|STARTED|Extension Phase||20
72022|NCT01475838|171501|P1|STARTED|Extension Phase||42
72023|NCT01475838|171500|P2|NOT COMPLETED|Randomized Phase||36
72024|NCT01475838|171501|P1|NOT COMPLETED|Randomized Phase||30
72025|NCT01475838|171500|P2|COMPLETED|Randomized Phase||109
72026|NCT01475838|171501|P1|COMPLETED|Randomized Phase||263
72027|NCT01475838|171500|P2|STARTED|Randomized Phase||145
72028|NCT01475838|171501|P1|STARTED|Randomized Phase||293
72029|NCT01475487|171516|P2|NOT COMPLETED|Overall Study||1
72030|NCT01475487|171517|P1|NOT COMPLETED|Overall Study||2
72031|NCT01475487|171516|P2|COMPLETED|Overall Study||24
72032|NCT01475487|171517|P1|COMPLETED|Overall Study||23
72033|NCT01475487|171516|P2|STARTED|Overall Study||25
72034|NCT01475487|171517|P1|STARTED|Overall Study||25
72035|NCT01475474|171529|P1|NOT COMPLETED|Return to Baseline Period - 4 Weeks||2
72036|NCT01475474|171529|P1|COMPLETED|Return to Baseline Period - 4 Weeks||71
72037|NCT01475474|171529|P1|STARTED|Return to Baseline Period - 4 Weeks||73
72038|NCT01475474|171529|P1|NOT COMPLETED|Treatment Period - 12 Weeks||18
72039|NCT01475474|171529|P1|COMPLETED|Treatment Period - 12 Weeks||73
72040|NCT01475474|171529|P1|STARTED|Treatment Period - 12 Weeks||91
72041|NCT01475474|171529|P1|NOT COMPLETED|Baseline Period - 4 Weeks||6
72042|NCT01475474|171529|P1|COMPLETED|Baseline Period - 4 Weeks||91
72043|NCT01475474|171529|P1|STARTED|Baseline Period - 4 Weeks||97
72044|NCT01475461|171540|P7|NOT COMPLETED|Treatment Period||2
72045|NCT01475461|171541|P6|NOT COMPLETED|Treatment Period||5
72046|NCT01475461|171542|P5|NOT COMPLETED|Treatment Period||4
72047|NCT01475461|171543|P4|NOT COMPLETED|Treatment Period||8
72048|NCT01475461|171544|P3|NOT COMPLETED|Treatment Period||4
72049|NCT01475461|171545|P2|NOT COMPLETED|Treatment Period||9
72050|NCT01475461|171546|P1|NOT COMPLETED|Treatment Period||0
72051|NCT01475461|171540|P7|COMPLETED|Treatment Period||53
72052|NCT01475461|171541|P6|COMPLETED|Treatment Period||51
72053|NCT01475461|171542|P5|COMPLETED|Treatment Period||52
72054|NCT01475461|171543|P4|COMPLETED|Treatment Period||46
72055|NCT01475461|171544|P3|COMPLETED|Treatment Period||53
72056|NCT01475461|171545|P2|COMPLETED|Treatment Period||48
72057|NCT01475461|171546|P1|COMPLETED|Treatment Period||0
72058|NCT01475461|171540|P7|STARTED|Treatment Period||55
72059|NCT01475461|171541|P6|STARTED|Treatment Period||56
72060|NCT01475461|171542|P5|STARTED|Treatment Period||56
72061|NCT01475461|171543|P4|STARTED|Treatment Period||54
72062|NCT01475461|171544|P3|STARTED|Treatment Period||57
72063|NCT01475461|171545|P2|STARTED|Treatment Period||57
72064|NCT01475461|171546|P1|STARTED|Treatment Period||0
72065|NCT01475461|171540|P7|NOT COMPLETED|Run-in Period||0
72066|NCT01475461|171541|P6|NOT COMPLETED|Run-in Period||0
72067|NCT01475461|171542|P5|NOT COMPLETED|Run-in Period||0
72068|NCT01475461|171543|P4|NOT COMPLETED|Run-in Period||0
72069|NCT01475461|171544|P3|NOT COMPLETED|Run-in Period||0
72070|NCT01475461|171545|P2|NOT COMPLETED|Run-in Period||0
72071|NCT01475461|171546|P1|NOT COMPLETED|Run-in Period||41
72072|NCT01475461|171540|P7|COMPLETED|Run-in Period||0
72073|NCT01475461|171541|P6|COMPLETED|Run-in Period||0
72074|NCT01475461|171542|P5|COMPLETED|Run-in Period||0
72075|NCT01475461|171543|P4|COMPLETED|Run-in Period||0
72076|NCT01475461|171544|P3|COMPLETED|Run-in Period||0
72077|NCT01475461|171545|P2|COMPLETED|Run-in Period||0
72078|NCT01475461|171546|P1|COMPLETED|Run-in Period||335
72079|NCT01475461|171540|P7|STARTED|Run-in Period||0
72080|NCT01475461|171541|P6|STARTED|Run-in Period||0
72081|NCT01475461|171542|P5|STARTED|Run-in Period||0
72082|NCT01475461|171543|P4|STARTED|Run-in Period||0
72083|NCT01475461|171544|P3|STARTED|Run-in Period||0
72084|NCT01475461|171545|P2|STARTED|Run-in Period||0
72085|NCT01475461|171546|P1|STARTED|Run-in Period||376
72086|NCT01475305|171626|P2|NOT COMPLETED|Overall Study||0
72087|NCT01475305|171627|P1|NOT COMPLETED|Overall Study||0
72088|NCT01475305|171626|P2|COMPLETED|Overall Study||3
72089|NCT01475305|171627|P1|COMPLETED|Overall Study||4
72090|NCT01475305|171626|P2|End of Quarantine, Day 15|Overall Study||3
72091|NCT01475305|171627|P1|End of Quarantine, Day 15|Overall Study||4
72092|NCT01475305|171626|P2|STARTED|Overall Study||3
72093|NCT01475305|171627|P1|STARTED|Overall Study||4
72094|NCT01475253|171670|P4|NOT COMPLETED|Open Label Extension||0
72095|NCT01475253|171671|P3|NOT COMPLETED|Open Label Extension||0
72096|NCT01475253|171672|P2|NOT COMPLETED|Open Label Extension||0
72097|NCT01475253|171673|P1|NOT COMPLETED|Open Label Extension||0
72098|NCT01475253|171670|P4|COMPLETED|Open Label Extension||56
72099|NCT01475253|171671|P3|COMPLETED|Open Label Extension||0
72100|NCT01475253|171672|P2|COMPLETED|Open Label Extension||0
72101|NCT01475253|171673|P1|COMPLETED|Open Label Extension||0
72102|NCT01475253|171670|P4|STARTED|Open Label Extension||56
72103|NCT01475253|171671|P3|STARTED|Open Label Extension||0
72104|NCT01475253|171672|P2|STARTED|Open Label Extension||0
72105|NCT01475253|171673|P1|STARTED|Open Label Extension||0
72106|NCT01475253|171670|P4|NOT COMPLETED|Randomized, Blinded Study||0
72107|NCT01475253|171671|P3|NOT COMPLETED|Randomized, Blinded Study||0
72108|NCT01475253|171672|P2|NOT COMPLETED|Randomized, Blinded Study||1
72109|NCT01475253|171673|P1|NOT COMPLETED|Randomized, Blinded Study||2
72110|NCT01475253|171670|P4|COMPLETED|Randomized, Blinded Study||0
72111|NCT01475253|171671|P3|COMPLETED|Randomized, Blinded Study||11
72112|NCT01475253|171672|P2|COMPLETED|Randomized, Blinded Study||45
72113|NCT01475253|171673|P1|COMPLETED|Randomized, Blinded Study||45
72114|NCT01475253|171670|P4|STARTED|Randomized, Blinded Study||0
72115|NCT01475253|171671|P3|STARTED|Randomized, Blinded Study||11
72116|NCT01475253|171672|P2|STARTED|Randomized, Blinded Study||46
72117|NCT01475253|171673|P1|STARTED|Randomized, Blinded Study||47
72118|NCT01475214|171702|P3|NOT COMPLETED|Overall Study||2
72119|NCT01475214|171703|P2|NOT COMPLETED|Overall Study||4
72120|NCT01475214|171704|P1|NOT COMPLETED|Overall Study||5
72121|NCT01475214|171702|P3|COMPLETED|Overall Study||79
72122|NCT01475214|171703|P2|COMPLETED|Overall Study||75
72123|NCT01475214|171704|P1|COMPLETED|Overall Study||79
72124|NCT01475214|171702|P3|STARTED|Overall Study||81
72125|NCT01475214|171703|P2|STARTED|Overall Study||79
72126|NCT01475214|171704|P1|STARTED|Overall Study||84
72127|NCT01475175|171715|P1|NOT COMPLETED|Overall Study||0
72128|NCT01475175|171715|P1|COMPLETED|Overall Study||12
72129|NCT01475175|171715|P1|STARTED|Overall Study||12
72130|NCT01475097|171729|P2|NOT COMPLETED|Overall Study||1
72131|NCT01475097|171730|P1|NOT COMPLETED|Overall Study||1
72132|NCT01475097|171729|P2|COMPLETED|Overall Study||126
72133|NCT01475097|171730|P1|COMPLETED|Overall Study||127
72134|NCT01475097|171729|P2|STARTED|Overall Study||127
72135|NCT01475097|171730|P1|STARTED|Overall Study||128
72136|NCT01475071|171738|P1|NOT COMPLETED|Overall Study||8
72137|NCT01475071|171738|P1|COMPLETED|Overall Study||92
72138|NCT01475071|171738|P1|STARTED|Overall Study||100
72139|NCT01474993|171748|P2|NOT COMPLETED|Overall Study||3
72140|NCT01474993|171749|P1|NOT COMPLETED|Overall Study||1
72141|NCT01474993|171748|P2|COMPLETED|Overall Study||26
72142|NCT01474993|171749|P1|COMPLETED|Overall Study||14
72143|NCT01474993|171748|P2|STARTED|Overall Study||29
72144|NCT01474993|171749|P1|STARTED|Overall Study||15
72145|NCT01474915|171775|P2|NOT COMPLETED|Overall Study||10
72146|NCT01474915|171776|P1|NOT COMPLETED|Overall Study||10
72147|NCT01474915|171775|P2|COMPLETED|Overall Study||51
72148|NCT01474915|171776|P1|COMPLETED|Overall Study||50
72149|NCT01474915|171775|P2|STARTED|Overall Study||61
72150|NCT01474915|171776|P1|STARTED|Overall Study||60
72151|NCT01474876|171787|P3|NOT COMPLETED|Overall Study||0
72152|NCT01474876|171788|P2|NOT COMPLETED|Overall Study||23
72153|NCT01474876|171789|P1|NOT COMPLETED|Overall Study||66
72154|NCT01474876|171787|P3|COMPLETED|Overall Study||1
72155|NCT01474876|171788|P2|COMPLETED|Overall Study||128
72156|NCT01474876|171789|P1|COMPLETED|Overall Study||337
72157|NCT01474876|171787|P3|STARTED|Overall Study||1
72158|NCT01474876|171788|P2|STARTED|Overall Study||151
72159|NCT01474876|171789|P1|STARTED|Overall Study||403
72160|NCT01474863|171823|P3|NOT COMPLETED|Overall Study||0
72161|NCT01474863|171824|P2|NOT COMPLETED|Overall Study||0
72162|NCT01474863|171825|P1|NOT COMPLETED|Overall Study||0
72163|NCT01474863|171823|P3|COMPLETED|Overall Study||24
72164|NCT01474863|171824|P2|COMPLETED|Overall Study||22
72165|NCT01474863|171825|P1|COMPLETED|Overall Study||26
72166|NCT01474863|171823|P3|STARTED|Overall Study||24
72167|NCT01474863|171824|P2|STARTED|Overall Study||22
72168|NCT01474863|171825|P1|STARTED|Overall Study||26
72169|NCT01474772|171835|P2|NOT COMPLETED|Follow-up||1
72170|NCT01474772|171836|P1|NOT COMPLETED|Follow-up||0
72171|NCT01474772|171835|P2|COMPLETED|Follow-up||86
72172|NCT01474772|171836|P1|COMPLETED|Follow-up||77
72173|NCT01474772|171835|P2|STARTED|Follow-up||87
72174|NCT01474772|171836|P1|STARTED|Follow-up||77
72175|NCT01474772|171835|P2|NOT COMPLETED|Period 2||10
72176|NCT01474772|171836|P1|NOT COMPLETED|Period 2||9
72177|NCT01474772|171835|P2|COMPLETED|Period 2||87
72178|NCT01474772|171836|P1|COMPLETED|Period 2||77
72179|NCT01474772|171835|P2|STARTED|Period 2||97
72180|NCT01474772|171836|P1|STARTED|Period 2||86
72181|NCT01474772|171835|P2|NOT COMPLETED|Washout||2
72182|NCT01474772|171836|P1|NOT COMPLETED|Washout||3
72183|NCT01474772|171835|P2|COMPLETED|Washout||97
72184|NCT01474772|171836|P1|COMPLETED|Washout||86
72185|NCT01474772|171835|P2|STARTED|Washout||99
72186|NCT01474772|171836|P1|STARTED|Washout||89
72187|NCT01474772|171835|P2|NOT COMPLETED|Period 1||3
72188|NCT01474772|171836|P1|NOT COMPLETED|Period 1||12
72189|NCT01474772|171835|P2|COMPLETED|Period 1||99
72190|NCT01474772|171836|P1|COMPLETED|Period 1||89
72191|NCT01474772|171835|P2|STARTED|Period 1|STARTED=treated|102
72192|NCT01474772|171836|P1|STARTED|Period 1|STARTED=treated. In Period 1 a participant discontinued due to an AE and later died due to the AE.|101
72193|NCT01474681|171886|P4|NOT COMPLETED|Overall Study||6
72194|NCT01474681|171887|P3|NOT COMPLETED|Overall Study||2
72195|NCT01474681|171888|P2|NOT COMPLETED|Overall Study||3
72196|NCT01474681|171889|P1|NOT COMPLETED|Overall Study||0
72197|NCT01474681|171886|P4|COMPLETED|Overall Study||9
72198|NCT01474681|171887|P3|COMPLETED|Overall Study||1
72199|NCT01474681|171888|P2|COMPLETED|Overall Study||5
72200|NCT01474681|171889|P1|COMPLETED|Overall Study||1
72201|NCT01474681|171886|P4|STARTED|Overall Study||15
72202|NCT01474681|171887|P3|STARTED|Overall Study||3
72203|NCT01474681|171888|P2|STARTED|Overall Study||8
72204|NCT01474681|171889|P1|STARTED|Overall Study||1
72205|NCT01474590|171933|P2|NOT COMPLETED|Overall Study||17
72206|NCT01474590|171934|P1|NOT COMPLETED|Overall Study||28
72207|NCT01474590|171933|P2|COMPLETED|Overall Study||116
72208|NCT01474590|171934|P1|COMPLETED|Overall Study||105
72209|NCT01474590|171933|P2|STARTED|Overall Study||133
72210|NCT01474590|171934|P1|STARTED|Overall Study||133
72211|NCT01474551|171940|P1|NOT COMPLETED|Overall Study||1
72212|NCT01474551|171940|P1|COMPLETED|Overall Study||1
72213|NCT01474551|171940|P1|STARTED|Overall Study||2
72214|NCT01474538|171946|P2|NOT COMPLETED|Treatment Period 2||2
72215|NCT01474538|171947|P1|NOT COMPLETED|Treatment Period 2||6
72216|NCT01474538|171946|P2|COMPLETED|Treatment Period 2||56
72217|NCT01474538|171947|P1|COMPLETED|Treatment Period 2||51
72218|NCT01474538|171946|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||58
72219|NCT01474538|171947|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||57
72220|NCT01474538|171946|P2|STARTED|Treatment Period 2||58
72221|NCT01474538|171947|P1|STARTED|Treatment Period 2||57
72222|NCT01474538|171946|P2|NOT COMPLETED|Treatment Period 1||4
72223|NCT01474538|171947|P1|NOT COMPLETED|Treatment Period 1||3
72224|NCT01474538|171946|P2|COMPLETED|Treatment Period 1||58
72225|NCT01474538|171947|P1|COMPLETED|Treatment Period 1||57
72226|NCT01474538|171946|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||62
72227|NCT01474538|171947|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||60
72228|NCT01474538|171946|P2|STARTED|Treatment Period 1||62
72229|NCT01474538|171947|P1|STARTED|Treatment Period 1||60
72230|NCT01474512|171964|P10|NOT COMPLETED|Maintenance Period||18
72231|NCT01474512|171965|P9|NOT COMPLETED|Maintenance Period||16
72232|NCT01474512|171966|P8|NOT COMPLETED|Maintenance Period||41
72233|NCT01474512|171967|P7|NOT COMPLETED|Maintenance Period||10
72234|NCT01474512|171968|P6|NOT COMPLETED|Maintenance Period||52
72235|NCT01474512|171969|P5|NOT COMPLETED|Maintenance Period||119
72236|NCT01474512|171970|P4|NOT COMPLETED|Maintenance Period||202
72237|NCT01474512|171971|P3|NOT COMPLETED|Maintenance Period||0
72238|NCT01474512|171972|P2|NOT COMPLETED|Maintenance Period||0
72239|NCT01474512|171973|P1|NOT COMPLETED|Maintenance Period||0
72240|NCT01474512|171964|P10|COMPLETED|Maintenance Period||44
72241|NCT01474512|171965|P9|COMPLETED|Maintenance Period||62
72242|NCT01474512|171966|P8|COMPLETED|Maintenance Period||350
72243|NCT01474512|171967|P7|COMPLETED|Maintenance Period||6
72244|NCT01474512|171968|P6|COMPLETED|Maintenance Period||177
72245|NCT01474512|171969|P5|COMPLETED|Maintenance Period||108
72246|NCT01474512|171970|P4|COMPLETED|Maintenance Period||24
72247|NCT01474512|171971|P3|COMPLETED|Maintenance Period||0
72248|NCT01474512|171972|P2|COMPLETED|Maintenance Period||0
72249|NCT01474512|171973|P1|COMPLETED|Maintenance Period||0
72250|NCT01474512|171964|P10|Received Study Drug|Maintenance Period||62
72251|NCT01474512|171965|P9|Received Study Drug|Maintenance Period||78
72252|NCT01474512|171966|P8|Received Study Drug|Maintenance Period||391
72253|NCT01474512|171967|P7|Received Study Drug|Maintenance Period||16
72254|NCT01474512|171968|P6|Received Study Drug|Maintenance Period||229
72255|NCT01474512|171969|P5|Received Study Drug|Maintenance Period||227
72256|NCT01474512|171970|P4|Received Study Drug|Maintenance Period||226
72257|NCT01474512|171971|P3|Received Study Drug|Maintenance Period||0
72258|NCT01474512|171972|P2|Received Study Drug|Maintenance Period||0
72259|NCT01474512|171973|P1|Received Study Drug|Maintenance Period||0
72260|NCT01474512|171964|P10|STARTED|Maintenance Period||62
72261|NCT01474512|171965|P9|STARTED|Maintenance Period||78
72262|NCT01474512|171966|P8|STARTED|Maintenance Period||391
72263|NCT01474512|171967|P7|STARTED|Maintenance Period||16
72264|NCT01474512|171968|P6|STARTED|Maintenance Period||229
72265|NCT01474512|171969|P5|STARTED|Maintenance Period|One participant withdrew end of Induction but re-randomized and treated with maintenance dose ixe.|227
72266|NCT01474512|171970|P4|STARTED|Maintenance Period||226
72267|NCT01474512|171971|P3|STARTED|Maintenance Period||0
72268|NCT01474512|171972|P2|STARTED|Maintenance Period||0
72269|NCT01474512|171973|P1|STARTED|Maintenance Period||0
72270|NCT01474512|171964|P10|NOT COMPLETED|Induction Period||0
72271|NCT01474512|171965|P9|NOT COMPLETED|Induction Period||0
72272|NCT01474512|171966|P8|NOT COMPLETED|Induction Period||0
72273|NCT01474512|171967|P7|NOT COMPLETED|Induction Period||0
72274|NCT01474512|171968|P6|NOT COMPLETED|Induction Period||0
72275|NCT01474512|171969|P5|NOT COMPLETED|Induction Period||0
72276|NCT01474512|171970|P4|NOT COMPLETED|Induction Period||0
72277|NCT01474512|171971|P3|NOT COMPLETED|Induction Period||18
72278|NCT01474512|171972|P2|NOT COMPLETED|Induction Period||24
72279|NCT01474512|171973|P1|NOT COMPLETED|Induction Period||24
72280|NCT01474512|171964|P10|COMPLETED|Induction Period||0
72281|NCT01474512|171965|P9|COMPLETED|Induction Period||0
72282|NCT01474512|171966|P8|COMPLETED|Induction Period||0
72283|NCT01474512|171967|P7|COMPLETED|Induction Period||0
72284|NCT01474512|171968|P6|COMPLETED|Induction Period||0
72285|NCT01474512|171969|P5|COMPLETED|Induction Period||0
72286|NCT01474512|171970|P4|COMPLETED|Induction Period||0
72287|NCT01474512|171971|P3|COMPLETED|Induction Period||415
72288|NCT01474512|171972|P2|COMPLETED|Induction Period||408
72289|NCT01474512|171973|P1|COMPLETED|Induction Period||407
72290|NCT01474512|171964|P10|Received Study Drug|Induction Period||0
72291|NCT01474512|171965|P9|Received Study Drug|Induction Period||0
72292|NCT01474512|171966|P8|Received Study Drug|Induction Period||0
72293|NCT01474512|171967|P7|Received Study Drug|Induction Period||0
72294|NCT01474512|171968|P6|Received Study Drug|Induction Period||0
72295|NCT01474512|171969|P5|Received Study Drug|Induction Period||0
72296|NCT01474512|171970|P4|Received Study Drug|Induction Period||0
72297|NCT01474512|171971|P3|Received Study Drug|Induction Period||433
72298|NCT01474512|171972|P2|Received Study Drug|Induction Period||432
72299|NCT01474512|171973|P1|Received Study Drug|Induction Period||431
72300|NCT01474512|171964|P10|STARTED|Induction Period||0
72301|NCT01474512|171965|P9|STARTED|Induction Period||0
72302|NCT01474512|171966|P8|STARTED|Induction Period||0
72303|NCT01474512|171967|P7|STARTED|Induction Period||0
72304|NCT01474512|171968|P6|STARTED|Induction Period||0
72305|NCT01474512|171969|P5|STARTED|Induction Period||0
72306|NCT01474512|171970|P4|STARTED|Induction Period||0
72307|NCT01474512|171971|P3|STARTED|Induction Period||433
72308|NCT01474512|171972|P2|STARTED|Induction Period||432
72309|NCT01474512|171973|P1|STARTED|Induction Period||431
72310|NCT01474434|172042|P4|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
72311|NCT01474434|172043|P3|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
72312|NCT01474434|172044|P2|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
72313|NCT01474434|172045|P1|NOT COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||0
72314|NCT01474434|172042|P4|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||11
72315|NCT01474434|172043|P3|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||10
72316|NCT01474434|172044|P2|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||9
72317|NCT01474434|172045|P1|COMPLETED|Treatment Period 2(5 Days[Day 36 - 40])||7
72318|NCT01474434|172042|P4|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||11
72319|NCT01474434|172043|P3|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||10
72320|NCT01474434|172044|P2|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||9
72321|NCT01474434|172045|P1|STARTED|Treatment Period 2(5 Days[Day 36 - 40])||7
72322|NCT01474434|172042|P4|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||2
72323|NCT01474434|172043|P3|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
72324|NCT01474434|172044|P2|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||0
72325|NCT01474434|172045|P1|NOT COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||1
72326|NCT01474434|172042|P4|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||11
72327|NCT01474434|172043|P3|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||10
72328|NCT01474434|172044|P2|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||9
72329|NCT01474434|172045|P1|COMPLETED|Treatment Period 1 (5 Days [Day 1 - 5])||7
72330|NCT01474434|172042|P4|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||13
72331|NCT01474434|172043|P3|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||11
72332|NCT01474434|172044|P2|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||9
72333|NCT01474434|172045|P1|STARTED|Treatment Period 1 (5 Days [Day 1 - 5])||8
72334|NCT01474317|172087|P1|NOT COMPLETED|Overall Study||2
72335|NCT01474317|172087|P1|COMPLETED|Overall Study||224
72336|NCT01474317|172087|P1|STARTED|Overall Study||226
72337|NCT01474291|172096|P1|NOT COMPLETED|Overall Study||220
72338|NCT01474291|172096|P1|COMPLETED|Overall Study||383
72339|NCT01474291|172096|P1|Evaluable for Efficacy|Overall Study|Received tocilizumab infusion and met all inclusion/exclusion criteria|577
72340|NCT01474291|172096|P1|STARTED|Overall Study||603
72341|NCT01474239|172140|P2|NOT COMPLETED|Overall Study||32
72342|NCT01474239|172141|P1|NOT COMPLETED|Overall Study||59
72343|NCT01474239|172140|P2|COMPLETED|Overall Study||0
72344|NCT01474239|172141|P1|COMPLETED|Overall Study||0
72345|NCT01474239|172140|P2|STARTED|Overall Study||32
72346|NCT01474239|172141|P1|STARTED|Overall Study||59
72347|NCT01474213|172179|P2|NOT COMPLETED|Overall Study||0
72348|NCT01474213|172180|P1|NOT COMPLETED|Overall Study||0
72349|NCT01474213|172179|P2|COMPLETED|Overall Study||20
72350|NCT01474213|172180|P1|COMPLETED|Overall Study||20
72351|NCT01474213|172179|P2|STARTED|Overall Study||20
72352|NCT01474213|172180|P1|STARTED|Overall Study||20
72353|NCT01474200|172204|P2|NOT COMPLETED|Overall Study||30
72354|NCT01474200|172205|P1|NOT COMPLETED|Overall Study||29
72355|NCT01474200|172204|P2|COMPLETED|Overall Study||84
72356|NCT01474200|172205|P1|COMPLETED|Overall Study||81
72357|NCT01474200|172204|P2|STARTED|Overall Study||114
72358|NCT01474200|172205|P1|STARTED|Overall Study||110
72359|NCT01474122|172258|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||15
72360|NCT01474122|172259|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||13
72361|NCT01474122|172260|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||17
72362|NCT01474122|172258|P3|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
72363|NCT01474122|172259|P2|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|73
72364|NCT01474122|172260|P1|COMPLETED|Period 2: Week 16 to End of Study|Patients on treatment at the time of study termination|70
72365|NCT01474122|172258|P3|STARTED|Period 2: Week 16 to End of Study||88
72366|NCT01474122|172259|P2|STARTED|Period 2: Week 16 to End of Study||86
72367|NCT01474122|172260|P1|STARTED|Period 2: Week 16 to End of Study||87
72368|NCT01474122|172258|P3|NOT COMPLETED|Period 1: Baseline to Week 16||1
72369|NCT01474122|172259|P2|NOT COMPLETED|Period 1: Baseline to Week 16||2
72370|NCT01474122|172260|P1|NOT COMPLETED|Period 1: Baseline to Week 16||1
72371|NCT01474122|172258|P3|COMPLETED|Period 1: Baseline to Week 16||88
72372|NCT01474122|172259|P2|COMPLETED|Period 1: Baseline to Week 16||86
72373|NCT01474122|172260|P1|COMPLETED|Period 1: Baseline to Week 16||87
72374|NCT01474122|172258|P3|STARTED|Period 1: Baseline to Week 16||89
72375|NCT01474122|172259|P2|STARTED|Period 1: Baseline to Week 16|One patient was randomised but did not receive study treatment|88
72376|NCT01474122|172260|P1|STARTED|Period 1: Baseline to Week 16||88
72377|NCT01474109|172286|P3|NOT COMPLETED|Period 2: Week 16 to End of Study||12
72378|NCT01474109|172287|P2|NOT COMPLETED|Period 2: Week 16 to End of Study||18
72379|NCT01474109|172288|P1|NOT COMPLETED|Period 2: Week 16 to End of Study||18
72380|NCT01474109|172286|P3|COMPLETED|Period 2: Week 16 to End of Study||83
72381|NCT01474109|172287|P2|COMPLETED|Period 2: Week 16 to End of Study||73
72382|NCT01474109|172288|P1|COMPLETED|Period 2: Week 16 to End of Study||70
72383|NCT01474109|172286|P3|STARTED|Period 2: Week 16 to End of Study||95
72384|NCT01474109|172287|P2|STARTED|Period 2: Week 16 to End of Study||91
72385|NCT01474109|172288|P1|STARTED|Period 2: Week 16 to End of Study||88
72386|NCT01474109|172286|P3|NOT COMPLETED|Period 1: Baseline to Week 16||2
72387|NCT01474109|172287|P2|NOT COMPLETED|Period 1: Baseline to Week 16||6
72388|NCT01474109|172288|P1|NOT COMPLETED|Period 1: Baseline to Week 16||7
72389|NCT01474109|172286|P3|COMPLETED|Period 1: Baseline to Week 16||95
72390|NCT01474109|172287|P2|COMPLETED|Period 1: Baseline to Week 16||91
72391|NCT01474109|172288|P1|COMPLETED|Period 1: Baseline to Week 16||88
72392|NCT01474109|172286|P3|STARTED|Period 1: Baseline to Week 16||97
72393|NCT01474109|172287|P2|STARTED|Period 1: Baseline to Week 16||97
72394|NCT01474109|172288|P1|STARTED|Period 1: Baseline to Week 16||95
72395|NCT01473992|172313|P3|NOT COMPLETED|Overall Study||0
72396|NCT01473992|172314|P2|NOT COMPLETED|Overall Study||0
72397|NCT01473992|172315|P1|NOT COMPLETED|Overall Study||0
72398|NCT01473992|172313|P3|COMPLETED|Overall Study||5
72399|NCT01473992|172314|P2|COMPLETED|Overall Study||10
72400|NCT01473992|172315|P1|COMPLETED|Overall Study||10
72401|NCT01473992|172313|P3|STARTED|Overall Study||5
72402|NCT01473992|172314|P2|STARTED|Overall Study||10
72403|NCT01473992|172315|P1|STARTED|Overall Study||10
72404|NCT01473953|172335|P5|NOT COMPLETED|Overall Study||0
72405|NCT01473953|172336|P4|NOT COMPLETED|Overall Study||0
72406|NCT01473953|172337|P3|NOT COMPLETED|Overall Study||0
72407|NCT01473953|172338|P2|NOT COMPLETED|Overall Study||0
72408|NCT01473953|172339|P1|NOT COMPLETED|Overall Study||1
72409|NCT01473953|172335|P5|COMPLETED|Overall Study||8
72410|NCT01473953|172336|P4|COMPLETED|Overall Study||5
72411|NCT01473953|172337|P3|COMPLETED|Overall Study||6
72412|NCT01473953|172338|P2|COMPLETED|Overall Study||6
72413|NCT01473953|172339|P1|COMPLETED|Overall Study||5
72414|NCT01473953|172335|P5|STARTED|Overall Study||8
72415|NCT01473953|172336|P4|STARTED|Overall Study||5
72416|NCT01473953|172337|P3|STARTED|Overall Study||6
72417|NCT01473953|172338|P2|STARTED|Overall Study||6
72418|NCT01473953|172339|P1|STARTED|Overall Study||6
72419|NCT01473836|172381|P1|NOT COMPLETED|Overall Study||6
72420|NCT01473836|172381|P1|COMPLETED|Overall Study||32
72421|NCT01473836|172381|P1|STARTED|Overall Study||38
72422|NCT01473758|172392|P4|NOT COMPLETED|Cycle 2||0
72423|NCT01473758|172393|P3|NOT COMPLETED|Cycle 2||5
72424|NCT01473758|172394|P2|NOT COMPLETED|Cycle 2||0
72425|NCT01473758|172395|P1|NOT COMPLETED|Cycle 2||0
72426|NCT01473758|172392|P4|COMPLETED|Cycle 2||4
72427|NCT01473758|172393|P3|COMPLETED|Cycle 2||5
72428|NCT01473758|172394|P2|COMPLETED|Cycle 2||0
72429|NCT01473758|172395|P1|COMPLETED|Cycle 2||0
72430|NCT01473758|172392|P4|STARTED|Cycle 2||4
72431|NCT01473758|172393|P3|STARTED|Cycle 2||10
72432|NCT01473758|172394|P2|STARTED|Cycle 2||0
72433|NCT01473758|172395|P1|STARTED|Cycle 2||0
72434|NCT01473758|172392|P4|NOT COMPLETED|Cycle 1||0
72435|NCT01473758|172393|P3|NOT COMPLETED|Cycle 1||0
72436|NCT01473758|172394|P2|NOT COMPLETED|Cycle 1||3
72437|NCT01473758|172395|P1|NOT COMPLETED|Cycle 1||11
72438|NCT01473758|172392|P4|COMPLETED|Cycle 1||0
72439|NCT01473758|172393|P3|COMPLETED|Cycle 1||0
72440|NCT01473758|172394|P2|COMPLETED|Cycle 1||40
72441|NCT01473758|172395|P1|COMPLETED|Cycle 1||27
72442|NCT01473758|172392|P4|STARTED|Cycle 1||0
72443|NCT01473758|172393|P3|STARTED|Cycle 1||0
72444|NCT01473758|172394|P2|STARTED|Cycle 1||43
72445|NCT01473758|172395|P1|STARTED|Cycle 1||38
72446|NCT01473745|172519|P2|NOT COMPLETED|Overall Study||0
72447|NCT01473745|172520|P1|NOT COMPLETED|Overall Study||0
72448|NCT01473745|172519|P2|COMPLETED|Overall Study||24
72449|NCT01473745|172520|P1|COMPLETED|Overall Study||24
72450|NCT01473745|172519|P2|STARTED|Overall Study||24
72451|NCT01473745|172520|P1|STARTED|Overall Study||24
72452|NCT01473602|172532|P2|NOT COMPLETED|Overall Study||8
72453|NCT01473602|172533|P1|NOT COMPLETED|Overall Study||8
72454|NCT01473602|172532|P2|COMPLETED|Overall Study||13
72455|NCT01473602|172533|P1|COMPLETED|Overall Study||10
72456|NCT01473602|172532|P2|Completed 12 Months|Overall Study||13
72457|NCT01473602|172533|P1|Completed 12 Months|Overall Study||10
72458|NCT01473602|172532|P2|Completed 6 Months|Overall Study||15
72459|NCT01473602|172533|P1|Completed 6 Months|Overall Study||12
72460|NCT01473602|172532|P2|Received at Least 1 Dose of Study Drug|Overall Study||20
72461|NCT01473602|172533|P1|Received at Least 1 Dose of Study Drug|Overall Study||18
72462|NCT01473602|172532|P2|STARTED|Overall Study||21
72463|NCT01473602|172533|P1|STARTED|Overall Study||18
72464|NCT01473589|172569|P2|NOT COMPLETED|Overall Study||16
72465|NCT01473589|172570|P1|NOT COMPLETED|Overall Study||11
72466|NCT01473589|172569|P2|COMPLETED|Overall Study||46
72467|NCT01473589|172570|P1|COMPLETED|Overall Study||49
72468|NCT01473589|172569|P2|Completed 12 Months|Overall Study||48
72469|NCT01473589|172570|P1|Completed 12 Months|Overall Study||49
72470|NCT01473589|172569|P2|Completed 6 Months|Overall Study||54
72471|NCT01473589|172570|P1|Completed 6 Months|Overall Study||51
72472|NCT01473589|172569|P2|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|61
72473|NCT01473589|172570|P1|Received at Least 1 Dose of Study Drug|Overall Study|Randomized participants who received at least 1 dose of study drug.|60
72474|NCT01473589|172569|P2|STARTED|Overall Study||62
72475|NCT01473589|172570|P1|STARTED|Overall Study||60
72476|NCT01473563|172604|P1|NOT COMPLETED|Overall Study||1
72477|NCT01473563|172604|P1|COMPLETED|Overall Study||51
72478|NCT01473563|172604|P1|Received at Least 1 Dose of Study Drug|Overall Study||52
72479|NCT01473563|172604|P1|STARTED|Overall Study||52
72480|NCT01473524|172626|P3|NOT COMPLETED|Overall Study||3
72481|NCT01473524|172627|P2|NOT COMPLETED|Overall Study||9
72482|NCT01473524|172628|P1|NOT COMPLETED|Overall Study||7
72483|NCT01473524|172626|P3|COMPLETED|Overall Study||70
72484|NCT01473524|172627|P2|COMPLETED|Overall Study||64
72485|NCT01473524|172628|P1|COMPLETED|Overall Study||64
72486|NCT01473524|172626|P3|STARTED|Overall Study||73
72487|NCT01473524|172627|P2|STARTED|Overall Study||73
72488|NCT01473524|172628|P1|STARTED|Overall Study||71
72489|NCT01473394|172661|P2|NOT COMPLETED|Overall Study||43
72490|NCT01473394|172662|P1|NOT COMPLETED|Overall Study||45
72491|NCT01473394|172661|P2|COMPLETED|Overall Study||212
72492|NCT01473394|172662|P1|COMPLETED|Overall Study||208
72493|NCT01473394|172661|P2|STARTED|Overall Study||255
72494|NCT01473394|172662|P1|STARTED|Overall Study||253
72495|NCT01473381|172676|P4|NOT COMPLETED|Overall Study||89
72496|NCT01473381|172677|P3|NOT COMPLETED|Overall Study||102
72497|NCT01473381|172678|P2|NOT COMPLETED|Overall Study||93
72498|NCT01473381|172679|P1|NOT COMPLETED|Overall Study||80
72499|NCT01473381|172676|P4|COMPLETED|Overall Study||200
72500|NCT01473381|172677|P3|COMPLETED|Overall Study||189
72501|NCT01473381|172678|P2|COMPLETED|Overall Study||199
72502|NCT01473381|172679|P1|COMPLETED|Overall Study||210
72503|NCT01473381|172676|P4|Safety Population|Overall Study||282
72504|NCT01473381|172677|P3|Safety Population|Overall Study||287
72505|NCT01473381|172678|P2|Safety Population|Overall Study||288
72506|NCT01473381|172679|P1|Safety Population|Overall Study||281
72507|NCT01473381|172676|P4|STARTED|Overall Study||289
72508|NCT01473381|172677|P3|STARTED|Overall Study||291
72509|NCT01473381|172678|P2|STARTED|Overall Study||292
72510|NCT01473381|172679|P1|STARTED|Overall Study||290
72511|NCT01473368|172701|P4|NOT COMPLETED|Overall Study||0
72512|NCT01473368|172702|P3|NOT COMPLETED|Overall Study||3
72513|NCT01473368|172703|P2|NOT COMPLETED|Overall Study||0
72514|NCT01473368|172704|P1|NOT COMPLETED|Overall Study||1
72515|NCT01473368|172701|P4|COMPLETED|Overall Study||12
72516|NCT01473368|172702|P3|COMPLETED|Overall Study||12
72517|NCT01473368|172703|P2|COMPLETED|Overall Study||12
72518|NCT01473368|172704|P1|COMPLETED|Overall Study||13
72519|NCT01473368|172701|P4|STARTED|Overall Study||12
72520|NCT01473368|172702|P3|STARTED|Overall Study||15
72521|NCT01473368|172703|P2|STARTED|Overall Study||12
72522|NCT01473368|172704|P1|STARTED|Overall Study||14
72523|NCT01473160|172741|P1|NOT COMPLETED|Overall Study||0
72524|NCT01473160|172741|P1|COMPLETED|Overall Study||9
72525|NCT01473160|172741|P1|STARTED|Overall Study||9
72526|NCT01472939|172763|P4|NOT COMPLETED|Overall Study||20
72527|NCT01472939|172764|P3|NOT COMPLETED|Overall Study||11
72528|NCT01472939|172765|P2|NOT COMPLETED|Overall Study||14
72529|NCT01472939|172766|P1|NOT COMPLETED|Overall Study||20
72530|NCT01472939|172763|P4|COMPLETED|Overall Study||99
72531|NCT01472939|172764|P3|COMPLETED|Overall Study||108
72532|NCT01472939|172765|P2|COMPLETED|Overall Study||105
72533|NCT01472939|172766|P1|COMPLETED|Overall Study||103
72534|NCT01472939|172763|P4|STARTED|Overall Study||119
72535|NCT01472939|172764|P3|STARTED|Overall Study||119
72536|NCT01472939|172765|P2|STARTED|Overall Study||119
72537|NCT01472939|172766|P1|STARTED|Overall Study||123
72538|NCT01472874|172793|P1|NOT COMPLETED|Overall Study||0
72539|NCT01472874|172793|P1|COMPLETED|Overall Study||8
72540|NCT01472874|172793|P1|STARTED|Overall Study||8
72541|NCT01472835|172810|P2|NOT COMPLETED|Overall Study||0
72542|NCT01472835|172811|P1|NOT COMPLETED|Overall Study||2
72543|NCT01472835|172810|P2|COMPLETED|Overall Study||36
72544|NCT01472835|172811|P1|COMPLETED|Overall Study||35
72545|NCT01472835|172810|P2|STARTED|Overall Study||36
72546|NCT01472835|172811|P1|STARTED|Overall Study||37
72547|NCT01472822|172827|P2|NOT COMPLETED|Overall Study||2
72548|NCT01472822|172828|P1|NOT COMPLETED|Overall Study||2
72549|NCT01472822|172827|P2|COMPLETED|Overall Study||28
72550|NCT01472822|172828|P1|COMPLETED|Overall Study||28
72551|NCT01472822|172827|P2|STARTED|Overall Study||30
72552|NCT01472822|172828|P1|STARTED|Overall Study||30
72553|NCT01472562|172842|P1|NOT COMPLETED|Maintenance Phase (Week 49 to PD)||23
72554|NCT01472562|172842|P1|COMPLETED|Maintenance Phase (Week 49 to PD)||4
72555|NCT01472562|172842|P1|STARTED|Maintenance Phase (Week 49 to PD)||27
72556|NCT01472562|172842|P1|NOT COMPLETED|Induction Phase (Week 1- 48)||11
72557|NCT01472562|172842|P1|COMPLETED|Induction Phase (Week 1- 48)||27
72558|NCT01472562|172842|P1|STARTED|Induction Phase (Week 1- 48)||38
72559|NCT01472432|172849|P2|NOT COMPLETED|Overall Study||0
72560|NCT01472432|172850|P1|NOT COMPLETED|Overall Study||0
72561|NCT01472432|172849|P2|COMPLETED|Overall Study||53
72562|NCT01472432|172850|P1|COMPLETED|Overall Study||53
72563|NCT01472432|172849|P2|Ulcer Reduction|Overall Study||33
72564|NCT01472432|172850|P1|Ulcer Reduction|Overall Study||13
72565|NCT01472432|172849|P2|STARTED|Overall Study||53
72566|NCT01472432|172850|P1|STARTED|Overall Study||53
72567|NCT01472380|172866|P1|NOT COMPLETED|Efavirenz and FFA||0
72568|NCT01472380|172866|P1|COMPLETED|Efavirenz and FFA||28
72569|NCT01472380|172866|P1|STARTED|Efavirenz and FFA||28
72570|NCT01472380|172866|P1|NOT COMPLETED|1 Day Period Between Dosing||1
72571|NCT01472380|172866|P1|COMPLETED|1 Day Period Between Dosing||28
72572|NCT01472380|172866|P1|STARTED|1 Day Period Between Dosing||29
72573|NCT01472380|172866|P1|NOT COMPLETED|Fenofibric Acid (FFA) Alone||0
72574|NCT01472380|172866|P1|COMPLETED|Fenofibric Acid (FFA) Alone||29
72575|NCT01472380|172866|P1|STARTED|Fenofibric Acid (FFA) Alone||29
72576|NCT01472380|172866|P1|NOT COMPLETED|Efavirenz Alone||1
72577|NCT01472380|172866|P1|COMPLETED|Efavirenz Alone||29
72578|NCT01472380|172866|P1|STARTED|Efavirenz Alone||30
72579|NCT01472341|172877|P1|NOT COMPLETED|Overall Study||272
72580|NCT01472341|172877|P1|COMPLETED|Overall Study||235
72581|NCT01472341|172877|P1|STARTED|Overall Study||507
72582|NCT01472289|172883|P1|NOT COMPLETED|Overall Study||2
72583|NCT01472289|172883|P1|COMPLETED|Overall Study||15
72584|NCT01472289|172883|P1|STARTED|Overall Study||17
72585|NCT01472185|172895|P2|NOT COMPLETED|Overall Study||34
72586|NCT01472185|172896|P1|NOT COMPLETED|Overall Study||34
72587|NCT01472185|172895|P2|COMPLETED|Overall Study||199
72588|NCT01472185|172896|P1|COMPLETED|Overall Study||198
72589|NCT01472185|172895|P2|STARTED|Overall Study||233
72590|NCT01472185|172896|P1|STARTED|Overall Study||232
72591|NCT01471782|172916|P6|NOT COMPLETED|Overall Study||41
72592|NCT01471782|172917|P5|NOT COMPLETED|Overall Study||26
72593|NCT01471782|172918|P4|NOT COMPLETED|Overall Study||5
72594|NCT01471782|172919|P3|NOT COMPLETED|Overall Study||5
72595|NCT01471782|172920|P2|NOT COMPLETED|Overall Study||6
72596|NCT01471782|172921|P1|NOT COMPLETED|Overall Study||5
72597|NCT01471782|172916|P6|COMPLETED|Overall Study|Completed 5 cycles|3
72598|NCT01471782|172917|P5|COMPLETED|Overall Study|Completed 5 cycles|0
72599|NCT01471782|172918|P4|COMPLETED|Overall Study|Completed 5 cycles|1
72600|NCT01471782|172919|P3|COMPLETED|Overall Study|Completed 5 cycles|0
72601|NCT01471782|172920|P2|COMPLETED|Overall Study|Completed 5 cycles|1
72602|NCT01471782|172921|P1|COMPLETED|Overall Study|Completed 5 cycles|0
72603|NCT01471782|172916|P6|STARTED|Overall Study||44
72604|NCT01471782|172917|P5|STARTED|Overall Study||26
72605|NCT01471782|172918|P4|STARTED|Overall Study||6
72606|NCT01471782|172919|P3|STARTED|Overall Study||5
72607|NCT01471782|172920|P2|STARTED|Overall Study||7
72608|NCT01471782|172921|P1|STARTED|Overall Study||5
72609|NCT01471691|172975|P2|NOT COMPLETED|Overall Study||1
72610|NCT01471691|172976|P1|NOT COMPLETED|Overall Study||0
72611|NCT01471691|172975|P2|COMPLETED|Overall Study||5
72612|NCT01471691|172976|P1|COMPLETED|Overall Study||8
72613|NCT01471691|172975|P2|STARTED|Overall Study||6
72614|NCT01471691|172976|P1|STARTED|Overall Study||8
72615|NCT01471626|172982|P1|NOT COMPLETED|Overall Study||0
72616|NCT01471626|172982|P1|COMPLETED|Overall Study||21
72617|NCT01471626|172982|P1|STARTED|Overall Study||21
72618|NCT01471574|172990|P4|NOT COMPLETED|Follow-up Period||3
72619|NCT01471574|172991|P3|NOT COMPLETED|Follow-up Period||7
72620|NCT01471574|172992|P2|NOT COMPLETED|Follow-up Period||2
72621|NCT01471574|172993|P1|NOT COMPLETED|Follow-up Period||7
72622|NCT01471574|172990|P4|COMPLETED|Follow-up Period||21
72623|NCT01471574|172991|P3|COMPLETED|Follow-up Period||95
72624|NCT01471574|172992|P2|COMPLETED|Follow-up Period||32
72625|NCT01471574|172993|P1|COMPLETED|Follow-up Period||114
72626|NCT01471574|172990|P4|STARTED|Follow-up Period||24
72627|NCT01471574|172991|P3|STARTED|Follow-up Period||102
72628|NCT01471574|172992|P2|STARTED|Follow-up Period||34
72629|NCT01471574|172993|P1|STARTED|Follow-up Period||121
72630|NCT01471574|172990|P4|NOT COMPLETED|Treatment Period||3
72631|NCT01471574|172991|P3|NOT COMPLETED|Treatment Period||24
72632|NCT01471574|172992|P2|NOT COMPLETED|Treatment Period||10
72633|NCT01471574|172993|P1|NOT COMPLETED|Treatment Period||31
72634|NCT01471574|172990|P4|COMPLETED|Treatment Period||21
72635|NCT01471574|172991|P3|COMPLETED|Treatment Period||82
72636|NCT01471574|172992|P2|COMPLETED|Treatment Period||29
72637|NCT01471574|172993|P1|COMPLETED|Treatment Period||101
72638|NCT01471574|172990|P4|STARTED|Treatment Period||24
72639|NCT01471574|172991|P3|STARTED|Treatment Period||106
72640|NCT01471574|172992|P2|STARTED|Treatment Period||39
72641|NCT01471574|172993|P1|STARTED|Treatment Period||132
72642|NCT01471379|173025|P3|NOT COMPLETED|Overall Study||0
72643|NCT01471379|173026|P2|NOT COMPLETED|Overall Study||1
72644|NCT01471379|173027|P1|NOT COMPLETED|Overall Study||1
72645|NCT01471379|173025|P3|COMPLETED|Overall Study||0
72646|NCT01471379|173026|P2|COMPLETED|Overall Study||0
72647|NCT01471379|173027|P1|COMPLETED|Overall Study||0
72648|NCT01471379|173025|P3|STARTED|Overall Study||0
72649|NCT01471379|173026|P2|STARTED|Overall Study||1
72650|NCT01471379|173027|P1|STARTED|Overall Study||1
72651|NCT01471353|173047|P1|NOT COMPLETED|Overall Study||3
72652|NCT01471353|173047|P1|COMPLETED|Overall Study||39
72653|NCT01471353|173047|P1|STARTED|Overall Study||42
72654|NCT01471197|173055|P2|NOT COMPLETED|Overall Study||2
72655|NCT01471197|173056|P1|NOT COMPLETED|Overall Study||6
72656|NCT01471197|173055|P2|COMPLETED|Overall Study||0
72657|NCT01471197|173056|P1|COMPLETED|Overall Study||0
72658|NCT01471197|173055|P2|STARTED|Overall Study||2
72659|NCT01471197|173056|P1|STARTED|Overall Study||6
72660|NCT01471171|173066|P2|NOT COMPLETED|Treatment Period 2||0
72661|NCT01471171|173067|P1|NOT COMPLETED|Treatment Period 2||1
72662|NCT01471171|173066|P2|COMPLETED|Treatment Period 2||54
72663|NCT01471171|173067|P1|COMPLETED|Treatment Period 2||52
72664|NCT01471171|173066|P2|STARTED|Treatment Period 2||54
72665|NCT01471171|173067|P1|STARTED|Treatment Period 2||53
72666|NCT01471171|173066|P2|NOT COMPLETED|Treatment Period 1||1
72667|NCT01471171|173067|P1|NOT COMPLETED|Treatment Period 1||4
72668|NCT01471171|173066|P2|COMPLETED|Treatment Period 1||54
72669|NCT01471171|173067|P1|COMPLETED|Treatment Period 1||53
72670|NCT01471171|173066|P2|STARTED|Treatment Period 1||55
72671|NCT01471171|173067|P1|STARTED|Treatment Period 1||57
72672|NCT01471041|173077|P1|NOT COMPLETED|Overall Study||7
72673|NCT01471041|173077|P1|COMPLETED|Overall Study||47
72674|NCT01471041|173077|P1|STARTED|Overall Study||54
72675|NCT01471015|173085|P3|NOT COMPLETED|Overall Study||1
72676|NCT01471015|173086|P2|NOT COMPLETED|Overall Study||1
72677|NCT01471015|173087|P1|NOT COMPLETED|Overall Study||0
72678|NCT01471015|173085|P3|COMPLETED|Overall Study||9
72679|NCT01471015|173086|P2|COMPLETED|Overall Study||9
72680|NCT01471015|173087|P1|COMPLETED|Overall Study||10
72681|NCT01471015|173085|P3|STARTED|Overall Study||10
72682|NCT01471015|173086|P2|STARTED|Overall Study||10
72683|NCT01471015|173087|P1|STARTED|Overall Study||10
72684|NCT01470859|173101|P2|NOT COMPLETED|Overall Study||0
72685|NCT01470859|173102|P1|NOT COMPLETED|Overall Study||1
72686|NCT01470859|173101|P2|COMPLETED|Overall Study||15
72687|NCT01470859|173102|P1|COMPLETED|Overall Study||14
72688|NCT01470859|173101|P2|STARTED|Overall Study||15
72689|NCT01470859|173102|P1|STARTED|Overall Study||15
72690|NCT01470651|173118|P2|NOT COMPLETED|Overall Study||3
72691|NCT01470651|173119|P1|NOT COMPLETED|Overall Study||7
72692|NCT01470651|173118|P2|COMPLETED|Overall Study||10
72693|NCT01470651|173119|P1|COMPLETED|Overall Study||6
72694|NCT01470651|173118|P2|STARTED|Overall Study||13
72695|NCT01470651|173119|P1|STARTED|Overall Study||13
72696|NCT01470469|173129|P2|NOT COMPLETED|Overall Study||24
72697|NCT01470469|173130|P1|NOT COMPLETED|Overall Study||10
72698|NCT01470469|173129|P2|COMPLETED|Overall Study||38
72699|NCT01470469|173130|P1|COMPLETED|Overall Study||11
72700|NCT01470469|173129|P2|STARTED|Overall Study||62
72701|NCT01470469|173130|P1|STARTED|Overall Study||21
72702|NCT01470417|173150|P2|NOT COMPLETED|Overall Study||2
72703|NCT01470417|173151|P1|NOT COMPLETED|Overall Study||0
72704|NCT01470417|173150|P2|COMPLETED|Overall Study||5
72705|NCT01470417|173151|P1|COMPLETED|Overall Study||3
72706|NCT01470417|173150|P2|STARTED|Overall Study||7
72707|NCT01470417|173151|P1|STARTED|Overall Study||3
72708|NCT01470248|173163|P1|NOT COMPLETED|Overall Study||1
72709|NCT01470248|173163|P1|COMPLETED|Overall Study||19
72710|NCT01470248|173163|P1|STARTED|Overall Study||20
72711|NCT01470196|173170|P1|NOT COMPLETED|Overall Study||0
72712|NCT01470196|173170|P1|COMPLETED|Overall Study||31
72713|NCT01470196|173170|P1|STARTED|Overall Study||31
72714|NCT01470170|173183|P5|NOT COMPLETED|Overall Study||0
72715|NCT01470170|173184|P4|NOT COMPLETED|Overall Study||0
72716|NCT01470170|173185|P3|NOT COMPLETED|Overall Study||0
72717|NCT01470170|173186|P2|NOT COMPLETED|Overall Study||0
72718|NCT01470170|173187|P1|NOT COMPLETED|Overall Study||0
72719|NCT01470170|173183|P5|COMPLETED|Overall Study||34
72720|NCT01470170|173184|P4|COMPLETED|Overall Study||36
72721|NCT01470170|173185|P3|COMPLETED|Overall Study||34
72722|NCT01470170|173186|P2|COMPLETED|Overall Study||35
72723|NCT01470170|173187|P1|COMPLETED|Overall Study||34
72724|NCT01470170|173183|P5|STARTED|Overall Study||34
72725|NCT01470170|173184|P4|STARTED|Overall Study||36
72726|NCT01470170|173185|P3|STARTED|Overall Study||34
72727|NCT01470170|173186|P2|STARTED|Overall Study||35
72728|NCT01470170|173187|P1|STARTED|Overall Study||34
72729|NCT01470144|173219|P1|NOT COMPLETED|Overall Study||10
72730|NCT01470144|173219|P1|COMPLETED|Overall Study|"Completed corresponds to subjects switching to commercial EFI upon market approval/reimbursement"|31
72731|NCT01470144|173219|P1|STARTED|Overall Study||41
72732|NCT01470118|173227|P3|NOT COMPLETED|Overall Study||2
72733|NCT01470118|173228|P2|NOT COMPLETED|Overall Study||5
72734|NCT01470118|173229|P1|NOT COMPLETED|Overall Study||5
72735|NCT01470118|173227|P3|COMPLETED|Overall Study||39
72736|NCT01470118|173228|P2|COMPLETED|Overall Study||38
72737|NCT01470118|173229|P1|COMPLETED|Overall Study||38
72738|NCT01470118|173227|P3|STARTED|Overall Study||41
72739|NCT01470118|173228|P2|STARTED|Overall Study||43
72740|NCT01470118|173229|P1|STARTED|Overall Study||43
72741|NCT01470001|173260|P2|NOT COMPLETED|Overall Study||2
72742|NCT01470001|173261|P1|NOT COMPLETED|Overall Study||5
72743|NCT01470001|173260|P2|COMPLETED|Overall Study||58
72744|NCT01470001|173261|P1|COMPLETED|Overall Study||53
72745|NCT01470001|173260|P2|STARTED|Overall Study||60
72746|NCT01470001|173261|P1|STARTED|Overall Study||58
72747|NCT01469819|173271|P1|NOT COMPLETED|Overall Study||8
72748|NCT01469819|173271|P1|COMPLETED|Overall Study||29
72749|NCT01469819|173271|P1|STARTED|Overall Study||37
72750|NCT01469767|173281|P1|NOT COMPLETED|Overall Study||0
72751|NCT01469767|173281|P1|COMPLETED|Overall Study||10
72752|NCT01469767|173281|P1|STARTED|Overall Study||10
72753|NCT01469715|173289|P1|NOT COMPLETED|Overall Study||0
72754|NCT01469715|173289|P1|COMPLETED|Overall Study||16
72755|NCT01469715|173289|P1|STARTED|Overall Study||16
72756|NCT01469637|173295|P2|NOT COMPLETED|Second Intervention||0
72757|NCT01469637|173296|P1|NOT COMPLETED|Second Intervention||1
72758|NCT01469637|173295|P2|COMPLETED|Second Intervention||21
72759|NCT01469637|173296|P1|COMPLETED|Second Intervention||21
72760|NCT01469637|173295|P2|STARTED|Second Intervention||21
72761|NCT01469637|173296|P1|STARTED|Second Intervention||22
72762|NCT01469637|173295|P2|NOT COMPLETED|First Intervention||1
72763|NCT01469637|173296|P1|NOT COMPLETED|First Intervention||0
72764|NCT01469637|173295|P2|COMPLETED|First Intervention||21
72765|NCT01469637|173296|P1|COMPLETED|First Intervention||22
72766|NCT01469637|173295|P2|STARTED|First Intervention||22
72767|NCT01469637|173296|P1|STARTED|First Intervention||22
72768|NCT01469546|173304|P1|NOT COMPLETED|Dose Escalation to 10 mg||0
72769|NCT01469546|173304|P1|COMPLETED|Dose Escalation to 10 mg||19
72770|NCT01469546|173304|P1|STARTED|Dose Escalation to 10 mg||19
72771|NCT01469546|173304|P1|NOT COMPLETED|Received 5 mg Dose||23
72772|NCT01469546|173304|P1|COMPLETED|Received 5 mg Dose||19
72773|NCT01469546|173304|P1|Completed First Cycle|Received 5 mg Dose||30
72774|NCT01469546|173304|P1|STARTED|Received 5 mg Dose||42
72775|NCT01469364|173311|P1|NOT COMPLETED|Overall Study||2
72776|NCT01469364|173311|P1|COMPLETED|Overall Study||28
72777|NCT01469364|173311|P1|STARTED|Overall Study||30
72778|NCT01469234|173329|P3|NOT COMPLETED|Overall Study||0
72779|NCT01469234|173330|P2|NOT COMPLETED|Overall Study||0
72780|NCT01469234|173331|P1|NOT COMPLETED|Overall Study||0
72781|NCT01469234|173329|P3|COMPLETED|Overall Study||85
72782|NCT01469234|173330|P2|COMPLETED|Overall Study||85
72783|NCT01469234|173331|P1|COMPLETED|Overall Study||85
72784|NCT01469234|173329|P3|STARTED|Overall Study||85
72785|NCT01469234|173330|P2|STARTED|Overall Study||85
72786|NCT01469234|173331|P1|STARTED|Overall Study||85
72787|NCT01469182|173362|P2|NOT COMPLETED|Overall Study||6
72788|NCT01469182|173363|P1|NOT COMPLETED|Overall Study||35
72789|NCT01469182|173362|P2|COMPLETED|Overall Study||298
72790|NCT01469182|173363|P1|COMPLETED|Overall Study||575
72791|NCT01469182|173362|P2|Treated|Overall Study||304
72792|NCT01469182|173363|P1|Treated|Overall Study||609
72793|NCT01469182|173362|P2|STARTED|Overall Study||304
72794|NCT01469182|173363|P1|STARTED|Overall Study||610
72795|NCT01469065|173390|P5|NOT COMPLETED|Overall Study||1
72796|NCT01469065|173391|P4|NOT COMPLETED|Overall Study||0
72797|NCT01469065|173392|P3|NOT COMPLETED|Overall Study||0
72798|NCT01469065|173393|P2|NOT COMPLETED|Overall Study||1
72799|NCT01469065|173394|P1|NOT COMPLETED|Overall Study||0
72800|NCT01469065|173390|P5|COMPLETED|Overall Study||16
72801|NCT01469065|173391|P4|COMPLETED|Overall Study||16
72802|NCT01469065|173392|P3|COMPLETED|Overall Study||16
72803|NCT01469065|173393|P2|COMPLETED|Overall Study||16
72804|NCT01469065|173394|P1|COMPLETED|Overall Study||16
72805|NCT01469065|173390|P5|STARTED|Overall Study||17
72806|NCT01469065|173391|P4|STARTED|Overall Study||16
72807|NCT01469065|173392|P3|STARTED|Overall Study||16
72808|NCT01469065|173393|P2|STARTED|Overall Study||17
72809|NCT01469065|173394|P1|STARTED|Overall Study||16
72810|NCT01469052|173490|P6|NOT COMPLETED|Overall Study||6
72811|NCT01469052|173491|P5|NOT COMPLETED|Overall Study||8
72812|NCT01469052|173492|P4|NOT COMPLETED|Overall Study||5
72813|NCT01469052|173493|P3|NOT COMPLETED|Overall Study||6
72814|NCT01469052|173494|P2|NOT COMPLETED|Overall Study||4
72815|NCT01469052|173495|P1|NOT COMPLETED|Overall Study||6
72816|NCT01469052|173490|P6|COMPLETED|Overall Study||0
72817|NCT01469052|173491|P5|COMPLETED|Overall Study||0
72818|NCT01469052|173492|P4|COMPLETED|Overall Study||1
72819|NCT01469052|173493|P3|COMPLETED|Overall Study||0
72820|NCT01469052|173494|P2|COMPLETED|Overall Study||0
72821|NCT01469052|173495|P1|COMPLETED|Overall Study||0
72822|NCT01469052|173490|P6|STARTED|Overall Study||6
72823|NCT01469052|173491|P5|STARTED|Overall Study||8
72824|NCT01469052|173492|P4|STARTED|Overall Study||6
72825|NCT01469052|173493|P3|STARTED|Overall Study||6
72826|NCT01469052|173494|P2|STARTED|Overall Study||4
72827|NCT01469052|173495|P1|STARTED|Overall Study||6
72828|NCT01469039|173542|P3|NOT COMPLETED|Overall Study||113
72829|NCT01469039|173543|P2|NOT COMPLETED|Overall Study||73
72830|NCT01469039|173544|P1|NOT COMPLETED|Overall Study||77
72831|NCT01469039|173542|P3|COMPLETED|Overall Study||95
72832|NCT01469039|173543|P2|COMPLETED|Overall Study||135
72833|NCT01469039|173544|P1|COMPLETED|Overall Study||130
72834|NCT01469039|173542|P3|STARTED|Overall Study||208
72835|NCT01469039|173543|P2|STARTED|Overall Study||208
72836|NCT01469039|173544|P1|STARTED|Overall Study||207
72837|NCT01469000|173557|P2|NOT COMPLETED|Overall Study||9
72838|NCT01469000|173558|P1|NOT COMPLETED|Overall Study||33
72839|NCT01469000|173557|P2|COMPLETED|Overall Study||57
72840|NCT01469000|173558|P1|COMPLETED|Overall Study||96
72841|NCT01469000|173557|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
72842|NCT01469000|173558|P1|Received at Least 1 Dose of Study Drug|Overall Study||126
72843|NCT01469000|173557|P2|STARTED|Overall Study||66
72844|NCT01469000|173558|P1|STARTED|Overall Study||129
72845|NCT01468896|173574|P2|NOT COMPLETED|Overall Study||0
72846|NCT01468896|173575|P1|NOT COMPLETED|Overall Study||0
72847|NCT01468896|173574|P2|COMPLETED|Overall Study||17
72848|NCT01468896|173575|P1|COMPLETED|Overall Study||6
72849|NCT01468896|173574|P2|STARTED|Overall Study||17
72850|NCT01468896|173575|P1|STARTED|Overall Study||6
72851|NCT01468818|173591|P1|NOT COMPLETED|Overall Study||2
72852|NCT01468818|173591|P1|COMPLETED|Overall Study||16
72853|NCT01468818|173591|P1|STARTED|Overall Study||18
72854|NCT01468675|173598|P2|NOT COMPLETED|Overall Study||1372
72855|NCT01468675|173599|P1|NOT COMPLETED|Overall Study||1000
72856|NCT01468675|173598|P2|COMPLETED|Overall Study||2004
72857|NCT01468675|173599|P1|COMPLETED|Overall Study||1699
72858|NCT01468675|173598|P2|STARTED|Overall Study||3376
72859|NCT01468675|173599|P1|STARTED|Overall Study||2699
72860|NCT01468584|173605|P1|NOT COMPLETED|Overall Study||0
72861|NCT01468584|173605|P1|COMPLETED|Overall Study||10
72862|NCT01468584|173605|P1|STARTED|Overall Study||10
72863|NCT01468558|173609|P1|NOT COMPLETED|Overall Study||2
72864|NCT01468558|173609|P1|COMPLETED|Overall Study||22
72865|NCT01468558|173609|P1|STARTED|Overall Study||24
72866|NCT01468350|173624|P4|NOT COMPLETED|(PART B) Day 1, Day 15||0
72867|NCT01468350|173625|P3|NOT COMPLETED|(PART B) Day 1, Day 15||0
72868|NCT01468350|173626|P2|NOT COMPLETED|(PART B) Day 1, Day 15||0
72869|NCT01468350|173627|P1|NOT COMPLETED|(PART B) Day 1, Day 15||0
72870|NCT01468350|173624|P4|COMPLETED|(PART B) Day 1, Day 15||12
72871|NCT01468350|173625|P3|COMPLETED|(PART B) Day 1, Day 15||12
72872|NCT01468350|173626|P2|COMPLETED|(PART B) Day 1, Day 15||0
72873|NCT01468350|173627|P1|COMPLETED|(PART B) Day 1, Day 15||0
72874|NCT01468350|173624|P4|STARTED|(PART B) Day 1, Day 15||12
72875|NCT01468350|173625|P3|STARTED|(PART B) Day 1, Day 15||12
72876|NCT01468350|173626|P2|STARTED|(PART B) Day 1, Day 15||0
72877|NCT01468350|173627|P1|STARTED|(PART B) Day 1, Day 15||0
72878|NCT01468350|173624|P4|NOT COMPLETED|(PART A) Day 1, Day 3||0
72879|NCT01468350|173625|P3|NOT COMPLETED|(PART A) Day 1, Day 3||0
72880|NCT01468350|173626|P2|NOT COMPLETED|(PART A) Day 1, Day 3||0
72881|NCT01468350|173627|P1|NOT COMPLETED|(PART A) Day 1, Day 3||0
72882|NCT01468350|173624|P4|COMPLETED|(PART A) Day 1, Day 3||0
72883|NCT01468350|173625|P3|COMPLETED|(PART A) Day 1, Day 3||0
72884|NCT01468350|173626|P2|COMPLETED|(PART A) Day 1, Day 3||5
72885|NCT01468350|173627|P1|COMPLETED|(PART A) Day 1, Day 3||6
72886|NCT01468350|173624|P4|STARTED|(PART A) Day 1, Day 3||0
72887|NCT01468350|173625|P3|STARTED|(PART A) Day 1, Day 3||0
72888|NCT01468350|173626|P2|STARTED|(PART A) Day 1, Day 3||5
72889|NCT01468350|173627|P1|STARTED|(PART A) Day 1, Day 3||6
72890|NCT01468337|173637|P1|NOT COMPLETED|Overall Study||0
72891|NCT01468337|173637|P1|COMPLETED|Overall Study||5
72892|NCT01468337|173637|P1|Week 48|Overall Study|Two participants did not have a Week 48 visit but completed the study.|3
72893|NCT01468337|173637|P1|Received Interferon Gamma-1b After Wk 8|Overall Study|Two participants had 2 Interferon gamma-1b dosing cycles after Wk 8|4
72894|NCT01468337|173637|P1|Received Interferon Gamma-1b at Week 4|Overall Study|One participant received additional Interferon gamma-1b dosing at Week 4 and after Week 8|2
72895|NCT01468337|173637|P1|Week 2|Overall Study||5
72896|NCT01468337|173637|P1|STARTED|Overall Study||5
72897|NCT01468311|173649|P1|NOT COMPLETED|Overall Study||2
72898|NCT01468311|173649|P1|COMPLETED|Overall Study||4
72899|NCT01468311|173649|P1|STARTED|Overall Study||6
72900|NCT01468233|173661|P6|NOT COMPLETED|Treatment Period 2||23
72901|NCT01468233|173662|P5|NOT COMPLETED|Treatment Period 2||28
72902|NCT01468233|173663|P4|NOT COMPLETED|Treatment Period 2||28
72903|NCT01468233|173664|P3|NOT COMPLETED|Treatment Period 2||111
72904|NCT01468233|173665|P2|NOT COMPLETED|Treatment Period 2||0
72905|NCT01468233|173666|P1|NOT COMPLETED|Treatment Period 2||0
72906|NCT01468233|173661|P6|COMPLETED|Treatment Period 2||28
72907|NCT01468233|173662|P5|COMPLETED|Treatment Period 2||25
72908|NCT01468233|173663|P4|COMPLETED|Treatment Period 2||23
72909|NCT01468233|173664|P3|COMPLETED|Treatment Period 2||40
72910|NCT01468233|173665|P2|COMPLETED|Treatment Period 2||0
72911|NCT01468233|173666|P1|COMPLETED|Treatment Period 2||0
72912|NCT01468233|173661|P6|STARTED|Treatment Period 2||51
72913|NCT01468233|173662|P5|STARTED|Treatment Period 2||53
72914|NCT01468233|173663|P4|STARTED|Treatment Period 2||51
72915|NCT01468233|173664|P3|STARTED|Treatment Period 2||151
72916|NCT01468233|173665|P2|STARTED|Treatment Period 2||0
72917|NCT01468233|173666|P1|STARTED|Treatment Period 2||0
72918|NCT01468233|173661|P6|NOT COMPLETED|Treatment Period 1||0
72919|NCT01468233|173662|P5|NOT COMPLETED|Treatment Period 1||0
72920|NCT01468233|173663|P4|NOT COMPLETED|Treatment Period 1||0
72921|NCT01468233|173664|P3|NOT COMPLETED|Treatment Period 1||0
72922|NCT01468233|173665|P2|NOT COMPLETED|Treatment Period 1||8
72923|NCT01468233|173666|P1|NOT COMPLETED|Treatment Period 1||12
72924|NCT01468233|173661|P6|COMPLETED|Treatment Period 1||0
72925|NCT01468233|173662|P5|COMPLETED|Treatment Period 1||0
72926|NCT01468233|173663|P4|COMPLETED|Treatment Period 1||0
72927|NCT01468233|173664|P3|COMPLETED|Treatment Period 1||0
72928|NCT01468233|173665|P2|COMPLETED|Treatment Period 1||155
72929|NCT01468233|173666|P1|COMPLETED|Treatment Period 1||151
72930|NCT01468233|173661|P6|STARTED|Treatment Period 1||0
72931|NCT01468233|173662|P5|STARTED|Treatment Period 1||0
72932|NCT01468233|173663|P4|STARTED|Treatment Period 1||0
72933|NCT01468233|173664|P3|STARTED|Treatment Period 1||0
72934|NCT01468233|173665|P2|STARTED|Treatment Period 1||163
72935|NCT01468233|173666|P1|STARTED|Treatment Period 1||163
72936|NCT01468207|173688|P6|NOT COMPLETED|Treatment Period 2||20
72937|NCT01468207|173689|P5|NOT COMPLETED|Treatment Period 2||21
72938|NCT01468207|173690|P4|NOT COMPLETED|Treatment Period 2||27
72939|NCT01468207|173691|P3|NOT COMPLETED|Treatment Period 2||52
72940|NCT01468207|173692|P2|NOT COMPLETED|Treatment Period 2||0
72941|NCT01468207|173693|P1|NOT COMPLETED|Treatment Period 2||0
72942|NCT01468207|173688|P6|COMPLETED|Treatment Period 2||28
72943|NCT01468207|173689|P5|COMPLETED|Treatment Period 2||27
72944|NCT01468207|173690|P4|COMPLETED|Treatment Period 2||22
72945|NCT01468207|173691|P3|COMPLETED|Treatment Period 2||93
72946|NCT01468207|173692|P2|COMPLETED|Treatment Period 2||0
72947|NCT01468207|173693|P1|COMPLETED|Treatment Period 2||0
72948|NCT01468207|173688|P6|STARTED|Treatment Period 2||48
72949|NCT01468207|173689|P5|STARTED|Treatment Period 2||48
72950|NCT01468207|173690|P4|STARTED|Treatment Period 2||49
72951|NCT01468207|173691|P3|STARTED|Treatment Period 2||145
72952|NCT01468207|173692|P2|STARTED|Treatment Period 2||0
72953|NCT01468207|173693|P1|STARTED|Treatment Period 2||0
72954|NCT01468207|173688|P6|NOT COMPLETED|Treatment Period 1||0
72955|NCT01468207|173689|P5|NOT COMPLETED|Treatment Period 1||0
72956|NCT01468207|173690|P4|NOT COMPLETED|Treatment Period 1||0
72957|NCT01468207|173691|P3|NOT COMPLETED|Treatment Period 1||0
72958|NCT01468207|173692|P2|NOT COMPLETED|Treatment Period 1||8
72959|NCT01468207|173693|P1|NOT COMPLETED|Treatment Period 1||9
72960|NCT01468207|173688|P6|COMPLETED|Treatment Period 1||0
72961|NCT01468207|173689|P5|COMPLETED|Treatment Period 1||0
72962|NCT01468207|173690|P4|COMPLETED|Treatment Period 1||0
72963|NCT01468207|173691|P3|COMPLETED|Treatment Period 1||0
72964|NCT01468207|173692|P2|COMPLETED|Treatment Period 1||145
72965|NCT01468207|173693|P1|COMPLETED|Treatment Period 1||145
72966|NCT01468207|173688|P6|Received Study Drug|Treatment Period 1||0
72967|NCT01468207|173689|P5|Received Study Drug|Treatment Period 1||0
72968|NCT01468207|173690|P4|Received Study Drug|Treatment Period 1||0
72969|NCT01468207|173691|P3|Received Study Drug|Treatment Period 1||0
72970|NCT01468207|173692|P2|Received Study Drug|Treatment Period 1||153
72971|NCT01468207|173693|P1|Received Study Drug|Treatment Period 1||152
72972|NCT01468207|173688|P6|STARTED|Treatment Period 1||0
72973|NCT01468207|173689|P5|STARTED|Treatment Period 1||0
72974|NCT01468207|173690|P4|STARTED|Treatment Period 1||0
72975|NCT01468207|173691|P3|STARTED|Treatment Period 1||0
72976|NCT01468207|173692|P2|STARTED|Treatment Period 1||153
72977|NCT01468207|173693|P1|STARTED|Treatment Period 1||154
72978|NCT01468181|173718|P5|NOT COMPLETED|Overall Study||5
72979|NCT01468181|173719|P4|NOT COMPLETED|Overall Study||3
72980|NCT01468181|173720|P3|NOT COMPLETED|Overall Study||8
72981|NCT01468181|173721|P2|NOT COMPLETED|Overall Study||2
72982|NCT01468181|173722|P1|NOT COMPLETED|Overall Study||10
72983|NCT01468181|173718|P5|COMPLETED|Overall Study||66
72984|NCT01468181|173719|P4|COMPLETED|Overall Study||63
72985|NCT01468181|173720|P3|COMPLETED|Overall Study||57
72986|NCT01468181|173721|P2|COMPLETED|Overall Study||59
72987|NCT01468181|173722|P1|COMPLETED|Overall Study||121
72988|NCT01468181|173718|P5|Received at Least 1 Dose of Study Drug|Overall Study||71
72989|NCT01468181|173719|P4|Received at Least 1 Dose of Study Drug|Overall Study||66
72990|NCT01468181|173720|P3|Received at Least 1 Dose of Study Drug|Overall Study||65
72991|NCT01468181|173721|P2|Received at Least 1 Dose of Study Drug|Overall Study||61
72992|NCT01468181|173722|P1|Received at Least 1 Dose of Study Drug|Overall Study||131
72993|NCT01468181|173718|P5|STARTED|Overall Study||71
72994|NCT01468181|173719|P4|STARTED|Overall Study||66
72995|NCT01468181|173720|P3|STARTED|Overall Study||65
72996|NCT01468181|173721|P2|STARTED|Overall Study||61
72997|NCT01468181|173722|P1|STARTED|Overall Study||131
72998|NCT01468077|173771|P2|NOT COMPLETED|Overall Study||3
72999|NCT01468077|173772|P1|NOT COMPLETED|Overall Study||4
73000|NCT01468077|173771|P2|COMPLETED|Overall Study||22
73001|NCT01468077|173772|P1|COMPLETED|Overall Study||18
73002|NCT01468077|173771|P2|STARTED|Overall Study||25
73003|NCT01468077|173772|P1|STARTED|Overall Study||22
73004|NCT01468012|173811|P3|NOT COMPLETED|Overall Study||4
73005|NCT01468012|173812|P2|NOT COMPLETED|Overall Study||1
73006|NCT01468012|173813|P1|NOT COMPLETED|Overall Study||2
73007|NCT01468012|173811|P3|COMPLETED|Overall Study||0
73008|NCT01468012|173812|P2|COMPLETED|Overall Study||9
73009|NCT01468012|173813|P1|COMPLETED|Overall Study||7
73010|NCT01468012|173811|P3|STARTED|Overall Study||4
73011|NCT01468012|173812|P2|STARTED|Overall Study||10
73012|NCT01468012|173813|P1|STARTED|Overall Study||9
73013|NCT01467960|173825|P6|NOT COMPLETED|Overall Study||30
73014|NCT01467960|173826|P5|NOT COMPLETED|Overall Study||30
73015|NCT01467960|173827|P4|NOT COMPLETED|Overall Study||30
73016|NCT01467960|173828|P3|NOT COMPLETED|Overall Study||0
73017|NCT01467960|173829|P2|NOT COMPLETED|Overall Study||0
73018|NCT01467960|173830|P1|NOT COMPLETED|Overall Study||0
73019|NCT01467960|173825|P6|COMPLETED|Overall Study||0
73020|NCT01467960|173826|P5|COMPLETED|Overall Study||0
73021|NCT01467960|173827|P4|COMPLETED|Overall Study||0
73022|NCT01467960|173828|P3|COMPLETED|Overall Study||30
73023|NCT01467960|173829|P2|COMPLETED|Overall Study||30
73024|NCT01467960|173830|P1|COMPLETED|Overall Study||30
73025|NCT01467960|173825|P6|STARTED|Overall Study||30
73026|NCT01467960|173826|P5|STARTED|Overall Study||30
73027|NCT01467960|173827|P4|STARTED|Overall Study||30
73028|NCT01467960|173828|P3|STARTED|Overall Study||30
73029|NCT01467960|173829|P2|STARTED|Overall Study||30
73030|NCT01467960|173830|P1|STARTED|Overall Study||30
73031|NCT01467947|173844|P1|NOT COMPLETED|Overall Study||0
73032|NCT01467947|173844|P1|COMPLETED|Overall Study||46
73033|NCT01467947|173844|P1|STARTED|Overall Study||46
73034|NCT01467934|173852|P3|NOT COMPLETED|Overall Study||0
73035|NCT01467934|173853|P2|NOT COMPLETED|Overall Study||0
73036|NCT01467934|173854|P1|NOT COMPLETED|Overall Study||0
73037|NCT01467934|173852|P3|COMPLETED|Overall Study||110
73038|NCT01467934|173853|P2|COMPLETED|Overall Study||212
73039|NCT01467934|173854|P1|COMPLETED|Overall Study||208
73040|NCT01467934|173852|P3|STARTED|Overall Study||110
73041|NCT01467934|173853|P2|STARTED|Overall Study||212
73042|NCT01467934|173854|P1|STARTED|Overall Study||208
73043|NCT01467882|173862|P1|NOT COMPLETED|Overall Study||0
73044|NCT01467882|173862|P1|COMPLETED|Overall Study||44
73045|NCT01467882|173862|P1|STARTED|Overall Study||44
73046|NCT01467713|173889|P4|NOT COMPLETED|Overall Study||109
73047|NCT01467713|173890|P3|NOT COMPLETED|Overall Study||102
73048|NCT01467713|173891|P2|NOT COMPLETED|Overall Study||104
73049|NCT01467713|173892|P1|NOT COMPLETED|Overall Study||102
73050|NCT01467713|173889|P4|COMPLETED|Overall Study||45
73051|NCT01467713|173890|P3|COMPLETED|Overall Study||58
73052|NCT01467713|173891|P2|COMPLETED|Overall Study||60
73053|NCT01467713|173892|P1|COMPLETED|Overall Study||62
73054|NCT01467713|173889|P4|Safety Analysis Set: Received Treatment|Overall Study||154
73055|NCT01467713|173890|P3|Safety Analysis Set: Received Treatment|Overall Study||159
73056|NCT01467713|173891|P2|Safety Analysis Set: Received Treatment|Overall Study||164
73057|NCT01467713|173892|P1|Safety Analysis Set: Received Treatment|Overall Study||163
73058|NCT01467713|173889|P4|STARTED|Overall Study||154
73059|NCT01467713|173890|P3|STARTED|Overall Study||160
73060|NCT01467713|173891|P2|STARTED|Overall Study||164
73061|NCT01467713|173892|P1|STARTED|Overall Study||164
73062|NCT01467700|173946|P4|NOT COMPLETED|Overall Study||27
73063|NCT01467700|173947|P3|NOT COMPLETED|Overall Study||27
73064|NCT01467700|173948|P2|NOT COMPLETED|Overall Study||28
73065|NCT01467700|173949|P1|NOT COMPLETED|Overall Study||29
73066|NCT01467700|173946|P4|COMPLETED|Overall Study||96
73067|NCT01467700|173947|P3|COMPLETED|Overall Study||97
73068|NCT01467700|173948|P2|COMPLETED|Overall Study||100
73069|NCT01467700|173949|P1|COMPLETED|Overall Study||86
73070|NCT01467700|173946|P4|Safety Set - Received Treatment|Overall Study||123
73071|NCT01467700|173947|P3|Safety Set - Received Treatment|Overall Study||124
73072|NCT01467700|173948|P2|Safety Set - Received Treatment|Overall Study||127
73073|NCT01467700|173949|P1|Safety Set - Received Treatment|Overall Study||115
73074|NCT01467700|173946|P4|STARTED|Overall Study||123
73075|NCT01467700|173947|P3|STARTED|Overall Study||124
73076|NCT01467700|173948|P2|STARTED|Overall Study||128
73077|NCT01467700|173949|P1|STARTED|Overall Study||115
73078|NCT01467661|173991|P1|NOT COMPLETED|Overall Study||21
73079|NCT01467661|173991|P1|COMPLETED|Overall Study|Completed study SPD422-309 (NCT01467661)|32
73080|NCT01467661|173991|P1|Started Post Marketing Trial|Overall Study||33
73081|NCT01467661|173991|P1|Started SPD422-309 (NCT01467661)|Overall Study||41
73082|NCT01467661|173991|P1|Completed SPD422-308 (NCT01214915)|Overall Study||42
73083|NCT01467661|173991|P1|STARTED|Overall Study|Started Study SPD422-308 (NCT01214915)|53
73084|NCT01467583|174011|P3|NOT COMPLETED|Overall Study||2
73085|NCT01467583|174012|P2|NOT COMPLETED|Overall Study||1
73086|NCT01467583|174013|P1|NOT COMPLETED|Overall Study||2
73087|NCT01467583|174011|P3|COMPLETED|Overall Study||10
73088|NCT01467583|174012|P2|COMPLETED|Overall Study|Death unrelated to study drug on day #3. Data to that point is included in the results|3
73089|NCT01467583|174013|P1|COMPLETED|Overall Study|Both patients completed > 1 dose and so their data was included in the results.|14
73090|NCT01467583|174011|P3|STARTED|Overall Study||12
73091|NCT01467583|174012|P2|STARTED|Overall Study||4
73092|NCT01467583|174013|P1|STARTED|Overall Study||16
73093|NCT01467570|174026|P2|NOT COMPLETED|Overall Study||9
73094|NCT01467570|174027|P1|NOT COMPLETED|Overall Study||8
73095|NCT01467570|174026|P2|COMPLETED|Overall Study||63
73096|NCT01467570|174027|P1|COMPLETED|Overall Study||67
73097|NCT01467570|174026|P2|STARTED|Overall Study||72
73098|NCT01467570|174027|P1|STARTED|Overall Study||75
73099|NCT01467557|174053|P2|NOT COMPLETED|Overall Study||107
73100|NCT01467557|174054|P1|NOT COMPLETED|Overall Study||99
73101|NCT01467557|174053|P2|COMPLETED|Overall Study||463
73102|NCT01467557|174054|P1|COMPLETED|Overall Study||502
73103|NCT01467557|174053|P2|12 Month Survey Completed|Overall Study||463
73104|NCT01467557|174054|P1|12 Month Survey Completed|Overall Study||502
73105|NCT01467557|174053|P2|4 Month Survey Completed|Overall Study||493
73106|NCT01467557|174054|P1|4 Month Survey Completed|Overall Study||533
73107|NCT01467557|174053|P2|2 Week Survey Completed|Overall Study||522
73108|NCT01467557|174054|P1|2 Week Survey Completed|Overall Study||551
73109|NCT01467557|174053|P2|STARTED|Overall Study||570
73110|NCT01467557|174054|P1|STARTED|Overall Study||601
73111|NCT01467505|174064|P2|NOT COMPLETED|Overall Study||3
73112|NCT01467505|174065|P1|NOT COMPLETED|Overall Study||33
73113|NCT01467505|174064|P2|COMPLETED|Overall Study||7
73114|NCT01467505|174065|P1|COMPLETED|Overall Study||18
73115|NCT01467505|174064|P2|STARTED|Overall Study||10
73116|NCT01467505|174065|P1|STARTED|Overall Study||51
73117|NCT01467492|174097|P2|NOT COMPLETED|Overall Study||13
73118|NCT01467492|174098|P1|NOT COMPLETED|Overall Study||22
73119|NCT01467492|174097|P2|COMPLETED|Overall Study||25
73120|NCT01467492|174098|P1|COMPLETED|Overall Study||61
73121|NCT01467492|174097|P2|STARTED|Overall Study||38
73122|NCT01467492|174098|P1|STARTED|Overall Study||83
73123|NCT01467479|174122|P3|NOT COMPLETED|Overall Study||16
73124|NCT01467479|174123|P2|NOT COMPLETED|Overall Study||17
73125|NCT01467479|174124|P1|NOT COMPLETED|Overall Study||9
73126|NCT01467479|174122|P3|COMPLETED|Overall Study||45
73127|NCT01467479|174123|P2|COMPLETED|Overall Study||52
73128|NCT01467479|174124|P1|COMPLETED|Overall Study||46
73129|NCT01467479|174122|P3|Treated|Overall Study||59
73130|NCT01467479|174123|P2|Treated|Overall Study||69
73131|NCT01467479|174124|P1|Treated|Overall Study||54
73132|NCT01467479|174122|P3|STARTED|Overall Study||61
73133|NCT01467479|174123|P2|STARTED|Overall Study||69
73134|NCT01467479|174124|P1|STARTED|Overall Study||55
73135|NCT01467076|174154|P3|NOT COMPLETED|Overall Study||0
73136|NCT01467076|174155|P2|NOT COMPLETED|Overall Study||0
73137|NCT01467076|174156|P1|NOT COMPLETED|Overall Study||1
73138|NCT01467076|174154|P3|COMPLETED|Overall Study||2
73139|NCT01467076|174155|P2|COMPLETED|Overall Study||2
73140|NCT01467076|174156|P1|COMPLETED|Overall Study||2
73141|NCT01467076|174154|P3|STARTED|Overall Study||2
73142|NCT01467076|174155|P2|STARTED|Overall Study||2
73143|NCT01467076|174156|P1|STARTED|Overall Study||3
73144|NCT01467037|174166|P1|NOT COMPLETED|Overall Study||0
73145|NCT01467037|174166|P1|COMPLETED|Overall Study||374
73146|NCT01467037|174166|P1|STARTED|Overall Study||374
73147|NCT01466881|174173|P1|NOT COMPLETED|Overall Study||40
73148|NCT01466881|174173|P1|COMPLETED|Overall Study||2
73149|NCT01466881|174173|P1|Eligible and Treated|Overall Study||37
73150|NCT01466881|174173|P1|STARTED|Overall Study||42
73151|NCT01466790|174190|P8|NOT COMPLETED|Overall Study||1
73152|NCT01466790|174191|P7|NOT COMPLETED|Overall Study||1
73153|NCT01466790|174192|P6|NOT COMPLETED|Overall Study||0
73154|NCT01466790|174193|P5|NOT COMPLETED|Overall Study||3
73155|NCT01466790|174194|P4|NOT COMPLETED|Overall Study||0
73156|NCT01466790|174195|P3|NOT COMPLETED|Overall Study||0
73157|NCT01466790|174196|P2|NOT COMPLETED|Overall Study||1
73158|NCT01466790|174197|P1|NOT COMPLETED|Overall Study||4
73159|NCT01466790|174190|P8|COMPLETED|Overall Study||13
73160|NCT01466790|174191|P7|COMPLETED|Overall Study||26
73161|NCT01466790|174192|P6|COMPLETED|Overall Study||16
73162|NCT01466790|174193|P5|COMPLETED|Overall Study||27
73163|NCT01466790|174194|P4|COMPLETED|Overall Study||14
73164|NCT01466790|174195|P3|COMPLETED|Overall Study||27
73165|NCT01466790|174196|P2|COMPLETED|Overall Study||14
73166|NCT01466790|174197|P1|COMPLETED|Overall Study||20
73167|NCT01466790|174190|P8|STARTED|Overall Study||14
73168|NCT01466790|174191|P7|STARTED|Overall Study||27
73169|NCT01466790|174192|P6|STARTED|Overall Study||16
73170|NCT01466790|174193|P5|STARTED|Overall Study||30
73171|NCT01466790|174194|P4|STARTED|Overall Study||14
73172|NCT01466790|174195|P3|STARTED|Overall Study||27
73173|NCT01466790|174196|P2|STARTED|Overall Study||15
73174|NCT01466790|174197|P1|STARTED|Overall Study|Not including 1 participant who was randomized to this group, but never received treatment.|24
73175|NCT01466764|174261|P2|NOT COMPLETED|Overall Study||0
73176|NCT01466764|174262|P1|NOT COMPLETED|Overall Study||0
73177|NCT01466764|174261|P2|COMPLETED|Overall Study||5
73178|NCT01466764|174262|P1|COMPLETED|Overall Study||5
73179|NCT01466764|174261|P2|STARTED|Overall Study||5
73180|NCT01466764|174262|P1|STARTED|Overall Study||5
73181|NCT01466673|174282|P2|NOT COMPLETED|Overall Study||6
73182|NCT01466673|174283|P1|NOT COMPLETED|Overall Study||7
73183|NCT01466673|174282|P2|COMPLETED|Overall Study||95
73184|NCT01466673|174283|P1|COMPLETED|Overall Study||93
73185|NCT01466673|174282|P2|STARTED|Overall Study||101
73186|NCT01466673|174283|P1|STARTED|Overall Study||100
73187|NCT01466660|174309|P2|NOT COMPLETED|Overall Study||151
73188|NCT01466660|174310|P1|NOT COMPLETED|Overall Study||146
73189|NCT01466660|174309|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|8
73190|NCT01466660|174310|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date, 08 April 2016|14
73191|NCT01466660|174309|P2|STARTED|Overall Study||159
73192|NCT01466660|174310|P1|STARTED|Overall Study||160
73193|NCT01466595|174336|P2|NOT COMPLETED|Overall Study||1
73194|NCT01466595|174337|P1|NOT COMPLETED|Overall Study||0
73195|NCT01466595|174336|P2|COMPLETED|Overall Study||23
73196|NCT01466595|174337|P1|COMPLETED|Overall Study||49
73197|NCT01466595|174336|P2|STARTED|Overall Study||24
73198|NCT01466595|174337|P1|STARTED|Overall Study||49
73199|NCT01466491|174431|P4|NOT COMPLETED|Overall Study||0
73200|NCT01466491|174432|P3|NOT COMPLETED|Overall Study||3
73201|NCT01466491|174433|P2|NOT COMPLETED|Overall Study||3
73202|NCT01466491|174434|P1|NOT COMPLETED|Overall Study||0
73203|NCT01466491|174431|P4|COMPLETED|Overall Study||83
73204|NCT01466491|174432|P3|COMPLETED|Overall Study||80
73205|NCT01466491|174433|P2|COMPLETED|Overall Study||80
73206|NCT01466491|174434|P1|COMPLETED|Overall Study||83
73207|NCT01466491|174431|P4|STARTED|Overall Study||83
73208|NCT01466491|174432|P3|STARTED|Overall Study||83
73209|NCT01466491|174433|P2|STARTED|Overall Study||83
73210|NCT01466491|174434|P1|STARTED|Overall Study||83
73211|NCT01466387|174454|P6|NOT COMPLETED|Overall Study||1
73212|NCT01466387|174455|P5|NOT COMPLETED|Overall Study||0
73213|NCT01466387|174456|P4|NOT COMPLETED|Overall Study||2
73214|NCT01466387|174457|P3|NOT COMPLETED|Overall Study||1
73215|NCT01466387|174458|P2|NOT COMPLETED|Overall Study||0
73216|NCT01466387|174459|P1|NOT COMPLETED|Overall Study||1
73217|NCT01466387|174454|P6|COMPLETED|Overall Study||99
73218|NCT01466387|174455|P5|COMPLETED|Overall Study||51
73219|NCT01466387|174456|P4|COMPLETED|Overall Study||99
73220|NCT01466387|174457|P3|COMPLETED|Overall Study||98
73221|NCT01466387|174458|P2|COMPLETED|Overall Study||100
73222|NCT01466387|174459|P1|COMPLETED|Overall Study||100
73223|NCT01466387|174454|P6|STARTED|Overall Study||100
73224|NCT01466387|174455|P5|STARTED|Overall Study||51
73225|NCT01466387|174456|P4|STARTED|Overall Study||101
73226|NCT01466387|174457|P3|STARTED|Overall Study||99
73227|NCT01466387|174458|P2|STARTED|Overall Study||100
73228|NCT01466387|174459|P1|STARTED|Overall Study||101
73229|NCT01466361|174501|P4|NOT COMPLETED|Overall Study||0
73230|NCT01466361|174502|P3|NOT COMPLETED|Overall Study||0
73231|NCT01466361|174503|P2|NOT COMPLETED|Overall Study||0
73232|NCT01466361|174504|P1|NOT COMPLETED|Overall Study||0
73233|NCT01466361|174501|P4|COMPLETED|Overall Study||41
73234|NCT01466361|174502|P3|COMPLETED|Overall Study||60
73235|NCT01466361|174503|P2|COMPLETED|Overall Study||34
73236|NCT01466361|174504|P1|COMPLETED|Overall Study||52
73237|NCT01466361|174501|P4|STARTED|Overall Study||41
73238|NCT01466361|174502|P3|STARTED|Overall Study||60
73239|NCT01466361|174503|P2|STARTED|Overall Study||34
73240|NCT01466361|174504|P1|STARTED|Overall Study||52
73241|NCT01466348|174520|P2|NOT COMPLETED|Period II - Second Intervention||0
73242|NCT01466348|174521|P1|NOT COMPLETED|Period II - Second Intervention||0
73243|NCT01466348|174520|P2|COMPLETED|Period II - Second Intervention||36
73244|NCT01466348|174521|P1|COMPLETED|Period II - Second Intervention||35
73245|NCT01466348|174520|P2|STARTED|Period II - Second Intervention||36
73246|NCT01466348|174521|P1|STARTED|Period II - Second Intervention||35
73247|NCT01466348|174520|P2|NOT COMPLETED|Period I - First Intervention||1
73248|NCT01466348|174521|P1|NOT COMPLETED|Period I - First Intervention||0
73249|NCT01466348|174520|P2|COMPLETED|Period I - First Intervention||35
73250|NCT01466348|174521|P1|COMPLETED|Period I - First Intervention||36
73251|NCT01466348|174520|P2|Intent To Treat (ITT) Population|Period I - First Intervention|1 participant withdrew prior receiving the treatment|35
73252|NCT01466348|174521|P1|Intent To Treat (ITT) Population|Period I - First Intervention||36
73253|NCT01466348|174520|P2|STARTED|Period I - First Intervention||36
73254|NCT01466348|174521|P1|STARTED|Period I - First Intervention||36
73255|NCT01466270|174549|P2|NOT COMPLETED|Overall Study||6
73256|NCT01466270|174550|P1|NOT COMPLETED|Overall Study||12
73257|NCT01466270|174549|P2|COMPLETED|Overall Study||25
73258|NCT01466270|174550|P1|COMPLETED|Overall Study||19
73259|NCT01466270|174549|P2|STARTED|Overall Study||31
73260|NCT01466270|174550|P1|STARTED|Overall Study||31
73261|NCT01466192|174562|P1|NOT COMPLETED|Overall Study||4
73262|NCT01466192|174562|P1|COMPLETED|Overall Study||104
73263|NCT01466192|174562|P1|STARTED|Overall Study||108
73264|NCT01466179|174566|P1|NOT COMPLETED|Overall Study||179
73265|NCT01466179|174566|P1|COMPLETED|Overall Study|Completed 5 cycles of treatment; Data as of the time of the data cut-off date (10 October 2013).|10
73266|NCT01466179|174566|P1|STARTED|Overall Study|Participants enrolled during the first 3 stages of the study|189
73267|NCT01466153|174589|P3|NOT COMPLETED|Overall Study||25
73268|NCT01466153|174590|P2|NOT COMPLETED|Overall Study||24
73269|NCT01466153|174591|P1|NOT COMPLETED|Overall Study||29
73270|NCT01466153|174589|P3|COMPLETED|Overall Study||36
73271|NCT01466153|174590|P2|COMPLETED|Overall Study||12
73272|NCT01466153|174591|P1|COMPLETED|Overall Study||33
73273|NCT01466153|174589|P3|STARTED|Overall Study||61
73274|NCT01466153|174590|P2|STARTED|Overall Study||36
73275|NCT01466153|174591|P1|STARTED|Overall Study||62
73276|NCT01466127|174632|P2|NOT COMPLETED|Overall Study||16
73277|NCT01466127|174633|P1|NOT COMPLETED|Overall Study||14
73278|NCT01466127|174632|P2|COMPLETED|Overall Study||14
73279|NCT01466127|174633|P1|COMPLETED|Overall Study||16
73280|NCT01466127|174632|P2|STARTED|Overall Study||30
73281|NCT01466127|174633|P1|STARTED|Overall Study||30
73282|NCT01466075|174639|P1|NOT COMPLETED|Overall Study||0
73283|NCT01466075|174639|P1|COMPLETED|Overall Study||207
73284|NCT01466075|174639|P1|STARTED|Overall Study||207
73285|NCT01466062|174646|P1|NOT COMPLETED|Overall Study||2
73286|NCT01466062|174646|P1|COMPLETED|Overall Study||26
73287|NCT01466062|174646|P1|STARTED|Overall Study||28
73288|NCT01465997|174669|P2|NOT COMPLETED|Overall Study||89
73289|NCT01465997|174670|P1|NOT COMPLETED|Overall Study||68
73290|NCT01465997|174669|P2|COMPLETED|Overall Study||180
73291|NCT01465997|174670|P1|COMPLETED|Overall Study||211
73292|NCT01465997|174669|P2|STARTED|Overall Study||269
73293|NCT01465997|174670|P1|STARTED|Overall Study||279
73294|NCT01465958|174680|P2|NOT COMPLETED|Subcutaneous (SC) Phase||1
73295|NCT01465958|174681|P1|NOT COMPLETED|Subcutaneous (SC) Phase||0
73296|NCT01465958|174680|P2|COMPLETED|Subcutaneous (SC) Phase||10
73297|NCT01465958|174681|P1|COMPLETED|Subcutaneous (SC) Phase||0
73298|NCT01465958|174680|P2|STARTED|Subcutaneous (SC) Phase|Eleven subjects completed the IV phase and entered the SC phase.|11
73299|NCT01465958|174681|P1|STARTED|Subcutaneous (SC) Phase|After completing the intravenous (IV) phase, subjects entered the subcutaneous (SC) phase.|0
73300|NCT01465958|174680|P2|NOT COMPLETED|Intravenous (IV) Phase||0
73301|NCT01465958|174681|P1|NOT COMPLETED|Intravenous (IV) Phase||0
73302|NCT01465958|174680|P2|COMPLETED|Intravenous (IV) Phase||0
73303|NCT01465958|174681|P1|COMPLETED|Intravenous (IV) Phase||11
73304|NCT01465958|174680|P2|STARTED|Intravenous (IV) Phase||0
73305|NCT01465958|174681|P1|STARTED|Intravenous (IV) Phase|One subject entered the IV phase directly.|11
73306|NCT01465958|174680|P2|NOT COMPLETED|Run-in Phase||0
73307|NCT01465958|174681|P1|NOT COMPLETED|Run-in Phase||1
73308|NCT01465958|174680|P2|COMPLETED|Run-in Phase||0
73309|NCT01465958|174681|P1|COMPLETED|Run-in Phase||10
73310|NCT01465958|174680|P2|STARTED|Run-in Phase||0
73311|NCT01465958|174681|P1|STARTED|Run-in Phase||11
73312|NCT01465802|174694|P5|NOT COMPLETED|Overall Study||12
73313|NCT01465802|174695|P4|NOT COMPLETED|Overall Study||29
73314|NCT01465802|174696|P3|NOT COMPLETED|Overall Study||0
73315|NCT01465802|174697|P2|NOT COMPLETED|Overall Study||24
73316|NCT01465802|174698|P1|NOT COMPLETED|Overall Study||33
73317|NCT01465802|174694|P5|COMPLETED|Overall Study||13
73318|NCT01465802|174695|P4|COMPLETED|Overall Study||38
73319|NCT01465802|174696|P3|COMPLETED|Overall Study||7
73320|NCT01465802|174697|P2|COMPLETED|Overall Study||42
73321|NCT01465802|174698|P1|COMPLETED|Overall Study||33
73322|NCT01465802|174694|P5|STARTED|Overall Study||25
73323|NCT01465802|174695|P4|STARTED|Overall Study|An additional 5 participants were enrolled in Cohort II but not treated.|67
73324|NCT01465802|174696|P3|STARTED|Overall Study||7
73325|NCT01465802|174697|P2|STARTED|Overall Study||66
73326|NCT01465802|174698|P1|STARTED|Overall Study||66
73327|NCT01465763|174750|P3|NOT COMPLETED|Overall Study||4
73328|NCT01465763|174751|P2|NOT COMPLETED|Overall Study||1
73329|NCT01465763|174752|P1|NOT COMPLETED|Overall Study||31
73330|NCT01465763|174750|P3|COMPLETED|Overall Study||118
73331|NCT01465763|174751|P2|COMPLETED|Overall Study||15
73332|NCT01465763|174752|P1|COMPLETED|Overall Study||445
73333|NCT01465763|174750|P3|STARTED|Overall Study||122
73334|NCT01465763|174751|P2|STARTED|Overall Study||16
73335|NCT01465763|174752|P1|STARTED|Overall Study||476
73336|NCT01465412|174781|P4|NOT COMPLETED|Overall Study||0
73337|NCT01465412|174782|P3|NOT COMPLETED|Overall Study||0
73338|NCT01465412|174783|P2|NOT COMPLETED|Overall Study||0
73339|NCT01465412|174784|P1|NOT COMPLETED|Overall Study||0
73340|NCT01465412|174781|P4|COMPLETED|Overall Study||9
73341|NCT01465412|174782|P3|COMPLETED|Overall Study||9
73342|NCT01465412|174783|P2|COMPLETED|Overall Study||12
73343|NCT01465412|174784|P1|COMPLETED|Overall Study||12
73344|NCT01465412|174781|P4|STARTED|Overall Study||9
73345|NCT01465412|174782|P3|STARTED|Overall Study||9
73346|NCT01465412|174783|P2|STARTED|Overall Study||12
73347|NCT01465412|174784|P1|STARTED|Overall Study||12
73348|NCT01465386|174822|P1|NOT COMPLETED|Overall Study||4
73349|NCT01465386|174822|P1|COMPLETED|Overall Study||2
73350|NCT01465386|174822|P1|STARTED|Overall Study||6
73351|NCT01465347|174826|P2|NOT COMPLETED|Overall Study||3
73352|NCT01465347|174827|P1|NOT COMPLETED|Overall Study||1
73353|NCT01465347|174826|P2|COMPLETED|Overall Study||53
73354|NCT01465347|174827|P1|COMPLETED|Overall Study||2
73355|NCT01465347|174826|P2|STARTED|Overall Study||56
73356|NCT01465347|174827|P1|STARTED|Overall Study||3
73357|NCT01465230|174837|P1|NOT COMPLETED|Overall Study||2
73358|NCT01465230|174837|P1|COMPLETED|Overall Study||0
73359|NCT01465230|174837|P1|STARTED|Overall Study||2
73360|NCT01465178|174843|P2|NOT COMPLETED|Overall Study||0
73361|NCT01465178|174844|P1|NOT COMPLETED|Overall Study||1
73362|NCT01465178|174843|P2|COMPLETED|Overall Study||31
73363|NCT01465178|174844|P1|COMPLETED|Overall Study||30
73364|NCT01465178|174843|P2|STARTED|Overall Study||31
73365|NCT01465178|174844|P1|STARTED|Overall Study||31
73366|NCT01465048|174855|P3|NOT COMPLETED|Overall Study||0
73367|NCT01465048|174856|P2|NOT COMPLETED|Overall Study||0
73368|NCT01465048|174857|P1|NOT COMPLETED|Overall Study||0
73369|NCT01465048|174855|P3|COMPLETED|Overall Study||6
73370|NCT01465048|174856|P2|COMPLETED|Overall Study||6
73371|NCT01465048|174857|P1|COMPLETED|Overall Study||6
73372|NCT01465048|174855|P3|STARTED|Overall Study||6
73373|NCT01465048|174856|P2|STARTED|Overall Study||6
73374|NCT01465048|174857|P1|STARTED|Overall Study||6
73375|NCT01465022|174868|P3|NOT COMPLETED|Overall Study||70
73376|NCT01465022|174869|P2|NOT COMPLETED|Overall Study||23
73377|NCT01465022|174870|P1|NOT COMPLETED|Overall Study||23
73378|NCT01465022|174868|P3|COMPLETED|Overall Study||0
73379|NCT01465022|174869|P2|COMPLETED|Overall Study||40
73380|NCT01465022|174870|P1|COMPLETED|Overall Study||41
73381|NCT01465022|174868|P3|STARTED|Overall Study||70
73382|NCT01465022|174869|P2|STARTED|Overall Study||63
73383|NCT01465022|174870|P1|STARTED|Overall Study||64
73384|NCT01464996|174884|P1|NOT COMPLETED|Overall Study||0
73385|NCT01464996|174884|P1|COMPLETED|Overall Study||24
73386|NCT01464996|174884|P1|OptiBond FL|Overall Study||24
73387|NCT01464996|174884|P1|OptiBond XTR|Overall Study||23
73388|NCT01464996|174884|P1|STARTED|Overall Study||24
73389|NCT01464931|174904|P2|NOT COMPLETED|Overall Study||0
73390|NCT01464931|174905|P1|NOT COMPLETED|Overall Study||1
73391|NCT01464931|174904|P2|COMPLETED|Overall Study||16
73392|NCT01464931|174905|P1|COMPLETED|Overall Study||15
73393|NCT01464931|174904|P2|STARTED|Overall Study||16
73394|NCT01464931|174905|P1|STARTED|Overall Study||16
73395|NCT01464879|174942|P1|NOT COMPLETED|Overall Study||2
73396|NCT01464879|174942|P1|COMPLETED|Overall Study||18
73397|NCT01464879|174942|P1|STARTED|Overall Study||20
73398|NCT01464840|174979|P3|NOT COMPLETED|Overall Study||0
73399|NCT01464840|174980|P2|NOT COMPLETED|Overall Study||0
73400|NCT01464840|174981|P1|NOT COMPLETED|Overall Study||0
73401|NCT01464840|174979|P3|COMPLETED|Overall Study||10
73402|NCT01464840|174980|P2|COMPLETED|Overall Study||10
73403|NCT01464840|174981|P1|COMPLETED|Overall Study||10
73404|NCT01464840|174979|P3|STARTED|Overall Study||10
73405|NCT01464840|174980|P2|STARTED|Overall Study||10
73406|NCT01464840|174981|P1|STARTED|Overall Study||10
73407|NCT01464827|175003|P14|NOT COMPLETED|Overall Study||3
73408|NCT01464827|175004|P13|NOT COMPLETED|Overall Study||2
73409|NCT01464827|175005|P12|NOT COMPLETED|Overall Study||2
73410|NCT01464827|175006|P11|NOT COMPLETED|Overall Study||2
73411|NCT01464827|175007|P10|NOT COMPLETED|Overall Study||3
73412|NCT01464827|175008|P9|NOT COMPLETED|Overall Study||3
73413|NCT01464827|175009|P8|NOT COMPLETED|Overall Study||3
73414|NCT01464827|175010|P7|NOT COMPLETED|Overall Study||4
73415|NCT01464827|175011|P6|NOT COMPLETED|Overall Study||1
73416|NCT01464827|175012|P5|NOT COMPLETED|Overall Study||8
73417|NCT01464827|175013|P4|NOT COMPLETED|Overall Study||4
73418|NCT01464827|175014|P3|NOT COMPLETED|Overall Study||0
73419|NCT01464827|175015|P2|NOT COMPLETED|Overall Study||7
73420|NCT01464827|175016|P1|NOT COMPLETED|Overall Study||3
73421|NCT01464827|175003|P14|COMPLETED|Overall Study||19
73422|NCT01464827|175004|P13|COMPLETED|Overall Study||21
73423|NCT01464827|175005|P12|COMPLETED|Overall Study||21
73424|NCT01464827|175006|P11|COMPLETED|Overall Study||21
73425|NCT01464827|175007|P10|COMPLETED|Overall Study||44
73426|NCT01464827|175008|P9|COMPLETED|Overall Study||37
73427|NCT01464827|175009|P8|COMPLETED|Overall Study||37
73428|NCT01464827|175010|P7|COMPLETED|Overall Study||37
73429|NCT01464827|175011|P6|COMPLETED|Overall Study||38
73430|NCT01464827|175012|P5|COMPLETED|Overall Study||72
73431|NCT01464827|175013|P4|COMPLETED|Overall Study||36
73432|NCT01464827|175014|P3|COMPLETED|Overall Study||39
73433|NCT01464827|175015|P2|COMPLETED|Overall Study||36
73434|NCT01464827|175016|P1|COMPLETED|Overall Study||77
73435|NCT01464827|175003|P14|Treated|Overall Study||20
73436|NCT01464827|175004|P13|Treated|Overall Study||23
73437|NCT01464827|175005|P12|Treated|Overall Study||22
73438|NCT01464827|175006|P11|Treated|Overall Study||23
73439|NCT01464827|175007|P10|Treated|Overall Study||45
73440|NCT01464827|175008|P9|Treated|Overall Study||40
73441|NCT01464827|175009|P8|Treated|Overall Study||40
73442|NCT01464827|175010|P7|Treated|Overall Study||40
73443|NCT01464827|175011|P6|Treated|Overall Study||39
73444|NCT01464827|175012|P5|Treated|Overall Study||79
73445|NCT01464827|175013|P4|Treated|Overall Study||40
73446|NCT01464827|175014|P3|Treated|Overall Study||39
73447|NCT01464827|175015|P2|Treated|Overall Study||41
73448|NCT01464827|175016|P1|Treated|Overall Study||80
73449|NCT01464827|175003|P14|STARTED|Overall Study||22
73450|NCT01464827|175004|P13|STARTED|Overall Study||23
73451|NCT01464827|175005|P12|STARTED|Overall Study||23
73452|NCT01464827|175006|P11|STARTED|Overall Study||23
73453|NCT01464827|175007|P10|STARTED|Overall Study||47
73454|NCT01464827|175008|P9|STARTED|Overall Study||40
73455|NCT01464827|175009|P8|STARTED|Overall Study||40
73456|NCT01464827|175010|P7|STARTED|Overall Study||41
73457|NCT01464827|175011|P6|STARTED|Overall Study||39
73458|NCT01464827|175012|P5|STARTED|Overall Study||80
73459|NCT01464827|175013|P4|STARTED|Overall Study||40
73460|NCT01464827|175014|P3|STARTED|Overall Study||39
73461|NCT01464827|175015|P2|STARTED|Overall Study||43
73462|NCT01464827|175016|P1|STARTED|Overall Study||80
73463|NCT01464788|175063|P3|NOT COMPLETED|Overall Study||0
73464|NCT01464788|175064|P2|NOT COMPLETED|Overall Study||2
73465|NCT01464788|175065|P1|NOT COMPLETED|Overall Study||0
73466|NCT01464788|175063|P3|COMPLETED|Overall Study||29
73467|NCT01464788|175064|P2|COMPLETED|Overall Study||29
73468|NCT01464788|175065|P1|COMPLETED|Overall Study||30
73469|NCT01464788|175063|P3|STARTED|Overall Study||29
73470|NCT01464788|175064|P2|STARTED|Overall Study||31
73471|NCT01464788|175065|P1|STARTED|Overall Study||30
73472|NCT01464619|175078|P2|NOT COMPLETED|Overall Study||4
73473|NCT01464619|175079|P1|NOT COMPLETED|Overall Study||3
73474|NCT01464619|175078|P2|COMPLETED|Overall Study||25
73475|NCT01464619|175079|P1|COMPLETED|Overall Study||29
73476|NCT01464619|175078|P2|STARTED|Overall Study||29
73477|NCT01464619|175079|P1|STARTED|Overall Study||32
73478|NCT01464424|175099|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
73479|NCT01464424|175100|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
73480|NCT01464424|175099|P2|COMPLETED|Period 2, Second 6 Weeks||41
73481|NCT01464424|175100|P1|COMPLETED|Period 2, Second 6 Weeks||42
73482|NCT01464424|175099|P2|STARTED|Period 2, Second 6 Weeks||41
73483|NCT01464424|175100|P1|STARTED|Period 2, Second 6 Weeks||42
73484|NCT01464424|175099|P2|NOT COMPLETED|Period 1, First 6 Weeks||1
73485|NCT01464424|175100|P1|NOT COMPLETED|Period 1, First 6 Weeks||0
73486|NCT01464424|175099|P2|COMPLETED|Period 1, First 6 Weeks||41
73487|NCT01464424|175100|P1|COMPLETED|Period 1, First 6 Weeks||42
73488|NCT01464424|175099|P2|STARTED|Period 1, First 6 Weeks||42
73489|NCT01464424|175100|P1|STARTED|Period 1, First 6 Weeks||42
73490|NCT01464359|175108|P1|NOT COMPLETED|Overall Study||0
73491|NCT01464359|175108|P1|COMPLETED|Overall Study||3
73492|NCT01464359|175108|P1|STARTED|Overall Study||3
73493|NCT01464307|175122|P2|NOT COMPLETED|Open-Label Extension Period||0
73494|NCT01464307|175123|P1|NOT COMPLETED|Open-Label Extension Period||51
73495|NCT01464307|175122|P2|COMPLETED|Open-Label Extension Period||0
73496|NCT01464307|175123|P1|COMPLETED|Open-Label Extension Period||218
73497|NCT01464307|175122|P2|Treated|Open-Label Extension Period||0
73498|NCT01464307|175123|P1|Treated|Open-Label Extension Period||269
73499|NCT01464307|175122|P2|STARTED|Open-Label Extension Period||0
73500|NCT01464307|175123|P1|STARTED|Open-Label Extension Period||269
73501|NCT01464307|175122|P2|NOT COMPLETED|Main Period||5
73502|NCT01464307|175123|P1|NOT COMPLETED|Main Period||15
73503|NCT01464307|175122|P2|COMPLETED|Main Period||140
73504|NCT01464307|175123|P1|COMPLETED|Main Period||129
73505|NCT01464307|175122|P2|Treated|Main Period||145
73506|NCT01464307|175123|P1|Treated|Main Period||144
73507|NCT01464307|175122|P2|STARTED|Main Period||145
73508|NCT01464307|175123|P1|STARTED|Main Period||144
73509|NCT01464255|175138|P2|NOT COMPLETED|Overall Study||1
73510|NCT01464255|175139|P1|NOT COMPLETED|Overall Study||0
73511|NCT01464255|175138|P2|COMPLETED|Overall Study||24
73512|NCT01464255|175139|P1|COMPLETED|Overall Study||25
73513|NCT01464255|175138|P2|STARTED|Overall Study||25
73514|NCT01464255|175139|P1|STARTED|Overall Study||25
73515|NCT01464229|175164|P2|NOT COMPLETED|Overall Study||2
73516|NCT01464229|175165|P1|NOT COMPLETED|Overall Study||5
73517|NCT01464229|175164|P2|COMPLETED|Overall Study||8
73518|NCT01464229|175165|P1|COMPLETED|Overall Study||5
73519|NCT01464229|175164|P2|STARTED|Overall Study||10
73520|NCT01464229|175165|P1|STARTED|Overall Study||10
73521|NCT01464190|175173|P2|NOT COMPLETED|Overall Study||41
73522|NCT01464190|175174|P1|NOT COMPLETED|Overall Study||69
73523|NCT01464190|175173|P2|COMPLETED|Overall Study||227
73524|NCT01464190|175174|P1|COMPLETED|Overall Study||322
73525|NCT01464190|175173|P2|STARTED|Overall Study||268
73526|NCT01464190|175174|P1|STARTED|Overall Study||391
73527|NCT01464021|175184|P1|NOT COMPLETED|Overall Study||26
73528|NCT01464021|175184|P1|COMPLETED|Overall Study||0
73529|NCT01464021|175184|P1|STARTED|Overall Study||26
73530|NCT01463982|175200|P4|NOT COMPLETED|Overall Study||0
73531|NCT01463982|175201|P3|NOT COMPLETED|Overall Study||2
73532|NCT01463982|175202|P2|NOT COMPLETED|Overall Study||1
73533|NCT01463982|175203|P1|NOT COMPLETED|Overall Study||0
73534|NCT01463982|175200|P4|COMPLETED|Overall Study||6
73535|NCT01463982|175201|P3|COMPLETED|Overall Study||2
73536|NCT01463982|175202|P2|COMPLETED|Overall Study||7
73537|NCT01463982|175203|P1|COMPLETED|Overall Study||3
73538|NCT01463982|175200|P4|STARTED|Overall Study||6
73539|NCT01463982|175201|P3|STARTED|Overall Study||4
73540|NCT01463982|175202|P2|STARTED|Overall Study||8
73541|NCT01463982|175203|P1|STARTED|Overall Study||3
73542|NCT01463878|175219|P2|NOT COMPLETED|Overall Study||2
73543|NCT01463878|175220|P1|NOT COMPLETED|Overall Study||2
73544|NCT01463878|175219|P2|COMPLETED|Overall Study||7
73545|NCT01463878|175220|P1|COMPLETED|Overall Study||7
73546|NCT01463878|175219|P2|STARTED|Overall Study||9
73547|NCT01463878|175220|P1|STARTED|Overall Study||9
73548|NCT01463696|175234|P8|NOT COMPLETED|Overall Study||4
73549|NCT01463696|175235|P7|NOT COMPLETED|Overall Study||10
73550|NCT01463696|175236|P6|NOT COMPLETED|Overall Study||3
73551|NCT01463696|175237|P5|NOT COMPLETED|Overall Study||1
73552|NCT01463696|175238|P4|NOT COMPLETED|Overall Study||4
73553|NCT01463696|175239|P3|NOT COMPLETED|Overall Study||1
73554|NCT01463696|175240|P2|NOT COMPLETED|Overall Study||2
73555|NCT01463696|175241|P1|NOT COMPLETED|Overall Study||0
73556|NCT01463696|175234|P8|COMPLETED|Overall Study||2
73557|NCT01463696|175235|P7|COMPLETED|Overall Study||6
73558|NCT01463696|175236|P6|COMPLETED|Overall Study||3
73559|NCT01463696|175237|P5|COMPLETED|Overall Study||2
73560|NCT01463696|175238|P4|COMPLETED|Overall Study||3
73561|NCT01463696|175239|P3|COMPLETED|Overall Study||2
73562|NCT01463696|175240|P2|COMPLETED|Overall Study||4
73563|NCT01463696|175241|P1|COMPLETED|Overall Study||1
73564|NCT01463696|175234|P8|Treated|Overall Study||6
73565|NCT01463696|175235|P7|Treated|Overall Study||15
73566|NCT01463696|175236|P6|Treated|Overall Study||6
73567|NCT01463696|175237|P5|Treated|Overall Study||3
73568|NCT01463696|175238|P4|Treated|Overall Study||7
73569|NCT01463696|175239|P3|Treated|Overall Study||3
73570|NCT01463696|175240|P2|Treated|Overall Study||6
73571|NCT01463696|175241|P1|Treated|Overall Study||1
73572|NCT01463696|175234|P8|STARTED|Overall Study||6
73573|NCT01463696|175235|P7|STARTED|Overall Study||16
73574|NCT01463696|175236|P6|STARTED|Overall Study||6
73575|NCT01463696|175237|P5|STARTED|Overall Study||3
73576|NCT01463696|175238|P4|STARTED|Overall Study||7
73577|NCT01463696|175239|P3|STARTED|Overall Study||3
73578|NCT01463696|175240|P2|STARTED|Overall Study||6
73579|NCT01463696|175241|P1|STARTED|Overall Study||1
73580|NCT01463683|175294|P3|NOT COMPLETED|Overall Study||11
73581|NCT01463683|175295|P2|NOT COMPLETED|Overall Study||31
73582|NCT01463683|175296|P1|NOT COMPLETED|Overall Study||19
73583|NCT01463683|175294|P3|COMPLETED|Overall Study||93
73584|NCT01463683|175295|P2|COMPLETED|Overall Study||278
73585|NCT01463683|175296|P1|COMPLETED|Overall Study||290
73586|NCT01463683|175294|P3|Received Vaccination 3 (Month 6)|Overall Study||93
73587|NCT01463683|175295|P2|Received Vaccination 3 (Month 6)|Overall Study||281
73588|NCT01463683|175296|P1|Received Vaccination 3 (Month 6)|Overall Study||290
73589|NCT01463683|175294|P3|Received Vaccination 2 (Month 1)|Overall Study||103
73590|NCT01463683|175295|P2|Received Vaccination 2 (Month 1)|Overall Study||300
73591|NCT01463683|175296|P1|Received Vaccination 2 (Month 1)|Overall Study||302
73592|NCT01463683|175294|P3|Received Vaccination 1 (Day 1)|Overall Study||104
73593|NCT01463683|175295|P2|Received Vaccination 1 (Day 1)|Overall Study||308
73594|NCT01463683|175296|P1|Received Vaccination 1 (Day 1)|Overall Study||309
73595|NCT01463683|175294|P3|STARTED|Overall Study||104
73596|NCT01463683|175295|P2|STARTED|Overall Study||309
73597|NCT01463683|175296|P1|STARTED|Overall Study||309
73598|NCT01462773|175309|P1|NOT COMPLETED|Overall Study||0
73599|NCT01462773|175309|P1|COMPLETED|Overall Study||16
73600|NCT01462773|175309|P1|STARTED|Overall Study||16
73601|NCT01463527|175316|P2|NOT COMPLETED|Overall Study||7
73602|NCT01463527|175317|P1|NOT COMPLETED|Overall Study||6
73603|NCT01463527|175316|P2|COMPLETED|Overall Study||77
73604|NCT01463527|175317|P1|COMPLETED|Overall Study||77
73605|NCT01463527|175316|P2|STARTED|Overall Study||84
73606|NCT01463527|175317|P1|STARTED|Overall Study||83
73607|NCT01463384|175323|P1|NOT COMPLETED|Overall Study||0
73608|NCT01463384|175323|P1|COMPLETED|Overall Study||13
73609|NCT01463384|175323|P1|STARTED|Overall Study||13
73610|NCT01463293|175338|P3|NOT COMPLETED|Overall Study||12
73611|NCT01463293|175339|P2|NOT COMPLETED|Overall Study||16
73612|NCT01463293|175340|P1|NOT COMPLETED|Overall Study||6
73613|NCT01463293|175338|P3|COMPLETED|Overall Study||59
73614|NCT01463293|175339|P2|COMPLETED|Overall Study||63
73615|NCT01463293|175340|P1|COMPLETED|Overall Study||68
73616|NCT01463293|175338|P3|STARTED|Overall Study||71
73617|NCT01463293|175339|P2|STARTED|Overall Study||79
73618|NCT01463293|175340|P1|STARTED|Overall Study||74
73619|NCT01463111|175348|P1|NOT COMPLETED|Overall Study||9
73620|NCT01463111|175348|P1|COMPLETED|Overall Study||17
73621|NCT01463111|175348|P1|STARTED|Overall Study||26
73622|NCT01463033|175358|P2|NOT COMPLETED|Overall Study||6
73623|NCT01463033|175359|P1|NOT COMPLETED|Overall Study||7
73624|NCT01463033|175358|P2|COMPLETED|Overall Study|2 deaths, 4 lost to follow up|54
73625|NCT01463033|175359|P1|COMPLETED|Overall Study|3 deaths, 4 lost to follow up|59
73626|NCT01463033|175358|P2|STARTED|Overall Study||60
73627|NCT01463033|175359|P1|STARTED|Overall Study||66
73628|NCT01463007|175366|P1|NOT COMPLETED|Overall Study||1
73629|NCT01463007|175366|P1|COMPLETED|Overall Study||40
73630|NCT01463007|175366|P1|STARTED|Overall Study||41
73631|NCT01462942|175377|P5|NOT COMPLETED|Overall Study||45
73632|NCT01462942|175378|P4|NOT COMPLETED|Overall Study||50
73633|NCT01462942|175379|P3|NOT COMPLETED|Overall Study||40
73634|NCT01462942|175380|P2|NOT COMPLETED|Overall Study||34
73635|NCT01462942|175381|P1|NOT COMPLETED|Overall Study||34
73636|NCT01462942|175377|P5|COMPLETED|Overall Study||339
73637|NCT01462942|175378|P4|COMPLETED|Overall Study||335
73638|NCT01462942|175379|P3|COMPLETED|Overall Study||341
73639|NCT01462942|175380|P2|COMPLETED|Overall Study||351
73640|NCT01462942|175381|P1|COMPLETED|Overall Study||160
73641|NCT01462942|175377|P5|STARTED|Overall Study||384
73642|NCT01462942|175378|P4|STARTED|Overall Study||385
73643|NCT01462942|175379|P3|STARTED|Overall Study||381
73644|NCT01462942|175380|P2|STARTED|Overall Study||385
73645|NCT01462942|175381|P1|STARTED|Overall Study||194
73646|NCT01462929|175411|P3|NOT COMPLETED|Overall Study||5
73647|NCT01462929|175412|P2|NOT COMPLETED|Overall Study||4
73648|NCT01462929|175413|P1|NOT COMPLETED|Overall Study||5
73649|NCT01462929|175411|P3|COMPLETED|Overall Study||80
73650|NCT01462929|175412|P2|COMPLETED|Overall Study||154
73651|NCT01462929|175413|P1|COMPLETED|Overall Study||166
73652|NCT01462929|175411|P3|STARTED|Overall Study||85
73653|NCT01462929|175412|P2|STARTED|Overall Study||158
73654|NCT01462929|175413|P1|STARTED|Overall Study||171
73655|NCT01462877|175424|P1|NOT COMPLETED|Overall Study||71
73656|NCT01462877|175424|P1|COMPLETED|Overall Study||435
73657|NCT01462877|175424|P1|Per-protocol Set|Overall Study||364
73658|NCT01462877|175424|P1|Full Analysis Set|Overall Study||468
73659|NCT01462877|175424|P1|Safety Set|Overall Study||492
73660|NCT01462877|175424|P1|STARTED|Overall Study||506
73661|NCT01462812|175440|P2|NOT COMPLETED|Overall Study||1
73662|NCT01462812|175441|P1|NOT COMPLETED|Overall Study||0
73663|NCT01462812|175440|P2|COMPLETED|Overall Study||111
73664|NCT01462812|175441|P1|COMPLETED|Overall Study||111
73665|NCT01462812|175440|P2|STARTED|Overall Study||112
73666|NCT01462812|175441|P1|STARTED|Overall Study||111
73667|NCT01462695|175449|P2|NOT COMPLETED|Overall Study||13
73668|NCT01462695|175450|P1|NOT COMPLETED|Overall Study||17
73669|NCT01462695|175449|P2|COMPLETED|Overall Study||0
73670|NCT01462695|175450|P1|COMPLETED|Overall Study||0
73671|NCT01462695|175449|P2|STARTED|Overall Study||13
73672|NCT01462695|175450|P1|STARTED|Overall Study||17
73673|NCT01462435|175460|P4|NOT COMPLETED|Overall Study||5
73674|NCT01462435|175461|P3|NOT COMPLETED|Overall Study||1
73675|NCT01462435|175462|P2|NOT COMPLETED|Overall Study||0
73676|NCT01462435|175463|P1|NOT COMPLETED|Overall Study||1
73677|NCT01462435|175460|P4|COMPLETED|Overall Study||101
73678|NCT01462435|175461|P3|COMPLETED|Overall Study||106
73679|NCT01462435|175462|P2|COMPLETED|Overall Study||109
73680|NCT01462435|175463|P1|COMPLETED|Overall Study||105
73681|NCT01462435|175460|P4|STARTED|Overall Study||106
73682|NCT01462435|175461|P3|STARTED|Overall Study||107
73683|NCT01462435|175462|P2|STARTED|Overall Study||109
73684|NCT01462435|175463|P1|STARTED|Overall Study||106
73685|NCT01462370|175501|P2|NOT COMPLETED|Overall Study||5
73686|NCT01462370|175502|P1|NOT COMPLETED|Overall Study||1
73687|NCT01462370|175501|P2|COMPLETED|Overall Study||65
73688|NCT01462370|175502|P1|COMPLETED|Overall Study||68
73689|NCT01462370|175501|P2|STARTED|Overall Study||70
73690|NCT01462370|175502|P1|STARTED|Overall Study||69
73691|NCT01462357|175537|P3|NOT COMPLETED|Month 36||0
73692|NCT01462357|175538|P2|NOT COMPLETED|Month 36||0
73693|NCT01462357|175539|P1|NOT COMPLETED|Month 36||0
73694|NCT01462357|175537|P3|COMPLETED|Month 36||346
73695|NCT01462357|175538|P2|COMPLETED|Month 36||339
73696|NCT01462357|175539|P1|COMPLETED|Month 36||351
73697|NCT01462357|175537|P3|STARTED|Month 36||346
73698|NCT01462357|175538|P2|STARTED|Month 36||339
73699|NCT01462357|175539|P1|STARTED|Month 36||351
73700|NCT01462357|175537|P3|NOT COMPLETED|Month 24||9
73701|NCT01462357|175538|P2|NOT COMPLETED|Month 24||14
73702|NCT01462357|175539|P1|NOT COMPLETED|Month 24||4
73703|NCT01462357|175537|P3|COMPLETED|Month 24||349
73704|NCT01462357|175538|P2|COMPLETED|Month 24||344
73705|NCT01462357|175539|P1|COMPLETED|Month 24||355
73706|NCT01462357|175537|P3|STARTED|Month 24||358
73707|NCT01462357|175538|P2|STARTED|Month 24||358
73708|NCT01462357|175539|P1|STARTED|Month 24||359
73709|NCT01462357|175537|P3|NOT COMPLETED|Month 18||9
73710|NCT01462357|175538|P2|NOT COMPLETED|Month 18||11
73711|NCT01462357|175539|P1|NOT COMPLETED|Month 18||3
73712|NCT01462357|175537|P3|COMPLETED|Month 18||349
73713|NCT01462357|175538|P2|COMPLETED|Month 18||347
73714|NCT01462357|175539|P1|COMPLETED|Month 18||356
73715|NCT01462357|175537|P3|STARTED|Month 18||358
73716|NCT01462357|175538|P2|STARTED|Month 18||358
73717|NCT01462357|175539|P1|STARTED|Month 18||359
73718|NCT01462357|175537|P3|NOT COMPLETED|Month 12||8
73719|NCT01462357|175538|P2|NOT COMPLETED|Month 12||10
73720|NCT01462357|175539|P1|NOT COMPLETED|Month 12||3
73721|NCT01462357|175537|P3|COMPLETED|Month 12||350
73722|NCT01462357|175538|P2|COMPLETED|Month 12||348
73723|NCT01462357|175539|P1|COMPLETED|Month 12||356
73724|NCT01462357|175537|P3|STARTED|Month 12||358
73725|NCT01462357|175538|P2|STARTED|Month 12||358
73726|NCT01462357|175539|P1|STARTED|Month 12||359
73727|NCT01462357|175537|P3|NOT COMPLETED|Month 7||6
73728|NCT01462357|175538|P2|NOT COMPLETED|Month 7||5
73729|NCT01462357|175539|P1|NOT COMPLETED|Month 7||1
73730|NCT01462357|175537|P3|COMPLETED|Month 7||352
73731|NCT01462357|175538|P2|COMPLETED|Month 7||353
73732|NCT01462357|175539|P1|COMPLETED|Month 7||358
73733|NCT01462357|175537|P3|STARTED|Month 7||358
73734|NCT01462357|175538|P2|STARTED|Month 7||358
73735|NCT01462357|175539|P1|STARTED|Month 7||359
73736|NCT01462344|175612|P2|NOT COMPLETED|Overall Study||350
73737|NCT01462344|175613|P1|NOT COMPLETED|Overall Study||383
73738|NCT01462344|175612|P2|COMPLETED|Overall Study||2751
73739|NCT01462344|175613|P1|COMPLETED|Overall Study||2724
73740|NCT01462344|175612|P2|STARTED|Overall Study||3101
73741|NCT01462344|175613|P1|STARTED|Overall Study||3107
73742|NCT01462318|175635|P3|NOT COMPLETED|Extension Phase||45
73743|NCT01462318|175636|P2|NOT COMPLETED|Extension Phase||0
73744|NCT01462318|175637|P1|NOT COMPLETED|Extension Phase||0
73745|NCT01462318|175635|P3|COMPLETED|Extension Phase||70
73746|NCT01462318|175636|P2|COMPLETED|Extension Phase||0
73747|NCT01462318|175637|P1|COMPLETED|Extension Phase||0
73748|NCT01462318|175635|P3|STARTED|Extension Phase|10 participants from the Main Study did not enter the Extension Phase.|115
73749|NCT01462318|175636|P2|STARTED|Extension Phase|20 participants from the TP-DI Study entered the Extension Phase|0
73750|NCT01462318|175637|P1|STARTED|Extension Phase|95 participants from the Main Study entered the Extension Phase|0
73751|NCT01462318|175635|P3|NOT COMPLETED|Main Study / TP-DI Study||0
73752|NCT01462318|175636|P2|NOT COMPLETED|Main Study / TP-DI Study||0
73753|NCT01462318|175637|P1|NOT COMPLETED|Main Study / TP-DI Study||8
73754|NCT01462318|175635|P3|COMPLETED|Main Study / TP-DI Study||0
73755|NCT01462318|175636|P2|COMPLETED|Main Study / TP-DI Study||20
73756|NCT01462318|175637|P1|COMPLETED|Main Study / TP-DI Study||105
73757|NCT01462318|175635|P3|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
73758|NCT01462318|175636|P2|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||0
73759|NCT01462318|175637|P1|Enrolled in Intensive PK Substudy|Main Study / TP-DI Study||26
73760|NCT01462318|175635|P3|STARTED|Main Study / TP-DI Study||0
73761|NCT01462318|175636|P2|STARTED|Main Study / TP-DI Study||20
73762|NCT01462318|175637|P1|STARTED|Main Study / TP-DI Study||113
73763|NCT01462279|175654|P1|NOT COMPLETED|Overall Study||3
73764|NCT01462279|175654|P1|COMPLETED|Overall Study||17
73765|NCT01462279|175654|P1|STARTED|Overall Study||20
73766|NCT01462266|175660|P2|NOT COMPLETED|Overall Study||27
73767|NCT01462266|175661|P1|NOT COMPLETED|Overall Study||35
73768|NCT01462266|175660|P2|COMPLETED|Overall Study||303
73769|NCT01462266|175661|P1|COMPLETED|Overall Study||295
73770|NCT01462266|175660|P2|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
73771|NCT01462266|175661|P1|Treated|Overall Study|One participant was randomized in error and did not receive study medication.|329
73772|NCT01462266|175660|P2|STARTED|Overall Study||330
73773|NCT01462266|175661|P1|STARTED|Overall Study||330
73774|NCT01462227|175677|P4|NOT COMPLETED|Second Assignment||0
73775|NCT01462227|175678|P3|NOT COMPLETED|Second Assignment||1
73776|NCT01462227|175679|P2|NOT COMPLETED|Second Assignment||1
73777|NCT01462227|175680|P1|NOT COMPLETED|Second Assignment||1
73778|NCT01462227|175677|P4|COMPLETED|Second Assignment||5
73779|NCT01462227|175678|P3|COMPLETED|Second Assignment||5
73780|NCT01462227|175679|P2|COMPLETED|Second Assignment||1
73781|NCT01462227|175680|P1|COMPLETED|Second Assignment||3
73782|NCT01462227|175677|P4|STARTED|Second Assignment||5
73783|NCT01462227|175678|P3|STARTED|Second Assignment||6
73784|NCT01462227|175679|P2|STARTED|Second Assignment||2
73785|NCT01462227|175680|P1|STARTED|Second Assignment||4
73786|NCT01462227|175677|P4|NOT COMPLETED|First Assignment||0
73787|NCT01462227|175678|P3|NOT COMPLETED|First Assignment||0
73788|NCT01462227|175679|P2|NOT COMPLETED|First Assignment||0
73789|NCT01462227|175680|P1|NOT COMPLETED|First Assignment||0
73790|NCT01462227|175677|P4|COMPLETED|First Assignment||5
73791|NCT01462227|175678|P3|COMPLETED|First Assignment||6
73792|NCT01462227|175679|P2|COMPLETED|First Assignment||2
73793|NCT01462227|175680|P1|COMPLETED|First Assignment||4
73794|NCT01462227|175677|P4|STARTED|First Assignment||5
73795|NCT01462227|175678|P3|STARTED|First Assignment||6
73796|NCT01462227|175679|P2|STARTED|First Assignment||2
73797|NCT01462227|175680|P1|STARTED|First Assignment||4
73798|NCT01462162|175698|P1|NOT COMPLETED|Overall Study||12
73799|NCT01462162|175698|P1|COMPLETED|Overall Study||108
73800|NCT01462162|175698|P1|STARTED|Overall Study||120
73801|NCT01462084|175723|P2|NOT COMPLETED|Overall Study||1
73802|NCT01462084|175724|P1|NOT COMPLETED|Overall Study||2
73803|NCT01462084|175723|P2|COMPLETED|Overall Study||9
73804|NCT01462084|175724|P1|COMPLETED|Overall Study||9
73805|NCT01462084|175723|P2|Included for Analysis|Overall Study||9
73806|NCT01462084|175724|P1|Included for Analysis|Overall Study||9
73807|NCT01462084|175723|P2|STARTED|Overall Study||10
73808|NCT01462084|175724|P1|STARTED|Overall Study||11
73809|NCT01462045|175735|P3|NOT COMPLETED|Overall Study||0
73810|NCT01462045|175736|P2|NOT COMPLETED|Overall Study||1
73811|NCT01462045|175737|P1|NOT COMPLETED|Overall Study||0
73812|NCT01462045|175735|P3|COMPLETED|Overall Study||7
73813|NCT01462045|175736|P2|COMPLETED|Overall Study||10
73814|NCT01462045|175737|P1|COMPLETED|Overall Study||11
73815|NCT01462045|175735|P3|STARTED|Overall Study||7
73816|NCT01462045|175736|P2|STARTED|Overall Study||11
73817|NCT01462045|175737|P1|STARTED|Overall Study||11
73818|NCT01461993|175751|P3|NOT COMPLETED|Overall Study||64
73819|NCT01461993|175752|P2|NOT COMPLETED|Overall Study||157
73820|NCT01461993|175753|P1|NOT COMPLETED|Overall Study||151
73821|NCT01461993|175751|P3|COMPLETED|Overall Study||438
73822|NCT01461993|175752|P2|COMPLETED|Overall Study||841
73823|NCT01461993|175753|P1|COMPLETED|Overall Study||848
73824|NCT01461993|175751|P3|STARTED|Overall Study||502
73825|NCT01461993|175752|P2|STARTED|Overall Study||998
73826|NCT01461993|175753|P1|STARTED|Overall Study||999
73827|NCT01461980|175778|P3|NOT COMPLETED|Overall Study||165
73828|NCT01461980|175779|P2|NOT COMPLETED|Overall Study||145
73829|NCT01461980|175780|P1|NOT COMPLETED|Overall Study||166
73830|NCT01461980|175778|P3|COMPLETED|Overall Study||717
73831|NCT01461980|175779|P2|COMPLETED|Overall Study||733
73832|NCT01461980|175780|P1|COMPLETED|Overall Study||722
73833|NCT01461980|175778|P3|Vaccination 3|Overall Study||748
73834|NCT01461980|175779|P2|Vaccination 3|Overall Study||777
73835|NCT01461980|175780|P1|Vaccination 3|Overall Study||757
73836|NCT01461980|175778|P3|Vaccination 2|Overall Study||799
73837|NCT01461980|175779|P2|Vaccination 2|Overall Study||819
73838|NCT01461980|175780|P1|Vaccination 2|Overall Study||802
73839|NCT01461980|175778|P3|Vaccination 1|Overall Study||875
73840|NCT01461980|175779|P2|Vaccination 1|Overall Study||870
73841|NCT01461980|175780|P1|Vaccination 1|Overall Study||884
73842|NCT01461980|175778|P3|STARTED|Overall Study||882
73843|NCT01461980|175779|P2|STARTED|Overall Study||878
73844|NCT01461980|175780|P1|STARTED|Overall Study||888
73845|NCT01461811|175812|P2|NOT COMPLETED|Overall Study||3
73846|NCT01461811|175813|P1|NOT COMPLETED|Overall Study||4
73847|NCT01461811|175812|P2|COMPLETED|Overall Study||46
73848|NCT01461811|175813|P1|COMPLETED|Overall Study||91
73849|NCT01461811|175812|P2|STARTED|Overall Study||49
73850|NCT01461811|175813|P1|STARTED|Overall Study||95
73851|NCT01461733|175843|P2|NOT COMPLETED|Overall Study||4
73852|NCT01461733|175844|P1|NOT COMPLETED|Overall Study||4
73853|NCT01461733|175843|P2|COMPLETED|Overall Study||8
73854|NCT01461733|175844|P1|COMPLETED|Overall Study||8
73855|NCT01461733|175843|P2|STARTED|Overall Study||12
73856|NCT01461733|175844|P1|STARTED|Overall Study||12
73857|NCT01461707|175852|P2|NOT COMPLETED|Overall Study||0
73858|NCT01461707|175853|P1|NOT COMPLETED|Overall Study||1
73859|NCT01461707|175852|P2|COMPLETED|Overall Study||15
73860|NCT01461707|175853|P1|COMPLETED|Overall Study||14
73861|NCT01461707|175852|P2|STARTED|Overall Study||15
73862|NCT01461707|175853|P1|STARTED|Overall Study||15
73863|NCT01461655|175861|P1|NOT COMPLETED|Overall Study||0
73864|NCT01461655|175861|P1|COMPLETED|Overall Study||40
73865|NCT01461655|175861|P1|STARTED|Overall Study||40
73866|NCT01461551|175881|P3|NOT COMPLETED|Overall Study||2
73867|NCT01461551|175882|P2|NOT COMPLETED|Overall Study||1
73868|NCT01461551|175883|P1|NOT COMPLETED|Overall Study||2
73869|NCT01461551|175881|P3|COMPLETED|Overall Study||33
73870|NCT01461551|175882|P2|COMPLETED|Overall Study||34
73871|NCT01461551|175883|P1|COMPLETED|Overall Study||33
73872|NCT01461551|175881|P3|STARTED|Overall Study||35
73873|NCT01461551|175882|P2|STARTED|Overall Study||35
73874|NCT01461551|175883|P1|STARTED|Overall Study||35
73875|NCT01461538|175894|P3|NOT COMPLETED|Overall Study||2
73876|NCT01461538|175895|P2|NOT COMPLETED|Overall Study||8
73877|NCT01461538|175896|P1|NOT COMPLETED|Overall Study||18
73878|NCT01461538|175894|P3|COMPLETED|Overall Study||7
73879|NCT01461538|175895|P2|COMPLETED|Overall Study||20
73880|NCT01461538|175896|P1|COMPLETED|Overall Study||28
73881|NCT01461538|175894|P3|STARTED|Overall Study||9
73882|NCT01461538|175895|P2|STARTED|Overall Study||28
73883|NCT01461538|175896|P1|STARTED|Overall Study||46
73884|NCT01461473|175934|P2|NOT COMPLETED|Overall Study||4
73885|NCT01461473|175935|P1|NOT COMPLETED|Overall Study||5
73886|NCT01461473|175934|P2|COMPLETED|Overall Study||55
73887|NCT01461473|175935|P1|COMPLETED|Overall Study||67
73888|NCT01461473|175934|P2|STARTED|Overall Study||59
73889|NCT01461473|175935|P1|STARTED|Overall Study||72
73890|NCT01461369|175954|P3|NOT COMPLETED|Overall Study||17
73891|NCT01461369|175955|P2|NOT COMPLETED|Overall Study||17
73892|NCT01461369|175956|P1|NOT COMPLETED|Overall Study||13
73893|NCT01461369|175954|P3|COMPLETED|Overall Study||86
73894|NCT01461369|175955|P2|COMPLETED|Overall Study||81
73895|NCT01461369|175956|P1|COMPLETED|Overall Study||91
73896|NCT01461369|175954|P3|STARTED|Overall Study||103
73897|NCT01461369|175955|P2|STARTED|Overall Study||98
73898|NCT01461369|175956|P1|STARTED|Overall Study||104
73899|NCT01461096|175981|P2|NOT COMPLETED|Overall Study||61
73900|NCT01461096|175982|P1|NOT COMPLETED|Overall Study||62
73901|NCT01461096|175981|P2|COMPLETED|Overall Study||226
73902|NCT01461096|175982|P1|COMPLETED|Overall Study||226
73903|NCT01461096|175981|P2|Did Not Start Treatment|Overall Study|Randomized but never started treatment and was discontinued from the study|1
73904|NCT01461096|175982|P1|Did Not Start Treatment|Overall Study||0
73905|NCT01461096|175981|P2|STARTED|Overall Study||287
73906|NCT01461096|175982|P1|STARTED|Overall Study||288
73907|NCT01461057|175998|P2|NOT COMPLETED|Overall Study||15
73908|NCT01461057|175999|P1|NOT COMPLETED|Overall Study||15
73909|NCT01461057|175998|P2|COMPLETED|Overall Study||0
73910|NCT01461057|175999|P1|COMPLETED|Overall Study||0
73911|NCT01461057|175998|P2|STARTED|Overall Study||15
73912|NCT01461057|175999|P1|STARTED|Overall Study||15
73913|NCT01461044|176009|P2|NOT COMPLETED|Overall Study||40
73914|NCT01461044|176010|P1|NOT COMPLETED|Overall Study||70
73915|NCT01461044|176009|P2|COMPLETED|Overall Study||37
73916|NCT01461044|176010|P1|COMPLETED|Overall Study||80
73917|NCT01461044|176009|P2|Participants Alive at Inclusion|Overall Study||58
73918|NCT01461044|176010|P1|Participants Alive at Inclusion|Overall Study||127
73919|NCT01461044|176009|P2|STARTED|Overall Study||77
73920|NCT01461044|176010|P1|STARTED|Overall Study||150
73921|NCT01460940|176083|P1|NOT COMPLETED|Overall Study||0
73922|NCT01460940|176083|P1|COMPLETED|Overall Study||24
73923|NCT01460940|176083|P1|STARTED|Overall Study||24
73924|NCT01460927|176089|P1|NOT COMPLETED|Overall Study||0
73925|NCT01460927|176089|P1|COMPLETED|Overall Study||25
73926|NCT01460927|176089|P1|STARTED|Overall Study||25
73927|NCT01460732|176097|P1|NOT COMPLETED|Overall Study||0
73928|NCT01460732|176097|P1|COMPLETED|Overall Study||81
73929|NCT01460732|176097|P1|STARTED|Overall Study||81
73930|NCT01460628|176110|P1|NOT COMPLETED|Overall Study||5
73931|NCT01460628|176110|P1|COMPLETED|Overall Study||20
73932|NCT01460628|176110|P1|STARTED|Overall Study||25
73933|NCT01460446|176122|P2|NOT COMPLETED|Overall Study||20
73934|NCT01460446|176123|P1|NOT COMPLETED|Overall Study||5
73935|NCT01460446|176122|P2|COMPLETED|Overall Study||93
73936|NCT01460446|176123|P1|COMPLETED|Overall Study||100
73937|NCT01460446|176122|P2|STARTED|Overall Study||113
73938|NCT01460446|176123|P1|STARTED|Overall Study||105
73939|NCT01460342|176152|P2|NOT COMPLETED|Overall Study||14
73940|NCT01460342|176153|P1|NOT COMPLETED|Overall Study||11
73941|NCT01460342|176152|P2|COMPLETED|Overall Study||292
73942|NCT01460342|176153|P1|COMPLETED|Overall Study||293
73943|NCT01460342|176152|P2|Received at Least 1 Dose of Study Drug|Overall Study||306
73944|NCT01460342|176153|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
73945|NCT01460342|176152|P2|STARTED|Overall Study||306
73946|NCT01460342|176153|P1|STARTED|Overall Study||304
73947|NCT01460290|176173|P1|NOT COMPLETED|Overall Study||4
73948|NCT01460290|176173|P1|COMPLETED|Overall Study||11
73949|NCT01460290|176173|P1|STARTED|Overall Study||15
73950|NCT01459913|176197|P4|NOT COMPLETED|Overall Study||33
73951|NCT01459913|176198|P3|NOT COMPLETED|Overall Study||13
73952|NCT01459913|176199|P2|NOT COMPLETED|Overall Study||20
73953|NCT01459913|176200|P1|NOT COMPLETED|Overall Study||41
73954|NCT01459913|176197|P4|COMPLETED|Overall Study||29
73955|NCT01459913|176198|P3|COMPLETED|Overall Study||6
73956|NCT01459913|176199|P2|COMPLETED|Overall Study||32
73957|NCT01459913|176200|P1|COMPLETED|Overall Study||65
73958|NCT01459913|176197|P4|STARTED|Overall Study||62
73959|NCT01459913|176198|P3|STARTED|Overall Study||19
73960|NCT01459913|176199|P2|STARTED|Overall Study||52
73961|NCT01459913|176200|P1|STARTED|Overall Study||106
73962|NCT01459796|176231|P2|NOT COMPLETED|Overall Study||126
73963|NCT01459796|176232|P1|NOT COMPLETED|Overall Study||94
73964|NCT01459796|176231|P2|COMPLETED|Overall Study||0
73965|NCT01459796|176232|P1|COMPLETED|Overall Study||0
73966|NCT01459796|176231|P2|STARTED|Overall Study||126
73967|NCT01459796|176232|P1|STARTED|Overall Study||94
73968|NCT01459783|176250|P2|NOT COMPLETED|6 Months to 12 Months||30
73969|NCT01459783|176251|P1|NOT COMPLETED|6 Months to 12 Months||19
73970|NCT01459783|176250|P2|COMPLETED|6 Months to 12 Months||23
73971|NCT01459783|176251|P1|COMPLETED|6 Months to 12 Months||20
73972|NCT01459783|176250|P2|STARTED|6 Months to 12 Months||53
73973|NCT01459783|176251|P1|STARTED|6 Months to 12 Months||39
73974|NCT01459783|176250|P2|NOT COMPLETED|Baseline to 6 Months||20
73975|NCT01459783|176251|P1|NOT COMPLETED|Baseline to 6 Months||32
73976|NCT01459783|176250|P2|COMPLETED|Baseline to 6 Months||53
73977|NCT01459783|176251|P1|COMPLETED|Baseline to 6 Months||39
73978|NCT01459783|176250|P2|STARTED|Baseline to 6 Months||73
73979|NCT01459783|176251|P1|STARTED|Baseline to 6 Months||71
73980|NCT01459705|176262|P3|NOT COMPLETED|Overall Study||7
73981|NCT01459705|176263|P2|NOT COMPLETED|Overall Study||24
73982|NCT01459705|176264|P1|NOT COMPLETED|Overall Study||22
73983|NCT01459705|176262|P3|COMPLETED|Overall Study||47
73984|NCT01459705|176263|P2|COMPLETED|Overall Study||30
73985|NCT01459705|176264|P1|COMPLETED|Overall Study||32
73986|NCT01459705|176262|P3|STARTED|Overall Study||54
73987|NCT01459705|176263|P2|STARTED|Overall Study||54
73988|NCT01459705|176264|P1|STARTED|Overall Study||54
73989|NCT01459653|176282|P1|NOT COMPLETED|Overall Study||668
73990|NCT01459653|176282|P1|COMPLETED|Overall Study||828
73991|NCT01459653|176282|P1|STARTED|Overall Study||1496
73992|NCT01459588|176432|P4|NOT COMPLETED|Overall Study||1
73993|NCT01459588|176433|P3|NOT COMPLETED|Overall Study||1
73994|NCT01459588|176434|P2|NOT COMPLETED|Overall Study||2
73995|NCT01459588|176435|P1|NOT COMPLETED|Overall Study||1
73996|NCT01459588|176432|P4|COMPLETED|Overall Study||55
73997|NCT01459588|176433|P3|COMPLETED|Overall Study||102
73998|NCT01459588|176434|P2|COMPLETED|Overall Study||49
73999|NCT01459588|176435|P1|COMPLETED|Overall Study||104
74000|NCT01459588|176432|P4|STARTED|Overall Study||56
74001|NCT01459588|176433|P3|STARTED|Overall Study||103
74002|NCT01459588|176434|P2|STARTED|Overall Study||51
74003|NCT01459588|176435|P1|STARTED|Overall Study||105
74004|NCT01459068|176463|P2|NOT COMPLETED|Overall Study||34
74005|NCT01459068|176464|P1|NOT COMPLETED|Overall Study||39
74006|NCT01459068|176463|P2|COMPLETED|Overall Study||148
74007|NCT01459068|176464|P1|COMPLETED|Overall Study||126
74008|NCT01459068|176463|P2|STARTED|Overall Study||182
74009|NCT01459068|176464|P1|STARTED|Overall Study||165
74010|NCT01459016|176480|P1|NOT COMPLETED|Overall Study||15
74011|NCT01459016|176480|P1|COMPLETED|Overall Study||41
74012|NCT01459016|176480|P1|STARTED|Overall Study||56
74013|NCT01458951|176497|P3|NOT COMPLETED|Overall Study||15
74014|NCT01458951|176498|P2|NOT COMPLETED|Overall Study||1
74015|NCT01458951|176499|P1|NOT COMPLETED|Overall Study||32
74016|NCT01458951|176497|P3|COMPLETED|Overall Study||97
74017|NCT01458951|176498|P2|COMPLETED|Overall Study||5
74018|NCT01458951|176499|P1|COMPLETED|Overall Study||397
74019|NCT01458951|176497|P3|STARTED|Overall Study||112
74020|NCT01458951|176498|P2|STARTED|Overall Study||6
74021|NCT01458951|176499|P1|STARTED|Overall Study||429
74022|NCT01458639|176524|P1|NOT COMPLETED|Overall Study||6
74023|NCT01458639|176524|P1|COMPLETED|Overall Study||12
74024|NCT01458639|176524|P1|STARTED|Overall Study||18
74025|NCT01458587|176536|P2|NOT COMPLETED|Overall Study||0
74026|NCT01458587|176537|P1|NOT COMPLETED|Overall Study||1
74027|NCT01458587|176536|P2|COMPLETED|Overall Study||35
74028|NCT01458587|176537|P1|COMPLETED|Overall Study||34
74029|NCT01458587|176536|P2|STARTED|Overall Study||35
74030|NCT01458587|176537|P1|STARTED|Overall Study||35
74031|NCT01458574|176700|P3|NOT COMPLETED|Overall Study||145
74032|NCT01458574|176701|P2|NOT COMPLETED|Overall Study||71
74033|NCT01458574|176702|P1|NOT COMPLETED|Overall Study||87
74034|NCT01458574|176700|P3|COMPLETED|Overall Study||53
74035|NCT01458574|176701|P2|COMPLETED|Overall Study||126
74036|NCT01458574|176702|P1|COMPLETED|Overall Study||111
74037|NCT01458574|176700|P3|Treated|Overall Study||198
74038|NCT01458574|176701|P2|Treated|Overall Study||196
74039|NCT01458574|176702|P1|Treated|Overall Study||198
74040|NCT01458574|176700|P3|STARTED|Overall Study||198
74041|NCT01458574|176701|P2|STARTED|Overall Study||197
74042|NCT01458574|176702|P1|STARTED|Overall Study||198
74043|NCT01458561|176787|P2|NOT COMPLETED|Overall Study||0
74044|NCT01458561|176788|P1|NOT COMPLETED|Overall Study||0
74045|NCT01458561|176787|P2|COMPLETED|Overall Study||1
74046|NCT01458561|176788|P1|COMPLETED|Overall Study||0
74047|NCT01458561|176787|P2|STARTED|Overall Study||1
74048|NCT01458561|176788|P1|STARTED|Overall Study||0
74049|NCT01458535|176832|P6|NOT COMPLETED|Overall Study||4
74050|NCT01458535|176833|P5|NOT COMPLETED|Overall Study||4
74051|NCT01458535|176834|P4|NOT COMPLETED|Overall Study||4
74052|NCT01458535|176835|P3|NOT COMPLETED|Overall Study||2
74053|NCT01458535|176836|P2|NOT COMPLETED|Overall Study||2
74054|NCT01458535|176837|P1|NOT COMPLETED|Overall Study||0
74055|NCT01458535|176832|P6|COMPLETED|Overall Study||7
74056|NCT01458535|176833|P5|COMPLETED|Overall Study||6
74057|NCT01458535|176834|P4|COMPLETED|Overall Study||6
74058|NCT01458535|176835|P3|COMPLETED|Overall Study||8
74059|NCT01458535|176836|P2|COMPLETED|Overall Study||8
74060|NCT01458535|176837|P1|COMPLETED|Overall Study||10
74061|NCT01458535|176832|P6|STARTED|Overall Study||11
74062|NCT01458535|176833|P5|STARTED|Overall Study||10
74063|NCT01458535|176834|P4|STARTED|Overall Study||10
74064|NCT01458535|176835|P3|STARTED|Overall Study||10
74065|NCT01458535|176836|P2|STARTED|Overall Study||10
74066|NCT01458535|176837|P1|STARTED|Overall Study||10
74067|NCT01458392|176890|P3|NOT COMPLETED|Overall Study||31
74068|NCT01458392|176891|P2|NOT COMPLETED|Overall Study||13
74069|NCT01458392|176892|P1|NOT COMPLETED|Overall Study||2
74070|NCT01458392|176890|P3|COMPLETED|Overall Study||0
74071|NCT01458392|176891|P2|COMPLETED|Overall Study||0
74072|NCT01458392|176892|P1|COMPLETED|Overall Study||0
74073|NCT01458392|176890|P3|STARTED|Overall Study||31
74074|NCT01458392|176891|P2|STARTED|Overall Study||13
74075|NCT01458392|176892|P1|STARTED|Overall Study||2
74076|NCT01458288|176912|P1|NOT COMPLETED|Overall Study||0
74077|NCT01458288|176912|P1|COMPLETED|Overall Study||12
74078|NCT01458288|176912|P1|STARTED|Overall Study||12
74079|NCT01458275|176920|P3|NOT COMPLETED|Overall Study||9
74080|NCT01458275|176921|P2|NOT COMPLETED|Overall Study||13
74081|NCT01458275|176922|P1|NOT COMPLETED|Overall Study||14
74082|NCT01458275|176920|P3|COMPLETED|Overall Study||273
74083|NCT01458275|176921|P2|COMPLETED|Overall Study||269
74084|NCT01458275|176922|P1|COMPLETED|Overall Study||269
74085|NCT01458275|176920|P3|STARTED|Overall Study||282
74086|NCT01458275|176921|P2|STARTED|Overall Study||282
74087|NCT01458275|176922|P1|STARTED|Overall Study||283
74088|NCT01458249|176964|P1|NOT COMPLETED|Overall Study||8
74089|NCT01458249|176964|P1|COMPLETED|Overall Study||44
74090|NCT01458249|176964|P1|Participants Treated|Overall Study||51
74091|NCT01458249|176964|P1|STARTED|Overall Study||52
74092|NCT01458210|176983|P1|NOT COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||3
74093|NCT01458210|176983|P1|COMPLETED|Ortho-Cyclen + Dulaglutide (Period 2)||15
74094|NCT01458210|176983|P1|STARTED|Ortho-Cyclen + Dulaglutide (Period 2)|1 participant received Ortho-Cyclen, discontinued due to Adverse Event before receiving Dulaglutide.|18
74095|NCT01458210|176983|P1|NOT COMPLETED|Ortho-Cyclen Alone (Period 1)||4
74096|NCT01458210|176983|P1|COMPLETED|Ortho-Cyclen Alone (Period 1)||18
74097|NCT01458210|176983|P1|STARTED|Ortho-Cyclen Alone (Period 1)||22
74098|NCT01458210|176983|P1|NOT COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||0
74099|NCT01458210|176983|P1|COMPLETED|Lead-in (1st Course of Ortho-Cyclen)||22
74100|NCT01458210|176983|P1|Received at Least One Dose of Study Drug|Lead-in (1st Course of Ortho-Cyclen)||22
74101|NCT01458210|176983|P1|STARTED|Lead-in (1st Course of Ortho-Cyclen)||22
74102|NCT01458171|177000|P1|NOT COMPLETED|Overall Study||1
74103|NCT01458171|177000|P1|COMPLETED|Overall Study||22
74104|NCT01458171|177000|P1|STARTED|Overall Study||23
74105|NCT01458106|177023|P2|NOT COMPLETED|Overall Study||1
74106|NCT01458106|177024|P1|NOT COMPLETED|Overall Study||3
74107|NCT01458106|177023|P2|COMPLETED|Overall Study||34
74108|NCT01458106|177024|P1|COMPLETED|Overall Study||33
74109|NCT01458106|177023|P2|Non-PK Subgroup|Overall Study||0
74110|NCT01458106|177024|P1|Non-PK Subgroup|Overall Study||11
74111|NCT01458106|177023|P2|PK Subgroup|Overall Study||35
74112|NCT01458106|177024|P1|PK Subgroup|Overall Study||25
74113|NCT01458106|177023|P2|STARTED|Overall Study||35
74114|NCT01458106|177024|P1|STARTED|Overall Study||36
74115|NCT01457950|177101|P4|NOT COMPLETED|Open-Label Phase||2
74116|NCT01457950|177102|P3|NOT COMPLETED|Open-Label Phase||2
74117|NCT01457950|177103|P2|NOT COMPLETED|Open-Label Phase||0
74118|NCT01457950|177104|P1|NOT COMPLETED|Open-Label Phase||0
74119|NCT01457950|177101|P4|COMPLETED|Open-Label Phase||61
74120|NCT01457950|177102|P3|COMPLETED|Open-Label Phase||58
74121|NCT01457950|177103|P2|COMPLETED|Open-Label Phase||0
74122|NCT01457950|177104|P1|COMPLETED|Open-Label Phase||0
74123|NCT01457950|177101|P4|STARTED|Open-Label Phase||63
74124|NCT01457950|177102|P3|STARTED|Open-Label Phase||60
74125|NCT01457950|177103|P2|STARTED|Open-Label Phase||0
74126|NCT01457950|177104|P1|STARTED|Open-Label Phase||0
74127|NCT01457950|177101|P4|NOT COMPLETED|Double-Blind Phase||0
74128|NCT01457950|177102|P3|NOT COMPLETED|Double-Blind Phase||0
74129|NCT01457950|177103|P2|NOT COMPLETED|Double-Blind Phase||3
74130|NCT01457950|177104|P1|NOT COMPLETED|Double-Blind Phase||9
74131|NCT01457950|177101|P4|COMPLETED|Double-Blind Phase||0
74132|NCT01457950|177102|P3|COMPLETED|Double-Blind Phase||0
74133|NCT01457950|177103|P2|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|63
74134|NCT01457950|177104|P1|COMPLETED|Double-Blind Phase|“Completed” refers to par. that did not have a withdraw reason at the 6 month visit.|60
74135|NCT01457950|177101|P4|Completed the 6 Month Assessment|Double-Blind Phase||0
74136|NCT01457950|177102|P3|Completed the 6 Month Assessment|Double-Blind Phase||0
74137|NCT01457950|177103|P2|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|64
74138|NCT01457950|177104|P1|Completed the 6 Month Assessment|Double-Blind Phase|“Completed 6 month assessment” refers to par. that completed at least one 6 month assessment.|62
74139|NCT01457950|177101|P4|STARTED|Double-Blind Phase||0
74140|NCT01457950|177102|P3|STARTED|Double-Blind Phase||0
74141|NCT01457950|177103|P2|STARTED|Double-Blind Phase||66
74142|NCT01457950|177104|P1|STARTED|Double-Blind Phase||69
74143|NCT01457885|177178|P1|NOT COMPLETED|Overall Study||0
74144|NCT01457885|177178|P1|COMPLETED|Overall Study||74
74145|NCT01457885|177178|P1|STARTED|Overall Study||74
74146|NCT01457846|177186|P2|NOT COMPLETED|Overall Study||30
74147|NCT01457846|177187|P1|NOT COMPLETED|Overall Study||41
74148|NCT01457846|177186|P2|COMPLETED|Overall Study||0
74149|NCT01457846|177187|P1|COMPLETED|Overall Study||0
74150|NCT01457846|177186|P2|Ongoing Treatment at Data Cut-off|Overall Study||1
74151|NCT01457846|177187|P1|Ongoing Treatment at Data Cut-off|Overall Study||1
74152|NCT01457846|177186|P2|Did Not Receive Treatment|Overall Study||3
74153|NCT01457846|177187|P1|Did Not Receive Treatment|Overall Study||1
74154|NCT01457846|177186|P2|Received Treatment|Overall Study||27
74155|NCT01457846|177187|P1|Received Treatment|Overall Study||40
74156|NCT01457846|177186|P2|STARTED|Overall Study||30
74157|NCT01457846|177187|P1|STARTED|Overall Study||41
74158|NCT01457703|177203|P2|NOT COMPLETED|Overall Study||11
74159|NCT01457703|177204|P1|NOT COMPLETED|Overall Study||6
74160|NCT01457703|177203|P2|COMPLETED|Overall Study||22
74161|NCT01457703|177204|P1|COMPLETED|Overall Study||23
74162|NCT01457703|177203|P2|STARTED|Overall Study||33
74163|NCT01457703|177204|P1|STARTED|Overall Study||29
74164|NCT01457521|177220|P2|NOT COMPLETED|Overall Study||10
74165|NCT01457521|177221|P1|NOT COMPLETED|Overall Study||12
74166|NCT01457521|177220|P2|COMPLETED|Overall Study||117
74167|NCT01457521|177221|P1|COMPLETED|Overall Study||111
74168|NCT01457521|177220|P2|STARTED|Overall Study||127
74169|NCT01457521|177221|P1|STARTED|Overall Study||123
74170|NCT01457430|177227|P1|NOT COMPLETED|Overall Study||0
74171|NCT01457430|177227|P1|COMPLETED|Overall Study||19
74172|NCT01457430|177227|P1|STARTED|Overall Study||19
74173|NCT01457417|177239|P5|NOT COMPLETED|Overall Study||0
74174|NCT01457417|177240|P4|NOT COMPLETED|Overall Study||0
74175|NCT01457417|177241|P3|NOT COMPLETED|Overall Study||0
74176|NCT01457417|177242|P2|NOT COMPLETED|Overall Study||0
74177|NCT01457417|177243|P1|NOT COMPLETED|Overall Study||0
74178|NCT01457417|177239|P5|COMPLETED|Overall Study||19
74179|NCT01457417|177240|P4|COMPLETED|Overall Study||3
74180|NCT01457417|177241|P3|COMPLETED|Overall Study||4
74181|NCT01457417|177242|P2|COMPLETED|Overall Study||3
74182|NCT01457417|177243|P1|COMPLETED|Overall Study||3
74183|NCT01457417|177239|P5|STARTED|Overall Study||19
74184|NCT01457417|177240|P4|STARTED|Overall Study||3
74185|NCT01457417|177241|P3|STARTED|Overall Study||4
74186|NCT01457417|177242|P2|STARTED|Overall Study||3
74187|NCT01457417|177243|P1|STARTED|Overall Study||3
74188|NCT01457339|177301|P2|NOT COMPLETED|Period 6 (250 mg)||1
74189|NCT01457339|177302|P1|NOT COMPLETED|Period 6 (250 mg)||1
74190|NCT01457339|177301|P2|COMPLETED|Period 6 (250 mg)||21
74191|NCT01457339|177302|P1|COMPLETED|Period 6 (250 mg)||6
74192|NCT01457339|177301|P2|STARTED|Period 6 (250 mg)||22
74193|NCT01457339|177302|P1|STARTED|Period 6 (250 mg)||7
74194|NCT01457339|177301|P2|NOT COMPLETED|Period 5 (200 mg)||1
74195|NCT01457339|177302|P1|NOT COMPLETED|Period 5 (200 mg)||0
74196|NCT01457339|177301|P2|COMPLETED|Period 5 (200 mg)||22
74197|NCT01457339|177302|P1|COMPLETED|Period 5 (200 mg)||7
74198|NCT01457339|177301|P2|STARTED|Period 5 (200 mg)||23
74199|NCT01457339|177302|P1|STARTED|Period 5 (200 mg)||7
74200|NCT01457339|177301|P2|NOT COMPLETED|Period 4 (150 mg)||0
74201|NCT01457339|177302|P1|NOT COMPLETED|Period 4 (150 mg)||0
74202|NCT01457339|177301|P2|COMPLETED|Period 4 (150 mg)||23
74203|NCT01457339|177302|P1|COMPLETED|Period 4 (150 mg)||7
74204|NCT01457339|177301|P2|STARTED|Period 4 (150 mg)||23
74205|NCT01457339|177302|P1|STARTED|Period 4 (150 mg)||7
74206|NCT01457339|177301|P2|NOT COMPLETED|Period 3 (100 mg)||1
74207|NCT01457339|177302|P1|NOT COMPLETED|Period 3 (100 mg)||0
74208|NCT01457339|177301|P2|COMPLETED|Period 3 (100 mg)||23
74209|NCT01457339|177302|P1|COMPLETED|Period 3 (100 mg)||7
74210|NCT01457339|177301|P2|STARTED|Period 3 (100 mg)||24
74211|NCT01457339|177302|P1|STARTED|Period 3 (100 mg)||7
74212|NCT01457339|177301|P2|NOT COMPLETED|Period 2 (70 mg)||0
74213|NCT01457339|177302|P1|NOT COMPLETED|Period 2 (70 mg)||0
74214|NCT01457339|177301|P2|COMPLETED|Period 2 (70 mg)||24
74215|NCT01457339|177302|P1|COMPLETED|Period 2 (70 mg)||7
74216|NCT01457339|177301|P2|STARTED|Period 2 (70 mg)||24
74217|NCT01457339|177302|P1|STARTED|Period 2 (70 mg)||7
74218|NCT01457339|177301|P2|NOT COMPLETED|Period 1 (50 mg)||0
74219|NCT01457339|177302|P1|NOT COMPLETED|Period 1 (50 mg)||0
74220|NCT01457339|177301|P2|COMPLETED|Period 1 (50 mg)||24
74221|NCT01457339|177302|P1|COMPLETED|Period 1 (50 mg)||7
74222|NCT01457339|177301|P2|STARTED|Period 1 (50 mg)||24
74223|NCT01457339|177302|P1|STARTED|Period 1 (50 mg)||7
74224|NCT01457053|177468|P2|NOT COMPLETED|Overall Study||1
74225|NCT01457053|177469|P1|NOT COMPLETED|Overall Study||1
74226|NCT01457053|177468|P2|COMPLETED|Overall Study||1
74227|NCT01457053|177469|P1|COMPLETED|Overall Study||1
74228|NCT01457053|177468|P2|STARTED|Overall Study||2
74229|NCT01457053|177469|P1|STARTED|Overall Study||2
74230|NCT01457014|177475|P4|NOT COMPLETED|Fourth Night||0
74231|NCT01457014|177476|P3|NOT COMPLETED|Fourth Night||0
74232|NCT01457014|177477|P2|NOT COMPLETED|Fourth Night||0
74233|NCT01457014|177478|P1|NOT COMPLETED|Fourth Night||0
74234|NCT01457014|177475|P4|COMPLETED|Fourth Night||11
74235|NCT01457014|177476|P3|COMPLETED|Fourth Night||12
74236|NCT01457014|177477|P2|COMPLETED|Fourth Night||11
74237|NCT01457014|177478|P1|COMPLETED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
74238|NCT01457014|177475|P4|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
74239|NCT01457014|177476|P3|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
74240|NCT01457014|177477|P2|STARTED|Fourth Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
74241|NCT01457014|177478|P1|STARTED|Fourth Night|The Diagnostic PSG was only completed on the First night|0
74242|NCT01457014|177475|P4|NOT COMPLETED|Third Night||0
74243|NCT01457014|177476|P3|NOT COMPLETED|Third Night||0
74244|NCT01457014|177477|P2|NOT COMPLETED|Third Night||0
74245|NCT01457014|177478|P1|NOT COMPLETED|Third Night||0
74246|NCT01457014|177475|P4|COMPLETED|Third Night||12
74247|NCT01457014|177476|P3|COMPLETED|Third Night||11
74248|NCT01457014|177477|P2|COMPLETED|Third Night||11
74249|NCT01457014|177478|P1|COMPLETED|Third Night|The Diagnostic PSG was only completed on the First night|0
74250|NCT01457014|177475|P4|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
74251|NCT01457014|177476|P3|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
74252|NCT01457014|177477|P2|STARTED|Third Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
74253|NCT01457014|177478|P1|STARTED|Third Night|The Diagnostic PSG was only completed on the First night|0
74254|NCT01457014|177475|P4|NOT COMPLETED|Second Night||0
74255|NCT01457014|177476|P3|NOT COMPLETED|Second Night||0
74256|NCT01457014|177477|P2|NOT COMPLETED|Second Night||0
74257|NCT01457014|177478|P1|NOT COMPLETED|Second Night||0
74258|NCT01457014|177475|P4|COMPLETED|Second Night||11
74259|NCT01457014|177476|P3|COMPLETED|Second Night||11
74260|NCT01457014|177477|P2|COMPLETED|Second Night||12
74261|NCT01457014|177478|P1|COMPLETED|Second Night|The Diagnostic PSG was only completed on the First night|0
74262|NCT01457014|177475|P4|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
74263|NCT01457014|177476|P3|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|11
74264|NCT01457014|177477|P2|STARTED|Second Night|Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.|12
74265|NCT01457014|177478|P1|STARTED|Second Night|The Diagnostic PSG was only completed on the First night|0
74266|NCT01457014|177475|P4|NOT COMPLETED|First Night||0
74267|NCT01457014|177476|P3|NOT COMPLETED|First Night||0
74268|NCT01457014|177477|P2|NOT COMPLETED|First Night||0
74269|NCT01457014|177478|P1|NOT COMPLETED|First Night||40
74270|NCT01457014|177475|P4|COMPLETED|First Night||0
74271|NCT01457014|177476|P3|COMPLETED|First Night||0
74272|NCT01457014|177477|P2|COMPLETED|First Night||0
74273|NCT01457014|177478|P1|COMPLETED|First Night||34
74274|NCT01457014|177475|P4|STARTED|First Night||0
74275|NCT01457014|177476|P3|STARTED|First Night||0
74276|NCT01457014|177477|P2|STARTED|First Night||0
74277|NCT01457014|177478|P1|STARTED|First Night||74
74278|NCT01456962|177495|P2|NOT COMPLETED|Overall Study||1
74279|NCT01456962|177496|P1|NOT COMPLETED|Overall Study||2
74280|NCT01456962|177495|P2|COMPLETED|Overall Study||19
74281|NCT01456962|177496|P1|COMPLETED|Overall Study||14
74282|NCT01456962|177495|P2|STARTED|Overall Study||20
74283|NCT01456962|177496|P1|STARTED|Overall Study||16
74284|NCT01456936|177506|P4|NOT COMPLETED|Overall Study||483
74285|NCT01456936|177507|P3|NOT COMPLETED|Overall Study||481
74286|NCT01456936|177508|P2|NOT COMPLETED|Overall Study||448
74287|NCT01456936|177509|P1|NOT COMPLETED|Overall Study||439
74288|NCT01456936|177506|P4|COMPLETED|Overall Study||1552
74289|NCT01456936|177507|P3|COMPLETED|Overall Study||1557
74290|NCT01456936|177508|P2|COMPLETED|Overall Study||1586
74291|NCT01456936|177509|P1|COMPLETED|Overall Study||1598
74292|NCT01456936|177506|P4|Randomized and Treated|Overall Study||2014
74293|NCT01456936|177507|P3|Randomized and Treated|Overall Study||2022
74294|NCT01456936|177508|P2|Randomized and Treated|Overall Study||2006
74295|NCT01456936|177509|P1|Randomized and Treated|Overall Study||2016
74296|NCT01456936|177506|P4|STARTED|Overall Study||2035
74297|NCT01456936|177507|P3|STARTED|Overall Study||2038
74298|NCT01456936|177508|P2|STARTED|Overall Study||2034
74299|NCT01456936|177509|P1|STARTED|Overall Study||2037
74300|NCT01456780|177618|P3|NOT COMPLETED|Overall Study||0
74301|NCT01456780|177619|P2|NOT COMPLETED|Overall Study||3
74302|NCT01456780|177620|P1|NOT COMPLETED|Overall Study||3
74303|NCT01456780|177618|P3|COMPLETED|Overall Study||20
74304|NCT01456780|177619|P2|COMPLETED|Overall Study||17
74305|NCT01456780|177620|P1|COMPLETED|Overall Study||17
74306|NCT01456780|177618|P3|STARTED|Overall Study||20
74307|NCT01456780|177619|P2|STARTED|Overall Study||20
74308|NCT01456780|177620|P1|STARTED|Overall Study||20
74309|NCT01456299|177640|P3|NOT COMPLETED|Overall Study||1
74310|NCT01456299|177641|P2|NOT COMPLETED|Overall Study||1
74311|NCT01456299|177642|P1|NOT COMPLETED|Overall Study||0
74312|NCT01456299|177640|P3|COMPLETED|Overall Study||33
74313|NCT01456299|177641|P2|COMPLETED|Overall Study||33
74314|NCT01456299|177642|P1|COMPLETED|Overall Study||34
74315|NCT01456299|177640|P3|STARTED|Overall Study||34
74316|NCT01456299|177641|P2|STARTED|Overall Study||34
74317|NCT01456299|177642|P1|STARTED|Overall Study||34
74318|NCT01456195|177653|P3|NOT COMPLETED|Overall Study||14
74319|NCT01456195|177654|P2|NOT COMPLETED|Overall Study||10
74320|NCT01456195|177655|P1|NOT COMPLETED|Overall Study||11
74321|NCT01456195|177653|P3|COMPLETED|Overall Study||127
74322|NCT01456195|177654|P2|COMPLETED|Overall Study||127
74323|NCT01456195|177655|P1|COMPLETED|Overall Study||132
74324|NCT01456195|177653|P3|STARTED|Overall Study||141
74325|NCT01456195|177654|P2|STARTED|Overall Study||137
74326|NCT01456195|177655|P1|STARTED|Overall Study||143
74327|NCT01456169|177675|P3|NOT COMPLETED|Overall Study||12
74328|NCT01456169|177676|P2|NOT COMPLETED|Overall Study||5
74329|NCT01456169|177677|P1|NOT COMPLETED|Overall Study||10
74330|NCT01456169|177675|P3|COMPLETED|Overall Study||123
74331|NCT01456169|177676|P2|COMPLETED|Overall Study||122
74332|NCT01456169|177677|P1|COMPLETED|Overall Study||123
74333|NCT01456169|177675|P3|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|135
74334|NCT01456169|177676|P2|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|127
74335|NCT01456169|177677|P1|STARTED|Overall Study|Indicates participants who were randomized into the double-blind treatment period|133
74336|NCT01456143|177728|P1|NOT COMPLETED|Overall Study||0
74337|NCT01456143|177728|P1|COMPLETED|Overall Study||33
74338|NCT01456143|177728|P1|STARTED|Overall Study||33
74339|NCT01456130|177737|P1|NOT COMPLETED|Overall Study||10
74340|NCT01456130|177737|P1|COMPLETED|Overall Study||57
74341|NCT01456130|177737|P1|STARTED|Overall Study||67
74342|NCT01456052|177747|P3|NOT COMPLETED|Overall Study||5
74343|NCT01456052|177748|P2|NOT COMPLETED|Overall Study||5
74344|NCT01456052|177749|P1|NOT COMPLETED|Overall Study||2
74345|NCT01456052|177747|P3|COMPLETED|Overall Study||19
74346|NCT01456052|177748|P2|COMPLETED|Overall Study||20
74347|NCT01456052|177749|P1|COMPLETED|Overall Study||8
74348|NCT01456052|177747|P3|STARTED|Overall Study||24
74349|NCT01456052|177748|P2|STARTED|Overall Study|One subject did not receive any study drug. That subject is not included in the safety population.|25
74350|NCT01456052|177749|P1|STARTED|Overall Study||10
74351|NCT01456039|177769|P3|NOT COMPLETED|Phase 2 (Second Step)||33
74352|NCT01456039|177770|P2|NOT COMPLETED|Phase 2 (Second Step)||0
74353|NCT01456039|177771|P1|NOT COMPLETED|Phase 2 (Second Step)||0
74354|NCT01456039|177769|P3|COMPLETED|Phase 2 (Second Step)||7
74355|NCT01456039|177770|P2|COMPLETED|Phase 2 (Second Step)||0
74356|NCT01456039|177771|P1|COMPLETED|Phase 2 (Second Step)||0
74357|NCT01456039|177769|P3|STARTED|Phase 2 (Second Step)||40
74358|NCT01456039|177770|P2|STARTED|Phase 2 (Second Step)||0
74359|NCT01456039|177771|P1|STARTED|Phase 2 (Second Step)||0
74360|NCT01456039|177769|P3|NOT COMPLETED|Phase 1 (First Step)||0
74361|NCT01456039|177770|P2|NOT COMPLETED|Phase 1 (First Step)||7
74362|NCT01456039|177771|P1|NOT COMPLETED|Phase 1 (First Step)||2
74363|NCT01456039|177769|P3|COMPLETED|Phase 1 (First Step)||0
74364|NCT01456039|177770|P2|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
74365|NCT01456039|177771|P1|COMPLETED|Phase 1 (First Step)|Completed = on treatment|1
74366|NCT01456039|177769|P3|STARTED|Phase 1 (First Step)||0
74367|NCT01456039|177770|P2|STARTED|Phase 1 (First Step)||8
74368|NCT01456039|177771|P1|STARTED|Phase 1 (First Step)||3
74369|NCT01456000|177843|P2|NOT COMPLETED|Overall Study||3
74370|NCT01456000|177844|P1|NOT COMPLETED|Overall Study||8
74371|NCT01456000|177843|P2|COMPLETED|Overall Study||172
74372|NCT01456000|177844|P1|COMPLETED|Overall Study||170
74373|NCT01456000|177843|P2|STARTED|Overall Study||175
74374|NCT01456000|177844|P1|STARTED|Overall Study||178
74375|NCT01455545|177850|P2|NOT COMPLETED|Overall Study||0
74376|NCT01455545|177851|P1|NOT COMPLETED|Overall Study||0
74377|NCT01455545|177850|P2|COMPLETED|Overall Study||45
74378|NCT01455545|177851|P1|COMPLETED|Overall Study||55
74379|NCT01455545|177850|P2|STARTED|Overall Study||45
74380|NCT01455545|177851|P1|STARTED|Overall Study||55
74381|NCT01455519|177881|P2|NOT COMPLETED|Overall Study||5
74382|NCT01455519|177882|P1|NOT COMPLETED|Overall Study||4
74383|NCT01455519|177881|P2|COMPLETED|Overall Study||18
74384|NCT01455519|177882|P1|COMPLETED|Overall Study||8
74385|NCT01455519|177881|P2|STARTED|Overall Study||23
74386|NCT01455519|177882|P1|STARTED|Overall Study||12
74387|NCT01455428|177914|P2|NOT COMPLETED|Overall Study||18
74388|NCT01455428|177915|P1|NOT COMPLETED|Overall Study||14
74389|NCT01455428|177914|P2|COMPLETED|Overall Study||92
74390|NCT01455428|177915|P1|COMPLETED|Overall Study||98
74391|NCT01455428|177914|P2|Treated|Overall Study||109
74392|NCT01455428|177915|P1|Treated|Overall Study||111
74393|NCT01455428|177914|P2|STARTED|Overall Study||110
74394|NCT01455428|177915|P1|STARTED|Overall Study||112
74395|NCT01455415|177971|P2|NOT COMPLETED|Follow-up||2
74396|NCT01455415|177972|P1|NOT COMPLETED|Follow-up||3
74397|NCT01455415|177971|P2|COMPLETED|Follow-up||104
74398|NCT01455415|177972|P1|COMPLETED|Follow-up||111
74399|NCT01455415|177971|P2|STARTED|Follow-up||106
74400|NCT01455415|177972|P1|STARTED|Follow-up||114
74401|NCT01455415|177971|P2|NOT COMPLETED|Period 2||10
74402|NCT01455415|177972|P1|NOT COMPLETED|Period 2||13
74403|NCT01455415|177971|P2|COMPLETED|Period 2||106
74404|NCT01455415|177972|P1|COMPLETED|Period 2||114
74405|NCT01455415|177971|P2|STARTED|Period 2||116
74406|NCT01455415|177972|P1|STARTED|Period 2||127
74407|NCT01455415|177971|P2|NOT COMPLETED|Washout||7
74408|NCT01455415|177972|P1|NOT COMPLETED|Washout||8
74409|NCT01455415|177971|P2|COMPLETED|Washout||116
74410|NCT01455415|177972|P1|COMPLETED|Washout||127
74411|NCT01455415|177971|P2|STARTED|Washout||123
74412|NCT01455415|177972|P1|STARTED|Washout||135
74413|NCT01455415|177971|P2|NOT COMPLETED|Period 1||24
74414|NCT01455415|177972|P1|NOT COMPLETED|Period 1||19
74415|NCT01455415|177971|P2|COMPLETED|Period 1||123
74416|NCT01455415|177972|P1|COMPLETED|Period 1||135
74417|NCT01455415|177971|P2|STARTED|Period 1|Started=Treated|147
74418|NCT01455415|177972|P1|STARTED|Period 1|Started=Treated|154
74419|NCT01455220|178022|P1|NOT COMPLETED|Overall Study||30
74420|NCT01455220|178022|P1|COMPLETED|Overall Study||15
74421|NCT01455220|178022|P1|STARTED|Overall Study||45
74422|NCT01455194|178032|P4|NOT COMPLETED|Overall Study||28
74423|NCT01455194|178033|P3|NOT COMPLETED|Overall Study||30
74424|NCT01455194|178034|P2|NOT COMPLETED|Overall Study||31
74425|NCT01455194|178035|P1|NOT COMPLETED|Overall Study||153
74426|NCT01455194|178032|P4|COMPLETED|Overall Study||97
74427|NCT01455194|178033|P3|COMPLETED|Overall Study||92
74428|NCT01455194|178034|P2|COMPLETED|Overall Study||89
74429|NCT01455194|178035|P1|COMPLETED|Overall Study||0
74430|NCT01455194|178032|P4|STARTED|Overall Study||125
74431|NCT01455194|178033|P3|STARTED|Overall Study||122
74432|NCT01455194|178034|P2|STARTED|Overall Study||120
74433|NCT01455194|178035|P1|STARTED|Overall Study||153
74434|NCT01455181|178084|P1|NOT COMPLETED|Overall Study||0
74435|NCT01455181|178084|P1|COMPLETED|Overall Study||24
74436|NCT01455181|178084|P1|STARTED|Overall Study||24
74437|NCT01455064|178092|P1|NOT COMPLETED|Overall Study||1
74438|NCT01455064|178092|P1|COMPLETED|Overall Study||30
74439|NCT01455064|178092|P1|STARTED|Overall Study||31
74440|NCT01455012|178098|P2|NOT COMPLETED|Overall Study||4
74441|NCT01455012|178099|P1|NOT COMPLETED|Overall Study||11
74442|NCT01455012|178098|P2|COMPLETED|Overall Study||36
74443|NCT01455012|178099|P1|COMPLETED|Overall Study||30
74444|NCT01455012|178098|P2|STARTED|Overall Study||40
74445|NCT01455012|178099|P1|STARTED|Overall Study||41
74446|NCT01454947|178139|P8|NOT COMPLETED|Overall Study||5
74447|NCT01454947|178140|P7|NOT COMPLETED|Overall Study||1
74448|NCT01454947|178141|P6|NOT COMPLETED|Overall Study||3
74449|NCT01454947|178142|P5|NOT COMPLETED|Overall Study||1
74450|NCT01454947|178143|P4|NOT COMPLETED|Overall Study||1
74451|NCT01454947|178144|P3|NOT COMPLETED|Overall Study||3
74452|NCT01454947|178145|P2|NOT COMPLETED|Overall Study||4
74453|NCT01454947|178146|P1|NOT COMPLETED|Overall Study||3
74454|NCT01454947|178139|P8|COMPLETED|Overall Study||23
74455|NCT01454947|178140|P7|COMPLETED|Overall Study||26
74456|NCT01454947|178141|P6|COMPLETED|Overall Study||32
74457|NCT01454947|178142|P5|COMPLETED|Overall Study||33
74458|NCT01454947|178143|P4|COMPLETED|Overall Study||19
74459|NCT01454947|178144|P3|COMPLETED|Overall Study||32
74460|NCT01454947|178145|P2|COMPLETED|Overall Study||38
74461|NCT01454947|178146|P1|COMPLETED|Overall Study||24
74462|NCT01454947|178139|P8|STARTED|Overall Study||28
74463|NCT01454947|178140|P7|STARTED|Overall Study||27
74464|NCT01454947|178141|P6|STARTED|Overall Study||35
74465|NCT01454947|178142|P5|STARTED|Overall Study||34
74466|NCT01454947|178143|P4|STARTED|Overall Study||20
74467|NCT01454947|178144|P3|STARTED|Overall Study||35
74468|NCT01454947|178145|P2|STARTED|Overall Study||42
74469|NCT01454947|178146|P1|STARTED|Overall Study||27
74470|NCT01454934|178166|P2|NOT COMPLETED|Overall Study||270
74471|NCT01454934|178167|P1|NOT COMPLETED|Overall Study||270
74472|NCT01454934|178166|P2|COMPLETED|Overall Study||0
74473|NCT01454934|178167|P1|COMPLETED|Overall Study||0
74474|NCT01454934|178166|P2|STARTED|Overall Study||270
74475|NCT01454934|178167|P1|STARTED|Overall Study||270
74476|NCT01454830|178179|P2|NOT COMPLETED|Overall Study||27
74477|NCT01454830|178180|P1|NOT COMPLETED|Overall Study||31
74478|NCT01454830|178179|P2|COMPLETED|Overall Study||30
74479|NCT01454830|178180|P1|COMPLETED|Overall Study||30
74480|NCT01454830|178179|P2|STARTED|Overall Study||57
74481|NCT01454830|178180|P1|STARTED|Overall Study||61
74482|NCT01454791|178200|P2|NOT COMPLETED|Overall Study||0
74483|NCT01454791|178201|P1|NOT COMPLETED|Overall Study||0
74484|NCT01454791|178200|P2|COMPLETED|Overall Study|20 subjects started with placebo, then switched to Diclofenac|20
74485|NCT01454791|178201|P1|COMPLETED|Overall Study|20 subjects started with Diclofenac, then switched to placebo|20
74486|NCT01454791|178200|P2|STARTED|Overall Study||20
74487|NCT01454791|178201|P1|STARTED|Overall Study||20
74488|NCT01454778|178211|P1|NOT COMPLETED|Overall Study||3
74489|NCT01454778|178211|P1|COMPLETED|Overall Study||47
74490|NCT01454778|178211|P1|STARTED|Overall Study||50
74491|NCT01454726|178222|P2|NOT COMPLETED|Overall Study||1
74492|NCT01454726|178223|P1|NOT COMPLETED|Overall Study||0
74493|NCT01454726|178222|P2|COMPLETED|Overall Study||10
74494|NCT01454726|178223|P1|COMPLETED|Overall Study||16
74495|NCT01454726|178222|P2|STARTED|Overall Study||11
74496|NCT01454726|178223|P1|STARTED|Overall Study||16
74497|NCT01454583|178232|P3|NOT COMPLETED|3rd Year||297
74498|NCT01454583|178233|P2|NOT COMPLETED|3rd Year||512
74499|NCT01454583|178234|P1|NOT COMPLETED|3rd Year||1959
74500|NCT01454583|178232|P3|COMPLETED|3rd Year||285
74501|NCT01454583|178233|P2|COMPLETED|3rd Year||470
74502|NCT01454583|178234|P1|COMPLETED|3rd Year||1832
74503|NCT01454583|178232|P3|STARTED|3rd Year||582
74504|NCT01454583|178233|P2|STARTED|3rd Year||982
74505|NCT01454583|178234|P1|STARTED|3rd Year||3791
74506|NCT01454583|178232|P3|NOT COMPLETED|2nd Year||737
74507|NCT01454583|178233|P2|NOT COMPLETED|2nd Year||1049
74508|NCT01454583|178234|P1|NOT COMPLETED|2nd Year||3965
74509|NCT01454583|178232|P3|COMPLETED|2nd Year||1376
74510|NCT01454583|178233|P2|COMPLETED|2nd Year||1647
74511|NCT01454583|178234|P1|COMPLETED|2nd Year||6212
74512|NCT01454583|178232|P3|STARTED|2nd Year||2113
74513|NCT01454583|178233|P2|STARTED|2nd Year||2696
74514|NCT01454583|178234|P1|STARTED|2nd Year||10177
74515|NCT01454583|178232|P3|NOT COMPLETED|1st Year||180
74516|NCT01454583|178233|P2|NOT COMPLETED|1st Year||318
74517|NCT01454583|178234|P1|NOT COMPLETED|1st Year||1057
74518|NCT01454583|178232|P3|COMPLETED|1st Year||1933
74519|NCT01454583|178233|P2|COMPLETED|1st Year||2378
74520|NCT01454583|178234|P1|COMPLETED|1st Year||9120
74521|NCT01454583|178232|P3|STARTED|1st Year||2113
74522|NCT01454583|178233|P2|STARTED|1st Year||2696
74523|NCT01454583|178234|P1|STARTED|1st Year|From initially 15337 pat. 351 withdrawed from the registry, 14986 pat. were assigned to the groups.|10177
74524|NCT01454531|178302|P1|NOT COMPLETED|Overall Study||23
74525|NCT01454531|178302|P1|COMPLETED|Overall Study||173
74526|NCT01454531|178302|P1|Subjects Treated|Overall Study||192
74527|NCT01454531|178302|P1|STARTED|Overall Study||196
74528|NCT01454505|178314|P4|NOT COMPLETED|Overall Study||0
74529|NCT01454505|178315|P3|NOT COMPLETED|Overall Study||0
74530|NCT01454505|178316|P2|NOT COMPLETED|Overall Study||0
74531|NCT01454505|178317|P1|NOT COMPLETED|Overall Study||0
74532|NCT01454505|178314|P4|COMPLETED|Overall Study||20
74533|NCT01454505|178315|P3|COMPLETED|Overall Study||40
74534|NCT01454505|178316|P2|COMPLETED|Overall Study||15
74535|NCT01454505|178317|P1|COMPLETED|Overall Study||35
74536|NCT01454505|178314|P4|STARTED|Overall Study||20
74537|NCT01454505|178315|P3|STARTED|Overall Study||40
74538|NCT01454505|178316|P2|STARTED|Overall Study||15
74539|NCT01454505|178317|P1|STARTED|Overall Study||35
74540|NCT01454414|178331|P2|NOT COMPLETED|Overall Study||16
74541|NCT01454414|178332|P1|NOT COMPLETED|Overall Study||13
74542|NCT01454414|178331|P2|COMPLETED|Overall Study||64
74543|NCT01454414|178332|P1|COMPLETED|Overall Study||66
74544|NCT01454414|178331|P2|Baseline: Subjects That Sent Uniforms|Overall Study||66
74545|NCT01454414|178332|P1|Baseline: Subjects That Sent Uniforms|Overall Study||67
74546|NCT01454414|178331|P2|STARTED|Overall Study||80
74547|NCT01454414|178332|P1|STARTED|Overall Study||79
74548|NCT01454401|178338|P1|NOT COMPLETED|Overall Study||5
74549|NCT01454401|178338|P1|COMPLETED|Overall Study|Per Protocol (PP)|39
74550|NCT01454401|178338|P1|STARTED|Overall Study|ITT|44
74551|NCT01454258|178343|P1|NOT COMPLETED|Overall Study||997
74552|NCT01454258|178343|P1|COMPLETED|Overall Study||9103
74553|NCT01454258|178343|P1|STARTED|Overall Study||10100
74554|NCT01454063|178351|P2|NOT COMPLETED|Treated||0
74555|NCT01454063|178352|P1|NOT COMPLETED|Treated||2
74556|NCT01454063|178351|P2|COMPLETED|Treated||201
74557|NCT01454063|178352|P1|COMPLETED|Treated||199
74558|NCT01454063|178351|P2|STARTED|Treated||201
74559|NCT01454063|178352|P1|STARTED|Treated||201
74560|NCT01454063|178351|P2|NOT COMPLETED|Randomized||2
74561|NCT01454063|178352|P1|NOT COMPLETED|Randomized||1
74562|NCT01454063|178351|P2|COMPLETED|Randomized||201
74563|NCT01454063|178352|P1|COMPLETED|Randomized||201
74564|NCT01454063|178351|P2|STARTED|Randomized||203
74565|NCT01454063|178352|P1|STARTED|Randomized||202
74566|NCT01453998|178373|P3|NOT COMPLETED|After Protocol Amendment 2.||0
74567|NCT01453998|178374|P2|NOT COMPLETED|After Protocol Amendment 2.||0
74568|NCT01453998|178375|P1|NOT COMPLETED|After Protocol Amendment 2.||1
74569|NCT01453998|178373|P3|COMPLETED|After Protocol Amendment 2.||183
74570|NCT01453998|178374|P2|COMPLETED|After Protocol Amendment 2.||99
74571|NCT01453998|178375|P1|COMPLETED|After Protocol Amendment 2.||102
74572|NCT01453998|178373|P3|STARTED|After Protocol Amendment 2.||183
74573|NCT01453998|178374|P2|STARTED|After Protocol Amendment 2.||99
74574|NCT01453998|178375|P1|STARTED|After Protocol Amendment 2.||103
74575|NCT01453998|178373|P3|NOT COMPLETED|Before Protocol Amendment 2||0
74576|NCT01453998|178374|P2|NOT COMPLETED|Before Protocol Amendment 2||0
74577|NCT01453998|178375|P1|NOT COMPLETED|Before Protocol Amendment 2||0
74578|NCT01453998|178373|P3|COMPLETED|Before Protocol Amendment 2||99
74579|NCT01453998|178374|P2|COMPLETED|Before Protocol Amendment 2||88
74580|NCT01453998|178375|P1|COMPLETED|Before Protocol Amendment 2||85
74581|NCT01453998|178373|P3|STARTED|Before Protocol Amendment 2||99
74582|NCT01453998|178374|P2|STARTED|Before Protocol Amendment 2||88
74583|NCT01453998|178375|P1|STARTED|Before Protocol Amendment 2||85
74584|NCT01453946|178440|P1|NOT COMPLETED|Overall Study||9
74585|NCT01453946|178440|P1|COMPLETED|Overall Study||41
74586|NCT01453946|178440|P1|STARTED|Overall Study||50
74587|NCT01453894|178448|P2|NOT COMPLETED|Overall Study||0
74588|NCT01453894|178449|P1|NOT COMPLETED|Overall Study||0
74589|NCT01453894|178448|P2|COMPLETED|Overall Study||225
74590|NCT01453894|178449|P1|COMPLETED|Overall Study||225
74591|NCT01453894|178448|P2|STARTED|Overall Study||225
74592|NCT01453894|178449|P1|STARTED|Overall Study||225
74593|NCT01453855|178457|P2|NOT COMPLETED|Overall Study||14
74594|NCT01453855|178458|P1|NOT COMPLETED|Overall Study||10
74595|NCT01453855|178457|P2|COMPLETED|Overall Study||408
74596|NCT01453855|178458|P1|COMPLETED|Overall Study||432
74597|NCT01453855|178457|P2|STARTED|Overall Study||422
74598|NCT01453855|178458|P1|STARTED|Overall Study||442
74599|NCT01453725|178466|P2|NOT COMPLETED|Overall Study||11
74600|NCT01453725|178467|P1|NOT COMPLETED|Overall Study||13
74601|NCT01453725|178466|P2|COMPLETED|Overall Study||89
74602|NCT01453725|178467|P1|COMPLETED|Overall Study||85
74603|NCT01453725|178466|P2|STARTED|Overall Study||100
74604|NCT01453725|178467|P1|STARTED|Overall Study||98
74605|NCT01452529|178489|P3|NOT COMPLETED|Double-blind (DB) Period||82
74606|NCT01452529|178490|P2|NOT COMPLETED|Double-blind (DB) Period||67
74607|NCT01452529|178491|P1|NOT COMPLETED|Double-blind (DB) Period||0
74608|NCT01452529|178489|P3|COMPLETED|Double-blind (DB) Period||210
74609|NCT01452529|178490|P2|COMPLETED|Double-blind (DB) Period|4 subjects who did not receive DB medication were still counted as discontinued in the DB period|229
74610|NCT01452529|178491|P1|COMPLETED|Double-blind (DB) Period||0
74611|NCT01452529|178489|P3|STARTED|Double-blind (DB) Period||292
74612|NCT01452529|178490|P2|STARTED|Double-blind (DB) Period|Four subjects were randomized but did not receive DB medication|296
74613|NCT01452529|178491|P1|STARTED|Double-blind (DB) Period||0
74614|NCT01452529|178489|P3|NOT COMPLETED|Run-in Period||0
74615|NCT01452529|178490|P2|NOT COMPLETED|Run-in Period||0
74616|NCT01452529|178491|P1|NOT COMPLETED|Run-in Period||313
74617|NCT01452529|178489|P3|COMPLETED|Run-in Period||0
74618|NCT01452529|178490|P2|COMPLETED|Run-in Period||0
74619|NCT01452529|178491|P1|COMPLETED|Run-in Period||592
74620|NCT01452529|178489|P3|STARTED|Run-in Period||0
74621|NCT01452529|178490|P2|STARTED|Run-in Period||0
74622|NCT01452529|178491|P1|STARTED|Run-in Period||905
74623|NCT01452425|178498|P1|NOT COMPLETED|Overall Study||0
74624|NCT01452425|178498|P1|COMPLETED|Overall Study||10
74625|NCT01452425|178498|P1|STARTED|Overall Study||10
74626|NCT01453595|178506|P3|NOT COMPLETED|Overall Study||2
74627|NCT01453595|178507|P2|NOT COMPLETED|Overall Study||1
74628|NCT01453595|178508|P1|NOT COMPLETED|Overall Study||2
74629|NCT01453595|178506|P3|COMPLETED|Overall Study||0
74630|NCT01453595|178507|P2|COMPLETED|Overall Study||5
74631|NCT01453595|178508|P1|COMPLETED|Overall Study||0
74632|NCT01453595|178506|P3|STARTED|Overall Study||2
74633|NCT01453595|178507|P2|STARTED|Overall Study||6
74634|NCT01453595|178508|P1|STARTED|Overall Study||2
74635|NCT01453569|178517|P3|NOT COMPLETED|Overall Study||7
74636|NCT01453569|178518|P2|NOT COMPLETED|Overall Study||14
74637|NCT01453569|178519|P1|NOT COMPLETED|Overall Study||11
74638|NCT01453569|178517|P3|COMPLETED|Overall Study||78
74639|NCT01453569|178518|P2|COMPLETED|Overall Study||70
74640|NCT01453569|178519|P1|COMPLETED|Overall Study||75
74641|NCT01453569|178517|P3|STARTED|Overall Study||85
74642|NCT01453569|178518|P2|STARTED|Overall Study||84
74643|NCT01453569|178519|P1|STARTED|Overall Study||86
74644|NCT01453413|178536|P1|NOT COMPLETED|Overall Study||0
74645|NCT01453413|178536|P1|COMPLETED|Overall Study||297
74646|NCT01453413|178536|P1|STARTED|Overall Study||297
74647|NCT01453387|178543|P2|NOT COMPLETED|Overall Study||0
74648|NCT01453387|178544|P1|NOT COMPLETED|Overall Study||0
74649|NCT01453387|178543|P2|COMPLETED|Overall Study||7
74650|NCT01453387|178544|P1|COMPLETED|Overall Study||21
74651|NCT01453387|178543|P2|STARTED|Overall Study||7
74652|NCT01453387|178544|P1|STARTED|Overall Study||21
74653|NCT01453374|178627|P1|NOT COMPLETED|Overall Study||18
74654|NCT01453374|178627|P1|COMPLETED|Overall Study|Defined as receiving 7 injections and 2 follow-up visits.|9
74655|NCT01453374|178627|P1|STARTED|Overall Study||27
74656|NCT01453348|178646|P3|NOT COMPLETED|Overall Study||1
74657|NCT01453348|178647|P2|NOT COMPLETED|Overall Study||1
74658|NCT01453348|178648|P1|NOT COMPLETED|Overall Study||1
74659|NCT01453348|178646|P3|COMPLETED|Overall Study||83
74660|NCT01453348|178647|P2|COMPLETED|Overall Study||83
74661|NCT01453348|178648|P1|COMPLETED|Overall Study||83
74662|NCT01453348|178646|P3|STARTED|Overall Study||84
74663|NCT01453348|178647|P2|STARTED|Overall Study||84
74664|NCT01453348|178648|P1|STARTED|Overall Study||84
74665|NCT01453296|178664|P2|NOT COMPLETED|Treatment Period 2||0
74666|NCT01453296|178665|P1|NOT COMPLETED|Treatment Period 2||2
74667|NCT01453296|178664|P2|COMPLETED|Treatment Period 2||13
74668|NCT01453296|178665|P1|COMPLETED|Treatment Period 2||11
74669|NCT01453296|178664|P2|STARTED|Treatment Period 2||13
74670|NCT01453296|178665|P1|STARTED|Treatment Period 2||13
74671|NCT01453296|178664|P2|NOT COMPLETED|Washout Period||0
74672|NCT01453296|178665|P1|NOT COMPLETED|Washout Period||0
74673|NCT01453296|178664|P2|COMPLETED|Washout Period||13
74674|NCT01453296|178665|P1|COMPLETED|Washout Period||13
74675|NCT01453296|178664|P2|STARTED|Washout Period||13
74676|NCT01453296|178665|P1|STARTED|Washout Period||13
74677|NCT01453296|178664|P2|NOT COMPLETED|Treatment Period 1||1
74678|NCT01453296|178665|P1|NOT COMPLETED|Treatment Period 1||1
74679|NCT01453296|178664|P2|COMPLETED|Treatment Period 1||13
74680|NCT01453296|178665|P1|COMPLETED|Treatment Period 1||13
74681|NCT01453296|178664|P2|STARTED|Treatment Period 1||14
74682|NCT01453296|178665|P1|STARTED|Treatment Period 1||14
74683|NCT01453166|178732|P3|NOT COMPLETED|Overall Study||1
74684|NCT01453166|178733|P2|NOT COMPLETED|Overall Study||2
74685|NCT01453166|178734|P1|NOT COMPLETED|Overall Study||2
74686|NCT01453166|178732|P3|COMPLETED|Overall Study||38
74687|NCT01453166|178733|P2|COMPLETED|Overall Study||39
74688|NCT01453166|178734|P1|COMPLETED|Overall Study||40
74689|NCT01453166|178732|P3|STARTED|Overall Study||39
74690|NCT01453166|178733|P2|STARTED|Overall Study||41
74691|NCT01453166|178734|P1|STARTED|Overall Study||42
74692|NCT01453075|178756|P2|NOT COMPLETED|Overall Study||1
74693|NCT01453075|178757|P1|NOT COMPLETED|Overall Study||5
74694|NCT01453075|178756|P2|COMPLETED|Overall Study||14
74695|NCT01453075|178757|P1|COMPLETED|Overall Study||11
74696|NCT01453075|178756|P2|STARTED|Overall Study||15
74697|NCT01453075|178757|P1|STARTED|Overall Study||16
74698|NCT01453049|178765|P2|NOT COMPLETED|Overall Study||42
74699|NCT01453049|178766|P1|NOT COMPLETED|Overall Study||41
74700|NCT01453049|178765|P2|COMPLETED|Overall Study||2
74701|NCT01453049|178766|P1|COMPLETED|Overall Study||1
74702|NCT01453049|178765|P2|STARTED|Overall Study||44
74703|NCT01453049|178766|P1|STARTED|Overall Study||42
74704|NCT01453036|178839|P3|NOT COMPLETED|Overall Study||31
74705|NCT01453036|178840|P2|NOT COMPLETED|Overall Study||115
74706|NCT01453036|178841|P1|NOT COMPLETED|Overall Study||26
74707|NCT01453036|178839|P3|COMPLETED|Overall Study||277
74708|NCT01453036|178840|P2|COMPLETED|Overall Study||193
74709|NCT01453036|178841|P1|COMPLETED|Overall Study||282
74710|NCT01453036|178839|P3|STARTED|Overall Study||308
74711|NCT01453036|178840|P2|STARTED|Overall Study||308
74712|NCT01453036|178841|P1|STARTED|Overall Study||308
74713|NCT01453023|178849|P2|NOT COMPLETED|Treatment Period 2||1
74714|NCT01453023|178850|P1|NOT COMPLETED|Treatment Period 2||0
74715|NCT01453023|178849|P2|COMPLETED|Treatment Period 2||11
74716|NCT01453023|178850|P1|COMPLETED|Treatment Period 2||12
74717|NCT01453023|178849|P2|STARTED|Treatment Period 2||12
74718|NCT01453023|178850|P1|STARTED|Treatment Period 2||12
74719|NCT01453023|178849|P2|NOT COMPLETED|Washout Period||0
74720|NCT01453023|178850|P1|NOT COMPLETED|Washout Period||0
74721|NCT01453023|178849|P2|COMPLETED|Washout Period||12
74722|NCT01453023|178850|P1|COMPLETED|Washout Period||12
74723|NCT01453023|178849|P2|STARTED|Washout Period||12
74724|NCT01453023|178850|P1|STARTED|Washout Period||12
74725|NCT01453023|178849|P2|NOT COMPLETED|Treatment Period (TP) 1||1
74726|NCT01453023|178850|P1|NOT COMPLETED|Treatment Period (TP) 1||1
74727|NCT01453023|178849|P2|COMPLETED|Treatment Period (TP) 1||12
74728|NCT01453023|178850|P1|COMPLETED|Treatment Period (TP) 1||12
74729|NCT01453023|178849|P2|STARTED|Treatment Period (TP) 1||13
74730|NCT01453023|178850|P1|STARTED|Treatment Period (TP) 1||13
74731|NCT01452854|178918|P1|NOT COMPLETED|Overall Study||0
74732|NCT01452854|178918|P1|COMPLETED|Overall Study||2
74733|NCT01452854|178918|P1|STARTED|Overall Study||2
74734|NCT01452347|178924|P2|NOT COMPLETED|Overall Study||7
74735|NCT01452347|178925|P1|NOT COMPLETED|Overall Study||17
74736|NCT01452347|178924|P2|COMPLETED|Overall Study||77
74737|NCT01452347|178925|P1|COMPLETED|Overall Study||151
74738|NCT01452347|178924|P2|STARTED|Overall Study||84
74739|NCT01452347|178925|P1|STARTED|Overall Study||168
74740|NCT01452269|178943|P2|NOT COMPLETED|Overall Study||5
74741|NCT01452269|178944|P1|NOT COMPLETED|Overall Study||1
74742|NCT01452269|178943|P2|COMPLETED|Overall Study||51
74743|NCT01452269|178944|P1|COMPLETED|Overall Study||47
74744|NCT01452269|178943|P2|STARTED|Overall Study||56
74745|NCT01452269|178944|P1|STARTED|Overall Study||48
74746|NCT01452152|178957|P3|NOT COMPLETED|Overall Study||4
74747|NCT01452152|178958|P2|NOT COMPLETED|Overall Study||0
74748|NCT01452152|178959|P1|NOT COMPLETED|Overall Study||5
74749|NCT01452152|178957|P3|COMPLETED|Overall Study||0
74750|NCT01452152|178958|P2|COMPLETED|Overall Study||0
74751|NCT01452152|178959|P1|COMPLETED|Overall Study||0
74752|NCT01452152|178957|P3|STARTED|Overall Study||4
74753|NCT01452152|178958|P2|STARTED|Overall Study||0
74754|NCT01452152|178959|P1|STARTED|Overall Study||5
74755|NCT01452126|178967|P1|NOT COMPLETED|Overall Study||0
74756|NCT01452126|178967|P1|COMPLETED|Overall Study||49
74757|NCT01452126|178967|P1|STARTED|Overall Study||49
74758|NCT01451983|178979|P4|NOT COMPLETED|Overall Study||0
74759|NCT01451983|178980|P3|NOT COMPLETED|Overall Study||0
74760|NCT01451983|178981|P2|NOT COMPLETED|Overall Study||0
74761|NCT01451983|178982|P1|NOT COMPLETED|Overall Study||0
74762|NCT01451983|178979|P4|COMPLETED|Overall Study||24
74763|NCT01451983|178980|P3|COMPLETED|Overall Study||61
74764|NCT01451983|178981|P2|COMPLETED|Overall Study||27
74765|NCT01451983|178982|P1|COMPLETED|Overall Study||26
74766|NCT01451983|178979|P4|STARTED|Overall Study||24
74767|NCT01451983|178980|P3|STARTED|Overall Study||61
74768|NCT01451983|178981|P2|STARTED|Overall Study||27
74769|NCT01451983|178982|P1|STARTED|Overall Study||26
74770|NCT01451931|178995|P3|NOT COMPLETED|Overall Study||43
74771|NCT01451931|178996|P2|NOT COMPLETED|Overall Study||58
74772|NCT01451931|178997|P1|NOT COMPLETED|Overall Study||33
74773|NCT01451931|178995|P3|COMPLETED|Overall Study||923
74774|NCT01451931|178996|P2|COMPLETED|Overall Study||843
74775|NCT01451931|178997|P1|COMPLETED|Overall Study||876
74776|NCT01451931|178995|P3|6-month Follow up|Overall Study||923
74777|NCT01451931|178996|P2|6-month Follow up|Overall Study||843
74778|NCT01451931|178997|P1|6-month Follow up|Overall Study||876
74779|NCT01451931|178995|P3|Baseline Data Collection|Overall Study||958
74780|NCT01451931|178996|P2|Baseline Data Collection|Overall Study||893
74781|NCT01451931|178997|P1|Baseline Data Collection|Overall Study||908
74782|NCT01451931|178995|P3|STARTED|Overall Study||966
74783|NCT01451931|178996|P2|STARTED|Overall Study||901
74784|NCT01451931|178997|P1|STARTED|Overall Study||909
74785|NCT01451814|179019|P2|NOT COMPLETED|Overall Study||5
74786|NCT01451814|179020|P1|NOT COMPLETED|Overall Study||6
74787|NCT01451814|179019|P2|COMPLETED|Overall Study||26
74788|NCT01451814|179020|P1|COMPLETED|Overall Study||29
74789|NCT01451814|179019|P2|Attended a Session|Overall Study||31
74790|NCT01451814|179020|P1|Attended a Session|Overall Study||35
74791|NCT01451814|179019|P2|STARTED|Overall Study||31
74792|NCT01451814|179020|P1|STARTED|Overall Study||35
74793|NCT01451775|179030|P6|NOT COMPLETED|Overall Study||0
74794|NCT01451775|179031|P5|NOT COMPLETED|Overall Study||0
74795|NCT01451775|179032|P4|NOT COMPLETED|Overall Study||0
74796|NCT01451775|179033|P3|NOT COMPLETED|Overall Study||0
74797|NCT01451775|179034|P2|NOT COMPLETED|Overall Study||0
74798|NCT01451775|179035|P1|NOT COMPLETED|Overall Study||0
74799|NCT01451775|179030|P6|COMPLETED|Overall Study||3
74800|NCT01451775|179031|P5|COMPLETED|Overall Study||3
74801|NCT01451775|179032|P4|COMPLETED|Overall Study||3
74802|NCT01451775|179033|P3|COMPLETED|Overall Study||3
74803|NCT01451775|179034|P2|COMPLETED|Overall Study||3
74804|NCT01451775|179035|P1|COMPLETED|Overall Study||3
74805|NCT01451775|179030|P6|STARTED|Overall Study||3
74806|NCT01451775|179031|P5|STARTED|Overall Study||3
74807|NCT01451775|179032|P4|STARTED|Overall Study||3
74808|NCT01451775|179033|P3|STARTED|Overall Study||3
74809|NCT01451775|179034|P2|STARTED|Overall Study||3
74810|NCT01451775|179035|P1|STARTED|Overall Study||3
74811|NCT01451762|179052|P3|NOT COMPLETED|Overall Study||6
74812|NCT01451762|179053|P2|NOT COMPLETED|Overall Study||6
74813|NCT01451762|179054|P1|NOT COMPLETED|Overall Study||3
74814|NCT01451762|179052|P3|COMPLETED|Overall Study||24
74815|NCT01451762|179053|P2|COMPLETED|Overall Study||24
74816|NCT01451762|179054|P1|COMPLETED|Overall Study||27
74817|NCT01451762|179052|P3|STARTED|Overall Study||30
74818|NCT01451762|179053|P2|STARTED|Overall Study||30
74819|NCT01451762|179054|P1|STARTED|Overall Study||30
74820|NCT01451749|179064|P2|NOT COMPLETED|Overall Study||14
74821|NCT01451749|179065|P1|NOT COMPLETED|Overall Study||32
74822|NCT01451749|179064|P2|COMPLETED|Overall Study||94
74823|NCT01451749|179065|P1|COMPLETED|Overall Study||184
74824|NCT01451749|179064|P2|STARTED|Overall Study||108
74825|NCT01451749|179065|P1|STARTED|Overall Study||216
74826|NCT01451723|179077|P2|NOT COMPLETED|Overall Study||5
74827|NCT01451723|179078|P1|NOT COMPLETED|Overall Study||6
74828|NCT01451723|179077|P2|COMPLETED|Overall Study||0
74829|NCT01451723|179078|P1|COMPLETED|Overall Study||0
74830|NCT01451723|179077|P2|STARTED|Overall Study||5
74831|NCT01451723|179078|P1|STARTED|Overall Study||6
74832|NCT01451645|179088|P2|NOT COMPLETED|Overall Study||8
74833|NCT01451645|179089|P1|NOT COMPLETED|Overall Study||9
74834|NCT01451645|179088|P2|COMPLETED|Overall Study||33
74835|NCT01451645|179089|P1|COMPLETED|Overall Study||32
74836|NCT01451645|179088|P2|STARTED|Overall Study||41
74837|NCT01451645|179089|P1|STARTED|Overall Study||41
74838|NCT01451632|179103|P10|NOT COMPLETED|Overall Study||0
74839|NCT01451632|179104|P9|NOT COMPLETED|Overall Study||0
74840|NCT01451632|179105|P8|NOT COMPLETED|Overall Study||0
74841|NCT01451632|179106|P7|NOT COMPLETED|Overall Study||0
74842|NCT01451632|179107|P6|NOT COMPLETED|Overall Study||0
74843|NCT01451632|179108|P5|NOT COMPLETED|Overall Study||0
74844|NCT01451632|179109|P4|NOT COMPLETED|Overall Study||0
74845|NCT01451632|179110|P3|NOT COMPLETED|Overall Study||0
74846|NCT01451632|179111|P2|NOT COMPLETED|Overall Study||0
74847|NCT01451632|179112|P1|NOT COMPLETED|Overall Study||0
74848|NCT01451632|179103|P10|COMPLETED|Overall Study||4
74849|NCT01451632|179104|P9|COMPLETED|Overall Study||4
74850|NCT01451632|179105|P8|COMPLETED|Overall Study||6
74851|NCT01451632|179106|P7|COMPLETED|Overall Study||8
74852|NCT01451632|179107|P6|COMPLETED|Overall Study||4
74853|NCT01451632|179108|P5|COMPLETED|Overall Study||4
74854|NCT01451632|179109|P4|COMPLETED|Overall Study||3
74855|NCT01451632|179110|P3|COMPLETED|Overall Study||3
74856|NCT01451632|179111|P2|COMPLETED|Overall Study||4
74857|NCT01451632|179112|P1|COMPLETED|Overall Study||8
74858|NCT01451632|179103|P10|STARTED|Overall Study||4
74859|NCT01451632|179104|P9|STARTED|Overall Study||4
74860|NCT01451632|179105|P8|STARTED|Overall Study||6
74861|NCT01451632|179106|P7|STARTED|Overall Study||8
74862|NCT01451632|179107|P6|STARTED|Overall Study||4
74863|NCT01451632|179108|P5|STARTED|Overall Study||4
74864|NCT01451632|179109|P4|STARTED|Overall Study||3
74865|NCT01451632|179110|P3|STARTED|Overall Study||3
74866|NCT01451632|179111|P2|STARTED|Overall Study||4
74867|NCT01451632|179112|P1|STARTED|Overall Study||8
74868|NCT01451554|179160|P2|NOT COMPLETED|Overall Study||9
74869|NCT01451554|179161|P1|NOT COMPLETED|Overall Study||14
74870|NCT01451554|179160|P2|COMPLETED|Overall Study||23
74871|NCT01451554|179161|P1|COMPLETED|Overall Study||19
74872|NCT01451554|179160|P2|STARTED|Overall Study||32
74873|NCT01451554|179161|P1|STARTED|Overall Study||33
74874|NCT01451541|179172|P3|NOT COMPLETED|Overall Study||27
74875|NCT01451541|179173|P2|NOT COMPLETED|Overall Study||25
74876|NCT01451541|179174|P1|NOT COMPLETED|Overall Study||36
74877|NCT01451541|179172|P3|COMPLETED|Overall Study||254
74878|NCT01451541|179173|P2|COMPLETED|Overall Study||257
74879|NCT01451541|179174|P1|COMPLETED|Overall Study||247
74880|NCT01451541|179172|P3|STARTED|Overall Study|283 randomized. ITT = 281 (2 subjects discontinued prior to study medication).|281
74881|NCT01451541|179173|P2|STARTED|Overall Study||282
74882|NCT01451541|179174|P1|STARTED|Overall Study||283
74883|NCT01451437|179223|P9|NOT COMPLETED|Overall Study||4
74884|NCT01451437|179224|P8|NOT COMPLETED|Overall Study||3
74885|NCT01451437|179225|P7|NOT COMPLETED|Overall Study||6
74886|NCT01451437|179226|P6|NOT COMPLETED|Overall Study||3
74887|NCT01451437|179227|P5|NOT COMPLETED|Overall Study||4
74888|NCT01451437|179228|P4|NOT COMPLETED|Overall Study||1
74889|NCT01451437|179229|P3|NOT COMPLETED|Overall Study||3
74890|NCT01451437|179230|P2|NOT COMPLETED|Overall Study||1
74891|NCT01451437|179231|P1|NOT COMPLETED|Overall Study||1
74892|NCT01451437|179223|P9|COMPLETED|Overall Study||0
74893|NCT01451437|179224|P8|COMPLETED|Overall Study||0
74894|NCT01451437|179225|P7|COMPLETED|Overall Study||0
74895|NCT01451437|179226|P6|COMPLETED|Overall Study||0
74896|NCT01451437|179227|P5|COMPLETED|Overall Study||0
74897|NCT01451437|179228|P4|COMPLETED|Overall Study||0
74898|NCT01451437|179229|P3|COMPLETED|Overall Study||0
74899|NCT01451437|179230|P2|COMPLETED|Overall Study||0
74900|NCT01451437|179231|P1|COMPLETED|Overall Study||0
74901|NCT01451437|179223|P9|STARTED|Overall Study||4
74902|NCT01451437|179224|P8|STARTED|Overall Study||3
74903|NCT01451437|179225|P7|STARTED|Overall Study||6
74904|NCT01451437|179226|P6|STARTED|Overall Study||3
74905|NCT01451437|179227|P5|STARTED|Overall Study||4
74906|NCT01451437|179228|P4|STARTED|Overall Study||1
74907|NCT01451437|179229|P3|STARTED|Overall Study||3
74908|NCT01451437|179230|P2|STARTED|Overall Study||1
74909|NCT01451437|179231|P1|STARTED|Overall Study||1
74910|NCT01451424|179363|P4|NOT COMPLETED|Overall Study||5
74911|NCT01451424|179364|P3|NOT COMPLETED|Overall Study||1
74912|NCT01451424|179365|P2|NOT COMPLETED|Overall Study||2
74913|NCT01451424|179366|P1|NOT COMPLETED|Overall Study||1
74914|NCT01451424|179363|P4|COMPLETED|Overall Study||5
74915|NCT01451424|179364|P3|COMPLETED|Overall Study||11
74916|NCT01451424|179365|P2|COMPLETED|Overall Study||7
74917|NCT01451424|179366|P1|COMPLETED|Overall Study||8
74918|NCT01451424|179363|P4|STARTED|Overall Study||10
74919|NCT01451424|179364|P3|STARTED|Overall Study||12
74920|NCT01451424|179365|P2|STARTED|Overall Study||9
74921|NCT01451424|179366|P1|STARTED|Overall Study||9
74922|NCT01451411|179399|P2|NOT COMPLETED|Overall Study||0
74923|NCT01451411|179400|P1|NOT COMPLETED|Overall Study||0
74924|NCT01451411|179399|P2|COMPLETED|Overall Study||1
74925|NCT01451411|179400|P1|COMPLETED|Overall Study||3
74926|NCT01451411|179399|P2|STARTED|Overall Study||1
74927|NCT01451411|179400|P1|STARTED|Overall Study||3
74928|NCT01451398|179424|P2|NOT COMPLETED|Overall Study||37
74929|NCT01451398|179425|P1|NOT COMPLETED|Overall Study||27
74930|NCT01451398|179424|P2|COMPLETED|Overall Study||139
74931|NCT01451398|179425|P1|COMPLETED|Overall Study||150
74932|NCT01451398|179424|P2|STARTED|Overall Study||176
74933|NCT01451398|179425|P1|STARTED|Overall Study||177
74934|NCT01451203|179459|P2|NOT COMPLETED|Post-treatment Period||34
74935|NCT01451203|179460|P1|NOT COMPLETED|Post-treatment Period||14
74936|NCT01451203|179459|P2|COMPLETED|Post-treatment Period||74
74937|NCT01451203|179460|P1|COMPLETED|Post-treatment Period||57
75022|NCT01450306|179600|P1|STARTED|Overall Study||10
75023|NCT01450189|179613|P3|NOT COMPLETED|Overall Study||0
74938|NCT01451203|179459|P2|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|28
74939|NCT01451203|179460|P1|Received Rescue Treatment|Post-treatment Period|Participants who presented with flares at any time were dropped out of study schedule.|12
74940|NCT01451203|179459|P2|STARTED|Post-treatment Period|Three participants received rescue treatment and did not enter this period.|108
74941|NCT01451203|179460|P1|STARTED|Post-treatment Period|Two participants received rescue treatment and did not enter this period.|71
74942|NCT01451203|179459|P2|NOT COMPLETED|Double-blind Treatment Period||50
74943|NCT01451203|179460|P1|NOT COMPLETED|Double-blind Treatment Period||85
74944|NCT01451203|179459|P2|COMPLETED|Double-blind Treatment Period||111
74945|NCT01451203|179460|P1|COMPLETED|Double-blind Treatment Period||73
74946|NCT01451203|179459|P2|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|36
74947|NCT01451203|179460|P1|Received Rescue Treatment|Double-blind Treatment Period|Participants who did not achieve improvement at & after Week 24 were dropped out of study schedule.|70
74948|NCT01451203|179459|P2|Received Treatment|Double-blind Treatment Period||159
74949|NCT01451203|179460|P1|Received Treatment|Double-blind Treatment Period||157
74950|NCT01451203|179459|P2|STARTED|Double-blind Treatment Period||161
74951|NCT01451203|179460|P1|STARTED|Double-blind Treatment Period||158
74952|NCT01450813|179478|P4|NOT COMPLETED|Overall Study||3
74953|NCT01450813|179479|P3|NOT COMPLETED|Overall Study||0
74954|NCT01450813|179480|P2|NOT COMPLETED|Overall Study||1
74955|NCT01450813|179481|P1|NOT COMPLETED|Overall Study||1
74956|NCT01450813|179478|P4|COMPLETED|Overall Study||17
74957|NCT01450813|179479|P3|COMPLETED|Overall Study||20
74958|NCT01450813|179480|P2|COMPLETED|Overall Study||19
74959|NCT01450813|179481|P1|COMPLETED|Overall Study||19
74960|NCT01450813|179478|P4|STARTED|Overall Study||20
74961|NCT01450813|179479|P3|STARTED|Overall Study||20
74962|NCT01450813|179480|P2|STARTED|Overall Study||20
74963|NCT01450813|179481|P1|STARTED|Overall Study||20
74964|NCT01450800|179495|P2|NOT COMPLETED|Overall Study||3
74965|NCT01450800|179496|P1|NOT COMPLETED|Overall Study||1
74966|NCT01450800|179495|P2|COMPLETED|Overall Study||78
74967|NCT01450800|179496|P1|COMPLETED|Overall Study||81
74968|NCT01450800|179495|P2|STARTED|Overall Study|81 participants were randomized to placebo|81
74969|NCT01450800|179496|P1|STARTED|Overall Study|82 participants were randomized to nitrofurantoin|82
74970|NCT01450787|179512|P2|NOT COMPLETED|Overall Study||0
74971|NCT01450787|179513|P1|NOT COMPLETED|Overall Study||0
74972|NCT01450787|179512|P2|COMPLETED|Overall Study||25
74973|NCT01450787|179513|P1|COMPLETED|Overall Study||38
74974|NCT01450787|179512|P2|STARTED|Overall Study||25
74975|NCT01450787|179513|P1|STARTED|Overall Study||38
74976|NCT01450761|179531|P2|NOT COMPLETED|Treatment With Blinded Study Therapy||466
74977|NCT01450761|179532|P1|NOT COMPLETED|Treatment With Blinded Study Therapy||464
74978|NCT01450761|179531|P2|COMPLETED|Treatment With Blinded Study Therapy||10
74979|NCT01450761|179532|P1|COMPLETED|Treatment With Blinded Study Therapy||14
74980|NCT01450761|179531|P2|STARTED|Treatment With Blinded Study Therapy||476
74981|NCT01450761|179532|P1|STARTED|Treatment With Blinded Study Therapy||478
74982|NCT01450761|179531|P2|NOT COMPLETED|Lead-in Chemotherapy||85
74983|NCT01450761|179532|P1|NOT COMPLETED|Lead-in Chemotherapy||84
74984|NCT01450761|179531|P2|COMPLETED|Lead-in Chemotherapy||476
74985|NCT01450761|179532|P1|COMPLETED|Lead-in Chemotherapy||478
74986|NCT01450761|179531|P2|STARTED|Lead-in Chemotherapy||561
74987|NCT01450761|179532|P1|STARTED|Lead-in Chemotherapy||562
74988|NCT01450761|179531|P2|NOT COMPLETED|Randomization||5
74989|NCT01450761|179532|P1|NOT COMPLETED|Randomization||4
74990|NCT01450761|179531|P2|COMPLETED|Randomization||561
74991|NCT01450761|179532|P1|COMPLETED|Randomization||562
74992|NCT01450761|179531|P2|STARTED|Randomization||566
74993|NCT01450761|179532|P1|STARTED|Randomization||566
74994|NCT01450696|179544|P2|NOT COMPLETED|Overall Study||148
74995|NCT01450696|179545|P1|NOT COMPLETED|Overall Study||148
74996|NCT01450696|179544|P2|COMPLETED|Overall Study||0
74997|NCT01450696|179545|P1|COMPLETED|Overall Study||0
74998|NCT01450696|179544|P2|Treated (Safety Population)|Overall Study||147
74999|NCT01450696|179545|P1|Treated (Safety Population)|Overall Study||147
75000|NCT01450696|179544|P2|STARTED|Overall Study||148
75001|NCT01450696|179545|P1|STARTED|Overall Study||148
75002|NCT01450683|179567|P1|NOT COMPLETED|Overall Study||2
75003|NCT01450683|179567|P1|COMPLETED|Overall Study||2
75004|NCT01450683|179567|P1|STARTED|Overall Study||4
75005|NCT01450631|179573|P2|NOT COMPLETED|Overall Study||4
75006|NCT01450631|179574|P1|NOT COMPLETED|Overall Study||3
75007|NCT01450631|179573|P2|COMPLETED|Overall Study||42
75008|NCT01450631|179574|P1|COMPLETED|Overall Study||43
75009|NCT01450631|179573|P2|STARTED|Overall Study||46
75010|NCT01450631|179574|P1|STARTED|Overall Study||46
75011|NCT01450397|179582|P1|NOT COMPLETED|Overall Study||0
75012|NCT01450397|179582|P1|COMPLETED|Overall Study||5
75013|NCT01450397|179582|P1|STARTED|Overall Study||5
75014|NCT01450319|179586|P1|NOT COMPLETED|Overall Study||0
75015|NCT01450319|179586|P1|COMPLETED|Overall Study||70
75016|NCT01450319|179586|P1|STARTED|Overall Study||70
75017|NCT01450306|179599|P2|NOT COMPLETED|Overall Study||0
75018|NCT01450306|179600|P1|NOT COMPLETED|Overall Study||0
75019|NCT01450306|179599|P2|COMPLETED|Overall Study||10
75020|NCT01450306|179600|P1|COMPLETED|Overall Study||10
75021|NCT01450306|179599|P2|STARTED|Overall Study||10
75024|NCT01450189|179614|P2|NOT COMPLETED|Overall Study||0
75025|NCT01450189|179615|P1|NOT COMPLETED|Overall Study||0
75026|NCT01450189|179613|P3|COMPLETED|Overall Study||19
75027|NCT01450189|179614|P2|COMPLETED|Overall Study||18
75028|NCT01450189|179615|P1|COMPLETED|Overall Study||9
75029|NCT01450189|179613|P3|STARTED|Overall Study||19
75030|NCT01450189|179614|P2|STARTED|Overall Study||18
75031|NCT01450189|179615|P1|STARTED|Overall Study||9
75032|NCT01450007|179705|P3|NOT COMPLETED|Overall Study||3
75033|NCT01450007|179706|P2|NOT COMPLETED|Overall Study||5
75034|NCT01450007|179707|P1|NOT COMPLETED|Overall Study||2
75035|NCT01450007|179705|P3|COMPLETED|Overall Study||41
75036|NCT01450007|179706|P2|COMPLETED|Overall Study||37
75037|NCT01450007|179707|P1|COMPLETED|Overall Study||42
75038|NCT01450007|179705|P3|STARTED|Overall Study||44
75039|NCT01450007|179706|P2|STARTED|Overall Study||42
75040|NCT01450007|179707|P1|STARTED|Overall Study||44
75041|NCT01449955|179726|P2|NOT COMPLETED|Overall Study||2
75042|NCT01449955|179727|P1|NOT COMPLETED|Overall Study||1
75043|NCT01449955|179726|P2|COMPLETED|Overall Study||24
75044|NCT01449955|179727|P1|COMPLETED|Overall Study||27
75045|NCT01449955|179726|P2|STARTED|Overall Study||26
75046|NCT01449955|179727|P1|STARTED|Overall Study||28
75047|NCT01449929|179735|P2|NOT COMPLETED|Overall Study||242
75048|NCT01449929|179736|P1|NOT COMPLETED|Overall Study||242
75049|NCT01449929|179735|P2|COMPLETED|Overall Study||0
75050|NCT01449929|179736|P1|COMPLETED|Overall Study||0
75051|NCT01449929|179735|P2|Ongoing|Overall Study||213
75052|NCT01449929|179736|P1|Ongoing|Overall Study||224
75053|NCT01449929|179735|P2|STARTED|Overall Study||242
75054|NCT01449929|179736|P1|STARTED|Overall Study||242
75055|NCT01449812|179775|P3|NOT COMPLETED|Overall Study||1
75056|NCT01449812|179776|P2|NOT COMPLETED|Overall Study||0
75057|NCT01449812|179777|P1|NOT COMPLETED|Overall Study||2
75058|NCT01449812|179775|P3|COMPLETED|Overall Study||279
75059|NCT01449812|179776|P2|COMPLETED|Overall Study||273
75060|NCT01449812|179777|P1|COMPLETED|Overall Study||270
75061|NCT01449812|179775|P3|STARTED|Overall Study||280
75062|NCT01449812|179776|P2|STARTED|Overall Study||273
75063|NCT01449812|179777|P1|STARTED|Overall Study||272
75064|NCT01449747|179871|P2|NOT COMPLETED|Overall Study||0
75065|NCT01449747|179872|P1|NOT COMPLETED|Overall Study||0
75066|NCT01449747|179871|P2|COMPLETED|Overall Study||12
75067|NCT01449747|179872|P1|COMPLETED|Overall Study||12
75068|NCT01449747|179871|P2|STARTED|Overall Study||12
75069|NCT01449747|179872|P1|STARTED|Overall Study||12
75070|NCT01449734|179886|P1|NOT COMPLETED|Overall Study||0
75071|NCT01449734|179886|P1|COMPLETED|Overall Study||215
75072|NCT01449734|179886|P1|STARTED|Overall Study||215
75073|NCT01449708|179892|P2|NOT COMPLETED|Overall Study||3
75074|NCT01449708|179893|P1|NOT COMPLETED|Overall Study||2
75075|NCT01449708|179892|P2|COMPLETED|Overall Study||60
75076|NCT01449708|179893|P1|COMPLETED|Overall Study||59
75077|NCT01449708|179892|P2|STARTED|Overall Study||63
75078|NCT01449708|179893|P1|STARTED|Overall Study||61
75079|NCT01449682|179904|P2|NOT COMPLETED|Overall Study||1
75080|NCT01449682|179905|P1|NOT COMPLETED|Overall Study||1
75081|NCT01449682|179904|P2|COMPLETED|Overall Study||4
75082|NCT01449682|179905|P1|COMPLETED|Overall Study||4
75083|NCT01449682|179904|P2|STARTED|Overall Study||5
75084|NCT01449682|179905|P1|STARTED|Overall Study||5
75085|NCT01449539|179917|P1|NOT COMPLETED|Overall Study||4
75086|NCT01449539|179917|P1|COMPLETED|Overall Study||4
75087|NCT01449539|179917|P1|STARTED|Overall Study||8
75088|NCT01449526|179923|P2|NOT COMPLETED|Overall Study||6
75089|NCT01449526|179924|P1|NOT COMPLETED|Overall Study||2
75090|NCT01449526|179923|P2|COMPLETED|Overall Study||77
75091|NCT01449526|179924|P1|COMPLETED|Overall Study||81
75092|NCT01449526|179923|P2|STARTED|Overall Study||83
75093|NCT01449526|179924|P1|STARTED|Overall Study||83
75094|NCT01449513|179934|P2|NOT COMPLETED|Overall Study||0
75095|NCT01449513|179935|P1|NOT COMPLETED|Overall Study||0
75096|NCT01449513|179934|P2|COMPLETED|Overall Study||8
75097|NCT01449513|179935|P1|COMPLETED|Overall Study||16
75098|NCT01449513|179934|P2|STARTED|Overall Study||8
75099|NCT01449513|179935|P1|STARTED|Overall Study||16
75100|NCT01449461|179993|P6|NOT COMPLETED|Overall Study||15
75101|NCT01449461|179994|P5|NOT COMPLETED|Overall Study||48
75102|NCT01449461|179995|P4|NOT COMPLETED|Overall Study||32
75103|NCT01449461|179996|P3|NOT COMPLETED|Overall Study||18
75104|NCT01449461|179997|P2|NOT COMPLETED|Overall Study||18
75105|NCT01449461|179998|P1|NOT COMPLETED|Overall Study||6
75106|NCT01449461|179993|P6|COMPLETED|Overall Study||0
75107|NCT01449461|179994|P5|COMPLETED|Overall Study||0
75108|NCT01449461|179995|P4|COMPLETED|Overall Study||0
75109|NCT01449461|179996|P3|COMPLETED|Overall Study||0
75110|NCT01449461|179997|P2|COMPLETED|Overall Study||0
75111|NCT01449461|179998|P1|COMPLETED|Overall Study||0
75112|NCT01449461|179993|P6|STARTED|Overall Study||15
75113|NCT01449461|179994|P5|STARTED|Overall Study||48
75114|NCT01449461|179995|P4|STARTED|Overall Study||32
75115|NCT01449461|179996|P3|STARTED|Overall Study||18
75116|NCT01449461|179997|P2|STARTED|Overall Study||18
75117|NCT01449461|179998|P1|STARTED|Overall Study||6
75118|NCT01449370|180135|P25|NOT COMPLETED|Overall Study||8
75119|NCT01449370|180136|P24|NOT COMPLETED|Overall Study||10
75120|NCT01449370|180137|P23|NOT COMPLETED|Overall Study||4
75121|NCT01449370|180138|P22|NOT COMPLETED|Overall Study||4
75122|NCT01449370|180139|P21|NOT COMPLETED|Overall Study||6
75123|NCT01449370|180140|P20|NOT COMPLETED|Overall Study||3
75124|NCT01449370|180141|P19|NOT COMPLETED|Overall Study||3
75125|NCT01449370|180142|P18|NOT COMPLETED|Overall Study||3
75126|NCT01449370|180143|P17|NOT COMPLETED|Overall Study||7
75127|NCT01449370|180144|P16|NOT COMPLETED|Overall Study||3
75128|NCT01449370|180145|P15|NOT COMPLETED|Overall Study||3
75129|NCT01449370|180146|P14|NOT COMPLETED|Overall Study||11
75130|NCT01449370|180147|P13|NOT COMPLETED|Overall Study||3
75131|NCT01449370|180148|P12|NOT COMPLETED|Overall Study||3
75132|NCT01449370|180149|P11|NOT COMPLETED|Overall Study||3
75133|NCT01449370|180150|P10|NOT COMPLETED|Overall Study||3
75134|NCT01449370|180151|P9|NOT COMPLETED|Overall Study||12
75135|NCT01449370|180152|P8|NOT COMPLETED|Overall Study||3
75136|NCT01449370|180153|P7|NOT COMPLETED|Overall Study||3
75137|NCT01449370|180154|P6|NOT COMPLETED|Overall Study||3
75138|NCT01449370|180155|P5|NOT COMPLETED|Overall Study||3
75139|NCT01449370|180156|P4|NOT COMPLETED|Overall Study||4
75140|NCT01449370|180157|P3|NOT COMPLETED|Overall Study||8
75141|NCT01449370|180158|P2|NOT COMPLETED|Overall Study||6
75142|NCT01449370|180159|P1|NOT COMPLETED|Overall Study||6
75143|NCT01449370|180135|P25|COMPLETED|Overall Study||0
75144|NCT01449370|180136|P24|COMPLETED|Overall Study||0
75145|NCT01449370|180137|P23|COMPLETED|Overall Study||0
75146|NCT01449370|180138|P22|COMPLETED|Overall Study||0
75147|NCT01449370|180139|P21|COMPLETED|Overall Study||0
75148|NCT01449370|180140|P20|COMPLETED|Overall Study||0
75149|NCT01449370|180141|P19|COMPLETED|Overall Study||0
75150|NCT01449370|180142|P18|COMPLETED|Overall Study||0
75151|NCT01449370|180143|P17|COMPLETED|Overall Study||0
75152|NCT01449370|180144|P16|COMPLETED|Overall Study||0
75153|NCT01449370|180145|P15|COMPLETED|Overall Study||0
75154|NCT01449370|180146|P14|COMPLETED|Overall Study||0
75155|NCT01449370|180147|P13|COMPLETED|Overall Study||0
75156|NCT01449370|180148|P12|COMPLETED|Overall Study||0
75157|NCT01449370|180149|P11|COMPLETED|Overall Study||0
75158|NCT01449370|180150|P10|COMPLETED|Overall Study||0
75159|NCT01449370|180151|P9|COMPLETED|Overall Study||0
75160|NCT01449370|180152|P8|COMPLETED|Overall Study||0
75161|NCT01449370|180153|P7|COMPLETED|Overall Study||0
75162|NCT01449370|180154|P6|COMPLETED|Overall Study||0
75163|NCT01449370|180155|P5|COMPLETED|Overall Study||0
75164|NCT01449370|180156|P4|COMPLETED|Overall Study||0
75165|NCT01449370|180157|P3|COMPLETED|Overall Study||0
75166|NCT01449370|180158|P2|COMPLETED|Overall Study||0
75167|NCT01449370|180159|P1|COMPLETED|Overall Study||0
75168|NCT01449370|180135|P25|STARTED|Overall Study||8
75169|NCT01449370|180136|P24|STARTED|Overall Study||10
75170|NCT01449370|180137|P23|STARTED|Overall Study||4
75171|NCT01449370|180138|P22|STARTED|Overall Study||4
75172|NCT01449370|180139|P21|STARTED|Overall Study||6
75173|NCT01449370|180140|P20|STARTED|Overall Study||3
75174|NCT01449370|180141|P19|STARTED|Overall Study||3
75175|NCT01449370|180142|P18|STARTED|Overall Study||3
75176|NCT01449370|180143|P17|STARTED|Overall Study||7
75177|NCT01449370|180144|P16|STARTED|Overall Study||3
75178|NCT01449370|180145|P15|STARTED|Overall Study||3
75179|NCT01449370|180146|P14|STARTED|Overall Study||11
75180|NCT01449370|180147|P13|STARTED|Overall Study||3
75181|NCT01449370|180148|P12|STARTED|Overall Study||3
75182|NCT01449370|180149|P11|STARTED|Overall Study||3
75183|NCT01449370|180150|P10|STARTED|Overall Study||3
75184|NCT01449370|180151|P9|STARTED|Overall Study||12
75185|NCT01449370|180152|P8|STARTED|Overall Study||3
75186|NCT01449370|180153|P7|STARTED|Overall Study||3
75187|NCT01449370|180154|P6|STARTED|Overall Study||3
75188|NCT01449370|180155|P5|STARTED|Overall Study||3
75189|NCT01449370|180156|P4|STARTED|Overall Study||4
75190|NCT01449370|180157|P3|STARTED|Overall Study||8
75191|NCT01449370|180158|P2|STARTED|Overall Study||6
75192|NCT01449370|180159|P1|STARTED|Overall Study||6
75193|NCT01449305|180532|P1|NOT COMPLETED|Overall Study||2
75194|NCT01449305|180532|P1|COMPLETED|Overall Study||42
75195|NCT01449305|180532|P1|STARTED|Overall Study||44
75196|NCT01449279|180537|P1|NOT COMPLETED|Overall Study||7
75197|NCT01449279|180537|P1|COMPLETED|Overall Study||15
75198|NCT01449279|180537|P1|STARTED|Overall Study||22
75199|NCT01449266|180548|P1|NOT COMPLETED|Overall Study||0
75200|NCT01449266|180548|P1|COMPLETED|Overall Study||10
75201|NCT01449266|180548|P1|STARTED|Overall Study||10
75202|NCT01449240|180555|P1|NOT COMPLETED|Overall Study||0
75203|NCT01449240|180555|P1|COMPLETED|Overall Study||10
75204|NCT01449240|180555|P1|STARTED|Overall Study||10
75205|NCT01449006|180562|P2|NOT COMPLETED|Overall Study||0
75206|NCT01449006|180563|P1|NOT COMPLETED|Overall Study||3
75207|NCT01449006|180562|P2|COMPLETED|Overall Study||9
75208|NCT01449006|180563|P1|COMPLETED|Overall Study||5
75209|NCT01449006|180562|P2|STARTED|Overall Study||9
75210|NCT01449006|180563|P1|STARTED|Overall Study||8
75211|NCT01448850|180577|P2|NOT COMPLETED|Overall Study||40
75212|NCT01448850|180578|P1|NOT COMPLETED|Overall Study||34
75213|NCT01448850|180577|P2|COMPLETED|Overall Study||120
75214|NCT01448850|180578|P1|COMPLETED|Overall Study||130
75215|NCT01448850|180577|P2|STARTED|Overall Study||160
75216|NCT01448850|180578|P1|STARTED|Overall Study||164
75217|NCT01448707|180603|P2|NOT COMPLETED|Overall Study||18
75218|NCT01448707|180604|P1|NOT COMPLETED|Overall Study||18
75219|NCT01448707|180603|P2|COMPLETED|Overall Study||118
75220|NCT01448707|180604|P1|COMPLETED|Overall Study||119
75221|NCT01448707|180603|P2|STARTED|Overall Study||136
75222|NCT01448707|180604|P1|STARTED|Overall Study||137
75223|NCT01448616|180625|P4|NOT COMPLETED|Study Drug (Treatment Phase)||4
75224|NCT01448616|180626|P3|NOT COMPLETED|Study Drug (Treatment Phase)||4
75225|NCT01448616|180627|P2|NOT COMPLETED|Study Drug (Treatment Phase)||2
75226|NCT01448616|180628|P1|NOT COMPLETED|Study Drug (Treatment Phase)||0
75227|NCT01448616|180625|P4|COMPLETED|Study Drug (Treatment Phase)||9
75228|NCT01448616|180626|P3|COMPLETED|Study Drug (Treatment Phase)||23
75229|NCT01448616|180627|P2|COMPLETED|Study Drug (Treatment Phase)||22
75230|NCT01448616|180628|P1|COMPLETED|Study Drug (Treatment Phase)||0
75231|NCT01448616|180625|P4|STARTED|Study Drug (Treatment Phase)||13
75232|NCT01448616|180626|P3|STARTED|Study Drug (Treatment Phase)||27
75233|NCT01448616|180627|P2|STARTED|Study Drug (Treatment Phase)||24
75234|NCT01448616|180628|P1|STARTED|Study Drug (Treatment Phase)|All qualifying participants from this group moved to treatment group.|0
75235|NCT01448616|180625|P4|NOT COMPLETED|Lead-In (Observational Phase)||0
75236|NCT01448616|180626|P3|NOT COMPLETED|Lead-In (Observational Phase)||0
75237|NCT01448616|180627|P2|NOT COMPLETED|Lead-In (Observational Phase)||0
75238|NCT01448616|180628|P1|NOT COMPLETED|Lead-In (Observational Phase)||9
75239|NCT01448616|180625|P4|COMPLETED|Lead-In (Observational Phase)||0
75240|NCT01448616|180626|P3|COMPLETED|Lead-In (Observational Phase)||0
75241|NCT01448616|180627|P2|COMPLETED|Lead-In (Observational Phase)|completed >90% of sample collection to qualify for randomization for next phase|0
75242|NCT01448616|180628|P1|COMPLETED|Lead-In (Observational Phase)|Participants who swabbed >90% completed this phase and were randomized to treatment 2:2:1.|64
75243|NCT01448616|180625|P4|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
75244|NCT01448616|180626|P3|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
75245|NCT01448616|180627|P2|STARTED|Lead-In (Observational Phase)|N/A during observational phase as participants randomized subsequently|0
75246|NCT01448616|180628|P1|STARTED|Lead-In (Observational Phase)||73
75247|NCT01448525|180648|P2|NOT COMPLETED|Overall Study||2
75248|NCT01448525|180649|P1|NOT COMPLETED|Overall Study||1
75249|NCT01448525|180648|P2|COMPLETED|Overall Study||42
75250|NCT01448525|180649|P1|COMPLETED|Overall Study||43
75251|NCT01448525|180648|P2|STARTED|Overall Study||44
75252|NCT01448525|180649|P1|STARTED|Overall Study||44
75253|NCT01448486|180659|P2|NOT COMPLETED|Overall Study||0
75254|NCT01448486|180660|P1|NOT COMPLETED|Overall Study||0
75255|NCT01448486|180659|P2|COMPLETED|Overall Study||3
75256|NCT01448486|180660|P1|COMPLETED|Overall Study||3
75257|NCT01448486|180659|P2|STARTED|Overall Study||3
75258|NCT01448486|180660|P1|STARTED|Overall Study||3
75259|NCT01448356|180668|P1|NOT COMPLETED|Overall Study||0
75260|NCT01448356|180668|P1|COMPLETED|Overall Study|cross-over|10
75261|NCT01448356|180668|P1|STARTED|Overall Study||10
75262|NCT01448213|180675|P2|NOT COMPLETED|Overall Study||22
75263|NCT01448213|180676|P1|NOT COMPLETED|Overall Study||17
75264|NCT01448213|180675|P2|COMPLETED|Overall Study||112
75265|NCT01448213|180676|P1|COMPLETED|Overall Study||113
75266|NCT01448213|180675|P2|STARTED|Overall Study||134
75267|NCT01448213|180676|P1|STARTED|Overall Study||130
75268|NCT01448057|180686|P2|NOT COMPLETED|Overall Study||4
75269|NCT01448057|180687|P1|NOT COMPLETED|Overall Study||8
75270|NCT01448057|180686|P2|COMPLETED|Overall Study||167
75271|NCT01448057|180687|P1|COMPLETED|Overall Study||162
75272|NCT01448057|180686|P2|STARTED|Overall Study||171
75273|NCT01448057|180687|P1|STARTED|Overall Study||170
75274|NCT01448044|180697|P2|NOT COMPLETED|Follow Up Period||14
75275|NCT01448044|180698|P1|NOT COMPLETED|Follow Up Period||12
75276|NCT01448044|180697|P2|COMPLETED|Follow Up Period||26
75277|NCT01448044|180698|P1|COMPLETED|Follow Up Period||65
75278|NCT01448044|180697|P2|STARTED|Follow Up Period|Out of 42 participants who entered the treatment period, 40 continued in the follow-up period.|40
75279|NCT01448044|180698|P1|STARTED|Follow Up Period|Out of 82 participants who entered the treatment period, 77 continued in the follow-up period.|77
75280|NCT01448044|180697|P2|NOT COMPLETED|Treatment Period||16
75281|NCT01448044|180698|P1|NOT COMPLETED|Treatment Period||23
75282|NCT01448044|180697|P2|COMPLETED|Treatment Period||26
75283|NCT01448044|180698|P1|COMPLETED|Treatment Period||59
75284|NCT01448044|180697|P2|STARTED|Treatment Period||42
75285|NCT01448044|180698|P1|STARTED|Treatment Period||82
75286|NCT01447927|180714|P2|NOT COMPLETED|Overall Study||3
75287|NCT01447927|180715|P1|NOT COMPLETED|Overall Study||5
75288|NCT01447927|180714|P2|COMPLETED|Overall Study||33
75289|NCT01447927|180715|P1|COMPLETED|Overall Study||33
75290|NCT01447927|180714|P2|STARTED|Overall Study||36
75291|NCT01447927|180715|P1|STARTED|Overall Study||38
75292|NCT01447914|180723|P1|NOT COMPLETED|Overall Study||0
75293|NCT01447914|180723|P1|COMPLETED|Overall Study||16
75294|NCT01447914|180723|P1|STARTED|Overall Study||16
75295|NCT01447849|180732|P4|NOT COMPLETED|Second Intervention||0
75296|NCT01447849|180733|P3|NOT COMPLETED|Second Intervention||0
75297|NCT01447849|180734|P2|NOT COMPLETED|Second Intervention||0
75298|NCT01447849|180735|P1|NOT COMPLETED|Second Intervention||0
75299|NCT01447849|180732|P4|COMPLETED|Second Intervention||10
75300|NCT01447849|180733|P3|COMPLETED|Second Intervention||10
75301|NCT01447849|180734|P2|COMPLETED|Second Intervention||10
75302|NCT01447849|180735|P1|COMPLETED|Second Intervention||10
75303|NCT01447849|180732|P4|STARTED|Second Intervention||10
75304|NCT01447849|180733|P3|STARTED|Second Intervention||10
75305|NCT01447849|180734|P2|STARTED|Second Intervention||10
75306|NCT01447849|180735|P1|STARTED|Second Intervention||10
75307|NCT01447849|180732|P4|NOT COMPLETED|Washout Period for 1 Week||0
75308|NCT01447849|180733|P3|NOT COMPLETED|Washout Period for 1 Week||0
75309|NCT01447849|180734|P2|NOT COMPLETED|Washout Period for 1 Week||0
75310|NCT01447849|180735|P1|NOT COMPLETED|Washout Period for 1 Week||0
75311|NCT01447849|180732|P4|COMPLETED|Washout Period for 1 Week||10
75312|NCT01447849|180733|P3|COMPLETED|Washout Period for 1 Week||10
75313|NCT01447849|180734|P2|COMPLETED|Washout Period for 1 Week||10
75314|NCT01447849|180735|P1|COMPLETED|Washout Period for 1 Week||10
75315|NCT01447849|180732|P4|STARTED|Washout Period for 1 Week||10
75316|NCT01447849|180733|P3|STARTED|Washout Period for 1 Week||10
75317|NCT01447849|180734|P2|STARTED|Washout Period for 1 Week||10
75318|NCT01447849|180735|P1|STARTED|Washout Period for 1 Week||10
75319|NCT01447849|180732|P4|NOT COMPLETED|First Intervention||0
75320|NCT01447849|180733|P3|NOT COMPLETED|First Intervention||0
75321|NCT01447849|180734|P2|NOT COMPLETED|First Intervention||0
75322|NCT01447849|180735|P1|NOT COMPLETED|First Intervention||0
75323|NCT01447849|180732|P4|COMPLETED|First Intervention||10
75324|NCT01447849|180733|P3|COMPLETED|First Intervention||10
75325|NCT01447849|180734|P2|COMPLETED|First Intervention||10
75326|NCT01447849|180735|P1|COMPLETED|First Intervention||10
75327|NCT01447849|180732|P4|STARTED|First Intervention||10
75328|NCT01447849|180733|P3|STARTED|First Intervention||10
75329|NCT01447849|180734|P2|STARTED|First Intervention||10
75330|NCT01447849|180735|P1|STARTED|First Intervention||10
75331|NCT01447719|180745|P1|NOT COMPLETED|Overall Study||93
75332|NCT01447719|180745|P1|COMPLETED|Overall Study||59
75333|NCT01447719|180745|P1|Deceased <2 Years After AV-45 Scan|Overall Study||66
75334|NCT01447719|180745|P1|Valid AV-45 Scan Acquired|Overall Study||147
75335|NCT01447719|180745|P1|STARTED|Overall Study||152
75336|NCT01447706|180758|P2|NOT COMPLETED|Overall Study||3
75337|NCT01447706|180759|P1|NOT COMPLETED|Overall Study||0
75338|NCT01447706|180758|P2|COMPLETED|Overall Study||80
75339|NCT01447706|180759|P1|COMPLETED|Overall Study||140
75340|NCT01447706|180758|P2|STARTED|Overall Study|3 patients enrolled but not dosed|83
75341|NCT01447706|180759|P1|STARTED|Overall Study||140
75342|NCT01447576|180771|P1|NOT COMPLETED|Overall Study||476
75343|NCT01447576|180771|P1|COMPLETED|Overall Study||560
75344|NCT01447576|180771|P1|STARTED|Overall Study||1036
75345|NCT01447511|180782|P5|NOT COMPLETED|Rifampin Period||0
75346|NCT01447511|180783|P4|NOT COMPLETED|Rifampin Period||1
75347|NCT01447511|180784|P3|NOT COMPLETED|Rifampin Period||0
75348|NCT01447511|180785|P2|NOT COMPLETED|Rifampin Period||0
75349|NCT01447511|180786|P1|NOT COMPLETED|Rifampin Period||0
75350|NCT01447511|180782|P5|COMPLETED|Rifampin Period||4
75351|NCT01447511|180783|P4|COMPLETED|Rifampin Period||2
75352|NCT01447511|180784|P3|COMPLETED|Rifampin Period||8
75353|NCT01447511|180785|P2|COMPLETED|Rifampin Period||5
75354|NCT01447511|180786|P1|COMPLETED|Rifampin Period||8
75355|NCT01447511|180782|P5|STARTED|Rifampin Period||4
75356|NCT01447511|180783|P4|STARTED|Rifampin Period||3
75357|NCT01447511|180784|P3|STARTED|Rifampin Period||8
75358|NCT01447511|180785|P2|STARTED|Rifampin Period||5
75359|NCT01447511|180786|P1|STARTED|Rifampin Period||8
75360|NCT01447511|180782|P5|NOT COMPLETED|Fluconazole Period||0
75361|NCT01447511|180783|P4|NOT COMPLETED|Fluconazole Period||0
75362|NCT01447511|180784|P3|NOT COMPLETED|Fluconazole Period||1
75363|NCT01447511|180785|P2|NOT COMPLETED|Fluconazole Period||0
75364|NCT01447511|180786|P1|NOT COMPLETED|Fluconazole Period||0
75365|NCT01447511|180782|P5|COMPLETED|Fluconazole Period||4
75366|NCT01447511|180783|P4|COMPLETED|Fluconazole Period||3
75367|NCT01447511|180784|P3|COMPLETED|Fluconazole Period||8
75368|NCT01447511|180785|P2|COMPLETED|Fluconazole Period||0
75369|NCT01447511|180786|P1|COMPLETED|Fluconazole Period||8
75370|NCT01447511|180782|P5|STARTED|Fluconazole Period||4
75371|NCT01447511|180783|P4|STARTED|Fluconazole Period||3
75372|NCT01447511|180784|P3|STARTED|Fluconazole Period||9
75373|NCT01447511|180785|P2|STARTED|Fluconazole Period||0
75374|NCT01447511|180786|P1|STARTED|Fluconazole Period||8
75375|NCT01447511|180782|P5|NOT COMPLETED|Control Period||0
75376|NCT01447511|180783|P4|NOT COMPLETED|Control Period||0
75377|NCT01447511|180784|P3|NOT COMPLETED|Control Period||0
75378|NCT01447511|180785|P2|NOT COMPLETED|Control Period||0
75379|NCT01447511|180786|P1|NOT COMPLETED|Control Period||0
75380|NCT01447511|180782|P5|COMPLETED|Control Period||4
75381|NCT01447511|180783|P4|COMPLETED|Control Period||3
75382|NCT01447511|180784|P3|COMPLETED|Control Period||9
75383|NCT01447511|180785|P2|COMPLETED|Control Period||5
75384|NCT01447511|180786|P1|COMPLETED|Control Period||8
75385|NCT01447511|180782|P5|STARTED|Control Period||4
75386|NCT01447511|180783|P4|STARTED|Control Period||3
75387|NCT01447511|180784|P3|STARTED|Control Period||9
75388|NCT01447511|180785|P2|STARTED|Control Period||5
75389|NCT01447511|180786|P1|STARTED|Control Period||8
75390|NCT01447446|180804|P6|NOT COMPLETED|Overall Study||32
75391|NCT01447446|180805|P5|NOT COMPLETED|Overall Study||211
75392|NCT01447446|180806|P4|NOT COMPLETED|Overall Study||33
75393|NCT01447446|180807|P3|NOT COMPLETED|Overall Study||100
75394|NCT01447446|180808|P2|NOT COMPLETED|Overall Study||165
75395|NCT01447446|180809|P1|NOT COMPLETED|Overall Study||722
75396|NCT01447446|180804|P6|COMPLETED|Overall Study||54
75397|NCT01447446|180805|P5|COMPLETED|Overall Study||610
75398|NCT01447446|180806|P4|COMPLETED|Overall Study||60
75399|NCT01447446|180807|P3|COMPLETED|Overall Study||192
75400|NCT01447446|180808|P2|COMPLETED|Overall Study|Insuff.=Insufficient VR= Virological response TRT.=Treatment SVR= Sustained Virological Response|331
75401|NCT01447446|180809|P1|COMPLETED|Overall Study|Completed means the participants who completed the 24- weeks of follow-up period.|1590
75402|NCT01447446|180804|P6|STARTED|Overall Study||86
75403|NCT01447446|180805|P5|STARTED|Overall Study||821
75404|NCT01447446|180806|P4|STARTED|Overall Study||93
75405|NCT01447446|180807|P3|STARTED|Overall Study||292
75406|NCT01447446|180808|P2|STARTED|Overall Study||496
75407|NCT01447446|180809|P1|STARTED|Overall Study|Started means participants who started treatment and included in core population.|2312
75408|NCT01447433|180899|P2|NOT COMPLETED|Overall Study||6
75409|NCT01447433|180900|P1|NOT COMPLETED|Overall Study||4
75410|NCT01447433|180899|P2|COMPLETED|Overall Study||21
75411|NCT01447433|180900|P1|COMPLETED|Overall Study||22
75412|NCT01447433|180899|P2|STARTED|Overall Study||27
75413|NCT01447433|180900|P1|STARTED|Overall Study||26
75414|NCT01447420|180927|P3|NOT COMPLETED|Overall Study||10
75415|NCT01447420|180928|P2|NOT COMPLETED|Overall Study||27
75416|NCT01447420|180929|P1|NOT COMPLETED|Overall Study||10
75417|NCT01447420|180927|P3|COMPLETED|Overall Study||8
75418|NCT01447420|180928|P2|COMPLETED|Overall Study||45
75419|NCT01447420|180929|P1|COMPLETED|Overall Study||29
75420|NCT01447420|180927|P3|STARTED|Overall Study||18
75421|NCT01447420|180928|P2|STARTED|Overall Study||72
75422|NCT01447420|180929|P1|STARTED|Overall Study||39
75423|NCT01447225|180949|P10|NOT COMPLETED|Overall Study||0
75424|NCT01447225|180950|P9|NOT COMPLETED|Overall Study||0
75425|NCT01447225|180951|P8|NOT COMPLETED|Overall Study||0
75426|NCT01447225|180952|P7|NOT COMPLETED|Overall Study||0
75427|NCT01447225|180953|P6|NOT COMPLETED|Overall Study||0
75428|NCT01447225|180954|P5|NOT COMPLETED|Overall Study||0
75429|NCT01447225|180955|P4|NOT COMPLETED|Overall Study||0
75430|NCT01447225|180956|P3|NOT COMPLETED|Overall Study||0
75431|NCT01447225|180957|P2|NOT COMPLETED|Overall Study||0
75432|NCT01447225|180958|P1|NOT COMPLETED|Overall Study||0
75433|NCT01447225|180949|P10|COMPLETED|Overall Study||4
75434|NCT01447225|180950|P9|COMPLETED|Overall Study||3
75435|NCT01447225|180951|P8|COMPLETED|Overall Study||4
75436|NCT01447225|180952|P7|COMPLETED|Overall Study||7
75437|NCT01447225|180953|P6|COMPLETED|Overall Study||3
75438|NCT01447225|180954|P5|COMPLETED|Overall Study||3
75439|NCT01447225|180955|P4|COMPLETED|Overall Study||3
75440|NCT01447225|180956|P3|COMPLETED|Overall Study||5
75441|NCT01447225|180957|P2|COMPLETED|Overall Study||8
75442|NCT01447225|180958|P1|COMPLETED|Overall Study||3
75443|NCT01447225|180949|P10|STARTED|Overall Study||4
75444|NCT01447225|180950|P9|STARTED|Overall Study||3
75445|NCT01447225|180951|P8|STARTED|Overall Study||4
75446|NCT01447225|180952|P7|STARTED|Overall Study||7
75447|NCT01447225|180953|P6|STARTED|Overall Study||3
75448|NCT01447225|180954|P5|STARTED|Overall Study||3
75449|NCT01447225|180955|P4|STARTED|Overall Study||3
75450|NCT01447225|180956|P3|STARTED|Overall Study||5
75451|NCT01447225|180957|P2|STARTED|Overall Study||8
75452|NCT01447225|180958|P1|STARTED|Overall Study||3
75453|NCT01447121|181028|P1|NOT COMPLETED|Overall Study||0
75454|NCT01447121|181028|P1|COMPLETED|Overall Study||118
75455|NCT01447121|181028|P1|STARTED|Overall Study||118
75456|NCT01447017|181035|P2|NOT COMPLETED|Overall Study||10
75457|NCT01447017|181036|P1|NOT COMPLETED|Overall Study||10
75458|NCT01447017|181035|P2|COMPLETED|Overall Study|In safety analysis: 24. In efficacy analyses: 24 in full analysis set, and 22 in per-protocol set.|14
75459|NCT01447017|181036|P1|COMPLETED|Overall Study|In safety analysis: 42. In efficacy analyses: 40 in full analysis set, and 39 in per-protocol set.|35
75460|NCT01447017|181035|P2|Performed Visit 2|Overall Study||24
75461|NCT01447017|181036|P1|Performed Visit 2|Overall Study||43
75462|NCT01447017|181035|P2|STARTED|Overall Study||24
75463|NCT01447017|181036|P1|STARTED|Overall Study||45
75464|NCT01446796|181042|P2|NOT COMPLETED|Overall Study||0
75465|NCT01446796|181043|P1|NOT COMPLETED|Overall Study||1
75466|NCT01446796|181042|P2|COMPLETED|Overall Study|Study terminated early|0
75467|NCT01446796|181043|P1|COMPLETED|Overall Study|"Study terminated early
One subject of three withdrew prior to randomization and did not start"|2
75468|NCT01446796|181042|P2|STARTED|Overall Study||0
75469|NCT01446796|181043|P1|STARTED|Overall Study||3
75470|NCT01446705|181057|P2|NOT COMPLETED|Overall Study||0
75471|NCT01446705|181058|P1|NOT COMPLETED|Overall Study||0
75472|NCT01446705|181057|P2|COMPLETED|Overall Study||6627
75473|NCT01446705|181058|P1|COMPLETED|Overall Study||50446
75474|NCT01446705|181057|P2|STARTED|Overall Study||6627
75475|NCT01446705|181058|P1|STARTED|Overall Study||50446
75476|NCT01446419|181068|P2|NOT COMPLETED|Overall Study||1
75477|NCT01446419|181069|P1|NOT COMPLETED|Overall Study||5
75478|NCT01446419|181068|P2|COMPLETED|Overall Study||77
75479|NCT01446419|181069|P1|COMPLETED|Overall Study||142
75480|NCT01446419|181068|P2|12 Month Follow-up|Overall Study||77
75481|NCT01446419|181069|P1|12 Month Follow-up|Overall Study||142
75482|NCT01446419|181068|P2|6 Month Follow-up|Overall Study||77
75483|NCT01446419|181069|P1|6 Month Follow-up|Overall Study||144
75484|NCT01446419|181068|P2|3 Month Follow-up|Overall Study||77
75485|NCT01446419|181069|P1|3 Month Follow-up|Overall Study||146
75486|NCT01446419|181068|P2|STARTED|Overall Study||78
75487|NCT01446419|181069|P1|STARTED|Overall Study||147
75488|NCT01446289|181083|P4|NOT COMPLETED|Overall Study||0
75489|NCT01446289|181084|P3|NOT COMPLETED|Overall Study||1
75490|NCT01446289|181085|P2|NOT COMPLETED|Overall Study||0
75491|NCT01446289|181086|P1|NOT COMPLETED|Overall Study||1
75492|NCT01446289|181083|P4|COMPLETED|Overall Study||35
75493|NCT01446289|181084|P3|COMPLETED|Overall Study||50
75494|NCT01446289|181085|P2|COMPLETED|Overall Study||35
75495|NCT01446289|181086|P1|COMPLETED|Overall Study||50
75496|NCT01446289|181083|P4|STARTED|Overall Study||35
75497|NCT01446289|181084|P3|STARTED|Overall Study||51
75498|NCT01446289|181085|P2|STARTED|Overall Study||35
75499|NCT01446289|181086|P1|STARTED|Overall Study||51
75500|NCT01446250|181114|P4|NOT COMPLETED|Follow-up||6
75501|NCT01446250|181115|P3|NOT COMPLETED|Follow-up||0
75502|NCT01446250|181116|P2|NOT COMPLETED|Follow-up||0
75503|NCT01446250|181117|P1|NOT COMPLETED|Follow-up||0
75504|NCT01446250|181114|P4|COMPLETED|Follow-up||0
75505|NCT01446250|181115|P3|COMPLETED|Follow-up||0
75506|NCT01446250|181116|P2|COMPLETED|Follow-up||0
75507|NCT01446250|181117|P1|COMPLETED|Follow-up||0
75508|NCT01446250|181114|P4|STARTED|Follow-up||6
75509|NCT01446250|181115|P3|STARTED|Follow-up||0
75510|NCT01446250|181116|P2|STARTED|Follow-up||0
75511|NCT01446250|181117|P1|STARTED|Follow-up||0
75512|NCT01446250|181114|P4|NOT COMPLETED|Treatment Period 2||0
75513|NCT01446250|181115|P3|NOT COMPLETED|Treatment Period 2||0
75514|NCT01446250|181116|P2|NOT COMPLETED|Treatment Period 2||1
75515|NCT01446250|181117|P1|NOT COMPLETED|Treatment Period 2||0
75516|NCT01446250|181114|P4|COMPLETED|Treatment Period 2||0
75517|NCT01446250|181115|P3|COMPLETED|Treatment Period 2||0
75518|NCT01446250|181116|P2|COMPLETED|Treatment Period 2||6
75519|NCT01446250|181117|P1|COMPLETED|Treatment Period 2||0
75520|NCT01446250|181114|P4|STARTED|Treatment Period 2||0
75521|NCT01446250|181115|P3|STARTED|Treatment Period 2||0
75522|NCT01446250|181116|P2|STARTED|Treatment Period 2||7
75523|NCT01446250|181117|P1|STARTED|Treatment Period 2||0
75524|NCT01446250|181114|P4|NOT COMPLETED|Clinical Hold||0
75525|NCT01446250|181115|P3|NOT COMPLETED|Clinical Hold||0
75526|NCT01446250|181116|P2|NOT COMPLETED|Clinical Hold||0
75527|NCT01446250|181117|P1|NOT COMPLETED|Clinical Hold||0
75528|NCT01446250|181114|P4|COMPLETED|Clinical Hold||0
75529|NCT01446250|181115|P3|COMPLETED|Clinical Hold||5
75530|NCT01446250|181116|P2|COMPLETED|Clinical Hold||2
75531|NCT01446250|181117|P1|COMPLETED|Clinical Hold||0
75532|NCT01446250|181114|P4|STARTED|Clinical Hold||0
75533|NCT01446250|181115|P3|STARTED|Clinical Hold||5
75534|NCT01446250|181116|P2|STARTED|Clinical Hold||2
75535|NCT01446250|181117|P1|STARTED|Clinical Hold||0
75536|NCT01446250|181114|P4|NOT COMPLETED|Treatment Period 1||0
75537|NCT01446250|181115|P3|NOT COMPLETED|Treatment Period 1||0
75538|NCT01446250|181116|P2|NOT COMPLETED|Treatment Period 1||1
75539|NCT01446250|181117|P1|NOT COMPLETED|Treatment Period 1||0
75540|NCT01446250|181114|P4|COMPLETED|Treatment Period 1||0
75541|NCT01446250|181115|P3|COMPLETED|Treatment Period 1||0
75542|NCT01446250|181116|P2|COMPLETED|Treatment Period 1||2
75543|NCT01446250|181117|P1|COMPLETED|Treatment Period 1||5
75544|NCT01446250|181114|P4|STARTED|Treatment Period 1||0
75545|NCT01446250|181115|P3|STARTED|Treatment Period 1||0
75546|NCT01446250|181116|P2|STARTED|Treatment Period 1||3
75547|NCT01446250|181117|P1|STARTED|Treatment Period 1||5
75548|NCT01446237|181129|P1|NOT COMPLETED|Overall Study||10
75549|NCT01446237|181129|P1|COMPLETED|Overall Study||115
75550|NCT01446237|181129|P1|STARTED|Overall Study||125
75551|NCT01446003|181137|P2|NOT COMPLETED|Period 2||0
75552|NCT01446003|181138|P1|NOT COMPLETED|Period 2||1
75553|NCT01446003|181137|P2|COMPLETED|Period 2||15
75554|NCT01446003|181138|P1|COMPLETED|Period 2||13
75555|NCT01446003|181137|P2|STARTED|Period 2||15
75556|NCT01446003|181138|P1|STARTED|Period 2||14
75557|NCT01446003|181137|P2|NOT COMPLETED|Period 1||0
75558|NCT01446003|181138|P1|NOT COMPLETED|Period 1||2
75559|NCT01446003|181137|P2|COMPLETED|Period 1||15
75560|NCT01446003|181138|P1|COMPLETED|Period 1||14
75561|NCT01446003|181137|P2|STARTED|Period 1||15
75562|NCT01446003|181138|P1|STARTED|Period 1||16
75563|NCT01445951|181159|P3|NOT COMPLETED|Overall Study||19
75564|NCT01445951|181160|P2|NOT COMPLETED|Overall Study||36
75565|NCT01445951|181161|P1|NOT COMPLETED|Overall Study||44
75566|NCT01445951|181159|P3|COMPLETED|Overall Study||151
75567|NCT01445951|181160|P2|COMPLETED|Overall Study||138
75568|NCT01445951|181161|P1|COMPLETED|Overall Study||130
75569|NCT01445951|181159|P3|STARTED|Overall Study||170
75570|NCT01445951|181160|P2|STARTED|Overall Study||174
75571|NCT01445951|181161|P1|STARTED|Overall Study||174
75572|NCT01445873|181199|P1|NOT COMPLETED|Overall Study||0
75573|NCT01445873|181199|P1|COMPLETED|Overall Study||36
75574|NCT01445873|181199|P1|STARTED|Overall Study||36
75575|NCT01445847|181229|P2|NOT COMPLETED|Overall Study||14
75576|NCT01445847|181230|P1|NOT COMPLETED|Overall Study||14
75577|NCT01445847|181229|P2|COMPLETED|Overall Study||36
75578|NCT01445847|181230|P1|COMPLETED|Overall Study||36
75579|NCT01445847|181229|P2|STARTED|Overall Study||50
75580|NCT01445847|181230|P1|STARTED|Overall Study||50
75581|NCT01445769|181236|P1|NOT COMPLETED|Overall Study||8
75582|NCT01445769|181236|P1|COMPLETED|Overall Study||37
75583|NCT01445769|181236|P1|STARTED|Overall Study||45
75584|NCT01445678|181256|P2|NOT COMPLETED|Overall Study||21
75585|NCT01445678|181257|P1|NOT COMPLETED|Overall Study||30
75586|NCT01445678|181256|P2|COMPLETED|Overall Study||476
75587|NCT01445678|181257|P1|COMPLETED|Overall Study||452
75588|NCT01445678|181256|P2|STARTED|Overall Study||497
75589|NCT01445678|181257|P1|STARTED|Overall Study||482
75590|NCT01445652|181275|P2|NOT COMPLETED|Overall Study||3
75591|NCT01445652|181276|P1|NOT COMPLETED|Overall Study||10
75592|NCT01445652|181275|P2|COMPLETED|Overall Study||50
75593|NCT01445652|181276|P1|COMPLETED|Overall Study||47
75594|NCT01445652|181275|P2|STARTED|Overall Study||53
75595|NCT01445652|181276|P1|STARTED|Overall Study||57
75596|NCT01445626|181284|P1|NOT COMPLETED|Overall Study||0
75597|NCT01445626|181284|P1|COMPLETED|Overall Study||87
75598|NCT01445626|181284|P1|STARTED|Overall Study||87
75599|NCT01445613|181294|P1|NOT COMPLETED|1-year Follow-up||77
75600|NCT01445613|181294|P1|COMPLETED|1-year Follow-up||1088
75601|NCT01445613|181294|P1|STARTED|1-year Follow-up||1165
75602|NCT01445613|181294|P1|NOT COMPLETED|30-day Follow-up||35
75603|NCT01445613|181294|P1|COMPLETED|30-day Follow-up||1165
75604|NCT01445613|181294|P1|STARTED|30-day Follow-up||1200
75605|NCT01445548|181312|P1|NOT COMPLETED|Overall Study||1
75606|NCT01445548|181312|P1|COMPLETED|Overall Study||5
75607|NCT01445548|181312|P1|STARTED|Overall Study||6
75608|NCT01445028|181335|P2|NOT COMPLETED|Overall Study||3
75609|NCT01445028|181336|P1|NOT COMPLETED|Overall Study||0
75610|NCT01445028|181335|P2|COMPLETED|Overall Study||51
75611|NCT01445028|181336|P1|COMPLETED|Overall Study||58
75612|NCT01445028|181335|P2|STARTED|Overall Study||54
75613|NCT01445028|181336|P1|STARTED|Overall Study||58
75614|NCT01444924|181344|P2|NOT COMPLETED|Overall Study||0
75615|NCT01444924|181345|P1|NOT COMPLETED|Overall Study||0
75616|NCT01444924|181344|P2|COMPLETED|Overall Study||33
75617|NCT01444924|181345|P1|COMPLETED|Overall Study||31
75618|NCT01444924|181344|P2|STARTED|Overall Study||33
75619|NCT01444924|181345|P1|STARTED|Overall Study||31
75620|NCT01444911|181353|P2|NOT COMPLETED|Overall Study||0
75621|NCT01444911|181354|P1|NOT COMPLETED|Overall Study||8
75622|NCT01444911|181353|P2|COMPLETED|Overall Study||13
75623|NCT01444911|181354|P1|COMPLETED|Overall Study||8
75624|NCT01444911|181353|P2|STARTED|Overall Study||13
75625|NCT01444911|181354|P1|STARTED|Overall Study||16
75626|NCT01444898|181366|P1|NOT COMPLETED|Overall Study||1
75627|NCT01444898|181366|P1|COMPLETED|Overall Study||9
75628|NCT01444898|181366|P1|STARTED|Overall Study||10
75629|NCT01444781|181381|P3|NOT COMPLETED|Overall Study||3
75630|NCT01444781|181382|P2|NOT COMPLETED|Overall Study||4
75631|NCT01444781|181383|P1|NOT COMPLETED|Overall Study||3
75632|NCT01444781|181381|P3|COMPLETED|Overall Study||272
75633|NCT01444781|181382|P2|COMPLETED|Overall Study||411
75634|NCT01444781|181383|P1|COMPLETED|Overall Study||413
75635|NCT01444781|181381|P3|STARTED|Overall Study||275
75636|NCT01444781|181382|P2|STARTED|Overall Study||415
75637|NCT01444781|181383|P1|STARTED|Overall Study||416
75638|NCT01444651|181423|P2|NOT COMPLETED|Overall Study||9
75639|NCT01444651|181424|P1|NOT COMPLETED|Overall Study||11
75640|NCT01444651|181423|P2|COMPLETED|Overall Study||28
75641|NCT01444651|181424|P1|COMPLETED|Overall Study||25
75642|NCT01444651|181423|P2|STARTED|Overall Study||37
75643|NCT01444651|181424|P1|STARTED|Overall Study||36
75644|NCT01444456|181440|P1|NOT COMPLETED|Overall Study||285
75645|NCT01444456|181440|P1|COMPLETED|Overall Study|Defined as 4 weeks after last dose of ESA or chemotherapy or 13 weeks after enrolment|977
75646|NCT01444456|181440|P1|Received Darbepoetin Alfa|Overall Study||1134
75647|NCT01444456|181440|P1|Received Darbepoetin Alfa or Other ESA|Overall Study||1158
75648|NCT01444456|181440|P1|STARTED|Overall Study||1262
75649|NCT01444430|181451|P2|NOT COMPLETED|Overall Study||81
75650|NCT01444430|181452|P1|NOT COMPLETED|Overall Study||61
75651|NCT01444430|181451|P2|COMPLETED|Overall Study||5766
75652|NCT01444430|181452|P1|COMPLETED|Overall Study||5785
75653|NCT01444430|181451|P2|STARTED|Overall Study||5847
75654|NCT01444430|181452|P1|STARTED|Overall Study||5846
75655|NCT01444417|181474|P2|NOT COMPLETED|Overall Study||1
75656|NCT01444417|181475|P1|NOT COMPLETED|Overall Study||2
75657|NCT01444417|181474|P2|COMPLETED|Overall Study||41
75658|NCT01444417|181475|P1|COMPLETED|Overall Study||18
75659|NCT01444417|181474|P2|Received Treatment|Overall Study||42
75660|NCT01444417|181475|P1|Received Treatment|Overall Study||19
75661|NCT01444417|181474|P2|STARTED|Overall Study||42
75662|NCT01444417|181475|P1|STARTED|Overall Study||20
75663|NCT01444391|181491|P1|NOT COMPLETED|Overall Study||1
75664|NCT01444391|181491|P1|COMPLETED|Overall Study||41
75665|NCT01444391|181491|P1|STARTED|Overall Study||42
75666|NCT01444378|181499|P1|NOT COMPLETED|Overall Study||17
75667|NCT01444378|181499|P1|COMPLETED|Overall Study||124
75668|NCT01444378|181499|P1|STARTED|Overall Study|A total of 141 patients were enrolled into MOMENTUM|141
75669|NCT01444300|181611|P2|NOT COMPLETED|Overall Study||0
75670|NCT01444300|181612|P1|NOT COMPLETED|Overall Study||4
75671|NCT01444300|181611|P2|COMPLETED|Overall Study||12
75672|NCT01444300|181612|P1|COMPLETED|Overall Study||8
75673|NCT01444300|181611|P2|STARTED|Overall Study||12
75674|NCT01444300|181612|P1|STARTED|Overall Study||12
75675|NCT01444287|181622|P1|NOT COMPLETED|Period 4||0
75676|NCT01444287|181622|P1|COMPLETED|Period 4||22
75677|NCT01444287|181622|P1|STARTED|Period 4||22
75678|NCT01444287|181622|P1|NOT COMPLETED|Period 3||0
75679|NCT01444287|181622|P1|COMPLETED|Period 3||22
75680|NCT01444287|181622|P1|STARTED|Period 3||22
75681|NCT01444287|181622|P1|NOT COMPLETED|Period 2||0
75682|NCT01444287|181622|P1|COMPLETED|Period 2||22
75683|NCT01444287|181622|P1|STARTED|Period 2||22
75684|NCT01444287|181622|P1|NOT COMPLETED|Period 1||0
75685|NCT01444287|181622|P1|COMPLETED|Period 1||22
75686|NCT01444287|181622|P1|STARTED|Period 1||22
75687|NCT01444092|181644|P1|NOT COMPLETED|Overall Study||17
75688|NCT01444092|181644|P1|COMPLETED|Overall Study||91
75689|NCT01444092|181644|P1|INFORMED CONSENT OBTAINED|Overall Study||108
75690|NCT01444092|181644|P1|STARTED|Overall Study||108
75691|NCT01443923|181652|P2|NOT COMPLETED|Overall Study||0
75692|NCT01443923|181653|P1|NOT COMPLETED|Overall Study||1
75693|NCT01443923|181652|P2|COMPLETED|Overall Study||1
75694|NCT01443923|181653|P1|COMPLETED|Overall Study||2
75695|NCT01443923|181652|P2|STARTED|Overall Study||1
75696|NCT01443923|181653|P1|STARTED|Overall Study||3
75697|NCT01443858|181670|P3|NOT COMPLETED|Overall Study||7
75698|NCT01443858|181671|P2|NOT COMPLETED|Overall Study||13
75699|NCT01443858|181672|P1|NOT COMPLETED|Overall Study||15
75700|NCT01443858|181670|P3|COMPLETED|Overall Study||18
75701|NCT01443858|181671|P2|COMPLETED|Overall Study||12
75702|NCT01443858|181672|P1|COMPLETED|Overall Study||10
75703|NCT01443858|181670|P3|STARTED|Overall Study||25
75704|NCT01443858|181671|P2|STARTED|Overall Study||25
75705|NCT01443858|181672|P1|STARTED|Overall Study||25
75706|NCT01443845|181694|P2|NOT COMPLETED|Overall Study||337
75707|NCT01443845|181695|P1|NOT COMPLETED|Overall Study||254
75708|NCT01443845|181694|P2|COMPLETED|Overall Study||841
75709|NCT01443845|181695|P1|COMPLETED|Overall Study||922
75710|NCT01443845|181694|P2|STARTED|Overall Study||1178
75711|NCT01443845|181695|P1|STARTED|Overall Study||1176
75712|NCT01443494|181707|P1|NOT COMPLETED|Overall Study||0
75713|NCT01443494|181707|P1|COMPLETED|Overall Study||19
75714|NCT01443494|181707|P1|STARTED|Overall Study||19
75715|NCT01443403|181716|P4|NOT COMPLETED|Overall Study||9
75716|NCT01443403|181717|P3|NOT COMPLETED|Overall Study||7
75717|NCT01443403|181718|P2|NOT COMPLETED|Overall Study||6
75718|NCT01443403|181719|P1|NOT COMPLETED|Overall Study||6
75719|NCT01443403|181716|P4|COMPLETED|Overall Study||52
75720|NCT01443403|181717|P3|COMPLETED|Overall Study||54
75721|NCT01443403|181718|P2|COMPLETED|Overall Study||55
75722|NCT01443403|181719|P1|COMPLETED|Overall Study||55
75723|NCT01443403|181716|P4|Received Treatment|Overall Study||61
75724|NCT01443403|181717|P3|Received Treatment|Overall Study||60
75725|NCT01443403|181718|P2|Received Treatment|Overall Study||61
75726|NCT01443403|181719|P1|Received Treatment|Overall Study||61
75727|NCT01443403|181716|P4|STARTED|Overall Study||61
75728|NCT01443403|181717|P3|STARTED|Overall Study||61
75729|NCT01443403|181718|P2|STARTED|Overall Study||61
75730|NCT01443403|181719|P1|STARTED|Overall Study||61
75731|NCT01443364|181866|P1|NOT COMPLETED|Overall Study||41
75732|NCT01443364|181866|P1|COMPLETED|Overall Study||91
75733|NCT01443364|181866|P1|STARTED|Overall Study||132
75734|NCT01443130|181995|P6|NOT COMPLETED|Overall Study||34
75735|NCT01443130|181996|P5|NOT COMPLETED|Overall Study||44
75736|NCT01443130|181997|P4|NOT COMPLETED|Overall Study||39
75737|NCT01443130|181998|P3|NOT COMPLETED|Overall Study||77
75738|NCT01443130|181999|P2|NOT COMPLETED|Overall Study||69
75739|NCT01443130|182000|P1|NOT COMPLETED|Overall Study||68
75740|NCT01443130|181995|P6|COMPLETED|Overall Study||225
75741|NCT01443130|181996|P5|COMPLETED|Overall Study||230
75742|NCT01443130|181997|P4|COMPLETED|Overall Study||231
75743|NCT01443130|181998|P3|COMPLETED|Overall Study||223
75744|NCT01443130|181999|P2|COMPLETED|Overall Study||231
75745|NCT01443130|182000|P1|COMPLETED|Overall Study||232
75746|NCT01443130|181995|P6|STARTED|Overall Study||259
75747|NCT01443130|181996|P5|STARTED|Overall Study||274
75748|NCT01443130|181997|P4|STARTED|Overall Study||270
75749|NCT01443130|181998|P3|STARTED|Overall Study||300
75750|NCT01443130|181999|P2|STARTED|Overall Study||300
75751|NCT01443130|182000|P1|STARTED|Overall Study||300
75752|NCT01443078|182050|P1|NOT COMPLETED|Overall Study||29
75753|NCT01443078|182050|P1|COMPLETED|Overall Study||13
75754|NCT01443078|182050|P1|STARTED|Overall Study||42
75755|NCT01443026|182056|P2|NOT COMPLETED|Overall Study||5
75756|NCT01443026|182057|P1|NOT COMPLETED|Overall Study||3
75757|NCT01443026|182056|P2|COMPLETED|Overall Study||32
75758|NCT01443026|182057|P1|COMPLETED|Overall Study||26
75759|NCT01443026|182056|P2|STARTED|Overall Study||37
75760|NCT01443026|182057|P1|STARTED|Overall Study||29
75761|NCT01442844|182065|P2|NOT COMPLETED|Overall Study||0
75762|NCT01442844|182066|P1|NOT COMPLETED|Overall Study||0
75763|NCT01442844|182065|P2|COMPLETED|Overall Study||2
75764|NCT01442844|182066|P1|COMPLETED|Overall Study||1
75765|NCT01442844|182065|P2|STARTED|Overall Study||2
75766|NCT01442844|182066|P1|STARTED|Overall Study||1
75767|NCT01442779|182072|P1|NOT COMPLETED|Overall Study||7
75768|NCT01442779|182072|P1|COMPLETED|Overall Study||11
75769|NCT01442779|182072|P1|STARTED|Overall Study||18
75770|NCT01442688|182080|P2|NOT COMPLETED|Second Intervention||0
75771|NCT01442688|182081|P1|NOT COMPLETED|Second Intervention||1
75772|NCT01442688|182080|P2|COMPLETED|Second Intervention||31
75773|NCT01442688|182081|P1|COMPLETED|Second Intervention||28
75774|NCT01442688|182080|P2|STARTED|Second Intervention||31
75775|NCT01442688|182081|P1|STARTED|Second Intervention||29
75776|NCT01442688|182080|P2|NOT COMPLETED|First Intervention||0
75777|NCT01442688|182081|P1|NOT COMPLETED|First Intervention||2
75778|NCT01442688|182080|P2|COMPLETED|First Intervention||31
75779|NCT01442688|182081|P1|COMPLETED|First Intervention||29
75780|NCT01442688|182080|P2|STARTED|First Intervention||31
75781|NCT01442688|182081|P1|STARTED|First Intervention||31
75782|NCT01442675|182089|P1|NOT COMPLETED|Overall Study||12
75783|NCT01442675|182089|P1|COMPLETED|Overall Study||822
75784|NCT01442675|182089|P1|Per-Protocol Analysis Set|Overall Study|The Per-Protocol Analysis Set are subjects with no pre-defined protocol deviations.|781
75785|NCT01442675|182089|P1|Safety Analysis Set|Overall Study|Safety Analysis Set are subjects who received study vaccine and for whom safety data were available.|831
75786|NCT01442675|182089|P1|STARTED|Overall Study||834
75787|NCT01442376|182102|P3|NOT COMPLETED|Overall Study||5
75788|NCT01442376|182103|P2|NOT COMPLETED|Overall Study||9
75789|NCT01442376|182104|P1|NOT COMPLETED|Overall Study||3
75790|NCT01442376|182102|P3|COMPLETED|Overall Study||159
75791|NCT01442376|182103|P2|COMPLETED|Overall Study||160
75792|NCT01442376|182104|P1|COMPLETED|Overall Study||166
75793|NCT01442376|182102|P3|STARTED|Overall Study|Randomized patients|164
75794|NCT01442376|182103|P2|STARTED|Overall Study|Randomized patients|169
75795|NCT01442376|182104|P1|STARTED|Overall Study|Randomized patients|169
75796|NCT01442181|182117|P2|NOT COMPLETED|Overall Study||3
75797|NCT01442181|182118|P1|NOT COMPLETED|Overall Study||4
75798|NCT01442181|182117|P2|COMPLETED|Overall Study||8
75799|NCT01442181|182118|P1|COMPLETED|Overall Study||10
75800|NCT01442181|182117|P2|STARTED|Overall Study||11
75801|NCT01442181|182118|P1|STARTED|Overall Study||14
75802|NCT01442155|182142|P1|NOT COMPLETED|Overall Study||65
75803|NCT01442155|182142|P1|COMPLETED|Overall Study||9
75804|NCT01442155|182142|P1|STARTED|Overall Study||74
75805|NCT01442129|182149|P2|NOT COMPLETED|Overall Study||0
75806|NCT01442129|182150|P1|NOT COMPLETED|Overall Study||0
75807|NCT01442129|182149|P2|COMPLETED|Overall Study||10
75808|NCT01442129|182150|P1|COMPLETED|Overall Study|Treatment withheld from 1 patient randomized before results of screening PRA known|20
75809|NCT01442129|182149|P2|STARTED|Overall Study||10
75810|NCT01442129|182150|P1|STARTED|Overall Study||20
75811|NCT01442103|182158|P1|NOT COMPLETED|Overall Study||2
75812|NCT01442103|182158|P1|COMPLETED|Overall Study||8
75813|NCT01442103|182158|P1|STARTED|Overall Study||10
75814|NCT01442064|182168|P6|NOT COMPLETED|Overall Study||99
75815|NCT01442064|182169|P5|NOT COMPLETED|Overall Study||106
75816|NCT01442064|182170|P4|NOT COMPLETED|Overall Study||98
75817|NCT01442064|182171|P3|NOT COMPLETED|Overall Study||104
75818|NCT01442064|182172|P2|NOT COMPLETED|Overall Study||101
75819|NCT01442064|182173|P1|NOT COMPLETED|Overall Study||97
75820|NCT01442064|182168|P6|COMPLETED|Overall Study||0
75821|NCT01442064|182169|P5|COMPLETED|Overall Study||1
75822|NCT01442064|182170|P4|COMPLETED|Overall Study||0
75823|NCT01442064|182171|P3|COMPLETED|Overall Study||0
75824|NCT01442064|182172|P2|COMPLETED|Overall Study||2
75825|NCT01442064|182173|P1|COMPLETED|Overall Study||0
75826|NCT01442064|182168|P6|Received Study Drug in Extension Study|Overall Study||81
75827|NCT01442064|182169|P5|Received Study Drug in Extension Study|Overall Study||89
75828|NCT01442064|182170|P4|Received Study Drug in Extension Study|Overall Study||70
75829|NCT01442064|182171|P3|Received Study Drug in Extension Study|Overall Study||60
75830|NCT01442064|182172|P2|Received Study Drug in Extension Study|Overall Study||70
75831|NCT01442064|182173|P1|Received Study Drug in Extension Study|Overall Study||61
75832|NCT01442064|182168|P6|Ranibizumab-Treated Subjects|Overall Study||99
75833|NCT01442064|182169|P5|Ranibizumab-Treated Subjects|Overall Study||107
75834|NCT01442064|182170|P4|Ranibizumab-Treated Subjects|Overall Study||96
75835|NCT01442064|182171|P3|Ranibizumab-Treated Subjects|Overall Study||104
75836|NCT01442064|182172|P2|Ranibizumab-Treated Subjects|Overall Study||103
75837|NCT01442064|182173|P1|Ranibizumab-Treated Subjects|Overall Study|Includes participants who received Ranibizumab in either the initial studies or the extension study.|93
75838|NCT01442064|182168|P6|STARTED|Overall Study||99
75839|NCT01442064|182169|P5|STARTED|Overall Study||107
75840|NCT01442064|182170|P4|STARTED|Overall Study||98
75841|NCT01442064|182171|P3|STARTED|Overall Study||104
75842|NCT01442064|182172|P2|STARTED|Overall Study||103
75843|NCT01442064|182173|P1|STARTED|Overall Study||97
75844|NCT01442038|182210|P2|NOT COMPLETED|Overall Study||279
75845|NCT01442038|182211|P1|NOT COMPLETED|Overall Study||303
75846|NCT01442038|182210|P2|COMPLETED|Overall Study||1040
75847|NCT01442038|182211|P1|COMPLETED|Overall Study||1029
75848|NCT01442038|182210|P2|STARTED|Overall Study||1319
75849|NCT01442038|182211|P1|STARTED|Overall Study||1332
75850|NCT01441973|182225|P2|NOT COMPLETED|Overall Study||5
75851|NCT01441973|182226|P1|NOT COMPLETED|Overall Study||8
75852|NCT01441973|182225|P2|COMPLETED|Overall Study|Still receiving treatment|11
75853|NCT01441973|182226|P1|COMPLETED|Overall Study|Still receiving treatment|7
75854|NCT01441973|182225|P2|STARTED|Overall Study||16
75855|NCT01441973|182226|P1|STARTED|Overall Study||15
75856|NCT01441960|182240|P2|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
75857|NCT01441960|182241|P1|NOT COMPLETED|Second Neuromuscular Blocking Agent||0
75858|NCT01441960|182240|P2|COMPLETED|Second Neuromuscular Blocking Agent||13
75859|NCT01441960|182241|P1|COMPLETED|Second Neuromuscular Blocking Agent||18
75860|NCT01441960|182240|P2|STARTED|Second Neuromuscular Blocking Agent||13
75861|NCT01441960|182241|P1|STARTED|Second Neuromuscular Blocking Agent||18
75862|NCT01441960|182240|P2|NOT COMPLETED|First Neuromuscular Blocking Agent:||6
75863|NCT01441960|182241|P1|NOT COMPLETED|First Neuromuscular Blocking Agent:||8
75864|NCT01441960|182240|P2|COMPLETED|First Neuromuscular Blocking Agent:||13
75865|NCT01441960|182241|P1|COMPLETED|First Neuromuscular Blocking Agent:||18
75866|NCT01441960|182240|P2|STARTED|First Neuromuscular Blocking Agent:||19
75867|NCT01441960|182241|P1|STARTED|First Neuromuscular Blocking Agent:||26
75868|NCT01441843|182253|P2|NOT COMPLETED|Overall Study||5
75869|NCT01441843|182254|P1|NOT COMPLETED|Overall Study||12
75870|NCT01441843|182253|P2|COMPLETED|Overall Study||195
75871|NCT01441843|182254|P1|COMPLETED|Overall Study||188
75872|NCT01441843|182253|P2|STARTED|Overall Study||200
75873|NCT01441843|182254|P1|STARTED|Overall Study||200
75874|NCT01441765|182262|P2|NOT COMPLETED|Overall Study||0
75875|NCT01441765|182263|P1|NOT COMPLETED|Overall Study||1
75876|NCT01441765|182262|P2|COMPLETED|Overall Study|not opened|0
75877|NCT01441765|182263|P1|COMPLETED|Overall Study||10
75878|NCT01441765|182262|P2|STARTED|Overall Study|not opened|0
75879|NCT01441765|182263|P1|STARTED|Overall Study||11
75880|NCT01441596|182280|P3|NOT COMPLETED|Overall Study||4
75881|NCT01441596|182281|P2|NOT COMPLETED|Overall Study||3
75882|NCT01441596|182282|P1|NOT COMPLETED|Overall Study||4
75883|NCT01441596|182280|P3|COMPLETED|Overall Study||39
75884|NCT01441596|182281|P2|COMPLETED|Overall Study||35
75885|NCT01441596|182282|P1|COMPLETED|Overall Study||36
75886|NCT01441596|182280|P3|STARTED|Overall Study||43
75887|NCT01441596|182281|P2|STARTED|Overall Study||38
75888|NCT01441596|182282|P1|STARTED|Overall Study||40
75889|NCT01441570|182298|P2|NOT COMPLETED|Overall Study||0
75890|NCT01441570|182299|P1|NOT COMPLETED|Overall Study||0
75891|NCT01441570|182298|P2|COMPLETED|Overall Study||5
75892|NCT01441570|182299|P1|COMPLETED|Overall Study||6
75893|NCT01441570|182298|P2|STARTED|Overall Study||5
75894|NCT01441570|182299|P1|STARTED|Overall Study||6
75895|NCT01441466|182309|P2|NOT COMPLETED|Overall Study||0
75896|NCT01441466|182310|P1|NOT COMPLETED|Overall Study||0
75897|NCT01441466|182309|P2|COMPLETED|Overall Study||11
75898|NCT01441466|182310|P1|COMPLETED|Overall Study||37
75899|NCT01441466|182309|P2|STARTED|Overall Study||11
75900|NCT01441466|182310|P1|STARTED|Overall Study||37
75901|NCT01441440|182329|P3|NOT COMPLETED|Overall Study||22
75902|NCT01441440|182330|P2|NOT COMPLETED|Overall Study||23
75903|NCT01441440|182331|P1|NOT COMPLETED|Overall Study||17
75904|NCT01441440|182329|P3|COMPLETED|Overall Study||158
75905|NCT01441440|182330|P2|COMPLETED|Overall Study||151
75906|NCT01441440|182331|P1|COMPLETED|Overall Study||166
75907|NCT01441440|182329|P3|STARTED|Overall Study|Safety analysis set|180
75908|NCT01441440|182330|P2|STARTED|Overall Study|Safety analysis set|174
75909|NCT01441440|182331|P1|STARTED|Overall Study|Safety analysis set|183
75910|NCT01441414|182354|P1|NOT COMPLETED|Overall Study||15
75911|NCT01441414|182354|P1|COMPLETED|Overall Study||3
75912|NCT01441414|182354|P1|STARTED|Overall Study||18
75913|NCT01441401|182379|P1|NOT COMPLETED|Overall Study||0
75914|NCT01441401|182379|P1|COMPLETED|Overall Study|Number of participants whose survey form was collected was presented.|82
75915|NCT01441401|182379|P1|STARTED|Overall Study||82
75916|NCT01441245|182407|P2|NOT COMPLETED|Overall Study||0
75917|NCT01441245|182408|P1|NOT COMPLETED|Overall Study||0
75918|NCT01441245|182407|P2|COMPLETED|Overall Study||27
75919|NCT01441245|182408|P1|COMPLETED|Overall Study||30
75920|NCT01441245|182407|P2|STARTED|Overall Study||27
75921|NCT01441245|182408|P1|STARTED|Overall Study||30
75922|NCT01441180|182433|P3|NOT COMPLETED|Overall Study||3
75923|NCT01441180|182434|P2|NOT COMPLETED|Overall Study||1
75924|NCT01441180|182435|P1|NOT COMPLETED|Overall Study||1
75925|NCT01441180|182433|P3|COMPLETED|Overall Study||22
75926|NCT01441180|182434|P2|COMPLETED|Overall Study||24
75927|NCT01441180|182435|P1|COMPLETED|Overall Study||9
75928|NCT01441180|182433|P3|STARTED|Overall Study||25
75929|NCT01441180|182434|P2|STARTED|Overall Study||25
75930|NCT01441180|182435|P1|STARTED|Overall Study||10
75931|NCT01441102|182446|P1|NOT COMPLETED|Overall Study||3
75932|NCT01441102|182446|P1|COMPLETED|Overall Study||4
75933|NCT01441102|182446|P1|STARTED|Overall Study|Two participants withdrew prior to Month 6; therefore, two additional participants were enrolled.|7
75934|NCT01441076|182466|P1|NOT COMPLETED|Overall Study||2
75935|NCT01441076|182466|P1|COMPLETED|Overall Study||4
75936|NCT01441076|182466|P1|STARTED|Overall Study||6
75937|NCT01440972|182486|P2|NOT COMPLETED|Overall Study||2
75938|NCT01440972|182487|P1|NOT COMPLETED|Overall Study||3
75939|NCT01440972|182486|P2|COMPLETED|Overall Study||19
75940|NCT01440972|182487|P1|COMPLETED|Overall Study||21
75941|NCT01440972|182486|P2|STARTED|Overall Study||21
75942|NCT01440972|182487|P1|STARTED|Overall Study||24
75943|NCT01440959|182501|P1|NOT COMPLETED|Overall Study||0
75944|NCT01440959|182501|P1|COMPLETED|Overall Study||30
75945|NCT01440959|182501|P1|STARTED|Overall Study||30
75946|NCT01440946|182511|P2|NOT COMPLETED|Overall Study||1
75947|NCT01440946|182512|P1|NOT COMPLETED|Overall Study||2
75948|NCT01440946|182511|P2|COMPLETED|Overall Study||14
75949|NCT01440946|182512|P1|COMPLETED|Overall Study||13
75950|NCT01440946|182511|P2|STARTED|Overall Study||15
75951|NCT01440946|182512|P1|STARTED|Overall Study||15
75952|NCT01440881|182551|P2|NOT COMPLETED|Overall Study||1
75953|NCT01440881|182552|P1|NOT COMPLETED|Overall Study||0
75954|NCT01440881|182551|P2|COMPLETED|Overall Study||14
75955|NCT01440881|182552|P1|COMPLETED|Overall Study||14
75956|NCT01440881|182551|P2|STARTED|Overall Study||15
75957|NCT01440881|182552|P1|STARTED|Overall Study||14
75958|NCT01440764|182566|P7|NOT COMPLETED|Test Day 3||0
75959|NCT01440764|182567|P6|NOT COMPLETED|Test Day 3||0
75960|NCT01440764|182568|P5|NOT COMPLETED|Test Day 3||0
75961|NCT01440764|182569|P4|NOT COMPLETED|Test Day 3||0
75962|NCT01440764|182570|P3|NOT COMPLETED|Test Day 3||0
75963|NCT01440764|182571|P2|NOT COMPLETED|Test Day 3||0
75964|NCT01440764|182572|P1|NOT COMPLETED|Test Day 3||0
75965|NCT01440764|182566|P7|COMPLETED|Test Day 3||3
75966|NCT01440764|182567|P6|COMPLETED|Test Day 3||5
75967|NCT01440764|182568|P5|COMPLETED|Test Day 3||3
75968|NCT01440764|182569|P4|COMPLETED|Test Day 3||1
75969|NCT01440764|182570|P3|COMPLETED|Test Day 3||6
75970|NCT01440764|182571|P2|COMPLETED|Test Day 3||2
75971|NCT01440764|182572|P1|COMPLETED|Test Day 3||3
75972|NCT01440764|182566|P7|STARTED|Test Day 3||3
75973|NCT01440764|182567|P6|STARTED|Test Day 3||5
75974|NCT01440764|182568|P5|STARTED|Test Day 3||3
75975|NCT01440764|182569|P4|STARTED|Test Day 3||1
75976|NCT01440764|182570|P3|STARTED|Test Day 3||6
75977|NCT01440764|182571|P2|STARTED|Test Day 3||2
75978|NCT01440764|182572|P1|STARTED|Test Day 3||3
75979|NCT01440764|182566|P7|NOT COMPLETED|Test Day 2||0
75980|NCT01440764|182567|P6|NOT COMPLETED|Test Day 2||0
75981|NCT01440764|182568|P5|NOT COMPLETED|Test Day 2||0
75982|NCT01440764|182569|P4|NOT COMPLETED|Test Day 2||0
75983|NCT01440764|182570|P3|NOT COMPLETED|Test Day 2||0
75984|NCT01440764|182571|P2|NOT COMPLETED|Test Day 2||0
75985|NCT01440764|182572|P1|NOT COMPLETED|Test Day 2||0
75986|NCT01440764|182566|P7|COMPLETED|Test Day 2||3
75987|NCT01440764|182567|P6|COMPLETED|Test Day 2||5
75988|NCT01440764|182568|P5|COMPLETED|Test Day 2||3
75989|NCT01440764|182569|P4|COMPLETED|Test Day 2||1
75990|NCT01440764|182570|P3|COMPLETED|Test Day 2||6
75991|NCT01440764|182571|P2|COMPLETED|Test Day 2||2
75992|NCT01440764|182572|P1|COMPLETED|Test Day 2||3
75993|NCT01440764|182566|P7|STARTED|Test Day 2||3
75994|NCT01440764|182567|P6|STARTED|Test Day 2||5
75995|NCT01440764|182568|P5|STARTED|Test Day 2||3
75996|NCT01440764|182569|P4|STARTED|Test Day 2||1
75997|NCT01440764|182570|P3|STARTED|Test Day 2||6
75998|NCT01440764|182571|P2|STARTED|Test Day 2||2
75999|NCT01440764|182572|P1|STARTED|Test Day 2|Following Test Day 1, 1 subject withdrew from the study before beginning Test Day 2.|3
76000|NCT01440764|182566|P7|NOT COMPLETED|Test Day 1||0
76001|NCT01440764|182567|P6|NOT COMPLETED|Test Day 1||0
76002|NCT01440764|182568|P5|NOT COMPLETED|Test Day 1||0
76003|NCT01440764|182569|P4|NOT COMPLETED|Test Day 1||0
76004|NCT01440764|182570|P3|NOT COMPLETED|Test Day 1||0
76005|NCT01440764|182571|P2|NOT COMPLETED|Test Day 1||0
76006|NCT01440764|182572|P1|NOT COMPLETED|Test Day 1||0
76007|NCT01440764|182566|P7|COMPLETED|Test Day 1||3
76008|NCT01440764|182567|P6|COMPLETED|Test Day 1||5
76009|NCT01440764|182568|P5|COMPLETED|Test Day 1||3
76010|NCT01440764|182569|P4|COMPLETED|Test Day 1||1
76011|NCT01440764|182570|P3|COMPLETED|Test Day 1||6
76012|NCT01440764|182571|P2|COMPLETED|Test Day 1||2
76013|NCT01440764|182572|P1|COMPLETED|Test Day 1||4
76014|NCT01440764|182566|P7|STARTED|Test Day 1||3
76015|NCT01440764|182567|P6|STARTED|Test Day 1||5
76016|NCT01440764|182568|P5|STARTED|Test Day 1||3
76017|NCT01440764|182569|P4|STARTED|Test Day 1||1
76018|NCT01440764|182570|P3|STARTED|Test Day 1||6
76019|NCT01440764|182571|P2|STARTED|Test Day 1||2
76020|NCT01440764|182572|P1|STARTED|Test Day 1||4
76021|NCT01440647|182593|P2|NOT COMPLETED|Overall Study||3
76022|NCT01440647|182594|P1|NOT COMPLETED|Overall Study||2
76023|NCT01440647|182593|P2|COMPLETED|Overall Study||15
76024|NCT01440647|182594|P1|COMPLETED|Overall Study||14
76025|NCT01440647|182593|P2|STARTED|Overall Study||18
76026|NCT01440647|182594|P1|STARTED|Overall Study||16
76027|NCT01440634|182604|P2|NOT COMPLETED|Randomization Phase||10
76028|NCT01440634|182605|P1|NOT COMPLETED|Randomization Phase||6
76029|NCT01440634|182604|P2|COMPLETED|Randomization Phase||14
76030|NCT01440634|182605|P1|COMPLETED|Randomization Phase||24
76031|NCT01440634|182604|P2|STARTED|Randomization Phase||24
76032|NCT01440634|182605|P1|STARTED|Randomization Phase||30
76033|NCT01440634|182604|P2|NOT COMPLETED|Cross Sectional Phase||0
76034|NCT01440634|182605|P1|NOT COMPLETED|Cross Sectional Phase||0
76035|NCT01440634|182604|P2|COMPLETED|Cross Sectional Phase||347
76036|NCT01440634|182605|P1|COMPLETED|Cross Sectional Phase||0
76037|NCT01440634|182604|P2|STARTED|Cross Sectional Phase||347
76038|NCT01440634|182605|P1|STARTED|Cross Sectional Phase||0
76039|NCT01440595|182613|P3|NOT COMPLETED|Overall Study||1
76040|NCT01440595|182614|P2|NOT COMPLETED|Overall Study||3
76041|NCT01440595|182615|P1|NOT COMPLETED|Overall Study||1
76042|NCT01440595|182613|P3|COMPLETED|Overall Study||0
76043|NCT01440595|182614|P2|COMPLETED|Overall Study||0
76044|NCT01440595|182615|P1|COMPLETED|Overall Study||0
76045|NCT01440595|182613|P3|STARTED|Overall Study||1
76046|NCT01440595|182614|P2|STARTED|Overall Study||3
76047|NCT01440595|182615|P1|STARTED|Overall Study||1
76048|NCT01440569|182635|P2|NOT COMPLETED|Open-Label Rollover Phase||6
76049|NCT01440569|182636|P1|NOT COMPLETED|Open-Label Rollover Phase||47
76050|NCT01440569|182635|P2|COMPLETED|Open-Label Rollover Phase||7
76051|NCT01440569|182636|P1|COMPLETED|Open-Label Rollover Phase||204
76052|NCT01440569|182635|P2|STARTED|Open-Label Rollover Phase|1 participant who completed the Main Study did not enroll into the Rollover Phase.|13
76053|NCT01440569|182636|P1|STARTED|Open-Label Rollover Phase|9 participants who completed the Main Study did not enroll into the Rollover Phase.|251
76054|NCT01440569|182635|P2|NOT COMPLETED|Main Study||4
76055|NCT01440569|182636|P1|NOT COMPLETED|Main Study||36
76056|NCT01440569|182635|P2|COMPLETED|Main Study||14
76057|NCT01440569|182636|P1|COMPLETED|Main Study||260
76058|NCT01440569|182635|P2|Enrolled and Treated|Main Study||18
76059|NCT01440569|182636|P1|Enrolled and Treated|Main Study||295
76060|NCT01440569|182635|P2|STARTED|Main Study||18
76061|NCT01440569|182636|P1|STARTED|Main Study||296
76062|NCT01440543|182658|P4|NOT COMPLETED|Overall Study||6
76063|NCT01440543|182659|P3|NOT COMPLETED|Overall Study||2
76064|NCT01440543|182660|P2|NOT COMPLETED|Overall Study||4
76065|NCT01440543|182661|P1|NOT COMPLETED|Overall Study||4
76066|NCT01440543|182658|P4|COMPLETED|Overall Study||101
76067|NCT01440543|182659|P3|COMPLETED|Overall Study||100
76068|NCT01440543|182660|P2|COMPLETED|Overall Study||101
76069|NCT01440543|182661|P1|COMPLETED|Overall Study||102
76070|NCT01440543|182658|P4|STARTED|Overall Study||107
76071|NCT01440543|182659|P3|STARTED|Overall Study||102
76072|NCT01440543|182660|P2|STARTED|Overall Study||105
76073|NCT01440543|182661|P1|STARTED|Overall Study||106
76074|NCT01440517|182671|P1|NOT COMPLETED|Overall Study||1
76075|NCT01440517|182671|P1|COMPLETED|Overall Study||4
76076|NCT01440517|182671|P1|STARTED|Overall Study||5
76077|NCT01440387|182678|P2|NOT COMPLETED|Overall Study||0
76078|NCT01440387|182679|P1|NOT COMPLETED|Overall Study||0
76079|NCT01440387|182678|P2|COMPLETED|Overall Study||56
76080|NCT01440387|182679|P1|COMPLETED|Overall Study||56
76081|NCT01440387|182678|P2|STARTED|Overall Study||56
76082|NCT01440387|182679|P1|STARTED|Overall Study||56
76083|NCT01440374|182702|P4|NOT COMPLETED|Part 3: Extension||32
76084|NCT01440374|182703|P3|NOT COMPLETED|Part 3: Extension||0
76085|NCT01440374|182704|P2|NOT COMPLETED|Part 3: Extension||0
76086|NCT01440374|182705|P1|NOT COMPLETED|Part 3: Extension||0
76087|NCT01440374|182702|P4|COMPLETED|Part 3: Extension||27
76088|NCT01440374|182703|P3|COMPLETED|Part 3: Extension||0
76089|NCT01440374|182704|P2|COMPLETED|Part 3: Extension||0
76090|NCT01440374|182705|P1|COMPLETED|Part 3: Extension||0
76091|NCT01440374|182702|P4|STARTED|Part 3: Extension||59
76092|NCT01440374|182703|P3|STARTED|Part 3: Extension||0
76093|NCT01440374|182704|P2|STARTED|Part 3: Extension||0
76094|NCT01440374|182705|P1|STARTED|Part 3: Extension||0
76095|NCT01440374|182702|P4|NOT COMPLETED|Part 2; Double-blind Phase||0
76096|NCT01440374|182703|P3|NOT COMPLETED|Part 2; Double-blind Phase||55
76097|NCT01440374|182704|P2|NOT COMPLETED|Part 2; Double-blind Phase||20
76098|NCT01440374|182705|P1|NOT COMPLETED|Part 2; Double-blind Phase||0
76099|NCT01440374|182702|P4|COMPLETED|Part 2; Double-blind Phase||0
76100|NCT01440374|182703|P3|COMPLETED|Part 2; Double-blind Phase||43
76101|NCT01440374|182704|P2|COMPLETED|Part 2; Double-blind Phase||27
76102|NCT01440374|182705|P1|COMPLETED|Part 2; Double-blind Phase||0
76103|NCT01440374|182702|P4|STARTED|Part 2; Double-blind Phase||0
76104|NCT01440374|182703|P3|STARTED|Part 2; Double-blind Phase||98
76105|NCT01440374|182704|P2|STARTED|Part 2; Double-blind Phase||47
76106|NCT01440374|182705|P1|STARTED|Part 2; Double-blind Phase||0
76107|NCT01440374|182702|P4|NOT COMPLETED|Part 1: Open-label Phase||0
76108|NCT01440374|182703|P3|NOT COMPLETED|Part 1: Open-label Phase||0
76109|NCT01440374|182704|P2|NOT COMPLETED|Part 1: Open-label Phase||0
76110|NCT01440374|182705|P1|NOT COMPLETED|Part 1: Open-label Phase||6
76111|NCT01440374|182702|P4|COMPLETED|Part 1: Open-label Phase||0
76112|NCT01440374|182703|P3|COMPLETED|Part 1: Open-label Phase||0
76113|NCT01440374|182704|P2|COMPLETED|Part 1: Open-label Phase||0
76114|NCT01440374|182705|P1|COMPLETED|Part 1: Open-label Phase||11
76115|NCT01440374|182702|P4|STARTED|Part 1: Open-label Phase||0
76116|NCT01440374|182703|P3|STARTED|Part 1: Open-label Phase||0
76117|NCT01440374|182704|P2|STARTED|Part 1: Open-label Phase||0
76118|NCT01440374|182705|P1|STARTED|Part 1: Open-label Phase||17
76119|NCT01440322|182740|P2|NOT COMPLETED|Overall Study||1
76120|NCT01440322|182741|P1|NOT COMPLETED|Overall Study||7
76121|NCT01440322|182740|P2|COMPLETED|Overall Study||49
76122|NCT01440322|182741|P1|COMPLETED|Overall Study||90
76123|NCT01440322|182740|P2|STARTED|Overall Study||50
76124|NCT01440322|182741|P1|STARTED|Overall Study||97
76125|NCT01440283|182763|P1|NOT COMPLETED|Overall Study||10
76126|NCT01440283|182763|P1|COMPLETED|Overall Study||4
76127|NCT01440283|182763|P1|STARTED|Overall Study||14
76128|NCT01440101|182778|P3|NOT COMPLETED|Overall Study||1
76129|NCT01440101|182779|P2|NOT COMPLETED|Overall Study||4
76130|NCT01440101|182780|P1|NOT COMPLETED|Overall Study||2
76131|NCT01440101|182778|P3|COMPLETED|Overall Study||46
76132|NCT01440101|182779|P2|COMPLETED|Overall Study||43
76133|NCT01440101|182780|P1|COMPLETED|Overall Study||10
76134|NCT01440101|182778|P3|STARTED|Overall Study||47
76135|NCT01440101|182779|P2|STARTED|Overall Study||47
76136|NCT01440101|182780|P1|STARTED|Overall Study||12
76137|NCT01440049|182813|P1|NOT COMPLETED|Overall Study||5
76138|NCT01440049|182813|P1|COMPLETED|Overall Study||155
76139|NCT01440049|182813|P1|STARTED|Overall Study||160
76140|NCT01439971|182845|P5|NOT COMPLETED|Overall Study||1
76141|NCT01439971|182846|P4|NOT COMPLETED|Overall Study||0
76142|NCT01439971|182847|P3|NOT COMPLETED|Overall Study||2
76143|NCT01439971|182848|P2|NOT COMPLETED|Overall Study||1
76144|NCT01439971|182849|P1|NOT COMPLETED|Overall Study||0
76145|NCT01439971|182845|P5|COMPLETED|Overall Study||6
76146|NCT01439971|182846|P4|COMPLETED|Overall Study||6
76147|NCT01439971|182847|P3|COMPLETED|Overall Study||6
76148|NCT01439971|182848|P2|COMPLETED|Overall Study||6
76149|NCT01439971|182849|P1|COMPLETED|Overall Study||1
76150|NCT01439971|182845|P5|Received Treatment|Overall Study||6
76151|NCT01439971|182846|P4|Received Treatment|Overall Study||6
76152|NCT01439971|182847|P3|Received Treatment|Overall Study||6
76153|NCT01439971|182848|P2|Received Treatment|Overall Study||6
76154|NCT01439971|182849|P1|Received Treatment|Overall Study||1
76155|NCT01439971|182845|P5|STARTED|Overall Study||7
76156|NCT01439971|182846|P4|STARTED|Overall Study||6
76157|NCT01439971|182847|P3|STARTED|Overall Study||8
76158|NCT01439971|182848|P2|STARTED|Overall Study||7
76159|NCT01439971|182849|P1|STARTED|Overall Study||1
76160|NCT01439945|183029|P4|NOT COMPLETED|Optional Continuation Phase||0
76161|NCT01439945|183030|P3|NOT COMPLETED|Optional Continuation Phase||0
76162|NCT01439945|183031|P2|NOT COMPLETED|Optional Continuation Phase||0
76163|NCT01439945|183032|P1|NOT COMPLETED|Optional Continuation Phase||0
76164|NCT01439945|183029|P4|COMPLETED|Optional Continuation Phase||0
76165|NCT01439945|183030|P3|COMPLETED|Optional Continuation Phase||0
76166|NCT01439945|183031|P2|COMPLETED|Optional Continuation Phase||44
76167|NCT01439945|183032|P1|COMPLETED|Optional Continuation Phase||72
76168|NCT01439945|183029|P4|STARTED|Optional Continuation Phase||0
76169|NCT01439945|183030|P3|STARTED|Optional Continuation Phase||0
76170|NCT01439945|183031|P2|STARTED|Optional Continuation Phase||44
76171|NCT01439945|183032|P1|STARTED|Optional Continuation Phase||72
76172|NCT01439945|183029|P4|NOT COMPLETED|Double-Blind Treatment Phase||2
76173|NCT01439945|183030|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
76174|NCT01439945|183031|P2|NOT COMPLETED|Double-Blind Treatment Phase||5
76175|NCT01439945|183032|P1|NOT COMPLETED|Double-Blind Treatment Phase||4
76176|NCT01439945|183029|P4|COMPLETED|Double-Blind Treatment Phase||46
76177|NCT01439945|183030|P3|COMPLETED|Double-Blind Treatment Phase||45
76178|NCT01439945|183031|P2|COMPLETED|Double-Blind Treatment Phase||91
76179|NCT01439945|183032|P1|COMPLETED|Double-Blind Treatment Phase||93
76180|NCT01439945|183029|P4|STARTED|Double-Blind Treatment Phase||48
76181|NCT01439945|183030|P3|STARTED|Double-Blind Treatment Phase||48
76182|NCT01439945|183031|P2|STARTED|Double-Blind Treatment Phase||96
76183|NCT01439945|183032|P1|STARTED|Double-Blind Treatment Phase||97
76184|NCT01439867|183057|P2|NOT COMPLETED|Overall Study||8
76185|NCT01439867|183058|P1|NOT COMPLETED|Overall Study||6
76186|NCT01439867|183057|P2|COMPLETED|Overall Study||2
76187|NCT01439867|183058|P1|COMPLETED|Overall Study||2
76188|NCT01439867|183057|P2|Received Treatment|Overall Study||10
76189|NCT01439867|183058|P1|Received Treatment|Overall Study||7
76190|NCT01439867|183057|P2|STARTED|Overall Study||10
76191|NCT01439867|183058|P1|STARTED|Overall Study||8
76192|NCT01439724|183099|P2|NOT COMPLETED|Overall Study||8
76193|NCT01439724|183100|P1|NOT COMPLETED|Overall Study||9
76194|NCT01439724|183099|P2|COMPLETED|Overall Study||39
76195|NCT01439724|183100|P1|COMPLETED|Overall Study||38
76196|NCT01439724|183099|P2|STARTED|Overall Study||47
76197|NCT01439724|183100|P1|STARTED|Overall Study||47
76198|NCT01439672|183106|P1|NOT COMPLETED|Overall Study||24
76199|NCT01439672|183106|P1|COMPLETED|Overall Study||11
76200|NCT01439672|183106|P1|STARTED|Overall Study||35
76201|NCT01439360|183112|P2|NOT COMPLETED|Overall Study||208
76202|NCT01439360|183113|P1|NOT COMPLETED|Overall Study||198
76203|NCT01439360|183112|P2|COMPLETED|Overall Study||5804
76204|NCT01439360|183113|P1|COMPLETED|Overall Study||5808
76205|NCT01439360|183112|P2|STARTED|Overall Study||6012
76206|NCT01439360|183113|P1|STARTED|Overall Study||6006
76207|NCT01439282|183163|P2|NOT COMPLETED|Overall Study||1
76208|NCT01439282|183164|P1|NOT COMPLETED|Overall Study||8
76209|NCT01439282|183163|P2|COMPLETED|Overall Study||9
76210|NCT01439282|183164|P1|COMPLETED|Overall Study||59
76211|NCT01439282|183163|P2|STARTED|Overall Study||10
76212|NCT01439282|183164|P1|STARTED|Overall Study||67
76213|NCT01439204|183174|P2|NOT COMPLETED|Overall Study||3
76214|NCT01439204|183175|P1|NOT COMPLETED|Overall Study||4
76215|NCT01439204|183174|P2|COMPLETED|Overall Study||33
76216|NCT01439204|183175|P1|COMPLETED|Overall Study||32
76217|NCT01439204|183174|P2|STARTED|Overall Study||36
76218|NCT01439204|183175|P1|STARTED|Overall Study||36
76219|NCT01439126|183209|P2|NOT COMPLETED|Overall Study||42
76220|NCT01439126|183210|P1|NOT COMPLETED|Overall Study||31
76221|NCT01439126|183209|P2|COMPLETED|Overall Study||25
76222|NCT01439126|183210|P1|COMPLETED|Overall Study||37
76223|NCT01439126|183209|P2|STARTED|Overall Study||67
76224|NCT01439126|183210|P1|STARTED|Overall Study||68
76225|NCT01439074|183232|P2|NOT COMPLETED|Overall Study||13
76226|NCT01439074|183233|P1|NOT COMPLETED|Overall Study||9
76227|NCT01439074|183232|P2|COMPLETED|Overall Study||74
76228|NCT01439074|183233|P1|COMPLETED|Overall Study||66
76229|NCT01439074|183232|P2|STARTED|Overall Study||87
76230|NCT01439074|183233|P1|STARTED|Overall Study||75
76231|NCT01438996|183248|P3|NOT COMPLETED|Overall Study||0
76232|NCT01438996|183249|P2|NOT COMPLETED|Overall Study||1
76233|NCT01438996|183250|P1|NOT COMPLETED|Overall Study||4
76234|NCT01438996|183248|P3|COMPLETED|Overall Study||20
76235|NCT01438996|183249|P2|COMPLETED|Overall Study||12
76236|NCT01438996|183250|P1|COMPLETED|Overall Study||14
76237|NCT01438996|183248|P3|STARTED|Overall Study||20
76238|NCT01438996|183249|P2|STARTED|Overall Study||13
76239|NCT01438996|183250|P1|STARTED|Overall Study||18
76240|NCT01438814|183284|P2|NOT COMPLETED|Overall Study||14
76241|NCT01438814|183285|P1|NOT COMPLETED|Overall Study||14
76242|NCT01438814|183284|P2|COMPLETED|Overall Study||331
76243|NCT01438814|183285|P1|COMPLETED|Overall Study||330
76244|NCT01438814|183284|P2|STARTED|Overall Study||345
76245|NCT01438814|183285|P1|STARTED|Overall Study||344
76246|NCT01438710|183315|P2|NOT COMPLETED|Second Week of Treatment||0
76247|NCT01438710|183316|P1|NOT COMPLETED|Second Week of Treatment||1
76248|NCT01438710|183315|P2|COMPLETED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
76249|NCT01438710|183316|P1|COMPLETED|Second Week of Treatment||40
76250|NCT01438710|183315|P2|STARTED|Second Week of Treatment|Patients are only treated with LCP-Tacro during the second week.|0
76251|NCT01438710|183316|P1|STARTED|Second Week of Treatment|Patients completing the first week will continue on LCP-Tacro treatment during the second week.|41
76252|NCT01438710|183315|P2|NOT COMPLETED|First Week of Treatment||3
76253|NCT01438710|183316|P1|NOT COMPLETED|First Week of Treatment||0
76254|NCT01438710|183315|P2|COMPLETED|First Week of Treatment||41
76255|NCT01438710|183316|P1|COMPLETED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
76256|NCT01438710|183315|P2|STARTED|First Week of Treatment||44
76257|NCT01438710|183316|P1|STARTED|First Week of Treatment|Patients are only treated with Prograf/generic Tacrolimus during the first week.|0
76258|NCT01438541|183321|P1|NOT COMPLETED|Overall Study||7
76259|NCT01438541|183321|P1|COMPLETED|Overall Study||22
76260|NCT01438541|183321|P1|STARTED|Overall Study||29
76261|NCT01438489|183330|P3|NOT COMPLETED|Overall Study||19
76262|NCT01438489|183331|P2|NOT COMPLETED|Overall Study||16
76263|NCT01438489|183332|P1|NOT COMPLETED|Overall Study||26
76264|NCT01438489|183330|P3|COMPLETED|Overall Study||85
76265|NCT01438489|183331|P2|COMPLETED|Overall Study||84
76266|NCT01438489|183332|P1|COMPLETED|Overall Study||77
76267|NCT01438489|183330|P3|STARTED|Overall Study||104
76268|NCT01438489|183331|P2|STARTED|Overall Study||100
76269|NCT01438489|183332|P1|STARTED|Overall Study||103
76270|NCT01438424|183375|P1|NOT COMPLETED|Overall Study||417
76271|NCT01438424|183375|P1|COMPLETED|Overall Study|Completed treatment|634
76272|NCT01438424|183375|P1|STARTED|Overall Study|Received treatment|1051
76273|NCT01438307|183413|P2|NOT COMPLETED|Overall Study||1
76274|NCT01438307|183414|P1|NOT COMPLETED|Overall Study||1
76275|NCT01438307|183413|P2|COMPLETED|Overall Study||13
76276|NCT01438307|183414|P1|COMPLETED|Overall Study||13
76277|NCT01438307|183413|P2|STARTED|Overall Study||14
76278|NCT01438307|183414|P1|STARTED|Overall Study||14
76279|NCT01438294|183428|P2|NOT COMPLETED|Overall Study||7
76280|NCT01438294|183429|P1|NOT COMPLETED|Overall Study||3
76281|NCT01438294|183428|P2|COMPLETED|Overall Study||13
76282|NCT01438294|183429|P1|COMPLETED|Overall Study||13
76283|NCT01438294|183428|P2|STARTED|Overall Study||20
76284|NCT01438294|183429|P1|STARTED|Overall Study||16
76285|NCT01438229|183439|P1|NOT COMPLETED|Overall Study||3
76286|NCT01438229|183439|P1|COMPLETED|Overall Study||44
76287|NCT01438229|183439|P1|Underwent Procedure|Overall Study||46
76288|NCT01438229|183439|P1|Excluded Due to Renal Artery Anatomy|Overall Study||1
76289|NCT01438229|183439|P1|STARTED|Overall Study||47
76290|NCT01438177|183472|P1|NOT COMPLETED|Overall Study||2
76291|NCT01438177|183472|P1|COMPLETED|Overall Study|Patients who were off due to disease progression|9
76292|NCT01438177|183472|P1|STARTED|Overall Study||11
76293|NCT01438151|183478|P1|NOT COMPLETED|Overall Study||8
76294|NCT01438151|183478|P1|COMPLETED|Overall Study||3
76295|NCT01438151|183478|P1|STARTED|Overall Study||11
76296|NCT01438060|183484|P2|NOT COMPLETED|On Study Beyond Week 140||8
76297|NCT01438060|183485|P1|NOT COMPLETED|On Study Beyond Week 140||0
76298|NCT01438060|183484|P2|COMPLETED|On Study Beyond Week 140||1
76299|NCT01438060|183485|P1|COMPLETED|On Study Beyond Week 140||0
76300|NCT01438060|183484|P2|STARTED|On Study Beyond Week 140|9 participants in France who showed improvement at Week 140 continued treatment beyond 140 weeks|9
76301|NCT01438060|183485|P1|STARTED|On Study Beyond Week 140||0
76302|NCT01438060|183484|P2|NOT COMPLETED|Extension Phase: Week 10 to Week 130||56
76303|NCT01438060|183485|P1|NOT COMPLETED|Extension Phase: Week 10 to Week 130||58
76304|NCT01438060|183484|P2|COMPLETED|Extension Phase: Week 10 to Week 130||25
76305|NCT01438060|183485|P1|COMPLETED|Extension Phase: Week 10 to Week 130||22
76306|NCT01438060|183484|P2|STARTED|Extension Phase: Week 10 to Week 130|Of the 88 participants, who completed Acute Phase, 81 opted to enter 130-week extension phase|81
76307|NCT01438060|183485|P1|STARTED|Extension Phase: Week 10 to Week 130|80 out of the 84 participants entered extension phase. All were treated with open-label aripiprazole|80
76308|NCT01438060|183484|P2|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
76309|NCT01438060|183485|P1|NOT COMPLETED|Acute Phase: Double-blind, 10 Weeks||18
76310|NCT01438060|183484|P2|COMPLETED|Acute Phase: Double-blind, 10 Weeks||88
76311|NCT01438060|183485|P1|COMPLETED|Acute Phase: Double-blind, 10 Weeks||84
76312|NCT01438060|183484|P2|STARTED|Acute Phase: Double-blind, 10 Weeks||106
76313|NCT01438060|183485|P1|STARTED|Acute Phase: Double-blind, 10 Weeks||102
76314|NCT01437995|183566|P3|NOT COMPLETED|Overall Study||20
76315|NCT01437995|183567|P2|NOT COMPLETED|Overall Study||18
76316|NCT01437995|183568|P1|NOT COMPLETED|Overall Study||11
76317|NCT01437995|183566|P3|COMPLETED|Overall Study||135
76318|NCT01437995|183567|P2|COMPLETED|Overall Study||131
76319|NCT01437995|183568|P1|COMPLETED|Overall Study||140
76320|NCT01437995|183566|P3|Included in Treatment Failure Analysis|Overall Study||151
76321|NCT01437995|183567|P2|Included in Treatment Failure Analysis|Overall Study||146
76322|NCT01437995|183568|P1|Included in Treatment Failure Analysis|Overall Study||150
76323|NCT01437995|183566|P3|STARTED|Overall Study||155
76324|NCT01437995|183567|P2|STARTED|Overall Study||149
76325|NCT01437995|183568|P1|STARTED|Overall Study||151
76326|NCT01437943|183590|P2|NOT COMPLETED|Overall Study||2
76327|NCT01437943|183591|P1|NOT COMPLETED|Overall Study||7
76328|NCT01437943|183590|P2|COMPLETED|Overall Study||1
76329|NCT01437943|183591|P1|COMPLETED|Overall Study||0
76330|NCT01437943|183590|P2|STARTED|Overall Study||3
76331|NCT01437943|183591|P1|STARTED|Overall Study||7
76332|NCT01437878|183599|P2|NOT COMPLETED|Overall Study||0
76333|NCT01437878|183600|P1|NOT COMPLETED|Overall Study||1
76334|NCT01437878|183599|P2|COMPLETED|Overall Study||1
76335|NCT01437878|183600|P1|COMPLETED|Overall Study||0
76336|NCT01437878|183599|P2|STARTED|Overall Study||1
76337|NCT01437878|183600|P1|STARTED|Overall Study|Patient discontinued the study prior to initiation of study treatment|1
76338|NCT01437540|183642|P2|NOT COMPLETED|Overall Study||65
76339|NCT01437540|183643|P1|NOT COMPLETED|Overall Study||127
76340|NCT01437540|183642|P2|COMPLETED|Overall Study||133
76341|NCT01437540|183643|P1|COMPLETED|Overall Study||265
76342|NCT01437540|183642|P2|STARTED|Overall Study||198
76343|NCT01437540|183643|P1|STARTED|Overall Study||392
76344|NCT01437501|183657|P2|NOT COMPLETED|Overall Study||11
76345|NCT01437501|183658|P1|NOT COMPLETED|Overall Study||13
76346|NCT01437501|183657|P2|COMPLETED|Overall Study||132
76347|NCT01437501|183658|P1|COMPLETED|Overall Study||135
76348|NCT01437501|183657|P2|STARTED|Overall Study||143
76349|NCT01437501|183658|P1|STARTED|Overall Study||148
76350|NCT01437488|183664|P1|NOT COMPLETED|Overall Study||0
76351|NCT01437488|183664|P1|COMPLETED|Overall Study||14
76352|NCT01437488|183664|P1|STARTED|Overall Study||14
76353|NCT01437423|183670|P1|NOT COMPLETED|Overall Study||15
76354|NCT01437423|183670|P1|COMPLETED|Overall Study||647
76355|NCT01437423|183670|P1|STARTED|Overall Study||662
76356|NCT01437397|183682|P5|NOT COMPLETED|Overall Study||101
76357|NCT01437397|183683|P4|NOT COMPLETED|Overall Study||69
76358|NCT01437397|183684|P3|NOT COMPLETED|Overall Study||72
76359|NCT01437397|183685|P2|NOT COMPLETED|Overall Study||62
76360|NCT01437397|183686|P1|NOT COMPLETED|Overall Study||66
76361|NCT01437397|183682|P5|COMPLETED|Overall Study||236
76362|NCT01437397|183683|P4|COMPLETED|Overall Study||270
76363|NCT01437397|183684|P3|COMPLETED|Overall Study||268
76364|NCT01437397|183685|P2|COMPLETED|Overall Study||276
76365|NCT01437397|183686|P1|COMPLETED|Overall Study||272
76366|NCT01437397|183682|P5|STARTED|Overall Study||337
76367|NCT01437397|183683|P4|STARTED|Overall Study||339
76368|NCT01437397|183684|P3|STARTED|Overall Study||340
76369|NCT01437397|183685|P2|STARTED|Overall Study||338
76370|NCT01437397|183686|P1|STARTED|Overall Study||338
76371|NCT01437319|183713|P3|NOT COMPLETED|Phase II||37
76372|NCT01437319|183714|P2|NOT COMPLETED|Phase II||44
76373|NCT01437319|183715|P1|NOT COMPLETED|Phase II||0
76374|NCT01437319|183713|P3|COMPLETED|Phase II||75
76375|NCT01437319|183714|P2|COMPLETED|Phase II||71
76376|NCT01437319|183715|P1|COMPLETED|Phase II||0
76377|NCT01437319|183713|P3|STARTED|Phase II||112
76378|NCT01437319|183714|P2|STARTED|Phase II||115
76379|NCT01437319|183715|P1|STARTED|Phase II||0
76380|NCT01437319|183713|P3|NOT COMPLETED|Phase I||0
76381|NCT01437319|183714|P2|NOT COMPLETED|Phase I||0
76382|NCT01437319|183715|P1|NOT COMPLETED|Phase I||55
76383|NCT01437319|183713|P3|COMPLETED|Phase I||0
76384|NCT01437319|183714|P2|COMPLETED|Phase I||0
76385|NCT01437319|183715|P1|COMPLETED|Phase I||227
76386|NCT01437319|183713|P3|STARTED|Phase I||0
76387|NCT01437319|183714|P2|STARTED|Phase I||0
76388|NCT01437319|183715|P1|STARTED|Phase I||282
76389|NCT01437267|183730|P6|NOT COMPLETED|Overall Study||0
76390|NCT01437267|183731|P5|NOT COMPLETED|Overall Study||0
76391|NCT01437267|183732|P4|NOT COMPLETED|Overall Study||1
76392|NCT01437267|183733|P3|NOT COMPLETED|Overall Study||0
76393|NCT01437267|183734|P2|NOT COMPLETED|Overall Study||1
76394|NCT01437267|183735|P1|NOT COMPLETED|Overall Study||0
76395|NCT01437267|183730|P6|COMPLETED|Overall Study||20
76396|NCT01437267|183731|P5|COMPLETED|Overall Study||20
76397|NCT01437267|183732|P4|COMPLETED|Overall Study||19
76398|NCT01437267|183733|P3|COMPLETED|Overall Study||20
76399|NCT01437267|183734|P2|COMPLETED|Overall Study||19
76400|NCT01437267|183735|P1|COMPLETED|Overall Study||20
76401|NCT01437267|183730|P6|STARTED|Overall Study||20
76402|NCT01437267|183731|P5|STARTED|Overall Study||20
76403|NCT01437267|183732|P4|STARTED|Overall Study||20
76404|NCT01437267|183733|P3|STARTED|Overall Study||20
76405|NCT01437267|183734|P2|STARTED|Overall Study||20
76406|NCT01437267|183735|P1|STARTED|Overall Study||20
76407|NCT01437124|183773|P1|NOT COMPLETED|Overall Study||0
76408|NCT01437124|183773|P1|COMPLETED|Overall Study||83
76409|NCT01437124|183773|P1|STARTED|Overall Study||83
76410|NCT01437111|183778|P1|NOT COMPLETED|Overall Study||18
76411|NCT01437111|183778|P1|COMPLETED|Overall Study||182
76412|NCT01437111|183778|P1|Treated Participants|Overall Study||198
76413|NCT01437111|183778|P1|STARTED|Overall Study||200
76414|NCT01437098|183789|P1|NOT COMPLETED|Overall Study||13
76415|NCT01437098|183789|P1|COMPLETED|Overall Study||42
76416|NCT01437098|183789|P1|36 Months|Overall Study||36
76417|NCT01437098|183789|P1|24 Months|Overall Study||42
76418|NCT01437098|183789|P1|12 Months|Overall Study||45
76419|NCT01437098|183789|P1|6 Months|Overall Study||47
76420|NCT01437098|183789|P1|30 Days|Overall Study||51
76421|NCT01437098|183789|P1|STARTED|Overall Study||55
76422|NCT01436799|183846|P2|NOT COMPLETED|Overall Study||0
76423|NCT01436799|183847|P1|NOT COMPLETED|Overall Study||0
76424|NCT01436799|183846|P2|COMPLETED|Overall Study||20
76425|NCT01436799|183847|P1|COMPLETED|Overall Study||20
76426|NCT01436799|183846|P2|STARTED|Overall Study||20
76427|NCT01436799|183847|P1|STARTED|Overall Study||20
76428|NCT01436643|183856|P4|NOT COMPLETED|Core Phase (16 Weeks)||0
76429|NCT01436643|183857|P3|NOT COMPLETED|Core Phase (16 Weeks)||3
76430|NCT01436643|183858|P2|NOT COMPLETED|Core Phase (16 Weeks)||4
76431|NCT01436643|183859|P1|NOT COMPLETED|Core Phase (16 Weeks)||1
76432|NCT01436643|183856|P4|COMPLETED|Core Phase (16 Weeks)||0
76433|NCT01436643|183857|P3|COMPLETED|Core Phase (16 Weeks)||17
76434|NCT01436643|183858|P2|COMPLETED|Core Phase (16 Weeks)||11
76435|NCT01436643|183859|P1|COMPLETED|Core Phase (16 Weeks)||16
76436|NCT01436643|183856|P4|STARTED|Core Phase (16 Weeks)||0
76437|NCT01436643|183857|P3|STARTED|Core Phase (16 Weeks)||20
76438|NCT01436643|183858|P2|STARTED|Core Phase (16 Weeks)||15
76439|NCT01436643|183859|P1|STARTED|Core Phase (16 Weeks)||17
76440|NCT01436643|183856|P4|NOT COMPLETED|2-week Pre-treatment||10
76441|NCT01436643|183857|P3|NOT COMPLETED|2-week Pre-treatment||0
76442|NCT01436643|183858|P2|NOT COMPLETED|2-week Pre-treatment||0
76443|NCT01436643|183859|P1|NOT COMPLETED|2-week Pre-treatment||0
76444|NCT01436643|183856|P4|COMPLETED|2-week Pre-treatment||44
76445|NCT01436643|183857|P3|COMPLETED|2-week Pre-treatment||0
76446|NCT01436643|183858|P2|COMPLETED|2-week Pre-treatment||0
76447|NCT01436643|183859|P1|COMPLETED|2-week Pre-treatment||0
76448|NCT01436643|183856|P4|STARTED|2-week Pre-treatment||54
76449|NCT01436643|183857|P3|STARTED|2-week Pre-treatment||0
76450|NCT01436643|183858|P2|STARTED|2-week Pre-treatment||0
76451|NCT01436643|183859|P1|STARTED|2-week Pre-treatment||0
76452|NCT01436526|183871|P2|NOT COMPLETED|Period 2||0
76453|NCT01436526|183872|P1|NOT COMPLETED|Period 2||0
76454|NCT01436526|183871|P2|COMPLETED|Period 2||13
76455|NCT01436526|183872|P1|COMPLETED|Period 2||13
76456|NCT01436526|183871|P2|Participants Received Treatment|Period 2||13
76457|NCT01436526|183872|P1|Participants Received Treatment|Period 2||13
76458|NCT01436526|183871|P2|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
76459|NCT01436526|183872|P1|STARTED|Period 2|1 participant withdrew his consent after completing the first period.|13
76460|NCT01436526|183871|P2|NOT COMPLETED|Period 1||0
76461|NCT01436526|183872|P1|NOT COMPLETED|Period 1||0
76462|NCT01436526|183871|P2|COMPLETED|Period 1||14
76463|NCT01436526|183872|P1|COMPLETED|Period 1||14
76464|NCT01436526|183871|P2|Participants Received Treatment|Period 1||14
76465|NCT01436526|183872|P1|Participants Received Treatment|Period 1||14
76466|NCT01436526|183871|P2|STARTED|Period 1||14
76467|NCT01436526|183872|P1|STARTED|Period 1||14
76468|NCT01436500|183894|P5|NOT COMPLETED|Overall Study||4
76469|NCT01436500|183895|P4|NOT COMPLETED|Overall Study||1
76470|NCT01436500|183896|P3|NOT COMPLETED|Overall Study||5
76471|NCT01436500|183897|P2|NOT COMPLETED|Overall Study||3
76472|NCT01436500|183898|P1|NOT COMPLETED|Overall Study||3
76473|NCT01436500|183894|P5|COMPLETED|Overall Study||9
76474|NCT01436500|183895|P4|COMPLETED|Overall Study||5
76475|NCT01436500|183896|P3|COMPLETED|Overall Study||7
76476|NCT01436500|183897|P2|COMPLETED|Overall Study||9
76477|NCT01436500|183898|P1|COMPLETED|Overall Study||9
76478|NCT01436500|183894|P5|STARTED|Overall Study||13
76479|NCT01436500|183895|P4|STARTED|Overall Study||6
76480|NCT01436500|183896|P3|STARTED|Overall Study||12
76481|NCT01436500|183897|P2|STARTED|Overall Study||12
76482|NCT01436500|183898|P1|STARTED|Overall Study||12
76483|NCT01436435|183931|P1|NOT COMPLETED|Overall Study||64
76484|NCT01436435|183931|P1|COMPLETED|Overall Study||177
76485|NCT01436435|183931|P1|STARTED|Overall Study||241
76486|NCT01436370|183948|P8|NOT COMPLETED|Overall Study||0
76487|NCT01436370|183949|P7|NOT COMPLETED|Overall Study||0
76488|NCT01436370|183950|P6|NOT COMPLETED|Overall Study||0
76489|NCT01436370|183951|P5|NOT COMPLETED|Overall Study||1
76490|NCT01436370|183952|P4|NOT COMPLETED|Overall Study||0
76491|NCT01436370|183953|P3|NOT COMPLETED|Overall Study||0
76492|NCT01436370|183954|P2|NOT COMPLETED|Overall Study||0
76493|NCT01436370|183955|P1|NOT COMPLETED|Overall Study||0
76494|NCT01436370|183948|P8|COMPLETED|Overall Study||16
76495|NCT01436370|183949|P7|COMPLETED|Overall Study||16
76496|NCT01436370|183950|P6|COMPLETED|Overall Study||19
76497|NCT01436370|183951|P5|COMPLETED|Overall Study||18
76498|NCT01436370|183952|P4|COMPLETED|Overall Study||10
76499|NCT01436370|183953|P3|COMPLETED|Overall Study||10
76500|NCT01436370|183954|P2|COMPLETED|Overall Study||6
76501|NCT01436370|183955|P1|COMPLETED|Overall Study||6
76502|NCT01436370|183948|P8|STARTED|Overall Study||16
76503|NCT01436370|183949|P7|STARTED|Overall Study||16
76504|NCT01436370|183950|P6|STARTED|Overall Study||19
76505|NCT01436370|183951|P5|STARTED|Overall Study||19
76506|NCT01436370|183952|P4|STARTED|Overall Study||10
76507|NCT01436370|183953|P3|STARTED|Overall Study||10
76508|NCT01436370|183954|P2|STARTED|Overall Study||6
76509|NCT01436370|183955|P1|STARTED|Overall Study||6
76510|NCT01436305|184036|P3|NOT COMPLETED|Overall Study||0
76511|NCT01436305|184037|P2|NOT COMPLETED|Overall Study||4
76512|NCT01436305|184038|P1|NOT COMPLETED|Overall Study||2
76513|NCT01436305|184036|P3|COMPLETED|Overall Study||7
76514|NCT01436305|184037|P2|COMPLETED|Overall Study||2
76515|NCT01436305|184038|P1|COMPLETED|Overall Study||4
76516|NCT01436305|184036|P3|STARTED|Overall Study||7
76517|NCT01436305|184037|P2|STARTED|Overall Study||6
76518|NCT01436305|184038|P1|STARTED|Overall Study||6
76519|NCT01436279|184135|P2|NOT COMPLETED|Overall Study||0
76520|NCT01436279|184136|P1|NOT COMPLETED|Overall Study||0
76521|NCT01436279|184135|P2|COMPLETED|Overall Study||20
76522|NCT01436279|184136|P1|COMPLETED|Overall Study||30
76523|NCT01436279|184135|P2|STARTED|Overall Study||20
76524|NCT01436279|184136|P1|STARTED|Overall Study||30
76525|NCT01436266|184158|P2|NOT COMPLETED|Overall Study||0
76526|NCT01436266|184159|P1|NOT COMPLETED|Overall Study||0
76527|NCT01436266|184158|P2|COMPLETED|Overall Study||1
76528|NCT01436266|184159|P1|COMPLETED|Overall Study||1
76529|NCT01436266|184158|P2|STARTED|Overall Study||1
76530|NCT01436266|184159|P1|STARTED|Overall Study||1
76531|NCT01436253|184165|P1|NOT COMPLETED|Overall Study||299
76532|NCT01436253|184165|P1|COMPLETED|Overall Study||1897
76533|NCT01436253|184165|P1|STARTED|Overall Study||2196
76534|NCT01436201|184170|P1|NOT COMPLETED|Overall Study||4
76535|NCT01436201|184170|P1|COMPLETED|Overall Study||20
76536|NCT01436201|184170|P1|Received at Least 1 Dose of Study Drug|Overall Study||24
76537|NCT01436201|184170|P1|STARTED|Overall Study||24
76538|NCT01436175|184180|P1|NOT COMPLETED|Overall Study||1270
76539|NCT01436175|184180|P1|COMPLETED|Overall Study||300
76540|NCT01436175|184180|P1|STARTED|Overall Study||1570
76541|NCT01436162|184207|P3|NOT COMPLETED|Randomized Phase||25
76542|NCT01436162|184208|P2|NOT COMPLETED|Randomized Phase||31
76543|NCT01436162|184209|P1|NOT COMPLETED|Randomized Phase||44
76544|NCT01436162|184207|P3|COMPLETED|Randomized Phase||189
76545|NCT01436162|184208|P2|COMPLETED|Randomized Phase||181
76546|NCT01436162|184209|P1|COMPLETED|Randomized Phase||353
76547|NCT01436162|184207|P3|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|214
76548|NCT01436162|184208|P2|STARTED|Randomized Phase|One subject was randomized to this arm but did not receive at least 1 dose of double-blind treatment|212
76549|NCT01436162|184209|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|397
76550|NCT01436162|184207|P3|NOT COMPLETED|Single-blind Lead-in Phase||0
76551|NCT01436162|184208|P2|NOT COMPLETED|Single-blind Lead-in Phase||0
76552|NCT01436162|184209|P1|NOT COMPLETED|Single-blind Lead-in Phase||282
76553|NCT01436162|184207|P3|COMPLETED|Single-blind Lead-in Phase||0
76554|NCT01436162|184208|P2|COMPLETED|Single-blind Lead-in Phase||0
76555|NCT01436162|184209|P1|COMPLETED|Single-blind Lead-in Phase||823
76556|NCT01436162|184207|P3|STARTED|Single-blind Lead-in Phase||0
76557|NCT01436162|184208|P2|STARTED|Single-blind Lead-in Phase||0
76558|NCT01436162|184209|P1|STARTED|Single-blind Lead-in Phase|Ten subjects were enrolled but not dosed.|1105
76559|NCT01436149|184243|P3|NOT COMPLETED|Randomized Phase||42
76560|NCT01436149|184244|P2|NOT COMPLETED|Randomized Phase||38
76561|NCT01436149|184245|P1|NOT COMPLETED|Randomized Phase||77
76562|NCT01436149|184243|P3|COMPLETED|Randomized Phase|1 subject completed the study without a Visit 14 MADRS and was not included in the completers set.|160
76563|NCT01436149|184244|P2|COMPLETED|Randomized Phase||164
76564|NCT01436149|184245|P1|COMPLETED|Randomized Phase||415
76565|NCT01436149|184243|P3|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
76566|NCT01436149|184244|P2|STARTED|Randomized Phase|One subject did not receive at least 1 dose of double-blind treatment.|202
76567|NCT01436149|184245|P1|STARTED|Randomized Phase|These subjects were not included in the Safety Analysis Set or Full Analysis Set.|492
76568|NCT01436149|184243|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
76569|NCT01436149|184244|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
76570|NCT01436149|184245|P1|NOT COMPLETED|Antidepressant Lead-in Phase||366
76571|NCT01436149|184243|P3|COMPLETED|Antidepressant Lead-in Phase||0
76572|NCT01436149|184244|P2|COMPLETED|Antidepressant Lead-in Phase||0
76573|NCT01436149|184245|P1|COMPLETED|Antidepressant Lead-in Phase||896
76574|NCT01436149|184243|P3|STARTED|Antidepressant Lead-in Phase||0
76575|NCT01436149|184244|P2|STARTED|Antidepressant Lead-in Phase||0
76576|NCT01436149|184245|P1|STARTED|Antidepressant Lead-in Phase|Twenty-three subjects were enrolled but not dosed.|1262
76577|NCT01436110|184276|P3|NOT COMPLETED|Overall Study||23
76578|NCT01436110|184277|P2|NOT COMPLETED|Overall Study||26
76579|NCT01436110|184278|P1|NOT COMPLETED|Overall Study||39
76580|NCT01436110|184276|P3|COMPLETED|Overall Study||95
76581|NCT01436110|184277|P2|COMPLETED|Overall Study||91
76582|NCT01436110|184278|P1|COMPLETED|Overall Study||77
76583|NCT01436110|184276|P3|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
76584|NCT01436110|184277|P2|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|117
76585|NCT01436110|184278|P1|Intent-to-Treat Population|Overall Study|These randomized participants received at least a single dose of trial medication.|115
76586|NCT01436110|184276|P3|STARTED|Overall Study|These participants were randomized to trial medication.|118
76587|NCT01436110|184277|P2|STARTED|Overall Study|These participants were randomized to trial medication.|117
76588|NCT01436110|184278|P1|STARTED|Overall Study|These participants were randomized to trial medication.|116
76589|NCT01436084|184301|P1|NOT COMPLETED|Overall Study||4
76590|NCT01436084|184301|P1|COMPLETED|Overall Study||0
76591|NCT01436084|184301|P1|STARTED|Overall Study||4
76592|NCT01436071|184307|P2|NOT COMPLETED|Overall Study||14
76593|NCT01436071|184308|P1|NOT COMPLETED|Overall Study||26
76594|NCT01436071|184307|P2|COMPLETED|Overall Study||110
76595|NCT01436071|184308|P1|COMPLETED|Overall Study||98
76596|NCT01436071|184307|P2|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
76597|NCT01436071|184308|P1|Safety Population|Overall Study|These randomized participants received at least a single dose of trial medication.|121
76598|NCT01436071|184307|P2|STARTED|Overall Study|These participants were randomized to trial medication.|124
76599|NCT01436071|184308|P1|STARTED|Overall Study|These participants were randomized to trial medication.|124
76600|NCT01436045|184324|P2|NOT COMPLETED|Overall Study||0
76601|NCT01436045|184325|P1|NOT COMPLETED|Overall Study||0
76602|NCT01436045|184324|P2|COMPLETED|Overall Study||6
76603|NCT01436045|184325|P1|COMPLETED|Overall Study||6
76604|NCT01436045|184324|P2|STARTED|Overall Study||6
76605|NCT01436045|184325|P1|STARTED|Overall Study||6
76606|NCT01436006|184336|P1|NOT COMPLETED|Overall Study||37
76607|NCT01436006|184336|P1|COMPLETED|Overall Study||6663
76608|NCT01436006|184336|P1|STARTED|Overall Study||6700
76609|NCT01435928|184350|P3|NOT COMPLETED|Double Blind Phase - 28 Weeks||121
76610|NCT01435928|184351|P2|NOT COMPLETED|Double Blind Phase - 28 Weeks||116
76611|NCT01435928|184352|P1|NOT COMPLETED|Double Blind Phase - 28 Weeks||0
76612|NCT01435928|184350|P3|COMPLETED|Double Blind Phase - 28 Weeks||20
76613|NCT01435928|184351|P2|COMPLETED|Double Blind Phase - 28 Weeks||28
76614|NCT01435928|184352|P1|COMPLETED|Double Blind Phase - 28 Weeks||0
76615|NCT01435928|184350|P3|STARTED|Double Blind Phase - 28 Weeks||141
76616|NCT01435928|184351|P2|STARTED|Double Blind Phase - 28 Weeks||144
76617|NCT01435928|184352|P1|STARTED|Double Blind Phase - 28 Weeks||0
76618|NCT01435928|184350|P3|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
76619|NCT01435928|184351|P2|NOT COMPLETED|Open Label Phase - up to 24 Weeks||0
76620|NCT01435928|184352|P1|NOT COMPLETED|Open Label Phase - up to 24 Weeks||389
76621|NCT01435928|184350|P3|COMPLETED|Open Label Phase - up to 24 Weeks||0
76622|NCT01435928|184351|P2|COMPLETED|Open Label Phase - up to 24 Weeks||0
76623|NCT01435928|184352|P1|COMPLETED|Open Label Phase - up to 24 Weeks||287
76624|NCT01435928|184350|P3|STARTED|Open Label Phase - up to 24 Weeks||0
76625|NCT01435928|184351|P2|STARTED|Open Label Phase - up to 24 Weeks||0
76626|NCT01435928|184352|P1|STARTED|Open Label Phase - up to 24 Weeks||676
76627|NCT01435798|184379|P1|NOT COMPLETED|Overall Study||1
76628|NCT01435798|184379|P1|COMPLETED|Overall Study|Crossover design|25
76629|NCT01435798|184379|P1|100% MTD|Overall Study||25
76630|NCT01435798|184379|P1|50% MTD|Overall Study||25
76631|NCT01435798|184379|P1|25% MTD|Overall Study||26
76632|NCT01435798|184379|P1|0% MTD|Overall Study||25
76633|NCT01435798|184379|P1|STARTED|Overall Study|Crossover design|26
76634|NCT01435759|184398|P6|NOT COMPLETED|Double-blind Phase||9
76635|NCT01435759|184399|P5|NOT COMPLETED|Double-blind Phase||9
76636|NCT01435759|184400|P4|NOT COMPLETED|Double-blind Phase||9
76637|NCT01435759|184401|P3|NOT COMPLETED|Double-blind Phase||7
76638|NCT01435759|184402|P2|NOT COMPLETED|Double-blind Phase||7
76639|NCT01435759|184403|P1|NOT COMPLETED|Double-blind Phase||66
76640|NCT01435759|184398|P6|COMPLETED|Double-blind Phase||71
76641|NCT01435759|184399|P5|COMPLETED|Double-blind Phase||69
76642|NCT01435759|184400|P4|COMPLETED|Double-blind Phase||69
76643|NCT01435759|184401|P3|COMPLETED|Double-blind Phase||71
76644|NCT01435759|184402|P2|COMPLETED|Double-blind Phase||71
76645|NCT01435759|184403|P1|COMPLETED|Double-blind Phase||397
76646|NCT01435759|184398|P6|STARTED|Double-blind Phase||80
76647|NCT01435759|184399|P5|STARTED|Double-blind Phase||78
76648|NCT01435759|184400|P4|STARTED|Double-blind Phase|Two subjects were not dosed.|78
76649|NCT01435759|184401|P3|STARTED|Double-blind Phase|One subject was not dosed.|78
76650|NCT01435759|184402|P2|STARTED|Double-blind Phase||78
76651|NCT01435759|184403|P1|STARTED|Double-blind Phase|These subjects were not included in the Safety Dose Response Evaluable Set or Safety Analysis Set.|463
76652|NCT01435759|184398|P6|NOT COMPLETED|Antidepressant Lead-in Phase||0
76653|NCT01435759|184399|P5|NOT COMPLETED|Antidepressant Lead-in Phase||0
76654|NCT01435759|184400|P4|NOT COMPLETED|Antidepressant Lead-in Phase||0
76655|NCT01435759|184401|P3|NOT COMPLETED|Antidepressant Lead-in Phase||0
76656|NCT01435759|184402|P2|NOT COMPLETED|Antidepressant Lead-in Phase||0
76657|NCT01435759|184403|P1|NOT COMPLETED|Antidepressant Lead-in Phase||342
76658|NCT01435759|184398|P6|COMPLETED|Antidepressant Lead-in Phase||0
76659|NCT01435759|184399|P5|COMPLETED|Antidepressant Lead-in Phase||0
76660|NCT01435759|184400|P4|COMPLETED|Antidepressant Lead-in Phase||0
76661|NCT01435759|184401|P3|COMPLETED|Antidepressant Lead-in Phase||0
76662|NCT01435759|184402|P2|COMPLETED|Antidepressant Lead-in Phase||0
76663|NCT01435759|184403|P1|COMPLETED|Antidepressant Lead-in Phase||855
76664|NCT01435759|184398|P6|STARTED|Antidepressant Lead-in Phase||0
76665|NCT01435759|184399|P5|STARTED|Antidepressant Lead-in Phase||0
76666|NCT01435759|184400|P4|STARTED|Antidepressant Lead-in Phase||0
76667|NCT01435759|184401|P3|STARTED|Antidepressant Lead-in Phase||0
76668|NCT01435759|184402|P2|STARTED|Antidepressant Lead-in Phase||0
76669|NCT01435759|184403|P1|STARTED|Antidepressant Lead-in Phase|Of these 1197 subjects, 19 subjects were not dosed.|1197
76670|NCT01435655|184430|P1|NOT COMPLETED|Overall Study||3
76671|NCT01435655|184430|P1|COMPLETED|Overall Study||7
76672|NCT01435655|184430|P1|STARTED|Overall Study||10
76673|NCT01435577|184444|P2|NOT COMPLETED|Overall Study||52
76674|NCT01435577|184445|P1|NOT COMPLETED|Overall Study||17
76675|NCT01435577|184444|P2|COMPLETED|Overall Study||13
76676|NCT01435577|184445|P1|COMPLETED|Overall Study||47
76677|NCT01435577|184444|P2|STARTED|Overall Study||65
76678|NCT01435577|184445|P1|STARTED|Overall Study||64
76679|NCT01435460|184495|P2|NOT COMPLETED|Overall Study||6
76680|NCT01435460|184496|P1|NOT COMPLETED|Overall Study||11
76681|NCT01435460|184495|P2|COMPLETED|Overall Study||143
76682|NCT01435460|184496|P1|COMPLETED|Overall Study||140
76683|NCT01435460|184495|P2|STARTED|Overall Study||149
76684|NCT01435460|184496|P1|STARTED|Overall Study||151
76685|NCT01435265|184510|P2|NOT COMPLETED|Overall Study||1
76686|NCT01435265|184511|P1|NOT COMPLETED|Overall Study||0
76687|NCT01435265|184510|P2|COMPLETED|Overall Study||3
76688|NCT01435265|184511|P1|COMPLETED|Overall Study||3
76689|NCT01435265|184510|P2|STARTED|Overall Study||4
76690|NCT01435265|184511|P1|STARTED|Overall Study||3
76691|NCT01435174|184521|P1|NOT COMPLETED|Overall Study||9
76692|NCT01435174|184521|P1|COMPLETED|Overall Study||8
76693|NCT01435174|184521|P1|STARTED|Overall Study||17
76694|NCT01435122|184525|P1|NOT COMPLETED|Overall Study||8
76695|NCT01435122|184525|P1|COMPLETED|Overall Study||22
76696|NCT01435122|184525|P1|STARTED|Overall Study||30
76697|NCT01435031|184534|P1|NOT COMPLETED|ITT at 2 Years||9
76698|NCT01435031|184534|P1|COMPLETED|ITT at 2 Years||194
76699|NCT01435031|184534|P1|STARTED|ITT at 2 Years||203
76700|NCT01435031|184534|P1|NOT COMPLETED|ITT at 1 Year||8
76701|NCT01435031|184534|P1|COMPLETED|ITT at 1 Year||203
76702|NCT01435031|184534|P1|STARTED|ITT at 1 Year||211
76703|NCT01435031|184534|P1|NOT COMPLETED|ITT at 6 Months||5
76704|NCT01435031|184534|P1|COMPLETED|ITT at 6 Months||211
76705|NCT01435031|184534|P1|STARTED|ITT at 6 Months||216
76706|NCT01435031|184534|P1|NOT COMPLETED|ITT at 1 Month||6
76707|NCT01435031|184534|P1|COMPLETED|ITT at 1 Month||216
76708|NCT01435031|184534|P1|STARTED|ITT at 1 Month|ITT population|222
76709|NCT01434823|184614|P2|NOT COMPLETED|Overall Study||7
76710|NCT01434823|184615|P1|NOT COMPLETED|Overall Study||4
76711|NCT01434823|184614|P2|COMPLETED|Overall Study||778
76712|NCT01434823|184615|P1|COMPLETED|Overall Study||820
76713|NCT01434823|184614|P2|STARTED|Overall Study||785
76714|NCT01434823|184615|P1|STARTED|Overall Study||824
76715|NCT01434693|184633|P4|NOT COMPLETED|Overall Study||1
76716|NCT01434693|184634|P3|NOT COMPLETED|Overall Study||1
76717|NCT01434693|184635|P2|NOT COMPLETED|Overall Study||0
76718|NCT01434693|184636|P1|NOT COMPLETED|Overall Study||3
76719|NCT01434693|184633|P4|COMPLETED|Overall Study||8
76720|NCT01434693|184634|P3|COMPLETED|Overall Study||8
76721|NCT01434693|184635|P2|COMPLETED|Overall Study||9
76722|NCT01434693|184636|P1|COMPLETED|Overall Study||6
76723|NCT01434693|184633|P4|STARTED|Overall Study||9
76724|NCT01434693|184634|P3|STARTED|Overall Study||9
76725|NCT01434693|184635|P2|STARTED|Overall Study||9
76726|NCT01434693|184636|P1|STARTED|Overall Study||9
76727|NCT01434680|184650|P4|NOT COMPLETED|Overall Study||0
76728|NCT01434680|184651|P3|NOT COMPLETED|Overall Study||2
76729|NCT01434680|184652|P2|NOT COMPLETED|Overall Study||2
76730|NCT01434680|184653|P1|NOT COMPLETED|Overall Study||3
76731|NCT01434680|184650|P4|COMPLETED|Overall Study||119
76732|NCT01434680|184651|P3|COMPLETED|Overall Study||304
76733|NCT01434680|184652|P2|COMPLETED|Overall Study||266
76734|NCT01434680|184653|P1|COMPLETED|Overall Study||296
76735|NCT01434680|184650|P4|STARTED|Overall Study||119
76736|NCT01434680|184651|P3|STARTED|Overall Study||306
76737|NCT01434680|184652|P2|STARTED|Overall Study||268
76738|NCT01434680|184653|P1|STARTED|Overall Study||299
76739|NCT01434654|184670|P2|NOT COMPLETED|Overall Study||0
76740|NCT01434654|184671|P1|NOT COMPLETED|Overall Study||2
76741|NCT01434654|184670|P2|COMPLETED|Overall Study||12
76742|NCT01434654|184671|P1|COMPLETED|Overall Study||5
76743|NCT01434654|184670|P2|STARTED|Overall Study||12
76744|NCT01434654|184671|P1|STARTED|Overall Study||7
76745|NCT01434641|184683|P1|NOT COMPLETED|Overall Study||0
76746|NCT01434641|184683|P1|COMPLETED|Overall Study||102
76747|NCT01434641|184683|P1|STARTED|Overall Study||102
76748|NCT01434511|184688|P1|NOT COMPLETED|Overall Study||0
76749|NCT01434511|184688|P1|COMPLETED|Overall Study||1
76750|NCT01434511|184688|P1|STARTED|Overall Study||1
76751|NCT01434342|184707|P2|NOT COMPLETED|Overall Study||17
76752|NCT01434342|184708|P1|NOT COMPLETED|Overall Study||48
76753|NCT01434342|184707|P2|COMPLETED|Overall Study||31
76754|NCT01434342|184708|P1|COMPLETED|Overall Study||50
76755|NCT01434342|184707|P2|STARTED|Overall Study||48
76756|NCT01434342|184708|P1|STARTED|Overall Study||98
76757|NCT01434186|184718|P2|NOT COMPLETED|Overall Study||0
76758|NCT01434186|184719|P1|NOT COMPLETED|Overall Study||0
76759|NCT01434186|184718|P2|COMPLETED|Overall Study||4
76760|NCT01434186|184719|P1|COMPLETED|Overall Study||2
76761|NCT01434186|184718|P2|STARTED|Overall Study||4
76762|NCT01434186|184719|P1|STARTED|Overall Study||2
76763|NCT01434121|184728|P3|NOT COMPLETED|Overall Study||0
76764|NCT01434121|184729|P2|NOT COMPLETED|Overall Study||0
76765|NCT01434121|184730|P1|NOT COMPLETED|Overall Study||0
76766|NCT01434121|184728|P3|COMPLETED|Overall Study||8
76767|NCT01434121|184729|P2|COMPLETED|Overall Study||8
76768|NCT01434121|184730|P1|COMPLETED|Overall Study||8
76769|NCT01434121|184728|P3|STARTED|Overall Study||8
76770|NCT01434121|184729|P2|STARTED|Overall Study||8
76771|NCT01434121|184730|P1|STARTED|Overall Study||8
76772|NCT01434030|184738|P1|NOT COMPLETED|Overall Study||1
76773|NCT01434030|184738|P1|COMPLETED|Overall Study||56
76774|NCT01434030|184738|P1|STARTED|Overall Study||57
76775|NCT01433913|184745|P2|NOT COMPLETED|Overall Study||0
76776|NCT01433913|184746|P1|NOT COMPLETED|Overall Study||1
76777|NCT01433913|184745|P2|COMPLETED|Overall Study||10
76778|NCT01433913|184746|P1|COMPLETED|Overall Study||9
76779|NCT01433913|184745|P2|STARTED|Overall Study||10
76780|NCT01433913|184746|P1|STARTED|Overall Study||10
76781|NCT01433731|184756|P4|NOT COMPLETED|Overall Study||0
76782|NCT01433731|184757|P3|NOT COMPLETED|Overall Study||0
76783|NCT01433731|184758|P2|NOT COMPLETED|Overall Study||0
76784|NCT01433731|184759|P1|NOT COMPLETED|Overall Study||0
76785|NCT01433731|184756|P4|COMPLETED|Overall Study||5
76786|NCT01433731|184757|P3|COMPLETED|Overall Study||5
76787|NCT01433731|184758|P2|COMPLETED|Overall Study||5
76788|NCT01433731|184759|P1|COMPLETED|Overall Study||3
76789|NCT01433731|184756|P4|STARTED|Overall Study||5
76790|NCT01433731|184757|P3|STARTED|Overall Study||5
76791|NCT01433731|184758|P2|STARTED|Overall Study||5
76792|NCT01433731|184759|P1|STARTED|Overall Study||3
76793|NCT01433549|184767|P2|NOT COMPLETED|Phase 2: Second Study Product||1
76794|NCT01433549|184768|P1|NOT COMPLETED|Phase 2: Second Study Product||0
76795|NCT01433549|184767|P2|COMPLETED|Phase 2: Second Study Product||12
76796|NCT01433549|184768|P1|COMPLETED|Phase 2: Second Study Product||12
76797|NCT01433549|184767|P2|STARTED|Phase 2: Second Study Product||13
76798|NCT01433549|184768|P1|STARTED|Phase 2: Second Study Product||12
76799|NCT01433549|184767|P2|NOT COMPLETED|Phase 1: First Study Product||0
76800|NCT01433549|184768|P1|NOT COMPLETED|Phase 1: First Study Product||0
76801|NCT01433549|184767|P2|COMPLETED|Phase 1: First Study Product||13
76802|NCT01433549|184768|P1|COMPLETED|Phase 1: First Study Product||12
76803|NCT01433549|184767|P2|STARTED|Phase 1: First Study Product||13
76804|NCT01433549|184768|P1|STARTED|Phase 1: First Study Product||12
76805|NCT01433471|184778|P2|NOT COMPLETED|Overall Study||1
76806|NCT01433471|184779|P1|NOT COMPLETED|Overall Study||0
76807|NCT01433471|184778|P2|COMPLETED|Overall Study||1
76808|NCT01433471|184779|P1|COMPLETED|Overall Study||2
76809|NCT01433471|184778|P2|STARTED|Overall Study||2
76810|NCT01433471|184779|P1|STARTED|Overall Study||2
76811|NCT01433354|184795|P1|NOT COMPLETED|Overall Study||119
76812|NCT01433354|184795|P1|COMPLETED|Overall Study||0
76813|NCT01433354|184795|P1|STARTED|Overall Study|120 enrolled of which 119 were administered drug|119
76814|NCT01433263|184811|P2|NOT COMPLETED|Overall Study||12
76815|NCT01433263|184812|P1|NOT COMPLETED|Overall Study||19
76816|NCT01433263|184811|P2|COMPLETED|Overall Study||16
76817|NCT01433263|184812|P1|COMPLETED|Overall Study||10
76818|NCT01433263|184811|P2|STARTED|Overall Study||28
76819|NCT01433263|184812|P1|STARTED|Overall Study||29
76820|NCT01433250|184841|P2|NOT COMPLETED|Overall Study||3
76821|NCT01433250|184842|P1|NOT COMPLETED|Overall Study||3
76822|NCT01433250|184841|P2|COMPLETED|Overall Study||14
76823|NCT01433250|184842|P1|COMPLETED|Overall Study||19
76824|NCT01433250|184841|P2|STARTED|Overall Study||17
76825|NCT01433250|184842|P1|STARTED|Overall Study||22
76826|NCT01433172|184861|P3|NOT COMPLETED|Overall Study||1
76827|NCT01433172|184862|P2|NOT COMPLETED|Overall Study||3
76828|NCT01433172|184863|P1|NOT COMPLETED|Overall Study||0
76829|NCT01433172|184861|P3|COMPLETED|Overall Study||32
76830|NCT01433172|184862|P2|COMPLETED|Overall Study||34
76831|NCT01433172|184863|P1|COMPLETED|Overall Study||3
76832|NCT01433172|184861|P3|STARTED|Overall Study||33
76833|NCT01433172|184862|P2|STARTED|Overall Study||37
76834|NCT01433172|184863|P1|STARTED|Overall Study||3
76835|NCT01433159|184875|P2|NOT COMPLETED|Overall Study||1
76836|NCT01433159|184876|P1|NOT COMPLETED|Overall Study||2
76837|NCT01433159|184875|P2|COMPLETED|Overall Study||9
76838|NCT01433159|184876|P1|COMPLETED|Overall Study||7
76839|NCT01433159|184875|P2|STARTED|Overall Study||10
76840|NCT01433159|184876|P1|STARTED|Overall Study||9
76841|NCT01433107|184884|P2|NOT COMPLETED|Overall Study||17
76842|NCT01433107|184885|P1|NOT COMPLETED|Overall Study||27
76843|NCT01433107|184884|P2|COMPLETED|Overall Study||128
76844|NCT01433107|184885|P1|COMPLETED|Overall Study||118
76845|NCT01433107|184884|P2|STARTED|Overall Study||145
76846|NCT01433107|184885|P1|STARTED|Overall Study||145
76847|NCT01433081|184897|P2|NOT COMPLETED|Overall Study||2
76848|NCT01433081|184898|P1|NOT COMPLETED|Overall Study||2
76849|NCT01433081|184897|P2|COMPLETED|Overall Study||23
76850|NCT01433081|184898|P1|COMPLETED|Overall Study||23
76851|NCT01433081|184897|P2|STARTED|Overall Study||25
76852|NCT01433081|184898|P1|STARTED|Overall Study||25
76853|NCT01433055|184908|P2|NOT COMPLETED|Overall Study||0
76854|NCT01433055|184909|P1|NOT COMPLETED|Overall Study||2
76855|NCT01433055|184908|P2|COMPLETED|Overall Study||23
76856|NCT01433055|184909|P1|COMPLETED|Overall Study||27
76857|NCT01433055|184908|P2|STARTED|Overall Study||23
76858|NCT01433055|184909|P1|STARTED|Overall Study||29
76859|NCT01433042|184923|P1|NOT COMPLETED|Overall Study||1
76860|NCT01433042|184923|P1|COMPLETED|Overall Study||224
76861|NCT01433042|184923|P1|STARTED|Overall Study||225
76862|NCT01433016|184927|P1|NOT COMPLETED|Overall Study||0
76863|NCT01433016|184927|P1|COMPLETED|Overall Study||20
76864|NCT01433016|184927|P1|STARTED|Overall Study||20
76865|NCT01432938|184931|P2|NOT COMPLETED|Second Intervention||0
76866|NCT01432938|184932|P1|NOT COMPLETED|Second Intervention||1
76867|NCT01432938|184931|P2|COMPLETED|Second Intervention||14
76868|NCT01432938|184932|P1|COMPLETED|Second Intervention||11
76869|NCT01432938|184931|P2|STARTED|Second Intervention||14
76870|NCT01432938|184932|P1|STARTED|Second Intervention||12
76871|NCT01432938|184931|P2|NOT COMPLETED|Washout Period of at Least 24 Days||0
76872|NCT01432938|184932|P1|NOT COMPLETED|Washout Period of at Least 24 Days||0
76873|NCT01432938|184931|P2|COMPLETED|Washout Period of at Least 24 Days||14
76874|NCT01432938|184932|P1|COMPLETED|Washout Period of at Least 24 Days||12
76875|NCT01432938|184931|P2|STARTED|Washout Period of at Least 24 Days||14
76876|NCT01432938|184932|P1|STARTED|Washout Period of at Least 24 Days||12
76877|NCT01432938|184931|P2|NOT COMPLETED|First Intervention||0
76878|NCT01432938|184932|P1|NOT COMPLETED|First Intervention||2
76879|NCT01432938|184931|P2|COMPLETED|First Intervention||14
76880|NCT01432938|184932|P1|COMPLETED|First Intervention||12
76881|NCT01432938|184931|P2|Received at Least 1 Dose of Study Drug|First Intervention||14
76882|NCT01432938|184932|P1|Received at Least 1 Dose of Study Drug|First Intervention||14
76883|NCT01432938|184931|P2|STARTED|First Intervention||14
76884|NCT01432938|184932|P1|STARTED|First Intervention||14
76885|NCT01432886|184949|P2|NOT COMPLETED|Overall Study||0
76886|NCT01432886|184950|P1|NOT COMPLETED|Overall Study||0
76887|NCT01432886|184949|P2|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
76888|NCT01432886|184950|P1|COMPLETED|Overall Study|Discontinuation met per discontinuation criteria|6
76889|NCT01432886|184949|P2|STARTED|Overall Study||6
76890|NCT01432886|184950|P1|STARTED|Overall Study||6
76891|NCT01432756|184962|P4|NOT COMPLETED|Overall Study||1
76892|NCT01432756|184963|P3|NOT COMPLETED|Overall Study||2
76893|NCT01432756|184964|P2|NOT COMPLETED|Overall Study||0
76894|NCT01432756|184965|P1|NOT COMPLETED|Overall Study||1
76895|NCT01432756|184962|P4|COMPLETED|Overall Study||33
76896|NCT01432756|184963|P3|COMPLETED|Overall Study||30
76897|NCT01432756|184964|P2|COMPLETED|Overall Study||34
76898|NCT01432756|184965|P1|COMPLETED|Overall Study||31
76899|NCT01432756|184962|P4|STARTED|Overall Study||34
76900|NCT01432756|184963|P3|STARTED|Overall Study||32
76901|NCT01432756|184964|P2|STARTED|Overall Study||34
76902|NCT01432756|184965|P1|STARTED|Overall Study||32
76903|NCT01432626|184973|P1|NOT COMPLETED|Overall Study||7
76904|NCT01432626|184973|P1|COMPLETED|Overall Study|Completed both images|3
76905|NCT01432626|184973|P1|STARTED|Overall Study||10
76906|NCT01432600|184980|P3|NOT COMPLETED|Overall Study||1
76907|NCT01432600|184981|P2|NOT COMPLETED|Overall Study||1
76908|NCT01432600|184982|P1|NOT COMPLETED|Overall Study||0
76909|NCT01432600|184980|P3|COMPLETED|Overall Study||33
76910|NCT01432600|184981|P2|COMPLETED|Overall Study||35
76911|NCT01432600|184982|P1|COMPLETED|Overall Study||10
76912|NCT01432600|184980|P3|STARTED|Overall Study||34
76913|NCT01432600|184981|P2|STARTED|Overall Study||36
76914|NCT01432600|184982|P1|STARTED|Overall Study||10
76915|NCT01432574|184998|P1|NOT COMPLETED|Overall Study||3
76916|NCT01432574|184998|P1|COMPLETED|Overall Study||147
76917|NCT01432574|184998|P1|STARTED|Overall Study||150
76918|NCT01432561|185004|P1|NOT COMPLETED|Overall Study||0
76919|NCT01432561|185004|P1|COMPLETED|Overall Study||8
76920|NCT01432561|185004|P1|STARTED|Overall Study||8
76921|NCT01432535|185013|P3|NOT COMPLETED|Overall Study||0
76922|NCT01432535|185014|P2|NOT COMPLETED|Overall Study||0
76923|NCT01432535|185015|P1|NOT COMPLETED|Overall Study||0
76924|NCT01432535|185013|P3|COMPLETED|Overall Study||6
76925|NCT01432535|185014|P2|COMPLETED|Overall Study||7
76926|NCT01432535|185015|P1|COMPLETED|Overall Study||12
76927|NCT01432535|185013|P3|STARTED|Overall Study||6
76928|NCT01432535|185014|P2|STARTED|Overall Study|One participant later determined ineligible is not included in baseline/efficacy analyses.|7
76929|NCT01432535|185015|P1|STARTED|Overall Study||12
76930|NCT01432457|185044|P3|NOT COMPLETED|Overall Study||59
76931|NCT01432457|185045|P2|NOT COMPLETED|Overall Study||48
76932|NCT01432457|185046|P1|NOT COMPLETED|Overall Study||37
76933|NCT01432457|185044|P3|COMPLETED|Overall Study||253
76934|NCT01432457|185045|P2|COMPLETED|Overall Study||258
76935|NCT01432457|185046|P1|COMPLETED|Overall Study||269
76936|NCT01432457|185044|P3|STARTED|Overall Study||312
76937|NCT01432457|185045|P2|STARTED|Overall Study||306
76938|NCT01432457|185046|P1|STARTED|Overall Study||306
76939|NCT01432444|185075|P3|NOT COMPLETED|Extension Phase||192
76940|NCT01432444|185076|P2|NOT COMPLETED|Extension Phase||0
76941|NCT01432444|185077|P1|NOT COMPLETED|Extension Phase||0
76942|NCT01432444|185075|P3|COMPLETED|Extension Phase||0
76943|NCT01432444|185076|P2|COMPLETED|Extension Phase||0
76944|NCT01432444|185077|P1|COMPLETED|Extension Phase||0
76945|NCT01432444|185075|P3|STARTED|Extension Phase||192
76946|NCT01432444|185076|P2|STARTED|Extension Phase||0
76947|NCT01432444|185077|P1|STARTED|Extension Phase||0
76948|NCT01432444|185075|P3|NOT COMPLETED|Treatment Phase||0
76949|NCT01432444|185076|P2|NOT COMPLETED|Treatment Phase||140
76950|NCT01432444|185077|P1|NOT COMPLETED|Treatment Phase||0
76951|NCT01432444|185075|P3|COMPLETED|Treatment Phase||0
76952|NCT01432444|185076|P2|COMPLETED|Treatment Phase||293
76953|NCT01432444|185077|P1|COMPLETED|Treatment Phase||0
76954|NCT01432444|185075|P3|STARTED|Treatment Phase||0
76955|NCT01432444|185076|P2|STARTED|Treatment Phase||433
76956|NCT01432444|185077|P1|STARTED|Treatment Phase||0
76957|NCT01432444|185075|P3|NOT COMPLETED|Tolerability/Cross-titration Phase||0
76958|NCT01432444|185076|P2|NOT COMPLETED|Tolerability/Cross-titration Phase||0
76959|NCT01432444|185077|P1|NOT COMPLETED|Tolerability/Cross-titration Phase||60
76960|NCT01432444|185075|P3|COMPLETED|Tolerability/Cross-titration Phase||0
76961|NCT01432444|185076|P2|COMPLETED|Tolerability/Cross-titration Phase||0
76962|NCT01432444|185077|P1|COMPLETED|Tolerability/Cross-titration Phase||265
76963|NCT01432444|185075|P3|STARTED|Tolerability/Cross-titration Phase||0
76964|NCT01432444|185076|P2|STARTED|Tolerability/Cross-titration Phase||0
76965|NCT01432444|185077|P1|STARTED|Tolerability/Cross-titration Phase||325
76966|NCT01432405|185089|P2|NOT COMPLETED|Overall Study||2
76967|NCT01432405|185090|P1|NOT COMPLETED|Overall Study||1
76968|NCT01432405|185089|P2|COMPLETED|Overall Study||10
76969|NCT01432405|185090|P1|COMPLETED|Overall Study||11
76970|NCT01432405|185089|P2|STARTED|Overall Study||12
76971|NCT01432405|185090|P1|STARTED|Overall Study||12
76972|NCT01432379|185098|P1|NOT COMPLETED|Overall Study||385
76973|NCT01432379|185098|P1|COMPLETED|Overall Study||783
76974|NCT01432379|185098|P1|STARTED|Overall Study||1168
76975|NCT01432366|185103|P1|NOT COMPLETED|Overall Study||68
76976|NCT01432366|185103|P1|COMPLETED|Overall Study||392
76977|NCT01432366|185103|P1|STARTED|Overall Study||460
76978|NCT01432327|185125|P4|NOT COMPLETED|Posttest 1 Year||23
76979|NCT01432327|185126|P3|NOT COMPLETED|Posttest 1 Year||20
76980|NCT01432327|185127|P2|NOT COMPLETED|Posttest 1 Year||28
76981|NCT01432327|185128|P1|NOT COMPLETED|Posttest 1 Year||24
76982|NCT01432327|185125|P4|COMPLETED|Posttest 1 Year||31
76983|NCT01432327|185126|P3|COMPLETED|Posttest 1 Year||30
76984|NCT01432327|185127|P2|COMPLETED|Posttest 1 Year||27
76985|NCT01432327|185128|P1|COMPLETED|Posttest 1 Year||28
76986|NCT01432327|185125|P4|STARTED|Posttest 1 Year||54
76987|NCT01432327|185126|P3|STARTED|Posttest 1 Year||50
76988|NCT01432327|185127|P2|STARTED|Posttest 1 Year||55
76989|NCT01432327|185128|P1|STARTED|Posttest 1 Year||52
76990|NCT01432327|185125|P4|NOT COMPLETED|Posttest 6 Months||2
76991|NCT01432327|185126|P3|NOT COMPLETED|Posttest 6 Months||5
76992|NCT01432327|185127|P2|NOT COMPLETED|Posttest 6 Months||0
76993|NCT01432327|185128|P1|NOT COMPLETED|Posttest 6 Months||0
76994|NCT01432327|185125|P4|COMPLETED|Posttest 6 Months||54
76995|NCT01432327|185126|P3|COMPLETED|Posttest 6 Months||50
76996|NCT01432327|185127|P2|COMPLETED|Posttest 6 Months||55
76997|NCT01432327|185128|P1|COMPLETED|Posttest 6 Months||52
76998|NCT01432327|185125|P4|STARTED|Posttest 6 Months||56
76999|NCT01432327|185126|P3|STARTED|Posttest 6 Months||55
77000|NCT01432327|185127|P2|STARTED|Posttest 6 Months||55
77001|NCT01432327|185128|P1|STARTED|Posttest 6 Months||52
77002|NCT01432327|185125|P4|NOT COMPLETED|Posttest 3 Months||1
77003|NCT01432327|185126|P3|NOT COMPLETED|Posttest 3 Months||2
77004|NCT01432327|185127|P2|NOT COMPLETED|Posttest 3 Months||2
77005|NCT01432327|185128|P1|NOT COMPLETED|Posttest 3 Months||4
77006|NCT01432327|185125|P4|COMPLETED|Posttest 3 Months||56
77007|NCT01432327|185126|P3|COMPLETED|Posttest 3 Months||55
77008|NCT01432327|185127|P2|COMPLETED|Posttest 3 Months||55
77009|NCT01432327|185128|P1|COMPLETED|Posttest 3 Months||52
77010|NCT01432327|185125|P4|STARTED|Posttest 3 Months||57
77011|NCT01432327|185126|P3|STARTED|Posttest 3 Months||57
77012|NCT01432327|185127|P2|STARTED|Posttest 3 Months||57
77013|NCT01432327|185128|P1|STARTED|Posttest 3 Months||56
77014|NCT01432327|185125|P4|NOT COMPLETED|Baseline||0
77015|NCT01432327|185126|P3|NOT COMPLETED|Baseline||0
77016|NCT01432327|185127|P2|NOT COMPLETED|Baseline||0
77017|NCT01432327|185128|P1|NOT COMPLETED|Baseline||0
77018|NCT01432327|185125|P4|COMPLETED|Baseline||57
77019|NCT01432327|185126|P3|COMPLETED|Baseline||57
77020|NCT01432327|185127|P2|COMPLETED|Baseline||57
77021|NCT01432327|185128|P1|COMPLETED|Baseline||56
77022|NCT01432327|185125|P4|STARTED|Baseline||57
77023|NCT01432327|185126|P3|STARTED|Baseline||57
77024|NCT01432327|185127|P2|STARTED|Baseline||57
77025|NCT01432327|185128|P1|STARTED|Baseline||56
77026|NCT01432275|185138|P2|NOT COMPLETED|ADC With Calculator (10 Days)||2
77027|NCT01432275|185139|P1|NOT COMPLETED|ADC With Calculator (10 Days)||3
77028|NCT01432275|185138|P2|COMPLETED|ADC With Calculator (10 Days)||79
77029|NCT01432275|185139|P1|COMPLETED|ADC With Calculator (10 Days)||85
77030|NCT01432275|185138|P2|STARTED|ADC With Calculator (10 Days)||81
77031|NCT01432275|185139|P1|STARTED|ADC With Calculator (10 Days)||88
77032|NCT01432275|185138|P2|NOT COMPLETED|Second BG Meter System (7 Days)||3
77033|NCT01432275|185139|P1|NOT COMPLETED|Second BG Meter System (7 Days)||2
77034|NCT01432275|185138|P2|COMPLETED|Second BG Meter System (7 Days)||81
77035|NCT01432275|185139|P1|COMPLETED|Second BG Meter System (7 Days)||88
77036|NCT01432275|185138|P2|STARTED|Second BG Meter System (7 Days)||84
77037|NCT01432275|185139|P1|STARTED|Second BG Meter System (7 Days)||90
77038|NCT01432275|185138|P2|NOT COMPLETED|First BG Meter System (7 Days)||3
77039|NCT01432275|185139|P1|NOT COMPLETED|First BG Meter System (7 Days)||0
77040|NCT01432275|185138|P2|COMPLETED|First BG Meter System (7 Days)||84
77041|NCT01432275|185139|P1|COMPLETED|First BG Meter System (7 Days)||90
77042|NCT01432275|185138|P2|STARTED|First BG Meter System (7 Days)||87
77043|NCT01432275|185139|P1|STARTED|First BG Meter System (7 Days)||90
77044|NCT01432262|185148|P2|NOT COMPLETED|Overall Study||1
77045|NCT01432262|185149|P1|NOT COMPLETED|Overall Study||2
77046|NCT01432262|185148|P2|COMPLETED|Overall Study||161
77047|NCT01432262|185149|P1|COMPLETED|Overall Study||160
77048|NCT01432262|185148|P2|Vaccinated|Overall Study||161
77049|NCT01432262|185149|P1|Vaccinated|Overall Study||162
77050|NCT01432262|185148|P2|STARTED|Overall Study||162
77051|NCT01432262|185149|P1|STARTED|Overall Study||162
77052|NCT01432236|185167|P2|NOT COMPLETED|Overall Study||18
77053|NCT01432236|185168|P1|NOT COMPLETED|Overall Study||26
77054|NCT01432236|185167|P2|COMPLETED|Overall Study||79
77055|NCT01432236|185168|P1|COMPLETED|Overall Study||70
77056|NCT01432236|185167|P2|STARTED|Overall Study||97
77057|NCT01432236|185168|P1|STARTED|Overall Study||96
77058|NCT01432015|185215|P2|NOT COMPLETED|Overall Study||0
77059|NCT01432015|185216|P1|NOT COMPLETED|Overall Study||0
77060|NCT01432015|185215|P2|COMPLETED|Overall Study||10
77061|NCT01432015|185216|P1|COMPLETED|Overall Study||10
77062|NCT01432015|185215|P2|STARTED|Overall Study||10
77063|NCT01432015|185216|P1|STARTED|Overall Study||10
77064|NCT01431989|185224|P2|NOT COMPLETED|Period 2||0
77065|NCT01431989|185225|P1|NOT COMPLETED|Period 2||0
77066|NCT01431989|185224|P2|COMPLETED|Period 2||14
77067|NCT01431989|185225|P1|COMPLETED|Period 2||14
77068|NCT01431989|185224|P2|STARTED|Period 2||14
77069|NCT01431989|185225|P1|STARTED|Period 2||14
77070|NCT01431989|185224|P2|NOT COMPLETED|14-Day Washout Period||0
77071|NCT01431989|185225|P1|NOT COMPLETED|14-Day Washout Period||0
77072|NCT01431989|185224|P2|COMPLETED|14-Day Washout Period||14
77073|NCT01431989|185225|P1|COMPLETED|14-Day Washout Period||14
77074|NCT01431989|185224|P2|STARTED|14-Day Washout Period||14
77075|NCT01431989|185225|P1|STARTED|14-Day Washout Period||14
77076|NCT01431989|185224|P2|NOT COMPLETED|Period 1||0
77077|NCT01431989|185225|P1|NOT COMPLETED|Period 1||0
77078|NCT01431989|185224|P2|COMPLETED|Period 1||14
77079|NCT01431989|185225|P1|COMPLETED|Period 1||14
77080|NCT01431989|185224|P2|STARTED|Period 1||14
77081|NCT01431989|185225|P1|STARTED|Period 1||14
77082|NCT01431976|185243|P1|NOT COMPLETED|Overall Study||14
77083|NCT01431976|185243|P1|COMPLETED|Overall Study||6
77084|NCT01431976|185243|P1|STARTED|Overall Study||20
77085|NCT01431963|185254|P1|NOT COMPLETED|Overall Study||35
77086|NCT01431963|185254|P1|COMPLETED|Overall Study||32
77087|NCT01431963|185254|P1|Complete ExP (gt= 24 Weeks)|Overall Study|(>=24 weeks); gt= abbreviation for greater than or equal to|19
77088|NCT01431963|185254|P1|Begin Extension Phase (ExP; gt= 24weeks)|Overall Study|Only Japanese participants in ExP,lamotrigine monotherapy was available in Korea. (>=24weeks)|19
77089|NCT01431963|185254|P1|Complete MP (24 Weeks)|Overall Study||42
77090|NCT01431963|185254|P1|Begin Maintenance Phase (MP; 24 Weeks)|Overall Study||52
77091|NCT01431963|185254|P1|Complete EP (6 Weeks)|Overall Study||52
77092|NCT01431963|185254|P1|Received Treatment|Overall Study||65
77093|NCT01431963|185254|P1|Begin Escalation Phase (EP; 6 Weeks)|Overall Study||67
77094|NCT01431963|185254|P1|STARTED|Overall Study||67
77095|NCT01431950|185262|P2|NOT COMPLETED|Overall Study||15
77096|NCT01431950|185263|P1|NOT COMPLETED|Overall Study||19
77097|NCT01431950|185262|P2|COMPLETED|Overall Study||104
77098|NCT01431950|185263|P1|COMPLETED|Overall Study||100
77099|NCT01431950|185262|P2|STARTED|Overall Study||119
77100|NCT01431950|185263|P1|STARTED|Overall Study||119
77101|NCT01431846|185280|P3|NOT COMPLETED|Overall Study||0
77102|NCT01431846|185281|P2|NOT COMPLETED|Overall Study||0
77103|NCT01431846|185282|P1|NOT COMPLETED|Overall Study||0
77104|NCT01431846|185280|P3|COMPLETED|Overall Study||8
77105|NCT01431846|185281|P2|COMPLETED|Overall Study||3
77106|NCT01431846|185282|P1|COMPLETED|Overall Study||8
77107|NCT01431846|185280|P3|STARTED|Overall Study||8
77108|NCT01431846|185281|P2|STARTED|Overall Study||3
77109|NCT01431846|185282|P1|STARTED|Overall Study||8
77110|NCT01431755|185290|P1|NOT COMPLETED|Overall Study||5
77111|NCT01431755|185290|P1|COMPLETED|Overall Study||49
77112|NCT01431755|185290|P1|STARTED|Overall Study||54
77113|NCT01431716|185301|P1|NOT COMPLETED|Overall Study||1
77114|NCT01431716|185301|P1|COMPLETED|Overall Study||41
77115|NCT01431716|185301|P1|STARTED|Overall Study||42
77116|NCT01431703|185318|P1|NOT COMPLETED|Overall Study||0
77117|NCT01431703|185318|P1|COMPLETED|Overall Study||326
77118|NCT01431703|185318|P1|STARTED|Overall Study||326
77119|NCT01431521|185326|P4|NOT COMPLETED|Overall Study||0
77120|NCT01431521|185327|P3|NOT COMPLETED|Overall Study||1
77121|NCT01431521|185328|P2|NOT COMPLETED|Overall Study||0
77122|NCT01431521|185329|P1|NOT COMPLETED|Overall Study||0
77123|NCT01431521|185326|P4|COMPLETED|Overall Study||5
77124|NCT01431521|185327|P3|COMPLETED|Overall Study||10
77125|NCT01431521|185328|P2|COMPLETED|Overall Study||5
77126|NCT01431521|185329|P1|COMPLETED|Overall Study||10
77127|NCT01431521|185326|P4|Treated|Overall Study||5
77128|NCT01431521|185327|P3|Treated|Overall Study||10
77129|NCT01431521|185328|P2|Treated|Overall Study||5
77130|NCT01431521|185329|P1|Treated|Overall Study||10
77131|NCT01431521|185326|P4|STARTED|Overall Study||5
77132|NCT01431521|185327|P3|STARTED|Overall Study||11
77133|NCT01431521|185328|P2|STARTED|Overall Study||5
77134|NCT01431521|185329|P1|STARTED|Overall Study||10
77135|NCT01431508|185350|P1|NOT COMPLETED|Overall Study||2
77136|NCT01431508|185350|P1|COMPLETED|Overall Study||13
77137|NCT01431508|185350|P1|STARTED|Overall Study||15
77138|NCT01431391|185356|P2|NOT COMPLETED|Overall Study||4
77139|NCT01431391|185357|P1|NOT COMPLETED|Overall Study||8
77140|NCT01431391|185356|P2|COMPLETED|Overall Study||30
77141|NCT01431391|185357|P1|COMPLETED|Overall Study||26
77142|NCT01431391|185356|P2|Received ≥1 Leaukapheresis|Overall Study||34
77143|NCT01431391|185357|P1|Received ≥1 Leaukapheresis|Overall Study||34
77144|NCT01431391|185356|P2|STARTED|Overall Study||34
77145|NCT01431391|185357|P1|STARTED|Overall Study||34
77146|NCT01431339|185367|P2|NOT COMPLETED|Overall Study||35
77147|NCT01431339|185368|P1|NOT COMPLETED|Overall Study||39
77148|NCT01431339|185367|P2|COMPLETED|Overall Study||333
77149|NCT01431339|185368|P1|COMPLETED|Overall Study||332
77150|NCT01431339|185367|P2|Safety Population|Overall Study||367
77151|NCT01431339|185368|P1|Safety Population|Overall Study||368
77152|NCT01431339|185367|P2|STARTED|Overall Study||368
77153|NCT01431339|185368|P1|STARTED|Overall Study||371
77154|NCT01431300|185383|P3|NOT COMPLETED|Overall Study||0
77155|NCT01431300|185384|P2|NOT COMPLETED|Overall Study||0
77156|NCT01431300|185385|P1|NOT COMPLETED|Overall Study||1
77157|NCT01431300|185383|P3|COMPLETED|Overall Study||10
77158|NCT01431300|185384|P2|COMPLETED|Overall Study||10
77159|NCT01431300|185385|P1|COMPLETED|Overall Study||10
77160|NCT01431300|185383|P3|STARTED|Overall Study||10
77161|NCT01431300|185384|P2|STARTED|Overall Study||10
77162|NCT01431300|185385|P1|STARTED|Overall Study|One subject with indeterminate pregnancy test, subject declined to proceed|11
77163|NCT01431287|185401|P5|NOT COMPLETED|Overall Study||77
77164|NCT01431287|185402|P4|NOT COMPLETED|Overall Study||63
77165|NCT01431287|185403|P3|NOT COMPLETED|Overall Study||97
77166|NCT01431287|185404|P2|NOT COMPLETED|Overall Study||98
77167|NCT01431287|185405|P1|NOT COMPLETED|Overall Study||98
77168|NCT01431287|185401|P5|COMPLETED|Overall Study||430
77169|NCT01431287|185402|P4|COMPLETED|Overall Study||445
77170|NCT01431287|185403|P3|COMPLETED|Overall Study||410
77171|NCT01431287|185404|P2|COMPLETED|Overall Study||409
77172|NCT01431287|185405|P1|COMPLETED|Overall Study||412
77173|NCT01431287|185401|P5|STARTED|Overall Study||507
77174|NCT01431287|185402|P4|STARTED|Overall Study||508
77175|NCT01431287|185403|P3|STARTED|Overall Study||507
77176|NCT01431287|185404|P2|STARTED|Overall Study||507
77177|NCT01431287|185405|P1|STARTED|Overall Study|started are actually the randomized|510
77178|NCT01431274|185567|P5|NOT COMPLETED|Overall Study||56
77179|NCT01431274|185568|P4|NOT COMPLETED|Overall Study||60
77180|NCT01431274|185569|P3|NOT COMPLETED|Overall Study||72
77181|NCT01431274|185570|P2|NOT COMPLETED|Overall Study||77
77182|NCT01431274|185571|P1|NOT COMPLETED|Overall Study||97
77183|NCT01431274|185567|P5|COMPLETED|Overall Study||466
77184|NCT01431274|185568|P4|COMPLETED|Overall Study||462
77185|NCT01431274|185569|P3|COMPLETED|Overall Study||455
77186|NCT01431274|185570|P2|COMPLETED|Overall Study||448
77187|NCT01431274|185571|P1|COMPLETED|Overall Study||431
77188|NCT01431274|185567|P5|STARTED|Overall Study||522
77189|NCT01431274|185568|P4|STARTED|Overall Study||522
77190|NCT01431274|185569|P3|STARTED|Overall Study||527
77191|NCT01431274|185570|P2|STARTED|Overall Study||525
77192|NCT01431274|185571|P1|STARTED|Overall Study||528
77193|NCT01431170|185730|P2|NOT COMPLETED|Overall Study||1
77194|NCT01431170|185731|P1|NOT COMPLETED|Overall Study||3
77195|NCT01431170|185730|P2|COMPLETED|Overall Study||11
77196|NCT01431170|185731|P1|COMPLETED|Overall Study||9
77197|NCT01431170|185730|P2|STARTED|Overall Study||12
77198|NCT01431170|185731|P1|STARTED|Overall Study||12
77199|NCT01431144|185749|P2|NOT COMPLETED|Overall Study||0
77200|NCT01431144|185750|P1|NOT COMPLETED|Overall Study||2
77201|NCT01431144|185749|P2|COMPLETED|Overall Study||14
77202|NCT01431144|185750|P1|COMPLETED|Overall Study||11
77203|NCT01431144|185749|P2|STARTED|Overall Study||14
77204|NCT01431144|185750|P1|STARTED|Overall Study||13
77205|NCT01431131|185758|P2|NOT COMPLETED|Overall Study||0
77206|NCT01431131|185759|P1|NOT COMPLETED|Overall Study||0
77207|NCT01431131|185758|P2|COMPLETED|Overall Study||12
77208|NCT01431131|185759|P1|COMPLETED|Overall Study||12
77209|NCT01431131|185758|P2|STARTED|Overall Study||12
77210|NCT01431131|185759|P1|STARTED|Overall Study||12
77211|NCT01431079|185769|P2|NOT COMPLETED|Overall Study||39
77212|NCT01431079|185770|P1|NOT COMPLETED|Overall Study||35
77213|NCT01431079|185769|P2|COMPLETED|Overall Study||6
77214|NCT01431079|185770|P1|COMPLETED|Overall Study||10
77215|NCT01431079|185769|P2|Post-test|Overall Study||45
77216|NCT01431079|185770|P1|Post-test|Overall Study||45
77217|NCT01431079|185769|P2|STARTED|Overall Study||45
77218|NCT01431079|185770|P1|STARTED|Overall Study||45
77219|NCT01431014|185824|P2|NOT COMPLETED|Overall Study||9
77220|NCT01431014|185825|P1|NOT COMPLETED|Overall Study||3
77221|NCT01431014|185824|P2|COMPLETED|Overall Study||25
77222|NCT01431014|185825|P1|COMPLETED|Overall Study||31
77223|NCT01431014|185824|P2|STARTED|Overall Study||34
77224|NCT01431014|185825|P1|STARTED|Overall Study||34
77225|NCT01430819|185833|P2|NOT COMPLETED|Overall Study||0
77226|NCT01430819|185834|P1|NOT COMPLETED|Overall Study||0
77227|NCT01430819|185833|P2|COMPLETED|Overall Study||150
77228|NCT01430819|185834|P1|COMPLETED|Overall Study||150
77229|NCT01430819|185833|P2|STARTED|Overall Study||150
77230|NCT01430819|185834|P1|STARTED|Overall Study||150
77231|NCT01430754|185849|P2|NOT COMPLETED|Randomized Phase||0
77232|NCT01430754|185850|P1|NOT COMPLETED|Randomized Phase||0
77233|NCT01430754|185849|P2|COMPLETED|Randomized Phase||10
77234|NCT01430754|185850|P1|COMPLETED|Randomized Phase||10
77235|NCT01430754|185849|P2|STARTED|Randomized Phase||10
77236|NCT01430754|185850|P1|STARTED|Randomized Phase||10
77237|NCT01430754|185849|P2|NOT COMPLETED|Run-In Phase||0
77238|NCT01430754|185850|P1|NOT COMPLETED|Run-In Phase||37
77239|NCT01430754|185849|P2|COMPLETED|Run-In Phase||0
77240|NCT01430754|185850|P1|COMPLETED|Run-In Phase|Defined as the number of patients who entered the randomized-withdrawal phase|20
77241|NCT01430754|185849|P2|Entrained - After Run-In Phase|Run-In Phase||0
77242|NCT01430754|185850|P1|Entrained - After Run-In Phase|Run-In Phase||24
77243|NCT01430754|185849|P2|STARTED|Run-In Phase|During the run-in phase, participants were treated with tasimelteon only.|0
77244|NCT01430754|185850|P1|STARTED|Run-In Phase||57
77245|NCT01430741|185872|P4|NOT COMPLETED|Overall Study||0
77246|NCT01430741|185873|P3|NOT COMPLETED|Overall Study||10
77247|NCT01430741|185874|P2|NOT COMPLETED|Overall Study||0
77248|NCT01430741|185875|P1|NOT COMPLETED|Overall Study||0
77249|NCT01430741|185872|P4|COMPLETED|Overall Study||81
77250|NCT01430741|185873|P3|COMPLETED|Overall Study||37
77251|NCT01430741|185874|P2|COMPLETED|Overall Study||87
77252|NCT01430741|185875|P1|COMPLETED|Overall Study||22
77253|NCT01430741|185872|P4|STARTED|Overall Study||81
77254|NCT01430741|185873|P3|STARTED|Overall Study||47
77255|NCT01430741|185874|P2|STARTED|Overall Study||87
77256|NCT01430741|185875|P1|STARTED|Overall Study||22
77257|NCT01430624|185908|P3|NOT COMPLETED|Overall Study||29
77258|NCT01430624|185909|P2|NOT COMPLETED|Overall Study||34
77259|NCT01430624|185910|P1|NOT COMPLETED|Overall Study||28
77260|NCT01430624|185908|P3|COMPLETED|Overall Study|Completed one or more follow-ups|52
77261|NCT01430624|185909|P2|COMPLETED|Overall Study|Completed one or more follow-ups|48
77262|NCT01430624|185910|P1|COMPLETED|Overall Study|Completed one or more follow-ups|54
77263|NCT01430624|185908|P3|Eligible Baseline Completes|Overall Study||79
77264|NCT01430624|185909|P2|Eligible Baseline Completes|Overall Study||77
77265|NCT01430624|185910|P1|Eligible Baseline Completes|Overall Study||77
77266|NCT01430624|185908|P3|STARTED|Overall Study||81
77267|NCT01430624|185909|P2|STARTED|Overall Study||82
77268|NCT01430624|185910|P1|STARTED|Overall Study|Initial potential eligible screened enrolled|82
77269|NCT01430611|185941|P2|NOT COMPLETED|Overall Study||15
77270|NCT01430611|185942|P1|NOT COMPLETED|Overall Study||17
77271|NCT01430611|185941|P2|COMPLETED|Overall Study||318
77272|NCT01430611|185942|P1|COMPLETED|Overall Study||315
77273|NCT01430611|185941|P2|STARTED|Overall Study||333
77274|NCT01430611|185942|P1|STARTED|Overall Study||332
77275|NCT01430585|185960|P1|NOT COMPLETED|Overall Study||14
77276|NCT01430585|185960|P1|COMPLETED|Overall Study||0
77277|NCT01430585|185960|P1|STARTED|Overall Study||14
77278|NCT01430468|185995|P2|NOT COMPLETED|Overall Study||2
77279|NCT01430468|185996|P1|NOT COMPLETED|Overall Study||3
77280|NCT01430468|185995|P2|COMPLETED|Overall Study||16
77281|NCT01430468|185996|P1|COMPLETED|Overall Study||15
77282|NCT01430468|185995|P2|STARTED|Overall Study||18
77283|NCT01430468|185996|P1|STARTED|Overall Study||18
77284|NCT01430403|186005|P3|NOT COMPLETED|Overall Study||8
77285|NCT01430403|186006|P2|NOT COMPLETED|Overall Study||9
77286|NCT01430403|186007|P1|NOT COMPLETED|Overall Study||17
77287|NCT01430403|186005|P3|COMPLETED|Overall Study||81
77288|NCT01430403|186006|P2|COMPLETED|Overall Study||121
77289|NCT01430403|186007|P1|COMPLETED|Overall Study||242
77290|NCT01430403|186005|P3|STARTED|Overall Study|Intent-to-treat|89
77291|NCT01430403|186006|P2|STARTED|Overall Study|Intent-to-treat|130
77292|NCT01430403|186007|P1|STARTED|Overall Study|Intent-to-treat|259
77293|NCT01430325|186060|P4|NOT COMPLETED|Overall Study||0
77294|NCT01430325|186061|P3|NOT COMPLETED|Overall Study||0
77295|NCT01430325|186062|P2|NOT COMPLETED|Overall Study||0
77296|NCT01430325|186063|P1|NOT COMPLETED|Overall Study||0
77297|NCT01430325|186060|P4|COMPLETED|Overall Study||12
77298|NCT01430325|186061|P3|COMPLETED|Overall Study||8
77299|NCT01430325|186062|P2|COMPLETED|Overall Study||12
77300|NCT01430325|186063|P1|COMPLETED|Overall Study||10
77301|NCT01430325|186060|P4|STARTED|Overall Study||12
77302|NCT01430325|186061|P3|STARTED|Overall Study||8
77303|NCT01430325|186062|P2|STARTED|Overall Study||12
77304|NCT01430325|186063|P1|STARTED|Overall Study||10
77305|NCT01430182|186083|P2|NOT COMPLETED|Overall Study||0
77306|NCT01430182|186084|P1|NOT COMPLETED|Overall Study||0
77307|NCT01430182|186083|P2|COMPLETED|Overall Study||8
77308|NCT01430182|186084|P1|COMPLETED|Overall Study||9
77309|NCT01430182|186083|P2|STARTED|Overall Study||8
77310|NCT01430182|186084|P1|STARTED|Overall Study||9
77311|NCT01430169|186090|P1|NOT COMPLETED|Overall Study||0
77312|NCT01430169|186090|P1|COMPLETED|Overall Study||20
77313|NCT01430169|186090|P1|STARTED|Overall Study||20
77314|NCT01430130|186105|P1|NOT COMPLETED|Overall Study||2
77315|NCT01430130|186105|P1|COMPLETED|Overall Study||10
77316|NCT01430130|186105|P1|STARTED|Overall Study||12
77317|NCT01430104|186111|P1|NOT COMPLETED|28-Day Teriparatide Treatment Period||1
77318|NCT01430104|186111|P1|COMPLETED|28-Day Teriparatide Treatment Period||28
77319|NCT01430104|186111|P1|Received at Least 1 Dose of Teriparatide|28-Day Teriparatide Treatment Period||29
77320|NCT01430104|186111|P1|STARTED|28-Day Teriparatide Treatment Period|1 participant withdrew from the study after completing the 14-day Lead-in Period.|29
77321|NCT01430104|186111|P1|NOT COMPLETED|14-Day Lead-In Period||0
77322|NCT01430104|186111|P1|COMPLETED|14-Day Lead-In Period||30
77323|NCT01430104|186111|P1|STARTED|14-Day Lead-In Period||30
77324|NCT01430091|186123|P1|NOT COMPLETED|Overall Study||0
77325|NCT01430091|186123|P1|COMPLETED|Overall Study||18
77326|NCT01430091|186123|P1|STARTED|Overall Study||18
77327|NCT01429623|186147|P2|NOT COMPLETED|Overall Study||59
77328|NCT01429623|186148|P1|NOT COMPLETED|Overall Study||51
77329|NCT01429623|186147|P2|COMPLETED|Overall Study||48
77330|NCT01429623|186148|P1|COMPLETED|Overall Study||51
77331|NCT01429623|186147|P2|Converted to Alzheimer's|Overall Study|21 of 103|21
77332|NCT01429623|186148|P1|Converted to Alzheimer's|Overall Study|14 of 99|14
77333|NCT01429623|186147|P2|STARTED|Overall Study|107 allocated, 4 lacked post baseline data|107
77334|NCT01429623|186148|P1|STARTED|Overall Study|103 allocated, 1 withdrew consent prior to first dose, 4 lacked post baseline data|102
77335|NCT01429584|186162|P2|NOT COMPLETED|Overall Study||1
77336|NCT01429584|186163|P1|NOT COMPLETED|Overall Study||1
77337|NCT01429584|186162|P2|COMPLETED|Overall Study||14
77338|NCT01429584|186163|P1|COMPLETED|Overall Study||14
77339|NCT01429584|186162|P2|STARTED|Overall Study||15
77340|NCT01429584|186163|P1|STARTED|Overall Study||15
77341|NCT01429532|186176|P3|NOT COMPLETED|Overall Study||0
77342|NCT01429532|186177|P2|NOT COMPLETED|Overall Study||0
77343|NCT01429532|186178|P1|NOT COMPLETED|Overall Study||0
77344|NCT01429532|186176|P3|COMPLETED|Overall Study||40
77345|NCT01429532|186177|P2|COMPLETED|Overall Study||40
77346|NCT01429532|186178|P1|COMPLETED|Overall Study||40
77347|NCT01429532|186176|P3|STARTED|Overall Study||40
77348|NCT01429532|186177|P2|STARTED|Overall Study||40
77349|NCT01429532|186178|P1|STARTED|Overall Study||40
77350|NCT01429441|186194|P2|NOT COMPLETED|Overall Study||23
77351|NCT01429441|186195|P1|NOT COMPLETED|Overall Study||38
77352|NCT01429441|186194|P2|COMPLETED|Overall Study||51
77353|NCT01429441|186195|P1|COMPLETED|Overall Study||108
77354|NCT01429441|186194|P2|STARTED|Overall Study||74
77355|NCT01429441|186195|P1|STARTED|Overall Study||146
77356|NCT01429259|186203|P1|NOT COMPLETED|Overall Study||0
77357|NCT01429259|186203|P1|COMPLETED|Overall Study||30
77358|NCT01429259|186203|P1|STARTED|Overall Study||30
77359|NCT01429077|186210|P2|NOT COMPLETED|Overall Study||3
77360|NCT01429077|186211|P1|NOT COMPLETED|Overall Study||0
77361|NCT01429077|186210|P2|COMPLETED|Overall Study||14
77362|NCT01429077|186211|P1|COMPLETED|Overall Study||19
77363|NCT01429077|186210|P2|Completed 6-week Intervention|Overall Study||17
77364|NCT01429077|186211|P1|Completed 6-week Intervention|Overall Study||19
77365|NCT01429077|186210|P2|STARTED|Overall Study||17
77366|NCT01429077|186211|P1|STARTED|Overall Study||19
77367|NCT01429064|186221|P4|NOT COMPLETED|Overall Study||0
77368|NCT01429064|186222|P3|NOT COMPLETED|Overall Study||0
77369|NCT01429064|186223|P2|NOT COMPLETED|Overall Study||0
77370|NCT01429064|186224|P1|NOT COMPLETED|Overall Study||0
77371|NCT01429064|186221|P4|COMPLETED|Overall Study||16
77372|NCT01429064|186222|P3|COMPLETED|Overall Study||19
77373|NCT01429064|186223|P2|COMPLETED|Overall Study||22
77374|NCT01429064|186224|P1|COMPLETED|Overall Study||19
77375|NCT01429064|186221|P4|STARTED|Overall Study||16
77376|NCT01429064|186222|P3|STARTED|Overall Study||19
77377|NCT01429064|186223|P2|STARTED|Overall Study||22
77378|NCT01429064|186224|P1|STARTED|Overall Study||19
77379|NCT01429051|186234|P1|NOT COMPLETED|Tolerability Phase||15
77380|NCT01429051|186234|P1|COMPLETED|Tolerability Phase||16
77381|NCT01429051|186234|P1|STARTED|Tolerability Phase|Participants entered directly from the Titration or Efficacy Phase|31
77382|NCT01429051|186234|P1|NOT COMPLETED|Efficacy Phase||2
77383|NCT01429051|186234|P1|COMPLETED|Efficacy Phase||13
77384|NCT01429051|186234|P1|STARTED|Efficacy Phase|Participants titrated to 200 or 400 μg INFS in Titration Phase|15
77385|NCT01429051|186234|P1|NOT COMPLETED|Titration Phase||12
77386|NCT01429051|186234|P1|COMPLETED|Titration Phase||33
77387|NCT01429051|186234|P1|STARTED|Titration Phase||45
77388|NCT01428882|186257|P2|NOT COMPLETED|Overall Study||10
77389|NCT01428882|186258|P1|NOT COMPLETED|Overall Study||6
77390|NCT01428882|186257|P2|COMPLETED|Overall Study||58
77391|NCT01428882|186258|P1|COMPLETED|Overall Study||61
77392|NCT01428882|186257|P2|STARTED|Overall Study||68
77393|NCT01428882|186258|P1|STARTED|Overall Study||67
77394|NCT01428765|186270|P1|NOT COMPLETED|Overall Study||0
77395|NCT01428765|186270|P1|COMPLETED|Overall Study||1063
77396|NCT01428765|186270|P1|STARTED|Overall Study||1063
77397|NCT01428713|186281|P2|NOT COMPLETED|Overall Study||5
77398|NCT01428713|186282|P1|NOT COMPLETED|Overall Study||3
77399|NCT01428713|186281|P2|COMPLETED|Overall Study||3
77400|NCT01428713|186282|P1|COMPLETED|Overall Study||6
77401|NCT01428713|186281|P2|STARTED|Overall Study||8
77402|NCT01428713|186282|P1|STARTED|Overall Study||9
77403|NCT01428661|186291|P3|NOT COMPLETED|Open Label Extension||320
77404|NCT01428661|186292|P2|NOT COMPLETED|Open Label Extension||0
77405|NCT01428661|186293|P1|NOT COMPLETED|Open Label Extension||0
77406|NCT01428661|186291|P3|COMPLETED|Open Label Extension||19
77407|NCT01428661|186292|P2|COMPLETED|Open Label Extension|Does not apply.|0
77408|NCT01428661|186293|P1|COMPLETED|Open Label Extension|Does not apply.|0
77409|NCT01428661|186291|P3|STARTED|Open Label Extension||339
77410|NCT01428661|186292|P2|STARTED|Open Label Extension|Does not apply.|0
77411|NCT01428661|186293|P1|STARTED|Open Label Extension|Does not apply.|0
77412|NCT01428661|186291|P3|NOT COMPLETED|Double-Masked Phase||0
77413|NCT01428661|186292|P2|NOT COMPLETED|Double-Masked Phase||49
77414|NCT01428661|186293|P1|NOT COMPLETED|Double-Masked Phase||57
77415|NCT01428661|186291|P3|COMPLETED|Double-Masked Phase|Does not apply.|0
77416|NCT01428661|186292|P2|COMPLETED|Double-Masked Phase||204
77417|NCT01428661|186293|P1|COMPLETED|Double-Masked Phase||197
77418|NCT01428661|186291|P3|STARTED|Double-Masked Phase|Does not apply.|0
77419|NCT01428661|186292|P2|STARTED|Double-Masked Phase||253
77420|NCT01428661|186293|P1|STARTED|Double-Masked Phase||254
77421|NCT01428583|186301|P1|NOT COMPLETED|Overall Study||237
77422|NCT01428583|186301|P1|COMPLETED|Overall Study||158
77423|NCT01428583|186301|P1|STARTED|Overall Study||395
77424|NCT01428336|186325|P2|NOT COMPLETED|Overall Study||0
77425|NCT01428336|186326|P1|NOT COMPLETED|Overall Study||0
77426|NCT01428336|186325|P2|COMPLETED|Overall Study||12
77427|NCT01428336|186326|P1|COMPLETED|Overall Study||10
77428|NCT01428336|186325|P2|STARTED|Overall Study||12
77429|NCT01428336|186326|P1|STARTED|Overall Study||10
77430|NCT01428258|186338|P2|NOT COMPLETED|Intervention 2||0
77431|NCT01428258|186339|P1|NOT COMPLETED|Intervention 2||0
77432|NCT01428258|186338|P2|COMPLETED|Intervention 2||15
77433|NCT01428258|186339|P1|COMPLETED|Intervention 2||15
77434|NCT01428258|186338|P2|STARTED|Intervention 2||15
77435|NCT01428258|186339|P1|STARTED|Intervention 2||15
77436|NCT01428258|186338|P2|NOT COMPLETED|Intervention 1||0
77437|NCT01428258|186339|P1|NOT COMPLETED|Intervention 1||2
77438|NCT01428258|186338|P2|COMPLETED|Intervention 1||15
77439|NCT01428258|186339|P1|COMPLETED|Intervention 1||15
77440|NCT01428258|186338|P2|STARTED|Intervention 1||15
77441|NCT01428258|186339|P1|STARTED|Intervention 1||17
77442|NCT01428219|186357|P1|NOT COMPLETED|Overall Study||0
77443|NCT01428219|186357|P1|COMPLETED|Overall Study||25
77444|NCT01428219|186357|P1|STARTED|Overall Study||25
77445|NCT01428128|186361|P1|NOT COMPLETED|Overall Study||17
77446|NCT01428128|186361|P1|COMPLETED|Overall Study||33
77447|NCT01428128|186361|P1|STARTED|Overall Study||50
77448|NCT01428115|186365|P1|NOT COMPLETED|Overall Study||21
77449|NCT01428115|186365|P1|COMPLETED|Overall Study||62
77450|NCT01428115|186365|P1|STARTED|Overall Study||83
77451|NCT01428076|186380|P2|NOT COMPLETED|Overall Study||1
77452|NCT01428076|186381|P1|NOT COMPLETED|Overall Study||0
77453|NCT01428076|186380|P2|COMPLETED|Overall Study||11
77454|NCT01428076|186381|P1|COMPLETED|Overall Study||9
77455|NCT01428076|186380|P2|STARTED|Overall Study||12
77456|NCT01428076|186381|P1|STARTED|Overall Study||9
77457|NCT01428063|186392|P3|NOT COMPLETED|Overall Study||1
77458|NCT01428063|186393|P2|NOT COMPLETED|Overall Study||10
77459|NCT01428063|186394|P1|NOT COMPLETED|Overall Study||10
77460|NCT01428063|186392|P3|COMPLETED|Overall Study||5
77461|NCT01428063|186393|P2|COMPLETED|Overall Study||112
77462|NCT01428063|186394|P1|COMPLETED|Overall Study||89
77463|NCT01428063|186392|P3|STARTED|Overall Study||6
77464|NCT01428063|186393|P2|STARTED|Overall Study||122
77465|NCT01428063|186394|P1|STARTED|Overall Study||99
77466|NCT01427933|186465|P2|NOT COMPLETED|Overall Study||13
77467|NCT01427933|186466|P1|NOT COMPLETED|Overall Study||8
77468|NCT01427933|186465|P2|COMPLETED|Overall Study||57
77469|NCT01427933|186466|P1|COMPLETED|Overall Study||63
77470|NCT01427933|186465|P2|Received at Least 1 Dose of Study Drug|Overall Study||65
77471|NCT01427933|186466|P1|Received at Least 1 Dose of Study Drug|Overall Study||69
77472|NCT01427933|186465|P2|STARTED|Overall Study||70
77473|NCT01427933|186466|P1|STARTED|Overall Study||71
77474|NCT01427920|186486|P2|NOT COMPLETED|Overall Study||17
77475|NCT01427920|186487|P1|NOT COMPLETED|Overall Study||9
77476|NCT01427920|186486|P2|COMPLETED|Overall Study||157
77477|NCT01427920|186487|P1|COMPLETED|Overall Study||165
77478|NCT01427920|186486|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|173
77479|NCT01427920|186487|P1|Exposed|Overall Study||174
77480|NCT01427920|186486|P2|STARTED|Overall Study||174
77481|NCT01427920|186487|P1|STARTED|Overall Study||174
77482|NCT01427907|186507|P2|NOT COMPLETED|Overall Study||4
77483|NCT01427907|186508|P1|NOT COMPLETED|Overall Study||3
77484|NCT01427907|186507|P2|COMPLETED|Overall Study|Completed study|14
77485|NCT01427907|186508|P1|COMPLETED|Overall Study|Completed study|17
77486|NCT01427907|186507|P2|STARTED|Overall Study|Randomized|18
77487|NCT01427907|186508|P1|STARTED|Overall Study|Randomized|20
77488|NCT01427881|186514|P1|NOT COMPLETED|Overall Study||0
77489|NCT01427881|186514|P1|COMPLETED|Overall Study||43
77490|NCT01427881|186514|P1|STARTED|Overall Study||43
77491|NCT01427803|186529|P2|NOT COMPLETED|Overall Study||26
77492|NCT01427803|186530|P1|NOT COMPLETED|Overall Study||63
77493|NCT01427803|186529|P2|COMPLETED|Overall Study|130 participants interviewed. Remaining subjects continued in trial to collect safety information.|226
77494|NCT01427803|186530|P1|COMPLETED|Overall Study||463
77495|NCT01427803|186529|P2|Took Product|Overall Study|Those who took at least one dose of investigational product as logged in e diary & 1 on Health Log.|237
77496|NCT01427803|186530|P1|Took Product|Overall Study|Those who took at least one dose of investigational product. Only 502 qualified for data analysis.|508
77497|NCT01427803|186529|P2|Baseline Assessment|Overall Study|only interviewed participants were assessed|130
77498|NCT01427803|186530|P1|Baseline Assessment|Overall Study||516
77499|NCT01427803|186529|P2|Purchased Product|Overall Study||252
77500|NCT01427803|186530|P1|Purchased Product|Overall Study|Only 516 participants used e-diary|525
77501|NCT01427803|186529|P2|STARTED|Overall Study||252
77502|NCT01427803|186530|P1|STARTED|Overall Study||526
77503|NCT01427751|186544|P2|NOT COMPLETED|Overall Study||14
77504|NCT01427751|186545|P1|NOT COMPLETED|Overall Study||42
77505|NCT01427751|186544|P2|COMPLETED|Overall Study||139
77506|NCT01427751|186545|P1|COMPLETED|Overall Study||112
77507|NCT01427751|186544|P2|STARTED|Overall Study||153
77508|NCT01427751|186545|P1|STARTED|Overall Study||154
77509|NCT01427738|186565|P2|NOT COMPLETED|Overall Study||21
77510|NCT01427738|186566|P1|NOT COMPLETED|Overall Study||19
77511|NCT01427738|186565|P2|COMPLETED|Overall Study||90
77512|NCT01427738|186566|P1|COMPLETED|Overall Study||91
77513|NCT01427738|186565|P2|STARTED|Overall Study||111
77514|NCT01427738|186566|P1|STARTED|Overall Study||110
77515|NCT01427517|186587|P3|NOT COMPLETED|Overall Study||0
77516|NCT01427517|186588|P2|NOT COMPLETED|Overall Study||0
77517|NCT01427517|186589|P1|NOT COMPLETED|Overall Study||0
77518|NCT01427517|186587|P3|COMPLETED|Overall Study||3
77519|NCT01427517|186588|P2|COMPLETED|Overall Study||3
77520|NCT01427517|186589|P1|COMPLETED|Overall Study||3
77521|NCT01427517|186587|P3|STARTED|Overall Study||3
77522|NCT01427517|186588|P2|STARTED|Overall Study||3
77523|NCT01427517|186589|P1|STARTED|Overall Study||3
77524|NCT01427504|186603|P6|NOT COMPLETED|Overall Study||2
77525|NCT01427504|186604|P5|NOT COMPLETED|Overall Study||1
77526|NCT01427504|186605|P4|NOT COMPLETED|Overall Study||1
77527|NCT01427504|186606|P3|NOT COMPLETED|Overall Study||1
77528|NCT01427504|186607|P2|NOT COMPLETED|Overall Study||1
77529|NCT01427504|186608|P1|NOT COMPLETED|Overall Study||0
77530|NCT01427504|186603|P6|COMPLETED|Overall Study||4
77531|NCT01427504|186604|P5|COMPLETED|Overall Study||2
77532|NCT01427504|186605|P4|COMPLETED|Overall Study||5
77533|NCT01427504|186606|P3|COMPLETED|Overall Study||3
77534|NCT01427504|186607|P2|COMPLETED|Overall Study||2
77535|NCT01427504|186608|P1|COMPLETED|Overall Study||4
77536|NCT01427504|186603|P6|Received Combination|Overall Study||6
77537|NCT01427504|186604|P5|Received Combination|Overall Study||3
77538|NCT01427504|186605|P4|Received Combination|Overall Study||6
77539|NCT01427504|186606|P3|Received Combination|Overall Study||3
77540|NCT01427504|186607|P2|Received Combination|Overall Study||3
77541|NCT01427504|186608|P1|Received Combination|Overall Study||4
77542|NCT01427504|186603|P6|Received Etravirine|Overall Study||4
77543|NCT01427504|186604|P5|Received Etravirine|Overall Study||2
77544|NCT01427504|186605|P4|Received Etravirine|Overall Study||6
77545|NCT01427504|186606|P3|Received Etravirine|Overall Study||4
77546|NCT01427504|186607|P2|Received Etravirine|Overall Study||2
77547|NCT01427504|186608|P1|Received Etravirine|Overall Study||4
77548|NCT01427504|186603|P6|Received Boceprevir|Overall Study||4
77549|NCT01427504|186604|P5|Received Boceprevir|Overall Study||2
77550|NCT01427504|186605|P4|Received Boceprevir|Overall Study||5
77551|NCT01427504|186606|P3|Received Boceprevir|Overall Study||3
77552|NCT01427504|186607|P2|Received Boceprevir|Overall Study||3
77553|NCT01427504|186608|P1|Received Boceprevir|Overall Study||4
77554|NCT01427504|186603|P6|STARTED|Overall Study||6
77555|NCT01427504|186604|P5|STARTED|Overall Study||3
77556|NCT01427504|186605|P4|STARTED|Overall Study||6
77557|NCT01427504|186606|P3|STARTED|Overall Study||4
77558|NCT01427504|186607|P2|STARTED|Overall Study||3
77559|NCT01427504|186608|P1|STARTED|Overall Study||4
77560|NCT01427309|186629|P4|NOT COMPLETED|Overall Study||376
77561|NCT01427309|186630|P3|NOT COMPLETED|Overall Study||361
77562|NCT01427309|186631|P2|NOT COMPLETED|Overall Study||407
77563|NCT01427309|186632|P1|NOT COMPLETED|Overall Study||372
77564|NCT01427309|186629|P4|COMPLETED|Overall Study||8373
77565|NCT01427309|186630|P3|COMPLETED|Overall Study||8376
77566|NCT01427309|186631|P2|COMPLETED|Overall Study||6837
77567|NCT01427309|186632|P1|COMPLETED|Overall Study||6881
77568|NCT01427309|186629|P4|STARTED|Overall Study||8749
77569|NCT01427309|186630|P3|STARTED|Overall Study||8737
77570|NCT01427309|186631|P2|STARTED|Overall Study||7244
77571|NCT01427309|186632|P1|STARTED|Overall Study||7253
77572|NCT01426958|186670|P1|NOT COMPLETED|Overall Study||2
77573|NCT01426958|186670|P1|COMPLETED|Overall Study||22
77574|NCT01426958|186670|P1|STARTED|Overall Study||24
77575|NCT01426867|186687|P3|NOT COMPLETED|Overall Study||0
77576|NCT01426867|186688|P2|NOT COMPLETED|Overall Study||0
77577|NCT01426867|186689|P1|NOT COMPLETED|Overall Study||0
77578|NCT01426867|186687|P3|COMPLETED|Overall Study||34
77579|NCT01426867|186688|P2|COMPLETED|Overall Study||34
77580|NCT01426867|186689|P1|COMPLETED|Overall Study||33
77581|NCT01426867|186687|P3|STARTED|Overall Study||34
77582|NCT01426867|186688|P2|STARTED|Overall Study||34
77583|NCT01426867|186689|P1|STARTED|Overall Study||33
77584|NCT01426854|186699|P2|NOT COMPLETED|Overall Study||31
77585|NCT01426854|186700|P1|NOT COMPLETED|Overall Study||12
77586|NCT01426854|186699|P2|COMPLETED|Overall Study||98
77587|NCT01426854|186700|P1|COMPLETED|Overall Study||119
77588|NCT01426854|186699|P2|STARTED|Overall Study||129
77589|NCT01426854|186700|P1|STARTED|Overall Study||131
77590|NCT01426789|186710|P6|NOT COMPLETED|Part 2||0
77591|NCT01426789|186711|P5|NOT COMPLETED|Part 2||8
77592|NCT01426789|186712|P4|NOT COMPLETED|Part 2||1
77593|NCT01426789|186713|P3|NOT COMPLETED|Part 2||15
77594|NCT01426789|186714|P2|NOT COMPLETED|Part 2||0
77595|NCT01426789|186715|P1|NOT COMPLETED|Part 2||0
77596|NCT01426789|186710|P6|COMPLETED|Part 2||1
77597|NCT01426789|186711|P5|COMPLETED|Part 2||19
77598|NCT01426789|186712|P4|COMPLETED|Part 2||12
77599|NCT01426789|186713|P3|COMPLETED|Part 2||34
77600|NCT01426789|186714|P2|COMPLETED|Part 2||0
77601|NCT01426789|186715|P1|COMPLETED|Part 2||0
77602|NCT01426789|186710|P6|STARTED|Part 2||1
77603|NCT01426789|186711|P5|STARTED|Part 2||27
77604|NCT01426789|186712|P4|STARTED|Part 2||13
77605|NCT01426789|186713|P3|STARTED|Part 2||49
77606|NCT01426789|186714|P2|STARTED|Part 2||0
77607|NCT01426789|186715|P1|STARTED|Part 2||0
77608|NCT01426789|186710|P6|NOT COMPLETED|Part 1||0
77609|NCT01426789|186711|P5|NOT COMPLETED|Part 1||0
77610|NCT01426789|186712|P4|NOT COMPLETED|Part 1||0
77611|NCT01426789|186713|P3|NOT COMPLETED|Part 1||0
77612|NCT01426789|186714|P2|NOT COMPLETED|Part 1||4
77613|NCT01426789|186715|P1|NOT COMPLETED|Part 1||6
77614|NCT01426789|186710|P6|COMPLETED|Part 1||0
77615|NCT01426789|186711|P5|COMPLETED|Part 1||0
77616|NCT01426789|186712|P4|COMPLETED|Part 1||0
77617|NCT01426789|186713|P3|COMPLETED|Part 1||0
77618|NCT01426789|186714|P2|COMPLETED|Part 1||28
77619|NCT01426789|186715|P1|COMPLETED|Part 1||62
77620|NCT01426789|186710|P6|STARTED|Part 1||0
77621|NCT01426789|186711|P5|STARTED|Part 1||0
77622|NCT01426789|186712|P4|STARTED|Part 1||0
77623|NCT01426789|186713|P3|STARTED|Part 1||0
77624|NCT01426789|186714|P2|STARTED|Part 1||32
77625|NCT01426789|186715|P1|STARTED|Part 1||68
77626|NCT01426763|186731|P2|NOT COMPLETED|Overall Study||0
77627|NCT01426763|186732|P1|NOT COMPLETED|Overall Study||0
77628|NCT01426763|186731|P2|COMPLETED|Overall Study||6
77629|NCT01426763|186732|P1|COMPLETED|Overall Study||6
77630|NCT01426763|186731|P2|STARTED|Overall Study||6
77631|NCT01426763|186732|P1|STARTED|Overall Study||6
77632|NCT01426555|186740|P2|NOT COMPLETED|Overall Study||15
77633|NCT01426555|186741|P1|NOT COMPLETED|Overall Study||18
77634|NCT01426555|186740|P2|COMPLETED|Overall Study||20
77635|NCT01426555|186741|P1|COMPLETED|Overall Study||17
77636|NCT01426555|186740|P2|STARTED|Overall Study||35
77637|NCT01426555|186741|P1|STARTED|Overall Study||35
77638|NCT01426516|186751|P2|NOT COMPLETED|Overall Study||0
77639|NCT01426516|186752|P1|NOT COMPLETED|Overall Study||0
77640|NCT01426516|186751|P2|COMPLETED|Overall Study||17
77641|NCT01426516|186752|P1|COMPLETED|Overall Study||12
77642|NCT01426516|186751|P2|STARTED|Overall Study||17
77643|NCT01426516|186752|P1|STARTED|Overall Study||12
77644|NCT01426438|186760|P2|NOT COMPLETED|Overall Study||10
77645|NCT01426438|186761|P1|NOT COMPLETED|Overall Study||15
77646|NCT01426438|186760|P2|COMPLETED|Overall Study||39
77647|NCT01426438|186761|P1|COMPLETED|Overall Study||35
77648|NCT01426438|186760|P2|STARTED|Overall Study||49
77649|NCT01426438|186761|P1|STARTED|Overall Study||50
77650|NCT01426425|186793|P1|NOT COMPLETED|Overall Study||175
77651|NCT01426425|186793|P1|COMPLETED|Overall Study|The pre-specified modified intent-to-treat analysis set was used for the primary objectives.|397
77652|NCT01426425|186793|P1|Intent to Treat|Overall Study|Met all inclusion and no exclusion criteria.|399
77653|NCT01426425|186793|P1|EP Study|Overall Study|EP study used to assess inclusion and exclusion criteria.|550
77654|NCT01426425|186793|P1|STARTED|Overall Study||572
77655|NCT01426373|186799|P1|NOT COMPLETED|Overall Study||34
77656|NCT01426373|186799|P1|COMPLETED|Overall Study|Completed the last follow-up visit 12 months after last treatment|131
77657|NCT01426373|186799|P1|STARTED|Overall Study||165
77658|NCT01426360|186817|P2|NOT COMPLETED|Overall Study||0
77659|NCT01426360|186818|P1|NOT COMPLETED|Overall Study||0
77660|NCT01426360|186817|P2|COMPLETED|Overall Study||41
77661|NCT01426360|186818|P1|COMPLETED|Overall Study||38
77662|NCT01426360|186817|P2|STARTED|Overall Study||41
77663|NCT01426360|186818|P1|STARTED|Overall Study||38
77664|NCT01426347|186832|P2|NOT COMPLETED|Overall Study||3
77665|NCT01426347|186833|P1|NOT COMPLETED|Overall Study||7
77666|NCT01426347|186832|P2|COMPLETED|Overall Study||39
77667|NCT01426347|186833|P1|COMPLETED|Overall Study||34
77668|NCT01426347|186832|P2|STARTED|Overall Study||42
77669|NCT01426347|186833|P1|STARTED|Overall Study||41
77670|NCT01426269|186841|P3|NOT COMPLETED|Period 2: 40 Weeks||47
77671|NCT01426269|186842|P2|NOT COMPLETED|Period 2: 40 Weeks||38
77672|NCT01426269|186843|P1|NOT COMPLETED|Period 2: 40 Weeks||0
77673|NCT01426269|186841|P3|COMPLETED|Period 2: 40 Weeks||18
77674|NCT01426269|186842|P2|COMPLETED|Period 2: 40 Weeks||27
77675|NCT01426269|186843|P1|COMPLETED|Period 2: 40 Weeks||0
77676|NCT01426269|186841|P3|STARTED|Period 2: 40 Weeks||65
77677|NCT01426269|186842|P2|STARTED|Period 2: 40 Weeks||65
77678|NCT01426269|186843|P1|STARTED|Period 2: 40 Weeks||0
77679|NCT01426269|186841|P3|NOT COMPLETED|Eligibility for Period 2, Randomization||0
77680|NCT01426269|186842|P2|NOT COMPLETED|Eligibility for Period 2, Randomization||0
77681|NCT01426269|186843|P1|NOT COMPLETED|Eligibility for Period 2, Randomization||50
77682|NCT01426269|186841|P3|COMPLETED|Eligibility for Period 2, Randomization||0
77683|NCT01426269|186842|P2|COMPLETED|Eligibility for Period 2, Randomization||0
77684|NCT01426269|186843|P1|COMPLETED|Eligibility for Period 2, Randomization||130
77685|NCT01426269|186841|P3|STARTED|Eligibility for Period 2, Randomization||0
77686|NCT01426269|186842|P2|STARTED|Eligibility for Period 2, Randomization||0
77687|NCT01426269|186843|P1|STARTED|Eligibility for Period 2, Randomization||180
77688|NCT01426269|186841|P3|NOT COMPLETED|Period 1: 12 Weeks||0
77689|NCT01426269|186842|P2|NOT COMPLETED|Period 1: 12 Weeks||0
77690|NCT01426269|186843|P1|NOT COMPLETED|Period 1: 12 Weeks||55
77691|NCT01426269|186841|P3|COMPLETED|Period 1: 12 Weeks||0
77692|NCT01426269|186842|P2|COMPLETED|Period 1: 12 Weeks||0
77693|NCT01426269|186843|P1|COMPLETED|Period 1: 12 Weeks||180
77694|NCT01426269|186841|P3|STARTED|Period 1: 12 Weeks||0
77695|NCT01426269|186842|P2|STARTED|Period 1: 12 Weeks||0
77696|NCT01426269|186843|P1|STARTED|Period 1: 12 Weeks||235
77697|NCT01426230|186870|P2|NOT COMPLETED|Overall Study||27
77698|NCT01426230|186871|P1|NOT COMPLETED|Overall Study||31
77699|NCT01426230|186870|P2|COMPLETED|Overall Study||84
77700|NCT01426230|186871|P1|COMPLETED|Overall Study||55
77701|NCT01426230|186870|P2|STARTED|Overall Study||111
77702|NCT01426230|186871|P1|STARTED|Overall Study|90 patients were enrolled, but only 86 received study treatment.|86
77703|NCT01426113|186878|P2|NOT COMPLETED|Overall Study||2
77704|NCT01426113|186879|P1|NOT COMPLETED|Overall Study||1
77705|NCT01426113|186878|P2|COMPLETED|Overall Study||1
77706|NCT01426113|186879|P1|COMPLETED|Overall Study||2
77707|NCT01426113|186878|P2|STARTED|Overall Study||3
77708|NCT01426113|186879|P1|STARTED|Overall Study||3
77709|NCT01425879|186885|P1|NOT COMPLETED|Overall Study||0
77710|NCT01425879|186885|P1|COMPLETED|Overall Study||8
77711|NCT01425879|186885|P1|STARTED|Overall Study||8
77712|NCT01425853|186894|P2|NOT COMPLETED|Overall Study||77
77713|NCT01425853|186895|P1|NOT COMPLETED|Overall Study||64
77714|NCT01425853|186894|P2|COMPLETED|Overall Study||225
77715|NCT01425853|186895|P1|COMPLETED|Overall Study||240
77716|NCT01425853|186894|P2|Per Protocol (PP)|Overall Study||258
77717|NCT01425853|186895|P1|Per Protocol (PP)|Overall Study||264
77718|NCT01425853|186894|P2|Safety Population|Overall Study||299
77719|NCT01425853|186895|P1|Safety Population|Overall Study||304
77720|NCT01425853|186894|P2|STARTED|Overall Study||302
77721|NCT01425853|186895|P1|STARTED|Overall Study||304
77722|NCT01425814|186925|P6|NOT COMPLETED|Period 5||1
77723|NCT01425814|186926|P5|NOT COMPLETED|Period 5||0
77724|NCT01425814|186927|P4|NOT COMPLETED|Period 5||0
77725|NCT01425814|186928|P3|NOT COMPLETED|Period 5||1
77726|NCT01425814|186929|P2|NOT COMPLETED|Period 5||0
77727|NCT01425814|186930|P1|NOT COMPLETED|Period 5||0
77728|NCT01425814|186925|P6|COMPLETED|Period 5||11
77729|NCT01425814|186926|P5|COMPLETED|Period 5||12
77730|NCT01425814|186927|P4|COMPLETED|Period 5||10
77731|NCT01425814|186928|P3|COMPLETED|Period 5||10
77732|NCT01425814|186929|P2|COMPLETED|Period 5||9
77733|NCT01425814|186930|P1|COMPLETED|Period 5||11
77734|NCT01425814|186925|P6|STARTED|Period 5||12
77735|NCT01425814|186926|P5|STARTED|Period 5||12
77736|NCT01425814|186927|P4|STARTED|Period 5||10
77737|NCT01425814|186928|P3|STARTED|Period 5||11
77738|NCT01425814|186929|P2|STARTED|Period 5||9
77739|NCT01425814|186930|P1|STARTED|Period 5||11
77740|NCT01425814|186925|P6|NOT COMPLETED|Period 4||0
77741|NCT01425814|186926|P5|NOT COMPLETED|Period 4||0
77742|NCT01425814|186927|P4|NOT COMPLETED|Period 4||0
77743|NCT01425814|186928|P3|NOT COMPLETED|Period 4||1
77744|NCT01425814|186929|P2|NOT COMPLETED|Period 4||0
77745|NCT01425814|186930|P1|NOT COMPLETED|Period 4||1
77746|NCT01425814|186925|P6|COMPLETED|Period 4||12
77747|NCT01425814|186926|P5|COMPLETED|Period 4||12
77748|NCT01425814|186927|P4|COMPLETED|Period 4||10
77749|NCT01425814|186928|P3|COMPLETED|Period 4||11
77750|NCT01425814|186929|P2|COMPLETED|Period 4||9
77751|NCT01425814|186930|P1|COMPLETED|Period 4||11
77752|NCT01425814|186925|P6|STARTED|Period 4||12
77753|NCT01425814|186926|P5|STARTED|Period 4||12
77754|NCT01425814|186927|P4|STARTED|Period 4||10
77755|NCT01425814|186928|P3|STARTED|Period 4||12
77756|NCT01425814|186929|P2|STARTED|Period 4||9
77757|NCT01425814|186930|P1|STARTED|Period 4||12
77758|NCT01425814|186925|P6|NOT COMPLETED|Period 3||1
77759|NCT01425814|186926|P5|NOT COMPLETED|Period 3||0
77760|NCT01425814|186927|P4|NOT COMPLETED|Period 3||0
77761|NCT01425814|186928|P3|NOT COMPLETED|Period 3||0
77762|NCT01425814|186929|P2|NOT COMPLETED|Period 3||0
77763|NCT01425814|186930|P1|NOT COMPLETED|Period 3||0
77764|NCT01425814|186925|P6|COMPLETED|Period 3||12
77765|NCT01425814|186926|P5|COMPLETED|Period 3||12
77766|NCT01425814|186927|P4|COMPLETED|Period 3||10
77767|NCT01425814|186928|P3|COMPLETED|Period 3||12
77768|NCT01425814|186929|P2|COMPLETED|Period 3||9
77769|NCT01425814|186930|P1|COMPLETED|Period 3||12
77770|NCT01425814|186925|P6|STARTED|Period 3||13
77771|NCT01425814|186926|P5|STARTED|Period 3||12
77772|NCT01425814|186927|P4|STARTED|Period 3||10
77773|NCT01425814|186928|P3|STARTED|Period 3||12
77774|NCT01425814|186929|P2|STARTED|Period 3||9
77775|NCT01425814|186930|P1|STARTED|Period 3||12
77776|NCT01425814|186925|P6|NOT COMPLETED|Period 2||0
77777|NCT01425814|186926|P5|NOT COMPLETED|Period 2||0
77778|NCT01425814|186927|P4|NOT COMPLETED|Period 2||0
77779|NCT01425814|186928|P3|NOT COMPLETED|Period 2||0
77780|NCT01425814|186929|P2|NOT COMPLETED|Period 2||1
77781|NCT01425814|186930|P1|NOT COMPLETED|Period 2||0
77782|NCT01425814|186925|P6|COMPLETED|Period 2||13
77783|NCT01425814|186926|P5|COMPLETED|Period 2||12
77784|NCT01425814|186927|P4|COMPLETED|Period 2||10
77785|NCT01425814|186928|P3|COMPLETED|Period 2||12
77786|NCT01425814|186929|P2|COMPLETED|Period 2||9
77787|NCT01425814|186930|P1|COMPLETED|Period 2||12
77788|NCT01425814|186925|P6|STARTED|Period 2||13
77789|NCT01425814|186926|P5|STARTED|Period 2||12
77790|NCT01425814|186927|P4|STARTED|Period 2||10
77791|NCT01425814|186928|P3|STARTED|Period 2||12
77792|NCT01425814|186929|P2|STARTED|Period 2||10
77793|NCT01425814|186930|P1|STARTED|Period 2||12
77794|NCT01425814|186925|P6|NOT COMPLETED|Period 1||0
77795|NCT01425814|186926|P5|NOT COMPLETED|Period 1||0
77796|NCT01425814|186927|P4|NOT COMPLETED|Period 1||0
77797|NCT01425814|186928|P3|NOT COMPLETED|Period 1||0
77798|NCT01425814|186929|P2|NOT COMPLETED|Period 1||1
77799|NCT01425814|186930|P1|NOT COMPLETED|Period 1||0
77800|NCT01425814|186925|P6|COMPLETED|Period 1||13
77801|NCT01425814|186926|P5|COMPLETED|Period 1||12
77802|NCT01425814|186927|P4|COMPLETED|Period 1||10
77803|NCT01425814|186928|P3|COMPLETED|Period 1||12
77804|NCT01425814|186929|P2|COMPLETED|Period 1||10
77805|NCT01425814|186930|P1|COMPLETED|Period 1||12
77806|NCT01425814|186925|P6|STARTED|Period 1||13
77807|NCT01425814|186926|P5|STARTED|Period 1||12
77808|NCT01425814|186927|P4|STARTED|Period 1||10
77809|NCT01425814|186928|P3|STARTED|Period 1||12
77810|NCT01425814|186929|P2|STARTED|Period 1||11
77811|NCT01425814|186930|P1|STARTED|Period 1||12
77812|NCT01425749|187024|P2|NOT COMPLETED|Overall Study||1
77813|NCT01425749|187025|P1|NOT COMPLETED|Overall Study||0
77814|NCT01425749|187024|P2|COMPLETED|Overall Study||11
77815|NCT01425749|187025|P1|COMPLETED|Overall Study||13
77816|NCT01425749|187024|P2|STARTED|Overall Study||12
77817|NCT01425749|187025|P1|STARTED|Overall Study||13
77818|NCT01425632|187043|P3|NOT COMPLETED|Overall Study||4
77819|NCT01425632|187044|P2|NOT COMPLETED|Overall Study||1
77820|NCT01425632|187045|P1|NOT COMPLETED|Overall Study||1
77821|NCT01425632|187043|P3|COMPLETED|Overall Study||159
77822|NCT01425632|187044|P2|COMPLETED|Overall Study||165
77823|NCT01425632|187045|P1|COMPLETED|Overall Study||160
77824|NCT01425632|187043|P3|STARTED|Overall Study||163
77825|NCT01425632|187044|P2|STARTED|Overall Study||166
77826|NCT01425632|187045|P1|STARTED|Overall Study||161
77827|NCT01425528|187055|P2|NOT COMPLETED|Overall Study||1
77828|NCT01425528|187056|P1|NOT COMPLETED|Overall Study||1
77829|NCT01425528|187055|P2|COMPLETED|Overall Study||5
77830|NCT01425528|187056|P1|COMPLETED|Overall Study||5
77831|NCT01425528|187055|P2|STARTED|Overall Study||6
77832|NCT01425528|187056|P1|STARTED|Overall Study||6
77833|NCT01425463|187064|P2|NOT COMPLETED|Overall Study||24
77834|NCT01425463|187065|P1|NOT COMPLETED|Overall Study||24
77835|NCT01425463|187064|P2|COMPLETED|Overall Study||102
77836|NCT01425463|187065|P1|COMPLETED|Overall Study||106
77837|NCT01425463|187064|P2|Full Analysis Set|Overall Study||116
77838|NCT01425463|187065|P1|Full Analysis Set|Overall Study||122
77839|NCT01425463|187064|P2|Safety Set|Overall Study||122
77840|NCT01425463|187065|P1|Safety Set|Overall Study||126
77841|NCT01425463|187064|P2|STARTED|Overall Study||126
77842|NCT01425463|187065|P1|STARTED|Overall Study||130
77843|NCT01425359|187081|P2|NOT COMPLETED|Overall Study||22
77844|NCT01425359|187082|P1|NOT COMPLETED|Overall Study||19
77845|NCT01425359|187081|P2|COMPLETED|Overall Study||451
77846|NCT01425359|187082|P1|COMPLETED|Overall Study||457
77847|NCT01425359|187081|P2|STARTED|Overall Study||473
77848|NCT01425359|187082|P1|STARTED|Overall Study||476
77849|NCT01425307|187100|P2|NOT COMPLETED|Overall Study||19
77850|NCT01425307|187101|P1|NOT COMPLETED|Overall Study||19
77851|NCT01425307|187100|P2|COMPLETED|Overall Study|Treatment Phase: 41; 6-Month Follow-up:59|41
77852|NCT01425307|187101|P1|COMPLETED|Overall Study|Treatment Phase: 42; 6-Month Follow up: 58|42
77853|NCT01425307|187100|P2|STARTED|Overall Study|Randomized Sample: 60; Intention-to Treat Sample:60|60
77854|NCT01425307|187101|P1|STARTED|Overall Study|Randomized Sample: 61; Intention-to Treat Sample:61|61
77855|NCT01425268|187113|P2|NOT COMPLETED|Overall Study||0
77856|NCT01425268|187114|P1|NOT COMPLETED|Overall Study||8
77857|NCT01425268|187113|P2|COMPLETED|Overall Study||52
77858|NCT01425268|187114|P1|COMPLETED|Overall Study||98
77859|NCT01425268|187113|P2|STARTED|Overall Study|52 Subjects Randomized to Saline Arm / 52 Subjects Treated (Implanted)|52
77860|NCT01425268|187114|P1|STARTED|Overall Study|106 Subjects Randomized to AeroForm Arm / 98 Subjects Treated (Implanted)|106
77861|NCT01425229|187122|P1|NOT COMPLETED|Bosentan During Clarithromycin||0
77862|NCT01425229|187122|P1|COMPLETED|Bosentan During Clarithromycin||16
77863|NCT01425229|187122|P1|STARTED|Bosentan During Clarithromycin||16
77864|NCT01425229|187122|P1|NOT COMPLETED|Bosentan Steady-state||0
77865|NCT01425229|187122|P1|COMPLETED|Bosentan Steady-state||16
77866|NCT01425229|187122|P1|STARTED|Bosentan Steady-state||16
77867|NCT01425229|187122|P1|NOT COMPLETED|Bosentan Single Dose||0
77868|NCT01425229|187122|P1|COMPLETED|Bosentan Single Dose||16
77869|NCT01425229|187122|P1|STARTED|Bosentan Single Dose||16
77870|NCT01425203|187135|P3|NOT COMPLETED|Follow-up Phase||0
77871|NCT01425203|187136|P2|NOT COMPLETED|Follow-up Phase||0
77872|NCT01425203|187137|P1|NOT COMPLETED|Follow-up Phase||0
77873|NCT01425203|187135|P3|COMPLETED|Follow-up Phase||27
77874|NCT01425203|187136|P2|COMPLETED|Follow-up Phase||49
77875|NCT01425203|187137|P1|COMPLETED|Follow-up Phase||153
77876|NCT01425203|187135|P3|STARTED|Follow-up Phase|All participants treated in crossover arm entered follow-up.|27
77877|NCT01425203|187136|P2|STARTED|Follow-up Phase|27 starting treatment in PBO+PR Control arm switched to Crossover arm and 2 did not enter follow-up|49
77878|NCT01425203|187137|P1|STARTED|Follow-up Phase|6 participants who started treatment in RGT BOC + PR arm did not enter follow-up.|153
77879|NCT01425203|187135|P3|NOT COMPLETED|Crossover Phase||6
77880|NCT01425203|187136|P2|NOT COMPLETED|Crossover Phase||0
77881|NCT01425203|187137|P1|NOT COMPLETED|Crossover Phase||0
77882|NCT01425203|187135|P3|COMPLETED|Crossover Phase||21
77883|NCT01425203|187136|P2|COMPLETED|Crossover Phase||0
77884|NCT01425203|187137|P1|COMPLETED|Crossover Phase||0
77885|NCT01425203|187135|P3|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|27
77886|NCT01425203|187136|P2|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
77887|NCT01425203|187137|P1|STARTED|Crossover Phase|Phase only for participants in PBO + PR Control arm who failed futility rule at TW12 or 24|0
77888|NCT01425203|187135|P3|NOT COMPLETED|Treatment Phase||0
77889|NCT01425203|187136|P2|NOT COMPLETED|Treatment Phase||37
77890|NCT01425203|187137|P1|NOT COMPLETED|Treatment Phase||27
77891|NCT01425203|187135|P3|COMPLETED|Treatment Phase||0
77892|NCT01425203|187136|P2|COMPLETED|Treatment Phase||42
77893|NCT01425203|187137|P1|COMPLETED|Treatment Phase||132
77894|NCT01425203|187135|P3|Treated (FAS)|Treatment Phase||0
77895|NCT01425203|187136|P2|Treated (FAS)|Treatment Phase||78
77896|NCT01425203|187137|P1|Treated (FAS)|Treatment Phase||159
77897|NCT01425203|187135|P3|STARTED|Treatment Phase||0
77898|NCT01425203|187136|P2|STARTED|Treatment Phase||79
77899|NCT01425203|187137|P1|STARTED|Treatment Phase||159
77900|NCT01425190|187154|P3|NOT COMPLETED|Overall Study||0
77901|NCT01425190|187155|P2|NOT COMPLETED|Overall Study||0
77902|NCT01425190|187156|P1|NOT COMPLETED|Overall Study||1
77903|NCT01425190|187154|P3|COMPLETED|Overall Study||0
77904|NCT01425190|187155|P2|COMPLETED|Overall Study||0
77905|NCT01425190|187156|P1|COMPLETED|Overall Study||15
77906|NCT01425190|187154|P3|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 3.|0
77907|NCT01425190|187155|P2|STARTED|Overall Study|The study was terminated prior to enrolling participants in Cohort 2.|0
77908|NCT01425190|187156|P1|STARTED|Overall Study||16
77909|NCT01424943|187175|P2|NOT COMPLETED|Overall Study||1
77910|NCT01424943|187176|P1|NOT COMPLETED|Overall Study||13
77911|NCT01424943|187175|P2|COMPLETED|Overall Study||23
77912|NCT01424943|187176|P1|COMPLETED|Overall Study||12
77913|NCT01424943|187175|P2|STARTED|Overall Study||24
77914|NCT01424943|187176|P1|STARTED|Overall Study||25
77915|NCT01424930|187192|P2|NOT COMPLETED|Overall Study||14
77916|NCT01424930|187193|P1|NOT COMPLETED|Overall Study||4
77917|NCT01424930|187192|P2|COMPLETED|Overall Study||4
77918|NCT01424930|187193|P1|COMPLETED|Overall Study||3
77919|NCT01424930|187192|P2|Completed Food Safety Evaluation|Overall Study||18
77920|NCT01424930|187193|P1|Completed Food Safety Evaluation|Overall Study||6
77921|NCT01424930|187192|P2|STARTED|Overall Study||18
77922|NCT01424930|187193|P1|STARTED|Overall Study||7
77923|NCT01424813|187207|P2|NOT COMPLETED|Overall Study||2
77924|NCT01424813|187208|P1|NOT COMPLETED|Overall Study||5
77925|NCT01424813|187207|P2|COMPLETED|Overall Study||77
77926|NCT01424813|187208|P1|COMPLETED|Overall Study||74
77927|NCT01424813|187207|P2|Treated|Overall Study|Safety set and full analysis set|78
77928|NCT01424813|187208|P1|Treated|Overall Study|Safety set and full analysis set|79
77929|NCT01424813|187207|P2|STARTED|Overall Study||79
77930|NCT01424813|187208|P1|STARTED|Overall Study||79
77931|NCT01424644|187228|P2|NOT COMPLETED|Overall Study||27
77932|NCT01424644|187229|P1|NOT COMPLETED|Overall Study||33
77933|NCT01424644|187228|P2|COMPLETED|Overall Study||372
77934|NCT01424644|187229|P1|COMPLETED|Overall Study||369
77935|NCT01424644|187228|P2|STARTED|Overall Study||399
77936|NCT01424644|187229|P1|STARTED|Overall Study||402
77937|NCT01424501|187249|P6|NOT COMPLETED|Overall Study||0
77938|NCT01424501|187250|P5|NOT COMPLETED|Overall Study||0
77939|NCT01424501|187251|P4|NOT COMPLETED|Overall Study||0
77940|NCT01424501|187252|P3|NOT COMPLETED|Overall Study||2
77941|NCT01424501|187253|P2|NOT COMPLETED|Overall Study||1
77942|NCT01424501|187254|P1|NOT COMPLETED|Overall Study||1
77943|NCT01424501|187249|P6|COMPLETED|Overall Study||40
77944|NCT01424501|187250|P5|COMPLETED|Overall Study||40
77945|NCT01424501|187251|P4|COMPLETED|Overall Study||25
77946|NCT01424501|187252|P3|COMPLETED|Overall Study||22
77947|NCT01424501|187253|P2|COMPLETED|Overall Study||5
77948|NCT01424501|187254|P1|COMPLETED|Overall Study||6
77949|NCT01424501|187249|P6|STARTED|Overall Study||40
77950|NCT01424501|187250|P5|STARTED|Overall Study||40
77951|NCT01424501|187251|P4|STARTED|Overall Study||25
77952|NCT01424501|187252|P3|STARTED|Overall Study||24
77953|NCT01424501|187253|P2|STARTED|Overall Study||6
77954|NCT01424501|187254|P1|STARTED|Overall Study||7
77955|NCT01424306|187418|P6|NOT COMPLETED|Overall Study||0
77956|NCT01424306|187419|P5|NOT COMPLETED|Overall Study||1
77957|NCT01424306|187420|P4|NOT COMPLETED|Overall Study||0
77958|NCT01424306|187421|P3|NOT COMPLETED|Overall Study||0
77959|NCT01424306|187422|P2|NOT COMPLETED|Overall Study||0
77960|NCT01424306|187423|P1|NOT COMPLETED|Overall Study||0
77961|NCT01424306|187418|P6|COMPLETED|Overall Study||6
77962|NCT01424306|187419|P5|COMPLETED|Overall Study||4
77963|NCT01424306|187420|P4|COMPLETED|Overall Study||3
77964|NCT01424306|187421|P3|COMPLETED|Overall Study||3
77965|NCT01424306|187422|P2|COMPLETED|Overall Study||4
77966|NCT01424306|187423|P1|COMPLETED|Overall Study||4
77967|NCT01424306|187418|P6|STARTED|Overall Study||6
77968|NCT01424306|187419|P5|STARTED|Overall Study||5
77969|NCT01424306|187420|P4|STARTED|Overall Study||3
77970|NCT01424306|187421|P3|STARTED|Overall Study||3
77971|NCT01424306|187422|P2|STARTED|Overall Study||4
77972|NCT01424306|187423|P1|STARTED|Overall Study||4
77973|NCT01424228|187472|P2|NOT COMPLETED|Overall Study||47
77974|NCT01424228|187473|P1|NOT COMPLETED|Overall Study||56
77975|NCT01424228|187472|P2|COMPLETED|Overall Study||135
77976|NCT01424228|187473|P1|COMPLETED|Overall Study||126
77977|NCT01424228|187472|P2|STARTED|Overall Study||182
77978|NCT01424228|187473|P1|STARTED|Overall Study||182
77979|NCT01424189|187513|P2|NOT COMPLETED|Overall Study||6
77980|NCT01424189|187514|P1|NOT COMPLETED|Overall Study||13
77981|NCT01424189|187513|P2|COMPLETED|Overall Study||182
77982|NCT01424189|187514|P1|COMPLETED|Overall Study||373
77983|NCT01424189|187513|P2|STARTED|Overall Study||188
77984|NCT01424189|187514|P1|STARTED|Overall Study||386
77985|NCT01424072|187529|P3|NOT COMPLETED|Overall Study||0
77986|NCT01424072|187530|P2|NOT COMPLETED|Overall Study||0
77987|NCT01424072|187531|P1|NOT COMPLETED|Overall Study||0
77988|NCT01424072|187529|P3|COMPLETED|Overall Study||22
77989|NCT01424072|187530|P2|COMPLETED|Overall Study||26
77990|NCT01424072|187531|P1|COMPLETED|Overall Study||27
77991|NCT01424072|187529|P3|STARTED|Overall Study||22
77992|NCT01424072|187530|P2|STARTED|Overall Study||26
77993|NCT01424072|187531|P1|STARTED|Overall Study||27
77994|NCT01424033|187548|P1|NOT COMPLETED|Overall Study||5
77995|NCT01424033|187548|P1|COMPLETED|Overall Study||0
77996|NCT01424033|187548|P1|STARTED|Overall Study||5
77997|NCT01423916|187555|P3|NOT COMPLETED|Overall Study||7
77998|NCT01423916|187556|P2|NOT COMPLETED|Overall Study||20
77999|NCT01423916|187557|P1|NOT COMPLETED|Overall Study||11
78000|NCT01423916|187555|P3|COMPLETED|Overall Study||64
78001|NCT01423916|187556|P2|COMPLETED|Overall Study||53
78002|NCT01423916|187557|P1|COMPLETED|Overall Study||63
78003|NCT01423916|187555|P3|STARTED|Overall Study||71
78004|NCT01423916|187556|P2|STARTED|Overall Study||73
78005|NCT01423916|187557|P1|STARTED|Overall Study||74
78006|NCT01423773|187611|P2|NOT COMPLETED|Period 2, 2 Days||0
78007|NCT01423773|187612|P1|NOT COMPLETED|Period 2, 2 Days||0
78008|NCT01423773|187611|P2|COMPLETED|Period 2, 2 Days||10
78009|NCT01423773|187612|P1|COMPLETED|Period 2, 2 Days||10
78010|NCT01423773|187611|P2|STARTED|Period 2, 2 Days||10
78011|NCT01423773|187612|P1|STARTED|Period 2, 2 Days||10
78012|NCT01423773|187611|P2|NOT COMPLETED|Period One, 2 Days||0
78013|NCT01423773|187612|P1|NOT COMPLETED|Period One, 2 Days||0
78014|NCT01423773|187611|P2|COMPLETED|Period One, 2 Days||10
78015|NCT01423773|187612|P1|COMPLETED|Period One, 2 Days||10
78016|NCT01423773|187611|P2|STARTED|Period One, 2 Days||10
78017|NCT01423773|187612|P1|STARTED|Period One, 2 Days||10
78018|NCT01423760|187620|P2|NOT COMPLETED|Overall Study||0
78019|NCT01423760|187621|P1|NOT COMPLETED|Overall Study||0
78020|NCT01423760|187620|P2|COMPLETED|Overall Study||13
78021|NCT01423760|187621|P1|COMPLETED|Overall Study||14
78022|NCT01423760|187620|P2|Safety Analysis Set|Overall Study||8
78023|NCT01423760|187621|P1|Safety Analysis Set|Overall Study||12
78024|NCT01423760|187620|P2|Number of Non-treatment Subjects|Overall Study||5
78025|NCT01423760|187621|P1|Number of Non-treatment Subjects|Overall Study||2
78026|NCT01423760|187620|P2|Number of Tecemotide Subjects|Overall Study||8
78027|NCT01423760|187621|P1|Number of Tecemotide Subjects|Overall Study||12
78028|NCT01423760|187620|P2|STARTED|Overall Study||13
78029|NCT01423760|187621|P1|STARTED|Overall Study||14
78030|NCT01423617|187631|P2|NOT COMPLETED|Overall Study||1
78031|NCT01423617|187632|P1|NOT COMPLETED|Overall Study||0
78032|NCT01423617|187631|P2|COMPLETED|Overall Study||45
78033|NCT01423617|187632|P1|COMPLETED|Overall Study||46
78034|NCT01423617|187631|P2|STARTED|Overall Study||46
78035|NCT01423617|187632|P1|STARTED|Overall Study||46
78036|NCT01423604|187649|P2|NOT COMPLETED|Randomized||63
78037|NCT01423604|187650|P1|NOT COMPLETED|Randomized||63
78038|NCT01423604|187649|P2|COMPLETED|Randomized||0
78039|NCT01423604|187650|P1|COMPLETED|Randomized|As of 07August2015, 1 subject was receiving treatment in the randomized portion.|1
78040|NCT01423604|187649|P2|STARTED|Randomized||63
78041|NCT01423604|187650|P1|STARTED|Randomized||64
78042|NCT01423604|187649|P2|NOT COMPLETED|Safety Run-In||0
78043|NCT01423604|187650|P1|NOT COMPLETED|Safety Run-In||9
78044|NCT01423604|187649|P2|COMPLETED|Safety Run-In||0
78045|NCT01423604|187650|P1|COMPLETED|Safety Run-In||0
78046|NCT01423604|187649|P2|STARTED|Safety Run-In||0
78047|NCT01423604|187650|P1|STARTED|Safety Run-In||9
78048|NCT01423253|187665|P1|NOT COMPLETED|Overall Study||9
78049|NCT01423253|187665|P1|COMPLETED|Overall Study||39
78050|NCT01423253|187665|P1|STARTED|Overall Study||48
78051|NCT01423162|187678|P2|NOT COMPLETED|Overall Study||0
78052|NCT01423162|187679|P1|NOT COMPLETED|Overall Study||0
78053|NCT01423162|187678|P2|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|9
78054|NCT01423162|187679|P1|COMPLETED|Overall Study|Crossover design: All subjects (n=20) completed both arms|11
78055|NCT01423162|187678|P2|STARTED|Overall Study||9
78056|NCT01423162|187679|P1|STARTED|Overall Study||11
78057|NCT01423084|187687|P2|NOT COMPLETED|Overall Study||4
78058|NCT01423084|187688|P1|NOT COMPLETED|Overall Study||2
78059|NCT01423084|187687|P2|COMPLETED|Overall Study||170
78060|NCT01423084|187688|P1|COMPLETED|Overall Study||168
78061|NCT01423084|187687|P2|STARTED|Overall Study||174
78062|NCT01423084|187688|P1|STARTED|Overall Study||170
78063|NCT01422915|187718|P1|NOT COMPLETED|Overall Study||1
78064|NCT01422915|187718|P1|COMPLETED|Overall Study||3
78065|NCT01422915|187718|P1|STARTED|Overall Study|1 subject with abnormal liver chemistries removed during the first period.|4
78066|NCT01422889|187723|P1|NOT COMPLETED|Overall Study||9
78067|NCT01422889|187723|P1|COMPLETED|Overall Study|9 subjects did not receive a study stent therefore 1111 subjects were eligible for follow up.|1111
78068|NCT01422889|187723|P1|STARTED|Overall Study||1120
78069|NCT01422876|187738|P10|NOT COMPLETED|Week 52||17
78070|NCT01422876|187739|P9|NOT COMPLETED|Week 52||21
78071|NCT01422876|187740|P8|NOT COMPLETED|Week 52||23
78072|NCT01422876|187741|P7|NOT COMPLETED|Week 52||16
78073|NCT01422876|187742|P6|NOT COMPLETED|Week 52||17
78074|NCT01422876|187743|P5|NOT COMPLETED|Week 52||15
78075|NCT01422876|187744|P4|NOT COMPLETED|Week 52||18
78076|NCT01422876|187745|P3|NOT COMPLETED|Week 52||13
78077|NCT01422876|187746|P2|NOT COMPLETED|Week 52||10
78078|NCT01422876|187747|P1|NOT COMPLETED|Week 52||12
78079|NCT01422876|187738|P10|COMPLETED|Week 52||118
78080|NCT01422876|187739|P9|COMPLETED|Week 52||113
78081|NCT01422876|187740|P8|COMPLETED|Week 52||112
78082|NCT01422876|187741|P7|COMPLETED|Week 52||120
78083|NCT01422876|187742|P6|COMPLETED|Week 52||120
78084|NCT01422876|187743|P5|COMPLETED|Week 52||117
78085|NCT01422876|187744|P4|COMPLETED|Week 52||122
78086|NCT01422876|187745|P3|COMPLETED|Week 52||128
78087|NCT01422876|187746|P2|COMPLETED|Week 52||126
78088|NCT01422876|187747|P1|COMPLETED|Week 52||125
78089|NCT01422876|187738|P10|STARTED|Week 52||135
78090|NCT01422876|187739|P9|STARTED|Week 52||134
78091|NCT01422876|187740|P8|STARTED|Week 52||135
78092|NCT01422876|187741|P7|STARTED|Week 52||136
78093|NCT01422876|187742|P6|STARTED|Week 52||137
78094|NCT01422876|187743|P5|STARTED|Week 52||132
78095|NCT01422876|187744|P4|STARTED|Week 52||140
78096|NCT01422876|187745|P3|STARTED|Week 52||141
78097|NCT01422876|187746|P2|STARTED|Week 52||136
78098|NCT01422876|187747|P1|STARTED|Week 52||137
78099|NCT01422876|187738|P10|NOT COMPLETED|Week 24||10
78100|NCT01422876|187739|P9|NOT COMPLETED|Week 24||6
78101|NCT01422876|187740|P8|NOT COMPLETED|Week 24||7
78102|NCT01422876|187741|P7|NOT COMPLETED|Week 24||6
78103|NCT01422876|187742|P6|NOT COMPLETED|Week 24||6
78104|NCT01422876|187743|P5|NOT COMPLETED|Week 24||7
78105|NCT01422876|187744|P4|NOT COMPLETED|Week 24||8
78106|NCT01422876|187745|P3|NOT COMPLETED|Week 24||5
78107|NCT01422876|187746|P2|NOT COMPLETED|Week 24||3
78108|NCT01422876|187747|P1|NOT COMPLETED|Week 24||6
78109|NCT01422876|187738|P10|COMPLETED|Week 24||125
78110|NCT01422876|187739|P9|COMPLETED|Week 24||128
78111|NCT01422876|187740|P8|COMPLETED|Week 24||128
78112|NCT01422876|187741|P7|COMPLETED|Week 24||130
78113|NCT01422876|187742|P6|COMPLETED|Week 24||131
78114|NCT01422876|187743|P5|COMPLETED|Week 24||125
78115|NCT01422876|187744|P4|COMPLETED|Week 24||132
78116|NCT01422876|187745|P3|COMPLETED|Week 24||136
78117|NCT01422876|187746|P2|COMPLETED|Week 24||133
78118|NCT01422876|187747|P1|COMPLETED|Week 24||131
78119|NCT01422876|187738|P10|STARTED|Week 24||135
78120|NCT01422876|187739|P9|STARTED|Week 24||134
78121|NCT01422876|187740|P8|STARTED|Week 24||135
78122|NCT01422876|187741|P7|STARTED|Week 24||136
78123|NCT01422876|187742|P6|STARTED|Week 24||137
78124|NCT01422876|187743|P5|STARTED|Week 24||132
78125|NCT01422876|187744|P4|STARTED|Week 24||140
78126|NCT01422876|187745|P3|STARTED|Week 24||141
78127|NCT01422876|187746|P2|STARTED|Week 24||136
78128|NCT01422876|187747|P1|STARTED|Week 24||137
78129|NCT01422850|187794|P1|NOT COMPLETED|Overall Study||3
78130|NCT01422850|187794|P1|COMPLETED|Overall Study||18
78131|NCT01422850|187794|P1|Week 15|Overall Study|One patient withdrawn by PI due to increased PSA. Started bicalutamide treatment.|18
78132|NCT01422850|187794|P1|Week 14 - Third Treatment|Overall Study|One patient withdrawn by PI and referred to external radiotherapy due to progressive disease.|19
78133|NCT01422850|187794|P1|Week 9 - Second Treatment|Overall Study||20
78134|NCT01422850|187794|P1|Week 5|Overall Study|One patient withdrawn by PI due to progressive disease|20
78135|NCT01422850|187794|P1|Week 4 - First Treatment|Overall Study||21
78136|NCT01422850|187794|P1|STARTED|Overall Study||21
78137|NCT01422824|187800|P1|NOT COMPLETED|Overall Study||38
78138|NCT01422824|187800|P1|COMPLETED|Overall Study||147
78139|NCT01422824|187800|P1|Treated|Overall Study||184
78140|NCT01422824|187800|P1|STARTED|Overall Study||185
78141|NCT01422720|187805|P1|NOT COMPLETED|Overall Study||22
78142|NCT01422720|187805|P1|COMPLETED|Overall Study||50
78143|NCT01422720|187805|P1|Per-Protocol Set (PPS)|Overall Study||55
78144|NCT01422720|187805|P1|Full Analysis Set (FAS)|Overall Study||71
78145|NCT01422720|187805|P1|Safety Set|Overall Study||72
78146|NCT01422720|187805|P1|STARTED|Overall Study||72
78147|NCT01422538|187816|P3|NOT COMPLETED|Overall Study||2
78148|NCT01422538|187817|P2|NOT COMPLETED|Overall Study||2
78149|NCT01422538|187818|P1|NOT COMPLETED|Overall Study||0
78150|NCT01422538|187816|P3|COMPLETED|Overall Study||8
78151|NCT01422538|187817|P2|COMPLETED|Overall Study||8
78152|NCT01422538|187818|P1|COMPLETED|Overall Study||10
78153|NCT01422538|187816|P3|STARTED|Overall Study||10
78154|NCT01422538|187817|P2|STARTED|Overall Study||10
78155|NCT01422538|187818|P1|STARTED|Overall Study||10
78156|NCT01422434|187843|P3|NOT COMPLETED|Overall Study||6
78157|NCT01422434|187844|P2|NOT COMPLETED|Overall Study||5
78158|NCT01422434|187845|P1|NOT COMPLETED|Overall Study||11
78159|NCT01422434|187843|P3|COMPLETED|Overall Study||217
78160|NCT01422434|187844|P2|COMPLETED|Overall Study||221
78161|NCT01422434|187845|P1|COMPLETED|Overall Study||216
78162|NCT01422434|187843|P3|STARTED|Overall Study||223
78163|NCT01422434|187844|P2|STARTED|Overall Study||226
78164|NCT01422434|187845|P1|STARTED|Overall Study||227
78165|NCT01422408|187862|P1|NOT COMPLETED|Overall Study||4
78166|NCT01422408|187862|P1|COMPLETED|Overall Study||30
78167|NCT01422408|187862|P1|STARTED|Overall Study||34
78168|NCT01422382|187891|P1|NOT COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||1
78169|NCT01422382|187891|P1|COMPLETED|NK-104 4mg QD and Diltiazem 240 mg QD||27
78170|NCT01422382|187891|P1|STARTED|NK-104 4mg QD and Diltiazem 240 mg QD||28
78171|NCT01422382|187891|P1|NOT COMPLETED|Diltiazem 240 mg QD||0
78172|NCT01422382|187891|P1|COMPLETED|Diltiazem 240 mg QD||28
78173|NCT01422382|187891|P1|STARTED|Diltiazem 240 mg QD||28
78174|NCT01422382|187891|P1|NOT COMPLETED|NK-104 4mg Once Daily (QD)||0
78175|NCT01422382|187891|P1|COMPLETED|NK-104 4mg Once Daily (QD)||28
78176|NCT01422382|187891|P1|STARTED|NK-104 4mg Once Daily (QD)||28
78177|NCT01422369|187896|P1|NOT COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||1
78178|NCT01422369|187896|P1|COMPLETED|NK-104 4mg QD & Prezista 800mg/100mg QD||27
78179|NCT01422369|187896|P1|STARTED|NK-104 4mg QD & Prezista 800mg/100mg QD||28
78180|NCT01422369|187896|P1|NOT COMPLETED|Prezista 800mg/100mg QD||0
78181|NCT01422369|187896|P1|COMPLETED|Prezista 800mg/100mg QD||28
78182|NCT01422369|187896|P1|STARTED|Prezista 800mg/100mg QD||28
78183|NCT01422369|187896|P1|NOT COMPLETED|NK-104 4mg QD||0
78184|NCT01422369|187896|P1|COMPLETED|NK-104 4mg QD||28
78185|NCT01422369|187896|P1|STARTED|NK-104 4mg QD||28
78186|NCT01422356|187901|P1|NOT COMPLETED|Overall Study||31
78187|NCT01422356|187901|P1|COMPLETED|Overall Study||169
78188|NCT01422356|187901|P1|STARTED|Overall Study||200
78189|NCT01422304|187907|P2|NOT COMPLETED|Overall Study||37
78190|NCT01422304|187908|P1|NOT COMPLETED|Overall Study||24
78191|NCT01422304|187907|P2|COMPLETED|Overall Study||563
78192|NCT01422304|187908|P1|COMPLETED|Overall Study||574
78193|NCT01422304|187907|P2|Treated|Overall Study|1 given sugammadex; thus All Participants as Treated (APaT) Ns are 596 Sugammadex, 588 Usual Care|589
78194|NCT01422304|187908|P1|Treated|Overall Study||595
78195|NCT01422304|187907|P2|STARTED|Overall Study|Randomized|600
78196|NCT01422304|187908|P1|STARTED|Overall Study|Randomized|598
78197|NCT01422239|187940|P2|NOT COMPLETED|Overall Study||3
78198|NCT01422239|187941|P1|NOT COMPLETED|Overall Study||4
78199|NCT01422239|187940|P2|COMPLETED|Overall Study||3
78200|NCT01422239|187941|P1|COMPLETED|Overall Study||10
78201|NCT01422239|187940|P2|STARTED|Overall Study||6
78202|NCT01422239|187941|P1|STARTED|Overall Study||14
78203|NCT01422226|187953|P2|NOT COMPLETED|Overall Study||0
78204|NCT01422226|187954|P1|NOT COMPLETED|Overall Study||0
78205|NCT01422226|187953|P2|COMPLETED|Overall Study||2
78206|NCT01422226|187954|P1|COMPLETED|Overall Study||1
78207|NCT01422226|187953|P2|STARTED|Overall Study||2
78208|NCT01422226|187954|P1|STARTED|Overall Study||1
78209|NCT01422213|187963|P3|NOT COMPLETED|Overall Study||29
78210|NCT01422213|187964|P2|NOT COMPLETED|Overall Study||22
78211|NCT01422213|187965|P1|NOT COMPLETED|Overall Study||33
78212|NCT01422213|187963|P3|COMPLETED|Overall Study||178
78213|NCT01422213|187964|P2|COMPLETED|Overall Study||173
78214|NCT01422213|187965|P1|COMPLETED|Overall Study||163
78215|NCT01422213|187963|P3|STARTED|Overall Study||207
78216|NCT01422213|187964|P2|STARTED|Overall Study||195
78217|NCT01422213|187965|P1|STARTED|Overall Study||196
78218|NCT01422187|188026|P3|NOT COMPLETED|Overall Study||0
78219|NCT01422187|188027|P2|NOT COMPLETED|Overall Study||1
78220|NCT01422187|188028|P1|NOT COMPLETED|Overall Study||1
78221|NCT01422187|188026|P3|COMPLETED|Overall Study||2
78222|NCT01422187|188027|P2|COMPLETED|Overall Study||8
78223|NCT01422187|188028|P1|COMPLETED|Overall Study||7
78224|NCT01422187|188026|P3|STARTED|Overall Study||2
78225|NCT01422187|188027|P2|STARTED|Overall Study||9
78226|NCT01422187|188028|P1|STARTED|Overall Study||8
78227|NCT01422070|188047|P2|NOT COMPLETED|Overall Study||0
78228|NCT01422070|188048|P1|NOT COMPLETED|Overall Study||0
78229|NCT01422070|188047|P2|COMPLETED|Overall Study||803
78230|NCT01422070|188048|P1|COMPLETED|Overall Study||5031
78231|NCT01422070|188047|P2|STARTED|Overall Study|Number of patients admitted to 27 intensive care units.|803
78232|NCT01422070|188048|P1|STARTED|Overall Study|Number of patients admitted to 140 intensive care units|5031
78233|NCT01421719|188059|P1|NOT COMPLETED|Overall Study||4
78234|NCT01421719|188059|P1|COMPLETED|Overall Study||16
78235|NCT01421719|188059|P1|STARTED|Overall Study||20
78236|NCT01421667|188068|P4|NOT COMPLETED|Overall Study||1
78237|NCT01421667|188069|P3|NOT COMPLETED|Overall Study||2
78238|NCT01421667|188070|P2|NOT COMPLETED|Overall Study||2
78239|NCT01421667|188071|P1|NOT COMPLETED|Overall Study||0
78240|NCT01421667|188068|P4|COMPLETED|Overall Study|Completed per protocol due to death [7] or study termination by sponsor [8]|15
78241|NCT01421667|188069|P3|COMPLETED|Overall Study|Completed per protocol due to death [33] or study termination by sponsor [18]|51
78242|NCT01421667|188070|P2|COMPLETED|Overall Study|Completed per protocol due to death [45] or study termination by sponsor [21]|66
78243|NCT01421667|188071|P1|COMPLETED|Overall Study|Completed per protocol due to death [24] or study termination by sponsor [11]|35
78244|NCT01421667|188068|P4|STARTED|Overall Study||16
78245|NCT01421667|188069|P3|STARTED|Overall Study||53
78246|NCT01421667|188070|P2|STARTED|Overall Study||68
78247|NCT01421667|188071|P1|STARTED|Overall Study||35
78248|NCT01421654|188123|P2|NOT COMPLETED|Overall Study||0
78249|NCT01421654|188124|P1|NOT COMPLETED|Overall Study||0
78250|NCT01421654|188123|P2|COMPLETED|Overall Study|10 subjects completed study, but 1 subject was found to not meet IEC at the end; data was not used.|9
78251|NCT01421654|188124|P1|COMPLETED|Overall Study||11
78252|NCT01421654|188123|P2|STARTED|Overall Study||9
78253|NCT01421654|188124|P1|STARTED|Overall Study||11
78254|NCT01421641|188132|P2|NOT COMPLETED|Overall Study||2
78255|NCT01421641|188133|P1|NOT COMPLETED|Overall Study||2
78256|NCT01421641|188132|P2|COMPLETED|Overall Study||35
78257|NCT01421641|188133|P1|COMPLETED|Overall Study||35
78258|NCT01421641|188132|P2|STARTED|Overall Study||37
78259|NCT01421641|188133|P1|STARTED|Overall Study||37
78260|NCT01421589|188143|P1|NOT COMPLETED|Overall Study||0
78261|NCT01421589|188143|P1|COMPLETED|Overall Study||15
78262|NCT01421589|188143|P1|STARTED|Overall Study||15
78263|NCT01421511|188155|P2|NOT COMPLETED|Overall Study||28
78264|NCT01421511|188156|P1|NOT COMPLETED|Overall Study||19
78265|NCT01421511|188155|P2|COMPLETED|Overall Study||306
78266|NCT01421511|188156|P1|COMPLETED|Overall Study||313
78267|NCT01421511|188155|P2|STARTED|Overall Study||334
78268|NCT01421511|188156|P1|STARTED|Overall Study||332
78269|NCT01421498|188178|P2|NOT COMPLETED|Overall Study||11
78270|NCT01421498|188179|P1|NOT COMPLETED|Overall Study||12
78271|NCT01421498|188178|P2|COMPLETED|Overall Study||284
78272|NCT01421498|188179|P1|COMPLETED|Overall Study||281
78273|NCT01421498|188178|P2|STARTED|Overall Study||295
78274|NCT01421498|188179|P1|STARTED|Overall Study||293
78275|NCT01421472|188191|P4|NOT COMPLETED|Overall Study||0
78276|NCT01421472|188192|P3|NOT COMPLETED|Overall Study||0
78277|NCT01421472|188193|P2|NOT COMPLETED|Overall Study||0
78278|NCT01421472|188194|P1|NOT COMPLETED|Overall Study||0
78279|NCT01421472|188191|P4|COMPLETED|Overall Study||32
78280|NCT01421472|188192|P3|COMPLETED|Overall Study||64
78281|NCT01421472|188193|P2|COMPLETED|Overall Study||33
78282|NCT01421472|188194|P1|COMPLETED|Overall Study||67
78283|NCT01421472|188191|P4|STARTED|Overall Study||32
78284|NCT01421472|188192|P3|STARTED|Overall Study||64
78285|NCT01421472|188193|P2|STARTED|Overall Study||33
78286|NCT01421472|188194|P1|STARTED|Overall Study||67
78287|NCT01421459|188206|P2|NOT COMPLETED|Overall Study||52
78288|NCT01421459|188207|P1|NOT COMPLETED|Overall Study||45
78289|NCT01421459|188206|P2|COMPLETED|Overall Study||328
78290|NCT01421459|188207|P1|COMPLETED|Overall Study||334
78291|NCT01421459|188206|P2|Received at Least 1 Dose of Study Drug|Overall Study||380
78292|NCT01421459|188207|P1|Received at Least 1 Dose of Study Drug|Overall Study||376
78293|NCT01421459|188206|P2|STARTED|Overall Study||380
78294|NCT01421459|188207|P1|STARTED|Overall Study||379
78295|NCT01421355|188241|P1|NOT COMPLETED|Overall Study||6
78296|NCT01421355|188241|P1|COMPLETED|Overall Study||15
78297|NCT01421355|188241|P1|STARTED|Overall Study||21
78298|NCT01421303|188245|P1|NOT COMPLETED|Overall Study||22
78299|NCT01421303|188245|P1|COMPLETED|Overall Study||58
78300|NCT01421303|188245|P1|STARTED|Overall Study||80
78301|NCT01421277|188272|P2|NOT COMPLETED|Overall Study||92
78302|NCT01421277|188273|P1|NOT COMPLETED|Overall Study||0
78303|NCT01421277|188272|P2|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|99
78304|NCT01421277|188273|P1|COMPLETED|Overall Study|Completed the online survey for at least one migraine attack.|25
78305|NCT01421277|188272|P2|STARTED|Overall Study||191
78306|NCT01421277|188273|P1|STARTED|Overall Study||25
78307|NCT01421147|188285|P2|NOT COMPLETED|Extension Period||11
78308|NCT01421147|188286|P1|NOT COMPLETED|Extension Period||8
78309|NCT01421147|188285|P2|COMPLETED|Extension Period||245
78310|NCT01421147|188286|P1|COMPLETED|Extension Period||245
78311|NCT01421147|188285|P2|STARTED|Extension Period||256
78312|NCT01421147|188286|P1|STARTED|Extension Period||253
78313|NCT01421147|188285|P2|NOT COMPLETED|Treatment Period||11
78314|NCT01421147|188286|P1|NOT COMPLETED|Treatment Period||16
78315|NCT01421147|188285|P2|COMPLETED|Treatment Period||256
78316|NCT01421147|188286|P1|COMPLETED|Treatment Period||253
78317|NCT01421147|188285|P2|Received at Least 1 Dose of Study Drug|Treatment Period||267
78318|NCT01421147|188286|P1|Received at Least 1 Dose of Study Drug|Treatment Period||268
78319|NCT01421147|188285|P2|STARTED|Treatment Period||267
78320|NCT01421147|188286|P1|STARTED|Treatment Period||269
78321|NCT01421134|188318|P2|NOT COMPLETED|Overall Study||15
78322|NCT01421134|188319|P1|NOT COMPLETED|Overall Study||7
78323|NCT01421134|188318|P2|COMPLETED|Overall Study||87
78324|NCT01421134|188319|P1|COMPLETED|Overall Study||102
78325|NCT01421134|188318|P2|STARTED|Overall Study||102
78326|NCT01421134|188319|P1|STARTED|Overall Study||109
78327|NCT01420926|188339|P2|NOT COMPLETED|Overall Study||65
78328|NCT01420926|188340|P1|NOT COMPLETED|Overall Study||60
78329|NCT01420926|188339|P2|COMPLETED|Overall Study||16
78330|NCT01420926|188340|P1|COMPLETED|Overall Study||22
78331|NCT01420926|188339|P2|STARTED|Overall Study||81
78332|NCT01420926|188340|P1|STARTED|Overall Study||82
78333|NCT01420848|188357|P3|NOT COMPLETED|Overall Study||0
78334|NCT01420848|188358|P2|NOT COMPLETED|Overall Study||0
78335|NCT01420848|188359|P1|NOT COMPLETED|Overall Study||0
78336|NCT01420848|188357|P3|COMPLETED|Overall Study||22
78337|NCT01420848|188358|P2|COMPLETED|Overall Study||25
78338|NCT01420848|188359|P1|COMPLETED|Overall Study||24
78339|NCT01420848|188357|P3|STARTED|Overall Study||22
78340|NCT01420848|188358|P2|STARTED|Overall Study||25
78341|NCT01420848|188359|P1|STARTED|Overall Study||24
78342|NCT01420289|188372|P2|NOT COMPLETED|Overall Study||0
78343|NCT01420289|188373|P1|NOT COMPLETED|Overall Study||0
78344|NCT01420289|188372|P2|COMPLETED|Overall Study||16
78345|NCT01420289|188373|P1|COMPLETED|Overall Study||18
78346|NCT01420289|188372|P2|STARTED|Overall Study||16
78347|NCT01420289|188373|P1|STARTED|Overall Study||18
78348|NCT01420146|188385|P1|NOT COMPLETED|Overall Study||0
78349|NCT01420146|188385|P1|COMPLETED|Overall Study||20
78350|NCT01420146|188385|P1|STARTED|Overall Study||20
78351|NCT01420081|188398|P9|NOT COMPLETED|Overall Study||3
78352|NCT01420081|188399|P8|NOT COMPLETED|Overall Study||3
78353|NCT01420081|188400|P7|NOT COMPLETED|Overall Study||3
78354|NCT01420081|188401|P6|NOT COMPLETED|Overall Study||20
78355|NCT01420081|188402|P5|NOT COMPLETED|Overall Study||20
78356|NCT01420081|188403|P4|NOT COMPLETED|Overall Study||3
78357|NCT01420081|188404|P3|NOT COMPLETED|Overall Study||11
78358|NCT01420081|188405|P2|NOT COMPLETED|Overall Study||1
78359|NCT01420081|188406|P1|NOT COMPLETED|Overall Study||3
78360|NCT01420081|188398|P9|COMPLETED|Overall Study||0
78361|NCT01420081|188399|P8|COMPLETED|Overall Study||0
78362|NCT01420081|188400|P7|COMPLETED|Overall Study||0
78363|NCT01420081|188401|P6|COMPLETED|Overall Study||0
78364|NCT01420081|188402|P5|COMPLETED|Overall Study||0
78365|NCT01420081|188403|P4|COMPLETED|Overall Study||0
78366|NCT01420081|188404|P3|COMPLETED|Overall Study||0
78367|NCT01420081|188405|P2|COMPLETED|Overall Study||0
78368|NCT01420081|188406|P1|COMPLETED|Overall Study||0
78369|NCT01420081|188398|P9|STARTED|Overall Study||3
78370|NCT01420081|188399|P8|STARTED|Overall Study||3
78371|NCT01420081|188400|P7|STARTED|Overall Study||3
78372|NCT01420081|188401|P6|STARTED|Overall Study||20
78373|NCT01420081|188402|P5|STARTED|Overall Study||20
78374|NCT01420081|188403|P4|STARTED|Overall Study||3
78375|NCT01420081|188404|P3|STARTED|Overall Study||11
78376|NCT01420081|188405|P2|STARTED|Overall Study||1
78377|NCT01420081|188406|P1|STARTED|Overall Study||3
78378|NCT01419977|188487|P2|NOT COMPLETED|Overall Study||0
78379|NCT01419977|188488|P1|NOT COMPLETED|Overall Study||0
78380|NCT01419977|188487|P2|COMPLETED|Overall Study||13
78381|NCT01419977|188488|P1|COMPLETED|Overall Study||16
78382|NCT01419977|188487|P2|STARTED|Overall Study||13
78383|NCT01419977|188488|P1|STARTED|Overall Study||16
78384|NCT01419795|188502|P2|NOT COMPLETED|Overall Study||0
78385|NCT01419795|188503|P1|NOT COMPLETED|Overall Study||0
78386|NCT01419795|188502|P2|COMPLETED|Overall Study||0
78387|NCT01419795|188503|P1|COMPLETED|Overall Study||3
78388|NCT01419795|188502|P2|STARTED|Overall Study||0
78389|NCT01419795|188503|P1|STARTED|Overall Study||3
78390|NCT01419769|188525|P1|NOT COMPLETED|Overall Study||4
78391|NCT01419769|188525|P1|COMPLETED|Overall Study||29
78392|NCT01419769|188525|P1|STARTED|Overall Study||33
78393|NCT01419639|188538|P1|NOT COMPLETED|Overall Study||1
78394|NCT01419639|188538|P1|COMPLETED|Overall Study||9
78395|NCT01419639|188538|P1|STARTED|Overall Study||10
78396|NCT01419314|188546|P2|NOT COMPLETED|Follow-up at Week 6 of the Trial||2
78397|NCT01419314|188547|P1|NOT COMPLETED|Follow-up at Week 6 of the Trial||1
78398|NCT01419314|188546|P2|COMPLETED|Follow-up at Week 6 of the Trial||19
78399|NCT01419314|188547|P1|COMPLETED|Follow-up at Week 6 of the Trial|2 people who missed the first follow-up, returned for the final follow-up at week 6 (n=18).|16
78400|NCT01419314|188546|P2|STARTED|Follow-up at Week 6 of the Trial|2 participants did not return for their final follow-up|21
78401|NCT01419314|188547|P1|STARTED|Follow-up at Week 6 of the Trial||17
78402|NCT01419314|188546|P2|NOT COMPLETED|Follow-up at Week 3 of the Trial||1
78403|NCT01419314|188547|P1|NOT COMPLETED|Follow-up at Week 3 of the Trial||6
78404|NCT01419314|188546|P2|COMPLETED|Follow-up at Week 3 of the Trial||21
78405|NCT01419314|188547|P1|COMPLETED|Follow-up at Week 3 of the Trial||17
78406|NCT01419314|188546|P2|STARTED|Follow-up at Week 3 of the Trial|one participant failed to return for the 3 week follow-up|22
78407|NCT01419314|188547|P1|STARTED|Follow-up at Week 3 of the Trial|3 participants discontinued the trial, 3 failed to return for additional follow-ups.|23
78408|NCT01419314|188546|P2|NOT COMPLETED|Start of Study||0
78409|NCT01419314|188547|P1|NOT COMPLETED|Start of Study||0
78410|NCT01419314|188546|P2|COMPLETED|Start of Study||22
78411|NCT01419314|188547|P1|COMPLETED|Start of Study||23
78412|NCT01419314|188546|P2|STARTED|Start of Study|No comfort issues reported.|22
78413|NCT01419314|188547|P1|STARTED|Start of Study|minor comfort issues were reported within the first 2 weeks of the trial|23
78414|NCT01419275|188567|P1|NOT COMPLETED|Overall Study||0
78415|NCT01419275|188567|P1|COMPLETED|Overall Study||126
78416|NCT01419275|188567|P1|STARTED|Overall Study||126
78417|NCT01419249|188573|P2|NOT COMPLETED|Overall Study||0
78418|NCT01419249|188574|P1|NOT COMPLETED|Overall Study||0
78419|NCT01419249|188573|P2|COMPLETED|Overall Study||140
78420|NCT01419249|188574|P1|COMPLETED|Overall Study||318
78421|NCT01419249|188573|P2|STARTED|Overall Study||140
78422|NCT01419249|188574|P1|STARTED|Overall Study||318
78423|NCT01419236|188588|P2|NOT COMPLETED|Overall Study||5
78424|NCT01419236|188589|P1|NOT COMPLETED|Overall Study||5
78425|NCT01419236|188588|P2|COMPLETED|Overall Study||35
78426|NCT01419236|188589|P1|COMPLETED|Overall Study||31
78427|NCT01419236|188588|P2|Received at Least 1 Dose of Study Drug|Overall Study||39
78428|NCT01419236|188589|P1|Received at Least 1 Dose of Study Drug|Overall Study||35
78429|NCT01419236|188588|P2|STARTED|Overall Study||40
78430|NCT01419236|188589|P1|STARTED|Overall Study||36
78431|NCT01419197|188613|P2|NOT COMPLETED|Overall Study||198
78432|NCT01419197|188614|P1|NOT COMPLETED|Overall Study||404
78433|NCT01419197|188613|P2|COMPLETED|Overall Study||0
78434|NCT01419197|188614|P1|COMPLETED|Overall Study||0
78435|NCT01419197|188613|P2|Switched to Trastuzumab Emtansine|Overall Study||94
78436|NCT01419197|188614|P1|Switched to Trastuzumab Emtansine|Overall Study||0
78437|NCT01419197|188613|P2|STARTED|Overall Study||198
78438|NCT01419197|188614|P1|STARTED|Overall Study||404
78439|NCT01419184|188639|P2|NOT COMPLETED|Overall Study||15
78440|NCT01419184|188640|P1|NOT COMPLETED|Overall Study||10
78441|NCT01419184|188639|P2|COMPLETED|Overall Study|13 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|106
78442|NCT01419184|188640|P1|COMPLETED|Overall Study|6 participants did not complete the study due to no valid infection-related length of stay (IRLOS)|118
78443|NCT01419184|188639|P2|Received at Least 1 Dose of Study Drug|Overall Study||106
78444|NCT01419184|188640|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
78445|NCT01419184|188639|P2|STARTED|Overall Study||121
78446|NCT01419184|188640|P1|STARTED|Overall Study||128
78447|NCT01419171|188656|P1|NOT COMPLETED|Overall Study||0
78448|NCT01419171|188656|P1|COMPLETED|Overall Study||328
78449|NCT01419171|188656|P1|STARTED|Overall Study||328
78450|NCT01419028|188673|P1|NOT COMPLETED|Overall Study||0
78451|NCT01419028|188673|P1|COMPLETED|Overall Study||48
78452|NCT01419028|188673|P1|STARTED|Overall Study||48
78453|NCT01418937|188678|P1|NOT COMPLETED|Overall Study||8
78454|NCT01418937|188678|P1|COMPLETED|Overall Study||156
78455|NCT01418937|188678|P1|STARTED|Overall Study||164
78456|NCT01418703|188687|P4|NOT COMPLETED|Overall Study||0
78457|NCT01418703|188688|P3|NOT COMPLETED|Overall Study||0
78458|NCT01418703|188689|P2|NOT COMPLETED|Overall Study||0
78459|NCT01418703|188690|P1|NOT COMPLETED|Overall Study||0
78460|NCT01418703|188687|P4|COMPLETED|Overall Study||6
78461|NCT01418703|188688|P3|COMPLETED|Overall Study||6
78462|NCT01418703|188689|P2|COMPLETED|Overall Study||13
78463|NCT01418703|188690|P1|COMPLETED|Overall Study||13
78464|NCT01418703|188687|P4|STARTED|Overall Study||6
78465|NCT01418703|188688|P3|STARTED|Overall Study||6
78466|NCT01418703|188689|P2|STARTED|Overall Study||13
78467|NCT01418703|188690|P1|STARTED|Overall Study||13
78468|NCT01418482|188701|P1|NOT COMPLETED|Overall Study||0
78469|NCT01418482|188701|P1|COMPLETED|Overall Study||15
78470|NCT01418482|188701|P1|STARTED|Overall Study||15
78471|NCT01418365|188709|P2|NOT COMPLETED|Second Intervention||1
78472|NCT01418365|188710|P1|NOT COMPLETED|Second Intervention||0
78473|NCT01418365|188709|P2|COMPLETED|Second Intervention||13
78474|NCT01418365|188710|P1|COMPLETED|Second Intervention||14
78475|NCT01418365|188709|P2|STARTED|Second Intervention||14
78476|NCT01418365|188710|P1|STARTED|Second Intervention||14
78477|NCT01418365|188709|P2|NOT COMPLETED|First Intervention||1
78478|NCT01418365|188710|P1|NOT COMPLETED|First Intervention||1
78479|NCT01418365|188709|P2|COMPLETED|First Intervention||14
78480|NCT01418365|188710|P1|COMPLETED|First Intervention||14
78481|NCT01418365|188709|P2|STARTED|First Intervention||15
78482|NCT01418365|188710|P1|STARTED|First Intervention||15
78483|NCT01418209|188721|P3|NOT COMPLETED|Overall Study||4
78484|NCT01418209|188722|P2|NOT COMPLETED|Overall Study||3
78485|NCT01418209|188723|P1|NOT COMPLETED|Overall Study||2
78486|NCT01418209|188721|P3|COMPLETED|Overall Study||142
78487|NCT01418209|188722|P2|COMPLETED|Overall Study||93
78488|NCT01418209|188723|P1|COMPLETED|Overall Study||95
78489|NCT01418209|188721|P3|STARTED|Overall Study||146
78490|NCT01418209|188722|P2|STARTED|Overall Study||96
78491|NCT01418209|188723|P1|STARTED|Overall Study||97
78492|NCT01418001|188752|P1|NOT COMPLETED|Overall Study||0
78493|NCT01418001|188752|P1|COMPLETED|Overall Study||5
78494|NCT01418001|188752|P1|STARTED|Overall Study||5
78495|NCT01417936|188756|P1|NOT COMPLETED|Overall Study||0
78496|NCT01417936|188756|P1|COMPLETED|Overall Study||26
78497|NCT01417936|188756|P1|STARTED|Overall Study||26
78498|NCT01417481|188777|P2|NOT COMPLETED|Second Period (8 Weeks)||0
78499|NCT01417481|188778|P1|NOT COMPLETED|Second Period (8 Weeks)||0
78500|NCT01417481|188777|P2|COMPLETED|Second Period (8 Weeks)||5
78501|NCT01417481|188778|P1|COMPLETED|Second Period (8 Weeks)||8
78502|NCT01417481|188777|P2|STARTED|Second Period (8 Weeks)||5
78503|NCT01417481|188778|P1|STARTED|Second Period (8 Weeks)||8
78504|NCT01417481|188777|P2|NOT COMPLETED|Washout (2 Weeks)||0
78505|NCT01417481|188778|P1|NOT COMPLETED|Washout (2 Weeks)||0
78506|NCT01417481|188777|P2|COMPLETED|Washout (2 Weeks)||5
78507|NCT01417481|188778|P1|COMPLETED|Washout (2 Weeks)||8
78508|NCT01417481|188777|P2|STARTED|Washout (2 Weeks)||5
78509|NCT01417481|188778|P1|STARTED|Washout (2 Weeks)||8
78510|NCT01417481|188777|P2|NOT COMPLETED|First Intervention (8 Weeks)||2
78511|NCT01417481|188778|P1|NOT COMPLETED|First Intervention (8 Weeks)||0
78512|NCT01417481|188777|P2|COMPLETED|First Intervention (8 Weeks)||5
78513|NCT01417481|188778|P1|COMPLETED|First Intervention (8 Weeks)||8
78514|NCT01417481|188777|P2|STARTED|First Intervention (8 Weeks)||7
78515|NCT01417481|188778|P1|STARTED|First Intervention (8 Weeks)||8
78516|NCT01417455|188810|P8|NOT COMPLETED|Overall Study||0
78517|NCT01417455|188811|P7|NOT COMPLETED|Overall Study||0
78518|NCT01417455|188812|P6|NOT COMPLETED|Overall Study||0
78519|NCT01417455|188813|P5|NOT COMPLETED|Overall Study||0
78520|NCT01417455|188814|P4|NOT COMPLETED|Overall Study||0
78521|NCT01417455|188815|P3|NOT COMPLETED|Overall Study||0
78522|NCT01417455|188816|P2|NOT COMPLETED|Overall Study||0
78523|NCT01417455|188817|P1|NOT COMPLETED|Overall Study||0
78524|NCT01417455|188810|P8|COMPLETED|Overall Study||25
78525|NCT01417455|188811|P7|COMPLETED|Overall Study||13
78526|NCT01417455|188812|P6|COMPLETED|Overall Study||13
78527|NCT01417455|188813|P5|COMPLETED|Overall Study||30
78528|NCT01417455|188814|P4|COMPLETED|Overall Study||17
78529|NCT01417455|188815|P3|COMPLETED|Overall Study||17
78530|NCT01417455|188816|P2|COMPLETED|Overall Study||16
78531|NCT01417455|188817|P1|COMPLETED|Overall Study||16
78532|NCT01417455|188810|P8|STARTED|Overall Study||25
78533|NCT01417455|188811|P7|STARTED|Overall Study||13
78534|NCT01417455|188812|P6|STARTED|Overall Study||13
78535|NCT01417455|188813|P5|STARTED|Overall Study||30
78536|NCT01417455|188814|P4|STARTED|Overall Study||17
78537|NCT01417455|188815|P3|STARTED|Overall Study||17
78538|NCT01417455|188816|P2|STARTED|Overall Study||16
78539|NCT01417455|188817|P1|STARTED|Overall Study||16
78540|NCT01417377|188843|P1|NOT COMPLETED|Overall Study||13
78541|NCT01417377|188843|P1|COMPLETED|Overall Study||9
78542|NCT01417377|188843|P1|Treated|Overall Study||21
78543|NCT01417377|188843|P1|STARTED|Overall Study||22
78544|NCT01417195|188852|P2|NOT COMPLETED|Overall Study||1
78545|NCT01417195|188853|P1|NOT COMPLETED|Overall Study||3
78546|NCT01417195|188852|P2|COMPLETED|Overall Study||61
78547|NCT01417195|188853|P1|COMPLETED|Overall Study||57
78548|NCT01417195|188852|P2|STARTED|Overall Study||62
78549|NCT01417195|188853|P1|STARTED|Overall Study||60
78550|NCT01417156|188869|P1|NOT COMPLETED|Overall Study||14
78551|NCT01417156|188869|P1|COMPLETED|Overall Study||6
78552|NCT01417156|188869|P1|STARTED|Overall Study||20
78553|NCT01417104|188879|P2|NOT COMPLETED|Overall Study||2
78554|NCT01417104|188880|P1|NOT COMPLETED|Overall Study||6
78555|NCT01417104|188879|P2|COMPLETED|Overall Study||35
78556|NCT01417104|188880|P1|COMPLETED|Overall Study||28
78557|NCT01417104|188879|P2|STARTED|Overall Study||37
78558|NCT01417104|188880|P1|STARTED|Overall Study||34
78559|NCT01417078|188890|P1|NOT COMPLETED|Overall Study||1
78560|NCT01417078|188890|P1|COMPLETED|Overall Study||30
78561|NCT01417078|188890|P1|STARTED|Overall Study||31
78562|NCT01417026|188902|P2|NOT COMPLETED|Overall Study||0
78563|NCT01417026|188903|P1|NOT COMPLETED|Overall Study||2
78564|NCT01417026|188902|P2|COMPLETED|Overall Study||13
78565|NCT01417026|188903|P1|COMPLETED|Overall Study||14
78566|NCT01417026|188902|P2|STARTED|Overall Study||13
78567|NCT01417026|188903|P1|STARTED|Overall Study||16
78568|NCT01416610|188913|P1|NOT COMPLETED|Overall Study||43
78569|NCT01416610|188913|P1|COMPLETED|Overall Study||45
78570|NCT01416610|188913|P1|Completed Follow-up|Overall Study||45
78571|NCT01416610|188913|P1|Completed Treatment|Overall Study||47
78572|NCT01416610|188913|P1|Per Protocol|Overall Study||83
78573|NCT01416610|188913|P1|Safety Population|Overall Study||86
78574|NCT01416610|188913|P1|Intention to Treat|Overall Study||88
78575|NCT01416610|188913|P1|STARTED|Overall Study||88
78576|NCT01416571|188927|P1|NOT COMPLETED|Overall Study||2
78577|NCT01416571|188927|P1|COMPLETED|Overall Study|Number of subjects completed at Day 385.|76
78578|NCT01416571|188927|P1|STARTED|Overall Study||78
78579|NCT01416272|188954|P1|NOT COMPLETED|Overall Study||4
78580|NCT01416272|188954|P1|COMPLETED|Overall Study||8
78581|NCT01416272|188954|P1|STARTED|Overall Study||12
78582|NCT01416181|188962|P2|NOT COMPLETED|Part 2||286
78583|NCT01416181|188963|P1|NOT COMPLETED|Part 2||271
78584|NCT01416181|188962|P2|COMPLETED|Part 2||6
78585|NCT01416181|188963|P1|COMPLETED|Part 2||3
78586|NCT01416181|188962|P2|Completed Treatment for > 96 Weeks|Part 2||0
78587|NCT01416181|188963|P1|Completed Treatment for > 96 Weeks|Part 2||1
78588|NCT01416181|188962|P2|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|0
78589|NCT01416181|188963|P1|Completed Treatment for 96 Weeks|Part 2|completed study treatment for 96 weeks in Part 2|1
78590|NCT01416181|188962|P2|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|111
78591|NCT01416181|188963|P1|Completed Treatment for 48 Weeks|Part 2|completed study treatment for 48 weeks in Part 2|98
78592|NCT01416181|188962|P2|STARTED|Part 2||292
78593|NCT01416181|188963|P1|STARTED|Part 2||274
78594|NCT01416181|188962|P2|NOT COMPLETED|Part 1||114
78595|NCT01416181|188963|P1|NOT COMPLETED|Part 1||137
78596|NCT01416181|188962|P2|COMPLETED|Part 1|Completed Study through Week 108|326
78597|NCT01416181|188963|P1|COMPLETED|Part 1|Completed Study through Week 108|312
78598|NCT01416181|188962|P2|Withdrew Prior to Dosing|Part 1||1
78599|NCT01416181|188963|P1|Withdrew Prior to Dosing|Part 1||0
78600|NCT01416181|188962|P2|STARTED|Part 1||440
78601|NCT01416181|188963|P1|STARTED|Part 1||449
78602|NCT01416155|189025|P1|NOT COMPLETED|Overall Study||58
78603|NCT01416155|189025|P1|COMPLETED|Overall Study||39
78604|NCT01416155|189025|P1|STARTED|Overall Study||97
78605|NCT01416142|189032|P3|NOT COMPLETED|PureVision2 HD||1
78606|NCT01416142|189033|P2|NOT COMPLETED|PureVision2 HD||0
78607|NCT01416142|189034|P1|NOT COMPLETED|PureVision2 HD||0
78608|NCT01416142|189032|P3|COMPLETED|PureVision2 HD||62
78609|NCT01416142|189033|P2|COMPLETED|PureVision2 HD||0
78610|NCT01416142|189034|P1|COMPLETED|PureVision2 HD||0
78611|NCT01416142|189032|P3|STARTED|PureVision2 HD||63
78612|NCT01416142|189033|P2|STARTED|PureVision2 HD||0
78613|NCT01416142|189034|P1|STARTED|PureVision2 HD||0
78614|NCT01416142|189032|P3|NOT COMPLETED|Cross Over at Movie Intermission||0
78615|NCT01416142|189033|P2|NOT COMPLETED|Cross Over at Movie Intermission||0
78616|NCT01416142|189034|P1|NOT COMPLETED|Cross Over at Movie Intermission||0
78617|NCT01416142|189032|P3|COMPLETED|Cross Over at Movie Intermission||0
78618|NCT01416142|189033|P2|COMPLETED|Cross Over at Movie Intermission||31
78619|NCT01416142|189034|P1|COMPLETED|Cross Over at Movie Intermission||32
78620|NCT01416142|189032|P3|STARTED|Cross Over at Movie Intermission||0
78621|NCT01416142|189033|P2|STARTED|Cross Over at Movie Intermission||31
78622|NCT01416142|189034|P1|STARTED|Cross Over at Movie Intermission||32
78623|NCT01416129|189045|P2|NOT COMPLETED|Experimental Condition: Brimless||0
78624|NCT01416129|189046|P1|NOT COMPLETED|Experimental Condition: Brimless||0
78625|NCT01416129|189045|P2|COMPLETED|Experimental Condition: Brimless||5
78626|NCT01416129|189046|P1|COMPLETED|Experimental Condition: Brimless||5
78627|NCT01416129|189045|P2|STARTED|Experimental Condition: Brimless||5
78628|NCT01416129|189046|P1|STARTED|Experimental Condition: Brimless||5
78629|NCT01416129|189045|P2|NOT COMPLETED|Control Condition: Ischial Containment||0
78630|NCT01416129|189046|P1|NOT COMPLETED|Control Condition: Ischial Containment||0
78631|NCT01416129|189045|P2|COMPLETED|Control Condition: Ischial Containment||5
78632|NCT01416129|189046|P1|COMPLETED|Control Condition: Ischial Containment||5
78633|NCT01416129|189045|P2|STARTED|Control Condition: Ischial Containment||5
78634|NCT01416129|189046|P1|STARTED|Control Condition: Ischial Containment||5
78635|NCT01416025|189054|P2|NOT COMPLETED|Overall Study||0
78636|NCT01416025|189055|P1|NOT COMPLETED|Overall Study||0
78637|NCT01416025|189054|P2|COMPLETED|Overall Study||15
78638|NCT01416025|189055|P1|COMPLETED|Overall Study||14
78639|NCT01416025|189054|P2|STARTED|Overall Study||15
78640|NCT01416025|189055|P1|STARTED|Overall Study||14
78641|NCT01415986|189061|P1|NOT COMPLETED|Overall Study||1
78642|NCT01415986|189061|P1|COMPLETED|Overall Study|Study terminated|0
78643|NCT01415986|189061|P1|STARTED|Overall Study||1
78644|NCT01415960|189066|P1|NOT COMPLETED|Overall Study||12
78645|NCT01415960|189066|P1|COMPLETED|Overall Study|Patients completed Study (151) Per protocol Patients (146)|151
78646|NCT01415960|189066|P1|PK Subgroup|Overall Study||30
78647|NCT01415960|189066|P1|ITT|Overall Study||161
78648|NCT01415960|189066|P1|STARTED|Overall Study||163
78649|NCT01415921|189078|P2|NOT COMPLETED|Overall Study||3
78650|NCT01415921|189079|P1|NOT COMPLETED|Overall Study||3
78651|NCT01415921|189078|P2|COMPLETED|Overall Study||14
78652|NCT01415921|189079|P1|COMPLETED|Overall Study||13
78653|NCT01415921|189078|P2|STARTED|Overall Study||17
78654|NCT01415921|189079|P1|STARTED|Overall Study||16
78655|NCT01415908|189089|P2|NOT COMPLETED|Overall Study||0
78656|NCT01415908|189090|P1|NOT COMPLETED|Overall Study||1
78657|NCT01415908|189089|P2|COMPLETED|Overall Study||4
78658|NCT01415908|189090|P1|COMPLETED|Overall Study||10
78659|NCT01415908|189089|P2|STARTED|Overall Study||4
78660|NCT01415908|189090|P1|STARTED|Overall Study||11
78661|NCT01415583|189118|P2|NOT COMPLETED|Overall Study||0
78662|NCT01415583|189119|P1|NOT COMPLETED|Overall Study||0
78663|NCT01415583|189118|P2|COMPLETED|Overall Study||157
78664|NCT01415583|189119|P1|COMPLETED|Overall Study||157
78665|NCT01415583|189118|P2|STARTED|Overall Study||157
78666|NCT01415583|189119|P1|STARTED|Overall Study||157
78667|NCT01415531|189127|P2|NOT COMPLETED|Overall Study||37
78668|NCT01415531|189128|P1|NOT COMPLETED|Overall Study||25
78669|NCT01415531|189127|P2|COMPLETED|Overall Study||390
78670|NCT01415531|189128|P1|COMPLETED|Overall Study||189
78671|NCT01415531|189127|P2|STARTED|Overall Study||427
78672|NCT01415531|189128|P1|STARTED|Overall Study||214
78673|NCT01415518|189138|P2|NOT COMPLETED|Overall Study||31
78674|NCT01415518|189139|P1|NOT COMPLETED|Overall Study||16
78675|NCT01415518|189138|P2|COMPLETED|Overall Study||261
78676|NCT01415518|189139|P1|COMPLETED|Overall Study||276
78767|NCT01414192|189363|P1|NOT COMPLETED|Overall Study||0
78768|NCT01414192|189360|P4|COMPLETED|Overall Study||1726
78677|NCT01415518|189138|P2|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 292 patients. Safety analysis used 292-3=289 patients.|289
78678|NCT01415518|189139|P1|Pts With Correct Randomized Treatment|Overall Study|Efficacy analysis used 290 patients. Safety analysis used 290+3=293 patients.|290
78679|NCT01415518|189138|P2|Patients Who Received Study Treatment|Overall Study||292
78680|NCT01415518|189139|P1|Patients Who Received Study Treatment|Overall Study||290
78681|NCT01415518|189138|P2|STARTED|Overall Study||292
78682|NCT01415518|189139|P1|STARTED|Overall Study||292
78683|NCT01415453|189191|P1|NOT COMPLETED|Overall Study||0
78684|NCT01415453|189191|P1|COMPLETED|Overall Study||1
78685|NCT01415453|189191|P1|Imaging Study|Overall Study||1
78686|NCT01415453|189191|P1|STARTED|Overall Study||1
78687|NCT01415427|189199|P4|NOT COMPLETED|Overall Study||56
78688|NCT01415427|189200|P3|NOT COMPLETED|Overall Study||58
78689|NCT01415427|189201|P2|NOT COMPLETED|Overall Study||29
78690|NCT01415427|189202|P1|NOT COMPLETED|Overall Study||29
78691|NCT01415427|189199|P4|COMPLETED|Overall Study||0
78692|NCT01415427|189200|P3|COMPLETED|Overall Study||1
78693|NCT01415427|189201|P2|COMPLETED|Overall Study||0
78694|NCT01415427|189202|P1|COMPLETED|Overall Study||0
78695|NCT01415427|189199|P4|STARTED|Overall Study||56
78696|NCT01415427|189200|P3|STARTED|Overall Study||59
78697|NCT01415427|189201|P2|STARTED|Overall Study||29
78698|NCT01415427|189202|P1|STARTED|Overall Study||29
78699|NCT01415401|189239|P1|NOT COMPLETED|Overall Study||7
78700|NCT01415401|189239|P1|COMPLETED|Overall Study||47
78701|NCT01415401|189239|P1|STARTED|Overall Study||54
78702|NCT01415349|189244|P2|NOT COMPLETED|Treatment Period 2||0
78703|NCT01415349|189245|P1|NOT COMPLETED|Treatment Period 2||0
78704|NCT01415349|189244|P2|COMPLETED|Treatment Period 2||19
78705|NCT01415349|189245|P1|COMPLETED|Treatment Period 2||21
78706|NCT01415349|189244|P2|STARTED|Treatment Period 2||19
78707|NCT01415349|189245|P1|STARTED|Treatment Period 2||21
78708|NCT01415349|189244|P2|NOT COMPLETED|Treatment Period 1||2
78709|NCT01415349|189245|P1|NOT COMPLETED|Treatment Period 1||0
78710|NCT01415349|189244|P2|COMPLETED|Treatment Period 1||19
78711|NCT01415349|189245|P1|COMPLETED|Treatment Period 1||21
78712|NCT01415349|189244|P2|STARTED|Treatment Period 1||21
78713|NCT01415349|189245|P1|STARTED|Treatment Period 1||21
78714|NCT01415232|189253|P1|NOT COMPLETED|Overall Study||0
78715|NCT01415232|189253|P1|COMPLETED|Overall Study||160
78716|NCT01415232|189253|P1|STARTED|Overall Study||160
78717|NCT01414855|189257|P1|NOT COMPLETED|Overall Study||13
78718|NCT01414855|189257|P1|COMPLETED|Overall Study|Completed=Completed treatment.|87
78719|NCT01414855|189257|P1|STARTED|Overall Study||100
78720|NCT01414634|189273|P8|NOT COMPLETED|Overall Study||0
78721|NCT01414634|189274|P7|NOT COMPLETED|Overall Study||0
78722|NCT01414634|189275|P6|NOT COMPLETED|Overall Study||0
78723|NCT01414634|189276|P5|NOT COMPLETED|Overall Study||0
78724|NCT01414634|189277|P4|NOT COMPLETED|Overall Study||0
78725|NCT01414634|189278|P3|NOT COMPLETED|Overall Study||0
78726|NCT01414634|189279|P2|NOT COMPLETED|Overall Study||0
78727|NCT01414634|189280|P1|NOT COMPLETED|Overall Study||0
78728|NCT01414634|189273|P8|COMPLETED|Overall Study||1
78729|NCT01414634|189274|P7|COMPLETED|Overall Study||1
78730|NCT01414634|189275|P6|COMPLETED|Overall Study||2
78731|NCT01414634|189276|P5|COMPLETED|Overall Study||1
78732|NCT01414634|189277|P4|COMPLETED|Overall Study||1
78733|NCT01414634|189278|P3|COMPLETED|Overall Study||1
78734|NCT01414634|189279|P2|COMPLETED|Overall Study||1
78735|NCT01414634|189280|P1|COMPLETED|Overall Study||1
78736|NCT01414634|189273|P8|STARTED|Overall Study||1
78737|NCT01414634|189274|P7|STARTED|Overall Study||1
78738|NCT01414634|189275|P6|STARTED|Overall Study||2
78739|NCT01414634|189276|P5|STARTED|Overall Study||1
78740|NCT01414634|189277|P4|STARTED|Overall Study||1
78741|NCT01414634|189278|P3|STARTED|Overall Study||1
78742|NCT01414634|189279|P2|STARTED|Overall Study||1
78743|NCT01414634|189280|P1|STARTED|Overall Study||1
78744|NCT01414413|189293|P2|NOT COMPLETED|Overall Study||0
78745|NCT01414413|189294|P1|NOT COMPLETED|Overall Study||0
78746|NCT01414413|189293|P2|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8466
78747|NCT01414413|189294|P1|COMPLETED|Overall Study|Adult population denominator for cluster randomised trial|8194
78748|NCT01414413|189293|P2|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8466
78749|NCT01414413|189294|P1|STARTED|Overall Study|Adult population denominator for cluster randomised trial|8194
78750|NCT01414244|189308|P2|NOT COMPLETED|Overall Study||0
78751|NCT01414244|189309|P1|NOT COMPLETED|Overall Study||0
78752|NCT01414244|189308|P2|COMPLETED|Overall Study||52
78753|NCT01414244|189309|P1|COMPLETED|Overall Study||54
78754|NCT01414244|189308|P2|STARTED|Overall Study||52
78755|NCT01414244|189309|P1|STARTED|Overall Study||54
78756|NCT01414205|189323|P2|NOT COMPLETED|Overall Study||7
78757|NCT01414205|189324|P1|NOT COMPLETED|Overall Study||7
78758|NCT01414205|189323|P2|COMPLETED|Overall Study||32
78759|NCT01414205|189324|P1|COMPLETED|Overall Study||34
78760|NCT01414205|189323|P2|Received Study Drug|Overall Study||38
78761|NCT01414205|189324|P1|Received Study Drug|Overall Study||40
78762|NCT01414205|189323|P2|STARTED|Overall Study||39
78763|NCT01414205|189324|P1|STARTED|Overall Study||41
78764|NCT01414192|189360|P4|NOT COMPLETED|Overall Study||0
78765|NCT01414192|189361|P3|NOT COMPLETED|Overall Study||0
78766|NCT01414192|189362|P2|NOT COMPLETED|Overall Study||0
78769|NCT01414192|189361|P3|COMPLETED|Overall Study||424
78770|NCT01414192|189362|P2|COMPLETED|Overall Study||575
78771|NCT01414192|189363|P1|COMPLETED|Overall Study||490
78772|NCT01414192|189360|P4|STARTED|Overall Study||1726
78773|NCT01414192|189361|P3|STARTED|Overall Study||424
78774|NCT01414192|189362|P2|STARTED|Overall Study||575
78775|NCT01414192|189363|P1|STARTED|Overall Study||490
78776|NCT01414166|189393|P2|NOT COMPLETED|Overall Study||83
78777|NCT01414166|189394|P1|NOT COMPLETED|Overall Study||91
78778|NCT01414166|189393|P2|COMPLETED|Overall Study||39
78779|NCT01414166|189394|P1|COMPLETED|Overall Study||31
78780|NCT01414166|189393|P2|Treated|Overall Study||121
78781|NCT01414166|189394|P1|Treated|Overall Study||120
78782|NCT01414166|189393|P2|STARTED|Overall Study||122
78783|NCT01414166|189394|P1|STARTED|Overall Study||122
78784|NCT01414153|189420|P4|NOT COMPLETED|Overall Study||4
78785|NCT01414153|189421|P3|NOT COMPLETED|Overall Study||4
78786|NCT01414153|189422|P2|NOT COMPLETED|Overall Study||2
78787|NCT01414153|189423|P1|NOT COMPLETED|Overall Study||8
78788|NCT01414153|189420|P4|COMPLETED|Overall Study||37
78789|NCT01414153|189421|P3|COMPLETED|Overall Study||35
78790|NCT01414153|189422|P2|COMPLETED|Overall Study||38
78791|NCT01414153|189423|P1|COMPLETED|Overall Study||30
78792|NCT01414153|189420|P4|STARTED|Overall Study||41
78793|NCT01414153|189421|P3|STARTED|Overall Study||39
78794|NCT01414153|189422|P2|STARTED|Overall Study||40
78795|NCT01414153|189423|P1|STARTED|Overall Study||38
78796|NCT01414114|189457|P1|NOT COMPLETED|Overall Study||5
78797|NCT01414114|189457|P1|COMPLETED|Overall Study|Completed 12-week treatment period|32
78798|NCT01414114|189457|P1|STARTED|Overall Study||37
78799|NCT01414036|189477|P2|NOT COMPLETED|Completed 3 Month Survey||5
78800|NCT01414036|189478|P1|NOT COMPLETED|Completed 3 Month Survey||9
78801|NCT01414036|189477|P2|COMPLETED|Completed 3 Month Survey||19
78802|NCT01414036|189478|P1|COMPLETED|Completed 3 Month Survey||14
78803|NCT01414036|189477|P2|STARTED|Completed 3 Month Survey||24
78804|NCT01414036|189478|P1|STARTED|Completed 3 Month Survey||23
78805|NCT01414036|189477|P2|NOT COMPLETED|Received Allocated Intervention||13
78806|NCT01414036|189478|P1|NOT COMPLETED|Received Allocated Intervention||0
78807|NCT01414036|189477|P2|COMPLETED|Received Allocated Intervention||11
78808|NCT01414036|189478|P1|COMPLETED|Received Allocated Intervention||23
78809|NCT01414036|189477|P2|STARTED|Received Allocated Intervention||24
78810|NCT01414036|189478|P1|STARTED|Received Allocated Intervention||23
78811|NCT01414010|189492|P4|NOT COMPLETED|Overall Study||0
78812|NCT01414010|189493|P3|NOT COMPLETED|Overall Study||0
78813|NCT01414010|189494|P2|NOT COMPLETED|Overall Study||0
78814|NCT01414010|189495|P1|NOT COMPLETED|Overall Study||2
78815|NCT01414010|189492|P4|COMPLETED|Overall Study||8
78816|NCT01414010|189493|P3|COMPLETED|Overall Study||8
78817|NCT01414010|189494|P2|COMPLETED|Overall Study||8
78818|NCT01414010|189495|P1|COMPLETED|Overall Study||6
78819|NCT01414010|189492|P4|STARTED|Overall Study||8
78820|NCT01414010|189493|P3|STARTED|Overall Study||8
78821|NCT01414010|189494|P2|STARTED|Overall Study||8
78822|NCT01414010|189495|P1|STARTED|Overall Study||8
78823|NCT01413958|189513|P2|NOT COMPLETED|Overall Study||1
78824|NCT01413958|189514|P1|NOT COMPLETED|Overall Study||0
78825|NCT01413958|189513|P2|COMPLETED|Overall Study||286
78826|NCT01413958|189514|P1|COMPLETED|Overall Study||288
78827|NCT01413958|189513|P2|STARTED|Overall Study||287
78828|NCT01413958|189514|P1|STARTED|Overall Study||288
78829|NCT01413750|189549|P4|NOT COMPLETED|Overall Study||0
78830|NCT01413750|189550|P3|NOT COMPLETED|Overall Study||0
78831|NCT01413750|189551|P2|NOT COMPLETED|Overall Study||0
78832|NCT01413750|189552|P1|NOT COMPLETED|Overall Study||0
78833|NCT01413750|189549|P4|COMPLETED|Overall Study||7
78834|NCT01413750|189550|P3|COMPLETED|Overall Study||4
78835|NCT01413750|189551|P2|COMPLETED|Overall Study||6
78836|NCT01413750|189552|P1|COMPLETED|Overall Study||6
78837|NCT01413750|189549|P4|STARTED|Overall Study||7
78838|NCT01413750|189550|P3|STARTED|Overall Study||4
78839|NCT01413750|189551|P2|STARTED|Overall Study||6
78840|NCT01413750|189552|P1|STARTED|Overall Study||6
78841|NCT01413542|189565|P4|NOT COMPLETED|Overall Study||1
78842|NCT01413542|189566|P3|NOT COMPLETED|Overall Study||3
78843|NCT01413542|189567|P2|NOT COMPLETED|Overall Study||0
78844|NCT01413542|189568|P1|NOT COMPLETED|Overall Study||1
78845|NCT01413542|189565|P4|COMPLETED|Overall Study||7
78846|NCT01413542|189566|P3|COMPLETED|Overall Study||6
78847|NCT01413542|189567|P2|COMPLETED|Overall Study||6
78848|NCT01413542|189568|P1|COMPLETED|Overall Study||5
78849|NCT01413542|189565|P4|STARTED|Overall Study||8
78850|NCT01413542|189566|P3|STARTED|Overall Study||9
78851|NCT01413542|189567|P2|STARTED|Overall Study||6
78852|NCT01413542|189568|P1|STARTED|Overall Study||6
78853|NCT01413516|189583|P2|NOT COMPLETED|Overall Study||0
78854|NCT01413516|189584|P1|NOT COMPLETED|Overall Study||0
78855|NCT01413516|189583|P2|COMPLETED|Overall Study||9
78856|NCT01413516|189584|P1|COMPLETED|Overall Study||8
78857|NCT01413516|189583|P2|STARTED|Overall Study||9
78858|NCT01413516|189584|P1|STARTED|Overall Study||8
78859|NCT01413360|189590|P1|NOT COMPLETED|Overall Study||3
78860|NCT01413360|189590|P1|COMPLETED|Overall Study||7
78861|NCT01413360|189590|P1|STARTED|Overall Study||10
78862|NCT01413204|189598|P3|NOT COMPLETED|Overall Study||19
78863|NCT01413204|189599|P2|NOT COMPLETED|Overall Study||6
78864|NCT01413204|189600|P1|NOT COMPLETED|Overall Study||6
78865|NCT01413204|189598|P3|COMPLETED|Overall Study||74
78866|NCT01413204|189599|P2|COMPLETED|Overall Study||83
78867|NCT01413204|189600|P1|COMPLETED|Overall Study||84
78868|NCT01413204|189598|P3|STARTED|Overall Study||93
78869|NCT01413204|189599|P2|STARTED|Overall Study||89
78870|NCT01413204|189600|P1|STARTED|Overall Study||90
78871|NCT01413191|189608|P1|NOT COMPLETED|Overall Study||11
78872|NCT01413191|189608|P1|COMPLETED|Overall Study||7
78873|NCT01413191|189608|P1|STARTED|Overall Study||18
78874|NCT01412983|189612|P2|NOT COMPLETED|2nd Period||0
78875|NCT01412983|189613|P1|NOT COMPLETED|2nd Period||0
78876|NCT01412983|189612|P2|COMPLETED|2nd Period||46
78877|NCT01412983|189613|P1|COMPLETED|2nd Period||50
78878|NCT01412983|189612|P2|STARTED|2nd Period||46
78879|NCT01412983|189613|P1|STARTED|2nd Period||50
78880|NCT01412983|189612|P2|NOT COMPLETED|1st Period||4
78881|NCT01412983|189613|P1|NOT COMPLETED|1st Period||0
78882|NCT01412983|189612|P2|COMPLETED|1st Period||46
78883|NCT01412983|189613|P1|COMPLETED|1st Period||50
78884|NCT01412983|189612|P2|STARTED|1st Period||50
78885|NCT01412983|189613|P1|STARTED|1st Period||50
78886|NCT01412957|189623|P2|NOT COMPLETED|Overall Study||157
78887|NCT01412957|189624|P1|NOT COMPLETED|Overall Study||149
78888|NCT01412957|189623|P2|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|31
78889|NCT01412957|189624|P1|COMPLETED|Overall Study|Participants continuing study at the time of data cut-off|40
78890|NCT01412957|189623|P2|STARTED|Overall Study||188
78891|NCT01412957|189624|P1|STARTED|Overall Study||189
78892|NCT01412944|189646|P6|NOT COMPLETED|Follow-up||0
78893|NCT01412944|189647|P5|NOT COMPLETED|Follow-up||0
78894|NCT01412944|189648|P4|NOT COMPLETED|Follow-up||0
78895|NCT01412944|189649|P3|NOT COMPLETED|Follow-up||0
78896|NCT01412944|189650|P2|NOT COMPLETED|Follow-up||0
78897|NCT01412944|189651|P1|NOT COMPLETED|Follow-up||0
78898|NCT01412944|189646|P6|COMPLETED|Follow-up||0
78899|NCT01412944|189647|P5|COMPLETED|Follow-up||2
78900|NCT01412944|189648|P4|COMPLETED|Follow-up||1
78901|NCT01412944|189649|P3|COMPLETED|Follow-up||2
78902|NCT01412944|189650|P2|COMPLETED|Follow-up||0
78903|NCT01412944|189651|P1|COMPLETED|Follow-up||0
78904|NCT01412944|189646|P6|STARTED|Follow-up||0
78905|NCT01412944|189647|P5|STARTED|Follow-up||2
78906|NCT01412944|189648|P4|STARTED|Follow-up||1
78907|NCT01412944|189649|P3|STARTED|Follow-up||2
78908|NCT01412944|189650|P2|STARTED|Follow-up||0
78909|NCT01412944|189651|P1|STARTED|Follow-up||0
78910|NCT01412944|189646|P6|NOT COMPLETED|Entire: IV + Maintenance||0
78911|NCT01412944|189647|P5|NOT COMPLETED|Entire: IV + Maintenance||0
78912|NCT01412944|189648|P4|NOT COMPLETED|Entire: IV + Maintenance||0
78913|NCT01412944|189649|P3|NOT COMPLETED|Entire: IV + Maintenance||0
78914|NCT01412944|189650|P2|NOT COMPLETED|Entire: IV + Maintenance||5
78915|NCT01412944|189651|P1|NOT COMPLETED|Entire: IV + Maintenance||2
78916|NCT01412944|189646|P6|COMPLETED|Entire: IV + Maintenance||0
78917|NCT01412944|189647|P5|COMPLETED|Entire: IV + Maintenance||0
78918|NCT01412944|189648|P4|COMPLETED|Entire: IV + Maintenance||0
78919|NCT01412944|189649|P3|COMPLETED|Entire: IV + Maintenance||0
78920|NCT01412944|189650|P2|COMPLETED|Entire: IV + Maintenance||17
78921|NCT01412944|189651|P1|COMPLETED|Entire: IV + Maintenance||19
78922|NCT01412944|189646|P6|STARTED|Entire: IV + Maintenance||0
78923|NCT01412944|189647|P5|STARTED|Entire: IV + Maintenance||0
78924|NCT01412944|189648|P4|STARTED|Entire: IV + Maintenance||0
78925|NCT01412944|189649|P3|STARTED|Entire: IV + Maintenance||0
78926|NCT01412944|189650|P2|STARTED|Entire: IV + Maintenance||22
78927|NCT01412944|189651|P1|STARTED|Entire: IV + Maintenance||21
78928|NCT01412944|189646|P6|NOT COMPLETED|Entire: IV + Maintenance||2
78929|NCT01412944|189647|P5|NOT COMPLETED|Entire: IV + Maintenance||3
78930|NCT01412944|189648|P4|NOT COMPLETED|Entire: IV + Maintenance||1
78931|NCT01412944|189649|P3|NOT COMPLETED|Entire: IV + Maintenance||1
78932|NCT01412944|189650|P2|NOT COMPLETED|Entire: IV + Maintenance||0
78933|NCT01412944|189651|P1|NOT COMPLETED|Entire: IV + Maintenance||0
78934|NCT01412944|189646|P6|COMPLETED|Entire: IV + Maintenance||6
78935|NCT01412944|189647|P5|COMPLETED|Entire: IV + Maintenance||11
78936|NCT01412944|189648|P4|COMPLETED|Entire: IV + Maintenance||5
78937|NCT01412944|189649|P3|COMPLETED|Entire: IV + Maintenance||14
78938|NCT01412944|189650|P2|COMPLETED|Entire: IV + Maintenance||0
78939|NCT01412944|189651|P1|COMPLETED|Entire: IV + Maintenance||0
78940|NCT01412944|189646|P6|STARTED|Entire: IV + Maintenance||8
78941|NCT01412944|189647|P5|STARTED|Entire: IV + Maintenance||14
78942|NCT01412944|189648|P4|STARTED|Entire: IV + Maintenance||6
78943|NCT01412944|189649|P3|STARTED|Entire: IV + Maintenance||15
78944|NCT01412944|189650|P2|STARTED|Entire: IV + Maintenance||0
78945|NCT01412944|189651|P1|STARTED|Entire: IV + Maintenance||0
78946|NCT01412944|189646|P6|NOT COMPLETED|IV: Per CAIN457A2307||0
78947|NCT01412944|189647|P5|NOT COMPLETED|IV: Per CAIN457A2307||0
78948|NCT01412944|189648|P4|NOT COMPLETED|IV: Per CAIN457A2307||0
78949|NCT01412944|189649|P3|NOT COMPLETED|IV: Per CAIN457A2307||0
78950|NCT01412944|189650|P2|NOT COMPLETED|IV: Per CAIN457A2307||2
78951|NCT01412944|189651|P1|NOT COMPLETED|IV: Per CAIN457A2307||1
78952|NCT01412944|189646|P6|COMPLETED|IV: Per CAIN457A2307||0
78953|NCT01412944|189647|P5|COMPLETED|IV: Per CAIN457A2307||0
78954|NCT01412944|189648|P4|COMPLETED|IV: Per CAIN457A2307||0
78955|NCT01412944|189649|P3|COMPLETED|IV: Per CAIN457A2307||0
78956|NCT01412944|189650|P2|COMPLETED|IV: Per CAIN457A2307||20
78957|NCT01412944|189651|P1|COMPLETED|IV: Per CAIN457A2307||20
78958|NCT01412944|189646|P6|STARTED|IV: Per CAIN457A2307||0
78959|NCT01412944|189647|P5|STARTED|IV: Per CAIN457A2307||0
78960|NCT01412944|189648|P4|STARTED|IV: Per CAIN457A2307||0
78961|NCT01412944|189649|P3|STARTED|IV: Per CAIN457A2307||0
78962|NCT01412944|189650|P2|STARTED|IV: Per CAIN457A2307||22
78963|NCT01412944|189651|P1|STARTED|IV: Per CAIN457A2307||21
78964|NCT01412944|189646|P6|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||2
78965|NCT01412944|189647|P5|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
78966|NCT01412944|189648|P4|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
78967|NCT01412944|189649|P3|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||1
78968|NCT01412944|189650|P2|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
78969|NCT01412944|189651|P1|NOT COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
78970|NCT01412944|189646|P6|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
78971|NCT01412944|189647|P5|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
78972|NCT01412944|189648|P4|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||6
78973|NCT01412944|189649|P3|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||14
78974|NCT01412944|189650|P2|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
78975|NCT01412944|189651|P1|COMPLETED|IV: Per Previous CAIN457A2304 Treatment||0
78976|NCT01412944|189646|P6|STARTED|IV: Per Previous CAIN457A2304 Treatment||8
78977|NCT01412944|189647|P5|STARTED|IV: Per Previous CAIN457A2304 Treatment||14
78978|NCT01412944|189648|P4|STARTED|IV: Per Previous CAIN457A2304 Treatment||6
78979|NCT01412944|189649|P3|STARTED|IV: Per Previous CAIN457A2304 Treatment||15
78980|NCT01412944|189650|P2|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
78981|NCT01412944|189651|P1|STARTED|IV: Per Previous CAIN457A2304 Treatment||0
78982|NCT01412918|189687|P2|NOT COMPLETED|Overall Study||0
78983|NCT01412918|189688|P1|NOT COMPLETED|Overall Study||0
78984|NCT01412918|189687|P2|COMPLETED|Overall Study||1
78985|NCT01412918|189688|P1|COMPLETED|Overall Study||20
78986|NCT01412918|189687|P2|STARTED|Overall Study||1
78987|NCT01412918|189688|P1|STARTED|Overall Study||20
78988|NCT01412879|189697|P3|NOT COMPLETED|Consolidation Therapy||0
78989|NCT01412879|189698|P2|NOT COMPLETED|Consolidation Therapy||0
78990|NCT01412879|189699|P1|NOT COMPLETED|Consolidation Therapy||0
78991|NCT01412879|189697|P3|COMPLETED|Consolidation Therapy||26
78992|NCT01412879|189698|P2|COMPLETED|Consolidation Therapy||0
78993|NCT01412879|189699|P1|COMPLETED|Consolidation Therapy||0
78994|NCT01412879|189697|P3|STARTED|Consolidation Therapy|Only eligible patients who are able to have stem cell harvested receive consolidation therapy.|26
78995|NCT01412879|189698|P2|STARTED|Consolidation Therapy||0
78996|NCT01412879|189699|P1|STARTED|Consolidation Therapy||0
78997|NCT01412879|189697|P3|NOT COMPLETED|Initial Registration (Induction Therapy)||0
78998|NCT01412879|189698|P2|NOT COMPLETED|Initial Registration (Induction Therapy)||8
78999|NCT01412879|189699|P1|NOT COMPLETED|Initial Registration (Induction Therapy)||13
79000|NCT01412879|189697|P3|COMPLETED|Initial Registration (Induction Therapy)||0
79001|NCT01412879|189698|P2|COMPLETED|Initial Registration (Induction Therapy)||27
79002|NCT01412879|189699|P1|COMPLETED|Initial Registration (Induction Therapy)||5
79003|NCT01412879|189697|P3|Treatment Started|Initial Registration (Induction Therapy)||0
79004|NCT01412879|189698|P2|Treatment Started|Initial Registration (Induction Therapy)||35
79005|NCT01412879|189699|P1|Treatment Started|Initial Registration (Induction Therapy)||17
79006|NCT01412879|189697|P3|STARTED|Initial Registration (Induction Therapy)||0
79007|NCT01412879|189698|P2|STARTED|Initial Registration (Induction Therapy)||35
79008|NCT01412879|189699|P1|STARTED|Initial Registration (Induction Therapy)||18
79009|NCT01412801|189719|P6|NOT COMPLETED|Overall Study||3
79010|NCT01412801|189720|P5|NOT COMPLETED|Overall Study||3
79011|NCT01412801|189721|P4|NOT COMPLETED|Overall Study||4
79012|NCT01412801|189722|P3|NOT COMPLETED|Overall Study||7
79013|NCT01412801|189723|P2|NOT COMPLETED|Overall Study||5
79014|NCT01412801|189724|P1|NOT COMPLETED|Overall Study||4
79015|NCT01412801|189719|P6|COMPLETED|Overall Study||84
79016|NCT01412801|189720|P5|COMPLETED|Overall Study||85
79017|NCT01412801|189721|P4|COMPLETED|Overall Study||87
79018|NCT01412801|189722|P3|COMPLETED|Overall Study||83
79019|NCT01412801|189723|P2|COMPLETED|Overall Study||84
79020|NCT01412801|189724|P1|COMPLETED|Overall Study||87
79021|NCT01412801|189719|P6|STARTED|Overall Study||87
79022|NCT01412801|189720|P5|STARTED|Overall Study||88
79023|NCT01412801|189721|P4|STARTED|Overall Study||91
79024|NCT01412801|189722|P3|STARTED|Overall Study||90
79025|NCT01412801|189723|P2|STARTED|Overall Study||89
79026|NCT01412801|189724|P1|STARTED|Overall Study||91
79027|NCT01412541|189763|P2|NOT COMPLETED|Overall Study||20
79028|NCT01412541|189764|P1|NOT COMPLETED|Overall Study||36
79029|NCT01412541|189763|P2|COMPLETED|Overall Study||140
79030|NCT01412541|189764|P1|COMPLETED|Overall Study||280
79031|NCT01412541|189763|P2|STARTED|Overall Study||160
79032|NCT01412541|189764|P1|STARTED|Overall Study||316
79033|NCT01412424|189872|P1|NOT COMPLETED|Extension Treatment Period||6
79034|NCT01412424|189872|P1|COMPLETED|Extension Treatment Period||82
79035|NCT01412424|189872|P1|STARTED|Extension Treatment Period|86% of participants who completed the core period voluntarily entered the optional extension period.|88
79036|NCT01412424|189872|P1|NOT COMPLETED|Core Treatment Period||53
79037|NCT01412424|189872|P1|COMPLETED|Core Treatment Period||102
79038|NCT01412424|189872|P1|STARTED|Core Treatment Period||155
79039|NCT01412333|189890|P2|NOT COMPLETED|Overall Study||57
79040|NCT01412333|189891|P1|NOT COMPLETED|Overall Study||98
79041|NCT01412333|189890|P2|COMPLETED|Overall Study||360
79042|NCT01412333|189891|P1|COMPLETED|Overall Study||320
79043|NCT01412333|189890|P2|STARTED|Overall Study||417
79044|NCT01412333|189891|P1|STARTED|Overall Study||418
79045|NCT01412281|189926|P4|NOT COMPLETED|Overall Study||0
79046|NCT01412281|189927|P3|NOT COMPLETED|Overall Study||0
79047|NCT01412281|189928|P2|NOT COMPLETED|Overall Study||0
79048|NCT01412281|189929|P1|NOT COMPLETED|Overall Study||0
79049|NCT01412281|189926|P4|COMPLETED|Overall Study||110
79050|NCT01412281|189927|P3|COMPLETED|Overall Study||110
79051|NCT01412281|189928|P2|COMPLETED|Overall Study||110
79052|NCT01412281|189929|P1|COMPLETED|Overall Study||110
79053|NCT01412281|189926|P4|STARTED|Overall Study||110
79054|NCT01412281|189927|P3|STARTED|Overall Study||110
79055|NCT01412281|189928|P2|STARTED|Overall Study||110
79056|NCT01412281|189929|P1|STARTED|Overall Study||110
79057|NCT01412229|189951|P1|NOT COMPLETED|Overall Study||1
79058|NCT01412229|189951|P1|COMPLETED|Overall Study||38
79059|NCT01412229|189951|P1|STARTED|Overall Study||39
79060|NCT01412164|189963|P1|NOT COMPLETED|Overall Study||18
79061|NCT01412164|189963|P1|COMPLETED|Overall Study||712
79062|NCT01412164|189963|P1|STARTED|Overall Study||730
79063|NCT01412151|189967|P1|NOT COMPLETED|Week 306 - 310 - Washout Period||2
79064|NCT01412151|189967|P1|COMPLETED|Week 306 - 310 - Washout Period||3
79065|NCT01412151|189967|P1|STARTED|Week 306 - 310 - Washout Period||5
79066|NCT01412151|189967|P1|NOT COMPLETED|Week 0 - 306 - Treatment Period||5
79067|NCT01412151|189967|P1|COMPLETED|Week 0 - 306 - Treatment Period||5
79068|NCT01412151|189967|P1|STARTED|Week 0 - 306 - Treatment Period||10
79069|NCT01412086|189971|P1|NOT COMPLETED|Overall Study||0
79070|NCT01412086|189971|P1|COMPLETED|Overall Study||112
79071|NCT01412086|189971|P1|STARTED|Overall Study||112
79072|NCT01411891|189978|P2|NOT COMPLETED|Overall Study||2
79073|NCT01411891|189979|P1|NOT COMPLETED|Overall Study||3
79074|NCT01411891|189978|P2|COMPLETED|Overall Study||48
79075|NCT01411891|189979|P1|COMPLETED|Overall Study||47
79076|NCT01411891|189978|P2|STARTED|Overall Study||50
79077|NCT01411891|189979|P1|STARTED|Overall Study||50
79078|NCT01411852|189987|P2|NOT COMPLETED|Hospital Intervention Phase||18
79079|NCT01411852|189988|P1|NOT COMPLETED|Hospital Intervention Phase||24
79080|NCT01411852|189987|P2|COMPLETED|Hospital Intervention Phase|18 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|71
79081|NCT01411852|189988|P1|COMPLETED|Hospital Intervention Phase|24 patients had intervention stopped prior to 2 hours after arrival or hemorrhage control|59
79082|NCT01411852|189987|P2|STARTED|Hospital Intervention Phase||89
79083|NCT01411852|189988|P1|STARTED|Hospital Intervention Phase||83
79084|NCT01411852|189987|P2|NOT COMPLETED|Prehospital Intervention Phase||7
79085|NCT01411852|189988|P1|NOT COMPLETED|Prehospital Intervention Phase||12
79086|NCT01411852|189987|P2|COMPLETED|Prehospital Intervention Phase|7 patients had intervention stopped prior to hospital arrival|89
79087|NCT01411852|189988|P1|COMPLETED|Prehospital Intervention Phase|12 patients had the intervention stopped prior to hospital arrival|83
79088|NCT01411852|189987|P2|STARTED|Prehospital Intervention Phase|One patient was in police custody at the time of enrollment. Patient's data omitted from analyses.|96
79089|NCT01411852|189988|P1|STARTED|Prehospital Intervention Phase|1 patient randomized to 2000 mL bolus arm but received 250 mL bolus. Analyzed in 2000 mL arm.|95
79090|NCT01411696|190031|P1|NOT COMPLETED|Overall Study||0
79091|NCT01411696|190031|P1|COMPLETED|Overall Study||289
79092|NCT01411696|190031|P1|STARTED|Overall Study||289
79093|NCT01411592|190040|P2|NOT COMPLETED|Overall Study||0
79094|NCT01411592|190041|P1|NOT COMPLETED|Overall Study||0
79095|NCT01411592|190040|P2|COMPLETED|Overall Study||16
79096|NCT01411592|190041|P1|COMPLETED|Overall Study||14
79097|NCT01411592|190040|P2|5-Year Time Frame|Overall Study||16
79098|NCT01411592|190041|P1|5-Year Time Frame|Overall Study||14
79099|NCT01411592|190040|P2|STARTED|Overall Study||16
79100|NCT01411592|190041|P1|STARTED|Overall Study||14
79101|NCT01411501|190053|P4|NOT COMPLETED|Overall Study||7
79102|NCT01411501|190054|P3|NOT COMPLETED|Overall Study||6
79103|NCT01411501|190055|P2|NOT COMPLETED|Overall Study||6
79104|NCT01411501|190056|P1|NOT COMPLETED|Overall Study||10
79105|NCT01411501|190053|P4|COMPLETED|Overall Study||163
79106|NCT01411501|190054|P3|COMPLETED|Overall Study||159
79107|NCT01411501|190055|P2|COMPLETED|Overall Study||166
79108|NCT01411501|190056|P1|COMPLETED|Overall Study||158
79109|NCT01411501|190053|P4|STARTED|Overall Study||170
79110|NCT01411501|190054|P3|STARTED|Overall Study||165
79111|NCT01411501|190055|P2|STARTED|Overall Study||172
79112|NCT01411501|190056|P1|STARTED|Overall Study||168
79113|NCT01411228|190089|P3|NOT COMPLETED|Overall Study||1
79114|NCT01411228|190090|P2|NOT COMPLETED|Overall Study||0
79115|NCT01411228|190091|P1|NOT COMPLETED|Overall Study||1
79116|NCT01411228|190089|P3|COMPLETED|Overall Study||4
79117|NCT01411228|190090|P2|COMPLETED|Overall Study||5
79118|NCT01411228|190091|P1|COMPLETED|Overall Study||4
79119|NCT01411228|190089|P3|STARTED|Overall Study||5
79120|NCT01411228|190090|P2|STARTED|Overall Study||5
79121|NCT01411228|190091|P1|STARTED|Overall Study||5
79122|NCT01411215|190113|P2|NOT COMPLETED|Overall Study||84
79123|NCT01411215|190114|P1|NOT COMPLETED|Overall Study||66
79124|NCT01411215|190113|P2|COMPLETED|Overall Study||7
79125|NCT01411215|190114|P1|COMPLETED|Overall Study||3
79126|NCT01411215|190113|P2|Treated|Overall Study|1 participant was considered as screen failure and therefore not treated.|90
79127|NCT01411215|190114|P1|Treated|Overall Study||69
79128|NCT01411215|190113|P2|STARTED|Overall Study||91
79129|NCT01411215|190114|P1|STARTED|Overall Study||69
79130|NCT01411137|190147|P1|NOT COMPLETED|Part 3: Open-Label Extension||0
79131|NCT01411137|190147|P1|COMPLETED|Part 3: Open-Label Extension||12
79132|NCT01411137|190147|P1|STARTED|Part 3: Open-Label Extension|Two sites with 11 completers of Part 2 did not participate in Part 3. Two subjects lost contact.|12
79133|NCT01411137|190147|P1|NOT COMPLETED|Part 2: Open-Label Extension||7
79134|NCT01411137|190147|P1|COMPLETED|Part 2: Open-Label Extension||25
79135|NCT01411137|190147|P1|STARTED|Part 2: Open-Label Extension|1 subject who completed Part 1 did not elect to continue into Part 2.|32
79136|NCT01411137|190147|P1|NOT COMPLETED|Part 1: Dose Conversion||10
79137|NCT01411137|190147|P1|COMPLETED|Part 1: Dose Conversion||33
79138|NCT01411137|190147|P1|STARTED|Part 1: Dose Conversion||43
79139|NCT01410773|190166|P1|NOT COMPLETED|Overall Study||0
79140|NCT01410773|190166|P1|COMPLETED|Overall Study||110
79141|NCT01410773|190166|P1|STARTED|Overall Study||110
79142|NCT01410604|190173|P2|NOT COMPLETED|Overall Study||2
79143|NCT01410604|190174|P1|NOT COMPLETED|Overall Study||3
79144|NCT01410604|190173|P2|COMPLETED|Overall Study||14
79145|NCT01410604|190174|P1|COMPLETED|Overall Study||12
79146|NCT01410604|190173|P2|STARTED|Overall Study||16
79147|NCT01410604|190174|P1|STARTED|Overall Study||15
79148|NCT01410565|190196|P3|NOT COMPLETED|Double Blind Phase||0
79149|NCT01410565|190197|P2|NOT COMPLETED|Double Blind Phase||15
79150|NCT01410565|190198|P1|NOT COMPLETED|Double Blind Phase||13
79151|NCT01410565|190196|P3|COMPLETED|Double Blind Phase||0
79152|NCT01410565|190197|P2|COMPLETED|Double Blind Phase||0
79153|NCT01410565|190198|P1|COMPLETED|Double Blind Phase||0
79154|NCT01410565|190196|P3|STARTED|Double Blind Phase||0
79155|NCT01410565|190197|P2|STARTED|Double Blind Phase||15
79156|NCT01410565|190198|P1|STARTED|Double Blind Phase|All 66 patients received one dose of Apaziquone in the open label phase.|13
79157|NCT01410565|190196|P3|NOT COMPLETED|Open Label Phase Apaziquone||8
79158|NCT01410565|190197|P2|NOT COMPLETED|Open Label Phase Apaziquone||0
79159|NCT01410565|190198|P1|NOT COMPLETED|Open Label Phase Apaziquone||0
79160|NCT01410565|190196|P3|COMPLETED|Open Label Phase Apaziquone||58
79161|NCT01410565|190197|P2|COMPLETED|Open Label Phase Apaziquone||0
79162|NCT01410565|190198|P1|COMPLETED|Open Label Phase Apaziquone||0
79163|NCT01410565|190196|P3|STARTED|Open Label Phase Apaziquone||66
79164|NCT01410565|190197|P2|STARTED|Open Label Phase Apaziquone||0
79165|NCT01410565|190198|P1|STARTED|Open Label Phase Apaziquone||0
79166|NCT01410474|190210|P2|NOT COMPLETED|Overall Study||1
79167|NCT01410474|190211|P1|NOT COMPLETED|Overall Study||0
79168|NCT01410474|190210|P2|COMPLETED|Overall Study||167
79169|NCT01410474|190211|P1|COMPLETED|Overall Study||173
79170|NCT01410474|190210|P2|STARTED|Overall Study||168
79171|NCT01410474|190211|P1|STARTED|Overall Study||173
79172|NCT01410448|190234|P2|NOT COMPLETED|Overall Study||35
79173|NCT01410448|190235|P1|NOT COMPLETED|Overall Study||12
79174|NCT01410448|190234|P2|COMPLETED|Overall Study||155
79175|NCT01410448|190235|P1|COMPLETED|Overall Study||181
79176|NCT01410448|190234|P2|Modified ITT Analysis Set|Overall Study||149
79177|NCT01410448|190235|P1|Modified ITT Analysis Set|Overall Study||161
79178|NCT01410448|190234|P2|Intent-to Treat (ITT) Analysis Set|Overall Study||190
79179|NCT01410448|190235|P1|Intent-to Treat (ITT) Analysis Set|Overall Study||193
79180|NCT01410448|190234|P2|STARTED|Overall Study||190
79181|NCT01410448|190235|P1|STARTED|Overall Study||193
79182|NCT01410409|190275|P2|NOT COMPLETED|Overall Study||4
79183|NCT01410409|190276|P1|NOT COMPLETED|Overall Study||1
79184|NCT01410409|190275|P2|COMPLETED|Overall Study||46
79185|NCT01410409|190276|P1|COMPLETED|Overall Study||49
79186|NCT01410409|190275|P2|STARTED|Overall Study||50
79187|NCT01410409|190276|P1|STARTED|Overall Study||50
79188|NCT01410240|190301|P3|NOT COMPLETED|Overall Study||2
79189|NCT01410240|190302|P2|NOT COMPLETED|Overall Study||1
79190|NCT01410240|190303|P1|NOT COMPLETED|Overall Study||1
79191|NCT01410240|190301|P3|COMPLETED|Overall Study||10
79192|NCT01410240|190302|P2|COMPLETED|Overall Study||52
79193|NCT01410240|190303|P1|COMPLETED|Overall Study||52
79194|NCT01410240|190301|P3|STARTED|Overall Study||12
79195|NCT01410240|190302|P2|STARTED|Overall Study||53
79196|NCT01410240|190303|P1|STARTED|Overall Study||53
79197|NCT01410227|190374|P4|NOT COMPLETED|Overall Study||1
79198|NCT01410227|190375|P3|NOT COMPLETED|Overall Study||2
79199|NCT01410227|190376|P2|NOT COMPLETED|Overall Study||0
79200|NCT01410227|190377|P1|NOT COMPLETED|Overall Study||4
79201|NCT01410227|190374|P4|COMPLETED|Overall Study||5
79202|NCT01410227|190375|P3|COMPLETED|Overall Study||13
79203|NCT01410227|190376|P2|COMPLETED|Overall Study||8
79204|NCT01410227|190377|P1|COMPLETED|Overall Study||4
79205|NCT01410227|190374|P4|STARTED|Overall Study||6
79206|NCT01410227|190375|P3|STARTED|Overall Study||15
79207|NCT01410227|190376|P2|STARTED|Overall Study||8
79208|NCT01410227|190377|P1|STARTED|Overall Study||8
79209|NCT01410110|190449|P2|NOT COMPLETED|Overall Study||2
79210|NCT01410110|190450|P1|NOT COMPLETED|Overall Study||4
79211|NCT01410110|190449|P2|COMPLETED|Overall Study||22
79212|NCT01410110|190450|P1|COMPLETED|Overall Study||20
79213|NCT01410110|190449|P2|6 Month Follow-up|Overall Study||22
79214|NCT01410110|190450|P1|6 Month Follow-up|Overall Study||20
79215|NCT01410110|190449|P2|3 Months (End of Intervention)|Overall Study||22
79216|NCT01410110|190450|P1|3 Months (End of Intervention)|Overall Study||20
79217|NCT01410110|190449|P2|Randomization|Overall Study||24
79218|NCT01410110|190450|P1|Randomization|Overall Study||24
79219|NCT01410110|190449|P2|STARTED|Overall Study||24
79220|NCT01410110|190450|P1|STARTED|Overall Study||24
79221|NCT01409993|190474|P4|NOT COMPLETED|Overall Study||5
79222|NCT01409993|190475|P3|NOT COMPLETED|Overall Study||3
79223|NCT01409993|190476|P2|NOT COMPLETED|Overall Study||5
79224|NCT01409993|190477|P1|NOT COMPLETED|Overall Study||4
79225|NCT01409993|190474|P4|COMPLETED|Overall Study||8
79226|NCT01409993|190475|P3|COMPLETED|Overall Study||11
79227|NCT01409993|190476|P2|COMPLETED|Overall Study||21
79228|NCT01409993|190477|P1|COMPLETED|Overall Study||21
79229|NCT01409993|190474|P4|STARTED|Overall Study||13
79230|NCT01409993|190475|P3|STARTED|Overall Study||14
79231|NCT01409993|190476|P2|STARTED|Overall Study||26
79232|NCT01409993|190477|P1|STARTED|Overall Study||25
79233|NCT01409837|190497|P2|NOT COMPLETED|Overall Study||2
79234|NCT01409837|190498|P1|NOT COMPLETED|Overall Study||3
79235|NCT01409837|190497|P2|COMPLETED|Overall Study||14
79236|NCT01409837|190498|P1|COMPLETED|Overall Study||14
79237|NCT01409837|190497|P2|282nd Week|Overall Study||14
79238|NCT01409837|190498|P1|282nd Week|Overall Study||14
79239|NCT01409837|190497|P2|186th Week|Overall Study||14
79240|NCT01409837|190498|P1|186th Week|Overall Study|Moved away to another location|14
79241|NCT01409837|190497|P2|138th Week|Overall Study||14
79242|NCT01409837|190498|P1|138th Week|Overall Study||15
79243|NCT01409837|190497|P2|114th Week|Overall Study||14
79244|NCT01409837|190498|P1|114th Week|Overall Study||15
79245|NCT01409837|190497|P2|102nd Week|Overall Study|Married another wife|14
79246|NCT01409837|190498|P1|102nd Week|Overall Study||15
79247|NCT01409837|190497|P2|96th Week|Overall Study||15
79248|NCT01409837|190498|P1|96th Week|Overall Study||15
79249|NCT01409837|190497|P2|48th Week|Overall Study||15
79250|NCT01409837|190498|P1|48th Week|Overall Study|Lost to follow-up|15
79251|NCT01409837|190497|P2|24th Week|Overall Study|Diagnosed with Lymphocytic Lymphoma and withdrawn|15
79252|NCT01409837|190498|P1|24th Week|Overall Study||16
79253|NCT01409837|190497|P2|12th Week|Overall Study||16
79254|NCT01409837|190498|P1|12th Week|Overall Study|Moved away to another location|16
79255|NCT01409837|190497|P2|6th Week|Overall Study||16
79256|NCT01409837|190498|P1|6th Week|Overall Study||17
79257|NCT01409837|190497|P2|STARTED|Overall Study||16
79258|NCT01409837|190498|P1|STARTED|Overall Study||17
79259|NCT01409707|190523|P3|NOT COMPLETED|Overall Study||16
79260|NCT01409707|190524|P2|NOT COMPLETED|Overall Study||17
79261|NCT01409707|190525|P1|NOT COMPLETED|Overall Study||5
79262|NCT01409707|190523|P3|COMPLETED|Overall Study||24
79263|NCT01409707|190524|P2|COMPLETED|Overall Study||28
79264|NCT01409707|190525|P1|COMPLETED|Overall Study||36
79265|NCT01409707|190523|P3|STARTED|Overall Study||40
79266|NCT01409707|190524|P2|STARTED|Overall Study||45
79267|NCT01409707|190525|P1|STARTED|Overall Study||41
79268|NCT01409564|190537|P2|NOT COMPLETED|Overall Study||5
79269|NCT01409564|190538|P1|NOT COMPLETED|Overall Study||5
79270|NCT01409564|190537|P2|COMPLETED|Overall Study||18
79271|NCT01409564|190538|P1|COMPLETED|Overall Study||18
79272|NCT01409564|190537|P2|STARTED|Overall Study||23
79273|NCT01409564|190538|P1|STARTED|Overall Study||23
79274|NCT01409434|190556|P1|NOT COMPLETED|Overall Study||4
79275|NCT01409434|190556|P1|COMPLETED|Overall Study||40
79276|NCT01409434|190556|P1|STARTED|Overall Study||44
79277|NCT01409382|190566|P2|NOT COMPLETED|Overall Study||80
79278|NCT01409382|190567|P1|NOT COMPLETED|Overall Study||81
79279|NCT01409382|190566|P2|COMPLETED|Overall Study||160
79280|NCT01409382|190567|P1|COMPLETED|Overall Study||159
79281|NCT01409382|190566|P2|STARTED|Overall Study||240
79282|NCT01409382|190567|P1|STARTED|Overall Study||240
79283|NCT01409291|190581|P2|NOT COMPLETED|Overall Study||9
79284|NCT01409291|190582|P1|NOT COMPLETED|Overall Study||7
79285|NCT01409291|190581|P2|COMPLETED|Overall Study||19
79286|NCT01409291|190582|P1|COMPLETED|Overall Study||29
79287|NCT01409291|190581|P2|STARTED|Overall Study||28
79288|NCT01409291|190582|P1|STARTED|Overall Study||36
79289|NCT01409239|190592|P2|NOT COMPLETED|Overall Study||0
79290|NCT01409239|190593|P1|NOT COMPLETED|Overall Study||0
79291|NCT01409239|190592|P2|COMPLETED|Overall Study||17
79292|NCT01409239|190593|P1|COMPLETED|Overall Study||16
79293|NCT01409239|190592|P2|STARTED|Overall Study||17
79294|NCT01409239|190593|P1|STARTED|Overall Study||16
79295|NCT01409213|190599|P1|NOT COMPLETED|Overall Study||0
79296|NCT01409213|190599|P1|COMPLETED|Overall Study||1523
79297|NCT01409213|190599|P1|STARTED|Overall Study||1523
79298|NCT01409096|190606|P2|NOT COMPLETED|Overall Study||5
79299|NCT01409096|190607|P1|NOT COMPLETED|Overall Study||2
79300|NCT01409096|190606|P2|COMPLETED|Overall Study||35
79301|NCT01409096|190607|P1|COMPLETED|Overall Study||38
79302|NCT01409096|190606|P2|STARTED|Overall Study||40
79303|NCT01409096|190607|P1|STARTED|Overall Study||40
79304|NCT01408992|190619|P1|NOT COMPLETED|Overall Study||0
79305|NCT01408992|190619|P1|COMPLETED|Overall Study||558
79306|NCT01408992|190619|P1|STARTED|Overall Study||558
79307|NCT01408914|190634|P3|NOT COMPLETED|Overall Study||13
79308|NCT01408914|190635|P2|NOT COMPLETED|Overall Study||12
79309|NCT01408914|190636|P1|NOT COMPLETED|Overall Study||12
79310|NCT01408914|190634|P3|COMPLETED|Overall Study||47
79311|NCT01408914|190635|P2|COMPLETED|Overall Study||48
79312|NCT01408914|190636|P1|COMPLETED|Overall Study||48
79313|NCT01408914|190634|P3|STARTED|Overall Study||60
79314|NCT01408914|190635|P2|STARTED|Overall Study||60
79315|NCT01408914|190636|P1|STARTED|Overall Study||60
79316|NCT01408888|190650|P2|NOT COMPLETED|Second Intervention||0
79317|NCT01408888|190651|P1|NOT COMPLETED|Second Intervention||2
79318|NCT01408888|190650|P2|COMPLETED|Second Intervention||8
79319|NCT01408888|190651|P1|COMPLETED|Second Intervention||16
79320|NCT01408888|190650|P2|STARTED|Second Intervention||8
79321|NCT01408888|190651|P1|STARTED|Second Intervention||18
79322|NCT01408888|190650|P2|NOT COMPLETED|Washout of at Least 21 Days||0
79323|NCT01408888|190651|P1|NOT COMPLETED|Washout of at Least 21 Days||0
79324|NCT01408888|190650|P2|COMPLETED|Washout of at Least 21 Days||8
79325|NCT01408888|190651|P1|COMPLETED|Washout of at Least 21 Days||18
79326|NCT01408888|190650|P2|STARTED|Washout of at Least 21 Days||8
79327|NCT01408888|190651|P1|STARTED|Washout of at Least 21 Days||18
79328|NCT01408888|190650|P2|NOT COMPLETED|First Intervention||3
79329|NCT01408888|190651|P1|NOT COMPLETED|First Intervention||0
79330|NCT01408888|190650|P2|COMPLETED|First Intervention||8
79331|NCT01408888|190651|P1|COMPLETED|First Intervention||18
79332|NCT01408888|190650|P2|Received at Least 1 Dose of Drug|First Intervention||11
79333|NCT01408888|190651|P1|Received at Least 1 Dose of Drug|First Intervention||18
79334|NCT01408888|190650|P2|STARTED|First Intervention||11
79335|NCT01408888|190651|P1|STARTED|First Intervention||18
79336|NCT01408862|190674|P1|NOT COMPLETED|Overall Study||0
79337|NCT01408862|190674|P1|COMPLETED|Overall Study||20
79338|NCT01408862|190674|P1|STARTED|Overall Study||20
79339|NCT01408719|190699|P20|NOT COMPLETED|Fourth Intervention (35 Days)||0
79340|NCT01408719|190700|P19|NOT COMPLETED|Fourth Intervention (35 Days)||0
79341|NCT01408719|190701|P18|NOT COMPLETED|Fourth Intervention (35 Days)||0
79342|NCT01408719|190702|P17|NOT COMPLETED|Fourth Intervention (35 Days)||0
79343|NCT01408719|190703|P16|NOT COMPLETED|Fourth Intervention (35 Days)||0
79344|NCT01408719|190704|P15|NOT COMPLETED|Fourth Intervention (35 Days)||0
79345|NCT01408719|190705|P14|NOT COMPLETED|Fourth Intervention (35 Days)||0
79346|NCT01408719|190706|P13|NOT COMPLETED|Fourth Intervention (35 Days)||0
79347|NCT01408719|190707|P12|NOT COMPLETED|Fourth Intervention (35 Days)||0
79348|NCT01408719|190708|P11|NOT COMPLETED|Fourth Intervention (35 Days)||0
79349|NCT01408719|190709|P10|NOT COMPLETED|Fourth Intervention (35 Days)||0
79350|NCT01408719|190710|P9|NOT COMPLETED|Fourth Intervention (35 Days)||0
79351|NCT01408719|190711|P8|NOT COMPLETED|Fourth Intervention (35 Days)||0
79352|NCT01408719|190712|P7|NOT COMPLETED|Fourth Intervention (35 Days)||0
79353|NCT01408719|190713|P6|NOT COMPLETED|Fourth Intervention (35 Days)||0
79354|NCT01408719|190714|P5|NOT COMPLETED|Fourth Intervention (35 Days)||0
79355|NCT01408719|190715|P4|NOT COMPLETED|Fourth Intervention (35 Days)||0
79356|NCT01408719|190716|P3|NOT COMPLETED|Fourth Intervention (35 Days)||0
79357|NCT01408719|190717|P2|NOT COMPLETED|Fourth Intervention (35 Days)||0
79358|NCT01408719|190718|P1|NOT COMPLETED|Fourth Intervention (35 Days)||0
79359|NCT01408719|190699|P20|COMPLETED|Fourth Intervention (35 Days)||1
79360|NCT01408719|190700|P19|COMPLETED|Fourth Intervention (35 Days)||0
79361|NCT01408719|190701|P18|COMPLETED|Fourth Intervention (35 Days)||2
79362|NCT01408719|190702|P17|COMPLETED|Fourth Intervention (35 Days)||2
79363|NCT01408719|190703|P16|COMPLETED|Fourth Intervention (35 Days)||1
79364|NCT01408719|190704|P15|COMPLETED|Fourth Intervention (35 Days)||1
79365|NCT01408719|190705|P14|COMPLETED|Fourth Intervention (35 Days)||3
79366|NCT01408719|190706|P13|COMPLETED|Fourth Intervention (35 Days)||1
79367|NCT01408719|190707|P12|COMPLETED|Fourth Intervention (35 Days)||2
79368|NCT01408719|190708|P11|COMPLETED|Fourth Intervention (35 Days)||2
79369|NCT01408719|190709|P10|COMPLETED|Fourth Intervention (35 Days)||1
79370|NCT01408719|190710|P9|COMPLETED|Fourth Intervention (35 Days)||1
79371|NCT01408719|190711|P8|COMPLETED|Fourth Intervention (35 Days)||2
79372|NCT01408719|190712|P7|COMPLETED|Fourth Intervention (35 Days)||2
79373|NCT01408719|190713|P6|COMPLETED|Fourth Intervention (35 Days)||3
79374|NCT01408719|190714|P5|COMPLETED|Fourth Intervention (35 Days)||3
79375|NCT01408719|190715|P4|COMPLETED|Fourth Intervention (35 Days)||2
79376|NCT01408719|190716|P3|COMPLETED|Fourth Intervention (35 Days)||1
79377|NCT01408719|190717|P2|COMPLETED|Fourth Intervention (35 Days)||3
79378|NCT01408719|190718|P1|COMPLETED|Fourth Intervention (35 Days)||2
79379|NCT01408719|190699|P20|STARTED|Fourth Intervention (35 Days)||1
79380|NCT01408719|190700|P19|STARTED|Fourth Intervention (35 Days)||0
79381|NCT01408719|190701|P18|STARTED|Fourth Intervention (35 Days)||2
79382|NCT01408719|190702|P17|STARTED|Fourth Intervention (35 Days)||2
79383|NCT01408719|190703|P16|STARTED|Fourth Intervention (35 Days)||1
79384|NCT01408719|190704|P15|STARTED|Fourth Intervention (35 Days)||1
79385|NCT01408719|190705|P14|STARTED|Fourth Intervention (35 Days)||3
79386|NCT01408719|190706|P13|STARTED|Fourth Intervention (35 Days)||1
79387|NCT01408719|190707|P12|STARTED|Fourth Intervention (35 Days)||2
79388|NCT01408719|190708|P11|STARTED|Fourth Intervention (35 Days)||2
79389|NCT01408719|190709|P10|STARTED|Fourth Intervention (35 Days)||1
79390|NCT01408719|190710|P9|STARTED|Fourth Intervention (35 Days)||1
79391|NCT01408719|190711|P8|STARTED|Fourth Intervention (35 Days)||2
79392|NCT01408719|190712|P7|STARTED|Fourth Intervention (35 Days)||2
79393|NCT01408719|190713|P6|STARTED|Fourth Intervention (35 Days)||3
79394|NCT01408719|190714|P5|STARTED|Fourth Intervention (35 Days)||3
79395|NCT01408719|190715|P4|STARTED|Fourth Intervention (35 Days)||2
79396|NCT01408719|190716|P3|STARTED|Fourth Intervention (35 Days)||1
79397|NCT01408719|190717|P2|STARTED|Fourth Intervention (35 Days)||3
79398|NCT01408719|190718|P1|STARTED|Fourth Intervention (35 Days)||2
79399|NCT01408719|190699|P20|NOT COMPLETED|Washout Period (28 Days)||0
79400|NCT01408719|190700|P19|NOT COMPLETED|Washout Period (28 Days)||0
79401|NCT01408719|190701|P18|NOT COMPLETED|Washout Period (28 Days)||0
79402|NCT01408719|190702|P17|NOT COMPLETED|Washout Period (28 Days)||0
79403|NCT01408719|190703|P16|NOT COMPLETED|Washout Period (28 Days)||0
79404|NCT01408719|190704|P15|NOT COMPLETED|Washout Period (28 Days)||0
79405|NCT01408719|190705|P14|NOT COMPLETED|Washout Period (28 Days)||0
79406|NCT01408719|190706|P13|NOT COMPLETED|Washout Period (28 Days)||0
79407|NCT01408719|190707|P12|NOT COMPLETED|Washout Period (28 Days)||0
79408|NCT01408719|190708|P11|NOT COMPLETED|Washout Period (28 Days)||0
79409|NCT01408719|190709|P10|NOT COMPLETED|Washout Period (28 Days)||0
79410|NCT01408719|190710|P9|NOT COMPLETED|Washout Period (28 Days)||0
79411|NCT01408719|190711|P8|NOT COMPLETED|Washout Period (28 Days)||0
79412|NCT01408719|190712|P7|NOT COMPLETED|Washout Period (28 Days)||0
79413|NCT01408719|190713|P6|NOT COMPLETED|Washout Period (28 Days)||0
79414|NCT01408719|190714|P5|NOT COMPLETED|Washout Period (28 Days)||0
79415|NCT01408719|190715|P4|NOT COMPLETED|Washout Period (28 Days)||0
79416|NCT01408719|190716|P3|NOT COMPLETED|Washout Period (28 Days)||0
79417|NCT01408719|190717|P2|NOT COMPLETED|Washout Period (28 Days)||0
79418|NCT01408719|190718|P1|NOT COMPLETED|Washout Period (28 Days)||0
79419|NCT01408719|190699|P20|COMPLETED|Washout Period (28 Days)||1
79420|NCT01408719|190700|P19|COMPLETED|Washout Period (28 Days)||0
79421|NCT01408719|190701|P18|COMPLETED|Washout Period (28 Days)||2
79422|NCT01408719|190702|P17|COMPLETED|Washout Period (28 Days)||2
79423|NCT01408719|190703|P16|COMPLETED|Washout Period (28 Days)||1
79424|NCT01408719|190704|P15|COMPLETED|Washout Period (28 Days)||1
79425|NCT01408719|190705|P14|COMPLETED|Washout Period (28 Days)||3
79426|NCT01408719|190706|P13|COMPLETED|Washout Period (28 Days)||1
79427|NCT01408719|190707|P12|COMPLETED|Washout Period (28 Days)||2
79428|NCT01408719|190708|P11|COMPLETED|Washout Period (28 Days)||2
79429|NCT01408719|190709|P10|COMPLETED|Washout Period (28 Days)||1
79430|NCT01408719|190710|P9|COMPLETED|Washout Period (28 Days)||1
79431|NCT01408719|190711|P8|COMPLETED|Washout Period (28 Days)||2
79432|NCT01408719|190712|P7|COMPLETED|Washout Period (28 Days)||2
79433|NCT01408719|190713|P6|COMPLETED|Washout Period (28 Days)||3
79434|NCT01408719|190714|P5|COMPLETED|Washout Period (28 Days)||3
79435|NCT01408719|190715|P4|COMPLETED|Washout Period (28 Days)||2
79436|NCT01408719|190716|P3|COMPLETED|Washout Period (28 Days)||1
79437|NCT01408719|190717|P2|COMPLETED|Washout Period (28 Days)||3
79438|NCT01408719|190718|P1|COMPLETED|Washout Period (28 Days)||2
79439|NCT01408719|190699|P20|STARTED|Washout Period (28 Days)||1
79440|NCT01408719|190700|P19|STARTED|Washout Period (28 Days)||0
79441|NCT01408719|190701|P18|STARTED|Washout Period (28 Days)||2
79442|NCT01408719|190702|P17|STARTED|Washout Period (28 Days)||2
79443|NCT01408719|190703|P16|STARTED|Washout Period (28 Days)||1
79444|NCT01408719|190704|P15|STARTED|Washout Period (28 Days)||1
79445|NCT01408719|190705|P14|STARTED|Washout Period (28 Days)||3
79446|NCT01408719|190706|P13|STARTED|Washout Period (28 Days)||1
79447|NCT01408719|190707|P12|STARTED|Washout Period (28 Days)||2
79448|NCT01408719|190708|P11|STARTED|Washout Period (28 Days)||2
79449|NCT01408719|190709|P10|STARTED|Washout Period (28 Days)||1
79450|NCT01408719|190710|P9|STARTED|Washout Period (28 Days)||1
79451|NCT01408719|190711|P8|STARTED|Washout Period (28 Days)||2
79452|NCT01408719|190712|P7|STARTED|Washout Period (28 Days)||2
79453|NCT01408719|190713|P6|STARTED|Washout Period (28 Days)||3
79454|NCT01408719|190714|P5|STARTED|Washout Period (28 Days)||3
79455|NCT01408719|190715|P4|STARTED|Washout Period (28 Days)||2
79456|NCT01408719|190716|P3|STARTED|Washout Period (28 Days)||1
79457|NCT01408719|190717|P2|STARTED|Washout Period (28 Days)||3
79458|NCT01408719|190718|P1|STARTED|Washout Period (28 Days)||2
79459|NCT01408719|190699|P20|NOT COMPLETED|Third Intervention (35 Days)||0
79460|NCT01408719|190700|P19|NOT COMPLETED|Third Intervention (35 Days)||0
79461|NCT01408719|190701|P18|NOT COMPLETED|Third Intervention (35 Days)||0
79462|NCT01408719|190702|P17|NOT COMPLETED|Third Intervention (35 Days)||0
79463|NCT01408719|190703|P16|NOT COMPLETED|Third Intervention (35 Days)||0
79464|NCT01408719|190704|P15|NOT COMPLETED|Third Intervention (35 Days)||0
79465|NCT01408719|190705|P14|NOT COMPLETED|Third Intervention (35 Days)||0
79466|NCT01408719|190706|P13|NOT COMPLETED|Third Intervention (35 Days)||0
79467|NCT01408719|190707|P12|NOT COMPLETED|Third Intervention (35 Days)||0
79468|NCT01408719|190708|P11|NOT COMPLETED|Third Intervention (35 Days)||0
79469|NCT01408719|190709|P10|NOT COMPLETED|Third Intervention (35 Days)||0
79470|NCT01408719|190710|P9|NOT COMPLETED|Third Intervention (35 Days)||0
79471|NCT01408719|190711|P8|NOT COMPLETED|Third Intervention (35 Days)||1
79472|NCT01408719|190712|P7|NOT COMPLETED|Third Intervention (35 Days)||0
79473|NCT01408719|190713|P6|NOT COMPLETED|Third Intervention (35 Days)||0
79474|NCT01408719|190714|P5|NOT COMPLETED|Third Intervention (35 Days)||0
79475|NCT01408719|190715|P4|NOT COMPLETED|Third Intervention (35 Days)||0
79476|NCT01408719|190716|P3|NOT COMPLETED|Third Intervention (35 Days)||0
79477|NCT01408719|190717|P2|NOT COMPLETED|Third Intervention (35 Days)||0
79478|NCT01408719|190718|P1|NOT COMPLETED|Third Intervention (35 Days)||0
79479|NCT01408719|190699|P20|COMPLETED|Third Intervention (35 Days)||1
79480|NCT01408719|190700|P19|COMPLETED|Third Intervention (35 Days)||0
79481|NCT01408719|190701|P18|COMPLETED|Third Intervention (35 Days)||2
79482|NCT01408719|190702|P17|COMPLETED|Third Intervention (35 Days)||2
79483|NCT01408719|190703|P16|COMPLETED|Third Intervention (35 Days)||1
79484|NCT01408719|190704|P15|COMPLETED|Third Intervention (35 Days)||1
79485|NCT01408719|190705|P14|COMPLETED|Third Intervention (35 Days)||3
79486|NCT01408719|190706|P13|COMPLETED|Third Intervention (35 Days)||2
79487|NCT01408719|190707|P12|COMPLETED|Third Intervention (35 Days)||2
79488|NCT01408719|190708|P11|COMPLETED|Third Intervention (35 Days)||2
79489|NCT01408719|190709|P10|COMPLETED|Third Intervention (35 Days)||1
79490|NCT01408719|190710|P9|COMPLETED|Third Intervention (35 Days)||1
79491|NCT01408719|190711|P8|COMPLETED|Third Intervention (35 Days)||2
79492|NCT01408719|190712|P7|COMPLETED|Third Intervention (35 Days)||2
79493|NCT01408719|190713|P6|COMPLETED|Third Intervention (35 Days)||3
79494|NCT01408719|190714|P5|COMPLETED|Third Intervention (35 Days)||3
79495|NCT01408719|190715|P4|COMPLETED|Third Intervention (35 Days)||2
79496|NCT01408719|190716|P3|COMPLETED|Third Intervention (35 Days)||1
79497|NCT01408719|190717|P2|COMPLETED|Third Intervention (35 Days)||3
79498|NCT01408719|190718|P1|COMPLETED|Third Intervention (35 Days)||2
79499|NCT01408719|190699|P20|STARTED|Third Intervention (35 Days)||1
79500|NCT01408719|190700|P19|STARTED|Third Intervention (35 Days)||0
79501|NCT01408719|190701|P18|STARTED|Third Intervention (35 Days)||2
79502|NCT01408719|190702|P17|STARTED|Third Intervention (35 Days)||2
79503|NCT01408719|190703|P16|STARTED|Third Intervention (35 Days)||1
79504|NCT01408719|190704|P15|STARTED|Third Intervention (35 Days)||1
79505|NCT01408719|190705|P14|STARTED|Third Intervention (35 Days)||3
79506|NCT01408719|190706|P13|STARTED|Third Intervention (35 Days)||2
79507|NCT01408719|190707|P12|STARTED|Third Intervention (35 Days)||2
79508|NCT01408719|190708|P11|STARTED|Third Intervention (35 Days)||2
79509|NCT01408719|190709|P10|STARTED|Third Intervention (35 Days)||1
79510|NCT01408719|190710|P9|STARTED|Third Intervention (35 Days)||1
79511|NCT01408719|190711|P8|STARTED|Third Intervention (35 Days)||3
79512|NCT01408719|190712|P7|STARTED|Third Intervention (35 Days)||2
79513|NCT01408719|190713|P6|STARTED|Third Intervention (35 Days)||3
79514|NCT01408719|190714|P5|STARTED|Third Intervention (35 Days)||3
79515|NCT01408719|190715|P4|STARTED|Third Intervention (35 Days)||2
79516|NCT01408719|190716|P3|STARTED|Third Intervention (35 Days)||1
79517|NCT01408719|190717|P2|STARTED|Third Intervention (35 Days)||3
79518|NCT01408719|190718|P1|STARTED|Third Intervention (35 Days)||2
79519|NCT01408719|190699|P20|NOT COMPLETED|Washout Period (28 Days)||0
79520|NCT01408719|190700|P19|NOT COMPLETED|Washout Period (28 Days)||0
79521|NCT01408719|190701|P18|NOT COMPLETED|Washout Period (28 Days)||0
79522|NCT01408719|190702|P17|NOT COMPLETED|Washout Period (28 Days)||0
79523|NCT01408719|190703|P16|NOT COMPLETED|Washout Period (28 Days)||0
79524|NCT01408719|190704|P15|NOT COMPLETED|Washout Period (28 Days)||0
79525|NCT01408719|190705|P14|NOT COMPLETED|Washout Period (28 Days)||0
79526|NCT01408719|190706|P13|NOT COMPLETED|Washout Period (28 Days)||0
79527|NCT01408719|190707|P12|NOT COMPLETED|Washout Period (28 Days)||0
79528|NCT01408719|190708|P11|NOT COMPLETED|Washout Period (28 Days)||0
79529|NCT01408719|190709|P10|NOT COMPLETED|Washout Period (28 Days)||0
79530|NCT01408719|190710|P9|NOT COMPLETED|Washout Period (28 Days)||0
79531|NCT01408719|190711|P8|NOT COMPLETED|Washout Period (28 Days)||0
79532|NCT01408719|190712|P7|NOT COMPLETED|Washout Period (28 Days)||0
79533|NCT01408719|190713|P6|NOT COMPLETED|Washout Period (28 Days)||0
79534|NCT01408719|190714|P5|NOT COMPLETED|Washout Period (28 Days)||0
79535|NCT01408719|190715|P4|NOT COMPLETED|Washout Period (28 Days)||0
79536|NCT01408719|190716|P3|NOT COMPLETED|Washout Period (28 Days)||0
79537|NCT01408719|190717|P2|NOT COMPLETED|Washout Period (28 Days)||0
79538|NCT01408719|190718|P1|NOT COMPLETED|Washout Period (28 Days)||0
79539|NCT01408719|190699|P20|COMPLETED|Washout Period (28 Days)||1
79540|NCT01408719|190700|P19|COMPLETED|Washout Period (28 Days)||0
79541|NCT01408719|190701|P18|COMPLETED|Washout Period (28 Days)||2
79542|NCT01408719|190702|P17|COMPLETED|Washout Period (28 Days)||2
79543|NCT01408719|190703|P16|COMPLETED|Washout Period (28 Days)||1
79544|NCT01408719|190704|P15|COMPLETED|Washout Period (28 Days)||1
79545|NCT01408719|190705|P14|COMPLETED|Washout Period (28 Days)||3
79546|NCT01408719|190706|P13|COMPLETED|Washout Period (28 Days)||2
79547|NCT01408719|190707|P12|COMPLETED|Washout Period (28 Days)||2
79548|NCT01408719|190708|P11|COMPLETED|Washout Period (28 Days)||2
79549|NCT01408719|190709|P10|COMPLETED|Washout Period (28 Days)||1
79550|NCT01408719|190710|P9|COMPLETED|Washout Period (28 Days)||1
79551|NCT01408719|190711|P8|COMPLETED|Washout Period (28 Days)||3
79552|NCT01408719|190712|P7|COMPLETED|Washout Period (28 Days)||2
79553|NCT01408719|190713|P6|COMPLETED|Washout Period (28 Days)||3
79554|NCT01408719|190714|P5|COMPLETED|Washout Period (28 Days)||3
79555|NCT01408719|190715|P4|COMPLETED|Washout Period (28 Days)||2
79556|NCT01408719|190716|P3|COMPLETED|Washout Period (28 Days)||1
79557|NCT01408719|190717|P2|COMPLETED|Washout Period (28 Days)||3
79558|NCT01408719|190718|P1|COMPLETED|Washout Period (28 Days)||2
79559|NCT01408719|190699|P20|STARTED|Washout Period (28 Days)||1
79560|NCT01408719|190700|P19|STARTED|Washout Period (28 Days)||0
79561|NCT01408719|190701|P18|STARTED|Washout Period (28 Days)||2
79562|NCT01408719|190702|P17|STARTED|Washout Period (28 Days)||2
79563|NCT01408719|190703|P16|STARTED|Washout Period (28 Days)||1
79564|NCT01408719|190704|P15|STARTED|Washout Period (28 Days)||1
79565|NCT01408719|190705|P14|STARTED|Washout Period (28 Days)||3
79566|NCT01408719|190706|P13|STARTED|Washout Period (28 Days)||2
79567|NCT01408719|190707|P12|STARTED|Washout Period (28 Days)||2
79568|NCT01408719|190708|P11|STARTED|Washout Period (28 Days)||2
79569|NCT01408719|190709|P10|STARTED|Washout Period (28 Days)||1
79570|NCT01408719|190710|P9|STARTED|Washout Period (28 Days)||1
79571|NCT01408719|190711|P8|STARTED|Washout Period (28 Days)||3
79572|NCT01408719|190712|P7|STARTED|Washout Period (28 Days)||2
79573|NCT01408719|190713|P6|STARTED|Washout Period (28 Days)||3
79574|NCT01408719|190714|P5|STARTED|Washout Period (28 Days)||3
79575|NCT01408719|190715|P4|STARTED|Washout Period (28 Days)||2
79576|NCT01408719|190716|P3|STARTED|Washout Period (28 Days)||1
79577|NCT01408719|190717|P2|STARTED|Washout Period (28 Days)||3
79578|NCT01408719|190718|P1|STARTED|Washout Period (28 Days)||2
79579|NCT01408719|190699|P20|NOT COMPLETED|Second Intervention (35 Days)||0
79580|NCT01408719|190700|P19|NOT COMPLETED|Second Intervention (35 Days)||0
79581|NCT01408719|190701|P18|NOT COMPLETED|Second Intervention (35 Days)||0
79582|NCT01408719|190702|P17|NOT COMPLETED|Second Intervention (35 Days)||0
79583|NCT01408719|190703|P16|NOT COMPLETED|Second Intervention (35 Days)||0
79584|NCT01408719|190704|P15|NOT COMPLETED|Second Intervention (35 Days)||0
79585|NCT01408719|190705|P14|NOT COMPLETED|Second Intervention (35 Days)||1
79586|NCT01408719|190706|P13|NOT COMPLETED|Second Intervention (35 Days)||0
79587|NCT01408719|190707|P12|NOT COMPLETED|Second Intervention (35 Days)||0
79588|NCT01408719|190708|P11|NOT COMPLETED|Second Intervention (35 Days)||0
79589|NCT01408719|190709|P10|NOT COMPLETED|Second Intervention (35 Days)||0
79590|NCT01408719|190710|P9|NOT COMPLETED|Second Intervention (35 Days)||0
79591|NCT01408719|190711|P8|NOT COMPLETED|Second Intervention (35 Days)||0
79592|NCT01408719|190712|P7|NOT COMPLETED|Second Intervention (35 Days)||0
79593|NCT01408719|190713|P6|NOT COMPLETED|Second Intervention (35 Days)||0
79594|NCT01408719|190714|P5|NOT COMPLETED|Second Intervention (35 Days)||0
79595|NCT01408719|190715|P4|NOT COMPLETED|Second Intervention (35 Days)||0
79596|NCT01408719|190716|P3|NOT COMPLETED|Second Intervention (35 Days)||0
79597|NCT01408719|190717|P2|NOT COMPLETED|Second Intervention (35 Days)||0
79598|NCT01408719|190718|P1|NOT COMPLETED|Second Intervention (35 Days)||0
79599|NCT01408719|190699|P20|COMPLETED|Second Intervention (35 Days)||1
79600|NCT01408719|190700|P19|COMPLETED|Second Intervention (35 Days)||0
79601|NCT01408719|190701|P18|COMPLETED|Second Intervention (35 Days)||2
79602|NCT01408719|190702|P17|COMPLETED|Second Intervention (35 Days)||2
79603|NCT01408719|190703|P16|COMPLETED|Second Intervention (35 Days)||2
79604|NCT01408719|190704|P15|COMPLETED|Second Intervention (35 Days)||1
79605|NCT01408719|190705|P14|COMPLETED|Second Intervention (35 Days)||3
79606|NCT01408719|190706|P13|COMPLETED|Second Intervention (35 Days)||2
79607|NCT01408719|190707|P12|COMPLETED|Second Intervention (35 Days)||2
79608|NCT01408719|190708|P11|COMPLETED|Second Intervention (35 Days)||2
79609|NCT01408719|190709|P10|COMPLETED|Second Intervention (35 Days)||1
79610|NCT01408719|190710|P9|COMPLETED|Second Intervention (35 Days)||1
79611|NCT01408719|190711|P8|COMPLETED|Second Intervention (35 Days)||3
79612|NCT01408719|190712|P7|COMPLETED|Second Intervention (35 Days)||2
79613|NCT01408719|190713|P6|COMPLETED|Second Intervention (35 Days)||3
79614|NCT01408719|190714|P5|COMPLETED|Second Intervention (35 Days)||3
79615|NCT01408719|190715|P4|COMPLETED|Second Intervention (35 Days)||2
79616|NCT01408719|190716|P3|COMPLETED|Second Intervention (35 Days)||1
79617|NCT01408719|190717|P2|COMPLETED|Second Intervention (35 Days)||3
79618|NCT01408719|190718|P1|COMPLETED|Second Intervention (35 Days)||2
79619|NCT01408719|190699|P20|STARTED|Second Intervention (35 Days)||1
79620|NCT01408719|190700|P19|STARTED|Second Intervention (35 Days)||0
79621|NCT01408719|190701|P18|STARTED|Second Intervention (35 Days)||2
79622|NCT01408719|190702|P17|STARTED|Second Intervention (35 Days)||2
79623|NCT01408719|190703|P16|STARTED|Second Intervention (35 Days)||2
79624|NCT01408719|190704|P15|STARTED|Second Intervention (35 Days)||1
79625|NCT01408719|190705|P14|STARTED|Second Intervention (35 Days)||4
79626|NCT01408719|190706|P13|STARTED|Second Intervention (35 Days)||2
79627|NCT01408719|190707|P12|STARTED|Second Intervention (35 Days)||2
79628|NCT01408719|190708|P11|STARTED|Second Intervention (35 Days)||2
79629|NCT01408719|190709|P10|STARTED|Second Intervention (35 Days)||1
79630|NCT01408719|190710|P9|STARTED|Second Intervention (35 Days)||1
79631|NCT01408719|190711|P8|STARTED|Second Intervention (35 Days)||3
79632|NCT01408719|190712|P7|STARTED|Second Intervention (35 Days)||2
79633|NCT01408719|190713|P6|STARTED|Second Intervention (35 Days)||3
79634|NCT01408719|190714|P5|STARTED|Second Intervention (35 Days)||3
79635|NCT01408719|190715|P4|STARTED|Second Intervention (35 Days)||2
79636|NCT01408719|190716|P3|STARTED|Second Intervention (35 Days)||1
79637|NCT01408719|190717|P2|STARTED|Second Intervention (35 Days)||3
79638|NCT01408719|190718|P1|STARTED|Second Intervention (35 Days)||2
79639|NCT01408719|190699|P20|NOT COMPLETED|Washout Period (28 Days)||0
79640|NCT01408719|190700|P19|NOT COMPLETED|Washout Period (28 Days)||0
79641|NCT01408719|190701|P18|NOT COMPLETED|Washout Period (28 Days)||0
79642|NCT01408719|190702|P17|NOT COMPLETED|Washout Period (28 Days)||0
79643|NCT01408719|190703|P16|NOT COMPLETED|Washout Period (28 Days)||0
79644|NCT01408719|190704|P15|NOT COMPLETED|Washout Period (28 Days)||0
79645|NCT01408719|190705|P14|NOT COMPLETED|Washout Period (28 Days)||0
79646|NCT01408719|190706|P13|NOT COMPLETED|Washout Period (28 Days)||0
79647|NCT01408719|190707|P12|NOT COMPLETED|Washout Period (28 Days)||0
79648|NCT01408719|190708|P11|NOT COMPLETED|Washout Period (28 Days)||0
79649|NCT01408719|190709|P10|NOT COMPLETED|Washout Period (28 Days)||0
79650|NCT01408719|190710|P9|NOT COMPLETED|Washout Period (28 Days)||0
79651|NCT01408719|190711|P8|NOT COMPLETED|Washout Period (28 Days)||0
79652|NCT01408719|190712|P7|NOT COMPLETED|Washout Period (28 Days)||0
79653|NCT01408719|190713|P6|NOT COMPLETED|Washout Period (28 Days)||0
79654|NCT01408719|190714|P5|NOT COMPLETED|Washout Period (28 Days)||0
79655|NCT01408719|190715|P4|NOT COMPLETED|Washout Period (28 Days)||0
79656|NCT01408719|190716|P3|NOT COMPLETED|Washout Period (28 Days)||0
79657|NCT01408719|190717|P2|NOT COMPLETED|Washout Period (28 Days)||0
79658|NCT01408719|190718|P1|NOT COMPLETED|Washout Period (28 Days)||0
79659|NCT01408719|190699|P20|COMPLETED|Washout Period (28 Days)||1
79660|NCT01408719|190700|P19|COMPLETED|Washout Period (28 Days)||0
79661|NCT01408719|190701|P18|COMPLETED|Washout Period (28 Days)||2
79662|NCT01408719|190702|P17|COMPLETED|Washout Period (28 Days)||2
79663|NCT01408719|190703|P16|COMPLETED|Washout Period (28 Days)||2
79664|NCT01408719|190704|P15|COMPLETED|Washout Period (28 Days)||1
79665|NCT01408719|190705|P14|COMPLETED|Washout Period (28 Days)||4
79666|NCT01408719|190706|P13|COMPLETED|Washout Period (28 Days)||2
79667|NCT01408719|190707|P12|COMPLETED|Washout Period (28 Days)||2
79668|NCT01408719|190708|P11|COMPLETED|Washout Period (28 Days)||2
79669|NCT01408719|190709|P10|COMPLETED|Washout Period (28 Days)||1
79670|NCT01408719|190710|P9|COMPLETED|Washout Period (28 Days)||1
79671|NCT01408719|190711|P8|COMPLETED|Washout Period (28 Days)||3
79672|NCT01408719|190712|P7|COMPLETED|Washout Period (28 Days)||2
79673|NCT01408719|190713|P6|COMPLETED|Washout Period (28 Days)||3
79674|NCT01408719|190714|P5|COMPLETED|Washout Period (28 Days)||3
79675|NCT01408719|190715|P4|COMPLETED|Washout Period (28 Days)||2
79676|NCT01408719|190716|P3|COMPLETED|Washout Period (28 Days)||1
79677|NCT01408719|190717|P2|COMPLETED|Washout Period (28 Days)||3
79678|NCT01408719|190718|P1|COMPLETED|Washout Period (28 Days)||2
79679|NCT01408719|190699|P20|STARTED|Washout Period (28 Days)||1
79680|NCT01408719|190700|P19|STARTED|Washout Period (28 Days)||0
79681|NCT01408719|190701|P18|STARTED|Washout Period (28 Days)||2
79682|NCT01408719|190702|P17|STARTED|Washout Period (28 Days)||2
79683|NCT01408719|190703|P16|STARTED|Washout Period (28 Days)||2
79684|NCT01408719|190704|P15|STARTED|Washout Period (28 Days)||1
79685|NCT01408719|190705|P14|STARTED|Washout Period (28 Days)||4
79686|NCT01408719|190706|P13|STARTED|Washout Period (28 Days)||2
79687|NCT01408719|190707|P12|STARTED|Washout Period (28 Days)||2
79688|NCT01408719|190708|P11|STARTED|Washout Period (28 Days)||2
79689|NCT01408719|190709|P10|STARTED|Washout Period (28 Days)||1
79690|NCT01408719|190710|P9|STARTED|Washout Period (28 Days)||1
79691|NCT01408719|190711|P8|STARTED|Washout Period (28 Days)||3
79692|NCT01408719|190712|P7|STARTED|Washout Period (28 Days)||2
79693|NCT01408719|190713|P6|STARTED|Washout Period (28 Days)||3
79694|NCT01408719|190714|P5|STARTED|Washout Period (28 Days)||3
79695|NCT01408719|190715|P4|STARTED|Washout Period (28 Days)||2
79696|NCT01408719|190716|P3|STARTED|Washout Period (28 Days)||1
79697|NCT01408719|190717|P2|STARTED|Washout Period (28 Days)||3
79698|NCT01408719|190718|P1|STARTED|Washout Period (28 Days)||2
79699|NCT01408719|190699|P20|NOT COMPLETED|First Intervention (35 Days)||0
79700|NCT01408719|190700|P19|NOT COMPLETED|First Intervention (35 Days)||1
79701|NCT01408719|190701|P18|NOT COMPLETED|First Intervention (35 Days)||0
79702|NCT01408719|190702|P17|NOT COMPLETED|First Intervention (35 Days)||1
79703|NCT01408719|190703|P16|NOT COMPLETED|First Intervention (35 Days)||0
79704|NCT01408719|190704|P15|NOT COMPLETED|First Intervention (35 Days)||0
79705|NCT01408719|190705|P14|NOT COMPLETED|First Intervention (35 Days)||1
79706|NCT01408719|190706|P13|NOT COMPLETED|First Intervention (35 Days)||0
79707|NCT01408719|190707|P12|NOT COMPLETED|First Intervention (35 Days)||0
79708|NCT01408719|190708|P11|NOT COMPLETED|First Intervention (35 Days)||0
79709|NCT01408719|190709|P10|NOT COMPLETED|First Intervention (35 Days)||0
79710|NCT01408719|190710|P9|NOT COMPLETED|First Intervention (35 Days)||1
79711|NCT01408719|190711|P8|NOT COMPLETED|First Intervention (35 Days)||0
79712|NCT01408719|190712|P7|NOT COMPLETED|First Intervention (35 Days)||0
79713|NCT01408719|190713|P6|NOT COMPLETED|First Intervention (35 Days)||0
79714|NCT01408719|190714|P5|NOT COMPLETED|First Intervention (35 Days)||1
79715|NCT01408719|190715|P4|NOT COMPLETED|First Intervention (35 Days)||0
79716|NCT01408719|190716|P3|NOT COMPLETED|First Intervention (35 Days)||1
79717|NCT01408719|190717|P2|NOT COMPLETED|First Intervention (35 Days)||0
79718|NCT01408719|190718|P1|NOT COMPLETED|First Intervention (35 Days)||0
79719|NCT01408719|190699|P20|COMPLETED|First Intervention (35 Days)||1
79720|NCT01408719|190700|P19|COMPLETED|First Intervention (35 Days)||0
79721|NCT01408719|190701|P18|COMPLETED|First Intervention (35 Days)||2
79722|NCT01408719|190702|P17|COMPLETED|First Intervention (35 Days)||2
79723|NCT01408719|190703|P16|COMPLETED|First Intervention (35 Days)||2
79724|NCT01408719|190704|P15|COMPLETED|First Intervention (35 Days)||1
79725|NCT01408719|190705|P14|COMPLETED|First Intervention (35 Days)||4
79726|NCT01408719|190706|P13|COMPLETED|First Intervention (35 Days)||2
79727|NCT01408719|190707|P12|COMPLETED|First Intervention (35 Days)||2
79728|NCT01408719|190708|P11|COMPLETED|First Intervention (35 Days)||2
79729|NCT01408719|190709|P10|COMPLETED|First Intervention (35 Days)||1
79730|NCT01408719|190710|P9|COMPLETED|First Intervention (35 Days)||1
79731|NCT01408719|190711|P8|COMPLETED|First Intervention (35 Days)||3
79732|NCT01408719|190712|P7|COMPLETED|First Intervention (35 Days)||2
79733|NCT01408719|190713|P6|COMPLETED|First Intervention (35 Days)||3
79734|NCT01408719|190714|P5|COMPLETED|First Intervention (35 Days)||3
79735|NCT01408719|190715|P4|COMPLETED|First Intervention (35 Days)||2
79736|NCT01408719|190716|P3|COMPLETED|First Intervention (35 Days)||1
79737|NCT01408719|190717|P2|COMPLETED|First Intervention (35 Days)||3
79738|NCT01408719|190718|P1|COMPLETED|First Intervention (35 Days)||2
79739|NCT01408719|190699|P20|STARTED|First Intervention (35 Days)||1
79740|NCT01408719|190700|P19|STARTED|First Intervention (35 Days)||1
79741|NCT01408719|190701|P18|STARTED|First Intervention (35 Days)||2
79742|NCT01408719|190702|P17|STARTED|First Intervention (35 Days)||3
79743|NCT01408719|190703|P16|STARTED|First Intervention (35 Days)||2
79744|NCT01408719|190704|P15|STARTED|First Intervention (35 Days)||1
79745|NCT01408719|190705|P14|STARTED|First Intervention (35 Days)||5
79746|NCT01408719|190706|P13|STARTED|First Intervention (35 Days)||2
79747|NCT01408719|190707|P12|STARTED|First Intervention (35 Days)||2
79748|NCT01408719|190708|P11|STARTED|First Intervention (35 Days)||2
79749|NCT01408719|190709|P10|STARTED|First Intervention (35 Days)||1
79750|NCT01408719|190710|P9|STARTED|First Intervention (35 Days)||2
79751|NCT01408719|190711|P8|STARTED|First Intervention (35 Days)||3
79752|NCT01408719|190712|P7|STARTED|First Intervention (35 Days)||2
79753|NCT01408719|190713|P6|STARTED|First Intervention (35 Days)||3
79754|NCT01408719|190714|P5|STARTED|First Intervention (35 Days)||4
79755|NCT01408719|190715|P4|STARTED|First Intervention (35 Days)||2
79756|NCT01408719|190716|P3|STARTED|First Intervention (35 Days)||2
79757|NCT01408719|190717|P2|STARTED|First Intervention (35 Days)||3
79758|NCT01408719|190718|P1|STARTED|First Intervention (35 Days)||2
79759|NCT01408706|190730|P2|NOT COMPLETED|Overall Study||0
79760|NCT01408706|190731|P1|NOT COMPLETED|Overall Study||1
79761|NCT01408706|190730|P2|COMPLETED|Overall Study||30
79762|NCT01408706|190731|P1|COMPLETED|Overall Study||29
79763|NCT01408706|190730|P2|STARTED|Overall Study||30
79764|NCT01408706|190731|P1|STARTED|Overall Study||30
79765|NCT01408628|190741|P1|NOT COMPLETED|Completed 6 Month Follow-Up||14
79766|NCT01408628|190741|P1|COMPLETED|Completed 6 Month Follow-Up||25
79767|NCT01408628|190741|P1|STARTED|Completed 6 Month Follow-Up||39
79768|NCT01408628|190741|P1|NOT COMPLETED|Started Classes/Intervention||0
79769|NCT01408628|190741|P1|COMPLETED|Started Classes/Intervention||39
79770|NCT01408628|190741|P1|STARTED|Started Classes/Intervention||39
79771|NCT01408628|190741|P1|NOT COMPLETED|Consented||12
79772|NCT01408628|190741|P1|COMPLETED|Consented||39
79773|NCT01408628|190741|P1|STARTED|Consented||51
79774|NCT01408537|190747|P1|NOT COMPLETED|Overall Study||8
79775|NCT01408537|190747|P1|COMPLETED|Overall Study||144
79776|NCT01408537|190747|P1|STARTED|Overall Study||152
79777|NCT01408485|190763|P1|NOT COMPLETED|Overall Study||21
79778|NCT01408485|190763|P1|COMPLETED|Overall Study||179
79779|NCT01408485|190763|P1|STARTED|Overall Study||200
79780|NCT01408329|190771|P2|NOT COMPLETED|Overall Study||4
79781|NCT01408329|190772|P1|NOT COMPLETED|Overall Study||3
79782|NCT01408329|190771|P2|COMPLETED|Overall Study||11
79783|NCT01408329|190772|P1|COMPLETED|Overall Study||10
79784|NCT01408329|190771|P2|STARTED|Overall Study||15
79785|NCT01408329|190772|P1|STARTED|Overall Study||13
79786|NCT01408303|190781|P3|NOT COMPLETED|Overall Study||6
79787|NCT01408303|190782|P2|NOT COMPLETED|Overall Study||12
79788|NCT01408303|190783|P1|NOT COMPLETED|Overall Study||6
79789|NCT01408303|190781|P3|COMPLETED|Overall Study||210
79790|NCT01408303|190782|P2|COMPLETED|Overall Study||204
79791|NCT01408303|190783|P1|COMPLETED|Overall Study||209
79792|NCT01408303|190781|P3|STARTED|Overall Study||216
79793|NCT01408303|190782|P2|STARTED|Overall Study||216
79794|NCT01408303|190783|P1|STARTED|Overall Study||215
79795|NCT01408277|190793|P2|NOT COMPLETED|Overall Study||4
79796|NCT01408277|190794|P1|NOT COMPLETED|Overall Study||8
79797|NCT01408277|190793|P2|COMPLETED|Overall Study||23
79798|NCT01408277|190794|P1|COMPLETED|Overall Study||20
79799|NCT01408277|190793|P2|STARTED|Overall Study||27
79800|NCT01408277|190794|P1|STARTED|Overall Study||28
79801|NCT01407575|190802|P2|NOT COMPLETED|Overall Study||1
79802|NCT01407575|190803|P1|NOT COMPLETED|Overall Study||2
79803|NCT01407575|190802|P2|COMPLETED|Overall Study||5
79804|NCT01407575|190803|P1|COMPLETED|Overall Study||5
79805|NCT01407575|190802|P2|STARTED|Overall Study||6
79806|NCT01407575|190803|P1|STARTED|Overall Study||7
79807|NCT01407523|190821|P1|NOT COMPLETED|Overall Study||0
79808|NCT01407523|190821|P1|COMPLETED|Overall Study||16
79809|NCT01407523|190821|P1|STARTED|Overall Study||16
79810|NCT01407354|190831|P2|NOT COMPLETED|Second Intervention||2
79811|NCT01407354|190832|P1|NOT COMPLETED|Second Intervention||0
79812|NCT01407354|190831|P2|COMPLETED|Second Intervention||13
79813|NCT01407354|190832|P1|COMPLETED|Second Intervention||18
79814|NCT01407354|190831|P2|STARTED|Second Intervention||15
79815|NCT01407354|190832|P1|STARTED|Second Intervention||18
79816|NCT01407354|190831|P2|NOT COMPLETED|First Intervention||2
79817|NCT01407354|190832|P1|NOT COMPLETED|First Intervention||2
79818|NCT01407354|190831|P2|COMPLETED|First Intervention||15
79819|NCT01407354|190832|P1|COMPLETED|First Intervention||18
79820|NCT01407354|190831|P2|STARTED|First Intervention||17
79821|NCT01407354|190832|P1|STARTED|First Intervention||20
79822|NCT01407276|190848|P8|NOT COMPLETED|Overall Study||1
79823|NCT01407276|190849|P7|NOT COMPLETED|Overall Study||0
79824|NCT01407276|190850|P6|NOT COMPLETED|Overall Study||0
79825|NCT01407276|190851|P5|NOT COMPLETED|Overall Study||0
79826|NCT01407276|190852|P4|NOT COMPLETED|Overall Study||0
79827|NCT01407276|190853|P3|NOT COMPLETED|Overall Study||0
79828|NCT01407276|190854|P2|NOT COMPLETED|Overall Study||0
79829|NCT01407276|190855|P1|NOT COMPLETED|Overall Study||0
79830|NCT01407276|190848|P8|COMPLETED|Overall Study||6
79831|NCT01407276|190849|P7|COMPLETED|Overall Study||6
79832|NCT01407276|190850|P6|COMPLETED|Overall Study||6
79833|NCT01407276|190851|P5|COMPLETED|Overall Study||6
79834|NCT01407276|190852|P4|COMPLETED|Overall Study||6
79835|NCT01407276|190853|P3|COMPLETED|Overall Study||6
79836|NCT01407276|190854|P2|COMPLETED|Overall Study||6
79837|NCT01407276|190855|P1|COMPLETED|Overall Study||6
79838|NCT01407276|190848|P8|STARTED|Overall Study||7
79839|NCT01407276|190849|P7|STARTED|Overall Study||6
79840|NCT01407276|190850|P6|STARTED|Overall Study||6
79841|NCT01407276|190851|P5|STARTED|Overall Study||6
79842|NCT01407276|190852|P4|STARTED|Overall Study||6
79843|NCT01407276|190853|P3|STARTED|Overall Study||6
79844|NCT01407276|190854|P2|STARTED|Overall Study||6
79845|NCT01407276|190855|P1|STARTED|Overall Study||6
79846|NCT01407068|190979|P1|NOT COMPLETED|Overall Study||0
79847|NCT01407068|190979|P1|COMPLETED|Overall Study||60
79848|NCT01407068|190979|P1|STARTED|Overall Study||60
79849|NCT01406990|190988|P1|NOT COMPLETED|Overall Study||0
79850|NCT01406990|190988|P1|COMPLETED|Overall Study||15
79851|NCT01406990|190988|P1|STARTED|Overall Study||15
79852|NCT01406938|190994|P6|NOT COMPLETED|Follow up||3
79853|NCT01406938|190995|P5|NOT COMPLETED|Follow up||9
79854|NCT01406938|190996|P4|NOT COMPLETED|Follow up||3
79855|NCT01406938|190997|P3|NOT COMPLETED|Follow up||8
79856|NCT01406938|190998|P2|NOT COMPLETED|Follow up||5
79857|NCT01406938|190999|P1|NOT COMPLETED|Follow up||8
79858|NCT01406938|190994|P6|COMPLETED|Follow up||32
79859|NCT01406938|190995|P5|COMPLETED|Follow up||31
79860|NCT01406938|190996|P4|COMPLETED|Follow up||36
79861|NCT01406938|190997|P3|COMPLETED|Follow up||32
79862|NCT01406938|190998|P2|COMPLETED|Follow up||18
79863|NCT01406938|190999|P1|COMPLETED|Follow up||18
79864|NCT01406938|190994|P6|STARTED|Follow up||35
79865|NCT01406938|190995|P5|STARTED|Follow up||40
79866|NCT01406938|190996|P4|STARTED|Follow up||39
79867|NCT01406938|190997|P3|STARTED|Follow up||40
79868|NCT01406938|190998|P2|STARTED|Follow up||23
79869|NCT01406938|190999|P1|STARTED|Follow up||26
79870|NCT01406938|190994|P6|NOT COMPLETED|Maintenance Period||16
79871|NCT01406938|190995|P5|NOT COMPLETED|Maintenance Period||25
79872|NCT01406938|190996|P4|NOT COMPLETED|Maintenance Period||18
79873|NCT01406938|190997|P3|NOT COMPLETED|Maintenance Period||17
79874|NCT01406938|190998|P2|NOT COMPLETED|Maintenance Period||0
79875|NCT01406938|190999|P1|NOT COMPLETED|Maintenance Period||0
79876|NCT01406938|190994|P6|COMPLETED|Maintenance Period||201
79877|NCT01406938|190995|P5|COMPLETED|Maintenance Period||181
79878|NCT01406938|190996|P4|COMPLETED|Maintenance Period||199
79879|NCT01406938|190997|P3|COMPLETED|Maintenance Period||186
79880|NCT01406938|190998|P2|COMPLETED|Maintenance Period||0
79881|NCT01406938|190999|P1|COMPLETED|Maintenance Period||0
79882|NCT01406938|190994|P6|FAS: Patients Assigned Treatment Drug|Maintenance Period||217
79883|NCT01406938|190995|P5|FAS: Patients Assigned Treatment Drug|Maintenance Period||206
79884|NCT01406938|190996|P4|FAS: Patients Assigned Treatment Drug|Maintenance Period||216
79885|NCT01406938|190997|P3|FAS: Patients Assigned Treatment Drug|Maintenance Period||203
79886|NCT01406938|190998|P2|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
79887|NCT01406938|190999|P1|FAS: Patients Assigned Treatment Drug|Maintenance Period||0
79888|NCT01406938|190994|P6|STARTED|Maintenance Period||217
79889|NCT01406938|190995|P5|STARTED|Maintenance Period||206
79890|NCT01406938|190996|P4|STARTED|Maintenance Period||217
79891|NCT01406938|190997|P3|STARTED|Maintenance Period||203
79892|NCT01406938|190998|P2|STARTED|Maintenance Period||0
79893|NCT01406938|190999|P1|STARTED|Maintenance Period||0
79894|NCT01406938|190994|P6|NOT COMPLETED|Induction Period||0
79895|NCT01406938|190995|P5|NOT COMPLETED|Induction Period||0
79896|NCT01406938|190996|P4|NOT COMPLETED|Induction Period||0
79897|NCT01406938|190997|P3|NOT COMPLETED|Induction Period||0
79898|NCT01406938|190998|P2|NOT COMPLETED|Induction Period||20
79899|NCT01406938|190999|P1|NOT COMPLETED|Induction Period||18
79900|NCT01406938|190994|P6|COMPLETED|Induction Period||0
79901|NCT01406938|190995|P5|COMPLETED|Induction Period||0
79902|NCT01406938|190996|P4|COMPLETED|Induction Period||0
79903|NCT01406938|190997|P3|COMPLETED|Induction Period||0
79904|NCT01406938|190998|P2|COMPLETED|Induction Period||464
79905|NCT01406938|190999|P1|COMPLETED|Induction Period||464
79906|NCT01406938|190994|P6|FAS:Patients Assigned Study Treatment|Induction Period||0
79907|NCT01406938|190995|P5|FAS:Patients Assigned Study Treatment|Induction Period||0
79908|NCT01406938|190996|P4|FAS:Patients Assigned Study Treatment|Induction Period||0
79909|NCT01406938|190997|P3|FAS:Patients Assigned Study Treatment|Induction Period||0
79910|NCT01406938|190998|P2|FAS:Patients Assigned Study Treatment|Induction Period||483
79911|NCT01406938|190999|P1|FAS:Patients Assigned Study Treatment|Induction Period||482
79912|NCT01406938|190994|P6|STARTED|Induction Period||0
79913|NCT01406938|190995|P5|STARTED|Induction Period||0
79914|NCT01406938|190996|P4|STARTED|Induction Period||0
79915|NCT01406938|190997|P3|STARTED|Induction Period||0
79916|NCT01406938|190998|P2|STARTED|Induction Period||484
79917|NCT01406938|190999|P1|STARTED|Induction Period||482
79918|NCT01406795|191115|P1|NOT COMPLETED|Overall Study||1
79919|NCT01406795|191115|P1|COMPLETED|Overall Study||0
79920|NCT01406795|191115|P1|STARTED|Overall Study||1
79921|NCT01406574|191129|P4|NOT COMPLETED|Overall Study||4
79922|NCT01406574|191130|P3|NOT COMPLETED|Overall Study||1
79923|NCT01406574|191131|P2|NOT COMPLETED|Overall Study||1
79924|NCT01406574|191132|P1|NOT COMPLETED|Overall Study||1
79925|NCT01406574|191129|P4|COMPLETED|Overall Study||1
79926|NCT01406574|191130|P3|COMPLETED|Overall Study||6
79927|NCT01406574|191131|P2|COMPLETED|Overall Study||3
79928|NCT01406574|191132|P1|COMPLETED|Overall Study||6
79929|NCT01406574|191129|P4|STARTED|Overall Study||5
79930|NCT01406574|191130|P3|STARTED|Overall Study||7
79931|NCT01406574|191131|P2|STARTED|Overall Study||4
79932|NCT01406574|191132|P1|STARTED|Overall Study||7
79933|NCT01406223|191148|P4|NOT COMPLETED|Overall Study||16
79934|NCT01406223|191149|P3|NOT COMPLETED|Overall Study||18
79935|NCT01406223|191150|P2|NOT COMPLETED|Overall Study||12
79936|NCT01406223|191151|P1|NOT COMPLETED|Overall Study||12
79937|NCT01406223|191148|P4|COMPLETED|Overall Study||3
79938|NCT01406223|191149|P3|COMPLETED|Overall Study||2
79939|NCT01406223|191150|P2|COMPLETED|Overall Study||7
79940|NCT01406223|191151|P1|COMPLETED|Overall Study||6
79941|NCT01406223|191148|P4|STARTED|Overall Study||19
79942|NCT01406223|191149|P3|STARTED|Overall Study||20
79943|NCT01406223|191150|P2|STARTED|Overall Study||19
79944|NCT01406223|191151|P1|STARTED|Overall Study||18
79945|NCT01406015|191167|P2|NOT COMPLETED|Overall Study||3
79946|NCT01406015|191168|P1|NOT COMPLETED|Overall Study||3
79947|NCT01406015|191167|P2|COMPLETED|Overall Study||16
79948|NCT01406015|191168|P1|COMPLETED|Overall Study||16
79949|NCT01406015|191167|P2|STARTED|Overall Study||19
79950|NCT01406015|191168|P1|STARTED|Overall Study||19
79951|NCT01405950|191184|P4|NOT COMPLETED|Overall Study||0
79952|NCT01405950|191185|P3|NOT COMPLETED|Overall Study||0
79953|NCT01405950|191186|P2|NOT COMPLETED|Overall Study||0
79954|NCT01405950|191187|P1|NOT COMPLETED|Overall Study||1
79955|NCT01405950|191184|P4|COMPLETED|Overall Study||0
79956|NCT01405950|191185|P3|COMPLETED|Overall Study||0
79957|NCT01405950|191186|P2|COMPLETED|Overall Study||2
79958|NCT01405950|191187|P1|COMPLETED|Overall Study||7
79959|NCT01405950|191184|P4|STARTED|Overall Study||0
79960|NCT01405950|191185|P3|STARTED|Overall Study||0
79961|NCT01405950|191186|P2|STARTED|Overall Study||2
79962|NCT01405950|191187|P1|STARTED|Overall Study||8
79963|NCT01405937|191201|P2|NOT COMPLETED|Overall Study||0
79964|NCT01405937|191202|P1|NOT COMPLETED|Overall Study||0
79965|NCT01405937|191201|P2|COMPLETED|Overall Study||26
79966|NCT01405937|191202|P1|COMPLETED|Overall Study||25
79967|NCT01405937|191201|P2|STARTED|Overall Study||26
79968|NCT01405937|191202|P1|STARTED|Overall Study||25
79969|NCT01405924|191222|P1|NOT COMPLETED|Overall Study||10
79970|NCT01405924|191222|P1|COMPLETED|Overall Study||101
79971|NCT01405924|191222|P1|STARTED|Overall Study||111
79972|NCT01405898|191234|P2|NOT COMPLETED|Overall Study||2
79973|NCT01405898|191235|P1|NOT COMPLETED|Overall Study||2
79974|NCT01405898|191234|P2|COMPLETED|Overall Study||32
79975|NCT01405898|191235|P1|COMPLETED|Overall Study||32
79976|NCT01405898|191234|P2|STARTED|Overall Study||34
79977|NCT01405898|191235|P1|STARTED|Overall Study||34
79978|NCT01405820|191259|P6|NOT COMPLETED|Open-Label Treatment Period||2
79979|NCT01405820|191260|P5|NOT COMPLETED|Open-Label Treatment Period||2
79980|NCT01405820|191261|P4|NOT COMPLETED|Open-Label Treatment Period||5
79981|NCT01405820|191262|P3|NOT COMPLETED|Open-Label Treatment Period||3
79982|NCT01405820|191263|P2|NOT COMPLETED|Open-Label Treatment Period||2
79983|NCT01405820|191264|P1|NOT COMPLETED|Open-Label Treatment Period||4
79984|NCT01405820|191259|P6|COMPLETED|Open-Label Treatment Period||30
79985|NCT01405820|191260|P5|COMPLETED|Open-Label Treatment Period||40
79986|NCT01405820|191261|P4|COMPLETED|Open-Label Treatment Period||37
79987|NCT01405820|191262|P3|COMPLETED|Open-Label Treatment Period||39
79988|NCT01405820|191263|P2|COMPLETED|Open-Label Treatment Period||33
79989|NCT01405820|191264|P1|COMPLETED|Open-Label Treatment Period||40
79990|NCT01405820|191259|P6|STARTED|Open-Label Treatment Period||32
79991|NCT01405820|191260|P5|STARTED|Open-Label Treatment Period||42
79992|NCT01405820|191261|P4|STARTED|Open-Label Treatment Period||42
79993|NCT01405820|191262|P3|STARTED|Open-Label Treatment Period||42
79994|NCT01405820|191263|P2|STARTED|Open-Label Treatment Period||35
79995|NCT01405820|191264|P1|STARTED|Open-Label Treatment Period|1 participant discontinued randomized period due to an adverse event but entered open-label period.|44
79996|NCT01405820|191259|P6|NOT COMPLETED|Randomized Treatment Period||37
79997|NCT01405820|191260|P5|NOT COMPLETED|Randomized Treatment Period||45
79998|NCT01405820|191261|P4|NOT COMPLETED|Randomized Treatment Period||51
79999|NCT01405820|191262|P3|NOT COMPLETED|Randomized Treatment Period||43
80000|NCT01405820|191263|P2|NOT COMPLETED|Randomized Treatment Period||10
80001|NCT01405820|191264|P1|NOT COMPLETED|Randomized Treatment Period||11
80002|NCT01405820|191259|P6|COMPLETED|Randomized Treatment Period||1
80003|NCT01405820|191260|P5|COMPLETED|Randomized Treatment Period||2
80004|NCT01405820|191261|P4|COMPLETED|Randomized Treatment Period||3
80005|NCT01405820|191262|P3|COMPLETED|Randomized Treatment Period||9
80006|NCT01405820|191263|P2|COMPLETED|Randomized Treatment Period||35
80007|NCT01405820|191264|P1|COMPLETED|Randomized Treatment Period||43
80008|NCT01405820|191259|P6|Safety Population|Randomized Treatment Period||38
80009|NCT01405820|191260|P5|Safety Population|Randomized Treatment Period||47
80010|NCT01405820|191261|P4|Safety Population|Randomized Treatment Period|1 participant did not receive any study medication.|53
80011|NCT01405820|191262|P3|Safety Population|Randomized Treatment Period||52
80012|NCT01405820|191263|P2|Safety Population|Randomized Treatment Period||45
80013|NCT01405820|191264|P1|Safety Population|Randomized Treatment Period||54
80014|NCT01405820|191259|P6|STARTED|Randomized Treatment Period||38
80015|NCT01405820|191260|P5|STARTED|Randomized Treatment Period||47
80016|NCT01405820|191261|P4|STARTED|Randomized Treatment Period||54
80017|NCT01405820|191262|P3|STARTED|Randomized Treatment Period||52
80018|NCT01405820|191263|P2|STARTED|Randomized Treatment Period||45
80019|NCT01405820|191264|P1|STARTED|Randomized Treatment Period||54
80020|NCT01405794|191284|P1|NOT COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||0
80021|NCT01405794|191284|P1|COMPLETED|Second Dose 32ppm Oral Silver (14 Days)||12
80022|NCT01405794|191284|P1|STARTED|Second Dose 32ppm Oral Silver (14 Days)||12
80023|NCT01405794|191284|P1|NOT COMPLETED|72 hr Washout||0
80024|NCT01405794|191284|P1|COMPLETED|72 hr Washout||12
80025|NCT01405794|191284|P1|STARTED|72 hr Washout||12
80026|NCT01405794|191284|P1|NOT COMPLETED|First Dose Placebo (14 Days)||0
80027|NCT01405794|191284|P1|COMPLETED|First Dose Placebo (14 Days)||12
80028|NCT01405794|191284|P1|STARTED|First Dose Placebo (14 Days)||12
80029|NCT01405768|191360|P2|NOT COMPLETED|Overall Study||0
80030|NCT01405768|191361|P1|NOT COMPLETED|Overall Study||4
80031|NCT01405768|191360|P2|COMPLETED|Overall Study||28
80032|NCT01405768|191361|P1|COMPLETED|Overall Study||24
80033|NCT01405768|191360|P2|STARTED|Overall Study||28
80034|NCT01405768|191361|P1|STARTED|Overall Study||28
80035|NCT01405742|191373|P2|NOT COMPLETED|Overall Study||0
80036|NCT01405742|191374|P1|NOT COMPLETED|Overall Study||1
80037|NCT01405742|191373|P2|COMPLETED|Overall Study||2
80038|NCT01405742|191374|P1|COMPLETED|Overall Study||1
80039|NCT01405742|191373|P2|STARTED|Overall Study||2
80040|NCT01405742|191374|P1|STARTED|Overall Study||2
80041|NCT01405560|191384|P1|NOT COMPLETED|Overall Study||1
80042|NCT01405560|191384|P1|COMPLETED|Overall Study||41
80043|NCT01405560|191384|P1|STARTED|Overall Study||42
80044|NCT01405508|191399|P4|NOT COMPLETED|Overall Study||0
80045|NCT01405508|191400|P3|NOT COMPLETED|Overall Study||0
80046|NCT01405508|191401|P2|NOT COMPLETED|Overall Study||1
80047|NCT01405508|191402|P1|NOT COMPLETED|Overall Study||1
80048|NCT01405508|191399|P4|COMPLETED|Overall Study||26
80049|NCT01405508|191400|P3|COMPLETED|Overall Study||27
80050|NCT01405508|191401|P2|COMPLETED|Overall Study||25
80051|NCT01405508|191402|P1|COMPLETED|Overall Study||25
80052|NCT01405508|191399|P4|STARTED|Overall Study||26
80053|NCT01405508|191400|P3|STARTED|Overall Study||27
80054|NCT01405508|191401|P2|STARTED|Overall Study||26
80055|NCT01405508|191402|P1|STARTED|Overall Study||26
80056|NCT01405469|191420|P1|NOT COMPLETED|Overall Study||0
80057|NCT01405469|191420|P1|COMPLETED|Overall Study||16
80058|NCT01405469|191420|P1|STARTED|Overall Study||16
80059|NCT01405313|191432|P1|NOT COMPLETED|Overall Study||0
80060|NCT01405313|191432|P1|COMPLETED|Overall Study||21
80061|NCT01405313|191432|P1|STARTED|Overall Study||21
80062|NCT01405027|191442|P2|NOT COMPLETED|Overall Study||51
80063|NCT01405027|191443|P1|NOT COMPLETED|Overall Study||32
80064|NCT01405027|191442|P2|COMPLETED|Overall Study||62
80065|NCT01405027|191443|P1|COMPLETED|Overall Study||52
80066|NCT01405027|191442|P2|STARTED|Overall Study||113
80067|NCT01405027|191443|P1|STARTED|Overall Study||84
80068|NCT01404988|191460|P3|NOT COMPLETED|Overall Study||3
80069|NCT01404988|191461|P2|NOT COMPLETED|Overall Study||4
80070|NCT01404988|191462|P1|NOT COMPLETED|Overall Study||6
80071|NCT01404988|191460|P3|COMPLETED|Overall Study||30
80072|NCT01404988|191461|P2|COMPLETED|Overall Study||29
80073|NCT01404988|191462|P1|COMPLETED|Overall Study||27
80074|NCT01404988|191460|P3|STARTED|Overall Study||33
80075|NCT01404988|191461|P2|STARTED|Overall Study||33
80076|NCT01404988|191462|P1|STARTED|Overall Study||33
80077|NCT01404936|191479|P1|NOT COMPLETED|Overall Study||0
80078|NCT01404936|191479|P1|COMPLETED|Overall Study||30
80079|NCT01404936|191479|P1|STARTED|Overall Study||30
80080|NCT01404923|191485|P2|NOT COMPLETED|Overall Study||17
80081|NCT01404923|191486|P1|NOT COMPLETED|Overall Study||23
80082|NCT01404923|191485|P2|COMPLETED|Overall Study||197
80083|NCT01404923|191486|P1|COMPLETED|Overall Study||199
80084|NCT01404923|191485|P2|STARTED|Overall Study||214
80085|NCT01404923|191486|P1|STARTED|Overall Study||222
80086|NCT01404832|191494|P1|NOT COMPLETED|Overall Study||0
80087|NCT01404832|191494|P1|COMPLETED|Overall Study||21
80088|NCT01404832|191494|P1|STARTED|Overall Study||21
80089|NCT01404650|191499|P1|NOT COMPLETED|Overall Study||0
80090|NCT01404650|191499|P1|COMPLETED|Overall Study||25
80091|NCT01404650|191499|P1|STARTED|Overall Study|Twenty-five patients received a median of 2 cycles of AUY922.|25
80092|NCT01404611|191509|P3|NOT COMPLETED|Overall Study||5
80093|NCT01404611|191510|P2|NOT COMPLETED|Overall Study||19
80094|NCT01404611|191511|P1|NOT COMPLETED|Overall Study||8
80095|NCT01404611|191509|P3|COMPLETED|Overall Study||106
80096|NCT01404611|191510|P2|COMPLETED|Overall Study||89
80097|NCT01404611|191511|P1|COMPLETED|Overall Study||104
80098|NCT01404611|191509|P3|STARTED|Overall Study||111
80099|NCT01404611|191510|P2|STARTED|Overall Study||108
80100|NCT01404611|191511|P1|STARTED|Overall Study||112
80101|NCT01404572|191519|P3|NOT COMPLETED|Overall Study||0
80102|NCT01404572|191520|P2|NOT COMPLETED|Overall Study||0
80103|NCT01404572|191521|P1|NOT COMPLETED|Overall Study||0
80104|NCT01404572|191519|P3|COMPLETED|Overall Study||4
80105|NCT01404572|191520|P2|COMPLETED|Overall Study||4
80106|NCT01404572|191521|P1|COMPLETED|Overall Study||4
80107|NCT01404572|191519|P3|STARTED|Overall Study||4
80108|NCT01404572|191520|P2|STARTED|Overall Study||4
80109|NCT01404572|191521|P1|STARTED|Overall Study||4
80110|NCT01404559|191552|P4|NOT COMPLETED|Overall Study||0
80111|NCT01404559|191553|P3|NOT COMPLETED|Overall Study||0
80112|NCT01404559|191554|P2|NOT COMPLETED|Overall Study||0
80113|NCT01404559|191555|P1|NOT COMPLETED|Overall Study||0
80114|NCT01404559|191552|P4|COMPLETED|Overall Study||14
80115|NCT01404559|191553|P3|COMPLETED|Overall Study||4
80116|NCT01404559|191554|P2|COMPLETED|Overall Study||5
80117|NCT01404559|191555|P1|COMPLETED|Overall Study||5
80118|NCT01404559|191552|P4|STARTED|Overall Study||14
80119|NCT01404559|191553|P3|STARTED|Overall Study||4
80120|NCT01404559|191554|P2|STARTED|Overall Study||5
80121|NCT01404559|191555|P1|STARTED|Overall Study||5
80122|NCT01404429|191568|P2|NOT COMPLETED|Overall Study||7
80123|NCT01404429|191569|P1|NOT COMPLETED|Overall Study||9
80124|NCT01404429|191568|P2|COMPLETED|Overall Study||46
80125|NCT01404429|191569|P1|COMPLETED|Overall Study||38
80126|NCT01404429|191568|P2|STARTED|Overall Study||53
80127|NCT01404429|191569|P1|STARTED|Overall Study||47
80128|NCT01404260|191583|P2|NOT COMPLETED|Overall Study||9
80129|NCT01404260|191584|P1|NOT COMPLETED|Overall Study||3
80130|NCT01404260|191583|P2|COMPLETED|Overall Study||101
80131|NCT01404260|191584|P1|COMPLETED|Overall Study||106
80132|NCT01404260|191583|P2|STARTED|Overall Study||110
80133|NCT01404260|191584|P1|STARTED|Overall Study||109
80134|NCT01404234|191590|P1|NOT COMPLETED|Overall Study||2
80135|NCT01404234|191590|P1|COMPLETED|Overall Study||59
80136|NCT01404234|191590|P1|STARTED|Overall Study||61
80137|NCT01404208|191606|P2|NOT COMPLETED|Overall Study||0
80138|NCT01404208|191607|P1|NOT COMPLETED|Overall Study||3
80139|NCT01404208|191606|P2|COMPLETED|Overall Study||72
80140|NCT01404208|191607|P1|COMPLETED|Overall Study||67
80141|NCT01404208|191606|P2|STARTED|Overall Study||72
80142|NCT01404208|191607|P1|STARTED|Overall Study||70
80143|NCT01404078|191617|P2|NOT COMPLETED|Overall Study||20
80144|NCT01404078|191618|P1|NOT COMPLETED|Overall Study||18
80145|NCT01404078|191617|P2|COMPLETED|Overall Study||237
80146|NCT01404078|191618|P1|COMPLETED|Overall Study||243
80147|NCT01404078|191617|P2|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|257
80148|NCT01404078|191618|P1|STARTED|Overall Study|725 Started on Phase 1 run in low dose polycap 645 started on phase 2 run in full dose polycap|261
80149|NCT01404039|191633|P13|NOT COMPLETED|Overall Study||0
80150|NCT01404039|191634|P12|NOT COMPLETED|Overall Study||0
80151|NCT01404039|191635|P11|NOT COMPLETED|Overall Study||1
80152|NCT01404039|191636|P10|NOT COMPLETED|Overall Study||1
80153|NCT01404039|191637|P9|NOT COMPLETED|Overall Study||0
80154|NCT01404039|191638|P8|NOT COMPLETED|Overall Study||0
80155|NCT01404039|191639|P7|NOT COMPLETED|Overall Study||0
80156|NCT01404039|191640|P6|NOT COMPLETED|Overall Study||0
80157|NCT01404039|191641|P5|NOT COMPLETED|Overall Study||0
80158|NCT01404039|191642|P4|NOT COMPLETED|Overall Study||0
80159|NCT01404039|191643|P3|NOT COMPLETED|Overall Study||0
80160|NCT01404039|191644|P2|NOT COMPLETED|Overall Study||0
80161|NCT01404039|191645|P1|NOT COMPLETED|Overall Study||1
80162|NCT01404039|191633|P13|COMPLETED|Overall Study||0
80163|NCT01404039|191634|P12|COMPLETED|Overall Study||0
80164|NCT01404039|191635|P11|COMPLETED|Overall Study||14
80165|NCT01404039|191636|P10|COMPLETED|Overall Study||14
80166|NCT01404039|191637|P9|COMPLETED|Overall Study||15
80167|NCT01404039|191638|P8|COMPLETED|Overall Study||15
80168|NCT01404039|191639|P7|COMPLETED|Overall Study||10
80169|NCT01404039|191640|P6|COMPLETED|Overall Study||10
80170|NCT01404039|191641|P5|COMPLETED|Overall Study||10
80171|NCT01404039|191642|P4|COMPLETED|Overall Study||10
80172|NCT01404039|191643|P3|COMPLETED|Overall Study||5
80173|NCT01404039|191644|P2|COMPLETED|Overall Study||5
80174|NCT01404039|191645|P1|COMPLETED|Overall Study||4
80175|NCT01404039|191633|P13|STARTED|Overall Study||0
80176|NCT01404039|191634|P12|STARTED|Overall Study||0
80177|NCT01404039|191635|P11|STARTED|Overall Study||15
80178|NCT01404039|191636|P10|STARTED|Overall Study||15
80179|NCT01404039|191637|P9|STARTED|Overall Study||15
80180|NCT01404039|191638|P8|STARTED|Overall Study||15
80181|NCT01404039|191639|P7|STARTED|Overall Study||10
80182|NCT01404039|191640|P6|STARTED|Overall Study||10
80183|NCT01404039|191641|P5|STARTED|Overall Study||10
80184|NCT01404039|191642|P4|STARTED|Overall Study||10
80185|NCT01404039|191643|P3|STARTED|Overall Study||5
80186|NCT01404039|191644|P2|STARTED|Overall Study||5
80187|NCT01404039|191645|P1|STARTED|Overall Study||5
80188|NCT01403987|191672|P3|NOT COMPLETED|Overall Study||18
80189|NCT01403987|191673|P2|NOT COMPLETED|Overall Study||17
80190|NCT01403987|191674|P1|NOT COMPLETED|Overall Study||18
80191|NCT01403987|191672|P3|COMPLETED|Overall Study||50
80192|NCT01403987|191673|P2|COMPLETED|Overall Study||17
80193|NCT01403987|191674|P1|COMPLETED|Overall Study||16
80194|NCT01403987|191672|P3|STARTED|Overall Study||68
80195|NCT01403987|191673|P2|STARTED|Overall Study||34
80196|NCT01403987|191674|P1|STARTED|Overall Study||34
80197|NCT01403805|191690|P2|NOT COMPLETED|Overall Study||7
80198|NCT01403805|191691|P1|NOT COMPLETED|Overall Study||0
80199|NCT01403805|191690|P2|COMPLETED|Overall Study||98
80200|NCT01403805|191691|P1|COMPLETED|Overall Study||94
80201|NCT01403805|191690|P2|Pneumonia Diagnosis|Overall Study||2
80202|NCT01403805|191691|P1|Pneumonia Diagnosis|Overall Study||21
80203|NCT01403805|191690|P2|STARTED|Overall Study||105
80204|NCT01403805|191691|P1|STARTED|Overall Study||94
80205|NCT01402427|191705|P2|NOT COMPLETED|Overall Study||0
80206|NCT01402427|191706|P1|NOT COMPLETED|Overall Study||0
80207|NCT01402427|191705|P2|COMPLETED|Overall Study||294
80208|NCT01402427|191706|P1|COMPLETED|Overall Study||297
80209|NCT01402427|191705|P2|STARTED|Overall Study||294
80210|NCT01402427|191706|P1|STARTED|Overall Study||297
80211|NCT01403376|191727|P3|NOT COMPLETED|Overall Study||0
80212|NCT01403376|191728|P2|NOT COMPLETED|Overall Study||0
80213|NCT01403376|191729|P1|NOT COMPLETED|Overall Study||0
80214|NCT01403376|191727|P3|COMPLETED|Overall Study||46
80215|NCT01403376|191728|P2|COMPLETED|Overall Study||41
80216|NCT01403376|191729|P1|COMPLETED|Overall Study||41
80217|NCT01403376|191727|P3|STARTED|Overall Study||46
80218|NCT01403376|191728|P2|STARTED|Overall Study||41
80219|NCT01403376|191729|P1|STARTED|Overall Study||41
80220|NCT01403194|191749|P1|NOT COMPLETED|Overall Study||10
80221|NCT01403194|191749|P1|COMPLETED|Overall Study||1
80222|NCT01403194|191749|P1|STARTED|Overall Study||11
80223|NCT01403090|191755|P1|NOT COMPLETED|Overall Study||0
80224|NCT01403090|191755|P1|COMPLETED|Overall Study||8
80225|NCT01403090|191755|P1|STARTED|Overall Study||8
80226|NCT01403051|191761|P2|NOT COMPLETED|Overall Study||6
80227|NCT01403051|191762|P1|NOT COMPLETED|Overall Study||10
80228|NCT01403051|191761|P2|COMPLETED|Overall Study||80
80229|NCT01403051|191762|P1|COMPLETED|Overall Study||71
80230|NCT01403051|191761|P2|Initiated Study Treatment|Overall Study||86
80231|NCT01403051|191762|P1|Initiated Study Treatment|Overall Study||81
80232|NCT01403051|191761|P2|STARTED|Overall Study||86
80233|NCT01403051|191762|P1|STARTED|Overall Study||81
80234|NCT01402986|191798|P4|NOT COMPLETED|Overall Study||22
80235|NCT01402986|191799|P3|NOT COMPLETED|Overall Study||8
80236|NCT01402986|191800|P2|NOT COMPLETED|Overall Study||15
80237|NCT01402986|191801|P1|NOT COMPLETED|Overall Study||9
80238|NCT01402986|191798|P4|COMPLETED|Overall Study||129
80239|NCT01402986|191799|P3|COMPLETED|Overall Study||67
80240|NCT01402986|191800|P2|COMPLETED|Overall Study||135
80241|NCT01402986|191801|P1|COMPLETED|Overall Study||67
80242|NCT01402986|191798|P4|STARTED|Overall Study||151
80243|NCT01402986|191799|P3|STARTED|Overall Study||75
80244|NCT01402986|191800|P2|STARTED|Overall Study||150
80245|NCT01402986|191801|P1|STARTED|Overall Study||76
80246|NCT01402947|191936|P2|NOT COMPLETED|Second Intervention||0
80247|NCT01402947|191937|P1|NOT COMPLETED|Second Intervention||0
80248|NCT01402947|191936|P2|COMPLETED|Second Intervention||14
80249|NCT01402947|191937|P1|COMPLETED|Second Intervention||15
80250|NCT01402947|191936|P2|STARTED|Second Intervention||14
80251|NCT01402947|191937|P1|STARTED|Second Intervention||15
80252|NCT01402947|191936|P2|NOT COMPLETED|First Intervention||1
80253|NCT01402947|191937|P1|NOT COMPLETED|First Intervention||0
80254|NCT01402947|191936|P2|COMPLETED|First Intervention||14
80255|NCT01402947|191937|P1|COMPLETED|First Intervention||15
80256|NCT01402947|191936|P2|STARTED|First Intervention||15
80257|NCT01402947|191937|P1|STARTED|First Intervention||15
80258|NCT01402869|191948|P3|NOT COMPLETED|Overall Study||1
80259|NCT01402869|191949|P2|NOT COMPLETED|Overall Study||0
80260|NCT01402869|191950|P1|NOT COMPLETED|Overall Study||0
80261|NCT01402869|191948|P3|COMPLETED|Overall Study||30
80262|NCT01402869|191949|P2|COMPLETED|Overall Study||30
80263|NCT01402869|191950|P1|COMPLETED|Overall Study||30
80264|NCT01402869|191948|P3|STARTED|Overall Study||31
80265|NCT01402869|191949|P2|STARTED|Overall Study||30
80266|NCT01402869|191950|P1|STARTED|Overall Study||30
80267|NCT01402817|191964|P1|NOT COMPLETED|Overall Study||11
80268|NCT01402817|191964|P1|COMPLETED|Overall Study||8
80269|NCT01402817|191964|P1|STARTED|Overall Study||19
80270|NCT01402700|191969|P1|NOT COMPLETED|Overall Study||7
80271|NCT01402700|191969|P1|COMPLETED|Overall Study||68
80272|NCT01402700|191969|P1|STARTED|Overall Study||75
80273|NCT01402570|191973|P1|NOT COMPLETED|Overall Study||1
80274|NCT01402570|191973|P1|COMPLETED|Overall Study||19
80275|NCT01402570|191973|P1|STARTED|Overall Study||20
80276|NCT01402284|191980|P1|NOT COMPLETED|Overall Study||15
80277|NCT01402284|191980|P1|COMPLETED|Overall Study||30
80278|NCT01402284|191980|P1|STARTED|Overall Study||45
80279|NCT01402141|191993|P2|NOT COMPLETED|Overall Study||2
80280|NCT01402141|191994|P1|NOT COMPLETED|Overall Study||1
80281|NCT01402141|191993|P2|COMPLETED|Overall Study||28
80282|NCT01402141|191994|P1|COMPLETED|Overall Study||29
80283|NCT01402141|191993|P2|STARTED|Overall Study||30
80284|NCT01402141|191994|P1|STARTED|Overall Study||30
80285|NCT01402128|192016|P2|NOT COMPLETED|Overall Study||0
80286|NCT01402128|192017|P1|NOT COMPLETED|Overall Study||1
80287|NCT01402128|192016|P2|COMPLETED|Overall Study||40
80288|NCT01402128|192017|P1|COMPLETED|Overall Study||39
80289|NCT01402128|192016|P2|STARTED|Overall Study||40
80290|NCT01402128|192017|P1|STARTED|Overall Study||40
80291|NCT01402115|192045|P2|NOT COMPLETED|Overall Study||1
80292|NCT01402115|192046|P1|NOT COMPLETED|Overall Study||1
80293|NCT01402115|192045|P2|COMPLETED|Overall Study||29
80294|NCT01402115|192046|P1|COMPLETED|Overall Study||29
80295|NCT01402115|192045|P2|STARTED|Overall Study||30
80296|NCT01402115|192046|P1|STARTED|Overall Study||30
80297|NCT01402102|192062|P2|NOT COMPLETED|Overall Study||3
80298|NCT01402102|192063|P1|NOT COMPLETED|Overall Study||2
80299|NCT01402102|192062|P2|COMPLETED|Overall Study||27
80300|NCT01402102|192063|P1|COMPLETED|Overall Study||28
80301|NCT01402102|192062|P2|STARTED|Overall Study||30
80302|NCT01402102|192063|P1|STARTED|Overall Study||30
80303|NCT01402063|192083|P2|NOT COMPLETED|Overall Study||3
80304|NCT01402063|192084|P1|NOT COMPLETED|Overall Study||3
80305|NCT01402063|192083|P2|COMPLETED|Overall Study||18
80306|NCT01402063|192084|P1|COMPLETED|Overall Study||39
80307|NCT01402063|192083|P2|STARTED|Overall Study||21
80308|NCT01402063|192084|P1|STARTED|Overall Study||42
80309|NCT01401907|192092|P2|NOT COMPLETED|Overall Study||51
80310|NCT01401907|192093|P1|NOT COMPLETED|Overall Study||57
80311|NCT01401907|192092|P2|COMPLETED|Overall Study||124
80312|NCT01401907|192093|P1|COMPLETED|Overall Study||118
80313|NCT01401907|192092|P2|12 Week Outcomes|Overall Study||153
80314|NCT01401907|192093|P1|12 Week Outcomes|Overall Study||148
80315|NCT01401907|192092|P2|STARTED|Overall Study||175
80316|NCT01401907|192093|P1|STARTED|Overall Study||175
80317|NCT01401842|192113|P2|NOT COMPLETED|Overall Study||67
80318|NCT01401842|192114|P1|NOT COMPLETED|Overall Study||68
80319|NCT01401842|192113|P2|COMPLETED|Overall Study||217
80320|NCT01401842|192114|P1|COMPLETED|Overall Study||230
80321|NCT01401842|192113|P2|STARTED|Overall Study||284
80322|NCT01401842|192114|P1|STARTED|Overall Study||298
80323|NCT01401647|192127|P3|NOT COMPLETED|Overall Study||3
80324|NCT01401647|192128|P2|NOT COMPLETED|Overall Study||8
80325|NCT01401647|192129|P1|NOT COMPLETED|Overall Study||4
80326|NCT01401647|192127|P3|COMPLETED|Overall Study||1056
80327|NCT01401647|192128|P2|COMPLETED|Overall Study||985
80328|NCT01401647|192129|P1|COMPLETED|Overall Study||968
80329|NCT01401647|192127|P3|STARTED|Overall Study||1059
80330|NCT01401647|192128|P2|STARTED|Overall Study||993
80331|NCT01401647|192129|P1|STARTED|Overall Study||972
80332|NCT01401595|192142|P2|NOT COMPLETED|Imaging and Treatment (for NE Arm)||0
80333|NCT01401595|192143|P1|NOT COMPLETED|Imaging and Treatment (for NE Arm)||14
80334|NCT01401595|192142|P2|COMPLETED|Imaging and Treatment (for NE Arm)||10
80335|NCT01401595|192143|P1|COMPLETED|Imaging and Treatment (for NE Arm)||18
80336|NCT01401595|192142|P2|STARTED|Imaging and Treatment (for NE Arm)||10
80337|NCT01401595|192143|P1|STARTED|Imaging and Treatment (for NE Arm)||32
80338|NCT01401595|192142|P2|NOT COMPLETED|Recruitment and Screening||2
80339|NCT01401595|192143|P1|NOT COMPLETED|Recruitment and Screening||43
80340|NCT01401595|192142|P2|COMPLETED|Recruitment and Screening|10 of the 12 remained eligible/interested after the initial screening visit.|10
80341|NCT01401595|192143|P1|COMPLETED|Recruitment and Screening|Of the 75, 32 remained interested/eligible after the initial screening period.|32
80342|NCT01401595|192142|P2|STARTED|Recruitment and Screening|Of 32 calls, 12 control subjects attended an initial screening visit.|12
80343|NCT01401595|192143|P1|STARTED|Recruitment and Screening|Of 345 calls, 75 potential NES subjects attended the screening visit and provided informed consent.|75
80344|NCT01401582|192154|P2|NOT COMPLETED|Overall Study||117
80345|NCT01401582|192155|P1|NOT COMPLETED|Overall Study||110
80346|NCT01401582|192154|P2|COMPLETED|Overall Study||291
80347|NCT01401582|192155|P1|COMPLETED|Overall Study||116
80348|NCT01401582|192154|P2|Baseline Completed|Overall Study||348
80349|NCT01401582|192155|P1|Baseline Completed|Overall Study||168
80350|NCT01401582|192154|P2|STARTED|Overall Study||408
80351|NCT01401582|192155|P1|STARTED|Overall Study||226
80352|NCT01401517|192174|P3|NOT COMPLETED|Overall Study||3
80353|NCT01401517|192175|P2|NOT COMPLETED|Overall Study||2
80354|NCT01401517|192176|P1|NOT COMPLETED|Overall Study||3
80355|NCT01401517|192174|P3|COMPLETED|Overall Study||15
80356|NCT01401517|192175|P2|COMPLETED|Overall Study||17
80357|NCT01401517|192176|P1|COMPLETED|Overall Study||15
80358|NCT01401517|192174|P3|STARTED|Overall Study||18
80359|NCT01401517|192175|P2|STARTED|Overall Study||19
80360|NCT01401517|192176|P1|STARTED|Overall Study||18
80361|NCT01401478|192184|P1|NOT COMPLETED|Overall Study||31
80362|NCT01401478|192184|P1|COMPLETED|Overall Study||55
80363|NCT01401478|192184|P1|STARTED|Overall Study||86
80364|NCT01401465|192197|P2|NOT COMPLETED|Treatment Period 2||2
80365|NCT01401465|192198|P1|NOT COMPLETED|Treatment Period 2||0
80366|NCT01401465|192197|P2|COMPLETED|Treatment Period 2||144
80367|NCT01401465|192198|P1|COMPLETED|Treatment Period 2||150
80368|NCT01401465|192197|P2|STARTED|Treatment Period 2||146
80369|NCT01401465|192198|P1|STARTED|Treatment Period 2||150
80370|NCT01401465|192197|P2|NOT COMPLETED|Washout||0
80371|NCT01401465|192198|P1|NOT COMPLETED|Washout||0
80372|NCT01401465|192197|P2|COMPLETED|Washout||146
80373|NCT01401465|192198|P1|COMPLETED|Washout||150
80374|NCT01401465|192197|P2|STARTED|Washout||146
80375|NCT01401465|192198|P1|STARTED|Washout||150
80376|NCT01401465|192197|P2|NOT COMPLETED|Treatment Period 1||16
80377|NCT01401465|192198|P1|NOT COMPLETED|Treatment Period 1||15
80378|NCT01401465|192197|P2|COMPLETED|Treatment Period 1||146
80379|NCT01401465|192198|P1|COMPLETED|Treatment Period 1||150
80380|NCT01401465|192197|P2|STARTED|Treatment Period 1||162
80381|NCT01401465|192198|P1|STARTED|Treatment Period 1||165
80382|NCT01401361|192261|P1|NOT COMPLETED|Overall Study||28
80383|NCT01401361|192261|P1|COMPLETED|Overall Study|16 subjects were withdrawn prior to the use of the investigational device|122
80384|NCT01401361|192261|P1|STARTED|Overall Study||150
80385|NCT01401322|192267|P1|NOT COMPLETED|Overall Study||2
80386|NCT01401322|192267|P1|COMPLETED|Overall Study||3
80387|NCT01401322|192267|P1|STARTED|Overall Study||5
80388|NCT01401283|192273|P2|NOT COMPLETED|Overall Study||10
80389|NCT01401283|192274|P1|NOT COMPLETED|Overall Study||10
80390|NCT01401283|192273|P2|COMPLETED|Overall Study||81
80391|NCT01401283|192274|P1|COMPLETED|Overall Study||79
80392|NCT01401283|192273|P2|STARTED|Overall Study||91
80393|NCT01401283|192274|P1|STARTED|Overall Study||89
80394|NCT01401257|192286|P4|NOT COMPLETED|Overall Study||2
80395|NCT01401257|192287|P3|NOT COMPLETED|Overall Study||3
80396|NCT01401257|192288|P2|NOT COMPLETED|Overall Study||2
80397|NCT01401257|192289|P1|NOT COMPLETED|Overall Study||0
80398|NCT01401257|192286|P4|COMPLETED|Overall Study||17
80399|NCT01401257|192287|P3|COMPLETED|Overall Study||16
80400|NCT01401257|192288|P2|COMPLETED|Overall Study||19
80401|NCT01401257|192289|P1|COMPLETED|Overall Study||21
80402|NCT01401257|192286|P4|STARTED|Overall Study||19
80403|NCT01401257|192287|P3|STARTED|Overall Study||19
80404|NCT01401257|192288|P2|STARTED|Overall Study||21
80405|NCT01401257|192289|P1|STARTED|Overall Study||21
80406|NCT01401166|192301|P4|NOT COMPLETED|Safety Follow-Up Period||19
80407|NCT01401166|192302|P3|NOT COMPLETED|Safety Follow-Up Period||17
80408|NCT01401166|192303|P2|NOT COMPLETED|Safety Follow-Up Period||18
80409|NCT01401166|192304|P1|NOT COMPLETED|Safety Follow-Up Period||25
80410|NCT01401166|192301|P4|COMPLETED|Safety Follow-Up Period||100
80411|NCT01401166|192302|P3|COMPLETED|Safety Follow-Up Period||104
80412|NCT01401166|192303|P2|COMPLETED|Safety Follow-Up Period||106
80413|NCT01401166|192304|P1|COMPLETED|Safety Follow-Up Period||99
80414|NCT01401166|192301|P4|STARTED|Safety Follow-Up Period|All 119 randomized participants entered follow-up regardless of whether they received treatment.|119
80415|NCT01401166|192302|P3|STARTED|Safety Follow-Up Period|All 121 randomized participants entered follow-up regardless of whether they received treatment.|121
80416|NCT01401166|192303|P2|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
80417|NCT01401166|192304|P1|STARTED|Safety Follow-Up Period|All 124 randomized participants entered follow-up regardless of whether they received treatment.|124
80418|NCT01401166|192301|P4|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||3
80419|NCT01401166|192302|P3|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||2
80420|NCT01401166|192303|P2|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||7
80421|NCT01401166|192304|P1|NOT COMPLETED|Continuation Treatment (Cycles 9 to 18)||4
80422|NCT01401166|192301|P4|COMPLETED|Continuation Treatment (Cycles 9 to 18)||102
80423|NCT01401166|192302|P3|COMPLETED|Continuation Treatment (Cycles 9 to 18)||105
80424|NCT01401166|192303|P2|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
80425|NCT01401166|192304|P1|COMPLETED|Continuation Treatment (Cycles 9 to 18)||109
80426|NCT01401166|192301|P4|STARTED|Continuation Treatment (Cycles 9 to 18)||105
80427|NCT01401166|192302|P3|STARTED|Continuation Treatment (Cycles 9 to 18)||107
80428|NCT01401166|192303|P2|STARTED|Continuation Treatment (Cycles 9 to 18)||116
80429|NCT01401166|192304|P1|STARTED|Continuation Treatment (Cycles 9 to 18)||113
80430|NCT01401166|192301|P4|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||11
80431|NCT01401166|192302|P3|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||12
80432|NCT01401166|192303|P2|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||4
80433|NCT01401166|192304|P1|NOT COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||6
80434|NCT01401166|192301|P4|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||105
80435|NCT01401166|192302|P3|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||107
80436|NCT01401166|192303|P2|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||116
80437|NCT01401166|192304|P1|COMPLETED|Crossover Treatment 2 (Cycles 5 to 8)||113
80438|NCT01401166|192301|P4|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||116
80439|NCT01401166|192302|P3|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
80440|NCT01401166|192303|P2|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||120
80441|NCT01401166|192304|P1|STARTED|Crossover Treatment 2 (Cycles 5 to 8)||119
80442|NCT01401166|192301|P4|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
80443|NCT01401166|192302|P3|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
80444|NCT01401166|192303|P2|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||2
80445|NCT01401166|192304|P1|NOT COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||3
80446|NCT01401166|192301|P4|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||116
80447|NCT01401166|192302|P3|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
80448|NCT01401166|192303|P2|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||120
80449|NCT01401166|192304|P1|COMPLETED|Crossover Treatment 1 (Cycles 1 to 4)||119
80450|NCT01401166|192301|P4|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 119 participants were randomized, but 1 did not receive any treatment.|118
80451|NCT01401166|192302|P3|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 121 participants were randomized who all received study treatment.|121
80452|NCT01401166|192303|P2|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
80453|NCT01401166|192304|P1|STARTED|Crossover Treatment 1 (Cycles 1 to 4)|A total of 124 participants were randomized, but 2 did not receive any treatment.|122
80454|NCT01401153|192340|P2|NOT COMPLETED|Second Test Day||5
80455|NCT01401153|192341|P1|NOT COMPLETED|Second Test Day||0
80456|NCT01401153|192340|P2|COMPLETED|Second Test Day||60
80457|NCT01401153|192341|P1|COMPLETED|Second Test Day||45
80458|NCT01401153|192340|P2|STARTED|Second Test Day||65
80459|NCT01401153|192341|P1|STARTED|Second Test Day||45
80460|NCT01401153|192340|P2|NOT COMPLETED|First Test Day||10
80461|NCT01401153|192341|P1|NOT COMPLETED|First Test Day||1
80462|NCT01401153|192340|P2|COMPLETED|First Test Day||45
80463|NCT01401153|192341|P1|COMPLETED|First Test Day||65
80464|NCT01401153|192340|P2|STARTED|First Test Day||55
80465|NCT01401153|192341|P1|STARTED|First Test Day||66
80466|NCT01401101|192375|P2|NOT COMPLETED|Overall Study||27
80467|NCT01401101|192376|P1|NOT COMPLETED|Overall Study||22
80468|NCT01401101|192375|P2|COMPLETED|Overall Study||171
80469|NCT01401101|192376|P1|COMPLETED|Overall Study||184
80470|NCT01401101|192375|P2|STARTED|Overall Study||198
80471|NCT01401101|192376|P1|STARTED|Overall Study||206
80472|NCT01401062|192388|P2|NOT COMPLETED|Overall Study||8
80473|NCT01401062|192389|P1|NOT COMPLETED|Overall Study||11
80474|NCT01401062|192388|P2|COMPLETED|Overall Study|At time of data entry, these 4 patients are still undergoing follow-up|4
80475|NCT01401062|192389|P1|COMPLETED|Overall Study||0
80476|NCT01401062|192388|P2|STARTED|Overall Study||12
80477|NCT01401062|192389|P1|STARTED|Overall Study||11
80478|NCT01401049|192397|P2|NOT COMPLETED|Overall Study||0
80479|NCT01401049|192398|P1|NOT COMPLETED|Overall Study||0
80480|NCT01401049|192397|P2|COMPLETED|Overall Study||0
80481|NCT01401049|192398|P1|COMPLETED|Overall Study||0
80482|NCT01401049|192397|P2|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
80483|NCT01401049|192398|P1|STARTED|Overall Study|Due to flooding from Hurricane Sandy at our site, all files and pertinent patient data were lost.|0
80484|NCT01401023|192404|P1|NOT COMPLETED|Overall Study||0
80485|NCT01401023|192404|P1|COMPLETED|Overall Study||10
80486|NCT01401023|192404|P1|STARTED|Overall Study||10
80487|NCT01401010|192412|P2|NOT COMPLETED|Overall Study||0
80488|NCT01401010|192413|P1|NOT COMPLETED|Overall Study||1
80489|NCT01401010|192412|P2|COMPLETED|Overall Study||6
80490|NCT01401010|192413|P1|COMPLETED|Overall Study||5
80491|NCT01401010|192412|P2|STARTED|Overall Study||6
80492|NCT01401010|192413|P1|STARTED|Overall Study||6
80493|NCT01400958|192438|P2|NOT COMPLETED|Overall Study||2
80494|NCT01400958|192439|P1|NOT COMPLETED|Overall Study||1
80495|NCT01400958|192438|P2|COMPLETED|Overall Study||1
80496|NCT01400958|192439|P1|COMPLETED|Overall Study||2
80497|NCT01400958|192438|P2|STARTED|Overall Study||3
80498|NCT01400958|192439|P1|STARTED|Overall Study||3
80499|NCT01400932|192449|P2|NOT COMPLETED|Overall Study||15
80500|NCT01400932|192450|P1|NOT COMPLETED|Overall Study||14
80501|NCT01400932|192449|P2|COMPLETED|Overall Study||167
80502|NCT01400932|192450|P1|COMPLETED|Overall Study||164
80503|NCT01400932|192449|P2|STARTED|Overall Study||182
80504|NCT01400932|192450|P1|STARTED|Overall Study||178
80505|NCT01400919|192472|P1|NOT COMPLETED|Overall Study||8
80506|NCT01400919|192472|P1|COMPLETED|Overall Study||67
80507|NCT01400919|192472|P1|STARTED|Overall Study||75
80508|NCT01400906|192476|P6|NOT COMPLETED|Treatment Period 3||0
80509|NCT01400906|192477|P5|NOT COMPLETED|Treatment Period 3||0
80510|NCT01400906|192478|P4|NOT COMPLETED|Treatment Period 3||0
80511|NCT01400906|192479|P3|NOT COMPLETED|Treatment Period 3||0
80512|NCT01400906|192480|P2|NOT COMPLETED|Treatment Period 3||0
80513|NCT01400906|192481|P1|NOT COMPLETED|Treatment Period 3||0
80514|NCT01400906|192476|P6|COMPLETED|Treatment Period 3||5
80515|NCT01400906|192477|P5|COMPLETED|Treatment Period 3||6
80516|NCT01400906|192478|P4|COMPLETED|Treatment Period 3||6
80517|NCT01400906|192479|P3|COMPLETED|Treatment Period 3||6
80518|NCT01400906|192480|P2|COMPLETED|Treatment Period 3||6
80519|NCT01400906|192481|P1|COMPLETED|Treatment Period 3||6
80520|NCT01400906|192476|P6|STARTED|Treatment Period 3||5
80521|NCT01400906|192477|P5|STARTED|Treatment Period 3||6
80522|NCT01400906|192478|P4|STARTED|Treatment Period 3||6
80523|NCT01400906|192479|P3|STARTED|Treatment Period 3||6
80524|NCT01400906|192480|P2|STARTED|Treatment Period 3||6
80525|NCT01400906|192481|P1|STARTED|Treatment Period 3||6
80526|NCT01400906|192476|P6|NOT COMPLETED|Washout Period 2||0
80527|NCT01400906|192477|P5|NOT COMPLETED|Washout Period 2||0
80528|NCT01400906|192478|P4|NOT COMPLETED|Washout Period 2||0
80529|NCT01400906|192479|P3|NOT COMPLETED|Washout Period 2||0
80530|NCT01400906|192480|P2|NOT COMPLETED|Washout Period 2||0
80531|NCT01400906|192481|P1|NOT COMPLETED|Washout Period 2||0
80532|NCT01400906|192476|P6|COMPLETED|Washout Period 2||5
80533|NCT01400906|192477|P5|COMPLETED|Washout Period 2||6
80534|NCT01400906|192478|P4|COMPLETED|Washout Period 2||6
80535|NCT01400906|192479|P3|COMPLETED|Washout Period 2||6
80536|NCT01400906|192480|P2|COMPLETED|Washout Period 2||6
80537|NCT01400906|192481|P1|COMPLETED|Washout Period 2||6
80538|NCT01400906|192476|P6|STARTED|Washout Period 2||5
80539|NCT01400906|192477|P5|STARTED|Washout Period 2||6
80540|NCT01400906|192478|P4|STARTED|Washout Period 2||6
80541|NCT01400906|192479|P3|STARTED|Washout Period 2||6
80542|NCT01400906|192480|P2|STARTED|Washout Period 2||6
80543|NCT01400906|192481|P1|STARTED|Washout Period 2||6
80544|NCT01400906|192476|P6|NOT COMPLETED|Treatment Period 2||0
80545|NCT01400906|192477|P5|NOT COMPLETED|Treatment Period 2||0
80546|NCT01400906|192478|P4|NOT COMPLETED|Treatment Period 2||0
80547|NCT01400906|192479|P3|NOT COMPLETED|Treatment Period 2||0
80548|NCT01400906|192480|P2|NOT COMPLETED|Treatment Period 2||0
80549|NCT01400906|192481|P1|NOT COMPLETED|Treatment Period 2||0
80550|NCT01400906|192476|P6|COMPLETED|Treatment Period 2||5
80551|NCT01400906|192477|P5|COMPLETED|Treatment Period 2||6
80552|NCT01400906|192478|P4|COMPLETED|Treatment Period 2||6
80553|NCT01400906|192479|P3|COMPLETED|Treatment Period 2||6
80554|NCT01400906|192480|P2|COMPLETED|Treatment Period 2||6
80555|NCT01400906|192481|P1|COMPLETED|Treatment Period 2||6
80556|NCT01400906|192476|P6|STARTED|Treatment Period 2||5
80557|NCT01400906|192477|P5|STARTED|Treatment Period 2||6
80558|NCT01400906|192478|P4|STARTED|Treatment Period 2||6
80559|NCT01400906|192479|P3|STARTED|Treatment Period 2||6
80560|NCT01400906|192480|P2|STARTED|Treatment Period 2||6
80561|NCT01400906|192481|P1|STARTED|Treatment Period 2||6
80562|NCT01400906|192476|P6|NOT COMPLETED|Washout Period 1||0
80563|NCT01400906|192477|P5|NOT COMPLETED|Washout Period 1||0
80564|NCT01400906|192478|P4|NOT COMPLETED|Washout Period 1||0
80565|NCT01400906|192479|P3|NOT COMPLETED|Washout Period 1||0
80566|NCT01400906|192480|P2|NOT COMPLETED|Washout Period 1||0
80567|NCT01400906|192481|P1|NOT COMPLETED|Washout Period 1||0
80568|NCT01400906|192476|P6|COMPLETED|Washout Period 1||5
80569|NCT01400906|192477|P5|COMPLETED|Washout Period 1||6
80570|NCT01400906|192478|P4|COMPLETED|Washout Period 1||6
80571|NCT01400906|192479|P3|COMPLETED|Washout Period 1||6
80572|NCT01400906|192480|P2|COMPLETED|Washout Period 1||6
80573|NCT01400906|192481|P1|COMPLETED|Washout Period 1||6
80574|NCT01400906|192476|P6|STARTED|Washout Period 1||5
80575|NCT01400906|192477|P5|STARTED|Washout Period 1||6
80576|NCT01400906|192478|P4|STARTED|Washout Period 1||6
80577|NCT01400906|192479|P3|STARTED|Washout Period 1||6
80578|NCT01400906|192480|P2|STARTED|Washout Period 1||6
80579|NCT01400906|192481|P1|STARTED|Washout Period 1||6
80580|NCT01400906|192476|P6|NOT COMPLETED|Treatment Period 1||0
80581|NCT01400906|192477|P5|NOT COMPLETED|Treatment Period 1||0
80582|NCT01400906|192478|P4|NOT COMPLETED|Treatment Period 1||0
80583|NCT01400906|192479|P3|NOT COMPLETED|Treatment Period 1||0
80584|NCT01400906|192480|P2|NOT COMPLETED|Treatment Period 1||0
80585|NCT01400906|192481|P1|NOT COMPLETED|Treatment Period 1||0
80586|NCT01400906|192476|P6|COMPLETED|Treatment Period 1||5
80587|NCT01400906|192477|P5|COMPLETED|Treatment Period 1||6
80588|NCT01400906|192478|P4|COMPLETED|Treatment Period 1||6
80589|NCT01400906|192479|P3|COMPLETED|Treatment Period 1||6
80590|NCT01400906|192480|P2|COMPLETED|Treatment Period 1||6
80591|NCT01400906|192481|P1|COMPLETED|Treatment Period 1||6
80592|NCT01400906|192476|P6|STARTED|Treatment Period 1||5
80593|NCT01400906|192477|P5|STARTED|Treatment Period 1||6
80594|NCT01400906|192478|P4|STARTED|Treatment Period 1||6
80595|NCT01400906|192479|P3|STARTED|Treatment Period 1||6
80596|NCT01400906|192480|P2|STARTED|Treatment Period 1||6
80597|NCT01400906|192481|P1|STARTED|Treatment Period 1||6
80598|NCT01400893|192515|P2|NOT COMPLETED|Overall Study||27
80599|NCT01400893|192516|P1|NOT COMPLETED|Overall Study||27
80600|NCT01400893|192515|P2|COMPLETED|Overall Study||38
80601|NCT01400893|192516|P1|COMPLETED|Overall Study||42
80602|NCT01400893|192515|P2|STARTED|Overall Study||65
80603|NCT01400893|192516|P1|STARTED|Overall Study||69
80604|NCT01400880|192524|P1|NOT COMPLETED|Overall Study||2
80605|NCT01400880|192524|P1|COMPLETED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|101
80606|NCT01400880|192524|P1|STARTED|Overall Study|patients were added throughout the study. There was not a set number of patients that we began with|103
80607|NCT01400841|192528|P1|NOT COMPLETED|Extended Study Phase (2 Years)||2
80608|NCT01400841|192528|P1|COMPLETED|Extended Study Phase (2 Years)||11
80609|NCT01400841|192528|P1|STARTED|Extended Study Phase (2 Years)|"1 subject refused further participation
1 subject death prior to agreeing to extended follow-up"|13
80610|NCT01400841|192528|P1|NOT COMPLETED|Initial Study Phase (6 Months)||1
80611|NCT01400841|192528|P1|COMPLETED|Initial Study Phase (6 Months)||15
80612|NCT01400841|192528|P1|STARTED|Initial Study Phase (6 Months)|2 of the 18 consented subjects did not receive the device|16
80613|NCT01400698|192566|P6|NOT COMPLETED|Overall Study||6
80614|NCT01400698|192567|P5|NOT COMPLETED|Overall Study||7
80615|NCT01400698|192568|P4|NOT COMPLETED|Overall Study||8
80616|NCT01400698|192569|P3|NOT COMPLETED|Overall Study||2
80617|NCT01400698|192570|P2|NOT COMPLETED|Overall Study||11
80618|NCT01400698|192571|P1|NOT COMPLETED|Overall Study||15
80619|NCT01400698|192566|P6|COMPLETED|Overall Study||9
80620|NCT01400698|192567|P5|COMPLETED|Overall Study||7
80621|NCT01400698|192568|P4|COMPLETED|Overall Study||6
80622|NCT01400698|192569|P3|COMPLETED|Overall Study||0
80623|NCT01400698|192570|P2|COMPLETED|Overall Study||12
80624|NCT01400698|192571|P1|COMPLETED|Overall Study||8
80625|NCT01400698|192566|P6|STARTED|Overall Study||15
80626|NCT01400698|192567|P5|STARTED|Overall Study||14
80627|NCT01400698|192568|P4|STARTED|Overall Study||14
80628|NCT01400698|192569|P3|STARTED|Overall Study||2
80629|NCT01400698|192570|P2|STARTED|Overall Study||23
80630|NCT01400698|192571|P1|STARTED|Overall Study||23
80631|NCT01400516|192595|P2|NOT COMPLETED|Extension Trial||0
80632|NCT01400516|192596|P1|NOT COMPLETED|Extension Trial||0
80633|NCT01400516|192595|P2|COMPLETED|Extension Trial||7
80634|NCT01400516|192596|P1|COMPLETED|Extension Trial||6
80635|NCT01400516|192595|P2|STARTED|Extension Trial|Only 7 participants in the Teriparatide arm entered the Extension Trial.|7
80636|NCT01400516|192596|P1|STARTED|Extension Trial|Only 6 participants in the Control arm entered the Extension Trial.|6
80637|NCT01400516|192595|P2|NOT COMPLETED|Primary Trial||2
80638|NCT01400516|192596|P1|NOT COMPLETED|Primary Trial||0
80639|NCT01400516|192595|P2|COMPLETED|Primary Trial||12
80640|NCT01400516|192596|P1|COMPLETED|Primary Trial||12
80641|NCT01400516|192595|P2|STARTED|Primary Trial||14
80642|NCT01400516|192596|P1|STARTED|Primary Trial||12
80643|NCT01400451|192609|P3|NOT COMPLETED|Combination Treatment (or Intended)||2
80644|NCT01400451|192610|P2|NOT COMPLETED|Combination Treatment (or Intended)||4
80645|NCT01400451|192611|P1|NOT COMPLETED|Combination Treatment (or Intended)||6
80646|NCT01400451|192609|P3|COMPLETED|Combination Treatment (or Intended)||0
80647|NCT01400451|192610|P2|COMPLETED|Combination Treatment (or Intended)||0
80648|NCT01400451|192611|P1|COMPLETED|Combination Treatment (or Intended)||0
80649|NCT01400451|192609|P3|STARTED|Combination Treatment (or Intended)|Did not start Ipilimumab but remained on vemurafenib alone.|2
80650|NCT01400451|192610|P2|STARTED|Combination Treatment (or Intended)||4
80651|NCT01400451|192611|P1|STARTED|Combination Treatment (or Intended)||6
80652|NCT01400451|192609|P3|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
80653|NCT01400451|192610|P2|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
80654|NCT01400451|192611|P1|NOT COMPLETED|28 Day Lead In With Vemurafenib Alone||0
80655|NCT01400451|192609|P3|COMPLETED|28 Day Lead In With Vemurafenib Alone||2
80656|NCT01400451|192610|P2|COMPLETED|28 Day Lead In With Vemurafenib Alone||4
80657|NCT01400451|192611|P1|COMPLETED|28 Day Lead In With Vemurafenib Alone||6
80658|NCT01400451|192609|P3|STARTED|28 Day Lead In With Vemurafenib Alone||2
80659|NCT01400451|192610|P2|STARTED|28 Day Lead In With Vemurafenib Alone||4
80660|NCT01400451|192611|P1|STARTED|28 Day Lead In With Vemurafenib Alone||6
80661|NCT01400425|192625|P1|NOT COMPLETED|Overall Study||10
80662|NCT01400425|192625|P1|COMPLETED|Overall Study||229
80663|NCT01400425|192625|P1|STARTED|Overall Study||239
80664|NCT01400412|192638|P2|NOT COMPLETED|Overall Study||17
80665|NCT01400412|192639|P1|NOT COMPLETED|Overall Study||10
80666|NCT01400412|192638|P2|COMPLETED|Overall Study||115
80667|NCT01400412|192639|P1|COMPLETED|Overall Study||120
80668|NCT01400412|192638|P2|STARTED|Overall Study||132
80669|NCT01400412|192639|P1|STARTED|Overall Study||130
80670|NCT01400243|192685|P2|NOT COMPLETED|Overall Study||11
80671|NCT01400243|192686|P1|NOT COMPLETED|Overall Study||8
80672|NCT01400243|192685|P2|COMPLETED|Overall Study||52
80673|NCT01400243|192686|P1|COMPLETED|Overall Study||56
80674|NCT01400243|192685|P2|STARTED|Overall Study||63
80675|NCT01400243|192686|P1|STARTED|Overall Study||64
80676|NCT01400139|192708|P1|NOT COMPLETED|HYD Extension Period||23
80677|NCT01400139|192708|P1|COMPLETED|HYD Extension Period||83
80678|NCT01400139|192708|P1|STARTED|HYD Extension Period|Subjects completing the Core Study were offered an option to enter the 24-week open-label Extension|106
80679|NCT01400139|192708|P1|NOT COMPLETED|HYD Core Study||512
80680|NCT01400139|192708|P1|COMPLETED|HYD Core Study||410
80681|NCT01400139|192708|P1|STARTED|HYD Core Study||922
80682|NCT01400113|192718|P2|NOT COMPLETED|Overall Study||1
80683|NCT01400113|192719|P1|NOT COMPLETED|Overall Study||1
80684|NCT01400113|192718|P2|COMPLETED|Overall Study||59
80685|NCT01400113|192719|P1|COMPLETED|Overall Study||59
80686|NCT01400113|192718|P2|STARTED|Overall Study||60
80687|NCT01400113|192719|P1|STARTED|Overall Study||60
80688|NCT01399866|192727|P2|NOT COMPLETED|Overall Study||2
80689|NCT01399866|192728|P1|NOT COMPLETED|Overall Study||4
80690|NCT01399866|192727|P2|COMPLETED|Overall Study||28
80691|NCT01399866|192728|P1|COMPLETED|Overall Study||28
80692|NCT01399866|192727|P2|STARTED|Overall Study||30
80693|NCT01399866|192728|P1|STARTED|Overall Study||32
80694|NCT01399788|192734|P2|NOT COMPLETED|Second Intervention Period||0
80695|NCT01399788|192735|P1|NOT COMPLETED|Second Intervention Period||0
80696|NCT01399788|192734|P2|COMPLETED|Second Intervention Period||18
80697|NCT01399788|192735|P1|COMPLETED|Second Intervention Period||17
80698|NCT01399788|192734|P2|STARTED|Second Intervention Period||18
80699|NCT01399788|192735|P1|STARTED|Second Intervention Period||17
80700|NCT01399788|192734|P2|NOT COMPLETED|Washout Period (at Least 1 Week)||0
80701|NCT01399788|192735|P1|NOT COMPLETED|Washout Period (at Least 1 Week)||0
80702|NCT01399788|192734|P2|COMPLETED|Washout Period (at Least 1 Week)||18
80703|NCT01399788|192735|P1|COMPLETED|Washout Period (at Least 1 Week)||17
80704|NCT01399788|192734|P2|STARTED|Washout Period (at Least 1 Week)||18
80705|NCT01399788|192735|P1|STARTED|Washout Period (at Least 1 Week)||17
80706|NCT01399788|192734|P2|NOT COMPLETED|First Intervention Period||0
80707|NCT01399788|192735|P1|NOT COMPLETED|First Intervention Period||1
80708|NCT01399788|192734|P2|COMPLETED|First Intervention Period||18
80709|NCT01399788|192735|P1|COMPLETED|First Intervention Period||17
80710|NCT01399788|192734|P2|STARTED|First Intervention Period||18
80711|NCT01399788|192735|P1|STARTED|First Intervention Period||18
80712|NCT01399723|192757|P2|NOT COMPLETED|Overall Study||1
80713|NCT01399723|192758|P1|NOT COMPLETED|Overall Study||0
80714|NCT01399723|192757|P2|COMPLETED|Overall Study||263
80715|NCT01399723|192758|P1|COMPLETED|Overall Study||263
80716|NCT01399723|192757|P2|STARTED|Overall Study||264
80717|NCT01399723|192758|P1|STARTED|Overall Study||263
80718|NCT01399697|192771|P3|NOT COMPLETED|Overall Study||4
80719|NCT01399697|192772|P2|NOT COMPLETED|Overall Study||3
80720|NCT01399697|192773|P1|NOT COMPLETED|Overall Study||41
80721|NCT01399697|192771|P3|COMPLETED|Overall Study||78
80722|NCT01399697|192772|P2|COMPLETED|Overall Study||80
80723|NCT01399697|192773|P1|COMPLETED|Overall Study||55
80724|NCT01399697|192771|P3|STARTED|Overall Study||82
80725|NCT01399697|192772|P2|STARTED|Overall Study||83
80726|NCT01399697|192773|P1|STARTED|Overall Study||96
80727|NCT01399619|192800|P4|NOT COMPLETED|Overall Study||17
80728|NCT01399619|192801|P3|NOT COMPLETED|Overall Study||12
80729|NCT01399619|192802|P2|NOT COMPLETED|Overall Study||0
80730|NCT01399619|192803|P1|NOT COMPLETED|Overall Study||25
80731|NCT01399619|192800|P4|COMPLETED|Overall Study||0
80732|NCT01399619|192801|P3|COMPLETED|Overall Study||74
80733|NCT01399619|192802|P2|COMPLETED|Overall Study||84
80734|NCT01399619|192803|P1|COMPLETED|Overall Study||98
80735|NCT01399619|192800|P4|STARTED|Overall Study||17
80736|NCT01399619|192801|P3|STARTED|Overall Study||86
80737|NCT01399619|192802|P2|STARTED|Overall Study||84
80738|NCT01399619|192803|P1|STARTED|Overall Study||123
80739|NCT01399593|192866|P2|NOT COMPLETED|Overall Study||2
80740|NCT01399593|192867|P1|NOT COMPLETED|Overall Study||3
80741|NCT01399593|192866|P2|COMPLETED|Overall Study||49
80742|NCT01399593|192867|P1|COMPLETED|Overall Study||48
80743|NCT01399593|192866|P2|STARTED|Overall Study||51
80744|NCT01399593|192867|P1|STARTED|Overall Study||51
80745|NCT01399268|192875|P2|NOT COMPLETED|Overall Study||0
80746|NCT01399268|192876|P1|NOT COMPLETED|Overall Study||0
80747|NCT01399268|192875|P2|COMPLETED|Overall Study||15
80748|NCT01399268|192876|P1|COMPLETED|Overall Study||15
80749|NCT01399268|192875|P2|STARTED|Overall Study||15
80750|NCT01399268|192876|P1|STARTED|Overall Study||15
80751|NCT01399229|192894|P3|NOT COMPLETED|Overall Study||0
80752|NCT01399229|192895|P2|NOT COMPLETED|Overall Study||0
80753|NCT01399229|192896|P1|NOT COMPLETED|Overall Study||0
80754|NCT01399229|192894|P3|COMPLETED|Overall Study||5
80755|NCT01399229|192895|P2|COMPLETED|Overall Study||5
80756|NCT01399229|192896|P1|COMPLETED|Overall Study||20
80757|NCT01399229|192894|P3|STARTED|Overall Study||5
80758|NCT01399229|192895|P2|STARTED|Overall Study||5
80759|NCT01399229|192896|P1|STARTED|Overall Study||20
80760|NCT01399190|192900|P1|NOT COMPLETED|Overall Study||20
80761|NCT01399190|192900|P1|COMPLETED|Overall Study||48
80762|NCT01399190|192900|P1|Evaluable for Primary Endpoint Analysis|Overall Study||60
80763|NCT01399190|192900|P1|Included in Final Analysis|Overall Study||63
80764|NCT01399190|192900|P1|STARTED|Overall Study||68
80765|NCT01399125|192908|P2|NOT COMPLETED|Overall Study||60
80766|NCT01399125|192909|P1|NOT COMPLETED|Overall Study||51
80767|NCT01399125|192908|P2|COMPLETED|Overall Study||193
80768|NCT01399125|192909|P1|COMPLETED|Overall Study||197
80769|NCT01399125|192908|P2|Per Protocol (PP) Population|Overall Study||188
80770|NCT01399125|192909|P1|Per Protocol (PP) Population|Overall Study||192
80771|NCT01399125|192908|P2|STARTED|Overall Study||253
80772|NCT01399125|192909|P1|STARTED|Overall Study||248
80773|NCT01399099|192923|P1|NOT COMPLETED|Overall Study||31
80774|NCT01399099|192923|P1|COMPLETED|Overall Study||36
80775|NCT01399099|192923|P1|6 Months|Overall Study||47
80776|NCT01399099|192923|P1|STARTED|Overall Study||67
80777|NCT01399047|192930|P2|NOT COMPLETED|Overall Study||1
80778|NCT01399047|192931|P1|NOT COMPLETED|Overall Study||0
80779|NCT01399047|192930|P2|COMPLETED|Overall Study||8
80780|NCT01399047|192931|P1|COMPLETED|Overall Study||10
80781|NCT01399047|192930|P2|STARTED|Overall Study||9
80782|NCT01399047|192931|P1|STARTED|Overall Study||10
80783|NCT01399008|192940|P3|NOT COMPLETED|Overall Study||2
80784|NCT01399008|192941|P2|NOT COMPLETED|Overall Study||5
80785|NCT01399008|192942|P1|NOT COMPLETED|Overall Study||3
80786|NCT01399008|192940|P3|COMPLETED|Overall Study||31
80787|NCT01399008|192941|P2|COMPLETED|Overall Study||27
80788|NCT01399008|192942|P1|COMPLETED|Overall Study||32
80789|NCT01399008|192940|P3|STARTED|Overall Study||33
80790|NCT01399008|192941|P2|STARTED|Overall Study||32
80791|NCT01399008|192942|P1|STARTED|Overall Study||35
80792|NCT01398982|192952|P2|NOT COMPLETED|Overall Study||2
80793|NCT01398982|192953|P1|NOT COMPLETED|Overall Study||6
80794|NCT01398982|192952|P2|COMPLETED|Overall Study||47
80795|NCT01398982|192953|P1|COMPLETED|Overall Study||38
80796|NCT01398982|192952|P2|STARTED|Overall Study||49
80797|NCT01398982|192953|P1|STARTED|Overall Study||44
80798|NCT01398956|192959|P1|NOT COMPLETED|Overall Study||10
80799|NCT01398956|192959|P1|COMPLETED|Overall Study||34
80800|NCT01398956|192959|P1|STARTED|Overall Study||44
80801|NCT01398943|192967|P4|NOT COMPLETED|Second Intervention (1 Day)||0
80802|NCT01398943|192968|P3|NOT COMPLETED|Second Intervention (1 Day)||0
80803|NCT01398943|192969|P2|NOT COMPLETED|Second Intervention (1 Day)||0
80804|NCT01398943|192970|P1|NOT COMPLETED|Second Intervention (1 Day)||0
80805|NCT01398943|192967|P4|COMPLETED|Second Intervention (1 Day)||15
80806|NCT01398943|192968|P3|COMPLETED|Second Intervention (1 Day)||15
80807|NCT01398943|192969|P2|COMPLETED|Second Intervention (1 Day)||15
80808|NCT01398943|192970|P1|COMPLETED|Second Intervention (1 Day)||15
80809|NCT01398943|192967|P4|STARTED|Second Intervention (1 Day)||15
80810|NCT01398943|192968|P3|STARTED|Second Intervention (1 Day)||15
80811|NCT01398943|192969|P2|STARTED|Second Intervention (1 Day)||15
80812|NCT01398943|192970|P1|STARTED|Second Intervention (1 Day)||15
80813|NCT01398943|192967|P4|NOT COMPLETED|Washout (2-7 Days)||0
80814|NCT01398943|192968|P3|NOT COMPLETED|Washout (2-7 Days)||0
80815|NCT01398943|192969|P2|NOT COMPLETED|Washout (2-7 Days)||0
80816|NCT01398943|192970|P1|NOT COMPLETED|Washout (2-7 Days)||0
80817|NCT01398943|192967|P4|COMPLETED|Washout (2-7 Days)||15
80818|NCT01398943|192968|P3|COMPLETED|Washout (2-7 Days)||15
80819|NCT01398943|192969|P2|COMPLETED|Washout (2-7 Days)||15
80820|NCT01398943|192970|P1|COMPLETED|Washout (2-7 Days)||15
80821|NCT01398943|192967|P4|STARTED|Washout (2-7 Days)||15
80822|NCT01398943|192968|P3|STARTED|Washout (2-7 Days)||15
80823|NCT01398943|192969|P2|STARTED|Washout (2-7 Days)||15
80824|NCT01398943|192970|P1|STARTED|Washout (2-7 Days)||15
80825|NCT01398943|192967|P4|NOT COMPLETED|First Intervention (1 Day)||0
80826|NCT01398943|192968|P3|NOT COMPLETED|First Intervention (1 Day)||0
80827|NCT01398943|192969|P2|NOT COMPLETED|First Intervention (1 Day)||0
80828|NCT01398943|192970|P1|NOT COMPLETED|First Intervention (1 Day)||0
80829|NCT01398943|192967|P4|COMPLETED|First Intervention (1 Day)||15
80830|NCT01398943|192968|P3|COMPLETED|First Intervention (1 Day)||15
80831|NCT01398943|192969|P2|COMPLETED|First Intervention (1 Day)||15
80832|NCT01398943|192970|P1|COMPLETED|First Intervention (1 Day)||15
80833|NCT01398943|192967|P4|STARTED|First Intervention (1 Day)||15
80834|NCT01398943|192968|P3|STARTED|First Intervention (1 Day)||15
80835|NCT01398943|192969|P2|STARTED|First Intervention (1 Day)||15
80836|NCT01398943|192970|P1|STARTED|First Intervention (1 Day)||15
80837|NCT01398852|192978|P1|NOT COMPLETED|Overall Study||372
80838|NCT01398852|192978|P1|COMPLETED|Overall Study||0
80839|NCT01398852|192978|P1|STARTED|Overall Study|Due to termination of the study the exact number of participants enrolled is unknown at this time.|372
80840|NCT01398839|192984|P2|NOT COMPLETED|Overall Study||0
80841|NCT01398839|192985|P1|NOT COMPLETED|Overall Study||0
80842|NCT01398839|192984|P2|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|37
80843|NCT01398839|192985|P1|COMPLETED|Overall Study|The study was terminated. The exact number of patients completing all visits is unknown.|35
80844|NCT01398839|192984|P2|STARTED|Overall Study||37
80845|NCT01398839|192985|P1|STARTED|Overall Study||35
80846|NCT01398787|192991|P1|NOT COMPLETED|Overall Study||1
80847|NCT01398787|192991|P1|COMPLETED|Overall Study||197
80848|NCT01398787|192991|P1|STARTED|Overall Study||198
80849|NCT01398514|193009|P2|NOT COMPLETED|Overall Study||6
80850|NCT01398514|193010|P1|NOT COMPLETED|Overall Study||8
80851|NCT01398514|193009|P2|COMPLETED|Overall Study||20
80852|NCT01398514|193010|P1|COMPLETED|Overall Study||18
80853|NCT01398514|193009|P2|STARTED|Overall Study||26
80854|NCT01398514|193010|P1|STARTED|Overall Study||26
80855|NCT01398475|193022|P4|NOT COMPLETED|Overall Study||0
80856|NCT01398475|193023|P3|NOT COMPLETED|Overall Study||0
80857|NCT01398475|193024|P2|NOT COMPLETED|Overall Study||0
80858|NCT01398475|193025|P1|NOT COMPLETED|Overall Study||0
80859|NCT01398475|193022|P4|COMPLETED|Overall Study||4
80860|NCT01398475|193023|P3|COMPLETED|Overall Study||4
80861|NCT01398475|193024|P2|COMPLETED|Overall Study||3
80862|NCT01398475|193025|P1|COMPLETED|Overall Study||4
80863|NCT01398475|193022|P4|Received Fourth Intervention|Overall Study||4
80864|NCT01398475|193023|P3|Received Fourth Intervention|Overall Study||4
80865|NCT01398475|193024|P2|Received Fourth Intervention|Overall Study||3
80866|NCT01398475|193025|P1|Received Fourth Intervention|Overall Study||4
80867|NCT01398475|193022|P4|Received Third Intervention|Overall Study||4
80868|NCT01398475|193023|P3|Received Third Intervention|Overall Study||4
80869|NCT01398475|193024|P2|Received Third Intervention|Overall Study||3
80870|NCT01398475|193025|P1|Received Third Intervention|Overall Study||4
80871|NCT01398475|193022|P4|Received Second Intervention|Overall Study||4
80872|NCT01398475|193023|P3|Received Second Intervention|Overall Study||4
80873|NCT01398475|193024|P2|Received Second Intervention|Overall Study||3
80874|NCT01398475|193025|P1|Received Second Intervention|Overall Study||4
80875|NCT01398475|193022|P4|Received First Intervention|Overall Study||4
80876|NCT01398475|193023|P3|Received First Intervention|Overall Study||4
80877|NCT01398475|193024|P2|Received First Intervention|Overall Study||3
80878|NCT01398475|193025|P1|Received First Intervention|Overall Study||4
80879|NCT01398475|193022|P4|STARTED|Overall Study||4
80880|NCT01398475|193023|P3|STARTED|Overall Study||4
80881|NCT01398475|193024|P2|STARTED|Overall Study||3
80882|NCT01398475|193025|P1|STARTED|Overall Study||4
80883|NCT01398410|193045|P2|NOT COMPLETED|Overall Study||56
80884|NCT01398410|193046|P1|NOT COMPLETED|Overall Study||58
80885|NCT01398410|193045|P2|COMPLETED|Overall Study||148
80886|NCT01398410|193046|P1|COMPLETED|Overall Study||143
80887|NCT01398410|193045|P2|STARTED|Overall Study||204
80888|NCT01398410|193046|P1|STARTED|Overall Study|Treated participants (all participants who received at least one dose of rabeprazole).|201
80889|NCT01398176|193056|P2|NOT COMPLETED|Overall Study||6
80890|NCT01398176|193057|P1|NOT COMPLETED|Overall Study||3
80891|NCT01398176|193056|P2|COMPLETED|Overall Study||19
80892|NCT01398176|193057|P1|COMPLETED|Overall Study||23
80893|NCT01398176|193056|P2|STARTED|Overall Study||25
80894|NCT01398176|193057|P1|STARTED|Overall Study||26
80895|NCT01397890|193065|P2|NOT COMPLETED|Overall Study||31
80896|NCT01397890|193066|P1|NOT COMPLETED|Overall Study||23
80897|NCT01397890|193065|P2|COMPLETED|Overall Study||260
80898|NCT01397890|193066|P1|COMPLETED|Overall Study||264
80899|NCT01397890|193065|P2|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =291+1-3=289.|287
80900|NCT01397890|193066|P1|Received Correct Randomized Treatment|Overall Study|'Safety Analysis Set' =287+3-1=289. 3 and 1 pts in respective groups received opposite treatment.|286
80901|NCT01397890|193065|P2|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|290
80902|NCT01397890|193066|P1|Post-baseline Efficacy Data Collected|Overall Study|'Full Analysis Set' used for efficacy analysis|287
80903|NCT01397890|193065|P2|STARTED|Overall Study||291
80904|NCT01397890|193066|P1|STARTED|Overall Study||287
80905|NCT01397851|193120|P2|NOT COMPLETED|Overall Study||46
80906|NCT01397851|193121|P1|NOT COMPLETED|Overall Study||79
80907|NCT01397851|193120|P2|COMPLETED|Overall Study||39917
80908|NCT01397851|193121|P1|COMPLETED|Overall Study||41555
80909|NCT01397851|193120|P2|STARTED|Overall Study||39963
80910|NCT01397851|193121|P1|STARTED|Overall Study||41634
80911|NCT01397786|193136|P3|NOT COMPLETED|Phase B||138
80912|NCT01397786|193137|P2|NOT COMPLETED|Phase B||95
80913|NCT01397786|193138|P1|NOT COMPLETED|Phase B||303
80914|NCT01397786|193136|P3|COMPLETED|Phase B||91
80915|NCT01397786|193137|P2|COMPLETED|Phase B||109
80916|NCT01397786|193138|P1|COMPLETED|Phase B||308
80917|NCT01397786|193136|P3|STARTED|Phase B||229
80918|NCT01397786|193137|P2|STARTED|Phase B||204
80919|NCT01397786|193138|P1|STARTED|Phase B||611
80920|NCT01397786|193136|P3|NOT COMPLETED|Phase A||28
80921|NCT01397786|193137|P2|NOT COMPLETED|Phase A||0
80922|NCT01397786|193138|P1|NOT COMPLETED|Phase A||0
80923|NCT01397786|193136|P3|COMPLETED|Phase A||199
80924|NCT01397786|193137|P2|COMPLETED|Phase A||0
80925|NCT01397786|193138|P1|COMPLETED|Phase A||12
80926|NCT01397786|193136|P3|STARTED|Phase A||227
80927|NCT01397786|193137|P2|STARTED|Phase A||0
80928|NCT01397786|193138|P1|STARTED|Phase A|Subjects in NCT01668797 Phase A at IA-related study termination rolled over to NCT01397786 Phase A.|12
80929|NCT01397747|193204|P1|NOT COMPLETED|Overall Study||1027
80930|NCT01397747|193204|P1|COMPLETED|Overall Study||9989
80931|NCT01397747|193204|P1|STARTED|Overall Study||11016
80932|NCT01397617|193212|P3|NOT COMPLETED|Overall Study||29
80933|NCT01397617|193213|P2|NOT COMPLETED|Overall Study||23
80934|NCT01397617|193214|P1|NOT COMPLETED|Overall Study||31
80935|NCT01397617|193212|P3|COMPLETED|Overall Study||31
80936|NCT01397617|193213|P2|COMPLETED|Overall Study||30
80937|NCT01397617|193214|P1|COMPLETED|Overall Study||33
80938|NCT01397617|193212|P3|STARTED|Overall Study||60
80939|NCT01397617|193213|P2|STARTED|Overall Study||53
80940|NCT01397617|193214|P1|STARTED|Overall Study||64
80941|NCT01397591|193225|P1|NOT COMPLETED|Overall Study||0
80942|NCT01397591|193225|P1|COMPLETED|Overall Study||2
80943|NCT01397591|193225|P1|STARTED|Overall Study||2
80944|NCT01397461|193236|P3|NOT COMPLETED|Overall Study||2
80945|NCT01397461|193237|P2|NOT COMPLETED|Overall Study||6
80946|NCT01397461|193238|P1|NOT COMPLETED|Overall Study||2
80947|NCT01397461|193236|P3|COMPLETED|Overall Study||152
80948|NCT01397461|193237|P2|COMPLETED|Overall Study||150
80949|NCT01397461|193238|P1|COMPLETED|Overall Study||153
80950|NCT01397461|193236|P3|STARTED|Overall Study||154
80951|NCT01397461|193237|P2|STARTED|Overall Study||156
80952|NCT01397461|193238|P1|STARTED|Overall Study||155
80953|NCT01397448|193249|P3|NOT COMPLETED|Overall Study||18
80954|NCT01397448|193250|P2|NOT COMPLETED|Overall Study||15
80955|NCT01397448|193251|P1|NOT COMPLETED|Overall Study||18
80956|NCT01397448|193249|P3|COMPLETED|Overall Study||140
80957|NCT01397448|193250|P2|COMPLETED|Overall Study||142
80958|NCT01397448|193251|P1|COMPLETED|Overall Study||138
80959|NCT01397448|193249|P3|STARTED|Overall Study||158
80960|NCT01397448|193250|P2|STARTED|Overall Study|158 participants were randomized but 1 participant was not treated with drug.|157
80961|NCT01397448|193251|P1|STARTED|Overall Study||156
80962|NCT01397409|193272|P10|NOT COMPLETED|Stage 3||0
80963|NCT01397409|193273|P9|NOT COMPLETED|Stage 3||0
80964|NCT01397409|193274|P8|NOT COMPLETED|Stage 3||2
80965|NCT01397409|193275|P7|NOT COMPLETED|Stage 3||0
80966|NCT01397409|193276|P6|NOT COMPLETED|Stage 3||0
80967|NCT01397409|193277|P5|NOT COMPLETED|Stage 3||0
80968|NCT01397409|193278|P4|NOT COMPLETED|Stage 3||0
80969|NCT01397409|193279|P3|NOT COMPLETED|Stage 3||0
80970|NCT01397409|193280|P2|NOT COMPLETED|Stage 3||0
80971|NCT01397409|193281|P1|NOT COMPLETED|Stage 3||0
80972|NCT01397409|193272|P10|COMPLETED|Stage 3||16
80973|NCT01397409|193273|P9|COMPLETED|Stage 3||25
80974|NCT01397409|193274|P8|COMPLETED|Stage 3||21
80975|NCT01397409|193275|P7|COMPLETED|Stage 3||0
80976|NCT01397409|193276|P6|COMPLETED|Stage 3||0
80977|NCT01397409|193277|P5|COMPLETED|Stage 3||0
80978|NCT01397409|193278|P4|COMPLETED|Stage 3||0
80979|NCT01397409|193279|P3|COMPLETED|Stage 3||0
80980|NCT01397409|193280|P2|COMPLETED|Stage 3||0
80981|NCT01397409|193281|P1|COMPLETED|Stage 3||0
80982|NCT01397409|193272|P10|STARTED|Stage 3||16
80983|NCT01397409|193273|P9|STARTED|Stage 3||25
80984|NCT01397409|193274|P8|STARTED|Stage 3||23
80985|NCT01397409|193275|P7|STARTED|Stage 3||0
80986|NCT01397409|193276|P6|STARTED|Stage 3||0
80987|NCT01397409|193277|P5|STARTED|Stage 3||0
80988|NCT01397409|193278|P4|STARTED|Stage 3||0
80989|NCT01397409|193279|P3|STARTED|Stage 3||0
80990|NCT01397409|193280|P2|STARTED|Stage 3||0
80991|NCT01397409|193281|P1|STARTED|Stage 3||0
80992|NCT01397409|193272|P10|NOT COMPLETED|Stage 2||0
80993|NCT01397409|193273|P9|NOT COMPLETED|Stage 2||0
80994|NCT01397409|193274|P8|NOT COMPLETED|Stage 2||0
80995|NCT01397409|193275|P7|NOT COMPLETED|Stage 2||0
80996|NCT01397409|193276|P6|NOT COMPLETED|Stage 2||4
80997|NCT01397409|193277|P5|NOT COMPLETED|Stage 2||8
80998|NCT01397409|193278|P4|NOT COMPLETED|Stage 2||0
80999|NCT01397409|193279|P3|NOT COMPLETED|Stage 2||0
81000|NCT01397409|193280|P2|NOT COMPLETED|Stage 2||0
81001|NCT01397409|193281|P1|NOT COMPLETED|Stage 2||0
81002|NCT01397409|193272|P10|COMPLETED|Stage 2||0
81003|NCT01397409|193273|P9|COMPLETED|Stage 2||0
81004|NCT01397409|193274|P8|COMPLETED|Stage 2||0
81005|NCT01397409|193275|P7|COMPLETED|Stage 2||58
81006|NCT01397409|193276|P6|COMPLETED|Stage 2||54
81007|NCT01397409|193277|P5|COMPLETED|Stage 2||59
81008|NCT01397409|193278|P4|COMPLETED|Stage 2||0
81009|NCT01397409|193279|P3|COMPLETED|Stage 2||0
81010|NCT01397409|193280|P2|COMPLETED|Stage 2||0
81011|NCT01397409|193281|P1|COMPLETED|Stage 2||0
81012|NCT01397409|193272|P10|STARTED|Stage 2||0
81013|NCT01397409|193273|P9|STARTED|Stage 2||0
81014|NCT01397409|193274|P8|STARTED|Stage 2||0
81015|NCT01397409|193275|P7|STARTED|Stage 2||58
81016|NCT01397409|193276|P6|STARTED|Stage 2||58
81017|NCT01397409|193277|P5|STARTED|Stage 2||67
81018|NCT01397409|193278|P4|STARTED|Stage 2||0
81019|NCT01397409|193279|P3|STARTED|Stage 2||0
81020|NCT01397409|193280|P2|STARTED|Stage 2||0
81021|NCT01397409|193281|P1|STARTED|Stage 2||0
81022|NCT01397409|193272|P10|NOT COMPLETED|Stage 1||0
81023|NCT01397409|193273|P9|NOT COMPLETED|Stage 1||0
81024|NCT01397409|193274|P8|NOT COMPLETED|Stage 1||0
81025|NCT01397409|193275|P7|NOT COMPLETED|Stage 1||0
81026|NCT01397409|193276|P6|NOT COMPLETED|Stage 1||0
81027|NCT01397409|193277|P5|NOT COMPLETED|Stage 1||0
81028|NCT01397409|193278|P4|NOT COMPLETED|Stage 1||0
81029|NCT01397409|193279|P3|NOT COMPLETED|Stage 1||0
81030|NCT01397409|193280|P2|NOT COMPLETED|Stage 1||0
81031|NCT01397409|193281|P1|NOT COMPLETED|Stage 1||0
81032|NCT01397409|193272|P10|COMPLETED|Stage 1||0
81033|NCT01397409|193273|P9|COMPLETED|Stage 1||0
81034|NCT01397409|193274|P8|COMPLETED|Stage 1||0
81035|NCT01397409|193275|P7|COMPLETED|Stage 1||0
81036|NCT01397409|193276|P6|COMPLETED|Stage 1||0
81037|NCT01397409|193277|P5|COMPLETED|Stage 1||0
81038|NCT01397409|193278|P4|COMPLETED|Stage 1||3
81039|NCT01397409|193279|P3|COMPLETED|Stage 1||6
81040|NCT01397409|193280|P2|COMPLETED|Stage 1||6
81041|NCT01397409|193281|P1|COMPLETED|Stage 1||9
81042|NCT01397409|193272|P10|STARTED|Stage 1||0
81043|NCT01397409|193273|P9|STARTED|Stage 1||0
81044|NCT01397409|193274|P8|STARTED|Stage 1||0
81045|NCT01397409|193275|P7|STARTED|Stage 1||0
81046|NCT01397409|193276|P6|STARTED|Stage 1||0
81047|NCT01397409|193277|P5|STARTED|Stage 1||0
81048|NCT01397409|193278|P4|STARTED|Stage 1||3
81049|NCT01397409|193279|P3|STARTED|Stage 1||6
81050|NCT01397409|193280|P2|STARTED|Stage 1||6
81051|NCT01397409|193281|P1|STARTED|Stage 1||9
81052|NCT01397253|193321|P2|NOT COMPLETED|Overall Study||149
81053|NCT01397253|193322|P1|NOT COMPLETED|Overall Study||126
81054|NCT01397253|193321|P2|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|243
81055|NCT01397253|193322|P1|COMPLETED|Overall Study|Primary analysis, remaining patients included in a sensitivity analysis|317
81056|NCT01397253|193321|P2|STARTED|Overall Study||392
81057|NCT01397253|193322|P1|STARTED|Overall Study||443
81058|NCT01397084|193328|P1|NOT COMPLETED|Overall Study||8
81059|NCT01397084|193328|P1|COMPLETED|Overall Study||100
81060|NCT01397084|193328|P1|STARTED|Overall Study||108
81061|NCT01396525|193335|P1|NOT COMPLETED|Overall Study||26
81062|NCT01396525|193335|P1|COMPLETED|Overall Study||127
81063|NCT01396525|193335|P1|STARTED|Overall Study||153
81064|NCT01396512|193435|P2|NOT COMPLETED|Overall Study||1
81065|NCT01396512|193436|P1|NOT COMPLETED|Overall Study||0
81066|NCT01396512|193435|P2|COMPLETED|Overall Study||136
81067|NCT01396512|193436|P1|COMPLETED|Overall Study||137
81068|NCT01396512|193435|P2|STARTED|Overall Study||137
81069|NCT01396512|193436|P1|STARTED|Overall Study||137
81070|NCT01396434|193451|P3|NOT COMPLETED|Overall Study||0
81071|NCT01396434|193452|P2|NOT COMPLETED|Overall Study||0
81072|NCT01396434|193453|P1|NOT COMPLETED|Overall Study||11
81073|NCT01396434|193451|P3|COMPLETED|Overall Study||14
81074|NCT01396434|193452|P2|COMPLETED|Overall Study||175
81075|NCT01396434|193453|P1|COMPLETED|Overall Study||2806
81076|NCT01396434|193451|P3|STARTED|Overall Study||14
81077|NCT01396434|193452|P2|STARTED|Overall Study||175
81078|NCT01396434|193453|P1|STARTED|Overall Study||2817
81079|NCT01396421|193465|P4|NOT COMPLETED|Overall Study||75
81080|NCT01396421|193466|P3|NOT COMPLETED|Overall Study||34
81081|NCT01396421|193467|P2|NOT COMPLETED|Overall Study||58
81082|NCT01396421|193468|P1|NOT COMPLETED|Overall Study||59
81083|NCT01396421|193465|P4|COMPLETED|Overall Study||109
81084|NCT01396421|193466|P3|COMPLETED|Overall Study||56
81085|NCT01396421|193467|P2|COMPLETED|Overall Study||124
81086|NCT01396421|193468|P1|COMPLETED|Overall Study||121
81087|NCT01396421|193465|P4|STARTED|Overall Study||184
81088|NCT01396421|193466|P3|STARTED|Overall Study||90
81089|NCT01396421|193467|P2|STARTED|Overall Study||182
81090|NCT01396421|193468|P1|STARTED|Overall Study||180
81091|NCT01396395|193540|P2|NOT COMPLETED|Overall Study||27
81092|NCT01396395|193541|P1|NOT COMPLETED|Overall Study||40
81093|NCT01396395|193540|P2|COMPLETED|Overall Study||175
81094|NCT01396395|193541|P1|COMPLETED|Overall Study||160
81095|NCT01396395|193540|P2|Safety Analysis Set|Overall Study|4 subjects randomized to standard+nicorandil were included in standard as no nicorandil was received|205
81096|NCT01396395|193541|P1|Safety Analysis Set|Overall Study|1 subject randomized to standard was included in standard+nicorandil as nicorandil was received.|197
81097|NCT01396395|193540|P2|STARTED|Overall Study||202
81098|NCT01396395|193541|P1|STARTED|Overall Study||200
81099|NCT01396382|193576|P1|NOT COMPLETED|Overall Study||0
81100|NCT01396382|193576|P1|COMPLETED|Overall Study||97
81101|NCT01396382|193576|P1|STARTED|Overall Study||97
81102|NCT01396265|193581|P1|NOT COMPLETED|Rifa+Afatinib||1
81103|NCT01396265|193581|P1|COMPLETED|Rifa+Afatinib||21
81104|NCT01396265|193581|P1|STARTED|Rifa+Afatinib||22
81105|NCT01396265|193581|P1|NOT COMPLETED|Washout||0
81106|NCT01396265|193581|P1|COMPLETED|Washout||22
81107|NCT01396265|193581|P1|STARTED|Washout||22
81108|NCT01396265|193581|P1|NOT COMPLETED|Afatinib||0
81109|NCT01396265|193581|P1|COMPLETED|Afatinib||22
81110|NCT01396265|193581|P1|STARTED|Afatinib||22
81111|NCT01396239|193608|P4|NOT COMPLETED|Overall Study||0
81112|NCT01396239|193609|P3|NOT COMPLETED|Overall Study||0
81113|NCT01396239|193610|P2|NOT COMPLETED|Overall Study||0
81114|NCT01396239|193611|P1|NOT COMPLETED|Overall Study||0
81115|NCT01396239|193608|P4|COMPLETED|Overall Study||2
81116|NCT01396239|193609|P3|COMPLETED|Overall Study||4
81117|NCT01396239|193610|P2|COMPLETED|Overall Study||2
81118|NCT01396239|193611|P1|COMPLETED|Overall Study||4
81119|NCT01396239|193608|P4|STARTED|Overall Study||2
81120|NCT01396239|193609|P3|STARTED|Overall Study||4
81121|NCT01396239|193610|P2|STARTED|Overall Study||2
81122|NCT01396239|193611|P1|STARTED|Overall Study||4
81123|NCT01396226|193634|P2|NOT COMPLETED|Overall Study||0
81124|NCT01396226|193635|P1|NOT COMPLETED|Overall Study||0
81125|NCT01396226|193634|P2|COMPLETED|Overall Study||6
81126|NCT01396226|193635|P1|COMPLETED|Overall Study||12
81127|NCT01396226|193634|P2|Patients Who Completed Treatment|Overall Study||6
81128|NCT01396226|193635|P1|Patients Who Completed Treatment|Overall Study||12
81129|NCT01396226|193634|P2|Patients Who Received Treatment|Overall Study||6
81130|NCT01396226|193635|P1|Patients Who Received Treatment|Overall Study||12
81131|NCT01396226|193634|P2|STARTED|Overall Study||6
81132|NCT01396226|193635|P1|STARTED|Overall Study||12
81133|NCT01396187|193670|P5|NOT COMPLETED|Overall Study||1
81134|NCT01396187|193671|P4|NOT COMPLETED|Overall Study||0
81135|NCT01396187|193672|P3|NOT COMPLETED|Overall Study||1
81136|NCT01396187|193673|P2|NOT COMPLETED|Overall Study||3
81137|NCT01396187|193674|P1|NOT COMPLETED|Overall Study||1
81138|NCT01396187|193670|P5|COMPLETED|Overall Study||9
81139|NCT01396187|193671|P4|COMPLETED|Overall Study||10
81140|NCT01396187|193672|P3|COMPLETED|Overall Study||9
81141|NCT01396187|193673|P2|COMPLETED|Overall Study||9
81142|NCT01396187|193674|P1|COMPLETED|Overall Study||7
81143|NCT01396187|193670|P5|STARTED|Overall Study||10
81144|NCT01396187|193671|P4|STARTED|Overall Study||10
81145|NCT01396187|193672|P3|STARTED|Overall Study||10
81146|NCT01396187|193673|P2|STARTED|Overall Study||12
81147|NCT01396187|193674|P1|STARTED|Overall Study||8
81148|NCT01396161|193774|P7|NOT COMPLETED|Overall Study||1
81149|NCT01396161|193775|P6|NOT COMPLETED|Overall Study||0
81150|NCT01396161|193776|P5|NOT COMPLETED|Overall Study||1
81151|NCT01396161|193777|P4|NOT COMPLETED|Overall Study||0
81152|NCT01396161|193778|P3|NOT COMPLETED|Overall Study||0
81153|NCT01396161|193779|P2|NOT COMPLETED|Overall Study||0
81154|NCT01396161|193780|P1|NOT COMPLETED|Overall Study||0
81155|NCT01396161|193774|P7|COMPLETED|Overall Study||10
81156|NCT01396161|193775|P6|COMPLETED|Overall Study||9
81157|NCT01396161|193776|P5|COMPLETED|Overall Study||8
81158|NCT01396161|193777|P4|COMPLETED|Overall Study||9
81159|NCT01396161|193778|P3|COMPLETED|Overall Study||9
81160|NCT01396161|193779|P2|COMPLETED|Overall Study||5
81161|NCT01396161|193780|P1|COMPLETED|Overall Study||12
81162|NCT01396161|193774|P7|STARTED|Overall Study||11
81163|NCT01396161|193775|P6|STARTED|Overall Study||9
81164|NCT01396161|193776|P5|STARTED|Overall Study||9
81165|NCT01396161|193777|P4|STARTED|Overall Study||9
81166|NCT01396161|193778|P3|STARTED|Overall Study||9
81167|NCT01396161|193779|P2|STARTED|Overall Study||5
81168|NCT01396161|193780|P1|STARTED|Overall Study||12
81169|NCT01396083|193835|P2|NOT COMPLETED|Overall Study||47
81170|NCT01396083|193836|P1|NOT COMPLETED|Overall Study||11
81171|NCT01396083|193835|P2|COMPLETED|Overall Study||72
81172|NCT01396083|193836|P1|COMPLETED|Overall Study||113
81173|NCT01396083|193835|P2|STARTED|Overall Study||119
81174|NCT01396083|193836|P1|STARTED|Overall Study||124
81175|NCT01396070|193860|P1|NOT COMPLETED|Overall Study||19
81176|NCT01396070|193860|P1|COMPLETED|Overall Study||17
81177|NCT01396070|193860|P1|STARTED|Overall Study||36
81178|NCT01396057|193869|P2|NOT COMPLETED|Overall Study||18
81179|NCT01396057|193870|P1|NOT COMPLETED|Overall Study||11
81180|NCT01396057|193869|P2|COMPLETED|Overall Study||100
81181|NCT01396057|193870|P1|COMPLETED|Overall Study||115
81182|NCT01396057|193869|P2|STARTED|Overall Study||118
81183|NCT01396057|193870|P1|STARTED|Overall Study||126
81184|NCT01396044|193896|P2|NOT COMPLETED|Overall Study||0
81185|NCT01396044|193897|P1|NOT COMPLETED|Overall Study||0
81186|NCT01396044|193896|P2|COMPLETED|Overall Study||171
81187|NCT01396044|193897|P1|COMPLETED|Overall Study||125
81188|NCT01396044|193896|P2|STARTED|Overall Study||171
81189|NCT01396044|193897|P1|STARTED|Overall Study||125
81190|NCT01396005|193919|P2|NOT COMPLETED|Overall Study||2
81191|NCT01396005|193920|P1|NOT COMPLETED|Overall Study||0
81192|NCT01396005|193919|P2|COMPLETED|Overall Study||9
81193|NCT01396005|193920|P1|COMPLETED|Overall Study||10
81194|NCT01396005|193919|P2|STARTED|Overall Study||11
81195|NCT01396005|193920|P1|STARTED|Overall Study||10
81196|NCT01395966|193939|P3|NOT COMPLETED|Overall Study||8
81197|NCT01395966|193940|P2|NOT COMPLETED|Overall Study||19
81198|NCT01395966|193941|P1|NOT COMPLETED|Overall Study||10
81199|NCT01395966|193939|P3|COMPLETED|Overall Study||104
81200|NCT01395966|193940|P2|COMPLETED|Overall Study||91
81201|NCT01395966|193941|P1|COMPLETED|Overall Study||99
81202|NCT01395966|193939|P3|STARTED|Overall Study||112
81203|NCT01395966|193940|P2|STARTED|Overall Study||110
81204|NCT01395966|193941|P1|STARTED|Overall Study||109
81205|NCT01395914|193951|P2|NOT COMPLETED|Overall Study||37
81206|NCT01395914|193952|P1|NOT COMPLETED|Overall Study||72
81207|NCT01395914|193951|P2|COMPLETED|Overall Study||131
81208|NCT01395914|193952|P1|COMPLETED|Overall Study||273
81209|NCT01395914|193951|P2|Safety Population|Overall Study||167
81210|NCT01395914|193952|P1|Safety Population|Overall Study||343
81211|NCT01395914|193951|P2|ITT Population|Overall Study||168
81212|NCT01395914|193952|P1|ITT Population|Overall Study||345
81213|NCT01395914|193951|P2|STARTED|Overall Study||168
81214|NCT01395914|193952|P1|STARTED|Overall Study||345
81215|NCT01395901|193966|P2|NOT COMPLETED|Overall Study||5
81216|NCT01395901|193967|P1|NOT COMPLETED|Overall Study||10
81217|NCT01395901|193966|P2|COMPLETED|Overall Study|Treated patients completing the study|329
81218|NCT01395901|193967|P1|COMPLETED|Overall Study|Treated patients completing the study|326
81219|NCT01395901|193966|P2|STARTED|Overall Study|Randomized Population|334
81220|NCT01395901|193967|P1|STARTED|Overall Study|Randomized Population|336
81221|NCT01395888|193983|P3|NOT COMPLETED|Treatment Period (TP)||17
81222|NCT01395888|193984|P2|NOT COMPLETED|Treatment Period (TP)||15
81223|NCT01395888|193985|P1|NOT COMPLETED|Treatment Period (TP)||0
81224|NCT01395888|193983|P3|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|113
81225|NCT01395888|193984|P2|COMPLETED|Treatment Period (TP)|Par. completed the study if they completed the TP and a safety follow-up phone contact 1 week later.|112
81226|NCT01395888|193985|P1|COMPLETED|Treatment Period (TP)||0
81227|NCT01395888|193983|P3|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|113
81228|NCT01395888|193984|P2|Completed the Treatment Period|Treatment Period (TP)|Participants were considered to have completed the TP if they attended Visit 5 (Week 12).|112
81229|NCT01395888|193985|P1|Completed the Treatment Period|Treatment Period (TP)||0
81230|NCT01395888|193983|P3|STARTED|Treatment Period (TP)||130
81231|NCT01395888|193984|P2|STARTED|Treatment Period (TP)||127
81232|NCT01395888|193985|P1|STARTED|Treatment Period (TP)||0
81233|NCT01395888|193983|P3|NOT COMPLETED|2-week Run-in Period||0
81234|NCT01395888|193984|P2|NOT COMPLETED|2-week Run-in Period||0
81235|NCT01395888|193985|P1|NOT COMPLETED|2-week Run-in Period||22
81236|NCT01395888|193983|P3|COMPLETED|2-week Run-in Period||0
81237|NCT01395888|193984|P2|COMPLETED|2-week Run-in Period||0
81238|NCT01395888|193985|P1|COMPLETED|2-week Run-in Period||257
81239|NCT01395888|193983|P3|STARTED|2-week Run-in Period||0
81240|NCT01395888|193984|P2|STARTED|2-week Run-in Period||0
81241|NCT01395888|193985|P1|STARTED|2-week Run-in Period||279
81242|NCT01395823|193993|P2|NOT COMPLETED|Overall Study||9
81243|NCT01395823|193994|P1|NOT COMPLETED|Overall Study||15
81244|NCT01395823|193993|P2|COMPLETED|Overall Study||130
81245|NCT01395823|193994|P1|COMPLETED|Overall Study||122
81246|NCT01395823|193993|P2|STARTED|Overall Study||139
81247|NCT01395823|193994|P1|STARTED|Overall Study||137
81248|NCT01395797|194006|P6|NOT COMPLETED|Overall Study||3
81249|NCT01395797|194007|P5|NOT COMPLETED|Overall Study||2
81250|NCT01395797|194008|P4|NOT COMPLETED|Overall Study||2
81251|NCT01395797|194009|P3|NOT COMPLETED|Overall Study||4
81252|NCT01395797|194010|P2|NOT COMPLETED|Overall Study||1
81253|NCT01395797|194011|P1|NOT COMPLETED|Overall Study||3
81254|NCT01395797|194006|P6|COMPLETED|Overall Study||14
81255|NCT01395797|194007|P5|COMPLETED|Overall Study||7
81256|NCT01395797|194008|P4|COMPLETED|Overall Study||13
81257|NCT01395797|194009|P3|COMPLETED|Overall Study||14
81258|NCT01395797|194010|P2|COMPLETED|Overall Study||3
81259|NCT01395797|194011|P1|COMPLETED|Overall Study||16
81260|NCT01395797|194006|P6|STARTED|Overall Study||17
81261|NCT01395797|194007|P5|STARTED|Overall Study||9
81262|NCT01395797|194008|P4|STARTED|Overall Study||15
81263|NCT01395797|194009|P3|STARTED|Overall Study||18
81264|NCT01395797|194010|P2|STARTED|Overall Study||4
81265|NCT01395797|194011|P1|STARTED|Overall Study||19
81266|NCT01395784|194031|P1|NOT COMPLETED|Overall Study||15
81267|NCT01395784|194031|P1|COMPLETED|Overall Study||17
81268|NCT01395784|194031|P1|STARTED|Overall Study||32
81269|NCT01395524|194039|P3|NOT COMPLETED|Overall Study||17
81270|NCT01395524|194040|P2|NOT COMPLETED|Overall Study||16
81271|NCT01395524|194041|P1|NOT COMPLETED|Overall Study||18
81272|NCT01395524|194039|P3|COMPLETED|Overall Study||89
81273|NCT01395524|194040|P2|COMPLETED|Overall Study||83
81274|NCT01395524|194041|P1|COMPLETED|Overall Study||79
81275|NCT01395524|194039|P3|STARTED|Overall Study||106
81276|NCT01395524|194040|P2|STARTED|Overall Study||99
81277|NCT01395524|194041|P1|STARTED|Overall Study||97
81278|NCT01395394|194064|P3|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
81279|NCT01395394|194065|P2|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
81280|NCT01395394|194066|P1|NOT COMPLETED|Study Visit 2 (Non-responders Only)||0
81281|NCT01395394|194064|P3|COMPLETED|Study Visit 2 (Non-responders Only)||0
81282|NCT01395394|194065|P2|COMPLETED|Study Visit 2 (Non-responders Only)||0
81283|NCT01395394|194066|P1|COMPLETED|Study Visit 2 (Non-responders Only)||3
81284|NCT01395394|194064|P3|STARTED|Study Visit 2 (Non-responders Only)||0
81285|NCT01395394|194065|P2|STARTED|Study Visit 2 (Non-responders Only)||0
81286|NCT01395394|194066|P1|STARTED|Study Visit 2 (Non-responders Only)||3
81287|NCT01395394|194064|P3|NOT COMPLETED|Baseline Study Visit||0
81288|NCT01395394|194065|P2|NOT COMPLETED|Baseline Study Visit||0
81289|NCT01395394|194066|P1|NOT COMPLETED|Baseline Study Visit||1
81290|NCT01395394|194064|P3|COMPLETED|Baseline Study Visit||5
81291|NCT01395394|194065|P2|COMPLETED|Baseline Study Visit||3
81292|NCT01395394|194066|P1|COMPLETED|Baseline Study Visit||3
81293|NCT01395394|194064|P3|STARTED|Baseline Study Visit||5
81294|NCT01395394|194065|P2|STARTED|Baseline Study Visit||3
81295|NCT01395394|194066|P1|STARTED|Baseline Study Visit||4
81296|NCT01395368|194077|P1|NOT COMPLETED|Overall Study||16
81297|NCT01395368|194077|P1|COMPLETED|Overall Study||92
81298|NCT01395368|194077|P1|STARTED|Overall Study||108
81299|NCT01395277|194083|P2|NOT COMPLETED|Overall Study||0
81300|NCT01395277|194084|P1|NOT COMPLETED|Overall Study||0
81301|NCT01395277|194083|P2|COMPLETED|Overall Study||15
81302|NCT01395277|194084|P1|COMPLETED|Overall Study||15
81303|NCT01395277|194083|P2|STARTED|Overall Study||15
81304|NCT01395277|194084|P1|STARTED|Overall Study||15
81305|NCT01395043|194092|P1|NOT COMPLETED|Overall Study||0
81306|NCT01395043|194092|P1|COMPLETED|Overall Study||15
81307|NCT01395043|194092|P1|STARTED|Overall Study||15
81308|NCT01395017|194099|P2|NOT COMPLETED|Overall Study||102
81309|NCT01395017|194100|P1|NOT COMPLETED|Overall Study||100
81310|NCT01395017|194099|P2|COMPLETED|Overall Study||0
81311|NCT01395017|194100|P1|COMPLETED|Overall Study||0
81312|NCT01395017|194099|P2|Treated|Overall Study||101
81313|NCT01395017|194100|P1|Treated|Overall Study||98
81314|NCT01395017|194099|P2|STARTED|Overall Study||102
81315|NCT01395017|194100|P1|STARTED|Overall Study||100
81316|NCT01394991|194110|P2|NOT COMPLETED|Overall Study||72
81317|NCT01394991|194111|P1|NOT COMPLETED|Overall Study||59
81318|NCT01394991|194110|P2|COMPLETED|Overall Study||190
81319|NCT01394991|194111|P1|COMPLETED|Overall Study||183
81320|NCT01394991|194110|P2|STARTED|Overall Study||262
81321|NCT01394991|194111|P1|STARTED|Overall Study||242
81322|NCT01394978|194133|P2|NOT COMPLETED|Overall Study||31
81323|NCT01394978|194134|P1|NOT COMPLETED|Overall Study||21
81324|NCT01394978|194133|P2|COMPLETED|Overall Study||245
81325|NCT01394978|194134|P1|COMPLETED|Overall Study||147
81326|NCT01394978|194133|P2|STARTED|Overall Study||276
81327|NCT01394978|194134|P1|STARTED|Overall Study||168
81328|NCT01394926|194140|P1|NOT COMPLETED|Overall Study||0
81329|NCT01394926|194140|P1|COMPLETED|Overall Study||21
81330|NCT01394926|194140|P1|STARTED|Overall Study||21
81331|NCT01394718|194151|P2|NOT COMPLETED|Overall Study||1
81332|NCT01394718|194152|P1|NOT COMPLETED|Overall Study||2
81333|NCT01394718|194151|P2|COMPLETED|Overall Study||29
81334|NCT01394718|194152|P1|COMPLETED|Overall Study||28
81335|NCT01394718|194151|P2|STARTED|Overall Study||30
81336|NCT01394718|194152|P1|STARTED|Overall Study||30
81337|NCT01394692|194166|P2|NOT COMPLETED|Overall Study||0
81338|NCT01394692|194167|P1|NOT COMPLETED|Overall Study||0
81339|NCT01394692|194166|P2|COMPLETED|Overall Study||29
81340|NCT01394692|194167|P1|COMPLETED|Overall Study||29
81341|NCT01394692|194166|P2|STARTED|Overall Study||29
81342|NCT01394692|194167|P1|STARTED|Overall Study||29
81343|NCT01394614|194175|P2|NOT COMPLETED|Overall Study||0
81344|NCT01394614|194176|P1|NOT COMPLETED|Overall Study||0
81345|NCT01394614|194175|P2|COMPLETED|Overall Study||16
81346|NCT01394614|194176|P1|COMPLETED|Overall Study||8
81347|NCT01394614|194175|P2|STARTED|Overall Study||16
81348|NCT01394614|194176|P1|STARTED|Overall Study||8
81349|NCT01394510|194182|P1|NOT COMPLETED|Overall Study||0
81350|NCT01394510|194182|P1|COMPLETED|Overall Study||13
81351|NCT01394510|194182|P1|STARTED|Overall Study||13
81352|NCT01394276|194188|P1|NOT COMPLETED|Overall Study||62
81353|NCT01394276|194188|P1|COMPLETED|Overall Study||260
81354|NCT01394276|194188|P1|STARTED|Overall Study||322
81355|NCT01394250|194212|P2|NOT COMPLETED|Successful IV Placement & Follow-Up||11
81356|NCT01394250|194213|P1|NOT COMPLETED|Successful IV Placement & Follow-Up||6
81357|NCT01394250|194212|P2|COMPLETED|Successful IV Placement & Follow-Up||110
81358|NCT01394250|194213|P1|COMPLETED|Successful IV Placement & Follow-Up||114
81359|NCT01394250|194212|P2|STARTED|Successful IV Placement & Follow-Up||121
81360|NCT01394250|194213|P1|STARTED|Successful IV Placement & Follow-Up||120
81361|NCT01394250|194212|P2|NOT COMPLETED|Randomization and IV Placement Attempt||13
81362|NCT01394250|194213|P1|NOT COMPLETED|Randomization and IV Placement Attempt||14
81363|NCT01394250|194212|P2|COMPLETED|Randomization and IV Placement Attempt||121
81364|NCT01394250|194213|P1|COMPLETED|Randomization and IV Placement Attempt||120
81365|NCT01394250|194212|P2|STARTED|Randomization and IV Placement Attempt||134
81366|NCT01394250|194213|P1|STARTED|Randomization and IV Placement Attempt||134
81367|NCT01394185|194221|P6|NOT COMPLETED|Overall Study||1
81368|NCT01394185|194222|P5|NOT COMPLETED|Overall Study||4
81369|NCT01394185|194223|P4|NOT COMPLETED|Overall Study||1
81370|NCT01394185|194224|P3|NOT COMPLETED|Overall Study||0
81371|NCT01394185|194225|P2|NOT COMPLETED|Overall Study||0
81372|NCT01394185|194226|P1|NOT COMPLETED|Overall Study||6
81373|NCT01394185|194221|P6|COMPLETED|Overall Study||2
81374|NCT01394185|194222|P5|COMPLETED|Overall Study||2
81375|NCT01394185|194223|P4|COMPLETED|Overall Study||3
81376|NCT01394185|194224|P3|COMPLETED|Overall Study||2
81377|NCT01394185|194225|P2|COMPLETED|Overall Study||2
81378|NCT01394185|194226|P1|COMPLETED|Overall Study||2
81379|NCT01394185|194221|P6|STARTED|Overall Study||3
81380|NCT01394185|194222|P5|STARTED|Overall Study||6
81381|NCT01394185|194223|P4|STARTED|Overall Study||4
81382|NCT01394185|194224|P3|STARTED|Overall Study||2
81383|NCT01394185|194225|P2|STARTED|Overall Study||2
81384|NCT01394185|194226|P1|STARTED|Overall Study||8
81385|NCT01394159|194239|P2|NOT COMPLETED|Overall Study||0
81386|NCT01394159|194240|P1|NOT COMPLETED|Overall Study||0
81387|NCT01394159|194239|P2|COMPLETED|Overall Study||28
81388|NCT01394159|194240|P1|COMPLETED|Overall Study||28
81389|NCT01394159|194239|P2|STARTED|Overall Study||28
81390|NCT01394159|194240|P1|STARTED|Overall Study||28
81391|NCT01393964|194253|P3|NOT COMPLETED|Overall Study||9
81392|NCT01393964|194254|P2|NOT COMPLETED|Overall Study||9
81393|NCT01393964|194255|P1|NOT COMPLETED|Overall Study||8
81394|NCT01393964|194253|P3|COMPLETED|Overall Study|Completed=treatment on-going|0
81395|NCT01393964|194254|P2|COMPLETED|Overall Study|Completed=treatment on-going|0
81396|NCT01393964|194255|P1|COMPLETED|Overall Study|Completed=treatment on-going|0
81397|NCT01393964|194253|P3|STARTED|Overall Study||9
81398|NCT01393964|194254|P2|STARTED|Overall Study||9
81399|NCT01393964|194255|P1|STARTED|Overall Study||8
81400|NCT01393899|194296|P3|NOT COMPLETED|Overall Study||23
81401|NCT01393899|194297|P2|NOT COMPLETED|Overall Study||28
81402|NCT01393899|194298|P1|NOT COMPLETED|Overall Study||32
81403|NCT01393899|194296|P3|COMPLETED|Overall Study||38
81404|NCT01393899|194297|P2|COMPLETED|Overall Study||32
81405|NCT01393899|194298|P1|COMPLETED|Overall Study||27
81406|NCT01393899|194296|P3|STARTED|Overall Study||61
81407|NCT01393899|194297|P2|STARTED|Overall Study||60
81408|NCT01393899|194298|P1|STARTED|Overall Study||59
81409|NCT01393743|194352|P3|NOT COMPLETED|Extension Phase||60
81410|NCT01393743|194353|P2|NOT COMPLETED|Extension Phase||0
81411|NCT01393743|194354|P1|NOT COMPLETED|Extension Phase||0
81412|NCT01393743|194352|P3|COMPLETED|Extension Phase||78
81413|NCT01393743|194353|P2|COMPLETED|Extension Phase||0
81414|NCT01393743|194354|P1|COMPLETED|Extension Phase||0
81415|NCT01393743|194352|P3|STARTED|Extension Phase|Continuation into the Extension Phase was optional.|138
81416|NCT01393743|194353|P2|STARTED|Extension Phase||0
81417|NCT01393743|194354|P1|STARTED|Extension Phase||0
81418|NCT01393743|194352|P3|NOT COMPLETED|Core Study||0
81419|NCT01393743|194353|P2|NOT COMPLETED|Core Study||13
81420|NCT01393743|194354|P1|NOT COMPLETED|Core Study||10
81421|NCT01393743|194352|P3|COMPLETED|Core Study||0
81422|NCT01393743|194353|P2|COMPLETED|Core Study||68
81423|NCT01393743|194354|P1|COMPLETED|Core Study||72
81424|NCT01393743|194352|P3|STARTED|Core Study||0
81425|NCT01393743|194353|P2|STARTED|Core Study|Treated|81
81426|NCT01393743|194354|P1|STARTED|Core Study|Treated|82
81427|NCT01393730|194377|P1|NOT COMPLETED|Overall Study||6
81428|NCT01393730|194377|P1|COMPLETED|Overall Study||34
81429|NCT01393730|194377|P1|Evaluable AR Mutation|Overall Study||14
81430|NCT01393730|194377|P1|Evaluable AR Amplification|Overall Study||21
81431|NCT01393730|194377|P1|Treated|Overall Study||38
81432|NCT01393730|194377|P1|STARTED|Overall Study||40
81433|NCT01393704|194391|P2|NOT COMPLETED|Overall Study||0
81434|NCT01393704|194392|P1|NOT COMPLETED|Overall Study||0
81435|NCT01393704|194391|P2|COMPLETED|Overall Study||76
81436|NCT01393704|194392|P1|COMPLETED|Overall Study||76
81437|NCT01393704|194391|P2|STARTED|Overall Study||76
81438|NCT01393704|194392|P1|STARTED|Overall Study||76
81439|NCT01393626|194410|P4|NOT COMPLETED|Overall Study||1
81440|NCT01393626|194411|P3|NOT COMPLETED|Overall Study||12
81441|NCT01393626|194412|P2|NOT COMPLETED|Overall Study||12
81442|NCT01393626|194413|P1|NOT COMPLETED|Overall Study||18
81443|NCT01393626|194410|P4|COMPLETED|Overall Study||15
81444|NCT01393626|194411|P3|COMPLETED|Overall Study||74
81445|NCT01393626|194412|P2|COMPLETED|Overall Study||74
81446|NCT01393626|194413|P1|COMPLETED|Overall Study||73
81447|NCT01393626|194410|P4|STARTED|Overall Study||16
81448|NCT01393626|194411|P3|STARTED|Overall Study||86
81449|NCT01393626|194412|P2|STARTED|Overall Study||86
81450|NCT01393626|194413|P1|STARTED|Overall Study||91
81451|NCT01393613|194493|P4|NOT COMPLETED|Overall Study||66
81452|NCT01393613|194494|P3|NOT COMPLETED|Overall Study||54
81453|NCT01393613|194495|P2|NOT COMPLETED|Overall Study||57
81454|NCT01393613|194496|P1|NOT COMPLETED|Overall Study||39
81455|NCT01393613|194493|P4|COMPLETED|Overall Study||118
81456|NCT01393613|194494|P3|COMPLETED|Overall Study||130
81457|NCT01393613|194495|P2|COMPLETED|Overall Study||129
81458|NCT01393613|194496|P1|COMPLETED|Overall Study||81
81459|NCT01393613|194493|P4|STARTED|Overall Study||184
81460|NCT01393613|194494|P3|STARTED|Overall Study||184
81461|NCT01393613|194495|P2|STARTED|Overall Study||186
81462|NCT01393613|194496|P1|STARTED|Overall Study||120
81463|NCT01393600|194558|P4|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
81464|NCT01393600|194559|P3|NOT COMPLETED|Follow-up Period (Day 29 to 35)||1
81465|NCT01393600|194560|P2|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
81466|NCT01393600|194561|P1|NOT COMPLETED|Follow-up Period (Day 29 to 35)||0
81467|NCT01393600|194558|P4|COMPLETED|Follow-up Period (Day 29 to 35)||8
81468|NCT01393600|194559|P3|COMPLETED|Follow-up Period (Day 29 to 35)||6
81469|NCT01393600|194560|P2|COMPLETED|Follow-up Period (Day 29 to 35)||7
81470|NCT01393600|194561|P1|COMPLETED|Follow-up Period (Day 29 to 35)||9
81471|NCT01393600|194558|P4|STARTED|Follow-up Period (Day 29 to 35)||8
81472|NCT01393600|194559|P3|STARTED|Follow-up Period (Day 29 to 35)||7
81473|NCT01393600|194560|P2|STARTED|Follow-up Period (Day 29 to 35)||7
81474|NCT01393600|194561|P1|STARTED|Follow-up Period (Day 29 to 35)||9
81475|NCT01393600|194558|P4|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||1
81476|NCT01393600|194559|P3|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||2
81477|NCT01393600|194560|P2|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
81478|NCT01393600|194561|P1|NOT COMPLETED|Treatment Period 2 (Day 15 to 28)||0
81479|NCT01393600|194558|P4|COMPLETED|Treatment Period 2 (Day 15 to 28)||8
81480|NCT01393600|194559|P3|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
81481|NCT01393600|194560|P2|COMPLETED|Treatment Period 2 (Day 15 to 28)||7
81482|NCT01393600|194561|P1|COMPLETED|Treatment Period 2 (Day 15 to 28)||9
81483|NCT01393600|194558|P4|STARTED|Treatment Period 2 (Day 15 to 28)||9
81484|NCT01393600|194559|P3|STARTED|Treatment Period 2 (Day 15 to 28)||9
81485|NCT01393600|194560|P2|STARTED|Treatment Period 2 (Day 15 to 28)||7
81486|NCT01393600|194561|P1|STARTED|Treatment Period 2 (Day 15 to 28)||9
81487|NCT01393600|194558|P4|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
81488|NCT01393600|194559|P3|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
81489|NCT01393600|194560|P2|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||1
81490|NCT01393600|194561|P1|NOT COMPLETED|Treatment Period 1 (Day 1 to 14)||0
81491|NCT01393600|194558|P4|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
81492|NCT01393600|194559|P3|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
81493|NCT01393600|194560|P2|COMPLETED|Treatment Period 1 (Day 1 to 14)||7
81494|NCT01393600|194561|P1|COMPLETED|Treatment Period 1 (Day 1 to 14)||9
81495|NCT01393600|194558|P4|STARTED|Treatment Period 1 (Day 1 to 14)||10
81496|NCT01393600|194559|P3|STARTED|Treatment Period 1 (Day 1 to 14)||10
81497|NCT01393600|194560|P2|STARTED|Treatment Period 1 (Day 1 to 14)||8
81498|NCT01393600|194561|P1|STARTED|Treatment Period 1 (Day 1 to 14)||9
81499|NCT01393444|194576|P1|NOT COMPLETED|Overall Study||3
81500|NCT01393444|194576|P1|COMPLETED|Overall Study|2015: Third implanted subject completed the study. This fulfilled the requirements of our grant.|3
81501|NCT01393444|194576|P1|Sixth (3rd Implanted) Subject|Overall Study|2014: Individual with brachial plexus injury enrolled and was eligible. Implanted in 2015.|1
81502|NCT01393444|194576|P1|Fifth (2nd Implanted) Subject Enrolled|Overall Study|2013: Individual with ALS enrolled and was eligible. Implanted in 2014.|1
81503|NCT01393444|194576|P1|Fourth Subject Enrolled|Overall Study|2013: Fourth participant enrolled. Ineligible.|1
81504|NCT01393444|194576|P1|Third Subject Enrolled|Overall Study|2013: Third participant enrolled. Withdrew due to family commitments.|1
81505|NCT01393444|194576|P1|Second Subject Enrolled|Overall Study|2012: Second participant enrolled. Ineligible.|1
81506|NCT01393444|194576|P1|First (1st Implanted) Subject Enrolled|Overall Study|2011: Individual with cervical spinal cord injury enrolled and was eligible. Implanted in 2011.|1
81507|NCT01393444|194576|P1|STARTED|Overall Study||6
81508|NCT01393132|194583|P2|NOT COMPLETED|Overall Study||0
81509|NCT01393132|194584|P1|NOT COMPLETED|Overall Study||0
81510|NCT01393132|194583|P2|COMPLETED|Overall Study||3
81511|NCT01393132|194584|P1|COMPLETED|Overall Study||6
81512|NCT01393132|194583|P2|STARTED|Overall Study||3
81513|NCT01393132|194584|P1|STARTED|Overall Study||6
81514|NCT01393106|194596|P1|NOT COMPLETED|Overall Study||5
81515|NCT01393106|194596|P1|COMPLETED|Overall Study|Completed: Disease Progression/Death|20
81516|NCT01393106|194596|P1|STARTED|Overall Study||25
81517|NCT01392742|194613|P1|NOT COMPLETED|Overall Study||201
81518|NCT01392742|194613|P1|COMPLETED|Overall Study||242
81519|NCT01392742|194613|P1|STARTED|Overall Study||443
81520|NCT01392703|194628|P3|NOT COMPLETED|Day 9||0
81521|NCT01392703|194629|P2|NOT COMPLETED|Day 9||0
81522|NCT01392703|194630|P1|NOT COMPLETED|Day 9||0
81523|NCT01392703|194628|P3|COMPLETED|Day 9||25
81524|NCT01392703|194629|P2|COMPLETED|Day 9||26
81525|NCT01392703|194630|P1|COMPLETED|Day 9||26
81526|NCT01392703|194628|P3|STARTED|Day 9||25
81527|NCT01392703|194629|P2|STARTED|Day 9||26
81528|NCT01392703|194630|P1|STARTED|Day 9||26
81529|NCT01392703|194628|P3|NOT COMPLETED|Day 5||0
81530|NCT01392703|194629|P2|NOT COMPLETED|Day 5||0
81531|NCT01392703|194630|P1|NOT COMPLETED|Day 5||0
81532|NCT01392703|194628|P3|COMPLETED|Day 5||26
81533|NCT01392703|194629|P2|COMPLETED|Day 5||25
81534|NCT01392703|194630|P1|COMPLETED|Day 5||26
81535|NCT01392703|194628|P3|STARTED|Day 5||26
81536|NCT01392703|194629|P2|STARTED|Day 5|1 participant no longer met dosing criteria and dropped out during washout period prior to Day 5.|25
81537|NCT01392703|194630|P1|STARTED|Day 5||26
81538|NCT01392703|194628|P3|NOT COMPLETED|Day 1||0
81539|NCT01392703|194629|P2|NOT COMPLETED|Day 1||0
81540|NCT01392703|194630|P1|NOT COMPLETED|Day 1||0
81541|NCT01392703|194628|P3|COMPLETED|Day 1||26
81542|NCT01392703|194629|P2|COMPLETED|Day 1||26
81543|NCT01392703|194630|P1|COMPLETED|Day 1||26
81544|NCT01392703|194628|P3|STARTED|Day 1||26
81545|NCT01392703|194629|P2|STARTED|Day 1||26
81546|NCT01392703|194630|P1|STARTED|Day 1||26
81547|NCT01392677|194659|P2|NOT COMPLETED|Overall Study||8
81548|NCT01392677|194660|P1|NOT COMPLETED|Overall Study||8
81549|NCT01392677|194659|P2|COMPLETED|Overall Study||101
81550|NCT01392677|194660|P1|COMPLETED|Overall Study||101
81551|NCT01392677|194659|P2|STARTED|Overall Study||109
81552|NCT01392677|194660|P1|STARTED|Overall Study||109
81553|NCT01392573|194676|P2|NOT COMPLETED|Overall Study||35
81554|NCT01392573|194677|P1|NOT COMPLETED|Overall Study||32
81555|NCT01392573|194676|P2|COMPLETED|Overall Study||171
81556|NCT01392573|194677|P1|COMPLETED|Overall Study||175
81557|NCT01392573|194676|P2|Exposed|Overall Study||206
81558|NCT01392573|194677|P1|Exposed|Overall Study||207
81559|NCT01392573|194676|P2|STARTED|Overall Study||206
81560|NCT01392573|194677|P1|STARTED|Overall Study||207
81561|NCT01392560|194685|P1|NOT COMPLETED|Overall Study||12
81562|NCT01392560|194685|P1|COMPLETED|Overall Study||40
81563|NCT01392560|194685|P1|STARTED|Overall Study||52
81564|NCT01392547|194691|P1|NOT COMPLETED|Overall Study||8
81565|NCT01392547|194691|P1|COMPLETED|Overall Study||64
81566|NCT01392547|194691|P1|STARTED|Overall Study|567 bleeds by 69 subjects, 340 were treated with vatreptacog alfa and 227 with rFVIIa|72
81567|NCT01392495|194705|P1|NOT COMPLETED|Overall Study||16
81568|NCT01392495|194705|P1|COMPLETED|Overall Study||1
81569|NCT01392495|194705|P1|Received 400 mg|Overall Study||13
81570|NCT01392495|194705|P1|Received 200 mg|Overall Study||4
81571|NCT01392495|194705|P1|STARTED|Overall Study||17
81572|NCT01392378|194722|P5|NOT COMPLETED|Toddler Dose||1
81573|NCT01392378|194723|P4|NOT COMPLETED|Toddler Dose||2
81574|NCT01392378|194724|P3|NOT COMPLETED|Toddler Dose||0
81575|NCT01392378|194725|P2|NOT COMPLETED|Toddler Dose||1
81576|NCT01392378|194726|P1|NOT COMPLETED|Toddler Dose||0
81577|NCT01392378|194722|P5|COMPLETED|Toddler Dose||208
81578|NCT01392378|194723|P4|COMPLETED|Toddler Dose||173
81579|NCT01392378|194724|P3|COMPLETED|Toddler Dose||170
81580|NCT01392378|194725|P2|COMPLETED|Toddler Dose||172
81581|NCT01392378|194726|P1|COMPLETED|Toddler Dose||169
81582|NCT01392378|194722|P5|STARTED|Toddler Dose||209
81583|NCT01392378|194723|P4|STARTED|Toddler Dose||175
81584|NCT01392378|194724|P3|STARTED|Toddler Dose||170
81585|NCT01392378|194725|P2|STARTED|Toddler Dose||173
81586|NCT01392378|194726|P1|STARTED|Toddler Dose||169
81587|NCT01392378|194722|P5|NOT COMPLETED|After Infant Series||1
81588|NCT01392378|194723|P4|NOT COMPLETED|After Infant Series||0
81589|NCT01392378|194724|P3|NOT COMPLETED|After Infant Series||2
81590|NCT01392378|194725|P2|NOT COMPLETED|After Infant Series||1
81591|NCT01392378|194726|P1|NOT COMPLETED|After Infant Series||0
81592|NCT01392378|194722|P5|COMPLETED|After Infant Series||209
81593|NCT01392378|194723|P4|COMPLETED|After Infant Series||175
81594|NCT01392378|194724|P3|COMPLETED|After Infant Series||170
81595|NCT01392378|194725|P2|COMPLETED|After Infant Series||173
81596|NCT01392378|194726|P1|COMPLETED|After Infant Series||169
81597|NCT01392378|194722|P5|STARTED|After Infant Series||210
81598|NCT01392378|194723|P4|STARTED|After Infant Series||175
81599|NCT01392378|194724|P3|STARTED|After Infant Series||172
81600|NCT01392378|194725|P2|STARTED|After Infant Series||174
81601|NCT01392378|194726|P1|STARTED|After Infant Series||169
81602|NCT01392378|194722|P5|NOT COMPLETED|Infant Series||0
81603|NCT01392378|194723|P4|NOT COMPLETED|Infant Series||2
81604|NCT01392378|194724|P3|NOT COMPLETED|Infant Series||0
81605|NCT01392378|194725|P2|NOT COMPLETED|Infant Series||2
81606|NCT01392378|194726|P1|NOT COMPLETED|Infant Series||4
81607|NCT01392378|194722|P5|COMPLETED|Infant Series||210
81608|NCT01392378|194723|P4|COMPLETED|Infant Series||175
81609|NCT01392378|194724|P3|COMPLETED|Infant Series||172
81610|NCT01392378|194725|P2|COMPLETED|Infant Series||174
81611|NCT01392378|194726|P1|COMPLETED|Infant Series||169
81612|NCT01392378|194722|P5|Vaccinated Dose 3|Infant Series||210
81613|NCT01392378|194723|P4|Vaccinated Dose 3|Infant Series||176
81614|NCT01392378|194724|P3|Vaccinated Dose 3|Infant Series||172
81615|NCT01392378|194725|P2|Vaccinated Dose 3|Infant Series||174
81616|NCT01392378|194726|P1|Vaccinated Dose 3|Infant Series||170
81617|NCT01392378|194722|P5|Vaccinated Dose 2|Infant Series||210
81618|NCT01392378|194723|P4|Vaccinated Dose 2|Infant Series||177
81619|NCT01392378|194724|P3|Vaccinated Dose 2|Infant Series||172
81620|NCT01392378|194725|P2|Vaccinated Dose 2|Infant Series||174
81621|NCT01392378|194726|P1|Vaccinated Dose 2|Infant Series||171
81622|NCT01392378|194722|P5|Vaccinated Dose 1|Infant Series||210
81623|NCT01392378|194723|P4|Vaccinated Dose 1|Infant Series||177
81624|NCT01392378|194724|P3|Vaccinated Dose 1|Infant Series||172
81625|NCT01392378|194725|P2|Vaccinated Dose 1|Infant Series||176
81626|NCT01392378|194726|P1|Vaccinated Dose 1|Infant Series||173
81627|NCT01392378|194722|P5|STARTED|Infant Series||210
81628|NCT01392378|194723|P4|STARTED|Infant Series||177
81629|NCT01392378|194724|P3|STARTED|Infant Series||172
81630|NCT01392378|194725|P2|STARTED|Infant Series||176
81631|NCT01392378|194726|P1|STARTED|Infant Series||173
81632|NCT01392326|194866|P3|NOT COMPLETED|Overall Study||48
81633|NCT01392326|194867|P2|NOT COMPLETED|Overall Study||35
81634|NCT01392326|194868|P1|NOT COMPLETED|Overall Study||47
81635|NCT01392326|194866|P3|COMPLETED|Overall Study||154
81636|NCT01392326|194867|P2|COMPLETED|Overall Study||167
81637|NCT01392326|194868|P1|COMPLETED|Overall Study||155
81638|NCT01392326|194866|P3|STARTED|Overall Study||202
81639|NCT01392326|194867|P2|STARTED|Overall Study||202
81640|NCT01392326|194868|P1|STARTED|Overall Study||202
81641|NCT01392300|194905|P3|NOT COMPLETED|Open Label Extension (OLEX) Period||51
81642|NCT01392300|194906|P2|NOT COMPLETED|Open Label Extension (OLEX) Period||0
81643|NCT01392300|194907|P1|NOT COMPLETED|Open Label Extension (OLEX) Period||0
81644|NCT01392300|194905|P3|COMPLETED|Open Label Extension (OLEX) Period||248
81645|NCT01392300|194906|P2|COMPLETED|Open Label Extension (OLEX) Period||0
81646|NCT01392300|194907|P1|COMPLETED|Open Label Extension (OLEX) Period||0
81647|NCT01392300|194905|P3|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|299
81648|NCT01392300|194906|P2|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
81649|NCT01392300|194907|P1|STARTED|Open Label Extension (OLEX) Period|Subjects from double-blind arms were switched to arm OLEX IncobotulinumtoxinA (Xeomin) (...)|0
81650|NCT01392300|194905|P3|NOT COMPLETED|Main Period (MP)||0
81651|NCT01392300|194906|P2|NOT COMPLETED|Main Period (MP)||7
81652|NCT01392300|194907|P1|NOT COMPLETED|Main Period (MP)||11
81653|NCT01392300|194905|P3|COMPLETED|Main Period (MP)||0
81654|NCT01392300|194906|P2|COMPLETED|Main Period (MP)||100
81655|NCT01392300|194907|P1|COMPLETED|Main Period (MP)||199
81656|NCT01392300|194905|P3|STARTED|Main Period (MP)||0
81657|NCT01392300|194906|P2|STARTED|Main Period (MP)||107
81658|NCT01392300|194907|P1|STARTED|Main Period (MP)||210
81659|NCT01392170|195012|P1|NOT COMPLETED|Overall Study||2
81660|NCT01392170|195012|P1|COMPLETED|Overall Study||0
81661|NCT01392170|195012|P1|STARTED|Overall Study||2
81662|NCT01392053|195018|P2|NOT COMPLETED|Overall Study||0
81663|NCT01392053|195019|P1|NOT COMPLETED|Overall Study||0
81664|NCT01392053|195018|P2|COMPLETED|Overall Study||23
81665|NCT01392053|195019|P1|COMPLETED|Overall Study||23
81666|NCT01392053|195018|P2|STARTED|Overall Study||23
81667|NCT01392053|195019|P1|STARTED|Overall Study||23
81668|NCT01391858|195039|P2|NOT COMPLETED|Overall Study||0
81669|NCT01391858|195040|P1|NOT COMPLETED|Overall Study||2
81670|NCT01391858|195039|P2|COMPLETED|Overall Study||24
81671|NCT01391858|195040|P1|COMPLETED|Overall Study||23
81672|NCT01391858|195039|P2|STARTED|Overall Study||24
81673|NCT01391858|195040|P1|STARTED|Overall Study||25
81674|NCT01391819|195060|P1|NOT COMPLETED|Overall Study||402
81675|NCT01391819|195060|P1|COMPLETED|Overall Study||1714
81676|NCT01391819|195060|P1|STARTED|Overall Study||2116
81677|NCT01391663|195091|P4|NOT COMPLETED|Overall Study||0
81678|NCT01391663|195092|P3|NOT COMPLETED|Overall Study||1
81679|NCT01391663|195093|P2|NOT COMPLETED|Overall Study||0
81680|NCT01391663|195094|P1|NOT COMPLETED|Overall Study||0
81681|NCT01391663|195091|P4|COMPLETED|Overall Study||12
81682|NCT01391663|195092|P3|COMPLETED|Overall Study||11
81683|NCT01391663|195093|P2|COMPLETED|Overall Study||12
81684|NCT01391663|195094|P1|COMPLETED|Overall Study||12
81685|NCT01391663|195091|P4|STARTED|Overall Study||12
81686|NCT01391663|195092|P3|STARTED|Overall Study||12
81687|NCT01391663|195093|P2|STARTED|Overall Study||12
81688|NCT01391663|195094|P1|STARTED|Overall Study||12
81689|NCT01391611|195124|P1|NOT COMPLETED|Overall Study||22
81690|NCT01391611|195124|P1|COMPLETED|Overall Study||3
81691|NCT01391611|195124|P1|STARTED|Overall Study||25
81692|NCT01391559|195129|P2|NOT COMPLETED|Second Intervention||0
81693|NCT01391559|195130|P1|NOT COMPLETED|Second Intervention||0
81694|NCT01391559|195129|P2|COMPLETED|Second Intervention||10
81695|NCT01391559|195130|P1|COMPLETED|Second Intervention||10
81696|NCT01391559|195129|P2|STARTED|Second Intervention||10
81697|NCT01391559|195130|P1|STARTED|Second Intervention||10
81698|NCT01391559|195129|P2|NOT COMPLETED|First Intervention||0
81699|NCT01391559|195130|P1|NOT COMPLETED|First Intervention||0
81700|NCT01391559|195129|P2|COMPLETED|First Intervention||10
81701|NCT01391559|195130|P1|COMPLETED|First Intervention||10
81702|NCT01391559|195129|P2|STARTED|First Intervention||10
81703|NCT01391559|195130|P1|STARTED|First Intervention||10
81704|NCT01391507|195140|P4|NOT COMPLETED|Overall Study||7
81705|NCT01391507|195141|P3|NOT COMPLETED|Overall Study||4
81706|NCT01391507|195142|P2|NOT COMPLETED|Overall Study||4
81707|NCT01391507|195143|P1|NOT COMPLETED|Overall Study||4
81708|NCT01391507|195140|P4|COMPLETED|Overall Study||5
81709|NCT01391507|195141|P3|COMPLETED|Overall Study||2
81710|NCT01391507|195142|P2|COMPLETED|Overall Study||4
81711|NCT01391507|195143|P1|COMPLETED|Overall Study||6
81712|NCT01391507|195140|P4|STARTED|Overall Study||12
81713|NCT01391507|195141|P3|STARTED|Overall Study||6
81714|NCT01391507|195142|P2|STARTED|Overall Study||8
81715|NCT01391507|195143|P1|STARTED|Overall Study||10
81716|NCT01391468|195191|P2|NOT COMPLETED|Overall Study||2
81717|NCT01391468|195192|P1|NOT COMPLETED|Overall Study||6
81718|NCT01391468|195191|P2|COMPLETED|Overall Study||21
81719|NCT01391468|195192|P1|COMPLETED|Overall Study||18
81720|NCT01391468|195191|P2|STARTED|Overall Study||23
81721|NCT01391468|195192|P1|STARTED|Overall Study||24
81722|NCT01391325|195204|P1|NOT COMPLETED|Overall Study||494
81723|NCT01391325|195204|P1|COMPLETED|Overall Study||1238
81724|NCT01391325|195204|P1|STARTED|Overall Study||1732
81725|NCT01391312|195213|P2|NOT COMPLETED|Overall Study||1
81726|NCT01391312|195214|P1|NOT COMPLETED|Overall Study||2
81727|NCT01391312|195213|P2|COMPLETED|Overall Study||19
81728|NCT01391312|195214|P1|COMPLETED|Overall Study||18
81729|NCT01391312|195213|P2|STARTED|Overall Study||20
81730|NCT01391312|195214|P1|STARTED|Overall Study||20
81731|NCT01391299|195227|P3|NOT COMPLETED|Overall Study||2
81732|NCT01391299|195228|P2|NOT COMPLETED|Overall Study||1
81733|NCT01391299|195229|P1|NOT COMPLETED|Overall Study||0
81734|NCT01391299|195227|P3|COMPLETED|Overall Study||56
81735|NCT01391299|195228|P2|COMPLETED|Overall Study||59
81736|NCT01391299|195229|P1|COMPLETED|Overall Study||57
81737|NCT01391299|195227|P3|STARTED|Overall Study||58
81738|NCT01391299|195228|P2|STARTED|Overall Study||60
81739|NCT01391299|195229|P1|STARTED|Overall Study||57
81740|NCT01391286|195251|P2|NOT COMPLETED|Overall Study||0
81741|NCT01391286|195252|P1|NOT COMPLETED|Overall Study||0
81742|NCT01391286|195251|P2|COMPLETED|Overall Study||18
81743|NCT01391286|195252|P1|COMPLETED|Overall Study||18
81744|NCT01391286|195251|P2|STARTED|Overall Study||18
81745|NCT01391286|195252|P1|STARTED|Overall Study||18
81746|NCT01391273|195266|P2|NOT COMPLETED|Overall Study||2
81747|NCT01391273|195267|P1|NOT COMPLETED|Overall Study||4
81748|NCT01391273|195266|P2|COMPLETED|Overall Study||83
81749|NCT01391273|195267|P1|COMPLETED|Overall Study||84
81750|NCT01391273|195266|P2|STARTED|Overall Study||85
81751|NCT01391273|195267|P1|STARTED|Overall Study||88
81752|NCT01391013|195281|P2|NOT COMPLETED|Overall Study||0
81753|NCT01391013|195282|P1|NOT COMPLETED|Overall Study||0
81754|NCT01391013|195281|P2|COMPLETED|Overall Study||15
81755|NCT01391013|195282|P1|COMPLETED|Overall Study||15
81756|NCT01391013|195281|P2|STARTED|Overall Study||15
81757|NCT01391013|195282|P1|STARTED|Overall Study||15
81758|NCT01391000|195322|P2|NOT COMPLETED|Overall Study||0
81759|NCT01391000|195323|P1|NOT COMPLETED|Overall Study||2
81760|NCT01391000|195322|P2|COMPLETED|Overall Study||35
81761|NCT01391000|195323|P1|COMPLETED|Overall Study||33
81762|NCT01391000|195322|P2|STARTED|Overall Study||35
81763|NCT01391000|195323|P1|STARTED|Overall Study||35
81764|NCT01390948|195336|P3|NOT COMPLETED|Overall Study||3
81765|NCT01390948|195337|P2|NOT COMPLETED|Overall Study||62
81766|NCT01390948|195338|P1|NOT COMPLETED|Overall Study||59
81767|NCT01390948|195336|P3|COMPLETED|Overall Study||0
81768|NCT01390948|195337|P2|COMPLETED|Overall Study||0
81769|NCT01390948|195338|P1|COMPLETED|Overall Study||0
81770|NCT01390948|195336|P3|Treated|Overall Study||3
81771|NCT01390948|195337|P2|Treated|Overall Study||60
81772|NCT01390948|195338|P1|Treated|Overall Study||56
81773|NCT01390948|195336|P3|STARTED|Overall Study||3
81774|NCT01390948|195337|P2|STARTED|Overall Study||62
81775|NCT01390948|195338|P1|STARTED|Overall Study||59
81776|NCT01390909|195377|P6|NOT COMPLETED|Overall Study||0
81777|NCT01390909|195378|P5|NOT COMPLETED|Overall Study||0
81778|NCT01390909|195379|P4|NOT COMPLETED|Overall Study||0
81779|NCT01390909|195380|P3|NOT COMPLETED|Overall Study||0
81780|NCT01390909|195381|P2|NOT COMPLETED|Overall Study||0
81781|NCT01390909|195382|P1|NOT COMPLETED|Overall Study||0
81782|NCT01390909|195377|P6|COMPLETED|Overall Study||613
81783|NCT01390909|195378|P5|COMPLETED|Overall Study||613
81784|NCT01390909|195379|P4|COMPLETED|Overall Study||602
81785|NCT01390909|195380|P3|COMPLETED|Overall Study||3552
81786|NCT01390909|195381|P2|COMPLETED|Overall Study||3552
81787|NCT01390909|195382|P1|COMPLETED|Overall Study||3454
81788|NCT01390909|195377|P6|Participants in Subgroup|Overall Study||0
81789|NCT01390909|195378|P5|Participants in Subgroup|Overall Study||602
81790|NCT01390909|195379|P4|Participants in Subgroup|Overall Study||0
81791|NCT01390909|195380|P3|Participants in Subgroup|Overall Study||0
81792|NCT01390909|195381|P2|Participants in Subgroup|Overall Study||3454
81793|NCT01390909|195382|P1|Participants in Subgroup|Overall Study||0
81794|NCT01390909|195377|P6|STARTED|Overall Study||613
81795|NCT01390909|195378|P5|STARTED|Overall Study||613
81796|NCT01390909|195379|P4|STARTED|Overall Study||602
81797|NCT01390909|195380|P3|STARTED|Overall Study||3552
81798|NCT01390909|195381|P2|STARTED|Overall Study||3552
81799|NCT01390909|195382|P1|STARTED|Overall Study||3454
81800|NCT01390870|195400|P1|NOT COMPLETED|Overall Study||0
81801|NCT01390870|195400|P1|COMPLETED|Overall Study||400
81802|NCT01390870|195400|P1|STARTED|Overall Study||400
81803|NCT01390857|195404|P1|NOT COMPLETED|Overall Study||10
81804|NCT01390857|195404|P1|COMPLETED|Overall Study||369
81805|NCT01390857|195404|P1|STARTED|Overall Study||379
81806|NCT01390844|195415|P4|NOT COMPLETED|Follow-Up Phase||0
81807|NCT01390844|195416|P3|NOT COMPLETED|Follow-Up Phase||1
81808|NCT01390844|195417|P2|NOT COMPLETED|Follow-Up Phase||1
81809|NCT01390844|195418|P1|NOT COMPLETED|Follow-Up Phase||1
81810|NCT01390844|195415|P4|COMPLETED|Follow-Up Phase||8
81811|NCT01390844|195416|P3|COMPLETED|Follow-Up Phase||25
81812|NCT01390844|195417|P2|COMPLETED|Follow-Up Phase||36
81813|NCT01390844|195418|P1|COMPLETED|Follow-Up Phase||92
81814|NCT01390844|195415|P4|STARTED|Follow-Up Phase||8
81815|NCT01390844|195416|P3|STARTED|Follow-Up Phase||26
81816|NCT01390844|195417|P2|STARTED|Follow-Up Phase||37
81817|NCT01390844|195418|P1|STARTED|Follow-Up Phase||93
81818|NCT01390844|195415|P4|NOT COMPLETED|Treatment Phase||19
81819|NCT01390844|195416|P3|NOT COMPLETED|Treatment Phase||31
81820|NCT01390844|195417|P2|NOT COMPLETED|Treatment Phase||28
81821|NCT01390844|195418|P1|NOT COMPLETED|Treatment Phase||40
81822|NCT01390844|195415|P4|COMPLETED|Treatment Phase||8
81823|NCT01390844|195416|P3|COMPLETED|Treatment Phase||26
81824|NCT01390844|195417|P2|COMPLETED|Treatment Phase||37
81825|NCT01390844|195418|P1|COMPLETED|Treatment Phase||93
81826|NCT01390844|195415|P4|Followed Good Clinical Practice (GCP)|Treatment Phase||24
81827|NCT01390844|195416|P3|Followed Good Clinical Practice (GCP)|Treatment Phase||47
81828|NCT01390844|195417|P2|Followed Good Clinical Practice (GCP)|Treatment Phase||65
81829|NCT01390844|195418|P1|Followed Good Clinical Practice (GCP)|Treatment Phase||133
81830|NCT01390844|195415|P4|STARTED|Treatment Phase||27
81831|NCT01390844|195416|P3|STARTED|Treatment Phase||57
81832|NCT01390844|195417|P2|STARTED|Treatment Phase||65
81833|NCT01390844|195418|P1|STARTED|Treatment Phase||133
81834|NCT01390818|195459|P15|NOT COMPLETED|Overall Study||0
81835|NCT01390818|195460|P14|NOT COMPLETED|Overall Study||0
81836|NCT01390818|195461|P13|NOT COMPLETED|Overall Study||0
81837|NCT01390818|195462|P12|NOT COMPLETED|Overall Study||0
81838|NCT01390818|195463|P11|NOT COMPLETED|Overall Study||0
81839|NCT01390818|195464|P10|NOT COMPLETED|Overall Study||0
81840|NCT01390818|195465|P9|NOT COMPLETED|Overall Study||0
81841|NCT01390818|195466|P8|NOT COMPLETED|Overall Study||0
81842|NCT01390818|195467|P7|NOT COMPLETED|Overall Study||0
81843|NCT01390818|195468|P6|NOT COMPLETED|Overall Study||0
81844|NCT01390818|195469|P5|NOT COMPLETED|Overall Study||0
81845|NCT01390818|195470|P4|NOT COMPLETED|Overall Study||0
81846|NCT01390818|195471|P3|NOT COMPLETED|Overall Study||0
81847|NCT01390818|195472|P2|NOT COMPLETED|Overall Study||0
81848|NCT01390818|195473|P1|NOT COMPLETED|Overall Study||0
81849|NCT01390818|195459|P15|COMPLETED|Overall Study||15
81850|NCT01390818|195460|P14|COMPLETED|Overall Study||18
81851|NCT01390818|195461|P13|COMPLETED|Overall Study||24
81852|NCT01390818|195462|P12|COMPLETED|Overall Study||26
81853|NCT01390818|195463|P11|COMPLETED|Overall Study||4
81854|NCT01390818|195464|P10|COMPLETED|Overall Study||3
81855|NCT01390818|195465|P9|COMPLETED|Overall Study||3
81856|NCT01390818|195466|P8|COMPLETED|Overall Study||14
81857|NCT01390818|195467|P7|COMPLETED|Overall Study||19
81858|NCT01390818|195468|P6|COMPLETED|Overall Study||3
81859|NCT01390818|195469|P5|COMPLETED|Overall Study||4
81860|NCT01390818|195470|P4|COMPLETED|Overall Study||4
81861|NCT01390818|195471|P3|COMPLETED|Overall Study||3
81862|NCT01390818|195472|P2|COMPLETED|Overall Study||3
81863|NCT01390818|195473|P1|COMPLETED|Overall Study||3
81864|NCT01390818|195459|P15|STARTED|Overall Study||15
81865|NCT01390818|195460|P14|STARTED|Overall Study||18
81866|NCT01390818|195461|P13|STARTED|Overall Study||24
81867|NCT01390818|195462|P12|STARTED|Overall Study||26
81868|NCT01390818|195463|P11|STARTED|Overall Study||4
81869|NCT01390818|195464|P10|STARTED|Overall Study||3
81870|NCT01390818|195465|P9|STARTED|Overall Study||3
81871|NCT01390818|195466|P8|STARTED|Overall Study||14
81872|NCT01390818|195467|P7|STARTED|Overall Study||19
81873|NCT01390818|195468|P6|STARTED|Overall Study||3
81874|NCT01390818|195469|P5|STARTED|Overall Study||4
81875|NCT01390818|195470|P4|STARTED|Overall Study||4
81876|NCT01390818|195471|P3|STARTED|Overall Study||3
81877|NCT01390818|195472|P2|STARTED|Overall Study||3
81878|NCT01390818|195473|P1|STARTED|Overall Study||3
81879|NCT01390779|195745|P1|NOT COMPLETED|Overall Study||1
81880|NCT01390779|195745|P1|COMPLETED|Overall Study||32
81881|NCT01390779|195745|P1|STARTED|Overall Study||33
81882|NCT01390649|195750|P1|NOT COMPLETED|Overall Study||1
81883|NCT01390649|195750|P1|COMPLETED|Overall Study||56
81884|NCT01390649|195750|P1|STARTED|Overall Study|Subjects treated with Privigen|57
81885|NCT01390441|195760|P5|NOT COMPLETED|Extension Period||0
81886|NCT01390441|195761|P4|NOT COMPLETED|Extension Period||1
81887|NCT01390441|195762|P3|NOT COMPLETED|Extension Period||0
81888|NCT01390441|195763|P2|NOT COMPLETED|Extension Period||1
81889|NCT01390441|195764|P1|NOT COMPLETED|Extension Period||3
81890|NCT01390441|195760|P5|COMPLETED|Extension Period||3
81891|NCT01390441|195761|P4|COMPLETED|Extension Period||0
81892|NCT01390441|195762|P3|COMPLETED|Extension Period||1
81893|NCT01390441|195763|P2|COMPLETED|Extension Period||12
81894|NCT01390441|195764|P1|COMPLETED|Extension Period||12
81895|NCT01390441|195760|P5|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|3
81896|NCT01390441|195761|P4|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
81897|NCT01390441|195762|P3|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|1
81898|NCT01390441|195763|P2|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|13
81899|NCT01390441|195764|P1|STARTED|Extension Period|Not all participants entered the Extension Period due to early termination of the study.|15
81900|NCT01390441|195760|P5|NOT COMPLETED|Treatment Period||11
81901|NCT01390441|195761|P4|NOT COMPLETED|Treatment Period||13
81902|NCT01390441|195762|P3|NOT COMPLETED|Treatment Period||10
81903|NCT01390441|195763|P2|NOT COMPLETED|Treatment Period||1
81904|NCT01390441|195764|P1|NOT COMPLETED|Treatment Period||1
81905|NCT01390441|195760|P5|COMPLETED|Treatment Period||7
81906|NCT01390441|195761|P4|COMPLETED|Treatment Period||6
81907|NCT01390441|195762|P3|COMPLETED|Treatment Period||8
81908|NCT01390441|195763|P2|COMPLETED|Treatment Period||21
81909|NCT01390441|195764|P1|COMPLETED|Treatment Period||22
81910|NCT01390441|195760|P5|STARTED|Treatment Period||18
81911|NCT01390441|195761|P4|STARTED|Treatment Period||19
81912|NCT01390441|195762|P3|STARTED|Treatment Period||18
81913|NCT01390441|195763|P2|STARTED|Treatment Period||22
81914|NCT01390441|195764|P1|STARTED|Treatment Period||23
81915|NCT01390428|195829|P6|NOT COMPLETED|Overall Study||0
81916|NCT01390428|195830|P5|NOT COMPLETED|Overall Study||1
81917|NCT01390428|195831|P4|NOT COMPLETED|Overall Study||0
81918|NCT01390428|195832|P3|NOT COMPLETED|Overall Study||1
81919|NCT01390428|195833|P2|NOT COMPLETED|Overall Study||0
81920|NCT01390428|195834|P1|NOT COMPLETED|Overall Study||0
81921|NCT01390428|195829|P6|COMPLETED|Overall Study||8
81922|NCT01390428|195830|P5|COMPLETED|Overall Study||7
81923|NCT01390428|195831|P4|COMPLETED|Overall Study||9
81924|NCT01390428|195832|P3|COMPLETED|Overall Study||8
81925|NCT01390428|195833|P2|COMPLETED|Overall Study||8
81926|NCT01390428|195834|P1|COMPLETED|Overall Study||8
81927|NCT01390428|195829|P6|STARTED|Overall Study||8
81928|NCT01390428|195830|P5|STARTED|Overall Study||8
81929|NCT01390428|195831|P4|STARTED|Overall Study||9
81930|NCT01390428|195832|P3|STARTED|Overall Study||9
81931|NCT01390428|195833|P2|STARTED|Overall Study||8
81932|NCT01390428|195834|P1|STARTED|Overall Study||8
81933|NCT01390415|195886|P2|NOT COMPLETED|Overall Study||0
81934|NCT01390415|195887|P1|NOT COMPLETED|Overall Study||0
81935|NCT01390415|195886|P2|COMPLETED|Overall Study||37
81936|NCT01390415|195887|P1|COMPLETED|Overall Study||99
81937|NCT01390415|195886|P2|STARTED|Overall Study||37
81938|NCT01390415|195887|P1|STARTED|Overall Study||99
81939|NCT01390402|195897|P1|NOT COMPLETED|Overall Study||5
81940|NCT01390402|195897|P1|COMPLETED|Overall Study||1
81941|NCT01390402|195897|P1|STARTED|Overall Study||6
81942|NCT01390389|195903|P2|NOT COMPLETED|Overall Study||1
81943|NCT01390389|195904|P1|NOT COMPLETED|Overall Study||4
81944|NCT01390389|195903|P2|COMPLETED|Overall Study||8
81945|NCT01390389|195904|P1|COMPLETED|Overall Study||6
81946|NCT01390389|195903|P2|STARTED|Overall Study||9
81947|NCT01390389|195904|P1|STARTED|Overall Study||10
81948|NCT01390259|195910|P2|NOT COMPLETED|Overall Study||0
81949|NCT01390259|195911|P1|NOT COMPLETED|Overall Study||0
81950|NCT01390259|195910|P2|COMPLETED|Overall Study||6
81951|NCT01390259|195911|P1|COMPLETED|Overall Study||5
81952|NCT01390259|195910|P2|STARTED|Overall Study||6
81953|NCT01390259|195911|P1|STARTED|Overall Study||5
81954|NCT01390233|195923|P3|NOT COMPLETED|Overall Study||6
81955|NCT01390233|195924|P2|NOT COMPLETED|Overall Study||2
81956|NCT01390233|195925|P1|NOT COMPLETED|Overall Study||5
81957|NCT01390233|195923|P3|COMPLETED|Overall Study||30
81958|NCT01390233|195924|P2|COMPLETED|Overall Study||29
81959|NCT01390233|195925|P1|COMPLETED|Overall Study||30
81960|NCT01390233|195923|P3|STARTED|Overall Study||36
81961|NCT01390233|195924|P2|STARTED|Overall Study||31
81962|NCT01390233|195925|P1|STARTED|Overall Study||35
81963|NCT01390181|195933|P1|NOT COMPLETED|Overall Study||4
81964|NCT01390181|195933|P1|COMPLETED|Overall Study||0
81965|NCT01390181|195933|P1|STARTED|Overall Study||4
81966|NCT01390038|195937|P1|NOT COMPLETED|Overall Study||8
81967|NCT01390038|195937|P1|COMPLETED|Overall Study||149
81968|NCT01390038|195937|P1|STARTED|Overall Study||157
81969|NCT01389973|195947|P1|NOT COMPLETED|Overall Study||20
81970|NCT01389973|195947|P1|COMPLETED|Overall Study||0
81971|NCT01389973|195947|P1|STARTED|Overall Study||20
81972|NCT01389882|195957|P2|NOT COMPLETED|Overall Study||4
81973|NCT01389882|195958|P1|NOT COMPLETED|Overall Study||1
81974|NCT01389882|195957|P2|COMPLETED|Overall Study||7
81975|NCT01389882|195958|P1|COMPLETED|Overall Study||12
81976|NCT01389882|195957|P2|STARTED|Overall Study||11
81977|NCT01389882|195958|P1|STARTED|Overall Study||13
81978|NCT01389856|195988|P2|NOT COMPLETED|Overall Study||0
81979|NCT01389856|195989|P1|NOT COMPLETED|Overall Study||0
81980|NCT01389856|195988|P2|COMPLETED|Overall Study||8
81981|NCT01389856|195989|P1|COMPLETED|Overall Study||13
81982|NCT01389856|195988|P2|STARTED|Overall Study|Randomized and treated.|8
81983|NCT01389856|195989|P1|STARTED|Overall Study|Randomized and treated. An additional 2 patients were randomized but not treated.|13
81984|NCT01389817|196046|P2|NOT COMPLETED|Overall Study||0
81985|NCT01389817|196047|P1|NOT COMPLETED|Overall Study||4
81986|NCT01389817|196046|P2|COMPLETED|Overall Study||0
81987|NCT01389817|196047|P1|COMPLETED|Overall Study||0
81988|NCT01389817|196046|P2|STARTED|Overall Study||0
81989|NCT01389817|196047|P1|STARTED|Overall Study||4
81990|NCT01389596|196056|P3|NOT COMPLETED|Overall Study||10
81991|NCT01389596|196057|P2|NOT COMPLETED|Overall Study||16
81992|NCT01389596|196058|P1|NOT COMPLETED|Overall Study||10
81993|NCT01389596|196056|P3|COMPLETED|Overall Study||84
81994|NCT01389596|196057|P2|COMPLETED|Overall Study||81
81995|NCT01389596|196058|P1|COMPLETED|Overall Study||94
81996|NCT01389596|196056|P3|STARTED|Overall Study||94
81997|NCT01389596|196057|P2|STARTED|Overall Study||97
81998|NCT01389596|196058|P1|STARTED|Overall Study||104
81999|NCT01389323|196117|P1|NOT COMPLETED|Follow-up Period (up to 48 Weeks)||37
82000|NCT01389323|196117|P1|COMPLETED|Follow-up Period (up to 48 Weeks)||184
82001|NCT01389323|196117|P1|STARTED|Follow-up Period (up to 48 Weeks)|Out of 246 participants who entered the treatment period, 221 continued in the follow-up period.|221
82002|NCT01389323|196117|P1|NOT COMPLETED|Treatment Period (up to 48 Weeks)||95
82003|NCT01389323|196117|P1|COMPLETED|Treatment Period (up to 48 Weeks)||151
82004|NCT01389323|196117|P1|STARTED|Treatment Period (up to 48 Weeks)||246
82005|NCT01389284|196140|P3|NOT COMPLETED|Overall Study||0
82006|NCT01389284|196141|P2|NOT COMPLETED|Overall Study||0
82007|NCT01389284|196142|P1|NOT COMPLETED|Overall Study||0
82008|NCT01389284|196140|P3|COMPLETED|Overall Study||60
82009|NCT01389284|196141|P2|COMPLETED|Overall Study||120
82010|NCT01389284|196142|P1|COMPLETED|Overall Study||120
82011|NCT01389284|196140|P3|STARTED|Overall Study||60
82012|NCT01389284|196141|P2|STARTED|Overall Study||120
82013|NCT01389284|196142|P1|STARTED|Overall Study||120
82014|NCT01389102|196180|P6|NOT COMPLETED|Overall Study||8
82015|NCT01389102|196181|P5|NOT COMPLETED|Overall Study||13
82016|NCT01389102|196182|P4|NOT COMPLETED|Overall Study||7
82017|NCT01389102|196183|P3|NOT COMPLETED|Overall Study||19
82018|NCT01389102|196184|P2|NOT COMPLETED|Overall Study||12
82019|NCT01389102|196185|P1|NOT COMPLETED|Overall Study||18
82020|NCT01389102|196180|P6|COMPLETED|Overall Study||68
82021|NCT01389102|196181|P5|COMPLETED|Overall Study||61
82022|NCT01389102|196182|P4|COMPLETED|Overall Study||69
82023|NCT01389102|196183|P3|COMPLETED|Overall Study||58
82024|NCT01389102|196184|P2|COMPLETED|Overall Study||64
82025|NCT01389102|196185|P1|COMPLETED|Overall Study||57
82026|NCT01389102|196180|P6|STARTED|Overall Study||76
82027|NCT01389102|196181|P5|STARTED|Overall Study||74
82028|NCT01389102|196182|P4|STARTED|Overall Study||76
82029|NCT01389102|196183|P3|STARTED|Overall Study||77
82030|NCT01389102|196184|P2|STARTED|Overall Study||76
82031|NCT01389102|196185|P1|STARTED|Overall Study||75
82032|NCT01389076|196205|P1|NOT COMPLETED|Overall Study||0
82033|NCT01389076|196205|P1|COMPLETED|Overall Study||22
82034|NCT01389076|196205|P1|STARTED|Overall Study||22
82035|NCT01388946|196215|P2|NOT COMPLETED|Overall Study||3
82036|NCT01388946|196216|P1|NOT COMPLETED|Overall Study||6
82037|NCT01388946|196215|P2|COMPLETED|Overall Study||52
82038|NCT01388946|196216|P1|COMPLETED|Overall Study||49
82039|NCT01388946|196215|P2|STARTED|Overall Study||55
82040|NCT01388946|196216|P1|STARTED|Overall Study||55
82041|NCT01388920|196251|P3|NOT COMPLETED|Overall Study||0
82042|NCT01388920|196252|P2|NOT COMPLETED|Overall Study||0
82043|NCT01388920|196253|P1|NOT COMPLETED|Overall Study||0
82044|NCT01388920|196251|P3|COMPLETED|Overall Study||0
82045|NCT01388920|196252|P2|COMPLETED|Overall Study||1
82046|NCT01388920|196253|P1|COMPLETED|Overall Study||1
82047|NCT01388920|196251|P3|STARTED|Overall Study||0
82048|NCT01388920|196252|P2|STARTED|Overall Study||1
82049|NCT01388920|196253|P1|STARTED|Overall Study||1
82050|NCT01388907|196263|P2|NOT COMPLETED|Overall Study||0
82051|NCT01388907|196264|P1|NOT COMPLETED|Overall Study||2
82052|NCT01388907|196263|P2|COMPLETED|Overall Study||28
82053|NCT01388907|196264|P1|COMPLETED|Overall Study||31
82054|NCT01388907|196263|P2|STARTED|Overall Study||28
82055|NCT01388907|196264|P1|STARTED|Overall Study||33
82056|NCT01388816|196280|P4|NOT COMPLETED|Overall Study||0
82057|NCT01388816|196281|P3|NOT COMPLETED|Overall Study||3
82058|NCT01388816|196282|P2|NOT COMPLETED|Overall Study||4
82059|NCT01388816|196283|P1|NOT COMPLETED|Overall Study||2
82060|NCT01388816|196280|P4|COMPLETED|Overall Study||44
82061|NCT01388816|196281|P3|COMPLETED|Overall Study||41
82062|NCT01388816|196282|P2|COMPLETED|Overall Study||39
82063|NCT01388816|196283|P1|COMPLETED|Overall Study||43
82064|NCT01388816|196280|P4|STARTED|Overall Study||44
82065|NCT01388816|196281|P3|STARTED|Overall Study||44
82066|NCT01388816|196282|P2|STARTED|Overall Study||43
82067|NCT01388816|196283|P1|STARTED|Overall Study||45
82068|NCT01388790|196312|P1|NOT COMPLETED|Overall Study||8
82069|NCT01388790|196312|P1|COMPLETED|Overall Study||32
82070|NCT01388790|196312|P1|STARTED|Overall Study||40
82071|NCT01388647|196319|P2|NOT COMPLETED|Overall Study||2
82072|NCT01388647|196320|P1|NOT COMPLETED|Overall Study||1
82073|NCT01388647|196319|P2|COMPLETED|Overall Study|two subjects ended study treatment due to adverse events|4
82074|NCT01388647|196320|P1|COMPLETED|Overall Study|one subject ended study treatment due to adverse events|5
82075|NCT01388647|196319|P2|STARTED|Overall Study||6
82076|NCT01388647|196320|P1|STARTED|Overall Study||6
82077|NCT01388530|196331|P1|NOT COMPLETED|Overall Study||5
82078|NCT01388530|196331|P1|COMPLETED|Overall Study||20
82079|NCT01388530|196331|P1|STARTED|Overall Study||25
82080|NCT01388491|196340|P2|NOT COMPLETED|Overall Study||29
82081|NCT01388491|196341|P1|NOT COMPLETED|Overall Study||34
82082|NCT01388491|196340|P2|COMPLETED|Overall Study||114
82083|NCT01388491|196341|P1|COMPLETED|Overall Study||116
82084|NCT01388491|196340|P2|Per Protocol (PP) Population|Overall Study||121
82085|NCT01388491|196341|P1|Per Protocol (PP) Population|Overall Study|PP: all data from ITT participants obtained prior to any major protocol violations|125
82086|NCT01388491|196340|P2|Intent-to-Treat (ITT) Population|Overall Study||136
82087|NCT01388491|196341|P1|Intent-to-Treat (ITT) Population|Overall Study|ITT:participants in safety population with baseline (BL) + ≥1 post-BL prothrombin fragment 1+2 value|140
82088|NCT01388491|196340|P2|Safety Population|Overall Study||142
82089|NCT01388491|196341|P1|Safety Population|Overall Study|Safety: all randomized participants who took 1 or more doses of study drug|145
82090|NCT01388491|196340|P2|STARTED|Overall Study||143
82091|NCT01388491|196341|P1|STARTED|Overall Study|number randomized|150
82092|NCT01388361|196376|P3|NOT COMPLETED|Overall Study||14
82093|NCT01388361|196377|P2|NOT COMPLETED|Overall Study||12
82094|NCT01388361|196378|P1|NOT COMPLETED|Overall Study||12
82095|NCT01388361|196376|P3|COMPLETED|Overall Study||75
82096|NCT01388361|196377|P2|COMPLETED|Overall Study||76
82097|NCT01388361|196378|P1|COMPLETED|Overall Study||224
82098|NCT01388361|196376|P3|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug.|86
82099|NCT01388361|196377|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|87
82100|NCT01388361|196378|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to IDeg during NN1250-3948|234
82101|NCT01388361|196376|P3|STARTED|Overall Study||89
82102|NCT01388361|196377|P2|STARTED|Overall Study||88
82103|NCT01388361|196378|P1|STARTED|Overall Study||236
82104|NCT01388166|196395|P1|NOT COMPLETED|Overall Study||59
82105|NCT01388166|196395|P1|COMPLETED|Overall Study||1194
82106|NCT01388166|196395|P1|STARTED|Overall Study||1253
82107|NCT01387789|196401|P1|NOT COMPLETED|Overall Study||8
82108|NCT01387789|196401|P1|COMPLETED|Overall Study||63
82109|NCT01387789|196401|P1|STARTED|Overall Study||71
82110|NCT01387737|196415|P2|NOT COMPLETED|Overall Study||74
82111|NCT01387737|196416|P1|NOT COMPLETED|Overall Study||52
82112|NCT01387737|196415|P2|COMPLETED|Overall Study||641
82113|NCT01387737|196416|P1|COMPLETED|Overall Study||532
82114|NCT01387737|196415|P2|STARTED|Overall Study||715
82115|NCT01387737|196416|P1|STARTED|Overall Study||584
82116|NCT01387672|196428|P6|NOT COMPLETED|Overall Study||0
82117|NCT01387672|196429|P5|NOT COMPLETED|Overall Study||4
82118|NCT01387672|196430|P4|NOT COMPLETED|Overall Study||4
82119|NCT01387672|196431|P3|NOT COMPLETED|Overall Study||5
82120|NCT01387672|196432|P2|NOT COMPLETED|Overall Study||7
82121|NCT01387672|196433|P1|NOT COMPLETED|Overall Study||7
82122|NCT01387672|196428|P6|COMPLETED|Overall Study||37
82123|NCT01387672|196429|P5|COMPLETED|Overall Study||34
82124|NCT01387672|196430|P4|COMPLETED|Overall Study||35
82125|NCT01387672|196431|P3|COMPLETED|Overall Study||33
82126|NCT01387672|196432|P2|COMPLETED|Overall Study||31
82127|NCT01387672|196433|P1|COMPLETED|Overall Study||32
82128|NCT01387672|196428|P6|STARTED|Overall Study||37
82129|NCT01387672|196429|P5|STARTED|Overall Study||38
82130|NCT01387672|196430|P4|STARTED|Overall Study||39
82131|NCT01387672|196431|P3|STARTED|Overall Study||38
82132|NCT01387672|196432|P2|STARTED|Overall Study||38
82133|NCT01387672|196433|P1|STARTED|Overall Study||39
82134|NCT01387594|196450|P2|NOT COMPLETED|Overall Study||3
82135|NCT01387594|196451|P1|NOT COMPLETED|Overall Study||0
82136|NCT01387594|196450|P2|COMPLETED|Overall Study||36
82137|NCT01387594|196451|P1|COMPLETED|Overall Study||10
82138|NCT01387594|196450|P2|STARTED|Overall Study||39
82139|NCT01387594|196451|P1|STARTED|Overall Study||10
82140|NCT01387581|196466|P3|NOT COMPLETED|Overall Study||3
82141|NCT01387581|196467|P2|NOT COMPLETED|Overall Study||6
82142|NCT01387581|196468|P1|NOT COMPLETED|Overall Study||7
82143|NCT01387581|196466|P3|COMPLETED|Overall Study||9
82144|NCT01387581|196467|P2|COMPLETED|Overall Study||101
82145|NCT01387581|196468|P1|COMPLETED|Overall Study||101
82146|NCT01387581|196466|P3|STARTED|Overall Study||12
82147|NCT01387581|196467|P2|STARTED|Overall Study||107
82148|NCT01387581|196468|P1|STARTED|Overall Study||108
82149|NCT01387542|196479|P1|NOT COMPLETED|Overall Study||8
82150|NCT01387542|196479|P1|COMPLETED|Overall Study||32
82151|NCT01387542|196479|P1|Treated|Overall Study||38
82152|NCT01387542|196479|P1|STARTED|Overall Study||40
82153|NCT01387464|196488|P2|NOT COMPLETED|Overall Study||1
82154|NCT01387464|196489|P1|NOT COMPLETED|Overall Study||1
82155|NCT01387464|196488|P2|COMPLETED|Overall Study||29
82156|NCT01387464|196489|P1|COMPLETED|Overall Study||29
82157|NCT01387464|196488|P2|Per-Protocol Population|Overall Study||29
82158|NCT01387464|196489|P1|Per-Protocol Population|Overall Study|Safety subjects who completed surgery|29
82159|NCT01387464|196488|P2|Safety Population|Overall Study||29
82160|NCT01387464|196489|P1|Safety Population|Overall Study||30
82161|NCT01387464|196488|P2|STARTED|Overall Study||30
82162|NCT01387464|196489|P1|STARTED|Overall Study||30
82163|NCT01387347|196497|P2|NOT COMPLETED|Overall Study||1
82164|NCT01387347|196498|P1|NOT COMPLETED|Overall Study||2
82165|NCT01387347|196497|P2|COMPLETED|Overall Study||35
82166|NCT01387347|196498|P1|COMPLETED|Overall Study||34
82167|NCT01387347|196497|P2|STARTED|Overall Study||36
82168|NCT01387347|196498|P1|STARTED|Overall Study||36
82169|NCT01387282|196510|P2|NOT COMPLETED|Overall Study||47
82170|NCT01387282|196511|P1|NOT COMPLETED|Overall Study||97
82171|NCT01387282|196510|P2|COMPLETED|Overall Study||118
82172|NCT01387282|196511|P1|COMPLETED|Overall Study||233
82173|NCT01387282|196510|P2|Safety Population|Overall Study||161
82174|NCT01387282|196511|P1|Safety Population|Overall Study||330
82175|NCT01387282|196510|P2|MITT Population|Overall Study||136
82176|NCT01387282|196511|P1|MITT Population|Overall Study||268
82177|NCT01387282|196510|P2|ITT Population|Overall Study||165
82178|NCT01387282|196511|P1|ITT Population|Overall Study||330
82179|NCT01387282|196510|P2|STARTED|Overall Study||165
82180|NCT01387282|196511|P1|STARTED|Overall Study||330
82181|NCT01387269|196527|P2|NOT COMPLETED|Overall Study||40
82182|NCT01387269|196528|P1|NOT COMPLETED|Overall Study||92
82183|NCT01387269|196527|P2|COMPLETED|Overall Study||121
82184|NCT01387269|196528|P1|COMPLETED|Overall Study||231
82185|NCT01387269|196527|P2|Safety Population|Overall Study||161
82186|NCT01387269|196528|P1|Safety Population|Overall Study||320
82187|NCT01387269|196527|P2|MITT Population|Overall Study||141
82188|NCT01387269|196528|P1|MITT Population|Overall Study||284
82189|NCT01387269|196527|P2|ITT Population|Overall Study||161
82190|NCT01387269|196528|P1|ITT Population|Overall Study||323
82191|NCT01387269|196527|P2|STARTED|Overall Study||161
82192|NCT01387269|196528|P1|STARTED|Overall Study||323
82193|NCT01387230|196545|P3|NOT COMPLETED|Overall Study||13
82194|NCT01387230|196546|P2|NOT COMPLETED|Overall Study||7
82195|NCT01387230|196547|P1|NOT COMPLETED|Overall Study||18
82196|NCT01387230|196545|P3|COMPLETED|Overall Study||56
82197|NCT01387230|196546|P2|COMPLETED|Overall Study||62
82198|NCT01387230|196547|P1|COMPLETED|Overall Study||50
82199|NCT01387230|196545|P3|STARTED|Overall Study||69
82200|NCT01387230|196546|P2|STARTED|Overall Study||69
82201|NCT01387230|196547|P1|STARTED|Overall Study||68
82202|NCT01387178|196563|P2|NOT COMPLETED|Overall Study||0
82203|NCT01387178|196564|P1|NOT COMPLETED|Overall Study||0
82204|NCT01387178|196563|P2|COMPLETED|Overall Study||10641
82205|NCT01387178|196564|P1|COMPLETED|Overall Study||11582
82206|NCT01387178|196563|P2|STARTED|Overall Study||10641
82207|NCT01387178|196564|P1|STARTED|Overall Study||11582
82208|NCT01387139|196576|P2|NOT COMPLETED|Overall Study||0
82209|NCT01387139|196577|P1|NOT COMPLETED|Overall Study||0
82210|NCT01387139|196576|P2|COMPLETED|Overall Study||84
82211|NCT01387139|196577|P1|COMPLETED|Overall Study||99
82212|NCT01387139|196576|P2|STARTED|Overall Study||84
82213|NCT01387139|196577|P1|STARTED|Overall Study||99
82214|NCT01387074|196593|P1|NOT COMPLETED|Overall Study||8
82215|NCT01387074|196593|P1|COMPLETED|Overall Study||100
82216|NCT01387074|196593|P1|STARTED|Overall Study||108
82217|NCT01387022|196606|P2|NOT COMPLETED|Overall Study||4
82218|NCT01387022|196607|P1|NOT COMPLETED|Overall Study||1
82219|NCT01387022|196606|P2|COMPLETED|Overall Study||26
82220|NCT01387022|196607|P1|COMPLETED|Overall Study||28
82221|NCT01387022|196606|P2|STARTED|Overall Study||30
82222|NCT01387022|196607|P1|STARTED|Overall Study||29
82223|NCT01386983|196625|P2|NOT COMPLETED|Overall Study||0
82224|NCT01386983|196626|P1|NOT COMPLETED|Overall Study||0
82225|NCT01386983|196625|P2|COMPLETED|Overall Study||68
82226|NCT01386983|196626|P1|COMPLETED|Overall Study||264
82227|NCT01386983|196625|P2|STARTED|Overall Study||68
82228|NCT01386983|196626|P1|STARTED|Overall Study||264
82229|NCT01386944|196634|P1|NOT COMPLETED|Overall Study||56
82230|NCT01386944|196634|P1|COMPLETED|Overall Study||46
82231|NCT01386944|196634|P1|STARTED|Overall Study||102
82232|NCT01386788|196644|P1|NOT COMPLETED|Overall Study||2
82233|NCT01386788|196644|P1|COMPLETED|Overall Study||100
82234|NCT01386788|196644|P1|STARTED|Overall Study||102
82235|NCT01386632|196651|P2|NOT COMPLETED|Overall Study||4
82236|NCT01386632|196652|P1|NOT COMPLETED|Overall Study||5
82237|NCT01386632|196651|P2|COMPLETED|Overall Study||21
82238|NCT01386632|196652|P1|COMPLETED|Overall Study||20
82239|NCT01386632|196651|P2|STARTED|Overall Study||25
82240|NCT01386632|196652|P1|STARTED|Overall Study||25
82241|NCT01386606|196664|P4|NOT COMPLETED|Overall Study||1
82242|NCT01386606|196665|P3|NOT COMPLETED|Overall Study||3
82243|NCT01386606|196666|P2|NOT COMPLETED|Overall Study||4
82244|NCT01386606|196667|P1|NOT COMPLETED|Overall Study||4
82245|NCT01386606|196664|P4|COMPLETED|Overall Study||13
82246|NCT01386606|196665|P3|COMPLETED|Overall Study||13
82247|NCT01386606|196666|P2|COMPLETED|Overall Study||10
82248|NCT01386606|196667|P1|COMPLETED|Overall Study||12
82249|NCT01386606|196664|P4|STARTED|Overall Study||14
82250|NCT01386606|196665|P3|STARTED|Overall Study||16
82251|NCT01386606|196666|P2|STARTED|Overall Study||14
82252|NCT01386606|196667|P1|STARTED|Overall Study||16
82253|NCT01386528|196695|P1|NOT COMPLETED|Overall Study||0
82254|NCT01386528|196695|P1|COMPLETED|Overall Study||13
82255|NCT01386528|196695|P1|STARTED|Overall Study||13
82256|NCT01386125|196707|P2|NOT COMPLETED|Overall Study||37
82257|NCT01386125|196708|P1|NOT COMPLETED|Overall Study||25
82258|NCT01386125|196707|P2|COMPLETED|Overall Study||336
82259|NCT01386125|196708|P1|COMPLETED|Overall Study||350
82260|NCT01386125|196707|P2|STARTED|Overall Study||373
82261|NCT01386125|196708|P1|STARTED|Overall Study||375
82262|NCT01386008|196716|P1|NOT COMPLETED|Overall Study||20
82263|NCT01386008|196716|P1|COMPLETED|Overall Study||0
82264|NCT01386008|196716|P1|STARTED|Overall Study||20
82265|NCT01385995|196725|P2|NOT COMPLETED|Period 2, 2 Months||0
82266|NCT01385995|196726|P1|NOT COMPLETED|Period 2, 2 Months||0
82267|NCT01385995|196725|P2|COMPLETED|Period 2, 2 Months||25
82268|NCT01385995|196726|P1|COMPLETED|Period 2, 2 Months||24
82269|NCT01385995|196725|P2|STARTED|Period 2, 2 Months||25
82270|NCT01385995|196726|P1|STARTED|Period 2, 2 Months||24
82271|NCT01385995|196725|P2|NOT COMPLETED|Washout Period, 1 Month||0
82272|NCT01385995|196726|P1|NOT COMPLETED|Washout Period, 1 Month||0
82273|NCT01385995|196725|P2|COMPLETED|Washout Period, 1 Month||25
82274|NCT01385995|196726|P1|COMPLETED|Washout Period, 1 Month||24
82275|NCT01385995|196725|P2|STARTED|Washout Period, 1 Month||25
82276|NCT01385995|196726|P1|STARTED|Washout Period, 1 Month||24
82277|NCT01385995|196725|P2|NOT COMPLETED|Period 1, 2 Months||0
82278|NCT01385995|196726|P1|NOT COMPLETED|Period 1, 2 Months||1
82279|NCT01385995|196725|P2|COMPLETED|Period 1, 2 Months||25
82280|NCT01385995|196726|P1|COMPLETED|Period 1, 2 Months||24
82281|NCT01385995|196725|P2|STARTED|Period 1, 2 Months||25
82282|NCT01385995|196726|P1|STARTED|Period 1, 2 Months||25
82283|NCT01385748|196743|P3|NOT COMPLETED|Overall Study||13
82284|NCT01385748|196744|P2|NOT COMPLETED|Overall Study||14
82285|NCT01385748|196745|P1|NOT COMPLETED|Overall Study||15
82286|NCT01385748|196743|P3|COMPLETED|Overall Study||49
82287|NCT01385748|196744|P2|COMPLETED|Overall Study||51
82288|NCT01385748|196745|P1|COMPLETED|Overall Study||41
82289|NCT01385748|196743|P3|STARTED|Overall Study||62
82290|NCT01385748|196744|P2|STARTED|Overall Study||65
82291|NCT01385748|196745|P1|STARTED|Overall Study||56
82292|NCT01385696|196786|P2|NOT COMPLETED|Overall Study||0
82293|NCT01385696|196787|P1|NOT COMPLETED|Overall Study||0
82294|NCT01385696|196786|P2|COMPLETED|Overall Study||64
82295|NCT01385696|196787|P1|COMPLETED|Overall Study||66
82296|NCT01385696|196786|P2|STARTED|Overall Study|1 patient used Handihaler® once only, Genuair® zero times, & was excluded from the safety population|64
82297|NCT01385696|196787|P1|STARTED|Overall Study||66
82298|NCT01385644|196798|P2|NOT COMPLETED|Overall Study||0
82299|NCT01385644|196799|P1|NOT COMPLETED|Overall Study||0
82300|NCT01385644|196798|P2|COMPLETED|Overall Study||4
82301|NCT01385644|196799|P1|COMPLETED|Overall Study||4
82302|NCT01385644|196798|P2|STARTED|Overall Study||4
82303|NCT01385644|196799|P1|STARTED|Overall Study||4
82304|NCT01385579|196813|P2|NOT COMPLETED|Overall Study||0
82305|NCT01385579|196814|P1|NOT COMPLETED|Overall Study||0
82306|NCT01385579|196813|P2|COMPLETED|Overall Study||104
82307|NCT01385579|196814|P1|COMPLETED|Overall Study||98
82308|NCT01385579|196813|P2|STARTED|Overall Study||104
82309|NCT01385579|196814|P1|STARTED|Overall Study||98
82310|NCT01385566|196826|P6|NOT COMPLETED|Overall Study||0
82311|NCT01385566|196827|P5|NOT COMPLETED|Overall Study||0
82312|NCT01385566|196828|P4|NOT COMPLETED|Overall Study||1
82313|NCT01385566|196829|P3|NOT COMPLETED|Overall Study||0
82314|NCT01385566|196830|P2|NOT COMPLETED|Overall Study||0
82315|NCT01385566|196831|P1|NOT COMPLETED|Overall Study||1
82316|NCT01385566|196826|P6|COMPLETED|Overall Study||34
82317|NCT01385566|196827|P5|COMPLETED|Overall Study||34
82318|NCT01385566|196828|P4|COMPLETED|Overall Study||34
82319|NCT01385566|196829|P3|COMPLETED|Overall Study||34
82320|NCT01385566|196830|P2|COMPLETED|Overall Study||34
82321|NCT01385566|196831|P1|COMPLETED|Overall Study||51
82322|NCT01385566|196826|P6|STARTED|Overall Study||34
82323|NCT01385566|196827|P5|STARTED|Overall Study||34
82324|NCT01385566|196828|P4|STARTED|Overall Study||35
82325|NCT01385566|196829|P3|STARTED|Overall Study||34
82326|NCT01385566|196830|P2|STARTED|Overall Study||34
82327|NCT01385566|196831|P1|STARTED|Overall Study||52
82328|NCT01385371|196885|P2|NOT COMPLETED|Overall Study||97
82329|NCT01385371|196886|P1|NOT COMPLETED|Overall Study||149
82330|NCT01385371|196885|P2|COMPLETED|Overall Study||652
82331|NCT01385371|196886|P1|COMPLETED|Overall Study||603
82332|NCT01385371|196885|P2|STARTED|Overall Study||749
82333|NCT01385371|196886|P1|STARTED|Overall Study||752
82334|NCT01385293|196906|P1|NOT COMPLETED|Overall Study||0
82335|NCT01385293|196906|P1|COMPLETED|Overall Study||30
82336|NCT01385293|196906|P1|STARTED|Overall Study||30
82337|NCT01385202|196916|P1|NOT COMPLETED|Overall Study||18
82338|NCT01385202|196916|P1|COMPLETED|Overall Study||154
82339|NCT01385202|196916|P1|Undergoing Ablation|Overall Study||160
82340|NCT01385202|196916|P1|Study Catheter Inserted|Overall Study||161
82341|NCT01385202|196916|P1|STARTED|Overall Study|Per protocol, enrolled subjects were defined as those who signed inform consent form.|172
82342|NCT01385189|196928|P5|NOT COMPLETED|Overall Study||2
82343|NCT01385189|196929|P4|NOT COMPLETED|Overall Study||1
82344|NCT01385189|196930|P3|NOT COMPLETED|Overall Study||0
82345|NCT01385189|196931|P2|NOT COMPLETED|Overall Study||1
82346|NCT01385189|196932|P1|NOT COMPLETED|Overall Study||1
82347|NCT01385189|196928|P5|COMPLETED|Overall Study||6
82348|NCT01385189|196929|P4|COMPLETED|Overall Study||3
82349|NCT01385189|196930|P3|COMPLETED|Overall Study||4
82350|NCT01385189|196931|P2|COMPLETED|Overall Study||11
82351|NCT01385189|196932|P1|COMPLETED|Overall Study||11
82352|NCT01385189|196928|P5|STARTED|Overall Study||8
82353|NCT01385189|196929|P4|STARTED|Overall Study||4
82354|NCT01385189|196930|P3|STARTED|Overall Study||4
82355|NCT01385189|196931|P2|STARTED|Overall Study||12
82356|NCT01385189|196932|P1|STARTED|Overall Study||12
82357|NCT01385137|196953|P2|NOT COMPLETED|Evaluable for Primary Endpoint||24
82358|NCT01385137|196954|P1|NOT COMPLETED|Evaluable for Primary Endpoint||29
82359|NCT01385137|196953|P2|COMPLETED|Evaluable for Primary Endpoint||107
82360|NCT01385137|196954|P1|COMPLETED|Evaluable for Primary Endpoint||102
82361|NCT01385137|196953|P2|STARTED|Evaluable for Primary Endpoint||131
82362|NCT01385137|196954|P1|STARTED|Evaluable for Primary Endpoint||131
82363|NCT01385137|196953|P2|NOT COMPLETED|Evaluable at Baseline||4
82364|NCT01385137|196954|P1|NOT COMPLETED|Evaluable at Baseline||9
82365|NCT01385137|196953|P2|COMPLETED|Evaluable at Baseline||127
82366|NCT01385137|196954|P1|COMPLETED|Evaluable at Baseline||122
82367|NCT01385137|196953|P2|STARTED|Evaluable at Baseline||131
82368|NCT01385137|196954|P1|STARTED|Evaluable at Baseline||131
82369|NCT01385033|196970|P6|NOT COMPLETED|Part III||0
82370|NCT01385033|196971|P5|NOT COMPLETED|Part III||0
82371|NCT01385033|196972|P4|NOT COMPLETED|Part III||0
82372|NCT01385033|196973|P3|NOT COMPLETED|Part III||0
82373|NCT01385033|196974|P2|NOT COMPLETED|Part III||0
82374|NCT01385033|196975|P1|NOT COMPLETED|Part III||0
82375|NCT01385033|196970|P6|COMPLETED|Part III||0
82376|NCT01385033|196971|P5|COMPLETED|Part III||0
82377|NCT01385033|196972|P4|COMPLETED|Part III||0
82378|NCT01385033|196973|P3|COMPLETED|Part III||0
82379|NCT01385033|196974|P2|COMPLETED|Part III||0
82380|NCT01385033|196975|P1|COMPLETED|Part III||0
82381|NCT01385033|196970|P6|STARTED|Part III||0
82382|NCT01385033|196971|P5|STARTED|Part III||0
82383|NCT01385033|196972|P4|STARTED|Part III||0
82384|NCT01385033|196973|P3|STARTED|Part III||0
82385|NCT01385033|196974|P2|STARTED|Part III||0
82386|NCT01385033|196975|P1|STARTED|Part III||0
82387|NCT01385033|196970|P6|NOT COMPLETED|Part II||0
82388|NCT01385033|196971|P5|NOT COMPLETED|Part II||0
82389|NCT01385033|196972|P4|NOT COMPLETED|Part II||0
82390|NCT01385033|196973|P3|NOT COMPLETED|Part II||0
82391|NCT01385033|196974|P2|NOT COMPLETED|Part II||0
82392|NCT01385033|196975|P1|NOT COMPLETED|Part II||0
82393|NCT01385033|196970|P6|COMPLETED|Part II||0
82394|NCT01385033|196971|P5|COMPLETED|Part II||0
82395|NCT01385033|196972|P4|COMPLETED|Part II||0
82396|NCT01385033|196973|P3|COMPLETED|Part II||0
82397|NCT01385033|196974|P2|COMPLETED|Part II||0
82398|NCT01385033|196975|P1|COMPLETED|Part II||0
82399|NCT01385033|196970|P6|STARTED|Part II||0
82400|NCT01385033|196971|P5|STARTED|Part II||0
82401|NCT01385033|196972|P4|STARTED|Part II||0
82402|NCT01385033|196973|P3|STARTED|Part II||0
82403|NCT01385033|196974|P2|STARTED|Part II||0
82404|NCT01385033|196975|P1|STARTED|Part II||0
82405|NCT01385033|196970|P6|NOT COMPLETED|Part I||0
82406|NCT01385033|196971|P5|NOT COMPLETED|Part I||0
82407|NCT01385033|196972|P4|NOT COMPLETED|Part I||0
82408|NCT01385033|196973|P3|NOT COMPLETED|Part I||0
82409|NCT01385033|196974|P2|NOT COMPLETED|Part I||0
82410|NCT01385033|196975|P1|NOT COMPLETED|Part I||0
82411|NCT01385033|196970|P6|COMPLETED|Part I||0
82412|NCT01385033|196971|P5|COMPLETED|Part I||0
82413|NCT01385033|196972|P4|COMPLETED|Part I||0
82414|NCT01385033|196973|P3|COMPLETED|Part I||0
82415|NCT01385033|196974|P2|COMPLETED|Part I||14
82416|NCT01385033|196975|P1|COMPLETED|Part I||6
82417|NCT01385033|196970|P6|STARTED|Part I||0
82418|NCT01385033|196971|P5|STARTED|Part I||0
82419|NCT01385033|196972|P4|STARTED|Part I||0
82420|NCT01385033|196973|P3|STARTED|Part I||0
82421|NCT01385033|196974|P2|STARTED|Part I|These subjects did not participate in Part II or III|14
82422|NCT01385033|196975|P1|STARTED|Part I|These subjects did not participate in Part II or III|6
82423|NCT01384760|196984|P2|NOT COMPLETED|Overall Study||6
82424|NCT01384760|196985|P1|NOT COMPLETED|Overall Study||16
82425|NCT01384760|196984|P2|COMPLETED|Overall Study||37
82426|NCT01384760|196985|P1|COMPLETED|Overall Study||45
82427|NCT01384760|196984|P2|Randomized|Overall Study||43
82428|NCT01384760|196985|P1|Randomized|Overall Study||61
82429|NCT01384760|196984|P2|STARTED|Overall Study||43
82430|NCT01384760|196985|P1|STARTED|Overall Study||61
82431|NCT01384539|196995|P2|NOT COMPLETED|Overall Study||7
82432|NCT01384539|196996|P1|NOT COMPLETED|Overall Study||6
82433|NCT01384539|196995|P2|COMPLETED|Overall Study||57
82434|NCT01384539|196996|P1|COMPLETED|Overall Study||58
82435|NCT01384539|196995|P2|STARTED|Overall Study||64
82436|NCT01384539|196996|P1|STARTED|Overall Study||64
82437|NCT01384292|197005|P3|NOT COMPLETED|Part B||0
82438|NCT01384292|197006|P2|NOT COMPLETED|Part B||0
82439|NCT01384292|197007|P1|NOT COMPLETED|Part B||1
82440|NCT01384292|197005|P3|COMPLETED|Part B||0
82441|NCT01384292|197006|P2|COMPLETED|Part B||6
82442|NCT01384292|197007|P1|COMPLETED|Part B||2
82443|NCT01384292|197005|P3|STARTED|Part B||0
82444|NCT01384292|197006|P2|STARTED|Part B||6
82445|NCT01384292|197007|P1|STARTED|Part B||3
82446|NCT01384292|197005|P3|NOT COMPLETED|Part A||0
82447|NCT01384292|197006|P2|NOT COMPLETED|Part A||0
82448|NCT01384292|197007|P1|NOT COMPLETED|Part A||0
82449|NCT01384292|197005|P3|COMPLETED|Part A||4
82450|NCT01384292|197006|P2|COMPLETED|Part A||5
82451|NCT01384292|197007|P1|COMPLETED|Part A||5
82452|NCT01384292|197005|P3|STARTED|Part A||4
82453|NCT01384292|197006|P2|STARTED|Part A||5
82454|NCT01384292|197007|P1|STARTED|Part A||5
82455|NCT01384019|197019|P2|NOT COMPLETED|Overall Study||6
82456|NCT01384019|197020|P1|NOT COMPLETED|Overall Study||10
82457|NCT01384019|197019|P2|COMPLETED|Overall Study||55
82458|NCT01384019|197020|P1|COMPLETED|Overall Study||55
82459|NCT01384019|197019|P2|STARTED|Overall Study||61
82460|NCT01384019|197020|P1|STARTED|Overall Study||65
82461|NCT01383993|197029|P3|NOT COMPLETED|Overall Study||1
82462|NCT01383993|197030|P2|NOT COMPLETED|Overall Study||1
82463|NCT01383993|197031|P1|NOT COMPLETED|Overall Study||3
82464|NCT01383993|197029|P3|COMPLETED|Overall Study||1
82465|NCT01383993|197030|P2|COMPLETED|Overall Study||3
82466|NCT01383993|197031|P1|COMPLETED|Overall Study||12
82467|NCT01383993|197029|P3|STARTED|Overall Study||2
82468|NCT01383993|197030|P2|STARTED|Overall Study||4
82469|NCT01383993|197031|P1|STARTED|Overall Study||15
82470|NCT01383954|197078|P1|NOT COMPLETED|Overall Study||14
82471|NCT01383954|197078|P1|COMPLETED|Overall Study||38
82472|NCT01383954|197078|P1|Safety Population: Received Treatment|Overall Study||48
82473|NCT01383954|197078|P1|STARTED|Overall Study||52
82474|NCT01383928|197086|P3|NOT COMPLETED|Phase 2||40
82475|NCT01383928|197087|P2|NOT COMPLETED|Phase 2||0
82476|NCT01383928|197088|P1|NOT COMPLETED|Phase 2||0
82477|NCT01383928|197086|P3|COMPLETED|Phase 2||10
82478|NCT01383928|197087|P2|COMPLETED|Phase 2||0
82479|NCT01383928|197088|P1|COMPLETED|Phase 2||0
82480|NCT01383928|197086|P3|STARTED|Phase 2||50
82481|NCT01383928|197087|P2|STARTED|Phase 2||0
82482|NCT01383928|197088|P1|STARTED|Phase 2||0
82483|NCT01383928|197086|P3|NOT COMPLETED|Phase 1||0
82484|NCT01383928|197087|P2|NOT COMPLETED|Phase 1||7
82485|NCT01383928|197088|P1|NOT COMPLETED|Phase 1||5
82486|NCT01383928|197086|P3|COMPLETED|Phase 1||0
82487|NCT01383928|197087|P2|COMPLETED|Phase 1||0
82488|NCT01383928|197088|P1|COMPLETED|Phase 1||2
82489|NCT01383928|197086|P3|STARTED|Phase 1||0
82490|NCT01383928|197087|P2|STARTED|Phase 1||7
82491|NCT01383928|197088|P1|STARTED|Phase 1||7
82492|NCT01383720|197130|P1|NOT COMPLETED|Overall Study||0
82493|NCT01383720|197130|P1|COMPLETED|Overall Study|Study is continuing to 5 years. All patients are still in the study.|11
82494|NCT01383720|197130|P1|Primary Endpoint (Discharge/7 Days)|Overall Study||11
82495|NCT01383720|197130|P1|STARTED|Overall Study||11
82496|NCT01383707|197152|P1|NOT COMPLETED|Overall Study||72
82497|NCT01383707|197152|P1|COMPLETED|Overall Study||5
82498|NCT01383707|197152|P1|STARTED|Overall Study||77
82499|NCT01383681|197161|P1|NOT COMPLETED|Overall Study||46
82500|NCT01383681|197161|P1|COMPLETED|Overall Study||189
82501|NCT01383681|197161|P1|STARTED|Overall Study||235
82502|NCT01383616|197168|P2|NOT COMPLETED|Overall Study||23
82503|NCT01383616|197169|P1|NOT COMPLETED|Overall Study||17
82504|NCT01383616|197168|P2|COMPLETED|Overall Study||21
82505|NCT01383616|197169|P1|COMPLETED|Overall Study||23
82506|NCT01383616|197168|P2|STARTED|Overall Study||44
82507|NCT01383616|197169|P1|STARTED|Overall Study||40
82508|NCT01383499|197192|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
82509|NCT01383499|197193|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
82510|NCT01383499|197194|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
82511|NCT01383499|197195|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
82512|NCT01383499|197192|P4|COMPLETED|Period 3 (4 Weeks)||25
82513|NCT01383499|197193|P3|COMPLETED|Period 3 (4 Weeks)||25
82514|NCT01383499|197194|P2|COMPLETED|Period 3 (4 Weeks)||24
82515|NCT01383499|197195|P1|COMPLETED|Period 3 (4 Weeks)||26
82516|NCT01383499|197192|P4|STARTED|Period 3 (4 Weeks)||25
82517|NCT01383499|197193|P3|STARTED|Period 3 (4 Weeks)||25
82518|NCT01383499|197194|P2|STARTED|Period 3 (4 Weeks)||24
82519|NCT01383499|197195|P1|STARTED|Period 3 (4 Weeks)||26
82520|NCT01383499|197192|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
82521|NCT01383499|197193|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
82522|NCT01383499|197194|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
82523|NCT01383499|197195|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
82524|NCT01383499|197192|P4|COMPLETED|Period 2 (4 Weeks)||25
82525|NCT01383499|197193|P3|COMPLETED|Period 2 (4 Weeks)||25
82526|NCT01383499|197194|P2|COMPLETED|Period 2 (4 Weeks)||24
82527|NCT01383499|197195|P1|COMPLETED|Period 2 (4 Weeks)||26
82528|NCT01383499|197192|P4|STARTED|Period 2 (4 Weeks)||25
82529|NCT01383499|197193|P3|STARTED|Period 2 (4 Weeks)||25
82530|NCT01383499|197194|P2|STARTED|Period 2 (4 Weeks)||24
82531|NCT01383499|197195|P1|STARTED|Period 2 (4 Weeks)||26
82532|NCT01383499|197192|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
82533|NCT01383499|197193|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
82534|NCT01383499|197194|P2|NOT COMPLETED|Period 1 (4 Weeks)||0
82535|NCT01383499|197195|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
82536|NCT01383499|197192|P4|COMPLETED|Period 1 (4 Weeks)||25
82537|NCT01383499|197193|P3|COMPLETED|Period 1 (4 Weeks)||25
82538|NCT01383499|197194|P2|COMPLETED|Period 1 (4 Weeks)||24
82539|NCT01383499|197195|P1|COMPLETED|Period 1 (4 Weeks)||26
82540|NCT01383499|197192|P4|STARTED|Period 1 (4 Weeks)||25
82541|NCT01383499|197193|P3|STARTED|Period 1 (4 Weeks)||25
82542|NCT01383499|197194|P2|STARTED|Period 1 (4 Weeks)||24
82543|NCT01383499|197195|P1|STARTED|Period 1 (4 Weeks)||27
82544|NCT01383486|197245|P1|NOT COMPLETED|Overall Study||18
82545|NCT01383486|197245|P1|COMPLETED|Overall Study|Took any study medication and gave estimated duration of pain (Selection Evaluation Population)|235
82546|NCT01383486|197245|P1|Treated|Overall Study|Number of participants who took any study medication (Safety Population)|237
82547|NCT01383486|197245|P1|STARTED|Overall Study|Number of participants who were provided with investigational products|253
82548|NCT01383447|197251|P1|NOT COMPLETED|Overall Study||2
82549|NCT01383447|197251|P1|COMPLETED|Overall Study||0
82550|NCT01383447|197251|P1|STARTED|Overall Study||2
82551|NCT01383421|197259|P1|NOT COMPLETED|Overall Study||346
82552|NCT01383421|197259|P1|COMPLETED|Overall Study||679
82553|NCT01383421|197259|P1|STARTED|Overall Study|ITT population: all enrolled participants who received at least 1 dose of study drug.|1025
82554|NCT01383356|197322|P2|NOT COMPLETED|Period 2||0
82555|NCT01383356|197323|P1|NOT COMPLETED|Period 2||0
82556|NCT01383356|197322|P2|COMPLETED|Period 2|Completed period 2.|23
82557|NCT01383356|197323|P1|COMPLETED|Period 2|Completed period 2.|21
82558|NCT01383356|197322|P2|STARTED|Period 2|Entered and treated.|23
82559|NCT01383356|197323|P1|STARTED|Period 2|Entered and treated.|21
82560|NCT01383356|197322|P2|NOT COMPLETED|Washout Period (at Least 35 Days)||0
82561|NCT01383356|197323|P1|NOT COMPLETED|Washout Period (at Least 35 Days)||0
82562|NCT01383356|197322|P2|COMPLETED|Washout Period (at Least 35 Days)||23
82563|NCT01383356|197323|P1|COMPLETED|Washout Period (at Least 35 Days)||21
82564|NCT01383356|197322|P2|STARTED|Washout Period (at Least 35 Days)||23
82565|NCT01383356|197323|P1|STARTED|Washout Period (at Least 35 Days)||21
82566|NCT01383356|197322|P2|NOT COMPLETED|Period 1||6
82567|NCT01383356|197323|P1|NOT COMPLETED|Period 1||8
82568|NCT01383356|197322|P2|COMPLETED|Period 1|Completed period 1.|23
82569|NCT01383356|197323|P1|COMPLETED|Period 1|Completed period 1.|21
82570|NCT01383356|197322|P2|STARTED|Period 1|Entered and treated.|29
82571|NCT01383356|197323|P1|STARTED|Period 1|Entered and treated.|29
82572|NCT01383213|197335|P2|NOT COMPLETED|Overall Study||0
82573|NCT01383213|197336|P1|NOT COMPLETED|Overall Study||0
82574|NCT01383213|197335|P2|COMPLETED|Overall Study||41
82575|NCT01383213|197336|P1|COMPLETED|Overall Study||40
82576|NCT01383213|197335|P2|STARTED|Overall Study||41
82577|NCT01383213|197336|P1|STARTED|Overall Study||40
82578|NCT01383200|197344|P2|NOT COMPLETED|Overall Study||0
82579|NCT01383200|197345|P1|NOT COMPLETED|Overall Study||0
82580|NCT01383200|197344|P2|COMPLETED|Overall Study||6
82581|NCT01383200|197345|P1|COMPLETED|Overall Study||5
82582|NCT01383200|197344|P2|STARTED|Overall Study||6
82583|NCT01383200|197345|P1|STARTED|Overall Study||5
82584|NCT01383174|197353|P2|NOT COMPLETED|6 Month Assessment||1
82585|NCT01383174|197354|P1|NOT COMPLETED|6 Month Assessment||5
82586|NCT01383174|197353|P2|COMPLETED|6 Month Assessment|These 73 completed the 6 month assessment and completed the study.|73
82587|NCT01383174|197354|P1|COMPLETED|6 Month Assessment|These 71 completed the 6 month assessment and completed the study.|71
82588|NCT01383174|197353|P2|STARTED|6 Month Assessment||74
82589|NCT01383174|197354|P1|STARTED|6 Month Assessment|All 76 people were contacted at 6 months;1 person returned and 5 did not return to study at 6 months|76
82590|NCT01383174|197353|P2|NOT COMPLETED|3 Month Assessment||1
82591|NCT01383174|197354|P1|NOT COMPLETED|3 Month Assessment||6
82592|NCT01383174|197353|P2|COMPLETED|3 Month Assessment|These 74 completed the 3 month assessment and continued in the study.|74
82593|NCT01383174|197354|P1|COMPLETED|3 Month Assessment|These 70 completed the 3 month assessment and continued in the study.|70
82594|NCT01383174|197353|P2|STARTED|3 Month Assessment||75
82595|NCT01383174|197354|P1|STARTED|3 Month Assessment||76
82596|NCT01383174|197353|P2|NOT COMPLETED|Baseline Assessment||0
82597|NCT01383174|197354|P1|NOT COMPLETED|Baseline Assessment||0
82598|NCT01383174|197353|P2|COMPLETED|Baseline Assessment|These 75 completed the baseline assessment and continued in the study.|75
82599|NCT01383174|197354|P1|COMPLETED|Baseline Assessment|These 76 completed the baseline assessment and continued in the study.|76
82600|NCT01383174|197353|P2|STARTED|Baseline Assessment||75
82601|NCT01383174|197354|P1|STARTED|Baseline Assessment||76
82602|NCT01383096|197381|P3|NOT COMPLETED|Fifth Intervention (8 Days)||0
82603|NCT01383096|197382|P2|NOT COMPLETED|Fifth Intervention (8 Days)||0
82604|NCT01383096|197383|P1|NOT COMPLETED|Fifth Intervention (8 Days)||2
82605|NCT01383096|197381|P3|COMPLETED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
82606|NCT01383096|197382|P2|COMPLETED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
82607|NCT01383096|197383|P1|COMPLETED|Fifth Intervention (8 Days)||11
82608|NCT01383096|197381|P3|STARTED|Fifth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
82609|NCT01383096|197382|P2|STARTED|Fifth Intervention (8 Days)|Only 4 interventions in Cohort 2.|0
82610|NCT01383096|197383|P1|STARTED|Fifth Intervention (8 Days)||13
82611|NCT01383096|197381|P3|NOT COMPLETED|Fourth Intervention (8 Days)||0
82612|NCT01383096|197382|P2|NOT COMPLETED|Fourth Intervention (8 Days)||0
82613|NCT01383096|197383|P1|NOT COMPLETED|Fourth Intervention (8 Days)||2
82614|NCT01383096|197381|P3|COMPLETED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
82615|NCT01383096|197382|P2|COMPLETED|Fourth Intervention (8 Days)||12
82616|NCT01383096|197383|P1|COMPLETED|Fourth Intervention (8 Days)||13
82617|NCT01383096|197381|P3|STARTED|Fourth Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
82618|NCT01383096|197382|P2|STARTED|Fourth Intervention (8 Days)||12
82619|NCT01383096|197383|P1|STARTED|Fourth Intervention (8 Days)||15
82620|NCT01383096|197381|P3|NOT COMPLETED|Third Intervention (8 Days)||0
82621|NCT01383096|197382|P2|NOT COMPLETED|Third Intervention (8 Days)||4
82622|NCT01383096|197383|P1|NOT COMPLETED|Third Intervention (8 Days)||4
82623|NCT01383096|197381|P3|COMPLETED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
82624|NCT01383096|197382|P2|COMPLETED|Third Intervention (8 Days)||12
82625|NCT01383096|197383|P1|COMPLETED|Third Intervention (8 Days)||15
82626|NCT01383096|197381|P3|STARTED|Third Intervention (8 Days)|Only 2 interventions in Cohort 3.|0
82627|NCT01383096|197382|P2|STARTED|Third Intervention (8 Days)||16
82628|NCT01383096|197383|P1|STARTED|Third Intervention (8 Days)||19
82629|NCT01383096|197381|P3|NOT COMPLETED|Second Intervention (8 Days)||2
82630|NCT01383096|197382|P2|NOT COMPLETED|Second Intervention (8 Days)||1
82631|NCT01383096|197383|P1|NOT COMPLETED|Second Intervention (8 Days)||0
82632|NCT01383096|197381|P3|COMPLETED|Second Intervention (8 Days)||14
82633|NCT01383096|197382|P2|COMPLETED|Second Intervention (8 Days)||16
82634|NCT01383096|197383|P1|COMPLETED|Second Intervention (8 Days)||19
82635|NCT01383096|197381|P3|STARTED|Second Intervention (8 Days)||16
82636|NCT01383096|197382|P2|STARTED|Second Intervention (8 Days)||17
82637|NCT01383096|197383|P1|STARTED|Second Intervention (8 Days)||19
82638|NCT01383096|197381|P3|NOT COMPLETED|First Intervention (8 Days)||0
82639|NCT01383096|197382|P2|NOT COMPLETED|First Intervention (8 Days)||0
82640|NCT01383096|197383|P1|NOT COMPLETED|First Intervention (8 Days)||0
82641|NCT01383096|197381|P3|COMPLETED|First Intervention (8 Days)||16
82642|NCT01383096|197382|P2|COMPLETED|First Intervention (8 Days)||17
82643|NCT01383096|197383|P1|COMPLETED|First Intervention (8 Days)||19
82644|NCT01383096|197381|P3|STARTED|First Intervention (8 Days)||16
82645|NCT01383096|197382|P2|STARTED|First Intervention (8 Days)||17
82646|NCT01383096|197383|P1|STARTED|First Intervention (8 Days)||19
82647|NCT01383005|197431|P2|NOT COMPLETED|Overall Study||0
82648|NCT01383005|197432|P1|NOT COMPLETED|Overall Study||0
82649|NCT01383005|197431|P2|COMPLETED|Overall Study||60
82650|NCT01383005|197432|P1|COMPLETED|Overall Study||34
82651|NCT01383005|197431|P2|STARTED|Overall Study||60
82652|NCT01383005|197432|P1|STARTED|Overall Study||34
82653|NCT01382940|197451|P1|NOT COMPLETED|Overall Study||73
82654|NCT01382940|197451|P1|COMPLETED|Overall Study||278
82655|NCT01382940|197451|P1|Received Day 182 Infusion|Overall Study||278
82656|NCT01382940|197451|P1|Received Day 168 Infusion|Overall Study||290
82657|NCT01382940|197451|P1|Received Day 15 Infusions|Overall Study||341
82658|NCT01382940|197451|P1|Received Day 1 Infusion|Overall Study||351
82659|NCT01382940|197451|P1|STARTED|Overall Study||351
82660|NCT01382901|197463|P2|NOT COMPLETED|Overall Study||14
82661|NCT01382901|197464|P1|NOT COMPLETED|Overall Study||17
82662|NCT01382901|197463|P2|COMPLETED|Overall Study||7
82663|NCT01382901|197464|P1|COMPLETED|Overall Study||7
82664|NCT01382901|197463|P2|STARTED|Overall Study||21
82665|NCT01382901|197464|P1|STARTED|Overall Study||24
82666|NCT01382719|197474|P4|NOT COMPLETED|Overall Study||33
82667|NCT01382719|197475|P3|NOT COMPLETED|Overall Study||34
82668|NCT01382719|197476|P2|NOT COMPLETED|Overall Study||19
82669|NCT01382719|197477|P1|NOT COMPLETED|Overall Study||18
82670|NCT01382719|197474|P4|COMPLETED|Overall Study||66
82671|NCT01382719|197475|P3|COMPLETED|Overall Study||66
82672|NCT01382719|197476|P2|COMPLETED|Overall Study||81
82673|NCT01382719|197477|P1|COMPLETED|Overall Study||80
82674|NCT01382719|197474|P4|Subjects Not Dosed|Overall Study||1
82675|NCT01382719|197475|P3|Subjects Not Dosed|Overall Study||1
82676|NCT01382719|197476|P2|Subjects Not Dosed|Overall Study||0
82677|NCT01382719|197477|P1|Subjects Not Dosed|Overall Study||1
82678|NCT01382719|197474|P4|STARTED|Overall Study||99
82679|NCT01382719|197475|P3|STARTED|Overall Study||100
82680|NCT01382719|197476|P2|STARTED|Overall Study||100
82681|NCT01382719|197477|P1|STARTED|Overall Study||98
82682|NCT01382446|197513|P2|NOT COMPLETED|Overall Study||4
82683|NCT01382446|197514|P1|NOT COMPLETED|Overall Study||3
82684|NCT01382446|197513|P2|COMPLETED|Overall Study||29
82685|NCT01382446|197514|P1|COMPLETED|Overall Study||30
82686|NCT01382446|197513|P2|STARTED|Overall Study||33
82687|NCT01382446|197514|P1|STARTED|Overall Study||33
82688|NCT01382303|197522|P2|NOT COMPLETED|Overall Study||17
82689|NCT01382303|197523|P1|NOT COMPLETED|Overall Study||35
82690|NCT01382303|197522|P2|COMPLETED|Overall Study||70
82691|NCT01382303|197523|P1|COMPLETED|Overall Study||52
82692|NCT01382303|197522|P2|STARTED|Overall Study||87
82693|NCT01382303|197523|P1|STARTED|Overall Study||87
82694|NCT01382251|197541|P2|NOT COMPLETED|Overall Study||21
82695|NCT01382251|197542|P1|NOT COMPLETED|Overall Study||21
82696|NCT01382251|197541|P2|COMPLETED|Overall Study||102
82697|NCT01382251|197542|P1|COMPLETED|Overall Study||102
82698|NCT01382251|197541|P2|STARTED|Overall Study||123
82699|NCT01382251|197542|P1|STARTED|Overall Study||123
82700|NCT01382225|197555|P2|NOT COMPLETED|Overall Study||7
82701|NCT01382225|197556|P1|NOT COMPLETED|Overall Study||14
82702|NCT01382225|197555|P2|COMPLETED|Overall Study||722
82703|NCT01382225|197556|P1|COMPLETED|Overall Study||711
82704|NCT01382225|197555|P2|STARTED|Overall Study||729
82705|NCT01382225|197556|P1|STARTED|Overall Study||725
82706|NCT01382212|197578|P1|NOT COMPLETED|Overall Study||2
82707|NCT01382212|197578|P1|COMPLETED|Overall Study||11
82708|NCT01382212|197578|P1|STARTED|Overall Study||13
82709|NCT01382186|197604|P2|NOT COMPLETED|Overall Study||0
82710|NCT01382186|197605|P1|NOT COMPLETED|Overall Study||1
82711|NCT01382186|197604|P2|COMPLETED|Overall Study||819
82712|NCT01382186|197605|P1|COMPLETED|Overall Study||32
82713|NCT01382186|197604|P2|STARTED|Overall Study||819
82714|NCT01382186|197605|P1|STARTED|Overall Study||33
82715|NCT01382108|197621|P2|NOT COMPLETED|Overall Study||0
82716|NCT01382108|197622|P1|NOT COMPLETED|Overall Study||0
82717|NCT01382108|197621|P2|COMPLETED|Overall Study||19
82718|NCT01382108|197622|P1|COMPLETED|Overall Study||20
82719|NCT01382108|197621|P2|STARTED|Overall Study||19
82720|NCT01382108|197622|P1|STARTED|Overall Study||20
82721|NCT01381952|197632|P1|NOT COMPLETED|Overall Study||0
82722|NCT01381952|197632|P1|COMPLETED|Overall Study||20
82723|NCT01381952|197632|P1|Collected Dose and Image Information|Overall Study||20
82724|NCT01381952|197632|P1|STARTED|Overall Study||20
82725|NCT01381926|197641|P2|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
82726|NCT01381926|197642|P1|NOT COMPLETED|Low/High Dose of 2nd Treatment (2months)||0
82727|NCT01381926|197641|P2|COMPLETED|Low/High Dose of 2nd Treatment (2months)||4
82728|NCT01381926|197642|P1|COMPLETED|Low/High Dose of 2nd Treatment (2months)||3
82729|NCT01381926|197641|P2|STARTED|Low/High Dose of 2nd Treatment (2months)||4
82730|NCT01381926|197642|P1|STARTED|Low/High Dose of 2nd Treatment (2months)||3
82731|NCT01381926|197641|P2|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||1
82732|NCT01381926|197642|P1|NOT COMPLETED|Low/High Dose of 1st Treatment (2months)||2
82733|NCT01381926|197641|P2|COMPLETED|Low/High Dose of 1st Treatment (2months)||4
82734|NCT01381926|197642|P1|COMPLETED|Low/High Dose of 1st Treatment (2months)||3
82735|NCT01381926|197641|P2|STARTED|Low/High Dose of 1st Treatment (2months)||5
82736|NCT01381926|197642|P1|STARTED|Low/High Dose of 1st Treatment (2months)||5
82737|NCT01381900|197655|P3|NOT COMPLETED|Overall Study||12
82738|NCT01381900|197656|P2|NOT COMPLETED|Overall Study||9
82739|NCT01381900|197657|P1|NOT COMPLETED|Overall Study||9
82740|NCT01381900|197655|P3|COMPLETED|Overall Study||215
82741|NCT01381900|197656|P2|COMPLETED|Overall Study||214
82742|NCT01381900|197657|P1|COMPLETED|Overall Study||217
82743|NCT01381900|197655|P3|STARTED|Overall Study||227
82744|NCT01381900|197656|P2|STARTED|Overall Study||223
82745|NCT01381900|197657|P1|STARTED|Overall Study||226
82746|NCT01380782|197679|P4|NOT COMPLETED|Overall Study||4
82747|NCT01380782|197680|P3|NOT COMPLETED|Overall Study||11
82748|NCT01380782|197681|P2|NOT COMPLETED|Overall Study||10
82749|NCT01380782|197682|P1|NOT COMPLETED|Overall Study||12
82750|NCT01380782|197679|P4|COMPLETED|Overall Study||0
82751|NCT01380782|197680|P3|COMPLETED|Overall Study||0
82752|NCT01380782|197681|P2|COMPLETED|Overall Study||0
82753|NCT01380782|197682|P1|COMPLETED|Overall Study||0
82754|NCT01380782|197679|P4|STARTED|Overall Study||4
82755|NCT01380782|197680|P3|STARTED|Overall Study||11
82756|NCT01380782|197681|P2|STARTED|Overall Study||10
82757|NCT01380782|197682|P1|STARTED|Overall Study||12
82758|NCT01380769|197705|P2|NOT COMPLETED|Overall Study||14
82759|NCT01380769|197706|P1|NOT COMPLETED|Overall Study||9
82760|NCT01380769|197705|P2|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|43
82761|NCT01380769|197706|P1|COMPLETED|Overall Study|subjects in ITT with reported date of death, alive with progression, or alive without progression|91
82762|NCT01380769|197705|P2|STARTED|Overall Study||57
82763|NCT01380769|197706|P1|STARTED|Overall Study||100
82764|NCT01380730|197722|P8|NOT COMPLETED|Overall Study||0
82765|NCT01380730|197723|P7|NOT COMPLETED|Overall Study||0
82766|NCT01380730|197724|P6|NOT COMPLETED|Overall Study||0
82767|NCT01380730|197725|P5|NOT COMPLETED|Overall Study||1
82768|NCT01380730|197726|P4|NOT COMPLETED|Overall Study||0
82769|NCT01380730|197727|P3|NOT COMPLETED|Overall Study||0
82770|NCT01380730|197728|P2|NOT COMPLETED|Overall Study||0
82771|NCT01380730|197729|P1|NOT COMPLETED|Overall Study||0
82772|NCT01380730|197722|P8|COMPLETED|Overall Study||80
82773|NCT01380730|197723|P7|COMPLETED|Overall Study||79
82774|NCT01380730|197724|P6|COMPLETED|Overall Study||79
82775|NCT01380730|197725|P5|COMPLETED|Overall Study||77
82776|NCT01380730|197726|P4|COMPLETED|Overall Study||79
82777|NCT01380730|197727|P3|COMPLETED|Overall Study||79
82778|NCT01380730|197728|P2|COMPLETED|Overall Study||79
82779|NCT01380730|197729|P1|COMPLETED|Overall Study||78
82780|NCT01380730|197722|P8|Received Treatment|Overall Study||80
82781|NCT01380730|197723|P7|Received Treatment|Overall Study||79
82782|NCT01380730|197724|P6|Received Treatment|Overall Study||79
82783|NCT01380730|197725|P5|Received Treatment|Overall Study||78
82784|NCT01380730|197726|P4|Received Treatment|Overall Study||79
82785|NCT01380730|197727|P3|Received Treatment|Overall Study||79
82786|NCT01380730|197728|P2|Received Treatment|Overall Study|2 participants did not receive treatment but were followed until the end of study|77
82787|NCT01380730|197729|P1|Received Treatment|Overall Study||78
82788|NCT01380730|197722|P8|STARTED|Overall Study||80
82789|NCT01380730|197723|P7|STARTED|Overall Study||79
82790|NCT01380730|197724|P6|STARTED|Overall Study||79
82791|NCT01380730|197725|P5|STARTED|Overall Study||78
82792|NCT01380730|197726|P4|STARTED|Overall Study||79
82793|NCT01380730|197727|P3|STARTED|Overall Study||79
82794|NCT01380730|197728|P2|STARTED|Overall Study||79
82795|NCT01380730|197729|P1|STARTED|Overall Study||78
82796|NCT01381679|197787|P1|NOT COMPLETED|Overall Study||888
82797|NCT01381679|197787|P1|COMPLETED|Overall Study||794
82798|NCT01381679|197787|P1|STARTED|Overall Study||1682
82799|NCT01381575|197802|P3|NOT COMPLETED|Overall Study||7
82800|NCT01381575|197803|P2|NOT COMPLETED|Overall Study||10
82801|NCT01381575|197804|P1|NOT COMPLETED|Overall Study||2
82802|NCT01381575|197802|P3|COMPLETED|Overall Study||408
82803|NCT01381575|197803|P2|COMPLETED|Overall Study||472
82804|NCT01381575|197804|P1|COMPLETED|Overall Study||548
82805|NCT01381575|197802|P3|STARTED|Overall Study||415
82806|NCT01381575|197803|P2|STARTED|Overall Study||482
82807|NCT01381575|197804|P1|STARTED|Overall Study||550
82808|NCT01381471|197858|P1|NOT COMPLETED|Overall Study||0
82809|NCT01381471|197858|P1|COMPLETED|Overall Study||11060
82810|NCT01381471|197858|P1|STARTED|Overall Study||11060
82811|NCT01381406|197865|P2|NOT COMPLETED|Overall Study||0
82812|NCT01381406|197866|P1|NOT COMPLETED|Overall Study||0
82813|NCT01381406|197865|P2|COMPLETED|Overall Study||852
82814|NCT01381406|197866|P1|COMPLETED|Overall Study||2481
82815|NCT01381406|197865|P2|STARTED|Overall Study||852
82816|NCT01381406|197866|P1|STARTED|Overall Study||2481
82817|NCT01381120|197878|P2|NOT COMPLETED|Overall Study||9
82818|NCT01381120|197879|P1|NOT COMPLETED|Overall Study||11
82819|NCT01381120|197878|P2|COMPLETED|Overall Study||18
82820|NCT01381120|197879|P1|COMPLETED|Overall Study||39
82821|NCT01381120|197878|P2|STARTED|Overall Study||27
82822|NCT01381120|197879|P1|STARTED|Overall Study||50
82823|NCT01381016|197889|P2|NOT COMPLETED|Overall Study||6
82824|NCT01381016|197890|P1|NOT COMPLETED|Overall Study||3
82825|NCT01381016|197889|P2|COMPLETED|Overall Study||11
82826|NCT01381016|197890|P1|COMPLETED|Overall Study||10
82827|NCT01381016|197889|P2|STARTED|Overall Study||17
82828|NCT01381016|197890|P1|STARTED|Overall Study||13
82829|NCT01380834|197900|P2|NOT COMPLETED|Overall Study||0
82830|NCT01380834|197901|P1|NOT COMPLETED|Overall Study||1
82831|NCT01380834|197900|P2|COMPLETED|Overall Study||42
82832|NCT01380834|197901|P1|COMPLETED|Overall Study||41
82833|NCT01380834|197900|P2|STARTED|Overall Study||42
82834|NCT01380834|197901|P1|STARTED|Overall Study||42
82835|NCT01380639|197913|P2|NOT COMPLETED|Overall Study||4
82836|NCT01380639|197914|P1|NOT COMPLETED|Overall Study||6
82837|NCT01380639|197913|P2|COMPLETED|Overall Study||36
82838|NCT01380639|197914|P1|COMPLETED|Overall Study||36
82839|NCT01380639|197913|P2|STARTED|Overall Study||40
82840|NCT01380639|197914|P1|STARTED|Overall Study||42
82841|NCT01380379|197920|P1|NOT COMPLETED|Overall Study||1
82842|NCT01380379|197920|P1|COMPLETED|Overall Study||8
82843|NCT01380379|197920|P1|STARTED|Overall Study||9
82844|NCT01380366|197925|P1|NOT COMPLETED|Overall Study||0
82845|NCT01380366|197925|P1|COMPLETED|Overall Study||15
82846|NCT01380366|197925|P1|STARTED|Overall Study||15
82847|NCT01380327|197933|P3|NOT COMPLETED|Overall Study||7
82848|NCT01380327|197934|P2|NOT COMPLETED|Overall Study||3
82849|NCT01380327|197935|P1|NOT COMPLETED|Overall Study||3
82850|NCT01380327|197933|P3|COMPLETED|Overall Study||21
82851|NCT01380327|197934|P2|COMPLETED|Overall Study||28
82852|NCT01380327|197935|P1|COMPLETED|Overall Study||27
82853|NCT01380327|197933|P3|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|28
82854|NCT01380327|197934|P2|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|31
82855|NCT01380327|197935|P1|STARTED|Overall Study|Number in intent-to-treat having reached maximum tolerated dose with =/> 1 one post-baseline measure|30
82856|NCT01380197|197957|P2|NOT COMPLETED|Overall Study||0
82857|NCT01380197|197958|P1|NOT COMPLETED|Overall Study||0
82858|NCT01380197|197957|P2|COMPLETED|Overall Study||20
82859|NCT01380197|197958|P1|COMPLETED|Overall Study||20
82860|NCT01380197|197957|P2|STARTED|Overall Study||20
82861|NCT01380197|197958|P1|STARTED|Overall Study||20
82862|NCT01380145|197966|P1|NOT COMPLETED|Overall Study||4
82863|NCT01380145|197966|P1|COMPLETED|Overall Study||9
82864|NCT01380145|197966|P1|STARTED|Overall Study||13
82865|NCT01380093|197974|P9|NOT COMPLETED|Treatment Phase: Third Intervention||2
82866|NCT01380093|197975|P8|NOT COMPLETED|Treatment Phase: Third Intervention||0
82867|NCT01380093|197976|P7|NOT COMPLETED|Treatment Phase: Third Intervention||0
82868|NCT01380093|197977|P6|NOT COMPLETED|Treatment Phase: Third Intervention||0
82869|NCT01380093|197978|P5|NOT COMPLETED|Treatment Phase: Third Intervention||0
82870|NCT01380093|197979|P4|NOT COMPLETED|Treatment Phase: Third Intervention||0
82871|NCT01380093|197980|P3|NOT COMPLETED|Treatment Phase: Third Intervention||0
82872|NCT01380093|197981|P2|NOT COMPLETED|Treatment Phase: Third Intervention||0
82873|NCT01380093|197982|P1|NOT COMPLETED|Treatment Phase: Third Intervention||0
82874|NCT01380093|197974|P9|COMPLETED|Treatment Phase: Third Intervention||4
82875|NCT01380093|197975|P8|COMPLETED|Treatment Phase: Third Intervention||6
82876|NCT01380093|197976|P7|COMPLETED|Treatment Phase: Third Intervention||6
82877|NCT01380093|197977|P6|COMPLETED|Treatment Phase: Third Intervention||6
82878|NCT01380093|197978|P5|COMPLETED|Treatment Phase: Third Intervention||6
82879|NCT01380093|197979|P4|COMPLETED|Treatment Phase: Third Intervention||5
82880|NCT01380093|197980|P3|COMPLETED|Treatment Phase: Third Intervention||0
82881|NCT01380093|197981|P2|COMPLETED|Treatment Phase: Third Intervention||0
82882|NCT01380093|197982|P1|COMPLETED|Treatment Phase: Third Intervention||0
82883|NCT01380093|197974|P9|STARTED|Treatment Phase: Third Intervention||6
82884|NCT01380093|197975|P8|STARTED|Treatment Phase: Third Intervention||6
82885|NCT01380093|197976|P7|STARTED|Treatment Phase: Third Intervention||6
82886|NCT01380093|197977|P6|STARTED|Treatment Phase: Third Intervention||6
82887|NCT01380093|197978|P5|STARTED|Treatment Phase: Third Intervention||6
82888|NCT01380093|197979|P4|STARTED|Treatment Phase: Third Intervention||5
82889|NCT01380093|197980|P3|STARTED|Treatment Phase: Third Intervention||0
82890|NCT01380093|197981|P2|STARTED|Treatment Phase: Third Intervention||0
82891|NCT01380093|197982|P1|STARTED|Treatment Phase: Third Intervention||0
82892|NCT01380093|197974|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
82893|NCT01380093|197975|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
82894|NCT01380093|197976|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
82895|NCT01380093|197977|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
82896|NCT01380093|197978|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
82897|NCT01380093|197979|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
82898|NCT01380093|197980|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
82899|NCT01380093|197981|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
82900|NCT01380093|197982|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
82901|NCT01380093|197974|P9|COMPLETED|Treatment Phase: Washout Period||6
82902|NCT01380093|197975|P8|COMPLETED|Treatment Phase: Washout Period||6
82903|NCT01380093|197976|P7|COMPLETED|Treatment Phase: Washout Period||6
82904|NCT01380093|197977|P6|COMPLETED|Treatment Phase: Washout Period||6
82905|NCT01380093|197978|P5|COMPLETED|Treatment Phase: Washout Period||6
82906|NCT01380093|197979|P4|COMPLETED|Treatment Phase: Washout Period||5
82907|NCT01380093|197980|P3|COMPLETED|Treatment Phase: Washout Period||0
82908|NCT01380093|197981|P2|COMPLETED|Treatment Phase: Washout Period||0
82909|NCT01380093|197982|P1|COMPLETED|Treatment Phase: Washout Period||0
82910|NCT01380093|197974|P9|STARTED|Treatment Phase: Washout Period||6
82911|NCT01380093|197975|P8|STARTED|Treatment Phase: Washout Period||6
82912|NCT01380093|197976|P7|STARTED|Treatment Phase: Washout Period||6
82913|NCT01380093|197977|P6|STARTED|Treatment Phase: Washout Period||6
82914|NCT01380093|197978|P5|STARTED|Treatment Phase: Washout Period||6
82915|NCT01380093|197979|P4|STARTED|Treatment Phase: Washout Period||5
82916|NCT01380093|197980|P3|STARTED|Treatment Phase: Washout Period||0
82917|NCT01380093|197981|P2|STARTED|Treatment Phase: Washout Period||0
82918|NCT01380093|197982|P1|STARTED|Treatment Phase: Washout Period||0
82919|NCT01380093|197974|P9|NOT COMPLETED|Treatment Phase: Second Intervention||0
82920|NCT01380093|197975|P8|NOT COMPLETED|Treatment Phase: Second Intervention||0
82921|NCT01380093|197976|P7|NOT COMPLETED|Treatment Phase: Second Intervention||0
82922|NCT01380093|197977|P6|NOT COMPLETED|Treatment Phase: Second Intervention||0
82923|NCT01380093|197978|P5|NOT COMPLETED|Treatment Phase: Second Intervention||0
82924|NCT01380093|197979|P4|NOT COMPLETED|Treatment Phase: Second Intervention||1
82925|NCT01380093|197980|P3|NOT COMPLETED|Treatment Phase: Second Intervention||0
82926|NCT01380093|197981|P2|NOT COMPLETED|Treatment Phase: Second Intervention||0
82927|NCT01380093|197982|P1|NOT COMPLETED|Treatment Phase: Second Intervention||0
82928|NCT01380093|197974|P9|COMPLETED|Treatment Phase: Second Intervention||6
82929|NCT01380093|197975|P8|COMPLETED|Treatment Phase: Second Intervention||6
82930|NCT01380093|197976|P7|COMPLETED|Treatment Phase: Second Intervention||6
82931|NCT01380093|197977|P6|COMPLETED|Treatment Phase: Second Intervention||6
82932|NCT01380093|197978|P5|COMPLETED|Treatment Phase: Second Intervention||6
82933|NCT01380093|197979|P4|COMPLETED|Treatment Phase: Second Intervention||5
82934|NCT01380093|197980|P3|COMPLETED|Treatment Phase: Second Intervention||0
82935|NCT01380093|197981|P2|COMPLETED|Treatment Phase: Second Intervention||0
82936|NCT01380093|197982|P1|COMPLETED|Treatment Phase: Second Intervention||0
82937|NCT01380093|197974|P9|STARTED|Treatment Phase: Second Intervention||6
82938|NCT01380093|197975|P8|STARTED|Treatment Phase: Second Intervention||6
82939|NCT01380093|197976|P7|STARTED|Treatment Phase: Second Intervention||6
82940|NCT01380093|197977|P6|STARTED|Treatment Phase: Second Intervention||6
82941|NCT01380093|197978|P5|STARTED|Treatment Phase: Second Intervention||6
82942|NCT01380093|197979|P4|STARTED|Treatment Phase: Second Intervention||6
82943|NCT01380093|197980|P3|STARTED|Treatment Phase: Second Intervention||0
82944|NCT01380093|197981|P2|STARTED|Treatment Phase: Second Intervention||0
82945|NCT01380093|197982|P1|STARTED|Treatment Phase: Second Intervention||0
82946|NCT01380093|197974|P9|NOT COMPLETED|Treatment Phase: Washout Period||0
82947|NCT01380093|197975|P8|NOT COMPLETED|Treatment Phase: Washout Period||0
82948|NCT01380093|197976|P7|NOT COMPLETED|Treatment Phase: Washout Period||0
82949|NCT01380093|197977|P6|NOT COMPLETED|Treatment Phase: Washout Period||0
82950|NCT01380093|197978|P5|NOT COMPLETED|Treatment Phase: Washout Period||0
82951|NCT01380093|197979|P4|NOT COMPLETED|Treatment Phase: Washout Period||0
82952|NCT01380093|197980|P3|NOT COMPLETED|Treatment Phase: Washout Period||0
82953|NCT01380093|197981|P2|NOT COMPLETED|Treatment Phase: Washout Period||0
82954|NCT01380093|197982|P1|NOT COMPLETED|Treatment Phase: Washout Period||0
82955|NCT01380093|197974|P9|COMPLETED|Treatment Phase: Washout Period||6
82956|NCT01380093|197975|P8|COMPLETED|Treatment Phase: Washout Period||6
82957|NCT01380093|197976|P7|COMPLETED|Treatment Phase: Washout Period||6
82958|NCT01380093|197977|P6|COMPLETED|Treatment Phase: Washout Period||6
82959|NCT01380093|197978|P5|COMPLETED|Treatment Phase: Washout Period||6
82960|NCT01380093|197979|P4|COMPLETED|Treatment Phase: Washout Period||6
82961|NCT01380093|197980|P3|COMPLETED|Treatment Phase: Washout Period||0
82962|NCT01380093|197981|P2|COMPLETED|Treatment Phase: Washout Period||0
82963|NCT01380093|197982|P1|COMPLETED|Treatment Phase: Washout Period||0
82964|NCT01380093|197974|P9|STARTED|Treatment Phase: Washout Period||6
82965|NCT01380093|197975|P8|STARTED|Treatment Phase: Washout Period||6
82966|NCT01380093|197976|P7|STARTED|Treatment Phase: Washout Period||6
82967|NCT01380093|197977|P6|STARTED|Treatment Phase: Washout Period||6
82968|NCT01380093|197978|P5|STARTED|Treatment Phase: Washout Period||6
82969|NCT01380093|197979|P4|STARTED|Treatment Phase: Washout Period||6
82970|NCT01380093|197980|P3|STARTED|Treatment Phase: Washout Period||0
82971|NCT01380093|197981|P2|STARTED|Treatment Phase: Washout Period||0
82972|NCT01380093|197982|P1|STARTED|Treatment Phase: Washout Period||0
82973|NCT01380093|197974|P9|NOT COMPLETED|Treatment Phase: First Intervention||0
82974|NCT01380093|197975|P8|NOT COMPLETED|Treatment Phase: First Intervention||0
82975|NCT01380093|197976|P7|NOT COMPLETED|Treatment Phase: First Intervention||0
82976|NCT01380093|197977|P6|NOT COMPLETED|Treatment Phase: First Intervention||0
82977|NCT01380093|197978|P5|NOT COMPLETED|Treatment Phase: First Intervention||0
82978|NCT01380093|197979|P4|NOT COMPLETED|Treatment Phase: First Intervention||0
82979|NCT01380093|197980|P3|NOT COMPLETED|Treatment Phase: First Intervention||0
82980|NCT01380093|197981|P2|NOT COMPLETED|Treatment Phase: First Intervention||0
82981|NCT01380093|197982|P1|NOT COMPLETED|Treatment Phase: First Intervention||0
82982|NCT01380093|197974|P9|COMPLETED|Treatment Phase: First Intervention||6
82983|NCT01380093|197975|P8|COMPLETED|Treatment Phase: First Intervention||6
82984|NCT01380093|197976|P7|COMPLETED|Treatment Phase: First Intervention||6
82985|NCT01380093|197977|P6|COMPLETED|Treatment Phase: First Intervention||6
82986|NCT01380093|197978|P5|COMPLETED|Treatment Phase: First Intervention||6
82987|NCT01380093|197979|P4|COMPLETED|Treatment Phase: First Intervention||6
82988|NCT01380093|197980|P3|COMPLETED|Treatment Phase: First Intervention||0
82989|NCT01380093|197981|P2|COMPLETED|Treatment Phase: First Intervention||0
82990|NCT01380093|197982|P1|COMPLETED|Treatment Phase: First Intervention||0
82991|NCT01380093|197974|P9|STARTED|Treatment Phase: First Intervention||6
82992|NCT01380093|197975|P8|STARTED|Treatment Phase: First Intervention||6
82993|NCT01380093|197976|P7|STARTED|Treatment Phase: First Intervention||6
82994|NCT01380093|197977|P6|STARTED|Treatment Phase: First Intervention||6
82995|NCT01380093|197978|P5|STARTED|Treatment Phase: First Intervention||6
82996|NCT01380093|197979|P4|STARTED|Treatment Phase: First Intervention||6
82997|NCT01380093|197980|P3|STARTED|Treatment Phase: First Intervention||0
82998|NCT01380093|197981|P2|STARTED|Treatment Phase: First Intervention||0
82999|NCT01380093|197982|P1|STARTED|Treatment Phase: First Intervention||0
83000|NCT01380093|197974|P9|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
83001|NCT01380093|197975|P8|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
83002|NCT01380093|197976|P7|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
83003|NCT01380093|197977|P6|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
83004|NCT01380093|197978|P5|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
83005|NCT01380093|197979|P4|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
83006|NCT01380093|197980|P3|NOT COMPLETED|Drug Discrimination Phase: Day 2||13
83007|NCT01380093|197981|P2|NOT COMPLETED|Drug Discrimination Phase: Day 2||9
83008|NCT01380093|197982|P1|NOT COMPLETED|Drug Discrimination Phase: Day 2||0
83009|NCT01380093|197974|P9|COMPLETED|Drug Discrimination Phase: Day 2||0
83010|NCT01380093|197975|P8|COMPLETED|Drug Discrimination Phase: Day 2||0
83011|NCT01380093|197976|P7|COMPLETED|Drug Discrimination Phase: Day 2||0
83012|NCT01380093|197977|P6|COMPLETED|Drug Discrimination Phase: Day 2||0
83013|NCT01380093|197978|P5|COMPLETED|Drug Discrimination Phase: Day 2||0
83014|NCT01380093|197979|P4|COMPLETED|Drug Discrimination Phase: Day 2||0
83015|NCT01380093|197980|P3|COMPLETED|Drug Discrimination Phase: Day 2||16
83016|NCT01380093|197981|P2|COMPLETED|Drug Discrimination Phase: Day 2||20
83017|NCT01380093|197982|P1|COMPLETED|Drug Discrimination Phase: Day 2||0
83018|NCT01380093|197974|P9|STARTED|Drug Discrimination Phase: Day 2||0
83019|NCT01380093|197975|P8|STARTED|Drug Discrimination Phase: Day 2||0
83020|NCT01380093|197976|P7|STARTED|Drug Discrimination Phase: Day 2||0
83021|NCT01380093|197977|P6|STARTED|Drug Discrimination Phase: Day 2||0
83022|NCT01380093|197978|P5|STARTED|Drug Discrimination Phase: Day 2||0
83023|NCT01380093|197979|P4|STARTED|Drug Discrimination Phase: Day 2||0
83024|NCT01380093|197980|P3|STARTED|Drug Discrimination Phase: Day 2||29
83025|NCT01380093|197981|P2|STARTED|Drug Discrimination Phase: Day 2||29
83026|NCT01380093|197982|P1|STARTED|Drug Discrimination Phase: Day 2||0
83027|NCT01380093|197974|P9|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83028|NCT01380093|197975|P8|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83029|NCT01380093|197976|P7|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83030|NCT01380093|197977|P6|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83031|NCT01380093|197978|P5|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83032|NCT01380093|197979|P4|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83033|NCT01380093|197980|P3|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83034|NCT01380093|197981|P2|NOT COMPLETED|Drug Discrimination Phase: Day 1||1
83035|NCT01380093|197982|P1|NOT COMPLETED|Drug Discrimination Phase: Day 1||0
83036|NCT01380093|197974|P9|COMPLETED|Drug Discrimination Phase: Day 1||0
83037|NCT01380093|197975|P8|COMPLETED|Drug Discrimination Phase: Day 1||0
83038|NCT01380093|197976|P7|COMPLETED|Drug Discrimination Phase: Day 1||0
83039|NCT01380093|197977|P6|COMPLETED|Drug Discrimination Phase: Day 1||0
83040|NCT01380093|197978|P5|COMPLETED|Drug Discrimination Phase: Day 1||0
83041|NCT01380093|197979|P4|COMPLETED|Drug Discrimination Phase: Day 1||0
83042|NCT01380093|197980|P3|COMPLETED|Drug Discrimination Phase: Day 1||29
83043|NCT01380093|197981|P2|COMPLETED|Drug Discrimination Phase: Day 1||29
83044|NCT01380093|197982|P1|COMPLETED|Drug Discrimination Phase: Day 1||0
83045|NCT01380093|197974|P9|STARTED|Drug Discrimination Phase: Day 1||0
83046|NCT01380093|197975|P8|STARTED|Drug Discrimination Phase: Day 1||0
83047|NCT01380093|197976|P7|STARTED|Drug Discrimination Phase: Day 1||0
83048|NCT01380093|197977|P6|STARTED|Drug Discrimination Phase: Day 1||0
83049|NCT01380093|197978|P5|STARTED|Drug Discrimination Phase: Day 1||0
83050|NCT01380093|197979|P4|STARTED|Drug Discrimination Phase: Day 1||0
83051|NCT01380093|197980|P3|STARTED|Drug Discrimination Phase: Day 1||29
83052|NCT01380093|197981|P2|STARTED|Drug Discrimination Phase: Day 1||30
83053|NCT01380093|197982|P1|STARTED|Drug Discrimination Phase: Day 1||0
83054|NCT01380093|197974|P9|NOT COMPLETED|Naloxone Challenge Phase||0
83055|NCT01380093|197975|P8|NOT COMPLETED|Naloxone Challenge Phase||0
83056|NCT01380093|197976|P7|NOT COMPLETED|Naloxone Challenge Phase||0
83057|NCT01380093|197977|P6|NOT COMPLETED|Naloxone Challenge Phase||0
83058|NCT01380093|197978|P5|NOT COMPLETED|Naloxone Challenge Phase||0
83059|NCT01380093|197979|P4|NOT COMPLETED|Naloxone Challenge Phase||0
83060|NCT01380093|197980|P3|NOT COMPLETED|Naloxone Challenge Phase||0
83061|NCT01380093|197981|P2|NOT COMPLETED|Naloxone Challenge Phase||0
83062|NCT01380093|197982|P1|NOT COMPLETED|Naloxone Challenge Phase||21
83063|NCT01380093|197974|P9|COMPLETED|Naloxone Challenge Phase||0
83064|NCT01380093|197975|P8|COMPLETED|Naloxone Challenge Phase||0
83065|NCT01380093|197976|P7|COMPLETED|Naloxone Challenge Phase||0
83066|NCT01380093|197977|P6|COMPLETED|Naloxone Challenge Phase||0
83067|NCT01380093|197978|P5|COMPLETED|Naloxone Challenge Phase||0
83068|NCT01380093|197979|P4|COMPLETED|Naloxone Challenge Phase||0
83069|NCT01380093|197980|P3|COMPLETED|Naloxone Challenge Phase||0
83070|NCT01380093|197981|P2|COMPLETED|Naloxone Challenge Phase||0
83071|NCT01380093|197982|P1|COMPLETED|Naloxone Challenge Phase||59
83072|NCT01380093|197974|P9|TREATED|Naloxone Challenge Phase||0
83073|NCT01380093|197975|P8|TREATED|Naloxone Challenge Phase||0
83074|NCT01380093|197976|P7|TREATED|Naloxone Challenge Phase||0
83075|NCT01380093|197977|P6|TREATED|Naloxone Challenge Phase||0
83076|NCT01380093|197978|P5|TREATED|Naloxone Challenge Phase||0
83077|NCT01380093|197979|P4|TREATED|Naloxone Challenge Phase||0
83078|NCT01380093|197980|P3|TREATED|Naloxone Challenge Phase||0
83079|NCT01380093|197981|P2|TREATED|Naloxone Challenge Phase||0
83080|NCT01380093|197982|P1|TREATED|Naloxone Challenge Phase||59
83081|NCT01380093|197974|P9|STARTED|Naloxone Challenge Phase||0
83082|NCT01380093|197975|P8|STARTED|Naloxone Challenge Phase||0
83083|NCT01380093|197976|P7|STARTED|Naloxone Challenge Phase||0
83084|NCT01380093|197977|P6|STARTED|Naloxone Challenge Phase||0
83085|NCT01380093|197978|P5|STARTED|Naloxone Challenge Phase||0
83086|NCT01380093|197979|P4|STARTED|Naloxone Challenge Phase||0
83087|NCT01380093|197980|P3|STARTED|Naloxone Challenge Phase||0
83088|NCT01380093|197981|P2|STARTED|Naloxone Challenge Phase||0
83089|NCT01380093|197982|P1|STARTED|Naloxone Challenge Phase||80
83090|NCT01380080|198274|P2|NOT COMPLETED|Overall Study||23
83091|NCT01380080|198275|P1|NOT COMPLETED|Overall Study||33
83092|NCT01380080|198274|P2|COMPLETED|Overall Study||403
83093|NCT01380080|198275|P1|COMPLETED|Overall Study||391
83094|NCT01380080|198274|P2|STARTED|Overall Study||426
83095|NCT01380080|198275|P1|STARTED|Overall Study||424
83096|NCT01379963|198291|P1|NOT COMPLETED|Overall Study||0
83097|NCT01379963|198291|P1|COMPLETED|Overall Study||780
83098|NCT01379963|198291|P1|STARTED|Overall Study||780
83099|NCT01379937|198300|P4|NOT COMPLETED|Overall Study||1
83100|NCT01379937|198301|P3|NOT COMPLETED|Overall Study||2
83101|NCT01379937|198302|P2|NOT COMPLETED|Overall Study||3
83102|NCT01379937|198303|P1|NOT COMPLETED|Overall Study||1
83103|NCT01379937|198300|P4|COMPLETED|Overall Study||103
83104|NCT01379937|198301|P3|COMPLETED|Overall Study||102
83105|NCT01379937|198302|P2|COMPLETED|Overall Study||153
83106|NCT01379937|198303|P1|COMPLETED|Overall Study||155
83107|NCT01379937|198300|P4|STARTED|Overall Study||104
83108|NCT01379937|198301|P3|STARTED|Overall Study||104
83109|NCT01379937|198302|P2|STARTED|Overall Study||156
83110|NCT01379937|198303|P1|STARTED|Overall Study||156
83111|NCT01379781|198385|P2|NOT COMPLETED|Overall Study||8
83112|NCT01379781|198386|P1|NOT COMPLETED|Overall Study||11
83113|NCT01379781|198385|P2|COMPLETED|Overall Study||19
83114|NCT01379781|198386|P1|COMPLETED|Overall Study||16
83115|NCT01379781|198385|P2|STARTED|Overall Study||27
83116|NCT01379781|198386|P1|STARTED|Overall Study||27
83117|NCT01379768|198395|P3|NOT COMPLETED|Overall Study||0
83118|NCT01379768|198396|P2|NOT COMPLETED|Overall Study||1
83119|NCT01379768|198397|P1|NOT COMPLETED|Overall Study||3
83120|NCT01379768|198395|P3|COMPLETED|Overall Study||20
83121|NCT01379768|198396|P2|COMPLETED|Overall Study||21
83122|NCT01379768|198397|P1|COMPLETED|Overall Study||20
83123|NCT01379768|198395|P3|STARTED|Overall Study||20
83124|NCT01379768|198396|P2|STARTED|Overall Study||22
83125|NCT01379768|198397|P1|STARTED|Overall Study||23
83126|NCT01379703|198420|P3|NOT COMPLETED|9 Months Through 18 Months||0
83127|NCT01379703|198421|P2|NOT COMPLETED|9 Months Through 18 Months||230
83128|NCT01379703|198422|P1|NOT COMPLETED|9 Months Through 18 Months||0
83129|NCT01379703|198420|P3|COMPLETED|9 Months Through 18 Months||0
83130|NCT01379703|198421|P2|COMPLETED|9 Months Through 18 Months||854
83131|NCT01379703|198422|P1|COMPLETED|9 Months Through 18 Months||0
83132|NCT01379703|198420|P3|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
83133|NCT01379703|198421|P2|STARTED|9 Months Through 18 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
83134|NCT01379703|198422|P1|STARTED|9 Months Through 18 Months|Participants in this subgroup were followed for 9 months.|0
83135|NCT01379703|198420|P3|NOT COMPLETED|Study Start Through 9 Months||143
83136|NCT01379703|198421|P2|NOT COMPLETED|Study Start Through 9 Months||122
83137|NCT01379703|198422|P1|NOT COMPLETED|Study Start Through 9 Months||4
83138|NCT01379703|198420|P3|COMPLETED|Study Start Through 9 Months||873
83139|NCT01379703|198421|P2|COMPLETED|Study Start Through 9 Months|Participants taking the capsule formulation were followed for an additional 9 months (up to 18 mos).|1084
83140|NCT01379703|198422|P1|COMPLETED|Study Start Through 9 Months||62
83141|NCT01379703|198420|P3|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir tablet formulation (only) during study (1016/2288)|1016
83142|NCT01379703|198421|P2|STARTED|Study Start Through 9 Months|Participants taking the lopinavir/ritonavir capsule formulation (only) during study (1206/2288)|1206
83143|NCT01379703|198422|P1|STARTED|Study Start Through 9 Months|Participants taking lopinavir/ritonavir tablets/capsules or oral solution during the study (66/2288)|66
83144|NCT01379664|198485|P2|NOT COMPLETED|Overall Study||0
83145|NCT01379664|198486|P1|NOT COMPLETED|Overall Study||0
83146|NCT01379664|198485|P2|COMPLETED|Overall Study||870
83147|NCT01379664|198486|P1|COMPLETED|Overall Study||714
83148|NCT01379664|198485|P2|STARTED|Overall Study||870
83149|NCT01379664|198486|P1|STARTED|Overall Study||714
83150|NCT01379651|198498|P2|NOT COMPLETED|Overall Study||0
83151|NCT01379651|198499|P1|NOT COMPLETED|Overall Study||0
83152|NCT01379651|198498|P2|COMPLETED|Overall Study||10
83153|NCT01379651|198499|P1|COMPLETED|Overall Study||10
83154|NCT01379651|198498|P2|STARTED|Overall Study||10
83155|NCT01379651|198499|P1|STARTED|Overall Study||10
83156|NCT01379625|198509|P2|NOT COMPLETED|Overall Study||0
83157|NCT01379625|198510|P1|NOT COMPLETED|Overall Study||0
83158|NCT01379625|198509|P2|COMPLETED|Overall Study||16
83159|NCT01379625|198510|P1|COMPLETED|Overall Study||16
83160|NCT01379625|198509|P2|STARTED|Overall Study||16
83161|NCT01379625|198510|P1|STARTED|Overall Study||16
83162|NCT01379534|198522|P2|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||2
83163|NCT01379534|198523|P1|NOT COMPLETED|Tumor Assessment Follow-up (f/u) Phase||4
83164|NCT01379534|198522|P2|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
83165|NCT01379534|198523|P1|COMPLETED|Tumor Assessment Follow-up (f/u) Phase||0
83166|NCT01379534|198522|P2|STARTED|Tumor Assessment Follow-up (f/u) Phase||2
83167|NCT01379534|198523|P1|STARTED|Tumor Assessment Follow-up (f/u) Phase|All participants discontinued the Treatment Phase. Of these, only 6 qualified for f/u tumor assess..|4
83168|NCT01379534|198522|P2|NOT COMPLETED|Treatment Phase||31
83169|NCT01379534|198523|P1|NOT COMPLETED|Treatment Phase||22
83170|NCT01379534|198522|P2|COMPLETED|Treatment Phase||0
83171|NCT01379534|198523|P1|COMPLETED|Treatment Phase||0
83172|NCT01379534|198522|P2|STARTED|Treatment Phase||31
83173|NCT01379534|198523|P1|STARTED|Treatment Phase||22
83174|NCT01379521|198543|P2|NOT COMPLETED|Post-Treatment Evaluations||21
83175|NCT01379521|198544|P1|NOT COMPLETED|Post-Treatment Evaluations||25
83176|NCT01379521|198543|P2|COMPLETED|Post-Treatment Evaluations||0
83177|NCT01379521|198544|P1|COMPLETED|Post-Treatment Evaluations||0
83178|NCT01379521|198543|P2|STARTED|Post-Treatment Evaluations||21
83179|NCT01379521|198544|P1|STARTED|Post-Treatment Evaluations||25
83180|NCT01379521|198543|P2|NOT COMPLETED|Overall Study -Treatment Period||26
83181|NCT01379521|198544|P1|NOT COMPLETED|Overall Study -Treatment Period||33
83182|NCT01379521|198543|P2|COMPLETED|Overall Study -Treatment Period||0
83183|NCT01379521|198544|P1|COMPLETED|Overall Study -Treatment Period||0
83184|NCT01379521|198543|P2|STARTED|Overall Study -Treatment Period||26
83185|NCT01379521|198544|P1|STARTED|Overall Study -Treatment Period||33
83186|NCT01379183|198564|P2|NOT COMPLETED|Overall Study||0
83187|NCT01379183|198565|P1|NOT COMPLETED|Overall Study||0
83188|NCT01379183|198564|P2|COMPLETED|Overall Study||21
83189|NCT01379183|198565|P1|COMPLETED|Overall Study||19
83190|NCT01379183|198564|P2|STARTED|Overall Study||21
83191|NCT01379183|198565|P1|STARTED|Overall Study||19
83192|NCT01378988|198583|P2|NOT COMPLETED|Overall Study||0
83193|NCT01378988|198584|P1|NOT COMPLETED|Overall Study||0
83194|NCT01378988|198583|P2|COMPLETED|Overall Study||3
83195|NCT01378988|198584|P1|COMPLETED|Overall Study||2
83196|NCT01378988|198583|P2|STARTED|Overall Study||3
83197|NCT01378988|198584|P1|STARTED|Overall Study||2
83198|NCT01378975|198614|P2|NOT COMPLETED|Overall Study||50
83199|NCT01378975|198615|P1|NOT COMPLETED|Overall Study||86
83200|NCT01378975|198614|P2|COMPLETED|Overall Study||6
83201|NCT01378975|198615|P1|COMPLETED|Overall Study||4
83202|NCT01378975|198614|P2|STARTED|Overall Study||56
83203|NCT01378975|198615|P1|STARTED|Overall Study||90
83204|NCT01378962|198641|P1|NOT COMPLETED|Overall Study||17
83205|NCT01378962|198641|P1|COMPLETED|Overall Study||33
83206|NCT01378962|198641|P1|STARTED|Overall Study||50
83207|NCT01378520|198654|P2|NOT COMPLETED|Second Intervention||0
83208|NCT01378520|198655|P1|NOT COMPLETED|Second Intervention||0
83209|NCT01378520|198654|P2|COMPLETED|Second Intervention||10
83210|NCT01378520|198655|P1|COMPLETED|Second Intervention||10
83211|NCT01378520|198654|P2|STARTED|Second Intervention||10
83212|NCT01378520|198655|P1|STARTED|Second Intervention||10
83213|NCT01378520|198654|P2|NOT COMPLETED|First Intervention||0
83214|NCT01378520|198655|P1|NOT COMPLETED|First Intervention||0
83215|NCT01378520|198654|P2|COMPLETED|First Intervention||10
83216|NCT01378520|198655|P1|COMPLETED|First Intervention||10
83217|NCT01378520|198654|P2|STARTED|First Intervention||10
83218|NCT01378520|198655|P1|STARTED|First Intervention||10
83219|NCT01378429|198667|P2|NOT COMPLETED|Overall Study||0
83220|NCT01378429|198668|P1|NOT COMPLETED|Overall Study||1
83221|NCT01378429|198667|P2|COMPLETED|Overall Study||47
83222|NCT01378429|198668|P1|COMPLETED|Overall Study||41
83223|NCT01378429|198667|P2|STARTED|Overall Study||47
83224|NCT01378429|198668|P1|STARTED|Overall Study||42
83225|NCT01378416|198700|P1|NOT COMPLETED|Overall Study||0
83226|NCT01378416|198700|P1|COMPLETED|Overall Study||16
83227|NCT01378416|198700|P1|STARTED|Overall Study||16
83228|NCT01378325|198710|P2|NOT COMPLETED|Overall Study||1
83229|NCT01378325|198711|P1|NOT COMPLETED|Overall Study||0
83230|NCT01378325|198710|P2|COMPLETED|Overall Study||39
83231|NCT01378325|198711|P1|COMPLETED|Overall Study||40
83232|NCT01378325|198710|P2|STARTED|Overall Study||40
83233|NCT01378325|198711|P1|STARTED|Overall Study||40
83234|NCT01378221|198719|P2|NOT COMPLETED|Overall Study||9
83235|NCT01378221|198720|P1|NOT COMPLETED|Overall Study||7
83236|NCT01378221|198719|P2|COMPLETED|Overall Study||30
83237|NCT01378221|198720|P1|COMPLETED|Overall Study||29
83238|NCT01378221|198719|P2|STARTED|Overall Study||39
83239|NCT01378221|198720|P1|STARTED|Overall Study||36
83240|NCT01378195|198728|P2|NOT COMPLETED|Overall Study||18
83241|NCT01378195|198729|P1|NOT COMPLETED|Overall Study||29
83242|NCT01378195|198728|P2|COMPLETED|Overall Study||57
83243|NCT01378195|198729|P1|COMPLETED|Overall Study||46
83244|NCT01378195|198728|P2|STARTED|Overall Study||75
83245|NCT01378195|198729|P1|STARTED|Overall Study||75
83246|NCT01378117|198742|P3|NOT COMPLETED|Overall Study||3
83247|NCT01378117|198743|P2|NOT COMPLETED|Overall Study||1
83248|NCT01378117|198744|P1|NOT COMPLETED|Overall Study||4
83249|NCT01378117|198742|P3|COMPLETED|Overall Study||26
83250|NCT01378117|198743|P2|COMPLETED|Overall Study||29
83251|NCT01378117|198744|P1|COMPLETED|Overall Study||27
83252|NCT01378117|198742|P3|STARTED|Overall Study||29
83253|NCT01378117|198743|P2|STARTED|Overall Study||30
83254|NCT01378117|198744|P1|STARTED|Overall Study||31
83255|NCT01378104|198754|P2|NOT COMPLETED|Overall Study||26
83256|NCT01378104|198755|P1|NOT COMPLETED|Overall Study||27
83257|NCT01378104|198754|P2|COMPLETED|Overall Study||60
83258|NCT01378104|198755|P1|COMPLETED|Overall Study||65
83259|NCT01378104|198754|P2|STARTED|Overall Study||86
83260|NCT01378104|198755|P1|STARTED|Overall Study||92
83261|NCT01378065|198763|P1|NOT COMPLETED|Overall Study||0
83262|NCT01378065|198763|P1|COMPLETED|Overall Study||30
83263|NCT01378065|198763|P1|12 Months|Overall Study||30
83264|NCT01378065|198763|P1|6 Months|Overall Study||30
83265|NCT01378065|198763|P1|3 Months|Overall Study||30
83266|NCT01378065|198763|P1|6 Week|Overall Study||30
83267|NCT01378065|198763|P1|STARTED|Overall Study|31 subjects were enrolled/consented. However, 1 subject was not implanted with a study device.|30
83268|NCT01377636|198800|P1|NOT COMPLETED|Overall Study||0
83269|NCT01377636|198800|P1|COMPLETED|Overall Study||20
83270|NCT01377636|198800|P1|STARTED|Overall Study||20
83271|NCT01377623|198814|P2|NOT COMPLETED|Overall Study||5
83272|NCT01377623|198815|P1|NOT COMPLETED|Overall Study||7
83273|NCT01377623|198814|P2|COMPLETED|Overall Study||28
83274|NCT01377623|198815|P1|COMPLETED|Overall Study||26
83275|NCT01377623|198814|P2|STARTED|Overall Study||33
83276|NCT01377623|198815|P1|STARTED|Overall Study||33
83277|NCT01377480|198833|P4|NOT COMPLETED|Overall Study||11
83278|NCT01377480|198834|P3|NOT COMPLETED|Overall Study||10
83279|NCT01377480|198835|P2|NOT COMPLETED|Overall Study||1
83280|NCT01377480|198836|P1|NOT COMPLETED|Overall Study||0
83281|NCT01377480|198833|P4|COMPLETED|Overall Study||19
83282|NCT01377480|198834|P3|COMPLETED|Overall Study||18
83283|NCT01377480|198835|P2|COMPLETED|Overall Study||29
83284|NCT01377480|198836|P1|COMPLETED|Overall Study||32
83285|NCT01377480|198833|P4|STARTED|Overall Study||30
83286|NCT01377480|198834|P3|STARTED|Overall Study|2 participants received only POS and were analyzed as part of the posaconazole group|28
83287|NCT01377480|198835|P2|STARTED|Overall Study||30
83288|NCT01377480|198836|P1|STARTED|Overall Study|Includes 2 participants randomized to POS + BNZ but who only received POS|32
83289|NCT01377467|198848|P2|NOT COMPLETED|Overall Study||0
83290|NCT01377467|198849|P1|NOT COMPLETED|Overall Study||0
83291|NCT01377467|198848|P2|COMPLETED|Overall Study||44
83292|NCT01377467|198849|P1|COMPLETED|Overall Study||46
83293|NCT01377467|198848|P2|STARTED|Overall Study||44
83294|NCT01377467|198849|P1|STARTED|Overall Study||46
83295|NCT01377441|198897|P2|NOT COMPLETED|Overall Study||0
83296|NCT01377441|198898|P1|NOT COMPLETED|Overall Study||0
83297|NCT01377441|198897|P2|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
83298|NCT01377441|198898|P1|COMPLETED|Overall Study|All data for this study was lost after Hurricane Sandy.|0
83299|NCT01377441|198897|P2|STARTED|Overall Study||0
83300|NCT01377441|198898|P1|STARTED|Overall Study||0
83301|NCT01377402|198904|P1|NOT COMPLETED|Overall Study||0
83302|NCT01377402|198904|P1|COMPLETED|Overall Study||982
83303|NCT01377402|198904|P1|STARTED|Overall Study||982
83304|NCT01377233|198915|P5|NOT COMPLETED|Double-blind||2
83305|NCT01377233|198916|P4|NOT COMPLETED|Double-blind||4
83306|NCT01377233|198917|P3|NOT COMPLETED|Double-blind||2
83307|NCT01377233|198918|P2|NOT COMPLETED|Double-blind||1
83308|NCT01377233|198919|P1|NOT COMPLETED|Double-blind||0
83309|NCT01377233|198915|P5|COMPLETED|Double-blind||8
83310|NCT01377233|198916|P4|COMPLETED|Double-blind||7
83311|NCT01377233|198917|P3|COMPLETED|Double-blind||8
83312|NCT01377233|198918|P2|COMPLETED|Double-blind||10
83313|NCT01377233|198919|P1|COMPLETED|Double-blind||0
83314|NCT01377233|198915|P5|STARTED|Double-blind||10
83315|NCT01377233|198916|P4|STARTED|Double-blind||11
83316|NCT01377233|198917|P3|STARTED|Double-blind||10
83317|NCT01377233|198918|P2|STARTED|Double-blind||11
83318|NCT01377233|198919|P1|STARTED|Double-blind||0
83319|NCT01377233|198915|P5|NOT COMPLETED|Open-label||0
83320|NCT01377233|198916|P4|NOT COMPLETED|Open-label||0
83321|NCT01377233|198917|P3|NOT COMPLETED|Open-label||0
83322|NCT01377233|198918|P2|NOT COMPLETED|Open-label||0
83323|NCT01377233|198919|P1|NOT COMPLETED|Open-label||4
83324|NCT01377233|198915|P5|COMPLETED|Open-label||0
83325|NCT01377233|198916|P4|COMPLETED|Open-label||0
83326|NCT01377233|198917|P3|COMPLETED|Open-label||0
83327|NCT01377233|198918|P2|COMPLETED|Open-label||0
83328|NCT01377233|198919|P1|COMPLETED|Open-label||42
83329|NCT01377233|198915|P5|STARTED|Open-label||0
83330|NCT01377233|198916|P4|STARTED|Open-label||0
83331|NCT01377233|198917|P3|STARTED|Open-label||0
83332|NCT01377233|198918|P2|STARTED|Open-label||0
83333|NCT01377233|198919|P1|STARTED|Open-label||46
83334|NCT01377194|198946|P3|NOT COMPLETED|Overall Study||46
83335|NCT01377194|198947|P2|NOT COMPLETED|Overall Study||43
83336|NCT01377194|198948|P1|NOT COMPLETED|Overall Study||32
83337|NCT01377194|198946|P3|COMPLETED|Overall Study||142
83338|NCT01377194|198947|P2|COMPLETED|Overall Study||145
83339|NCT01377194|198948|P1|COMPLETED|Overall Study||154
83340|NCT01377194|198946|P3|STARTED|Overall Study||188
83341|NCT01377194|198947|P2|STARTED|Overall Study||188
83342|NCT01377194|198948|P1|STARTED|Overall Study||186
83343|NCT01377012|198962|P3|NOT COMPLETED|Extension Study, Weeks 104-260||68
83344|NCT01377012|198963|P2|NOT COMPLETED|Extension Study, Weeks 104-260||71
83345|NCT01377012|198964|P1|NOT COMPLETED|Extension Study, Weeks 104-260||57
83346|NCT01377012|198962|P3|COMPLETED|Extension Study, Weeks 104-260||0
83347|NCT01377012|198963|P2|COMPLETED|Extension Study, Weeks 104-260||0
83348|NCT01377012|198964|P1|COMPLETED|Extension Study, Weeks 104-260||0
83349|NCT01377012|198962|P3|STARTED|Extension Study, Weeks 104-260||68
83350|NCT01377012|198963|P2|STARTED|Extension Study, Weeks 104-260||71
83351|NCT01377012|198964|P1|STARTED|Extension Study, Weeks 104-260||57
83352|NCT01377012|198962|P3|NOT COMPLETED|Core Study||134
83353|NCT01377012|198963|P2|NOT COMPLETED|Core Study||132
83354|NCT01377012|198964|P1|NOT COMPLETED|Core Study||134
83355|NCT01377012|198962|P3|COMPLETED|Core Study||80
83356|NCT01377012|198963|P2|COMPLETED|Core Study||81
83357|NCT01377012|198964|P1|COMPLETED|Core Study||76
83358|NCT01377012|198962|P3|wk 24 Re-randomized to AIN 150 mg Res|Core Study||34
83359|NCT01377012|198963|P2|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
83360|NCT01377012|198964|P1|wk 24 Re-randomized to AIN 150 mg Res|Core Study||0
83361|NCT01377012|198962|P3|wk 24 Re-randomized to AIN 75 mg Res|Core Study|Res= responder|38
83362|NCT01377012|198963|P2|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
83363|NCT01377012|198964|P1|wk 24 Re-randomized to AIN 75 mg Res|Core Study||0
83364|NCT01377012|198962|P3|wk16 Re-randomized to AIN 150mg NR|Core Study||53
83365|NCT01377012|198963|P2|wk16 Re-randomized to AIN 150mg NR|Core Study||0
83366|NCT01377012|198964|P1|wk16 Re-randomized to AIN 150mg NR|Core Study||0
83367|NCT01377012|198962|P3|wk16 Re-randomized to AIN 75mg NR|Core Study|NR=Non-responder|56
83368|NCT01377012|198963|P2|wk16 Re-randomized to AIN 75mg NR|Core Study||0
83369|NCT01377012|198964|P1|wk16 Re-randomized to AIN 75mg NR|Core Study||0
83370|NCT01377012|198962|P3|STARTED|Core Study||214
83371|NCT01377012|198963|P2|STARTED|Core Study||213
83372|NCT01377012|198964|P1|STARTED|Core Study||210
83373|NCT01376908|199001|P2|NOT COMPLETED|Overall Study||3
83374|NCT01376908|199002|P1|NOT COMPLETED|Overall Study||2
83375|NCT01376908|199001|P2|COMPLETED|Overall Study||26
83376|NCT01376908|199002|P1|COMPLETED|Overall Study||25
83377|NCT01376908|199001|P2|STARTED|Overall Study||29
83378|NCT01376908|199002|P1|STARTED|Overall Study||27
83379|NCT01376804|199035|P1|NOT COMPLETED|Follow-up Period||0
83380|NCT01376804|199035|P1|COMPLETED|Follow-up Period||55
83381|NCT01376804|199035|P1|STARTED|Follow-up Period|6 of the 7 patients who withdrew from treatment continued to the Follow-up Period.|55
83382|NCT01376804|199035|P1|NOT COMPLETED|Treatment Period||8
83383|NCT01376804|199035|P1|COMPLETED|Treatment Period||49
83384|NCT01376804|199035|P1|Received Study Drug|Treatment Period||56
83385|NCT01376804|199035|P1|STARTED|Treatment Period||57
83386|NCT01376700|199046|P1|NOT COMPLETED|Overall Study||16
83387|NCT01376700|199046|P1|COMPLETED|Overall Study||3
83388|NCT01376700|199046|P1|STARTED|Overall Study||19
83389|NCT01376557|199067|P5|NOT COMPLETED|Overall Study||7
83390|NCT01376557|199068|P4|NOT COMPLETED|Overall Study||6
83391|NCT01376557|199069|P3|NOT COMPLETED|Overall Study||5
83392|NCT01376557|199070|P2|NOT COMPLETED|Overall Study||6
83393|NCT01376557|199071|P1|NOT COMPLETED|Overall Study||8
83394|NCT01376557|199067|P5|COMPLETED|Overall Study||53
83395|NCT01376557|199068|P4|COMPLETED|Overall Study||54
83396|NCT01376557|199069|P3|COMPLETED|Overall Study||55
83397|NCT01376557|199070|P2|COMPLETED|Overall Study||54
83398|NCT01376557|199071|P1|COMPLETED|Overall Study||51
83399|NCT01376557|199067|P5|STARTED|Overall Study||60
83400|NCT01376557|199068|P4|STARTED|Overall Study||60
83401|NCT01376557|199069|P3|STARTED|Overall Study||60
83402|NCT01376557|199070|P2|STARTED|Overall Study||60
83403|NCT01376557|199071|P1|STARTED|Overall Study||59
83404|NCT01376388|199108|P1|NOT COMPLETED|Overall Study||18
83405|NCT01376388|199108|P1|COMPLETED|Overall Study||112
83406|NCT01376388|199108|P1|STARTED|Overall Study||130
83407|NCT01376362|199123|P1|NOT COMPLETED|Overall Study||0
83408|NCT01376362|199123|P1|COMPLETED|Overall Study||5
83409|NCT01376362|199123|P1|STARTED|Overall Study||5
83410|NCT01376349|199146|P3|NOT COMPLETED|Optional Continuation Phase||0
83411|NCT01376349|199147|P2|NOT COMPLETED|Optional Continuation Phase||0
83412|NCT01376349|199148|P1|NOT COMPLETED|Optional Continuation Phase||0
83413|NCT01376349|199146|P3|COMPLETED|Optional Continuation Phase||94
83414|NCT01376349|199147|P2|COMPLETED|Optional Continuation Phase||0
83415|NCT01376349|199148|P1|COMPLETED|Optional Continuation Phase||0
83416|NCT01376349|199146|P3|STARTED|Optional Continuation Phase|Patients completing Arm III Placebo were offered the option of continuing High Dose DHEA|94
83417|NCT01376349|199147|P2|STARTED|Optional Continuation Phase||0
83418|NCT01376349|199148|P1|STARTED|Optional Continuation Phase||0
83419|NCT01376349|199146|P3|NOT COMPLETED|Raondomized Treatment||29
83420|NCT01376349|199147|P2|NOT COMPLETED|Raondomized Treatment||35
83421|NCT01376349|199148|P1|NOT COMPLETED|Raondomized Treatment||24
83422|NCT01376349|199146|P3|COMPLETED|Raondomized Treatment||118
83423|NCT01376349|199147|P2|COMPLETED|Raondomized Treatment||114
83424|NCT01376349|199148|P1|COMPLETED|Raondomized Treatment||123
83425|NCT01376349|199146|P3|STARTED|Raondomized Treatment||147
83426|NCT01376349|199147|P2|STARTED|Raondomized Treatment||149
83427|NCT01376349|199148|P1|STARTED|Raondomized Treatment||147
83428|NCT01376297|199159|P2|NOT COMPLETED|Overall Study||49
83429|NCT01376297|199160|P1|NOT COMPLETED|Overall Study||128
83430|NCT01376297|199159|P2|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|55
83431|NCT01376297|199160|P1|COMPLETED|Overall Study|number of patients completing planned/unplanned chemotherapy cycles|181
83432|NCT01376297|199159|P2|STARTED|Overall Study|number of randomised patients|104
83433|NCT01376297|199160|P1|STARTED|Overall Study|number of randomised patients|309
83434|NCT01376245|199170|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||26
83435|NCT01376245|199171|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||23
83436|NCT01376245|199172|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||25
83437|NCT01376245|199173|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||32
83438|NCT01376245|199174|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
83439|NCT01376245|199170|P5|COMPLETED|24-week, Double-blind Treatment Period||134
83440|NCT01376245|199171|P4|COMPLETED|24-week, Double-blind Treatment Period||138
83441|NCT01376245|199172|P3|COMPLETED|24-week, Double-blind Treatment Period||135
83442|NCT01376245|199173|P2|COMPLETED|24-week, Double-blind Treatment Period||130
83443|NCT01376245|199174|P1|COMPLETED|24-week, Double-blind Treatment Period||0
83444|NCT01376245|199170|P5|STARTED|24-week, Double-blind Treatment Period||160
83445|NCT01376245|199171|P4|STARTED|24-week, Double-blind Treatment Period||161
83446|NCT01376245|199172|P3|STARTED|24-week, Double-blind Treatment Period||160
83447|NCT01376245|199173|P2|STARTED|24-week, Double-blind Treatment Period||162
83448|NCT01376245|199174|P1|STARTED|24-week, Double-blind Treatment Period||0
83449|NCT01376245|199170|P5|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83450|NCT01376245|199171|P4|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83451|NCT01376245|199172|P3|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83452|NCT01376245|199173|P2|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83453|NCT01376245|199174|P1|NOT COMPLETED|2-wk Single-blind Placebo Run-in Period||101
83454|NCT01376245|199170|P5|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83455|NCT01376245|199171|P4|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83456|NCT01376245|199172|P3|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83457|NCT01376245|199173|P2|COMPLETED|2-wk Single-blind Placebo Run-in Period||0
83458|NCT01376245|199174|P1|COMPLETED|2-wk Single-blind Placebo Run-in Period||643
83459|NCT01376245|199170|P5|STARTED|2-wk Single-blind Placebo Run-in Period||0
83460|NCT01376245|199171|P4|STARTED|2-wk Single-blind Placebo Run-in Period||0
83461|NCT01376245|199172|P3|STARTED|2-wk Single-blind Placebo Run-in Period||0
83462|NCT01376245|199173|P2|STARTED|2-wk Single-blind Placebo Run-in Period||0
83463|NCT01376245|199174|P1|STARTED|2-wk Single-blind Placebo Run-in Period||744
83464|NCT01376089|199190|P2|NOT COMPLETED|Overall Study||4
83465|NCT01376089|199191|P1|NOT COMPLETED|Overall Study||3
83466|NCT01376089|199190|P2|COMPLETED|Overall Study||144
83467|NCT01376089|199191|P1|COMPLETED|Overall Study||148
83468|NCT01376089|199190|P2|STARTED|Overall Study||148
83469|NCT01376089|199191|P1|STARTED|Overall Study||151
83470|NCT01376050|199203|P2|NOT COMPLETED|Overall Study||0
83471|NCT01376050|199204|P1|NOT COMPLETED|Overall Study||0
83472|NCT01376050|199203|P2|COMPLETED|Overall Study||11
83473|NCT01376050|199204|P1|COMPLETED|Overall Study||13
83474|NCT01376050|199203|P2|STARTED|Overall Study||11
83475|NCT01376050|199204|P1|STARTED|Overall Study||13
83476|NCT01376037|199214|P2|NOT COMPLETED|Overall Study||2
83477|NCT01376037|199215|P1|NOT COMPLETED|Overall Study||0
83478|NCT01376037|199214|P2|COMPLETED|Overall Study||29
83479|NCT01376037|199215|P1|COMPLETED|Overall Study||31
83480|NCT01376037|199214|P2|STARTED|Overall Study||31
83481|NCT01376037|199215|P1|STARTED|Overall Study||31
83482|NCT01375777|199230|P9|NOT COMPLETED|Overall Study||2
83483|NCT01375777|199231|P8|NOT COMPLETED|Overall Study||2
83484|NCT01375777|199232|P7|NOT COMPLETED|Overall Study||2
83485|NCT01375777|199233|P6|NOT COMPLETED|Overall Study||1
83486|NCT01375777|199234|P5|NOT COMPLETED|Overall Study||1
83487|NCT01375777|199235|P4|NOT COMPLETED|Overall Study||0
83488|NCT01375777|199236|P3|NOT COMPLETED|Overall Study||1
83489|NCT01375777|199237|P2|NOT COMPLETED|Overall Study||3
83490|NCT01375777|199238|P1|NOT COMPLETED|Overall Study||2
83491|NCT01375777|199230|P9|COMPLETED|Overall Study||44
83492|NCT01375777|199231|P8|COMPLETED|Overall Study||44
83493|NCT01375777|199232|P7|COMPLETED|Overall Study||44
83494|NCT01375777|199233|P6|COMPLETED|Overall Study||44
83495|NCT01375777|199234|P5|COMPLETED|Overall Study||45
83496|NCT01375777|199235|P4|COMPLETED|Overall Study||45
83497|NCT01375777|199236|P3|COMPLETED|Overall Study||45
83498|NCT01375777|199237|P2|COMPLETED|Overall Study||42
83499|NCT01375777|199238|P1|COMPLETED|Overall Study||44
83500|NCT01375777|199230|P9|Received Treatment|Overall Study||45
83501|NCT01375777|199231|P8|Received Treatment|Overall Study||45
83502|NCT01375777|199232|P7|Received Treatment|Overall Study||45
83503|NCT01375777|199233|P6|Received Treatment|Overall Study||45
83504|NCT01375777|199234|P5|Received Treatment|Overall Study||46
83505|NCT01375777|199235|P4|Received Treatment|Overall Study||45
83506|NCT01375777|199236|P3|Received Treatment|Overall Study||45
83507|NCT01375777|199237|P2|Received Treatment|Overall Study||45
83508|NCT01375777|199238|P1|Received Treatment|Overall Study||45
83509|NCT01375777|199230|P9|STARTED|Overall Study||46
83510|NCT01375777|199231|P8|STARTED|Overall Study||46
83511|NCT01375777|199232|P7|STARTED|Overall Study||46
83512|NCT01375777|199233|P6|STARTED|Overall Study||45
83513|NCT01375777|199234|P5|STARTED|Overall Study||46
83514|NCT01375777|199235|P4|STARTED|Overall Study||45
83515|NCT01375777|199236|P3|STARTED|Overall Study||46
83516|NCT01375777|199237|P2|STARTED|Overall Study||45
83517|NCT01375777|199238|P1|STARTED|Overall Study||46
83518|NCT01375764|199308|P5|NOT COMPLETED|Overall Study||1
83519|NCT01375764|199309|P4|NOT COMPLETED|Overall Study||1
83520|NCT01375764|199310|P3|NOT COMPLETED|Overall Study||0
83521|NCT01375764|199311|P2|NOT COMPLETED|Overall Study||1
83522|NCT01375764|199312|P1|NOT COMPLETED|Overall Study||2
83523|NCT01375764|199308|P5|COMPLETED|Overall Study||31
83524|NCT01375764|199309|P4|COMPLETED|Overall Study||31
83525|NCT01375764|199310|P3|COMPLETED|Overall Study||32
83526|NCT01375764|199311|P2|COMPLETED|Overall Study||30
83527|NCT01375764|199312|P1|COMPLETED|Overall Study||31
83528|NCT01375764|199308|P5|Received Treatment|Overall Study||32
83529|NCT01375764|199309|P4|Received Treatment|Overall Study||31
83530|NCT01375764|199310|P3|Received Treatment|Overall Study||32
83531|NCT01375764|199311|P2|Received Treatment|Overall Study||30
83532|NCT01375764|199312|P1|Received Treatment|Overall Study||32
83533|NCT01375764|199308|P5|STARTED|Overall Study||32
83534|NCT01375764|199309|P4|STARTED|Overall Study||32
83535|NCT01375764|199310|P3|STARTED|Overall Study||32
83536|NCT01375764|199311|P2|STARTED|Overall Study||31
83537|NCT01375764|199312|P1|STARTED|Overall Study||33
83538|NCT01375751|199358|P3|NOT COMPLETED|Overall Study||0
83539|NCT01375751|199359|P2|NOT COMPLETED|Overall Study||1
83540|NCT01375751|199360|P1|NOT COMPLETED|Overall Study||0
83541|NCT01375751|199358|P3|COMPLETED|Overall Study||56
83542|NCT01375751|199359|P2|COMPLETED|Overall Study||55
83543|NCT01375751|199360|P1|COMPLETED|Overall Study||56
83544|NCT01375751|199358|P3|Received Treatment|Overall Study||56
83545|NCT01375751|199359|P2|Received Treatment|Overall Study||55
83546|NCT01375751|199360|P1|Received Treatment|Overall Study||56
83547|NCT01375751|199358|P3|STARTED|Overall Study||56
83548|NCT01375751|199359|P2|STARTED|Overall Study||56
83549|NCT01375751|199360|P1|STARTED|Overall Study||56
83550|NCT01375660|199385|P2|NOT COMPLETED|Overall Study||16
83551|NCT01375660|199386|P1|NOT COMPLETED|Overall Study||16
83552|NCT01375660|199385|P2|COMPLETED|Overall Study||87
83553|NCT01375660|199386|P1|COMPLETED|Overall Study||86
83554|NCT01375660|199385|P2|STARTED|Overall Study||103
83555|NCT01375660|199386|P1|STARTED|Overall Study||102
83556|NCT01375608|199404|P1|NOT COMPLETED|Overall Study||2
83557|NCT01375608|199404|P1|COMPLETED|Overall Study||8
83558|NCT01375608|199404|P1|STARTED|Overall Study||10
83559|NCT01375569|199408|P1|NOT COMPLETED|Overall Study||0
83560|NCT01375569|199408|P1|COMPLETED|Overall Study||11
83561|NCT01375569|199408|P1|STARTED|Overall Study||11
83562|NCT01375374|199413|P1|NOT COMPLETED|Overall Study||1
83563|NCT01375374|199413|P1|COMPLETED|Overall Study||10
83564|NCT01375374|199413|P1|STARTED|Overall Study||11
83565|NCT01375127|199426|P6|NOT COMPLETED|Overall Study||0
83566|NCT01375127|199427|P5|NOT COMPLETED|Overall Study||0
83567|NCT01375127|199428|P4|NOT COMPLETED|Overall Study||0
83568|NCT01375127|199429|P3|NOT COMPLETED|Overall Study||0
83569|NCT01375127|199430|P2|NOT COMPLETED|Overall Study||0
83570|NCT01375127|199431|P1|NOT COMPLETED|Overall Study||0
83571|NCT01375127|199426|P6|COMPLETED|Overall Study||3
83572|NCT01375127|199427|P5|COMPLETED|Overall Study||5
83573|NCT01375127|199428|P4|COMPLETED|Overall Study||33
83574|NCT01375127|199429|P3|COMPLETED|Overall Study||40
83575|NCT01375127|199430|P2|COMPLETED|Overall Study||1
83576|NCT01375127|199431|P1|COMPLETED|Overall Study||1
83577|NCT01375127|199426|P6|STARTED|Overall Study||3
83578|NCT01375127|199427|P5|STARTED|Overall Study||5
83579|NCT01375127|199428|P4|STARTED|Overall Study||33
83580|NCT01375127|199429|P3|STARTED|Overall Study||40
83581|NCT01375127|199430|P2|STARTED|Overall Study||1
83582|NCT01375127|199431|P1|STARTED|Overall Study||1
83583|NCT01375049|199463|P1|NOT COMPLETED|Overall Study||50
83584|NCT01375049|199463|P1|COMPLETED|Overall Study||55
83585|NCT01375049|199463|P1|STARTED|Overall Study||105
83586|NCT01374971|199478|P1|NOT COMPLETED|Overall Study||1
83587|NCT01374971|199478|P1|COMPLETED|Overall Study||11
83588|NCT01374971|199478|P1|STARTED|Overall Study||12
83589|NCT01374919|199483|P1|NOT COMPLETED|Overall Study||2
83590|NCT01374919|199483|P1|COMPLETED|Overall Study||58
83591|NCT01374919|199483|P1|STARTED|Overall Study||60
83592|NCT01374802|199488|P1|NOT COMPLETED|Overall Study||0
83593|NCT01374802|199488|P1|COMPLETED|Overall Study||14
83594|NCT01374802|199488|P1|STARTED|Overall Study||14
83595|NCT01374568|199502|P2|NOT COMPLETED|Overall Study||2
83596|NCT01374568|199503|P1|NOT COMPLETED|Overall Study||0
83597|NCT01374568|199502|P2|COMPLETED|Overall Study||1
83598|NCT01374568|199503|P1|COMPLETED|Overall Study||2
83599|NCT01374568|199502|P2|STARTED|Overall Study||3
83600|NCT01374568|199503|P1|STARTED|Overall Study||2
83601|NCT01374451|199513|P2|NOT COMPLETED|Overall Study||0
83602|NCT01374451|199514|P1|NOT COMPLETED|Overall Study||1
83603|NCT01374451|199513|P2|COMPLETED|Overall Study||81
83604|NCT01374451|199514|P1|COMPLETED|Overall Study||78
83605|NCT01374451|199513|P2|STARTED|Overall Study||81
83606|NCT01374451|199514|P1|STARTED|Overall Study||79
83607|NCT01374438|199543|P2|NOT COMPLETED|Overall Study||0
83608|NCT01374438|199544|P1|NOT COMPLETED|Overall Study||0
83609|NCT01374438|199543|P2|COMPLETED|Overall Study||13
83610|NCT01374438|199544|P1|COMPLETED|Overall Study||16
83611|NCT01374438|199543|P2|STARTED|Overall Study||13
83612|NCT01374438|199544|P1|STARTED|Overall Study||16
83613|NCT01374425|199560|P2|NOT COMPLETED|Overall Study||188
83614|NCT01374425|199561|P1|NOT COMPLETED|Overall Study||188
83615|NCT01374425|199560|P2|COMPLETED|Overall Study||0
83616|NCT01374425|199561|P1|COMPLETED|Overall Study||0
83617|NCT01374425|199560|P2|STARTED|Overall Study||188
83618|NCT01374425|199561|P1|STARTED|Overall Study||188
83619|NCT01373671|199639|P1|NOT COMPLETED|Overall Study||92
83620|NCT01373671|199639|P1|COMPLETED|Overall Study||672
83621|NCT01373671|199639|P1|STARTED|Overall Study||764
83622|NCT01374269|199646|P2|NOT COMPLETED|Overall Study||5
83623|NCT01374269|199647|P1|NOT COMPLETED|Overall Study||6
83624|NCT01374269|199646|P2|COMPLETED|Overall Study||39
83625|NCT01374269|199647|P1|COMPLETED|Overall Study||40
83626|NCT01374269|199646|P2|STARTED|Overall Study||44
83627|NCT01374269|199647|P1|STARTED|Overall Study||46
83628|NCT01374178|199775|P2|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||0
83629|NCT01374178|199776|P1|NOT COMPLETED|Period 2 (up to 24 Hours After Dosing)||2
83630|NCT01374178|199775|P2|COMPLETED|Period 2 (up to 24 Hours After Dosing)||5
83631|NCT01374178|199776|P1|COMPLETED|Period 2 (up to 24 Hours After Dosing)||8
83632|NCT01374178|199775|P2|STARTED|Period 2 (up to 24 Hours After Dosing)||5
83633|NCT01374178|199776|P1|STARTED|Period 2 (up to 24 Hours After Dosing)||10
83634|NCT01374178|199775|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
83635|NCT01374178|199776|P1|NOT COMPLETED|Washout Period of at Least 7 Days||1
83636|NCT01374178|199775|P2|COMPLETED|Washout Period of at Least 7 Days||5
83637|NCT01374178|199776|P1|COMPLETED|Washout Period of at Least 7 Days||10
83638|NCT01374178|199775|P2|STARTED|Washout Period of at Least 7 Days||5
83639|NCT01374178|199776|P1|STARTED|Washout Period of at Least 7 Days||11
83640|NCT01374178|199775|P2|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
83641|NCT01374178|199776|P1|NOT COMPLETED|Period 1 (up to 24 Hours After Dosing)||0
83642|NCT01374178|199775|P2|COMPLETED|Period 1 (up to 24 Hours After Dosing)||5
83643|NCT01374178|199776|P1|COMPLETED|Period 1 (up to 24 Hours After Dosing)||11
83644|NCT01374178|199775|P2|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||5
83645|NCT01374178|199776|P1|Received at Least 1 Dose of LY2963016|Period 1 (up to 24 Hours After Dosing)||11
83646|NCT01374178|199775|P2|STARTED|Period 1 (up to 24 Hours After Dosing)||5
83647|NCT01374178|199776|P1|STARTED|Period 1 (up to 24 Hours After Dosing)||11
83648|NCT01374087|199794|P2|NOT COMPLETED|Overall Study||16
83649|NCT01374087|199795|P1|NOT COMPLETED|Overall Study||15
83650|NCT01374087|199794|P2|COMPLETED|Overall Study||0
83651|NCT01374087|199795|P1|COMPLETED|Overall Study||0
83652|NCT01374087|199794|P2|STARTED|Overall Study||16
83653|NCT01374087|199795|P1|STARTED|Overall Study||15
83654|NCT01373918|199805|P2|NOT COMPLETED|Overall Study||1
83655|NCT01373918|199806|P1|NOT COMPLETED|Overall Study||0
83656|NCT01373918|199805|P2|COMPLETED|Overall Study||15
83657|NCT01373918|199806|P1|COMPLETED|Overall Study||20
83658|NCT01373918|199805|P2|STARTED|Overall Study||16
83659|NCT01373918|199806|P1|STARTED|Overall Study||20
83660|NCT01373450|199818|P6|NOT COMPLETED|Crossover Period 4||0
83661|NCT01373450|199819|P5|NOT COMPLETED|Crossover Period 4||0
83662|NCT01373450|199820|P4|NOT COMPLETED|Crossover Period 4||0
83663|NCT01373450|199821|P3|NOT COMPLETED|Crossover Period 4||0
83664|NCT01373450|199822|P2|NOT COMPLETED|Crossover Period 4||0
83665|NCT01373450|199823|P1|NOT COMPLETED|Crossover Period 4||0
83666|NCT01373450|199818|P6|COMPLETED|Crossover Period 4||2
83667|NCT01373450|199819|P5|COMPLETED|Crossover Period 4||2
83668|NCT01373450|199820|P4|COMPLETED|Crossover Period 4||2
83669|NCT01373450|199821|P3|COMPLETED|Crossover Period 4||2
83670|NCT01373450|199822|P2|COMPLETED|Crossover Period 4||2
83671|NCT01373450|199823|P1|COMPLETED|Crossover Period 4||2
83672|NCT01373450|199818|P6|STARTED|Crossover Period 4||2
83673|NCT01373450|199819|P5|STARTED|Crossover Period 4||2
83674|NCT01373450|199820|P4|STARTED|Crossover Period 4||2
83675|NCT01373450|199821|P3|STARTED|Crossover Period 4||2
83676|NCT01373450|199822|P2|STARTED|Crossover Period 4||2
83677|NCT01373450|199823|P1|STARTED|Crossover Period 4||2
83678|NCT01373450|199818|P6|NOT COMPLETED|7 Day Wash-out||0
83679|NCT01373450|199819|P5|NOT COMPLETED|7 Day Wash-out||0
83680|NCT01373450|199820|P4|NOT COMPLETED|7 Day Wash-out||0
83681|NCT01373450|199821|P3|NOT COMPLETED|7 Day Wash-out||0
83682|NCT01373450|199822|P2|NOT COMPLETED|7 Day Wash-out||0
83683|NCT01373450|199823|P1|NOT COMPLETED|7 Day Wash-out||0
83684|NCT01373450|199818|P6|COMPLETED|7 Day Wash-out||2
83685|NCT01373450|199819|P5|COMPLETED|7 Day Wash-out||2
83686|NCT01373450|199820|P4|COMPLETED|7 Day Wash-out||2
83687|NCT01373450|199821|P3|COMPLETED|7 Day Wash-out||2
83688|NCT01373450|199822|P2|COMPLETED|7 Day Wash-out||2
83689|NCT01373450|199823|P1|COMPLETED|7 Day Wash-out||2
83690|NCT01373450|199818|P6|STARTED|7 Day Wash-out||2
83691|NCT01373450|199819|P5|STARTED|7 Day Wash-out||2
83692|NCT01373450|199820|P4|STARTED|7 Day Wash-out||2
83693|NCT01373450|199821|P3|STARTED|7 Day Wash-out||2
83694|NCT01373450|199822|P2|STARTED|7 Day Wash-out||2
83695|NCT01373450|199823|P1|STARTED|7 Day Wash-out||2
83696|NCT01373450|199818|P6|NOT COMPLETED|Crossover Period 3||0
83697|NCT01373450|199819|P5|NOT COMPLETED|Crossover Period 3||0
83698|NCT01373450|199820|P4|NOT COMPLETED|Crossover Period 3||0
83699|NCT01373450|199821|P3|NOT COMPLETED|Crossover Period 3||0
83700|NCT01373450|199822|P2|NOT COMPLETED|Crossover Period 3||0
83701|NCT01373450|199823|P1|NOT COMPLETED|Crossover Period 3||0
83702|NCT01373450|199818|P6|COMPLETED|Crossover Period 3||2
83703|NCT01373450|199819|P5|COMPLETED|Crossover Period 3||2
83704|NCT01373450|199820|P4|COMPLETED|Crossover Period 3||2
83705|NCT01373450|199821|P3|COMPLETED|Crossover Period 3||2
83706|NCT01373450|199822|P2|COMPLETED|Crossover Period 3||2
83707|NCT01373450|199823|P1|COMPLETED|Crossover Period 3||2
83708|NCT01373450|199818|P6|STARTED|Crossover Period 3||2
83709|NCT01373450|199819|P5|STARTED|Crossover Period 3||2
83710|NCT01373450|199820|P4|STARTED|Crossover Period 3||2
83711|NCT01373450|199821|P3|STARTED|Crossover Period 3||2
83712|NCT01373450|199822|P2|STARTED|Crossover Period 3||2
83713|NCT01373450|199823|P1|STARTED|Crossover Period 3||2
83714|NCT01373450|199818|P6|NOT COMPLETED|7 Day Wash-out||0
83715|NCT01373450|199819|P5|NOT COMPLETED|7 Day Wash-out||0
83716|NCT01373450|199820|P4|NOT COMPLETED|7 Day Wash-out||0
83717|NCT01373450|199821|P3|NOT COMPLETED|7 Day Wash-out||0
83718|NCT01373450|199822|P2|NOT COMPLETED|7 Day Wash-out||0
83719|NCT01373450|199823|P1|NOT COMPLETED|7 Day Wash-out||0
83720|NCT01373450|199818|P6|COMPLETED|7 Day Wash-out||2
83721|NCT01373450|199819|P5|COMPLETED|7 Day Wash-out||2
83722|NCT01373450|199820|P4|COMPLETED|7 Day Wash-out||2
83723|NCT01373450|199821|P3|COMPLETED|7 Day Wash-out||2
83724|NCT01373450|199822|P2|COMPLETED|7 Day Wash-out||2
83725|NCT01373450|199823|P1|COMPLETED|7 Day Wash-out||2
83726|NCT01373450|199818|P6|STARTED|7 Day Wash-out||2
83727|NCT01373450|199819|P5|STARTED|7 Day Wash-out||2
83728|NCT01373450|199820|P4|STARTED|7 Day Wash-out||2
83729|NCT01373450|199821|P3|STARTED|7 Day Wash-out||2
83730|NCT01373450|199822|P2|STARTED|7 Day Wash-out||2
83731|NCT01373450|199823|P1|STARTED|7 Day Wash-out||2
83732|NCT01373450|199818|P6|NOT COMPLETED|Crossover Period 2||0
83733|NCT01373450|199819|P5|NOT COMPLETED|Crossover Period 2||0
83734|NCT01373450|199820|P4|NOT COMPLETED|Crossover Period 2||0
83735|NCT01373450|199821|P3|NOT COMPLETED|Crossover Period 2||0
83736|NCT01373450|199822|P2|NOT COMPLETED|Crossover Period 2||0
83737|NCT01373450|199823|P1|NOT COMPLETED|Crossover Period 2||0
83738|NCT01373450|199818|P6|COMPLETED|Crossover Period 2||2
83739|NCT01373450|199819|P5|COMPLETED|Crossover Period 2||2
83740|NCT01373450|199820|P4|COMPLETED|Crossover Period 2||2
83741|NCT01373450|199821|P3|COMPLETED|Crossover Period 2||2
83742|NCT01373450|199822|P2|COMPLETED|Crossover Period 2||2
83743|NCT01373450|199823|P1|COMPLETED|Crossover Period 2||2
83744|NCT01373450|199818|P6|STARTED|Crossover Period 2||2
83745|NCT01373450|199819|P5|STARTED|Crossover Period 2||2
83746|NCT01373450|199820|P4|STARTED|Crossover Period 2||2
83747|NCT01373450|199821|P3|STARTED|Crossover Period 2||2
83748|NCT01373450|199822|P2|STARTED|Crossover Period 2||2
83749|NCT01373450|199823|P1|STARTED|Crossover Period 2||2
83750|NCT01373450|199818|P6|NOT COMPLETED|7 Day Wash-out||0
83751|NCT01373450|199819|P5|NOT COMPLETED|7 Day Wash-out||0
83752|NCT01373450|199820|P4|NOT COMPLETED|7 Day Wash-out||0
83753|NCT01373450|199821|P3|NOT COMPLETED|7 Day Wash-out||0
83754|NCT01373450|199822|P2|NOT COMPLETED|7 Day Wash-out||0
83755|NCT01373450|199823|P1|NOT COMPLETED|7 Day Wash-out||0
83756|NCT01373450|199818|P6|COMPLETED|7 Day Wash-out||2
83757|NCT01373450|199819|P5|COMPLETED|7 Day Wash-out||2
83758|NCT01373450|199820|P4|COMPLETED|7 Day Wash-out||2
83759|NCT01373450|199821|P3|COMPLETED|7 Day Wash-out||2
83760|NCT01373450|199822|P2|COMPLETED|7 Day Wash-out||2
83761|NCT01373450|199823|P1|COMPLETED|7 Day Wash-out||2
83762|NCT01373450|199818|P6|STARTED|7 Day Wash-out||2
83763|NCT01373450|199819|P5|STARTED|7 Day Wash-out||2
83764|NCT01373450|199820|P4|STARTED|7 Day Wash-out||2
83765|NCT01373450|199821|P3|STARTED|7 Day Wash-out||2
83766|NCT01373450|199822|P2|STARTED|7 Day Wash-out||2
83767|NCT01373450|199823|P1|STARTED|7 Day Wash-out||2
83768|NCT01373450|199818|P6|NOT COMPLETED|Crossover Period 1||0
83769|NCT01373450|199819|P5|NOT COMPLETED|Crossover Period 1||0
83770|NCT01373450|199820|P4|NOT COMPLETED|Crossover Period 1||0
83771|NCT01373450|199821|P3|NOT COMPLETED|Crossover Period 1||0
83772|NCT01373450|199822|P2|NOT COMPLETED|Crossover Period 1||0
83773|NCT01373450|199823|P1|NOT COMPLETED|Crossover Period 1||0
83774|NCT01373450|199818|P6|COMPLETED|Crossover Period 1||2
83775|NCT01373450|199819|P5|COMPLETED|Crossover Period 1||2
83776|NCT01373450|199820|P4|COMPLETED|Crossover Period 1||2
83777|NCT01373450|199821|P3|COMPLETED|Crossover Period 1||2
83778|NCT01373450|199822|P2|COMPLETED|Crossover Period 1||2
83779|NCT01373450|199823|P1|COMPLETED|Crossover Period 1||2
83780|NCT01373450|199818|P6|STARTED|Crossover Period 1||2
83781|NCT01373450|199819|P5|STARTED|Crossover Period 1||2
83782|NCT01373450|199820|P4|STARTED|Crossover Period 1||2
83783|NCT01373450|199821|P3|STARTED|Crossover Period 1||2
83784|NCT01373450|199822|P2|STARTED|Crossover Period 1||2
83785|NCT01373450|199823|P1|STARTED|Crossover Period 1||2
83786|NCT01373346|199845|P1|NOT COMPLETED|Overall Study||1
83787|NCT01373346|199845|P1|COMPLETED|Overall Study||14
83788|NCT01373346|199845|P1|STARTED|Overall Study||15
83789|NCT01373294|199868|P2|NOT COMPLETED|Overall Study||0
83790|NCT01373294|199869|P1|NOT COMPLETED|Overall Study||1
83791|NCT01373294|199868|P2|COMPLETED|Overall Study||2
83792|NCT01373294|199869|P1|COMPLETED|Overall Study||14
83793|NCT01373294|199868|P2|STARTED|Overall Study||2
83794|NCT01373294|199869|P1|STARTED|Overall Study||15
83795|NCT01373281|199878|P2|NOT COMPLETED|Overall Study||45
83796|NCT01373281|199879|P1|NOT COMPLETED|Overall Study||79
83797|NCT01373281|199878|P2|COMPLETED|Overall Study||3379
83798|NCT01373281|199879|P1|COMPLETED|Overall Study||6772
83799|NCT01373281|199878|P2|STARTED|Overall Study||3424
83800|NCT01373281|199879|P1|STARTED|Overall Study||6851
83801|NCT01372995|199898|P3|NOT COMPLETED|Overall Study||1
83802|NCT01372995|199899|P2|NOT COMPLETED|Overall Study||1
83803|NCT01372995|199900|P1|NOT COMPLETED|Overall Study||0
83804|NCT01372995|199898|P3|COMPLETED|Overall Study|The transferred participant was included in the intent to treat analyses.|10
83805|NCT01372995|199899|P2|COMPLETED|Overall Study||9
83806|NCT01372995|199900|P1|COMPLETED|Overall Study||10
83807|NCT01372995|199898|P3|STARTED|Overall Study|One participant was transferred to comfort care prior to completing the intervention.|11
83808|NCT01372995|199899|P2|STARTED|Overall Study||10
83809|NCT01372995|199900|P1|STARTED|Overall Study||10
83810|NCT01372878|199947|P1|NOT COMPLETED|Overall Study||184
83811|NCT01372878|199947|P1|COMPLETED|Overall Study||700
83812|NCT01372878|199947|P1|STARTED|Overall Study||884
83813|NCT01372813|199952|P1|NOT COMPLETED|Overall Study||0
83814|NCT01372813|199952|P1|COMPLETED|Overall Study||3
83815|NCT01372813|199952|P1|STARTED|Overall Study||3
83816|NCT01372748|199967|P2|NOT COMPLETED|Overall Study||39
83817|NCT01372748|199968|P1|NOT COMPLETED|Overall Study||23
83818|NCT01372748|199967|P2|COMPLETED|Overall Study|defined as having vital status|12603
83819|NCT01372748|199968|P1|COMPLETED|Overall Study|defined as having vital status|11022
83820|NCT01372748|199967|P2|STARTED|Overall Study||12642
83821|NCT01372748|199968|P1|STARTED|Overall Study||11045
83822|NCT01372605|199978|P2|NOT COMPLETED|Overall Study||10
83823|NCT01372605|199979|P1|NOT COMPLETED|Overall Study||12
83824|NCT01372605|199978|P2|COMPLETED|Overall Study||145
83825|NCT01372605|199979|P1|COMPLETED|Overall Study||137
83826|NCT01372605|199978|P2|STARTED|Overall Study||155
83827|NCT01372605|199979|P1|STARTED|Overall Study||149
83828|NCT01372501|200005|P1|NOT COMPLETED|Overall Study||5
83829|NCT01372501|200005|P1|COMPLETED|Overall Study||14
83830|NCT01372501|200005|P1|STARTED|Overall Study||19
83831|NCT01372462|200010|P1|NOT COMPLETED|No Treatment Control||0
83832|NCT01372462|200010|P1|COMPLETED|No Treatment Control||15
83833|NCT01372462|200010|P1|STARTED|No Treatment Control||15
83834|NCT01372462|200010|P1|NOT COMPLETED|Oxygen Nasal Cannula||0
83835|NCT01372462|200010|P1|COMPLETED|Oxygen Nasal Cannula||15
83836|NCT01372462|200010|P1|STARTED|Oxygen Nasal Cannula||15
83837|NCT01372462|200010|P1|NOT COMPLETED|NIOV - Oxygen||0
83838|NCT01372462|200010|P1|COMPLETED|NIOV - Oxygen||15
83839|NCT01372462|200010|P1|STARTED|NIOV - Oxygen||15
83840|NCT01372462|200010|P1|NOT COMPLETED|NIOV - Room Air||0
83841|NCT01372462|200010|P1|COMPLETED|NIOV - Room Air||15
83842|NCT01372462|200010|P1|STARTED|NIOV - Room Air||15
83843|NCT01372410|200028|P8|NOT COMPLETED|Treatment Period 3 (7 Days)||0
83844|NCT01372410|200029|P7|NOT COMPLETED|Treatment Period 3 (7 Days)||0
83845|NCT01372410|200030|P6|NOT COMPLETED|Treatment Period 3 (7 Days)||1
83846|NCT01372410|200031|P5|NOT COMPLETED|Treatment Period 3 (7 Days)||0
83847|NCT01372410|200032|P4|NOT COMPLETED|Treatment Period 3 (7 Days)||0
83848|NCT01372410|200033|P3|NOT COMPLETED|Treatment Period 3 (7 Days)||1
83849|NCT01372410|200034|P2|NOT COMPLETED|Treatment Period 3 (7 Days)||0
83850|NCT01372410|200035|P1|NOT COMPLETED|Treatment Period 3 (7 Days)||0
83851|NCT01372410|200028|P8|COMPLETED|Treatment Period 3 (7 Days)||18
83852|NCT01372410|200029|P7|COMPLETED|Treatment Period 3 (7 Days)||15
83853|NCT01372410|200030|P6|COMPLETED|Treatment Period 3 (7 Days)||18
83854|NCT01372410|200031|P5|COMPLETED|Treatment Period 3 (7 Days)||20
83855|NCT01372410|200032|P4|COMPLETED|Treatment Period 3 (7 Days)||22
83856|NCT01372410|200033|P3|COMPLETED|Treatment Period 3 (7 Days)||15
83857|NCT01372410|200034|P2|COMPLETED|Treatment Period 3 (7 Days)||18
83858|NCT01372410|200035|P1|COMPLETED|Treatment Period 3 (7 Days)||21
83859|NCT01372410|200028|P8|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
83860|NCT01372410|200029|P7|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|15
83861|NCT01372410|200030|P6|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
83862|NCT01372410|200031|P5|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|20
83863|NCT01372410|200032|P4|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
83864|NCT01372410|200033|P3|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
83865|NCT01372410|200034|P2|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|18
83866|NCT01372410|200035|P1|STARTED|Treatment Period 3 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
83867|NCT01372410|200028|P8|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
83868|NCT01372410|200029|P7|NOT COMPLETED|Washout Period 2 (10-14 Days)||1
83869|NCT01372410|200030|P6|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
83870|NCT01372410|200031|P5|NOT COMPLETED|Washout Period 2 (10-14 Days)||2
83871|NCT01372410|200032|P4|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
83872|NCT01372410|200033|P3|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
83873|NCT01372410|200034|P2|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
83874|NCT01372410|200035|P1|NOT COMPLETED|Washout Period 2 (10-14 Days)||0
83875|NCT01372410|200028|P8|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
83876|NCT01372410|200029|P7|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
83877|NCT01372410|200030|P6|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|16
83878|NCT01372410|200031|P5|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
83879|NCT01372410|200032|P4|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|17
83880|NCT01372410|200033|P3|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|22
83881|NCT01372410|200034|P2|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
83882|NCT01372410|200035|P1|COMPLETED|Washout Period 2 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
83883|NCT01372410|200028|P8|STARTED|Washout Period 2 (10-14 Days)||19
83884|NCT01372410|200029|P7|STARTED|Washout Period 2 (10-14 Days)||21
83885|NCT01372410|200030|P6|STARTED|Washout Period 2 (10-14 Days)||16
83886|NCT01372410|200031|P5|STARTED|Washout Period 2 (10-14 Days)||19
83887|NCT01372410|200032|P4|STARTED|Washout Period 2 (10-14 Days)||17
83888|NCT01372410|200033|P3|STARTED|Washout Period 2 (10-14 Days)||22
83889|NCT01372410|200034|P2|STARTED|Washout Period 2 (10-14 Days)||21
83890|NCT01372410|200035|P1|STARTED|Washout Period 2 (10-14 Days)||19
83891|NCT01372410|200028|P8|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83892|NCT01372410|200029|P7|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83893|NCT01372410|200030|P6|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83894|NCT01372410|200031|P5|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83895|NCT01372410|200032|P4|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83896|NCT01372410|200033|P3|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83897|NCT01372410|200034|P2|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83898|NCT01372410|200035|P1|NOT COMPLETED|Treatment Period 2 (7 Days)||0
83899|NCT01372410|200028|P8|COMPLETED|Treatment Period 2 (7 Days)||19
83900|NCT01372410|200029|P7|COMPLETED|Treatment Period 2 (7 Days)||21
83901|NCT01372410|200030|P6|COMPLETED|Treatment Period 2 (7 Days)||16
83902|NCT01372410|200031|P5|COMPLETED|Treatment Period 2 (7 Days)||19
83903|NCT01372410|200032|P4|COMPLETED|Treatment Period 2 (7 Days)||17
83904|NCT01372410|200033|P3|COMPLETED|Treatment Period 2 (7 Days)||22
83905|NCT01372410|200034|P2|COMPLETED|Treatment Period 2 (7 Days)||21
83906|NCT01372410|200035|P1|COMPLETED|Treatment Period 2 (7 Days)||19
83907|NCT01372410|200028|P8|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
83908|NCT01372410|200029|P7|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
83909|NCT01372410|200030|P6|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|16
83910|NCT01372410|200031|P5|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
83911|NCT01372410|200032|P4|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|17
83912|NCT01372410|200033|P3|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|22
83913|NCT01372410|200034|P2|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|21
83914|NCT01372410|200035|P1|STARTED|Treatment Period 2 (7 Days)|By crossover design, participants were assigned to a different treatment arm in each period.|19
83915|NCT01372410|200028|P8|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
83916|NCT01372410|200029|P7|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
83917|NCT01372410|200030|P6|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
83918|NCT01372410|200031|P5|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
83919|NCT01372410|200032|P4|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
83920|NCT01372410|200033|P3|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
83921|NCT01372410|200034|P2|NOT COMPLETED|Washout Period 1 (10-14 Days)||0
83922|NCT01372410|200035|P1|NOT COMPLETED|Washout Period 1 (10-14 Days)||1
83923|NCT01372410|200028|P8|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
83924|NCT01372410|200029|P7|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
83925|NCT01372410|200030|P6|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
83926|NCT01372410|200031|P5|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
83927|NCT01372410|200032|P4|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
83928|NCT01372410|200033|P3|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
83929|NCT01372410|200034|P2|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|19
83930|NCT01372410|200035|P1|COMPLETED|Washout Period 1 (10-14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
83931|NCT01372410|200028|P8|STARTED|Washout Period 1 (10-14 Days)||19
83932|NCT01372410|200029|P7|STARTED|Washout Period 1 (10-14 Days)||20
83933|NCT01372410|200030|P6|STARTED|Washout Period 1 (10-14 Days)||21
83934|NCT01372410|200031|P5|STARTED|Washout Period 1 (10-14 Days)||19
83935|NCT01372410|200032|P4|STARTED|Washout Period 1 (10-14 Days)||20
83936|NCT01372410|200033|P3|STARTED|Washout Period 1 (10-14 Days)||19
83937|NCT01372410|200034|P2|STARTED|Washout Period 1 (10-14 Days)||19
83938|NCT01372410|200035|P1|STARTED|Washout Period 1 (10-14 Days)||19
83939|NCT01372410|200028|P8|NOT COMPLETED|Treatment Period 1 (7 Days)||0
83940|NCT01372410|200029|P7|NOT COMPLETED|Treatment Period 1 (7 Days)||2
83941|NCT01372410|200030|P6|NOT COMPLETED|Treatment Period 1 (7 Days)||0
83942|NCT01372410|200031|P5|NOT COMPLETED|Treatment Period 1 (7 Days)||2
83943|NCT01372410|200032|P4|NOT COMPLETED|Treatment Period 1 (7 Days)||0
83944|NCT01372410|200033|P3|NOT COMPLETED|Treatment Period 1 (7 Days)||0
83945|NCT01372410|200034|P2|NOT COMPLETED|Treatment Period 1 (7 Days)||2
83946|NCT01372410|200035|P1|NOT COMPLETED|Treatment Period 1 (7 Days)||1
83947|NCT01372410|200028|P8|COMPLETED|Treatment Period 1 (7 Days)||19
83948|NCT01372410|200029|P7|COMPLETED|Treatment Period 1 (7 Days)||20
83949|NCT01372410|200030|P6|COMPLETED|Treatment Period 1 (7 Days)||21
83950|NCT01372410|200031|P5|COMPLETED|Treatment Period 1 (7 Days)||19
83951|NCT01372410|200032|P4|COMPLETED|Treatment Period 1 (7 Days)||20
83952|NCT01372410|200033|P3|COMPLETED|Treatment Period 1 (7 Days)||19
83953|NCT01372410|200034|P2|COMPLETED|Treatment Period 1 (7 Days)||19
83954|NCT01372410|200035|P1|COMPLETED|Treatment Period 1 (7 Days)||19
83955|NCT01372410|200028|P8|STARTED|Treatment Period 1 (7 Days)||19
83956|NCT01372410|200029|P7|STARTED|Treatment Period 1 (7 Days)||22
83957|NCT01372410|200030|P6|STARTED|Treatment Period 1 (7 Days)||21
83958|NCT01372410|200031|P5|STARTED|Treatment Period 1 (7 Days)||21
83959|NCT01372410|200032|P4|STARTED|Treatment Period 1 (7 Days)||20
83960|NCT01372410|200033|P3|STARTED|Treatment Period 1 (7 Days)||19
83961|NCT01372410|200034|P2|STARTED|Treatment Period 1 (7 Days)||21
83962|NCT01372410|200035|P1|STARTED|Treatment Period 1 (7 Days)||20
83963|NCT01372384|200072|P1|NOT COMPLETED|Overall Study||3
83964|NCT01372384|200072|P1|COMPLETED|Overall Study||3
83965|NCT01372384|200072|P1|STARTED|Overall Study||6
83966|NCT01372202|200082|P3|NOT COMPLETED|Overall Study||0
83967|NCT01372202|200083|P2|NOT COMPLETED|Overall Study||0
83968|NCT01372202|200084|P1|NOT COMPLETED|Overall Study||0
83969|NCT01372202|200082|P3|COMPLETED|Overall Study||9
83970|NCT01372202|200083|P2|COMPLETED|Overall Study||9
83971|NCT01372202|200084|P1|COMPLETED|Overall Study||13
83972|NCT01372202|200082|P3|STARTED|Overall Study||9
83973|NCT01372202|200083|P2|STARTED|Overall Study||9
83974|NCT01372202|200084|P1|STARTED|Overall Study||13
83975|NCT01372150|200095|P3|NOT COMPLETED|Overall Study||16
83976|NCT01372150|200096|P2|NOT COMPLETED|Overall Study||14
83977|NCT01372150|200097|P1|NOT COMPLETED|Overall Study||13
83978|NCT01372150|200095|P3|COMPLETED|Overall Study||99
83979|NCT01372150|200096|P2|COMPLETED|Overall Study||99
83980|NCT01372150|200097|P1|COMPLETED|Overall Study||99
83981|NCT01372150|200095|P3|Treated|Overall Study||115
83982|NCT01372150|200096|P2|Treated|Overall Study||112
83983|NCT01372150|200097|P1|Treated|Overall Study||112
83984|NCT01372150|200095|P3|STARTED|Overall Study||115
83985|NCT01372150|200096|P2|STARTED|Overall Study||113
83986|NCT01372150|200097|P1|STARTED|Overall Study||112
83987|NCT01371994|200116|P2|NOT COMPLETED|Overall Study||42
83988|NCT01371994|200117|P1|NOT COMPLETED|Overall Study||57
83989|NCT01371994|200116|P2|COMPLETED|Overall Study||278
83990|NCT01371994|200117|P1|COMPLETED|Overall Study||263
83991|NCT01371994|200116|P2|Received Treatment|Overall Study||313
83992|NCT01371994|200117|P1|Received Treatment|Overall Study||310
83993|NCT01371994|200116|P2|STARTED|Overall Study||320
83994|NCT01371994|200117|P1|STARTED|Overall Study||320
83995|NCT01371877|200161|P2|NOT COMPLETED|Overall Study||4
83996|NCT01371877|200162|P1|NOT COMPLETED|Overall Study||0
83997|NCT01371877|200161|P2|COMPLETED|Overall Study||17
83998|NCT01371877|200162|P1|COMPLETED|Overall Study||21
83999|NCT01371877|200161|P2|STARTED|Overall Study||21
84000|NCT01371877|200162|P1|STARTED|Overall Study||21
84001|NCT01371851|200174|P2|NOT COMPLETED|Overall Study||9
84002|NCT01371851|200175|P1|NOT COMPLETED|Overall Study||8
84003|NCT01371851|200174|P2|COMPLETED|Overall Study||2
84004|NCT01371851|200175|P1|COMPLETED|Overall Study||3
84005|NCT01371851|200174|P2|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
84006|NCT01371851|200175|P1|STARTED|Overall Study|Eligible participants who showed up on day 1 of week 1 and received at least one dose of study med.|11
84007|NCT01371838|200183|P2|NOT COMPLETED|Overall Study||66
84008|NCT01371838|200184|P1|NOT COMPLETED|Overall Study||49
84009|NCT01371838|200183|P2|COMPLETED|Overall Study||317
84010|NCT01371838|200184|P1|COMPLETED|Overall Study||332
84011|NCT01371838|200183|P2|STARTED|Overall Study||383
84012|NCT01371838|200184|P1|STARTED|Overall Study||381
84013|NCT01371825|200220|P1|NOT COMPLETED|Long-term Treatment Period||0
84014|NCT01371825|200220|P1|COMPLETED|Long-term Treatment Period|This period is currently ongoing.|6
84015|NCT01371825|200220|P1|STARTED|Long-term Treatment Period||6
84016|NCT01371825|200220|P1|NOT COMPLETED|Primary Efficacy Analysis Period||3
84017|NCT01371825|200220|P1|COMPLETED|Primary Efficacy Analysis Period||6
84018|NCT01371825|200220|P1|STARTED|Primary Efficacy Analysis Period||9
84019|NCT01371786|200234|P2|NOT COMPLETED|Overall Study||0
84020|NCT01371786|200235|P1|NOT COMPLETED|Overall Study||0
84021|NCT01371786|200234|P2|COMPLETED|Overall Study||7
84022|NCT01371786|200235|P1|COMPLETED|Overall Study||7
84023|NCT01371786|200234|P2|STARTED|Overall Study||7
84024|NCT01371786|200235|P1|STARTED|Overall Study||7
84025|NCT01371747|200255|P6|NOT COMPLETED|Overall Study||14
84026|NCT01371747|200256|P5|NOT COMPLETED|Overall Study||7
84027|NCT01371747|200257|P4|NOT COMPLETED|Overall Study||9
84028|NCT01371747|200258|P3|NOT COMPLETED|Overall Study||24
84029|NCT01371747|200259|P2|NOT COMPLETED|Overall Study||23
84030|NCT01371747|200260|P1|NOT COMPLETED|Overall Study||18
84031|NCT01371747|200255|P6|COMPLETED|Overall Study||16
84032|NCT01371747|200256|P5|COMPLETED|Overall Study||21
84033|NCT01371747|200257|P4|COMPLETED|Overall Study||17
84034|NCT01371747|200258|P3|COMPLETED|Overall Study||50
84035|NCT01371747|200259|P2|COMPLETED|Overall Study||51
84036|NCT01371747|200260|P1|COMPLETED|Overall Study||56
84037|NCT01371747|200255|P6|STARTED|Overall Study||30
84038|NCT01371747|200256|P5|STARTED|Overall Study||28
84039|NCT01371747|200257|P4|STARTED|Overall Study||26
84040|NCT01371747|200258|P3|STARTED|Overall Study||74
84041|NCT01371747|200259|P2|STARTED|Overall Study||74
84042|NCT01371747|200260|P1|STARTED|Overall Study||74
84043|NCT01371734|200325|P3|NOT COMPLETED|Overall Study||17
84044|NCT01371734|200326|P2|NOT COMPLETED|Overall Study||19
84045|NCT01371734|200327|P1|NOT COMPLETED|Overall Study||23
84046|NCT01371734|200325|P3|COMPLETED|Overall Study||104
84047|NCT01371734|200326|P2|COMPLETED|Overall Study||103
84048|NCT01371734|200327|P1|COMPLETED|Overall Study||97
84049|NCT01371734|200325|P3|STARTED|Overall Study||121
84050|NCT01371734|200326|P2|STARTED|Overall Study||122
84051|NCT01371734|200327|P1|STARTED|Overall Study||120
84052|NCT01371721|200347|P3|NOT COMPLETED|Overall Study||30
84053|NCT01371721|200348|P2|NOT COMPLETED|Overall Study||24
84054|NCT01371721|200349|P1|NOT COMPLETED|Overall Study||29
84055|NCT01371721|200347|P3|COMPLETED|Overall Study||62
84056|NCT01371721|200348|P2|COMPLETED|Overall Study||65
84057|NCT01371721|200349|P1|COMPLETED|Overall Study||59
84058|NCT01371721|200347|P3|Treated|Overall Study||92
84059|NCT01371721|200348|P2|Treated|Overall Study||89
84060|NCT01371721|200349|P1|Treated|Overall Study||87
84061|NCT01371721|200347|P3|STARTED|Overall Study||92
84062|NCT01371721|200348|P2|STARTED|Overall Study||89
84063|NCT01371721|200349|P1|STARTED|Overall Study||88
84064|NCT01371708|200382|P3|NOT COMPLETED|Overall Study||39
84065|NCT01371708|200383|P2|NOT COMPLETED|Overall Study||30
84066|NCT01371708|200384|P1|NOT COMPLETED|Overall Study||26
84067|NCT01371708|200382|P3|COMPLETED|Overall Study||59
84068|NCT01371708|200383|P2|COMPLETED|Overall Study||63
84069|NCT01371708|200384|P1|COMPLETED|Overall Study||66
84070|NCT01371708|200382|P3|Received Treatment|Overall Study||97
84071|NCT01371708|200383|P2|Received Treatment|Overall Study||93
84072|NCT01371708|200384|P1|Received Treatment|Overall Study||91
84073|NCT01371708|200382|P3|STARTED|Overall Study||98
84074|NCT01371708|200383|P2|STARTED|Overall Study||93
84075|NCT01371708|200384|P1|STARTED|Overall Study||92
84076|NCT01371643|200416|P2|NOT COMPLETED|Overall Study||0
84077|NCT01371643|200417|P1|NOT COMPLETED|Overall Study||3
84078|NCT01371643|200416|P2|COMPLETED|Overall Study||26
84079|NCT01371643|200417|P1|COMPLETED|Overall Study||12
84080|NCT01371643|200416|P2|STARTED|Overall Study||26
84081|NCT01371643|200417|P1|STARTED|Overall Study||15
84082|NCT01371565|200427|P1|NOT COMPLETED|Overall Study||3
84083|NCT01371565|200427|P1|COMPLETED|Overall Study||1
84084|NCT01371565|200427|P1|STARTED|Overall Study||4
84085|NCT01371552|200431|P6|NOT COMPLETED|Part 2, One Week||0
84086|NCT01371552|200432|P5|NOT COMPLETED|Part 2, One Week||0
84087|NCT01371552|200433|P4|NOT COMPLETED|Part 2, One Week||0
84088|NCT01371552|200434|P3|NOT COMPLETED|Part 2, One Week||0
84089|NCT01371552|200435|P2|NOT COMPLETED|Part 2, One Week||0
84090|NCT01371552|200436|P1|NOT COMPLETED|Part 2, One Week||0
84091|NCT01371552|200431|P6|COMPLETED|Part 2, One Week||18
84092|NCT01371552|200432|P5|COMPLETED|Part 2, One Week||15
84093|NCT01371552|200433|P4|COMPLETED|Part 2, One Week||20
84094|NCT01371552|200434|P3|COMPLETED|Part 2, One Week||18
84095|NCT01371552|200435|P2|COMPLETED|Part 2, One Week||17
84096|NCT01371552|200436|P1|COMPLETED|Part 2, One Week||18
84097|NCT01371552|200431|P6|STARTED|Part 2, One Week||18
84098|NCT01371552|200432|P5|STARTED|Part 2, One Week||15
84099|NCT01371552|200433|P4|STARTED|Part 2, One Week||20
84100|NCT01371552|200434|P3|STARTED|Part 2, One Week||18
84101|NCT01371552|200435|P2|STARTED|Part 2, One Week||17
84102|NCT01371552|200436|P1|STARTED|Part 2, One Week|One participant discontinued between Part 1 and Part 2 due to inconvenience|18
84103|NCT01371552|200431|P6|NOT COMPLETED|Part 1, Third 3 Days||1
84104|NCT01371552|200432|P5|NOT COMPLETED|Part 1, Third 3 Days||1
84105|NCT01371552|200433|P4|NOT COMPLETED|Part 1, Third 3 Days||0
84106|NCT01371552|200434|P3|NOT COMPLETED|Part 1, Third 3 Days||0
84107|NCT01371552|200435|P2|NOT COMPLETED|Part 1, Third 3 Days||0
84108|NCT01371552|200436|P1|NOT COMPLETED|Part 1, Third 3 Days||0
84109|NCT01371552|200431|P6|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to discomfort, but continued into Part 2.|17
84110|NCT01371552|200432|P5|COMPLETED|Part 1, Third 3 Days|One subject did not complete period due to randomization error, but continued into Part 2.|14
84111|NCT01371552|200433|P4|COMPLETED|Part 1, Third 3 Days||20
84112|NCT01371552|200434|P3|COMPLETED|Part 1, Third 3 Days||18
84113|NCT01371552|200435|P2|COMPLETED|Part 1, Third 3 Days||17
84114|NCT01371552|200436|P1|COMPLETED|Part 1, Third 3 Days||19
84115|NCT01371552|200431|P6|STARTED|Part 1, Third 3 Days||18
84116|NCT01371552|200432|P5|STARTED|Part 1, Third 3 Days||15
84117|NCT01371552|200433|P4|STARTED|Part 1, Third 3 Days||20
84118|NCT01371552|200434|P3|STARTED|Part 1, Third 3 Days||18
84119|NCT01371552|200435|P2|STARTED|Part 1, Third 3 Days||17
84120|NCT01371552|200436|P1|STARTED|Part 1, Third 3 Days||19
84121|NCT01371552|200431|P6|NOT COMPLETED|Part 1, Second 3 Days||0
84122|NCT01371552|200432|P5|NOT COMPLETED|Part 1, Second 3 Days||0
84123|NCT01371552|200433|P4|NOT COMPLETED|Part 1, Second 3 Days||0
84124|NCT01371552|200434|P3|NOT COMPLETED|Part 1, Second 3 Days||0
84125|NCT01371552|200435|P2|NOT COMPLETED|Part 1, Second 3 Days||0
84126|NCT01371552|200436|P1|NOT COMPLETED|Part 1, Second 3 Days||1
84127|NCT01371552|200431|P6|COMPLETED|Part 1, Second 3 Days||18
84128|NCT01371552|200432|P5|COMPLETED|Part 1, Second 3 Days||15
84129|NCT01371552|200433|P4|COMPLETED|Part 1, Second 3 Days||20
84130|NCT01371552|200434|P3|COMPLETED|Part 1, Second 3 Days||18
84131|NCT01371552|200435|P2|COMPLETED|Part 1, Second 3 Days||17
84132|NCT01371552|200436|P1|COMPLETED|Part 1, Second 3 Days|One subject did not complete period due to discomfort but continued to next, as allowed by protocol|18
84133|NCT01371552|200431|P6|STARTED|Part 1, Second 3 Days||18
84134|NCT01371552|200432|P5|STARTED|Part 1, Second 3 Days||15
84135|NCT01371552|200433|P4|STARTED|Part 1, Second 3 Days||20
84136|NCT01371552|200434|P3|STARTED|Part 1, Second 3 Days|1 subject discontinued after First 3 days due to positive slit lamp findings unrelated to lens wear|18
84137|NCT01371552|200435|P2|STARTED|Part 1, Second 3 Days||17
84138|NCT01371552|200436|P1|STARTED|Part 1, Second 3 Days||19
84139|NCT01371552|200431|P6|NOT COMPLETED|Part 1, First 3 Days||0
84140|NCT01371552|200432|P5|NOT COMPLETED|Part 1, First 3 Days||0
84141|NCT01371552|200433|P4|NOT COMPLETED|Part 1, First 3 Days||0
84142|NCT01371552|200434|P3|NOT COMPLETED|Part 1, First 3 Days||1
84143|NCT01371552|200435|P2|NOT COMPLETED|Part 1, First 3 Days||0
84144|NCT01371552|200436|P1|NOT COMPLETED|Part 1, First 3 Days||0
84145|NCT01371552|200431|P6|COMPLETED|Part 1, First 3 Days||18
84146|NCT01371552|200432|P5|COMPLETED|Part 1, First 3 Days||15
84147|NCT01371552|200433|P4|COMPLETED|Part 1, First 3 Days||20
84148|NCT01371552|200434|P3|COMPLETED|Part 1, First 3 Days||19
84149|NCT01371552|200435|P2|COMPLETED|Part 1, First 3 Days||17
84150|NCT01371552|200436|P1|COMPLETED|Part 1, First 3 Days||19
84151|NCT01371552|200431|P6|STARTED|Part 1, First 3 Days||18
84152|NCT01371552|200432|P5|STARTED|Part 1, First 3 Days||15
84153|NCT01371552|200433|P4|STARTED|Part 1, First 3 Days||20
84154|NCT01371552|200434|P3|STARTED|Part 1, First 3 Days||20
84155|NCT01371552|200435|P2|STARTED|Part 1, First 3 Days||17
84156|NCT01371552|200436|P1|STARTED|Part 1, First 3 Days||19
84157|NCT01371539|200463|P2|NOT COMPLETED|Period Two: One Week||3
84158|NCT01371539|200464|P1|NOT COMPLETED|Period Two: One Week||0
84159|NCT01371539|200463|P2|COMPLETED|Period Two: One Week||47
84160|NCT01371539|200464|P1|COMPLETED|Period Two: One Week||53
84161|NCT01371539|200463|P2|STARTED|Period Two: One Week||50
84162|NCT01371539|200464|P1|STARTED|Period Two: One Week||53
84163|NCT01371539|200463|P2|NOT COMPLETED|Period One: One Week||1
84164|NCT01371539|200464|P1|NOT COMPLETED|Period One: One Week||0
84165|NCT01371539|200463|P2|COMPLETED|Period One: One Week||50
84166|NCT01371539|200464|P1|COMPLETED|Period One: One Week||53
84167|NCT01371539|200463|P2|STARTED|Period One: One Week||51
84168|NCT01371539|200464|P1|STARTED|Period One: One Week||53
84169|NCT01371006|200474|P2|NOT COMPLETED|Overall Study||0
84170|NCT01371006|200475|P1|NOT COMPLETED|Overall Study||1
84171|NCT01371006|200474|P2|COMPLETED|Overall Study||15
84172|NCT01371006|200475|P1|COMPLETED|Overall Study||13
84173|NCT01371006|200474|P2|STARTED|Overall Study||15
84174|NCT01371006|200475|P1|STARTED|Overall Study||14
84175|NCT01370863|200516|P2|NOT COMPLETED|Overall Study||3
84176|NCT01370863|200517|P1|NOT COMPLETED|Overall Study||2
84177|NCT01370863|200516|P2|COMPLETED|Overall Study||30
84178|NCT01370863|200517|P1|COMPLETED|Overall Study||32
84179|NCT01370863|200516|P2|STARTED|Overall Study||33
84180|NCT01370863|200517|P1|STARTED|Overall Study||34
84181|NCT01370837|200530|P3|NOT COMPLETED|Overall Study||0
84182|NCT01370837|200531|P2|NOT COMPLETED|Overall Study||0
84183|NCT01370837|200532|P1|NOT COMPLETED|Overall Study||0
84184|NCT01370837|200530|P3|COMPLETED|Overall Study||17
84185|NCT01370837|200531|P2|COMPLETED|Overall Study||12
84186|NCT01370837|200532|P1|COMPLETED|Overall Study||12
84187|NCT01370837|200530|P3|STARTED|Overall Study||17
84188|NCT01370837|200531|P2|STARTED|Overall Study||12
84189|NCT01370837|200532|P1|STARTED|Overall Study||12
84190|NCT01370733|200542|P2|NOT COMPLETED|Overall Study||22
84191|NCT01370733|200543|P1|NOT COMPLETED|Overall Study||17
84192|NCT01370733|200542|P2|COMPLETED|Overall Study||77
84193|NCT01370733|200543|P1|COMPLETED|Overall Study||86
84194|NCT01370733|200542|P2|STARTED|Overall Study||99
84195|NCT01370733|200543|P1|STARTED|Overall Study||103
84196|NCT01370694|200565|P1|NOT COMPLETED|Overall Study||6
84197|NCT01370694|200565|P1|COMPLETED|Overall Study||1
84198|NCT01370694|200565|P1|STARTED|Overall Study||7
84199|NCT01370655|200587|P12|NOT COMPLETED|Period 2||0
84200|NCT01370655|200588|P11|NOT COMPLETED|Period 2||1
84201|NCT01370655|200589|P10|NOT COMPLETED|Period 2||0
84202|NCT01370655|200590|P9|NOT COMPLETED|Period 2||2
84203|NCT01370655|200591|P8|NOT COMPLETED|Period 2||1
84204|NCT01370655|200592|P7|NOT COMPLETED|Period 2||1
84205|NCT01370655|200593|P6|NOT COMPLETED|Period 2||0
84206|NCT01370655|200594|P5|NOT COMPLETED|Period 2||1
84207|NCT01370655|200595|P4|NOT COMPLETED|Period 2||0
84208|NCT01370655|200596|P3|NOT COMPLETED|Period 2||2
84209|NCT01370655|200597|P2|NOT COMPLETED|Period 2||0
84210|NCT01370655|200598|P1|NOT COMPLETED|Period 2||0
84211|NCT01370655|200587|P12|COMPLETED|Period 2||3
84212|NCT01370655|200588|P11|COMPLETED|Period 2||2
84213|NCT01370655|200589|P10|COMPLETED|Period 2||2
84214|NCT01370655|200590|P9|COMPLETED|Period 2||1
84215|NCT01370655|200591|P8|COMPLETED|Period 2||3
84216|NCT01370655|200592|P7|COMPLETED|Period 2||2
84217|NCT01370655|200593|P6|COMPLETED|Period 2||4
84218|NCT01370655|200594|P5|COMPLETED|Period 2||2
84219|NCT01370655|200595|P4|COMPLETED|Period 2||3
84220|NCT01370655|200596|P3|COMPLETED|Period 2||1
84221|NCT01370655|200597|P2|COMPLETED|Period 2||7
84222|NCT01370655|200598|P1|COMPLETED|Period 2||5
84223|NCT01370655|200587|P12|STARTED|Period 2||3
84224|NCT01370655|200588|P11|STARTED|Period 2||3
84225|NCT01370655|200589|P10|STARTED|Period 2||2
84226|NCT01370655|200590|P9|STARTED|Period 2||3
84227|NCT01370655|200591|P8|STARTED|Period 2||4
84228|NCT01370655|200592|P7|STARTED|Period 2||3
84229|NCT01370655|200593|P6|STARTED|Period 2||4
84230|NCT01370655|200594|P5|STARTED|Period 2||3
84231|NCT01370655|200595|P4|STARTED|Period 2||3
84232|NCT01370655|200596|P3|STARTED|Period 2||3
84233|NCT01370655|200597|P2|STARTED|Period 2||7
84234|NCT01370655|200598|P1|STARTED|Period 2||5
84235|NCT01370655|200587|P12|NOT COMPLETED|Period 1||0
84236|NCT01370655|200588|P11|NOT COMPLETED|Period 1||0
84237|NCT01370655|200589|P10|NOT COMPLETED|Period 1||0
84238|NCT01370655|200590|P9|NOT COMPLETED|Period 1||0
84239|NCT01370655|200591|P8|NOT COMPLETED|Period 1||0
84240|NCT01370655|200592|P7|NOT COMPLETED|Period 1||1
84241|NCT01370655|200593|P6|NOT COMPLETED|Period 1||0
84242|NCT01370655|200594|P5|NOT COMPLETED|Period 1||0
84243|NCT01370655|200595|P4|NOT COMPLETED|Period 1||0
84244|NCT01370655|200596|P3|NOT COMPLETED|Period 1||0
84245|NCT01370655|200597|P2|NOT COMPLETED|Period 1||0
84246|NCT01370655|200598|P1|NOT COMPLETED|Period 1||2
84247|NCT01370655|200587|P12|COMPLETED|Period 1||3
84248|NCT01370655|200588|P11|COMPLETED|Period 1||3
84249|NCT01370655|200589|P10|COMPLETED|Period 1||2
84250|NCT01370655|200590|P9|COMPLETED|Period 1||3
84251|NCT01370655|200591|P8|COMPLETED|Period 1||4
84252|NCT01370655|200592|P7|COMPLETED|Period 1||3
84253|NCT01370655|200593|P6|COMPLETED|Period 1||4
84254|NCT01370655|200594|P5|COMPLETED|Period 1||3
84255|NCT01370655|200595|P4|COMPLETED|Period 1||3
84256|NCT01370655|200596|P3|COMPLETED|Period 1||3
84257|NCT01370655|200597|P2|COMPLETED|Period 1||7
84258|NCT01370655|200598|P1|COMPLETED|Period 1||5
84259|NCT01370655|200587|P12|STARTED|Period 1||3
84260|NCT01370655|200588|P11|STARTED|Period 1||3
84261|NCT01370655|200589|P10|STARTED|Period 1||2
84262|NCT01370655|200590|P9|STARTED|Period 1||3
84263|NCT01370655|200591|P8|STARTED|Period 1||4
84264|NCT01370655|200592|P7|STARTED|Period 1||4
84265|NCT01370655|200593|P6|STARTED|Period 1||4
84266|NCT01370655|200594|P5|STARTED|Period 1||3
84267|NCT01370655|200595|P4|STARTED|Period 1||3
84268|NCT01370655|200596|P3|STARTED|Period 1||3
84269|NCT01370655|200597|P2|STARTED|Period 1||7
84270|NCT01370655|200598|P1|STARTED|Period 1||7
84271|NCT01370642|200635|P3|NOT COMPLETED|Overall Study||29
84272|NCT01370642|200636|P2|NOT COMPLETED|Overall Study||6
84273|NCT01370642|200637|P1|NOT COMPLETED|Overall Study||8
84274|NCT01370642|200635|P3|COMPLETED|Overall Study||69
84275|NCT01370642|200636|P2|COMPLETED|Overall Study||92
84276|NCT01370642|200637|P1|COMPLETED|Overall Study||90
84277|NCT01370642|200635|P3|FAS Population|Overall Study||98
84278|NCT01370642|200636|P2|FAS Population|Overall Study||97
84279|NCT01370642|200637|P1|FAS Population|Overall Study||98
84280|NCT01370642|200635|P3|STARTED|Overall Study||98
84281|NCT01370642|200636|P2|STARTED|Overall Study||98
84282|NCT01370642|200637|P1|STARTED|Overall Study||98
84283|NCT01370616|200668|P2|NOT COMPLETED|Overall Study||67
84284|NCT01370616|200669|P1|NOT COMPLETED|Overall Study||62
84285|NCT01370616|200668|P2|COMPLETED|Overall Study||216
84286|NCT01370616|200669|P1|COMPLETED|Overall Study||220
84287|NCT01370616|200668|P2|Treated|Overall Study||275
84288|NCT01370616|200669|P1|Treated|Overall Study||275
84289|NCT01370616|200668|P2|STARTED|Overall Study|Participants randomized|283
84290|NCT01370616|200669|P1|STARTED|Overall Study|Participants randomized|282
84291|NCT01370603|200693|P2|NOT COMPLETED|Period 2||4
84292|NCT01370603|200694|P1|NOT COMPLETED|Period 2||3
84293|NCT01370603|200693|P2|COMPLETED|Period 2||146
84294|NCT01370603|200694|P1|COMPLETED|Period 2||138
84295|NCT01370603|200693|P2|STARTED|Period 2||150
84296|NCT01370603|200694|P1|STARTED|Period 2||141
84297|NCT01370603|200693|P2|NOT COMPLETED|Crossover Washout||4
84298|NCT01370603|200694|P1|NOT COMPLETED|Crossover Washout||9
84299|NCT01370603|200693|P2|COMPLETED|Crossover Washout||150
84300|NCT01370603|200694|P1|COMPLETED|Crossover Washout||141
84301|NCT01370603|200693|P2|STARTED|Crossover Washout||154
84302|NCT01370603|200694|P1|STARTED|Crossover Washout||150
84303|NCT01370603|200693|P2|NOT COMPLETED|Period 1||10
84304|NCT01370603|200694|P1|NOT COMPLETED|Period 1||14
84305|NCT01370603|200693|P2|COMPLETED|Period 1||154
84306|NCT01370603|200694|P1|COMPLETED|Period 1||150
84307|NCT01370603|200693|P2|STARTED|Period 1||164
84308|NCT01370603|200694|P1|STARTED|Period 1||164
84309|NCT01370590|200712|P2|NOT COMPLETED|Period 2||2
84310|NCT01370590|200713|P1|NOT COMPLETED|Period 2||1
84311|NCT01370590|200712|P2|COMPLETED|Period 2||184
84312|NCT01370590|200713|P1|COMPLETED|Period 2||180
84313|NCT01370590|200712|P2|STARTED|Period 2||186
84314|NCT01370590|200713|P1|STARTED|Period 2||181
84315|NCT01370590|200712|P2|NOT COMPLETED|Crossover Washout Period||6
84316|NCT01370590|200713|P1|NOT COMPLETED|Crossover Washout Period||6
84317|NCT01370590|200712|P2|COMPLETED|Crossover Washout Period||186
84318|NCT01370590|200713|P1|COMPLETED|Crossover Washout Period||181
84319|NCT01370590|200712|P2|STARTED|Crossover Washout Period||192
84320|NCT01370590|200713|P1|STARTED|Crossover Washout Period||187
84321|NCT01370590|200712|P2|NOT COMPLETED|Period 1||11
84322|NCT01370590|200713|P1|NOT COMPLETED|Period 1||16
84323|NCT01370590|200712|P2|COMPLETED|Period 1||192
84324|NCT01370590|200713|P1|COMPLETED|Period 1||187
84325|NCT01370590|200712|P2|STARTED|Period 1||203
84326|NCT01370590|200713|P1|STARTED|Period 1||203
84327|NCT01370538|200731|P2|NOT COMPLETED|Overall Study||19
84328|NCT01370538|200732|P1|NOT COMPLETED|Overall Study||19
84329|NCT01370538|200731|P2|COMPLETED|Overall Study||152
84330|NCT01370538|200732|P1|COMPLETED|Overall Study||151
84331|NCT01370538|200731|P2|Patients Who Completed Treatment|Overall Study||152
84332|NCT01370538|200732|P1|Patients Who Completed Treatment|Overall Study||151
84333|NCT01370538|200731|P2|Patients Who Received Treatment|Overall Study||161
84334|NCT01370538|200732|P1|Patients Who Received Treatment|Overall Study||165
84335|NCT01370538|200731|P2|STARTED|Overall Study||171
84336|NCT01370538|200732|P1|STARTED|Overall Study||170
84337|NCT01370525|200748|P2|NOT COMPLETED|Overall Study||11
84338|NCT01370525|200749|P1|NOT COMPLETED|Overall Study||8
84339|NCT01370525|200748|P2|COMPLETED|Overall Study||158
84340|NCT01370525|200749|P1|COMPLETED|Overall Study||163
84341|NCT01370525|200748|P2|Patients Who Completed Treatment|Overall Study||158
84342|NCT01370525|200749|P1|Patients Who Completed Treatment|Overall Study||163
84343|NCT01370525|200748|P2|Patients Who Received Treatment|Overall Study||163
84344|NCT01370525|200749|P1|Patients Who Received Treatment|Overall Study||168
84345|NCT01370525|200748|P2|STARTED|Overall Study||169
84346|NCT01370525|200749|P1|STARTED|Overall Study||171
84347|NCT01370460|200765|P2|NOT COMPLETED|Overall Study||0
84348|NCT01370460|200766|P1|NOT COMPLETED|Overall Study||0
84349|NCT01370460|200765|P2|COMPLETED|Overall Study||51
84350|NCT01370460|200766|P1|COMPLETED|Overall Study||50
84351|NCT01370460|200765|P2|STARTED|Overall Study||51
84352|NCT01370460|200766|P1|STARTED|Overall Study||50
84353|NCT01370408|200773|P1|NOT COMPLETED|Overall Study||9
84354|NCT01370408|200773|P1|COMPLETED|Overall Study||76
84355|NCT01370408|200773|P1|STARTED|Overall Study||85
84356|NCT01370369|200784|P1|NOT COMPLETED|Overall Study||0
84357|NCT01370369|200784|P1|COMPLETED|Overall Study||20
84358|NCT01370369|200784|P1|STARTED|Overall Study||20
84359|NCT01370356|200833|P2|NOT COMPLETED|Overall Study||227
84360|NCT01370356|200834|P1|NOT COMPLETED|Overall Study||192
84361|NCT01370356|200833|P2|COMPLETED|Overall Study||515
84362|NCT01370356|200834|P1|COMPLETED|Overall Study||559
84363|NCT01370356|200833|P2|STARTED|Overall Study||742
84364|NCT01370356|200834|P1|STARTED|Overall Study||751
84365|NCT01370265|200848|P2|NOT COMPLETED|Second Intervention||0
84366|NCT01370265|200849|P1|NOT COMPLETED|Second Intervention||0
84367|NCT01370265|200848|P2|COMPLETED|Second Intervention||5
84368|NCT01370265|200849|P1|COMPLETED|Second Intervention||5
84369|NCT01370265|200848|P2|STARTED|Second Intervention||5
84370|NCT01370265|200849|P1|STARTED|Second Intervention||5
84371|NCT01370265|200848|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
84372|NCT01370265|200849|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
84373|NCT01370265|200848|P2|COMPLETED|Washout Period (50-minute Period Decay)||5
84374|NCT01370265|200849|P1|COMPLETED|Washout Period (50-minute Period Decay)||5
84375|NCT01370265|200848|P2|STARTED|Washout Period (50-minute Period Decay)||5
84376|NCT01370265|200849|P1|STARTED|Washout Period (50-minute Period Decay)||5
84377|NCT01370265|200848|P2|NOT COMPLETED|First Intervention||1
84378|NCT01370265|200849|P1|NOT COMPLETED|First Intervention||1
84379|NCT01370265|200848|P2|COMPLETED|First Intervention||5
84380|NCT01370265|200849|P1|COMPLETED|First Intervention||5
84381|NCT01370265|200848|P2|STARTED|First Intervention||6
84382|NCT01370265|200849|P1|STARTED|First Intervention||6
84383|NCT01370265|200848|P2|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
84384|NCT01370265|200849|P1|NOT COMPLETED|Washout Period (50-minute Period Decay)||0
84385|NCT01370265|200848|P2|COMPLETED|Washout Period (50-minute Period Decay)||6
84386|NCT01370265|200849|P1|COMPLETED|Washout Period (50-minute Period Decay)||6
84387|NCT01370265|200848|P2|STARTED|Washout Period (50-minute Period Decay)||6
84388|NCT01370265|200849|P1|STARTED|Washout Period (50-minute Period Decay)||6
84389|NCT01370265|200848|P2|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
84390|NCT01370265|200849|P1|NOT COMPLETED|Resting Myocardial Blood Flow (MBF)||0
84391|NCT01370265|200848|P2|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
84392|NCT01370265|200849|P1|COMPLETED|Resting Myocardial Blood Flow (MBF)||6
84393|NCT01370265|200848|P2|STARTED|Resting Myocardial Blood Flow (MBF)||6
84394|NCT01370265|200849|P1|STARTED|Resting Myocardial Blood Flow (MBF)||6
84395|NCT01370083|200868|P2|NOT COMPLETED|Overall Study||1
84396|NCT01370083|200869|P1|NOT COMPLETED|Overall Study||2
84397|NCT01370083|200868|P2|COMPLETED|Overall Study||6
84398|NCT01370083|200869|P1|COMPLETED|Overall Study||5
84399|NCT01370083|200868|P2|STARTED|Overall Study||7
84400|NCT01370083|200869|P1|STARTED|Overall Study||7
84401|NCT01370005|200882|P3|NOT COMPLETED|Overall Study||11
84402|NCT01370005|200883|P2|NOT COMPLETED|Overall Study||11
84403|NCT01370005|200884|P1|NOT COMPLETED|Overall Study||16
84404|NCT01370005|200882|P3|COMPLETED|Overall Study||266
84405|NCT01370005|200883|P2|COMPLETED|Overall Study||265
84406|NCT01370005|200884|P1|COMPLETED|Overall Study||256
84407|NCT01370005|200882|P3|STARTED|Overall Study||277
84408|NCT01370005|200883|P2|STARTED|Overall Study||276
84409|NCT01370005|200884|P1|STARTED|Overall Study||272
84410|NCT01369888|200941|P4|NOT COMPLETED|Overall Study||0
84411|NCT01369888|200942|P3|NOT COMPLETED|Overall Study||0
84412|NCT01369888|200943|P2|NOT COMPLETED|Overall Study||0
84413|NCT01369888|200944|P1|NOT COMPLETED|Overall Study||0
84414|NCT01369888|200941|P4|COMPLETED|Overall Study||0
84415|NCT01369888|200942|P3|COMPLETED|Overall Study||0
84416|NCT01369888|200943|P2|COMPLETED|Overall Study||2
84417|NCT01369888|200944|P1|COMPLETED|Overall Study||1
84418|NCT01369888|200941|P4|STARTED|Overall Study||0
84419|NCT01369888|200942|P3|STARTED|Overall Study||0
84420|NCT01369888|200943|P2|STARTED|Overall Study||2
84421|NCT01369888|200944|P1|STARTED|Overall Study||1
84422|NCT01369875|200954|P2|NOT COMPLETED|Overall Study||0
84423|NCT01369875|200955|P1|NOT COMPLETED|Overall Study||0
84424|NCT01369875|200954|P2|COMPLETED|Overall Study||1
84425|NCT01369875|200955|P1|COMPLETED|Overall Study||1
84426|NCT01369875|200954|P2|STARTED|Overall Study||1
84427|NCT01369875|200955|P1|STARTED|Overall Study||1
84428|NCT01369849|200966|P3|NOT COMPLETED|Overall Study||1
84429|NCT01369849|200967|P2|NOT COMPLETED|Overall Study||0
84430|NCT01369849|200968|P1|NOT COMPLETED|Overall Study||0
84431|NCT01369849|200966|P3|COMPLETED|Overall Study||4
84432|NCT01369849|200967|P2|COMPLETED|Overall Study||4
84433|NCT01369849|200968|P1|COMPLETED|Overall Study||6
84434|NCT01369849|200966|P3|STARTED|Overall Study||5
84435|NCT01369849|200967|P2|STARTED|Overall Study||4
84436|NCT01369849|200968|P1|STARTED|Overall Study||6
84437|NCT01369784|200977|P1|NOT COMPLETED|Overall Study||12
84438|NCT01369784|200977|P1|COMPLETED|Overall Study||146
84439|NCT01369784|200977|P1|STARTED|Overall Study||158
84440|NCT01369745|201007|P5|NOT COMPLETED|Overall Study||18
84441|NCT01369745|201008|P4|NOT COMPLETED|Overall Study||20
84442|NCT01369745|201009|P3|NOT COMPLETED|Overall Study||2
84443|NCT01369745|201010|P2|NOT COMPLETED|Overall Study||13
84444|NCT01369745|201011|P1|NOT COMPLETED|Overall Study||7
84445|NCT01369745|201007|P5|COMPLETED|Overall Study||65
84446|NCT01369745|201008|P4|COMPLETED|Overall Study||64
84447|NCT01369745|201009|P3|COMPLETED|Overall Study||16
84448|NCT01369745|201010|P2|COMPLETED|Overall Study||28
84449|NCT01369745|201011|P1|COMPLETED|Overall Study||25
84450|NCT01369745|201007|P5|STARTED|Overall Study||83
84451|NCT01369745|201008|P4|STARTED|Overall Study||84
84452|NCT01369745|201009|P3|STARTED|Overall Study||18
84453|NCT01369745|201010|P2|STARTED|Overall Study||41
84454|NCT01369745|201011|P1|STARTED|Overall Study||32
84455|NCT01369732|201045|P2|NOT COMPLETED|Overall Study||2
84456|NCT01369732|201046|P1|NOT COMPLETED|Overall Study||4
84457|NCT01369732|201045|P2|COMPLETED|Overall Study||31
84458|NCT01369732|201046|P1|COMPLETED|Overall Study||29
84459|NCT01369732|201045|P2|STARTED|Overall Study||33
84460|NCT01369732|201046|P1|STARTED|Overall Study||33
84461|NCT01369706|201052|P1|NOT COMPLETED|Overall Study||0
84462|NCT01369706|201052|P1|COMPLETED|Overall Study||388
84463|NCT01369706|201052|P1|STARTED|Overall Study||388
84464|NCT01369680|201060|P4|NOT COMPLETED|Overall Study||2
84465|NCT01369680|201061|P3|NOT COMPLETED|Overall Study||1
84466|NCT01369680|201062|P2|NOT COMPLETED|Overall Study||0
84467|NCT01369680|201063|P1|NOT COMPLETED|Overall Study||0
84468|NCT01369680|201060|P4|COMPLETED|Overall Study||1
84469|NCT01369680|201061|P3|COMPLETED|Overall Study||2
84470|NCT01369680|201062|P2|COMPLETED|Overall Study||3
84471|NCT01369680|201063|P1|COMPLETED|Overall Study||3
84472|NCT01369680|201060|P4|STARTED|Overall Study||3
84473|NCT01369680|201061|P3|STARTED|Overall Study||3
84474|NCT01369680|201062|P2|STARTED|Overall Study||3
84475|NCT01369680|201063|P1|STARTED|Overall Study||3
84476|NCT01369641|201084|P1|NOT COMPLETED|Overall Study||1
84477|NCT01369641|201084|P1|COMPLETED|Overall Study||0
84478|NCT01369641|201084|P1|STARTED|Overall Study||1
84479|NCT01369615|201090|P2|NOT COMPLETED|Overall Study||2
84480|NCT01369615|201091|P1|NOT COMPLETED|Overall Study||0
84481|NCT01369615|201090|P2|COMPLETED|Overall Study||12
84482|NCT01369615|201091|P1|COMPLETED|Overall Study||9
84483|NCT01369615|201090|P2|STARTED|Overall Study||14
84484|NCT01369615|201091|P1|STARTED|Overall Study||9
84485|NCT01369485|201099|P2|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||40
84486|NCT01369485|201100|P1|NOT COMPLETED|Open Label Phase (Week 12 to Month 12)||33
84487|NCT01369485|201099|P2|COMPLETED|Open Label Phase (Week 12 to Month 12)||26
84488|NCT01369485|201100|P1|COMPLETED|Open Label Phase (Week 12 to Month 12)||24
84489|NCT01369485|201099|P2|STARTED|Open Label Phase (Week 12 to Month 12)||66
84490|NCT01369485|201100|P1|STARTED|Open Label Phase (Week 12 to Month 12)||57
84491|NCT01369485|201099|P2|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||17
84492|NCT01369485|201100|P1|NOT COMPLETED|Randomized Phase (Day 0 to Week 12)||23
84493|NCT01369485|201099|P2|COMPLETED|Randomized Phase (Day 0 to Week 12)||66
84494|NCT01369485|201100|P1|COMPLETED|Randomized Phase (Day 0 to Week 12)||57
84495|NCT01369485|201099|P2|STARTED|Randomized Phase (Day 0 to Week 12)||83
84496|NCT01369485|201100|P1|STARTED|Randomized Phase (Day 0 to Week 12)||80
84497|NCT01369355|201146|P6|NOT COMPLETED|Overall Study||272
84498|NCT01369355|201147|P5|NOT COMPLETED|Overall Study||154
84499|NCT01369355|201148|P4|NOT COMPLETED|Overall Study||30
84500|NCT01369355|201149|P3|NOT COMPLETED|Overall Study||31
84501|NCT01369355|201150|P2|NOT COMPLETED|Overall Study||29
84502|NCT01369355|201151|P1|NOT COMPLETED|Overall Study||31
84503|NCT01369355|201146|P6|COMPLETED|Overall Study||204
84504|NCT01369355|201147|P5|COMPLETED|Overall Study||131
84505|NCT01369355|201148|P4|COMPLETED|Overall Study||93
84506|NCT01369355|201149|P3|COMPLETED|Overall Study||101
84507|NCT01369355|201150|P2|COMPLETED|Overall Study||103
84508|NCT01369355|201151|P1|COMPLETED|Overall Study||102
84509|NCT01369355|201146|P6|Treated|Overall Study||476
84510|NCT01369355|201147|P5|Treated|Overall Study||285
84511|NCT01369355|201148|P4|Treated|Overall Study||123
84512|NCT01369355|201149|P3|Treated|Overall Study||131
84513|NCT01369355|201150|P2|Treated|Overall Study||132
84514|NCT01369355|201151|P1|Treated|Overall Study||133
84515|NCT01369355|201146|P6|STARTED|Overall Study||476
84516|NCT01369355|201147|P5|STARTED|Overall Study||285
84517|NCT01369355|201148|P4|STARTED|Overall Study||123
84518|NCT01369355|201149|P3|STARTED|Overall Study||132
84519|NCT01369355|201150|P2|STARTED|Overall Study||132
84520|NCT01369355|201151|P1|STARTED|Overall Study||133
84521|NCT01369342|201180|P3|NOT COMPLETED|Overall Study||3
84522|NCT01369342|201181|P2|NOT COMPLETED|Overall Study||9
84523|NCT01369342|201182|P1|NOT COMPLETED|Overall Study||13
84524|NCT01369342|201180|P3|COMPLETED|Overall Study||210
84525|NCT01369342|201181|P2|COMPLETED|Overall Study||204
84526|NCT01369342|201182|P1|COMPLETED|Overall Study||201
84527|NCT01369342|201180|P3|STARTED|Overall Study||213
84528|NCT01369342|201181|P2|STARTED|Overall Study||213
84529|NCT01369342|201182|P1|STARTED|Overall Study||214
84530|NCT01369329|201205|P3|NOT COMPLETED|Overall Study||14
84531|NCT01369329|201206|P2|NOT COMPLETED|Overall Study||11
84532|NCT01369329|201207|P1|NOT COMPLETED|Overall Study||12
84533|NCT01369329|201205|P3|COMPLETED|Overall Study||245
84534|NCT01369329|201206|P2|COMPLETED|Overall Study||243
84535|NCT01369329|201207|P1|COMPLETED|Overall Study||244
84536|NCT01369329|201205|P3|STARTED|Overall Study||259
84537|NCT01369329|201206|P2|STARTED|Overall Study||254
84538|NCT01369329|201207|P1|STARTED|Overall Study||256
84539|NCT01369225|201233|P6|NOT COMPLETED|Overall Study||0
84540|NCT01369225|201234|P5|NOT COMPLETED|Overall Study||2
84541|NCT01369225|201235|P4|NOT COMPLETED|Overall Study||2
84542|NCT01369225|201236|P3|NOT COMPLETED|Overall Study||3
84543|NCT01369225|201237|P2|NOT COMPLETED|Overall Study||0
84544|NCT01369225|201238|P1|NOT COMPLETED|Overall Study||2
84545|NCT01369225|201233|P6|COMPLETED|Overall Study||9
84546|NCT01369225|201234|P5|COMPLETED|Overall Study||10
84547|NCT01369225|201235|P4|COMPLETED|Overall Study||8
84548|NCT01369225|201236|P3|COMPLETED|Overall Study||9
84549|NCT01369225|201237|P2|COMPLETED|Overall Study||3
84550|NCT01369225|201238|P1|COMPLETED|Overall Study||4
84551|NCT01369225|201233|P6|STARTED|Overall Study||9
84552|NCT01369225|201234|P5|STARTED|Overall Study||12
84553|NCT01369225|201235|P4|STARTED|Overall Study||10
84554|NCT01369225|201236|P3|STARTED|Overall Study||12
84555|NCT01369225|201237|P2|STARTED|Overall Study||3
84556|NCT01369225|201238|P1|STARTED|Overall Study||6
84557|NCT01369030|201330|P1|NOT COMPLETED|Overall Study||40
84558|NCT01369030|201330|P1|COMPLETED|Overall Study||554
84559|NCT01369030|201330|P1|STARTED|Overall Study||594
84560|NCT01368965|201336|P1|NOT COMPLETED|Overall Study||12
84561|NCT01368965|201336|P1|COMPLETED|Overall Study||40
84562|NCT01368965|201336|P1|Subject Withdrawal Prior to Treatment|Overall Study||2
84563|NCT01368965|201336|P1|STARTED|Overall Study|Two subjects withdrew consent prior to study treatment. Data analyses are based on 52 subjects.|52
84564|NCT01368900|201345|P1|NOT COMPLETED|Overall Study||7
84565|NCT01368900|201345|P1|COMPLETED|Overall Study||61
84566|NCT01368900|201345|P1|STARTED|Overall Study||68
84567|NCT01368874|201358|P3|NOT COMPLETED|Overall Study||1
84568|NCT01368874|201359|P2|NOT COMPLETED|Overall Study||0
84569|NCT01368874|201360|P1|NOT COMPLETED|Overall Study||3
84570|NCT01368874|201358|P3|COMPLETED|Overall Study||24
84571|NCT01368874|201359|P2|COMPLETED|Overall Study||5
84572|NCT01368874|201360|P1|COMPLETED|Overall Study||31
84573|NCT01368874|201358|P3|STARTED|Overall Study||25
84574|NCT01368874|201359|P2|STARTED|Overall Study||5
84575|NCT01368874|201360|P1|STARTED|Overall Study||34
84576|NCT01368835|201420|P1|NOT COMPLETED|Overall Study||33
84577|NCT01368835|201420|P1|COMPLETED|Overall Study||70
84578|NCT01368835|201420|P1|STARTED|Overall Study|103 Subjects Enrolled|103
84579|NCT01368809|201429|P2|NOT COMPLETED|Overall Study||0
84580|NCT01368809|201430|P1|NOT COMPLETED|Overall Study||0
84581|NCT01368809|201429|P2|COMPLETED|Overall Study||50
84582|NCT01368809|201430|P1|COMPLETED|Overall Study||50
84583|NCT01368809|201429|P2|STARTED|Overall Study||50
84584|NCT01368809|201430|P1|STARTED|Overall Study||50
84585|NCT01368653|201442|P2|NOT COMPLETED|Overall Study||9
84586|NCT01368653|201443|P1|NOT COMPLETED|Overall Study||6
84587|NCT01368653|201442|P2|COMPLETED|Overall Study||37
84588|NCT01368653|201443|P1|COMPLETED|Overall Study||41
84589|NCT01368653|201442|P2|Randomized to Advice Only in Phase 2|Overall Study||10
84590|NCT01368653|201443|P1|Randomized to Advice Only in Phase 2|Overall Study||10
84591|NCT01368653|201442|P2|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|9
84592|NCT01368653|201443|P1|Randomized to VLNC in Phase 2|Overall Study|VLNC=6-week supply of Very Low Nicotine Cigarettes plus Advice to Quit (vs. Advice Only)|11
84593|NCT01368653|201442|P2|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|19
84594|NCT01368653|201443|P1|Randomized to Phase 2|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|21
84595|NCT01368653|201442|P2|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|20
84596|NCT01368653|201443|P1|Smoked in Past 7 Days at 4-weeks|Overall Study|The first 40 who smoked between weeks 3 and 4 post-quit were eligible for Phase 2 (VLNC vs. Advice)|29
84597|NCT01368653|201442|P2|Completed 4-week Follow-up|Overall Study||37
84598|NCT01368653|201443|P1|Completed 4-week Follow-up|Overall Study||44
84599|NCT01368653|201442|P2|STARTED|Overall Study||46
84600|NCT01368653|201443|P1|STARTED|Overall Study||47
84601|NCT01368536|201462|P3|NOT COMPLETED|Overall Study||59
84602|NCT01368536|201463|P2|NOT COMPLETED|Overall Study||59
84603|NCT01368536|201464|P1|NOT COMPLETED|Overall Study||51
84604|NCT01368536|201462|P3|COMPLETED|Overall Study||83
84605|NCT01368536|201463|P2|COMPLETED|Overall Study||78
84606|NCT01368536|201464|P1|COMPLETED|Overall Study||87
84607|NCT01368536|201462|P3|Full Analysis Set|Overall Study|One patient was excluded from efficacy analysis as there was no post baseline data|141
84608|NCT01368536|201463|P2|Full Analysis Set|Overall Study||137
84609|NCT01368536|201464|P1|Full Analysis Set|Overall Study||138
84610|NCT01368536|201462|P3|STARTED|Overall Study||142
84611|NCT01368536|201463|P2|STARTED|Overall Study||137
84612|NCT01368536|201464|P1|STARTED|Overall Study||138
84613|NCT01368432|201487|P2|NOT COMPLETED|Overall Study||1
84614|NCT01368432|201488|P1|NOT COMPLETED|Overall Study||0
84615|NCT01368432|201487|P2|COMPLETED|Overall Study||7
84616|NCT01368432|201488|P1|COMPLETED|Overall Study||6
84617|NCT01368432|201487|P2|STARTED|Overall Study||8
84618|NCT01368432|201488|P1|STARTED|Overall Study||6
84619|NCT01368406|201522|P2|NOT COMPLETED|Overall Study||13
84620|NCT01368406|201523|P1|NOT COMPLETED|Overall Study||21
84621|NCT01368406|201522|P2|COMPLETED|Overall Study||66
84622|NCT01368406|201523|P1|COMPLETED|Overall Study||60
84623|NCT01368406|201522|P2|STARTED|Overall Study||79
84624|NCT01368406|201523|P1|STARTED|Overall Study||81
84625|NCT01368276|201531|P2|NOT COMPLETED|Overall Study||10
84626|NCT01368276|201532|P1|NOT COMPLETED|Overall Study||1
84627|NCT01368276|201531|P2|COMPLETED|Overall Study||18
84628|NCT01368276|201532|P1|COMPLETED|Overall Study||2
84629|NCT01368276|201531|P2|STARTED|Overall Study||28
84630|NCT01368276|201532|P1|STARTED|Overall Study||3
84631|NCT01368263|201545|P3|NOT COMPLETED|Overall Study||0
84632|NCT01368263|201546|P2|NOT COMPLETED|Overall Study||0
84633|NCT01368263|201547|P1|NOT COMPLETED|Overall Study||0
84634|NCT01368263|201545|P3|COMPLETED|Overall Study||1
84635|NCT01368263|201546|P2|COMPLETED|Overall Study||1
84636|NCT01368263|201547|P1|COMPLETED|Overall Study||6
84637|NCT01368263|201545|P3|STARTED|Overall Study||1
84638|NCT01368263|201546|P2|STARTED|Overall Study||1
84639|NCT01368263|201547|P1|STARTED|Overall Study||6
84640|NCT01368211|201569|P2|NOT COMPLETED|Second Platelets Transfusion||2
84641|NCT01368211|201570|P1|NOT COMPLETED|Second Platelets Transfusion||1
84642|NCT01368211|201569|P2|COMPLETED|Second Platelets Transfusion||5
84643|NCT01368211|201570|P1|COMPLETED|Second Platelets Transfusion||7
84644|NCT01368211|201569|P2|STARTED|Second Platelets Transfusion||7
84645|NCT01368211|201570|P1|STARTED|Second Platelets Transfusion||8
84646|NCT01368211|201569|P2|NOT COMPLETED|First Platelets Transfusion||0
84647|NCT01368211|201570|P1|NOT COMPLETED|First Platelets Transfusion||0
84648|NCT01368211|201569|P2|COMPLETED|First Platelets Transfusion||7
84649|NCT01368211|201570|P1|COMPLETED|First Platelets Transfusion||8
84650|NCT01368211|201569|P2|STARTED|First Platelets Transfusion||7
84651|NCT01368211|201570|P1|STARTED|First Platelets Transfusion||8
84652|NCT01368185|201578|P1|NOT COMPLETED|Overall Study||0
84653|NCT01368185|201578|P1|COMPLETED|Overall Study||1705
84654|NCT01368185|201578|P1|STARTED|Overall Study||1705
84655|NCT01368081|201598|P13|NOT COMPLETED|Overall Study||7
84656|NCT01368081|201599|P12|NOT COMPLETED|Overall Study||3
84657|NCT01368081|201600|P11|NOT COMPLETED|Overall Study||9
84658|NCT01368081|201601|P10|NOT COMPLETED|Overall Study||10
84659|NCT01368081|201602|P9|NOT COMPLETED|Overall Study||8
84660|NCT01368081|201603|P8|NOT COMPLETED|Overall Study||7
84661|NCT01368081|201604|P7|NOT COMPLETED|Overall Study||12
84662|NCT01368081|201605|P6|NOT COMPLETED|Overall Study||10
84663|NCT01368081|201606|P5|NOT COMPLETED|Overall Study||2
84664|NCT01368081|201607|P4|NOT COMPLETED|Overall Study||5
84665|NCT01368081|201608|P3|NOT COMPLETED|Overall Study||4
84666|NCT01368081|201609|P2|NOT COMPLETED|Overall Study||9
84667|NCT01368081|201610|P1|NOT COMPLETED|Overall Study||10
84668|NCT01368081|201598|P13|COMPLETED|Overall Study||63
84669|NCT01368081|201599|P12|COMPLETED|Overall Study||67
84670|NCT01368081|201600|P11|COMPLETED|Overall Study||62
84671|NCT01368081|201601|P10|COMPLETED|Overall Study||58
84672|NCT01368081|201602|P9|COMPLETED|Overall Study||62
84673|NCT01368081|201603|P8|COMPLETED|Overall Study||62
84674|NCT01368081|201604|P7|COMPLETED|Overall Study||124
84675|NCT01368081|201605|P6|COMPLETED|Overall Study||127
84676|NCT01368081|201606|P5|COMPLETED|Overall Study||63
84677|NCT01368081|201607|P4|COMPLETED|Overall Study||63
84678|NCT01368081|201608|P3|COMPLETED|Overall Study||59
84679|NCT01368081|201609|P2|COMPLETED|Overall Study||128
84680|NCT01368081|201610|P1|COMPLETED|Overall Study||126
84681|NCT01368081|201598|P13|STARTED|Overall Study||70
84682|NCT01368081|201599|P12|STARTED|Overall Study||70
84683|NCT01368081|201600|P11|STARTED|Overall Study||71
84684|NCT01368081|201601|P10|STARTED|Overall Study||68
84685|NCT01368081|201602|P9|STARTED|Overall Study||70
84686|NCT01368081|201603|P8|STARTED|Overall Study||69
84687|NCT01368081|201604|P7|STARTED|Overall Study||136
84688|NCT01368081|201605|P6|STARTED|Overall Study||137
84689|NCT01368081|201606|P5|STARTED|Overall Study||65
84690|NCT01368081|201607|P4|STARTED|Overall Study||68
84691|NCT01368081|201608|P3|STARTED|Overall Study||63
84692|NCT01368081|201609|P2|STARTED|Overall Study||137
84693|NCT01368081|201610|P1|STARTED|Overall Study||136
84694|NCT01368042|201664|P1|NOT COMPLETED|Overall Study||30
84695|NCT01368042|201664|P1|COMPLETED|Overall Study||235
84696|NCT01368042|201664|P1|STARTED|Overall Study||265
84697|NCT01367886|201684|P1|NOT COMPLETED|Overall Study||7
84698|NCT01367886|201684|P1|COMPLETED|Overall Study||14
84699|NCT01367886|201684|P1|STARTED|Overall Study||21
84700|NCT01367860|201693|P2|NOT COMPLETED|Overall Study||0
84701|NCT01367860|201694|P1|NOT COMPLETED|Overall Study||0
84702|NCT01367860|201693|P2|COMPLETED|Overall Study||20
84703|NCT01367860|201694|P1|COMPLETED|Overall Study||20
84704|NCT01367860|201693|P2|STARTED|Overall Study||20
84705|NCT01367860|201694|P1|STARTED|Overall Study||20
84706|NCT01367834|201734|P2|NOT COMPLETED|Overall Study||3
84707|NCT01367834|201735|P1|NOT COMPLETED|Overall Study||2
84708|NCT01367834|201734|P2|COMPLETED|Overall Study||3
84709|NCT01367834|201735|P1|COMPLETED|Overall Study||9
84710|NCT01367834|201734|P2|STARTED|Overall Study||6
84711|NCT01367834|201735|P1|STARTED|Overall Study||11
84712|NCT01367704|201759|P2|NOT COMPLETED|Overall Study||161
84713|NCT01367704|201760|P1|NOT COMPLETED|Overall Study||47
84714|NCT01367704|201759|P2|COMPLETED|Overall Study||847
84715|NCT01367704|201760|P1|COMPLETED|Overall Study||951
84716|NCT01367704|201759|P2|STARTED|Overall Study||1008
84717|NCT01367704|201760|P1|STARTED|Overall Study||998
84718|NCT01367457|201773|P3|NOT COMPLETED|Overall Study||0
84719|NCT01367457|201774|P2|NOT COMPLETED|Overall Study||0
84720|NCT01367457|201775|P1|NOT COMPLETED|Overall Study||188
84721|NCT01367457|201773|P3|COMPLETED|Overall Study||26
84722|NCT01367457|201774|P2|COMPLETED|Overall Study||23
84723|NCT01367457|201775|P1|COMPLETED|Overall Study||5
84724|NCT01367457|201773|P3|STARTED|Overall Study||26
84725|NCT01367457|201774|P2|STARTED|Overall Study||23
84726|NCT01367457|201775|P1|STARTED|Overall Study||193
84727|NCT01367249|201797|P2|NOT COMPLETED|Overall Study||16
84728|NCT01367249|201798|P1|NOT COMPLETED|Overall Study||9
84729|NCT01367249|201797|P2|COMPLETED|Overall Study||202
84730|NCT01367249|201798|P1|COMPLETED|Overall Study||213
84731|NCT01367249|201797|P2|STARTED|Overall Study||218
84732|NCT01367249|201798|P1|STARTED|Overall Study||222
84733|NCT01367158|201817|P11|NOT COMPLETED|Overall Study||1
84734|NCT01367158|201818|P10|NOT COMPLETED|Overall Study||0
84735|NCT01367158|201819|P9|NOT COMPLETED|Overall Study||0
84736|NCT01367158|201820|P8|NOT COMPLETED|Overall Study||2
84737|NCT01367158|201821|P7|NOT COMPLETED|Overall Study||0
84738|NCT01367158|201822|P6|NOT COMPLETED|Overall Study||2
84739|NCT01367158|201823|P5|NOT COMPLETED|Overall Study||2
84740|NCT01367158|201824|P4|NOT COMPLETED|Overall Study||1
84741|NCT01367158|201825|P3|NOT COMPLETED|Overall Study||1
84742|NCT01367158|201826|P2|NOT COMPLETED|Overall Study||3
84743|NCT01367158|201827|P1|NOT COMPLETED|Overall Study||0
84744|NCT01367158|201817|P11|COMPLETED|Overall Study||72
84745|NCT01367158|201818|P10|COMPLETED|Overall Study||50
84746|NCT01367158|201819|P9|COMPLETED|Overall Study||23
84747|NCT01367158|201820|P8|COMPLETED|Overall Study||47
84748|NCT01367158|201821|P7|COMPLETED|Overall Study||25
84749|NCT01367158|201822|P6|COMPLETED|Overall Study||46
84750|NCT01367158|201823|P5|COMPLETED|Overall Study||23
84751|NCT01367158|201824|P4|COMPLETED|Overall Study||48
84752|NCT01367158|201825|P3|COMPLETED|Overall Study||23
84753|NCT01367158|201826|P2|COMPLETED|Overall Study||46
84754|NCT01367158|201827|P1|COMPLETED|Overall Study||25
84755|NCT01367158|201817|P11|STARTED|Overall Study||73
84756|NCT01367158|201818|P10|STARTED|Overall Study||50
84757|NCT01367158|201819|P9|STARTED|Overall Study||23
84758|NCT01367158|201820|P8|STARTED|Overall Study||49
84759|NCT01367158|201821|P7|STARTED|Overall Study||25
84760|NCT01367158|201822|P6|STARTED|Overall Study||48
84761|NCT01367158|201823|P5|STARTED|Overall Study||25
84762|NCT01367158|201824|P4|STARTED|Overall Study||49
84763|NCT01367158|201825|P3|STARTED|Overall Study||24
84764|NCT01367158|201826|P2|STARTED|Overall Study||49
84765|NCT01367158|201827|P1|STARTED|Overall Study||25
84766|NCT01367119|201971|P2|NOT COMPLETED|Overall Study||1
84767|NCT01367119|201972|P1|NOT COMPLETED|Overall Study||2
84768|NCT01367119|201971|P2|COMPLETED|Overall Study||16
84769|NCT01367119|201972|P1|COMPLETED|Overall Study||19
84770|NCT01367119|201971|P2|STARTED|Overall Study||17
84771|NCT01367119|201972|P1|STARTED|Overall Study||21
84772|NCT01367080|201984|P2|NOT COMPLETED|2nd Administration||0
84773|NCT01367080|201985|P1|NOT COMPLETED|2nd Administration||0
84774|NCT01367080|201984|P2|COMPLETED|2nd Administration||6
84775|NCT01367080|201985|P1|COMPLETED|2nd Administration||6
84776|NCT01367080|201984|P2|STARTED|2nd Administration||6
84777|NCT01367080|201985|P1|STARTED|2nd Administration||6
84778|NCT01367080|201984|P2|NOT COMPLETED|1st Administration||0
84779|NCT01367080|201985|P1|NOT COMPLETED|1st Administration||0
84780|NCT01367080|201984|P2|COMPLETED|1st Administration||6
84781|NCT01367080|201985|P1|COMPLETED|1st Administration||6
84782|NCT01367080|201984|P2|STARTED|1st Administration||6
84783|NCT01367080|201985|P1|STARTED|1st Administration||6
84784|NCT01366976|201999|P2|NOT COMPLETED|Overall Study||0
84785|NCT01366976|202000|P1|NOT COMPLETED|Overall Study||0
84786|NCT01366976|201999|P2|COMPLETED|Overall Study||30
84787|NCT01366976|202000|P1|COMPLETED|Overall Study||30
84788|NCT01366976|201999|P2|STARTED|Overall Study||30
84789|NCT01366976|202000|P1|STARTED|Overall Study||30
84790|NCT01366885|202012|P1|NOT COMPLETED|Overall Study||1
84791|NCT01366885|202012|P1|COMPLETED|Overall Study|We completed our study when the last child born had reached 36 months of age.|19
84792|NCT01366885|202012|P1|STARTED|Overall Study|We started recruiting in February 2008 and recruited 20 mothers.|20
84793|NCT01366872|202017|P1|NOT COMPLETED|Overall Study||0
84794|NCT01366872|202017|P1|COMPLETED|Overall Study||50
84795|NCT01366872|202017|P1|STARTED|Overall Study||50
84796|NCT01366846|202027|P4|NOT COMPLETED|Overall Study||1
84797|NCT01366846|202028|P3|NOT COMPLETED|Overall Study||1
84798|NCT01366846|202029|P2|NOT COMPLETED|Overall Study||4
84799|NCT01366846|202030|P1|NOT COMPLETED|Overall Study||3
84800|NCT01366846|202027|P4|COMPLETED|Overall Study||45
84801|NCT01366846|202028|P3|COMPLETED|Overall Study||46
84802|NCT01366846|202029|P2|COMPLETED|Overall Study||224
84803|NCT01366846|202030|P1|COMPLETED|Overall Study||232
84804|NCT01366846|202027|P4|STARTED|Overall Study||46
84805|NCT01366846|202028|P3|STARTED|Overall Study||47
84806|NCT01366846|202029|P2|STARTED|Overall Study||228
84807|NCT01366846|202030|P1|STARTED|Overall Study||235
84808|NCT01366638|202053|P3|NOT COMPLETED|Overall Study||6
84809|NCT01366638|202054|P2|NOT COMPLETED|Overall Study||0
84810|NCT01366638|202055|P1|NOT COMPLETED|Overall Study||1
84811|NCT01366638|202053|P3|COMPLETED|Overall Study||20
84812|NCT01366638|202054|P2|COMPLETED|Overall Study||29
84813|NCT01366638|202055|P1|COMPLETED|Overall Study||23
84814|NCT01366638|202053|P3|STARTED|Overall Study||26
84815|NCT01366638|202054|P2|STARTED|Overall Study||29
84816|NCT01366638|202055|P1|STARTED|Overall Study||24
84817|NCT01366534|202092|P3|NOT COMPLETED|Overall Study||0
84818|NCT01366534|202093|P2|NOT COMPLETED|Overall Study||2
84819|NCT01366534|202094|P1|NOT COMPLETED|Overall Study||2
84820|NCT01366534|202092|P3|COMPLETED|Overall Study||12
84821|NCT01366534|202093|P2|COMPLETED|Overall Study||25
84822|NCT01366534|202094|P1|COMPLETED|Overall Study||26
84823|NCT01366534|202092|P3|STARTED|Overall Study||12
84824|NCT01366534|202093|P2|STARTED|Overall Study||27
84825|NCT01366534|202094|P1|STARTED|Overall Study||28
84826|NCT01366521|202144|P4|NOT COMPLETED|Overall Study||0
84827|NCT01366521|202145|P3|NOT COMPLETED|Overall Study||2
84828|NCT01366521|202146|P2|NOT COMPLETED|Overall Study||1
84829|NCT01366521|202147|P1|NOT COMPLETED|Overall Study||1
84830|NCT01366521|202144|P4|COMPLETED|Overall Study||11
84831|NCT01366521|202145|P3|COMPLETED|Overall Study||21
84832|NCT01366521|202146|P2|COMPLETED|Overall Study||14
84833|NCT01366521|202147|P1|COMPLETED|Overall Study||20
84834|NCT01366521|202144|P4|STARTED|Overall Study||11
84835|NCT01366521|202145|P3|STARTED|Overall Study||23
84836|NCT01366521|202146|P2|STARTED|Overall Study||15
84837|NCT01366521|202147|P1|STARTED|Overall Study||21
84838|NCT01366443|202222|P1|NOT COMPLETED|Overall Study||3
84839|NCT01366443|202222|P1|COMPLETED|Overall Study||285
84840|NCT01366443|202222|P1|STARTED|Overall Study||288
84841|NCT01366417|202227|P1|NOT COMPLETED|Overall Study||18
84842|NCT01366417|202227|P1|COMPLETED|Overall Study|25 subjects included in the analysis|25
84843|NCT01366417|202227|P1|Excluded From Analysis|Overall Study|3 subjects did not have qualifying Treatment Day microbial counts and were excluded from analysis|3
84844|NCT01366417|202227|P1|Discontinued Prior to Treatment|Overall Study|5 eligible subjects were not treated because enrollment target of 25 was met and enrollment closed.|5
84845|NCT01366417|202227|P1|Completed the Study|Overall Study|treatment baseline microbial counts not available until after treatment; subjects not evaluable|28
84846|NCT01366417|202227|P1|Completed Treatment Visit|Overall Study|28 subjects were treated with ChloraPrep and 70% Isopropyl Alcohol (single topical treatment)|28
84847|NCT01366417|202227|P1|Completed Screen Visit|Overall Study|33 subjects had qualifying screening bacterial counts and were eligible for the Treatment Visit|33
84848|NCT01366417|202227|P1|Signed Informed Consent|Overall Study|Microbial samples were taken from 43 subjects for screening baseline.|43
84849|NCT01366417|202227|P1|STARTED|Overall Study||43
84850|NCT01366209|202236|P2|NOT COMPLETED|Overall Study||36
84851|NCT01366209|202237|P1|NOT COMPLETED|Overall Study||35
84852|NCT01366209|202236|P2|COMPLETED|Overall Study||241
84853|NCT01366209|202237|P1|COMPLETED|Overall Study|Participants completing study assessment at Week 52 were completers, even if treatment was withdrawn|243
84854|NCT01366209|202236|P2|STARTED|Overall Study||277
84855|NCT01366209|202237|P1|STARTED|Overall Study||278
84856|NCT01366196|202245|P2|NOT COMPLETED|Overall Study||0
84857|NCT01366196|202246|P1|NOT COMPLETED|Overall Study||0
84858|NCT01366196|202245|P2|COMPLETED|Overall Study||43
84859|NCT01366196|202246|P1|COMPLETED|Overall Study||43
84860|NCT01366196|202245|P2|STARTED|Overall Study||43
84861|NCT01366196|202246|P1|STARTED|Overall Study||43
84862|NCT01366092|202254|P1|NOT COMPLETED|Overall Study||4
84863|NCT01366092|202254|P1|COMPLETED|Overall Study||31
84864|NCT01366092|202254|P1|STARTED|Overall Study||35
84865|NCT01365910|202263|P1|NOT COMPLETED|Overall Study||30
84866|NCT01365910|202263|P1|COMPLETED|Overall Study||0
84867|NCT01365910|202263|P1|STARTED|Overall Study||30
84868|NCT01365845|202270|P3|NOT COMPLETED|Treatment Phase||0
84869|NCT01365845|202271|P2|NOT COMPLETED|Treatment Phase||0
84870|NCT01365845|202272|P1|NOT COMPLETED|Treatment Phase||0
84871|NCT01365845|202270|P3|COMPLETED|Treatment Phase||18
84872|NCT01365845|202271|P2|COMPLETED|Treatment Phase||0
84873|NCT01365845|202272|P1|COMPLETED|Treatment Phase||0
84874|NCT01365845|202270|P3|STARTED|Treatment Phase||18
84875|NCT01365845|202271|P2|STARTED|Treatment Phase||0
84876|NCT01365845|202272|P1|STARTED|Treatment Phase||0
84877|NCT01365845|202270|P3|NOT COMPLETED|Induction Phase||0
84878|NCT01365845|202271|P2|NOT COMPLETED|Induction Phase||0
84879|NCT01365845|202272|P1|NOT COMPLETED|Induction Phase||0
84880|NCT01365845|202270|P3|COMPLETED|Induction Phase||0
84881|NCT01365845|202271|P2|COMPLETED|Induction Phase||0
84882|NCT01365845|202272|P1|COMPLETED|Induction Phase||18
84883|NCT01365845|202270|P3|STARTED|Induction Phase||0
84884|NCT01365845|202271|P2|STARTED|Induction Phase||0
84885|NCT01365845|202272|P1|STARTED|Induction Phase||18
84886|NCT01365819|202279|P2|NOT COMPLETED|Overall Study||13
84887|NCT01365819|202280|P1|NOT COMPLETED|Overall Study||13
84888|NCT01365819|202279|P2|COMPLETED|Overall Study||14
84889|NCT01365819|202280|P1|COMPLETED|Overall Study||12
84890|NCT01365819|202279|P2|STARTED|Overall Study||27
84891|NCT01365819|202280|P1|STARTED|Overall Study||25
84892|NCT01365650|202286|P1|NOT COMPLETED|Treatment C||0
84893|NCT01365650|202286|P1|COMPLETED|Treatment C||24
84894|NCT01365650|202286|P1|STARTED|Treatment C||24
84895|NCT01365650|202286|P1|NOT COMPLETED|Treatment B||0
84896|NCT01365650|202286|P1|COMPLETED|Treatment B||24
84897|NCT01365650|202286|P1|STARTED|Treatment B||24
84898|NCT01365650|202286|P1|NOT COMPLETED|Treatment A||0
84899|NCT01365650|202286|P1|COMPLETED|Treatment A||24
84900|NCT01365650|202286|P1|STARTED|Treatment A||24
84901|NCT01365624|202311|P2|NOT COMPLETED|Overall Study||0
84902|NCT01365624|202312|P1|NOT COMPLETED|Overall Study||0
84903|NCT01365624|202311|P2|COMPLETED|Overall Study||15
84904|NCT01365624|202312|P1|COMPLETED|Overall Study||15
84905|NCT01365624|202311|P2|STARTED|Overall Study||15
84906|NCT01365624|202312|P1|STARTED|Overall Study||15
84907|NCT01365611|202328|P1|NOT COMPLETED|Overall Study||0
84908|NCT01365611|202328|P1|COMPLETED|Overall Study||36
84909|NCT01365611|202328|P1|STARTED|Overall Study||36
84910|NCT01365585|202344|P1|NOT COMPLETED|Overall Study||0
84911|NCT01365585|202344|P1|COMPLETED|Overall Study||227
84912|NCT01365585|202344|P1|STARTED|Overall Study||227
84913|NCT01365546|202358|P1|NOT COMPLETED|Overall Study||11
84914|NCT01365546|202358|P1|COMPLETED|Overall Study||30
84915|NCT01365546|202358|P1|STARTED|Overall Study|in this study 41 patients were screened but only 30 patients completed the study.|41
84916|NCT01365507|202368|P2|NOT COMPLETED|Overall Study||9
84917|NCT01365507|202369|P1|NOT COMPLETED|Overall Study||9
84918|NCT01365507|202368|P2|COMPLETED|Overall Study||131
84919|NCT01365507|202369|P1|COMPLETED|Overall Study||127
84920|NCT01365507|202368|P2|Exposed|Overall Study||140
84921|NCT01365507|202369|P1|Exposed|Overall Study|Two subjects withdrew before exposure to trial drug|134
84922|NCT01365507|202368|P2|STARTED|Overall Study||140
84923|NCT01365507|202369|P1|STARTED|Overall Study||136
84924|NCT01365494|202385|P2|NOT COMPLETED|Overall Study||3
84925|NCT01365494|202386|P1|NOT COMPLETED|Overall Study||2
84926|NCT01365494|202385|P2|COMPLETED|Overall Study||121
84927|NCT01365494|202386|P1|COMPLETED|Overall Study||124
84928|NCT01365494|202385|P2|STARTED|Overall Study||124
84929|NCT01365494|202386|P1|STARTED|Overall Study||126
84930|NCT01365481|202402|P4|NOT COMPLETED|Overall Study||7
84931|NCT01365481|202403|P3|NOT COMPLETED|Overall Study||4
84932|NCT01365481|202404|P2|NOT COMPLETED|Overall Study||15
84933|NCT01365481|202405|P1|NOT COMPLETED|Overall Study||7
84934|NCT01365481|202402|P4|COMPLETED|Overall Study||50
84935|NCT01365481|202403|P3|COMPLETED|Overall Study||14
84936|NCT01365481|202404|P2|COMPLETED|Overall Study||37
84937|NCT01365481|202405|P1|COMPLETED|Overall Study||16
84938|NCT01365481|202402|P4|STARTED|Overall Study||57
84939|NCT01365481|202403|P3|STARTED|Overall Study||18
84940|NCT01365481|202404|P2|STARTED|Overall Study||52
84941|NCT01365481|202405|P1|STARTED|Overall Study||23
84942|NCT01365468|202425|P2|NOT COMPLETED|Overall Study||0
84943|NCT01365468|202426|P1|NOT COMPLETED|Overall Study||4
84944|NCT01365468|202425|P2|COMPLETED|Overall Study||5
84945|NCT01365468|202426|P1|COMPLETED|Overall Study||0
84946|NCT01365468|202425|P2|STARTED|Overall Study||5
84947|NCT01365468|202426|P1|STARTED|Overall Study||4
84948|NCT01365455|202441|P5|NOT COMPLETED|Follow-up Period||0
84949|NCT01365455|202442|P4|NOT COMPLETED|Follow-up Period||0
84950|NCT01365455|202443|P3|NOT COMPLETED|Follow-up Period||0
84951|NCT01365455|202444|P2|NOT COMPLETED|Follow-up Period||0
84952|NCT01365455|202445|P1|NOT COMPLETED|Follow-up Period||0
84953|NCT01365455|202441|P5|COMPLETED|Follow-up Period||0
84954|NCT01365455|202442|P4|COMPLETED|Follow-up Period||0
84955|NCT01365455|202443|P3|COMPLETED|Follow-up Period||18
84956|NCT01365455|202444|P2|COMPLETED|Follow-up Period||47
84957|NCT01365455|202445|P1|COMPLETED|Follow-up Period||58
84958|NCT01365455|202441|P5|STARTED|Follow-up Period||0
84959|NCT01365455|202442|P4|STARTED|Follow-up Period||0
84960|NCT01365455|202443|P3|STARTED|Follow-up Period||18
84961|NCT01365455|202444|P2|STARTED|Follow-up Period||47
84962|NCT01365455|202445|P1|STARTED|Follow-up Period||58
84963|NCT01365455|202441|P5|NOT COMPLETED|Maintenance Period||13
84964|NCT01365455|202442|P4|NOT COMPLETED|Maintenance Period||9
84965|NCT01365455|202443|P3|NOT COMPLETED|Maintenance Period||3
84966|NCT01365455|202444|P2|NOT COMPLETED|Maintenance Period||23
84967|NCT01365455|202445|P1|NOT COMPLETED|Maintenance Period||29
84968|NCT01365455|202441|P5|COMPLETED|Maintenance Period||92
84969|NCT01365455|202442|P4|COMPLETED|Maintenance Period||100
84970|NCT01365455|202443|P3|COMPLETED|Maintenance Period||15
84971|NCT01365455|202444|P2|COMPLETED|Maintenance Period||215
84972|NCT01365455|202445|P1|COMPLETED|Maintenance Period||201
84973|NCT01365455|202441|P5|STARTED|Maintenance Period||105
84974|NCT01365455|202442|P4|STARTED|Maintenance Period||109
84975|NCT01365455|202443|P3|STARTED|Maintenance Period||18
84976|NCT01365455|202444|P2|STARTED|Maintenance Period||238
84977|NCT01365455|202445|P1|STARTED|Maintenance Period||230
84978|NCT01365455|202441|P5|NOT COMPLETED|Induction Period||0
84979|NCT01365455|202442|P4|NOT COMPLETED|Induction Period||0
84980|NCT01365455|202443|P3|NOT COMPLETED|Induction Period||16
84981|NCT01365455|202444|P2|NOT COMPLETED|Induction Period||7
84982|NCT01365455|202445|P1|NOT COMPLETED|Induction Period||15
84983|NCT01365455|202441|P5|COMPLETED|Induction Period||0
84984|NCT01365455|202442|P4|COMPLETED|Induction Period||0
84985|NCT01365455|202443|P3|COMPLETED|Induction Period||232
84986|NCT01365455|202444|P2|COMPLETED|Induction Period||238
84987|NCT01365455|202445|P1|COMPLETED|Induction Period||230
84988|NCT01365455|202441|P5|STARTED|Induction Period||0
84989|NCT01365455|202442|P4|STARTED|Induction Period||0
84990|NCT01365455|202443|P3|STARTED|Induction Period||248
84991|NCT01365455|202444|P2|STARTED|Induction Period||245
84992|NCT01365455|202445|P1|STARTED|Induction Period||245
84993|NCT01365273|202535|P2|NOT COMPLETED|Overall Study||1
84994|NCT01365273|202536|P1|NOT COMPLETED|Overall Study||2
84995|NCT01365273|202535|P2|COMPLETED|Overall Study||20
84996|NCT01365273|202536|P1|COMPLETED|Overall Study||20
84997|NCT01365273|202535|P2|Compl. Pts, Not Evaluable for Pain.|Overall Study||4
84998|NCT01365273|202536|P1|Compl. Pts, Not Evaluable for Pain.|Overall Study||2
84999|NCT01365273|202535|P2|STARTED|Overall Study||21
85000|NCT01365273|202536|P1|STARTED|Overall Study||22
85001|NCT01365130|202546|P1|NOT COMPLETED|Overall Study||2
85002|NCT01365130|202546|P1|COMPLETED|Overall Study||13
85003|NCT01365130|202546|P1|STARTED|Overall Study|15 patients were enrolled to the study but only 13 went on to begin treatment|15
85004|NCT01365091|202554|P4|NOT COMPLETED|Period 2||0
85005|NCT01365091|202555|P3|NOT COMPLETED|Period 2||1
85006|NCT01365091|202556|P2|NOT COMPLETED|Period 2||0
85007|NCT01365091|202557|P1|NOT COMPLETED|Period 2||1
85008|NCT01365091|202554|P4|COMPLETED|Period 2||25
85009|NCT01365091|202555|P3|COMPLETED|Period 2||24
85010|NCT01365091|202556|P2|COMPLETED|Period 2||26
85011|NCT01365091|202557|P1|COMPLETED|Period 2||25
85012|NCT01365091|202554|P4|STARTED|Period 2||25
85013|NCT01365091|202555|P3|STARTED|Period 2||25
85014|NCT01365091|202556|P2|STARTED|Period 2||26
85015|NCT01365091|202557|P1|STARTED|Period 2||26
85016|NCT01365091|202554|P4|NOT COMPLETED|Period 1||3
85017|NCT01365091|202555|P3|NOT COMPLETED|Period 1||3
85018|NCT01365091|202556|P2|NOT COMPLETED|Period 1||2
85019|NCT01365091|202557|P1|NOT COMPLETED|Period 1||2
85020|NCT01365091|202554|P4|COMPLETED|Period 1||25
85021|NCT01365091|202555|P3|COMPLETED|Period 1||25
85022|NCT01365091|202556|P2|COMPLETED|Period 1||26
85023|NCT01365091|202557|P1|COMPLETED|Period 1||26
85024|NCT01365091|202554|P4|STARTED|Period 1||28
85025|NCT01365091|202555|P3|STARTED|Period 1||28
85026|NCT01365091|202556|P2|STARTED|Period 1||28
85027|NCT01365091|202557|P1|STARTED|Period 1||28
85028|NCT01365052|202585|P2|NOT COMPLETED|Overall Study||4
85029|NCT01365052|202586|P1|NOT COMPLETED|Overall Study||4
85030|NCT01365052|202585|P2|COMPLETED|Overall Study||105
85031|NCT01365052|202586|P1|COMPLETED|Overall Study||213
85032|NCT01365052|202585|P2|STARTED|Overall Study||109
85033|NCT01365052|202586|P1|STARTED|Overall Study||217
85034|NCT01365039|202602|P2|NOT COMPLETED|Overall Study||0
85035|NCT01365039|202603|P1|NOT COMPLETED|Overall Study||1
85036|NCT01365039|202602|P2|COMPLETED|Overall Study||87
85037|NCT01365039|202603|P1|COMPLETED|Overall Study||85
85038|NCT01365039|202602|P2|STARTED|Overall Study||87
85039|NCT01365039|202603|P1|STARTED|Overall Study||86
85040|NCT01364922|202614|P3|NOT COMPLETED|Double-Blind (DB) Period||5
85041|NCT01364922|202615|P2|NOT COMPLETED|Double-Blind (DB) Period||5
85042|NCT01364922|202616|P1|NOT COMPLETED|Double-Blind (DB) Period||0
85043|NCT01364922|202614|P3|COMPLETED|Double-Blind (DB) Period||42
85044|NCT01364922|202615|P2|COMPLETED|Double-Blind (DB) Period||94
85045|NCT01364922|202616|P1|COMPLETED|Double-Blind (DB) Period||0
85046|NCT01364922|202614|P3|STARTED|Double-Blind (DB) Period||47
85047|NCT01364922|202615|P2|STARTED|Double-Blind (DB) Period||99
85048|NCT01364922|202616|P1|STARTED|Double-Blind (DB) Period||0
85049|NCT01364922|202614|P3|NOT COMPLETED|Open-label (OL) Period||0
85050|NCT01364922|202615|P2|NOT COMPLETED|Open-label (OL) Period||0
85051|NCT01364922|202616|P1|NOT COMPLETED|Open-label (OL) Period||22
85052|NCT01364922|202614|P3|COMPLETED|Open-label (OL) Period||0
85053|NCT01364922|202615|P2|COMPLETED|Open-label (OL) Period||0
85054|NCT01364922|202616|P1|COMPLETED|Open-label (OL) Period||146
85055|NCT01364922|202614|P3|STARTED|Open-label (OL) Period||0
85056|NCT01364922|202615|P2|STARTED|Open-label (OL) Period||0
85057|NCT01364922|202616|P1|STARTED|Open-label (OL) Period||168
85058|NCT01364896|202627|P1|NOT COMPLETED|Overall Study||0
85059|NCT01364896|202627|P1|COMPLETED|Overall Study||46
85060|NCT01364896|202627|P1|STARTED|Overall Study||46
85061|NCT01364740|202635|P1|NOT COMPLETED|Overall Study||0
85062|NCT01364740|202635|P1|COMPLETED|Overall Study||10
85063|NCT01364740|202635|P1|STARTED|Overall Study||10
85064|NCT01364727|202643|P1|NOT COMPLETED|Overall Study||2
85065|NCT01364727|202643|P1|COMPLETED|Overall Study||33
85066|NCT01364727|202643|P1|STARTED|Overall Study||35
85067|NCT01364649|202651|P2|NOT COMPLETED|Overall Study||43
85068|NCT01364649|202652|P1|NOT COMPLETED|Overall Study||56
85069|NCT01364649|202651|P2|COMPLETED|Overall Study||179
85070|NCT01364649|202652|P1|COMPLETED|Overall Study||169
85071|NCT01364649|202651|P2|STARTED|Overall Study||222
85072|NCT01364649|202652|P1|STARTED|Overall Study||225
85073|NCT01364558|202662|P3|NOT COMPLETED|Dose Three||0
85074|NCT01364558|202663|P2|NOT COMPLETED|Dose Three||0
85075|NCT01364558|202664|P1|NOT COMPLETED|Dose Three||0
85076|NCT01364558|202662|P3|COMPLETED|Dose Three||8
85077|NCT01364558|202663|P2|COMPLETED|Dose Three||8
85078|NCT01364558|202664|P1|COMPLETED|Dose Three||8
85079|NCT01364558|202662|P3|STARTED|Dose Three||8
85080|NCT01364558|202663|P2|STARTED|Dose Three||8
85081|NCT01364558|202664|P1|STARTED|Dose Three||8
85082|NCT01364558|202662|P3|NOT COMPLETED|Dose Two||0
85083|NCT01364558|202663|P2|NOT COMPLETED|Dose Two||0
85084|NCT01364558|202664|P1|NOT COMPLETED|Dose Two||0
85085|NCT01364558|202662|P3|COMPLETED|Dose Two||8
85086|NCT01364558|202663|P2|COMPLETED|Dose Two||8
85087|NCT01364558|202664|P1|COMPLETED|Dose Two||8
85088|NCT01364558|202662|P3|STARTED|Dose Two||8
85089|NCT01364558|202663|P2|STARTED|Dose Two||8
85090|NCT01364558|202664|P1|STARTED|Dose Two||8
85091|NCT01364558|202662|P3|NOT COMPLETED|Dose One||0
85092|NCT01364558|202663|P2|NOT COMPLETED|Dose One||0
85093|NCT01364558|202664|P1|NOT COMPLETED|Dose One||0
85094|NCT01364558|202662|P3|COMPLETED|Dose One||8
85095|NCT01364558|202663|P2|COMPLETED|Dose One||8
85096|NCT01364558|202664|P1|COMPLETED|Dose One||8
85097|NCT01364558|202662|P3|STARTED|Dose One||8
85098|NCT01364558|202663|P2|STARTED|Dose One||8
85099|NCT01364558|202664|P1|STARTED|Dose One||8
85100|NCT01364428|202674|P2|NOT COMPLETED|Overall Study||15
85101|NCT01364428|202675|P1|NOT COMPLETED|Overall Study||20
85102|NCT01364428|202674|P2|COMPLETED|Overall Study||172
85103|NCT01364428|202675|P1|COMPLETED|Overall Study||166
85104|NCT01364428|202674|P2|Exposed|Overall Study||187
85105|NCT01364428|202675|P1|Exposed|Overall Study|Two subjects were randomised in error and withdrew prior to exposure to drug|184
85106|NCT01364428|202674|P2|STARTED|Overall Study||187
85107|NCT01364428|202675|P1|STARTED|Overall Study||186
85108|NCT01364389|202692|P3|NOT COMPLETED|Overall Study||1
85109|NCT01364389|202693|P2|NOT COMPLETED|Overall Study||1
85110|NCT01364389|202694|P1|NOT COMPLETED|Overall Study||2
85111|NCT01364389|202692|P3|COMPLETED|Overall Study||4
85112|NCT01364389|202693|P2|COMPLETED|Overall Study||5
85113|NCT01364389|202694|P1|COMPLETED|Overall Study||3
85114|NCT01364389|202692|P3|Pharmacodynamic (PD) Analysis Set|Overall Study|One patient excluded: did not receive study drug; received placebo caps. and infusion only in error.|4
85115|NCT01364389|202693|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||6
85116|NCT01364389|202694|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||5
85117|NCT01364389|202692|P3|STARTED|Overall Study||5
85118|NCT01364389|202693|P2|STARTED|Overall Study||6
85119|NCT01364389|202694|P1|STARTED|Overall Study||5
85120|NCT01364298|202713|P2|NOT COMPLETED|Overall Study||23
85121|NCT01364298|202714|P1|NOT COMPLETED|Overall Study||14
85122|NCT01364298|202713|P2|COMPLETED|Overall Study||154
85123|NCT01364298|202714|P1|COMPLETED|Overall Study||162
85124|NCT01364298|202713|P2|Treated|Overall Study||174
85125|NCT01364298|202714|P1|Treated|Overall Study||174
85126|NCT01364298|202713|P2|STARTED|Overall Study||177
85127|NCT01364298|202714|P1|STARTED|Overall Study||176
85128|NCT01364259|202738|P2|NOT COMPLETED|Overall Study||0
85129|NCT01364259|202739|P1|NOT COMPLETED|Overall Study||0
85130|NCT01364259|202738|P2|COMPLETED|Overall Study||8
85131|NCT01364259|202739|P1|COMPLETED|Overall Study||9
85132|NCT01364259|202738|P2|STARTED|Overall Study||8
85133|NCT01364259|202739|P1|STARTED|Overall Study||9
85134|NCT01364207|202747|P2|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
85135|NCT01364207|202748|P1|NOT COMPLETED|Second Visit (~1.5-2 Hours)||0
85136|NCT01364207|202747|P2|COMPLETED|Second Visit (~1.5-2 Hours)||54
85137|NCT01364207|202748|P1|COMPLETED|Second Visit (~1.5-2 Hours)||52
85138|NCT01364207|202747|P2|STARTED|Second Visit (~1.5-2 Hours)||54
85139|NCT01364207|202748|P1|STARTED|Second Visit (~1.5-2 Hours)||52
85140|NCT01364207|202747|P2|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||4
85141|NCT01364207|202748|P1|NOT COMPLETED|Time Between Visits (2 Days to 4 Weeks)||2
85142|NCT01364207|202747|P2|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||54
85143|NCT01364207|202748|P1|COMPLETED|Time Between Visits (2 Days to 4 Weeks)||52
85144|NCT01364207|202747|P2|STARTED|Time Between Visits (2 Days to 4 Weeks)||58
85145|NCT01364207|202748|P1|STARTED|Time Between Visits (2 Days to 4 Weeks)||54
85146|NCT01364207|202747|P2|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
85147|NCT01364207|202748|P1|NOT COMPLETED|First Visit (~1.5-2 Hours)||0
85148|NCT01364207|202747|P2|COMPLETED|First Visit (~1.5-2 Hours)||58
85149|NCT01364207|202748|P1|COMPLETED|First Visit (~1.5-2 Hours)||54
85150|NCT01364207|202747|P2|STARTED|First Visit (~1.5-2 Hours)||58
85151|NCT01364207|202748|P1|STARTED|First Visit (~1.5-2 Hours)||54
85152|NCT01363986|202756|P1|NOT COMPLETED|Overall Study||1
85153|NCT01363986|202756|P1|COMPLETED|Overall Study||2
85154|NCT01363986|202756|P1|STARTED|Overall Study||3
85155|NCT01363908|202766|P2|NOT COMPLETED|Chronic Dosing (CD) Phase||6
85156|NCT01363908|202767|P1|NOT COMPLETED|Chronic Dosing (CD) Phase||10
85157|NCT01363908|202766|P2|COMPLETED|Chronic Dosing (CD) Phase||10
85158|NCT01363908|202767|P1|COMPLETED|Chronic Dosing (CD) Phase||3
85159|NCT01363908|202766|P2|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|16
85160|NCT01363908|202767|P1|STARTED|Chronic Dosing (CD) Phase|The CD phase enrolled willing participants who completed the PK phase plus additional participants.|13
85161|NCT01363908|202766|P2|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
85162|NCT01363908|202767|P1|NOT COMPLETED|Pharmacokinetic (PK) Phase||0
85163|NCT01363908|202766|P2|COMPLETED|Pharmacokinetic (PK) Phase||8
85164|NCT01363908|202767|P1|COMPLETED|Pharmacokinetic (PK) Phase||8
85165|NCT01363908|202766|P2|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
85166|NCT01363908|202767|P1|STARTED|Pharmacokinetic (PK) Phase|Per study design, at least 8 participants in each age cohort participated in the PK phase.|8
85167|NCT01363908|202766|P2|NOT COMPLETED|Screening/Enrollment||0
85168|NCT01363908|202767|P1|NOT COMPLETED|Screening/Enrollment||1
85169|NCT01363908|202766|P2|COMPLETED|Screening/Enrollment||16
85170|NCT01363908|202767|P1|COMPLETED|Screening/Enrollment|One participant did not receive investigational product.|13
85171|NCT01363908|202766|P2|STARTED|Screening/Enrollment||16
85172|NCT01363908|202767|P1|STARTED|Screening/Enrollment||14
85173|NCT01363843|202797|P1|NOT COMPLETED|Overall Study||1
85174|NCT01363843|202797|P1|COMPLETED|Overall Study|39 enrolled, 36 completed 8 cycles of mFOLFOX6, 35 completed chemo-radiation, 38 underwent surgery.|38
85175|NCT01363843|202797|P1|STARTED|Overall Study||39
85176|NCT01363765|202803|P2|NOT COMPLETED|Overall Study||4731
85177|NCT01363765|202804|P1|NOT COMPLETED|Overall Study||5800
85178|NCT01363765|202803|P2|COMPLETED|Overall Study|Samples contributing to observation arm. Excluded were duplicates, non-residents, missing age.|11705
85179|NCT01363765|202804|P1|COMPLETED|Overall Study|Excluded were duplicates, non-residents, missing age, unavailability of system (smears done instead)|12522
85180|NCT01363765|202803|P2|STARTED|Overall Study|This is number of participants enrolled, each with one sample considered in baseline arm.|16436
85181|NCT01363765|202804|P1|STARTED|Overall Study|This is number of participants enrolled, each with one sample submitted to Xpert in intervention arm|18322
85182|NCT01363713|202816|P1|NOT COMPLETED|Overall Study||6
85183|NCT01363713|202816|P1|COMPLETED|Overall Study|Analysed (n=130)|124
85184|NCT01363713|202816|P1|ALLOCATED|Overall Study||130
85185|NCT01363713|202816|P1|STARTED|Overall Study|Assessed for eligibility|130
85186|NCT01363700|202825|P5|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
85187|NCT01363700|202826|P4|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
85188|NCT01363700|202827|P3|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
85189|NCT01363700|202828|P2|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
85190|NCT01363700|202829|P1|NOT COMPLETED|Epinastine vs Olopatadine Period2||0
85191|NCT01363700|202825|P5|COMPLETED|Epinastine vs Olopatadine Period2||43
85192|NCT01363700|202826|P4|COMPLETED|Epinastine vs Olopatadine Period2||43
85193|NCT01363700|202827|P3|COMPLETED|Epinastine vs Olopatadine Period2||0
85194|NCT01363700|202828|P2|COMPLETED|Epinastine vs Olopatadine Period2||0
85195|NCT01363700|202829|P1|COMPLETED|Epinastine vs Olopatadine Period2||0
85196|NCT01363700|202825|P5|STARTED|Epinastine vs Olopatadine Period2||43
85197|NCT01363700|202826|P4|STARTED|Epinastine vs Olopatadine Period2||43
85198|NCT01363700|202827|P3|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
85199|NCT01363700|202828|P2|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
85200|NCT01363700|202829|P1|STARTED|Epinastine vs Olopatadine Period2|No Allocation|0
85201|NCT01363700|202825|P5|NOT COMPLETED|Epinastine vs Placebo Period1||0
85202|NCT01363700|202826|P4|NOT COMPLETED|Epinastine vs Placebo Period1||0
85203|NCT01363700|202827|P3|NOT COMPLETED|Epinastine vs Placebo Period1||0
85204|NCT01363700|202828|P2|NOT COMPLETED|Epinastine vs Placebo Period1||1
85205|NCT01363700|202829|P1|NOT COMPLETED|Epinastine vs Placebo Period1||0
85206|NCT01363700|202825|P5|COMPLETED|Epinastine vs Placebo Period1||0
85207|NCT01363700|202826|P4|COMPLETED|Epinastine vs Placebo Period1||0
85208|NCT01363700|202827|P3|COMPLETED|Epinastine vs Placebo Period1||22
85209|NCT01363700|202828|P2|COMPLETED|Epinastine vs Placebo Period1||21
85210|NCT01363700|202829|P1|COMPLETED|Epinastine vs Placebo Period1||43
85211|NCT01363700|202825|P5|STARTED|Epinastine vs Placebo Period1|No Allocation|0
85212|NCT01363700|202826|P4|STARTED|Epinastine vs Placebo Period1|No Allocation|0
85213|NCT01363700|202827|P3|STARTED|Epinastine vs Placebo Period1||22
85214|NCT01363700|202828|P2|STARTED|Epinastine vs Placebo Period1||22
85215|NCT01363700|202829|P1|STARTED|Epinastine vs Placebo Period1||43
85216|NCT01363661|202848|P2|NOT COMPLETED|Overall Study||4
85217|NCT01363661|202849|P1|NOT COMPLETED|Overall Study||14
85218|NCT01363661|202848|P2|COMPLETED|Overall Study||28
85219|NCT01363661|202849|P1|COMPLETED|Overall Study||18
85220|NCT01363661|202848|P2|STARTED|Overall Study||32
85221|NCT01363661|202849|P1|STARTED|Overall Study||32
85222|NCT01363492|202865|P1|NOT COMPLETED|Overall Study||0
85223|NCT01363492|202865|P1|COMPLETED|Overall Study||14
85224|NCT01363492|202865|P1|STARTED|Overall Study||14
85225|NCT01363479|202880|P2|NOT COMPLETED|Overall Study||21
85226|NCT01363479|202881|P1|NOT COMPLETED|Overall Study||12
85227|NCT01363479|202880|P2|COMPLETED|Overall Study||351
85228|NCT01363479|202881|P1|COMPLETED|Overall Study||359
85229|NCT01363479|202880|P2|STARTED|Overall Study|number of randomised patients|372
85230|NCT01363479|202881|P1|STARTED|Overall Study|number of randomised patients|371
85231|NCT01363440|202890|P3|NOT COMPLETED|Overall Study||27
85232|NCT01363440|202891|P2|NOT COMPLETED|Overall Study||31
85233|NCT01363440|202892|P1|NOT COMPLETED|Overall Study||23
85234|NCT01363440|202890|P3|COMPLETED|Overall Study|Completed Week 100|127
85235|NCT01363440|202891|P2|COMPLETED|Overall Study|Completed Week 100|125
85236|NCT01363440|202892|P1|COMPLETED|Overall Study|Completed Week 100|133
85237|NCT01363440|202890|P3|Completed Week 100|Overall Study||127
85238|NCT01363440|202891|P2|Completed Week 100|Overall Study||125
85239|NCT01363440|202892|P1|Completed Week 100|Overall Study||133
85240|NCT01363440|202890|P3|Completed Week 52|Overall Study||144
85241|NCT01363440|202891|P2|Completed Week 52|Overall Study||146
85242|NCT01363440|202892|P1|Completed Week 52|Overall Study||145
85243|NCT01363440|202890|P3|Participants Received Treatment|Overall Study|safety analysis set (SAF)|152
85244|NCT01363440|202891|P2|Participants Received Treatment|Overall Study|safety analysis set (SAF)|155
85245|NCT01363440|202892|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|154
85246|NCT01363440|202890|P3|STARTED|Overall Study|randomized|154
85247|NCT01363440|202891|P2|STARTED|Overall Study|randomized|156
85248|NCT01363440|202892|P1|STARTED|Overall Study|randomized|156
85249|NCT01363401|202923|P2|NOT COMPLETED|Overall Study||4
85250|NCT01363401|202924|P1|NOT COMPLETED|Overall Study||2
85251|NCT01363401|202923|P2|COMPLETED|Overall Study||27
85252|NCT01363401|202924|P1|COMPLETED|Overall Study||39
85253|NCT01363401|202923|P2|STARTED|Overall Study||31
85254|NCT01363401|202924|P1|STARTED|Overall Study|"Including 8 subjects of Phase 1 safety assessment. (Called Modified ITT in this clinical trials)"|41
85255|NCT01363349|202938|P2|NOT COMPLETED|Overall Study||70
85256|NCT01363349|202939|P1|NOT COMPLETED|Overall Study||67
85257|NCT01363349|202938|P2|COMPLETED|Overall Study||66
85258|NCT01363349|202939|P1|COMPLETED|Overall Study||66
85259|NCT01363349|202938|P2|Randomized|Overall Study||136
85260|NCT01363349|202939|P1|Randomized|Overall Study||133
85261|NCT01363349|202938|P2|STARTED|Overall Study||136
85262|NCT01363349|202939|P1|STARTED|Overall Study||133
85263|NCT01363297|202950|P5|NOT COMPLETED|Overall Study||31
85264|NCT01363297|202951|P4|NOT COMPLETED|Overall Study||10
85265|NCT01363297|202952|P3|NOT COMPLETED|Overall Study||6
85266|NCT01363297|202953|P2|NOT COMPLETED|Overall Study||6
85267|NCT01363297|202954|P1|NOT COMPLETED|Overall Study||3
85268|NCT01363297|202950|P5|COMPLETED|Overall Study||4
85269|NCT01363297|202951|P4|COMPLETED|Overall Study||3
85270|NCT01363297|202952|P3|COMPLETED|Overall Study||3
85271|NCT01363297|202953|P2|COMPLETED|Overall Study||6
85272|NCT01363297|202954|P1|COMPLETED|Overall Study||0
85273|NCT01363297|202950|P5|STARTED|Overall Study||35
85274|NCT01363297|202951|P4|STARTED|Overall Study||13
85275|NCT01363297|202952|P3|STARTED|Overall Study||9
85276|NCT01363297|202953|P2|STARTED|Overall Study||12
85277|NCT01363297|202954|P1|STARTED|Overall Study||3
85278|NCT01363076|203046|P2|NOT COMPLETED|Overall Study||1
85279|NCT01363076|203047|P1|NOT COMPLETED|Overall Study||0
85280|NCT01363076|203046|P2|COMPLETED|Overall Study||12
85281|NCT01363076|203047|P1|COMPLETED|Overall Study||7
85282|NCT01363076|203046|P2|STARTED|Overall Study||13
85283|NCT01363076|203047|P1|STARTED|Overall Study||7
85284|NCT01363050|203065|P1|NOT COMPLETED|Overall Study||0
85285|NCT01363050|203065|P1|COMPLETED|Overall Study||15
85286|NCT01363050|203065|P1|STARTED|Overall Study||15
85287|NCT01363011|203079|P2|NOT COMPLETED|Extension Phase||8
85288|NCT01363011|203080|P1|NOT COMPLETED|Extension Phase||5
85289|NCT01363011|203079|P2|COMPLETED|Extension Phase||41
85290|NCT01363011|203080|P1|COMPLETED|Extension Phase||13
85291|NCT01363011|203079|P2|STARTED|Extension Phase|15 participants who completed the main study did not enroll into the extension phase.|49
85292|NCT01363011|203080|P1|STARTED|Extension Phase|11 participants who completed the main study did not enroll into the extension phase.|18
85293|NCT01363011|203079|P2|NOT COMPLETED|Main Study||9
85294|NCT01363011|203080|P1|NOT COMPLETED|Main Study||4
85295|NCT01363011|203079|P2|COMPLETED|Main Study||64
85296|NCT01363011|203080|P1|COMPLETED|Main Study||29
85297|NCT01363011|203079|P2|STARTED|Main Study||73
85298|NCT01363011|203080|P1|STARTED|Main Study||33
85299|NCT01362946|203120|P2|NOT COMPLETED|Second Behavior Modification Block||0
85300|NCT01362946|203121|P1|NOT COMPLETED|Second Behavior Modification Block||0
85301|NCT01362946|203120|P2|COMPLETED|Second Behavior Modification Block||24
85302|NCT01362946|203121|P1|COMPLETED|Second Behavior Modification Block||23
85303|NCT01362946|203120|P2|STARTED|Second Behavior Modification Block||24
85304|NCT01362946|203121|P1|STARTED|Second Behavior Modification Block|1 participant withdrew after last but before this treatment period - illness unrelated to study.|23
85305|NCT01362946|203120|P2|NOT COMPLETED|First Behavior Modification Block||0
85306|NCT01362946|203121|P1|NOT COMPLETED|First Behavior Modification Block||0
85307|NCT01362946|203120|P2|COMPLETED|First Behavior Modification Block||24
85308|NCT01362946|203121|P1|COMPLETED|First Behavior Modification Block||24
85309|NCT01362946|203120|P2|STARTED|First Behavior Modification Block||24
85310|NCT01362946|203121|P1|STARTED|First Behavior Modification Block||24
85311|NCT01362907|203154|P2|NOT COMPLETED|Period 2, One Week||0
85312|NCT01362907|203155|P1|NOT COMPLETED|Period 2, One Week||0
85313|NCT01362907|203154|P2|COMPLETED|Period 2, One Week||20
85314|NCT01362907|203155|P1|COMPLETED|Period 2, One Week||20
85315|NCT01362907|203154|P2|STARTED|Period 2, One Week||20
85316|NCT01362907|203155|P1|STARTED|Period 2, One Week||20
85317|NCT01362907|203154|P2|NOT COMPLETED|Period 1, One Week||0
85318|NCT01362907|203155|P1|NOT COMPLETED|Period 1, One Week||0
85319|NCT01362907|203154|P2|COMPLETED|Period 1, One Week||20
85320|NCT01362907|203155|P1|COMPLETED|Period 1, One Week||20
85321|NCT01362907|203154|P2|STARTED|Period 1, One Week||20
85322|NCT01362907|203155|P1|STARTED|Period 1, One Week||20
85323|NCT01362894|203169|P2|NOT COMPLETED|Period Two, 1 Week||0
85324|NCT01362894|203170|P1|NOT COMPLETED|Period Two, 1 Week||0
85325|NCT01362894|203169|P2|COMPLETED|Period Two, 1 Week||115
85326|NCT01362894|203170|P1|COMPLETED|Period Two, 1 Week||118
85327|NCT01362894|203169|P2|STARTED|Period Two, 1 Week|Three participants discontinued between Periods 1 and 2 due to unacceptable vision.|115
85328|NCT01362894|203170|P1|STARTED|Period Two, 1 Week|Two participants discontinued between Periods 1 and 2 due to discomfort (1) and poor fit (1).|118
85329|NCT01362894|203169|P2|NOT COMPLETED|Period One, 1 Week||0
85330|NCT01362894|203170|P1|NOT COMPLETED|Period One, 1 Week||0
85331|NCT01362894|203169|P2|COMPLETED|Period One, 1 Week||117
85332|NCT01362894|203170|P1|COMPLETED|Period One, 1 Week||119
85333|NCT01362894|203169|P2|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|117
85334|NCT01362894|203170|P1|STARTED|Period One, 1 Week|One participant was not dispensed lenses until Period 2.|119
85335|NCT01362686|203187|P3|NOT COMPLETED|Overall Study||10
85336|NCT01362686|203188|P2|NOT COMPLETED|Overall Study||12
85337|NCT01362686|203189|P1|NOT COMPLETED|Overall Study||8
85338|NCT01362686|203187|P3|COMPLETED|Overall Study||53
85339|NCT01362686|203188|P2|COMPLETED|Overall Study||54
85340|NCT01362686|203189|P1|COMPLETED|Overall Study||59
85341|NCT01362686|203187|P3|STARTED|Overall Study||63
85342|NCT01362686|203188|P2|STARTED|Overall Study||66
85343|NCT01362686|203189|P1|STARTED|Overall Study||67
85344|NCT01362608|203205|P2|NOT COMPLETED|Overall Study||8
85345|NCT01362608|203206|P1|NOT COMPLETED|Overall Study||4
85346|NCT01362608|203205|P2|COMPLETED|Overall Study||61
85347|NCT01362608|203206|P1|COMPLETED|Overall Study||63
85348|NCT01362608|203205|P2|STARTED|Overall Study||69
85349|NCT01362608|203206|P1|STARTED|Overall Study||67
85350|NCT01362530|203244|P2|NOT COMPLETED|Optional Extension (Cycles 2-6)||0
85351|NCT01362530|203245|P1|NOT COMPLETED|Optional Extension (Cycles 2-6)||125
85352|NCT01362530|203244|P2|COMPLETED|Optional Extension (Cycles 2-6)||0
85353|NCT01362530|203245|P1|COMPLETED|Optional Extension (Cycles 2-6)||46
85354|NCT01362530|203244|P2|STARTED|Optional Extension (Cycles 2-6)||0
85355|NCT01362530|203245|P1|STARTED|Optional Extension (Cycles 2-6)||171
85356|NCT01362530|203244|P2|NOT COMPLETED|Base Study (Cycle 1)||3
85357|NCT01362530|203245|P1|NOT COMPLETED|Base Study (Cycle 1)||5
85358|NCT01362530|203244|P2|COMPLETED|Base Study (Cycle 1)||149
85359|NCT01362530|203245|P1|COMPLETED|Base Study (Cycle 1)||150
85360|NCT01362530|203244|P2|Received Study Treatment|Base Study (Cycle 1)||150
85361|NCT01362530|203245|P1|Received Study Treatment|Base Study (Cycle 1)||152
85362|NCT01362530|203244|P2|STARTED|Base Study (Cycle 1)||152
85363|NCT01362530|203245|P1|STARTED|Base Study (Cycle 1)||155
85364|NCT01362517|203258|P1|NOT COMPLETED|Overall Study||2
85365|NCT01362517|203258|P1|COMPLETED|Overall Study||129
85366|NCT01362517|203258|P1|STARTED|Overall Study||131
85367|NCT01362491|203269|P3|NOT COMPLETED|Overall Study||0
85368|NCT01362491|203270|P2|NOT COMPLETED|Overall Study||0
85369|NCT01362491|203271|P1|NOT COMPLETED|Overall Study||1
85370|NCT01362491|203269|P3|COMPLETED|Overall Study||46
85371|NCT01362491|203270|P2|COMPLETED|Overall Study||89
85372|NCT01362491|203271|P1|COMPLETED|Overall Study||90
85373|NCT01362491|203269|P3|STARTED|Overall Study||46
85374|NCT01362491|203270|P2|STARTED|Overall Study||89
85375|NCT01362491|203271|P1|STARTED|Overall Study||91
85376|NCT01362439|203319|P1|NOT COMPLETED|Overall Study||15
85377|NCT01362439|203319|P1|COMPLETED|Overall Study||118
85378|NCT01362439|203319|P1|STARTED|Overall Study||133
85379|NCT01362348|203334|P1|NOT COMPLETED|Overall Study||14
85380|NCT01362348|203334|P1|COMPLETED|Overall Study||5
85381|NCT01362348|203334|P1|STARTED|Overall Study||19
85382|NCT01362296|203353|P4|NOT COMPLETED|Crossover Phase||2
85383|NCT01362296|203354|P3|NOT COMPLETED|Crossover Phase||23
85384|NCT01362296|203355|P2|NOT COMPLETED|Crossover Phase||0
85385|NCT01362296|203356|P1|NOT COMPLETED|Crossover Phase||0
85386|NCT01362296|203353|P4|COMPLETED|Crossover Phase||0
85387|NCT01362296|203354|P3|COMPLETED|Crossover Phase||0
85388|NCT01362296|203355|P2|COMPLETED|Crossover Phase||0
85389|NCT01362296|203356|P1|COMPLETED|Crossover Phase||0
85390|NCT01362296|203353|P4|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|2
85391|NCT01362296|203354|P3|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|23
85392|NCT01362296|203355|P2|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
85393|NCT01362296|203356|P1|STARTED|Crossover Phase|These participants elected to enter the Crossover Phase at the time of disease progression.|0
85394|NCT01362296|203353|P4|NOT COMPLETED|Randomized Phase (RP)||0
85395|NCT01362296|203354|P3|NOT COMPLETED|Randomized Phase (RP)||0
85396|NCT01362296|203355|P2|NOT COMPLETED|Randomized Phase (RP)||43
85397|NCT01362296|203356|P1|NOT COMPLETED|Randomized Phase (RP)||87
85398|NCT01362296|203353|P4|COMPLETED|Randomized Phase (RP)||0
85399|NCT01362296|203354|P3|COMPLETED|Randomized Phase (RP)||0
85400|NCT01362296|203355|P2|COMPLETED|Randomized Phase (RP)||0
85401|NCT01362296|203356|P1|COMPLETED|Randomized Phase (RP)||0
85402|NCT01362296|203353|P4|STARTED|Randomized Phase (RP)||0
85403|NCT01362296|203354|P3|STARTED|Randomized Phase (RP)||0
85404|NCT01362296|203355|P2|STARTED|Randomized Phase (RP)||43
85405|NCT01362296|203356|P1|STARTED|Randomized Phase (RP)||87
85406|NCT01362244|203404|P2|NOT COMPLETED|Overall Study||32
85407|NCT01362244|203405|P1|NOT COMPLETED|Overall Study||32
85408|NCT01362244|203404|P2|COMPLETED|Overall Study||19
85409|NCT01362244|203405|P1|COMPLETED|Overall Study||22
85410|NCT01362244|203404|P2|STARTED|Overall Study||51
85411|NCT01362244|203405|P1|STARTED|Overall Study||54
85412|NCT01362205|203478|P2|NOT COMPLETED|Overall Study||0
85413|NCT01362205|203479|P1|NOT COMPLETED|Overall Study||0
85414|NCT01362205|203478|P2|COMPLETED|Overall Study||27
85415|NCT01362205|203479|P1|COMPLETED|Overall Study||22
85416|NCT01362205|203478|P2|STARTED|Overall Study||27
85417|NCT01362205|203479|P1|STARTED|Overall Study||22
85418|NCT01362192|203505|P1|NOT COMPLETED|Overall Study||4
85419|NCT01362192|203505|P1|COMPLETED|Overall Study||16
85420|NCT01362192|203505|P1|STARTED|Overall Study||20
85421|NCT01362140|203517|P2|NOT COMPLETED|Overall Study||11
85422|NCT01362140|203518|P1|NOT COMPLETED|Overall Study||10
85423|NCT01362140|203517|P2|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|87
85424|NCT01362140|203518|P1|COMPLETED|Overall Study|Completed treatment in the double-blind treatment period|39
85425|NCT01362140|203517|P2|Received Treatment|Overall Study||97
85426|NCT01362140|203518|P1|Received Treatment|Overall Study||49
85427|NCT01362140|203517|P2|STARTED|Overall Study||98
85428|NCT01362140|203518|P1|STARTED|Overall Study||49
85429|NCT01362062|203542|P2|NOT COMPLETED|Overall Study||0
85430|NCT01362062|203543|P1|NOT COMPLETED|Overall Study||26
85431|NCT01362062|203542|P2|COMPLETED|Overall Study||62
85432|NCT01362062|203543|P1|COMPLETED|Overall Study||22
85433|NCT01362062|203542|P2|STARTED|Overall Study||62
85434|NCT01362062|203543|P1|STARTED|Overall Study||48
85435|NCT01362049|203564|P4|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
85436|NCT01362049|203565|P3|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||2
85437|NCT01362049|203566|P2|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||3
85438|NCT01362049|203567|P1|NOT COMPLETED|Follow-Up at 52 Weeks (12 Months)||5
85439|NCT01362049|203564|P4|COMPLETED|Follow-Up at 52 Weeks (12 Months)||21
85440|NCT01362049|203565|P3|COMPLETED|Follow-Up at 52 Weeks (12 Months)||28
85441|NCT01362049|203566|P2|COMPLETED|Follow-Up at 52 Weeks (12 Months)||13
85442|NCT01362049|203567|P1|COMPLETED|Follow-Up at 52 Weeks (12 Months)||18
85443|NCT01362049|203564|P4|STARTED|Follow-Up at 52 Weeks (12 Months)||24
85444|NCT01362049|203565|P3|STARTED|Follow-Up at 52 Weeks (12 Months)||30
85445|NCT01362049|203566|P2|STARTED|Follow-Up at 52 Weeks (12 Months)||16
85446|NCT01362049|203567|P1|STARTED|Follow-Up at 52 Weeks (12 Months)||23
85447|NCT01362049|203564|P4|NOT COMPLETED|Follow-Up at 7 Weeks||1
85448|NCT01362049|203565|P3|NOT COMPLETED|Follow-Up at 7 Weeks||2
85449|NCT01362049|203566|P2|NOT COMPLETED|Follow-Up at 7 Weeks||3
85450|NCT01362049|203567|P1|NOT COMPLETED|Follow-Up at 7 Weeks||3
85451|NCT01362049|203564|P4|COMPLETED|Follow-Up at 7 Weeks||24
85452|NCT01362049|203565|P3|COMPLETED|Follow-Up at 7 Weeks||30
85453|NCT01362049|203566|P2|COMPLETED|Follow-Up at 7 Weeks||16
85454|NCT01362049|203567|P1|COMPLETED|Follow-Up at 7 Weeks||23
85455|NCT01362049|203564|P4|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||25
85456|NCT01362049|203565|P3|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||32
85457|NCT01362049|203566|P2|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||18
85458|NCT01362049|203567|P1|Randomized and Started PT Treatment|Follow-Up at 7 Weeks||26
85459|NCT01362049|203564|P4|STARTED|Follow-Up at 7 Weeks||25
85460|NCT01362049|203565|P3|STARTED|Follow-Up at 7 Weeks||32
85461|NCT01362049|203566|P2|STARTED|Follow-Up at 7 Weeks||19
85462|NCT01362049|203567|P1|STARTED|Follow-Up at 7 Weeks||26
85463|NCT01361867|203605|P1|NOT COMPLETED|Overall Study||0
85464|NCT01361867|203605|P1|COMPLETED|Overall Study||15
85465|NCT01361867|203605|P1|STARTED|Overall Study||15
85466|NCT01361854|203610|P2|NOT COMPLETED|Second Intervention||0
85467|NCT01361854|203611|P1|NOT COMPLETED|Second Intervention||0
85468|NCT01361854|203610|P2|COMPLETED|Second Intervention||48
85469|NCT01361854|203611|P1|COMPLETED|Second Intervention||47
85470|NCT01361854|203610|P2|STARTED|Second Intervention||48
85471|NCT01361854|203611|P1|STARTED|Second Intervention||47
85472|NCT01361854|203610|P2|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
85473|NCT01361854|203611|P1|NOT COMPLETED|Wash-out, Maximum 2 Weeks||0
85474|NCT01361854|203610|P2|COMPLETED|Wash-out, Maximum 2 Weeks||48
85475|NCT01361854|203611|P1|COMPLETED|Wash-out, Maximum 2 Weeks||47
85476|NCT01361854|203610|P2|STARTED|Wash-out, Maximum 2 Weeks||48
85477|NCT01361854|203611|P1|STARTED|Wash-out, Maximum 2 Weeks||47
85478|NCT01361854|203610|P2|NOT COMPLETED|Day 1||3
85479|NCT01361854|203611|P1|NOT COMPLETED|Day 1||4
85480|NCT01361854|203610|P2|COMPLETED|Day 1||48
85481|NCT01361854|203611|P1|COMPLETED|Day 1||47
85482|NCT01361854|203610|P2|STARTED|Day 1||51
85483|NCT01361854|203611|P1|STARTED|Day 1||51
85484|NCT01360645|203619|P4|NOT COMPLETED|Phase A+||24
85485|NCT01360645|203620|P3|NOT COMPLETED|Phase A+||0
85486|NCT01360645|203621|P2|NOT COMPLETED|Phase A+||0
85487|NCT01360645|203622|P1|NOT COMPLETED|Phase A+||0
85488|NCT01360645|203619|P4|COMPLETED|Phase A+||307
85489|NCT01360645|203620|P3|COMPLETED|Phase A+||0
85490|NCT01360645|203621|P2|COMPLETED|Phase A+||0
85491|NCT01360645|203622|P1|COMPLETED|Phase A+||0
85492|NCT01360645|203619|P4|STARTED|Phase A+||331
85493|NCT01360645|203620|P3|STARTED|Phase A+||0
85494|NCT01360645|203621|P2|STARTED|Phase A+||0
85495|NCT01360645|203622|P1|STARTED|Phase A+||0
85496|NCT01360645|203619|P4|NOT COMPLETED|Phase B (6 Weeks)||0
85497|NCT01360645|203620|P3|NOT COMPLETED|Phase B (6 Weeks)||13
85498|NCT01360645|203621|P2|NOT COMPLETED|Phase B (6 Weeks)||14
85499|NCT01360645|203622|P1|NOT COMPLETED|Phase B (6 Weeks)||0
85500|NCT01360645|203619|P4|COMPLETED|Phase B (6 Weeks)||0
85501|NCT01360645|203620|P3|COMPLETED|Phase B (6 Weeks)||178
85502|NCT01360645|203621|P2|COMPLETED|Phase B (6 Weeks)||174
85503|NCT01360645|203622|P1|COMPLETED|Phase B (6 Weeks)||0
85504|NCT01360645|203619|P4|STARTED|Phase B (6 Weeks)||0
85505|NCT01360645|203620|P3|STARTED|Phase B (6 Weeks)||191
85506|NCT01360645|203621|P2|STARTED|Phase B (6 Weeks)||188
85507|NCT01360645|203622|P1|STARTED|Phase B (6 Weeks)||0
85508|NCT01360645|203619|P4|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85509|NCT01360645|203620|P3|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85510|NCT01360645|203621|P2|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85511|NCT01360645|203622|P1|NOT COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||114
85512|NCT01360645|203619|P4|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85513|NCT01360645|203620|P3|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85514|NCT01360645|203621|P2|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85515|NCT01360645|203622|P1|COMPLETED|Placebo+ADT Prospective Phase-A(8 Weeks)||710
85516|NCT01360645|203619|P4|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85517|NCT01360645|203620|P3|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85518|NCT01360645|203621|P2|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)||0
85519|NCT01360645|203622|P1|STARTED|Placebo+ADT Prospective Phase-A(8 Weeks)|826 participants were enrolled but 2 participants discontinued trial before taking study medication.|824
85520|NCT01360632|203677|P5|NOT COMPLETED|Phase A+||25
85521|NCT01360632|203678|P4|NOT COMPLETED|Phase A+||0
85522|NCT01360632|203679|P3|NOT COMPLETED|Phase A+||0
85523|NCT01360632|203680|P2|NOT COMPLETED|Phase A+||0
85524|NCT01360632|203681|P1|NOT COMPLETED|Phase A+||0
85525|NCT01360632|203677|P5|COMPLETED|Phase A+||575
85526|NCT01360632|203678|P4|COMPLETED|Phase A+||0
85527|NCT01360632|203679|P3|COMPLETED|Phase A+||0
85528|NCT01360632|203680|P2|COMPLETED|Phase A+||0
85529|NCT01360632|203681|P1|COMPLETED|Phase A+||0
85530|NCT01360632|203677|P5|STARTED|Phase A+||600
85531|NCT01360632|203678|P4|STARTED|Phase A+||0
85532|NCT01360632|203679|P3|STARTED|Phase A+||0
85533|NCT01360632|203680|P2|STARTED|Phase A+||0
85534|NCT01360632|203681|P1|STARTED|Phase A+||0
85535|NCT01360632|203677|P5|NOT COMPLETED|Phase B (6 Weeks)||0
85536|NCT01360632|203678|P4|NOT COMPLETED|Phase B (6 Weeks)||13
85537|NCT01360632|203679|P3|NOT COMPLETED|Phase B (6 Weeks)||20
85538|NCT01360632|203680|P2|NOT COMPLETED|Phase B (6 Weeks)||10
85539|NCT01360632|203681|P1|NOT COMPLETED|Phase B (6 Weeks)||0
85540|NCT01360632|203677|P5|COMPLETED|Phase B (6 Weeks)||0
85541|NCT01360632|203678|P4|COMPLETED|Phase B (6 Weeks)||208
85542|NCT01360632|203679|P3|COMPLETED|Phase B (6 Weeks)||210
85543|NCT01360632|203680|P2|COMPLETED|Phase B (6 Weeks)||216
85544|NCT01360632|203681|P1|COMPLETED|Phase B (6 Weeks)||0
85545|NCT01360632|203677|P5|STARTED|Phase B (6 Weeks)||0
85546|NCT01360632|203678|P4|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|221
85547|NCT01360632|203679|P3|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|230
85548|NCT01360632|203680|P2|STARTED|Phase B (6 Weeks)|These participants were from the randomized sample.|226
85549|NCT01360632|203681|P1|STARTED|Phase B (6 Weeks)||0
85550|NCT01360632|203677|P5|NOT COMPLETED|Phase A (8 Weeks)||0
85551|NCT01360632|203678|P4|NOT COMPLETED|Phase A (8 Weeks)||0
85552|NCT01360632|203679|P3|NOT COMPLETED|Phase A (8 Weeks)||0
85553|NCT01360632|203680|P2|NOT COMPLETED|Phase A (8 Weeks)||0
85554|NCT01360632|203681|P1|NOT COMPLETED|Phase A (8 Weeks)||255
85555|NCT01360632|203677|P5|COMPLETED|Phase A (8 Weeks)||0
85556|NCT01360632|203678|P4|COMPLETED|Phase A (8 Weeks)||0
85557|NCT01360632|203679|P3|COMPLETED|Phase A (8 Weeks)||0
85558|NCT01360632|203680|P2|COMPLETED|Phase A (8 Weeks)||0
85559|NCT01360632|203681|P1|COMPLETED|Phase A (8 Weeks)||1277
85560|NCT01360632|203677|P5|STARTED|Phase A (8 Weeks)||0
85561|NCT01360632|203678|P4|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
85562|NCT01360632|203679|P3|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
85563|NCT01360632|203680|P2|STARTED|Phase A (8 Weeks)|These participants were from the randomized sample.|0
85564|NCT01360632|203681|P1|STARTED|Phase A (8 Weeks)|A total of 1539 participants were enrolled, 7 discontinued before taking any sponsor-provided ADT|1532
85565|NCT01360554|203760|P2|NOT COMPLETED|Overall Study||439
85566|NCT01360554|203761|P1|NOT COMPLETED|Overall Study||439
85567|NCT01360554|203760|P2|COMPLETED|Overall Study||0
85568|NCT01360554|203761|P1|COMPLETED|Overall Study||0
85569|NCT01360554|203760|P2|Treated|Overall Study||436
85570|NCT01360554|203761|P1|Treated|Overall Study||436
85571|NCT01360554|203760|P2|STARTED|Overall Study|Three participants were randomized but not treated.|439
85572|NCT01360554|203761|P1|STARTED|Overall Study|Three participants were randomized but not treated.|439
85573|NCT01361633|203799|P2|NOT COMPLETED|Overall Study||3
85574|NCT01361633|203800|P1|NOT COMPLETED|Overall Study||6
85575|NCT01361633|203799|P2|COMPLETED|Overall Study||23
85576|NCT01361633|203800|P1|COMPLETED|Overall Study||19
85577|NCT01361633|203799|P2|STARTED|Overall Study||26
85578|NCT01361633|203800|P1|STARTED|Overall Study||25
85579|NCT01361620|203806|P1|NOT COMPLETED|Overall Study||0
85580|NCT01361620|203806|P1|COMPLETED|Overall Study||132
85581|NCT01361620|203806|P1|STARTED|Overall Study||132
85582|NCT01361594|203812|P2|NOT COMPLETED|Overall Study||2
85583|NCT01361594|203813|P1|NOT COMPLETED|Overall Study||1
85584|NCT01361594|203812|P2|COMPLETED|Overall Study||151
85585|NCT01361594|203813|P1|COMPLETED|Overall Study||151
85586|NCT01361594|203812|P2|STARTED|Overall Study||153
85587|NCT01361594|203813|P1|STARTED|Overall Study||152
85588|NCT01361568|203827|P6|NOT COMPLETED|Overall Study||2
85589|NCT01361568|203828|P5|NOT COMPLETED|Overall Study||1
85590|NCT01361568|203829|P4|NOT COMPLETED|Overall Study||0
85591|NCT01361568|203830|P3|NOT COMPLETED|Overall Study||0
85592|NCT01361568|203831|P2|NOT COMPLETED|Overall Study||1
85593|NCT01361568|203832|P1|NOT COMPLETED|Overall Study||2
85594|NCT01361568|203827|P6|COMPLETED|Overall Study||11
85595|NCT01361568|203828|P5|COMPLETED|Overall Study||6
85596|NCT01361568|203829|P4|COMPLETED|Overall Study||21
85597|NCT01361568|203830|P3|COMPLETED|Overall Study||20
85598|NCT01361568|203831|P2|COMPLETED|Overall Study||70
85599|NCT01361568|203832|P1|COMPLETED|Overall Study||69
85600|NCT01361568|203827|P6|STARTED|Overall Study||13
85601|NCT01361568|203828|P5|STARTED|Overall Study||7
85602|NCT01361568|203829|P4|STARTED|Overall Study||21
85603|NCT01361568|203830|P3|STARTED|Overall Study||20
85604|NCT01361568|203831|P2|STARTED|Overall Study||71
85605|NCT01361568|203832|P1|STARTED|Overall Study||71
85606|NCT01361464|203862|P1|NOT COMPLETED|Overall Study||3
85607|NCT01361464|203862|P1|COMPLETED|Overall Study||18
85608|NCT01361464|203862|P1|STARTED|Overall Study||21
85609|NCT01361308|203871|P2|NOT COMPLETED|Overall Study||30
85610|NCT01361308|203872|P1|NOT COMPLETED|Overall Study||35
85611|NCT01361308|203871|P2|COMPLETED|Overall Study||278
85612|NCT01361308|203872|P1|COMPLETED|Overall Study||271
85613|NCT01361308|203871|P2|STARTED|Overall Study||308
85614|NCT01361308|203872|P1|STARTED|Overall Study||306
85615|NCT01361178|203914|P2|NOT COMPLETED|Overall Study||0
85616|NCT01361178|203915|P1|NOT COMPLETED|Overall Study||13
85617|NCT01361178|203914|P2|COMPLETED|Overall Study||11
85618|NCT01361178|203915|P1|COMPLETED|Overall Study||109
85619|NCT01361178|203914|P2|STARTED|Overall Study||11
85620|NCT01361178|203915|P1|STARTED|Overall Study||122
85621|NCT01361126|203923|P2|NOT COMPLETED|Overall Study||2
85622|NCT01361126|203924|P1|NOT COMPLETED|Overall Study||0
85623|NCT01361126|203923|P2|COMPLETED|Overall Study||2
85624|NCT01361126|203924|P1|COMPLETED|Overall Study||13
85625|NCT01361126|203923|P2|STARTED|Overall Study||4
85626|NCT01361126|203924|P1|STARTED|Overall Study||13
85627|NCT01361113|203939|P1|NOT COMPLETED|Overall Study||0
85628|NCT01361113|203939|P1|COMPLETED|Overall Study||21
85629|NCT01361113|203939|P1|STARTED|Overall Study||21
85630|NCT01361048|203947|P3|NOT COMPLETED|Overall Study||1
85631|NCT01361048|203948|P2|NOT COMPLETED|Overall Study||0
85632|NCT01361048|203949|P1|NOT COMPLETED|Overall Study||0
85633|NCT01361048|203947|P3|COMPLETED|Overall Study||9
85634|NCT01361048|203948|P2|COMPLETED|Overall Study||10
85635|NCT01361048|203949|P1|COMPLETED|Overall Study||20
85636|NCT01361048|203947|P3|STARTED|Overall Study||10
85637|NCT01361048|203948|P2|STARTED|Overall Study||10
85638|NCT01361048|203949|P1|STARTED|Overall Study||20
85639|NCT01361009|203957|P1|NOT COMPLETED|Overall Study||116
85640|NCT01361009|203957|P1|COMPLETED|Overall Study||1901
85641|NCT01361009|203957|P1|STARTED|Overall Study||2017
85642|NCT01360996|203967|P3|NOT COMPLETED|Overall Study||2
85643|NCT01360996|203968|P2|NOT COMPLETED|Overall Study||3
85644|NCT01360996|203969|P1|NOT COMPLETED|Overall Study||6
85645|NCT01360996|203967|P3|COMPLETED|Overall Study||21
85646|NCT01360996|203968|P2|COMPLETED|Overall Study||18
85647|NCT01360996|203969|P1|COMPLETED|Overall Study||14
85648|NCT01360996|203967|P3|STARTED|Overall Study||23
85649|NCT01360996|203968|P2|STARTED|Overall Study||21
85650|NCT01360996|203969|P1|STARTED|Overall Study||20
85651|NCT01360840|203991|P3|NOT COMPLETED|Overall Study||9
85652|NCT01360840|203992|P2|NOT COMPLETED|Overall Study||10
85653|NCT01360840|203993|P1|NOT COMPLETED|Overall Study||10
85654|NCT01360840|203991|P3|COMPLETED|Overall Study||51
85655|NCT01360840|203992|P2|COMPLETED|Overall Study||50
85656|NCT01360840|203993|P1|COMPLETED|Overall Study||50
85657|NCT01360840|203991|P3|STARTED|Overall Study||60
85658|NCT01360840|203992|P2|STARTED|Overall Study||60
85659|NCT01360840|203993|P1|STARTED|Overall Study||60
85660|NCT01360021|204046|P3|NOT COMPLETED|Overall Study||7
85661|NCT01360021|204047|P2|NOT COMPLETED|Overall Study||4
85662|NCT01360021|204048|P1|NOT COMPLETED|Overall Study||8
85663|NCT01360021|204046|P3|COMPLETED|Overall Study|Patients who completed study|65
85664|NCT01360021|204047|P2|COMPLETED|Overall Study|Patients who completed study|67
85665|NCT01360021|204048|P1|COMPLETED|Overall Study|Patients who completed study|63
85666|NCT01360021|204046|P3|STARTED|Overall Study|Patients randomized|72
85667|NCT01360021|204047|P2|STARTED|Overall Study|Patients randomized|71
85668|NCT01360021|204048|P1|STARTED|Overall Study|Patients randomized|71
85669|NCT01359943|204074|P3|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
85670|NCT01359943|204075|P2|NOT COMPLETED|Follow-up (Weeks 52 - 60)||15
85671|NCT01359943|204076|P1|NOT COMPLETED|Follow-up (Weeks 52 - 60)||8
85672|NCT01359943|204074|P3|COMPLETED|Follow-up (Weeks 52 - 60)||36
85673|NCT01359943|204075|P2|COMPLETED|Follow-up (Weeks 52 - 60)||69
85674|NCT01359943|204076|P1|COMPLETED|Follow-up (Weeks 52 - 60)||78
85675|NCT01359943|204074|P3|STARTED|Follow-up (Weeks 52 - 60)||44
85676|NCT01359943|204075|P2|STARTED|Follow-up (Weeks 52 - 60)||84
85677|NCT01359943|204076|P1|STARTED|Follow-up (Weeks 52 - 60)||86
85678|NCT01359943|204074|P3|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
85679|NCT01359943|204075|P2|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||13
85680|NCT01359943|204076|P1|NOT COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||8
85681|NCT01359943|204074|P3|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||36
85682|NCT01359943|204075|P2|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||71
85683|NCT01359943|204076|P1|COMPLETED|Open Label 150 mg s.c. (Weeks 16 - 52)||78
85684|NCT01359943|204074|P3|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||44
85685|NCT01359943|204075|P2|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)|One participant, who was continuing as of week 12, did not receive study drug at week 16.|84
85686|NCT01359943|204076|P1|STARTED|Open Label 150 mg s.c. (Weeks 16 - 52)||86
85687|NCT01359943|204074|P3|NOT COMPLETED|Double-blind (Weeks 0 - 16)||0
85688|NCT01359943|204075|P2|NOT COMPLETED|Double-blind (Weeks 0 - 16)||4
85689|NCT01359943|204076|P1|NOT COMPLETED|Double-blind (Weeks 0 - 16)||2
85690|NCT01359943|204074|P3|COMPLETED|Double-blind (Weeks 0 - 16)||44
85691|NCT01359943|204075|P2|COMPLETED|Double-blind (Weeks 0 - 16)||85
85692|NCT01359943|204076|P1|COMPLETED|Double-blind (Weeks 0 - 16)||86
85693|NCT01359943|204074|P3|STARTED|Double-blind (Weeks 0 - 16)||44
85694|NCT01359943|204075|P2|STARTED|Double-blind (Weeks 0 - 16)||89
85695|NCT01359943|204076|P1|STARTED|Double-blind (Weeks 0 - 16)||88
85696|NCT01359904|204124|P2|NOT COMPLETED|Overall Study||0
85697|NCT01359904|204125|P1|NOT COMPLETED|Overall Study||1
85698|NCT01359904|204124|P2|COMPLETED|Overall Study||19
85699|NCT01359904|204125|P1|COMPLETED|Overall Study||14
85700|NCT01359904|204124|P2|STARTED|Overall Study||19
85701|NCT01359904|204125|P1|STARTED|Overall Study||15
85702|NCT01359748|204141|P4|NOT COMPLETED|Overall Study||0
85703|NCT01359748|204142|P3|NOT COMPLETED|Overall Study||0
85704|NCT01359748|204143|P2|NOT COMPLETED|Overall Study||0
85705|NCT01359748|204144|P1|NOT COMPLETED|Overall Study||0
85706|NCT01359748|204141|P4|COMPLETED|Overall Study||11
85707|NCT01359748|204142|P3|COMPLETED|Overall Study||10
85708|NCT01359748|204143|P2|COMPLETED|Overall Study||20
85709|NCT01359748|204144|P1|COMPLETED|Overall Study||48
85710|NCT01359748|204141|P4|STARTED|Overall Study||11
85711|NCT01359748|204142|P3|STARTED|Overall Study||10
85712|NCT01359748|204143|P2|STARTED|Overall Study||20
85713|NCT01359748|204144|P1|STARTED|Overall Study||48
85714|NCT01359735|204154|P2|NOT COMPLETED|Overall Study||0
85715|NCT01359735|204155|P1|NOT COMPLETED|Overall Study||0
85716|NCT01359735|204154|P2|COMPLETED|Overall Study||4
85717|NCT01359735|204155|P1|COMPLETED|Overall Study||4
85718|NCT01359735|204154|P2|STARTED|Overall Study||4
85719|NCT01359735|204155|P1|STARTED|Overall Study||4
85720|NCT01359644|204179|P10|NOT COMPLETED|Follow-up Period||0
85721|NCT01359644|204180|P9|NOT COMPLETED|Follow-up Period||0
85722|NCT01359644|204181|P8|NOT COMPLETED|Follow-up Period||2
85723|NCT01359644|204182|P7|NOT COMPLETED|Follow-up Period||1
85724|NCT01359644|204183|P6|NOT COMPLETED|Follow-up Period||1
85725|NCT01359644|204184|P5|NOT COMPLETED|Follow-up Period||0
85726|NCT01359644|204185|P4|NOT COMPLETED|Follow-up Period||0
85727|NCT01359644|204186|P3|NOT COMPLETED|Follow-up Period||0
85728|NCT01359644|204187|P2|NOT COMPLETED|Follow-up Period||0
85729|NCT01359644|204188|P1|NOT COMPLETED|Follow-up Period||0
85730|NCT01359644|204179|P10|COMPLETED|Follow-up Period||20
85731|NCT01359644|204180|P9|COMPLETED|Follow-up Period||21
85732|NCT01359644|204181|P8|COMPLETED|Follow-up Period||39
85733|NCT01359644|204182|P7|COMPLETED|Follow-up Period||40
85734|NCT01359644|204183|P6|COMPLETED|Follow-up Period||12
85735|NCT01359644|204184|P5|COMPLETED|Follow-up Period||15
85736|NCT01359644|204185|P4|COMPLETED|Follow-up Period||14
85737|NCT01359644|204186|P3|COMPLETED|Follow-up Period||14
85738|NCT01359644|204187|P2|COMPLETED|Follow-up Period||16
85739|NCT01359644|204188|P1|COMPLETED|Follow-up Period||15
85740|NCT01359644|204179|P10|STARTED|Follow-up Period||20
85741|NCT01359644|204180|P9|STARTED|Follow-up Period||21
85742|NCT01359644|204181|P8|STARTED|Follow-up Period||41
85743|NCT01359644|204182|P7|STARTED|Follow-up Period||41
85744|NCT01359644|204183|P6|STARTED|Follow-up Period||13
85745|NCT01359644|204184|P5|STARTED|Follow-up Period||15
85746|NCT01359644|204185|P4|STARTED|Follow-up Period||14
85747|NCT01359644|204186|P3|STARTED|Follow-up Period||14
85748|NCT01359644|204187|P2|STARTED|Follow-up Period||16
85749|NCT01359644|204188|P1|STARTED|Follow-up Period||15
85750|NCT01359644|204179|P10|NOT COMPLETED|Treatment Period||0
85751|NCT01359644|204180|P9|NOT COMPLETED|Treatment Period||0
85752|NCT01359644|204181|P8|NOT COMPLETED|Treatment Period||0
85753|NCT01359644|204182|P7|NOT COMPLETED|Treatment Period||0
85754|NCT01359644|204183|P6|NOT COMPLETED|Treatment Period||2
85755|NCT01359644|204184|P5|NOT COMPLETED|Treatment Period||0
85756|NCT01359644|204185|P4|NOT COMPLETED|Treatment Period||0
85757|NCT01359644|204186|P3|NOT COMPLETED|Treatment Period||1
85758|NCT01359644|204187|P2|NOT COMPLETED|Treatment Period||1
85759|NCT01359644|204188|P1|NOT COMPLETED|Treatment Period||0
85760|NCT01359644|204179|P10|COMPLETED|Treatment Period||20
85761|NCT01359644|204180|P9|COMPLETED|Treatment Period||21
85762|NCT01359644|204181|P8|COMPLETED|Treatment Period||41
85763|NCT01359644|204182|P7|COMPLETED|Treatment Period||41
85764|NCT01359644|204183|P6|COMPLETED|Treatment Period||12
85765|NCT01359644|204184|P5|COMPLETED|Treatment Period||15
85766|NCT01359644|204185|P4|COMPLETED|Treatment Period||14
85767|NCT01359644|204186|P3|COMPLETED|Treatment Period||13
85768|NCT01359644|204187|P2|COMPLETED|Treatment Period||15
85769|NCT01359644|204188|P1|COMPLETED|Treatment Period||15
85770|NCT01359644|204179|P10|STARTED|Treatment Period||20
85771|NCT01359644|204180|P9|STARTED|Treatment Period||21
85772|NCT01359644|204181|P8|STARTED|Treatment Period||41
85773|NCT01359644|204182|P7|STARTED|Treatment Period||41
85774|NCT01359644|204183|P6|STARTED|Treatment Period||14
85775|NCT01359644|204184|P5|STARTED|Treatment Period||15
85776|NCT01359644|204185|P4|STARTED|Treatment Period||14
85777|NCT01359644|204186|P3|STARTED|Treatment Period||14
85778|NCT01359644|204187|P2|STARTED|Treatment Period||16
85779|NCT01359644|204188|P1|STARTED|Treatment Period||15
85780|NCT01359449|204232|P2|NOT COMPLETED|Overall Study||4
85781|NCT01359449|204233|P1|NOT COMPLETED|Overall Study||4
85782|NCT01359449|204232|P2|COMPLETED|Overall Study||58
85783|NCT01359449|204233|P1|COMPLETED|Overall Study||57
85784|NCT01359449|204232|P2|STARTED|Overall Study||62
85785|NCT01359449|204233|P1|STARTED|Overall Study||61
85786|NCT01359410|204257|P2|NOT COMPLETED|Overall Study||0
85787|NCT01359410|204258|P1|NOT COMPLETED|Overall Study||0
85788|NCT01359410|204257|P2|COMPLETED|Overall Study||46
85789|NCT01359410|204258|P1|COMPLETED|Overall Study||54
85790|NCT01359410|204257|P2|STARTED|Overall Study||46
85791|NCT01359410|204258|P1|STARTED|Overall Study||54
85792|NCT01359371|204272|P1|NOT COMPLETED|Overall Study||0
85793|NCT01359371|204272|P1|COMPLETED|Overall Study||41
85794|NCT01359371|204272|P1|STARTED|Overall Study||41
85795|NCT01359254|204279|P2|NOT COMPLETED|Overall Study||0
85796|NCT01359254|204280|P1|NOT COMPLETED|Overall Study||1
85797|NCT01359254|204279|P2|COMPLETED|Overall Study||0
85798|NCT01359254|204280|P1|COMPLETED|Overall Study||0
85799|NCT01359254|204279|P2|STARTED|Overall Study||0
85800|NCT01359254|204280|P1|STARTED|Overall Study||1
85801|NCT01359150|204290|P2|NOT COMPLETED|Overall Study||5
85802|NCT01359150|204291|P1|NOT COMPLETED|Overall Study||7
85803|NCT01359150|204290|P2|COMPLETED|Overall Study||106
85804|NCT01359150|204291|P1|COMPLETED|Overall Study||105
85805|NCT01359150|204290|P2|STARTED|Overall Study||111
85806|NCT01359150|204291|P1|STARTED|Overall Study||112
85807|NCT01359111|204313|P1|NOT COMPLETED|Overall Study||0
85808|NCT01359111|204313|P1|COMPLETED|Overall Study||20
85809|NCT01359111|204313|P1|STARTED|Overall Study||20
85810|NCT01358864|204328|P8|NOT COMPLETED|Overall Study||55
85811|NCT01358864|204329|P7|NOT COMPLETED|Overall Study||65
85812|NCT01358864|204330|P6|NOT COMPLETED|Overall Study||13
85813|NCT01358864|204331|P5|NOT COMPLETED|Overall Study||11
85814|NCT01358864|204332|P4|NOT COMPLETED|Overall Study||19
85815|NCT01358864|204333|P3|NOT COMPLETED|Overall Study||16
85816|NCT01358864|204334|P2|NOT COMPLETED|Overall Study||13
85817|NCT01358864|204335|P1|NOT COMPLETED|Overall Study||31
85818|NCT01358864|204328|P8|COMPLETED|Overall Study||85
85819|NCT01358864|204329|P7|COMPLETED|Overall Study||81
85820|NCT01358864|204330|P6|COMPLETED|Overall Study||42
85821|NCT01358864|204331|P5|COMPLETED|Overall Study||46
85822|NCT01358864|204332|P4|COMPLETED|Overall Study||10
85823|NCT01358864|204333|P3|COMPLETED|Overall Study||87
85824|NCT01358864|204334|P2|COMPLETED|Overall Study||86
85825|NCT01358864|204335|P1|COMPLETED|Overall Study||18
85826|NCT01358864|204328|P8|STARTED|Overall Study||140
85827|NCT01358864|204329|P7|STARTED|Overall Study||146
85828|NCT01358864|204330|P6|STARTED|Overall Study||55
85829|NCT01358864|204331|P5|STARTED|Overall Study||57
85830|NCT01358864|204332|P4|STARTED|Overall Study||29
85831|NCT01358864|204333|P3|STARTED|Overall Study||103
85832|NCT01358864|204334|P2|STARTED|Overall Study||99
85833|NCT01358864|204335|P1|STARTED|Overall Study||49
85834|NCT01358825|204426|P2|NOT COMPLETED|Overall Study||1
85835|NCT01358825|204427|P1|NOT COMPLETED|Overall Study||0
85836|NCT01358825|204426|P2|COMPLETED|Overall Study||45
85837|NCT01358825|204427|P1|COMPLETED|Overall Study||12
85838|NCT01358825|204426|P2|STARTED|Overall Study||46
85839|NCT01358825|204427|P1|STARTED|Overall Study||12
85840|NCT01358760|204451|P3|NOT COMPLETED|Overall Study||25
85841|NCT01358760|204452|P2|NOT COMPLETED|Overall Study||20
85842|NCT01358760|204453|P1|NOT COMPLETED|Overall Study||22
85843|NCT01358760|204451|P3|COMPLETED|Overall Study||125
85844|NCT01358760|204452|P2|COMPLETED|Overall Study||128
85845|NCT01358760|204453|P1|COMPLETED|Overall Study||130
85846|NCT01358760|204451|P3|ITT Population|Overall Study||134
85847|NCT01358760|204452|P2|ITT Population|Overall Study||134
85848|NCT01358760|204453|P1|ITT Population|Overall Study||139
85849|NCT01358760|204451|P3|Safety Population|Overall Study||148
85850|NCT01358760|204452|P2|Safety Population|Overall Study||143
85851|NCT01358760|204453|P1|Safety Population|Overall Study||150
85852|NCT01358760|204451|P3|STARTED|Overall Study||150
85853|NCT01358760|204452|P2|STARTED|Overall Study||148
85854|NCT01358760|204453|P1|STARTED|Overall Study||152
85855|NCT01358734|204488|P3|NOT COMPLETED|Overall Study||29
85856|NCT01358734|204489|P2|NOT COMPLETED|Overall Study||37
85857|NCT01358734|204490|P1|NOT COMPLETED|Overall Study||15
85858|NCT01358734|204488|P3|COMPLETED|Overall Study|Includes participants still receiving study treatment|5
85859|NCT01358734|204489|P2|COMPLETED|Overall Study|Includes participants still receiving study treatment|2
85860|NCT01358734|204490|P1|COMPLETED|Overall Study||0
85861|NCT01358734|204488|P3|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|32
85862|NCT01358734|204489|P2|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|38
85863|NCT01358734|204490|P1|Safety Population|Overall Study|The safety population includes all participants who received at least one dose of study drug.|14
85864|NCT01358734|204488|P3|STARTED|Overall Study||34
85865|NCT01358734|204489|P2|STARTED|Overall Study||39
85866|NCT01358734|204490|P1|STARTED|Overall Study||15
85867|NCT01358708|204509|P2|NOT COMPLETED|Open-Label Treatment Phase||0
85868|NCT01358708|204510|P1|NOT COMPLETED|Open-Label Treatment Phase||0
85869|NCT01358708|204509|P2|COMPLETED|Open-Label Treatment Phase||12
85870|NCT01358708|204510|P1|COMPLETED|Open-Label Treatment Phase||5
85871|NCT01358708|204509|P2|STARTED|Open-Label Treatment Phase|Number of subjects on PLACEBO during double-blind treatment and entering the Open-Label Phase|12
85872|NCT01358708|204510|P1|STARTED|Open-Label Treatment Phase|Number of subjects on LACTEOL® during double-blind treatment and entering the Open-Label Phase|5
85873|NCT01358708|204509|P2|NOT COMPLETED|Double-Blind Treatment Phase||0
85874|NCT01358708|204510|P1|NOT COMPLETED|Double-Blind Treatment Phase||3
85875|NCT01358708|204509|P2|COMPLETED|Double-Blind Treatment Phase||13
85876|NCT01358708|204510|P1|COMPLETED|Double-Blind Treatment Phase||10
85877|NCT01358708|204509|P2|Received Study Medication|Double-Blind Treatment Phase||13
85878|NCT01358708|204510|P1|Received Study Medication|Double-Blind Treatment Phase|For 1 subject, unused med not returned to the site and intake of study medication not confirmed.|12
85879|NCT01358708|204509|P2|Randomized|Double-Blind Treatment Phase||13
85880|NCT01358708|204510|P1|Randomized|Double-Blind Treatment Phase||13
85881|NCT01358708|204509|P2|STARTED|Double-Blind Treatment Phase||13
85882|NCT01358708|204510|P1|STARTED|Double-Blind Treatment Phase||13
85883|NCT01358578|204533|P6|NOT COMPLETED|Follow-up Period||0
85884|NCT01358578|204534|P5|NOT COMPLETED|Follow-up Period||0
85885|NCT01358578|204535|P4|NOT COMPLETED|Follow-up Period||19
85886|NCT01358578|204536|P3|NOT COMPLETED|Follow-up Period||5
85887|NCT01358578|204537|P2|NOT COMPLETED|Follow-up Period||6
85888|NCT01358578|204538|P1|NOT COMPLETED|Follow-up Period||10
85889|NCT01358578|204533|P6|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
85890|NCT01358578|204534|P5|COMPLETED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
85891|NCT01358578|204535|P4|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|260
85892|NCT01358578|204536|P3|COMPLETED|Follow-up Period|contains patients who completed follow up period from induction and maintenance|21
85893|NCT01358578|204537|P2|COMPLETED|Follow-up Period||119
85894|NCT01358578|204538|P1|COMPLETED|Follow-up Period||138
85895|NCT01358578|204533|P6|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
85896|NCT01358578|204534|P5|STARTED|Follow-up Period|all placebo patients from induction were 1: 1 into either AIN457A 150 mg or 300 mg doses|0
85897|NCT01358578|204535|P4|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|279
85898|NCT01358578|204536|P3|STARTED|Follow-up Period|contains patients who participated in follow up period from induction and maintenance|26
85899|NCT01358578|204537|P2|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 300 mg dose|125
85900|NCT01358578|204538|P1|STARTED|Follow-up Period|Patients prior to follow up who did not enter the extension study but received the 150 mg dose|148
85901|NCT01358578|204533|P6|NOT COMPLETED|Maintenance Period||11
85902|NCT01358578|204534|P5|NOT COMPLETED|Maintenance Period||17
85903|NCT01358578|204535|P4|NOT COMPLETED|Maintenance Period||42
85904|NCT01358578|204536|P3|NOT COMPLETED|Maintenance Period||2
85905|NCT01358578|204537|P2|NOT COMPLETED|Maintenance Period||22
85906|NCT01358578|204538|P1|NOT COMPLETED|Maintenance Period||39
85907|NCT01358578|204533|P6|COMPLETED|Maintenance Period||131
85908|NCT01358578|204534|P5|COMPLETED|Maintenance Period||125
85909|NCT01358578|204535|P4|COMPLETED|Maintenance Period||263
85910|NCT01358578|204536|P3|COMPLETED|Maintenance Period||15
85911|NCT01358578|204537|P2|COMPLETED|Maintenance Period||290
85912|NCT01358578|204538|P1|COMPLETED|Maintenance Period||276
85913|NCT01358578|204533|P6|STARTED|Maintenance Period||142
85914|NCT01358578|204534|P5|STARTED|Maintenance Period||142
85915|NCT01358578|204535|P4|STARTED|Maintenance Period||305
85916|NCT01358578|204536|P3|STARTED|Maintenance Period||17
85917|NCT01358578|204537|P2|STARTED|Maintenance Period||312
85918|NCT01358578|204538|P1|STARTED|Maintenance Period||315
85919|NCT01358578|204533|P6|NOT COMPLETED|Induction Period||0
85920|NCT01358578|204534|P5|NOT COMPLETED|Induction Period||0
85921|NCT01358578|204535|P4|NOT COMPLETED|Induction Period||21
85922|NCT01358578|204536|P3|NOT COMPLETED|Induction Period||25
85923|NCT01358578|204537|P2|NOT COMPLETED|Induction Period||15
85924|NCT01358578|204538|P1|NOT COMPLETED|Induction Period||12
85925|NCT01358578|204533|P6|COMPLETED|Induction Period|These groups are populated after the induction period|0
85926|NCT01358578|204534|P5|COMPLETED|Induction Period|These groups are populated after the induction period|0
85927|NCT01358578|204535|P4|COMPLETED|Induction Period||305
85928|NCT01358578|204536|P3|COMPLETED|Induction Period||301
85929|NCT01358578|204537|P2|COMPLETED|Induction Period||312
85930|NCT01358578|204538|P1|COMPLETED|Induction Period||315
85931|NCT01358578|204533|P6|STARTED|Induction Period|These groups are populated after the induction period|0
85932|NCT01358578|204534|P5|STARTED|Induction Period|These groups are populated after the induction period|0
85933|NCT01358578|204535|P4|STARTED|Induction Period||326
85934|NCT01358578|204536|P3|STARTED|Induction Period||326
85935|NCT01358578|204537|P2|STARTED|Induction Period||327
85936|NCT01358578|204538|P1|STARTED|Induction Period||327
85937|NCT01358526|204590|P3|NOT COMPLETED|Double-blind Phase||121
85938|NCT01358526|204591|P2|NOT COMPLETED|Double-blind Phase||80
85939|NCT01358526|204592|P1|NOT COMPLETED|Double-blind Phase||0
85940|NCT01358526|204590|P3|COMPLETED|Double-blind Phase||181
85941|NCT01358526|204591|P2|COMPLETED|Double-blind Phase||218
85942|NCT01358526|204592|P1|COMPLETED|Double-blind Phase||0
85943|NCT01358526|204590|P3|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|302
85944|NCT01358526|204591|P2|STARTED|Double-blind Phase|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|298
85945|NCT01358526|204592|P1|STARTED|Double-blind Phase||0
85946|NCT01358526|204590|P3|NOT COMPLETED|Open-label Titration Period||0
85947|NCT01358526|204591|P2|NOT COMPLETED|Open-label Titration Period||0
85948|NCT01358526|204592|P1|NOT COMPLETED|Open-label Titration Period||494
85949|NCT01358526|204590|P3|COMPLETED|Open-label Titration Period||0
85950|NCT01358526|204591|P2|COMPLETED|Open-label Titration Period||0
85951|NCT01358526|204592|P1|COMPLETED|Open-label Titration Period|1 subject was randomized but never received double-blind treatment: Randomized Safety Population=600|601
85952|NCT01358526|204590|P3|STARTED|Open-label Titration Period||0
85953|NCT01358526|204591|P2|STARTED|Open-label Titration Period||0
85954|NCT01358526|204592|P1|STARTED|Open-label Titration Period||1095
85955|NCT01358357|204609|P3|NOT COMPLETED|Double-Blind Phase||0
85956|NCT01358357|204610|P2|NOT COMPLETED|Double-Blind Phase||100
85957|NCT01358357|204611|P1|NOT COMPLETED|Double-Blind Phase||80
85958|NCT01358357|204609|P3|COMPLETED|Double-Blind Phase||0
85959|NCT01358357|204610|P2|COMPLETED|Double-Blind Phase||150
85960|NCT01358357|204611|P1|COMPLETED|Double-Blind Phase||166
85961|NCT01358357|204609|P3|STARTED|Double-Blind Phase||0
85962|NCT01358357|204610|P2|STARTED|Double-Blind Phase||250
85963|NCT01358357|204611|P1|STARTED|Double-Blind Phase||246
85964|NCT01358357|204609|P3|NOT COMPLETED|Open Label Phase||462
85965|NCT01358357|204610|P2|NOT COMPLETED|Open Label Phase||0
85966|NCT01358357|204611|P1|NOT COMPLETED|Open Label Phase||0
85967|NCT01358357|204609|P3|COMPLETED|Open Label Phase||503
85968|NCT01358357|204610|P2|COMPLETED|Open Label Phase||0
85969|NCT01358357|204611|P1|COMPLETED|Open Label Phase||0
85970|NCT01358357|204609|P3|STARTED|Open Label Phase||965
85971|NCT01358357|204610|P2|STARTED|Open Label Phase||0
85972|NCT01358357|204611|P1|STARTED|Open Label Phase||0
85973|NCT01358175|204647|P3|NOT COMPLETED|Overall Study||32
85974|NCT01358175|204648|P2|NOT COMPLETED|Overall Study||28
85975|NCT01358175|204649|P1|NOT COMPLETED|Overall Study||21
85976|NCT01358175|204647|P3|COMPLETED|Overall Study||90
85977|NCT01358175|204648|P2|COMPLETED|Overall Study||97
85978|NCT01358175|204649|P1|COMPLETED|Overall Study||103
85979|NCT01358175|204647|P3|STARTED|Overall Study||122
85980|NCT01358175|204648|P2|STARTED|Overall Study||125
85981|NCT01358175|204649|P1|STARTED|Overall Study||124
85982|NCT01357980|204686|P4|NOT COMPLETED|Overall Study||0
85983|NCT01357980|204687|P3|NOT COMPLETED|Overall Study||1
85984|NCT01357980|204688|P2|NOT COMPLETED|Overall Study||1
85985|NCT01357980|204689|P1|NOT COMPLETED|Overall Study||0
85986|NCT01357980|204686|P4|COMPLETED|Overall Study||7
85987|NCT01357980|204687|P3|COMPLETED|Overall Study||16
85988|NCT01357980|204688|P2|COMPLETED|Overall Study||6
85989|NCT01357980|204689|P1|COMPLETED|Overall Study||16
85990|NCT01357980|204686|P4|STARTED|Overall Study||7
85991|NCT01357980|204687|P3|STARTED|Overall Study||17
85992|NCT01357980|204688|P2|STARTED|Overall Study||7
85993|NCT01357980|204689|P1|STARTED|Overall Study||16
85994|NCT01357889|204733|P2|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||4
85995|NCT01357889|204734|P1|NOT COMPLETED|Follow-up Phase (FUP) (8 Weeks)||3
85996|NCT01357889|204733|P2|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
85997|NCT01357889|204734|P1|COMPLETED|Follow-up Phase (FUP) (8 Weeks)||138
85998|NCT01357889|204733|P2|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|142
85999|NCT01357889|204734|P1|STARTED|Follow-up Phase (FUP) (8 Weeks)|All participants who started the MDP entered the FUP, regardless of MDP completion status.|141
86000|NCT01357889|204733|P2|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
86001|NCT01357889|204734|P1|NOT COMPLETED|Multiple-dose Phase (MDP) (Overall)||16
86002|NCT01357889|204733|P2|COMPLETED|Multiple-dose Phase (MDP) (Overall)||126
86003|NCT01357889|204734|P1|COMPLETED|Multiple-dose Phase (MDP) (Overall)||125
86004|NCT01357889|204733|P2|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|142
86005|NCT01357889|204734|P1|STARTED|Multiple-dose Phase (MDP) (Overall)|After completion of the BE Phase, additional participants were randomized to the Overall Phase.|141
86006|NCT01357889|204733|P2|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||2
86007|NCT01357889|204734|P1|NOT COMPLETED|Single-dose Phase (BE Phase: 28 Days)||4
86008|NCT01357889|204733|P2|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||79
86009|NCT01357889|204734|P1|COMPLETED|Single-dose Phase (BE Phase: 28 Days)||82
86010|NCT01357889|204733|P2|STARTED|Single-dose Phase (BE Phase: 28 Days)||81
86011|NCT01357889|204734|P1|STARTED|Single-dose Phase (BE Phase: 28 Days)||86
86012|NCT01357850|204778|P4|NOT COMPLETED|Overall Study||0
86013|NCT01357850|204779|P3|NOT COMPLETED|Overall Study||0
86014|NCT01357850|204780|P2|NOT COMPLETED|Overall Study||0
86015|NCT01357850|204781|P1|NOT COMPLETED|Overall Study||1
86016|NCT01357850|204778|P4|COMPLETED|Overall Study||27
86017|NCT01357850|204779|P3|COMPLETED|Overall Study||13
86018|NCT01357850|204780|P2|COMPLETED|Overall Study||12
86019|NCT01357850|204781|P1|COMPLETED|Overall Study||29
86020|NCT01357850|204778|P4|STARTED|Overall Study||27
86021|NCT01357850|204779|P3|STARTED|Overall Study||13
86022|NCT01357850|204780|P2|STARTED|Overall Study||12
86023|NCT01357850|204781|P1|STARTED|Overall Study||30
86024|NCT01357720|204855|P2|NOT COMPLETED|Overall Study||5
86025|NCT01357720|204856|P1|NOT COMPLETED|Overall Study||2
86026|NCT01357720|204855|P2|COMPLETED|Overall Study||195
86027|NCT01357720|204856|P1|COMPLETED|Overall Study||198
86028|NCT01357720|204855|P2|STARTED|Overall Study||200
86029|NCT01357720|204856|P1|STARTED|Overall Study||200
86030|NCT01357655|204872|P2|NOT COMPLETED|Overall Study||0
86031|NCT01357655|204873|P1|NOT COMPLETED|Overall Study||66
86032|NCT01357655|204872|P2|COMPLETED|Overall Study||0
86033|NCT01357655|204873|P1|COMPLETED|Overall Study||0
86034|NCT01357655|204872|P2|STARTED|Overall Study||0
86035|NCT01357655|204873|P1|STARTED|Overall Study||66
86036|NCT01357616|204890|P2|NOT COMPLETED|Overall Study||9
86037|NCT01357616|204891|P1|NOT COMPLETED|Overall Study||10
86038|NCT01357616|204890|P2|COMPLETED|Overall Study||153
86039|NCT01357616|204891|P1|COMPLETED|Overall Study||156
86040|NCT01357616|204890|P2|STARTED|Overall Study||162
86041|NCT01357616|204891|P1|STARTED|Overall Study||166
86042|NCT01357551|204905|P2|NOT COMPLETED|Overall Study||11
86043|NCT01357551|204906|P1|NOT COMPLETED|Overall Study||22
86044|NCT01357551|204905|P2|COMPLETED|Overall Study||101
86045|NCT01357551|204906|P1|COMPLETED|Overall Study||88
86046|NCT01357551|204905|P2|STARTED|Overall Study||112
86047|NCT01357551|204906|P1|STARTED|Overall Study||110
86048|NCT01357512|204920|P2|NOT COMPLETED|Overall Study||5
86049|NCT01357512|204921|P1|NOT COMPLETED|Overall Study||12
86050|NCT01357512|204920|P2|COMPLETED|Overall Study||60
86051|NCT01357512|204921|P1|COMPLETED|Overall Study||53
86052|NCT01357512|204920|P2|STARTED|Overall Study||65
86053|NCT01357512|204921|P1|STARTED|Overall Study||65
86054|NCT01357239|204933|P4|NOT COMPLETED|Stratum II: Partially-Methylated||2
86055|NCT01357239|204934|P3|NOT COMPLETED|Stratum II: Partially-Methylated||1
86056|NCT01357239|204935|P2|NOT COMPLETED|Stratum II: Partially-Methylated||0
86057|NCT01357239|204936|P1|NOT COMPLETED|Stratum II: Partially-Methylated||0
86058|NCT01357239|204933|P4|COMPLETED|Stratum II: Partially-Methylated||18
86059|NCT01357239|204934|P3|COMPLETED|Stratum II: Partially-Methylated||21
86060|NCT01357239|204935|P2|COMPLETED|Stratum II: Partially-Methylated||21
86061|NCT01357239|204936|P1|COMPLETED|Stratum II: Partially-Methylated||23
86062|NCT01357239|204933|P4|STARTED|Stratum II: Partially-Methylated||20
86063|NCT01357239|204934|P3|STARTED|Stratum II: Partially-Methylated||22
86064|NCT01357239|204935|P2|STARTED|Stratum II: Partially-Methylated||21
86065|NCT01357239|204936|P1|STARTED|Stratum II: Partially-Methylated||23
86066|NCT01357239|204933|P4|NOT COMPLETED|Stratum I: Fully-Methylated||0
86067|NCT01357239|204934|P3|NOT COMPLETED|Stratum I: Fully-Methylated||1
86068|NCT01357239|204935|P2|NOT COMPLETED|Stratum I: Fully-Methylated||0
86069|NCT01357239|204936|P1|NOT COMPLETED|Stratum I: Fully-Methylated||0
86070|NCT01357239|204933|P4|COMPLETED|Stratum I: Fully-Methylated||22
86071|NCT01357239|204934|P3|COMPLETED|Stratum I: Fully-Methylated||16
86072|NCT01357239|204935|P2|COMPLETED|Stratum I: Fully-Methylated||6
86073|NCT01357239|204936|P1|COMPLETED|Stratum I: Fully-Methylated||8
86074|NCT01357239|204933|P4|STARTED|Stratum I: Fully-Methylated||22
86075|NCT01357239|204934|P3|STARTED|Stratum I: Fully-Methylated||17
86076|NCT01357239|204935|P2|STARTED|Stratum I: Fully-Methylated||6
86077|NCT01357239|204936|P1|STARTED|Stratum I: Fully-Methylated||8
86078|NCT01357239|204933|P4|NOT COMPLETED|Stratum: All Patients||2
86079|NCT01357239|204934|P3|NOT COMPLETED|Stratum: All Patients||2
86080|NCT01357239|204935|P2|NOT COMPLETED|Stratum: All Patients||0
86081|NCT01357239|204936|P1|NOT COMPLETED|Stratum: All Patients||0
86082|NCT01357239|204933|P4|COMPLETED|Stratum: All Patients||40
86083|NCT01357239|204934|P3|COMPLETED|Stratum: All Patients||37
86084|NCT01357239|204935|P2|COMPLETED|Stratum: All Patients||27
86085|NCT01357239|204936|P1|COMPLETED|Stratum: All Patients||31
86086|NCT01357239|204933|P4|STARTED|Stratum: All Patients||42
86087|NCT01357239|204934|P3|STARTED|Stratum: All Patients||39
86088|NCT01357239|204935|P2|STARTED|Stratum: All Patients||27
86089|NCT01357239|204936|P1|STARTED|Stratum: All Patients||31
86090|NCT01357148|204991|P1|NOT COMPLETED|Overall Study||0
86091|NCT01357148|204991|P1|COMPLETED|Overall Study||143
86092|NCT01357148|204991|P1|STARTED|Overall Study||143
86093|NCT01357135|205001|P3|NOT COMPLETED|Overall Study||263
86094|NCT01357135|205002|P2|NOT COMPLETED|Overall Study||223
86095|NCT01357135|205003|P1|NOT COMPLETED|Overall Study||598
86096|NCT01357135|205001|P3|COMPLETED|Overall Study||583
86097|NCT01357135|205002|P2|COMPLETED|Overall Study||510
86098|NCT01357135|205003|P1|COMPLETED|Overall Study||1276
86099|NCT01357135|205001|P3|STARTED|Overall Study||846
86100|NCT01357135|205002|P2|STARTED|Overall Study||733
86101|NCT01357135|205003|P1|STARTED|Overall Study||1874
86102|NCT01356966|205014|P2|NOT COMPLETED|Overall Study||2
86103|NCT01356966|205015|P1|NOT COMPLETED|Overall Study||2
86104|NCT01356966|205014|P2|COMPLETED|Overall Study||12
86105|NCT01356966|205015|P1|COMPLETED|Overall Study||16
86106|NCT01356966|205014|P2|STARTED|Overall Study||14
86107|NCT01356966|205015|P1|STARTED|Overall Study||18
86108|NCT01356940|205027|P2|NOT COMPLETED|Second Intervention (28 Days)||0
86109|NCT01356940|205028|P1|NOT COMPLETED|Second Intervention (28 Days)||1
86110|NCT01356940|205027|P2|COMPLETED|Second Intervention (28 Days)||21
86111|NCT01356940|205028|P1|COMPLETED|Second Intervention (28 Days)||20
86112|NCT01356940|205027|P2|STARTED|Second Intervention (28 Days)||21
86113|NCT01356940|205028|P1|STARTED|Second Intervention (28 Days)||21
86114|NCT01356940|205027|P2|NOT COMPLETED|Washout (14 Days)||0
86115|NCT01356940|205028|P1|NOT COMPLETED|Washout (14 Days)||0
86116|NCT01356940|205027|P2|COMPLETED|Washout (14 Days)||21
86117|NCT01356940|205028|P1|COMPLETED|Washout (14 Days)||21
86118|NCT01356940|205027|P2|STARTED|Washout (14 Days)||21
86119|NCT01356940|205028|P1|STARTED|Washout (14 Days)||21
86120|NCT01356940|205027|P2|NOT COMPLETED|First Intervention (28 Days)||0
86121|NCT01356940|205028|P1|NOT COMPLETED|First Intervention (28 Days)||1
86122|NCT01356940|205027|P2|COMPLETED|First Intervention (28 Days)||21
86123|NCT01356940|205028|P1|COMPLETED|First Intervention (28 Days)||21
86124|NCT01356940|205027|P2|STARTED|First Intervention (28 Days)||21
86125|NCT01356940|205028|P1|STARTED|First Intervention (28 Days)||22
86126|NCT01356667|205036|P2|NOT COMPLETED|Overall Study||6
86127|NCT01356667|205037|P1|NOT COMPLETED|Overall Study||4
86128|NCT01356667|205036|P2|COMPLETED|Overall Study||0
86129|NCT01356667|205037|P1|COMPLETED|Overall Study||0
86130|NCT01356667|205036|P2|STARTED|Overall Study||6
86131|NCT01356667|205037|P1|STARTED|Overall Study||4
86132|NCT01356602|205050|P3|NOT COMPLETED|Overall Study||24
86133|NCT01356602|205051|P2|NOT COMPLETED|Overall Study||15
86134|NCT01356602|205052|P1|NOT COMPLETED|Overall Study||9
86135|NCT01356602|205050|P3|COMPLETED|Overall Study||108
86136|NCT01356602|205051|P2|COMPLETED|Overall Study||117
86137|NCT01356602|205052|P1|COMPLETED|Overall Study||124
86138|NCT01356602|205050|P3|Full Analysis Set|Overall Study||129
86139|NCT01356602|205051|P2|Full Analysis Set|Overall Study||129
86140|NCT01356602|205052|P1|Full Analysis Set|Overall Study||131
86141|NCT01356602|205050|P3|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
86142|NCT01356602|205051|P2|Safety Set|Overall Study|In this arm, 3 patients also took other active drug.|133
86143|NCT01356602|205052|P1|Safety Set|Overall Study|In this arm, 1 patient had only 3 placebo injections and 3 patients also took other active drug.|133
86144|NCT01356602|205050|P3|STARTED|Overall Study||132
86145|NCT01356602|205051|P2|STARTED|Overall Study||132
86146|NCT01356602|205052|P1|STARTED|Overall Study||133
86147|NCT01356589|205111|P1|NOT COMPLETED|Overall Study||5
86148|NCT01356589|205111|P1|COMPLETED|Overall Study||1283
86149|NCT01356589|205111|P1|Treated|Overall Study||1285
86150|NCT01356589|205111|P1|STARTED|Overall Study||1288
86151|NCT01356498|205123|P6|NOT COMPLETED|Overall Study||14
86152|NCT01356498|205124|P5|NOT COMPLETED|Overall Study||20
86153|NCT01356498|205125|P4|NOT COMPLETED|Overall Study||14
86154|NCT01356498|205126|P3|NOT COMPLETED|Overall Study||12
86155|NCT01356498|205127|P2|NOT COMPLETED|Overall Study||8
86156|NCT01356498|205128|P1|NOT COMPLETED|Overall Study||11
86157|NCT01356498|205123|P6|COMPLETED|Overall Study||2
86158|NCT01356498|205124|P5|COMPLETED|Overall Study||8
86159|NCT01356498|205125|P4|COMPLETED|Overall Study||8
86160|NCT01356498|205126|P3|COMPLETED|Overall Study||11
86161|NCT01356498|205127|P2|COMPLETED|Overall Study||17
86162|NCT01356498|205128|P1|COMPLETED|Overall Study||24
86163|NCT01356498|205123|P6|STARTED|Overall Study||16
86164|NCT01356498|205124|P5|STARTED|Overall Study||28
86165|NCT01356498|205125|P4|STARTED|Overall Study||22
86166|NCT01356498|205126|P3|STARTED|Overall Study||23
86167|NCT01356498|205127|P2|STARTED|Overall Study|2 other patients received no investigational drug in C0407 but elected to be followed in Observation|25
86168|NCT01356498|205128|P1|STARTED|Overall Study||35
86169|NCT01356407|205168|P2|NOT COMPLETED|Overall Study||4
86170|NCT01356407|205169|P1|NOT COMPLETED|Overall Study||6
86171|NCT01356407|205168|P2|COMPLETED|Overall Study||146
86172|NCT01356407|205169|P1|COMPLETED|Overall Study||144
86173|NCT01356407|205168|P2|STARTED|Overall Study||150
86174|NCT01356407|205169|P1|STARTED|Overall Study||150
86175|NCT01356147|205187|P2|NOT COMPLETED|Overall Study||0
86176|NCT01356147|205188|P1|NOT COMPLETED|Overall Study||0
86177|NCT01356147|205187|P2|COMPLETED|Overall Study||6
86178|NCT01356147|205188|P1|COMPLETED|Overall Study||5
86179|NCT01356147|205187|P2|STARTED|Overall Study||6
86180|NCT01356147|205188|P1|STARTED|Overall Study||5
86181|NCT01355978|205194|P1|NOT COMPLETED|Overall Study||4
86182|NCT01355978|205194|P1|COMPLETED|Overall Study||18
86183|NCT01355978|205194|P1|STARTED|Overall Study||22
86184|NCT01355705|205200|P1|NOT COMPLETED|Overall Study||0
86185|NCT01355705|205200|P1|COMPLETED|Overall Study||14
86186|NCT01355705|205200|P1|STARTED|Overall Study||14
86187|NCT01355679|205207|P1|NOT COMPLETED|Overall Study||2
86188|NCT01355679|205207|P1|COMPLETED|Overall Study||14
86189|NCT01355679|205207|P1|STARTED|Overall Study||16
86190|NCT01355627|205216|P2|NOT COMPLETED|Overall Study||38
86191|NCT01355627|205217|P1|NOT COMPLETED|Overall Study||33
86192|NCT01355627|205216|P2|COMPLETED|Overall Study||326
86193|NCT01355627|205217|P1|COMPLETED|Overall Study||329
86194|NCT01355627|205216|P2|Full Analysis Set|Overall Study|One participant randomized to Current Practice actually received TachoSil®.|365
86195|NCT01355627|205217|P1|Full Analysis Set|Overall Study|One participant's data for final follow-up is missing, completion status could not be confirmed.|361
86196|NCT01355627|205216|P2|Safety Analysis Set|Overall Study||364
86197|NCT01355627|205217|P1|Safety Analysis Set|Overall Study||362
86198|NCT01355627|205216|P2|STARTED|Overall Study||364
86199|NCT01355627|205217|P1|STARTED|Overall Study||362
86200|NCT01355588|205229|P4|NOT COMPLETED|Fourth Intervention (After Washout)||0
86201|NCT01355588|205230|P3|NOT COMPLETED|Fourth Intervention (After Washout)||0
86202|NCT01355588|205231|P2|NOT COMPLETED|Fourth Intervention (After Washout)||0
86203|NCT01355588|205232|P1|NOT COMPLETED|Fourth Intervention (After Washout)||0
86204|NCT01355588|205229|P4|COMPLETED|Fourth Intervention (After Washout)||4
86205|NCT01355588|205230|P3|COMPLETED|Fourth Intervention (After Washout)||4
86206|NCT01355588|205231|P2|COMPLETED|Fourth Intervention (After Washout)||4
86207|NCT01355588|205232|P1|COMPLETED|Fourth Intervention (After Washout)||4
86208|NCT01355588|205229|P4|STARTED|Fourth Intervention (After Washout)||4
86209|NCT01355588|205230|P3|STARTED|Fourth Intervention (After Washout)||4
86210|NCT01355588|205231|P2|STARTED|Fourth Intervention (After Washout)||4
86211|NCT01355588|205232|P1|STARTED|Fourth Intervention (After Washout)||4
86212|NCT01355588|205229|P4|NOT COMPLETED|Washout (3-7 Days)||0
86213|NCT01355588|205230|P3|NOT COMPLETED|Washout (3-7 Days)||0
86214|NCT01355588|205231|P2|NOT COMPLETED|Washout (3-7 Days)||0
86215|NCT01355588|205232|P1|NOT COMPLETED|Washout (3-7 Days)||0
86216|NCT01355588|205229|P4|COMPLETED|Washout (3-7 Days)||4
86217|NCT01355588|205230|P3|COMPLETED|Washout (3-7 Days)||4
86218|NCT01355588|205231|P2|COMPLETED|Washout (3-7 Days)||4
86219|NCT01355588|205232|P1|COMPLETED|Washout (3-7 Days)||4
86220|NCT01355588|205229|P4|STARTED|Washout (3-7 Days)||4
86221|NCT01355588|205230|P3|STARTED|Washout (3-7 Days)||4
86222|NCT01355588|205231|P2|STARTED|Washout (3-7 Days)||4
86223|NCT01355588|205232|P1|STARTED|Washout (3-7 Days)||4
86224|NCT01355588|205229|P4|NOT COMPLETED|Third Intervention (After Washout)||0
86225|NCT01355588|205230|P3|NOT COMPLETED|Third Intervention (After Washout)||0
86226|NCT01355588|205231|P2|NOT COMPLETED|Third Intervention (After Washout)||0
86227|NCT01355588|205232|P1|NOT COMPLETED|Third Intervention (After Washout)||0
86228|NCT01355588|205229|P4|COMPLETED|Third Intervention (After Washout)||4
86229|NCT01355588|205230|P3|COMPLETED|Third Intervention (After Washout)||4
86230|NCT01355588|205231|P2|COMPLETED|Third Intervention (After Washout)||4
86231|NCT01355588|205232|P1|COMPLETED|Third Intervention (After Washout)||4
86232|NCT01355588|205229|P4|STARTED|Third Intervention (After Washout)||4
86233|NCT01355588|205230|P3|STARTED|Third Intervention (After Washout)||4
86234|NCT01355588|205231|P2|STARTED|Third Intervention (After Washout)||4
86235|NCT01355588|205232|P1|STARTED|Third Intervention (After Washout)||4
86236|NCT01355588|205229|P4|NOT COMPLETED|Washout (3-7 Days)||0
86237|NCT01355588|205230|P3|NOT COMPLETED|Washout (3-7 Days)||0
86238|NCT01355588|205231|P2|NOT COMPLETED|Washout (3-7 Days)||0
86239|NCT01355588|205232|P1|NOT COMPLETED|Washout (3-7 Days)||0
86240|NCT01355588|205229|P4|COMPLETED|Washout (3-7 Days)||4
86241|NCT01355588|205230|P3|COMPLETED|Washout (3-7 Days)||4
86242|NCT01355588|205231|P2|COMPLETED|Washout (3-7 Days)||4
86243|NCT01355588|205232|P1|COMPLETED|Washout (3-7 Days)||4
86244|NCT01355588|205229|P4|STARTED|Washout (3-7 Days)||4
86245|NCT01355588|205230|P3|STARTED|Washout (3-7 Days)||4
86246|NCT01355588|205231|P2|STARTED|Washout (3-7 Days)||4
86247|NCT01355588|205232|P1|STARTED|Washout (3-7 Days)||4
86248|NCT01355588|205229|P4|NOT COMPLETED|Second Intervention (After Washout)||0
86249|NCT01355588|205230|P3|NOT COMPLETED|Second Intervention (After Washout)||0
86250|NCT01355588|205231|P2|NOT COMPLETED|Second Intervention (After Washout)||0
86251|NCT01355588|205232|P1|NOT COMPLETED|Second Intervention (After Washout)||0
86252|NCT01355588|205229|P4|COMPLETED|Second Intervention (After Washout)||4
86253|NCT01355588|205230|P3|COMPLETED|Second Intervention (After Washout)||4
86254|NCT01355588|205231|P2|COMPLETED|Second Intervention (After Washout)||4
86255|NCT01355588|205232|P1|COMPLETED|Second Intervention (After Washout)||4
86256|NCT01355588|205229|P4|STARTED|Second Intervention (After Washout)||4
86257|NCT01355588|205230|P3|STARTED|Second Intervention (After Washout)||4
86258|NCT01355588|205231|P2|STARTED|Second Intervention (After Washout)||4
86259|NCT01355588|205232|P1|STARTED|Second Intervention (After Washout)||4
86260|NCT01355588|205229|P4|NOT COMPLETED|Washout (3-7 Days)||0
86261|NCT01355588|205230|P3|NOT COMPLETED|Washout (3-7 Days)||0
86262|NCT01355588|205231|P2|NOT COMPLETED|Washout (3-7 Days)||0
86263|NCT01355588|205232|P1|NOT COMPLETED|Washout (3-7 Days)||0
86264|NCT01355588|205229|P4|COMPLETED|Washout (3-7 Days)||4
86265|NCT01355588|205230|P3|COMPLETED|Washout (3-7 Days)||4
86266|NCT01355588|205231|P2|COMPLETED|Washout (3-7 Days)||4
86267|NCT01355588|205232|P1|COMPLETED|Washout (3-7 Days)||4
86268|NCT01355588|205229|P4|STARTED|Washout (3-7 Days)||4
86269|NCT01355588|205230|P3|STARTED|Washout (3-7 Days)||4
86270|NCT01355588|205231|P2|STARTED|Washout (3-7 Days)||4
86271|NCT01355588|205232|P1|STARTED|Washout (3-7 Days)||4
86272|NCT01355588|205229|P4|NOT COMPLETED|First Intervention (Day 1)||0
86273|NCT01355588|205230|P3|NOT COMPLETED|First Intervention (Day 1)||0
86274|NCT01355588|205231|P2|NOT COMPLETED|First Intervention (Day 1)||0
86275|NCT01355588|205232|P1|NOT COMPLETED|First Intervention (Day 1)||0
86276|NCT01355588|205229|P4|COMPLETED|First Intervention (Day 1)||4
86277|NCT01355588|205230|P3|COMPLETED|First Intervention (Day 1)||4
86278|NCT01355588|205231|P2|COMPLETED|First Intervention (Day 1)||4
86279|NCT01355588|205232|P1|COMPLETED|First Intervention (Day 1)||4
86280|NCT01355588|205229|P4|STARTED|First Intervention (Day 1)||4
86281|NCT01355588|205230|P3|STARTED|First Intervention (Day 1)||4
86282|NCT01355588|205231|P2|STARTED|First Intervention (Day 1)||4
86283|NCT01355588|205232|P1|STARTED|First Intervention (Day 1)||4
86284|NCT01355523|205256|P2|NOT COMPLETED|Overall Study||10
86285|NCT01355523|205257|P1|NOT COMPLETED|Overall Study||1
86286|NCT01355523|205256|P2|COMPLETED|Overall Study||16
86287|NCT01355523|205257|P1|COMPLETED|Overall Study||27
86288|NCT01355523|205256|P2|STARTED|Overall Study||26
86289|NCT01355523|205257|P1|STARTED|Overall Study||28
86290|NCT01355484|205301|P2|NOT COMPLETED|Overall Study||54
86291|NCT01355484|205302|P1|NOT COMPLETED|Overall Study||51
86292|NCT01355484|205301|P2|COMPLETED|Overall Study||107
86293|NCT01355484|205302|P1|COMPLETED|Overall Study||109
86294|NCT01355484|205301|P2|STARTED|Overall Study||161
86295|NCT01355484|205302|P1|STARTED|Overall Study||160
86296|NCT01355471|205312|P2|NOT COMPLETED|Overall Study||3
86297|NCT01355471|205313|P1|NOT COMPLETED|Overall Study||7
86298|NCT01355471|205312|P2|COMPLETED|Overall Study||142
86299|NCT01355471|205313|P1|COMPLETED|Overall Study||141
86300|NCT01355471|205312|P2|STARTED|Overall Study||145
86301|NCT01355471|205313|P1|STARTED|Overall Study||148
86302|NCT01355458|205321|P2|NOT COMPLETED|Overall Study||4
86303|NCT01355458|205322|P1|NOT COMPLETED|Overall Study||2
86304|NCT01355458|205321|P2|COMPLETED|Overall Study||127
86305|NCT01355458|205322|P1|COMPLETED|Overall Study||127
86306|NCT01355458|205321|P2|STARTED|Overall Study||131
86307|NCT01355458|205322|P1|STARTED|Overall Study||129
86308|NCT01355419|205328|P1|NOT COMPLETED|Overall Study||8
86309|NCT01355419|205328|P1|COMPLETED|Overall Study||142
86310|NCT01355419|205328|P1|STARTED|Overall Study||150
86311|NCT01355302|205333|P3|NOT COMPLETED|Phase 2||0
86312|NCT01355302|205334|P2|NOT COMPLETED|Phase 2||0
86313|NCT01355302|205335|P1|NOT COMPLETED|Phase 2||0
86314|NCT01355302|205333|P3|COMPLETED|Phase 2||0
86315|NCT01355302|205334|P2|COMPLETED|Phase 2||0
86316|NCT01355302|205335|P1|COMPLETED|Phase 2||0
86317|NCT01355302|205333|P3|STARTED|Phase 2|The study was terminated prior to enrollment|0
86318|NCT01355302|205334|P2|STARTED|Phase 2|The study was terminated prior to enrollment|0
86319|NCT01355302|205335|P1|STARTED|Phase 2|Treatment arm not designated for phase 2.|0
86320|NCT01355302|205333|P3|NOT COMPLETED|Phase 1b||0
86321|NCT01355302|205334|P2|NOT COMPLETED|Phase 1b||0
86322|NCT01355302|205335|P1|NOT COMPLETED|Phase 1b||6
86323|NCT01355302|205333|P3|COMPLETED|Phase 1b||0
86324|NCT01355302|205334|P2|COMPLETED|Phase 1b||0
86325|NCT01355302|205335|P1|COMPLETED|Phase 1b|The subject who completed 6 cycles was withdrawn by sponsor request.|1
86326|NCT01355302|205333|P3|STARTED|Phase 1b||0
86327|NCT01355302|205334|P2|STARTED|Phase 1b||0
86328|NCT01355302|205335|P1|STARTED|Phase 1b|Replaced 1 subject; who discontinued study drug in first cycle|7
86329|NCT01355224|205350|P4|NOT COMPLETED|Overall Study||29
86330|NCT01355224|205351|P3|NOT COMPLETED|Overall Study||19
86331|NCT01355224|205352|P2|NOT COMPLETED|Overall Study||23
86332|NCT01355224|205353|P1|NOT COMPLETED|Overall Study||31
86333|NCT01355224|205350|P4|COMPLETED|Overall Study||172
86334|NCT01355224|205351|P3|COMPLETED|Overall Study||177
86335|NCT01355224|205352|P2|COMPLETED|Overall Study||180
86336|NCT01355224|205353|P1|COMPLETED|Overall Study||167
86337|NCT01355224|205350|P4|Competed Baseline|Overall Study||193
86338|NCT01355224|205351|P3|Competed Baseline|Overall Study||193
86339|NCT01355224|205352|P2|Competed Baseline|Overall Study||200
86340|NCT01355224|205353|P1|Competed Baseline|Overall Study||191
86341|NCT01355224|205350|P4|STARTED|Overall Study||201
86342|NCT01355224|205351|P3|STARTED|Overall Study||196
86343|NCT01355224|205352|P2|STARTED|Overall Study||203
86344|NCT01355224|205353|P1|STARTED|Overall Study||198
86345|NCT01355081|205376|P3|NOT COMPLETED|Overall Study||11
86346|NCT01355081|205377|P2|NOT COMPLETED|Overall Study||10
86347|NCT01355081|205378|P1|NOT COMPLETED|Overall Study||7
86348|NCT01355081|205376|P3|COMPLETED|Overall Study||113
86349|NCT01355081|205377|P2|COMPLETED|Overall Study||113
86350|NCT01355081|205378|P1|COMPLETED|Overall Study||112
86351|NCT01355081|205376|P3|STARTED|Overall Study||124
86352|NCT01355081|205377|P2|STARTED|Overall Study||123
86353|NCT01355081|205378|P1|STARTED|Overall Study||119
86354|NCT01355068|205401|P2|NOT COMPLETED|Second Intervention Period||0
86355|NCT01355068|205402|P1|NOT COMPLETED|Second Intervention Period||0
86356|NCT01355068|205401|P2|COMPLETED|Second Intervention Period||11
86357|NCT01355068|205402|P1|COMPLETED|Second Intervention Period||13
86358|NCT01355068|205401|P2|STARTED|Second Intervention Period||11
86359|NCT01355068|205402|P1|STARTED|Second Intervention Period||13
86360|NCT01355068|205401|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
86361|NCT01355068|205402|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
86362|NCT01355068|205401|P2|COMPLETED|Washout Period (at Least 7 Days)||11
86363|NCT01355068|205402|P1|COMPLETED|Washout Period (at Least 7 Days)||13
86364|NCT01355068|205401|P2|STARTED|Washout Period (at Least 7 Days)||11
86365|NCT01355068|205402|P1|STARTED|Washout Period (at Least 7 Days)||13
86366|NCT01355068|205401|P2|NOT COMPLETED|First Intervention Period||2
86367|NCT01355068|205402|P1|NOT COMPLETED|First Intervention Period||0
86368|NCT01355068|205401|P2|COMPLETED|First Intervention Period||11
86369|NCT01355068|205402|P1|COMPLETED|First Intervention Period||13
86370|NCT01355068|205401|P2|STARTED|First Intervention Period||13
86371|NCT01355068|205402|P1|STARTED|First Intervention Period||13
86372|NCT01354990|205418|P1|NOT COMPLETED|Overall Study||0
86373|NCT01354990|205418|P1|COMPLETED|Overall Study||2974
86374|NCT01354990|205418|P1|STARTED|Overall Study||2974
86375|NCT01354938|205425|P1|NOT COMPLETED|Overall Study||1
86376|NCT01354938|205425|P1|COMPLETED|Overall Study||219
86377|NCT01354938|205425|P1|STARTED|Overall Study||220
86378|NCT01354899|205431|P1|NOT COMPLETED|Overall Study||3
86379|NCT01354899|205431|P1|COMPLETED|Overall Study||21
86380|NCT01354899|205431|P1|STARTED|Overall Study||24
86381|NCT01354652|205439|P3|NOT COMPLETED|Overall Study||0
86382|NCT01354652|205440|P2|NOT COMPLETED|Overall Study||2
86383|NCT01354652|205441|P1|NOT COMPLETED|Overall Study||3
86384|NCT01354652|205439|P3|COMPLETED|Overall Study||0
86385|NCT01354652|205440|P2|COMPLETED|Overall Study||0
86386|NCT01354652|205441|P1|COMPLETED|Overall Study||0
86387|NCT01354652|205439|P3|STARTED|Overall Study||0
86388|NCT01354652|205440|P2|STARTED|Overall Study||2
86389|NCT01354652|205441|P1|STARTED|Overall Study||3
86390|NCT01354431|205452|P3|NOT COMPLETED|Participants Treated||54
86391|NCT01354431|205453|P2|NOT COMPLETED|Participants Treated||54
86392|NCT01354431|205454|P1|NOT COMPLETED|Participants Treated||59
86393|NCT01354431|205452|P3|COMPLETED|Participants Treated||0
86394|NCT01354431|205453|P2|COMPLETED|Participants Treated||0
86395|NCT01354431|205454|P1|COMPLETED|Participants Treated||0
86396|NCT01354431|205452|P3|STARTED|Participants Treated||54
86397|NCT01354431|205453|P2|STARTED|Participants Treated||54
86398|NCT01354431|205454|P1|STARTED|Participants Treated||59
86399|NCT01354431|205452|P3|NOT COMPLETED|Randomized to Enter Treatment Period||0
86400|NCT01354431|205453|P2|NOT COMPLETED|Randomized to Enter Treatment Period||0
86401|NCT01354431|205454|P1|NOT COMPLETED|Randomized to Enter Treatment Period||1
86402|NCT01354431|205452|P3|COMPLETED|Randomized to Enter Treatment Period||54
86403|NCT01354431|205453|P2|COMPLETED|Randomized to Enter Treatment Period||54
86404|NCT01354431|205454|P1|COMPLETED|Randomized to Enter Treatment Period||59
86405|NCT01354431|205452|P3|STARTED|Randomized to Enter Treatment Period||54
86406|NCT01354431|205453|P2|STARTED|Randomized to Enter Treatment Period||54
86407|NCT01354431|205454|P1|STARTED|Randomized to Enter Treatment Period||60
86408|NCT01354314|205478|P4|NOT COMPLETED|Overall Study||6
86409|NCT01354314|205479|P3|NOT COMPLETED|Overall Study||8
86410|NCT01354314|205480|P2|NOT COMPLETED|Overall Study||3
86411|NCT01354314|205481|P1|NOT COMPLETED|Overall Study||6
86412|NCT01354314|205478|P4|COMPLETED|Overall Study||5
86413|NCT01354314|205479|P3|COMPLETED|Overall Study||3
86414|NCT01354314|205480|P2|COMPLETED|Overall Study||8
86415|NCT01354314|205481|P1|COMPLETED|Overall Study||6
86416|NCT01354314|205478|P4|Completed (ITT)|Overall Study||10
86417|NCT01354314|205479|P3|Completed (ITT)|Overall Study||9
86418|NCT01354314|205480|P2|Completed (ITT)|Overall Study||11
86419|NCT01354314|205481|P1|Completed (ITT)|Overall Study||11
86420|NCT01354314|205478|P4|STARTED|Overall Study||11
86421|NCT01354314|205479|P3|STARTED|Overall Study||11
86422|NCT01354314|205480|P2|STARTED|Overall Study||11
86423|NCT01354314|205481|P1|STARTED|Overall Study||12
86424|NCT01354223|205617|P2|NOT COMPLETED|Overall Study||1
86425|NCT01354223|205618|P1|NOT COMPLETED|Overall Study||3
86426|NCT01354223|205617|P2|COMPLETED|Overall Study||29
86427|NCT01354223|205618|P1|COMPLETED|Overall Study||57
86428|NCT01354223|205617|P2|STARTED|Overall Study||30
86429|NCT01354223|205618|P1|STARTED|Overall Study||60
86430|NCT01354197|205634|P1|NOT COMPLETED|Overall Study||0
86431|NCT01354197|205634|P1|COMPLETED|Overall Study||4652
86432|NCT01354197|205634|P1|STARTED|Overall Study||4652
86433|NCT01354145|205642|P2|NOT COMPLETED|Overall Study||34
86434|NCT01354145|205643|P1|NOT COMPLETED|Overall Study||39
86435|NCT01354145|205642|P2|COMPLETED|Overall Study||63
86436|NCT01354145|205643|P1|COMPLETED|Overall Study||58
86437|NCT01354145|205642|P2|STARTED|Overall Study||97
86438|NCT01354145|205643|P1|STARTED|Overall Study||97
86439|NCT01354132|205677|P2|NOT COMPLETED|1 Month Post Study Medication||3
86440|NCT01354132|205678|P1|NOT COMPLETED|1 Month Post Study Medication||1
86441|NCT01354132|205677|P2|COMPLETED|1 Month Post Study Medication||16
86442|NCT01354132|205678|P1|COMPLETED|1 Month Post Study Medication||21
86443|NCT01354132|205677|P2|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||16
86444|NCT01354132|205678|P1|1 Follow-up Visit (Visit 8)|1 Month Post Study Medication||21
86445|NCT01354132|205677|P2|STARTED|1 Month Post Study Medication||19
86446|NCT01354132|205678|P1|STARTED|1 Month Post Study Medication||22
86447|NCT01354132|205677|P2|NOT COMPLETED|Double Blind (Visits 1-7)||11
86448|NCT01354132|205678|P1|NOT COMPLETED|Double Blind (Visits 1-7)||9
86449|NCT01354132|205677|P2|COMPLETED|Double Blind (Visits 1-7)||19
86450|NCT01354132|205678|P1|COMPLETED|Double Blind (Visits 1-7)||22
86451|NCT01354132|205677|P2|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||4
86452|NCT01354132|205678|P1|Didn't Complete at Least 1 Visit|Double Blind (Visits 1-7)||2
86453|NCT01354132|205677|P2|Stopped After First Visit|Double Blind (Visits 1-7)||2
86454|NCT01354132|205678|P1|Stopped After First Visit|Double Blind (Visits 1-7)||3
86455|NCT01354132|205677|P2|Completed More Than 1 Visit|Double Blind (Visits 1-7)||5
86456|NCT01354132|205678|P1|Completed More Than 1 Visit|Double Blind (Visits 1-7)||4
86457|NCT01354132|205677|P2|STARTED|Double Blind (Visits 1-7)|11 did not compete 7 study visits|30
86458|NCT01354132|205678|P1|STARTED|Double Blind (Visits 1-7)|9 did not compete 7 study visits|31
86459|NCT01354132|205677|P2|NOT COMPLETED|Randomization||1
86460|NCT01354132|205678|P1|NOT COMPLETED|Randomization||1
86461|NCT01354132|205677|P2|COMPLETED|Randomization||30
86462|NCT01354132|205678|P1|COMPLETED|Randomization||31
86463|NCT01354132|205677|P2|STARTED|Randomization|1 never took study medication due to subject withdrawal|31
86464|NCT01354132|205678|P1|STARTED|Randomization|1 never took study medication dropped by physician decision (White matter lesion on MRI)|32
86465|NCT01354106|205716|P1|NOT COMPLETED|Overall Study||2
86466|NCT01354106|205716|P1|COMPLETED|Overall Study||24
86467|NCT01354106|205716|P1|STARTED|Overall Study||26
86468|NCT01354028|205722|P2|NOT COMPLETED|Overall Study||5
86469|NCT01354028|205723|P1|NOT COMPLETED|Overall Study||2
86470|NCT01354028|205722|P2|COMPLETED|Overall Study||10
86471|NCT01354028|205723|P1|COMPLETED|Overall Study||13
86472|NCT01354028|205722|P2|STARTED|Overall Study||15
86473|NCT01354028|205723|P1|STARTED|Overall Study||15
86474|NCT01354015|205737|P2|NOT COMPLETED|Overall Study||5
86475|NCT01354015|205738|P1|NOT COMPLETED|Overall Study||6
86476|NCT01354015|205737|P2|COMPLETED|Overall Study||43
86477|NCT01354015|205738|P1|COMPLETED|Overall Study||44
86478|NCT01354015|205737|P2|STARTED|Overall Study||48
86479|NCT01354015|205738|P1|STARTED|Overall Study||50
86480|NCT01353976|205748|P2|NOT COMPLETED|Overall Study||51
86481|NCT01353976|205749|P1|NOT COMPLETED|Overall Study||48
86482|NCT01353976|205748|P2|COMPLETED|Overall Study||83
86483|NCT01353976|205749|P1|COMPLETED|Overall Study||82
86484|NCT01353976|205748|P2|STARTED|Overall Study||134
86485|NCT01353976|205749|P1|STARTED|Overall Study||130
86486|NCT01353963|205759|P1|NOT COMPLETED|Overall Study||2
86487|NCT01353963|205759|P1|COMPLETED|Overall Study||11
86488|NCT01353963|205759|P1|STARTED|Overall Study||13
86489|NCT01353911|205777|P8|NOT COMPLETED|Overall Study||15
86490|NCT01353911|205778|P7|NOT COMPLETED|Overall Study||6
86491|NCT01353911|205779|P6|NOT COMPLETED|Overall Study||7
86492|NCT01353911|205780|P5|NOT COMPLETED|Overall Study||6
86493|NCT01353911|205781|P4|NOT COMPLETED|Overall Study||2
86494|NCT01353911|205782|P3|NOT COMPLETED|Overall Study||9
86495|NCT01353911|205783|P2|NOT COMPLETED|Overall Study||9
86496|NCT01353911|205784|P1|NOT COMPLETED|Overall Study||8
86497|NCT01353911|205777|P8|COMPLETED|Overall Study||51
86498|NCT01353911|205778|P7|COMPLETED|Overall Study||30
86499|NCT01353911|205779|P6|COMPLETED|Overall Study||36
86500|NCT01353911|205780|P5|COMPLETED|Overall Study||23
86501|NCT01353911|205781|P4|COMPLETED|Overall Study||22
86502|NCT01353911|205782|P3|COMPLETED|Overall Study||59
86503|NCT01353911|205783|P2|COMPLETED|Overall Study||57
86504|NCT01353911|205784|P1|COMPLETED|Overall Study||28
86505|NCT01353911|205777|P8|STARTED|Overall Study||66
86506|NCT01353911|205778|P7|STARTED|Overall Study||36
86507|NCT01353911|205779|P6|STARTED|Overall Study||43
86508|NCT01353911|205780|P5|STARTED|Overall Study||29
86509|NCT01353911|205781|P4|STARTED|Overall Study||24
86510|NCT01353911|205782|P3|STARTED|Overall Study||68
86511|NCT01353911|205783|P2|STARTED|Overall Study||66
86512|NCT01353911|205784|P1|STARTED|Overall Study||36
86513|NCT01353898|205864|P6|NOT COMPLETED|Overall Study||1
86514|NCT01353898|205865|P5|NOT COMPLETED|Overall Study||0
86515|NCT01353898|205866|P4|NOT COMPLETED|Overall Study||0
86516|NCT01353898|205867|P3|NOT COMPLETED|Overall Study||0
86517|NCT01353898|205868|P2|NOT COMPLETED|Overall Study||0
86518|NCT01353898|205869|P1|NOT COMPLETED|Overall Study||0
86519|NCT01353898|205864|P6|COMPLETED|Overall Study||1
86520|NCT01353898|205865|P5|COMPLETED|Overall Study||2
86521|NCT01353898|205866|P4|COMPLETED|Overall Study||2
86522|NCT01353898|205867|P3|COMPLETED|Overall Study||2
86523|NCT01353898|205868|P2|COMPLETED|Overall Study||2
86524|NCT01353898|205869|P1|COMPLETED|Overall Study||2
86525|NCT01353898|205864|P6|STARTED|Overall Study||2
86526|NCT01353898|205865|P5|STARTED|Overall Study||2
86527|NCT01353898|205866|P4|STARTED|Overall Study||2
86528|NCT01353898|205867|P3|STARTED|Overall Study||2
86529|NCT01353898|205868|P2|STARTED|Overall Study||2
86530|NCT01353898|205869|P1|STARTED|Overall Study||2
86531|NCT01353859|205895|P1|NOT COMPLETED|Overall Study||4
86532|NCT01353859|205895|P1|COMPLETED|Overall Study||35
86533|NCT01353859|205895|P1|STARTED|Overall Study||39
86534|NCT01353664|205908|P1|NOT COMPLETED|Overall Study||19
86535|NCT01353664|205908|P1|COMPLETED|Overall Study|Completed = Number of participants who continued on Romidepsin treatment|0
86536|NCT01353664|205908|P1|STARTED|Overall Study|Participants who received at least 1 dose of study drug.|19
86537|NCT01353586|205914|P2|NOT COMPLETED|Overall Study||2
86538|NCT01353586|205915|P1|NOT COMPLETED|Overall Study||7
86539|NCT01353586|205914|P2|COMPLETED|Overall Study||17
86540|NCT01353586|205915|P1|COMPLETED|Overall Study||160
86541|NCT01353586|205914|P2|Participated in SNA Substudy|Overall Study||19
86542|NCT01353586|205915|P1|Participated in SNA Substudy|Overall Study||19
86543|NCT01353586|205914|P2|Participated in Roll-in Phase|Overall Study||0
86544|NCT01353586|205915|P1|Participated in Roll-in Phase|Overall Study||22
86545|NCT01353586|205914|P2|Participated in Workflow Phase|Overall Study||0
86546|NCT01353586|205915|P1|Participated in Workflow Phase|Overall Study||20
86547|NCT01353586|205914|P2|STARTED|Overall Study||19
86548|NCT01353586|205915|P1|STARTED|Overall Study||167
86549|NCT01353508|205933|P4|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
86550|NCT01353508|205934|P3|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
86551|NCT01353508|205935|P2|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||0
86552|NCT01353508|205936|P1|NOT COMPLETED|Period 2 - Second Intervention (7 Days)||1
86553|NCT01353508|205933|P4|COMPLETED|Period 2 - Second Intervention (7 Days)||7
86554|NCT01353508|205934|P3|COMPLETED|Period 2 - Second Intervention (7 Days)||8
86555|NCT01353508|205935|P2|COMPLETED|Period 2 - Second Intervention (7 Days)||8
86556|NCT01353508|205936|P1|COMPLETED|Period 2 - Second Intervention (7 Days)||7
86557|NCT01353508|205933|P4|STARTED|Period 2 - Second Intervention (7 Days)||7
86558|NCT01353508|205934|P3|STARTED|Period 2 - Second Intervention (7 Days)||8
86559|NCT01353508|205935|P2|STARTED|Period 2 - Second Intervention (7 Days)||8
86560|NCT01353508|205936|P1|STARTED|Period 2 - Second Intervention (7 Days)||8
86561|NCT01353508|205933|P4|NOT COMPLETED|Period 1 - First Intervention (7 Days)||1
86562|NCT01353508|205934|P3|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
86563|NCT01353508|205935|P2|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
86564|NCT01353508|205936|P1|NOT COMPLETED|Period 1 - First Intervention (7 Days)||0
86565|NCT01353508|205933|P4|COMPLETED|Period 1 - First Intervention (7 Days)||7
86566|NCT01353508|205934|P3|COMPLETED|Period 1 - First Intervention (7 Days)||8
86567|NCT01353508|205935|P2|COMPLETED|Period 1 - First Intervention (7 Days)||8
86568|NCT01353508|205936|P1|COMPLETED|Period 1 - First Intervention (7 Days)||8
86569|NCT01353508|205933|P4|STARTED|Period 1 - First Intervention (7 Days)||8
86570|NCT01353508|205934|P3|STARTED|Period 1 - First Intervention (7 Days)||8
86571|NCT01353508|205935|P2|STARTED|Period 1 - First Intervention (7 Days)||8
86572|NCT01353508|205936|P1|STARTED|Period 1 - First Intervention (7 Days)||8
86573|NCT01353274|206014|P1|NOT COMPLETED|Overall Study||28
86574|NCT01353274|206014|P1|COMPLETED|Overall Study||1129
86575|NCT01353274|206014|P1|STARTED|Overall Study||1157
86576|NCT01353222|206024|P2|NOT COMPLETED|Overall Study||72
86577|NCT01353222|206025|P1|NOT COMPLETED|Overall Study||70
86578|NCT01353222|206024|P2|COMPLETED|Overall Study||0
86579|NCT01353222|206025|P1|COMPLETED|Overall Study||0
86580|NCT01353222|206024|P2|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||72
86581|NCT01353222|206025|P1|Standard Care Arm ≥1 Post-baseline Visit|Overall Study||0
86582|NCT01353222|206024|P2|DN24-02 Arm ≥1 Leukapheresis|Overall Study||0
86583|NCT01353222|206025|P1|DN24-02 Arm ≥1 Leukapheresis|Overall Study||67
86584|NCT01353222|206024|P2|STARTED|Overall Study||72
86585|NCT01353222|206025|P1|STARTED|Overall Study||70
86586|NCT01353144|206033|P2|NOT COMPLETED|Overall Study||8
86587|NCT01353144|206034|P1|NOT COMPLETED|Overall Study||9
86588|NCT01353144|206033|P2|COMPLETED|Overall Study||81
86589|NCT01353144|206034|P1|COMPLETED|Overall Study||80
86590|NCT01353144|206033|P2|STARTED|Overall Study||89
86591|NCT01353144|206034|P1|STARTED|Overall Study||89
86592|NCT01353079|206044|P2|NOT COMPLETED|Overall Study||21
86593|NCT01353079|206045|P1|NOT COMPLETED|Overall Study||27
86594|NCT01353079|206044|P2|COMPLETED|Overall Study||190
86595|NCT01353079|206045|P1|COMPLETED|Overall Study||191
86596|NCT01353079|206044|P2|STARTED|Overall Study||211
86597|NCT01353079|206045|P1|STARTED|Overall Study||218
86598|NCT01352845|206059|P2|NOT COMPLETED|Overall Study||203
86599|NCT01352845|206060|P1|NOT COMPLETED|Overall Study||671
86600|NCT01352845|206059|P2|COMPLETED|Overall Study||619
86601|NCT01352845|206060|P1|COMPLETED|Overall Study||1800
86602|NCT01352845|206059|P2|STARTED|Overall Study||822
86603|NCT01352845|206060|P1|STARTED|Overall Study||2471
86604|NCT01352793|206149|P2|NOT COMPLETED|Overall Study||245
86605|NCT01352793|206150|P1|NOT COMPLETED|Overall Study||585
86606|NCT01352793|206149|P2|COMPLETED|Overall Study||1663
86607|NCT01352793|206150|P1|COMPLETED|Overall Study||3219
86608|NCT01352793|206149|P2|Vaccination 3|Overall Study||1710
86609|NCT01352793|206150|P1|Vaccination 3|Overall Study||3314
86610|NCT01352793|206149|P2|Vaccination 2|Overall Study||1806
86611|NCT01352793|206150|P1|Vaccination 2|Overall Study||3530
86612|NCT01352793|206149|P2|Vaccination 1|Overall Study||1908
86613|NCT01352793|206150|P1|Vaccination 1|Overall Study||3796
86614|NCT01352793|206149|P2|STARTED|Overall Study||1908
86615|NCT01352793|206150|P1|STARTED|Overall Study||3804
86616|NCT01352741|206174|P2|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
86617|NCT01352741|206175|P1|NOT COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
86618|NCT01352741|206174|P2|COMPLETED|Open-Label Tapentadol Pick-Up Arm||0
86619|NCT01352741|206175|P1|COMPLETED|Open-Label Tapentadol Pick-Up Arm||37
86620|NCT01352741|206174|P2|STARTED|Open-Label Tapentadol Pick-Up Arm|Participants did not continue treatment. They were switched to tapentadol PR or discontinued.|0
86621|NCT01352741|206175|P1|STARTED|Open-Label Tapentadol Pick-Up Arm|19 from tapentadol in the comparative phase and 18 from tapentadol & pregabalin entered this arm.|37
86622|NCT01352741|206174|P2|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||0
86623|NCT01352741|206175|P1|NOT COMPLETED|Open-Label Tapentadol Continuation Arm||8
86624|NCT01352741|206174|P2|COMPLETED|Open-Label Tapentadol Continuation Arm||0
86625|NCT01352741|206175|P1|COMPLETED|Open-Label Tapentadol Continuation Arm||51
86626|NCT01352741|206174|P2|Full Analysis Set|Open-Label Tapentadol Continuation Arm||0
86627|NCT01352741|206175|P1|Full Analysis Set|Open-Label Tapentadol Continuation Arm||57
86628|NCT01352741|206174|P2|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||0
86629|NCT01352741|206175|P1|Major Protocol Deviation|Open-Label Tapentadol Continuation Arm||2
86630|NCT01352741|206174|P2|STARTED|Open-Label Tapentadol Continuation Arm|In this period no tapentadol PR and pregabalin treatment was planned by the protocol.|0
86631|NCT01352741|206175|P1|STARTED|Open-Label Tapentadol Continuation Arm|59 of the 73 participants that did not qualify for the comparative period entered this arm.|59
86632|NCT01352741|206174|P2|NOT COMPLETED|Double-blind Comparative Period||26
86633|NCT01352741|206175|P1|NOT COMPLETED|Double-blind Comparative Period||28
86634|NCT01352741|206174|P2|COMPLETED|Double-blind Comparative Period||133
86635|NCT01352741|206175|P1|COMPLETED|Double-blind Comparative Period||126
86636|NCT01352741|206174|P2|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||137
86637|NCT01352741|206175|P1|Sleep Evaluations (Hours Slept) PPS|Double-blind Comparative Period||123
86638|NCT01352741|206174|P2|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||137
86639|NCT01352741|206175|P1|Sleep Evaluations (Awakenings) PPS|Double-blind Comparative Period||123
86640|NCT01352741|206174|P2|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||137
86641|NCT01352741|206175|P1|Sleep Evaluation (Latency) PPS|Double-blind Comparative Period||123
86642|NCT01352741|206174|P2|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||137
86643|NCT01352741|206175|P1|HADS Per Protocol Set (PPS)|Double-blind Comparative Period||123
86644|NCT01352741|206174|P2|EQ-5D Per Protocol Set|Double-blind Comparative Period||143
86645|NCT01352741|206175|P1|EQ-5D Per Protocol Set|Double-blind Comparative Period||131
86646|NCT01352741|206174|P2|SF-12 Per Protocol Set|Double-blind Comparative Period||143
86647|NCT01352741|206175|P1|SF-12 Per Protocol Set|Double-blind Comparative Period||131
86648|NCT01352741|206174|P2|painDetect Per Protocol Set|Double-blind Comparative Period||127
86649|NCT01352741|206175|P1|painDetect Per Protocol Set|Double-blind Comparative Period||109
86650|NCT01352741|206174|P2|Per Protocol Set|Double-blind Comparative Period||149
86651|NCT01352741|206175|P1|Per Protocol Set|Double-blind Comparative Period||139
86652|NCT01352741|206174|P2|Major Protocol Deviations|Double-blind Comparative Period||8
86653|NCT01352741|206175|P1|Major Protocol Deviations|Double-blind Comparative Period||13
86654|NCT01352741|206174|P2|Full Analysis Set|Double-blind Comparative Period||157
86655|NCT01352741|206175|P1|Full Analysis Set|Double-blind Comparative Period||152
86656|NCT01352741|206174|P2|No Pain Assessments Available|Double-blind Comparative Period||2
86657|NCT01352741|206175|P1|No Pain Assessments Available|Double-blind Comparative Period||2
86658|NCT01352741|206174|P2|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||18
86659|NCT01352741|206175|P1|Switched to Open-label Pick-up Arm|Double-blind Comparative Period||19
86660|NCT01352741|206174|P2|STARTED|Double-blind Comparative Period|159 of the 313 participants that qualified were randomized to tapentadol and pregabalin treatment.|159
86661|NCT01352741|206175|P1|STARTED|Double-blind Comparative Period|Of the 313 participants that qualified for randomization 154 were randomized to tapentadol.|154
86662|NCT01352741|206174|P2|NOT COMPLETED|Open-label Tapentadol Titration Period||0
86663|NCT01352741|206175|P1|NOT COMPLETED|Open-label Tapentadol Titration Period||73
86664|NCT01352741|206174|P2|COMPLETED|Open-label Tapentadol Titration Period||0
86665|NCT01352741|206175|P1|COMPLETED|Open-label Tapentadol Titration Period|59 of 73 participants not completing the titration period entered the open-label continuation arm.|372
86666|NCT01352741|206174|P2|Full Analysis Set|Open-label Tapentadol Titration Period||0
86667|NCT01352741|206175|P1|Full Analysis Set|Open-label Tapentadol Titration Period||436
86668|NCT01352741|206174|P2|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||0
86669|NCT01352741|206175|P1|Switched to Open-label Continuation Arm|Open-label Tapentadol Titration Period||59
86670|NCT01352741|206174|P2|STARTED|Open-label Tapentadol Titration Period||0
86671|NCT01352741|206175|P1|STARTED|Open-label Tapentadol Titration Period|All participants started with 2 x 50 mg tapentadol PR and titrated upwards in steps of 100 mg/day.|445
86672|NCT01352715|206269|P2|NOT COMPLETED|Overall Study||46
86673|NCT01352715|206270|P1|NOT COMPLETED|Overall Study||45
86674|NCT01352715|206269|P2|COMPLETED|Overall Study||209
86675|NCT01352715|206270|P1|COMPLETED|Overall Study||215
86676|NCT01352715|206269|P2|STARTED|Overall Study||255
86677|NCT01352715|206270|P1|STARTED|Overall Study||260
86678|NCT01352585|206292|P1|NOT COMPLETED|Overall Study||11
86679|NCT01352585|206292|P1|COMPLETED|Overall Study||36
86680|NCT01352585|206292|P1|STARTED|Overall Study||47
86681|NCT01352546|206303|P1|NOT COMPLETED|Overall Study||0
86682|NCT01352546|206303|P1|COMPLETED|Overall Study||31
86683|NCT01352546|206303|P1|STARTED|Overall Study||31
86684|NCT01352507|206309|P2|NOT COMPLETED|Extension Phase||0
86685|NCT01352507|206310|P1|NOT COMPLETED|Extension Phase||0
86686|NCT01352507|206309|P2|COMPLETED|Extension Phase||173
86687|NCT01352507|206310|P1|COMPLETED|Extension Phase||164
86688|NCT01352507|206309|P2|STARTED|Extension Phase||173
86689|NCT01352507|206310|P1|STARTED|Extension Phase||164
86690|NCT01352507|206309|P2|NOT COMPLETED|Treatment Period 2||3
86691|NCT01352507|206310|P1|NOT COMPLETED|Treatment Period 2||6
86692|NCT01352507|206309|P2|COMPLETED|Treatment Period 2|Seven participants who completed Treatment Period 2 chose not to enter the Extension Phase.|180
86693|NCT01352507|206310|P1|COMPLETED|Treatment Period 2|Six participants who completed Treatment Period 2 chose not to enter the Extension Phase.|170
86694|NCT01352507|206309|P2|Received Treatment|Treatment Period 2||181
86695|NCT01352507|206310|P1|Received Treatment|Treatment Period 2||173
86696|NCT01352507|206309|P2|STARTED|Treatment Period 2||183
86697|NCT01352507|206310|P1|STARTED|Treatment Period 2||176
86698|NCT01352507|206309|P2|NOT COMPLETED|Washout Period||1
86699|NCT01352507|206310|P1|NOT COMPLETED|Washout Period||0
86700|NCT01352507|206309|P2|COMPLETED|Washout Period||183
86701|NCT01352507|206310|P1|COMPLETED|Washout Period||176
86702|NCT01352507|206309|P2|STARTED|Washout Period||184
86703|NCT01352507|206310|P1|STARTED|Washout Period||176
86704|NCT01352507|206309|P2|NOT COMPLETED|Treatment Period 1||9
86705|NCT01352507|206310|P1|NOT COMPLETED|Treatment Period 1||14
86706|NCT01352507|206309|P2|COMPLETED|Treatment Period 1||184
86707|NCT01352507|206310|P1|COMPLETED|Treatment Period 1||176
86708|NCT01352507|206309|P2|Received Treatment|Treatment Period 1||188
86709|NCT01352507|206310|P1|Received Treatment|Treatment Period 1||182
86710|NCT01352507|206309|P2|STARTED|Treatment Period 1||193
86711|NCT01352507|206310|P1|STARTED|Treatment Period 1||190
86712|NCT01352468|206343|P2|NOT COMPLETED|Overall Study||4
86713|NCT01352468|206344|P1|NOT COMPLETED|Overall Study||5
86714|NCT01352468|206343|P2|COMPLETED|Overall Study||18
86715|NCT01352468|206344|P1|COMPLETED|Overall Study||17
86716|NCT01352468|206343|P2|STARTED|Overall Study||22
86717|NCT01352468|206344|P1|STARTED|Overall Study||22
86718|NCT01352442|206354|P1|NOT COMPLETED|Overall Study||12
86719|NCT01352442|206354|P1|COMPLETED|Overall Study||139
86720|NCT01352442|206354|P1|STARTED|Overall Study||151
86721|NCT01352416|206363|P4|NOT COMPLETED|Overall Study||1
86722|NCT01352416|206364|P3|NOT COMPLETED|Overall Study||2
86723|NCT01352416|206365|P2|NOT COMPLETED|Overall Study||2
86724|NCT01352416|206366|P1|NOT COMPLETED|Overall Study||1
86725|NCT01352416|206363|P4|COMPLETED|Overall Study||1
86726|NCT01352416|206364|P3|COMPLETED|Overall Study||0
86727|NCT01352416|206365|P2|COMPLETED|Overall Study||5
86728|NCT01352416|206366|P1|COMPLETED|Overall Study||3
86729|NCT01352416|206363|P4|STARTED|Overall Study||2
86730|NCT01352416|206364|P3|STARTED|Overall Study||2
86731|NCT01352416|206365|P2|STARTED|Overall Study||7
86732|NCT01352416|206366|P1|STARTED|Overall Study||4
86733|NCT01352117|206378|P2|NOT COMPLETED|Overall Study||96
86734|NCT01352117|206379|P1|NOT COMPLETED|Overall Study||68
86735|NCT01352117|206378|P2|COMPLETED|Overall Study||0
86736|NCT01352117|206379|P1|COMPLETED|Overall Study||28
86737|NCT01352117|206378|P2|Study Week 96 Data Potential|Overall Study||61
86738|NCT01352117|206379|P1|Study Week 96 Data Potential|Overall Study||58
86739|NCT01352117|206378|P2|Study Week 48 Data Potential|Overall Study||83
86740|NCT01352117|206379|P1|Study Week 48 Data Potential|Overall Study||80
86741|NCT01352117|206378|P2|Entered Step 2 to Initiate Delayed ET|Overall Study|Only Arm A participants could enter Step 2 to receive delayed ET.|0
86742|NCT01352117|206379|P1|Entered Step 2 to Initiate Delayed ET|Overall Study||32
86743|NCT01352117|206378|P2|STARTED|Overall Study||96
86744|NCT01352117|206379|P1|STARTED|Overall Study||96
86745|NCT01351623|206431|P1|NOT COMPLETED|Overall Study||9
86746|NCT01351623|206431|P1|COMPLETED|Overall Study||35
86747|NCT01351623|206431|P1|STARTED|Overall Study||44
86748|NCT01351506|206437|P1|NOT COMPLETED|Overall Study||137
86749|NCT01351506|206437|P1|COMPLETED|Overall Study||465
86750|NCT01351506|206437|P1|STARTED|Overall Study||602
86751|NCT01351480|206447|P1|NOT COMPLETED|Overall Study||8
86752|NCT01351480|206447|P1|COMPLETED|Overall Study||26
86753|NCT01351480|206447|P1|STARTED|Overall Study||34
86754|NCT01351337|206455|P1|NOT COMPLETED|Overall Study||0
86755|NCT01351337|206455|P1|COMPLETED|Overall Study||58
86756|NCT01351337|206455|P1|STARTED|Overall Study||58
86757|NCT01351090|206464|P3|NOT COMPLETED|Overall Study||6
86758|NCT01351090|206465|P2|NOT COMPLETED|Overall Study||11
86759|NCT01351090|206466|P1|NOT COMPLETED|Overall Study||11
86760|NCT01351090|206464|P3|COMPLETED|Overall Study||36
86761|NCT01351090|206465|P2|COMPLETED|Overall Study||31
86762|NCT01351090|206466|P1|COMPLETED|Overall Study||32
86763|NCT01351090|206464|P3|STARTED|Overall Study||42
86764|NCT01351090|206465|P2|STARTED|Overall Study||42
86765|NCT01351090|206466|P1|STARTED|Overall Study||43
86766|NCT01351077|206485|P2|NOT COMPLETED|Overall Study||0
86767|NCT01351077|206486|P1|NOT COMPLETED|Overall Study||0
86768|NCT01351077|206485|P2|COMPLETED|Overall Study||180
86769|NCT01351077|206486|P1|COMPLETED|Overall Study||180
86770|NCT01351077|206485|P2|STARTED|Overall Study||180
86771|NCT01351077|206486|P1|STARTED|Overall Study||180
86772|NCT01351064|206502|P2|NOT COMPLETED|Overall Study||0
86773|NCT01351064|206503|P1|NOT COMPLETED|Overall Study||0
86774|NCT01351064|206502|P2|COMPLETED|Overall Study||42
86775|NCT01351064|206503|P1|COMPLETED|Overall Study||42
86776|NCT01351064|206502|P2|STARTED|Overall Study||42
86777|NCT01351064|206503|P1|STARTED|Overall Study||42
86778|NCT01351025|206513|P2|NOT COMPLETED|Week 44 - 48||0
86779|NCT01351025|206514|P1|NOT COMPLETED|Week 44 - 48||0
86780|NCT01351025|206513|P2|COMPLETED|Week 44 - 48||43
86781|NCT01351025|206514|P1|COMPLETED|Week 44 - 48||42
86782|NCT01351025|206513|P2|STARTED|Week 44 - 48||43
86783|NCT01351025|206514|P1|STARTED|Week 44 - 48||42
86784|NCT01351025|206513|P2|NOT COMPLETED|Week 24 - 44||4
86785|NCT01351025|206514|P1|NOT COMPLETED|Week 24 - 44||1
86786|NCT01351025|206513|P2|COMPLETED|Week 24 - 44||43
86787|NCT01351025|206514|P1|COMPLETED|Week 24 - 44||42
86788|NCT01351025|206513|P2|STARTED|Week 24 - 44||47
86789|NCT01351025|206514|P1|STARTED|Week 24 - 44||43
86790|NCT01351025|206513|P2|NOT COMPLETED|Week 20 - 24||0
86791|NCT01351025|206514|P1|NOT COMPLETED|Week 20 - 24||0
86792|NCT01351025|206513|P2|COMPLETED|Week 20 - 24||47
86793|NCT01351025|206514|P1|COMPLETED|Week 20 - 24||43
86794|NCT01351025|206513|P2|STARTED|Week 20 - 24||47
86795|NCT01351025|206514|P1|STARTED|Week 20 - 24||43
86796|NCT01351025|206513|P2|NOT COMPLETED|Week 0 - 20||1
86797|NCT01351025|206514|P1|NOT COMPLETED|Week 0 - 20||3
86798|NCT01351025|206513|P2|COMPLETED|Week 0 - 20||47
86799|NCT01351025|206514|P1|COMPLETED|Week 0 - 20||43
86800|NCT01351025|206513|P2|STARTED|Week 0 - 20||48
86801|NCT01351025|206514|P1|STARTED|Week 0 - 20||46
86802|NCT01350999|206547|P3|NOT COMPLETED|Overall Study||21
86803|NCT01350999|206548|P2|NOT COMPLETED|Overall Study||14
86804|NCT01350999|206549|P1|NOT COMPLETED|Overall Study||8
86805|NCT01350999|206547|P3|COMPLETED|Overall Study||146
86806|NCT01350999|206548|P2|COMPLETED|Overall Study||157
86807|NCT01350999|206549|P1|COMPLETED|Overall Study||157
86808|NCT01350999|206547|P3|Treated|Overall Study||167
86809|NCT01350999|206548|P2|Treated|Overall Study||171
86810|NCT01350999|206549|P1|Treated|Overall Study||165
86811|NCT01350999|206547|P3|STARTED|Overall Study||167
86812|NCT01350999|206548|P2|STARTED|Overall Study||171
86813|NCT01350999|206549|P1|STARTED|Overall Study||165
86814|NCT01350973|206587|P3|NOT COMPLETED|Overall Study||8
86815|NCT01350973|206588|P2|NOT COMPLETED|Overall Study||8
86816|NCT01350973|206589|P1|NOT COMPLETED|Overall Study||6
86817|NCT01350973|206587|P3|COMPLETED|Overall Study||187
86818|NCT01350973|206588|P2|COMPLETED|Overall Study||202
86819|NCT01350973|206589|P1|COMPLETED|Overall Study||200
86820|NCT01350973|206587|P3|Received Treatment|Overall Study||195
86821|NCT01350973|206588|P2|Received Treatment|Overall Study||210
86822|NCT01350973|206589|P1|Received Treatment|Overall Study||205
86823|NCT01350973|206587|P3|STARTED|Overall Study||195
86824|NCT01350973|206588|P2|STARTED|Overall Study||210
86825|NCT01350973|206589|P1|STARTED|Overall Study||206
86826|NCT01350947|206624|P1|NOT COMPLETED|Overall Study||0
86827|NCT01350947|206624|P1|COMPLETED|Overall Study||11
86828|NCT01350947|206624|P1|STARTED|Overall Study||11
86829|NCT01350934|206630|P2|NOT COMPLETED|Extension Study||4
86830|NCT01350934|206631|P1|NOT COMPLETED|Extension Study||5
86831|NCT01350934|206630|P2|COMPLETED|Extension Study||101
86832|NCT01350934|206631|P1|COMPLETED|Extension Study||95
86833|NCT01350934|206630|P2|STARTED|Extension Study||105
86834|NCT01350934|206631|P1|STARTED|Extension Study||100
86835|NCT01350934|206630|P2|NOT COMPLETED|Base Study||3
86836|NCT01350934|206631|P1|NOT COMPLETED|Base Study||11
86837|NCT01350934|206630|P2|COMPLETED|Base Study||105
86838|NCT01350934|206631|P1|COMPLETED|Base Study||100
86839|NCT01350934|206630|P2|STARTED|Base Study||108
86840|NCT01350934|206631|P1|STARTED|Base Study||111
86841|NCT01350804|206653|P4|NOT COMPLETED|Extension Study, Weeks 52 - 260||23
86842|NCT01350804|206654|P3|NOT COMPLETED|Extension Study, Weeks 52 - 260||72
86843|NCT01350804|206655|P2|NOT COMPLETED|Extension Study, Weeks 52 - 260||79
86844|NCT01350804|206656|P1|NOT COMPLETED|Extension Study, Weeks 52 - 260||80
86845|NCT01350804|206653|P4|COMPLETED|Extension Study, Weeks 52 - 260||0
86846|NCT01350804|206654|P3|COMPLETED|Extension Study, Weeks 52 - 260||0
86847|NCT01350804|206655|P2|COMPLETED|Extension Study, Weeks 52 - 260||0
86848|NCT01350804|206656|P1|COMPLETED|Extension Study, Weeks 52 - 260||0
86849|NCT01350804|206653|P4|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|23
86850|NCT01350804|206654|P3|STARTED|Extension Study, Weeks 52 - 260|During the extension, these participants received AIN457.|72
86851|NCT01350804|206655|P2|STARTED|Extension Study, Weeks 52 - 260||79
86852|NCT01350804|206656|P1|STARTED|Extension Study, Weeks 52 - 260||80
86853|NCT01350804|206653|P4|NOT COMPLETED|Core Study||26
86854|NCT01350804|206654|P3|NOT COMPLETED|Core Study||47
86855|NCT01350804|206655|P2|NOT COMPLETED|Core Study||47
86856|NCT01350804|206656|P1|NOT COMPLETED|Core Study||41
86857|NCT01350804|206653|P4|COMPLETED|Core Study||112
86858|NCT01350804|206654|P3|COMPLETED|Core Study||91
86859|NCT01350804|206655|P2|COMPLETED|Core Study||90
86860|NCT01350804|206656|P1|COMPLETED|Core Study||97
86861|NCT01350804|206653|P4|Full Analysis Set|Core Study||138
86862|NCT01350804|206654|P3|Full Analysis Set|Core Study||138
86863|NCT01350804|206655|P2|Full Analysis Set|Core Study||137
86864|NCT01350804|206656|P1|Full Analysis Set|Core Study||138
86865|NCT01350804|206653|P4|Treatment Switch to AIN457 at Week 24|Core Study||37
86866|NCT01350804|206654|P3|Treatment Switch to AIN457 at Week 24|Core Study||45
86867|NCT01350804|206655|P2|Treatment Switch to AIN457 at Week 24|Core Study||0
86868|NCT01350804|206656|P1|Treatment Switch to AIN457 at Week 24|Core Study||0
86869|NCT01350804|206653|P4|Tratment Switch to AIN457 at Week 16|Core Study||0
86870|NCT01350804|206654|P3|Tratment Switch to AIN457 at Week 16|Core Study|15 participantsdiscontinued prior to the treatment switch|78
86871|NCT01350804|206655|P2|Tratment Switch to AIN457 at Week 16|Core Study||0
86872|NCT01350804|206656|P1|Tratment Switch to AIN457 at Week 16|Core Study||0
86873|NCT01350804|206653|P4|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|137
86874|NCT01350804|206654|P3|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|139
86875|NCT01350804|206655|P2|Safety Set|Core Study|1 participant did not receive treatment; therefore participant was not counted in safety analysis.|136
86876|NCT01350804|206656|P1|Safety Set|Core Study|1 participant actually received placebo; participant was reassigned to placebo for safety analysis.|137
86877|NCT01350804|206653|P4|STARTED|Core Study||138
86878|NCT01350804|206654|P3|STARTED|Core Study||138
86879|NCT01350804|206655|P2|STARTED|Core Study||137
86880|NCT01350804|206656|P1|STARTED|Core Study||138
86881|NCT01350583|206745|P1|NOT COMPLETED|Overall Study||0
86882|NCT01350583|206745|P1|COMPLETED|Overall Study||2
86883|NCT01350583|206745|P1|STARTED|Overall Study||2
86884|NCT01350544|206753|P2|NOT COMPLETED|Overall Study||22
86885|NCT01350544|206754|P1|NOT COMPLETED|Overall Study||23
86886|NCT01350544|206753|P2|COMPLETED|Overall Study||86
86887|NCT01350544|206754|P1|COMPLETED|Overall Study||85
86888|NCT01350544|206753|P2|STARTED|Overall Study||108
86889|NCT01350544|206754|P1|STARTED|Overall Study||108
86890|NCT01350479|206762|P2|NOT COMPLETED|Overall Study||0
86891|NCT01350479|206763|P1|NOT COMPLETED|Overall Study||0
86892|NCT01350479|206762|P2|COMPLETED|Overall Study||106
86893|NCT01350479|206763|P1|COMPLETED|Overall Study||94
86894|NCT01350479|206762|P2|STARTED|Overall Study||106
86895|NCT01350479|206763|P1|STARTED|Overall Study||94
86896|NCT01350414|206769|P1|NOT COMPLETED|Overall Study||19
86897|NCT01350414|206769|P1|COMPLETED|Overall Study||162
86898|NCT01350414|206769|P1|Year 5|Overall Study||162
86899|NCT01350414|206769|P1|Year 4|Overall Study||159
86900|NCT01350414|206769|P1|Year 3|Overall Study||162
86901|NCT01350414|206769|P1|Year 2|Overall Study||165
86902|NCT01350414|206769|P1|STARTED|Overall Study||181
86903|NCT01350388|206788|P2|NOT COMPLETED|Overall Study||1
86904|NCT01350388|206789|P1|NOT COMPLETED|Overall Study||3
86905|NCT01350388|206788|P2|COMPLETED|Overall Study||39
86906|NCT01350388|206789|P1|COMPLETED|Overall Study||37
86907|NCT01350388|206788|P2|STARTED|Overall Study||40
86908|NCT01350388|206789|P1|STARTED|Overall Study||40
86909|NCT01350271|206808|P3|NOT COMPLETED|Overall Study||26
86910|NCT01350271|206809|P2|NOT COMPLETED|Overall Study||17
86911|NCT01350271|206810|P1|NOT COMPLETED|Overall Study||21
86912|NCT01350271|206808|P3|COMPLETED|Overall Study||48
86913|NCT01350271|206809|P2|COMPLETED|Overall Study||53
86914|NCT01350271|206810|P1|COMPLETED|Overall Study||49
86915|NCT01350271|206808|P3|STARTED|Overall Study||74
86916|NCT01350271|206809|P2|STARTED|Overall Study||70
86917|NCT01350271|206810|P1|STARTED|Overall Study||70
86918|NCT01350258|206824|P1|NOT COMPLETED|Overall Study||0
86919|NCT01350258|206824|P1|COMPLETED|Overall Study||8
86920|NCT01350258|206824|P1|STARTED|Overall Study||8
86921|NCT01350245|206833|P1|NOT COMPLETED|Overall Study||0
86922|NCT01350245|206833|P1|COMPLETED|Overall Study||28
86923|NCT01350245|206833|P1|STARTED|Overall Study||28
86924|NCT01350232|206838|P1|NOT COMPLETED|Overall Study||0
86925|NCT01350232|206838|P1|COMPLETED|Overall Study||2
86926|NCT01350232|206838|P1|STARTED|Overall Study||2
86927|NCT01350128|206849|P1|NOT COMPLETED|Overall Study||14
86928|NCT01350128|206849|P1|COMPLETED|Overall Study||89
86929|NCT01350128|206849|P1|Atrovent HFA 34 µg BID|Overall Study||48
86930|NCT01350128|206849|P1|Placebo MDI BID|Overall Study||48
86931|NCT01350128|206849|P1|GP MDI 4.6 µg BID|Overall Study||45
86932|NCT01350128|206849|P1|GP MDI 9 µg BID|Overall Study||49
86933|NCT01350128|206849|P1|GP MDI 18 µg BID|Overall Study||49
86934|NCT01350128|206849|P1|GP MDI 36 µg BID|Overall Study|Glycopyrronium Metered Dose Inhaler|49
86935|NCT01350128|206849|P1|STARTED|Overall Study||103
86936|NCT01350115|206913|P2|NOT COMPLETED|Long Term Follow-Up (All Patients)||2
86937|NCT01350115|206914|P1|NOT COMPLETED|Long Term Follow-Up (All Patients)||1
86938|NCT01350115|206913|P2|COMPLETED|Long Term Follow-Up (All Patients)||0
86939|NCT01350115|206914|P1|COMPLETED|Long Term Follow-Up (All Patients)||7
86940|NCT01350115|206913|P2|STARTED|Long Term Follow-Up (All Patients)||2
86941|NCT01350115|206914|P1|STARTED|Long Term Follow-Up (All Patients)||8
86942|NCT01350115|206913|P2|NOT COMPLETED|Core Study (All Patients)||0
86943|NCT01350115|206914|P1|NOT COMPLETED|Core Study (All Patients)||0
86944|NCT01350115|206913|P2|COMPLETED|Core Study (All Patients)||2
86945|NCT01350115|206914|P1|COMPLETED|Core Study (All Patients)||8
86946|NCT01350115|206913|P2|Pharmacodynamic Set|Core Study (All Patients)||2
86947|NCT01350115|206914|P1|Pharmacodynamic Set|Core Study (All Patients)||7
86948|NCT01350115|206913|P2|Safety Anlysis Set|Core Study (All Patients)||2
86949|NCT01350115|206914|P1|Safety Anlysis Set|Core Study (All Patients)||8
86950|NCT01350115|206913|P2|STARTED|Core Study (All Patients)||2
86951|NCT01350115|206914|P1|STARTED|Core Study (All Patients)||8
86952|NCT01349972|206928|P2|NOT COMPLETED|Overall Study||2
86953|NCT01349972|206929|P1|NOT COMPLETED|Overall Study||5
86954|NCT01349972|206928|P2|COMPLETED|Overall Study||56
86955|NCT01349972|206929|P1|COMPLETED|Overall Study||109
86956|NCT01349972|206928|P2|STARTED|Overall Study||58
86957|NCT01349972|206929|P1|STARTED|Overall Study||114
86958|NCT01349959|206945|P1|NOT COMPLETED|Overall Study||7
86959|NCT01349959|206945|P1|COMPLETED|Overall Study||33
86960|NCT01349959|206945|P1|STARTED|Overall Study|58 consented, 18 failed screening and did not receive study treatment|40
86961|NCT01349933|206951|P1|NOT COMPLETED|Overall Study||0
86962|NCT01349933|206951|P1|COMPLETED|Overall Study||21
86963|NCT01349933|206951|P1|STARTED|Overall Study||21
86964|NCT01349920|206956|P1|NOT COMPLETED|Overall Study||0
86965|NCT01349920|206956|P1|COMPLETED|Overall Study||15
86966|NCT01349920|206956|P1|STARTED|Overall Study||15
86967|NCT01349907|206976|P2|NOT COMPLETED|Overall Study||43
86968|NCT01349907|206977|P1|NOT COMPLETED|Overall Study||139
86969|NCT01349907|206976|P2|COMPLETED|Overall Study||38
86970|NCT01349907|206977|P1|COMPLETED|Overall Study||102
86971|NCT01349907|206976|P2|STARTED|Overall Study|Enrolled and Treated|81
86972|NCT01349907|206977|P1|STARTED|Overall Study|Enrolled and Treated|241
86973|NCT01349829|207015|P2|NOT COMPLETED|Overall Study||23
86974|NCT01349829|207016|P1|NOT COMPLETED|Overall Study||9
86975|NCT01349829|207015|P2|COMPLETED|Overall Study||102
86976|NCT01349829|207016|P1|COMPLETED|Overall Study||117
86977|NCT01349829|207015|P2|STARTED|Overall Study||125
86978|NCT01349829|207016|P1|STARTED|Overall Study||126
86979|NCT01349816|207034|P1|NOT COMPLETED|Overall Study||30
86980|NCT01349816|207034|P1|COMPLETED|Overall Study||155
86981|NCT01349816|207034|P1|FF MDI 9.6 µg|Overall Study||61
86982|NCT01349816|207034|P1|GFF MDI 9/9.6 µg|Overall Study||57
86983|NCT01349816|207034|P1|GFF MDI 18/9.6 µg|Overall Study||57
86984|NCT01349816|207034|P1|GFF MDI 36/9.6 µg|Overall Study||56
86985|NCT01349816|207034|P1|GFF MDI 36/7.2 µg|Overall Study||58
86986|NCT01349816|207034|P1|GP MDI 36 µg|Overall Study||61
86987|NCT01349816|207034|P1|STARTED|Overall Study||185
86988|NCT01349803|207100|P4|NOT COMPLETED|Overall Study||2
86989|NCT01349803|207101|P3|NOT COMPLETED|Overall Study||3
86990|NCT01349803|207102|P2|NOT COMPLETED|Overall Study||1
86991|NCT01349803|207103|P1|NOT COMPLETED|Overall Study||1
86992|NCT01349803|207100|P4|COMPLETED|Overall Study||57
86993|NCT01349803|207101|P3|COMPLETED|Overall Study||57
86994|NCT01349803|207102|P2|COMPLETED|Overall Study||57
86995|NCT01349803|207103|P1|COMPLETED|Overall Study||59
86996|NCT01349803|207100|P4|STARTED|Overall Study||59
86997|NCT01349803|207101|P3|STARTED|Overall Study||60
86998|NCT01349803|207102|P2|STARTED|Overall Study||58
86999|NCT01349803|207103|P1|STARTED|Overall Study||60
87000|NCT01349790|207173|P1|NOT COMPLETED|Overall Study||9
87001|NCT01349790|207173|P1|COMPLETED|Overall Study||31
87002|NCT01349790|207173|P1|STARTED|Overall Study||40
87003|NCT01349595|207194|P2|NOT COMPLETED|Overall Study||2
87004|NCT01349595|207195|P1|NOT COMPLETED|Overall Study||2
87005|NCT01349595|207194|P2|COMPLETED|Overall Study||0
87006|NCT01349595|207195|P1|COMPLETED|Overall Study||0
87007|NCT01349595|207194|P2|STARTED|Overall Study||2
87008|NCT01349595|207195|P1|STARTED|Overall Study||2
87009|NCT01349491|207203|P2|NOT COMPLETED|Overall Study||0
87010|NCT01349491|207204|P1|NOT COMPLETED|Overall Study||0
87011|NCT01349491|207203|P2|COMPLETED|Overall Study||5
87012|NCT01349491|207204|P1|COMPLETED|Overall Study||5
87013|NCT01349491|207203|P2|STARTED|Overall Study||5
87014|NCT01349491|207204|P1|STARTED|Overall Study||5
87015|NCT01349465|207212|P2|NOT COMPLETED|Overall Study||22
87016|NCT01349465|207213|P1|NOT COMPLETED|Overall Study||18
87017|NCT01349465|207212|P2|COMPLETED|Overall Study||27
87018|NCT01349465|207213|P1|COMPLETED|Overall Study||182
87019|NCT01349465|207212|P2|STARTED|Overall Study||49
87020|NCT01349465|207213|P1|STARTED|Overall Study||200
87021|NCT01349231|207225|P1|NOT COMPLETED|Overall Study||0
87022|NCT01349231|207225|P1|COMPLETED|Overall Study||10
87023|NCT01349231|207225|P1|STARTED|Overall Study||10
87024|NCT01349192|207234|P2|NOT COMPLETED|Overall Study||6
87025|NCT01349192|207235|P1|NOT COMPLETED|Overall Study||3
87026|NCT01349192|207234|P2|COMPLETED|Overall Study||17
87027|NCT01349192|207235|P1|COMPLETED|Overall Study||21
87028|NCT01349192|207234|P2|Withdrawals|Overall Study||6
87029|NCT01349192|207235|P1|Withdrawals|Overall Study||3
87030|NCT01349192|207234|P2|Evaluable for Primary Endpoint|Overall Study||19
87031|NCT01349192|207235|P1|Evaluable for Primary Endpoint|Overall Study||22
87032|NCT01349192|207234|P2|STARTED|Overall Study||23
87033|NCT01349192|207235|P1|STARTED|Overall Study||24
87034|NCT01349114|207249|P2|NOT COMPLETED|Overall Study||0
87035|NCT01349114|207250|P1|NOT COMPLETED|Overall Study||0
87036|NCT01349114|207249|P2|COMPLETED|Overall Study||11
87037|NCT01349114|207250|P1|COMPLETED|Overall Study||10
87038|NCT01349114|207249|P2|STARTED|Overall Study||11
87039|NCT01349114|207250|P1|STARTED|Overall Study||10
87040|NCT01348854|207260|P2|NOT COMPLETED|Overall Study||1
87041|NCT01348854|207261|P1|NOT COMPLETED|Overall Study||3
87042|NCT01348854|207260|P2|COMPLETED|Overall Study|9 eyes of 5 participants|5
87043|NCT01348854|207261|P1|COMPLETED|Overall Study|47 eyes of 31 participants|31
87044|NCT01348854|207260|P2|STARTED|Overall Study|10 eyes of 6 participants|6
87045|NCT01348854|207261|P1|STARTED|Overall Study|53 eyes of 34 participants|34
87046|NCT01348789|207269|P1|NOT COMPLETED|Overall Study||4
87047|NCT01348789|207269|P1|COMPLETED|Overall Study|4 subjects did not complete all 3 treatments but were evaluated for primary and secondary endpoints.|33
87048|NCT01348789|207269|P1|STARTED|Overall Study||37
87049|NCT01348776|207280|P1|NOT COMPLETED|Overall Study||3
87050|NCT01348776|207280|P1|COMPLETED|Overall Study||84
87051|NCT01348776|207280|P1|STARTED|Overall Study|3 subjects were lost to follow-up: 2 after the 1-month follow-up, 1 after performing 4 treatments|87
87052|NCT01348607|207296|P3|NOT COMPLETED|Overall Study||0
87053|NCT01348607|207297|P2|NOT COMPLETED|Overall Study||0
87054|NCT01348607|207298|P1|NOT COMPLETED|Overall Study||0
87055|NCT01348607|207296|P3|COMPLETED|Overall Study||0
87056|NCT01348607|207297|P2|COMPLETED|Overall Study||0
87057|NCT01348607|207298|P1|COMPLETED|Overall Study||1
87058|NCT01348607|207296|P3|STARTED|Overall Study||0
87059|NCT01348607|207297|P2|STARTED|Overall Study||0
87060|NCT01348607|207298|P1|STARTED|Overall Study||1
87061|NCT01348425|207311|P2|NOT COMPLETED|Overall Study||1
87062|NCT01348425|207312|P1|NOT COMPLETED|Overall Study||1
87063|NCT01348425|207311|P2|COMPLETED|Overall Study||13
87064|NCT01348425|207312|P1|COMPLETED|Overall Study||30
87065|NCT01348425|207311|P2|STARTED|Overall Study||14
87066|NCT01348425|207312|P1|STARTED|Overall Study||31
87067|NCT01348165|207324|P7|NOT COMPLETED|Overall Study||1
87068|NCT01348165|207325|P6|NOT COMPLETED|Overall Study||0
87069|NCT01348165|207326|P5|NOT COMPLETED|Overall Study||0
87070|NCT01348165|207327|P4|NOT COMPLETED|Overall Study||0
87071|NCT01348165|207328|P3|NOT COMPLETED|Overall Study||0
87072|NCT01348165|207329|P2|NOT COMPLETED|Overall Study||0
87073|NCT01348165|207330|P1|NOT COMPLETED|Overall Study||0
87074|NCT01348165|207324|P7|COMPLETED|Overall Study||5
87075|NCT01348165|207325|P6|COMPLETED|Overall Study||1
87076|NCT01348165|207326|P5|COMPLETED|Overall Study||6
87077|NCT01348165|207327|P4|COMPLETED|Overall Study||6
87078|NCT01348165|207328|P3|COMPLETED|Overall Study||6
87079|NCT01348165|207329|P2|COMPLETED|Overall Study||5
87080|NCT01348165|207330|P1|COMPLETED|Overall Study||10
87081|NCT01348165|207324|P7|STARTED|Overall Study||6
87082|NCT01348165|207325|P6|STARTED|Overall Study||1
87083|NCT01348165|207326|P5|STARTED|Overall Study||6
87084|NCT01348165|207327|P4|STARTED|Overall Study||6
87085|NCT01348165|207328|P3|STARTED|Overall Study||6
87086|NCT01348165|207329|P2|STARTED|Overall Study||5
87087|NCT01348165|207330|P1|STARTED|Overall Study||10
87088|NCT01348139|207459|P6|NOT COMPLETED|Period 6||0
87089|NCT01348139|207460|P5|NOT COMPLETED|Period 6||0
87090|NCT01348139|207461|P4|NOT COMPLETED|Period 6||0
87091|NCT01348139|207462|P3|NOT COMPLETED|Period 6||0
87092|NCT01348139|207463|P2|NOT COMPLETED|Period 6||0
87093|NCT01348139|207464|P1|NOT COMPLETED|Period 6||0
87094|NCT01348139|207459|P6|COMPLETED|Period 6||4
87095|NCT01348139|207460|P5|COMPLETED|Period 6||5
87096|NCT01348139|207461|P4|COMPLETED|Period 6||4
87097|NCT01348139|207462|P3|COMPLETED|Period 6||4
87098|NCT01348139|207463|P2|COMPLETED|Period 6||4
87099|NCT01348139|207464|P1|COMPLETED|Period 6||4
87100|NCT01348139|207459|P6|STARTED|Period 6||4
87101|NCT01348139|207460|P5|STARTED|Period 6||5
87102|NCT01348139|207461|P4|STARTED|Period 6||4
87103|NCT01348139|207462|P3|STARTED|Period 6||4
87104|NCT01348139|207463|P2|STARTED|Period 6||4
87105|NCT01348139|207464|P1|STARTED|Period 6||4
87106|NCT01348139|207459|P6|NOT COMPLETED|Period 5||0
87107|NCT01348139|207460|P5|NOT COMPLETED|Period 5||0
87108|NCT01348139|207461|P4|NOT COMPLETED|Period 5||0
87109|NCT01348139|207462|P3|NOT COMPLETED|Period 5||0
87110|NCT01348139|207463|P2|NOT COMPLETED|Period 5||0
87111|NCT01348139|207464|P1|NOT COMPLETED|Period 5||0
87112|NCT01348139|207459|P6|COMPLETED|Period 5||4
87113|NCT01348139|207460|P5|COMPLETED|Period 5||5
87114|NCT01348139|207461|P4|COMPLETED|Period 5||4
87115|NCT01348139|207462|P3|COMPLETED|Period 5||4
87116|NCT01348139|207463|P2|COMPLETED|Period 5||4
87117|NCT01348139|207464|P1|COMPLETED|Period 5||4
87118|NCT01348139|207459|P6|STARTED|Period 5||4
87119|NCT01348139|207460|P5|STARTED|Period 5||5
87120|NCT01348139|207461|P4|STARTED|Period 5||4
87121|NCT01348139|207462|P3|STARTED|Period 5||4
87122|NCT01348139|207463|P2|STARTED|Period 5||4
87123|NCT01348139|207464|P1|STARTED|Period 5||4
87124|NCT01348139|207459|P6|NOT COMPLETED|Period 4||0
87125|NCT01348139|207460|P5|NOT COMPLETED|Period 4||0
87126|NCT01348139|207461|P4|NOT COMPLETED|Period 4||0
87127|NCT01348139|207462|P3|NOT COMPLETED|Period 4||0
87128|NCT01348139|207463|P2|NOT COMPLETED|Period 4||0
87129|NCT01348139|207464|P1|NOT COMPLETED|Period 4||0
87130|NCT01348139|207459|P6|COMPLETED|Period 4||4
87131|NCT01348139|207460|P5|COMPLETED|Period 4||5
87132|NCT01348139|207461|P4|COMPLETED|Period 4||4
87133|NCT01348139|207462|P3|COMPLETED|Period 4||4
87134|NCT01348139|207463|P2|COMPLETED|Period 4||4
87135|NCT01348139|207464|P1|COMPLETED|Period 4||4
87136|NCT01348139|207459|P6|STARTED|Period 4||4
87137|NCT01348139|207460|P5|STARTED|Period 4||5
87138|NCT01348139|207461|P4|STARTED|Period 4||4
87139|NCT01348139|207462|P3|STARTED|Period 4||4
87140|NCT01348139|207463|P2|STARTED|Period 4||4
87141|NCT01348139|207464|P1|STARTED|Period 4||4
87142|NCT01348139|207459|P6|NOT COMPLETED|Period 3||0
87143|NCT01348139|207460|P5|NOT COMPLETED|Period 3||0
87144|NCT01348139|207461|P4|NOT COMPLETED|Period 3||0
87145|NCT01348139|207462|P3|NOT COMPLETED|Period 3||0
87146|NCT01348139|207463|P2|NOT COMPLETED|Period 3||0
87147|NCT01348139|207464|P1|NOT COMPLETED|Period 3||0
87148|NCT01348139|207459|P6|COMPLETED|Period 3||4
87149|NCT01348139|207460|P5|COMPLETED|Period 3||5
87150|NCT01348139|207461|P4|COMPLETED|Period 3||4
87151|NCT01348139|207462|P3|COMPLETED|Period 3||4
87152|NCT01348139|207463|P2|COMPLETED|Period 3||4
87153|NCT01348139|207464|P1|COMPLETED|Period 3||4
87154|NCT01348139|207459|P6|STARTED|Period 3||4
87155|NCT01348139|207460|P5|STARTED|Period 3||5
87156|NCT01348139|207461|P4|STARTED|Period 3||4
87157|NCT01348139|207462|P3|STARTED|Period 3||4
87158|NCT01348139|207463|P2|STARTED|Period 3||4
87159|NCT01348139|207464|P1|STARTED|Period 3||4
87160|NCT01348139|207459|P6|NOT COMPLETED|Period 2||0
87161|NCT01348139|207460|P5|NOT COMPLETED|Period 2||0
87162|NCT01348139|207461|P4|NOT COMPLETED|Period 2||0
87163|NCT01348139|207462|P3|NOT COMPLETED|Period 2||0
87164|NCT01348139|207463|P2|NOT COMPLETED|Period 2||0
87165|NCT01348139|207464|P1|NOT COMPLETED|Period 2||0
87166|NCT01348139|207459|P6|COMPLETED|Period 2||4
87167|NCT01348139|207460|P5|COMPLETED|Period 2||5
87168|NCT01348139|207461|P4|COMPLETED|Period 2||4
87169|NCT01348139|207462|P3|COMPLETED|Period 2||4
87170|NCT01348139|207463|P2|COMPLETED|Period 2||4
87171|NCT01348139|207464|P1|COMPLETED|Period 2||4
87172|NCT01348139|207459|P6|STARTED|Period 2||4
87173|NCT01348139|207460|P5|STARTED|Period 2||5
87174|NCT01348139|207461|P4|STARTED|Period 2||4
87175|NCT01348139|207462|P3|STARTED|Period 2||4
87176|NCT01348139|207463|P2|STARTED|Period 2||4
87177|NCT01348139|207464|P1|STARTED|Period 2||4
87178|NCT01348139|207459|P6|NOT COMPLETED|Period 1||0
87179|NCT01348139|207460|P5|NOT COMPLETED|Period 1||0
87180|NCT01348139|207461|P4|NOT COMPLETED|Period 1||0
87181|NCT01348139|207462|P3|NOT COMPLETED|Period 1||0
87182|NCT01348139|207463|P2|NOT COMPLETED|Period 1||0
87183|NCT01348139|207464|P1|NOT COMPLETED|Period 1||1
87184|NCT01348139|207459|P6|COMPLETED|Period 1||4
87185|NCT01348139|207460|P5|COMPLETED|Period 1||5
87186|NCT01348139|207461|P4|COMPLETED|Period 1||4
87187|NCT01348139|207462|P3|COMPLETED|Period 1||4
87188|NCT01348139|207463|P2|COMPLETED|Period 1||4
87189|NCT01348139|207464|P1|COMPLETED|Period 1||4
87190|NCT01348139|207459|P6|STARTED|Period 1||4
87191|NCT01348139|207460|P5|STARTED|Period 1||5
87192|NCT01348139|207461|P4|STARTED|Period 1||4
87193|NCT01348139|207462|P3|STARTED|Period 1||4
87194|NCT01348139|207463|P2|STARTED|Period 1||4
87195|NCT01348139|207464|P1|STARTED|Period 1||5
87196|NCT01348100|207545|P7|NOT COMPLETED|Overall Study||3
87197|NCT01348100|207546|P6|NOT COMPLETED|Overall Study||2
87198|NCT01348100|207547|P5|NOT COMPLETED|Overall Study||1
87199|NCT01348100|207548|P4|NOT COMPLETED|Overall Study||1
87200|NCT01348100|207549|P3|NOT COMPLETED|Overall Study||2
87201|NCT01348100|207550|P2|NOT COMPLETED|Overall Study||0
87202|NCT01348100|207551|P1|NOT COMPLETED|Overall Study||0
87203|NCT01348100|207545|P7|COMPLETED|Overall Study||13
87204|NCT01348100|207546|P6|COMPLETED|Overall Study||14
87205|NCT01348100|207547|P5|COMPLETED|Overall Study||14
87206|NCT01348100|207548|P4|COMPLETED|Overall Study||14
87207|NCT01348100|207549|P3|COMPLETED|Overall Study||13
87208|NCT01348100|207550|P2|COMPLETED|Overall Study||2
87209|NCT01348100|207551|P1|COMPLETED|Overall Study||2
87210|NCT01348100|207545|P7|STARTED|Overall Study||16
87211|NCT01348100|207546|P6|STARTED|Overall Study||16
87212|NCT01348100|207547|P5|STARTED|Overall Study||15
87213|NCT01348100|207548|P4|STARTED|Overall Study||15
87214|NCT01348100|207549|P3|STARTED|Overall Study||15
87215|NCT01348100|207550|P2|STARTED|Overall Study||2
87216|NCT01348100|207551|P1|STARTED|Overall Study||2
87217|NCT01348087|207596|P1|NOT COMPLETED|Overall Study||148
87218|NCT01348087|207596|P1|COMPLETED|Overall Study||0
87219|NCT01348087|207596|P1|STARTED|Overall Study||148
87220|NCT01347931|207610|P1|NOT COMPLETED|NIOV System||0
87221|NCT01347931|207610|P1|COMPLETED|NIOV System||29
87222|NCT01347931|207610|P1|STARTED|NIOV System||29
87223|NCT01347931|207610|P1|NOT COMPLETED|Standard Oxygen Therapy||1
87224|NCT01347931|207610|P1|COMPLETED|Standard Oxygen Therapy||29
87225|NCT01347931|207610|P1|STARTED|Standard Oxygen Therapy||30
87226|NCT01347879|207622|P2|NOT COMPLETED|Overall Study||17
87227|NCT01347879|207623|P1|NOT COMPLETED|Overall Study||7
87228|NCT01347879|207622|P2|COMPLETED|Overall Study||83
87229|NCT01347879|207623|P1|COMPLETED|Overall Study||46
87230|NCT01347879|207622|P2|STARTED|Overall Study||100
87231|NCT01347879|207623|P1|STARTED|Overall Study||53
87232|NCT01347840|207655|P1|NOT COMPLETED|Overall Study||1
87233|NCT01347840|207655|P1|COMPLETED|Overall Study||0
87234|NCT01347840|207655|P1|STARTED|Overall Study|1 subject enrolled but withdrew consent|1
87235|NCT01347788|207668|P3|NOT COMPLETED|Overall Study||0
87236|NCT01347788|207669|P2|NOT COMPLETED|Overall Study||0
87237|NCT01347788|207670|P1|NOT COMPLETED|Overall Study||0
87238|NCT01347788|207668|P3|COMPLETED|Overall Study||13
87239|NCT01347788|207669|P2|COMPLETED|Overall Study||10
87240|NCT01347788|207670|P1|COMPLETED|Overall Study||11
87241|NCT01347788|207668|P3|STARTED|Overall Study||13
87242|NCT01347788|207669|P2|STARTED|Overall Study||10
87243|NCT01347788|207670|P1|STARTED|Overall Study||11
87244|NCT01347710|207678|P1|NOT COMPLETED|Overall Study||31
87245|NCT01347710|207678|P1|COMPLETED|Overall Study||764
87246|NCT01347710|207678|P1|STARTED|Overall Study||795
87247|NCT01347632|207693|P1|NOT COMPLETED|Overall Study||2
87248|NCT01347632|207693|P1|COMPLETED|Overall Study||33
87249|NCT01347632|207693|P1|STARTED|Overall Study||35
87250|NCT01347580|207699|P2|NOT COMPLETED|Overall Study||56
87251|NCT01347580|207700|P1|NOT COMPLETED|Overall Study||65
87252|NCT01347580|207699|P2|COMPLETED|Overall Study|based on randomized treatment|897
87253|NCT01347580|207700|P1|COMPLETED|Overall Study|based on randomized treatment|844
87254|NCT01347580|207699|P2|Safety Population|Overall Study|based on actual treatment|950
87255|NCT01347580|207700|P1|Safety Population|Overall Study|based on actual treatment|908
87256|NCT01347580|207699|P2|Modified Intent to Treat Population|Overall Study|based on randomized treatment|952
87257|NCT01347580|207700|P1|Modified Intent to Treat Population|Overall Study|based on randomized treatment|906
87258|NCT01347580|207699|P2|STARTED|Overall Study|based on randomized treatment|953
87259|NCT01347580|207700|P1|STARTED|Overall Study|based on randomized treatment|909
87260|NCT01347554|207730|P2|NOT COMPLETED|Overall Study||11
87261|NCT01347554|207731|P1|NOT COMPLETED|Overall Study||7
87262|NCT01347554|207730|P2|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=11) were excluded.|231
87263|NCT01347554|207731|P1|COMPLETED|Overall Study|Final TIMI flow grade 0 or 1 patients or failed PCI cases (N=7) were excluded.|230
87264|NCT01347554|207730|P2|STARTED|Overall Study||242
87265|NCT01347554|207731|P1|STARTED|Overall Study||237
87266|NCT01347255|207743|P1|NOT COMPLETED|Overall Study||0
87267|NCT01347255|207743|P1|COMPLETED|Overall Study||24
87268|NCT01347255|207743|P1|STARTED|Overall Study||24
87269|NCT01347112|207768|P2|NOT COMPLETED|Overall Study||12
87270|NCT01347112|207769|P1|NOT COMPLETED|Overall Study||4
87271|NCT01347112|207768|P2|COMPLETED|Overall Study||5
87272|NCT01347112|207769|P1|COMPLETED|Overall Study||12
87273|NCT01347112|207768|P2|STARTED|Overall Study||17
87274|NCT01347112|207769|P1|STARTED|Overall Study||16
87275|NCT01347086|207789|P10|NOT COMPLETED|Overall Study||1
87276|NCT01347086|207790|P9|NOT COMPLETED|Overall Study||0
87277|NCT01347086|207791|P8|NOT COMPLETED|Overall Study||1
87278|NCT01347086|207792|P7|NOT COMPLETED|Overall Study||1
87279|NCT01347086|207793|P6|NOT COMPLETED|Overall Study||0
87280|NCT01347086|207794|P5|NOT COMPLETED|Overall Study||0
87281|NCT01347086|207795|P4|NOT COMPLETED|Overall Study||0
87282|NCT01347086|207796|P3|NOT COMPLETED|Overall Study||1
87283|NCT01347086|207797|P2|NOT COMPLETED|Overall Study||0
87284|NCT01347086|207798|P1|NOT COMPLETED|Overall Study||0
87285|NCT01347086|207789|P10|COMPLETED|Overall Study||6
87286|NCT01347086|207790|P9|COMPLETED|Overall Study||6
87287|NCT01347086|207791|P8|COMPLETED|Overall Study||6
87288|NCT01347086|207792|P7|COMPLETED|Overall Study||6
87289|NCT01347086|207793|P6|COMPLETED|Overall Study||6
87290|NCT01347086|207794|P5|COMPLETED|Overall Study||6
87291|NCT01347086|207795|P4|COMPLETED|Overall Study||6
87292|NCT01347086|207796|P3|COMPLETED|Overall Study||6
87293|NCT01347086|207797|P2|COMPLETED|Overall Study||6
87294|NCT01347086|207798|P1|COMPLETED|Overall Study||2
87295|NCT01347086|207789|P10|STARTED|Overall Study|One subject was not treated.|7
87296|NCT01347086|207790|P9|STARTED|Overall Study||6
87297|NCT01347086|207791|P8|STARTED|Overall Study|One subject was not treated.|7
87298|NCT01347086|207792|P7|STARTED|Overall Study|"2 participants treated together with each dose level of Deleobuvir.
1 subject was not treated."|7
87299|NCT01347086|207793|P6|STARTED|Overall Study||6
87300|NCT01347086|207794|P5|STARTED|Overall Study||6
87301|NCT01347086|207795|P4|STARTED|Overall Study||6
87302|NCT01347086|207796|P3|STARTED|Overall Study|"2 participants were treated together with each dose level of Deleobuvir.
1 subject was not treated."|7
87303|NCT01347086|207797|P2|STARTED|Overall Study||6
87304|NCT01347086|207798|P1|STARTED|Overall Study||2
87305|NCT01347073|207897|P1|NOT COMPLETED|Overall Study||2
87306|NCT01347073|207897|P1|COMPLETED|Overall Study||21
87307|NCT01347073|207897|P1|STARTED|Overall Study||23
87308|NCT01347060|207911|P2|NOT COMPLETED|Overall Study||0
87309|NCT01347060|207912|P1|NOT COMPLETED|Overall Study||0
87310|NCT01347060|207911|P2|COMPLETED|Overall Study||7580
87311|NCT01347060|207912|P1|COMPLETED|Overall Study||9868
87312|NCT01347060|207911|P2|STARTED|Overall Study||7580
87313|NCT01347060|207912|P1|STARTED|Overall Study||9868
87314|NCT01347034|207924|P2|NOT COMPLETED|Overall Study||0
87315|NCT01347034|207925|P1|NOT COMPLETED|Overall Study||0
87316|NCT01347034|207924|P2|COMPLETED|Overall Study||14
87317|NCT01347034|207925|P1|COMPLETED|Overall Study||6
87318|NCT01347034|207924|P2|STARTED|Overall Study||14
87319|NCT01347034|207925|P1|STARTED|Overall Study||6
87320|NCT01347008|207935|P2|NOT COMPLETED|Overall Study||0
87321|NCT01347008|207936|P1|NOT COMPLETED|Overall Study||0
87322|NCT01347008|207935|P2|COMPLETED|Overall Study||20
87323|NCT01347008|207936|P1|COMPLETED|Overall Study||21
87324|NCT01347008|207935|P2|STARTED|Overall Study||20
87325|NCT01347008|207936|P1|STARTED|Overall Study||21
87326|NCT01346852|207948|P2|NOT COMPLETED|Overall Study||0
87327|NCT01346852|207949|P1|NOT COMPLETED|Overall Study||0
87328|NCT01346852|207948|P2|COMPLETED|Overall Study||59684
87329|NCT01346852|207949|P1|COMPLETED|Overall Study||41753
87330|NCT01346852|207948|P2|STARTED|Overall Study||59684
87331|NCT01346852|207949|P1|STARTED|Overall Study||41753
87332|NCT01346839|207959|P2|NOT COMPLETED|Overall Study||209
87333|NCT01346839|207960|P1|NOT COMPLETED|Overall Study||314
87334|NCT01346839|207959|P2|COMPLETED|Overall Study|All triggers were applied retrospectively on 7/19/2012.|364
87335|NCT01346839|207960|P1|COMPLETED|Overall Study||369
87336|NCT01346839|207959|P2|STARTED|Overall Study||573
87337|NCT01346839|207960|P1|STARTED|Overall Study||683
87338|NCT01346774|207976|P2|NOT COMPLETED|Overall Study||17
87339|NCT01346774|207977|P1|NOT COMPLETED|Overall Study||13
87340|NCT01346774|207976|P2|COMPLETED|Overall Study||63
87341|NCT01346774|207977|P1|COMPLETED|Overall Study||67
87342|NCT01346774|207976|P2|STARTED|Overall Study||80
87343|NCT01346774|207977|P1|STARTED|Overall Study||80
87344|NCT01346592|207986|P3|NOT COMPLETED|Overall Study||78
87345|NCT01346592|207987|P2|NOT COMPLETED|Overall Study||89
87346|NCT01346592|207988|P1|NOT COMPLETED|Overall Study||153
87347|NCT01346592|207986|P3|COMPLETED|Overall Study||1408
87348|NCT01346592|207987|P2|COMPLETED|Overall Study||1389
87349|NCT01346592|207988|P1|COMPLETED|Overall Study||2983
87350|NCT01346592|207986|P3|STARTED|Overall Study||1486
87351|NCT01346592|207987|P2|STARTED|Overall Study||1478
87352|NCT01346592|207988|P1|STARTED|Overall Study||3136
87353|NCT01346514|208080|P2|NOT COMPLETED|Overall Study||37
87354|NCT01346514|208081|P1|NOT COMPLETED|Overall Study||29
87355|NCT01346514|208080|P2|COMPLETED|Overall Study|Number of patients completing BL-12 months.|53
87356|NCT01346514|208081|P1|COMPLETED|Overall Study|Number of patients completing BL-12 months|62
87357|NCT01346514|208080|P2|12 Month Assessment|Overall Study||53
87358|NCT01346514|208081|P1|12 Month Assessment|Overall Study||62
87359|NCT01346514|208080|P2|9 Month Assessment|Overall Study||59
87360|NCT01346514|208081|P1|9 Month Assessment|Overall Study||67
87361|NCT01346514|208080|P2|6 Month Assessment|Overall Study||61
87362|NCT01346514|208081|P1|6 Month Assessment|Overall Study||74
87363|NCT01346514|208080|P2|3 Month Assessment|Overall Study||68
87364|NCT01346514|208081|P1|3 Month Assessment|Overall Study||83
87365|NCT01346514|208080|P2|STARTED|Overall Study||90
87366|NCT01346514|208081|P1|STARTED|Overall Study||91
87367|NCT01346501|208101|P2|NOT COMPLETED|Overall Study||13
87368|NCT01346501|208102|P1|NOT COMPLETED|Overall Study||11
87369|NCT01346501|208101|P2|COMPLETED|Overall Study||80
87370|NCT01346501|208102|P1|COMPLETED|Overall Study||68
87371|NCT01346501|208101|P2|STARTED|Overall Study||93
87372|NCT01346501|208102|P1|STARTED|Overall Study||79
87373|NCT01346488|208115|P1|NOT COMPLETED|Overall Study||706
87374|NCT01346488|208115|P1|COMPLETED|Overall Study||1262
87375|NCT01346488|208115|P1|STARTED|Overall Study||1968
87376|NCT01346475|208135|P2|NOT COMPLETED|Second Intervention||0
87377|NCT01346475|208136|P1|NOT COMPLETED|Second Intervention||0
87378|NCT01346475|208135|P2|COMPLETED|Second Intervention||25
87379|NCT01346475|208136|P1|COMPLETED|Second Intervention||18
87380|NCT01346475|208135|P2|STARTED|Second Intervention||25
87381|NCT01346475|208136|P1|STARTED|Second Intervention||18
87382|NCT01346475|208135|P2|NOT COMPLETED|First Intervention||3
87383|NCT01346475|208136|P1|NOT COMPLETED|First Intervention||4
87384|NCT01346475|208135|P2|COMPLETED|First Intervention||25
87385|NCT01346475|208136|P1|COMPLETED|First Intervention||18
87386|NCT01346475|208135|P2|STARTED|First Intervention||28
87387|NCT01346475|208136|P1|STARTED|First Intervention||22
87388|NCT01346397|208150|P2|NOT COMPLETED|Overall Study||0
87389|NCT01346397|208151|P1|NOT COMPLETED|Overall Study||0
87390|NCT01346397|208150|P2|COMPLETED|Overall Study||85
87391|NCT01346397|208151|P1|COMPLETED|Overall Study||85
87392|NCT01346397|208150|P2|STARTED|Overall Study||85
87393|NCT01346397|208151|P1|STARTED|Overall Study||85
87394|NCT01346293|208161|P2|NOT COMPLETED|Overall Study||21
87395|NCT01346293|208162|P1|NOT COMPLETED|Overall Study||67
87396|NCT01346293|208161|P2|COMPLETED|Overall Study||608
87397|NCT01346293|208162|P1|COMPLETED|Overall Study||2676
87398|NCT01346293|208161|P2|STARTED|Overall Study||629
87399|NCT01346293|208162|P1|STARTED|Overall Study||2743
87400|NCT01346176|208191|P3|NOT COMPLETED|Completed Satisfaction Survey||6
87401|NCT01346176|208192|P2|NOT COMPLETED|Completed Satisfaction Survey||4
87402|NCT01346176|208193|P1|NOT COMPLETED|Completed Satisfaction Survey||6
87403|NCT01346176|208191|P3|COMPLETED|Completed Satisfaction Survey||27
87404|NCT01346176|208192|P2|COMPLETED|Completed Satisfaction Survey||22
87405|NCT01346176|208193|P1|COMPLETED|Completed Satisfaction Survey||29
87406|NCT01346176|208191|P3|STARTED|Completed Satisfaction Survey||33
87407|NCT01346176|208192|P2|STARTED|Completed Satisfaction Survey||26
87408|NCT01346176|208193|P1|STARTED|Completed Satisfaction Survey||35
87409|NCT01346176|208191|P3|NOT COMPLETED|Completed Advance Directive||10
87410|NCT01346176|208192|P2|NOT COMPLETED|Completed Advance Directive||14
87411|NCT01346176|208193|P1|NOT COMPLETED|Completed Advance Directive||13
87412|NCT01346176|208191|P3|COMPLETED|Completed Advance Directive||33
87413|NCT01346176|208192|P2|COMPLETED|Completed Advance Directive||26
87414|NCT01346176|208193|P1|COMPLETED|Completed Advance Directive||35
87415|NCT01346176|208191|P3|STARTED|Completed Advance Directive||43
87416|NCT01346176|208192|P2|STARTED|Completed Advance Directive||40
87417|NCT01346176|208193|P1|STARTED|Completed Advance Directive||48
87418|NCT01346176|208191|P3|NOT COMPLETED|Recruited||0
87419|NCT01346176|208192|P2|NOT COMPLETED|Recruited||0
87420|NCT01346176|208193|P1|NOT COMPLETED|Recruited||1
87421|NCT01346176|208191|P3|COMPLETED|Recruited||43
87422|NCT01346176|208192|P2|COMPLETED|Recruited||40
87423|NCT01346176|208193|P1|COMPLETED|Recruited||48
87424|NCT01346176|208191|P3|STARTED|Recruited||43
87425|NCT01346176|208192|P2|STARTED|Recruited||40
87426|NCT01346176|208193|P1|STARTED|Recruited||49
87427|NCT01346085|208204|P1|NOT COMPLETED|Overall Study||0
87428|NCT01346085|208204|P1|COMPLETED|Overall Study||10
87429|NCT01346085|208204|P1|STARTED|Overall Study||10
87430|NCT01346072|208211|P2|NOT COMPLETED|Overall Study||0
87431|NCT01346072|208212|P1|NOT COMPLETED|Overall Study||0
87432|NCT01346072|208211|P2|COMPLETED|Overall Study||10
87433|NCT01346072|208212|P1|COMPLETED|Overall Study||11
87434|NCT01346072|208211|P2|STARTED|Overall Study||10
87435|NCT01346072|208212|P1|STARTED|Overall Study||11
87436|NCT01346059|208222|P2|NOT COMPLETED|Overall Study||0
87437|NCT01346059|208223|P1|NOT COMPLETED|Overall Study||1
87438|NCT01346059|208222|P2|COMPLETED|Overall Study||1
87439|NCT01346059|208223|P1|COMPLETED|Overall Study||0
87440|NCT01346059|208222|P2|STARTED|Overall Study||1
87441|NCT01346059|208223|P1|STARTED|Overall Study||1
87442|NCT01345929|208235|P2|NOT COMPLETED|Overall Study||19
87443|NCT01345929|208236|P1|NOT COMPLETED|Overall Study||21
87444|NCT01345929|208235|P2|COMPLETED|Overall Study||516
87445|NCT01345929|208236|P1|COMPLETED|Overall Study||512
87446|NCT01345929|208235|P2|STARTED|Overall Study||535
87447|NCT01345929|208236|P1|STARTED|Overall Study||533
87448|NCT01345786|208248|P4|NOT COMPLETED|Overall Study||3
87449|NCT01345786|208249|P3|NOT COMPLETED|Overall Study||5
87450|NCT01345786|208250|P2|NOT COMPLETED|Overall Study||8
87451|NCT01345786|208251|P1|NOT COMPLETED|Overall Study||6
87452|NCT01345786|208248|P4|COMPLETED|Overall Study||35
87453|NCT01345786|208249|P3|COMPLETED|Overall Study||33
87454|NCT01345786|208250|P2|COMPLETED|Overall Study||33
87455|NCT01345786|208251|P1|COMPLETED|Overall Study||35
87456|NCT01345786|208248|P4|Treated|Overall Study||37
87457|NCT01345786|208249|P3|Treated|Overall Study||37
87458|NCT01345786|208250|P2|Treated|Overall Study||41
87459|NCT01345786|208251|P1|Treated|Overall Study||41
87460|NCT01345786|208248|P4|STARTED|Overall Study|Number randomized|38
87461|NCT01345786|208249|P3|STARTED|Overall Study|Number randomized|38
87462|NCT01345786|208250|P2|STARTED|Overall Study|Number randomized|41
87463|NCT01345786|208251|P1|STARTED|Overall Study|Number randomized|41
87464|NCT01345721|208300|P3|NOT COMPLETED|Overall Study||0
87465|NCT01345721|208301|P2|NOT COMPLETED|Overall Study||0
87466|NCT01345721|208302|P1|NOT COMPLETED|Overall Study||0
87467|NCT01345721|208300|P3|COMPLETED|Overall Study||65
87468|NCT01345721|208301|P2|COMPLETED|Overall Study||66
87469|NCT01345721|208302|P1|COMPLETED|Overall Study||74
87470|NCT01345721|208300|P3|STARTED|Overall Study||65
87471|NCT01345721|208301|P2|STARTED|Overall Study||66
87472|NCT01345721|208302|P1|STARTED|Overall Study||74
87473|NCT01345682|208331|P2|NOT COMPLETED|Overall Study||157
87474|NCT01345682|208332|P1|NOT COMPLETED|Overall Study||306
87475|NCT01345682|208331|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|4
87476|NCT01345682|208332|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (07May2014)|16
87477|NCT01345682|208331|P2|STARTED|Overall Study|Randomised|161
87478|NCT01345682|208332|P1|STARTED|Overall Study|Randomised|322
87479|NCT01345630|208366|P2|NOT COMPLETED|Overall Study||359
87480|NCT01345630|208367|P1|NOT COMPLETED|Overall Study||361
87481|NCT01345630|208366|P2|COMPLETED|Overall Study||42
87482|NCT01345630|208367|P1|COMPLETED|Overall Study||35
87483|NCT01345630|208366|P2|STARTED|Overall Study||401
87484|NCT01345630|208367|P1|STARTED|Overall Study||396
87485|NCT01345591|208423|P1|NOT COMPLETED|Overall Study||1
87486|NCT01345591|208423|P1|COMPLETED|Overall Study||19
87487|NCT01345591|208423|P1|STARTED|Overall Study||20
87488|NCT01345318|208432|P1|NOT COMPLETED|Overall Study||80
87489|NCT01345318|208432|P1|COMPLETED|Overall Study||111
87490|NCT01345318|208432|P1|STARTED|Overall Study||191
87491|NCT01345292|208440|P3|NOT COMPLETED|Overall Study||1
87492|NCT01345292|208441|P2|NOT COMPLETED|Overall Study||0
87493|NCT01345292|208442|P1|NOT COMPLETED|Overall Study||2
87494|NCT01345292|208440|P3|COMPLETED|Overall Study||74
87495|NCT01345292|208441|P2|COMPLETED|Overall Study||76
87496|NCT01345292|208442|P1|COMPLETED|Overall Study||73
87497|NCT01345292|208440|P3|STARTED|Overall Study||75
87498|NCT01345292|208441|P2|STARTED|Overall Study||76
87499|NCT01345292|208442|P1|STARTED|Overall Study||75
87500|NCT01345253|208473|P2|NOT COMPLETED|Overall Study||79
87501|NCT01345253|208474|P1|NOT COMPLETED|Overall Study||56
87502|NCT01345253|208473|P2|COMPLETED|Overall Study||372
87503|NCT01345253|208474|P1|COMPLETED|Overall Study||170
87504|NCT01345253|208473|P2|STARTED|Overall Study||451
87505|NCT01345253|208474|P1|STARTED|Overall Study||226
87506|NCT01345240|208493|P5|NOT COMPLETED|Overall Study||7
87507|NCT01345240|208494|P4|NOT COMPLETED|Overall Study||10
87508|NCT01345240|208495|P3|NOT COMPLETED|Overall Study||10
87509|NCT01345240|208496|P2|NOT COMPLETED|Overall Study||14
87510|NCT01345240|208497|P1|NOT COMPLETED|Overall Study||2
87511|NCT01345240|208493|P5|COMPLETED|Overall Study||132
87512|NCT01345240|208494|P4|COMPLETED|Overall Study||131
87513|NCT01345240|208495|P3|COMPLETED|Overall Study||131
87514|NCT01345240|208496|P2|COMPLETED|Overall Study||128
87515|NCT01345240|208497|P1|COMPLETED|Overall Study||140
87516|NCT01345240|208493|P5|STARTED|Overall Study||139
87517|NCT01345240|208494|P4|STARTED|Overall Study||141
87518|NCT01345240|208495|P3|STARTED|Overall Study||141
87519|NCT01345240|208496|P2|STARTED|Overall Study||142
87520|NCT01345240|208497|P1|STARTED|Overall Study||142
87521|NCT01345162|208592|P2|NOT COMPLETED|Overall Study||4
87522|NCT01345162|208593|P1|NOT COMPLETED|Overall Study||2
87523|NCT01345162|208592|P2|COMPLETED|Overall Study||96
87524|NCT01345162|208593|P1|COMPLETED|Overall Study||98
87525|NCT01345162|208592|P2|STARTED|Overall Study||100
87526|NCT01345162|208593|P1|STARTED|Overall Study||100
87527|NCT01345123|208602|P3|NOT COMPLETED|Overall Study||88
87528|NCT01345123|208603|P2|NOT COMPLETED|Overall Study||85
87529|NCT01345123|208604|P1|NOT COMPLETED|Overall Study||79
87530|NCT01345123|208602|P3|COMPLETED|Overall Study|3291 - 88 study participants who were no longer health plan eligible members (zero eligible months)|3203
87531|NCT01345123|208603|P2|COMPLETED|Overall Study|3311 - 85 study participants who were no longer health plan eligible members (zero eligible months)|3226
87532|NCT01345123|208604|P1|COMPLETED|Overall Study|3323 - 79 study participants who were no longer health plan eligible members (zero eligible months)|3244
87533|NCT01345123|208602|P3|STARTED|Overall Study||3291
87534|NCT01345123|208603|P2|STARTED|Overall Study||3311
87535|NCT01345123|208604|P1|STARTED|Overall Study||3323
87536|NCT01345058|208626|P2|NOT COMPLETED|Overall Study||0
87537|NCT01345058|208627|P1|NOT COMPLETED|Overall Study||5
87538|NCT01345058|208626|P2|COMPLETED|Overall Study||36
87539|NCT01345058|208627|P1|COMPLETED|Overall Study||15
87540|NCT01345058|208626|P2|Received Lacosamide|Overall Study||0
87541|NCT01345058|208627|P1|Received Lacosamide|Overall Study||19
87542|NCT01345058|208626|P2|STARTED|Overall Study||36
87543|NCT01345058|208627|P1|STARTED|Overall Study||20
87544|NCT01344876|208641|P5|NOT COMPLETED|Overall Study||1
87545|NCT01344876|208642|P4|NOT COMPLETED|Overall Study||3
87546|NCT01344876|208643|P3|NOT COMPLETED|Overall Study||1
87547|NCT01344876|208644|P2|NOT COMPLETED|Overall Study||0
87548|NCT01344876|208645|P1|NOT COMPLETED|Overall Study||1
87549|NCT01344876|208641|P5|COMPLETED|Overall Study||2
87550|NCT01344876|208642|P4|COMPLETED|Overall Study||3
87551|NCT01344876|208643|P3|COMPLETED|Overall Study||3
87552|NCT01344876|208644|P2|COMPLETED|Overall Study||3
87553|NCT01344876|208645|P1|COMPLETED|Overall Study||3
87554|NCT01344876|208641|P5|STARTED|Overall Study||3
87555|NCT01344876|208642|P4|STARTED|Overall Study||6
87556|NCT01344876|208643|P3|STARTED|Overall Study||4
87557|NCT01344876|208644|P2|STARTED|Overall Study||3
87558|NCT01344876|208645|P1|STARTED|Overall Study||4
87559|NCT01344824|208659|P1|NOT COMPLETED|Overall Study||37
87560|NCT01344824|208659|P1|COMPLETED|Overall Study||1
87561|NCT01344824|208659|P1|STARTED|Overall Study||38
87562|NCT01344759|208667|P2|NOT COMPLETED|Overall Study||2
87563|NCT01344759|208668|P1|NOT COMPLETED|Overall Study||0
87564|NCT01344759|208667|P2|COMPLETED|Overall Study|Two of the original DEX group subjects were removed, due to receiving dexmedetomidine and propofol.|28
87565|NCT01344759|208668|P1|COMPLETED|Overall Study||30
87566|NCT01344759|208667|P2|STARTED|Overall Study||30
87567|NCT01344759|208668|P1|STARTED|Overall Study||30
87568|NCT01344629|208700|P2|NOT COMPLETED|Crossover Period 4||0
87569|NCT01344629|208701|P1|NOT COMPLETED|Crossover Period 4||0
87570|NCT01344629|208700|P2|COMPLETED|Crossover Period 4||31
87571|NCT01344629|208701|P1|COMPLETED|Crossover Period 4||32
87572|NCT01344629|208700|P2|STARTED|Crossover Period 4||31
87573|NCT01344629|208701|P1|STARTED|Crossover Period 4||32
87574|NCT01344629|208700|P2|NOT COMPLETED|Crossover Period 3||0
87575|NCT01344629|208701|P1|NOT COMPLETED|Crossover Period 3||0
87576|NCT01344629|208700|P2|COMPLETED|Crossover Period 3||31
87577|NCT01344629|208701|P1|COMPLETED|Crossover Period 3||32
87578|NCT01344629|208700|P2|STARTED|Crossover Period 3||31
87579|NCT01344629|208701|P1|STARTED|Crossover Period 3||32
87580|NCT01344629|208700|P2|NOT COMPLETED|Crossover Period 2||1
87581|NCT01344629|208701|P1|NOT COMPLETED|Crossover Period 2||0
87582|NCT01344629|208700|P2|COMPLETED|Crossover Period 2||31
87583|NCT01344629|208701|P1|COMPLETED|Crossover Period 2||32
87584|NCT01344629|208700|P2|STARTED|Crossover Period 2||32
87585|NCT01344629|208701|P1|STARTED|Crossover Period 2||32
87586|NCT01344629|208700|P2|NOT COMPLETED|Crossover Period 1||0
87587|NCT01344629|208701|P1|NOT COMPLETED|Crossover Period 1||0
87588|NCT01344629|208700|P2|COMPLETED|Crossover Period 1||32
87589|NCT01344629|208701|P1|COMPLETED|Crossover Period 1||32
87590|NCT01344629|208700|P2|STARTED|Crossover Period 1||32
87591|NCT01344629|208701|P1|STARTED|Crossover Period 1||32
87592|NCT01344616|208721|P2|NOT COMPLETED|Overall Study||44
87593|NCT01344616|208722|P1|NOT COMPLETED|Overall Study||35
87594|NCT01344616|208721|P2|COMPLETED|Overall Study||194
87595|NCT01344616|208722|P1|COMPLETED|Overall Study||209
87596|NCT01344616|208721|P2|STARTED|Overall Study||238
87597|NCT01344616|208722|P1|STARTED|Overall Study||244
87598|NCT01344538|208730|P2|NOT COMPLETED|Overall Study||1
87599|NCT01344538|208731|P1|NOT COMPLETED|Overall Study||2
87600|NCT01344538|208730|P2|COMPLETED|Overall Study||16
87601|NCT01344538|208731|P1|COMPLETED|Overall Study||14
87602|NCT01344538|208730|P2|STARTED|Overall Study||17
87603|NCT01344538|208731|P1|STARTED|Overall Study||16
87604|NCT01344460|208737|P1|NOT COMPLETED|Overall Study||3
87605|NCT01344460|208737|P1|COMPLETED|Overall Study||312
87606|NCT01344460|208737|P1|Fulfilled Requirements of FAS Population|Overall Study|Full analysis set (FAS)|292
87607|NCT01344460|208737|P1|STARTED|Overall Study|Participants received study drug; Safety analysis set|315
87608|NCT01344447|208782|P1|NOT COMPLETED|Overall Study||8
87609|NCT01344447|208782|P1|COMPLETED|Overall Study||471
87610|NCT01344447|208782|P1|Fulfilled Requirement of FAS Population|Overall Study|Full Analysis Set (FAS)|457
87611|NCT01344447|208782|P1|STARTED|Overall Study|Participant received study drug; Safety analysis set|479
87612|NCT01344369|208826|P2|NOT COMPLETED|Second Intervention||1
87613|NCT01344369|208827|P1|NOT COMPLETED|Second Intervention||0
87614|NCT01344369|208826|P2|COMPLETED|Second Intervention||16
87615|NCT01344369|208827|P1|COMPLETED|Second Intervention||17
87616|NCT01344369|208826|P2|STARTED|Second Intervention||17
87617|NCT01344369|208827|P1|STARTED|Second Intervention||17
87618|NCT01344369|208826|P2|NOT COMPLETED|Washout of 28 Days||1
87619|NCT01344369|208827|P1|NOT COMPLETED|Washout of 28 Days||1
87620|NCT01344369|208826|P2|COMPLETED|Washout of 28 Days||17
87621|NCT01344369|208827|P1|COMPLETED|Washout of 28 Days||17
87622|NCT01344369|208826|P2|STARTED|Washout of 28 Days||18
87623|NCT01344369|208827|P1|STARTED|Washout of 28 Days||18
87624|NCT01344369|208826|P2|NOT COMPLETED|First Intervention||0
87625|NCT01344369|208827|P1|NOT COMPLETED|First Intervention||0
87626|NCT01344369|208826|P2|COMPLETED|First Intervention||18
87627|NCT01344369|208827|P1|COMPLETED|First Intervention||18
87628|NCT01344369|208826|P2|STARTED|First Intervention||18
87629|NCT01344369|208827|P1|STARTED|First Intervention||18
87630|NCT01344161|208845|P2|NOT COMPLETED|Overall Study||3
87631|NCT01344161|208846|P1|NOT COMPLETED|Overall Study||5
87632|NCT01344161|208845|P2|COMPLETED|Overall Study||39
87633|NCT01344161|208846|P1|COMPLETED|Overall Study||38
87634|NCT01344161|208845|P2|STARTED|Overall Study||42
87635|NCT01344161|208846|P1|STARTED|Overall Study||43
87636|NCT01344057|208858|P1|NOT COMPLETED|Overall Study||1
87637|NCT01344057|208858|P1|COMPLETED|Overall Study||62
87638|NCT01344057|208858|P1|STARTED|Overall Study||63
87639|NCT01343901|208865|P1|NOT COMPLETED|Overall Study||113
87640|NCT01343901|208865|P1|COMPLETED|Overall Study||97
87641|NCT01343901|208865|P1|Efficacy Population|Overall Study||205
87642|NCT01343901|208865|P1|STARTED|Overall Study||210
87643|NCT01343888|208889|P3|NOT COMPLETED|Overall Study||22
87644|NCT01343888|208890|P2|NOT COMPLETED|Overall Study||39
87645|NCT01343888|208891|P1|NOT COMPLETED|Overall Study||25
87646|NCT01343888|208889|P3|COMPLETED|Overall Study||110
87647|NCT01343888|208890|P2|COMPLETED|Overall Study||222
87648|NCT01343888|208891|P1|COMPLETED|Overall Study||234
87649|NCT01343888|208889|P3|STARTED|Overall Study|133 subject randomized; 132 subjects treated with at least one dose; 1 subject was not treated|132
87742|NCT01342965|209123|P1|STARTED|Overall Study||110
87650|NCT01343888|208890|P2|STARTED|Overall Study|262 subject randomized; 261 subjects treated with at least one dose; 1 subject was not treated|261
87651|NCT01343888|208891|P1|STARTED|Overall Study|261 subject randomized; 259 subjects treated with at least one dose; 2 subjects were not treated|259
87652|NCT01343823|208933|P4|NOT COMPLETED|Overall Study||1
87653|NCT01343823|208934|P3|NOT COMPLETED|Overall Study||0
87654|NCT01343823|208935|P2|NOT COMPLETED|Overall Study||0
87655|NCT01343823|208936|P1|NOT COMPLETED|Overall Study||2
87656|NCT01343823|208933|P4|COMPLETED|Overall Study||19
87657|NCT01343823|208934|P3|COMPLETED|Overall Study||19
87658|NCT01343823|208935|P2|COMPLETED|Overall Study||20
87659|NCT01343823|208936|P1|COMPLETED|Overall Study||18
87660|NCT01343823|208933|P4|STARTED|Overall Study||20
87661|NCT01343823|208934|P3|STARTED|Overall Study||19
87662|NCT01343823|208935|P2|STARTED|Overall Study||20
87663|NCT01343823|208936|P1|STARTED|Overall Study||20
87664|NCT01343667|208952|P2|NOT COMPLETED|Overall Study||56
87665|NCT01343667|208953|P1|NOT COMPLETED|Overall Study||12
87666|NCT01343667|208952|P2|COMPLETED|Overall Study||916
87667|NCT01343667|208953|P1|COMPLETED|Overall Study||413
87668|NCT01343667|208952|P2|STARTED|Overall Study||972
87669|NCT01343667|208953|P1|STARTED|Overall Study||425
87670|NCT01343485|208961|P2|NOT COMPLETED|Overall Study||134
87671|NCT01343485|208962|P1|NOT COMPLETED|Overall Study||149
87672|NCT01343485|208961|P2|COMPLETED|Overall Study||46
87673|NCT01343485|208962|P1|COMPLETED|Overall Study||36
87674|NCT01343485|208961|P2|STARTED|Overall Study||180
87675|NCT01343485|208962|P1|STARTED|Overall Study||185
87676|NCT01343368|208970|P2|NOT COMPLETED|Overall Study||0
87677|NCT01343368|208971|P1|NOT COMPLETED|Overall Study||2
87678|NCT01343368|208970|P2|COMPLETED|Overall Study||10
87679|NCT01343368|208971|P1|COMPLETED|Overall Study||7
87680|NCT01343368|208970|P2|STARTED|Overall Study||10
87681|NCT01343368|208971|P1|STARTED|Overall Study||9
87682|NCT01343277|209007|P2|NOT COMPLETED|Overall Study||193
87683|NCT01343277|209008|P1|NOT COMPLETED|Overall Study||384
87684|NCT01343277|209007|P2|COMPLETED|Overall Study||0
87685|NCT01343277|209008|P1|COMPLETED|Overall Study||0
87686|NCT01343277|209007|P2|Treated|Overall Study||172
87687|NCT01343277|209008|P1|Treated|Overall Study||378
87688|NCT01343277|209007|P2|STARTED|Overall Study||193
87689|NCT01343277|209008|P1|STARTED|Overall Study||384
87690|NCT01343251|209026|P2|NOT COMPLETED|Overall Study||0
87691|NCT01343251|209027|P1|NOT COMPLETED|Overall Study||0
87692|NCT01343251|209026|P2|COMPLETED|Overall Study||17
87693|NCT01343251|209027|P1|COMPLETED|Overall Study||16
87694|NCT01343251|209026|P2|STARTED|Overall Study||17
87695|NCT01343251|209027|P1|STARTED|Overall Study||16
87696|NCT01343082|209041|P3|NOT COMPLETED|Treatment Period , Switched to DE-111||12
87697|NCT01343082|209042|P2|NOT COMPLETED|Treatment Period , Switched to DE-111||9
87698|NCT01343082|209043|P1|NOT COMPLETED|Treatment Period , Switched to DE-111||5
87699|NCT01343082|209041|P3|COMPLETED|Treatment Period , Switched to DE-111||31
87700|NCT01343082|209042|P2|COMPLETED|Treatment Period , Switched to DE-111||36
87701|NCT01343082|209043|P1|COMPLETED|Treatment Period , Switched to DE-111||43
87702|NCT01343082|209041|P3|STARTED|Treatment Period , Switched to DE-111||43
87703|NCT01343082|209042|P2|STARTED|Treatment Period , Switched to DE-111||45
87704|NCT01343082|209043|P1|STARTED|Treatment Period , Switched to DE-111||48
87705|NCT01343082|209041|P3|NOT COMPLETED|The run-in Period||5
87706|NCT01343082|209042|P2|NOT COMPLETED|The run-in Period||4
87707|NCT01343082|209043|P1|NOT COMPLETED|The run-in Period||3
87708|NCT01343082|209041|P3|COMPLETED|The run-in Period||43
87709|NCT01343082|209042|P2|COMPLETED|The run-in Period||45
87710|NCT01343082|209043|P1|COMPLETED|The run-in Period||48
87711|NCT01343082|209041|P3|STARTED|The run-in Period||48
87712|NCT01343082|209042|P2|STARTED|The run-in Period||49
87713|NCT01343082|209043|P1|STARTED|The run-in Period||51
87714|NCT01343056|209051|P4|NOT COMPLETED|Overall Study||9
87715|NCT01343056|209052|P3|NOT COMPLETED|Overall Study||3
87716|NCT01343056|209053|P2|NOT COMPLETED|Overall Study||5
87717|NCT01343056|209054|P1|NOT COMPLETED|Overall Study||7
87718|NCT01343056|209051|P4|COMPLETED|Overall Study||29
87719|NCT01343056|209052|P3|COMPLETED|Overall Study||29
87720|NCT01343056|209053|P2|COMPLETED|Overall Study||31
87721|NCT01343056|209054|P1|COMPLETED|Overall Study||28
87722|NCT01343056|209051|P4|STARTED|Overall Study||38
87723|NCT01343056|209052|P3|STARTED|Overall Study||32
87724|NCT01343056|209053|P2|STARTED|Overall Study||36
87725|NCT01343056|209054|P1|STARTED|Overall Study||35
87726|NCT01343004|209095|P3|NOT COMPLETED|Overall Study||160
87727|NCT01343004|209096|P2|NOT COMPLETED|Overall Study||218
87728|NCT01343004|209097|P1|NOT COMPLETED|Overall Study||184
87729|NCT01343004|209095|P3|COMPLETED|Overall Study||658
87730|NCT01343004|209096|P2|COMPLETED|Overall Study||606
87731|NCT01343004|209097|P1|COMPLETED|Overall Study||637
87732|NCT01343004|209095|P3|STARTED|Overall Study||818
87733|NCT01343004|209096|P2|STARTED|Overall Study||824
87734|NCT01343004|209097|P1|STARTED|Overall Study||821
87735|NCT01342965|209122|P2|NOT COMPLETED|Overall Study||107
87736|NCT01342965|209123|P1|NOT COMPLETED|Overall Study||109
87737|NCT01342965|209122|P2|COMPLETED|Overall Study||0
87738|NCT01342965|209123|P1|COMPLETED|Overall Study||1
87739|NCT01342965|209122|P2|Received Treatment|Overall Study||104
87740|NCT01342965|209123|P1|Received Treatment|Overall Study||110
87741|NCT01342965|209122|P2|STARTED|Overall Study||107
87743|NCT01342926|209141|P4|NOT COMPLETED|Overall Study||12
87744|NCT01342926|209142|P3|NOT COMPLETED|Overall Study||14
87745|NCT01342926|209143|P2|NOT COMPLETED|Overall Study||15
87746|NCT01342926|209144|P1|NOT COMPLETED|Overall Study||9
87747|NCT01342926|209141|P4|COMPLETED|Overall Study||39
87748|NCT01342926|209142|P3|COMPLETED|Overall Study||34
87749|NCT01342926|209143|P2|COMPLETED|Overall Study||31
87750|NCT01342926|209144|P1|COMPLETED|Overall Study||37
87751|NCT01342926|209141|P4|STARTED|Overall Study||51
87752|NCT01342926|209142|P3|STARTED|Overall Study||48
87753|NCT01342926|209143|P2|STARTED|Overall Study||46
87754|NCT01342926|209144|P1|STARTED|Overall Study||46
87755|NCT01342913|209224|P3|NOT COMPLETED|Double-Blind Treatment Period||23
87756|NCT01342913|209225|P2|NOT COMPLETED|Double-Blind Treatment Period||16
87757|NCT01342913|209226|P1|NOT COMPLETED|Double-Blind Treatment Period||0
87758|NCT01342913|209224|P3|COMPLETED|Double-Blind Treatment Period||243
87759|NCT01342913|209225|P2|COMPLETED|Double-Blind Treatment Period||246
87760|NCT01342913|209226|P1|COMPLETED|Double-Blind Treatment Period||0
87761|NCT01342913|209224|P3|STARTED|Double-Blind Treatment Period||266
87762|NCT01342913|209225|P2|STARTED|Double-Blind Treatment Period||262
87763|NCT01342913|209226|P1|STARTED|Double-Blind Treatment Period||0
87764|NCT01342913|209224|P3|NOT COMPLETED|2-week Run-in Period||0
87765|NCT01342913|209225|P2|NOT COMPLETED|2-week Run-in Period||0
87766|NCT01342913|209226|P1|NOT COMPLETED|2-week Run-in Period||174
87767|NCT01342913|209224|P3|COMPLETED|2-week Run-in Period||0
87768|NCT01342913|209225|P2|COMPLETED|2-week Run-in Period||0
87769|NCT01342913|209226|P1|COMPLETED|2-week Run-in Period||528
87770|NCT01342913|209224|P3|STARTED|2-week Run-in Period||0
87771|NCT01342913|209225|P2|STARTED|2-week Run-in Period||0
87772|NCT01342913|209226|P1|STARTED|2-week Run-in Period||702
87773|NCT01342887|209236|P1|NOT COMPLETED|Overall Study||2
87774|NCT01342887|209236|P1|COMPLETED|Overall Study||4
87775|NCT01342887|209236|P1|STARTED|Overall Study||6
87776|NCT01342770|209243|P1|NOT COMPLETED|Overall Study||0
87777|NCT01342770|209243|P1|COMPLETED|Overall Study||6
87778|NCT01342770|209243|P1|STARTED|Overall Study||6
87779|NCT01342757|209256|P1|NOT COMPLETED|Overall Study||0
87780|NCT01342757|209256|P1|COMPLETED|Overall Study||12
87781|NCT01342757|209256|P1|STARTED|Overall Study||12
87782|NCT01342666|209263|P2|NOT COMPLETED|Overall Study||0
87783|NCT01342666|209264|P1|NOT COMPLETED|Overall Study||0
87784|NCT01342666|209263|P2|COMPLETED|Overall Study||24
87785|NCT01342666|209264|P1|COMPLETED|Overall Study||26
87786|NCT01342666|209263|P2|STARTED|Overall Study||24
87787|NCT01342666|209264|P1|STARTED|Overall Study||26
87788|NCT01342640|209270|P1|NOT COMPLETED|Overall Study||41
87789|NCT01342640|209270|P1|COMPLETED|Overall Study||29
87790|NCT01342640|209270|P1|STARTED|Overall Study||70
87791|NCT01342549|209278|P2|NOT COMPLETED|Overall Study||0
87792|NCT01342549|209279|P1|NOT COMPLETED|Overall Study||0
87793|NCT01342549|209278|P2|COMPLETED|Overall Study||31
87794|NCT01342549|209279|P1|COMPLETED|Overall Study||31
87795|NCT01342549|209278|P2|STARTED|Overall Study||31
87796|NCT01342549|209279|P1|STARTED|Overall Study||31
87797|NCT01342523|209317|P32|NOT COMPLETED|Overall Study||1
87798|NCT01342523|209318|P31|NOT COMPLETED|Overall Study||1
87799|NCT01342523|209319|P30|NOT COMPLETED|Overall Study||1
87800|NCT01342523|209320|P29|NOT COMPLETED|Overall Study||1
87801|NCT01342523|209321|P28|NOT COMPLETED|Overall Study||1
87802|NCT01342523|209322|P27|NOT COMPLETED|Overall Study||1
87803|NCT01342523|209323|P26|NOT COMPLETED|Overall Study||2
87804|NCT01342523|209324|P25|NOT COMPLETED|Overall Study||1
87805|NCT01342523|209325|P24|NOT COMPLETED|Overall Study||1
87806|NCT01342523|209326|P23|NOT COMPLETED|Overall Study||0
87807|NCT01342523|209327|P22|NOT COMPLETED|Overall Study||0
87808|NCT01342523|209328|P21|NOT COMPLETED|Overall Study||0
87809|NCT01342523|209329|P20|NOT COMPLETED|Overall Study||0
87810|NCT01342523|209330|P19|NOT COMPLETED|Overall Study||0
87811|NCT01342523|209331|P18|NOT COMPLETED|Overall Study||0
87812|NCT01342523|209332|P17|NOT COMPLETED|Overall Study||1
87813|NCT01342523|209333|P16|NOT COMPLETED|Overall Study||0
87814|NCT01342523|209334|P15|NOT COMPLETED|Overall Study||1
87815|NCT01342523|209335|P14|NOT COMPLETED|Overall Study||2
87816|NCT01342523|209336|P13|NOT COMPLETED|Overall Study||0
87817|NCT01342523|209337|P12|NOT COMPLETED|Overall Study||2
87818|NCT01342523|209338|P11|NOT COMPLETED|Overall Study||0
87819|NCT01342523|209339|P10|NOT COMPLETED|Overall Study||0
87820|NCT01342523|209340|P9|NOT COMPLETED|Overall Study||0
87821|NCT01342523|209341|P8|NOT COMPLETED|Overall Study||0
87822|NCT01342523|209342|P7|NOT COMPLETED|Overall Study||0
87823|NCT01342523|209343|P6|NOT COMPLETED|Overall Study||0
87824|NCT01342523|209344|P5|NOT COMPLETED|Overall Study||0
87825|NCT01342523|209345|P4|NOT COMPLETED|Overall Study||1
87826|NCT01342523|209346|P3|NOT COMPLETED|Overall Study||0
87827|NCT01342523|209347|P2|NOT COMPLETED|Overall Study||0
87828|NCT01342523|209348|P1|NOT COMPLETED|Overall Study||1
87829|NCT01342523|209317|P32|COMPLETED|Overall Study||27
87830|NCT01342523|209318|P31|COMPLETED|Overall Study||30
87831|NCT01342523|209319|P30|COMPLETED|Overall Study||28
87832|NCT01342523|209320|P29|COMPLETED|Overall Study||34
87833|NCT01342523|209321|P28|COMPLETED|Overall Study||30
87834|NCT01342523|209322|P27|COMPLETED|Overall Study||33
87835|NCT01342523|209323|P26|COMPLETED|Overall Study||36
87836|NCT01342523|209324|P25|COMPLETED|Overall Study||36
87837|NCT01342523|209325|P24|COMPLETED|Overall Study||35
87838|NCT01342523|209326|P23|COMPLETED|Overall Study||36
87839|NCT01342523|209327|P22|COMPLETED|Overall Study||30
87840|NCT01342523|209328|P21|COMPLETED|Overall Study||29
87841|NCT01342523|209329|P20|COMPLETED|Overall Study||27
87842|NCT01342523|209330|P19|COMPLETED|Overall Study||21
87843|NCT01342523|209331|P18|COMPLETED|Overall Study||27
87844|NCT01342523|209332|P17|COMPLETED|Overall Study||28
87845|NCT01342523|209333|P16|COMPLETED|Overall Study||32
87846|NCT01342523|209334|P15|COMPLETED|Overall Study||37
87847|NCT01342523|209335|P14|COMPLETED|Overall Study||36
87848|NCT01342523|209336|P13|COMPLETED|Overall Study||39
87849|NCT01342523|209337|P12|COMPLETED|Overall Study||36
87850|NCT01342523|209338|P11|COMPLETED|Overall Study||38
87851|NCT01342523|209339|P10|COMPLETED|Overall Study||28
87852|NCT01342523|209340|P9|COMPLETED|Overall Study||28
87853|NCT01342523|209341|P8|COMPLETED|Overall Study||27
87854|NCT01342523|209342|P7|COMPLETED|Overall Study||22
87855|NCT01342523|209343|P6|COMPLETED|Overall Study||36
87856|NCT01342523|209344|P5|COMPLETED|Overall Study||36
87857|NCT01342523|209345|P4|COMPLETED|Overall Study||32
87858|NCT01342523|209346|P3|COMPLETED|Overall Study||36
87859|NCT01342523|209347|P2|COMPLETED|Overall Study||32
87860|NCT01342523|209348|P1|COMPLETED|Overall Study||34
87861|NCT01342523|209317|P32|STARTED|Overall Study||28
87862|NCT01342523|209318|P31|STARTED|Overall Study||31
87863|NCT01342523|209319|P30|STARTED|Overall Study||29
87864|NCT01342523|209320|P29|STARTED|Overall Study||35
87865|NCT01342523|209321|P28|STARTED|Overall Study||31
87866|NCT01342523|209322|P27|STARTED|Overall Study||34
87867|NCT01342523|209323|P26|STARTED|Overall Study||38
87868|NCT01342523|209324|P25|STARTED|Overall Study||37
87869|NCT01342523|209325|P24|STARTED|Overall Study||36
87870|NCT01342523|209326|P23|STARTED|Overall Study||36
87871|NCT01342523|209327|P22|STARTED|Overall Study||30
87872|NCT01342523|209328|P21|STARTED|Overall Study||29
87873|NCT01342523|209329|P20|STARTED|Overall Study||27
87874|NCT01342523|209330|P19|STARTED|Overall Study||21
87875|NCT01342523|209331|P18|STARTED|Overall Study||27
87876|NCT01342523|209332|P17|STARTED|Overall Study||29
87877|NCT01342523|209333|P16|STARTED|Overall Study||32
87878|NCT01342523|209334|P15|STARTED|Overall Study||38
87879|NCT01342523|209335|P14|STARTED|Overall Study||38
87880|NCT01342523|209336|P13|STARTED|Overall Study||39
87881|NCT01342523|209337|P12|STARTED|Overall Study||38
87882|NCT01342523|209338|P11|STARTED|Overall Study||38
87883|NCT01342523|209339|P10|STARTED|Overall Study||28
87884|NCT01342523|209340|P9|STARTED|Overall Study||28
87885|NCT01342523|209341|P8|STARTED|Overall Study||27
87886|NCT01342523|209342|P7|STARTED|Overall Study||22
87887|NCT01342523|209343|P6|STARTED|Overall Study||36
87888|NCT01342523|209344|P5|STARTED|Overall Study||36
87889|NCT01342523|209345|P4|STARTED|Overall Study||33
87890|NCT01342523|209346|P3|STARTED|Overall Study||36
87891|NCT01342523|209347|P2|STARTED|Overall Study||32
87892|NCT01342523|209348|P1|STARTED|Overall Study||35
87893|NCT01342510|209365|P4|NOT COMPLETED|Overall Study||11
87894|NCT01342510|209366|P3|NOT COMPLETED|Overall Study||13
87895|NCT01342510|209367|P2|NOT COMPLETED|Overall Study||6
87896|NCT01342510|209368|P1|NOT COMPLETED|Overall Study||12
87897|NCT01342510|209365|P4|COMPLETED|Overall Study||39
87898|NCT01342510|209366|P3|COMPLETED|Overall Study||37
87899|NCT01342510|209367|P2|COMPLETED|Overall Study||44
87900|NCT01342510|209368|P1|COMPLETED|Overall Study||38
87901|NCT01342510|209365|P4|STARTED|Overall Study||50
87902|NCT01342510|209366|P3|STARTED|Overall Study||50
87903|NCT01342510|209367|P2|STARTED|Overall Study||50
87904|NCT01342510|209368|P1|STARTED|Overall Study||50
87905|NCT01342484|209381|P3|NOT COMPLETED|Overall Study||1
87906|NCT01342484|209382|P2|NOT COMPLETED|Overall Study||0
87907|NCT01342484|209383|P1|NOT COMPLETED|Overall Study||2
87908|NCT01342484|209381|P3|COMPLETED|Overall Study||13
87909|NCT01342484|209382|P2|COMPLETED|Overall Study||10
87910|NCT01342484|209383|P1|COMPLETED|Overall Study||13
87911|NCT01342484|209381|P3|STARTED|Overall Study||14
87912|NCT01342484|209382|P2|STARTED|Overall Study||10
87913|NCT01342484|209383|P1|STARTED|Overall Study||15
87914|NCT01342471|209399|P2|NOT COMPLETED|Overall Study||6
87915|NCT01342471|209400|P1|NOT COMPLETED|Overall Study||5
87916|NCT01342471|209399|P2|COMPLETED|Overall Study||23
87917|NCT01342471|209400|P1|COMPLETED|Overall Study||24
87918|NCT01342471|209399|P2|STARTED|Overall Study||29
87919|NCT01342471|209400|P1|STARTED|Overall Study||29
87920|NCT01342458|209416|P2|NOT COMPLETED|Overall Study||4
87921|NCT01342458|209417|P1|NOT COMPLETED|Overall Study||2
87922|NCT01342458|209416|P2|COMPLETED|Overall Study||24
87923|NCT01342458|209417|P1|COMPLETED|Overall Study||26
87924|NCT01342458|209416|P2|STARTED|Overall Study||28
87925|NCT01342458|209417|P1|STARTED|Overall Study||28
87926|NCT01342445|209439|P2|NOT COMPLETED|Overall Study||2
87927|NCT01342445|209440|P1|NOT COMPLETED|Overall Study||0
87928|NCT01342445|209439|P2|COMPLETED|Overall Study||22
87929|NCT01342445|209440|P1|COMPLETED|Overall Study||26
87930|NCT01342445|209439|P2|STARTED|Overall Study||24
87931|NCT01342445|209440|P1|STARTED|Overall Study||26
87932|NCT01342341|209456|P2|NOT COMPLETED|Overall Study||4
87933|NCT01342341|209457|P1|NOT COMPLETED|Overall Study||4
87934|NCT01342341|209456|P2|COMPLETED|Overall Study||20
87935|NCT01342341|209457|P1|COMPLETED|Overall Study||20
87936|NCT01342341|209456|P2|STARTED|Overall Study||24
87937|NCT01342341|209457|P1|STARTED|Overall Study||24
87938|NCT01342172|209463|P1|NOT COMPLETED|Overall Study||0
87939|NCT01342172|209463|P1|COMPLETED|Overall Study||9
87940|NCT01342172|209463|P1|STARTED|Overall Study||9
87941|NCT01342107|209469|P2|NOT COMPLETED|Overall Study||0
87942|NCT01342107|209470|P1|NOT COMPLETED|Overall Study||0
87943|NCT01342107|209469|P2|COMPLETED|Overall Study||32
87944|NCT01342107|209470|P1|COMPLETED|Overall Study||34
87945|NCT01342107|209469|P2|STARTED|Overall Study||32
87946|NCT01342107|209470|P1|STARTED|Overall Study||34
87947|NCT01342094|209478|P2|NOT COMPLETED|Overall Study||3
87948|NCT01342094|209479|P1|NOT COMPLETED|Overall Study||5
87949|NCT01342094|209478|P2|COMPLETED|Overall Study||81
87950|NCT01342094|209479|P1|COMPLETED|Overall Study||77
87951|NCT01342094|209478|P2|STARTED|Overall Study||84
87952|NCT01342094|209479|P1|STARTED|Overall Study||82
87953|NCT01342081|209488|P3|NOT COMPLETED|Overall Study||1
87954|NCT01342081|209489|P2|NOT COMPLETED|Overall Study||2
87955|NCT01342081|209490|P1|NOT COMPLETED|Overall Study||2
87956|NCT01342081|209488|P3|COMPLETED|Overall Study||163
87957|NCT01342081|209489|P2|COMPLETED|Overall Study||162
87958|NCT01342081|209490|P1|COMPLETED|Overall Study||159
87959|NCT01342081|209488|P3|STARTED|Overall Study||164
87960|NCT01342081|209489|P2|STARTED|Overall Study||164
87961|NCT01342081|209490|P1|STARTED|Overall Study||161
87962|NCT01341990|209500|P2|NOT COMPLETED|Overall Study||1
87963|NCT01341990|209501|P1|NOT COMPLETED|Overall Study||3
87964|NCT01341990|209500|P2|COMPLETED|Overall Study||32
87965|NCT01341990|209501|P1|COMPLETED|Overall Study||32
87966|NCT01341990|209500|P2|STARTED|Overall Study||33
87967|NCT01341990|209501|P1|STARTED|Overall Study||35
87968|NCT01341977|209511|P2|NOT COMPLETED|Overall Study||15
87969|NCT01341977|209512|P1|NOT COMPLETED|Overall Study||14
87970|NCT01341977|209511|P2|COMPLETED|Overall Study||270
87971|NCT01341977|209512|P1|COMPLETED|Overall Study||274
87972|NCT01341977|209511|P2|STARTED|Overall Study||285
87973|NCT01341977|209512|P1|STARTED|Overall Study||288
87974|NCT01341912|209518|P1|NOT COMPLETED|Overall Study||0
87975|NCT01341912|209518|P1|COMPLETED|Overall Study||3
87976|NCT01341912|209518|P1|STARTED|Overall Study||3
87977|NCT01341782|209525|P2|NOT COMPLETED|Overall Study||14
87978|NCT01341782|209526|P1|NOT COMPLETED|Overall Study||15
87979|NCT01341782|209525|P2|COMPLETED|Overall Study||114
87980|NCT01341782|209526|P1|COMPLETED|Overall Study||112
87981|NCT01341782|209525|P2|STARTED|Overall Study||128
87982|NCT01341782|209526|P1|STARTED|Overall Study||127
87983|NCT01341600|209545|P3|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
87984|NCT01341600|209546|P2|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
87985|NCT01341600|209547|P1|NOT COMPLETED|Clopidogrel Plus Omeprazole||0
87986|NCT01341600|209545|P3|COMPLETED|Clopidogrel Plus Omeprazole||4
87987|NCT01341600|209546|P2|COMPLETED|Clopidogrel Plus Omeprazole||5
87988|NCT01341600|209547|P1|COMPLETED|Clopidogrel Plus Omeprazole||5
87989|NCT01341600|209545|P3|STARTED|Clopidogrel Plus Omeprazole||4
87990|NCT01341600|209546|P2|STARTED|Clopidogrel Plus Omeprazole||5
87991|NCT01341600|209547|P1|STARTED|Clopidogrel Plus Omeprazole||5
87992|NCT01341600|209545|P3|NOT COMPLETED|Clopidogrel 225 mg||0
87993|NCT01341600|209546|P2|NOT COMPLETED|Clopidogrel 225 mg||0
87994|NCT01341600|209547|P1|NOT COMPLETED|Clopidogrel 225 mg||0
87995|NCT01341600|209545|P3|COMPLETED|Clopidogrel 225 mg||6
87996|NCT01341600|209546|P2|COMPLETED|Clopidogrel 225 mg||6
87997|NCT01341600|209547|P1|COMPLETED|Clopidogrel 225 mg||6
87998|NCT01341600|209545|P3|STARTED|Clopidogrel 225 mg||6
87999|NCT01341600|209546|P2|STARTED|Clopidogrel 225 mg||6
88000|NCT01341600|209547|P1|STARTED|Clopidogrel 225 mg||6
88001|NCT01341600|209545|P3|NOT COMPLETED|Clopidogrel 150 mg||0
88002|NCT01341600|209546|P2|NOT COMPLETED|Clopidogrel 150 mg||0
88003|NCT01341600|209547|P1|NOT COMPLETED|Clopidogrel 150 mg||0
88004|NCT01341600|209545|P3|COMPLETED|Clopidogrel 150 mg||6
88005|NCT01341600|209546|P2|COMPLETED|Clopidogrel 150 mg||6
88006|NCT01341600|209547|P1|COMPLETED|Clopidogrel 150 mg||6
88007|NCT01341600|209545|P3|STARTED|Clopidogrel 150 mg||6
88008|NCT01341600|209546|P2|STARTED|Clopidogrel 150 mg||6
88009|NCT01341600|209547|P1|STARTED|Clopidogrel 150 mg||6
88010|NCT01341600|209545|P3|NOT COMPLETED|Clopidogrel 75 mg||0
88011|NCT01341600|209546|P2|NOT COMPLETED|Clopidogrel 75 mg||0
88012|NCT01341600|209547|P1|NOT COMPLETED|Clopidogrel 75 mg||0
88013|NCT01341600|209545|P3|COMPLETED|Clopidogrel 75 mg||6
88014|NCT01341600|209546|P2|COMPLETED|Clopidogrel 75 mg||6
88015|NCT01341600|209547|P1|COMPLETED|Clopidogrel 75 mg||6
88016|NCT01341600|209545|P3|STARTED|Clopidogrel 75 mg||6
88017|NCT01341600|209546|P2|STARTED|Clopidogrel 75 mg||6
88018|NCT01341600|209547|P1|STARTED|Clopidogrel 75 mg||6
88019|NCT01341444|209566|P2|NOT COMPLETED|Overall Study||3
88020|NCT01341444|209567|P1|NOT COMPLETED|Overall Study||5
88021|NCT01341444|209566|P2|COMPLETED|Overall Study||29
88022|NCT01341444|209567|P1|COMPLETED|Overall Study||26
88023|NCT01341444|209566|P2|STARTED|Overall Study||32
88024|NCT01341444|209567|P1|STARTED|Overall Study||31
88025|NCT01340144|209575|P2|NOT COMPLETED|Overall Study||58
88026|NCT01340144|209576|P1|NOT COMPLETED|Overall Study||72
88027|NCT01340144|209575|P2|COMPLETED|Overall Study||567
88028|NCT01340144|209576|P1|COMPLETED|Overall Study||553
88029|NCT01340144|209575|P2|STARTED|Overall Study||625
88030|NCT01340144|209576|P1|STARTED|Overall Study||625
88031|NCT01341067|209582|P1|NOT COMPLETED|Overall Study||4
88032|NCT01341067|209582|P1|COMPLETED|Overall Study||26
88033|NCT01341067|209582|P1|STARTED|Overall Study||30
88034|NCT01340937|209593|P4|NOT COMPLETED|Period 3: Toddler Vaccinations||10
88035|NCT01340937|209594|P3|NOT COMPLETED|Period 3: Toddler Vaccinations||9
88036|NCT01340937|209595|P2|NOT COMPLETED|Period 3: Toddler Vaccinations||17
88037|NCT01340937|209596|P1|NOT COMPLETED|Period 3: Toddler Vaccinations||9
88038|NCT01340937|209593|P4|COMPLETED|Period 3: Toddler Vaccinations||319
88039|NCT01340937|209594|P3|COMPLETED|Period 3: Toddler Vaccinations||660
88040|NCT01340937|209595|P2|COMPLETED|Period 3: Toddler Vaccinations||641
88041|NCT01340937|209596|P1|COMPLETED|Period 3: Toddler Vaccinations||666
88042|NCT01340937|209593|P4|STARTED|Period 3: Toddler Vaccinations||329
88043|NCT01340937|209594|P3|STARTED|Period 3: Toddler Vaccinations||669
88044|NCT01340937|209595|P2|STARTED|Period 3: Toddler Vaccinations||658
88045|NCT01340937|209596|P1|STARTED|Period 3: Toddler Vaccinations||675
88046|NCT01340937|209593|P4|NOT COMPLETED|Period 2: Interim Period||41
88047|NCT01340937|209594|P3|NOT COMPLETED|Period 2: Interim Period||84
88048|NCT01340937|209595|P2|NOT COMPLETED|Period 2: Interim Period||79
88049|NCT01340937|209596|P1|NOT COMPLETED|Period 2: Interim Period||67
88050|NCT01340937|209593|P4|COMPLETED|Period 2: Interim Period||329
88051|NCT01340937|209594|P3|COMPLETED|Period 2: Interim Period||669
88052|NCT01340937|209595|P2|COMPLETED|Period 2: Interim Period||658
88053|NCT01340937|209596|P1|COMPLETED|Period 2: Interim Period||675
88054|NCT01340937|209593|P4|STARTED|Period 2: Interim Period||370
88055|NCT01340937|209594|P3|STARTED|Period 2: Interim Period||753
88056|NCT01340937|209595|P2|STARTED|Period 2: Interim Period||737
88057|NCT01340937|209596|P1|STARTED|Period 2: Interim Period||742
88058|NCT01340937|209593|P4|NOT COMPLETED|Period 1: Infant Series||32
88059|NCT01340937|209594|P3|NOT COMPLETED|Period 1: Infant Series||56
88060|NCT01340937|209595|P2|NOT COMPLETED|Period 1: Infant Series||60
88061|NCT01340937|209596|P1|NOT COMPLETED|Period 1: Infant Series||58
88062|NCT01340937|209593|P4|COMPLETED|Period 1: Infant Series||370
88063|NCT01340937|209594|P3|COMPLETED|Period 1: Infant Series||753
88064|NCT01340937|209595|P2|COMPLETED|Period 1: Infant Series||737
88065|NCT01340937|209596|P1|COMPLETED|Period 1: Infant Series||742
88066|NCT01340937|209593|P4|STARTED|Period 1: Infant Series||402
88067|NCT01340937|209594|P3|STARTED|Period 1: Infant Series||809
88068|NCT01340937|209595|P2|STARTED|Period 1: Infant Series||797
88069|NCT01340937|209596|P1|STARTED|Period 1: Infant Series||800
88070|NCT01340794|209755|P2|NOT COMPLETED|Overall Study||1
88071|NCT01340794|209756|P1|NOT COMPLETED|Overall Study||0
88072|NCT01340794|209755|P2|COMPLETED|Overall Study||4
88073|NCT01340794|209756|P1|COMPLETED|Overall Study||2
88074|NCT01340794|209755|P2|STARTED|Overall Study||5
88075|NCT01340794|209756|P1|STARTED|Overall Study||2
88076|NCT01340768|209772|P2|NOT COMPLETED|Overall Study||5
88077|NCT01340768|209773|P1|NOT COMPLETED|Overall Study||17
88078|NCT01340768|209772|P2|COMPLETED|Overall Study||429
88079|NCT01340768|209773|P1|COMPLETED|Overall Study||419
88080|NCT01340768|209772|P2|STARTED|Overall Study||434
88081|NCT01340768|209773|P1|STARTED|Overall Study||436
88082|NCT01340664|209784|P3|NOT COMPLETED|Overall Study||13
88083|NCT01340664|209785|P2|NOT COMPLETED|Overall Study||8
88084|NCT01340664|209786|P1|NOT COMPLETED|Overall Study||7
88085|NCT01340664|209784|P3|COMPLETED|Overall Study||80
88086|NCT01340664|209785|P2|COMPLETED|Overall Study||85
88087|NCT01340664|209786|P1|COMPLETED|Overall Study||86
88088|NCT01340664|209784|P3|STARTED|Overall Study||93
88089|NCT01340664|209785|P2|STARTED|Overall Study||93
88090|NCT01340664|209786|P1|STARTED|Overall Study||93
88091|NCT01340651|209803|P1|NOT COMPLETED|Overall Study||17
88092|NCT01340651|209803|P1|COMPLETED|Overall Study||24
88093|NCT01340651|209803|P1|STARTED|Overall Study||41
88094|NCT01340625|209819|P2|NOT COMPLETED|Second Intervention||0
88095|NCT01340625|209820|P1|NOT COMPLETED|Second Intervention||0
88096|NCT01340625|209819|P2|COMPLETED|Second Intervention||18
88097|NCT01340625|209820|P1|COMPLETED|Second Intervention||16
88098|NCT01340625|209819|P2|STARTED|Second Intervention||18
88099|NCT01340625|209820|P1|STARTED|Second Intervention||16
88100|NCT01340625|209819|P2|NOT COMPLETED|Washout Period of 28 Days||0
88101|NCT01340625|209820|P1|NOT COMPLETED|Washout Period of 28 Days||1
88102|NCT01340625|209819|P2|COMPLETED|Washout Period of 28 Days||18
88103|NCT01340625|209820|P1|COMPLETED|Washout Period of 28 Days||16
88104|NCT01340625|209819|P2|STARTED|Washout Period of 28 Days||18
88105|NCT01340625|209820|P1|STARTED|Washout Period of 28 Days||17
88106|NCT01340625|209819|P2|NOT COMPLETED|First Intervention||0
88107|NCT01340625|209820|P1|NOT COMPLETED|First Intervention||1
88108|NCT01340625|209819|P2|COMPLETED|First Intervention||18
88109|NCT01340625|209820|P1|COMPLETED|First Intervention||17
88110|NCT01340625|209819|P2|STARTED|First Intervention||18
88111|NCT01340625|209820|P1|STARTED|First Intervention||18
88112|NCT01340586|209838|P2|NOT COMPLETED|Overall Study||0
88113|NCT01340586|209839|P1|NOT COMPLETED|Overall Study||0
88114|NCT01340586|209838|P2|COMPLETED|Overall Study||8
88115|NCT01340586|209839|P1|COMPLETED|Overall Study||8
88116|NCT01340586|209838|P2|STARTED|Overall Study||8
88117|NCT01340586|209839|P1|STARTED|Overall Study||8
88118|NCT01340573|209904|P1|NOT COMPLETED|Overall Study||3
88119|NCT01340573|209904|P1|COMPLETED|Overall Study||0
88120|NCT01340573|209904|P1|STARTED|Overall Study||3
88121|NCT01340209|209928|P3|NOT COMPLETED|Overall Study||8
88122|NCT01340209|209929|P2|NOT COMPLETED|Overall Study||8
88123|NCT01340209|209930|P1|NOT COMPLETED|Overall Study||5
88124|NCT01340209|209928|P3|COMPLETED|Overall Study||106
88125|NCT01340209|209929|P2|COMPLETED|Overall Study||106
88126|NCT01340209|209930|P1|COMPLETED|Overall Study||52
88127|NCT01340209|209928|P3|STARTED|Overall Study||114
88128|NCT01340209|209929|P2|STARTED|Overall Study||114
88129|NCT01340209|209930|P1|STARTED|Overall Study||57
88130|NCT01340196|209965|P1|NOT COMPLETED|Treat. Period 3 (Faldaprevir)||2
88131|NCT01340196|209965|P1|COMPLETED|Treat. Period 3 (Faldaprevir)||14
88132|NCT01340196|209965|P1|STARTED|Treat. Period 3 (Faldaprevir)||16
88133|NCT01340196|209965|P1|NOT COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||0
88134|NCT01340196|209965|P1|COMPLETED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
88135|NCT01340196|209965|P1|STARTED|Treat. Period 2 (Tenofovir/Faldaprevir)||16
88136|NCT01340196|209965|P1|NOT COMPLETED|Treat. Period 1 (Tenofovir)||0
88137|NCT01340196|209965|P1|COMPLETED|Treat. Period 1 (Tenofovir)||16
88138|NCT01340196|209965|P1|STARTED|Treat. Period 1 (Tenofovir)||16
88139|NCT01340066|209996|P3|NOT COMPLETED|5 Week Double Blind Randomization Period||3
88140|NCT01340066|209997|P2|NOT COMPLETED|5 Week Double Blind Randomization Period||5
88141|NCT01340066|209998|P1|NOT COMPLETED|5 Week Double Blind Randomization Period||0
88142|NCT01340066|209996|P3|COMPLETED|5 Week Double Blind Randomization Period||31
88143|NCT01340066|209997|P2|COMPLETED|5 Week Double Blind Randomization Period||28
88144|NCT01340066|209998|P1|COMPLETED|5 Week Double Blind Randomization Period||0
88145|NCT01340066|209996|P3|STARTED|5 Week Double Blind Randomization Period||34
88146|NCT01340066|209997|P2|STARTED|5 Week Double Blind Randomization Period||33
88147|NCT01340066|209998|P1|STARTED|5 Week Double Blind Randomization Period||0
88148|NCT01340066|209996|P3|NOT COMPLETED|Placebo Run in Period||0
88149|NCT01340066|209997|P2|NOT COMPLETED|Placebo Run in Period||0
88150|NCT01340066|209998|P1|NOT COMPLETED|Placebo Run in Period||27
88151|NCT01340066|209996|P3|COMPLETED|Placebo Run in Period||0
88152|NCT01340066|209997|P2|COMPLETED|Placebo Run in Period||0
88153|NCT01340066|209998|P1|COMPLETED|Placebo Run in Period|Completed run in period and were eligible for randomization|67
88154|NCT01340066|209996|P3|STARTED|Placebo Run in Period||0
88155|NCT01340066|209997|P2|STARTED|Placebo Run in Period||0
88156|NCT01340066|209998|P1|STARTED|Placebo Run in Period||94
88157|NCT01340027|210017|P12|NOT COMPLETED|Overall Study||4
88158|NCT01340027|210018|P11|NOT COMPLETED|Overall Study||2
88159|NCT01340027|210019|P10|NOT COMPLETED|Overall Study||6
88160|NCT01340027|210020|P9|NOT COMPLETED|Overall Study||8
88161|NCT01340027|210021|P8|NOT COMPLETED|Overall Study||7
88162|NCT01340027|210022|P7|NOT COMPLETED|Overall Study||7
88163|NCT01340027|210023|P6|NOT COMPLETED|Overall Study||4
88164|NCT01340027|210024|P5|NOT COMPLETED|Overall Study||10
88165|NCT01340027|210025|P4|NOT COMPLETED|Overall Study||4
88166|NCT01340027|210026|P3|NOT COMPLETED|Overall Study||4
88167|NCT01340027|210027|P2|NOT COMPLETED|Overall Study||7
88168|NCT01340027|210028|P1|NOT COMPLETED|Overall Study||5
88169|NCT01340027|210017|P12|COMPLETED|Overall Study||77
88170|NCT01340027|210018|P11|COMPLETED|Overall Study||79
88171|NCT01340027|210019|P10|COMPLETED|Overall Study||146
88172|NCT01340027|210020|P9|COMPLETED|Overall Study||136
88173|NCT01340027|210021|P8|COMPLETED|Overall Study||142
88174|NCT01340027|210022|P7|COMPLETED|Overall Study||142
88175|NCT01340027|210023|P6|COMPLETED|Overall Study||74
88176|NCT01340027|210024|P5|COMPLETED|Overall Study||146
88177|NCT01340027|210025|P4|COMPLETED|Overall Study||75
88178|NCT01340027|210026|P3|COMPLETED|Overall Study||75
88179|NCT01340027|210027|P2|COMPLETED|Overall Study||71
88180|NCT01340027|210028|P1|COMPLETED|Overall Study||76
88181|NCT01340027|210017|P12|Received Treatment|Overall Study||81
88182|NCT01340027|210018|P11|Received Treatment|Overall Study||81
88183|NCT01340027|210019|P10|Received Treatment|Overall Study||152
88184|NCT01340027|210020|P9|Received Treatment|Overall Study||144
88185|NCT01340027|210021|P8|Received Treatment|Overall Study||149
88186|NCT01340027|210022|P7|Received Treatment|Overall Study||149
88187|NCT01340027|210023|P6|Received Treatment|Overall Study||78
88188|NCT01340027|210024|P5|Received Treatment|Overall Study||156
88189|NCT01340027|210025|P4|Received Treatment|Overall Study||79
88190|NCT01340027|210026|P3|Received Treatment|Overall Study||78
88191|NCT01340027|210027|P2|Received Treatment|Overall Study||78
88192|NCT01340027|210028|P1|Received Treatment|Overall Study||81
88193|NCT01340027|210017|P12|STARTED|Overall Study||81
88194|NCT01340027|210018|P11|STARTED|Overall Study||81
88195|NCT01340027|210019|P10|STARTED|Overall Study||152
88196|NCT01340027|210020|P9|STARTED|Overall Study||144
88197|NCT01340027|210021|P8|STARTED|Overall Study||149
88198|NCT01340027|210022|P7|STARTED|Overall Study||149
88199|NCT01340027|210023|P6|STARTED|Overall Study||78
88200|NCT01340027|210024|P5|STARTED|Overall Study||156
88201|NCT01340027|210025|P4|STARTED|Overall Study||79
88202|NCT01340027|210026|P3|STARTED|Overall Study||79
88203|NCT01340027|210027|P2|STARTED|Overall Study||78
88204|NCT01340027|210028|P1|STARTED|Overall Study||81
88205|NCT01340014|210404|P2|NOT COMPLETED|Period 2, Second 7 Days||1
88206|NCT01340014|210405|P1|NOT COMPLETED|Period 2, Second 7 Days||0
88207|NCT01340014|210404|P2|COMPLETED|Period 2, Second 7 Days||56
88208|NCT01340014|210405|P1|COMPLETED|Period 2, Second 7 Days||53
88209|NCT01340014|210404|P2|STARTED|Period 2, Second 7 Days||57
88210|NCT01340014|210405|P1|STARTED|Period 2, Second 7 Days||53
88211|NCT01340014|210404|P2|NOT COMPLETED|Period 1, First 7 Days||0
88212|NCT01340014|210405|P1|NOT COMPLETED|Period 1, First 7 Days||2
88213|NCT01340014|210404|P2|COMPLETED|Period 1, First 7 Days||57
88214|NCT01340014|210405|P1|COMPLETED|Period 1, First 7 Days||53
88215|NCT01340014|210404|P2|STARTED|Period 1, First 7 Days||57
88216|NCT01340014|210405|P1|STARTED|Period 1, First 7 Days||55
88217|NCT01339936|210413|P1|NOT COMPLETED|Overall Study||2
88218|NCT01339936|210413|P1|COMPLETED|Overall Study|plus 1 excluded from analysis set|36
88219|NCT01339936|210413|P1|STARTED|Overall Study|plus 2 screen failures|38
88220|NCT01339923|210426|P7|NOT COMPLETED|Overall Study||14
88221|NCT01339923|210427|P6|NOT COMPLETED|Overall Study||9
88222|NCT01339923|210428|P5|NOT COMPLETED|Overall Study||5
88223|NCT01339923|210429|P4|NOT COMPLETED|Overall Study||4
88224|NCT01339923|210430|P3|NOT COMPLETED|Overall Study||8
88225|NCT01339923|210431|P2|NOT COMPLETED|Overall Study||16
88226|NCT01339923|210432|P1|NOT COMPLETED|Overall Study||14
88227|NCT01339923|210426|P7|COMPLETED|Overall Study||111
88228|NCT01339923|210427|P6|COMPLETED|Overall Study||117
88229|NCT01339923|210428|P5|COMPLETED|Overall Study||295
88230|NCT01339923|210429|P4|COMPLETED|Overall Study||100
88231|NCT01339923|210430|P3|COMPLETED|Overall Study||243
88232|NCT01339923|210431|P2|COMPLETED|Overall Study||234
88233|NCT01339923|210432|P1|COMPLETED|Overall Study||239
88234|NCT01339923|210426|P7|STARTED|Overall Study||125
88235|NCT01339923|210427|P6|STARTED|Overall Study||126
88236|NCT01339923|210428|P5|STARTED|Overall Study||300
88237|NCT01339923|210429|P4|STARTED|Overall Study||104
88238|NCT01339923|210430|P3|STARTED|Overall Study||251
88239|NCT01339923|210431|P2|STARTED|Overall Study||250
88240|NCT01339923|210432|P1|STARTED|Overall Study||253
88241|NCT01339897|210505|P4|NOT COMPLETED|Overall Study||1
88242|NCT01339897|210506|P3|NOT COMPLETED|Overall Study||0
88243|NCT01339897|210507|P2|NOT COMPLETED|Overall Study||0
88244|NCT01339897|210508|P1|NOT COMPLETED|Overall Study||1
88245|NCT01339897|210505|P4|COMPLETED|Overall Study||5
88246|NCT01339897|210506|P3|COMPLETED|Overall Study||6
88247|NCT01339897|210507|P2|COMPLETED|Overall Study||6
88248|NCT01339897|210508|P1|COMPLETED|Overall Study||6
88249|NCT01339897|210505|P4|STARTED|Overall Study||6
88250|NCT01339897|210506|P3|STARTED|Overall Study||6
88251|NCT01339897|210507|P2|STARTED|Overall Study||6
88252|NCT01339897|210508|P1|STARTED|Overall Study||7
88253|NCT01339832|210534|P1|NOT COMPLETED|Overall Study||14
88254|NCT01339832|210534|P1|COMPLETED|Overall Study||37
88255|NCT01339832|210534|P1|STARTED|Overall Study||51
88256|NCT01339429|210545|P1|NOT COMPLETED|Overall Study||4
88257|NCT01339429|210545|P1|COMPLETED|Overall Study||37
88258|NCT01339429|210545|P1|STARTED|Overall Study||41
88259|NCT01339416|210550|P1|NOT COMPLETED|Overall Study||0
88260|NCT01339416|210550|P1|COMPLETED|Overall Study||8202
88261|NCT01339416|210550|P1|STARTED|Overall Study||8202
88262|NCT01339403|210562|P2|NOT COMPLETED|Overall Study||0
88263|NCT01339403|210563|P1|NOT COMPLETED|Overall Study||0
88264|NCT01339403|210562|P2|COMPLETED|Overall Study||257600
88265|NCT01339403|210563|P1|COMPLETED|Overall Study||24768
88266|NCT01339403|210562|P2|STARTED|Overall Study||257600
88267|NCT01339403|210563|P1|STARTED|Overall Study||24768
88268|NCT01339390|210585|P2|NOT COMPLETED|Overall Study||156
88269|NCT01339390|210586|P1|NOT COMPLETED|Overall Study||157
88270|NCT01339390|210585|P2|COMPLETED|Overall Study||1442
88271|NCT01339390|210586|P1|COMPLETED|Overall Study||1414
88272|NCT01339390|210585|P2|STARTED|Overall Study||1598
88273|NCT01339390|210586|P1|STARTED|Overall Study||1571
88274|NCT01339299|210594|P2|NOT COMPLETED|Overall Study||0
88275|NCT01339299|210595|P1|NOT COMPLETED|Overall Study||0
88276|NCT01339299|210594|P2|COMPLETED|Overall Study||50
88277|NCT01339299|210595|P1|COMPLETED|Overall Study||50
88278|NCT01339299|210594|P2|STARTED|Overall Study||50
88279|NCT01339299|210595|P1|STARTED|Overall Study||50
88280|NCT01339260|210603|P2|NOT COMPLETED|Multi-cycle Extension||193
88281|NCT01339260|210604|P1|NOT COMPLETED|Multi-cycle Extension||186
88282|NCT01339260|210603|P2|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|458
88283|NCT01339260|210604|P1|COMPLETED|Multi-cycle Extension|Patients completing at least number of cycles they were scheduled to|449
88284|NCT01339260|210603|P2|Safety Population|Multi-cycle Extension|Patients receiving palonosetron|651
88285|NCT01339260|210604|P1|Safety Population|Multi-cycle Extension|Patients receiving netupitant/palonosetron combination|635
88286|NCT01339260|210603|P2|STARTED|Multi-cycle Extension|Patients scheduled to palonosetron|651
88287|NCT01339260|210604|P1|STARTED|Multi-cycle Extension|Patients scheduled to netupitant/palonosetron combination|635
88288|NCT01339260|210603|P2|NOT COMPLETED|Cycle 1||10
88289|NCT01339260|210604|P1|NOT COMPLETED|Cycle 1||7
88290|NCT01339260|210603|P2|COMPLETED|Cycle 1||719
88291|NCT01339260|210604|P1|COMPLETED|Cycle 1||719
88292|NCT01339260|210603|P2|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to palonosetron|725
88383|NCT01338610|210789|P1|STARTED|Overall Study||39
88293|NCT01339260|210604|P1|Full Analysis Set|Cycle 1|Patients receiving chemotherapy and randomized to netupitant/palonosetron combination|724
88294|NCT01339260|210603|P2|Safety Population|Cycle 1|Patients receiving palonosetron|725
88295|NCT01339260|210604|P1|Safety Population|Cycle 1|Patients receiving netupitant/palonosetron combination|725
88296|NCT01339260|210603|P2|STARTED|Cycle 1|Intent-To-Treat: randomized patients|729
88297|NCT01339260|210604|P1|STARTED|Cycle 1|Intent-To-Treat: randomized patients|726
88298|NCT01339247|210616|P2|NOT COMPLETED|Period 2||0
88299|NCT01339247|210617|P1|NOT COMPLETED|Period 2||0
88300|NCT01339247|210616|P2|COMPLETED|Period 2||30
88301|NCT01339247|210617|P1|COMPLETED|Period 2||30
88302|NCT01339247|210616|P2|STARTED|Period 2||30
88303|NCT01339247|210617|P1|STARTED|Period 2||30
88304|NCT01339247|210616|P2|NOT COMPLETED|Period 1||0
88305|NCT01339247|210617|P1|NOT COMPLETED|Period 1||0
88306|NCT01339247|210616|P2|COMPLETED|Period 1||30
88307|NCT01339247|210617|P1|COMPLETED|Period 1||30
88308|NCT01339247|210616|P2|STARTED|Period 1||30
88309|NCT01339247|210617|P1|STARTED|Period 1||30
88310|NCT01339091|210629|P2|NOT COMPLETED|Overall Study||28
88311|NCT01339091|210630|P1|NOT COMPLETED|Overall Study||27
88312|NCT01339091|210629|P2|COMPLETED|Overall Study||257
88313|NCT01339091|210630|P1|COMPLETED|Overall Study||261
88314|NCT01339091|210629|P2|Safety Population|Overall Study||284
88315|NCT01339091|210630|P1|Safety Population|Overall Study||284
88316|NCT01339091|210629|P2|STARTED|Overall Study||285
88317|NCT01339091|210630|P1|STARTED|Overall Study||288
88318|NCT01339052|210644|P2|NOT COMPLETED|Overall Study||50
88319|NCT01339052|210645|P1|NOT COMPLETED|Overall Study||15
88320|NCT01339052|210644|P2|COMPLETED|Overall Study||0
88321|NCT01339052|210645|P1|COMPLETED|Overall Study||0
88322|NCT01339052|210644|P2|Evaluable Plasma Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
88323|NCT01339052|210645|P1|Evaluable Plasma Sample at Surgery|Overall Study||13
88324|NCT01339052|210644|P2|Evaluable Tumor Sample at Surgery|Overall Study|Milestone is not relevant for non-surgical cohort.|0
88325|NCT01339052|210645|P1|Evaluable Tumor Sample at Surgery|Overall Study||14
88326|NCT01339052|210644|P2|Measurable Disease|Overall Study|Radiographic response evaluated on participants with measurable disease only.|40
88327|NCT01339052|210645|P1|Measurable Disease|Overall Study||11
88328|NCT01339052|210644|P2|STARTED|Overall Study||50
88329|NCT01339052|210645|P1|STARTED|Overall Study||15
88330|NCT01339013|210665|P1|NOT COMPLETED|Overall Study||0
88331|NCT01339013|210665|P1|COMPLETED|Overall Study||6
88332|NCT01339013|210665|P1|STARTED|Overall Study||6
88333|NCT01339000|210671|P2|NOT COMPLETED|Overall Study||0
88334|NCT01339000|210672|P1|NOT COMPLETED|Overall Study||1
88335|NCT01339000|210671|P2|COMPLETED|Overall Study||0
88336|NCT01339000|210672|P1|COMPLETED|Overall Study||0
88337|NCT01339000|210671|P2|STARTED|Overall Study||0
88338|NCT01339000|210672|P1|STARTED|Overall Study|The patient received day 1, 29, 36, 43, 50, and 57 vaccines but did not receive interleukin-7 (IL-7)|1
88339|NCT01338870|210692|P6|NOT COMPLETED|Overall Study||6
88340|NCT01338870|210693|P5|NOT COMPLETED|Overall Study||6
88341|NCT01338870|210694|P4|NOT COMPLETED|Overall Study||9
88342|NCT01338870|210695|P3|NOT COMPLETED|Overall Study||11
88343|NCT01338870|210696|P2|NOT COMPLETED|Overall Study||12
88344|NCT01338870|210697|P1|NOT COMPLETED|Overall Study||9
88345|NCT01338870|210692|P6|COMPLETED|Overall Study||44
88346|NCT01338870|210693|P5|COMPLETED|Overall Study||46
88347|NCT01338870|210694|P4|COMPLETED|Overall Study||41
88348|NCT01338870|210695|P3|COMPLETED|Overall Study||39
88349|NCT01338870|210696|P2|COMPLETED|Overall Study||37
88350|NCT01338870|210697|P1|COMPLETED|Overall Study||41
88351|NCT01338870|210692|P6|STARTED|Overall Study||50
88352|NCT01338870|210693|P5|STARTED|Overall Study||52
88353|NCT01338870|210694|P4|STARTED|Overall Study||50
88354|NCT01338870|210695|P3|STARTED|Overall Study||50
88355|NCT01338870|210696|P2|STARTED|Overall Study||49
88356|NCT01338870|210697|P1|STARTED|Overall Study||50
88357|NCT01338857|210747|P1|NOT COMPLETED|Overall Study||11
88358|NCT01338857|210747|P1|COMPLETED|Overall Study||1
88359|NCT01338857|210747|P1|STARTED|Overall Study||12
88360|NCT01338818|210752|P1|NOT COMPLETED|Overall Study||36
88361|NCT01338818|210752|P1|COMPLETED|Overall Study||262
88362|NCT01338818|210752|P1|STARTED|Overall Study||298
88363|NCT01338792|210758|P1|NOT COMPLETED|Overall Study||4
88364|NCT01338792|210758|P1|COMPLETED|Overall Study||43
88365|NCT01338792|210758|P1|STARTED|Overall Study||47
88366|NCT01338649|210766|P2|NOT COMPLETED|Overall Study||0
88367|NCT01338649|210767|P1|NOT COMPLETED|Overall Study||0
88368|NCT01338649|210766|P2|COMPLETED|Overall Study||14
88369|NCT01338649|210767|P1|COMPLETED|Overall Study||13
88370|NCT01338649|210766|P2|STARTED|Overall Study||14
88371|NCT01338649|210767|P1|STARTED|Overall Study||13
88372|NCT01338636|210773|P1|NOT COMPLETED|Overall Study||8
88373|NCT01338636|210773|P1|COMPLETED|Overall Study||22
88374|NCT01338636|210773|P1|STARTED|Overall Study||30
88375|NCT01338610|210787|P3|NOT COMPLETED|Overall Study||1
88376|NCT01338610|210788|P2|NOT COMPLETED|Overall Study||1
88377|NCT01338610|210789|P1|NOT COMPLETED|Overall Study||5
88378|NCT01338610|210787|P3|COMPLETED|Overall Study||28
88379|NCT01338610|210788|P2|COMPLETED|Overall Study||55
88380|NCT01338610|210789|P1|COMPLETED|Overall Study||34
88381|NCT01338610|210787|P3|STARTED|Overall Study||29
88382|NCT01338610|210788|P2|STARTED|Overall Study||56
88384|NCT01338493|210796|P1|NOT COMPLETED|24 Months Follow up||0
88385|NCT01338493|210796|P1|COMPLETED|24 Months Follow up||104
88386|NCT01338493|210796|P1|STARTED|24 Months Follow up||104
88387|NCT01338493|210796|P1|NOT COMPLETED|12 Months Follow up||9
88388|NCT01338493|210796|P1|COMPLETED|12 Months Follow up||104
88389|NCT01338493|210796|P1|STARTED|12 Months Follow up||113
88390|NCT01338493|210796|P1|NOT COMPLETED|6 Months Follow up||19
88391|NCT01338493|210796|P1|COMPLETED|6 Months Follow up||113
88392|NCT01338493|210796|P1|STARTED|6 Months Follow up||132
88393|NCT01338493|210796|P1|NOT COMPLETED|Discharge||2
88394|NCT01338493|210796|P1|COMPLETED|Discharge||132
88395|NCT01338493|210796|P1|STARTED|Discharge||134
88396|NCT01338493|210796|P1|NOT COMPLETED|Implant||0
88397|NCT01338493|210796|P1|COMPLETED|Implant||134
88398|NCT01338493|210796|P1|STARTED|Implant||134
88399|NCT01338493|210796|P1|NOT COMPLETED|Enrolled||5
88400|NCT01338493|210796|P1|COMPLETED|Enrolled||134
88401|NCT01338493|210796|P1|STARTED|Enrolled||139
88402|NCT01338025|210803|P2|NOT COMPLETED|Overall Study||11
88403|NCT01338025|210804|P1|NOT COMPLETED|Overall Study||11
88404|NCT01338025|210803|P2|COMPLETED|Overall Study||6
88405|NCT01338025|210804|P1|COMPLETED|Overall Study||5
88406|NCT01338025|210803|P2|STARTED|Overall Study||17
88407|NCT01338025|210804|P1|STARTED|Overall Study||16
88408|NCT01338012|210816|P1|NOT COMPLETED|Overall Study||8
88409|NCT01338012|210816|P1|COMPLETED|Overall Study||0
88410|NCT01338012|210816|P1|STARTED|Overall Study||8
88411|NCT01337960|210823|P3|NOT COMPLETED|Overall Study||0
88412|NCT01337960|210824|P2|NOT COMPLETED|Overall Study||0
88413|NCT01337960|210825|P1|NOT COMPLETED|Overall Study||2
88414|NCT01337960|210823|P3|COMPLETED|Overall Study||6
88415|NCT01337960|210824|P2|COMPLETED|Overall Study||14
88416|NCT01337960|210825|P1|COMPLETED|Overall Study||12
88417|NCT01337960|210823|P3|STARTED|Overall Study||6
88418|NCT01337960|210824|P2|STARTED|Overall Study||14
88419|NCT01337960|210825|P1|STARTED|Overall Study||14
88420|NCT01337739|210847|P2|NOT COMPLETED|Overall Study||0
88421|NCT01337739|210848|P1|NOT COMPLETED|Overall Study||0
88422|NCT01337739|210847|P2|COMPLETED|Overall Study||4
88423|NCT01337739|210848|P1|COMPLETED|Overall Study||6
88424|NCT01337739|210847|P2|STARTED|Overall Study||4
88425|NCT01337739|210848|P1|STARTED|Overall Study||6
88426|NCT01337674|210858|P4|NOT COMPLETED|Treatment Period 2||0
88427|NCT01337674|210859|P3|NOT COMPLETED|Treatment Period 2||1
88428|NCT01337674|210860|P2|NOT COMPLETED|Treatment Period 2||0
88429|NCT01337674|210861|P1|NOT COMPLETED|Treatment Period 2||0
88430|NCT01337674|210858|P4|COMPLETED|Treatment Period 2||6
88431|NCT01337674|210859|P3|COMPLETED|Treatment Period 2||5
88432|NCT01337674|210860|P2|COMPLETED|Treatment Period 2||6
88433|NCT01337674|210861|P1|COMPLETED|Treatment Period 2||6
88434|NCT01337674|210858|P4|STARTED|Treatment Period 2||6
88435|NCT01337674|210859|P3|STARTED|Treatment Period 2||6
88436|NCT01337674|210860|P2|STARTED|Treatment Period 2||6
88437|NCT01337674|210861|P1|STARTED|Treatment Period 2||6
88438|NCT01337674|210858|P4|NOT COMPLETED|Two-week Washout Period||0
88439|NCT01337674|210859|P3|NOT COMPLETED|Two-week Washout Period||0
88440|NCT01337674|210860|P2|NOT COMPLETED|Two-week Washout Period||0
88441|NCT01337674|210861|P1|NOT COMPLETED|Two-week Washout Period||0
88442|NCT01337674|210858|P4|COMPLETED|Two-week Washout Period||6
88443|NCT01337674|210859|P3|COMPLETED|Two-week Washout Period||6
88444|NCT01337674|210860|P2|COMPLETED|Two-week Washout Period||6
88445|NCT01337674|210861|P1|COMPLETED|Two-week Washout Period||6
88446|NCT01337674|210858|P4|STARTED|Two-week Washout Period||6
88447|NCT01337674|210859|P3|STARTED|Two-week Washout Period||6
88448|NCT01337674|210860|P2|STARTED|Two-week Washout Period||6
88449|NCT01337674|210861|P1|STARTED|Two-week Washout Period||6
88450|NCT01337674|210858|P4|NOT COMPLETED|Treatment Period 1||1
88451|NCT01337674|210859|P3|NOT COMPLETED|Treatment Period 1||0
88452|NCT01337674|210860|P2|NOT COMPLETED|Treatment Period 1||1
88453|NCT01337674|210861|P1|NOT COMPLETED|Treatment Period 1||0
88454|NCT01337674|210858|P4|COMPLETED|Treatment Period 1||6
88455|NCT01337674|210859|P3|COMPLETED|Treatment Period 1||6
88456|NCT01337674|210860|P2|COMPLETED|Treatment Period 1||6
88457|NCT01337674|210861|P1|COMPLETED|Treatment Period 1||6
88458|NCT01337674|210858|P4|STARTED|Treatment Period 1|The discontinued participant was replaced|7
88459|NCT01337674|210859|P3|STARTED|Treatment Period 1||6
88460|NCT01337674|210860|P2|STARTED|Treatment Period 1|The discontinued participant was replaced|7
88461|NCT01337674|210861|P1|STARTED|Treatment Period 1||6
88462|NCT01337635|210879|P2|NOT COMPLETED|Overall Study||1
88463|NCT01337635|210880|P1|NOT COMPLETED|Overall Study||0
88464|NCT01337635|210879|P2|COMPLETED|Overall Study||2
88465|NCT01337635|210880|P1|COMPLETED|Overall Study||4
88466|NCT01337635|210879|P2|STARTED|Overall Study||3
88467|NCT01337635|210880|P1|STARTED|Overall Study||4
88468|NCT01337609|210889|P3|NOT COMPLETED|Overall Study||0
88469|NCT01337609|210890|P2|NOT COMPLETED|Overall Study||0
88470|NCT01337609|210891|P1|NOT COMPLETED|Overall Study||1
88471|NCT01337609|210889|P3|COMPLETED|Overall Study||2
88472|NCT01337609|210890|P2|COMPLETED|Overall Study||2
88473|NCT01337609|210891|P1|COMPLETED|Overall Study||0
88474|NCT01337609|210889|P3|STARTED|Overall Study||2
88475|NCT01337609|210890|P2|STARTED|Overall Study||2
88476|NCT01337609|210891|P1|STARTED|Overall Study||1
88477|NCT01337336|210913|P2|NOT COMPLETED|Overall Study||0
88478|NCT01337336|210914|P1|NOT COMPLETED|Overall Study||0
88479|NCT01337336|210913|P2|COMPLETED|Overall Study||2923
88480|NCT01337336|210914|P1|COMPLETED|Overall Study||1078
88481|NCT01337336|210913|P2|STARTED|Overall Study||2923
88482|NCT01337336|210914|P1|STARTED|Overall Study||1078
88483|NCT01337297|210928|P2|NOT COMPLETED|Overall Study||6
88484|NCT01337297|210929|P1|NOT COMPLETED|Overall Study||5
88485|NCT01337297|210928|P2|COMPLETED|Overall Study||3
88486|NCT01337297|210929|P1|COMPLETED|Overall Study||6
88487|NCT01337297|210928|P2|STARTED|Overall Study||9
88488|NCT01337297|210929|P1|STARTED|Overall Study||11
88489|NCT01337167|210937|P2|NOT COMPLETED|Toddler Vaccinations||13
88490|NCT01337167|210938|P1|NOT COMPLETED|Toddler Vaccinations||14
88491|NCT01337167|210937|P2|COMPLETED|Toddler Vaccinations||407
88492|NCT01337167|210938|P1|COMPLETED|Toddler Vaccinations||829
88493|NCT01337167|210937|P2|STARTED|Toddler Vaccinations||420
88494|NCT01337167|210938|P1|STARTED|Toddler Vaccinations||843
88495|NCT01337167|210937|P2|NOT COMPLETED|Interim Period||40
88496|NCT01337167|210938|P1|NOT COMPLETED|Interim Period||81
88497|NCT01337167|210937|P2|COMPLETED|Interim Period||420
88498|NCT01337167|210938|P1|COMPLETED|Interim Period||843
88499|NCT01337167|210937|P2|STARTED|Interim Period||460
88500|NCT01337167|210938|P1|STARTED|Interim Period||924
88501|NCT01337167|210937|P2|NOT COMPLETED|Infant Series||27
88502|NCT01337167|210938|P1|NOT COMPLETED|Infant Series||62
88503|NCT01337167|210937|P2|COMPLETED|Infant Series||460
88504|NCT01337167|210938|P1|COMPLETED|Infant Series||924
88505|NCT01337167|210937|P2|STARTED|Infant Series||487
88506|NCT01337167|210938|P1|STARTED|Infant Series||986
88507|NCT01337115|211006|P2|NOT COMPLETED|Overall Study||0
88508|NCT01337115|211007|P1|NOT COMPLETED|Overall Study||2
88509|NCT01337115|211006|P2|COMPLETED|Overall Study||25
88510|NCT01337115|211007|P1|COMPLETED|Overall Study|2 patients could not be assessed after 12h because of catheter dislocation|23
88511|NCT01337115|211006|P2|STARTED|Overall Study||25
88512|NCT01337115|211007|P1|STARTED|Overall Study||25
88513|NCT01337076|211019|P1|NOT COMPLETED|Overall Study||2
88514|NCT01337076|211019|P1|COMPLETED|Overall Study|subjects met the primary endpoint of 6 months postimplant activation|19
88515|NCT01337076|211019|P1|STARTED|Overall Study|subjects implanted|21
88516|NCT01337050|211026|P3|NOT COMPLETED|Overall Study||19
88517|NCT01337050|211027|P2|NOT COMPLETED|Overall Study||13
88518|NCT01337050|211028|P1|NOT COMPLETED|Overall Study||4
88519|NCT01337050|211026|P3|COMPLETED|Overall Study||0
88520|NCT01337050|211027|P2|COMPLETED|Overall Study||0
88521|NCT01337050|211028|P1|COMPLETED|Overall Study||0
88522|NCT01337050|211026|P3|STARTED|Overall Study||19
88523|NCT01337050|211027|P2|STARTED|Overall Study||13
88524|NCT01337050|211028|P1|STARTED|Overall Study||4
88525|NCT01336972|211089|P3|NOT COMPLETED|Overall Study||0
88526|NCT01336972|211090|P2|NOT COMPLETED|Overall Study||1
88527|NCT01336972|211091|P1|NOT COMPLETED|Overall Study||1
88528|NCT01336972|211089|P3|COMPLETED|Overall Study||9
88529|NCT01336972|211090|P2|COMPLETED|Overall Study||9
88530|NCT01336972|211091|P1|COMPLETED|Overall Study||9
88531|NCT01336972|211089|P3|STARTED|Overall Study||9
88532|NCT01336972|211090|P2|STARTED|Overall Study||10
88533|NCT01336972|211091|P1|STARTED|Overall Study||10
88534|NCT01336894|211128|P2|NOT COMPLETED|Follow-up||7
88535|NCT01336894|211129|P1|NOT COMPLETED|Follow-up||2
88536|NCT01336894|211128|P2|COMPLETED|Follow-up||0
88537|NCT01336894|211129|P1|COMPLETED|Follow-up||2
88538|NCT01336894|211128|P2|STARTED|Follow-up||7
88539|NCT01336894|211129|P1|STARTED|Follow-up||4
88540|NCT01336894|211128|P2|NOT COMPLETED|Protocol Interventions||0
88541|NCT01336894|211129|P1|NOT COMPLETED|Protocol Interventions||0
88542|NCT01336894|211128|P2|COMPLETED|Protocol Interventions||7
88543|NCT01336894|211129|P1|COMPLETED|Protocol Interventions||4
88544|NCT01336894|211128|P2|STARTED|Protocol Interventions||7
88545|NCT01336894|211129|P1|STARTED|Protocol Interventions||4
88546|NCT01336764|211149|P2|NOT COMPLETED|Overall Study||5
88547|NCT01336764|211150|P1|NOT COMPLETED|Overall Study||5
88548|NCT01336764|211149|P2|COMPLETED|Overall Study||5
88549|NCT01336764|211150|P1|COMPLETED|Overall Study||7
88550|NCT01336764|211149|P2|STARTED|Overall Study||10
88551|NCT01336764|211150|P1|STARTED|Overall Study||12
88552|NCT01336738|211161|P5|NOT COMPLETED|Overall Study||10
88553|NCT01336738|211162|P4|NOT COMPLETED|Overall Study||7
88554|NCT01336738|211163|P3|NOT COMPLETED|Overall Study||8
88555|NCT01336738|211164|P2|NOT COMPLETED|Overall Study||9
88556|NCT01336738|211165|P1|NOT COMPLETED|Overall Study||7
88557|NCT01336738|211161|P5|COMPLETED|Overall Study||43
88558|NCT01336738|211162|P4|COMPLETED|Overall Study||47
88559|NCT01336738|211163|P3|COMPLETED|Overall Study||45
88560|NCT01336738|211164|P2|COMPLETED|Overall Study||45
88561|NCT01336738|211165|P1|COMPLETED|Overall Study||45
88562|NCT01336738|211161|P5|STARTED|Overall Study||53
88563|NCT01336738|211162|P4|STARTED|Overall Study||54
88564|NCT01336738|211163|P3|STARTED|Overall Study||53
88565|NCT01336738|211164|P2|STARTED|Overall Study||54
88566|NCT01336738|211165|P1|STARTED|Overall Study||52
88567|NCT01336712|211207|P1|NOT COMPLETED|Overall Study||3
88568|NCT01336712|211207|P1|COMPLETED|Overall Study||27
88569|NCT01336712|211207|P1|STARTED|Overall Study||30
88570|NCT01336647|211220|P3|NOT COMPLETED|Overall Study||3
88571|NCT01336647|211221|P2|NOT COMPLETED|Overall Study||1
88572|NCT01336647|211222|P1|NOT COMPLETED|Overall Study||4
88573|NCT01336647|211220|P3|COMPLETED|Overall Study||44
88574|NCT01336647|211221|P2|COMPLETED|Overall Study||48
88575|NCT01336647|211222|P1|COMPLETED|Overall Study||42
88576|NCT01336647|211220|P3|STARTED|Overall Study||47
88577|NCT01336647|211221|P2|STARTED|Overall Study||49
88578|NCT01336647|211222|P1|STARTED|Overall Study||46
88579|NCT01336608|211236|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||24
88580|NCT01336608|211237|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||30
88581|NCT01336608|211238|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||44
88582|NCT01336608|211239|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
88583|NCT01336608|211236|P4|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|111
88584|NCT01336608|211237|P3|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|124
88585|NCT01336608|211238|P2|COMPLETED|24-week, Double-blind Treatment Period|Par. completed study if attended Wk 24, had 1-wk follow-up contact and no early withdrawal.|97
88586|NCT01336608|211239|P1|COMPLETED|24-week, Double-blind Treatment Period||0
88587|NCT01336608|211236|P4|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|110
88588|NCT01336608|211237|P3|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|124
88589|NCT01336608|211238|P2|Completed the Treatment Period|24-week, Double-blind Treatment Period|Par. were considered to have completed the TP if they attended Visit 6 (Week 24).|96
88590|NCT01336608|211239|P1|Completed the Treatment Period|24-week, Double-blind Treatment Period||0
88591|NCT01336608|211236|P4|STARTED|24-week, Double-blind Treatment Period||135
88592|NCT01336608|211237|P3|STARTED|24-week, Double-blind Treatment Period||154
88593|NCT01336608|211238|P2|STARTED|24-week, Double-blind Treatment Period||141
88594|NCT01336608|211239|P1|STARTED|24-week, Double-blind Treatment Period||0
88595|NCT01336608|211236|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
88596|NCT01336608|211237|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
88597|NCT01336608|211238|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
88598|NCT01336608|211239|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||115
88599|NCT01336608|211236|P4|COMPLETED|2-week, Single-blind Run-In Period||0
88600|NCT01336608|211237|P3|COMPLETED|2-week, Single-blind Run-In Period||0
88601|NCT01336608|211238|P2|COMPLETED|2-week, Single-blind Run-In Period||0
88602|NCT01336608|211239|P1|COMPLETED|2-week, Single-blind Run-In Period||444
88603|NCT01336608|211236|P4|STARTED|2-week, Single-blind Run-In Period||0
88604|NCT01336608|211237|P3|STARTED|2-week, Single-blind Run-In Period||0
88605|NCT01336608|211238|P2|STARTED|2-week, Single-blind Run-In Period||0
88606|NCT01336608|211239|P1|STARTED|2-week, Single-blind Run-In Period||559
88607|NCT01336569|211253|P1|NOT COMPLETED|Overall Study||4
88608|NCT01336569|211253|P1|COMPLETED|Overall Study||45
88609|NCT01336569|211253|P1|STARTED|Overall Study||49
88610|NCT01336296|211259|P2|NOT COMPLETED|Overall Study||4
88611|NCT01336296|211260|P1|NOT COMPLETED|Overall Study||5
88612|NCT01336296|211259|P2|COMPLETED|Overall Study||17
88613|NCT01336296|211260|P1|COMPLETED|Overall Study||35
88614|NCT01336296|211259|P2|STARTED|Overall Study||21
88615|NCT01336296|211260|P1|STARTED|Overall Study||40
88616|NCT01336205|211276|P2|NOT COMPLETED|Overall Study||89
88617|NCT01336205|211277|P1|NOT COMPLETED|Overall Study||233
88618|NCT01336205|211276|P2|COMPLETED|Overall Study||192
88619|NCT01336205|211277|P1|COMPLETED|Overall Study||330
88620|NCT01336205|211276|P2|STARTED|Overall Study||281
88621|NCT01336205|211277|P1|STARTED|Overall Study||563
88622|NCT01336140|211289|P2|NOT COMPLETED|Overall Study||0
88623|NCT01336140|211290|P1|NOT COMPLETED|Overall Study||0
88624|NCT01336140|211289|P2|COMPLETED|Overall Study||150
88625|NCT01336140|211290|P1|COMPLETED|Overall Study||150
88626|NCT01336140|211289|P2|STARTED|Overall Study||150
88627|NCT01336140|211290|P1|STARTED|Overall Study||150
88628|NCT01336023|211305|P3|NOT COMPLETED|Week 27 to 52||28
88629|NCT01336023|211306|P2|NOT COMPLETED|Week 27 to 52||44
88630|NCT01336023|211307|P1|NOT COMPLETED|Week 27 to 52||28
88631|NCT01336023|211305|P3|COMPLETED|Week 27 to 52||285
88632|NCT01336023|211306|P2|COMPLETED|Week 27 to 52||621
88633|NCT01336023|211307|P1|COMPLETED|Week 27 to 52||305
88634|NCT01336023|211305|P3|STARTED|Week 27 to 52|From the main trial, 29 subjects were not enrolled in the extension (week 27-52).|313
88635|NCT01336023|211306|P2|STARTED|Week 27 to 52|From the main trial, 71 subjects were not enrolled in the extension (week 27-52).|665
88636|NCT01336023|211307|P1|STARTED|Week 27 to 52|From the main trial, 33 subjects were not enrolled in the extension (week 27-52).|333
88637|NCT01336023|211305|P3|NOT COMPLETED|Week 0 to Week 26||73
88638|NCT01336023|211306|P2|NOT COMPLETED|Week 0 to Week 26||98
88639|NCT01336023|211307|P1|NOT COMPLETED|Week 0 to Week 26||48
88640|NCT01336023|211305|P3|COMPLETED|Week 0 to Week 26||342
88641|NCT01336023|211306|P2|COMPLETED|Week 0 to Week 26||736
88642|NCT01336023|211307|P1|COMPLETED|Week 0 to Week 26||366
88643|NCT01336023|211305|P3|Exposed|Week 0 to Week 26|2 subjects withdrew before exposure to trial drug and were not included in the analysis|413
88644|NCT01336023|211306|P2|Exposed|Week 0 to Week 26|8 subjects withdrew before exposure to trial drug and were not included in the analysis|826
88645|NCT01336023|211307|P1|Exposed|Week 0 to Week 26|1 subject withdrew before exposure to trial drug and was not included in the analysis|413
88646|NCT01336023|211305|P3|STARTED|Week 0 to Week 26||415
88647|NCT01336023|211306|P2|STARTED|Week 0 to Week 26||834
88648|NCT01336023|211307|P1|STARTED|Week 0 to Week 26||414
88649|NCT01335997|211328|P2|NOT COMPLETED|Period III||79
88650|NCT01335997|211329|P1|NOT COMPLETED|Period III||78
88651|NCT01335997|211328|P2|COMPLETED|Period III||4
88652|NCT01335997|211329|P1|COMPLETED|Period III||6
88653|NCT01335997|211328|P2|STARTED|Period III||83
88654|NCT01335997|211329|P1|STARTED|Period III||84
88655|NCT01335997|211328|P2|NOT COMPLETED|Period I and II||479
88656|NCT01335997|211329|P1|NOT COMPLETED|Period I and II||493
88657|NCT01335997|211328|P2|COMPLETED|Period I and II||83
88658|NCT01335997|211329|P1|COMPLETED|Period I and II||84
88659|NCT01335997|211328|P2|STARTED|Period I and II||562
88660|NCT01335997|211329|P1|STARTED|Period I and II||577
88661|NCT01335971|211342|P3|NOT COMPLETED|Overall Study||1
88662|NCT01335971|211343|P2|NOT COMPLETED|Overall Study||1
88663|NCT01335971|211344|P1|NOT COMPLETED|Overall Study||2
88664|NCT01335971|211342|P3|COMPLETED|Overall Study||28
88665|NCT01335971|211343|P2|COMPLETED|Overall Study||28
88666|NCT01335971|211344|P1|COMPLETED|Overall Study||29
88667|NCT01335971|211342|P3|STARTED|Overall Study||29
88668|NCT01335971|211343|P2|STARTED|Overall Study||29
88669|NCT01335971|211344|P1|STARTED|Overall Study||31
88670|NCT01335867|211381|P2|NOT COMPLETED|Overall Study||4
88671|NCT01335867|211382|P1|NOT COMPLETED|Overall Study||7
88672|NCT01335867|211381|P2|COMPLETED|Overall Study||12
88673|NCT01335867|211382|P1|COMPLETED|Overall Study||9
88674|NCT01335867|211381|P2|STARTED|Overall Study||16
88675|NCT01335867|211382|P1|STARTED|Overall Study||16
88676|NCT01335789|211392|P2|NOT COMPLETED|Overall Study||0
88677|NCT01335789|211393|P1|NOT COMPLETED|Overall Study||0
88678|NCT01335789|211392|P2|COMPLETED|Overall Study||8
88679|NCT01335789|211393|P1|COMPLETED|Overall Study||8
88680|NCT01335789|211392|P2|STARTED|Overall Study||8
88681|NCT01335789|211393|P1|STARTED|Overall Study||8
88682|NCT01335750|211403|P1|NOT COMPLETED|Overall Study||0
88683|NCT01335750|211403|P1|COMPLETED|Overall Study||32
88684|NCT01335750|211403|P1|STARTED|Overall Study||32
88685|NCT01335724|211424|P2|NOT COMPLETED|Overall Study||0
88686|NCT01335724|211425|P1|NOT COMPLETED|Overall Study||0
88687|NCT01335724|211424|P2|COMPLETED|Overall Study||36
88688|NCT01335724|211425|P1|COMPLETED|Overall Study||36
88689|NCT01335724|211424|P2|STARTED|Overall Study||36
88690|NCT01335724|211425|P1|STARTED|Overall Study||36
88691|NCT01335698|211440|P5|NOT COMPLETED|Treatment Stage 2||6
88692|NCT01335698|211441|P4|NOT COMPLETED|Treatment Stage 2||24
88693|NCT01335698|211442|P3|NOT COMPLETED|Treatment Stage 2||16
88694|NCT01335698|211443|P2|NOT COMPLETED|Treatment Stage 2||4
88695|NCT01335698|211444|P1|NOT COMPLETED|Treatment Stage 2||15
88696|NCT01335698|211440|P5|COMPLETED|Treatment Stage 2||0
88697|NCT01335698|211441|P4|COMPLETED|Treatment Stage 2||2
88698|NCT01335698|211442|P3|COMPLETED|Treatment Stage 2||0
88699|NCT01335698|211443|P2|COMPLETED|Treatment Stage 2||0
88700|NCT01335698|211444|P1|COMPLETED|Treatment Stage 2||0
88701|NCT01335698|211440|P5|STARTED|Treatment Stage 2||6
88702|NCT01335698|211441|P4|STARTED|Treatment Stage 2||26
88703|NCT01335698|211442|P3|STARTED|Treatment Stage 2||16
88704|NCT01335698|211443|P2|STARTED|Treatment Stage 2||4
88705|NCT01335698|211444|P1|STARTED|Treatment Stage 2||15
88706|NCT01335698|211440|P5|NOT COMPLETED|Treatment Stage 1||2
88707|NCT01335698|211441|P4|NOT COMPLETED|Treatment Stage 1||9
88708|NCT01335698|211442|P3|NOT COMPLETED|Treatment Stage 1||5
88709|NCT01335698|211443|P2|NOT COMPLETED|Treatment Stage 1||8
88710|NCT01335698|211444|P1|NOT COMPLETED|Treatment Stage 1||8
88711|NCT01335698|211440|P5|COMPLETED|Treatment Stage 1||6
88712|NCT01335698|211441|P4|COMPLETED|Treatment Stage 1||26
88713|NCT01335698|211442|P3|COMPLETED|Treatment Stage 1||16
88714|NCT01335698|211443|P2|COMPLETED|Treatment Stage 1||4
88715|NCT01335698|211444|P1|COMPLETED|Treatment Stage 1||15
88716|NCT01335698|211440|P5|STARTED|Treatment Stage 1||8
88717|NCT01335698|211441|P4|STARTED|Treatment Stage 1||35
88718|NCT01335698|211442|P3|STARTED|Treatment Stage 1||21
88719|NCT01335698|211443|P2|STARTED|Treatment Stage 1||12
88720|NCT01335698|211444|P1|STARTED|Treatment Stage 1||23
88721|NCT01335542|211493|P2|NOT COMPLETED|Overall Study||0
88722|NCT01335542|211494|P1|NOT COMPLETED|Overall Study||0
88723|NCT01335542|211493|P2|COMPLETED|Overall Study||45
88724|NCT01335542|211494|P1|COMPLETED|Overall Study||45
88725|NCT01335542|211493|P2|STARTED|Overall Study||45
88726|NCT01335542|211494|P1|STARTED|Overall Study||45
88727|NCT01335477|211502|P2|NOT COMPLETED|Overall Study||59
88728|NCT01335477|211503|P1|NOT COMPLETED|Overall Study||41
88729|NCT01335477|211502|P2|COMPLETED|Overall Study||272
88730|NCT01335477|211503|P1|COMPLETED|Overall Study||179
88731|NCT01335477|211502|P2|STARTED|Overall Study||331
88732|NCT01335477|211503|P1|STARTED|Overall Study||220
88733|NCT01335464|211567|P2|NOT COMPLETED|Overall Study||49
88734|NCT01335464|211568|P1|NOT COMPLETED|Overall Study||32
88735|NCT01335464|211567|P2|COMPLETED|Overall Study||260
88736|NCT01335464|211568|P1|COMPLETED|Overall Study||174
88737|NCT01335464|211567|P2|STARTED|Overall Study||309
88738|NCT01335464|211568|P1|STARTED|Overall Study||206
88739|NCT01335308|211633|P3|NOT COMPLETED|Overall Study||81
88740|NCT01335308|211634|P2|NOT COMPLETED|Overall Study||67
88741|NCT01335308|211635|P1|NOT COMPLETED|Overall Study||40
88742|NCT01335308|211633|P3|COMPLETED|Overall Study||154
88743|NCT01335308|211634|P2|COMPLETED|Overall Study||145
88744|NCT01335308|211635|P1|COMPLETED|Overall Study||158
88745|NCT01335308|211633|P3|STARTED|Overall Study||235
88746|NCT01335308|211634|P2|STARTED|Overall Study||212
88747|NCT01335308|211635|P1|STARTED|Overall Study||198
88748|NCT01335230|211656|P4|NOT COMPLETED|Overall Study||0
88749|NCT01335230|211657|P3|NOT COMPLETED|Overall Study||0
88750|NCT01335230|211658|P2|NOT COMPLETED|Overall Study||0
88751|NCT01335230|211659|P1|NOT COMPLETED|Overall Study||0
88752|NCT01335230|211656|P4|COMPLETED|Overall Study|subjects|10
88753|NCT01335230|211657|P3|COMPLETED|Overall Study|subjects|10
88754|NCT01335230|211658|P2|COMPLETED|Overall Study|subjects|10
88755|NCT01335230|211659|P1|COMPLETED|Overall Study|subjects|10
88756|NCT01335230|211656|P4|STARTED|Overall Study|subjects|10
88757|NCT01335230|211657|P3|STARTED|Overall Study|subjects|10
88758|NCT01335230|211658|P2|STARTED|Overall Study|subjects|10
88759|NCT01335230|211659|P1|STARTED|Overall Study|subjects|10
88760|NCT01335191|211671|P2|NOT COMPLETED|Overall Study||0
88761|NCT01335191|211672|P1|NOT COMPLETED|Overall Study||0
88762|NCT01335191|211671|P2|COMPLETED|Overall Study||11
88763|NCT01335191|211672|P1|COMPLETED|Overall Study||16
88764|NCT01335191|211671|P2|STARTED|Overall Study||11
88765|NCT01335191|211672|P1|STARTED|Overall Study||16
88766|NCT01335061|211678|P1|NOT COMPLETED|Overall Study||0
88767|NCT01335061|211678|P1|COMPLETED|Overall Study||25
88768|NCT01335061|211678|P1|STARTED|Overall Study||25
88769|NCT01334957|211693|P1|NOT COMPLETED|Overall Study||0
88770|NCT01334957|211693|P1|COMPLETED|Overall Study||300
88771|NCT01334957|211693|P1|Received Multiple Doses|Overall Study||48
88772|NCT01334957|211693|P1|Received Single Dose|Overall Study||252
88773|NCT01334957|211693|P1|STARTED|Overall Study||300
88774|NCT01334944|211701|P2|NOT COMPLETED|Overall Study||0
88775|NCT01334944|211702|P1|NOT COMPLETED|Overall Study||0
88776|NCT01334944|211701|P2|COMPLETED|Overall Study||139
88777|NCT01334944|211702|P1|COMPLETED|Overall Study||11
88778|NCT01334944|211701|P2|Received Multiple Doses|Overall Study||43
88779|NCT01334944|211702|P1|Received Multiple Doses|Overall Study||10
88780|NCT01334944|211701|P2|Received Singel Dose|Overall Study||96
88781|NCT01334944|211702|P1|Received Singel Dose|Overall Study||1
88782|NCT01334944|211701|P2|STARTED|Overall Study||139
88783|NCT01334944|211702|P1|STARTED|Overall Study||11
88784|NCT01334918|211728|P2|NOT COMPLETED|Overall Study||1
88785|NCT01334918|211729|P1|NOT COMPLETED|Overall Study||8
88786|NCT01334918|211728|P2|COMPLETED|Overall Study||60
88787|NCT01334918|211729|P1|COMPLETED|Overall Study||55
88788|NCT01334918|211728|P2|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|61
88789|NCT01334918|211729|P1|Randomized + 1 Stress Scan|Overall Study|Equates to Safety Analysis Set (SAF)|57
88790|NCT01334918|211728|P2|STARTED|Overall Study||61
88791|NCT01334918|211729|P1|STARTED|Overall Study||63
88792|NCT01334866|211755|P1|NOT COMPLETED|Overall Study||19
88793|NCT01334866|211755|P1|COMPLETED|Overall Study||72
88794|NCT01334866|211755|P1|STARTED|Overall Study|91 subjects were enrolled in the study; with 89 subjects receiving the study treatment.|91
88795|NCT01334723|211765|P2|NOT COMPLETED|Overall Study||0
88796|NCT01334723|211766|P1|NOT COMPLETED|Overall Study||0
88797|NCT01334723|211765|P2|COMPLETED|Overall Study||17739
88798|NCT01334723|211766|P1|COMPLETED|Overall Study||17293
88799|NCT01334723|211765|P2|STARTED|Overall Study||17739
88800|NCT01334723|211766|P1|STARTED|Overall Study||17293
88801|NCT01334710|211792|P1|NOT COMPLETED|Overall Study||3
88802|NCT01334710|211792|P1|COMPLETED|Overall Study|Due to safety signals in a parallel trial ON OSI906 in Hepatocellular cancer the trial was stopped.|0
88803|NCT01334710|211792|P1|STARTED|Overall Study||3
88804|NCT01334606|211796|P1|NOT COMPLETED|Overall Study||18
88805|NCT01334606|211796|P1|COMPLETED|Overall Study||3
88806|NCT01334606|211796|P1|STARTED|Overall Study||21
88807|NCT01334554|211804|P2|NOT COMPLETED|Overall Study||2
88808|NCT01334554|211805|P1|NOT COMPLETED|Overall Study||4
88809|NCT01334554|211804|P2|COMPLETED|Overall Study||21
88810|NCT01334554|211805|P1|COMPLETED|Overall Study||19
88811|NCT01334554|211804|P2|STARTED|Overall Study||23
88812|NCT01334554|211805|P1|STARTED|Overall Study||23
88813|NCT01334515|211815|P2|NOT COMPLETED|Overall Study||29
88814|NCT01334515|211816|P1|NOT COMPLETED|Overall Study||12
88815|NCT01334515|211815|P2|COMPLETED|Overall Study||7
88816|NCT01334515|211816|P1|COMPLETED|Overall Study||4
88817|NCT01334515|211815|P2|STARTED|Overall Study||36
88818|NCT01334515|211816|P1|STARTED|Overall Study||16
88819|NCT01334229|211826|P2|NOT COMPLETED|Overall Study||0
88820|NCT01334229|211827|P1|NOT COMPLETED|Overall Study||0
88821|NCT01334229|211826|P2|COMPLETED|Overall Study||11
88822|NCT01334229|211827|P1|COMPLETED|Overall Study||11
88823|NCT01334229|211826|P2|STARTED|Overall Study||11
88824|NCT01334229|211827|P1|STARTED|Overall Study||11
88825|NCT01334216|211845|P2|NOT COMPLETED|Overall Study||0
88826|NCT01334216|211846|P1|NOT COMPLETED|Overall Study||0
88827|NCT01334216|211845|P2|COMPLETED|Overall Study||194
88828|NCT01334216|211846|P1|COMPLETED|Overall Study||168
88829|NCT01334216|211845|P2|STARTED|Overall Study||194
88830|NCT01334216|211846|P1|STARTED|Overall Study||168
88831|NCT01334125|211854|P2|NOT COMPLETED|Overall Study||3
88832|NCT01334125|211855|P1|NOT COMPLETED|Overall Study||3
88833|NCT01334125|211854|P2|COMPLETED|Overall Study|3 subjects left for college and moved out of the area|10
88834|NCT01334125|211855|P1|COMPLETED|Overall Study|3 subjects move to another city|12
88835|NCT01334125|211854|P2|STARTED|Overall Study||13
88836|NCT01334125|211855|P1|STARTED|Overall Study||15
88837|NCT01333956|211871|P4|NOT COMPLETED|Overall Study||2
88838|NCT01333956|211872|P3|NOT COMPLETED|Overall Study||1
88839|NCT01333956|211873|P2|NOT COMPLETED|Overall Study||4
88840|NCT01333956|211874|P1|NOT COMPLETED|Overall Study||2
88841|NCT01333956|211871|P4|COMPLETED|Overall Study||28
88842|NCT01333956|211872|P3|COMPLETED|Overall Study||29
88843|NCT01333956|211873|P2|COMPLETED|Overall Study||26
88844|NCT01333956|211874|P1|COMPLETED|Overall Study||28
88845|NCT01333956|211871|P4|STARTED|Overall Study||30
88846|NCT01333956|211872|P3|STARTED|Overall Study||30
88847|NCT01333956|211873|P2|STARTED|Overall Study||30
88848|NCT01333956|211874|P1|STARTED|Overall Study||30
88849|NCT01333865|211908|P1|NOT COMPLETED|Overall Study||2
88850|NCT01333865|211908|P1|COMPLETED|Overall Study|2 participants were withdrawn. One was still analyzed, but one was withdrawn too early for analysis|17
88851|NCT01333865|211908|P1|STARTED|Overall Study|25 participants signed consent, but only 19 completed screening and were analyzed at baseline.|19
88852|NCT01333813|211913|P1|NOT COMPLETED|Overall Study||0
88853|NCT01333813|211913|P1|COMPLETED|Overall Study||297
88854|NCT01333813|211913|P1|STARTED|Overall Study||297
88855|NCT01333722|211928|P2|NOT COMPLETED|Overall Study||3
88856|NCT01333722|211929|P1|NOT COMPLETED|Overall Study||0
88857|NCT01333722|211928|P2|COMPLETED|Overall Study||46
88858|NCT01333722|211929|P1|COMPLETED|Overall Study||51
88859|NCT01333722|211928|P2|STARTED|Overall Study||49
88860|NCT01333722|211929|P1|STARTED|Overall Study||51
88861|NCT01333592|211943|P2|NOT COMPLETED|Overall Study||17
88862|NCT01333592|211944|P1|NOT COMPLETED|Overall Study||9
88863|NCT01333592|211943|P2|COMPLETED|Overall Study||52
88864|NCT01333592|211944|P1|COMPLETED|Overall Study||58
88865|NCT01333592|211943|P2|STARTED|Overall Study||69
88866|NCT01333592|211944|P1|STARTED|Overall Study||67
88867|NCT01333501|211954|P2|NOT COMPLETED|Overall Study||21
88868|NCT01333501|211955|P1|NOT COMPLETED|Overall Study||9
88869|NCT01333501|211954|P2|COMPLETED|Overall Study||30
88870|NCT01333501|211955|P1|COMPLETED|Overall Study||97
88871|NCT01333501|211954|P2|Safety Population|Overall Study||47
88872|NCT01333501|211955|P1|Safety Population|Overall Study||104
88873|NCT01333501|211954|P2|Full Analysis Set (FAS)|Overall Study||28
88874|NCT01333501|211955|P1|Full Analysis Set (FAS)|Overall Study||80
88875|NCT01333501|211954|P2|STARTED|Overall Study||51
88876|NCT01333501|211955|P1|STARTED|Overall Study||106
88877|NCT01333488|212004|P3|NOT COMPLETED|Overall Study||0
88878|NCT01333488|212005|P2|NOT COMPLETED|Overall Study||0
88879|NCT01333488|212006|P1|NOT COMPLETED|Overall Study||0
88880|NCT01333488|212004|P3|COMPLETED|Overall Study||3
88881|NCT01333488|212005|P2|COMPLETED|Overall Study||1
88882|NCT01333488|212006|P1|COMPLETED|Overall Study||2
88883|NCT01333488|212004|P3|STARTED|Overall Study||3
88884|NCT01333488|212005|P2|STARTED|Overall Study||1
88885|NCT01333488|212006|P1|STARTED|Overall Study||2
88886|NCT01333475|212022|P2|NOT COMPLETED|Overall Study||3
88887|NCT01333475|212023|P1|NOT COMPLETED|Overall Study||2
88888|NCT01333475|212022|P2|COMPLETED|Overall Study||6
88889|NCT01333475|212023|P1|COMPLETED|Overall Study||10
88890|NCT01333475|212022|P2|STARTED|Overall Study||9
88891|NCT01333475|212023|P1|STARTED|Overall Study||12
88892|NCT01333436|212033|P2|NOT COMPLETED|Overall Study||0
88893|NCT01333436|212034|P1|NOT COMPLETED|Overall Study||0
88894|NCT01333436|212033|P2|COMPLETED|Overall Study||50
88895|NCT01333436|212034|P1|COMPLETED|Overall Study||43
88896|NCT01333436|212033|P2|STARTED|Overall Study||50
88897|NCT01333436|212034|P1|STARTED|Overall Study||43
88898|NCT01333397|212049|P5|NOT COMPLETED|Overall Study||0
88899|NCT01333397|212050|P4|NOT COMPLETED|Overall Study||1
88900|NCT01333397|212051|P3|NOT COMPLETED|Overall Study||0
88901|NCT01333397|212052|P2|NOT COMPLETED|Overall Study||0
88902|NCT01333397|212053|P1|NOT COMPLETED|Overall Study||1
88903|NCT01333397|212049|P5|COMPLETED|Overall Study||35
88904|NCT01333397|212050|P4|COMPLETED|Overall Study||34
88905|NCT01333397|212051|P3|COMPLETED|Overall Study||35
88906|NCT01333397|212052|P2|COMPLETED|Overall Study||36
88907|NCT01333397|212053|P1|COMPLETED|Overall Study||34
88908|NCT01333397|212049|P5|STARTED|Overall Study||35
88909|NCT01333397|212050|P4|STARTED|Overall Study||35
88910|NCT01333397|212051|P3|STARTED|Overall Study||35
88911|NCT01333397|212052|P2|STARTED|Overall Study||36
88912|NCT01333397|212053|P1|STARTED|Overall Study||35
88913|NCT01333189|212127|P2|NOT COMPLETED|Overall Study||2
88914|NCT01333189|212128|P1|NOT COMPLETED|Overall Study||2
88915|NCT01333189|212127|P2|COMPLETED|Overall Study||11
88916|NCT01333189|212128|P1|COMPLETED|Overall Study||11
88917|NCT01333189|212127|P2|STARTED|Overall Study||13
88918|NCT01333189|212128|P1|STARTED|Overall Study||13
88919|NCT01333111|212159|P3|NOT COMPLETED|Overall Study||2
88920|NCT01333111|212160|P2|NOT COMPLETED|Overall Study||3
88921|NCT01333111|212161|P1|NOT COMPLETED|Overall Study||2
88922|NCT01333111|212159|P3|COMPLETED|Overall Study||13
88923|NCT01333111|212160|P2|COMPLETED|Overall Study||26
88924|NCT01333111|212161|P1|COMPLETED|Overall Study||28
88925|NCT01333111|212159|P3|STARTED|Overall Study||15
88926|NCT01333111|212160|P2|STARTED|Overall Study||29
88927|NCT01333111|212161|P1|STARTED|Overall Study||30
88928|NCT01332994|212185|P1|NOT COMPLETED|Overall Study||71
88929|NCT01332994|212185|P1|COMPLETED|Overall Study||448
88930|NCT01332994|212185|P1|Completed Week 66 (TCZ/RTX)|Overall Study||25
88931|NCT01332994|212185|P1|Completed Week 32 (TCZ/RTX)|Overall Study||26
88932|NCT01332994|212185|P1|Completed Week 32 (TCZ/TCZ)|Overall Study||200
88933|NCT01332994|212185|P1|Completed Week 16|Overall Study||463
88934|NCT01332994|212185|P1|STARTED|Overall Study||519
88935|NCT01332981|212241|P1|NOT COMPLETED|Overall Study||0
88936|NCT01332981|212241|P1|COMPLETED|Overall Study||220
88937|NCT01332981|212241|P1|STARTED|Overall Study||220
88938|NCT01332968|212254|P8|NOT COMPLETED|Follow-Up Period||531
88939|NCT01332968|212255|P7|NOT COMPLETED|Follow-Up Period||542
88940|NCT01332968|212256|P6|NOT COMPLETED|Follow-Up Period||0
88941|NCT01332968|212257|P5|NOT COMPLETED|Follow-Up Period||0
88942|NCT01332968|212258|P4|NOT COMPLETED|Follow-Up Period||0
88943|NCT01332968|212259|P3|NOT COMPLETED|Follow-Up Period||0
88944|NCT01332968|212260|P2|NOT COMPLETED|Follow-Up Period||0
88945|NCT01332968|212261|P1|NOT COMPLETED|Follow-Up Period||0
88946|NCT01332968|212254|P8|COMPLETED|Follow-Up Period||0
88947|NCT01332968|212255|P7|COMPLETED|Follow-Up Period||0
88948|NCT01332968|212256|P6|COMPLETED|Follow-Up Period||0
88949|NCT01332968|212257|P5|COMPLETED|Follow-Up Period||0
88950|NCT01332968|212258|P4|COMPLETED|Follow-Up Period||0
88951|NCT01332968|212259|P3|COMPLETED|Follow-Up Period||0
88952|NCT01332968|212260|P2|COMPLETED|Follow-Up Period||0
88953|NCT01332968|212261|P1|COMPLETED|Follow-Up Period||0
88954|NCT01332968|212254|P8|STARTED|Follow-Up Period||531
88955|NCT01332968|212255|P7|STARTED|Follow-Up Period||542
88956|NCT01332968|212256|P6|STARTED|Follow-Up Period||0
88957|NCT01332968|212257|P5|STARTED|Follow-Up Period||0
88958|NCT01332968|212258|P4|STARTED|Follow-Up Period||0
88959|NCT01332968|212259|P3|STARTED|Follow-Up Period||0
88960|NCT01332968|212260|P2|STARTED|Follow-Up Period||0
88961|NCT01332968|212261|P1|STARTED|Follow-Up Period||0
88962|NCT01332968|212254|P8|NOT COMPLETED|Maintenance/Observation Period||0
88963|NCT01332968|212255|P7|NOT COMPLETED|Maintenance/Observation Period||0
88964|NCT01332968|212256|P6|NOT COMPLETED|Maintenance/Observation Period||9
88965|NCT01332968|212257|P5|NOT COMPLETED|Maintenance/Observation Period||10
88966|NCT01332968|212258|P4|NOT COMPLETED|Maintenance/Observation Period||207
88967|NCT01332968|212259|P3|NOT COMPLETED|Maintenance/Observation Period||213
88968|NCT01332968|212260|P2|NOT COMPLETED|Maintenance/Observation Period||0
88969|NCT01332968|212261|P1|NOT COMPLETED|Maintenance/Observation Period||0
88970|NCT01332968|212254|P8|COMPLETED|Maintenance/Observation Period||0
88971|NCT01332968|212255|P7|COMPLETED|Maintenance/Observation Period||0
88972|NCT01332968|212256|P6|COMPLETED|Maintenance/Observation Period||2
88973|NCT01332968|212257|P5|COMPLETED|Maintenance/Observation Period||2
88974|NCT01332968|212258|P4|COMPLETED|Maintenance/Observation Period||417
88975|NCT01332968|212259|P3|COMPLETED|Maintenance/Observation Period||399
88976|NCT01332968|212260|P2|COMPLETED|Maintenance/Observation Period||0
88977|NCT01332968|212261|P1|COMPLETED|Maintenance/Observation Period||0
88978|NCT01332968|212254|P8|STARTED|Maintenance/Observation Period||0
88979|NCT01332968|212255|P7|STARTED|Maintenance/Observation Period||0
88980|NCT01332968|212256|P6|STARTED|Maintenance/Observation Period||11
88981|NCT01332968|212257|P5|STARTED|Maintenance/Observation Period||12
88982|NCT01332968|212258|P4|STARTED|Maintenance/Observation Period||624
88983|NCT01332968|212259|P3|STARTED|Maintenance/Observation Period||612
88984|NCT01332968|212260|P2|STARTED|Maintenance/Observation Period||0
88985|NCT01332968|212261|P1|STARTED|Maintenance/Observation Period||0
88986|NCT01332968|212254|P8|NOT COMPLETED|Induction Period||0
88987|NCT01332968|212255|P7|NOT COMPLETED|Induction Period||0
88988|NCT01332968|212256|P6|NOT COMPLETED|Induction Period||0
88989|NCT01332968|212257|P5|NOT COMPLETED|Induction Period||0
88990|NCT01332968|212258|P4|NOT COMPLETED|Induction Period||0
88991|NCT01332968|212259|P3|NOT COMPLETED|Induction Period||0
88992|NCT01332968|212260|P2|NOT COMPLETED|Induction Period||56
88993|NCT01332968|212261|P1|NOT COMPLETED|Induction Period||58
88994|NCT01332968|212254|P8|COMPLETED|Induction Period||0
88995|NCT01332968|212255|P7|COMPLETED|Induction Period||0
88996|NCT01332968|212256|P6|COMPLETED|Induction Period||0
88997|NCT01332968|212257|P5|COMPLETED|Induction Period||0
88998|NCT01332968|212258|P4|COMPLETED|Induction Period||0
88999|NCT01332968|212259|P3|COMPLETED|Induction Period||0
89000|NCT01332968|212260|P2|COMPLETED|Induction Period||646
89001|NCT01332968|212261|P1|COMPLETED|Induction Period||641
89002|NCT01332968|212254|P8|STARTED|Induction Period||0
89003|NCT01332968|212255|P7|STARTED|Induction Period||0
89004|NCT01332968|212256|P6|STARTED|Induction Period||0
89005|NCT01332968|212257|P5|STARTED|Induction Period||0
89006|NCT01332968|212258|P4|STARTED|Induction Period||0
89007|NCT01332968|212259|P3|STARTED|Induction Period||0
89008|NCT01332968|212260|P2|STARTED|Induction Period||702
89009|NCT01332968|212261|P1|STARTED|Induction Period||699
89010|NCT01332721|212325|P1|NOT COMPLETED|Overall Study||0
89011|NCT01332721|212325|P1|COMPLETED|Overall Study||38
89012|NCT01332721|212325|P1|STARTED|Overall Study||38
89013|NCT01332578|212331|P2|NOT COMPLETED|Period II||0
89014|NCT01332578|212332|P1|NOT COMPLETED|Period II||0
89015|NCT01332578|212331|P2|COMPLETED|Period II||13
89016|NCT01332578|212332|P1|COMPLETED|Period II||12
89017|NCT01332578|212331|P2|STARTED|Period II||13
89018|NCT01332578|212332|P1|STARTED|Period II||12
89019|NCT01332578|212331|P2|NOT COMPLETED|Washout Period||0
89020|NCT01332578|212332|P1|NOT COMPLETED|Washout Period||0
89021|NCT01332578|212331|P2|COMPLETED|Washout Period||13
89022|NCT01332578|212332|P1|COMPLETED|Washout Period||12
89023|NCT01332578|212331|P2|STARTED|Washout Period||13
89024|NCT01332578|212332|P1|STARTED|Washout Period||12
89025|NCT01332578|212331|P2|NOT COMPLETED|Period I||0
89026|NCT01332578|212332|P1|NOT COMPLETED|Period I||0
89027|NCT01332578|212331|P2|COMPLETED|Period I||13
89028|NCT01332578|212332|P1|COMPLETED|Period I||12
89029|NCT01332578|212331|P2|STARTED|Period I||13
89030|NCT01332578|212332|P1|STARTED|Period I||12
89031|NCT01332500|212355|P4|NOT COMPLETED|Overall Study||0
89032|NCT01332500|212356|P3|NOT COMPLETED|Overall Study||0
89033|NCT01332500|212357|P2|NOT COMPLETED|Overall Study||0
89034|NCT01332500|212358|P1|NOT COMPLETED|Overall Study||0
89035|NCT01332500|212355|P4|COMPLETED|Overall Study||5806
89036|NCT01332500|212356|P3|COMPLETED|Overall Study||2903
89037|NCT01332500|212357|P2|COMPLETED|Overall Study||39771
89038|NCT01332500|212358|P1|COMPLETED|Overall Study||13257
89039|NCT01332500|212355|P4|STARTED|Overall Study||5806
89040|NCT01332500|212356|P3|STARTED|Overall Study||2903
89041|NCT01332500|212357|P2|STARTED|Overall Study||39771
89042|NCT01332500|212358|P1|STARTED|Overall Study||13257
89043|NCT01332487|212378|P2|NOT COMPLETED|Overall Study||0
89044|NCT01332487|212379|P1|NOT COMPLETED|Overall Study||0
89045|NCT01332487|212378|P2|COMPLETED|Overall Study||3063
89046|NCT01332487|212379|P1|COMPLETED|Overall Study||5554
89047|NCT01332487|212378|P2|STARTED|Overall Study||3063
89048|NCT01332487|212379|P1|STARTED|Overall Study||5554
89049|NCT01332461|212389|P2|NOT COMPLETED|Overall Study||0
89050|NCT01332461|212390|P1|NOT COMPLETED|Overall Study||0
89051|NCT01332461|212389|P2|COMPLETED|Overall Study||4386
89052|NCT01332461|212390|P1|COMPLETED|Overall Study||1291
89053|NCT01332461|212389|P2|STARTED|Overall Study||4386
89054|NCT01332461|212390|P1|STARTED|Overall Study||1291
89055|NCT01332435|212404|P4|NOT COMPLETED|Overall Study||0
89056|NCT01332435|212405|P3|NOT COMPLETED|Overall Study||0
89057|NCT01332435|212406|P2|NOT COMPLETED|Overall Study||0
89058|NCT01332435|212407|P1|NOT COMPLETED|Overall Study||0
89059|NCT01332435|212404|P4|COMPLETED|Overall Study||1656
89060|NCT01332435|212405|P3|COMPLETED|Overall Study||2604
89061|NCT01332435|212406|P2|COMPLETED|Overall Study||1064
89062|NCT01332435|212407|P1|COMPLETED|Overall Study||1572
89063|NCT01332435|212404|P4|STARTED|Overall Study||1656
89064|NCT01332435|212405|P3|STARTED|Overall Study||2604
89065|NCT01332435|212406|P2|STARTED|Overall Study||1064
89066|NCT01332435|212407|P1|STARTED|Overall Study||1572
89067|NCT01332357|212437|P1|NOT COMPLETED|Overall Study||0
89068|NCT01332357|212437|P1|COMPLETED|Overall Study||6139
89069|NCT01332357|212437|P1|STARTED|Overall Study||6139
89070|NCT01332318|212445|P4|NOT COMPLETED|Overall Study||2
89071|NCT01332318|212446|P3|NOT COMPLETED|Overall Study||1
89072|NCT01332318|212447|P2|NOT COMPLETED|Overall Study||4
89073|NCT01332318|212448|P1|NOT COMPLETED|Overall Study||2
89074|NCT01332318|212445|P4|COMPLETED|Overall Study||28
89075|NCT01332318|212446|P3|COMPLETED|Overall Study||33
89076|NCT01332318|212447|P2|COMPLETED|Overall Study||28
89077|NCT01332318|212448|P1|COMPLETED|Overall Study||32
89078|NCT01332318|212445|P4|STARTED|Overall Study||30
89079|NCT01332318|212446|P3|STARTED|Overall Study||34
89080|NCT01332318|212447|P2|STARTED|Overall Study||32
89081|NCT01332318|212448|P1|STARTED|Overall Study||34
89082|NCT01332305|212559|P5|NOT COMPLETED|Overall Study||12
89083|NCT01332305|212560|P4|NOT COMPLETED|Overall Study||8
89084|NCT01332305|212561|P3|NOT COMPLETED|Overall Study||14
89085|NCT01332305|212562|P2|NOT COMPLETED|Overall Study||14
89086|NCT01332305|212563|P1|NOT COMPLETED|Overall Study||10
89087|NCT01332305|212559|P5|COMPLETED|Overall Study||33
89088|NCT01332305|212560|P4|COMPLETED|Overall Study||30
89089|NCT01332305|212561|P3|COMPLETED|Overall Study||31
89090|NCT01332305|212562|P2|COMPLETED|Overall Study||34
89091|NCT01332305|212563|P1|COMPLETED|Overall Study||31
89092|NCT01332305|212559|P5|STARTED|Overall Study||45
89093|NCT01332305|212560|P4|STARTED|Overall Study||38
89094|NCT01332305|212561|P3|STARTED|Overall Study||45
89095|NCT01332305|212562|P2|STARTED|Overall Study||48
89096|NCT01332305|212563|P1|STARTED|Overall Study||41
89097|NCT01332292|212585|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
89098|NCT01332292|212586|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||1
89099|NCT01332292|212585|P2|COMPLETED|Treatment Period 2 (14 Days)||11
89100|NCT01332292|212586|P1|COMPLETED|Treatment Period 2 (14 Days)||11
89101|NCT01332292|212585|P2|STARTED|Treatment Period 2 (14 Days)||12
89102|NCT01332292|212586|P1|STARTED|Treatment Period 2 (14 Days)||12
89103|NCT01332292|212585|P2|NOT COMPLETED|Washout Period (>=7 Days)||0
89104|NCT01332292|212586|P1|NOT COMPLETED|Washout Period (>=7 Days)||0
89105|NCT01332292|212585|P2|COMPLETED|Washout Period (>=7 Days)||12
89106|NCT01332292|212586|P1|COMPLETED|Washout Period (>=7 Days)||12
89107|NCT01332292|212585|P2|STARTED|Washout Period (>=7 Days)||12
89108|NCT01332292|212586|P1|STARTED|Washout Period (>=7 Days)||12
89109|NCT01332292|212585|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||1
89110|NCT01332292|212586|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
89111|NCT01332292|212585|P2|COMPLETED|Treatment Period 1 (14 Days)||12
89112|NCT01332292|212586|P1|COMPLETED|Treatment Period 1 (14 Days)||12
89113|NCT01332292|212585|P2|STARTED|Treatment Period 1 (14 Days)||13
89114|NCT01332292|212586|P1|STARTED|Treatment Period 1 (14 Days)||14
89115|NCT01332253|212648|P2|NOT COMPLETED|Overall Study||0
89116|NCT01332253|212649|P1|NOT COMPLETED|Overall Study||0
89117|NCT01332253|212648|P2|COMPLETED|Overall Study||79
89118|NCT01332253|212649|P1|COMPLETED|Overall Study||82
89119|NCT01332253|212648|P2|STARTED|Overall Study||79
89120|NCT01332253|212649|P1|STARTED|Overall Study||82
89121|NCT01332227|212677|P2|NOT COMPLETED|Overall Study||5
89122|NCT01332227|212678|P1|NOT COMPLETED|Overall Study||16
89123|NCT01332227|212677|P2|COMPLETED|Overall Study||32
89124|NCT01332227|212678|P1|COMPLETED|Overall Study||56
89125|NCT01332227|212677|P2|STARTED|Overall Study|Participants who received treatment|37
89126|NCT01332227|212678|P1|STARTED|Overall Study|Participants who received treatment|72
89127|NCT01332188|212700|P4|NOT COMPLETED|Overall Study||0
89128|NCT01332188|212701|P3|NOT COMPLETED|Overall Study||4
89129|NCT01332188|212702|P2|NOT COMPLETED|Overall Study||1
89130|NCT01332188|212703|P1|NOT COMPLETED|Overall Study||2
89131|NCT01332188|212700|P4|COMPLETED|Overall Study||25
89132|NCT01332188|212701|P3|COMPLETED|Overall Study||21
89133|NCT01332188|212702|P2|COMPLETED|Overall Study||25
89134|NCT01332188|212703|P1|COMPLETED|Overall Study||23
89135|NCT01332188|212700|P4|STARTED|Overall Study||25
89136|NCT01332188|212701|P3|STARTED|Overall Study||25
89137|NCT01332188|212702|P2|STARTED|Overall Study||26
89138|NCT01332188|212703|P1|STARTED|Overall Study||25
89139|NCT01332149|212859|P2|NOT COMPLETED|Overall Study||38
89140|NCT01332149|212860|P1|NOT COMPLETED|Overall Study||30
89141|NCT01332149|212859|P2|COMPLETED|Overall Study||271
89142|NCT01332149|212860|P1|COMPLETED|Overall Study||284
89143|NCT01332149|212859|P2|Treated|Overall Study||307
89144|NCT01332149|212860|P1|Treated|Overall Study||313
89145|NCT01332149|212859|P2|STARTED|Overall Study|Assigned to study treatment.|309
89146|NCT01332149|212860|P1|STARTED|Overall Study|Assigned to study treatment.|314
89147|NCT01332123|212914|P1|NOT COMPLETED|Overall Study||0
89148|NCT01332123|212914|P1|COMPLETED|Overall Study||10
89149|NCT01332123|212914|P1|STARTED|Overall Study||10
89150|NCT01332071|212919|P2|NOT COMPLETED|Period 2||0
89151|NCT01332071|212920|P1|NOT COMPLETED|Period 2||0
89152|NCT01332071|212919|P2|COMPLETED|Period 2||13
89153|NCT01332071|212920|P1|COMPLETED|Period 2||13
89154|NCT01332071|212919|P2|STARTED|Period 2||13
89155|NCT01332071|212920|P1|STARTED|Period 2||13
89156|NCT01332071|212919|P2|NOT COMPLETED|7-Day Washout Period||0
89157|NCT01332071|212920|P1|NOT COMPLETED|7-Day Washout Period||0
89158|NCT01332071|212919|P2|COMPLETED|7-Day Washout Period||13
89159|NCT01332071|212920|P1|COMPLETED|7-Day Washout Period||13
89160|NCT01332071|212919|P2|STARTED|7-Day Washout Period||13
89161|NCT01332071|212920|P1|STARTED|7-Day Washout Period||13
89162|NCT01332071|212919|P2|NOT COMPLETED|Period 1||0
89163|NCT01332071|212920|P1|NOT COMPLETED|Period 1||0
89164|NCT01332071|212919|P2|COMPLETED|Period 1||13
89165|NCT01332071|212920|P1|COMPLETED|Period 1||13
89166|NCT01332071|212919|P2|STARTED|Period 1||13
89167|NCT01332071|212920|P1|STARTED|Period 1||13
89168|NCT01332019|212938|P2|NOT COMPLETED|Overall Study||122
89169|NCT01332019|212939|P1|NOT COMPLETED|Overall Study||113
89170|NCT01332019|212938|P2|COMPLETED|Overall Study||425
89171|NCT01332019|212939|P1|COMPLETED|Overall Study||417
89172|NCT01332019|212938|P2|STARTED|Overall Study||547
89173|NCT01332019|212939|P1|STARTED|Overall Study||530
89174|NCT01331837|213023|P2|NOT COMPLETED|Overall Study||67
89175|NCT01331837|213024|P1|NOT COMPLETED|Overall Study||56
89176|NCT01331837|213023|P2|COMPLETED|Overall Study||1475
89177|NCT01331837|213024|P1|COMPLETED|Overall Study||1482
89178|NCT01331837|213023|P2|STARTED|Overall Study||1542
89179|NCT01331837|213024|P1|STARTED|Overall Study||1538
89180|NCT01331824|213064|P1|NOT COMPLETED|Overall Study||13
89181|NCT01331824|213064|P1|COMPLETED|Overall Study||9
89182|NCT01331824|213064|P1|STARTED|Overall Study||22
89183|NCT01331694|213076|P6|NOT COMPLETED|Overall Study||0
89184|NCT01331694|213077|P5|NOT COMPLETED|Overall Study||0
89185|NCT01331694|213078|P4|NOT COMPLETED|Overall Study||0
89186|NCT01331694|213079|P3|NOT COMPLETED|Overall Study||0
89187|NCT01331694|213080|P2|NOT COMPLETED|Overall Study||0
89188|NCT01331694|213081|P1|NOT COMPLETED|Overall Study||0
89189|NCT01331694|213076|P6|COMPLETED|Overall Study||9126
89190|NCT01331694|213077|P5|COMPLETED|Overall Study||10617
89191|NCT01331694|213078|P4|COMPLETED|Overall Study||12595
89192|NCT01331694|213079|P3|COMPLETED|Overall Study||12659
89193|NCT01331694|213080|P2|COMPLETED|Overall Study||14449
89194|NCT01331694|213081|P1|COMPLETED|Overall Study||16684
89195|NCT01331694|213076|P6|STARTED|Overall Study||9126
89196|NCT01331694|213077|P5|STARTED|Overall Study||10617
89197|NCT01331694|213078|P4|STARTED|Overall Study||12595
89198|NCT01331694|213079|P3|STARTED|Overall Study||12659
89199|NCT01331694|213080|P2|STARTED|Overall Study||14449
89200|NCT01331694|213081|P1|STARTED|Overall Study||16684
89201|NCT01331681|213098|P3|NOT COMPLETED|Overall Study||35
89202|NCT01331681|213099|P2|NOT COMPLETED|Overall Study||34
89203|NCT01331681|213100|P1|NOT COMPLETED|Overall Study||35
89204|NCT01331681|213098|P3|COMPLETED|Overall Study|Completed Week 148|100
89205|NCT01331681|213099|P2|COMPLETED|Overall Study|Completed Week 148|101
89206|NCT01331681|213100|P1|COMPLETED|Overall Study|Completed Week 148|101
89207|NCT01331681|213098|P3|Completed Week 148|Overall Study||100
89208|NCT01331681|213099|P2|Completed Week 148|Overall Study||101
89209|NCT01331681|213100|P1|Completed Week 148|Overall Study||101
89210|NCT01331681|213098|P3|Completed Week 100|Overall Study||105
89211|NCT01331681|213099|P2|Completed Week 100|Overall Study||110
89212|NCT01331681|213100|P1|Completed Week 100|Overall Study||115
89213|NCT01331681|213098|P3|Completed Week 52|Overall Study||115
89214|NCT01331681|213099|P2|Completed Week 52|Overall Study||121
89215|NCT01331681|213100|P1|Completed Week 52|Overall Study||125
89216|NCT01331681|213098|P3|Participants Received Treatment|Overall Study|safety population|133
89217|NCT01331681|213099|P2|Participants Received Treatment|Overall Study|safety population|135
89218|NCT01331681|213100|P1|Participants Received Treatment|Overall Study|safety population|136
89219|NCT01331681|213098|P3|STARTED|Overall Study|randomized|135
89220|NCT01331681|213099|P2|STARTED|Overall Study|randomized|135
89221|NCT01331681|213100|P1|STARTED|Overall Study|randomized|136
89222|NCT01331304|213128|P2|NOT COMPLETED|Overall Study||60
89223|NCT01331304|213129|P1|NOT COMPLETED|Overall Study||58
89224|NCT01331304|213128|P2|COMPLETED|Overall Study||182
89225|NCT01331304|213129|P1|COMPLETED|Overall Study||182
89226|NCT01331304|213128|P2|STARTED|Overall Study||242
89227|NCT01331304|213129|P1|STARTED|Overall Study||240
89228|NCT01331291|213139|P2|NOT COMPLETED|Overall Study||9
89229|NCT01331291|213140|P1|NOT COMPLETED|Overall Study||2
89230|NCT01331291|213139|P2|COMPLETED|Overall Study||0
89231|NCT01331291|213140|P1|COMPLETED|Overall Study||0
89232|NCT01331291|213139|P2|STARTED|Overall Study||9
89233|NCT01331291|213140|P1|STARTED|Overall Study||2
89234|NCT01331213|213153|P2|NOT COMPLETED|Overall Study||0
89235|NCT01331213|213154|P1|NOT COMPLETED|Overall Study||0
89236|NCT01331213|213153|P2|COMPLETED|Overall Study||10
89237|NCT01331213|213154|P1|COMPLETED|Overall Study||8
89238|NCT01331213|213153|P2|STARTED|Overall Study||10
89239|NCT01331213|213154|P1|STARTED|Overall Study||8
89240|NCT01331161|213174|P2|NOT COMPLETED|Overall Study||2
89241|NCT01331161|213175|P1|NOT COMPLETED|Overall Study||1
89242|NCT01331161|213174|P2|COMPLETED|Overall Study||31
89243|NCT01331161|213175|P1|COMPLETED|Overall Study||43
89244|NCT01331161|213174|P2|STARTED|Overall Study||33
89245|NCT01331161|213175|P1|STARTED|Overall Study||44
89246|NCT01331109|213183|P1|NOT COMPLETED|Overall Study||57
89247|NCT01331109|213183|P1|COMPLETED|Overall Study||0
89248|NCT01331109|213183|P1|STARTED|Overall Study||57
89249|NCT01331005|213195|P2|NOT COMPLETED|Overall Study||4
89250|NCT01331005|213196|P1|NOT COMPLETED|Overall Study||4
89251|NCT01331005|213195|P2|COMPLETED|Overall Study||57
89252|NCT01331005|213196|P1|COMPLETED|Overall Study||60
89253|NCT01331005|213195|P2|STARTED|Overall Study||61
89254|NCT01331005|213196|P1|STARTED|Overall Study||64
89255|NCT01330914|213202|P1|NOT COMPLETED|Overall Study||7
89256|NCT01330914|213202|P1|COMPLETED|Overall Study||48
89257|NCT01330914|213202|P1|STARTED|Overall Study||55
89258|NCT01330628|213208|P2|NOT COMPLETED|Overall Study||40
89259|NCT01330628|213209|P1|NOT COMPLETED|Overall Study||70
89260|NCT01330628|213208|P2|COMPLETED|Overall Study||42
89261|NCT01330628|213209|P1|COMPLETED|Overall Study||100
89262|NCT01330628|213208|P2|6 Month Follow-up|Overall Study||60
89263|NCT01330628|213209|P1|6 Month Follow-up|Overall Study||135
89264|NCT01330628|213208|P2|30 Day Follow-up|Overall Study||73
89265|NCT01330628|213209|P1|30 Day Follow-up|Overall Study||165
89266|NCT01330628|213208|P2|STARTED|Overall Study||82
89267|NCT01330628|213209|P1|STARTED|Overall Study||170
89268|NCT01330433|213219|P2|NOT COMPLETED|Overall Study||3
89269|NCT01330433|213220|P1|NOT COMPLETED|Overall Study||2
89270|NCT01330433|213219|P2|COMPLETED|Overall Study||16
89271|NCT01330433|213220|P1|COMPLETED|Overall Study||14
89272|NCT01330433|213219|P2|STARTED|Overall Study||19
89273|NCT01330433|213220|P1|STARTED|Overall Study||16
89274|NCT01330420|213240|P1|NOT COMPLETED|Overall Study||4
89275|NCT01330420|213240|P1|COMPLETED|Overall Study||24
89276|NCT01330420|213240|P1|STARTED|Overall Study||28
89277|NCT01330394|213250|P2|NOT COMPLETED|Overall Study||0
89278|NCT01330394|213251|P1|NOT COMPLETED|Overall Study||0
89279|NCT01330394|213250|P2|COMPLETED|Overall Study||16
89280|NCT01330394|213251|P1|COMPLETED|Overall Study||17
89281|NCT01330394|213250|P2|STARTED|Overall Study||16
89282|NCT01330394|213251|P1|STARTED|Overall Study||17
89283|NCT01330381|213259|P3|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||18
89284|NCT01330381|213260|P2|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||0
89285|NCT01330381|213261|P1|NOT COMPLETED|Open-label Treatment Period (16 Weeks)||10
89286|NCT01330381|213259|P3|COMPLETED|Open-label Treatment Period (16 Weeks)||81
89287|NCT01330381|213260|P2|COMPLETED|Open-label Treatment Period (16 Weeks)||0
89288|NCT01330381|213261|P1|COMPLETED|Open-label Treatment Period (16 Weeks)||88
89289|NCT01330381|213259|P3|STARTED|Open-label Treatment Period (16 Weeks)||99
89290|NCT01330381|213260|P2|STARTED|Open-label Treatment Period (16 Weeks)||0
89291|NCT01330381|213261|P1|STARTED|Open-label Treatment Period (16 Weeks)||98
89292|NCT01330381|213259|P3|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||0
89293|NCT01330381|213260|P2|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||7
89294|NCT01330381|213261|P1|NOT COMPLETED|Double-blind Treatment Period (8 Weeks)||11
89295|NCT01330381|213259|P3|COMPLETED|Double-blind Treatment Period (8 Weeks)||0
89296|NCT01330381|213260|P2|COMPLETED|Double-blind Treatment Period (8 Weeks)||101
89297|NCT01330381|213261|P1|COMPLETED|Double-blind Treatment Period (8 Weeks)||96
89298|NCT01330381|213259|P3|Received Treatment|Double-blind Treatment Period (8 Weeks)||0
89299|NCT01330381|213260|P2|Received Treatment|Double-blind Treatment Period (8 Weeks)||107
89300|NCT01330381|213261|P1|Received Treatment|Double-blind Treatment Period (8 Weeks)||106
89301|NCT01330381|213259|P3|STARTED|Double-blind Treatment Period (8 Weeks)||0
89302|NCT01330381|213260|P2|STARTED|Double-blind Treatment Period (8 Weeks)||108
89303|NCT01330381|213261|P1|STARTED|Double-blind Treatment Period (8 Weeks)||107
89304|NCT01330355|213307|P2|NOT COMPLETED|Overall Study||0
89305|NCT01330355|213308|P1|NOT COMPLETED|Overall Study||0
89306|NCT01330355|213307|P2|COMPLETED|Overall Study||17
89307|NCT01330355|213308|P1|COMPLETED|Overall Study||16
89308|NCT01330355|213307|P2|STARTED|Overall Study||17
89309|NCT01330355|213308|P1|STARTED|Overall Study||16
89310|NCT01330316|213322|P2|NOT COMPLETED|Overall Study||15
89311|NCT01330316|213323|P1|NOT COMPLETED|Overall Study||2
89312|NCT01330316|213322|P2|COMPLETED|Overall Study||60
89313|NCT01330316|213323|P1|COMPLETED|Overall Study||41
89314|NCT01330316|213322|P2|STARTED|Overall Study||75
89315|NCT01330316|213323|P1|STARTED|Overall Study||43
89316|NCT01330303|213359|P2|NOT COMPLETED|Period 2||0
89317|NCT01330303|213360|P1|NOT COMPLETED|Period 2||0
89318|NCT01330303|213359|P2|COMPLETED|Period 2||18
89319|NCT01330303|213360|P1|COMPLETED|Period 2||19
89320|NCT01330303|213359|P2|STARTED|Period 2||18
89321|NCT01330303|213360|P1|STARTED|Period 2||19
89322|NCT01330303|213359|P2|NOT COMPLETED|7-Day Washout Period||0
89323|NCT01330303|213360|P1|NOT COMPLETED|7-Day Washout Period||0
89324|NCT01330303|213359|P2|COMPLETED|7-Day Washout Period||18
89325|NCT01330303|213360|P1|COMPLETED|7-Day Washout Period||19
89326|NCT01330303|213359|P2|STARTED|7-Day Washout Period||18
89327|NCT01330303|213360|P1|STARTED|7-Day Washout Period||19
89328|NCT01330303|213359|P2|NOT COMPLETED|Period 1||2
89329|NCT01330303|213360|P1|NOT COMPLETED|Period 1||1
89330|NCT01330303|213359|P2|COMPLETED|Period 1||18
89331|NCT01330303|213360|P1|COMPLETED|Period 1||19
89332|NCT01330303|213359|P2|STARTED|Period 1||20
89333|NCT01330303|213360|P1|STARTED|Period 1||20
89334|NCT01330290|213370|P1|NOT COMPLETED|Overall Study||0
89335|NCT01330290|213370|P1|COMPLETED|Overall Study|As this is a cross-sectional study, the terms completed/not completed are not applicable.|148
89336|NCT01330290|213370|P1|STARTED|Overall Study||148
89337|NCT01330108|213394|P1|NOT COMPLETED|Overall Study||4
89338|NCT01330108|213394|P1|COMPLETED|Overall Study||28
89339|NCT01330108|213394|P1|STARTED|Overall Study||32
89340|NCT01330043|213401|P2|NOT COMPLETED|Overall Study||4
89341|NCT01330043|213402|P1|NOT COMPLETED|Overall Study||0
89342|NCT01330043|213401|P2|COMPLETED|Overall Study||108
89343|NCT01330043|213402|P1|COMPLETED|Overall Study||111
89344|NCT01330043|213401|P2|STARTED|Overall Study||112
89345|NCT01330043|213402|P1|STARTED|Overall Study||111
89346|NCT01330030|213412|P2|NOT COMPLETED|Overall Study||17
89347|NCT01330030|213413|P1|NOT COMPLETED|Overall Study||16
89348|NCT01330030|213412|P2|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
89349|NCT01330030|213413|P1|COMPLETED|Overall Study|number assessed at week 52 follow-up|105
89350|NCT01330030|213412|P2|STARTED|Overall Study||122
89351|NCT01330030|213413|P1|STARTED|Overall Study||121
89352|NCT01330017|213424|P5|NOT COMPLETED|Overall Study||3
89353|NCT01330017|213425|P4|NOT COMPLETED|Overall Study||12
89354|NCT01330017|213426|P3|NOT COMPLETED|Overall Study||8
89355|NCT01330017|213427|P2|NOT COMPLETED|Overall Study||4
89356|NCT01330017|213428|P1|NOT COMPLETED|Overall Study||5
89357|NCT01330017|213424|P5|COMPLETED|Overall Study||100
89358|NCT01330017|213425|P4|COMPLETED|Overall Study||100
89359|NCT01330017|213426|P3|COMPLETED|Overall Study||99
89360|NCT01330017|213427|P2|COMPLETED|Overall Study||104
89361|NCT01330017|213428|P1|COMPLETED|Overall Study||104
89362|NCT01330017|213424|P5|STARTED|Overall Study||103
89363|NCT01330017|213425|P4|STARTED|Overall Study||112
89364|NCT01330017|213426|P3|STARTED|Overall Study||107
89365|NCT01330017|213427|P2|STARTED|Overall Study||108
89366|NCT01330017|213428|P1|STARTED|Overall Study||109
89367|NCT01329978|213477|P5|NOT COMPLETED|Rerandomization Treatment Period||4
89368|NCT01329978|213478|P4|NOT COMPLETED|Rerandomization Treatment Period||5
89369|NCT01329978|213479|P3|NOT COMPLETED|Rerandomization Treatment Period||0
89370|NCT01329978|213480|P2|NOT COMPLETED|Rerandomization Treatment Period||0
89371|NCT01329978|213481|P1|NOT COMPLETED|Rerandomization Treatment Period||0
89372|NCT01329978|213477|P5|COMPLETED|Rerandomization Treatment Period||71
89373|NCT01329978|213478|P4|COMPLETED|Rerandomization Treatment Period||70
89374|NCT01329978|213479|P3|COMPLETED|Rerandomization Treatment Period||0
89375|NCT01329978|213480|P2|COMPLETED|Rerandomization Treatment Period||0
89376|NCT01329978|213481|P1|COMPLETED|Rerandomization Treatment Period||0
89377|NCT01329978|213477|P5|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
89378|NCT01329978|213478|P4|STARTED|Rerandomization Treatment Period|This group includes participants rerandomized from the SOF+PEG+RBV 12 week/Rerandomization Group.|75
89379|NCT01329978|213479|P3|STARTED|Rerandomization Treatment Period||0
89380|NCT01329978|213480|P2|STARTED|Rerandomization Treatment Period||0
89381|NCT01329978|213481|P1|STARTED|Rerandomization Treatment Period||0
89382|NCT01329978|213477|P5|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
89383|NCT01329978|213478|P4|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
89384|NCT01329978|213479|P3|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||5
89385|NCT01329978|213480|P2|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||13
89386|NCT01329978|213481|P1|NOT COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||4
89387|NCT01329978|213477|P5|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
89388|NCT01329978|213478|P4|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period||0
89389|NCT01329978|213479|P3|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|150 participants were re-randomized after 12 weeks of treatment.|150
89390|NCT01329978|213480|P2|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|112
89391|NCT01329978|213481|P1|COMPLETED|Sofosbuvir+PEG+RBV Treatment Period|Participants in this group were not re-randomized for further treatment|48
89392|NCT01329978|213477|P5|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
89393|NCT01329978|213478|P4|STARTED|Sofosbuvir+PEG+RBV Treatment Period||0
89394|NCT01329978|213479|P3|STARTED|Sofosbuvir+PEG+RBV Treatment Period||155
89395|NCT01329978|213480|P2|STARTED|Sofosbuvir+PEG+RBV Treatment Period||125
89396|NCT01329978|213481|P1|STARTED|Sofosbuvir+PEG+RBV Treatment Period||52
89397|NCT01329939|213555|P4|NOT COMPLETED|Overall Study||5
89398|NCT01329939|213556|P3|NOT COMPLETED|Overall Study||1
89399|NCT01329939|213557|P2|NOT COMPLETED|Overall Study||1
89400|NCT01329939|213558|P1|NOT COMPLETED|Overall Study||3
89401|NCT01329939|213555|P4|COMPLETED|Overall Study||4
89402|NCT01329939|213556|P3|COMPLETED|Overall Study||4
89403|NCT01329939|213557|P2|COMPLETED|Overall Study||4
89404|NCT01329939|213558|P1|COMPLETED|Overall Study||4
89405|NCT01329939|213555|P4|STARTED|Overall Study||9
89406|NCT01329939|213556|P3|STARTED|Overall Study||5
89407|NCT01329939|213557|P2|STARTED|Overall Study||5
89408|NCT01329939|213558|P1|STARTED|Overall Study||7
89409|NCT01329848|213596|P1|NOT COMPLETED|Overall Study||29
89410|NCT01329848|213596|P1|COMPLETED|Overall Study||54
89411|NCT01329848|213596|P1|STARTED|Overall Study||83
89412|NCT01329679|213601|P2|NOT COMPLETED|Overall Study||0
89413|NCT01329679|213602|P1|NOT COMPLETED|Overall Study||0
89414|NCT01329679|213601|P2|COMPLETED|Overall Study||13
89415|NCT01329679|213602|P1|COMPLETED|Overall Study||13
89416|NCT01329679|213601|P2|STARTED|Overall Study||13
89417|NCT01329679|213602|P1|STARTED|Overall Study||13
89418|NCT01329562|213622|P2|NOT COMPLETED|Overall Study||7
89419|NCT01329562|213623|P1|NOT COMPLETED|Overall Study||9
89420|NCT01329562|213622|P2|COMPLETED|Overall Study||14
89421|NCT01329562|213623|P1|COMPLETED|Overall Study||11
89422|NCT01329562|213622|P2|STARTED|Overall Study||21
89423|NCT01329562|213623|P1|STARTED|Overall Study||20
89424|NCT01329549|213672|P1|NOT COMPLETED|Overall Study||2
89425|NCT01329549|213672|P1|COMPLETED|Overall Study||0
89426|NCT01329549|213672|P1|STARTED|Overall Study||2
89427|NCT01329419|213683|P1|NOT COMPLETED|Overall Study||235
89428|NCT01329419|213683|P1|COMPLETED|Overall Study||4158
89429|NCT01329419|213683|P1|STARTED|Overall Study||4393
89430|NCT01329263|213691|P2|NOT COMPLETED|Overall Study||23
89431|NCT01329263|213692|P1|NOT COMPLETED|Overall Study||5
89432|NCT01329263|213691|P2|COMPLETED|Overall Study||22
89433|NCT01329263|213692|P1|COMPLETED|Overall Study||10
89434|NCT01329263|213691|P2|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||22
89435|NCT01329263|213692|P1|CompletedPer 3 Own or CCrush Non-menthol|Overall Study||10
89436|NCT01329263|213691|P2|Completed Period 2 Own or CCrush Menthol|Overall Study||30
89437|NCT01329263|213692|P1|Completed Period 2 Own or CCrush Menthol|Overall Study||10
89438|NCT01329263|213691|P2|Completed Period 1 Own Menthol|Overall Study||45
89439|NCT01329263|213692|P1|Completed Period 1 Own Menthol|Overall Study||15
89440|NCT01329263|213691|P2|STARTED|Overall Study||45
89441|NCT01329263|213692|P1|STARTED|Overall Study||15
89442|NCT01329198|213706|P2|NOT COMPLETED|Overall Study||0
89443|NCT01329198|213707|P1|NOT COMPLETED|Overall Study||0
89444|NCT01329198|213706|P2|COMPLETED|Overall Study||2
89445|NCT01329198|213707|P1|COMPLETED|Overall Study||3
89446|NCT01329198|213706|P2|STARTED|Overall Study||2
89447|NCT01329198|213707|P1|STARTED|Overall Study||3
89448|NCT01329185|213720|P2|NOT COMPLETED|Overall Study||0
89449|NCT01329185|213721|P1|NOT COMPLETED|Overall Study||0
89450|NCT01329185|213720|P2|COMPLETED|Overall Study||7
89451|NCT01329185|213721|P1|COMPLETED|Overall Study||10
89452|NCT01329185|213720|P2|PTLD|Overall Study||0
89453|NCT01329185|213721|P1|PTLD|Overall Study||1
89454|NCT01329185|213720|P2|CMV Disease|Overall Study||0
89455|NCT01329185|213721|P1|CMV Disease|Overall Study||1
89456|NCT01329185|213720|P2|STARTED|Overall Study||7
89457|NCT01329185|213721|P1|STARTED|Overall Study||10
89458|NCT01329029|213729|P2|NOT COMPLETED|Overall Study||192
89459|NCT01329029|213730|P1|NOT COMPLETED|Overall Study||269
89460|NCT01329029|213729|P2|COMPLETED|Overall Study||780
89461|NCT01329029|213730|P1|COMPLETED|Overall Study||704
89462|NCT01329029|213729|P2|Safety Population|Overall Study||967
89463|NCT01329029|213730|P1|Safety Population|Overall Study||968
89464|NCT01329029|213729|P2|Full Analysis Set (FAS)|Overall Study||966
89465|NCT01329029|213730|P1|Full Analysis Set (FAS)|Overall Study||969
89466|NCT01329029|213729|P2|STARTED|Overall Study||972
89467|NCT01329029|213730|P1|STARTED|Overall Study||973
89468|NCT01328964|213803|P3|NOT COMPLETED|Overall Study||0
89469|NCT01328964|213804|P2|NOT COMPLETED|Overall Study||0
89470|NCT01328964|213805|P1|NOT COMPLETED|Overall Study||0
89471|NCT01328964|213803|P3|COMPLETED|Overall Study||4424
89472|NCT01328964|213804|P2|COMPLETED|Overall Study||3270
89473|NCT01328964|213805|P1|COMPLETED|Overall Study||2212
89474|NCT01328964|213803|P3|STARTED|Overall Study||4424
89475|NCT01328964|213804|P2|STARTED|Overall Study||3270
89476|NCT01328964|213805|P1|STARTED|Overall Study||2212
89477|NCT01328951|213820|P2|NOT COMPLETED|Overall Study||322
89478|NCT01328951|213821|P1|NOT COMPLETED|Overall Study||321
89479|NCT01328951|213820|P2|COMPLETED|Overall Study||0
89480|NCT01328951|213821|P1|COMPLETED|Overall Study||0
89481|NCT01328951|213820|P2|STARTED|Overall Study||322
89482|NCT01328951|213821|P1|STARTED|Overall Study||321
89483|NCT01328873|213845|P1|NOT COMPLETED|Overall Study||0
89484|NCT01328873|213845|P1|COMPLETED|Overall Study||49
89485|NCT01328873|213845|P1|STARTED|Overall Study||49
89486|NCT01328782|213857|P3|NOT COMPLETED|Overall Study||0
89487|NCT01328782|213858|P2|NOT COMPLETED|Overall Study||0
89488|NCT01328782|213859|P1|NOT COMPLETED|Overall Study||0
89489|NCT01328782|213857|P3|COMPLETED|Overall Study||39
89490|NCT01328782|213858|P2|COMPLETED|Overall Study||42
89491|NCT01328782|213859|P1|COMPLETED|Overall Study||43
89492|NCT01328782|213857|P3|STARTED|Overall Study||39
89493|NCT01328782|213858|P2|STARTED|Overall Study||42
89494|NCT01328782|213859|P1|STARTED|Overall Study||43
89495|NCT01328769|213881|P2|NOT COMPLETED|Overall Study||1
89496|NCT01328769|213882|P1|NOT COMPLETED|Overall Study||0
89497|NCT01328769|213881|P2|COMPLETED|Overall Study||23
89498|NCT01328769|213882|P1|COMPLETED|Overall Study||25
89499|NCT01328769|213881|P2|STARTED|Overall Study||24
89500|NCT01328769|213882|P1|STARTED|Overall Study||25
89501|NCT01328756|213890|P1|NOT COMPLETED|Overall Study||123
89502|NCT01328756|213890|P1|COMPLETED|Overall Study||191
89503|NCT01328756|213890|P1|STARTED|Overall Study||314
89504|NCT01328717|213907|P1|NOT COMPLETED|Overall Study||1
89505|NCT01328717|213907|P1|COMPLETED|Overall Study||77
89506|NCT01328717|213907|P1|STARTED|Overall Study||78
89507|NCT01328574|213912|P1|NOT COMPLETED|Overall Study||1
89508|NCT01328574|213912|P1|COMPLETED|Overall Study||12
89509|NCT01328574|213912|P1|STARTED|Overall Study||13
89510|NCT01328548|213926|P2|NOT COMPLETED|Overall Study||0
89511|NCT01328548|213927|P1|NOT COMPLETED|Overall Study||4
89512|NCT01328548|213926|P2|COMPLETED|Overall Study||50
89513|NCT01328548|213927|P1|COMPLETED|Overall Study||187
89514|NCT01328548|213926|P2|STARTED|Overall Study||50
89515|NCT01328548|213927|P1|STARTED|Overall Study||191
89516|NCT01328496|213947|P2|NOT COMPLETED|Overall Study||0
89517|NCT01328496|213948|P1|NOT COMPLETED|Overall Study||1
89518|NCT01328496|213947|P2|COMPLETED|Overall Study||4
89519|NCT01328496|213948|P1|COMPLETED|Overall Study||9
89520|NCT01328496|213947|P2|STARTED|Overall Study||4
89521|NCT01328496|213948|P1|STARTED|Overall Study||10
89522|NCT01328444|213966|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
89523|NCT01328444|213967|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||8
89524|NCT01328444|213968|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||5
89525|NCT01328444|213969|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
89526|NCT01328444|213970|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
89527|NCT01328444|213971|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||11
89528|NCT01328444|213966|P6|COMPLETED|Treatment Period 2 (12 Weeks)||59
89529|NCT01328444|213967|P5|COMPLETED|Treatment Period 2 (12 Weeks)||63
89530|NCT01328444|213968|P4|COMPLETED|Treatment Period 2 (12 Weeks)||30
89531|NCT01328444|213969|P3|COMPLETED|Treatment Period 2 (12 Weeks)||19
89532|NCT01328444|213970|P2|COMPLETED|Treatment Period 2 (12 Weeks)||22
89533|NCT01328444|213971|P1|COMPLETED|Treatment Period 2 (12 Weeks)||65
89534|NCT01328444|213966|P6|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|66
89535|NCT01328444|213967|P5|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|71
89536|NCT01328444|213968|P4|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|35
89537|NCT01328444|213969|P3|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|22
89538|NCT01328444|213970|P2|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|23
89539|NCT01328444|213971|P1|STARTED|Treatment Period 2 (12 Weeks)|By crossover design, participants were assigned to a different treatment arm in each period.|76
89540|NCT01328444|213966|P6|NOT COMPLETED|Washout Period (14 Days)||4
89541|NCT01328444|213967|P5|NOT COMPLETED|Washout Period (14 Days)||1
89542|NCT01328444|213968|P4|NOT COMPLETED|Washout Period (14 Days)||1
89543|NCT01328444|213969|P3|NOT COMPLETED|Washout Period (14 Days)||0
89544|NCT01328444|213970|P2|NOT COMPLETED|Washout Period (14 Days)||1
89545|NCT01328444|213971|P1|NOT COMPLETED|Washout Period (14 Days)||1
89546|NCT01328444|213966|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|68
89547|NCT01328444|213967|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|66
89548|NCT01328444|213968|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|32
89715|NCT01327651|214323|P5|COMPLETED|Self-administered Dosing Period||56
89549|NCT01328444|213969|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|25
89550|NCT01328444|213970|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|20
89551|NCT01328444|213971|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|82
89552|NCT01328444|213966|P6|STARTED|Washout Period (14 Days)||72
89553|NCT01328444|213967|P5|STARTED|Washout Period (14 Days)||67
89554|NCT01328444|213968|P4|STARTED|Washout Period (14 Days)||33
89555|NCT01328444|213969|P3|STARTED|Washout Period (14 Days)||25
89556|NCT01328444|213970|P2|STARTED|Washout Period (14 Days)||21
89557|NCT01328444|213971|P1|STARTED|Washout Period (14 Days)||83
89558|NCT01328444|213966|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||6
89559|NCT01328444|213967|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||14
89560|NCT01328444|213968|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||8
89561|NCT01328444|213969|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
89562|NCT01328444|213970|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
89563|NCT01328444|213971|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||11
89564|NCT01328444|213966|P6|COMPLETED|Treatment Period 1 (12 Weeks)||72
89565|NCT01328444|213967|P5|COMPLETED|Treatment Period 1 (12 Weeks)||67
89566|NCT01328444|213968|P4|COMPLETED|Treatment Period 1 (12 Weeks)||33
89567|NCT01328444|213969|P3|COMPLETED|Treatment Period 1 (12 Weeks)||25
89568|NCT01328444|213970|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
89569|NCT01328444|213971|P1|COMPLETED|Treatment Period 1 (12 Weeks)||83
89570|NCT01328444|213966|P6|STARTED|Treatment Period 1 (12 Weeks)||78
89571|NCT01328444|213967|P5|STARTED|Treatment Period 1 (12 Weeks)||81
89572|NCT01328444|213968|P4|STARTED|Treatment Period 1 (12 Weeks)||41
89573|NCT01328444|213969|P3|STARTED|Treatment Period 1 (12 Weeks)||28
89574|NCT01328444|213970|P2|STARTED|Treatment Period 1 (12 Weeks)||26
89575|NCT01328444|213971|P1|STARTED|Treatment Period 1 (12 Weeks)||94
89576|NCT01328431|214017|P2|NOT COMPLETED|12 Month (12M)||97
89577|NCT01328431|214018|P1|NOT COMPLETED|12 Month (12M)||84
89578|NCT01328431|214017|P2|COMPLETED|12 Month (12M)||289
89579|NCT01328431|214018|P1|COMPLETED|12 Month (12M)||304
89580|NCT01328431|214017|P2|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|386
89581|NCT01328431|214018|P1|STARTED|12 Month (12M)|Attempted to contact all subjects at 12M follow-up. Deceased subjects excluded.|388
89582|NCT01328431|214017|P2|NOT COMPLETED|3 Month (3M)||72
89583|NCT01328431|214018|P1|NOT COMPLETED|3 Month (3M)||77
89584|NCT01328431|214017|P2|COMPLETED|3 Month (3M)||316
89585|NCT01328431|214018|P1|COMPLETED|3 Month (3M)||313
89586|NCT01328431|214017|P2|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|388
89587|NCT01328431|214018|P1|STARTED|3 Month (3M)|Attempted to contact all subjects for 3M follow-up, regardless of whether they completed 1M.|390
89588|NCT01328431|214017|P2|NOT COMPLETED|1 Month (1M)||58
89589|NCT01328431|214018|P1|NOT COMPLETED|1 Month (1M)||55
89590|NCT01328431|214017|P2|COMPLETED|1 Month (1M)||330
89591|NCT01328431|214018|P1|COMPLETED|1 Month (1M)||335
89592|NCT01328431|214017|P2|STARTED|1 Month (1M)||388
89593|NCT01328431|214018|P1|STARTED|1 Month (1M)||390
89594|NCT01328431|214017|P2|NOT COMPLETED|Baseline||2
89595|NCT01328431|214018|P1|NOT COMPLETED|Baseline||0
89596|NCT01328431|214017|P2|COMPLETED|Baseline|Two subjects enrolled in study twice. Protocol violation.|388
89597|NCT01328431|214018|P1|COMPLETED|Baseline||390
89598|NCT01328431|214017|P2|STARTED|Baseline||390
89599|NCT01328431|214018|P1|STARTED|Baseline||390
89600|NCT01328405|214028|P2|NOT COMPLETED|Overall Study||0
89601|NCT01328405|214029|P1|NOT COMPLETED|Overall Study||0
89602|NCT01328405|214028|P2|COMPLETED|Overall Study||48
89603|NCT01328405|214029|P1|COMPLETED|Overall Study||52
89604|NCT01328405|214028|P2|STARTED|Overall Study||48
89605|NCT01328405|214029|P1|STARTED|Overall Study||52
89606|NCT01328379|214046|P3|NOT COMPLETED|Overall Study||0
89607|NCT01328379|214047|P2|NOT COMPLETED|Overall Study||0
89608|NCT01328379|214048|P1|NOT COMPLETED|Overall Study||1
89609|NCT01328379|214046|P3|COMPLETED|Overall Study||143
89610|NCT01328379|214047|P2|COMPLETED|Overall Study||144
89611|NCT01328379|214048|P1|COMPLETED|Overall Study||142
89612|NCT01328379|214046|P3|STARTED|Overall Study||143
89613|NCT01328379|214047|P2|STARTED|Overall Study||144
89614|NCT01328379|214048|P1|STARTED|Overall Study||143
89615|NCT01328366|214074|P1|NOT COMPLETED|Overall Study||10
89616|NCT01328366|214074|P1|COMPLETED|Overall Study||143
89617|NCT01328366|214074|P1|STARTED|Overall Study||153
89618|NCT01328184|214092|P1|NOT COMPLETED|Overall Study||0
89619|NCT01328184|214092|P1|COMPLETED|Overall Study||18
89620|NCT01328184|214092|P1|STARTED|Overall Study||18
89621|NCT01328158|214132|P1|NOT COMPLETED|Overall Study||0
89622|NCT01328158|214132|P1|COMPLETED|Overall Study||220
89623|NCT01328158|214132|P1|STARTED|Overall Study||220
89624|NCT01328080|214170|P1|NOT COMPLETED|Overall Study||5
89625|NCT01328080|214170|P1|COMPLETED|Overall Study||6
89626|NCT01328080|214170|P1|STARTED|Overall Study|11 subjects consented; 1 withdrew consent before first UVB treatment|11
89627|NCT01328054|214174|P2|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||5
89628|NCT01328054|214175|P1|NOT COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
89629|NCT01328054|214174|P2|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||53
89630|NCT01328054|214175|P1|COMPLETED|Lapatinib on Day 3 and Day 4 (2 Days)||0
89716|NCT01327651|214324|P4|COMPLETED|Self-administered Dosing Period||57
89631|NCT01328054|214174|P2|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)|One par. was double dosed with lapatinib due to a dosing error - reason for difference in # Started.|58
89632|NCT01328054|214175|P1|STARTED|Lapatinib on Day 3 and Day 4 (2 Days)||0
89633|NCT01328054|214174|P2|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
89634|NCT01328054|214175|P1|NOT COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
89635|NCT01328054|214174|P2|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||0
89636|NCT01328054|214175|P1|COMPLETED|Placebo on Day 1 and Day 2 (2 Days)||57
89637|NCT01328054|214174|P2|STARTED|Placebo on Day 1 and Day 2 (2 Days)||0
89638|NCT01328054|214175|P1|STARTED|Placebo on Day 1 and Day 2 (2 Days)||57
89639|NCT01328041|214200|P1|NOT COMPLETED|Overall Study||57
89640|NCT01328041|214200|P1|COMPLETED|Overall Study||126
89641|NCT01328041|214200|P1|STARTED|Overall Study||183
89642|NCT01327989|214222|P1|NOT COMPLETED|Overall Study||14
89643|NCT01327989|214222|P1|COMPLETED|Overall Study||188
89644|NCT01327989|214222|P1|STARTED|Overall Study||202
89645|NCT01327976|214236|P2|NOT COMPLETED|Overall Study||7
89646|NCT01327976|214237|P1|NOT COMPLETED|Overall Study||8
89647|NCT01327976|214236|P2|COMPLETED|Overall Study||70
89648|NCT01327976|214237|P1|COMPLETED|Overall Study||154
89649|NCT01327976|214236|P2|STARTED|Overall Study||77
89650|NCT01327976|214237|P1|STARTED|Overall Study||162
89651|NCT01327885|214249|P2|NOT COMPLETED|Overall Study||224
89652|NCT01327885|214250|P1|NOT COMPLETED|Overall Study||228
89653|NCT01327885|214249|P2|COMPLETED|Overall Study||0
89654|NCT01327885|214250|P1|COMPLETED|Overall Study||0
89655|NCT01327885|214249|P2|STARTED|Overall Study||224
89656|NCT01327885|214250|P1|STARTED|Overall Study||228
89657|NCT01327703|214262|P2|NOT COMPLETED|Second Treatment Period||2
89658|NCT01327703|214263|P1|NOT COMPLETED|Second Treatment Period||1
89659|NCT01327703|214262|P2|COMPLETED|Second Treatment Period||42
89660|NCT01327703|214263|P1|COMPLETED|Second Treatment Period||39
89661|NCT01327703|214262|P2|STARTED|Second Treatment Period|One participant discontinued between first and second treatment periods due to adverse event.|44
89662|NCT01327703|214263|P1|STARTED|Second Treatment Period|Two participants discontinued between first and second treatment periods due to adverse event.|40
89663|NCT01327703|214262|P2|NOT COMPLETED|First Treatment Period||0
89664|NCT01327703|214263|P1|NOT COMPLETED|First Treatment Period||0
89665|NCT01327703|214262|P2|COMPLETED|First Treatment Period||45
89666|NCT01327703|214263|P1|COMPLETED|First Treatment Period||42
89667|NCT01327703|214262|P2|STARTED|First Treatment Period||45
89668|NCT01327703|214263|P1|STARTED|First Treatment Period||42
89669|NCT01327677|214297|P2|NOT COMPLETED|Overall Study||13
89670|NCT01327677|214298|P1|NOT COMPLETED|Overall Study||20
89671|NCT01327677|214297|P2|COMPLETED|Overall Study||56
89672|NCT01327677|214298|P1|COMPLETED|Overall Study||48
89673|NCT01327677|214297|P2|STARTED|Overall Study||69
89674|NCT01327677|214298|P1|STARTED|Overall Study||68
89675|NCT01327651|214319|P9|NOT COMPLETED|Post Study Follow-up||2
89676|NCT01327651|214320|P8|NOT COMPLETED|Post Study Follow-up||1
89677|NCT01327651|214321|P7|NOT COMPLETED|Post Study Follow-up||4
89678|NCT01327651|214322|P6|NOT COMPLETED|Post Study Follow-up||0
89679|NCT01327651|214323|P5|NOT COMPLETED|Post Study Follow-up||0
89680|NCT01327651|214324|P4|NOT COMPLETED|Post Study Follow-up||0
89681|NCT01327651|214325|P3|NOT COMPLETED|Post Study Follow-up||1
89682|NCT01327651|214326|P2|NOT COMPLETED|Post Study Follow-up||1
89683|NCT01327651|214327|P1|NOT COMPLETED|Post Study Follow-up||0
89684|NCT01327651|214319|P9|COMPLETED|Post Study Follow-up||47
89685|NCT01327651|214320|P8|COMPLETED|Post Study Follow-up||49
89686|NCT01327651|214321|P7|COMPLETED|Post Study Follow-up||45
89687|NCT01327651|214322|P6|COMPLETED|Post Study Follow-up||59
89688|NCT01327651|214323|P5|COMPLETED|Post Study Follow-up||56
89689|NCT01327651|214324|P4|COMPLETED|Post Study Follow-up||57
89690|NCT01327651|214325|P3|COMPLETED|Post Study Follow-up||55
89691|NCT01327651|214326|P2|COMPLETED|Post Study Follow-up||55
89692|NCT01327651|214327|P1|COMPLETED|Post Study Follow-up||56
89693|NCT01327651|214319|P9|STARTED|Post Study Follow-up||49
89694|NCT01327651|214320|P8|STARTED|Post Study Follow-up||50
89695|NCT01327651|214321|P7|STARTED|Post Study Follow-up||49
89696|NCT01327651|214322|P6|STARTED|Post Study Follow-up||59
89697|NCT01327651|214323|P5|STARTED|Post Study Follow-up||56
89698|NCT01327651|214324|P4|STARTED|Post Study Follow-up||57
89699|NCT01327651|214325|P3|STARTED|Post Study Follow-up||56
89700|NCT01327651|214326|P2|STARTED|Post Study Follow-up||56
89701|NCT01327651|214327|P1|STARTED|Post Study Follow-up||56
89702|NCT01327651|214319|P9|NOT COMPLETED|Self-administered Dosing Period||11
89703|NCT01327651|214320|P8|NOT COMPLETED|Self-administered Dosing Period||10
89704|NCT01327651|214321|P7|NOT COMPLETED|Self-administered Dosing Period||10
89705|NCT01327651|214322|P6|NOT COMPLETED|Self-administered Dosing Period||0
89706|NCT01327651|214323|P5|NOT COMPLETED|Self-administered Dosing Period||3
89707|NCT01327651|214324|P4|NOT COMPLETED|Self-administered Dosing Period||3
89708|NCT01327651|214325|P3|NOT COMPLETED|Self-administered Dosing Period||4
89709|NCT01327651|214326|P2|NOT COMPLETED|Self-administered Dosing Period||3
89710|NCT01327651|214327|P1|NOT COMPLETED|Self-administered Dosing Period||4
89711|NCT01327651|214319|P9|COMPLETED|Self-administered Dosing Period||49
89712|NCT01327651|214320|P8|COMPLETED|Self-administered Dosing Period||50
89713|NCT01327651|214321|P7|COMPLETED|Self-administered Dosing Period||49
89714|NCT01327651|214322|P6|COMPLETED|Self-administered Dosing Period||59
89717|NCT01327651|214325|P3|COMPLETED|Self-administered Dosing Period||56
89718|NCT01327651|214326|P2|COMPLETED|Self-administered Dosing Period||56
89719|NCT01327651|214327|P1|COMPLETED|Self-administered Dosing Period||56
89720|NCT01327651|214319|P9|Week 26|Self-administered Dosing Period||49
89721|NCT01327651|214320|P8|Week 26|Self-administered Dosing Period||51
89722|NCT01327651|214321|P7|Week 26|Self-administered Dosing Period||50
89723|NCT01327651|214322|P6|Week 26|Self-administered Dosing Period||58
89724|NCT01327651|214323|P5|Week 26|Self-administered Dosing Period||56
89725|NCT01327651|214324|P4|Week 26|Self-administered Dosing Period||57
89726|NCT01327651|214325|P3|Week 26|Self-administered Dosing Period||53
89727|NCT01327651|214326|P2|Week 26|Self-administered Dosing Period||56
89728|NCT01327651|214327|P1|Week 26|Self-administered Dosing Period||58
89729|NCT01327651|214319|P9|Week 22|Self-administered Dosing Period||51
89730|NCT01327651|214320|P8|Week 22|Self-administered Dosing Period||50
89731|NCT01327651|214321|P7|Week 22|Self-administered Dosing Period||50
89732|NCT01327651|214322|P6|Week 22|Self-administered Dosing Period||59
89733|NCT01327651|214323|P5|Week 22|Self-administered Dosing Period||56
89734|NCT01327651|214324|P4|Week 22|Self-administered Dosing Period||58
89735|NCT01327651|214325|P3|Week 22|Self-administered Dosing Period||55
89736|NCT01327651|214326|P2|Week 22|Self-administered Dosing Period||56
89737|NCT01327651|214327|P1|Week 22|Self-administered Dosing Period||59
89738|NCT01327651|214319|P9|Week 18|Self-administered Dosing Period||53
89739|NCT01327651|214320|P8|Week 18|Self-administered Dosing Period||49
89740|NCT01327651|214321|P7|Week 18|Self-administered Dosing Period||53
89741|NCT01327651|214322|P6|Week 18|Self-administered Dosing Period||59
89742|NCT01327651|214323|P5|Week 18|Self-administered Dosing Period||57
89743|NCT01327651|214324|P4|Week 18|Self-administered Dosing Period||60
89744|NCT01327651|214325|P3|Week 18|Self-administered Dosing Period||56
89745|NCT01327651|214326|P2|Week 18|Self-administered Dosing Period||56
89746|NCT01327651|214327|P1|Week 18|Self-administered Dosing Period||57
89747|NCT01327651|214319|P9|Week 14|Self-administered Dosing Period||54
89748|NCT01327651|214320|P8|Week 14|Self-administered Dosing Period||51
89749|NCT01327651|214321|P7|Week 14|Self-administered Dosing Period||54
89750|NCT01327651|214322|P6|Week 14|Self-administered Dosing Period||59
89751|NCT01327651|214323|P5|Week 14|Self-administered Dosing Period||58
89752|NCT01327651|214324|P4|Week 14|Self-administered Dosing Period||60
89753|NCT01327651|214325|P3|Week 14|Self-administered Dosing Period||57
89754|NCT01327651|214326|P2|Week 14|Self-administered Dosing Period||55
89755|NCT01327651|214327|P1|Week 14|Self-administered Dosing Period||59
89756|NCT01327651|214319|P9|Week 10|Self-administered Dosing Period||56
89757|NCT01327651|214320|P8|Week 10|Self-administered Dosing Period||57
89758|NCT01327651|214321|P7|Week 10|Self-administered Dosing Period||57
89759|NCT01327651|214322|P6|Week 10|Self-administered Dosing Period||59
89760|NCT01327651|214323|P5|Week 10|Self-administered Dosing Period||59
89761|NCT01327651|214324|P4|Week 10|Self-administered Dosing Period||60
89762|NCT01327651|214325|P3|Week 10|Self-administered Dosing Period||60
89763|NCT01327651|214326|P2|Week 10|Self-administered Dosing Period||58
89764|NCT01327651|214327|P1|Week 10|Self-administered Dosing Period||59
89765|NCT01327651|214319|P9|STARTED|Self-administered Dosing Period||60
89766|NCT01327651|214320|P8|STARTED|Self-administered Dosing Period||60
89767|NCT01327651|214321|P7|STARTED|Self-administered Dosing Period||59
89768|NCT01327651|214322|P6|STARTED|Self-administered Dosing Period||59
89769|NCT01327651|214323|P5|STARTED|Self-administered Dosing Period||59
89770|NCT01327651|214324|P4|STARTED|Self-administered Dosing Period||60
89771|NCT01327651|214325|P3|STARTED|Self-administered Dosing Period||60
89772|NCT01327651|214326|P2|STARTED|Self-administered Dosing Period||59
89773|NCT01327651|214327|P1|STARTED|Self-administered Dosing Period||60
89774|NCT01327599|214446|P1|NOT COMPLETED|Overall Study||3
89775|NCT01327599|214446|P1|COMPLETED|Overall Study||57
89776|NCT01327599|214446|P1|STARTED|Overall Study||60
89777|NCT01327547|214456|P2|NOT COMPLETED|Overall Study||67
89778|NCT01327547|214457|P1|NOT COMPLETED|Overall Study||70
89779|NCT01327547|214456|P2|COMPLETED|Overall Study||0
89780|NCT01327547|214457|P1|COMPLETED|Overall Study||0
89781|NCT01327547|214456|P2|In Study, Off Drug|Overall Study||2
89782|NCT01327547|214457|P1|In Study, Off Drug|Overall Study||2
89783|NCT01327547|214456|P2|STARTED|Overall Study||67
89784|NCT01327547|214457|P1|STARTED|Overall Study||70
89785|NCT01327508|214493|P2|NOT COMPLETED|Overall Study||0
89786|NCT01327508|214494|P1|NOT COMPLETED|Overall Study||0
89787|NCT01327508|214493|P2|COMPLETED|Overall Study||30
89788|NCT01327508|214494|P1|COMPLETED|Overall Study||30
89789|NCT01327508|214493|P2|STARTED|Overall Study||30
89790|NCT01327508|214494|P1|STARTED|Overall Study||30
89791|NCT01327482|214502|P1|NOT COMPLETED|Overall Study||1
89792|NCT01327482|214502|P1|COMPLETED|Overall Study|The 10th participant completed 2/3 visits|9
89793|NCT01327482|214502|P1|STARTED|Overall Study||10
89794|NCT01327339|214507|P1|NOT COMPLETED|Overall Study||8
89795|NCT01327339|214507|P1|COMPLETED|Overall Study||747
89796|NCT01327339|214507|P1|STARTED|Overall Study||755
89797|NCT01327313|214517|P4|NOT COMPLETED|Overall Study||0
89798|NCT01327313|214518|P3|NOT COMPLETED|Overall Study||0
89799|NCT01327313|214519|P2|NOT COMPLETED|Overall Study||0
89800|NCT01327313|214520|P1|NOT COMPLETED|Overall Study||0
89801|NCT01327313|214517|P4|COMPLETED|Overall Study||7
89802|NCT01327313|214518|P3|COMPLETED|Overall Study||6
89803|NCT01327313|214519|P2|COMPLETED|Overall Study||6
89804|NCT01327313|214520|P1|COMPLETED|Overall Study||8
89805|NCT01327313|214517|P4|STARTED|Overall Study||7
89806|NCT01327313|214518|P3|STARTED|Overall Study||6
89807|NCT01327313|214519|P2|STARTED|Overall Study||6
89808|NCT01327313|214520|P1|STARTED|Overall Study||8
89809|NCT01327300|214642|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
89810|NCT01327300|214643|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
89811|NCT01327300|214642|P2|COMPLETED|Second Intervention (12 Weeks)||2
89812|NCT01327300|214643|P1|COMPLETED|Second Intervention (12 Weeks)||4
89813|NCT01327300|214642|P2|STARTED|Second Intervention (12 Weeks)||2
89814|NCT01327300|214643|P1|STARTED|Second Intervention (12 Weeks)||4
89815|NCT01327300|214642|P2|NOT COMPLETED|Washout (3 Weeks)||0
89816|NCT01327300|214643|P1|NOT COMPLETED|Washout (3 Weeks)||1
89817|NCT01327300|214642|P2|COMPLETED|Washout (3 Weeks)||2
89818|NCT01327300|214643|P1|COMPLETED|Washout (3 Weeks)||4
89819|NCT01327300|214642|P2|STARTED|Washout (3 Weeks)||2
89820|NCT01327300|214643|P1|STARTED|Washout (3 Weeks)||5
89821|NCT01327300|214642|P2|NOT COMPLETED|First Intervention (12 Weeks)||0
89822|NCT01327300|214643|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
89823|NCT01327300|214642|P2|COMPLETED|First Intervention (12 Weeks)||2
89824|NCT01327300|214643|P1|COMPLETED|First Intervention (12 Weeks)||5
89825|NCT01327300|214642|P2|STARTED|First Intervention (12 Weeks)||2
89826|NCT01327300|214643|P1|STARTED|First Intervention (12 Weeks)||5
89827|NCT01327053|214661|P2|NOT COMPLETED|Overall Study||105
89828|NCT01327053|214662|P1|NOT COMPLETED|Overall Study||40
89829|NCT01327053|214661|P2|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|46
89830|NCT01327053|214662|P1|COMPLETED|Overall Study|Completed = patients ongoing at time of cut-off date (28-Jun-2013)|39
89831|NCT01327053|214661|P2|STARTED|Overall Study||151
89832|NCT01327053|214662|P1|STARTED|Overall Study||79
89833|NCT01326962|214690|P1|NOT COMPLETED|Overall Study||7
89834|NCT01326962|214690|P1|COMPLETED|Overall Study||21
89835|NCT01326962|214690|P1|STARTED|Overall Study||28
89836|NCT01326910|214708|P2|NOT COMPLETED|Overall Study||3
89837|NCT01326910|214709|P1|NOT COMPLETED|Overall Study||4
89838|NCT01326910|214708|P2|COMPLETED|Overall Study||42
89839|NCT01326910|214709|P1|COMPLETED|Overall Study||41
89840|NCT01326910|214708|P2|STARTED|Overall Study||45
89841|NCT01326910|214709|P1|STARTED|Overall Study||45
89842|NCT01326845|214723|P2|NOT COMPLETED|Overall Study||5
89843|NCT01326845|214724|P1|NOT COMPLETED|Overall Study||7
89844|NCT01326845|214723|P2|COMPLETED|Overall Study|Study terminated early|0
89845|NCT01326845|214724|P1|COMPLETED|Overall Study|Study terminated early|0
89846|NCT01326845|214723|P2|STARTED|Overall Study||5
89847|NCT01326845|214724|P1|STARTED|Overall Study||7
89848|NCT01326533|214748|P2|NOT COMPLETED|Overall Study||0
89849|NCT01326533|214749|P1|NOT COMPLETED|Overall Study||4
89850|NCT01326533|214748|P2|COMPLETED|Overall Study||15
89851|NCT01326533|214749|P1|COMPLETED|Overall Study||13
89852|NCT01326533|214748|P2|STARTED|Overall Study||15
89853|NCT01326533|214749|P1|STARTED|Overall Study||17
89854|NCT01326026|214759|P2|NOT COMPLETED|Overall Study||13
89855|NCT01326026|214760|P1|NOT COMPLETED|Overall Study||12
89856|NCT01326026|214759|P2|COMPLETED|Overall Study||98
89857|NCT01326026|214760|P1|COMPLETED|Overall Study||99
89858|NCT01326026|214759|P2|Exposed|Overall Study||111
89859|NCT01326026|214760|P1|Exposed|Overall Study|One subject withdrew before exposure to trial drug|110
89860|NCT01326026|214759|P2|STARTED|Overall Study||111
89861|NCT01326026|214760|P1|STARTED|Overall Study||111
89862|NCT01325870|214777|P3|NOT COMPLETED|Overall Study||8
89863|NCT01325870|214778|P2|NOT COMPLETED|Overall Study||13
89864|NCT01325870|214779|P1|NOT COMPLETED|Overall Study||11
89865|NCT01325870|214777|P3|COMPLETED|Overall Study||6
89866|NCT01325870|214778|P2|COMPLETED|Overall Study||3
89867|NCT01325870|214779|P1|COMPLETED|Overall Study||7
89868|NCT01325870|214777|P3|STARTED|Overall Study||14
89869|NCT01325870|214778|P2|STARTED|Overall Study||16
89870|NCT01325870|214779|P1|STARTED|Overall Study||18
89871|NCT01325792|214793|P1|NOT COMPLETED|Overall Study||17
89872|NCT01325792|214793|P1|COMPLETED|Overall Study||87
89873|NCT01325792|214793|P1|STARTED|Overall Study||104
89874|NCT01325714|214800|P2|NOT COMPLETED|Overall Study||31
89875|NCT01325714|214801|P1|NOT COMPLETED|Overall Study||34
89876|NCT01325714|214800|P2|COMPLETED|Overall Study||71
89877|NCT01325714|214801|P1|COMPLETED|Overall Study||67
89878|NCT01325714|214800|P2|12 Month Assessment|Overall Study||71
89879|NCT01325714|214801|P1|12 Month Assessment|Overall Study||67
89880|NCT01325714|214800|P2|6 Month Asessment|Overall Study||82
89881|NCT01325714|214801|P1|6 Month Asessment|Overall Study||75
89882|NCT01325714|214800|P2|3 Month Assessment|Overall Study||86
89883|NCT01325714|214801|P1|3 Month Assessment|Overall Study||82
89884|NCT01325714|214800|P2|STARTED|Overall Study||102
89885|NCT01325714|214801|P1|STARTED|Overall Study||101
89886|NCT01325701|214825|P2|NOT COMPLETED|Overall Study||3
89887|NCT01325701|214826|P1|NOT COMPLETED|Overall Study||21
89888|NCT01325701|214825|P2|COMPLETED|Overall Study||5
89889|NCT01325701|214826|P1|COMPLETED|Overall Study||49
89890|NCT01325701|214825|P2|STARTED|Overall Study||8
89891|NCT01325701|214826|P1|STARTED|Overall Study||70
89892|NCT01325623|214836|P1|NOT COMPLETED|Overall Study||3
89893|NCT01325623|214836|P1|COMPLETED|Overall Study||28
89894|NCT01325623|214836|P1|STARTED|Overall Study||31
89895|NCT01325532|214880|P2|NOT COMPLETED|Overall Study||0
89896|NCT01325532|214881|P1|NOT COMPLETED|Overall Study||2
89897|NCT01325532|214880|P2|COMPLETED|Overall Study||13
89898|NCT01325532|214881|P1|COMPLETED|Overall Study||15
89899|NCT01325532|214880|P2|STARTED|Overall Study||13
89900|NCT01325532|214881|P1|STARTED|Overall Study||17
89901|NCT01325493|214893|P2|NOT COMPLETED|Overall Study||3
89902|NCT01325493|214894|P1|NOT COMPLETED|Overall Study||1
89903|NCT01325493|214893|P2|COMPLETED|Overall Study||21
89904|NCT01325493|214894|P1|COMPLETED|Overall Study||29
89905|NCT01325493|214893|P2|STARTED|Overall Study||24
89906|NCT01325493|214894|P1|STARTED|Overall Study||30
89907|NCT01325428|214906|P1|NOT COMPLETED|Part B||3
89908|NCT01325428|214906|P1|COMPLETED|Part B||7
89909|NCT01325428|214906|P1|STARTED|Part B||10
89910|NCT01325428|214906|P1|NOT COMPLETED|Part A||16
89911|NCT01325428|214906|P1|COMPLETED|Part A||10
89912|NCT01325428|214906|P1|STARTED|Part A||26
89913|NCT01325350|214926|P5|NOT COMPLETED|Overall Study||12
89914|NCT01325350|214927|P4|NOT COMPLETED|Overall Study||9
89915|NCT01325350|214928|P3|NOT COMPLETED|Overall Study||17
89916|NCT01325350|214929|P2|NOT COMPLETED|Overall Study||5
89917|NCT01325350|214930|P1|NOT COMPLETED|Overall Study||6
89918|NCT01325350|214926|P5|COMPLETED|Overall Study||50
89919|NCT01325350|214927|P4|COMPLETED|Overall Study||52
89920|NCT01325350|214928|P3|COMPLETED|Overall Study||44
89921|NCT01325350|214929|P2|COMPLETED|Overall Study||56
89922|NCT01325350|214930|P1|COMPLETED|Overall Study||55
89923|NCT01325350|214926|P5|STARTED|Overall Study||62
89924|NCT01325350|214927|P4|STARTED|Overall Study||61
89925|NCT01325350|214928|P3|STARTED|Overall Study||61
89926|NCT01325350|214929|P2|STARTED|Overall Study||61
89927|NCT01325350|214930|P1|STARTED|Overall Study||61
89928|NCT01325337|214972|P5|NOT COMPLETED|Overall Study||8
89929|NCT01325337|214973|P4|NOT COMPLETED|Overall Study||10
89930|NCT01325337|214974|P3|NOT COMPLETED|Overall Study||9
89931|NCT01325337|214975|P2|NOT COMPLETED|Overall Study||9
89932|NCT01325337|214976|P1|NOT COMPLETED|Overall Study||5
89933|NCT01325337|214972|P5|COMPLETED|Overall Study||53
89934|NCT01325337|214973|P4|COMPLETED|Overall Study||52
89935|NCT01325337|214974|P3|COMPLETED|Overall Study||53
89936|NCT01325337|214975|P2|COMPLETED|Overall Study||52
89937|NCT01325337|214976|P1|COMPLETED|Overall Study||56
89938|NCT01325337|214972|P5|STARTED|Overall Study||61
89939|NCT01325337|214973|P4|STARTED|Overall Study||62
89940|NCT01325337|214974|P3|STARTED|Overall Study||62
89941|NCT01325337|214975|P2|STARTED|Overall Study||61
89942|NCT01325337|214976|P1|STARTED|Overall Study||61
89943|NCT01325311|215015|P2|NOT COMPLETED|Overall Study||0
89944|NCT01325311|215016|P1|NOT COMPLETED|Overall Study||0
89945|NCT01325311|215015|P2|COMPLETED|Overall Study||7
89946|NCT01325311|215016|P1|COMPLETED|Overall Study||8
89947|NCT01325311|215015|P2|STARTED|Overall Study||7
89948|NCT01325311|215016|P1|STARTED|Overall Study||8
89949|NCT01325181|215052|P2|NOT COMPLETED|Overall Study||2
89950|NCT01325181|215053|P1|NOT COMPLETED|Overall Study||0
89951|NCT01325181|215052|P2|COMPLETED|Overall Study||14
89952|NCT01325181|215053|P1|COMPLETED|Overall Study||18
89953|NCT01325181|215052|P2|STARTED|Overall Study||16
89954|NCT01325181|215053|P1|STARTED|Overall Study||18
89955|NCT01324999|215059|P1|NOT COMPLETED|Overall Study||5
89956|NCT01324999|215059|P1|COMPLETED|Overall Study||7
89957|NCT01324999|215059|P1|STARTED|Overall Study||12
89958|NCT01324947|215070|P1|NOT COMPLETED|Overall Study||74
89959|NCT01324947|215070|P1|COMPLETED|Overall Study||0
89960|NCT01324947|215070|P1|Efficacy Evaluable Population (EEP)|Overall Study|Participants who received ≥ 1 dose of study drug and had at least 1 postbaseline efficacy assessment|64
89961|NCT01324947|215070|P1|Safety Population|Overall Study|Safety Population includes those who were enrolled and received at least one dose of study drug|73
89962|NCT01324947|215070|P1|STARTED|Overall Study||74
89963|NCT01324882|215083|P2|NOT COMPLETED|Overall Study||0
89964|NCT01324882|215084|P1|NOT COMPLETED|Overall Study||0
89965|NCT01324882|215083|P2|COMPLETED|Overall Study|30 patients had the colonoscopy|30
89966|NCT01324882|215084|P1|COMPLETED|Overall Study|27 patients had the colonoscopy|27
89967|NCT01324882|215083|P2|STARTED|Overall Study|30 patients were randomized to this arm|30
89968|NCT01324882|215084|P1|STARTED|Overall Study|27 patients were randomized to this arm.|27
89969|NCT01324687|215092|P2|NOT COMPLETED|Overall Study||15
89970|NCT01324687|215093|P1|NOT COMPLETED|Overall Study||0
89971|NCT01324687|215092|P2|COMPLETED|Overall Study||479
89972|NCT01324687|215093|P1|COMPLETED|Overall Study||1058
89973|NCT01324687|215092|P2|STARTED|Overall Study||494
89974|NCT01324687|215093|P1|STARTED|Overall Study||1058
89975|NCT01324622|215103|P2|NOT COMPLETED|Overall Study||7
89976|NCT01324622|215104|P1|NOT COMPLETED|Overall Study||9
89977|NCT01324622|215103|P2|COMPLETED|Overall Study||4
89978|NCT01324622|215104|P1|COMPLETED|Overall Study||4
89979|NCT01324622|215103|P2|STARTED|Overall Study||11
89980|NCT01324622|215104|P1|STARTED|Overall Study||13
89981|NCT01324570|215134|P2|NOT COMPLETED|Overall Study||14
89982|NCT01324570|215135|P1|NOT COMPLETED|Overall Study||4
89983|NCT01324570|215134|P2|COMPLETED|Overall Study||21
89984|NCT01324570|215135|P1|COMPLETED|Overall Study||2
89985|NCT01324570|215134|P2|STARTED|Overall Study||35
89986|NCT01324570|215135|P1|STARTED|Overall Study||6
89987|NCT01324440|215149|P2|NOT COMPLETED|Overall Study||1
89988|NCT01324440|215150|P1|NOT COMPLETED|Overall Study||0
89989|NCT01324440|215149|P2|COMPLETED|Overall Study||31
89990|NCT01324440|215150|P1|COMPLETED|Overall Study||32
89991|NCT01324440|215149|P2|STARTED|Overall Study||32
89992|NCT01324440|215150|P1|STARTED|Overall Study||32
89993|NCT01324401|215164|P2|NOT COMPLETED|Overall Study||6
89994|NCT01324401|215165|P1|NOT COMPLETED|Overall Study||1
89995|NCT01324401|215164|P2|COMPLETED|Overall Study|three (3) unable to complete due to adverse events|20
89996|NCT01324401|215165|P1|COMPLETED|Overall Study|one (1) could not tolerate minimum starting dose|3
89997|NCT01324401|215164|P2|STARTED|Overall Study|3 excluded from ITT analysis: 1 screen fail, 2 voluntary withdrawal pre-treatment|26
89998|NCT01324401|215165|P1|STARTED|Overall Study||4
89999|NCT01324388|215176|P4|NOT COMPLETED|Part 2 of Study: Second Intervention||0
90000|NCT01324388|215177|P3|NOT COMPLETED|Part 2 of Study: Second Intervention||1
90001|NCT01324388|215178|P2|NOT COMPLETED|Part 2 of Study: Second Intervention||0
90002|NCT01324388|215179|P1|NOT COMPLETED|Part 2 of Study: Second Intervention||0
90003|NCT01324388|215176|P4|COMPLETED|Part 2 of Study: Second Intervention||9
90004|NCT01324388|215177|P3|COMPLETED|Part 2 of Study: Second Intervention||9
90005|NCT01324388|215178|P2|COMPLETED|Part 2 of Study: Second Intervention||0
90006|NCT01324388|215179|P1|COMPLETED|Part 2 of Study: Second Intervention||0
90007|NCT01324388|215176|P4|STARTED|Part 2 of Study: Second Intervention||9
90008|NCT01324388|215177|P3|STARTED|Part 2 of Study: Second Intervention||10
90009|NCT01324388|215178|P2|STARTED|Part 2 of Study: Second Intervention||0
90010|NCT01324388|215179|P1|STARTED|Part 2 of Study: Second Intervention||0
90011|NCT01324388|215176|P4|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
90012|NCT01324388|215177|P3|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
90013|NCT01324388|215178|P2|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
90014|NCT01324388|215179|P1|NOT COMPLETED|Part 2: Washout of at Least 21 Days||0
90015|NCT01324388|215176|P4|COMPLETED|Part 2: Washout of at Least 21 Days||9
90016|NCT01324388|215177|P3|COMPLETED|Part 2: Washout of at Least 21 Days||10
90017|NCT01324388|215178|P2|COMPLETED|Part 2: Washout of at Least 21 Days||0
90018|NCT01324388|215179|P1|COMPLETED|Part 2: Washout of at Least 21 Days||0
90019|NCT01324388|215176|P4|STARTED|Part 2: Washout of at Least 21 Days||9
90020|NCT01324388|215177|P3|STARTED|Part 2: Washout of at Least 21 Days||10
90021|NCT01324388|215178|P2|STARTED|Part 2: Washout of at Least 21 Days||0
90022|NCT01324388|215179|P1|STARTED|Part 2: Washout of at Least 21 Days||0
90023|NCT01324388|215176|P4|NOT COMPLETED|Part 2 of Study: First Intervention||1
90024|NCT01324388|215177|P3|NOT COMPLETED|Part 2 of Study: First Intervention||0
90025|NCT01324388|215178|P2|NOT COMPLETED|Part 2 of Study: First Intervention||0
90026|NCT01324388|215179|P1|NOT COMPLETED|Part 2 of Study: First Intervention||0
90027|NCT01324388|215176|P4|COMPLETED|Part 2 of Study: First Intervention||9
90028|NCT01324388|215177|P3|COMPLETED|Part 2 of Study: First Intervention||10
90029|NCT01324388|215178|P2|COMPLETED|Part 2 of Study: First Intervention||0
90030|NCT01324388|215179|P1|COMPLETED|Part 2 of Study: First Intervention||0
90031|NCT01324388|215176|P4|STARTED|Part 2 of Study: First Intervention||10
90032|NCT01324388|215177|P3|STARTED|Part 2 of Study: First Intervention||10
90033|NCT01324388|215178|P2|STARTED|Part 2 of Study: First Intervention||0
90034|NCT01324388|215179|P1|STARTED|Part 2 of Study: First Intervention||0
90035|NCT01324388|215176|P4|NOT COMPLETED|Part 1 of Study||0
90036|NCT01324388|215177|P3|NOT COMPLETED|Part 1 of Study||0
90037|NCT01324388|215178|P2|NOT COMPLETED|Part 1 of Study||2
90038|NCT01324388|215179|P1|NOT COMPLETED|Part 1 of Study||4
90039|NCT01324388|215176|P4|COMPLETED|Part 1 of Study||0
90040|NCT01324388|215177|P3|COMPLETED|Part 1 of Study||0
90041|NCT01324388|215178|P2|COMPLETED|Part 1 of Study||6
90042|NCT01324388|215179|P1|COMPLETED|Part 1 of Study||19
90043|NCT01324388|215176|P4|Received at Least 1 Dose|Part 1 of Study||0
90044|NCT01324388|215177|P3|Received at Least 1 Dose|Part 1 of Study||0
90045|NCT01324388|215178|P2|Received at Least 1 Dose|Part 1 of Study||8
90046|NCT01324388|215179|P1|Received at Least 1 Dose|Part 1 of Study||23
90047|NCT01324388|215176|P4|STARTED|Part 1 of Study||0
90048|NCT01324388|215177|P3|STARTED|Part 1 of Study||0
90049|NCT01324388|215178|P2|STARTED|Part 1 of Study||8
90050|NCT01324388|215179|P1|STARTED|Part 1 of Study||23
90051|NCT01324349|215200|P2|NOT COMPLETED|Overall Study||2
90052|NCT01324349|215201|P1|NOT COMPLETED|Overall Study||1
90053|NCT01324349|215200|P2|COMPLETED|Overall Study||16
90054|NCT01324349|215201|P1|COMPLETED|Overall Study||31
90055|NCT01324349|215200|P2|STARTED|Overall Study||18
90056|NCT01324349|215201|P1|STARTED|Overall Study||32
90057|NCT01324323|215211|P1|NOT COMPLETED|Overall Study||1
90058|NCT01324323|215211|P1|COMPLETED|Overall Study||13
90059|NCT01324323|215211|P1|STARTED|Overall Study||14
90060|NCT01324310|215231|P1|NOT COMPLETED|Overall Study||2
90061|NCT01324310|215231|P1|COMPLETED|Overall Study||13
90062|NCT01324310|215231|P1|STARTED|Overall Study||15
90063|NCT01324271|215251|P2|NOT COMPLETED|Overall Study||0
90064|NCT01324271|215252|P1|NOT COMPLETED|Overall Study||4
90065|NCT01324271|215251|P2|COMPLETED|Overall Study||28
90066|NCT01324271|215252|P1|COMPLETED|Overall Study||53
90067|NCT01324271|215251|P2|STARTED|Overall Study||28
90068|NCT01324271|215252|P1|STARTED|Overall Study||57
90069|NCT01324128|215260|P4|NOT COMPLETED|Stage 2||3
90070|NCT01324128|215261|P3|NOT COMPLETED|Stage 2||8
90071|NCT01324128|215262|P2|NOT COMPLETED|Stage 2||0
90072|NCT01324128|215263|P1|NOT COMPLETED|Stage 2||0
90073|NCT01324128|215260|P4|COMPLETED|Stage 2||46
90074|NCT01324128|215261|P3|COMPLETED|Stage 2||42
90075|NCT01324128|215262|P2|COMPLETED|Stage 2||0
90076|NCT01324128|215263|P1|COMPLETED|Stage 2||0
90077|NCT01324128|215260|P4|STARTED|Stage 2||49
90078|NCT01324128|215261|P3|STARTED|Stage 2||50
90079|NCT01324128|215262|P2|STARTED|Stage 2||0
90080|NCT01324128|215263|P1|STARTED|Stage 2||0
90081|NCT01324128|215260|P4|NOT COMPLETED|Stage 1||0
90082|NCT01324128|215261|P3|NOT COMPLETED|Stage 1||0
90083|NCT01324128|215262|P2|NOT COMPLETED|Stage 1||56
90084|NCT01324128|215263|P1|NOT COMPLETED|Stage 1||195
90085|NCT01324128|215260|P4|COMPLETED|Stage 1||0
90086|NCT01324128|215261|P3|COMPLETED|Stage 1||0
90087|NCT01324128|215262|P2|COMPLETED|Stage 1||293
90088|NCT01324128|215263|P1|COMPLETED|Stage 1||515
90089|NCT01324128|215260|P4|STARTED|Stage 1||0
90090|NCT01324128|215261|P3|STARTED|Stage 1||0
90091|NCT01324128|215262|P2|STARTED|Stage 1||349
90092|NCT01324128|215263|P1|STARTED|Stage 1||710
90093|NCT01324102|215275|P2|NOT COMPLETED|Overall Study||6
90094|NCT01324102|215276|P1|NOT COMPLETED|Overall Study||1
90095|NCT01324102|215275|P2|COMPLETED|Overall Study||6
90096|NCT01324102|215276|P1|COMPLETED|Overall Study||10
90097|NCT01324102|215275|P2|STARTED|Overall Study|Yoga group 4 and 6|12
90098|NCT01324102|215276|P1|STARTED|Overall Study|Yoga groups 3 and 5 (not including pre-randomization group)|11
90099|NCT01324024|215283|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
90100|NCT01324024|215284|P1|NOT COMPLETED|Second Intervention (4 Weeks)||2
90101|NCT01324024|215283|P2|COMPLETED|Second Intervention (4 Weeks)||16
90102|NCT01324024|215284|P1|COMPLETED|Second Intervention (4 Weeks)||16
90103|NCT01324024|215283|P2|STARTED|Second Intervention (4 Weeks)||17
90104|NCT01324024|215284|P1|STARTED|Second Intervention (4 Weeks)||18
90105|NCT01324024|215283|P2|NOT COMPLETED|Washout (2 Weeks)||0
90106|NCT01324024|215284|P1|NOT COMPLETED|Washout (2 Weeks)||0
90107|NCT01324024|215283|P2|COMPLETED|Washout (2 Weeks)||17
90108|NCT01324024|215284|P1|COMPLETED|Washout (2 Weeks)||18
90109|NCT01324024|215283|P2|STARTED|Washout (2 Weeks)||17
90110|NCT01324024|215284|P1|STARTED|Washout (2 Weeks)||18
90111|NCT01324024|215283|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
90112|NCT01324024|215284|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
90113|NCT01324024|215283|P2|COMPLETED|First Intervention (4 Weeks)||17
90114|NCT01324024|215284|P1|COMPLETED|First Intervention (4 Weeks)||18
90115|NCT01324024|215283|P2|STARTED|First Intervention (4 Weeks)||17
90116|NCT01324024|215284|P1|STARTED|First Intervention (4 Weeks)||18
90117|NCT01323998|215302|P5|NOT COMPLETED|Overall Study||0
90118|NCT01323998|215303|P4|NOT COMPLETED|Overall Study||0
90119|NCT01323998|215304|P3|NOT COMPLETED|Overall Study||0
90120|NCT01323998|215305|P2|NOT COMPLETED|Overall Study||0
90121|NCT01323998|215306|P1|NOT COMPLETED|Overall Study||0
90122|NCT01323998|215302|P5|COMPLETED|Overall Study||6735
90123|NCT01323998|215303|P4|COMPLETED|Overall Study||12052
90124|NCT01323998|215304|P3|COMPLETED|Overall Study||10294
90125|NCT01323998|215305|P2|COMPLETED|Overall Study||18681
90126|NCT01323998|215306|P1|COMPLETED|Overall Study||200631
90127|NCT01323998|215302|P5|STARTED|Overall Study||6735
90128|NCT01323998|215303|P4|STARTED|Overall Study||12052
90129|NCT01323998|215304|P3|STARTED|Overall Study||10294
90130|NCT01323998|215305|P2|STARTED|Overall Study||18681
90131|NCT01323998|215306|P1|STARTED|Overall Study||200631
90132|NCT01323972|215322|P4|NOT COMPLETED|Overall Study||1
90133|NCT01323972|215323|P3|NOT COMPLETED|Overall Study||2
90134|NCT01323972|215324|P2|NOT COMPLETED|Overall Study||3
90135|NCT01323972|215325|P1|NOT COMPLETED|Overall Study||2
90136|NCT01323972|215322|P4|COMPLETED|Overall Study||79
90137|NCT01323972|215323|P3|COMPLETED|Overall Study||78
90138|NCT01323972|215324|P2|COMPLETED|Overall Study||76
90139|NCT01323972|215325|P1|COMPLETED|Overall Study||79
90140|NCT01323972|215322|P4|STARTED|Overall Study||80
90141|NCT01323972|215323|P3|STARTED|Overall Study||80
90142|NCT01323972|215324|P2|STARTED|Overall Study||79
90143|NCT01323972|215325|P1|STARTED|Overall Study||81
90144|NCT01323959|215360|P3|NOT COMPLETED|Overall Study||0
90145|NCT01323959|215361|P2|NOT COMPLETED|Overall Study||0
90146|NCT01323959|215362|P1|NOT COMPLETED|Overall Study||0
90147|NCT01323959|215360|P3|COMPLETED|Overall Study||72
90148|NCT01323959|215361|P2|COMPLETED|Overall Study||72
90149|NCT01323959|215362|P1|COMPLETED|Overall Study||67
90150|NCT01323959|215360|P3|STARTED|Overall Study||72
90151|NCT01323959|215361|P2|STARTED|Overall Study||72
90152|NCT01323959|215362|P1|STARTED|Overall Study||67
90153|NCT01323920|215418|P1|NOT COMPLETED|Overall Study||6
90154|NCT01323920|215418|P1|COMPLETED|Overall Study||29
90155|NCT01323920|215418|P1|STARTED|Overall Study||35
90156|NCT01323855|215430|P5|NOT COMPLETED|Overall Study||0
90157|NCT01323855|215431|P4|NOT COMPLETED|Overall Study||0
90158|NCT01323855|215432|P3|NOT COMPLETED|Overall Study||0
90159|NCT01323855|215433|P2|NOT COMPLETED|Overall Study||0
90160|NCT01323855|215434|P1|NOT COMPLETED|Overall Study||0
90161|NCT01323855|215430|P5|COMPLETED|Overall Study||11
90162|NCT01323855|215431|P4|COMPLETED|Overall Study||9
90163|NCT01323855|215432|P3|COMPLETED|Overall Study||8
90164|NCT01323855|215433|P2|COMPLETED|Overall Study||9
90165|NCT01323855|215434|P1|COMPLETED|Overall Study||9
90166|NCT01323855|215430|P5|STARTED|Overall Study||11
90167|NCT01323855|215431|P4|STARTED|Overall Study||9
90168|NCT01323855|215432|P3|STARTED|Overall Study||8
90169|NCT01323855|215433|P2|STARTED|Overall Study||9
90170|NCT01323855|215434|P1|STARTED|Overall Study||9
90171|NCT01323790|215459|P3|NOT COMPLETED|Overall Study||45
90172|NCT01323790|215460|P2|NOT COMPLETED|Overall Study||60
90173|NCT01323790|215461|P1|NOT COMPLETED|Overall Study||55
90174|NCT01323790|215459|P3|COMPLETED|Overall Study||188
90175|NCT01323790|215460|P2|COMPLETED|Overall Study||174
90176|NCT01323790|215461|P1|COMPLETED|Overall Study||178
90177|NCT01323790|215459|P3|STARTED|Overall Study||233
90178|NCT01323790|215460|P2|STARTED|Overall Study||234
90179|NCT01323790|215461|P1|STARTED|Overall Study||233
90180|NCT01323777|215499|P1|NOT COMPLETED|Overall Study||0
90181|NCT01323777|215499|P1|COMPLETED|Overall Study||65
90182|NCT01323777|215499|P1|STARTED|Overall Study||65
90183|NCT01323673|215512|P2|NOT COMPLETED|Overall Study||5
90184|NCT01323673|215513|P1|NOT COMPLETED|Overall Study||3
90185|NCT01323673|215512|P2|COMPLETED|Overall Study||58
90186|NCT01323673|215513|P1|COMPLETED|Overall Study||59
90187|NCT01323673|215512|P2|STARTED|Overall Study||63
90188|NCT01323673|215513|P1|STARTED|Overall Study||62
90189|NCT01323660|215533|P6|NOT COMPLETED|Treatment Period 2 (12 Weeks)||7
90190|NCT01323660|215534|P5|NOT COMPLETED|Treatment Period 2 (12 Weeks)||4
90191|NCT01323660|215535|P4|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
90192|NCT01323660|215536|P3|NOT COMPLETED|Treatment Period 2 (12 Weeks)||3
90193|NCT01323660|215537|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||1
90194|NCT01323660|215538|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||12
90195|NCT01323660|215533|P6|COMPLETED|Treatment Period 2 (12 Weeks)||51
90196|NCT01323660|215534|P5|COMPLETED|Treatment Period 2 (12 Weeks)||55
90197|NCT01323660|215535|P4|COMPLETED|Treatment Period 2 (12 Weeks)||25
90198|NCT01323660|215536|P3|COMPLETED|Treatment Period 2 (12 Weeks)||14
90199|NCT01323660|215537|P2|COMPLETED|Treatment Period 2 (12 Weeks)||17
90200|NCT01323660|215538|P1|COMPLETED|Treatment Period 2 (12 Weeks)||55
90201|NCT01323660|215533|P6|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|58
90202|NCT01323660|215534|P5|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|59
90203|NCT01323660|215535|P4|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|28
90204|NCT01323660|215536|P3|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|17
90205|NCT01323660|215537|P2|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|18
90206|NCT01323660|215538|P1|STARTED|Treatment Period 2 (12 Weeks)|“By crossover design, participants were assigned to a different treatment arm in each period.|67
90207|NCT01323660|215533|P6|NOT COMPLETED|Washout Period (14 Days)||2
90208|NCT01323660|215534|P5|NOT COMPLETED|Washout Period (14 Days)||3
90209|NCT01323660|215535|P4|NOT COMPLETED|Washout Period (14 Days)||3
90210|NCT01323660|215536|P3|NOT COMPLETED|Washout Period (14 Days)||1
90211|NCT01323660|215537|P2|NOT COMPLETED|Washout Period (14 Days)||0
90212|NCT01323660|215538|P1|NOT COMPLETED|Washout Period (14 Days)||0
90213|NCT01323660|215533|P6|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|59
90214|NCT01323660|215534|P5|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|58
90215|NCT01323660|215535|P4|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|28
90216|NCT01323660|215536|P3|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|18
90217|NCT01323660|215537|P2|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|21
90218|NCT01323660|215538|P1|COMPLETED|Washout Period (14 Days)|Participants withdrawing during washout are counted under the last treatment taken.|65
90219|NCT01323660|215533|P6|STARTED|Washout Period (14 Days)||61
90220|NCT01323660|215534|P5|STARTED|Washout Period (14 Days)||61
90221|NCT01323660|215535|P4|STARTED|Washout Period (14 Days)||31
90222|NCT01323660|215536|P3|STARTED|Washout Period (14 Days)||19
90223|NCT01323660|215537|P2|STARTED|Washout Period (14 Days)||21
90224|NCT01323660|215538|P1|STARTED|Washout Period (14 Days)||65
90225|NCT01323660|215533|P6|NOT COMPLETED|Treatment Period 1 (12 Weeks)||9
90226|NCT01323660|215534|P5|NOT COMPLETED|Treatment Period 1 (12 Weeks)||10
90227|NCT01323660|215535|P4|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
90228|NCT01323660|215536|P3|NOT COMPLETED|Treatment Period 1 (12 Weeks)||5
90229|NCT01323660|215537|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||1
90230|NCT01323660|215538|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||19
90231|NCT01323660|215533|P6|COMPLETED|Treatment Period 1 (12 Weeks)||61
90232|NCT01323660|215534|P5|COMPLETED|Treatment Period 1 (12 Weeks)||61
90233|NCT01323660|215535|P4|COMPLETED|Treatment Period 1 (12 Weeks)||31
90234|NCT01323660|215536|P3|COMPLETED|Treatment Period 1 (12 Weeks)||19
90235|NCT01323660|215537|P2|COMPLETED|Treatment Period 1 (12 Weeks)||21
90236|NCT01323660|215538|P1|COMPLETED|Treatment Period 1 (12 Weeks)||65
90237|NCT01323660|215533|P6|STARTED|Treatment Period 1 (12 Weeks)||70
90238|NCT01323660|215534|P5|STARTED|Treatment Period 1 (12 Weeks)||71
90239|NCT01323660|215535|P4|STARTED|Treatment Period 1 (12 Weeks)||36
90240|NCT01323660|215536|P3|STARTED|Treatment Period 1 (12 Weeks)||24
90241|NCT01323660|215537|P2|STARTED|Treatment Period 1 (12 Weeks)||22
90242|NCT01323660|215538|P1|STARTED|Treatment Period 1 (12 Weeks)||84
90243|NCT01323647|215584|P2|NOT COMPLETED|Overall Study||0
90244|NCT01323647|215585|P1|NOT COMPLETED|Overall Study||9
90245|NCT01323647|215584|P2|COMPLETED|Overall Study||487
90246|NCT01323647|215585|P1|COMPLETED|Overall Study||461
90247|NCT01323647|215584|P2|STARTED|Overall Study||487
90248|NCT01323647|215585|P1|STARTED|Overall Study||470
90249|NCT01323634|215602|P3|NOT COMPLETED|Double-Blind (DB) Treatment Period||22
90250|NCT01323634|215603|P2|NOT COMPLETED|Double-Blind (DB) Treatment Period||25
90251|NCT01323634|215604|P1|NOT COMPLETED|Double-Blind (DB) Treatment Period||0
90252|NCT01323634|215602|P3|COMPLETED|Double-Blind (DB) Treatment Period||239
90253|NCT01323634|215603|P2|COMPLETED|Double-Blind (DB) Treatment Period||235
90254|NCT01323634|215604|P1|COMPLETED|Double-Blind (DB) Treatment Period||0
90255|NCT01323634|215602|P3|STARTED|Double-Blind (DB) Treatment Period||261
90256|NCT01323634|215603|P2|STARTED|Double-Blind (DB) Treatment Period||260
90257|NCT01323634|215604|P1|STARTED|Double-Blind (DB) Treatment Period||0
90258|NCT01323634|215602|P3|NOT COMPLETED|2-week Run-in Period||0
90259|NCT01323634|215603|P2|NOT COMPLETED|2-week Run-in Period||0
90260|NCT01323634|215604|P1|NOT COMPLETED|2-week Run-in Period||212
90261|NCT01323634|215602|P3|COMPLETED|2-week Run-in Period||0
90262|NCT01323634|215603|P2|COMPLETED|2-week Run-in Period||0
90263|NCT01323634|215604|P1|COMPLETED|2-week Run-in Period||521
90264|NCT01323634|215602|P3|STARTED|2-week Run-in Period||0
90265|NCT01323634|215603|P2|STARTED|2-week Run-in Period||0
90266|NCT01323634|215604|P1|STARTED|2-week Run-in Period||733
90267|NCT01323621|215614|P3|NOT COMPLETED|12-week, Double-blind Treatment Period||20
90268|NCT01323621|215615|P2|NOT COMPLETED|12-week, Double-blind Treatment Period||15
90269|NCT01323621|215616|P1|NOT COMPLETED|12-week, Double-blind Treatment Period||0
90270|NCT01323621|215614|P3|COMPLETED|12-week, Double-blind Treatment Period||239
90271|NCT01323621|215615|P2|COMPLETED|12-week, Double-blind Treatment Period||237
90272|NCT01323621|215616|P1|COMPLETED|12-week, Double-blind Treatment Period||0
90273|NCT01323621|215614|P3|STARTED|12-week, Double-blind Treatment Period||259
90274|NCT01323621|215615|P2|STARTED|12-week, Double-blind Treatment Period||252
90275|NCT01323621|215616|P1|STARTED|12-week, Double-blind Treatment Period||0
90276|NCT01323621|215614|P3|NOT COMPLETED|2-week, Single-blind Run In Period||0
90277|NCT01323621|215615|P2|NOT COMPLETED|2-week, Single-blind Run In Period||0
90278|NCT01323621|215616|P1|NOT COMPLETED|2-week, Single-blind Run In Period||228
90279|NCT01323621|215614|P3|COMPLETED|2-week, Single-blind Run In Period||0
90280|NCT01323621|215615|P2|COMPLETED|2-week, Single-blind Run In Period||0
90281|NCT01323621|215616|P1|COMPLETED|2-week, Single-blind Run In Period||511
90282|NCT01323621|215614|P3|STARTED|2-week, Single-blind Run In Period||0
90283|NCT01323621|215615|P2|STARTED|2-week, Single-blind Run In Period||0
90284|NCT01323621|215616|P1|STARTED|2-week, Single-blind Run In Period||739
90285|NCT01323595|215626|P2|NOT COMPLETED|Overall Study||21
90286|NCT01323595|215627|P1|NOT COMPLETED|Overall Study||23
90287|NCT01323595|215626|P2|COMPLETED|Overall Study|Remaining subjects did not return questionaire|18
90288|NCT01323595|215627|P1|COMPLETED|Overall Study|Remaining subjects did not return questionnaire|16
90289|NCT01323595|215626|P2|STARTED|Overall Study||39
90290|NCT01323595|215627|P1|STARTED|Overall Study||39
90291|NCT01323582|215635|P2|NOT COMPLETED|Weeks 8-11 (Period 2)||1
90292|NCT01323582|215636|P1|NOT COMPLETED|Weeks 8-11 (Period 2)||0
90293|NCT01323582|215635|P2|COMPLETED|Weeks 8-11 (Period 2)||10
90294|NCT01323582|215636|P1|COMPLETED|Weeks 8-11 (Period 2)||10
90295|NCT01323582|215635|P2|STARTED|Weeks 8-11 (Period 2)||11
90296|NCT01323582|215636|P1|STARTED|Weeks 8-11 (Period 2)||10
90297|NCT01323582|215635|P2|NOT COMPLETED|Weeks 5-7 (Washout)||1
90298|NCT01323582|215636|P1|NOT COMPLETED|Weeks 5-7 (Washout)||0
90299|NCT01323582|215635|P2|COMPLETED|Weeks 5-7 (Washout)||11
90300|NCT01323582|215636|P1|COMPLETED|Weeks 5-7 (Washout)||10
90301|NCT01323582|215635|P2|STARTED|Weeks 5-7 (Washout)||12
90302|NCT01323582|215636|P1|STARTED|Weeks 5-7 (Washout)||10
90303|NCT01323582|215635|P2|NOT COMPLETED|Weeks 1-4 (First Period)||2
90304|NCT01323582|215636|P1|NOT COMPLETED|Weeks 1-4 (First Period)||2
90305|NCT01323582|215635|P2|COMPLETED|Weeks 1-4 (First Period)||12
90306|NCT01323582|215636|P1|COMPLETED|Weeks 1-4 (First Period)||10
90307|NCT01323582|215635|P2|STARTED|Weeks 1-4 (First Period)||14
90308|NCT01323582|215636|P1|STARTED|Weeks 1-4 (First Period)||12
90309|NCT01323478|215652|P1|NOT COMPLETED|Overall Study||24
90310|NCT01323478|215652|P1|COMPLETED|Overall Study||47
90311|NCT01323478|215652|P1|STARTED|Overall Study||71
90312|NCT01323387|215665|P1|NOT COMPLETED|Overall Study||84
90313|NCT01323387|215665|P1|COMPLETED|Overall Study||94
90314|NCT01323387|215665|P1|STARTED|Overall Study|178 subjects enrolled, 162 subjects treated, 150 subjects analyzed per protocol.|178
90315|NCT01323270|215678|P2|NOT COMPLETED|Overall Study||29
90316|NCT01323270|215679|P1|NOT COMPLETED|Overall Study||43
90317|NCT01323270|215678|P2|COMPLETED|Overall Study||347
90318|NCT01323270|215679|P1|COMPLETED|Overall Study||330
90319|NCT01323270|215678|P2|STARTED|Overall Study||376
90320|NCT01323270|215679|P1|STARTED|Overall Study||373
90321|NCT01323192|215701|P2|NOT COMPLETED|Overall Study||6
90322|NCT01323192|215702|P1|NOT COMPLETED|Overall Study||9
90323|NCT01323192|215701|P2|COMPLETED|Overall Study||135
90324|NCT01323192|215702|P1|COMPLETED|Overall Study||134
90325|NCT01323192|215701|P2|STARTED|Overall Study||141
90326|NCT01323192|215702|P1|STARTED|Overall Study||143
90327|NCT01323140|215718|P1|NOT COMPLETED|Overall Study||2
90328|NCT01323140|215718|P1|COMPLETED|Overall Study||38
90329|NCT01323140|215718|P1|STARTED|Overall Study||40
90330|NCT01323010|215724|P2|NOT COMPLETED|Overall Study||0
90331|NCT01323010|215725|P1|NOT COMPLETED|Overall Study||0
90332|NCT01323010|215724|P2|COMPLETED|Overall Study||59
90333|NCT01323010|215725|P1|COMPLETED|Overall Study||60
90334|NCT01323010|215724|P2|STARTED|Overall Study||59
90335|NCT01323010|215725|P1|STARTED|Overall Study||60
90336|NCT01322971|215776|P2|NOT COMPLETED|Overall Study||1
90337|NCT01322971|215777|P1|NOT COMPLETED|Overall Study||1
90338|NCT01322971|215776|P2|COMPLETED|Overall Study||0
90339|NCT01322971|215777|P1|COMPLETED|Overall Study||0
90340|NCT01322971|215776|P2|STARTED|Overall Study||1
90341|NCT01322971|215777|P1|STARTED|Overall Study||1
90342|NCT01322945|215791|P2|NOT COMPLETED|Overall Study||0
90343|NCT01322945|215792|P1|NOT COMPLETED|Overall Study||0
90344|NCT01322945|215791|P2|COMPLETED|Overall Study||42
90345|NCT01322945|215792|P1|COMPLETED|Overall Study||52
90346|NCT01322945|215791|P2|STARTED|Overall Study||42
90347|NCT01322945|215792|P1|STARTED|Overall Study||52
90348|NCT01322841|215802|P2|NOT COMPLETED|Overall Study||0
90349|NCT01322841|215803|P1|NOT COMPLETED|Overall Study||0
90350|NCT01322841|215802|P2|COMPLETED|Overall Study||1123
90351|NCT01322841|215803|P1|COMPLETED|Overall Study||1116
90352|NCT01322841|215802|P2|STARTED|Overall Study||1123
90353|NCT01322841|215803|P1|STARTED|Overall Study||1116
90354|NCT01322815|215813|P2|NOT COMPLETED|Overall Study||0
90355|NCT01322815|215814|P1|NOT COMPLETED|Overall Study||0
90356|NCT01322815|215813|P2|COMPLETED|Overall Study||4
90357|NCT01322815|215814|P1|COMPLETED|Overall Study||7
90358|NCT01322815|215813|P2|STARTED|Overall Study||4
90359|NCT01322815|215814|P1|STARTED|Overall Study||7
90360|NCT01322633|215822|P2|NOT COMPLETED|Overall Study||0
90361|NCT01322633|215823|P1|NOT COMPLETED|Overall Study||0
90362|NCT01322633|215822|P2|COMPLETED|Overall Study||27686
90363|NCT01322633|215823|P1|COMPLETED|Overall Study||34178
90364|NCT01322633|215822|P2|STARTED|Overall Study||27686
90365|NCT01322633|215823|P1|STARTED|Overall Study||34178
90366|NCT01322607|215835|P2|NOT COMPLETED|Overall Study||0
90367|NCT01322607|215836|P1|NOT COMPLETED|Overall Study||1
90368|NCT01322607|215835|P2|COMPLETED|Overall Study||9
90369|NCT01322607|215836|P1|COMPLETED|Overall Study||10
90370|NCT01322607|215835|P2|STARTED|Overall Study||9
90371|NCT01322607|215836|P1|STARTED|Overall Study||11
90372|NCT01322594|215854|P6|NOT COMPLETED|Overall Study||0
90373|NCT01322594|215855|P5|NOT COMPLETED|Overall Study||0
90374|NCT01322594|215856|P4|NOT COMPLETED|Overall Study||0
90375|NCT01322594|215857|P3|NOT COMPLETED|Overall Study||0
90376|NCT01322594|215858|P2|NOT COMPLETED|Overall Study||0
90377|NCT01322594|215859|P1|NOT COMPLETED|Overall Study||0
90378|NCT01322594|215854|P6|COMPLETED|Overall Study||6
90379|NCT01322594|215855|P5|COMPLETED|Overall Study||7
90380|NCT01322594|215856|P4|COMPLETED|Overall Study||6
90381|NCT01322594|215857|P3|COMPLETED|Overall Study||3
90382|NCT01322594|215858|P2|COMPLETED|Overall Study||3
90383|NCT01322594|215859|P1|COMPLETED|Overall Study||6
90384|NCT01322594|215854|P6|STARTED|Overall Study||6
90385|NCT01322594|215855|P5|STARTED|Overall Study||7
90386|NCT01322594|215856|P4|STARTED|Overall Study||6
90387|NCT01322594|215857|P3|STARTED|Overall Study||3
90388|NCT01322594|215858|P2|STARTED|Overall Study||3
90389|NCT01322594|215859|P1|STARTED|Overall Study|RANDOMIZED SUBJECTS THROUGH STUDY DAY 240-300|6
90390|NCT01322386|215941|P2|NOT COMPLETED|Overall Study||2
90391|NCT01322386|215942|P1|NOT COMPLETED|Overall Study||0
90392|NCT01322386|215941|P2|COMPLETED|Overall Study||9
90393|NCT01322386|215942|P1|COMPLETED|Overall Study||10
90394|NCT01322386|215941|P2|STARTED|Overall Study||11
90395|NCT01322386|215942|P1|STARTED|Overall Study||10
90396|NCT01322360|215950|P1|NOT COMPLETED|Overall Study||0
90397|NCT01322360|215950|P1|COMPLETED|Overall Study||50
90398|NCT01322360|215950|P1|STARTED|Overall Study||50
90399|NCT01322347|215957|P2|NOT COMPLETED|Overall Study||35
90400|NCT01322347|215958|P1|NOT COMPLETED|Overall Study||51
90401|NCT01322347|215957|P2|COMPLETED|Overall Study||112
90402|NCT01322347|215958|P1|COMPLETED|Overall Study||96
90403|NCT01322347|215957|P2|Completed St 3|Overall Study||86
90404|NCT01322347|215958|P1|Completed St 3|Overall Study||82
90405|NCT01322347|215957|P2|Enrolled in St 3|Overall Study||113
90406|NCT01322347|215958|P1|Enrolled in St 3|Overall Study||101
90407|NCT01322347|215957|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||90
90408|NCT01322347|215958|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||68
90409|NCT01322347|215957|P2|Completed 48 Wks in St 2|Overall Study||22
90410|NCT01322347|215958|P1|Completed 48 Wks in St 2|Overall Study||28
90411|NCT01322347|215957|P2|STARTED|Overall Study||147
90412|NCT01322347|215958|P1|STARTED|Overall Study||147
90413|NCT01322048|215995|P2|NOT COMPLETED|Overall Study||0
90414|NCT01322048|215996|P1|NOT COMPLETED|Overall Study||0
90415|NCT01322048|215995|P2|COMPLETED|Overall Study||26
90416|NCT01322048|215996|P1|COMPLETED|Overall Study||21
90417|NCT01322048|215995|P2|STARTED|Overall Study||26
90418|NCT01322048|215996|P1|STARTED|Overall Study||21
90419|NCT01322022|216006|P2|NOT COMPLETED|Overall Study||2
90420|NCT01322022|216007|P1|NOT COMPLETED|Overall Study||5
90421|NCT01322022|216006|P2|COMPLETED|Overall Study||18
90422|NCT01322022|216007|P1|COMPLETED|Overall Study||15
90423|NCT01322022|216006|P2|Week 4|Overall Study||18
90424|NCT01322022|216007|P1|Week 4|Overall Study||15
90425|NCT01322022|216006|P2|STARTED|Overall Study||20
90426|NCT01322022|216007|P1|STARTED|Overall Study||20
90427|NCT01322009|216021|P2|NOT COMPLETED|Overall Study||3
90428|NCT01322009|216022|P1|NOT COMPLETED|Overall Study||0
90429|NCT01322009|216021|P2|COMPLETED|Overall Study||4
90430|NCT01322009|216022|P1|COMPLETED|Overall Study||7
90431|NCT01322009|216021|P2|STARTED|Overall Study||7
90432|NCT01322009|216022|P1|STARTED|Overall Study||7
90433|NCT01321749|216032|P2|NOT COMPLETED|Overall Study||22
90434|NCT01321749|216033|P1|NOT COMPLETED|Overall Study||13
90435|NCT01321749|216032|P2|COMPLETED|Overall Study||30
90436|NCT01321749|216033|P1|COMPLETED|Overall Study||38
90437|NCT01321749|216032|P2|STARTED|Overall Study||52
90438|NCT01321749|216033|P1|STARTED|Overall Study||51
90439|NCT01321723|216042|P3|NOT COMPLETED|Overall Study||4
90440|NCT01321723|216043|P2|NOT COMPLETED|Overall Study||5
90441|NCT01321723|216044|P1|NOT COMPLETED|Overall Study||5
90442|NCT01321723|216042|P3|COMPLETED|Overall Study||28
90443|NCT01321723|216043|P2|COMPLETED|Overall Study||28
90444|NCT01321723|216044|P1|COMPLETED|Overall Study||27
90445|NCT01321723|216042|P3|STARTED|Overall Study||32
90446|NCT01321723|216043|P2|STARTED|Overall Study||33
90447|NCT01321723|216044|P1|STARTED|Overall Study||32
90448|NCT01321710|216066|P3|NOT COMPLETED|Overall Study||0
90449|NCT01321710|216067|P2|NOT COMPLETED|Overall Study||5
90450|NCT01321710|216068|P1|NOT COMPLETED|Overall Study||4
90451|NCT01321710|216066|P3|COMPLETED|Overall Study||44
90452|NCT01321710|216067|P2|COMPLETED|Overall Study||53
90453|NCT01321710|216068|P1|COMPLETED|Overall Study||46
90454|NCT01321710|216066|P3|STARTED|Overall Study||44
90455|NCT01321710|216067|P2|STARTED|Overall Study||58
90456|NCT01321710|216068|P1|STARTED|Overall Study||50
90457|NCT01321697|216083|P1|NOT COMPLETED|Overall Study||7
90458|NCT01321697|216083|P1|COMPLETED|Overall Study||0
90459|NCT01321697|216083|P1|STARTED|Overall Study||7
90460|NCT01320553|216091|P4|NOT COMPLETED|Overall Study||1
90461|NCT01320553|216092|P3|NOT COMPLETED|Overall Study||2
90462|NCT01320553|216093|P2|NOT COMPLETED|Overall Study||4
90463|NCT01320553|216094|P1|NOT COMPLETED|Overall Study||1
90464|NCT01320553|216091|P4|COMPLETED|Overall Study||29
90465|NCT01320553|216092|P3|COMPLETED|Overall Study||29
90466|NCT01320553|216093|P2|COMPLETED|Overall Study||26
90467|NCT01320553|216094|P1|COMPLETED|Overall Study||30
90468|NCT01320553|216091|P4|STARTED|Overall Study||30
90469|NCT01320553|216092|P3|STARTED|Overall Study||31
90470|NCT01320553|216093|P2|STARTED|Overall Study||30
90471|NCT01320553|216094|P1|STARTED|Overall Study||31
90472|NCT01321554|216110|P4|NOT COMPLETED|OOL Lenvatinib Treatment Period||2
90473|NCT01321554|216111|P3|NOT COMPLETED|OOL Lenvatinib Treatment Period||28
90474|NCT01321554|216112|P2|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
90475|NCT01321554|216113|P1|NOT COMPLETED|OOL Lenvatinib Treatment Period||0
90476|NCT01321554|216110|P4|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|25
90477|NCT01321554|216111|P3|COMPLETED|OOL Lenvatinib Treatment Period|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|54
90478|NCT01321554|216112|P2|COMPLETED|OOL Lenvatinib Treatment Period||0
90479|NCT01321554|216113|P1|COMPLETED|OOL Lenvatinib Treatment Period||0
90480|NCT01321554|216110|P4|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||3
90481|NCT01321554|216111|P3|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||18
90482|NCT01321554|216112|P2|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
90483|NCT01321554|216113|P1|Discontinued Due to Disease Progression|OOL Lenvatinib Treatment Period||0
90484|NCT01321554|216110|P4|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||22
90485|NCT01321554|216111|P3|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||36
90486|NCT01321554|216112|P2|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
90487|NCT01321554|216113|P1|Treatment Ongoing at Data Cutoff|OOL Lenvatinib Treatment Period||0
90488|NCT01321554|216110|P4|STARTED|OOL Lenvatinib Treatment Period||27
90489|NCT01321554|216111|P3|STARTED|OOL Lenvatinib Treatment Period||82
90490|NCT01321554|216112|P2|STARTED|OOL Lenvatinib Treatment Period||0
90491|NCT01321554|216113|P1|STARTED|OOL Lenvatinib Treatment Period||0
90492|NCT01321554|216110|P4|NOT COMPLETED|Randomization Phase||0
90493|NCT01321554|216111|P3|NOT COMPLETED|Randomization Phase||0
90494|NCT01321554|216112|P2|NOT COMPLETED|Randomization Phase||4
90495|NCT01321554|216113|P1|NOT COMPLETED|Randomization Phase||45
90496|NCT01321554|216110|P4|COMPLETED|Randomization Phase||0
90497|NCT01321554|216111|P3|COMPLETED|Randomization Phase||0
90498|NCT01321554|216112|P2|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|127
90499|NCT01321554|216113|P1|COMPLETED|Randomization Phase|Discontinued due to disease progression or treatment ongoing at data cut off (15 Nov 2013)|216
90500|NCT01321554|216110|P4|Discontinued Due to Disease Progression|Randomization Phase||0
90501|NCT01321554|216111|P3|Discontinued Due to Disease Progression|Randomization Phase||0
90502|NCT01321554|216112|P2|Discontinued Due to Disease Progression|Randomization Phase||119
90503|NCT01321554|216113|P1|Discontinued Due to Disease Progression|Randomization Phase||94
90504|NCT01321554|216110|P4|Treatment Ongoing at Data Cutoff|Randomization Phase||0
90505|NCT01321554|216111|P3|Treatment Ongoing at Data Cutoff|Randomization Phase||0
90506|NCT01321554|216112|P2|Treatment Ongoing at Data Cutoff|Randomization Phase||8
90507|NCT01321554|216113|P1|Treatment Ongoing at Data Cutoff|Randomization Phase||122
90508|NCT01321554|216110|P4|STARTED|Randomization Phase||0
90509|NCT01321554|216111|P3|STARTED|Randomization Phase||0
90510|NCT01321554|216112|P2|STARTED|Randomization Phase||131
90511|NCT01321554|216113|P1|STARTED|Randomization Phase||261
90512|NCT01321008|216126|P1|NOT COMPLETED|Overall Study||1
90513|NCT01321008|216126|P1|COMPLETED|Overall Study||0
90514|NCT01321008|216126|P1|STARTED|Overall Study||1
90515|NCT01320943|216132|P2|NOT COMPLETED|Overall Study||2
90516|NCT01320943|216133|P1|NOT COMPLETED|Overall Study||1
90517|NCT01320943|216132|P2|COMPLETED|Overall Study||20
90518|NCT01320943|216133|P1|COMPLETED|Overall Study||20
90519|NCT01320943|216132|P2|STARTED|Overall Study||22
90520|NCT01320943|216133|P1|STARTED|Overall Study|13 participants did not restart TDF; 8 participants restarted TDF during the study.|21
90521|NCT01320826|216152|P1|NOT COMPLETED|Overall Study||0
90522|NCT01320826|216152|P1|COMPLETED|Overall Study||577
90523|NCT01320826|216152|P1|STARTED|Overall Study||577
90524|NCT01320735|216167|P1|NOT COMPLETED|Overall Study||106
90525|NCT01320735|216167|P1|COMPLETED|Overall Study||194
90526|NCT01320735|216167|P1|STARTED|Overall Study||300
90527|NCT01320722|216189|P5|NOT COMPLETED|Overall Study||8
90528|NCT01320722|216190|P4|NOT COMPLETED|Overall Study||14
90529|NCT01320722|216191|P3|NOT COMPLETED|Overall Study||7
90530|NCT01320722|216192|P2|NOT COMPLETED|Overall Study||6
90531|NCT01320722|216193|P1|NOT COMPLETED|Overall Study||3
90532|NCT01320722|216189|P5|COMPLETED|Overall Study||45
90533|NCT01320722|216190|P4|COMPLETED|Overall Study||35
90534|NCT01320722|216191|P3|COMPLETED|Overall Study||40
90535|NCT01320722|216192|P2|COMPLETED|Overall Study||41
90536|NCT01320722|216193|P1|COMPLETED|Overall Study||43
90537|NCT01320722|216189|P5|Received Intervention|Overall Study||51
90538|NCT01320722|216190|P4|Received Intervention|Overall Study||48
90539|NCT01320722|216191|P3|Received Intervention|Overall Study||46
90540|NCT01320722|216192|P2|Received Intervention|Overall Study||45
90541|NCT01320722|216193|P1|Received Intervention|Overall Study||43
90542|NCT01320722|216189|P5|STARTED|Overall Study||53
90543|NCT01320722|216190|P4|STARTED|Overall Study||49
90544|NCT01320722|216191|P3|STARTED|Overall Study||47
90545|NCT01320722|216192|P2|STARTED|Overall Study||47
90546|NCT01320722|216193|P1|STARTED|Overall Study||46
90547|NCT01320683|216230|P1|NOT COMPLETED|Overall Study||1
90548|NCT01320683|216230|P1|COMPLETED|Overall Study||0
90549|NCT01320683|216230|P1|STARTED|Overall Study||1
90550|NCT01320293|216235|P1|NOT COMPLETED|Overall Study||2
90551|NCT01320293|216235|P1|COMPLETED|Overall Study||16
90552|NCT01320293|216235|P1|STARTED|Overall Study||18
90553|NCT01320202|216243|P2|NOT COMPLETED|Overall Study||44
90554|NCT01320202|216244|P1|NOT COMPLETED|Overall Study||56
90555|NCT01320202|216243|P2|COMPLETED|Overall Study||109
90556|NCT01320202|216244|P1|COMPLETED|Overall Study||96
90557|NCT01320202|216243|P2|Completed St 3|Overall Study||82
90558|NCT01320202|216244|P1|Completed St 3|Overall Study||79
90559|NCT01320202|216243|P2|Enrolled in St 3|Overall Study||109
90560|NCT01320202|216244|P1|Enrolled in St 3|Overall Study||98
90561|NCT01320202|216243|P2|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||82
90562|NCT01320202|216244|P1|Comp St 2 Due to ESA/IV Iron Needs|Overall Study||69
90563|NCT01320202|216243|P2|Comp 48 Wks in St 2|Overall Study||27
90564|NCT01320202|216244|P1|Comp 48 Wks in St 2|Overall Study||27
90565|NCT01320202|216243|P2|STARTED|Overall Study||153
90566|NCT01320202|216244|P1|STARTED|Overall Study||152
90567|NCT01320137|216281|P2|NOT COMPLETED|Overall Study||0
90568|NCT01320137|216282|P1|NOT COMPLETED|Overall Study||0
90569|NCT01320137|216281|P2|COMPLETED|Overall Study||40
90570|NCT01320137|216282|P1|COMPLETED|Overall Study||40
90571|NCT01320137|216281|P2|STARTED|Overall Study||40
90572|NCT01320137|216282|P1|STARTED|Overall Study||40
90573|NCT01320072|216296|P2|NOT COMPLETED|Overall Study||0
90574|NCT01320072|216297|P1|NOT COMPLETED|Overall Study||0
90575|NCT01320072|216296|P2|COMPLETED|Overall Study||13
90576|NCT01320072|216297|P1|COMPLETED|Overall Study||16
90577|NCT01320072|216296|P2|STARTED|Overall Study||13
90578|NCT01320072|216297|P1|STARTED|Overall Study||16
90579|NCT01319877|216308|P2|NOT COMPLETED|Overall Study||45
90580|NCT01319877|216309|P1|NOT COMPLETED|Overall Study||108
90581|NCT01319877|216308|P2|COMPLETED|Overall Study||108
90582|NCT01319877|216309|P1|COMPLETED|Overall Study||345
90583|NCT01319877|216308|P2|STARTED|Overall Study||153
90584|NCT01319877|216309|P1|STARTED|Overall Study||453
90585|NCT01319851|216344|P1|NOT COMPLETED|Overall Study||0
90586|NCT01319851|216344|P1|COMPLETED|Overall Study||3
90587|NCT01319851|216344|P1|STARTED|Overall Study||3
90588|NCT01319812|216356|P2|NOT COMPLETED|Overall Study||22
90589|NCT01319812|216357|P1|NOT COMPLETED|Overall Study||16
90590|NCT01319812|216356|P2|COMPLETED|Overall Study||280
90591|NCT01319812|216357|P1|COMPLETED|Overall Study||145
90592|NCT01319812|216356|P2|STARTED|Overall Study||302
90593|NCT01319812|216357|P1|STARTED|Overall Study||161
90594|NCT01319799|216429|P1|NOT COMPLETED|Overall Study||0
90595|NCT01319799|216429|P1|COMPLETED|Overall Study||10
90596|NCT01319799|216429|P1|STARTED|Overall Study||10
90597|NCT01319773|216439|P5|NOT COMPLETED|Overall Study||0
90598|NCT01319773|216440|P4|NOT COMPLETED|Overall Study||0
90599|NCT01319773|216441|P3|NOT COMPLETED|Overall Study||0
90600|NCT01319773|216442|P2|NOT COMPLETED|Overall Study||0
90601|NCT01319773|216443|P1|NOT COMPLETED|Overall Study||0
90602|NCT01319773|216439|P5|COMPLETED|Overall Study||8
90603|NCT01319773|216440|P4|COMPLETED|Overall Study||8
90604|NCT01319773|216441|P3|COMPLETED|Overall Study||8
90605|NCT01319773|216442|P2|COMPLETED|Overall Study||10
90606|NCT01319773|216443|P1|COMPLETED|Overall Study||10
90607|NCT01319773|216439|P5|STARTED|Overall Study||8
90608|NCT01319773|216440|P4|STARTED|Overall Study||8
90609|NCT01319773|216441|P3|STARTED|Overall Study||8
90610|NCT01319773|216442|P2|STARTED|Overall Study||10
90611|NCT01319773|216443|P1|STARTED|Overall Study||10
90612|NCT01319721|216459|P2|NOT COMPLETED|Overall Study||6
90613|NCT01319721|216460|P1|NOT COMPLETED|Overall Study||1
90614|NCT01319721|216459|P2|COMPLETED|Overall Study|The unit of measure is eyes.|42
90615|NCT01319721|216460|P1|COMPLETED|Overall Study|The unit of measure is eyes.|47
90616|NCT01319721|216459|P2|STARTED|Overall Study|The unit of measure is eyes.|48
90617|NCT01319721|216460|P1|STARTED|Overall Study|The unit of measure is eyes.|48
90618|NCT01319617|216474|P1|NOT COMPLETED|Overall Study||1
90619|NCT01319617|216474|P1|COMPLETED|Overall Study||40
90620|NCT01319617|216474|P1|STARTED|Overall Study||41
90621|NCT01319552|216478|P1|NOT COMPLETED|Overall Study||0
90622|NCT01319552|216478|P1|COMPLETED|Overall Study||14
90623|NCT01319552|216478|P1|STARTED|Overall Study||14
90624|NCT01319539|216483|P1|NOT COMPLETED|Overall Study||0
90625|NCT01319539|216483|P1|COMPLETED|Overall Study||12
90626|NCT01319539|216483|P1|STARTED|Overall Study||12
90627|NCT01319500|216493|P2|NOT COMPLETED|Overall Study||0
90628|NCT01319500|216494|P1|NOT COMPLETED|Overall Study||0
90629|NCT01319500|216493|P2|COMPLETED|Overall Study||2589
90630|NCT01319500|216494|P1|COMPLETED|Overall Study||1187
90631|NCT01319500|216493|P2|STARTED|Overall Study||2589
90632|NCT01319500|216494|P1|STARTED|Overall Study||1187
90633|NCT01319422|216513|P2|NOT COMPLETED|Overall Study||0
90634|NCT01319422|216514|P1|NOT COMPLETED|Overall Study||1
90635|NCT01319422|216513|P2|COMPLETED|Overall Study||20
90636|NCT01319422|216514|P1|COMPLETED|Overall Study||19
90637|NCT01319422|216513|P2|STARTED|Overall Study||20
90638|NCT01319422|216514|P1|STARTED|Overall Study||20
90639|NCT01319396|216528|P1|NOT COMPLETED|Overall Study||0
90640|NCT01319396|216528|P1|COMPLETED|Overall Study||24
90641|NCT01319396|216528|P1|STARTED|Overall Study||24
90642|NCT01319383|216532|P2|NOT COMPLETED|Overall Study||10
90643|NCT01319383|216533|P1|NOT COMPLETED|Overall Study||12
90644|NCT01319383|216532|P2|COMPLETED|Overall Study||3
90645|NCT01319383|216533|P1|COMPLETED|Overall Study||0
90646|NCT01319383|216532|P2|Step 4|Overall Study|Only 3/6 completed the study.|3
90647|NCT01319383|216533|P1|Step 4|Overall Study|Arm 1 did not have a Step 4|0
90648|NCT01319383|216532|P2|Step 3|Overall Study|3 Arm 1 participants enrolled here; 6/7 had in vivo response to 2 VOR doses given 72 hours apart.|6
90649|NCT01319383|216533|P1|Step 3|Overall Study|None who qualified for the 2 series of 11 doses of VOR (taken M-T-W & off for 4 days for 4 wks).|0
90650|NCT01319383|216532|P2|Step 2|Overall Study||0
90651|NCT01319383|216533|P1|Step 2|Overall Study|The 4 without ex vivo response (Step 1) took a single dose to see if in vivo response would occur|4
90652|NCT01319383|216532|P2|Step 2|Overall Study|The 7 participants without an in vivo response to single dose of VOR 400 mg PO were terminated.|4
90653|NCT01319383|216533|P1|Step 2|Overall Study|These participants demonstrated an ex vivo response in Step 1|8
90654|NCT01319383|216532|P2|Step 1|Overall Study|The 2 participants without an ex vivo response were terminated from the study.|11
90655|NCT01319383|216533|P1|Step 1|Overall Study||8
90656|NCT01319383|216532|P2|STARTED|Overall Study||13
90657|NCT01319383|216533|P1|STARTED|Overall Study||12
90658|NCT01319318|216550|P1|NOT COMPLETED|Overall Study||0
90659|NCT01319318|216550|P1|COMPLETED|Overall Study||25
90660|NCT01319318|216550|P1|STARTED|Overall Study||25
90661|NCT01318408|216554|P1|NOT COMPLETED|Overall Study||8
90662|NCT01318408|216554|P1|COMPLETED|Overall Study||16
90663|NCT01318408|216554|P1|STARTED|Overall Study||24
90664|NCT01318382|216559|P1|NOT COMPLETED|Overall Study||13
90665|NCT01318382|216559|P1|COMPLETED|Overall Study||289
90666|NCT01318382|216559|P1|STARTED|Overall Study||302
90667|NCT01319110|216568|P2|NOT COMPLETED|Overall Study||0
90668|NCT01319110|216569|P1|NOT COMPLETED|Overall Study||0
90669|NCT01319110|216568|P2|COMPLETED|Overall Study||5
90670|NCT01319110|216569|P1|COMPLETED|Overall Study||5
90671|NCT01319110|216568|P2|STARTED|Overall Study||5
90672|NCT01319110|216569|P1|STARTED|Overall Study||5
90673|NCT01319045|216577|P1|NOT COMPLETED|Overall Study||2
90674|NCT01319045|216577|P1|COMPLETED|Overall Study|Study was discontinued due to low enrollment|3
90675|NCT01319045|216577|P1|STARTED|Overall Study||5
90676|NCT01318967|216584|P1|NOT COMPLETED|Overall Study||0
90677|NCT01318967|216584|P1|COMPLETED|Overall Study||10
90678|NCT01318967|216584|P1|STARTED|Overall Study||10
90679|NCT01318876|216589|P1|NOT COMPLETED|Day 29 Survey||1825
90680|NCT01318876|216589|P1|COMPLETED|Day 29 Survey||5724
90681|NCT01318876|216589|P1|STARTED|Day 29 Survey|All participants with a valid e-mail, have received the second survey|7549
90682|NCT01318876|216589|P1|NOT COMPLETED|Day 8 Survey||1820
90683|NCT01318876|216589|P1|COMPLETED|Day 8 Survey||5825
90684|NCT01318876|216589|P1|STARTED|Day 8 Survey||7645
90685|NCT01318733|216594|P1|NOT COMPLETED|Overall Study||170
90686|NCT01318733|216594|P1|COMPLETED|Overall Study||279
90687|NCT01318733|216594|P1|STARTED|Overall Study||449
90688|NCT01318694|216602|P4|NOT COMPLETED|Overall Study||68
90689|NCT01318694|216603|P3|NOT COMPLETED|Overall Study||43
90690|NCT01318694|216604|P2|NOT COMPLETED|Overall Study||58
90691|NCT01318694|216605|P1|NOT COMPLETED|Overall Study||52
90692|NCT01318694|216602|P4|COMPLETED|Overall Study||200
90693|NCT01318694|216603|P3|COMPLETED|Overall Study||225
90694|NCT01318694|216604|P2|COMPLETED|Overall Study||212
90695|NCT01318694|216605|P1|COMPLETED|Overall Study||223
90696|NCT01318694|216602|P4|Safety Set|Overall Study||265
90697|NCT01318694|216603|P3|Safety Set|Overall Study||265
90698|NCT01318694|216604|P2|Safety Set|Overall Study||268
90699|NCT01318694|216605|P1|Safety Set|Overall Study||273
90700|NCT01318694|216602|P4|Full Analysis Set|Overall Study||268
90701|NCT01318694|216603|P3|Full Analysis Set|Overall Study||265
90702|NCT01318694|216604|P2|Full Analysis Set|Overall Study||270
90703|NCT01318694|216605|P1|Full Analysis Set|Overall Study||274
90704|NCT01318694|216602|P4|STARTED|Overall Study||268
90705|NCT01318694|216603|P3|STARTED|Overall Study||268
90706|NCT01318694|216604|P2|STARTED|Overall Study||270
90707|NCT01318694|216605|P1|STARTED|Overall Study||275
90708|NCT01318538|216661|P3|NOT COMPLETED|Overall Study||0
90709|NCT01318538|216662|P2|NOT COMPLETED|Overall Study||0
90710|NCT01318538|216663|P1|NOT COMPLETED|Overall Study||0
90711|NCT01318538|216661|P3|COMPLETED|Overall Study||8
90712|NCT01318538|216662|P2|COMPLETED|Overall Study||106
90713|NCT01318538|216663|P1|COMPLETED|Overall Study||52
90714|NCT01318538|216661|P3|STARTED|Overall Study||8
90715|NCT01318538|216662|P2|STARTED|Overall Study||106
90716|NCT01318538|216663|P1|STARTED|Overall Study||52
90717|NCT01318512|216687|P1|NOT COMPLETED|Maintenance Period (6 Months)||11
90718|NCT01318512|216687|P1|COMPLETED|Maintenance Period (6 Months)||329
90719|NCT01318512|216687|P1|STARTED|Maintenance Period (6 Months)||340
90720|NCT01318512|216687|P1|NOT COMPLETED|Titration Period (4 Months)||0
90721|NCT01318512|216687|P1|COMPLETED|Titration Period (4 Months)||340
90722|NCT01318512|216687|P1|STARTED|Titration Period (4 Months)||340
90723|NCT01318499|216706|P3|NOT COMPLETED|Overall Study||147
90724|NCT01318499|216707|P2|NOT COMPLETED|Overall Study||76
90725|NCT01318499|216708|P1|NOT COMPLETED|Overall Study||65
90726|NCT01318499|216706|P3|COMPLETED|Overall Study||121
90727|NCT01318499|216707|P2|COMPLETED|Overall Study||458
90728|NCT01318499|216708|P1|COMPLETED|Overall Study||475
90729|NCT01318499|216706|P3|STARTED|Overall Study||268
90730|NCT01318499|216707|P2|STARTED|Overall Study||534
90731|NCT01318499|216708|P1|STARTED|Overall Study||540
90732|NCT01318278|216729|P3|NOT COMPLETED|Overall Study||0
90733|NCT01318278|216730|P2|NOT COMPLETED|Overall Study||0
90734|NCT01318278|216731|P1|NOT COMPLETED|Overall Study||0
90735|NCT01318278|216729|P3|COMPLETED|Overall Study||50
90736|NCT01318278|216730|P2|COMPLETED|Overall Study||10
90737|NCT01318278|216731|P1|COMPLETED|Overall Study||10
90738|NCT01318278|216729|P3|STARTED|Overall Study||50
90739|NCT01318278|216730|P2|STARTED|Overall Study||10
90740|NCT01318278|216731|P1|STARTED|Overall Study||10
90741|NCT01318135|216777|P8|NOT COMPLETED|Entered - Long-Term Extension Study||3
90742|NCT01318135|216778|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
90743|NCT01318135|216779|P6|NOT COMPLETED|Entered - Long-Term Extension Study||4
90744|NCT01318135|216780|P5|NOT COMPLETED|Entered - Long-Term Extension Study||9
90745|NCT01318135|216781|P4|NOT COMPLETED|Entered - Long-Term Extension Study||7
90746|NCT01318135|216782|P3|NOT COMPLETED|Entered - Long-Term Extension Study||8
90747|NCT01318135|216783|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
90748|NCT01318135|216784|P1|NOT COMPLETED|Entered - Long-Term Extension Study||17
90749|NCT01318135|216777|P8|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|46
90750|NCT01318135|216778|P7|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|49
90751|NCT01318135|216779|P6|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|83
90752|NCT01318135|216780|P5|COMPLETED|Entered - Long-Term Extension Study|280 participants enrolled and 276 completed metformin add-on study and entered the present study.|81
90753|NCT01318135|216781|P4|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|42
90754|NCT01318135|216782|P3|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|38
90755|NCT01318135|216783|P2|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|89
90756|NCT01318135|216784|P1|COMPLETED|Entered - Long-Term Extension Study|296 participants enrolled and 294 completed glimepiride add-on study and entered the present study.|80
90757|NCT01318135|216777|P8|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|49
90758|NCT01318135|216778|P7|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|50
90759|NCT01318135|216779|P6|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|87
90760|NCT01318135|216780|P5|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-006 but not entered OCT-005 are excluded in Participant Flow.|90
90761|NCT01318135|216781|P4|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|49
90762|NCT01318135|216782|P3|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|46
90763|NCT01318135|216783|P2|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|102
90764|NCT01318135|216784|P1|STARTED|Entered - Long-Term Extension Study|Patients participated in CCT-005 but not entered OCT-005 are excluded in Participant Flow.|97
90765|NCT01318135|216777|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90766|NCT01318135|216778|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90767|NCT01318135|216779|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90768|NCT01318135|216780|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90769|NCT01318135|216781|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90770|NCT01318135|216782|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90771|NCT01318135|216783|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90772|NCT01318135|216784|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
90773|NCT01318135|216777|P8|COMPLETED|Enrolled - Long-Term Extension Study||49
90774|NCT01318135|216778|P7|COMPLETED|Enrolled - Long-Term Extension Study||50
90775|NCT01318135|216779|P6|COMPLETED|Enrolled - Long-Term Extension Study||90
90776|NCT01318135|216780|P5|COMPLETED|Enrolled - Long-Term Extension Study||91
90777|NCT01318135|216781|P4|COMPLETED|Enrolled - Long-Term Extension Study||49
90778|NCT01318135|216782|P3|COMPLETED|Enrolled - Long-Term Extension Study||46
90779|NCT01318135|216783|P2|COMPLETED|Enrolled - Long-Term Extension Study||102
90780|NCT01318135|216784|P1|COMPLETED|Enrolled - Long-Term Extension Study||97
90781|NCT01318135|216777|P8|STARTED|Enrolled - Long-Term Extension Study||49
90782|NCT01318135|216778|P7|STARTED|Enrolled - Long-Term Extension Study||50
90783|NCT01318135|216779|P6|STARTED|Enrolled - Long-Term Extension Study||90
90784|NCT01318135|216780|P5|STARTED|Enrolled - Long-Term Extension Study||91
90785|NCT01318135|216781|P4|STARTED|Enrolled - Long-Term Extension Study||49
90786|NCT01318135|216782|P3|STARTED|Enrolled - Long-Term Extension Study||46
90787|NCT01318135|216783|P2|STARTED|Enrolled - Long-Term Extension Study||102
90788|NCT01318135|216784|P1|STARTED|Enrolled - Long-Term Extension Study||99
90789|NCT01318122|216916|P4|NOT COMPLETED|Entered - Long-Term Extension Study||4
90790|NCT01318122|216917|P3|NOT COMPLETED|Entered - Long-Term Extension Study||6
90791|NCT01318122|216918|P2|NOT COMPLETED|Entered - Long-Term Extension Study||11
90792|NCT01318122|216919|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
90793|NCT01318122|216916|P4|COMPLETED|Entered - Long-Term Extension Study||48
90794|NCT01318122|216917|P3|COMPLETED|Entered - Long-Term Extension Study||49
90795|NCT01318122|216918|P2|COMPLETED|Entered - Long-Term Extension Study||99
90796|NCT01318122|216919|P1|COMPLETED|Entered - Long-Term Extension Study||96
90797|NCT01318122|216916|P4|STARTED|Entered - Long-Term Extension Study||52
90798|NCT01318122|216917|P3|STARTED|Entered - Long-Term Extension Study||55
90799|NCT01318122|216918|P2|STARTED|Entered - Long-Term Extension Study||110
90800|NCT01318122|216919|P1|STARTED|Entered - Long-Term Extension Study||105
90801|NCT01318122|216916|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
90802|NCT01318122|216917|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
90803|NCT01318122|216918|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
90804|NCT01318122|216919|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
90805|NCT01318122|216916|P4|COMPLETED|Enrolled - Long-Term Extension Study||52
90806|NCT01318122|216917|P3|COMPLETED|Enrolled - Long-Term Extension Study||55
90807|NCT01318122|216918|P2|COMPLETED|Enrolled - Long-Term Extension Study||110
90808|NCT01318122|216919|P1|COMPLETED|Enrolled - Long-Term Extension Study||105
90809|NCT01318122|216916|P4|STARTED|Enrolled - Long-Term Extension Study||53
90810|NCT01318122|216917|P3|STARTED|Enrolled - Long-Term Extension Study||57
90811|NCT01318122|216918|P2|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|110
90812|NCT01318122|216919|P1|STARTED|Enrolled - Long-Term Extension Study|5 randomized participants from alogliptin 12.5 & 25 mg group CCT-004 study did not enter this study|106
90813|NCT01318109|216988|P3|NOT COMPLETED|Overall Study||0
90814|NCT01318109|216989|P2|NOT COMPLETED|Overall Study||3
90815|NCT01318109|216990|P1|NOT COMPLETED|Overall Study||1
90816|NCT01318109|216988|P3|COMPLETED|Overall Study||100
90817|NCT01318109|216989|P2|COMPLETED|Overall Study||93
90818|NCT01318109|216990|P1|COMPLETED|Overall Study||91
90819|NCT01318109|216988|P3|STARTED|Overall Study||100
90820|NCT01318109|216989|P2|STARTED|Overall Study||96
90821|NCT01318109|216990|P1|STARTED|Overall Study||92
90822|NCT01318083|217025|P3|NOT COMPLETED|Overall Study||5
90823|NCT01318083|217026|P2|NOT COMPLETED|Overall Study||2
90824|NCT01318083|217027|P1|NOT COMPLETED|Overall Study||6
90825|NCT01318083|217025|P3|COMPLETED|Overall Study||98
90826|NCT01318083|217026|P2|COMPLETED|Overall Study||102
90827|NCT01318083|217027|P1|COMPLETED|Overall Study||99
90828|NCT01318083|217025|P3|STARTED|Overall Study||103
90829|NCT01318083|217026|P2|STARTED|Overall Study||104
90830|NCT01318083|217027|P1|STARTED|Overall Study||105
90831|NCT01318070|217062|P3|NOT COMPLETED|Overall Study||7
90832|NCT01318070|217063|P2|NOT COMPLETED|Overall Study||2
90833|NCT01318070|217064|P1|NOT COMPLETED|Overall Study||2
90834|NCT01318070|217062|P3|COMPLETED|Overall Study||108
90835|NCT01318070|217063|P2|COMPLETED|Overall Study||111
90836|NCT01318070|217064|P1|COMPLETED|Overall Study||109
90837|NCT01318070|217062|P3|STARTED|Overall Study||115
90838|NCT01318070|217063|P2|STARTED|Overall Study||113
90839|NCT01318070|217064|P1|STARTED|Overall Study||111
90840|NCT01317901|217098|P2|NOT COMPLETED|Overall Study||0
90841|NCT01317901|217099|P1|NOT COMPLETED|Overall Study||0
90842|NCT01317901|217098|P2|COMPLETED|Overall Study||6
90843|NCT01317901|217099|P1|COMPLETED|Overall Study||6
90844|NCT01317901|217098|P2|STARTED|Overall Study||6
90845|NCT01317901|217099|P1|STARTED|Overall Study||6
90846|NCT01317797|217108|P3|NOT COMPLETED|Overall Study||1
90847|NCT01317797|217109|P2|NOT COMPLETED|Overall Study||1
90848|NCT01317797|217110|P1|NOT COMPLETED|Overall Study||0
90849|NCT01317797|217108|P3|COMPLETED|Overall Study||8
90850|NCT01317797|217109|P2|COMPLETED|Overall Study||6
90851|NCT01317797|217110|P1|COMPLETED|Overall Study||8
90852|NCT01317797|217108|P3|STARTED|Overall Study||9
90853|NCT01317797|217109|P2|STARTED|Overall Study||7
90854|NCT01317797|217110|P1|STARTED|Overall Study||8
90855|NCT01317667|217165|P3|NOT COMPLETED|Overall Study||0
90856|NCT01317667|217166|P2|NOT COMPLETED|Overall Study||0
90857|NCT01317667|217167|P1|NOT COMPLETED|Overall Study||0
90858|NCT01317667|217165|P3|COMPLETED|Overall Study|The original trial design was modified to limit the number of vaccinations in Group 3 to 1 dose.|10
90859|NCT01317667|217166|P2|COMPLETED|Overall Study||10
90860|NCT01317667|217167|P1|COMPLETED|Overall Study||10
90861|NCT01317667|217165|P3|STARTED|Overall Study||10
90862|NCT01317667|217166|P2|STARTED|Overall Study||10
90863|NCT01317667|217167|P1|STARTED|Overall Study||10
90864|NCT01317641|217187|P9|NOT COMPLETED|Overall Study||5
90865|NCT01317641|217188|P8|NOT COMPLETED|Overall Study||5
90866|NCT01317641|217189|P7|NOT COMPLETED|Overall Study||3
90867|NCT01317641|217190|P6|NOT COMPLETED|Overall Study||0
90868|NCT01317641|217191|P5|NOT COMPLETED|Overall Study||0
90869|NCT01317641|217192|P4|NOT COMPLETED|Overall Study||1
90870|NCT01317641|217193|P3|NOT COMPLETED|Overall Study||0
90871|NCT01317641|217194|P2|NOT COMPLETED|Overall Study||1
90872|NCT01317641|217195|P1|NOT COMPLETED|Overall Study||1
90873|NCT01317641|217187|P9|COMPLETED|Overall Study||31
90874|NCT01317641|217188|P8|COMPLETED|Overall Study||33
90875|NCT01317641|217189|P7|COMPLETED|Overall Study||35
90876|NCT01317641|217190|P6|COMPLETED|Overall Study||3
90877|NCT01317641|217191|P5|COMPLETED|Overall Study||3
90878|NCT01317641|217192|P4|COMPLETED|Overall Study||3
90879|NCT01317641|217193|P3|COMPLETED|Overall Study||3
90880|NCT01317641|217194|P2|COMPLETED|Overall Study||6
90881|NCT01317641|217195|P1|COMPLETED|Overall Study||3
90882|NCT01317641|217187|P9|STARTED|Overall Study||36
90883|NCT01317641|217188|P8|STARTED|Overall Study||38
90884|NCT01317641|217189|P7|STARTED|Overall Study||38
90885|NCT01317641|217190|P6|STARTED|Overall Study||3
90886|NCT01317641|217191|P5|STARTED|Overall Study||3
90887|NCT01317641|217192|P4|STARTED|Overall Study||4
90888|NCT01317641|217193|P3|STARTED|Overall Study||3
90889|NCT01317641|217194|P2|STARTED|Overall Study||7
90890|NCT01317641|217195|P1|STARTED|Overall Study||4
90891|NCT01317615|217297|P1|NOT COMPLETED|Overall Study||49
90892|NCT01317615|217297|P1|COMPLETED|Overall Study||0
90893|NCT01317615|217297|P1|STARTED|Overall Study||49
90894|NCT01317160|217308|P2|NOT COMPLETED|Overall Study||6
90895|NCT01317160|217309|P1|NOT COMPLETED|Overall Study||4
90896|NCT01317160|217308|P2|COMPLETED|Overall Study||69
90897|NCT01317160|217309|P1|COMPLETED|Overall Study||71
90898|NCT01317160|217308|P2|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
90899|NCT01317160|217309|P1|Allocation to Treatment|Overall Study|1 patient was incorrect included|74
90900|NCT01317160|217308|P2|STARTED|Overall Study||75
90901|NCT01317160|217309|P1|STARTED|Overall Study||75
90902|NCT01317004|217319|P2|NOT COMPLETED|Overall Study||9
90903|NCT01317004|217320|P1|NOT COMPLETED|Overall Study||4
90904|NCT01317004|217319|P2|COMPLETED|Overall Study||5
90905|NCT01317004|217320|P1|COMPLETED|Overall Study||47
90906|NCT01317004|217319|P2|Safety Set|Overall Study||11
90907|NCT01317004|217320|P1|Safety Set|Overall Study||50
90908|NCT01317004|217319|P2|STARTED|Overall Study||14
90909|NCT01317004|217320|P1|STARTED|Overall Study||51
90910|NCT01316926|217338|P2|NOT COMPLETED|Period 2||0
90911|NCT01316926|217339|P1|NOT COMPLETED|Period 2||0
90912|NCT01316926|217338|P2|COMPLETED|Period 2||30
90913|NCT01316926|217339|P1|COMPLETED|Period 2||29
90914|NCT01316926|217338|P2|STARTED|Period 2||30
90915|NCT01316926|217339|P1|STARTED|Period 2|One participant completed Period 1, but did not appear in Period 2|29
90916|NCT01316926|217338|P2|NOT COMPLETED|Period 1||0
90917|NCT01316926|217339|P1|NOT COMPLETED|Period 1||0
90918|NCT01316926|217338|P2|COMPLETED|Period 1||30
90919|NCT01316926|217339|P1|COMPLETED|Period 1||30
90920|NCT01316926|217338|P2|STARTED|Period 1||30
90921|NCT01316926|217339|P1|STARTED|Period 1||30
90922|NCT01316913|217353|P4|NOT COMPLETED|Overall Study||39
90923|NCT01316913|217354|P3|NOT COMPLETED|Overall Study||49
90924|NCT01316913|217355|P2|NOT COMPLETED|Overall Study||54
90925|NCT01316913|217356|P1|NOT COMPLETED|Overall Study||57
90926|NCT01316913|217353|P4|COMPLETED|Overall Study||176
90927|NCT01316913|217354|P3|COMPLETED|Overall Study||166
90928|NCT01316913|217355|P2|COMPLETED|Overall Study||163
90929|NCT01316913|217356|P1|COMPLETED|Overall Study||165
90930|NCT01316913|217353|P4|STARTED|Overall Study||215
90931|NCT01316913|217354|P3|STARTED|Overall Study||215
90932|NCT01316913|217355|P2|STARTED|Overall Study||217
90933|NCT01316913|217356|P1|STARTED|Overall Study||222
90934|NCT01316900|217378|P4|NOT COMPLETED|Overall Study||31
90935|NCT01316900|217379|P3|NOT COMPLETED|Overall Study||41
90936|NCT01316900|217380|P2|NOT COMPLETED|Overall Study||31
90937|NCT01316900|217381|P1|NOT COMPLETED|Overall Study||44
90938|NCT01316900|217378|P4|COMPLETED|Overall Study||177
90939|NCT01316900|217379|P3|COMPLETED|Overall Study||173
90940|NCT01316900|217380|P2|COMPLETED|Overall Study||181
90941|NCT01316900|217381|P1|COMPLETED|Overall Study||165
90942|NCT01316900|217378|P4|STARTED|Overall Study||208
90943|NCT01316900|217379|P3|STARTED|Overall Study||214
90944|NCT01316900|217380|P2|STARTED|Overall Study||212
90945|NCT01316900|217381|P1|STARTED|Overall Study||209
90946|NCT01316887|217402|P3|NOT COMPLETED|Overall Study||83
90947|NCT01316887|217403|P2|NOT COMPLETED|Overall Study||94
90948|NCT01316887|217404|P1|NOT COMPLETED|Overall Study||43
90949|NCT01316887|217402|P3|COMPLETED|Overall Study||143
90950|NCT01316887|217403|P2|COMPLETED|Overall Study||133
90951|NCT01316887|217404|P1|COMPLETED|Overall Study||66
90952|NCT01316887|217402|P3|STARTED|Overall Study||226
90953|NCT01316887|217403|P2|STARTED|Overall Study||227
90954|NCT01316887|217404|P1|STARTED|Overall Study||109
90955|NCT01316692|217466|P1|NOT COMPLETED|Overall Study||12
90956|NCT01316692|217466|P1|COMPLETED|Overall Study||0
90957|NCT01316692|217466|P1|STARTED|Overall Study||12
90958|NCT01316614|217475|P1|NOT COMPLETED|Overall Study||37
90959|NCT01316614|217475|P1|COMPLETED|Overall Study||100
90960|NCT01316614|217475|P1|STARTED|Overall Study||137
90961|NCT01316575|217492|P2|NOT COMPLETED|Overall Study||1
90962|NCT01316575|217493|P1|NOT COMPLETED|Overall Study||2
90963|NCT01316575|217492|P2|COMPLETED|Overall Study||19
90964|NCT01316575|217493|P1|COMPLETED|Overall Study||18
90965|NCT01316575|217492|P2|STARTED|Overall Study||20
90966|NCT01316575|217493|P1|STARTED|Overall Study||20
90967|NCT01316419|217505|P1|NOT COMPLETED|Overall Study||265
90968|NCT01316419|217505|P1|COMPLETED|Overall Study||1824
90969|NCT01316419|217505|P1|STARTED|Overall Study||2089
90970|NCT01316380|217531|P3|NOT COMPLETED|Overall Study||3
90971|NCT01316380|217532|P2|NOT COMPLETED|Overall Study||5
90972|NCT01316380|217533|P1|NOT COMPLETED|Overall Study||2
90973|NCT01316380|217531|P3|COMPLETED|Overall Study||152
90974|NCT01316380|217532|P2|COMPLETED|Overall Study||149
90975|NCT01316380|217533|P1|COMPLETED|Overall Study||154
90976|NCT01316380|217531|P3|STARTED|Overall Study||155
90977|NCT01316380|217532|P2|STARTED|Overall Study||154
90978|NCT01316380|217533|P1|STARTED|Overall Study||156
90979|NCT01316341|217574|P3|NOT COMPLETED|Overall Study||0
90980|NCT01316341|217575|P2|NOT COMPLETED|Overall Study||0
90981|NCT01316341|217576|P1|NOT COMPLETED|Overall Study||0
90982|NCT01316341|217574|P3|COMPLETED|Overall Study||9
90983|NCT01316341|217575|P2|COMPLETED|Overall Study||9
90984|NCT01316341|217576|P1|COMPLETED|Overall Study||6
90985|NCT01316341|217574|P3|STARTED|Overall Study||9
90986|NCT01316341|217575|P2|STARTED|Overall Study||9
90987|NCT01316341|217576|P1|STARTED|Overall Study||6
90988|NCT01316315|217644|P2|NOT COMPLETED|Sequence 2||0
90989|NCT01316315|217645|P1|NOT COMPLETED|Sequence 2||0
90990|NCT01316315|217644|P2|COMPLETED|Sequence 2||7
90991|NCT01316315|217645|P1|COMPLETED|Sequence 2||7
90992|NCT01316315|217644|P2|STARTED|Sequence 2||7
90993|NCT01316315|217645|P1|STARTED|Sequence 2||7
90994|NCT01316315|217644|P2|NOT COMPLETED|Sequence 1||0
90995|NCT01316315|217645|P1|NOT COMPLETED|Sequence 1||0
90996|NCT01316315|217644|P2|COMPLETED|Sequence 1||7
90997|NCT01316315|217645|P1|COMPLETED|Sequence 1||7
90998|NCT01316315|217644|P2|STARTED|Sequence 1||7
90999|NCT01316315|217645|P1|STARTED|Sequence 1||7
91000|NCT01316302|217659|P2|NOT COMPLETED|Overall Study||11
91001|NCT01316302|217660|P1|NOT COMPLETED|Overall Study||10
91002|NCT01316302|217659|P2|COMPLETED|Overall Study||22
91003|NCT01316302|217660|P1|COMPLETED|Overall Study||20
91004|NCT01316302|217659|P2|STARTED|Overall Study||33
91005|NCT01316302|217660|P1|STARTED|Overall Study||30
91006|NCT01316263|217672|P2|NOT COMPLETED|Overall Study||0
91007|NCT01316263|217673|P1|NOT COMPLETED|Overall Study||0
91008|NCT01316263|217672|P2|COMPLETED|Overall Study||14
91009|NCT01316263|217673|P1|COMPLETED|Overall Study||7
91010|NCT01316263|217672|P2|Received Any Study Drug|Overall Study||14
91011|NCT01316263|217673|P1|Received Any Study Drug|Overall Study||7
91012|NCT01316263|217672|P2|STARTED|Overall Study||14
91013|NCT01316263|217673|P1|STARTED|Overall Study||7
91014|NCT01316224|217699|P1|NOT COMPLETED|Overall Study||10
91015|NCT01316224|217699|P1|COMPLETED|Overall Study||42
91016|NCT01316224|217699|P1|Completed Visit 4 to Rheumatologist|Overall Study||28
91017|NCT01316224|217699|P1|Completed Visit 4 to Dermatologist|Overall Study||42
91018|NCT01316224|217699|P1|Completed Visit 3 to Rheumatologist|Overall Study||39
91019|NCT01316224|217699|P1|Completed Visit 3 to Dermatologist|Overall Study||48
91020|NCT01316224|217699|P1|Completed Visit 2 to Dermatologist|Overall Study||51
91021|NCT01316224|217699|P1|Completed Visit 1 to Rheumatologist|Overall Study||49
91022|NCT01316224|217699|P1|Completed Visit 1 to Dermatologist|Overall Study||52
91023|NCT01316224|217699|P1|STARTED|Overall Study||52
91024|NCT01316055|217716|P3|NOT COMPLETED|Overall Study||0
91025|NCT01316055|217717|P2|NOT COMPLETED|Overall Study||0
91026|NCT01316055|217718|P1|NOT COMPLETED|Overall Study||1
91027|NCT01316055|217716|P3|COMPLETED|Overall Study||12
91028|NCT01316055|217717|P2|COMPLETED|Overall Study||17
91029|NCT01316055|217718|P1|COMPLETED|Overall Study||12
91030|NCT01316055|217716|P3|STARTED|Overall Study||12
91031|NCT01316055|217717|P2|STARTED|Overall Study||17
91032|NCT01316055|217718|P1|STARTED|Overall Study||13
91033|NCT01316042|217734|P2|NOT COMPLETED|Overall Study||1
91034|NCT01316042|217735|P1|NOT COMPLETED|Overall Study||0
91035|NCT01316042|217734|P2|COMPLETED|Overall Study||1
91036|NCT01316042|217735|P1|COMPLETED|Overall Study||2
91037|NCT01316042|217734|P2|STARTED|Overall Study||2
91038|NCT01316042|217735|P1|STARTED|Overall Study||2
91039|NCT01315847|217743|P2|NOT COMPLETED|Part III, Period 2||0
91040|NCT01315847|217744|P1|NOT COMPLETED|Part III, Period 2||0
91041|NCT01315847|217743|P2|COMPLETED|Part III, Period 2||3
91042|NCT01315847|217744|P1|COMPLETED|Part III, Period 2||0
91043|NCT01315847|217743|P2|Received [11C]MK-4232|Part III, Period 2||3
91044|NCT01315847|217744|P1|Received [11C]MK-4232|Part III, Period 2||0
91045|NCT01315847|217743|P2|Received Telcagepant|Part III, Period 2||3
91046|NCT01315847|217744|P1|Received Telcagepant|Part III, Period 2||0
91047|NCT01315847|217743|P2|STARTED|Part III, Period 2||3
91048|NCT01315847|217744|P1|STARTED|Part III, Period 2||0
91049|NCT01315847|217743|P2|NOT COMPLETED|Part III, Period 1||1
91050|NCT01315847|217744|P1|NOT COMPLETED|Part III, Period 1||0
91051|NCT01315847|217743|P2|COMPLETED|Part III, Period 1||3
91052|NCT01315847|217744|P1|COMPLETED|Part III, Period 1||0
91053|NCT01315847|217743|P2|Received [11C]MK-4232|Part III, Period 1|One of these participants received [11C]MK-4232 only at baseline.|4
91054|NCT01315847|217744|P1|Received [11C]MK-4232|Part III, Period 1||0
91055|NCT01315847|217743|P2|Received Telcagepant|Part III, Period 1||4
91056|NCT01315847|217744|P1|Received Telcagepant|Part III, Period 1||0
91057|NCT01315847|217743|P2|STARTED|Part III, Period 1|Subjects who participated in Part III did not participate in Part I.|4
91058|NCT01315847|217744|P1|STARTED|Part III, Period 1||0
91059|NCT01315847|217743|P2|NOT COMPLETED|Part I, Period 2||0
91060|NCT01315847|217744|P1|NOT COMPLETED|Part I, Period 2||0
91061|NCT01315847|217743|P2|COMPLETED|Part I, Period 2||0
91062|NCT01315847|217744|P1|COMPLETED|Part I, Period 2||3
91063|NCT01315847|217743|P2|Received [11C]MK-4232|Part I, Period 2||0
91064|NCT01315847|217744|P1|Received [11C]MK-4232|Part I, Period 2||3
91065|NCT01315847|217743|P2|Received Telcagepant|Part I, Period 2||0
91066|NCT01315847|217744|P1|Received Telcagepant|Part I, Period 2||3
91067|NCT01315847|217743|P2|STARTED|Part I, Period 2||0
91068|NCT01315847|217744|P1|STARTED|Part I, Period 2|One of these subjects did not participate in Part I, Period 1.|3
91069|NCT01315847|217743|P2|NOT COMPLETED|Part I, Period 1||0
91070|NCT01315847|217744|P1|NOT COMPLETED|Part I, Period 1||3
91071|NCT01315847|217743|P2|COMPLETED|Part I, Period 1||0
91072|NCT01315847|217744|P1|COMPLETED|Part I, Period 1||2
91073|NCT01315847|217743|P2|Received [11C]MK-4232|Part I, Period 1||0
91074|NCT01315847|217744|P1|Received [11C]MK-4232|Part I, Period 1|One of these participants received [11C]MK-4232 only at baseline.|5
91075|NCT01315847|217743|P2|Received Telcagepant|Part I, Period 1||0
91076|NCT01315847|217744|P1|Received Telcagepant|Part I, Period 1||5
91077|NCT01315847|217743|P2|STARTED|Part I, Period 1||0
91078|NCT01315847|217744|P1|STARTED|Part I, Period 1|Subjects who participated in Part I did not participate in Part III.|5
91079|NCT01315665|217758|P2|NOT COMPLETED|Overall Study||0
91080|NCT01315665|217759|P1|NOT COMPLETED|Overall Study||0
91081|NCT01315665|217758|P2|COMPLETED|Overall Study||5
91082|NCT01315665|217759|P1|COMPLETED|Overall Study||10
91083|NCT01315665|217758|P2|STARTED|Overall Study||5
91084|NCT01315665|217759|P1|STARTED|Overall Study||10
91085|NCT01315574|217775|P2|NOT COMPLETED|Overall Study||0
91086|NCT01315574|217776|P1|NOT COMPLETED|Overall Study||0
91087|NCT01315574|217775|P2|COMPLETED|Overall Study||7
91088|NCT01315574|217776|P1|COMPLETED|Overall Study||7
91089|NCT01315574|217775|P2|STARTED|Overall Study||7
91090|NCT01315574|217776|P1|STARTED|Overall Study||7
91091|NCT01315249|217788|P2|NOT COMPLETED|Overall Study||47
91092|NCT01315249|217789|P1|NOT COMPLETED|Overall Study||44
91093|NCT01315249|217788|P2|COMPLETED|Overall Study||217
91094|NCT01315249|217789|P1|COMPLETED|Overall Study||215
91095|NCT01315249|217788|P2|STARTED|Overall Study||264
91096|NCT01315249|217789|P1|STARTED|Overall Study||259
91097|NCT01315158|217817|P2|NOT COMPLETED|Overall Study||0
91098|NCT01315158|217818|P1|NOT COMPLETED|Overall Study||0
91099|NCT01315158|217817|P2|COMPLETED|Overall Study||19
91100|NCT01315158|217818|P1|COMPLETED|Overall Study||17
91101|NCT01315158|217817|P2|STARTED|Overall Study||19
91102|NCT01315158|217818|P1|STARTED|Overall Study||17
91103|NCT01315145|217842|P2|NOT COMPLETED|Overall Study||5
91104|NCT01315145|217843|P1|NOT COMPLETED|Overall Study||17
91105|NCT01315145|217842|P2|COMPLETED|Overall Study||11
91106|NCT01315145|217843|P1|COMPLETED|Overall Study||105
91107|NCT01315145|217842|P2|STARTED|Overall Study||16
91108|NCT01315145|217843|P1|STARTED|Overall Study||122
91109|NCT01315028|217851|P2|NOT COMPLETED|Overall Study||1
91110|NCT01315028|217852|P1|NOT COMPLETED|Overall Study||1
91111|NCT01315028|217851|P2|COMPLETED|Overall Study||9
91112|NCT01315028|217852|P1|COMPLETED|Overall Study||9
91113|NCT01315028|217851|P2|STARTED|Overall Study||10
91114|NCT01315028|217852|P1|STARTED|Overall Study||10
91115|NCT01315002|217864|P2|NOT COMPLETED|Overall Study||5
91116|NCT01315002|217865|P1|NOT COMPLETED|Overall Study||5
91117|NCT01315002|217864|P2|COMPLETED|Overall Study||55
91118|NCT01315002|217865|P1|COMPLETED|Overall Study||56
91119|NCT01315002|217864|P2|STARTED|Overall Study||60
91120|NCT01315002|217865|P1|STARTED|Overall Study||61
91121|NCT01314872|217882|P15|NOT COMPLETED|Period 2||24
91122|NCT01314872|217883|P14|NOT COMPLETED|Period 2||53
91123|NCT01314872|217884|P13|NOT COMPLETED|Period 2||60
91124|NCT01314872|217885|P12|NOT COMPLETED|Period 2||48
91125|NCT01314872|217886|P11|NOT COMPLETED|Period 2||0
91126|NCT01314872|217887|P10|NOT COMPLETED|Period 2||0
91127|NCT01314872|217888|P9|NOT COMPLETED|Period 2||0
91128|NCT01314872|217889|P8|NOT COMPLETED|Period 2||0
91129|NCT01314872|217890|P7|NOT COMPLETED|Period 2||0
91130|NCT01314872|217891|P6|NOT COMPLETED|Period 2||0
91131|NCT01314872|217892|P5|NOT COMPLETED|Period 2||0
91132|NCT01314872|217893|P4|NOT COMPLETED|Period 2||0
91133|NCT01314872|217894|P3|NOT COMPLETED|Period 2||0
91134|NCT01314872|217895|P2|NOT COMPLETED|Period 2||0
91135|NCT01314872|217896|P1|NOT COMPLETED|Period 2||0
91136|NCT01314872|217882|P15|COMPLETED|Period 2||110
91137|NCT01314872|217883|P14|COMPLETED|Period 2||187
91138|NCT01314872|217884|P13|COMPLETED|Period 2||188
91139|NCT01314872|217885|P12|COMPLETED|Period 2||175
91140|NCT01314872|217886|P11|COMPLETED|Period 2||0
91141|NCT01314872|217887|P10|COMPLETED|Period 2||0
91142|NCT01314872|217888|P9|COMPLETED|Period 2||0
91143|NCT01314872|217889|P8|COMPLETED|Period 2||0
91144|NCT01314872|217890|P7|COMPLETED|Period 2||0
91145|NCT01314872|217891|P6|COMPLETED|Period 2||0
91146|NCT01314872|217892|P5|COMPLETED|Period 2||0
91147|NCT01314872|217893|P4|COMPLETED|Period 2||0
91148|NCT01314872|217894|P3|COMPLETED|Period 2||0
91149|NCT01314872|217895|P2|COMPLETED|Period 2||0
91150|NCT01314872|217896|P1|COMPLETED|Period 2||0
91151|NCT01314872|217882|P15|STARTED|Period 2||134
91152|NCT01314872|217883|P14|STARTED|Period 2||240
91153|NCT01314872|217884|P13|STARTED|Period 2||248
91154|NCT01314872|217885|P12|STARTED|Period 2||223
91155|NCT01314872|217886|P11|STARTED|Period 2||0
91156|NCT01314872|217887|P10|STARTED|Period 2||0
91157|NCT01314872|217888|P9|STARTED|Period 2||0
91158|NCT01314872|217889|P8|STARTED|Period 2||0
91159|NCT01314872|217890|P7|STARTED|Period 2||0
91160|NCT01314872|217891|P6|STARTED|Period 2||0
91161|NCT01314872|217892|P5|STARTED|Period 2||0
91162|NCT01314872|217893|P4|STARTED|Period 2||0
91163|NCT01314872|217894|P3|STARTED|Period 2||0
91164|NCT01314872|217895|P2|STARTED|Period 2||0
91165|NCT01314872|217896|P1|STARTED|Period 2||0
91166|NCT01314872|217882|P15|NOT COMPLETED|Treatment Period 1||0
91167|NCT01314872|217883|P14|NOT COMPLETED|Treatment Period 1||0
91168|NCT01314872|217884|P13|NOT COMPLETED|Treatment Period 1||0
91169|NCT01314872|217885|P12|NOT COMPLETED|Treatment Period 1||0
91170|NCT01314872|217886|P11|NOT COMPLETED|Treatment Period 1||3
91171|NCT01314872|217887|P10|NOT COMPLETED|Treatment Period 1||4
91172|NCT01314872|217888|P9|NOT COMPLETED|Treatment Period 1||6
91173|NCT01314872|217889|P8|NOT COMPLETED|Treatment Period 1||7
91174|NCT01314872|217890|P7|NOT COMPLETED|Treatment Period 1||8
91175|NCT01314872|217891|P6|NOT COMPLETED|Treatment Period 1||7
91176|NCT01314872|217892|P5|NOT COMPLETED|Treatment Period 1||7
91177|NCT01314872|217893|P4|NOT COMPLETED|Treatment Period 1||7
91178|NCT01314872|217894|P3|NOT COMPLETED|Treatment Period 1||6
91179|NCT01314872|217895|P2|NOT COMPLETED|Treatment Period 1||6
91180|NCT01314872|217896|P1|NOT COMPLETED|Treatment Period 1||10
91181|NCT01314872|217882|P15|COMPLETED|Treatment Period 1||0
91182|NCT01314872|217883|P14|COMPLETED|Treatment Period 1||0
91183|NCT01314872|217884|P13|COMPLETED|Treatment Period 1||0
91184|NCT01314872|217885|P12|COMPLETED|Treatment Period 1||0
91185|NCT01314872|217886|P11|COMPLETED|Treatment Period 1||107
91186|NCT01314872|217887|P10|COMPLETED|Treatment Period 1||118
91187|NCT01314872|217888|P9|COMPLETED|Treatment Period 1||106
91188|NCT01314872|217889|P8|COMPLETED|Treatment Period 1||57
91189|NCT01314872|217890|P7|COMPLETED|Treatment Period 1||126
91190|NCT01314872|217891|P6|COMPLETED|Treatment Period 1||128
91191|NCT01314872|217892|P5|COMPLETED|Treatment Period 1||142
91192|NCT01314872|217893|P4|COMPLETED|Treatment Period 1||143
91193|NCT01314872|217894|P3|COMPLETED|Treatment Period 1||128
91194|NCT01314872|217895|P2|COMPLETED|Treatment Period 1||138
91195|NCT01314872|217896|P1|COMPLETED|Treatment Period 1||131
91196|NCT01314872|217882|P15|STARTED|Treatment Period 1||0
91197|NCT01314872|217883|P14|STARTED|Treatment Period 1||0
91198|NCT01314872|217884|P13|STARTED|Treatment Period 1||0
91199|NCT01314872|217885|P12|STARTED|Treatment Period 1||0
91200|NCT01314872|217886|P11|STARTED|Treatment Period 1||110
91201|NCT01314872|217887|P10|STARTED|Treatment Period 1||122
91202|NCT01314872|217888|P9|STARTED|Treatment Period 1||112
91203|NCT01314872|217889|P8|STARTED|Treatment Period 1||64
91204|NCT01314872|217890|P7|STARTED|Treatment Period 1||134
91205|NCT01314872|217891|P6|STARTED|Treatment Period 1||135
91206|NCT01314872|217892|P5|STARTED|Treatment Period 1||149
91207|NCT01314872|217893|P4|STARTED|Treatment Period 1||150
91208|NCT01314872|217894|P3|STARTED|Treatment Period 1||134
91209|NCT01314872|217895|P2|STARTED|Treatment Period 1||144
91210|NCT01314872|217896|P1|STARTED|Treatment Period 1||141
91211|NCT01314742|217989|P2|NOT COMPLETED|Overall Study||0
91212|NCT01314742|217990|P1|NOT COMPLETED|Overall Study||0
91213|NCT01314742|217989|P2|COMPLETED|Overall Study||21
91214|NCT01314742|217990|P1|COMPLETED|Overall Study||20
91215|NCT01314742|217989|P2|STARTED|Overall Study||21
91216|NCT01314742|217990|P1|STARTED|Overall Study||20
91217|NCT01314716|218000|P2|NOT COMPLETED|Open-Label Phase||12
91218|NCT01314716|218001|P1|NOT COMPLETED|Open-Label Phase||10
91219|NCT01314716|218000|P2|COMPLETED|Open-Label Phase||98
91220|NCT01314716|218001|P1|COMPLETED|Open-Label Phase||102
91221|NCT01314716|218000|P2|STARTED|Open-Label Phase|13 participants in this group did not continue from the randomized to the open-label phase.|110
91222|NCT01314716|218001|P1|STARTED|Open-Label Phase|7 participants in this group did not continue from the randomized to the open-label phase.|112
91223|NCT01314716|218000|P2|NOT COMPLETED|Double-Blind Phase||15
91224|NCT01314716|218001|P1|NOT COMPLETED|Double-Blind Phase||17
91225|NCT01314716|218000|P2|COMPLETED|Double-Blind Phase||123
91226|NCT01314716|218001|P1|COMPLETED|Double-Blind Phase||119
91227|NCT01314716|218000|P2|Randomized and Treated|Double-Blind Phase||137
91228|NCT01314716|218001|P1|Randomized and Treated|Double-Blind Phase||135
91229|NCT01314716|218000|P2|STARTED|Double-Blind Phase||138
91230|NCT01314716|218001|P1|STARTED|Double-Blind Phase||136
91231|NCT01314703|218013|P1|NOT COMPLETED|Overall Study||8
91232|NCT01314703|218013|P1|COMPLETED|Overall Study||27
91233|NCT01314703|218013|P1|Discontinued When Enrollment Completed|Overall Study||3
91234|NCT01314703|218013|P1|Non Qualified Bacterial Screening Counts|Overall Study||3
91235|NCT01314703|218013|P1|Excluded Prior to Screening Baseline|Overall Study||2
91236|NCT01314703|218013|P1|Completed Study|Overall Study||27
91237|NCT01314703|218013|P1|Completed Treatment Visit|Overall Study||27
91238|NCT01314703|218013|P1|Completed Screen Visit|Overall Study||33
91239|NCT01314703|218013|P1|Signed Informed Consent|Overall Study||35
91240|NCT01314703|218013|P1|STARTED|Overall Study||35
91241|NCT01314443|218022|P4|NOT COMPLETED|Overall Study||2
91242|NCT01314443|218023|P3|NOT COMPLETED|Overall Study||2
91243|NCT01314443|218024|P2|NOT COMPLETED|Overall Study||3
91244|NCT01314443|218025|P1|NOT COMPLETED|Overall Study||4
91245|NCT01314443|218022|P4|COMPLETED|Overall Study||13
91246|NCT01314443|218023|P3|COMPLETED|Overall Study||13
91247|NCT01314443|218024|P2|COMPLETED|Overall Study||16
91248|NCT01314443|218025|P1|COMPLETED|Overall Study||14
91249|NCT01314443|218022|P4|STARTED|Overall Study||15
91250|NCT01314443|218023|P3|STARTED|Overall Study||15
91251|NCT01314443|218024|P2|STARTED|Overall Study||19
91252|NCT01314443|218025|P1|STARTED|Overall Study||18
91253|NCT01314417|218043|P1|NOT COMPLETED|Overall Study||0
91254|NCT01314417|218043|P1|COMPLETED|Overall Study||2
91255|NCT01314417|218043|P1|STARTED|Overall Study||2
91256|NCT01314261|218074|P4|NOT COMPLETED|Overall Study||3
91257|NCT01314261|218075|P3|NOT COMPLETED|Overall Study||3
91258|NCT01314261|218076|P2|NOT COMPLETED|Overall Study||4
91259|NCT01314261|218077|P1|NOT COMPLETED|Overall Study||2
91260|NCT01314261|218074|P4|COMPLETED|Overall Study||6
91261|NCT01314261|218075|P3|COMPLETED|Overall Study||7
91262|NCT01314261|218076|P2|COMPLETED|Overall Study||5
91263|NCT01314261|218077|P1|COMPLETED|Overall Study||7
91264|NCT01314261|218074|P4|Discontinued pegIFN/RBV|Overall Study||1
91265|NCT01314261|218075|P3|Discontinued pegIFN/RBV|Overall Study||5
91266|NCT01314261|218076|P2|Discontinued pegIFN/RBV|Overall Study||4
91267|NCT01314261|218077|P1|Discontinued pegIFN/RBV|Overall Study||1
91268|NCT01314261|218074|P4|Discontinued ABT-267 or Placebo|Overall Study||0
91269|NCT01314261|218075|P3|Discontinued ABT-267 or Placebo|Overall Study||1
91270|NCT01314261|218076|P2|Discontinued ABT-267 or Placebo|Overall Study||0
91271|NCT01314261|218077|P1|Discontinued ABT-267 or Placebo|Overall Study||1
91272|NCT01314261|218074|P4|STARTED|Overall Study||9
91273|NCT01314261|218075|P3|STARTED|Overall Study||10
91274|NCT01314261|218076|P2|STARTED|Overall Study||9
91275|NCT01314261|218077|P1|STARTED|Overall Study||9
91276|NCT01314118|218128|P1|NOT COMPLETED|Overall Study||131
91277|NCT01314118|218128|P1|COMPLETED|Overall Study||0
91278|NCT01314118|218128|P1|STARTED|Overall Study||131
91279|NCT01314105|218137|P2|NOT COMPLETED|Overall Study||4
91280|NCT01314105|218138|P1|NOT COMPLETED|Overall Study||6
91281|NCT01314105|218137|P2|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|2
91282|NCT01314105|218138|P1|COMPLETED|Overall Study|On treatment at analysis cut off date of 15 April 2014|1
91283|NCT01314105|218137|P2|STARTED|Overall Study||6
91284|NCT01314105|218138|P1|STARTED|Overall Study||7
91285|NCT01314014|218160|P1|NOT COMPLETED|Overall Study||0
91286|NCT01314014|218160|P1|COMPLETED|Overall Study|Treatment continued for as long as the subject derived benefit.|22
91287|NCT01314014|218160|P1|STARTED|Overall Study||22
91288|NCT01314001|218171|P6|NOT COMPLETED|Overall Study||71
91289|NCT01314001|218172|P5|NOT COMPLETED|Overall Study||72
91290|NCT01314001|218173|P4|NOT COMPLETED|Overall Study||69
91291|NCT01314001|218174|P3|NOT COMPLETED|Overall Study||69
91292|NCT01314001|218175|P2|NOT COMPLETED|Overall Study||69
91293|NCT01314001|218176|P1|NOT COMPLETED|Overall Study||75
91294|NCT01314001|218171|P6|COMPLETED|Overall Study||129
91295|NCT01314001|218172|P5|COMPLETED|Overall Study||148
91296|NCT01314001|218173|P4|COMPLETED|Overall Study||122
91297|NCT01314001|218174|P3|COMPLETED|Overall Study||158
91298|NCT01314001|218175|P2|COMPLETED|Overall Study||124
91299|NCT01314001|218176|P1|COMPLETED|Overall Study||140
91300|NCT01314001|218171|P6|6-Month Follow Up Survey|Overall Study||139
91301|NCT01314001|218172|P5|6-Month Follow Up Survey|Overall Study||157
91302|NCT01314001|218173|P4|6-Month Follow Up Survey|Overall Study||135
91303|NCT01314001|218174|P3|6-Month Follow Up Survey|Overall Study||165
91304|NCT01314001|218175|P2|6-Month Follow Up Survey|Overall Study||137
91305|NCT01314001|218176|P1|6-Month Follow Up Survey|Overall Study||146
91306|NCT01314001|218171|P6|End-of-Treatment Visit|Overall Study||160
91307|NCT01314001|218172|P5|End-of-Treatment Visit|Overall Study||174
91308|NCT01314001|218173|P4|End-of-Treatment Visit|Overall Study||146
91309|NCT01314001|218174|P3|End-of-Treatment Visit|Overall Study||179
91310|NCT01314001|218175|P2|End-of-Treatment Visit|Overall Study||141
91311|NCT01314001|218176|P1|End-of-Treatment Visit|Overall Study||156
91312|NCT01314001|218171|P6|STARTED|Overall Study||200
91313|NCT01314001|218172|P5|STARTED|Overall Study||220
91314|NCT01314001|218173|P4|STARTED|Overall Study||191
91315|NCT01314001|218174|P3|STARTED|Overall Study||227
91316|NCT01314001|218175|P2|STARTED|Overall Study||193
91317|NCT01314001|218176|P1|STARTED|Overall Study||215
91318|NCT01313936|218222|P2|NOT COMPLETED|Overall Study||0
91319|NCT01313936|218223|P1|NOT COMPLETED|Overall Study||0
91320|NCT01313936|218222|P2|COMPLETED|Overall Study||26
91321|NCT01313936|218223|P1|COMPLETED|Overall Study||6
91322|NCT01313936|218222|P2|STARTED|Overall Study||26
91323|NCT01313936|218223|P1|STARTED|Overall Study||6
91324|NCT01313923|218231|P1|NOT COMPLETED|Overall Study||3
91325|NCT01313923|218231|P1|COMPLETED|Overall Study||0
91326|NCT01313923|218231|P1|STARTED|Overall Study||3
91327|NCT01313910|218235|P1|NOT COMPLETED|Overall Study||0
91328|NCT01313910|218235|P1|COMPLETED|Overall Study||8
91329|NCT01313910|218235|P1|STARTED|Overall Study||8
91330|NCT01313897|218243|P1|NOT COMPLETED|Overall Study||2
91331|NCT01313897|218243|P1|COMPLETED|Overall Study||8
91332|NCT01313897|218243|P1|STARTED|Overall Study||10
91333|NCT01313884|218247|P1|NOT COMPLETED|Overall Study||1
91334|NCT01313884|218247|P1|COMPLETED|Overall Study||2
91335|NCT01313884|218247|P1|STARTED|Overall Study||3
91336|NCT01313858|218254|P3|NOT COMPLETED|Overall Study||238
91337|NCT01313858|218255|P2|NOT COMPLETED|Overall Study||270
91338|NCT01313858|218256|P1|NOT COMPLETED|Overall Study||286
91339|NCT01313858|218254|P3|COMPLETED|Overall Study||305
91340|NCT01313858|218255|P2|COMPLETED|Overall Study||276
91341|NCT01313858|218256|P1|COMPLETED|Overall Study||238
91342|NCT01313858|218254|P3|STARTED|Overall Study||543
91343|NCT01313858|218255|P2|STARTED|Overall Study||546
91344|NCT01313858|218256|P1|STARTED|Overall Study||524
91345|NCT01313780|218279|P2|NOT COMPLETED|Overall Study||28
91346|NCT01313780|218280|P1|NOT COMPLETED|Overall Study||25
91347|NCT01313780|218279|P2|COMPLETED|Overall Study|PPS|31
91348|NCT01313780|218280|P1|COMPLETED|Overall Study|PPS|33
91349|NCT01313780|218279|P2|STARTED|Overall Study|FAS|59
91350|NCT01313780|218280|P1|STARTED|Overall Study|FAS|58
91351|NCT01313728|218288|P1|NOT COMPLETED|Baseline to Completion||0
91352|NCT01313728|218288|P1|COMPLETED|Baseline to Completion||25
91353|NCT01313728|218288|P1|STARTED|Baseline to Completion||25
91354|NCT01313728|218288|P1|NOT COMPLETED|Informed Consent to Baseline||1
91355|NCT01313728|218288|P1|COMPLETED|Informed Consent to Baseline|One subject withdrew after signing informed consent, but prior to Baseline measurements being taken.|25
91356|NCT01313728|218288|P1|STARTED|Informed Consent to Baseline||26
91357|NCT01313689|218305|P4|NOT COMPLETED|24-Week Randomization 2||1
91358|NCT01313689|218306|P3|NOT COMPLETED|24-Week Randomization 2||3
91359|NCT01313689|218307|P2|NOT COMPLETED|24-Week Randomization 2||0
91360|NCT01313689|218308|P1|NOT COMPLETED|24-Week Randomization 2||0
91361|NCT01313689|218305|P4|COMPLETED|24-Week Randomization 2||12
91362|NCT01313689|218306|P3|COMPLETED|24-Week Randomization 2||21
91363|NCT01313689|218307|P2|COMPLETED|24-Week Randomization 2||0
91364|NCT01313689|218308|P1|COMPLETED|24-Week Randomization 2||0
91365|NCT01313689|218305|P4|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|13
91366|NCT01313689|218306|P3|STARTED|24-Week Randomization 2|Not all participants from Randomization 1 continued to Randomization 2.|24
91367|NCT01313689|218307|P2|STARTED|24-Week Randomization 2||0
91368|NCT01313689|218308|P1|STARTED|24-Week Randomization 2||0
91369|NCT01313689|218305|P4|NOT COMPLETED|24-Week Randomization 1||0
91370|NCT01313689|218306|P3|NOT COMPLETED|24-Week Randomization 1||0
91371|NCT01313689|218307|P2|NOT COMPLETED|24-Week Randomization 1||10
91372|NCT01313689|218308|P1|NOT COMPLETED|24-Week Randomization 1||19
91373|NCT01313689|218305|P4|COMPLETED|24-Week Randomization 1||0
91374|NCT01313689|218306|P3|COMPLETED|24-Week Randomization 1||0
91375|NCT01313689|218307|P2|COMPLETED|24-Week Randomization 1|Par. that did not receive OFA salvage continued visits for Follow-up and overall survival assessment|33
91376|NCT01313689|218308|P1|COMPLETED|24-Week Randomization 1|Par. not entering Randomization 2 continued visits for Follow-up and overall survival assessment|60
91377|NCT01313689|218305|P4|STARTED|24-Week Randomization 1||0
91378|NCT01313689|218306|P3|STARTED|24-Week Randomization 1||0
91379|NCT01313689|218307|P2|STARTED|24-Week Randomization 1||43
91380|NCT01313689|218308|P1|STARTED|24-Week Randomization 1||79
91381|NCT01313676|218375|P4|NOT COMPLETED|Overall Study||994
91382|NCT01313676|218376|P3|NOT COMPLETED|Overall Study||1088
91383|NCT01313676|218377|P2|NOT COMPLETED|Overall Study||1113
91384|NCT01313676|218378|P1|NOT COMPLETED|Overall Study||1250
91385|NCT01313676|218375|P4|COMPLETED|Overall Study||3146
91386|NCT01313676|218376|P3|COMPLETED|Overall Study||3052
91387|NCT01313676|218377|P2|COMPLETED|Overall Study||3044
91388|NCT01313676|218378|P1|COMPLETED|Overall Study||2881
91389|NCT01313676|218375|P4|STARTED|Overall Study||4140
91390|NCT01313676|218376|P3|STARTED|Overall Study||4140
91391|NCT01313676|218377|P2|STARTED|Overall Study||4157
91392|NCT01313676|218378|P1|STARTED|Overall Study||4131
91393|NCT01313663|218398|P2|NOT COMPLETED|Overall Study||8
91394|NCT01313663|218399|P1|NOT COMPLETED|Overall Study||4
91395|NCT01313663|218398|P2|COMPLETED|Overall Study||3
91396|NCT01313663|218399|P1|COMPLETED|Overall Study||5
91397|NCT01313663|218398|P2|STARTED|Overall Study||11
91398|NCT01313663|218399|P1|STARTED|Overall Study||9
91399|NCT01313650|218437|P4|NOT COMPLETED|Overall Study||81
91400|NCT01313650|218438|P3|NOT COMPLETED|Overall Study||103
91401|NCT01313650|218439|P2|NOT COMPLETED|Overall Study||94
91402|NCT01313650|218440|P1|NOT COMPLETED|Overall Study||76
91403|NCT01313650|218437|P4|COMPLETED|Overall Study||332
91404|NCT01313650|218438|P3|COMPLETED|Overall Study||318
91405|NCT01313650|218439|P2|COMPLETED|Overall Study||324
91406|NCT01313650|218440|P1|COMPLETED|Overall Study||204
91407|NCT01313650|218437|P4|STARTED|Overall Study||413
91408|NCT01313650|218438|P3|STARTED|Overall Study||421
91409|NCT01313650|218439|P2|STARTED|Overall Study||418
91410|NCT01313650|218440|P1|STARTED|Overall Study||280
91411|NCT01313637|218466|P4|NOT COMPLETED|Overall Study||78
91412|NCT01313637|218467|P3|NOT COMPLETED|Overall Study||106
91413|NCT01313637|218468|P2|NOT COMPLETED|Overall Study||95
91414|NCT01313637|218469|P1|NOT COMPLETED|Overall Study||92
91415|NCT01313637|218466|P4|COMPLETED|Overall Study||325
91416|NCT01313637|218467|P3|COMPLETED|Overall Study||298
91417|NCT01313637|218468|P2|COMPLETED|Overall Study||312
91418|NCT01313637|218469|P1|COMPLETED|Overall Study||183
91419|NCT01313637|218466|P4|STARTED|Overall Study||403
91420|NCT01313637|218467|P3|STARTED|Overall Study||404
91421|NCT01313637|218468|P2|STARTED|Overall Study||407
91422|NCT01313637|218469|P1|STARTED|Overall Study||275
91423|NCT01313624|218493|P2|NOT COMPLETED|Open-Label Phase||13
91424|NCT01313624|218494|P1|NOT COMPLETED|Open-Label Phase||4
91425|NCT01313624|218493|P2|COMPLETED|Open-Label Phase||109
91426|NCT01313624|218494|P1|COMPLETED|Open-Label Phase||92
91427|NCT01313624|218493|P2|STARTED|Open-Label Phase||122
91428|NCT01313624|218494|P1|STARTED|Open-Label Phase||96
91429|NCT01313624|218493|P2|NOT COMPLETED|Double-Blind Phase||10
91430|NCT01313624|218494|P1|NOT COMPLETED|Double-Blind Phase||38
91431|NCT01313624|218493|P2|COMPLETED|Double-Blind Phase||122
91432|NCT01313624|218494|P1|COMPLETED|Double-Blind Phase||96
91433|NCT01313624|218493|P2|STARTED|Double-Blind Phase||132
91434|NCT01313624|218494|P1|STARTED|Double-Blind Phase||134
91435|NCT01313520|218508|P2|NOT COMPLETED|Overall Study||0
91436|NCT01313520|218509|P1|NOT COMPLETED|Overall Study||0
91437|NCT01313520|218508|P2|COMPLETED|Overall Study||31
91438|NCT01313520|218509|P1|COMPLETED|Overall Study||30
91439|NCT01313520|218508|P2|STARTED|Overall Study||31
91440|NCT01313520|218509|P1|STARTED|Overall Study||30
91441|NCT01313507|218529|P1|NOT COMPLETED|Overall Study||0
91442|NCT01313507|218529|P1|COMPLETED|Overall Study||21
91443|NCT01313507|218529|P1|STARTED|Overall Study||21
91444|NCT01313494|218537|P2|NOT COMPLETED|Overall Study||50
91445|NCT01313494|218538|P1|NOT COMPLETED|Overall Study||67
91446|NCT01313494|218537|P2|COMPLETED|Overall Study||263
91447|NCT01313494|218538|P1|COMPLETED|Overall Study||246
91448|NCT01313494|218537|P2|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|311
91449|NCT01313494|218538|P1|Safety Set|Overall Study|2 patients in the placebo arm were misallocated and may have received roflumilast in error.|315
91450|NCT01313494|218537|P2|STARTED|Overall Study||313
91451|NCT01313494|218538|P1|STARTED|Overall Study||313
91452|NCT01313312|218590|P1|NOT COMPLETED|Overall Study||36
91453|NCT01313312|218590|P1|COMPLETED|Overall Study||222
91454|NCT01313312|218590|P1|Cycle 5|Overall Study||11
91455|NCT01313312|218590|P1|Cycle 4|Overall Study||81
91456|NCT01313312|218590|P1|Cycle 3|Overall Study||175
91457|NCT01313312|218590|P1|Cycle 2|Overall Study||229
91458|NCT01313312|218590|P1|Cycle 1|Overall Study||254
91459|NCT01313312|218590|P1|STARTED|Overall Study||258
91460|NCT01313299|218637|P3|NOT COMPLETED|Overall Study||4
91461|NCT01313299|218638|P2|NOT COMPLETED|Overall Study||3
91462|NCT01313299|218639|P1|NOT COMPLETED|Overall Study||7
91463|NCT01313299|218637|P3|COMPLETED|Overall Study||77
91464|NCT01313299|218638|P2|COMPLETED|Overall Study||78
91465|NCT01313299|218639|P1|COMPLETED|Overall Study||74
91466|NCT01313299|218637|P3|STARTED|Overall Study||81
91467|NCT01313299|218638|P2|STARTED|Overall Study||81
91468|NCT01313299|218639|P1|STARTED|Overall Study||81
91469|NCT01313273|218655|P2|NOT COMPLETED|Overall Study||1
91470|NCT01313273|218656|P1|NOT COMPLETED|Overall Study||2
91471|NCT01313273|218655|P2|COMPLETED|Overall Study||0
91472|NCT01313273|218656|P1|COMPLETED|Overall Study||0
91473|NCT01313273|218655|P2|STARTED|Overall Study||1
91474|NCT01313273|218656|P1|STARTED|Overall Study||2
91475|NCT01313221|218671|P3|NOT COMPLETED|Overall Study||23
91476|NCT01313221|218672|P2|NOT COMPLETED|Overall Study||8
91477|NCT01313221|218673|P1|NOT COMPLETED|Overall Study||12
91478|NCT01313221|218671|P3|COMPLETED|Overall Study||0
91479|NCT01313221|218672|P2|COMPLETED|Overall Study||135
91480|NCT01313221|218673|P1|COMPLETED|Overall Study||132
91481|NCT01313221|218671|P3|Randomized|Overall Study||0
91482|NCT01313221|218672|P2|Randomized|Overall Study||143
91483|NCT01313221|218673|P1|Randomized|Overall Study||144
91484|NCT01313221|218671|P3|STARTED|Overall Study||23
91485|NCT01313221|218672|P2|STARTED|Overall Study||143
91486|NCT01313221|218673|P1|STARTED|Overall Study||144
91487|NCT01313208|218725|P2|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||3
91488|NCT01313208|218726|P1|NOT COMPLETED|Open-label Phase (Weeks 13 - 24)||6
91489|NCT01313208|218725|P2|COMPLETED|Open-label Phase (Weeks 13 - 24)||98
91490|NCT01313208|218726|P1|COMPLETED|Open-label Phase (Weeks 13 - 24)||92
91491|NCT01313208|218725|P2|STARTED|Open-label Phase (Weeks 13 - 24)||101
91492|NCT01313208|218726|P1|STARTED|Open-label Phase (Weeks 13 - 24)||98
91493|NCT01313208|218725|P2|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||5
91494|NCT01313208|218726|P1|NOT COMPLETED|Double-blind Phase (Weeks 1 - 12)||6
91495|NCT01313208|218725|P2|COMPLETED|Double-blind Phase (Weeks 1 - 12)||101
91496|NCT01313208|218726|P1|COMPLETED|Double-blind Phase (Weeks 1 - 12)||98
91497|NCT01313208|218725|P2|STARTED|Double-blind Phase (Weeks 1 - 12)||106
91498|NCT01313208|218726|P1|STARTED|Double-blind Phase (Weeks 1 - 12)||104
91499|NCT01313182|218816|P2|NOT COMPLETED|Overall Study||92
91500|NCT01313182|218817|P1|NOT COMPLETED|Overall Study||66
91501|NCT01313182|218816|P2|COMPLETED|Overall Study||763
91502|NCT01313182|218817|P1|COMPLETED|Overall Study||776
91503|NCT01313182|218816|P2|STARTED|Overall Study||855
91504|NCT01313182|218817|P1|STARTED|Overall Study||842
91505|NCT01313117|218823|P1|NOT COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
91506|NCT01313117|218823|P1|COMPLETED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||0
91507|NCT01313117|218823|P1|STARTED|Cohort 5: Dose Level 2 (ALA 600mg Daily)||1
91508|NCT01313117|218823|P1|NOT COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||0
91509|NCT01313117|218823|P1|COMPLETED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
91510|NCT01313117|218823|P1|STARTED|Cohort 4: Dose Level 4 (ALA 500mg Daily)||2
91511|NCT01313117|218823|P1|NOT COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||0
91512|NCT01313117|218823|P1|COMPLETED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
91513|NCT01313117|218823|P1|STARTED|Cohort 3: Dose Level 3 (ALA 400mg Daily)||2
91514|NCT01313117|218823|P1|NOT COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
91515|NCT01313117|218823|P1|COMPLETED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||1
91516|NCT01313117|218823|P1|STARTED|Cohort 2: Dose Level 2 (ALA 600mg Daily)||2
91517|NCT01313117|218823|P1|NOT COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||0
91518|NCT01313117|218823|P1|COMPLETED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
91519|NCT01313117|218823|P1|STARTED|Cohort 1: Dose Level 1 (ALA 300mg Daily)||2
91520|NCT01313078|218830|P1|NOT COMPLETED|Overall Study||3
91521|NCT01313078|218830|P1|COMPLETED|Overall Study||1
91522|NCT01313078|218830|P1|STARTED|Overall Study||4
91523|NCT01313039|218835|P1|NOT COMPLETED|Overall Study||2
91524|NCT01313039|218835|P1|COMPLETED|Overall Study||2
91525|NCT01313039|218835|P1|STARTED|Overall Study||4
91526|NCT01312961|218841|P2|NOT COMPLETED|Overall Study||7
91527|NCT01312961|218842|P1|NOT COMPLETED|Overall Study||17
91528|NCT01312961|218841|P2|COMPLETED|Overall Study||45
91529|NCT01312961|218842|P1|COMPLETED|Overall Study||35
91530|NCT01312961|218841|P2|Treated|Overall Study||52
91531|NCT01312961|218842|P1|Treated|Overall Study||52
91532|NCT01312961|218841|P2|STARTED|Overall Study||52
91533|NCT01312961|218842|P1|STARTED|Overall Study||52
91534|NCT01312948|218868|P1|NOT COMPLETED|Overall Study||0
91535|NCT01312948|218868|P1|COMPLETED|Overall Study||6
91536|NCT01312948|218868|P1|STARTED|Overall Study||6
91537|NCT01312844|218877|P2|NOT COMPLETED|Overall Study||0
91538|NCT01312844|218878|P1|NOT COMPLETED|Overall Study||0
91539|NCT01312844|218877|P2|COMPLETED|Overall Study||3
91540|NCT01312844|218878|P1|COMPLETED|Overall Study||4
91541|NCT01312844|218877|P2|STARTED|Overall Study||3
91542|NCT01312844|218878|P1|STARTED|Overall Study||4
91543|NCT01312818|218900|P1|NOT COMPLETED|Overall Study||0
91544|NCT01312818|218900|P1|COMPLETED|Overall Study||2
91545|NCT01312818|218900|P1|STARTED|Overall Study||2
91546|NCT01312805|218908|P2|NOT COMPLETED|Overall Study||0
91547|NCT01312805|218909|P1|NOT COMPLETED|Overall Study||0
91548|NCT01312805|218908|P2|COMPLETED|Overall Study||1082
91549|NCT01312805|218909|P1|COMPLETED|Overall Study||1016
91550|NCT01312805|218908|P2|STARTED|Overall Study||1082
91551|NCT01312805|218909|P1|STARTED|Overall Study||1016
91552|NCT01312766|218917|P2|NOT COMPLETED|Overall Study||5
91553|NCT01312766|218918|P1|NOT COMPLETED|Overall Study||6
91554|NCT01312766|218917|P2|COMPLETED|Overall Study||130
91555|NCT01312766|218918|P1|COMPLETED|Overall Study||129
91556|NCT01312766|218917|P2|STARTED|Overall Study||135
91557|NCT01312766|218918|P1|STARTED|Overall Study||135
91558|NCT01312519|218950|P2|NOT COMPLETED|Overall Study||0
91559|NCT01312519|218951|P1|NOT COMPLETED|Overall Study||0
91560|NCT01312519|218950|P2|COMPLETED|Overall Study||24
91561|NCT01312519|218951|P1|COMPLETED|Overall Study||26
91562|NCT01312519|218950|P2|STARTED|Overall Study||24
91563|NCT01312519|218951|P1|STARTED|Overall Study||26
91564|NCT01312467|218959|P1|NOT COMPLETED|Overall Study||13
91565|NCT01312467|218959|P1|COMPLETED|Overall Study||32
91566|NCT01312467|218959|P1|STARTED|Overall Study||45
91567|NCT01312428|218965|P2|NOT COMPLETED|Overall Study||4
91568|NCT01312428|218966|P1|NOT COMPLETED|Overall Study||3
91569|NCT01312428|218965|P2|COMPLETED|Overall Study||0
91570|NCT01312428|218966|P1|COMPLETED|Overall Study||0
91571|NCT01312428|218965|P2|STARTED|Overall Study||4
91572|NCT01312428|218966|P1|STARTED|Overall Study||3
91573|NCT01312272|218974|P2|NOT COMPLETED|Overall Study||1
91574|NCT01312272|218975|P1|NOT COMPLETED|Overall Study||0
91575|NCT01312272|218974|P2|COMPLETED|Overall Study||11
91576|NCT01312272|218975|P1|COMPLETED|Overall Study||12
91577|NCT01312272|218974|P2|STARTED|Overall Study||12
91578|NCT01312272|218975|P1|STARTED|Overall Study||12
91579|NCT01312129|218993|P2|NOT COMPLETED|Second Intervention (24 Hours)||1
91580|NCT01312129|218994|P1|NOT COMPLETED|Second Intervention (24 Hours)||0
91581|NCT01312129|218993|P2|COMPLETED|Second Intervention (24 Hours)||6
91582|NCT01312129|218994|P1|COMPLETED|Second Intervention (24 Hours)||6
91583|NCT01312129|218993|P2|Alcohol Cue|Second Intervention (24 Hours)||6
91584|NCT01312129|218994|P1|Alcohol Cue|Second Intervention (24 Hours)||6
91585|NCT01312129|218993|P2|Control Cue|Second Intervention (24 Hours)||6
91586|NCT01312129|218994|P1|Control Cue|Second Intervention (24 Hours)||6
91587|NCT01312129|218993|P2|STARTED|Second Intervention (24 Hours)||7
91588|NCT01312129|218994|P1|STARTED|Second Intervention (24 Hours)||6
91589|NCT01312129|218993|P2|NOT COMPLETED|Washout (1 Week)||0
91590|NCT01312129|218994|P1|NOT COMPLETED|Washout (1 Week)||0
91591|NCT01312129|218993|P2|COMPLETED|Washout (1 Week)||7
91592|NCT01312129|218994|P1|COMPLETED|Washout (1 Week)||6
91593|NCT01312129|218993|P2|STARTED|Washout (1 Week)||7
91594|NCT01312129|218994|P1|STARTED|Washout (1 Week)||6
91595|NCT01312129|218993|P2|NOT COMPLETED|First Intervention (24 Hours)||0
91596|NCT01312129|218994|P1|NOT COMPLETED|First Intervention (24 Hours)||0
91597|NCT01312129|218993|P2|COMPLETED|First Intervention (24 Hours)||7
91598|NCT01312129|218994|P1|COMPLETED|First Intervention (24 Hours)||6
91599|NCT01312129|218993|P2|Alcohol Cue|First Intervention (24 Hours)||7
91600|NCT01312129|218994|P1|Alcohol Cue|First Intervention (24 Hours)||6
91601|NCT01312129|218993|P2|Control Cue|First Intervention (24 Hours)||7
91602|NCT01312129|218994|P1|Control Cue|First Intervention (24 Hours)||6
91603|NCT01312129|218993|P2|STARTED|First Intervention (24 Hours)||7
91604|NCT01312129|218994|P1|STARTED|First Intervention (24 Hours)||6
91605|NCT01312038|219002|P2|NOT COMPLETED|Overall Study||0
91606|NCT01312038|219003|P1|NOT COMPLETED|Overall Study||0
91607|NCT01312038|219002|P2|COMPLETED|Overall Study||12
91608|NCT01312038|219003|P1|COMPLETED|Overall Study||13
91609|NCT01312038|219002|P2|STARTED|Overall Study||12
91610|NCT01312038|219003|P1|STARTED|Overall Study||13
91611|NCT01311687|219011|P2|NOT COMPLETED|PFS Follow-up Phase||1
91612|NCT01311687|219012|P1|NOT COMPLETED|PFS Follow-up Phase||3
91613|NCT01311687|219011|P2|COMPLETED|PFS Follow-up Phase||7
91614|NCT01311687|219012|P1|COMPLETED|PFS Follow-up Phase||5
91615|NCT01311687|219011|P2|STARTED|PFS Follow-up Phase||8
91616|NCT01311687|219012|P1|STARTED|PFS Follow-up Phase||8
91617|NCT01311687|219011|P2|NOT COMPLETED|Treatment Phase||11
91618|NCT01311687|219012|P1|NOT COMPLETED|Treatment Phase||60
91619|NCT01311687|219011|P2|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|142
91620|NCT01311687|219012|P1|COMPLETED|Treatment Phase|Completed represents participants who discontinued from study treatment|242
91621|NCT01311687|219011|P2|Received Study Treatment|Treatment Phase||150
91622|NCT01311687|219012|P1|Received Study Treatment|Treatment Phase||300
91623|NCT01311687|219011|P2|STARTED|Treatment Phase||153
91624|NCT01311687|219012|P1|STARTED|Treatment Phase||302
91625|NCT01311661|219062|P1|NOT COMPLETED|Overall Study||7
91626|NCT01311661|219062|P1|COMPLETED|Overall Study||199
91627|NCT01311661|219062|P1|Received Olo 10 mcg qd|Overall Study||102
91628|NCT01311661|219062|P1|Received Olo 5 mcg Bid|Overall Study||101
91629|NCT01311661|219062|P1|Received Olo 5 mcg qd|Overall Study||101
91630|NCT01311661|219062|P1|Received Olo 2.5 mcg Bid|Overall Study||101
91631|NCT01311661|219062|P1|Received Placebo|Overall Study||201
91632|NCT01311661|219062|P1|STARTED|Overall Study|Entered and treated|206
91633|NCT01311557|219206|P2|NOT COMPLETED|Overall Study||6
91634|NCT01311557|219207|P1|NOT COMPLETED|Overall Study||5
91635|NCT01311557|219206|P2|COMPLETED|Overall Study||645
91636|NCT01311557|219207|P1|COMPLETED|Overall Study||646
91637|NCT01311557|219206|P2|STARTED|Overall Study||651
91638|NCT01311557|219207|P1|STARTED|Overall Study||651
91639|NCT01311505|219223|P2|NOT COMPLETED|Second Intervention Period||0
91640|NCT01311505|219224|P1|NOT COMPLETED|Second Intervention Period||0
91641|NCT01311505|219223|P2|COMPLETED|Second Intervention Period||10
91642|NCT01311505|219224|P1|COMPLETED|Second Intervention Period||10
91643|NCT01311505|219223|P2|STARTED|Second Intervention Period||10
91644|NCT01311505|219224|P1|STARTED|Second Intervention Period||10
91645|NCT01311505|219223|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
91646|NCT01311505|219224|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
91647|NCT01311505|219223|P2|COMPLETED|Washout Period (at Least 7 Days)||10
91648|NCT01311505|219224|P1|COMPLETED|Washout Period (at Least 7 Days)||10
91649|NCT01311505|219223|P2|STARTED|Washout Period (at Least 7 Days)||10
91650|NCT01311505|219224|P1|STARTED|Washout Period (at Least 7 Days)||10
91651|NCT01311505|219223|P2|NOT COMPLETED|First Intervention Period||1
91652|NCT01311505|219224|P1|NOT COMPLETED|First Intervention Period||0
91653|NCT01311505|219223|P2|COMPLETED|First Intervention Period||10
91654|NCT01311505|219224|P1|COMPLETED|First Intervention Period||10
91655|NCT01311505|219223|P2|STARTED|First Intervention Period||11
91656|NCT01311505|219224|P1|STARTED|First Intervention Period||10
91657|NCT01311362|219252|P1|NOT COMPLETED|Ambrisentan and SJW||0
91658|NCT01311362|219252|P1|COMPLETED|Ambrisentan and SJW||20
91659|NCT01311362|219252|P1|STARTED|Ambrisentan and SJW||20
91660|NCT01311362|219252|P1|NOT COMPLETED|Ambrisentan Steady-state||0
91661|NCT01311362|219252|P1|COMPLETED|Ambrisentan Steady-state||20
91662|NCT01311362|219252|P1|STARTED|Ambrisentan Steady-state||20
91663|NCT01311362|219252|P1|NOT COMPLETED|Ambrisentan Single Dose||0
91664|NCT01311362|219252|P1|COMPLETED|Ambrisentan Single Dose||20
91665|NCT01311362|219252|P1|STARTED|Ambrisentan Single Dose|All 20 study participants completed each study period. Total number of study participants: 20|20
91666|NCT01311102|219265|P2|NOT COMPLETED|Overall Study||0
91667|NCT01311102|219266|P1|NOT COMPLETED|Overall Study||0
91668|NCT01311102|219265|P2|COMPLETED|Overall Study||20
91669|NCT01311102|219266|P1|COMPLETED|Overall Study||20
91670|NCT01311102|219265|P2|STARTED|Overall Study||20
91671|NCT01311102|219266|P1|STARTED|Overall Study||20
91672|NCT01311024|219280|P2|NOT COMPLETED|Overall Study||22
91673|NCT01311024|219281|P1|NOT COMPLETED|Overall Study||35
91674|NCT01311024|219280|P2|COMPLETED|Overall Study||789
91675|NCT01311024|219281|P1|COMPLETED|Overall Study||1495
91676|NCT01311024|219280|P2|STARTED|Overall Study||811
91677|NCT01311024|219281|P1|STARTED|Overall Study||1530
91678|NCT01309997|219289|P2|NOT COMPLETED|Overall Study||6
91679|NCT01309997|219290|P1|NOT COMPLETED|Overall Study||5
91680|NCT01309997|219289|P2|COMPLETED|Overall Study||31
91681|NCT01309997|219290|P1|COMPLETED|Overall Study||30
91682|NCT01309997|219289|P2|Crossed Over to Second Arm|Overall Study||23
91683|NCT01309997|219290|P1|Crossed Over to Second Arm|Overall Study||19
91684|NCT01309997|219289|P2|Remained on First Arm Only|Overall Study||14
91685|NCT01309997|219290|P1|Remained on First Arm Only|Overall Study||16
91686|NCT01309997|219289|P2|STARTED|Overall Study||37
91687|NCT01309997|219290|P1|STARTED|Overall Study||35
91688|NCT01309919|219314|P2|NOT COMPLETED|Overall Study||48
91689|NCT01309919|219315|P1|NOT COMPLETED|Overall Study||17
91690|NCT01309919|219314|P2|COMPLETED|Overall Study||27
91691|NCT01309919|219315|P1|COMPLETED|Overall Study||58
91692|NCT01309919|219314|P2|STARTED|Overall Study||75
91693|NCT01309919|219315|P1|STARTED|Overall Study||75
91694|NCT01310868|219327|P1|NOT COMPLETED|Overall Study||13
91695|NCT01310868|219327|P1|COMPLETED|Overall Study||59
91696|NCT01310868|219327|P1|STARTED|Overall Study||72
91697|NCT01310855|219333|P2|NOT COMPLETED|Overall Study||0
91698|NCT01310855|219334|P1|NOT COMPLETED|Overall Study||0
91699|NCT01310855|219333|P2|COMPLETED|Overall Study||19
91700|NCT01310855|219334|P1|COMPLETED|Overall Study||19
91701|NCT01310855|219333|P2|STARTED|Overall Study||19
91702|NCT01310855|219334|P1|STARTED|Overall Study||19
91703|NCT01310803|219342|P2|NOT COMPLETED|Overall Study||0
91704|NCT01310803|219343|P1|NOT COMPLETED|Overall Study||1
91705|NCT01310803|219342|P2|COMPLETED|Overall Study||0
91706|NCT01310803|219343|P1|COMPLETED|Overall Study||0
91707|NCT01310803|219342|P2|STARTED|Overall Study||0
91708|NCT01310803|219343|P1|STARTED|Overall Study||1
91709|NCT01310777|219354|P3|NOT COMPLETED|Overall Study||30
91710|NCT01310777|219355|P2|NOT COMPLETED|Overall Study||14
91711|NCT01310777|219356|P1|NOT COMPLETED|Overall Study||33
91712|NCT01310777|219354|P3|COMPLETED|Overall Study||145
91713|NCT01310777|219355|P2|COMPLETED|Overall Study||178
91714|NCT01310777|219356|P1|COMPLETED|Overall Study||160
91715|NCT01310777|219354|P3|STARTED|Overall Study||175
91716|NCT01310777|219355|P2|STARTED|Overall Study||192
91717|NCT01310777|219356|P1|STARTED|Overall Study||193
91718|NCT01310699|219366|P2|NOT COMPLETED|Overall Study||6
91719|NCT01310699|219367|P1|NOT COMPLETED|Overall Study||4
91720|NCT01310699|219366|P2|COMPLETED|Overall Study||143
91721|NCT01310699|219367|P1|COMPLETED|Overall Study||128
91722|NCT01310699|219366|P2|STARTED|Overall Study||149
91723|NCT01310699|219367|P1|STARTED|Overall Study||132
91724|NCT01310582|219379|P2|NOT COMPLETED|Overall Study||0
91725|NCT01310582|219380|P1|NOT COMPLETED|Overall Study||0
91726|NCT01310582|219379|P2|COMPLETED|Overall Study||26
91727|NCT01310582|219380|P1|COMPLETED|Overall Study||31
91728|NCT01310582|219379|P2|STARTED|Overall Study||26
91729|NCT01310582|219380|P1|STARTED|Overall Study||31
91730|NCT01310413|219394|P7|NOT COMPLETED|From Day U0 to Day U385||3
91731|NCT01310413|219395|P6|NOT COMPLETED|From Day U0 to Day U385||0
91732|NCT01310413|219396|P5|NOT COMPLETED|From Day U0 to Day U385||0
91733|NCT01310413|219397|P4|NOT COMPLETED|From Day U0 to Day U385||0
91734|NCT01310413|219398|P3|NOT COMPLETED|From Day U0 to Day U385||0
91735|NCT01310413|219399|P2|NOT COMPLETED|From Day U0 to Day U385||0
91736|NCT01310413|219400|P1|NOT COMPLETED|From Day U0 to Day U385||0
91737|NCT01310413|219394|P7|COMPLETED|From Day U0 to Day U385|Upto Day U42|152
91738|NCT01310413|219395|P6|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
91739|NCT01310413|219396|P5|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
91740|NCT01310413|219397|P4|COMPLETED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
91741|NCT01310413|219398|P3|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
91742|NCT01310413|219399|P2|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
91743|NCT01310413|219400|P1|COMPLETED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
91744|NCT01310413|219394|P7|STARTED|From Day U0 to Day U385|Upto Day U42|155
91745|NCT01310413|219395|P6|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
91746|NCT01310413|219396|P5|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
91747|NCT01310413|219397|P4|STARTED|From Day U0 to Day U385|Eligible subjects who provided consent were included in Placebo/Influenza A (H5N1) Adjuvanted Group.|0
91748|NCT01310413|219398|P3|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
91749|NCT01310413|219399|P2|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
91750|NCT01310413|219400|P1|STARTED|From Day U0 to Day U385|Subjects from this group were not included in Day U0 to Day U42 analysis as per study protocol.|0
91751|NCT01310413|219394|P7|NOT COMPLETED|Day 0 to Day 385||0
91752|NCT01310413|219395|P6|NOT COMPLETED|Day 0 to Day 385||3
91753|NCT01310413|219396|P5|NOT COMPLETED|Day 0 to Day 385||3
91754|NCT01310413|219397|P4|NOT COMPLETED|Day 0 to Day 385||8
91755|NCT01310413|219398|P3|NOT COMPLETED|Day 0 to Day 385||7
91756|NCT01310413|219399|P2|NOT COMPLETED|Day 0 to Day 385||8
91757|NCT01310413|219400|P1|NOT COMPLETED|Day 0 to Day 385||27
91758|NCT01310413|219394|P7|COMPLETED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
91759|NCT01310413|219395|P6|COMPLETED|Day 0 to Day 385||77
91760|NCT01310413|219396|P5|COMPLETED|Day 0 to Day 385||73
91761|NCT01310413|219397|P4|COMPLETED|Day 0 to Day 385||67
91762|NCT01310413|219398|P3|COMPLETED|Day 0 to Day 385||203
91763|NCT01310413|219399|P2|COMPLETED|Day 0 to Day 385||190
91764|NCT01310413|219400|P1|COMPLETED|Day 0 to Day 385||172
91765|NCT01310413|219394|P7|STARTED|Day 0 to Day 385|This group is only followed during the Unblinded Phase of the study, from Days U0 to U385.|0
91766|NCT01310413|219395|P6|STARTED|Day 0 to Day 385||80
91767|NCT01310413|219396|P5|STARTED|Day 0 to Day 385||76
91768|NCT01310413|219397|P4|STARTED|Day 0 to Day 385||75
91769|NCT01310413|219398|P3|STARTED|Day 0 to Day 385||210
91770|NCT01310413|219399|P2|STARTED|Day 0 to Day 385||198
91771|NCT01310413|219400|P1|STARTED|Day 0 to Day 385||199
91772|NCT01310400|219556|P3|NOT COMPLETED|Overall Study||30
91773|NCT01310400|219557|P2|NOT COMPLETED|Overall Study||32
91774|NCT01310400|219558|P1|NOT COMPLETED|Overall Study||28
91775|NCT01310400|219556|P3|COMPLETED|Overall Study||422
91776|NCT01310400|219557|P2|COMPLETED|Overall Study||420
91777|NCT01310400|219558|P1|COMPLETED|Overall Study||424
91778|NCT01310400|219556|P3|STARTED|Overall Study||452
91779|NCT01310400|219557|P2|STARTED|Overall Study||452
91780|NCT01310400|219558|P1|STARTED|Overall Study||452
91781|NCT01310179|219575|P1|NOT COMPLETED|Overall Study||0
91782|NCT01310179|219575|P1|COMPLETED|Overall Study||12
91783|NCT01310179|219575|P1|STARTED|Overall Study||12
91784|NCT01310127|219582|P2|NOT COMPLETED|Overall Study||1
91785|NCT01310127|219583|P1|NOT COMPLETED|Overall Study||2
91786|NCT01310127|219582|P2|COMPLETED|Overall Study||10
91787|NCT01310127|219583|P1|COMPLETED|Overall Study||10
91788|NCT01310127|219582|P2|STARTED|Overall Study||11
91789|NCT01310127|219583|P1|STARTED|Overall Study||12
91790|NCT01309893|219595|P2|NOT COMPLETED|Week 2 - Crossover Intervention||1
91791|NCT01309893|219596|P1|NOT COMPLETED|Week 2 - Crossover Intervention||1
91792|NCT01309893|219595|P2|COMPLETED|Week 2 - Crossover Intervention||32
91793|NCT01309893|219596|P1|COMPLETED|Week 2 - Crossover Intervention||32
91794|NCT01309893|219595|P2|STARTED|Week 2 - Crossover Intervention||33
91795|NCT01309893|219596|P1|STARTED|Week 2 - Crossover Intervention||33
91796|NCT01309893|219595|P2|NOT COMPLETED|Week 1 - First Intervention||0
91797|NCT01309893|219596|P1|NOT COMPLETED|Week 1 - First Intervention||0
91798|NCT01309893|219595|P2|COMPLETED|Week 1 - First Intervention||33
91799|NCT01309893|219596|P1|COMPLETED|Week 1 - First Intervention||33
91800|NCT01309893|219595|P2|STARTED|Week 1 - First Intervention||33
91801|NCT01309893|219596|P1|STARTED|Week 1 - First Intervention||33
91802|NCT01309880|219606|P2|NOT COMPLETED|Overall Study||0
91803|NCT01309880|219607|P1|NOT COMPLETED|Overall Study||0
91804|NCT01309880|219606|P2|COMPLETED|Overall Study||33
91805|NCT01309880|219607|P1|COMPLETED|Overall Study||33
91806|NCT01309880|219606|P2|STARTED|Overall Study||33
91807|NCT01309880|219607|P1|STARTED|Overall Study||33
91808|NCT01309841|219620|P3|NOT COMPLETED|Overall Study||37
91809|NCT01309841|219621|P2|NOT COMPLETED|Overall Study||41
91810|NCT01309841|219622|P1|NOT COMPLETED|Overall Study||39
91811|NCT01309841|219620|P3|COMPLETED|Overall Study||180
91812|NCT01309841|219621|P2|COMPLETED|Overall Study||177
91813|NCT01309841|219622|P1|COMPLETED|Overall Study||178
91814|NCT01309841|219620|P3|STARTED|Overall Study||217
91815|NCT01309841|219621|P2|STARTED|Overall Study||218
91816|NCT01309841|219622|P1|STARTED|Overall Study||217
91817|NCT01309828|219662|P2|NOT COMPLETED|Overall Study||16
91818|NCT01309828|219663|P1|NOT COMPLETED|Overall Study||16
91819|NCT01309828|219662|P2|COMPLETED|Overall Study||60
91820|NCT01309828|219663|P1|COMPLETED|Overall Study||61
91821|NCT01309828|219662|P2|STARTED|Overall Study||76
91822|NCT01309828|219663|P1|STARTED|Overall Study||77
91823|NCT01309802|219677|P2|NOT COMPLETED|Overall Study||9
91824|NCT01309802|219678|P1|NOT COMPLETED|Overall Study||12
91825|NCT01309802|219677|P2|COMPLETED|Overall Study||14
91826|NCT01309802|219678|P1|COMPLETED|Overall Study||13
91827|NCT01309802|219677|P2|STARTED|Overall Study||23
91828|NCT01309802|219678|P1|STARTED|Overall Study||25
91829|NCT01309737|219697|P5|NOT COMPLETED|Week 16 to 52||33
91830|NCT01309737|219698|P4|NOT COMPLETED|Week 16 to 52||34
91831|NCT01309737|219699|P3|NOT COMPLETED|Week 16 to 52||0
91832|NCT01309737|219700|P2|NOT COMPLETED|Week 16 to 52||103
91833|NCT01309737|219701|P1|NOT COMPLETED|Week 16 to 52||133
91834|NCT01309737|219697|P5|COMPLETED|Week 16 to 52||44
91835|NCT01309737|219698|P4|COMPLETED|Week 16 to 52||41
91836|NCT01309737|219699|P3|COMPLETED|Week 16 to 52||0
91837|NCT01309737|219700|P2|COMPLETED|Week 16 to 52||238
91838|NCT01309737|219701|P1|COMPLETED|Week 16 to 52||198
91839|NCT01309737|219697|P5|STARTED|Week 16 to 52||77
91840|NCT01309737|219698|P4|STARTED|Week 16 to 52||75
91841|NCT01309737|219699|P3|STARTED|Week 16 to 52||0
91842|NCT01309737|219700|P2|STARTED|Week 16 to 52||341
91843|NCT01309737|219701|P1|STARTED|Week 16 to 52||331
91844|NCT01309737|219697|P5|NOT COMPLETED|Week 0 to 16||0
91845|NCT01309737|219698|P4|NOT COMPLETED|Week 0 to 16||0
91846|NCT01309737|219699|P3|NOT COMPLETED|Week 0 to 16||44
91847|NCT01309737|219700|P2|NOT COMPLETED|Week 0 to 16||40
91848|NCT01309737|219701|P1|NOT COMPLETED|Week 0 to 16||52
91849|NCT01309737|219697|P5|COMPLETED|Week 0 to 16||0
91850|NCT01309737|219698|P4|COMPLETED|Week 0 to 16||0
91851|NCT01309737|219699|P3|COMPLETED|Week 0 to 16||152
91852|NCT01309737|219700|P2|COMPLETED|Week 0 to 16||341
91853|NCT01309737|219701|P1|COMPLETED|Week 0 to 16||331
91854|NCT01309737|219697|P5|Treated|Week 0 to 16||0
91855|NCT01309737|219698|P4|Treated|Week 0 to 16||0
91856|NCT01309737|219699|P3|Treated|Week 0 to 16||196
91857|NCT01309737|219700|P2|Treated|Week 0 to 16||381
91858|NCT01309737|219701|P1|Treated|Week 0 to 16||382
91859|NCT01309737|219697|P5|STARTED|Week 0 to 16||0
91860|NCT01309737|219698|P4|STARTED|Week 0 to 16||0
91861|NCT01309737|219699|P3|STARTED|Week 0 to 16||196
91862|NCT01309737|219700|P2|STARTED|Week 0 to 16||381
91863|NCT01309737|219701|P1|STARTED|Week 0 to 16||383
91864|NCT01309672|219896|P1|NOT COMPLETED|Overall Study||37
91865|NCT01309672|219896|P1|COMPLETED|Overall Study||4
91866|NCT01309672|219896|P1|Received Protocol Treatment|Overall Study||40
91867|NCT01309672|219896|P1|STARTED|Overall Study||41
91868|NCT01309659|219906|P2|NOT COMPLETED|Overall Study||1
91869|NCT01309659|219907|P1|NOT COMPLETED|Overall Study||0
91870|NCT01309659|219906|P2|COMPLETED|Overall Study||9
91871|NCT01309659|219907|P1|COMPLETED|Overall Study||9
91872|NCT01309659|219906|P2|STARTED|Overall Study||10
91873|NCT01309659|219907|P1|STARTED|Overall Study||9
91874|NCT01309646|219949|P2|NOT COMPLETED|Overall Study||0
91875|NCT01309646|219950|P1|NOT COMPLETED|Overall Study||0
91876|NCT01309646|219949|P2|COMPLETED|Overall Study||227
91877|NCT01309646|219950|P1|COMPLETED|Overall Study||224
91878|NCT01309646|219949|P2|STARTED|Overall Study||227
91879|NCT01309646|219950|P1|STARTED|Overall Study||224
91880|NCT01309581|219990|P2|NOT COMPLETED|Overall Study||0
91881|NCT01309581|219991|P1|NOT COMPLETED|Overall Study||0
91882|NCT01309581|219990|P2|COMPLETED|Overall Study||1
91883|NCT01309581|219991|P1|COMPLETED|Overall Study||2
91884|NCT01309581|219990|P2|STARTED|Overall Study||1
91885|NCT01309581|219991|P1|STARTED|Overall Study||2
91886|NCT01309451|220001|P2|NOT COMPLETED|Overall Study||3
91887|NCT01309451|220002|P1|NOT COMPLETED|Overall Study||2
91888|NCT01309451|220001|P2|COMPLETED|Overall Study|unit of measure is number of eyes|18
91889|NCT01309451|220002|P1|COMPLETED|Overall Study|unit of measure is number of eyes|17
91890|NCT01309451|220001|P2|STARTED|Overall Study|unit of measure is number of eyes|21
91891|NCT01309451|220002|P1|STARTED|Overall Study|unit of measure is number of eyes|19
91892|NCT01309386|220012|P2|NOT COMPLETED|Overall Study||21
91893|NCT01309386|220013|P1|NOT COMPLETED|Overall Study||22
91894|NCT01309386|220012|P2|COMPLETED|Overall Study||29
91895|NCT01309386|220013|P1|COMPLETED|Overall Study||28
91896|NCT01309386|220012|P2|STARTED|Overall Study||50
91897|NCT01309386|220013|P1|STARTED|Overall Study||50
91898|NCT01309360|220034|P3|NOT COMPLETED|Overall Study||0
91899|NCT01309360|220035|P2|NOT COMPLETED|Overall Study||0
91900|NCT01309360|220036|P1|NOT COMPLETED|Overall Study||0
91901|NCT01309360|220034|P3|COMPLETED|Overall Study||40
91902|NCT01309360|220035|P2|COMPLETED|Overall Study||40
91903|NCT01309360|220036|P1|COMPLETED|Overall Study||40
91904|NCT01309360|220034|P3|STARTED|Overall Study||40
91905|NCT01309360|220035|P2|STARTED|Overall Study||40
91906|NCT01309360|220036|P1|STARTED|Overall Study||40
91907|NCT01309308|220061|P2|NOT COMPLETED|Overall Study||4
91908|NCT01309308|220062|P1|NOT COMPLETED|Overall Study||6
91909|NCT01309308|220061|P2|COMPLETED|Overall Study||71
91910|NCT01309308|220062|P1|COMPLETED|Overall Study||69
91911|NCT01309308|220061|P2|STARTED|Overall Study||75
91912|NCT01309308|220062|P1|STARTED|Overall Study||75
91913|NCT01309282|220070|P1|NOT COMPLETED|Overall Study||1
91914|NCT01309282|220070|P1|COMPLETED|Overall Study||8
91915|NCT01309282|220070|P1|STARTED|Overall Study||9
91916|NCT01309269|220087|P1|NOT COMPLETED|Overall Study||840
91917|NCT01309269|220087|P1|COMPLETED|Overall Study||245
91918|NCT01309269|220087|P1|Treated|Overall Study||978
91919|NCT01309269|220087|P1|STARTED|Overall Study||1085
91920|NCT01309243|220095|P2|NOT COMPLETED|Extension Phase||0
91921|NCT01309243|220096|P1|NOT COMPLETED|Extension Phase||6
91922|NCT01309243|220095|P2|COMPLETED|Extension Phase||117
91923|NCT01309243|220096|P1|COMPLETED|Extension Phase||34
91924|NCT01309243|220095|P2|STARTED|Extension Phase|117 participants from the Randomized Phase continued the study in the Extension Phase.|117
91925|NCT01309243|220096|P1|STARTED|Extension Phase|40 participants from the Randomized Phase continued the study in the Extension Phase.|40
91926|NCT01309243|220095|P2|NOT COMPLETED|Randomized Phase Through Week 96||109
91927|NCT01309243|220096|P1|NOT COMPLETED|Randomized Phase Through Week 96||84
91928|NCT01309243|220095|P2|COMPLETED|Randomized Phase Through Week 96||290
91929|NCT01309243|220096|P1|COMPLETED|Randomized Phase Through Week 96||316
91930|NCT01309243|220095|P2|Randomized and Treated|Randomized Phase Through Week 96||392
91931|NCT01309243|220096|P1|Randomized and Treated|Randomized Phase Through Week 96||394
91932|NCT01309243|220095|P2|STARTED|Randomized Phase Through Week 96||399
91933|NCT01309243|220096|P1|STARTED|Randomized Phase Through Week 96||400
91934|NCT01309204|220122|P2|NOT COMPLETED|Overall Study||75
91935|NCT01309204|220123|P1|NOT COMPLETED|Overall Study||67
91936|NCT01309204|220122|P2|COMPLETED|Overall Study||361
91937|NCT01309204|220123|P1|COMPLETED|Overall Study||385
91938|NCT01309204|220122|P2|STARTED|Overall Study||436
91939|NCT01309204|220123|P1|STARTED|Overall Study||452
91940|NCT01309100|220129|P1|NOT COMPLETED|Overall Study||2
91941|NCT01309100|220129|P1|COMPLETED|Overall Study||142
91942|NCT01309100|220129|P1|STARTED|Overall Study||144
91943|NCT01308918|220140|P1|NOT COMPLETED|Overall Study||0
91944|NCT01308918|220140|P1|COMPLETED|Overall Study||50
91945|NCT01308918|220140|P1|STARTED|Overall Study||50
91946|NCT01308840|220147|P1|NOT COMPLETED|Overall Study||0
91947|NCT01308840|220147|P1|COMPLETED|Overall Study||31
91948|NCT01308840|220147|P1|STARTED|Overall Study||31
91949|NCT01308814|220156|P2|NOT COMPLETED|Overall Study||23
91950|NCT01308814|220157|P1|NOT COMPLETED|Overall Study||17
91951|NCT01308814|220156|P2|COMPLETED|Overall Study||63
91952|NCT01308814|220157|P1|COMPLETED|Overall Study||69
91953|NCT01308814|220156|P2|STARTED|Overall Study||86
91954|NCT01308814|220157|P1|STARTED|Overall Study||86
91955|NCT01308788|220177|P2|NOT COMPLETED|2-year Treatment||11
91956|NCT01308788|220178|P1|NOT COMPLETED|2-year Treatment||4
91957|NCT01308788|220177|P2|COMPLETED|2-year Treatment||10
91958|NCT01308788|220178|P1|COMPLETED|2-year Treatment||10
91959|NCT01308788|220177|P2|STARTED|2-year Treatment||21
91960|NCT01308788|220178|P1|STARTED|2-year Treatment||14
91961|NCT01308788|220177|P2|NOT COMPLETED|6-month Treatment||0
91962|NCT01308788|220178|P1|NOT COMPLETED|6-month Treatment||0
91963|NCT01308788|220177|P2|COMPLETED|6-month Treatment||21
91964|NCT01308788|220178|P1|COMPLETED|6-month Treatment||14
91965|NCT01308788|220177|P2|STARTED|6-month Treatment||21
91966|NCT01308788|220178|P1|STARTED|6-month Treatment||14
91967|NCT01308762|220213|P3|NOT COMPLETED|Overall Study||0
91968|NCT01308762|220214|P2|NOT COMPLETED|Overall Study||1
91969|NCT01308762|220215|P1|NOT COMPLETED|Overall Study||0
91970|NCT01308762|220213|P3|COMPLETED|Overall Study||6
91971|NCT01308762|220214|P2|COMPLETED|Overall Study|One patient was withdrawn as they were retrospecively found to have been ineligible at study entry|6
91972|NCT01308762|220215|P1|COMPLETED|Overall Study||6
91973|NCT01308762|220213|P3|STARTED|Overall Study||6
91974|NCT01308762|220214|P2|STARTED|Overall Study||7
91975|NCT01308762|220215|P1|STARTED|Overall Study||6
91976|NCT01308749|220228|P2|NOT COMPLETED|Period 2: Open Label Treatment||2
91977|NCT01308749|220229|P1|NOT COMPLETED|Period 2: Open Label Treatment||0
91978|NCT01308749|220228|P2|COMPLETED|Period 2: Open Label Treatment||11
91979|NCT01308749|220229|P1|COMPLETED|Period 2: Open Label Treatment||11
91980|NCT01308749|220228|P2|STARTED|Period 2: Open Label Treatment||13
91981|NCT01308749|220229|P1|STARTED|Period 2: Open Label Treatment||11
91982|NCT01308749|220228|P2|NOT COMPLETED|Period 1: Double Blind Treatment||0
91983|NCT01308749|220229|P1|NOT COMPLETED|Period 1: Double Blind Treatment||1
91984|NCT01308749|220228|P2|COMPLETED|Period 1: Double Blind Treatment||13
91985|NCT01308749|220229|P1|COMPLETED|Period 1: Double Blind Treatment||11
91986|NCT01308749|220228|P2|STARTED|Period 1: Double Blind Treatment||13
91987|NCT01308749|220229|P1|STARTED|Period 1: Double Blind Treatment||12
91988|NCT01308736|220259|P2|NOT COMPLETED|Overall Study||5
91989|NCT01308736|220260|P1|NOT COMPLETED|Overall Study||6
91990|NCT01308736|220259|P2|COMPLETED|Overall Study||27
91991|NCT01308736|220260|P1|COMPLETED|Overall Study||25
91992|NCT01308736|220259|P2|STARTED|Overall Study||32
91993|NCT01308736|220260|P1|STARTED|Overall Study||31
91994|NCT01308619|220268|P2|NOT COMPLETED|Overall Study||3
91995|NCT01308619|220269|P1|NOT COMPLETED|Overall Study||7
91996|NCT01308619|220268|P2|COMPLETED|Overall Study||83
91997|NCT01308619|220269|P1|COMPLETED|Overall Study||77
91998|NCT01308619|220268|P2|STARTED|Overall Study||86
91999|NCT01308619|220269|P1|STARTED|Overall Study||84
92000|NCT01308580|220283|P2|NOT COMPLETED|Overall Study||7
92001|NCT01308580|220284|P1|NOT COMPLETED|Overall Study||12
92002|NCT01308580|220283|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|595
92003|NCT01308580|220284|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival|586
92004|NCT01308580|220283|P2|Treated|Overall Study|Random assignment, was not actual treatment in some cases|588
92005|NCT01308580|220284|P1|Treated|Overall Study|Random assignment, was not actual treatment in some cases|587
92006|NCT01308580|220283|P2|STARTED|Overall Study||602
92007|NCT01308580|220284|P1|STARTED|Overall Study||598
92008|NCT01308567|220327|P3|NOT COMPLETED|Overall Study||4
92009|NCT01308567|220328|P2|NOT COMPLETED|Overall Study||4
92010|NCT01308567|220329|P1|NOT COMPLETED|Overall Study||2
92011|NCT01308567|220327|P3|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|384
92012|NCT01308567|220328|P2|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|385
92013|NCT01308567|220329|P1|COMPLETED|Overall Study|Completed participants included those who withdrew treatment consent but were followed for survival.|389
92014|NCT01308567|220327|P3|Ongoing Treatment at Data Cut-off|Overall Study||3
92015|NCT01308567|220328|P2|Ongoing Treatment at Data Cut-off|Overall Study||6
92016|NCT01308567|220329|P1|Ongoing Treatment at Data Cut-off|Overall Study||4
92017|NCT01308567|220327|P3|Treated|Overall Study|For 2 participants, actual treatment received was Cabazitaxel 20 mg/m^2.|377
92018|NCT01308567|220328|P2|Treated|Overall Study|For 15 participants, actual treatment received was Cabazitaxel 25 mg/m^2.|382
92019|NCT01308567|220329|P1|Treated|Overall Study|For 1 participant, actual treatment received was Cabazitaxel 25 mg/m^2.|388
92020|NCT01308567|220327|P3|STARTED|Overall Study|Randomized|388
92021|NCT01308567|220328|P2|STARTED|Overall Study|Randomized|389
92022|NCT01308567|220329|P1|STARTED|Overall Study|Randomized|391
92023|NCT01308476|220369|P2|NOT COMPLETED|Overall Study||2
92024|NCT01308476|220370|P1|NOT COMPLETED|Overall Study||3
92025|NCT01308476|220369|P2|COMPLETED|Overall Study||45
92026|NCT01308476|220370|P1|COMPLETED|Overall Study||45
92027|NCT01308476|220369|P2|STARTED|Overall Study|Entered and treated.|47
92028|NCT01308476|220370|P1|STARTED|Overall Study|Entered and treated.|48
92029|NCT01308463|220390|P1|NOT COMPLETED|Overall Study||29
92030|NCT01308463|220390|P1|COMPLETED|Overall Study||0
92031|NCT01308463|220390|P1|12 Years|Overall Study||2
92032|NCT01308463|220390|P1|11 Years|Overall Study||8
92033|NCT01308463|220390|P1|10 Years|Overall Study||8
92034|NCT01308463|220390|P1|9 Years|Overall Study||11
92035|NCT01308463|220390|P1|8 Years|Overall Study||14
92036|NCT01308463|220390|P1|7 Years|Overall Study||12
92037|NCT01308463|220390|P1|6 Years|Overall Study||11
92038|NCT01308463|220390|P1|5 Years|Overall Study||20
92039|NCT01308463|220390|P1|4 Years|Overall Study||20
92040|NCT01308463|220390|P1|3 Years|Overall Study||17
92041|NCT01308463|220390|P1|2 Years|Overall Study||18
92042|NCT01308463|220390|P1|1 Year|Overall Study||21
92043|NCT01308463|220390|P1|6 Months|Overall Study||23
92044|NCT01308463|220390|P1|STARTED|Overall Study||29
92045|NCT01308450|220397|P1|NOT COMPLETED|Overall Study||2
92046|NCT01308450|220397|P1|COMPLETED|Overall Study|Last subject was enrolled 06/28/2011|300
92047|NCT01308450|220397|P1|STARTED|Overall Study|302 subjects were screen. 300 subjects were enrolled in this one site, one visit study.|302
92048|NCT01308424|220403|P3|NOT COMPLETED|Randomization||2
92049|NCT01308424|220404|P2|NOT COMPLETED|Randomization||3
92050|NCT01308424|220405|P1|NOT COMPLETED|Randomization||0
92051|NCT01308424|220403|P3|COMPLETED|Randomization||82
92052|NCT01308424|220404|P2|COMPLETED|Randomization||84
92053|NCT01308424|220405|P1|COMPLETED|Randomization||0
92054|NCT01308424|220403|P3|STARTED|Randomization||84
92055|NCT01308424|220404|P2|STARTED|Randomization||87
92056|NCT01308424|220405|P1|STARTED|Randomization||0
92057|NCT01308424|220403|P3|NOT COMPLETED|Baseline Eligibility||0
92058|NCT01308424|220404|P2|NOT COMPLETED|Baseline Eligibility||0
92059|NCT01308424|220405|P1|NOT COMPLETED|Baseline Eligibility||71
92060|NCT01308424|220403|P3|COMPLETED|Baseline Eligibility||0
92061|NCT01308424|220404|P2|COMPLETED|Baseline Eligibility||0
92062|NCT01308424|220405|P1|COMPLETED|Baseline Eligibility|Completed baseline run in and were eligible for randomization|171
92063|NCT01308424|220403|P3|STARTED|Baseline Eligibility||0
92064|NCT01308424|220404|P2|STARTED|Baseline Eligibility||0
92065|NCT01308424|220405|P1|STARTED|Baseline Eligibility||242
92066|NCT01307787|220414|P2|NOT COMPLETED|Overall Study||0
92067|NCT01307787|220415|P1|NOT COMPLETED|Overall Study||2
92068|NCT01307787|220414|P2|COMPLETED|Overall Study||15
92069|NCT01307787|220415|P1|COMPLETED|Overall Study||17
92070|NCT01307787|220414|P2|T2= After 22 Weeks at Follow-up|Overall Study||15
92071|NCT01307787|220415|P1|T2= After 22 Weeks at Follow-up|Overall Study||17
92072|NCT01307787|220414|P2|T1= After 9 Weeks Post Intervention|Overall Study||15
92073|NCT01307787|220415|P1|T1= After 9 Weeks Post Intervention|Overall Study||18
92074|NCT01307787|220414|P2|STARTED|Overall Study||15
92075|NCT01307787|220415|P1|STARTED|Overall Study||19
92076|NCT01307618|220437|P2|NOT COMPLETED|Overall Study||0
92077|NCT01307618|220438|P1|NOT COMPLETED|Overall Study||0
92078|NCT01307618|220437|P2|COMPLETED|Overall Study||5
92079|NCT01307618|220438|P1|COMPLETED|Overall Study||5
92080|NCT01307618|220437|P2|STARTED|Overall Study||5
92081|NCT01307618|220438|P1|STARTED|Overall Study||5
92082|NCT01307423|220457|P7|NOT COMPLETED|Active Treatment Phase (Week 25-52)||1
92083|NCT01307423|220458|P6|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
92084|NCT01307423|220459|P5|NOT COMPLETED|Active Treatment Phase (Week 25-52)||3
92085|NCT01307423|220460|P4|NOT COMPLETED|Active Treatment Phase (Week 25-52)||8
92086|NCT01307423|220461|P3|NOT COMPLETED|Active Treatment Phase (Week 25-52)||9
92087|NCT01307423|220462|P2|NOT COMPLETED|Active Treatment Phase (Week 25-52)||19
92088|NCT01307423|220463|P1|NOT COMPLETED|Active Treatment Phase (Week 25-52)||0
92089|NCT01307423|220457|P7|COMPLETED|Active Treatment Phase (Week 25-52)||25
92090|NCT01307423|220458|P6|COMPLETED|Active Treatment Phase (Week 25-52)||43
92091|NCT01307423|220459|P5|COMPLETED|Active Treatment Phase (Week 25-52)||23
92092|NCT01307423|220460|P4|COMPLETED|Active Treatment Phase (Week 25-52)||38
92093|NCT01307423|220461|P3|COMPLETED|Active Treatment Phase (Week 25-52)||141
92094|NCT01307423|220462|P2|COMPLETED|Active Treatment Phase (Week 25-52)||132
92095|NCT01307423|220463|P1|COMPLETED|Active Treatment Phase (Week 25-52)||0
92096|NCT01307423|220457|P7|STARTED|Active Treatment Phase (Week 25-52)||26
92097|NCT01307423|220458|P6|STARTED|Active Treatment Phase (Week 25-52)|Six participants who escaped early and completed Week 24 did not enter the active treatment phase|46
92098|NCT01307423|220459|P5|STARTED|Active Treatment Phase (Week 25-52)||26
92099|NCT01307423|220460|P4|STARTED|Active Treatment Phase (Week 25-52)|Four participants who escaped early and completed Week 24 did not enter the active treatment phase.|46
92100|NCT01307423|220461|P3|STARTED|Active Treatment Phase (Week 25-52)|Five participants who completed Week 24 did not enter active treatment phase|150
92101|NCT01307423|220462|P2|STARTED|Active Treatment Phase (Week 25-52)|Nine participants who completed Week 24 did not enter active treatment phase|151
92102|NCT01307423|220463|P1|STARTED|Active Treatment Phase (Week 25-52)||0
92103|NCT01307423|220457|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92104|NCT01307423|220458|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92105|NCT01307423|220459|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92106|NCT01307423|220460|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92107|NCT01307423|220461|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
92108|NCT01307423|220462|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||15
92109|NCT01307423|220463|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
92110|NCT01307423|220457|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92111|NCT01307423|220458|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92112|NCT01307423|220459|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92113|NCT01307423|220460|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
92114|NCT01307423|220461|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||155
92115|NCT01307423|220462|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||160
92116|NCT01307423|220463|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants did not escape early and finished Week 24 did not enter the active treatment phase|156
92117|NCT01307423|220457|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92118|NCT01307423|220458|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92119|NCT01307423|220459|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92120|NCT01307423|220460|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92121|NCT01307423|220461|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||79
92122|NCT01307423|220462|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||73
92123|NCT01307423|220463|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|103
92124|NCT01307423|220457|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92125|NCT01307423|220458|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92126|NCT01307423|220459|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92127|NCT01307423|220460|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
92128|NCT01307423|220461|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
92129|NCT01307423|220462|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||168
92130|NCT01307423|220463|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||166
92131|NCT01307423|220457|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
92132|NCT01307423|220458|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
92133|NCT01307423|220459|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
92134|NCT01307423|220460|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
92135|NCT01307423|220461|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
92136|NCT01307423|220462|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||175
92137|NCT01307423|220463|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||176
92138|NCT01307423|220457|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
92139|NCT01307423|220458|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
92140|NCT01307423|220459|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
92141|NCT01307423|220460|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
92142|NCT01307423|220461|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||177
92143|NCT01307423|220462|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||175
92144|NCT01307423|220463|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||176
92145|NCT01307319|220575|P3|NOT COMPLETED|Overall Study||7
92146|NCT01307319|220576|P2|NOT COMPLETED|Overall Study||8
92147|NCT01307319|220577|P1|NOT COMPLETED|Overall Study||4
92148|NCT01307319|220575|P3|COMPLETED|Overall Study||227
92149|NCT01307319|220576|P2|COMPLETED|Overall Study||234
92150|NCT01307319|220577|P1|COMPLETED|Overall Study||235
92151|NCT01307319|220575|P3|ITT Population|Overall Study||234
92152|NCT01307319|220576|P2|ITT Population|Overall Study||241
92153|NCT01307319|220577|P1|ITT Population|Overall Study|One participant provided no post-baseline assessment.|238
92154|NCT01307319|220575|P3|Safety Population|Overall Study||234
92155|NCT01307319|220576|P2|Safety Population|Overall Study|One participant was randomized in error and did not receive study medication.|241
92156|NCT01307319|220577|P1|Safety Population|Overall Study||239
92157|NCT01307319|220575|P3|STARTED|Overall Study|Randomized|234
92158|NCT01307319|220576|P2|STARTED|Overall Study|Randomized|242
92159|NCT01307319|220577|P1|STARTED|Overall Study|Randomized|239
92160|NCT01307111|220591|P2|NOT COMPLETED|1-2 Week IUD Check up||2
92161|NCT01307111|220592|P1|NOT COMPLETED|1-2 Week IUD Check up||2
92162|NCT01307111|220591|P2|COMPLETED|1-2 Week IUD Check up||38
92163|NCT01307111|220592|P1|COMPLETED|1-2 Week IUD Check up||38
92164|NCT01307111|220591|P2|STARTED|1-2 Week IUD Check up||40
92165|NCT01307111|220592|P1|STARTED|1-2 Week IUD Check up||40
92166|NCT01307111|220591|P2|NOT COMPLETED|IUD Insertion||0
92167|NCT01307111|220592|P1|NOT COMPLETED|IUD Insertion||2
92168|NCT01307111|220591|P2|COMPLETED|IUD Insertion||40
92169|NCT01307111|220592|P1|COMPLETED|IUD Insertion||40
92170|NCT01307111|220591|P2|STARTED|IUD Insertion||40
92171|NCT01307111|220592|P1|STARTED|IUD Insertion||42
92172|NCT01307046|220602|P2|NOT COMPLETED|Overall Study||11
92173|NCT01307046|220603|P1|NOT COMPLETED|Overall Study||12
92174|NCT01307046|220602|P2|COMPLETED|Overall Study||159
92175|NCT01307046|220603|P1|COMPLETED|Overall Study||154
92176|NCT01307046|220602|P2|STARTED|Overall Study||170
92177|NCT01307046|220603|P1|STARTED|Overall Study||166
92178|NCT01307033|220615|P4|NOT COMPLETED|44-week Open-label Extension||12
92179|NCT01307033|220616|P3|NOT COMPLETED|44-week Open-label Extension||11
92180|NCT01307033|220617|P2|NOT COMPLETED|44-week Open-label Extension||0
92181|NCT01307033|220618|P1|NOT COMPLETED|44-week Open-label Extension||0
92182|NCT01307033|220615|P4|COMPLETED|44-week Open-label Extension||115
92183|NCT01307033|220616|P3|COMPLETED|44-week Open-label Extension||120
92184|NCT01307033|220617|P2|COMPLETED|44-week Open-label Extension||0
92185|NCT01307033|220618|P1|COMPLETED|44-week Open-label Extension||0
92186|NCT01307033|220615|P4|STARTED|44-week Open-label Extension||127
92187|NCT01307033|220616|P3|STARTED|44-week Open-label Extension||131
92188|NCT01307033|220617|P2|STARTED|44-week Open-label Extension||0
92189|NCT01307033|220618|P1|STARTED|44-week Open-label Extension||0
92190|NCT01307033|220615|P4|NOT COMPLETED|8-week Double-blind Period||0
92191|NCT01307033|220616|P3|NOT COMPLETED|8-week Double-blind Period||0
92192|NCT01307033|220617|P2|NOT COMPLETED|8-week Double-blind Period||7
92193|NCT01307033|220618|P1|NOT COMPLETED|8-week Double-blind Period||13
92194|NCT01307033|220615|P4|COMPLETED|8-week Double-blind Period||0
92195|NCT01307033|220616|P3|COMPLETED|8-week Double-blind Period||0
92196|NCT01307033|220617|P2|COMPLETED|8-week Double-blind Period||127
92197|NCT01307033|220618|P1|COMPLETED|8-week Double-blind Period||131
92198|NCT01307033|220615|P4|STARTED|8-week Double-blind Period||0
92199|NCT01307033|220616|P3|STARTED|8-week Double-blind Period||0
92200|NCT01307033|220617|P2|STARTED|8-week Double-blind Period||134
92201|NCT01307033|220618|P1|STARTED|8-week Double-blind Period||144
92202|NCT01307020|220640|P10|NOT COMPLETED|Overall Study||0
92203|NCT01307020|220641|P9|NOT COMPLETED|Overall Study||0
92204|NCT01307020|220642|P8|NOT COMPLETED|Overall Study||0
92205|NCT01307020|220643|P7|NOT COMPLETED|Overall Study||1
92206|NCT01307020|220644|P6|NOT COMPLETED|Overall Study||0
92207|NCT01307020|220645|P5|NOT COMPLETED|Overall Study||0
92208|NCT01307020|220646|P4|NOT COMPLETED|Overall Study||1
92209|NCT01307020|220647|P3|NOT COMPLETED|Overall Study||1
92210|NCT01307020|220648|P2|NOT COMPLETED|Overall Study||1
92211|NCT01307020|220649|P1|NOT COMPLETED|Overall Study||0
92212|NCT01307020|220640|P10|COMPLETED|Overall Study||62
92213|NCT01307020|220641|P9|COMPLETED|Overall Study||61
92214|NCT01307020|220642|P8|COMPLETED|Overall Study||60
92215|NCT01307020|220643|P7|COMPLETED|Overall Study||58
92216|NCT01307020|220644|P6|COMPLETED|Overall Study||61
92217|NCT01307020|220645|P5|COMPLETED|Overall Study||60
92218|NCT01307020|220646|P4|COMPLETED|Overall Study||60
92219|NCT01307020|220647|P3|COMPLETED|Overall Study||62
92220|NCT01307020|220648|P2|COMPLETED|Overall Study||62
92221|NCT01307020|220649|P1|COMPLETED|Overall Study||61
92222|NCT01307020|220640|P10|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
92223|NCT01307020|220641|P9|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
92224|NCT01307020|220642|P8|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
92225|NCT01307020|220643|P7|ITT (>= 1 Assessment Post Randomization)|Overall Study||59
92226|NCT01307020|220644|P6|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
92227|NCT01307020|220645|P5|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
92228|NCT01307020|220646|P4|ITT (>= 1 Assessment Post Randomization)|Overall Study||61
92229|NCT01307020|220647|P3|ITT (>= 1 Assessment Post Randomization)|Overall Study||63
92230|NCT01307020|220648|P2|ITT (>= 1 Assessment Post Randomization)|Overall Study||62
92231|NCT01307020|220649|P1|ITT (>= 1 Assessment Post Randomization)|Overall Study||60
92232|NCT01307020|220640|P10|Safety Population|Overall Study||62
92233|NCT01307020|220641|P9|Safety Population|Overall Study||61
92234|NCT01307020|220642|P8|Safety Population|Overall Study||60
92235|NCT01307020|220643|P7|Safety Population|Overall Study||59
92236|NCT01307020|220644|P6|Safety Population|Overall Study||61
92237|NCT01307020|220645|P5|Safety Population|Overall Study||60
92238|NCT01307020|220646|P4|Safety Population|Overall Study||61
92239|NCT01307020|220647|P3|Safety Population|Overall Study||63
92240|NCT01307020|220648|P2|Safety Population|Overall Study||63
92241|NCT01307020|220649|P1|Safety Population|Overall Study||61
92242|NCT01307020|220640|P10|STARTED|Overall Study||62
92243|NCT01307020|220641|P9|STARTED|Overall Study||61
92244|NCT01307020|220642|P8|STARTED|Overall Study||60
92245|NCT01307020|220643|P7|STARTED|Overall Study||59
92246|NCT01307020|220644|P6|STARTED|Overall Study||61
92247|NCT01307020|220645|P5|STARTED|Overall Study||60
92248|NCT01307020|220646|P4|STARTED|Overall Study||61
92249|NCT01307020|220647|P3|STARTED|Overall Study||63
92250|NCT01307020|220648|P2|STARTED|Overall Study||63
92251|NCT01307020|220649|P1|STARTED|Overall Study||61
92252|NCT01307007|220693|P2|NOT COMPLETED|Overall Study||0
92253|NCT01307007|220694|P1|NOT COMPLETED|Overall Study||0
92254|NCT01307007|220693|P2|COMPLETED|Overall Study||30
92255|NCT01307007|220694|P1|COMPLETED|Overall Study||25
92256|NCT01307007|220693|P2|STARTED|Overall Study||30
92257|NCT01307007|220694|P1|STARTED|Overall Study||25
92258|NCT01306968|220704|P4|NOT COMPLETED|Overall Study||4
92259|NCT01306968|220705|P3|NOT COMPLETED|Overall Study||1
92260|NCT01306968|220706|P2|NOT COMPLETED|Overall Study||3
92261|NCT01306968|220707|P1|NOT COMPLETED|Overall Study||1
92262|NCT01306968|220704|P4|COMPLETED|Overall Study||21
92263|NCT01306968|220705|P3|COMPLETED|Overall Study||23
92264|NCT01306968|220706|P2|COMPLETED|Overall Study||20
92265|NCT01306968|220707|P1|COMPLETED|Overall Study||6
92266|NCT01306968|220704|P4|STARTED|Overall Study|2 participants withdrew before chamber sessions were initiated|25
92267|NCT01306968|220705|P3|STARTED|Overall Study||24
92268|NCT01306968|220706|P2|STARTED|Overall Study||23
92269|NCT01306968|220707|P1|STARTED|Overall Study||7
92270|NCT01306877|220731|P2|NOT COMPLETED|Overall Study||4
92271|NCT01306877|220732|P1|NOT COMPLETED|Overall Study||3
92272|NCT01306877|220731|P2|COMPLETED|Overall Study||67
92273|NCT01306877|220732|P1|COMPLETED|Overall Study||75
92274|NCT01306877|220731|P2|STARTED|Overall Study||71
92275|NCT01306877|220732|P1|STARTED|Overall Study||78
92276|NCT01306643|220750|P1|NOT COMPLETED|Overall Study||13
92277|NCT01306643|220750|P1|COMPLETED|Overall Study|Completed Study was defined as participants who completed through Cycle 12 (Week 48) per protocol.|5
92278|NCT01306643|220750|P1|STARTED|Overall Study||18
92279|NCT01306617|220762|P3|NOT COMPLETED|Overall Study||5
92280|NCT01306617|220763|P2|NOT COMPLETED|Overall Study||1
92281|NCT01306617|220764|P1|NOT COMPLETED|Overall Study||1
92282|NCT01306617|220762|P3|COMPLETED|Overall Study|The number of participants who completed study drug|12
92283|NCT01306617|220763|P2|COMPLETED|Overall Study|The number of participants who completed study drug|13
92284|NCT01306617|220764|P1|COMPLETED|Overall Study|The number of participants who completed study drug|18
92285|NCT01306617|220762|P3|STARTED|Overall Study||17
92286|NCT01306617|220763|P2|STARTED|Overall Study||14
92287|NCT01306617|220764|P1|STARTED|Overall Study||19
92288|NCT01306305|220807|P2|NOT COMPLETED|Overall Study||0
92289|NCT01306305|220808|P1|NOT COMPLETED|Overall Study||2
92290|NCT01306305|220807|P2|COMPLETED|Overall Study||55
92291|NCT01306305|220808|P1|COMPLETED|Overall Study||53
92292|NCT01306305|220807|P2|STARTED|Overall Study||55
92293|NCT01306305|220808|P1|STARTED|Overall Study||55
92294|NCT01306292|220824|P4|NOT COMPLETED|Second Injection||0
92295|NCT01306292|220825|P3|NOT COMPLETED|Second Injection||1
92296|NCT01306292|220826|P2|NOT COMPLETED|Second Injection||0
92297|NCT01306292|220827|P1|NOT COMPLETED|Second Injection||0
92298|NCT01306292|220824|P4|COMPLETED|Second Injection||10
92299|NCT01306292|220825|P3|COMPLETED|Second Injection|1 subject completed both injections but not 24-hour follow-up; all other values were recorded.|7
92300|NCT01306292|220826|P2|COMPLETED|Second Injection||8
92301|NCT01306292|220827|P1|COMPLETED|Second Injection||10
92302|NCT01306292|220824|P4|STARTED|Second Injection||10
92303|NCT01306292|220825|P3|STARTED|Second Injection||8
92304|NCT01306292|220826|P2|STARTED|Second Injection||8
92305|NCT01306292|220827|P1|STARTED|Second Injection||10
92306|NCT01306292|220824|P4|NOT COMPLETED|Washout (at Least 10 Minutes)||0
92307|NCT01306292|220825|P3|NOT COMPLETED|Washout (at Least 10 Minutes)||0
92308|NCT01306292|220826|P2|NOT COMPLETED|Washout (at Least 10 Minutes)||0
92309|NCT01306292|220827|P1|NOT COMPLETED|Washout (at Least 10 Minutes)||0
92310|NCT01306292|220824|P4|COMPLETED|Washout (at Least 10 Minutes)||10
92311|NCT01306292|220825|P3|COMPLETED|Washout (at Least 10 Minutes)||8
92312|NCT01306292|220826|P2|COMPLETED|Washout (at Least 10 Minutes)||8
92313|NCT01306292|220827|P1|COMPLETED|Washout (at Least 10 Minutes)||10
92314|NCT01306292|220824|P4|STARTED|Washout (at Least 10 Minutes)||10
92315|NCT01306292|220825|P3|STARTED|Washout (at Least 10 Minutes)||8
92316|NCT01306292|220826|P2|STARTED|Washout (at Least 10 Minutes)||8
92317|NCT01306292|220827|P1|STARTED|Washout (at Least 10 Minutes)||10
92318|NCT01306292|220824|P4|NOT COMPLETED|First Injection||0
92319|NCT01306292|220825|P3|NOT COMPLETED|First Injection||0
92320|NCT01306292|220826|P2|NOT COMPLETED|First Injection||0
92321|NCT01306292|220827|P1|NOT COMPLETED|First Injection||0
92322|NCT01306292|220824|P4|COMPLETED|First Injection||10
92323|NCT01306292|220825|P3|COMPLETED|First Injection||8
92324|NCT01306292|220826|P2|COMPLETED|First Injection||8
92325|NCT01306292|220827|P1|COMPLETED|First Injection||10
92326|NCT01306292|220824|P4|STARTED|First Injection||10
92327|NCT01306292|220825|P3|STARTED|First Injection||8
92328|NCT01306292|220826|P2|STARTED|First Injection||8
92329|NCT01306292|220827|P1|STARTED|First Injection||10
92330|NCT01306253|220845|P2|NOT COMPLETED|Overall Study||1
92331|NCT01306253|220846|P1|NOT COMPLETED|Overall Study||1
92332|NCT01306253|220845|P2|COMPLETED|Overall Study||56
92333|NCT01306253|220846|P1|COMPLETED|Overall Study||56
92334|NCT01306253|220845|P2|STARTED|Overall Study||57
92335|NCT01306253|220846|P1|STARTED|Overall Study||57
92336|NCT01306214|220863|P3|NOT COMPLETED|Overall Study||22
92337|NCT01306214|220864|P2|NOT COMPLETED|Overall Study||28
92338|NCT01306214|220865|P1|NOT COMPLETED|Overall Study||28
92339|NCT01306214|220863|P3|COMPLETED|Overall Study||168
92340|NCT01306214|220864|P2|COMPLETED|Overall Study||159
92341|NCT01306214|220865|P1|COMPLETED|Overall Study||161
92342|NCT01306214|220863|P3|STARTED|Overall Study||190
92343|NCT01306214|220864|P2|STARTED|Overall Study||187
92344|NCT01306214|220865|P1|STARTED|Overall Study||189
92345|NCT01306201|220882|P1|NOT COMPLETED|Overall Study||10
92346|NCT01306201|220882|P1|COMPLETED|Overall Study|Total of 10 subjects were excluded from analysis|53
92347|NCT01306201|220882|P1|STARTED|Overall Study||63
92348|NCT01306175|220890|P1|NOT COMPLETED|Second Intervention||0
92349|NCT01306175|220890|P1|COMPLETED|Second Intervention||20
92350|NCT01306175|220890|P1|STARTED|Second Intervention||20
92351|NCT01306175|220890|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
92352|NCT01306175|220890|P1|COMPLETED|Washout Period of at Least 14 Days||20
92353|NCT01306175|220890|P1|STARTED|Washout Period of at Least 14 Days||20
92354|NCT01306175|220890|P1|NOT COMPLETED|First Intervention||0
92355|NCT01306175|220890|P1|COMPLETED|First Intervention||20
92356|NCT01306175|220890|P1|STARTED|First Intervention||20
92357|NCT01306162|220904|P4|NOT COMPLETED|Period 4||0
92358|NCT01306162|220905|P3|NOT COMPLETED|Period 4||0
92359|NCT01306162|220906|P2|NOT COMPLETED|Period 4||0
92360|NCT01306162|220907|P1|NOT COMPLETED|Period 4||0
92361|NCT01306162|220904|P4|COMPLETED|Period 4||8
92362|NCT01306162|220905|P3|COMPLETED|Period 4||9
92363|NCT01306162|220906|P2|COMPLETED|Period 4||8
92364|NCT01306162|220907|P1|COMPLETED|Period 4||9
92365|NCT01306162|220904|P4|STARTED|Period 4||8
92366|NCT01306162|220905|P3|STARTED|Period 4||9
92367|NCT01306162|220906|P2|STARTED|Period 4||8
92368|NCT01306162|220907|P1|STARTED|Period 4||9
92369|NCT01306162|220904|P4|NOT COMPLETED|Washout 2||0
92370|NCT01306162|220905|P3|NOT COMPLETED|Washout 2||0
92371|NCT01306162|220906|P2|NOT COMPLETED|Washout 2||0
92372|NCT01306162|220907|P1|NOT COMPLETED|Washout 2||0
92373|NCT01306162|220904|P4|COMPLETED|Washout 2||8
92374|NCT01306162|220905|P3|COMPLETED|Washout 2||9
92375|NCT01306162|220906|P2|COMPLETED|Washout 2||8
92376|NCT01306162|220907|P1|COMPLETED|Washout 2||9
92377|NCT01306162|220904|P4|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|8
92378|NCT01306162|220905|P3|STARTED|Washout 2|The last dose of Dronedarone was followed by a washout period of at least 10 days.|9
92379|NCT01306162|220906|P2|STARTED|Washout 2|No washout period. Treatment D followed directly after treatment E.|8
92380|NCT01306162|220907|P1|STARTED|Washout 2|No washout period. Treatment E followed directly after treatment D.|9
92381|NCT01306162|220904|P4|NOT COMPLETED|Period 3||0
92382|NCT01306162|220905|P3|NOT COMPLETED|Period 3||0
92383|NCT01306162|220906|P2|NOT COMPLETED|Period 3||0
92384|NCT01306162|220907|P1|NOT COMPLETED|Period 3||0
92385|NCT01306162|220904|P4|COMPLETED|Period 3||8
92386|NCT01306162|220905|P3|COMPLETED|Period 3||9
92387|NCT01306162|220906|P2|COMPLETED|Period 3||8
92388|NCT01306162|220907|P1|COMPLETED|Period 3||9
92389|NCT01306162|220904|P4|STARTED|Period 3||8
92390|NCT01306162|220905|P3|STARTED|Period 3||9
92391|NCT01306162|220906|P2|STARTED|Period 3||8
92392|NCT01306162|220907|P1|STARTED|Period 3||9
92393|NCT01306162|220904|P4|NOT COMPLETED|Period 2||0
92394|NCT01306162|220905|P3|NOT COMPLETED|Period 2||0
92395|NCT01306162|220906|P2|NOT COMPLETED|Period 2||0
92396|NCT01306162|220907|P1|NOT COMPLETED|Period 2||0
92397|NCT01306162|220904|P4|COMPLETED|Period 2||8
92398|NCT01306162|220905|P3|COMPLETED|Period 2||9
92399|NCT01306162|220906|P2|COMPLETED|Period 2||8
92400|NCT01306162|220907|P1|COMPLETED|Period 2||9
92401|NCT01306162|220904|P4|STARTED|Period 2|No washout phase after Period 2.|8
92402|NCT01306162|220905|P3|STARTED|Period 2|No washout phase after Period 2.|9
92403|NCT01306162|220906|P2|STARTED|Period 2|No washout phase after Period 2.|8
92404|NCT01306162|220907|P1|STARTED|Period 2|No washout phase after Period 2.|9
92405|NCT01306162|220904|P4|NOT COMPLETED|Washout 1||0
92406|NCT01306162|220905|P3|NOT COMPLETED|Washout 1||0
92407|NCT01306162|220906|P2|NOT COMPLETED|Washout 1||1
92408|NCT01306162|220907|P1|NOT COMPLETED|Washout 1||0
92409|NCT01306162|220904|P4|COMPLETED|Washout 1||8
92410|NCT01306162|220905|P3|COMPLETED|Washout 1||9
92411|NCT01306162|220906|P2|COMPLETED|Washout 1||8
92412|NCT01306162|220907|P1|COMPLETED|Washout 1||9
92413|NCT01306162|220904|P4|STARTED|Washout 1|No washout period.Treatment E followed directly after treatment C.|8
92414|NCT01306162|220905|P3|STARTED|Washout 1|No washout period. Treatment D followed directly after treatment B.|9
92415|NCT01306162|220906|P2|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
92416|NCT01306162|220907|P1|STARTED|Washout 1|Treatment A was followed by a washout period of at least 96 hours.|9
92417|NCT01306162|220904|P4|NOT COMPLETED|Period 1||1
92418|NCT01306162|220905|P3|NOT COMPLETED|Period 1||0
92419|NCT01306162|220906|P2|NOT COMPLETED|Period 1||0
92420|NCT01306162|220907|P1|NOT COMPLETED|Period 1||0
92421|NCT01306162|220904|P4|COMPLETED|Period 1||8
92422|NCT01306162|220905|P3|COMPLETED|Period 1||9
92423|NCT01306162|220906|P2|COMPLETED|Period 1||9
92424|NCT01306162|220907|P1|COMPLETED|Period 1||9
92425|NCT01306162|220904|P4|STARTED|Period 1||9
92426|NCT01306162|220905|P3|STARTED|Period 1||9
92427|NCT01306162|220906|P2|STARTED|Period 1||9
92428|NCT01306162|220907|P1|STARTED|Period 1||9
92429|NCT01306032|220941|P6|NOT COMPLETED|Disease Progression/Crossover||0
92430|NCT01306032|220942|P5|NOT COMPLETED|Disease Progression/Crossover||0
92431|NCT01306032|220943|P4|NOT COMPLETED|Disease Progression/Crossover||3
92432|NCT01306032|220944|P3|NOT COMPLETED|Disease Progression/Crossover||0
92433|NCT01306032|220945|P2|NOT COMPLETED|Disease Progression/Crossover||2
92434|NCT01306032|220946|P1|NOT COMPLETED|Disease Progression/Crossover||0
92435|NCT01306032|220941|P6|COMPLETED|Disease Progression/Crossover||0
92436|NCT01306032|220942|P5|COMPLETED|Disease Progression/Crossover||0
92437|NCT01306032|220943|P4|COMPLETED|Disease Progression/Crossover||26
92438|NCT01306032|220944|P3|COMPLETED|Disease Progression/Crossover||0
92439|NCT01306032|220945|P2|COMPLETED|Disease Progression/Crossover||14
92440|NCT01306032|220946|P1|COMPLETED|Disease Progression/Crossover||0
92441|NCT01306032|220941|P6|STARTED|Disease Progression/Crossover||0
92442|NCT01306032|220942|P5|STARTED|Disease Progression/Crossover||0
92443|NCT01306032|220943|P4|STARTED|Disease Progression/Crossover||29
92444|NCT01306032|220944|P3|STARTED|Disease Progression/Crossover||0
92445|NCT01306032|220945|P2|STARTED|Disease Progression/Crossover||16
92446|NCT01306032|220946|P1|STARTED|Disease Progression/Crossover||0
92447|NCT01306032|220941|P6|NOT COMPLETED|First Intervention||2
92448|NCT01306032|220942|P5|NOT COMPLETED|First Intervention||2
92449|NCT01306032|220943|P4|NOT COMPLETED|First Intervention||1
92450|NCT01306032|220944|P3|NOT COMPLETED|First Intervention||2
92451|NCT01306032|220945|P2|NOT COMPLETED|First Intervention||2
92452|NCT01306032|220946|P1|NOT COMPLETED|First Intervention||1
92453|NCT01306032|220941|P6|COMPLETED|First Intervention||0
92454|NCT01306032|220942|P5|COMPLETED|First Intervention||0
92455|NCT01306032|220943|P4|COMPLETED|First Intervention||37
92456|NCT01306032|220944|P3|COMPLETED|First Intervention||35
92457|NCT01306032|220945|P2|COMPLETED|First Intervention||18
92458|NCT01306032|220946|P1|COMPLETED|First Intervention||21
92459|NCT01306032|220941|P6|STARTED|First Intervention||2
92460|NCT01306032|220942|P5|STARTED|First Intervention||2
92461|NCT01306032|220943|P4|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|38
92462|NCT01306032|220944|P3|STARTED|First Intervention||37
92463|NCT01306032|220945|P2|STARTED|First Intervention|Not all participants on the Cyclophosphamide Alone Arm met eligibility criteria to crossover.|20
92464|NCT01306032|220946|P1|STARTED|First Intervention||22
92465|NCT01305811|221000|P2|NOT COMPLETED|Overall Study||11
92466|NCT01305811|221001|P1|NOT COMPLETED|Overall Study||8
92467|NCT01305811|221000|P2|COMPLETED|Overall Study||41
92468|NCT01305811|221001|P1|COMPLETED|Overall Study||44
92469|NCT01305811|221000|P2|STARTED|Overall Study||52
92470|NCT01305811|221001|P1|STARTED|Overall Study||52
92471|NCT01305772|221011|P2|NOT COMPLETED|Overall Study||0
92472|NCT01305772|221012|P1|NOT COMPLETED|Overall Study||0
92473|NCT01305772|221011|P2|COMPLETED|Overall Study||1
92474|NCT01305772|221012|P1|COMPLETED|Overall Study||5
92475|NCT01305772|221011|P2|RT + Panitumumab Dose #2 / #3|Overall Study||1
92476|NCT01305772|221012|P1|RT + Panitumumab Dose #2 / #3|Overall Study|RT and doses #2 and #3 of panitumumab administered to patients regardless of 2nd biopsy status.|5
92477|NCT01305772|221011|P2|Surgery/Biopsy #2|Overall Study||1
92478|NCT01305772|221012|P1|Surgery/Biopsy #2|Overall Study|2nd research tissue sample not collected for 4 patients due to safety risk to subject.|1
92479|NCT01305772|221011|P2|Research PET/CT #2|Overall Study||1
92480|NCT01305772|221012|P1|Research PET/CT #2|Overall Study||5
92481|NCT01305772|221011|P2|Panitumumab Dose #1|Overall Study||1
92482|NCT01305772|221012|P1|Panitumumab Dose #1|Overall Study||5
92483|NCT01305772|221011|P2|Research PET/CT #1|Overall Study||1
92484|NCT01305772|221012|P1|Research PET/CT #1|Overall Study||5
92485|NCT01305772|221011|P2|Genomic Screening + Biopsy #1|Overall Study||1
92486|NCT01305772|221012|P1|Genomic Screening + Biopsy #1|Overall Study||5
92487|NCT01305772|221011|P2|STARTED|Overall Study||1
92488|NCT01305772|221012|P1|STARTED|Overall Study||5
92489|NCT01305655|221019|P1|NOT COMPLETED|Overall Study||0
92490|NCT01305655|221019|P1|COMPLETED|Overall Study|December 31, 2014|47
92491|NCT01305655|221019|P1|STARTED|Overall Study|July 2008|47
92492|NCT01305577|221026|P3|NOT COMPLETED|Overall Study||10
92493|NCT01305577|221027|P2|NOT COMPLETED|Overall Study||11
92494|NCT01305577|221028|P1|NOT COMPLETED|Overall Study||13
92495|NCT01305577|221026|P3|COMPLETED|Overall Study||112
92496|NCT01305577|221027|P2|COMPLETED|Overall Study||110
92497|NCT01305577|221028|P1|COMPLETED|Overall Study||107
92498|NCT01305577|221026|P3|Received Treatment|Overall Study||122
92499|NCT01305577|221027|P2|Received Treatment|Overall Study||121
92500|NCT01305577|221028|P1|Received Treatment|Overall Study||119
92501|NCT01305577|221026|P3|STARTED|Overall Study||122
92502|NCT01305577|221027|P2|STARTED|Overall Study||121
92503|NCT01305577|221028|P1|STARTED|Overall Study||120
92504|NCT01305564|221057|P1|NOT COMPLETED|Overall Study||37
92505|NCT01305564|221057|P1|COMPLETED|Overall Study||163
92506|NCT01305564|221057|P1|STARTED|Overall Study||200
92507|NCT01305473|221072|P1|NOT COMPLETED|Overall Study||0
92508|NCT01305473|221072|P1|COMPLETED|Overall Study||90
92509|NCT01305473|221072|P1|STARTED|Overall Study||90
92510|NCT01305408|221084|P2|NOT COMPLETED|Overall Study||31
92511|NCT01305408|221085|P1|NOT COMPLETED|Overall Study||32
92512|NCT01305408|221084|P2|COMPLETED|Overall Study||169
92513|NCT01305408|221085|P1|COMPLETED|Overall Study||167
92514|NCT01305408|221084|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
92515|NCT01305408|221085|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
92516|NCT01305408|221084|P2|Safety Population|Overall Study|Treated participants.|200
92517|NCT01305408|221085|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|198
92518|NCT01305408|221084|P2|STARTED|Overall Study||200
92519|NCT01305408|221085|P1|STARTED|Overall Study||199
92520|NCT01305265|221137|P2|NOT COMPLETED|Overall Study||6
92521|NCT01305265|221138|P1|NOT COMPLETED|Overall Study||2
92522|NCT01305265|221137|P2|COMPLETED|Overall Study||64
92523|NCT01305265|221138|P1|COMPLETED|Overall Study||69
92524|NCT01305265|221137|P2|STARTED|Overall Study||70
92525|NCT01305265|221138|P1|STARTED|Overall Study||71
92526|NCT01305252|221146|P2|NOT COMPLETED|Overall Study||0
92527|NCT01305252|221147|P1|NOT COMPLETED|Overall Study||1
92528|NCT01305252|221146|P2|COMPLETED|Overall Study||11
92529|NCT01305252|221147|P1|COMPLETED|Overall Study||9
92530|NCT01305252|221146|P2|STARTED|Overall Study||11
92531|NCT01305252|221147|P1|STARTED|Overall Study||10
92532|NCT01305239|221161|P1|NOT COMPLETED|Overall Study||23
92533|NCT01305239|221161|P1|COMPLETED|Overall Study||375
92534|NCT01305239|221161|P1|Intent to Treat Population|Overall Study||287
92535|NCT01305239|221161|P1|Safety Set|Overall Study||397
92536|NCT01305239|221161|P1|STARTED|Overall Study||398
92537|NCT01305213|221171|P2|NOT COMPLETED|Overall Study||0
92538|NCT01305213|221172|P1|NOT COMPLETED|Overall Study||0
92539|NCT01305213|221171|P2|COMPLETED|Overall Study||54
92540|NCT01305213|221172|P1|COMPLETED|Overall Study||53
92541|NCT01305213|221171|P2|STARTED|Overall Study||54
92542|NCT01305213|221172|P1|STARTED|Overall Study||53
92543|NCT01305200|221183|P3|NOT COMPLETED|Overall Study||3
92544|NCT01305200|221184|P2|NOT COMPLETED|Overall Study||31
92545|NCT01305200|221185|P1|NOT COMPLETED|Overall Study||29
92546|NCT01305200|221183|P3|COMPLETED|Overall Study||0
92547|NCT01305200|221184|P2|COMPLETED|Overall Study||81
92548|NCT01305200|221185|P1|COMPLETED|Overall Study||82
92549|NCT01305200|221183|P3|STARTED|Overall Study||3
92550|NCT01305200|221184|P2|STARTED|Overall Study||112
92551|NCT01305200|221185|P1|STARTED|Overall Study||111
92552|NCT01305044|221215|P2|NOT COMPLETED|Overall Study||6
92553|NCT01305044|221216|P1|NOT COMPLETED|Overall Study||3
92554|NCT01305044|221215|P2|COMPLETED|Overall Study||25
92555|NCT01305044|221216|P1|COMPLETED|Overall Study||29
92556|NCT01305044|221215|P2|STARTED|Overall Study||31
92557|NCT01305044|221216|P1|STARTED|Overall Study||32
92558|NCT01304966|221240|P1|NOT COMPLETED|Overall Study||0
92559|NCT01304966|221240|P1|COMPLETED|Overall Study||15
92560|NCT01304966|221240|P1|STARTED|Overall Study||15
92561|NCT01304706|221246|P1|NOT COMPLETED|Overall Study||17
92562|NCT01304706|221246|P1|COMPLETED|Overall Study||104
92563|NCT01304706|221246|P1|STARTED|Overall Study||121
92564|NCT01304693|221255|P5|NOT COMPLETED|Overall Study||1
92565|NCT01304693|221256|P4|NOT COMPLETED|Overall Study||1
92566|NCT01304693|221257|P3|NOT COMPLETED|Overall Study||1
92567|NCT01304693|221258|P2|NOT COMPLETED|Overall Study||0
92568|NCT01304693|221259|P1|NOT COMPLETED|Overall Study||0
92569|NCT01304693|221255|P5|COMPLETED|Overall Study||60
92570|NCT01304693|221256|P4|COMPLETED|Overall Study||39
92571|NCT01304693|221257|P3|COMPLETED|Overall Study||47
92572|NCT01304693|221258|P2|COMPLETED|Overall Study||35
92573|NCT01304693|221259|P1|COMPLETED|Overall Study||10
92574|NCT01304693|221255|P5|STARTED|Overall Study||61
92575|NCT01304693|221256|P4|STARTED|Overall Study||40
92576|NCT01304693|221257|P3|STARTED|Overall Study||48
92577|NCT01304693|221258|P2|STARTED|Overall Study||35
92578|NCT01304693|221259|P1|STARTED|Overall Study||10
92579|NCT01304641|221278|P2|NOT COMPLETED|Overall Study||0
92580|NCT01304641|221279|P1|NOT COMPLETED|Overall Study||0
92581|NCT01304641|221278|P2|COMPLETED|Overall Study||20132
92582|NCT01304641|221279|P1|COMPLETED|Overall Study||11470
92583|NCT01304641|221278|P2|STARTED|Overall Study||20132
92584|NCT01304641|221279|P1|STARTED|Overall Study||11470
92585|NCT01304589|221297|P1|NOT COMPLETED|Overall Study||13
92586|NCT01304589|221297|P1|COMPLETED|Overall Study||18
92587|NCT01304589|221297|P1|STARTED|Overall Study||31
92588|NCT01304498|221306|P2|NOT COMPLETED|Overall Study||5
92589|NCT01304498|221307|P1|NOT COMPLETED|Overall Study||6
92590|NCT01304498|221306|P2|COMPLETED|Overall Study||295
92591|NCT01304498|221307|P1|COMPLETED|Overall Study||294
92592|NCT01304498|221306|P2|Received ≥1 Dose|Overall Study||300
92593|NCT01304498|221307|P1|Received ≥1 Dose|Overall Study||300
92594|NCT01304498|221306|P2|STARTED|Overall Study||300
92595|NCT01304498|221307|P1|STARTED|Overall Study||300
92596|NCT01304329|221327|P6|NOT COMPLETED|Third Intervention (3 Days)||0
92597|NCT01304329|221328|P5|NOT COMPLETED|Third Intervention (3 Days)||0
92598|NCT01304329|221329|P4|NOT COMPLETED|Third Intervention (3 Days)||0
92599|NCT01304329|221330|P3|NOT COMPLETED|Third Intervention (3 Days)||0
92600|NCT01304329|221331|P2|NOT COMPLETED|Third Intervention (3 Days)||1
92601|NCT01304329|221332|P1|NOT COMPLETED|Third Intervention (3 Days)||0
92602|NCT01304329|221327|P6|COMPLETED|Third Intervention (3 Days)||3
92603|NCT01304329|221328|P5|COMPLETED|Third Intervention (3 Days)||3
92604|NCT01304329|221329|P4|COMPLETED|Third Intervention (3 Days)||3
92605|NCT01304329|221330|P3|COMPLETED|Third Intervention (3 Days)||3
92606|NCT01304329|221331|P2|COMPLETED|Third Intervention (3 Days)||2
92607|NCT01304329|221332|P1|COMPLETED|Third Intervention (3 Days)||3
92608|NCT01304329|221327|P6|STARTED|Third Intervention (3 Days)||3
92609|NCT01304329|221328|P5|STARTED|Third Intervention (3 Days)||3
92610|NCT01304329|221329|P4|STARTED|Third Intervention (3 Days)||3
92611|NCT01304329|221330|P3|STARTED|Third Intervention (3 Days)||3
92612|NCT01304329|221331|P2|STARTED|Third Intervention (3 Days)||3
92613|NCT01304329|221332|P1|STARTED|Third Intervention (3 Days)||3
92614|NCT01304329|221327|P6|NOT COMPLETED|Second Intervention (3 Days)||0
92615|NCT01304329|221328|P5|NOT COMPLETED|Second Intervention (3 Days)||0
92616|NCT01304329|221329|P4|NOT COMPLETED|Second Intervention (3 Days)||0
92617|NCT01304329|221330|P3|NOT COMPLETED|Second Intervention (3 Days)||0
92618|NCT01304329|221331|P2|NOT COMPLETED|Second Intervention (3 Days)||0
92619|NCT01304329|221332|P1|NOT COMPLETED|Second Intervention (3 Days)||0
92620|NCT01304329|221327|P6|COMPLETED|Second Intervention (3 Days)||3
92621|NCT01304329|221328|P5|COMPLETED|Second Intervention (3 Days)||3
92622|NCT01304329|221329|P4|COMPLETED|Second Intervention (3 Days)||3
92623|NCT01304329|221330|P3|COMPLETED|Second Intervention (3 Days)||3
92624|NCT01304329|221331|P2|COMPLETED|Second Intervention (3 Days)||3
92625|NCT01304329|221332|P1|COMPLETED|Second Intervention (3 Days)||3
92626|NCT01304329|221327|P6|STARTED|Second Intervention (3 Days)||3
92627|NCT01304329|221328|P5|STARTED|Second Intervention (3 Days)||3
92628|NCT01304329|221329|P4|STARTED|Second Intervention (3 Days)||3
92629|NCT01304329|221330|P3|STARTED|Second Intervention (3 Days)||3
92630|NCT01304329|221331|P2|STARTED|Second Intervention (3 Days)||3
92631|NCT01304329|221332|P1|STARTED|Second Intervention (3 Days)||3
92632|NCT01304329|221327|P6|NOT COMPLETED|First Intervention (3 Days)||0
92633|NCT01304329|221328|P5|NOT COMPLETED|First Intervention (3 Days)||0
92634|NCT01304329|221329|P4|NOT COMPLETED|First Intervention (3 Days)||0
92635|NCT01304329|221330|P3|NOT COMPLETED|First Intervention (3 Days)||0
92636|NCT01304329|221331|P2|NOT COMPLETED|First Intervention (3 Days)||0
92637|NCT01304329|221332|P1|NOT COMPLETED|First Intervention (3 Days)||0
92638|NCT01304329|221327|P6|COMPLETED|First Intervention (3 Days)||3
92639|NCT01304329|221328|P5|COMPLETED|First Intervention (3 Days)||3
92640|NCT01304329|221329|P4|COMPLETED|First Intervention (3 Days)||3
92641|NCT01304329|221330|P3|COMPLETED|First Intervention (3 Days)||3
92642|NCT01304329|221331|P2|COMPLETED|First Intervention (3 Days)||3
92643|NCT01304329|221332|P1|COMPLETED|First Intervention (3 Days)||3
92644|NCT01304329|221327|P6|STARTED|First Intervention (3 Days)||3
92645|NCT01304329|221328|P5|STARTED|First Intervention (3 Days)||3
92646|NCT01304329|221329|P4|STARTED|First Intervention (3 Days)||3
92647|NCT01304329|221330|P3|STARTED|First Intervention (3 Days)||3
92648|NCT01304329|221331|P2|STARTED|First Intervention (3 Days)||3
92649|NCT01304329|221332|P1|STARTED|First Intervention (3 Days)||3
92650|NCT01304316|221349|P1|NOT COMPLETED|Overall Study||0
92651|NCT01304316|221349|P1|COMPLETED|Overall Study||12
92652|NCT01304316|221349|P1|STARTED|Overall Study||12
92653|NCT01304277|221363|P1|NOT COMPLETED|Treatment (Replagal AF, Week 2- EOS)||0
92654|NCT01304277|221363|P1|COMPLETED|Treatment (Replagal AF, Week 2- EOS)||17
92655|NCT01304277|221363|P1|STARTED|Treatment (Replagal AF, Week 2- EOS)||17
92656|NCT01304277|221363|P1|NOT COMPLETED|Screening (Replagal RB, Week 0- Week 2)||0
92657|NCT01304277|221363|P1|COMPLETED|Screening (Replagal RB, Week 0- Week 2)||17
92658|NCT01304277|221363|P1|STARTED|Screening (Replagal RB, Week 0- Week 2)||17
92659|NCT01304238|221385|P10|NOT COMPLETED|Overall Study||0
92660|NCT01304238|221386|P9|NOT COMPLETED|Overall Study||0
92661|NCT01304238|221387|P8|NOT COMPLETED|Overall Study||0
92662|NCT01304238|221388|P7|NOT COMPLETED|Overall Study||0
92663|NCT01304238|221389|P6|NOT COMPLETED|Overall Study||0
92664|NCT01304238|221390|P5|NOT COMPLETED|Overall Study||0
92665|NCT01304238|221391|P4|NOT COMPLETED|Overall Study||0
92666|NCT01304238|221392|P3|NOT COMPLETED|Overall Study||0
92667|NCT01304238|221393|P2|NOT COMPLETED|Overall Study||0
92668|NCT01304238|221394|P1|NOT COMPLETED|Overall Study||0
92669|NCT01304238|221385|P10|COMPLETED|Overall Study||3
92670|NCT01304238|221386|P9|COMPLETED|Overall Study||1
92671|NCT01304238|221387|P8|COMPLETED|Overall Study||4
92672|NCT01304238|221388|P7|COMPLETED|Overall Study||5
92673|NCT01304238|221389|P6|COMPLETED|Overall Study||11
92674|NCT01304238|221390|P5|COMPLETED|Overall Study||11
92675|NCT01304238|221391|P4|COMPLETED|Overall Study||78
92676|NCT01304238|221392|P3|COMPLETED|Overall Study||46
92677|NCT01304238|221393|P2|COMPLETED|Overall Study||4
92678|NCT01304238|221394|P1|COMPLETED|Overall Study||32
92679|NCT01304238|221385|P10|STARTED|Overall Study||3
92680|NCT01304238|221386|P9|STARTED|Overall Study||1
92681|NCT01304238|221387|P8|STARTED|Overall Study||4
92682|NCT01304238|221388|P7|STARTED|Overall Study||5
92683|NCT01304238|221389|P6|STARTED|Overall Study||11
92684|NCT01304238|221390|P5|STARTED|Overall Study||11
92685|NCT01304238|221391|P4|STARTED|Overall Study||78
92686|NCT01304238|221392|P3|STARTED|Overall Study||46
92687|NCT01304238|221393|P2|STARTED|Overall Study||4
92688|NCT01304238|221394|P1|STARTED|Overall Study||32
92689|NCT01304147|221466|P2|NOT COMPLETED|Second Intervention (7days)||1
92690|NCT01304147|221467|P1|NOT COMPLETED|Second Intervention (7days)||1
92691|NCT01304147|221466|P2|COMPLETED|Second Intervention (7days)||9
92692|NCT01304147|221467|P1|COMPLETED|Second Intervention (7days)||9
92693|NCT01304147|221466|P2|STARTED|Second Intervention (7days)||10
92694|NCT01304147|221467|P1|STARTED|Second Intervention (7days)||10
92695|NCT01304147|221466|P2|NOT COMPLETED|Washout (1 Day)||0
92696|NCT01304147|221467|P1|NOT COMPLETED|Washout (1 Day)||0
92697|NCT01304147|221466|P2|COMPLETED|Washout (1 Day)||10
92698|NCT01304147|221467|P1|COMPLETED|Washout (1 Day)||10
92699|NCT01304147|221466|P2|STARTED|Washout (1 Day)||10
92700|NCT01304147|221467|P1|STARTED|Washout (1 Day)||10
92701|NCT01304147|221466|P2|NOT COMPLETED|First Intervention (7days)||0
92702|NCT01304147|221467|P1|NOT COMPLETED|First Intervention (7days)||0
92703|NCT01304147|221466|P2|COMPLETED|First Intervention (7days)||10
92704|NCT01304147|221467|P1|COMPLETED|First Intervention (7days)||10
92705|NCT01304147|221466|P2|STARTED|First Intervention (7days)||10
92706|NCT01304147|221467|P1|STARTED|First Intervention (7days)||10
92707|NCT01304082|221475|P5|NOT COMPLETED|Overall Study||0
92708|NCT01304082|221476|P4|NOT COMPLETED|Overall Study||0
92709|NCT01304082|221477|P3|NOT COMPLETED|Overall Study||0
92710|NCT01304082|221478|P2|NOT COMPLETED|Overall Study||0
92711|NCT01304082|221479|P1|NOT COMPLETED|Overall Study||0
92712|NCT01304082|221475|P5|COMPLETED|Overall Study||5
92713|NCT01304082|221476|P4|COMPLETED|Overall Study||8
92714|NCT01304082|221477|P3|COMPLETED|Overall Study||11
92715|NCT01304082|221478|P2|COMPLETED|Overall Study||2
92716|NCT01304082|221479|P1|COMPLETED|Overall Study||3
92717|NCT01304082|221475|P5|Third Intervention|Overall Study||5
92718|NCT01304082|221476|P4|Third Intervention|Overall Study||8
92719|NCT01304082|221477|P3|Third Intervention|Overall Study||11
92720|NCT01304082|221478|P2|Third Intervention|Overall Study||2
92721|NCT01304082|221479|P1|Third Intervention|Overall Study||3
92722|NCT01304082|221475|P5|Second Intervention|Overall Study||5
92723|NCT01304082|221476|P4|Second Intervention|Overall Study||8
92724|NCT01304082|221477|P3|Second Intervention|Overall Study||11
92725|NCT01304082|221478|P2|Second Intervention|Overall Study||2
92726|NCT01304082|221479|P1|Second Intervention|Overall Study||3
92727|NCT01304082|221475|P5|First Intervention|Overall Study||5
92728|NCT01304082|221476|P4|First Intervention|Overall Study||8
92729|NCT01304082|221477|P3|First Intervention|Overall Study||11
92730|NCT01304082|221478|P2|First Intervention|Overall Study||2
92731|NCT01304082|221479|P1|First Intervention|Overall Study||3
92732|NCT01304082|221475|P5|STARTED|Overall Study||5
92733|NCT01304082|221476|P4|STARTED|Overall Study||8
92734|NCT01304082|221477|P3|STARTED|Overall Study||11
92735|NCT01304082|221478|P2|STARTED|Overall Study||2
92736|NCT01304082|221479|P1|STARTED|Overall Study||3
92737|NCT01303861|221501|P4|NOT COMPLETED|Overall Study||59
92738|NCT01303861|221502|P3|NOT COMPLETED|Overall Study||36
92739|NCT01303861|221503|P2|NOT COMPLETED|Overall Study||25
92740|NCT01303861|221504|P1|NOT COMPLETED|Overall Study||58
92741|NCT01303861|221501|P4|COMPLETED|Overall Study||54
92742|NCT01303861|221502|P3|COMPLETED|Overall Study||19
92743|NCT01303861|221503|P2|COMPLETED|Overall Study||25
92744|NCT01303861|221504|P1|COMPLETED|Overall Study||51
92745|NCT01303861|221501|P4|Finished Treatment Phase|Overall Study||72
92746|NCT01303861|221502|P3|Finished Treatment Phase|Overall Study||39
92747|NCT01303861|221503|P2|Finished Treatment Phase|Overall Study||34
92748|NCT01303861|221504|P1|Finished Treatment Phase|Overall Study||71
92749|NCT01303861|221501|P4|STARTED|Overall Study||113
92750|NCT01303861|221502|P3|STARTED|Overall Study||55
92751|NCT01303861|221503|P2|STARTED|Overall Study||50
92752|NCT01303861|221504|P1|STARTED|Overall Study||109
92753|NCT01303835|221525|P2|NOT COMPLETED|Overall Study||25
92754|NCT01303835|221526|P1|NOT COMPLETED|Overall Study||19
92755|NCT01303835|221525|P2|COMPLETED|Overall Study||31
92756|NCT01303835|221526|P1|COMPLETED|Overall Study||35
92757|NCT01303835|221525|P2|STARTED|Overall Study||56
92758|NCT01303835|221526|P1|STARTED|Overall Study||54
92759|NCT01303744|221540|P4|NOT COMPLETED|Overall Study||0
92760|NCT01303744|221541|P3|NOT COMPLETED|Overall Study||0
92761|NCT01303744|221542|P2|NOT COMPLETED|Overall Study||0
92762|NCT01303744|221543|P1|NOT COMPLETED|Overall Study||0
92763|NCT01303744|221540|P4|COMPLETED|Overall Study||24
92764|NCT01303744|221541|P3|COMPLETED|Overall Study||24
92765|NCT01303744|221542|P2|COMPLETED|Overall Study||24
92766|NCT01303744|221543|P1|COMPLETED|Overall Study||24
92767|NCT01303744|221540|P4|STARTED|Overall Study||24
92768|NCT01303744|221541|P3|STARTED|Overall Study||24
92769|NCT01303744|221542|P2|STARTED|Overall Study||24
92770|NCT01303744|221543|P1|STARTED|Overall Study||24
92771|NCT01303627|221563|P2|NOT COMPLETED|Overall Study||1
92772|NCT01303627|221564|P1|NOT COMPLETED|Overall Study||0
92773|NCT01303627|221563|P2|COMPLETED|Overall Study|One patient excluded from the study because of the failure while performing uretero-renoscopy|20
92774|NCT01303627|221564|P1|COMPLETED|Overall Study||21
92775|NCT01303627|221563|P2|STARTED|Overall Study||21
92776|NCT01303627|221564|P1|STARTED|Overall Study||21
92777|NCT01303510|221572|P2|NOT COMPLETED|Overall Study||0
92778|NCT01303510|221573|P1|NOT COMPLETED|Overall Study||1
92779|NCT01303510|221572|P2|COMPLETED|Overall Study||56
92780|NCT01303510|221573|P1|COMPLETED|Overall Study||54
92781|NCT01303510|221572|P2|STARTED|Overall Study||56
92782|NCT01303510|221573|P1|STARTED|Overall Study||55
92783|NCT01303445|221587|P2|NOT COMPLETED|Follow-up Period (14 Days)||1
92784|NCT01303445|221588|P1|NOT COMPLETED|Follow-up Period (14 Days)||0
92785|NCT01303445|221587|P2|COMPLETED|Follow-up Period (14 Days)||25
92786|NCT01303445|221588|P1|COMPLETED|Follow-up Period (14 Days)||26
92787|NCT01303445|221587|P2|STARTED|Follow-up Period (14 Days)||26
92788|NCT01303445|221588|P1|STARTED|Follow-up Period (14 Days)||26
92789|NCT01303445|221587|P2|NOT COMPLETED|Fourth Intervention (7 Days)||0
92790|NCT01303445|221588|P1|NOT COMPLETED|Fourth Intervention (7 Days)||1
92791|NCT01303445|221587|P2|COMPLETED|Fourth Intervention (7 Days)||26
92792|NCT01303445|221588|P1|COMPLETED|Fourth Intervention (7 Days)||26
92793|NCT01303445|221587|P2|STARTED|Fourth Intervention (7 Days)||26
92794|NCT01303445|221588|P1|STARTED|Fourth Intervention (7 Days)||27
92795|NCT01303445|221587|P2|NOT COMPLETED|Third Intervention (7 Days)||0
92796|NCT01303445|221588|P1|NOT COMPLETED|Third Intervention (7 Days)||0
92797|NCT01303445|221587|P2|COMPLETED|Third Intervention (7 Days)||26
92798|NCT01303445|221588|P1|COMPLETED|Third Intervention (7 Days)||27
92799|NCT01303445|221587|P2|STARTED|Third Intervention (7 Days)||26
92800|NCT01303445|221588|P1|STARTED|Third Intervention (7 Days)||27
92801|NCT01303445|221587|P2|NOT COMPLETED|Washout (14 Days)||2
92802|NCT01303445|221588|P1|NOT COMPLETED|Washout (14 Days)||1
92803|NCT01303445|221587|P2|COMPLETED|Washout (14 Days)||26
92804|NCT01303445|221588|P1|COMPLETED|Washout (14 Days)||27
92805|NCT01303445|221587|P2|STARTED|Washout (14 Days)||28
92806|NCT01303445|221588|P1|STARTED|Washout (14 Days)||28
92807|NCT01303445|221587|P2|NOT COMPLETED|Second Intervention (7 Days)||2
92808|NCT01303445|221588|P1|NOT COMPLETED|Second Intervention (7 Days)||1
92809|NCT01303445|221587|P2|COMPLETED|Second Intervention (7 Days)||28
92810|NCT01303445|221588|P1|COMPLETED|Second Intervention (7 Days)||28
92811|NCT01303445|221587|P2|STARTED|Second Intervention (7 Days)||30
92812|NCT01303445|221588|P1|STARTED|Second Intervention (7 Days)||29
92813|NCT01303445|221587|P2|NOT COMPLETED|First Intervention (7 Days)||0
92814|NCT01303445|221588|P1|NOT COMPLETED|First Intervention (7 Days)||1
92815|NCT01303445|221587|P2|COMPLETED|First Intervention (7 Days)||30
92816|NCT01303445|221588|P1|COMPLETED|First Intervention (7 Days)||29
92817|NCT01303445|221587|P2|STARTED|First Intervention (7 Days)||30
92818|NCT01303445|221588|P1|STARTED|First Intervention (7 Days)||30
92819|NCT01303406|221620|P2|NOT COMPLETED|Overall Study||1
92820|NCT01303406|221621|P1|NOT COMPLETED|Overall Study||0
92821|NCT01303406|221620|P2|COMPLETED|Overall Study||15
92822|NCT01303406|221621|P1|COMPLETED|Overall Study||13
92823|NCT01303406|221620|P2|STARTED|Overall Study||16
92824|NCT01303406|221621|P1|STARTED|Overall Study||13
92825|NCT01303380|221629|P1|NOT COMPLETED|Overall Study||1
92826|NCT01303380|221629|P1|COMPLETED|Overall Study||8
92827|NCT01303380|221629|P1|STARTED|Overall Study||9
92828|NCT01303224|221659|P4|NOT COMPLETED|Overall Study||10
92829|NCT01303224|221660|P3|NOT COMPLETED|Overall Study||6
92830|NCT01303224|221661|P2|NOT COMPLETED|Overall Study||11
92831|NCT01303224|221662|P1|NOT COMPLETED|Overall Study||11
92832|NCT01303224|221659|P4|COMPLETED|Overall Study||133
92833|NCT01303224|221660|P3|COMPLETED|Overall Study||133
92834|NCT01303224|221661|P2|COMPLETED|Overall Study||131
92835|NCT01303224|221662|P1|COMPLETED|Overall Study||130
92836|NCT01303224|221659|P4|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|142
92837|NCT01303224|221660|P3|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|139
92838|NCT01303224|221661|P2|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|138
92839|NCT01303224|221662|P1|Intention To Treat|Overall Study|subjects with at least 1 primary endpoint evaluation post randomisation|140
92840|NCT01303224|221659|P4|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|143
92841|NCT01303224|221660|P3|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|139
92842|NCT01303224|221661|P2|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|142
92843|NCT01303224|221662|P1|STARTED|Overall Study|randomised, safety population, >= 1 dose of study medication|141
92844|NCT01303159|221688|P1|NOT COMPLETED|Overall Study||23
92845|NCT01303159|221688|P1|COMPLETED|Overall Study||6
92846|NCT01303159|221688|P1|STARTED|Overall Study||29
92847|NCT01302938|221695|P2|NOT COMPLETED|Overall Study||0
92848|NCT01302938|221696|P1|NOT COMPLETED|Overall Study||2
92849|NCT01302938|221695|P2|COMPLETED|Overall Study||6
92850|NCT01302938|221696|P1|COMPLETED|Overall Study||10
92851|NCT01302938|221695|P2|STARTED|Overall Study||6
92852|NCT01302938|221696|P1|STARTED|Overall Study||12
92853|NCT01302899|221741|P2|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
92854|NCT01302899|221742|P1|NOT COMPLETED|Period 4 (Weeks 19 to 26)||0
92855|NCT01302899|221741|P2|COMPLETED|Period 4 (Weeks 19 to 26)||3
92856|NCT01302899|221742|P1|COMPLETED|Period 4 (Weeks 19 to 26)||3
92857|NCT01302899|221741|P2|STARTED|Period 4 (Weeks 19 to 26)||3
92858|NCT01302899|221742|P1|STARTED|Period 4 (Weeks 19 to 26)||3
92859|NCT01302899|221741|P2|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
92860|NCT01302899|221742|P1|NOT COMPLETED|Period 3 (Weeks 13 to 18)||0
92861|NCT01302899|221741|P2|COMPLETED|Period 3 (Weeks 13 to 18)||3
92862|NCT01302899|221742|P1|COMPLETED|Period 3 (Weeks 13 to 18)||3
92863|NCT01302899|221741|P2|STARTED|Period 3 (Weeks 13 to 18)||3
92864|NCT01302899|221742|P1|STARTED|Period 3 (Weeks 13 to 18)||3
92865|NCT01302899|221741|P2|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
92866|NCT01302899|221742|P1|NOT COMPLETED|Period 2 (Weeks 7 to 12)||1
92867|NCT01302899|221741|P2|COMPLETED|Period 2 (Weeks 7 to 12)||3
92868|NCT01302899|221742|P1|COMPLETED|Period 2 (Weeks 7 to 12)||3
92869|NCT01302899|221741|P2|STARTED|Period 2 (Weeks 7 to 12)||4
92870|NCT01302899|221742|P1|STARTED|Period 2 (Weeks 7 to 12)||4
92871|NCT01302899|221741|P2|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
92872|NCT01302899|221742|P1|NOT COMPLETED|Period 1 (Day 1 to End of Week 6)||0
92873|NCT01302899|221741|P2|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
92874|NCT01302899|221742|P1|COMPLETED|Period 1 (Day 1 to End of Week 6)||4
92875|NCT01302899|221741|P2|STARTED|Period 1 (Day 1 to End of Week 6)||4
92876|NCT01302899|221742|P1|STARTED|Period 1 (Day 1 to End of Week 6)||4
92877|NCT01302860|221792|P1|NOT COMPLETED|Overall Study||0
92878|NCT01302860|221792|P1|COMPLETED|Overall Study||17
92879|NCT01302860|221792|P1|STARTED|Overall Study||17
92880|NCT01302743|221807|P3|NOT COMPLETED|Overall Study||2
92881|NCT01302743|221808|P2|NOT COMPLETED|Overall Study||1
92882|NCT01302743|221809|P1|NOT COMPLETED|Overall Study||1
92883|NCT01302743|221807|P3|COMPLETED|Overall Study||8
92884|NCT01302743|221808|P2|COMPLETED|Overall Study||7
92885|NCT01302743|221809|P1|COMPLETED|Overall Study||6
92886|NCT01302743|221807|P3|STARTED|Overall Study||10
92887|NCT01302743|221808|P2|STARTED|Overall Study||8
92888|NCT01302743|221809|P1|STARTED|Overall Study||7
92889|NCT01302691|221822|P2|NOT COMPLETED|Overall Study||6
92890|NCT01302691|221823|P1|NOT COMPLETED|Overall Study||10
92891|NCT01302691|221822|P2|COMPLETED|Overall Study||157
92892|NCT01302691|221823|P1|COMPLETED|Overall Study||154
92893|NCT01302691|221822|P2|STARTED|Overall Study||163
92894|NCT01302691|221823|P1|STARTED|Overall Study||164
92895|NCT01302548|221843|P2|NOT COMPLETED|Overall Study||1
92896|NCT01302548|221844|P1|NOT COMPLETED|Overall Study||2
92897|NCT01302548|221843|P2|COMPLETED|Overall Study||18
92898|NCT01302548|221844|P1|COMPLETED|Overall Study||12
92899|NCT01302548|221843|P2|STARTED|Overall Study||19
92900|NCT01302548|221844|P1|STARTED|Overall Study||14
92901|NCT01302483|221856|P2|NOT COMPLETED|Overall Study||0
92902|NCT01302483|221857|P1|NOT COMPLETED|Overall Study||0
92903|NCT01302483|221856|P2|COMPLETED|Overall Study||15
92904|NCT01302483|221857|P1|COMPLETED|Overall Study||30
92905|NCT01302483|221856|P2|STARTED|Overall Study||15
92906|NCT01302483|221857|P1|STARTED|Overall Study||30
92907|NCT01302444|221873|P2|NOT COMPLETED|Overall Study||0
92908|NCT01302444|221874|P1|NOT COMPLETED|Overall Study||0
92909|NCT01302444|221873|P2|COMPLETED|Overall Study||0
92910|NCT01302444|221874|P1|COMPLETED|Overall Study||1
92911|NCT01302444|221873|P2|STARTED|Overall Study||0
92912|NCT01302444|221874|P1|STARTED|Overall Study||1
92913|NCT01302418|221894|P1|NOT COMPLETED|Overall Study||18
92914|NCT01302418|221894|P1|COMPLETED|Overall Study||254
92915|NCT01302418|221894|P1|STARTED|Overall Study||272
92916|NCT01302392|221900|P2|NOT COMPLETED|Overall Study||1
92917|NCT01302392|221901|P1|NOT COMPLETED|Overall Study||7
92918|NCT01302392|221900|P2|COMPLETED|Overall Study||156
92919|NCT01302392|221901|P1|COMPLETED|Overall Study||151
92920|NCT01302392|221900|P2|Treated|Overall Study||157
92921|NCT01302392|221901|P1|Treated|Overall Study||153
92922|NCT01302392|221900|P2|STARTED|Overall Study||157
92923|NCT01302392|221901|P1|STARTED|Overall Study||158
92924|NCT01302366|221921|P1|NOT COMPLETED|Overall Study||5
92925|NCT01302366|221921|P1|COMPLETED|Overall Study||15
92926|NCT01302366|221921|P1|STARTED|Overall Study||20
92927|NCT01302119|221929|P2|NOT COMPLETED|Overall Study||28
92928|NCT01302119|221930|P1|NOT COMPLETED|Overall Study||50
92929|NCT01302119|221929|P2|COMPLETED|Overall Study||177
92930|NCT01302119|221930|P1|COMPLETED|Overall Study||349
92931|NCT01302119|221929|P2|STARTED|Overall Study||205
92932|NCT01302119|221930|P1|STARTED|Overall Study||399
92933|NCT01302067|221945|P3|NOT COMPLETED|Overall Study||98
92934|NCT01302067|221946|P2|NOT COMPLETED|Overall Study||34
92935|NCT01302067|221947|P1|NOT COMPLETED|Overall Study||78
92936|NCT01302067|221945|P3|COMPLETED|Overall Study||681
92937|NCT01302067|221946|P2|COMPLETED|Overall Study||352
92938|NCT01302067|221947|P1|COMPLETED|Overall Study||712
92939|NCT01302067|221945|P3|STARTED|Overall Study||779
92940|NCT01302067|221946|P2|STARTED|Overall Study||386
92941|NCT01302067|221947|P1|STARTED|Overall Study||790
92942|NCT01302054|222018|P3|NOT COMPLETED|Double-Blind Treatment Phase||46
92943|NCT01302054|222019|P2|NOT COMPLETED|Double-Blind Treatment Phase||27
92944|NCT01302054|222020|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
92945|NCT01302054|222018|P3|COMPLETED|Double-Blind Treatment Phase||255
92946|NCT01302054|222019|P2|COMPLETED|Double-Blind Treatment Phase||281
92947|NCT01302054|222020|P1|COMPLETED|Double-Blind Treatment Phase||0
92948|NCT01302054|222018|P3|STARTED|Double-Blind Treatment Phase||301
92949|NCT01302054|222019|P2|STARTED|Double-Blind Treatment Phase||308
92950|NCT01302054|222020|P1|STARTED|Double-Blind Treatment Phase||0
92951|NCT01302054|222018|P3|NOT COMPLETED|Between Open-Label and Double Blind||0
92952|NCT01302054|222019|P2|NOT COMPLETED|Between Open-Label and Double Blind||0
92953|NCT01302054|222020|P1|NOT COMPLETED|Between Open-Label and Double Blind||2
92954|NCT01302054|222018|P3|COMPLETED|Between Open-Label and Double Blind||0
92955|NCT01302054|222019|P2|COMPLETED|Between Open-Label and Double Blind||0
92956|NCT01302054|222020|P1|COMPLETED|Between Open-Label and Double Blind||609
92957|NCT01302054|222018|P3|STARTED|Between Open-Label and Double Blind||0
92958|NCT01302054|222019|P2|STARTED|Between Open-Label and Double Blind||0
92959|NCT01302054|222020|P1|STARTED|Between Open-Label and Double Blind||611
92960|NCT01302054|222018|P3|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
92961|NCT01302054|222019|P2|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||0
92962|NCT01302054|222020|P1|NOT COMPLETED|Tolterodine Open-Label Run-In Phase||379
92963|NCT01302054|222018|P3|COMPLETED|Tolterodine Open-Label Run-In Phase||0
92964|NCT01302054|222019|P2|COMPLETED|Tolterodine Open-Label Run-In Phase||0
92965|NCT01302054|222020|P1|COMPLETED|Tolterodine Open-Label Run-In Phase||611
92966|NCT01302054|222018|P3|STARTED|Tolterodine Open-Label Run-In Phase||0
92967|NCT01302054|222019|P2|STARTED|Tolterodine Open-Label Run-In Phase||0
92968|NCT01302054|222020|P1|STARTED|Tolterodine Open-Label Run-In Phase||990
92969|NCT01302041|222047|P1|NOT COMPLETED|Overall Study||50
92970|NCT01302041|222047|P1|COMPLETED|Overall Study|Participants who discontinued treatment and completed the 30-day follow-up visit|17
92971|NCT01302041|222047|P1|STARTED|Overall Study||67
92972|NCT01301963|222078|P2|NOT COMPLETED|Overall Study||0
92973|NCT01301963|222079|P1|NOT COMPLETED|Overall Study||0
92974|NCT01301963|222078|P2|COMPLETED|Overall Study||4
92975|NCT01301963|222079|P1|COMPLETED|Overall Study||5
92976|NCT01301963|222078|P2|STARTED|Overall Study||4
92977|NCT01301963|222079|P1|STARTED|Overall Study||5
92978|NCT01301950|222089|P2|NOT COMPLETED|Overall Study||1
92979|NCT01301950|222090|P1|NOT COMPLETED|Overall Study||0
92980|NCT01301950|222089|P2|COMPLETED|Overall Study||14
92981|NCT01301950|222090|P1|COMPLETED|Overall Study||15
92982|NCT01301950|222089|P2|STARTED|Overall Study||15
92983|NCT01301950|222090|P1|STARTED|Overall Study||15
92984|NCT01301833|222108|P4|NOT COMPLETED|Overall Study||7
92985|NCT01301833|222109|P3|NOT COMPLETED|Overall Study||7
92986|NCT01301833|222110|P2|NOT COMPLETED|Overall Study||8
92987|NCT01301833|222111|P1|NOT COMPLETED|Overall Study||15
92988|NCT01301833|222108|P4|COMPLETED|Overall Study||68
92989|NCT01301833|222109|P3|COMPLETED|Overall Study||88
92990|NCT01301833|222110|P2|COMPLETED|Overall Study||72
92991|NCT01301833|222111|P1|COMPLETED|Overall Study||197
92992|NCT01301833|222108|P4|STARTED|Overall Study||75
92993|NCT01301833|222109|P3|STARTED|Overall Study||95
92994|NCT01301833|222110|P2|STARTED|Overall Study||80
92995|NCT01301833|222111|P1|STARTED|Overall Study||212
92996|NCT01301742|222137|P2|NOT COMPLETED|Second Intervention||0
92997|NCT01301742|222138|P1|NOT COMPLETED|Second Intervention||0
92998|NCT01301742|222137|P2|COMPLETED|Second Intervention||9
92999|NCT01301742|222138|P1|COMPLETED|Second Intervention||9
93000|NCT01301742|222137|P2|STARTED|Second Intervention||9
93001|NCT01301742|222138|P1|STARTED|Second Intervention||9
93002|NCT01301742|222137|P2|NOT COMPLETED|Washout Period of at Least 7 Days||0
93003|NCT01301742|222138|P1|NOT COMPLETED|Washout Period of at Least 7 Days||0
93004|NCT01301742|222137|P2|COMPLETED|Washout Period of at Least 7 Days||9
93005|NCT01301742|222138|P1|COMPLETED|Washout Period of at Least 7 Days||9
93006|NCT01301742|222137|P2|STARTED|Washout Period of at Least 7 Days||9
93007|NCT01301742|222138|P1|STARTED|Washout Period of at Least 7 Days||9
93008|NCT01301742|222137|P2|NOT COMPLETED|First Intervention||0
93009|NCT01301742|222138|P1|NOT COMPLETED|First Intervention||0
93010|NCT01301742|222137|P2|COMPLETED|First Intervention||9
93011|NCT01301742|222138|P1|COMPLETED|First Intervention||9
93012|NCT01301742|222137|P2|STARTED|First Intervention||9
93013|NCT01301742|222138|P1|STARTED|First Intervention||9
93014|NCT01301729|222149|P1|NOT COMPLETED|Overall Study||4
93015|NCT01301729|222149|P1|COMPLETED|Overall Study||28
93016|NCT01301729|222149|P1|STARTED|Overall Study||32
93017|NCT01301508|222162|P2|NOT COMPLETED|Overall Study||3
93018|NCT01301508|222163|P1|NOT COMPLETED|Overall Study||1
93019|NCT01301508|222162|P2|COMPLETED|Overall Study||22
93020|NCT01301508|222163|P1|COMPLETED|Overall Study||20
93021|NCT01301508|222162|P2|STARTED|Overall Study||25
93022|NCT01301508|222163|P1|STARTED|Overall Study||21
93023|NCT01301274|222183|P2|NOT COMPLETED|Overall Study||1
93024|NCT01301274|222184|P1|NOT COMPLETED|Overall Study||2
93025|NCT01301274|222183|P2|COMPLETED|Overall Study||31
93026|NCT01301274|222184|P1|COMPLETED|Overall Study||32
93027|NCT01301274|222183|P2|STARTED|Overall Study||32
93028|NCT01301274|222184|P1|STARTED|Overall Study||34
93029|NCT01301092|222199|P3|NOT COMPLETED|Overall Study||1
93030|NCT01301092|222200|P2|NOT COMPLETED|Overall Study||0
93031|NCT01301092|222201|P1|NOT COMPLETED|Overall Study||0
93032|NCT01301092|222199|P3|COMPLETED|Overall Study||7
93033|NCT01301092|222200|P2|COMPLETED|Overall Study||16
93034|NCT01301092|222201|P1|COMPLETED|Overall Study||6
93035|NCT01301092|222199|P3|STARTED|Overall Study||8
93036|NCT01301092|222200|P2|STARTED|Overall Study||16
93037|NCT01301092|222201|P1|STARTED|Overall Study||6
93038|NCT01301079|222218|P2|NOT COMPLETED|Overall Study||2
93039|NCT01301079|222219|P1|NOT COMPLETED|Overall Study||2
93040|NCT01301079|222218|P2|COMPLETED|Overall Study||28
93041|NCT01301079|222219|P1|COMPLETED|Overall Study||28
93042|NCT01301079|222218|P2|STARTED|Overall Study||30
93043|NCT01301079|222219|P1|STARTED|Overall Study||30
93044|NCT01301066|222297|P2|NOT COMPLETED|Overall Study||35
93045|NCT01301066|222298|P1|NOT COMPLETED|Overall Study||27
93046|NCT01301066|222297|P2|COMPLETED|Overall Study||91
93047|NCT01301066|222298|P1|COMPLETED|Overall Study||99
93048|NCT01301066|222297|P2|STARTED|Overall Study||126
93049|NCT01301066|222298|P1|STARTED|Overall Study||126
93050|NCT01301027|222306|P2|NOT COMPLETED|Overall Study||10
93051|NCT01301027|222307|P1|NOT COMPLETED|Overall Study||8
93052|NCT01301027|222306|P2|COMPLETED|Overall Study||37
93053|NCT01301027|222307|P1|COMPLETED|Overall Study||40
93054|NCT01301027|222306|P2|STARTED|Overall Study||47
93055|NCT01301027|222307|P1|STARTED|Overall Study||48
93056|NCT01300923|222319|P2|NOT COMPLETED|Overall Study||2
93057|NCT01300923|222320|P1|NOT COMPLETED|Overall Study||0
93058|NCT01300923|222319|P2|COMPLETED|Overall Study||0
93059|NCT01300923|222320|P1|COMPLETED|Overall Study||12
93060|NCT01300923|222319|P2|STARTED|Overall Study||2
93061|NCT01300923|222320|P1|STARTED|Overall Study||12
93062|NCT01300819|222333|P2|NOT COMPLETED|Overall Study||44
93063|NCT01300819|222334|P1|NOT COMPLETED|Overall Study||22
93064|NCT01300819|222333|P2|COMPLETED|Overall Study||180
93065|NCT01300819|222334|P1|COMPLETED|Overall Study||103
93066|NCT01300819|222333|P2|STARTED|Overall Study||224
93067|NCT01300819|222334|P1|STARTED|Overall Study||125
93068|NCT01300767|222362|P1|NOT COMPLETED|Overall Study||4
93069|NCT01300767|222362|P1|COMPLETED|Overall Study||70
93070|NCT01300767|222362|P1|STARTED|Overall Study||74
93071|NCT01300741|222390|P1|NOT COMPLETED|Overall Study||3
93072|NCT01300741|222390|P1|COMPLETED|Overall Study||72
93073|NCT01300741|222390|P1|STARTED|Overall Study||75
93074|NCT01300728|222420|P2|NOT COMPLETED|Overall Study||1
93075|NCT01300728|222421|P1|NOT COMPLETED|Overall Study||2
93076|NCT01300728|222420|P2|COMPLETED|Overall Study||25
93077|NCT01300728|222421|P1|COMPLETED|Overall Study||24
93078|NCT01300728|222420|P2|STARTED|Overall Study||26
93079|NCT01300728|222421|P1|STARTED|Overall Study||26
93080|NCT01300650|222435|P1|NOT COMPLETED|Overall Study||1
93081|NCT01300650|222435|P1|COMPLETED|Overall Study||7
93082|NCT01300650|222435|P1|STARTED|Overall Study||8
93083|NCT01300624|222441|P1|NOT COMPLETED|Overall Study||0
93084|NCT01300624|222441|P1|COMPLETED|Overall Study||11
93085|NCT01300624|222441|P1|STARTED|Overall Study||11
93086|NCT01300559|222453|P2|NOT COMPLETED|Overall Study||0
93087|NCT01300559|222454|P1|NOT COMPLETED|Overall Study||0
93088|NCT01300559|222453|P2|COMPLETED|Overall Study||30
93089|NCT01300559|222454|P1|COMPLETED|Overall Study||30
93090|NCT01300559|222453|P2|STARTED|Overall Study||30
93091|NCT01300559|222454|P1|STARTED|Overall Study||30
93092|NCT01300546|222462|P2|NOT COMPLETED|Overall Study||6
93093|NCT01300546|222463|P1|NOT COMPLETED|Overall Study||1
93094|NCT01300546|222462|P2|COMPLETED|Overall Study||14
93095|NCT01300546|222463|P1|COMPLETED|Overall Study||18
93096|NCT01300546|222462|P2|STARTED|Overall Study||20
93097|NCT01300546|222463|P1|STARTED|Overall Study||19
93098|NCT01300455|222493|P2|NOT COMPLETED|Period 2||0
93099|NCT01300455|222494|P1|NOT COMPLETED|Period 2||0
93100|NCT01300455|222493|P2|COMPLETED|Period 2||13
93101|NCT01300455|222494|P1|COMPLETED|Period 2||12
93102|NCT01300455|222493|P2|STARTED|Period 2||13
93103|NCT01300455|222494|P1|STARTED|Period 2||12
93104|NCT01300455|222493|P2|NOT COMPLETED|Washout||0
93105|NCT01300455|222494|P1|NOT COMPLETED|Washout||1
93106|NCT01300455|222493|P2|COMPLETED|Washout||13
93107|NCT01300455|222494|P1|COMPLETED|Washout||12
93108|NCT01300455|222493|P2|STARTED|Washout||13
93109|NCT01300455|222494|P1|STARTED|Washout||13
93110|NCT01300455|222493|P2|NOT COMPLETED|Period 1||0
93111|NCT01300455|222494|P1|NOT COMPLETED|Period 1||0
93112|NCT01300455|222493|P2|COMPLETED|Period 1||13
93113|NCT01300455|222494|P1|COMPLETED|Period 1||13
93114|NCT01300455|222493|P2|STARTED|Period 1||13
93115|NCT01300455|222494|P1|STARTED|Period 1||13
93116|NCT01300351|222514|P2|NOT COMPLETED|Overall Study||38
93117|NCT01300351|222515|P1|NOT COMPLETED|Overall Study||36
93118|NCT01300351|222514|P2|COMPLETED|Overall Study||72
93119|NCT01300351|222515|P1|COMPLETED|Overall Study||75
93120|NCT01300351|222514|P2|Received Study Treatment|Overall Study||110
93121|NCT01300351|222515|P1|Received Study Treatment|Overall Study||109
93122|NCT01300351|222514|P2|STARTED|Overall Study||110
93123|NCT01300351|222515|P1|STARTED|Overall Study||111
93124|NCT01300338|222531|P2|NOT COMPLETED|Overall Study||0
93125|NCT01300338|222532|P1|NOT COMPLETED|Overall Study||5
93126|NCT01300338|222531|P2|COMPLETED|Overall Study||25
93127|NCT01300338|222532|P1|COMPLETED|Overall Study||20
93128|NCT01300338|222531|P2|STARTED|Overall Study||25
93129|NCT01300338|222532|P1|STARTED|Overall Study||25
93130|NCT01300286|222540|P1|NOT COMPLETED|Overall Study||1
93131|NCT01300286|222540|P1|COMPLETED|Overall Study||22
93132|NCT01300286|222540|P1|STARTED|Overall Study||23
93133|NCT01300260|222550|P2|NOT COMPLETED|Period 2 of Study: Second Intervention||1
93134|NCT01300260|222551|P1|NOT COMPLETED|Period 2 of Study: Second Intervention||0
93226|NCT01299454|222789|P2|STARTED|Overall Study||8
93135|NCT01300260|222550|P2|COMPLETED|Period 2 of Study: Second Intervention||15
93136|NCT01300260|222551|P1|COMPLETED|Period 2 of Study: Second Intervention||14
93137|NCT01300260|222550|P2|STARTED|Period 2 of Study: Second Intervention||16
93138|NCT01300260|222551|P1|STARTED|Period 2 of Study: Second Intervention||14
93139|NCT01300260|222550|P2|NOT COMPLETED|Washout Period of at Least 28 Days||0
93140|NCT01300260|222551|P1|NOT COMPLETED|Washout Period of at Least 28 Days||0
93141|NCT01300260|222550|P2|COMPLETED|Washout Period of at Least 28 Days||16
93142|NCT01300260|222551|P1|COMPLETED|Washout Period of at Least 28 Days||14
93143|NCT01300260|222550|P2|STARTED|Washout Period of at Least 28 Days||16
93144|NCT01300260|222551|P1|STARTED|Washout Period of at Least 28 Days||14
93145|NCT01300260|222550|P2|NOT COMPLETED|Period 1 of Study: First Intervention||1
93146|NCT01300260|222551|P1|NOT COMPLETED|Period 1 of Study: First Intervention||1
93147|NCT01300260|222550|P2|COMPLETED|Period 1 of Study: First Intervention||16
93148|NCT01300260|222551|P1|COMPLETED|Period 1 of Study: First Intervention||14
93149|NCT01300260|222550|P2|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||17
93150|NCT01300260|222551|P1|Received at Least 1 Dose of Study Drug|Period 1 of Study: First Intervention||15
93151|NCT01300260|222550|P2|STARTED|Period 1 of Study: First Intervention||17
93152|NCT01300260|222551|P1|STARTED|Period 1 of Study: First Intervention||15
93153|NCT01300247|222583|P2|NOT COMPLETED|Overall Study||2
93154|NCT01300247|222584|P1|NOT COMPLETED|Overall Study||4
93155|NCT01300247|222583|P2|COMPLETED|Overall Study||18
93156|NCT01300247|222584|P1|COMPLETED|Overall Study||17
93157|NCT01300247|222583|P2|STARTED|Overall Study||20
93158|NCT01300247|222584|P1|STARTED|Overall Study||21
93159|NCT01300234|222616|P2|NOT COMPLETED|Overall Study||10
93160|NCT01300234|222617|P1|NOT COMPLETED|Overall Study||4
93161|NCT01300234|222616|P2|COMPLETED|Overall Study||245
93162|NCT01300234|222617|P1|COMPLETED|Overall Study||253
93163|NCT01300234|222616|P2|STARTED|Overall Study||255
93164|NCT01300234|222617|P1|STARTED|Overall Study||257
93165|NCT01300052|222649|P2|NOT COMPLETED|Overall Study||3
93166|NCT01300052|222650|P1|NOT COMPLETED|Overall Study||6
93167|NCT01300052|222649|P2|COMPLETED|Overall Study||19
93168|NCT01300052|222650|P1|COMPLETED|Overall Study||40
93169|NCT01300052|222649|P2|STARTED|Overall Study||22
93170|NCT01300052|222650|P1|STARTED|Overall Study||46
93171|NCT01299961|222668|P1|NOT COMPLETED|Overall Study||6
93172|NCT01299961|222668|P1|COMPLETED|Overall Study||19
93173|NCT01299961|222668|P1|STARTED|Overall Study||25
93174|NCT01299909|222677|P3|NOT COMPLETED|Overall Study||17
93175|NCT01299909|222678|P2|NOT COMPLETED|Overall Study||18
93176|NCT01299909|222679|P1|NOT COMPLETED|Overall Study||22
93177|NCT01299909|222677|P3|COMPLETED|Overall Study||23
93178|NCT01299909|222678|P2|COMPLETED|Overall Study||49
93179|NCT01299909|222679|P1|COMPLETED|Overall Study||46
93180|NCT01299909|222677|P3|STARTED|Overall Study||40
93181|NCT01299909|222678|P2|STARTED|Overall Study||67
93182|NCT01299909|222679|P1|STARTED|Overall Study||68
93183|NCT01299896|222688|P2|NOT COMPLETED|Overall Study||18
93184|NCT01299896|222689|P1|NOT COMPLETED|Overall Study||1
93185|NCT01299896|222688|P2|COMPLETED|Overall Study||296
93186|NCT01299896|222689|P1|COMPLETED|Overall Study||318
93187|NCT01299896|222688|P2|STARTED|Overall Study||314
93188|NCT01299896|222689|P1|STARTED|Overall Study||319
93189|NCT01299805|222697|P2|NOT COMPLETED|Overall Study||0
93190|NCT01299805|222698|P1|NOT COMPLETED|Overall Study||2
93191|NCT01299805|222697|P2|COMPLETED|Overall Study||5
93192|NCT01299805|222698|P1|COMPLETED|Overall Study||10
93193|NCT01299805|222697|P2|STARTED|Overall Study||5
93194|NCT01299805|222698|P1|STARTED|Overall Study||12
93195|NCT01299584|222726|P1|NOT COMPLETED|Overall Study||9
93196|NCT01299584|222726|P1|COMPLETED|Overall Study||766
93197|NCT01299584|222726|P1|STARTED|Overall Study||775
93198|NCT01299571|222733|P1|NOT COMPLETED|Overall Study||107
93199|NCT01299571|222733|P1|COMPLETED|Overall Study||3870
93200|NCT01299571|222733|P1|STARTED|Overall Study||3977
93201|NCT01299480|222744|P5|NOT COMPLETED|Overall Study||20
93202|NCT01299480|222745|P4|NOT COMPLETED|Overall Study||25
93203|NCT01299480|222746|P3|NOT COMPLETED|Overall Study||41
93204|NCT01299480|222747|P2|NOT COMPLETED|Overall Study||35
93205|NCT01299480|222748|P1|NOT COMPLETED|Overall Study||42
93206|NCT01299480|222744|P5|COMPLETED|Overall Study||123
93207|NCT01299480|222745|P4|COMPLETED|Overall Study||261
93208|NCT01299480|222746|P3|COMPLETED|Overall Study||386
93209|NCT01299480|222747|P2|COMPLETED|Overall Study||395
93210|NCT01299480|222748|P1|COMPLETED|Overall Study||385
93211|NCT01299480|222744|P5|STARTED|Overall Study||143
93212|NCT01299480|222745|P4|STARTED|Overall Study||286
93213|NCT01299480|222746|P3|STARTED|Overall Study||427
93214|NCT01299480|222747|P2|STARTED|Overall Study||430
93215|NCT01299480|222748|P1|STARTED|Overall Study||427
93216|NCT01299454|222787|P4|NOT COMPLETED|Overall Study||0
93217|NCT01299454|222788|P3|NOT COMPLETED|Overall Study||0
93218|NCT01299454|222789|P2|NOT COMPLETED|Overall Study||0
93219|NCT01299454|222790|P1|NOT COMPLETED|Overall Study||0
93220|NCT01299454|222787|P4|COMPLETED|Overall Study||23
93221|NCT01299454|222788|P3|COMPLETED|Overall Study||6
93222|NCT01299454|222789|P2|COMPLETED|Overall Study||8
93223|NCT01299454|222790|P1|COMPLETED|Overall Study||8
93224|NCT01299454|222787|P4|STARTED|Overall Study||23
93225|NCT01299454|222788|P3|STARTED|Overall Study||6
93227|NCT01299454|222790|P1|STARTED|Overall Study||8
93228|NCT01299389|222950|P4|NOT COMPLETED|Post-observational||6
93229|NCT01299389|222951|P3|NOT COMPLETED|Post-observational||12
93230|NCT01299389|222952|P2|NOT COMPLETED|Post-observational||0
93231|NCT01299389|222953|P1|NOT COMPLETED|Post-observational||0
93232|NCT01299389|222950|P4|COMPLETED|Post-observational||149
93233|NCT01299389|222951|P3|COMPLETED|Post-observational||144
93234|NCT01299389|222952|P2|COMPLETED|Post-observational||0
93235|NCT01299389|222953|P1|COMPLETED|Post-observational||0
93236|NCT01299389|222950|P4|STARTED|Post-observational||155
93237|NCT01299389|222951|P3|STARTED|Post-observational||156
93238|NCT01299389|222952|P2|STARTED|Post-observational||0
93239|NCT01299389|222953|P1|STARTED|Post-observational||0
93240|NCT01299389|222950|P4|NOT COMPLETED|Double-blind||0
93241|NCT01299389|222951|P3|NOT COMPLETED|Double-blind||0
93242|NCT01299389|222952|P2|NOT COMPLETED|Double-blind||64
93243|NCT01299389|222953|P1|NOT COMPLETED|Double-blind||109
93244|NCT01299389|222950|P4|COMPLETED|Double-blind||0
93245|NCT01299389|222951|P3|COMPLETED|Double-blind||0
93246|NCT01299389|222952|P2|COMPLETED|Double-blind||95
93247|NCT01299389|222953|P1|COMPLETED|Double-blind||55
93248|NCT01299389|222950|P4|STARTED|Double-blind||0
93249|NCT01299389|222951|P3|STARTED|Double-blind||0
93250|NCT01299389|222952|P2|STARTED|Double-blind||159
93251|NCT01299389|222953|P1|STARTED|Double-blind||164
93252|NCT01299376|222975|P2|NOT COMPLETED|Extension (Weeks 9 to 52)||15
93253|NCT01299376|222976|P1|NOT COMPLETED|Extension (Weeks 9 to 52)||10
93254|NCT01299376|222975|P2|COMPLETED|Extension (Weeks 9 to 52)||118
93255|NCT01299376|222976|P1|COMPLETED|Extension (Weeks 9 to 52)||124
93256|NCT01299376|222975|P2|STARTED|Extension (Weeks 9 to 52)||133
93257|NCT01299376|222976|P1|STARTED|Extension (Weeks 9 to 52)||134
93258|NCT01299376|222975|P2|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||12
93259|NCT01299376|222976|P1|NOT COMPLETED|Double-blind Treatment (Weeks 1 to 8)||7
93260|NCT01299376|222975|P2|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||133
93261|NCT01299376|222976|P1|COMPLETED|Double-blind Treatment (Weeks 1 to 8)||134
93262|NCT01299376|222975|P2|STARTED|Double-blind Treatment (Weeks 1 to 8)||145
93263|NCT01299376|222976|P1|STARTED|Double-blind Treatment (Weeks 1 to 8)||141
93264|NCT01299285|223006|P1|NOT COMPLETED|Overall Study||0
93265|NCT01299285|223006|P1|COMPLETED|Overall Study||6
93266|NCT01299285|223006|P1|STARTED|Overall Study||6
93267|NCT01299103|223022|P3|NOT COMPLETED|Overall Study||2
93268|NCT01299103|223023|P2|NOT COMPLETED|Overall Study||2
93269|NCT01299103|223024|P1|NOT COMPLETED|Overall Study||0
93270|NCT01299103|223022|P3|COMPLETED|Overall Study||8
93271|NCT01299103|223023|P2|COMPLETED|Overall Study||13
93272|NCT01299103|223024|P1|COMPLETED|Overall Study||15
93273|NCT01299103|223022|P3|STARTED|Overall Study||10
93274|NCT01299103|223023|P2|STARTED|Overall Study||15
93275|NCT01299103|223024|P1|STARTED|Overall Study||15
93276|NCT01299090|223035|P1|NOT COMPLETED|Overall Study||0
93277|NCT01299090|223035|P1|COMPLETED|Overall Study||49
93278|NCT01299090|223035|P1|STARTED|Overall Study||49
93279|NCT01299077|223040|P1|NOT COMPLETED|Overall Study||0
93280|NCT01299077|223040|P1|COMPLETED|Overall Study||478
93281|NCT01299077|223040|P1|STARTED|Overall Study||478
93282|NCT01299025|223050|P2|NOT COMPLETED|Overall Study||1
93283|NCT01299025|223051|P1|NOT COMPLETED|Overall Study||3
93284|NCT01299025|223050|P2|COMPLETED|Overall Study||41
93285|NCT01299025|223051|P1|COMPLETED|Overall Study||39
93286|NCT01299025|223050|P2|STARTED|Overall Study||42
93287|NCT01299025|223051|P1|STARTED|Overall Study||42
93288|NCT01298778|223065|P2|NOT COMPLETED|Overall Study||6
93289|NCT01298778|223066|P1|NOT COMPLETED|Overall Study||3
93290|NCT01298778|223065|P2|COMPLETED|Overall Study||30
93291|NCT01298778|223066|P1|COMPLETED|Overall Study||30
93292|NCT01298778|223065|P2|STARTED|Overall Study||36
93293|NCT01298778|223066|P1|STARTED|Overall Study||33
93294|NCT01298661|223089|P3|NOT COMPLETED|Overall Study||2
93295|NCT01298661|223090|P2|NOT COMPLETED|Overall Study||0
93296|NCT01298661|223091|P1|NOT COMPLETED|Overall Study||2
93297|NCT01298661|223089|P3|COMPLETED|Overall Study||32
93298|NCT01298661|223090|P2|COMPLETED|Overall Study||24
93299|NCT01298661|223091|P1|COMPLETED|Overall Study||31
93300|NCT01298661|223089|P3|STARTED|Overall Study||34
93301|NCT01298661|223090|P2|STARTED|Overall Study||24
93302|NCT01298661|223091|P1|STARTED|Overall Study||33
93303|NCT01298648|223169|P1|NOT COMPLETED|Overall Study||23
93304|NCT01298648|223169|P1|COMPLETED|Overall Study||1693
93305|NCT01298648|223169|P1|STARTED|Overall Study||1716
93306|NCT01298544|223178|P1|NOT COMPLETED|Overall Study||0
93307|NCT01298544|223178|P1|COMPLETED|Overall Study||335
93308|NCT01298544|223178|P1|STARTED|Overall Study||335
93309|NCT01298531|223189|P2|NOT COMPLETED|Overall Study||7
93310|NCT01298531|223190|P1|NOT COMPLETED|Overall Study||9
93311|NCT01298531|223189|P2|COMPLETED|Overall Study||41
93312|NCT01298531|223190|P1|COMPLETED|Overall Study||33
93313|NCT01298531|223189|P2|STARTED|Overall Study||48
93314|NCT01298531|223190|P1|STARTED|Overall Study||42
93315|NCT01298518|223319|P3|NOT COMPLETED|Overall Study||1
93316|NCT01298518|223320|P2|NOT COMPLETED|Overall Study||0
93317|NCT01298518|223321|P1|NOT COMPLETED|Overall Study||0
93318|NCT01298518|223319|P3|COMPLETED|Overall Study||15
93319|NCT01298518|223320|P2|COMPLETED|Overall Study||16
93320|NCT01298518|223321|P1|COMPLETED|Overall Study||16
93321|NCT01298518|223319|P3|STARTED|Overall Study||16
93322|NCT01298518|223320|P2|STARTED|Overall Study||16
93323|NCT01298518|223321|P1|STARTED|Overall Study||16
93324|NCT01298492|223373|P1|NOT COMPLETED|Overall Study||119
93325|NCT01298492|223373|P1|COMPLETED|Overall Study||149
93326|NCT01298492|223373|P1|STARTED|Overall Study||268
93327|NCT01298362|223381|P2|NOT COMPLETED|Overall Study||43
93328|NCT01298362|223382|P1|NOT COMPLETED|Overall Study||38
93329|NCT01298362|223381|P2|COMPLETED|Overall Study||123
93330|NCT01298362|223382|P1|COMPLETED|Overall Study||86
93331|NCT01298362|223381|P2|STARTED|Overall Study||166
93332|NCT01298362|223382|P1|STARTED|Overall Study||124
93333|NCT01298323|223402|P2|NOT COMPLETED|Overall Study||88
93334|NCT01298323|223403|P1|NOT COMPLETED|Overall Study||86
93335|NCT01298323|223402|P2|COMPLETED|Overall Study||15
93336|NCT01298323|223403|P1|COMPLETED|Overall Study||16
93337|NCT01298323|223402|P2|Ongoing|Overall Study||55
93338|NCT01298323|223403|P1|Ongoing|Overall Study||55
93339|NCT01298323|223402|P2|STARTED|Overall Study||103
93340|NCT01298323|223403|P1|STARTED|Overall Study||102
93341|NCT01298167|223411|P2|NOT COMPLETED|Overall Study||0
93342|NCT01298167|223412|P1|NOT COMPLETED|Overall Study||1
93343|NCT01298167|223411|P2|COMPLETED|Overall Study||8
93344|NCT01298167|223412|P1|COMPLETED|Overall Study||5
93345|NCT01298167|223411|P2|STARTED|Overall Study||8
93346|NCT01298167|223412|P1|STARTED|Overall Study||6
93347|NCT01298128|223420|P2|NOT COMPLETED|Overall Study||8
93348|NCT01298128|223421|P1|NOT COMPLETED|Overall Study||9
93349|NCT01298128|223420|P2|COMPLETED|Overall Study||27
93350|NCT01298128|223421|P1|COMPLETED|Overall Study||26
93351|NCT01298128|223420|P2|STARTED|Overall Study||35
93352|NCT01298128|223421|P1|STARTED|Overall Study||35
93353|NCT01298063|223432|P5|NOT COMPLETED|Overall Study||0
93354|NCT01298063|223433|P4|NOT COMPLETED|Overall Study||0
93355|NCT01298063|223434|P3|NOT COMPLETED|Overall Study||0
93356|NCT01298063|223435|P2|NOT COMPLETED|Overall Study||0
93357|NCT01298063|223436|P1|NOT COMPLETED|Overall Study||0
93358|NCT01298063|223432|P5|COMPLETED|Overall Study||8
93359|NCT01298063|223433|P4|COMPLETED|Overall Study||8
93360|NCT01298063|223434|P3|COMPLETED|Overall Study||8
93361|NCT01298063|223435|P2|COMPLETED|Overall Study||3
93362|NCT01298063|223436|P1|COMPLETED|Overall Study||8
93363|NCT01298063|223432|P5|STARTED|Overall Study||8
93364|NCT01298063|223433|P4|STARTED|Overall Study||8
93365|NCT01298063|223434|P3|STARTED|Overall Study||8
93366|NCT01298063|223435|P2|STARTED|Overall Study||3
93367|NCT01298063|223436|P1|STARTED|Overall Study||8
93368|NCT01297920|223466|P3|NOT COMPLETED|Overall Study||57
93369|NCT01297920|223467|P2|NOT COMPLETED|Overall Study||27
93370|NCT01297920|223468|P1|NOT COMPLETED|Overall Study||58
93371|NCT01297920|223466|P3|COMPLETED|Overall Study||178
93372|NCT01297920|223467|P2|COMPLETED|Overall Study||207
93373|NCT01297920|223468|P1|COMPLETED|Overall Study||163
93374|NCT01297920|223466|P3|STARTED|Overall Study||235
93375|NCT01297920|223467|P2|STARTED|Overall Study||234
93376|NCT01297920|223468|P1|STARTED|Overall Study||221
93377|NCT01297595|223476|P2|NOT COMPLETED|Second Intervention Period||0
93378|NCT01297595|223477|P1|NOT COMPLETED|Second Intervention Period||0
93379|NCT01297595|223476|P2|COMPLETED|Second Intervention Period||11
93380|NCT01297595|223477|P1|COMPLETED|Second Intervention Period||11
93381|NCT01297595|223476|P2|STARTED|Second Intervention Period||11
93382|NCT01297595|223477|P1|STARTED|Second Intervention Period||11
93383|NCT01297595|223476|P2|NOT COMPLETED|Washout Period (At Least 14 Days)||0
93384|NCT01297595|223477|P1|NOT COMPLETED|Washout Period (At Least 14 Days)||0
93385|NCT01297595|223476|P2|COMPLETED|Washout Period (At Least 14 Days)||11
93386|NCT01297595|223477|P1|COMPLETED|Washout Period (At Least 14 Days)||11
93387|NCT01297595|223476|P2|STARTED|Washout Period (At Least 14 Days)||11
93388|NCT01297595|223477|P1|STARTED|Washout Period (At Least 14 Days)||11
93389|NCT01297595|223476|P2|NOT COMPLETED|First Intervention Period||0
93390|NCT01297595|223477|P1|NOT COMPLETED|First Intervention Period||0
93391|NCT01297595|223476|P2|COMPLETED|First Intervention Period||11
93392|NCT01297595|223477|P1|COMPLETED|First Intervention Period||11
93393|NCT01297595|223476|P2|STARTED|First Intervention Period||11
93394|NCT01297595|223477|P1|STARTED|First Intervention Period||11
93395|NCT01297517|223512|P3|NOT COMPLETED|Overall Study||27
93396|NCT01297517|223513|P2|NOT COMPLETED|Overall Study||12
93397|NCT01297517|223514|P1|NOT COMPLETED|Overall Study||27
93398|NCT01297517|223512|P3|COMPLETED|Overall Study||193
93399|NCT01297517|223513|P2|COMPLETED|Overall Study||214
93400|NCT01297517|223514|P1|COMPLETED|Overall Study||187
93401|NCT01297517|223512|P3|STARTED|Overall Study||220
93402|NCT01297517|223513|P2|STARTED|Overall Study||226
93403|NCT01297517|223514|P1|STARTED|Overall Study||214
93404|NCT01297504|223522|P1|NOT COMPLETED|Overall Study||67
93405|NCT01297504|223522|P1|COMPLETED|Overall Study||397
93406|NCT01297504|223522|P1|Participants Studied|Overall Study|Six participants were eliminated due to invalid consent, previous palivizumab or no study visits|458
93407|NCT01297504|223522|P1|STARTED|Overall Study||464
93408|NCT01297491|223536|P2|NOT COMPLETED|Overall Study||33
93409|NCT01297491|223537|P1|NOT COMPLETED|Overall Study||30
93410|NCT01297491|223536|P2|COMPLETED|Overall Study||0
93411|NCT01297491|223537|P1|COMPLETED|Overall Study||0
93412|NCT01297491|223536|P2|STARTED|Overall Study||33
93413|NCT01297491|223537|P1|STARTED|Overall Study||30
93414|NCT01297465|223555|P2|NOT COMPLETED|Overall Study||10
93415|NCT01297465|223556|P1|NOT COMPLETED|Overall Study||8
93416|NCT01297465|223555|P2|COMPLETED|Overall Study||93
93417|NCT01297465|223556|P1|COMPLETED|Overall Study||91
93418|NCT01297465|223555|P2|STARTED|Overall Study||103
93419|NCT01297465|223556|P1|STARTED|Overall Study||99
93420|NCT01297348|223590|P2|NOT COMPLETED|Overall Study||0
93421|NCT01297348|223591|P1|NOT COMPLETED|Overall Study||0
93422|NCT01297348|223590|P2|COMPLETED|Overall Study||586401
93423|NCT01297348|223591|P1|COMPLETED|Overall Study||12281
93424|NCT01297348|223590|P2|STARTED|Overall Study||586401
93425|NCT01297348|223591|P1|STARTED|Overall Study||12281
93426|NCT01297335|223601|P1|NOT COMPLETED|Overall Study||0
93427|NCT01297335|223601|P1|COMPLETED|Overall Study||10
93428|NCT01297335|223601|P1|STARTED|Overall Study||10
93429|NCT01297322|223609|P2|NOT COMPLETED|Overall Study||1
93430|NCT01297322|223610|P1|NOT COMPLETED|Overall Study||1
93431|NCT01297322|223609|P2|COMPLETED|Overall Study||274
93432|NCT01297322|223610|P1|COMPLETED|Overall Study||141
93433|NCT01297322|223609|P2|STARTED|Overall Study||275
93434|NCT01297322|223610|P1|STARTED|Overall Study||142
93435|NCT01297283|223630|P1|NOT COMPLETED|Overall Study||19
93436|NCT01297283|223630|P1|COMPLETED|Overall Study||176
93437|NCT01297283|223630|P1|STARTED|Overall Study||195
93438|NCT01297270|223638|P3|NOT COMPLETED|Overall Study||29
93439|NCT01297270|223639|P2|NOT COMPLETED|Overall Study||72
93440|NCT01297270|223640|P1|NOT COMPLETED|Overall Study||45
93441|NCT01297270|223638|P3|COMPLETED|Overall Study||103
93442|NCT01297270|223639|P2|COMPLETED|Overall Study||192
93443|NCT01297270|223640|P1|COMPLETED|Overall Study||217
93444|NCT01297270|223638|P3|STARTED|Overall Study||132
93445|NCT01297270|223639|P2|STARTED|Overall Study||264
93446|NCT01297270|223640|P1|STARTED|Overall Study||262
93447|NCT01297257|223678|P1|NOT COMPLETED|Overall Study||0
93448|NCT01297257|223678|P1|COMPLETED|Overall Study||7740
93449|NCT01297257|223678|P1|STARTED|Overall Study||7740
93450|NCT01297062|223689|P7|NOT COMPLETED|Overall Study||8
93451|NCT01297062|223690|P6|NOT COMPLETED|Overall Study||1
93452|NCT01297062|223691|P5|NOT COMPLETED|Overall Study||2
93453|NCT01297062|223692|P4|NOT COMPLETED|Overall Study||1
93454|NCT01297062|223693|P3|NOT COMPLETED|Overall Study||2
93455|NCT01297062|223694|P2|NOT COMPLETED|Overall Study||1
93456|NCT01297062|223695|P1|NOT COMPLETED|Overall Study||4
93457|NCT01297062|223689|P7|COMPLETED|Overall Study||0
93458|NCT01297062|223690|P6|COMPLETED|Overall Study||13
93459|NCT01297062|223691|P5|COMPLETED|Overall Study||13
93460|NCT01297062|223692|P4|COMPLETED|Overall Study||13
93461|NCT01297062|223693|P3|COMPLETED|Overall Study||12
93462|NCT01297062|223694|P2|COMPLETED|Overall Study||13
93463|NCT01297062|223695|P1|COMPLETED|Overall Study||11
93464|NCT01297062|223689|P7|Evaluable Population|Overall Study||0
93465|NCT01297062|223690|P6|Evaluable Population|Overall Study||13
93466|NCT01297062|223691|P5|Evaluable Population|Overall Study||13
93467|NCT01297062|223692|P4|Evaluable Population|Overall Study||13
93468|NCT01297062|223693|P3|Evaluable Population|Overall Study||12
93469|NCT01297062|223694|P2|Evaluable Population|Overall Study||12
93470|NCT01297062|223695|P1|Evaluable Population|Overall Study||11
93471|NCT01297062|223689|P7|Intent to Treat (ITT)|Overall Study||0
93472|NCT01297062|223690|P6|Intent to Treat (ITT)|Overall Study||14
93473|NCT01297062|223691|P5|Intent to Treat (ITT)|Overall Study||15
93474|NCT01297062|223692|P4|Intent to Treat (ITT)|Overall Study||14
93475|NCT01297062|223693|P3|Intent to Treat (ITT)|Overall Study||14
93476|NCT01297062|223694|P2|Intent to Treat (ITT)|Overall Study||14
93477|NCT01297062|223695|P1|Intent to Treat (ITT)|Overall Study||15
93478|NCT01297062|223689|P7|STARTED|Overall Study||8
93479|NCT01297062|223690|P6|STARTED|Overall Study||14
93480|NCT01297062|223691|P5|STARTED|Overall Study||15
93481|NCT01297062|223692|P4|STARTED|Overall Study||14
93482|NCT01297062|223693|P3|STARTED|Overall Study||14
93483|NCT01297062|223694|P2|STARTED|Overall Study||14
93484|NCT01297062|223695|P1|STARTED|Overall Study||15
93485|NCT01296841|223719|P2|NOT COMPLETED|Overall Study||0
93486|NCT01296841|223720|P1|NOT COMPLETED|Overall Study||0
93487|NCT01296841|223719|P2|COMPLETED|Overall Study||15
93488|NCT01296841|223720|P1|COMPLETED|Overall Study||19
93489|NCT01296841|223719|P2|STARTED|Overall Study||15
93490|NCT01296841|223720|P1|STARTED|Overall Study||19
93491|NCT01296815|223732|P2|NOT COMPLETED|Overall Study||0
93492|NCT01296815|223733|P1|NOT COMPLETED|Overall Study||0
93493|NCT01296815|223732|P2|COMPLETED|Overall Study||7
93494|NCT01296815|223733|P1|COMPLETED|Overall Study||7
93495|NCT01296815|223732|P2|STARTED|Overall Study||7
93496|NCT01296815|223733|P1|STARTED|Overall Study||7
93497|NCT01296763|223742|P3|NOT COMPLETED|Overall Study||0
93498|NCT01296763|223743|P2|NOT COMPLETED|Overall Study||0
93499|NCT01296763|223744|P1|NOT COMPLETED|Overall Study||0
93500|NCT01296763|223742|P3|COMPLETED|Overall Study||6
93501|NCT01296763|223743|P2|COMPLETED|Overall Study||5
93502|NCT01296763|223744|P1|COMPLETED|Overall Study||7
93503|NCT01296763|223742|P3|STARTED|Overall Study||6
93504|NCT01296763|223743|P2|STARTED|Overall Study||5
93505|NCT01296763|223744|P1|STARTED|Overall Study||7
93506|NCT01296698|223757|P2|NOT COMPLETED|Overall Study||13
93507|NCT01296698|223758|P1|NOT COMPLETED|Overall Study||244
93508|NCT01296698|223757|P2|COMPLETED|Overall Study||0
93509|NCT01296698|223758|P1|COMPLETED|Overall Study||0
93510|NCT01296698|223757|P2|STARTED|Overall Study||13
93511|NCT01296698|223758|P1|STARTED|Overall Study||244
93512|NCT01296646|223812|P2|NOT COMPLETED|Overall Study||11
93513|NCT01296646|223813|P1|NOT COMPLETED|Overall Study||11
93514|NCT01296646|223812|P2|COMPLETED|Overall Study||29
93515|NCT01296646|223813|P1|COMPLETED|Overall Study||29
93516|NCT01296646|223812|P2|STARTED|Overall Study||40
93517|NCT01296646|223813|P1|STARTED|Overall Study||40
93518|NCT01296412|223823|P2|NOT COMPLETED|Overall Study||70
93519|NCT01296412|223824|P1|NOT COMPLETED|Overall Study||51
93520|NCT01296412|223823|P2|COMPLETED|Overall Study||257
93521|NCT01296412|223824|P1|COMPLETED|Overall Study||275
93522|NCT01296412|223823|P2|STARTED|Overall Study||327
93523|NCT01296412|223824|P1|STARTED|Overall Study||326
93524|NCT01296360|223838|P2|NOT COMPLETED|Overall Study||8
93525|NCT01296360|223839|P1|NOT COMPLETED|Overall Study||6
93526|NCT01296360|223838|P2|COMPLETED|Overall Study||142
93527|NCT01296360|223839|P1|COMPLETED|Overall Study||144
93528|NCT01296360|223838|P2|Visit 2a (Month 13)|Overall Study||0
93529|NCT01296360|223839|P1|Visit 2a (Month 13)|Overall Study|visit in Booster Group only: ~13 months after immunization in IC51-323 (i.e., 1 month post booster)|148
93530|NCT01296360|223838|P2|Visit 2 (Month 12)|Overall Study||149
93531|NCT01296360|223839|P1|Visit 2 (Month 12)|Overall Study|booster was administered|148
93532|NCT01296360|223838|P2|STARTED|Overall Study||150
93533|NCT01296360|223839|P1|STARTED|Overall Study||150
93534|NCT01296347|223847|P2|NOT COMPLETED|Overall Study||5
93535|NCT01296347|223848|P1|NOT COMPLETED|Overall Study||0
93536|NCT01296347|223847|P2|COMPLETED|Overall Study||47
93537|NCT01296347|223848|P1|COMPLETED|Overall Study||52
93538|NCT01296347|223847|P2|6 Weeks Afer Surgery|Overall Study||47
93539|NCT01296347|223848|P1|6 Weeks Afer Surgery|Overall Study||52
93540|NCT01296347|223847|P2|STARTED|Overall Study||52
93541|NCT01296347|223848|P1|STARTED|Overall Study||52
93542|NCT01296152|223854|P1|NOT COMPLETED|Overall Study||1
93543|NCT01296152|223854|P1|COMPLETED|Overall Study||24
93544|NCT01296152|223854|P1|STARTED|Overall Study||25
93545|NCT01296035|223881|P1|NOT COMPLETED|Overall Study||1
93546|NCT01296035|223881|P1|COMPLETED|Overall Study||7
93547|NCT01296035|223881|P1|STARTED|Overall Study||8
93548|NCT01295905|223888|P2|NOT COMPLETED|Overall Study||0
93549|NCT01295905|223889|P1|NOT COMPLETED|Overall Study||2
93550|NCT01295905|223888|P2|COMPLETED|Overall Study||30
93551|NCT01295905|223889|P1|COMPLETED|Overall Study||58
93552|NCT01295905|223888|P2|STARTED|Overall Study||30
93553|NCT01295905|223889|P1|STARTED|Overall Study||60
93554|NCT01295879|223901|P1|NOT COMPLETED|Overall Study||0
93555|NCT01295879|223901|P1|COMPLETED|Overall Study||29
93556|NCT01295879|223901|P1|STARTED|Overall Study||29
93557|NCT01295840|223907|P1|NOT COMPLETED|Overall Study||1
93558|NCT01295840|223907|P1|COMPLETED|Overall Study||50
93559|NCT01295840|223907|P1|STARTED|Overall Study||51
93560|NCT01295814|223923|P2|NOT COMPLETED|Overall Study||2
93561|NCT01295814|223924|P1|NOT COMPLETED|Overall Study||2
93562|NCT01295814|223923|P2|COMPLETED|Overall Study||19
93563|NCT01295814|223924|P1|COMPLETED|Overall Study||20
93564|NCT01295814|223923|P2|STARTED|Overall Study||21
93565|NCT01295814|223924|P1|STARTED|Overall Study||22
93566|NCT01295281|223940|P2|NOT COMPLETED|Second Intervention (7days)||0
93567|NCT01295281|223941|P1|NOT COMPLETED|Second Intervention (7days)||0
93568|NCT01295281|223940|P2|COMPLETED|Second Intervention (7days)||51
93569|NCT01295281|223941|P1|COMPLETED|Second Intervention (7days)||53
93570|NCT01295281|223940|P2|STARTED|Second Intervention (7days)||51
93571|NCT01295281|223941|P1|STARTED|Second Intervention (7days)||53
93572|NCT01295281|223940|P2|NOT COMPLETED|First Intervention (7 Days)||1
93573|NCT01295281|223941|P1|NOT COMPLETED|First Intervention (7 Days)||0
93574|NCT01295281|223940|P2|COMPLETED|First Intervention (7 Days)||51
93575|NCT01295281|223941|P1|COMPLETED|First Intervention (7 Days)||53
93576|NCT01295281|223940|P2|STARTED|First Intervention (7 Days)||52
93577|NCT01295281|223941|P1|STARTED|First Intervention (7 Days)||53
93578|NCT01295216|223949|P2|NOT COMPLETED|Overall Study||34
93579|NCT01295216|223950|P1|NOT COMPLETED|Overall Study||50
93580|NCT01295216|223949|P2|COMPLETED|Overall Study||287
93581|NCT01295216|223950|P1|COMPLETED|Overall Study||266
93582|NCT01295216|223949|P2|STARTED|Overall Study||321
93583|NCT01295216|223950|P1|STARTED|Overall Study||316
93584|NCT01295034|223968|P2|NOT COMPLETED|Overall Study||5
93585|NCT01295034|223969|P1|NOT COMPLETED|Overall Study||5
93586|NCT01295034|223968|P2|COMPLETED|Overall Study||25
93587|NCT01295034|223969|P1|COMPLETED|Overall Study||27
93588|NCT01295034|223968|P2|STARTED|Overall Study||30
93589|NCT01295034|223969|P1|STARTED|Overall Study||32
93590|NCT01294917|223977|P1|NOT COMPLETED|Overall Study||6
93591|NCT01294917|223977|P1|COMPLETED|Overall Study||36
93592|NCT01294917|223977|P1|Received OptiFree RepleniSH MPS|Overall Study||36
93593|NCT01294917|223977|P1|Received Clear Care|Overall Study||36
93594|NCT01294917|223977|P1|Received Investigational MPS|Overall Study||36
93595|NCT01294917|223977|P1|STARTED|Overall Study||42
93596|NCT01294800|223987|P4|NOT COMPLETED|Overall Study||16
93597|NCT01294800|223988|P3|NOT COMPLETED|Overall Study||17
93598|NCT01294800|223989|P2|NOT COMPLETED|Overall Study||10
93599|NCT01294800|223990|P1|NOT COMPLETED|Overall Study||11
93600|NCT01294800|223987|P4|COMPLETED|Overall Study||97
93601|NCT01294800|223988|P3|COMPLETED|Overall Study||96
93602|NCT01294800|223989|P2|COMPLETED|Overall Study||103
93603|NCT01294800|223990|P1|COMPLETED|Overall Study||100
93604|NCT01294800|223987|P4|STARTED|Overall Study||113
93605|NCT01294800|223988|P3|STARTED|Overall Study||113
93606|NCT01294800|223989|P2|STARTED|Overall Study||113
93607|NCT01294800|223990|P1|STARTED|Overall Study||111
93608|NCT01294787|224016|P6|NOT COMPLETED|Period 3||0
93609|NCT01294787|224017|P5|NOT COMPLETED|Period 3||1
93610|NCT01294787|224018|P4|NOT COMPLETED|Period 3||0
93611|NCT01294787|224019|P3|NOT COMPLETED|Period 3||0
93612|NCT01294787|224020|P2|NOT COMPLETED|Period 3||0
93613|NCT01294787|224021|P1|NOT COMPLETED|Period 3||0
93614|NCT01294787|224016|P6|COMPLETED|Period 3||13
93615|NCT01294787|224017|P5|COMPLETED|Period 3||13
93616|NCT01294787|224018|P4|COMPLETED|Period 3||9
93617|NCT01294787|224019|P3|COMPLETED|Period 3||13
93618|NCT01294787|224020|P2|COMPLETED|Period 3||13
93619|NCT01294787|224021|P1|COMPLETED|Period 3||12
93620|NCT01294787|224016|P6|STARTED|Period 3||13
93621|NCT01294787|224017|P5|STARTED|Period 3||14
93622|NCT01294787|224018|P4|STARTED|Period 3||9
93623|NCT01294787|224019|P3|STARTED|Period 3||13
93624|NCT01294787|224020|P2|STARTED|Period 3||13
93625|NCT01294787|224021|P1|STARTED|Period 3||12
93626|NCT01294787|224016|P6|NOT COMPLETED|Period 2||0
93627|NCT01294787|224017|P5|NOT COMPLETED|Period 2||0
93628|NCT01294787|224018|P4|NOT COMPLETED|Period 2||2
93629|NCT01294787|224019|P3|NOT COMPLETED|Period 2||0
93630|NCT01294787|224020|P2|NOT COMPLETED|Period 2||3
93631|NCT01294787|224021|P1|NOT COMPLETED|Period 2||0
93632|NCT01294787|224016|P6|COMPLETED|Period 2||13
93633|NCT01294787|224017|P5|COMPLETED|Period 2||14
93634|NCT01294787|224018|P4|COMPLETED|Period 2||9
93635|NCT01294787|224019|P3|COMPLETED|Period 2||13
93636|NCT01294787|224020|P2|COMPLETED|Period 2||13
93637|NCT01294787|224021|P1|COMPLETED|Period 2||12
93638|NCT01294787|224016|P6|STARTED|Period 2||13
93639|NCT01294787|224017|P5|STARTED|Period 2||14
93640|NCT01294787|224018|P4|STARTED|Period 2||11
93641|NCT01294787|224019|P3|STARTED|Period 2||13
93642|NCT01294787|224020|P2|STARTED|Period 2||16
93643|NCT01294787|224021|P1|STARTED|Period 2||12
93644|NCT01294787|224016|P6|NOT COMPLETED|Period 1||2
93645|NCT01294787|224017|P5|NOT COMPLETED|Period 1||2
93646|NCT01294787|224018|P4|NOT COMPLETED|Period 1||1
93647|NCT01294787|224019|P3|NOT COMPLETED|Period 1||1
93648|NCT01294787|224020|P2|NOT COMPLETED|Period 1||0
93649|NCT01294787|224021|P1|NOT COMPLETED|Period 1||0
93650|NCT01294787|224016|P6|COMPLETED|Period 1||13
93651|NCT01294787|224017|P5|COMPLETED|Period 1||14
93652|NCT01294787|224018|P4|COMPLETED|Period 1||11
93653|NCT01294787|224019|P3|COMPLETED|Period 1||13
93654|NCT01294787|224020|P2|COMPLETED|Period 1||16
93655|NCT01294787|224021|P1|COMPLETED|Period 1||12
93656|NCT01294787|224016|P6|STARTED|Period 1|One randomized participant did not receive study drug|15
93657|NCT01294787|224017|P5|STARTED|Period 1||16
93658|NCT01294787|224018|P4|STARTED|Period 1||12
93659|NCT01294787|224019|P3|STARTED|Period 1||14
93660|NCT01294787|224020|P2|STARTED|Period 1||16
93661|NCT01294787|224021|P1|STARTED|Period 1||12
93662|NCT01294748|224065|P2|NOT COMPLETED|Overall Study||2
93663|NCT01294748|224066|P1|NOT COMPLETED|Overall Study||5
93664|NCT01294748|224065|P2|COMPLETED|Overall Study|At 270 days|59
93665|NCT01294748|224066|P1|COMPLETED|Overall Study|At 270 days|118
93666|NCT01294748|224065|P2|STARTED|Overall Study||61
93667|NCT01294748|224066|P1|STARTED|Overall Study||123
93668|NCT01294709|224092|P2|NOT COMPLETED|Period 2||0
93669|NCT01294709|224093|P1|NOT COMPLETED|Period 2||1
93670|NCT01294709|224092|P2|COMPLETED|Period 2||31
93671|NCT01294709|224093|P1|COMPLETED|Period 2||28
93672|NCT01294709|224092|P2|STARTED|Period 2||31
93673|NCT01294709|224093|P1|STARTED|Period 2||29
93674|NCT01294709|224092|P2|NOT COMPLETED|Washout Period||1
93675|NCT01294709|224093|P1|NOT COMPLETED|Washout Period||1
93676|NCT01294709|224092|P2|COMPLETED|Washout Period||31
93677|NCT01294709|224093|P1|COMPLETED|Washout Period||29
93678|NCT01294709|224092|P2|STARTED|Washout Period||32
93679|NCT01294709|224093|P1|STARTED|Washout Period||30
93680|NCT01294709|224092|P2|NOT COMPLETED|Period 1||1
93681|NCT01294709|224093|P1|NOT COMPLETED|Period 1||1
93682|NCT01294709|224092|P2|COMPLETED|Period 1||32
93683|NCT01294709|224093|P1|COMPLETED|Period 1||30
93684|NCT01294709|224092|P2|STARTED|Period 1||33
93685|NCT01294709|224093|P1|STARTED|Period 1||31
93686|NCT01294696|224112|P1|NOT COMPLETED|Overall Study||74
93687|NCT01294696|224112|P1|COMPLETED|Overall Study||1187
93688|NCT01294696|224112|P1|STARTED|Overall Study||1261
93689|NCT01294683|224126|P2|NOT COMPLETED|Post Crossover (Period III)||32
93690|NCT01294683|224127|P1|NOT COMPLETED|Post Crossover (Period III)||33
93691|NCT01294683|224126|P2|COMPLETED|Post Crossover (Period III)||190
93692|NCT01294683|224127|P1|COMPLETED|Post Crossover (Period III)||199
93693|NCT01294683|224126|P2|STARTED|Post Crossover (Period III)||222
93694|NCT01294683|224127|P1|STARTED|Post Crossover (Period III)||232
93695|NCT01294683|224126|P2|NOT COMPLETED|Precrossover (Periods I/II)||266
93696|NCT01294683|224127|P1|NOT COMPLETED|Precrossover (Periods I/II)||257
93697|NCT01294683|224126|P2|COMPLETED|Precrossover (Periods I/II)||222
93698|NCT01294683|224127|P1|COMPLETED|Precrossover (Periods I/II)||232
93699|NCT01294683|224126|P2|Treated|Precrossover (Periods I/II)||486
93700|NCT01294683|224127|P1|Treated|Precrossover (Periods I/II)||486
93701|NCT01294683|224126|P2|STARTED|Precrossover (Periods I/II)||488
93702|NCT01294683|224127|P1|STARTED|Precrossover (Periods I/II)||489
93703|NCT01294644|224180|P3|NOT COMPLETED|Overall Study||14
93704|NCT01294644|224181|P2|NOT COMPLETED|Overall Study||10
93705|NCT01294644|224182|P1|NOT COMPLETED|Overall Study||10
93706|NCT01294644|224180|P3|COMPLETED|Overall Study||103
93707|NCT01294644|224181|P2|COMPLETED|Overall Study||112
93708|NCT01294644|224182|P1|COMPLETED|Overall Study||111
93709|NCT01294644|224180|P3|Received Treatment|Overall Study||114
93710|NCT01294644|224181|P2|Received Treatment|Overall Study||122
93711|NCT01294644|224182|P1|Received Treatment|Overall Study||118
93712|NCT01294644|224180|P3|STARTED|Overall Study||117
93713|NCT01294644|224181|P2|STARTED|Overall Study||122
93714|NCT01294644|224182|P1|STARTED|Overall Study||121
93715|NCT01294592|224213|P2|NOT COMPLETED|Overall Study||73
93716|NCT01294592|224214|P1|NOT COMPLETED|Overall Study||77
93717|NCT01294592|224213|P2|COMPLETED|Overall Study||300
93718|NCT01294592|224214|P1|COMPLETED|Overall Study||292
93719|NCT01294592|224213|P2|STARTED|Overall Study||373
93720|NCT01294592|224214|P1|STARTED|Overall Study||369
93721|NCT01294553|224242|P1|NOT COMPLETED|Overall Study||269
93722|NCT01294553|224242|P1|COMPLETED|Overall Study||713
93723|NCT01294553|224242|P1|STARTED|Overall Study||982
93724|NCT01294514|224248|P1|NOT COMPLETED|Overall Study||1
93725|NCT01294514|224248|P1|COMPLETED|Overall Study||26
93726|NCT01294514|224248|P1|STARTED|Overall Study||27
93727|NCT01294462|224258|P2|NOT COMPLETED|Overall Study||63
93728|NCT01294462|224259|P1|NOT COMPLETED|Overall Study||66
93729|NCT01294462|224258|P2|COMPLETED|Overall Study||337
93730|NCT01294462|224259|P1|COMPLETED|Overall Study||335
93731|NCT01294462|224258|P2|Received Randomized Treatment|Overall Study||380
93732|NCT01294462|224259|P1|Received Randomized Treatment|Overall Study||387
93733|NCT01294462|224258|P2|STARTED|Overall Study||400
93734|NCT01294462|224259|P1|STARTED|Overall Study||401
93735|NCT01294449|224273|P2|NOT COMPLETED|Overall Study||15
93736|NCT01294449|224274|P1|NOT COMPLETED|Overall Study||12
93737|NCT01294449|224273|P2|COMPLETED|Overall Study||237
93738|NCT01294449|224274|P1|COMPLETED|Overall Study||144
93739|NCT01294449|224273|P2|Consent to Registry|Overall Study||245
93740|NCT01294449|224274|P1|Consent to Registry|Overall Study||149
93741|NCT01294449|224273|P2|STARTED|Overall Study||252
93742|NCT01294449|224274|P1|STARTED|Overall Study||156
93743|NCT01294436|224282|P2|NOT COMPLETED|Overall Study||70
93744|NCT01294436|224283|P1|NOT COMPLETED|Overall Study||28
93745|NCT01294436|224282|P2|COMPLETED|Overall Study||409
93746|NCT01294436|224283|P1|COMPLETED|Overall Study||221
93747|NCT01294436|224282|P2|STARTED|Overall Study||479
93748|NCT01294436|224283|P1|STARTED|Overall Study||249
93749|NCT01294423|224318|P3|NOT COMPLETED|Overall Study||8
93750|NCT01294423|224319|P2|NOT COMPLETED|Overall Study||9
93751|NCT01294423|224320|P1|NOT COMPLETED|Overall Study||5
93752|NCT01294423|224318|P3|COMPLETED|Overall Study||79
93753|NCT01294423|224319|P2|COMPLETED|Overall Study||79
93754|NCT01294423|224320|P1|COMPLETED|Overall Study||81
93755|NCT01294423|224318|P3|STARTED|Overall Study||87
93756|NCT01294423|224319|P2|STARTED|Overall Study||88
93757|NCT01294423|224320|P1|STARTED|Overall Study||86
93758|NCT01294397|224334|P1|NOT COMPLETED|Overall Study||2
93759|NCT01294397|224334|P1|COMPLETED|Overall Study||17
93760|NCT01294397|224334|P1|STARTED|Overall Study||19
93761|NCT01294384|224347|P3|NOT COMPLETED|Overall Study||9
93762|NCT01294384|224348|P2|NOT COMPLETED|Overall Study||6
93763|NCT01294384|224349|P1|NOT COMPLETED|Overall Study||4
93764|NCT01294384|224347|P3|COMPLETED|Overall Study||95
93765|NCT01294384|224348|P2|COMPLETED|Overall Study||94
93766|NCT01294384|224349|P1|COMPLETED|Overall Study||97
93767|NCT01294384|224347|P3|STARTED|Overall Study||104
93768|NCT01294384|224348|P2|STARTED|Overall Study||100
93769|NCT01294384|224349|P1|STARTED|Overall Study||101
93770|NCT01294371|224378|P1|NOT COMPLETED|Overall Study||34
93771|NCT01294371|224378|P1|COMPLETED|Overall Study||357
93772|NCT01294371|224378|P1|Treated|Overall Study||390
93773|NCT01294371|224378|P1|STARTED|Overall Study||391
93774|NCT01294306|224388|P2|NOT COMPLETED|Overall Study||0
93775|NCT01294306|224389|P1|NOT COMPLETED|Overall Study||0
93776|NCT01294306|224388|P2|COMPLETED|Overall Study||35
93777|NCT01294306|224389|P1|COMPLETED|Overall Study||45
93778|NCT01294306|224388|P2|STARTED|Overall Study||35
93779|NCT01294306|224389|P1|STARTED|Overall Study||45
93780|NCT01294228|224403|P1|NOT COMPLETED|Overall Study||0
93781|NCT01294228|224403|P1|COMPLETED|Overall Study||1001
93782|NCT01294228|224403|P1|STARTED|Overall Study||1001
93783|NCT01294163|224410|P3|NOT COMPLETED|Overall Study||3
93784|NCT01294163|224411|P2|NOT COMPLETED|Overall Study||0
93785|NCT01294163|224412|P1|NOT COMPLETED|Overall Study||1
93786|NCT01294163|224410|P3|COMPLETED|Overall Study||163
93787|NCT01294163|224411|P2|COMPLETED|Overall Study||165
93788|NCT01294163|224412|P1|COMPLETED|Overall Study||177
93789|NCT01294163|224410|P3|STARTED|Overall Study||166
93790|NCT01294163|224411|P2|STARTED|Overall Study||165
93791|NCT01294163|224412|P1|STARTED|Overall Study||178
93792|NCT01294150|224423|P2|NOT COMPLETED|Overall Study||2
93793|NCT01294150|224424|P1|NOT COMPLETED|Overall Study||2
93794|NCT01294150|224423|P2|COMPLETED|Overall Study||64
93795|NCT01294150|224424|P1|COMPLETED|Overall Study||138
93796|NCT01294150|224423|P2|STARTED|Overall Study||66
93797|NCT01294150|224424|P1|STARTED|Overall Study||140
93798|NCT01294046|224433|P1|NOT COMPLETED|Overall Study||3
93799|NCT01294046|224433|P1|COMPLETED|Overall Study||0
93800|NCT01294046|224433|P1|STARTED|Overall Study||3
93801|NCT01293968|224448|P2|NOT COMPLETED|Overall Study||3
93802|NCT01293968|224449|P1|NOT COMPLETED|Overall Study||3
93803|NCT01293968|224448|P2|COMPLETED|Overall Study||14
93804|NCT01293968|224449|P1|COMPLETED|Overall Study||17
93805|NCT01293968|224448|P2|STARTED|Overall Study||17
93806|NCT01293968|224449|P1|STARTED|Overall Study||20
93807|NCT01293825|224455|P1|NOT COMPLETED|Overall Study||10
93808|NCT01293825|224455|P1|COMPLETED|Overall Study||20
93809|NCT01293825|224455|P1|STARTED|Overall Study||30
93810|NCT01293695|224469|P2|NOT COMPLETED|Overall Study||7
93811|NCT01293695|224470|P1|NOT COMPLETED|Overall Study||15
93812|NCT01293695|224469|P2|COMPLETED|Overall Study||87
93813|NCT01293695|224470|P1|COMPLETED|Overall Study||78
93814|NCT01293695|224469|P2|STARTED|Overall Study||94
93815|NCT01293695|224470|P1|STARTED|Overall Study||93
93816|NCT01293539|224484|P1|NOT COMPLETED|Overall Study||1
93817|NCT01293539|224484|P1|COMPLETED|Overall Study||9
93818|NCT01293539|224484|P1|STARTED|Overall Study||10
93819|NCT01293240|224488|P1|NOT COMPLETED|Overall Study||2
93820|NCT01293240|224488|P1|COMPLETED|Overall Study||115
93821|NCT01293240|224488|P1|STARTED|Overall Study||117
93822|NCT01293084|224503|P1|NOT COMPLETED|Overall Study||5
93823|NCT01293084|224503|P1|COMPLETED|Overall Study||12
93824|NCT01293084|224503|P1|STARTED|Overall Study||17
93825|NCT01293032|224515|P4|NOT COMPLETED|Treatment||1
93826|NCT01293032|224516|P3|NOT COMPLETED|Treatment||1
93827|NCT01293032|224517|P2|NOT COMPLETED|Treatment||5
93828|NCT01293032|224518|P1|NOT COMPLETED|Treatment||2
93829|NCT01293032|224515|P4|COMPLETED|Treatment||13
93830|NCT01293032|224516|P3|COMPLETED|Treatment||10
93831|NCT01293032|224517|P2|COMPLETED|Treatment||14
93832|NCT01293032|224518|P1|COMPLETED|Treatment||10
93833|NCT01293032|224515|P4|STARTED|Treatment||14
93834|NCT01293032|224516|P3|STARTED|Treatment||11
93835|NCT01293032|224517|P2|STARTED|Treatment|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|19
93836|NCT01293032|224518|P1|STARTED|Treatment||12
93837|NCT01293032|224515|P4|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
93838|NCT01293032|224516|P3|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||5
93839|NCT01293032|224517|P2|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
93840|NCT01293032|224518|P1|NOT COMPLETED|Recurrence Score(RS)Assigned/Randomized||0
93841|NCT01293032|224515|P4|COMPLETED|Recurrence Score(RS)Assigned/Randomized||14
93842|NCT01293032|224516|P3|COMPLETED|Recurrence Score(RS)Assigned/Randomized|2/5 subjects who refused Arm 2(chemo) were treated with Arm 1(hormonal) and evaluable for response.|11
93843|NCT01293032|224517|P2|COMPLETED|Recurrence Score(RS)Assigned/Randomized||17
93844|NCT01293032|224518|P1|COMPLETED|Recurrence Score(RS)Assigned/Randomized||12
93845|NCT01293032|224515|P4|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||14
93846|NCT01293032|224516|P3|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||16
93847|NCT01293032|224517|P2|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||17
93848|NCT01293032|224518|P1|Assigned/Randomized to Arm|Recurrence Score(RS)Assigned/Randomized||12
93849|NCT01293032|224515|P4|STARTED|Recurrence Score(RS)Assigned/Randomized||14
93850|NCT01293032|224516|P3|STARTED|Recurrence Score(RS)Assigned/Randomized||16
93851|NCT01293032|224517|P2|STARTED|Recurrence Score(RS)Assigned/Randomized||17
93852|NCT01293032|224518|P1|STARTED|Recurrence Score(RS)Assigned/Randomized||12
93853|NCT01293006|224529|P4|NOT COMPLETED|Period 2||0
93854|NCT01293006|224530|P3|NOT COMPLETED|Period 2||0
93855|NCT01293006|224531|P2|NOT COMPLETED|Period 2||0
93856|NCT01293006|224532|P1|NOT COMPLETED|Period 2||1
93857|NCT01293006|224529|P4|COMPLETED|Period 2||3
93858|NCT01293006|224530|P3|COMPLETED|Period 2||9
93859|NCT01293006|224531|P2|COMPLETED|Period 2||2
93860|NCT01293006|224532|P1|COMPLETED|Period 2||10
93861|NCT01293006|224529|P4|STARTED|Period 2||3
93862|NCT01293006|224530|P3|STARTED|Period 2||9
93863|NCT01293006|224531|P2|STARTED|Period 2||2
93864|NCT01293006|224532|P1|STARTED|Period 2||11
93865|NCT01293006|224529|P4|NOT COMPLETED|Washout||0
93866|NCT01293006|224530|P3|NOT COMPLETED|Washout||0
93867|NCT01293006|224531|P2|NOT COMPLETED|Washout||0
93868|NCT01293006|224532|P1|NOT COMPLETED|Washout||0
93869|NCT01293006|224529|P4|COMPLETED|Washout||3
93870|NCT01293006|224530|P3|COMPLETED|Washout||9
93871|NCT01293006|224531|P2|COMPLETED|Washout||2
93872|NCT01293006|224532|P1|COMPLETED|Washout||11
93873|NCT01293006|224529|P4|STARTED|Washout||3
93874|NCT01293006|224530|P3|STARTED|Washout||9
93875|NCT01293006|224531|P2|STARTED|Washout||2
93876|NCT01293006|224532|P1|STARTED|Washout||11
93877|NCT01293006|224529|P4|NOT COMPLETED|Period 1||0
93878|NCT01293006|224530|P3|NOT COMPLETED|Period 1||0
93879|NCT01293006|224531|P2|NOT COMPLETED|Period 1||0
93880|NCT01293006|224532|P1|NOT COMPLETED|Period 1||0
93881|NCT01293006|224529|P4|COMPLETED|Period 1||3
93882|NCT01293006|224530|P3|COMPLETED|Period 1||9
93883|NCT01293006|224531|P2|COMPLETED|Period 1||2
93884|NCT01293006|224532|P1|COMPLETED|Period 1||11
93885|NCT01293006|224529|P4|STARTED|Period 1||3
93886|NCT01293006|224530|P3|STARTED|Period 1||9
93887|NCT01293006|224531|P2|STARTED|Period 1||2
93888|NCT01293006|224532|P1|STARTED|Period 1||11
93889|NCT01292928|224553|P1|NOT COMPLETED|Overall Study||24
93890|NCT01292928|224553|P1|COMPLETED|Overall Study||275
93891|NCT01292928|224553|P1|Completed 12-Month Clinical Follow-up|Overall Study||266
93892|NCT01292928|224553|P1|STARTED|Overall Study||299
93893|NCT01292876|224570|P1|NOT COMPLETED|Overall Study||4
93894|NCT01292876|224570|P1|COMPLETED|Overall Study||13
93895|NCT01292876|224570|P1|STARTED|Overall Study||17
93896|NCT01292837|224576|P1|NOT COMPLETED|Overall Study||2
93897|NCT01292837|224576|P1|COMPLETED|Overall Study||11
93898|NCT01292837|224576|P1|STARTED|Overall Study||13
93899|NCT01292798|224585|P1|NOT COMPLETED|Overall Study||0
93900|NCT01292798|224585|P1|COMPLETED|Overall Study||43
93901|NCT01292798|224585|P1|Persistent DME After 3 Months|Overall Study|Subjects with persistent DME after 3 monthly injections of 0.5 mg of ranibizumab|29
93902|NCT01292798|224585|P1|STARTED|Overall Study||43
93903|NCT01292746|224591|P1|NOT COMPLETED|Overall Study||0
93904|NCT01292746|224591|P1|COMPLETED|Overall Study||14
93905|NCT01292746|224591|P1|STARTED|Overall Study||14
93906|NCT01292642|224595|P1|NOT COMPLETED|Overall Study||5
93907|NCT01292642|224595|P1|COMPLETED|Overall Study||7
93908|NCT01292642|224595|P1|STARTED|Overall Study||12
93909|NCT01292629|224603|P1|NOT COMPLETED|Overall Study||0
93910|NCT01292629|224603|P1|COMPLETED|Overall Study||125
93911|NCT01292629|224603|P1|STARTED|Overall Study||125
93912|NCT01292603|224613|P6|NOT COMPLETED|Part 2: Survival Follow-UP||13
93913|NCT01292603|224614|P5|NOT COMPLETED|Part 2: Survival Follow-UP||11
93914|NCT01292603|224615|P4|NOT COMPLETED|Part 2: Survival Follow-UP||0
93915|NCT01292603|224616|P3|NOT COMPLETED|Part 2: Survival Follow-UP||0
93916|NCT01292603|224617|P2|NOT COMPLETED|Part 2: Survival Follow-UP||0
93917|NCT01292603|224618|P1|NOT COMPLETED|Part 2: Survival Follow-UP||0
93918|NCT01292603|224613|P6|COMPLETED|Part 2: Survival Follow-UP||0
93919|NCT01292603|224614|P5|COMPLETED|Part 2: Survival Follow-UP||0
93920|NCT01292603|224615|P4|COMPLETED|Part 2: Survival Follow-UP||0
93921|NCT01292603|224616|P3|COMPLETED|Part 2: Survival Follow-UP||0
93922|NCT01292603|224617|P2|COMPLETED|Part 2: Survival Follow-UP||0
93923|NCT01292603|224618|P1|COMPLETED|Part 2: Survival Follow-UP||0
93924|NCT01292603|224613|P6|STARTED|Part 2: Survival Follow-UP||13
93925|NCT01292603|224614|P5|STARTED|Part 2: Survival Follow-UP||11
93926|NCT01292603|224615|P4|STARTED|Part 2: Survival Follow-UP||0
93927|NCT01292603|224616|P3|STARTED|Part 2: Survival Follow-UP||0
93928|NCT01292603|224617|P2|STARTED|Part 2: Survival Follow-UP||0
93929|NCT01292603|224618|P1|STARTED|Part 2: Survival Follow-UP||0
93930|NCT01292603|224613|P6|NOT COMPLETED|Part 2: Regular Follow-Up||78
93931|NCT01292603|224614|P5|NOT COMPLETED|Part 2: Regular Follow-Up||78
93932|NCT01292603|224615|P4|NOT COMPLETED|Part 2: Regular Follow-Up||0
93933|NCT01292603|224616|P3|NOT COMPLETED|Part 2: Regular Follow-Up||0
93934|NCT01292603|224617|P2|NOT COMPLETED|Part 2: Regular Follow-Up||0
93935|NCT01292603|224618|P1|NOT COMPLETED|Part 2: Regular Follow-Up||0
93936|NCT01292603|224613|P6|COMPLETED|Part 2: Regular Follow-Up||0
93937|NCT01292603|224614|P5|COMPLETED|Part 2: Regular Follow-Up||0
93938|NCT01292603|224615|P4|COMPLETED|Part 2: Regular Follow-Up||0
93939|NCT01292603|224616|P3|COMPLETED|Part 2: Regular Follow-Up||0
93940|NCT01292603|224617|P2|COMPLETED|Part 2: Regular Follow-Up||0
93941|NCT01292603|224618|P1|COMPLETED|Part 2: Regular Follow-Up||0
93942|NCT01292603|224613|P6|STARTED|Part 2: Regular Follow-Up||78
93943|NCT01292603|224614|P5|STARTED|Part 2: Regular Follow-Up||78
93944|NCT01292603|224615|P4|STARTED|Part 2: Regular Follow-Up||0
93945|NCT01292603|224616|P3|STARTED|Part 2: Regular Follow-Up||0
93946|NCT01292603|224617|P2|STARTED|Part 2: Regular Follow-Up||0
93947|NCT01292603|224618|P1|STARTED|Part 2: Regular Follow-Up||0
93948|NCT01292603|224613|P6|NOT COMPLETED|Part 2: Dose Confirmation Period||15
93949|NCT01292603|224614|P5|NOT COMPLETED|Part 2: Dose Confirmation Period||16
93950|NCT01292603|224615|P4|NOT COMPLETED|Part 2: Dose Confirmation Period||0
93951|NCT01292603|224616|P3|NOT COMPLETED|Part 2: Dose Confirmation Period||0
93952|NCT01292603|224617|P2|NOT COMPLETED|Part 2: Dose Confirmation Period||0
93953|NCT01292603|224618|P1|NOT COMPLETED|Part 2: Dose Confirmation Period||0
93954|NCT01292603|224613|P6|COMPLETED|Part 2: Dose Confirmation Period||73
93955|NCT01292603|224614|P5|COMPLETED|Part 2: Dose Confirmation Period||72
93956|NCT01292603|224615|P4|COMPLETED|Part 2: Dose Confirmation Period||0
93957|NCT01292603|224616|P3|COMPLETED|Part 2: Dose Confirmation Period||0
93958|NCT01292603|224617|P2|COMPLETED|Part 2: Dose Confirmation Period||0
93959|NCT01292603|224618|P1|COMPLETED|Part 2: Dose Confirmation Period||0
93960|NCT01292603|224613|P6|STARTED|Part 2: Dose Confirmation Period||88
93961|NCT01292603|224614|P5|STARTED|Part 2: Dose Confirmation Period||88
93962|NCT01292603|224615|P4|STARTED|Part 2: Dose Confirmation Period||0
93963|NCT01292603|224616|P3|STARTED|Part 2: Dose Confirmation Period||0
93964|NCT01292603|224617|P2|STARTED|Part 2: Dose Confirmation Period||0
93965|NCT01292603|224618|P1|STARTED|Part 2: Dose Confirmation Period||0
93966|NCT01292603|224613|P6|NOT COMPLETED|Part 1: Survival Follow-Up||0
93967|NCT01292603|224614|P5|NOT COMPLETED|Part 1: Survival Follow-Up||0
93968|NCT01292603|224615|P4|NOT COMPLETED|Part 1: Survival Follow-Up||0
93969|NCT01292603|224616|P3|NOT COMPLETED|Part 1: Survival Follow-Up||2
93970|NCT01292603|224617|P2|NOT COMPLETED|Part 1: Survival Follow-Up||2
93971|NCT01292603|224618|P1|NOT COMPLETED|Part 1: Survival Follow-Up||4
93972|NCT01292603|224613|P6|COMPLETED|Part 1: Survival Follow-Up||0
93973|NCT01292603|224614|P5|COMPLETED|Part 1: Survival Follow-Up||0
93974|NCT01292603|224615|P4|COMPLETED|Part 1: Survival Follow-Up||0
93975|NCT01292603|224616|P3|COMPLETED|Part 1: Survival Follow-Up||0
93976|NCT01292603|224617|P2|COMPLETED|Part 1: Survival Follow-Up||0
93977|NCT01292603|224618|P1|COMPLETED|Part 1: Survival Follow-Up||0
93978|NCT01292603|224613|P6|STARTED|Part 1: Survival Follow-Up||0
93979|NCT01292603|224614|P5|STARTED|Part 1: Survival Follow-Up||0
93980|NCT01292603|224615|P4|STARTED|Part 1: Survival Follow-Up||0
93981|NCT01292603|224616|P3|STARTED|Part 1: Survival Follow-Up||2
93982|NCT01292603|224617|P2|STARTED|Part 1: Survival Follow-Up||2
93983|NCT01292603|224618|P1|STARTED|Part 1: Survival Follow-Up||4
93984|NCT01292603|224613|P6|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
93985|NCT01292603|224614|P5|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
93986|NCT01292603|224615|P4|NOT COMPLETED|Part 1: Regular Follow-Up Period||0
93987|NCT01292603|224616|P3|NOT COMPLETED|Part 1: Regular Follow-Up Period||23
93988|NCT01292603|224617|P2|NOT COMPLETED|Part 1: Regular Follow-Up Period||17
93989|NCT01292603|224618|P1|NOT COMPLETED|Part 1: Regular Follow-Up Period||16
93990|NCT01292603|224613|P6|COMPLETED|Part 1: Regular Follow-Up Period||0
93991|NCT01292603|224614|P5|COMPLETED|Part 1: Regular Follow-Up Period||0
93992|NCT01292603|224615|P4|COMPLETED|Part 1: Regular Follow-Up Period||0
93993|NCT01292603|224616|P3|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
93994|NCT01292603|224617|P2|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
93995|NCT01292603|224618|P1|COMPLETED|Part 1: Regular Follow-Up Period|Participants withdrawn from regular follow-up who were still alive entered survival follow-up|0
93996|NCT01292603|224613|P6|STARTED|Part 1: Regular Follow-Up Period||0
93997|NCT01292603|224614|P5|STARTED|Part 1: Regular Follow-Up Period||0
93998|NCT01292603|224615|P4|STARTED|Part 1: Regular Follow-Up Period||0
93999|NCT01292603|224616|P3|STARTED|Part 1: Regular Follow-Up Period||23
94000|NCT01292603|224617|P2|STARTED|Part 1: Regular Follow-Up Period||17
94001|NCT01292603|224618|P1|STARTED|Part 1: Regular Follow-Up Period||16
94002|NCT01292603|224613|P6|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
94003|NCT01292603|224614|P5|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
94004|NCT01292603|224615|P4|NOT COMPLETED|Part 1: Pilot Dose Selection Period||8
94005|NCT01292603|224616|P3|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
94006|NCT01292603|224617|P2|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
94007|NCT01292603|224618|P1|NOT COMPLETED|Part 1: Pilot Dose Selection Period||0
94008|NCT01292603|224613|P6|COMPLETED|Part 1: Pilot Dose Selection Period||0
94009|NCT01292603|224614|P5|COMPLETED|Part 1: Pilot Dose Selection Period||0
94010|NCT01292603|224615|P4|COMPLETED|Part 1: Pilot Dose Selection Period||0
94011|NCT01292603|224616|P3|COMPLETED|Part 1: Pilot Dose Selection Period||23
94012|NCT01292603|224617|P2|COMPLETED|Part 1: Pilot Dose Selection Period||17
94013|NCT01292603|224618|P1|COMPLETED|Part 1: Pilot Dose Selection Period||16
94014|NCT01292603|224613|P6|STARTED|Part 1: Pilot Dose Selection Period||0
94015|NCT01292603|224614|P5|STARTED|Part 1: Pilot Dose Selection Period||0
94016|NCT01292603|224615|P4|STARTED|Part 1: Pilot Dose Selection Period|These participants were withdrawn prior to SC treatment.|8
94017|NCT01292603|224616|P3|STARTED|Part 1: Pilot Dose Selection Period|1 participant received a dose of 1000mg of rituximab by oversight.|23
94018|NCT01292603|224617|P2|STARTED|Part 1: Pilot Dose Selection Period||17
94019|NCT01292603|224618|P1|STARTED|Part 1: Pilot Dose Selection Period||16
94020|NCT01292538|224664|P2|NOT COMPLETED|Overall Study||0
94021|NCT01292538|224665|P1|NOT COMPLETED|Overall Study||0
94022|NCT01292538|224664|P2|COMPLETED|Overall Study||32
94023|NCT01292538|224665|P1|COMPLETED|Overall Study||35
94024|NCT01292538|224664|P2|STARTED|Overall Study||32
94025|NCT01292538|224665|P1|STARTED|Overall Study||35
94026|NCT01292486|224671|P1|NOT COMPLETED|Overall Study||6
94027|NCT01292486|224671|P1|COMPLETED|Overall Study||26
94028|NCT01292486|224671|P1|STARTED|Overall Study||32
94029|NCT01292473|224685|P4|NOT COMPLETED|Overall Study||12
94030|NCT01292473|224686|P3|NOT COMPLETED|Overall Study||9
94031|NCT01292473|224687|P2|NOT COMPLETED|Overall Study||7
94032|NCT01292473|224688|P1|NOT COMPLETED|Overall Study||5
94033|NCT01292473|224685|P4|COMPLETED|Overall Study||67
94034|NCT01292473|224686|P3|COMPLETED|Overall Study||74
94035|NCT01292473|224687|P2|COMPLETED|Overall Study||75
94036|NCT01292473|224688|P1|COMPLETED|Overall Study||74
94037|NCT01292473|224685|P4|STARTED|Overall Study||79
94038|NCT01292473|224686|P3|STARTED|Overall Study||83
94039|NCT01292473|224687|P2|STARTED|Overall Study||82
94040|NCT01292473|224688|P1|STARTED|Overall Study||79
94041|NCT01292304|224730|P1|NOT COMPLETED|Overall Study||0
94042|NCT01292304|224730|P1|COMPLETED|Overall Study||10
94043|NCT01292304|224730|P1|STARTED|Overall Study||10
94044|NCT01292265|224738|P1|NOT COMPLETED|Overall Study||0
94045|NCT01292265|224738|P1|COMPLETED|Overall Study||3
94046|NCT01292265|224738|P1|STARTED|Overall Study||3
94047|NCT01292239|224747|P2|NOT COMPLETED|Overall Study||7
94048|NCT01292239|224748|P1|NOT COMPLETED|Overall Study||4
94049|NCT01292239|224747|P2|COMPLETED|Overall Study||53
94050|NCT01292239|224748|P1|COMPLETED|Overall Study||119
94051|NCT01292239|224747|P2|STARTED|Overall Study||60
94052|NCT01292239|224748|P1|STARTED|Overall Study||123
94053|NCT01292226|224769|P1|NOT COMPLETED|Overall Study||13
94054|NCT01292226|224769|P1|COMPLETED|Overall Study||32
94055|NCT01292226|224769|P1|STARTED|Overall Study||45
94056|NCT01292187|224802|P2|NOT COMPLETED|Overall Study||13
94057|NCT01292187|224803|P1|NOT COMPLETED|Overall Study||17
94058|NCT01292187|224802|P2|COMPLETED|Overall Study||30
94059|NCT01292187|224803|P1|COMPLETED|Overall Study||69
94060|NCT01292187|224802|P2|STARTED|Overall Study||43
94061|NCT01292187|224803|P1|STARTED|Overall Study||86
94062|NCT01292135|224813|P2|NOT COMPLETED|Overall Study||9
94063|NCT01292135|224814|P1|NOT COMPLETED|Overall Study||0
94064|NCT01292135|224813|P2|COMPLETED|Overall Study||21
94065|NCT01292135|224814|P1|COMPLETED|Overall Study||3
94066|NCT01292135|224813|P2|STARTED|Overall Study||30
94067|NCT01292135|224814|P1|STARTED|Overall Study||3
94068|NCT01292070|224832|P1|NOT COMPLETED|Overall Study||0
94069|NCT01292070|224832|P1|COMPLETED|Overall Study||4
94070|NCT01292070|224832|P1|STARTED|Overall Study||4
94071|NCT01292057|224838|P2|NOT COMPLETED|Overall Study||2
94072|NCT01292057|224839|P1|NOT COMPLETED|Overall Study||2
94073|NCT01292057|224838|P2|COMPLETED|Overall Study||48
94074|NCT01292057|224839|P1|COMPLETED|Overall Study||47
94075|NCT01292057|224838|P2|STARTED|Overall Study||50
94076|NCT01292057|224839|P1|STARTED|Overall Study||49
94077|NCT01292005|224849|P2|NOT COMPLETED|Overall Study||0
94078|NCT01292005|224850|P1|NOT COMPLETED|Overall Study||0
94079|NCT01292005|224849|P2|COMPLETED|Overall Study||14
94080|NCT01292005|224850|P1|COMPLETED|Overall Study||14
94081|NCT01292005|224849|P2|STARTED|Overall Study||14
94082|NCT01292005|224850|P1|STARTED|Overall Study||14
94083|NCT01291784|224874|P3|NOT COMPLETED|Overall Study||0
94084|NCT01291784|224875|P2|NOT COMPLETED|Overall Study||1
94085|NCT01291784|224876|P1|NOT COMPLETED|Overall Study||0
94086|NCT01291784|224874|P3|COMPLETED|Overall Study||1
94087|NCT01291784|224875|P2|COMPLETED|Overall Study||0
94088|NCT01291784|224876|P1|COMPLETED|Overall Study||1
94089|NCT01291784|224874|P3|STARTED|Overall Study||1
94090|NCT01291784|224875|P2|STARTED|Overall Study||1
94091|NCT01291784|224876|P1|STARTED|Overall Study||1
94092|NCT01291498|224896|P1|NOT COMPLETED|Overall Study||1
94093|NCT01291498|224896|P1|COMPLETED|Overall Study||0
94094|NCT01291498|224896|P1|STARTED|Overall Study||1
94095|NCT01291277|224904|P2|NOT COMPLETED|Overall Study||3
94096|NCT01291277|224905|P1|NOT COMPLETED|Overall Study||5
94097|NCT01291277|224904|P2|COMPLETED|Overall Study||42
94098|NCT01291277|224905|P1|COMPLETED|Overall Study||40
94099|NCT01291277|224904|P2|STARTED|Overall Study||45
94100|NCT01291277|224905|P1|STARTED|Overall Study||45
94101|NCT01291264|224911|P1|NOT COMPLETED|Overall Study||0
94102|NCT01291264|224911|P1|COMPLETED|Overall Study||260
94103|NCT01291264|224911|P1|STARTED|Overall Study||260
94104|NCT01291225|224917|P2|NOT COMPLETED|Overall Study||39
94105|NCT01291225|224918|P1|NOT COMPLETED|Overall Study||85
94106|NCT01291225|224917|P2|COMPLETED|Overall Study||121
94107|NCT01291225|224918|P1|COMPLETED|Overall Study||66
94108|NCT01291225|224917|P2|STARTED|Overall Study||160
94109|NCT01291225|224918|P1|STARTED|Overall Study||151
94110|NCT01291173|224932|P4|NOT COMPLETED|Overall Study||13
94111|NCT01291173|224933|P3|NOT COMPLETED|Overall Study||13
94112|NCT01291173|224934|P2|NOT COMPLETED|Overall Study||15
94113|NCT01291173|224935|P1|NOT COMPLETED|Overall Study||17
94114|NCT01291173|224932|P4|COMPLETED|Overall Study||52
94115|NCT01291173|224933|P3|COMPLETED|Overall Study||52
94116|NCT01291173|224934|P2|COMPLETED|Overall Study||51
94117|NCT01291173|224935|P1|COMPLETED|Overall Study||47
94118|NCT01291173|224932|P4|STARTED|Overall Study||65
94119|NCT01291173|224933|P3|STARTED|Overall Study||65
94120|NCT01291173|224934|P2|STARTED|Overall Study||66
94121|NCT01291173|224935|P1|STARTED|Overall Study||64
94122|NCT01291160|224999|P2|NOT COMPLETED|Overall Study||16
94123|NCT01291160|225000|P1|NOT COMPLETED|Overall Study||18
94124|NCT01291160|224999|P2|COMPLETED|Overall Study||48
94125|NCT01291160|225000|P1|COMPLETED|Overall Study||48
94126|NCT01291160|224999|P2|STARTED|Overall Study||64
94127|NCT01291160|225000|P1|STARTED|Overall Study||66
94128|NCT01291108|225010|P6|NOT COMPLETED|Month 2 (Adjunctive Therapy)||1
94129|NCT01291108|225011|P5|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
94130|NCT01291108|225012|P4|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
94131|NCT01291108|225013|P3|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
94132|NCT01291108|225014|P2|NOT COMPLETED|Month 2 (Adjunctive Therapy)||2
94133|NCT01291108|225015|P1|NOT COMPLETED|Month 2 (Adjunctive Therapy)||0
94134|NCT01291108|225010|P6|COMPLETED|Month 2 (Adjunctive Therapy)||25
94135|NCT01291108|225011|P5|COMPLETED|Month 2 (Adjunctive Therapy)||34
94136|NCT01291108|225012|P4|COMPLETED|Month 2 (Adjunctive Therapy)||0
94137|NCT01291108|225013|P3|COMPLETED|Month 2 (Adjunctive Therapy)||24
94138|NCT01291108|225014|P2|COMPLETED|Month 2 (Adjunctive Therapy)||38
94139|NCT01291108|225015|P1|COMPLETED|Month 2 (Adjunctive Therapy)||0
94140|NCT01291108|225010|P6|STARTED|Month 2 (Adjunctive Therapy)||26
94141|NCT01291108|225011|P5|STARTED|Month 2 (Adjunctive Therapy)||34
94142|NCT01291108|225012|P4|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
94143|NCT01291108|225013|P3|STARTED|Month 2 (Adjunctive Therapy)||24
94144|NCT01291108|225014|P2|STARTED|Month 2 (Adjunctive Therapy)||40
94145|NCT01291108|225015|P1|STARTED|Month 2 (Adjunctive Therapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|0
94146|NCT01291108|225010|P6|NOT COMPLETED|Month 1 (Monotherapy)||0
94147|NCT01291108|225011|P5|NOT COMPLETED|Month 1 (Monotherapy)||0
94148|NCT01291108|225012|P4|NOT COMPLETED|Month 1 (Monotherapy)||0
94149|NCT01291108|225013|P3|NOT COMPLETED|Month 1 (Monotherapy)||0
94150|NCT01291108|225014|P2|NOT COMPLETED|Month 1 (Monotherapy)||0
94151|NCT01291108|225015|P1|NOT COMPLETED|Month 1 (Monotherapy)||1
94152|NCT01291108|225010|P6|COMPLETED|Month 1 (Monotherapy)||0
94153|NCT01291108|225011|P5|COMPLETED|Month 1 (Monotherapy)||0
94154|NCT01291108|225012|P4|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|60
94155|NCT01291108|225013|P3|COMPLETED|Month 1 (Monotherapy)||0
94156|NCT01291108|225014|P2|COMPLETED|Month 1 (Monotherapy)||0
94157|NCT01291108|225015|P1|COMPLETED|Month 1 (Monotherapy)|All patients who completed Month 1 were randomized to adjunctive therapy for Month 2.|64
94158|NCT01291108|225010|P6|STARTED|Month 1 (Monotherapy)||0
94159|NCT01291108|225011|P5|STARTED|Month 1 (Monotherapy)||0
94160|NCT01291108|225012|P4|STARTED|Month 1 (Monotherapy)||60
94161|NCT01291108|225013|P3|STARTED|Month 1 (Monotherapy)||0
94162|NCT01291108|225014|P2|STARTED|Month 1 (Monotherapy)||0
94163|NCT01291108|225015|P1|STARTED|Month 1 (Monotherapy)||65
94164|NCT01291056|225031|P2|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
94165|NCT01291056|225032|P1|NOT COMPLETED|Intervention Two (Menstration Days 3-7)||0
94166|NCT01291056|225031|P2|COMPLETED|Intervention Two (Menstration Days 3-7)||10
94167|NCT01291056|225032|P1|COMPLETED|Intervention Two (Menstration Days 3-7)||10
94168|NCT01291056|225031|P2|STARTED|Intervention Two (Menstration Days 3-7)||10
94169|NCT01291056|225032|P1|STARTED|Intervention Two (Menstration Days 3-7)||10
94170|NCT01291056|225031|P2|NOT COMPLETED|Washout||0
94171|NCT01291056|225032|P1|NOT COMPLETED|Washout||0
94172|NCT01291056|225031|P2|COMPLETED|Washout||10
94173|NCT01291056|225032|P1|COMPLETED|Washout||10
94174|NCT01291056|225031|P2|STARTED|Washout||10
94175|NCT01291056|225032|P1|STARTED|Washout||10
94176|NCT01291056|225031|P2|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
94177|NCT01291056|225032|P1|NOT COMPLETED|Intervention One (Menstraution Day 3-7)||0
94178|NCT01291056|225031|P2|COMPLETED|Intervention One (Menstraution Day 3-7)||10
94179|NCT01291056|225032|P1|COMPLETED|Intervention One (Menstraution Day 3-7)||10
94180|NCT01291056|225031|P2|STARTED|Intervention One (Menstraution Day 3-7)||10
94181|NCT01291056|225032|P1|STARTED|Intervention One (Menstraution Day 3-7)||10
94182|NCT01291017|225044|P1|NOT COMPLETED|Overall Study||5
94183|NCT01291017|225044|P1|COMPLETED|Overall Study||14
94184|NCT01291017|225044|P1|STARTED|Overall Study||19
94185|NCT01290978|225052|P1|NOT COMPLETED|Overall Study||0
94186|NCT01290978|225052|P1|COMPLETED|Overall Study||22
94187|NCT01290978|225052|P1|STARTED|Overall Study||22
94188|NCT01290952|225061|P2|NOT COMPLETED|Overall Study||14
94189|NCT01290952|225062|P1|NOT COMPLETED|Overall Study||12
94190|NCT01290952|225061|P2|COMPLETED|Overall Study||193
94191|NCT01290952|225062|P1|COMPLETED|Overall Study||192
94192|NCT01290952|225061|P2|STARTED|Overall Study||207
94193|NCT01290952|225062|P1|STARTED|Overall Study||204
94194|NCT01290913|225070|P1|NOT COMPLETED|Overall Study||1
94195|NCT01290913|225070|P1|COMPLETED|Overall Study||12
94196|NCT01290913|225070|P1|STARTED|Overall Study||13
94197|NCT01290887|225077|P2|NOT COMPLETED|Overall Study||536
94198|NCT01290887|225078|P1|NOT COMPLETED|Overall Study||466
94199|NCT01290887|225077|P2|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|35
94200|NCT01290887|225078|P1|COMPLETED|Overall Study|Completed study includes completion of the 104 week treatment phase and the 90-day follow-up.|15
94201|NCT01290887|225077|P2|Safety Analysis Set|Overall Study||571
94202|NCT01290887|225078|P1|Safety Analysis Set|Overall Study|One patient was enrolled but not treated.|480
94203|NCT01290887|225077|P2|STARTED|Overall Study||571
94204|NCT01290887|225078|P1|STARTED|Overall Study||481
94205|NCT01290822|225116|P1|NOT COMPLETED|Overall Study||11
94206|NCT01290822|225116|P1|COMPLETED|Overall Study||1
94207|NCT01290822|225116|P1|STARTED|Overall Study||12
94208|NCT01290796|225125|P1|NOT COMPLETED|Overall Study||30
94209|NCT01290796|225125|P1|COMPLETED|Overall Study||123
94210|NCT01290796|225125|P1|STARTED|Overall Study||153
94211|NCT01290757|225141|P2|NOT COMPLETED|Overall Study||2
94212|NCT01290757|225142|P1|NOT COMPLETED|Overall Study||2
94213|NCT01290757|225141|P2|COMPLETED|Overall Study||88
94214|NCT01290757|225142|P1|COMPLETED|Overall Study||88
94215|NCT01290757|225141|P2|STARTED|Overall Study||90
94216|NCT01290757|225142|P1|STARTED|Overall Study||90
94217|NCT01290731|225158|P1|NOT COMPLETED|Overall Study||1
94218|NCT01290731|225158|P1|COMPLETED|Overall Study||48
94219|NCT01290731|225158|P1|STARTED|Overall Study||49
94220|NCT01290718|225170|P1|NOT COMPLETED|Overall Study||4
94221|NCT01290718|225170|P1|COMPLETED|Overall Study||0
94222|NCT01290718|225170|P1|STARTED|Overall Study||4
94223|NCT01290679|225179|P2|NOT COMPLETED|Overall Study||21
94224|NCT01290679|225180|P1|NOT COMPLETED|Overall Study||16
94225|NCT01290679|225179|P2|COMPLETED|Overall Study||113
94226|NCT01290679|225180|P1|COMPLETED|Overall Study||241
94227|NCT01290679|225179|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|134
94228|NCT01290679|225180|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|257
94229|NCT01290666|225249|P1|NOT COMPLETED|Overall Study||38
94230|NCT01290666|225249|P1|COMPLETED|Overall Study||55
94231|NCT01290666|225249|P1|STARTED|Overall Study||93
94232|NCT01290640|225255|P2|NOT COMPLETED|Overall Study||0
94233|NCT01290640|225256|P1|NOT COMPLETED|Overall Study||0
94234|NCT01290640|225255|P2|COMPLETED|Overall Study||10
94235|NCT01290640|225256|P1|COMPLETED|Overall Study||12
94236|NCT01290640|225255|P2|STARTED|Overall Study||10
94237|NCT01290640|225256|P1|STARTED|Overall Study||12
94238|NCT01290627|225267|P3|NOT COMPLETED|Overall Study||0
94239|NCT01290627|225268|P2|NOT COMPLETED|Overall Study||0
94240|NCT01290627|225269|P1|NOT COMPLETED|Overall Study||0
94241|NCT01290627|225267|P3|COMPLETED|Overall Study||10
94242|NCT01290627|225268|P2|COMPLETED|Overall Study||10
94243|NCT01290627|225269|P1|COMPLETED|Overall Study||10
94244|NCT01290627|225267|P3|STARTED|Overall Study||10
94245|NCT01290627|225268|P2|STARTED|Overall Study||10
94246|NCT01290627|225269|P1|STARTED|Overall Study||10
94247|NCT01290614|225291|P2|NOT COMPLETED|Overall Study||0
94248|NCT01290614|225292|P1|NOT COMPLETED|Overall Study||552
94249|NCT01290614|225291|P2|COMPLETED|Overall Study||1129
94250|NCT01290614|225292|P1|COMPLETED|Overall Study||518
94251|NCT01290614|225291|P2|STARTED|Overall Study||1129
94252|NCT01290614|225292|P1|STARTED|Overall Study||1070
94253|NCT01290536|225300|P1|NOT COMPLETED|Overall Study||0
94254|NCT01290536|225300|P1|COMPLETED|Overall Study||42
94255|NCT01290536|225300|P1|STARTED|Overall Study||42
94256|NCT01290523|225307|P1|NOT COMPLETED|Overall Study||0
94257|NCT01290523|225307|P1|COMPLETED|Overall Study||14
94258|NCT01290523|225307|P1|STARTED|Overall Study||14
94259|NCT01290484|225312|P1|NOT COMPLETED|Overall Study||0
94260|NCT01290484|225312|P1|COMPLETED|Overall Study||7
94261|NCT01290484|225312|P1|STARTED|Overall Study||7
94262|NCT01290341|225318|P2|NOT COMPLETED|Overall Study||29
94263|NCT01290341|225319|P1|NOT COMPLETED|Overall Study||92
94264|NCT01290341|225318|P2|COMPLETED|Overall Study||258
94265|NCT01290341|225319|P1|COMPLETED|Overall Study||481
94266|NCT01290341|225318|P2|STARTED|Overall Study||287
94267|NCT01290341|225319|P1|STARTED|Overall Study||573
94268|NCT01290263|225329|P5|NOT COMPLETED|Overall Study||37
94269|NCT01290263|225330|P4|NOT COMPLETED|Overall Study||27
94270|NCT01290263|225331|P3|NOT COMPLETED|Overall Study||7
94271|NCT01290263|225332|P2|NOT COMPLETED|Overall Study||3
94272|NCT01290263|225333|P1|NOT COMPLETED|Overall Study||11
94273|NCT01290263|225329|P5|COMPLETED|Overall Study||0
94274|NCT01290263|225330|P4|COMPLETED|Overall Study||0
94275|NCT01290263|225331|P3|COMPLETED|Overall Study||0
94276|NCT01290263|225332|P2|COMPLETED|Overall Study||0
94277|NCT01290263|225333|P1|COMPLETED|Overall Study||0
94278|NCT01290263|225329|P5|STARTED|Overall Study||37
94279|NCT01290263|225330|P4|STARTED|Overall Study||27
94280|NCT01290263|225331|P3|STARTED|Overall Study||7
94281|NCT01290263|225332|P2|STARTED|Overall Study||3
94282|NCT01290263|225333|P1|STARTED|Overall Study||11
94283|NCT01290224|225349|P1|NOT COMPLETED|Overall Study||5
94284|NCT01290224|225349|P1|COMPLETED|Overall Study||5
94285|NCT01290224|225349|P1|STARTED|Overall Study||10
94286|NCT01290094|225360|P1|NOT COMPLETED|Overall Study||6
94287|NCT01290094|225360|P1|COMPLETED|Overall Study||35
94288|NCT01290094|225360|P1|STARTED|Overall Study||41
94289|NCT01290068|225373|P2|NOT COMPLETED|Overall Study||6
94290|NCT01290068|225374|P1|NOT COMPLETED|Overall Study||7
94291|NCT01290068|225373|P2|COMPLETED|Overall Study||94
94292|NCT01290068|225374|P1|COMPLETED|Overall Study||101
94293|NCT01290068|225373|P2|Implanted|Overall Study||98
94294|NCT01290068|225374|P1|Implanted|Overall Study||108
94295|NCT01290068|225373|P2|STARTED|Overall Study||100
94296|NCT01290068|225374|P1|STARTED|Overall Study||108
94297|NCT01290029|225386|P1|NOT COMPLETED|Overall Study||2
94298|NCT01290029|225386|P1|COMPLETED|Overall Study||12
94299|NCT01290029|225386|P1|Received Study Treatment|Overall Study||12
94300|NCT01290029|225386|P1|STARTED|Overall Study||14
94301|NCT01289990|225412|P13|NOT COMPLETED|Overall Study||98
94302|NCT01289990|225413|P12|NOT COMPLETED|Overall Study||68
94303|NCT01289990|225414|P11|NOT COMPLETED|Overall Study||76
94304|NCT01289990|225415|P10|NOT COMPLETED|Overall Study||86
94305|NCT01289990|225416|P9|NOT COMPLETED|Overall Study||75
94306|NCT01289990|225417|P8|NOT COMPLETED|Overall Study||55
94307|NCT01289990|225418|P7|NOT COMPLETED|Overall Study||88
94308|NCT01289990|225419|P6|NOT COMPLETED|Overall Study||74
94309|NCT01289990|225420|P5|NOT COMPLETED|Overall Study||72
94310|NCT01289990|225421|P4|NOT COMPLETED|Overall Study||87
94311|NCT01289990|225422|P3|NOT COMPLETED|Overall Study||109
94312|NCT01289990|225423|P2|NOT COMPLETED|Overall Study||81
94313|NCT01289990|225424|P1|NOT COMPLETED|Overall Study||77
94314|NCT01289990|225412|P13|COMPLETED|Overall Study||127
94315|NCT01289990|225413|P12|COMPLETED|Overall Study||150
94316|NCT01289990|225414|P11|COMPLETED|Overall Study||150
94317|NCT01289990|225415|P10|COMPLETED|Overall Study||121
94318|NCT01289990|225416|P9|COMPLETED|Overall Study||139
94319|NCT01289990|225417|P8|COMPLETED|Overall Study||162
94320|NCT01289990|225418|P7|COMPLETED|Overall Study||78
94321|NCT01289990|225419|P6|COMPLETED|Overall Study||94
94322|NCT01289990|225420|P5|COMPLETED|Overall Study||93
94323|NCT01289990|225421|P4|COMPLETED|Overall Study||136
94324|NCT01289990|225422|P3|COMPLETED|Overall Study||119
94325|NCT01289990|225423|P2|COMPLETED|Overall Study||143
94326|NCT01289990|225424|P1|COMPLETED|Overall Study||147
94327|NCT01289990|225412|P13|STARTED|Overall Study||225
94328|NCT01289990|225413|P12|STARTED|Overall Study||218
94329|NCT01289990|225414|P11|STARTED|Overall Study||226
94330|NCT01289990|225415|P10|STARTED|Overall Study||207
94331|NCT01289990|225416|P9|STARTED|Overall Study||214
94332|NCT01289990|225417|P8|STARTED|Overall Study||217
94333|NCT01289990|225418|P7|STARTED|Overall Study||166
94334|NCT01289990|225419|P6|STARTED|Overall Study||168
94335|NCT01289990|225420|P5|STARTED|Overall Study||165
94336|NCT01289990|225421|P4|STARTED|Overall Study||223
94337|NCT01289990|225422|P3|STARTED|Overall Study||228
94338|NCT01289990|225423|P2|STARTED|Overall Study||224
94339|NCT01289990|225424|P1|STARTED|Overall Study||224
94340|NCT01289847|225608|P1|NOT COMPLETED|Overall Study||1
94341|NCT01289847|225608|P1|COMPLETED|Overall Study||24
94342|NCT01289847|225608|P1|STARTED|Overall Study||25
94343|NCT01289821|225617|P1|NOT COMPLETED|Survival Follow-up Period||18
94344|NCT01289821|225617|P1|COMPLETED|Survival Follow-up Period|34 participants died and completed survival follow-up period.|34
94345|NCT01289821|225617|P1|STARTED|Survival Follow-up Period||52
94346|NCT01289821|225617|P1|NOT COMPLETED|Safety Follow-up Period||5
94347|NCT01289821|225617|P1|COMPLETED|Safety Follow-up Period||49
94348|NCT01289821|225617|P1|STARTED|Safety Follow-up Period||54
94349|NCT01289821|225617|P1|NOT COMPLETED|Treatment Period||54
94350|NCT01289821|225617|P1|COMPLETED|Treatment Period||0
94351|NCT01289821|225617|P1|Participants Received Regorafenib|Treatment Period||54
94352|NCT01289821|225617|P1|STARTED|Treatment Period||54
94353|NCT01289782|225628|P2|NOT COMPLETED|Overall Study||12
94354|NCT01289782|225629|P1|NOT COMPLETED|Overall Study||25
94355|NCT01289782|225628|P2|COMPLETED|Overall Study||118
94356|NCT01289782|225629|P1|COMPLETED|Overall Study||239
94357|NCT01289782|225628|P2|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|130
94358|NCT01289782|225629|P1|STARTED|Overall Study||264
94359|NCT01289639|225701|P3|NOT COMPLETED|Overall Study||0
94360|NCT01289639|225702|P2|NOT COMPLETED|Overall Study||0
94361|NCT01289639|225703|P1|NOT COMPLETED|Overall Study||1
94362|NCT01289639|225701|P3|COMPLETED|Overall Study||0
94363|NCT01289639|225702|P2|COMPLETED|Overall Study||6
94364|NCT01289639|225703|P1|COMPLETED|Overall Study||4
94365|NCT01289639|225701|P3|STARTED|Overall Study||0
94366|NCT01289639|225702|P2|STARTED|Overall Study||6
94367|NCT01289639|225703|P1|STARTED|Overall Study||5
94368|NCT01289574|225729|P3|NOT COMPLETED|Overall Study||3
94369|NCT01289574|225730|P2|NOT COMPLETED|Overall Study||3
94370|NCT01289574|225731|P1|NOT COMPLETED|Overall Study||7
94371|NCT01289574|225729|P3|COMPLETED|Overall Study||60
94372|NCT01289574|225730|P2|COMPLETED|Overall Study||57
94373|NCT01289574|225731|P1|COMPLETED|Overall Study||51
94374|NCT01289574|225729|P3|STARTED|Overall Study||63
94375|NCT01289574|225730|P2|STARTED|Overall Study||60
94376|NCT01289574|225731|P1|STARTED|Overall Study||58
94377|NCT01289548|225748|P3|NOT COMPLETED|Overall Study||0
94378|NCT01289548|225749|P2|NOT COMPLETED|Overall Study||0
94379|NCT01289548|225750|P1|NOT COMPLETED|Overall Study||0
94380|NCT01289548|225748|P3|COMPLETED|Overall Study||40
94381|NCT01289548|225749|P2|COMPLETED|Overall Study||40
94382|NCT01289548|225750|P1|COMPLETED|Overall Study||40
94383|NCT01289548|225748|P3|Recipients|Overall Study||20
94384|NCT01289548|225749|P2|Recipients|Overall Study||20
94385|NCT01289548|225750|P1|Recipients|Overall Study||20
94386|NCT01289548|225748|P3|Donors|Overall Study||20
94387|NCT01289548|225749|P2|Donors|Overall Study||20
94388|NCT01289548|225750|P1|Donors|Overall Study||20
94389|NCT01289548|225748|P3|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
94390|NCT01289548|225749|P2|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
94391|NCT01289548|225750|P1|STARTED|Overall Study|include both donors and recipients listed as milestones below|40
94392|NCT01289522|225794|P1|NOT COMPLETED|Overall Study||11
94393|NCT01289522|225794|P1|COMPLETED|Overall Study||43
94394|NCT01289522|225794|P1|STARTED|Overall Study||54
94395|NCT01289418|225803|P1|NOT COMPLETED|Day 29 Survey||2468
94396|NCT01289418|225803|P1|COMPLETED|Day 29 Survey||4057
94397|NCT01289418|225803|P1|STARTED|Day 29 Survey||6525
94398|NCT01289418|225803|P1|NOT COMPLETED|Day 8 Survey||2218
94399|NCT01289418|225803|P1|COMPLETED|Day 8 Survey||4307
94400|NCT01289418|225803|P1|STARTED|Day 8 Survey||6525
94401|NCT01289392|225812|P3|NOT COMPLETED|Overall Study||0
94402|NCT01289392|225813|P2|NOT COMPLETED|Overall Study||0
94403|NCT01289392|225814|P1|NOT COMPLETED|Overall Study||0
94404|NCT01289392|225812|P3|COMPLETED|Overall Study||7
94405|NCT01289392|225813|P2|COMPLETED|Overall Study||9
94406|NCT01289392|225814|P1|COMPLETED|Overall Study||9
94407|NCT01289392|225812|P3|STARTED|Overall Study||7
94408|NCT01289392|225813|P2|STARTED|Overall Study||9
94409|NCT01289392|225814|P1|STARTED|Overall Study||9
94410|NCT01289210|225822|P1|NOT COMPLETED|Overall Study||1
94411|NCT01289210|225822|P1|COMPLETED|Overall Study||1
94412|NCT01289210|225822|P1|STARTED|Overall Study||2
94413|NCT01289119|225832|P6|NOT COMPLETED|Overall Study||4
94414|NCT01289119|225833|P5|NOT COMPLETED|Overall Study||5
94415|NCT01289119|225834|P4|NOT COMPLETED|Overall Study||6
94416|NCT01289119|225835|P3|NOT COMPLETED|Overall Study||9
94417|NCT01289119|225836|P2|NOT COMPLETED|Overall Study||9
94418|NCT01289119|225837|P1|NOT COMPLETED|Overall Study||9
94419|NCT01289119|225832|P6|COMPLETED|Overall Study||57
94420|NCT01289119|225833|P5|COMPLETED|Overall Study||58
94421|NCT01289119|225834|P4|COMPLETED|Overall Study||93
94422|NCT01289119|225835|P3|COMPLETED|Overall Study||89
94423|NCT01289119|225836|P2|COMPLETED|Overall Study||83
94424|NCT01289119|225837|P1|COMPLETED|Overall Study||84
94425|NCT01289119|225832|P6|Treated|Overall Study||61
94426|NCT01289119|225833|P5|Treated|Overall Study||63
94427|NCT01289119|225834|P4|Treated|Overall Study||99
94428|NCT01289119|225835|P3|Treated|Overall Study||98
94429|NCT01289119|225836|P2|Treated|Overall Study||92
94430|NCT01289119|225837|P1|Treated|Overall Study|Patients who took at least one dose of double-blind study drug.|92
94431|NCT01289119|225832|P6|STARTED|Overall Study||61
94432|NCT01289119|225833|P5|STARTED|Overall Study||63
94433|NCT01289119|225834|P4|STARTED|Overall Study||99
94434|NCT01289119|225835|P3|STARTED|Overall Study||98
94435|NCT01289119|225836|P2|STARTED|Overall Study||92
94436|NCT01289119|225837|P1|STARTED|Overall Study||93
94437|NCT01289080|225919|P2|NOT COMPLETED|Overall Study||0
94438|NCT01289080|225920|P1|NOT COMPLETED|Overall Study||0
94439|NCT01289080|225919|P2|COMPLETED|Overall Study||10
94440|NCT01289080|225920|P1|COMPLETED|Overall Study||9
94441|NCT01289080|225919|P2|STARTED|Overall Study||10
94442|NCT01289080|225920|P1|STARTED|Overall Study||9
94443|NCT01289041|225951|P1|NOT COMPLETED|Overall Study||70
94444|NCT01289041|225951|P1|COMPLETED|Overall Study||0
94445|NCT01289041|225951|P1|STARTED|Overall Study||70
94446|NCT01289028|225963|P1|NOT COMPLETED|Overall Study||83
94447|NCT01289028|225963|P1|COMPLETED|Overall Study||42
94448|NCT01289028|225963|P1|STARTED|Overall Study||125
94449|NCT01289015|225977|P2|NOT COMPLETED|Overall Study||54
94450|NCT01289015|225978|P1|NOT COMPLETED|Overall Study||99
94451|NCT01289015|225977|P2|COMPLETED|Overall Study||230
94452|NCT01289015|225978|P1|COMPLETED|Overall Study||472
94453|NCT01289015|225977|P2|STARTED|Overall Study||284
94454|NCT01289015|225978|P1|STARTED|Overall Study||571
94455|NCT01288911|225988|P2|NOT COMPLETED|Overall Study||170
94456|NCT01288911|225989|P1|NOT COMPLETED|Overall Study||125
94457|NCT01288911|225988|P2|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|21
94458|NCT01288911|225989|P1|COMPLETED|Overall Study|Indicates participants still receiving treatment as of 19 October 2014|59
94459|NCT01288911|225988|P2|Received Treatment|Overall Study||189
94460|NCT01288911|225989|P1|Received Treatment|Overall Study||183
94461|NCT01288911|225988|P2|STARTED|Overall Study||191
94462|NCT01288911|225989|P1|STARTED|Overall Study||184
94463|NCT01288859|226017|P6|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94464|NCT01288859|226018|P5|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94465|NCT01288859|226019|P4|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94466|NCT01288859|226020|P3|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94467|NCT01288859|226021|P2|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94468|NCT01288859|226022|P1|NOT COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94469|NCT01288859|226017|P6|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94470|NCT01288859|226018|P5|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
94471|NCT01288859|226019|P4|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||5
94472|NCT01288859|226020|P3|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94473|NCT01288859|226021|P2|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94474|NCT01288859|226022|P1|COMPLETED|Control Cream Then Enc Polyph. (1 Day)||0
94475|NCT01288859|226017|P6|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
94476|NCT01288859|226018|P5|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
94477|NCT01288859|226019|P4|STARTED|Control Cream Then Enc Polyph. (1 Day)||5
94478|NCT01288859|226020|P3|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
94479|NCT01288859|226021|P2|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
94480|NCT01288859|226022|P1|STARTED|Control Cream Then Enc Polyph. (1 Day)||0
94481|NCT01288859|226017|P6|NOT COMPLETED|Washout Period of 1 Week||0
94482|NCT01288859|226018|P5|NOT COMPLETED|Washout Period of 1 Week||0
94483|NCT01288859|226019|P4|NOT COMPLETED|Washout Period of 1 Week||0
94484|NCT01288859|226020|P3|NOT COMPLETED|Washout Period of 1 Week||0
94485|NCT01288859|226021|P2|NOT COMPLETED|Washout Period of 1 Week||0
94486|NCT01288859|226022|P1|NOT COMPLETED|Washout Period of 1 Week||0
94487|NCT01288859|226017|P6|COMPLETED|Washout Period of 1 Week||0
94488|NCT01288859|226018|P5|COMPLETED|Washout Period of 1 Week||5
94489|NCT01288859|226019|P4|COMPLETED|Washout Period of 1 Week||5
94490|NCT01288859|226020|P3|COMPLETED|Washout Period of 1 Week||0
94491|NCT01288859|226021|P2|COMPLETED|Washout Period of 1 Week||0
94492|NCT01288859|226022|P1|COMPLETED|Washout Period of 1 Week||0
94493|NCT01288859|226017|P6|STARTED|Washout Period of 1 Week||0
94494|NCT01288859|226018|P5|STARTED|Washout Period of 1 Week||5
94495|NCT01288859|226019|P4|STARTED|Washout Period of 1 Week||5
94496|NCT01288859|226020|P3|STARTED|Washout Period of 1 Week||0
94497|NCT01288859|226021|P2|STARTED|Washout Period of 1 Week||0
94498|NCT01288859|226022|P1|STARTED|Washout Period of 1 Week||0
94499|NCT01288859|226017|P6|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94751|NCT01288027|226267|P1|COMPLETED|Overall Study||16
94500|NCT01288859|226018|P5|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94501|NCT01288859|226019|P4|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94502|NCT01288859|226020|P3|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94503|NCT01288859|226021|P2|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94504|NCT01288859|226022|P1|NOT COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94505|NCT01288859|226017|P6|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94506|NCT01288859|226018|P5|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
94507|NCT01288859|226019|P4|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||5
94508|NCT01288859|226020|P3|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94509|NCT01288859|226021|P2|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94510|NCT01288859|226022|P1|COMPLETED|Enc Polyph. Then Control Cream (1 Day)||0
94511|NCT01288859|226017|P6|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
94512|NCT01288859|226018|P5|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
94513|NCT01288859|226019|P4|STARTED|Enc Polyph. Then Control Cream (1 Day)||5
94514|NCT01288859|226020|P3|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
94515|NCT01288859|226021|P2|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
94516|NCT01288859|226022|P1|STARTED|Enc Polyph. Then Control Cream (1 Day)||0
94517|NCT01288859|226017|P6|NOT COMPLETED|Washout Period of 1 Week||0
94518|NCT01288859|226018|P5|NOT COMPLETED|Washout Period of 1 Week||0
94519|NCT01288859|226019|P4|NOT COMPLETED|Washout Period of 1 Week||0
94520|NCT01288859|226020|P3|NOT COMPLETED|Washout Period of 1 Week||0
94521|NCT01288859|226021|P2|NOT COMPLETED|Washout Period of 1 Week||0
94522|NCT01288859|226022|P1|NOT COMPLETED|Washout Period of 1 Week||0
94523|NCT01288859|226017|P6|COMPLETED|Washout Period of 1 Week||0
94524|NCT01288859|226018|P5|COMPLETED|Washout Period of 1 Week||5
94525|NCT01288859|226019|P4|COMPLETED|Washout Period of 1 Week||5
94526|NCT01288859|226020|P3|COMPLETED|Washout Period of 1 Week||0
94527|NCT01288859|226021|P2|COMPLETED|Washout Period of 1 Week||0
94528|NCT01288859|226022|P1|COMPLETED|Washout Period of 1 Week||0
94529|NCT01288859|226017|P6|STARTED|Washout Period of 1 Week||0
94530|NCT01288859|226018|P5|STARTED|Washout Period of 1 Week||5
94531|NCT01288859|226019|P4|STARTED|Washout Period of 1 Week||5
94532|NCT01288859|226020|P3|STARTED|Washout Period of 1 Week||0
94533|NCT01288859|226021|P2|STARTED|Washout Period of 1 Week||0
94534|NCT01288859|226022|P1|STARTED|Washout Period of 1 Week||0
94535|NCT01288859|226017|P6|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94536|NCT01288859|226018|P5|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94537|NCT01288859|226019|P4|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94538|NCT01288859|226020|P3|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94539|NCT01288859|226021|P2|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94540|NCT01288859|226022|P1|NOT COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94541|NCT01288859|226017|P6|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94542|NCT01288859|226018|P5|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94543|NCT01288859|226019|P4|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94544|NCT01288859|226020|P3|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
94545|NCT01288859|226021|P2|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
94546|NCT01288859|226022|P1|COMPLETED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94547|NCT01288859|226017|P6|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94548|NCT01288859|226018|P5|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94549|NCT01288859|226019|P4|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94550|NCT01288859|226020|P3|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
94551|NCT01288859|226021|P2|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||5
94552|NCT01288859|226022|P1|STARTED|Free Polyph. Then Enc Curc + PQG (1 Day)||0
94553|NCT01288859|226017|P6|NOT COMPLETED|Washout Period of 1 Week||0
94554|NCT01288859|226018|P5|NOT COMPLETED|Washout Period of 1 Week||0
94555|NCT01288859|226019|P4|NOT COMPLETED|Washout Period of 1 Week||0
94556|NCT01288859|226020|P3|NOT COMPLETED|Washout Period of 1 Week||0
94557|NCT01288859|226021|P2|NOT COMPLETED|Washout Period of 1 Week||0
94558|NCT01288859|226022|P1|NOT COMPLETED|Washout Period of 1 Week||0
94559|NCT01288859|226017|P6|COMPLETED|Washout Period of 1 Week||0
94560|NCT01288859|226018|P5|COMPLETED|Washout Period of 1 Week||0
94561|NCT01288859|226019|P4|COMPLETED|Washout Period of 1 Week||0
94562|NCT01288859|226020|P3|COMPLETED|Washout Period of 1 Week||5
94563|NCT01288859|226021|P2|COMPLETED|Washout Period of 1 Week||5
94564|NCT01288859|226022|P1|COMPLETED|Washout Period of 1 Week||0
94565|NCT01288859|226017|P6|STARTED|Washout Period of 1 Week||0
94566|NCT01288859|226018|P5|STARTED|Washout Period of 1 Week||0
94567|NCT01288859|226019|P4|STARTED|Washout Period of 1 Week||0
94568|NCT01288859|226020|P3|STARTED|Washout Period of 1 Week||5
94569|NCT01288859|226021|P2|STARTED|Washout Period of 1 Week||5
94570|NCT01288859|226022|P1|STARTED|Washout Period of 1 Week||0
94571|NCT01288859|226017|P6|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94572|NCT01288859|226018|P5|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94573|NCT01288859|226019|P4|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94574|NCT01288859|226020|P3|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94575|NCT01288859|226021|P2|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94576|NCT01288859|226022|P1|NOT COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94577|NCT01288859|226017|P6|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94578|NCT01288859|226018|P5|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94579|NCT01288859|226019|P4|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94580|NCT01288859|226020|P3|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
94581|NCT01288859|226021|P2|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
94582|NCT01288859|226022|P1|COMPLETED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94583|NCT01288859|226017|P6|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94584|NCT01288859|226018|P5|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94585|NCT01288859|226019|P4|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94586|NCT01288859|226020|P3|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
94587|NCT01288859|226021|P2|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||5
94588|NCT01288859|226022|P1|STARTED|Enc Curc + PQG Then Free Polyph. (1 Day)||0
94589|NCT01288859|226017|P6|NOT COMPLETED|Washout Period of 1 Week||0
94590|NCT01288859|226018|P5|NOT COMPLETED|Washout Period of 1 Week||0
94591|NCT01288859|226019|P4|NOT COMPLETED|Washout Period of 1 Week||0
94592|NCT01288859|226020|P3|NOT COMPLETED|Washout Period of 1 Week||0
94593|NCT01288859|226021|P2|NOT COMPLETED|Washout Period of 1 Week||0
94594|NCT01288859|226022|P1|NOT COMPLETED|Washout Period of 1 Week||0
94595|NCT01288859|226017|P6|COMPLETED|Washout Period of 1 Week||5
94596|NCT01288859|226018|P5|COMPLETED|Washout Period of 1 Week||0
94597|NCT01288859|226019|P4|COMPLETED|Washout Period of 1 Week||0
94598|NCT01288859|226020|P3|COMPLETED|Washout Period of 1 Week||0
94599|NCT01288859|226021|P2|COMPLETED|Washout Period of 1 Week||0
94600|NCT01288859|226022|P1|COMPLETED|Washout Period of 1 Week||5
94601|NCT01288859|226017|P6|STARTED|Washout Period of 1 Week||5
94602|NCT01288859|226018|P5|STARTED|Washout Period of 1 Week||0
94603|NCT01288859|226019|P4|STARTED|Washout Period of 1 Week||0
94604|NCT01288859|226020|P3|STARTED|Washout Period of 1 Week||0
94605|NCT01288859|226021|P2|STARTED|Washout Period of 1 Week||0
94606|NCT01288859|226022|P1|STARTED|Washout Period of 1 Week||5
94607|NCT01288859|226017|P6|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94608|NCT01288859|226018|P5|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94609|NCT01288859|226019|P4|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94610|NCT01288859|226020|P3|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94611|NCT01288859|226021|P2|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94612|NCT01288859|226022|P1|NOT COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94613|NCT01288859|226017|P6|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
94614|NCT01288859|226018|P5|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94615|NCT01288859|226019|P4|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94616|NCT01288859|226020|P3|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94617|NCT01288859|226021|P2|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||0
94618|NCT01288859|226022|P1|COMPLETED|Encapsulated Then Free Curcumin (1 Day)||5
94619|NCT01288859|226017|P6|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
94620|NCT01288859|226018|P5|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
94621|NCT01288859|226019|P4|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
94622|NCT01288859|226020|P3|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
94623|NCT01288859|226021|P2|STARTED|Encapsulated Then Free Curcumin (1 Day)||0
94624|NCT01288859|226022|P1|STARTED|Encapsulated Then Free Curcumin (1 Day)||5
94625|NCT01288859|226017|P6|NOT COMPLETED|Washout Period of 1 Week||0
94626|NCT01288859|226018|P5|NOT COMPLETED|Washout Period of 1 Week||0
94627|NCT01288859|226019|P4|NOT COMPLETED|Washout Period of 1 Week||0
94628|NCT01288859|226020|P3|NOT COMPLETED|Washout Period of 1 Week||0
94629|NCT01288859|226021|P2|NOT COMPLETED|Washout Period of 1 Week||0
94630|NCT01288859|226022|P1|NOT COMPLETED|Washout Period of 1 Week||0
94631|NCT01288859|226017|P6|COMPLETED|Washout Period of 1 Week||5
94632|NCT01288859|226018|P5|COMPLETED|Washout Period of 1 Week||0
94633|NCT01288859|226019|P4|COMPLETED|Washout Period of 1 Week||0
94634|NCT01288859|226020|P3|COMPLETED|Washout Period of 1 Week||0
94635|NCT01288859|226021|P2|COMPLETED|Washout Period of 1 Week||0
94636|NCT01288859|226022|P1|COMPLETED|Washout Period of 1 Week||5
94637|NCT01288859|226017|P6|STARTED|Washout Period of 1 Week||5
94638|NCT01288859|226018|P5|STARTED|Washout Period of 1 Week||0
94639|NCT01288859|226019|P4|STARTED|Washout Period of 1 Week||0
94640|NCT01288859|226020|P3|STARTED|Washout Period of 1 Week||0
94641|NCT01288859|226021|P2|STARTED|Washout Period of 1 Week||0
94642|NCT01288859|226022|P1|STARTED|Washout Period of 1 Week||5
94643|NCT01288859|226017|P6|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94644|NCT01288859|226018|P5|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94645|NCT01288859|226019|P4|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94646|NCT01288859|226020|P3|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94647|NCT01288859|226021|P2|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94648|NCT01288859|226022|P1|NOT COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94649|NCT01288859|226017|P6|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
94650|NCT01288859|226018|P5|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94651|NCT01288859|226019|P4|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94652|NCT01288859|226020|P3|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94653|NCT01288859|226021|P2|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||0
94654|NCT01288859|226022|P1|COMPLETED|Free Then Encapsulated Curcumin (1 Day)||5
94655|NCT01288859|226017|P6|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
94656|NCT01288859|226018|P5|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
94657|NCT01288859|226019|P4|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
94658|NCT01288859|226020|P3|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
94659|NCT01288859|226021|P2|STARTED|Free Then Encapsulated Curcumin (1 Day)||0
94660|NCT01288859|226022|P1|STARTED|Free Then Encapsulated Curcumin (1 Day)||5
94661|NCT01288781|226050|P2|NOT COMPLETED|Overall Study||0
94662|NCT01288781|226051|P1|NOT COMPLETED|Overall Study||0
94663|NCT01288781|226050|P2|COMPLETED|Overall Study||12
94664|NCT01288781|226051|P1|COMPLETED|Overall Study||11
94665|NCT01288781|226050|P2|STARTED|Overall Study||12
94666|NCT01288781|226051|P1|STARTED|Overall Study||11
94667|NCT01288729|226071|P2|NOT COMPLETED|Overall Study||0
94668|NCT01288729|226072|P1|NOT COMPLETED|Overall Study||1
94669|NCT01288729|226071|P2|COMPLETED|Overall Study||10
94670|NCT01288729|226072|P1|COMPLETED|Overall Study||9
94671|NCT01288729|226071|P2|STARTED|Overall Study||10
94672|NCT01288729|226072|P1|STARTED|Overall Study||10
94673|NCT01288612|226081|P3|NOT COMPLETED|Overall Study||82
94674|NCT01288612|226082|P2|NOT COMPLETED|Overall Study||82
94675|NCT01288612|226083|P1|NOT COMPLETED|Overall Study||89
94676|NCT01288612|226081|P3|COMPLETED|Overall Study||76
94677|NCT01288612|226082|P2|COMPLETED|Overall Study||69
94678|NCT01288612|226083|P1|COMPLETED|Overall Study||61
94679|NCT01288612|226081|P3|Agreed to Take Part|Overall Study||76
94680|NCT01288612|226082|P2|Agreed to Take Part|Overall Study||72
94681|NCT01288612|226083|P1|Agreed to Take Part|Overall Study||61
94682|NCT01288612|226081|P3|Contacted|Overall Study||138
94683|NCT01288612|226082|P2|Contacted|Overall Study||135
94684|NCT01288612|226083|P1|Contacted|Overall Study||139
94685|NCT01288612|226081|P3|STARTED|Overall Study||158
94686|NCT01288612|226082|P2|STARTED|Overall Study||151
94687|NCT01288612|226083|P1|STARTED|Overall Study||150
94688|NCT01288534|226112|P1|NOT COMPLETED|Overall Study||0
94689|NCT01288534|226112|P1|COMPLETED|Overall Study||68
94690|NCT01288534|226112|P1|STARTED|Overall Study||68
94691|NCT01288469|226119|P3|NOT COMPLETED|Overall Study||2
94692|NCT01288469|226120|P2|NOT COMPLETED|Overall Study||3
94693|NCT01288469|226121|P1|NOT COMPLETED|Overall Study||7
94694|NCT01288469|226119|P3|COMPLETED|Overall Study||28
94695|NCT01288469|226120|P2|COMPLETED|Overall Study||28
94696|NCT01288469|226121|P1|COMPLETED|Overall Study||24
94697|NCT01288469|226119|P3|Treated|Overall Study||30
94698|NCT01288469|226120|P2|Treated|Overall Study||31
94699|NCT01288469|226121|P1|Treated|Overall Study||31
94700|NCT01288469|226119|P3|STARTED|Overall Study|Randomized|30
94701|NCT01288469|226120|P2|STARTED|Overall Study|Randomized|31
94702|NCT01288469|226121|P1|STARTED|Overall Study|Randomized|31
94703|NCT01288443|226153|P6|NOT COMPLETED|Overall Study||5
94704|NCT01288443|226154|P5|NOT COMPLETED|Overall Study||7
94705|NCT01288443|226155|P4|NOT COMPLETED|Overall Study||4
94706|NCT01288443|226156|P3|NOT COMPLETED|Overall Study||1
94707|NCT01288443|226157|P2|NOT COMPLETED|Overall Study||1
94708|NCT01288443|226158|P1|NOT COMPLETED|Overall Study||0
94709|NCT01288443|226153|P6|COMPLETED|Overall Study||25
94710|NCT01288443|226154|P5|COMPLETED|Overall Study||23
94711|NCT01288443|226155|P4|COMPLETED|Overall Study||27
94712|NCT01288443|226156|P3|COMPLETED|Overall Study||30
94713|NCT01288443|226157|P2|COMPLETED|Overall Study||29
94714|NCT01288443|226158|P1|COMPLETED|Overall Study||31
94715|NCT01288443|226153|P6|Treated|Overall Study||30
94716|NCT01288443|226154|P5|Treated|Overall Study||29
94717|NCT01288443|226155|P4|Treated|Overall Study||31
94718|NCT01288443|226156|P3|Treated|Overall Study||31
94719|NCT01288443|226157|P2|Treated|Overall Study||30
94720|NCT01288443|226158|P1|Treated|Overall Study||31
94721|NCT01288443|226153|P6|STARTED|Overall Study|Randomized|30
94722|NCT01288443|226154|P5|STARTED|Overall Study|Randomized|30
94723|NCT01288443|226155|P4|STARTED|Overall Study|Randomized|31
94724|NCT01288443|226156|P3|STARTED|Overall Study|Randomized|31
94725|NCT01288443|226157|P2|STARTED|Overall Study|Randomized|30
94726|NCT01288443|226158|P1|STARTED|Overall Study|Randomized|31
94727|NCT01288287|226208|P1|NOT COMPLETED|Overall Study||46
94728|NCT01288287|226208|P1|COMPLETED|Overall Study||103
94729|NCT01288287|226208|P1|Full Analysis Set|Overall Study||111
94730|NCT01288287|226208|P1|Safety Set|Overall Study||147
94731|NCT01288287|226208|P1|STARTED|Overall Study||149
94732|NCT01288209|226223|P2|NOT COMPLETED|Overall Study||3
94733|NCT01288209|226224|P1|NOT COMPLETED|Overall Study||2
94734|NCT01288209|226223|P2|COMPLETED|Overall Study||50
94735|NCT01288209|226224|P1|COMPLETED|Overall Study||51
94736|NCT01288209|226223|P2|STARTED|Overall Study||53
94737|NCT01288209|226224|P1|STARTED|Overall Study||53
94738|NCT01288079|226254|P4|NOT COMPLETED|Overall Study||17
94739|NCT01288079|226255|P3|NOT COMPLETED|Overall Study||19
94740|NCT01288079|226256|P2|NOT COMPLETED|Overall Study||27
94741|NCT01288079|226257|P1|NOT COMPLETED|Overall Study||20
94742|NCT01288079|226254|P4|COMPLETED|Overall Study||18
94743|NCT01288079|226255|P3|COMPLETED|Overall Study||18
94744|NCT01288079|226256|P2|COMPLETED|Overall Study||9
94745|NCT01288079|226257|P1|COMPLETED|Overall Study||17
94746|NCT01288079|226254|P4|STARTED|Overall Study||35
94747|NCT01288079|226255|P3|STARTED|Overall Study||37
94748|NCT01288079|226256|P2|STARTED|Overall Study||36
94749|NCT01288079|226257|P1|STARTED|Overall Study||37
94750|NCT01288027|226267|P1|NOT COMPLETED|Overall Study||0
94752|NCT01288027|226267|P1|Full Analysis Set (FAS)|Overall Study|All participants who received at least 1 complete infusion of alglucosidase alfa.|16
94753|NCT01288027|226267|P1|STARTED|Overall Study||16
94754|NCT01287897|226281|P4|NOT COMPLETED|Overall Study||7
94755|NCT01287897|226282|P3|NOT COMPLETED|Overall Study||12
94756|NCT01287897|226283|P2|NOT COMPLETED|Overall Study||11
94757|NCT01287897|226284|P1|NOT COMPLETED|Overall Study||11
94758|NCT01287897|226281|P4|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|33
94759|NCT01287897|226282|P3|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
94760|NCT01287897|226283|P2|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|58
94761|NCT01287897|226284|P1|COMPLETED|Overall Study|Include participants who completed the follow-up period or enrolled in NCT01345318.|59
94762|NCT01287897|226281|P4|Enrolled in NCT01345318|Overall Study||29
94763|NCT01287897|226282|P3|Enrolled in NCT01345318|Overall Study||56
94764|NCT01287897|226283|P2|Enrolled in NCT01345318|Overall Study||50
94765|NCT01287897|226284|P1|Enrolled in NCT01345318|Overall Study||56
94766|NCT01287897|226281|P4|Completed Follow-up Period|Overall Study||4
94767|NCT01287897|226282|P3|Completed Follow-up Period|Overall Study||3
94768|NCT01287897|226283|P2|Completed Follow-up Period|Overall Study||8
94769|NCT01287897|226284|P1|Completed Follow-up Period|Overall Study||3
94770|NCT01287897|226281|P4|Completed Treatment Period|Overall Study||29
94771|NCT01287897|226282|P3|Completed Treatment Period|Overall Study||58
94772|NCT01287897|226283|P2|Completed Treatment Period|Overall Study||52
94773|NCT01287897|226284|P1|Completed Treatment Period|Overall Study||58
94774|NCT01287897|226281|P4|Treated|Overall Study||40
94775|NCT01287897|226282|P3|Treated|Overall Study||71
94776|NCT01287897|226283|P2|Treated|Overall Study||67
94777|NCT01287897|226284|P1|Treated|Overall Study||69
94778|NCT01287897|226281|P4|STARTED|Overall Study|Enrollment was halted before reaching the planned sample size due to safety findings in NCT01405196.|40
94779|NCT01287897|226282|P3|STARTED|Overall Study||71
94780|NCT01287897|226283|P2|STARTED|Overall Study||69
94781|NCT01287897|226284|P1|STARTED|Overall Study||70
94782|NCT01287832|226335|P2|NOT COMPLETED|Overall Study||1
94783|NCT01287832|226336|P1|NOT COMPLETED|Overall Study||1
94784|NCT01287832|226335|P2|COMPLETED|Overall Study||4
94785|NCT01287832|226336|P1|COMPLETED|Overall Study||5
94786|NCT01287832|226335|P2|STARTED|Overall Study||5
94787|NCT01287832|226336|P1|STARTED|Overall Study||6
94788|NCT01287754|226344|P2|NOT COMPLETED|Overall Study||21
94789|NCT01287754|226345|P1|NOT COMPLETED|Overall Study||3
94790|NCT01287754|226344|P2|COMPLETED|Overall Study||0
94791|NCT01287754|226345|P1|COMPLETED|Overall Study||0
94792|NCT01287754|226344|P2|STARTED|Overall Study||21
94793|NCT01287754|226345|P1|STARTED|Overall Study||3
94794|NCT01287741|226357|P2|NOT COMPLETED|Overall Study||706
94795|NCT01287741|226358|P1|NOT COMPLETED|Overall Study||712
94796|NCT01287741|226357|P2|COMPLETED|Overall Study||0
94797|NCT01287741|226358|P1|COMPLETED|Overall Study||0
94798|NCT01287741|226357|P2|STARTED|Overall Study||706
94799|NCT01287741|226358|P1|STARTED|Overall Study||712
94800|NCT01287611|226394|P2|NOT COMPLETED|Overall Study||19
94801|NCT01287611|226395|P1|NOT COMPLETED|Overall Study||33
94802|NCT01287611|226394|P2|COMPLETED|Overall Study||65
94803|NCT01287611|226395|P1|COMPLETED|Overall Study||51
94804|NCT01287611|226394|P2|The Number of Patients Who Underwent C/S|Overall Study||84
94805|NCT01287611|226395|P1|The Number of Patients Who Underwent C/S|Overall Study||84
94806|NCT01287611|226394|P2|STARTED|Overall Study||84
94807|NCT01287611|226395|P1|STARTED|Overall Study||84
94808|NCT01287416|226405|P2|NOT COMPLETED|6 Month Follow-up||2
94809|NCT01287416|226406|P1|NOT COMPLETED|6 Month Follow-up||3
94810|NCT01287416|226405|P2|COMPLETED|6 Month Follow-up||22
94811|NCT01287416|226406|P1|COMPLETED|6 Month Follow-up||28
94812|NCT01287416|226405|P2|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|24
94813|NCT01287416|226406|P1|STARTED|6 Month Follow-up|all participants that had completed the baseline measure were invited to do the follow-up|31
94814|NCT01287416|226405|P2|NOT COMPLETED|Pre-post Training||25
94815|NCT01287416|226406|P1|NOT COMPLETED|Pre-post Training||22
94816|NCT01287416|226405|P2|COMPLETED|Pre-post Training||23
94817|NCT01287416|226406|P1|COMPLETED|Pre-post Training||26
94818|NCT01287416|226405|P2|Post Training Questionnaire|Pre-post Training||23
94819|NCT01287416|226406|P1|Post Training Questionnaire|Pre-post Training||26
94820|NCT01287416|226405|P2|Training Workshop|Pre-post Training|number of people that showed up for the training session|24
94821|NCT01287416|226406|P1|Training Workshop|Pre-post Training|number of people that showed up for the training session|31
94822|NCT01287416|226405|P2|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
94823|NCT01287416|226406|P1|STARTED|Pre-post Training|number of people that were invited to participate based on eligibility and consent received|48
94824|NCT01287403|226442|P1|NOT COMPLETED|6th and Last Intervention (1 Day)||0
94825|NCT01287403|226442|P1|COMPLETED|6th and Last Intervention (1 Day)||13
94826|NCT01287403|226442|P1|STARTED|6th and Last Intervention (1 Day)||13
94827|NCT01287403|226442|P1|NOT COMPLETED|Washout (7 Days)||0
94828|NCT01287403|226442|P1|COMPLETED|Washout (7 Days)||13
94829|NCT01287403|226442|P1|STARTED|Washout (7 Days)||13
94830|NCT01287403|226442|P1|NOT COMPLETED|5th Intervention (1 Day)||0
94831|NCT01287403|226442|P1|COMPLETED|5th Intervention (1 Day)||13
94832|NCT01287403|226442|P1|STARTED|5th Intervention (1 Day)||13
94833|NCT01287403|226442|P1|NOT COMPLETED|Washout (7 Days)||0
94834|NCT01287403|226442|P1|COMPLETED|Washout (7 Days)||13
94835|NCT01287403|226442|P1|STARTED|Washout (7 Days)||13
94836|NCT01287403|226442|P1|NOT COMPLETED|4th Intervention (1 Day)||0
94837|NCT01287403|226442|P1|COMPLETED|4th Intervention (1 Day)||13
94838|NCT01287403|226442|P1|STARTED|4th Intervention (1 Day)||13
94839|NCT01287403|226442|P1|NOT COMPLETED|Washout (7 Days)||0
94840|NCT01287403|226442|P1|COMPLETED|Washout (7 Days)||13
94841|NCT01287403|226442|P1|STARTED|Washout (7 Days)||13
94842|NCT01287403|226442|P1|NOT COMPLETED|3rd Intervention (1 Day)||0
94843|NCT01287403|226442|P1|COMPLETED|3rd Intervention (1 Day)||13
94844|NCT01287403|226442|P1|STARTED|3rd Intervention (1 Day)||13
94845|NCT01287403|226442|P1|NOT COMPLETED|Washout (7 Days)||0
94846|NCT01287403|226442|P1|COMPLETED|Washout (7 Days)||13
94847|NCT01287403|226442|P1|STARTED|Washout (7 Days)||13
94848|NCT01287403|226442|P1|NOT COMPLETED|2nd Intervention (1 Day)||0
94849|NCT01287403|226442|P1|COMPLETED|2nd Intervention (1 Day)||13
94850|NCT01287403|226442|P1|STARTED|2nd Intervention (1 Day)||13
94851|NCT01287403|226442|P1|NOT COMPLETED|Washout 7 Days||0
94852|NCT01287403|226442|P1|COMPLETED|Washout 7 Days||13
94853|NCT01287403|226442|P1|STARTED|Washout 7 Days||13
94854|NCT01287403|226442|P1|NOT COMPLETED|1st Intervention (1 Day)||1
94855|NCT01287403|226442|P1|COMPLETED|1st Intervention (1 Day)|"The adverse event was linked to the intake of refined wheat flour"|13
94856|NCT01287403|226442|P1|STARTED|1st Intervention (1 Day)||14
94857|NCT01287403|226442|P1|NOT COMPLETED|Diet Restriction (7 Days)||0
94858|NCT01287403|226442|P1|COMPLETED|Diet Restriction (7 Days)||14
94859|NCT01287403|226442|P1|STARTED|Diet Restriction (7 Days)||14
94860|NCT01287364|226458|P2|NOT COMPLETED|Overall Study||10
94861|NCT01287364|226459|P1|NOT COMPLETED|Overall Study||9
94862|NCT01287364|226458|P2|COMPLETED|Overall Study||81
94863|NCT01287364|226459|P1|COMPLETED|Overall Study||85
94864|NCT01287364|226458|P2|STARTED|Overall Study||91
94865|NCT01287364|226459|P1|STARTED|Overall Study||94
94866|NCT01287221|226481|P2|NOT COMPLETED|Overall Study||5
94867|NCT01287221|226482|P1|NOT COMPLETED|Overall Study||4
94868|NCT01287221|226481|P2|COMPLETED|Overall Study||45
94869|NCT01287221|226482|P1|COMPLETED|Overall Study||46
94870|NCT01287221|226481|P2|Completed 12 Months Follow-up|Overall Study||39
94871|NCT01287221|226482|P1|Completed 12 Months Follow-up|Overall Study||40
94872|NCT01287221|226481|P2|Completed 9 Months Follow-up|Overall Study||40
94873|NCT01287221|226482|P1|Completed 9 Months Follow-up|Overall Study||42
94874|NCT01287221|226481|P2|Completed 6 Months Follow-up|Overall Study||43
94875|NCT01287221|226482|P1|Completed 6 Months Follow-up|Overall Study||47
94876|NCT01287221|226481|P2|Completed 3 Months Follow-up|Overall Study||50
94877|NCT01287221|226482|P1|Completed 3 Months Follow-up|Overall Study||49
94878|NCT01287221|226481|P2|STARTED|Overall Study||50
94879|NCT01287221|226482|P1|STARTED|Overall Study||50
94880|NCT01287208|226502|P2|NOT COMPLETED|Phase 2: Team Competition||0
94881|NCT01287208|226503|P1|NOT COMPLETED|Phase 2: Team Competition||0
94882|NCT01287208|226502|P2|COMPLETED|Phase 2: Team Competition||49
94883|NCT01287208|226503|P1|COMPLETED|Phase 2: Team Competition||50
94884|NCT01287208|226502|P2|STARTED|Phase 2: Team Competition||49
94885|NCT01287208|226503|P1|STARTED|Phase 2: Team Competition||50
94886|NCT01287208|226502|P2|NOT COMPLETED|Phase 1: Randomized Phase||3
94887|NCT01287208|226503|P1|NOT COMPLETED|Phase 1: Randomized Phase||2
94888|NCT01287208|226502|P2|COMPLETED|Phase 1: Randomized Phase||49
94889|NCT01287208|226503|P1|COMPLETED|Phase 1: Randomized Phase||50
94890|NCT01287208|226502|P2|STARTED|Phase 1: Randomized Phase||52
94891|NCT01287208|226503|P1|STARTED|Phase 1: Randomized Phase||52
94892|NCT01287195|226509|P1|NOT COMPLETED|Overall Study||2
94893|NCT01287195|226509|P1|COMPLETED|Overall Study||4
94894|NCT01287195|226509|P1|STARTED|Overall Study||6
94895|NCT01287117|226524|P4|NOT COMPLETED|Overall Study||12
94896|NCT01287117|226525|P3|NOT COMPLETED|Overall Study||16
94897|NCT01287117|226526|P2|NOT COMPLETED|Overall Study||14
94898|NCT01287117|226527|P1|NOT COMPLETED|Overall Study||15
94899|NCT01287117|226524|P4|COMPLETED|Overall Study||69
94900|NCT01287117|226525|P3|COMPLETED|Overall Study||64
94901|NCT01287117|226526|P2|COMPLETED|Overall Study||64
94902|NCT01287117|226527|P1|COMPLETED|Overall Study||65
94903|NCT01287117|226524|P4|Received Treatment|Overall Study||81
94904|NCT01287117|226525|P3|Received Treatment|Overall Study||80
94905|NCT01287117|226526|P2|Received Treatment|Overall Study||77
94906|NCT01287117|226527|P1|Received Treatment|Overall Study||80
94907|NCT01287117|226524|P4|STARTED|Overall Study||81
94908|NCT01287117|226525|P3|STARTED|Overall Study||80
94909|NCT01287117|226526|P2|STARTED|Overall Study||78
94910|NCT01287117|226527|P1|STARTED|Overall Study||80
94911|NCT01287065|226573|P6|NOT COMPLETED|Treatment Period 3||0
94912|NCT01287065|226574|P5|NOT COMPLETED|Treatment Period 3||0
94913|NCT01287065|226575|P4|NOT COMPLETED|Treatment Period 3||0
94914|NCT01287065|226576|P3|NOT COMPLETED|Treatment Period 3||0
94915|NCT01287065|226577|P2|NOT COMPLETED|Treatment Period 3||0
94916|NCT01287065|226578|P1|NOT COMPLETED|Treatment Period 3||0
94917|NCT01287065|226573|P6|COMPLETED|Treatment Period 3||4
94918|NCT01287065|226574|P5|COMPLETED|Treatment Period 3||4
94919|NCT01287065|226575|P4|COMPLETED|Treatment Period 3||4
94920|NCT01287065|226576|P3|COMPLETED|Treatment Period 3||4
94921|NCT01287065|226577|P2|COMPLETED|Treatment Period 3||4
94922|NCT01287065|226578|P1|COMPLETED|Treatment Period 3||4
94923|NCT01287065|226573|P6|STARTED|Treatment Period 3||4
94924|NCT01287065|226574|P5|STARTED|Treatment Period 3||4
94925|NCT01287065|226575|P4|STARTED|Treatment Period 3||4
94926|NCT01287065|226576|P3|STARTED|Treatment Period 3||4
94927|NCT01287065|226577|P2|STARTED|Treatment Period 3||4
94928|NCT01287065|226578|P1|STARTED|Treatment Period 3||4
94929|NCT01287065|226573|P6|NOT COMPLETED|Washout Period 2||0
94930|NCT01287065|226574|P5|NOT COMPLETED|Washout Period 2||0
94931|NCT01287065|226575|P4|NOT COMPLETED|Washout Period 2||0
94932|NCT01287065|226576|P3|NOT COMPLETED|Washout Period 2||0
94933|NCT01287065|226577|P2|NOT COMPLETED|Washout Period 2||0
94934|NCT01287065|226578|P1|NOT COMPLETED|Washout Period 2||0
94935|NCT01287065|226573|P6|COMPLETED|Washout Period 2||4
94936|NCT01287065|226574|P5|COMPLETED|Washout Period 2||4
94937|NCT01287065|226575|P4|COMPLETED|Washout Period 2||4
94938|NCT01287065|226576|P3|COMPLETED|Washout Period 2||4
94939|NCT01287065|226577|P2|COMPLETED|Washout Period 2||4
94940|NCT01287065|226578|P1|COMPLETED|Washout Period 2||4
94941|NCT01287065|226573|P6|STARTED|Washout Period 2||4
94942|NCT01287065|226574|P5|STARTED|Washout Period 2||4
94943|NCT01287065|226575|P4|STARTED|Washout Period 2||4
94944|NCT01287065|226576|P3|STARTED|Washout Period 2||4
94945|NCT01287065|226577|P2|STARTED|Washout Period 2||4
94946|NCT01287065|226578|P1|STARTED|Washout Period 2||4
94947|NCT01287065|226573|P6|NOT COMPLETED|Treatment Period 2||0
94948|NCT01287065|226574|P5|NOT COMPLETED|Treatment Period 2||0
94949|NCT01287065|226575|P4|NOT COMPLETED|Treatment Period 2||0
94950|NCT01287065|226576|P3|NOT COMPLETED|Treatment Period 2||0
94951|NCT01287065|226577|P2|NOT COMPLETED|Treatment Period 2||0
94952|NCT01287065|226578|P1|NOT COMPLETED|Treatment Period 2||0
94953|NCT01287065|226573|P6|COMPLETED|Treatment Period 2||4
94954|NCT01287065|226574|P5|COMPLETED|Treatment Period 2||4
94955|NCT01287065|226575|P4|COMPLETED|Treatment Period 2||4
94956|NCT01287065|226576|P3|COMPLETED|Treatment Period 2||4
94957|NCT01287065|226577|P2|COMPLETED|Treatment Period 2||4
94958|NCT01287065|226578|P1|COMPLETED|Treatment Period 2||4
94959|NCT01287065|226573|P6|STARTED|Treatment Period 2||4
94960|NCT01287065|226574|P5|STARTED|Treatment Period 2||4
94961|NCT01287065|226575|P4|STARTED|Treatment Period 2||4
94962|NCT01287065|226576|P3|STARTED|Treatment Period 2||4
94963|NCT01287065|226577|P2|STARTED|Treatment Period 2||4
94964|NCT01287065|226578|P1|STARTED|Treatment Period 2||4
94965|NCT01287065|226573|P6|NOT COMPLETED|Washout Period 1||0
94966|NCT01287065|226574|P5|NOT COMPLETED|Washout Period 1||0
94967|NCT01287065|226575|P4|NOT COMPLETED|Washout Period 1||0
94968|NCT01287065|226576|P3|NOT COMPLETED|Washout Period 1||0
94969|NCT01287065|226577|P2|NOT COMPLETED|Washout Period 1||0
94970|NCT01287065|226578|P1|NOT COMPLETED|Washout Period 1||0
94971|NCT01287065|226573|P6|COMPLETED|Washout Period 1||4
94972|NCT01287065|226574|P5|COMPLETED|Washout Period 1||4
94973|NCT01287065|226575|P4|COMPLETED|Washout Period 1||4
94974|NCT01287065|226576|P3|COMPLETED|Washout Period 1||4
94975|NCT01287065|226577|P2|COMPLETED|Washout Period 1||4
94976|NCT01287065|226578|P1|COMPLETED|Washout Period 1||4
94977|NCT01287065|226573|P6|STARTED|Washout Period 1||4
94978|NCT01287065|226574|P5|STARTED|Washout Period 1||4
94979|NCT01287065|226575|P4|STARTED|Washout Period 1||4
94980|NCT01287065|226576|P3|STARTED|Washout Period 1||4
94981|NCT01287065|226577|P2|STARTED|Washout Period 1||4
94982|NCT01287065|226578|P1|STARTED|Washout Period 1||4
94983|NCT01287065|226573|P6|NOT COMPLETED|Treatment Period 1||1
94984|NCT01287065|226574|P5|NOT COMPLETED|Treatment Period 1||1
94985|NCT01287065|226575|P4|NOT COMPLETED|Treatment Period 1||0
94986|NCT01287065|226576|P3|NOT COMPLETED|Treatment Period 1||0
94987|NCT01287065|226577|P2|NOT COMPLETED|Treatment Period 1||0
94988|NCT01287065|226578|P1|NOT COMPLETED|Treatment Period 1||0
94989|NCT01287065|226573|P6|COMPLETED|Treatment Period 1||4
94990|NCT01287065|226574|P5|COMPLETED|Treatment Period 1||4
94991|NCT01287065|226575|P4|COMPLETED|Treatment Period 1||4
94992|NCT01287065|226576|P3|COMPLETED|Treatment Period 1||4
94993|NCT01287065|226577|P2|COMPLETED|Treatment Period 1||4
94994|NCT01287065|226578|P1|COMPLETED|Treatment Period 1||4
94995|NCT01287065|226573|P6|STARTED|Treatment Period 1||5
94996|NCT01287065|226574|P5|STARTED|Treatment Period 1||5
94997|NCT01287065|226575|P4|STARTED|Treatment Period 1||4
94998|NCT01287065|226576|P3|STARTED|Treatment Period 1||4
94999|NCT01287065|226577|P2|STARTED|Treatment Period 1||4
95000|NCT01287065|226578|P1|STARTED|Treatment Period 1||4
95001|NCT01287039|226597|P2|NOT COMPLETED|Overall Study||27
95002|NCT01287039|226598|P1|NOT COMPLETED|Overall Study||29
95003|NCT01287039|226597|P2|COMPLETED|Overall Study||218
95004|NCT01287039|226598|P1|COMPLETED|Overall Study||215
95005|NCT01287039|226597|P2|STARTED|Overall Study||245
95006|NCT01287039|226598|P1|STARTED|Overall Study||244
95007|NCT01286818|226628|P1|NOT COMPLETED|Overall Study||0
95008|NCT01286818|226628|P1|COMPLETED|Overall Study||6
95009|NCT01286818|226628|P1|Completed DLT Assessment Period|Overall Study||5
95010|NCT01286818|226628|P1|STARTED|Overall Study||6
95011|NCT01286805|226642|P2|NOT COMPLETED|Overall Study||1
95012|NCT01286805|226643|P1|NOT COMPLETED|Overall Study||0
95013|NCT01286805|226642|P2|COMPLETED|Overall Study||41
95014|NCT01286805|226643|P1|COMPLETED|Overall Study||41
95015|NCT01286805|226642|P2|STARTED|Overall Study||42
95016|NCT01286805|226643|P1|STARTED|Overall Study||41
95017|NCT01286753|226665|P2|NOT COMPLETED|Overall Study||25
95018|NCT01286753|226666|P1|NOT COMPLETED|Overall Study||26
95019|NCT01286753|226665|P2|COMPLETED|Overall Study||0
95020|NCT01286753|226666|P1|COMPLETED|Overall Study||0
95021|NCT01286753|226665|P2|STARTED|Overall Study||25
95022|NCT01286753|226666|P1|STARTED|Overall Study||26
95023|NCT01286740|226684|P1|NOT COMPLETED|Overall Study||2
95024|NCT01286740|226684|P1|COMPLETED|Overall Study||48
95025|NCT01286740|226684|P1|Week 12 (Primary Endpoint)|Overall Study||49
95026|NCT01286740|226684|P1|Enrolled and Treated|Overall Study||49
95027|NCT01286740|226684|P1|STARTED|Overall Study||50
95028|NCT01286558|226702|P2|NOT COMPLETED|Overall Study||2
95029|NCT01286558|226703|P1|NOT COMPLETED|Overall Study||1
95030|NCT01286558|226702|P2|COMPLETED|Overall Study||111
95031|NCT01286558|226703|P1|COMPLETED|Overall Study||111
95032|NCT01286558|226702|P2|STARTED|Overall Study||113
95033|NCT01286558|226703|P1|STARTED|Overall Study||112
95034|NCT01286493|226733|P1|NOT COMPLETED|Overall Study||3
95035|NCT01286493|226733|P1|COMPLETED|Overall Study||30
95036|NCT01286493|226733|P1|STARTED|Overall Study||33
95037|NCT01286480|226739|P2|NOT COMPLETED|Overall Study||3
95038|NCT01286480|226740|P1|NOT COMPLETED|Overall Study||5
95039|NCT01286480|226739|P2|COMPLETED|Overall Study||31
95040|NCT01286480|226740|P1|COMPLETED|Overall Study||27
95041|NCT01286480|226739|P2|STARTED|Overall Study||34
95042|NCT01286480|226740|P1|STARTED|Overall Study||32
95043|NCT01286454|226748|P11|NOT COMPLETED|Part II- Sixth Intervention Period||0
95044|NCT01286454|226749|P10|NOT COMPLETED|Part II- Sixth Intervention Period||0
95045|NCT01286454|226750|P9|NOT COMPLETED|Part II- Sixth Intervention Period||0
95046|NCT01286454|226751|P8|NOT COMPLETED|Part II- Sixth Intervention Period||0
95047|NCT01286454|226752|P7|NOT COMPLETED|Part II- Sixth Intervention Period||0
95048|NCT01286454|226753|P6|NOT COMPLETED|Part II- Sixth Intervention Period||0
95049|NCT01286454|226754|P5|NOT COMPLETED|Part II- Sixth Intervention Period||0
95050|NCT01286454|226755|P4|NOT COMPLETED|Part II- Sixth Intervention Period||0
95051|NCT01286454|226756|P3|NOT COMPLETED|Part II- Sixth Intervention Period||0
95052|NCT01286454|226757|P2|NOT COMPLETED|Part II- Sixth Intervention Period||0
95053|NCT01286454|226758|P1|NOT COMPLETED|Part II- Sixth Intervention Period||0
95054|NCT01286454|226748|P11|COMPLETED|Part II- Sixth Intervention Period||20
95055|NCT01286454|226749|P10|COMPLETED|Part II- Sixth Intervention Period||0
95056|NCT01286454|226750|P9|COMPLETED|Part II- Sixth Intervention Period||0
95057|NCT01286454|226751|P8|COMPLETED|Part II- Sixth Intervention Period||0
95058|NCT01286454|226752|P7|COMPLETED|Part II- Sixth Intervention Period||0
95059|NCT01286454|226753|P6|COMPLETED|Part II- Sixth Intervention Period||0
95060|NCT01286454|226754|P5|COMPLETED|Part II- Sixth Intervention Period||0
95061|NCT01286454|226755|P4|COMPLETED|Part II- Sixth Intervention Period||0
95062|NCT01286454|226756|P3|COMPLETED|Part II- Sixth Intervention Period||0
95063|NCT01286454|226757|P2|COMPLETED|Part II- Sixth Intervention Period||0
95064|NCT01286454|226758|P1|COMPLETED|Part II- Sixth Intervention Period||0
95065|NCT01286454|226748|P11|STARTED|Part II- Sixth Intervention Period||20
95066|NCT01286454|226749|P10|STARTED|Part II- Sixth Intervention Period||0
95067|NCT01286454|226750|P9|STARTED|Part II- Sixth Intervention Period||0
95068|NCT01286454|226751|P8|STARTED|Part II- Sixth Intervention Period||0
95069|NCT01286454|226752|P7|STARTED|Part II- Sixth Intervention Period||0
95070|NCT01286454|226753|P6|STARTED|Part II- Sixth Intervention Period||0
95071|NCT01286454|226754|P5|STARTED|Part II- Sixth Intervention Period||0
95072|NCT01286454|226755|P4|STARTED|Part II- Sixth Intervention Period||0
95073|NCT01286454|226756|P3|STARTED|Part II- Sixth Intervention Period||0
95074|NCT01286454|226757|P2|STARTED|Part II- Sixth Intervention Period||0
95075|NCT01286454|226758|P1|STARTED|Part II- Sixth Intervention Period||0
95076|NCT01286454|226748|P11|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95077|NCT01286454|226749|P10|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95078|NCT01286454|226750|P9|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95079|NCT01286454|226751|P8|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95080|NCT01286454|226752|P7|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95081|NCT01286454|226753|P6|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95082|NCT01286454|226754|P5|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95083|NCT01286454|226755|P4|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95084|NCT01286454|226756|P3|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95085|NCT01286454|226757|P2|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95086|NCT01286454|226758|P1|NOT COMPLETED|Washout Period (Approximately 2 Weeks)||0
95087|NCT01286454|226748|P11|COMPLETED|Washout Period (Approximately 2 Weeks)||0
95088|NCT01286454|226749|P10|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95089|NCT01286454|226750|P9|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95090|NCT01286454|226751|P8|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95091|NCT01286454|226752|P7|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95092|NCT01286454|226753|P6|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95093|NCT01286454|226754|P5|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95094|NCT01286454|226755|P4|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95095|NCT01286454|226756|P3|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95096|NCT01286454|226757|P2|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95097|NCT01286454|226758|P1|COMPLETED|Washout Period (Approximately 2 Weeks)||2
95098|NCT01286454|226748|P11|STARTED|Washout Period (Approximately 2 Weeks)||0
95099|NCT01286454|226749|P10|STARTED|Washout Period (Approximately 2 Weeks)||2
95100|NCT01286454|226750|P9|STARTED|Washout Period (Approximately 2 Weeks)||2
95101|NCT01286454|226751|P8|STARTED|Washout Period (Approximately 2 Weeks)||2
95102|NCT01286454|226752|P7|STARTED|Washout Period (Approximately 2 Weeks)||2
95103|NCT01286454|226753|P6|STARTED|Washout Period (Approximately 2 Weeks)||2
95104|NCT01286454|226754|P5|STARTED|Washout Period (Approximately 2 Weeks)||2
95105|NCT01286454|226755|P4|STARTED|Washout Period (Approximately 2 Weeks)||2
95106|NCT01286454|226756|P3|STARTED|Washout Period (Approximately 2 Weeks)||2
95107|NCT01286454|226757|P2|STARTED|Washout Period (Approximately 2 Weeks)||2
95108|NCT01286454|226758|P1|STARTED|Washout Period (Approximately 2 Weeks)||2
95109|NCT01286454|226748|P11|NOT COMPLETED|Fifth Intervention Period||0
95110|NCT01286454|226749|P10|NOT COMPLETED|Fifth Intervention Period||0
95111|NCT01286454|226750|P9|NOT COMPLETED|Fifth Intervention Period||0
95112|NCT01286454|226751|P8|NOT COMPLETED|Fifth Intervention Period||0
95113|NCT01286454|226752|P7|NOT COMPLETED|Fifth Intervention Period||0
95114|NCT01286454|226753|P6|NOT COMPLETED|Fifth Intervention Period||0
95115|NCT01286454|226754|P5|NOT COMPLETED|Fifth Intervention Period||0
95116|NCT01286454|226755|P4|NOT COMPLETED|Fifth Intervention Period||0
95117|NCT01286454|226756|P3|NOT COMPLETED|Fifth Intervention Period||0
95118|NCT01286454|226757|P2|NOT COMPLETED|Fifth Intervention Period||0
95119|NCT01286454|226758|P1|NOT COMPLETED|Fifth Intervention Period||0
95120|NCT01286454|226748|P11|COMPLETED|Fifth Intervention Period||0
95121|NCT01286454|226749|P10|COMPLETED|Fifth Intervention Period||2
95122|NCT01286454|226750|P9|COMPLETED|Fifth Intervention Period||2
95123|NCT01286454|226751|P8|COMPLETED|Fifth Intervention Period||2
95124|NCT01286454|226752|P7|COMPLETED|Fifth Intervention Period||2
95125|NCT01286454|226753|P6|COMPLETED|Fifth Intervention Period||2
95126|NCT01286454|226754|P5|COMPLETED|Fifth Intervention Period||2
95127|NCT01286454|226755|P4|COMPLETED|Fifth Intervention Period||2
95128|NCT01286454|226756|P3|COMPLETED|Fifth Intervention Period||2
95129|NCT01286454|226757|P2|COMPLETED|Fifth Intervention Period||2
95130|NCT01286454|226758|P1|COMPLETED|Fifth Intervention Period||2
95131|NCT01286454|226748|P11|STARTED|Fifth Intervention Period||0
95132|NCT01286454|226749|P10|STARTED|Fifth Intervention Period||2
95133|NCT01286454|226750|P9|STARTED|Fifth Intervention Period||2
95134|NCT01286454|226751|P8|STARTED|Fifth Intervention Period||2
95135|NCT01286454|226752|P7|STARTED|Fifth Intervention Period||2
95136|NCT01286454|226753|P6|STARTED|Fifth Intervention Period||2
95137|NCT01286454|226754|P5|STARTED|Fifth Intervention Period||2
95138|NCT01286454|226755|P4|STARTED|Fifth Intervention Period||2
95139|NCT01286454|226756|P3|STARTED|Fifth Intervention Period||2
95140|NCT01286454|226757|P2|STARTED|Fifth Intervention Period||2
95141|NCT01286454|226758|P1|STARTED|Fifth Intervention Period||2
95142|NCT01286454|226748|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95143|NCT01286454|226749|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95144|NCT01286454|226750|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95145|NCT01286454|226751|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95146|NCT01286454|226752|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95147|NCT01286454|226753|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95148|NCT01286454|226754|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95149|NCT01286454|226755|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95150|NCT01286454|226756|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95151|NCT01286454|226757|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95152|NCT01286454|226758|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95153|NCT01286454|226748|P11|COMPLETED|Washout Period (At Least 3 Days)||0
95154|NCT01286454|226749|P10|COMPLETED|Washout Period (At Least 3 Days)||2
95155|NCT01286454|226750|P9|COMPLETED|Washout Period (At Least 3 Days)||2
95156|NCT01286454|226751|P8|COMPLETED|Washout Period (At Least 3 Days)||2
95157|NCT01286454|226752|P7|COMPLETED|Washout Period (At Least 3 Days)||2
95158|NCT01286454|226753|P6|COMPLETED|Washout Period (At Least 3 Days)||2
95159|NCT01286454|226754|P5|COMPLETED|Washout Period (At Least 3 Days)||2
95160|NCT01286454|226755|P4|COMPLETED|Washout Period (At Least 3 Days)||2
95161|NCT01286454|226756|P3|COMPLETED|Washout Period (At Least 3 Days)||2
95162|NCT01286454|226757|P2|COMPLETED|Washout Period (At Least 3 Days)||2
95163|NCT01286454|226758|P1|COMPLETED|Washout Period (At Least 3 Days)||2
95164|NCT01286454|226748|P11|STARTED|Washout Period (At Least 3 Days)||0
95165|NCT01286454|226749|P10|STARTED|Washout Period (At Least 3 Days)||2
95166|NCT01286454|226750|P9|STARTED|Washout Period (At Least 3 Days)||2
95167|NCT01286454|226751|P8|STARTED|Washout Period (At Least 3 Days)||2
95168|NCT01286454|226752|P7|STARTED|Washout Period (At Least 3 Days)||2
95169|NCT01286454|226753|P6|STARTED|Washout Period (At Least 3 Days)||2
95170|NCT01286454|226754|P5|STARTED|Washout Period (At Least 3 Days)||2
95171|NCT01286454|226755|P4|STARTED|Washout Period (At Least 3 Days)||2
95172|NCT01286454|226756|P3|STARTED|Washout Period (At Least 3 Days)||2
95173|NCT01286454|226757|P2|STARTED|Washout Period (At Least 3 Days)||2
95174|NCT01286454|226758|P1|STARTED|Washout Period (At Least 3 Days)||2
95175|NCT01286454|226748|P11|NOT COMPLETED|Fourth Intervention Period||0
95176|NCT01286454|226749|P10|NOT COMPLETED|Fourth Intervention Period||0
95177|NCT01286454|226750|P9|NOT COMPLETED|Fourth Intervention Period||0
95178|NCT01286454|226751|P8|NOT COMPLETED|Fourth Intervention Period||0
95179|NCT01286454|226752|P7|NOT COMPLETED|Fourth Intervention Period||0
95180|NCT01286454|226753|P6|NOT COMPLETED|Fourth Intervention Period||0
95181|NCT01286454|226754|P5|NOT COMPLETED|Fourth Intervention Period||0
95182|NCT01286454|226755|P4|NOT COMPLETED|Fourth Intervention Period||0
95183|NCT01286454|226756|P3|NOT COMPLETED|Fourth Intervention Period||0
95184|NCT01286454|226757|P2|NOT COMPLETED|Fourth Intervention Period||0
95185|NCT01286454|226758|P1|NOT COMPLETED|Fourth Intervention Period||0
95186|NCT01286454|226748|P11|COMPLETED|Fourth Intervention Period||0
95187|NCT01286454|226749|P10|COMPLETED|Fourth Intervention Period||2
95188|NCT01286454|226750|P9|COMPLETED|Fourth Intervention Period||2
95189|NCT01286454|226751|P8|COMPLETED|Fourth Intervention Period||2
95190|NCT01286454|226752|P7|COMPLETED|Fourth Intervention Period||2
95191|NCT01286454|226753|P6|COMPLETED|Fourth Intervention Period||2
95192|NCT01286454|226754|P5|COMPLETED|Fourth Intervention Period||2
95193|NCT01286454|226755|P4|COMPLETED|Fourth Intervention Period||2
95194|NCT01286454|226756|P3|COMPLETED|Fourth Intervention Period||2
95195|NCT01286454|226757|P2|COMPLETED|Fourth Intervention Period||2
95196|NCT01286454|226758|P1|COMPLETED|Fourth Intervention Period||2
95197|NCT01286454|226748|P11|STARTED|Fourth Intervention Period||0
95198|NCT01286454|226749|P10|STARTED|Fourth Intervention Period||2
95199|NCT01286454|226750|P9|STARTED|Fourth Intervention Period||2
95200|NCT01286454|226751|P8|STARTED|Fourth Intervention Period||2
95201|NCT01286454|226752|P7|STARTED|Fourth Intervention Period||2
95202|NCT01286454|226753|P6|STARTED|Fourth Intervention Period||2
95203|NCT01286454|226754|P5|STARTED|Fourth Intervention Period||2
95204|NCT01286454|226755|P4|STARTED|Fourth Intervention Period||2
95205|NCT01286454|226756|P3|STARTED|Fourth Intervention Period||2
95206|NCT01286454|226757|P2|STARTED|Fourth Intervention Period||2
95207|NCT01286454|226758|P1|STARTED|Fourth Intervention Period||2
95208|NCT01286454|226748|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95209|NCT01286454|226749|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95210|NCT01286454|226750|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95211|NCT01286454|226751|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95212|NCT01286454|226752|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95213|NCT01286454|226753|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95214|NCT01286454|226754|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95215|NCT01286454|226755|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95216|NCT01286454|226756|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95217|NCT01286454|226757|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95218|NCT01286454|226758|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95219|NCT01286454|226748|P11|COMPLETED|Washout Period (At Least 3 Days)||0
95220|NCT01286454|226749|P10|COMPLETED|Washout Period (At Least 3 Days)||2
95221|NCT01286454|226750|P9|COMPLETED|Washout Period (At Least 3 Days)||2
95222|NCT01286454|226751|P8|COMPLETED|Washout Period (At Least 3 Days)||2
95223|NCT01286454|226752|P7|COMPLETED|Washout Period (At Least 3 Days)||2
95224|NCT01286454|226753|P6|COMPLETED|Washout Period (At Least 3 Days)||2
95225|NCT01286454|226754|P5|COMPLETED|Washout Period (At Least 3 Days)||2
95226|NCT01286454|226755|P4|COMPLETED|Washout Period (At Least 3 Days)||2
95227|NCT01286454|226756|P3|COMPLETED|Washout Period (At Least 3 Days)||2
95228|NCT01286454|226757|P2|COMPLETED|Washout Period (At Least 3 Days)||2
95229|NCT01286454|226758|P1|COMPLETED|Washout Period (At Least 3 Days)||2
95230|NCT01286454|226748|P11|STARTED|Washout Period (At Least 3 Days)||0
95231|NCT01286454|226749|P10|STARTED|Washout Period (At Least 3 Days)||2
95232|NCT01286454|226750|P9|STARTED|Washout Period (At Least 3 Days)||2
95233|NCT01286454|226751|P8|STARTED|Washout Period (At Least 3 Days)||2
95234|NCT01286454|226752|P7|STARTED|Washout Period (At Least 3 Days)||2
95235|NCT01286454|226753|P6|STARTED|Washout Period (At Least 3 Days)||2
95236|NCT01286454|226754|P5|STARTED|Washout Period (At Least 3 Days)||2
95237|NCT01286454|226755|P4|STARTED|Washout Period (At Least 3 Days)||2
95238|NCT01286454|226756|P3|STARTED|Washout Period (At Least 3 Days)||2
95239|NCT01286454|226757|P2|STARTED|Washout Period (At Least 3 Days)||2
95240|NCT01286454|226758|P1|STARTED|Washout Period (At Least 3 Days)||2
95241|NCT01286454|226748|P11|NOT COMPLETED|Third Intervention Period||0
95242|NCT01286454|226749|P10|NOT COMPLETED|Third Intervention Period||0
95243|NCT01286454|226750|P9|NOT COMPLETED|Third Intervention Period||0
95244|NCT01286454|226751|P8|NOT COMPLETED|Third Intervention Period||0
95245|NCT01286454|226752|P7|NOT COMPLETED|Third Intervention Period||0
95246|NCT01286454|226753|P6|NOT COMPLETED|Third Intervention Period||0
95247|NCT01286454|226754|P5|NOT COMPLETED|Third Intervention Period||0
95248|NCT01286454|226755|P4|NOT COMPLETED|Third Intervention Period||0
95249|NCT01286454|226756|P3|NOT COMPLETED|Third Intervention Period||0
95250|NCT01286454|226757|P2|NOT COMPLETED|Third Intervention Period||0
95251|NCT01286454|226758|P1|NOT COMPLETED|Third Intervention Period||0
95252|NCT01286454|226748|P11|COMPLETED|Third Intervention Period||0
95253|NCT01286454|226749|P10|COMPLETED|Third Intervention Period||2
95254|NCT01286454|226750|P9|COMPLETED|Third Intervention Period||2
95255|NCT01286454|226751|P8|COMPLETED|Third Intervention Period||2
95256|NCT01286454|226752|P7|COMPLETED|Third Intervention Period||2
95257|NCT01286454|226753|P6|COMPLETED|Third Intervention Period||2
95258|NCT01286454|226754|P5|COMPLETED|Third Intervention Period||2
95259|NCT01286454|226755|P4|COMPLETED|Third Intervention Period||2
95260|NCT01286454|226756|P3|COMPLETED|Third Intervention Period||2
95261|NCT01286454|226757|P2|COMPLETED|Third Intervention Period||2
95262|NCT01286454|226758|P1|COMPLETED|Third Intervention Period||2
95263|NCT01286454|226748|P11|STARTED|Third Intervention Period||0
95264|NCT01286454|226749|P10|STARTED|Third Intervention Period||2
95265|NCT01286454|226750|P9|STARTED|Third Intervention Period||2
95266|NCT01286454|226751|P8|STARTED|Third Intervention Period||2
95267|NCT01286454|226752|P7|STARTED|Third Intervention Period||2
95268|NCT01286454|226753|P6|STARTED|Third Intervention Period||2
95269|NCT01286454|226754|P5|STARTED|Third Intervention Period||2
95270|NCT01286454|226755|P4|STARTED|Third Intervention Period||2
95271|NCT01286454|226756|P3|STARTED|Third Intervention Period||2
95272|NCT01286454|226757|P2|STARTED|Third Intervention Period||2
95273|NCT01286454|226758|P1|STARTED|Third Intervention Period||2
95274|NCT01286454|226748|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95275|NCT01286454|226749|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95276|NCT01286454|226750|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95277|NCT01286454|226751|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95278|NCT01286454|226752|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95279|NCT01286454|226753|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95280|NCT01286454|226754|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95281|NCT01286454|226755|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95282|NCT01286454|226756|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95283|NCT01286454|226757|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95284|NCT01286454|226758|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95285|NCT01286454|226748|P11|COMPLETED|Washout Period (At Least 3 Days)||0
95286|NCT01286454|226749|P10|COMPLETED|Washout Period (At Least 3 Days)||2
95287|NCT01286454|226750|P9|COMPLETED|Washout Period (At Least 3 Days)||2
95288|NCT01286454|226751|P8|COMPLETED|Washout Period (At Least 3 Days)||2
95289|NCT01286454|226752|P7|COMPLETED|Washout Period (At Least 3 Days)||2
95290|NCT01286454|226753|P6|COMPLETED|Washout Period (At Least 3 Days)||2
95291|NCT01286454|226754|P5|COMPLETED|Washout Period (At Least 3 Days)||2
95292|NCT01286454|226755|P4|COMPLETED|Washout Period (At Least 3 Days)||2
95293|NCT01286454|226756|P3|COMPLETED|Washout Period (At Least 3 Days)||2
95294|NCT01286454|226757|P2|COMPLETED|Washout Period (At Least 3 Days)||2
95295|NCT01286454|226758|P1|COMPLETED|Washout Period (At Least 3 Days)||2
95296|NCT01286454|226748|P11|STARTED|Washout Period (At Least 3 Days)||0
95297|NCT01286454|226749|P10|STARTED|Washout Period (At Least 3 Days)||2
95298|NCT01286454|226750|P9|STARTED|Washout Period (At Least 3 Days)||2
95299|NCT01286454|226751|P8|STARTED|Washout Period (At Least 3 Days)||2
95300|NCT01286454|226752|P7|STARTED|Washout Period (At Least 3 Days)||2
95301|NCT01286454|226753|P6|STARTED|Washout Period (At Least 3 Days)||2
95302|NCT01286454|226754|P5|STARTED|Washout Period (At Least 3 Days)||2
95303|NCT01286454|226755|P4|STARTED|Washout Period (At Least 3 Days)||2
95304|NCT01286454|226756|P3|STARTED|Washout Period (At Least 3 Days)||2
95305|NCT01286454|226757|P2|STARTED|Washout Period (At Least 3 Days)||2
95306|NCT01286454|226758|P1|STARTED|Washout Period (At Least 3 Days)||2
95307|NCT01286454|226748|P11|NOT COMPLETED|Second Intervention Period||0
95308|NCT01286454|226749|P10|NOT COMPLETED|Second Intervention Period||0
95309|NCT01286454|226750|P9|NOT COMPLETED|Second Intervention Period||0
95310|NCT01286454|226751|P8|NOT COMPLETED|Second Intervention Period||0
95311|NCT01286454|226752|P7|NOT COMPLETED|Second Intervention Period||0
95312|NCT01286454|226753|P6|NOT COMPLETED|Second Intervention Period||0
95313|NCT01286454|226754|P5|NOT COMPLETED|Second Intervention Period||0
95314|NCT01286454|226755|P4|NOT COMPLETED|Second Intervention Period||0
95315|NCT01286454|226756|P3|NOT COMPLETED|Second Intervention Period||0
95316|NCT01286454|226757|P2|NOT COMPLETED|Second Intervention Period||0
95317|NCT01286454|226758|P1|NOT COMPLETED|Second Intervention Period||0
95318|NCT01286454|226748|P11|COMPLETED|Second Intervention Period||0
95319|NCT01286454|226749|P10|COMPLETED|Second Intervention Period||2
95320|NCT01286454|226750|P9|COMPLETED|Second Intervention Period||2
95321|NCT01286454|226751|P8|COMPLETED|Second Intervention Period||2
95322|NCT01286454|226752|P7|COMPLETED|Second Intervention Period||2
95323|NCT01286454|226753|P6|COMPLETED|Second Intervention Period||2
95324|NCT01286454|226754|P5|COMPLETED|Second Intervention Period||2
95325|NCT01286454|226755|P4|COMPLETED|Second Intervention Period||2
95326|NCT01286454|226756|P3|COMPLETED|Second Intervention Period||2
95327|NCT01286454|226757|P2|COMPLETED|Second Intervention Period||2
95328|NCT01286454|226758|P1|COMPLETED|Second Intervention Period||2
95329|NCT01286454|226748|P11|STARTED|Second Intervention Period||0
95330|NCT01286454|226749|P10|STARTED|Second Intervention Period||2
95331|NCT01286454|226750|P9|STARTED|Second Intervention Period||2
95332|NCT01286454|226751|P8|STARTED|Second Intervention Period||2
95333|NCT01286454|226752|P7|STARTED|Second Intervention Period||2
95334|NCT01286454|226753|P6|STARTED|Second Intervention Period||2
95335|NCT01286454|226754|P5|STARTED|Second Intervention Period||2
95336|NCT01286454|226755|P4|STARTED|Second Intervention Period||2
95337|NCT01286454|226756|P3|STARTED|Second Intervention Period||2
95338|NCT01286454|226757|P2|STARTED|Second Intervention Period||2
95339|NCT01286454|226758|P1|STARTED|Second Intervention Period||2
95340|NCT01286454|226748|P11|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95341|NCT01286454|226749|P10|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95342|NCT01286454|226750|P9|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95343|NCT01286454|226751|P8|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95344|NCT01286454|226752|P7|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95345|NCT01286454|226753|P6|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95346|NCT01286454|226754|P5|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95347|NCT01286454|226755|P4|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95348|NCT01286454|226756|P3|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95349|NCT01286454|226757|P2|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95350|NCT01286454|226758|P1|NOT COMPLETED|Washout Period (At Least 3 Days)||0
95351|NCT01286454|226748|P11|COMPLETED|Washout Period (At Least 3 Days)||0
95352|NCT01286454|226749|P10|COMPLETED|Washout Period (At Least 3 Days)||2
95353|NCT01286454|226750|P9|COMPLETED|Washout Period (At Least 3 Days)||2
95354|NCT01286454|226751|P8|COMPLETED|Washout Period (At Least 3 Days)||2
95355|NCT01286454|226752|P7|COMPLETED|Washout Period (At Least 3 Days)||2
95356|NCT01286454|226753|P6|COMPLETED|Washout Period (At Least 3 Days)||2
95357|NCT01286454|226754|P5|COMPLETED|Washout Period (At Least 3 Days)||2
95358|NCT01286454|226755|P4|COMPLETED|Washout Period (At Least 3 Days)||2
95359|NCT01286454|226756|P3|COMPLETED|Washout Period (At Least 3 Days)||2
95360|NCT01286454|226757|P2|COMPLETED|Washout Period (At Least 3 Days)||2
95361|NCT01286454|226758|P1|COMPLETED|Washout Period (At Least 3 Days)||2
95362|NCT01286454|226748|P11|STARTED|Washout Period (At Least 3 Days)||0
95363|NCT01286454|226749|P10|STARTED|Washout Period (At Least 3 Days)||2
95364|NCT01286454|226750|P9|STARTED|Washout Period (At Least 3 Days)||2
95365|NCT01286454|226751|P8|STARTED|Washout Period (At Least 3 Days)||2
95366|NCT01286454|226752|P7|STARTED|Washout Period (At Least 3 Days)||2
95367|NCT01286454|226753|P6|STARTED|Washout Period (At Least 3 Days)||2
95368|NCT01286454|226754|P5|STARTED|Washout Period (At Least 3 Days)||2
95369|NCT01286454|226755|P4|STARTED|Washout Period (At Least 3 Days)||2
95370|NCT01286454|226756|P3|STARTED|Washout Period (At Least 3 Days)||2
95371|NCT01286454|226757|P2|STARTED|Washout Period (At Least 3 Days)||2
95372|NCT01286454|226758|P1|STARTED|Washout Period (At Least 3 Days)||2
95373|NCT01286454|226748|P11|NOT COMPLETED|Part I- First Intervention Period||0
95374|NCT01286454|226749|P10|NOT COMPLETED|Part I- First Intervention Period||0
95375|NCT01286454|226750|P9|NOT COMPLETED|Part I- First Intervention Period||0
95376|NCT01286454|226751|P8|NOT COMPLETED|Part I- First Intervention Period||0
95377|NCT01286454|226752|P7|NOT COMPLETED|Part I- First Intervention Period||0
95378|NCT01286454|226753|P6|NOT COMPLETED|Part I- First Intervention Period||0
95379|NCT01286454|226754|P5|NOT COMPLETED|Part I- First Intervention Period||0
95380|NCT01286454|226755|P4|NOT COMPLETED|Part I- First Intervention Period||0
95381|NCT01286454|226756|P3|NOT COMPLETED|Part I- First Intervention Period||0
95382|NCT01286454|226757|P2|NOT COMPLETED|Part I- First Intervention Period||0
95383|NCT01286454|226758|P1|NOT COMPLETED|Part I- First Intervention Period||0
95384|NCT01286454|226748|P11|COMPLETED|Part I- First Intervention Period||0
95385|NCT01286454|226749|P10|COMPLETED|Part I- First Intervention Period||2
95386|NCT01286454|226750|P9|COMPLETED|Part I- First Intervention Period||2
95387|NCT01286454|226751|P8|COMPLETED|Part I- First Intervention Period||2
95388|NCT01286454|226752|P7|COMPLETED|Part I- First Intervention Period||2
95389|NCT01286454|226753|P6|COMPLETED|Part I- First Intervention Period||2
95390|NCT01286454|226754|P5|COMPLETED|Part I- First Intervention Period||2
95391|NCT01286454|226755|P4|COMPLETED|Part I- First Intervention Period||2
95392|NCT01286454|226756|P3|COMPLETED|Part I- First Intervention Period||2
95393|NCT01286454|226757|P2|COMPLETED|Part I- First Intervention Period||2
95394|NCT01286454|226758|P1|COMPLETED|Part I- First Intervention Period||2
95395|NCT01286454|226748|P11|STARTED|Part I- First Intervention Period||0
95396|NCT01286454|226749|P10|STARTED|Part I- First Intervention Period||2
95397|NCT01286454|226750|P9|STARTED|Part I- First Intervention Period||2
95398|NCT01286454|226751|P8|STARTED|Part I- First Intervention Period||2
95399|NCT01286454|226752|P7|STARTED|Part I- First Intervention Period||2
95400|NCT01286454|226753|P6|STARTED|Part I- First Intervention Period||2
95401|NCT01286454|226754|P5|STARTED|Part I- First Intervention Period||2
95402|NCT01286454|226755|P4|STARTED|Part I- First Intervention Period||2
95403|NCT01286454|226756|P3|STARTED|Part I- First Intervention Period||2
95404|NCT01286454|226757|P2|STARTED|Part I- First Intervention Period||2
95405|NCT01286454|226758|P1|STARTED|Part I- First Intervention Period||2
95406|NCT01286402|226798|P2|NOT COMPLETED|Overall Study||0
95407|NCT01286402|226799|P1|NOT COMPLETED|Overall Study||0
95408|NCT01286402|226798|P2|COMPLETED|Overall Study||6
95409|NCT01286402|226799|P1|COMPLETED|Overall Study||5
95410|NCT01286402|226798|P2|STARTED|Overall Study||6
95411|NCT01286402|226799|P1|STARTED|Overall Study||5
95412|NCT01286324|226807|P2|NOT COMPLETED|Overall Study||0
95413|NCT01286324|226808|P1|NOT COMPLETED|Overall Study||0
95414|NCT01286324|226807|P2|COMPLETED|Overall Study||17
95415|NCT01286324|226808|P1|COMPLETED|Overall Study||17
95416|NCT01286324|226807|P2|STARTED|Overall Study||17
95417|NCT01286324|226808|P1|STARTED|Overall Study||17
95418|NCT01286311|226816|P2|NOT COMPLETED|Overall Study||0
95419|NCT01286311|226817|P1|NOT COMPLETED|Overall Study||14
95420|NCT01286311|226816|P2|COMPLETED|Overall Study|217 patients (of the 15 physician randomized to the intervention) completed the study.|232
95421|NCT01286311|226817|P1|COMPLETED|Overall Study|204 patients (of the 14 physician randomized to the intervention) completed the study.|218
95422|NCT01286311|226816|P2|STARTED|Overall Study|217 patients (of the 15 physician randomized to the intervention) started the study.|232
95423|NCT01286311|226817|P1|STARTED|Overall Study|218 patients (of the 14 physician randomized to the intervention) started the study.|232
95424|NCT01286207|226834|P3|NOT COMPLETED|Overall Study||90
95425|NCT01286207|226835|P2|NOT COMPLETED|Overall Study||248
95426|NCT01286207|226836|P1|NOT COMPLETED|Overall Study||298
95427|NCT01286207|226834|P3|COMPLETED|Overall Study||261
95428|NCT01286207|226835|P2|COMPLETED|Overall Study||609
95429|NCT01286207|226836|P1|COMPLETED|Overall Study||453
95430|NCT01286207|226834|P3|STARTED|Overall Study||351
95431|NCT01286207|226835|P2|STARTED|Overall Study||857
95432|NCT01286207|226836|P1|STARTED|Overall Study||751
95433|NCT01286168|226856|P1|NOT COMPLETED|Overall Study||3
95434|NCT01286168|226856|P1|COMPLETED|Overall Study||101
95435|NCT01286168|226856|P1|STARTED|Overall Study||104
95436|NCT01286129|226870|P2|NOT COMPLETED|Overall Study||5
95437|NCT01286129|226871|P1|NOT COMPLETED|Overall Study||8
95438|NCT01286129|226870|P2|COMPLETED|Overall Study||13
95439|NCT01286129|226871|P1|COMPLETED|Overall Study||19
95440|NCT01286129|226870|P2|STARTED|Overall Study||18
95441|NCT01286129|226871|P1|STARTED|Overall Study||27
95442|NCT01286077|226881|P2|NOT COMPLETED|Overall Study||7
95443|NCT01286077|226882|P1|NOT COMPLETED|Overall Study||10
95444|NCT01286077|226881|P2|COMPLETED|Overall Study||46
95445|NCT01286077|226882|P1|COMPLETED|Overall Study||41
95446|NCT01286077|226881|P2|STARTED|Overall Study|One patient did not have any post-baseline assessment and was excluded from the ITT population.|53
95447|NCT01286077|226882|P1|STARTED|Overall Study|One patient did not start treatment and was excluded from the Intent to Treat (ITT) population.|51
95448|NCT01286012|226918|P2|NOT COMPLETED|Overall Study||14
95449|NCT01286012|226919|P1|NOT COMPLETED|Overall Study||13
95450|NCT01286012|226918|P2|COMPLETED|Overall Study||40
95451|NCT01286012|226919|P1|COMPLETED|Overall Study||41
95452|NCT01286012|226918|P2|STARTED|Overall Study|3 patients randomized to placebo did not receive study drug.|54
95453|NCT01286012|226919|P1|STARTED|Overall Study|2 patients randomized to SFP did not receive study drug.|54
95454|NCT01285947|226929|P2|NOT COMPLETED|Overall Study||0
95455|NCT01285947|226930|P1|NOT COMPLETED|Overall Study||0
95456|NCT01285947|226929|P2|COMPLETED|Overall Study||10
95457|NCT01285947|226930|P1|COMPLETED|Overall Study||10
95458|NCT01285947|226929|P2|STARTED|Overall Study||10
95459|NCT01285947|226930|P1|STARTED|Overall Study||10
95460|NCT01285908|226936|P3|NOT COMPLETED|Treatment Crossover||0
95461|NCT01285908|226937|P2|NOT COMPLETED|Treatment Crossover||0
95462|NCT01285908|226938|P1|NOT COMPLETED|Treatment Crossover||0
95463|NCT01285908|226936|P3|COMPLETED|Treatment Crossover||2
95464|NCT01285908|226937|P2|COMPLETED|Treatment Crossover||2
95465|NCT01285908|226938|P1|COMPLETED|Treatment Crossover||0
95466|NCT01285908|226936|P3|STARTED|Treatment Crossover||2
95467|NCT01285908|226937|P2|STARTED|Treatment Crossover|One subject in treatment crossover did not complete baseline testing as unable to complete tasks|2
95468|NCT01285908|226938|P1|STARTED|Treatment Crossover||0
95469|NCT01285908|226936|P3|NOT COMPLETED|Baseline Measurement||0
95470|NCT01285908|226937|P2|NOT COMPLETED|Baseline Measurement||0
95471|NCT01285908|226938|P1|NOT COMPLETED|Baseline Measurement||3
95472|NCT01285908|226936|P3|COMPLETED|Baseline Measurement||0
95473|NCT01285908|226937|P2|COMPLETED|Baseline Measurement||0
95474|NCT01285908|226938|P1|COMPLETED|Baseline Measurement||3
95475|NCT01285908|226936|P3|STARTED|Baseline Measurement||0
95476|NCT01285908|226937|P2|STARTED|Baseline Measurement||0
95477|NCT01285908|226938|P1|STARTED|Baseline Measurement||6
95478|NCT01285843|226972|P2|NOT COMPLETED|Overall Study||2
95479|NCT01285843|226973|P1|NOT COMPLETED|Overall Study||2
95480|NCT01285843|226972|P2|COMPLETED|Overall Study||18
95481|NCT01285843|226973|P1|COMPLETED|Overall Study||18
95482|NCT01285843|226972|P2|STARTED|Overall Study||20
95483|NCT01285843|226973|P1|STARTED|Overall Study||20
95484|NCT01285791|226988|P3|NOT COMPLETED|Overall Study||0
95485|NCT01285791|226989|P2|NOT COMPLETED|Overall Study||0
95486|NCT01285791|226990|P1|NOT COMPLETED|Overall Study||0
95487|NCT01285791|226988|P3|COMPLETED|Overall Study||13
95488|NCT01285791|226989|P2|COMPLETED|Overall Study||15
95489|NCT01285791|226990|P1|COMPLETED|Overall Study||11
95490|NCT01285791|226988|P3|STARTED|Overall Study||13
95491|NCT01285791|226989|P2|STARTED|Overall Study||15
95492|NCT01285791|226990|P1|STARTED|Overall Study||11
95493|NCT01285713|227000|P2|NOT COMPLETED|Overall Study||0
95494|NCT01285713|227001|P1|NOT COMPLETED|Overall Study||0
95495|NCT01285713|227000|P2|COMPLETED|Overall Study||41
95496|NCT01285713|227001|P1|COMPLETED|Overall Study||42
95497|NCT01285713|227000|P2|STARTED|Overall Study||41
95498|NCT01285713|227001|P1|STARTED|Overall Study||42
95499|NCT01285635|227010|P3|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
95500|NCT01285635|227011|P2|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
95501|NCT01285635|227012|P1|NOT COMPLETED|Second Intervention (10, 3 Week Cycles)||0
95502|NCT01285635|227010|P3|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
95503|NCT01285635|227011|P2|COMPLETED|Second Intervention (10, 3 Week Cycles)||11
95504|NCT01285635|227012|P1|COMPLETED|Second Intervention (10, 3 Week Cycles)||13
95505|NCT01285635|227010|P3|STARTED|Second Intervention (10, 3 Week Cycles)||11
95506|NCT01285635|227011|P2|STARTED|Second Intervention (10, 3 Week Cycles)||11
95507|NCT01285635|227012|P1|STARTED|Second Intervention (10, 3 Week Cycles)||13
95508|NCT01285635|227010|P3|NOT COMPLETED|First Intervention (2 Weeks)||0
95509|NCT01285635|227011|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
95510|NCT01285635|227012|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
95511|NCT01285635|227010|P3|COMPLETED|First Intervention (2 Weeks)||11
95512|NCT01285635|227011|P2|COMPLETED|First Intervention (2 Weeks)||11
95513|NCT01285635|227012|P1|COMPLETED|First Intervention (2 Weeks)||13
95514|NCT01285635|227010|P3|STARTED|First Intervention (2 Weeks)||11
95515|NCT01285635|227011|P2|STARTED|First Intervention (2 Weeks)||11
95516|NCT01285635|227012|P1|STARTED|First Intervention (2 Weeks)||13
95517|NCT01285609|227032|P2|NOT COMPLETED|Treated With Blinded Therapy||353
95518|NCT01285609|227033|P1|NOT COMPLETED|Treated With Blinded Therapy||379
95519|NCT01285609|227032|P2|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|8
95520|NCT01285609|227033|P1|COMPLETED|Treated With Blinded Therapy|Completed = Still on Treatment|9
95521|NCT01285609|227032|P2|STARTED|Treated With Blinded Therapy||361
95522|NCT01285609|227033|P1|STARTED|Treated With Blinded Therapy||388
95523|NCT01285609|227032|P2|NOT COMPLETED|Randomized||116
95524|NCT01285609|227033|P1|NOT COMPLETED|Randomized||91
95525|NCT01285609|227032|P2|COMPLETED|Randomized||361
95526|NCT01285609|227033|P1|COMPLETED|Randomized||388
95527|NCT01285609|227032|P2|Treated With Chemotherapy (1st Dose)|Randomized||473
95528|NCT01285609|227033|P1|Treated With Chemotherapy (1st Dose)|Randomized||475
95529|NCT01285609|227032|P2|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|477
95530|NCT01285609|227033|P1|STARTED|Randomized|Represents participants randomized to this arm prior to 1st dose of chemotherapy treatment|479
95531|NCT01285518|227051|P8|NOT COMPLETED|Overall Study||0
95532|NCT01285518|227052|P7|NOT COMPLETED|Overall Study||0
95533|NCT01285518|227053|P6|NOT COMPLETED|Overall Study||1
95534|NCT01285518|227054|P5|NOT COMPLETED|Overall Study||0
95535|NCT01285518|227055|P4|NOT COMPLETED|Overall Study||0
95536|NCT01285518|227056|P3|NOT COMPLETED|Overall Study||0
95537|NCT01285518|227057|P2|NOT COMPLETED|Overall Study||0
95538|NCT01285518|227058|P1|NOT COMPLETED|Overall Study||0
95539|NCT01285518|227051|P8|COMPLETED|Overall Study||14
95540|NCT01285518|227052|P7|COMPLETED|Overall Study||10
95541|NCT01285518|227053|P6|COMPLETED|Overall Study||9
95542|NCT01285518|227054|P5|COMPLETED|Overall Study||10
95543|NCT01285518|227055|P4|COMPLETED|Overall Study||10
95544|NCT01285518|227056|P3|COMPLETED|Overall Study||10
95545|NCT01285518|227057|P2|COMPLETED|Overall Study||10
95546|NCT01285518|227058|P1|COMPLETED|Overall Study||10
95547|NCT01285518|227051|P8|STARTED|Overall Study||14
95548|NCT01285518|227052|P7|STARTED|Overall Study||10
95549|NCT01285518|227053|P6|STARTED|Overall Study||10
95550|NCT01285518|227054|P5|STARTED|Overall Study||10
95551|NCT01285518|227055|P4|STARTED|Overall Study||10
95552|NCT01285518|227056|P3|STARTED|Overall Study||10
95553|NCT01285518|227057|P2|STARTED|Overall Study||10
95554|NCT01285518|227058|P1|STARTED|Overall Study||10
95555|NCT01285492|227318|P2|NOT COMPLETED|Overall Study||1
95556|NCT01285492|227319|P1|NOT COMPLETED|Overall Study||17
95557|NCT01285492|227318|P2|COMPLETED|Overall Study||38
95558|NCT01285492|227319|P1|COMPLETED|Overall Study||104
95559|NCT01285492|227318|P2|Safety Set (for Demographics)|Overall Study|All patients who took study drug|39
95560|NCT01285492|227319|P1|Safety Set (for Demographics)|Overall Study|All patients who took study drug; 2 patients did not|119
95561|NCT01285492|227318|P2|STARTED|Overall Study|All patients randomized to this group|39
95562|NCT01285492|227319|P1|STARTED|Overall Study|All patients randomized to this group|121
95563|NCT01285427|227337|P1|NOT COMPLETED|Overall Study||1
95564|NCT01285427|227337|P1|COMPLETED|Overall Study|One sample be discarded per FDA, sample drawn with heparin tube, not specified in protocol.|299
95565|NCT01285427|227337|P1|STARTED|Overall Study||300
95566|NCT01285401|227351|P2|NOT COMPLETED|Overall Study||29
95567|NCT01285401|227352|P1|NOT COMPLETED|Overall Study||17
95568|NCT01285401|227351|P2|COMPLETED|Overall Study||88
95569|NCT01285401|227352|P1|COMPLETED|Overall Study||98
95570|NCT01285401|227351|P2|Treated|Overall Study||116
95571|NCT01285401|227352|P1|Treated|Overall Study||113
95572|NCT01285401|227351|P2|STARTED|Overall Study||117
95573|NCT01285401|227352|P1|STARTED|Overall Study||115
95574|NCT01285323|227392|P2|NOT COMPLETED|Overall Study||30
95575|NCT01285323|227393|P1|NOT COMPLETED|Overall Study||33
95576|NCT01285323|227392|P2|COMPLETED|Overall Study||202
95577|NCT01285323|227393|P1|COMPLETED|Overall Study||199
95578|NCT01285323|227392|P2|Safety Analysis Set|Overall Study||232
95579|NCT01285323|227393|P1|Safety Analysis Set|Overall Study|Participants who received at least 1 dose of study drug|232
95580|NCT01285323|227392|P2|Full Analysis Set|Overall Study||232
95581|NCT01285323|227393|P1|Full Analysis Set|Overall Study|Randomized participants who received at least 1 dose of study drug|232
95582|NCT01285323|227392|P2|STARTED|Overall Study||232
95583|NCT01285323|227393|P1|STARTED|Overall Study||232
95584|NCT01285310|227428|P5|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||19
95585|NCT01285310|227429|P4|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||10
95586|NCT01285310|227430|P3|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||26
95587|NCT01285310|227431|P2|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||32
95588|NCT01285310|227432|P1|NOT COMPLETED|Active Treatment Phase: Weeks 25-52||0
95589|NCT01285310|227428|P5|COMPLETED|Active Treatment Phase: Weeks 25-52||23
95590|NCT01285310|227429|P4|COMPLETED|Active Treatment Phase: Weeks 25-52||17
95591|NCT01285310|227430|P3|COMPLETED|Active Treatment Phase: Weeks 25-52||34
95592|NCT01285310|227431|P2|COMPLETED|Active Treatment Phase: Weeks 25-52||31
95593|NCT01285310|227432|P1|COMPLETED|Active Treatment Phase: Weeks 25-52||0
95594|NCT01285310|227428|P5|STARTED|Active Treatment Phase: Weeks 25-52||42
95595|NCT01285310|227429|P4|STARTED|Active Treatment Phase: Weeks 25-52||27
95596|NCT01285310|227430|P3|STARTED|Active Treatment Phase: Weeks 25-52||60
95597|NCT01285310|227431|P2|STARTED|Active Treatment Phase: Weeks 25-52||63
95598|NCT01285310|227432|P1|STARTED|Active Treatment Phase: Weeks 25-52||0
95599|NCT01285310|227428|P5|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
95600|NCT01285310|227429|P4|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
95601|NCT01285310|227430|P3|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
95602|NCT01285310|227431|P2|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||15
95603|NCT01285310|227432|P1|NOT COMPLETED|Placebo Controlled Phase: Weeks 0-24||9
95604|NCT01285310|227428|P5|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
95605|NCT01285310|227429|P4|COMPLETED|Placebo Controlled Phase: Weeks 0-24||0
95606|NCT01285310|227430|P3|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter active treatment phase|61
95607|NCT01285310|227431|P2|COMPLETED|Placebo Controlled Phase: Weeks 0-24|Four participants chose not to enter the active treatment phase|67
95608|NCT01285310|227432|P1|COMPLETED|Placebo Controlled Phase: Weeks 0-24|1 participant chose not to enter the active treatment phase|70
95609|NCT01285310|227428|P5|STARTED|Placebo Controlled Phase: Weeks 0-24||0
95610|NCT01285310|227429|P4|STARTED|Placebo Controlled Phase: Weeks 0-24||0
95611|NCT01285310|227430|P3|STARTED|Placebo Controlled Phase: Weeks 0-24||76
95612|NCT01285310|227431|P2|STARTED|Placebo Controlled Phase: Weeks 0-24||82
95613|NCT01285310|227432|P1|STARTED|Placebo Controlled Phase: Weeks 0-24||79
95614|NCT01285076|227665|P1|NOT COMPLETED|Overall Study||0
95615|NCT01285076|227665|P1|COMPLETED|Overall Study||834
95616|NCT01285076|227665|P1|STARTED|Overall Study||834
95617|NCT01285050|227678|P1|NOT COMPLETED|Overall Study||1
95618|NCT01285050|227678|P1|COMPLETED|Overall Study||19
95619|NCT01285050|227678|P1|STARTED|Overall Study||20
95620|NCT01285024|227685|P2|NOT COMPLETED|Overall Study||0
95621|NCT01285024|227686|P1|NOT COMPLETED|Overall Study||0
95622|NCT01285024|227685|P2|COMPLETED|Overall Study||60
95623|NCT01285024|227686|P1|COMPLETED|Overall Study||49
95624|NCT01285024|227685|P2|STARTED|Overall Study||60
95625|NCT01285024|227686|P1|STARTED|Overall Study||49
95626|NCT01284959|227697|P3|NOT COMPLETED|Overall Study||1
95627|NCT01284959|227698|P2|NOT COMPLETED|Overall Study||0
95628|NCT01284959|227699|P1|NOT COMPLETED|Overall Study||1
95629|NCT01284959|227697|P3|COMPLETED|Overall Study||10
95630|NCT01284959|227698|P2|COMPLETED|Overall Study||12
95631|NCT01284959|227699|P1|COMPLETED|Overall Study||10
95632|NCT01284959|227697|P3|STARTED|Overall Study||11
95633|NCT01284959|227698|P2|STARTED|Overall Study||12
95634|NCT01284959|227699|P1|STARTED|Overall Study||11
95635|NCT01284634|227729|P4|NOT COMPLETED|Overall Study||1
95636|NCT01284634|227730|P3|NOT COMPLETED|Overall Study||2
95637|NCT01284634|227731|P2|NOT COMPLETED|Overall Study||0
95638|NCT01284634|227732|P1|NOT COMPLETED|Overall Study||1
95639|NCT01284634|227729|P4|COMPLETED|Overall Study||4
95640|NCT01284634|227730|P3|COMPLETED|Overall Study||5
95641|NCT01284634|227731|P2|COMPLETED|Overall Study||6
95642|NCT01284634|227732|P1|COMPLETED|Overall Study||6
95643|NCT01284634|227729|P4|STARTED|Overall Study||5
95644|NCT01284634|227730|P3|STARTED|Overall Study||7
95645|NCT01284634|227731|P2|STARTED|Overall Study||6
95646|NCT01284634|227732|P1|STARTED|Overall Study||7
95647|NCT01284621|227874|P6|NOT COMPLETED|Third Intervention (8 Days)||0
95648|NCT01284621|227875|P5|NOT COMPLETED|Third Intervention (8 Days)||0
95649|NCT01284621|227876|P4|NOT COMPLETED|Third Intervention (8 Days)||0
95650|NCT01284621|227877|P3|NOT COMPLETED|Third Intervention (8 Days)||0
95651|NCT01284621|227878|P2|NOT COMPLETED|Third Intervention (8 Days)||0
95652|NCT01284621|227879|P1|NOT COMPLETED|Third Intervention (8 Days)||0
95653|NCT01284621|227874|P6|COMPLETED|Third Intervention (8 Days)||4
95654|NCT01284621|227875|P5|COMPLETED|Third Intervention (8 Days)||3
95655|NCT01284621|227876|P4|COMPLETED|Third Intervention (8 Days)||4
95656|NCT01284621|227877|P3|COMPLETED|Third Intervention (8 Days)||4
95657|NCT01284621|227878|P2|COMPLETED|Third Intervention (8 Days)||4
95658|NCT01284621|227879|P1|COMPLETED|Third Intervention (8 Days)||3
95659|NCT01284621|227874|P6|STARTED|Third Intervention (8 Days)||4
95660|NCT01284621|227875|P5|STARTED|Third Intervention (8 Days)||3
95661|NCT01284621|227876|P4|STARTED|Third Intervention (8 Days)||4
95662|NCT01284621|227877|P3|STARTED|Third Intervention (8 Days)||4
95663|NCT01284621|227878|P2|STARTED|Third Intervention (8 Days)||4
95664|NCT01284621|227879|P1|STARTED|Third Intervention (8 Days)||3
95665|NCT01284621|227874|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
95666|NCT01284621|227875|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
95667|NCT01284621|227876|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
95668|NCT01284621|227877|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
95669|NCT01284621|227878|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
95670|NCT01284621|227879|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
95671|NCT01284621|227874|P6|COMPLETED|Washout Period 2 (7 Days)||4
95672|NCT01284621|227875|P5|COMPLETED|Washout Period 2 (7 Days)||3
95673|NCT01284621|227876|P4|COMPLETED|Washout Period 2 (7 Days)||4
95674|NCT01284621|227877|P3|COMPLETED|Washout Period 2 (7 Days)||4
95675|NCT01284621|227878|P2|COMPLETED|Washout Period 2 (7 Days)||4
95676|NCT01284621|227879|P1|COMPLETED|Washout Period 2 (7 Days)||3
95677|NCT01284621|227874|P6|STARTED|Washout Period 2 (7 Days)||4
95678|NCT01284621|227875|P5|STARTED|Washout Period 2 (7 Days)||3
95679|NCT01284621|227876|P4|STARTED|Washout Period 2 (7 Days)||4
95680|NCT01284621|227877|P3|STARTED|Washout Period 2 (7 Days)||4
95681|NCT01284621|227878|P2|STARTED|Washout Period 2 (7 Days)||4
95682|NCT01284621|227879|P1|STARTED|Washout Period 2 (7 Days)||3
95683|NCT01284621|227874|P6|NOT COMPLETED|Second Intervention (8 Days)||0
95684|NCT01284621|227875|P5|NOT COMPLETED|Second Intervention (8 Days)||0
95685|NCT01284621|227876|P4|NOT COMPLETED|Second Intervention (8 Days)||0
95686|NCT01284621|227877|P3|NOT COMPLETED|Second Intervention (8 Days)||0
95687|NCT01284621|227878|P2|NOT COMPLETED|Second Intervention (8 Days)||0
95688|NCT01284621|227879|P1|NOT COMPLETED|Second Intervention (8 Days)||0
95689|NCT01284621|227874|P6|COMPLETED|Second Intervention (8 Days)||4
95690|NCT01284621|227875|P5|COMPLETED|Second Intervention (8 Days)||3
95691|NCT01284621|227876|P4|COMPLETED|Second Intervention (8 Days)||4
95692|NCT01284621|227877|P3|COMPLETED|Second Intervention (8 Days)||4
95693|NCT01284621|227878|P2|COMPLETED|Second Intervention (8 Days)||4
95694|NCT01284621|227879|P1|COMPLETED|Second Intervention (8 Days)||3
95695|NCT01284621|227874|P6|STARTED|Second Intervention (8 Days)||4
95696|NCT01284621|227875|P5|STARTED|Second Intervention (8 Days)||3
95697|NCT01284621|227876|P4|STARTED|Second Intervention (8 Days)||4
95698|NCT01284621|227877|P3|STARTED|Second Intervention (8 Days)||4
95699|NCT01284621|227878|P2|STARTED|Second Intervention (8 Days)||4
95700|NCT01284621|227879|P1|STARTED|Second Intervention (8 Days)||3
95701|NCT01284621|227874|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
95702|NCT01284621|227875|P5|NOT COMPLETED|Washout Period 1 (7 Days)||1
95703|NCT01284621|227876|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
95704|NCT01284621|227877|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
95705|NCT01284621|227878|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
95706|NCT01284621|227879|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
95707|NCT01284621|227874|P6|COMPLETED|Washout Period 1 (7 Days)||4
95708|NCT01284621|227875|P5|COMPLETED|Washout Period 1 (7 Days)||3
95709|NCT01284621|227876|P4|COMPLETED|Washout Period 1 (7 Days)||4
95710|NCT01284621|227877|P3|COMPLETED|Washout Period 1 (7 Days)||4
95711|NCT01284621|227878|P2|COMPLETED|Washout Period 1 (7 Days)||4
95712|NCT01284621|227879|P1|COMPLETED|Washout Period 1 (7 Days)||3
95713|NCT01284621|227874|P6|STARTED|Washout Period 1 (7 Days)||4
95714|NCT01284621|227875|P5|STARTED|Washout Period 1 (7 Days)||4
95715|NCT01284621|227876|P4|STARTED|Washout Period 1 (7 Days)||4
95716|NCT01284621|227877|P3|STARTED|Washout Period 1 (7 Days)||4
95717|NCT01284621|227878|P2|STARTED|Washout Period 1 (7 Days)||4
95718|NCT01284621|227879|P1|STARTED|Washout Period 1 (7 Days)||3
95719|NCT01284621|227874|P6|NOT COMPLETED|First Intervention (8 Days)||0
95720|NCT01284621|227875|P5|NOT COMPLETED|First Intervention (8 Days)||0
95721|NCT01284621|227876|P4|NOT COMPLETED|First Intervention (8 Days)||0
95722|NCT01284621|227877|P3|NOT COMPLETED|First Intervention (8 Days)||0
95723|NCT01284621|227878|P2|NOT COMPLETED|First Intervention (8 Days)||0
95724|NCT01284621|227879|P1|NOT COMPLETED|First Intervention (8 Days)||0
95725|NCT01284621|227874|P6|COMPLETED|First Intervention (8 Days)||4
95726|NCT01284621|227875|P5|COMPLETED|First Intervention (8 Days)||4
95727|NCT01284621|227876|P4|COMPLETED|First Intervention (8 Days)||4
95728|NCT01284621|227877|P3|COMPLETED|First Intervention (8 Days)||4
95729|NCT01284621|227878|P2|COMPLETED|First Intervention (8 Days)||4
95730|NCT01284621|227879|P1|COMPLETED|First Intervention (8 Days)||3
95731|NCT01284621|227874|P6|STARTED|First Intervention (8 Days)||4
95732|NCT01284621|227875|P5|STARTED|First Intervention (8 Days)||4
95733|NCT01284621|227876|P4|STARTED|First Intervention (8 Days)||4
95734|NCT01284621|227877|P3|STARTED|First Intervention (8 Days)||4
95735|NCT01284621|227878|P2|STARTED|First Intervention (8 Days)||4
95736|NCT01284621|227879|P1|STARTED|First Intervention (8 Days)||3
95737|NCT01284517|227923|P2|NOT COMPLETED|Overall Study||36
95738|NCT01284517|227924|P1|NOT COMPLETED|Overall Study||32
95739|NCT01284517|227923|P2|COMPLETED|Overall Study||140
95740|NCT01284517|227924|P1|COMPLETED|Overall Study||148
95741|NCT01284517|227923|P2|STARTED|Overall Study||176
95742|NCT01284517|227924|P1|STARTED|Overall Study||180
95743|NCT01284504|227936|P2|NOT COMPLETED|Overall Study||0
95744|NCT01284504|227937|P1|NOT COMPLETED|Overall Study||1
95745|NCT01284504|227936|P2|COMPLETED|Overall Study||0
95746|NCT01284504|227937|P1|COMPLETED|Overall Study||0
95747|NCT01284504|227936|P2|STARTED|Overall Study||0
95748|NCT01284504|227937|P1|STARTED|Overall Study|Patient changed her mind before randomization to any of the treatment groups|1
95749|NCT01284491|227943|P1|NOT COMPLETED|Overall Study||13
95750|NCT01284491|227943|P1|COMPLETED|Overall Study||0
95751|NCT01284491|227943|P1|STARTED|Overall Study||13
95752|NCT01284426|227949|P1|NOT COMPLETED|Overall Study||2
95753|NCT01284426|227949|P1|COMPLETED|Overall Study||92
95754|NCT01284426|227949|P1|STARTED|Overall Study||94
95755|NCT01284361|227953|P1|NOT COMPLETED|Overall Study||9
95756|NCT01284361|227953|P1|COMPLETED|Overall Study||82
95757|NCT01284361|227953|P1|STARTED|Overall Study||91
95758|NCT01284296|227960|P1|NOT COMPLETED|Overall Study||0
95759|NCT01284296|227960|P1|COMPLETED|Overall Study||20
95760|NCT01284296|227960|P1|STARTED|Overall Study||20
95761|NCT01284244|227967|P2|NOT COMPLETED|Overall Study||0
95762|NCT01284244|227968|P1|NOT COMPLETED|Overall Study||0
95763|NCT01284244|227967|P2|COMPLETED|Overall Study||18
95764|NCT01284244|227968|P1|COMPLETED|Overall Study||18
95765|NCT01284244|227967|P2|STARTED|Overall Study||18
95766|NCT01284244|227968|P1|STARTED|Overall Study||18
95767|NCT01284114|227974|P1|NOT COMPLETED|Overall Study||4
95768|NCT01284114|227974|P1|COMPLETED|Overall Study||19
95769|NCT01284114|227974|P1|STARTED|Overall Study||23
95770|NCT01284062|227986|P4|NOT COMPLETED|Overall Study||14
95771|NCT01284062|227987|P3|NOT COMPLETED|Overall Study||6
95772|NCT01284062|227988|P2|NOT COMPLETED|Overall Study||8
95773|NCT01284062|227989|P1|NOT COMPLETED|Overall Study||11
95774|NCT01284062|227986|P4|COMPLETED|Overall Study||7
95775|NCT01284062|227987|P3|COMPLETED|Overall Study||15
95776|NCT01284062|227988|P2|COMPLETED|Overall Study||13
95777|NCT01284062|227989|P1|COMPLETED|Overall Study||10
95778|NCT01284062|227986|P4|STARTED|Overall Study||21
95779|NCT01284062|227987|P3|STARTED|Overall Study||21
95780|NCT01284062|227988|P2|STARTED|Overall Study||21
95781|NCT01284062|227989|P1|STARTED|Overall Study||21
95782|NCT01283971|228063|P2|NOT COMPLETED|Overall Study||12
95783|NCT01283971|228064|P1|NOT COMPLETED|Overall Study||15
95784|NCT01283971|228063|P2|COMPLETED|Overall Study||36
95785|NCT01283971|228064|P1|COMPLETED|Overall Study||33
95786|NCT01283971|228063|P2|Intent to Treat Population|Overall Study||48
95787|NCT01283971|228064|P1|Intent to Treat Population|Overall Study||46
95788|NCT01283971|228063|P2|STARTED|Overall Study||48
95789|NCT01283971|228064|P1|STARTED|Overall Study||48
95790|NCT01283581|228111|P3|NOT COMPLETED|Overall Study||20
95791|NCT01283581|228112|P2|NOT COMPLETED|Overall Study||14
95792|NCT01283581|228113|P1|NOT COMPLETED|Overall Study||12
95793|NCT01283581|228111|P3|COMPLETED|Overall Study||78
95794|NCT01283581|228112|P2|COMPLETED|Overall Study||63
95795|NCT01283581|228113|P1|COMPLETED|Overall Study||69
95796|NCT01283581|228111|P3|STARTED|Overall Study||98
95797|NCT01283581|228112|P2|STARTED|Overall Study||77
95798|NCT01283581|228113|P1|STARTED|Overall Study||81
95799|NCT01283555|228124|P2|NOT COMPLETED|Second Intervention||0
95800|NCT01283555|228125|P1|NOT COMPLETED|Second Intervention||0
95801|NCT01283555|228124|P2|COMPLETED|Second Intervention||12
95802|NCT01283555|228125|P1|COMPLETED|Second Intervention||13
95803|NCT01283555|228124|P2|STARTED|Second Intervention||12
95804|NCT01283555|228125|P1|STARTED|Second Intervention||13
95805|NCT01283555|228124|P2|NOT COMPLETED|Washout Period of at Least 21 Days||0
95806|NCT01283555|228125|P1|NOT COMPLETED|Washout Period of at Least 21 Days||0
95807|NCT01283555|228124|P2|COMPLETED|Washout Period of at Least 21 Days||12
95808|NCT01283555|228125|P1|COMPLETED|Washout Period of at Least 21 Days||13
95809|NCT01283555|228124|P2|STARTED|Washout Period of at Least 21 Days||12
95810|NCT01283555|228125|P1|STARTED|Washout Period of at Least 21 Days||13
95811|NCT01283555|228124|P2|NOT COMPLETED|First Intervention||0
95812|NCT01283555|228125|P1|NOT COMPLETED|First Intervention||0
95813|NCT01283555|228124|P2|COMPLETED|First Intervention||12
95814|NCT01283555|228125|P1|COMPLETED|First Intervention||13
95815|NCT01283555|228124|P2|STARTED|First Intervention||12
95816|NCT01283555|228125|P1|STARTED|First Intervention||13
95817|NCT01283516|228177|P9|NOT COMPLETED|Overall Study||122
95818|NCT01283516|228178|P8|NOT COMPLETED|Overall Study||3
95819|NCT01283516|228179|P7|NOT COMPLETED|Overall Study||8
95820|NCT01283516|228180|P6|NOT COMPLETED|Overall Study||8
95821|NCT01283516|228181|P5|NOT COMPLETED|Overall Study||13
95822|NCT01283516|228182|P4|NOT COMPLETED|Overall Study||3
95823|NCT01283516|228183|P3|NOT COMPLETED|Overall Study||2
95824|NCT01283516|228184|P2|NOT COMPLETED|Overall Study||2
95825|NCT01283516|228185|P1|NOT COMPLETED|Overall Study||2
95826|NCT01283516|228177|P9|COMPLETED|Overall Study||133
95827|NCT01283516|228178|P8|COMPLETED|Overall Study||2
95828|NCT01283516|228179|P7|COMPLETED|Overall Study||2
95829|NCT01283516|228180|P6|COMPLETED|Overall Study||2
95830|NCT01283516|228181|P5|COMPLETED|Overall Study||1
95831|NCT01283516|228182|P4|COMPLETED|Overall Study||0
95832|NCT01283516|228183|P3|COMPLETED|Overall Study||1
95833|NCT01283516|228184|P2|COMPLETED|Overall Study||0
95834|NCT01283516|228185|P1|COMPLETED|Overall Study|Completed = Treatment Ongoing|0
95835|NCT01283516|228177|P9|Dose-Determining Set (DDS)|Overall Study||8
95836|NCT01283516|228178|P8|Dose-Determining Set (DDS)|Overall Study||5
95837|NCT01283516|228179|P7|Dose-Determining Set (DDS)|Overall Study||10
95838|NCT01283516|228180|P6|Dose-Determining Set (DDS)|Overall Study||8
95839|NCT01283516|228181|P5|Dose-Determining Set (DDS)|Overall Study||14
95840|NCT01283516|228182|P4|Dose-Determining Set (DDS)|Overall Study||3
95841|NCT01283516|228183|P3|Dose-Determining Set (DDS)|Overall Study||3
95842|NCT01283516|228184|P2|Dose-Determining Set (DDS)|Overall Study||1
95843|NCT01283516|228185|P1|Dose-Determining Set (DDS)|Overall Study||2
95844|NCT01283516|228177|P9|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||246
95845|NCT01283516|228178|P8|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||5
95846|NCT01283516|228179|P7|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||9
95847|NCT01283516|228180|P6|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||10
95848|NCT01283516|228181|P5|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||12
95849|NCT01283516|228182|P4|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||3
95850|NCT01283516|228183|P3|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
95851|NCT01283516|228184|P2|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||1
95852|NCT01283516|228185|P1|Non-Small Cell Lung Cancer (NSCLC)|Overall Study||2
95853|NCT01283516|228177|P9|STARTED|Overall Study||255
95854|NCT01283516|228178|P8|STARTED|Overall Study||5
95855|NCT01283516|228179|P7|STARTED|Overall Study||10
95856|NCT01283516|228180|P6|STARTED|Overall Study||10
95857|NCT01283516|228181|P5|STARTED|Overall Study||14
95858|NCT01283516|228182|P4|STARTED|Overall Study||3
95859|NCT01283516|228183|P3|STARTED|Overall Study||3
95860|NCT01283516|228184|P2|STARTED|Overall Study||2
95861|NCT01283516|228185|P1|STARTED|Overall Study|Started = Full Analysis Set and Safety Set|2
95862|NCT01283464|228209|P2|NOT COMPLETED|Overall Study||1
95863|NCT01283464|228210|P1|NOT COMPLETED|Overall Study||2
95864|NCT01283464|228209|P2|COMPLETED|Overall Study||11
95865|NCT01283464|228210|P1|COMPLETED|Overall Study||10
95866|NCT01283464|228209|P2|STARTED|Overall Study||12
95867|NCT01283464|228210|P1|STARTED|Overall Study||12
95868|NCT01283334|228216|P1|NOT COMPLETED|Overall Study||7
95869|NCT01283334|228216|P1|COMPLETED|Overall Study||13
95870|NCT01283334|228216|P1|STARTED|Overall Study||20
95871|NCT01283321|228224|P2|NOT COMPLETED|Overall Study||0
95872|NCT01283321|228225|P1|NOT COMPLETED|Overall Study||0
95873|NCT01283321|228224|P2|COMPLETED|Overall Study||10
95874|NCT01283321|228225|P1|COMPLETED|Overall Study||10
95875|NCT01283321|228224|P2|STARTED|Overall Study||10
95876|NCT01283321|228225|P1|STARTED|Overall Study||10
95877|NCT01283282|228231|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
95878|NCT01283282|228232|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
95879|NCT01283282|228231|P2|COMPLETED|Second Intervention (6 Weeks)||19
95880|NCT01283282|228232|P1|COMPLETED|Second Intervention (6 Weeks)||22
95881|NCT01283282|228231|P2|STARTED|Second Intervention (6 Weeks)||19
95882|NCT01283282|228232|P1|STARTED|Second Intervention (6 Weeks)||22
95883|NCT01283282|228231|P2|NOT COMPLETED|First Intervention (6 Weeks)||4
95884|NCT01283282|228232|P1|NOT COMPLETED|First Intervention (6 Weeks)||3
95885|NCT01283282|228231|P2|COMPLETED|First Intervention (6 Weeks)||19
95886|NCT01283282|228232|P1|COMPLETED|First Intervention (6 Weeks)||22
95887|NCT01283282|228231|P2|STARTED|First Intervention (6 Weeks)||23
95888|NCT01283282|228232|P1|STARTED|First Intervention (6 Weeks)||25
95889|NCT01283152|228252|P2|NOT COMPLETED|Overall Study||0
95890|NCT01283152|228253|P1|NOT COMPLETED|Overall Study||2
95891|NCT01283152|228252|P2|COMPLETED|Overall Study||25
95892|NCT01283152|228253|P1|COMPLETED|Overall Study||23
95893|NCT01283152|228252|P2|24-hr HESA Attempted|Overall Study||25
95894|NCT01283152|228253|P1|24-hr HESA Attempted|Overall Study||25
95895|NCT01283152|228252|P2|Study Treatment Received|Overall Study||25
95896|NCT01283152|228253|P1|Study Treatment Received|Overall Study||25
95897|NCT01283152|228252|P2|ITT Population|Overall Study||25
95898|NCT01283152|228253|P1|ITT Population|Overall Study||25
95899|NCT01283152|228252|P2|STARTED|Overall Study||25
95900|NCT01283152|228253|P1|STARTED|Overall Study||25
95901|NCT01283139|228267|P4|NOT COMPLETED|Overall Study||15
95902|NCT01283139|228268|P3|NOT COMPLETED|Overall Study||18
95903|NCT01283139|228269|P2|NOT COMPLETED|Overall Study||18
95904|NCT01283139|228270|P1|NOT COMPLETED|Overall Study||17
95905|NCT01283139|228267|P4|COMPLETED|Overall Study||92
95906|NCT01283139|228268|P3|COMPLETED|Overall Study||91
95907|NCT01283139|228269|P2|COMPLETED|Overall Study||90
95908|NCT01283139|228270|P1|COMPLETED|Overall Study||91
95909|NCT01283139|228267|P4|STARTED|Overall Study||107
95910|NCT01283139|228268|P3|STARTED|Overall Study||109
95911|NCT01283139|228269|P2|STARTED|Overall Study||108
95912|NCT01283139|228270|P1|STARTED|Overall Study||108
95913|NCT01283035|228312|P1|NOT COMPLETED|Overall Study||1
95914|NCT01283035|228312|P1|COMPLETED|Overall Study||5
95915|NCT01283035|228312|P1|STARTED|Overall Study||6
95916|NCT01283022|228321|P1|NOT COMPLETED|Overall Study||0
95917|NCT01283022|228321|P1|COMPLETED|Overall Study||24
95918|NCT01283022|228321|P1|STARTED|Overall Study||24
95919|NCT01282866|228327|P1|NOT COMPLETED|Overall Study||1
95920|NCT01282866|228327|P1|COMPLETED|Overall Study||34
95921|NCT01282866|228327|P1|STARTED|Overall Study||35
95922|NCT01282814|228335|P2|NOT COMPLETED|Second Intervention||0
95923|NCT01282814|228336|P1|NOT COMPLETED|Second Intervention||0
95924|NCT01282814|228335|P2|COMPLETED|Second Intervention||9
95925|NCT01282814|228336|P1|COMPLETED|Second Intervention||10
95926|NCT01282814|228335|P2|STARTED|Second Intervention||9
95927|NCT01282814|228336|P1|STARTED|Second Intervention||10
95928|NCT01282814|228335|P2|NOT COMPLETED|Washout of 7 Days||0
95929|NCT01282814|228336|P1|NOT COMPLETED|Washout of 7 Days||2
95930|NCT01282814|228335|P2|COMPLETED|Washout of 7 Days||9
95931|NCT01282814|228336|P1|COMPLETED|Washout of 7 Days||10
95932|NCT01282814|228335|P2|STARTED|Washout of 7 Days||9
95933|NCT01282814|228336|P1|STARTED|Washout of 7 Days||12
95934|NCT01282814|228335|P2|NOT COMPLETED|First Intervention||3
95935|NCT01282814|228336|P1|NOT COMPLETED|First Intervention||0
95936|NCT01282814|228335|P2|COMPLETED|First Intervention||9
95937|NCT01282814|228336|P1|COMPLETED|First Intervention||12
95938|NCT01282814|228335|P2|STARTED|First Intervention||12
95939|NCT01282814|228336|P1|STARTED|First Intervention||12
95940|NCT01282801|228348|P2|NOT COMPLETED|Second Intervention||1
95941|NCT01282801|228349|P1|NOT COMPLETED|Second Intervention||0
95942|NCT01282801|228348|P2|COMPLETED|Second Intervention||8
95943|NCT01282801|228349|P1|COMPLETED|Second Intervention||9
95944|NCT01282801|228348|P2|STARTED|Second Intervention||9
95945|NCT01282801|228349|P1|STARTED|Second Intervention||9
95946|NCT01282801|228348|P2|NOT COMPLETED|Washout of 7 Days||0
95947|NCT01282801|228349|P1|NOT COMPLETED|Washout of 7 Days||0
95948|NCT01282801|228348|P2|COMPLETED|Washout of 7 Days||9
95949|NCT01282801|228349|P1|COMPLETED|Washout of 7 Days||9
95950|NCT01282801|228348|P2|STARTED|Washout of 7 Days||9
95951|NCT01282801|228349|P1|STARTED|Washout of 7 Days||9
95952|NCT01282801|228348|P2|NOT COMPLETED|First Intervention||0
95953|NCT01282801|228349|P1|NOT COMPLETED|First Intervention||0
95954|NCT01282801|228348|P2|COMPLETED|First Intervention||9
95955|NCT01282801|228349|P1|COMPLETED|First Intervention||9
95956|NCT01282801|228348|P2|STARTED|First Intervention||9
95957|NCT01282801|228349|P1|STARTED|First Intervention||9
95958|NCT01282723|228365|P1|NOT COMPLETED|Overall Study||0
95959|NCT01282723|228365|P1|COMPLETED|Overall Study||20
95960|NCT01282723|228365|P1|STARTED|Overall Study||20
95961|NCT01282710|228369|P1|NOT COMPLETED|Overall Study||0
95962|NCT01282710|228369|P1|COMPLETED|Overall Study||20
95963|NCT01282710|228369|P1|STARTED|Overall Study||20
95964|NCT01282476|228373|P1|NOT COMPLETED|Overall Study||11
95965|NCT01282476|228373|P1|COMPLETED|Overall Study||7
95966|NCT01282476|228373|P1|STARTED|Overall Study||18
95967|NCT01282424|228379|P1|NOT COMPLETED|Overall Study||76
95968|NCT01282424|228379|P1|COMPLETED|Overall Study||49
95969|NCT01282424|228379|P1|Completed: Death|Overall Study||8
95970|NCT01282424|228379|P1|Completed: Disease Progression|Overall Study||41
95971|NCT01282424|228379|P1|STARTED|Overall Study||125
95972|NCT01282372|228396|P1|NOT COMPLETED|Overall Study||79
95973|NCT01282372|228396|P1|COMPLETED|Overall Study||421
95974|NCT01282372|228396|P1|STARTED|Overall Study||500
95975|NCT01282294|228424|P1|NOT COMPLETED|Overall Study||19
95976|NCT01282294|228424|P1|COMPLETED|Overall Study||81
95977|NCT01282294|228424|P1|12 Months|Overall Study||86
95978|NCT01282294|228424|P1|6 Months|Overall Study||94
95979|NCT01282294|228424|P1|3 Months|Overall Study||95
95980|NCT01282294|228424|P1|6 Weeks|Overall Study||95
95981|NCT01282294|228424|P1|Post-operative|Overall Study||99
95982|NCT01282294|228424|P1|Intra-operative|Overall Study||99
95983|NCT01282294|228424|P1|STARTED|Overall Study||100
95984|NCT01282242|228444|P2|NOT COMPLETED|Overall Study||0
95985|NCT01282242|228445|P1|NOT COMPLETED|Overall Study||0
95986|NCT01282242|228444|P2|COMPLETED|Overall Study||8
95987|NCT01282242|228445|P1|COMPLETED|Overall Study||80
95988|NCT01282242|228444|P2|STARTED|Overall Study||8
95989|NCT01282242|228445|P1|STARTED|Overall Study||80
95990|NCT01282229|228453|P1|NOT COMPLETED|Overall Study||2
95991|NCT01282229|228453|P1|COMPLETED|Overall Study|57 Participants contributed 228 quadrants (57*4)|57
95992|NCT01282229|228453|P1|STARTED|Overall Study|59 Participants contributed 236 quadrants (59*4)|59
95993|NCT01282203|228483|P1|NOT COMPLETED|Overall Study||1
95994|NCT01282203|228483|P1|COMPLETED|Overall Study||1121
95995|NCT01282203|228483|P1|STARTED|Overall Study||1122
95996|NCT01282164|228505|P2|NOT COMPLETED|Overall Study||0
95997|NCT01282164|228506|P1|NOT COMPLETED|Overall Study||1
95998|NCT01282164|228505|P2|COMPLETED|Overall Study||14
95999|NCT01282164|228506|P1|COMPLETED|Overall Study||28
96000|NCT01282164|228505|P2|STARTED|Overall Study||14
96001|NCT01282164|228506|P1|STARTED|Overall Study||29
96002|NCT01282138|228531|P2|NOT COMPLETED|CAPT||0
96003|NCT01282138|228532|P1|NOT COMPLETED|CAPT||0
96004|NCT01282138|228531|P2|COMPLETED|CAPT||7
96005|NCT01282138|228532|P1|COMPLETED|CAPT||6
96006|NCT01282138|228531|P2|STARTED|CAPT||7
96007|NCT01282138|228532|P1|STARTED|CAPT||6
96008|NCT01282138|228531|P2|NOT COMPLETED|EEC||0
96009|NCT01282138|228532|P1|NOT COMPLETED|EEC||0
96010|NCT01282138|228531|P2|COMPLETED|EEC||7
96011|NCT01282138|228532|P1|COMPLETED|EEC||6
96012|NCT01282138|228531|P2|STARTED|EEC||7
96013|NCT01282138|228532|P1|STARTED|EEC||6
96014|NCT01282086|228540|P1|NOT COMPLETED|Overall Study||0
96015|NCT01282086|228540|P1|COMPLETED|Overall Study||1365
96016|NCT01282086|228540|P1|STARTED|Overall Study||1365
96017|NCT01281917|228557|P1|NOT COMPLETED|Overall Study||1
96018|NCT01281917|228557|P1|COMPLETED|Overall Study||39
96019|NCT01281917|228557|P1|STARTED|Overall Study||40
96020|NCT01281865|228569|P2|NOT COMPLETED|Overall Study||1
96021|NCT01281865|228570|P1|NOT COMPLETED|Overall Study||3
96022|NCT01281865|228569|P2|COMPLETED|Overall Study||1
96023|NCT01281865|228570|P1|COMPLETED|Overall Study||9
96024|NCT01281865|228569|P2|STARTED|Overall Study||2
96025|NCT01281865|228570|P1|STARTED|Overall Study||12
96026|NCT01281839|228578|P2|NOT COMPLETED|Overall Study||14
96027|NCT01281839|228579|P1|NOT COMPLETED|Overall Study||10
96028|NCT01281839|228578|P2|COMPLETED|Overall Study||119
96029|NCT01281839|228579|P1|COMPLETED|Overall Study||250
96030|NCT01281839|228578|P2|STARTED|Overall Study||133
96031|NCT01281839|228579|P1|STARTED|Overall Study|Not including 1 participant was randomized to this group, but never received treatment.|260
96032|NCT01281644|228640|P1|NOT COMPLETED|Overall Study||5
96033|NCT01281644|228640|P1|COMPLETED|Overall Study||18
96034|NCT01281644|228640|P1|STARTED|Overall Study||23
96035|NCT01281501|228650|P2|NOT COMPLETED|Overall Study||0
96036|NCT01281501|228651|P1|NOT COMPLETED|Overall Study||0
96037|NCT01281501|228650|P2|COMPLETED|Overall Study||43
96038|NCT01281501|228651|P1|COMPLETED|Overall Study||44
96039|NCT01281501|228650|P2|STARTED|Overall Study||43
96040|NCT01281501|228651|P1|STARTED|Overall Study||44
96041|NCT01281475|228665|P2|NOT COMPLETED|Overall Study||8
96042|NCT01281475|228666|P1|NOT COMPLETED|Overall Study||4
96043|NCT01281475|228665|P2|COMPLETED|Overall Study||26
96044|NCT01281475|228666|P1|COMPLETED|Overall Study||29
96045|NCT01281475|228665|P2|STARTED|Overall Study||34
96046|NCT01281475|228666|P1|STARTED|Overall Study||33
96047|NCT01281306|228681|P7|NOT COMPLETED|Overall Study||7
96048|NCT01281306|228682|P6|NOT COMPLETED|Overall Study||7
96049|NCT01281306|228683|P5|NOT COMPLETED|Overall Study||9
96050|NCT01281306|228684|P4|NOT COMPLETED|Overall Study||11
96051|NCT01281306|228685|P3|NOT COMPLETED|Overall Study||8
96052|NCT01281306|228686|P2|NOT COMPLETED|Overall Study||4
96053|NCT01281306|228687|P1|NOT COMPLETED|Overall Study||8
96054|NCT01281306|228681|P7|COMPLETED|Overall Study||51
96055|NCT01281306|228682|P6|COMPLETED|Overall Study||135
96056|NCT01281306|228683|P5|COMPLETED|Overall Study||134
96057|NCT01281306|228684|P4|COMPLETED|Overall Study||123
96058|NCT01281306|228685|P3|COMPLETED|Overall Study||133
96059|NCT01281306|228686|P2|COMPLETED|Overall Study||141
96060|NCT01281306|228687|P1|COMPLETED|Overall Study||136
96061|NCT01281306|228681|P7|Ambulatory Blood Pressure Monitoring Set|Overall Study||35
96062|NCT01281306|228682|P6|Ambulatory Blood Pressure Monitoring Set|Overall Study||91
96063|NCT01281306|228683|P5|Ambulatory Blood Pressure Monitoring Set|Overall Study||93
96064|NCT01281306|228684|P4|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
96065|NCT01281306|228685|P3|Ambulatory Blood Pressure Monitoring Set|Overall Study||92
96066|NCT01281306|228686|P2|Ambulatory Blood Pressure Monitoring Set|Overall Study||99
96067|NCT01281306|228687|P1|Ambulatory Blood Pressure Monitoring Set|Overall Study||95
96068|NCT01281306|228681|P7|Safety Set|Overall Study||58
96069|NCT01281306|228682|P6|Safety Set|Overall Study||142
96070|NCT01281306|228683|P5|Safety Set|Overall Study||143
96071|NCT01281306|228684|P4|Safety Set|Overall Study||133
96072|NCT01281306|228685|P3|Safety Set|Overall Study||141
96073|NCT01281306|228686|P2|Safety Set|Overall Study||145
96074|NCT01281306|228687|P1|Safety Set|Overall Study||143
96075|NCT01281306|228681|P7|Full Analysis Set|Overall Study||58
96076|NCT01281306|228682|P6|Full Analysis Set|Overall Study||142
96077|NCT01281306|228683|P5|Full Analysis Set|Overall Study||143
96078|NCT01281306|228684|P4|Full Analysis Set|Overall Study||133
96079|NCT01281306|228685|P3|Full Analysis Set|Overall Study||141
96080|NCT01281306|228686|P2|Full Analysis Set|Overall Study||145
96081|NCT01281306|228687|P1|Full Analysis Set|Overall Study||143
96082|NCT01281306|228681|P7|STARTED|Overall Study||58
96083|NCT01281306|228682|P6|STARTED|Overall Study||142
96084|NCT01281306|228683|P5|STARTED|Overall Study||143
96085|NCT01281306|228684|P4|STARTED|Overall Study||134
96086|NCT01281306|228685|P3|STARTED|Overall Study||141
96087|NCT01281306|228686|P2|STARTED|Overall Study||145
96088|NCT01281306|228687|P1|STARTED|Overall Study||144
96089|NCT01281202|228803|P2|NOT COMPLETED|Overall Study||36
96090|NCT01281202|228804|P1|NOT COMPLETED|Overall Study||28
96091|NCT01281202|228803|P2|COMPLETED|Overall Study||68
96092|NCT01281202|228804|P1|COMPLETED|Overall Study||75
96093|NCT01281202|228803|P2|STARTED|Overall Study||104
96094|NCT01281202|228804|P1|STARTED|Overall Study||103
96095|NCT01281124|228812|P1|NOT COMPLETED|Overall Study||1
96096|NCT01281124|228812|P1|COMPLETED|Overall Study||0
96097|NCT01281124|228812|P1|STARTED|Overall Study||1
96098|NCT01281007|228820|P2|NOT COMPLETED|Overall Study||8
96099|NCT01281007|228821|P1|NOT COMPLETED|Overall Study||4
96100|NCT01281007|228820|P2|COMPLETED|Overall Study||67
96101|NCT01281007|228821|P1|COMPLETED|Overall Study||71
96102|NCT01281007|228820|P2|STARTED|Overall Study||75
96103|NCT01281007|228821|P1|STARTED|Overall Study||75
96104|NCT01280981|228827|P1|NOT COMPLETED|Overall Study||92
96105|NCT01280981|228827|P1|COMPLETED|Overall Study||196
96106|NCT01280981|228827|P1|Intent to Treat (ITT) Population|Overall Study|Participants who took drug during at least one menstrual cycle|260
96107|NCT01280981|228827|P1|STARTED|Overall Study||288
96108|NCT01280968|228838|P2|NOT COMPLETED|Overall Study||3
96109|NCT01280968|228839|P1|NOT COMPLETED|Overall Study||18
96110|NCT01280968|228838|P2|COMPLETED|Overall Study||4
96111|NCT01280968|228839|P1|COMPLETED|Overall Study||27
96112|NCT01280968|228838|P2|STARTED|Overall Study||7
96113|NCT01280968|228839|P1|STARTED|Overall Study||45
96114|NCT01280955|228855|P1|NOT COMPLETED|Overall Study||3
96115|NCT01280955|228855|P1|COMPLETED|Overall Study||27
96116|NCT01280955|228855|P1|STARTED|Overall Study||30
96117|NCT01280695|228891|P5|NOT COMPLETED|Overall Study||2
96118|NCT01280695|228892|P4|NOT COMPLETED|Overall Study||4
96119|NCT01280695|228893|P3|NOT COMPLETED|Overall Study||5
96120|NCT01280695|228894|P2|NOT COMPLETED|Overall Study||1
96121|NCT01280695|228895|P1|NOT COMPLETED|Overall Study||0
96122|NCT01280695|228891|P5|COMPLETED|Overall Study||24
96123|NCT01280695|228892|P4|COMPLETED|Overall Study||22
96124|NCT01280695|228893|P3|COMPLETED|Overall Study||21
96125|NCT01280695|228894|P2|COMPLETED|Overall Study||24
96126|NCT01280695|228895|P1|COMPLETED|Overall Study||26
96127|NCT01280695|228891|P5|STARTED|Overall Study||26
96128|NCT01280695|228892|P4|STARTED|Overall Study||26
96129|NCT01280695|228893|P3|STARTED|Overall Study||26
96130|NCT01280695|228894|P2|STARTED|Overall Study||25
96131|NCT01280695|228895|P1|STARTED|Overall Study||26
96132|NCT01280656|228935|P3|NOT COMPLETED|Overall Study||63
96133|NCT01280656|228936|P2|NOT COMPLETED|Overall Study||47
96134|NCT01280656|228937|P1|NOT COMPLETED|Overall Study||3
96135|NCT01280656|228935|P3|COMPLETED|Overall Study||223
96136|NCT01280656|228936|P2|COMPLETED|Overall Study||265
96137|NCT01280656|228937|P1|COMPLETED|Overall Study||59
96138|NCT01280656|228935|P3|STARTED|Overall Study||286
96139|NCT01280656|228936|P2|STARTED|Overall Study||312
96140|NCT01280656|228937|P1|STARTED|Overall Study||62
96141|NCT01280604|228983|P2|NOT COMPLETED|Overall Study||5
96142|NCT01280604|228984|P1|NOT COMPLETED|Overall Study||9
96143|NCT01280604|228983|P2|COMPLETED|Overall Study||28
96144|NCT01280604|228984|P1|COMPLETED|Overall Study||24
96145|NCT01280604|228983|P2|Subjects Meeting All Inclusion Criteria|Overall Study||29
96146|NCT01280604|228984|P1|Subjects Meeting All Inclusion Criteria|Overall Study||25
96147|NCT01280604|228983|P2|STARTED|Overall Study||33
96148|NCT01280604|228984|P1|STARTED|Overall Study||33
96149|NCT01280591|229004|P4|NOT COMPLETED|Overall Study||3
96150|NCT01280591|229005|P3|NOT COMPLETED|Overall Study||0
96151|NCT01280591|229006|P2|NOT COMPLETED|Overall Study||0
96152|NCT01280591|229007|P1|NOT COMPLETED|Overall Study||0
96153|NCT01280591|229004|P4|COMPLETED|Overall Study||99
96154|NCT01280591|229005|P3|COMPLETED|Overall Study||203
96155|NCT01280591|229006|P2|COMPLETED|Overall Study||204
96156|NCT01280591|229007|P1|COMPLETED|Overall Study||203
96157|NCT01280591|229004|P4|STARTED|Overall Study||102
96158|NCT01280591|229005|P3|STARTED|Overall Study||203
96159|NCT01280591|229006|P2|STARTED|Overall Study||204
96160|NCT01280591|229007|P1|STARTED|Overall Study||203
96161|NCT01280552|229099|P2|NOT COMPLETED|Overall Study||1
96162|NCT01280552|229100|P1|NOT COMPLETED|Overall Study||6
96163|NCT01280552|229099|P2|COMPLETED|Overall Study||42
96164|NCT01280552|229100|P1|COMPLETED|Overall Study|Survival is still being assessed|75
96165|NCT01280552|229099|P2|STARTED|Overall Study||43
96166|NCT01280552|229100|P1|STARTED|Overall Study||81
96167|NCT01280357|229112|P1|NOT COMPLETED|Overall Study||26
96168|NCT01280357|229112|P1|COMPLETED|Overall Study||34
96169|NCT01280357|229112|P1|STARTED|Overall Study||60
96170|NCT01280266|229121|P2|NOT COMPLETED|Second Intervention (Week 5-9)||0
96171|NCT01280266|229122|P1|NOT COMPLETED|Second Intervention (Week 5-9)||0
96172|NCT01280266|229121|P2|COMPLETED|Second Intervention (Week 5-9)||12
96173|NCT01280266|229122|P1|COMPLETED|Second Intervention (Week 5-9)||14
96174|NCT01280266|229121|P2|STARTED|Second Intervention (Week 5-9)||12
96175|NCT01280266|229122|P1|STARTED|Second Intervention (Week 5-9)||14
96176|NCT01280266|229121|P2|NOT COMPLETED|Washout Period (Week 4-5)||0
96177|NCT01280266|229122|P1|NOT COMPLETED|Washout Period (Week 4-5)||0
96178|NCT01280266|229121|P2|COMPLETED|Washout Period (Week 4-5)||12
96179|NCT01280266|229122|P1|COMPLETED|Washout Period (Week 4-5)||14
96180|NCT01280266|229121|P2|STARTED|Washout Period (Week 4-5)||12
96181|NCT01280266|229122|P1|STARTED|Washout Period (Week 4-5)||14
96182|NCT01280266|229121|P2|NOT COMPLETED|First Intervention (Week 1-4)||2
96183|NCT01280266|229122|P1|NOT COMPLETED|First Intervention (Week 1-4)||1
96184|NCT01280266|229121|P2|COMPLETED|First Intervention (Week 1-4)||12
96185|NCT01280266|229122|P1|COMPLETED|First Intervention (Week 1-4)||14
96186|NCT01280266|229121|P2|STARTED|First Intervention (Week 1-4)||14
96187|NCT01280266|229122|P1|STARTED|First Intervention (Week 1-4)||15
96188|NCT01280123|229147|P3|NOT COMPLETED|Overall Study||1
96189|NCT01280123|229148|P2|NOT COMPLETED|Overall Study||4
96190|NCT01280123|229149|P1|NOT COMPLETED|Overall Study||1
96191|NCT01280123|229147|P3|COMPLETED|Overall Study||70
96192|NCT01280123|229148|P2|COMPLETED|Overall Study||63
96193|NCT01280123|229149|P1|COMPLETED|Overall Study||71
96194|NCT01280123|229147|P3|STARTED|Overall Study||71
96195|NCT01280123|229148|P2|STARTED|Overall Study||67
96196|NCT01280123|229149|P1|STARTED|Overall Study||72
96197|NCT01280110|229174|P2|NOT COMPLETED|Overall Study||0
96198|NCT01280110|229175|P1|NOT COMPLETED|Overall Study||0
96199|NCT01280110|229174|P2|COMPLETED|Overall Study||22
96200|NCT01280110|229175|P1|COMPLETED|Overall Study||22
96201|NCT01280110|229174|P2|STARTED|Overall Study||22
96202|NCT01280110|229175|P1|STARTED|Overall Study||22
96203|NCT01279564|229185|P2|NOT COMPLETED|Overall Study||0
96204|NCT01279564|229186|P1|NOT COMPLETED|Overall Study||0
96205|NCT01279564|229185|P2|COMPLETED|Overall Study||32
96206|NCT01279564|229186|P1|COMPLETED|Overall Study||40
96207|NCT01279564|229185|P2|STARTED|Overall Study||32
96208|NCT01279564|229186|P1|STARTED|Overall Study||40
96209|NCT01279447|229194|P2|NOT COMPLETED|Overall Study||1
96210|NCT01279447|229195|P1|NOT COMPLETED|Overall Study||3
96211|NCT01279447|229194|P2|COMPLETED|Overall Study||33
96212|NCT01279447|229195|P1|COMPLETED|Overall Study||31
96213|NCT01279447|229194|P2|STARTED|Overall Study||34
96214|NCT01279447|229195|P1|STARTED|Overall Study||34
96215|NCT01279317|229201|P2|NOT COMPLETED|Period 2||0
96216|NCT01279317|229202|P1|NOT COMPLETED|Period 2||0
96217|NCT01279317|229201|P2|COMPLETED|Period 2||6
96218|NCT01279317|229202|P1|COMPLETED|Period 2||6
96219|NCT01279317|229201|P2|STARTED|Period 2||6
96220|NCT01279317|229202|P1|STARTED|Period 2||6
96221|NCT01279317|229201|P2|NOT COMPLETED|Washout||0
96222|NCT01279317|229202|P1|NOT COMPLETED|Washout||0
96223|NCT01279317|229201|P2|COMPLETED|Washout||6
96224|NCT01279317|229202|P1|COMPLETED|Washout||6
96225|NCT01279317|229201|P2|STARTED|Washout||6
96226|NCT01279317|229202|P1|STARTED|Washout||6
96227|NCT01279317|229201|P2|NOT COMPLETED|Period 1||0
96228|NCT01279317|229202|P1|NOT COMPLETED|Period 1||0
96229|NCT01279317|229201|P2|COMPLETED|Period 1||6
96230|NCT01279317|229202|P1|COMPLETED|Period 1||6
96231|NCT01279317|229201|P2|STARTED|Period 1||6
96232|NCT01279317|229202|P1|STARTED|Period 1||6
96233|NCT01279265|229209|P2|NOT COMPLETED|Overall Study||6
96234|NCT01279265|229210|P1|NOT COMPLETED|Overall Study||4
96235|NCT01279265|229209|P2|COMPLETED|Overall Study||11
96236|NCT01279265|229210|P1|COMPLETED|Overall Study||9
96237|NCT01279265|229209|P2|STARTED|Overall Study||17
96238|NCT01279265|229210|P1|STARTED|Overall Study||13
96239|NCT01279200|229222|P2|NOT COMPLETED|Overall Study||7
96240|NCT01279200|229223|P1|NOT COMPLETED|Overall Study||2
96241|NCT01279200|229222|P2|COMPLETED|Overall Study||4
96242|NCT01279200|229223|P1|COMPLETED|Overall Study||8
96243|NCT01279200|229222|P2|STARTED|Overall Study||11
96244|NCT01279200|229223|P1|STARTED|Overall Study||10
96245|NCT01279109|229233|P2|NOT COMPLETED|Overall Study||12
96246|NCT01279109|229234|P1|NOT COMPLETED|Overall Study||13
96247|NCT01279109|229233|P2|COMPLETED|Overall Study||55
96248|NCT01279109|229234|P1|COMPLETED|Overall Study||55
96249|NCT01279109|229233|P2|STARTED|Overall Study||67
96250|NCT01279109|229234|P1|STARTED|Overall Study||68
96251|NCT01279070|229244|P2|NOT COMPLETED|Overall Study||4
96252|NCT01279070|229245|P1|NOT COMPLETED|Overall Study||5
96253|NCT01279070|229244|P2|COMPLETED|Overall Study|4 outpatients left the leisure group up to 2 months after starting Leisure group.|24
96254|NCT01279070|229245|P1|COMPLETED|Overall Study|5 outpatients left the treatment up to 2 months after starting REPYFLEC.|29
96255|NCT01279070|229244|P2|STARTED|Overall Study|28 outpatients were randomly assigned to 32 sessions of leisure group.|28
96256|NCT01279070|229245|P1|STARTED|Overall Study|34 outpatients were randomly assigned to 32 sessions of REPYFLEC.|34
96257|NCT01279044|229264|P3|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||3
96258|NCT01279044|229265|P2|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||11
96259|NCT01279044|229266|P1|NOT COMPLETED|PHASE 2 - Randmonized Controlled Trial||0
96260|NCT01279044|229264|P3|COMPLETED|PHASE 2 - Randmonized Controlled Trial||161
96261|NCT01279044|229265|P2|COMPLETED|PHASE 2 - Randmonized Controlled Trial||151
96262|NCT01279044|229266|P1|COMPLETED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
96263|NCT01279044|229264|P3|STARTED|PHASE 2 - Randmonized Controlled Trial||164
96264|NCT01279044|229265|P2|STARTED|PHASE 2 - Randmonized Controlled Trial||162
96265|NCT01279044|229266|P1|STARTED|PHASE 2 - Randmonized Controlled Trial|Participants who participated in the RCT did not participate in the formative phase.|0
96266|NCT01279044|229264|P3|NOT COMPLETED|PHASE 1 - Formative||0
96267|NCT01279044|229265|P2|NOT COMPLETED|PHASE 1 - Formative||0
96268|NCT01279044|229266|P1|NOT COMPLETED|PHASE 1 - Formative||0
96269|NCT01279044|229264|P3|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
96270|NCT01279044|229265|P2|COMPLETED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
96271|NCT01279044|229266|P1|COMPLETED|PHASE 1 - Formative||59
96272|NCT01279044|229264|P3|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
96273|NCT01279044|229265|P2|STARTED|PHASE 1 - Formative|Participants who participated in the formative phase did not participate in the RCT.|0
96274|NCT01279044|229266|P1|STARTED|PHASE 1 - Formative||59
96275|NCT01278953|229286|P2|NOT COMPLETED|Overall Study||11
96276|NCT01278953|229287|P1|NOT COMPLETED|Overall Study||9
96277|NCT01278953|229286|P2|COMPLETED|Overall Study||134
96278|NCT01278953|229287|P1|COMPLETED|Overall Study||146
96279|NCT01278953|229286|P2|STARTED|Overall Study||145
96280|NCT01278953|229287|P1|STARTED|Overall Study||155
96281|NCT01278927|229299|P4|NOT COMPLETED|Overall Study||0
96282|NCT01278927|229300|P3|NOT COMPLETED|Overall Study||0
96283|NCT01278927|229301|P2|NOT COMPLETED|Overall Study||0
96284|NCT01278927|229302|P1|NOT COMPLETED|Overall Study||0
96285|NCT01278927|229299|P4|COMPLETED|Overall Study||175
96286|NCT01278927|229300|P3|COMPLETED|Overall Study||178
96287|NCT01278927|229301|P2|COMPLETED|Overall Study||178
96288|NCT01278927|229302|P1|COMPLETED|Overall Study||180
96289|NCT01278927|229299|P4|STARTED|Overall Study||175
96290|NCT01278927|229300|P3|STARTED|Overall Study||178
96291|NCT01278927|229301|P2|STARTED|Overall Study||178
96292|NCT01278927|229302|P1|STARTED|Overall Study||180
96293|NCT01278797|229340|P2|NOT COMPLETED|Period 2||0
96294|NCT01278797|229341|P1|NOT COMPLETED|Period 2||0
96295|NCT01278797|229340|P2|COMPLETED|Period 2||13
96296|NCT01278797|229341|P1|COMPLETED|Period 2||13
96297|NCT01278797|229340|P2|STARTED|Period 2||13
96298|NCT01278797|229341|P1|STARTED|Period 2||13
96299|NCT01278797|229340|P2|NOT COMPLETED|Washout Period of 21 Days||0
96300|NCT01278797|229341|P1|NOT COMPLETED|Washout Period of 21 Days||0
96301|NCT01278797|229340|P2|COMPLETED|Washout Period of 21 Days||13
96302|NCT01278797|229341|P1|COMPLETED|Washout Period of 21 Days||13
96303|NCT01278797|229340|P2|STARTED|Washout Period of 21 Days||13
96304|NCT01278797|229341|P1|STARTED|Washout Period of 21 Days||13
96305|NCT01278797|229340|P2|NOT COMPLETED|Period 1||1
96306|NCT01278797|229341|P1|NOT COMPLETED|Period 1||1
96307|NCT01278797|229340|P2|COMPLETED|Period 1||13
96308|NCT01278797|229341|P1|COMPLETED|Period 1||13
96309|NCT01278797|229340|P2|STARTED|Period 1||14
96310|NCT01278797|229341|P1|STARTED|Period 1||14
96311|NCT01278745|229353|P4|NOT COMPLETED|Overall Study||78
96312|NCT01278745|229354|P3|NOT COMPLETED|Overall Study||121
96313|NCT01278745|229355|P2|NOT COMPLETED|Overall Study||6
96314|NCT01278745|229356|P1|NOT COMPLETED|Overall Study||5
96315|NCT01278745|229353|P4|COMPLETED|Overall Study||0
96316|NCT01278745|229354|P3|COMPLETED|Overall Study||0
96317|NCT01278745|229355|P2|COMPLETED|Overall Study||68
96318|NCT01278745|229356|P1|COMPLETED|Overall Study||84
96319|NCT01278745|229353|P4|STARTED|Overall Study||78
96320|NCT01278745|229354|P3|STARTED|Overall Study||121
96321|NCT01278745|229355|P2|STARTED|Overall Study||74
96322|NCT01278745|229356|P1|STARTED|Overall Study||89
96323|NCT01278615|229388|P1|NOT COMPLETED|Overall Study||2
96324|NCT01278615|229388|P1|COMPLETED|Overall Study||14
96325|NCT01278615|229388|P1|STARTED|Overall Study||16
96326|NCT01278485|229398|P1|NOT COMPLETED|Overall Study||0
96327|NCT01278485|229398|P1|COMPLETED|Overall Study||719
96328|NCT01278485|229398|P1|STARTED|Overall Study||719
96329|NCT01278407|229414|P5|NOT COMPLETED|Extension Phase||30
96330|NCT01278407|229415|P4|NOT COMPLETED|Extension Phase||12
96331|NCT01278407|229416|P3|NOT COMPLETED|Extension Phase||0
96332|NCT01278407|229417|P2|NOT COMPLETED|Extension Phase||0
96333|NCT01278407|229418|P1|NOT COMPLETED|Extension Phase||0
96334|NCT01278407|229414|P5|COMPLETED|Extension Phase||66
96335|NCT01278407|229415|P4|COMPLETED|Extension Phase||34
96336|NCT01278407|229416|P3|COMPLETED|Extension Phase||0
96337|NCT01278407|229417|P2|COMPLETED|Extension Phase||0
96338|NCT01278407|229418|P1|COMPLETED|Extension Phase||0
96339|NCT01278407|229414|P5|STARTED|Extension Phase||96
96340|NCT01278407|229415|P4|STARTED|Extension Phase||46
96341|NCT01278407|229416|P3|STARTED|Extension Phase||0
96342|NCT01278407|229417|P2|STARTED|Extension Phase||0
96343|NCT01278407|229418|P1|STARTED|Extension Phase||0
96344|NCT01278407|229414|P5|NOT COMPLETED|Confirmatory Phase||0
96345|NCT01278407|229415|P4|NOT COMPLETED|Confirmatory Phase||0
96346|NCT01278407|229416|P3|NOT COMPLETED|Confirmatory Phase||6
96347|NCT01278407|229417|P2|NOT COMPLETED|Confirmatory Phase||16
96348|NCT01278407|229418|P1|NOT COMPLETED|Confirmatory Phase||9
96349|NCT01278407|229414|P5|COMPLETED|Confirmatory Phase||0
96350|NCT01278407|229415|P4|COMPLETED|Confirmatory Phase||0
96351|NCT01278407|229416|P3|COMPLETED|Confirmatory Phase||43
96352|NCT01278407|229417|P2|COMPLETED|Confirmatory Phase||31
96353|NCT01278407|229418|P1|COMPLETED|Confirmatory Phase||37
96354|NCT01278407|229414|P5|STARTED|Confirmatory Phase||0
96355|NCT01278407|229415|P4|STARTED|Confirmatory Phase||0
96356|NCT01278407|229416|P3|STARTED|Confirmatory Phase||49
96357|NCT01278407|229417|P2|STARTED|Confirmatory Phase||47
96358|NCT01278407|229418|P1|STARTED|Confirmatory Phase||46
96359|NCT01278394|229431|P1|NOT COMPLETED|Overall Study||1
96360|NCT01278394|229431|P1|COMPLETED|Overall Study||28
96361|NCT01278394|229431|P1|STARTED|Overall Study||29
96362|NCT01278342|229444|P3|NOT COMPLETED|Overall Study||0
96363|NCT01278342|229445|P2|NOT COMPLETED|Overall Study||1
96364|NCT01278342|229446|P1|NOT COMPLETED|Overall Study||4
96365|NCT01278342|229444|P3|COMPLETED|Overall Study||32
96366|NCT01278342|229445|P2|COMPLETED|Overall Study||30
96367|NCT01278342|229446|P1|COMPLETED|Overall Study||3
96368|NCT01278342|229444|P3|STARTED|Overall Study||32
96369|NCT01278342|229445|P2|STARTED|Overall Study||31
96370|NCT01278342|229446|P1|STARTED|Overall Study||7
96371|NCT01278303|229460|P1|NOT COMPLETED|Overall Study||0
96372|NCT01278303|229460|P1|COMPLETED|Overall Study||82
96373|NCT01278303|229460|P1|STARTED|Overall Study||82
96374|NCT01278173|229466|P1|NOT COMPLETED|Overall Study||27
96375|NCT01278173|229466|P1|COMPLETED|Overall Study||38
96376|NCT01278173|229466|P1|STARTED|Overall Study||65
96377|NCT01278160|229473|P2|NOT COMPLETED|Overall Study||6
96378|NCT01278160|229474|P1|NOT COMPLETED|Overall Study||5
96379|NCT01278160|229473|P2|COMPLETED|Overall Study||84
96380|NCT01278160|229474|P1|COMPLETED|Overall Study||84
96381|NCT01278160|229473|P2|STARTED|Overall Study||90
96382|NCT01278160|229474|P1|STARTED|Overall Study||89
96383|NCT01278030|229490|P2|NOT COMPLETED|Overall Study||4
96384|NCT01278030|229491|P1|NOT COMPLETED|Overall Study||8
96385|NCT01278030|229490|P2|COMPLETED|Overall Study||31
96386|NCT01278030|229491|P1|COMPLETED|Overall Study||35
96387|NCT01278030|229490|P2|STARTED|Overall Study||35
96388|NCT01278030|229491|P1|STARTED|Overall Study||43
96389|NCT01277861|229499|P2|NOT COMPLETED|Overall Study||2
96390|NCT01277861|229500|P1|NOT COMPLETED|Overall Study||2
96391|NCT01277861|229499|P2|COMPLETED|Overall Study||47
96392|NCT01277861|229500|P1|COMPLETED|Overall Study||49
96393|NCT01277861|229499|P2|STARTED|Overall Study||49
96394|NCT01277861|229500|P1|STARTED|Overall Study||51
96395|NCT01277822|229512|P2|NOT COMPLETED|Overall Study||11
96396|NCT01277822|229513|P1|NOT COMPLETED|Overall Study||15
96397|NCT01277822|229512|P2|COMPLETED|Overall Study||155
96398|NCT01277822|229513|P1|COMPLETED|Overall Study||153
96399|NCT01277822|229512|P2|STARTED|Overall Study||166
96400|NCT01277822|229513|P1|STARTED|Overall Study||168
96401|NCT01277757|229533|P1|NOT COMPLETED|Overall Study||2
96402|NCT01277757|229533|P1|COMPLETED|Overall Study||28
96403|NCT01277757|229533|P1|STARTED|Overall Study||30
96404|NCT01277718|229540|P2|NOT COMPLETED|Period 3 - Third Intervention||0
96405|NCT01277718|229541|P1|NOT COMPLETED|Period 3 - Third Intervention||0
96406|NCT01277718|229540|P2|COMPLETED|Period 3 - Third Intervention||7
96407|NCT01277718|229541|P1|COMPLETED|Period 3 - Third Intervention||10
96408|NCT01277718|229540|P2|STARTED|Period 3 - Third Intervention||7
96409|NCT01277718|229541|P1|STARTED|Period 3 - Third Intervention||10
96410|NCT01277718|229540|P2|NOT COMPLETED|Washout Period of 13 Days||0
96411|NCT01277718|229541|P1|NOT COMPLETED|Washout Period of 13 Days||0
96412|NCT01277718|229540|P2|COMPLETED|Washout Period of 13 Days||7
96413|NCT01277718|229541|P1|COMPLETED|Washout Period of 13 Days||10
96414|NCT01277718|229540|P2|STARTED|Washout Period of 13 Days||7
96415|NCT01277718|229541|P1|STARTED|Washout Period of 13 Days||10
96416|NCT01277718|229540|P2|NOT COMPLETED|Period 2 - Second Intervention||3
96417|NCT01277718|229541|P1|NOT COMPLETED|Period 2 - Second Intervention||0
96418|NCT01277718|229540|P2|COMPLETED|Period 2 - Second Intervention||7
96419|NCT01277718|229541|P1|COMPLETED|Period 2 - Second Intervention||10
96420|NCT01277718|229540|P2|STARTED|Period 2 - Second Intervention||10
96421|NCT01277718|229541|P1|STARTED|Period 2 - Second Intervention||10
96422|NCT01277718|229540|P2|NOT COMPLETED|Washout Period of 13 Days||0
96423|NCT01277718|229541|P1|NOT COMPLETED|Washout Period of 13 Days||0
96424|NCT01277718|229540|P2|COMPLETED|Washout Period of 13 Days||10
96425|NCT01277718|229541|P1|COMPLETED|Washout Period of 13 Days||10
96426|NCT01277718|229540|P2|STARTED|Washout Period of 13 Days||10
96427|NCT01277718|229541|P1|STARTED|Washout Period of 13 Days||10
96428|NCT01277718|229540|P2|NOT COMPLETED|Period 1 - First Intervention||0
96429|NCT01277718|229541|P1|NOT COMPLETED|Period 1 - First Intervention||0
96430|NCT01277718|229540|P2|COMPLETED|Period 1 - First Intervention||10
96431|NCT01277718|229541|P1|COMPLETED|Period 1 - First Intervention||10
96432|NCT01277718|229540|P2|STARTED|Period 1 - First Intervention||10
96433|NCT01277718|229541|P1|STARTED|Period 1 - First Intervention||10
96434|NCT01277601|229556|P4|NOT COMPLETED|Overall Study||36
96435|NCT01277601|229557|P3|NOT COMPLETED|Overall Study||27
96436|NCT01277601|229558|P2|NOT COMPLETED|Overall Study||48
96437|NCT01277601|229559|P1|NOT COMPLETED|Overall Study||37
96438|NCT01277601|229556|P4|COMPLETED|Overall Study||150
96439|NCT01277601|229557|P3|COMPLETED|Overall Study||163
96440|NCT01277601|229558|P2|COMPLETED|Overall Study||139
96441|NCT01277601|229559|P1|COMPLETED|Overall Study||151
96442|NCT01277601|229556|P4|STARTED|Overall Study||186
96443|NCT01277601|229557|P3|STARTED|Overall Study||190
96444|NCT01277601|229558|P2|STARTED|Overall Study||187
96445|NCT01277601|229559|P1|STARTED|Overall Study||188
96446|NCT01277549|229650|P2|NOT COMPLETED|Overall Study||14
96447|NCT01277549|229651|P1|NOT COMPLETED|Overall Study||26
96448|NCT01277549|229650|P2|COMPLETED|Overall Study||15
96449|NCT01277549|229651|P1|COMPLETED|Overall Study||15
96450|NCT01277549|229650|P2|STARTED|Overall Study||29
96451|NCT01277549|229651|P1|STARTED|Overall Study||41
96452|NCT01277523|229668|P3|NOT COMPLETED|Overall Study||0
96453|NCT01277523|229669|P2|NOT COMPLETED|Overall Study||1
96454|NCT01277523|229670|P1|NOT COMPLETED|Overall Study||3
96455|NCT01277523|229668|P3|COMPLETED|Overall Study||130
96456|NCT01277523|229669|P2|COMPLETED|Overall Study||126
96457|NCT01277523|229670|P1|COMPLETED|Overall Study||132
96458|NCT01277523|229668|P3|STARTED|Overall Study||130
96459|NCT01277523|229669|P2|STARTED|Overall Study||127
96460|NCT01277523|229670|P1|STARTED|Overall Study||135
96461|NCT01277510|229722|P2|NOT COMPLETED|Open-label Phase||3
96462|NCT01277510|229723|P1|NOT COMPLETED|Open-label Phase||7
96463|NCT01277510|229722|P2|COMPLETED|Open-label Phase|Completed investigational product|1
96464|NCT01277510|229723|P1|COMPLETED|Open-label Phase|Completed investigational product|1
96465|NCT01277510|229722|P2|Received Investigational Product|Open-label Phase||4
96466|NCT01277510|229723|P1|Received Investigational Product|Open-label Phase||6
96467|NCT01277510|229722|P2|STARTED|Open-label Phase||4
96468|NCT01277510|229723|P1|STARTED|Open-label Phase||8
96469|NCT01277510|229722|P2|NOT COMPLETED|Double-blind Phase||18
96470|NCT01277510|229723|P1|NOT COMPLETED|Double-blind Phase||13
96471|NCT01277510|229722|P2|COMPLETED|Double-blind Phase|Completed investigational product|4
96472|NCT01277510|229723|P1|COMPLETED|Double-blind Phase|Completed investigational product|8
96473|NCT01277510|229722|P2|Received Investigational Product|Double-blind Phase||22
96474|NCT01277510|229723|P1|Received Investigational Product|Double-blind Phase||21
96475|NCT01277510|229722|P2|STARTED|Double-blind Phase||22
96476|NCT01277510|229723|P1|STARTED|Double-blind Phase||21
96477|NCT01277354|229747|P2|NOT COMPLETED|Overall Study||0
96478|NCT01277354|229748|P1|NOT COMPLETED|Overall Study||0
96479|NCT01277354|229747|P2|COMPLETED|Overall Study||1
96480|NCT01277354|229748|P1|COMPLETED|Overall Study||1
96481|NCT01277354|229747|P2|STARTED|Overall Study||1
96482|NCT01277354|229748|P1|STARTED|Overall Study||1
96483|NCT01277302|229757|P3|NOT COMPLETED|8-Month Alternate Dose Regimen Period||6
96484|NCT01277302|229758|P2|NOT COMPLETED|8-Month Alternate Dose Regimen Period||4
96485|NCT01277302|229759|P1|NOT COMPLETED|8-Month Alternate Dose Regimen Period||5
96486|NCT01277302|229757|P3|COMPLETED|8-Month Alternate Dose Regimen Period||13
96487|NCT01277302|229758|P2|COMPLETED|8-Month Alternate Dose Regimen Period||82
96488|NCT01277302|229759|P1|COMPLETED|8-Month Alternate Dose Regimen Period||80
96489|NCT01277302|229757|P3|STARTED|8-Month Alternate Dose Regimen Period||19
96490|NCT01277302|229758|P2|STARTED|8-Month Alternate Dose Regimen Period||86
96491|NCT01277302|229759|P1|STARTED|8-Month Alternate Dose Regimen Period||85
96492|NCT01277302|229757|P3|NOT COMPLETED|7-Month Fixed Treatment Period||12
96493|NCT01277302|229758|P2|NOT COMPLETED|7-Month Fixed Treatment Period||0
96494|NCT01277302|229759|P1|NOT COMPLETED|7-Month Fixed Treatment Period||0
96495|NCT01277302|229757|P3|COMPLETED|7-Month Fixed Treatment Period||19
96496|NCT01277302|229758|P2|COMPLETED|7-Month Fixed Treatment Period||86
96497|NCT01277302|229759|P1|COMPLETED|7-Month Fixed Treatment Period||85
96498|NCT01277302|229757|P3|STARTED|7-Month Fixed Treatment Period||31
96499|NCT01277302|229758|P2|STARTED|7-Month Fixed Treatment Period||86
96500|NCT01277302|229759|P1|STARTED|7-Month Fixed Treatment Period||85
96501|NCT01277211|229791|P2|NOT COMPLETED|Overall Study||63
96502|NCT01277211|229792|P1|NOT COMPLETED|Overall Study||150
96503|NCT01277211|229791|P2|COMPLETED|Overall Study||182
96504|NCT01277211|229792|P1|COMPLETED|Overall Study||588
96505|NCT01277211|229791|P2|Treated|Overall Study||232
96506|NCT01277211|229792|P1|Treated|Overall Study||714
96507|NCT01277211|229791|P2|STARTED|Overall Study||245
96508|NCT01277211|229792|P1|STARTED|Overall Study||738
96509|NCT01277159|229807|P5|NOT COMPLETED|Overall Study||5
96510|NCT01277159|229808|P4|NOT COMPLETED|Overall Study||3
96511|NCT01277159|229809|P3|NOT COMPLETED|Overall Study||3
96512|NCT01277159|229810|P2|NOT COMPLETED|Overall Study||1
96513|NCT01277159|229811|P1|NOT COMPLETED|Overall Study||4
96514|NCT01277159|229807|P5|COMPLETED|Overall Study||16
96515|NCT01277159|229808|P4|COMPLETED|Overall Study||19
96516|NCT01277159|229809|P3|COMPLETED|Overall Study||19
96517|NCT01277159|229810|P2|COMPLETED|Overall Study||21
96518|NCT01277159|229811|P1|COMPLETED|Overall Study||17
96519|NCT01277159|229807|P5|STARTED|Overall Study||21
96520|NCT01277159|229808|P4|STARTED|Overall Study||22
96521|NCT01277159|229809|P3|STARTED|Overall Study||22
96522|NCT01277159|229810|P2|STARTED|Overall Study||22
96523|NCT01277159|229811|P1|STARTED|Overall Study||21
96524|NCT01277081|229825|P2|NOT COMPLETED|Overall Study||0
96525|NCT01277081|229826|P1|NOT COMPLETED|Overall Study||0
96526|NCT01277081|229825|P2|COMPLETED|Overall Study||100
96527|NCT01277081|229826|P1|COMPLETED|Overall Study||100
96528|NCT01277081|229825|P2|STARTED|Overall Study||100
96529|NCT01277081|229826|P1|STARTED|Overall Study||100
96530|NCT01277042|229844|P2|NOT COMPLETED|Overall Study||5
96531|NCT01277042|229845|P1|NOT COMPLETED|Overall Study||8
96532|NCT01277042|229844|P2|COMPLETED|Overall Study||601
96533|NCT01277042|229845|P1|COMPLETED|Overall Study||598
96534|NCT01277042|229844|P2|STARTED|Overall Study||606
96535|NCT01277042|229845|P1|STARTED|Overall Study||606
96536|NCT01276847|229870|P3|NOT COMPLETED|Overall Study||0
96537|NCT01276847|229871|P2|NOT COMPLETED|Overall Study||0
96538|NCT01276847|229872|P1|NOT COMPLETED|Overall Study||1
96539|NCT01276847|229870|P3|COMPLETED|Overall Study||20
96540|NCT01276847|229871|P2|COMPLETED|Overall Study||10
96541|NCT01276847|229872|P1|COMPLETED|Overall Study||9
96542|NCT01276847|229870|P3|STARTED|Overall Study||20
96543|NCT01276847|229871|P2|STARTED|Overall Study||10
96544|NCT01276847|229872|P1|STARTED|Overall Study||10
96545|NCT01276821|229882|P2|NOT COMPLETED|Overall Study||1
96546|NCT01276821|229883|P1|NOT COMPLETED|Overall Study||0
96547|NCT01276821|229882|P2|COMPLETED|Overall Study||49
96548|NCT01276821|229883|P1|COMPLETED|Overall Study||50
96549|NCT01276821|229882|P2|STARTED|Overall Study||50
96550|NCT01276821|229883|P1|STARTED|Overall Study||50
96551|NCT01276756|229903|P2|NOT COMPLETED|Overall Study||2
96552|NCT01276756|229904|P1|NOT COMPLETED|Overall Study||5
96553|NCT01276756|229903|P2|COMPLETED|Overall Study||48
96554|NCT01276756|229904|P1|COMPLETED|Overall Study||45
96555|NCT01276756|229903|P2|STARTED|Overall Study||50
96556|NCT01276756|229904|P1|STARTED|Overall Study||50
96557|NCT01276639|229921|P5|NOT COMPLETED|Week 16 to 52||21
96558|NCT01276639|229922|P4|NOT COMPLETED|Week 16 to 52||16
96559|NCT01276639|229923|P3|NOT COMPLETED|Week 16 to 52||0
96560|NCT01276639|229924|P2|NOT COMPLETED|Week 16 to 52||101
96561|NCT01276639|229925|P1|NOT COMPLETED|Week 16 to 52||127
96562|NCT01276639|229921|P5|COMPLETED|Week 16 to 52||45
96563|NCT01276639|229922|P4|COMPLETED|Week 16 to 52||50
96564|NCT01276639|229923|P3|COMPLETED|Week 16 to 52||0
96565|NCT01276639|229924|P2|COMPLETED|Week 16 to 52||219
96566|NCT01276639|229925|P1|COMPLETED|Week 16 to 52||186
96567|NCT01276639|229921|P5|STARTED|Week 16 to 52||66
96568|NCT01276639|229922|P4|STARTED|Week 16 to 52||66
96569|NCT01276639|229923|P3|STARTED|Week 16 to 52||0
96570|NCT01276639|229924|P2|STARTED|Week 16 to 52||320
96571|NCT01276639|229925|P1|STARTED|Week 16 to 52||313
96572|NCT01276639|229921|P5|NOT COMPLETED|Week 0 to 16||0
96573|NCT01276639|229922|P4|NOT COMPLETED|Week 0 to 16||0
96574|NCT01276639|229923|P3|NOT COMPLETED|Week 0 to 16||45
96575|NCT01276639|229924|P2|NOT COMPLETED|Week 0 to 16||41
96576|NCT01276639|229925|P1|NOT COMPLETED|Week 0 to 16||50
96577|NCT01276639|229921|P5|COMPLETED|Week 0 to 16||0
96578|NCT01276639|229922|P4|COMPLETED|Week 0 to 16||0
96579|NCT01276639|229923|P3|COMPLETED|Week 0 to 16||132
96580|NCT01276639|229924|P2|COMPLETED|Week 0 to 16||320
96581|NCT01276639|229925|P1|COMPLETED|Week 0 to 16||313
96582|NCT01276639|229921|P5|Treated|Week 0 to 16||0
96583|NCT01276639|229922|P4|Treated|Week 0 to 16||0
96584|NCT01276639|229923|P3|Treated|Week 0 to 16||177
96585|NCT01276639|229924|P2|Treated|Week 0 to 16||360
96586|NCT01276639|229925|P1|Treated|Week 0 to 16||363
96587|NCT01276639|229921|P5|STARTED|Week 0 to 16||0
96588|NCT01276639|229922|P4|STARTED|Week 0 to 16||0
96589|NCT01276639|229923|P3|STARTED|Week 0 to 16||177
96590|NCT01276639|229924|P2|STARTED|Week 0 to 16||361
96591|NCT01276639|229925|P1|STARTED|Week 0 to 16||363
96592|NCT01276535|230120|P1|NOT COMPLETED|Overall Study||0
96593|NCT01276535|230120|P1|COMPLETED|Overall Study||12
96594|NCT01276535|230120|P1|STARTED|Overall Study||12
96595|NCT01276509|230130|P4|NOT COMPLETED|Overall Study||5
96596|NCT01276509|230131|P3|NOT COMPLETED|Overall Study||5
96597|NCT01276509|230132|P2|NOT COMPLETED|Overall Study||12
96598|NCT01276509|230133|P1|NOT COMPLETED|Overall Study||13
96599|NCT01276509|230130|P4|COMPLETED|Overall Study||58
96600|NCT01276509|230131|P3|COMPLETED|Overall Study||63
96601|NCT01276509|230132|P2|COMPLETED|Overall Study||53
96602|NCT01276509|230133|P1|COMPLETED|Overall Study||53
96603|NCT01276509|230130|P4|STARTED|Overall Study||63
96604|NCT01276509|230131|P3|STARTED|Overall Study||68
96605|NCT01276509|230132|P2|STARTED|Overall Study||65
96606|NCT01276509|230133|P1|STARTED|Overall Study||66
96607|NCT01276457|230186|P2|NOT COMPLETED|Extension Study||2
96608|NCT01276457|230187|P1|NOT COMPLETED|Extension Study||6
96609|NCT01276457|230186|P2|COMPLETED|Extension Study||110
96610|NCT01276457|230187|P1|COMPLETED|Extension Study||105
96611|NCT01276457|230186|P2|STARTED|Extension Study||112
96612|NCT01276457|230187|P1|STARTED|Extension Study||111
96613|NCT01276457|230186|P2|NOT COMPLETED|Core Study||20
96614|NCT01276457|230187|P1|NOT COMPLETED|Core Study||13
96615|NCT01276457|230186|P2|COMPLETED|Core Study||123
96616|NCT01276457|230187|P1|COMPLETED|Core Study||129
96617|NCT01276457|230186|P2|STARTED|Core Study||143
96618|NCT01276457|230187|P1|STARTED|Core Study||142
96619|NCT01276353|230201|P2|NOT COMPLETED|Extension||9
96620|NCT01276353|230202|P1|NOT COMPLETED|Extension||7
96621|NCT01276353|230201|P2|COMPLETED|Extension||14
96622|NCT01276353|230202|P1|COMPLETED|Extension||12
96623|NCT01276353|230201|P2|STARTED|Extension||23
96624|NCT01276353|230202|P1|STARTED|Extension||19
96625|NCT01276353|230201|P2|NOT COMPLETED|Double-blind||0
96626|NCT01276353|230202|P1|NOT COMPLETED|Double-blind||3
96627|NCT01276353|230201|P2|COMPLETED|Double-blind||23
96628|NCT01276353|230202|P1|COMPLETED|Double-blind||19
96629|NCT01276353|230201|P2|STARTED|Double-blind||23
96630|NCT01276353|230202|P1|STARTED|Double-blind||22
96631|NCT01276327|230214|P2|NOT COMPLETED|Overall Study||3
96632|NCT01276327|230215|P1|NOT COMPLETED|Overall Study||2
96633|NCT01276327|230214|P2|COMPLETED|Overall Study||29
96634|NCT01276327|230215|P1|COMPLETED|Overall Study||30
96635|NCT01276327|230214|P2|STARTED|Overall Study||32
96636|NCT01276327|230215|P1|STARTED|Overall Study||32
96637|NCT01276301|230237|P2|NOT COMPLETED|Second Intervention||0
96638|NCT01276301|230238|P1|NOT COMPLETED|Second Intervention||0
96639|NCT01276301|230237|P2|COMPLETED|Second Intervention||8
96640|NCT01276301|230238|P1|COMPLETED|Second Intervention||8
96641|NCT01276301|230237|P2|STARTED|Second Intervention||8
96642|NCT01276301|230238|P1|STARTED|Second Intervention||8
96643|NCT01276301|230237|P2|NOT COMPLETED|Washout Period of 7 Days||0
96644|NCT01276301|230238|P1|NOT COMPLETED|Washout Period of 7 Days||0
96645|NCT01276301|230237|P2|COMPLETED|Washout Period of 7 Days||8
96646|NCT01276301|230238|P1|COMPLETED|Washout Period of 7 Days||8
96647|NCT01276301|230237|P2|STARTED|Washout Period of 7 Days||8
96648|NCT01276301|230238|P1|STARTED|Washout Period of 7 Days||8
96649|NCT01276301|230237|P2|NOT COMPLETED|First Intervention||0
96650|NCT01276301|230238|P1|NOT COMPLETED|First Intervention||0
96651|NCT01276301|230237|P2|COMPLETED|First Intervention||8
96652|NCT01276301|230238|P1|COMPLETED|First Intervention||8
96653|NCT01276301|230237|P2|STARTED|First Intervention||8
96654|NCT01276301|230238|P1|STARTED|First Intervention||8
96655|NCT01276288|230265|P4|NOT COMPLETED|Overall Study||0
96656|NCT01276288|230266|P3|NOT COMPLETED|Overall Study||0
96657|NCT01276288|230267|P2|NOT COMPLETED|Overall Study||1
96658|NCT01276288|230268|P1|NOT COMPLETED|Overall Study||2
96659|NCT01276288|230265|P4|COMPLETED|Overall Study||5
96660|NCT01276288|230266|P3|COMPLETED|Overall Study||5
96661|NCT01276288|230267|P2|COMPLETED|Overall Study||5
96662|NCT01276288|230268|P1|COMPLETED|Overall Study||5
96663|NCT01276288|230265|P4|Received EMPA+TOR|Overall Study||5
96664|NCT01276288|230266|P3|Received EMPA+TOR|Overall Study||5
96665|NCT01276288|230267|P2|Received EMPA+TOR|Overall Study||0
96666|NCT01276288|230268|P1|Received EMPA+TOR|Overall Study||0
96667|NCT01276288|230265|P4|Received EMPA+HCT|Overall Study||0
96668|NCT01276288|230266|P3|Received EMPA+HCT|Overall Study||0
96669|NCT01276288|230267|P2|Received EMPA+HCT|Overall Study||5
96670|NCT01276288|230268|P1|Received EMPA+HCT|Overall Study||5
96671|NCT01276288|230265|P4|Received EMPA|Overall Study||5
96672|NCT01276288|230266|P3|Received EMPA|Overall Study||5
96673|NCT01276288|230267|P2|Received EMPA|Overall Study||5
96674|NCT01276288|230268|P1|Received EMPA|Overall Study||6
96675|NCT01276288|230265|P4|STARTED|Overall Study||5
96676|NCT01276288|230266|P3|STARTED|Overall Study||5
96677|NCT01276288|230267|P2|STARTED|Overall Study||6
96678|NCT01276288|230268|P1|STARTED|Overall Study||7
96679|NCT01276223|230395|P3|NOT COMPLETED|Overall Study||3
96680|NCT01276223|230396|P2|NOT COMPLETED|Overall Study||4
96681|NCT01276223|230397|P1|NOT COMPLETED|Overall Study||11
96682|NCT01276223|230395|P3|COMPLETED|Overall Study||101
96683|NCT01276223|230396|P2|COMPLETED|Overall Study||103
96684|NCT01276223|230397|P1|COMPLETED|Overall Study||67
96685|NCT01276223|230395|P3|STARTED|Overall Study||104
96686|NCT01276223|230396|P2|STARTED|Overall Study||107
96687|NCT01276223|230397|P1|STARTED|Overall Study||78
96688|NCT01276197|230406|P2|NOT COMPLETED|Overall Study||110
96689|NCT01276197|230407|P1|NOT COMPLETED|Overall Study||108
96690|NCT01276197|230406|P2|COMPLETED|Overall Study||200
96691|NCT01276197|230407|P1|COMPLETED|Overall Study||200
96692|NCT01276197|230406|P2|STARTED|Overall Study||310
96693|NCT01276197|230407|P1|STARTED|Overall Study||308
96694|NCT01276171|230418|P3|NOT COMPLETED|Overall Study||0
96695|NCT01276171|230419|P2|NOT COMPLETED|Overall Study||0
96696|NCT01276171|230420|P1|NOT COMPLETED|Overall Study||0
96697|NCT01276171|230418|P3|COMPLETED|Overall Study||256
96698|NCT01276171|230419|P2|COMPLETED|Overall Study||244
96699|NCT01276171|230420|P1|COMPLETED|Overall Study||249
96700|NCT01276171|230418|P3|STARTED|Overall Study||256
96701|NCT01276171|230419|P2|STARTED|Overall Study||244
96702|NCT01276171|230420|P1|STARTED|Overall Study||249
96703|NCT01276106|230438|P4|NOT COMPLETED|Overall Study||13
96704|NCT01276106|230439|P3|NOT COMPLETED|Overall Study||16
96705|NCT01276106|230440|P2|NOT COMPLETED|Overall Study||9
96706|NCT01276106|230441|P1|NOT COMPLETED|Overall Study||12
96707|NCT01276106|230438|P4|COMPLETED|Overall Study||52
96708|NCT01276106|230439|P3|COMPLETED|Overall Study||49
96709|NCT01276106|230440|P2|COMPLETED|Overall Study||55
96710|NCT01276106|230441|P1|COMPLETED|Overall Study||53
96711|NCT01276106|230438|P4|STARTED|Overall Study||65
96712|NCT01276106|230439|P3|STARTED|Overall Study||65
96713|NCT01276106|230440|P2|STARTED|Overall Study||64
96714|NCT01276106|230441|P1|STARTED|Overall Study||65
96715|NCT01276054|230453|P2|NOT COMPLETED|Overall Study||2
96716|NCT01276054|230454|P1|NOT COMPLETED|Overall Study||2
96717|NCT01276054|230453|P2|COMPLETED|Overall Study||0
96718|NCT01276054|230454|P1|COMPLETED|Overall Study||0
96719|NCT01276054|230453|P2|STARTED|Overall Study||2
96720|NCT01276054|230454|P1|STARTED|Overall Study||2
96721|NCT01275833|230462|P2|NOT COMPLETED|Overall Study||1
96722|NCT01275833|230463|P1|NOT COMPLETED|Overall Study||1
96723|NCT01275833|230462|P2|COMPLETED|Overall Study||0
96724|NCT01275833|230463|P1|COMPLETED|Overall Study||0
96725|NCT01275833|230462|P2|STARTED|Overall Study||1
96726|NCT01275833|230463|P1|STARTED|Overall Study||1
96727|NCT01275755|230471|P2|NOT COMPLETED|Run-out Placebo Period||0
96728|NCT01275755|230472|P1|NOT COMPLETED|Run-out Placebo Period||1
96729|NCT01275755|230471|P2|COMPLETED|Run-out Placebo Period||37
96730|NCT01275755|230472|P1|COMPLETED|Run-out Placebo Period||38
96731|NCT01275755|230471|P2|STARTED|Run-out Placebo Period||37
96732|NCT01275755|230472|P1|STARTED|Run-out Placebo Period||39
96733|NCT01275755|230471|P2|NOT COMPLETED|Double-blind Treatment Period||3
96734|NCT01275755|230472|P1|NOT COMPLETED|Double-blind Treatment Period||2
96735|NCT01275755|230471|P2|COMPLETED|Double-blind Treatment Period||37
96736|NCT01275755|230472|P1|COMPLETED|Double-blind Treatment Period||39
96737|NCT01275755|230471|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||40
96738|NCT01275755|230472|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||41
96739|NCT01275755|230471|P2|STARTED|Double-blind Treatment Period||40
96740|NCT01275755|230472|P1|STARTED|Double-blind Treatment Period||41
96741|NCT01275755|230471|P2|NOT COMPLETED|Run-in Placebo Period||0
96742|NCT01275755|230472|P1|NOT COMPLETED|Run-in Placebo Period||0
96743|NCT01275755|230471|P2|COMPLETED|Run-in Placebo Period||40
96744|NCT01275755|230472|P1|COMPLETED|Run-in Placebo Period||41
96745|NCT01275755|230471|P2|STARTED|Run-in Placebo Period||40
96746|NCT01275755|230472|P1|STARTED|Run-in Placebo Period||41
96747|NCT01275625|230478|P1|NOT COMPLETED|Overall Study||13
96748|NCT01275625|230478|P1|COMPLETED|Overall Study||64
96749|NCT01275625|230478|P1|Treated|Overall Study||77
96750|NCT01275625|230478|P1|STARTED|Overall Study||77
96751|NCT01275586|230492|P1|NOT COMPLETED|Overall Study||3
96752|NCT01275586|230492|P1|COMPLETED|Overall Study||3
96753|NCT01275586|230492|P1|STARTED|Overall Study||6
96754|NCT01275430|230496|P1|NOT COMPLETED|Overall Study||9
96755|NCT01275430|230496|P1|COMPLETED|Overall Study||18
96756|NCT01275430|230496|P1|STARTED|Overall Study||27
96757|NCT01275313|230506|P2|NOT COMPLETED|Overall Study||52
96758|NCT01275313|230507|P1|NOT COMPLETED|Overall Study||25
96759|NCT01275313|230506|P2|COMPLETED|Overall Study||79
96760|NCT01275313|230507|P1|COMPLETED|Overall Study||102
96761|NCT01275313|230506|P2|STARTED|Overall Study||131
96762|NCT01275313|230507|P1|STARTED|Overall Study||127
96763|NCT01275196|230515|P2|NOT COMPLETED|Overall Study||21
96764|NCT01275196|230516|P1|NOT COMPLETED|Overall Study||20
96765|NCT01275196|230515|P2|COMPLETED|Overall Study||113
96766|NCT01275196|230516|P1|COMPLETED|Overall Study||113
96767|NCT01275196|230515|P2|Intended to Continue Into Extension|Overall Study||113
96768|NCT01275196|230516|P1|Intended to Continue Into Extension|Overall Study||112
96769|NCT01275196|230515|P2|STARTED|Overall Study||134
96770|NCT01275196|230516|P1|STARTED|Overall Study||133
96771|NCT01275131|230559|P4|NOT COMPLETED|Period 2 (Crossover)||2
96772|NCT01275131|230560|P3|NOT COMPLETED|Period 2 (Crossover)||1
96773|NCT01275131|230561|P2|NOT COMPLETED|Period 2 (Crossover)||1
96774|NCT01275131|230562|P1|NOT COMPLETED|Period 2 (Crossover)||1
96775|NCT01275131|230559|P4|COMPLETED|Period 2 (Crossover)||8
96776|NCT01275131|230560|P3|COMPLETED|Period 2 (Crossover)||9
96777|NCT01275131|230561|P2|COMPLETED|Period 2 (Crossover)||8
96778|NCT01275131|230562|P1|COMPLETED|Period 2 (Crossover)||8
96779|NCT01275131|230559|P4|STARTED|Period 2 (Crossover)||10
96780|NCT01275131|230560|P3|STARTED|Period 2 (Crossover)||10
96781|NCT01275131|230561|P2|STARTED|Period 2 (Crossover)||9
96782|NCT01275131|230562|P1|STARTED|Period 2 (Crossover)||9
96783|NCT01275131|230559|P4|NOT COMPLETED|5- to 14-Day Washout Period||0
96784|NCT01275131|230560|P3|NOT COMPLETED|5- to 14-Day Washout Period||0
96785|NCT01275131|230561|P2|NOT COMPLETED|5- to 14-Day Washout Period||0
96786|NCT01275131|230562|P1|NOT COMPLETED|5- to 14-Day Washout Period||0
96787|NCT01275131|230559|P4|COMPLETED|5- to 14-Day Washout Period||10
96788|NCT01275131|230560|P3|COMPLETED|5- to 14-Day Washout Period||10
96789|NCT01275131|230561|P2|COMPLETED|5- to 14-Day Washout Period||9
96790|NCT01275131|230562|P1|COMPLETED|5- to 14-Day Washout Period||9
96791|NCT01275131|230559|P4|STARTED|5- to 14-Day Washout Period||10
96792|NCT01275131|230560|P3|STARTED|5- to 14-Day Washout Period||10
96793|NCT01275131|230561|P2|STARTED|5- to 14-Day Washout Period||9
96794|NCT01275131|230562|P1|STARTED|5- to 14-Day Washout Period||9
96795|NCT01275131|230559|P4|NOT COMPLETED|Period 1||2
96796|NCT01275131|230560|P3|NOT COMPLETED|Period 1||3
96797|NCT01275131|230561|P2|NOT COMPLETED|Period 1||0
96798|NCT01275131|230562|P1|NOT COMPLETED|Period 1||2
96799|NCT01275131|230559|P4|COMPLETED|Period 1||10
96800|NCT01275131|230560|P3|COMPLETED|Period 1||10
96801|NCT01275131|230561|P2|COMPLETED|Period 1||9
96802|NCT01275131|230562|P1|COMPLETED|Period 1||9
96803|NCT01275131|230559|P4|Received at Least One Dose of Study Drug|Period 1||12
96804|NCT01275131|230560|P3|Received at Least One Dose of Study Drug|Period 1||13
96805|NCT01275131|230561|P2|Received at Least One Dose of Study Drug|Period 1||9
96806|NCT01275131|230562|P1|Received at Least One Dose of Study Drug|Period 1||11
96807|NCT01275131|230559|P4|STARTED|Period 1||12
96808|NCT01275131|230560|P3|STARTED|Period 1||13
96809|NCT01275131|230561|P2|STARTED|Period 1||9
96810|NCT01275131|230562|P1|STARTED|Period 1||11
96811|NCT01275092|230596|P1|NOT COMPLETED|Overall Study||0
96812|NCT01275092|230596|P1|COMPLETED|Overall Study||164
96813|NCT01275092|230596|P1|STARTED|Overall Study||164
96814|NCT01275066|230605|P3|NOT COMPLETED|Overall Study||1
96815|NCT01275066|230606|P2|NOT COMPLETED|Overall Study||0
96816|NCT01275066|230607|P1|NOT COMPLETED|Overall Study||1
96817|NCT01275066|230605|P3|COMPLETED|Overall Study||57
96818|NCT01275066|230606|P2|COMPLETED|Overall Study||59
96819|NCT01275066|230607|P1|COMPLETED|Overall Study||59
96820|NCT01275066|230605|P3|Treated|Overall Study||58
96821|NCT01275066|230606|P2|Treated|Overall Study||59
96822|NCT01275066|230607|P1|Treated|Overall Study||59
96823|NCT01275066|230605|P3|STARTED|Overall Study||58
96824|NCT01275066|230606|P2|STARTED|Overall Study||59
96825|NCT01275066|230607|P1|STARTED|Overall Study||60
96826|NCT01275053|230621|P1|NOT COMPLETED|Overall Study||0
96827|NCT01275053|230621|P1|COMPLETED|Overall Study||12
96828|NCT01275053|230621|P1|STARTED|Overall Study||12
96829|NCT01274897|230627|P2|NOT COMPLETED|Overall Study||0
96830|NCT01274897|230628|P1|NOT COMPLETED|Overall Study||0
96831|NCT01274897|230627|P2|COMPLETED|Overall Study||153
96832|NCT01274897|230628|P1|COMPLETED|Overall Study||297
96833|NCT01274897|230627|P2|STARTED|Overall Study||153
96834|NCT01274897|230628|P1|STARTED|Overall Study||297
96835|NCT01274715|230640|P1|NOT COMPLETED|Overall Study||4
96836|NCT01274715|230640|P1|COMPLETED|Overall Study||8
96837|NCT01274715|230640|P1|Screened Out at Baseline|Overall Study||3
96838|NCT01274715|230640|P1|STARTED|Overall Study||12
96839|NCT01274637|230647|P2|NOT COMPLETED|Overall Study||2
96840|NCT01274637|230648|P1|NOT COMPLETED|Overall Study||0
96841|NCT01274637|230647|P2|COMPLETED|Overall Study||30
96842|NCT01274637|230648|P1|COMPLETED|Overall Study||30
96843|NCT01274637|230647|P2|STARTED|Overall Study||32
96844|NCT01274637|230648|P1|STARTED|Overall Study||30
96845|NCT01274611|230664|P1|NOT COMPLETED|Overall Study||0
96846|NCT01274611|230664|P1|COMPLETED|Overall Study||20
96847|NCT01274611|230664|P1|STARTED|Overall Study||20
96848|NCT01274585|230674|P2|NOT COMPLETED|Overall Study||0
96849|NCT01274585|230675|P1|NOT COMPLETED|Overall Study||0
96850|NCT01274585|230674|P2|COMPLETED|Overall Study||3
96851|NCT01274585|230675|P1|COMPLETED|Overall Study||2
96852|NCT01274585|230674|P2|STARTED|Overall Study||3
96853|NCT01274585|230675|P1|STARTED|Overall Study||2
96854|NCT01274559|230683|P2|NOT COMPLETED|Overall Study||145
96855|NCT01274559|230684|P1|NOT COMPLETED|Overall Study||197
96856|NCT01274559|230683|P2|COMPLETED|Overall Study||441
96857|NCT01274559|230684|P1|COMPLETED|Overall Study||390
96858|NCT01274559|230683|P2|Treated|Overall Study||572
96859|NCT01274559|230684|P1|Treated|Overall Study||572
96860|NCT01274559|230683|P2|STARTED|Overall Study||586
96861|NCT01274559|230684|P1|STARTED|Overall Study||587
96862|NCT01274533|230734|P1|NOT COMPLETED|Overall Study||4
96863|NCT01274533|230734|P1|COMPLETED|Overall Study||0
96864|NCT01274533|230734|P1|STARTED|Overall Study||4
96865|NCT01274429|230739|P1|NOT COMPLETED|Overall Study||5
96866|NCT01274429|230739|P1|COMPLETED|Overall Study||0
96867|NCT01274429|230739|P1|STARTED|Overall Study||5
96868|NCT01273896|230744|P1|NOT COMPLETED|Overall Study||0
96869|NCT01273896|230744|P1|COMPLETED|Overall Study||22
96870|NCT01273896|230744|P1|STARTED|Overall Study||22
96871|NCT01273883|230748|P2|NOT COMPLETED|Second Intervention||1
96872|NCT01273883|230749|P1|NOT COMPLETED|Second Intervention||2
96873|NCT01273883|230748|P2|COMPLETED|Second Intervention||17
96874|NCT01273883|230749|P1|COMPLETED|Second Intervention||15
96875|NCT01273883|230748|P2|STARTED|Second Intervention||18
96876|NCT01273883|230749|P1|STARTED|Second Intervention||17
96877|NCT01273883|230748|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
96878|NCT01273883|230749|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
96879|NCT01273883|230748|P2|COMPLETED|Washout Period of 2 Weeks||18
96880|NCT01273883|230749|P1|COMPLETED|Washout Period of 2 Weeks||17
96881|NCT01273883|230748|P2|STARTED|Washout Period of 2 Weeks||18
96882|NCT01273883|230749|P1|STARTED|Washout Period of 2 Weeks||17
96883|NCT01273883|230748|P2|NOT COMPLETED|First Intervention||1
96884|NCT01273883|230749|P1|NOT COMPLETED|First Intervention||2
96885|NCT01273883|230748|P2|COMPLETED|First Intervention||18
96886|NCT01273883|230749|P1|COMPLETED|First Intervention||17
96887|NCT01273883|230748|P2|STARTED|First Intervention|Received at least 1 dose of study drug.|19
96888|NCT01273883|230749|P1|STARTED|First Intervention|Received at least 1 dose of study drug.|19
96889|NCT01273857|230763|P2|NOT COMPLETED|Overall Study||0
96890|NCT01273857|230764|P1|NOT COMPLETED|Overall Study||0
96891|NCT01273857|230763|P2|COMPLETED|Overall Study||7
96892|NCT01273857|230764|P1|COMPLETED|Overall Study||7
96893|NCT01273857|230763|P2|STARTED|Overall Study||7
96894|NCT01273857|230764|P1|STARTED|Overall Study||7
96895|NCT01273818|230775|P3|NOT COMPLETED|Overall Study||9
96896|NCT01273818|230776|P2|NOT COMPLETED|Overall Study||2
96897|NCT01273818|230777|P1|NOT COMPLETED|Overall Study||13
96898|NCT01273818|230775|P3|COMPLETED|Overall Study||91
96899|NCT01273818|230776|P2|COMPLETED|Overall Study||98
96900|NCT01273818|230777|P1|COMPLETED|Overall Study||87
96901|NCT01273818|230775|P3|STARTED|Overall Study||100
96902|NCT01273818|230776|P2|STARTED|Overall Study||100
96903|NCT01273818|230777|P1|STARTED|Overall Study||100
96904|NCT01273805|230787|P2|NOT COMPLETED|Overall Study||10
96905|NCT01273805|230788|P1|NOT COMPLETED|Overall Study||10
96906|NCT01273805|230787|P2|COMPLETED|Overall Study||0
96907|NCT01273805|230788|P1|COMPLETED|Overall Study||0
96908|NCT01273805|230787|P2|STARTED|Overall Study||10
96909|NCT01273805|230788|P1|STARTED|Overall Study||10
96910|NCT01273766|230807|P3|NOT COMPLETED|Overall Study||0
96911|NCT01273766|230808|P2|NOT COMPLETED|Overall Study||0
96912|NCT01273766|230809|P1|NOT COMPLETED|Overall Study||0
96913|NCT01273766|230807|P3|COMPLETED|Overall Study||5
96914|NCT01273766|230808|P2|COMPLETED|Overall Study||7
96915|NCT01273766|230809|P1|COMPLETED|Overall Study||4
96916|NCT01273766|230807|P3|STARTED|Overall Study||5
96917|NCT01273766|230808|P2|STARTED|Overall Study||7
96918|NCT01273766|230809|P1|STARTED|Overall Study||4
96919|NCT01273623|230815|P1|NOT COMPLETED|Overall Study||29
96920|NCT01273623|230815|P1|COMPLETED|Overall Study|met IVUS criteria|26
96921|NCT01273623|230815|P1|STARTED|Overall Study|met angiographic criteria|55
96922|NCT01273597|230822|P1|NOT COMPLETED|Overall Study||8
96923|NCT01273597|230822|P1|COMPLETED|Overall Study||52
96924|NCT01273597|230822|P1|STARTED|Overall Study||60
96925|NCT01273519|230837|P3|NOT COMPLETED|Overall Study||8
96926|NCT01273519|230838|P2|NOT COMPLETED|Overall Study||5
96927|NCT01273519|230839|P1|NOT COMPLETED|Overall Study||19
96928|NCT01273519|230837|P3|COMPLETED|Overall Study||39
96929|NCT01273519|230838|P2|COMPLETED|Overall Study||25
96930|NCT01273519|230839|P1|COMPLETED|Overall Study||59
96931|NCT01273519|230837|P3|STARTED|Overall Study||47
96932|NCT01273519|230838|P2|STARTED|Overall Study||30
96933|NCT01273519|230839|P1|STARTED|Overall Study||78
96934|NCT01273181|230876|P4|NOT COMPLETED|Phase 2, Dose 2||1
96935|NCT01273181|230877|P3|NOT COMPLETED|Phase 2, Dose 2||0
96936|NCT01273181|230878|P2|NOT COMPLETED|Phase 2, Dose 2||0
96937|NCT01273181|230879|P1|NOT COMPLETED|Phase 2, Dose 2||0
96938|NCT01273181|230876|P4|COMPLETED|Phase 2, Dose 2||0
96939|NCT01273181|230877|P3|COMPLETED|Phase 2, Dose 2||0
96940|NCT01273181|230878|P2|COMPLETED|Phase 2, Dose 2||0
96941|NCT01273181|230879|P1|COMPLETED|Phase 2, Dose 2||0
96942|NCT01273181|230876|P4|STARTED|Phase 2, Dose 2||1
96943|NCT01273181|230877|P3|STARTED|Phase 2, Dose 2||0
96944|NCT01273181|230878|P2|STARTED|Phase 2, Dose 2||0
96945|NCT01273181|230879|P1|STARTED|Phase 2, Dose 2||0
96946|NCT01273181|230876|P4|NOT COMPLETED|Phase 2, Dose 1||0
96947|NCT01273181|230877|P3|NOT COMPLETED|Phase 2, Dose 1||1
96948|NCT01273181|230878|P2|NOT COMPLETED|Phase 2, Dose 1||0
96949|NCT01273181|230879|P1|NOT COMPLETED|Phase 2, Dose 1||0
96950|NCT01273181|230876|P4|COMPLETED|Phase 2, Dose 1||0
96951|NCT01273181|230877|P3|COMPLETED|Phase 2, Dose 1||1
96952|NCT01273181|230878|P2|COMPLETED|Phase 2, Dose 1||0
96953|NCT01273181|230879|P1|COMPLETED|Phase 2, Dose 1||0
96954|NCT01273181|230876|P4|STARTED|Phase 2, Dose 1||0
96955|NCT01273181|230877|P3|STARTED|Phase 2, Dose 1||2
96956|NCT01273181|230878|P2|STARTED|Phase 2, Dose 1||0
96957|NCT01273181|230879|P1|STARTED|Phase 2, Dose 1||0
96958|NCT01273181|230876|P4|NOT COMPLETED|Phase I, Dose 2||0
96959|NCT01273181|230877|P3|NOT COMPLETED|Phase I, Dose 2||0
96960|NCT01273181|230878|P2|NOT COMPLETED|Phase I, Dose 2||1
96961|NCT01273181|230879|P1|NOT COMPLETED|Phase I, Dose 2||0
96962|NCT01273181|230876|P4|COMPLETED|Phase I, Dose 2||0
96963|NCT01273181|230877|P3|COMPLETED|Phase I, Dose 2||0
96964|NCT01273181|230878|P2|COMPLETED|Phase I, Dose 2||2
96965|NCT01273181|230879|P1|COMPLETED|Phase I, Dose 2||0
96966|NCT01273181|230876|P4|STARTED|Phase I, Dose 2||0
96967|NCT01273181|230877|P3|STARTED|Phase I, Dose 2||0
96968|NCT01273181|230878|P2|STARTED|Phase I, Dose 2||3
96969|NCT01273181|230879|P1|STARTED|Phase I, Dose 2||0
96970|NCT01273181|230876|P4|NOT COMPLETED|Phase I, Dose 1||0
96971|NCT01273181|230877|P3|NOT COMPLETED|Phase I, Dose 1||0
96972|NCT01273181|230878|P2|NOT COMPLETED|Phase I, Dose 1||0
96973|NCT01273181|230879|P1|NOT COMPLETED|Phase I, Dose 1||1
96974|NCT01273181|230876|P4|COMPLETED|Phase I, Dose 1||0
96975|NCT01273181|230877|P3|COMPLETED|Phase I, Dose 1||0
96976|NCT01273181|230878|P2|COMPLETED|Phase I, Dose 1||0
96977|NCT01273181|230879|P1|COMPLETED|Phase I, Dose 1||2
96978|NCT01273181|230876|P4|STARTED|Phase I, Dose 1||0
96979|NCT01273181|230877|P3|STARTED|Phase I, Dose 1||0
96980|NCT01273181|230878|P2|STARTED|Phase I, Dose 1||0
96981|NCT01273181|230879|P1|STARTED|Phase I, Dose 1||3
96982|NCT01273064|230898|P5|NOT COMPLETED|Overall Study||10
96983|NCT01273064|230899|P4|NOT COMPLETED|Overall Study||20
96984|NCT01273064|230900|P3|NOT COMPLETED|Overall Study||31
96985|NCT01273064|230901|P2|NOT COMPLETED|Overall Study||30
96986|NCT01273064|230902|P1|NOT COMPLETED|Overall Study||23
96987|NCT01273064|230898|P5|COMPLETED|Overall Study||0
96988|NCT01273064|230899|P4|COMPLETED|Overall Study||0
96989|NCT01273064|230900|P3|COMPLETED|Overall Study||0
96990|NCT01273064|230901|P2|COMPLETED|Overall Study||0
96991|NCT01273064|230902|P1|COMPLETED|Overall Study||0
96992|NCT01273064|230898|P5|STARTED|Overall Study|Began study on the placebo arm, and crossed over to CTS-1027 15 mg at Wk 12 due to lack of response|10
96993|NCT01273064|230899|P4|STARTED|Overall Study||20
96994|NCT01273064|230900|P3|STARTED|Overall Study||31
96995|NCT01273064|230901|P2|STARTED|Overall Study||30
96996|NCT01273064|230902|P1|STARTED|Overall Study||23
96997|NCT01273038|230921|P2|NOT COMPLETED|Second Intervention (14 Days)||2
96998|NCT01273038|230922|P1|NOT COMPLETED|Second Intervention (14 Days)||0
96999|NCT01273038|230921|P2|COMPLETED|Second Intervention (14 Days)||8
97000|NCT01273038|230922|P1|COMPLETED|Second Intervention (14 Days)||10
97001|NCT01273038|230921|P2|STARTED|Second Intervention (14 Days)||10
97002|NCT01273038|230922|P1|STARTED|Second Intervention (14 Days)||10
97003|NCT01273038|230921|P2|NOT COMPLETED|First Intervention (14 Days)||0
97004|NCT01273038|230922|P1|NOT COMPLETED|First Intervention (14 Days)||0
97005|NCT01273038|230921|P2|COMPLETED|First Intervention (14 Days)||10
97006|NCT01273038|230922|P1|COMPLETED|First Intervention (14 Days)||10
97007|NCT01273038|230921|P2|STARTED|First Intervention (14 Days)||10
97008|NCT01273038|230922|P1|STARTED|First Intervention (14 Days)||10
97009|NCT01272947|230930|P2|NOT COMPLETED|Overall Study||2
97010|NCT01272947|230931|P1|NOT COMPLETED|Overall Study||2
97011|NCT01272947|230930|P2|COMPLETED|Overall Study||98
97012|NCT01272947|230931|P1|COMPLETED|Overall Study||102
97013|NCT01272947|230930|P2|STARTED|Overall Study||100
97014|NCT01272947|230931|P1|STARTED|Overall Study||104
97015|NCT01272934|230941|P2|NOT COMPLETED|Overall Study||2
97016|NCT01272934|230942|P1|NOT COMPLETED|Overall Study||0
97017|NCT01272934|230941|P2|COMPLETED|Overall Study||101
97018|NCT01272934|230942|P1|COMPLETED|Overall Study||102
97019|NCT01272934|230941|P2|STARTED|Overall Study||103
97020|NCT01272934|230942|P1|STARTED|Overall Study||102
97021|NCT01272921|230952|P2|NOT COMPLETED|Overall Study||1
97022|NCT01272921|230953|P1|NOT COMPLETED|Overall Study||2
97023|NCT01272921|230952|P2|COMPLETED|Overall Study||70
97024|NCT01272921|230953|P1|COMPLETED|Overall Study||69
97025|NCT01272921|230952|P2|STARTED|Overall Study||71
97026|NCT01272921|230953|P1|STARTED|Overall Study||71
97027|NCT01272908|230961|P1|NOT COMPLETED|Re-Treatment Period||6
97028|NCT01272908|230961|P1|COMPLETED|Re-Treatment Period||71
97029|NCT01272908|230961|P1|STARTED|Re-Treatment Period|Only participants with active disease as characterized by DAS-28 score ≥2.6 were included.|77
97030|NCT01272908|230961|P1|NOT COMPLETED|Initial Treatment Period||8
97031|NCT01272908|230961|P1|COMPLETED|Initial Treatment Period||112
97032|NCT01272908|230961|P1|STARTED|Initial Treatment Period||120
97033|NCT01272882|230995|P1|NOT COMPLETED|Overall Study||0
97034|NCT01272882|230995|P1|COMPLETED|Overall Study||13
97035|NCT01272882|230995|P1|STARTED|Overall Study||13
97036|NCT01272869|231001|P2|NOT COMPLETED|Period 2 (14 Days)||0
97037|NCT01272869|231002|P1|NOT COMPLETED|Period 2 (14 Days)||1
97038|NCT01272869|231001|P2|COMPLETED|Period 2 (14 Days)||10
97039|NCT01272869|231002|P1|COMPLETED|Period 2 (14 Days)||9
97040|NCT01272869|231001|P2|STARTED|Period 2 (14 Days)||10
97041|NCT01272869|231002|P1|STARTED|Period 2 (14 Days)||10
97042|NCT01272869|231001|P2|NOT COMPLETED|Period 1 (14 Days)||0
97043|NCT01272869|231002|P1|NOT COMPLETED|Period 1 (14 Days)||0
97044|NCT01272869|231001|P2|COMPLETED|Period 1 (14 Days)||10
97045|NCT01272869|231002|P1|COMPLETED|Period 1 (14 Days)||10
97046|NCT01272869|231001|P2|STARTED|Period 1 (14 Days)||10
97047|NCT01272869|231002|P1|STARTED|Period 1 (14 Days)||10
97048|NCT01272804|231014|P6|NOT COMPLETED|Overall Study||1
97049|NCT01272804|231015|P5|NOT COMPLETED|Overall Study||2
97050|NCT01272804|231016|P4|NOT COMPLETED|Overall Study||0
97051|NCT01272804|231017|P3|NOT COMPLETED|Overall Study||0
97052|NCT01272804|231018|P2|NOT COMPLETED|Overall Study||0
97053|NCT01272804|231019|P1|NOT COMPLETED|Overall Study||1
97054|NCT01272804|231014|P6|COMPLETED|Overall Study||15
97055|NCT01272804|231015|P5|COMPLETED|Overall Study||7
97056|NCT01272804|231016|P4|COMPLETED|Overall Study||9
97057|NCT01272804|231017|P3|COMPLETED|Overall Study||9
97058|NCT01272804|231018|P2|COMPLETED|Overall Study||9
97059|NCT01272804|231019|P1|COMPLETED|Overall Study||8
97060|NCT01272804|231014|P6|STARTED|Overall Study||16
97061|NCT01272804|231015|P5|STARTED|Overall Study||9
97062|NCT01272804|231016|P4|STARTED|Overall Study||9
97063|NCT01272804|231017|P3|STARTED|Overall Study||9
97064|NCT01272804|231018|P2|STARTED|Overall Study||9
97065|NCT01272804|231019|P1|STARTED|Overall Study||9
97066|NCT01272661|231177|P3|NOT COMPLETED|Overall Study||72
97067|NCT01272661|231178|P2|NOT COMPLETED|Overall Study||209
97068|NCT01272661|231179|P1|NOT COMPLETED|Overall Study||126
97069|NCT01272661|231177|P3|COMPLETED|Overall Study||314
97070|NCT01272661|231178|P2|COMPLETED|Overall Study||288
97071|NCT01272661|231179|P1|COMPLETED|Overall Study||287
97072|NCT01272661|231177|P3|STARTED|Overall Study||386
97073|NCT01272661|231178|P2|STARTED|Overall Study||497
97074|NCT01272661|231179|P1|STARTED|Overall Study||413
97075|NCT01272635|231204|P4|NOT COMPLETED|Overall Study||23
97076|NCT01272635|231205|P3|NOT COMPLETED|Overall Study||31
97077|NCT01272635|231206|P2|NOT COMPLETED|Overall Study||20
97078|NCT01272635|231207|P1|NOT COMPLETED|Overall Study||31
97079|NCT01272635|231204|P4|COMPLETED|Overall Study||129
97080|NCT01272635|231205|P3|COMPLETED|Overall Study||117
97081|NCT01272635|231206|P2|COMPLETED|Overall Study||134
97082|NCT01272635|231207|P1|COMPLETED|Overall Study||122
97083|NCT01272635|231204|P4|STARTED|Overall Study||152
97084|NCT01272635|231205|P3|STARTED|Overall Study||148
97085|NCT01272635|231206|P2|STARTED|Overall Study||154
97086|NCT01272635|231207|P1|STARTED|Overall Study||153
97087|NCT01272583|231225|P2|NOT COMPLETED|Overall Study||0
97088|NCT01272583|231226|P1|NOT COMPLETED|Overall Study||0
97089|NCT01272583|231225|P2|COMPLETED|Overall Study||8
97090|NCT01272583|231226|P1|COMPLETED|Overall Study||8
97091|NCT01272583|231225|P2|STARTED|Overall Study||8
97092|NCT01272583|231226|P1|STARTED|Overall Study||8
97093|NCT01272284|231255|P1|NOT COMPLETED|12-month Follow-up Visit||4
97094|NCT01272284|231255|P1|COMPLETED|12-month Follow-up Visit||105
97095|NCT01272284|231255|P1|STARTED|12-month Follow-up Visit||109
97096|NCT01272284|231255|P1|NOT COMPLETED|6-month Follow-up Visit||3
97097|NCT01272284|231255|P1|COMPLETED|6-month Follow-up Visit||109
97098|NCT01272284|231255|P1|STARTED|6-month Follow-up Visit||112
97099|NCT01272284|231255|P1|NOT COMPLETED|3-month Follow-up Visit||1
97100|NCT01272284|231255|P1|COMPLETED|3-month Follow-up Visit||112
97101|NCT01272284|231255|P1|STARTED|3-month Follow-up Visit||113
97102|NCT01272232|231272|P3|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||5
97103|NCT01272232|231273|P2|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||10
97104|NCT01272232|231274|P1|NOT COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||14
97105|NCT01272232|231272|P3|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||135
97106|NCT01272232|231273|P2|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||154
97107|NCT01272232|231274|P1|COMPLETED|Off Drug Follow-up Period (Weeks 56-68)||310
97108|NCT01272232|231272|P3|STARTED|Off Drug Follow-up Period (Weeks 56-68)||140
97109|NCT01272232|231273|P2|STARTED|Off Drug Follow-up Period (Weeks 56-68)||164
97110|NCT01272232|231274|P1|STARTED|Off Drug Follow-up Period (Weeks 56-68)||324
97111|NCT01272232|231272|P3|NOT COMPLETED|Weeks 0-56||72
97112|NCT01272232|231273|P2|NOT COMPLETED|Weeks 0-56||47
97113|NCT01272232|231274|P1|NOT COMPLETED|Weeks 0-56||99
97114|NCT01272232|231272|P3|COMPLETED|Weeks 0-56||140
97115|NCT01272232|231273|P2|COMPLETED|Weeks 0-56||164
97116|NCT01272232|231274|P1|COMPLETED|Weeks 0-56||324
97117|NCT01272232|231272|P3|Exposed|Weeks 0-56||212
97118|NCT01272232|231273|P2|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|210
97119|NCT01272232|231274|P1|Exposed|Weeks 0-56|1 subject dropped out after randomisation and before exposure to trial drug.|422
97120|NCT01272232|231272|P3|STARTED|Weeks 0-56||212
97121|NCT01272232|231273|P2|STARTED|Weeks 0-56||211
97122|NCT01272232|231274|P1|STARTED|Weeks 0-56||423
97123|NCT01272219|231319|P6|NOT COMPLETED|Main + Extension Period: Week 0-172||422
97124|NCT01272219|231320|P5|NOT COMPLETED|Main + Extension Period: Week 0-172||722
97125|NCT01272219|231321|P4|NOT COMPLETED|Main + Extension Period: Week 0-172||0
97126|NCT01272219|231322|P3|NOT COMPLETED|Main + Extension Period: Week 0-172||0
97127|NCT01272219|231323|P2|NOT COMPLETED|Main + Extension Period: Week 0-172||0
97128|NCT01272219|231324|P1|NOT COMPLETED|Main + Extension Period: Week 0-172||0
97129|NCT01272219|231319|P6|COMPLETED|Main + Extension Period: Week 0-172||327
97130|NCT01272219|231320|P5|COMPLETED|Main + Extension Period: Week 0-172||783
97131|NCT01272219|231321|P4|COMPLETED|Main + Extension Period: Week 0-172||0
97132|NCT01272219|231322|P3|COMPLETED|Main + Extension Period: Week 0-172||0
97133|NCT01272219|231323|P2|COMPLETED|Main + Extension Period: Week 0-172||0
97134|NCT01272219|231324|P1|COMPLETED|Main + Extension Period: Week 0-172||0
97135|NCT01272219|231319|P6|Exposed|Main + Extension Period: Week 0-172||747
97136|NCT01272219|231320|P5|Exposed|Main + Extension Period: Week 0-172||1501
97137|NCT01272219|231321|P4|Exposed|Main + Extension Period: Week 0-172||0
97138|NCT01272219|231322|P3|Exposed|Main + Extension Period: Week 0-172||0
97139|NCT01272219|231323|P2|Exposed|Main + Extension Period: Week 0-172||0
97140|NCT01272219|231324|P1|Exposed|Main + Extension Period: Week 0-172||0
97141|NCT01272219|231319|P6|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|749
97142|NCT01272219|231320|P5|STARTED|Main + Extension Period: Week 0-172|Incorrect stratification: In this period, overall 6 subjects with no pre-diabetes included by error.|1505
97143|NCT01272219|231321|P4|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main and re-randomised period|0
97144|NCT01272219|231322|P3|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
97145|NCT01272219|231323|P2|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to re-randomised period|0
97146|NCT01272219|231324|P1|STARTED|Main + Extension Period: Week 0-172|This arm is not considered for this period as these subjects belong to main period|0
97147|NCT01272219|231319|P6|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
97148|NCT01272219|231320|P5|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
97149|NCT01272219|231321|P4|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||15
97150|NCT01272219|231322|P3|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||7
97151|NCT01272219|231323|P2|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||9
97152|NCT01272219|231324|P1|NOT COMPLETED|Re-randomised Period: Week 56 to Week 68||0
97153|NCT01272219|231319|P6|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
97154|NCT01272219|231320|P5|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
97155|NCT01272219|231321|P4|COMPLETED|Re-randomised Period: Week 56 to Week 68||289
97156|NCT01272219|231322|P3|COMPLETED|Re-randomised Period: Week 56 to Week 68||343
97157|NCT01272219|231323|P2|COMPLETED|Re-randomised Period: Week 56 to Week 68||342
97158|NCT01272219|231324|P1|COMPLETED|Re-randomised Period: Week 56 to Week 68||0
97159|NCT01272219|231319|P6|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
97160|NCT01272219|231320|P5|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
97161|NCT01272219|231321|P4|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|304
97162|NCT01272219|231322|P3|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|350
97163|NCT01272219|231323|P2|STARTED|Re-randomised Period: Week 56 to Week 68|Incorrect stratification: In this period, overall 37 pre-diabetic subjects were included by error.|351
97164|NCT01272219|231324|P1|STARTED|Re-randomised Period: Week 56 to Week 68|This arm is not considered for re-randomised period as these subjects belong to main period|0
97165|NCT01272219|231319|P6|NOT COMPLETED|Main Period: Week 0 to Week 56||252
97166|NCT01272219|231320|P5|NOT COMPLETED|Main Period: Week 0 to Week 56||418
97167|NCT01272219|231321|P4|NOT COMPLETED|Main Period: Week 0 to Week 56||191
97168|NCT01272219|231322|P3|NOT COMPLETED|Main Period: Week 0 to Week 56||0
97169|NCT01272219|231323|P2|NOT COMPLETED|Main Period: Week 0 to Week 56||0
97170|NCT01272219|231324|P1|NOT COMPLETED|Main Period: Week 0 to Week 56||280
97171|NCT01272219|231319|P6|COMPLETED|Main Period: Week 0 to Week 56||505
97172|NCT01272219|231320|P5|COMPLETED|Main Period: Week 0 to Week 56||1110
97173|NCT01272219|231321|P4|COMPLETED|Main Period: Week 0 to Week 56||296
97174|NCT01272219|231322|P3|COMPLETED|Main Period: Week 0 to Week 56||0
97175|NCT01272219|231323|P2|COMPLETED|Main Period: Week 0 to Week 56||0
97176|NCT01272219|231324|P1|COMPLETED|Main Period: Week 0 to Week 56||679
97177|NCT01272219|231319|P6|Exposed|Main Period: Week 0 to Week 56||755
97178|NCT01272219|231320|P5|Exposed|Main Period: Week 0 to Week 56||1524
97179|NCT01272219|231321|P4|Exposed|Main Period: Week 0 to Week 56||487
97180|NCT01272219|231322|P3|Exposed|Main Period: Week 0 to Week 56||0
97181|NCT01272219|231323|P2|Exposed|Main Period: Week 0 to Week 56||0
97182|NCT01272219|231324|P1|Exposed|Main Period: Week 0 to Week 56||957
97183|NCT01272219|231319|P6|STARTED|Main Period: Week 0 to Week 56||757
97184|NCT01272219|231320|P5|STARTED|Main Period: Week 0 to Week 56||1528
97185|NCT01272219|231321|P4|STARTED|Main Period: Week 0 to Week 56||487
97186|NCT01272219|231322|P3|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
97187|NCT01272219|231323|P2|STARTED|Main Period: Week 0 to Week 56|This arm is not considered for main period as these subjects belong to re-randomised period|0
97188|NCT01272219|231324|P1|STARTED|Main Period: Week 0 to Week 56||959
97189|NCT01272193|231358|P2|NOT COMPLETED|Overall Study||12
97190|NCT01272193|231359|P1|NOT COMPLETED|Overall Study||10
97191|NCT01272193|231358|P2|COMPLETED|Overall Study||137
97192|NCT01272193|231359|P1|COMPLETED|Overall Study||137
97193|NCT01272193|231358|P2|STARTED|Overall Study||149
97194|NCT01272193|231359|P1|STARTED|Overall Study||147
97195|NCT01272180|231379|P4|NOT COMPLETED|Overall Study||14
97196|NCT01272180|231380|P3|NOT COMPLETED|Overall Study||13
97197|NCT01272180|231381|P2|NOT COMPLETED|Overall Study||21
97198|NCT01272180|231382|P1|NOT COMPLETED|Overall Study||17
97199|NCT01272180|231379|P4|COMPLETED|Overall Study||107
97200|NCT01272180|231380|P3|COMPLETED|Overall Study||109
97201|NCT01272180|231381|P2|COMPLETED|Overall Study||100
97202|NCT01272180|231382|P1|COMPLETED|Overall Study||103
97203|NCT01272180|231379|P4|STARTED|Overall Study||121
97204|NCT01272180|231380|P3|STARTED|Overall Study||122
97205|NCT01272180|231381|P2|STARTED|Overall Study||121
97206|NCT01272180|231382|P1|STARTED|Overall Study||120
97207|NCT01272141|231419|P1|NOT COMPLETED|Overall Study||0
97208|NCT01272141|231419|P1|COMPLETED|Overall Study||5
97209|NCT01272141|231419|P1|STARTED|Overall Study||5
97210|NCT01272076|231424|P1|NOT COMPLETED|Overall Study||0
97211|NCT01272076|231424|P1|COMPLETED|Overall Study||52
97212|NCT01272076|231424|P1|STARTED|Overall Study||52
97213|NCT01272011|231431|P3|NOT COMPLETED|Overall Study||0
97214|NCT01272011|231432|P2|NOT COMPLETED|Overall Study||2
97215|NCT01272011|231433|P1|NOT COMPLETED|Overall Study||0
97216|NCT01272011|231431|P3|COMPLETED|Overall Study||3
97217|NCT01272011|231432|P2|COMPLETED|Overall Study||8
97218|NCT01272011|231433|P1|COMPLETED|Overall Study||3
97219|NCT01272011|231431|P3|STARTED|Overall Study||3
97220|NCT01272011|231432|P2|STARTED|Overall Study||10
97221|NCT01272011|231433|P1|STARTED|Overall Study||3
97222|NCT01271946|231446|P2|NOT COMPLETED|Overall Study||0
97223|NCT01271946|231447|P1|NOT COMPLETED|Overall Study||0
97224|NCT01271946|231446|P2|COMPLETED|Overall Study||5
97225|NCT01271946|231447|P1|COMPLETED|Overall Study||346
97226|NCT01271946|231446|P2|STARTED|Overall Study||5
97227|NCT01271946|231447|P1|STARTED|Overall Study||346
97228|NCT01271907|231472|P3|NOT COMPLETED|Overall Study||0
97229|NCT01271907|231473|P2|NOT COMPLETED|Overall Study||0
97230|NCT01271907|231474|P1|NOT COMPLETED|Overall Study||0
97231|NCT01271907|231472|P3|COMPLETED|Overall Study||0
97232|NCT01271907|231473|P2|COMPLETED|Overall Study||0
97233|NCT01271907|231474|P1|COMPLETED|Overall Study||3
97234|NCT01271907|231472|P3|STARTED|Overall Study||0
97235|NCT01271907|231473|P2|STARTED|Overall Study||0
97236|NCT01271907|231474|P1|STARTED|Overall Study||3
97237|NCT01271803|231500|P12|NOT COMPLETED|Stage 2||39
97238|NCT01271803|231501|P11|NOT COMPLETED|Stage 2||27
97239|NCT01271803|231502|P10|NOT COMPLETED|Stage 2||0
97240|NCT01271803|231503|P9|NOT COMPLETED|Stage 2||0
97241|NCT01271803|231504|P8|NOT COMPLETED|Stage 2||0
97242|NCT01271803|231505|P7|NOT COMPLETED|Stage 2||0
97243|NCT01271803|231506|P6|NOT COMPLETED|Stage 2||0
97244|NCT01271803|231507|P5|NOT COMPLETED|Stage 2||0
97245|NCT01271803|231508|P4|NOT COMPLETED|Stage 2||0
97246|NCT01271803|231509|P3|NOT COMPLETED|Stage 2||0
97247|NCT01271803|231510|P2|NOT COMPLETED|Stage 2||0
97248|NCT01271803|231511|P1|NOT COMPLETED|Stage 2||0
97249|NCT01271803|231500|P12|COMPLETED|Stage 2||0
97250|NCT01271803|231501|P11|COMPLETED|Stage 2||0
97251|NCT01271803|231502|P10|COMPLETED|Stage 2||0
97252|NCT01271803|231503|P9|COMPLETED|Stage 2||0
97253|NCT01271803|231504|P8|COMPLETED|Stage 2||0
97254|NCT01271803|231505|P7|COMPLETED|Stage 2||0
97255|NCT01271803|231506|P6|COMPLETED|Stage 2||0
97256|NCT01271803|231507|P5|COMPLETED|Stage 2||0
97257|NCT01271803|231508|P4|COMPLETED|Stage 2||0
97258|NCT01271803|231509|P3|COMPLETED|Stage 2||0
97259|NCT01271803|231510|P2|COMPLETED|Stage 2||0
97260|NCT01271803|231511|P1|COMPLETED|Stage 2||0
97261|NCT01271803|231500|P12|STARTED|Stage 2||39
97262|NCT01271803|231501|P11|STARTED|Stage 2||27
97263|NCT01271803|231502|P10|STARTED|Stage 2||0
97264|NCT01271803|231503|P9|STARTED|Stage 2||0
97265|NCT01271803|231504|P8|STARTED|Stage 2||0
97266|NCT01271803|231505|P7|STARTED|Stage 2||0
97267|NCT01271803|231506|P6|STARTED|Stage 2||0
97268|NCT01271803|231507|P5|STARTED|Stage 2||0
97269|NCT01271803|231508|P4|STARTED|Stage 2||0
97270|NCT01271803|231509|P3|STARTED|Stage 2||0
97271|NCT01271803|231510|P2|STARTED|Stage 2||0
97272|NCT01271803|231511|P1|STARTED|Stage 2||0
97273|NCT01271803|231500|P12|NOT COMPLETED|Stage 1||0
97274|NCT01271803|231501|P11|NOT COMPLETED|Stage 1||0
97275|NCT01271803|231502|P10|NOT COMPLETED|Stage 1||2
97276|NCT01271803|231503|P9|NOT COMPLETED|Stage 1||5
97277|NCT01271803|231504|P8|NOT COMPLETED|Stage 1||3
97278|NCT01271803|231505|P7|NOT COMPLETED|Stage 1||4
97279|NCT01271803|231506|P6|NOT COMPLETED|Stage 1||4
97280|NCT01271803|231507|P5|NOT COMPLETED|Stage 1||4
97281|NCT01271803|231508|P4|NOT COMPLETED|Stage 1||3
97282|NCT01271803|231509|P3|NOT COMPLETED|Stage 1||27
97283|NCT01271803|231510|P2|NOT COMPLETED|Stage 1||8
97284|NCT01271803|231511|P1|NOT COMPLETED|Stage 1||5
97285|NCT01271803|231500|P12|COMPLETED|Stage 1||0
97286|NCT01271803|231501|P11|COMPLETED|Stage 1||0
97287|NCT01271803|231502|P10|COMPLETED|Stage 1||0
97288|NCT01271803|231503|P9|COMPLETED|Stage 1||0
97289|NCT01271803|231504|P8|COMPLETED|Stage 1||0
97290|NCT01271803|231505|P7|COMPLETED|Stage 1||0
97291|NCT01271803|231506|P6|COMPLETED|Stage 1||0
97292|NCT01271803|231507|P5|COMPLETED|Stage 1||0
97293|NCT01271803|231508|P4|COMPLETED|Stage 1||0
97294|NCT01271803|231509|P3|COMPLETED|Stage 1||0
97295|NCT01271803|231510|P2|COMPLETED|Stage 1||0
97296|NCT01271803|231511|P1|COMPLETED|Stage 1||0
97297|NCT01271803|231500|P12|STARTED|Stage 1||0
97298|NCT01271803|231501|P11|STARTED|Stage 1||0
97299|NCT01271803|231502|P10|STARTED|Stage 1||2
97300|NCT01271803|231503|P9|STARTED|Stage 1||5
97301|NCT01271803|231504|P8|STARTED|Stage 1||3
97302|NCT01271803|231505|P7|STARTED|Stage 1||4
97303|NCT01271803|231506|P6|STARTED|Stage 1||4
97304|NCT01271803|231507|P5|STARTED|Stage 1||4
97305|NCT01271803|231508|P4|STARTED|Stage 1||3
97306|NCT01271803|231509|P3|STARTED|Stage 1||27
97307|NCT01271803|231510|P2|STARTED|Stage 1||8
97308|NCT01271803|231511|P1|STARTED|Stage 1||5
97309|NCT01271712|231684|P2|NOT COMPLETED|Survival Follow-up||4
97310|NCT01271712|231685|P1|NOT COMPLETED|Survival Follow-up||27
97311|NCT01271712|231684|P2|COMPLETED|Survival Follow-up||0
97312|NCT01271712|231685|P1|COMPLETED|Survival Follow-up||0
97313|NCT01271712|231684|P2|STARTED|Survival Follow-up|All participants entered Survival Follow-up 30 days after discontinuation of study drug|4
97314|NCT01271712|231685|P1|STARTED|Survival Follow-up|All participants entered Survival Follow-up 30 days after discontinuation of study drug|27
97315|NCT01271712|231684|P2|NOT COMPLETED|Safety Follow-up||3
97316|NCT01271712|231685|P1|NOT COMPLETED|Safety Follow-up||9
97317|NCT01271712|231684|P2|COMPLETED|Safety Follow-up||4
97318|NCT01271712|231685|P1|COMPLETED|Safety Follow-up||27
97319|NCT01271712|231684|P2|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|7
97320|NCT01271712|231685|P1|STARTED|Safety Follow-up|All participants who discontinued study drug entered 30-day Safety Follow-up|36
97321|NCT01271712|231684|P2|NOT COMPLETED|Open Label Treatment||56
97322|NCT01271712|231685|P1|NOT COMPLETED|Open Label Treatment||41
97323|NCT01271712|231684|P2|COMPLETED|Open Label Treatment||0
97324|NCT01271712|231685|P1|COMPLETED|Open Label Treatment||0
97325|NCT01271712|231684|P2|Participants Received Treatment|Open Label Treatment||56
97326|NCT01271712|231685|P1|Participants Received Treatment|Open Label Treatment||41
97327|NCT01271712|231684|P2|STARTED|Open Label Treatment||56
97328|NCT01271712|231685|P1|STARTED|Open Label Treatment||41
97329|NCT01271712|231684|P2|NOT COMPLETED|Double Blind Treatment||10
97330|NCT01271712|231685|P1|NOT COMPLETED|Double Blind Treatment||92
97331|NCT01271712|231684|P2|COMPLETED|Double Blind Treatment|56 participants started open-label treatment with regorafenib|56
97332|NCT01271712|231685|P1|COMPLETED|Double Blind Treatment|41 participants started open-label treatment with regorafenib|41
97333|NCT01271712|231684|P2|Participants Received Treatment|Double Blind Treatment||66
97334|NCT01271712|231685|P1|Participants Received Treatment|Double Blind Treatment||132
97335|NCT01271712|231684|P2|STARTED|Double Blind Treatment||66
97336|NCT01271712|231685|P1|STARTED|Double Blind Treatment||133
97337|NCT01271686|231705|P1|NOT COMPLETED|Overall Study||0
97338|NCT01271686|231705|P1|COMPLETED|Overall Study||16
97339|NCT01271686|231705|P1|STARTED|Overall Study||16
97340|NCT01271543|231711|P2|NOT COMPLETED|Overall Study||1
97341|NCT01271543|231712|P1|NOT COMPLETED|Overall Study||1
97342|NCT01271543|231711|P2|COMPLETED|Overall Study||29
97343|NCT01271543|231712|P1|COMPLETED|Overall Study||29
97344|NCT01271543|231711|P2|STARTED|Overall Study||30
97345|NCT01271543|231712|P1|STARTED|Overall Study||30
97346|NCT01271452|231722|P2|NOT COMPLETED|Overall Study||8
97347|NCT01271452|231723|P1|NOT COMPLETED|Overall Study||7
97348|NCT01271452|231722|P2|COMPLETED|Overall Study||104
97349|NCT01271452|231723|P1|COMPLETED|Overall Study||105
97350|NCT01271452|231722|P2|STARTED|Overall Study||112
97351|NCT01271452|231723|P1|STARTED|Overall Study||112
97352|NCT01271413|231745|P2|NOT COMPLETED|Overall Study||8
97353|NCT01271413|231746|P1|NOT COMPLETED|Overall Study||9
97354|NCT01271413|231745|P2|COMPLETED|Overall Study||28
97355|NCT01271413|231746|P1|COMPLETED|Overall Study||28
97356|NCT01271413|231745|P2|STARTED|Overall Study||36
97357|NCT01271413|231746|P1|STARTED|Overall Study||37
97358|NCT01271244|231754|P2|NOT COMPLETED|Overall Study||3
97359|NCT01271244|231755|P1|NOT COMPLETED|Overall Study||7
97360|NCT01271244|231754|P2|COMPLETED|Overall Study||5
97361|NCT01271244|231755|P1|COMPLETED|Overall Study||11
97362|NCT01271244|231754|P2|STARTED|Overall Study||8
97363|NCT01271244|231755|P1|STARTED|Overall Study||18
97364|NCT01271036|231763|P2|NOT COMPLETED|Overall Study||0
97365|NCT01271036|231764|P1|NOT COMPLETED|Overall Study||0
97366|NCT01271036|231763|P2|COMPLETED|Overall Study||62
97367|NCT01271036|231764|P1|COMPLETED|Overall Study||62
97368|NCT01271036|231763|P2|STARTED|Overall Study||62
97369|NCT01271036|231764|P1|STARTED|Overall Study||62
97370|NCT01270971|231780|P2|NOT COMPLETED|Overall Study||23
97371|NCT01270971|231781|P1|NOT COMPLETED|Overall Study||52
97372|NCT01270971|231780|P2|COMPLETED|Overall Study||171
97373|NCT01270971|231781|P1|COMPLETED|Overall Study||348
97374|NCT01270971|231780|P2|STARTED|Overall Study||194
97375|NCT01270971|231781|P1|STARTED|Overall Study||400
97376|NCT01270958|231793|P1|NOT COMPLETED|Overall Study||4
97377|NCT01270958|231793|P1|COMPLETED|Overall Study||56
97378|NCT01270958|231793|P1|STARTED|Overall Study||60
97379|NCT01270919|231817|P1|NOT COMPLETED|Overall Study||0
97380|NCT01270919|231817|P1|COMPLETED|Overall Study||0
97381|NCT01270919|231817|P1|STARTED|Overall Study|One participant was enrolled but was censored.|0
97382|NCT01270880|231822|P1|NOT COMPLETED|Overall Study||1
97383|NCT01270880|231822|P1|COMPLETED|Overall Study||17
97384|NCT01270880|231822|P1|STARTED|Overall Study||18
97385|NCT01270867|231828|P2|NOT COMPLETED|Overall Study||0
97386|NCT01270867|231829|P1|NOT COMPLETED|Overall Study||1
97387|NCT01270867|231828|P2|COMPLETED|Overall Study||88
97388|NCT01270867|231829|P1|COMPLETED|Overall Study||89
97389|NCT01270867|231828|P2|STARTED|Overall Study||88
97390|NCT01270867|231829|P1|STARTED|Overall Study||90
97391|NCT01270841|231847|P4|NOT COMPLETED|Overall Study||13
97392|NCT01270841|231848|P3|NOT COMPLETED|Overall Study||11
97393|NCT01270841|231849|P2|NOT COMPLETED|Overall Study||14
97394|NCT01270841|231850|P1|NOT COMPLETED|Overall Study||13
97395|NCT01270841|231847|P4|COMPLETED|Overall Study||20
97396|NCT01270841|231848|P3|COMPLETED|Overall Study||18
97397|NCT01270841|231849|P2|COMPLETED|Overall Study||19
97398|NCT01270841|231850|P1|COMPLETED|Overall Study||16
97399|NCT01270841|231847|P4|STARTED|Overall Study||33
97400|NCT01270841|231848|P3|STARTED|Overall Study||29
97401|NCT01270841|231849|P2|STARTED|Overall Study||33
97402|NCT01270841|231850|P1|STARTED|Overall Study||29
97403|NCT01270828|231874|P3|NOT COMPLETED|Double Blind Phase||0
97404|NCT01270828|231875|P2|NOT COMPLETED|Double Blind Phase||45
97405|NCT01270828|231876|P1|NOT COMPLETED|Double Blind Phase||26
97406|NCT01270828|231874|P3|COMPLETED|Double Blind Phase||0
97407|NCT01270828|231875|P2|COMPLETED|Double Blind Phase||160
97408|NCT01270828|231876|P1|COMPLETED|Double Blind Phase||182
97409|NCT01270828|231874|P3|STARTED|Double Blind Phase||0
97410|NCT01270828|231875|P2|STARTED|Double Blind Phase||205
97411|NCT01270828|231876|P1|STARTED|Double Blind Phase||208
97412|NCT01270828|231874|P3|NOT COMPLETED|Pregabalin CR SB||146
97413|NCT01270828|231875|P2|NOT COMPLETED|Pregabalin CR SB||0
97414|NCT01270828|231876|P1|NOT COMPLETED|Pregabalin CR SB||0
97415|NCT01270828|231874|P3|COMPLETED|Pregabalin CR SB||660
97416|NCT01270828|231875|P2|COMPLETED|Pregabalin CR SB||0
97417|NCT01270828|231876|P1|COMPLETED|Pregabalin CR SB||0
97418|NCT01270828|231874|P3|STARTED|Pregabalin CR SB||806
97419|NCT01270828|231875|P2|STARTED|Pregabalin CR SB||0
97420|NCT01270828|231876|P1|STARTED|Pregabalin CR SB||0
97421|NCT01270802|231918|P2|NOT COMPLETED|Overall Study||1
97422|NCT01270802|231919|P1|NOT COMPLETED|Overall Study||2
97423|NCT01270802|231918|P2|COMPLETED|Overall Study||14
97424|NCT01270802|231919|P1|COMPLETED|Overall Study||13
97425|NCT01270802|231918|P2|STARTED|Overall Study||15
97426|NCT01270802|231919|P1|STARTED|Overall Study||15
97427|NCT01270711|231935|P8|NOT COMPLETED|Part 2: Effectiveness||0
97428|NCT01270711|231936|P7|NOT COMPLETED|Part 2: Effectiveness||0
97429|NCT01270711|231937|P6|NOT COMPLETED|Part 2: Effectiveness||0
97430|NCT01270711|231938|P5|NOT COMPLETED|Part 2: Effectiveness||0
97431|NCT01270711|231939|P4|NOT COMPLETED|Part 2: Effectiveness||0
97432|NCT01270711|231940|P3|NOT COMPLETED|Part 2: Effectiveness||0
97433|NCT01270711|231941|P2|NOT COMPLETED|Part 2: Effectiveness||0
97434|NCT01270711|231942|P1|NOT COMPLETED|Part 2: Effectiveness||0
97435|NCT01270711|231935|P8|COMPLETED|Part 2: Effectiveness||48
97436|NCT01270711|231936|P7|COMPLETED|Part 2: Effectiveness||2
97437|NCT01270711|231937|P6|COMPLETED|Part 2: Effectiveness||11
97438|NCT01270711|231938|P5|COMPLETED|Part 2: Effectiveness||0
97439|NCT01270711|231939|P4|COMPLETED|Part 2: Effectiveness||0
97440|NCT01270711|231940|P3|COMPLETED|Part 2: Effectiveness||0
97441|NCT01270711|231941|P2|COMPLETED|Part 2: Effectiveness||0
97442|NCT01270711|231942|P1|COMPLETED|Part 2: Effectiveness||0
97443|NCT01270711|231935|P8|STARTED|Part 2: Effectiveness||48
97444|NCT01270711|231936|P7|STARTED|Part 2: Effectiveness||2
97445|NCT01270711|231937|P6|STARTED|Part 2: Effectiveness||11
97446|NCT01270711|231938|P5|STARTED|Part 2: Effectiveness||0
97447|NCT01270711|231939|P4|STARTED|Part 2: Effectiveness||0
97448|NCT01270711|231940|P3|STARTED|Part 2: Effectiveness||0
97449|NCT01270711|231941|P2|STARTED|Part 2: Effectiveness||0
97450|NCT01270711|231942|P1|STARTED|Part 2: Effectiveness||0
97451|NCT01270711|231935|P8|NOT COMPLETED|Part 1: Compliance||0
97452|NCT01270711|231936|P7|NOT COMPLETED|Part 1: Compliance||0
97453|NCT01270711|231937|P6|NOT COMPLETED|Part 1: Compliance||0
97454|NCT01270711|231938|P5|NOT COMPLETED|Part 1: Compliance||0
97455|NCT01270711|231939|P4|NOT COMPLETED|Part 1: Compliance||0
97456|NCT01270711|231940|P3|NOT COMPLETED|Part 1: Compliance||0
97457|NCT01270711|231941|P2|NOT COMPLETED|Part 1: Compliance||0
97458|NCT01270711|231942|P1|NOT COMPLETED|Part 1: Compliance||0
97459|NCT01270711|231935|P8|COMPLETED|Part 1: Compliance||0
97460|NCT01270711|231936|P7|COMPLETED|Part 1: Compliance||0
97461|NCT01270711|231937|P6|COMPLETED|Part 1: Compliance||0
97462|NCT01270711|231938|P5|COMPLETED|Part 1: Compliance||2024
97463|NCT01270711|231939|P4|COMPLETED|Part 1: Compliance||5486
97464|NCT01270711|231940|P3|COMPLETED|Part 1: Compliance||326
97465|NCT01270711|231941|P2|COMPLETED|Part 1: Compliance||6580
97466|NCT01270711|231942|P1|COMPLETED|Part 1: Compliance||7537
97467|NCT01270711|231935|P8|STARTED|Part 1: Compliance||0
97468|NCT01270711|231936|P7|STARTED|Part 1: Compliance||0
97469|NCT01270711|231937|P6|STARTED|Part 1: Compliance||0
97470|NCT01270711|231938|P5|STARTED|Part 1: Compliance||2024
97471|NCT01270711|231939|P4|STARTED|Part 1: Compliance||5486
97472|NCT01270711|231940|P3|STARTED|Part 1: Compliance||326
97473|NCT01270711|231941|P2|STARTED|Part 1: Compliance||6580
97474|NCT01270711|231942|P1|STARTED|Part 1: Compliance||7537
97475|NCT01270659|232043|P4|NOT COMPLETED|Overall Study||0
97476|NCT01270659|232044|P3|NOT COMPLETED|Overall Study||0
97477|NCT01270659|232045|P2|NOT COMPLETED|Overall Study||0
97478|NCT01270659|232046|P1|NOT COMPLETED|Overall Study||0
97479|NCT01270659|232043|P4|COMPLETED|Overall Study||25
97480|NCT01270659|232044|P3|COMPLETED|Overall Study||4
97481|NCT01270659|232045|P2|COMPLETED|Overall Study||25
97482|NCT01270659|232046|P1|COMPLETED|Overall Study||6
97483|NCT01270659|232043|P4|STARTED|Overall Study||25
97484|NCT01270659|232044|P3|STARTED|Overall Study||4
97485|NCT01270659|232045|P2|STARTED|Overall Study||25
97486|NCT01270659|232046|P1|STARTED|Overall Study||6
97487|NCT01270620|232066|P2|NOT COMPLETED|Overall Study||3
97488|NCT01270620|232067|P1|NOT COMPLETED|Overall Study||1
97489|NCT01270620|232066|P2|COMPLETED|Overall Study||47
97490|NCT01270620|232067|P1|COMPLETED|Overall Study||49
97491|NCT01270620|232066|P2|STARTED|Overall Study||50
97492|NCT01270620|232067|P1|STARTED|Overall Study||50
97493|NCT01270581|232119|P2|NOT COMPLETED|Overall Study||0
97494|NCT01270581|232120|P1|NOT COMPLETED|Overall Study||1
97495|NCT01270581|232119|P2|COMPLETED|Overall Study||3
97496|NCT01270581|232120|P1|COMPLETED|Overall Study||3
97497|NCT01270581|232119|P2|STARTED|Overall Study||3
97498|NCT01270581|232120|P1|STARTED|Overall Study||4
97499|NCT01270555|232126|P1|NOT COMPLETED|Overall Study||13
97500|NCT01270555|232126|P1|COMPLETED|Overall Study||19
97501|NCT01270555|232126|P1|STARTED|Overall Study||32
97502|NCT01270542|232138|P2|NOT COMPLETED|Overall Study||1
97503|NCT01270542|232139|P1|NOT COMPLETED|Overall Study||1
97504|NCT01270542|232138|P2|COMPLETED|Overall Study||8
97505|NCT01270542|232139|P1|COMPLETED|Overall Study||9
97506|NCT01270542|232138|P2|STARTED|Overall Study||9
97507|NCT01270542|232139|P1|STARTED|Overall Study||10
97508|NCT01270529|232152|P3|NOT COMPLETED|Overall Study||0
97509|NCT01270529|232153|P2|NOT COMPLETED|Overall Study||0
97510|NCT01270529|232154|P1|NOT COMPLETED|Overall Study||0
97511|NCT01270529|232152|P3|COMPLETED|Overall Study||25
97512|NCT01270529|232153|P2|COMPLETED|Overall Study||7
97513|NCT01270529|232154|P1|COMPLETED|Overall Study||12
97514|NCT01270529|232152|P3|STARTED|Overall Study||25
97515|NCT01270529|232153|P2|STARTED|Overall Study||7
97516|NCT01270529|232154|P1|STARTED|Overall Study||12
97517|NCT01270503|232162|P1|NOT COMPLETED|Overall Study||1
97518|NCT01270503|232162|P1|COMPLETED|Overall Study||537
97519|NCT01270503|232162|P1|STARTED|Overall Study||538
97520|NCT01270464|232170|P3|NOT COMPLETED|Overall Study||18
97521|NCT01270464|232171|P2|NOT COMPLETED|Overall Study||12
97522|NCT01270464|232172|P1|NOT COMPLETED|Overall Study||20
97523|NCT01270464|232170|P3|COMPLETED|Overall Study||88
97524|NCT01270464|232171|P2|COMPLETED|Overall Study||92
97525|NCT01270464|232172|P1|COMPLETED|Overall Study||85
97526|NCT01270464|232170|P3|Pharmacokinetic Analysis Set|Overall Study||103
97527|NCT01270464|232171|P2|Pharmacokinetic Analysis Set|Overall Study||103
97528|NCT01270464|232172|P1|Pharmacokinetic Analysis Set|Overall Study||105
97529|NCT01270464|232170|P3|Full Analysis Set|Overall Study||103
97530|NCT01270464|232171|P2|Full Analysis Set|Overall Study||103
97531|NCT01270464|232172|P1|Full Analysis Set|Overall Study||105
97532|NCT01270464|232170|P3|Safety Analysis Set|Overall Study||103
97533|NCT01270464|232171|P2|Safety Analysis Set|Overall Study||103
97534|NCT01270464|232172|P1|Safety Analysis Set|Overall Study||105
97535|NCT01270464|232170|P3|STARTED|Overall Study||106
97536|NCT01270464|232171|P2|STARTED|Overall Study||104
97537|NCT01270464|232172|P1|STARTED|Overall Study||105
97538|NCT01270256|232221|P2|NOT COMPLETED|Overall Study||0
97539|NCT01270256|232222|P1|NOT COMPLETED|Overall Study||1
97540|NCT01270256|232221|P2|COMPLETED|Overall Study||20
97541|NCT01270256|232222|P1|COMPLETED|Overall Study||20
97542|NCT01270256|232221|P2|STARTED|Overall Study||20
97543|NCT01270256|232222|P1|STARTED|Overall Study||21
97544|NCT01270139|232231|P3|NOT COMPLETED|Overall Study||20
97545|NCT01270139|232232|P2|NOT COMPLETED|Overall Study||26
97546|NCT01270139|232233|P1|NOT COMPLETED|Overall Study||18
97547|NCT01270139|232231|P3|COMPLETED|Overall Study|Pre-treatment evaluable population|40
97548|NCT01270139|232232|P2|COMPLETED|Overall Study|Pre-treatment evaluable population|34
97549|NCT01270139|232233|P1|COMPLETED|Overall Study|Pre-treatment evaluable population|42
97550|NCT01270139|232231|P3|STARTED|Overall Study|Intention-to-treat population|60
97551|NCT01270139|232232|P2|STARTED|Overall Study|Intention-to-treat population|60
97552|NCT01270139|232233|P1|STARTED|Overall Study|Intention-to-treat population|60
97553|NCT01270126|232276|P2|NOT COMPLETED|Overall Study||0
97554|NCT01270126|232277|P1|NOT COMPLETED|Overall Study||0
97555|NCT01270126|232276|P2|COMPLETED|Overall Study||10
97556|NCT01270126|232277|P1|COMPLETED|Overall Study||12
97557|NCT01270126|232276|P2|STARTED|Overall Study||10
97558|NCT01270126|232277|P1|STARTED|Overall Study||12
97559|NCT01269918|232285|P2|NOT COMPLETED|Overall Study||3
97560|NCT01269918|232286|P1|NOT COMPLETED|Overall Study||0
97561|NCT01269918|232285|P2|COMPLETED|Overall Study||68
97562|NCT01269918|232286|P1|COMPLETED|Overall Study||71
97563|NCT01269918|232285|P2|STARTED|Overall Study||71
97564|NCT01269918|232286|P1|STARTED|Overall Study||71
97565|NCT01269801|232320|P2|NOT COMPLETED|Overall Study||3
97566|NCT01269801|232321|P1|NOT COMPLETED|Overall Study||0
97567|NCT01269801|232320|P2|COMPLETED|Overall Study||77
97568|NCT01269801|232321|P1|COMPLETED|Overall Study||74
97569|NCT01269801|232320|P2|STARTED|Overall Study||80
97570|NCT01269801|232321|P1|STARTED|Overall Study||74
97571|NCT01269736|232329|P2|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
97572|NCT01269736|232330|P1|NOT COMPLETED|Patient Outcomes (Hospital Admissions)||0
97573|NCT01269736|232329|P2|COMPLETED|Patient Outcomes (Hospital Admissions)|43799 unique patients assessed overall (at any time point) by end of study.|43799
97574|NCT01269736|232330|P1|COMPLETED|Patient Outcomes (Hospital Admissions)|52085 unique patients assessed overall (at any time point) by end of study.|52085
97575|NCT01269736|232329|P2|30 Months Assessment|Patient Outcomes (Hospital Admissions)|13265 unique patients, assessed at 6 hospitals.|13265
97576|NCT01269736|232330|P1|30 Months Assessment|Patient Outcomes (Hospital Admissions)|16702 unique patients, assessed at 7 hospitals.|16702
97577|NCT01269736|232329|P2|15 Months Assessment|Patient Outcomes (Hospital Admissions)|14075 unique patients, assessed at 6 hospitals.|14075
97578|NCT01269736|232330|P1|15 Months Assessment|Patient Outcomes (Hospital Admissions)|18031 unique patients, assessed at 7 hospitals.|18031
97579|NCT01269736|232329|P2|Baseline Assessment|Patient Outcomes (Hospital Admissions)|16549 unique patients, assessed at 6 hospitals.|16549
97580|NCT01269736|232330|P1|Baseline Assessment|Patient Outcomes (Hospital Admissions)|17352 unique patients, assessed at 7 hospitals.|17352
97581|NCT01269736|232329|P2|STARTED|Patient Outcomes (Hospital Admissions)|16459 unique patients were assessed at 6 hospitals at the initiation of the study.|43799
97582|NCT01269736|232330|P1|STARTED|Patient Outcomes (Hospital Admissions)|17352 unique patients were assessed at 7 hospitals at the initiation of the study.|52085
97583|NCT01269736|232329|P2|NOT COMPLETED|Patient Quality of Care Assessments||0
97584|NCT01269736|232330|P1|NOT COMPLETED|Patient Quality of Care Assessments||0
97585|NCT01269736|232329|P2|COMPLETED|Patient Quality of Care Assessments|2288 unique patients assessed overall (at any time point) by end of study.|2288
97586|NCT01269736|232330|P1|COMPLETED|Patient Quality of Care Assessments|2299 unique patients assessed overall (at any time point) by end of study.|2299
97587|NCT01269736|232329|P2|30 Months Assessment|Patient Quality of Care Assessments|626 unique patients, assessed at 7 hospitals.|626
97588|NCT01269736|232330|P1|30 Months Assessment|Patient Quality of Care Assessments|697 unique patients, assessed at 8 hospitals.|697
97589|NCT01269736|232329|P2|15 Months Assessment|Patient Quality of Care Assessments|773 unique patients, assessed at 8 hospitals.|773
97590|NCT01269736|232330|P1|15 Months Assessment|Patient Quality of Care Assessments|687 unique patients, assessed at 8 hospitals.|687
97591|NCT01269736|232329|P2|Baseline Assessment|Patient Quality of Care Assessments|889 unique patients, assessed at 8 hospitals.|889
97592|NCT01269736|232330|P1|Baseline Assessment|Patient Quality of Care Assessments|915 unique patients, assessed at 9 hospitals.|915
97593|NCT01269736|232329|P2|STARTED|Patient Quality of Care Assessments|889 unique patients were assessed at 8 hospitals at the initiation of the study.|2288
97594|NCT01269736|232330|P1|STARTED|Patient Quality of Care Assessments|915 unique patients were assessed at 9 hospitals at the initiation of the study.|2299
97595|NCT01269736|232329|P2|NOT COMPLETED|Nurses' Knowledge Assessments||0
97596|NCT01269736|232330|P1|NOT COMPLETED|Nurses' Knowledge Assessments||0
97597|NCT01269736|232329|P2|COMPLETED|Nurses' Knowledge Assessments|1428 unique nurses assessed overall (at any time point) by end of study.|1428
97598|NCT01269736|232330|P1|COMPLETED|Nurses' Knowledge Assessments|1585 unique nurses assessed overall (at any time point) by end of study.|1585
97599|NCT01269736|232329|P2|30 Months Assessment|Nurses' Knowledge Assessments|926 unique nurses, assessed at 8 hospitals.|926
97600|NCT01269736|232330|P1|30 Months Assessment|Nurses' Knowledge Assessments|741 unique nurses, assessed at 8 hospitals.|741
97601|NCT01269736|232329|P2|15 Months Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|782
97602|NCT01269736|232330|P1|15 Months Assessment|Nurses' Knowledge Assessments|1108 unique nurses, assessed at 9 hospitals.|1108
97603|NCT01269736|232329|P2|Baseline Assessment|Nurses' Knowledge Assessments|866 unique nurses, assessed at 8 hospitals.|866
97604|NCT01269736|232330|P1|Baseline Assessment|Nurses' Knowledge Assessments|873 unique nurses, assessed at 9 hospitals.|873
97605|NCT01269736|232329|P2|STARTED|Nurses' Knowledge Assessments|866 unique nurses were assessed at 8 hospitals at the initiation of the study.|1428
97606|NCT01269736|232330|P1|STARTED|Nurses' Knowledge Assessments|873 unique nurses were assessed at 9 hospitals at the initiation of the study.|1585
97607|NCT01269710|232342|P1|NOT COMPLETED|Overall Study||3
97608|NCT01269710|232342|P1|COMPLETED|Overall Study|This refers to Week 52.|1
97609|NCT01269710|232342|P1|Week 36|Overall Study||2
97610|NCT01269710|232342|P1|Week 12|Overall Study||3
97611|NCT01269710|232342|P1|STARTED|Overall Study||4
97612|NCT01269346|232350|P1|NOT COMPLETED|Extension Phase||43
97613|NCT01269346|232350|P1|COMPLETED|Extension Phase||0
97614|NCT01269346|232350|P1|STARTED|Extension Phase|Out of 52 participants randomized, only 43 continued into the Extension Phase of the study.|43
97615|NCT01269346|232350|P1|NOT COMPLETED|Treatment Phase||9
97616|NCT01269346|232350|P1|COMPLETED|Treatment Phase||43
97617|NCT01269346|232350|P1|Completed 6 Cycles|Treatment Phase||45
97618|NCT01269346|232350|P1|STARTED|Treatment Phase||52
97619|NCT01269125|232361|P3|NOT COMPLETED|Overall Study||0
97620|NCT01269125|232362|P2|NOT COMPLETED|Overall Study||5
97621|NCT01269125|232363|P1|NOT COMPLETED|Overall Study||7
97622|NCT01269125|232361|P3|COMPLETED|Overall Study||60
97623|NCT01269125|232362|P2|COMPLETED|Overall Study|OHSS:4; premature luteinization: 1|55
97624|NCT01269125|232363|P1|COMPLETED|Overall Study|lost to follow up:4; OHSS: 2; premature luteinization: 1|53
97625|NCT01269125|232361|P3|STARTED|Overall Study||60
97626|NCT01269125|232362|P2|STARTED|Overall Study||60
97627|NCT01269125|232363|P1|STARTED|Overall Study||60
97628|NCT01268943|232387|P4|NOT COMPLETED|Overall Study||0
97629|NCT01268943|232388|P3|NOT COMPLETED|Overall Study||0
97630|NCT01268943|232389|P2|NOT COMPLETED|Overall Study||0
97631|NCT01268943|232390|P1|NOT COMPLETED|Overall Study||0
97632|NCT01268943|232387|P4|COMPLETED|Overall Study||6
97633|NCT01268943|232388|P3|COMPLETED|Overall Study||3
97634|NCT01268943|232389|P2|COMPLETED|Overall Study||3
97635|NCT01268943|232390|P1|COMPLETED|Overall Study||6
97636|NCT01268943|232387|P4|STARTED|Overall Study||6
97637|NCT01268943|232388|P3|STARTED|Overall Study||3
97638|NCT01268943|232389|P2|STARTED|Overall Study||3
97639|NCT01268943|232390|P1|STARTED|Overall Study||6
97640|NCT01268891|232402|P2|NOT COMPLETED|Overall Study||8
97641|NCT01268891|232403|P1|NOT COMPLETED|Overall Study||8
97642|NCT01268891|232402|P2|COMPLETED|Overall Study||58
97643|NCT01268891|232403|P1|COMPLETED|Overall Study||58
97644|NCT01268891|232402|P2|STARTED|Overall Study||66
97645|NCT01268891|232403|P1|STARTED|Overall Study||66
97646|NCT01268683|232415|P1|NOT COMPLETED|Overall Study||0
97647|NCT01268683|232415|P1|COMPLETED|Overall Study||10
97648|NCT01268683|232415|P1|STARTED|Overall Study||10
97649|NCT01268566|232422|P1|NOT COMPLETED|Overall Study||43
97650|NCT01268566|232422|P1|COMPLETED|Overall Study||13
97651|NCT01268566|232422|P1|STARTED|Overall Study||56
97652|NCT01268501|232440|P1|NOT COMPLETED|Overall Study||9
97653|NCT01268501|232440|P1|COMPLETED|Overall Study||87
97654|NCT01268501|232440|P1|STARTED|Overall Study||96
97655|NCT01268488|232444|P1|NOT COMPLETED|Overall Study||5
97656|NCT01268488|232444|P1|COMPLETED|Overall Study||93
97657|NCT01268488|232444|P1|STARTED|Overall Study||98
97658|NCT01268306|232451|P1|NOT COMPLETED|Overall Study||1
97659|NCT01268306|232451|P1|COMPLETED|Overall Study||7
97660|NCT01268306|232451|P1|STARTED|Overall Study||8
97661|NCT01268293|232455|P1|NOT COMPLETED|Overall Study||9
97662|NCT01268293|232455|P1|COMPLETED|Overall Study||0
97663|NCT01268293|232455|P1|Completed Cycle 1|Overall Study||9
97664|NCT01268293|232455|P1|STARTED|Overall Study||9
97665|NCT01268267|232460|P1|NOT COMPLETED|Overall Study||1
97666|NCT01268267|232460|P1|COMPLETED|Overall Study||93
97667|NCT01268267|232460|P1|STARTED|Overall Study||94
97668|NCT01268189|232467|P1|NOT COMPLETED|Overall Study||3
97669|NCT01268189|232467|P1|COMPLETED|Overall Study||17
97670|NCT01268189|232467|P1|STARTED|Overall Study||20
97671|NCT01268150|232481|P1|NOT COMPLETED|Extension Phase||27
97672|NCT01268150|232481|P1|COMPLETED|Extension Phase||1
97673|NCT01268150|232481|P1|Treatment Ongoing at Data Cutoff Date|Extension Phase||1
97674|NCT01268150|232481|P1|STARTED|Extension Phase|28 participants discontinued study drug in Treatment Phase so did not enter the Extension Phase|28
97675|NCT01268150|232481|P1|NOT COMPLETED|Treatment Phase||28
97676|NCT01268150|232481|P1|COMPLETED|Treatment Phase||28
97677|NCT01268150|232481|P1|STARTED|Treatment Phase||56
97678|NCT01268111|232491|P2|NOT COMPLETED|Overall Study||0
97679|NCT01268111|232492|P1|NOT COMPLETED|Overall Study||0
97680|NCT01268111|232491|P2|COMPLETED|Overall Study||6
97681|NCT01268111|232492|P1|COMPLETED|Overall Study||6
97682|NCT01268111|232491|P2|STARTED|Overall Study||6
97683|NCT01268111|232492|P1|STARTED|Overall Study||6
97684|NCT01268098|232500|P2|NOT COMPLETED|Overall Study||0
97685|NCT01268098|232501|P1|NOT COMPLETED|Overall Study||1
97686|NCT01268098|232500|P2|COMPLETED|Overall Study||23
97687|NCT01268098|232501|P1|COMPLETED|Overall Study||18
97688|NCT01268098|232500|P2|STARTED|Overall Study||23
97689|NCT01268098|232501|P1|STARTED|Overall Study||19
97690|NCT01267994|232509|P1|NOT COMPLETED|Overall Study||2
97691|NCT01267994|232509|P1|COMPLETED|Overall Study|Excluded from analysis, could not reach first milestone (day 28) for efficacy assessment, n=2|10
97692|NCT01267994|232509|P1|STARTED|Overall Study|Declined to participate. n=1 Did not receive intervention due to infeciton, n=1|12
97693|NCT01267929|232515|P2|NOT COMPLETED|Overall Study||0
97694|NCT01267929|232516|P1|NOT COMPLETED|Overall Study||0
97695|NCT01267929|232515|P2|COMPLETED|Overall Study||15
97696|NCT01267929|232516|P1|COMPLETED|Overall Study||15
97697|NCT01267929|232515|P2|STARTED|Overall Study||15
97698|NCT01267929|232516|P1|STARTED|Overall Study||15
97699|NCT01267422|232522|P2|NOT COMPLETED|Safety and Efficacy Study||0
97700|NCT01267422|232523|P1|NOT COMPLETED|Safety and Efficacy Study||0
97701|NCT01267422|232522|P2|COMPLETED|Safety and Efficacy Study||4
97702|NCT01267422|232523|P1|COMPLETED|Safety and Efficacy Study||5
97703|NCT01267422|232522|P2|STARTED|Safety and Efficacy Study||4
97704|NCT01267422|232523|P1|STARTED|Safety and Efficacy Study||5
97705|NCT01267422|232522|P2|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
97706|NCT01267422|232523|P1|NOT COMPLETED|Intravitreal rAAV2-ND4 Injection||0
97707|NCT01267422|232522|P2|COMPLETED|Intravitreal rAAV2-ND4 Injection||4
97708|NCT01267422|232523|P1|COMPLETED|Intravitreal rAAV2-ND4 Injection||5
97709|NCT01267422|232522|P2|STARTED|Intravitreal rAAV2-ND4 Injection||4
97710|NCT01267422|232523|P1|STARTED|Intravitreal rAAV2-ND4 Injection||5
97711|NCT01267292|232543|P2|NOT COMPLETED|Overall Study||6
97712|NCT01267292|232544|P1|NOT COMPLETED|Overall Study||4
97713|NCT01267292|232543|P2|COMPLETED|Overall Study||20
97714|NCT01267292|232544|P1|COMPLETED|Overall Study||20
97715|NCT01267292|232543|P2|STARTED|Overall Study||26
97716|NCT01267292|232544|P1|STARTED|Overall Study||24
97717|NCT01267266|232578|P2|NOT COMPLETED|Randomized Phase||0
97718|NCT01267266|232579|P1|NOT COMPLETED|Randomized Phase||0
97719|NCT01267266|232578|P2|COMPLETED|Randomized Phase||5
97720|NCT01267266|232579|P1|COMPLETED|Randomized Phase||3
97721|NCT01267266|232578|P2|STARTED|Randomized Phase|5 of 8 patients randomized to placebo.|5
97722|NCT01267266|232579|P1|STARTED|Randomized Phase|3 of 8 patients randomized to saracatinib.|3
97723|NCT01267266|232578|P2|NOT COMPLETED|Lead-in Phase||0
97724|NCT01267266|232579|P1|NOT COMPLETED|Lead-in Phase||23
97725|NCT01267266|232578|P2|COMPLETED|Lead-in Phase||0
97726|NCT01267266|232579|P1|COMPLETED|Lead-in Phase|12 patients had radiographic progression, 8 clinical progression, 2 toxicity, 1 withdrawal.|8
97727|NCT01267266|232578|P2|STARTED|Lead-in Phase||0
97728|NCT01267266|232579|P1|STARTED|Lead-in Phase||31
97729|NCT01267266|232578|P2|NOT COMPLETED|Enrollment Phase||0
97730|NCT01267266|232579|P1|NOT COMPLETED|Enrollment Phase||2
97731|NCT01267266|232578|P2|COMPLETED|Enrollment Phase||0
97732|NCT01267266|232579|P1|COMPLETED|Enrollment Phase|Two patients signed consent but did not proceed to treatment.|31
97733|NCT01267266|232578|P2|STARTED|Enrollment Phase||0
97734|NCT01267266|232579|P1|STARTED|Enrollment Phase||33
97735|NCT01267253|232592|P1|NOT COMPLETED|Overall Study||3
97736|NCT01267253|232592|P1|COMPLETED|Overall Study|Eligible and treated patients|28
97737|NCT01267253|232592|P1|STARTED|Overall Study||31
97738|NCT01267240|232600|P1|NOT COMPLETED|Overall Study||0
97739|NCT01267240|232600|P1|COMPLETED|Overall Study||25
97740|NCT01267240|232600|P1|STARTED|Overall Study||25
97741|NCT01267227|232610|P4|NOT COMPLETED|Overall Study||3
97742|NCT01267227|232611|P3|NOT COMPLETED|Overall Study||2
97743|NCT01267227|232612|P2|NOT COMPLETED|Overall Study||1
97744|NCT01267227|232613|P1|NOT COMPLETED|Overall Study||1
97745|NCT01267227|232610|P4|COMPLETED|Overall Study||17
97746|NCT01267227|232611|P3|COMPLETED|Overall Study||18
97747|NCT01267227|232612|P2|COMPLETED|Overall Study||19
97748|NCT01267227|232613|P1|COMPLETED|Overall Study||19
97749|NCT01267227|232610|P4|STARTED|Overall Study||20
97750|NCT01267227|232611|P3|STARTED|Overall Study||20
97751|NCT01267227|232612|P2|STARTED|Overall Study||20
97752|NCT01267227|232613|P1|STARTED|Overall Study||20
97753|NCT01267201|232627|P6|NOT COMPLETED|Third Intervention Period||0
97754|NCT01267201|232628|P5|NOT COMPLETED|Third Intervention Period||0
97755|NCT01267201|232629|P4|NOT COMPLETED|Third Intervention Period||0
97756|NCT01267201|232630|P3|NOT COMPLETED|Third Intervention Period||0
97757|NCT01267201|232631|P2|NOT COMPLETED|Third Intervention Period||0
97758|NCT01267201|232632|P1|NOT COMPLETED|Third Intervention Period||0
97759|NCT01267201|232627|P6|COMPLETED|Third Intervention Period||4
97760|NCT01267201|232628|P5|COMPLETED|Third Intervention Period||4
97761|NCT01267201|232629|P4|COMPLETED|Third Intervention Period||4
97762|NCT01267201|232630|P3|COMPLETED|Third Intervention Period||4
97763|NCT01267201|232631|P2|COMPLETED|Third Intervention Period||3
97764|NCT01267201|232632|P1|COMPLETED|Third Intervention Period||3
97765|NCT01267201|232627|P6|STARTED|Third Intervention Period||4
97766|NCT01267201|232628|P5|STARTED|Third Intervention Period||4
97767|NCT01267201|232629|P4|STARTED|Third Intervention Period||4
97768|NCT01267201|232630|P3|STARTED|Third Intervention Period||4
97769|NCT01267201|232631|P2|STARTED|Third Intervention Period||3
97770|NCT01267201|232632|P1|STARTED|Third Intervention Period||3
97771|NCT01267201|232627|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97772|NCT01267201|232628|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97773|NCT01267201|232629|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97774|NCT01267201|232630|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97775|NCT01267201|232631|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97776|NCT01267201|232632|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97777|NCT01267201|232627|P6|COMPLETED|Washout Period (At Least 2 Days)||4
97778|NCT01267201|232628|P5|COMPLETED|Washout Period (At Least 2 Days)||4
97779|NCT01267201|232629|P4|COMPLETED|Washout Period (At Least 2 Days)||4
97780|NCT01267201|232630|P3|COMPLETED|Washout Period (At Least 2 Days)||4
97781|NCT01267201|232631|P2|COMPLETED|Washout Period (At Least 2 Days)||3
97782|NCT01267201|232632|P1|COMPLETED|Washout Period (At Least 2 Days)||3
97783|NCT01267201|232627|P6|STARTED|Washout Period (At Least 2 Days)||4
97784|NCT01267201|232628|P5|STARTED|Washout Period (At Least 2 Days)||4
97785|NCT01267201|232629|P4|STARTED|Washout Period (At Least 2 Days)||4
97786|NCT01267201|232630|P3|STARTED|Washout Period (At Least 2 Days)||4
97787|NCT01267201|232631|P2|STARTED|Washout Period (At Least 2 Days)||3
97788|NCT01267201|232632|P1|STARTED|Washout Period (At Least 2 Days)||3
97789|NCT01267201|232627|P6|NOT COMPLETED|Second Intervention Period||0
97790|NCT01267201|232628|P5|NOT COMPLETED|Second Intervention Period||0
97791|NCT01267201|232629|P4|NOT COMPLETED|Second Intervention Period||0
97792|NCT01267201|232630|P3|NOT COMPLETED|Second Intervention Period||0
97793|NCT01267201|232631|P2|NOT COMPLETED|Second Intervention Period||1
97794|NCT01267201|232632|P1|NOT COMPLETED|Second Intervention Period||0
97795|NCT01267201|232627|P6|COMPLETED|Second Intervention Period||4
97796|NCT01267201|232628|P5|COMPLETED|Second Intervention Period||4
97797|NCT01267201|232629|P4|COMPLETED|Second Intervention Period||4
97798|NCT01267201|232630|P3|COMPLETED|Second Intervention Period||4
97799|NCT01267201|232631|P2|COMPLETED|Second Intervention Period||3
97800|NCT01267201|232632|P1|COMPLETED|Second Intervention Period||3
97801|NCT01267201|232627|P6|STARTED|Second Intervention Period||4
97802|NCT01267201|232628|P5|STARTED|Second Intervention Period||4
97803|NCT01267201|232629|P4|STARTED|Second Intervention Period||4
97804|NCT01267201|232630|P3|STARTED|Second Intervention Period||4
97805|NCT01267201|232631|P2|STARTED|Second Intervention Period||4
97806|NCT01267201|232632|P1|STARTED|Second Intervention Period||3
97807|NCT01267201|232627|P6|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97808|NCT01267201|232628|P5|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97809|NCT01267201|232629|P4|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97810|NCT01267201|232630|P3|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97811|NCT01267201|232631|P2|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97812|NCT01267201|232632|P1|NOT COMPLETED|Washout Period (At Least 2 Days)||0
97813|NCT01267201|232627|P6|COMPLETED|Washout Period (At Least 2 Days)||4
97814|NCT01267201|232628|P5|COMPLETED|Washout Period (At Least 2 Days)||4
97815|NCT01267201|232629|P4|COMPLETED|Washout Period (At Least 2 Days)||4
97816|NCT01267201|232630|P3|COMPLETED|Washout Period (At Least 2 Days)||4
97817|NCT01267201|232631|P2|COMPLETED|Washout Period (At Least 2 Days)||4
97818|NCT01267201|232632|P1|COMPLETED|Washout Period (At Least 2 Days)||3
97819|NCT01267201|232627|P6|STARTED|Washout Period (At Least 2 Days)||4
97820|NCT01267201|232628|P5|STARTED|Washout Period (At Least 2 Days)||4
97821|NCT01267201|232629|P4|STARTED|Washout Period (At Least 2 Days)||4
97822|NCT01267201|232630|P3|STARTED|Washout Period (At Least 2 Days)||4
97823|NCT01267201|232631|P2|STARTED|Washout Period (At Least 2 Days)||4
97824|NCT01267201|232632|P1|STARTED|Washout Period (At Least 2 Days)||3
97825|NCT01267201|232627|P6|NOT COMPLETED|First Intervention Period||0
97826|NCT01267201|232628|P5|NOT COMPLETED|First Intervention Period||0
97827|NCT01267201|232629|P4|NOT COMPLETED|First Intervention Period||0
97828|NCT01267201|232630|P3|NOT COMPLETED|First Intervention Period||0
97829|NCT01267201|232631|P2|NOT COMPLETED|First Intervention Period||0
97830|NCT01267201|232632|P1|NOT COMPLETED|First Intervention Period||1
97831|NCT01267201|232627|P6|COMPLETED|First Intervention Period||4
97832|NCT01267201|232628|P5|COMPLETED|First Intervention Period||4
97833|NCT01267201|232629|P4|COMPLETED|First Intervention Period||4
97834|NCT01267201|232630|P3|COMPLETED|First Intervention Period||4
97835|NCT01267201|232631|P2|COMPLETED|First Intervention Period||4
97836|NCT01267201|232632|P1|COMPLETED|First Intervention Period||3
97837|NCT01267201|232627|P6|STARTED|First Intervention Period||4
97838|NCT01267201|232628|P5|STARTED|First Intervention Period||4
97839|NCT01267201|232629|P4|STARTED|First Intervention Period||4
97840|NCT01267201|232630|P3|STARTED|First Intervention Period||4
97841|NCT01267201|232631|P2|STARTED|First Intervention Period||4
97842|NCT01267201|232632|P1|STARTED|First Intervention Period||4
97843|NCT01267175|232649|P1|NOT COMPLETED|Overall Study||2
97844|NCT01267175|232649|P1|COMPLETED|Overall Study||29
97845|NCT01267175|232649|P1|STARTED|Overall Study||31
97846|NCT01267136|232656|P2|NOT COMPLETED|Overall Study||6
97847|NCT01267136|232657|P1|NOT COMPLETED|Overall Study||4
97848|NCT01267136|232656|P2|COMPLETED|Overall Study||36
97849|NCT01267136|232657|P1|COMPLETED|Overall Study||38
97850|NCT01267136|232656|P2|STARTED|Overall Study||42
97851|NCT01267136|232657|P1|STARTED|Overall Study||42
97852|NCT01267045|232667|P2|NOT COMPLETED|6-month Outcome||3
97853|NCT01267045|232668|P1|NOT COMPLETED|6-month Outcome||0
97854|NCT01267045|232667|P2|COMPLETED|6-month Outcome||23
97855|NCT01267045|232668|P1|COMPLETED|6-month Outcome||22
97856|NCT01267045|232667|P2|STARTED|6-month Outcome||26
97857|NCT01267045|232668|P1|STARTED|6-month Outcome||22
97858|NCT01267045|232667|P2|NOT COMPLETED|2-month Outcomes||3
97859|NCT01267045|232668|P1|NOT COMPLETED|2-month Outcomes||4
97860|NCT01267045|232667|P2|COMPLETED|2-month Outcomes||26
97861|NCT01267045|232668|P1|COMPLETED|2-month Outcomes||22
97862|NCT01267045|232667|P2|STARTED|2-month Outcomes||29
97863|NCT01267045|232668|P1|STARTED|2-month Outcomes||26
97864|NCT01267019|232703|P3|NOT COMPLETED|Overall Study||6
97865|NCT01267019|232704|P2|NOT COMPLETED|Overall Study||6
97866|NCT01267019|232705|P1|NOT COMPLETED|Overall Study||6
97867|NCT01267019|232703|P3|COMPLETED|Overall Study||47
97868|NCT01267019|232704|P2|COMPLETED|Overall Study||47
97869|NCT01267019|232705|P1|COMPLETED|Overall Study||41
97870|NCT01267019|232703|P3|STARTED|Overall Study||53
97871|NCT01267019|232704|P2|STARTED|Overall Study||53
97872|NCT01267019|232705|P1|STARTED|Overall Study||47
97873|NCT01266967|232721|P2|NOT COMPLETED|Overall Study||83
97874|NCT01266967|232722|P1|NOT COMPLETED|Overall Study||89
97875|NCT01266967|232721|P2|COMPLETED|Overall Study||0
97876|NCT01266967|232722|P1|COMPLETED|Overall Study||0
97877|NCT01266967|232721|P2|STARTED|Overall Study||83
97878|NCT01266967|232722|P1|STARTED|Overall Study||89
97879|NCT01266876|232774|P5|NOT COMPLETED|Overall Study||0
97880|NCT01266876|232775|P4|NOT COMPLETED|Overall Study||1
97881|NCT01266876|232776|P3|NOT COMPLETED|Overall Study||0
97882|NCT01266876|232777|P2|NOT COMPLETED|Overall Study||0
97883|NCT01266876|232778|P1|NOT COMPLETED|Overall Study||0
97884|NCT01266876|232774|P5|COMPLETED|Overall Study||16
97885|NCT01266876|232775|P4|COMPLETED|Overall Study||14
97886|NCT01266876|232776|P3|COMPLETED|Overall Study||16
97887|NCT01266876|232777|P2|COMPLETED|Overall Study||15
97888|NCT01266876|232778|P1|COMPLETED|Overall Study||15
97889|NCT01266876|232774|P5|STARTED|Overall Study||16
97890|NCT01266876|232775|P4|STARTED|Overall Study||15
97891|NCT01266876|232776|P3|STARTED|Overall Study||16
97892|NCT01266876|232777|P2|STARTED|Overall Study||15
97893|NCT01266876|232778|P1|STARTED|Overall Study||15
97894|NCT01266850|232885|P5|NOT COMPLETED|Overall Study||30
97895|NCT01266850|232886|P4|NOT COMPLETED|Overall Study||28
97896|NCT01266850|232887|P3|NOT COMPLETED|Overall Study||24
97897|NCT01266850|232888|P2|NOT COMPLETED|Overall Study||36
97898|NCT01266850|232889|P1|NOT COMPLETED|Overall Study||30
97899|NCT01266850|232885|P5|COMPLETED|Overall Study||297
97900|NCT01266850|232886|P4|COMPLETED|Overall Study||301
97901|NCT01266850|232887|P3|COMPLETED|Overall Study||214
97902|NCT01266850|232888|P2|COMPLETED|Overall Study||212
97903|NCT01266850|232889|P1|COMPLETED|Overall Study||212
97904|NCT01266850|232885|P5|Received Third Vaccine|Overall Study||299
97905|NCT01266850|232886|P4|Received Third Vaccine|Overall Study||0
97906|NCT01266850|232887|P3|Received Third Vaccine|Overall Study||217
97907|NCT01266850|232888|P2|Received Third Vaccine|Overall Study||221
97908|NCT01266850|232889|P1|Received Third Vaccine|Overall Study||221
97909|NCT01266850|232885|P5|Received Second Vaccine|Overall Study||307
97910|NCT01266850|232886|P4|Received Second Vaccine|Overall Study||311
97911|NCT01266850|232887|P3|Received Second Vaccine|Overall Study||227
97912|NCT01266850|232888|P2|Received Second Vaccine|Overall Study||233
97913|NCT01266850|232889|P1|Received Second Vaccine|Overall Study||231
97914|NCT01266850|232885|P5|STARTED|Overall Study||327
97915|NCT01266850|232886|P4|STARTED|Overall Study||329
97916|NCT01266850|232887|P3|STARTED|Overall Study||238
97917|NCT01266850|232888|P2|STARTED|Overall Study||248
97918|NCT01266850|232889|P1|STARTED|Overall Study||242
97919|NCT01266824|232943|P2|NOT COMPLETED|Overall Study||3
97920|NCT01266824|232944|P1|NOT COMPLETED|Overall Study||2
97921|NCT01266824|232943|P2|COMPLETED|Overall Study||0
97922|NCT01266824|232944|P1|COMPLETED|Overall Study||0
97923|NCT01266824|232943|P2|STARTED|Overall Study||3
97924|NCT01266824|232944|P1|STARTED|Overall Study||2
97925|NCT01266447|232956|P1|NOT COMPLETED|Overall Study||0
97926|NCT01266447|232956|P1|COMPLETED|Overall Study|Eligible and treated patients|27
97927|NCT01266447|232956|P1|STARTED|Overall Study||27
97928|NCT01266291|232965|P1|NOT COMPLETED|Overall Study||1
97929|NCT01266291|232965|P1|COMPLETED|Overall Study||0
97930|NCT01266291|232965|P1|STARTED|Overall Study||1
97931|NCT01266265|232972|P2|NOT COMPLETED|Overall Study||190
97932|NCT01266265|232973|P1|NOT COMPLETED|Overall Study||205
97933|NCT01266265|232972|P2|COMPLETED|Overall Study||477
97934|NCT01266265|232973|P1|COMPLETED|Overall Study||461
97935|NCT01266265|232972|P2|STARTED|Overall Study||667
97936|NCT01266265|232973|P1|STARTED|Overall Study||666
97937|NCT01266148|232981|P2|NOT COMPLETED|Overall Study||3
97938|NCT01266148|232982|P1|NOT COMPLETED|Overall Study||7
97939|NCT01266148|232981|P2|COMPLETED|Overall Study||56
97940|NCT01266148|232982|P1|COMPLETED|Overall Study||49
97941|NCT01266148|232981|P2|STARTED|Overall Study||59
97942|NCT01266148|232982|P1|STARTED|Overall Study||56
97943|NCT01266122|233010|P2|NOT COMPLETED|Overall Study||6
97944|NCT01266122|233011|P1|NOT COMPLETED|Overall Study||6
97945|NCT01266122|233010|P2|COMPLETED|Overall Study||42
97946|NCT01266122|233011|P1|COMPLETED|Overall Study||42
97947|NCT01266122|233010|P2|STARTED|Overall Study||48
97948|NCT01266122|233011|P1|STARTED|Overall Study||48
97949|NCT01266070|233019|P1|NOT COMPLETED|Overall Study||4
97950|NCT01266070|233019|P1|COMPLETED|Overall Study||2
97951|NCT01266070|233019|P1|STARTED|Overall Study||6
97952|NCT01266031|233027|P3|NOT COMPLETED|Overall Study||3
97953|NCT01266031|233028|P2|NOT COMPLETED|Overall Study||3
97954|NCT01266031|233029|P1|NOT COMPLETED|Overall Study||0
97955|NCT01266031|233027|P3|COMPLETED|Overall Study||46
97956|NCT01266031|233028|P2|COMPLETED|Overall Study||38
97957|NCT01266031|233029|P1|COMPLETED|Overall Study||6
97958|NCT01266031|233027|P3|STARTED|Overall Study||49
97959|NCT01266031|233028|P2|STARTED|Overall Study||41
97960|NCT01266031|233029|P1|STARTED|Overall Study||6
97961|NCT01266018|233037|P2|NOT COMPLETED|Overall Study||1
97962|NCT01266018|233038|P1|NOT COMPLETED|Overall Study||1
97963|NCT01266018|233037|P2|COMPLETED|Overall Study||12
97964|NCT01266018|233038|P1|COMPLETED|Overall Study|Defined as evaluable for the primary endpoint|8
97965|NCT01266018|233037|P2|STARTED|Overall Study||13
97966|NCT01266018|233038|P1|STARTED|Overall Study||9
97967|NCT01265992|233049|P1|NOT COMPLETED|Overall Study||9
97968|NCT01265992|233049|P1|COMPLETED|Overall Study||41
97969|NCT01265992|233049|P1|Received Treatment|Overall Study||49
97970|NCT01265992|233049|P1|STARTED|Overall Study||50
97971|NCT01265966|233065|P3|NOT COMPLETED|Overall Study||2
97972|NCT01265966|233066|P2|NOT COMPLETED|Overall Study||2
97973|NCT01265966|233067|P1|NOT COMPLETED|Overall Study||3
97974|NCT01265966|233065|P3|COMPLETED|Overall Study||27
97975|NCT01265966|233066|P2|COMPLETED|Overall Study||39
97976|NCT01265966|233067|P1|COMPLETED|Overall Study||44
97977|NCT01265966|233065|P3|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
97978|NCT01265966|233066|P2|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|2
97979|NCT01265966|233067|P1|Analyzed Separately|Overall Study|Patients taking inhaled or intranasal corticosteroids were analyzed separately.|3
97980|NCT01265966|233065|P3|STARTED|Overall Study||29
97981|NCT01265966|233066|P2|STARTED|Overall Study||41
97982|NCT01265966|233067|P1|STARTED|Overall Study||47
97983|NCT01265953|233077|P2|NOT COMPLETED|Overall Study||3
97984|NCT01265953|233078|P1|NOT COMPLETED|Overall Study||5
97985|NCT01265953|233077|P2|COMPLETED|Overall Study||45
97986|NCT01265953|233078|P1|COMPLETED|Overall Study||45
97987|NCT01265953|233077|P2|STARTED|Overall Study||48
97988|NCT01265953|233078|P1|STARTED|Overall Study||50
97989|NCT01265875|233090|P1|NOT COMPLETED|Overall Study||1
97990|NCT01265875|233090|P1|COMPLETED|Overall Study||11
97991|NCT01265875|233090|P1|STARTED|Overall Study||12
97992|NCT01265823|233098|P1|NOT COMPLETED|Overall Study||7
97993|NCT01265823|233098|P1|COMPLETED|Overall Study||143
97994|NCT01265823|233098|P1|STARTED|Overall Study||150
97995|NCT01265797|233127|P2|NOT COMPLETED|Open Label Month||1
97996|NCT01265797|233128|P1|NOT COMPLETED|Open Label Month||0
97997|NCT01265797|233127|P2|COMPLETED|Open Label Month||26
97998|NCT01265797|233128|P1|COMPLETED|Open Label Month||24
97999|NCT01265797|233127|P2|STARTED|Open Label Month||27
98000|NCT01265797|233128|P1|STARTED|Open Label Month||24
98001|NCT01265797|233127|P2|NOT COMPLETED|Blinded Month||2
98002|NCT01265797|233128|P1|NOT COMPLETED|Blinded Month||10
98003|NCT01265797|233127|P2|COMPLETED|Blinded Month||27
98004|NCT01265797|233128|P1|COMPLETED|Blinded Month||24
98005|NCT01265797|233127|P2|STARTED|Blinded Month||29
98006|NCT01265797|233128|P1|STARTED|Blinded Month||34
98007|NCT01265797|233127|P2|NOT COMPLETED|Run-in Month||5
98008|NCT01265797|233128|P1|NOT COMPLETED|Run-in Month||0
98009|NCT01265797|233127|P2|COMPLETED|Run-in Month||29
98010|NCT01265797|233128|P1|COMPLETED|Run-in Month||34
98011|NCT01265797|233127|P2|STARTED|Run-in Month||34
98012|NCT01265797|233128|P1|STARTED|Run-in Month||34
98013|NCT01265784|233159|P3|NOT COMPLETED|Overall Study||4
98014|NCT01265784|233160|P2|NOT COMPLETED|Overall Study||8
98015|NCT01265784|233161|P1|NOT COMPLETED|Overall Study||12
98016|NCT01265784|233159|P3|COMPLETED|Overall Study||26
98017|NCT01265784|233160|P2|COMPLETED|Overall Study||49
98018|NCT01265784|233161|P1|COMPLETED|Overall Study||44
98019|NCT01265784|233159|P3|Received at Least 1 Dose of Study Drug|Overall Study||29
98020|NCT01265784|233160|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
98021|NCT01265784|233161|P1|Received at Least 1 Dose of Study Drug|Overall Study|1 participant randomized to TP-434 1.5 mg/kg took ertapenem. Results are included in ertapenem arm.|54
98022|NCT01265784|233159|P3|STARTED|Overall Study||30
98023|NCT01265784|233160|P2|STARTED|Overall Study||57
98024|NCT01265784|233161|P1|STARTED|Overall Study||56
98025|NCT01265615|233231|P4|NOT COMPLETED|Overall Study||3
98026|NCT01265615|233232|P3|NOT COMPLETED|Overall Study||4
98027|NCT01265615|233233|P2|NOT COMPLETED|Overall Study||2
98028|NCT01265615|233234|P1|NOT COMPLETED|Overall Study||2
98029|NCT01265615|233231|P4|COMPLETED|Overall Study||27
98030|NCT01265615|233232|P3|COMPLETED|Overall Study||26
98031|NCT01265615|233233|P2|COMPLETED|Overall Study||28
98032|NCT01265615|233234|P1|COMPLETED|Overall Study||28
98033|NCT01265615|233231|P4|STARTED|Overall Study||30
98034|NCT01265615|233232|P3|STARTED|Overall Study||30
98035|NCT01265615|233233|P2|STARTED|Overall Study||30
98036|NCT01265615|233234|P1|STARTED|Overall Study||30
98037|NCT01265563|233285|P5|NOT COMPLETED|Overall Study||2
98038|NCT01265563|233286|P4|NOT COMPLETED|Overall Study||0
98039|NCT01265563|233287|P3|NOT COMPLETED|Overall Study||1
98040|NCT01265563|233288|P2|NOT COMPLETED|Overall Study||1
98041|NCT01265563|233289|P1|NOT COMPLETED|Overall Study||0
98042|NCT01265563|233285|P5|COMPLETED|Overall Study||14
98043|NCT01265563|233286|P4|COMPLETED|Overall Study||16
98044|NCT01265563|233287|P3|COMPLETED|Overall Study||16
98045|NCT01265563|233288|P2|COMPLETED|Overall Study||12
98046|NCT01265563|233289|P1|COMPLETED|Overall Study||16
98047|NCT01265563|233285|P5|STARTED|Overall Study||16
98048|NCT01265563|233286|P4|STARTED|Overall Study||16
98049|NCT01265563|233287|P3|STARTED|Overall Study||17
98050|NCT01265563|233288|P2|STARTED|Overall Study||13
98051|NCT01265563|233289|P1|STARTED|Overall Study||16
98052|NCT01265524|233308|P2|NOT COMPLETED|Overall Study||6
98053|NCT01265524|233309|P1|NOT COMPLETED|Overall Study||18
98054|NCT01265524|233308|P2|COMPLETED|Overall Study||46
98055|NCT01265524|233309|P1|COMPLETED|Overall Study||41
98056|NCT01265524|233308|P2|STARTED|Overall Study||52
98057|NCT01265524|233309|P1|STARTED|Overall Study||59
98058|NCT01265511|233329|P2|NOT COMPLETED|Overall Study||3
98059|NCT01265511|233330|P1|NOT COMPLETED|Overall Study||2
98060|NCT01265511|233329|P2|COMPLETED|Overall Study||5
98061|NCT01265511|233330|P1|COMPLETED|Overall Study||0
98062|NCT01265511|233329|P2|STARTED|Overall Study||8
98063|NCT01265511|233330|P1|STARTED|Overall Study||2
98064|NCT01265498|233344|P2|NOT COMPLETED|Overall Study||33
98065|NCT01265498|233345|P1|NOT COMPLETED|Overall Study||31
98066|NCT01265498|233344|P2|COMPLETED|Overall Study||109
98067|NCT01265498|233345|P1|COMPLETED|Overall Study||110
98068|NCT01265498|233344|P2|Both Baseline and Week 72 Biopsy|Overall Study||98
98069|NCT01265498|233345|P1|Both Baseline and Week 72 Biopsy|Overall Study||102
98070|NCT01265498|233344|P2|STARTED|Overall Study||142
98071|NCT01265498|233345|P1|STARTED|Overall Study||141
98072|NCT01265459|233448|P3|NOT COMPLETED|Overall Study||2
98073|NCT01265459|233449|P2|NOT COMPLETED|Overall Study||0
98074|NCT01265459|233450|P1|NOT COMPLETED|Overall Study||0
98075|NCT01265459|233448|P3|COMPLETED|Overall Study||20
98076|NCT01265459|233449|P2|COMPLETED|Overall Study||23
98077|NCT01265459|233450|P1|COMPLETED|Overall Study||23
98078|NCT01265459|233448|P3|STARTED|Overall Study||22
98079|NCT01265459|233449|P2|STARTED|Overall Study||23
98080|NCT01265459|233450|P1|STARTED|Overall Study||23
98081|NCT01265446|233472|P2|NOT COMPLETED|Overall Study||0
98082|NCT01265446|233473|P1|NOT COMPLETED|Overall Study||1
98083|NCT01265446|233472|P2|COMPLETED|Overall Study||125
98084|NCT01265446|233473|P1|COMPLETED|Overall Study||124
98085|NCT01265446|233472|P2|STARTED|Overall Study||125
98086|NCT01265446|233473|P1|STARTED|Overall Study||125
98087|NCT01265420|233481|P1|NOT COMPLETED|Overall Study||1
98088|NCT01265420|233481|P1|COMPLETED|Overall Study|One patient was seen at Day 10 but did not return for Day 30 evaluation|6
98089|NCT01265420|233481|P1|STARTED|Overall Study||7
98090|NCT01265394|233485|P1|NOT COMPLETED|Overall Study||37
98091|NCT01265394|233485|P1|COMPLETED|Overall Study||181
98092|NCT01265394|233485|P1|STARTED|Overall Study||218
98093|NCT01265056|233492|P2|NOT COMPLETED|Overall Study||2
98094|NCT01265056|233493|P1|NOT COMPLETED|Overall Study||2
98095|NCT01265056|233492|P2|COMPLETED|Overall Study||25
98096|NCT01265056|233493|P1|COMPLETED|Overall Study||24
98097|NCT01265056|233492|P2|STARTED|Overall Study||27
98098|NCT01265056|233493|P1|STARTED|Overall Study||26
98099|NCT01264952|233502|P3|NOT COMPLETED|Overall Study||0
98100|NCT01264952|233503|P2|NOT COMPLETED|Overall Study||0
98101|NCT01264952|233504|P1|NOT COMPLETED|Overall Study||0
98102|NCT01264952|233502|P3|COMPLETED|Overall Study||8
98103|NCT01264952|233503|P2|COMPLETED|Overall Study||2
98104|NCT01264952|233504|P1|COMPLETED|Overall Study||6
98105|NCT01264952|233502|P3|STARTED|Overall Study||8
98106|NCT01264952|233503|P2|STARTED|Overall Study||2
98107|NCT01264952|233504|P1|STARTED|Overall Study||6
98108|NCT01264939|233520|P2|NOT COMPLETED|Overall Study||28
98109|NCT01264939|233521|P1|NOT COMPLETED|Overall Study||18
98110|NCT01264939|233520|P2|COMPLETED|Overall Study||224
98111|NCT01264939|233521|P1|COMPLETED|Overall Study||66
98112|NCT01264939|233520|P2|STARTED|Overall Study||252
98113|NCT01264939|233521|P1|STARTED|Overall Study||84
98114|NCT01263925|233549|P2|NOT COMPLETED|Overall Study||52
98115|NCT01263925|233550|P1|NOT COMPLETED|Overall Study||51
98116|NCT01263925|233549|P2|COMPLETED|Overall Study||233
98117|NCT01263925|233550|P1|COMPLETED|Overall Study||225
98118|NCT01263925|233549|P2|Full Analysis Set|Overall Study||272
98119|NCT01263925|233550|P1|Full Analysis Set|Overall Study||269
98120|NCT01263925|233549|P2|STARTED|Overall Study||285
98121|NCT01263925|233550|P1|STARTED|Overall Study||276
98122|NCT01263873|233584|P2|NOT COMPLETED|Overall Study||1
98123|NCT01263873|233585|P1|NOT COMPLETED|Overall Study||1
98124|NCT01263873|233584|P2|COMPLETED|Overall Study||29
98125|NCT01263873|233585|P1|COMPLETED|Overall Study||29
98126|NCT01263873|233584|P2|STARTED|Overall Study||30
98127|NCT01263873|233585|P1|STARTED|Overall Study||30
98128|NCT01264887|233595|P1|NOT COMPLETED|Overall Study||31
98129|NCT01264887|233595|P1|COMPLETED|Overall Study||0
98130|NCT01264887|233595|P1|STARTED|Overall Study||31
98131|NCT01264835|233606|P1|NOT COMPLETED|Overall Study||1
98132|NCT01264835|233606|P1|COMPLETED|Overall Study||1
98133|NCT01264835|233606|P1|STARTED|Overall Study||2
98134|NCT01264770|233616|P6|NOT COMPLETED|Overall Study||6
98135|NCT01264770|233617|P5|NOT COMPLETED|Overall Study||8
98136|NCT01264770|233618|P4|NOT COMPLETED|Overall Study||6
98137|NCT01264770|233619|P3|NOT COMPLETED|Overall Study||16
98138|NCT01264770|233620|P2|NOT COMPLETED|Overall Study||10
98139|NCT01264770|233621|P1|NOT COMPLETED|Overall Study||18
98140|NCT01264770|233616|P6|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
98141|NCT01264770|233617|P5|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|19
98142|NCT01264770|233618|P4|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|48
98143|NCT01264770|233619|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|41
98144|NCT01264770|233620|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|38
98145|NCT01264770|233621|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|36
98146|NCT01264770|233616|P6|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|0
98147|NCT01264770|233617|P5|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
98148|NCT01264770|233618|P4|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|3
98149|NCT01264770|233619|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
98150|NCT01264770|233620|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|5
98151|NCT01264770|233621|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/subject decision/other|2
98152|NCT01264770|233616|P6|STARTED|Overall Study|Patients who received treatment|25
98153|NCT01264770|233617|P5|STARTED|Overall Study|Patients who received treatment|27
98154|NCT01264770|233618|P4|STARTED|Overall Study|Patients who received treatment|54
98155|NCT01264770|233619|P3|STARTED|Overall Study|Patients who received treatment|57
98156|NCT01264770|233620|P2|STARTED|Overall Study|Patients who received treatment|48
98157|NCT01264770|233621|P1|STARTED|Overall Study|Patients who received treatment|54
98158|NCT01264614|233707|P2|NOT COMPLETED|Overall Study||2
98159|NCT01264614|233708|P1|NOT COMPLETED|Overall Study||1
98160|NCT01264614|233707|P2|COMPLETED|Overall Study||7
98161|NCT01264614|233708|P1|COMPLETED|Overall Study||12
98162|NCT01264614|233707|P2|STARTED|Overall Study||9
98163|NCT01264614|233708|P1|STARTED|Overall Study||13
98164|NCT01264380|233722|P3|NOT COMPLETED|Period C||14
98165|NCT01264380|233723|P2|NOT COMPLETED|Period C||0
98166|NCT01264380|233724|P1|NOT COMPLETED|Period C||0
98167|NCT01264380|233722|P3|COMPLETED|Period C||2
98168|NCT01264380|233723|P2|COMPLETED|Period C||0
98169|NCT01264380|233724|P1|COMPLETED|Period C||0
98170|NCT01264380|233722|P3|STARTED|Period C||16
98171|NCT01264380|233723|P2|STARTED|Period C||0
98172|NCT01264380|233724|P1|STARTED|Period C||0
98173|NCT01264380|233722|P3|NOT COMPLETED|Period B||0
98174|NCT01264380|233723|P2|NOT COMPLETED|Period B||0
98175|NCT01264380|233724|P1|NOT COMPLETED|Period B||0
98176|NCT01264380|233722|P3|COMPLETED|Period B||0
98177|NCT01264380|233723|P2|COMPLETED|Period B||8
98178|NCT01264380|233724|P1|COMPLETED|Period B||8
98179|NCT01264380|233722|P3|STARTED|Period B||0
98180|NCT01264380|233723|P2|STARTED|Period B||8
98181|NCT01264380|233724|P1|STARTED|Period B||8
98182|NCT01264380|233722|P3|NOT COMPLETED|Period A||0
98183|NCT01264380|233723|P2|NOT COMPLETED|Period A||0
98184|NCT01264380|233724|P1|NOT COMPLETED|Period A||0
98185|NCT01264380|233722|P3|COMPLETED|Period A||0
98186|NCT01264380|233723|P2|COMPLETED|Period A||8
98187|NCT01264380|233724|P1|COMPLETED|Period A||8
98188|NCT01264380|233722|P3|STARTED|Period A||0
98189|NCT01264380|233723|P2|STARTED|Period A||8
98190|NCT01264380|233724|P1|STARTED|Period A||8
98191|NCT01264081|233745|P1|NOT COMPLETED|Analysis||0
98192|NCT01264081|233745|P1|COMPLETED|Analysis||2
98193|NCT01264081|233745|P1|STARTED|Analysis||2
98194|NCT01264081|233745|P1|NOT COMPLETED|Started Treatment||2
98195|NCT01264081|233745|P1|COMPLETED|Started Treatment||2
98196|NCT01264081|233745|P1|STARTED|Started Treatment||4
98197|NCT01264081|233745|P1|NOT COMPLETED|Participants Screened||30
98198|NCT01264081|233745|P1|COMPLETED|Participants Screened||4
98199|NCT01264081|233745|P1|STARTED|Participants Screened||34
98200|NCT01264016|233750|P1|NOT COMPLETED|Overall Study||2
98201|NCT01264016|233750|P1|COMPLETED|Overall Study||94
98202|NCT01264016|233750|P1|STARTED|Overall Study||96
98203|NCT01263717|233758|P2|NOT COMPLETED|Overall Study||6
98204|NCT01263717|233759|P1|NOT COMPLETED|Overall Study||5
98205|NCT01263717|233758|P2|COMPLETED|Overall Study||20
98206|NCT01263717|233759|P1|COMPLETED|Overall Study||23
98207|NCT01263717|233758|P2|Baseline Visit|Overall Study||22
98208|NCT01263717|233759|P1|Baseline Visit|Overall Study||28
98209|NCT01263717|233758|P2|STARTED|Overall Study||26
98210|NCT01263717|233759|P1|STARTED|Overall Study||28
98211|NCT01263691|233791|P6|NOT COMPLETED|Overall Study||0
98212|NCT01263691|233792|P5|NOT COMPLETED|Overall Study||0
98213|NCT01263691|233793|P4|NOT COMPLETED|Overall Study||1
98214|NCT01263691|233794|P3|NOT COMPLETED|Overall Study||1
98215|NCT01263691|233795|P2|NOT COMPLETED|Overall Study||0
98216|NCT01263691|233796|P1|NOT COMPLETED|Overall Study||3
98217|NCT01263691|233791|P6|COMPLETED|Overall Study||15
98218|NCT01263691|233792|P5|COMPLETED|Overall Study||18
98219|NCT01263691|233793|P4|COMPLETED|Overall Study||18
98220|NCT01263691|233794|P3|COMPLETED|Overall Study||16
98221|NCT01263691|233795|P2|COMPLETED|Overall Study||18
98222|NCT01263691|233796|P1|COMPLETED|Overall Study||15
98223|NCT01263691|233791|P6|STARTED|Overall Study||15
98224|NCT01263691|233792|P5|STARTED|Overall Study||18
98225|NCT01263691|233793|P4|STARTED|Overall Study||19
98226|NCT01263691|233794|P3|STARTED|Overall Study||17
98227|NCT01263691|233795|P2|STARTED|Overall Study||18
98228|NCT01263691|233796|P1|STARTED|Overall Study||18
98229|NCT01263665|233906|P1|NOT COMPLETED|Overall Study||9
98230|NCT01263665|233906|P1|COMPLETED|Overall Study||62
98231|NCT01263665|233906|P1|STARTED|Overall Study||71
98232|NCT01263639|233913|P2|NOT COMPLETED|Overall Study||79
98233|NCT01263639|233914|P1|NOT COMPLETED|Overall Study||73
98234|NCT01263639|233913|P2|COMPLETED|Overall Study||42
98235|NCT01263639|233914|P1|COMPLETED|Overall Study||34
98236|NCT01263639|233913|P2|STARTED|Overall Study||121
98237|NCT01263639|233914|P1|STARTED|Overall Study||107
98238|NCT01263561|233922|P2|NOT COMPLETED|Overall Study||2
98239|NCT01263561|233923|P1|NOT COMPLETED|Overall Study||1
98240|NCT01263561|233922|P2|COMPLETED|Overall Study||31
98241|NCT01263561|233923|P1|COMPLETED|Overall Study||30
98242|NCT01263561|233922|P2|STARTED|Overall Study||33
98243|NCT01263561|233923|P1|STARTED|Overall Study||31
98244|NCT01263509|233935|P4|NOT COMPLETED|Entered - Long-Term Extension Study||2
98245|NCT01263509|233936|P3|NOT COMPLETED|Entered - Long-Term Extension Study||5
98246|NCT01263509|233937|P2|NOT COMPLETED|Entered - Long-Term Extension Study||12
98247|NCT01263509|233938|P1|NOT COMPLETED|Entered - Long-Term Extension Study||8
98248|NCT01263509|233935|P4|COMPLETED|Entered - Long-Term Extension Study||24
98249|NCT01263509|233936|P3|COMPLETED|Entered - Long-Term Extension Study||27
98250|NCT01263509|233937|P2|COMPLETED|Entered - Long-Term Extension Study||48
98251|NCT01263509|233938|P1|COMPLETED|Entered - Long-Term Extension Study||53
98252|NCT01263509|233935|P4|STARTED|Entered - Long-Term Extension Study||26
98253|NCT01263509|233936|P3|STARTED|Entered - Long-Term Extension Study||32
98254|NCT01263509|233937|P2|STARTED|Entered - Long-Term Extension Study||60
98255|NCT01263509|233938|P1|STARTED|Entered - Long-Term Extension Study||61
98256|NCT01263509|233935|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98257|NCT01263509|233936|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98258|NCT01263509|233937|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98259|NCT01263509|233938|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98260|NCT01263509|233935|P4|COMPLETED|Enrolled - Long-Term Extension Study||26
98261|NCT01263509|233936|P3|COMPLETED|Enrolled - Long-Term Extension Study||32
98262|NCT01263509|233937|P2|COMPLETED|Enrolled - Long-Term Extension Study||60
98263|NCT01263509|233938|P1|COMPLETED|Enrolled - Long-Term Extension Study||61
98264|NCT01263509|233935|P4|STARTED|Enrolled - Long-Term Extension Study||26
98265|NCT01263509|233936|P3|STARTED|Enrolled - Long-Term Extension Study||32
98266|NCT01263509|233937|P2|STARTED|Enrolled - Long-Term Extension Study||60
98267|NCT01263509|233938|P1|STARTED|Enrolled - Long-Term Extension Study||61
98268|NCT01263496|234067|P9|NOT COMPLETED|Entered - Long-Term Extension Study||3
98269|NCT01263496|234068|P8|NOT COMPLETED|Entered - Long-Term Extension Study||1
98270|NCT01263496|234069|P7|NOT COMPLETED|Entered - Long-Term Extension Study||1
98271|NCT01263496|234070|P6|NOT COMPLETED|Entered - Long-Term Extension Study||1
98272|NCT01263496|234071|P5|NOT COMPLETED|Entered - Long-Term Extension Study||10
98273|NCT01263496|234072|P4|NOT COMPLETED|Entered - Long-Term Extension Study||6
98274|NCT01263496|234073|P3|NOT COMPLETED|Entered - Long-Term Extension Study||10
98275|NCT01263496|234074|P2|NOT COMPLETED|Entered - Long-Term Extension Study||13
98276|NCT01263496|234075|P1|NOT COMPLETED|Entered - Long-Term Extension Study||9
98277|NCT01263496|234067|P9|COMPLETED|Entered - Long-Term Extension Study||15
98278|NCT01263496|234068|P8|COMPLETED|Entered - Long-Term Extension Study||16
98279|NCT01263496|234069|P7|COMPLETED|Entered - Long-Term Extension Study||16
98280|NCT01263496|234070|P6|COMPLETED|Entered - Long-Term Extension Study||16
98281|NCT01263496|234071|P5|COMPLETED|Entered - Long-Term Extension Study||61
98282|NCT01263496|234072|P4|COMPLETED|Entered - Long-Term Extension Study||68
98283|NCT01263496|234073|P3|COMPLETED|Entered - Long-Term Extension Study||62
98284|NCT01263496|234074|P2|COMPLETED|Entered - Long-Term Extension Study||59
98285|NCT01263496|234075|P1|COMPLETED|Entered - Long-Term Extension Study||62
98286|NCT01263496|234067|P9|STARTED|Entered - Long-Term Extension Study||18
98287|NCT01263496|234068|P8|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|17
98288|NCT01263496|234069|P7|STARTED|Entered - Long-Term Extension Study||17
98289|NCT01263496|234070|P6|STARTED|Entered - Long-Term Extension Study||17
98290|NCT01263496|234071|P5|STARTED|Entered - Long-Term Extension Study|1 participant did not enter from previous period (voluntary withdraw).|71
98291|NCT01263496|234072|P4|STARTED|Entered - Long-Term Extension Study||74
98292|NCT01263496|234073|P3|STARTED|Entered - Long-Term Extension Study||72
98293|NCT01263496|234074|P2|STARTED|Entered - Long-Term Extension Study|3 participants did not enter from previous period (1 voluntary withdraw; 2 did not meet criteria).|72
98294|NCT01263496|234075|P1|STARTED|Entered - Long-Term Extension Study||71
98295|NCT01263496|234067|P9|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98296|NCT01263496|234068|P8|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98297|NCT01263496|234069|P7|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98298|NCT01263496|234070|P6|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98299|NCT01263496|234071|P5|NOT COMPLETED|Enrolled - Long-Term Extension Study||2
98300|NCT01263496|234072|P4|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
98301|NCT01263496|234073|P3|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98302|NCT01263496|234074|P2|NOT COMPLETED|Enrolled - Long-Term Extension Study||0
98303|NCT01263496|234075|P1|NOT COMPLETED|Enrolled - Long-Term Extension Study||1
98304|NCT01263496|234067|P9|COMPLETED|Enrolled - Long-Term Extension Study||18
98305|NCT01263496|234068|P8|COMPLETED|Enrolled - Long-Term Extension Study||18
98306|NCT01263496|234069|P7|COMPLETED|Enrolled - Long-Term Extension Study||17
98307|NCT01263496|234070|P6|COMPLETED|Enrolled - Long-Term Extension Study||17
98308|NCT01263496|234071|P5|COMPLETED|Enrolled - Long-Term Extension Study||72
98309|NCT01263496|234072|P4|COMPLETED|Enrolled - Long-Term Extension Study||74
98310|NCT01263496|234073|P3|COMPLETED|Enrolled - Long-Term Extension Study||72
98311|NCT01263496|234074|P2|COMPLETED|Enrolled - Long-Term Extension Study||75
98312|NCT01263496|234075|P1|COMPLETED|Enrolled - Long-Term Extension Study||71
98313|NCT01263496|234067|P9|STARTED|Enrolled - Long-Term Extension Study||18
98314|NCT01263496|234068|P8|STARTED|Enrolled - Long-Term Extension Study||18
98315|NCT01263496|234069|P7|STARTED|Enrolled - Long-Term Extension Study||17
98316|NCT01263496|234070|P6|STARTED|Enrolled - Long-Term Extension Study||17
98317|NCT01263496|234071|P5|STARTED|Enrolled - Long-Term Extension Study||74
98318|NCT01263496|234072|P4|STARTED|Enrolled - Long-Term Extension Study||75
98319|NCT01263496|234073|P3|STARTED|Enrolled - Long-Term Extension Study||72
98320|NCT01263496|234074|P2|STARTED|Enrolled - Long-Term Extension Study||75
98321|NCT01263496|234075|P1|STARTED|Enrolled - Long-Term Extension Study||72
98322|NCT01263483|234370|P3|NOT COMPLETED|Overall Study||5
98323|NCT01263483|234371|P2|NOT COMPLETED|Overall Study||2
98324|NCT01263483|234372|P1|NOT COMPLETED|Overall Study||7
98325|NCT01263483|234370|P3|COMPLETED|Overall Study||74
98326|NCT01263483|234371|P2|COMPLETED|Overall Study||74
98327|NCT01263483|234372|P1|COMPLETED|Overall Study||68
98328|NCT01263483|234370|P3|STARTED|Overall Study||79
98329|NCT01263483|234371|P2|STARTED|Overall Study||76
98330|NCT01263483|234372|P1|STARTED|Overall Study||75
98331|NCT01263470|234434|P6|NOT COMPLETED|Overall Study||5
98332|NCT01263470|234435|P5|NOT COMPLETED|Overall Study||3
98333|NCT01263470|234436|P4|NOT COMPLETED|Overall Study||3
98334|NCT01263470|234437|P3|NOT COMPLETED|Overall Study||4
98335|NCT01263470|234438|P2|NOT COMPLETED|Overall Study||5
98336|NCT01263470|234439|P1|NOT COMPLETED|Overall Study||2
98337|NCT01263470|234434|P6|COMPLETED|Overall Study||78
98338|NCT01263470|234435|P5|COMPLETED|Overall Study||76
98339|NCT01263470|234436|P4|COMPLETED|Overall Study||77
98340|NCT01263470|234437|P3|COMPLETED|Overall Study||80
98341|NCT01263470|234438|P2|COMPLETED|Overall Study||74
98342|NCT01263470|234439|P1|COMPLETED|Overall Study||73
98343|NCT01263470|234434|P6|STARTED|Overall Study||83
98344|NCT01263470|234435|P5|STARTED|Overall Study||79
98345|NCT01263470|234436|P4|STARTED|Overall Study||80
98346|NCT01263470|234437|P3|STARTED|Overall Study||84
98347|NCT01263470|234438|P2|STARTED|Overall Study||79
98348|NCT01263470|234439|P1|STARTED|Overall Study||75
98349|NCT01263444|234549|P1|NOT COMPLETED|Overall Study||10
98350|NCT01263444|234549|P1|COMPLETED|Overall Study||37
98351|NCT01263444|234549|P1|STARTED|Overall Study||47
98352|NCT01263301|234558|P2|NOT COMPLETED|Overall Study||0
98353|NCT01263301|234559|P1|NOT COMPLETED|Overall Study||0
98354|NCT01263301|234558|P2|COMPLETED|Overall Study||11
98355|NCT01263301|234559|P1|COMPLETED|Overall Study||5
98356|NCT01263301|234558|P2|STARTED|Overall Study||11
98357|NCT01263301|234559|P1|STARTED|Overall Study||5
98358|NCT01263132|234573|P2|NOT COMPLETED|Overall Study||0
98359|NCT01263132|234574|P1|NOT COMPLETED|Overall Study||0
98360|NCT01263132|234573|P2|COMPLETED|Overall Study||37
98361|NCT01263132|234574|P1|COMPLETED|Overall Study||38
98362|NCT01263132|234573|P2|STARTED|Overall Study||37
98363|NCT01263132|234574|P1|STARTED|Overall Study||38
98364|NCT01263054|234590|P2|NOT COMPLETED|Overall Study||6
98365|NCT01263054|234591|P1|NOT COMPLETED|Overall Study||5
98366|NCT01263054|234590|P2|COMPLETED|Overall Study||28
98367|NCT01263054|234591|P1|COMPLETED|Overall Study||24
98368|NCT01263054|234590|P2|STARTED|Overall Study||34
98369|NCT01263054|234591|P1|STARTED|Overall Study||29
98370|NCT01263028|234609|P1|NOT COMPLETED|Overall Study||6
98371|NCT01263028|234609|P1|COMPLETED|Overall Study||0
98372|NCT01263028|234609|P1|STARTED|Overall Study||6
98373|NCT01263015|234619|P2|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||31
98374|NCT01263015|234620|P1|NOT COMPLETED|Open-label Phase: 48 Weeks Duration||24
98375|NCT01263015|234619|P2|COMPLETED|Open-label Phase: 48 Weeks Duration||278
98376|NCT01263015|234620|P1|COMPLETED|Open-label Phase: 48 Weeks Duration||317
98377|NCT01263015|234619|P2|STARTED|Open-label Phase: 48 Weeks Duration||309
98378|NCT01263015|234620|P1|STARTED|Open-label Phase: 48 Weeks Duration||341
98379|NCT01263015|234619|P2|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||109
98380|NCT01263015|234620|P1|NOT COMPLETED|Double-blind Phase: 96 Weeks Duration||72
98381|NCT01263015|234619|P2|COMPLETED|Double-blind Phase: 96 Weeks Duration||310
98382|NCT01263015|234620|P1|COMPLETED|Double-blind Phase: 96 Weeks Duration||342
98383|NCT01263015|234619|P2|STARTED|Double-blind Phase: 96 Weeks Duration||419
98384|NCT01263015|234620|P1|STARTED|Double-blind Phase: 96 Weeks Duration||414
98385|NCT01262989|234646|P2|NOT COMPLETED|Period 2||1
98386|NCT01262989|234647|P1|NOT COMPLETED|Period 2||0
98387|NCT01262989|234646|P2|COMPLETED|Period 2||16
98388|NCT01262989|234647|P1|COMPLETED|Period 2||19
98389|NCT01262989|234646|P2|STARTED|Period 2||17
98390|NCT01262989|234647|P1|STARTED|Period 2||19
98391|NCT01262989|234646|P2|NOT COMPLETED|7-Day Washout Period||0
98392|NCT01262989|234647|P1|NOT COMPLETED|7-Day Washout Period||0
98393|NCT01262989|234646|P2|COMPLETED|7-Day Washout Period||17
98394|NCT01262989|234647|P1|COMPLETED|7-Day Washout Period||19
98395|NCT01262989|234646|P2|STARTED|7-Day Washout Period||17
98396|NCT01262989|234647|P1|STARTED|7-Day Washout Period||19
98397|NCT01262989|234646|P2|NOT COMPLETED|Period 1||3
98398|NCT01262989|234647|P1|NOT COMPLETED|Period 1||1
98399|NCT01262989|234646|P2|COMPLETED|Period 1||17
98400|NCT01262989|234647|P1|COMPLETED|Period 1||19
98401|NCT01262989|234646|P2|STARTED|Period 1||20
98402|NCT01262989|234647|P1|STARTED|Period 1||20
98403|NCT01262872|234665|P8|NOT COMPLETED|Step 2||6
98404|NCT01262872|234666|P7|NOT COMPLETED|Step 2||9
98405|NCT01262872|234667|P6|NOT COMPLETED|Step 2||9
98406|NCT01262872|234668|P5|NOT COMPLETED|Step 2||5
98407|NCT01262872|234669|P4|NOT COMPLETED|Step 2||10
98408|NCT01262872|234670|P3|NOT COMPLETED|Step 2||9
98409|NCT01262872|234671|P2|NOT COMPLETED|Step 2||0
98410|NCT01262872|234672|P1|NOT COMPLETED|Step 2||0
98411|NCT01262872|234665|P8|COMPLETED|Step 2||194
98412|NCT01262872|234666|P7|COMPLETED|Step 2||191
98413|NCT01262872|234667|P6|COMPLETED|Step 2||191
98414|NCT01262872|234668|P5|COMPLETED|Step 2||195
98415|NCT01262872|234669|P4|COMPLETED|Step 2||190
98416|NCT01262872|234670|P3|COMPLETED|Step 2||191
98417|NCT01262872|234671|P2|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98418|NCT01262872|234672|P1|COMPLETED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98419|NCT01262872|234665|P8|STARTED|Step 2||200
98420|NCT01262872|234666|P7|STARTED|Step 2||200
98421|NCT01262872|234667|P6|STARTED|Step 2||200
98422|NCT01262872|234668|P5|STARTED|Step 2||200
98423|NCT01262872|234669|P4|STARTED|Step 2||200
98424|NCT01262872|234670|P3|STARTED|Step 2||200
98425|NCT01262872|234671|P2|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98426|NCT01262872|234672|P1|STARTED|Step 2|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98427|NCT01262872|234665|P8|NOT COMPLETED|Step 1||0
98428|NCT01262872|234666|P7|NOT COMPLETED|Step 1||0
98429|NCT01262872|234667|P6|NOT COMPLETED|Step 1||0
98430|NCT01262872|234668|P5|NOT COMPLETED|Step 1||0
98431|NCT01262872|234669|P4|NOT COMPLETED|Step 1||0
98432|NCT01262872|234670|P3|NOT COMPLETED|Step 1||0
98433|NCT01262872|234671|P2|NOT COMPLETED|Step 1||0
98434|NCT01262872|234672|P1|NOT COMPLETED|Step 1||0
98435|NCT01262872|234665|P8|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98436|NCT01262872|234666|P7|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98437|NCT01262872|234667|P6|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98438|NCT01262872|234668|P5|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98439|NCT01262872|234669|P4|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone|0
98440|NCT01262872|234670|P3|COMPLETED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98441|NCT01262872|234671|P2|COMPLETED|Step 1||60
98442|NCT01262872|234672|P1|COMPLETED|Step 1||60
98443|NCT01262872|234665|P8|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98444|NCT01262872|234666|P7|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98445|NCT01262872|234667|P6|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98446|NCT01262872|234668|P5|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98447|NCT01262872|234669|P4|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98448|NCT01262872|234670|P3|STARTED|Step 1|The 2 first groups included subjects for Step 1 alone. The 6 other groups were part of Step 2 alone.|0
98449|NCT01262872|234671|P2|STARTED|Step 1||60
98450|NCT01262872|234672|P1|STARTED|Step 1||60
98451|NCT01262846|234927|P2|NOT COMPLETED|Overall Study||3
98452|NCT01262846|234928|P1|NOT COMPLETED|Overall Study||2
98453|NCT01262846|234927|P2|COMPLETED|Overall Study||97
98454|NCT01262846|234928|P1|COMPLETED|Overall Study||93
98455|NCT01262846|234927|P2|STARTED|Overall Study||100
98456|NCT01262846|234928|P1|STARTED|Overall Study||95
98457|NCT01262820|234934|P1|NOT COMPLETED|Overall Study||15
98458|NCT01262820|234934|P1|COMPLETED|Overall Study||0
98459|NCT01262820|234934|P1|STARTED|Overall Study||15
98460|NCT01262755|234941|P1|NOT COMPLETED|Overall Study||0
98461|NCT01262755|234941|P1|COMPLETED|Overall Study||450
98462|NCT01262755|234941|P1|STARTED|Overall Study||450
98463|NCT01262599|234947|P2|NOT COMPLETED|Overall Study||0
98464|NCT01262599|234948|P1|NOT COMPLETED|Overall Study||0
98465|NCT01262599|234947|P2|COMPLETED|Overall Study||16
98466|NCT01262599|234948|P1|COMPLETED|Overall Study||16
98467|NCT01262599|234947|P2|STARTED|Overall Study||16
98468|NCT01262599|234948|P1|STARTED|Overall Study||16
98469|NCT01262573|234956|P2|NOT COMPLETED|Overall Study||1
98470|NCT01262573|234957|P1|NOT COMPLETED|Overall Study||0
98471|NCT01262573|234956|P2|COMPLETED|Overall Study||31
98472|NCT01262573|234957|P1|COMPLETED|Overall Study||32
98473|NCT01262573|234956|P2|STARTED|Overall Study||32
98474|NCT01262573|234957|P1|STARTED|Overall Study||32
98484|NCT01262547|235005|P1|NOT COMPLETED|Overall Study||0
98485|NCT01262547|235005|P1|COMPLETED|Overall Study||3
98486|NCT01262547|235005|P1|STARTED|Overall Study||3
98487|NCT01262456|235019|P3|NOT COMPLETED|1-Month Open-Label Extension Period||5
98488|NCT01262456|235020|P2|NOT COMPLETED|1-Month Open-Label Extension Period||3
98489|NCT01262456|235021|P1|NOT COMPLETED|1-Month Open-Label Extension Period||4
98490|NCT01262456|235019|P3|COMPLETED|1-Month Open-Label Extension Period||98
98491|NCT01262456|235020|P2|COMPLETED|1-Month Open-Label Extension Period||97
98492|NCT01262456|235021|P1|COMPLETED|1-Month Open-Label Extension Period||120
98493|NCT01262456|235019|P3|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period|1 subject was randomized to Desmopressin 75 μg but received 50 μg. Also true in Double-Blind Period|102
98494|NCT01262456|235020|P2|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||101
98495|NCT01262456|235021|P1|Safety Analysis Set (SAS)|1-Month Open-Label Extension Period||124
98496|NCT01262456|235019|P3|STARTED|1-Month Open-Label Extension Period||103
98497|NCT01262456|235020|P2|STARTED|1-Month Open-Label Extension Period||100
98498|NCT01262456|235021|P1|STARTED|1-Month Open-Label Extension Period||124
98499|NCT01262456|235019|P3|NOT COMPLETED|3-Month Double-Blind Period||26
98500|NCT01262456|235020|P2|NOT COMPLETED|3-Month Double-Blind Period||23
98501|NCT01262456|235021|P1|NOT COMPLETED|3-Month Double-Blind Period||19
98502|NCT01262456|235019|P3|COMPLETED|3-Month Double-Blind Period||103
98503|NCT01262456|235020|P2|COMPLETED|3-Month Double-Blind Period||100
98504|NCT01262456|235021|P1|COMPLETED|3-Month Double-Blind Period||124
98505|NCT01262456|235019|P3|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|122
98506|NCT01262456|235020|P2|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|119
98507|NCT01262456|235021|P1|Safety Analysis Set (SAS)|3-Month Double-Blind Period|SAS: received at least 1 dose and had at least 1 safety assessment. Analysis on actual treatment.|143
98590|NCT01262027|235152|P1|NOT COMPLETED|Overall Study||5
98591|NCT01262027|235152|P1|COMPLETED|Overall Study||17
98508|NCT01262456|235019|P3|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|124
98509|NCT01262456|235020|P2|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|119
98510|NCT01262456|235021|P1|Full Analysis Set (FAS)|3-Month Double-Blind Period|FAS: ITT with at least 1 post-treatment efficacy assessment. Analysis as randomized.|142
98511|NCT01262456|235019|P3|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|129
98512|NCT01262456|235020|P2|STARTED|3-Month Double-Blind Period|ITT population: randomized participants regardless of exposure to treatment|123
98513|NCT01262456|235021|P1|STARTED|3-Month Double-Blind Period|Intent-to-Treat (ITT) population: randomized participants regardless of exposure to treatment|143
98514|NCT01262352|235064|P2|NOT COMPLETED|Period 2||0
98515|NCT01262352|235065|P1|NOT COMPLETED|Period 2||0
98516|NCT01262352|235064|P2|COMPLETED|Period 2||8
98517|NCT01262352|235065|P1|COMPLETED|Period 2||9
98518|NCT01262352|235064|P2|Dosed|Period 2||8
98519|NCT01262352|235065|P1|Dosed|Period 2||9
98520|NCT01262352|235064|P2|STARTED|Period 2||8
98521|NCT01262352|235065|P1|STARTED|Period 2||9
98522|NCT01262352|235064|P2|NOT COMPLETED|Washout||2
98523|NCT01262352|235065|P1|NOT COMPLETED|Washout||1
98524|NCT01262352|235064|P2|COMPLETED|Washout||8
98525|NCT01262352|235065|P1|COMPLETED|Washout||9
98526|NCT01262352|235064|P2|STARTED|Washout||10
98527|NCT01262352|235065|P1|STARTED|Washout||10
98528|NCT01262352|235064|P2|NOT COMPLETED|Period 1||0
98529|NCT01262352|235065|P1|NOT COMPLETED|Period 1||1
98530|NCT01262352|235064|P2|COMPLETED|Period 1||10
98531|NCT01262352|235065|P1|COMPLETED|Period 1||10
98532|NCT01262352|235064|P2|Dosed|Period 1||10
98533|NCT01262352|235065|P1|Dosed|Period 1||10
98534|NCT01262352|235064|P2|STARTED|Period 1||10
98535|NCT01262352|235065|P1|STARTED|Period 1||11
98536|NCT01262339|235077|P1|NOT COMPLETED|Overall Study||0
98537|NCT01262339|235077|P1|COMPLETED|Overall Study||2
98538|NCT01262339|235077|P1|STARTED|Overall Study||2
98539|NCT01262287|235083|P2|NOT COMPLETED|Overall Study||1
98540|NCT01262287|235084|P1|NOT COMPLETED|Overall Study||2
98541|NCT01262287|235083|P2|COMPLETED|Overall Study||18
98542|NCT01262287|235084|P1|COMPLETED|Overall Study||18
98543|NCT01262287|235083|P2|STARTED|Overall Study||19
98544|NCT01262287|235084|P1|STARTED|Overall Study||20
98545|NCT01262131|235097|P3|NOT COMPLETED|Overall Study||0
98546|NCT01262131|235098|P2|NOT COMPLETED|Overall Study||0
98547|NCT01262131|235099|P1|NOT COMPLETED|Overall Study||0
98548|NCT01262131|235097|P3|COMPLETED|Overall Study||4
98549|NCT01262131|235098|P2|COMPLETED|Overall Study||4
98550|NCT01262131|235099|P1|COMPLETED|Overall Study||5
98551|NCT01262131|235097|P3|STARTED|Overall Study||4
98552|NCT01262131|235098|P2|STARTED|Overall Study||4
98553|NCT01262131|235099|P1|STARTED|Overall Study||5
98554|NCT01262118|235109|P2|NOT COMPLETED|Treatment Period (6 Weeks)||0
98555|NCT01262118|235110|P1|NOT COMPLETED|Treatment Period (6 Weeks)||0
98556|NCT01262118|235109|P2|COMPLETED|Treatment Period (6 Weeks)||0
98557|NCT01262118|235110|P1|COMPLETED|Treatment Period (6 Weeks)||36
98558|NCT01262118|235109|P2|STARTED|Treatment Period (6 Weeks)||0
98559|NCT01262118|235110|P1|STARTED|Treatment Period (6 Weeks)||36
98560|NCT01262118|235109|P2|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
98561|NCT01262118|235110|P1|NOT COMPLETED|Baseline Assessment Period (3 Days)||0
98562|NCT01262118|235109|P2|COMPLETED|Baseline Assessment Period (3 Days)||33
98563|NCT01262118|235110|P1|COMPLETED|Baseline Assessment Period (3 Days)||36
98564|NCT01262118|235109|P2|STARTED|Baseline Assessment Period (3 Days)||33
98565|NCT01262118|235110|P1|STARTED|Baseline Assessment Period (3 Days)||36
98566|NCT01262105|235136|P2|NOT COMPLETED|Overall Study||0
98567|NCT01262105|235137|P1|NOT COMPLETED|Overall Study||0
98568|NCT01262105|235136|P2|COMPLETED|Overall Study||10
98569|NCT01262105|235137|P1|COMPLETED|Overall Study||13
98570|NCT01262105|235136|P2|STARTED|Overall Study||10
98571|NCT01262105|235137|P1|STARTED|Overall Study||13
98572|NCT01262092|235145|P2|NOT COMPLETED|Gabapentin Taper||0
98573|NCT01262092|235146|P1|NOT COMPLETED|Gabapentin Taper||1
98574|NCT01262092|235145|P2|COMPLETED|Gabapentin Taper||11
98575|NCT01262092|235146|P1|COMPLETED|Gabapentin Taper||9
98576|NCT01262092|235145|P2|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|11
98577|NCT01262092|235146|P1|STARTED|Gabapentin Taper|One participant dropped out after the buprenorphine taper but prior to the gabapentin taper|10
98578|NCT01262092|235145|P2|NOT COMPLETED|Buprenorphine Taper||1
98579|NCT01262092|235146|P1|NOT COMPLETED|Buprenorphine Taper||1
98580|NCT01262092|235145|P2|COMPLETED|Buprenorphine Taper||12
98581|NCT01262092|235146|P1|COMPLETED|Buprenorphine Taper||11
98582|NCT01262092|235145|P2|STARTED|Buprenorphine Taper||13
98660|NCT01260948|235435|P1|STARTED|Second Intervention||12
98583|NCT01262092|235146|P1|STARTED|Buprenorphine Taper|One left the study prior to starting the taper due to pharmacy error (started taper in wk 2)|12
98584|NCT01262092|235145|P2|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||1
98585|NCT01262092|235146|P1|NOT COMPLETED|Buprenorphine+Gabapentin/Plac Induction||3
98586|NCT01262092|235145|P2|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
98587|NCT01262092|235146|P1|COMPLETED|Buprenorphine+Gabapentin/Plac Induction||13
98588|NCT01262092|235145|P2|STARTED|Buprenorphine+Gabapentin/Plac Induction||14
98589|NCT01262092|235146|P1|STARTED|Buprenorphine+Gabapentin/Plac Induction||16
98592|NCT01262027|235152|P1|STARTED|Overall Study||22
98593|NCT01261975|235157|P1|NOT COMPLETED|Overall Study||1
98594|NCT01261975|235157|P1|COMPLETED|Overall Study|35 Participants 70 eyes completed|35
98595|NCT01261975|235157|P1|STARTED|Overall Study|36 Participants 72 eyes started|36
98596|NCT01261624|235178|P2|NOT COMPLETED|Week 13 to Week 24||1
98597|NCT01261624|235179|P1|NOT COMPLETED|Week 13 to Week 24||0
98598|NCT01261624|235178|P2|COMPLETED|Week 13 to Week 24||10
98599|NCT01261624|235179|P1|COMPLETED|Week 13 to Week 24||1
98600|NCT01261624|235178|P2|STARTED|Week 13 to Week 24|Of 6 pts of HDTC: 3 non-responders went out of study, 3 continued. 8 swithched from LDTC to HDTC|11
98601|NCT01261624|235179|P1|STARTED|Week 13 to Week 24|Of 9 pts from LDTC: 5 non-responders switched to HDTC; 4 pts responded, but 3 switched to HDTC|1
98602|NCT01261624|235178|P2|NOT COMPLETED|Week 0 to Week 12||3
98603|NCT01261624|235179|P1|NOT COMPLETED|Week 0 to Week 12||1
98604|NCT01261624|235178|P2|COMPLETED|Week 0 to Week 12||3
98605|NCT01261624|235179|P1|COMPLETED|Week 0 to Week 12||9
98606|NCT01261624|235178|P2|STARTED|Week 0 to Week 12||6
98607|NCT01261624|235179|P1|STARTED|Week 0 to Week 12||10
98608|NCT01261559|235198|P2|NOT COMPLETED|Overall Study||0
98609|NCT01261559|235199|P1|NOT COMPLETED|Overall Study||0
98610|NCT01261559|235198|P2|COMPLETED|Overall Study||36
98611|NCT01261559|235199|P1|COMPLETED|Overall Study||36
98612|NCT01261559|235198|P2|STARTED|Overall Study||36
98613|NCT01261559|235199|P1|STARTED|Overall Study||36
98614|NCT01261507|235207|P1|NOT COMPLETED|Overall Study||0
98615|NCT01261507|235207|P1|COMPLETED|Overall Study||15
98616|NCT01261507|235207|P1|STARTED|Overall Study||15
98617|NCT01261390|235220|P4|NOT COMPLETED|Overall Study||8
98618|NCT01261390|235221|P3|NOT COMPLETED|Overall Study||7
98619|NCT01261390|235222|P2|NOT COMPLETED|Overall Study||9
98620|NCT01261390|235223|P1|NOT COMPLETED|Overall Study||7
98621|NCT01261390|235220|P4|COMPLETED|Overall Study|14 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
98622|NCT01261390|235221|P3|COMPLETED|Overall Study|16 of the 35 participants that completed the study in this arm were under the 6-Month protocol.|35
98623|NCT01261390|235222|P2|COMPLETED|Overall Study|12 of the 33 participants that completed the study in this arm were under the 6-Month protocol.|33
98624|NCT01261390|235223|P1|COMPLETED|Overall Study|14 of the 37 participants that completed the study in this arm were under the 6-Month protocol.|37
98625|NCT01261390|235220|P4|12-Month Visit|Overall Study||19
98626|NCT01261390|235221|P3|12-Month Visit|Overall Study||19
98627|NCT01261390|235222|P2|12-Month Visit|Overall Study||21
98628|NCT01261390|235223|P1|12-Month Visit|Overall Study||23
98629|NCT01261390|235220|P4|6-Month Visit|Overall Study|For 14 of the 32 participants in this arm, this was their final visit.|32
98630|NCT01261390|235221|P3|6-Month Visit|Overall Study|For 16 of the 34 participants in this arm, this was their final visit.|34
98631|NCT01261390|235222|P2|6-Month Visit|Overall Study|For 12 of the 34 participants in this arm, this was their final visit.|34
98632|NCT01261390|235223|P1|6-Month Visit|Overall Study|For 14 of the 30 participants in this arm, this was their final visit.|37
98633|NCT01261390|235220|P4|STARTED|Overall Study|15 of the 41 participants only had to complete a 6-month follow-up assessment.|41
98634|NCT01261390|235221|P3|STARTED|Overall Study|16 of the 42 participants only had to complete a 6-month follow-up assessment.|42
98635|NCT01261390|235222|P2|STARTED|Overall Study|15 of the 42 participants only had to complete a 6-month follow-up assessment.|42
98636|NCT01261390|235223|P1|STARTED|Overall Study|15 of the 44 participants only had to complete a 6-month follow-up assessment.|44
98637|NCT01261325|235388|P3|NOT COMPLETED|Overall Study||26
98638|NCT01261325|235389|P2|NOT COMPLETED|Overall Study||29
98639|NCT01261325|235390|P1|NOT COMPLETED|Overall Study||17
98640|NCT01261325|235388|P3|COMPLETED|Overall Study||225
98641|NCT01261325|235389|P2|COMPLETED|Overall Study||225
98642|NCT01261325|235390|P1|COMPLETED|Overall Study||246
98643|NCT01261325|235388|P3|STARTED|Overall Study||251
98644|NCT01261325|235389|P2|STARTED|Overall Study||254
98645|NCT01261325|235390|P1|STARTED|Overall Study||263
98646|NCT01261052|235422|P1|NOT COMPLETED|APD Only Intervention (33 Hours)||0
98647|NCT01261052|235422|P1|COMPLETED|APD Only Intervention (33 Hours)||14
98648|NCT01261052|235422|P1|STARTED|APD Only Intervention (33 Hours)||14
98649|NCT01261052|235422|P1|NOT COMPLETED|FMPD/APD Intervention (33 Hours)||0
98650|NCT01261052|235422|P1|COMPLETED|FMPD/APD Intervention (33 Hours)||14
98651|NCT01261052|235422|P1|STARTED|FMPD/APD Intervention (33 Hours)||14
98652|NCT01261000|235428|P1|NOT COMPLETED|Overall Study||1
98653|NCT01261000|235428|P1|COMPLETED|Overall Study||7
98654|NCT01261000|235428|P1|STARTED|Overall Study||8
98655|NCT01260948|235434|P2|NOT COMPLETED|Second Intervention||1
98656|NCT01260948|235435|P1|NOT COMPLETED|Second Intervention||0
98657|NCT01260948|235434|P2|COMPLETED|Second Intervention||9
98658|NCT01260948|235435|P1|COMPLETED|Second Intervention||12
98659|NCT01260948|235434|P2|STARTED|Second Intervention||10
98661|NCT01260948|235434|P2|NOT COMPLETED|Washout of 28 Days||3
98662|NCT01260948|235435|P1|NOT COMPLETED|Washout of 28 Days||1
98663|NCT01260948|235434|P2|COMPLETED|Washout of 28 Days||10
98664|NCT01260948|235435|P1|COMPLETED|Washout of 28 Days||12
98665|NCT01260948|235434|P2|STARTED|Washout of 28 Days||13
98666|NCT01260948|235435|P1|STARTED|Washout of 28 Days||13
98667|NCT01260948|235434|P2|NOT COMPLETED|First Intervention||0
98668|NCT01260948|235435|P1|NOT COMPLETED|First Intervention||0
98669|NCT01260948|235434|P2|COMPLETED|First Intervention||13
98670|NCT01260948|235435|P1|COMPLETED|First Intervention||13
98671|NCT01260948|235434|P2|STARTED|First Intervention||13
98672|NCT01260948|235435|P1|STARTED|First Intervention||13
98673|NCT01260922|235445|P2|NOT COMPLETED|Second Intervention||2
98674|NCT01260922|235446|P1|NOT COMPLETED|Second Intervention||0
98675|NCT01260922|235445|P2|COMPLETED|Second Intervention||8
98676|NCT01260922|235446|P1|COMPLETED|Second Intervention||9
98677|NCT01260922|235445|P2|STARTED|Second Intervention||10
98678|NCT01260922|235446|P1|STARTED|Second Intervention||9
98679|NCT01260922|235445|P2|NOT COMPLETED|Washout of 28 Days||2
98680|NCT01260922|235446|P1|NOT COMPLETED|Washout of 28 Days||4
98681|NCT01260922|235445|P2|COMPLETED|Washout of 28 Days||10
98682|NCT01260922|235446|P1|COMPLETED|Washout of 28 Days||9
98683|NCT01260922|235445|P2|STARTED|Washout of 28 Days||12
98684|NCT01260922|235446|P1|STARTED|Washout of 28 Days||13
98685|NCT01260922|235445|P2|NOT COMPLETED|First Intervention||1
98686|NCT01260922|235446|P1|NOT COMPLETED|First Intervention||0
98687|NCT01260922|235445|P2|COMPLETED|First Intervention||12
98688|NCT01260922|235446|P1|COMPLETED|First Intervention||13
98689|NCT01260922|235445|P2|STARTED|First Intervention||13
98690|NCT01260922|235446|P1|STARTED|First Intervention||13
98691|NCT01260896|235456|P2|NOT COMPLETED|Second Intervention||0
98692|NCT01260896|235457|P1|NOT COMPLETED|Second Intervention||0
98693|NCT01260896|235456|P2|COMPLETED|Second Intervention||12
98694|NCT01260896|235457|P1|COMPLETED|Second Intervention||10
98695|NCT01260896|235456|P2|STARTED|Second Intervention||12
98696|NCT01260896|235457|P1|STARTED|Second Intervention||10
98697|NCT01260896|235456|P2|NOT COMPLETED|Washout of 7 Days||0
98698|NCT01260896|235457|P1|NOT COMPLETED|Washout of 7 Days||0
98699|NCT01260896|235456|P2|COMPLETED|Washout of 7 Days||12
98700|NCT01260896|235457|P1|COMPLETED|Washout of 7 Days||10
98701|NCT01260896|235456|P2|STARTED|Washout of 7 Days||12
98702|NCT01260896|235457|P1|STARTED|Washout of 7 Days||10
98703|NCT01260896|235456|P2|NOT COMPLETED|First Intervention||0
98704|NCT01260896|235457|P1|NOT COMPLETED|First Intervention||2
98705|NCT01260896|235456|P2|COMPLETED|First Intervention||12
98706|NCT01260896|235457|P1|COMPLETED|First Intervention||10
98707|NCT01260896|235456|P2|STARTED|First Intervention||12
98708|NCT01260896|235457|P1|STARTED|First Intervention||12
98709|NCT01260883|235476|P3|NOT COMPLETED|Overall Study||0
98710|NCT01260883|235477|P2|NOT COMPLETED|Overall Study||0
98711|NCT01260883|235478|P1|NOT COMPLETED|Overall Study||0
98712|NCT01260883|235476|P3|COMPLETED|Overall Study||18
98713|NCT01260883|235477|P2|COMPLETED|Overall Study||11
98714|NCT01260883|235478|P1|COMPLETED|Overall Study||22
98715|NCT01260883|235476|P3|STARTED|Overall Study||18
98716|NCT01260883|235477|P2|STARTED|Overall Study||11
98717|NCT01260883|235478|P1|STARTED|Overall Study||22
98718|NCT01260701|235515|P1|NOT COMPLETED|Overall Study||75
98719|NCT01260701|235515|P1|COMPLETED|Overall Study||0
98720|NCT01260701|235515|P1|Eligible and Began Protocol Therapy|Overall Study||70
98721|NCT01260701|235515|P1|Eligible|Overall Study||71
98722|NCT01260701|235515|P1|STARTED|Overall Study||75
98723|NCT01260688|235524|P2|NOT COMPLETED|Overall Study||0
98724|NCT01260688|235525|P1|NOT COMPLETED|Overall Study||0
98725|NCT01260688|235524|P2|COMPLETED|Overall Study||11
98726|NCT01260688|235525|P1|COMPLETED|Overall Study||11
98727|NCT01260688|235524|P2|STARTED|Overall Study||11
98728|NCT01260688|235525|P1|STARTED|Overall Study||11
98729|NCT01260662|235534|P3|NOT COMPLETED|Overall Study||0
98730|NCT01260662|235535|P2|NOT COMPLETED|Overall Study||0
98731|NCT01260662|235536|P1|NOT COMPLETED|Overall Study||0
98732|NCT01260662|235534|P3|COMPLETED|Overall Study||96
98733|NCT01260662|235535|P2|COMPLETED|Overall Study||85
98734|NCT01260662|235536|P1|COMPLETED|Overall Study||90
98735|NCT01260662|235534|P3|STARTED|Overall Study||96
98736|NCT01260662|235535|P2|STARTED|Overall Study||85
98737|NCT01260662|235536|P1|STARTED|Overall Study||90
98738|NCT01260649|235555|P2|NOT COMPLETED|Overall Study||1
98739|NCT01260649|235556|P1|NOT COMPLETED|Overall Study||2
98740|NCT01260649|235555|P2|COMPLETED|Overall Study||8
98741|NCT01260649|235556|P1|COMPLETED|Overall Study||6
98742|NCT01260649|235555|P2|STARTED|Overall Study||9
98743|NCT01260649|235556|P1|STARTED|Overall Study||8
98744|NCT01260584|235568|P4|NOT COMPLETED|Period 2||1
98745|NCT01260584|235569|P3|NOT COMPLETED|Period 2||5
98746|NCT01260584|235570|P2|NOT COMPLETED|Period 2||3
98747|NCT01260584|235571|P1|NOT COMPLETED|Period 2||1
98748|NCT01260584|235568|P4|COMPLETED|Period 2||26
98749|NCT01260584|235569|P3|COMPLETED|Period 2||20
98750|NCT01260584|235570|P2|COMPLETED|Period 2||25
98751|NCT01260584|235571|P1|COMPLETED|Period 2||26
98752|NCT01260584|235568|P4|STARTED|Period 2||27
98753|NCT01260584|235569|P3|STARTED|Period 2||25
98754|NCT01260584|235570|P2|STARTED|Period 2||28
98755|NCT01260584|235571|P1|STARTED|Period 2||27
98756|NCT01260584|235568|P4|NOT COMPLETED|Period 1||1
98757|NCT01260584|235569|P3|NOT COMPLETED|Period 1||2
98758|NCT01260584|235570|P2|NOT COMPLETED|Period 1||0
98759|NCT01260584|235571|P1|NOT COMPLETED|Period 1||0
98760|NCT01260584|235568|P4|COMPLETED|Period 1||27
98761|NCT01260584|235569|P3|COMPLETED|Period 1||25
98762|NCT01260584|235570|P2|COMPLETED|Period 1||28
98763|NCT01260584|235571|P1|COMPLETED|Period 1||27
98764|NCT01260584|235568|P4|STARTED|Period 1||28
98765|NCT01260584|235569|P3|STARTED|Period 1||27
98766|NCT01260584|235570|P2|STARTED|Period 1||28
98767|NCT01260584|235571|P1|STARTED|Period 1||27
98768|NCT01260493|235607|P2|NOT COMPLETED|Overall Study||4
98769|NCT01260493|235608|P1|NOT COMPLETED|Overall Study||16
98770|NCT01260493|235607|P2|COMPLETED|Overall Study||85
98771|NCT01260493|235608|P1|COMPLETED|Overall Study||76
98772|NCT01260493|235607|P2|STARTED|Overall Study||89
98773|NCT01260493|235608|P1|STARTED|Overall Study||92
98774|NCT01260467|235614|P1|NOT COMPLETED|Overall Study||2
98775|NCT01260467|235614|P1|COMPLETED|Overall Study||2
98776|NCT01260467|235614|P1|STARTED|Overall Study||4
98777|NCT01260454|235620|P1|NOT COMPLETED|Overall Study||0
98778|NCT01260454|235620|P1|COMPLETED|Overall Study||6
98779|NCT01260454|235620|P1|STARTED|Overall Study||6
98780|NCT01260350|235646|P22|NOT COMPLETED|Overall Study||0
98781|NCT01260350|235647|P21|NOT COMPLETED|Overall Study||3
98782|NCT01260350|235648|P20|NOT COMPLETED|Overall Study||0
98783|NCT01260350|235649|P19|NOT COMPLETED|Overall Study||0
98784|NCT01260350|235650|P18|NOT COMPLETED|Overall Study||1
98785|NCT01260350|235651|P17|NOT COMPLETED|Overall Study||0
98786|NCT01260350|235652|P16|NOT COMPLETED|Overall Study||0
98787|NCT01260350|235653|P15|NOT COMPLETED|Overall Study||0
98788|NCT01260350|235654|P14|NOT COMPLETED|Overall Study||0
98789|NCT01260350|235655|P13|NOT COMPLETED|Overall Study||0
98790|NCT01260350|235656|P12|NOT COMPLETED|Overall Study||0
98791|NCT01260350|235657|P11|NOT COMPLETED|Overall Study||0
98792|NCT01260350|235658|P10|NOT COMPLETED|Overall Study||0
98793|NCT01260350|235659|P9|NOT COMPLETED|Overall Study||1
98794|NCT01260350|235660|P8|NOT COMPLETED|Overall Study||0
98795|NCT01260350|235661|P7|NOT COMPLETED|Overall Study||0
98796|NCT01260350|235662|P6|NOT COMPLETED|Overall Study||0
98797|NCT01260350|235663|P5|NOT COMPLETED|Overall Study||0
98798|NCT01260350|235664|P4|NOT COMPLETED|Overall Study||0
98799|NCT01260350|235665|P3|NOT COMPLETED|Overall Study||0
98800|NCT01260350|235666|P2|NOT COMPLETED|Overall Study||0
98801|NCT01260350|235667|P1|NOT COMPLETED|Overall Study||0
98802|NCT01260350|235646|P22|COMPLETED|Overall Study||0
98803|NCT01260350|235647|P21|COMPLETED|Overall Study||22
98804|NCT01260350|235648|P20|COMPLETED|Overall Study||14
98805|NCT01260350|235649|P19|COMPLETED|Overall Study||0
98806|NCT01260350|235650|P18|COMPLETED|Overall Study||9
98807|NCT01260350|235651|P17|COMPLETED|Overall Study||9
98808|NCT01260350|235652|P16|COMPLETED|Overall Study||10
98809|NCT01260350|235653|P15|COMPLETED|Overall Study||25
98810|NCT01260350|235654|P14|COMPLETED|Overall Study||10
98811|NCT01260350|235655|P13|COMPLETED|Overall Study||25
98812|NCT01260350|235656|P12|COMPLETED|Overall Study||9
98813|NCT01260350|235657|P11|COMPLETED|Overall Study||10
98814|NCT01260350|235658|P10|COMPLETED|Overall Study||25
98815|NCT01260350|235659|P9|COMPLETED|Overall Study||24
98816|NCT01260350|235660|P8|COMPLETED|Overall Study||25
98817|NCT01260350|235661|P7|COMPLETED|Overall Study||10
98818|NCT01260350|235662|P6|COMPLETED|Overall Study||10
98819|NCT01260350|235663|P5|COMPLETED|Overall Study||10
98820|NCT01260350|235664|P4|COMPLETED|Overall Study||11
98821|NCT01260350|235665|P3|COMPLETED|Overall Study||10
98822|NCT01260350|235666|P2|COMPLETED|Overall Study||9
98823|NCT01260350|235667|P1|COMPLETED|Overall Study||10
98824|NCT01260350|235646|P22|STARTED|Overall Study||0
98825|NCT01260350|235647|P21|STARTED|Overall Study||25
98826|NCT01260350|235648|P20|STARTED|Overall Study||14
98827|NCT01260350|235649|P19|STARTED|Overall Study||0
98828|NCT01260350|235650|P18|STARTED|Overall Study||10
98829|NCT01260350|235651|P17|STARTED|Overall Study||9
98830|NCT01260350|235652|P16|STARTED|Overall Study||10
98831|NCT01260350|235653|P15|STARTED|Overall Study||25
98832|NCT01260350|235654|P14|STARTED|Overall Study||10
98833|NCT01260350|235655|P13|STARTED|Overall Study||25
98834|NCT01260350|235656|P12|STARTED|Overall Study||9
98835|NCT01260350|235657|P11|STARTED|Overall Study||10
98836|NCT01260350|235658|P10|STARTED|Overall Study||25
98837|NCT01260350|235659|P9|STARTED|Overall Study||25
98838|NCT01260350|235660|P8|STARTED|Overall Study||25
98839|NCT01260350|235661|P7|STARTED|Overall Study||10
98840|NCT01260350|235662|P6|STARTED|Overall Study||10
98841|NCT01260350|235663|P5|STARTED|Overall Study||10
98842|NCT01260350|235664|P4|STARTED|Overall Study||11
98843|NCT01260350|235665|P3|STARTED|Overall Study||10
98844|NCT01260350|235666|P2|STARTED|Overall Study||9
98845|NCT01260350|235667|P1|STARTED|Overall Study||10
98846|NCT01260324|235859|P2|NOT COMPLETED|Overall Study||0
98847|NCT01260324|235860|P1|NOT COMPLETED|Overall Study||0
98848|NCT01260324|235859|P2|COMPLETED|Overall Study||20000
98849|NCT01260324|235860|P1|COMPLETED|Overall Study||1283
98850|NCT01260324|235859|P2|STARTED|Overall Study||20000
98851|NCT01260324|235860|P1|STARTED|Overall Study||1283
98852|NCT01260311|235874|P1|NOT COMPLETED|Overall Study||127
98853|NCT01260311|235874|P1|COMPLETED|Overall Study||381
98854|NCT01260311|235874|P1|STARTED|Overall Study||508
98855|NCT01260272|235884|P2|NOT COMPLETED|Overall Study||2
98856|NCT01260272|235885|P1|NOT COMPLETED|Overall Study||2
98857|NCT01260272|235884|P2|COMPLETED|Overall Study||30
98858|NCT01260272|235885|P1|COMPLETED|Overall Study||15
98859|NCT01260272|235884|P2|STARTED|Overall Study||32
98860|NCT01260272|235885|P1|STARTED|Overall Study||17
98861|NCT01260194|235905|P1|NOT COMPLETED|Overall Study||1
98862|NCT01260194|235905|P1|COMPLETED|Overall Study||3
98863|NCT01260194|235905|P1|STARTED|Overall Study||4
98864|NCT01260142|235923|P6|NOT COMPLETED|Treatment Period 2||0
98865|NCT01260142|235924|P5|NOT COMPLETED|Treatment Period 2||0
98866|NCT01260142|235925|P4|NOT COMPLETED|Treatment Period 2||0
98867|NCT01260142|235926|P3|NOT COMPLETED|Treatment Period 2||0
98868|NCT01260142|235927|P2|NOT COMPLETED|Treatment Period 2||0
98869|NCT01260142|235928|P1|NOT COMPLETED|Treatment Period 2||0
98870|NCT01260142|235923|P6|COMPLETED|Treatment Period 2||3
98871|NCT01260142|235924|P5|COMPLETED|Treatment Period 2||4
98872|NCT01260142|235925|P4|COMPLETED|Treatment Period 2||6
98873|NCT01260142|235926|P3|COMPLETED|Treatment Period 2||6
98874|NCT01260142|235927|P2|COMPLETED|Treatment Period 2||5
98875|NCT01260142|235928|P1|COMPLETED|Treatment Period 2||5
98876|NCT01260142|235923|P6|STARTED|Treatment Period 2||3
98877|NCT01260142|235924|P5|STARTED|Treatment Period 2||4
98878|NCT01260142|235925|P4|STARTED|Treatment Period 2||6
98879|NCT01260142|235926|P3|STARTED|Treatment Period 2||6
98880|NCT01260142|235927|P2|STARTED|Treatment Period 2||5
98881|NCT01260142|235928|P1|STARTED|Treatment Period 2||5
98882|NCT01260142|235923|P6|NOT COMPLETED|Treatment Period 1||3
98883|NCT01260142|235924|P5|NOT COMPLETED|Treatment Period 1||2
98884|NCT01260142|235925|P4|NOT COMPLETED|Treatment Period 1||0
98885|NCT01260142|235926|P3|NOT COMPLETED|Treatment Period 1||0
98886|NCT01260142|235927|P2|NOT COMPLETED|Treatment Period 1||1
98887|NCT01260142|235928|P1|NOT COMPLETED|Treatment Period 1||1
98888|NCT01260142|235923|P6|COMPLETED|Treatment Period 1||3
98889|NCT01260142|235924|P5|COMPLETED|Treatment Period 1||4
98890|NCT01260142|235925|P4|COMPLETED|Treatment Period 1||6
98891|NCT01260142|235926|P3|COMPLETED|Treatment Period 1||6
98892|NCT01260142|235927|P2|COMPLETED|Treatment Period 1||5
98893|NCT01260142|235928|P1|COMPLETED|Treatment Period 1||5
98894|NCT01260142|235923|P6|STARTED|Treatment Period 1||6
98895|NCT01260142|235924|P5|STARTED|Treatment Period 1||6
98896|NCT01260142|235925|P4|STARTED|Treatment Period 1||6
98897|NCT01260142|235926|P3|STARTED|Treatment Period 1||6
98898|NCT01260142|235927|P2|STARTED|Treatment Period 1||6
98899|NCT01260142|235928|P1|STARTED|Treatment Period 1||6
98900|NCT01259726|235982|P4|NOT COMPLETED|Overall Study||5
98901|NCT01259726|235983|P3|NOT COMPLETED|Overall Study||4
98902|NCT01259726|235984|P2|NOT COMPLETED|Overall Study||4
98903|NCT01259726|235985|P1|NOT COMPLETED|Overall Study||5
98904|NCT01259726|235982|P4|COMPLETED|Overall Study||36
98905|NCT01259726|235983|P3|COMPLETED|Overall Study||39
98906|NCT01259726|235984|P2|COMPLETED|Overall Study||37
98907|NCT01259726|235985|P1|COMPLETED|Overall Study||38
98908|NCT01259726|235982|P4|Treated|Overall Study||39
98909|NCT01259726|235983|P3|Treated|Overall Study||41
98910|NCT01259726|235984|P2|Treated|Overall Study||37
98911|NCT01259726|235985|P1|Treated|Overall Study||40
98912|NCT01259726|235982|P4|STARTED|Overall Study||41
98913|NCT01259726|235983|P3|STARTED|Overall Study||43
98914|NCT01259726|235984|P2|STARTED|Overall Study||41
98915|NCT01259726|235985|P1|STARTED|Overall Study||43
98916|NCT01259713|236017|P2|NOT COMPLETED|Overall Study||41
98917|NCT01259713|236018|P1|NOT COMPLETED|Overall Study||95
98918|NCT01259713|236017|P2|COMPLETED|Overall Study||77
98919|NCT01259713|236018|P1|COMPLETED|Overall Study||142
98920|NCT01259713|236017|P2|STARTED|Overall Study||118
98921|NCT01259713|236018|P1|STARTED|Overall Study||237
98922|NCT01259492|236044|P4|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||81
98923|NCT01259492|236045|P3|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||50
98924|NCT01259492|236046|P2|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||69
98925|NCT01259492|236047|P1|NOT COMPLETED|Period 3 (Week 15 to End of Week 40)||54
98926|NCT01259492|236044|P4|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|42
98927|NCT01259492|236045|P3|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|70
98928|NCT01259492|236046|P2|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|63
98929|NCT01259492|236047|P1|COMPLETED|Period 3 (Week 15 to End of Week 40)|completed study|60
98930|NCT01259492|236044|P4|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||115
98931|NCT01259492|236045|P3|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||114
98932|NCT01259492|236046|P2|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||128
98933|NCT01259492|236047|P1|Full Analysis Set|Period 3 (Week 15 to End of Week 40)||110
98934|NCT01259492|236044|P4|STARTED|Period 3 (Week 15 to End of Week 40)||123
98935|NCT01259492|236045|P3|STARTED|Period 3 (Week 15 to End of Week 40)||120
98936|NCT01259492|236046|P2|STARTED|Period 3 (Week 15 to End of Week 40)||132
98937|NCT01259492|236047|P1|STARTED|Period 3 (Week 15 to End of Week 40)|In period 3, all 489 patients who completed period 2 were re-randomized to 4 arms.|114
98938|NCT01259492|236044|P4|NOT COMPLETED|Period 2 (Week 10 to Week 14)||28
98939|NCT01259492|236045|P3|NOT COMPLETED|Period 2 (Week 10 to Week 14)||24
98940|NCT01259492|236046|P2|NOT COMPLETED|Period 2 (Week 10 to Week 14)||18
98941|NCT01259492|236047|P1|NOT COMPLETED|Period 2 (Week 10 to Week 14)||25
98942|NCT01259492|236044|P4|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|125
98943|NCT01259492|236045|P3|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|114
98944|NCT01259492|236046|P2|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|123
98945|NCT01259492|236047|P1|COMPLETED|Period 2 (Week 10 to Week 14)|Completed = entered Period 3|127
98946|NCT01259492|236044|P4|STARTED|Period 2 (Week 10 to Week 14)||153
98947|NCT01259492|236045|P3|STARTED|Period 2 (Week 10 to Week 14)||138
98948|NCT01259492|236046|P2|STARTED|Period 2 (Week 10 to Week 14)||141
98949|NCT01259492|236047|P1|STARTED|Period 2 (Week 10 to Week 14)|Treatment arms including Placebo indicate patients belong to respective treatment arms in Period 1|152
98950|NCT01259492|236044|P4|NOT COMPLETED|Period 1 (9 Weeks)||28
98951|NCT01259492|236045|P3|NOT COMPLETED|Period 1 (9 Weeks)||43
98952|NCT01259492|236046|P2|NOT COMPLETED|Period 1 (9 Weeks)||41
98953|NCT01259492|236047|P1|NOT COMPLETED|Period 1 (9 Weeks)||29
98954|NCT01259492|236044|P4|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|153
98955|NCT01259492|236045|P3|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|138
98956|NCT01259492|236046|P2|COMPLETED|Period 1 (9 Weeks)|Completed = entered Period 2|141
98957|NCT01259492|236047|P1|COMPLETED|Period 1 (9 Weeks)|"Completed indicates patients entered Period 2."|152
98958|NCT01259492|236044|P4|Full Analysis Set|Period 1 (9 Weeks)||172
98959|NCT01259492|236045|P3|Full Analysis Set|Period 1 (9 Weeks)||179
98960|NCT01259492|236046|P2|Full Analysis Set|Period 1 (9 Weeks)||175
98961|NCT01259492|236047|P1|Full Analysis Set|Period 1 (9 Weeks)||174
98962|NCT01259492|236044|P4|STARTED|Period 1 (9 Weeks)||181
98963|NCT01259492|236045|P3|STARTED|Period 1 (9 Weeks)||181
98964|NCT01259492|236046|P2|STARTED|Period 1 (9 Weeks)||182
98965|NCT01259492|236047|P1|STARTED|Period 1 (9 Weeks)||181
98966|NCT01259466|236096|P2|NOT COMPLETED|Overall Study||9
98967|NCT01259466|236097|P1|NOT COMPLETED|Overall Study||1
98968|NCT01259466|236096|P2|COMPLETED|Overall Study||18
98969|NCT01259466|236097|P1|COMPLETED|Overall Study||26
98970|NCT01259466|236096|P2|STARTED|Overall Study||27
98971|NCT01259466|236097|P1|STARTED|Overall Study||27
98972|NCT01259440|236107|P2|NOT COMPLETED|Overall Study||0
98973|NCT01259440|236108|P1|NOT COMPLETED|Overall Study||0
98974|NCT01259440|236107|P2|COMPLETED|Overall Study||10
98975|NCT01259440|236108|P1|COMPLETED|Overall Study||13
98976|NCT01259440|236107|P2|STARTED|Overall Study||10
98977|NCT01259440|236108|P1|STARTED|Overall Study||13
98978|NCT01259427|236116|P2|NOT COMPLETED|Overall Study||14
98979|NCT01259427|236117|P1|NOT COMPLETED|Overall Study||18
98980|NCT01259427|236116|P2|COMPLETED|Overall Study||110
98981|NCT01259427|236117|P1|COMPLETED|Overall Study||106
98982|NCT01259427|236116|P2|STARTED|Overall Study||124
98983|NCT01259427|236117|P1|STARTED|Overall Study||124
98984|NCT01259401|236135|P2|NOT COMPLETED|4-month Follow-up||2
98985|NCT01259401|236136|P1|NOT COMPLETED|4-month Follow-up||0
98986|NCT01259401|236135|P2|COMPLETED|4-month Follow-up||19
98987|NCT01259401|236136|P1|COMPLETED|4-month Follow-up||21
98988|NCT01259401|236135|P2|STARTED|4-month Follow-up||21
98989|NCT01259401|236136|P1|STARTED|4-month Follow-up||21
98990|NCT01259401|236135|P2|NOT COMPLETED|End of 4-week Intervention||0
98991|NCT01259401|236136|P1|NOT COMPLETED|End of 4-week Intervention||0
98992|NCT01259401|236135|P2|COMPLETED|End of 4-week Intervention||21
98993|NCT01259401|236136|P1|COMPLETED|End of 4-week Intervention||21
98994|NCT01259401|236135|P2|STARTED|End of 4-week Intervention||21
98995|NCT01259401|236136|P1|STARTED|End of 4-week Intervention||21
98996|NCT01259375|236144|P1|NOT COMPLETED|Overall Study||1
98997|NCT01259375|236144|P1|COMPLETED|Overall Study||23
98998|NCT01259375|236144|P1|STARTED|Overall Study||24
98999|NCT01259297|236161|P8|NOT COMPLETED|Double Blind Randomized Period||3
99000|NCT01259297|236162|P7|NOT COMPLETED|Double Blind Randomized Period||6
99001|NCT01259297|236163|P6|NOT COMPLETED|Double Blind Randomized Period||8
99002|NCT01259297|236164|P5|NOT COMPLETED|Double Blind Randomized Period||4
99003|NCT01259297|236165|P4|NOT COMPLETED|Double Blind Randomized Period||4
99004|NCT01259297|236166|P3|NOT COMPLETED|Double Blind Randomized Period||1
99005|NCT01259297|236167|P2|NOT COMPLETED|Double Blind Randomized Period||3
99006|NCT01259297|236168|P1|NOT COMPLETED|Double Blind Randomized Period||2
99007|NCT01259297|236161|P8|COMPLETED|Double Blind Randomized Period||196
99008|NCT01259297|236162|P7|COMPLETED|Double Blind Randomized Period||190
99009|NCT01259297|236163|P6|COMPLETED|Double Blind Randomized Period||245
99010|NCT01259297|236164|P5|COMPLETED|Double Blind Randomized Period||247
99011|NCT01259297|236165|P4|COMPLETED|Double Blind Randomized Period||191
99012|NCT01259297|236166|P3|COMPLETED|Double Blind Randomized Period||188
99013|NCT01259297|236167|P2|COMPLETED|Double Blind Randomized Period||229
99014|NCT01259297|236168|P1|COMPLETED|Double Blind Randomized Period||242
99015|NCT01259297|236161|P8|STARTED|Double Blind Randomized Period||199
99016|NCT01259297|236162|P7|STARTED|Double Blind Randomized Period||196
99017|NCT01259297|236163|P6|STARTED|Double Blind Randomized Period||253
99018|NCT01259297|236164|P5|STARTED|Double Blind Randomized Period||251
99019|NCT01259297|236165|P4|STARTED|Double Blind Randomized Period||195
99020|NCT01259297|236166|P3|STARTED|Double Blind Randomized Period||189
99021|NCT01259297|236167|P2|STARTED|Double Blind Randomized Period||232
99022|NCT01259297|236168|P1|STARTED|Double Blind Randomized Period||244
99023|NCT01259297|236161|P8|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99024|NCT01259297|236162|P7|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99025|NCT01259297|236163|P6|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99026|NCT01259297|236164|P5|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99027|NCT01259297|236165|P4|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99028|NCT01259297|236166|P3|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||222
99029|NCT01259297|236167|P2|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99030|NCT01259297|236168|P1|NOT COMPLETED|Run-in Open Label Period (4-5 Weeks)||355
99031|NCT01259297|236161|P8|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99032|NCT01259297|236162|P7|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99033|NCT01259297|236163|P6|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99034|NCT01259297|236164|P5|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99035|NCT01259297|236165|P4|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99036|NCT01259297|236166|P3|COMPLETED|Run-in Open Label Period (4-5 Weeks)||779
99037|NCT01259297|236167|P2|COMPLETED|Run-in Open Label Period (4-5 Weeks)||0
99038|NCT01259297|236168|P1|COMPLETED|Run-in Open Label Period (4-5 Weeks)||980
99039|NCT01259297|236161|P8|STARTED|Run-in Open Label Period (4-5 Weeks)||0
99040|NCT01259297|236162|P7|STARTED|Run-in Open Label Period (4-5 Weeks)||0
99041|NCT01259297|236163|P6|STARTED|Run-in Open Label Period (4-5 Weeks)||0
99042|NCT01259297|236164|P5|STARTED|Run-in Open Label Period (4-5 Weeks)||0
99043|NCT01259297|236165|P4|STARTED|Run-in Open Label Period (4-5 Weeks)||0
99044|NCT01259297|236166|P3|STARTED|Run-in Open Label Period (4-5 Weeks)||1001
99045|NCT01259297|236167|P2|STARTED|Run-in Open Label Period (4-5 Weeks)||0
99046|NCT01259297|236168|P1|STARTED|Run-in Open Label Period (4-5 Weeks)||1335
99047|NCT01259284|236199|P3|NOT COMPLETED|Overall Study||0
99048|NCT01259284|236200|P2|NOT COMPLETED|Overall Study||0
99049|NCT01259284|236201|P1|NOT COMPLETED|Overall Study||2
99050|NCT01259284|236199|P3|COMPLETED|Overall Study||0
99051|NCT01259284|236200|P2|COMPLETED|Overall Study||0
99052|NCT01259284|236201|P1|COMPLETED|Overall Study||0
99053|NCT01259284|236199|P3|STARTED|Overall Study||0
99054|NCT01259284|236200|P2|STARTED|Overall Study||0
99055|NCT01259284|236201|P1|STARTED|Overall Study||2
99056|NCT01259245|236211|P2|NOT COMPLETED|Overall Study||26
99057|NCT01259245|236212|P1|NOT COMPLETED|Overall Study||28
99058|NCT01259245|236211|P2|COMPLETED|Overall Study|24 discontinued intervention and 2 deceased|68
99059|NCT01259245|236212|P1|COMPLETED|Overall Study|27 were lost to follow-up and 1 deceased|70
99060|NCT01259245|236211|P2|STARTED|Overall Study||94
99061|NCT01259245|236212|P1|STARTED|Overall Study||98
99062|NCT01256983|236238|P2|NOT COMPLETED|Overall Study||3
99063|NCT01256983|236239|P1|NOT COMPLETED|Overall Study||1
99064|NCT01256983|236238|P2|COMPLETED|Overall Study||12
99065|NCT01256983|236239|P1|COMPLETED|Overall Study||14
99066|NCT01256983|236238|P2|STARTED|Overall Study||15
99067|NCT01256983|236239|P1|STARTED|Overall Study||15
99068|NCT01256944|236247|P2|NOT COMPLETED|Overall Study||0
99069|NCT01256944|236248|P1|NOT COMPLETED|Overall Study||0
99070|NCT01256944|236247|P2|COMPLETED|Overall Study||220
99071|NCT01256944|236248|P1|COMPLETED|Overall Study||70
99072|NCT01256944|236247|P2|STARTED|Overall Study||220
99073|NCT01256944|236248|P1|STARTED|Overall Study||70
99074|NCT01256918|236276|P1|NOT COMPLETED|Overall Study||0
99075|NCT01256918|236276|P1|COMPLETED|Overall Study||200
99076|NCT01256918|236276|P1|Full Thickness Nuclear Crack Achieved|Overall Study||200
99077|NCT01256918|236276|P1|STARTED|Overall Study||200
99078|NCT01259115|236287|P2|NOT COMPLETED|Period 2||0
99079|NCT01259115|236288|P1|NOT COMPLETED|Period 2||1
99080|NCT01259115|236287|P2|COMPLETED|Period 2||9
99081|NCT01259115|236288|P1|COMPLETED|Period 2||6
99082|NCT01259115|236287|P2|STARTED|Period 2||9
99083|NCT01259115|236288|P1|STARTED|Period 2||7
99084|NCT01259115|236287|P2|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
99085|NCT01259115|236288|P1|NOT COMPLETED|Period: Washout Period of 4 to 18 Days||0
99086|NCT01259115|236287|P2|COMPLETED|Period: Washout Period of 4 to 18 Days||9
99087|NCT01259115|236288|P1|COMPLETED|Period: Washout Period of 4 to 18 Days||7
99088|NCT01259115|236287|P2|STARTED|Period: Washout Period of 4 to 18 Days||9
99089|NCT01259115|236288|P1|STARTED|Period: Washout Period of 4 to 18 Days||7
99090|NCT01259115|236287|P2|NOT COMPLETED|Period 1||1
99091|NCT01259115|236288|P1|NOT COMPLETED|Period 1||3
99092|NCT01259115|236287|P2|COMPLETED|Period 1||9
99093|NCT01259115|236288|P1|COMPLETED|Period 1||7
99094|NCT01259115|236287|P2|STARTED|Period 1||10
99095|NCT01259115|236288|P1|STARTED|Period 1||10
99096|NCT01259102|236324|P5|NOT COMPLETED|Overall Study||1
99097|NCT01259102|236325|P4|NOT COMPLETED|Overall Study||2
99098|NCT01259102|236326|P3|NOT COMPLETED|Overall Study||2
99099|NCT01259102|236327|P2|NOT COMPLETED|Overall Study||0
99100|NCT01259102|236328|P1|NOT COMPLETED|Overall Study||1
99101|NCT01259102|236324|P5|COMPLETED|Overall Study||13
99102|NCT01259102|236325|P4|COMPLETED|Overall Study||12
99103|NCT01259102|236326|P3|COMPLETED|Overall Study||13
99104|NCT01259102|236327|P2|COMPLETED|Overall Study||14
99105|NCT01259102|236328|P1|COMPLETED|Overall Study||12
99106|NCT01259102|236324|P5|STARTED|Overall Study||14
99107|NCT01259102|236325|P4|STARTED|Overall Study||14
99108|NCT01259102|236326|P3|STARTED|Overall Study||15
99109|NCT01259102|236327|P2|STARTED|Overall Study||14
99110|NCT01259102|236328|P1|STARTED|Overall Study||13
99111|NCT01259024|236385|P1|NOT COMPLETED|Overall Study||1
99112|NCT01259024|236385|P1|COMPLETED|Overall Study||0
99113|NCT01259024|236385|P1|STARTED|Overall Study||1
99114|NCT01258998|236389|P1|NOT COMPLETED|Overall Study||1
99115|NCT01258998|236389|P1|COMPLETED|Overall Study||59
99116|NCT01258998|236389|P1|STARTED|Overall Study||60
99117|NCT01258985|236395|P2|NOT COMPLETED|Overall Study||0
99118|NCT01258985|236396|P1|NOT COMPLETED|Overall Study||0
99119|NCT01258985|236395|P2|COMPLETED|Overall Study||98
99120|NCT01258985|236396|P1|COMPLETED|Overall Study||106
99121|NCT01258985|236395|P2|STARTED|Overall Study||98
99122|NCT01258985|236396|P1|STARTED|Overall Study||106
99123|NCT01258803|236422|P6|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
99124|NCT01258803|236423|P5|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
99125|NCT01258803|236424|P4|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
99126|NCT01258803|236425|P3|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
99127|NCT01258803|236426|P2|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
99128|NCT01258803|236427|P1|NOT COMPLETED|Treatment Period 4 (1 Dose)||0
99129|NCT01258803|236422|P6|COMPLETED|Treatment Period 4 (1 Dose)||15
99130|NCT01258803|236423|P5|COMPLETED|Treatment Period 4 (1 Dose)||15
99131|NCT01258803|236424|P4|COMPLETED|Treatment Period 4 (1 Dose)||15
99132|NCT01258803|236425|P3|COMPLETED|Treatment Period 4 (1 Dose)||14
99133|NCT01258803|236426|P2|COMPLETED|Treatment Period 4 (1 Dose)||14
99134|NCT01258803|236427|P1|COMPLETED|Treatment Period 4 (1 Dose)||14
99135|NCT01258803|236422|P6|STARTED|Treatment Period 4 (1 Dose)||15
99136|NCT01258803|236423|P5|STARTED|Treatment Period 4 (1 Dose)||15
99137|NCT01258803|236424|P4|STARTED|Treatment Period 4 (1 Dose)||15
99138|NCT01258803|236425|P3|STARTED|Treatment Period 4 (1 Dose)||14
99139|NCT01258803|236426|P2|STARTED|Treatment Period 4 (1 Dose)||14
99140|NCT01258803|236427|P1|STARTED|Treatment Period 4 (1 Dose)||14
99141|NCT01258803|236422|P6|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
99142|NCT01258803|236423|P5|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
99143|NCT01258803|236424|P4|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
99144|NCT01258803|236425|P3|NOT COMPLETED|Treatment Period 3 (1 Dose)||1
99145|NCT01258803|236426|P2|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
99146|NCT01258803|236427|P1|NOT COMPLETED|Treatment Period 3 (1 Dose)||0
99147|NCT01258803|236422|P6|COMPLETED|Treatment Period 3 (1 Dose)||15
99148|NCT01258803|236423|P5|COMPLETED|Treatment Period 3 (1 Dose)||15
99149|NCT01258803|236424|P4|COMPLETED|Treatment Period 3 (1 Dose)||15
99150|NCT01258803|236425|P3|COMPLETED|Treatment Period 3 (1 Dose)||14
99151|NCT01258803|236426|P2|COMPLETED|Treatment Period 3 (1 Dose)||14
99152|NCT01258803|236427|P1|COMPLETED|Treatment Period 3 (1 Dose)||14
99153|NCT01258803|236422|P6|STARTED|Treatment Period 3 (1 Dose)||15
99154|NCT01258803|236423|P5|STARTED|Treatment Period 3 (1 Dose)||15
99155|NCT01258803|236424|P4|STARTED|Treatment Period 3 (1 Dose)||15
99156|NCT01258803|236425|P3|STARTED|Treatment Period 3 (1 Dose)||15
99157|NCT01258803|236426|P2|STARTED|Treatment Period 3 (1 Dose)||14
99158|NCT01258803|236427|P1|STARTED|Treatment Period 3 (1 Dose)||14
99159|NCT01258803|236422|P6|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
99160|NCT01258803|236423|P5|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
99161|NCT01258803|236424|P4|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
99162|NCT01258803|236425|P3|NOT COMPLETED|Treatment Period 2 (1 Dose)||0
99163|NCT01258803|236426|P2|NOT COMPLETED|Treatment Period 2 (1 Dose)||2
99164|NCT01258803|236427|P1|NOT COMPLETED|Treatment Period 2 (1 Dose)||1
99165|NCT01258803|236422|P6|COMPLETED|Treatment Period 2 (1 Dose)||15
99166|NCT01258803|236423|P5|COMPLETED|Treatment Period 2 (1 Dose)||15
99167|NCT01258803|236424|P4|COMPLETED|Treatment Period 2 (1 Dose)||15
99168|NCT01258803|236425|P3|COMPLETED|Treatment Period 2 (1 Dose)||15
99169|NCT01258803|236426|P2|COMPLETED|Treatment Period 2 (1 Dose)||14
99170|NCT01258803|236427|P1|COMPLETED|Treatment Period 2 (1 Dose)||14
99171|NCT01258803|236422|P6|STARTED|Treatment Period 2 (1 Dose)||16
99172|NCT01258803|236423|P5|STARTED|Treatment Period 2 (1 Dose)||15
99173|NCT01258803|236424|P4|STARTED|Treatment Period 2 (1 Dose)||15
99174|NCT01258803|236425|P3|STARTED|Treatment Period 2 (1 Dose)||15
99175|NCT01258803|236426|P2|STARTED|Treatment Period 2 (1 Dose)||16
99176|NCT01258803|236427|P1|STARTED|Treatment Period 2 (1 Dose)||15
99177|NCT01258803|236422|P6|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
99178|NCT01258803|236423|P5|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
99179|NCT01258803|236424|P4|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
99180|NCT01258803|236425|P3|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
99181|NCT01258803|236426|P2|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
99182|NCT01258803|236427|P1|NOT COMPLETED|Treatment Period 1 (1 Dose)||0
99183|NCT01258803|236422|P6|COMPLETED|Treatment Period 1 (1 Dose)||16
99184|NCT01258803|236423|P5|COMPLETED|Treatment Period 1 (1 Dose)||15
99185|NCT01258803|236424|P4|COMPLETED|Treatment Period 1 (1 Dose)||15
99186|NCT01258803|236425|P3|COMPLETED|Treatment Period 1 (1 Dose)||15
99187|NCT01258803|236426|P2|COMPLETED|Treatment Period 1 (1 Dose)||16
99188|NCT01258803|236427|P1|COMPLETED|Treatment Period 1 (1 Dose)||15
99189|NCT01258803|236422|P6|STARTED|Treatment Period 1 (1 Dose)||16
99190|NCT01258803|236423|P5|STARTED|Treatment Period 1 (1 Dose)||15
99191|NCT01258803|236424|P4|STARTED|Treatment Period 1 (1 Dose)||15
99192|NCT01258803|236425|P3|STARTED|Treatment Period 1 (1 Dose)||15
99193|NCT01258803|236426|P2|STARTED|Treatment Period 1 (1 Dose)||16
99194|NCT01258803|236427|P1|STARTED|Treatment Period 1 (1 Dose)||15
99195|NCT01258790|236455|P2|NOT COMPLETED|Overall Study||0
99196|NCT01258790|236456|P1|NOT COMPLETED|Overall Study||0
99197|NCT01258790|236455|P2|COMPLETED|Overall Study||6
99198|NCT01258790|236456|P1|COMPLETED|Overall Study||6
99199|NCT01258790|236455|P2|STARTED|Overall Study||6
99200|NCT01258790|236456|P1|STARTED|Overall Study||6
99201|NCT01258738|236464|P2|NOT COMPLETED|Open-label Period||21
99202|NCT01258738|236465|P1|NOT COMPLETED|Open-label Period||17
99203|NCT01258738|236464|P2|COMPLETED|Open-label Period||85
99204|NCT01258738|236465|P1|COMPLETED|Open-label Period||85
99205|NCT01258738|236464|P2|STARTED|Open-label Period||106
99206|NCT01258738|236465|P1|STARTED|Open-label Period||102
99207|NCT01258738|236464|P2|NOT COMPLETED|Double-blind Period||7
99208|NCT01258738|236465|P1|NOT COMPLETED|Double-blind Period||9
99209|NCT01258738|236464|P2|COMPLETED|Double-blind Period|Only 106 participants entered the open label period.|107
99210|NCT01258738|236465|P1|COMPLETED|Double-blind Period||102
99211|NCT01258738|236464|P2|Treated|Double-blind Period||113
99212|NCT01258738|236465|P1|Treated|Double-blind Period||111
99213|NCT01258738|236464|P2|STARTED|Double-blind Period||114
99214|NCT01258738|236465|P1|STARTED|Double-blind Period||111
99215|NCT01258660|236603|P2|NOT COMPLETED|Overall Study||11
99216|NCT01258660|236604|P1|NOT COMPLETED|Overall Study||11
99217|NCT01258660|236603|P2|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
99218|NCT01258660|236604|P1|COMPLETED|Overall Study|completed and valid for primary analysis data set|75
99219|NCT01258660|236603|P2|Completed Treatment|Overall Study||81
99220|NCT01258660|236604|P1|Completed Treatment|Overall Study||79
99221|NCT01258660|236603|P2|Received Treatment|Overall Study||82
99222|NCT01258660|236604|P1|Received Treatment|Overall Study||79
99223|NCT01258660|236603|P2|STARTED|Overall Study|randomized and received at least one dose of treatment|86
99224|NCT01258660|236604|P1|STARTED|Overall Study|randomized and received at least one dose of treatment|86
99225|NCT01258595|236623|P2|NOT COMPLETED|Overall Study||1
99226|NCT01258595|236624|P1|NOT COMPLETED|Overall Study||1
99227|NCT01258595|236623|P2|COMPLETED|Overall Study||151
99228|NCT01258595|236624|P1|COMPLETED|Overall Study||147
99229|NCT01258595|236623|P2|STARTED|Overall Study||152
99230|NCT01258595|236624|P1|STARTED|Overall Study||148
99231|NCT01258582|236640|P2|NOT COMPLETED|Overall Study||258
99232|NCT01258582|236641|P1|NOT COMPLETED|Overall Study||282
99233|NCT01258582|236640|P2|COMPLETED|Overall Study||563
99234|NCT01258582|236641|P1|COMPLETED|Overall Study||548
99235|NCT01258582|236640|P2|STARTED|Overall Study||821
99236|NCT01258582|236641|P1|STARTED|Overall Study||830
99237|NCT01258504|236647|P1|NOT COMPLETED|Bosentan and SJW||0
99238|NCT01258504|236647|P1|COMPLETED|Bosentan and SJW||13
99239|NCT01258504|236647|P1|STARTED|Bosentan and SJW||13
99240|NCT01258504|236647|P1|NOT COMPLETED|Bosentan Steady-state||0
99241|NCT01258504|236647|P1|COMPLETED|Bosentan Steady-state||13
99242|NCT01258504|236647|P1|STARTED|Bosentan Steady-state||13
99243|NCT01258504|236647|P1|NOT COMPLETED|Bosentan Single Dose||0
99244|NCT01258504|236647|P1|COMPLETED|Bosentan Single Dose||13
99245|NCT01258504|236647|P1|STARTED|Bosentan Single Dose||13
99246|NCT01256684|236661|P3|NOT COMPLETED|Overall Study||11
99247|NCT01256684|236662|P2|NOT COMPLETED|Overall Study||13
99248|NCT01256684|236663|P1|NOT COMPLETED|Overall Study||9
99249|NCT01256684|236661|P3|COMPLETED|Overall Study||76
99250|NCT01256684|236662|P2|COMPLETED|Overall Study||74
99251|NCT01256684|236663|P1|COMPLETED|Overall Study||72
99252|NCT01256684|236661|P3|ITT Population|Overall Study||81
99253|NCT01256684|236662|P2|ITT Population|Overall Study||79
99254|NCT01256684|236663|P1|ITT Population|Overall Study||77
99255|NCT01256684|236661|P3|Safety Population|Overall Study||87
99256|NCT01256684|236662|P2|Safety Population|Overall Study||86
99257|NCT01256684|236663|P1|Safety Population|Overall Study||80
99258|NCT01256684|236661|P3|STARTED|Overall Study||87
99259|NCT01256684|236662|P2|STARTED|Overall Study||87
99260|NCT01256684|236663|P1|STARTED|Overall Study||81
99261|NCT01256658|236697|P2|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||6372
99262|NCT01256658|236698|P1|NOT COMPLETED|Period 2 - Follow up Only - No Treatment||5854
99263|NCT01256658|236697|P2|COMPLETED|Period 2 - Follow up Only - No Treatment||0
99264|NCT01256658|236698|P1|COMPLETED|Period 2 - Follow up Only - No Treatment||0
99265|NCT01256658|236697|P2|Study Termination|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6287
99266|NCT01256658|236698|P1|Study Termination|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5777
99267|NCT01256658|236697|P2|Death|Period 2 - Follow up Only - No Treatment||8
99268|NCT01256658|236698|P1|Death|Period 2 - Follow up Only - No Treatment||6
99269|NCT01256658|236697|P2|Lost to Follow up|Period 2 - Follow up Only - No Treatment||77
99270|NCT01256658|236698|P1|Lost to Follow up|Period 2 - Follow up Only - No Treatment||71
99271|NCT01256658|236697|P2|STARTED|Period 2 - Follow up Only - No Treatment|138 participants who completed period 1 did not enroll to continue on period 2|6372
99272|NCT01256658|236698|P1|STARTED|Period 2 - Follow up Only - No Treatment|43 participants who completed period 1 did not enroll to continue on period 2|5854
99273|NCT01256658|236697|P2|NOT COMPLETED|Period 1||748
99274|NCT01256658|236698|P1|NOT COMPLETED|Period 1||920
99275|NCT01256658|236697|P2|COMPLETED|Period 1||6510
99276|NCT01256658|236698|P1|COMPLETED|Period 1||5897
99277|NCT01256658|236697|P2|STARTED|Period 1||7258
99278|NCT01256658|236698|P1|STARTED|Period 1||6817
99279|NCT01256567|236748|P1|NOT COMPLETED|Overall Study||1
99280|NCT01256567|236748|P1|COMPLETED|Overall Study||6
99281|NCT01256567|236748|P1|Received at Least 1 Dose of Study Drug|Overall Study||7
99282|NCT01256567|236748|P1|STARTED|Overall Study||7
99283|NCT01256502|236758|P1|NOT COMPLETED|Overall Study||10
99284|NCT01256502|236758|P1|COMPLETED|Overall Study||129
99285|NCT01256502|236758|P1|STARTED|Overall Study|Implanted with SERI during Stage I breast reconstruction surgery|139
99286|NCT01256476|236770|P2|NOT COMPLETED|Overall Study||7
99287|NCT01256476|236771|P1|NOT COMPLETED|Overall Study||6
99288|NCT01256476|236770|P2|COMPLETED|Overall Study||157
99289|NCT01256476|236771|P1|COMPLETED|Overall Study||158
99290|NCT01256476|236770|P2|STARTED|Overall Study||164
99291|NCT01256476|236771|P1|STARTED|Overall Study||164
99292|NCT01256450|236779|P3|NOT COMPLETED|Double-blind Treatment||37
99293|NCT01256450|236780|P2|NOT COMPLETED|Double-blind Treatment||28
99294|NCT01256450|236781|P1|NOT COMPLETED|Double-blind Treatment||0
99295|NCT01256450|236779|P3|COMPLETED|Double-blind Treatment||81
99296|NCT01256450|236780|P2|COMPLETED|Double-blind Treatment||89
99297|NCT01256450|236781|P1|COMPLETED|Double-blind Treatment||0
99298|NCT01256450|236779|P3|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|118
99299|NCT01256450|236780|P2|STARTED|Double-blind Treatment|Subjects were randomized to DB treatment after completing OL titration in the previous period.|117
99300|NCT01256450|236781|P1|STARTED|Double-blind Treatment|All subjects completing OL titration in the previous period were randomized to a DB treatment.|0
99301|NCT01256450|236779|P3|NOT COMPLETED|Open-label Titration||0
99302|NCT01256450|236780|P2|NOT COMPLETED|Open-label Titration||0
99303|NCT01256450|236781|P1|NOT COMPLETED|Open-label Titration||99
99304|NCT01256450|236779|P3|COMPLETED|Open-label Titration||0
99305|NCT01256450|236780|P2|COMPLETED|Open-label Titration||0
99306|NCT01256450|236781|P1|COMPLETED|Open-label Titration||235
99307|NCT01256450|236779|P3|STARTED|Open-label Titration||0
99308|NCT01256450|236780|P2|STARTED|Open-label Titration||0
99309|NCT01256450|236781|P1|STARTED|Open-label Titration||334
99310|NCT01258387|236814|P7|NOT COMPLETED|Overall Study||0
99311|NCT01258387|236815|P6|NOT COMPLETED|Overall Study||0
99312|NCT01258387|236816|P5|NOT COMPLETED|Overall Study||0
99313|NCT01258387|236817|P4|NOT COMPLETED|Overall Study||0
99314|NCT01258387|236818|P3|NOT COMPLETED|Overall Study||0
99315|NCT01258387|236819|P2|NOT COMPLETED|Overall Study||0
99316|NCT01258387|236820|P1|NOT COMPLETED|Overall Study||0
99317|NCT01258387|236814|P7|COMPLETED|Overall Study||4
99318|NCT01258387|236815|P6|COMPLETED|Overall Study||6
99319|NCT01258387|236816|P5|COMPLETED|Overall Study||6
99320|NCT01258387|236817|P4|COMPLETED|Overall Study||6
99321|NCT01258387|236818|P3|COMPLETED|Overall Study||6
99322|NCT01258387|236819|P2|COMPLETED|Overall Study||6
99323|NCT01258387|236820|P1|COMPLETED|Overall Study||6
99324|NCT01258387|236814|P7|Patients Randomized to Placebo|Overall Study||1
99325|NCT01258387|236815|P6|Patients Randomized to Placebo|Overall Study||2
99326|NCT01258387|236816|P5|Patients Randomized to Placebo|Overall Study||2
99327|NCT01258387|236817|P4|Patients Randomized to Placebo|Overall Study||2
99328|NCT01258387|236818|P3|Patients Randomized to Placebo|Overall Study||2
99329|NCT01258387|236819|P2|Patients Randomized to Placebo|Overall Study||2
99330|NCT01258387|236820|P1|Patients Randomized to Placebo|Overall Study||2
99331|NCT01258387|236814|P7|Patients Randomized to GGF2|Overall Study||3
99332|NCT01258387|236815|P6|Patients Randomized to GGF2|Overall Study||4
99333|NCT01258387|236816|P5|Patients Randomized to GGF2|Overall Study||4
99334|NCT01258387|236817|P4|Patients Randomized to GGF2|Overall Study||4
99335|NCT01258387|236818|P3|Patients Randomized to GGF2|Overall Study||4
99336|NCT01258387|236819|P2|Patients Randomized to GGF2|Overall Study||4
99337|NCT01258387|236820|P1|Patients Randomized to GGF2|Overall Study||4
99338|NCT01258387|236814|P7|STARTED|Overall Study||4
99339|NCT01258387|236815|P6|STARTED|Overall Study||6
99340|NCT01258387|236816|P5|STARTED|Overall Study||6
99341|NCT01258387|236817|P4|STARTED|Overall Study||6
99342|NCT01258387|236818|P3|STARTED|Overall Study||6
99343|NCT01258387|236819|P2|STARTED|Overall Study||6
99344|NCT01258387|236820|P1|STARTED|Overall Study||6
99345|NCT01258153|236865|P3|NOT COMPLETED|Overall Study||1
99346|NCT01258153|236866|P2|NOT COMPLETED|Overall Study||1
99347|NCT01258153|236867|P1|NOT COMPLETED|Overall Study||1
99348|NCT01258153|236865|P3|COMPLETED|Overall Study||36
99349|NCT01258153|236866|P2|COMPLETED|Overall Study||37
99350|NCT01258153|236867|P1|COMPLETED|Overall Study||39
99351|NCT01258153|236865|P3|STARTED|Overall Study||37
99352|NCT01258153|236866|P2|STARTED|Overall Study||38
99353|NCT01258153|236867|P1|STARTED|Overall Study||40
99354|NCT01258101|236894|P4|NOT COMPLETED|Overall Study||25
99355|NCT01258101|236895|P3|NOT COMPLETED|Overall Study||11
99356|NCT01258101|236896|P2|NOT COMPLETED|Overall Study||34
99357|NCT01258101|236897|P1|NOT COMPLETED|Overall Study||33
99358|NCT01258101|236894|P4|COMPLETED|Overall Study||27
99359|NCT01258101|236895|P3|COMPLETED|Overall Study||22
99360|NCT01258101|236896|P2|COMPLETED|Overall Study||110
99361|NCT01258101|236897|P1|COMPLETED|Overall Study||118
99362|NCT01258101|236894|P4|Standard Analysis Population|Overall Study||26
99363|NCT01258101|236895|P3|Standard Analysis Population|Overall Study||21
99364|NCT01258101|236896|P2|Standard Analysis Population|Overall Study||110
99365|NCT01258101|236897|P1|Standard Analysis Population|Overall Study||115
99366|NCT01258101|236894|P4|Safety Analysis Population|Overall Study||48
99367|NCT01258101|236895|P3|Safety Analysis Population|Overall Study||30
99368|NCT01258101|236896|P2|Safety Analysis Population|Overall Study||141
99369|NCT01258101|236897|P1|Safety Analysis Population|Overall Study||144
99370|NCT01258101|236894|P4|STARTED|Overall Study||52
99371|NCT01258101|236895|P3|STARTED|Overall Study||33
99372|NCT01258101|236896|P2|STARTED|Overall Study||144
99373|NCT01258101|236897|P1|STARTED|Overall Study||151
99374|NCT01258049|236949|P2|NOT COMPLETED|Overall Study||2
99375|NCT01258049|236950|P1|NOT COMPLETED|Overall Study||2
99376|NCT01258049|236949|P2|COMPLETED|Overall Study||72
99377|NCT01258049|236950|P1|COMPLETED|Overall Study||75
99378|NCT01258049|236949|P2|STARTED|Overall Study||74
99379|NCT01258049|236950|P1|STARTED|Overall Study||77
99380|NCT01257880|236988|P2|NOT COMPLETED|Overall Study||0
99381|NCT01257880|236989|P1|NOT COMPLETED|Overall Study||0
99382|NCT01257880|236988|P2|COMPLETED|Overall Study||19
99383|NCT01257880|236989|P1|COMPLETED|Overall Study||12
99384|NCT01257880|236988|P2|STARTED|Overall Study||19
99385|NCT01257880|236989|P1|STARTED|Overall Study||12
99386|NCT01257802|236999|P2|NOT COMPLETED|Overall Study||6
99387|NCT01257802|237000|P1|NOT COMPLETED|Overall Study||1
99388|NCT01257802|236999|P2|COMPLETED|Overall Study||2
99389|NCT01257802|237000|P1|COMPLETED|Overall Study||5
99390|NCT01257802|236999|P2|6 Month / 24 Week Visit|Overall Study||2
99391|NCT01257802|237000|P1|6 Month / 24 Week Visit|Overall Study||5
99392|NCT01257802|236999|P2|STARTED|Overall Study||8
99393|NCT01257802|237000|P1|STARTED|Overall Study||6
99394|NCT01257750|237014|P1|NOT COMPLETED|Overall Study||0
99395|NCT01257750|237014|P1|COMPLETED|Overall Study||20
99396|NCT01257750|237014|P1|STARTED|Overall Study||20
99397|NCT01257581|237022|P3|NOT COMPLETED|Overall Study||6
99398|NCT01257581|237023|P2|NOT COMPLETED|Overall Study||3
99399|NCT01257581|237024|P1|NOT COMPLETED|Overall Study||5
99400|NCT01257581|237022|P3|COMPLETED|Overall Study||11
99401|NCT01257581|237023|P2|COMPLETED|Overall Study||18
99402|NCT01257581|237024|P1|COMPLETED|Overall Study||17
99403|NCT01257581|237022|P3|STARTED|Overall Study||17
99404|NCT01257581|237023|P2|STARTED|Overall Study||21
99405|NCT01257581|237024|P1|STARTED|Overall Study||22
99406|NCT01257542|237064|P2|NOT COMPLETED|Overall Study||7
99407|NCT01257542|237065|P1|NOT COMPLETED|Overall Study||3
99408|NCT01257542|237064|P2|COMPLETED|Overall Study||45
99409|NCT01257542|237065|P1|COMPLETED|Overall Study||52
99410|NCT01257542|237064|P2|STARTED|Overall Study||52
99411|NCT01257542|237065|P1|STARTED|Overall Study||55
99412|NCT01257503|237085|P2|NOT COMPLETED|Overall Study||11
99413|NCT01257503|237086|P1|NOT COMPLETED|Overall Study||8
99414|NCT01257503|237085|P2|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|119
99415|NCT01257503|237086|P1|COMPLETED|Overall Study|Completed defined as participants who completed telephone follow-up at end of study period|125
99416|NCT01257503|237085|P2|Returned Dosage Logbooks|Overall Study||80
99417|NCT01257503|237086|P1|Returned Dosage Logbooks|Overall Study||75
99418|NCT01257503|237085|P2|Returned Symptom Diaries|Overall Study||83
99419|NCT01257503|237086|P1|Returned Symptom Diaries|Overall Study||80
99420|NCT01257503|237085|P2|STARTED|Overall Study||130
99421|NCT01257503|237086|P1|STARTED|Overall Study||133
99422|NCT01257438|237102|P2|NOT COMPLETED|Overall Study||46
99423|NCT01257438|237103|P1|NOT COMPLETED|Overall Study||30
99424|NCT01257438|237102|P2|COMPLETED|Overall Study||97
99425|NCT01257438|237103|P1|COMPLETED|Overall Study||102
99426|NCT01257438|237102|P2|STARTED|Overall Study||143
99427|NCT01257438|237103|P1|STARTED|Overall Study||132
99428|NCT01257425|237115|P2|NOT COMPLETED|Overall Study||6
99429|NCT01257425|237116|P1|NOT COMPLETED|Overall Study||6
99430|NCT01257425|237115|P2|COMPLETED|Overall Study||45
99431|NCT01257425|237116|P1|COMPLETED|Overall Study||46
99432|NCT01257425|237115|P2|STARTED|Overall Study||51
99433|NCT01257425|237116|P1|STARTED|Overall Study||52
99434|NCT01257347|237138|P4|NOT COMPLETED|Overall Study||0
99435|NCT01257347|237139|P3|NOT COMPLETED|Overall Study||0
99436|NCT01257347|237140|P2|NOT COMPLETED|Overall Study||0
99437|NCT01257347|237141|P1|NOT COMPLETED|Overall Study||0
99438|NCT01257347|237138|P4|COMPLETED|Overall Study||65
99439|NCT01257347|237139|P3|COMPLETED|Overall Study||35
99440|NCT01257347|237140|P2|COMPLETED|Overall Study||12
99441|NCT01257347|237141|P1|COMPLETED|Overall Study||12
99442|NCT01257347|237138|P4|STARTED|Overall Study||65
99443|NCT01257347|237139|P3|STARTED|Overall Study||35
99444|NCT01257347|237140|P2|STARTED|Overall Study|Median patients per provider = 4; range 1-13 (65 patients)|12
99445|NCT01257347|237141|P1|STARTED|Overall Study|Median patients per provider = 3; range 1-10 (35 patients)|12
99446|NCT01257230|237158|P3|NOT COMPLETED|Overall Study||6
99447|NCT01257230|237159|P2|NOT COMPLETED|Overall Study||10
99448|NCT01257230|237160|P1|NOT COMPLETED|Overall Study||6
99449|NCT01257230|237158|P3|COMPLETED|Overall Study||129
99450|NCT01257230|237159|P2|COMPLETED|Overall Study||115
99451|NCT01257230|237160|P1|COMPLETED|Overall Study||132
99452|NCT01257230|237158|P3|STARTED|Overall Study||135
99453|NCT01257230|237159|P2|STARTED|Overall Study||125
99454|NCT01257230|237160|P1|STARTED|Overall Study||138
99455|NCT01257217|237215|P2|NOT COMPLETED|Overall Study||0
99456|NCT01257217|237216|P1|NOT COMPLETED|Overall Study||2
99457|NCT01257217|237215|P2|COMPLETED|Overall Study||10
99458|NCT01257217|237216|P1|COMPLETED|Overall Study||13
99459|NCT01257217|237215|P2|STARTED|Overall Study||10
99460|NCT01257217|237216|P1|STARTED|Overall Study||15
99461|NCT01257204|237237|P3|NOT COMPLETED|Follow-up Period (up to Week 48)||10
99462|NCT01257204|237238|P2|NOT COMPLETED|Follow-up Period (up to Week 48)||6
99463|NCT01257204|237239|P1|NOT COMPLETED|Follow-up Period (up to Week 48)||1
99464|NCT01257204|237237|P3|COMPLETED|Follow-up Period (up to Week 48)||39
99465|NCT01257204|237238|P2|COMPLETED|Follow-up Period (up to Week 48)||41
99466|NCT01257204|237239|P1|COMPLETED|Follow-up Period (up to Week 48)||48
99467|NCT01257204|237237|P3|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
99468|NCT01257204|237238|P2|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|47
99469|NCT01257204|237239|P1|STARTED|Follow-up Period (up to Week 48)|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment.|49
99470|NCT01257204|237237|P3|NOT COMPLETED|Treatment Period (up to Week 24)||9
99471|NCT01257204|237238|P2|NOT COMPLETED|Treatment Period (up to Week 24)||6
99472|NCT01257204|237239|P1|NOT COMPLETED|Treatment Period (up to Week 24)||5
99473|NCT01257204|237237|P3|COMPLETED|Treatment Period (up to Week 24)||42
99474|NCT01257204|237238|P2|COMPLETED|Treatment Period (up to Week 24)||44
99475|NCT01257204|237239|P1|COMPLETED|Treatment Period (up to Week 24)||45
99476|NCT01257204|237237|P3|STARTED|Treatment Period (up to Week 24)||51
99477|NCT01257204|237238|P2|STARTED|Treatment Period (up to Week 24)||50
99478|NCT01257204|237239|P1|STARTED|Treatment Period (up to Week 24)||50
99479|NCT01256424|237287|P4|NOT COMPLETED|Overall Study||7
99480|NCT01256424|237288|P3|NOT COMPLETED|Overall Study||7
99481|NCT01256424|237289|P2|NOT COMPLETED|Overall Study||8
99482|NCT01256424|237290|P1|NOT COMPLETED|Overall Study||9
99483|NCT01256424|237287|P4|COMPLETED|Overall Study||61
99484|NCT01256424|237288|P3|COMPLETED|Overall Study||55
99485|NCT01256424|237289|P2|COMPLETED|Overall Study||59
99486|NCT01256424|237290|P1|COMPLETED|Overall Study||56
99487|NCT01256424|237287|P4|STARTED|Overall Study||68
99488|NCT01256424|237288|P3|STARTED|Overall Study||62
99489|NCT01256424|237289|P2|STARTED|Overall Study||67
99490|NCT01256424|237290|P1|STARTED|Overall Study||65
99491|NCT01256411|237316|P6|NOT COMPLETED|Extension by Mono or Combination Therapy||4
99492|NCT01256411|237317|P5|NOT COMPLETED|Extension by Mono or Combination Therapy||17
99493|NCT01256411|237318|P4|NOT COMPLETED|Extension by Mono or Combination Therapy||0
99494|NCT01256411|237319|P3|NOT COMPLETED|Extension by Mono or Combination Therapy||0
99495|NCT01256411|237320|P2|NOT COMPLETED|Extension by Mono or Combination Therapy||0
99496|NCT01256411|237321|P1|NOT COMPLETED|Extension by Mono or Combination Therapy||0
99497|NCT01256411|237316|P6|COMPLETED|Extension by Mono or Combination Therapy||109
99498|NCT01256411|237317|P5|COMPLETED|Extension by Mono or Combination Therapy||211
99499|NCT01256411|237318|P4|COMPLETED|Extension by Mono or Combination Therapy||0
99500|NCT01256411|237319|P3|COMPLETED|Extension by Mono or Combination Therapy||0
99501|NCT01256411|237320|P2|COMPLETED|Extension by Mono or Combination Therapy||0
99502|NCT01256411|237321|P1|COMPLETED|Extension by Mono or Combination Therapy||0
99503|NCT01256411|237316|P6|STARTED|Extension by Mono or Combination Therapy||113
99504|NCT01256411|237317|P5|STARTED|Extension by Mono or Combination Therapy||228
99505|NCT01256411|237318|P4|STARTED|Extension by Mono or Combination Therapy||0
99506|NCT01256411|237319|P3|STARTED|Extension by Mono or Combination Therapy||0
99507|NCT01256411|237320|P2|STARTED|Extension by Mono or Combination Therapy||0
99508|NCT01256411|237321|P1|STARTED|Extension by Mono or Combination Therapy||0
99509|NCT01256411|237316|P6|NOT COMPLETED|Extension by Maximum Treatment||0
99510|NCT01256411|237317|P5|NOT COMPLETED|Extension by Maximum Treatment||0
99511|NCT01256411|237318|P4|NOT COMPLETED|Extension by Maximum Treatment||0
99512|NCT01256411|237319|P3|NOT COMPLETED|Extension by Maximum Treatment||4
99513|NCT01256411|237320|P2|NOT COMPLETED|Extension by Maximum Treatment||10
99514|NCT01256411|237321|P1|NOT COMPLETED|Extension by Maximum Treatment||7
99515|NCT01256411|237316|P6|COMPLETED|Extension by Maximum Treatment||0
99516|NCT01256411|237317|P5|COMPLETED|Extension by Maximum Treatment||0
99517|NCT01256411|237318|P4|COMPLETED|Extension by Maximum Treatment||4
99518|NCT01256411|237319|P3|COMPLETED|Extension by Maximum Treatment||105
99519|NCT01256411|237320|P2|COMPLETED|Extension by Maximum Treatment||79
99520|NCT01256411|237321|P1|COMPLETED|Extension by Maximum Treatment||132
99521|NCT01256411|237316|P6|Down Titrated to 100 mg|Extension by Maximum Treatment||0
99522|NCT01256411|237317|P5|Down Titrated to 100 mg|Extension by Maximum Treatment||0
99523|NCT01256411|237318|P4|Down Titrated to 100 mg|Extension by Maximum Treatment||0
99524|NCT01256411|237319|P3|Down Titrated to 100 mg|Extension by Maximum Treatment||0
99525|NCT01256411|237320|P2|Down Titrated to 100 mg|Extension by Maximum Treatment||0
99526|NCT01256411|237321|P1|Down Titrated to 100 mg|Extension by Maximum Treatment||12
99527|NCT01256411|237316|P6|STARTED|Extension by Maximum Treatment||0
99528|NCT01256411|237317|P5|STARTED|Extension by Maximum Treatment||0
99529|NCT01256411|237318|P4|STARTED|Extension by Maximum Treatment||4
99530|NCT01256411|237319|P3|STARTED|Extension by Maximum Treatment||109
99531|NCT01256411|237320|P2|STARTED|Extension by Maximum Treatment||89
99532|NCT01256411|237321|P1|STARTED|Extension by Maximum Treatment||139
99533|NCT01256385|237347|P2|NOT COMPLETED|Overall Study||3
99534|NCT01256385|237348|P1|NOT COMPLETED|Overall Study||3
99535|NCT01256385|237347|P2|COMPLETED|Overall Study||40
99536|NCT01256385|237348|P1|COMPLETED|Overall Study||40
99537|NCT01256385|237347|P2|Crossover From Arm B to Arm A|Overall Study||15
99538|NCT01256385|237348|P1|Crossover From Arm B to Arm A|Overall Study||0
99539|NCT01256385|237347|P2|STARTED|Overall Study||43
99540|NCT01256385|237348|P1|STARTED|Overall Study||43
99541|NCT01256294|237368|P2|NOT COMPLETED|Overall Study||2
99542|NCT01256294|237369|P1|NOT COMPLETED|Overall Study||4
99543|NCT01256294|237368|P2|COMPLETED|Overall Study||33
99544|NCT01256294|237369|P1|COMPLETED|Overall Study||32
99545|NCT01256294|237368|P2|STARTED|Overall Study||35
99546|NCT01256294|237369|P1|STARTED|Overall Study||36
99547|NCT01256281|237385|P1|NOT COMPLETED|Overall Study||0
99548|NCT01256281|237385|P1|COMPLETED|Overall Study||2
99549|NCT01256281|237385|P1|STARTED|Overall Study||2
99550|NCT01256190|237391|P2|NOT COMPLETED|Overall Study||0
99551|NCT01256190|237392|P1|NOT COMPLETED|Overall Study||2
99552|NCT01256190|237391|P2|COMPLETED|Overall Study||17
99553|NCT01256190|237392|P1|COMPLETED|Overall Study||37
99554|NCT01256190|237391|P2|STARTED|Overall Study||17
99555|NCT01256190|237392|P1|STARTED|Overall Study||39
99556|NCT01256177|237408|P2|NOT COMPLETED|Overall Study||37
99557|NCT01256177|237409|P1|NOT COMPLETED|Overall Study||50
99558|NCT01256177|237408|P2|COMPLETED|Overall Study||111
99559|NCT01256177|237409|P1|COMPLETED|Overall Study||98
99560|NCT01256177|237408|P2|STARTED|Overall Study||148
99561|NCT01256177|237409|P1|STARTED|Overall Study||148
99562|NCT01256164|237433|P2|NOT COMPLETED|Overall Study||0
99563|NCT01256164|237434|P1|NOT COMPLETED|Overall Study||0
99564|NCT01256164|237433|P2|COMPLETED|Overall Study||23
99565|NCT01256164|237434|P1|COMPLETED|Overall Study||47
99566|NCT01256164|237433|P2|STARTED|Overall Study||23
99567|NCT01256164|237434|P1|STARTED|Overall Study||47
99568|NCT01256086|237452|P4|NOT COMPLETED|Treatment Day 4||0
99569|NCT01256086|237453|P3|NOT COMPLETED|Treatment Day 4||0
99570|NCT01256086|237454|P2|NOT COMPLETED|Treatment Day 4||0
99571|NCT01256086|237455|P1|NOT COMPLETED|Treatment Day 4||0
99572|NCT01256086|237452|P4|COMPLETED|Treatment Day 4||11
99573|NCT01256086|237453|P3|COMPLETED|Treatment Day 4||9
99574|NCT01256086|237454|P2|COMPLETED|Treatment Day 4||10
99575|NCT01256086|237455|P1|COMPLETED|Treatment Day 4||11
99576|NCT01256086|237452|P4|STARTED|Treatment Day 4||11
99577|NCT01256086|237453|P3|STARTED|Treatment Day 4||9
99578|NCT01256086|237454|P2|STARTED|Treatment Day 4||10
99579|NCT01256086|237455|P1|STARTED|Treatment Day 4||11
99580|NCT01256086|237452|P4|NOT COMPLETED|Treatment Day 3||0
99581|NCT01256086|237453|P3|NOT COMPLETED|Treatment Day 3||0
99582|NCT01256086|237454|P2|NOT COMPLETED|Treatment Day 3||0
99583|NCT01256086|237455|P1|NOT COMPLETED|Treatment Day 3||0
99584|NCT01256086|237452|P4|COMPLETED|Treatment Day 3||11
99585|NCT01256086|237453|P3|COMPLETED|Treatment Day 3||9
99586|NCT01256086|237454|P2|COMPLETED|Treatment Day 3||10
99587|NCT01256086|237455|P1|COMPLETED|Treatment Day 3||11
99588|NCT01256086|237452|P4|STARTED|Treatment Day 3||11
99589|NCT01256086|237453|P3|STARTED|Treatment Day 3||9
99590|NCT01256086|237454|P2|STARTED|Treatment Day 3||10
99591|NCT01256086|237455|P1|STARTED|Treatment Day 3||11
99592|NCT01256086|237452|P4|NOT COMPLETED|Treatment Day 2||0
99593|NCT01256086|237453|P3|NOT COMPLETED|Treatment Day 2||0
99594|NCT01256086|237454|P2|NOT COMPLETED|Treatment Day 2||0
99595|NCT01256086|237455|P1|NOT COMPLETED|Treatment Day 2||0
99596|NCT01256086|237452|P4|COMPLETED|Treatment Day 2||11
99597|NCT01256086|237453|P3|COMPLETED|Treatment Day 2||9
99598|NCT01256086|237454|P2|COMPLETED|Treatment Day 2||10
99599|NCT01256086|237455|P1|COMPLETED|Treatment Day 2||11
99600|NCT01256086|237452|P4|STARTED|Treatment Day 2||11
99601|NCT01256086|237453|P3|STARTED|Treatment Day 2||9
99602|NCT01256086|237454|P2|STARTED|Treatment Day 2||10
99603|NCT01256086|237455|P1|STARTED|Treatment Day 2||11
99604|NCT01256086|237452|P4|NOT COMPLETED|Treatment Day 1||0
99605|NCT01256086|237453|P3|NOT COMPLETED|Treatment Day 1||0
99606|NCT01256086|237454|P2|NOT COMPLETED|Treatment Day 1||0
99607|NCT01256086|237455|P1|NOT COMPLETED|Treatment Day 1||0
99608|NCT01256086|237452|P4|COMPLETED|Treatment Day 1||11
99609|NCT01256086|237453|P3|COMPLETED|Treatment Day 1||11
99610|NCT01256086|237454|P2|COMPLETED|Treatment Day 1||11
99611|NCT01256086|237455|P1|COMPLETED|Treatment Day 1||11
99612|NCT01256086|237452|P4|STARTED|Treatment Day 1||11
99613|NCT01256086|237453|P3|STARTED|Treatment Day 1||11
99614|NCT01256086|237454|P2|STARTED|Treatment Day 1||11
99615|NCT01256086|237455|P1|STARTED|Treatment Day 1||11
99616|NCT01256060|237465|P4|NOT COMPLETED|Overall Study||0
99617|NCT01256060|237466|P3|NOT COMPLETED|Overall Study||0
99618|NCT01256060|237467|P2|NOT COMPLETED|Overall Study||1
99619|NCT01256060|237468|P1|NOT COMPLETED|Overall Study||0
99620|NCT01256060|237465|P4|COMPLETED|Overall Study||6
99621|NCT01256060|237466|P3|COMPLETED|Overall Study||3
99622|NCT01256060|237467|P2|COMPLETED|Overall Study||2
99623|NCT01256060|237468|P1|COMPLETED|Overall Study||3
99624|NCT01256060|237465|P4|STARTED|Overall Study||6
99625|NCT01256060|237466|P3|STARTED|Overall Study||3
99626|NCT01256060|237467|P2|STARTED|Overall Study||3
99627|NCT01256060|237468|P1|STARTED|Overall Study||3
99628|NCT01256034|237477|P2|NOT COMPLETED|Overall Study||25
99629|NCT01256034|237478|P1|NOT COMPLETED|Overall Study||25
99630|NCT01256034|237477|P2|COMPLETED|Overall Study||0
99631|NCT01256034|237478|P1|COMPLETED|Overall Study||0
99632|NCT01256034|237477|P2|STARTED|Overall Study||25
99633|NCT01256034|237478|P1|STARTED|Overall Study||25
99634|NCT01256008|237487|P3|NOT COMPLETED|Overall Study||21
99635|NCT01256008|237488|P2|NOT COMPLETED|Overall Study||7
99636|NCT01256008|237489|P1|NOT COMPLETED|Overall Study||8
99637|NCT01256008|237487|P3|COMPLETED|Overall Study||175
99638|NCT01256008|237488|P2|COMPLETED|Overall Study||91
99639|NCT01256008|237489|P1|COMPLETED|Overall Study||90
99640|NCT01256008|237487|P3|STARTED|Overall Study||196
99641|NCT01256008|237488|P2|STARTED|Overall Study||98
99642|NCT01256008|237489|P1|STARTED|Overall Study||98
99643|NCT01255904|237511|P2|NOT COMPLETED|Overall Study||4
99644|NCT01255904|237512|P1|NOT COMPLETED|Overall Study||1
99645|NCT01255904|237511|P2|COMPLETED|Overall Study||41
99646|NCT01255904|237512|P1|COMPLETED|Overall Study||44
99647|NCT01255904|237511|P2|STARTED|Overall Study||45
99648|NCT01255904|237512|P1|STARTED|Overall Study||45
99649|NCT01255787|237522|P4|NOT COMPLETED|Overall Study||22
99650|NCT01255787|237523|P3|NOT COMPLETED|Overall Study||18
99651|NCT01255787|237524|P2|NOT COMPLETED|Overall Study||17
99652|NCT01255787|237525|P1|NOT COMPLETED|Overall Study||16
99653|NCT01255787|237522|P4|COMPLETED|Overall Study||132
99654|NCT01255787|237523|P3|COMPLETED|Overall Study||132
99655|NCT01255787|237524|P2|COMPLETED|Overall Study||127
99656|NCT01255787|237525|P1|COMPLETED|Overall Study||136
99657|NCT01255787|237522|P4|Treated|Overall Study||150
99658|NCT01255787|237523|P3|Treated|Overall Study||148
99659|NCT01255787|237524|P2|Treated|Overall Study||144
99660|NCT01255787|237525|P1|Treated|Overall Study||152
99661|NCT01255787|237522|P4|STARTED|Overall Study||154
99662|NCT01255787|237523|P3|STARTED|Overall Study||150
99663|NCT01255787|237524|P2|STARTED|Overall Study||144
99664|NCT01255787|237525|P1|STARTED|Overall Study||152
99665|NCT01255761|237553|P2|NOT COMPLETED|Overall Study||175
99666|NCT01255761|237554|P1|NOT COMPLETED|Overall Study||182
99667|NCT01255761|237553|P2|COMPLETED|Overall Study||192
99668|NCT01255761|237554|P1|COMPLETED|Overall Study||187
99669|NCT01255761|237553|P2|STARTED|Overall Study||367
99670|NCT01255761|237554|P1|STARTED|Overall Study||369
99671|NCT01255722|237639|P3|NOT COMPLETED|Overall Study||1
99672|NCT01255722|237640|P2|NOT COMPLETED|Overall Study||1
99673|NCT01255722|237641|P1|NOT COMPLETED|Overall Study||3
99674|NCT01255722|237639|P3|COMPLETED|Overall Study||152
99675|NCT01255722|237640|P2|COMPLETED|Overall Study||159
99676|NCT01255722|237641|P1|COMPLETED|Overall Study||152
99677|NCT01255722|237639|P3|STARTED|Overall Study||153
99678|NCT01255722|237640|P2|STARTED|Overall Study||160
99679|NCT01255722|237641|P1|STARTED|Overall Study||155
99680|NCT01255631|237666|P2|NOT COMPLETED|Overall Study||6
99681|NCT01255631|237667|P1|NOT COMPLETED|Overall Study||9
99682|NCT01255631|237666|P2|COMPLETED|Overall Study|study terminated due to poor enrollment|3
99683|NCT01255631|237667|P1|COMPLETED|Overall Study|study terminated due to poor enrollment|4
99684|NCT01255631|237666|P2|STARTED|Overall Study||9
99685|NCT01255631|237667|P1|STARTED|Overall Study||13
99686|NCT01255592|237685|P2|NOT COMPLETED|Overall Study||1
99687|NCT01255592|237686|P1|NOT COMPLETED|Overall Study||6
99688|NCT01255592|237685|P2|COMPLETED|Overall Study||25
99689|NCT01255592|237686|P1|COMPLETED|Overall Study||20
99690|NCT01255592|237685|P2|STARTED|Overall Study||26
99691|NCT01255592|237686|P1|STARTED|Overall Study||26
99692|NCT01255449|237742|P1|NOT COMPLETED|Overall Study||0
99693|NCT01255449|237742|P1|COMPLETED|Overall Study||26
99694|NCT01255449|237742|P1|STARTED|Overall Study||26
99695|NCT01255436|237749|P2|NOT COMPLETED|Overall Study||194
99696|NCT01255436|237750|P1|NOT COMPLETED|Overall Study||182
99697|NCT01255436|237749|P2|COMPLETED|Overall Study||135
99698|NCT01255436|237750|P1|COMPLETED|Overall Study||151
99699|NCT01255436|237749|P2|STARTED|Overall Study|350 patients enrolled but 21 excluded because of missing baseline data|329
99700|NCT01255436|237750|P1|STARTED|Overall Study|350 patients enrolled but 17 excluded because of missing baseline data.|333
99701|NCT01255423|237764|P2|NOT COMPLETED|Overall Study||3
99702|NCT01255423|237765|P1|NOT COMPLETED|Overall Study||3
99703|NCT01255423|237764|P2|COMPLETED|Overall Study||99
99704|NCT01255423|237765|P1|COMPLETED|Overall Study||101
99705|NCT01255423|237764|P2|STARTED|Overall Study||102
99706|NCT01255423|237765|P1|STARTED|Overall Study||104
99707|NCT01255306|237781|P2|NOT COMPLETED|Overall Study||1
99708|NCT01255306|237782|P1|NOT COMPLETED|Overall Study||1
99709|NCT01255306|237781|P2|COMPLETED|Overall Study||32
99710|NCT01255306|237782|P1|COMPLETED|Overall Study||25
99711|NCT01255306|237781|P2|STARTED|Overall Study||33
99712|NCT01255306|237782|P1|STARTED|Overall Study||26
99713|NCT01255137|237791|P1|NOT COMPLETED|Overall Study||0
99714|NCT01255137|237791|P1|COMPLETED|Overall Study||13
99715|NCT01255137|237791|P1|STARTED|Overall Study||13
99716|NCT01254890|237798|P2|NOT COMPLETED|Overall Study||10
99717|NCT01254890|237799|P1|NOT COMPLETED|Overall Study||1
99718|NCT01254890|237798|P2|COMPLETED|Overall Study||47
99719|NCT01254890|237799|P1|COMPLETED|Overall Study||2
99720|NCT01254890|237798|P2|STARTED|Overall Study||57
99721|NCT01254890|237799|P1|STARTED|Overall Study||3
99722|NCT01254851|237807|P2|NOT COMPLETED|Overall Study||9
99723|NCT01254851|237808|P1|NOT COMPLETED|Overall Study||8
99724|NCT01254851|237807|P2|COMPLETED|Overall Study||68
99725|NCT01254851|237808|P1|COMPLETED|Overall Study||61
99726|NCT01254851|237807|P2|STARTED|Overall Study||77
99727|NCT01254851|237808|P1|STARTED|Overall Study||69
99728|NCT01254760|237814|P2|NOT COMPLETED|Second Period, 5 Days of Wear||0
99729|NCT01254760|237815|P1|NOT COMPLETED|Second Period, 5 Days of Wear||0
99730|NCT01254760|237814|P2|COMPLETED|Second Period, 5 Days of Wear||38
99731|NCT01254760|237815|P1|COMPLETED|Second Period, 5 Days of Wear||34
99732|NCT01254760|237814|P2|STARTED|Second Period, 5 Days of Wear||38
99733|NCT01254760|237815|P1|STARTED|Second Period, 5 Days of Wear||34
99734|NCT01254760|237814|P2|NOT COMPLETED|First Period, 5 Days of Wear||0
99735|NCT01254760|237815|P1|NOT COMPLETED|First Period, 5 Days of Wear||0
99736|NCT01254760|237814|P2|COMPLETED|First Period, 5 Days of Wear||38
99737|NCT01254760|237815|P1|COMPLETED|First Period, 5 Days of Wear||34
99738|NCT01254760|237814|P2|STARTED|First Period, 5 Days of Wear||38
99739|NCT01254760|237815|P1|STARTED|First Period, 5 Days of Wear||34
99740|NCT01254747|237833|P4|NOT COMPLETED|Overall Study||2
99741|NCT01254747|237834|P3|NOT COMPLETED|Overall Study||4
99742|NCT01254747|237835|P2|NOT COMPLETED|Overall Study||6
99743|NCT01254747|237836|P1|NOT COMPLETED|Overall Study||0
99744|NCT01254747|237833|P4|COMPLETED|Overall Study||28
99745|NCT01254747|237834|P3|COMPLETED|Overall Study||26
99746|NCT01254747|237835|P2|COMPLETED|Overall Study||23
99747|NCT01254747|237836|P1|COMPLETED|Overall Study||40
99748|NCT01254747|237833|P4|STARTED|Overall Study||30
99749|NCT01254747|237834|P3|STARTED|Overall Study||30
99750|NCT01254747|237835|P2|STARTED|Overall Study||29
99751|NCT01254747|237836|P1|STARTED|Overall Study||40
99752|NCT01254721|237876|P2|NOT COMPLETED|Overall Study||22
99753|NCT01254721|237877|P1|NOT COMPLETED|Overall Study||15
99754|NCT01254721|237876|P2|COMPLETED|Overall Study||42
99755|NCT01254721|237877|P1|COMPLETED|Overall Study||52
99756|NCT01254721|237876|P2|STARTED|Overall Study|Seroquel XR: 300mg Lithium: 900mg|64
99757|NCT01254721|237877|P1|STARTED|Overall Study|Seroquel XR: 300mg|67
99758|NCT01254669|237887|P2|NOT COMPLETED|Overall Study||4
99759|NCT01254669|237888|P1|NOT COMPLETED|Overall Study||3
99760|NCT01254669|237887|P2|COMPLETED|Overall Study||96
99761|NCT01254669|237888|P1|COMPLETED|Overall Study||97
99762|NCT01254669|237887|P2|STARTED|Overall Study||100
99763|NCT01254669|237888|P1|STARTED|Overall Study||100
99764|NCT01254656|237899|P3|NOT COMPLETED|Overall Study||18
99765|NCT01254656|237900|P2|NOT COMPLETED|Overall Study||43
99766|NCT01254656|237901|P1|NOT COMPLETED|Overall Study||47
99767|NCT01254656|237899|P3|COMPLETED|Overall Study||0
99768|NCT01254656|237900|P2|COMPLETED|Overall Study||0
99769|NCT01254656|237901|P1|COMPLETED|Overall Study||0
99770|NCT01254656|237899|P3|Treated|Overall Study||18
99771|NCT01254656|237900|P2|Treated|Overall Study||43
99772|NCT01254656|237901|P1|Treated|Overall Study||47
99773|NCT01254656|237899|P3|STARTED|Overall Study||18
99774|NCT01254656|237900|P2|STARTED|Overall Study||43
99775|NCT01254656|237901|P1|STARTED|Overall Study||47
99776|NCT01254643|237927|P1|NOT COMPLETED|Overall Study||1
99777|NCT01254643|237927|P1|COMPLETED|Overall Study||99
99778|NCT01254643|237927|P1|Vaccination 3|Overall Study||99
99779|NCT01254643|237927|P1|Vaccination 2|Overall Study||99
99780|NCT01254643|237927|P1|Vaccination 1|Overall Study||100
99781|NCT01254643|237927|P1|STARTED|Overall Study||100
99782|NCT01254604|237937|P2|NOT COMPLETED|Overall Study||9
99783|NCT01254604|237938|P1|NOT COMPLETED|Overall Study||8
99784|NCT01254604|237937|P2|COMPLETED|Overall Study||86
99785|NCT01254604|237938|P1|COMPLETED|Overall Study||87
99786|NCT01254604|237937|P2|Treated|Overall Study|"The 1 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|94
99787|NCT01254604|237938|P1|Treated|Overall Study|"The 2 out of 95 started who did not take study drug discontinued due to Withdrawal by Subject"|93
99788|NCT01254604|237937|P2|STARTED|Overall Study||95
99789|NCT01254604|237938|P1|STARTED|Overall Study||95
99790|NCT01254565|237956|P6|NOT COMPLETED|Overall Study||4
99791|NCT01254565|237957|P5|NOT COMPLETED|Overall Study||4
99792|NCT01254565|237958|P4|NOT COMPLETED|Overall Study||1
99793|NCT01254565|237959|P3|NOT COMPLETED|Overall Study||0
99794|NCT01254565|237960|P2|NOT COMPLETED|Overall Study||1
99795|NCT01254565|237961|P1|NOT COMPLETED|Overall Study||1
99796|NCT01254565|237956|P6|COMPLETED|Overall Study||13
99797|NCT01254565|237957|P5|COMPLETED|Overall Study||12
99798|NCT01254565|237958|P4|COMPLETED|Overall Study||20
99799|NCT01254565|237959|P3|COMPLETED|Overall Study||21
99800|NCT01254565|237960|P2|COMPLETED|Overall Study||6
99801|NCT01254565|237961|P1|COMPLETED|Overall Study||4
99802|NCT01254565|237956|P6|Received Treatment|Overall Study||13
99803|NCT01254565|237957|P5|Received Treatment|Overall Study||13
99804|NCT01254565|237958|P4|Received Treatment|Overall Study||21
99805|NCT01254565|237959|P3|Received Treatment|Overall Study||21
99806|NCT01254565|237960|P2|Received Treatment|Overall Study||6
99807|NCT01254565|237961|P1|Received Treatment|Overall Study||4
99808|NCT01254565|237956|P6|STARTED|Overall Study||17
99809|NCT01254565|237957|P5|STARTED|Overall Study||16
99810|NCT01254565|237958|P4|STARTED|Overall Study||21
99811|NCT01254565|237959|P3|STARTED|Overall Study||21
99812|NCT01254565|237960|P2|STARTED|Overall Study||7
99813|NCT01254565|237961|P1|STARTED|Overall Study||5
99814|NCT01254409|238015|P4|NOT COMPLETED|Overall Study||0
99815|NCT01254409|238016|P3|NOT COMPLETED|Overall Study||0
99816|NCT01254409|238017|P2|NOT COMPLETED|Overall Study||1
99817|NCT01254409|238018|P1|NOT COMPLETED|Overall Study||0
99818|NCT01254409|238015|P4|COMPLETED|Overall Study||4
99819|NCT01254409|238016|P3|COMPLETED|Overall Study||5
99820|NCT01254409|238017|P2|COMPLETED|Overall Study||5
99821|NCT01254409|238018|P1|COMPLETED|Overall Study||6
99822|NCT01254409|238015|P4|STARTED|Overall Study||4
99823|NCT01254409|238016|P3|STARTED|Overall Study||5
99824|NCT01254409|238017|P2|STARTED|Overall Study||6
99825|NCT01254409|238018|P1|STARTED|Overall Study||6
99826|NCT01254396|238070|P2|NOT COMPLETED|Second Intervention Period||0
99827|NCT01254396|238071|P1|NOT COMPLETED|Second Intervention Period||0
99828|NCT01254396|238070|P2|COMPLETED|Second Intervention Period||6
99829|NCT01254396|238071|P1|COMPLETED|Second Intervention Period||6
99830|NCT01254396|238070|P2|STARTED|Second Intervention Period||6
99831|NCT01254396|238071|P1|STARTED|Second Intervention Period||6
99832|NCT01254396|238070|P2|NOT COMPLETED|Washout Period (at Least 1 Day)||0
99833|NCT01254396|238071|P1|NOT COMPLETED|Washout Period (at Least 1 Day)||0
99834|NCT01254396|238070|P2|COMPLETED|Washout Period (at Least 1 Day)||6
99835|NCT01254396|238071|P1|COMPLETED|Washout Period (at Least 1 Day)||6
99836|NCT01254396|238070|P2|STARTED|Washout Period (at Least 1 Day)||6
99837|NCT01254396|238071|P1|STARTED|Washout Period (at Least 1 Day)||6
99838|NCT01254396|238070|P2|NOT COMPLETED|First Intervention Period||0
99839|NCT01254396|238071|P1|NOT COMPLETED|First Intervention Period||0
99840|NCT01254396|238070|P2|COMPLETED|First Intervention Period||6
99841|NCT01254396|238071|P1|COMPLETED|First Intervention Period||6
99842|NCT01254396|238070|P2|STARTED|First Intervention Period||6
99843|NCT01254396|238071|P1|STARTED|First Intervention Period||6
99844|NCT01254344|238087|P2|NOT COMPLETED|Overall Study||19
99845|NCT01254344|238088|P1|NOT COMPLETED|Overall Study||13
99846|NCT01254344|238087|P2|COMPLETED|Overall Study||281
99847|NCT01254344|238088|P1|COMPLETED|Overall Study||286
99848|NCT01254344|238087|P2|Treated|Overall Study||297
99849|NCT01254344|238088|P1|Treated|Overall Study||290
99850|NCT01254344|238087|P2|STARTED|Overall Study||300
99851|NCT01254344|238088|P1|STARTED|Overall Study||299
99852|NCT01254331|238096|P1|NOT COMPLETED|Extension Phase||4
99853|NCT01254331|238096|P1|COMPLETED|Extension Phase||41
99854|NCT01254331|238096|P1|STARTED|Extension Phase|1 participant withdrew consent after completing initial phase and did not enter the extension phase|45
99855|NCT01254331|238096|P1|NOT COMPLETED|Initial Phase||5
99856|NCT01254331|238096|P1|COMPLETED|Initial Phase||46
99857|NCT01254331|238096|P1|STARTED|Initial Phase||51
99858|NCT01254318|238114|P1|NOT COMPLETED|Overall Study||52
99859|NCT01254318|238114|P1|COMPLETED|Overall Study|Alive at end of study|78
99860|NCT01254318|238114|P1|STARTED|Overall Study|Alive at start of study|130
99861|NCT01254305|238123|P3|NOT COMPLETED|Overall Study||17
99862|NCT01254305|238124|P2|NOT COMPLETED|Overall Study||18
99863|NCT01254305|238125|P1|NOT COMPLETED|Overall Study||22
99864|NCT01254305|238123|P3|COMPLETED|Overall Study||62
99865|NCT01254305|238124|P2|COMPLETED|Overall Study||72
99866|NCT01254305|238125|P1|COMPLETED|Overall Study||71
99867|NCT01254305|238123|P3|Safety Population|Overall Study||77
99868|NCT01254305|238124|P2|Safety Population|Overall Study||85
99869|NCT01254305|238125|P1|Safety Population|Overall Study||89
99870|NCT01254305|238123|P3|STARTED|Overall Study||79
99871|NCT01254305|238124|P2|STARTED|Overall Study||90
99872|NCT01254305|238125|P1|STARTED|Overall Study||93
99873|NCT01254292|238141|P2|NOT COMPLETED|LCS12 Extension Phase||0
99874|NCT01254292|238142|P1|NOT COMPLETED|LCS12 Extension Phase||37
99875|NCT01254292|238141|P2|COMPLETED|LCS12 Extension Phase||0
99876|NCT01254292|238142|P1|COMPLETED|LCS12 Extension Phase||163
99877|NCT01254292|238141|P2|STARTED|LCS12 Extension Phase|Optional Extension Phase was for LCS12 group only.|0
99878|NCT01254292|238142|P1|STARTED|LCS12 Extension Phase|A total of 200 participants elected to enter this optional Extension Phase.|200
99879|NCT01254292|238141|P2|NOT COMPLETED|Comparative Phase||81
99880|NCT01254292|238142|P1|NOT COMPLETED|Comparative Phase||55
99881|NCT01254292|238141|P2|COMPLETED|Comparative Phase||204
99882|NCT01254292|238142|P1|COMPLETED|Comparative Phase||227
99883|NCT01254292|238141|P2|Participants Received Treatment|Comparative Phase|safety population|281
99884|NCT01254292|238142|P1|Participants Received Treatment|Comparative Phase|safety population|279
99885|NCT01254292|238141|P2|STARTED|Comparative Phase||285
99886|NCT01254292|238142|P1|STARTED|Comparative Phase||282
99887|NCT01254214|238200|P2|NOT COMPLETED|Overall Study||1
99888|NCT01254214|238201|P1|NOT COMPLETED|Overall Study||3
99889|NCT01254214|238200|P2|COMPLETED|Overall Study||27
99890|NCT01254214|238201|P1|COMPLETED|Overall Study||24
99891|NCT01254214|238200|P2|STARTED|Overall Study||28
99892|NCT01254214|238201|P1|STARTED|Overall Study||27
99893|NCT01254188|238215|P1|NOT COMPLETED|Overall Study||93
99894|NCT01254188|238215|P1|COMPLETED|Overall Study||328
99895|NCT01254188|238215|P1|STARTED|Overall Study||421
99896|NCT01254045|238226|P6|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
99897|NCT01254045|238227|P5|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
99898|NCT01254045|238228|P4|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
99899|NCT01254045|238229|P3|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
99900|NCT01254045|238230|P2|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
99901|NCT01254045|238231|P1|NOT COMPLETED|Third/Time 3 (1 Day at Week 3)||0
99902|NCT01254045|238226|P6|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
99903|NCT01254045|238227|P5|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
99904|NCT01254045|238228|P4|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
99905|NCT01254045|238229|P3|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
99906|NCT01254045|238230|P2|COMPLETED|Third/Time 3 (1 Day at Week 3)||2
99907|NCT01254045|238231|P1|COMPLETED|Third/Time 3 (1 Day at Week 3)||1
99908|NCT01254045|238226|P6|STARTED|Third/Time 3 (1 Day at Week 3)||1
99909|NCT01254045|238227|P5|STARTED|Third/Time 3 (1 Day at Week 3)||1
99910|NCT01254045|238228|P4|STARTED|Third/Time 3 (1 Day at Week 3)||1
99911|NCT01254045|238229|P3|STARTED|Third/Time 3 (1 Day at Week 3)||2
99912|NCT01254045|238230|P2|STARTED|Third/Time 3 (1 Day at Week 3)||2
99913|NCT01254045|238231|P1|STARTED|Third/Time 3 (1 Day at Week 3)||1
99914|NCT01254045|238226|P6|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
99915|NCT01254045|238227|P5|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
99916|NCT01254045|238228|P4|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
99917|NCT01254045|238229|P3|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
99918|NCT01254045|238230|P2|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
99919|NCT01254045|238231|P1|NOT COMPLETED|Second/Time 2 (1 Day at Week 2)||0
99920|NCT01254045|238226|P6|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
99921|NCT01254045|238227|P5|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
99922|NCT01254045|238228|P4|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
99923|NCT01254045|238229|P3|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
99924|NCT01254045|238230|P2|COMPLETED|Second/Time 2 (1 Day at Week 2)||2
99925|NCT01254045|238231|P1|COMPLETED|Second/Time 2 (1 Day at Week 2)||1
99926|NCT01254045|238226|P6|STARTED|Second/Time 2 (1 Day at Week 2)||1
99927|NCT01254045|238227|P5|STARTED|Second/Time 2 (1 Day at Week 2)||1
99928|NCT01254045|238228|P4|STARTED|Second/Time 2 (1 Day at Week 2)||1
99929|NCT01254045|238229|P3|STARTED|Second/Time 2 (1 Day at Week 2)||2
99930|NCT01254045|238230|P2|STARTED|Second/Time 2 (1 Day at Week 2)||2
99931|NCT01254045|238231|P1|STARTED|Second/Time 2 (1 Day at Week 2)||1
99932|NCT01254045|238226|P6|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
99933|NCT01254045|238227|P5|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
99934|NCT01254045|238228|P4|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
99935|NCT01254045|238229|P3|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
99936|NCT01254045|238230|P2|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||0
99937|NCT01254045|238231|P1|NOT COMPLETED|First/Baseline (1 Day at Week 1 )||1
99938|NCT01254045|238226|P6|COMPLETED|First/Baseline (1 Day at Week 1 )||1
99939|NCT01254045|238227|P5|COMPLETED|First/Baseline (1 Day at Week 1 )||1
99940|NCT01254045|238228|P4|COMPLETED|First/Baseline (1 Day at Week 1 )||1
99941|NCT01254045|238229|P3|COMPLETED|First/Baseline (1 Day at Week 1 )||2
99942|NCT01254045|238230|P2|COMPLETED|First/Baseline (1 Day at Week 1 )||2
99943|NCT01254045|238231|P1|COMPLETED|First/Baseline (1 Day at Week 1 )||1
99944|NCT01254045|238226|P6|STARTED|First/Baseline (1 Day at Week 1 )||1
99945|NCT01254045|238227|P5|STARTED|First/Baseline (1 Day at Week 1 )||1
99946|NCT01254045|238228|P4|STARTED|First/Baseline (1 Day at Week 1 )||1
99947|NCT01254045|238229|P3|STARTED|First/Baseline (1 Day at Week 1 )||2
99948|NCT01254045|238230|P2|STARTED|First/Baseline (1 Day at Week 1 )||2
99949|NCT01254045|238231|P1|STARTED|First/Baseline (1 Day at Week 1 )|One completed all baseline measures including administration of placebo, but then lost to follow-up.|2
99950|NCT01253980|238244|P2|NOT COMPLETED|Overall Study||0
99951|NCT01253980|238245|P1|NOT COMPLETED|Overall Study||0
99952|NCT01253980|238244|P2|COMPLETED|Overall Study||39
99953|NCT01253980|238245|P1|COMPLETED|Overall Study||35
99954|NCT01253980|238244|P2|STARTED|Overall Study||39
99955|NCT01253980|238245|P1|STARTED|Overall Study||35
99956|NCT01253902|238254|P3|NOT COMPLETED|Overall Study||4
99957|NCT01253902|238255|P2|NOT COMPLETED|Overall Study||2
99958|NCT01253902|238256|P1|NOT COMPLETED|Overall Study||5
99959|NCT01253902|238254|P3|COMPLETED|Overall Study||51
99960|NCT01253902|238255|P2|COMPLETED|Overall Study||51
99961|NCT01253902|238256|P1|COMPLETED|Overall Study||51
99962|NCT01253902|238254|P3|STARTED|Overall Study||55
99963|NCT01253902|238255|P2|STARTED|Overall Study||53
99964|NCT01253902|238256|P1|STARTED|Overall Study||56
99965|NCT01253824|238272|P2|NOT COMPLETED|Overall Study||0
99966|NCT01253824|238273|P1|NOT COMPLETED|Overall Study||0
99967|NCT01253824|238272|P2|COMPLETED|Overall Study||7
99968|NCT01253824|238273|P1|COMPLETED|Overall Study||7
99969|NCT01253824|238272|P2|STARTED|Overall Study||7
99970|NCT01253824|238273|P1|STARTED|Overall Study||7
99971|NCT01253811|238285|P1|NOT COMPLETED|Overall Study||1
99972|NCT01253811|238285|P1|COMPLETED|Overall Study||5
99973|NCT01253811|238285|P1|Exposed|Overall Study||6
99974|NCT01253811|238285|P1|STARTED|Overall Study||6
99975|NCT01253577|238304|P1|NOT COMPLETED|Overall Study||3
99976|NCT01253577|238304|P1|COMPLETED|Overall Study||102
99977|NCT01253577|238304|P1|STARTED|Overall Study||105
99978|NCT01253564|238312|P1|NOT COMPLETED|Overall Study||24
99979|NCT01253564|238312|P1|COMPLETED|Overall Study||0
99980|NCT01253564|238312|P1|STARTED|Overall Study||24
99981|NCT01253525|238329|P1|NOT COMPLETED|Overall Study||0
99982|NCT01253525|238329|P1|COMPLETED|Overall Study||6
99983|NCT01253525|238329|P1|Received Any Quantity of Study Drug|Overall Study||6
99984|NCT01253525|238329|P1|STARTED|Overall Study||6
99985|NCT01253447|238356|P1|NOT COMPLETED|Overall Study||2
99986|NCT01253447|238356|P1|COMPLETED|Overall Study||17
99987|NCT01253447|238356|P1|STARTED|Overall Study||19
99988|NCT01253408|238363|P3|NOT COMPLETED|Overall Study||0
99989|NCT01253408|238364|P2|NOT COMPLETED|Overall Study||1
99990|NCT01253408|238365|P1|NOT COMPLETED|Overall Study||0
99991|NCT01253408|238363|P3|COMPLETED|Overall Study||13
99992|NCT01253408|238364|P2|COMPLETED|Overall Study||12
99993|NCT01253408|238365|P1|COMPLETED|Overall Study||10
99994|NCT01253408|238363|P3|STARTED|Overall Study||13
99995|NCT01253408|238364|P2|STARTED|Overall Study||13
99996|NCT01253408|238365|P1|STARTED|Overall Study||10
99997|NCT01253369|238388|P1|NOT COMPLETED|Overall Study||33
99998|NCT01253369|238388|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
99999|NCT01253369|238388|P1|Evaluable|Overall Study|Evaluable pts were w/ measurable disease, min 1 cycle of trt rcvd and 1 on-trt disease assessment.|30
100000|NCT01253369|238388|P1|STARTED|Overall Study||33
100001|NCT01253343|238395|P2|NOT COMPLETED|Overall Study||0
100002|NCT01253343|238396|P1|NOT COMPLETED|Overall Study||0
100003|NCT01253343|238395|P2|COMPLETED|Overall Study||8
100004|NCT01253343|238396|P1|COMPLETED|Overall Study||9
100005|NCT01253343|238395|P2|STARTED|Overall Study||8
100006|NCT01253343|238396|P1|STARTED|Overall Study||9
100007|NCT01253317|238418|P1|NOT COMPLETED|Overall Study||2
100008|NCT01253317|238418|P1|COMPLETED|Overall Study||10
100009|NCT01253317|238418|P1|STARTED|Overall Study||12
100010|NCT01253304|238430|P4|NOT COMPLETED|Overall Study||1
100011|NCT01253304|238431|P3|NOT COMPLETED|Overall Study||0
100012|NCT01253304|238432|P2|NOT COMPLETED|Overall Study||0
100013|NCT01253304|238433|P1|NOT COMPLETED|Overall Study||0
100014|NCT01253304|238430|P4|COMPLETED|Overall Study||2
100015|NCT01253304|238431|P3|COMPLETED|Overall Study||6
100016|NCT01253304|238432|P2|COMPLETED|Overall Study||6
100017|NCT01253304|238433|P1|COMPLETED|Overall Study||11
100018|NCT01253304|238430|P4|Received at Least 1 Dose of Study Drug|Overall Study||3
100019|NCT01253304|238431|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
100020|NCT01253304|238432|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
100021|NCT01253304|238433|P1|Received at Least 1 Dose of Study Drug|Overall Study||11
100022|NCT01253304|238430|P4|STARTED|Overall Study||3
100023|NCT01253304|238431|P3|STARTED|Overall Study||6
100024|NCT01253304|238432|P2|STARTED|Overall Study||6
100025|NCT01253304|238433|P1|STARTED|Overall Study||11
100026|NCT01253265|238472|P5|NOT COMPLETED|Overall Study||1
100027|NCT01253265|238473|P4|NOT COMPLETED|Overall Study||0
100028|NCT01253265|238474|P3|NOT COMPLETED|Overall Study||0
100029|NCT01253265|238475|P2|NOT COMPLETED|Overall Study||0
100030|NCT01253265|238476|P1|NOT COMPLETED|Overall Study||1
100031|NCT01253265|238472|P5|COMPLETED|Overall Study||7
100032|NCT01253265|238473|P4|COMPLETED|Overall Study||6
100033|NCT01253265|238474|P3|COMPLETED|Overall Study||6
100034|NCT01253265|238475|P2|COMPLETED|Overall Study||6
100035|NCT01253265|238476|P1|COMPLETED|Overall Study||5
100036|NCT01253265|238472|P5|STARTED|Overall Study||8
100037|NCT01253265|238473|P4|STARTED|Overall Study||6
100038|NCT01253265|238474|P3|STARTED|Overall Study||6
100039|NCT01253265|238475|P2|STARTED|Overall Study||6
100040|NCT01253265|238476|P1|STARTED|Overall Study||6
100041|NCT01253187|238520|P6|NOT COMPLETED|Period 3||0
100042|NCT01253187|238521|P5|NOT COMPLETED|Period 3||1
100043|NCT01253187|238522|P4|NOT COMPLETED|Period 3||0
100044|NCT01253187|238523|P3|NOT COMPLETED|Period 3||0
100045|NCT01253187|238524|P2|NOT COMPLETED|Period 3||1
100046|NCT01253187|238525|P1|NOT COMPLETED|Period 3||1
100047|NCT01253187|238520|P6|COMPLETED|Period 3||6
100048|NCT01253187|238521|P5|COMPLETED|Period 3||7
100049|NCT01253187|238522|P4|COMPLETED|Period 3||7
100050|NCT01253187|238523|P3|COMPLETED|Period 3||7
100051|NCT01253187|238524|P2|COMPLETED|Period 3||7
100052|NCT01253187|238525|P1|COMPLETED|Period 3||6
100053|NCT01253187|238520|P6|STARTED|Period 3||6
100054|NCT01253187|238521|P5|STARTED|Period 3||8
100055|NCT01253187|238522|P4|STARTED|Period 3||7
100056|NCT01253187|238523|P3|STARTED|Period 3||7
100057|NCT01253187|238524|P2|STARTED|Period 3||8
100058|NCT01253187|238525|P1|STARTED|Period 3||7
100059|NCT01253187|238520|P6|NOT COMPLETED|Period 2||0
100060|NCT01253187|238521|P5|NOT COMPLETED|Period 2||1
100061|NCT01253187|238522|P4|NOT COMPLETED|Period 2||0
100062|NCT01253187|238523|P3|NOT COMPLETED|Period 2||0
100063|NCT01253187|238524|P2|NOT COMPLETED|Period 2||0
100064|NCT01253187|238525|P1|NOT COMPLETED|Period 2||0
100065|NCT01253187|238520|P6|COMPLETED|Period 2||6
100066|NCT01253187|238521|P5|COMPLETED|Period 2||8
100067|NCT01253187|238522|P4|COMPLETED|Period 2||7
100068|NCT01253187|238523|P3|COMPLETED|Period 2||7
100069|NCT01253187|238524|P2|COMPLETED|Period 2||8
100070|NCT01253187|238525|P1|COMPLETED|Period 2||7
100071|NCT01253187|238520|P6|STARTED|Period 2||6
100072|NCT01253187|238521|P5|STARTED|Period 2||9
100073|NCT01253187|238522|P4|STARTED|Period 2||7
100074|NCT01253187|238523|P3|STARTED|Period 2||7
100075|NCT01253187|238524|P2|STARTED|Period 2||8
100076|NCT01253187|238525|P1|STARTED|Period 2||7
100077|NCT01253187|238520|P6|NOT COMPLETED|Period 1||0
100078|NCT01253187|238521|P5|NOT COMPLETED|Period 1||0
100079|NCT01253187|238522|P4|NOT COMPLETED|Period 1||0
100080|NCT01253187|238523|P3|NOT COMPLETED|Period 1||0
100081|NCT01253187|238524|P2|NOT COMPLETED|Period 1||0
100082|NCT01253187|238525|P1|NOT COMPLETED|Period 1||0
100083|NCT01253187|238520|P6|COMPLETED|Period 1||6
100084|NCT01253187|238521|P5|COMPLETED|Period 1||9
100085|NCT01253187|238522|P4|COMPLETED|Period 1||7
100086|NCT01253187|238523|P3|COMPLETED|Period 1||7
100087|NCT01253187|238524|P2|COMPLETED|Period 1||8
100088|NCT01253187|238525|P1|COMPLETED|Period 1||7
100089|NCT01253187|238520|P6|STARTED|Period 1||6
100090|NCT01253187|238521|P5|STARTED|Period 1||9
100091|NCT01253187|238522|P4|STARTED|Period 1||7
100092|NCT01253187|238523|P3|STARTED|Period 1||7
100093|NCT01253187|238524|P2|STARTED|Period 1||8
100094|NCT01253187|238525|P1|STARTED|Period 1||7
100095|NCT01253174|238554|P6|NOT COMPLETED|Period 3||0
100096|NCT01253174|238555|P5|NOT COMPLETED|Period 3||1
100097|NCT01253174|238556|P4|NOT COMPLETED|Period 3||0
100098|NCT01253174|238557|P3|NOT COMPLETED|Period 3||1
100099|NCT01253174|238558|P2|NOT COMPLETED|Period 3||1
100100|NCT01253174|238559|P1|NOT COMPLETED|Period 3||0
100101|NCT01253174|238554|P6|COMPLETED|Period 3||7
100102|NCT01253174|238555|P5|COMPLETED|Period 3||7
100103|NCT01253174|238556|P4|COMPLETED|Period 3||7
100104|NCT01253174|238557|P3|COMPLETED|Period 3||6
100105|NCT01253174|238558|P2|COMPLETED|Period 3||8
100106|NCT01253174|238559|P1|COMPLETED|Period 3||6
100107|NCT01253174|238554|P6|STARTED|Period 3||7
100108|NCT01253174|238555|P5|STARTED|Period 3||8
100109|NCT01253174|238556|P4|STARTED|Period 3||7
100110|NCT01253174|238557|P3|STARTED|Period 3||7
100111|NCT01253174|238558|P2|STARTED|Period 3||9
100112|NCT01253174|238559|P1|STARTED|Period 3||6
100113|NCT01253174|238554|P6|NOT COMPLETED|Period 2||0
100114|NCT01253174|238555|P5|NOT COMPLETED|Period 2||0
100115|NCT01253174|238556|P4|NOT COMPLETED|Period 2||0
100116|NCT01253174|238557|P3|NOT COMPLETED|Period 2||1
100117|NCT01253174|238558|P2|NOT COMPLETED|Period 2||0
100118|NCT01253174|238559|P1|NOT COMPLETED|Period 2||0
100119|NCT01253174|238554|P6|COMPLETED|Period 2||7
100120|NCT01253174|238555|P5|COMPLETED|Period 2||8
100121|NCT01253174|238556|P4|COMPLETED|Period 2||7
100122|NCT01253174|238557|P3|COMPLETED|Period 2||7
100123|NCT01253174|238558|P2|COMPLETED|Period 2||9
100124|NCT01253174|238559|P1|COMPLETED|Period 2||6
100125|NCT01253174|238554|P6|STARTED|Period 2||7
100126|NCT01253174|238555|P5|STARTED|Period 2||8
100127|NCT01253174|238556|P4|STARTED|Period 2||7
100128|NCT01253174|238557|P3|STARTED|Period 2||8
100129|NCT01253174|238558|P2|STARTED|Period 2||9
100130|NCT01253174|238559|P1|STARTED|Period 2||6
100131|NCT01253174|238554|P6|NOT COMPLETED|Period 1||0
100132|NCT01253174|238555|P5|NOT COMPLETED|Period 1||1
100133|NCT01253174|238556|P4|NOT COMPLETED|Period 1||0
100134|NCT01253174|238557|P3|NOT COMPLETED|Period 1||1
100135|NCT01253174|238558|P2|NOT COMPLETED|Period 1||1
100136|NCT01253174|238559|P1|NOT COMPLETED|Period 1||0
100137|NCT01253174|238554|P6|COMPLETED|Period 1||7
100138|NCT01253174|238555|P5|COMPLETED|Period 1||8
100139|NCT01253174|238556|P4|COMPLETED|Period 1||7
100140|NCT01253174|238557|P3|COMPLETED|Period 1||8
100141|NCT01253174|238558|P2|COMPLETED|Period 1||9
100142|NCT01253174|238559|P1|COMPLETED|Period 1||6
100143|NCT01253174|238554|P6|STARTED|Period 1||7
100144|NCT01253174|238555|P5|STARTED|Period 1||9
100145|NCT01253174|238556|P4|STARTED|Period 1||7
100146|NCT01253174|238557|P3|STARTED|Period 1||9
100147|NCT01253174|238558|P2|STARTED|Period 1||10
100148|NCT01253174|238559|P1|STARTED|Period 1||6
100149|NCT01253148|238588|P1|NOT COMPLETED|Overall Study||0
100150|NCT01253148|238588|P1|COMPLETED|Overall Study||25
100151|NCT01253148|238588|P1|STARTED|Overall Study||25
100152|NCT01253135|238594|P1|NOT COMPLETED|Amended Protocol||1
100153|NCT01253135|238594|P1|COMPLETED|Amended Protocol||24
100154|NCT01253135|238594|P1|STARTED|Amended Protocol||25
100155|NCT01253135|238594|P1|NOT COMPLETED|Original Protocol||15
100156|NCT01253135|238594|P1|COMPLETED|Original Protocol||0
100157|NCT01253135|238594|P1|STARTED|Original Protocol||15
100158|NCT01253070|238602|P1|NOT COMPLETED|Overall Study||0
100159|NCT01253070|238602|P1|COMPLETED|Overall Study||54
100160|NCT01253070|238602|P1|STARTED|Overall Study||54
100161|NCT01253044|238613|P2|NOT COMPLETED|Overall Study||29
100162|NCT01253044|238614|P1|NOT COMPLETED|Overall Study||38
100163|NCT01253044|238613|P2|COMPLETED|Overall Study||51
100164|NCT01253044|238614|P1|COMPLETED|Overall Study||42
100165|NCT01253044|238613|P2|STARTED|Overall Study||80
100166|NCT01253044|238614|P1|STARTED|Overall Study||80
100167|NCT01253018|238624|P2|NOT COMPLETED|Overall Study||2
100168|NCT01253018|238625|P1|NOT COMPLETED|Overall Study||4
100169|NCT01253018|238624|P2|COMPLETED|Overall Study||21
100170|NCT01253018|238625|P1|COMPLETED|Overall Study||18
100171|NCT01253018|238624|P2|STARTED|Overall Study||23
100172|NCT01253018|238625|P1|STARTED|Overall Study||22
100173|NCT01252966|238639|P2|NOT COMPLETED|Overall Study||13
100174|NCT01252966|238640|P1|NOT COMPLETED|Overall Study||23
100175|NCT01252966|238639|P2|COMPLETED|Overall Study||92
100176|NCT01252966|238640|P1|COMPLETED|Overall Study||85
100177|NCT01252966|238639|P2|STARTED|Overall Study||105
100178|NCT01252966|238640|P1|STARTED|Overall Study||108
100179|NCT01252940|238656|P2|NOT COMPLETED|Extension Phase||3
100180|NCT01252940|238657|P1|NOT COMPLETED|Extension Phase||10
100181|NCT01252940|238656|P2|COMPLETED|Extension Phase||46
100182|NCT01252940|238657|P1|COMPLETED|Extension Phase||100
100183|NCT01252940|238656|P2|STARTED|Extension Phase|SBR/Delayed Switch Group: 49 participants completing the main study continued in extension phase.|49
100184|NCT01252940|238657|P1|STARTED|Extension Phase|FTC/RPV/TDF group: 110 participants completing the main study continued in extension phase.|110
100185|NCT01252940|238656|P2|NOT COMPLETED|Main Study Phase||12
100186|NCT01252940|238657|P1|NOT COMPLETED|Main Study Phase||26
100187|NCT01252940|238656|P2|COMPLETED|Main Study Phase|Discontinuations after switch: withdrawal by subject, 2; adverse event, 1; protocol violation, 1.|149
100188|NCT01252940|238657|P1|COMPLETED|Main Study Phase||295
100189|NCT01252940|238656|P2|Completed 24 Weeks|Main Study Phase|152 participants switched regimens at Week 24.|153
100190|NCT01252940|238657|P1|Completed 24 Weeks|Main Study Phase||0
100191|NCT01252940|238656|P2|STARTED|Main Study Phase||161
100192|NCT01252940|238657|P1|STARTED|Main Study Phase||321
100193|NCT01252810|238688|P2|NOT COMPLETED|Overall Study||3
100194|NCT01252810|238689|P1|NOT COMPLETED|Overall Study||14
100195|NCT01252810|238688|P2|COMPLETED|Overall Study||139
100196|NCT01252810|238689|P1|COMPLETED|Overall Study||128
100197|NCT01252810|238688|P2|STARTED|Overall Study||142
100198|NCT01252810|238689|P1|STARTED|Overall Study||142
100199|NCT01252355|238702|P3|NOT COMPLETED|Overall Study||179
100200|NCT01252355|238703|P2|NOT COMPLETED|Overall Study||178
100201|NCT01252355|238704|P1|NOT COMPLETED|Overall Study||177
100202|NCT01252355|238702|P3|COMPLETED|Overall Study||0
100203|NCT01252355|238703|P2|COMPLETED|Overall Study||0
100204|NCT01252355|238704|P1|COMPLETED|Overall Study||0
100205|NCT01252355|238702|P3|Treated|Overall Study|One participant received teriflunomide 7 mg.|179
100206|NCT01252355|238703|P2|Treated|Overall Study||178
100207|NCT01252355|238704|P1|Treated|Overall Study||175
100208|NCT01252355|238702|P3|STARTED|Overall Study|Randomized.|179
100209|NCT01252355|238703|P2|STARTED|Overall Study|Randomized.|178
100210|NCT01252355|238704|P1|STARTED|Overall Study|Randomized.|177
100211|NCT01252290|238742|P1|NOT COMPLETED|Overall Study||1
100212|NCT01252290|238742|P1|COMPLETED|Overall Study||34
100213|NCT01252290|238742|P1|STARTED|Overall Study||35
100214|NCT01252277|238750|P1|NOT COMPLETED|Overall Study||2
100215|NCT01252277|238750|P1|COMPLETED|Overall Study||34
100216|NCT01252277|238750|P1|STARTED|Overall Study||36
100217|NCT01252251|238758|P1|NOT COMPLETED|Overall Study||1
100218|NCT01252251|238758|P1|COMPLETED|Overall Study||13
100219|NCT01252251|238758|P1|STARTED|Overall Study||14
100220|NCT01252238|238770|P3|NOT COMPLETED|Overall Study||4
100221|NCT01252238|238771|P2|NOT COMPLETED|Overall Study||4
100222|NCT01252238|238772|P1|NOT COMPLETED|Overall Study||4
100223|NCT01252238|238770|P3|COMPLETED|Overall Study|sponsor terminated study|4
100224|NCT01252238|238771|P2|COMPLETED|Overall Study|sponsor terminated study|4
100225|NCT01252238|238772|P1|COMPLETED|Overall Study|sponsor terminated study|4
100226|NCT01252238|238770|P3|STARTED|Overall Study||8
100227|NCT01252238|238771|P2|STARTED|Overall Study||8
100228|NCT01252238|238772|P1|STARTED|Overall Study||8
100229|NCT01252186|238783|P3|NOT COMPLETED|Overall Study||34
100230|NCT01252186|238784|P2|NOT COMPLETED|Overall Study||32
100231|NCT01252186|238785|P1|NOT COMPLETED|Overall Study||30
100232|NCT01252186|238783|P3|COMPLETED|Overall Study||53
100233|NCT01252186|238784|P2|COMPLETED|Overall Study||59
100234|NCT01252186|238785|P1|COMPLETED|Overall Study||57
100235|NCT01252186|238783|P3|Received Study Drug|Overall Study||80
100236|NCT01252186|238784|P2|Received Study Drug|Overall Study||89
100237|NCT01252186|238785|P1|Received Study Drug|Overall Study||83
100238|NCT01252186|238783|P3|STARTED|Overall Study||87
100239|NCT01252186|238784|P2|STARTED|Overall Study||91
100240|NCT01252186|238785|P1|STARTED|Overall Study||87
100241|NCT01252147|238853|P1|NOT COMPLETED|Overall Study||0
100242|NCT01252147|238853|P1|COMPLETED|Overall Study||68
100243|NCT01252147|238853|P1|STARTED|Overall Study||68
100244|NCT01252134|238858|P6|NOT COMPLETED|Period 3, 8 Hours||0
100245|NCT01252134|238859|P5|NOT COMPLETED|Period 3, 8 Hours||0
100246|NCT01252134|238860|P4|NOT COMPLETED|Period 3, 8 Hours||0
100247|NCT01252134|238861|P3|NOT COMPLETED|Period 3, 8 Hours||0
100248|NCT01252134|238862|P2|NOT COMPLETED|Period 3, 8 Hours||0
100249|NCT01252134|238863|P1|NOT COMPLETED|Period 3, 8 Hours||0
100250|NCT01252134|238858|P6|COMPLETED|Period 3, 8 Hours||4
100251|NCT01252134|238859|P5|COMPLETED|Period 3, 8 Hours||3
100252|NCT01252134|238860|P4|COMPLETED|Period 3, 8 Hours||5
100253|NCT01252134|238861|P3|COMPLETED|Period 3, 8 Hours||2
100254|NCT01252134|238862|P2|COMPLETED|Period 3, 8 Hours||3
100255|NCT01252134|238863|P1|COMPLETED|Period 3, 8 Hours||3
100256|NCT01252134|238858|P6|STARTED|Period 3, 8 Hours||4
100257|NCT01252134|238859|P5|STARTED|Period 3, 8 Hours||3
100258|NCT01252134|238860|P4|STARTED|Period 3, 8 Hours||5
100259|NCT01252134|238861|P3|STARTED|Period 3, 8 Hours||2
100260|NCT01252134|238862|P2|STARTED|Period 3, 8 Hours||3
100261|NCT01252134|238863|P1|STARTED|Period 3, 8 Hours||3
100262|NCT01252134|238858|P6|NOT COMPLETED|Period 2, 8 Hours||0
100263|NCT01252134|238859|P5|NOT COMPLETED|Period 2, 8 Hours||0
100264|NCT01252134|238860|P4|NOT COMPLETED|Period 2, 8 Hours||0
100265|NCT01252134|238861|P3|NOT COMPLETED|Period 2, 8 Hours||0
100266|NCT01252134|238862|P2|NOT COMPLETED|Period 2, 8 Hours||0
100267|NCT01252134|238863|P1|NOT COMPLETED|Period 2, 8 Hours||0
100268|NCT01252134|238858|P6|COMPLETED|Period 2, 8 Hours||4
100269|NCT01252134|238859|P5|COMPLETED|Period 2, 8 Hours||3
100270|NCT01252134|238860|P4|COMPLETED|Period 2, 8 Hours||5
100271|NCT01252134|238861|P3|COMPLETED|Period 2, 8 Hours||2
100272|NCT01252134|238862|P2|COMPLETED|Period 2, 8 Hours||3
100273|NCT01252134|238863|P1|COMPLETED|Period 2, 8 Hours||3
100274|NCT01252134|238858|P6|STARTED|Period 2, 8 Hours||4
100275|NCT01252134|238859|P5|STARTED|Period 2, 8 Hours||3
100276|NCT01252134|238860|P4|STARTED|Period 2, 8 Hours||5
100277|NCT01252134|238861|P3|STARTED|Period 2, 8 Hours||2
100278|NCT01252134|238862|P2|STARTED|Period 2, 8 Hours||3
100279|NCT01252134|238863|P1|STARTED|Period 2, 8 Hours||3
100280|NCT01252134|238858|P6|NOT COMPLETED|Period 1, 8 Hours||0
100281|NCT01252134|238859|P5|NOT COMPLETED|Period 1, 8 Hours||0
100282|NCT01252134|238860|P4|NOT COMPLETED|Period 1, 8 Hours||0
100283|NCT01252134|238861|P3|NOT COMPLETED|Period 1, 8 Hours||1
100284|NCT01252134|238862|P2|NOT COMPLETED|Period 1, 8 Hours||1
100285|NCT01252134|238863|P1|NOT COMPLETED|Period 1, 8 Hours||0
100286|NCT01252134|238858|P6|COMPLETED|Period 1, 8 Hours||4
100287|NCT01252134|238859|P5|COMPLETED|Period 1, 8 Hours||3
100288|NCT01252134|238860|P4|COMPLETED|Period 1, 8 Hours||5
100289|NCT01252134|238861|P3|COMPLETED|Period 1, 8 Hours||2
100290|NCT01252134|238862|P2|COMPLETED|Period 1, 8 Hours||3
100291|NCT01252134|238863|P1|COMPLETED|Period 1, 8 Hours||3
100292|NCT01252134|238858|P6|STARTED|Period 1, 8 Hours||4
100293|NCT01252134|238859|P5|STARTED|Period 1, 8 Hours||3
100294|NCT01252134|238860|P4|STARTED|Period 1, 8 Hours||5
100295|NCT01252134|238861|P3|STARTED|Period 1, 8 Hours||3
100296|NCT01252134|238862|P2|STARTED|Period 1, 8 Hours||4
100297|NCT01252134|238863|P1|STARTED|Period 1, 8 Hours||3
100298|NCT01252095|238882|P2|NOT COMPLETED|Overall Study||0
100299|NCT01252095|238883|P1|NOT COMPLETED|Overall Study||1
100300|NCT01252095|238882|P2|COMPLETED|Overall Study||1
100301|NCT01252095|238883|P1|COMPLETED|Overall Study||2
100302|NCT01252095|238882|P2|STARTED|Overall Study||1
100303|NCT01252095|238883|P1|STARTED|Overall Study||3
100304|NCT01251978|238891|P2|NOT COMPLETED|Overall Study||0
100305|NCT01251978|238892|P1|NOT COMPLETED|Overall Study||0
100306|NCT01251978|238891|P2|COMPLETED|Overall Study||3
100307|NCT01251978|238892|P1|COMPLETED|Overall Study||5
100308|NCT01251978|238891|P2|STARTED|Overall Study||3
100309|NCT01251978|238892|P1|STARTED|Overall Study||5
100310|NCT01251952|238901|P1|NOT COMPLETED|Overall Study||1
100311|NCT01251952|238901|P1|COMPLETED|Overall Study||1
100312|NCT01251952|238901|P1|STARTED|Overall Study||2
100313|NCT01251770|238907|P2|NOT COMPLETED|Overall Study||7
100314|NCT01251770|238908|P1|NOT COMPLETED|Overall Study||13
100315|NCT01251770|238907|P2|COMPLETED|Overall Study||29
100316|NCT01251770|238908|P1|COMPLETED|Overall Study||29
100317|NCT01251770|238907|P2|STARTED|Overall Study||36
100318|NCT01251770|238908|P1|STARTED|Overall Study||42
100319|NCT01251757|238919|P3|NOT COMPLETED|Overall Study||0
100320|NCT01251757|238920|P2|NOT COMPLETED|Overall Study||0
100321|NCT01251757|238921|P1|NOT COMPLETED|Overall Study||0
100322|NCT01251757|238919|P3|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.5) mos, but we computed an adherence score for everyone.|7250
100323|NCT01251757|238920|P2|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.6 (2.4) mos, but we computed an adherence score for everyone.|7247
100324|NCT01251757|238921|P1|COMPLETED|Overall Study|mean (SD) duration of follow-up was 9.7 (2.3) mos, but we computed an adherence score for everyone.|7255
100325|NCT01251757|238919|P3|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7250
100326|NCT01251757|238920|P2|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7247
100327|NCT01251757|238921|P1|STARTED|Overall Study|Separate analyses were done for statin users and ACEI/ARB users. This is the combined N.|7255
100328|NCT01251653|238959|P9|NOT COMPLETED|Overall Study||6
100329|NCT01251653|238960|P8|NOT COMPLETED|Overall Study||12
100330|NCT01251653|238961|P7|NOT COMPLETED|Overall Study||18
100331|NCT01251653|238962|P6|NOT COMPLETED|Overall Study||18
100332|NCT01251653|238963|P5|NOT COMPLETED|Overall Study||2
100333|NCT01251653|238964|P4|NOT COMPLETED|Overall Study||6
100334|NCT01251653|238965|P3|NOT COMPLETED|Overall Study||20
100335|NCT01251653|238966|P2|NOT COMPLETED|Overall Study||8
100336|NCT01251653|238967|P1|NOT COMPLETED|Overall Study||3
100337|NCT01251653|238959|P9|COMPLETED|Overall Study||0
100338|NCT01251653|238960|P8|COMPLETED|Overall Study||0
100339|NCT01251653|238961|P7|COMPLETED|Overall Study||0
100340|NCT01251653|238962|P6|COMPLETED|Overall Study||0
100341|NCT01251653|238963|P5|COMPLETED|Overall Study||0
100342|NCT01251653|238964|P4|COMPLETED|Overall Study||0
100343|NCT01251653|238965|P3|COMPLETED|Overall Study||0
100344|NCT01251653|238966|P2|COMPLETED|Overall Study||0
100345|NCT01251653|238967|P1|COMPLETED|Overall Study||0
100346|NCT01251653|238959|P9|STARTED|Overall Study||6
100347|NCT01251653|238960|P8|STARTED|Overall Study||12
100348|NCT01251653|238961|P7|STARTED|Overall Study||18
100349|NCT01251653|238962|P6|STARTED|Overall Study||18
100350|NCT01251653|238963|P5|STARTED|Overall Study||2
100351|NCT01251653|238964|P4|STARTED|Overall Study||6
100352|NCT01251653|238965|P3|STARTED|Overall Study||20
100353|NCT01251653|238966|P2|STARTED|Overall Study||8
100354|NCT01251653|238967|P1|STARTED|Overall Study||3
100355|NCT01251614|239095|P3|NOT COMPLETED|Overall Study||8
100356|NCT01251614|239096|P2|NOT COMPLETED|Overall Study||13
100357|NCT01251614|239097|P1|NOT COMPLETED|Overall Study||3
100358|NCT01251614|239095|P3|COMPLETED|Overall Study||30
100359|NCT01251614|239096|P2|COMPLETED|Overall Study||26
100360|NCT01251614|239097|P1|COMPLETED|Overall Study||34
100361|NCT01251614|239095|P3|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
100362|NCT01251614|239096|P2|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
100363|NCT01251614|239097|P1|Entered Period D|Overall Study|Long-Term Follow-Up Phase (52 Weeks)|36
100364|NCT01251614|239095|P3|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|19
100365|NCT01251614|239096|P2|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|11
100366|NCT01251614|239097|P1|Entered Period C|Overall Study|Only participants who experienced loss of disease control in Period B entered the Re-Treatment Phase|8
100367|NCT01251614|239095|P3|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|23
100368|NCT01251614|239096|P2|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|18
100369|NCT01251614|239097|P1|Entered Period B|Overall Study|Only participants who were responders at Week 16 (Period A) entered the Treatment Withdrawal Phase|13
100370|NCT01251614|239095|P3|STARTED|Overall Study||38
100371|NCT01251614|239096|P2|STARTED|Overall Study||39
100372|NCT01251614|239097|P1|STARTED|Overall Study||37
100373|NCT01251588|239171|P2|NOT COMPLETED|Overall Study||4
100374|NCT01251588|239172|P1|NOT COMPLETED|Overall Study||0
100375|NCT01251588|239171|P2|COMPLETED|Overall Study||59
100376|NCT01251588|239172|P1|COMPLETED|Overall Study||65
100377|NCT01251588|239171|P2|STARTED|Overall Study||63
100378|NCT01251588|239172|P1|STARTED|Overall Study||65
100379|NCT01251380|239204|P1|NOT COMPLETED|Overall Study||22
100380|NCT01251380|239204|P1|COMPLETED|Overall Study||194
100381|NCT01251380|239204|P1|Cycle 4|Overall Study||11
100382|NCT01251380|239204|P1|Cycle 3|Overall Study||86
100383|NCT01251380|239204|P1|Cycle 2|Overall Study||175
100384|NCT01251380|239204|P1|Cycle 1|Overall Study||207
100385|NCT01251380|239204|P1|STARTED|Overall Study|Safety population.|216
100386|NCT01251354|239228|P1|NOT COMPLETED|Overall Study||6
100387|NCT01251354|239228|P1|COMPLETED|Overall Study||0
100388|NCT01251354|239228|P1|STARTED|Overall Study||6
100389|NCT01251315|239244|P6|NOT COMPLETED|Overall Study||0
100390|NCT01251315|239245|P5|NOT COMPLETED|Overall Study||0
100391|NCT01251315|239246|P4|NOT COMPLETED|Overall Study||0
100392|NCT01251315|239247|P3|NOT COMPLETED|Overall Study||0
100393|NCT01251315|239248|P2|NOT COMPLETED|Overall Study||0
100394|NCT01251315|239249|P1|NOT COMPLETED|Overall Study||0
100395|NCT01251315|239244|P6|COMPLETED|Overall Study||4
100396|NCT01251315|239245|P5|COMPLETED|Overall Study||4
100397|NCT01251315|239246|P4|COMPLETED|Overall Study||4
100398|NCT01251315|239247|P3|COMPLETED|Overall Study||4
100399|NCT01251315|239248|P2|COMPLETED|Overall Study||4
100400|NCT01251315|239249|P1|COMPLETED|Overall Study||4
100401|NCT01251315|239244|P6|STARTED|Overall Study||4
100402|NCT01251315|239245|P5|STARTED|Overall Study||4
100403|NCT01251315|239246|P4|STARTED|Overall Study||4
100404|NCT01251315|239247|P3|STARTED|Overall Study||4
100405|NCT01251315|239248|P2|STARTED|Overall Study||4
100406|NCT01251315|239249|P1|STARTED|Overall Study||4
100407|NCT01251276|239271|P2|NOT COMPLETED|Overall Study||1
100408|NCT01251276|239272|P1|NOT COMPLETED|Overall Study||1
100409|NCT01251276|239271|P2|COMPLETED|Overall Study||107
100410|NCT01251276|239272|P1|COMPLETED|Overall Study||95
100411|NCT01251276|239271|P2|Vaccinated|Overall Study||108
100412|NCT01251276|239272|P1|Vaccinated|Overall Study||96
100413|NCT01251276|239271|P2|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|108
100414|NCT01251276|239272|P1|STARTED|Overall Study|Not all Base Study completers enrolled in the Challenge Dose Study|96
100415|NCT01251146|239290|P2|NOT COMPLETED|Overall Study||10
100416|NCT01251146|239291|P1|NOT COMPLETED|Overall Study||3
100417|NCT01251146|239290|P2|COMPLETED|Overall Study||81
100418|NCT01251146|239291|P1|COMPLETED|Overall Study||83
100419|NCT01251146|239290|P2|STARTED|Overall Study||91
100420|NCT01251146|239291|P1|STARTED|Overall Study||86
100421|NCT01251120|239313|P2|NOT COMPLETED|Overall Study||1
100422|NCT01251120|239314|P1|NOT COMPLETED|Overall Study||0
100423|NCT01251120|239313|P2|COMPLETED|Overall Study||0
100424|NCT01251120|239314|P1|COMPLETED|Overall Study||1
100425|NCT01251120|239313|P2|STARTED|Overall Study||1
100426|NCT01251120|239314|P1|STARTED|Overall Study||1
100427|NCT01251042|239336|P2|NOT COMPLETED|Overall Study||0
100428|NCT01251042|239337|P1|NOT COMPLETED|Overall Study||0
100429|NCT01251042|239336|P2|COMPLETED|Overall Study||23
100430|NCT01251042|239337|P1|COMPLETED|Overall Study||26
100431|NCT01251042|239336|P2|STARTED|Overall Study||23
100432|NCT01251042|239337|P1|STARTED|Overall Study||26
100433|NCT01250990|239369|P2|NOT COMPLETED|Overall Study||2
100434|NCT01250990|239370|P1|NOT COMPLETED|Overall Study||4
100435|NCT01250990|239369|P2|COMPLETED|Overall Study||9
100436|NCT01250990|239370|P1|COMPLETED|Overall Study||7
100437|NCT01250990|239369|P2|STARTED|Overall Study||11
100438|NCT01250990|239370|P1|STARTED|Overall Study||11
100439|NCT01250925|239379|P3|NOT COMPLETED|Overall Study||2
100440|NCT01250925|239380|P2|NOT COMPLETED|Overall Study||3
100441|NCT01250925|239381|P1|NOT COMPLETED|Overall Study||5
100442|NCT01250925|239379|P3|COMPLETED|Overall Study||30
100443|NCT01250925|239380|P2|COMPLETED|Overall Study||28
100444|NCT01250925|239381|P1|COMPLETED|Overall Study||26
100445|NCT01250925|239379|P3|STARTED|Overall Study||32
100446|NCT01250925|239380|P2|STARTED|Overall Study||31
100447|NCT01250925|239381|P1|STARTED|Overall Study||31
100448|NCT01250899|239421|P2|NOT COMPLETED|Overall Study||0
100449|NCT01250899|239422|P1|NOT COMPLETED|Overall Study||0
100450|NCT01250899|239421|P2|COMPLETED|Overall Study||82
100451|NCT01250899|239422|P1|COMPLETED|Overall Study||40
100452|NCT01250899|239421|P2|STARTED|Overall Study||82
100453|NCT01250899|239422|P1|STARTED|Overall Study||40
100454|NCT01250834|239426|P1|NOT COMPLETED|Overall Study||0
100455|NCT01250834|239426|P1|COMPLETED|Overall Study||27
100456|NCT01250834|239426|P1|STARTED|Overall Study||27
100457|NCT01250769|239447|P4|NOT COMPLETED|Overall Study||0
100458|NCT01250769|239448|P3|NOT COMPLETED|Overall Study||2
100459|NCT01250769|239449|P2|NOT COMPLETED|Overall Study||1
100460|NCT01250769|239450|P1|NOT COMPLETED|Overall Study||0
100461|NCT01250769|239447|P4|COMPLETED|Overall Study||11
100462|NCT01250769|239448|P3|COMPLETED|Overall Study||73
100463|NCT01250769|239449|P2|COMPLETED|Overall Study||72
100464|NCT01250769|239450|P1|COMPLETED|Overall Study||11
100465|NCT01250769|239447|P4|Day 14|Overall Study||11
100466|NCT01250769|239448|P3|Day 14|Overall Study||74
100467|NCT01250769|239449|P2|Day 14|Overall Study||72
100468|NCT01250769|239450|P1|Day 14|Overall Study||11
100469|NCT01250769|239447|P4|STARTED|Overall Study||11
100470|NCT01250769|239448|P3|STARTED|Overall Study||75
100471|NCT01250769|239449|P2|STARTED|Overall Study||73
100472|NCT01250769|239450|P1|STARTED|Overall Study||11
100473|NCT01250756|239482|P2|NOT COMPLETED|After Toddler Dose||1
100474|NCT01250756|239483|P1|NOT COMPLETED|After Toddler Dose||0
100475|NCT01250756|239482|P2|COMPLETED|After Toddler Dose||147
100476|NCT01250756|239483|P1|COMPLETED|After Toddler Dose||0
100477|NCT01250756|239482|P2|STARTED|After Toddler Dose||148
100478|NCT01250756|239483|P1|STARTED|After Toddler Dose||0
100479|NCT01250756|239482|P2|NOT COMPLETED|Toddler Dose||1
100480|NCT01250756|239483|P1|NOT COMPLETED|Toddler Dose||0
100481|NCT01250756|239482|P2|COMPLETED|Toddler Dose||148
100482|NCT01250756|239483|P1|COMPLETED|Toddler Dose||122
100483|NCT01250756|239482|P2|STARTED|Toddler Dose||149
100484|NCT01250756|239483|P1|STARTED|Toddler Dose||122
100485|NCT01250756|239482|P2|NOT COMPLETED|After Infant Series||4
100486|NCT01250756|239483|P1|NOT COMPLETED|After Infant Series||11
100487|NCT01250756|239482|P2|COMPLETED|After Infant Series||149
100488|NCT01250756|239483|P1|COMPLETED|After Infant Series||122
100489|NCT01250756|239482|P2|STARTED|After Infant Series||153
100490|NCT01250756|239483|P1|STARTED|After Infant Series||133
100491|NCT01250756|239482|P2|NOT COMPLETED|Infant Series||7
100492|NCT01250756|239483|P1|NOT COMPLETED|Infant Series||28
100493|NCT01250756|239482|P2|COMPLETED|Infant Series||153
100494|NCT01250756|239483|P1|COMPLETED|Infant Series||133
100495|NCT01250756|239482|P2|Vaccinated Dose 3|Infant Series||155
100496|NCT01250756|239483|P1|Vaccinated Dose 3|Infant Series||133
100497|NCT01250756|239482|P2|Vaccinated Dose 2|Infant Series||157
100498|NCT01250756|239483|P1|Vaccinated Dose 2|Infant Series||147
100499|NCT01250756|239482|P2|Vaccinated Dose 1|Infant Series||158
100500|NCT01250756|239483|P1|Vaccinated Dose 1|Infant Series||159
100501|NCT01250756|239482|P2|STARTED|Infant Series||160
100502|NCT01250756|239483|P1|STARTED|Infant Series||161
100503|NCT01250730|239536|P3|NOT COMPLETED|Overall Study||0
100504|NCT01250730|239537|P2|NOT COMPLETED|Overall Study||0
100505|NCT01250730|239538|P1|NOT COMPLETED|Overall Study||0
100506|NCT01250730|239536|P3|COMPLETED|Overall Study||6
100507|NCT01250730|239537|P2|COMPLETED|Overall Study||6
100508|NCT01250730|239538|P1|COMPLETED|Overall Study||6
100509|NCT01250730|239536|P3|STARTED|Overall Study||6
100510|NCT01250730|239537|P2|STARTED|Overall Study||6
100511|NCT01250730|239538|P1|STARTED|Overall Study||6
100512|NCT01250717|239594|P1|NOT COMPLETED|Overall Study||0
100513|NCT01250717|239594|P1|COMPLETED|Overall Study||28
100514|NCT01250717|239594|P1|STARTED|Overall Study||28
100515|NCT01250509|239600|P2|NOT COMPLETED|Overall Study||2
100516|NCT01250509|239601|P1|NOT COMPLETED|Overall Study||5
100517|NCT01250509|239600|P2|COMPLETED|Overall Study||21
100518|NCT01250509|239601|P1|COMPLETED|Overall Study||19
100519|NCT01250509|239600|P2|STARTED|Overall Study||23
100520|NCT01250509|239601|P1|STARTED|Overall Study||24
100521|NCT01250418|239615|P2|NOT COMPLETED|Overall Study||1
100522|NCT01250418|239616|P1|NOT COMPLETED|Overall Study||1
100523|NCT01250418|239615|P2|COMPLETED|Overall Study||15
100524|NCT01250418|239616|P1|COMPLETED|Overall Study||8
100525|NCT01250418|239615|P2|STARTED|Overall Study||16
100526|NCT01250418|239616|P1|STARTED|Overall Study||9
100527|NCT01250379|239624|P2|NOT COMPLETED|Overall Study||193
100528|NCT01250379|239625|P1|NOT COMPLETED|Overall Study||202
100529|NCT01250379|239624|P2|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|54
100530|NCT01250379|239625|P1|COMPLETED|Overall Study|Participants under study follow-up as of Data Cutoff 30 April 2015 were considered as completers.|45
100531|NCT01250379|239624|P2|STARTED|Overall Study||247
100532|NCT01250379|239625|P1|STARTED|Overall Study||247
100533|NCT01250184|239686|P3|NOT COMPLETED|Overall Study||0
100534|NCT01250184|239687|P2|NOT COMPLETED|Overall Study||0
100535|NCT01250184|239688|P1|NOT COMPLETED|Overall Study||0
100536|NCT01250184|239686|P3|COMPLETED|Overall Study||43
100537|NCT01250184|239687|P2|COMPLETED|Overall Study||41
100538|NCT01250184|239688|P1|COMPLETED|Overall Study||43
100539|NCT01250184|239686|P3|STARTED|Overall Study||43
100540|NCT01250184|239687|P2|STARTED|Overall Study||41
100541|NCT01250184|239688|P1|STARTED|Overall Study||43
100542|NCT01250171|239714|P3|NOT COMPLETED|Overall Study||0
100543|NCT01250171|239715|P2|NOT COMPLETED|Overall Study||0
100544|NCT01250171|239716|P1|NOT COMPLETED|Overall Study||1
100545|NCT01250171|239714|P3|COMPLETED|Overall Study||24
100546|NCT01250171|239715|P2|COMPLETED|Overall Study||22
100547|NCT01250171|239716|P1|COMPLETED|Overall Study||25
100548|NCT01250171|239714|P3|STARTED|Overall Study||24
100549|NCT01250171|239715|P2|STARTED|Overall Study||22
100550|NCT01250171|239716|P1|STARTED|Overall Study||26
100551|NCT01250145|239747|P2|NOT COMPLETED|Overall Study||5
100552|NCT01250145|239748|P1|NOT COMPLETED|Overall Study||2
100553|NCT01250145|239747|P2|COMPLETED|Overall Study||205
100554|NCT01250145|239748|P1|COMPLETED|Overall Study||39
100555|NCT01250145|239747|P2|STARTED|Overall Study||210
100556|NCT01250145|239748|P1|STARTED|Overall Study||41
100557|NCT01250119|239768|P2|NOT COMPLETED|Treatment Phase||41
100558|NCT01250119|239769|P1|NOT COMPLETED|Treatment Phase||0
100559|NCT01250119|239768|P2|COMPLETED|Treatment Phase||0
100560|NCT01250119|239769|P1|COMPLETED|Treatment Phase||0
100561|NCT01250119|239768|P2|STARTED|Treatment Phase|Out of 52 participants with positive EGFR mutation test result, only 41 participants were treated.|41
100562|NCT01250119|239769|P1|STARTED|Treatment Phase||0
100563|NCT01250119|239768|P2|NOT COMPLETED|Diagnostic Phase||0
100564|NCT01250119|239769|P1|NOT COMPLETED|Diagnostic Phase||113
100565|NCT01250119|239768|P2|COMPLETED|Diagnostic Phase||0
100566|NCT01250119|239769|P1|COMPLETED|Diagnostic Phase|Completed refers to participants with both positive and negative EGFR mutation test result.|575
100567|NCT01250119|239768|P2|STARTED|Diagnostic Phase||0
100568|NCT01250119|239769|P1|STARTED|Diagnostic Phase||688
100569|NCT01250054|239784|P2|NOT COMPLETED|Period 2, One Week of Wear||0
100570|NCT01250054|239785|P1|NOT COMPLETED|Period 2, One Week of Wear||1
100571|NCT01250054|239784|P2|COMPLETED|Period 2, One Week of Wear||8
100572|NCT01250054|239785|P1|COMPLETED|Period 2, One Week of Wear||6
100573|NCT01250054|239784|P2|STARTED|Period 2, One Week of Wear||8
100574|NCT01250054|239785|P1|STARTED|Period 2, One Week of Wear||7
100575|NCT01250054|239784|P2|NOT COMPLETED|Period 1, One Week of Wear||0
100576|NCT01250054|239785|P1|NOT COMPLETED|Period 1, One Week of Wear||0
100577|NCT01250054|239784|P2|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to noncompliance.|8
100578|NCT01250054|239785|P1|COMPLETED|Period 1, One Week of Wear|One subject discontinued between Period 1 and Period 2 due to power availability.|8
100579|NCT01250054|239784|P2|STARTED|Period 1, One Week of Wear|One subject did not wear Period 1 lenses due to power availability and proceeded to Period 2 lenses.|8
100580|NCT01250054|239785|P1|STARTED|Period 1, One Week of Wear||8
100581|NCT01250002|239793|P2|NOT COMPLETED|Overall Study||3
100582|NCT01250002|239794|P1|NOT COMPLETED|Overall Study||4
100583|NCT01250002|239793|P2|COMPLETED|Overall Study||32
100584|NCT01250002|239794|P1|COMPLETED|Overall Study||31
100585|NCT01250002|239793|P2|STARTED|Overall Study||35
100586|NCT01250002|239794|P1|STARTED|Overall Study||35
100587|NCT01249872|239808|P6|NOT COMPLETED|Overall Study||0
100588|NCT01249872|239809|P5|NOT COMPLETED|Overall Study||0
100589|NCT01249872|239810|P4|NOT COMPLETED|Overall Study||0
100590|NCT01249872|239811|P3|NOT COMPLETED|Overall Study||0
100591|NCT01249872|239812|P2|NOT COMPLETED|Overall Study||0
100592|NCT01249872|239813|P1|NOT COMPLETED|Overall Study||0
100593|NCT01249872|239808|P6|COMPLETED|Overall Study||16
100594|NCT01249872|239809|P5|COMPLETED|Overall Study||16
100595|NCT01249872|239810|P4|COMPLETED|Overall Study||16
100596|NCT01249872|239811|P3|COMPLETED|Overall Study||16
100597|NCT01249872|239812|P2|COMPLETED|Overall Study||16
100598|NCT01249872|239813|P1|COMPLETED|Overall Study||16
100599|NCT01249872|239808|P6|STARTED|Overall Study||16
100600|NCT01249872|239809|P5|STARTED|Overall Study||16
100601|NCT01249872|239810|P4|STARTED|Overall Study||16
100602|NCT01249872|239811|P3|STARTED|Overall Study||16
100603|NCT01249872|239812|P2|STARTED|Overall Study||16
100604|NCT01249872|239813|P1|STARTED|Overall Study||16
100605|NCT01249833|239859|P2|NOT COMPLETED|Overall Study||1
100606|NCT01249833|239860|P1|NOT COMPLETED|Overall Study||0
100607|NCT01249833|239859|P2|COMPLETED|Overall Study||62
100608|NCT01249833|239860|P1|COMPLETED|Overall Study||59
100609|NCT01249833|239859|P2|STARTED|Overall Study||63
100610|NCT01249833|239860|P1|STARTED|Overall Study||59
100611|NCT01249664|239874|P2|NOT COMPLETED|Overall Study||0
100612|NCT01249664|239875|P1|NOT COMPLETED|Overall Study||6
100613|NCT01249664|239874|P2|COMPLETED|Overall Study|Completers of study visits up to week 48|31
100614|NCT01249664|239875|P1|COMPLETED|Overall Study|Completers of study visits up to week 48|85
100615|NCT01249664|239874|P2|Completed 48 Weeks Treatment|Overall Study||24
100616|NCT01249664|239875|P1|Completed 48 Weeks Treatment|Overall Study||78
100617|NCT01249664|239874|P2|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|25
100618|NCT01249664|239875|P1|Completed 24 Weeks Treatment|Overall Study|Withdrawal from treatment does not equal to withdrawal from study.|83
100619|NCT01249664|239874|P2|Fulfilled Requirements of FAS Population|Overall Study|FAS population: Basis of efficacy evaluation|31
100620|NCT01249664|239875|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) population: Basis of efficacy evaluation|90
100621|NCT01249664|239874|P2|Participants Received Treatment|Overall Study|Safety population|31
100622|NCT01249664|239875|P1|Participants Received Treatment|Overall Study|Safety population|91
100623|NCT01249664|239874|P2|STARTED|Overall Study||31
100624|NCT01249664|239875|P1|STARTED|Overall Study||91
100625|NCT01249651|239925|P1|NOT COMPLETED|Overall Study||7
100626|NCT01249651|239925|P1|COMPLETED|Overall Study|Completed the 8-week treatment period|94
100627|NCT01249651|239925|P1|STARTED|Overall Study|Enrolled|101
100628|NCT01249417|239935|P3|NOT COMPLETED|Treatment Phase - ITT Population||4
100629|NCT01249417|239936|P2|NOT COMPLETED|Treatment Phase - ITT Population||4
100630|NCT01249417|239937|P1|NOT COMPLETED|Treatment Phase - ITT Population||1
100631|NCT01249417|239935|P3|COMPLETED|Treatment Phase - ITT Population||73
100632|NCT01249417|239936|P2|COMPLETED|Treatment Phase - ITT Population||75
100633|NCT01249417|239937|P1|COMPLETED|Treatment Phase - ITT Population||78
100634|NCT01249417|239935|P3|STARTED|Treatment Phase - ITT Population||77
100635|NCT01249417|239936|P2|STARTED|Treatment Phase - ITT Population||79
100636|NCT01249417|239937|P1|STARTED|Treatment Phase - ITT Population||79
100637|NCT01249417|239935|P3|NOT COMPLETED|Randomised Population||4
100638|NCT01249417|239936|P2|NOT COMPLETED|Randomised Population||1
100639|NCT01249417|239937|P1|NOT COMPLETED|Randomised Population||1
100640|NCT01249417|239935|P3|COMPLETED|Randomised Population||77
100641|NCT01249417|239936|P2|COMPLETED|Randomised Population||79
100642|NCT01249417|239937|P1|COMPLETED|Randomised Population||79
100643|NCT01249417|239935|P3|Treated|Randomised Population||79
100644|NCT01249417|239936|P2|Treated|Randomised Population||80
100645|NCT01249417|239937|P1|Treated|Randomised Population||80
100646|NCT01249417|239935|P3|STARTED|Randomised Population||81
100647|NCT01249417|239936|P2|STARTED|Randomised Population||80
100648|NCT01249417|239937|P1|STARTED|Randomised Population||80
100649|NCT01249274|239953|P2|NOT COMPLETED|Overall Study||6
100650|NCT01249274|239954|P1|NOT COMPLETED|Overall Study||4
100651|NCT01249274|239953|P2|COMPLETED|Overall Study||19
100652|NCT01249274|239954|P1|COMPLETED|Overall Study||21
100653|NCT01249274|239953|P2|Completed Post Trial Visit But Not tx|Overall Study||2
100654|NCT01249274|239954|P1|Completed Post Trial Visit But Not tx|Overall Study||1
100655|NCT01249274|239953|P2|Completed Treatment & Post Trial Visit|Overall Study||17
100656|NCT01249274|239954|P1|Completed Treatment & Post Trial Visit|Overall Study||20
100657|NCT01249274|239953|P2|Completed Treatment|Overall Study||19
100658|NCT01249274|239954|P1|Completed Treatment|Overall Study||21
100659|NCT01249274|239953|P2|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
100660|NCT01249274|239954|P1|STARTED|Overall Study|all 25 were included in intention-to-treat and safety analyses|25
100661|NCT01249261|239980|P2|NOT COMPLETED|Overall Study||0
100662|NCT01249261|239981|P1|NOT COMPLETED|Overall Study||1
100663|NCT01249261|239980|P2|COMPLETED|Overall Study||31
100664|NCT01249261|239981|P1|COMPLETED|Overall Study||29
100665|NCT01249261|239980|P2|STARTED|Overall Study||31
100666|NCT01249261|239981|P1|STARTED|Overall Study||30
100667|NCT01249157|240009|P1|NOT COMPLETED|Overall Study||1
100668|NCT01249157|240009|P1|COMPLETED|Overall Study|No data displayed because Outcome Measure has zero total participants analyzed.|0
100669|NCT01249157|240009|P1|STARTED|Overall Study||1
100670|NCT01249131|240013|P6|NOT COMPLETED|Third Intervention||0
100671|NCT01249131|240014|P5|NOT COMPLETED|Third Intervention||0
100672|NCT01249131|240015|P4|NOT COMPLETED|Third Intervention||0
100673|NCT01249131|240016|P3|NOT COMPLETED|Third Intervention||0
100674|NCT01249131|240017|P2|NOT COMPLETED|Third Intervention||0
100675|NCT01249131|240018|P1|NOT COMPLETED|Third Intervention||0
100676|NCT01249131|240013|P6|COMPLETED|Third Intervention||4
100677|NCT01249131|240014|P5|COMPLETED|Third Intervention||2
100678|NCT01249131|240015|P4|COMPLETED|Third Intervention||3
100679|NCT01249131|240016|P3|COMPLETED|Third Intervention||4
100680|NCT01249131|240017|P2|COMPLETED|Third Intervention||3
100681|NCT01249131|240018|P1|COMPLETED|Third Intervention||3
100682|NCT01249131|240013|P6|STARTED|Third Intervention||4
100683|NCT01249131|240014|P5|STARTED|Third Intervention||2
100684|NCT01249131|240015|P4|STARTED|Third Intervention||3
100685|NCT01249131|240016|P3|STARTED|Third Intervention||4
100686|NCT01249131|240017|P2|STARTED|Third Intervention||3
100687|NCT01249131|240018|P1|STARTED|Third Intervention||3
100688|NCT01249131|240013|P6|NOT COMPLETED|Washout Period of 10 Days||0
100689|NCT01249131|240014|P5|NOT COMPLETED|Washout Period of 10 Days||0
100690|NCT01249131|240015|P4|NOT COMPLETED|Washout Period of 10 Days||0
100691|NCT01249131|240016|P3|NOT COMPLETED|Washout Period of 10 Days||0
100692|NCT01249131|240017|P2|NOT COMPLETED|Washout Period of 10 Days||0
100693|NCT01249131|240018|P1|NOT COMPLETED|Washout Period of 10 Days||0
100694|NCT01249131|240013|P6|COMPLETED|Washout Period of 10 Days||4
100695|NCT01249131|240014|P5|COMPLETED|Washout Period of 10 Days||2
100696|NCT01249131|240015|P4|COMPLETED|Washout Period of 10 Days||3
100697|NCT01249131|240016|P3|COMPLETED|Washout Period of 10 Days||4
100698|NCT01249131|240017|P2|COMPLETED|Washout Period of 10 Days||3
100699|NCT01249131|240018|P1|COMPLETED|Washout Period of 10 Days||3
100700|NCT01249131|240013|P6|STARTED|Washout Period of 10 Days||4
100701|NCT01249131|240014|P5|STARTED|Washout Period of 10 Days||2
100702|NCT01249131|240015|P4|STARTED|Washout Period of 10 Days||3
100703|NCT01249131|240016|P3|STARTED|Washout Period of 10 Days||4
100704|NCT01249131|240017|P2|STARTED|Washout Period of 10 Days||3
100705|NCT01249131|240018|P1|STARTED|Washout Period of 10 Days||3
100706|NCT01249131|240013|P6|NOT COMPLETED|Second Intervention||0
100707|NCT01249131|240014|P5|NOT COMPLETED|Second Intervention||0
100708|NCT01249131|240015|P4|NOT COMPLETED|Second Intervention||0
100709|NCT01249131|240016|P3|NOT COMPLETED|Second Intervention||0
100710|NCT01249131|240017|P2|NOT COMPLETED|Second Intervention||0
100711|NCT01249131|240018|P1|NOT COMPLETED|Second Intervention||0
100712|NCT01249131|240013|P6|COMPLETED|Second Intervention||4
100713|NCT01249131|240014|P5|COMPLETED|Second Intervention||2
100714|NCT01249131|240015|P4|COMPLETED|Second Intervention||3
100715|NCT01249131|240016|P3|COMPLETED|Second Intervention||4
100716|NCT01249131|240017|P2|COMPLETED|Second Intervention||3
100717|NCT01249131|240018|P1|COMPLETED|Second Intervention||3
100718|NCT01249131|240013|P6|STARTED|Second Intervention||4
100719|NCT01249131|240014|P5|STARTED|Second Intervention||2
100720|NCT01249131|240015|P4|STARTED|Second Intervention||3
100721|NCT01249131|240016|P3|STARTED|Second Intervention||4
100722|NCT01249131|240017|P2|STARTED|Second Intervention||3
100723|NCT01249131|240018|P1|STARTED|Second Intervention||3
100724|NCT01249131|240013|P6|NOT COMPLETED|Washout Period of 10 Days||0
100725|NCT01249131|240014|P5|NOT COMPLETED|Washout Period of 10 Days||1
100726|NCT01249131|240015|P4|NOT COMPLETED|Washout Period of 10 Days||0
100727|NCT01249131|240016|P3|NOT COMPLETED|Washout Period of 10 Days||0
100728|NCT01249131|240017|P2|NOT COMPLETED|Washout Period of 10 Days||0
100729|NCT01249131|240018|P1|NOT COMPLETED|Washout Period of 10 Days||0
100730|NCT01249131|240013|P6|COMPLETED|Washout Period of 10 Days||4
100731|NCT01249131|240014|P5|COMPLETED|Washout Period of 10 Days||2
100732|NCT01249131|240015|P4|COMPLETED|Washout Period of 10 Days||3
100733|NCT01249131|240016|P3|COMPLETED|Washout Period of 10 Days||4
100734|NCT01249131|240017|P2|COMPLETED|Washout Period of 10 Days||3
100735|NCT01249131|240018|P1|COMPLETED|Washout Period of 10 Days||3
100736|NCT01249131|240013|P6|STARTED|Washout Period of 10 Days||4
100737|NCT01249131|240014|P5|STARTED|Washout Period of 10 Days||3
100738|NCT01249131|240015|P4|STARTED|Washout Period of 10 Days||3
100739|NCT01249131|240016|P3|STARTED|Washout Period of 10 Days||4
100740|NCT01249131|240017|P2|STARTED|Washout Period of 10 Days||3
100741|NCT01249131|240018|P1|STARTED|Washout Period of 10 Days||3
100742|NCT01249131|240013|P6|NOT COMPLETED|First Intervention||0
100743|NCT01249131|240014|P5|NOT COMPLETED|First Intervention||0
100744|NCT01249131|240015|P4|NOT COMPLETED|First Intervention||0
100745|NCT01249131|240016|P3|NOT COMPLETED|First Intervention||0
100746|NCT01249131|240017|P2|NOT COMPLETED|First Intervention||0
100747|NCT01249131|240018|P1|NOT COMPLETED|First Intervention||0
100748|NCT01249131|240013|P6|COMPLETED|First Intervention||4
100749|NCT01249131|240014|P5|COMPLETED|First Intervention||3
100750|NCT01249131|240015|P4|COMPLETED|First Intervention||3
100751|NCT01249131|240016|P3|COMPLETED|First Intervention||4
100752|NCT01249131|240017|P2|COMPLETED|First Intervention||3
100753|NCT01249131|240018|P1|COMPLETED|First Intervention||3
100754|NCT01249131|240013|P6|STARTED|First Intervention||4
100755|NCT01249131|240014|P5|STARTED|First Intervention||3
100756|NCT01249131|240015|P4|STARTED|First Intervention||3
100757|NCT01249131|240016|P3|STARTED|First Intervention||4
100758|NCT01249131|240017|P2|STARTED|First Intervention||3
100759|NCT01249131|240018|P1|STARTED|First Intervention||3
100760|NCT01249118|240038|P3|NOT COMPLETED|Second Washout Period||0
100761|NCT01249118|240039|P2|NOT COMPLETED|Second Washout Period||0
100762|NCT01249118|240040|P1|NOT COMPLETED|Second Washout Period||0
100763|NCT01249118|240038|P3|COMPLETED|Second Washout Period||5
100764|NCT01249118|240039|P2|COMPLETED|Second Washout Period||5
100765|NCT01249118|240040|P1|COMPLETED|Second Washout Period||2
100766|NCT01249118|240038|P3|STARTED|Second Washout Period||5
100767|NCT01249118|240039|P2|STARTED|Second Washout Period||5
100768|NCT01249118|240040|P1|STARTED|Second Washout Period||2
100769|NCT01249118|240038|P3|NOT COMPLETED|Second Intervention Period||0
100770|NCT01249118|240039|P2|NOT COMPLETED|Second Intervention Period||0
100771|NCT01249118|240040|P1|NOT COMPLETED|Second Intervention Period||0
100772|NCT01249118|240038|P3|COMPLETED|Second Intervention Period||5
100773|NCT01249118|240039|P2|COMPLETED|Second Intervention Period||5
100774|NCT01249118|240040|P1|COMPLETED|Second Intervention Period||2
100775|NCT01249118|240038|P3|STARTED|Second Intervention Period||5
100776|NCT01249118|240039|P2|STARTED|Second Intervention Period||5
100777|NCT01249118|240040|P1|STARTED|Second Intervention Period||2
100778|NCT01249118|240038|P3|NOT COMPLETED|First Washout Period||0
100779|NCT01249118|240039|P2|NOT COMPLETED|First Washout Period||1
100780|NCT01249118|240040|P1|NOT COMPLETED|First Washout Period||0
100781|NCT01249118|240038|P3|COMPLETED|First Washout Period||5
100782|NCT01249118|240039|P2|COMPLETED|First Washout Period||5
100783|NCT01249118|240040|P1|COMPLETED|First Washout Period||2
100784|NCT01249118|240038|P3|STARTED|First Washout Period||5
100785|NCT01249118|240039|P2|STARTED|First Washout Period||6
100786|NCT01249118|240040|P1|STARTED|First Washout Period||2
100787|NCT01249118|240038|P3|NOT COMPLETED|First Intervention Period||0
100788|NCT01249118|240039|P2|NOT COMPLETED|First Intervention Period||0
100789|NCT01249118|240040|P1|NOT COMPLETED|First Intervention Period||0
100790|NCT01249118|240038|P3|COMPLETED|First Intervention Period||5
100791|NCT01249118|240039|P2|COMPLETED|First Intervention Period||6
100792|NCT01249118|240040|P1|COMPLETED|First Intervention Period||2
100793|NCT01249118|240038|P3|STARTED|First Intervention Period||5
100794|NCT01249118|240039|P2|STARTED|First Intervention Period||6
100795|NCT01249118|240040|P1|STARTED|First Intervention Period||2
100796|NCT01249092|240074|P1|NOT COMPLETED|Overall Study||2
100797|NCT01249092|240074|P1|COMPLETED|Overall Study||18
100798|NCT01249092|240074|P1|STARTED|Overall Study||20
100799|NCT01248949|240085|P5|NOT COMPLETED|Overall Study||4
100800|NCT01248949|240086|P4|NOT COMPLETED|Overall Study||10
100801|NCT01248949|240087|P3|NOT COMPLETED|Overall Study||37
100802|NCT01248949|240088|P2|NOT COMPLETED|Overall Study||13
100803|NCT01248949|240089|P1|NOT COMPLETED|Overall Study||33
100804|NCT01248949|240085|P5|COMPLETED|Overall Study||3
100805|NCT01248949|240086|P4|COMPLETED|Overall Study||3
100806|NCT01248949|240087|P3|COMPLETED|Overall Study||1
100807|NCT01248949|240088|P2|COMPLETED|Overall Study||3
100808|NCT01248949|240089|P1|COMPLETED|Overall Study||9
100809|NCT01248949|240085|P5|STARTED|Overall Study||7
100810|NCT01248949|240086|P4|STARTED|Overall Study||13
100811|NCT01248949|240087|P3|STARTED|Overall Study||38
100812|NCT01248949|240088|P2|STARTED|Overall Study||16
100813|NCT01248949|240089|P1|STARTED|Overall Study||42
100814|NCT01248936|240201|P1|NOT COMPLETED|Overall Study||374
100815|NCT01248936|240201|P1|COMPLETED|Overall Study||0
100816|NCT01248936|240201|P1|STARTED|Overall Study||374
100817|NCT01248884|240214|P3|NOT COMPLETED|Overall Study||1
100818|NCT01248884|240215|P2|NOT COMPLETED|Overall Study||3
100819|NCT01248884|240216|P1|NOT COMPLETED|Overall Study||2
100820|NCT01248884|240214|P3|COMPLETED|Overall Study||238
100821|NCT01248884|240215|P2|COMPLETED|Overall Study||239
100822|NCT01248884|240216|P1|COMPLETED|Overall Study||238
100823|NCT01248884|240214|P3|STARTED|Overall Study||239
100824|NCT01248884|240215|P2|STARTED|Overall Study||242
100825|NCT01248884|240216|P1|STARTED|Overall Study||240
100826|NCT01248793|240268|P2|NOT COMPLETED|Overall Study||6
100827|NCT01248793|240269|P1|NOT COMPLETED|Overall Study||4
100828|NCT01248793|240268|P2|COMPLETED|Overall Study||102
100829|NCT01248793|240269|P1|COMPLETED|Overall Study||101
100830|NCT01248793|240268|P2|STARTED|Overall Study||108
100831|NCT01248793|240269|P1|STARTED|Overall Study||105
100832|NCT01248780|240283|P2|NOT COMPLETED|Overall Study||15
100833|NCT01248780|240284|P1|NOT COMPLETED|Overall Study||9
100834|NCT01248780|240283|P2|COMPLETED|Overall Study||117
100835|NCT01248780|240284|P1|COMPLETED|Overall Study||123
100836|NCT01248780|240283|P2|STARTED|Overall Study||132
100837|NCT01248780|240284|P1|STARTED|Overall Study||132
100838|NCT01248728|240298|P2|NOT COMPLETED|Overall Study||2
100839|NCT01248728|240299|P1|NOT COMPLETED|Overall Study||4
100840|NCT01248728|240298|P2|COMPLETED|Overall Study||17
100841|NCT01248728|240299|P1|COMPLETED|Overall Study||15
100842|NCT01248728|240298|P2|STARTED|Overall Study||19
100843|NCT01248728|240299|P1|STARTED|Overall Study||19
100844|NCT01248468|240316|P3|NOT COMPLETED|Overall Study||4
100845|NCT01248468|240317|P2|NOT COMPLETED|Overall Study||14
100846|NCT01248468|240318|P1|NOT COMPLETED|Overall Study||15
100847|NCT01248468|240316|P3|COMPLETED|Overall Study||145
100848|NCT01248468|240317|P2|COMPLETED|Overall Study||290
100849|NCT01248468|240318|P1|COMPLETED|Overall Study||284
100850|NCT01248468|240316|P3|ITT Population|Overall Study||125
100851|NCT01248468|240317|P2|ITT Population|Overall Study||261
100852|NCT01248468|240318|P1|ITT Population|Overall Study||256
100853|NCT01248468|240316|P3|Safety Population|Overall Study||133
100854|NCT01248468|240317|P2|Safety Population|Overall Study||271
100855|NCT01248468|240318|P1|Safety Population|Overall Study||266
100856|NCT01248468|240316|P3|STARTED|Overall Study||149
100857|NCT01248468|240317|P2|STARTED|Overall Study||304
100858|NCT01248468|240318|P1|STARTED|Overall Study||299
100859|NCT01248455|240335|P1|NOT COMPLETED|Overall Study||1
100860|NCT01248455|240335|P1|COMPLETED|Overall Study||8
100861|NCT01248455|240335|P1|STARTED|Overall Study||9
100862|NCT01248364|240344|P4|NOT COMPLETED|Overall Study||0
100863|NCT01248364|240345|P3|NOT COMPLETED|Overall Study||0
100864|NCT01248364|240346|P2|NOT COMPLETED|Overall Study||1
100865|NCT01248364|240347|P1|NOT COMPLETED|Overall Study||0
100866|NCT01248364|240344|P4|COMPLETED|Overall Study||12
100867|NCT01248364|240345|P3|COMPLETED|Overall Study||13
100868|NCT01248364|240346|P2|COMPLETED|Overall Study||33
100869|NCT01248364|240347|P1|COMPLETED|Overall Study||32
100870|NCT01248364|240344|P4|Completed Chronic Phase:28-day Treatment|Overall Study||0
100871|NCT01248364|240345|P3|Completed Chronic Phase:28-day Treatment|Overall Study||13
100872|NCT01248364|240346|P2|Completed Chronic Phase:28-day Treatment|Overall Study||33
100873|NCT01248364|240347|P1|Completed Chronic Phase:28-day Treatment|Overall Study||32
100874|NCT01248364|240344|P4|Completed Acute Phase:Single Dose, Day 1|Overall Study||12
100875|NCT01248364|240345|P3|Completed Acute Phase:Single Dose, Day 1|Overall Study||13
100876|NCT01248364|240346|P2|Completed Acute Phase:Single Dose, Day 1|Overall Study||34
100877|NCT01248364|240347|P1|Completed Acute Phase:Single Dose, Day 1|Overall Study||32
100878|NCT01248364|240344|P4|STARTED|Overall Study||12
100879|NCT01248364|240345|P3|STARTED|Overall Study||13
100880|NCT01248364|240346|P2|STARTED|Overall Study||34
100881|NCT01248364|240347|P1|STARTED|Overall Study||32
100882|NCT01248221|240395|P2|NOT COMPLETED|Overall Study||0
100883|NCT01248221|240396|P1|NOT COMPLETED|Overall Study||0
100884|NCT01248221|240395|P2|COMPLETED|Overall Study||15
100885|NCT01248221|240396|P1|COMPLETED|Overall Study||15
100886|NCT01248221|240395|P2|STARTED|Overall Study||15
100887|NCT01248221|240396|P1|STARTED|Overall Study||15
100888|NCT01248130|240410|P2|NOT COMPLETED|Overall Study||0
100889|NCT01248130|240411|P1|NOT COMPLETED|Overall Study||2
100890|NCT01248130|240410|P2|COMPLETED|Overall Study||4
100891|NCT01248130|240411|P1|COMPLETED|Overall Study||1
100892|NCT01248130|240410|P2|STARTED|Overall Study||4
100893|NCT01248130|240411|P1|STARTED|Overall Study||3
100894|NCT01248065|240419|P2|NOT COMPLETED|Overall Study||22
100895|NCT01248065|240420|P1|NOT COMPLETED|Overall Study||26
100896|NCT01248065|240419|P2|COMPLETED|Overall Study|All 201 participants were included in the primary time-to-event analysis.|179
100897|NCT01248065|240420|P1|COMPLETED|Overall Study|All 207 participants were included in the primary time-to-event analysis.|181
100898|NCT01248065|240419|P2|STARTED|Overall Study||201
100899|NCT01248065|240420|P1|STARTED|Overall Study||207
100900|NCT01248013|240430|P1|NOT COMPLETED|Overall Study||14
100901|NCT01248013|240430|P1|COMPLETED|Overall Study||75
100902|NCT01248013|240430|P1|Irritable Bowel Syndrome Hypnotherapy|Overall Study||75
100903|NCT01248013|240430|P1|STARTED|Overall Study||89
100904|NCT01247974|240436|P2|NOT COMPLETED|Overall Study||19
100905|NCT01247974|240437|P1|NOT COMPLETED|Overall Study||26
100906|NCT01247974|240436|P2|COMPLETED|Overall Study||203
100907|NCT01247974|240437|P1|COMPLETED|Overall Study||191
100908|NCT01247974|240436|P2|STARTED|Overall Study||222
100909|NCT01247974|240437|P1|STARTED|Overall Study||217
100910|NCT01247922|240445|P1|NOT COMPLETED|Overall Study||4
100911|NCT01247922|240445|P1|COMPLETED|Overall Study||0
100912|NCT01247922|240445|P1|Treated|Overall Study||4
100913|NCT01247922|240445|P1|STARTED|Overall Study||4
100914|NCT01247675|240455|P4|NOT COMPLETED|Overall Study||0
100915|NCT01247675|240456|P3|NOT COMPLETED|Overall Study||0
100916|NCT01247675|240457|P2|NOT COMPLETED|Overall Study||2
100917|NCT01247675|240458|P1|NOT COMPLETED|Overall Study||2
100918|NCT01247675|240455|P4|COMPLETED|Overall Study||8
100919|NCT01247675|240456|P3|COMPLETED|Overall Study||9
100920|NCT01247675|240457|P2|COMPLETED|Overall Study||8
100921|NCT01247675|240458|P1|COMPLETED|Overall Study||8
100922|NCT01247675|240455|P4|STARTED|Overall Study||8
100923|NCT01247675|240456|P3|STARTED|Overall Study||9
100924|NCT01247675|240457|P2|STARTED|Overall Study||10
100925|NCT01247675|240458|P1|STARTED|Overall Study||10
100926|NCT01247571|240480|P1|NOT COMPLETED|Overall Study||3
100927|NCT01247571|240480|P1|COMPLETED|Overall Study||19
100928|NCT01247571|240480|P1|STARTED|Overall Study||22
100929|NCT01247428|240488|P1|NOT COMPLETED|Overall Study||0
100930|NCT01247428|240488|P1|COMPLETED|Overall Study||30
100931|NCT01247428|240488|P1|STARTED|Overall Study||30
100932|NCT01247324|240511|P2|NOT COMPLETED|Overall Study||44
100933|NCT01247324|240512|P1|NOT COMPLETED|Overall Study||71
100934|NCT01247324|240511|P2|COMPLETED|Overall Study||366
100935|NCT01247324|240512|P1|COMPLETED|Overall Study||340
100936|NCT01247324|240511|P2|STARTED|Overall Study||410
100937|NCT01247324|240512|P1|STARTED|Overall Study||411
100938|NCT01247298|240543|P1|NOT COMPLETED|Overall Study||0
100939|NCT01247298|240543|P1|COMPLETED|Overall Study||17
100940|NCT01247298|240543|P1|STARTED|Overall Study||17
100941|NCT01247285|240553|P2|NOT COMPLETED|Second Intervention||0
100942|NCT01247285|240554|P1|NOT COMPLETED|Second Intervention||0
100943|NCT01247285|240553|P2|COMPLETED|Second Intervention||13
100944|NCT01247285|240554|P1|COMPLETED|Second Intervention||13
100945|NCT01247285|240553|P2|STARTED|Second Intervention||13
100946|NCT01247285|240554|P1|STARTED|Second Intervention||13
100947|NCT01247285|240553|P2|NOT COMPLETED|Washout of 28 Days||0
100948|NCT01247285|240554|P1|NOT COMPLETED|Washout of 28 Days||0
100949|NCT01247285|240553|P2|COMPLETED|Washout of 28 Days||13
100950|NCT01247285|240554|P1|COMPLETED|Washout of 28 Days||13
100951|NCT01247285|240553|P2|STARTED|Washout of 28 Days||13
100952|NCT01247285|240554|P1|STARTED|Washout of 28 Days||13
100953|NCT01247285|240553|P2|NOT COMPLETED|First Intervention||0
100954|NCT01247285|240554|P1|NOT COMPLETED|First Intervention||0
100955|NCT01247285|240553|P2|COMPLETED|First Intervention||13
100956|NCT01247285|240554|P1|COMPLETED|First Intervention||13
100957|NCT01247285|240553|P2|STARTED|First Intervention||13
100958|NCT01247285|240554|P1|STARTED|First Intervention||13
100959|NCT01247272|240572|P2|NOT COMPLETED|Second Intervention||0
100960|NCT01247272|240573|P1|NOT COMPLETED|Second Intervention||0
100961|NCT01247272|240572|P2|COMPLETED|Second Intervention||13
100962|NCT01247272|240573|P1|COMPLETED|Second Intervention||13
100963|NCT01247272|240572|P2|STARTED|Second Intervention||13
100964|NCT01247272|240573|P1|STARTED|Second Intervention||13
100965|NCT01247272|240572|P2|NOT COMPLETED|Washout of 28 Days||0
100966|NCT01247272|240573|P1|NOT COMPLETED|Washout of 28 Days||0
100967|NCT01247272|240572|P2|COMPLETED|Washout of 28 Days||13
100968|NCT01247272|240573|P1|COMPLETED|Washout of 28 Days||13
100969|NCT01247272|240572|P2|STARTED|Washout of 28 Days||13
100970|NCT01247272|240573|P1|STARTED|Washout of 28 Days||13
100971|NCT01247272|240572|P2|NOT COMPLETED|First Intervention||0
100972|NCT01247272|240573|P1|NOT COMPLETED|First Intervention||0
100973|NCT01247272|240572|P2|COMPLETED|First Intervention||13
100974|NCT01247272|240573|P1|COMPLETED|First Intervention||13
100975|NCT01247272|240572|P2|STARTED|First Intervention||13
100976|NCT01247272|240573|P1|STARTED|First Intervention||13
100977|NCT01247220|240591|P2|NOT COMPLETED|Overall Study||0
100978|NCT01247220|240592|P1|NOT COMPLETED|Overall Study||0
100979|NCT01247220|240591|P2|COMPLETED|Overall Study||6
100980|NCT01247220|240592|P1|COMPLETED|Overall Study||6
100981|NCT01247220|240591|P2|STARTED|Overall Study||6
100982|NCT01247220|240592|P1|STARTED|Overall Study||6
100983|NCT01247090|240605|P3|NOT COMPLETED|Overall Study||0
100984|NCT01247090|240606|P2|NOT COMPLETED|Overall Study||1
100985|NCT01247090|240607|P1|NOT COMPLETED|Overall Study||1
100986|NCT01247090|240605|P3|COMPLETED|Overall Study||4
100987|NCT01247090|240606|P2|COMPLETED|Overall Study||3
100988|NCT01247090|240607|P1|COMPLETED|Overall Study||3
100989|NCT01247090|240605|P3|STARTED|Overall Study||4
100990|NCT01247090|240606|P2|STARTED|Overall Study||4
100991|NCT01247090|240607|P1|STARTED|Overall Study||4
100992|NCT01247064|240617|P2|NOT COMPLETED|Overall Study||0
100993|NCT01247064|240618|P1|NOT COMPLETED|Overall Study||0
100994|NCT01247064|240617|P2|COMPLETED|Overall Study||31
100995|NCT01247064|240618|P1|COMPLETED|Overall Study||31
100996|NCT01247064|240617|P2|STARTED|Overall Study||31
100997|NCT01247064|240618|P1|STARTED|Overall Study||31
100998|NCT01246999|240636|P4|NOT COMPLETED|Overall Study||2
100999|NCT01246999|240637|P3|NOT COMPLETED|Overall Study||0
101000|NCT01246999|240638|P2|NOT COMPLETED|Overall Study||1
101001|NCT01246999|240639|P1|NOT COMPLETED|Overall Study||0
101002|NCT01246999|240636|P4|COMPLETED|Overall Study||15
101003|NCT01246999|240637|P3|COMPLETED|Overall Study||2
101004|NCT01246999|240638|P2|COMPLETED|Overall Study||3
101005|NCT01246999|240639|P1|COMPLETED|Overall Study||11
101006|NCT01246999|240636|P4|STARTED|Overall Study||17
101007|NCT01246999|240637|P3|STARTED|Overall Study||2
101008|NCT01246999|240638|P2|STARTED|Overall Study||4
101009|NCT01246999|240639|P1|STARTED|Overall Study||11
101010|NCT01246973|240674|P2|NOT COMPLETED|Overall Study||47
101011|NCT01246973|240675|P1|NOT COMPLETED|Overall Study||61
101012|NCT01246973|240674|P2|COMPLETED|Overall Study||295
101013|NCT01246973|240675|P1|COMPLETED|Overall Study||283
101014|NCT01246973|240674|P2|STARTED|Overall Study||342
101015|NCT01246973|240675|P1|STARTED|Overall Study||344
101016|NCT01246960|240685|P2|NOT COMPLETED|Overall Study||4
101017|NCT01246960|240686|P1|NOT COMPLETED|Overall Study||6
101018|NCT01246960|240685|P2|COMPLETED|Overall Study||80
101019|NCT01246960|240686|P1|COMPLETED|Overall Study||78
101020|NCT01246960|240685|P2|Received Any Quantity of Study Drug|Overall Study||80
101021|NCT01246960|240686|P1|Received Any Quantity of Study Drug|Overall Study||82
101022|NCT01246960|240685|P2|STARTED|Overall Study||84
101023|NCT01246960|240686|P1|STARTED|Overall Study||84
101024|NCT01246791|240704|P1|NOT COMPLETED|Overall Study||0
101025|NCT01246791|240704|P1|COMPLETED|Overall Study||12
101026|NCT01246791|240704|P1|STARTED|Overall Study||12
101027|NCT01246713|240719|P2|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
101028|NCT01246713|240720|P1|NOT COMPLETED|Second Acetaminophen Dosing (1 Day)||0
101029|NCT01246713|240719|P2|COMPLETED|Second Acetaminophen Dosing (1 Day)||9
101030|NCT01246713|240720|P1|COMPLETED|Second Acetaminophen Dosing (1 Day)||6
101031|NCT01246713|240719|P2|STARTED|Second Acetaminophen Dosing (1 Day)||9
101032|NCT01246713|240720|P1|STARTED|Second Acetaminophen Dosing (1 Day)||6
101033|NCT01246713|240719|P2|NOT COMPLETED|Washout (at Least 14 Days)||0
101034|NCT01246713|240720|P1|NOT COMPLETED|Washout (at Least 14 Days)||0
101035|NCT01246713|240719|P2|COMPLETED|Washout (at Least 14 Days)||9
101036|NCT01246713|240720|P1|COMPLETED|Washout (at Least 14 Days)||6
101037|NCT01246713|240719|P2|STARTED|Washout (at Least 14 Days)||9
101038|NCT01246713|240720|P1|STARTED|Washout (at Least 14 Days)||6
101039|NCT01246713|240719|P2|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
101040|NCT01246713|240720|P1|NOT COMPLETED|First Acetaminophen Dosing (1 Day)||0
101041|NCT01246713|240719|P2|COMPLETED|First Acetaminophen Dosing (1 Day)||9
101042|NCT01246713|240720|P1|COMPLETED|First Acetaminophen Dosing (1 Day)||6
101043|NCT01246713|240719|P2|STARTED|First Acetaminophen Dosing (1 Day)||9
101044|NCT01246713|240720|P1|STARTED|First Acetaminophen Dosing (1 Day)||6
101045|NCT01246479|240726|P1|NOT COMPLETED|Overall Study||5
101046|NCT01246479|240726|P1|COMPLETED|Overall Study|primary endpoint at Month 12|18
101047|NCT01246479|240726|P1|STARTED|Overall Study||23
101048|NCT01246401|240732|P2|NOT COMPLETED|Overall Study||0
101049|NCT01246401|240733|P1|NOT COMPLETED|Overall Study||0
101050|NCT01246401|240732|P2|COMPLETED|Overall Study||27
101051|NCT01246401|240733|P1|COMPLETED|Overall Study||66
101052|NCT01246401|240732|P2|STARTED|Overall Study||27
101053|NCT01246401|240733|P1|STARTED|Overall Study||66
101054|NCT01246349|240759|P2|NOT COMPLETED|Overall Study||0
101055|NCT01246349|240760|P1|NOT COMPLETED|Overall Study||0
101056|NCT01246349|240759|P2|COMPLETED|Overall Study||20
101057|NCT01246349|240760|P1|COMPLETED|Overall Study||20
101058|NCT01246349|240759|P2|STARTED|Overall Study||20
101059|NCT01246349|240760|P1|STARTED|Overall Study||20
101060|NCT01246258|240772|P1|NOT COMPLETED|Overall Study||0
101061|NCT01246258|240772|P1|COMPLETED|Overall Study||5
101062|NCT01246258|240772|P1|STARTED|Overall Study||5
101063|NCT01246206|240777|P1|NOT COMPLETED|Overall Study||1
101064|NCT01246206|240777|P1|COMPLETED|Overall Study||20
101065|NCT01246206|240777|P1|STARTED|Overall Study||21
101066|NCT01246076|240788|P1|NOT COMPLETED|Overall Study||0
101067|NCT01246076|240788|P1|COMPLETED|Overall Study||24
101068|NCT01246076|240788|P1|STARTED|Overall Study||24
101069|NCT01246011|240800|P3|NOT COMPLETED|Overall Study||4
101070|NCT01246011|240801|P2|NOT COMPLETED|Overall Study||0
101071|NCT01246011|240802|P1|NOT COMPLETED|Overall Study||0
101072|NCT01246011|240800|P3|COMPLETED|Overall Study||5
101073|NCT01246011|240801|P2|COMPLETED|Overall Study||0
101074|NCT01246011|240802|P1|COMPLETED|Overall Study||0
101075|NCT01246011|240800|P3|STARTED|Overall Study||9
101076|NCT01246011|240801|P2|STARTED|Overall Study||0
101077|NCT01246011|240802|P1|STARTED|Overall Study||0
101078|NCT01245764|240814|P4|NOT COMPLETED|Study Phase B||0
101079|NCT01245764|240815|P3|NOT COMPLETED|Study Phase B||0
101080|NCT01245764|240816|P2|NOT COMPLETED|Study Phase B||0
101081|NCT01245764|240817|P1|NOT COMPLETED|Study Phase B||0
101082|NCT01245764|240814|P4|COMPLETED|Study Phase B||17
101083|NCT01245764|240815|P3|COMPLETED|Study Phase B||0
101084|NCT01245764|240816|P2|COMPLETED|Study Phase B||0
101085|NCT01245764|240817|P1|COMPLETED|Study Phase B||0
101086|NCT01245764|240814|P4|Completed Vaccinations in Study Phase B|Study Phase B||17
101087|NCT01245764|240815|P3|Completed Vaccinations in Study Phase B|Study Phase B||0
101088|NCT01245764|240816|P2|Completed Vaccinations in Study Phase B|Study Phase B||0
101089|NCT01245764|240817|P1|Completed Vaccinations in Study Phase B|Study Phase B||0
101090|NCT01245764|240814|P4|STARTED|Study Phase B||17
101091|NCT01245764|240815|P3|STARTED|Study Phase B||0
101092|NCT01245764|240816|P2|STARTED|Study Phase B||0
101093|NCT01245764|240817|P1|STARTED|Study Phase B||0
101094|NCT01245764|240814|P4|NOT COMPLETED|Study Phase A||3
101095|NCT01245764|240815|P3|NOT COMPLETED|Study Phase A||10
101096|NCT01245764|240816|P2|NOT COMPLETED|Study Phase A||5
101097|NCT01245764|240817|P1|NOT COMPLETED|Study Phase A||9
101098|NCT01245764|240814|P4|COMPLETED|Study Phase A||17
101099|NCT01245764|240815|P3|COMPLETED|Study Phase A||110
101100|NCT01245764|240816|P2|COMPLETED|Study Phase A||25
101101|NCT01245764|240817|P1|COMPLETED|Study Phase A||71
101102|NCT01245764|240814|P4|Completed Vaccinations in Study Phase A|Study Phase A||19
101103|NCT01245764|240815|P3|Completed Vaccinations in Study Phase A|Study Phase A||117
101104|NCT01245764|240816|P2|Completed Vaccinations in Study Phase A|Study Phase A||28
101105|NCT01245764|240817|P1|Completed Vaccinations in Study Phase A|Study Phase A||77
101106|NCT01245764|240814|P4|STARTED|Study Phase A||20
101107|NCT01245764|240815|P3|STARTED|Study Phase A||120
101108|NCT01245764|240816|P2|STARTED|Study Phase A||30
101109|NCT01245764|240817|P1|STARTED|Study Phase A||80
101110|NCT01245751|240855|P4|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
101111|NCT01245751|240856|P3|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
101112|NCT01245751|240857|P2|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
101113|NCT01245751|240858|P1|NOT COMPLETED|Part 2: Week 156 (3 Year) Visit||0
101114|NCT01245751|240855|P4|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
101115|NCT01245751|240856|P3|COMPLETED|Part 2: Week 156 (3 Year) Visit||0
101116|NCT01245751|240857|P2|COMPLETED|Part 2: Week 156 (3 Year) Visit||139
101117|NCT01245751|240858|P1|COMPLETED|Part 2: Week 156 (3 Year) Visit||161
101118|NCT01245751|240855|P4|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
101119|NCT01245751|240856|P3|STARTED|Part 2: Week 156 (3 Year) Visit|Part 2 was planned for Groups 1 and 2 only|0
101120|NCT01245751|240857|P2|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|139
101121|NCT01245751|240858|P1|STARTED|Part 2: Week 156 (3 Year) Visit|Enrollment in Part 2 was voluntary|161
101122|NCT01245751|240855|P4|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
101123|NCT01245751|240856|P3|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||0
101124|NCT01245751|240857|P2|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||5
101125|NCT01245751|240858|P1|NOT COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||2
101126|NCT01245751|240855|P4|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||98
101127|NCT01245751|240856|P3|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||100
101128|NCT01245751|240857|P2|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||194
101129|NCT01245751|240858|P1|COMPLETED|Part 1: Day 1 to Week 52 (1 Year)||199
101130|NCT01245751|240855|P4|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
101131|NCT01245751|240856|P3|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||100
101132|NCT01245751|240857|P2|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||199
101133|NCT01245751|240858|P1|Completed 42-day Postvaccination Period|Part 1: Day 1 to Week 52 (1 Year)||201
101134|NCT01245751|240855|P4|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
101135|NCT01245751|240856|P3|STARTED|Part 1: Day 1 to Week 52 (1 Year)||100
101136|NCT01245751|240857|P2|STARTED|Part 1: Day 1 to Week 52 (1 Year)||199
101137|NCT01245751|240858|P1|STARTED|Part 1: Day 1 to Week 52 (1 Year)||201
101138|NCT01245738|240871|P1|NOT COMPLETED|Overall Study||40
101139|NCT01245738|240871|P1|COMPLETED|Overall Study||474
101140|NCT01245738|240871|P1|STARTED|Overall Study||514
101141|NCT01245647|240890|P2|NOT COMPLETED|Overall Study||4
101142|NCT01245647|240891|P1|NOT COMPLETED|Overall Study||0
101143|NCT01245647|240890|P2|COMPLETED|Overall Study||8
101144|NCT01245647|240891|P1|COMPLETED|Overall Study||7
101145|NCT01245647|240890|P2|STARTED|Overall Study||12
101146|NCT01245647|240891|P1|STARTED|Overall Study||7
101147|NCT01245595|240907|P2|NOT COMPLETED|Overall Study||0
101148|NCT01245595|240908|P1|NOT COMPLETED|Overall Study||0
101149|NCT01245595|240907|P2|COMPLETED|Overall Study||72
101150|NCT01245595|240908|P1|COMPLETED|Overall Study||72
101151|NCT01245595|240907|P2|Completed Full Course of Study Drug|Overall Study||61
101152|NCT01245595|240908|P1|Completed Full Course of Study Drug|Overall Study||57
101153|NCT01245595|240907|P2|STARTED|Overall Study||72
101154|NCT01245595|240908|P1|STARTED|Overall Study||72
101155|NCT01245439|240914|P1|NOT COMPLETED|Overall Study||0
101156|NCT01245439|240914|P1|COMPLETED|Overall Study||65
101157|NCT01245439|240914|P1|STARTED|Overall Study||65
101158|NCT01245413|240945|P2|NOT COMPLETED|Athena First,||0
101159|NCT01245413|240946|P1|NOT COMPLETED|Athena First,||0
101160|NCT01245413|240945|P2|COMPLETED|Athena First,||16
101161|NCT01245413|240946|P1|COMPLETED|Athena First,||16
101162|NCT01245413|240945|P2|STARTED|Athena First,||16
101163|NCT01245413|240946|P1|STARTED|Athena First,||16
101164|NCT01245413|240945|P2|NOT COMPLETED|Sensura First,||0
101165|NCT01245413|240946|P1|NOT COMPLETED|Sensura First,||0
101166|NCT01245413|240945|P2|COMPLETED|Sensura First,||16
101167|NCT01245413|240946|P1|COMPLETED|Sensura First,||16
101168|NCT01245413|240945|P2|STARTED|Sensura First,||16
101169|NCT01245413|240946|P1|STARTED|Sensura First,||16
101170|NCT01245387|240952|P1|NOT COMPLETED|Overall Study||813
101171|NCT01245387|240952|P1|COMPLETED|Overall Study||188
101172|NCT01245387|240952|P1|STARTED|Overall Study||1001
101173|NCT01245374|241001|P1|NOT COMPLETED|Overall Study||4
101174|NCT01245374|241001|P1|COMPLETED|Overall Study||99
101175|NCT01245374|241001|P1|STARTED|Overall Study||103
101176|NCT01245283|241024|P3|NOT COMPLETED|Overall Study||11
101177|NCT01245283|241025|P2|NOT COMPLETED|Overall Study||11
101178|NCT01245283|241026|P1|NOT COMPLETED|Overall Study||14
101179|NCT01245283|241024|P3|COMPLETED|Overall Study||19
101180|NCT01245283|241025|P2|COMPLETED|Overall Study||17
101181|NCT01245283|241026|P1|COMPLETED|Overall Study||18
101182|NCT01245283|241024|P3|STARTED|Overall Study||30
101183|NCT01245283|241025|P2|STARTED|Overall Study||28
101184|NCT01245283|241026|P1|STARTED|Overall Study||32
101185|NCT01245270|241060|P2|NOT COMPLETED|Overall Study||0
101186|NCT01245270|241061|P1|NOT COMPLETED|Overall Study||0
101187|NCT01245270|241060|P2|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
101188|NCT01245270|241061|P1|COMPLETED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
101189|NCT01245270|241060|P2|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
101190|NCT01245270|241061|P1|STARTED|Overall Study|In a cross-over design, volunteers (n=8) were randomised and double blinded into two groups (n=4)|4
101191|NCT01245140|241071|P2|NOT COMPLETED|Overall Study||10
101192|NCT01245140|241072|P1|NOT COMPLETED|Overall Study||3
101193|NCT01245140|241071|P2|COMPLETED|Overall Study||14
101194|NCT01245140|241072|P1|COMPLETED|Overall Study||6
101195|NCT01245140|241071|P2|STARTED|Overall Study||24
101196|NCT01245140|241072|P1|STARTED|Overall Study||9
101197|NCT01245101|241128|P2|NOT COMPLETED|Period 3 (Treatment)||0
101198|NCT01245101|241129|P1|NOT COMPLETED|Period 3 (Treatment)||1
101199|NCT01245101|241128|P2|COMPLETED|Period 3 (Treatment)||0
101200|NCT01245101|241129|P1|COMPLETED|Period 3 (Treatment)||11
101201|NCT01245101|241128|P2|STARTED|Period 3 (Treatment)||0
101202|NCT01245101|241129|P1|STARTED|Period 3 (Treatment)||12
101203|NCT01245101|241128|P2|NOT COMPLETED|Period 2 (Washout)||0
101204|NCT01245101|241129|P1|NOT COMPLETED|Period 2 (Washout)||1
101205|NCT01245101|241128|P2|COMPLETED|Period 2 (Washout)||0
101206|NCT01245101|241129|P1|COMPLETED|Period 2 (Washout)||12
101207|NCT01245101|241128|P2|STARTED|Period 2 (Washout)||0
101208|NCT01245101|241129|P1|STARTED|Period 2 (Washout)||13
101209|NCT01245101|241128|P2|NOT COMPLETED|Period 1 (Treatment)||0
101210|NCT01245101|241129|P1|NOT COMPLETED|Period 1 (Treatment)||2
101211|NCT01245101|241128|P2|COMPLETED|Period 1 (Treatment)||0
101212|NCT01245101|241129|P1|COMPLETED|Period 1 (Treatment)||13
101213|NCT01245101|241128|P2|STARTED|Period 1 (Treatment)||0
101214|NCT01245101|241129|P1|STARTED|Period 1 (Treatment)||15
101215|NCT01245062|241139|P3|NOT COMPLETED|Cross-over Phase||51
101216|NCT01245062|241140|P2|NOT COMPLETED|Cross-over Phase||0
101217|NCT01245062|241141|P1|NOT COMPLETED|Cross-over Phase||0
101218|NCT01245062|241139|P3|COMPLETED|Cross-over Phase||0
101219|NCT01245062|241140|P2|COMPLETED|Cross-over Phase||0
101220|NCT01245062|241141|P1|COMPLETED|Cross-over Phase||0
101221|NCT01245062|241139|P3|Ongoing|Cross-over Phase||34
101222|NCT01245062|241140|P2|Ongoing|Cross-over Phase||0
101223|NCT01245062|241141|P1|Ongoing|Cross-over Phase||0
101224|NCT01245062|241139|P3|STARTED|Cross-over Phase|51 of the 108 participants randomized to chemotherapy elected to cross-over to Trametinib.|51
101225|NCT01245062|241140|P2|STARTED|Cross-over Phase||0
101226|NCT01245062|241141|P1|STARTED|Cross-over Phase||0
101227|NCT01245062|241139|P3|NOT COMPLETED|Randomization Phase||0
101228|NCT01245062|241140|P2|NOT COMPLETED|Randomization Phase||108
101229|NCT01245062|241141|P1|NOT COMPLETED|Randomization Phase||214
101230|NCT01245062|241139|P3|COMPLETED|Randomization Phase||0
101231|NCT01245062|241140|P2|COMPLETED|Randomization Phase||0
101232|NCT01245062|241141|P1|COMPLETED|Randomization Phase||0
101233|NCT01245062|241139|P3|Ongoing|Randomization Phase||0
101234|NCT01245062|241140|P2|Ongoing|Randomization Phase||65
101235|NCT01245062|241141|P1|Ongoing|Randomization Phase||169
101236|NCT01245062|241139|P3|STARTED|Randomization Phase||0
101237|NCT01245062|241140|P2|STARTED|Randomization Phase||108
101238|NCT01245062|241141|P1|STARTED|Randomization Phase||214
101239|NCT01245049|241175|P2|NOT COMPLETED|Overall Study||4
101240|NCT01245049|241176|P1|NOT COMPLETED|Overall Study||1
101241|NCT01245049|241175|P2|COMPLETED|Overall Study||126
101242|NCT01245049|241176|P1|COMPLETED|Overall Study||254
101243|NCT01245049|241175|P2|STARTED|Overall Study||130
101244|NCT01245049|241176|P1|STARTED|Overall Study||255
101245|NCT01244984|241229|P3|NOT COMPLETED|Overall Study||4
101246|NCT01244984|241230|P2|NOT COMPLETED|Overall Study||14
101247|NCT01244984|241231|P1|NOT COMPLETED|Overall Study||5
101248|NCT01244984|241229|P3|COMPLETED|Overall Study||86
101249|NCT01244984|241230|P2|COMPLETED|Overall Study||79
101250|NCT01244984|241231|P1|COMPLETED|Overall Study||55
101251|NCT01244984|241229|P3|STARTED|Overall Study||90
101252|NCT01244984|241230|P2|STARTED|Overall Study||93
101253|NCT01244984|241231|P1|STARTED|Overall Study||60
101254|NCT01244906|241305|P1|NOT COMPLETED|Overall Study||8
101255|NCT01244906|241305|P1|COMPLETED|Overall Study||18
101256|NCT01244906|241305|P1|STARTED|Overall Study||26
101275|NCT01244828|241327|P1|NOT COMPLETED|Overall Study||78
101276|NCT01244828|241327|P1|COMPLETED|Overall Study||79
101277|NCT01244828|241327|P1|STARTED|Overall Study|Received study drug|157
101278|NCT01244815|241343|P4|NOT COMPLETED|Overall Study||12
101279|NCT01244815|241344|P3|NOT COMPLETED|Overall Study||11
101280|NCT01244815|241345|P2|NOT COMPLETED|Overall Study||17
101281|NCT01244815|241346|P1|NOT COMPLETED|Overall Study||14
101282|NCT01244815|241343|P4|COMPLETED|Overall Study||87
101283|NCT01244815|241344|P3|COMPLETED|Overall Study||88
101284|NCT01244815|241345|P2|COMPLETED|Overall Study||88
101285|NCT01244815|241346|P1|COMPLETED|Overall Study||87
101286|NCT01244815|241343|P4|Treated|Overall Study||99
101287|NCT01244815|241344|P3|Treated|Overall Study||99
101288|NCT01244815|241345|P2|Treated|Overall Study||104
101289|NCT01244815|241346|P1|Treated|Overall Study||101
101290|NCT01244815|241343|P4|STARTED|Overall Study|Randomized|99
101291|NCT01244815|241344|P3|STARTED|Overall Study|Randomized|99
101292|NCT01244815|241345|P2|STARTED|Overall Study|Randomized|105
101293|NCT01244815|241346|P1|STARTED|Overall Study|Randomized|101
101294|NCT01244724|241420|P1|NOT COMPLETED|Overall Study||8
101295|NCT01244724|241420|P1|COMPLETED|Overall Study||9
101296|NCT01244724|241420|P1|Week 2 Visit|Overall Study||15
101297|NCT01244724|241420|P1|STARTED|Overall Study|Of these 15 returned for a week 2 visit and are included in the efficacy analysis.|17
101298|NCT01244711|241424|P1|NOT COMPLETED|Overall Study||0
101299|NCT01244711|241424|P1|COMPLETED|Overall Study||1
101300|NCT01244711|241424|P1|STARTED|Overall Study||1
101301|NCT01244633|241428|P1|NOT COMPLETED|Overall Study||3
101302|NCT01244633|241428|P1|COMPLETED|Overall Study||15
101303|NCT01244633|241428|P1|STARTED|Overall Study||18
101304|NCT01244620|241432|P4|NOT COMPLETED|Overall Study||4
101305|NCT01244620|241433|P3|NOT COMPLETED|Overall Study||4
101306|NCT01244620|241434|P2|NOT COMPLETED|Overall Study||4
101307|NCT01244620|241435|P1|NOT COMPLETED|Overall Study||4
101308|NCT01244620|241432|P4|COMPLETED|Overall Study||0
101309|NCT01244620|241433|P3|COMPLETED|Overall Study||0
101310|NCT01244620|241434|P2|COMPLETED|Overall Study||0
101311|NCT01244620|241435|P1|COMPLETED|Overall Study||0
101312|NCT01244620|241432|P4|STARTED|Overall Study||4
101313|NCT01244620|241433|P3|STARTED|Overall Study||4
101314|NCT01244620|241434|P2|STARTED|Overall Study||4
101315|NCT01244620|241435|P1|STARTED|Overall Study||4
101316|NCT01244529|241469|P1|NOT COMPLETED|Overall Study||0
101317|NCT01244529|241469|P1|COMPLETED|Overall Study||41
101318|NCT01244529|241469|P1|STARTED|Overall Study||41
101319|NCT01244516|241494|P3|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||2
101320|NCT01244516|241495|P2|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||1
101321|NCT01244516|241496|P1|NOT COMPLETED|Period 2 (1-week to 2-week Visit)||3
101322|NCT01244516|241494|P3|COMPLETED|Period 2 (1-week to 2-week Visit)||168
101323|NCT01244516|241495|P2|COMPLETED|Period 2 (1-week to 2-week Visit)||170
101324|NCT01244516|241496|P1|COMPLETED|Period 2 (1-week to 2-week Visit)||163
101325|NCT01244516|241494|P3|STARTED|Period 2 (1-week to 2-week Visit)||170
101326|NCT01244516|241495|P2|STARTED|Period 2 (1-week to 2-week Visit)||171
101327|NCT01244516|241496|P1|STARTED|Period 2 (1-week to 2-week Visit)||166
101328|NCT01244516|241494|P3|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||3
101329|NCT01244516|241495|P2|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||6
101330|NCT01244516|241496|P1|NOT COMPLETED|Period 1 (Baseline to 1-week Visit)||4
101331|NCT01244516|241494|P3|COMPLETED|Period 1 (Baseline to 1-week Visit)||170
101332|NCT01244516|241495|P2|COMPLETED|Period 1 (Baseline to 1-week Visit)||171
101333|NCT01244516|241496|P1|COMPLETED|Period 1 (Baseline to 1-week Visit)||166
101334|NCT01244516|241494|P3|STARTED|Period 1 (Baseline to 1-week Visit)||173
101335|NCT01244516|241495|P2|STARTED|Period 1 (Baseline to 1-week Visit)||177
101336|NCT01244516|241496|P1|STARTED|Period 1 (Baseline to 1-week Visit)||170
101337|NCT01244503|241509|P1|NOT COMPLETED|Overall Study||0
101338|NCT01244503|241509|P1|COMPLETED|Overall Study||61
101339|NCT01244503|241509|P1|STARTED|Overall Study||61
101340|NCT01244490|241517|P3|NOT COMPLETED|Overall Study||23
101341|NCT01244490|241518|P2|NOT COMPLETED|Overall Study||24
101342|NCT01244490|241519|P1|NOT COMPLETED|Overall Study||19
101343|NCT01244490|241517|P3|COMPLETED|Overall Study||89
101344|NCT01244490|241518|P2|COMPLETED|Overall Study||91
101345|NCT01244490|241519|P1|COMPLETED|Overall Study||92
101346|NCT01244490|241517|P3|STARTED|Overall Study||112
101347|NCT01244490|241518|P2|STARTED|Overall Study||115
101348|NCT01244490|241519|P1|STARTED|Overall Study||111
101349|NCT01244477|241574|P2|NOT COMPLETED|Overall Study||3
101350|NCT01244477|241575|P1|NOT COMPLETED|Overall Study||20
101351|NCT01244477|241574|P2|COMPLETED|Overall Study||20
101352|NCT01244477|241575|P1|COMPLETED|Overall Study||18
101353|NCT01244477|241574|P2|STARTED|Overall Study||23
101354|NCT01244477|241575|P1|STARTED|Overall Study||38
101355|NCT01244425|241587|P2|NOT COMPLETED|Overall Study||3
101356|NCT01244425|241588|P1|NOT COMPLETED|Overall Study||3
101357|NCT01244425|241587|P2|COMPLETED|Overall Study|Adverse Event: septic shock with multi-organ failure due to liver abscess (death)|32
101358|NCT01244425|241588|P1|COMPLETED|Overall Study|Adverse Event: multi-organ failure (death)|32
101359|NCT01244425|241587|P2|STARTED|Overall Study||35
101360|NCT01244425|241588|P1|STARTED|Overall Study||35
101361|NCT01244412|241608|P1|NOT COMPLETED|Overall Study||0
101362|NCT01244412|241608|P1|COMPLETED|Overall Study||1
101363|NCT01244412|241608|P1|STARTED|Overall Study||1
101364|NCT01244243|241612|P1|NOT COMPLETED|Overall Study||0
101365|NCT01244243|241612|P1|COMPLETED|Overall Study||41
101366|NCT01244243|241612|P1|STARTED|Overall Study||41
101367|NCT01244126|241620|P3|NOT COMPLETED|Overall Study||9
101368|NCT01244126|241621|P2|NOT COMPLETED|Overall Study||3
101369|NCT01244126|241622|P1|NOT COMPLETED|Overall Study||3
101370|NCT01244126|241620|P3|COMPLETED|Overall Study||48
101371|NCT01244126|241621|P2|COMPLETED|Overall Study||52
101372|NCT01244126|241622|P1|COMPLETED|Overall Study||56
101373|NCT01244126|241620|P3|STARTED|Overall Study||57
101374|NCT01244126|241621|P2|STARTED|Overall Study||55
101375|NCT01244126|241622|P1|STARTED|Overall Study||59
101376|NCT01244061|241635|P2|NOT COMPLETED|Overall Study||103
101377|NCT01244061|241636|P1|NOT COMPLETED|Overall Study||82
101378|NCT01244061|241635|P2|COMPLETED|Overall Study||144
101379|NCT01244061|241636|P1|COMPLETED|Overall Study||169
101380|NCT01244061|241635|P2|STARTED|Overall Study||247
101381|NCT01244061|241636|P1|STARTED|Overall Study||251
101382|NCT01243944|241650|P2|NOT COMPLETED|Overall Study||108
101383|NCT01243944|241651|P1|NOT COMPLETED|Overall Study||17
101384|NCT01243944|241650|P2|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|3
101385|NCT01243944|241651|P1|COMPLETED|Overall Study|These are the numbers of subjects who completed 48 weeks of treatment.|93
101386|NCT01243944|241650|P2|STARTED|Overall Study|One subject withdrew consent 5 days after randomization to BAT arm and wasn't treated while on study|111
101387|NCT01243944|241651|P1|STARTED|Overall Study||110
101388|NCT01243892|241675|P2|NOT COMPLETED|Overall Study||0
101389|NCT01243892|241676|P1|NOT COMPLETED|Overall Study||2
101390|NCT01243892|241675|P2|COMPLETED|Overall Study||3
101391|NCT01243892|241676|P1|COMPLETED|Overall Study||13
101392|NCT01243892|241675|P2|STARTED|Overall Study||3
101393|NCT01243892|241676|P1|STARTED|Overall Study||15
101394|NCT01243775|241686|P1|NOT COMPLETED|Overall Study||2
101395|NCT01243775|241686|P1|COMPLETED|Overall Study||31
101396|NCT01243775|241686|P1|STARTED|Overall Study||33
101397|NCT01243671|241693|P1|NOT COMPLETED|Overall Study||5
101398|NCT01243671|241693|P1|COMPLETED|Overall Study|Completed 136 weeks of treatment.|15
101399|NCT01243671|241693|P1|Completed 52 Weeks of Treatment|Overall Study||17
101400|NCT01243671|241693|P1|Completed 24 Weeks of Treatment|Overall Study||18
101401|NCT01243671|241693|P1|STARTED|Overall Study||20
101402|NCT01243619|241706|P1|NOT COMPLETED|Overall Study||0
101403|NCT01243619|241706|P1|COMPLETED|Overall Study|Patient enrollment is complete, data analysis is ongoing|5
101404|NCT01243619|241706|P1|STARTED|Overall Study||5
101405|NCT01243567|241712|P2|NOT COMPLETED|Overall Study||0
101406|NCT01243567|241713|P1|NOT COMPLETED|Overall Study||1
101407|NCT01243567|241712|P2|COMPLETED|Overall Study||38
101408|NCT01243567|241713|P1|COMPLETED|Overall Study||42
101409|NCT01243567|241712|P2|STARTED|Overall Study||38
101410|NCT01243567|241713|P1|STARTED|Overall Study||43
101411|NCT01243450|241730|P3|NOT COMPLETED|Overall Study||67
101412|NCT01243450|241731|P2|NOT COMPLETED|Overall Study||25
101413|NCT01243450|241732|P1|NOT COMPLETED|Overall Study||83
101414|NCT01243450|241730|P3|COMPLETED|Overall Study||337
101415|NCT01243450|241731|P2|COMPLETED|Overall Study||110
101416|NCT01243450|241732|P1|COMPLETED|Overall Study||318
101417|NCT01243450|241730|P3|STARTED|Overall Study||404
101418|NCT01243450|241731|P2|STARTED|Overall Study||135
101419|NCT01243450|241732|P1|STARTED|Overall Study||401
101420|NCT01243411|241740|P1|NOT COMPLETED|Overall Study||41
101421|NCT01243411|241740|P1|COMPLETED|Overall Study||306
101422|NCT01243411|241740|P1|STARTED|Overall Study||347
101423|NCT01243320|241752|P1|NOT COMPLETED|32ppm Oral Silver (14 Days)||0
101424|NCT01243320|241752|P1|COMPLETED|32ppm Oral Silver (14 Days)||24
101425|NCT01243320|241752|P1|STARTED|32ppm Oral Silver (14 Days)||24
101426|NCT01243320|241752|P1|NOT COMPLETED|Washout (3 Days)||0
101427|NCT01243320|241752|P1|COMPLETED|Washout (3 Days)||36
101428|NCT01243320|241752|P1|STARTED|Washout (3 Days)||36
101429|NCT01243320|241752|P1|NOT COMPLETED|10ppm Oral Silver (14 Days)||0
101430|NCT01243320|241752|P1|COMPLETED|10ppm Oral Silver (14 Days)||36
101431|NCT01243320|241752|P1|STARTED|10ppm Oral Silver (14 Days)||36
101432|NCT01243320|241752|P1|NOT COMPLETED|10ppm Oral Silver (7 Days)||0
101433|NCT01243320|241752|P1|COMPLETED|10ppm Oral Silver (7 Days)||36
101434|NCT01243320|241752|P1|STARTED|10ppm Oral Silver (7 Days)||36
101435|NCT01243320|241752|P1|NOT COMPLETED|10ppm Oral Silver (3 Days)||0
101436|NCT01243320|241752|P1|COMPLETED|10ppm Oral Silver (3 Days)||36
101437|NCT01243320|241752|P1|STARTED|10ppm Oral Silver (3 Days)||36
101438|NCT01243294|241828|P2|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
101439|NCT01243294|241829|P1|NOT COMPLETED|Second Intervention (10 Days +/- 2 Days)||0
101440|NCT01243294|241828|P2|COMPLETED|Second Intervention (10 Days +/- 2 Days)||26
101441|NCT01243294|241829|P1|COMPLETED|Second Intervention (10 Days +/- 2 Days)||28
101442|NCT01243294|241828|P2|STARTED|Second Intervention (10 Days +/- 2 Days)||26
101443|NCT01243294|241829|P1|STARTED|Second Intervention (10 Days +/- 2 Days)||28
101444|NCT01243294|241828|P2|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
101445|NCT01243294|241829|P1|NOT COMPLETED|First Intervention (10 Days +/- 2 Days)||0
101446|NCT01243294|241828|P2|COMPLETED|First Intervention (10 Days +/- 2 Days)||26
101447|NCT01243294|241829|P1|COMPLETED|First Intervention (10 Days +/- 2 Days)||28
101448|NCT01243294|241828|P2|STARTED|First Intervention (10 Days +/- 2 Days)||26
101449|NCT01243294|241829|P1|STARTED|First Intervention (10 Days +/- 2 Days)||28
101450|NCT01243242|241847|P2|NOT COMPLETED|Overall Study||4
101451|NCT01243242|241848|P1|NOT COMPLETED|Overall Study||3
101452|NCT01243242|241847|P2|COMPLETED|Overall Study||56
101453|NCT01243242|241848|P1|COMPLETED|Overall Study||57
101454|NCT01243242|241847|P2|STARTED|Overall Study||60
101455|NCT01243242|241848|P1|STARTED|Overall Study||60
101456|NCT01243177|241862|P2|NOT COMPLETED|Overall Study||178
101457|NCT01243177|241863|P1|NOT COMPLETED|Overall Study||178
101458|NCT01243177|241862|P2|COMPLETED|Overall Study||264
101459|NCT01243177|241863|P1|COMPLETED|Overall Study||266
101460|NCT01243177|241862|P2|STARTED|Overall Study||442
101461|NCT01243177|241863|P1|STARTED|Overall Study||444
101462|NCT01243112|241879|P1|NOT COMPLETED|Overall Study||0
101463|NCT01243112|241879|P1|COMPLETED|Overall Study||25
101464|NCT01243112|241879|P1|STARTED|Overall Study||25
101465|NCT01242813|241884|P1|NOT COMPLETED|Overall Study||2
101466|NCT01242813|241884|P1|COMPLETED|Overall Study||18
101467|NCT01242813|241884|P1|STARTED|Overall Study||20
101468|NCT01242748|241906|P2|NOT COMPLETED|Overall Study||14
101469|NCT01242748|241907|P1|NOT COMPLETED|Overall Study||38
101470|NCT01242748|241906|P2|COMPLETED|Overall Study||80
101471|NCT01242748|241907|P1|COMPLETED|Overall Study|These participants were ongoing when the trial was closed by the Sponsor.|156
101472|NCT01242748|241906|P2|CS35/CS35A Full Analysis Set (FAS)|Overall Study||282
101473|NCT01242748|241907|P1|CS35/CS35A Full Analysis Set (FAS)|Overall Study|Received at least 1 dose of trial drug during CS35+had at least 1 efficacy assessment after dosing.|565
101474|NCT01242748|241906|P2|CS35/CS35A Safety Analysis Set|Overall Study||283
101475|NCT01242748|241907|P1|CS35/CS35A Safety Analysis Set|Overall Study|Received at least 1 dose of trial drug during the main CS35 trial.|565
101476|NCT01242748|241906|P2|STARTED|Overall Study||94
101477|NCT01242748|241907|P1|STARTED|Overall Study|Enrolled in CS35A, CS35A Full Analysis Set.|194
101478|NCT01242527|241931|P4|NOT COMPLETED|Overall Study||9
101479|NCT01242527|241932|P3|NOT COMPLETED|Overall Study||14
101480|NCT01242527|241933|P2|NOT COMPLETED|Overall Study||7
101481|NCT01242527|241934|P1|NOT COMPLETED|Overall Study||5
101482|NCT01242527|241931|P4|COMPLETED|Overall Study||90
101483|NCT01242527|241932|P3|COMPLETED|Overall Study||87
101484|NCT01242527|241933|P2|COMPLETED|Overall Study||93
101485|NCT01242527|241934|P1|COMPLETED|Overall Study||94
101486|NCT01242527|241931|P4|STARTED|Overall Study||99
101487|NCT01242527|241932|P3|STARTED|Overall Study||101
101488|NCT01242527|241933|P2|STARTED|Overall Study||100
101489|NCT01242527|241934|P1|STARTED|Overall Study||99
101490|NCT01242514|241947|P3|NOT COMPLETED|Overall Study||212
101491|NCT01242514|241948|P2|NOT COMPLETED|Overall Study||357
101492|NCT01242514|241949|P1|NOT COMPLETED|Overall Study||1343
101493|NCT01242514|241947|P3|COMPLETED|Overall Study|Due to project closure.|0
101494|NCT01242514|241948|P2|COMPLETED|Overall Study|Due to project closure.|0
101495|NCT01242514|241949|P1|COMPLETED|Overall Study|Due to project closure.|0
101496|NCT01242514|241947|P3|Enrolled But Did Not Receive Treatment|Overall Study|Adverse event/other|2
101497|NCT01242514|241948|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
101498|NCT01242514|241949|P1|Enrolled But Did Not Receive Treatment|Overall Study|Other|3
101499|NCT01242514|241947|P3|STARTED|Overall Study|Patients who received treatment|212
101500|NCT01242514|241948|P2|STARTED|Overall Study|Patients who received treatment|357
101501|NCT01242514|241949|P1|STARTED|Overall Study|Patients who received treatment|1343
101502|NCT01242371|241968|P2|NOT COMPLETED|Overall Study||5
101503|NCT01242371|241969|P1|NOT COMPLETED|Overall Study||2
101504|NCT01242371|241968|P2|COMPLETED|Overall Study||27
101505|NCT01242371|241969|P1|COMPLETED|Overall Study||31
101506|NCT01242371|241968|P2|STARTED|Overall Study||32
101507|NCT01242371|241969|P1|STARTED|Overall Study||33
101508|NCT01242176|241975|P2|NOT COMPLETED|Second Intervention||0
101509|NCT01242176|241976|P1|NOT COMPLETED|Second Intervention||0
101510|NCT01242176|241975|P2|COMPLETED|Second Intervention||10
101511|NCT01242176|241976|P1|COMPLETED|Second Intervention||11
101512|NCT01242176|241975|P2|STARTED|Second Intervention||10
101513|NCT01242176|241976|P1|STARTED|Second Intervention||11
101514|NCT01242176|241975|P2|NOT COMPLETED|Washout Period of 7 Days||2
101515|NCT01242176|241976|P1|NOT COMPLETED|Washout Period of 7 Days||1
101516|NCT01242176|241975|P2|COMPLETED|Washout Period of 7 Days||10
101517|NCT01242176|241976|P1|COMPLETED|Washout Period of 7 Days||11
101518|NCT01242176|241975|P2|STARTED|Washout Period of 7 Days||12
101519|NCT01242176|241976|P1|STARTED|Washout Period of 7 Days||12
101520|NCT01242176|241975|P2|NOT COMPLETED|First Intervention||0
101521|NCT01242176|241976|P1|NOT COMPLETED|First Intervention||0
101522|NCT01242176|241975|P2|COMPLETED|First Intervention||12
101523|NCT01242176|241976|P1|COMPLETED|First Intervention||12
101524|NCT01242176|241975|P2|STARTED|First Intervention||12
101525|NCT01242176|241976|P1|STARTED|First Intervention||12
101526|NCT01242111|241986|P1|NOT COMPLETED|Overall Study||3
101527|NCT01242111|241986|P1|COMPLETED|Overall Study||17
101528|NCT01242111|241986|P1|STARTED|Overall Study||20
101529|NCT01242085|241998|P3|NOT COMPLETED|Overall Study||0
101530|NCT01242085|241999|P2|NOT COMPLETED|Overall Study||7
101531|NCT01242085|242000|P1|NOT COMPLETED|Overall Study||8
101532|NCT01242085|241998|P3|COMPLETED|Overall Study||1
101533|NCT01242085|241999|P2|COMPLETED|Overall Study|7 patients did not receive allocated intervention since 5 had medical problems and 2 withdrew|26
101534|NCT01242085|242000|P1|COMPLETED|Overall Study|8 patients did not undergo intervention since 4 had medical problems and 4 withdrew|22
101535|NCT01242085|241998|P3|STARTED|Overall Study||1
101536|NCT01242085|241999|P2|STARTED|Overall Study||33
101537|NCT01242085|242000|P1|STARTED|Overall Study||30
101538|NCT01242020|242010|P2|NOT COMPLETED|Overall Study||0
101539|NCT01242020|242011|P1|NOT COMPLETED|Overall Study||3
101540|NCT01242020|242010|P2|COMPLETED|Overall Study||0
101541|NCT01242020|242011|P1|COMPLETED|Overall Study||3
101542|NCT01242020|242010|P2|STARTED|Overall Study||0
101543|NCT01242020|242011|P1|STARTED|Overall Study||6
101544|NCT01241916|242021|P2|NOT COMPLETED|Overall Study||10
101545|NCT01241916|242022|P1|NOT COMPLETED|Overall Study||7
101546|NCT01241916|242021|P2|COMPLETED|Overall Study||21
101547|NCT01241916|242022|P1|COMPLETED|Overall Study||28
101548|NCT01241916|242021|P2|STARTED|Overall Study||31
101549|NCT01241916|242022|P1|STARTED|Overall Study||35
101550|NCT01241903|242032|P2|NOT COMPLETED|Overall Study||0
101551|NCT01241903|242033|P1|NOT COMPLETED|Overall Study||1
101552|NCT01241903|242032|P2|COMPLETED|Overall Study||27
101553|NCT01241903|242033|P1|COMPLETED|Overall Study||26
101554|NCT01241903|242032|P2|STARTED|Overall Study||27
101555|NCT01241903|242033|P1|STARTED|Overall Study||27
101556|NCT01241760|242041|P2|NOT COMPLETED|Overall Study||40
101557|NCT01241760|242042|P1|NOT COMPLETED|Overall Study||34
101558|NCT01241760|242041|P2|COMPLETED|Overall Study||329
101559|NCT01241760|242042|P1|COMPLETED|Overall Study||337
101560|NCT01241760|242041|P2|STARTED|Overall Study||369
101561|NCT01241760|242042|P1|STARTED|Overall Study||371
101562|NCT01241591|242065|P4|NOT COMPLETED|Overall Study||12
101563|NCT01241591|242066|P3|NOT COMPLETED|Overall Study||22
101564|NCT01241591|242067|P2|NOT COMPLETED|Overall Study||24
101565|NCT01241591|242068|P1|NOT COMPLETED|Overall Study||23
101566|NCT01241591|242065|P4|COMPLETED|Overall Study||95
101567|NCT01241591|242066|P3|COMPLETED|Overall Study||313
101568|NCT01241591|242067|P2|COMPLETED|Overall Study||306
101569|NCT01241591|242068|P1|COMPLETED|Overall Study||306
101570|NCT01241591|242065|P4|STARTED|Overall Study||107
101571|NCT01241591|242066|P3|STARTED|Overall Study||335
101572|NCT01241591|242067|P2|STARTED|Overall Study||330
101573|NCT01241591|242068|P1|STARTED|Overall Study||329
101574|NCT01241565|242258|P1|NOT COMPLETED|Overall Study||0
101575|NCT01241565|242258|P1|COMPLETED|Overall Study||50
101576|NCT01241565|242258|P1|STARTED|Overall Study||50
101577|NCT01241552|242271|P4|NOT COMPLETED|Overall Study||64
101578|NCT01241552|242272|P3|NOT COMPLETED|Overall Study||60
101579|NCT01241552|242273|P2|NOT COMPLETED|Overall Study||63
101580|NCT01241552|242274|P1|NOT COMPLETED|Overall Study||41
101581|NCT01241552|242271|P4|COMPLETED|Overall Study||340
101582|NCT01241552|242272|P3|COMPLETED|Overall Study||343
101583|NCT01241552|242273|P2|COMPLETED|Overall Study||340
101584|NCT01241552|242274|P1|COMPLETED|Overall Study||201
101585|NCT01241552|242271|P4|Treated|Overall Study||397
101586|NCT01241552|242272|P3|Treated|Overall Study||388
101587|NCT01241552|242273|P2|Treated|Overall Study||392
101588|NCT01241552|242274|P1|Treated|Overall Study||235
101589|NCT01241552|242271|P4|STARTED|Overall Study||404
101590|NCT01241552|242272|P3|STARTED|Overall Study||403
101591|NCT01241552|242273|P2|STARTED|Overall Study||403
101592|NCT01241552|242274|P1|STARTED|Overall Study||242
101593|NCT01241539|242340|P1|NOT COMPLETED|Period 2||0
101594|NCT01241539|242340|P1|COMPLETED|Period 2||7
101595|NCT01241539|242340|P1|STARTED|Period 2|After a wash-out phase of at least 6 weeks.|7
101596|NCT01241539|242340|P1|NOT COMPLETED|Period 1||0
101597|NCT01241539|242340|P1|COMPLETED|Period 1||7
101598|NCT01241539|242340|P1|STARTED|Period 1||7
101599|NCT01241513|242361|P2|NOT COMPLETED|Overall Study||0
101600|NCT01241513|242362|P1|NOT COMPLETED|Overall Study||0
101601|NCT01241513|242361|P2|COMPLETED|Overall Study||9
101602|NCT01241513|242362|P1|COMPLETED|Overall Study|Study has been completed|10
101603|NCT01241513|242361|P2|STARTED|Overall Study||9
101604|NCT01241513|242362|P1|STARTED|Overall Study||10
101605|NCT01241292|242369|P2|NOT COMPLETED|Overall Study||2
101606|NCT01241292|242370|P1|NOT COMPLETED|Overall Study||1
101607|NCT01241292|242369|P2|COMPLETED|Overall Study|completed=treatment on-going|1
101608|NCT01241292|242370|P1|COMPLETED|Overall Study|completed=treatment on-going|2
101609|NCT01241292|242369|P2|STARTED|Overall Study||3
101610|NCT01241292|242370|P1|STARTED|Overall Study||3
101611|NCT01241279|242394|P2|NOT COMPLETED|Overall Study||1
101612|NCT01241279|242395|P1|NOT COMPLETED|Overall Study||0
101613|NCT01241279|242394|P2|COMPLETED|Overall Study||1
101614|NCT01241279|242395|P1|COMPLETED|Overall Study||4
101615|NCT01241279|242394|P2|STARTED|Overall Study||2
101616|NCT01241279|242395|P1|STARTED|Overall Study||4
101617|NCT01241240|242405|P2|NOT COMPLETED|Overall Study||9
101618|NCT01241240|242406|P1|NOT COMPLETED|Overall Study||8
101619|NCT01241240|242405|P2|COMPLETED|Overall Study||89
101620|NCT01241240|242406|P1|COMPLETED|Overall Study||86
101621|NCT01241240|242405|P2|STARTED|Overall Study||98
101622|NCT01241240|242406|P1|STARTED|Overall Study||94
101623|NCT01240915|242424|P9|NOT COMPLETED|Overall Study||8
101624|NCT01240915|242425|P8|NOT COMPLETED|Overall Study||4
101625|NCT01240915|242426|P7|NOT COMPLETED|Overall Study||8
101626|NCT01240915|242427|P6|NOT COMPLETED|Overall Study||10
101627|NCT01240915|242428|P5|NOT COMPLETED|Overall Study||4
101628|NCT01240915|242429|P4|NOT COMPLETED|Overall Study||3
101629|NCT01240915|242430|P3|NOT COMPLETED|Overall Study||0
101630|NCT01240915|242431|P2|NOT COMPLETED|Overall Study||1
101631|NCT01240915|242432|P1|NOT COMPLETED|Overall Study||2
101632|NCT01240915|242424|P9|COMPLETED|Overall Study||13
101633|NCT01240915|242425|P8|COMPLETED|Overall Study||15
101634|NCT01240915|242426|P7|COMPLETED|Overall Study||17
101635|NCT01240915|242427|P6|COMPLETED|Overall Study||13
101636|NCT01240915|242428|P5|COMPLETED|Overall Study||2
101637|NCT01240915|242429|P4|COMPLETED|Overall Study||1
101638|NCT01240915|242430|P3|COMPLETED|Overall Study||2
101639|NCT01240915|242431|P2|COMPLETED|Overall Study||2
101640|NCT01240915|242432|P1|COMPLETED|Overall Study||0
101641|NCT01240915|242424|P9|STARTED|Overall Study||21
101642|NCT01240915|242425|P8|STARTED|Overall Study||19
101643|NCT01240915|242426|P7|STARTED|Overall Study||25
101644|NCT01240915|242427|P6|STARTED|Overall Study||23
101645|NCT01240915|242428|P5|STARTED|Overall Study||6
101646|NCT01240915|242429|P4|STARTED|Overall Study||4
101647|NCT01240915|242430|P3|STARTED|Overall Study||2
101648|NCT01240915|242431|P2|STARTED|Overall Study||3
101649|NCT01240915|242432|P1|STARTED|Overall Study||2
101650|NCT01240902|242615|P4|NOT COMPLETED|Overall Study||165
101651|NCT01240902|242616|P3|NOT COMPLETED|Overall Study||100
101652|NCT01240902|242617|P2|NOT COMPLETED|Overall Study||79
101653|NCT01240902|242618|P1|NOT COMPLETED|Overall Study||211
101654|NCT01240902|242615|P4|COMPLETED|Overall Study||237
101655|NCT01240902|242616|P3|COMPLETED|Overall Study||295
101656|NCT01240902|242617|P2|COMPLETED|Overall Study||77
101657|NCT01240902|242618|P1|COMPLETED|Overall Study||289
101658|NCT01240902|242615|P4|STARTED|Overall Study||402
101659|NCT01240902|242616|P3|STARTED|Overall Study||395
101660|NCT01240902|242617|P2|STARTED|Overall Study||156
101661|NCT01240902|242618|P1|STARTED|Overall Study||500
101662|NCT01240863|242706|P3|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||52
101663|NCT01240863|242707|P2|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||46
101664|NCT01240863|242708|P1|NOT COMPLETED|Double-blind Treatment Period (12 Weeks)||0
101665|NCT01240863|242706|P3|COMPLETED|Double-blind Treatment Period (12 Weeks)||94
101666|NCT01240863|242707|P2|COMPLETED|Double-blind Treatment Period (12 Weeks)||102
101667|NCT01240863|242708|P1|COMPLETED|Double-blind Treatment Period (12 Weeks)||0
101668|NCT01240863|242706|P3|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||146
101669|NCT01240863|242707|P2|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||147
101670|NCT01240863|242708|P1|Full Analysis and Safety Analysis Sets|Double-blind Treatment Period (12 Weeks)||0
101671|NCT01240863|242706|P3|STARTED|Double-blind Treatment Period (12 Weeks)||146
101672|NCT01240863|242707|P2|STARTED|Double-blind Treatment Period (12 Weeks)||148
101673|NCT01240863|242708|P1|STARTED|Double-blind Treatment Period (12 Weeks)||0
101674|NCT01240863|242706|P3|NOT COMPLETED|Open-label Titration Period||0
101675|NCT01240863|242707|P2|NOT COMPLETED|Open-label Titration Period||0
101676|NCT01240863|242708|P1|NOT COMPLETED|Open-label Titration Period||97
101677|NCT01240863|242706|P3|COMPLETED|Open-label Titration Period||0
101678|NCT01240863|242707|P2|COMPLETED|Open-label Titration Period||0
101679|NCT01240863|242708|P1|COMPLETED|Open-label Titration Period||294
101680|NCT01240863|242706|P3|Safety Analysis Set|Open-label Titration Period||0
101681|NCT01240863|242707|P2|Safety Analysis Set|Open-label Titration Period||0
101682|NCT01240863|242708|P1|Safety Analysis Set|Open-label Titration Period||389
101683|NCT01240863|242706|P3|STARTED|Open-label Titration Period||0
101684|NCT01240863|242707|P2|STARTED|Open-label Titration Period||0
101685|NCT01240863|242708|P1|STARTED|Open-label Titration Period||391
101686|NCT01240811|242770|P3|NOT COMPLETED|Overall Study||1
101687|NCT01240811|242771|P2|NOT COMPLETED|Overall Study||1
101688|NCT01240811|242772|P1|NOT COMPLETED|Overall Study||0
101689|NCT01240811|242770|P3|COMPLETED|Overall Study||16
101690|NCT01240811|242771|P2|COMPLETED|Overall Study||16
101691|NCT01240811|242772|P1|COMPLETED|Overall Study||8
101692|NCT01240811|242770|P3|STARTED|Overall Study||17
101693|NCT01240811|242771|P2|STARTED|Overall Study||17
101694|NCT01240811|242772|P1|STARTED|Overall Study||8
101695|NCT01240785|242782|P2|NOT COMPLETED|Overall Study||3
101696|NCT01240785|242783|P1|NOT COMPLETED|Overall Study||1
101697|NCT01240785|242782|P2|COMPLETED|Overall Study||107
101698|NCT01240785|242783|P1|COMPLETED|Overall Study|110 women completed in the metformin arm and 107 women completed in the insulin arm.|110
101699|NCT01240785|242782|P2|STARTED|Overall Study||110
101700|NCT01240785|242783|P1|STARTED|Overall Study||111
101701|NCT01240746|242814|P3|NOT COMPLETED|Overall Study||243
101702|NCT01240746|242815|P2|NOT COMPLETED|Overall Study||48
101703|NCT01240746|242816|P1|NOT COMPLETED|Overall Study||59
101704|NCT01240746|242814|P3|COMPLETED|Overall Study||2659
101705|NCT01240746|242815|P2|COMPLETED|Overall Study||677
101706|NCT01240746|242816|P1|COMPLETED|Overall Study||677
101707|NCT01240746|242814|P3|STARTED|Overall Study||2902
101708|NCT01240746|242815|P2|STARTED|Overall Study||725
101709|NCT01240746|242816|P1|STARTED|Overall Study||736
101710|NCT01240590|242871|P5|NOT COMPLETED|Phase II||1
101711|NCT01240590|242872|P4|NOT COMPLETED|Phase II||2
101712|NCT01240590|242873|P3|NOT COMPLETED|Phase II||0
101713|NCT01240590|242874|P2|NOT COMPLETED|Phase II||0
101714|NCT01240590|242875|P1|NOT COMPLETED|Phase II||0
101715|NCT01240590|242871|P5|COMPLETED|Phase II||0
101716|NCT01240590|242872|P4|COMPLETED|Phase II||15
101717|NCT01240590|242873|P3|COMPLETED|Phase II||0
101718|NCT01240590|242874|P2|COMPLETED|Phase II||0
101719|NCT01240590|242875|P1|COMPLETED|Phase II||0
101720|NCT01240590|242871|P5|STARTED|Phase II||1
101721|NCT01240590|242872|P4|STARTED|Phase II||17
101722|NCT01240590|242873|P3|STARTED|Phase II||0
101723|NCT01240590|242874|P2|STARTED|Phase II||0
101724|NCT01240590|242875|P1|STARTED|Phase II||0
101725|NCT01240590|242871|P5|NOT COMPLETED|Phase I||0
101726|NCT01240590|242872|P4|NOT COMPLETED|Phase I||0
101727|NCT01240590|242873|P3|NOT COMPLETED|Phase I||3
101728|NCT01240590|242874|P2|NOT COMPLETED|Phase I||0
101729|NCT01240590|242875|P1|NOT COMPLETED|Phase I||0
101730|NCT01240590|242871|P5|COMPLETED|Phase I||0
101731|NCT01240590|242872|P4|COMPLETED|Phase I||0
101732|NCT01240590|242873|P3|COMPLETED|Phase I||0
101733|NCT01240590|242874|P2|COMPLETED|Phase I||6
101734|NCT01240590|242875|P1|COMPLETED|Phase I||0
101735|NCT01240590|242871|P5|STARTED|Phase I||0
101736|NCT01240590|242872|P4|STARTED|Phase I||0
101737|NCT01240590|242873|P3|STARTED|Phase I||3
101738|NCT01240590|242874|P2|STARTED|Phase I||6
101739|NCT01240590|242875|P1|STARTED|Phase I||0
101740|NCT01240551|242903|P2|NOT COMPLETED|Overall Study||3
101741|NCT01240551|242904|P1|NOT COMPLETED|Overall Study||4
101742|NCT01240551|242903|P2|COMPLETED|Overall Study||27
101743|NCT01240551|242904|P1|COMPLETED|Overall Study||26
101744|NCT01240551|242903|P2|STARTED|Overall Study||30
101745|NCT01240551|242904|P1|STARTED|Overall Study||30
101746|NCT01240382|242914|P2|NOT COMPLETED|Overall Study||4
101747|NCT01240382|242915|P1|NOT COMPLETED|Overall Study||2
101748|NCT01240382|242914|P2|COMPLETED|Overall Study||139
101749|NCT01240382|242915|P1|COMPLETED|Overall Study||142
101750|NCT01240382|242914|P2|STARTED|Overall Study||143
101751|NCT01240382|242915|P1|STARTED|Overall Study||144
101752|NCT01240356|242925|P2|NOT COMPLETED|Overall Study||0
101753|NCT01240356|242926|P1|NOT COMPLETED|Overall Study||3
101754|NCT01240356|242925|P2|COMPLETED|Overall Study||20
101755|NCT01240356|242926|P1|COMPLETED|Overall Study||15
101756|NCT01240356|242925|P2|STARTED|Overall Study||20
101757|NCT01240356|242926|P1|STARTED|Overall Study||18
101758|NCT01240330|242937|P1|NOT COMPLETED|Overall Study||0
101759|NCT01240330|242937|P1|COMPLETED|Overall Study||33
101760|NCT01240330|242937|P1|STARTED|Overall Study||33
101761|NCT01240200|242945|P2|NOT COMPLETED|12-week Crossover Phase - Period 2||0
101762|NCT01240200|242946|P1|NOT COMPLETED|12-week Crossover Phase - Period 2||0
101763|NCT01240200|242945|P2|COMPLETED|12-week Crossover Phase - Period 2||23
101764|NCT01240200|242946|P1|COMPLETED|12-week Crossover Phase - Period 2||23
101765|NCT01240200|242945|P2|STARTED|12-week Crossover Phase - Period 2||23
101766|NCT01240200|242946|P1|STARTED|12-week Crossover Phase - Period 2||23
101767|NCT01240200|242945|P2|NOT COMPLETED|12-week Crossover Phase - Period 1||1
101768|NCT01240200|242946|P1|NOT COMPLETED|12-week Crossover Phase - Period 1||2
101769|NCT01240200|242945|P2|COMPLETED|12-week Crossover Phase - Period 1||23
101770|NCT01240200|242946|P1|COMPLETED|12-week Crossover Phase - Period 1||23
101771|NCT01240200|242945|P2|STARTED|12-week Crossover Phase - Period 1||24
101772|NCT01240200|242946|P1|STARTED|12-week Crossover Phase - Period 1||25
101773|NCT01240135|242954|P2|NOT COMPLETED|Period Two, 14 Days of Wear||2
101774|NCT01240135|242955|P1|NOT COMPLETED|Period Two, 14 Days of Wear||1
101775|NCT01240135|242954|P2|COMPLETED|Period Two, 14 Days of Wear||43
101776|NCT01240135|242955|P1|COMPLETED|Period Two, 14 Days of Wear||43
101777|NCT01240135|242954|P2|STARTED|Period Two, 14 Days of Wear||45
101778|NCT01240135|242955|P1|STARTED|Period Two, 14 Days of Wear||44
101779|NCT01240135|242954|P2|NOT COMPLETED|Period One, 14 Days of Wear||0
101780|NCT01240135|242955|P1|NOT COMPLETED|Period One, 14 Days of Wear||0
101781|NCT01240135|242954|P2|COMPLETED|Period One, 14 Days of Wear||45
101782|NCT01240135|242955|P1|COMPLETED|Period One, 14 Days of Wear||44
101783|NCT01240135|242954|P2|STARTED|Period One, 14 Days of Wear||45
101784|NCT01240135|242955|P1|STARTED|Period One, 14 Days of Wear||44
101785|NCT01240122|242963|P1|NOT COMPLETED|Overall Study||0
101786|NCT01240122|242963|P1|COMPLETED|Overall Study||29
101787|NCT01240122|242963|P1|STARTED|Overall Study||29
101788|NCT01239992|242970|P1|NOT COMPLETED|Overall Study||2
101789|NCT01239992|242970|P1|COMPLETED|Overall Study||10
101790|NCT01239992|242970|P1|STARTED|Overall Study||12
101791|NCT01239797|242979|P2|NOT COMPLETED|Treated Participants||274
101792|NCT01239797|242980|P1|NOT COMPLETED|Treated Participants||235
101793|NCT01239797|242979|P2|COMPLETED|Treated Participants|Completed = Still on Treatment|43
101794|NCT01239797|242980|P1|COMPLETED|Treated Participants|Completed = Still on Treatment|83
101795|NCT01239797|242979|P2|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|317
101796|NCT01239797|242980|P1|STARTED|Treated Participants|1 participant was randomized to treatment E-Ld but received treatment Ld|318
101797|NCT01239797|242979|P2|NOT COMPLETED|Randomized Participants||9
101798|NCT01239797|242980|P1|NOT COMPLETED|Randomized Participants||2
101799|NCT01239797|242979|P2|COMPLETED|Randomized Participants||316
101800|NCT01239797|242980|P1|COMPLETED|Randomized Participants||319
101801|NCT01239797|242979|P2|STARTED|Randomized Participants||325
101802|NCT01239797|242980|P1|STARTED|Randomized Participants||321
101803|NCT01239745|242988|P1|NOT COMPLETED|Overall Study||46
101804|NCT01239745|242988|P1|COMPLETED|Overall Study||0
101805|NCT01239745|242988|P1|STARTED|Overall Study||46
101806|NCT01239732|242999|P1|NOT COMPLETED|Overall Study||1021
101807|NCT01239732|242999|P1|COMPLETED|Overall Study||0
101808|NCT01239732|242999|P1|STARTED|Overall Study||1021
101809|NCT01239680|243012|P2|NOT COMPLETED|Overall Study||0
101810|NCT01239680|243013|P1|NOT COMPLETED|Overall Study||2
101811|NCT01239680|243012|P2|COMPLETED|Overall Study||2
101812|NCT01239680|243013|P1|COMPLETED|Overall Study||1
101813|NCT01239680|243012|P2|STARTED|Overall Study||2
101814|NCT01239680|243013|P1|STARTED|Overall Study||3
101815|NCT01239511|243023|P4|NOT COMPLETED|Overall Study||9
101816|NCT01239511|243024|P3|NOT COMPLETED|Overall Study||4
101817|NCT01239511|243025|P2|NOT COMPLETED|Overall Study||5
101818|NCT01239511|243026|P1|NOT COMPLETED|Overall Study||1
101819|NCT01239511|243023|P4|COMPLETED|Overall Study||38
101820|NCT01239511|243024|P3|COMPLETED|Overall Study||43
101821|NCT01239511|243025|P2|COMPLETED|Overall Study||40
101822|NCT01239511|243026|P1|COMPLETED|Overall Study||46
101823|NCT01239511|243023|P4|STARTED|Overall Study||47
101824|NCT01239511|243024|P3|STARTED|Overall Study||47
101825|NCT01239511|243025|P2|STARTED|Overall Study||45
101826|NCT01239511|243026|P1|STARTED|Overall Study||47
101827|NCT01239394|243036|P1|NOT COMPLETED|Overall Study||1
101828|NCT01239394|243036|P1|COMPLETED|Overall Study||41
101829|NCT01239394|243036|P1|STARTED|Overall Study||42
101830|NCT01239381|243043|P1|NOT COMPLETED|Overall Study||2
101831|NCT01239381|243043|P1|COMPLETED|Overall Study||90
101832|NCT01239381|243043|P1|STARTED|Overall Study||92
101833|NCT01239355|243053|P1|NOT COMPLETED|Overall Study||0
101834|NCT01239355|243053|P1|COMPLETED|Overall Study||15
101835|NCT01239355|243053|P1|STARTED|Overall Study||15
101836|NCT01239342|243061|P2|NOT COMPLETED|Overall Study||6
101837|NCT01239342|243062|P1|NOT COMPLETED|Overall Study||3
101838|NCT01239342|243061|P2|COMPLETED|Overall Study||8
101839|NCT01239342|243062|P1|COMPLETED|Overall Study||26
101840|NCT01239342|243061|P2|STARTED|Overall Study||14
101841|NCT01239342|243062|P1|STARTED|Overall Study||29
101842|NCT01239316|243078|P1|NOT COMPLETED|Overall Study||12
101843|NCT01239316|243078|P1|COMPLETED|Overall Study||0
101844|NCT01239316|243078|P1|STARTED|Overall Study||12
101845|NCT01239212|243086|P1|NOT COMPLETED|Overall Study||0
101846|NCT01239212|243086|P1|COMPLETED|Overall Study||7
101847|NCT01239212|243086|P1|STARTED|Overall Study||7
101848|NCT01239121|243093|P3|NOT COMPLETED|Overall Study||0
101849|NCT01239121|243094|P2|NOT COMPLETED|Overall Study||4
101850|NCT01239121|243095|P1|NOT COMPLETED|Overall Study||2
101851|NCT01239121|243093|P3|COMPLETED|Overall Study||15
101852|NCT01239121|243094|P2|COMPLETED|Overall Study||195
101853|NCT01239121|243095|P1|COMPLETED|Overall Study||186
101854|NCT01239121|243093|P3|STARTED|Overall Study||15
101855|NCT01239121|243094|P2|STARTED|Overall Study||199
101856|NCT01239121|243095|P1|STARTED|Overall Study||188
101857|NCT01239056|243109|P1|NOT COMPLETED|Overall Study||0
101858|NCT01239056|243109|P1|COMPLETED|Overall Study||20
101859|NCT01239056|243109|P1|STARTED|Overall Study||20
101860|NCT01239043|243117|P2|NOT COMPLETED|Overall Study||1
101861|NCT01239043|243118|P1|NOT COMPLETED|Overall Study||2
101862|NCT01239043|243117|P2|COMPLETED|Overall Study||102
101863|NCT01239043|243118|P1|COMPLETED|Overall Study||34
101864|NCT01239043|243117|P2|STARTED|Overall Study||103
101865|NCT01239043|243118|P1|STARTED|Overall Study|For safety analysis number includes 1 participant randomized to Menactra who received Menomune.|36
101866|NCT01238991|243146|P10|NOT COMPLETED|Overall Study||2
101867|NCT01238991|243147|P9|NOT COMPLETED|Overall Study||4
101868|NCT01238991|243148|P8|NOT COMPLETED|Overall Study||5
101869|NCT01238991|243149|P7|NOT COMPLETED|Overall Study||8
101870|NCT01238991|243150|P6|NOT COMPLETED|Overall Study||0
101871|NCT01238991|243151|P5|NOT COMPLETED|Overall Study||2
101872|NCT01238991|243152|P4|NOT COMPLETED|Overall Study||2
101873|NCT01238991|243153|P3|NOT COMPLETED|Overall Study||6
101874|NCT01238991|243154|P2|NOT COMPLETED|Overall Study||0
101875|NCT01238991|243155|P1|NOT COMPLETED|Overall Study||2
101876|NCT01238991|243146|P10|COMPLETED|Overall Study||0
101877|NCT01238991|243147|P9|COMPLETED|Overall Study||0
101878|NCT01238991|243148|P8|COMPLETED|Overall Study||0
101879|NCT01238991|243149|P7|COMPLETED|Overall Study||0
101880|NCT01238991|243150|P6|COMPLETED|Overall Study||2
101881|NCT01238991|243151|P5|COMPLETED|Overall Study||3
101882|NCT01238991|243152|P4|COMPLETED|Overall Study||4
101883|NCT01238991|243153|P3|COMPLETED|Overall Study||5
101884|NCT01238991|243154|P2|COMPLETED|Overall Study||3
101885|NCT01238991|243155|P1|COMPLETED|Overall Study||5
101886|NCT01238991|243146|P10|Received Treatment|Overall Study||2
101887|NCT01238991|243147|P9|Received Treatment|Overall Study||4
101888|NCT01238991|243148|P8|Received Treatment|Overall Study||5
101889|NCT01238991|243149|P7|Received Treatment|Overall Study||8
101890|NCT01238991|243150|P6|Received Treatment|Overall Study||2
101891|NCT01238991|243151|P5|Received Treatment|Overall Study||5
101892|NCT01238991|243152|P4|Received Treatment|Overall Study||6
101893|NCT01238991|243153|P3|Received Treatment|Overall Study||11
101894|NCT01238991|243154|P2|Received Treatment|Overall Study||3
101895|NCT01238991|243155|P1|Received Treatment|Overall Study||7
101896|NCT01238991|243146|P10|STARTED|Overall Study||2
101897|NCT01238991|243147|P9|STARTED|Overall Study||4
101898|NCT01238991|243148|P8|STARTED|Overall Study||5
101899|NCT01238991|243149|P7|STARTED|Overall Study||8
101900|NCT01238991|243150|P6|STARTED|Overall Study||2
101901|NCT01238991|243151|P5|STARTED|Overall Study||5
101902|NCT01238991|243152|P4|STARTED|Overall Study||6
101903|NCT01238991|243153|P3|STARTED|Overall Study||11
101904|NCT01238991|243154|P2|STARTED|Overall Study||3
101905|NCT01238991|243155|P1|STARTED|Overall Study||7
101906|NCT01238900|243242|P1|NOT COMPLETED|<12 Months Post Stent Removal||5
101907|NCT01238900|243242|P1|COMPLETED|<12 Months Post Stent Removal||18
101908|NCT01238900|243242|P1|STARTED|<12 Months Post Stent Removal||23
101909|NCT01238900|243242|P1|NOT COMPLETED|6 Months Post Stent Placement||0
101910|NCT01238900|243242|P1|COMPLETED|6 Months Post Stent Placement||23
101911|NCT01238900|243242|P1|STARTED|6 Months Post Stent Placement||23
101912|NCT01238861|243256|P6|NOT COMPLETED|Overall Study||15
101913|NCT01238861|243257|P5|NOT COMPLETED|Overall Study||13
101914|NCT01238861|243258|P4|NOT COMPLETED|Overall Study||13
101915|NCT01238861|243259|P3|NOT COMPLETED|Overall Study||11
101916|NCT01238861|243260|P2|NOT COMPLETED|Overall Study||8
101917|NCT01238861|243261|P1|NOT COMPLETED|Overall Study||11
101918|NCT01238861|243256|P6|COMPLETED|Overall Study||125
101919|NCT01238861|243257|P5|COMPLETED|Overall Study||129
101920|NCT01238861|243258|P4|COMPLETED|Overall Study||69
101921|NCT01238861|243259|P3|COMPLETED|Overall Study||70
101922|NCT01238861|243260|P2|COMPLETED|Overall Study||73
101923|NCT01238861|243261|P1|COMPLETED|Overall Study||69
101924|NCT01238861|243256|P6|STARTED|Overall Study||140
101925|NCT01238861|243257|P5|STARTED|Overall Study||142
101926|NCT01238861|243258|P4|STARTED|Overall Study||82
101927|NCT01238861|243259|P3|STARTED|Overall Study||81
101928|NCT01238861|243260|P2|STARTED|Overall Study||81
101929|NCT01238861|243261|P1|STARTED|Overall Study||80
101930|NCT01238848|243341|P2|NOT COMPLETED|Overall Study||5
101931|NCT01238848|243342|P1|NOT COMPLETED|Overall Study||13
101932|NCT01238848|243341|P2|COMPLETED|Overall Study||45
101933|NCT01238848|243342|P1|COMPLETED|Overall Study||37
101934|NCT01238848|243341|P2|STARTED|Overall Study||50
101935|NCT01238848|243342|P1|STARTED|Overall Study||50
101936|NCT01238822|243350|P1|NOT COMPLETED|Overall Study||3
101937|NCT01238822|243350|P1|COMPLETED|Overall Study||93
101938|NCT01238822|243350|P1|Received High Dosage|Overall Study||93
101939|NCT01238822|243350|P1|Received Medium Dosage|Overall Study||93
101940|NCT01238822|243350|P1|Received Low Dosage|Overall Study||93
101941|NCT01238822|243350|P1|Received Placebo|Overall Study||93
101942|NCT01238822|243350|P1|STARTED|Overall Study||96
101943|NCT01238640|243360|P1|NOT COMPLETED|Overall Study||0
101944|NCT01238640|243360|P1|COMPLETED|Overall Study||84
101945|NCT01238640|243360|P1|STARTED|Overall Study||84
101946|NCT01238588|243377|P1|NOT COMPLETED|Overall Study||3
101947|NCT01238588|243377|P1|COMPLETED|Overall Study||9
101948|NCT01238588|243377|P1|STARTED|Overall Study||12
101949|NCT01238575|243390|P2|NOT COMPLETED|Overall Study||4
101950|NCT01238575|243391|P1|NOT COMPLETED|Overall Study||4
101951|NCT01238575|243390|P2|COMPLETED|Overall Study||28
101952|NCT01238575|243391|P1|COMPLETED|Overall Study||26
101953|NCT01238575|243390|P2|STARTED|Overall Study||32
101954|NCT01238575|243391|P1|STARTED|Overall Study||30
101955|NCT01238471|243429|P2|NOT COMPLETED|Overall Study||0
101956|NCT01238471|243430|P1|NOT COMPLETED|Overall Study||0
101957|NCT01238471|243429|P2|COMPLETED|Overall Study||10
101958|NCT01238471|243430|P1|COMPLETED|Overall Study||10
101959|NCT01238471|243429|P2|STARTED|Overall Study||10
101960|NCT01238471|243430|P1|STARTED|Overall Study||10
101961|NCT01238341|243436|P1|NOT COMPLETED|Overall Study||0
101962|NCT01238341|243436|P1|COMPLETED|Overall Study||7
101963|NCT01238341|243436|P1|STARTED|Overall Study||7
101964|NCT01238211|243443|P1|NOT COMPLETED|Overall Study||58
101965|NCT01238211|243443|P1|COMPLETED|Overall Study||3
101966|NCT01238211|243443|P1|STARTED|Overall Study||61
101967|NCT01237613|243447|P1|NOT COMPLETED|Overall Study||0
101968|NCT01237613|243447|P1|COMPLETED|Overall Study||4
101969|NCT01237613|243447|P1|STARTED|Overall Study||4
101970|NCT01237353|243471|P1|NOT COMPLETED|Overall Study||0
101971|NCT01237353|243471|P1|COMPLETED|Overall Study||6
101972|NCT01237353|243471|P1|STARTED|Overall Study||6
101973|NCT01237340|243476|P1|NOT COMPLETED|Overall Study||40
101974|NCT01237340|243476|P1|COMPLETED|Overall Study||19
101975|NCT01237340|243476|P1|STARTED|Overall Study||59
101976|NCT01237327|243490|P2|NOT COMPLETED|Overall Study||40
101977|NCT01237327|243491|P1|NOT COMPLETED|Overall Study||42
101978|NCT01237327|243490|P2|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
101979|NCT01237327|243491|P1|COMPLETED|Overall Study|On treatment at Extension Study cut-off date.|1
101980|NCT01237327|243490|P2|Continued Treatment in Extension Study|Overall Study||17
101981|NCT01237327|243491|P1|Continued Treatment in Extension Study|Overall Study||21
101982|NCT01237327|243490|P2|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|2
101983|NCT01237327|243491|P1|Completed Treatment in Core Study|Overall Study|Completed 26 weeks of treatment in Core Study; continued in Extension Study for follow-up only.|3
101984|NCT01237327|243490|P2|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|24
101985|NCT01237327|243491|P1|Stopped Treatment in Core Study (D/C)|Overall Study|Continued in Extension Study for follow-up only; not treated with study medication.|22
101986|NCT01237327|243490|P2|STARTED|Overall Study||41
101987|NCT01237327|243491|P1|STARTED|Overall Study||43
101988|NCT01237301|243507|P2|NOT COMPLETED|Overall Study||4
101989|NCT01237301|243508|P1|NOT COMPLETED|Overall Study||5
101990|NCT01237301|243507|P2|COMPLETED|Overall Study||55
101991|NCT01237301|243508|P1|COMPLETED|Overall Study||60
101992|NCT01237301|243507|P2|STARTED|Overall Study||59
101993|NCT01237301|243508|P1|STARTED|Overall Study||65
101994|NCT01237223|243520|P6|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
101995|NCT01237223|243521|P5|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||4
101996|NCT01237223|243522|P4|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||5
101997|NCT01237223|243523|P3|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
101998|NCT01237223|243524|P2|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||15
101999|NCT01237223|243525|P1|NOT COMPLETED|Double Blind (Treatment Period, 8 Weeks)||33
102000|NCT01237223|243520|P6|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||154
102001|NCT01237223|243521|P5|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||155
102002|NCT01237223|243522|P4|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||153
102003|NCT01237223|243523|P3|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||143
102004|NCT01237223|243524|P2|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||142
102005|NCT01237223|243525|P1|COMPLETED|Double Blind (Treatment Period, 8 Weeks)||120
102006|NCT01237223|243520|P6|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
102007|NCT01237223|243521|P5|STARTED|Double Blind (Treatment Period, 8 Weeks)||159
102008|NCT01237223|243522|P4|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
102009|NCT01237223|243523|P3|STARTED|Double Blind (Treatment Period, 8 Weeks)||158
102010|NCT01237223|243524|P2|STARTED|Double Blind (Treatment Period, 8 Weeks)||157
102011|NCT01237223|243525|P1|STARTED|Double Blind (Treatment Period, 8 Weeks)||153
102012|NCT01237223|243520|P6|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102013|NCT01237223|243521|P5|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102014|NCT01237223|243522|P4|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102015|NCT01237223|243523|P3|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102016|NCT01237223|243524|P2|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102017|NCT01237223|243525|P1|NOT COMPLETED|Single Blind(Run-in Period, 4 Weeks)||398
102018|NCT01237223|243520|P6|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102019|NCT01237223|243521|P5|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102020|NCT01237223|243522|P4|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102021|NCT01237223|243523|P3|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102022|NCT01237223|243524|P2|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||0
102023|NCT01237223|243525|P1|COMPLETED|Single Blind(Run-in Period, 4 Weeks)||944
102024|NCT01237223|243520|P6|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
102025|NCT01237223|243521|P5|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
102026|NCT01237223|243522|P4|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
102027|NCT01237223|243523|P3|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
102028|NCT01237223|243524|P2|STARTED|Single Blind(Run-in Period, 4 Weeks)||0
102029|NCT01237223|243525|P1|STARTED|Single Blind(Run-in Period, 4 Weeks)|All the patients enrolled to single blind period received only placebo treatment.|1342
102030|NCT01237197|243566|P2|NOT COMPLETED|Open Label Period||0
102031|NCT01237197|243567|P1|NOT COMPLETED|Open Label Period||0
102032|NCT01237197|243566|P2|COMPLETED|Open Label Period||10
102033|NCT01237197|243567|P1|COMPLETED|Open Label Period||12
102034|NCT01237197|243566|P2|STARTED|Open Label Period||10
102035|NCT01237197|243567|P1|STARTED|Open Label Period||12
102036|NCT01237197|243566|P2|NOT COMPLETED|Randomization Period||3
102037|NCT01237197|243567|P1|NOT COMPLETED|Randomization Period||1
102038|NCT01237197|243566|P2|COMPLETED|Randomization Period||10
102039|NCT01237197|243567|P1|COMPLETED|Randomization Period||12
102040|NCT01237197|243566|P2|STARTED|Randomization Period||13
102041|NCT01237197|243567|P1|STARTED|Randomization Period||13
102042|NCT01237080|243575|P2|NOT COMPLETED|Overall Study||0
102043|NCT01237080|243576|P1|NOT COMPLETED|Overall Study||0
102044|NCT01237080|243575|P2|COMPLETED|Overall Study||50
102045|NCT01237080|243576|P1|COMPLETED|Overall Study||50
102046|NCT01237080|243575|P2|STARTED|Overall Study||50
102047|NCT01237080|243576|P1|STARTED|Overall Study||50
102048|NCT01237054|243584|P1|NOT COMPLETED|Overall Study||1
102049|NCT01237054|243584|P1|COMPLETED|Overall Study||30
102050|NCT01237054|243584|P1|STARTED|Overall Study||31
102051|NCT01236573|243616|P11|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||1
102052|NCT01236573|243617|P10|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102053|NCT01236573|243618|P9|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102054|NCT01236573|243619|P8|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102055|NCT01236573|243620|P7|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102056|NCT01236573|243621|P6|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102057|NCT01236573|243622|P5|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102058|NCT01236573|243623|P4|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102059|NCT01236573|243624|P3|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102060|NCT01236573|243625|P2|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102061|NCT01236573|243626|P1|NOT COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102062|NCT01236573|243616|P11|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||5
102063|NCT01236573|243617|P10|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102064|NCT01236573|243618|P9|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102065|NCT01236573|243619|P8|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102066|NCT01236573|243620|P7|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102067|NCT01236573|243621|P6|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102068|NCT01236573|243622|P5|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102069|NCT01236573|243623|P4|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102146|NCT01236573|243623|P4|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
102070|NCT01236573|243624|P3|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102071|NCT01236573|243625|P2|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102072|NCT01236573|243626|P1|COMPLETED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102073|NCT01236573|243616|P11|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||6
102074|NCT01236573|243617|P10|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102075|NCT01236573|243618|P9|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102076|NCT01236573|243619|P8|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102077|NCT01236573|243620|P7|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102078|NCT01236573|243621|P6|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102079|NCT01236573|243622|P5|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102080|NCT01236573|243623|P4|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102081|NCT01236573|243624|P3|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102082|NCT01236573|243625|P2|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102083|NCT01236573|243626|P1|STARTED|Phase 2- MTD/Anti-IL-12 Cells-Cohort 11||0
102084|NCT01236573|243616|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102085|NCT01236573|243617|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
102086|NCT01236573|243618|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
102087|NCT01236573|243619|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102088|NCT01236573|243620|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
102089|NCT01236573|243621|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102090|NCT01236573|243622|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102091|NCT01236573|243623|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102092|NCT01236573|243624|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102093|NCT01236573|243625|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102094|NCT01236573|243626|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102095|NCT01236573|243616|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102096|NCT01236573|243617|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
102097|NCT01236573|243618|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
102098|NCT01236573|243619|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||3
102099|NCT01236573|243620|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||2
102100|NCT01236573|243621|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||4
102101|NCT01236573|243622|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||1
102102|NCT01236573|243623|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102103|NCT01236573|243624|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102104|NCT01236573|243625|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102105|NCT01236573|243626|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 5-10||0
102106|NCT01236573|243616|P11|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
102107|NCT01236573|243617|P10|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
102108|NCT01236573|243618|P9|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
102109|NCT01236573|243619|P8|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
102110|NCT01236573|243620|P7|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||3
102111|NCT01236573|243621|P6|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||4
102112|NCT01236573|243622|P5|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||1
102113|NCT01236573|243623|P4|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
102114|NCT01236573|243624|P3|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
102115|NCT01236573|243625|P2|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
102116|NCT01236573|243626|P1|STARTED|Phase 1-Dose Escalation-Cohorts 5-10||0
102117|NCT01236573|243616|P11|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102118|NCT01236573|243617|P10|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102119|NCT01236573|243618|P9|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102120|NCT01236573|243619|P8|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102121|NCT01236573|243620|P7|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102122|NCT01236573|243621|P6|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102123|NCT01236573|243622|P5|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102124|NCT01236573|243623|P4|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102125|NCT01236573|243624|P3|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102126|NCT01236573|243625|P2|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102127|NCT01236573|243626|P1|NOT COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102128|NCT01236573|243616|P11|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102129|NCT01236573|243617|P10|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102130|NCT01236573|243618|P9|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102131|NCT01236573|243619|P8|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102132|NCT01236573|243620|P7|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102133|NCT01236573|243621|P6|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102134|NCT01236573|243622|P5|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||0
102135|NCT01236573|243623|P4|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
102136|NCT01236573|243624|P3|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||6
102137|NCT01236573|243625|P2|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
102138|NCT01236573|243626|P1|COMPLETED|Phase 1-Dose Escalation-Cohorts 1-4||1
102139|NCT01236573|243616|P11|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
102140|NCT01236573|243617|P10|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
102141|NCT01236573|243618|P9|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
102142|NCT01236573|243619|P8|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
102143|NCT01236573|243620|P7|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
102144|NCT01236573|243621|P6|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
102145|NCT01236573|243622|P5|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||0
102147|NCT01236573|243624|P3|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||6
102148|NCT01236573|243625|P2|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
102149|NCT01236573|243626|P1|STARTED|Phase 1-Dose Escalation-Cohorts 1-4||1
102150|NCT01236534|243664|P2|NOT COMPLETED|Overall Study||0
102151|NCT01236534|243665|P1|NOT COMPLETED|Overall Study||3
102152|NCT01236534|243664|P2|COMPLETED|Overall Study||10
102153|NCT01236534|243665|P1|COMPLETED|Overall Study|2 subjects stopped treatment due to diarrhea, and 1 stopped treatment due to constipation.|8
102154|NCT01236534|243664|P2|STARTED|Overall Study||10
102155|NCT01236534|243665|P1|STARTED|Overall Study||11
102156|NCT01236391|243673|P1|NOT COMPLETED|Overall Study||16
102157|NCT01236391|243673|P1|COMPLETED|Overall Study|Participants who were on treatment or discontinued treatment due to disease progression or death|95
102158|NCT01236391|243673|P1|STARTED|Overall Study|Participants who received study treatment|111
102159|NCT01236378|243681|P1|NOT COMPLETED|Overall Study||0
102160|NCT01236378|243681|P1|COMPLETED|Overall Study||24
102161|NCT01236378|243681|P1|STARTED|Overall Study||24
102162|NCT01236365|243695|P2|NOT COMPLETED|Overall Study||2
102163|NCT01236365|243696|P1|NOT COMPLETED|Overall Study||2
102164|NCT01236365|243695|P2|COMPLETED|Overall Study||19
102165|NCT01236365|243696|P1|COMPLETED|Overall Study||19
102166|NCT01236365|243695|P2|STARTED|Overall Study||21
102167|NCT01236365|243696|P1|STARTED|Overall Study||21
102168|NCT01236339|243710|P2|NOT COMPLETED|Overall Study||13
102169|NCT01236339|243711|P1|NOT COMPLETED|Overall Study||11
102170|NCT01236339|243710|P2|COMPLETED|Overall Study||0
102171|NCT01236339|243711|P1|COMPLETED|Overall Study||2
102172|NCT01236339|243710|P2|LVP Crossover to TIPS|Overall Study|ONLY patients failing LVP and meeting crossover according to protocol definition|4
102173|NCT01236339|243711|P1|LVP Crossover to TIPS|Overall Study||0
102174|NCT01236339|243710|P2|STARTED|Overall Study||13
102175|NCT01236339|243711|P1|STARTED|Overall Study||13
102176|NCT01236326|243731|P2|NOT COMPLETED|Overall Study||4
102177|NCT01236326|243732|P1|NOT COMPLETED|Overall Study||1
102178|NCT01236326|243731|P2|COMPLETED|Overall Study||51
102179|NCT01236326|243732|P1|COMPLETED|Overall Study||49
102180|NCT01236326|243731|P2|STARTED|Overall Study||55
102181|NCT01236326|243732|P1|STARTED|Overall Study||50
102182|NCT01236300|243746|P1|NOT COMPLETED|Overall Study||0
102183|NCT01236300|243746|P1|COMPLETED|Overall Study||66
102184|NCT01236300|243746|P1|STARTED|Overall Study||66
102185|NCT01236196|243756|P2|NOT COMPLETED|Overall Study||8
102186|NCT01236196|243757|P1|NOT COMPLETED|Overall Study||1
102187|NCT01236196|243756|P2|COMPLETED|Overall Study||13
102188|NCT01236196|243757|P1|COMPLETED|Overall Study||17
102189|NCT01236196|243756|P2|STARTED|Overall Study||21
102190|NCT01236196|243757|P1|STARTED|Overall Study||18
102191|NCT01236170|243769|P1|NOT COMPLETED|Overall Study||15
102192|NCT01236170|243769|P1|COMPLETED|Overall Study||482
102193|NCT01236170|243769|P1|STARTED|Overall Study||497
102194|NCT01236118|243779|P3|NOT COMPLETED|Overall Study||3
102195|NCT01236118|243780|P2|NOT COMPLETED|Overall Study||1
102196|NCT01236118|243781|P1|NOT COMPLETED|Overall Study||2
102197|NCT01236118|243779|P3|COMPLETED|Overall Study||14
102198|NCT01236118|243780|P2|COMPLETED|Overall Study||4
102199|NCT01236118|243781|P1|COMPLETED|Overall Study||4
102200|NCT01236118|243779|P3|STARTED|Overall Study||17
102201|NCT01236118|243780|P2|STARTED|Overall Study||5
102202|NCT01236118|243781|P1|STARTED|Overall Study||6
102203|NCT01236105|243789|P1|NOT COMPLETED|Overall Study||0
102204|NCT01236105|243789|P1|COMPLETED|Overall Study||21
102205|NCT01236105|243789|P1|STARTED|Overall Study||21
102206|NCT01236053|243825|P22|NOT COMPLETED|Overall Study||0
102207|NCT01236053|243826|P21|NOT COMPLETED|Overall Study||0
102208|NCT01236053|243827|P20|NOT COMPLETED|Overall Study||0
102209|NCT01236053|243828|P19|NOT COMPLETED|Overall Study||0
102210|NCT01236053|243829|P18|NOT COMPLETED|Overall Study||0
102211|NCT01236053|243830|P17|NOT COMPLETED|Overall Study||0
102212|NCT01236053|243831|P16|NOT COMPLETED|Overall Study||0
102213|NCT01236053|243832|P15|NOT COMPLETED|Overall Study||0
102214|NCT01236053|243833|P14|NOT COMPLETED|Overall Study||0
102215|NCT01236053|243834|P13|NOT COMPLETED|Overall Study||0
102216|NCT01236053|243835|P12|NOT COMPLETED|Overall Study||0
102217|NCT01236053|243836|P11|NOT COMPLETED|Overall Study||0
102218|NCT01236053|243837|P10|NOT COMPLETED|Overall Study||0
102219|NCT01236053|243838|P9|NOT COMPLETED|Overall Study||0
102220|NCT01236053|243839|P8|NOT COMPLETED|Overall Study||0
102221|NCT01236053|243840|P7|NOT COMPLETED|Overall Study||0
102222|NCT01236053|243841|P6|NOT COMPLETED|Overall Study||0
102223|NCT01236053|243842|P5|NOT COMPLETED|Overall Study||0
102224|NCT01236053|243843|P4|NOT COMPLETED|Overall Study||0
102225|NCT01236053|243844|P3|NOT COMPLETED|Overall Study||0
102226|NCT01236053|243845|P2|NOT COMPLETED|Overall Study||0
102227|NCT01236053|243846|P1|NOT COMPLETED|Overall Study||0
102228|NCT01236053|243825|P22|COMPLETED|Overall Study||12167
102229|NCT01236053|243826|P21|COMPLETED|Overall Study||1272
102230|NCT01236053|243827|P20|COMPLETED|Overall Study||20382
102231|NCT01236053|243828|P19|COMPLETED|Overall Study||2155
102232|NCT01236053|243829|P18|COMPLETED|Overall Study||380
102233|NCT01236053|243830|P17|COMPLETED|Overall Study||38
102234|NCT01236053|243831|P16|COMPLETED|Overall Study||43559
102235|NCT01236053|243832|P15|COMPLETED|Overall Study||4600
102236|NCT01236053|243833|P14|COMPLETED|Overall Study||1396
102237|NCT01236053|243834|P13|COMPLETED|Overall Study||148
102238|NCT01236053|243835|P12|COMPLETED|Overall Study||188924
102239|NCT01236053|243836|P11|COMPLETED|Overall Study||19564
102240|NCT01236053|243837|P10|COMPLETED|Overall Study||2935
102241|NCT01236053|243838|P9|COMPLETED|Overall Study||300
102242|NCT01236053|243839|P8|COMPLETED|Overall Study||102836
102243|NCT01236053|243840|P7|COMPLETED|Overall Study||10855
102244|NCT01236053|243841|P6|COMPLETED|Overall Study||2067
102245|NCT01236053|243842|P5|COMPLETED|Overall Study||212
102246|NCT01236053|243843|P4|COMPLETED|Overall Study||17853
102247|NCT01236053|243844|P3|COMPLETED|Overall Study||1877
102248|NCT01236053|243845|P2|COMPLETED|Overall Study||1710950
102249|NCT01236053|243846|P1|COMPLETED|Overall Study||179138
102250|NCT01236053|243825|P22|STARTED|Overall Study||12167
102251|NCT01236053|243826|P21|STARTED|Overall Study||1272
102252|NCT01236053|243827|P20|STARTED|Overall Study||20382
102253|NCT01236053|243828|P19|STARTED|Overall Study||2155
102254|NCT01236053|243829|P18|STARTED|Overall Study||380
102255|NCT01236053|243830|P17|STARTED|Overall Study||38
102256|NCT01236053|243831|P16|STARTED|Overall Study||43559
102257|NCT01236053|243832|P15|STARTED|Overall Study||4600
102258|NCT01236053|243833|P14|STARTED|Overall Study||1396
102259|NCT01236053|243834|P13|STARTED|Overall Study||148
102260|NCT01236053|243835|P12|STARTED|Overall Study||188924
102261|NCT01236053|243836|P11|STARTED|Overall Study||19564
102262|NCT01236053|243837|P10|STARTED|Overall Study||2935
102263|NCT01236053|243838|P9|STARTED|Overall Study||300
102264|NCT01236053|243839|P8|STARTED|Overall Study||102836
102265|NCT01236053|243840|P7|STARTED|Overall Study||10855
102266|NCT01236053|243841|P6|STARTED|Overall Study||2067
102267|NCT01236053|243842|P5|STARTED|Overall Study||212
102268|NCT01236053|243843|P4|STARTED|Overall Study||17853
102269|NCT01236053|243844|P3|STARTED|Overall Study||1877
102270|NCT01236053|243845|P2|STARTED|Overall Study||1710950
102271|NCT01236053|243846|P1|STARTED|Overall Study||179138
102272|NCT01236001|243982|P2|NOT COMPLETED|Overall Study||22
102273|NCT01236001|243983|P1|NOT COMPLETED|Overall Study||18
102274|NCT01236001|243982|P2|COMPLETED|Overall Study||65
102275|NCT01236001|243983|P1|COMPLETED|Overall Study||87
102276|NCT01236001|243982|P2|STARTED|Overall Study||87
102277|NCT01236001|243983|P1|STARTED|Overall Study||105
102278|NCT01235975|244015|P2|NOT COMPLETED|Overall Study||7
102279|NCT01235975|244016|P1|NOT COMPLETED|Overall Study||17
102280|NCT01235975|244015|P2|COMPLETED|Overall Study||88
102281|NCT01235975|244016|P1|COMPLETED|Overall Study||257
102282|NCT01235975|244015|P2|STARTED|Overall Study||95
102283|NCT01235975|244016|P1|STARTED|Overall Study||274
102284|NCT01235923|244050|P2|NOT COMPLETED|Overall Study||0
102285|NCT01235923|244051|P1|NOT COMPLETED|Overall Study||0
102286|NCT01235923|244050|P2|COMPLETED|Overall Study||10
102287|NCT01235923|244051|P1|COMPLETED|Overall Study||10
102288|NCT01235923|244050|P2|STARTED|Overall Study||10
102289|NCT01235923|244051|P1|STARTED|Overall Study||10
102290|NCT01235910|244059|P1|NOT COMPLETED|Overall Study||0
102291|NCT01235910|244059|P1|COMPLETED|Overall Study||1
102292|NCT01235910|244059|P1|STARTED|Overall Study||1
102293|NCT01235897|244063|P1|NOT COMPLETED|Overall Study||0
102294|NCT01235897|244063|P1|COMPLETED|Overall Study||16
102295|NCT01235897|244063|P1|STARTED|Overall Study||16
102296|NCT01235741|244071|P3|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||7
102297|NCT01235741|244072|P2|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||9
102298|NCT01235741|244073|P1|NOT COMPLETED|Follow-Up Post Treatment up to Month 6||0
102299|NCT01235741|244071|P3|COMPLETED|Follow-Up Post Treatment up to Month 6|7 participants did not complete the 6 month follow up period|29
102300|NCT01235741|244072|P2|COMPLETED|Follow-Up Post Treatment up to Month 6|9 participants did not complete the 6 month follow up period|27
102301|NCT01235741|244073|P1|COMPLETED|Follow-Up Post Treatment up to Month 6||0
102302|NCT01235741|244071|P3|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with drug (36) were followed up 6 months post treatment.|36
102303|NCT01235741|244072|P2|STARTED|Follow-Up Post Treatment up to Month 6|No treatment; those who had been treated with placebo (36) were followed up 6 Months post treatment.|36
102304|NCT01235741|244073|P1|STARTED|Follow-Up Post Treatment up to Month 6||0
102305|NCT01235741|244071|P3|NOT COMPLETED|Randomized to Treatment||36
102306|NCT01235741|244072|P2|NOT COMPLETED|Randomized to Treatment||36
102307|NCT01235741|244073|P1|NOT COMPLETED|Randomized to Treatment||0
102308|NCT01235741|244071|P3|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
102309|NCT01235741|244072|P2|COMPLETED|Randomized to Treatment|Study terminated by Sponsor. Maximum exposure to study drug was 30 days.|0
102310|NCT01235741|244073|P1|COMPLETED|Randomized to Treatment||0
102311|NCT01235741|244071|P3|STARTED|Randomized to Treatment||36
102312|NCT01235741|244072|P2|STARTED|Randomized to Treatment||36
102313|NCT01235741|244073|P1|STARTED|Randomized to Treatment||0
102314|NCT01235741|244071|P3|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
102315|NCT01235741|244072|P2|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
102316|NCT01235741|244073|P1|NOT COMPLETED|Non-Randomized Low Calorie Diet Lead-In||141
102317|NCT01235741|244071|P3|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
102318|NCT01235741|244072|P2|COMPLETED|Non-Randomized Low Calorie Diet Lead-In||0
102319|NCT01235741|244073|P1|COMPLETED|Non-Randomized Low Calorie Diet Lead-In|Study terminated by Sponsor. 72 randomized to treatment at time study halted.|72
102320|NCT01235741|244071|P3|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
102321|NCT01235741|244072|P2|STARTED|Non-Randomized Low Calorie Diet Lead-In||0
102322|NCT01235741|244073|P1|STARTED|Non-Randomized Low Calorie Diet Lead-In|6 Week LCD period. Those who lost >=2% of body weight were randomized to treatment.|213
102323|NCT01235728|244100|P8|NOT COMPLETED|Overall Study||0
102324|NCT01235728|244101|P7|NOT COMPLETED|Overall Study||0
102325|NCT01235728|244102|P6|NOT COMPLETED|Overall Study||0
102326|NCT01235728|244103|P5|NOT COMPLETED|Overall Study||0
102327|NCT01235728|244104|P4|NOT COMPLETED|Overall Study||1
102328|NCT01235728|244105|P3|NOT COMPLETED|Overall Study||0
102329|NCT01235728|244106|P2|NOT COMPLETED|Overall Study||0
102330|NCT01235728|244107|P1|NOT COMPLETED|Overall Study||0
102331|NCT01235728|244100|P8|COMPLETED|Overall Study||3
102332|NCT01235728|244101|P7|COMPLETED|Overall Study||3
102333|NCT01235728|244102|P6|COMPLETED|Overall Study||3
102334|NCT01235728|244103|P5|COMPLETED|Overall Study||3
102335|NCT01235728|244104|P4|COMPLETED|Overall Study||2
102336|NCT01235728|244105|P3|COMPLETED|Overall Study||3
102337|NCT01235728|244106|P2|COMPLETED|Overall Study||3
102338|NCT01235728|244107|P1|COMPLETED|Overall Study||3
102339|NCT01235728|244100|P8|STARTED|Overall Study||3
102340|NCT01235728|244101|P7|STARTED|Overall Study||3
102341|NCT01235728|244102|P6|STARTED|Overall Study||3
102342|NCT01235728|244103|P5|STARTED|Overall Study||3
102343|NCT01235728|244104|P4|STARTED|Overall Study||3
102344|NCT01235728|244105|P3|STARTED|Overall Study||3
102345|NCT01235728|244106|P2|STARTED|Overall Study||3
102346|NCT01235728|244107|P1|STARTED|Overall Study||3
102347|NCT01235715|244117|P2|NOT COMPLETED|Overall Study||2
102348|NCT01235715|244118|P1|NOT COMPLETED|Overall Study||0
102349|NCT01235715|244117|P2|COMPLETED|Overall Study||100
102350|NCT01235715|244118|P1|COMPLETED|Overall Study||98
102351|NCT01235715|244117|P2|STARTED|Overall Study||102
102352|NCT01235715|244118|P1|STARTED|Overall Study||98
102353|NCT01235598|244158|P2|NOT COMPLETED|Overall Study||4
102354|NCT01235598|244159|P1|NOT COMPLETED|Overall Study||1
102355|NCT01235598|244158|P2|COMPLETED|Overall Study||24
102356|NCT01235598|244159|P1|COMPLETED|Overall Study||12
102357|NCT01235598|244158|P2|STARTED|Overall Study|One subject was randomized to the CZP Arm but never received an injection (due to pre-treatment AE)|28
102358|NCT01235598|244159|P1|STARTED|Overall Study||13
102359|NCT01235546|244204|P2|NOT COMPLETED|Overall Study||1
102360|NCT01235546|244205|P1|NOT COMPLETED|Overall Study||2
102361|NCT01235546|244204|P2|COMPLETED|Overall Study||1018
102362|NCT01235546|244205|P1|COMPLETED|Overall Study||992
102363|NCT01235546|244204|P2|STARTED|Overall Study||1019
102364|NCT01235546|244205|P1|STARTED|Overall Study||994
102365|NCT01235507|244229|P1|NOT COMPLETED|Overall Study||2
102366|NCT01235507|244229|P1|COMPLETED|Overall Study||69
102367|NCT01235507|244229|P1|STARTED|Overall Study||71
102368|NCT01235442|244243|P2|NOT COMPLETED|Overall Study||44
102369|NCT01235442|244244|P1|NOT COMPLETED|Overall Study||44
102370|NCT01235442|244243|P2|COMPLETED|Overall Study||251
102371|NCT01235442|244244|P1|COMPLETED|Overall Study||253
102372|NCT01235442|244243|P2|STARTED|Overall Study||295
102373|NCT01235442|244244|P1|STARTED|Overall Study||297
102374|NCT01235403|244262|P1|NOT COMPLETED|Overall Study||26
102375|NCT01235403|244262|P1|COMPLETED|Overall Study||74
102376|NCT01235403|244262|P1|STARTED|Overall Study||100
102377|NCT01235377|244270|P2|NOT COMPLETED|Overall Study||1
102378|NCT01235377|244271|P1|NOT COMPLETED|Overall Study||1
102379|NCT01235377|244270|P2|COMPLETED|Overall Study||8
102380|NCT01235377|244271|P1|COMPLETED|Overall Study||10
102381|NCT01235377|244270|P2|STARTED|Overall Study||9
102382|NCT01235377|244271|P1|STARTED|Overall Study||11
102383|NCT01235338|244279|P2|NOT COMPLETED|Overall Study||5
102384|NCT01235338|244280|P1|NOT COMPLETED|Overall Study||11
102385|NCT01235338|244279|P2|COMPLETED|Overall Study||33
102386|NCT01235338|244280|P1|COMPLETED|Overall Study||31
102387|NCT01235338|244279|P2|STARTED|Overall Study||38
102388|NCT01235338|244280|P1|STARTED|Overall Study||42
102389|NCT01235234|244325|P3|NOT COMPLETED|Overall Study||1
102390|NCT01235234|244326|P2|NOT COMPLETED|Overall Study||2
102391|NCT01235234|244327|P1|NOT COMPLETED|Overall Study||2
102392|NCT01235234|244325|P3|COMPLETED|Overall Study||80
102393|NCT01235234|244326|P2|COMPLETED|Overall Study||76
102394|NCT01235234|244327|P1|COMPLETED|Overall Study||75
102395|NCT01235234|244325|P3|STARTED|Overall Study||81
102396|NCT01235234|244326|P2|STARTED|Overall Study||78
102397|NCT01235234|244327|P1|STARTED|Overall Study||77
102398|NCT01235195|244335|P2|NOT COMPLETED|Second Intervention||0
102399|NCT01235195|244336|P1|NOT COMPLETED|Second Intervention||0
102400|NCT01235195|244335|P2|COMPLETED|Second Intervention||15
102401|NCT01235195|244336|P1|COMPLETED|Second Intervention||15
102402|NCT01235195|244335|P2|STARTED|Second Intervention||15
102403|NCT01235195|244336|P1|STARTED|Second Intervention||15
102404|NCT01235195|244335|P2|NOT COMPLETED|Washout Period of At Least 8 Days||0
102405|NCT01235195|244336|P1|NOT COMPLETED|Washout Period of At Least 8 Days||0
102406|NCT01235195|244335|P2|COMPLETED|Washout Period of At Least 8 Days||15
102407|NCT01235195|244336|P1|COMPLETED|Washout Period of At Least 8 Days||15
102408|NCT01235195|244335|P2|STARTED|Washout Period of At Least 8 Days||15
102409|NCT01235195|244336|P1|STARTED|Washout Period of At Least 8 Days||15
102410|NCT01235195|244335|P2|NOT COMPLETED|First Intervention||0
102411|NCT01235195|244336|P1|NOT COMPLETED|First Intervention||0
102412|NCT01235195|244335|P2|COMPLETED|First Intervention||15
102413|NCT01235195|244336|P1|COMPLETED|First Intervention||15
102414|NCT01235195|244335|P2|STARTED|First Intervention||15
102415|NCT01235195|244336|P1|STARTED|First Intervention||15
102416|NCT01234922|244356|P4|NOT COMPLETED|Overall Study||0
102417|NCT01234922|244357|P3|NOT COMPLETED|Overall Study||0
102418|NCT01234922|244358|P2|NOT COMPLETED|Overall Study||0
102419|NCT01234922|244359|P1|NOT COMPLETED|Overall Study||0
102420|NCT01234922|244356|P4|COMPLETED|Overall Study||2
102421|NCT01234922|244357|P3|COMPLETED|Overall Study||2
102422|NCT01234922|244358|P2|COMPLETED|Overall Study||1
102423|NCT01234922|244359|P1|COMPLETED|Overall Study||1
102424|NCT01234922|244356|P4|STARTED|Overall Study||2
102425|NCT01234922|244357|P3|STARTED|Overall Study||2
102426|NCT01234922|244358|P2|STARTED|Overall Study||1
102427|NCT01234922|244359|P1|STARTED|Overall Study||1
102428|NCT01234883|244371|P2|NOT COMPLETED|Overall Study||13
102429|NCT01234883|244372|P1|NOT COMPLETED|Overall Study||10
102430|NCT01234883|244371|P2|COMPLETED|Overall Study||36
102431|NCT01234883|244372|P1|COMPLETED|Overall Study||41
102432|NCT01234883|244371|P2|STARTED|Overall Study||49
102433|NCT01234883|244372|P1|STARTED|Overall Study||51
102434|NCT01234870|244378|P1|NOT COMPLETED|Overall Study||0
102435|NCT01234870|244378|P1|COMPLETED|Overall Study||40
102436|NCT01234870|244378|P1|STARTED|Overall Study||40
102437|NCT01234831|244385|P2|NOT COMPLETED|Overall Study||4
102438|NCT01234831|244386|P1|NOT COMPLETED|Overall Study||2
102439|NCT01234831|244385|P2|COMPLETED|Overall Study||198
102440|NCT01234831|244386|P1|COMPLETED|Overall Study||259
102441|NCT01234831|244385|P2|STARTED|Overall Study||202
102442|NCT01234831|244386|P1|STARTED|Overall Study||261
102443|NCT01234714|244397|P1|NOT COMPLETED|Overall Study||0
102444|NCT01234714|244397|P1|COMPLETED|Overall Study||84
102445|NCT01234714|244397|P1|STARTED|Overall Study||84
102446|NCT01234675|244414|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
102447|NCT01234675|244415|P1|NOT COMPLETED|Second Intervention (6 Weeks)||2
102448|NCT01234675|244414|P2|COMPLETED|Second Intervention (6 Weeks)||8
102449|NCT01234675|244415|P1|COMPLETED|Second Intervention (6 Weeks)||7
102450|NCT01234675|244414|P2|STARTED|Second Intervention (6 Weeks)||8
102451|NCT01234675|244415|P1|STARTED|Second Intervention (6 Weeks)||9
102452|NCT01234675|244414|P2|NOT COMPLETED|First Intervention (6 Weeks)||1
102453|NCT01234675|244415|P1|NOT COMPLETED|First Intervention (6 Weeks)||1
102454|NCT01234675|244414|P2|COMPLETED|First Intervention (6 Weeks)||8
102455|NCT01234675|244415|P1|COMPLETED|First Intervention (6 Weeks)||9
102456|NCT01234675|244414|P2|STARTED|First Intervention (6 Weeks)||9
102457|NCT01234675|244415|P1|STARTED|First Intervention (6 Weeks)||10
102458|NCT01234467|244429|P1|NOT COMPLETED|Overall Study||12
102459|NCT01234467|244429|P1|COMPLETED|Overall Study||11
102460|NCT01234467|244429|P1|STARTED|Overall Study||23
102461|NCT01234337|244440|P2|NOT COMPLETED|Overall Study||64
102462|NCT01234337|244441|P1|NOT COMPLETED|Overall Study||97
102463|NCT01234337|244440|P2|COMPLETED|Overall Study||207
102464|NCT01234337|244441|P1|COMPLETED|Overall Study||169
102465|NCT01234337|244440|P2|Participants Received Treatment|Overall Study||267
102466|NCT01234337|244441|P1|Participants Received Treatment|Overall Study||260
102467|NCT01234337|244440|P2|STARTED|Overall Study||271
102468|NCT01234337|244441|P1|STARTED|Overall Study||266
102469|NCT01234207|244469|P2|NOT COMPLETED|Second Intervention||0
102470|NCT01234207|244470|P1|NOT COMPLETED|Second Intervention||0
102471|NCT01234207|244469|P2|COMPLETED|Second Intervention||48
102472|NCT01234207|244470|P1|COMPLETED|Second Intervention||47
102473|NCT01234207|244469|P2|STARTED|Second Intervention||48
102474|NCT01234207|244470|P1|STARTED|Second Intervention||47
102475|NCT01234207|244469|P2|NOT COMPLETED|1-Week Washout Period||0
102476|NCT01234207|244470|P1|NOT COMPLETED|1-Week Washout Period||0
102477|NCT01234207|244469|P2|COMPLETED|1-Week Washout Period||48
102478|NCT01234207|244470|P1|COMPLETED|1-Week Washout Period||47
102479|NCT01234207|244469|P2|STARTED|1-Week Washout Period||48
102480|NCT01234207|244470|P1|STARTED|1-Week Washout Period||47
102481|NCT01234207|244469|P2|NOT COMPLETED|First Intervention||0
102482|NCT01234207|244470|P1|NOT COMPLETED|First Intervention||0
102483|NCT01234207|244469|P2|COMPLETED|First Intervention||48
102484|NCT01234207|244470|P1|COMPLETED|First Intervention||47
102485|NCT01234207|244469|P2|STARTED|First Intervention||48
102486|NCT01234207|244470|P1|STARTED|First Intervention||47
102487|NCT01234103|244492|P2|NOT COMPLETED|Overall Study||0
102488|NCT01234103|244493|P1|NOT COMPLETED|Overall Study||0
102489|NCT01234103|244492|P2|COMPLETED|Overall Study||391
102490|NCT01234103|244493|P1|COMPLETED|Overall Study||542
102491|NCT01234103|244492|P2|STARTED|Overall Study||391
102492|NCT01234103|244493|P1|STARTED|Overall Study||542
102493|NCT01233999|244501|P1|NOT COMPLETED|Overall Study||2
102494|NCT01233999|244501|P1|COMPLETED|Overall Study||8
102495|NCT01233999|244501|P1|STARTED|Overall Study||10
102496|NCT01233921|244507|P2|NOT COMPLETED|Overall Study||0
102497|NCT01233921|244508|P1|NOT COMPLETED|Overall Study||0
102498|NCT01233921|244507|P2|COMPLETED|Overall Study||3
102499|NCT01233921|244508|P1|COMPLETED|Overall Study||3
102500|NCT01233921|244507|P2|STARTED|Overall Study||3
102501|NCT01233921|244508|P1|STARTED|Overall Study||3
102502|NCT01233869|244520|P4|NOT COMPLETED|Extended Treatment Period (46 Months)||16
102503|NCT01233869|244521|P3|NOT COMPLETED|Extended Treatment Period (46 Months)||5
102504|NCT01233869|244522|P2|NOT COMPLETED|Extended Treatment Period (46 Months)||3
102582|NCT01232504|244714|P2|NOT COMPLETED|Overall Study||2
102505|NCT01233869|244523|P1|NOT COMPLETED|Extended Treatment Period (46 Months)||14
102506|NCT01233869|244520|P4|COMPLETED|Extended Treatment Period (46 Months)||18
102507|NCT01233869|244521|P3|COMPLETED|Extended Treatment Period (46 Months)||17
102508|NCT01233869|244522|P2|COMPLETED|Extended Treatment Period (46 Months)||0
102509|NCT01233869|244523|P1|COMPLETED|Extended Treatment Period (46 Months)||20
102510|NCT01233869|244520|P4|STARTED|Extended Treatment Period (46 Months)||34
102511|NCT01233869|244521|P3|STARTED|Extended Treatment Period (46 Months)||22
102512|NCT01233869|244522|P2|STARTED|Extended Treatment Period (46 Months)||3
102513|NCT01233869|244523|P1|STARTED|Extended Treatment Period (46 Months)||34
102514|NCT01233869|244520|P4|NOT COMPLETED|Washout Period 30 Days||0
102515|NCT01233869|244521|P3|NOT COMPLETED|Washout Period 30 Days||0
102516|NCT01233869|244522|P2|NOT COMPLETED|Washout Period 30 Days||0
102517|NCT01233869|244523|P1|NOT COMPLETED|Washout Period 30 Days||0
102518|NCT01233869|244520|P4|COMPLETED|Washout Period 30 Days||34
102519|NCT01233869|244521|P3|COMPLETED|Washout Period 30 Days||22
102520|NCT01233869|244522|P2|COMPLETED|Washout Period 30 Days||3
102521|NCT01233869|244523|P1|COMPLETED|Washout Period 30 Days||34
102522|NCT01233869|244520|P4|STARTED|Washout Period 30 Days||34
102523|NCT01233869|244521|P3|STARTED|Washout Period 30 Days||22
102524|NCT01233869|244522|P2|STARTED|Washout Period 30 Days||3
102525|NCT01233869|244523|P1|STARTED|Washout Period 30 Days||34
102526|NCT01233869|244520|P4|NOT COMPLETED|Initial Treatment Period (24 Months)||22
102527|NCT01233869|244521|P3|NOT COMPLETED|Initial Treatment Period (24 Months)||2
102528|NCT01233869|244522|P2|NOT COMPLETED|Initial Treatment Period (24 Months)||28
102529|NCT01233869|244523|P1|NOT COMPLETED|Initial Treatment Period (24 Months)||24
102530|NCT01233869|244520|P4|COMPLETED|Initial Treatment Period (24 Months)||34
102531|NCT01233869|244521|P3|COMPLETED|Initial Treatment Period (24 Months)||22
102532|NCT01233869|244522|P2|COMPLETED|Initial Treatment Period (24 Months)||3
102533|NCT01233869|244523|P1|COMPLETED|Initial Treatment Period (24 Months)||34
102534|NCT01233869|244520|P4|STARTED|Initial Treatment Period (24 Months)||56
102535|NCT01233869|244521|P3|STARTED|Initial Treatment Period (24 Months)||24
102536|NCT01233869|244522|P2|STARTED|Initial Treatment Period (24 Months)||31
102537|NCT01233869|244523|P1|STARTED|Initial Treatment Period (24 Months)||58
102538|NCT01233817|244609|P1|NOT COMPLETED|Overall Study||3
102539|NCT01233817|244609|P1|COMPLETED|Overall Study||9
102540|NCT01233817|244609|P1|STARTED|Overall Study||12
102541|NCT01233726|244616|P3|NOT COMPLETED|Overall Study||1
102542|NCT01233726|244617|P2|NOT COMPLETED|Overall Study||0
102543|NCT01233726|244618|P1|NOT COMPLETED|Overall Study||1
102544|NCT01233726|244616|P3|COMPLETED|Overall Study||52
102545|NCT01233726|244617|P2|COMPLETED|Overall Study||53
102546|NCT01233726|244618|P1|COMPLETED|Overall Study||52
102547|NCT01233726|244616|P3|STARTED|Overall Study||53
102548|NCT01233726|244617|P2|STARTED|Overall Study||53
102549|NCT01233726|244618|P1|STARTED|Overall Study||53
102550|NCT01233687|244656|P1|NOT COMPLETED|Phase II AMG 102 + Erlotinib||4
102551|NCT01233687|244656|P1|COMPLETED|Phase II AMG 102 + Erlotinib||45
102552|NCT01233687|244656|P1|Response-Evaluable|Phase II AMG 102 + Erlotinib||45
102553|NCT01233687|244656|P1|STARTED|Phase II AMG 102 + Erlotinib|Includes 7 participants from Phase 1 part of study.|49
102554|NCT01233687|244656|P1|NOT COMPLETED|Phase I RP2D AMG 102 + Erlotinib||0
102555|NCT01233687|244656|P1|COMPLETED|Phase I RP2D AMG 102 + Erlotinib||7
102556|NCT01233687|244656|P1|STARTED|Phase I RP2D AMG 102 + Erlotinib||7
102557|NCT01232569|244666|P4|NOT COMPLETED|Open-label Extension Period||27
102558|NCT01232569|244667|P3|NOT COMPLETED|Open-label Extension Period||27
102559|NCT01232569|244668|P2|NOT COMPLETED|Open-label Extension Period||0
102560|NCT01232569|244669|P1|NOT COMPLETED|Open-label Extension Period||0
102561|NCT01232569|244666|P4|COMPLETED|Open-label Extension Period||200
102562|NCT01232569|244667|P3|COMPLETED|Open-label Extension Period||203
102563|NCT01232569|244668|P2|COMPLETED|Open-label Extension Period||0
102564|NCT01232569|244669|P1|COMPLETED|Open-label Extension Period||0
102565|NCT01232569|244666|P4|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|227
102566|NCT01232569|244667|P3|STARTED|Open-label Extension Period|Some participants who completed the double-blind period did not enter the open-label period.|230
102567|NCT01232569|244668|P2|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
102568|NCT01232569|244669|P1|STARTED|Open-label Extension Period|There were no participants in this reporting group in this period.|0
102569|NCT01232569|244666|P4|NOT COMPLETED|Double-blind Treatment Period||0
102570|NCT01232569|244667|P3|NOT COMPLETED|Double-blind Treatment Period||0
102571|NCT01232569|244668|P2|NOT COMPLETED|Double-blind Treatment Period||9
102572|NCT01232569|244669|P1|NOT COMPLETED|Double-blind Treatment Period||28
102573|NCT01232569|244666|P4|COMPLETED|Double-blind Treatment Period||0
102574|NCT01232569|244667|P3|COMPLETED|Double-blind Treatment Period||0
102575|NCT01232569|244668|P2|COMPLETED|Double-blind Treatment Period||209
102576|NCT01232569|244669|P1|COMPLETED|Double-blind Treatment Period||410
102577|NCT01232569|244666|P4|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
102578|NCT01232569|244667|P3|STARTED|Double-blind Treatment Period|There were no participants in this reporting group in this period.|0
102579|NCT01232569|244668|P2|STARTED|Double-blind Treatment Period||218
102580|NCT01232569|244669|P1|STARTED|Double-blind Treatment Period||438
102581|NCT01232504|244713|P3|NOT COMPLETED|Overall Study||8
102583|NCT01232504|244715|P1|NOT COMPLETED|Overall Study||9
102584|NCT01232504|244713|P3|COMPLETED|Overall Study||61
102585|NCT01232504|244714|P2|COMPLETED|Overall Study||67
102586|NCT01232504|244715|P1|COMPLETED|Overall Study||59
102587|NCT01232504|244713|P3|STARTED|Overall Study||69
102588|NCT01232504|244714|P2|STARTED|Overall Study||69
102589|NCT01232504|244715|P1|STARTED|Overall Study||68
102590|NCT01232491|244749|P2|NOT COMPLETED|Overall Study||63
102591|NCT01232491|244750|P1|NOT COMPLETED|Overall Study||60
102592|NCT01232491|244749|P2|COMPLETED|Overall Study||242
102593|NCT01232491|244750|P1|COMPLETED|Overall Study||246
102594|NCT01232491|244749|P2|Exposed (Safety Analysis Set)|Overall Study|Four subjects withdrew prior to exposure to trial drug.|301
102595|NCT01232491|244750|P1|Exposed (Safety Analysis Set)|Overall Study|One subject withdrew prior to exposure to trial drug.|305
102596|NCT01232491|244749|P2|STARTED|Overall Study||305
102597|NCT01232491|244750|P1|STARTED|Overall Study||306
102598|NCT01232465|244770|P2|NOT COMPLETED|Overall Study||0
102599|NCT01232465|244771|P1|NOT COMPLETED|Overall Study||0
102600|NCT01232465|244770|P2|COMPLETED|Overall Study||402
102601|NCT01232465|244771|P1|COMPLETED|Overall Study||337
102602|NCT01232465|244770|P2|STARTED|Overall Study||402
102603|NCT01232465|244771|P1|STARTED|Overall Study||337
102604|NCT01233284|244777|P5|NOT COMPLETED|Period 4 (4 Weeks)||0
102605|NCT01233284|244778|P4|NOT COMPLETED|Period 4 (4 Weeks)||1
102606|NCT01233284|244779|P3|NOT COMPLETED|Period 4 (4 Weeks)||0
102607|NCT01233284|244780|P2|NOT COMPLETED|Period 4 (4 Weeks)||1
102608|NCT01233284|244781|P1|NOT COMPLETED|Period 4 (4 Weeks)||0
102609|NCT01233284|244777|P5|COMPLETED|Period 4 (4 Weeks)||1
102610|NCT01233284|244778|P4|COMPLETED|Period 4 (4 Weeks)||33
102611|NCT01233284|244779|P3|COMPLETED|Period 4 (4 Weeks)||35
102612|NCT01233284|244780|P2|COMPLETED|Period 4 (4 Weeks)||36
102613|NCT01233284|244781|P1|COMPLETED|Period 4 (4 Weeks)||36
102614|NCT01233284|244777|P5|STARTED|Period 4 (4 Weeks)||1
102615|NCT01233284|244778|P4|STARTED|Period 4 (4 Weeks)||34
102616|NCT01233284|244779|P3|STARTED|Period 4 (4 Weeks)||35
102617|NCT01233284|244780|P2|STARTED|Period 4 (4 Weeks)||37
102618|NCT01233284|244781|P1|STARTED|Period 4 (4 Weeks)||36
102619|NCT01233284|244777|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
102620|NCT01233284|244778|P4|NOT COMPLETED|Period 3 (4 Weeks)||1
102621|NCT01233284|244779|P3|NOT COMPLETED|Period 3 (4 Weeks)||1
102622|NCT01233284|244780|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
102623|NCT01233284|244781|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
102624|NCT01233284|244777|P5|COMPLETED|Period 3 (4 Weeks)||1
102625|NCT01233284|244778|P4|COMPLETED|Period 3 (4 Weeks)||34
102626|NCT01233284|244779|P3|COMPLETED|Period 3 (4 Weeks)||35
102627|NCT01233284|244780|P2|COMPLETED|Period 3 (4 Weeks)||37
102628|NCT01233284|244781|P1|COMPLETED|Period 3 (4 Weeks)||36
102629|NCT01233284|244777|P5|STARTED|Period 3 (4 Weeks)||1
102630|NCT01233284|244778|P4|STARTED|Period 3 (4 Weeks)||35
102631|NCT01233284|244779|P3|STARTED|Period 3 (4 Weeks)||36
102632|NCT01233284|244780|P2|STARTED|Period 3 (4 Weeks)||37
102633|NCT01233284|244781|P1|STARTED|Period 3 (4 Weeks)||36
102634|NCT01233284|244777|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
102635|NCT01233284|244778|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
102636|NCT01233284|244779|P3|NOT COMPLETED|Period 2 (4 Weeks)||1
102637|NCT01233284|244780|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
102638|NCT01233284|244781|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
102639|NCT01233284|244777|P5|COMPLETED|Period 2 (4 Weeks)||1
102640|NCT01233284|244778|P4|COMPLETED|Period 2 (4 Weeks)||35
102641|NCT01233284|244779|P3|COMPLETED|Period 2 (4 Weeks)||36
102642|NCT01233284|244780|P2|COMPLETED|Period 2 (4 Weeks)||37
102643|NCT01233284|244781|P1|COMPLETED|Period 2 (4 Weeks)||36
102644|NCT01233284|244777|P5|STARTED|Period 2 (4 Weeks)||1
102645|NCT01233284|244778|P4|STARTED|Period 2 (4 Weeks)||35
102646|NCT01233284|244779|P3|STARTED|Period 2 (4 Weeks)||37
102647|NCT01233284|244780|P2|STARTED|Period 2 (4 Weeks)||37
102648|NCT01233284|244781|P1|STARTED|Period 2 (4 Weeks)||36
102649|NCT01233284|244777|P5|NOT COMPLETED|Period 1 (4 Weeks)||0
102650|NCT01233284|244778|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
102651|NCT01233284|244779|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
102652|NCT01233284|244780|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
102653|NCT01233284|244781|P1|NOT COMPLETED|Period 1 (4 Weeks)||1
102654|NCT01233284|244777|P5|COMPLETED|Period 1 (4 Weeks)||1
102655|NCT01233284|244778|P4|COMPLETED|Period 1 (4 Weeks)||35
102656|NCT01233284|244779|P3|COMPLETED|Period 1 (4 Weeks)||37
102657|NCT01233284|244780|P2|COMPLETED|Period 1 (4 Weeks)||37
102658|NCT01233284|244781|P1|COMPLETED|Period 1 (4 Weeks)||36
102659|NCT01233284|244777|P5|STARTED|Period 1 (4 Weeks)||1
102660|NCT01233284|244778|P4|STARTED|Period 1 (4 Weeks)||35
102661|NCT01233284|244779|P3|STARTED|Period 1 (4 Weeks)||38
102662|NCT01233284|244780|P2|STARTED|Period 1 (4 Weeks)||38
102663|NCT01233284|244781|P1|STARTED|Period 1 (4 Weeks)||37
102664|NCT01233258|244862|P6|NOT COMPLETED|Second Intervention (6 Months)||0
102665|NCT01233258|244863|P5|NOT COMPLETED|Second Intervention (6 Months)||0
102666|NCT01233258|244864|P4|NOT COMPLETED|Second Intervention (6 Months)||0
102667|NCT01233258|244865|P3|NOT COMPLETED|Second Intervention (6 Months)||0
102668|NCT01233258|244866|P2|NOT COMPLETED|Second Intervention (6 Months)||0
102669|NCT01233258|244867|P1|NOT COMPLETED|Second Intervention (6 Months)||0
102670|NCT01233258|244862|P6|COMPLETED|Second Intervention (6 Months)||15
102671|NCT01233258|244863|P5|COMPLETED|Second Intervention (6 Months)||16
102672|NCT01233258|244864|P4|COMPLETED|Second Intervention (6 Months)||15
102673|NCT01233258|244865|P3|COMPLETED|Second Intervention (6 Months)||13
102674|NCT01233258|244866|P2|COMPLETED|Second Intervention (6 Months)||10
102675|NCT01233258|244867|P1|COMPLETED|Second Intervention (6 Months)||10
102676|NCT01233258|244862|P6|STARTED|Second Intervention (6 Months)||15
102677|NCT01233258|244863|P5|STARTED|Second Intervention (6 Months)||16
102678|NCT01233258|244864|P4|STARTED|Second Intervention (6 Months)||15
102679|NCT01233258|244865|P3|STARTED|Second Intervention (6 Months)||13
102680|NCT01233258|244866|P2|STARTED|Second Intervention (6 Months)||10
102681|NCT01233258|244867|P1|STARTED|Second Intervention (6 Months)||10
102682|NCT01233258|244862|P6|NOT COMPLETED|Washout (2-3 Days)||0
102683|NCT01233258|244863|P5|NOT COMPLETED|Washout (2-3 Days)||0
102684|NCT01233258|244864|P4|NOT COMPLETED|Washout (2-3 Days)||0
102685|NCT01233258|244865|P3|NOT COMPLETED|Washout (2-3 Days)||0
102686|NCT01233258|244866|P2|NOT COMPLETED|Washout (2-3 Days)||0
102687|NCT01233258|244867|P1|NOT COMPLETED|Washout (2-3 Days)||0
102688|NCT01233258|244862|P6|COMPLETED|Washout (2-3 Days)||15
102689|NCT01233258|244863|P5|COMPLETED|Washout (2-3 Days)||16
102690|NCT01233258|244864|P4|COMPLETED|Washout (2-3 Days)||15
102691|NCT01233258|244865|P3|COMPLETED|Washout (2-3 Days)||13
102692|NCT01233258|244866|P2|COMPLETED|Washout (2-3 Days)||10
102693|NCT01233258|244867|P1|COMPLETED|Washout (2-3 Days)||10
102694|NCT01233258|244862|P6|STARTED|Washout (2-3 Days)||15
102695|NCT01233258|244863|P5|STARTED|Washout (2-3 Days)||16
102696|NCT01233258|244864|P4|STARTED|Washout (2-3 Days)||15
102697|NCT01233258|244865|P3|STARTED|Washout (2-3 Days)||13
102698|NCT01233258|244866|P2|STARTED|Washout (2-3 Days)||10
102699|NCT01233258|244867|P1|STARTED|Washout (2-3 Days)||10
102700|NCT01233258|244862|P6|NOT COMPLETED|First Intervention (6 Months)||1
102701|NCT01233258|244863|P5|NOT COMPLETED|First Intervention (6 Months)||0
102702|NCT01233258|244864|P4|NOT COMPLETED|First Intervention (6 Months)||1
102703|NCT01233258|244865|P3|NOT COMPLETED|First Intervention (6 Months)||1
102704|NCT01233258|244866|P2|NOT COMPLETED|First Intervention (6 Months)||0
102705|NCT01233258|244867|P1|NOT COMPLETED|First Intervention (6 Months)||1
102706|NCT01233258|244862|P6|COMPLETED|First Intervention (6 Months)||15
102707|NCT01233258|244863|P5|COMPLETED|First Intervention (6 Months)||16
102708|NCT01233258|244864|P4|COMPLETED|First Intervention (6 Months)||15
102709|NCT01233258|244865|P3|COMPLETED|First Intervention (6 Months)||13
102710|NCT01233258|244866|P2|COMPLETED|First Intervention (6 Months)||10
102711|NCT01233258|244867|P1|COMPLETED|First Intervention (6 Months)||10
102712|NCT01233258|244862|P6|Participants Received Treatment|First Intervention (6 Months)||15
102713|NCT01233258|244863|P5|Participants Received Treatment|First Intervention (6 Months)||16
102714|NCT01233258|244864|P4|Participants Received Treatment|First Intervention (6 Months)||15
102715|NCT01233258|244865|P3|Participants Received Treatment|First Intervention (6 Months)||13
102716|NCT01233258|244866|P2|Participants Received Treatment|First Intervention (6 Months)||10
102717|NCT01233258|244867|P1|Participants Received Treatment|First Intervention (6 Months)||11
102718|NCT01233258|244862|P6|STARTED|First Intervention (6 Months)||16
102719|NCT01233258|244863|P5|STARTED|First Intervention (6 Months)||16
102720|NCT01233258|244864|P4|STARTED|First Intervention (6 Months)||16
102721|NCT01233258|244865|P3|STARTED|First Intervention (6 Months)||14
102722|NCT01233258|244866|P2|STARTED|First Intervention (6 Months)||10
102723|NCT01233258|244867|P1|STARTED|First Intervention (6 Months)||11
102724|NCT01233232|244887|P3|NOT COMPLETED|Overall Study||0
102725|NCT01233232|244888|P2|NOT COMPLETED|Overall Study||0
102726|NCT01233232|244889|P1|NOT COMPLETED|Overall Study||1
102727|NCT01233232|244887|P3|COMPLETED|Overall Study||28
102728|NCT01233232|244888|P2|COMPLETED|Overall Study||30
102729|NCT01233232|244889|P1|COMPLETED|Overall Study||28
102730|NCT01233232|244887|P3|STARTED|Overall Study||28
102731|NCT01233232|244888|P2|STARTED|Overall Study||30
102732|NCT01233232|244889|P1|STARTED|Overall Study||29
102733|NCT01233076|244942|P2|NOT COMPLETED|Period 2, One Week||0
102734|NCT01233076|244943|P1|NOT COMPLETED|Period 2, One Week||1
102735|NCT01233076|244942|P2|COMPLETED|Period 2, One Week||30
102736|NCT01233076|244943|P1|COMPLETED|Period 2, One Week||29
102737|NCT01233076|244942|P2|STARTED|Period 2, One Week||30
102738|NCT01233076|244943|P1|STARTED|Period 2, One Week||30
102739|NCT01233076|244942|P2|NOT COMPLETED|Period 1, One Week||0
102740|NCT01233076|244943|P1|NOT COMPLETED|Period 1, One Week||0
102741|NCT01233076|244942|P2|COMPLETED|Period 1, One Week||30
102742|NCT01233076|244943|P1|COMPLETED|Period 1, One Week||30
102743|NCT01233076|244942|P2|STARTED|Period 1, One Week||30
102744|NCT01233076|244943|P1|STARTED|Period 1, One Week||30
102745|NCT01232920|244951|P2|NOT COMPLETED|Overall Study||7
102746|NCT01232920|244952|P1|NOT COMPLETED|Overall Study||6
102747|NCT01232920|244951|P2|COMPLETED|Overall Study||32
102748|NCT01232920|244952|P1|COMPLETED|Overall Study||35
102749|NCT01232920|244951|P2|STARTED|Overall Study||39
102750|NCT01232920|244952|P1|STARTED|Overall Study||41
102751|NCT01232894|244966|P2|NOT COMPLETED|Overall Study||8
102752|NCT01232894|244967|P1|NOT COMPLETED|Overall Study||12
102753|NCT01232894|244966|P2|COMPLETED|Overall Study||22
102754|NCT01232894|244967|P1|COMPLETED|Overall Study||48
102755|NCT01232894|244966|P2|Received Study Drug|Overall Study||28
102756|NCT01232894|244967|P1|Received Study Drug|Overall Study||59
102757|NCT01232894|244966|P2|STARTED|Overall Study||30
102758|NCT01232894|244967|P1|STARTED|Overall Study||60
102759|NCT01232868|244975|P2|NOT COMPLETED|Overall Study||4
102760|NCT01232868|244976|P1|NOT COMPLETED|Overall Study||2
102761|NCT01232868|244975|P2|COMPLETED|Overall Study||40
102762|NCT01232868|244976|P1|COMPLETED|Overall Study||20
102763|NCT01232868|244975|P2|STARTED|Overall Study||44
102764|NCT01232868|244976|P1|STARTED|Overall Study||22
102765|NCT01232829|244984|P1|NOT COMPLETED|Overall Study||0
102766|NCT01232829|244984|P1|COMPLETED|Overall Study||18
102767|NCT01232829|244984|P1|STARTED|Overall Study||18
102768|NCT01232790|244990|P2|NOT COMPLETED|Second Crossover||2
102769|NCT01232790|244991|P1|NOT COMPLETED|Second Crossover||1
102770|NCT01232790|244990|P2|COMPLETED|Second Crossover||9
102771|NCT01232790|244991|P1|COMPLETED|Second Crossover||10
102772|NCT01232790|244990|P2|STARTED|Second Crossover||11
102773|NCT01232790|244991|P1|STARTED|Second Crossover||11
102774|NCT01232790|244990|P2|NOT COMPLETED|First Crossover||0
102775|NCT01232790|244991|P1|NOT COMPLETED|First Crossover||1
102776|NCT01232790|244990|P2|COMPLETED|First Crossover||11
102777|NCT01232790|244991|P1|COMPLETED|First Crossover||11
102778|NCT01232790|244990|P2|STARTED|First Crossover||11
102779|NCT01232790|244991|P1|STARTED|First Crossover||12
102780|NCT01232790|244990|P2|NOT COMPLETED|Initial Assessment||1
102781|NCT01232790|244991|P1|NOT COMPLETED|Initial Assessment||0
102782|NCT01232790|244990|P2|COMPLETED|Initial Assessment||11
102783|NCT01232790|244991|P1|COMPLETED|Initial Assessment||12
102784|NCT01232790|244990|P2|STARTED|Initial Assessment||12
102785|NCT01232790|244991|P1|STARTED|Initial Assessment||12
102786|NCT01232790|244990|P2|NOT COMPLETED|Randomization||2
102787|NCT01232790|244991|P1|NOT COMPLETED|Randomization||2
102788|NCT01232790|244990|P2|COMPLETED|Randomization||12
102789|NCT01232790|244991|P1|COMPLETED|Randomization||12
102790|NCT01232790|244990|P2|STARTED|Randomization||14
102791|NCT01232790|244991|P1|STARTED|Randomization||14
102792|NCT01232296|245047|P2|NOT COMPLETED|Overall Study||83
102793|NCT01232296|245048|P1|NOT COMPLETED|Overall Study||82
102794|NCT01232296|245047|P2|COMPLETED|Overall Study||0
102795|NCT01232296|245048|P1|COMPLETED|Overall Study||0
102796|NCT01232296|245047|P2|Safety Set|Overall Study||83
102797|NCT01232296|245048|P1|Safety Set|Overall Study|The Safety Set includes all patients who received at least one dose of study medication|79
102798|NCT01232296|245047|P2|Full Analysis Set|Overall Study||83
102799|NCT01232296|245048|P1|Full Analysis Set|Overall Study||82
102800|NCT01232296|245047|P2|STARTED|Overall Study||83
102801|NCT01232296|245048|P1|STARTED|Overall Study||82
102802|NCT01232283|245065|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
102803|NCT01232283|245066|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||17
102804|NCT01232283|245067|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||5
102805|NCT01232283|245068|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||12
102806|NCT01232283|245069|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102807|NCT01232283|245070|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102808|NCT01232283|245071|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102809|NCT01232283|245072|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102810|NCT01232283|245065|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||84
102811|NCT01232283|245066|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||41
102812|NCT01232283|245067|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||56
102813|NCT01232283|245068|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||50
102814|NCT01232283|245069|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102815|NCT01232283|245070|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102816|NCT01232283|245071|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102977|NCT01231581|245294|P2|NOT COMPLETED|Overall Study||80
102817|NCT01232283|245072|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
102818|NCT01232283|245065|P8|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||17
102819|NCT01232283|245066|P7|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||28
102820|NCT01232283|245067|P6|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
102821|NCT01232283|245068|P5|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
102822|NCT01232283|245069|P4|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
102823|NCT01232283|245070|P3|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
102824|NCT01232283|245071|P2|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
102825|NCT01232283|245072|P1|Treated With APR+ Topicals/Phototherapy|Randomized Withdrawal Phase(Weeks 32-52)||0
102826|NCT01232283|245065|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||96
102827|NCT01232283|245066|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||58
102828|NCT01232283|245067|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|13 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|61
102829|NCT01232283|245068|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|4 participants discontinued after Week 32 but prior to entry into the Randomized Withdrawal Phase|62
102830|NCT01232283|245069|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
102831|NCT01232283|245070|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
102832|NCT01232283|245071|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
102833|NCT01232283|245072|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
102834|NCT01232283|245065|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
102835|NCT01232283|245066|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
102836|NCT01232283|245067|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
102837|NCT01232283|245068|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
102838|NCT01232283|245069|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||8
102839|NCT01232283|245070|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||40
102840|NCT01232283|245071|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
102841|NCT01232283|245072|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
102842|NCT01232283|245065|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
102843|NCT01232283|245066|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
102844|NCT01232283|245067|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
102845|NCT01232283|245068|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
102846|NCT01232283|245069|P4|COMPLETED|Maintenance Phase (Weeks16-32)||100
102847|NCT01232283|245070|P3|COMPLETED|Maintenance Phase (Weeks16-32)||194
102848|NCT01232283|245071|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
102849|NCT01232283|245072|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
102850|NCT01232283|245065|P8|STARTED|Maintenance Phase (Weeks16-32)||0
102851|NCT01232283|245066|P7|STARTED|Maintenance Phase (Weeks16-32)||0
102852|NCT01232283|245067|P6|STARTED|Maintenance Phase (Weeks16-32)||0
102853|NCT01232283|245068|P5|STARTED|Maintenance Phase (Weeks16-32)||0
102854|NCT01232283|245069|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|108
102855|NCT01232283|245070|P3|STARTED|Maintenance Phase (Weeks16-32)|5 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|234
102856|NCT01232283|245071|P2|STARTED|Maintenance Phase (Weeks16-32)||0
102857|NCT01232283|245072|P1|STARTED|Maintenance Phase (Weeks16-32)||0
102858|NCT01232283|245065|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102859|NCT01232283|245066|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102860|NCT01232283|245067|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102861|NCT01232283|245068|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102862|NCT01232283|245069|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102863|NCT01232283|245070|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102864|NCT01232283|245071|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||26
102865|NCT01232283|245072|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||36
102866|NCT01232283|245065|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102867|NCT01232283|245066|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102868|NCT01232283|245067|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102869|NCT01232283|245068|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102870|NCT01232283|245069|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102871|NCT01232283|245070|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
102872|NCT01232283|245071|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||112
102873|NCT01232283|245072|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||239
102874|NCT01232283|245065|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
102875|NCT01232283|245066|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
102876|NCT01232283|245067|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
102877|NCT01232283|245068|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
102878|NCT01232283|245069|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
102879|NCT01232283|245070|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
102880|NCT01232283|245071|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|136
102881|NCT01232283|245072|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)|1 protocol violation occurred|272
102882|NCT01232283|245065|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
102883|NCT01232283|245066|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
102884|NCT01232283|245067|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
102885|NCT01232283|245068|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
102886|NCT01232283|245069|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
102887|NCT01232283|245070|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
102888|NCT01232283|245071|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||138
102889|NCT01232283|245072|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||275
102890|NCT01232205|245104|P2|NOT COMPLETED|Overall Study||3
102891|NCT01232205|245105|P1|NOT COMPLETED|Overall Study||3
102892|NCT01232205|245104|P2|COMPLETED|Overall Study||55
102893|NCT01232205|245105|P1|COMPLETED|Overall Study||49
102894|NCT01232205|245104|P2|STARTED|Overall Study||58
102895|NCT01232205|245105|P1|STARTED|Overall Study||52
102896|NCT01232127|245111|P3|NOT COMPLETED|Period 3: Days 18-24||0
102897|NCT01232127|245112|P2|NOT COMPLETED|Period 3: Days 18-24||0
102898|NCT01232127|245113|P1|NOT COMPLETED|Period 3: Days 18-24||0
102899|NCT01232127|245111|P3|COMPLETED|Period 3: Days 18-24||24
102900|NCT01232127|245112|P2|COMPLETED|Period 3: Days 18-24||0
102901|NCT01232127|245113|P1|COMPLETED|Period 3: Days 18-24||0
102902|NCT01232127|245111|P3|STARTED|Period 3: Days 18-24|Participants who received treatment.|24
102903|NCT01232127|245112|P2|STARTED|Period 3: Days 18-24||0
102904|NCT01232127|245113|P1|STARTED|Period 3: Days 18-24||0
102905|NCT01232127|245111|P3|NOT COMPLETED|Period 2: Days 11-17||0
102906|NCT01232127|245112|P2|NOT COMPLETED|Period 2: Days 11-17||0
102907|NCT01232127|245113|P1|NOT COMPLETED|Period 2: Days 11-17||0
102908|NCT01232127|245111|P3|COMPLETED|Period 2: Days 11-17||0
102909|NCT01232127|245112|P2|COMPLETED|Period 2: Days 11-17||24
102910|NCT01232127|245113|P1|COMPLETED|Period 2: Days 11-17||0
102911|NCT01232127|245111|P3|STARTED|Period 2: Days 11-17||0
102912|NCT01232127|245112|P2|STARTED|Period 2: Days 11-17|Participants who received treatment.|24
102913|NCT01232127|245113|P1|STARTED|Period 2: Days 11-17||0
102914|NCT01232127|245111|P3|NOT COMPLETED|Period 1: Days 1-10||0
102915|NCT01232127|245112|P2|NOT COMPLETED|Period 1: Days 1-10||0
102916|NCT01232127|245113|P1|NOT COMPLETED|Period 1: Days 1-10||1
102917|NCT01232127|245111|P3|COMPLETED|Period 1: Days 1-10||0
102918|NCT01232127|245112|P2|COMPLETED|Period 1: Days 1-10||0
102919|NCT01232127|245113|P1|COMPLETED|Period 1: Days 1-10||24
102920|NCT01232127|245111|P3|STARTED|Period 1: Days 1-10||0
102921|NCT01232127|245112|P2|STARTED|Period 1: Days 1-10||0
102922|NCT01232127|245113|P1|STARTED|Period 1: Days 1-10|Participants who received treatment.|25
102923|NCT01231984|245137|P4|NOT COMPLETED|Study Period 2||4
102924|NCT01231984|245138|P3|NOT COMPLETED|Study Period 2||0
102925|NCT01231984|245139|P2|NOT COMPLETED|Study Period 2||2
102926|NCT01231984|245140|P1|NOT COMPLETED|Study Period 2||3
102927|NCT01231984|245137|P4|COMPLETED|Study Period 2||56
102928|NCT01231984|245138|P3|COMPLETED|Study Period 2||59
102929|NCT01231984|245139|P2|COMPLETED|Study Period 2||61
102930|NCT01231984|245140|P1|COMPLETED|Study Period 2||54
102931|NCT01231984|245137|P4|STARTED|Study Period 2||60
102932|NCT01231984|245138|P3|STARTED|Study Period 2||59
102933|NCT01231984|245139|P2|STARTED|Study Period 2||63
102934|NCT01231984|245140|P1|STARTED|Study Period 2||57
102935|NCT01231984|245137|P4|NOT COMPLETED|Study Period 1||9
102936|NCT01231984|245138|P3|NOT COMPLETED|Study Period 1||7
102937|NCT01231984|245139|P2|NOT COMPLETED|Study Period 1||7
102938|NCT01231984|245140|P1|NOT COMPLETED|Study Period 1||12
102939|NCT01231984|245137|P4|COMPLETED|Study Period 1||60
102940|NCT01231984|245138|P3|COMPLETED|Study Period 1||59
102941|NCT01231984|245139|P2|COMPLETED|Study Period 1||63
102942|NCT01231984|245140|P1|COMPLETED|Study Period 1||57
102943|NCT01231984|245137|P4|STARTED|Study Period 1||69
102944|NCT01231984|245138|P3|STARTED|Study Period 1||66
102945|NCT01231984|245139|P2|STARTED|Study Period 1||70
102946|NCT01231984|245140|P1|STARTED|Study Period 1||69
102947|NCT01231841|245161|P1|NOT COMPLETED|Overall Study||0
102948|NCT01231841|245161|P1|COMPLETED|Overall Study||20
102949|NCT01231841|245161|P1|STARTED|Overall Study||20
102950|NCT01231750|245167|P2|NOT COMPLETED|Overall Study||0
102951|NCT01231750|245168|P1|NOT COMPLETED|Overall Study||0
102952|NCT01231750|245167|P2|COMPLETED|Overall Study||4
102953|NCT01231750|245168|P1|COMPLETED|Overall Study||3
102954|NCT01231750|245167|P2|STARTED|Overall Study||4
102955|NCT01231750|245168|P1|STARTED|Overall Study||3
102956|NCT01231646|245186|P2|NOT COMPLETED|Overall Study||0
102957|NCT01231646|245187|P1|NOT COMPLETED|Overall Study||0
102958|NCT01231646|245186|P2|COMPLETED|Overall Study||10
102959|NCT01231646|245187|P1|COMPLETED|Overall Study||28
102960|NCT01231646|245186|P2|STARTED|Overall Study||10
102961|NCT01231646|245187|P1|STARTED|Overall Study||28
102962|NCT01231607|245198|P5|NOT COMPLETED|Overall Study||24
102963|NCT01231607|245199|P4|NOT COMPLETED|Overall Study||38
102964|NCT01231607|245200|P3|NOT COMPLETED|Overall Study||31
102965|NCT01231607|245201|P2|NOT COMPLETED|Overall Study||34
102966|NCT01231607|245202|P1|NOT COMPLETED|Overall Study||29
102967|NCT01231607|245198|P5|COMPLETED|Overall Study||157
102968|NCT01231607|245199|P4|COMPLETED|Overall Study||141
102969|NCT01231607|245200|P3|COMPLETED|Overall Study||153
102970|NCT01231607|245201|P2|COMPLETED|Overall Study||154
102971|NCT01231607|245202|P1|COMPLETED|Overall Study||156
102972|NCT01231607|245198|P5|STARTED|Overall Study||181
102973|NCT01231607|245199|P4|STARTED|Overall Study||179
102974|NCT01231607|245200|P3|STARTED|Overall Study||184
102975|NCT01231607|245201|P2|STARTED|Overall Study||188
102976|NCT01231607|245202|P1|STARTED|Overall Study||185
102978|NCT01231581|245295|P1|NOT COMPLETED|Overall Study||80
102979|NCT01231581|245294|P2|COMPLETED|Overall Study||0
102980|NCT01231581|245295|P1|COMPLETED|Overall Study||0
102981|NCT01231581|245294|P2|Ongoing|Overall Study||0
102982|NCT01231581|245295|P1|Ongoing|Overall Study|Participant is continuing treatment with trametinib and gemcitabine under roll over study MEK114375.|1
102983|NCT01231581|245294|P2|STARTED|Overall Study||80
102984|NCT01231581|245295|P1|STARTED|Overall Study||80
102985|NCT01231516|245315|P2|NOT COMPLETED|Open-label Phase||26
102986|NCT01231516|245316|P1|NOT COMPLETED|Open-label Phase||295
102987|NCT01231516|245315|P2|COMPLETED|Open-label Phase||1
102988|NCT01231516|245316|P1|COMPLETED|Open-label Phase||0
102989|NCT01231516|245315|P2|Ongoing at the Time of Analysis|Open-label Phase||23
102990|NCT01231516|245316|P1|Ongoing at the Time of Analysis|Open-label Phase||282
102991|NCT01231516|245315|P2|STARTED|Open-label Phase|256 participants completed the Double-blind Phase but did not enter the Open-label Phase.|27
102992|NCT01231516|245316|P1|STARTED|Open-label Phase|4 participants completed the Double-blind Phase but did not enter the Open-label Phase.|295
102993|NCT01231516|245315|P2|NOT COMPLETED|48 Week Double-blind Phase||79
102994|NCT01231516|245316|P1|NOT COMPLETED|48 Week Double-blind Phase||58
102995|NCT01231516|245315|P2|COMPLETED|48 Week Double-blind Phase||283
102996|NCT01231516|245316|P1|COMPLETED|48 Week Double-blind Phase||299
102997|NCT01231516|245315|P2|STARTED|48 Week Double-blind Phase||362
102998|NCT01231516|245316|P1|STARTED|48 Week Double-blind Phase||357
102999|NCT01231503|245346|P8|NOT COMPLETED|Overall Study||8
103000|NCT01231503|245347|P7|NOT COMPLETED|Overall Study||7
103001|NCT01231503|245348|P6|NOT COMPLETED|Overall Study||16
103002|NCT01231503|245349|P5|NOT COMPLETED|Overall Study||10
103003|NCT01231503|245350|P4|NOT COMPLETED|Overall Study||8
103004|NCT01231503|245351|P3|NOT COMPLETED|Overall Study||12
103005|NCT01231503|245352|P2|NOT COMPLETED|Overall Study||13
103006|NCT01231503|245353|P1|NOT COMPLETED|Overall Study||14
103007|NCT01231503|245346|P8|COMPLETED|Overall Study||52
103008|NCT01231503|245347|P7|COMPLETED|Overall Study||53
103009|NCT01231503|245348|P6|COMPLETED|Overall Study||44
103010|NCT01231503|245349|P5|COMPLETED|Overall Study||50
103011|NCT01231503|245350|P4|COMPLETED|Overall Study||52
103012|NCT01231503|245351|P3|COMPLETED|Overall Study||48
103013|NCT01231503|245352|P2|COMPLETED|Overall Study||46
103014|NCT01231503|245353|P1|COMPLETED|Overall Study||46
103015|NCT01231503|245346|P8|STARTED|Overall Study||60
103016|NCT01231503|245347|P7|STARTED|Overall Study||60
103017|NCT01231503|245348|P6|STARTED|Overall Study||60
103018|NCT01231503|245349|P5|STARTED|Overall Study||60
103019|NCT01231503|245350|P4|STARTED|Overall Study||60
103020|NCT01231503|245351|P3|STARTED|Overall Study||60
103021|NCT01231503|245352|P2|STARTED|Overall Study||59
103022|NCT01231503|245353|P1|STARTED|Overall Study||60
103023|NCT01231464|245569|P2|NOT COMPLETED|Overall Study||7
103024|NCT01231464|245570|P1|NOT COMPLETED|Overall Study||5
103025|NCT01231464|245569|P2|COMPLETED|Overall Study||176
103026|NCT01231464|245570|P1|COMPLETED|Overall Study||177
103027|NCT01231464|245569|P2|STARTED|Overall Study||183
103028|NCT01231464|245570|P1|STARTED|Overall Study||182
103029|NCT01231399|245580|P1|NOT COMPLETED|Overall Study||0
103030|NCT01231399|245580|P1|COMPLETED|Overall Study||6
103031|NCT01231399|245580|P1|STARTED|Overall Study||6
103032|NCT01231373|245591|P4|NOT COMPLETED|Overall Study||1
103033|NCT01231373|245592|P3|NOT COMPLETED|Overall Study||0
103034|NCT01231373|245593|P2|NOT COMPLETED|Overall Study||1
103035|NCT01231373|245594|P1|NOT COMPLETED|Overall Study||3
103036|NCT01231373|245591|P4|COMPLETED|Overall Study||57
103037|NCT01231373|245592|P3|COMPLETED|Overall Study||60
103038|NCT01231373|245593|P2|COMPLETED|Overall Study||57
103039|NCT01231373|245594|P1|COMPLETED|Overall Study||56
103040|NCT01231373|245591|P4|Patients Receiving Blinded Treatment|Overall Study||58
103041|NCT01231373|245592|P3|Patients Receiving Blinded Treatment|Overall Study||60
103042|NCT01231373|245593|P2|Patients Receiving Blinded Treatment|Overall Study||57
103043|NCT01231373|245594|P1|Patients Receiving Blinded Treatment|Overall Study||57
103044|NCT01231373|245591|P4|STARTED|Overall Study||58
103045|NCT01231373|245592|P3|STARTED|Overall Study||60
103046|NCT01231373|245593|P2|STARTED|Overall Study||58
103047|NCT01231373|245594|P1|STARTED|Overall Study||59
103048|NCT01231334|245614|P2|NOT COMPLETED|Overall Study||21
103049|NCT01231334|245615|P1|NOT COMPLETED|Overall Study||19
103050|NCT01231334|245614|P2|COMPLETED|Overall Study||120
103051|NCT01231334|245615|P1|COMPLETED|Overall Study||126
103052|NCT01231334|245614|P2|STARTED|Overall Study||141
103053|NCT01231334|245615|P1|STARTED|Overall Study||145
103054|NCT01231321|245633|P1|NOT COMPLETED|Overall Study||5
103055|NCT01231321|245633|P1|COMPLETED|Overall Study||95
103056|NCT01231321|245633|P1|STARTED|Overall Study||100
103057|NCT01231230|245644|P1|NOT COMPLETED|Overall Study||0
103058|NCT01231230|245644|P1|COMPLETED|Overall Study||14
103059|NCT01231230|245644|P1|Placebo|Overall Study||14
103060|NCT01231230|245644|P1|Fluticasone/Salmeterol|Overall Study||14
103061|NCT01231230|245644|P1|Salmeterol|Overall Study||14
103062|NCT01231230|245644|P1|Fluticasone|Overall Study||14
103063|NCT01231230|245644|P1|STARTED|Overall Study||14
103064|NCT01230892|245656|P2|NOT COMPLETED|Overall Study||1
103065|NCT01230892|245657|P1|NOT COMPLETED|Overall Study||3
103066|NCT01230892|245656|P2|COMPLETED|Overall Study||13
103067|NCT01230892|245657|P1|COMPLETED|Overall Study||12
103068|NCT01230892|245656|P2|STARTED|Overall Study||14
103069|NCT01230892|245657|P1|STARTED|Overall Study||15
103070|NCT01230827|245667|P4|NOT COMPLETED|Overall Study||78
103071|NCT01230827|245668|P3|NOT COMPLETED|Overall Study||65
103072|NCT01230827|245669|P2|NOT COMPLETED|Overall Study||11
103073|NCT01230827|245670|P1|NOT COMPLETED|Overall Study||19
103074|NCT01230827|245667|P4|COMPLETED|Overall Study||0
103075|NCT01230827|245668|P3|COMPLETED|Overall Study||0
103076|NCT01230827|245669|P2|COMPLETED|Overall Study||0
103077|NCT01230827|245670|P1|COMPLETED|Overall Study||0
103078|NCT01230827|245667|P4|STARTED|Overall Study||78
103079|NCT01230827|245668|P3|STARTED|Overall Study||65
103080|NCT01230827|245669|P2|STARTED|Overall Study||11
103081|NCT01230827|245670|P1|STARTED|Overall Study||19
103082|NCT01230814|245686|P2|NOT COMPLETED|Overall Study||4
103083|NCT01230814|245687|P1|NOT COMPLETED|Overall Study||13
103084|NCT01230814|245686|P2|COMPLETED|Overall Study||112
103085|NCT01230814|245687|P1|COMPLETED|Overall Study||105
103086|NCT01230814|245686|P2|STARTED|Overall Study||116
103087|NCT01230814|245687|P1|STARTED|Overall Study||118
103088|NCT01230788|245699|P1|NOT COMPLETED|Overall Study||1
103089|NCT01230788|245699|P1|COMPLETED|Overall Study||0
103090|NCT01230788|245699|P1|STARTED|Overall Study||1
103091|NCT01230749|245711|P4|NOT COMPLETED|Overall Study||2
103092|NCT01230749|245712|P3|NOT COMPLETED|Overall Study||2
103093|NCT01230749|245713|P2|NOT COMPLETED|Overall Study||2
103094|NCT01230749|245714|P1|NOT COMPLETED|Overall Study||0
103095|NCT01230749|245711|P4|COMPLETED|Overall Study||20
103096|NCT01230749|245712|P3|COMPLETED|Overall Study||21
103097|NCT01230749|245713|P2|COMPLETED|Overall Study||20
103098|NCT01230749|245714|P1|COMPLETED|Overall Study||22
103099|NCT01230749|245711|P4|STARTED|Overall Study||22
103100|NCT01230749|245712|P3|STARTED|Overall Study||23
103101|NCT01230749|245713|P2|STARTED|Overall Study||22
103102|NCT01230749|245714|P1|STARTED|Overall Study||22
103103|NCT01230710|245749|P1|NOT COMPLETED|Overall Study||49
103104|NCT01230710|245749|P1|COMPLETED|Overall Study||2
103105|NCT01230710|245749|P1|STARTED|Overall Study||51
103106|NCT01230502|245760|P3|NOT COMPLETED|Overall Study||0
103107|NCT01230502|245761|P2|NOT COMPLETED|Overall Study||0
103108|NCT01230502|245762|P1|NOT COMPLETED|Overall Study||0
103109|NCT01230502|245760|P3|COMPLETED|Overall Study||0
103110|NCT01230502|245761|P2|COMPLETED|Overall Study||0
103111|NCT01230502|245762|P1|COMPLETED|Overall Study||9
103112|NCT01230502|245760|P3|STARTED|Overall Study||0
103113|NCT01230502|245761|P2|STARTED|Overall Study||0
103114|NCT01230502|245762|P1|STARTED|Overall Study||9
103115|NCT01230424|245775|P2|NOT COMPLETED|Overall Study||0
103116|NCT01230424|245776|P1|NOT COMPLETED|Overall Study||0
103117|NCT01230424|245775|P2|COMPLETED|Overall Study||70
103118|NCT01230424|245776|P1|COMPLETED|Overall Study||70
103119|NCT01230424|245775|P2|STARTED|Overall Study||70
103120|NCT01230424|245776|P1|STARTED|Overall Study||70
103121|NCT01230307|245804|P2|NOT COMPLETED|Overall Study||2
103122|NCT01230307|245805|P1|NOT COMPLETED|Overall Study||0
103123|NCT01230307|245804|P2|COMPLETED|Overall Study||4
103124|NCT01230307|245805|P1|COMPLETED|Overall Study||6
103125|NCT01230307|245804|P2|STARTED|Overall Study||6
103126|NCT01230307|245805|P1|STARTED|Overall Study||6
103127|NCT01230177|245817|P1|NOT COMPLETED|Overall Study||0
103128|NCT01230177|245817|P1|COMPLETED|Overall Study||3
103129|NCT01230177|245817|P1|STARTED|Overall Study||3
103130|NCT01230060|245825|P1|NOT COMPLETED|Overall Study||1
103131|NCT01230060|245825|P1|COMPLETED|Overall Study||121
103132|NCT01230060|245825|P1|STARTED|Overall Study||122
103133|NCT01230021|245829|P1|NOT COMPLETED|Overall Study||0
103134|NCT01230021|245829|P1|COMPLETED|Overall Study||6
103135|NCT01230021|245829|P1|STARTED|Overall Study||6
103136|NCT01229943|245851|P2|NOT COMPLETED|Overall Study||17
103137|NCT01229943|245852|P1|NOT COMPLETED|Overall Study||18
103138|NCT01229943|245851|P2|COMPLETED|Overall Study||58
103139|NCT01229943|245852|P1|COMPLETED|Overall Study||57
103140|NCT01229943|245851|P2|STARTED|Overall Study||75
103141|NCT01229943|245852|P1|STARTED|Overall Study||75
103142|NCT01229891|245865|P3|NOT COMPLETED|Overall Study||0
103143|NCT01229891|245866|P2|NOT COMPLETED|Overall Study||0
103144|NCT01229891|245867|P1|NOT COMPLETED|Overall Study||0
103145|NCT01229891|245865|P3|COMPLETED|Overall Study||30
103146|NCT01229891|245866|P2|COMPLETED|Overall Study||30
103147|NCT01229891|245867|P1|COMPLETED|Overall Study||30
103148|NCT01229891|245865|P3|STARTED|Overall Study||30
103149|NCT01229891|245866|P2|STARTED|Overall Study||30
103150|NCT01229891|245867|P1|STARTED|Overall Study||30
103151|NCT01229735|245898|P2|NOT COMPLETED|Overall Study||66
103152|NCT01229735|245899|P1|NOT COMPLETED|Overall Study||66
103153|NCT01229735|245898|P2|COMPLETED|Overall Study||100
103154|NCT01229735|245899|P1|COMPLETED|Overall Study||111
103155|NCT01229735|245898|P2|STARTED|Overall Study||166
103156|NCT01229735|245899|P1|STARTED|Overall Study||177
103157|NCT01229722|245915|P2|NOT COMPLETED|Overall Study||0
103158|NCT01229722|245916|P1|NOT COMPLETED|Overall Study||4
103159|NCT01229722|245915|P2|COMPLETED|Overall Study||36
103160|NCT01229722|245916|P1|COMPLETED|Overall Study||30
103161|NCT01229722|245915|P2|STARTED|Overall Study||36
103162|NCT01229722|245916|P1|STARTED|Overall Study||34
103163|NCT01229527|245925|P3|NOT COMPLETED|Overall Study||0
103164|NCT01229527|245926|P2|NOT COMPLETED|Overall Study||0
103165|NCT01229527|245927|P1|NOT COMPLETED|Overall Study||0
103166|NCT01229527|245925|P3|COMPLETED|Overall Study||30
103167|NCT01229527|245926|P2|COMPLETED|Overall Study||30
103168|NCT01229527|245927|P1|COMPLETED|Overall Study||30
103169|NCT01229527|245925|P3|STARTED|Overall Study||30
103170|NCT01229527|245926|P2|STARTED|Overall Study||30
103171|NCT01229527|245927|P1|STARTED|Overall Study||30
103172|NCT01229462|245940|P2|NOT COMPLETED|Overall Study||9
103173|NCT01229462|245941|P1|NOT COMPLETED|Overall Study||5
103174|NCT01229462|245940|P2|COMPLETED|Overall Study||109
103175|NCT01229462|245941|P1|COMPLETED|Overall Study||115
103176|NCT01229462|245940|P2|STARTED|Overall Study||118
103177|NCT01229462|245941|P1|STARTED|Overall Study||120
103178|NCT01229436|245947|P1|NOT COMPLETED|Overall Study||5
103179|NCT01229436|245947|P1|COMPLETED|Overall Study||249
103180|NCT01229436|245947|P1|STARTED|Overall Study||254
103181|NCT01229423|245985|P1|NOT COMPLETED|Overall Study||15
103182|NCT01229423|245985|P1|COMPLETED|Overall Study||47
103183|NCT01229423|245985|P1|STARTED|Overall Study||62
103184|NCT01229410|245996|P2|NOT COMPLETED|Overall Study||3
103185|NCT01229410|245997|P1|NOT COMPLETED|Overall Study||5
103186|NCT01229410|245996|P2|COMPLETED|Overall Study||9
103187|NCT01229410|245997|P1|COMPLETED|Overall Study||7
103188|NCT01229410|245996|P2|STARTED|Overall Study||12
103189|NCT01229410|245997|P1|STARTED|Overall Study||12
103190|NCT01229397|246009|P2|NOT COMPLETED|Overall Study||9
103191|NCT01229397|246010|P1|NOT COMPLETED|Overall Study||11
103192|NCT01229397|246009|P2|COMPLETED|Overall Study||93
103193|NCT01229397|246010|P1|COMPLETED|Overall Study||92
103194|NCT01229397|246009|P2|STARTED|Overall Study||102
103195|NCT01229397|246010|P1|STARTED|Overall Study||103
103196|NCT01229371|246028|P4|NOT COMPLETED|Overall Study||0
103197|NCT01229371|246029|P3|NOT COMPLETED|Overall Study||0
103198|NCT01229371|246030|P2|NOT COMPLETED|Overall Study||1
103199|NCT01229371|246031|P1|NOT COMPLETED|Overall Study||0
103200|NCT01229371|246028|P4|COMPLETED|Overall Study||110
103201|NCT01229371|246029|P3|COMPLETED|Overall Study||110
103202|NCT01229371|246030|P2|COMPLETED|Overall Study||110
103203|NCT01229371|246031|P1|COMPLETED|Overall Study||109
103204|NCT01229371|246028|P4|STARTED|Overall Study||110
103205|NCT01229371|246029|P3|STARTED|Overall Study||110
103206|NCT01229371|246030|P2|STARTED|Overall Study||111
103207|NCT01229371|246031|P1|STARTED|Overall Study||109
103208|NCT01229228|246058|P5|NOT COMPLETED|Overall Study||1
103209|NCT01229228|246059|P4|NOT COMPLETED|Overall Study||0
103210|NCT01229228|246060|P3|NOT COMPLETED|Overall Study||1
103211|NCT01229228|246061|P2|NOT COMPLETED|Overall Study||0
103212|NCT01229228|246062|P1|NOT COMPLETED|Overall Study||1
103213|NCT01229228|246058|P5|COMPLETED|Overall Study||50
103214|NCT01229228|246059|P4|COMPLETED|Overall Study||51
103215|NCT01229228|246060|P3|COMPLETED|Overall Study||49
103216|NCT01229228|246061|P2|COMPLETED|Overall Study||51
103217|NCT01229228|246062|P1|COMPLETED|Overall Study||50
103218|NCT01229228|246058|P5|STARTED|Overall Study||51
103219|NCT01229228|246059|P4|STARTED|Overall Study||51
103220|NCT01229228|246060|P3|STARTED|Overall Study||50
103221|NCT01229228|246061|P2|STARTED|Overall Study||51
103222|NCT01229228|246062|P1|STARTED|Overall Study||51
103223|NCT01229176|246082|P8|NOT COMPLETED|Overall Study||3
103224|NCT01229176|246083|P7|NOT COMPLETED|Overall Study||0
103225|NCT01229176|246084|P6|NOT COMPLETED|Overall Study||2
103226|NCT01229176|246085|P5|NOT COMPLETED|Overall Study||2
103227|NCT01229176|246086|P4|NOT COMPLETED|Overall Study||1
103228|NCT01229176|246087|P3|NOT COMPLETED|Overall Study||0
103229|NCT01229176|246088|P2|NOT COMPLETED|Overall Study||3
103230|NCT01229176|246089|P1|NOT COMPLETED|Overall Study||0
103231|NCT01229176|246082|P8|COMPLETED|Overall Study||17
103232|NCT01229176|246083|P7|COMPLETED|Overall Study||20
103233|NCT01229176|246084|P6|COMPLETED|Overall Study||18
103234|NCT01229176|246085|P5|COMPLETED|Overall Study||18
103235|NCT01229176|246086|P4|COMPLETED|Overall Study||19
103236|NCT01229176|246087|P3|COMPLETED|Overall Study||20
103237|NCT01229176|246088|P2|COMPLETED|Overall Study||37
103238|NCT01229176|246089|P1|COMPLETED|Overall Study||40
103239|NCT01229176|246082|P8|STARTED|Overall Study||20
103240|NCT01229176|246083|P7|STARTED|Overall Study||20
103241|NCT01229176|246084|P6|STARTED|Overall Study||20
103242|NCT01229176|246085|P5|STARTED|Overall Study||20
103243|NCT01229176|246086|P4|STARTED|Overall Study||20
103244|NCT01229176|246087|P3|STARTED|Overall Study||20
103245|NCT01229176|246088|P2|STARTED|Overall Study||40
103246|NCT01229176|246089|P1|STARTED|Overall Study||40
103247|NCT01229150|246143|P4|NOT COMPLETED|Overall Study||0
103248|NCT01229150|246144|P3|NOT COMPLETED|Overall Study||0
103249|NCT01229150|246145|P2|NOT COMPLETED|Overall Study||2
103250|NCT01229150|246146|P1|NOT COMPLETED|Overall Study||2
103251|NCT01229150|246143|P4|COMPLETED|Overall Study||19
103252|NCT01229150|246144|P3|COMPLETED|Overall Study||19
103253|NCT01229150|246145|P2|COMPLETED|Overall Study||9
103254|NCT01229150|246146|P1|COMPLETED|Overall Study||28
103255|NCT01229150|246143|P4|STARTED|Overall Study||19
103256|NCT01229150|246144|P3|STARTED|Overall Study||19
103257|NCT01229150|246145|P2|STARTED|Overall Study||11
103258|NCT01229150|246146|P1|STARTED|Overall Study||30
103259|NCT01229111|246203|P1|NOT COMPLETED|Overall Study||1
103260|NCT01229111|246203|P1|COMPLETED|Overall Study||13
103261|NCT01229111|246203|P1|STARTED|Overall Study||14
103262|NCT01228968|246211|P1|NOT COMPLETED|Overall Study||0
103263|NCT01228968|246211|P1|COMPLETED|Overall Study||9
103264|NCT01228968|246211|P1|STARTED|Overall Study||9
103265|NCT01228929|246221|P3|NOT COMPLETED|High Temperature Condition||0
103266|NCT01228929|246222|P2|NOT COMPLETED|High Temperature Condition||0
103267|NCT01228929|246223|P1|NOT COMPLETED|High Temperature Condition||0
103268|NCT01228929|246221|P3|COMPLETED|High Temperature Condition||6
103269|NCT01228929|246222|P2|COMPLETED|High Temperature Condition||6
103270|NCT01228929|246223|P1|COMPLETED|High Temperature Condition||6
103271|NCT01228929|246221|P3|STARTED|High Temperature Condition||6
103272|NCT01228929|246222|P2|STARTED|High Temperature Condition||6
103273|NCT01228929|246223|P1|STARTED|High Temperature Condition||6
103274|NCT01228929|246221|P3|NOT COMPLETED|Low Humidity Condition||0
103275|NCT01228929|246222|P2|NOT COMPLETED|Low Humidity Condition||0
103276|NCT01228929|246223|P1|NOT COMPLETED|Low Humidity Condition||0
103277|NCT01228929|246221|P3|COMPLETED|Low Humidity Condition||6
103278|NCT01228929|246222|P2|COMPLETED|Low Humidity Condition||6
103279|NCT01228929|246223|P1|COMPLETED|Low Humidity Condition||6
103280|NCT01228929|246221|P3|STARTED|Low Humidity Condition||6
103281|NCT01228929|246222|P2|STARTED|Low Humidity Condition||6
103282|NCT01228929|246223|P1|STARTED|Low Humidity Condition||6
103283|NCT01228929|246221|P3|NOT COMPLETED|Nominal Condition||0
103284|NCT01228929|246222|P2|NOT COMPLETED|Nominal Condition||0
103285|NCT01228929|246223|P1|NOT COMPLETED|Nominal Condition||0
103286|NCT01228929|246221|P3|COMPLETED|Nominal Condition||6
103287|NCT01228929|246222|P2|COMPLETED|Nominal Condition||6
103288|NCT01228929|246223|P1|COMPLETED|Nominal Condition||6
103289|NCT01228929|246221|P3|STARTED|Nominal Condition||6
103290|NCT01228929|246222|P2|STARTED|Nominal Condition||6
103291|NCT01228929|246223|P1|STARTED|Nominal Condition||6
103292|NCT01228903|246233|P2|NOT COMPLETED|Overall Study||5
103293|NCT01228903|246234|P1|NOT COMPLETED|Overall Study||5
103294|NCT01228903|246233|P2|COMPLETED|Overall Study||34
103295|NCT01228903|246234|P1|COMPLETED|Overall Study||36
103296|NCT01228903|246233|P2|STARTED|Overall Study||39
103297|NCT01228903|246234|P1|STARTED|Overall Study||41
103298|NCT01228747|246252|P2|NOT COMPLETED|Overall Study||45
103299|NCT01228747|246253|P1|NOT COMPLETED|Overall Study||65
103300|NCT01228747|246252|P2|COMPLETED|Overall Study||81
103301|NCT01228747|246253|P1|COMPLETED|Overall Study||60
103302|NCT01228747|246252|P2|STARTED|Overall Study||126
103303|NCT01228747|246253|P1|STARTED|Overall Study||125
103304|NCT01228734|246269|P2|NOT COMPLETED|Overall Study||8
103305|NCT01228734|246270|P1|NOT COMPLETED|Overall Study||16
103306|NCT01228734|246269|P2|COMPLETED|Overall Study||196
103307|NCT01228734|246270|P1|COMPLETED|Overall Study||177
103308|NCT01228734|246269|P2|Modified Safety Population|Overall Study||199
103309|NCT01228734|246270|P1|Modified Safety Population|Overall Study|One subject was randomized to FOLFOX-4 group but received cetuximab + FOLFOX-4 treatment instead|194
103310|NCT01228734|246269|P2|Modified Intent-to-treat (MITT) Populati|Overall Study||200
103311|NCT01228734|246270|P1|Modified Intent-to-treat (MITT) Populati|Overall Study||193
103312|NCT01228734|246269|P2|STARTED|Overall Study||204
103313|NCT01228734|246270|P1|STARTED|Overall Study||193
103314|NCT01228591|246284|P2|NOT COMPLETED|Final Visit||0
103315|NCT01228591|246285|P1|NOT COMPLETED|Final Visit||0
103316|NCT01228591|246284|P2|COMPLETED|Final Visit||16
103317|NCT01228591|246285|P1|COMPLETED|Final Visit||17
103318|NCT01228591|246284|P2|STARTED|Final Visit||16
103319|NCT01228591|246285|P1|STARTED|Final Visit||17
103320|NCT01228591|246284|P2|NOT COMPLETED|1-Week Follow-Up||0
103321|NCT01228591|246285|P1|NOT COMPLETED|1-Week Follow-Up||0
103322|NCT01228591|246284|P2|COMPLETED|1-Week Follow-Up||16
103323|NCT01228591|246285|P1|COMPLETED|1-Week Follow-Up||17
103324|NCT01228591|246284|P2|STARTED|1-Week Follow-Up||16
103325|NCT01228591|246285|P1|STARTED|1-Week Follow-Up||17
103326|NCT01228591|246284|P2|NOT COMPLETED|Baseline||2
103327|NCT01228591|246285|P1|NOT COMPLETED|Baseline||1
103328|NCT01228591|246284|P2|COMPLETED|Baseline||16
103329|NCT01228591|246285|P1|COMPLETED|Baseline||17
103330|NCT01228591|246284|P2|STARTED|Baseline||18
103331|NCT01228591|246285|P1|STARTED|Baseline||18
103332|NCT01228435|246303|P2|NOT COMPLETED|Overall Study||0
103333|NCT01228435|246304|P1|NOT COMPLETED|Overall Study||0
103334|NCT01228435|246303|P2|COMPLETED|Overall Study||2
103335|NCT01228435|246304|P1|COMPLETED|Overall Study||1
103336|NCT01228435|246303|P2|STARTED|Overall Study||2
103337|NCT01228435|246304|P1|STARTED|Overall Study||1
103338|NCT01228175|246312|P2|NOT COMPLETED|Overall Study||53
103339|NCT01228175|246313|P1|NOT COMPLETED|Overall Study||63
103340|NCT01228175|246312|P2|COMPLETED|Overall Study||46
103341|NCT01228175|246313|P1|COMPLETED|Overall Study||56
103342|NCT01228175|246312|P2|STARTED|Overall Study||99
103343|NCT01228175|246313|P1|STARTED|Overall Study||119
103344|NCT01228149|246321|P2|NOT COMPLETED|Overall Study||4
103345|NCT01228149|246322|P1|NOT COMPLETED|Overall Study||5
103346|NCT01228149|246321|P2|COMPLETED|Overall Study||26
103347|NCT01228149|246322|P1|COMPLETED|Overall Study||27
103348|NCT01228149|246321|P2|STARTED|Overall Study||30
103349|NCT01228149|246322|P1|STARTED|Overall Study||32
103350|NCT01228084|246344|P1|NOT COMPLETED|Overall Study||4
103351|NCT01228084|246344|P1|COMPLETED|Overall Study||16
103352|NCT01228084|246344|P1|STARTED|Overall Study||20
103353|NCT01228071|246355|P1|NOT COMPLETED|Overall Study||2
103354|NCT01228071|246355|P1|COMPLETED|Overall Study||32
103355|NCT01228071|246355|P1|STARTED|Overall Study||34
103356|NCT01228019|246361|P1|NOT COMPLETED|Overall Study||304
103357|NCT01228019|246361|P1|COMPLETED|Overall Study||862
103358|NCT01228019|246361|P1|STARTED|Overall Study||1166
103359|NCT01227993|246376|P1|NOT COMPLETED|Overall Study||0
103360|NCT01227993|246376|P1|COMPLETED|Overall Study||3
103361|NCT01227993|246376|P1|STARTED|Overall Study||3
103362|NCT01227980|246388|P2|NOT COMPLETED|Overall Study||5
103363|NCT01227980|246389|P1|NOT COMPLETED|Overall Study||2
103364|NCT01227980|246388|P2|COMPLETED|Overall Study||25
103365|NCT01227980|246389|P1|COMPLETED|Overall Study|Two subjects did not complete the scripts sessions but completed the remainder of the protocol|38
103366|NCT01227980|246388|P2|Measure Drug Level Concentration|Overall Study|No placebo subjects completed this milestone which measured active drug levels|0
103367|NCT01227980|246389|P1|Measure Drug Level Concentration|Overall Study||10
103368|NCT01227980|246388|P2|Scripts Challenge Sessions|Overall Study||25
103369|NCT01227980|246389|P1|Scripts Challenge Sessions|Overall Study||26
103370|NCT01227980|246388|P2|STARTED|Overall Study||30
103371|NCT01227980|246389|P1|STARTED|Overall Study||40
103372|NCT01227967|246427|P2|NOT COMPLETED|Overall Study||13
103373|NCT01227967|246428|P1|NOT COMPLETED|Overall Study||16
103374|NCT01227967|246427|P2|COMPLETED|Overall Study||303
103375|NCT01227967|246428|P1|COMPLETED|Overall Study||298
103376|NCT01227967|246427|P2|STARTED|Overall Study||316
103377|NCT01227967|246428|P1|STARTED|Overall Study||314
103378|NCT01227928|246464|P2|NOT COMPLETED|Overall Study||17
103379|NCT01227928|246465|P1|NOT COMPLETED|Overall Study||22
103380|NCT01227928|246464|P2|COMPLETED|Overall Study||56
103381|NCT01227928|246465|P1|COMPLETED|Overall Study||50
103382|NCT01227928|246464|P2|STARTED|Overall Study||73
103383|NCT01227928|246465|P1|STARTED|Overall Study||72
103384|NCT01227902|246503|P4|NOT COMPLETED|Overall Study||10
103385|NCT01227902|246504|P3|NOT COMPLETED|Overall Study||19
103386|NCT01227902|246505|P2|NOT COMPLETED|Overall Study||13
103387|NCT01227902|246506|P1|NOT COMPLETED|Overall Study||18
103388|NCT01227902|246503|P4|COMPLETED|Overall Study||42
103389|NCT01227902|246504|P3|COMPLETED|Overall Study||25
103390|NCT01227902|246505|P2|COMPLETED|Overall Study||38
103391|NCT01227902|246506|P1|COMPLETED|Overall Study||38
103392|NCT01227902|246503|P4|STARTED|Overall Study||52
103393|NCT01227902|246504|P3|STARTED|Overall Study||44
103394|NCT01227902|246505|P2|STARTED|Overall Study||51
103395|NCT01227902|246506|P1|STARTED|Overall Study||56
103396|NCT01227889|246599|P2|NOT COMPLETED|Crossover Phase||36
103397|NCT01227889|246600|P1|NOT COMPLETED|Crossover Phase||0
103398|NCT01227889|246599|P2|COMPLETED|Crossover Phase||0
103399|NCT01227889|246600|P1|COMPLETED|Crossover Phase||0
103400|NCT01227889|246599|P2|Ongoing|Crossover Phase||4
103401|NCT01227889|246600|P1|Ongoing|Crossover Phase||0
103402|NCT01227889|246599|P2|In Follow-up|Crossover Phase||11
103403|NCT01227889|246600|P1|In Follow-up|Crossover Phase||0
103404|NCT01227889|246599|P2|STARTED|Crossover Phase|As of the data cut on December 18, 2012, 36 of 63 participants crossed over from DTIC to GSK2118436.|36
103405|NCT01227889|246600|P1|STARTED|Crossover Phase||0
103406|NCT01227889|246599|P2|NOT COMPLETED|Randomized Phase (RP)||63
103407|NCT01227889|246600|P1|NOT COMPLETED|Randomized Phase (RP)||187
103408|NCT01227889|246599|P2|COMPLETED|Randomized Phase (RP)||0
103409|NCT01227889|246600|P1|COMPLETED|Randomized Phase (RP)||0
103410|NCT01227889|246599|P2|Crossed Over|Randomized Phase (RP)||36
103411|NCT01227889|246600|P1|Crossed Over|Randomized Phase (RP)||0
103412|NCT01227889|246599|P2|Ongoing|Randomized Phase (RP)||2
103413|NCT01227889|246600|P1|Ongoing|Randomized Phase (RP)||53
103414|NCT01227889|246599|P2|In Follow-up|Randomized Phase (RP)||10
103415|NCT01227889|246600|P1|In Follow-up|Randomized Phase (RP)||49
103416|NCT01227889|246599|P2|STARTED|Randomized Phase (RP)||63
103417|NCT01227889|246600|P1|STARTED|Randomized Phase (RP)||187
103418|NCT01227824|246628|P2|NOT COMPLETED|Open-label Phase||0
103419|NCT01227824|246629|P1|NOT COMPLETED|Open-label Phase||338
103420|NCT01227824|246628|P2|COMPLETED|Open-label Phase||0
103421|NCT01227824|246629|P1|COMPLETED|Open-label Phase||0
103422|NCT01227824|246628|P2|Ongoing|Open-label Phase||0
103423|NCT01227824|246629|P1|Ongoing|Open-label Phase||337
103424|NCT01227824|246628|P2|STARTED|Open-label Phase||0
103425|NCT01227824|246629|P1|STARTED|Open-label Phase|Eleven participant completing the Double-blind Phase did not continue into the Open-label Phase.|338
103426|NCT01227824|246628|P2|NOT COMPLETED|Double-blind Phase||79
103427|NCT01227824|246629|P1|NOT COMPLETED|Double-blind Phase||62
103428|NCT01227824|246628|P2|COMPLETED|Double-blind Phase||332
103429|NCT01227824|246629|P1|COMPLETED|Double-blind Phase||349
103430|NCT01227824|246628|P2|STARTED|Double-blind Phase||411
103431|NCT01227824|246629|P1|STARTED|Double-blind Phase||411
103432|NCT01227785|246657|P1|NOT COMPLETED|Overall Study||12
103433|NCT01227785|246657|P1|COMPLETED|Overall Study||108
103434|NCT01227785|246657|P1|STARTED|Overall Study||120
103435|NCT01227707|246723|P1|NOT COMPLETED|Overall Study||24
103436|NCT01227707|246723|P1|COMPLETED|Overall Study||19
103437|NCT01227707|246723|P1|STARTED|Overall Study||43
103438|NCT01227681|246742|P3|NOT COMPLETED|Overall Study||0
103439|NCT01227681|246743|P2|NOT COMPLETED|Overall Study||0
103440|NCT01227681|246744|P1|NOT COMPLETED|Overall Study||0
103441|NCT01227681|246742|P3|COMPLETED|Overall Study||0
103442|NCT01227681|246743|P2|COMPLETED|Overall Study||0
103443|NCT01227681|246744|P1|COMPLETED|Overall Study||4
103444|NCT01227681|246742|P3|STARTED|Overall Study||0
103445|NCT01227681|246743|P2|STARTED|Overall Study||0
103446|NCT01227681|246744|P1|STARTED|Overall Study||4
103447|NCT01227668|246750|P2|NOT COMPLETED|Phase 2 (Randomization Phase)||25
103448|NCT01227668|246751|P1|NOT COMPLETED|Phase 2 (Randomization Phase)||19
103449|NCT01227668|246750|P2|COMPLETED|Phase 2 (Randomization Phase)||19
103450|NCT01227668|246751|P1|COMPLETED|Phase 2 (Randomization Phase)||22
103451|NCT01227668|246750|P2|Received Treatment|Phase 2 (Randomization Phase)||43
103452|NCT01227668|246751|P1|Received Treatment|Phase 2 (Randomization Phase)||39
103453|NCT01227668|246750|P2|STARTED|Phase 2 (Randomization Phase)|Randomized|44
103454|NCT01227668|246751|P1|STARTED|Phase 2 (Randomization Phase)|Randomized|41
103455|NCT01227668|246750|P2|NOT COMPLETED|Phase 1 (Stabilization Phase)||0
103456|NCT01227668|246751|P1|NOT COMPLETED|Phase 1 (Stabilization Phase)||72
103457|NCT01227668|246750|P2|COMPLETED|Phase 1 (Stabilization Phase)||0
103458|NCT01227668|246751|P1|COMPLETED|Phase 1 (Stabilization Phase)||85
103459|NCT01227668|246750|P2|Received Treatment|Phase 1 (Stabilization Phase)||0
103460|NCT01227668|246751|P1|Received Treatment|Phase 1 (Stabilization Phase)||155
103461|NCT01227668|246750|P2|STARTED|Phase 1 (Stabilization Phase)||0
103462|NCT01227668|246751|P1|STARTED|Phase 1 (Stabilization Phase)|Randomized|157
103463|NCT01227655|246768|P3|NOT COMPLETED|Overall Study||14
103464|NCT01227655|246769|P2|NOT COMPLETED|Overall Study||26
103465|NCT01227655|246770|P1|NOT COMPLETED|Overall Study||11
103466|NCT01227655|246768|P3|COMPLETED|Overall Study||130
103467|NCT01227655|246769|P2|COMPLETED|Overall Study||128
103468|NCT01227655|246770|P1|COMPLETED|Overall Study||118
103469|NCT01227655|246768|P3|Full Analysis Set|Overall Study||135
103470|NCT01227655|246769|P2|Full Analysis Set|Overall Study||147
103471|NCT01227655|246770|P1|Full Analysis Set|Overall Study||125
103472|NCT01227655|246768|P3|Safety Set|Overall Study||136
103473|NCT01227655|246769|P2|Safety Set|Overall Study||150
103474|NCT01227655|246770|P1|Safety Set|Overall Study||125
103475|NCT01227655|246768|P3|STARTED|Overall Study||144
103476|NCT01227655|246769|P2|STARTED|Overall Study||154
103477|NCT01227655|246770|P1|STARTED|Overall Study||129
103478|NCT01227629|246797|P10|NOT COMPLETED|Overall Study||2
103479|NCT01227629|246798|P9|NOT COMPLETED|Overall Study||6
103480|NCT01227629|246799|P8|NOT COMPLETED|Overall Study||6
103481|NCT01227629|246800|P7|NOT COMPLETED|Overall Study||8
103482|NCT01227629|246801|P6|NOT COMPLETED|Overall Study||1
103483|NCT01227629|246802|P5|NOT COMPLETED|Overall Study||2
103484|NCT01227629|246803|P4|NOT COMPLETED|Overall Study||8
103485|NCT01227629|246804|P3|NOT COMPLETED|Overall Study||1
103486|NCT01227629|246805|P2|NOT COMPLETED|Overall Study||2
103487|NCT01227629|246806|P1|NOT COMPLETED|Overall Study||2
103488|NCT01227629|246797|P10|COMPLETED|Overall Study||68
103489|NCT01227629|246798|P9|COMPLETED|Overall Study||24
103490|NCT01227629|246799|P8|COMPLETED|Overall Study||27
103491|NCT01227629|246800|P7|COMPLETED|Overall Study||90
103492|NCT01227629|246801|P6|COMPLETED|Overall Study||32
103493|NCT01227629|246802|P5|COMPLETED|Overall Study||32
103494|NCT01227629|246803|P4|COMPLETED|Overall Study||91
103495|NCT01227629|246804|P3|COMPLETED|Overall Study||26
103496|NCT01227629|246805|P2|COMPLETED|Overall Study||18
103497|NCT01227629|246806|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|56
103498|NCT01227629|246797|P10|STARTED|Overall Study||70
103499|NCT01227629|246798|P9|STARTED|Overall Study||30
103500|NCT01227629|246799|P8|STARTED|Overall Study||33
103501|NCT01227629|246800|P7|STARTED|Overall Study||98
103502|NCT01227629|246801|P6|STARTED|Overall Study||33
103503|NCT01227629|246802|P5|STARTED|Overall Study||34
103504|NCT01227629|246803|P4|STARTED|Overall Study||99
103505|NCT01227629|246804|P3|STARTED|Overall Study||27
103506|NCT01227629|246805|P2|STARTED|Overall Study||20
103507|NCT01227629|246806|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|58
103508|NCT01227577|247042|P1|NOT COMPLETED|Overall Study||35
103509|NCT01227577|247042|P1|COMPLETED|Overall Study||93
103510|NCT01227577|247042|P1|STARTED|Overall Study||128
103511|NCT01227564|247057|P3|NOT COMPLETED|Overall Study||6
103512|NCT01227564|247058|P2|NOT COMPLETED|Overall Study||2
103513|NCT01227564|247059|P1|NOT COMPLETED|Overall Study||4
103514|NCT01227564|247057|P3|COMPLETED|Overall Study|Completed study|15
103515|NCT01227564|247058|P2|COMPLETED|Overall Study|Completed study|18
103516|NCT01227564|247059|P1|COMPLETED|Overall Study|Completed study|18
103517|NCT01227564|247057|P3|Completed Treatment|Overall Study|1 participant stopped treatment due to lack of efficacy, 3 due to no longer willing to participate.|17
103518|NCT01227564|247058|P2|Completed Treatment|Overall Study|2 participants discontinued treatment due to no longer willing to participate in study.|18
103519|NCT01227564|247059|P1|Completed Treatment|Overall Study|1 participant discontinued treatment due to an adverse event (AE).|21
103520|NCT01227564|247057|P3|Treated|Overall Study||21
103521|NCT01227564|247058|P2|Treated|Overall Study||20
103522|NCT01227564|247059|P1|Treated|Overall Study||22
103523|NCT01227564|247057|P3|STARTED|Overall Study||21
103524|NCT01227564|247058|P2|STARTED|Overall Study||20
103525|NCT01227564|247059|P1|STARTED|Overall Study||22
103526|NCT01227551|247190|P1|NOT COMPLETED|Overall Study||34
103527|NCT01227551|247190|P1|COMPLETED|Overall Study||23
103528|NCT01227551|247190|P1|STARTED|Overall Study||57
103529|NCT01227512|247197|P2|NOT COMPLETED|Overall Study||10
103530|NCT01227512|247198|P1|NOT COMPLETED|Overall Study||13
103531|NCT01227512|247197|P2|COMPLETED|Overall Study||48
103532|NCT01227512|247198|P1|COMPLETED|Overall Study||53
103533|NCT01227512|247197|P2|STARTED|Overall Study||58
103534|NCT01227512|247198|P1|STARTED|Overall Study||66
103535|NCT01227434|247220|P2|NOT COMPLETED|Overall Study||0
103536|NCT01227434|247221|P1|NOT COMPLETED|Overall Study||0
103537|NCT01227434|247220|P2|COMPLETED|Overall Study||16
103538|NCT01227434|247221|P1|COMPLETED|Overall Study||6
103539|NCT01227434|247220|P2|STARTED|Overall Study||16
103540|NCT01227434|247221|P1|STARTED|Overall Study||6
103541|NCT01227421|247232|P3|NOT COMPLETED|Overall Study||10
103542|NCT01227421|247233|P2|NOT COMPLETED|Overall Study||18
103543|NCT01227421|247234|P1|NOT COMPLETED|Overall Study||11
103544|NCT01227421|247232|P3|COMPLETED|Overall Study||201
103545|NCT01227421|247233|P2|COMPLETED|Overall Study||194
103546|NCT01227421|247234|P1|COMPLETED|Overall Study||190
103547|NCT01227421|247232|P3|STARTED|Overall Study||211
103548|NCT01227421|247233|P2|STARTED|Overall Study||212
103549|NCT01227421|247234|P1|STARTED|Overall Study||201
103550|NCT01227395|247286|P2|NOT COMPLETED|Overall Study||1
103551|NCT01227395|247287|P1|NOT COMPLETED|Overall Study||0
103552|NCT01227395|247286|P2|COMPLETED|Overall Study||84
103553|NCT01227395|247287|P1|COMPLETED|Overall Study||391
103554|NCT01227395|247286|P2|STARTED|Overall Study||85
103555|NCT01227395|247287|P1|STARTED|Overall Study||391
103556|NCT01227382|247315|P1|NOT COMPLETED|Overall Study||0
103557|NCT01227382|247315|P1|COMPLETED|Overall Study||26
103558|NCT01227382|247315|P1|STARTED|Overall Study||26
103559|NCT01227278|247327|P2|NOT COMPLETED|Overall Study||8
103560|NCT01227278|247328|P1|NOT COMPLETED|Overall Study||5
103561|NCT01227278|247327|P2|COMPLETED|Overall Study||43
103562|NCT01227278|247328|P1|COMPLETED|Overall Study||45
103563|NCT01227278|247327|P2|STARTED|Overall Study||51
103564|NCT01227278|247328|P1|STARTED|Overall Study||50
103565|NCT01227265|247355|P3|NOT COMPLETED|Overall Study||14
103566|NCT01227265|247356|P2|NOT COMPLETED|Overall Study||20
103567|NCT01227265|247357|P1|NOT COMPLETED|Overall Study||19
103568|NCT01227265|247355|P3|COMPLETED|Overall Study||145
103569|NCT01227265|247356|P2|COMPLETED|Overall Study||139
103570|NCT01227265|247357|P1|COMPLETED|Overall Study||139
103571|NCT01227265|247355|P3|Treated|Overall Study||159
103572|NCT01227265|247356|P2|Treated|Overall Study||157
103573|NCT01227265|247357|P1|Treated|Overall Study||157
103574|NCT01227265|247355|P3|STARTED|Overall Study||159
103575|NCT01227265|247356|P2|STARTED|Overall Study||159
103576|NCT01227265|247357|P1|STARTED|Overall Study||158
103577|NCT01227057|247385|P2|NOT COMPLETED|Overall Study||8
103578|NCT01227057|247386|P1|NOT COMPLETED|Overall Study||6
103579|NCT01227057|247385|P2|COMPLETED|Overall Study||19
103580|NCT01227057|247386|P1|COMPLETED|Overall Study||25
103581|NCT01227057|247385|P2|STARTED|Overall Study||27
103582|NCT01227057|247386|P1|STARTED|Overall Study||31
103583|NCT01227018|247394|P1|NOT COMPLETED|Overall Study||15
103584|NCT01227018|247394|P1|COMPLETED|Overall Study||0
103585|NCT01227018|247394|P1|STARTED|Overall Study||15
103586|NCT01227005|247404|P2|NOT COMPLETED|Overall Study||1
103587|NCT01227005|247405|P1|NOT COMPLETED|Overall Study||5
103588|NCT01227005|247404|P2|COMPLETED|Overall Study||51
103589|NCT01227005|247405|P1|COMPLETED|Overall Study||50
103590|NCT01227005|247404|P2|STARTED|Overall Study||52
103591|NCT01227005|247405|P1|STARTED|Overall Study||55
103592|NCT01226745|247421|P6|NOT COMPLETED|Overall Study||5
103593|NCT01226745|247422|P5|NOT COMPLETED|Overall Study||4
103594|NCT01226745|247423|P4|NOT COMPLETED|Overall Study||5
103595|NCT01226745|247424|P3|NOT COMPLETED|Overall Study||20
103596|NCT01226745|247425|P2|NOT COMPLETED|Overall Study||16
103597|NCT01226745|247426|P1|NOT COMPLETED|Overall Study||17
103598|NCT01226745|247421|P6|COMPLETED|Overall Study||24
103599|NCT01226745|247422|P5|COMPLETED|Overall Study||22
103600|NCT01226745|247423|P4|COMPLETED|Overall Study||24
103601|NCT01226745|247424|P3|COMPLETED|Overall Study||69
103602|NCT01226745|247425|P2|COMPLETED|Overall Study||71
103603|NCT01226745|247426|P1|COMPLETED|Overall Study||63
103604|NCT01226745|247421|P6|STARTED|Overall Study||29
103605|NCT01226745|247422|P5|STARTED|Overall Study||26
103606|NCT01226745|247423|P4|STARTED|Overall Study||29
103607|NCT01226745|247424|P3|STARTED|Overall Study||89
103608|NCT01226745|247425|P2|STARTED|Overall Study||87
103609|NCT01226745|247426|P1|STARTED|Overall Study||80
103610|NCT01226732|247506|P6|NOT COMPLETED|Overall Study||6
103611|NCT01226732|247507|P5|NOT COMPLETED|Overall Study||3
103612|NCT01226732|247508|P4|NOT COMPLETED|Overall Study||5
103613|NCT01226732|247509|P3|NOT COMPLETED|Overall Study||3
103614|NCT01226732|247510|P2|NOT COMPLETED|Overall Study||3
103615|NCT01226732|247511|P1|NOT COMPLETED|Overall Study||3
103616|NCT01226732|247506|P6|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
103617|NCT01226732|247507|P5|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
103618|NCT01226732|247508|P4|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
103619|NCT01226732|247509|P3|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
103620|NCT01226732|247510|P2|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
103621|NCT01226732|247511|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or intolerable toxicity|0
103622|NCT01226732|247506|P6|STARTED|Overall Study||6
103623|NCT01226732|247507|P5|STARTED|Overall Study||3
103624|NCT01226732|247508|P4|STARTED|Overall Study||5
103625|NCT01226732|247509|P3|STARTED|Overall Study||3
103626|NCT01226732|247510|P2|STARTED|Overall Study||3
103627|NCT01226732|247511|P1|STARTED|Overall Study||3
103628|NCT01226719|247527|P1|NOT COMPLETED|Overall Study||13
103629|NCT01226719|247527|P1|COMPLETED|Overall Study|Completed = patient is surgical candidate, underwent resection, received treatment to week 24.|2
103630|NCT01226719|247527|P1|STARTED|Overall Study||15
103631|NCT01226706|247537|P2|NOT COMPLETED|Overall Study||0
103632|NCT01226706|247538|P1|NOT COMPLETED|Overall Study||0
103633|NCT01226706|247537|P2|COMPLETED|Overall Study||11
103634|NCT01226706|247538|P1|COMPLETED|Overall Study||10
103635|NCT01226706|247537|P2|STARTED|Overall Study||11
103636|NCT01226706|247538|P1|STARTED|Overall Study||10
103637|NCT01226511|247622|P2|NOT COMPLETED|Taper Period||3
103638|NCT01226511|247623|P1|NOT COMPLETED|Taper Period||5
103639|NCT01226511|247622|P2|COMPLETED|Taper Period||54
103640|NCT01226511|247623|P1|COMPLETED|Taper Period||46
103641|NCT01226511|247622|P2|STARTED|Taper Period||57
103642|NCT01226511|247623|P1|STARTED|Taper Period||51
103643|NCT01226511|247622|P2|NOT COMPLETED|Extension Treatment Period||27
103644|NCT01226511|247623|P1|NOT COMPLETED|Extension Treatment Period||27
103645|NCT01226511|247622|P2|COMPLETED|Extension Treatment Period|Thirty-five (35) participants who completed extension treatment did not enter the taper period.|83
103646|NCT01226511|247623|P1|COMPLETED|Extension Treatment Period|Thirty-nine (39) participants who completed extension treatment did not enter the taper period.|81
103647|NCT01226511|247622|P2|STARTED|Extension Treatment Period|Twenty-three (23) participants who discontinued extension treatment did not enter the taper period.|110
103648|NCT01226511|247623|P1|STARTED|Extension Treatment Period|Nineteen (19) participants who discontinued extension treatment did not enter the taper period.|108
103649|NCT01226511|247622|P2|NOT COMPLETED|Acute Treatment Period||31
103650|NCT01226511|247623|P1|NOT COMPLETED|Acute Treatment Period||32
103651|NCT01226511|247622|P2|COMPLETED|Acute Treatment Period||110
103652|NCT01226511|247623|P1|COMPLETED|Acute Treatment Period||108
103653|NCT01226511|247622|P2|STARTED|Acute Treatment Period|Twenty-six (26) participants who discontinued acute treatment did not enter the taper period.|141
103654|NCT01226511|247623|P1|STARTED|Acute Treatment Period|Thirty-one (31) participants who discontinued acute treatment did not enter the taper period.|140
103655|NCT01226459|247661|P2|NOT COMPLETED|Overall Study||32
103656|NCT01226459|247662|P1|NOT COMPLETED|Overall Study||21
103657|NCT01226459|247661|P2|COMPLETED|Overall Study||171
103658|NCT01226459|247662|P1|COMPLETED|Overall Study||180
103659|NCT01226459|247661|P2|STARTED|Overall Study||203
103660|NCT01226459|247662|P1|STARTED|Overall Study||201
103661|NCT01226420|247672|P1|NOT COMPLETED|Overall Study||0
103662|NCT01226420|247672|P1|COMPLETED|Overall Study||6
103663|NCT01226420|247672|P1|STARTED|Overall Study||6
103664|NCT01226121|247680|P3|NOT COMPLETED|Overall Study||1
103665|NCT01226121|247681|P2|NOT COMPLETED|Overall Study||0
103666|NCT01226121|247682|P1|NOT COMPLETED|Overall Study||2
103667|NCT01226121|247680|P3|COMPLETED|Overall Study||12
103668|NCT01226121|247681|P2|COMPLETED|Overall Study||11
103669|NCT01226121|247682|P1|COMPLETED|Overall Study||11
103670|NCT01226121|247680|P3|30 Day Evaluation|Overall Study||13
103671|NCT01226121|247681|P2|30 Day Evaluation|Overall Study||11
103672|NCT01226121|247682|P1|30 Day Evaluation|Overall Study||12
103673|NCT01226121|247680|P3|STARTED|Overall Study||13
103674|NCT01226121|247681|P2|STARTED|Overall Study||11
103675|NCT01226121|247682|P1|STARTED|Overall Study||13
103676|NCT01226095|247693|P1|NOT COMPLETED|Overall Study||1
103677|NCT01226095|247693|P1|COMPLETED|Overall Study||518
103678|NCT01226095|247693|P1|STARTED|Overall Study||519
103679|NCT01226043|247718|P4|NOT COMPLETED|30-week Observational Phase||13
103680|NCT01226043|247719|P3|NOT COMPLETED|30-week Observational Phase||6
103681|NCT01226043|247720|P2|NOT COMPLETED|30-week Observational Phase||0
103682|NCT01226043|247721|P1|NOT COMPLETED|30-week Observational Phase||0
103683|NCT01226043|247718|P4|COMPLETED|30-week Observational Phase||140
103684|NCT01226043|247719|P3|COMPLETED|30-week Observational Phase||153
103685|NCT01226043|247720|P2|COMPLETED|30-week Observational Phase||0
103686|NCT01226043|247721|P1|COMPLETED|30-week Observational Phase||0
103687|NCT01226043|247718|P4|TREATED|30-week Observational Phase||153
103688|NCT01226043|247719|P3|TREATED|30-week Observational Phase||159
103689|NCT01226043|247720|P2|TREATED|30-week Observational Phase||0
103690|NCT01226043|247721|P1|TREATED|30-week Observational Phase||0
103691|NCT01226043|247718|P4|STARTED|30-week Observational Phase||153
103692|NCT01226043|247719|P3|STARTED|30-week Observational Phase||159
103693|NCT01226043|247720|P2|STARTED|30-week Observational Phase||0
103694|NCT01226043|247721|P1|STARTED|30-week Observational Phase||0
103695|NCT01226043|247718|P4|NOT COMPLETED|6-week Re-randomization Phase||11
103696|NCT01226043|247719|P3|NOT COMPLETED|6-week Re-randomization Phase||7
103697|NCT01226043|247720|P2|NOT COMPLETED|6-week Re-randomization Phase||0
103698|NCT01226043|247721|P1|NOT COMPLETED|6-week Re-randomization Phase||0
103699|NCT01226043|247718|P4|COMPLETED|6-week Re-randomization Phase|3 patients did not enter the observational phase of the study|156
103700|NCT01226043|247719|P3|COMPLETED|6-week Re-randomization Phase||159
103701|NCT01226043|247720|P2|COMPLETED|6-week Re-randomization Phase||0
103702|NCT01226043|247721|P1|COMPLETED|6-week Re-randomization Phase||0
103703|NCT01226043|247718|P4|TREATED|6-week Re-randomization Phase||165
103704|NCT01226043|247719|P3|TREATED|6-week Re-randomization Phase||165
103705|NCT01226043|247720|P2|TREATED|6-week Re-randomization Phase||0
103706|NCT01226043|247721|P1|TREATED|6-week Re-randomization Phase||0
103707|NCT01226043|247718|P4|STARTED|6-week Re-randomization Phase||167
103708|NCT01226043|247719|P3|STARTED|6-week Re-randomization Phase||166
103709|NCT01226043|247720|P2|STARTED|6-week Re-randomization Phase||0
103710|NCT01226043|247721|P1|STARTED|6-week Re-randomization Phase||0
103711|NCT01226043|247718|P4|NOT COMPLETED|4-week Crossover Phase - Period 2||0
103712|NCT01226043|247719|P3|NOT COMPLETED|4-week Crossover Phase - Period 2||0
103713|NCT01226043|247720|P2|NOT COMPLETED|4-week Crossover Phase - Period 2||6
103714|NCT01226043|247721|P1|NOT COMPLETED|4-week Crossover Phase - Period 2||4
103715|NCT01226043|247718|P4|COMPLETED|4-week Crossover Phase - Period 2||0
103716|NCT01226043|247719|P3|COMPLETED|4-week Crossover Phase - Period 2||0
103717|NCT01226043|247720|P2|COMPLETED|4-week Crossover Phase - Period 2|22 patients were not re-randomized to the second phase of the study|188
103718|NCT01226043|247721|P1|COMPLETED|4-week Crossover Phase - Period 2|28 patients were not re-randomized to the second phase of the study|195
103719|NCT01226043|247718|P4|TREATED|4-week Crossover Phase - Period 2||0
103720|NCT01226043|247719|P3|TREATED|4-week Crossover Phase - Period 2||0
103721|NCT01226043|247720|P2|TREATED|4-week Crossover Phase - Period 2||194
103722|NCT01226043|247721|P1|TREATED|4-week Crossover Phase - Period 2||199
103723|NCT01226043|247718|P4|STARTED|4-week Crossover Phase - Period 2||0
103724|NCT01226043|247719|P3|STARTED|4-week Crossover Phase - Period 2||0
103725|NCT01226043|247720|P2|STARTED|4-week Crossover Phase - Period 2||194
103726|NCT01226043|247721|P1|STARTED|4-week Crossover Phase - Period 2||199
103727|NCT01226043|247718|P4|NOT COMPLETED|4-week Crossover Phase - Period 1||0
103728|NCT01226043|247719|P3|NOT COMPLETED|4-week Crossover Phase - Period 1||0
103729|NCT01226043|247720|P2|NOT COMPLETED|4-week Crossover Phase - Period 1||9
103730|NCT01226043|247721|P1|NOT COMPLETED|4-week Crossover Phase - Period 1||3
103731|NCT01226043|247718|P4|COMPLETED|4-week Crossover Phase - Period 1||0
103732|NCT01226043|247719|P3|COMPLETED|4-week Crossover Phase - Period 1||0
103733|NCT01226043|247720|P2|COMPLETED|4-week Crossover Phase - Period 1||194
103734|NCT01226043|247721|P1|COMPLETED|4-week Crossover Phase - Period 1||199
103735|NCT01226043|247718|P4|TREATED|4-week Crossover Phase - Period 1||0
103736|NCT01226043|247719|P3|TREATED|4-week Crossover Phase - Period 1||0
103737|NCT01226043|247720|P2|TREATED|4-week Crossover Phase - Period 1||200
103738|NCT01226043|247721|P1|TREATED|4-week Crossover Phase - Period 1||202
103739|NCT01226043|247718|P4|STARTED|4-week Crossover Phase - Period 1||0
103740|NCT01226043|247719|P3|STARTED|4-week Crossover Phase - Period 1||0
103741|NCT01226043|247720|P2|STARTED|4-week Crossover Phase - Period 1||203
103742|NCT01226043|247721|P1|STARTED|4-week Crossover Phase - Period 1||202
103743|NCT01225991|247759|P1|NOT COMPLETED|Overall Study||6
103744|NCT01225991|247759|P1|COMPLETED|Overall Study||12
103745|NCT01225991|247759|P1|STARTED|Overall Study||18
103746|NCT01225952|247766|P3|NOT COMPLETED|Overall Study||6
103747|NCT01225952|247767|P2|NOT COMPLETED|Overall Study||4
103748|NCT01225952|247768|P1|NOT COMPLETED|Overall Study||6
103749|NCT01225952|247766|P3|COMPLETED|Overall Study||25
103750|NCT01225952|247767|P2|COMPLETED|Overall Study||27
103751|NCT01225952|247768|P1|COMPLETED|Overall Study||25
103752|NCT01225952|247766|P3|STARTED|Overall Study||31
103753|NCT01225952|247767|P2|STARTED|Overall Study||31
103754|NCT01225952|247768|P1|STARTED|Overall Study||31
103755|NCT01225926|247853|P2|NOT COMPLETED|Overall Study||0
103756|NCT01225926|247854|P1|NOT COMPLETED|Overall Study||0
103757|NCT01225926|247853|P2|COMPLETED|Overall Study||12
103758|NCT01225926|247854|P1|COMPLETED|Overall Study||12
103759|NCT01225926|247853|P2|STARTED|Overall Study||12
103760|NCT01225926|247854|P1|STARTED|Overall Study||12
103761|NCT01225835|247862|P2|NOT COMPLETED|Overall Study||3
103762|NCT01225835|247863|P1|NOT COMPLETED|Overall Study||7
103763|NCT01225835|247862|P2|COMPLETED|Overall Study|hCG criterion met|59
103764|NCT01225835|247863|P1|COMPLETED|Overall Study|hCG criterion met|55
103765|NCT01225835|247862|P2|Per Protocol Population|Overall Study||58
103766|NCT01225835|247863|P1|Per Protocol Population|Overall Study||48
103767|NCT01225835|247862|P2|STARTED|Overall Study||62
103768|NCT01225835|247863|P1|STARTED|Overall Study||62
103769|NCT01225822|247911|P5|NOT COMPLETED|Overall Study||31
103770|NCT01225822|247912|P4|NOT COMPLETED|Overall Study||52
103771|NCT01225822|247913|P3|NOT COMPLETED|Overall Study||38
103772|NCT01225822|247914|P2|NOT COMPLETED|Overall Study||56
103773|NCT01225822|247915|P1|NOT COMPLETED|Overall Study||38
103774|NCT01225822|247911|P5|COMPLETED|Overall Study||361
103775|NCT01225822|247912|P4|COMPLETED|Overall Study||333
103776|NCT01225822|247913|P3|COMPLETED|Overall Study||355
103777|NCT01225822|247914|P2|COMPLETED|Overall Study||334
103778|NCT01225822|247915|P1|COMPLETED|Overall Study||351
103779|NCT01225822|247911|P5|STARTED|Overall Study||392
103780|NCT01225822|247912|P4|STARTED|Overall Study||385
103781|NCT01225822|247913|P3|STARTED|Overall Study||393
103782|NCT01225822|247914|P2|STARTED|Overall Study||390
103783|NCT01225822|247915|P1|STARTED|Overall Study||389
103784|NCT01225731|247982|P13|NOT COMPLETED|Part 3||7
103785|NCT01225731|247983|P12|NOT COMPLETED|Part 3||10
103786|NCT01225731|247984|P11|NOT COMPLETED|Part 3||6
103787|NCT01225731|247985|P10|NOT COMPLETED|Part 3||0
103788|NCT01225731|247986|P9|NOT COMPLETED|Part 3||0
103789|NCT01225731|247987|P8|NOT COMPLETED|Part 3||0
103790|NCT01225731|247988|P7|NOT COMPLETED|Part 3||0
103791|NCT01225731|247989|P6|NOT COMPLETED|Part 3||0
103792|NCT01225731|247990|P5|NOT COMPLETED|Part 3||0
103793|NCT01225731|247991|P4|NOT COMPLETED|Part 3||0
103794|NCT01225731|247992|P3|NOT COMPLETED|Part 3||0
103795|NCT01225731|247993|P2|NOT COMPLETED|Part 3||0
103796|NCT01225731|247994|P1|NOT COMPLETED|Part 3||0
103797|NCT01225731|247982|P13|COMPLETED|Part 3||60
103798|NCT01225731|247983|P12|COMPLETED|Part 3||116
103799|NCT01225731|247984|P11|COMPLETED|Part 3||80
103800|NCT01225731|247985|P10|COMPLETED|Part 3||10
103801|NCT01225731|247986|P9|COMPLETED|Part 3||0
103802|NCT01225731|247987|P8|COMPLETED|Part 3||0
103803|NCT01225731|247988|P7|COMPLETED|Part 3||0
103804|NCT01225731|247989|P6|COMPLETED|Part 3||0
103805|NCT01225731|247990|P5|COMPLETED|Part 3||0
103806|NCT01225731|247991|P4|COMPLETED|Part 3||0
103807|NCT01225731|247992|P3|COMPLETED|Part 3||0
103808|NCT01225731|247993|P2|COMPLETED|Part 3||0
103809|NCT01225731|247994|P1|COMPLETED|Part 3||0
103810|NCT01225731|247982|P13|STARTED|Part 3|Not all participants entered follow-up|67
103811|NCT01225731|247983|P12|STARTED|Part 3|Not all participants entered follow-up|126
103812|NCT01225731|247984|P11|STARTED|Part 3|Not all participants entered follow-up|86
103813|NCT01225731|247985|P10|STARTED|Part 3|Not all participants entered follow-up|10
103814|NCT01225731|247986|P9|STARTED|Part 3|Participants could enter the follow-up period|0
103815|NCT01225731|247987|P8|STARTED|Part 3|Participants could enter the follow-up period|0
103816|NCT01225731|247988|P7|STARTED|Part 3|Participants could enter the follow-up period|0
103817|NCT01225731|247989|P6|STARTED|Part 3|Participants could enter the follow-up period|0
103818|NCT01225731|247990|P5|STARTED|Part 3||0
103819|NCT01225731|247991|P4|STARTED|Part 3||0
103820|NCT01225731|247992|P3|STARTED|Part 3||0
103821|NCT01225731|247993|P2|STARTED|Part 3||0
103822|NCT01225731|247994|P1|STARTED|Part 3||0
103823|NCT01225731|247982|P13|NOT COMPLETED|Part 2||0
103824|NCT01225731|247983|P12|NOT COMPLETED|Part 2||0
103825|NCT01225731|247984|P11|NOT COMPLETED|Part 2||0
103826|NCT01225731|247985|P10|NOT COMPLETED|Part 2||0
103827|NCT01225731|247986|P9|NOT COMPLETED|Part 2||11
103828|NCT01225731|247987|P8|NOT COMPLETED|Part 2||25
103829|NCT01225731|247988|P7|NOT COMPLETED|Part 2||8
103830|NCT01225731|247989|P6|NOT COMPLETED|Part 2||3
103831|NCT01225731|247990|P5|NOT COMPLETED|Part 2||0
103832|NCT01225731|247991|P4|NOT COMPLETED|Part 2||0
103833|NCT01225731|247992|P3|NOT COMPLETED|Part 2||0
103834|NCT01225731|247993|P2|NOT COMPLETED|Part 2||0
103835|NCT01225731|247994|P1|NOT COMPLETED|Part 2||0
103836|NCT01225731|247982|P13|COMPLETED|Part 2||0
103837|NCT01225731|247983|P12|COMPLETED|Part 2||0
103838|NCT01225731|247984|P11|COMPLETED|Part 2||0
103839|NCT01225731|247985|P10|COMPLETED|Part 2||0
103840|NCT01225731|247986|P9|COMPLETED|Part 2||68
103841|NCT01225731|247987|P8|COMPLETED|Part 2||128
103842|NCT01225731|247988|P7|COMPLETED|Part 2||86
103843|NCT01225731|247989|P6|COMPLETED|Part 2||10
103844|NCT01225731|247990|P5|COMPLETED|Part 2||0
103845|NCT01225731|247991|P4|COMPLETED|Part 2||0
103846|NCT01225731|247992|P3|COMPLETED|Part 2||0
103847|NCT01225731|247993|P2|COMPLETED|Part 2||0
103848|NCT01225731|247994|P1|COMPLETED|Part 2||0
103849|NCT01225731|247982|P13|STARTED|Part 2||0
103850|NCT01225731|247983|P12|STARTED|Part 2||0
103851|NCT01225731|247984|P11|STARTED|Part 2||0
103852|NCT01225731|247985|P10|STARTED|Part 2||0
103853|NCT01225731|247986|P9|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|79
103854|NCT01225731|247987|P8|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|153
103855|NCT01225731|247988|P7|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|94
103856|NCT01225731|247989|P6|STARTED|Part 2|Participants were reassigned based on PASI score at Week 16|13
103857|NCT01225731|247990|P5|STARTED|Part 2|Participants could progress into Part 2; no placebo was given in Part 2|0
103858|NCT01225731|247991|P4|STARTED|Part 2|Participants could progress into Part 2|0
103859|NCT01225731|247992|P3|STARTED|Part 2|Participants could progress into Part 2|0
103860|NCT01225731|247993|P2|STARTED|Part 2|Participants could progress into Part 2|0
103861|NCT01225731|247994|P1|STARTED|Part 2|Participants could progress into Part 2|0
103862|NCT01225731|247982|P13|NOT COMPLETED|Part 1||0
103863|NCT01225731|247983|P12|NOT COMPLETED|Part 1||0
103864|NCT01225731|247984|P11|NOT COMPLETED|Part 1||0
103865|NCT01225731|247985|P10|NOT COMPLETED|Part 1||0
103866|NCT01225731|247986|P9|NOT COMPLETED|Part 1||0
103867|NCT01225731|247987|P8|NOT COMPLETED|Part 1||0
103868|NCT01225731|247988|P7|NOT COMPLETED|Part 1||0
103869|NCT01225731|247989|P6|NOT COMPLETED|Part 1||0
103870|NCT01225731|247990|P5|NOT COMPLETED|Part 1||6
103871|NCT01225731|247991|P4|NOT COMPLETED|Part 1||2
103872|NCT01225731|247992|P3|NOT COMPLETED|Part 1||1
103873|NCT01225731|247993|P2|NOT COMPLETED|Part 1||5
103874|NCT01225731|247994|P1|NOT COMPLETED|Part 1||2
103875|NCT01225731|247982|P13|COMPLETED|Part 1||0
103876|NCT01225731|247983|P12|COMPLETED|Part 1||0
103877|NCT01225731|247984|P11|COMPLETED|Part 1||0
103878|NCT01225731|247985|P10|COMPLETED|Part 1||0
103879|NCT01225731|247986|P9|COMPLETED|Part 1||0
103880|NCT01225731|247987|P8|COMPLETED|Part 1||0
103881|NCT01225731|247988|P7|COMPLETED|Part 1||0
103882|NCT01225731|247989|P6|COMPLETED|Part 1||0
103883|NCT01225731|247990|P5|COMPLETED|Part 1||40
103884|NCT01225731|247991|P4|COMPLETED|Part 1||84
103885|NCT01225731|247992|P3|COMPLETED|Part 1||88
103886|NCT01225731|247993|P2|COMPLETED|Part 1||87
103887|NCT01225731|247994|P1|COMPLETED|Part 1||40
103888|NCT01225731|247982|P13|STARTED|Part 1||0
103889|NCT01225731|247983|P12|STARTED|Part 1||0
103890|NCT01225731|247984|P11|STARTED|Part 1||0
103891|NCT01225731|247985|P10|STARTED|Part 1||0
103892|NCT01225731|247986|P9|STARTED|Part 1||0
103893|NCT01225731|247987|P8|STARTED|Part 1||0
103894|NCT01225731|247988|P7|STARTED|Part 1||0
103895|NCT01225731|247989|P6|STARTED|Part 1||0
103896|NCT01225731|247990|P5|STARTED|Part 1||46
103897|NCT01225731|247991|P4|STARTED|Part 1||86
103898|NCT01225731|247992|P3|STARTED|Part 1||89
103899|NCT01225731|247993|P2|STARTED|Part 1||92
103900|NCT01225731|247994|P1|STARTED|Part 1||42
103901|NCT01225562|248089|P3|NOT COMPLETED|Overall Study||53
103902|NCT01225562|248090|P2|NOT COMPLETED|Overall Study||56
103903|NCT01225562|248091|P1|NOT COMPLETED|Overall Study||55
103904|NCT01225562|248089|P3|COMPLETED|Overall Study||7014
103905|NCT01225562|248090|P2|COMPLETED|Overall Study||6989
103906|NCT01225562|248091|P1|COMPLETED|Overall Study||6995
103907|NCT01225562|248089|P3|STARTED|Overall Study||7067
103908|NCT01225562|248090|P2|STARTED|Overall Study||7045
103909|NCT01225562|248091|P1|STARTED|Overall Study||7050
103910|NCT01225549|248108|P10|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103911|NCT01225549|248109|P9|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103912|NCT01225549|248110|P8|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103913|NCT01225549|248111|P7|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103914|NCT01225549|248112|P6|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103915|NCT01225549|248113|P5|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103916|NCT01225549|248114|P4|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103917|NCT01225549|248115|P3|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103918|NCT01225549|248116|P2|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103919|NCT01225549|248117|P1|NOT COMPLETED|Period 7 - Fourth Treatment Period||0
103920|NCT01225549|248108|P10|COMPLETED|Period 7 - Fourth Treatment Period||1
103921|NCT01225549|248109|P9|COMPLETED|Period 7 - Fourth Treatment Period||4
103922|NCT01225549|248110|P8|COMPLETED|Period 7 - Fourth Treatment Period||1
103923|NCT01225549|248111|P7|COMPLETED|Period 7 - Fourth Treatment Period||3
103924|NCT01225549|248112|P6|COMPLETED|Period 7 - Fourth Treatment Period||1
103925|NCT01225549|248113|P5|COMPLETED|Period 7 - Fourth Treatment Period||1
103926|NCT01225549|248114|P4|COMPLETED|Period 7 - Fourth Treatment Period||0
103927|NCT01225549|248115|P3|COMPLETED|Period 7 - Fourth Treatment Period||3
103928|NCT01225549|248116|P2|COMPLETED|Period 7 - Fourth Treatment Period||3
103929|NCT01225549|248117|P1|COMPLETED|Period 7 - Fourth Treatment Period||1
103930|NCT01225549|248108|P10|STARTED|Period 7 - Fourth Treatment Period||1
103931|NCT01225549|248109|P9|STARTED|Period 7 - Fourth Treatment Period||4
103932|NCT01225549|248110|P8|STARTED|Period 7 - Fourth Treatment Period||1
103933|NCT01225549|248111|P7|STARTED|Period 7 - Fourth Treatment Period||3
103934|NCT01225549|248112|P6|STARTED|Period 7 - Fourth Treatment Period||1
103935|NCT01225549|248113|P5|STARTED|Period 7 - Fourth Treatment Period||1
103936|NCT01225549|248114|P4|STARTED|Period 7 - Fourth Treatment Period||0
103937|NCT01225549|248115|P3|STARTED|Period 7 - Fourth Treatment Period||3
103938|NCT01225549|248116|P2|STARTED|Period 7 - Fourth Treatment Period||3
103939|NCT01225549|248117|P1|STARTED|Period 7 - Fourth Treatment Period||1
103940|NCT01225549|248108|P10|NOT COMPLETED|Period 6 - Washout||0
103941|NCT01225549|248109|P9|NOT COMPLETED|Period 6 - Washout||0
103942|NCT01225549|248110|P8|NOT COMPLETED|Period 6 - Washout||0
103943|NCT01225549|248111|P7|NOT COMPLETED|Period 6 - Washout||0
103944|NCT01225549|248112|P6|NOT COMPLETED|Period 6 - Washout||0
103945|NCT01225549|248113|P5|NOT COMPLETED|Period 6 - Washout||0
103946|NCT01225549|248114|P4|NOT COMPLETED|Period 6 - Washout||1
103947|NCT01225549|248115|P3|NOT COMPLETED|Period 6 - Washout||0
103948|NCT01225549|248116|P2|NOT COMPLETED|Period 6 - Washout||0
103949|NCT01225549|248117|P1|NOT COMPLETED|Period 6 - Washout||0
103950|NCT01225549|248108|P10|COMPLETED|Period 6 - Washout||1
103951|NCT01225549|248109|P9|COMPLETED|Period 6 - Washout||4
103952|NCT01225549|248110|P8|COMPLETED|Period 6 - Washout||1
103953|NCT01225549|248111|P7|COMPLETED|Period 6 - Washout||3
103954|NCT01225549|248112|P6|COMPLETED|Period 6 - Washout||1
103955|NCT01225549|248113|P5|COMPLETED|Period 6 - Washout||1
103956|NCT01225549|248114|P4|COMPLETED|Period 6 - Washout||0
103957|NCT01225549|248115|P3|COMPLETED|Period 6 - Washout||3
103958|NCT01225549|248116|P2|COMPLETED|Period 6 - Washout||3
103959|NCT01225549|248117|P1|COMPLETED|Period 6 - Washout||1
103960|NCT01225549|248108|P10|STARTED|Period 6 - Washout||1
103961|NCT01225549|248109|P9|STARTED|Period 6 - Washout||4
103962|NCT01225549|248110|P8|STARTED|Period 6 - Washout||1
103963|NCT01225549|248111|P7|STARTED|Period 6 - Washout||3
103964|NCT01225549|248112|P6|STARTED|Period 6 - Washout||1
103965|NCT01225549|248113|P5|STARTED|Period 6 - Washout||1
103966|NCT01225549|248114|P4|STARTED|Period 6 - Washout||1
103967|NCT01225549|248115|P3|STARTED|Period 6 - Washout||3
103968|NCT01225549|248116|P2|STARTED|Period 6 - Washout||3
103969|NCT01225549|248117|P1|STARTED|Period 6 - Washout||1
103970|NCT01225549|248108|P10|NOT COMPLETED|Period 5 - Third Treatment Period||0
103971|NCT01225549|248109|P9|NOT COMPLETED|Period 5 - Third Treatment Period||0
103972|NCT01225549|248110|P8|NOT COMPLETED|Period 5 - Third Treatment Period||0
103973|NCT01225549|248111|P7|NOT COMPLETED|Period 5 - Third Treatment Period||0
103974|NCT01225549|248112|P6|NOT COMPLETED|Period 5 - Third Treatment Period||0
103975|NCT01225549|248113|P5|NOT COMPLETED|Period 5 - Third Treatment Period||0
103976|NCT01225549|248114|P4|NOT COMPLETED|Period 5 - Third Treatment Period||0
103977|NCT01225549|248115|P3|NOT COMPLETED|Period 5 - Third Treatment Period||0
103978|NCT01225549|248116|P2|NOT COMPLETED|Period 5 - Third Treatment Period||0
103979|NCT01225549|248117|P1|NOT COMPLETED|Period 5 - Third Treatment Period||0
103980|NCT01225549|248108|P10|COMPLETED|Period 5 - Third Treatment Period||1
103981|NCT01225549|248109|P9|COMPLETED|Period 5 - Third Treatment Period||4
103982|NCT01225549|248110|P8|COMPLETED|Period 5 - Third Treatment Period||1
103983|NCT01225549|248111|P7|COMPLETED|Period 5 - Third Treatment Period||3
103984|NCT01225549|248112|P6|COMPLETED|Period 5 - Third Treatment Period||1
103985|NCT01225549|248113|P5|COMPLETED|Period 5 - Third Treatment Period||1
103986|NCT01225549|248114|P4|COMPLETED|Period 5 - Third Treatment Period||1
103987|NCT01225549|248115|P3|COMPLETED|Period 5 - Third Treatment Period||3
103988|NCT01225549|248116|P2|COMPLETED|Period 5 - Third Treatment Period||3
103989|NCT01225549|248117|P1|COMPLETED|Period 5 - Third Treatment Period||1
103990|NCT01225549|248108|P10|STARTED|Period 5 - Third Treatment Period||1
103991|NCT01225549|248109|P9|STARTED|Period 5 - Third Treatment Period||4
103992|NCT01225549|248110|P8|STARTED|Period 5 - Third Treatment Period||1
103993|NCT01225549|248111|P7|STARTED|Period 5 - Third Treatment Period||3
103994|NCT01225549|248112|P6|STARTED|Period 5 - Third Treatment Period||1
103995|NCT01225549|248113|P5|STARTED|Period 5 - Third Treatment Period||1
103996|NCT01225549|248114|P4|STARTED|Period 5 - Third Treatment Period||1
103997|NCT01225549|248115|P3|STARTED|Period 5 - Third Treatment Period||3
103998|NCT01225549|248116|P2|STARTED|Period 5 - Third Treatment Period||3
103999|NCT01225549|248117|P1|STARTED|Period 5 - Third Treatment Period||1
104000|NCT01225549|248108|P10|NOT COMPLETED|Period 4 - Washout||0
104001|NCT01225549|248109|P9|NOT COMPLETED|Period 4 - Washout||0
104002|NCT01225549|248110|P8|NOT COMPLETED|Period 4 - Washout||0
104003|NCT01225549|248111|P7|NOT COMPLETED|Period 4 - Washout||0
104004|NCT01225549|248112|P6|NOT COMPLETED|Period 4 - Washout||0
104005|NCT01225549|248113|P5|NOT COMPLETED|Period 4 - Washout||0
104006|NCT01225549|248114|P4|NOT COMPLETED|Period 4 - Washout||0
104007|NCT01225549|248115|P3|NOT COMPLETED|Period 4 - Washout||0
104008|NCT01225549|248116|P2|NOT COMPLETED|Period 4 - Washout||1
104009|NCT01225549|248117|P1|NOT COMPLETED|Period 4 - Washout||0
104010|NCT01225549|248108|P10|COMPLETED|Period 4 - Washout||1
104011|NCT01225549|248109|P9|COMPLETED|Period 4 - Washout||4
104012|NCT01225549|248110|P8|COMPLETED|Period 4 - Washout||1
104013|NCT01225549|248111|P7|COMPLETED|Period 4 - Washout||3
104014|NCT01225549|248112|P6|COMPLETED|Period 4 - Washout||1
104015|NCT01225549|248113|P5|COMPLETED|Period 4 - Washout||1
104016|NCT01225549|248114|P4|COMPLETED|Period 4 - Washout||1
104017|NCT01225549|248115|P3|COMPLETED|Period 4 - Washout||3
104018|NCT01225549|248116|P2|COMPLETED|Period 4 - Washout||3
104019|NCT01225549|248117|P1|COMPLETED|Period 4 - Washout||1
104020|NCT01225549|248108|P10|STARTED|Period 4 - Washout||1
104021|NCT01225549|248109|P9|STARTED|Period 4 - Washout||4
104022|NCT01225549|248110|P8|STARTED|Period 4 - Washout||1
104023|NCT01225549|248111|P7|STARTED|Period 4 - Washout||3
104024|NCT01225549|248112|P6|STARTED|Period 4 - Washout||1
104025|NCT01225549|248113|P5|STARTED|Period 4 - Washout||1
104026|NCT01225549|248114|P4|STARTED|Period 4 - Washout||1
104027|NCT01225549|248115|P3|STARTED|Period 4 - Washout||3
104028|NCT01225549|248116|P2|STARTED|Period 4 - Washout||4
104029|NCT01225549|248117|P1|STARTED|Period 4 - Washout||1
104030|NCT01225549|248108|P10|NOT COMPLETED|Period 3 - Second Treatment Period||0
104031|NCT01225549|248109|P9|NOT COMPLETED|Period 3 - Second Treatment Period||0
104032|NCT01225549|248110|P8|NOT COMPLETED|Period 3 - Second Treatment Period||0
104033|NCT01225549|248111|P7|NOT COMPLETED|Period 3 - Second Treatment Period||0
104034|NCT01225549|248112|P6|NOT COMPLETED|Period 3 - Second Treatment Period||0
104035|NCT01225549|248113|P5|NOT COMPLETED|Period 3 - Second Treatment Period||0
104036|NCT01225549|248114|P4|NOT COMPLETED|Period 3 - Second Treatment Period||0
104037|NCT01225549|248115|P3|NOT COMPLETED|Period 3 - Second Treatment Period||0
104038|NCT01225549|248116|P2|NOT COMPLETED|Period 3 - Second Treatment Period||0
104039|NCT01225549|248117|P1|NOT COMPLETED|Period 3 - Second Treatment Period||0
104040|NCT01225549|248108|P10|COMPLETED|Period 3 - Second Treatment Period||1
104041|NCT01225549|248109|P9|COMPLETED|Period 3 - Second Treatment Period||4
104042|NCT01225549|248110|P8|COMPLETED|Period 3 - Second Treatment Period||1
104043|NCT01225549|248111|P7|COMPLETED|Period 3 - Second Treatment Period||3
104044|NCT01225549|248112|P6|COMPLETED|Period 3 - Second Treatment Period||1
104045|NCT01225549|248113|P5|COMPLETED|Period 3 - Second Treatment Period||1
104046|NCT01225549|248114|P4|COMPLETED|Period 3 - Second Treatment Period||1
104047|NCT01225549|248115|P3|COMPLETED|Period 3 - Second Treatment Period||3
104048|NCT01225549|248116|P2|COMPLETED|Period 3 - Second Treatment Period||4
104049|NCT01225549|248117|P1|COMPLETED|Period 3 - Second Treatment Period||1
104050|NCT01225549|248108|P10|STARTED|Period 3 - Second Treatment Period||1
104051|NCT01225549|248109|P9|STARTED|Period 3 - Second Treatment Period||4
104052|NCT01225549|248110|P8|STARTED|Period 3 - Second Treatment Period||1
104053|NCT01225549|248111|P7|STARTED|Period 3 - Second Treatment Period||3
104054|NCT01225549|248112|P6|STARTED|Period 3 - Second Treatment Period||1
104055|NCT01225549|248113|P5|STARTED|Period 3 - Second Treatment Period||1
104056|NCT01225549|248114|P4|STARTED|Period 3 - Second Treatment Period||1
104057|NCT01225549|248115|P3|STARTED|Period 3 - Second Treatment Period||3
104058|NCT01225549|248116|P2|STARTED|Period 3 - Second Treatment Period||4
104059|NCT01225549|248117|P1|STARTED|Period 3 - Second Treatment Period||1
104060|NCT01225549|248108|P10|NOT COMPLETED|Period 2 - Washout||0
104061|NCT01225549|248109|P9|NOT COMPLETED|Period 2 - Washout||0
104062|NCT01225549|248110|P8|NOT COMPLETED|Period 2 - Washout||0
104063|NCT01225549|248111|P7|NOT COMPLETED|Period 2 - Washout||0
104064|NCT01225549|248112|P6|NOT COMPLETED|Period 2 - Washout||0
104065|NCT01225549|248113|P5|NOT COMPLETED|Period 2 - Washout||0
104066|NCT01225549|248114|P4|NOT COMPLETED|Period 2 - Washout||0
104067|NCT01225549|248115|P3|NOT COMPLETED|Period 2 - Washout||0
104068|NCT01225549|248116|P2|NOT COMPLETED|Period 2 - Washout||0
104069|NCT01225549|248117|P1|NOT COMPLETED|Period 2 - Washout||0
104070|NCT01225549|248108|P10|COMPLETED|Period 2 - Washout||1
104071|NCT01225549|248109|P9|COMPLETED|Period 2 - Washout||4
104072|NCT01225549|248110|P8|COMPLETED|Period 2 - Washout||1
104073|NCT01225549|248111|P7|COMPLETED|Period 2 - Washout||3
104074|NCT01225549|248112|P6|COMPLETED|Period 2 - Washout||1
104075|NCT01225549|248113|P5|COMPLETED|Period 2 - Washout||1
104076|NCT01225549|248114|P4|COMPLETED|Period 2 - Washout||1
104077|NCT01225549|248115|P3|COMPLETED|Period 2 - Washout||3
104078|NCT01225549|248116|P2|COMPLETED|Period 2 - Washout||4
104079|NCT01225549|248117|P1|COMPLETED|Period 2 - Washout||1
104080|NCT01225549|248108|P10|STARTED|Period 2 - Washout||1
104081|NCT01225549|248109|P9|STARTED|Period 2 - Washout||4
104082|NCT01225549|248110|P8|STARTED|Period 2 - Washout||1
104083|NCT01225549|248111|P7|STARTED|Period 2 - Washout||3
104084|NCT01225549|248112|P6|STARTED|Period 2 - Washout||1
104085|NCT01225549|248113|P5|STARTED|Period 2 - Washout||1
104086|NCT01225549|248114|P4|STARTED|Period 2 - Washout||1
104087|NCT01225549|248115|P3|STARTED|Period 2 - Washout||3
104088|NCT01225549|248116|P2|STARTED|Period 2 - Washout||4
104089|NCT01225549|248117|P1|STARTED|Period 2 - Washout||1
104090|NCT01225549|248108|P10|NOT COMPLETED|Period 1 - First Treatment Period||0
104091|NCT01225549|248109|P9|NOT COMPLETED|Period 1 - First Treatment Period||0
104092|NCT01225549|248110|P8|NOT COMPLETED|Period 1 - First Treatment Period||0
104093|NCT01225549|248111|P7|NOT COMPLETED|Period 1 - First Treatment Period||0
104094|NCT01225549|248112|P6|NOT COMPLETED|Period 1 - First Treatment Period||0
104095|NCT01225549|248113|P5|NOT COMPLETED|Period 1 - First Treatment Period||0
104096|NCT01225549|248114|P4|NOT COMPLETED|Period 1 - First Treatment Period||0
104097|NCT01225549|248115|P3|NOT COMPLETED|Period 1 - First Treatment Period||0
104098|NCT01225549|248116|P2|NOT COMPLETED|Period 1 - First Treatment Period||0
104099|NCT01225549|248117|P1|NOT COMPLETED|Period 1 - First Treatment Period||0
104100|NCT01225549|248108|P10|COMPLETED|Period 1 - First Treatment Period||1
104101|NCT01225549|248109|P9|COMPLETED|Period 1 - First Treatment Period||4
104102|NCT01225549|248110|P8|COMPLETED|Period 1 - First Treatment Period||1
104103|NCT01225549|248111|P7|COMPLETED|Period 1 - First Treatment Period||3
104104|NCT01225549|248112|P6|COMPLETED|Period 1 - First Treatment Period||1
104105|NCT01225549|248113|P5|COMPLETED|Period 1 - First Treatment Period||1
104106|NCT01225549|248114|P4|COMPLETED|Period 1 - First Treatment Period||1
104107|NCT01225549|248115|P3|COMPLETED|Period 1 - First Treatment Period||3
104108|NCT01225549|248116|P2|COMPLETED|Period 1 - First Treatment Period||4
104109|NCT01225549|248117|P1|COMPLETED|Period 1 - First Treatment Period||1
104110|NCT01225549|248108|P10|STARTED|Period 1 - First Treatment Period||1
104111|NCT01225549|248109|P9|STARTED|Period 1 - First Treatment Period||4
104112|NCT01225549|248110|P8|STARTED|Period 1 - First Treatment Period||1
104113|NCT01225549|248111|P7|STARTED|Period 1 - First Treatment Period||3
104114|NCT01225549|248112|P6|STARTED|Period 1 - First Treatment Period||1
104115|NCT01225549|248113|P5|STARTED|Period 1 - First Treatment Period||1
104116|NCT01225549|248114|P4|STARTED|Period 1 - First Treatment Period||1
104117|NCT01225549|248115|P3|STARTED|Period 1 - First Treatment Period||3
104118|NCT01225549|248116|P2|STARTED|Period 1 - First Treatment Period||4
104119|NCT01225549|248117|P1|STARTED|Period 1 - First Treatment Period||1
104120|NCT01225354|248159|P1|NOT COMPLETED|Overall Study||1
104121|NCT01225354|248159|P1|COMPLETED|Overall Study||19
104122|NCT01225354|248159|P1|STARTED|Overall Study||20
104123|NCT01225289|248166|P2|NOT COMPLETED|Overall Study||1
104124|NCT01225289|248167|P1|NOT COMPLETED|Overall Study||0
104125|NCT01225289|248166|P2|COMPLETED|Overall Study||17
104126|NCT01225289|248167|P1|COMPLETED|Overall Study||18
104127|NCT01225289|248166|P2|STARTED|Overall Study||18
104128|NCT01225289|248167|P1|STARTED|Overall Study||18
104129|NCT01225263|248181|P2|NOT COMPLETED|Weeks 13 to 24||1
104130|NCT01225263|248182|P1|NOT COMPLETED|Weeks 13 to 24||4
104131|NCT01225263|248181|P2|COMPLETED|Weeks 13 to 24||28
104132|NCT01225263|248182|P1|COMPLETED|Weeks 13 to 24||24
104133|NCT01225263|248181|P2|STARTED|Weeks 13 to 24||29
104134|NCT01225263|248182|P1|STARTED|Weeks 13 to 24||28
104135|NCT01225263|248181|P2|NOT COMPLETED|Weeks 1 to 12||0
104136|NCT01225263|248182|P1|NOT COMPLETED|Weeks 1 to 12||0
104137|NCT01225263|248181|P2|COMPLETED|Weeks 1 to 12||29
104138|NCT01225263|248182|P1|COMPLETED|Weeks 1 to 12||28
104139|NCT01225263|248181|P2|STARTED|Weeks 1 to 12||29
104140|NCT01225263|248182|P1|STARTED|Weeks 1 to 12||28
104141|NCT01225211|248200|P10|NOT COMPLETED|Overall Study||5
104142|NCT01225211|248201|P9|NOT COMPLETED|Overall Study||1
104143|NCT01225211|248202|P8|NOT COMPLETED|Overall Study||0
104144|NCT01225211|248203|P7|NOT COMPLETED|Overall Study||1
104145|NCT01225211|248204|P6|NOT COMPLETED|Overall Study||0
104146|NCT01225211|248205|P5|NOT COMPLETED|Overall Study||0
104147|NCT01225211|248206|P4|NOT COMPLETED|Overall Study||0
104148|NCT01225211|248207|P3|NOT COMPLETED|Overall Study||1
104149|NCT01225211|248208|P2|NOT COMPLETED|Overall Study||0
104150|NCT01225211|248209|P1|NOT COMPLETED|Overall Study||0
104151|NCT01225211|248200|P10|COMPLETED|Overall Study||57
104152|NCT01225211|248201|P9|COMPLETED|Overall Study||62
104153|NCT01225211|248202|P8|COMPLETED|Overall Study||11
104154|NCT01225211|248203|P7|COMPLETED|Overall Study||41
104155|NCT01225211|248204|P6|COMPLETED|Overall Study||21
104156|NCT01225211|248205|P5|COMPLETED|Overall Study||23
104157|NCT01225211|248206|P4|COMPLETED|Overall Study||27
104158|NCT01225211|248207|P3|COMPLETED|Overall Study||20
104159|NCT01225211|248208|P2|COMPLETED|Overall Study||20
104160|NCT01225211|248209|P1|COMPLETED|Overall Study||21
104161|NCT01225211|248200|P10|STARTED|Overall Study||62
104162|NCT01225211|248201|P9|STARTED|Overall Study||63
104163|NCT01225211|248202|P8|STARTED|Overall Study||11
104164|NCT01225211|248203|P7|STARTED|Overall Study||42
104165|NCT01225211|248204|P6|STARTED|Overall Study||21
104166|NCT01225211|248205|P5|STARTED|Overall Study||23
104167|NCT01225211|248206|P4|STARTED|Overall Study||27
104168|NCT01225211|248207|P3|STARTED|Overall Study||21
104169|NCT01225211|248208|P2|STARTED|Overall Study||20
104170|NCT01225211|248209|P1|STARTED|Overall Study||21
104171|NCT01225159|248312|P2|NOT COMPLETED|Overall Study||0
104172|NCT01225159|248313|P1|NOT COMPLETED|Overall Study||1
104173|NCT01225159|248312|P2|COMPLETED|Overall Study||100
104174|NCT01225159|248313|P1|COMPLETED|Overall Study||99
104175|NCT01225159|248312|P2|STARTED|Overall Study||100
104176|NCT01225159|248313|P1|STARTED|Overall Study||100
104177|NCT01225146|248323|P2|NOT COMPLETED|Overall Study||2
104178|NCT01225146|248324|P1|NOT COMPLETED|Overall Study||0
104179|NCT01225146|248323|P2|COMPLETED|Overall Study||0
104180|NCT01225146|248324|P1|COMPLETED|Overall Study||6
104181|NCT01225146|248323|P2|STARTED|Overall Study||2
104182|NCT01225146|248324|P1|STARTED|Overall Study||6
104183|NCT01225068|248342|P2|NOT COMPLETED|Overall Study||1
104184|NCT01225068|248343|P1|NOT COMPLETED|Overall Study||4
104185|NCT01225068|248342|P2|COMPLETED|Overall Study||19
104186|NCT01225068|248343|P1|COMPLETED|Overall Study||16
104187|NCT01225068|248342|P2|STARTED|Overall Study||20
104188|NCT01225068|248343|P1|STARTED|Overall Study||20
104189|NCT01225055|248352|P3|NOT COMPLETED|Overall Study||3
104190|NCT01225055|248353|P2|NOT COMPLETED|Overall Study||2
104191|NCT01225055|248354|P1|NOT COMPLETED|Overall Study||0
104192|NCT01225055|248352|P3|COMPLETED|Overall Study||18
104193|NCT01225055|248353|P2|COMPLETED|Overall Study||18
104194|NCT01225055|248354|P1|COMPLETED|Overall Study||20
104195|NCT01225055|248352|P3|STARTED|Overall Study||21
104196|NCT01225055|248353|P2|STARTED|Overall Study||20
104197|NCT01225055|248354|P1|STARTED|Overall Study||20
104198|NCT01225029|248379|P2|NOT COMPLETED|Overall Study||0
104199|NCT01225029|248380|P1|NOT COMPLETED|Overall Study||0
104200|NCT01225029|248379|P2|COMPLETED|Overall Study||32
104201|NCT01225029|248380|P1|COMPLETED|Overall Study||32
104202|NCT01225029|248379|P2|STARTED|Overall Study||32
104203|NCT01225029|248380|P1|STARTED|Overall Study||32
104204|NCT01224821|248390|P1|NOT COMPLETED|Long-Term Follow-Up||11
104205|NCT01224821|248390|P1|COMPLETED|Long-Term Follow-Up||0
104206|NCT01224821|248390|P1|STARTED|Long-Term Follow-Up|11/47 participants withdrawing from this study enrolled in the LTFU study for continued evaluation.|11
104207|NCT01224821|248390|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||46
104208|NCT01224821|248390|P1|COMPLETED|Dosimetric and Therapeutic Treatment|This participant completed the study per Protocol Amendment 2.|1
104209|NCT01224821|248390|P1|STARTED|Dosimetric and Therapeutic Treatment||47
104210|NCT01224782|248409|P1|NOT COMPLETED|Overall Study||264
104211|NCT01224782|248409|P1|COMPLETED|Overall Study||730
104212|NCT01224782|248409|P1|STARTED|Overall Study||994
104213|NCT01224639|248426|P8|NOT COMPLETED|Overall Study||2
104214|NCT01224639|248427|P7|NOT COMPLETED|Overall Study||1
104215|NCT01224639|248428|P6|NOT COMPLETED|Overall Study||0
104216|NCT01224639|248429|P5|NOT COMPLETED|Overall Study||2
104217|NCT01224639|248430|P4|NOT COMPLETED|Overall Study||0
104218|NCT01224639|248431|P3|NOT COMPLETED|Overall Study||0
104219|NCT01224639|248432|P2|NOT COMPLETED|Overall Study||0
104220|NCT01224639|248433|P1|NOT COMPLETED|Overall Study||0
104221|NCT01224639|248426|P8|COMPLETED|Overall Study||3
104222|NCT01224639|248427|P7|COMPLETED|Overall Study||17
104223|NCT01224639|248428|P6|COMPLETED|Overall Study||4
104224|NCT01224639|248429|P5|COMPLETED|Overall Study||19
104225|NCT01224639|248430|P4|COMPLETED|Overall Study||3
104226|NCT01224639|248431|P3|COMPLETED|Overall Study||21
104227|NCT01224639|248432|P2|COMPLETED|Overall Study||5
104228|NCT01224639|248433|P1|COMPLETED|Overall Study||19
104229|NCT01224639|248426|P8|STARTED|Overall Study||5
104230|NCT01224639|248427|P7|STARTED|Overall Study||18
104231|NCT01224639|248428|P6|STARTED|Overall Study||4
104232|NCT01224639|248429|P5|STARTED|Overall Study||21
104233|NCT01224639|248430|P4|STARTED|Overall Study||3
104234|NCT01224639|248431|P3|STARTED|Overall Study||21
104235|NCT01224639|248432|P2|STARTED|Overall Study||5
104236|NCT01224639|248433|P1|STARTED|Overall Study||19
104237|NCT01224626|248539|P1|NOT COMPLETED|Overall Study||1
104238|NCT01224626|248539|P1|COMPLETED|Overall Study||41
104239|NCT01224626|248539|P1|STARTED|Overall Study||42
104240|NCT01224444|248545|P1|NOT COMPLETED|Overall Study||0
104241|NCT01224444|248545|P1|COMPLETED|Overall Study||269
104242|NCT01224444|248545|P1|STARTED|Overall Study||269
104243|NCT01224431|248551|P2|NOT COMPLETED|Overall Study||5
104244|NCT01224431|248552|P1|NOT COMPLETED|Overall Study||0
104245|NCT01224431|248551|P2|COMPLETED|Overall Study||25
104246|NCT01224431|248552|P1|COMPLETED|Overall Study||30
104247|NCT01224431|248551|P2|STARTED|Overall Study||30
104248|NCT01224431|248552|P1|STARTED|Overall Study||30
104249|NCT01224236|248560|P2|NOT COMPLETED|Overall Study||1
104250|NCT01224236|248561|P1|NOT COMPLETED|Overall Study||1
104251|NCT01224236|248560|P2|COMPLETED|Overall Study||73
104252|NCT01224236|248561|P1|COMPLETED|Overall Study||75
104253|NCT01224236|248560|P2|STARTED|Overall Study||74
104254|NCT01224236|248561|P1|STARTED|Overall Study||76
104255|NCT01224171|248571|P2|NOT COMPLETED|Overall Study||13
104256|NCT01224171|248572|P1|NOT COMPLETED|Overall Study||15
104257|NCT01224171|248571|P2|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|196
104258|NCT01224171|248572|P1|COMPLETED|Overall Study|Completed study is defined as patients who completed the Week 10 assessments.|192
104259|NCT01224171|248571|P2|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|158
104347|NCT01223365|248873|P1|NOT COMPLETED|Open-label Treatment Period||102
104260|NCT01224171|248572|P1|TNFα Antagonist Failure Population|Overall Study|Previously failed (inadequate response, loss of response, or intolerance) TNFα antagonist therapy|157
104261|NCT01224171|248571|P2|STARTED|Overall Study||209
104262|NCT01224171|248572|P1|STARTED|Overall Study||207
104263|NCT01222533|248592|P1|NOT COMPLETED|Overall Study||14
104264|NCT01222533|248592|P1|COMPLETED|Overall Study|Completed planned observation time (week 21)|140
104265|NCT01222533|248592|P1|Received Tio HH18|Overall Study||146
104266|NCT01222533|248592|P1|Received Tio R5|Overall Study||150
104267|NCT01222533|248592|P1|Received Tio R2.5|Overall Study||145
104268|NCT01222533|248592|P1|Received Tio R1.25|Overall Study||147
104269|NCT01222533|248592|P1|Received Placebo|Overall Study||147
104270|NCT01222533|248592|P1|STARTED|Overall Study|Entered and treated.|154
104271|NCT01222520|248731|P2|NOT COMPLETED|Double-blind Period||2
104272|NCT01222520|248732|P1|NOT COMPLETED|Double-blind Period||1
104273|NCT01222520|248731|P2|COMPLETED|Double-blind Period||85
104274|NCT01222520|248732|P1|COMPLETED|Double-blind Period||86
104275|NCT01222520|248731|P2|STARTED|Double-blind Period||87
104276|NCT01222520|248732|P1|STARTED|Double-blind Period||87
104277|NCT01222520|248731|P2|NOT COMPLETED|Open-label run-in Period||23
104278|NCT01222520|248732|P1|NOT COMPLETED|Open-label run-in Period||0
104279|NCT01222520|248731|P2|COMPLETED|Open-label run-in Period||174
104280|NCT01222520|248732|P1|COMPLETED|Open-label run-in Period||0
104281|NCT01222520|248731|P2|STARTED|Open-label run-in Period||197
104282|NCT01222520|248732|P1|STARTED|Open-label run-in Period||0
104283|NCT01222507|248750|P1|NOT COMPLETED|Overall Study||2
104284|NCT01222507|248750|P1|COMPLETED|Overall Study||60
104285|NCT01222507|248750|P1|STARTED|Overall Study||62
104286|NCT01222416|248756|P2|NOT COMPLETED|Overall Study||0
104287|NCT01222416|248757|P1|NOT COMPLETED|Overall Study||20
104288|NCT01222416|248756|P2|COMPLETED|Overall Study||0
104289|NCT01222416|248757|P1|COMPLETED|Overall Study||30
104290|NCT01222416|248756|P2|STARTED|Overall Study||0
104291|NCT01222416|248757|P1|STARTED|Overall Study||50
104292|NCT01224015|248768|P3|NOT COMPLETED|Overall Study||13
104293|NCT01224015|248769|P2|NOT COMPLETED|Overall Study||16
104294|NCT01224015|248770|P1|NOT COMPLETED|Overall Study||14
104295|NCT01224015|248768|P3|COMPLETED|Overall Study||83
104296|NCT01224015|248769|P2|COMPLETED|Overall Study||211
104297|NCT01224015|248770|P1|COMPLETED|Overall Study||347
104298|NCT01224015|248768|P3|STARTED|Overall Study||96
104299|NCT01224015|248769|P2|STARTED|Overall Study||227
104300|NCT01224015|248770|P1|STARTED|Overall Study||361
104301|NCT01223937|248780|P2|NOT COMPLETED|Overall Study||18
104302|NCT01223937|248781|P1|NOT COMPLETED|Overall Study||17
104303|NCT01223937|248780|P2|COMPLETED|Overall Study||119
104304|NCT01223937|248781|P1|COMPLETED|Overall Study||114
104305|NCT01223937|248780|P2|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|135
104306|NCT01223937|248781|P1|Safety Analysis Set (SAS)|Overall Study|SAS: participants with at least one post-treatment safety assessment|126
104307|NCT01223937|248780|P2|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|133
104308|NCT01223937|248781|P1|Full Analysis Set (FAS)|Overall Study|FAS: participants with at least one post-treatment efficacy assessment|128
104309|NCT01223937|248780|P2|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|137
104310|NCT01223937|248781|P1|STARTED|Overall Study|Intent to treat population: randomized participants regardless if they were exposed to treatment.|131
104311|NCT01223703|248805|P2|NOT COMPLETED|Overall Study||0
104312|NCT01223703|248806|P1|NOT COMPLETED|Overall Study||0
104313|NCT01223703|248805|P2|COMPLETED|Overall Study||66
104314|NCT01223703|248806|P1|COMPLETED|Overall Study||67
104315|NCT01223703|248805|P2|STARTED|Overall Study||66
104316|NCT01223703|248806|P1|STARTED|Overall Study||67
104317|NCT01222403|248820|P2|NOT COMPLETED|Overall Study||2
104318|NCT01222403|248821|P1|NOT COMPLETED|Overall Study||0
104319|NCT01222403|248820|P2|COMPLETED|Overall Study||379
104320|NCT01222403|248821|P1|COMPLETED|Overall Study||386
104321|NCT01222403|248820|P2|STARTED|Overall Study||381
104322|NCT01222403|248821|P1|STARTED|Overall Study||386
104323|NCT01222390|248831|P1|NOT COMPLETED|Overall Study||0
104324|NCT01222390|248831|P1|COMPLETED|Overall Study||12
104325|NCT01222390|248831|P1|STARTED|Overall Study||12
104326|NCT01222286|248837|P2|NOT COMPLETED|Overall Study||0
104327|NCT01222286|248838|P1|NOT COMPLETED|Overall Study||0
104328|NCT01222286|248837|P2|COMPLETED|Overall Study||14
104329|NCT01222286|248838|P1|COMPLETED|Overall Study||16
104330|NCT01222286|248837|P2|STARTED|Overall Study||14
104331|NCT01222286|248838|P1|STARTED|Overall Study||16
104332|NCT01222234|248853|P3|NOT COMPLETED|Overall Study||2
104333|NCT01222234|248854|P2|NOT COMPLETED|Overall Study||2
104334|NCT01222234|248855|P1|NOT COMPLETED|Overall Study||0
104335|NCT01222234|248853|P3|COMPLETED|Overall Study||22
104336|NCT01222234|248854|P2|COMPLETED|Overall Study||15
104337|NCT01222234|248855|P1|COMPLETED|Overall Study||15
104338|NCT01222234|248853|P3|STARTED|Overall Study||24
104339|NCT01222234|248854|P2|STARTED|Overall Study||17
104340|NCT01222234|248855|P1|STARTED|Overall Study||15
104341|NCT01223469|248866|P2|NOT COMPLETED|Overall Study||0
104342|NCT01223469|248867|P1|NOT COMPLETED|Overall Study||0
104343|NCT01223469|248866|P2|COMPLETED|Overall Study||43
104344|NCT01223469|248867|P1|COMPLETED|Overall Study||34
104345|NCT01223469|248866|P2|STARTED|Overall Study||43
104346|NCT01223469|248867|P1|STARTED|Overall Study||34
104348|NCT01223365|248873|P1|COMPLETED|Open-label Treatment Period||189
104349|NCT01223365|248873|P1|STARTED|Open-label Treatment Period||291
104350|NCT01223365|248873|P1|NOT COMPLETED|Open-label Titration Period||39
104351|NCT01223365|248873|P1|COMPLETED|Open-label Titration Period||291
104352|NCT01223365|248873|P1|Achieved Stable Pain Relief|Open-label Titration Period||294
104353|NCT01223365|248873|P1|Safety Analysis Set|Open-label Titration Period||329
104354|NCT01223365|248873|P1|STARTED|Open-label Titration Period||330
104355|NCT01223352|248916|P2|NOT COMPLETED|Overall Study||0
104356|NCT01223352|248917|P1|NOT COMPLETED|Overall Study||0
104357|NCT01223352|248916|P2|COMPLETED|Overall Study||33
104358|NCT01223352|248917|P1|COMPLETED|Overall Study||31
104359|NCT01223352|248916|P2|STARTED|Overall Study||33
104360|NCT01223352|248917|P1|STARTED|Overall Study||31
104361|NCT01223196|248939|P2|NOT COMPLETED|Overall Study||0
104362|NCT01223196|248940|P1|NOT COMPLETED|Overall Study||4
104363|NCT01223196|248939|P2|COMPLETED|Overall Study||11
104364|NCT01223196|248940|P1|COMPLETED|Overall Study||9
104365|NCT01223196|248939|P2|STARTED|Overall Study||11
104366|NCT01223196|248940|P1|STARTED|Overall Study||13
104367|NCT01223027|248952|P2|NOT COMPLETED|Overall Study||277
104368|NCT01223027|248953|P1|NOT COMPLETED|Overall Study||274
104369|NCT01223027|248952|P2|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|9
104370|NCT01223027|248953|P1|COMPLETED|Overall Study|Completed = Ongoing at data cut-off of 25-Jan-2013|10
104371|NCT01223027|248952|P2|STARTED|Overall Study||286
104372|NCT01223027|248953|P1|STARTED|Overall Study||284
104373|NCT01223001|248976|P2|NOT COMPLETED|Overall Study||4
104374|NCT01223001|248977|P1|NOT COMPLETED|Overall Study||4
104375|NCT01223001|248976|P2|COMPLETED|Overall Study||0
104376|NCT01223001|248977|P1|COMPLETED|Overall Study||0
104377|NCT01223001|248976|P2|STARTED|Overall Study||4
104378|NCT01223001|248977|P1|STARTED|Overall Study||4
104379|NCT01222884|248985|P2|NOT COMPLETED|Overall Study||4
104380|NCT01222884|248986|P1|NOT COMPLETED|Overall Study||24
104381|NCT01222884|248985|P2|COMPLETED|Overall Study||113
104382|NCT01222884|248986|P1|COMPLETED|Overall Study||210
104383|NCT01222884|248985|P2|STARTED|Overall Study||117
104384|NCT01222884|248986|P1|STARTED|Overall Study||234
104385|NCT01222832|248996|P2|NOT COMPLETED|Overall Study||1
104386|NCT01222832|248997|P1|NOT COMPLETED|Overall Study||0
104387|NCT01222832|248996|P2|COMPLETED|Overall Study||112
104388|NCT01222832|248997|P1|COMPLETED|Overall Study||113
104389|NCT01222832|248996|P2|STARTED|Overall Study||113
104390|NCT01222832|248997|P1|STARTED|Overall Study||113
104391|NCT01222715|249005|P2|NOT COMPLETED|Overall Study||27
104392|NCT01222715|249006|P1|NOT COMPLETED|Overall Study||36
104393|NCT01222715|249005|P2|COMPLETED|Overall Study||16
104394|NCT01222715|249006|P1|COMPLETED|Overall Study||8
104395|NCT01222715|249005|P2|STARTED|Overall Study||43
104396|NCT01222715|249006|P1|STARTED|Overall Study||44
104397|NCT01222689|249016|P1|NOT COMPLETED|Overall Study||0
104398|NCT01222689|249016|P1|COMPLETED|Overall Study||46
104399|NCT01222689|249016|P1|STARTED|Overall Study||46
104400|NCT01222585|249029|P1|NOT COMPLETED|Overall Study||0
104401|NCT01222585|249029|P1|COMPLETED|Overall Study||24
104402|NCT01222585|249029|P1|STARTED|Overall Study||24
104403|NCT01222572|249039|P3|NOT COMPLETED|Overall Study||0
104404|NCT01222572|249040|P2|NOT COMPLETED|Overall Study||0
104405|NCT01222572|249041|P1|NOT COMPLETED|Overall Study||0
104406|NCT01222572|249039|P3|COMPLETED|Overall Study||0
104407|NCT01222572|249040|P2|COMPLETED|Overall Study||0
104408|NCT01222572|249041|P1|COMPLETED|Overall Study||1
104409|NCT01222572|249039|P3|STARTED|Overall Study||0
104410|NCT01222572|249040|P2|STARTED|Overall Study||0
104411|NCT01222572|249041|P1|STARTED|Overall Study||1
104412|NCT01222195|249045|P1|NOT COMPLETED|Overall Study||0
104413|NCT01222195|249045|P1|COMPLETED|Overall Study||1
104414|NCT01222195|249045|P1|STARTED|Overall Study||1
104415|NCT01222117|249060|P11|NOT COMPLETED|Overall Study||0
104416|NCT01222117|249061|P10|NOT COMPLETED|Overall Study||2
104417|NCT01222117|249062|P9|NOT COMPLETED|Overall Study||3
104418|NCT01222117|249063|P8|NOT COMPLETED|Overall Study||0
104419|NCT01222117|249064|P7|NOT COMPLETED|Overall Study||0
104420|NCT01222117|249065|P6|NOT COMPLETED|Overall Study||1
104421|NCT01222117|249066|P5|NOT COMPLETED|Overall Study||1
104422|NCT01222117|249067|P4|NOT COMPLETED|Overall Study||1
104423|NCT01222117|249068|P3|NOT COMPLETED|Overall Study||0
104424|NCT01222117|249069|P2|NOT COMPLETED|Overall Study||1
104425|NCT01222117|249070|P1|NOT COMPLETED|Overall Study||3
104426|NCT01222117|249060|P11|COMPLETED|Overall Study||6
104427|NCT01222117|249061|P10|COMPLETED|Overall Study||17
104428|NCT01222117|249062|P9|COMPLETED|Overall Study||20
104429|NCT01222117|249063|P8|COMPLETED|Overall Study||12
104430|NCT01222117|249064|P7|COMPLETED|Overall Study||13
104431|NCT01222117|249065|P6|COMPLETED|Overall Study||9
104432|NCT01222117|249066|P5|COMPLETED|Overall Study||8
104433|NCT01222117|249067|P4|COMPLETED|Overall Study||19
104434|NCT01222117|249068|P3|COMPLETED|Overall Study||22
104435|NCT01222117|249069|P2|COMPLETED|Overall Study||19
104436|NCT01222117|249070|P1|COMPLETED|Overall Study||17
104437|NCT01222117|249060|P11|STARTED|Overall Study||6
104438|NCT01222117|249061|P10|STARTED|Overall Study||19
104439|NCT01222117|249062|P9|STARTED|Overall Study||23
104440|NCT01222117|249063|P8|STARTED|Overall Study||12
104441|NCT01222117|249064|P7|STARTED|Overall Study||13
104442|NCT01222117|249065|P6|STARTED|Overall Study||10
104443|NCT01222117|249066|P5|STARTED|Overall Study||9
104444|NCT01222117|249067|P4|STARTED|Overall Study||20
104445|NCT01222117|249068|P3|STARTED|Overall Study||22
104446|NCT01222117|249069|P2|STARTED|Overall Study||20
104447|NCT01222117|249070|P1|STARTED|Overall Study||20
104448|NCT01222104|249105|P1|NOT COMPLETED|Overall Study||47
104449|NCT01222104|249105|P1|COMPLETED|Overall Study||587
104450|NCT01222104|249105|P1|Completed 30-day Visit-No Angio-Seal|Overall Study||90
104451|NCT01222104|249105|P1|Completed 30-day Visit-Angio-Seal|Overall Study||497
104452|NCT01222104|249105|P1|Successful Deployment and Hemostasis|Overall Study||524
104453|NCT01222104|249105|P1|Successful Deployment|Overall Study||529
104454|NCT01222104|249105|P1|Angio-Seal Deployment Attempted|Overall Study||534
104455|NCT01222104|249105|P1|STARTED|Overall Study||634
104456|NCT01222078|249119|P1|NOT COMPLETED|Overall Study||1
104457|NCT01222078|249119|P1|COMPLETED|Overall Study||0
104458|NCT01222078|249119|P1|STARTED|Overall Study||1
104459|NCT01221948|249153|P1|NOT COMPLETED|Overall Study||14
104460|NCT01221948|249153|P1|COMPLETED|Overall Study||39
104461|NCT01221948|249153|P1|STARTED|Overall Study||53
104462|NCT01221753|249164|P1|NOT COMPLETED|Overall Study||1
104463|NCT01221753|249164|P1|COMPLETED|Overall Study||6
104464|NCT01221753|249164|P1|STARTED|Overall Study||7
104465|NCT01221727|249171|P2|NOT COMPLETED|Overall Study||1
104466|NCT01221727|249172|P1|NOT COMPLETED|Overall Study||3
104467|NCT01221727|249171|P2|COMPLETED|Overall Study||8
104468|NCT01221727|249172|P1|COMPLETED|Overall Study||18
104469|NCT01221727|249171|P2|Treated|Overall Study|Number of subjects received investigational product|8
104470|NCT01221727|249172|P1|Treated|Overall Study|Number of subjects received investigational product|19
104471|NCT01221727|249171|P2|STARTED|Overall Study|Number of subjects randomized into the study|9
104472|NCT01221727|249172|P1|STARTED|Overall Study|Number of subjects randomized into the study|21
104473|NCT01221623|249193|P2|NOT COMPLETED|Overall Study||14
104474|NCT01221623|249194|P1|NOT COMPLETED|Overall Study||38
104475|NCT01221623|249193|P2|COMPLETED|Overall Study||127
104476|NCT01221623|249194|P1|COMPLETED|Overall Study||236
104477|NCT01221623|249193|P2|STARTED|Overall Study||141
104478|NCT01221623|249194|P1|STARTED|Overall Study||274
104479|NCT01221597|249218|P2|NOT COMPLETED|Overall Study||16
104480|NCT01221597|249219|P1|NOT COMPLETED|Overall Study||36
104481|NCT01221597|249218|P2|COMPLETED|Overall Study||124
104482|NCT01221597|249219|P1|COMPLETED|Overall Study||241
104483|NCT01221597|249218|P2|STARTED|Overall Study||140
104484|NCT01221597|249219|P1|STARTED|Overall Study||277
104485|NCT01221441|249243|P2|NOT COMPLETED|Overall Study||12
104486|NCT01221441|249244|P1|NOT COMPLETED|Overall Study||22
104487|NCT01221441|249243|P2|COMPLETED|Overall Study||23
104488|NCT01221441|249244|P1|COMPLETED|Overall Study||45
104489|NCT01221441|249243|P2|STARTED|Overall Study||35
104490|NCT01221441|249244|P1|STARTED|Overall Study||67
104491|NCT01221363|249276|P2|NOT COMPLETED|Overall Study||5
104492|NCT01221363|249277|P1|NOT COMPLETED|Overall Study||12
104493|NCT01221363|249276|P2|COMPLETED|Overall Study||68
104494|NCT01221363|249277|P1|COMPLETED|Overall Study||81
104495|NCT01221363|249276|P2|STARTED|Overall Study||73
104496|NCT01221363|249277|P1|STARTED|Overall Study||93
104497|NCT01221350|249287|P2|NOT COMPLETED|Overall Study||3
104498|NCT01221350|249288|P1|NOT COMPLETED|Overall Study||5
104499|NCT01221350|249287|P2|COMPLETED|Overall Study||24
104500|NCT01221350|249288|P1|COMPLETED|Overall Study||23
104501|NCT01221350|249287|P2|Analysis Population|Overall Study||24
104502|NCT01221350|249288|P1|Analysis Population|Overall Study||23
104503|NCT01221350|249287|P2|Received Intervention|Overall Study||27
104504|NCT01221350|249288|P1|Received Intervention|Overall Study||28
104505|NCT01221350|249287|P2|STARTED|Overall Study||27
104506|NCT01221350|249288|P1|STARTED|Overall Study||28
104507|NCT01221311|249330|P2|NOT COMPLETED|Overall Study||0
104508|NCT01221311|249331|P1|NOT COMPLETED|Overall Study||0
104509|NCT01221311|249330|P2|COMPLETED|Overall Study||55
104510|NCT01221311|249331|P1|COMPLETED|Overall Study||57
104511|NCT01221311|249330|P2|STARTED|Overall Study||55
104512|NCT01221311|249331|P1|STARTED|Overall Study||57
104513|NCT01221298|249337|P1|NOT COMPLETED|Overall Study||0
104514|NCT01221298|249337|P1|COMPLETED|Overall Study|The number of participants who completed study drug|11
104515|NCT01221298|249337|P1|STARTED|Overall Study||11
104516|NCT01221285|249347|P1|NOT COMPLETED|Overall Study||1
104517|NCT01221285|249347|P1|COMPLETED|Overall Study||10
104518|NCT01221285|249347|P1|STARTED|Overall Study||11
104519|NCT01221272|249356|P2|NOT COMPLETED|Period 2||2
104520|NCT01221272|249357|P1|NOT COMPLETED|Period 2||0
104521|NCT01221272|249356|P2|COMPLETED|Period 2||37
104522|NCT01221272|249357|P1|COMPLETED|Period 2||39
104523|NCT01221272|249356|P2|STARTED|Period 2|1 participant did not complete Period 1, but started and completed Period 2.|39
104524|NCT01221272|249357|P1|STARTED|Period 2||39
104525|NCT01221272|249356|P2|NOT COMPLETED|Period 1||2
104526|NCT01221272|249357|P1|NOT COMPLETED|Period 1||2
104527|NCT01221272|249356|P2|COMPLETED|Period 1||38
104528|NCT01221272|249357|P1|COMPLETED|Period 1||39
104529|NCT01221272|249356|P2|STARTED|Period 1||40
104530|NCT01221272|249357|P1|STARTED|Period 1||41
104531|NCT01221090|249376|P4|NOT COMPLETED|Overall Study||22
104532|NCT01221090|249377|P3|NOT COMPLETED|Overall Study||42
104533|NCT01221090|249378|P2|NOT COMPLETED|Overall Study||34
104534|NCT01221090|249379|P1|NOT COMPLETED|Overall Study||15
104535|NCT01221090|249376|P4|COMPLETED|Overall Study||73
104536|NCT01221090|249377|P3|COMPLETED|Overall Study||57
104537|NCT01221090|249378|P2|COMPLETED|Overall Study||47
104538|NCT01221090|249379|P1|COMPLETED|Overall Study||86
104539|NCT01221090|249376|P4|STARTED|Overall Study||95
104540|NCT01221090|249377|P3|STARTED|Overall Study||99
104541|NCT01221090|249378|P2|STARTED|Overall Study||81
104542|NCT01221090|249379|P1|STARTED|Overall Study||101
104543|NCT01220869|249405|P1|NOT COMPLETED|Overall Study||6
104544|NCT01220869|249405|P1|COMPLETED|Overall Study||104
104545|NCT01220869|249405|P1|STARTED|Overall Study||110
104546|NCT01220739|249415|P2|NOT COMPLETED|Overall Study||0
104547|NCT01220739|249416|P1|NOT COMPLETED|Overall Study||0
104548|NCT01220739|249415|P2|COMPLETED|Overall Study||5
104549|NCT01220739|249416|P1|COMPLETED|Overall Study||7
104550|NCT01220739|249415|P2|STARTED|Overall Study||5
104551|NCT01220739|249416|P1|STARTED|Overall Study||7
104552|NCT01220609|249424|P1|NOT COMPLETED|Overall Study||3
104553|NCT01220609|249424|P1|COMPLETED|Overall Study|Eligible and treated patients|23
104554|NCT01220609|249424|P1|STARTED|Overall Study||26
104555|NCT01220557|249432|P2|NOT COMPLETED|Overall Study||5
104556|NCT01220557|249433|P1|NOT COMPLETED|Overall Study||6
104557|NCT01220557|249432|P2|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|74
104558|NCT01220557|249433|P1|COMPLETED|Overall Study|per protocol analysis including patients which participated in at least 6 out of 12 lessons.|75
104559|NCT01220557|249432|P2|STARTED|Overall Study||79
104560|NCT01220557|249433|P1|STARTED|Overall Study||81
104561|NCT01220466|249442|P3|NOT COMPLETED|Overall Study||0
104562|NCT01220466|249443|P2|NOT COMPLETED|Overall Study||0
104563|NCT01220466|249444|P1|NOT COMPLETED|Overall Study||0
104564|NCT01220466|249442|P3|COMPLETED|Overall Study|16 eyes|10
104565|NCT01220466|249443|P2|COMPLETED|Overall Study|108 eyes|56
104566|NCT01220466|249444|P1|COMPLETED|Overall Study|19 eyes|11
104567|NCT01220466|249442|P3|STARTED|Overall Study|16 eyes|10
104568|NCT01220466|249443|P2|STARTED|Overall Study|108 eyes|56
104569|NCT01220466|249444|P1|STARTED|Overall Study|19 eyes|11
104570|NCT01220401|249464|P1|NOT COMPLETED|Overall Study||3
104571|NCT01220401|249464|P1|COMPLETED|Overall Study||18
104572|NCT01220401|249464|P1|STARTED|Overall Study||21
104573|NCT01220297|249473|P1|NOT COMPLETED|Overall Study||3
104574|NCT01220297|249473|P1|COMPLETED|Overall Study||0
104575|NCT01220297|249473|P1|STARTED|Overall Study||3
104576|NCT01220180|249490|P1|NOT COMPLETED|Overall Study||207
104577|NCT01220180|249490|P1|COMPLETED|Overall Study||3968
104578|NCT01220180|249490|P1|Treated|Overall Study||4174
104579|NCT01220180|249490|P1|STARTED|Overall Study||4175
104580|NCT01220128|249520|P7|NOT COMPLETED|Overall Study||5
104581|NCT01220128|249521|P6|NOT COMPLETED|Overall Study||0
104582|NCT01220128|249522|P5|NOT COMPLETED|Overall Study||0
104583|NCT01220128|249523|P4|NOT COMPLETED|Overall Study||0
104584|NCT01220128|249524|P3|NOT COMPLETED|Overall Study||3
104585|NCT01220128|249525|P2|NOT COMPLETED|Overall Study||1
104586|NCT01220128|249526|P1|NOT COMPLETED|Overall Study||4
104587|NCT01220128|249520|P7|COMPLETED|Overall Study||3
104588|NCT01220128|249521|P6|COMPLETED|Overall Study||4
104589|NCT01220128|249522|P5|COMPLETED|Overall Study||11
104590|NCT01220128|249523|P4|COMPLETED|Overall Study||6
104591|NCT01220128|249524|P3|COMPLETED|Overall Study||6
104592|NCT01220128|249525|P2|COMPLETED|Overall Study||6
104593|NCT01220128|249526|P1|COMPLETED|Overall Study||11
104594|NCT01220128|249520|P7|STARTED|Overall Study||8
104595|NCT01220128|249521|P6|STARTED|Overall Study||4
104596|NCT01220128|249522|P5|STARTED|Overall Study||11
104597|NCT01220128|249523|P4|STARTED|Overall Study||6
104598|NCT01220128|249524|P3|STARTED|Overall Study||9
104599|NCT01220128|249525|P2|STARTED|Overall Study||7
104600|NCT01220128|249526|P1|STARTED|Overall Study||15
104601|NCT01219985|249731|P1|NOT COMPLETED|Overall Study||20
104602|NCT01219985|249731|P1|COMPLETED|Overall Study||30
104603|NCT01219985|249731|P1|STARTED|Overall Study||50
104604|NCT01219933|249737|P1|NOT COMPLETED|Overall Study||38
104605|NCT01219933|249737|P1|COMPLETED|Overall Study||30
104606|NCT01219933|249737|P1|STARTED|Overall Study||68
104607|NCT01219881|249776|P2|NOT COMPLETED|Overall Study||5
104608|NCT01219881|249777|P1|NOT COMPLETED|Overall Study||4
104609|NCT01219881|249776|P2|COMPLETED|Overall Study||32
104610|NCT01219881|249777|P1|COMPLETED|Overall Study||34
104611|NCT01219881|249776|P2|STARTED|Overall Study||37
104612|NCT01219881|249777|P1|STARTED|Overall Study||38
104613|NCT01219855|249794|P5|NOT COMPLETED|Overall Study||1
104614|NCT01219855|249795|P4|NOT COMPLETED|Overall Study||1
104615|NCT01219855|249796|P3|NOT COMPLETED|Overall Study||1
104616|NCT01219855|249797|P2|NOT COMPLETED|Overall Study||5
104617|NCT01219855|249798|P1|NOT COMPLETED|Overall Study||1
104618|NCT01219855|249794|P5|COMPLETED|Overall Study||13
104619|NCT01219855|249795|P4|COMPLETED|Overall Study||12
104620|NCT01219855|249796|P3|COMPLETED|Overall Study||16
104621|NCT01219855|249797|P2|COMPLETED|Overall Study||12
104622|NCT01219855|249798|P1|COMPLETED|Overall Study||16
104623|NCT01219855|249794|P5|STARTED|Overall Study||14
104624|NCT01219855|249795|P4|STARTED|Overall Study||13
104625|NCT01219855|249796|P3|STARTED|Overall Study||17
104626|NCT01219855|249797|P2|STARTED|Overall Study||17
104627|NCT01219855|249798|P1|STARTED|Overall Study||17
104628|NCT01219777|249834|P1|NOT COMPLETED|Overall Study||0
104629|NCT01219777|249834|P1|COMPLETED|Overall Study||9
104630|NCT01219777|249834|P1|STARTED|Overall Study||9
104631|NCT01219738|249839|P1|NOT COMPLETED|Overall Study||0
104632|NCT01219738|249839|P1|COMPLETED|Overall Study||20
104633|NCT01219738|249839|P1|Budesonide 720- 4 Times|Overall Study||20
104634|NCT01219738|249839|P1|Budesonide 1440|Overall Study||20
104635|NCT01219738|249839|P1|Budesonide 720|Overall Study||20
104636|NCT01219738|249839|P1|Budesonide 360|Overall Study||20
104637|NCT01219738|249839|P1|STARTED|Overall Study||20
104638|NCT01219673|249860|P8|NOT COMPLETED|Overall Study||0
104639|NCT01219673|249861|P7|NOT COMPLETED|Overall Study||0
104640|NCT01219673|249862|P6|NOT COMPLETED|Overall Study||0
104641|NCT01219673|249863|P5|NOT COMPLETED|Overall Study||0
104642|NCT01219673|249864|P4|NOT COMPLETED|Overall Study||0
104643|NCT01219673|249865|P3|NOT COMPLETED|Overall Study||0
104644|NCT01219673|249866|P2|NOT COMPLETED|Overall Study||0
104645|NCT01219673|249867|P1|NOT COMPLETED|Overall Study||0
104646|NCT01219673|249860|P8|COMPLETED|Overall Study||0
104647|NCT01219673|249861|P7|COMPLETED|Overall Study||0
104648|NCT01219673|249862|P6|COMPLETED|Overall Study||0
104649|NCT01219673|249863|P5|COMPLETED|Overall Study||0
104650|NCT01219673|249864|P4|COMPLETED|Overall Study||0
104651|NCT01219673|249865|P3|COMPLETED|Overall Study||1
104652|NCT01219673|249866|P2|COMPLETED|Overall Study||0
104653|NCT01219673|249867|P1|COMPLETED|Overall Study||0
104654|NCT01219673|249860|P8|STARTED|Overall Study||0
104655|NCT01219673|249861|P7|STARTED|Overall Study||0
104656|NCT01219673|249862|P6|STARTED|Overall Study||0
104657|NCT01219673|249863|P5|STARTED|Overall Study||0
104658|NCT01219673|249864|P4|STARTED|Overall Study||0
104659|NCT01219673|249865|P3|STARTED|Overall Study||1
104660|NCT01219673|249866|P2|STARTED|Overall Study||0
104661|NCT01219673|249867|P1|STARTED|Overall Study||0
104662|NCT01218997|249887|P2|NOT COMPLETED|Overall Study||41
104663|NCT01218997|249888|P1|NOT COMPLETED|Overall Study||245
104664|NCT01218997|249887|P2|COMPLETED|Overall Study||24
104665|NCT01218997|249888|P1|COMPLETED|Overall Study||126
104666|NCT01218997|249887|P2|STARTED|Overall Study||65
104667|NCT01218997|249888|P1|STARTED|Overall Study||371
104668|NCT01218984|249897|P3|NOT COMPLETED|Overall Study||3
104669|NCT01218984|249898|P2|NOT COMPLETED|Overall Study||2
104670|NCT01218984|249899|P1|NOT COMPLETED|Overall Study||1
104671|NCT01218984|249897|P3|COMPLETED|Overall Study||7
104672|NCT01218984|249898|P2|COMPLETED|Overall Study||6
104673|NCT01218984|249899|P1|COMPLETED|Overall Study||8
104674|NCT01218984|249897|P3|STARTED|Overall Study||10
104675|NCT01218984|249898|P2|STARTED|Overall Study||8
104676|NCT01218984|249899|P1|STARTED|Overall Study||9
104677|NCT01218971|249909|P2|NOT COMPLETED|Overall Study||80
104678|NCT01218971|249910|P1|NOT COMPLETED|Overall Study||104
104679|NCT01218971|249909|P2|COMPLETED|Overall Study||77
104680|NCT01218971|249910|P1|COMPLETED|Overall Study||71
104681|NCT01218971|249909|P2|STARTED|Overall Study||157
104682|NCT01218971|249910|P1|STARTED|Overall Study||175
104683|NCT01218958|249923|P3|NOT COMPLETED|Overall Study||81
104684|NCT01218958|249924|P2|NOT COMPLETED|Overall Study||81
104685|NCT01218958|249925|P1|NOT COMPLETED|Overall Study||84
104686|NCT01218958|249923|P3|COMPLETED|Overall Study||128
104687|NCT01218958|249924|P2|COMPLETED|Overall Study||124
104688|NCT01218958|249925|P1|COMPLETED|Overall Study||126
104689|NCT01218958|249923|P3|STARTED|Overall Study||209
104690|NCT01218958|249924|P2|STARTED|Overall Study||205
104691|NCT01218958|249925|P1|STARTED|Overall Study||210
104692|NCT01218867|249947|P11|NOT COMPLETED|Overall Study||0
104693|NCT01218867|249948|P10|NOT COMPLETED|Overall Study||0
104694|NCT01218867|249949|P9|NOT COMPLETED|Overall Study||0
104695|NCT01218867|249950|P8|NOT COMPLETED|Overall Study||0
104696|NCT01218867|249951|P7|NOT COMPLETED|Overall Study||1
104697|NCT01218867|249952|P6|NOT COMPLETED|Overall Study||0
104698|NCT01218867|249953|P5|NOT COMPLETED|Overall Study||0
104699|NCT01218867|249954|P4|NOT COMPLETED|Overall Study||0
104700|NCT01218867|249955|P3|NOT COMPLETED|Overall Study||0
104701|NCT01218867|249956|P2|NOT COMPLETED|Overall Study||0
104702|NCT01218867|249957|P1|NOT COMPLETED|Overall Study||0
104703|NCT01218867|249947|P11|COMPLETED|Overall Study||2
104704|NCT01218867|249948|P10|COMPLETED|Overall Study||4
104705|NCT01218867|249949|P9|COMPLETED|Overall Study||3
104706|NCT01218867|249950|P8|COMPLETED|Overall Study||3
104707|NCT01218867|249951|P7|COMPLETED|Overall Study||3
104708|NCT01218867|249952|P6|COMPLETED|Overall Study||1
104709|NCT01218867|249953|P5|COMPLETED|Overall Study||1
104710|NCT01218867|249954|P4|COMPLETED|Overall Study||1
104711|NCT01218867|249955|P3|COMPLETED|Overall Study||3
104712|NCT01218867|249956|P2|COMPLETED|Overall Study||1
104713|NCT01218867|249957|P1|COMPLETED|Overall Study||1
104714|NCT01218867|249947|P11|STARTED|Overall Study||2
104715|NCT01218867|249948|P10|STARTED|Overall Study||4
104716|NCT01218867|249949|P9|STARTED|Overall Study||3
104717|NCT01218867|249950|P8|STARTED|Overall Study||3
104718|NCT01218867|249951|P7|STARTED|Overall Study||4
104719|NCT01218867|249952|P6|STARTED|Overall Study||1
104720|NCT01218867|249953|P5|STARTED|Overall Study||1
104721|NCT01218867|249954|P4|STARTED|Overall Study||1
104722|NCT01218867|249955|P3|STARTED|Overall Study||3
104723|NCT01218867|249956|P2|STARTED|Overall Study||1
104724|NCT01218867|249957|P1|STARTED|Overall Study||1
104725|NCT01218802|250005|P2|NOT COMPLETED|Overall Study||18
104726|NCT01218802|250006|P1|NOT COMPLETED|Overall Study||10
104727|NCT01218802|250005|P2|COMPLETED|Overall Study||57
104728|NCT01218802|250006|P1|COMPLETED|Overall Study||62
104729|NCT01218802|250005|P2|STARTED|Overall Study||75
104730|NCT01218802|250006|P1|STARTED|Overall Study||72
104731|NCT01218646|250018|P4|NOT COMPLETED|Overall Study||1
104732|NCT01218646|250019|P3|NOT COMPLETED|Overall Study||2
104733|NCT01218646|250020|P2|NOT COMPLETED|Overall Study||0
104734|NCT01218646|250021|P1|NOT COMPLETED|Overall Study||1
104735|NCT01218646|250018|P4|COMPLETED|Overall Study||63
104736|NCT01218646|250019|P3|COMPLETED|Overall Study||223
104737|NCT01218646|250020|P2|COMPLETED|Overall Study||225
104738|NCT01218646|250021|P1|COMPLETED|Overall Study||224
104739|NCT01218646|250018|P4|STARTED|Overall Study||64
104740|NCT01218646|250019|P3|STARTED|Overall Study||225
104741|NCT01218646|250020|P2|STARTED|Overall Study||225
104742|NCT01218646|250021|P1|STARTED|Overall Study||225
104743|NCT01218594|250059|P1|NOT COMPLETED|Overall Study||12
104744|NCT01218594|250059|P1|COMPLETED|Overall Study||36
104745|NCT01218594|250059|P1|STARTED|Overall Study||48
104746|NCT01218477|250067|P4|NOT COMPLETED|Overall Study||2
104747|NCT01218477|250068|P3|NOT COMPLETED|Overall Study||14
104748|NCT01218477|250069|P2|NOT COMPLETED|Overall Study||8
104749|NCT01218477|250070|P1|NOT COMPLETED|Overall Study||3
104750|NCT01218477|250067|P4|COMPLETED|Overall Study|Still receiving study drug|0
104751|NCT01218477|250068|P3|COMPLETED|Overall Study|Still receiving study drug|0
104752|NCT01218477|250069|P2|COMPLETED|Overall Study|Still receiving study drug|0
104753|NCT01218477|250070|P1|COMPLETED|Overall Study|Still receiving study drug|0
104754|NCT01218477|250067|P4|STARTED|Overall Study|Participants who received treatment|2
104755|NCT01218477|250068|P3|STARTED|Overall Study|Participants who received treatment|14
104756|NCT01218477|250069|P2|STARTED|Overall Study|Participants who received treatment|8
104757|NCT01218477|250070|P1|STARTED|Overall Study|Participants who received treatment|3
104758|NCT01218438|250087|P1|NOT COMPLETED|Epoch 4||3
104759|NCT01218438|250087|P1|COMPLETED|Epoch 4||67
104760|NCT01218438|250087|P1|STARTED|Epoch 4||70
104761|NCT01218438|250087|P1|NOT COMPLETED|Epoch 3||4
104762|NCT01218438|250087|P1|COMPLETED|Epoch 3||70
104763|NCT01218438|250087|P1|STARTED|Epoch 3||74
104764|NCT01218438|250087|P1|NOT COMPLETED|Epoch 2||0
104765|NCT01218438|250087|P1|COMPLETED|Epoch 2||45
104766|NCT01218438|250087|P1|STARTED|Epoch 2||45
104767|NCT01218438|250087|P1|NOT COMPLETED|Epoch 1||3
104768|NCT01218438|250087|P1|COMPLETED|Epoch 1||74
104769|NCT01218438|250087|P1|STARTED|Epoch 1||77
104770|NCT01218399|250242|P2|NOT COMPLETED|Overall Study||0
104771|NCT01218399|250243|P1|NOT COMPLETED|Overall Study||0
104772|NCT01218399|250242|P2|COMPLETED|Overall Study||5
104773|NCT01218399|250243|P1|COMPLETED|Overall Study||5
104774|NCT01218399|250242|P2|STARTED|Overall Study||5
104775|NCT01218399|250243|P1|STARTED|Overall Study||5
104776|NCT01218308|250253|P2|NOT COMPLETED|Overall Study||120
104777|NCT01218308|250254|P1|NOT COMPLETED|Overall Study||103
104778|NCT01218308|250253|P2|COMPLETED|Overall Study||2464
104779|NCT01218308|250254|P1|COMPLETED|Overall Study||2481
104780|NCT01218308|250253|P2|STARTED|Overall Study||2584
104781|NCT01218308|250254|P1|STARTED|Overall Study||2584
104782|NCT01218243|250298|P2|NOT COMPLETED|Overall Study||14
104783|NCT01218243|250299|P1|NOT COMPLETED|Overall Study||9
104784|NCT01218243|250298|P2|COMPLETED|Overall Study||36
104785|NCT01218243|250299|P1|COMPLETED|Overall Study||41
104786|NCT01218243|250298|P2|Treatment Completed|Overall Study||42
104787|NCT01218243|250299|P1|Treatment Completed|Overall Study||45
104788|NCT01218243|250298|P2|STARTED|Overall Study||50
104789|NCT01218243|250299|P1|STARTED|Overall Study||50
104790|NCT01218100|250317|P4|NOT COMPLETED|Overall Study||34
104791|NCT01218100|250318|P3|NOT COMPLETED|Overall Study||27
104792|NCT01218100|250319|P2|NOT COMPLETED|Overall Study||25
104793|NCT01218100|250320|P1|NOT COMPLETED|Overall Study||24
104794|NCT01218100|250317|P4|COMPLETED|Overall Study||156
104795|NCT01218100|250318|P3|COMPLETED|Overall Study||162
104796|NCT01218100|250319|P2|COMPLETED|Overall Study||165
104797|NCT01218100|250320|P1|COMPLETED|Overall Study||71
104798|NCT01218100|250317|P4|STARTED|Overall Study||190
104799|NCT01218100|250318|P3|STARTED|Overall Study||189
104800|NCT01218100|250319|P2|STARTED|Overall Study||190
104801|NCT01218100|250320|P1|STARTED|Overall Study||95
104802|NCT01218087|250336|P2|NOT COMPLETED|Overall Study||6
104803|NCT01218087|250337|P1|NOT COMPLETED|Overall Study||15
104804|NCT01218087|250336|P2|COMPLETED|Overall Study||35
104805|NCT01218087|250337|P1|COMPLETED|Overall Study||27
104806|NCT01218087|250336|P2|STARTED|Overall Study||41
104807|NCT01218087|250337|P1|STARTED|Overall Study||42
104808|NCT01218009|250347|P2|NOT COMPLETED|Overall Study||165
104809|NCT01218009|250348|P1|NOT COMPLETED|Overall Study||166
104810|NCT01218009|250347|P2|COMPLETED|Overall Study||0
104811|NCT01218009|250348|P1|COMPLETED|Overall Study||0
104812|NCT01218009|250347|P2|STARTED|Overall Study||165
104813|NCT01218009|250348|P1|STARTED|Overall Study||166
104814|NCT01217957|250371|P5|NOT COMPLETED|Phase 2||1
104815|NCT01217957|250372|P4|NOT COMPLETED|Phase 2||0
104816|NCT01217957|250373|P3|NOT COMPLETED|Phase 2||0
104817|NCT01217957|250374|P2|NOT COMPLETED|Phase 2||0
104818|NCT01217957|250375|P1|NOT COMPLETED|Phase 2||0
104819|NCT01217957|250371|P5|COMPLETED|Phase 2|Completed=Participants who are ongoing or who have died on study.|49
104820|NCT01217957|250372|P4|COMPLETED|Phase 2||0
104821|NCT01217957|250373|P3|COMPLETED|Phase 2||0
104822|NCT01217957|250374|P2|COMPLETED|Phase 2||0
104823|NCT01217957|250375|P1|COMPLETED|Phase 2||0
104824|NCT01217957|250371|P5|STARTED|Phase 2||50
104825|NCT01217957|250372|P4|STARTED|Phase 2||0
104826|NCT01217957|250373|P3|STARTED|Phase 2||0
104827|NCT01217957|250374|P2|STARTED|Phase 2||0
104828|NCT01217957|250375|P1|STARTED|Phase 2||0
104829|NCT01217957|250371|P5|NOT COMPLETED|Phase 1||0
104830|NCT01217957|250372|P4|NOT COMPLETED|Phase 1||1
104831|NCT01217957|250373|P3|NOT COMPLETED|Phase 1||1
104832|NCT01217957|250374|P2|NOT COMPLETED|Phase 1||0
104833|NCT01217957|250375|P1|NOT COMPLETED|Phase 1||1
104834|NCT01217957|250371|P5|COMPLETED|Phase 1||0
104835|NCT01217957|250372|P4|COMPLETED|Phase 1||2
104836|NCT01217957|250373|P3|COMPLETED|Phase 1||5
104837|NCT01217957|250374|P2|COMPLETED|Phase 1||3
104838|NCT01217957|250375|P1|COMPLETED|Phase 1||2
104839|NCT01217957|250371|P5|STARTED|Phase 1||0
104840|NCT01217957|250372|P4|STARTED|Phase 1||3
104841|NCT01217957|250373|P3|STARTED|Phase 1||6
104842|NCT01217957|250374|P2|STARTED|Phase 1||3
104843|NCT01217957|250375|P1|STARTED|Phase 1||3
104844|NCT01217944|250434|P3|NOT COMPLETED|Overall Study||0
104845|NCT01217944|250435|P2|NOT COMPLETED|Overall Study||4
104846|NCT01217944|250436|P1|NOT COMPLETED|Overall Study||6
104847|NCT01217944|250434|P3|COMPLETED|Overall Study||55
104848|NCT01217944|250435|P2|COMPLETED|Overall Study||112
104849|NCT01217944|250436|P1|COMPLETED|Overall Study||100
104850|NCT01217944|250434|P3|Completed 6 Months|Overall Study||55
104851|NCT01217944|250435|P2|Completed 6 Months|Overall Study||116
104852|NCT01217944|250436|P1|Completed 6 Months|Overall Study||103
104853|NCT01217944|250434|P3|Completed 3 Months|Overall Study||55
104854|NCT01217944|250435|P2|Completed 3 Months|Overall Study||116
104855|NCT01217944|250436|P1|Completed 3 Months|Overall Study||105
104856|NCT01217944|250434|P3|STARTED|Overall Study||55
104857|NCT01217944|250435|P2|STARTED|Overall Study||116
104858|NCT01217944|250436|P1|STARTED|Overall Study||106
104859|NCT01217892|250479|P4|NOT COMPLETED|Overall Study||8
104860|NCT01217892|250480|P3|NOT COMPLETED|Overall Study||9
104861|NCT01217892|250481|P2|NOT COMPLETED|Overall Study||6
104862|NCT01217892|250482|P1|NOT COMPLETED|Overall Study||7
104863|NCT01217892|250479|P4|COMPLETED|Overall Study||93
104864|NCT01217892|250480|P3|COMPLETED|Overall Study||90
104865|NCT01217892|250481|P2|COMPLETED|Overall Study||94
104866|NCT01217892|250482|P1|COMPLETED|Overall Study||93
104867|NCT01217892|250479|P4|STARTED|Overall Study||101
104868|NCT01217892|250480|P3|STARTED|Overall Study||99
104869|NCT01217892|250481|P2|STARTED|Overall Study||100
104870|NCT01217892|250482|P1|STARTED|Overall Study||100
104871|NCT01217840|250510|P2|NOT COMPLETED|Overall Study||3
104872|NCT01217840|250511|P1|NOT COMPLETED|Overall Study||6
104873|NCT01217840|250510|P2|COMPLETED|Overall Study||17
104874|NCT01217840|250511|P1|COMPLETED|Overall Study||14
104875|NCT01217840|250510|P2|STARTED|Overall Study||20
104876|NCT01217840|250511|P1|STARTED|Overall Study||20
104877|NCT01217827|250519|P2|NOT COMPLETED|Overall Study||0
104878|NCT01217827|250520|P1|NOT COMPLETED|Overall Study||0
104879|NCT01217827|250519|P2|COMPLETED|Overall Study||43
104880|NCT01217827|250520|P1|COMPLETED|Overall Study||46
104881|NCT01217827|250519|P2|STARTED|Overall Study||43
104882|NCT01217827|250520|P1|STARTED|Overall Study||46
104883|NCT01217801|250528|P2|NOT COMPLETED|Period 2||0
104884|NCT01217801|250529|P1|NOT COMPLETED|Period 2||0
104885|NCT01217801|250528|P2|COMPLETED|Period 2||22
104886|NCT01217801|250529|P1|COMPLETED|Period 2||23
104887|NCT01217801|250528|P2|STARTED|Period 2||22
104888|NCT01217801|250529|P1|STARTED|Period 2||23
104889|NCT01217801|250528|P2|NOT COMPLETED|Period 1||2
104890|NCT01217801|250529|P1|NOT COMPLETED|Period 1||1
104891|NCT01217801|250528|P2|COMPLETED|Period 1||22
104892|NCT01217801|250529|P1|COMPLETED|Period 1||23
104893|NCT01217801|250528|P2|STARTED|Period 1||24
104894|NCT01217801|250529|P1|STARTED|Period 1||24
104895|NCT01217749|250538|P3|NOT COMPLETED|Overall Study||2
104896|NCT01217749|250539|P2|NOT COMPLETED|Overall Study||3
104897|NCT01217749|250540|P1|NOT COMPLETED|Overall Study||3
104898|NCT01217749|250538|P3|COMPLETED|Overall Study||22
104899|NCT01217749|250539|P2|COMPLETED|Overall Study||17
104900|NCT01217749|250540|P1|COMPLETED|Overall Study||24
104901|NCT01217749|250538|P3|STARTED|Overall Study||24
104902|NCT01217749|250539|P2|STARTED|Overall Study||20
104903|NCT01217749|250540|P1|STARTED|Overall Study||27
104904|NCT01216631|250559|P3|NOT COMPLETED|Overall Study||0
104905|NCT01216631|250560|P2|NOT COMPLETED|Overall Study||0
104906|NCT01216631|250561|P1|NOT COMPLETED|Overall Study||0
104907|NCT01216631|250559|P3|COMPLETED|Overall Study||1
104908|NCT01216631|250560|P2|COMPLETED|Overall Study||0
104909|NCT01216631|250561|P1|COMPLETED|Overall Study||0
104910|NCT01216631|250559|P3|STARTED|Overall Study||1
104911|NCT01216631|250560|P2|STARTED|Overall Study||0
104912|NCT01216631|250561|P1|STARTED|Overall Study||0
104913|NCT01217606|250571|P2|NOT COMPLETED|9-Month Masked Extension||11
104914|NCT01217606|250572|P1|NOT COMPLETED|9-Month Masked Extension||13
104915|NCT01217606|250571|P2|COMPLETED|9-Month Masked Extension||62
104916|NCT01217606|250572|P1|COMPLETED|9-Month Masked Extension||54
104917|NCT01217606|250571|P2|Not Enrolled in Masked Extension|9-Month Masked Extension||10
104918|NCT01217606|250572|P1|Not Enrolled in Masked Extension|9-Month Masked Extension||9
104919|NCT01217606|250571|P2|STARTED|9-Month Masked Extension||73
104920|NCT01217606|250572|P1|STARTED|9-Month Masked Extension||67
104921|NCT01217606|250571|P2|NOT COMPLETED|Initial Treatment Phase||12
104922|NCT01217606|250572|P1|NOT COMPLETED|Initial Treatment Phase||14
104923|NCT01217606|250571|P2|COMPLETED|Initial Treatment Phase||83
104924|NCT01217606|250572|P1|COMPLETED|Initial Treatment Phase||76
104925|NCT01217606|250571|P2|STARTED|Initial Treatment Phase||95
104926|NCT01217606|250572|P1|STARTED|Initial Treatment Phase||90
104927|NCT01217515|250585|P3|NOT COMPLETED|Overall Study||10
104928|NCT01217515|250586|P2|NOT COMPLETED|Overall Study||8
104929|NCT01217515|250587|P1|NOT COMPLETED|Overall Study||7
104930|NCT01217515|250585|P3|COMPLETED|Overall Study||145
104931|NCT01217515|250586|P2|COMPLETED|Overall Study||148
104932|NCT01217515|250587|P1|COMPLETED|Overall Study||147
104933|NCT01217515|250585|P3|STARTED|Overall Study||155
104934|NCT01217515|250586|P2|STARTED|Overall Study||156
104935|NCT01217515|250587|P1|STARTED|Overall Study||154
104936|NCT01217476|250603|P2|NOT COMPLETED|Overall Study||7
104937|NCT01217476|250604|P1|NOT COMPLETED|Overall Study||12
104938|NCT01217476|250603|P2|COMPLETED|Overall Study||95
104939|NCT01217476|250604|P1|COMPLETED|Overall Study||93
104940|NCT01217476|250603|P2|STARTED|Overall Study||102
104941|NCT01217476|250604|P1|STARTED|Overall Study||105
104942|NCT01217463|250614|P2|NOT COMPLETED|Overall Study||8
104943|NCT01217463|250615|P1|NOT COMPLETED|Overall Study||13
104944|NCT01217463|250614|P2|COMPLETED|Overall Study||94
104945|NCT01217463|250615|P1|COMPLETED|Overall Study||86
104946|NCT01217463|250614|P2|STARTED|Overall Study||102
104947|NCT01217463|250615|P1|STARTED|Overall Study||99
104948|NCT01217411|250626|P3|NOT COMPLETED|Overall Study||0
104949|NCT01217411|250627|P2|NOT COMPLETED|Overall Study||0
104950|NCT01217411|250628|P1|NOT COMPLETED|Overall Study||0
104951|NCT01217411|250626|P3|COMPLETED|Overall Study||0
104952|NCT01217411|250627|P2|COMPLETED|Overall Study||0
104953|NCT01217411|250628|P1|COMPLETED|Overall Study||5
104954|NCT01217411|250626|P3|STARTED|Overall Study||0
104955|NCT01217411|250627|P2|STARTED|Overall Study||0
104956|NCT01217411|250628|P1|STARTED|Overall Study||5
104957|NCT01217229|250633|P1|NOT COMPLETED|Overall Study||0
104958|NCT01217229|250633|P1|COMPLETED|Overall Study||20
104959|NCT01217229|250633|P1|STARTED|Overall Study||20
104960|NCT01217112|250642|P5|NOT COMPLETED|Overall Study||1
104961|NCT01217112|250643|P4|NOT COMPLETED|Overall Study||2
104962|NCT01217112|250644|P3|NOT COMPLETED|Overall Study||1
104963|NCT01217112|250645|P2|NOT COMPLETED|Overall Study||2
104964|NCT01217112|250646|P1|NOT COMPLETED|Overall Study||0
104965|NCT01217112|250642|P5|COMPLETED|Overall Study||13
104966|NCT01217112|250643|P4|COMPLETED|Overall Study||10
104967|NCT01217112|250644|P3|COMPLETED|Overall Study||12
104968|NCT01217112|250645|P2|COMPLETED|Overall Study||10
104969|NCT01217112|250646|P1|COMPLETED|Overall Study||11
104970|NCT01217112|250642|P5|STARTED|Overall Study||14
104971|NCT01217112|250643|P4|STARTED|Overall Study||12
104972|NCT01217112|250644|P3|STARTED|Overall Study||13
104973|NCT01217112|250645|P2|STARTED|Overall Study||12
104974|NCT01217112|250646|P1|STARTED|Overall Study||11
104975|NCT01217073|250879|P8|NOT COMPLETED|Extension Period||20
104976|NCT01217073|250880|P7|NOT COMPLETED|Extension Period||91
104977|NCT01217073|250881|P6|NOT COMPLETED|Extension Period||0
104978|NCT01217073|250882|P5|NOT COMPLETED|Extension Period||0
104979|NCT01217073|250883|P4|NOT COMPLETED|Extension Period||0
104980|NCT01217073|250884|P3|NOT COMPLETED|Extension Period||0
104981|NCT01217073|250885|P2|NOT COMPLETED|Extension Period||0
104982|NCT01217073|250886|P1|NOT COMPLETED|Extension Period||0
104983|NCT01217073|250879|P8|COMPLETED|Extension Period||60
104984|NCT01217073|250880|P7|COMPLETED|Extension Period||314
104985|NCT01217073|250881|P6|COMPLETED|Extension Period||0
104986|NCT01217073|250882|P5|COMPLETED|Extension Period||0
104987|NCT01217073|250883|P4|COMPLETED|Extension Period||0
104988|NCT01217073|250884|P3|COMPLETED|Extension Period||0
104989|NCT01217073|250885|P2|COMPLETED|Extension Period||0
104990|NCT01217073|250886|P1|COMPLETED|Extension Period||0
104991|NCT01217073|250879|P8|STARTED|Extension Period||80
104992|NCT01217073|250880|P7|STARTED|Extension Period||405
104993|NCT01217073|250881|P6|STARTED|Extension Period||0
104994|NCT01217073|250882|P5|STARTED|Extension Period||0
104995|NCT01217073|250883|P4|STARTED|Extension Period||0
104996|NCT01217073|250884|P3|STARTED|Extension Period||0
104997|NCT01217073|250885|P2|STARTED|Extension Period||0
104998|NCT01217073|250886|P1|STARTED|Extension Period||0
104999|NCT01217073|250879|P8|NOT COMPLETED|Base Period||0
105000|NCT01217073|250880|P7|NOT COMPLETED|Base Period||0
105001|NCT01217073|250881|P6|NOT COMPLETED|Base Period||9
105002|NCT01217073|250882|P5|NOT COMPLETED|Base Period||15
105003|NCT01217073|250883|P4|NOT COMPLETED|Base Period||2
105004|NCT01217073|250884|P3|NOT COMPLETED|Base Period||7
105005|NCT01217073|250885|P2|NOT COMPLETED|Base Period||5
105006|NCT01217073|250886|P1|NOT COMPLETED|Base Period||7
105007|NCT01217073|250879|P8|COMPLETED|Base Period||0
105008|NCT01217073|250880|P7|COMPLETED|Base Period||0
105009|NCT01217073|250881|P6|COMPLETED|Base Period||105
105010|NCT01217073|250882|P5|COMPLETED|Base Period||99
105011|NCT01217073|250883|P4|COMPLETED|Base Period||113
105012|NCT01217073|250884|P3|COMPLETED|Base Period||107
105013|NCT01217073|250885|P2|COMPLETED|Base Period||110
105014|NCT01217073|250886|P1|COMPLETED|Base Period||106
105015|NCT01217073|250879|P8|STARTED|Base Period||0
105016|NCT01217073|250880|P7|STARTED|Base Period||0
105017|NCT01217073|250881|P6|STARTED|Base Period||114
105018|NCT01217073|250882|P5|STARTED|Base Period||114
105019|NCT01217073|250883|P4|STARTED|Base Period||115
105020|NCT01217073|250884|P3|STARTED|Base Period||114
105021|NCT01217073|250885|P2|STARTED|Base Period||115
105022|NCT01217073|250886|P1|STARTED|Base Period||113
105023|NCT01216943|250954|P1|NOT COMPLETED|Overall Study||13
105024|NCT01216943|250954|P1|COMPLETED|Overall Study||113
105025|NCT01216943|250954|P1|STARTED|Overall Study||126
105026|NCT01216761|250958|P3|NOT COMPLETED|Overall Study||0
105027|NCT01216761|250959|P2|NOT COMPLETED|Overall Study||0
105028|NCT01216761|250960|P1|NOT COMPLETED|Overall Study||0
105029|NCT01216761|250958|P3|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
105030|NCT01216761|250959|P2|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
105031|NCT01216761|250960|P1|COMPLETED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
105032|NCT01216761|250958|P3|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1379
105033|NCT01216761|250959|P2|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1410
105034|NCT01216761|250960|P1|STARTED|Overall Study|It is possible for the same patient to appear in multiple sequences throughout the study.|1421
105035|NCT01216748|250968|P1|NOT COMPLETED|Overall Study||0
105036|NCT01216748|250968|P1|COMPLETED|Overall Study||10
105037|NCT01216748|250968|P1|Eucapnic Hyperventilation|Overall Study||10
105038|NCT01216748|250968|P1|Hypercapnic Hyperventilation|Overall Study||10
105039|NCT01216748|250968|P1|Hypocapnic Hyperventilation|Overall Study||10
105040|NCT01216748|250968|P1|Quiet Breathing|Overall Study||10
105041|NCT01216748|250968|P1|STARTED|Overall Study||10
105042|NCT01216735|250975|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
105043|NCT01216735|250976|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
105044|NCT01216735|250975|P2|COMPLETED|Second Intervention (3 Weeks)||7
105045|NCT01216735|250976|P1|COMPLETED|Second Intervention (3 Weeks)||8
105046|NCT01216735|250975|P2|STARTED|Second Intervention (3 Weeks)||7
105047|NCT01216735|250976|P1|STARTED|Second Intervention (3 Weeks)||8
105048|NCT01216735|250975|P2|NOT COMPLETED|Washout (3 Weeks)||0
105049|NCT01216735|250976|P1|NOT COMPLETED|Washout (3 Weeks)||0
105050|NCT01216735|250975|P2|COMPLETED|Washout (3 Weeks)||7
105051|NCT01216735|250976|P1|COMPLETED|Washout (3 Weeks)||8
105052|NCT01216735|250975|P2|STARTED|Washout (3 Weeks)||7
105053|NCT01216735|250976|P1|STARTED|Washout (3 Weeks)||8
105054|NCT01216735|250975|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
105055|NCT01216735|250976|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
105056|NCT01216735|250975|P2|COMPLETED|First Intervention (3 Weeks)||7
105057|NCT01216735|250976|P1|COMPLETED|First Intervention (3 Weeks)||8
105058|NCT01216735|250975|P2|STARTED|First Intervention (3 Weeks)||7
105059|NCT01216735|250976|P1|STARTED|First Intervention (3 Weeks)||8
105060|NCT01216410|250987|P3|NOT COMPLETED|Overall Study||3
105061|NCT01216410|250988|P2|NOT COMPLETED|Overall Study||1
105062|NCT01216410|250989|P1|NOT COMPLETED|Overall Study||2
105063|NCT01216410|250987|P3|COMPLETED|Overall Study||100
105064|NCT01216410|250988|P2|COMPLETED|Overall Study||99
105065|NCT01216410|250989|P1|COMPLETED|Overall Study||101
105066|NCT01216410|250987|P3|STARTED|Overall Study||103
105067|NCT01216410|250988|P2|STARTED|Overall Study||100
105068|NCT01216410|250989|P1|STARTED|Overall Study||103
105069|NCT01216397|251009|P2|NOT COMPLETED|Period 2||0
105070|NCT01216397|251010|P1|NOT COMPLETED|Period 2||0
105071|NCT01216397|251009|P2|COMPLETED|Period 2||20
105072|NCT01216397|251010|P1|COMPLETED|Period 2||20
105073|NCT01216397|251009|P2|STARTED|Period 2||20
105074|NCT01216397|251010|P1|STARTED|Period 2||20
105075|NCT01216397|251009|P2|NOT COMPLETED|Washout (35 Days)||0
105076|NCT01216397|251010|P1|NOT COMPLETED|Washout (35 Days)||0
105077|NCT01216397|251009|P2|COMPLETED|Washout (35 Days)||20
105078|NCT01216397|251010|P1|COMPLETED|Washout (35 Days)||20
105079|NCT01216397|251009|P2|STARTED|Washout (35 Days)||20
105080|NCT01216397|251010|P1|STARTED|Washout (35 Days)||20
105081|NCT01216397|251009|P2|NOT COMPLETED|Period 1||0
105082|NCT01216397|251010|P1|NOT COMPLETED|Period 1||0
105083|NCT01216397|251009|P2|COMPLETED|Period 1||20
105084|NCT01216397|251010|P1|COMPLETED|Period 1||20
105085|NCT01216397|251009|P2|STARTED|Period 1||20
105086|NCT01216397|251010|P1|STARTED|Period 1||20
105087|NCT01216319|251062|P1|NOT COMPLETED|Overall Study||4
105088|NCT01216319|251062|P1|COMPLETED|Overall Study||46
105089|NCT01216319|251062|P1|STARTED|Overall Study||50
105090|NCT01216241|251069|P2|NOT COMPLETED|Overall Study||0
105091|NCT01216241|251070|P1|NOT COMPLETED|Overall Study||0
105092|NCT01216241|251069|P2|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
105093|NCT01216241|251070|P1|COMPLETED|Overall Study|Reporter remains blinded so the 4 completed could have been either study drug or placebo.|18
105094|NCT01216241|251069|P2|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
105177|NCT01215851|251278|P6|NOT COMPLETED|Treatment Period||1
105095|NCT01216241|251070|P1|STARTED|Overall Study|18 subjects randomized. All didn't receive study drug/placebo if they didn't have neutropenic fever|18
105096|NCT01216163|251079|P3|NOT COMPLETED|Overall Study||0
105097|NCT01216163|251080|P2|NOT COMPLETED|Overall Study||1
105098|NCT01216163|251081|P1|NOT COMPLETED|Overall Study||1
105099|NCT01216163|251079|P3|COMPLETED|Overall Study||85
105100|NCT01216163|251080|P2|COMPLETED|Overall Study||87
105101|NCT01216163|251081|P1|COMPLETED|Overall Study||44
105102|NCT01216163|251079|P3|STARTED|Overall Study||85
105103|NCT01216163|251080|P2|STARTED|Overall Study||88
105104|NCT01216163|251081|P1|STARTED|Overall Study||45
105105|NCT01216072|251133|P2|NOT COMPLETED|Open-Label Extension Period (3 Months)||14
105106|NCT01216072|251134|P1|NOT COMPLETED|Open-Label Extension Period (3 Months)||0
105107|NCT01216072|251133|P2|COMPLETED|Open-Label Extension Period (3 Months)||181
105108|NCT01216072|251134|P1|COMPLETED|Open-Label Extension Period (3 Months)||0
105109|NCT01216072|251133|P2|Safety Set|Open-Label Extension Period (3 Months)||193
105110|NCT01216072|251134|P1|Safety Set|Open-Label Extension Period (3 Months)||0
105111|NCT01216072|251133|P2|STARTED|Open-Label Extension Period (3 Months)|Only DMT patients, who completed the core study, were eligible for fingolimod.|195
105112|NCT01216072|251134|P1|STARTED|Open-Label Extension Period (3 Months)||0
105113|NCT01216072|251133|P2|NOT COMPLETED|Open-Label Core Period ( 6 Months)||34
105114|NCT01216072|251134|P1|NOT COMPLETED|Open-Label Core Period ( 6 Months)||76
105115|NCT01216072|251133|P2|COMPLETED|Open-Label Core Period ( 6 Months)||229
105116|NCT01216072|251134|P1|COMPLETED|Open-Label Core Period ( 6 Months)||714
105117|NCT01216072|251133|P2|Safety Set|Open-Label Core Period ( 6 Months)||245
105118|NCT01216072|251134|P1|Safety Set|Open-Label Core Period ( 6 Months)||783
105119|NCT01216072|251133|P2|Full Analysis Set|Open-Label Core Period ( 6 Months)||263
105120|NCT01216072|251134|P1|Full Analysis Set|Open-Label Core Period ( 6 Months)|One patient was randomized in error and was not included in FAS.|789
105121|NCT01216072|251133|P2|STARTED|Open-Label Core Period ( 6 Months)||263
105122|NCT01216072|251134|P1|STARTED|Open-Label Core Period ( 6 Months)||790
105123|NCT01215981|251162|P2|NOT COMPLETED|Overall Study||1
105124|NCT01215981|251163|P1|NOT COMPLETED|Overall Study||2
105125|NCT01215981|251162|P2|COMPLETED|Overall Study||32
105126|NCT01215981|251163|P1|COMPLETED|Overall Study||33
105127|NCT01215981|251162|P2|STARTED|Overall Study||33
105128|NCT01215981|251163|P1|STARTED|Overall Study||35
105129|NCT01215968|251173|P2|NOT COMPLETED|Overall Study||7
105130|NCT01215968|251174|P1|NOT COMPLETED|Overall Study||2
105131|NCT01215968|251173|P2|COMPLETED|Overall Study||18
105132|NCT01215968|251174|P1|COMPLETED|Overall Study||11
105133|NCT01215968|251173|P2|Received at Least 1 Dose of Study Drug|Overall Study|25 participants received placebo during Week 1.|24
105134|NCT01215968|251174|P1|Received at Least 1 Dose of Study Drug|Overall Study||13
105135|NCT01215968|251173|P2|STARTED|Overall Study||25
105136|NCT01215968|251174|P1|STARTED|Overall Study||13
105137|NCT01215955|251194|P4|NOT COMPLETED|Overall Study||53
105138|NCT01215955|251195|P3|NOT COMPLETED|Overall Study||48
105139|NCT01215955|251196|P2|NOT COMPLETED|Overall Study||53
105140|NCT01215955|251197|P1|NOT COMPLETED|Overall Study||45
105141|NCT01215955|251194|P4|COMPLETED|Overall Study||241
105142|NCT01215955|251195|P3|COMPLETED|Overall Study||244
105143|NCT01215955|251196|P2|COMPLETED|Overall Study||210
105144|NCT01215955|251197|P1|COMPLETED|Overall Study||223
105145|NCT01215955|251194|P4|Received at Least 1 Dose of Study Drug|Overall Study||290
105146|NCT01215955|251195|P3|Received at Least 1 Dose of Study Drug|Overall Study||288
105147|NCT01215955|251196|P2|Received at Least 1 Dose of Study Drug|Overall Study||261
105148|NCT01215955|251197|P1|Received at Least 1 Dose of Study Drug|Overall Study||267
105149|NCT01215955|251194|P4|STARTED|Overall Study|Two (2) participants from 1 site were excluded due to quality issues and validity of the data.|294
105240|NCT01215435|251492|P2|NOT COMPLETED|Overall Study||16
105150|NCT01215955|251195|P3|STARTED|Overall Study|Three (3) participants from 1 site were excluded due to quality issues and validity of data.|292
105151|NCT01215955|251196|P2|STARTED|Overall Study||263
105152|NCT01215955|251197|P1|STARTED|Overall Study||268
105153|NCT01215929|251265|P2|NOT COMPLETED|Overall Study||5
105154|NCT01215929|251266|P1|NOT COMPLETED|Overall Study||6
105155|NCT01215929|251265|P2|COMPLETED|Overall Study||12
105156|NCT01215929|251266|P1|COMPLETED|Overall Study||12
105157|NCT01215929|251265|P2|STARTED|Overall Study||17
105158|NCT01215929|251266|P1|STARTED|Overall Study||18
105159|NCT01215851|251278|P6|NOT COMPLETED|Follow up Period||1
105160|NCT01215851|251279|P5|NOT COMPLETED|Follow up Period||0
105161|NCT01215851|251280|P4|NOT COMPLETED|Follow up Period||0
105162|NCT01215851|251281|P3|NOT COMPLETED|Follow up Period||0
105163|NCT01215851|251282|P2|NOT COMPLETED|Follow up Period||0
105164|NCT01215851|251283|P1|NOT COMPLETED|Follow up Period||0
105165|NCT01215851|251278|P6|COMPLETED|Follow up Period||13
105166|NCT01215851|251279|P5|COMPLETED|Follow up Period||10
105167|NCT01215851|251280|P4|COMPLETED|Follow up Period||12
105168|NCT01215851|251281|P3|COMPLETED|Follow up Period||14
105169|NCT01215851|251282|P2|COMPLETED|Follow up Period||14
105170|NCT01215851|251283|P1|COMPLETED|Follow up Period||14
105171|NCT01215851|251278|P6|STARTED|Follow up Period||14
105172|NCT01215851|251279|P5|STARTED|Follow up Period||10
105173|NCT01215851|251280|P4|STARTED|Follow up Period||12
105174|NCT01215851|251281|P3|STARTED|Follow up Period||14
105175|NCT01215851|251282|P2|STARTED|Follow up Period||14
105176|NCT01215851|251283|P1|STARTED|Follow up Period||14
105178|NCT01215851|251279|P5|NOT COMPLETED|Treatment Period||0
105179|NCT01215851|251280|P4|NOT COMPLETED|Treatment Period||3
105180|NCT01215851|251281|P3|NOT COMPLETED|Treatment Period||1
105181|NCT01215851|251282|P2|NOT COMPLETED|Treatment Period||1
105182|NCT01215851|251283|P1|NOT COMPLETED|Treatment Period||1
105183|NCT01215851|251278|P6|COMPLETED|Treatment Period||14
105184|NCT01215851|251279|P5|COMPLETED|Treatment Period||10
105185|NCT01215851|251280|P4|COMPLETED|Treatment Period||12
105186|NCT01215851|251281|P3|COMPLETED|Treatment Period||14
105187|NCT01215851|251282|P2|COMPLETED|Treatment Period||14
105188|NCT01215851|251283|P1|COMPLETED|Treatment Period||14
105189|NCT01215851|251278|P6|STARTED|Treatment Period||15
105190|NCT01215851|251279|P5|STARTED|Treatment Period||10
105191|NCT01215851|251280|P4|STARTED|Treatment Period||15
105192|NCT01215851|251281|P3|STARTED|Treatment Period||15
105193|NCT01215851|251282|P2|STARTED|Treatment Period||15
105194|NCT01215851|251283|P1|STARTED|Treatment Period||15
105195|NCT01215786|251324|P3|NOT COMPLETED|Overall Study||0
105196|NCT01215786|251325|P2|NOT COMPLETED|Overall Study||0
105197|NCT01215786|251326|P1|NOT COMPLETED|Overall Study||0
105198|NCT01215786|251324|P3|COMPLETED|Overall Study||10
105199|NCT01215786|251325|P2|COMPLETED|Overall Study||19
105200|NCT01215786|251326|P1|COMPLETED|Overall Study||21
105201|NCT01215786|251324|P3|STARTED|Overall Study||10
105202|NCT01215786|251325|P2|STARTED|Overall Study||19
105203|NCT01215786|251326|P1|STARTED|Overall Study||21
105204|NCT01215734|251342|P2|NOT COMPLETED|Overall Study||1
105205|NCT01215734|251343|P1|NOT COMPLETED|Overall Study||0
105206|NCT01215734|251342|P2|COMPLETED|Overall Study||14
105207|NCT01215734|251343|P1|COMPLETED|Overall Study||29
105208|NCT01215734|251342|P2|STARTED|Overall Study||15
105209|NCT01215734|251343|P1|STARTED|Overall Study||29
105210|NCT01215721|251351|P1|NOT COMPLETED|Overall Study||2
105211|NCT01215721|251351|P1|COMPLETED|Overall Study||38
105212|NCT01215721|251351|P1|STARTED|Overall Study||40
105213|NCT01215695|251357|P2|NOT COMPLETED|Overall Study||0
105214|NCT01215695|251358|P1|NOT COMPLETED|Overall Study||0
105215|NCT01215695|251357|P2|COMPLETED|Overall Study||70
105216|NCT01215695|251358|P1|COMPLETED|Overall Study||70
105217|NCT01215695|251357|P2|STARTED|Overall Study||70
105218|NCT01215695|251358|P1|STARTED|Overall Study||70
105219|NCT01215643|251377|P5|NOT COMPLETED|Overall Study||11
105220|NCT01215643|251378|P4|NOT COMPLETED|Overall Study||4
105221|NCT01215643|251379|P3|NOT COMPLETED|Overall Study||12
105222|NCT01215643|251380|P2|NOT COMPLETED|Overall Study||4
105223|NCT01215643|251381|P1|NOT COMPLETED|Overall Study||9
105224|NCT01215643|251377|P5|COMPLETED|Overall Study||29
105225|NCT01215643|251378|P4|COMPLETED|Overall Study||35
105226|NCT01215643|251379|P3|COMPLETED|Overall Study||82
105227|NCT01215643|251380|P2|COMPLETED|Overall Study||80
105228|NCT01215643|251381|P1|COMPLETED|Overall Study||74
105229|NCT01215643|251377|P5|STARTED|Overall Study||40
105230|NCT01215643|251378|P4|STARTED|Overall Study||39
105231|NCT01215643|251379|P3|STARTED|Overall Study||94
105232|NCT01215643|251380|P2|STARTED|Overall Study||84
105233|NCT01215643|251381|P1|STARTED|Overall Study||83
105234|NCT01215513|251483|P1|NOT COMPLETED|Overall Study||45
105235|NCT01215513|251483|P1|COMPLETED|Overall Study||112
105236|NCT01215513|251483|P1|CS42A Safety Analysis Set|Overall Study|127 participants were enrolled in the extension study CS42A|127
105237|NCT01215513|251483|P1|CS42 and CS42A Full Analysis Set|Overall Study|155 participants received at least 1 dose of degarelix and had at least 1 efficacy assessment|155
105238|NCT01215513|251483|P1|CS42 and CS42A Safety Analysis Set|Overall Study|156 participants received at least 1 dose of degarelix|156
105239|NCT01215513|251483|P1|STARTED|Overall Study|157 participants were allocated to treatment in CS42 main study (Intent-to-treat analysis set)|157
105241|NCT01215435|251493|P1|NOT COMPLETED|Overall Study||19
105242|NCT01215435|251492|P2|COMPLETED|Overall Study||107
105243|NCT01215435|251493|P1|COMPLETED|Overall Study||103
105244|NCT01215435|251492|P2|STARTED|Overall Study||123
105245|NCT01215435|251493|P1|STARTED|Overall Study||122
105246|NCT01215422|251507|P4|NOT COMPLETED|Overall Study||8
105247|NCT01215422|251508|P3|NOT COMPLETED|Overall Study||3
105248|NCT01215422|251509|P2|NOT COMPLETED|Overall Study||0
105249|NCT01215422|251510|P1|NOT COMPLETED|Overall Study||8
105250|NCT01215422|251507|P4|COMPLETED|Overall Study||193
105251|NCT01215422|251508|P3|COMPLETED|Overall Study||193
105252|NCT01215422|251509|P2|COMPLETED|Overall Study||249
105253|NCT01215422|251510|P1|COMPLETED|Overall Study||6
105254|NCT01215422|251507|P4|STARTED|Overall Study||201
105255|NCT01215422|251508|P3|STARTED|Overall Study||196
105256|NCT01215422|251509|P2|STARTED|Overall Study||249
105257|NCT01215422|251510|P1|STARTED|Overall Study||14
105258|NCT01215357|251532|P1|NOT COMPLETED|Overall Study||12
105259|NCT01215357|251532|P1|COMPLETED|Overall Study||22
105260|NCT01215357|251532|P1|STARTED|Overall Study||34
105261|NCT01215344|251538|P2|NOT COMPLETED|Overall Study||0
105262|NCT01215344|251539|P1|NOT COMPLETED|Overall Study||10
105263|NCT01215344|251538|P2|COMPLETED|Overall Study||3
105264|NCT01215344|251539|P1|COMPLETED|Overall Study||23
105265|NCT01215344|251538|P2|STARTED|Overall Study||3
105266|NCT01215344|251539|P1|STARTED|Overall Study||33
105267|NCT01215292|251552|P5|NOT COMPLETED|Overall Study||0
105268|NCT01215292|251553|P4|NOT COMPLETED|Overall Study||0
105269|NCT01215292|251554|P3|NOT COMPLETED|Overall Study||0
105270|NCT01215292|251555|P2|NOT COMPLETED|Overall Study||0
105271|NCT01215292|251556|P1|NOT COMPLETED|Overall Study||0
105272|NCT01215292|251552|P5|COMPLETED|Overall Study||8
105273|NCT01215292|251553|P4|COMPLETED|Overall Study||8
105274|NCT01215292|251554|P3|COMPLETED|Overall Study||8
105275|NCT01215292|251555|P2|COMPLETED|Overall Study||8
105276|NCT01215292|251556|P1|COMPLETED|Overall Study||8
105277|NCT01215292|251552|P5|STARTED|Overall Study||8
105278|NCT01215292|251553|P4|STARTED|Overall Study||8
105279|NCT01215292|251554|P3|STARTED|Overall Study||8
105280|NCT01215292|251555|P2|STARTED|Overall Study||8
105281|NCT01215292|251556|P1|STARTED|Overall Study||8
105282|NCT01215279|251580|P2|NOT COMPLETED|Overall Study||0
105283|NCT01215279|251581|P1|NOT COMPLETED|Overall Study||0
105284|NCT01215279|251580|P2|COMPLETED|Overall Study||32
105285|NCT01215279|251581|P1|COMPLETED|Overall Study||31
105286|NCT01215279|251580|P2|STARTED|Overall Study||32
105287|NCT01215279|251581|P1|STARTED|Overall Study||31
105288|NCT01215227|251651|P6|NOT COMPLETED|Overall Study||58
105289|NCT01215227|251652|P5|NOT COMPLETED|Overall Study||48
105290|NCT01215227|251653|P4|NOT COMPLETED|Overall Study||49
105291|NCT01215227|251654|P3|NOT COMPLETED|Overall Study||57
105292|NCT01215227|251655|P2|NOT COMPLETED|Overall Study||119
105293|NCT01215227|251656|P1|NOT COMPLETED|Overall Study||121
105294|NCT01215227|251651|P6|COMPLETED|Overall Study||51
105295|NCT01215227|251652|P5|COMPLETED|Overall Study||45
105296|NCT01215227|251653|P4|COMPLETED|Overall Study||48
105297|NCT01215227|251654|P3|COMPLETED|Overall Study||50
105298|NCT01215227|251655|P2|COMPLETED|Overall Study||96
105299|NCT01215227|251656|P1|COMPLETED|Overall Study||97
105300|NCT01215227|251651|P6|Treated|Overall Study||108
105301|NCT01215227|251652|P5|Treated|Overall Study||93
105302|NCT01215227|251653|P4|Treated|Overall Study||96
105303|NCT01215227|251654|P3|Treated|Overall Study||106
105304|NCT01215227|251655|P2|Treated|Overall Study||215
105305|NCT01215227|251656|P1|Treated|Overall Study||218
105306|NCT01215227|251651|P6|STARTED|Overall Study||109
105307|NCT01215227|251652|P5|STARTED|Overall Study||93
105308|NCT01215227|251653|P4|STARTED|Overall Study||97
105309|NCT01215227|251654|P3|STARTED|Overall Study||107
105310|NCT01215227|251655|P2|STARTED|Overall Study||215
105311|NCT01215227|251656|P1|STARTED|Overall Study||218
105312|NCT01215123|251700|P1|NOT COMPLETED|Overall Study||0
105313|NCT01215123|251700|P1|COMPLETED|Overall Study||28
105314|NCT01215123|251700|P1|STARTED|Overall Study||28
105315|NCT01215110|251710|P5|NOT COMPLETED|Overall Study||0
105316|NCT01215110|251711|P4|NOT COMPLETED|Overall Study||1
105317|NCT01215110|251712|P3|NOT COMPLETED|Overall Study||2
105318|NCT01215110|251713|P2|NOT COMPLETED|Overall Study||0
105319|NCT01215110|251714|P1|NOT COMPLETED|Overall Study||0
105320|NCT01215110|251710|P5|COMPLETED|Overall Study||8
105321|NCT01215110|251711|P4|COMPLETED|Overall Study||14
105322|NCT01215110|251712|P3|COMPLETED|Overall Study||13
105323|NCT01215110|251713|P2|COMPLETED|Overall Study||15
105324|NCT01215110|251714|P1|COMPLETED|Overall Study||15
105325|NCT01215110|251710|P5|STARTED|Overall Study||8
105326|NCT01215110|251711|P4|STARTED|Overall Study||15
105327|NCT01215110|251712|P3|STARTED|Overall Study||15
105328|NCT01215110|251713|P2|STARTED|Overall Study||15
105329|NCT01215110|251714|P1|STARTED|Overall Study||15
105330|NCT01215097|251775|P2|NOT COMPLETED|Overall Study||14
105331|NCT01215097|251776|P1|NOT COMPLETED|Overall Study||12
105332|NCT01215097|251775|P2|COMPLETED|Overall Study||191
105333|NCT01215097|251776|P1|COMPLETED|Overall Study||88
105334|NCT01215097|251775|P2|STARTED|Overall Study|Patients who are randomised and treated with linagliptin.|205
105335|NCT01215097|251776|P1|STARTED|Overall Study|Patients who are randomised and treated with placebo. 1 patient was not treated then not included.|100
105336|NCT01215032|251808|P1|NOT COMPLETED|Overall Study||20
105337|NCT01215032|251808|P1|COMPLETED|Overall Study||1
105338|NCT01215032|251808|P1|STARTED|Overall Study||21
105339|NCT01214980|251818|P2|NOT COMPLETED|Overall Study||2
105340|NCT01214980|251819|P1|NOT COMPLETED|Overall Study||3
105341|NCT01214980|251818|P2|COMPLETED|Overall Study||14
105342|NCT01214980|251819|P1|COMPLETED|Overall Study||13
105343|NCT01214980|251818|P2|STARTED|Overall Study||16
105344|NCT01214980|251819|P1|STARTED|Overall Study||16
105345|NCT01214915|251833|P1|NOT COMPLETED|Overall Study||11
105346|NCT01214915|251833|P1|COMPLETED|Overall Study||42
105347|NCT01214915|251833|P1|STARTED|Overall Study||53
105348|NCT01214850|251844|P3|NOT COMPLETED|Overall Study||161
105349|NCT01214850|251845|P2|NOT COMPLETED|Overall Study||144
105350|NCT01214850|251846|P1|NOT COMPLETED|Overall Study||183
105351|NCT01214850|251844|P3|COMPLETED|Overall Study||826
105352|NCT01214850|251845|P2|COMPLETED|Overall Study||844
105353|NCT01214850|251846|P1|COMPLETED|Overall Study||796
105354|NCT01214850|251844|P3|STARTED|Overall Study||987
105355|NCT01214850|251845|P2|STARTED|Overall Study||988
105356|NCT01214850|251846|P1|STARTED|Overall Study||979
105357|NCT01214837|251930|P3|NOT COMPLETED|Overall Study||62
105358|NCT01214837|251931|P2|NOT COMPLETED|Overall Study||64
105359|NCT01214837|251932|P1|NOT COMPLETED|Overall Study||54
105360|NCT01214837|251930|P3|COMPLETED|Overall Study||184
105361|NCT01214837|251931|P2|COMPLETED|Overall Study||192
105362|NCT01214837|251932|P1|COMPLETED|Overall Study||195
105363|NCT01214837|251930|P3|STARTED|Overall Study||246
105364|NCT01214837|251931|P2|STARTED|Overall Study||256
105365|NCT01214837|251932|P1|STARTED|Overall Study||249
105366|NCT01214824|251969|P1|NOT COMPLETED|Overall Study||3
105367|NCT01214824|251969|P1|COMPLETED|Overall Study||29
105368|NCT01214824|251969|P1|STARTED|Overall Study||32
105369|NCT01214811|251976|P1|NOT COMPLETED|Overall Study||3
105370|NCT01214811|251976|P1|COMPLETED|Overall Study||24
105371|NCT01214811|251976|P1|STARTED|Overall Study||27
105372|NCT01213823|251982|P2|NOT COMPLETED|Overall Study||0
105373|NCT01213823|251983|P1|NOT COMPLETED|Overall Study||0
105374|NCT01213823|251982|P2|COMPLETED|Overall Study||467
105375|NCT01213823|251983|P1|COMPLETED|Overall Study||69
105376|NCT01213823|251982|P2|STARTED|Overall Study||467
105377|NCT01213823|251983|P1|STARTED|Overall Study||69
105378|NCT01213706|251989|P1|NOT COMPLETED|WBPA||0
105379|NCT01213706|251989|P1|COMPLETED|WBPA||45
105380|NCT01213706|251989|P1|STARTED|WBPA||45
105381|NCT01213706|251989|P1|NOT COMPLETED|Washout (1 Hour)||0
105382|NCT01213706|251989|P1|COMPLETED|Washout (1 Hour)||45
105383|NCT01213706|251989|P1|STARTED|Washout (1 Hour)||45
105384|NCT01213706|251989|P1|NOT COMPLETED|Sham WBPA||0
105385|NCT01213706|251989|P1|COMPLETED|Sham WBPA||45
105386|NCT01213706|251989|P1|STARTED|Sham WBPA||45
105387|NCT01213589|251998|P3|NOT COMPLETED|Overall Study||8
105388|NCT01213589|251999|P2|NOT COMPLETED|Overall Study||5
105389|NCT01213589|252000|P1|NOT COMPLETED|Overall Study||13
105390|NCT01213589|251998|P3|COMPLETED|Overall Study||18
105391|NCT01213589|251999|P2|COMPLETED|Overall Study||19
105392|NCT01213589|252000|P1|COMPLETED|Overall Study||37
105393|NCT01213589|251998|P3|STARTED|Overall Study||26
105394|NCT01213589|251999|P2|STARTED|Overall Study||24
105395|NCT01213589|252000|P1|STARTED|Overall Study||50
105396|NCT01213576|252030|P4|NOT COMPLETED|Overall Study||4
105397|NCT01213576|252031|P3|NOT COMPLETED|Overall Study||5
105398|NCT01213576|252032|P2|NOT COMPLETED|Overall Study||4
105399|NCT01213576|252033|P1|NOT COMPLETED|Overall Study||3
105400|NCT01213576|252030|P4|COMPLETED|Overall Study||13
105401|NCT01213576|252031|P3|COMPLETED|Overall Study||13
105402|NCT01213576|252032|P2|COMPLETED|Overall Study||13
105403|NCT01213576|252033|P1|COMPLETED|Overall Study||15
105404|NCT01213576|252030|P4|STARTED|Overall Study||17
105405|NCT01213576|252031|P3|STARTED|Overall Study||18
105406|NCT01213576|252032|P2|STARTED|Overall Study||17
105407|NCT01213576|252033|P1|STARTED|Overall Study||18
105408|NCT01214759|252047|P1|NOT COMPLETED|Overall Study||48
105409|NCT01214759|252047|P1|COMPLETED|Overall Study||55
105410|NCT01214759|252047|P1|28 Days nPEP Completion|Overall Study||85
105411|NCT01214759|252047|P1|STARTED|Overall Study||103
105412|NCT01214720|252055|P2|NOT COMPLETED|Overall Study||68
105413|NCT01214720|252056|P1|NOT COMPLETED|Overall Study||85
105414|NCT01214720|252055|P2|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|233
105415|NCT01214720|252056|P1|COMPLETED|Overall Study|Indicates patients who had died at the time of the data cut-off|221
105416|NCT01214720|252055|P2|STARTED|Overall Study||301
105417|NCT01214720|252056|P1|STARTED|Overall Study||306
105418|NCT01214616|252077|P4|NOT COMPLETED|Overall Study||6
105419|NCT01214616|252078|P3|NOT COMPLETED|Overall Study||3
105420|NCT01214616|252079|P2|NOT COMPLETED|Overall Study||5
105421|NCT01214616|252080|P1|NOT COMPLETED|Overall Study||3
105422|NCT01214616|252077|P4|COMPLETED|Overall Study||0
105423|NCT01214616|252078|P3|COMPLETED|Overall Study||0
105424|NCT01214616|252079|P2|COMPLETED|Overall Study||0
105425|NCT01214616|252080|P1|COMPLETED|Overall Study||0
105426|NCT01214616|252077|P4|STARTED|Overall Study|Cohort 3 with afatinib/vinorelbine modification. Skipping vinorelbine allowed and not considered DLT|6
105427|NCT01214616|252078|P3|STARTED|Overall Study||3
105428|NCT01214616|252079|P2|STARTED|Overall Study||5
105429|NCT01214616|252080|P1|STARTED|Overall Study||3
105430|NCT01214434|252116|P2|NOT COMPLETED|Overall Study||2
105431|NCT01214434|252117|P1|NOT COMPLETED|Overall Study||4
105432|NCT01214434|252116|P2|COMPLETED|Overall Study||25
105433|NCT01214434|252117|P1|COMPLETED|Overall Study||11
105434|NCT01214434|252116|P2|STARTED|Overall Study||27
105435|NCT01214434|252117|P1|STARTED|Overall Study||15
105436|NCT01214395|252133|P1|NOT COMPLETED|Overall Study||5
105437|NCT01214395|252133|P1|COMPLETED|Overall Study||0
105438|NCT01214395|252133|P1|STARTED|Overall Study||5
105439|NCT01214330|252138|P1|NOT COMPLETED|Overall Study||48
105440|NCT01214330|252138|P1|COMPLETED|Overall Study||102
105441|NCT01214330|252138|P1|STARTED|Overall Study||150
105442|NCT01214252|252142|P1|NOT COMPLETED|Overall Study||82
105443|NCT01214252|252142|P1|COMPLETED|Overall Study||343
105444|NCT01214252|252142|P1|STARTED|Overall Study||425
105445|NCT01214239|252150|P2|NOT COMPLETED|Overall Study||18
105446|NCT01214239|252151|P1|NOT COMPLETED|Overall Study||12
105447|NCT01214239|252150|P2|COMPLETED|Overall Study||182
105448|NCT01214239|252151|P1|COMPLETED|Overall Study||87
105449|NCT01214239|252150|P2|STARTED|Overall Study|patients who were randomised and treated with placebo. 1 patient was not treated then not included|200
105450|NCT01214239|252151|P1|STARTED|Overall Study|patients who were randomised and treated with placebo|99
105451|NCT01214187|252185|P2|NOT COMPLETED|Overall Study||6
105452|NCT01214187|252186|P1|NOT COMPLETED|Overall Study||7
105453|NCT01214187|252185|P2|COMPLETED|Overall Study||23
105454|NCT01214187|252186|P1|COMPLETED|Overall Study||22
105455|NCT01214187|252185|P2|STARTED|Overall Study||29
105456|NCT01214187|252186|P1|STARTED|Overall Study||29
105457|NCT01214174|252203|P3|NOT COMPLETED|Overall Study||1
105458|NCT01214174|252204|P2|NOT COMPLETED|Overall Study||0
105459|NCT01214174|252205|P1|NOT COMPLETED|Overall Study||0
105460|NCT01214174|252203|P3|COMPLETED|Overall Study||13
105461|NCT01214174|252204|P2|COMPLETED|Overall Study||16
105462|NCT01214174|252205|P1|COMPLETED|Overall Study||13
105463|NCT01214174|252203|P3|STARTED|Overall Study||14
105464|NCT01214174|252204|P2|STARTED|Overall Study||16
105465|NCT01214174|252205|P1|STARTED|Overall Study||13
105466|NCT01214161|252215|P2|NOT COMPLETED|Overall Study||0
105467|NCT01214161|252216|P1|NOT COMPLETED|Overall Study||0
105468|NCT01214161|252215|P2|COMPLETED|Overall Study||100
105469|NCT01214161|252216|P1|COMPLETED|Overall Study||100
105470|NCT01214161|252215|P2|STARTED|Overall Study||100
105471|NCT01214161|252216|P1|STARTED|Overall Study||100
105472|NCT01214109|252226|P4|NOT COMPLETED|Overall Study||0
105473|NCT01214109|252227|P3|NOT COMPLETED|Overall Study||0
105474|NCT01214109|252228|P2|NOT COMPLETED|Overall Study||0
105475|NCT01214109|252229|P1|NOT COMPLETED|Overall Study||0
105476|NCT01214109|252226|P4|COMPLETED|Overall Study||24
105477|NCT01214109|252227|P3|COMPLETED|Overall Study||24
105478|NCT01214109|252228|P2|COMPLETED|Overall Study||24
105479|NCT01214109|252229|P1|COMPLETED|Overall Study||24
105480|NCT01214109|252226|P4|STARTED|Overall Study||24
105481|NCT01214109|252227|P3|STARTED|Overall Study||24
105482|NCT01214109|252228|P2|STARTED|Overall Study||24
105483|NCT01214109|252229|P1|STARTED|Overall Study||24
105484|NCT01214083|252321|P3|NOT COMPLETED|Overall Study||10
105485|NCT01214083|252322|P2|NOT COMPLETED|Overall Study||10
105486|NCT01214083|252323|P1|NOT COMPLETED|Overall Study||12
105487|NCT01214083|252321|P3|COMPLETED|Overall Study||21
105488|NCT01214083|252322|P2|COMPLETED|Overall Study||23
105489|NCT01214083|252323|P1|COMPLETED|Overall Study||19
105490|NCT01214083|252321|P3|STARTED|Overall Study||31
105491|NCT01214083|252322|P2|STARTED|Overall Study||33
105492|NCT01214083|252323|P1|STARTED|Overall Study||31
105493|NCT01213966|252359|P4|NOT COMPLETED|Overall Study||1
105494|NCT01213966|252360|P3|NOT COMPLETED|Overall Study||3
105495|NCT01213966|252361|P2|NOT COMPLETED|Overall Study||0
105496|NCT01213966|252362|P1|NOT COMPLETED|Overall Study||1
105497|NCT01213966|252359|P4|COMPLETED|Overall Study||20
105498|NCT01213966|252360|P3|COMPLETED|Overall Study||17
105499|NCT01213966|252361|P2|COMPLETED|Overall Study||20
105500|NCT01213966|252362|P1|COMPLETED|Overall Study||19
105501|NCT01213966|252359|P4|STARTED|Overall Study||21
105502|NCT01213966|252360|P3|STARTED|Overall Study||20
105503|NCT01213966|252361|P2|STARTED|Overall Study||20
105504|NCT01213966|252362|P1|STARTED|Overall Study||20
105505|NCT01213836|252374|P2|NOT COMPLETED|Period 2, Second Intervention||0
105506|NCT01213836|252375|P1|NOT COMPLETED|Period 2, Second Intervention||0
105507|NCT01213836|252374|P2|COMPLETED|Period 2, Second Intervention||29
105508|NCT01213836|252375|P1|COMPLETED|Period 2, Second Intervention||31
105509|NCT01213836|252374|P2|STARTED|Period 2, Second Intervention||29
105510|NCT01213836|252375|P1|STARTED|Period 2, Second Intervention||31
105511|NCT01213836|252374|P2|NOT COMPLETED|Period 1, First Intervention||3
105512|NCT01213836|252375|P1|NOT COMPLETED|Period 1, First Intervention||3
105513|NCT01213836|252374|P2|COMPLETED|Period 1, First Intervention||29
105514|NCT01213836|252375|P1|COMPLETED|Period 1, First Intervention||31
105515|NCT01213836|252374|P2|STARTED|Period 1, First Intervention||32
105516|NCT01213836|252375|P1|STARTED|Period 1, First Intervention||34
105517|NCT01213329|252395|P2|NOT COMPLETED|Phase 2||0
105518|NCT01213329|252396|P1|NOT COMPLETED|Phase 2||0
105519|NCT01213329|252395|P2|COMPLETED|Phase 2||0
105520|NCT01213329|252396|P1|COMPLETED|Phase 2||0
105521|NCT01213329|252395|P2|STARTED|Phase 2||0
105522|NCT01213329|252396|P1|STARTED|Phase 2||0
105523|NCT01213329|252395|P2|NOT COMPLETED|Screening||0
105524|NCT01213329|252396|P1|NOT COMPLETED|Screening||0
105525|NCT01213329|252395|P2|COMPLETED|Screening||25
105526|NCT01213329|252396|P1|COMPLETED|Screening||25
105527|NCT01213329|252395|P2|STARTED|Screening||25
105528|NCT01213329|252396|P1|STARTED|Screening||25
105529|NCT01213316|252402|P1|NOT COMPLETED|Overall Study||0
105530|NCT01213316|252402|P1|COMPLETED|Overall Study||451
105531|NCT01213316|252402|P1|Initial Cohort|Overall Study|Participants >=18 years of age in the initial cohort|272
105532|NCT01213316|252402|P1|Discontinued Treatment Before 48 Weeks|Overall Study||67
105533|NCT01213316|252402|P1|Amendment Cohort: Newly Enrolled|Overall Study|Participants >=50 years of age newly enrolled|179
105534|NCT01213316|252402|P1|Amendment Cohort: Prolonged Participants|Overall Study|Participants >=50 years of age in the initial cohort who accept an additional 48-week observation|48
105535|NCT01213316|252402|P1|STARTED|Overall Study|Participants in the initial and amendment cohorts|451
105536|NCT01213264|252421|P3|NOT COMPLETED|Overall Study||6
105537|NCT01213264|252422|P2|NOT COMPLETED|Overall Study||2
105538|NCT01213264|252423|P1|NOT COMPLETED|Overall Study||2
105539|NCT01213264|252421|P3|COMPLETED|Overall Study||321
105540|NCT01213264|252422|P2|COMPLETED|Overall Study||175
105541|NCT01213264|252423|P1|COMPLETED|Overall Study||153
105542|NCT01213264|252421|P3|STARTED|Overall Study||327
105543|NCT01213264|252422|P2|STARTED|Overall Study||177
105544|NCT01213264|252423|P1|STARTED|Overall Study||155
105545|NCT01213251|252443|P3|NOT COMPLETED|Overall Study||11
105546|NCT01213251|252444|P2|NOT COMPLETED|Overall Study||4
105547|NCT01213251|252445|P1|NOT COMPLETED|Overall Study||6
105548|NCT01213251|252443|P3|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
105773|NCT01212172|253011|P1|NOT COMPLETED|Overall Study||1
105549|NCT01213251|252444|P2|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|37
105550|NCT01213251|252445|P1|COMPLETED|Overall Study|Patients that had the 18-Month follow-up visit|34
105551|NCT01213251|252443|P3|STARTED|Overall Study||45
105552|NCT01213251|252444|P2|STARTED|Overall Study||41
105553|NCT01213251|252445|P1|STARTED|Overall Study||40
105554|NCT01213199|252466|P1|NOT COMPLETED|Overall Study||4
105555|NCT01213199|252466|P1|COMPLETED|Overall Study||16
105556|NCT01213199|252466|P1|STARTED|Overall Study||20
105557|NCT01213173|252472|P2|NOT COMPLETED|Overall Study||16
105558|NCT01213173|252473|P1|NOT COMPLETED|Overall Study||12
105559|NCT01213173|252472|P2|COMPLETED|Overall Study|Patients who completed the study|110
105560|NCT01213173|252473|P1|COMPLETED|Overall Study|Patients who completed the study|113
105561|NCT01213173|252472|P2|Patients Included in PP Population|Overall Study||89
105562|NCT01213173|252473|P1|Patients Included in PP Population|Overall Study||102
105563|NCT01213173|252472|P2|Patients Included in ITT Population|Overall Study||115
105564|NCT01213173|252473|P1|Patients Included in ITT Population|Overall Study||116
105565|NCT01213173|252472|P2|Patients Included in Safety Population|Overall Study||112
105566|NCT01213173|252473|P1|Patients Included in Safety Population|Overall Study||139
105567|NCT01213173|252472|P2|STARTED|Overall Study|Patients who were randomized and received treatment|126
105568|NCT01213173|252473|P1|STARTED|Overall Study|Patients who were randomized and received treatment|125
105569|NCT01213043|252505|P2|NOT COMPLETED|Follow-up||0
105570|NCT01213043|252506|P1|NOT COMPLETED|Follow-up||0
105571|NCT01213043|252505|P2|COMPLETED|Follow-up||15
105572|NCT01213043|252506|P1|COMPLETED|Follow-up||15
105573|NCT01213043|252505|P2|STARTED|Follow-up||15
105574|NCT01213043|252506|P1|STARTED|Follow-up||15
105575|NCT01213043|252505|P2|NOT COMPLETED|Treatment Period 2||0
105576|NCT01213043|252506|P1|NOT COMPLETED|Treatment Period 2||0
105577|NCT01213043|252505|P2|COMPLETED|Treatment Period 2||15
105578|NCT01213043|252506|P1|COMPLETED|Treatment Period 2||15
105579|NCT01213043|252505|P2|STARTED|Treatment Period 2||15
105580|NCT01213043|252506|P1|STARTED|Treatment Period 2||15
105581|NCT01213043|252505|P2|NOT COMPLETED|Washout Period||0
105582|NCT01213043|252506|P1|NOT COMPLETED|Washout Period||0
105583|NCT01213043|252505|P2|COMPLETED|Washout Period||15
105584|NCT01213043|252506|P1|COMPLETED|Washout Period||15
105585|NCT01213043|252505|P2|STARTED|Washout Period||15
105586|NCT01213043|252506|P1|STARTED|Washout Period||15
105587|NCT01213043|252505|P2|NOT COMPLETED|Treatment Period 1||0
105588|NCT01213043|252506|P1|NOT COMPLETED|Treatment Period 1||0
105589|NCT01213043|252505|P2|COMPLETED|Treatment Period 1||15
105590|NCT01213043|252506|P1|COMPLETED|Treatment Period 1||15
105591|NCT01213043|252505|P2|STARTED|Treatment Period 1||15
105592|NCT01213043|252506|P1|STARTED|Treatment Period 1||15
105593|NCT01212991|252534|P2|NOT COMPLETED|Overall Study||374
105594|NCT01212991|252535|P1|NOT COMPLETED|Overall Study||613
105595|NCT01212991|252534|P2|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|471
105596|NCT01212991|252535|P1|COMPLETED|Overall Study|Indicates participants continuing in long-term follow-up as of 16SEP2013.|259
105597|NCT01212991|252534|P2|STARTED|Overall Study||845
105598|NCT01212991|252535|P1|STARTED|Overall Study||872
105599|NCT01212874|252555|P2|NOT COMPLETED|Overall Study||23
105600|NCT01212874|252556|P1|NOT COMPLETED|Overall Study||22
105601|NCT01212874|252555|P2|COMPLETED|Overall Study||12
105602|NCT01212874|252556|P1|COMPLETED|Overall Study||13
105603|NCT01212874|252555|P2|Received Allocated Intervention|Overall Study||12
105604|NCT01212874|252556|P1|Received Allocated Intervention|Overall Study||13
105605|NCT01212874|252555|P2|STARTED|Overall Study||35
105606|NCT01212874|252556|P1|STARTED|Overall Study||35
105743|NCT01212484|252951|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
105607|NCT01212770|252567|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
105608|NCT01212770|252568|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||3
105609|NCT01212770|252569|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
105610|NCT01212770|252570|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||11
105611|NCT01212770|252571|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
105612|NCT01212770|252572|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
105613|NCT01212770|252573|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
105614|NCT01212770|252567|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
105615|NCT01212770|252568|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
105616|NCT01212770|252569|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||23
105617|NCT01212770|252570|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||32
105618|NCT01212770|252571|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||126
105619|NCT01212770|252572|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||120
105620|NCT01212770|252573|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
105621|NCT01212770|252567|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
105622|NCT01212770|252568|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|47
105623|NCT01212770|252569|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||25
105624|NCT01212770|252570|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who escaped early and completed Week 24 did not enter the active treatment phase|43
105625|NCT01212770|252571|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Seven participants who completed the placebo-controlled phase did not enter this phase|138
105694|NCT01212757|252766|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105626|NCT01212770|252572|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed the placebo-controlled phase did not enter this phase|139
105627|NCT01212770|252573|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
105628|NCT01212770|252567|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105629|NCT01212770|252568|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105630|NCT01212770|252569|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105631|NCT01212770|252570|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105632|NCT01212770|252571|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
105633|NCT01212770|252572|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
105634|NCT01212770|252573|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||23
105635|NCT01212770|252567|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105636|NCT01212770|252568|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105637|NCT01212770|252569|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105638|NCT01212770|252570|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105639|NCT01212770|252571|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||145
105640|NCT01212770|252572|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||147
105641|NCT01212770|252573|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
105642|NCT01212770|252567|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105643|NCT01212770|252568|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105644|NCT01212770|252569|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105645|NCT01212770|252570|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105646|NCT01212770|252571|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|53
105647|NCT01212770|252572|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||76
105648|NCT01212770|252573|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|One participant who escaped early did not complete Week 24|97
105649|NCT01212770|252567|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105650|NCT01212770|252568|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105651|NCT01212770|252569|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105652|NCT01212770|252570|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105653|NCT01212770|252571|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
105654|NCT01212770|252572|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||157
105655|NCT01212770|252573|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||156
105656|NCT01212770|252567|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105657|NCT01212770|252568|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105658|NCT01212770|252569|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105659|NCT01212770|252570|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105660|NCT01212770|252571|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||167
105661|NCT01212770|252572|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
105662|NCT01212770|252573|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||169
105663|NCT01212770|252567|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105664|NCT01212770|252568|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105665|NCT01212770|252569|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105666|NCT01212770|252570|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105667|NCT01212770|252571|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||167
105668|NCT01212770|252572|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
105669|NCT01212770|252573|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||169
105670|NCT01212757|252763|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
105671|NCT01212757|252764|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
105672|NCT01212757|252765|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
105673|NCT01212757|252766|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||8
105674|NCT01212757|252767|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||20
105675|NCT01212757|252768|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
105676|NCT01212757|252769|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
105677|NCT01212757|252763|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||28
105678|NCT01212757|252764|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
105679|NCT01212757|252765|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||25
105680|NCT01212757|252766|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||35
105681|NCT01212757|252767|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||114
105682|NCT01212757|252768|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||125
105683|NCT01212757|252769|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
105684|NCT01212757|252763|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||28
105685|NCT01212757|252764|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|Two participants who escaped early and completed Week 24 did not enter the active treatment phase|41
105686|NCT01212757|252765|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||27
105687|NCT01212757|252766|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)||43
105688|NCT01212757|252767|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Eight participants who completed Week 24 did not enter the active treatment phase|134
105689|NCT01212757|252768|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Six participants who completed Week 24 did not enter the active treatment phase|137
105690|NCT01212757|252769|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
105691|NCT01212757|252763|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105692|NCT01212757|252764|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105693|NCT01212757|252765|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105695|NCT01212757|252767|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||21
105696|NCT01212757|252768|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
105697|NCT01212757|252769|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||19
105698|NCT01212757|252763|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105699|NCT01212757|252764|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105700|NCT01212757|252765|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105701|NCT01212757|252766|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
105702|NCT01212757|252767|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||142
105703|NCT01212757|252768|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||143
105704|NCT01212757|252769|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|Two participants who completed Week 24 did not enter the active treatment phase|143
105705|NCT01212757|252763|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105706|NCT01212757|252764|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105707|NCT01212757|252765|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105708|NCT01212757|252766|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105709|NCT01212757|252767|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||64
105710|NCT01212757|252768|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Three participants who escaped early did not complete Week 24|59
105711|NCT01212757|252769|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Two participants who escaped early did not complete Week 24|88
105712|NCT01212757|252763|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105713|NCT01212757|252764|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105714|NCT01212757|252765|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105715|NCT01212757|252766|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
105716|NCT01212757|252767|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||149
105717|NCT01212757|252768|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||151
105718|NCT01212757|252769|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||148
105719|NCT01212757|252763|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105720|NCT01212757|252764|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105721|NCT01212757|252765|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105722|NCT01212757|252766|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
105723|NCT01212757|252767|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||162
105724|NCT01212757|252768|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||163
105725|NCT01212757|252769|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||159
105726|NCT01212757|252763|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105727|NCT01212757|252764|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105728|NCT01212757|252765|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105729|NCT01212757|252766|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
105730|NCT01212757|252767|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
105731|NCT01212757|252768|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||163
105732|NCT01212757|252769|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||162
105733|NCT01212627|252946|P1|NOT COMPLETED|Overall Study||0
105734|NCT01212627|252946|P1|COMPLETED|Overall Study||12
105735|NCT01212627|252946|P1|STARTED|Overall Study||12
105736|NCT01212484|252950|P2|NOT COMPLETED|Second Intervention (4 Weeks)||1
105737|NCT01212484|252951|P1|NOT COMPLETED|Second Intervention (4 Weeks)||0
105738|NCT01212484|252950|P2|COMPLETED|Second Intervention (4 Weeks)||3
105739|NCT01212484|252951|P1|COMPLETED|Second Intervention (4 Weeks)||5
105740|NCT01212484|252950|P2|STARTED|Second Intervention (4 Weeks)||4
105741|NCT01212484|252951|P1|STARTED|Second Intervention (4 Weeks)||5
105742|NCT01212484|252950|P2|NOT COMPLETED|First Intervention (4 Weeks)||2
105744|NCT01212484|252950|P2|COMPLETED|First Intervention (4 Weeks)||4
105745|NCT01212484|252951|P1|COMPLETED|First Intervention (4 Weeks)||5
105746|NCT01212484|252950|P2|STARTED|First Intervention (4 Weeks)||6
105747|NCT01212484|252951|P1|STARTED|First Intervention (4 Weeks)||5
105748|NCT01212484|252950|P2|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||0
105749|NCT01212484|252951|P1|NOT COMPLETED|Carbidopa Titration Period (4 Weeks)||1
105750|NCT01212484|252950|P2|COMPLETED|Carbidopa Titration Period (4 Weeks)||6
105751|NCT01212484|252951|P1|COMPLETED|Carbidopa Titration Period (4 Weeks)||5
105752|NCT01212484|252950|P2|STARTED|Carbidopa Titration Period (4 Weeks)||6
105753|NCT01212484|252951|P1|STARTED|Carbidopa Titration Period (4 Weeks)||6
105754|NCT01212445|252964|P3|NOT COMPLETED|Overall Study||0
105755|NCT01212445|252965|P2|NOT COMPLETED|Overall Study||0
105756|NCT01212445|252966|P1|NOT COMPLETED|Overall Study||0
105757|NCT01212445|252964|P3|COMPLETED|Overall Study||51
105758|NCT01212445|252965|P2|COMPLETED|Overall Study||51
105759|NCT01212445|252966|P1|COMPLETED|Overall Study||52
105760|NCT01212445|252964|P3|STARTED|Overall Study||51
105761|NCT01212445|252965|P2|STARTED|Overall Study||51
105762|NCT01212445|252966|P1|STARTED|Overall Study||52
105763|NCT01212302|252995|P1|NOT COMPLETED|Overall Study||0
105764|NCT01212302|252995|P1|COMPLETED|Overall Study||504
105765|NCT01212302|252995|P1|STARTED|Overall Study||504
105766|NCT01212185|253001|P2|NOT COMPLETED|Overall Study||1
105767|NCT01212185|253002|P1|NOT COMPLETED|Overall Study||2
105768|NCT01212185|253001|P2|COMPLETED|Overall Study||7
105769|NCT01212185|253002|P1|COMPLETED|Overall Study||4
105770|NCT01212185|253001|P2|STARTED|Overall Study||8
105771|NCT01212185|253002|P1|STARTED|Overall Study||6
105772|NCT01212172|253010|P2|NOT COMPLETED|Overall Study||1
105774|NCT01212172|253010|P2|COMPLETED|Overall Study||9
105775|NCT01212172|253011|P1|COMPLETED|Overall Study||9
105776|NCT01212172|253010|P2|STARTED|Overall Study||10
105777|NCT01212172|253011|P1|STARTED|Overall Study||10
105778|NCT01212159|253021|P2|NOT COMPLETED|Overall Study||12
105779|NCT01212159|253022|P1|NOT COMPLETED|Overall Study||12
105780|NCT01212159|253021|P2|COMPLETED|Overall Study||32
105781|NCT01212159|253022|P1|COMPLETED|Overall Study||14
105782|NCT01212159|253021|P2|STARTED|Overall Study||44
105783|NCT01212159|253022|P1|STARTED|Overall Study||26
105784|NCT01212094|253035|P3|NOT COMPLETED|Years 2 & 3: Treatment Randomization||11
105785|NCT01212094|253036|P2|NOT COMPLETED|Years 2 & 3: Treatment Randomization||4
105786|NCT01212094|253037|P1|NOT COMPLETED|Years 2 & 3: Treatment Randomization||0
105787|NCT01212094|253035|P3|COMPLETED|Years 2 & 3: Treatment Randomization||7
105788|NCT01212094|253036|P2|COMPLETED|Years 2 & 3: Treatment Randomization||5
105789|NCT01212094|253037|P1|COMPLETED|Years 2 & 3: Treatment Randomization||0
105790|NCT01212094|253035|P3|STARTED|Years 2 & 3: Treatment Randomization||18
105791|NCT01212094|253036|P2|STARTED|Years 2 & 3: Treatment Randomization||9
105792|NCT01212094|253037|P1|STARTED|Years 2 & 3: Treatment Randomization||0
105793|NCT01212094|253035|P3|NOT COMPLETED|Year 1: Baseline Monitoring||0
105794|NCT01212094|253036|P2|NOT COMPLETED|Year 1: Baseline Monitoring||0
105795|NCT01212094|253037|P1|NOT COMPLETED|Year 1: Baseline Monitoring||16
105796|NCT01212094|253035|P3|COMPLETED|Year 1: Baseline Monitoring||0
105797|NCT01212094|253036|P2|COMPLETED|Year 1: Baseline Monitoring||0
105798|NCT01212094|253037|P1|COMPLETED|Year 1: Baseline Monitoring||27
105799|NCT01212094|253035|P3|STARTED|Year 1: Baseline Monitoring||0
105800|NCT01212094|253036|P2|STARTED|Year 1: Baseline Monitoring||0
105801|NCT01212094|253037|P1|STARTED|Year 1: Baseline Monitoring||43
105802|NCT01211873|253071|P3|NOT COMPLETED|Overall Study||2
105803|NCT01211873|253072|P2|NOT COMPLETED|Overall Study||2
105804|NCT01211873|253073|P1|NOT COMPLETED|Overall Study||5
105805|NCT01211873|253071|P3|COMPLETED|Overall Study||36
105806|NCT01211873|253072|P2|COMPLETED|Overall Study||117
105807|NCT01211873|253073|P1|COMPLETED|Overall Study||240
105808|NCT01211873|253071|P3|STARTED|Overall Study||38
105809|NCT01211873|253072|P2|STARTED|Overall Study||119
105810|NCT01211873|253073|P1|STARTED|Overall Study||245
105811|NCT01211769|253084|P4|NOT COMPLETED|Overall Study||11
105812|NCT01211769|253085|P3|NOT COMPLETED|Overall Study||8
105813|NCT01211769|253086|P2|NOT COMPLETED|Overall Study||10
105814|NCT01211769|253087|P1|NOT COMPLETED|Overall Study||9
105815|NCT01211769|253084|P4|COMPLETED|Overall Study||9
105816|NCT01211769|253085|P3|COMPLETED|Overall Study||12
105817|NCT01211769|253086|P2|COMPLETED|Overall Study||10
105818|NCT01211769|253087|P1|COMPLETED|Overall Study||11
105819|NCT01211769|253084|P4|Participants/Group|Overall Study||20
105820|NCT01211769|253085|P3|Participants/Group|Overall Study||20
105821|NCT01211769|253086|P2|Participants/Group|Overall Study||20
105822|NCT01211769|253087|P1|Participants/Group|Overall Study||20
105823|NCT01211769|253084|P4|STARTED|Overall Study||20
105824|NCT01211769|253085|P3|STARTED|Overall Study||20
105825|NCT01211769|253086|P2|STARTED|Overall Study||20
105826|NCT01211769|253087|P1|STARTED|Overall Study||20
105827|NCT01211730|253107|P2|NOT COMPLETED|Overall Study||0
105828|NCT01211730|253108|P1|NOT COMPLETED|Overall Study||0
105829|NCT01211730|253107|P2|COMPLETED|Overall Study||82
105830|NCT01211730|253108|P1|COMPLETED|Overall Study||82
105831|NCT01211730|253107|P2|STARTED|Overall Study||82
105832|NCT01211730|253108|P1|STARTED|Overall Study||82
105833|NCT01211665|253126|P2|NOT COMPLETED|Overall Study||0
105834|NCT01211665|253127|P1|NOT COMPLETED|Overall Study||2
105835|NCT01211665|253126|P2|COMPLETED|Overall Study|completed treatment with study drug|1
105836|NCT01211665|253127|P1|COMPLETED|Overall Study||0
105837|NCT01211665|253126|P2|STARTED|Overall Study||1
105838|NCT01211665|253127|P1|STARTED|Overall Study||2
105839|NCT01211613|253154|P3|NOT COMPLETED|Overall Study||2
105840|NCT01211613|253155|P2|NOT COMPLETED|Overall Study||2
105841|NCT01211613|253156|P1|NOT COMPLETED|Overall Study||3
105842|NCT01211613|253154|P3|COMPLETED|Overall Study||33
105843|NCT01211613|253155|P2|COMPLETED|Overall Study||33
105844|NCT01211613|253156|P1|COMPLETED|Overall Study||34
105845|NCT01211613|253154|P3|STARTED|Overall Study||35
105846|NCT01211613|253155|P2|STARTED|Overall Study||35
105847|NCT01211613|253156|P1|STARTED|Overall Study||37
105848|NCT01211535|253169|P2|NOT COMPLETED|Overall Study||1
105849|NCT01211535|253170|P1|NOT COMPLETED|Overall Study||0
105850|NCT01211535|253169|P2|COMPLETED|Overall Study||51
105851|NCT01211535|253170|P1|COMPLETED|Overall Study||52
105852|NCT01211535|253169|P2|STARTED|Overall Study||52
105853|NCT01211535|253170|P1|STARTED|Overall Study||52
105854|NCT01211340|253178|P2|NOT COMPLETED|Overall Study||0
105855|NCT01211340|253179|P1|NOT COMPLETED|Overall Study||0
105856|NCT01211340|253178|P2|COMPLETED|Overall Study||223
105857|NCT01211340|253179|P1|COMPLETED|Overall Study||223
105858|NCT01211340|253178|P2|STARTED|Overall Study||223
105859|NCT01211340|253179|P1|STARTED|Overall Study||223
105860|NCT01211197|253189|P6|NOT COMPLETED|Treatment Period 3 (1 Day)||0
105861|NCT01211197|253190|P5|NOT COMPLETED|Treatment Period 3 (1 Day)||0
105862|NCT01211197|253191|P4|NOT COMPLETED|Treatment Period 3 (1 Day)||0
105863|NCT01211197|253192|P3|NOT COMPLETED|Treatment Period 3 (1 Day)||0
105864|NCT01211197|253193|P2|NOT COMPLETED|Treatment Period 3 (1 Day)||0
105865|NCT01211197|253194|P1|NOT COMPLETED|Treatment Period 3 (1 Day)||0
105866|NCT01211197|253189|P6|COMPLETED|Treatment Period 3 (1 Day)||2
105867|NCT01211197|253190|P5|COMPLETED|Treatment Period 3 (1 Day)||2
105868|NCT01211197|253191|P4|COMPLETED|Treatment Period 3 (1 Day)||3
105869|NCT01211197|253192|P3|COMPLETED|Treatment Period 3 (1 Day)||2
105870|NCT01211197|253193|P2|COMPLETED|Treatment Period 3 (1 Day)||3
105871|NCT01211197|253194|P1|COMPLETED|Treatment Period 3 (1 Day)||2
105872|NCT01211197|253189|P6|STARTED|Treatment Period 3 (1 Day)||2
105873|NCT01211197|253190|P5|STARTED|Treatment Period 3 (1 Day)||2
105874|NCT01211197|253191|P4|STARTED|Treatment Period 3 (1 Day)||3
105875|NCT01211197|253192|P3|STARTED|Treatment Period 3 (1 Day)||2
105876|NCT01211197|253193|P2|STARTED|Treatment Period 3 (1 Day)||3
105877|NCT01211197|253194|P1|STARTED|Treatment Period 3 (1 Day)||2
105878|NCT01211197|253189|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
105879|NCT01211197|253190|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
105880|NCT01211197|253191|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
105881|NCT01211197|253192|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
105882|NCT01211197|253193|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
105883|NCT01211197|253194|P1|NOT COMPLETED|Washout Period 2 (7 Days)||1
105884|NCT01211197|253189|P6|COMPLETED|Washout Period 2 (7 Days)||2
105885|NCT01211197|253190|P5|COMPLETED|Washout Period 2 (7 Days)||2
105886|NCT01211197|253191|P4|COMPLETED|Washout Period 2 (7 Days)||3
105887|NCT01211197|253192|P3|COMPLETED|Washout Period 2 (7 Days)||2
105888|NCT01211197|253193|P2|COMPLETED|Washout Period 2 (7 Days)||3
105889|NCT01211197|253194|P1|COMPLETED|Washout Period 2 (7 Days)||2
105890|NCT01211197|253189|P6|STARTED|Washout Period 2 (7 Days)||2
105891|NCT01211197|253190|P5|STARTED|Washout Period 2 (7 Days)||2
105892|NCT01211197|253191|P4|STARTED|Washout Period 2 (7 Days)||3
105893|NCT01211197|253192|P3|STARTED|Washout Period 2 (7 Days)||2
105894|NCT01211197|253193|P2|STARTED|Washout Period 2 (7 Days)||3
105895|NCT01211197|253194|P1|STARTED|Washout Period 2 (7 Days)||3
105896|NCT01211197|253189|P6|NOT COMPLETED|Treatment Period 2 (1 Day)||0
105897|NCT01211197|253190|P5|NOT COMPLETED|Treatment Period 2 (1 Day)||0
105898|NCT01211197|253191|P4|NOT COMPLETED|Treatment Period 2 (1 Day)||0
105899|NCT01211197|253192|P3|NOT COMPLETED|Treatment Period 2 (1 Day)||0
105900|NCT01211197|253193|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
105901|NCT01211197|253194|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
105902|NCT01211197|253189|P6|COMPLETED|Treatment Period 2 (1 Day)||2
105903|NCT01211197|253190|P5|COMPLETED|Treatment Period 2 (1 Day)||2
105904|NCT01211197|253191|P4|COMPLETED|Treatment Period 2 (1 Day)||3
105905|NCT01211197|253192|P3|COMPLETED|Treatment Period 2 (1 Day)||2
105906|NCT01211197|253193|P2|COMPLETED|Treatment Period 2 (1 Day)||3
105907|NCT01211197|253194|P1|COMPLETED|Treatment Period 2 (1 Day)||3
105908|NCT01211197|253189|P6|STARTED|Treatment Period 2 (1 Day)||2
105909|NCT01211197|253190|P5|STARTED|Treatment Period 2 (1 Day)||2
105910|NCT01211197|253191|P4|STARTED|Treatment Period 2 (1 Day)||3
105911|NCT01211197|253192|P3|STARTED|Treatment Period 2 (1 Day)||2
105912|NCT01211197|253193|P2|STARTED|Treatment Period 2 (1 Day)||3
105913|NCT01211197|253194|P1|STARTED|Treatment Period 2 (1 Day)||3
105914|NCT01211197|253189|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
105915|NCT01211197|253190|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
105916|NCT01211197|253191|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
105917|NCT01211197|253192|P3|NOT COMPLETED|Washout Period 1 (7 Days)||1
105918|NCT01211197|253193|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
105919|NCT01211197|253194|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
105920|NCT01211197|253189|P6|COMPLETED|Washout Period 1 (7 Days)||2
105921|NCT01211197|253190|P5|COMPLETED|Washout Period 1 (7 Days)||2
105922|NCT01211197|253191|P4|COMPLETED|Washout Period 1 (7 Days)||3
105923|NCT01211197|253192|P3|COMPLETED|Washout Period 1 (7 Days)||2
105924|NCT01211197|253193|P2|COMPLETED|Washout Period 1 (7 Days)||3
105925|NCT01211197|253194|P1|COMPLETED|Washout Period 1 (7 Days)||3
105926|NCT01211197|253189|P6|STARTED|Washout Period 1 (7 Days)||2
105927|NCT01211197|253190|P5|STARTED|Washout Period 1 (7 Days)||2
105928|NCT01211197|253191|P4|STARTED|Washout Period 1 (7 Days)||3
105929|NCT01211197|253192|P3|STARTED|Washout Period 1 (7 Days)||3
105930|NCT01211197|253193|P2|STARTED|Washout Period 1 (7 Days)||3
105931|NCT01211197|253194|P1|STARTED|Washout Period 1 (7 Days)||3
105932|NCT01211197|253189|P6|NOT COMPLETED|Treatment Period 1 (1 Day)||0
105933|NCT01211197|253190|P5|NOT COMPLETED|Treatment Period 1 (1 Day)||0
105934|NCT01211197|253191|P4|NOT COMPLETED|Treatment Period 1 (1 Day)||0
105935|NCT01211197|253192|P3|NOT COMPLETED|Treatment Period 1 (1 Day)||0
105936|NCT01211197|253193|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
105937|NCT01211197|253194|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
105938|NCT01211197|253189|P6|COMPLETED|Treatment Period 1 (1 Day)||2
105939|NCT01211197|253190|P5|COMPLETED|Treatment Period 1 (1 Day)||2
105940|NCT01211197|253191|P4|COMPLETED|Treatment Period 1 (1 Day)||3
105941|NCT01211197|253192|P3|COMPLETED|Treatment Period 1 (1 Day)||3
105942|NCT01211197|253193|P2|COMPLETED|Treatment Period 1 (1 Day)||3
105943|NCT01211197|253194|P1|COMPLETED|Treatment Period 1 (1 Day)||3
105944|NCT01211197|253189|P6|STARTED|Treatment Period 1 (1 Day)||2
105945|NCT01211197|253190|P5|STARTED|Treatment Period 1 (1 Day)||2
105946|NCT01211197|253191|P4|STARTED|Treatment Period 1 (1 Day)||3
105947|NCT01211197|253192|P3|STARTED|Treatment Period 1 (1 Day)||3
105948|NCT01211197|253193|P2|STARTED|Treatment Period 1 (1 Day)||3
105949|NCT01211197|253194|P1|STARTED|Treatment Period 1 (1 Day)||3
105950|NCT01211184|253241|P3|NOT COMPLETED|Overall Study||1
105951|NCT01211184|253242|P2|NOT COMPLETED|Overall Study||2
105952|NCT01211184|253243|P1|NOT COMPLETED|Overall Study||0
105953|NCT01211184|253241|P3|COMPLETED|Overall Study||19
105954|NCT01211184|253242|P2|COMPLETED|Overall Study||18
105955|NCT01211184|253243|P1|COMPLETED|Overall Study||20
105956|NCT01211184|253241|P3|STARTED|Overall Study||20
105957|NCT01211184|253242|P2|STARTED|Overall Study||20
105958|NCT01211184|253243|P1|STARTED|Overall Study||20
105959|NCT01211145|253258|P4|NOT COMPLETED|Overall Study||20
105960|NCT01211145|253259|P3|NOT COMPLETED|Overall Study||13
105961|NCT01211145|253260|P2|NOT COMPLETED|Overall Study||17
105962|NCT01211145|253261|P1|NOT COMPLETED|Overall Study||26
105963|NCT01211145|253258|P4|COMPLETED|Overall Study||268
105964|NCT01211145|253259|P3|COMPLETED|Overall Study||86
105965|NCT01211145|253260|P2|COMPLETED|Overall Study||98
105966|NCT01211145|253261|P1|COMPLETED|Overall Study|1 patient was not counted as completed or discontinued due to incomplete information (N=270-1=269).|270
105967|NCT01211145|253258|P4|STARTED|Overall Study||288
105968|NCT01211145|253259|P3|STARTED|Overall Study||99
105969|NCT01211145|253260|P2|STARTED|Overall Study||115
105970|NCT01211145|253261|P1|STARTED|Overall Study||296
105971|NCT01211106|253293|P2|NOT COMPLETED|Overall Study||11
105972|NCT01211106|253294|P1|NOT COMPLETED|Overall Study||13
105973|NCT01211106|253293|P2|COMPLETED|Overall Study||77
105974|NCT01211106|253294|P1|COMPLETED|Overall Study||82
105975|NCT01211106|253293|P2|STARTED|Overall Study||88
105976|NCT01211106|253294|P1|STARTED|Overall Study||95
105977|NCT01210820|253304|P2|NOT COMPLETED|Overall Study||0
105978|NCT01210820|253305|P1|NOT COMPLETED|Overall Study||0
105979|NCT01210820|253304|P2|COMPLETED|Overall Study||4
105980|NCT01210820|253305|P1|COMPLETED|Overall Study||17
105981|NCT01210820|253304|P2|STARTED|Overall Study||4
105982|NCT01210820|253305|P1|STARTED|Overall Study||17
105983|NCT01210807|253315|P2|NOT COMPLETED|Overall Study||3
105984|NCT01210807|253316|P1|NOT COMPLETED|Overall Study||3
105985|NCT01210807|253315|P2|COMPLETED|Overall Study||31
105986|NCT01210807|253316|P1|COMPLETED|Overall Study||33
105987|NCT01210807|253315|P2|STARTED|Overall Study||34
105988|NCT01210807|253316|P1|STARTED|Overall Study||36
105989|NCT01210716|253324|P2|NOT COMPLETED|Second TPE Procedure||0
105990|NCT01210716|253325|P1|NOT COMPLETED|Second TPE Procedure||3
105991|NCT01210716|253324|P2|COMPLETED|Second TPE Procedure||15
105992|NCT01210716|253325|P1|COMPLETED|Second TPE Procedure||15
105993|NCT01210716|253324|P2|STARTED|Second TPE Procedure||15
105994|NCT01210716|253325|P1|STARTED|Second TPE Procedure||18
105995|NCT01210716|253324|P2|NOT COMPLETED|First TPE Procedure||2
105996|NCT01210716|253325|P1|NOT COMPLETED|First TPE Procedure||2
105997|NCT01210716|253324|P2|COMPLETED|First TPE Procedure||15
105998|NCT01210716|253325|P1|COMPLETED|First TPE Procedure||18
105999|NCT01210716|253324|P2|STARTED|First TPE Procedure||17
106000|NCT01210716|253325|P1|STARTED|First TPE Procedure||20
106001|NCT01210690|253331|P1|NOT COMPLETED|Overall Study||26
106002|NCT01210690|253331|P1|COMPLETED|Overall Study||75
106003|NCT01210690|253331|P1|STARTED|Overall Study||101
106004|NCT01210651|253346|P2|NOT COMPLETED|Overall Study||8
106005|NCT01210651|253347|P1|NOT COMPLETED|Overall Study||5
106006|NCT01210651|253346|P2|COMPLETED|Overall Study||10
106007|NCT01210651|253347|P1|COMPLETED|Overall Study||15
106008|NCT01210651|253346|P2|Number Attending 1st Assigned Session|Overall Study||12
106009|NCT01210651|253347|P1|Number Attending 1st Assigned Session|Overall Study||18
106102|NCT01209702|253574|P4|STARTED|Overall Study||153
106010|NCT01210651|253346|P2|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|18
106011|NCT01210651|253347|P1|STARTED|Overall Study|Number randomized to intervention, but not number who started intervention by attending 1st session.|20
106012|NCT01210495|253365|P4|NOT COMPLETED|Overall Study||68
106013|NCT01210495|253366|P3|NOT COMPLETED|Overall Study||134
106014|NCT01210495|253367|P2|NOT COMPLETED|Overall Study||7
106015|NCT01210495|253368|P1|NOT COMPLETED|Overall Study||15
106016|NCT01210495|253365|P4|COMPLETED|Overall Study||0
106017|NCT01210495|253366|P3|COMPLETED|Overall Study||0
106018|NCT01210495|253367|P2|COMPLETED|Overall Study||0
106019|NCT01210495|253368|P1|COMPLETED|Overall Study||0
106020|NCT01210495|253365|P4|STARTED|Overall Study||68
106021|NCT01210495|253366|P3|STARTED|Overall Study||134
106022|NCT01210495|253367|P2|STARTED|Overall Study||7
106023|NCT01210495|253368|P1|STARTED|Overall Study||15
106024|NCT01210443|253430|P1|NOT COMPLETED|Overall Study||2
106025|NCT01210443|253430|P1|COMPLETED|Overall Study||0
106026|NCT01210443|253430|P1|STARTED|Overall Study||2
106027|NCT01210170|253438|P1|NOT COMPLETED|Overall Study||7
106028|NCT01210170|253438|P1|COMPLETED|Overall Study||15
106029|NCT01210170|253438|P1|STARTED|Overall Study||22
106030|NCT01210144|253454|P2|NOT COMPLETED|Overall Study||0
106031|NCT01210144|253455|P1|NOT COMPLETED|Overall Study||3
106032|NCT01210144|253454|P2|COMPLETED|Overall Study||11
106033|NCT01210144|253455|P1|COMPLETED|Overall Study||10
106034|NCT01210144|253454|P2|STARTED|Overall Study||11
106035|NCT01210144|253455|P1|STARTED|Overall Study||13
106036|NCT01210118|253477|P2|NOT COMPLETED|Overall Study||5
106037|NCT01210118|253478|P1|NOT COMPLETED|Overall Study||3
106038|NCT01210118|253477|P2|COMPLETED|Overall Study||42
106039|NCT01210118|253478|P1|COMPLETED|Overall Study||42
106040|NCT01210118|253477|P2|STARTED|Overall Study||47
106041|NCT01210118|253478|P1|STARTED|Overall Study||45
106042|NCT01210079|253492|P2|NOT COMPLETED|Overall Study||0
106043|NCT01210079|253493|P1|NOT COMPLETED|Overall Study||0
106044|NCT01210079|253492|P2|COMPLETED|Overall Study||16
106045|NCT01210079|253493|P1|COMPLETED|Overall Study||10
106046|NCT01210079|253492|P2|STARTED|Overall Study||16
106047|NCT01210079|253493|P1|STARTED|Overall Study||10
106048|NCT01210001|253502|P3|NOT COMPLETED|Overall Study||12
106049|NCT01210001|253503|P2|NOT COMPLETED|Overall Study||11
106050|NCT01210001|253504|P1|NOT COMPLETED|Overall Study||19
106051|NCT01210001|253502|P3|COMPLETED|Overall Study||156
106052|NCT01210001|253503|P2|COMPLETED|Overall Study||154
106053|NCT01210001|253504|P1|COMPLETED|Overall Study||147
106054|NCT01210001|253502|P3|STARTED|Overall Study||168
106055|NCT01210001|253503|P2|STARTED|Overall Study||165
106056|NCT01210001|253504|P1|STARTED|Overall Study||166
106057|NCT01209949|253524|P1|NOT COMPLETED|Overall Study||3
106058|NCT01209949|253524|P1|COMPLETED|Overall Study||27
106059|NCT01209949|253524|P1|STARTED|Overall Study||30
106060|NCT01209780|253534|P5|NOT COMPLETED|Overall Study||5
106061|NCT01209780|253535|P4|NOT COMPLETED|Overall Study||10
106062|NCT01209780|253536|P3|NOT COMPLETED|Overall Study||4
106063|NCT01209780|253537|P2|NOT COMPLETED|Overall Study||18
106064|NCT01209780|253538|P1|NOT COMPLETED|Overall Study||26
106065|NCT01209780|253534|P5|COMPLETED|Overall Study||407
106066|NCT01209780|253535|P4|COMPLETED|Overall Study||807
106067|NCT01209780|253536|P3|COMPLETED|Overall Study||44
106068|NCT01209780|253537|P2|COMPLETED|Overall Study||467
106069|NCT01209780|253538|P1|COMPLETED|Overall Study||1016
106070|NCT01209780|253534|P5|STARTED|Overall Study||412
106071|NCT01209780|253535|P4|STARTED|Overall Study||817
106072|NCT01209780|253536|P3|STARTED|Overall Study||48
106073|NCT01209780|253537|P2|STARTED|Overall Study||485
106074|NCT01209780|253538|P1|STARTED|Overall Study||1042
106075|NCT01209767|253564|P1|NOT COMPLETED|Overall Study||4
106076|NCT01209767|253564|P1|COMPLETED|Overall Study||18
106077|NCT01209767|253564|P1|STARTED|Overall Study||22
106078|NCT01209702|253574|P4|NOT COMPLETED|Overall Study||153
106079|NCT01209702|253575|P3|NOT COMPLETED|Overall Study||51
106080|NCT01209702|253576|P2|NOT COMPLETED|Overall Study||51
106081|NCT01209702|253577|P1|NOT COMPLETED|Overall Study||51
106082|NCT01209702|253574|P4|COMPLETED|Overall Study||0
106083|NCT01209702|253575|P3|COMPLETED|Overall Study||0
106084|NCT01209702|253576|P2|COMPLETED|Overall Study||0
106085|NCT01209702|253577|P1|COMPLETED|Overall Study||0
106086|NCT01209702|253574|P4|Completed 24 Weeks Treatment|Overall Study||10
106087|NCT01209702|253575|P3|Completed 24 Weeks Treatment|Overall Study||3
106088|NCT01209702|253576|P2|Completed 24 Weeks Treatment|Overall Study||28
106089|NCT01209702|253577|P1|Completed 24 Weeks Treatment|Overall Study||19
106090|NCT01209702|253574|P4|Completed 12 Weeks Treatment|Overall Study||59
106091|NCT01209702|253575|P3|Completed 12 Weeks Treatment|Overall Study||12
106092|NCT01209702|253576|P2|Completed 12 Weeks Treatment|Overall Study||48
106093|NCT01209702|253577|P1|Completed 12 Weeks Treatment|Overall Study||50
106094|NCT01209702|253574|P4|Escape or Switched to Tocilizumab|Overall Study||0
106095|NCT01209702|253575|P3|Escape or Switched to Tocilizumab|Overall Study||6
106096|NCT01209702|253576|P2|Escape or Switched to Tocilizumab|Overall Study||0
106097|NCT01209702|253577|P1|Escape or Switched to Tocilizumab|Overall Study||51
106098|NCT01209702|253574|P4|Treated|Overall Study||152
106099|NCT01209702|253575|P3|Treated|Overall Study||51
106100|NCT01209702|253576|P2|Treated|Overall Study||51
106101|NCT01209702|253577|P1|Treated|Overall Study||51
106103|NCT01209702|253575|P3|STARTED|Overall Study||51
106104|NCT01209702|253576|P2|STARTED|Overall Study||51
106105|NCT01209702|253577|P1|STARTED|Overall Study||51
106106|NCT01209689|253633|P2|NOT COMPLETED|Overall Study||22
106107|NCT01209689|253634|P1|NOT COMPLETED|Overall Study||91
106108|NCT01209689|253633|P2|COMPLETED|Overall Study||0
106109|NCT01209689|253634|P1|COMPLETED|Overall Study||0
106110|NCT01209689|253633|P2|STARTED|Overall Study||22
106111|NCT01209689|253634|P1|STARTED|Overall Study||91
106112|NCT01209624|253640|P1|NOT COMPLETED|Overall Study||326
106113|NCT01209624|253640|P1|COMPLETED|Overall Study||576
106114|NCT01209624|253640|P1|Per Protocol Population|Overall Study||469
106115|NCT01209624|253640|P1|STARTED|Overall Study||902
106116|NCT01209520|253671|P1|NOT COMPLETED|Overall Study||3
106117|NCT01209520|253671|P1|COMPLETED|Overall Study||3
106118|NCT01209520|253671|P1|STARTED|Overall Study||6
106119|NCT01209286|253679|P3|NOT COMPLETED|Overall Study||3
106120|NCT01209286|253680|P2|NOT COMPLETED|Overall Study||10
106121|NCT01209286|253681|P1|NOT COMPLETED|Overall Study||5
106122|NCT01209286|253679|P3|COMPLETED|Overall Study||3
106123|NCT01209286|253680|P2|COMPLETED|Overall Study||13
106124|NCT01209286|253681|P1|COMPLETED|Overall Study||2
106125|NCT01209286|253679|P3|STARTED|Overall Study||6
106126|NCT01209286|253680|P2|STARTED|Overall Study||23
106127|NCT01209286|253681|P1|STARTED|Overall Study||7
106128|NCT01209260|253734|P2|NOT COMPLETED|Overall Study||0
106129|NCT01209260|253735|P1|NOT COMPLETED|Overall Study||0
106130|NCT01209260|253734|P2|COMPLETED|Overall Study||36
106131|NCT01209260|253735|P1|COMPLETED|Overall Study||36
106132|NCT01209260|253734|P2|STARTED|Overall Study||36
106133|NCT01209260|253735|P1|STARTED|Overall Study||36
106134|NCT01209195|253749|P6|NOT COMPLETED|Overall Study||0
106135|NCT01209195|253750|P5|NOT COMPLETED|Overall Study||0
106136|NCT01209195|253751|P4|NOT COMPLETED|Overall Study||0
106137|NCT01209195|253752|P3|NOT COMPLETED|Overall Study||0
106138|NCT01209195|253753|P2|NOT COMPLETED|Overall Study||0
106139|NCT01209195|253754|P1|NOT COMPLETED|Overall Study||0
106140|NCT01209195|253749|P6|COMPLETED|Overall Study||13
106141|NCT01209195|253750|P5|COMPLETED|Overall Study||6
106142|NCT01209195|253751|P4|COMPLETED|Overall Study||6
106143|NCT01209195|253752|P3|COMPLETED|Overall Study||6
106144|NCT01209195|253753|P2|COMPLETED|Overall Study||3
106145|NCT01209195|253754|P1|COMPLETED|Overall Study||7
106146|NCT01209195|253749|P6|STARTED|Overall Study||13
106147|NCT01209195|253750|P5|STARTED|Overall Study||6
106148|NCT01209195|253751|P4|STARTED|Overall Study||6
106149|NCT01209195|253752|P3|STARTED|Overall Study||6
106150|NCT01209195|253753|P2|STARTED|Overall Study||3
106151|NCT01209195|253754|P1|STARTED|Overall Study||7
106152|NCT01209143|253790|P2|NOT COMPLETED|Overall Study||20
106153|NCT01209143|253791|P1|NOT COMPLETED|Overall Study||19
106154|NCT01209143|253790|P2|COMPLETED|Overall Study||8
106155|NCT01209143|253791|P1|COMPLETED|Overall Study||5
106156|NCT01209143|253790|P2|STARTED|Overall Study||28
106157|NCT01209143|253791|P1|STARTED|Overall Study||24
106158|NCT01208961|253799|P2|NOT COMPLETED|High-Fat Period IV||0
106159|NCT01208961|253800|P1|NOT COMPLETED|High-Fat Period IV||0
106160|NCT01208961|253799|P2|COMPLETED|High-Fat Period IV||26
106161|NCT01208961|253800|P1|COMPLETED|High-Fat Period IV||25
106162|NCT01208961|253799|P2|STARTED|High-Fat Period IV||26
106163|NCT01208961|253800|P1|STARTED|High-Fat Period IV||25
106164|NCT01208961|253799|P2|NOT COMPLETED|High-Fat Period III||0
106165|NCT01208961|253800|P1|NOT COMPLETED|High-Fat Period III||1
106166|NCT01208961|253799|P2|COMPLETED|High-Fat Period III||26
106167|NCT01208961|253800|P1|COMPLETED|High-Fat Period III||25
106168|NCT01208961|253799|P2|STARTED|High-Fat Period III||26
106169|NCT01208961|253800|P1|STARTED|High-Fat Period III||26
106170|NCT01208961|253799|P2|NOT COMPLETED|Low-Fat Period II||0
106171|NCT01208961|253800|P1|NOT COMPLETED|Low-Fat Period II||0
106172|NCT01208961|253799|P2|COMPLETED|Low-Fat Period II||27
106173|NCT01208961|253800|P1|COMPLETED|Low-Fat Period II||26
106174|NCT01208961|253799|P2|STARTED|Low-Fat Period II||27
106175|NCT01208961|253800|P1|STARTED|Low-Fat Period II||26
106176|NCT01208961|253799|P2|NOT COMPLETED|Low-Fat Period I||0
106177|NCT01208961|253800|P1|NOT COMPLETED|Low-Fat Period I||0
106178|NCT01208961|253799|P2|COMPLETED|Low-Fat Period I||27
106179|NCT01208961|253800|P1|COMPLETED|Low-Fat Period I||27
106180|NCT01208961|253799|P2|STARTED|Low-Fat Period I||27
106181|NCT01208961|253800|P1|STARTED|Low-Fat Period I||27
106182|NCT01208415|253809|P1|NOT COMPLETED|Overall Study||40
106183|NCT01208415|253809|P1|COMPLETED|Overall Study||0
106184|NCT01208415|253809|P1|6 Months|Overall Study||37
106185|NCT01208415|253809|P1|STARTED|Overall Study||40
106186|NCT01208402|253815|P2|NOT COMPLETED|Overall Study||0
106187|NCT01208402|253816|P1|NOT COMPLETED|Overall Study||1
106188|NCT01208402|253815|P2|COMPLETED|Overall Study||28
106189|NCT01208402|253816|P1|COMPLETED|Overall Study||30
106190|NCT01208402|253815|P2|STARTED|Overall Study||28
106191|NCT01208402|253816|P1|STARTED|Overall Study||31
106192|NCT01208337|253832|P1|NOT COMPLETED|Overall Study||3
106193|NCT01208337|253832|P1|COMPLETED|Overall Study||20
106194|NCT01208337|253832|P1|Five-year Follow-up|Overall Study||20
106195|NCT01208337|253832|P1|One-year Follow-up|Overall Study||23
106196|NCT01208337|253832|P1|STARTED|Overall Study||23
106197|NCT01208233|253846|P6|NOT COMPLETED|Overall Study||21
106198|NCT01208233|253847|P5|NOT COMPLETED|Overall Study||24
106199|NCT01208233|253848|P4|NOT COMPLETED|Overall Study||1
106200|NCT01208233|253849|P3|NOT COMPLETED|Overall Study||4
106201|NCT01208233|253850|P2|NOT COMPLETED|Overall Study||3
106202|NCT01208233|253851|P1|NOT COMPLETED|Overall Study||5
106203|NCT01208233|253846|P6|COMPLETED|Overall Study||46
106204|NCT01208233|253847|P5|COMPLETED|Overall Study||46
106205|NCT01208233|253848|P4|COMPLETED|Overall Study||9
106206|NCT01208233|253849|P3|COMPLETED|Overall Study||7
106207|NCT01208233|253850|P2|COMPLETED|Overall Study||6
106208|NCT01208233|253851|P1|COMPLETED|Overall Study||6
106209|NCT01208233|253846|P6|STARTED|Overall Study||67
106210|NCT01208233|253847|P5|STARTED|Overall Study||70
106211|NCT01208233|253848|P4|STARTED|Overall Study||10
106212|NCT01208233|253849|P3|STARTED|Overall Study||11
106213|NCT01208233|253850|P2|STARTED|Overall Study||9
106214|NCT01208233|253851|P1|STARTED|Overall Study||11
106215|NCT01208220|253964|P2|NOT COMPLETED|Overall Study||0
106216|NCT01208220|253965|P1|NOT COMPLETED|Overall Study||0
106217|NCT01208220|253964|P2|COMPLETED|Overall Study||1
106218|NCT01208220|253965|P1|COMPLETED|Overall Study||1
106219|NCT01208220|253964|P2|STARTED|Overall Study||1
106220|NCT01208220|253965|P1|STARTED|Overall Study||1
106221|NCT01208207|253976|P7|NOT COMPLETED|Part II||11
106222|NCT01208207|253977|P6|NOT COMPLETED|Part II||16
106223|NCT01208207|253978|P5|NOT COMPLETED|Part II||23
106224|NCT01208207|253979|P4|NOT COMPLETED|Part II||32
106225|NCT01208207|253980|P3|NOT COMPLETED|Part II||0
106226|NCT01208207|253981|P2|NOT COMPLETED|Part II||0
106227|NCT01208207|253982|P1|NOT COMPLETED|Part II||0
106228|NCT01208207|253976|P7|COMPLETED|Part II||131
106229|NCT01208207|253977|P6|COMPLETED|Part II||129
106230|NCT01208207|253978|P5|COMPLETED|Part II||295
106231|NCT01208207|253979|P4|COMPLETED|Part II||282
106232|NCT01208207|253980|P3|COMPLETED|Part II||0
106233|NCT01208207|253981|P2|COMPLETED|Part II||0
106234|NCT01208207|253982|P1|COMPLETED|Part II||0
106235|NCT01208207|253976|P7|STARTED|Part II||142
106236|NCT01208207|253977|P6|STARTED|Part II||145
106237|NCT01208207|253978|P5|STARTED|Part II||318
106238|NCT01208207|253979|P4|STARTED|Part II||314
106239|NCT01208207|253980|P3|STARTED|Part II||0
106240|NCT01208207|253981|P2|STARTED|Part II||0
106241|NCT01208207|253982|P1|STARTED|Part II||0
106242|NCT01208207|253976|P7|NOT COMPLETED|Part I||0
106243|NCT01208207|253977|P6|NOT COMPLETED|Part I||0
106244|NCT01208207|253978|P5|NOT COMPLETED|Part I||0
106245|NCT01208207|253979|P4|NOT COMPLETED|Part I||0
106246|NCT01208207|253980|P3|NOT COMPLETED|Part I||15
106247|NCT01208207|253981|P2|NOT COMPLETED|Part I||11
106248|NCT01208207|253982|P1|NOT COMPLETED|Part I||70
106249|NCT01208207|253976|P7|COMPLETED|Part I||0
106250|NCT01208207|253977|P6|COMPLETED|Part I||0
106251|NCT01208207|253978|P5|COMPLETED|Part I||0
106252|NCT01208207|253979|P4|COMPLETED|Part I||0
106253|NCT01208207|253980|P3|COMPLETED|Part I||142
106254|NCT01208207|253981|P2|COMPLETED|Part I||145
106255|NCT01208207|253982|P1|COMPLETED|Part I||632
106256|NCT01208207|253976|P7|STARTED|Part I||0
106257|NCT01208207|253977|P6|STARTED|Part I||0
106258|NCT01208207|253978|P5|STARTED|Part I||0
106259|NCT01208207|253979|P4|STARTED|Part I||0
106260|NCT01208207|253980|P3|STARTED|Part I||157
106261|NCT01208207|253981|P2|STARTED|Part I||156
106262|NCT01208207|253982|P1|STARTED|Part I||702
106263|NCT01208181|254009|P5|NOT COMPLETED|Part 2||0
106264|NCT01208181|254010|P4|NOT COMPLETED|Part 2||20
106265|NCT01208181|254011|P3|NOT COMPLETED|Part 2||16
106266|NCT01208181|254012|P2|NOT COMPLETED|Part 2||0
106267|NCT01208181|254013|P1|NOT COMPLETED|Part 2||0
106268|NCT01208181|254009|P5|COMPLETED|Part 2||0
106269|NCT01208181|254010|P4|COMPLETED|Part 2||343
106270|NCT01208181|254011|P3|COMPLETED|Part 2||334
106271|NCT01208181|254012|P2|COMPLETED|Part 2||0
106272|NCT01208181|254013|P1|COMPLETED|Part 2||0
106273|NCT01208181|254009|P5|STARTED|Part 2|Per protocol, participants did not receive placebo during Part II of the study|0
106274|NCT01208181|254010|P4|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 90 mg in Part II of the study|363
106275|NCT01208181|254011|P3|STARTED|Part 2|Participants receiving etoricoxib 60 mg in Part I received etoricoxib 60 mg in Part II of the study|350
106276|NCT01208181|254012|P2|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
106277|NCT01208181|254013|P1|STARTED|Part 2|Per protocol, there were no participants in this arm during Part II of the study|0
106278|NCT01208181|254009|P5|NOT COMPLETED|Part 1||22
106279|NCT01208181|254010|P4|NOT COMPLETED|Part 1||0
106280|NCT01208181|254011|P3|NOT COMPLETED|Part 1||0
106281|NCT01208181|254012|P2|NOT COMPLETED|Part 1||55
106282|NCT01208181|254013|P1|NOT COMPLETED|Part 1||99
106283|NCT01208181|254009|P5|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|96
106284|NCT01208181|254010|P4|COMPLETED|Part 1||0
106285|NCT01208181|254011|P3|COMPLETED|Part 1||0
106286|NCT01208181|254012|P2|COMPLETED|Part 1|Per protocol, participants in this arm did not continue into Part II of the study|413
106287|NCT01208181|254013|P1|COMPLETED|Part 1|Six participants from this arm did not continue into Part II of the study|719
106288|NCT01208181|254009|P5|STARTED|Part 1||118
106289|NCT01208181|254010|P4|STARTED|Part 1||0
106290|NCT01208181|254011|P3|STARTED|Part 1||0
106291|NCT01208181|254012|P2|STARTED|Part 1||468
106292|NCT01208181|254013|P1|STARTED|Part 1||818
106293|NCT01207934|254045|P3|NOT COMPLETED|Overall Study||0
106294|NCT01207934|254046|P2|NOT COMPLETED|Overall Study||0
106295|NCT01207934|254047|P1|NOT COMPLETED|Overall Study||0
106296|NCT01207934|254045|P3|COMPLETED|Overall Study||6
106297|NCT01207934|254046|P2|COMPLETED|Overall Study||6
106298|NCT01207934|254047|P1|COMPLETED|Overall Study||6
106299|NCT01207934|254045|P3|STARTED|Overall Study||6
106300|NCT01207934|254046|P2|STARTED|Overall Study||6
106301|NCT01207934|254047|P1|STARTED|Overall Study||6
106302|NCT01207765|254064|P1|NOT COMPLETED|Overall Study||0
106303|NCT01207765|254064|P1|COMPLETED|Overall Study||8
106304|NCT01207765|254064|P1|STARTED|Overall Study||8
106305|NCT01207687|254070|P1|NOT COMPLETED|Overall Study||2
106306|NCT01207687|254070|P1|COMPLETED|Overall Study||12
106307|NCT01207687|254070|P1|STARTED|Overall Study||14
106308|NCT01207648|254082|P1|NOT COMPLETED|Overall Study||0
106309|NCT01207648|254082|P1|COMPLETED|Overall Study||307
106310|NCT01207648|254082|P1|STARTED|Overall Study||307
106311|NCT01207596|254090|P1|NOT COMPLETED|Overall Study||9
106312|NCT01207596|254090|P1|COMPLETED|Overall Study||21
106313|NCT01207596|254090|P1|STARTED|Overall Study||30
106314|NCT01207583|254103|P3|NOT COMPLETED|Overall Study||1
106315|NCT01207583|254104|P2|NOT COMPLETED|Overall Study||5
106316|NCT01207583|254105|P1|NOT COMPLETED|Overall Study||1
106317|NCT01207583|254103|P3|COMPLETED|Overall Study||54
106318|NCT01207583|254104|P2|COMPLETED|Overall Study||26
106319|NCT01207583|254105|P1|COMPLETED|Overall Study||13
106320|NCT01207583|254103|P3|Dose 4|Overall Study||0
106321|NCT01207583|254104|P2|Dose 4|Overall Study||0
106322|NCT01207583|254105|P1|Dose 4|Overall Study||7
106323|NCT01207583|254103|P3|Dose 3|Overall Study||0
106324|NCT01207583|254104|P2|Dose 3|Overall Study||27
106325|NCT01207583|254105|P1|Dose 3|Overall Study||13
106326|NCT01207583|254103|P3|Dose 2|Overall Study||54
106327|NCT01207583|254104|P2|Dose 2|Overall Study||29
106328|NCT01207583|254105|P1|Dose 2|Overall Study||13
106329|NCT01207583|254103|P3|Dose 1|Overall Study||55
106330|NCT01207583|254104|P2|Dose 1|Overall Study||31
106331|NCT01207583|254105|P1|Dose 1|Overall Study||14
106332|NCT01207583|254103|P3|STARTED|Overall Study||55
106333|NCT01207583|254104|P2|STARTED|Overall Study||31
106334|NCT01207583|254105|P1|STARTED|Overall Study||14
106335|NCT01207570|254145|P2|NOT COMPLETED|The Second Stage (After Crossover)||0
106336|NCT01207570|254146|P1|NOT COMPLETED|The Second Stage (After Crossover)||0
106337|NCT01207570|254145|P2|COMPLETED|The Second Stage (After Crossover)||23
106338|NCT01207570|254146|P1|COMPLETED|The Second Stage (After Crossover)||31
106339|NCT01207570|254145|P2|STARTED|The Second Stage (After Crossover)||23
106340|NCT01207570|254146|P1|STARTED|The Second Stage (After Crossover)||31
106341|NCT01207570|254145|P2|NOT COMPLETED|The First Stage (Before Crossover)||0
106342|NCT01207570|254146|P1|NOT COMPLETED|The First Stage (Before Crossover)||0
106343|NCT01207570|254145|P2|COMPLETED|The First Stage (Before Crossover)||31
106344|NCT01207570|254146|P1|COMPLETED|The First Stage (Before Crossover)||23
106345|NCT01207570|254145|P2|STARTED|The First Stage (Before Crossover)||31
106346|NCT01207570|254146|P1|STARTED|The First Stage (Before Crossover)||23
106347|NCT01207492|254158|P1|NOT COMPLETED|Overall Study||15
106348|NCT01207492|254158|P1|COMPLETED|Overall Study||2
106349|NCT01207492|254158|P1|STARTED|Overall Study||17
106350|NCT01207466|254164|P2|NOT COMPLETED|Period 2, One Week of Wear||0
106351|NCT01207466|254165|P1|NOT COMPLETED|Period 2, One Week of Wear||0
106352|NCT01207466|254164|P2|COMPLETED|Period 2, One Week of Wear||48
106353|NCT01207466|254165|P1|COMPLETED|Period 2, One Week of Wear||45
106354|NCT01207466|254164|P2|STARTED|Period 2, One Week of Wear||48
106355|NCT01207466|254165|P1|STARTED|Period 2, One Week of Wear||45
106356|NCT01207466|254164|P2|NOT COMPLETED|Period 1, One Week of Wear||0
106357|NCT01207466|254165|P1|NOT COMPLETED|Period 1, One Week of Wear||0
106358|NCT01207466|254164|P2|COMPLETED|Period 1, One Week of Wear||48
106359|NCT01207466|254165|P1|COMPLETED|Period 1, One Week of Wear|One participant discontinued between Period 1 and Period 2 due to inclusion/exclusion criteria.|46
106360|NCT01207466|254164|P2|STARTED|Period 1, One Week of Wear||48
106361|NCT01207466|254165|P1|STARTED|Period 1, One Week of Wear||46
106362|NCT01207453|254173|P2|NOT COMPLETED|2nd Intervention||2
106363|NCT01207453|254174|P1|NOT COMPLETED|2nd Intervention||2
106364|NCT01207453|254173|P2|COMPLETED|2nd Intervention||15
106365|NCT01207453|254174|P1|COMPLETED|2nd Intervention||17
106366|NCT01207453|254173|P2|STARTED|2nd Intervention||17
106367|NCT01207453|254174|P1|STARTED|2nd Intervention||19
106368|NCT01207453|254173|P2|NOT COMPLETED|Washout||0
106369|NCT01207453|254174|P1|NOT COMPLETED|Washout||2
106370|NCT01207453|254173|P2|COMPLETED|Washout||17
106371|NCT01207453|254174|P1|COMPLETED|Washout||19
106372|NCT01207453|254173|P2|STARTED|Washout||17
106373|NCT01207453|254174|P1|STARTED|Washout||21
106374|NCT01207453|254173|P2|NOT COMPLETED|First Intervention||1
106375|NCT01207453|254174|P1|NOT COMPLETED|First Intervention||2
106376|NCT01207453|254173|P2|COMPLETED|First Intervention||17
106377|NCT01207453|254174|P1|COMPLETED|First Intervention||21
106378|NCT01207453|254173|P2|STARTED|First Intervention||18
106379|NCT01207453|254174|P1|STARTED|First Intervention||23
106380|NCT01207427|254196|P3|NOT COMPLETED|Run-out Placebo Period||0
106381|NCT01207427|254197|P2|NOT COMPLETED|Run-out Placebo Period||0
106382|NCT01207427|254198|P1|NOT COMPLETED|Run-out Placebo Period||0
106383|NCT01207427|254196|P3|COMPLETED|Run-out Placebo Period||41
106384|NCT01207427|254197|P2|COMPLETED|Run-out Placebo Period||43
106385|NCT01207427|254198|P1|COMPLETED|Run-out Placebo Period||40
106386|NCT01207427|254196|P3|STARTED|Run-out Placebo Period||41
106387|NCT01207427|254197|P2|STARTED|Run-out Placebo Period||43
106388|NCT01207427|254198|P1|STARTED|Run-out Placebo Period||40
106389|NCT01207427|254196|P3|NOT COMPLETED|Double-blind Treatment Period||2
106390|NCT01207427|254197|P2|NOT COMPLETED|Double-blind Treatment Period||2
106391|NCT01207427|254198|P1|NOT COMPLETED|Double-blind Treatment Period||3
106392|NCT01207427|254196|P3|COMPLETED|Double-blind Treatment Period||41
106393|NCT01207427|254197|P2|COMPLETED|Double-blind Treatment Period||43
106394|NCT01207427|254198|P1|COMPLETED|Double-blind Treatment Period||40
106395|NCT01207427|254196|P3|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
106396|NCT01207427|254197|P2|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||45
106397|NCT01207427|254198|P1|Received at Least 1 Dose of Study Drug|Double-blind Treatment Period||43
106398|NCT01207427|254196|P3|STARTED|Double-blind Treatment Period||43
106399|NCT01207427|254197|P2|STARTED|Double-blind Treatment Period||45
106400|NCT01207427|254198|P1|STARTED|Double-blind Treatment Period||43
106401|NCT01207427|254196|P3|NOT COMPLETED|Run-in Placebo Period||0
106402|NCT01207427|254197|P2|NOT COMPLETED|Run-in Placebo Period||0
106403|NCT01207427|254198|P1|NOT COMPLETED|Run-in Placebo Period||0
106404|NCT01207427|254196|P3|COMPLETED|Run-in Placebo Period||43
106405|NCT01207427|254197|P2|COMPLETED|Run-in Placebo Period||45
106406|NCT01207427|254198|P1|COMPLETED|Run-in Placebo Period||43
106407|NCT01207427|254196|P3|STARTED|Run-in Placebo Period||43
106408|NCT01207427|254197|P2|STARTED|Run-in Placebo Period||45
106409|NCT01207427|254198|P1|STARTED|Run-in Placebo Period||43
106410|NCT01207414|254208|P2|NOT COMPLETED|Overall Study||82
106411|NCT01207414|254209|P1|NOT COMPLETED|Overall Study||73
106412|NCT01207414|254208|P2|COMPLETED|Overall Study||178
106413|NCT01207414|254209|P1|COMPLETED|Overall Study||168
106414|NCT01207414|254208|P2|Safety Population: Received Study Drug|Overall Study||260
106415|NCT01207414|254209|P1|Safety Population: Received Study Drug|Overall Study||240
106416|NCT01207414|254208|P2|STARTED|Overall Study||260
106417|NCT01207414|254209|P1|STARTED|Overall Study|Includes 1 patient randomized in error.|241
106418|NCT01207401|254227|P2|NOT COMPLETED|Overall Study||0
106419|NCT01207401|254228|P1|NOT COMPLETED|Overall Study||0
106420|NCT01207401|254227|P2|COMPLETED|Overall Study||24
106421|NCT01207401|254228|P1|COMPLETED|Overall Study||26
106422|NCT01207401|254227|P2|STARTED|Overall Study||24
106423|NCT01207401|254228|P1|STARTED|Overall Study||26
106424|NCT01207388|254234|P1|NOT COMPLETED|Overall Study||33
106425|NCT01207388|254234|P1|COMPLETED|Overall Study|Completed the core study|83
106426|NCT01207388|254234|P1|STARTED|Overall Study||116
106427|NCT01207219|254257|P3|NOT COMPLETED|Overall Study||7
106428|NCT01207219|254258|P2|NOT COMPLETED|Overall Study||11
106429|NCT01207219|254259|P1|NOT COMPLETED|Overall Study||11
106430|NCT01207219|254257|P3|COMPLETED|Overall Study||32
106431|NCT01207219|254258|P2|COMPLETED|Overall Study||29
106432|NCT01207219|254259|P1|COMPLETED|Overall Study||34
106433|NCT01207219|254257|P3|Included in ITT Analysis|Overall Study||38
106434|NCT01207219|254258|P2|Included in ITT Analysis|Overall Study||37
106435|NCT01207219|254259|P1|Included in ITT Analysis|Overall Study||40
106436|NCT01207219|254257|P3|STARTED|Overall Study||39
106437|NCT01207219|254258|P2|STARTED|Overall Study||40
106438|NCT01207219|254259|P1|STARTED|Overall Study||45
106439|NCT01207102|254279|P1|NOT COMPLETED|Overall Study||10
106440|NCT01207102|254279|P1|COMPLETED|Overall Study||0
106441|NCT01207102|254279|P1|STARTED|Overall Study||10
106442|NCT01205828|254284|P1|NOT COMPLETED|Overall Study||0
106443|NCT01205828|254284|P1|COMPLETED|Overall Study|Completed the first stage of the study, terminated as pre-planned due to lack of efficacy|16
106444|NCT01205828|254284|P1|STARTED|Overall Study||16
106445|NCT01206777|254292|P1|NOT COMPLETED|Overall Study||2
106446|NCT01206777|254292|P1|COMPLETED|Overall Study||50
106447|NCT01206777|254292|P1|Discontinued Trial and Deemed Ineligible|Overall Study||2
106448|NCT01206777|254292|P1|STARTED|Overall Study||52
106449|NCT01206738|254301|P3|NOT COMPLETED|Overall Study||19
106450|NCT01206738|254302|P2|NOT COMPLETED|Overall Study||25
106451|NCT01206738|254303|P1|NOT COMPLETED|Overall Study||23
106452|NCT01206738|254301|P3|COMPLETED|Overall Study||42
106453|NCT01206738|254302|P2|COMPLETED|Overall Study||49
106454|NCT01206738|254303|P1|COMPLETED|Overall Study||40
106455|NCT01206738|254301|P3|STARTED|Overall Study||61
106456|NCT01206738|254302|P2|STARTED|Overall Study||74
106457|NCT01206738|254303|P1|STARTED|Overall Study||63
106458|NCT01206660|254315|P2|NOT COMPLETED|Overall Study||0
106459|NCT01206660|254316|P1|NOT COMPLETED|Overall Study||0
106460|NCT01206660|254315|P2|COMPLETED|Overall Study||60
106461|NCT01206660|254316|P1|COMPLETED|Overall Study||60
106462|NCT01206660|254315|P2|STARTED|Overall Study||60
106463|NCT01206660|254316|P1|STARTED|Overall Study||60
106464|NCT01206608|254328|P2|NOT COMPLETED|Overall Study||0
106465|NCT01206608|254329|P1|NOT COMPLETED|Overall Study||0
106466|NCT01206608|254328|P2|COMPLETED|Overall Study||20
106467|NCT01206608|254329|P1|COMPLETED|Overall Study||20
106468|NCT01206608|254328|P2|STARTED|Overall Study||20
106469|NCT01206608|254329|P1|STARTED|Overall Study||20
106470|NCT01206595|254337|P2|NOT COMPLETED|Overall Study||0
106471|NCT01206595|254338|P1|NOT COMPLETED|Overall Study||0
106472|NCT01206595|254337|P2|COMPLETED|Overall Study||20
106473|NCT01206595|254338|P1|COMPLETED|Overall Study||38
106474|NCT01206595|254337|P2|STARTED|Overall Study||20
106475|NCT01206595|254338|P1|STARTED|Overall Study||38
106476|NCT01206582|254348|P2|NOT COMPLETED|Overall Study||2
106477|NCT01206582|254349|P1|NOT COMPLETED|Overall Study||2
106478|NCT01206582|254348|P2|COMPLETED|Overall Study||7
106479|NCT01206582|254349|P1|COMPLETED|Overall Study||9
106480|NCT01206582|254348|P2|STARTED|Overall Study||9
106481|NCT01206582|254349|P1|STARTED|Overall Study||11
106482|NCT01206517|254381|P6|NOT COMPLETED|Overall Study||0
106483|NCT01206517|254382|P5|NOT COMPLETED|Overall Study||1
106484|NCT01206517|254383|P4|NOT COMPLETED|Overall Study||0
106485|NCT01206517|254384|P3|NOT COMPLETED|Overall Study||2
106486|NCT01206517|254385|P2|NOT COMPLETED|Overall Study||0
106487|NCT01206517|254386|P1|NOT COMPLETED|Overall Study||0
106488|NCT01206517|254381|P6|COMPLETED|Overall Study||4
106489|NCT01206517|254382|P5|COMPLETED|Overall Study||3
106490|NCT01206517|254383|P4|COMPLETED|Overall Study||4
106491|NCT01206517|254384|P3|COMPLETED|Overall Study||4
106492|NCT01206517|254385|P2|COMPLETED|Overall Study||6
106493|NCT01206517|254386|P1|COMPLETED|Overall Study||6
106494|NCT01206517|254381|P6|STARTED|Overall Study||4
106495|NCT01206517|254382|P5|STARTED|Overall Study||4
106496|NCT01206517|254383|P4|STARTED|Overall Study||4
106497|NCT01206517|254384|P3|STARTED|Overall Study||6
106498|NCT01206517|254385|P2|STARTED|Overall Study||6
106499|NCT01206517|254386|P1|STARTED|Overall Study||6
106500|NCT01206478|254417|P2|NOT COMPLETED|Overall Study||5
106501|NCT01206478|254418|P1|NOT COMPLETED|Overall Study||2
106502|NCT01206478|254417|P2|COMPLETED|Overall Study||7
106503|NCT01206478|254418|P1|COMPLETED|Overall Study||7
106504|NCT01206478|254417|P2|STARTED|Overall Study||12
106505|NCT01206478|254418|P1|STARTED|Overall Study||9
106506|NCT01206452|254428|P2|NOT COMPLETED|Overall Study||0
106507|NCT01206452|254429|P1|NOT COMPLETED|Overall Study||0
106508|NCT01206452|254428|P2|COMPLETED|Overall Study||30
106509|NCT01206452|254429|P1|COMPLETED|Overall Study||30
106510|NCT01206452|254428|P2|STARTED|Overall Study||30
106511|NCT01206452|254429|P1|STARTED|Overall Study||30
106512|NCT01206439|254443|P1|NOT COMPLETED|Overall Study||1
106513|NCT01206439|254443|P1|COMPLETED|Overall Study||1
106514|NCT01206439|254443|P1|STARTED|Overall Study||2
106515|NCT01206387|254449|P2|NOT COMPLETED|Overall Study||0
106516|NCT01206387|254450|P1|NOT COMPLETED|Overall Study||1
106517|NCT01206387|254449|P2|COMPLETED|Overall Study||60
106518|NCT01206387|254450|P1|COMPLETED|Overall Study||59
106519|NCT01206387|254449|P2|STARTED|Overall Study||60
106520|NCT01206387|254450|P1|STARTED|Overall Study||60
106521|NCT01206322|254466|P4|NOT COMPLETED|Overall Study||1
106522|NCT01206322|254467|P3|NOT COMPLETED|Overall Study||0
106523|NCT01206322|254468|P2|NOT COMPLETED|Overall Study||0
106524|NCT01206322|254469|P1|NOT COMPLETED|Overall Study||0
106525|NCT01206322|254466|P4|COMPLETED|Overall Study||5
106526|NCT01206322|254467|P3|COMPLETED|Overall Study||9
106527|NCT01206322|254468|P2|COMPLETED|Overall Study||11
106528|NCT01206322|254469|P1|COMPLETED|Overall Study||4
106529|NCT01206322|254466|P4|STARTED|Overall Study||6
106530|NCT01206322|254467|P3|STARTED|Overall Study||9
106531|NCT01206322|254468|P2|STARTED|Overall Study||11
106532|NCT01206322|254469|P1|STARTED|Overall Study||4
106533|NCT01206140|254485|P2|NOT COMPLETED|Overall Study||0
106534|NCT01206140|254486|P1|NOT COMPLETED|Overall Study||1
106535|NCT01206140|254485|P2|COMPLETED|Overall Study||35
106536|NCT01206140|254486|P1|COMPLETED|Overall Study||34
106537|NCT01206140|254485|P2|STARTED|Overall Study||35
106538|NCT01206140|254486|P1|STARTED|Overall Study||35
106539|NCT01206101|254498|P2|NOT COMPLETED|Overall Study||1
106540|NCT01206101|254499|P1|NOT COMPLETED|Overall Study||2
106541|NCT01206101|254498|P2|COMPLETED|Overall Study||0
106542|NCT01206101|254499|P1|COMPLETED|Overall Study||0
106543|NCT01206101|254498|P2|STARTED|Overall Study||1
106544|NCT01206101|254499|P1|STARTED|Overall Study||2
106545|NCT01205685|254515|P1|NOT COMPLETED|Overall Study||11
106546|NCT01205685|254515|P1|COMPLETED|Overall Study||0
106547|NCT01205685|254515|P1|STARTED|Overall Study||11
106548|NCT01205646|254522|P1|NOT COMPLETED|Overall Study||0
106549|NCT01205646|254522|P1|COMPLETED|Overall Study||11
106550|NCT01205646|254522|P1|STARTED|Overall Study||11
106551|NCT01205581|254532|P6|NOT COMPLETED|Overall Study||0
106552|NCT01205581|254533|P5|NOT COMPLETED|Overall Study||0
106553|NCT01205581|254534|P4|NOT COMPLETED|Overall Study||0
106554|NCT01205581|254535|P3|NOT COMPLETED|Overall Study||0
106555|NCT01205581|254536|P2|NOT COMPLETED|Overall Study||0
106556|NCT01205581|254537|P1|NOT COMPLETED|Overall Study||1
106557|NCT01205581|254532|P6|COMPLETED|Overall Study||20
106558|NCT01205581|254533|P5|COMPLETED|Overall Study||20
106559|NCT01205581|254534|P4|COMPLETED|Overall Study||9
106560|NCT01205581|254535|P3|COMPLETED|Overall Study||8
106561|NCT01205581|254536|P2|COMPLETED|Overall Study||13
106562|NCT01205581|254537|P1|COMPLETED|Overall Study||13
106563|NCT01205581|254532|P6|STARTED|Overall Study||20
106564|NCT01205581|254533|P5|STARTED|Overall Study||20
106565|NCT01205581|254534|P4|STARTED|Overall Study||9
106566|NCT01205581|254535|P3|STARTED|Overall Study||8
106567|NCT01205581|254536|P2|STARTED|Overall Study||13
106568|NCT01205581|254537|P1|STARTED|Overall Study||14
106569|NCT01205503|254603|P2|NOT COMPLETED|Second Intervention (2nd Cycle)||0
106570|NCT01205503|254604|P1|NOT COMPLETED|Second Intervention (2nd Cycle)||0
106571|NCT01205503|254603|P2|COMPLETED|Second Intervention (2nd Cycle)||16
106572|NCT01205503|254604|P1|COMPLETED|Second Intervention (2nd Cycle)||16
106573|NCT01205503|254603|P2|STARTED|Second Intervention (2nd Cycle)||16
106574|NCT01205503|254604|P1|STARTED|Second Intervention (2nd Cycle)||16
106575|NCT01205503|254603|P2|NOT COMPLETED|First Intervention (1st Cycle)||0
106576|NCT01205503|254604|P1|NOT COMPLETED|First Intervention (1st Cycle)||0
106577|NCT01205503|254603|P2|COMPLETED|First Intervention (1st Cycle)||16
106578|NCT01205503|254604|P1|COMPLETED|First Intervention (1st Cycle)||16
106579|NCT01205503|254603|P2|STARTED|First Intervention (1st Cycle)||16
106580|NCT01205503|254604|P1|STARTED|First Intervention (1st Cycle)||16
106581|NCT01205451|254620|P2|NOT COMPLETED|Overall Study||10
106582|NCT01205451|254621|P1|NOT COMPLETED|Overall Study||6
106583|NCT01205451|254620|P2|COMPLETED|Overall Study||46
106584|NCT01205451|254621|P1|COMPLETED|Overall Study||47
106585|NCT01205451|254620|P2|STARTED|Overall Study||56
106586|NCT01205451|254621|P1|STARTED|Overall Study||53
106587|NCT01205399|254663|P1|NOT COMPLETED|Overall Study||0
106588|NCT01205399|254663|P1|COMPLETED|Overall Study||78
106589|NCT01205399|254663|P1|STARTED|Overall Study||78
106590|NCT01205269|254669|P6|NOT COMPLETED|Period 5 - Third Intervention||0
106591|NCT01205269|254670|P5|NOT COMPLETED|Period 5 - Third Intervention||0
106592|NCT01205269|254671|P4|NOT COMPLETED|Period 5 - Third Intervention||0
106593|NCT01205269|254672|P3|NOT COMPLETED|Period 5 - Third Intervention||0
106594|NCT01205269|254673|P2|NOT COMPLETED|Period 5 - Third Intervention||0
106595|NCT01205269|254674|P1|NOT COMPLETED|Period 5 - Third Intervention||0
106596|NCT01205269|254669|P6|COMPLETED|Period 5 - Third Intervention||5
106597|NCT01205269|254670|P5|COMPLETED|Period 5 - Third Intervention||5
106598|NCT01205269|254671|P4|COMPLETED|Period 5 - Third Intervention||5
106599|NCT01205269|254672|P3|COMPLETED|Period 5 - Third Intervention||4
106600|NCT01205269|254673|P2|COMPLETED|Period 5 - Third Intervention||4
106601|NCT01205269|254674|P1|COMPLETED|Period 5 - Third Intervention||4
106602|NCT01205269|254669|P6|STARTED|Period 5 - Third Intervention||5
106603|NCT01205269|254670|P5|STARTED|Period 5 - Third Intervention||5
106604|NCT01205269|254671|P4|STARTED|Period 5 - Third Intervention||5
106605|NCT01205269|254672|P3|STARTED|Period 5 - Third Intervention||4
106606|NCT01205269|254673|P2|STARTED|Period 5 - Third Intervention||4
106607|NCT01205269|254674|P1|STARTED|Period 5 - Third Intervention||4
106608|NCT01205269|254669|P6|NOT COMPLETED|Period 4 - Washout||0
106609|NCT01205269|254670|P5|NOT COMPLETED|Period 4 - Washout||0
106610|NCT01205269|254671|P4|NOT COMPLETED|Period 4 - Washout||1
106611|NCT01205269|254672|P3|NOT COMPLETED|Period 4 - Washout||0
106612|NCT01205269|254673|P2|NOT COMPLETED|Period 4 - Washout||0
106613|NCT01205269|254674|P1|NOT COMPLETED|Period 4 - Washout||0
106614|NCT01205269|254669|P6|COMPLETED|Period 4 - Washout||5
106615|NCT01205269|254670|P5|COMPLETED|Period 4 - Washout||5
106616|NCT01205269|254671|P4|COMPLETED|Period 4 - Washout||5
106617|NCT01205269|254672|P3|COMPLETED|Period 4 - Washout||4
106618|NCT01205269|254673|P2|COMPLETED|Period 4 - Washout||4
106619|NCT01205269|254674|P1|COMPLETED|Period 4 - Washout||4
106620|NCT01205269|254669|P6|STARTED|Period 4 - Washout||5
106621|NCT01205269|254670|P5|STARTED|Period 4 - Washout||5
106622|NCT01205269|254671|P4|STARTED|Period 4 - Washout||6
106623|NCT01205269|254672|P3|STARTED|Period 4 - Washout||4
106624|NCT01205269|254673|P2|STARTED|Period 4 - Washout||4
106625|NCT01205269|254674|P1|STARTED|Period 4 - Washout||4
106626|NCT01205269|254669|P6|NOT COMPLETED|Period 3 - Second Intervention||0
106627|NCT01205269|254670|P5|NOT COMPLETED|Period 3 - Second Intervention||0
106628|NCT01205269|254671|P4|NOT COMPLETED|Period 3 - Second Intervention||0
106629|NCT01205269|254672|P3|NOT COMPLETED|Period 3 - Second Intervention||0
106630|NCT01205269|254673|P2|NOT COMPLETED|Period 3 - Second Intervention||0
106631|NCT01205269|254674|P1|NOT COMPLETED|Period 3 - Second Intervention||0
106632|NCT01205269|254669|P6|COMPLETED|Period 3 - Second Intervention||5
106633|NCT01205269|254670|P5|COMPLETED|Period 3 - Second Intervention||5
106634|NCT01205269|254671|P4|COMPLETED|Period 3 - Second Intervention||6
106635|NCT01205269|254672|P3|COMPLETED|Period 3 - Second Intervention||4
106636|NCT01205269|254673|P2|COMPLETED|Period 3 - Second Intervention||4
106637|NCT01205269|254674|P1|COMPLETED|Period 3 - Second Intervention||4
106638|NCT01205269|254669|P6|STARTED|Period 3 - Second Intervention||5
106639|NCT01205269|254670|P5|STARTED|Period 3 - Second Intervention||5
106640|NCT01205269|254671|P4|STARTED|Period 3 - Second Intervention||6
106641|NCT01205269|254672|P3|STARTED|Period 3 - Second Intervention||4
106642|NCT01205269|254673|P2|STARTED|Period 3 - Second Intervention||4
106643|NCT01205269|254674|P1|STARTED|Period 3 - Second Intervention||4
106644|NCT01205269|254669|P6|NOT COMPLETED|Period 2 - Washout||0
106645|NCT01205269|254670|P5|NOT COMPLETED|Period 2 - Washout||0
106646|NCT01205269|254671|P4|NOT COMPLETED|Period 2 - Washout||0
106647|NCT01205269|254672|P3|NOT COMPLETED|Period 2 - Washout||0
106648|NCT01205269|254673|P2|NOT COMPLETED|Period 2 - Washout||0
106649|NCT01205269|254674|P1|NOT COMPLETED|Period 2 - Washout||0
106650|NCT01205269|254669|P6|COMPLETED|Period 2 - Washout||5
106651|NCT01205269|254670|P5|COMPLETED|Period 2 - Washout||5
106652|NCT01205269|254671|P4|COMPLETED|Period 2 - Washout||6
106653|NCT01205269|254672|P3|COMPLETED|Period 2 - Washout||4
106654|NCT01205269|254673|P2|COMPLETED|Period 2 - Washout||4
106655|NCT01205269|254674|P1|COMPLETED|Period 2 - Washout||4
106656|NCT01205269|254669|P6|STARTED|Period 2 - Washout||5
106657|NCT01205269|254670|P5|STARTED|Period 2 - Washout||5
106658|NCT01205269|254671|P4|STARTED|Period 2 - Washout||6
106659|NCT01205269|254672|P3|STARTED|Period 2 - Washout||4
106660|NCT01205269|254673|P2|STARTED|Period 2 - Washout||4
106661|NCT01205269|254674|P1|STARTED|Period 2 - Washout||4
106662|NCT01205269|254669|P6|NOT COMPLETED|Period 1 - First Intervention||0
106663|NCT01205269|254670|P5|NOT COMPLETED|Period 1 - First Intervention||0
106664|NCT01205269|254671|P4|NOT COMPLETED|Period 1 - First Intervention||0
106665|NCT01205269|254672|P3|NOT COMPLETED|Period 1 - First Intervention||0
106666|NCT01205269|254673|P2|NOT COMPLETED|Period 1 - First Intervention||0
106667|NCT01205269|254674|P1|NOT COMPLETED|Period 1 - First Intervention||0
106668|NCT01205269|254669|P6|COMPLETED|Period 1 - First Intervention||5
106669|NCT01205269|254670|P5|COMPLETED|Period 1 - First Intervention||5
106670|NCT01205269|254671|P4|COMPLETED|Period 1 - First Intervention||6
106671|NCT01205269|254672|P3|COMPLETED|Period 1 - First Intervention||4
106672|NCT01205269|254673|P2|COMPLETED|Period 1 - First Intervention||4
106673|NCT01205269|254674|P1|COMPLETED|Period 1 - First Intervention||4
106674|NCT01205269|254669|P6|STARTED|Period 1 - First Intervention||5
106675|NCT01205269|254670|P5|STARTED|Period 1 - First Intervention||5
106676|NCT01205269|254671|P4|STARTED|Period 1 - First Intervention||6
106677|NCT01205269|254672|P3|STARTED|Period 1 - First Intervention||4
106678|NCT01205269|254673|P2|STARTED|Period 1 - First Intervention||4
106679|NCT01205269|254674|P1|STARTED|Period 1 - First Intervention||4
106680|NCT01205230|254714|P2|NOT COMPLETED|Overall Study||0
106681|NCT01205230|254715|P1|NOT COMPLETED|Overall Study||5
106682|NCT01205230|254714|P2|COMPLETED|Overall Study||13
106683|NCT01205230|254715|P1|COMPLETED|Overall Study||16
106684|NCT01205230|254714|P2|Combination Therapy|Overall Study||13
106685|NCT01205230|254715|P1|Combination Therapy|Overall Study||21
106686|NCT01205230|254714|P2|STARTED|Overall Study||13
106687|NCT01205230|254715|P1|STARTED|Overall Study||21
106688|NCT01205126|254760|P2|NOT COMPLETED|Maintenance Phase||40
106689|NCT01205126|254761|P1|NOT COMPLETED|Maintenance Phase||37
106690|NCT01205126|254760|P2|COMPLETED|Maintenance Phase||67
106691|NCT01205126|254761|P1|COMPLETED|Maintenance Phase||70
106692|NCT01205126|254760|P2|STARTED|Maintenance Phase||107
106693|NCT01205126|254761|P1|STARTED|Maintenance Phase||107
106694|NCT01205126|254760|P2|NOT COMPLETED|Between Titration & Maintenance Phase||4
106695|NCT01205126|254761|P1|NOT COMPLETED|Between Titration & Maintenance Phase||0
106696|NCT01205126|254760|P2|COMPLETED|Between Titration & Maintenance Phase||107
106697|NCT01205126|254761|P1|COMPLETED|Between Titration & Maintenance Phase||107
106698|NCT01205126|254760|P2|STARTED|Between Titration & Maintenance Phase||111
106699|NCT01205126|254761|P1|STARTED|Between Titration & Maintenance Phase||107
106700|NCT01205126|254760|P2|NOT COMPLETED|Titration Phase||19
106701|NCT01205126|254761|P1|NOT COMPLETED|Titration Phase||23
106702|NCT01205126|254760|P2|COMPLETED|Titration Phase||111
106703|NCT01205126|254761|P1|COMPLETED|Titration Phase||107
106704|NCT01205126|254760|P2|STARTED|Titration Phase||130
106705|NCT01205126|254761|P1|STARTED|Titration Phase||130
106706|NCT01205035|254779|P2|NOT COMPLETED|Overall Study||0
106707|NCT01205035|254780|P1|NOT COMPLETED|Overall Study||2
106708|NCT01205035|254779|P2|COMPLETED|Overall Study||3
106709|NCT01205035|254780|P1|COMPLETED|Overall Study||1
106710|NCT01205035|254779|P2|STARTED|Overall Study||3
106711|NCT01205035|254780|P1|STARTED|Overall Study||3
106712|NCT01204853|254794|P1|NOT COMPLETED|Overall Study||0
106713|NCT01204853|254794|P1|COMPLETED|Overall Study||2
106714|NCT01204853|254794|P1|STARTED|Overall Study||2
106715|NCT01204788|254806|P2|NOT COMPLETED|Overall Study||3
106716|NCT01204788|254807|P1|NOT COMPLETED|Overall Study||1
106717|NCT01204788|254806|P2|COMPLETED|Overall Study||0
106718|NCT01204788|254807|P1|COMPLETED|Overall Study||0
106719|NCT01204788|254806|P2|STARTED|Overall Study||3
106720|NCT01204788|254807|P1|STARTED|Overall Study||1
106721|NCT01204775|254815|P2|NOT COMPLETED|Overall Study||1
106722|NCT01204775|254816|P1|NOT COMPLETED|Overall Study||1
106723|NCT01204775|254815|P2|COMPLETED|Overall Study||3
106724|NCT01204775|254816|P1|COMPLETED|Overall Study||3
106725|NCT01204775|254815|P2|Double-blind Treatment Period|Overall Study||4
106726|NCT01204775|254816|P1|Double-blind Treatment Period|Overall Study||4
106727|NCT01204775|254815|P2|STARTED|Overall Study||4
106728|NCT01204775|254816|P1|STARTED|Overall Study||4
106729|NCT01204736|254826|P4|NOT COMPLETED|Overall Study||0
106730|NCT01204736|254827|P3|NOT COMPLETED|Overall Study||0
106731|NCT01204736|254828|P2|NOT COMPLETED|Overall Study||0
106732|NCT01204736|254829|P1|NOT COMPLETED|Overall Study||0
106733|NCT01204736|254826|P4|COMPLETED|Overall Study||2
106734|NCT01204736|254827|P3|COMPLETED|Overall Study||3
106735|NCT01204736|254828|P2|COMPLETED|Overall Study||5
106736|NCT01204736|254829|P1|COMPLETED|Overall Study||4
106737|NCT01204736|254826|P4|STARTED|Overall Study||2
106738|NCT01204736|254827|P3|STARTED|Overall Study||3
106739|NCT01204736|254828|P2|STARTED|Overall Study||5
106740|NCT01204736|254829|P1|STARTED|Overall Study||4
106741|NCT01204697|254841|P2|NOT COMPLETED|Overall Study||36
106742|NCT01204697|254842|P1|NOT COMPLETED|Overall Study||31
106743|NCT01204697|254841|P2|COMPLETED|Overall Study||2
106744|NCT01204697|254842|P1|COMPLETED|Overall Study||5
106745|NCT01204697|254841|P2|Treated|Overall Study||37
106746|NCT01204697|254842|P1|Treated|Overall Study||36
106747|NCT01204697|254841|P2|STARTED|Overall Study||38
106748|NCT01204697|254842|P1|STARTED|Overall Study||36
106749|NCT01204671|254863|P5|NOT COMPLETED|Overall Study||4
106750|NCT01204671|254864|P4|NOT COMPLETED|Overall Study||13
106751|NCT01204671|254865|P3|NOT COMPLETED|Overall Study||13
106752|NCT01204671|254866|P2|NOT COMPLETED|Overall Study||15
106753|NCT01204671|254867|P1|NOT COMPLETED|Overall Study||14
106754|NCT01204671|254863|P5|COMPLETED|Overall Study||606
106755|NCT01204671|254864|P4|COMPLETED|Overall Study||997
106756|NCT01204671|254865|P3|COMPLETED|Overall Study||998
106757|NCT01204671|254866|P2|COMPLETED|Overall Study||998
106758|NCT01204671|254867|P1|COMPLETED|Overall Study||998
106759|NCT01204671|254863|P5|STARTED|Overall Study||610
106760|NCT01204671|254864|P4|STARTED|Overall Study||1010
106761|NCT01204671|254865|P3|STARTED|Overall Study||1011
106762|NCT01204671|254866|P2|STARTED|Overall Study||1013
106763|NCT01204671|254867|P1|STARTED|Overall Study||1012
106764|NCT01204658|254929|P4|NOT COMPLETED|Booster Phase||0
106765|NCT01204658|254930|P3|NOT COMPLETED|Booster Phase||0
106766|NCT01204658|254931|P2|NOT COMPLETED|Booster Phase||0
106767|NCT01204658|254932|P1|NOT COMPLETED|Booster Phase||0
106768|NCT01204658|254929|P4|COMPLETED|Booster Phase||140
106769|NCT01204658|254930|P3|COMPLETED|Booster Phase||140
106770|NCT01204658|254931|P2|COMPLETED|Booster Phase||140
106771|NCT01204658|254932|P1|COMPLETED|Booster Phase||144
106772|NCT01204658|254929|P4|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
106946|NCT01202903|255293|P2|STARTED|Overall Study||308
106773|NCT01204658|254930|P3|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
106774|NCT01204658|254931|P2|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|140
106775|NCT01204658|254932|P1|STARTED|Booster Phase|Not all subjects completing the primary vaccination returned for the booster phase.|144
106776|NCT01204658|254929|P4|NOT COMPLETED|Primary Phase||0
106777|NCT01204658|254930|P3|NOT COMPLETED|Primary Phase||1
106778|NCT01204658|254931|P2|NOT COMPLETED|Primary Phase||0
106779|NCT01204658|254932|P1|NOT COMPLETED|Primary Phase||0
106780|NCT01204658|254929|P4|COMPLETED|Primary Phase||142
106781|NCT01204658|254930|P3|COMPLETED|Primary Phase||144
106782|NCT01204658|254931|P2|COMPLETED|Primary Phase||142
106783|NCT01204658|254932|P1|COMPLETED|Primary Phase||146
106784|NCT01204658|254929|P4|STARTED|Primary Phase||142
106785|NCT01204658|254930|P3|STARTED|Primary Phase||145
106786|NCT01204658|254931|P2|STARTED|Primary Phase||142
106787|NCT01204658|254932|P1|STARTED|Primary Phase||146
106788|NCT01204398|255042|P1|NOT COMPLETED|Overall Study||1
106789|NCT01204398|255042|P1|COMPLETED|Overall Study|Completed trial medication.|26
106790|NCT01204398|255042|P1|STARTED|Overall Study|Entered and treated.|27
106791|NCT01204294|255059|P7|NOT COMPLETED|Overall Study||2
106792|NCT01204294|255060|P6|NOT COMPLETED|Overall Study||5
106793|NCT01204294|255061|P5|NOT COMPLETED|Overall Study||2
106794|NCT01204294|255062|P4|NOT COMPLETED|Overall Study||11
106795|NCT01204294|255063|P3|NOT COMPLETED|Overall Study||5
106796|NCT01204294|255064|P2|NOT COMPLETED|Overall Study||8
106797|NCT01204294|255065|P1|NOT COMPLETED|Overall Study||3
106798|NCT01204294|255059|P7|COMPLETED|Overall Study||59
106799|NCT01204294|255060|P6|COMPLETED|Overall Study||58
106800|NCT01204294|255061|P5|COMPLETED|Overall Study||83
106801|NCT01204294|255062|P4|COMPLETED|Overall Study||132
106802|NCT01204294|255063|P3|COMPLETED|Overall Study||69
106803|NCT01204294|255064|P2|COMPLETED|Overall Study||58
106804|NCT01204294|255065|P1|COMPLETED|Overall Study||79
106805|NCT01204294|255059|P7|STARTED|Overall Study||61
106806|NCT01204294|255060|P6|STARTED|Overall Study||63
106807|NCT01204294|255061|P5|STARTED|Overall Study||85
106808|NCT01204294|255062|P4|STARTED|Overall Study||143
106809|NCT01204294|255063|P3|STARTED|Overall Study||74
106810|NCT01204294|255064|P2|STARTED|Overall Study||66
106811|NCT01204294|255065|P1|STARTED|Overall Study||82
106812|NCT01204255|255088|P1|NOT COMPLETED|Overall Study||1
106813|NCT01204255|255088|P1|COMPLETED|Overall Study||10
106814|NCT01204255|255088|P1|STARTED|Overall Study||11
106815|NCT01204203|255092|P1|NOT COMPLETED|Overall Study||0
106816|NCT01204203|255092|P1|COMPLETED|Overall Study||8
106817|NCT01204203|255092|P1|STARTED|Overall Study||8
106818|NCT01203956|255098|P2|NOT COMPLETED|Second Two-week Period||6
106819|NCT01203956|255099|P1|NOT COMPLETED|Second Two-week Period||5
106820|NCT01203956|255098|P2|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|7
106821|NCT01203956|255099|P1|COMPLETED|Second Two-week Period|Completed with evaluable results, as assessed over both two-week study periods.|10
106822|NCT01203956|255098|P2|Attended Sleep Studies for 14 Nights|Second Two-week Period||13
106823|NCT01203956|255099|P1|Attended Sleep Studies for 14 Nights|Second Two-week Period||15
106824|NCT01203956|255098|P2|STARTED|Second Two-week Period||13
106825|NCT01203956|255099|P1|STARTED|Second Two-week Period||15
106826|NCT01203956|255098|P2|NOT COMPLETED|First Two-week Period||0
106827|NCT01203956|255099|P1|NOT COMPLETED|First Two-week Period||0
106828|NCT01203956|255098|P2|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|13
106829|NCT01203956|255099|P1|COMPLETED|First Two-week Period|All participants continued to the second two-week period, whether or not they had evaluable results.|15
106830|NCT01203956|255098|P2|STARTED|First Two-week Period||13
106831|NCT01203956|255099|P1|STARTED|First Two-week Period||15
106832|NCT01203930|255108|P2|NOT COMPLETED|Overall Study||41
106833|NCT01203930|255109|P1|NOT COMPLETED|Overall Study||21
106834|NCT01203930|255108|P2|COMPLETED|Overall Study||0
106835|NCT01203930|255109|P1|COMPLETED|Overall Study|43 participants completed 12 cycles and were then eligible to enroll in the extension study (101-99)|43
106836|NCT01203930|255108|P2|STARTED|Overall Study||41
106837|NCT01203930|255109|P1|STARTED|Overall Study||64
106838|NCT01203917|255131|P1|NOT COMPLETED|Overall Study||36
106839|NCT01203917|255131|P1|COMPLETED|Overall Study|Patients on-going study at data cut-off(of which 49 were still on study treatment).|71
106840|NCT01203917|255131|P1|STARTED|Overall Study|106 patients were EGFR M+ patients and 1 patient was EGFR M+I|107
106841|NCT01203878|255144|P3|NOT COMPLETED|Overall Study||3
106842|NCT01203878|255145|P2|NOT COMPLETED|Overall Study||0
106843|NCT01203878|255146|P1|NOT COMPLETED|Overall Study||0
106844|NCT01203878|255144|P3|COMPLETED|Overall Study||0
106845|NCT01203878|255145|P2|COMPLETED|Overall Study||9
106846|NCT01203878|255146|P1|COMPLETED|Overall Study||9
106847|NCT01203878|255144|P3|STARTED|Overall Study||3
106848|NCT01203878|255145|P2|STARTED|Overall Study||9
106849|NCT01203878|255146|P1|STARTED|Overall Study||9
106850|NCT01203852|255157|P1|NOT COMPLETED|Chlorthalidone 8 Weeks||0
106851|NCT01203852|255157|P1|COMPLETED|Chlorthalidone 8 Weeks||328
106852|NCT01203852|255157|P1|Continued From Metoprolol|Chlorthalidone 8 Weeks||282
106853|NCT01203852|255157|P1|STARTED|Chlorthalidone 8 Weeks|Subjects were allowed to enter the study at Chlorthalidone without completing Metoprolol.|328
106854|NCT01203852|255157|P1|NOT COMPLETED|Washout 2 Weeks||46
106855|NCT01203852|255157|P1|COMPLETED|Washout 2 Weeks||282
106856|NCT01203852|255157|P1|STARTED|Washout 2 Weeks|Some study subjects did not proceed to the washout phase after the first intervention.|328
106857|NCT01203852|255157|P1|NOT COMPLETED|Metoprolol 8 Weeks||470
106858|NCT01203852|255157|P1|COMPLETED|Metoprolol 8 Weeks||369
106859|NCT01203852|255157|P1|STARTED|Metoprolol 8 Weeks|This is the total number of subjects for both groups.|839
106860|NCT01203826|255166|P2|NOT COMPLETED|Overall Study||0
106861|NCT01203826|255167|P1|NOT COMPLETED|Overall Study||0
106862|NCT01203826|255166|P2|COMPLETED|Overall Study||6
106863|NCT01203826|255167|P1|COMPLETED|Overall Study||6
106864|NCT01203826|255166|P2|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
106865|NCT01203826|255167|P1|STARTED|Overall Study|Dose cohorts are per assigned dose in ENB-006-09. Results presented are for Study ENB-008-10 only.|6
106866|NCT01203787|255175|P2|NOT COMPLETED|Overall Study||27
106867|NCT01203787|255176|P1|NOT COMPLETED|Overall Study||31
106868|NCT01203787|255175|P2|COMPLETED|Overall Study||30
106869|NCT01203787|255176|P1|COMPLETED|Overall Study||32
106870|NCT01203787|255175|P2|STARTED|Overall Study||57
106871|NCT01203787|255176|P1|STARTED|Overall Study||63
106872|NCT01203644|255196|P2|NOT COMPLETED|Overall Study||0
106873|NCT01203644|255197|P1|NOT COMPLETED|Overall Study||0
106874|NCT01203644|255196|P2|COMPLETED|Overall Study||50
106875|NCT01203644|255197|P1|COMPLETED|Overall Study||26
106876|NCT01203644|255196|P2|STARTED|Overall Study||50
106877|NCT01203644|255197|P1|STARTED|Overall Study||26
106878|NCT01203319|255209|P3|NOT COMPLETED|Overall Study||5
106879|NCT01203319|255210|P2|NOT COMPLETED|Overall Study||9
106880|NCT01203319|255211|P1|NOT COMPLETED|Overall Study||6
106881|NCT01203319|255209|P3|COMPLETED|Overall Study||217
106882|NCT01203319|255210|P2|COMPLETED|Overall Study||426
106883|NCT01203319|255211|P1|COMPLETED|Overall Study||428
106884|NCT01203319|255209|P3|STARTED|Overall Study||222
106885|NCT01203319|255210|P2|STARTED|Overall Study||435
106886|NCT01203319|255211|P1|STARTED|Overall Study||434
106887|NCT01203098|255228|P3|NOT COMPLETED|Overall Study||11
106888|NCT01203098|255229|P2|NOT COMPLETED|Overall Study||4
106889|NCT01203098|255230|P1|NOT COMPLETED|Overall Study||6
106890|NCT01203098|255228|P3|COMPLETED|Overall Study||78
106891|NCT01203098|255229|P2|COMPLETED|Overall Study||82
106892|NCT01203098|255230|P1|COMPLETED|Overall Study||83
106893|NCT01203098|255228|P3|Safety Analysis Dataset|Overall Study||87
106894|NCT01203098|255229|P2|Safety Analysis Dataset|Overall Study||85
106895|NCT01203098|255230|P1|Safety Analysis Dataset|Overall Study||89
106896|NCT01203098|255228|P3|STARTED|Overall Study||89
106897|NCT01203098|255229|P2|STARTED|Overall Study||86
106898|NCT01203098|255230|P1|STARTED|Overall Study||89
106899|NCT01203072|255246|P5|NOT COMPLETED|Overall Study||6
106900|NCT01203072|255247|P4|NOT COMPLETED|Overall Study||6
106901|NCT01203072|255248|P3|NOT COMPLETED|Overall Study||3
106902|NCT01203072|255249|P2|NOT COMPLETED|Overall Study||6
106903|NCT01203072|255250|P1|NOT COMPLETED|Overall Study||10
106904|NCT01203072|255246|P5|COMPLETED|Overall Study||96
106905|NCT01203072|255247|P4|COMPLETED|Overall Study||100
106906|NCT01203072|255248|P3|COMPLETED|Overall Study||101
106907|NCT01203072|255249|P2|COMPLETED|Overall Study||100
106908|NCT01203072|255250|P1|COMPLETED|Overall Study||95
106909|NCT01203072|255246|P5|STARTED|Overall Study||102
106910|NCT01203072|255247|P4|STARTED|Overall Study||106
106911|NCT01203072|255248|P3|STARTED|Overall Study||104
106912|NCT01203072|255249|P2|STARTED|Overall Study||106
106913|NCT01203072|255250|P1|STARTED|Overall Study||105
106914|NCT01203046|255269|P2|NOT COMPLETED|Overall Study||0
106915|NCT01203046|255270|P1|NOT COMPLETED|Overall Study||0
106916|NCT01203046|255269|P2|COMPLETED|Overall Study||28
106917|NCT01203046|255270|P1|COMPLETED|Overall Study||28
106918|NCT01203046|255269|P2|STARTED|Overall Study||28
106919|NCT01203046|255270|P1|STARTED|Overall Study||28
106920|NCT01202955|255280|P2|NOT COMPLETED|Period 3: 10 Days||0
106921|NCT01202955|255281|P1|NOT COMPLETED|Period 3: 10 Days||0
106922|NCT01202955|255280|P2|COMPLETED|Period 3: 10 Days||8
106923|NCT01202955|255281|P1|COMPLETED|Period 3: 10 Days||9
106924|NCT01202955|255280|P2|STARTED|Period 3: 10 Days||8
106925|NCT01202955|255281|P1|STARTED|Period 3: 10 Days||9
106926|NCT01202955|255280|P2|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
106927|NCT01202955|255281|P1|NOT COMPLETED|Period 2: 7 Days (Wash-Out)||0
106928|NCT01202955|255280|P2|COMPLETED|Period 2: 7 Days (Wash-Out)||8
106929|NCT01202955|255281|P1|COMPLETED|Period 2: 7 Days (Wash-Out)||9
106930|NCT01202955|255280|P2|STARTED|Period 2: 7 Days (Wash-Out)||8
106931|NCT01202955|255281|P1|STARTED|Period 2: 7 Days (Wash-Out)||9
106932|NCT01202955|255280|P2|NOT COMPLETED|Period 1: 10 Days||2
106933|NCT01202955|255281|P1|NOT COMPLETED|Period 1: 10 Days||0
106934|NCT01202955|255280|P2|COMPLETED|Period 1: 10 Days||8
106935|NCT01202955|255281|P1|COMPLETED|Period 1: 10 Days||9
106936|NCT01202955|255280|P2|STARTED|Period 1: 10 Days||10
106937|NCT01202955|255281|P1|STARTED|Period 1: 10 Days||9
106938|NCT01202903|255293|P2|NOT COMPLETED|Overall Study||16
106939|NCT01202903|255294|P1|NOT COMPLETED|Overall Study||11
106940|NCT01202903|255293|P2|COMPLETED|Overall Study||292
106941|NCT01202903|255294|P1|COMPLETED|Overall Study||297
106942|NCT01202903|255293|P2|Safety Set*|Overall Study||299
106943|NCT01202903|255294|P1|Safety Set*|Overall Study||310
106944|NCT01202903|255293|P2|Full Analysis Set|Overall Study||302
106945|NCT01202903|255294|P1|Full Analysis Set|Overall Study||306
106947|NCT01202903|255294|P1|STARTED|Overall Study||308
106948|NCT01202877|255321|P3|NOT COMPLETED|Overall Study||6
106949|NCT01202877|255322|P2|NOT COMPLETED|Overall Study||1
106950|NCT01202877|255323|P1|NOT COMPLETED|Overall Study||0
106951|NCT01202877|255321|P3|COMPLETED|Overall Study||34
106952|NCT01202877|255322|P2|COMPLETED|Overall Study||7
106953|NCT01202877|255323|P1|COMPLETED|Overall Study||6
106954|NCT01202877|255321|P3|STARTED|Overall Study||40
106955|NCT01202877|255322|P2|STARTED|Overall Study||8
106956|NCT01202877|255323|P1|STARTED|Overall Study||6
106957|NCT01202747|255332|P1|NOT COMPLETED|Overall Study||1
106958|NCT01202747|255332|P1|COMPLETED|Overall Study|One subject did not return for the 4 Week visit due to inconvenience.|49
106959|NCT01202747|255332|P1|STARTED|Overall Study||50
106960|NCT01202656|255338|P2|NOT COMPLETED|CrossoverCycle||0
106961|NCT01202656|255339|P1|NOT COMPLETED|CrossoverCycle||0
106962|NCT01202656|255338|P2|COMPLETED|CrossoverCycle||14
106963|NCT01202656|255339|P1|COMPLETED|CrossoverCycle||18
106964|NCT01202656|255338|P2|STARTED|CrossoverCycle|14 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|14
106965|NCT01202656|255339|P1|STARTED|CrossoverCycle|16 ongoing pregnancies were not eligible for crossover, others chose to not have another IVF cycle|18
106966|NCT01202656|255338|P2|NOT COMPLETED|Cycle 1||0
106967|NCT01202656|255339|P1|NOT COMPLETED|Cycle 1||0
106968|NCT01202656|255338|P2|COMPLETED|Cycle 1||62
106969|NCT01202656|255339|P1|COMPLETED|Cycle 1||67
106970|NCT01202656|255338|P2|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|62
106971|NCT01202656|255339|P1|STARTED|Cycle 1|Results reported In Barad et al 2014 are combined from both G-CSF studies|67
106972|NCT01202643|255349|P2|NOT COMPLETED|Crossover Cycle||0
106973|NCT01202643|255350|P1|NOT COMPLETED|Crossover Cycle||0
106974|NCT01202643|255349|P2|COMPLETED|Crossover Cycle||2
106975|NCT01202643|255350|P1|COMPLETED|Crossover Cycle||1
106976|NCT01202643|255349|P2|STARTED|Crossover Cycle|Three patients became pregnant after Period 1, 1 patient chose not to cycle again|2
106977|NCT01202643|255350|P1|STARTED|Crossover Cycle|On patient became pregnant following Period 1, Only one non-pregnant chose to cycle again|1
106978|NCT01202643|255349|P2|NOT COMPLETED|Period 1||0
106979|NCT01202643|255350|P1|NOT COMPLETED|Period 1||0
106980|NCT01202643|255349|P2|COMPLETED|Period 1||6
106981|NCT01202643|255350|P1|COMPLETED|Period 1||6
106982|NCT01202643|255349|P2|STARTED|Period 1||6
106983|NCT01202643|255350|P1|STARTED|Period 1||6
106984|NCT01202591|255364|P6|NOT COMPLETED|Overall Study||4
106985|NCT01202591|255365|P5|NOT COMPLETED|Overall Study||5
106986|NCT01202591|255366|P4|NOT COMPLETED|Overall Study||7
106987|NCT01202591|255367|P3|NOT COMPLETED|Overall Study||11
106988|NCT01202591|255368|P2|NOT COMPLETED|Overall Study||5
106989|NCT01202591|255369|P1|NOT COMPLETED|Overall Study||5
106990|NCT01202591|255364|P6|COMPLETED|Overall Study||0
106991|NCT01202591|255365|P5|COMPLETED|Overall Study||0
106992|NCT01202591|255366|P4|COMPLETED|Overall Study||2
106993|NCT01202591|255367|P3|COMPLETED|Overall Study||1
106994|NCT01202591|255368|P2|COMPLETED|Overall Study||0
106995|NCT01202591|255369|P1|COMPLETED|Overall Study||0
106996|NCT01202591|255364|P6|STARTED|Overall Study||4
106997|NCT01202591|255365|P5|STARTED|Overall Study||5
106998|NCT01202591|255366|P4|STARTED|Overall Study||9
106999|NCT01202591|255367|P3|STARTED|Overall Study||12
107000|NCT01202591|255368|P2|STARTED|Overall Study||5
107001|NCT01202591|255369|P1|STARTED|Overall Study||5
107002|NCT01202578|255383|P1|NOT COMPLETED|Overall Study||0
107003|NCT01202578|255383|P1|COMPLETED|Overall Study||53
107004|NCT01202578|255383|P1|STARTED|Overall Study||53
107005|NCT01202565|255390|P1|NOT COMPLETED|Overall Study||67
107006|NCT01202565|255390|P1|COMPLETED|Overall Study|Indicates participants who completed the Month 12 visit|439
107007|NCT01202565|255390|P1|Full Analysis Set|Overall Study|Participants with a signed informed consent and any available data regarding adalimumab treatment.|501
107008|NCT01202565|255390|P1|STARTED|Overall Study||506
107009|NCT01202279|255415|P2|NOT COMPLETED|Overall Study||27
107010|NCT01202279|255416|P1|NOT COMPLETED|Overall Study||37
107011|NCT01202279|255415|P2|COMPLETED|Overall Study||561
107012|NCT01202279|255416|P1|COMPLETED|Overall Study||554
107013|NCT01202279|255415|P2|STARTED|Overall Study||588
107014|NCT01202279|255416|P1|STARTED|Overall Study||591
107015|NCT01202253|255424|P1|NOT COMPLETED|Overall Study||0
107016|NCT01202253|255424|P1|COMPLETED|Overall Study||50
107017|NCT01202253|255424|P1|STARTED|Overall Study||50
107018|NCT01202227|255468|P1|NOT COMPLETED|Overall Study||19
107019|NCT01202227|255468|P1|COMPLETED|Overall Study||84
107020|NCT01202227|255468|P1|STARTED|Overall Study|Treated|103
107021|NCT01202188|255492|P5|NOT COMPLETED|Overall Study||45
107022|NCT01202188|255493|P4|NOT COMPLETED|Overall Study||42
107023|NCT01202188|255494|P3|NOT COMPLETED|Overall Study||53
107024|NCT01202188|255495|P2|NOT COMPLETED|Overall Study||56
107025|NCT01202188|255496|P1|NOT COMPLETED|Overall Study||38
107026|NCT01202188|255492|P5|COMPLETED|Overall Study||189
107027|NCT01202188|255493|P4|COMPLETED|Overall Study||441
107028|NCT01202188|255494|P3|COMPLETED|Overall Study||422
107029|NCT01202188|255495|P2|COMPLETED|Overall Study||421
107030|NCT01202188|255496|P1|COMPLETED|Overall Study||437
107031|NCT01202188|255492|P5|Safety Set; Received Study Drug|Overall Study||232
107032|NCT01202188|255493|P4|Safety Set; Received Study Drug|Overall Study||480
107033|NCT01202188|255494|P3|Safety Set; Received Study Drug|Overall Study||473
107034|NCT01202188|255495|P2|Safety Set; Received Study Drug|Overall Study||476
107035|NCT01202188|255496|P1|Safety Set; Received Study Drug|Overall Study||474
107036|NCT01202188|255492|P5|STARTED|Overall Study||234
107037|NCT01202188|255493|P4|STARTED|Overall Study||483
107038|NCT01202188|255494|P3|STARTED|Overall Study||475
107039|NCT01202188|255495|P2|STARTED|Overall Study||477
107040|NCT01202188|255496|P1|STARTED|Overall Study||475
107041|NCT01202162|255604|P2|NOT COMPLETED|Overall Study||2
107042|NCT01202162|255605|P1|NOT COMPLETED|Overall Study||3
107043|NCT01202162|255604|P2|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
107044|NCT01202162|255605|P1|COMPLETED|Overall Study|40 completed the intraoperative through discharge phase of the study.|40
107045|NCT01202162|255604|P2|STARTED|Overall Study||42
107046|NCT01202162|255605|P1|STARTED|Overall Study||43
107047|NCT01202110|255615|P2|NOT COMPLETED|Overall Study||0
107048|NCT01202110|255616|P1|NOT COMPLETED|Overall Study||0
107049|NCT01202110|255615|P2|COMPLETED|Overall Study||0
107050|NCT01202110|255616|P1|COMPLETED|Overall Study||10
107051|NCT01202110|255615|P2|STARTED|Overall Study||0
107052|NCT01202110|255616|P1|STARTED|Overall Study||10
107053|NCT01202071|255620|P4|NOT COMPLETED|Overall Study||0
107054|NCT01202071|255621|P3|NOT COMPLETED|Overall Study||0
107055|NCT01202071|255622|P2|NOT COMPLETED|Overall Study||0
107056|NCT01202071|255623|P1|NOT COMPLETED|Overall Study||0
107057|NCT01202071|255620|P4|COMPLETED|Overall Study||6
107058|NCT01202071|255621|P3|COMPLETED|Overall Study||6
107059|NCT01202071|255622|P2|COMPLETED|Overall Study||6
107060|NCT01202071|255623|P1|COMPLETED|Overall Study||6
107061|NCT01202071|255620|P4|STARTED|Overall Study||6
107062|NCT01202071|255621|P3|STARTED|Overall Study||6
107063|NCT01202071|255622|P2|STARTED|Overall Study||6
107064|NCT01202071|255623|P1|STARTED|Overall Study||6
107065|NCT01201967|255643|P2|NOT COMPLETED|Overall Study||5
107066|NCT01201967|255644|P1|NOT COMPLETED|Overall Study||6
107067|NCT01201967|255643|P2|COMPLETED|Overall Study||86
107068|NCT01201967|255644|P1|COMPLETED|Overall Study||86
107069|NCT01201967|255643|P2|STARTED|Overall Study||91
107070|NCT01201967|255644|P1|STARTED|Overall Study||92
107071|NCT01201915|255669|P3|NOT COMPLETED|Overall Study||6
107072|NCT01201915|255670|P2|NOT COMPLETED|Overall Study||11
107073|NCT01201915|255671|P1|NOT COMPLETED|Overall Study||8
107074|NCT01201915|255669|P3|COMPLETED|Overall Study||19
107075|NCT01201915|255670|P2|COMPLETED|Overall Study||14
107076|NCT01201915|255671|P1|COMPLETED|Overall Study||16
107077|NCT01201915|255669|P3|STARTED|Overall Study||25
107078|NCT01201915|255670|P2|STARTED|Overall Study||25
107079|NCT01201915|255671|P1|STARTED|Overall Study||24
107080|NCT01201811|255682|P1|NOT COMPLETED|Overall Study||19
107081|NCT01201811|255682|P1|COMPLETED|Overall Study||25
107082|NCT01201811|255682|P1|STARTED|Overall Study||44
107083|NCT01201798|255704|P2|NOT COMPLETED|Overall Study||15
107084|NCT01201798|255705|P1|NOT COMPLETED|Overall Study||9
107085|NCT01201798|255704|P2|COMPLETED|Overall Study||39
107086|NCT01201798|255705|P1|COMPLETED|Overall Study||47
107087|NCT01201798|255704|P2|STARTED|Overall Study||54
107088|NCT01201798|255705|P1|STARTED|Overall Study||56
107089|NCT01201785|255729|P1|NOT COMPLETED|Overall Study||16
107090|NCT01201785|255729|P1|COMPLETED|Overall Study||20
107091|NCT01201785|255729|P1|STARTED|Overall Study||36
107092|NCT01201772|255736|P3|NOT COMPLETED|Overall Study||0
107093|NCT01201772|255737|P2|NOT COMPLETED|Overall Study||0
107094|NCT01201772|255738|P1|NOT COMPLETED|Overall Study||1
107095|NCT01201772|255736|P3|COMPLETED|Overall Study||21
107096|NCT01201772|255737|P2|COMPLETED|Overall Study||21
107097|NCT01201772|255738|P1|COMPLETED|Overall Study||22
107098|NCT01201772|255736|P3|STARTED|Overall Study||21
107099|NCT01201772|255737|P2|STARTED|Overall Study||21
107100|NCT01201772|255738|P1|STARTED|Overall Study||23
107101|NCT01201759|255746|P2|NOT COMPLETED|Visit 5||0
107102|NCT01201759|255747|P1|NOT COMPLETED|Visit 5||0
107103|NCT01201759|255746|P2|COMPLETED|Visit 5||3
107104|NCT01201759|255747|P1|COMPLETED|Visit 5||7
107105|NCT01201759|255746|P2|STARTED|Visit 5||3
107106|NCT01201759|255747|P1|STARTED|Visit 5||7
107107|NCT01201759|255746|P2|NOT COMPLETED|Visit 4 Crossover||1
107108|NCT01201759|255747|P1|NOT COMPLETED|Visit 4 Crossover||0
107109|NCT01201759|255746|P2|COMPLETED|Visit 4 Crossover||3
107110|NCT01201759|255747|P1|COMPLETED|Visit 4 Crossover||7
107111|NCT01201759|255746|P2|STARTED|Visit 4 Crossover||4
107112|NCT01201759|255747|P1|STARTED|Visit 4 Crossover||7
107113|NCT01201759|255746|P2|NOT COMPLETED|Visit 3 - Washout||3
107114|NCT01201759|255747|P1|NOT COMPLETED|Visit 3 - Washout||1
107115|NCT01201759|255746|P2|COMPLETED|Visit 3 - Washout||4
107116|NCT01201759|255747|P1|COMPLETED|Visit 3 - Washout||7
107117|NCT01201759|255746|P2|STARTED|Visit 3 - Washout||7
107118|NCT01201759|255747|P1|STARTED|Visit 3 - Washout||8
107119|NCT01201759|255746|P2|NOT COMPLETED|Visit 2||0
107120|NCT01201759|255747|P1|NOT COMPLETED|Visit 2||0
107121|NCT01201759|255746|P2|COMPLETED|Visit 2||7
107122|NCT01201759|255747|P1|COMPLETED|Visit 2||8
107123|NCT01201759|255746|P2|STARTED|Visit 2||7
107124|NCT01201759|255747|P1|STARTED|Visit 2||8
107125|NCT01201759|255746|P2|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||1
107126|NCT01201759|255747|P1|NOT COMPLETED|Visit 1 Wash-in ( Untreated)||2
107127|NCT01201759|255746|P2|COMPLETED|Visit 1 Wash-in ( Untreated)||7
107128|NCT01201759|255747|P1|COMPLETED|Visit 1 Wash-in ( Untreated)||8
107129|NCT01201759|255746|P2|STARTED|Visit 1 Wash-in ( Untreated)||8
107130|NCT01201759|255747|P1|STARTED|Visit 1 Wash-in ( Untreated)||10
107131|NCT01201629|255761|P2|NOT COMPLETED|Overall Study||0
107132|NCT01201629|255762|P1|NOT COMPLETED|Overall Study||0
107133|NCT01201629|255761|P2|COMPLETED|Overall Study||8
107134|NCT01201629|255762|P1|COMPLETED|Overall Study||8
107135|NCT01201629|255761|P2|STARTED|Overall Study||8
107136|NCT01201629|255762|P1|STARTED|Overall Study||8
107137|NCT01201486|255772|P1|NOT COMPLETED|Overall Study||0
107138|NCT01201486|255772|P1|COMPLETED|Overall Study||6781
107139|NCT01201486|255772|P1|STARTED|Overall Study||6781
107140|NCT01201343|255776|P1|NOT COMPLETED|Overall Study||19
107141|NCT01201343|255776|P1|COMPLETED|Overall Study||60
107142|NCT01201343|255776|P1|Treated|Overall Study||76
107143|NCT01201343|255776|P1|STARTED|Overall Study||79
107144|NCT01201317|255790|P3|NOT COMPLETED|Overall Study||8
107145|NCT01201317|255791|P2|NOT COMPLETED|Overall Study||7
107146|NCT01201317|255792|P1|NOT COMPLETED|Overall Study||9
107147|NCT01201317|255790|P3|COMPLETED|Overall Study||33
107148|NCT01201317|255791|P2|COMPLETED|Overall Study||38
107149|NCT01201317|255792|P1|COMPLETED|Overall Study||39
107150|NCT01201317|255790|P3|STARTED|Overall Study||41
107151|NCT01201317|255791|P2|STARTED|Overall Study||45
107152|NCT01201317|255792|P1|STARTED|Overall Study||48
107153|NCT01201265|255812|P1|NOT COMPLETED|Overall Study||38
107154|NCT01201265|255812|P1|COMPLETED|Overall Study||2
107155|NCT01201265|255812|P1|STARTED|Overall Study||40
107156|NCT01200992|255826|P2|NOT COMPLETED|Overall Study||41
107157|NCT01200992|255827|P1|NOT COMPLETED|Overall Study||37
107158|NCT01200992|255826|P2|COMPLETED|Overall Study||4
107159|NCT01200992|255827|P1|COMPLETED|Overall Study||2
107160|NCT01200992|255826|P2|STARTED|Overall Study||45
107161|NCT01200992|255827|P1|STARTED|Overall Study||39
107162|NCT01200875|255835|P1|NOT COMPLETED|Overall Study||0
107163|NCT01200875|255835|P1|COMPLETED|Overall Study||25
107164|NCT01200875|255835|P1|STARTED|Overall Study||25
107165|NCT01200810|255841|P2|NOT COMPLETED|Overall Study||5
107166|NCT01200810|255842|P1|NOT COMPLETED|Overall Study||5
107167|NCT01200810|255841|P2|COMPLETED|Overall Study||0
107168|NCT01200810|255842|P1|COMPLETED|Overall Study||0
107169|NCT01200810|255841|P2|STARTED|Overall Study||5
107170|NCT01200810|255842|P1|STARTED|Overall Study||5
107171|NCT01200797|255860|P1|NOT COMPLETED|Overall Study||19
107172|NCT01200797|255860|P1|COMPLETED|Overall Study||0
107173|NCT01200797|255860|P1|STARTED|Overall Study||19
107174|NCT01200758|255870|P4|NOT COMPLETED|Stage 2||50
107175|NCT01200758|255871|P3|NOT COMPLETED|Stage 2||41
107176|NCT01200758|255872|P2|NOT COMPLETED|Stage 2||0
107177|NCT01200758|255873|P1|NOT COMPLETED|Stage 2||0
107178|NCT01200758|255870|P4|COMPLETED|Stage 2|Participants completed treatment period.|92
107179|NCT01200758|255871|P3|COMPLETED|Stage 2|Participants completed treatment period.|100
107180|NCT01200758|255872|P2|COMPLETED|Stage 2||0
107181|NCT01200758|255873|P1|COMPLETED|Stage 2||0
107182|NCT01200758|255870|P4|STARTED|Stage 2||142
107183|NCT01200758|255871|P3|STARTED|Stage 2||141
107184|NCT01200758|255872|P2|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
107185|NCT01200758|255873|P1|STARTED|Stage 2|Different participants were randomized into different stages of the study.|0
107186|NCT01200758|255870|P4|NOT COMPLETED|Stage I||0
107187|NCT01200758|255871|P3|NOT COMPLETED|Stage I||0
107188|NCT01200758|255872|P2|NOT COMPLETED|Stage I||17
107189|NCT01200758|255873|P1|NOT COMPLETED|Stage I||18
107190|NCT01200758|255870|P4|COMPLETED|Stage I||0
107191|NCT01200758|255871|P3|COMPLETED|Stage I||0
107192|NCT01200758|255872|P2|COMPLETED|Stage I|Participants completed treatment period.|46
107193|NCT01200758|255873|P1|COMPLETED|Stage I|Participants completed treatment period.|46
107194|NCT01200758|255870|P4|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
107195|NCT01200758|255871|P3|STARTED|Stage I|Different participants were randomized into different stages of the study.|0
107196|NCT01200758|255872|P2|STARTED|Stage I||63
107197|NCT01200758|255873|P1|STARTED|Stage I||64
107198|NCT01200602|255929|P2|NOT COMPLETED|Overall Study||0
107199|NCT01200602|255930|P1|NOT COMPLETED|Overall Study||0
107200|NCT01200602|255929|P2|COMPLETED|Overall Study||0
107201|NCT01200602|255930|P1|COMPLETED|Overall Study||0
107202|NCT01200602|255929|P2|STARTED|Overall Study||0
107203|NCT01200602|255930|P1|STARTED|Overall Study||0
107204|NCT01200524|255947|P3|NOT COMPLETED|Overall Study||4
107205|NCT01200524|255948|P2|NOT COMPLETED|Overall Study||1
107206|NCT01200524|255949|P1|NOT COMPLETED|Overall Study||2
107207|NCT01200524|255947|P3|COMPLETED|Overall Study||40
107208|NCT01200524|255948|P2|COMPLETED|Overall Study||47
107209|NCT01200524|255949|P1|COMPLETED|Overall Study||39
107210|NCT01200524|255947|P3|STARTED|Overall Study||44
107211|NCT01200524|255948|P2|STARTED|Overall Study||48
107212|NCT01200524|255949|P1|STARTED|Overall Study||41
107213|NCT01200511|255969|P1|NOT COMPLETED|Overall Study||5
107214|NCT01200511|255969|P1|COMPLETED|Overall Study||44
107215|NCT01200511|255969|P1|STARTED|Overall Study||49
107216|NCT01200498|255977|P1|NOT COMPLETED|Overall Study||0
107217|NCT01200498|255977|P1|COMPLETED|Overall Study||22
107218|NCT01200498|255977|P1|STARTED|Overall Study||22
107219|NCT01200433|255983|P2|NOT COMPLETED|Overall Study||0
107220|NCT01200433|255984|P1|NOT COMPLETED|Overall Study||0
107221|NCT01200433|255983|P2|COMPLETED|Overall Study||23
107222|NCT01200433|255984|P1|COMPLETED|Overall Study||21
107223|NCT01200433|255983|P2|STARTED|Overall Study||23
107224|NCT01200433|255984|P1|STARTED|Overall Study||21
107225|NCT01200368|256007|P3|NOT COMPLETED|Toddler Dose||1
107226|NCT01200368|256008|P2|NOT COMPLETED|Toddler Dose||3
107227|NCT01200368|256009|P1|NOT COMPLETED|Toddler Dose||0
107228|NCT01200368|256007|P3|COMPLETED|Toddler Dose||168
107229|NCT01200368|256008|P2|COMPLETED|Toddler Dose||159
107230|NCT01200368|256009|P1|COMPLETED|Toddler Dose||162
107231|NCT01200368|256007|P3|STARTED|Toddler Dose||169
107232|NCT01200368|256008|P2|STARTED|Toddler Dose||162
107233|NCT01200368|256009|P1|STARTED|Toddler Dose||162
107234|NCT01200368|256007|P3|NOT COMPLETED|After Infant Series||9
107235|NCT01200368|256008|P2|NOT COMPLETED|After Infant Series||16
107236|NCT01200368|256009|P1|NOT COMPLETED|After Infant Series||18
107237|NCT01200368|256007|P3|COMPLETED|After Infant Series||169
107238|NCT01200368|256008|P2|COMPLETED|After Infant Series||162
107239|NCT01200368|256009|P1|COMPLETED|After Infant Series||162
107240|NCT01200368|256007|P3|STARTED|After Infant Series||178
107241|NCT01200368|256008|P2|STARTED|After Infant Series||178
107242|NCT01200368|256009|P1|STARTED|After Infant Series||180
107243|NCT01200368|256007|P3|NOT COMPLETED|Infant Series||6
107244|NCT01200368|256008|P2|NOT COMPLETED|Infant Series||6
107245|NCT01200368|256009|P1|NOT COMPLETED|Infant Series||3
107246|NCT01200368|256007|P3|COMPLETED|Infant Series||178
107247|NCT01200368|256008|P2|COMPLETED|Infant Series||178
107248|NCT01200368|256009|P1|COMPLETED|Infant Series||180
107249|NCT01200368|256007|P3|Vaccinated Dose 3|Infant Series||182
107250|NCT01200368|256008|P2|Vaccinated Dose 3|Infant Series||178
107251|NCT01200368|256009|P1|Vaccinated Dose 3|Infant Series||181
107252|NCT01200368|256007|P3|Vaccinated Dose 2|Infant Series||183
107253|NCT01200368|256008|P2|Vaccinated Dose 2|Infant Series||182
107254|NCT01200368|256009|P1|Vaccinated Dose 2|Infant Series||183
107255|NCT01200368|256007|P3|Vaccinated Dose 1|Infant Series||183
107256|NCT01200368|256008|P2|Vaccinated Dose 1|Infant Series||183
107257|NCT01200368|256009|P1|Vaccinated Dose 1|Infant Series||183
107258|NCT01200368|256007|P3|STARTED|Infant Series||184
107259|NCT01200368|256008|P2|STARTED|Infant Series||184
107260|NCT01200368|256009|P1|STARTED|Infant Series||183
107261|NCT01200355|256075|P2|NOT COMPLETED|Overall Study||2
107262|NCT01200355|256076|P1|NOT COMPLETED|Overall Study||7
107263|NCT01200355|256075|P2|COMPLETED|Overall Study||53
107264|NCT01200355|256076|P1|COMPLETED|Overall Study||51
107265|NCT01200355|256075|P2|STARTED|Overall Study||55
107266|NCT01200355|256076|P1|STARTED|Overall Study||58
107267|NCT01200342|256086|P1|NOT COMPLETED|Overall Study||1
107268|NCT01200342|256086|P1|COMPLETED|Overall Study||6
107269|NCT01200342|256086|P1|STARTED|Overall Study||7
107270|NCT01200160|256091|P1|NOT COMPLETED|Overall Study||62
107271|NCT01200160|256091|P1|COMPLETED|Overall Study||66
107272|NCT01200160|256091|P1|STARTED|Overall Study||128
107273|NCT01200069|256097|P2|NOT COMPLETED|Overall Study||1
107274|NCT01200069|256098|P1|NOT COMPLETED|Overall Study||0
107275|NCT01200069|256097|P2|COMPLETED|Overall Study||5
107276|NCT01200069|256098|P1|COMPLETED|Overall Study||8
107277|NCT01200069|256097|P2|STARTED|Overall Study||6
107278|NCT01200069|256098|P1|STARTED|Overall Study||8
107279|NCT01199965|256152|P2|NOT COMPLETED|Overall Study||0
107280|NCT01199965|256153|P1|NOT COMPLETED|Overall Study||1
107281|NCT01199965|256152|P2|COMPLETED|Overall Study||24
107282|NCT01199965|256153|P1|COMPLETED|Overall Study||22
107283|NCT01199965|256152|P2|STARTED|Overall Study||24
107284|NCT01199965|256153|P1|STARTED|Overall Study||23
107285|NCT01199939|256167|P1|NOT COMPLETED|Overall Study||13
107286|NCT01199939|256167|P1|COMPLETED|Overall Study||41
107287|NCT01199939|256167|P1|STARTED|Overall Study|Number of enrolled participants|54
107288|NCT01199926|256186|P2|NOT COMPLETED|Overall Study||4
107289|NCT01199926|256187|P1|NOT COMPLETED|Overall Study||7
107290|NCT01199926|256186|P2|COMPLETED|Overall Study||13
107291|NCT01199926|256187|P1|COMPLETED|Overall Study||10
107292|NCT01199926|256186|P2|STARTED|Overall Study||17
107293|NCT01199926|256187|P1|STARTED|Overall Study||17
107294|NCT01199861|256199|P2|NOT COMPLETED|Overall Study||0
107295|NCT01199861|256200|P1|NOT COMPLETED|Overall Study||2
107296|NCT01199861|256199|P2|COMPLETED|Overall Study||43
107297|NCT01199861|256200|P1|COMPLETED|Overall Study||93
107298|NCT01199861|256199|P2|STARTED|Overall Study||43
107299|NCT01199861|256200|P1|STARTED|Overall Study||95
107300|NCT01199822|256221|P3|NOT COMPLETED|Overall Study||0
107301|NCT01199822|256222|P2|NOT COMPLETED|Overall Study||1
107302|NCT01199822|256223|P1|NOT COMPLETED|Overall Study||0
107303|NCT01199822|256221|P3|COMPLETED|Overall Study||6
107304|NCT01199822|256222|P2|COMPLETED|Overall Study||6
107305|NCT01199822|256223|P1|COMPLETED|Overall Study||3
107306|NCT01199822|256221|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
107307|NCT01199822|256222|P2|Received at Least 1 Dose of Study Drug|Overall Study||7
107308|NCT01199822|256223|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
107309|NCT01199822|256221|P3|STARTED|Overall Study||6
107310|NCT01199822|256222|P2|STARTED|Overall Study||7
107311|NCT01199822|256223|P1|STARTED|Overall Study||3
107312|NCT01199744|256256|P1|NOT COMPLETED|Overall Study||0
107313|NCT01199744|256256|P1|COMPLETED|Overall Study||1575
107314|NCT01199744|256256|P1|STARTED|Overall Study||1575
107315|NCT01199705|256269|P1|NOT COMPLETED|SCIG Treatment (Efficacy)||0
107316|NCT01199705|256269|P1|COMPLETED|SCIG Treatment (Efficacy)||24
107317|NCT01199705|256269|P1|STARTED|SCIG Treatment (Efficacy)||24
107318|NCT01199705|256269|P1|NOT COMPLETED|SCIG Treatment (Wash-in/Wash-out)||1
107319|NCT01199705|256269|P1|COMPLETED|SCIG Treatment (Wash-in/Wash-out)||24
107320|NCT01199705|256269|P1|STARTED|SCIG Treatment (Wash-in/Wash-out)||25
107321|NCT01199705|256269|P1|NOT COMPLETED|IVIG Treatment||0
107322|NCT01199705|256269|P1|COMPLETED|IVIG Treatment||25
107323|NCT01199705|256269|P1|STARTED|IVIG Treatment||25
107324|NCT01199601|256301|P2|NOT COMPLETED|Overall Study||78
107325|NCT01199601|256302|P1|NOT COMPLETED|Overall Study||69
107326|NCT01199601|256301|P2|COMPLETED|Overall Study||344
107327|NCT01199601|256302|P1|COMPLETED|Overall Study||353
107328|NCT01199601|256301|P2|STARTED|Overall Study|Intervention Group|422
107329|NCT01199601|256302|P1|STARTED|Overall Study|Control Group|422
107330|NCT01199471|256312|P1|NOT COMPLETED|Overall Study||6
107331|NCT01199471|256312|P1|COMPLETED|Overall Study||3994
107332|NCT01199471|256312|P1|STARTED|Overall Study|3 patients who did not meet ASA Physical Status Class 1 - 3 were excluded from all analyses.|4000
107333|NCT01199237|256323|P2|NOT COMPLETED|Overall Study||0
107334|NCT01199237|256324|P1|NOT COMPLETED|Overall Study||0
107335|NCT01199237|256323|P2|COMPLETED|Overall Study||40
107336|NCT01199237|256324|P1|COMPLETED|Overall Study||41
107337|NCT01199237|256323|P2|STARTED|Overall Study||40
107338|NCT01199237|256324|P1|STARTED|Overall Study||41
107339|NCT01199042|256338|P1|NOT COMPLETED|At Home (3 Months)||1
107340|NCT01199042|256338|P1|COMPLETED|At Home (3 Months)||26
107341|NCT01199042|256338|P1|STARTED|At Home (3 Months)||27
107342|NCT01199042|256338|P1|NOT COMPLETED|Sleep Laboratory (3 Nights)||2
107343|NCT01199042|256338|P1|COMPLETED|Sleep Laboratory (3 Nights)||27
107344|NCT01199042|256338|P1|STARTED|Sleep Laboratory (3 Nights)||29
107345|NCT01199016|256347|P1|NOT COMPLETED|Overall Study||77
107346|NCT01199016|256347|P1|COMPLETED|Overall Study||162
107347|NCT01199016|256347|P1|Treated|Overall Study||236
107348|NCT01199016|256347|P1|STARTED|Overall Study||239
107349|NCT01198977|256356|P2|NOT COMPLETED|Overall Study||0
107350|NCT01198977|256357|P1|NOT COMPLETED|Overall Study||1
107351|NCT01198977|256356|P2|COMPLETED|Overall Study||33
107352|NCT01198977|256357|P1|COMPLETED|Overall Study||30
107353|NCT01198977|256356|P2|STARTED|Overall Study||33
107354|NCT01198977|256357|P1|STARTED|Overall Study||31
107355|NCT01198873|256369|P2|NOT COMPLETED|Overall Study||32
107356|NCT01198873|256370|P1|NOT COMPLETED|Overall Study||37
107357|NCT01198873|256369|P2|COMPLETED|Overall Study||3
107358|NCT01198873|256370|P1|COMPLETED|Overall Study||4
107359|NCT01198873|256369|P2|Evaluable for Efficacy|Overall Study|9 participants discontinued before completing 3-month treatment and were not assessed post-baseline|26
107360|NCT01198873|256370|P1|Evaluable for Efficacy|Overall Study|8 participants discontinued before completing 3-month treatment and were not assessed post-baseline|33
107361|NCT01198873|256369|P2|Treated|Overall Study||35
107362|NCT01198873|256370|P1|Treated|Overall Study||41
107363|NCT01198873|256369|P2|STARTED|Overall Study||35
107364|NCT01198873|256370|P1|STARTED|Overall Study||41
107365|NCT01198795|256384|P1|NOT COMPLETED|Overall Study||82
107366|NCT01198795|256384|P1|COMPLETED|Overall Study||80
107367|NCT01198795|256384|P1|STARTED|Overall Study||162
107368|NCT01198769|256388|P1|NOT COMPLETED|Overall Study||0
107369|NCT01198769|256388|P1|COMPLETED|Overall Study||15
107370|NCT01198769|256388|P1|STARTED|Overall Study||15
107371|NCT01198756|256401|P4|NOT COMPLETED|Overall Study||26
107372|NCT01198756|256402|P3|NOT COMPLETED|Overall Study||30
107373|NCT01198756|256403|P2|NOT COMPLETED|Overall Study||40
107374|NCT01198756|256404|P1|NOT COMPLETED|Overall Study||38
107375|NCT01198756|256401|P4|COMPLETED|Overall Study||275
107376|NCT01198756|256402|P3|COMPLETED|Overall Study||902
107377|NCT01198756|256403|P2|COMPLETED|Overall Study||889
107378|NCT01198756|256404|P1|COMPLETED|Overall Study||894
107379|NCT01198756|256401|P4|STARTED|Overall Study||301
107380|NCT01198756|256402|P3|STARTED|Overall Study||932
107381|NCT01198756|256403|P2|STARTED|Overall Study||929
107382|NCT01198756|256404|P1|STARTED|Overall Study||932
107383|NCT01198691|256502|P2|NOT COMPLETED|6 Week Post-partum Survey||24
107384|NCT01198691|256503|P1|NOT COMPLETED|6 Week Post-partum Survey||29
107385|NCT01198691|256502|P2|COMPLETED|6 Week Post-partum Survey||26
107386|NCT01198691|256503|P1|COMPLETED|6 Week Post-partum Survey||21
107387|NCT01198691|256502|P2|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
107388|NCT01198691|256503|P1|STARTED|6 Week Post-partum Survey|Survey was sent to all participants even if they were missing data from the previous two periods.|50
107389|NCT01198691|256502|P2|NOT COMPLETED|Survey Prior to Discharge||33
107390|NCT01198691|256503|P1|NOT COMPLETED|Survey Prior to Discharge||32
107391|NCT01198691|256502|P2|COMPLETED|Survey Prior to Discharge||17
107392|NCT01198691|256503|P1|COMPLETED|Survey Prior to Discharge||18
107393|NCT01198691|256502|P2|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
107394|NCT01198691|256503|P1|STARTED|Survey Prior to Discharge|Survey was given to all participants even if they were missing data from previous periods.|50
107395|NCT01198691|256502|P2|NOT COMPLETED|Completed VAS Score at Discharge||6
107396|NCT01198691|256503|P1|NOT COMPLETED|Completed VAS Score at Discharge||5
107397|NCT01198691|256502|P2|COMPLETED|Completed VAS Score at Discharge||44
107398|NCT01198691|256503|P1|COMPLETED|Completed VAS Score at Discharge||45
107399|NCT01198691|256502|P2|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
107400|NCT01198691|256503|P1|STARTED|Completed VAS Score at Discharge|Missing a VAS score on postop day one did not exclude participants from having a score at discharge.|50
107401|NCT01198691|256502|P2|NOT COMPLETED|Completed VAS Score Postop Day 1||4
107402|NCT01198691|256503|P1|NOT COMPLETED|Completed VAS Score Postop Day 1||3
107403|NCT01198691|256502|P2|COMPLETED|Completed VAS Score Postop Day 1||46
107404|NCT01198691|256503|P1|COMPLETED|Completed VAS Score Postop Day 1||47
107405|NCT01198691|256502|P2|STARTED|Completed VAS Score Postop Day 1||50
107406|NCT01198691|256503|P1|STARTED|Completed VAS Score Postop Day 1||50
107407|NCT01198691|256502|P2|NOT COMPLETED|Completed Surgery -Received Intervention||0
107408|NCT01198691|256503|P1|NOT COMPLETED|Completed Surgery -Received Intervention||0
107409|NCT01198691|256502|P2|COMPLETED|Completed Surgery -Received Intervention||50
107410|NCT01198691|256503|P1|COMPLETED|Completed Surgery -Received Intervention||50
107411|NCT01198691|256502|P2|STARTED|Completed Surgery -Received Intervention||50
107412|NCT01198691|256503|P1|STARTED|Completed Surgery -Received Intervention||50
107413|NCT01198600|256515|P4|NOT COMPLETED|Phase 3: 43 Days of Wear||0
107414|NCT01198600|256516|P3|NOT COMPLETED|Phase 3: 43 Days of Wear||0
107415|NCT01198600|256517|P2|NOT COMPLETED|Phase 3: 43 Days of Wear||0
107416|NCT01198600|256518|P1|NOT COMPLETED|Phase 3: 43 Days of Wear||0
107417|NCT01198600|256515|P4|COMPLETED|Phase 3: 43 Days of Wear||38
107418|NCT01198600|256516|P3|COMPLETED|Phase 3: 43 Days of Wear||0
107419|NCT01198600|256517|P2|COMPLETED|Phase 3: 43 Days of Wear||0
107420|NCT01198600|256518|P1|COMPLETED|Phase 3: 43 Days of Wear||0
107421|NCT01198600|256515|P4|STARTED|Phase 3: 43 Days of Wear||38
107422|NCT01198600|256516|P3|STARTED|Phase 3: 43 Days of Wear||0
107423|NCT01198600|256517|P2|STARTED|Phase 3: 43 Days of Wear||0
107424|NCT01198600|256518|P1|STARTED|Phase 3: 43 Days of Wear||0
107425|NCT01198600|256515|P4|NOT COMPLETED|Phase 2: 56 Days of Wear||0
107426|NCT01198600|256516|P3|NOT COMPLETED|Phase 2: 56 Days of Wear||5
107427|NCT01198600|256517|P2|NOT COMPLETED|Phase 2: 56 Days of Wear||0
107428|NCT01198600|256518|P1|NOT COMPLETED|Phase 2: 56 Days of Wear||0
107429|NCT01198600|256515|P4|COMPLETED|Phase 2: 56 Days of Wear||0
107430|NCT01198600|256516|P3|COMPLETED|Phase 2: 56 Days of Wear||62
107431|NCT01198600|256517|P2|COMPLETED|Phase 2: 56 Days of Wear||0
107432|NCT01198600|256518|P1|COMPLETED|Phase 2: 56 Days of Wear||0
107433|NCT01198600|256515|P4|STARTED|Phase 2: 56 Days of Wear||0
107434|NCT01198600|256516|P3|STARTED|Phase 2: 56 Days of Wear||67
107435|NCT01198600|256517|P2|STARTED|Phase 2: 56 Days of Wear||0
107436|NCT01198600|256518|P1|STARTED|Phase 2: 56 Days of Wear||0
107437|NCT01198600|256515|P4|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
107438|NCT01198600|256516|P3|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
107439|NCT01198600|256517|P2|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||1
107440|NCT01198600|256518|P1|NOT COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
107441|NCT01198600|256515|P4|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
107442|NCT01198600|256516|P3|COMPLETED|Phase 1: Period Two, 30 Days of Wear||0
107443|NCT01198600|256517|P2|COMPLETED|Phase 1: Period Two, 30 Days of Wear||35
107444|NCT01198600|256518|P1|COMPLETED|Phase 1: Period Two, 30 Days of Wear||32
107445|NCT01198600|256515|P4|STARTED|Phase 1: Period Two, 30 Days of Wear||0
107446|NCT01198600|256516|P3|STARTED|Phase 1: Period Two, 30 Days of Wear||0
107447|NCT01198600|256517|P2|STARTED|Phase 1: Period Two, 30 Days of Wear||36
107539|NCT01197898|256782|P1|COMPLETED|Overall Study||5
107540|NCT01197898|256781|P2|STARTED|Overall Study||5
107448|NCT01198600|256518|P1|STARTED|Phase 1: Period Two, 30 Days of Wear|One participant discontinued between Period One and Period Two due to unconvenience.|32
107449|NCT01198600|256515|P4|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
107450|NCT01198600|256516|P3|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||0
107451|NCT01198600|256517|P2|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||1
107452|NCT01198600|256518|P1|NOT COMPLETED|Phase 1: Period One, 30 Days of Wear||2
107453|NCT01198600|256515|P4|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
107454|NCT01198600|256516|P3|COMPLETED|Phase 1: Period One, 30 Days of Wear||0
107455|NCT01198600|256517|P2|COMPLETED|Phase 1: Period One, 30 Days of Wear||36
107456|NCT01198600|256518|P1|COMPLETED|Phase 1: Period One, 30 Days of Wear||33
107457|NCT01198600|256515|P4|STARTED|Phase 1: Period One, 30 Days of Wear||0
107458|NCT01198600|256516|P3|STARTED|Phase 1: Period One, 30 Days of Wear||0
107459|NCT01198600|256517|P2|STARTED|Phase 1: Period One, 30 Days of Wear||37
107460|NCT01198600|256518|P1|STARTED|Phase 1: Period One, 30 Days of Wear||35
107461|NCT01198574|256544|P4|NOT COMPLETED|Overall Study||4
107462|NCT01198574|256545|P3|NOT COMPLETED|Overall Study||1
107463|NCT01198574|256546|P2|NOT COMPLETED|Overall Study||1
107464|NCT01198574|256547|P1|NOT COMPLETED|Overall Study||4
107465|NCT01198574|256544|P4|COMPLETED|Overall Study||98
107466|NCT01198574|256545|P3|COMPLETED|Overall Study||99
107467|NCT01198574|256546|P2|COMPLETED|Overall Study||101
107468|NCT01198574|256547|P1|COMPLETED|Overall Study||94
107469|NCT01198574|256544|P4|STARTED|Overall Study||102
107470|NCT01198574|256545|P3|STARTED|Overall Study||100
107471|NCT01198574|256546|P2|STARTED|Overall Study||102
107472|NCT01198574|256547|P1|STARTED|Overall Study||98
107473|NCT01198548|256565|P1|NOT COMPLETED|Overall Study||10
107474|NCT01198548|256565|P1|COMPLETED|Overall Study||0
107475|NCT01198548|256565|P1|STARTED|Overall Study||10
107476|NCT01198509|256580|P6|NOT COMPLETED|Overall Study||0
107477|NCT01198509|256581|P5|NOT COMPLETED|Overall Study||0
107478|NCT01198509|256582|P4|NOT COMPLETED|Overall Study||0
107479|NCT01198509|256583|P3|NOT COMPLETED|Overall Study||0
107480|NCT01198509|256584|P2|NOT COMPLETED|Overall Study||0
107481|NCT01198509|256585|P1|NOT COMPLETED|Overall Study||1
107482|NCT01198509|256580|P6|COMPLETED|Overall Study||58
107483|NCT01198509|256581|P5|COMPLETED|Overall Study||20
107484|NCT01198509|256582|P4|COMPLETED|Overall Study||66
107485|NCT01198509|256583|P3|COMPLETED|Overall Study||19
107486|NCT01198509|256584|P2|COMPLETED|Overall Study||10
107487|NCT01198509|256585|P1|COMPLETED|Overall Study|Patient declined further participation after enrollment and allocation to treatment group|4
107488|NCT01198509|256580|P6|STARTED|Overall Study||58
107489|NCT01198509|256581|P5|STARTED|Overall Study||20
107490|NCT01198509|256582|P4|STARTED|Overall Study||66
107491|NCT01198509|256583|P3|STARTED|Overall Study||19
107492|NCT01198509|256584|P2|STARTED|Overall Study||10
107493|NCT01198509|256585|P1|STARTED|Overall Study||5
107494|NCT01198366|256608|P6|NOT COMPLETED|Overall Study||13
107495|NCT01198366|256609|P5|NOT COMPLETED|Overall Study||15
107496|NCT01198366|256610|P4|NOT COMPLETED|Overall Study||5
107497|NCT01198366|256611|P3|NOT COMPLETED|Overall Study||8
107498|NCT01198366|256612|P2|NOT COMPLETED|Overall Study||7
107499|NCT01198366|256613|P1|NOT COMPLETED|Overall Study||12
107500|NCT01198366|256608|P6|COMPLETED|Overall Study||128
107501|NCT01198366|256609|P5|COMPLETED|Overall Study||125
107502|NCT01198366|256610|P4|COMPLETED|Overall Study||47
107503|NCT01198366|256611|P3|COMPLETED|Overall Study||43
107504|NCT01198366|256612|P2|COMPLETED|Overall Study||44
107505|NCT01198366|256613|P1|COMPLETED|Overall Study||40
107506|NCT01198366|256608|P6|STARTED|Overall Study||141
107507|NCT01198366|256609|P5|STARTED|Overall Study||140
107508|NCT01198366|256610|P4|STARTED|Overall Study||52
107509|NCT01198366|256611|P3|STARTED|Overall Study||51
107510|NCT01198366|256612|P2|STARTED|Overall Study||51
107511|NCT01198366|256613|P1|STARTED|Overall Study||52
107512|NCT01198327|256651|P1|NOT COMPLETED|Overall Study||10
107513|NCT01198327|256651|P1|COMPLETED|Overall Study||56
107514|NCT01198327|256651|P1|STARTED|Overall Study||66
107515|NCT01198275|256661|P2|NOT COMPLETED|Overall Study||5
107516|NCT01198275|256662|P1|NOT COMPLETED|Overall Study||6
107517|NCT01198275|256661|P2|COMPLETED|Overall Study||94
107518|NCT01198275|256662|P1|COMPLETED|Overall Study||94
107519|NCT01198275|256661|P2|STARTED|Overall Study||99
107520|NCT01198275|256662|P1|STARTED|Overall Study||100
107521|NCT01198145|256670|P2|NOT COMPLETED|Overall Study||1
107522|NCT01198145|256671|P1|NOT COMPLETED|Overall Study||1
107523|NCT01198145|256670|P2|COMPLETED|Overall Study||42
107524|NCT01198145|256671|P1|COMPLETED|Overall Study||43
107525|NCT01198145|256670|P2|STARTED|Overall Study||43
107526|NCT01198145|256671|P1|STARTED|Overall Study||44
107527|NCT01197911|256694|P3|NOT COMPLETED|Overall Study||1
107528|NCT01197911|256695|P2|NOT COMPLETED|Overall Study||0
107529|NCT01197911|256696|P1|NOT COMPLETED|Overall Study||0
107530|NCT01197911|256694|P3|COMPLETED|Overall Study||9
107531|NCT01197911|256695|P2|COMPLETED|Overall Study||10
107532|NCT01197911|256696|P1|COMPLETED|Overall Study||18
107533|NCT01197911|256694|P3|STARTED|Overall Study||10
107534|NCT01197911|256695|P2|STARTED|Overall Study||10
107535|NCT01197911|256696|P1|STARTED|Overall Study||18
107536|NCT01197898|256781|P2|NOT COMPLETED|Overall Study||0
107537|NCT01197898|256782|P1|NOT COMPLETED|Overall Study||0
107538|NCT01197898|256781|P2|COMPLETED|Overall Study||5
107541|NCT01197898|256782|P1|STARTED|Overall Study||5
107542|NCT01197833|256791|P3|NOT COMPLETED|Overall Study||0
107543|NCT01197833|256792|P2|NOT COMPLETED|Overall Study||0
107544|NCT01197833|256793|P1|NOT COMPLETED|Overall Study||0
107545|NCT01197833|256791|P3|COMPLETED|Overall Study||40
107546|NCT01197833|256792|P2|COMPLETED|Overall Study||39
107547|NCT01197833|256793|P1|COMPLETED|Overall Study||38
107548|NCT01197833|256791|P3|STARTED|Overall Study||40
107549|NCT01197833|256792|P2|STARTED|Overall Study||39
107550|NCT01197833|256793|P1|STARTED|Overall Study||38
107551|NCT01197794|256811|P7|NOT COMPLETED|Overall Study||21
107552|NCT01197794|256812|P6|NOT COMPLETED|Overall Study||19
107553|NCT01197794|256813|P5|NOT COMPLETED|Overall Study||14
107554|NCT01197794|256814|P4|NOT COMPLETED|Overall Study||12
107555|NCT01197794|256815|P3|NOT COMPLETED|Overall Study||13
107556|NCT01197794|256816|P2|NOT COMPLETED|Overall Study||15
107557|NCT01197794|256817|P1|NOT COMPLETED|Overall Study||16
107558|NCT01197794|256811|P7|COMPLETED|Overall Study||142
107559|NCT01197794|256812|P6|COMPLETED|Overall Study||144
107560|NCT01197794|256813|P5|COMPLETED|Overall Study||149
107561|NCT01197794|256814|P4|COMPLETED|Overall Study||152
107562|NCT01197794|256815|P3|COMPLETED|Overall Study||153
107563|NCT01197794|256816|P2|COMPLETED|Overall Study||146
107564|NCT01197794|256817|P1|COMPLETED|Overall Study||148
107565|NCT01197794|256811|P7|STARTED|Overall Study|Two participants excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
107566|NCT01197794|256812|P6|STARTED|Overall Study||163
107567|NCT01197794|256813|P5|STARTED|Overall Study|One participant excluded due to Good Clinical Practice (GCP) violation at centre 4323|163
107568|NCT01197794|256814|P4|STARTED|Overall Study||164
107569|NCT01197794|256815|P3|STARTED|Overall Study|Two participants did not receive study treatment|166
107570|NCT01197794|256816|P2|STARTED|Overall Study|Two participants did not receive study treatment|161
107571|NCT01197794|256817|P1|STARTED|Overall Study||164
107572|NCT01197755|256899|P3|NOT COMPLETED|Overall Study||54
107573|NCT01197755|256900|P2|NOT COMPLETED|Overall Study||43
107574|NCT01197755|256901|P1|NOT COMPLETED|Overall Study||38
107575|NCT01197755|256899|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|55
107576|NCT01197755|256900|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|65
107577|NCT01197755|256901|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|67
107578|NCT01197755|256899|P3|Randomised But Did Not Receive Treatment|Overall Study|Severe non-compliance to the protocol|1
107579|NCT01197755|256900|P2|Randomised But Did Not Receive Treatment|Overall Study||0
107580|NCT01197755|256901|P1|Randomised But Did Not Receive Treatment|Overall Study||0
107581|NCT01197755|256899|P3|STARTED|Overall Study|Patients who received treatment|109
107582|NCT01197755|256900|P2|STARTED|Overall Study|Patients who received treatment|108
107583|NCT01197755|256901|P1|STARTED|Overall Study|Patients who received treatment|105
107584|NCT01197560|256943|P2|NOT COMPLETED|Overall Study||53
107585|NCT01197560|256944|P1|NOT COMPLETED|Overall Study||46
107586|NCT01197560|256943|P2|COMPLETED|Overall Study|Completed = those completed and ongoing on treatment at the time of the data cut-off of 04 July 2013|4
107587|NCT01197560|256944|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 04 July 2013|8
107588|NCT01197560|256943|P2|Discontinued Treatment After ≥ 6 Cycles|Overall Study||3
107589|NCT01197560|256944|P1|Discontinued Treatment After ≥ 6 Cycles|Overall Study||7
107590|NCT01197560|256943|P2|Lenalidomide Crossover|Overall Study||29
107591|NCT01197560|256944|P1|Lenalidomide Crossover|Overall Study||0
107592|NCT01197560|256943|P2|Received ≥ One Dose Study Drug|Overall Study||55
107593|NCT01197560|256944|P1|Received ≥ One Dose Study Drug|Overall Study||54
107594|NCT01197560|256943|P2|STARTED|Overall Study|This is the intent to treat population|57
107595|NCT01197560|256944|P1|STARTED|Overall Study|This is the intent to treat population|54
107596|NCT01197547|256968|P1|NOT COMPLETED|Overall Study||22
107597|NCT01197547|256968|P1|COMPLETED|Overall Study|992 Intent-To-Treat (ITT) 931 evaluable subjects|992
107598|NCT01197547|256968|P1|STARTED|Overall Study||1014
107599|NCT01197534|256977|P3|NOT COMPLETED|Overall Study||173
107600|NCT01197534|256978|P2|NOT COMPLETED|Overall Study||130
107601|NCT01197534|256979|P1|NOT COMPLETED|Overall Study||134
107602|NCT01197534|256977|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|129
107603|NCT01197534|256978|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|168
107604|NCT01197534|256979|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|174
107605|NCT01197534|256977|P3|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled / Severe non-compliance to protocol|3
107606|NCT01197534|256978|P2|Randomised But Did Not Receive Treatment|Overall Study|Adverse event / Other|2
107607|NCT01197534|256979|P1|Randomised But Did Not Receive Treatment|Overall Study||0
107608|NCT01197534|256977|P3|STARTED|Overall Study|Patients who received treatment|302
107609|NCT01197534|256978|P2|STARTED|Overall Study|Patients who received treatment|298
107610|NCT01197534|256979|P1|STARTED|Overall Study|Patients who received treatment|308
107611|NCT01197521|257023|P3|NOT COMPLETED|Overall Study||143
107612|NCT01197521|257024|P2|NOT COMPLETED|Overall Study||113
107613|NCT01197521|257025|P1|NOT COMPLETED|Overall Study||103
107614|NCT01197521|257023|P3|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|161
107705|NCT01196104|257503|P1|NOT COMPLETED|Overall Study||4
107615|NCT01197521|257024|P2|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|191
107616|NCT01197521|257025|P1|COMPLETED|Overall Study|Number of patients who completed treatment includes patients who had a dose reduction.|207
107617|NCT01197521|257023|P3|Randomised But Did Not Receive Treatment|Overall Study|Adverse event/eligibility criteria not fulfilled|2
107618|NCT01197521|257024|P2|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled/other|2
107619|NCT01197521|257025|P1|Randomised But Did Not Receive Treatment|Overall Study|Eligibility criteria not fulfilled|1
107620|NCT01197521|257023|P3|STARTED|Overall Study|Patients who received treatment|304
107621|NCT01197521|257024|P2|STARTED|Overall Study|Patients who received treatment|304
107622|NCT01197521|257025|P1|STARTED|Overall Study|Patients who received treatment|310
107623|NCT01197508|257070|P4|NOT COMPLETED|Overall Study||16
107624|NCT01197508|257071|P3|NOT COMPLETED|Overall Study||49
107625|NCT01197508|257072|P2|NOT COMPLETED|Overall Study||30
107626|NCT01197508|257073|P1|NOT COMPLETED|Overall Study||23
107627|NCT01197508|257070|P4|COMPLETED|Overall Study||158
107628|NCT01197508|257071|P3|COMPLETED|Overall Study||125
107629|NCT01197508|257072|P2|COMPLETED|Overall Study||144
107630|NCT01197508|257073|P1|COMPLETED|Overall Study||151
107631|NCT01197508|257070|P4|Received Treatment|Overall Study||174
107632|NCT01197508|257071|P3|Received Treatment|Overall Study||171
107633|NCT01197508|257072|P2|Received Treatment|Overall Study||174
107634|NCT01197508|257073|P1|Received Treatment|Overall Study||174
107635|NCT01197508|257070|P4|STARTED|Overall Study||174
107636|NCT01197508|257071|P3|STARTED|Overall Study||174
107637|NCT01197508|257072|P2|STARTED|Overall Study||174
107638|NCT01197508|257073|P1|STARTED|Overall Study||174
107639|NCT01197495|257169|P2|NOT COMPLETED|Overall Study||7
107640|NCT01197495|257170|P1|NOT COMPLETED|Overall Study||13
107641|NCT01197495|257169|P2|COMPLETED|Overall Study||49
107642|NCT01197495|257170|P1|COMPLETED|Overall Study||144
107643|NCT01197495|257169|P2|STARTED|Overall Study||56
107644|NCT01197495|257170|P1|STARTED|Overall Study||157
107645|NCT01197417|257183|P2|NOT COMPLETED|Overall Study||18
107646|NCT01197417|257184|P1|NOT COMPLETED|Overall Study||8
107647|NCT01197417|257183|P2|COMPLETED|Overall Study||86
107648|NCT01197417|257184|P1|COMPLETED|Overall Study||96
107649|NCT01197417|257183|P2|Received Study Drug|Overall Study||103
107650|NCT01197417|257184|P1|Received Study Drug|Overall Study||101
107651|NCT01197417|257183|P2|STARTED|Overall Study||104
107652|NCT01197417|257184|P1|STARTED|Overall Study||104
107653|NCT01197326|257204|P2|NOT COMPLETED|Overall Study||0
107654|NCT01197326|257205|P1|NOT COMPLETED|Overall Study||0
107655|NCT01197326|257204|P2|COMPLETED|Overall Study||209
107656|NCT01197326|257205|P1|COMPLETED|Overall Study||205
107657|NCT01197326|257204|P2|STARTED|Overall Study||209
107658|NCT01197326|257205|P1|STARTED|Overall Study||205
107659|NCT01196988|257217|P4|NOT COMPLETED|Overall Study||1
107660|NCT01196988|257218|P3|NOT COMPLETED|Overall Study||25
107661|NCT01196988|257219|P2|NOT COMPLETED|Overall Study||32
107662|NCT01196988|257220|P1|NOT COMPLETED|Overall Study||24
107663|NCT01196988|257217|P4|COMPLETED|Overall Study||276
107664|NCT01196988|257218|P3|COMPLETED|Overall Study||886
107665|NCT01196988|257219|P2|COMPLETED|Overall Study||880
107666|NCT01196988|257220|P1|COMPLETED|Overall Study||891
107667|NCT01196988|257217|P4|STARTED|Overall Study||277
107668|NCT01196988|257218|P3|STARTED|Overall Study||911
107669|NCT01196988|257219|P2|STARTED|Overall Study||912
107670|NCT01196988|257220|P1|STARTED|Overall Study||915
107671|NCT01196975|257314|P5|NOT COMPLETED|Overall Study||13
107672|NCT01196975|257315|P4|NOT COMPLETED|Overall Study||6
107673|NCT01196975|257316|P3|NOT COMPLETED|Overall Study||5
107674|NCT01196975|257317|P2|NOT COMPLETED|Overall Study||9
107675|NCT01196975|257318|P1|NOT COMPLETED|Overall Study||15
107676|NCT01196975|257314|P5|COMPLETED|Overall Study||205
107677|NCT01196975|257315|P4|COMPLETED|Overall Study||207
107678|NCT01196975|257316|P3|COMPLETED|Overall Study||420
107679|NCT01196975|257317|P2|COMPLETED|Overall Study||415
107680|NCT01196975|257318|P1|COMPLETED|Overall Study||408
107681|NCT01196975|257314|P5|STARTED|Overall Study||218
107682|NCT01196975|257315|P4|STARTED|Overall Study||213
107683|NCT01196975|257316|P3|STARTED|Overall Study||425
107684|NCT01196975|257317|P2|STARTED|Overall Study||424
107685|NCT01196975|257318|P1|STARTED|Overall Study||423
107686|NCT01196923|257450|P1|NOT COMPLETED|Overall Study||0
107687|NCT01196923|257450|P1|COMPLETED|Overall Study||20
107688|NCT01196923|257450|P1|STARTED|Overall Study||20
107689|NCT01196741|257456|P2|NOT COMPLETED|Overall Study||28
107690|NCT01196741|257457|P1|NOT COMPLETED|Overall Study||60
107691|NCT01196741|257456|P2|COMPLETED|Overall Study||8
107692|NCT01196741|257457|P1|COMPLETED|Overall Study||11
107693|NCT01196741|257456|P2|STARTED|Overall Study||36
107694|NCT01196741|257457|P1|STARTED|Overall Study||71
107695|NCT01196442|257471|P1|NOT COMPLETED|Overall Study||0
107696|NCT01196442|257471|P1|COMPLETED|Overall Study||39
107697|NCT01196442|257471|P1|STARTED|Overall Study||39
107698|NCT01196429|257483|P2|NOT COMPLETED|Overall Study||0
107699|NCT01196429|257484|P1|NOT COMPLETED|Overall Study||3
107700|NCT01196429|257483|P2|COMPLETED|Overall Study||45
107701|NCT01196429|257484|P1|COMPLETED|Overall Study||42
107702|NCT01196429|257483|P2|STARTED|Overall Study||45
107703|NCT01196429|257484|P1|STARTED|Overall Study||45
107704|NCT01196104|257502|P2|NOT COMPLETED|Overall Study||5
107706|NCT01196104|257502|P2|COMPLETED|Overall Study||15
107707|NCT01196104|257503|P1|COMPLETED|Overall Study||15
107708|NCT01196104|257502|P2|STARTED|Overall Study||20
107709|NCT01196104|257503|P1|STARTED|Overall Study||19
107710|NCT01196078|257545|P2|NOT COMPLETED|Overall Study||37
107711|NCT01196078|257546|P1|NOT COMPLETED|Overall Study||33
107712|NCT01196078|257545|P2|COMPLETED|Overall Study||20
107713|NCT01196078|257546|P1|COMPLETED|Overall Study||24
107714|NCT01196078|257545|P2|STARTED|Overall Study||57
107715|NCT01196078|257546|P1|STARTED|Overall Study||57
107716|NCT01196052|257574|P1|NOT COMPLETED|Overall Study||23
107717|NCT01196052|257574|P1|COMPLETED|Overall Study||130
107718|NCT01196052|257574|P1|Received Trastuzumab Emtansine|Overall Study||148
107719|NCT01196052|257574|P1|STARTED|Overall Study||153
107720|NCT01196026|257591|P6|NOT COMPLETED|Overall Study||0
107721|NCT01196026|257592|P5|NOT COMPLETED|Overall Study||1
107722|NCT01196026|257593|P4|NOT COMPLETED|Overall Study||0
107723|NCT01196026|257594|P3|NOT COMPLETED|Overall Study||0
107724|NCT01196026|257595|P2|NOT COMPLETED|Overall Study||8
107725|NCT01196026|257596|P1|NOT COMPLETED|Overall Study||1
107726|NCT01196026|257591|P6|COMPLETED|Overall Study||24
107727|NCT01196026|257592|P5|COMPLETED|Overall Study||42
107728|NCT01196026|257593|P4|COMPLETED|Overall Study||10
107729|NCT01196026|257594|P3|COMPLETED|Overall Study||23
107730|NCT01196026|257595|P2|COMPLETED|Overall Study||36
107731|NCT01196026|257596|P1|COMPLETED|Overall Study||9
107732|NCT01196026|257591|P6|Completed at Day 28|Overall Study||24
107733|NCT01196026|257592|P5|Completed at Day 28|Overall Study||42
107734|NCT01196026|257593|P4|Completed at Day 28|Overall Study||10
107735|NCT01196026|257594|P3|Completed at Day 28|Overall Study||23
107736|NCT01196026|257595|P2|Completed at Day 28|Overall Study||41
107737|NCT01196026|257596|P1|Completed at Day 28|Overall Study||9
107738|NCT01196026|257591|P6|STARTED|Overall Study||24
107739|NCT01196026|257592|P5|STARTED|Overall Study||43
107740|NCT01196026|257593|P4|STARTED|Overall Study||10
107741|NCT01196026|257594|P3|STARTED|Overall Study||23
107742|NCT01196026|257595|P2|STARTED|Overall Study||44
107743|NCT01196026|257596|P1|STARTED|Overall Study||10
107744|NCT01195948|257832|P3|NOT COMPLETED|Overall Study||2
107745|NCT01195948|257833|P2|NOT COMPLETED|Overall Study||1
107746|NCT01195948|257834|P1|NOT COMPLETED|Overall Study||0
107747|NCT01195948|257832|P3|COMPLETED|Overall Study||9
107748|NCT01195948|257833|P2|COMPLETED|Overall Study||9
107749|NCT01195948|257834|P1|COMPLETED|Overall Study||10
107750|NCT01195948|257832|P3|Week 24|Overall Study||10
107751|NCT01195948|257833|P2|Week 24|Overall Study||10
107752|NCT01195948|257834|P1|Week 24|Overall Study||10
107753|NCT01195948|257832|P3|STARTED|Overall Study||11
107754|NCT01195948|257833|P2|STARTED|Overall Study||10
107755|NCT01195948|257834|P1|STARTED|Overall Study||10
107756|NCT01195922|257860|P1|NOT COMPLETED|Overall Study||0
107757|NCT01195922|257860|P1|COMPLETED|Overall Study||16
107758|NCT01195922|257860|P1|STARTED|Overall Study||16
107759|NCT01195844|257866|P1|NOT COMPLETED|Overall Study||40
107760|NCT01195844|257866|P1|COMPLETED|Overall Study||190
107761|NCT01195844|257866|P1|STARTED|Overall Study||230
107762|NCT01195831|257883|P2|NOT COMPLETED|Overall Study||10
107763|NCT01195831|257884|P1|NOT COMPLETED|Overall Study||8
107764|NCT01195831|257883|P2|COMPLETED|Overall Study||114
107765|NCT01195831|257884|P1|COMPLETED|Overall Study||112
107766|NCT01195831|257883|P2|STARTED|Overall Study||124
107767|NCT01195831|257884|P1|STARTED|Overall Study||120
107768|NCT01195779|257912|P14|NOT COMPLETED|Overall Study||0
107769|NCT01195779|257913|P13|NOT COMPLETED|Overall Study||0
107770|NCT01195779|257914|P12|NOT COMPLETED|Overall Study||0
107771|NCT01195779|257915|P11|NOT COMPLETED|Overall Study||0
107772|NCT01195779|257916|P10|NOT COMPLETED|Overall Study||0
107773|NCT01195779|257917|P9|NOT COMPLETED|Overall Study||0
107774|NCT01195779|257918|P8|NOT COMPLETED|Overall Study||0
107775|NCT01195779|257919|P7|NOT COMPLETED|Overall Study||0
107776|NCT01195779|257920|P6|NOT COMPLETED|Overall Study||0
107777|NCT01195779|257921|P5|NOT COMPLETED|Overall Study||0
107778|NCT01195779|257922|P4|NOT COMPLETED|Overall Study||0
107779|NCT01195779|257923|P3|NOT COMPLETED|Overall Study||0
107780|NCT01195779|257924|P2|NOT COMPLETED|Overall Study||0
107781|NCT01195779|257925|P1|NOT COMPLETED|Overall Study||0
107782|NCT01195779|257912|P14|COMPLETED|Overall Study||1
107783|NCT01195779|257913|P13|COMPLETED|Overall Study||0
107784|NCT01195779|257914|P12|COMPLETED|Overall Study||1
107785|NCT01195779|257915|P11|COMPLETED|Overall Study||0
107786|NCT01195779|257916|P10|COMPLETED|Overall Study||0
107787|NCT01195779|257917|P9|COMPLETED|Overall Study||0
107788|NCT01195779|257918|P8|COMPLETED|Overall Study||1
107789|NCT01195779|257919|P7|COMPLETED|Overall Study||0
107790|NCT01195779|257920|P6|COMPLETED|Overall Study||0
107791|NCT01195779|257921|P5|COMPLETED|Overall Study||1
107792|NCT01195779|257922|P4|COMPLETED|Overall Study||0
107793|NCT01195779|257923|P3|COMPLETED|Overall Study||0
107794|NCT01195779|257924|P2|COMPLETED|Overall Study||0
107795|NCT01195779|257925|P1|COMPLETED|Overall Study||0
107796|NCT01195779|257912|P14|STARTED|Overall Study||1
107797|NCT01195779|257913|P13|STARTED|Overall Study||0
107798|NCT01195779|257914|P12|STARTED|Overall Study||1
107799|NCT01195779|257915|P11|STARTED|Overall Study||0
107800|NCT01195779|257916|P10|STARTED|Overall Study||0
107801|NCT01195779|257917|P9|STARTED|Overall Study||0
107802|NCT01195779|257918|P8|STARTED|Overall Study||1
107803|NCT01195779|257919|P7|STARTED|Overall Study||0
107804|NCT01195779|257920|P6|STARTED|Overall Study||0
107805|NCT01195779|257921|P5|STARTED|Overall Study||1
107806|NCT01195779|257922|P4|STARTED|Overall Study||0
107807|NCT01195779|257923|P3|STARTED|Overall Study||0
107808|NCT01195779|257924|P2|STARTED|Overall Study||0
107809|NCT01195779|257925|P1|STARTED|Overall Study||0
107810|NCT01195701|258097|P2|NOT COMPLETED|Overall Study||5
107811|NCT01195701|258098|P1|NOT COMPLETED|Overall Study||0
107812|NCT01195701|258097|P2|COMPLETED|Overall Study||20
107813|NCT01195701|258098|P1|COMPLETED|Overall Study||10
107814|NCT01195701|258097|P2|STARTED|Overall Study||25
107815|NCT01195701|258098|P1|STARTED|Overall Study||10
107816|NCT01195675|258124|P1|NOT COMPLETED|Overall Study||3
107817|NCT01195675|258124|P1|COMPLETED|Overall Study||27
107818|NCT01195675|258124|P1|Received Placebo 2|Overall Study||28
107819|NCT01195675|258124|P1|Received Placebo 1|Overall Study||29
107820|NCT01195675|258124|P1|Received Moxifloxacin|Overall Study||29
107821|NCT01195675|258124|P1|Received Empa 200mg|Overall Study||30
107822|NCT01195675|258124|P1|Received Empa 25mg|Overall Study||28
107823|NCT01195675|258124|P1|STARTED|Overall Study||30
107824|NCT01195662|258157|P3|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||1
107825|NCT01195662|258158|P2|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||0
107826|NCT01195662|258159|P1|NOT COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||3
107827|NCT01195662|258157|P3|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||119
107828|NCT01195662|258158|P2|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||209
107829|NCT01195662|258159|P1|COMPLETED|Follow-Up(Week 13/1 Week Post Last Dose)||200
107830|NCT01195662|258157|P3|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in the study and entered the follow up period.|120
107831|NCT01195662|258158|P2|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|2 participants completed treatment period but chose not to enter follow up period.|209
107832|NCT01195662|258159|P1|STARTED|Follow-Up(Week 13/1 Week Post Last Dose)|1 participant discontinued drug but remained in study and entered Follow-Up.|203
107833|NCT01195662|258157|P3|NOT COMPLETED|Double Blind Treatment Period||14
107834|NCT01195662|258158|P2|NOT COMPLETED|Double Blind Treatment Period||14
107835|NCT01195662|258159|P1|NOT COMPLETED|Double Blind Treatment Period||22
107836|NCT01195662|258157|P3|COMPLETED|Double Blind Treatment Period||119
107837|NCT01195662|258158|P2|COMPLETED|Double Blind Treatment Period||211
107838|NCT01195662|258159|P1|COMPLETED|Double Blind Treatment Period||202
107839|NCT01195662|258157|P3|STARTED|Double Blind Treatment Period||133
107840|NCT01195662|258158|P2|STARTED|Double Blind Treatment Period||225
107841|NCT01195662|258159|P1|STARTED|Double Blind Treatment Period||224
107842|NCT01195636|258189|P2|NOT COMPLETED|Second Intervention (3 Weeks)||2
107843|NCT01195636|258190|P1|NOT COMPLETED|Second Intervention (3 Weeks)||1
107844|NCT01195636|258189|P2|COMPLETED|Second Intervention (3 Weeks)||27
107845|NCT01195636|258190|P1|COMPLETED|Second Intervention (3 Weeks)||27
107846|NCT01195636|258189|P2|STARTED|Second Intervention (3 Weeks)||29
107847|NCT01195636|258190|P1|STARTED|Second Intervention (3 Weeks)||28
107848|NCT01195636|258189|P2|NOT COMPLETED|Washout Period (2 Weeks)||3
107849|NCT01195636|258190|P1|NOT COMPLETED|Washout Period (2 Weeks)||2
107850|NCT01195636|258189|P2|COMPLETED|Washout Period (2 Weeks)||29
107851|NCT01195636|258190|P1|COMPLETED|Washout Period (2 Weeks)||28
107852|NCT01195636|258189|P2|STARTED|Washout Period (2 Weeks)||32
107853|NCT01195636|258190|P1|STARTED|Washout Period (2 Weeks)||30
107854|NCT01195636|258189|P2|NOT COMPLETED|First Intervention (3 Weeks)||3
107855|NCT01195636|258190|P1|NOT COMPLETED|First Intervention (3 Weeks)||5
107856|NCT01195636|258189|P2|COMPLETED|First Intervention (3 Weeks)||32
107857|NCT01195636|258190|P1|COMPLETED|First Intervention (3 Weeks)||30
107858|NCT01195636|258189|P2|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||35
107859|NCT01195636|258190|P1|Received at Least 1 Dose of Drug|First Intervention (3 Weeks)||33
107860|NCT01195636|258189|P2|STARTED|First Intervention (3 Weeks)||35
107861|NCT01195636|258190|P1|STARTED|First Intervention (3 Weeks)||35
107862|NCT01195623|258216|P2|NOT COMPLETED|Overall Study||37
107863|NCT01195623|258217|P1|NOT COMPLETED|Overall Study||35
107864|NCT01195623|258216|P2|COMPLETED|Overall Study|129 legs|108
107865|NCT01195623|258217|P1|COMPLETED|Overall Study|127 legs|113
107866|NCT01195623|258216|P2|STARTED|Overall Study|177 legs total operated|145
107867|NCT01195623|258217|P1|STARTED|Overall Study|166 legs total operated|148
107868|NCT01195597|258225|P1|NOT COMPLETED|Overall Study||13
107869|NCT01195597|258225|P1|COMPLETED|Overall Study||27
107870|NCT01195597|258225|P1|STARTED|Overall Study||40
107871|NCT01195584|258233|P3|NOT COMPLETED|Overall Study||0
107872|NCT01195584|258234|P2|NOT COMPLETED|Overall Study||0
107873|NCT01195584|258235|P1|NOT COMPLETED|Overall Study||0
107874|NCT01195584|258233|P3|COMPLETED|Overall Study||27
107875|NCT01195584|258234|P2|COMPLETED|Overall Study||25
107876|NCT01195584|258235|P1|COMPLETED|Overall Study||20
107877|NCT01195584|258233|P3|STARTED|Overall Study||27
107878|NCT01195584|258234|P2|STARTED|Overall Study||25
107879|NCT01195584|258235|P1|STARTED|Overall Study||20
107880|NCT01195467|258246|P1|NOT COMPLETED|Overall Study||10
107881|NCT01195467|258246|P1|COMPLETED|Overall Study||30
107882|NCT01195467|258246|P1|STARTED|Overall Study||40
107883|NCT01195415|258251|P1|NOT COMPLETED|Overall Study||2
107884|NCT01195415|258251|P1|COMPLETED|Overall Study||23
107885|NCT01195415|258251|P1|STARTED|Overall Study||25
107886|NCT01195363|258260|P2|NOT COMPLETED|Overall Study||9
107887|NCT01195363|258261|P1|NOT COMPLETED|Overall Study||11
107888|NCT01195363|258260|P2|COMPLETED|Overall Study||4
107889|NCT01195363|258261|P1|COMPLETED|Overall Study||4
107890|NCT01195363|258260|P2|STARTED|Overall Study||13
107891|NCT01195363|258261|P1|STARTED|Overall Study||15
107892|NCT01195272|258267|P1|NOT COMPLETED|Overall Study||4
107893|NCT01195272|258267|P1|COMPLETED|Overall Study||17
107894|NCT01195272|258267|P1|STARTED|Overall Study||21
107895|NCT01195116|258286|P2|NOT COMPLETED|Overall Study||0
107896|NCT01195116|258287|P1|NOT COMPLETED|Overall Study||0
107897|NCT01195116|258286|P2|COMPLETED|Overall Study||20
107898|NCT01195116|258287|P1|COMPLETED|Overall Study||21
107899|NCT01195116|258286|P2|STARTED|Overall Study||20
107900|NCT01195116|258287|P1|STARTED|Overall Study||21
107901|NCT01195103|258296|P3|NOT COMPLETED|Overall Study||0
107902|NCT01195103|258297|P2|NOT COMPLETED|Overall Study||0
107903|NCT01195103|258298|P1|NOT COMPLETED|Overall Study||1
107904|NCT01195103|258296|P3|COMPLETED|Overall Study||5
107905|NCT01195103|258297|P2|COMPLETED|Overall Study||2
107906|NCT01195103|258298|P1|COMPLETED|Overall Study|One patient withdrew after randomization but before received study drug.|5
107907|NCT01195103|258296|P3|STARTED|Overall Study||5
107908|NCT01195103|258297|P2|STARTED|Overall Study||2
107909|NCT01195103|258298|P1|STARTED|Overall Study||6
107910|NCT01195090|258308|P2|NOT COMPLETED|Overall Study||8
107911|NCT01195090|258309|P1|NOT COMPLETED|Overall Study||6
107912|NCT01195090|258308|P2|COMPLETED|Overall Study||52
107913|NCT01195090|258309|P1|COMPLETED|Overall Study||54
107914|NCT01195090|258308|P2|STARTED|Overall Study||60
107915|NCT01195090|258309|P1|STARTED|Overall Study||60
107916|NCT01195025|258367|P5|NOT COMPLETED|Third Intervention C||0
107917|NCT01195025|258368|P4|NOT COMPLETED|Third Intervention C||0
107918|NCT01195025|258369|P3|NOT COMPLETED|Third Intervention C||0
107919|NCT01195025|258370|P2|NOT COMPLETED|Third Intervention C||0
107920|NCT01195025|258371|P1|NOT COMPLETED|Third Intervention C||0
107921|NCT01195025|258367|P5|COMPLETED|Third Intervention C||1
107922|NCT01195025|258368|P4|COMPLETED|Third Intervention C||2
107923|NCT01195025|258369|P3|COMPLETED|Third Intervention C||2
107924|NCT01195025|258370|P2|COMPLETED|Third Intervention C||3
107925|NCT01195025|258371|P1|COMPLETED|Third Intervention C||2
107926|NCT01195025|258367|P5|STARTED|Third Intervention C||1
107927|NCT01195025|258368|P4|STARTED|Third Intervention C||2
107928|NCT01195025|258369|P3|STARTED|Third Intervention C||2
107929|NCT01195025|258370|P2|STARTED|Third Intervention C||3
107930|NCT01195025|258371|P1|STARTED|Third Intervention C||2
107931|NCT01195025|258367|P5|NOT COMPLETED|Second Intervention B||0
107932|NCT01195025|258368|P4|NOT COMPLETED|Second Intervention B||0
107933|NCT01195025|258369|P3|NOT COMPLETED|Second Intervention B||0
107934|NCT01195025|258370|P2|NOT COMPLETED|Second Intervention B||0
107935|NCT01195025|258371|P1|NOT COMPLETED|Second Intervention B||0
107936|NCT01195025|258367|P5|COMPLETED|Second Intervention B||1
107937|NCT01195025|258368|P4|COMPLETED|Second Intervention B||2
107938|NCT01195025|258369|P3|COMPLETED|Second Intervention B||2
107939|NCT01195025|258370|P2|COMPLETED|Second Intervention B||3
107940|NCT01195025|258371|P1|COMPLETED|Second Intervention B||2
107941|NCT01195025|258367|P5|STARTED|Second Intervention B||1
107942|NCT01195025|258368|P4|STARTED|Second Intervention B||2
107943|NCT01195025|258369|P3|STARTED|Second Intervention B||2
107944|NCT01195025|258370|P2|STARTED|Second Intervention B||3
107945|NCT01195025|258371|P1|STARTED|Second Intervention B||2
107946|NCT01195025|258367|P5|NOT COMPLETED|First Intervention A||0
107947|NCT01195025|258368|P4|NOT COMPLETED|First Intervention A||0
107948|NCT01195025|258369|P3|NOT COMPLETED|First Intervention A||0
107949|NCT01195025|258370|P2|NOT COMPLETED|First Intervention A||0
107950|NCT01195025|258371|P1|NOT COMPLETED|First Intervention A||0
107951|NCT01195025|258367|P5|COMPLETED|First Intervention A||1
107952|NCT01195025|258368|P4|COMPLETED|First Intervention A||2
107953|NCT01195025|258369|P3|COMPLETED|First Intervention A||2
107954|NCT01195025|258370|P2|COMPLETED|First Intervention A||3
107955|NCT01195025|258371|P1|COMPLETED|First Intervention A||2
107956|NCT01195025|258367|P5|STARTED|First Intervention A||1
107957|NCT01195025|258368|P4|STARTED|First Intervention A||2
107958|NCT01195025|258369|P3|STARTED|First Intervention A||2
107959|NCT01195025|258370|P2|STARTED|First Intervention A||3
107960|NCT01195025|258371|P1|STARTED|First Intervention A||2
107961|NCT01194999|258378|P1|NOT COMPLETED|Overall Study||17
107962|NCT01194999|258378|P1|COMPLETED|Overall Study||115
107963|NCT01194999|258378|P1|STARTED|Overall Study||132
107964|NCT01194973|258382|P1|NOT COMPLETED|26 Week Treatment Period||3
107965|NCT01194973|258382|P1|COMPLETED|26 Week Treatment Period||38
107966|NCT01194973|258382|P1|STARTED|26 Week Treatment Period||41
107967|NCT01194973|258382|P1|NOT COMPLETED|Screening Period||3
107968|NCT01194973|258382|P1|COMPLETED|Screening Period||41
107969|NCT01194973|258382|P1|STARTED|Screening Period||44
107970|NCT01194908|258397|P1|NOT COMPLETED|Overall Study||0
107971|NCT01194908|258397|P1|COMPLETED|Overall Study||5
107972|NCT01194908|258397|P1|STARTED|Overall Study||5
107973|NCT01194869|258402|P1|NOT COMPLETED|Overall Study||4
107974|NCT01194869|258402|P1|COMPLETED|Overall Study||21
107975|NCT01194869|258402|P1|STARTED|Overall Study||25
107976|NCT01194856|258410|P2|NOT COMPLETED|Overall Study||0
107977|NCT01194856|258411|P1|NOT COMPLETED|Overall Study||1
107978|NCT01194856|258410|P2|COMPLETED|Overall Study||0
107979|NCT01194856|258411|P1|COMPLETED|Overall Study||0
107980|NCT01194856|258410|P2|STARTED|Overall Study||0
107981|NCT01194856|258411|P1|STARTED|Overall Study||1
107982|NCT01194830|258433|P2|NOT COMPLETED|Overall Study||27
107983|NCT01194830|258434|P1|NOT COMPLETED|Overall Study||36
107984|NCT01194830|258433|P2|COMPLETED|Overall Study||83
107985|NCT01194830|258434|P1|COMPLETED|Overall Study||88
107986|NCT01194830|258433|P2|STARTED|Overall Study||110
107987|NCT01194830|258434|P1|STARTED|Overall Study||124
107988|NCT01194154|258458|P2|NOT COMPLETED|Overall Study||33
107989|NCT01194154|258459|P1|NOT COMPLETED|Overall Study||49
107990|NCT01194154|258458|P2|COMPLETED|Overall Study||91
107991|NCT01194154|258459|P1|COMPLETED|Overall Study||68
107992|NCT01194154|258458|P2|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|117
107993|NCT01194154|258459|P1|Safety Analysis Set|Overall Study|3 participants randomized to placebo but received MIRCERA and included in MIRCERA arm (as treated).|118
107994|NCT01194154|258458|P2|Full Analysis Set|Overall Study||120
107995|NCT01194154|258459|P1|Full Analysis Set|Overall Study||115
107996|NCT01194154|258458|P2|STARTED|Overall Study||124
107997|NCT01194154|258459|P1|STARTED|Overall Study||117
107998|NCT01194089|258479|P2|NOT COMPLETED|Overall Study||0
107999|NCT01194089|258480|P1|NOT COMPLETED|Overall Study||0
108000|NCT01194089|258479|P2|COMPLETED|Overall Study||47
108001|NCT01194089|258480|P1|COMPLETED|Overall Study||42
108002|NCT01194089|258479|P2|STARTED|Overall Study||47
108003|NCT01194089|258480|P1|STARTED|Overall Study||42
108004|NCT01194674|258490|P1|NOT COMPLETED|Overall Study||0
108005|NCT01194674|258490|P1|COMPLETED|Overall Study||2
108006|NCT01194674|258490|P1|STARTED|Overall Study||2
108007|NCT01194531|258499|P2|NOT COMPLETED|Overall Study||3
108008|NCT01194531|258500|P1|NOT COMPLETED|Overall Study||5
108009|NCT01194531|258499|P2|COMPLETED|Overall Study||27
108010|NCT01194531|258500|P1|COMPLETED|Overall Study||24
108011|NCT01194531|258499|P2|STARTED|Overall Study||30
108012|NCT01194531|258500|P1|STARTED|Overall Study||29
108013|NCT01194479|258508|P4|NOT COMPLETED|Overall Study||0
108014|NCT01194479|258509|P3|NOT COMPLETED|Overall Study||0
108015|NCT01194479|258510|P2|NOT COMPLETED|Overall Study||0
108016|NCT01194479|258511|P1|NOT COMPLETED|Overall Study||0
108017|NCT01194479|258508|P4|COMPLETED|Overall Study||5
108018|NCT01194479|258509|P3|COMPLETED|Overall Study||2
108019|NCT01194479|258510|P2|COMPLETED|Overall Study||4
108020|NCT01194479|258511|P1|COMPLETED|Overall Study||3
108021|NCT01194479|258508|P4|Cross-over at Second Visit|Overall Study||5
108022|NCT01194479|258509|P3|Cross-over at Second Visit|Overall Study||2
108023|NCT01194479|258510|P2|Cross-over at Second Visit|Overall Study||4
108024|NCT01194479|258511|P1|Cross-over at Second Visit|Overall Study||3
108025|NCT01194479|258508|P4|STARTED|Overall Study||5
108026|NCT01194479|258509|P3|STARTED|Overall Study||2
108027|NCT01194479|258510|P2|STARTED|Overall Study||4
108028|NCT01194479|258511|P1|STARTED|Overall Study||3
108029|NCT01194453|258535|P2|NOT COMPLETED|Overall Study||17
108030|NCT01194453|258536|P1|NOT COMPLETED|Overall Study||17
108031|NCT01194453|258535|P2|COMPLETED|Overall Study||127
108032|NCT01194453|258536|P1|COMPLETED|Overall Study||127
108033|NCT01194453|258535|P2|STARTED|Overall Study||144
108034|NCT01194453|258536|P1|STARTED|Overall Study||144
108035|NCT01194440|258544|P1|NOT COMPLETED|Overall Study||12
108036|NCT01194440|258544|P1|COMPLETED|Overall Study||47
108037|NCT01194440|258544|P1|STARTED|Overall Study||59
108038|NCT01194427|258548|P1|NOT COMPLETED|Overall Study||0
108039|NCT01194427|258548|P1|COMPLETED|Overall Study||2
108040|NCT01194427|258548|P1|STARTED|Overall Study||2
108041|NCT01194414|258554|P4|NOT COMPLETED|72 Weeks Open Label Extension||26
108042|NCT01194414|258555|P3|NOT COMPLETED|72 Weeks Open Label Extension||8
108043|NCT01194414|258556|P2|NOT COMPLETED|72 Weeks Open Label Extension||66
108044|NCT01194414|258557|P1|NOT COMPLETED|72 Weeks Open Label Extension||79
108045|NCT01194414|258554|P4|COMPLETED|72 Weeks Open Label Extension||160
108046|NCT01194414|258555|P3|COMPLETED|72 Weeks Open Label Extension||40
108047|NCT01194414|258556|P2|COMPLETED|72 Weeks Open Label Extension||311
108048|NCT01194414|258557|P1|COMPLETED|72 Weeks Open Label Extension||445
108049|NCT01194414|258554|P4|STARTED|72 Weeks Open Label Extension||186
108050|NCT01194414|258555|P3|STARTED|72 Weeks Open Label Extension||48
108051|NCT01194414|258556|P2|STARTED|72 Weeks Open Label Extension||377
108052|NCT01194414|258557|P1|STARTED|72 Weeks Open Label Extension||524
108053|NCT01194414|258554|P4|NOT COMPLETED|24 Weeks Double Blind Period||0
108054|NCT01194414|258555|P3|NOT COMPLETED|24 Weeks Double Blind Period||0
108055|NCT01194414|258556|P2|NOT COMPLETED|24 Weeks Double Blind Period||67
108056|NCT01194414|258557|P1|NOT COMPLETED|24 Weeks Double Blind Period||59
108057|NCT01194414|258554|P4|COMPLETED|24 Weeks Double Blind Period||0
108058|NCT01194414|258555|P3|COMPLETED|24 Weeks Double Blind Period||0
108059|NCT01194414|258556|P2|COMPLETED|24 Weeks Double Blind Period||564
108060|NCT01194414|258557|P1|COMPLETED|24 Weeks Double Blind Period||572
108061|NCT01194414|258554|P4|Per Protocol Population|24 Weeks Double Blind Period||0
108062|NCT01194414|258555|P3|Per Protocol Population|24 Weeks Double Blind Period||0
108063|NCT01194414|258556|P2|Per Protocol Population|24 Weeks Double Blind Period||537
108064|NCT01194414|258557|P1|Per Protocol Population|24 Weeks Double Blind Period||558
108065|NCT01194414|258554|P4|STARTED|24 Weeks Double Blind Period||0
108066|NCT01194414|258555|P3|STARTED|24 Weeks Double Blind Period||0
108067|NCT01194414|258556|P2|STARTED|24 Weeks Double Blind Period||631
108068|NCT01194414|258557|P1|STARTED|24 Weeks Double Blind Period||631
108069|NCT01194297|258619|P2|NOT COMPLETED|Overall Study||0
108070|NCT01194297|258620|P1|NOT COMPLETED|Overall Study||0
108071|NCT01194297|258619|P2|COMPLETED|Overall Study||1
108072|NCT01194297|258620|P1|COMPLETED|Overall Study||2
108073|NCT01194297|258619|P2|STARTED|Overall Study||1
108074|NCT01194297|258620|P1|STARTED|Overall Study||2
108075|NCT01194258|258628|P5|NOT COMPLETED|Period 2 (12 Weeks)||2
108076|NCT01194258|258629|P4|NOT COMPLETED|Period 2 (12 Weeks)||0
108077|NCT01194258|258630|P3|NOT COMPLETED|Period 2 (12 Weeks)||1
108078|NCT01194258|258631|P2|NOT COMPLETED|Period 2 (12 Weeks)||2
108079|NCT01194258|258632|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
108080|NCT01194258|258628|P5|COMPLETED|Period 2 (12 Weeks)||30
108081|NCT01194258|258629|P4|COMPLETED|Period 2 (12 Weeks)||29
108082|NCT01194258|258630|P3|COMPLETED|Period 2 (12 Weeks)||29
108083|NCT01194258|258631|P2|COMPLETED|Period 2 (12 Weeks)||27
108084|NCT01194258|258632|P1|COMPLETED|Period 2 (12 Weeks)||0
108085|NCT01194258|258628|P5|STARTED|Period 2 (12 Weeks)||32
108086|NCT01194258|258629|P4|STARTED|Period 2 (12 Weeks)||29
108087|NCT01194258|258630|P3|STARTED|Period 2 (12 Weeks)||30
108088|NCT01194258|258631|P2|STARTED|Period 2 (12 Weeks)||29
108089|NCT01194258|258632|P1|STARTED|Period 2 (12 Weeks)||0
108090|NCT01194258|258628|P5|NOT COMPLETED|Period 1 (12 Weeks)||1
108091|NCT01194258|258629|P4|NOT COMPLETED|Period 1 (12 Weeks)||0
108092|NCT01194258|258630|P3|NOT COMPLETED|Period 1 (12 Weeks)||0
108093|NCT01194258|258631|P2|NOT COMPLETED|Period 1 (12 Weeks)||0
108094|NCT01194258|258632|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
108095|NCT01194258|258628|P5|COMPLETED|Period 1 (12 Weeks)||32
108096|NCT01194258|258629|P4|COMPLETED|Period 1 (12 Weeks)||29
108097|NCT01194258|258630|P3|COMPLETED|Period 1 (12 Weeks)||30
108098|NCT01194258|258631|P2|COMPLETED|Period 1 (12 Weeks)||29
108099|NCT01194258|258632|P1|COMPLETED|Period 1 (12 Weeks)||0
108100|NCT01194258|258628|P5|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||33
108101|NCT01194258|258629|P4|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
108102|NCT01194258|258630|P3|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||30
108103|NCT01194258|258631|P2|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||29
108104|NCT01194258|258632|P1|Received at Least 1 Dose of Study Drug|Period 1 (12 Weeks)||0
108105|NCT01194258|258628|P5|STARTED|Period 1 (12 Weeks)|After the titration phase, 33 participants were randomized to the Aspart-PH20/Insulin lispro group.|33
108106|NCT01194258|258629|P4|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Aspart-PH20 group.|29
108107|NCT01194258|258630|P3|STARTED|Period 1 (12 Weeks)|After the titration phase, 30 participants were randomized to the Lispro-PH20/Insulin lispro group.|30
108108|NCT01194258|258631|P2|STARTED|Period 1 (12 Weeks)|After the titration phase, 29 participants were randomized to the Insulin lispro/Lispro-PH20 group.|29
108109|NCT01194258|258632|P1|STARTED|Period 1 (12 Weeks)|Participants were randomized to the Insulin lispro or an Analog-PH20 group after titration.|0
108110|NCT01194258|258628|P5|NOT COMPLETED|Titration Period||0
108111|NCT01194258|258629|P4|NOT COMPLETED|Titration Period||0
108112|NCT01194258|258630|P3|NOT COMPLETED|Titration Period||0
108113|NCT01194258|258631|P2|NOT COMPLETED|Titration Period||0
108114|NCT01194258|258632|P1|NOT COMPLETED|Titration Period||11
108115|NCT01194258|258628|P5|COMPLETED|Titration Period||0
108116|NCT01194258|258629|P4|COMPLETED|Titration Period||0
108117|NCT01194258|258630|P3|COMPLETED|Titration Period||0
108118|NCT01194258|258631|P2|COMPLETED|Titration Period||0
108119|NCT01194258|258632|P1|COMPLETED|Titration Period||121
108120|NCT01194258|258628|P5|STARTED|Titration Period||0
108121|NCT01194258|258629|P4|STARTED|Titration Period||0
108122|NCT01194258|258630|P3|STARTED|Titration Period||0
108123|NCT01194258|258631|P2|STARTED|Titration Period||0
108124|NCT01194258|258632|P1|STARTED|Titration Period||132
108125|NCT01194245|258656|P5|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
108126|NCT01194245|258657|P4|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
108127|NCT01194245|258658|P3|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
108128|NCT01194245|258659|P2|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
108129|NCT01194245|258660|P1|NOT COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
108130|NCT01194245|258656|P5|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||28
108131|NCT01194245|258657|P4|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
108132|NCT01194245|258658|P3|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||27
108133|NCT01194245|258659|P2|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||29
108134|NCT01194245|258660|P1|COMPLETED|Treatment Period 2 (Weeks 12 to 24)||0
108135|NCT01194245|258656|P5|STARTED|Treatment Period 2 (Weeks 12 to 24)||28
108136|NCT01194245|258657|P4|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
108137|NCT01194245|258658|P3|STARTED|Treatment Period 2 (Weeks 12 to 24)||27
108138|NCT01194245|258659|P2|STARTED|Treatment Period 2 (Weeks 12 to 24)||29
108139|NCT01194245|258660|P1|STARTED|Treatment Period 2 (Weeks 12 to 24)||0
108140|NCT01194245|258656|P5|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||2
108141|NCT01194245|258657|P4|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
108142|NCT01194245|258658|P3|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||1
108143|NCT01194245|258659|P2|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
108144|NCT01194245|258660|P1|NOT COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
108145|NCT01194245|258656|P5|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||28
108146|NCT01194245|258657|P4|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
108147|NCT01194245|258658|P3|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||27
108148|NCT01194245|258659|P2|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||29
108149|NCT01194245|258660|P1|COMPLETED|Treatment Period 1 (Weeks 0 to 12)||0
108150|NCT01194245|258656|P5|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
108151|NCT01194245|258657|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||30
108152|NCT01194245|258658|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||28
108153|NCT01194245|258659|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||29
108154|NCT01194245|258660|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1 (Weeks 0 to 12)||0
108155|NCT01194245|258656|P5|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
108156|NCT01194245|258657|P4|STARTED|Treatment Period 1 (Weeks 0 to 12)||30
108157|NCT01194245|258658|P3|STARTED|Treatment Period 1 (Weeks 0 to 12)||28
108158|NCT01194245|258659|P2|STARTED|Treatment Period 1 (Weeks 0 to 12)||29
108159|NCT01194245|258660|P1|STARTED|Treatment Period 1 (Weeks 0 to 12)||0
108160|NCT01194245|258656|P5|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
108161|NCT01194245|258657|P4|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
108162|NCT01194245|258658|P3|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
108163|NCT01194245|258659|P2|NOT COMPLETED|Titration Period (4 to 6 Weeks)||0
108164|NCT01194245|258660|P1|NOT COMPLETED|Titration Period (4 to 6 Weeks)||18
108165|NCT01194245|258656|P5|COMPLETED|Titration Period (4 to 6 Weeks)||0
108166|NCT01194245|258657|P4|COMPLETED|Titration Period (4 to 6 Weeks)||0
108167|NCT01194245|258658|P3|COMPLETED|Titration Period (4 to 6 Weeks)||0
108168|NCT01194245|258659|P2|COMPLETED|Titration Period (4 to 6 Weeks)||0
108319|NCT01193686|258831|P1|COMPLETED|Overall Study||8
108169|NCT01194245|258660|P1|COMPLETED|Titration Period (4 to 6 Weeks)|Participants that completed the Titration Period were randomized to Treatment Period 1.|117
108170|NCT01194245|258656|P5|STARTED|Titration Period (4 to 6 Weeks)||0
108171|NCT01194245|258657|P4|STARTED|Titration Period (4 to 6 Weeks)||0
108172|NCT01194245|258658|P3|STARTED|Titration Period (4 to 6 Weeks)||0
108173|NCT01194245|258659|P2|STARTED|Titration Period (4 to 6 Weeks)||0
108174|NCT01194245|258660|P1|STARTED|Titration Period (4 to 6 Weeks)||135
108175|NCT01194219|258681|P8|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||45
108176|NCT01194219|258682|P7|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||61
108177|NCT01194219|258683|P6|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
108178|NCT01194219|258684|P5|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||4
108179|NCT01194219|258685|P4|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108180|NCT01194219|258686|P3|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108181|NCT01194219|258687|P2|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108182|NCT01194219|258688|P1|NOT COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108183|NCT01194219|258681|P8|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|10 participants discontinued after Week 52 but prior to entry into the long term extension study|163
108184|NCT01194219|258682|P7|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|18 participants discontinued after Week 52 but prior to entry into the long term extension study|184
108185|NCT01194219|258683|P6|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|5 participants discontinued after Week 52 but prior to entry into the long term extension study|73
108186|NCT01194219|258684|P5|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)|1 participant discontinued after Week 52 but prior to entry into the long term extension study|73
108187|NCT01194219|258685|P4|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108188|NCT01194219|258686|P3|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108189|NCT01194219|258687|P2|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108190|NCT01194219|258688|P1|COMPLETED|Randomized Withdrawal Phase(Weeks 32-52)||0
108191|NCT01194219|258681|P8|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||91
108192|NCT01194219|258682|P7|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||126
108193|NCT01194219|258683|P6|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
108194|NCT01194219|258684|P5|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
108195|NCT01194219|258685|P4|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
108196|NCT01194219|258686|P3|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
108197|NCT01194219|258687|P2|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
108198|NCT01194219|258688|P1|Received Topical + Light Therapy|Randomized Withdrawal Phase(Weeks 32-52)||0
108199|NCT01194219|258681|P8|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||208
108200|NCT01194219|258682|P7|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||245
108201|NCT01194219|258683|P6|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|25 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
108202|NCT01194219|258684|P5|STARTED|Randomized Withdrawal Phase(Weeks 32-52)|7 participants discontinued after week 32 but prior to entry into the Randomized withdrawal Phase|77
108203|NCT01194219|258685|P4|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
108204|NCT01194219|258686|P3|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
108205|NCT01194219|258687|P2|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
108206|NCT01194219|258688|P1|STARTED|Randomized Withdrawal Phase(Weeks 32-52)||0
108207|NCT01194219|258681|P8|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
108208|NCT01194219|258682|P7|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
108209|NCT01194219|258683|P6|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
108210|NCT01194219|258684|P5|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
108211|NCT01194219|258685|P4|NOT COMPLETED|Maintenance Phase (Weeks16-32)||30
108212|NCT01194219|258686|P3|NOT COMPLETED|Maintenance Phase (Weeks16-32)||70
108213|NCT01194219|258687|P2|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
108214|NCT01194219|258688|P1|NOT COMPLETED|Maintenance Phase (Weeks16-32)||0
108215|NCT01194219|258681|P8|COMPLETED|Maintenance Phase (Weeks16-32)||0
108216|NCT01194219|258682|P7|COMPLETED|Maintenance Phase (Weeks16-32)||0
108217|NCT01194219|258683|P6|COMPLETED|Maintenance Phase (Weeks16-32)||0
108218|NCT01194219|258684|P5|COMPLETED|Maintenance Phase (Weeks16-32)||0
108219|NCT01194219|258685|P4|COMPLETED|Maintenance Phase (Weeks16-32)||215
108220|NCT01194219|258686|P3|COMPLETED|Maintenance Phase (Weeks16-32)||424
108221|NCT01194219|258687|P2|COMPLETED|Maintenance Phase (Weeks16-32)||0
108222|NCT01194219|258688|P1|COMPLETED|Maintenance Phase (Weeks16-32)||0
108223|NCT01194219|258681|P8|Received Apremilast|Maintenance Phase (Weeks16-32)||0
108224|NCT01194219|258682|P7|Received Apremilast|Maintenance Phase (Weeks16-32)||0
108225|NCT01194219|258683|P6|Received Apremilast|Maintenance Phase (Weeks16-32)||0
108226|NCT01194219|258684|P5|Received Apremilast|Maintenance Phase (Weeks16-32)||0
108227|NCT01194219|258685|P4|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|244
108228|NCT01194219|258686|P3|Received Apremilast|Maintenance Phase (Weeks16-32)|1 participant elected not to participate at the time the first dose was dispensed.|493
108229|NCT01194219|258687|P2|Received Apremilast|Maintenance Phase (Weeks16-32)||0
108230|NCT01194219|258688|P1|Received Apremilast|Maintenance Phase (Weeks16-32)||0
108231|NCT01194219|258681|P8|STARTED|Maintenance Phase (Weeks16-32)||0
108232|NCT01194219|258682|P7|STARTED|Maintenance Phase (Weeks16-32)||0
108233|NCT01194219|258683|P6|STARTED|Maintenance Phase (Weeks16-32)||0
108234|NCT01194219|258684|P5|STARTED|Maintenance Phase (Weeks16-32)||0
108235|NCT01194219|258685|P4|STARTED|Maintenance Phase (Weeks16-32)|4 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|245
108236|NCT01194219|258686|P3|STARTED|Maintenance Phase (Weeks16-32)|9 participants discontinued after Week 16 but prior to entry into the Maintenance Phase|494
108237|NCT01194219|258687|P2|STARTED|Maintenance Phase (Weeks16-32)||0
108238|NCT01194219|258688|P1|STARTED|Maintenance Phase (Weeks16-32)||0
108239|NCT01194219|258681|P8|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108240|NCT01194219|258682|P7|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108241|NCT01194219|258683|P6|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108242|NCT01194219|258684|P5|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108243|NCT01194219|258685|P4|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108244|NCT01194219|258686|P3|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108245|NCT01194219|258687|P2|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||33
108246|NCT01194219|258688|P1|NOT COMPLETED|Placebo Controlled Phase (Weeks 0-16)||59
108247|NCT01194219|258681|P8|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108248|NCT01194219|258682|P7|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108249|NCT01194219|258683|P6|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108250|NCT01194219|258684|P5|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108251|NCT01194219|258685|P4|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108252|NCT01194219|258686|P3|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||0
108253|NCT01194219|258687|P2|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||249
108254|NCT01194219|258688|P1|COMPLETED|Placebo Controlled Phase (Weeks 0-16)||503
108255|NCT01194219|258681|P8|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
108256|NCT01194219|258682|P7|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
108257|NCT01194219|258683|P6|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
108258|NCT01194219|258684|P5|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
108259|NCT01194219|258685|P4|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
108260|NCT01194219|258686|P3|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||0
108261|NCT01194219|258687|P2|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||282
108262|NCT01194219|258688|P1|Received Apremilast|Placebo Controlled Phase (Weeks 0-16)||560
108263|NCT01194219|258681|P8|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
108264|NCT01194219|258682|P7|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
108265|NCT01194219|258683|P6|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
108266|NCT01194219|258684|P5|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
108267|NCT01194219|258685|P4|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
108268|NCT01194219|258686|P3|STARTED|Placebo Controlled Phase (Weeks 0-16)||0
108269|NCT01194219|258687|P2|STARTED|Placebo Controlled Phase (Weeks 0-16)||282
108270|NCT01194219|258688|P1|STARTED|Placebo Controlled Phase (Weeks 0-16)||562
108271|NCT01193920|258728|P10|NOT COMPLETED|Overall Study||7
108272|NCT01193920|258729|P9|NOT COMPLETED|Overall Study||5
108273|NCT01193920|258730|P8|NOT COMPLETED|Overall Study||4
108274|NCT01193920|258731|P7|NOT COMPLETED|Overall Study||6
108275|NCT01193920|258732|P6|NOT COMPLETED|Overall Study||4
108276|NCT01193920|258733|P5|NOT COMPLETED|Overall Study||6
108277|NCT01193920|258734|P4|NOT COMPLETED|Overall Study||4
108278|NCT01193920|258735|P3|NOT COMPLETED|Overall Study||6
108279|NCT01193920|258736|P2|NOT COMPLETED|Overall Study||0
108280|NCT01193920|258737|P1|NOT COMPLETED|Overall Study||3
108281|NCT01193920|258728|P10|COMPLETED|Overall Study||74
108282|NCT01193920|258729|P9|COMPLETED|Overall Study||71
108283|NCT01193920|258730|P8|COMPLETED|Overall Study||76
108284|NCT01193920|258731|P7|COMPLETED|Overall Study||74
108285|NCT01193920|258732|P6|COMPLETED|Overall Study||76
108286|NCT01193920|258733|P5|COMPLETED|Overall Study||74
108287|NCT01193920|258734|P4|COMPLETED|Overall Study||76
108288|NCT01193920|258735|P3|COMPLETED|Overall Study||74
108289|NCT01193920|258736|P2|COMPLETED|Overall Study||20
108290|NCT01193920|258737|P1|COMPLETED|Overall Study||37
108291|NCT01193920|258728|P10|STARTED|Overall Study||81
108292|NCT01193920|258729|P9|STARTED|Overall Study||76
108293|NCT01193920|258730|P8|STARTED|Overall Study||80
108294|NCT01193920|258731|P7|STARTED|Overall Study||80
108295|NCT01193920|258732|P6|STARTED|Overall Study||80
108296|NCT01193920|258733|P5|STARTED|Overall Study||80
108297|NCT01193920|258734|P4|STARTED|Overall Study||80
108298|NCT01193920|258735|P3|STARTED|Overall Study||80
108299|NCT01193920|258736|P2|STARTED|Overall Study||20
108300|NCT01193920|258737|P1|STARTED|Overall Study||40
108301|NCT01193907|258791|P4|NOT COMPLETED|Overall Study||1
108302|NCT01193907|258792|P3|NOT COMPLETED|Overall Study||0
108303|NCT01193907|258793|P2|NOT COMPLETED|Overall Study||0
108304|NCT01193907|258794|P1|NOT COMPLETED|Overall Study||1
108305|NCT01193907|258791|P4|COMPLETED|Overall Study||21
108306|NCT01193907|258792|P3|COMPLETED|Overall Study||22
108307|NCT01193907|258793|P2|COMPLETED|Overall Study||22
108308|NCT01193907|258794|P1|COMPLETED|Overall Study||21
108309|NCT01193907|258791|P4|STARTED|Overall Study||22
108310|NCT01193907|258792|P3|STARTED|Overall Study||22
108311|NCT01193907|258793|P2|STARTED|Overall Study||22
108312|NCT01193907|258794|P1|STARTED|Overall Study||22
108313|NCT01193868|258816|P1|NOT COMPLETED|Overall Study||0
108314|NCT01193868|258816|P1|COMPLETED|Overall Study||6
108315|NCT01193868|258816|P1|STARTED|Overall Study||6
108316|NCT01193686|258830|P2|NOT COMPLETED|Overall Study||1
108317|NCT01193686|258831|P1|NOT COMPLETED|Overall Study||7
108318|NCT01193686|258830|P2|COMPLETED|Overall Study||8
108320|NCT01193686|258830|P2|Completed Visits and Final Assessment|Overall Study||8
108321|NCT01193686|258831|P1|Completed Visits and Final Assessment|Overall Study||8
108322|NCT01193686|258830|P2|Completed Mentor Training|Overall Study|Not applicable. Recipients were not required to complete training.|0
108323|NCT01193686|258831|P1|Completed Mentor Training|Overall Study||9
108324|NCT01193686|258830|P2|Completed Baseline Assessment|Overall Study||9
108325|NCT01193686|258831|P1|Completed Baseline Assessment|Overall Study||15
108326|NCT01193686|258830|P2|STARTED|Overall Study||9
108327|NCT01193686|258831|P1|STARTED|Overall Study||15
108328|NCT01193660|258848|P3|NOT COMPLETED|Overall Study||2
108329|NCT01193660|258849|P2|NOT COMPLETED|Overall Study||3
108330|NCT01193660|258850|P1|NOT COMPLETED|Overall Study||4
108331|NCT01193660|258848|P3|COMPLETED|Overall Study||32
108332|NCT01193660|258849|P2|COMPLETED|Overall Study||33
108333|NCT01193660|258850|P1|COMPLETED|Overall Study||31
108334|NCT01193660|258848|P3|STARTED|Overall Study||34
108335|NCT01193660|258849|P2|STARTED|Overall Study||36
108336|NCT01193660|258850|P1|STARTED|Overall Study||35
108337|NCT01193608|258894|P6|NOT COMPLETED|Overall Study||2
108338|NCT01193608|258895|P5|NOT COMPLETED|Overall Study||5
108339|NCT01193608|258896|P4|NOT COMPLETED|Overall Study||3
108340|NCT01193608|258897|P3|NOT COMPLETED|Overall Study||2
108341|NCT01193608|258898|P2|NOT COMPLETED|Overall Study||2
108342|NCT01193608|258899|P1|NOT COMPLETED|Overall Study||0
108343|NCT01193608|258894|P6|COMPLETED|Overall Study||17
108344|NCT01193608|258895|P5|COMPLETED|Overall Study||19
108345|NCT01193608|258896|P4|COMPLETED|Overall Study||14
108346|NCT01193608|258897|P3|COMPLETED|Overall Study||14
108347|NCT01193608|258898|P2|COMPLETED|Overall Study||4
108348|NCT01193608|258899|P1|COMPLETED|Overall Study||6
108349|NCT01193608|258894|P6|STARTED|Overall Study||19
108350|NCT01193608|258895|P5|STARTED|Overall Study||24
108351|NCT01193608|258896|P4|STARTED|Overall Study||17
108352|NCT01193608|258897|P3|STARTED|Overall Study||16
108353|NCT01193608|258898|P2|STARTED|Overall Study||6
108354|NCT01193608|258899|P1|STARTED|Overall Study||6
108355|NCT01193582|259136|P4|NOT COMPLETED|12 Month Follow-up||11
108356|NCT01193582|259137|P3|NOT COMPLETED|12 Month Follow-up||4
108357|NCT01193582|259138|P2|NOT COMPLETED|12 Month Follow-up||0
108358|NCT01193582|259139|P1|NOT COMPLETED|12 Month Follow-up||6
108359|NCT01193582|259136|P4|COMPLETED|12 Month Follow-up||166
108360|NCT01193582|259137|P3|COMPLETED|12 Month Follow-up||113
108361|NCT01193582|259138|P2|COMPLETED|12 Month Follow-up||88
108362|NCT01193582|259139|P1|COMPLETED|12 Month Follow-up||83
108363|NCT01193582|259136|P4|STARTED|12 Month Follow-up||177
108364|NCT01193582|259137|P3|STARTED|12 Month Follow-up||117
108365|NCT01193582|259138|P2|STARTED|12 Month Follow-up||88
108366|NCT01193582|259139|P1|STARTED|12 Month Follow-up||89
108367|NCT01193582|259136|P4|NOT COMPLETED|Vaccination Series||3
108368|NCT01193582|259137|P3|NOT COMPLETED|Vaccination Series||8
108369|NCT01193582|259138|P2|NOT COMPLETED|Vaccination Series||13
108370|NCT01193582|259139|P1|NOT COMPLETED|Vaccination Series||11
108371|NCT01193582|259136|P4|COMPLETED|Vaccination Series||177
108372|NCT01193582|259137|P3|COMPLETED|Vaccination Series||117
108373|NCT01193582|259138|P2|COMPLETED|Vaccination Series||88
108374|NCT01193582|259139|P1|COMPLETED|Vaccination Series||89
108375|NCT01193582|259136|P4|Vaccinated Dose 4|Vaccination Series||0
108376|NCT01193582|259137|P3|Vaccinated Dose 4|Vaccination Series||0
108377|NCT01193582|259138|P2|Vaccinated Dose 4|Vaccination Series||0
108378|NCT01193582|259139|P1|Vaccinated Dose 4|Vaccination Series||90
108379|NCT01193582|259136|P4|Vaccinated Dose 3|Vaccination Series||0
108380|NCT01193582|259137|P3|Vaccinated Dose 3|Vaccination Series||0
108381|NCT01193582|259138|P2|Vaccinated Dose 3|Vaccination Series||89
108382|NCT01193582|259139|P1|Vaccinated Dose 3|Vaccination Series||90
108383|NCT01193582|259136|P4|Vaccinated Dose 2|Vaccination Series||0
108384|NCT01193582|259137|P3|Vaccinated Dose 2|Vaccination Series||118
108385|NCT01193582|259138|P2|Vaccinated Dose 2|Vaccination Series||91
108386|NCT01193582|259139|P1|Vaccinated Dose 2|Vaccination Series||92
108387|NCT01193582|259136|P4|Vaccinated Dose 1|Vaccination Series||180
108388|NCT01193582|259137|P3|Vaccinated Dose 1|Vaccination Series||125
108389|NCT01193582|259138|P2|Vaccinated Dose 1|Vaccination Series||100
108390|NCT01193582|259139|P1|Vaccinated Dose 1|Vaccination Series||100
108391|NCT01193582|259136|P4|STARTED|Vaccination Series||180
108392|NCT01193582|259137|P3|STARTED|Vaccination Series||125
108393|NCT01193582|259138|P2|STARTED|Vaccination Series||101
108394|NCT01193582|259139|P1|STARTED|Vaccination Series||100
108395|NCT01193556|259169|P2|NOT COMPLETED|Overall Study||25
108396|NCT01193556|259170|P1|NOT COMPLETED|Overall Study||26
108397|NCT01193556|259169|P2|COMPLETED|Overall Study||0
108398|NCT01193556|259170|P1|COMPLETED|Overall Study||0
108399|NCT01193556|259169|P2|STARTED|Overall Study||25
108400|NCT01193556|259170|P1|STARTED|Overall Study||26
108401|NCT01193348|259178|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||2
108402|NCT01193348|259178|P1|COMPLETED|Post Treatment Period (Patients Who Disc||8
108403|NCT01193348|259178|P1|STARTED|Post Treatment Period (Patients Who Disc||10
108404|NCT01193348|259178|P1|NOT COMPLETED|Extension Treatment Period||1
108405|NCT01193348|259178|P1|COMPLETED|Extension Treatment Period||16
108406|NCT01193348|259178|P1|STARTED|Extension Treatment Period||17
108407|NCT01193348|259178|P1|NOT COMPLETED|Treatment Period (26 Weeks)||3
108408|NCT01193348|259178|P1|COMPLETED|Treatment Period (26 Weeks)||19
108409|NCT01193348|259178|P1|STARTED|Treatment Period (26 Weeks)||22
108410|NCT01193348|259178|P1|NOT COMPLETED|Screening Period||5
108411|NCT01193348|259178|P1|COMPLETED|Screening Period||22
108412|NCT01193348|259178|P1|STARTED|Screening Period||27
108413|NCT01193335|259198|P2|NOT COMPLETED|2-Year Follow-up||8
108414|NCT01193335|259199|P1|NOT COMPLETED|2-Year Follow-up||7
108415|NCT01193335|259198|P2|COMPLETED|2-Year Follow-up||80
108416|NCT01193335|259199|P1|COMPLETED|2-Year Follow-up||81
108417|NCT01193335|259198|P2|STARTED|2-Year Follow-up||88
108418|NCT01193335|259199|P1|STARTED|2-Year Follow-up||88
108419|NCT01193335|259198|P2|NOT COMPLETED|1-Year Follow-up||9
108420|NCT01193335|259199|P1|NOT COMPLETED|1-Year Follow-up||11
108421|NCT01193335|259198|P2|COMPLETED|1-Year Follow-up||88
108422|NCT01193335|259199|P1|COMPLETED|1-Year Follow-up||88
108423|NCT01193335|259198|P2|STARTED|1-Year Follow-up||97
108424|NCT01193335|259199|P1|STARTED|1-Year Follow-up||99
108425|NCT01193335|259198|P2|NOT COMPLETED|Toddler Dose||0
108426|NCT01193335|259199|P1|NOT COMPLETED|Toddler Dose||0
108427|NCT01193335|259198|P2|COMPLETED|Toddler Dose||97
108428|NCT01193335|259199|P1|COMPLETED|Toddler Dose||99
108429|NCT01193335|259198|P2|STARTED|Toddler Dose||97
108430|NCT01193335|259199|P1|STARTED|Toddler Dose||99
108431|NCT01193335|259198|P2|NOT COMPLETED|After Infant Series||3
108432|NCT01193335|259199|P1|NOT COMPLETED|After Infant Series||1
108433|NCT01193335|259198|P2|COMPLETED|After Infant Series||97
108434|NCT01193335|259199|P1|COMPLETED|After Infant Series||99
108435|NCT01193335|259198|P2|STARTED|After Infant Series||100
108436|NCT01193335|259199|P1|STARTED|After Infant Series||100
108437|NCT01193335|259198|P2|NOT COMPLETED|Infant Series||0
108438|NCT01193335|259199|P1|NOT COMPLETED|Infant Series||0
108439|NCT01193335|259198|P2|COMPLETED|Infant Series||100
108440|NCT01193335|259199|P1|COMPLETED|Infant Series||100
108441|NCT01193335|259198|P2|STARTED|Infant Series||100
108442|NCT01193335|259199|P1|STARTED|Infant Series||100
108443|NCT01193283|259294|P1|NOT COMPLETED|Overall Study||1
108444|NCT01193283|259294|P1|COMPLETED|Overall Study||21
108445|NCT01193283|259294|P1|STARTED|Overall Study||22
108446|NCT01193244|259300|P2|NOT COMPLETED|Overall Study||390
108447|NCT01193244|259301|P1|NOT COMPLETED|Overall Study||388
108448|NCT01193244|259300|P2|COMPLETED|Overall Study||391
108449|NCT01193244|259301|P1|COMPLETED|Overall Study||391
108450|NCT01193244|259300|P2|Treated|Overall Study|Participants randomized to receive Placebo but crossed-over to receive Orteronel after unblinding.|784
108451|NCT01193244|259301|P1|Treated|Overall Study|Participants who continued to receive Placebo after unblinding.|770
108452|NCT01193244|259300|P2|STARTED|Overall Study||781
108453|NCT01193244|259301|P1|STARTED|Overall Study||779
108454|NCT01193218|259356|P8|NOT COMPLETED|12-52 Weeks||4
108455|NCT01193218|259357|P7|NOT COMPLETED|12-52 Weeks||3
108456|NCT01193218|259358|P6|NOT COMPLETED|12-52 Weeks||5
108457|NCT01193218|259359|P5|NOT COMPLETED|12-52 Weeks||4
108458|NCT01193218|259360|P4|NOT COMPLETED|12-52 Weeks||3
108459|NCT01193218|259361|P3|NOT COMPLETED|12-52 Weeks||4
108460|NCT01193218|259362|P2|NOT COMPLETED|12-52 Weeks||0
108461|NCT01193218|259363|P1|NOT COMPLETED|12-52 Weeks||5
108462|NCT01193218|259356|P8|COMPLETED|12-52 Weeks||49
108463|NCT01193218|259357|P7|COMPLETED|12-52 Weeks||51
108464|NCT01193218|259358|P6|COMPLETED|12-52 Weeks||101
108465|NCT01193218|259359|P5|COMPLETED|12-52 Weeks||104
108466|NCT01193218|259360|P4|COMPLETED|12-52 Weeks||50
108467|NCT01193218|259361|P3|COMPLETED|12-52 Weeks||50
108468|NCT01193218|259362|P2|COMPLETED|12-52 Weeks||50
108469|NCT01193218|259363|P1|COMPLETED|12-52 Weeks||45
108470|NCT01193218|259356|P8|STARTED|12-52 Weeks||53
108471|NCT01193218|259357|P7|STARTED|12-52 Weeks||54
108472|NCT01193218|259358|P6|STARTED|12-52 Weeks||106
108473|NCT01193218|259359|P5|STARTED|12-52 Weeks||108
108474|NCT01193218|259360|P4|STARTED|12-52 Weeks||53
108475|NCT01193218|259361|P3|STARTED|12-52 Weeks||54
108476|NCT01193218|259362|P2|STARTED|12-52 Weeks||50
108477|NCT01193218|259363|P1|STARTED|12-52 Weeks||50
108478|NCT01193218|259356|P8|NOT COMPLETED|0-12 Weeks||0
108479|NCT01193218|259357|P7|NOT COMPLETED|0-12 Weeks||3
108480|NCT01193218|259358|P6|NOT COMPLETED|0-12 Weeks||3
108481|NCT01193218|259359|P5|NOT COMPLETED|0-12 Weeks||1
108482|NCT01193218|259360|P4|NOT COMPLETED|0-12 Weeks||0
108483|NCT01193218|259361|P3|NOT COMPLETED|0-12 Weeks||3
108484|NCT01193218|259362|P2|NOT COMPLETED|0-12 Weeks||0
108485|NCT01193218|259363|P1|NOT COMPLETED|0-12 Weeks||9
108486|NCT01193218|259356|P8|COMPLETED|0-12 Weeks||0
108487|NCT01193218|259357|P7|COMPLETED|0-12 Weeks||107
108488|NCT01193218|259358|P6|COMPLETED|0-12 Weeks||106
108489|NCT01193218|259359|P5|COMPLETED|0-12 Weeks||108
108490|NCT01193218|259360|P4|COMPLETED|0-12 Weeks||0
108491|NCT01193218|259361|P3|COMPLETED|0-12 Weeks||107
108492|NCT01193218|259362|P2|COMPLETED|0-12 Weeks||0
108493|NCT01193218|259363|P1|COMPLETED|0-12 Weeks||100
108494|NCT01193218|259356|P8|STARTED|0-12 Weeks|It is actually N/A|0
108495|NCT01193218|259357|P7|STARTED|0-12 Weeks|It is actually empa 50mg group|110
108496|NCT01193218|259358|P6|STARTED|0-12 Weeks||109
108497|NCT01193218|259359|P5|STARTED|0-12 Weeks||109
108498|NCT01193218|259360|P4|STARTED|0-12 Weeks|It is actually N/A|0
108499|NCT01193218|259361|P3|STARTED|0-12 Weeks|It is actually empa 5mg group|110
108500|NCT01193218|259362|P2|STARTED|0-12 Weeks|It is actually N/A|0
108501|NCT01193218|259363|P1|STARTED|0-12 Weeks|It is actually placebo group|109
108502|NCT01193153|259394|P2|NOT COMPLETED|Double Blind Relapse Prevention Period||105
108503|NCT01193153|259395|P1|NOT COMPLETED|Double Blind Relapse Prevention Period||64
108504|NCT01193153|259394|P2|COMPLETED|Double Blind Relapse Prevention Period||65
108505|NCT01193153|259395|P1|COMPLETED|Double Blind Relapse Prevention Period||100
108506|NCT01193153|259394|P2|STARTED|Double Blind Relapse Prevention Period||170
108507|NCT01193153|259395|P1|STARTED|Double Blind Relapse Prevention Period||164
108508|NCT01193153|259394|P2|NOT COMPLETED|Open-label Stabilization Period||0
108509|NCT01193153|259395|P1|NOT COMPLETED|Open-label Stabilization Period||98
108510|NCT01193153|259394|P2|COMPLETED|Open-label Stabilization Period||0
108511|NCT01193153|259395|P1|COMPLETED|Open-label Stabilization Period||334
108512|NCT01193153|259394|P2|STARTED|Open-label Stabilization Period||0
108513|NCT01193153|259395|P1|STARTED|Open-label Stabilization Period||432
108514|NCT01193153|259394|P2|NOT COMPLETED|Open-label Lead in Period||0
108515|NCT01193153|259395|P1|NOT COMPLETED|Open-label Lead in Period||235
108516|NCT01193153|259394|P2|COMPLETED|Open-label Lead in Period||0
108517|NCT01193153|259395|P1|COMPLETED|Open-label Lead in Period||432
108518|NCT01193153|259394|P2|STARTED|Open-label Lead in Period||0
108519|NCT01193153|259395|P1|STARTED|Open-label Lead in Period||667
108520|NCT01193127|259430|P4|NOT COMPLETED|Treated||1
108521|NCT01193127|259431|P3|NOT COMPLETED|Treated||0
108522|NCT01193127|259432|P2|NOT COMPLETED|Treated||0
108523|NCT01193127|259433|P1|NOT COMPLETED|Treated||0
108524|NCT01193127|259430|P4|COMPLETED|Treated||55
108525|NCT01193127|259431|P3|COMPLETED|Treated||55
108526|NCT01193127|259432|P2|COMPLETED|Treated||54
108527|NCT01193127|259433|P1|COMPLETED|Treated||57
108528|NCT01193127|259430|P4|STARTED|Treated||56
108529|NCT01193127|259431|P3|STARTED|Treated||55
108530|NCT01193127|259432|P2|STARTED|Treated||54
108531|NCT01193127|259433|P1|STARTED|Treated||57
108532|NCT01193127|259430|P4|NOT COMPLETED|Randomized||1
108533|NCT01193127|259431|P3|NOT COMPLETED|Randomized||0
108534|NCT01193127|259432|P2|NOT COMPLETED|Randomized||0
108535|NCT01193127|259433|P1|NOT COMPLETED|Randomized||0
108536|NCT01193127|259430|P4|COMPLETED|Randomized||56
108537|NCT01193127|259431|P3|COMPLETED|Randomized||55
108538|NCT01193127|259432|P2|COMPLETED|Randomized||54
108539|NCT01193127|259433|P1|COMPLETED|Randomized||57
108540|NCT01193127|259430|P4|STARTED|Randomized||57
108541|NCT01193127|259431|P3|STARTED|Randomized||55
108542|NCT01193127|259432|P2|STARTED|Randomized||54
108543|NCT01193127|259433|P1|STARTED|Randomized||57
108544|NCT01193114|259737|P2|NOT COMPLETED|Overall Study||0
108545|NCT01193114|259738|P1|NOT COMPLETED|Overall Study||0
108546|NCT01193114|259737|P2|COMPLETED|Overall Study||30
108547|NCT01193114|259738|P1|COMPLETED|Overall Study||30
108548|NCT01193114|259737|P2|STARTED|Overall Study||30
108549|NCT01193114|259738|P1|STARTED|Overall Study||30
108550|NCT01193101|259758|P4|NOT COMPLETED|Overall Study||12
108551|NCT01193101|259759|P3|NOT COMPLETED|Overall Study||3
108552|NCT01193101|259760|P2|NOT COMPLETED|Overall Study||7
108553|NCT01193101|259761|P1|NOT COMPLETED|Overall Study||5
108554|NCT01193101|259758|P4|COMPLETED|Overall Study||80
108555|NCT01193101|259759|P3|COMPLETED|Overall Study||93
108556|NCT01193101|259760|P2|COMPLETED|Overall Study||94
108557|NCT01193101|259761|P1|COMPLETED|Overall Study||95
108558|NCT01193101|259758|P4|Placebo Withdrawal Set|Overall Study||80
108559|NCT01193101|259759|P3|Placebo Withdrawal Set|Overall Study||93
108560|NCT01193101|259760|P2|Placebo Withdrawal Set|Overall Study||94
108561|NCT01193101|259761|P1|Placebo Withdrawal Set|Overall Study||95
108562|NCT01193101|259758|P4|Full Analysis Set|Overall Study||92
108563|NCT01193101|259759|P3|Full Analysis Set|Overall Study||96
108564|NCT01193101|259760|P2|Full Analysis Set|Overall Study||101
108565|NCT01193101|259761|P1|Full Analysis Set|Overall Study||100
108566|NCT01193101|259758|P4|STARTED|Overall Study||92
108567|NCT01193101|259759|P3|STARTED|Overall Study||96
108568|NCT01193101|259760|P2|STARTED|Overall Study||101
108569|NCT01193101|259761|P1|STARTED|Overall Study||100
108570|NCT01193049|259817|P2|NOT COMPLETED|Period 3 : Double Blind Crossover||0
108571|NCT01193049|259818|P1|NOT COMPLETED|Period 3 : Double Blind Crossover||0
108572|NCT01193049|259817|P2|COMPLETED|Period 3 : Double Blind Crossover||6
108573|NCT01193049|259818|P1|COMPLETED|Period 3 : Double Blind Crossover||5
108574|NCT01193049|259817|P2|STARTED|Period 3 : Double Blind Crossover||6
108575|NCT01193049|259818|P1|STARTED|Period 3 : Double Blind Crossover||5
108576|NCT01193049|259817|P2|NOT COMPLETED|Washout 2 : 21 Day Washout||0
108577|NCT01193049|259818|P1|NOT COMPLETED|Washout 2 : 21 Day Washout||0
108578|NCT01193049|259817|P2|COMPLETED|Washout 2 : 21 Day Washout||6
108579|NCT01193049|259818|P1|COMPLETED|Washout 2 : 21 Day Washout||5
108580|NCT01193049|259817|P2|STARTED|Washout 2 : 21 Day Washout||6
108581|NCT01193049|259818|P1|STARTED|Washout 2 : 21 Day Washout||5
108582|NCT01193049|259817|P2|NOT COMPLETED|Period 2 : Double Blind Crossover||0
108583|NCT01193049|259818|P1|NOT COMPLETED|Period 2 : Double Blind Crossover||0
108584|NCT01193049|259817|P2|COMPLETED|Period 2 : Double Blind Crossover||6
108585|NCT01193049|259818|P1|COMPLETED|Period 2 : Double Blind Crossover||5
108586|NCT01193049|259817|P2|STARTED|Period 2 : Double Blind Crossover||6
108587|NCT01193049|259818|P1|STARTED|Period 2 : Double Blind Crossover||5
108588|NCT01193049|259817|P2|NOT COMPLETED|Washout 1 : 21 Day Washout||0
108589|NCT01193049|259818|P1|NOT COMPLETED|Washout 1 : 21 Day Washout||0
108590|NCT01193049|259817|P2|COMPLETED|Washout 1 : 21 Day Washout||6
108591|NCT01193049|259818|P1|COMPLETED|Washout 1 : 21 Day Washout||5
108592|NCT01193049|259817|P2|STARTED|Washout 1 : 21 Day Washout||6
108593|NCT01193049|259818|P1|STARTED|Washout 1 : 21 Day Washout||5
108594|NCT01193049|259817|P2|NOT COMPLETED|Period 1: Placebo Run-In||0
108595|NCT01193049|259818|P1|NOT COMPLETED|Period 1: Placebo Run-In||0
108596|NCT01193049|259817|P2|COMPLETED|Period 1: Placebo Run-In||6
108597|NCT01193049|259818|P1|COMPLETED|Period 1: Placebo Run-In||5
108598|NCT01193049|259817|P2|STARTED|Period 1: Placebo Run-In||6
108599|NCT01193049|259818|P1|STARTED|Period 1: Placebo Run-In||5
108600|NCT01192776|259852|P4|NOT COMPLETED|Overall Study||20
108601|NCT01192776|259853|P3|NOT COMPLETED|Overall Study||21
108602|NCT01192776|259854|P2|NOT COMPLETED|Overall Study||21
108603|NCT01192776|259855|P1|NOT COMPLETED|Overall Study||11
108604|NCT01192776|259852|P4|COMPLETED|Overall Study||63
108605|NCT01192776|259853|P3|COMPLETED|Overall Study||75
108606|NCT01192776|259854|P2|COMPLETED|Overall Study||69
108607|NCT01192776|259855|P1|COMPLETED|Overall Study||84
108608|NCT01192776|259852|P4|Died After Discharge|Overall Study||1
108609|NCT01192776|259853|P3|Died After Discharge|Overall Study||3
108610|NCT01192776|259854|P2|Died After Discharge|Overall Study||2
108611|NCT01192776|259855|P1|Died After Discharge|Overall Study||1
108612|NCT01192776|259852|P4|Died Prior to Discharge|Overall Study||14
108613|NCT01192776|259853|P3|Died Prior to Discharge|Overall Study||15
108614|NCT01192776|259854|P2|Died Prior to Discharge|Overall Study||13
108615|NCT01192776|259855|P1|Died Prior to Discharge|Overall Study||7
108616|NCT01192776|259852|P4|STARTED|Overall Study||83
108617|NCT01192776|259853|P3|STARTED|Overall Study||96
108618|NCT01192776|259854|P2|STARTED|Overall Study||90
108619|NCT01192776|259855|P1|STARTED|Overall Study||95
108620|NCT01192698|259907|P2|NOT COMPLETED|Overall Study||0
108621|NCT01192698|259908|P1|NOT COMPLETED|Overall Study||0
108622|NCT01192698|259907|P2|COMPLETED|Overall Study||5
108623|NCT01192698|259908|P1|COMPLETED|Overall Study||10
108624|NCT01192698|259907|P2|STARTED|Overall Study||5
108625|NCT01192698|259908|P1|STARTED|Overall Study||10
108626|NCT01192542|259914|P2|NOT COMPLETED|Period 2||0
108627|NCT01192542|259915|P1|NOT COMPLETED|Period 2||0
108628|NCT01192542|259914|P2|COMPLETED|Period 2||20
108629|NCT01192542|259915|P1|COMPLETED|Period 2||18
108630|NCT01192542|259914|P2|STARTED|Period 2||20
108631|NCT01192542|259915|P1|STARTED|Period 2||18
108632|NCT01192542|259914|P2|NOT COMPLETED|Period 1||0
108633|NCT01192542|259915|P1|NOT COMPLETED|Period 1||0
108634|NCT01192542|259914|P2|COMPLETED|Period 1||20
108635|NCT01192542|259915|P1|COMPLETED|Period 1||18
108636|NCT01192542|259914|P2|STARTED|Period 1||20
108637|NCT01192542|259915|P1|STARTED|Period 1||18
108638|NCT01192516|259929|P3|NOT COMPLETED|Overall Study||8
108639|NCT01192516|259930|P2|NOT COMPLETED|Overall Study||17
108640|NCT01192516|259931|P1|NOT COMPLETED|Overall Study||20
108641|NCT01192516|259929|P3|COMPLETED|Overall Study||55
108642|NCT01192516|259930|P2|COMPLETED|Overall Study||49
108643|NCT01192516|259931|P1|COMPLETED|Overall Study||46
108644|NCT01192516|259929|P3|STARTED|Overall Study|Indicates number of people initially randomized to group|63
108645|NCT01192516|259930|P2|STARTED|Overall Study|Indicates number of people initially randomized to group|66
108646|NCT01192516|259931|P1|STARTED|Overall Study|Indicates number of people initially randomized to group|66
108647|NCT01192412|259965|P2|NOT COMPLETED|Overall Study||2
108648|NCT01192412|259966|P1|NOT COMPLETED|Overall Study||4
108649|NCT01192412|259965|P2|COMPLETED|Overall Study||488
108650|NCT01192412|259966|P1|COMPLETED|Overall Study||493
108651|NCT01192412|259965|P2|STARTED|Overall Study||490
108652|NCT01192412|259966|P1|STARTED|Overall Study||497
108653|NCT01192347|259974|P1|NOT COMPLETED|Overall Study||12
108654|NCT01192347|259974|P1|COMPLETED|Overall Study||163
108655|NCT01192347|259974|P1|STARTED|Overall Study||175
108656|NCT01192295|259997|P2|NOT COMPLETED|Overall Study||23
108657|NCT01192295|259998|P1|NOT COMPLETED|Overall Study||10
108658|NCT01192295|259997|P2|COMPLETED|Overall Study||105
108659|NCT01192295|259998|P1|COMPLETED|Overall Study||17
108660|NCT01192295|259997|P2|STARTED|Overall Study||128
108661|NCT01192295|259998|P1|STARTED|Overall Study||27
108662|NCT01192282|260015|P1|NOT COMPLETED|Overall Study||0
108663|NCT01192282|260015|P1|COMPLETED|Overall Study||156
108664|NCT01192282|260015|P1|STARTED|Overall Study||156
108665|NCT01192204|260032|P2|NOT COMPLETED|Overall Study||0
108666|NCT01192204|260033|P1|NOT COMPLETED|Overall Study||1
108667|NCT01192204|260032|P2|COMPLETED|Overall Study||18
108668|NCT01192204|260033|P1|COMPLETED|Overall Study||22
108669|NCT01192204|260032|P2|STARTED|Overall Study||18
108670|NCT01192204|260033|P1|STARTED|Overall Study||23
108671|NCT01192191|260045|P2|NOT COMPLETED|Overall Study||21
108672|NCT01192191|260046|P1|NOT COMPLETED|Overall Study||11
108673|NCT01192191|260045|P2|COMPLETED|Overall Study||106
108674|NCT01192191|260046|P1|COMPLETED|Overall Study||49
108675|NCT01192191|260045|P2|STARTED|Overall Study||127
108676|NCT01192191|260046|P1|STARTED|Overall Study||60
108677|NCT01192178|260072|P2|NOT COMPLETED|Overall Study||23
108678|NCT01192178|260073|P1|NOT COMPLETED|Overall Study||24
108679|NCT01192178|260072|P2|COMPLETED|Overall Study||145
108680|NCT01192178|260073|P1|COMPLETED|Overall Study||147
108681|NCT01192178|260072|P2|STARTED|Overall Study||168
108682|NCT01192178|260073|P1|STARTED|Overall Study||171
108683|NCT01192152|260093|P2|NOT COMPLETED|Period 3||0
108684|NCT01192152|260094|P1|NOT COMPLETED|Period 3||1
108685|NCT01192152|260093|P2|COMPLETED|Period 3||0
108686|NCT01192152|260094|P1|COMPLETED|Period 3||14
108687|NCT01192152|260093|P2|STARTED|Period 3||0
108688|NCT01192152|260094|P1|STARTED|Period 3||15
108689|NCT01192152|260093|P2|NOT COMPLETED|Period 2||0
108690|NCT01192152|260094|P1|NOT COMPLETED|Period 2||0
108691|NCT01192152|260093|P2|COMPLETED|Period 2||14
108692|NCT01192152|260094|P1|COMPLETED|Period 2||15
108693|NCT01192152|260093|P2|STARTED|Period 2||14
108694|NCT01192152|260094|P1|STARTED|Period 2||15
108695|NCT01192152|260093|P2|NOT COMPLETED|Period 1||1
108696|NCT01192152|260094|P1|NOT COMPLETED|Period 1||0
108697|NCT01192152|260093|P2|COMPLETED|Period 1||14
108698|NCT01192152|260094|P1|COMPLETED|Period 1||15
108699|NCT01192152|260093|P2|STARTED|Period 1||15
108700|NCT01192152|260094|P1|STARTED|Period 1||15
108701|NCT01192139|260195|P6|NOT COMPLETED|Period 3||0
108702|NCT01192139|260196|P5|NOT COMPLETED|Period 3||0
108703|NCT01192139|260197|P4|NOT COMPLETED|Period 3||0
108704|NCT01192139|260198|P3|NOT COMPLETED|Period 3||0
108705|NCT01192139|260199|P2|NOT COMPLETED|Period 3||0
108706|NCT01192139|260200|P1|NOT COMPLETED|Period 3||0
108707|NCT01192139|260195|P6|COMPLETED|Period 3||5
108708|NCT01192139|260196|P5|COMPLETED|Period 3||5
108709|NCT01192139|260197|P4|COMPLETED|Period 3||5
108710|NCT01192139|260198|P3|COMPLETED|Period 3||5
108711|NCT01192139|260199|P2|COMPLETED|Period 3||5
108712|NCT01192139|260200|P1|COMPLETED|Period 3||5
108713|NCT01192139|260195|P6|STARTED|Period 3||5
108714|NCT01192139|260196|P5|STARTED|Period 3||5
108715|NCT01192139|260197|P4|STARTED|Period 3||5
108716|NCT01192139|260198|P3|STARTED|Period 3||5
108717|NCT01192139|260199|P2|STARTED|Period 3||5
108718|NCT01192139|260200|P1|STARTED|Period 3||5
108719|NCT01192139|260195|P6|NOT COMPLETED|Period 2||0
108720|NCT01192139|260196|P5|NOT COMPLETED|Period 2||0
108721|NCT01192139|260197|P4|NOT COMPLETED|Period 2||0
108722|NCT01192139|260198|P3|NOT COMPLETED|Period 2||0
108723|NCT01192139|260199|P2|NOT COMPLETED|Period 2||0
108724|NCT01192139|260200|P1|NOT COMPLETED|Period 2||0
108725|NCT01192139|260195|P6|COMPLETED|Period 2||5
108726|NCT01192139|260196|P5|COMPLETED|Period 2||5
108727|NCT01192139|260197|P4|COMPLETED|Period 2||5
108728|NCT01192139|260198|P3|COMPLETED|Period 2||5
108729|NCT01192139|260199|P2|COMPLETED|Period 2||5
108730|NCT01192139|260200|P1|COMPLETED|Period 2||5
108731|NCT01192139|260195|P6|STARTED|Period 2||5
108732|NCT01192139|260196|P5|STARTED|Period 2||5
108733|NCT01192139|260197|P4|STARTED|Period 2||5
108734|NCT01192139|260198|P3|STARTED|Period 2||5
108735|NCT01192139|260199|P2|STARTED|Period 2||5
108736|NCT01192139|260200|P1|STARTED|Period 2||5
108737|NCT01192139|260195|P6|NOT COMPLETED|Period 1||0
108738|NCT01192139|260196|P5|NOT COMPLETED|Period 1||0
108739|NCT01192139|260197|P4|NOT COMPLETED|Period 1||0
108740|NCT01192139|260198|P3|NOT COMPLETED|Period 1||0
108741|NCT01192139|260199|P2|NOT COMPLETED|Period 1||0
108742|NCT01192139|260200|P1|NOT COMPLETED|Period 1||0
108743|NCT01192139|260195|P6|COMPLETED|Period 1||5
108744|NCT01192139|260196|P5|COMPLETED|Period 1||5
108745|NCT01192139|260197|P4|COMPLETED|Period 1||5
108746|NCT01192139|260198|P3|COMPLETED|Period 1||5
108747|NCT01192139|260199|P2|COMPLETED|Period 1||5
108748|NCT01192139|260200|P1|COMPLETED|Period 1||5
108749|NCT01192139|260195|P6|STARTED|Period 1||5
108750|NCT01192139|260196|P5|STARTED|Period 1||5
108751|NCT01192139|260197|P4|STARTED|Period 1||5
108752|NCT01192139|260198|P3|STARTED|Period 1||5
108753|NCT01192139|260199|P2|STARTED|Period 1||5
108754|NCT01192139|260200|P1|STARTED|Period 1||5
108755|NCT01192126|260265|P2|NOT COMPLETED|Second Intervention (1 Week)||0
108756|NCT01192126|260266|P1|NOT COMPLETED|Second Intervention (1 Week)||0
108757|NCT01192126|260265|P2|COMPLETED|Second Intervention (1 Week)||50
108758|NCT01192126|260266|P1|COMPLETED|Second Intervention (1 Week)||49
108759|NCT01192126|260265|P2|STARTED|Second Intervention (1 Week)||50
108760|NCT01192126|260266|P1|STARTED|Second Intervention (1 Week)||49
108761|NCT01192126|260265|P2|NOT COMPLETED|First Intervention (1 Week)||1
108762|NCT01192126|260266|P1|NOT COMPLETED|First Intervention (1 Week)||2
108763|NCT01192126|260265|P2|COMPLETED|First Intervention (1 Week)||50
108764|NCT01192126|260266|P1|COMPLETED|First Intervention (1 Week)||49
108765|NCT01192126|260265|P2|STARTED|First Intervention (1 Week)||51
108766|NCT01192126|260266|P1|STARTED|First Intervention (1 Week)||51
108767|NCT01192022|260278|P5|NOT COMPLETED|Overall Study||1
108768|NCT01192022|260279|P4|NOT COMPLETED|Overall Study||2
108769|NCT01192022|260280|P3|NOT COMPLETED|Overall Study||1
108770|NCT01192022|260281|P2|NOT COMPLETED|Overall Study||11
108771|NCT01192022|260282|P1|NOT COMPLETED|Overall Study||13
108772|NCT01192022|260278|P5|COMPLETED|Overall Study||11
108773|NCT01192022|260279|P4|COMPLETED|Overall Study||7
108774|NCT01192022|260280|P3|COMPLETED|Overall Study||7
108775|NCT01192022|260281|P2|COMPLETED|Overall Study||99
108776|NCT01192022|260282|P1|COMPLETED|Overall Study||101
108777|NCT01192022|260278|P5|Safety Population-Received Treatment|Overall Study||12
108778|NCT01192022|260279|P4|Safety Population-Received Treatment|Overall Study||9
108779|NCT01192022|260280|P3|Safety Population-Received Treatment|Overall Study||8
108780|NCT01192022|260281|P2|Safety Population-Received Treatment|Overall Study||109
108781|NCT01192022|260282|P1|Safety Population-Received Treatment|Overall Study||114
108782|NCT01192022|260278|P5|STARTED|Overall Study||12
108783|NCT01192022|260279|P4|STARTED|Overall Study||9
108784|NCT01192022|260280|P3|STARTED|Overall Study||8
108785|NCT01192022|260281|P2|STARTED|Overall Study||110
108786|NCT01192022|260282|P1|STARTED|Overall Study||114
108787|NCT01191944|260305|P2|NOT COMPLETED|Overall Study||19
108788|NCT01191944|260306|P1|NOT COMPLETED|Overall Study||17
108789|NCT01191944|260305|P2|COMPLETED|Overall Study|Completed titration/maintenance|220
108790|NCT01191944|260306|P1|COMPLETED|Overall Study|Completed titration/maintenance|217
108791|NCT01191944|260305|P2|STARTED|Overall Study|Treated titration/maintenance|239
108792|NCT01191944|260306|P1|STARTED|Overall Study|Treated titration/maintenance|234
108793|NCT01191827|260352|P2|NOT COMPLETED|Overall Study||0
108794|NCT01191827|260353|P1|NOT COMPLETED|Overall Study||0
108795|NCT01191827|260352|P2|COMPLETED|Overall Study||20
108796|NCT01191827|260353|P1|COMPLETED|Overall Study||20
108797|NCT01191827|260352|P2|STARTED|Overall Study||20
108798|NCT01191827|260353|P1|STARTED|Overall Study||20
108799|NCT01191801|260361|P2|NOT COMPLETED|Overall Study||337
108800|NCT01191801|260362|P1|NOT COMPLETED|Overall Study||316
108801|NCT01191801|260361|P2|COMPLETED|Overall Study||18
108802|NCT01191801|260362|P1|COMPLETED|Overall Study||40
108803|NCT01191801|260361|P2|STARTED|Overall Study||355
108804|NCT01191801|260362|P1|STARTED|Overall Study||356
108805|NCT01191788|260382|P2|NOT COMPLETED|Overall Study||22
108806|NCT01191788|260383|P1|NOT COMPLETED|Overall Study||21
108807|NCT01191788|260382|P2|COMPLETED|Overall Study|Completed 3-month followup|137
108808|NCT01191788|260383|P1|COMPLETED|Overall Study|Completed 3-month followup|119
108809|NCT01191788|260382|P2|STARTED|Overall Study||159
108810|NCT01191788|260383|P1|STARTED|Overall Study||140
108811|NCT01191762|260393|P2|NOT COMPLETED|Overall Study||0
108812|NCT01191762|260394|P1|NOT COMPLETED|Overall Study||1
108813|NCT01191762|260393|P2|COMPLETED|Overall Study||15
108814|NCT01191762|260394|P1|COMPLETED|Overall Study|One subject dropped out on the 3rd treatment day because of gastrointestinal complaints.|14
108815|NCT01191762|260393|P2|STARTED|Overall Study||15
108816|NCT01191762|260394|P1|STARTED|Overall Study||15
108817|NCT01191749|260400|P1|NOT COMPLETED|Overall Study||0
108818|NCT01191749|260400|P1|COMPLETED|Overall Study||7
108819|NCT01191749|260400|P1|STARTED|Overall Study||7
108820|NCT01191736|260411|P7|NOT COMPLETED|Overall Study||0
108821|NCT01191736|260412|P6|NOT COMPLETED|Overall Study||0
108822|NCT01191736|260413|P5|NOT COMPLETED|Overall Study||0
108823|NCT01191736|260414|P4|NOT COMPLETED|Overall Study||0
108824|NCT01191736|260415|P3|NOT COMPLETED|Overall Study||0
108825|NCT01191736|260416|P2|NOT COMPLETED|Overall Study||0
108826|NCT01191736|260417|P1|NOT COMPLETED|Overall Study||0
108827|NCT01191736|260411|P7|COMPLETED|Overall Study||45
108828|NCT01191736|260412|P6|COMPLETED|Overall Study||50
108829|NCT01191736|260413|P5|COMPLETED|Overall Study||48
108830|NCT01191736|260414|P4|COMPLETED|Overall Study||46
108831|NCT01191736|260415|P3|COMPLETED|Overall Study||49
108832|NCT01191736|260416|P2|COMPLETED|Overall Study||47
108833|NCT01191736|260417|P1|COMPLETED|Overall Study||51
108834|NCT01191736|260411|P7|STARTED|Overall Study||45
108835|NCT01191736|260412|P6|STARTED|Overall Study||50
108836|NCT01191736|260413|P5|STARTED|Overall Study||48
108837|NCT01191736|260414|P4|STARTED|Overall Study||46
108838|NCT01191736|260415|P3|STARTED|Overall Study||49
108839|NCT01191736|260416|P2|STARTED|Overall Study||47
108840|NCT01191736|260417|P1|STARTED|Overall Study||51
108841|NCT01191723|260440|P6|NOT COMPLETED|Overall Study||0
108842|NCT01191723|260441|P5|NOT COMPLETED|Overall Study||0
108843|NCT01191723|260442|P4|NOT COMPLETED|Overall Study||0
108844|NCT01191723|260443|P3|NOT COMPLETED|Overall Study||0
108845|NCT01191723|260444|P2|NOT COMPLETED|Overall Study||0
108846|NCT01191723|260445|P1|NOT COMPLETED|Overall Study||0
108847|NCT01191723|260440|P6|COMPLETED|Overall Study||9
108848|NCT01191723|260441|P5|COMPLETED|Overall Study||9
108849|NCT01191723|260442|P4|COMPLETED|Overall Study||9
108850|NCT01191723|260443|P3|COMPLETED|Overall Study||9
108851|NCT01191723|260444|P2|COMPLETED|Overall Study||9
108852|NCT01191723|260445|P1|COMPLETED|Overall Study||9
108853|NCT01191723|260440|P6|STARTED|Overall Study||9
108854|NCT01191723|260441|P5|STARTED|Overall Study||9
108855|NCT01191723|260442|P4|STARTED|Overall Study||9
108856|NCT01191723|260443|P3|STARTED|Overall Study||9
108857|NCT01191723|260444|P2|STARTED|Overall Study||9
108858|NCT01191723|260445|P1|STARTED|Overall Study||9
108859|NCT01191476|260466|P3|NOT COMPLETED|Overall Study||0
108860|NCT01191476|260467|P2|NOT COMPLETED|Overall Study||4
108861|NCT01191476|260468|P1|NOT COMPLETED|Overall Study||3
108862|NCT01191476|260466|P3|COMPLETED|Overall Study||111
108863|NCT01191476|260467|P2|COMPLETED|Overall Study||107
108864|NCT01191476|260468|P1|COMPLETED|Overall Study||109
108865|NCT01191476|260466|P3|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
108866|NCT01191476|260467|P2|STARTED|Overall Study|Data was not collected for 1 subject for baseline characteristics or the full analysis set.|111
108867|NCT01191476|260468|P1|STARTED|Overall Study||112
108868|NCT01191411|260491|P3|NOT COMPLETED|Overall Study||3427
108869|NCT01191411|260492|P2|NOT COMPLETED|Overall Study||361
108870|NCT01191411|260493|P1|NOT COMPLETED|Overall Study||945
108871|NCT01191411|260491|P3|COMPLETED|Overall Study||471
108872|NCT01191411|260492|P2|COMPLETED|Overall Study||118
108873|NCT01191411|260493|P1|COMPLETED|Overall Study||648
108874|NCT01191411|260491|P3|STARTED|Overall Study||3898
108875|NCT01191411|260492|P2|STARTED|Overall Study||479
108876|NCT01191411|260493|P1|STARTED|Overall Study||1593
108877|NCT01191398|260504|P3|NOT COMPLETED|Overall Study||0
108878|NCT01191398|260505|P2|NOT COMPLETED|Overall Study||0
108879|NCT01191398|260506|P1|NOT COMPLETED|Overall Study||0
108880|NCT01191398|260504|P3|COMPLETED|Overall Study||18
108881|NCT01191398|260505|P2|COMPLETED|Overall Study||17
108882|NCT01191398|260506|P1|COMPLETED|Overall Study||17
108883|NCT01191398|260504|P3|STARTED|Overall Study||18
108884|NCT01191398|260505|P2|STARTED|Overall Study||17
108885|NCT01191398|260506|P1|STARTED|Overall Study||17
108886|NCT01191320|260520|P3|NOT COMPLETED|Overall Study||7
108887|NCT01191320|260521|P2|NOT COMPLETED|Overall Study||6
108888|NCT01191320|260522|P1|NOT COMPLETED|Overall Study||7
108889|NCT01191320|260520|P3|COMPLETED|Overall Study||31
108890|NCT01191320|260521|P2|COMPLETED|Overall Study||32
108891|NCT01191320|260522|P1|COMPLETED|Overall Study||36
108892|NCT01191320|260520|P3|STARTED|Overall Study||38
108893|NCT01191320|260521|P2|STARTED|Overall Study||38
108894|NCT01191320|260522|P1|STARTED|Overall Study||43
108895|NCT01191268|260533|P3|NOT COMPLETED|Overall Study||52
108896|NCT01191268|260534|P2|NOT COMPLETED|Overall Study||55
108897|NCT01191268|260535|P1|NOT COMPLETED|Overall Study||58
108898|NCT01191268|260533|P3|COMPLETED|Overall Study||244
108899|NCT01191268|260534|P2|COMPLETED|Overall Study||238
108900|NCT01191268|260535|P1|COMPLETED|Overall Study||237
108901|NCT01191268|260533|P3|Received at Least One Dose of Study Drug|Overall Study||296
108902|NCT01191268|260534|P2|Received at Least One Dose of Study Drug|Overall Study||293
108903|NCT01191268|260535|P1|Received at Least One Dose of Study Drug|Overall Study||295
108904|NCT01191268|260533|P3|STARTED|Overall Study||296
108905|NCT01191268|260534|P2|STARTED|Overall Study||293
108906|NCT01191268|260535|P1|STARTED|Overall Study||295
108907|NCT01191255|260632|P4|NOT COMPLETED|Efficacy Assessment Period||6
108908|NCT01191255|260633|P3|NOT COMPLETED|Efficacy Assessment Period||26
108909|NCT01191255|260634|P2|NOT COMPLETED|Efficacy Assessment Period||0
108910|NCT01191255|260635|P1|NOT COMPLETED|Efficacy Assessment Period||0
108911|NCT01191255|260632|P4|COMPLETED|Efficacy Assessment Period||90
108912|NCT01191255|260633|P3|COMPLETED|Efficacy Assessment Period||70
108913|NCT01191255|260634|P2|COMPLETED|Efficacy Assessment Period||0
108914|NCT01191255|260635|P1|COMPLETED|Efficacy Assessment Period||0
108915|NCT01191255|260632|P4|STARTED|Efficacy Assessment Period||96
108916|NCT01191255|260633|P3|STARTED|Efficacy Assessment Period||96
108917|NCT01191255|260634|P2|STARTED|Efficacy Assessment Period||0
108918|NCT01191255|260635|P1|STARTED|Efficacy Assessment Period||0
108919|NCT01191255|260632|P4|NOT COMPLETED|Safety Assessment Period||0
108920|NCT01191255|260633|P3|NOT COMPLETED|Safety Assessment Period||0
108921|NCT01191255|260634|P2|NOT COMPLETED|Safety Assessment Period||99
108922|NCT01191255|260635|P1|NOT COMPLETED|Safety Assessment Period||38
108923|NCT01191255|260632|P4|COMPLETED|Safety Assessment Period||0
108924|NCT01191255|260633|P3|COMPLETED|Safety Assessment Period||0
108925|NCT01191255|260634|P2|COMPLETED|Safety Assessment Period||193
108926|NCT01191255|260635|P1|COMPLETED|Safety Assessment Period||111
108927|NCT01191255|260632|P4|Safety Population|Safety Assessment Period||0
108928|NCT01191255|260633|P3|Safety Population|Safety Assessment Period||0
108929|NCT01191255|260634|P2|Safety Population|Safety Assessment Period||289
108930|NCT01191255|260635|P1|Safety Population|Safety Assessment Period||149
108931|NCT01191255|260632|P4|STARTED|Safety Assessment Period||0
108932|NCT01191255|260633|P3|STARTED|Safety Assessment Period||0
108933|NCT01191255|260634|P2|STARTED|Safety Assessment Period||292
108934|NCT01191255|260635|P1|STARTED|Safety Assessment Period|3 subjects were assigned to receive KRX-0502 but didn't receive a single dose|149
108935|NCT01191242|260661|P1|NOT COMPLETED|Overall Study||0
108936|NCT01191242|260661|P1|COMPLETED|Overall Study||31
108937|NCT01191242|260661|P1|STARTED|Overall Study||31
108938|NCT01191190|260676|P1|NOT COMPLETED|Overall Study||1
108939|NCT01191190|260676|P1|COMPLETED|Overall Study||20
108940|NCT01191190|260676|P1|STARTED|Overall Study||21
108941|NCT01191086|260689|P1|NOT COMPLETED|Overall Study||62
108942|NCT01191086|260689|P1|COMPLETED|Overall Study||148
108943|NCT01191086|260689|P1|STARTED|Overall Study||210
108944|NCT01191008|260693|P1|NOT COMPLETED|Overall Study||15
108945|NCT01191008|260693|P1|COMPLETED|Overall Study||618
108946|NCT01191008|260693|P1|STARTED|Overall Study||633
108947|NCT01190891|260701|P2|NOT COMPLETED|Overall Study||0
108948|NCT01190891|260702|P1|NOT COMPLETED|Overall Study||6
108949|NCT01190891|260701|P2|COMPLETED|Overall Study||52
108950|NCT01190891|260702|P1|COMPLETED|Overall Study||46
108951|NCT01190891|260701|P2|STARTED|Overall Study||52
108952|NCT01190891|260702|P1|STARTED|Overall Study||52
108953|NCT01190878|260714|P4|NOT COMPLETED|Overall Study||20
108954|NCT01190878|260715|P3|NOT COMPLETED|Overall Study||5
108955|NCT01190878|260716|P2|NOT COMPLETED|Overall Study||3
108956|NCT01190878|260717|P1|NOT COMPLETED|Overall Study||3
108957|NCT01190878|260714|P4|COMPLETED|Overall Study||22
108958|NCT01190878|260715|P3|COMPLETED|Overall Study||37
108959|NCT01190878|260716|P2|COMPLETED|Overall Study||42
108960|NCT01190878|260717|P1|COMPLETED|Overall Study||37
108961|NCT01190878|260714|P4|STARTED|Overall Study||42
108962|NCT01190878|260715|P3|STARTED|Overall Study||42
108963|NCT01190878|260716|P2|STARTED|Overall Study||45
108964|NCT01190878|260717|P1|STARTED|Overall Study||40
108965|NCT01190865|260727|P1|NOT COMPLETED|Overall Study||3
108966|NCT01190865|260727|P1|COMPLETED|Overall Study||25
108967|NCT01190865|260727|P1|STARTED|Overall Study||28
108968|NCT01190839|260734|P2|NOT COMPLETED|Overall Study||147
108969|NCT01190839|260735|P1|NOT COMPLETED|Overall Study||150
108970|NCT01190839|260734|P2|COMPLETED|Overall Study||0
108971|NCT01190839|260735|P1|COMPLETED|Overall Study||0
108972|NCT01190839|260734|P2|Treated|Overall Study||143
108973|NCT01190839|260735|P1|Treated|Overall Study||148
108974|NCT01190839|260734|P2|STARTED|Overall Study||147
108975|NCT01190839|260735|P1|STARTED|Overall Study||150
108976|NCT01190813|260749|P2|NOT COMPLETED|Overall Study||4
108977|NCT01190813|260750|P1|NOT COMPLETED|Overall Study||4
108978|NCT01190813|260749|P2|COMPLETED|Overall Study||45
108979|NCT01190813|260750|P1|COMPLETED|Overall Study||86
108980|NCT01190813|260749|P2|26-week Visit|Overall Study|0 missed, 0 dropped|45
108981|NCT01190813|260750|P1|26-week Visit|Overall Study|0 missed, 0 dropped|86
108982|NCT01190813|260749|P2|23-week Phone Call|Overall Study|4 missed, 0 dropped|41
108983|NCT01190813|260750|P1|23-week Phone Call|Overall Study|4 missed, 1 dropped|82
108984|NCT01190813|260749|P2|18-week Visit (Masked Primary)|Overall Study|1 dropped|45
108985|NCT01190813|260750|P1|18-week Visit (Masked Primary)|Overall Study|0 dropped|87
108986|NCT01190813|260749|P2|16-week Visit|Overall Study|2 dropped|46
108987|NCT01190813|260750|P1|16-week Visit|Overall Study|1 dropped|87
108988|NCT01190813|260749|P2|13-week Phone Call|Overall Study|0 dropped, 0 missed|48
108989|NCT01190813|260750|P1|13-week Phone Call|Overall Study|6 missed, 0 dropped|82
108990|NCT01190813|260749|P2|10-week Visit|Overall Study|0 dropped, 0 missed|48
108991|NCT01190813|260750|P1|10-week Visit|Overall Study|0 missed, 0 dropped|88
108992|NCT01190813|260749|P2|7-week Phone Call|Overall Study|2 missed, 0 dropped|46
108993|NCT01190813|260750|P1|7-week Phone Call|Overall Study|3 missed, 0 dropped|85
108994|NCT01190813|260749|P2|4-week Visit|Overall Study|1 missed, 1 dropped|47
108995|NCT01190813|260750|P1|4-week Visit|Overall Study|0 missed, 1 dropped|88
108996|NCT01190813|260749|P2|2-week Phone Call|Overall Study|1 missed, 0 dropped|48
108997|NCT01190813|260750|P1|2-week Phone Call|Overall Study|2 missed, 1 dropped|87
108998|NCT01190813|260749|P2|STARTED|Overall Study||49
108999|NCT01190813|260750|P1|STARTED|Overall Study||90
109000|NCT01190566|260842|P2|NOT COMPLETED|Overall Study||0
109001|NCT01190566|260843|P1|NOT COMPLETED|Overall Study||0
109002|NCT01190566|260842|P2|COMPLETED|Overall Study||42
109003|NCT01190566|260843|P1|COMPLETED|Overall Study||6
109004|NCT01190566|260842|P2|STARTED|Overall Study||42
109005|NCT01190566|260843|P1|STARTED|Overall Study||6
109006|NCT01190527|260864|P1|NOT COMPLETED|Overall Study||0
109007|NCT01190527|260864|P1|COMPLETED|Overall Study||42
109008|NCT01190527|260864|P1|STARTED|Overall Study||42
109009|NCT01190514|260871|P4|NOT COMPLETED|Fourth Intervention (Period 4)||0
109010|NCT01190514|260872|P3|NOT COMPLETED|Fourth Intervention (Period 4)||0
109011|NCT01190514|260873|P2|NOT COMPLETED|Fourth Intervention (Period 4)||0
109012|NCT01190514|260874|P1|NOT COMPLETED|Fourth Intervention (Period 4)||0
109013|NCT01190514|260871|P4|COMPLETED|Fourth Intervention (Period 4)||10
109014|NCT01190514|260872|P3|COMPLETED|Fourth Intervention (Period 4)||10
109015|NCT01190514|260873|P2|COMPLETED|Fourth Intervention (Period 4)||10
109016|NCT01190514|260874|P1|COMPLETED|Fourth Intervention (Period 4)||9
109017|NCT01190514|260871|P4|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment A|10
109018|NCT01190514|260872|P3|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment B|10
109019|NCT01190514|260873|P2|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment C|10
109020|NCT01190514|260874|P1|STARTED|Fourth Intervention (Period 4)|Period 4 received treatment D|9
109021|NCT01190514|260871|P4|NOT COMPLETED|Third Intervention (Period 3)||0
109022|NCT01190514|260872|P3|NOT COMPLETED|Third Intervention (Period 3)||0
109023|NCT01190514|260873|P2|NOT COMPLETED|Third Intervention (Period 3)||0
109024|NCT01190514|260874|P1|NOT COMPLETED|Third Intervention (Period 3)||1
109025|NCT01190514|260871|P4|COMPLETED|Third Intervention (Period 3)||10
109026|NCT01190514|260872|P3|COMPLETED|Third Intervention (Period 3)||10
109027|NCT01190514|260873|P2|COMPLETED|Third Intervention (Period 3)||10
109028|NCT01190514|260874|P1|COMPLETED|Third Intervention (Period 3)|Discontinued participant received treatments ABC of sequence ABCD.|9
109029|NCT01190514|260871|P4|STARTED|Third Intervention (Period 3)|Period 3 received treatment B|10
109030|NCT01190514|260872|P3|STARTED|Third Intervention (Period 3)|Period 3 received treatment A|10
109031|NCT01190514|260873|P2|STARTED|Third Intervention (Period 3)|Period 3 received treatment D|10
109032|NCT01190514|260874|P1|STARTED|Third Intervention (Period 3)|Period 3 received treatment C|10
109033|NCT01190514|260871|P4|NOT COMPLETED|Second Intervention (Period 2)||0
109034|NCT01190514|260872|P3|NOT COMPLETED|Second Intervention (Period 2)||0
109035|NCT01190514|260873|P2|NOT COMPLETED|Second Intervention (Period 2)||0
109036|NCT01190514|260874|P1|NOT COMPLETED|Second Intervention (Period 2)||0
109037|NCT01190514|260871|P4|COMPLETED|Second Intervention (Period 2)||10
109038|NCT01190514|260872|P3|COMPLETED|Second Intervention (Period 2)||10
109039|NCT01190514|260873|P2|COMPLETED|Second Intervention (Period 2)||10
109040|NCT01190514|260874|P1|COMPLETED|Second Intervention (Period 2)||10
109041|NCT01190514|260871|P4|STARTED|Second Intervention (Period 2)|Period 2 received treatment C|10
109042|NCT01190514|260872|P3|STARTED|Second Intervention (Period 2)|Period 2 received treatment D|10
109043|NCT01190514|260873|P2|STARTED|Second Intervention (Period 2)|Period 2 received treatment A|10
109044|NCT01190514|260874|P1|STARTED|Second Intervention (Period 2)|Period 2 received treatment B|10
109045|NCT01190514|260871|P4|NOT COMPLETED|First Intervention (Period 1)||0
109046|NCT01190514|260872|P3|NOT COMPLETED|First Intervention (Period 1)||0
109047|NCT01190514|260873|P2|NOT COMPLETED|First Intervention (Period 1)||0
109048|NCT01190514|260874|P1|NOT COMPLETED|First Intervention (Period 1)||1
109049|NCT01190514|260871|P4|COMPLETED|First Intervention (Period 1)||10
109050|NCT01190514|260872|P3|COMPLETED|First Intervention (Period 1)||10
109051|NCT01190514|260873|P2|COMPLETED|First Intervention (Period 1)||10
109052|NCT01190514|260874|P1|COMPLETED|First Intervention (Period 1)|Discontinued participant received treatment A of sequence ABCD.|10
109053|NCT01190514|260871|P4|STARTED|First Intervention (Period 1)||10
109054|NCT01190514|260872|P3|STARTED|First Intervention (Period 1)||10
109055|NCT01190514|260873|P2|STARTED|First Intervention (Period 1)||10
109056|NCT01190514|260874|P1|STARTED|First Intervention (Period 1)||11
109057|NCT01190436|260904|P1|NOT COMPLETED|Overall Study||39
109058|NCT01190436|260904|P1|COMPLETED|Overall Study||86
109059|NCT01190436|260904|P1|STARTED|Overall Study||125
109060|NCT01190306|260920|P2|NOT COMPLETED|Overall Study||0
109061|NCT01190306|260921|P1|NOT COMPLETED|Overall Study||0
109062|NCT01190306|260920|P2|COMPLETED|Overall Study||66
109063|NCT01190306|260921|P1|COMPLETED|Overall Study||61
109064|NCT01190306|260920|P2|STARTED|Overall Study||66
109065|NCT01190306|260921|P1|STARTED|Overall Study||61
109066|NCT01190267|260929|P2|NOT COMPLETED|Overall Study||4
109067|NCT01190267|260930|P1|NOT COMPLETED|Overall Study||41
109068|NCT01190267|260929|P2|COMPLETED|Overall Study||4
109069|NCT01190267|260930|P1|COMPLETED|Overall Study||155
109070|NCT01190267|260929|P2|STARTED|Overall Study||8
109071|NCT01190267|260930|P1|STARTED|Overall Study||196
109072|NCT01190254|260941|P3|NOT COMPLETED|Overall Study||22
109073|NCT01190254|260942|P2|NOT COMPLETED|Overall Study||17
109074|NCT01190254|260943|P1|NOT COMPLETED|Overall Study||21
109075|NCT01190254|260941|P3|COMPLETED|Overall Study||84
109076|NCT01190254|260942|P2|COMPLETED|Overall Study||81
109077|NCT01190254|260943|P1|COMPLETED|Overall Study||81
109078|NCT01190254|260941|P3|Treated|Overall Study||106
109079|NCT01190254|260942|P2|Treated|Overall Study||98
109080|NCT01190254|260943|P1|Treated|Overall Study||102
109081|NCT01190254|260941|P3|STARTED|Overall Study||106
109082|NCT01190254|260942|P2|STARTED|Overall Study||98
109083|NCT01190254|260943|P1|STARTED|Overall Study||102
109084|NCT01190215|261007|P2|NOT COMPLETED|Up to Month 6||0
109085|NCT01190215|261008|P1|NOT COMPLETED|Up to Month 6||2
109086|NCT01190215|261007|P2|COMPLETED|Up to Month 6||39
109087|NCT01190215|261008|P1|COMPLETED|Up to Month 6||36
109088|NCT01190215|261007|P2|STARTED|Up to Month 6||39
109089|NCT01190215|261008|P1|STARTED|Up to Month 6||38
109090|NCT01190215|261007|P2|NOT COMPLETED|Up to Day 28||0
109091|NCT01190215|261008|P1|NOT COMPLETED|Up to Day 28||0
109092|NCT01190215|261007|P2|COMPLETED|Up to Day 28||39
109093|NCT01190215|261008|P1|COMPLETED|Up to Day 28||38
109094|NCT01190215|261007|P2|STARTED|Up to Day 28||39
109095|NCT01190215|261008|P1|STARTED|Up to Day 28||38
109096|NCT01190150|261078|P2|NOT COMPLETED|Second Treatment||0
109097|NCT01190150|261079|P1|NOT COMPLETED|Second Treatment||0
109098|NCT01190150|261078|P2|COMPLETED|Second Treatment||7
109099|NCT01190150|261079|P1|COMPLETED|Second Treatment||10
109100|NCT01190150|261078|P2|STARTED|Second Treatment||7
109101|NCT01190150|261079|P1|STARTED|Second Treatment||10
109102|NCT01190150|261078|P2|NOT COMPLETED|Washout||2
109103|NCT01190150|261079|P1|NOT COMPLETED|Washout||0
109104|NCT01190150|261078|P2|COMPLETED|Washout||7
109105|NCT01190150|261079|P1|COMPLETED|Washout||10
109106|NCT01190150|261078|P2|STARTED|Washout||9
109107|NCT01190150|261079|P1|STARTED|Washout||10
109108|NCT01190150|261078|P2|NOT COMPLETED|First Treatment||0
109109|NCT01190150|261079|P1|NOT COMPLETED|First Treatment||1
109110|NCT01190150|261078|P2|COMPLETED|First Treatment||9
109111|NCT01190150|261079|P1|COMPLETED|First Treatment||10
109112|NCT01190150|261078|P2|STARTED|First Treatment|Randomized, as well as Safety and PK populations|9
109113|NCT01190150|261079|P1|STARTED|First Treatment|Randomized, as well as Safety and PK populations|11
109114|NCT01190124|261106|P3|NOT COMPLETED|Overall Study||1
109115|NCT01190124|261107|P2|NOT COMPLETED|Overall Study||0
109116|NCT01190124|261108|P1|NOT COMPLETED|Overall Study||17
109117|NCT01190124|261106|P3|COMPLETED|Overall Study||19
109118|NCT01190124|261107|P2|COMPLETED|Overall Study||24
109119|NCT01190124|261108|P1|COMPLETED|Overall Study||90
109120|NCT01190124|261106|P3|STARTED|Overall Study||20
109121|NCT01190124|261107|P2|STARTED|Overall Study||24
109122|NCT01190124|261108|P1|STARTED|Overall Study||107
109123|NCT01190098|261146|P2|NOT COMPLETED|Overall Study||2
109124|NCT01190098|261147|P1|NOT COMPLETED|Overall Study||3
109125|NCT01190098|261146|P2|COMPLETED|Overall Study||8
109126|NCT01190098|261147|P1|COMPLETED|Overall Study||39
109127|NCT01190098|261146|P2|STARTED|Overall Study||10
109128|NCT01190098|261147|P1|STARTED|Overall Study||42
109129|NCT01190085|261170|P3|NOT COMPLETED|Overall Study||0
109130|NCT01190085|261171|P2|NOT COMPLETED|Overall Study||0
109131|NCT01190085|261172|P1|NOT COMPLETED|Overall Study||0
109132|NCT01190085|261170|P3|COMPLETED|Overall Study||18
109133|NCT01190085|261171|P2|COMPLETED|Overall Study||14
109134|NCT01190085|261172|P1|COMPLETED|Overall Study||13
109135|NCT01190085|261170|P3|STARTED|Overall Study||18
109136|NCT01190085|261171|P2|STARTED|Overall Study||14
109137|NCT01190085|261172|P1|STARTED|Overall Study||13
109138|NCT01190007|261186|P1|NOT COMPLETED|Overall Study||14
109139|NCT01190007|261186|P1|COMPLETED|Overall Study||145
109140|NCT01190007|261186|P1|STARTED|Overall Study|Treated|159
109141|NCT01189890|261203|P2|NOT COMPLETED|Overall Study||39
109142|NCT01189890|261204|P1|NOT COMPLETED|Overall Study||37
109143|NCT01189890|261203|P2|COMPLETED|Overall Study||200
109144|NCT01189890|261204|P1|COMPLETED|Overall Study||204
109145|NCT01189890|261203|P2|STARTED|Overall Study|3 randomized glimepiride participants did not receive study drug.|239
109146|NCT01189890|261204|P1|STARTED|Overall Study||241
109147|NCT01189812|261226|P2|NOT COMPLETED|Overall Study||8
109148|NCT01189812|261227|P1|NOT COMPLETED|Overall Study||8
109149|NCT01189812|261226|P2|COMPLETED|Overall Study||32
109150|NCT01189812|261227|P1|COMPLETED|Overall Study||32
109151|NCT01189812|261226|P2|STARTED|Overall Study||40
109152|NCT01189812|261227|P1|STARTED|Overall Study||40
109153|NCT01189760|261236|P3|NOT COMPLETED|Overall Study||51
109154|NCT01189760|261237|P2|NOT COMPLETED|Overall Study||23
109155|NCT01189760|261238|P1|NOT COMPLETED|Overall Study||14
109156|NCT01189760|261236|P3|COMPLETED|Overall Study||255
109157|NCT01189760|261237|P2|COMPLETED|Overall Study||283
109158|NCT01189760|261238|P1|COMPLETED|Overall Study||291
109159|NCT01189760|261236|P3|STARTED|Overall Study||306
109160|NCT01189760|261237|P2|STARTED|Overall Study||306
109161|NCT01189760|261238|P1|STARTED|Overall Study||305
109162|NCT01189747|261272|P2|NOT COMPLETED|Overall Study||18
109163|NCT01189747|261273|P1|NOT COMPLETED|Overall Study||12
109164|NCT01189747|261272|P2|COMPLETED|Overall Study||206
109165|NCT01189747|261273|P1|COMPLETED|Overall Study||210
109166|NCT01189747|261272|P2|STARTED|Overall Study||224
109167|NCT01189747|261273|P1|STARTED|Overall Study||222
109168|NCT01189617|261297|P2|NOT COMPLETED|Overall Study||0
109169|NCT01189617|261298|P1|NOT COMPLETED|Overall Study||0
109170|NCT01189617|261297|P2|COMPLETED|Overall Study||35
109171|NCT01189617|261298|P1|COMPLETED|Overall Study||35
109172|NCT01189617|261297|P2|STARTED|Overall Study||35
109173|NCT01189617|261298|P1|STARTED|Overall Study||35
109174|NCT01189604|261311|P7|NOT COMPLETED|Overall Study||1
109175|NCT01189604|261312|P6|NOT COMPLETED|Overall Study||1
109176|NCT01189604|261313|P5|NOT COMPLETED|Overall Study||2
109177|NCT01189604|261314|P4|NOT COMPLETED|Overall Study||0
109178|NCT01189604|261315|P3|NOT COMPLETED|Overall Study||0
109179|NCT01189604|261316|P2|NOT COMPLETED|Overall Study||1
109180|NCT01189604|261317|P1|NOT COMPLETED|Overall Study||1
109181|NCT01189604|261311|P7|COMPLETED|Overall Study||9
109182|NCT01189604|261312|P6|COMPLETED|Overall Study||10
109183|NCT01189604|261313|P5|COMPLETED|Overall Study||18
109184|NCT01189604|261314|P4|COMPLETED|Overall Study||20
109185|NCT01189604|261315|P3|COMPLETED|Overall Study||20
109186|NCT01189604|261316|P2|COMPLETED|Overall Study||20
109187|NCT01189604|261317|P1|COMPLETED|Overall Study||20
109188|NCT01189604|261311|P7|Administered Study Drug|Overall Study||10
109189|NCT01189604|261312|P6|Administered Study Drug|Overall Study||10
109190|NCT01189604|261313|P5|Administered Study Drug|Overall Study||20
109191|NCT01189604|261314|P4|Administered Study Drug|Overall Study||20
109192|NCT01189604|261315|P3|Administered Study Drug|Overall Study||20
109193|NCT01189604|261316|P2|Administered Study Drug|Overall Study||20
109194|NCT01189604|261317|P1|Administered Study Drug|Overall Study||20
109195|NCT01189604|261311|P7|STARTED|Overall Study||10
109196|NCT01189604|261312|P6|STARTED|Overall Study||11
109197|NCT01189604|261313|P5|STARTED|Overall Study||20
109198|NCT01189604|261314|P4|STARTED|Overall Study||20
109199|NCT01189604|261315|P3|STARTED|Overall Study||20
109200|NCT01189604|261316|P2|STARTED|Overall Study||21
109201|NCT01189604|261317|P1|STARTED|Overall Study||21
109202|NCT01189500|261361|P1|NOT COMPLETED|Period 2: Coadministration TAMOX+DVS SR||1
109203|NCT01189500|261361|P1|COMPLETED|Period 2: Coadministration TAMOX+DVS SR||28
109204|NCT01189500|261361|P1|STARTED|Period 2: Coadministration TAMOX+DVS SR||29
109205|NCT01189500|261361|P1|NOT COMPLETED|Period 1: TAMOX Alone||1
109206|NCT01189500|261361|P1|COMPLETED|Period 1: TAMOX Alone||29
109207|NCT01189500|261361|P1|STARTED|Period 1: TAMOX Alone||30
109208|NCT01189487|261422|P1|NOT COMPLETED|Overall Study||3
109209|NCT01189487|261422|P1|COMPLETED|Overall Study||44
109210|NCT01189487|261422|P1|STARTED|Overall Study|Treated participants|47
109211|NCT01189461|261430|P1|NOT COMPLETED|Overall Study||34
109212|NCT01189461|261430|P1|COMPLETED|Overall Study||12
109213|NCT01189461|261430|P1|STARTED|Overall Study||46
109214|NCT01189435|261437|P1|NOT COMPLETED|Overall Study||2
109215|NCT01189435|261437|P1|COMPLETED|Overall Study||0
109216|NCT01189435|261437|P1|STARTED|Overall Study||2
109217|NCT01189370|261441|P3|NOT COMPLETED|Dose Level 3||6
109218|NCT01189370|261442|P2|NOT COMPLETED|Dose Level 3||0
109219|NCT01189370|261443|P1|NOT COMPLETED|Dose Level 3||0
109220|NCT01189370|261441|P3|COMPLETED|Dose Level 3||6
109221|NCT01189370|261442|P2|COMPLETED|Dose Level 3||0
109222|NCT01189370|261443|P1|COMPLETED|Dose Level 3||0
109223|NCT01189370|261441|P3|STARTED|Dose Level 3||12
109224|NCT01189370|261442|P2|STARTED|Dose Level 3||0
109225|NCT01189370|261443|P1|STARTED|Dose Level 3||0
109226|NCT01189370|261441|P3|NOT COMPLETED|Dose Level 2||0
109227|NCT01189370|261442|P2|NOT COMPLETED|Dose Level 2||4
109228|NCT01189370|261443|P1|NOT COMPLETED|Dose Level 2||0
109229|NCT01189370|261441|P3|COMPLETED|Dose Level 2||0
109230|NCT01189370|261442|P2|COMPLETED|Dose Level 2||12
109231|NCT01189370|261443|P1|COMPLETED|Dose Level 2||0
109232|NCT01189370|261441|P3|STARTED|Dose Level 2||0
109233|NCT01189370|261442|P2|STARTED|Dose Level 2||16
109234|NCT01189370|261443|P1|STARTED|Dose Level 2||0
109235|NCT01189370|261441|P3|NOT COMPLETED|Dose Level 1||0
109236|NCT01189370|261442|P2|NOT COMPLETED|Dose Level 1||0
109237|NCT01189370|261443|P1|NOT COMPLETED|Dose Level 1||9
109238|NCT01189370|261441|P3|COMPLETED|Dose Level 1||0
109239|NCT01189370|261442|P2|COMPLETED|Dose Level 1||0
109240|NCT01189370|261443|P1|COMPLETED|Dose Level 1||16
109241|NCT01189370|261441|P3|STARTED|Dose Level 1||0
109242|NCT01189370|261442|P2|STARTED|Dose Level 1||0
109243|NCT01189370|261443|P1|STARTED|Dose Level 1||25
109244|NCT01189292|261452|P2|NOT COMPLETED|Per Protocol Analysis||16
109245|NCT01189292|261453|P1|NOT COMPLETED|Per Protocol Analysis||11
109246|NCT01189292|261452|P2|COMPLETED|Per Protocol Analysis||60
109247|NCT01189292|261453|P1|COMPLETED|Per Protocol Analysis||65
109248|NCT01189292|261452|P2|STARTED|Per Protocol Analysis||76
109249|NCT01189292|261453|P1|STARTED|Per Protocol Analysis||76
109250|NCT01189292|261452|P2|NOT COMPLETED|Intention to Treat Analysis||0
109251|NCT01189292|261453|P1|NOT COMPLETED|Intention to Treat Analysis||0
109252|NCT01189292|261452|P2|COMPLETED|Intention to Treat Analysis||76
109253|NCT01189292|261453|P1|COMPLETED|Intention to Treat Analysis||76
109254|NCT01189292|261452|P2|STARTED|Intention to Treat Analysis||76
109255|NCT01189292|261453|P1|STARTED|Intention to Treat Analysis||76
109256|NCT01189279|261474|P3|NOT COMPLETED|Overall Study||1
109257|NCT01189279|261475|P2|NOT COMPLETED|Overall Study||0
109258|NCT01189279|261476|P1|NOT COMPLETED|Overall Study||1
109259|NCT01189279|261474|P3|COMPLETED|Overall Study||13
109260|NCT01189279|261475|P2|COMPLETED|Overall Study||14
109261|NCT01189279|261476|P1|COMPLETED|Overall Study||13
109262|NCT01189279|261474|P3|STARTED|Overall Study||14
109263|NCT01189279|261475|P2|STARTED|Overall Study||14
109264|NCT01189279|261476|P1|STARTED|Overall Study||14
109265|NCT01189240|261496|P3|NOT COMPLETED|Overall Study||0
109266|NCT01189240|261497|P2|NOT COMPLETED|Overall Study||0
109267|NCT01189240|261498|P1|NOT COMPLETED|Overall Study||0
109268|NCT01189240|261496|P3|COMPLETED|Overall Study||3
109269|NCT01189240|261497|P2|COMPLETED|Overall Study||6
109270|NCT01189240|261498|P1|COMPLETED|Overall Study||4
109271|NCT01189240|261496|P3|STARTED|Overall Study||3
109272|NCT01189240|261497|P2|STARTED|Overall Study||6
109273|NCT01189240|261498|P1|STARTED|Overall Study||4
109274|NCT01189227|261519|P2|NOT COMPLETED|Overall Study||3
109275|NCT01189227|261520|P1|NOT COMPLETED|Overall Study||6
109276|NCT01189227|261519|P2|COMPLETED|Overall Study||0
109277|NCT01189227|261520|P1|COMPLETED|Overall Study||0
109278|NCT01189227|261519|P2|STARTED|Overall Study||3
109279|NCT01189227|261520|P1|STARTED|Overall Study||6
109280|NCT01189201|261526|P1|NOT COMPLETED|Overall Study||1
109281|NCT01189201|261526|P1|COMPLETED|Overall Study||41
109282|NCT01189201|261526|P1|Received Empa/Linagliptin FDC A3(Fasted)|Overall Study||24
109283|NCT01189201|261526|P1|Received Empa/Linagliptin FDC A1 (Fed)|Overall Study||18
109284|NCT01189201|261526|P1|Rec. Empa/Linagliptin Ind.Tablet(Fasted)|Overall Study||41
109285|NCT01189201|261526|P1|Received Empa/Linagliptin FDC A1(Fasted)|Overall Study||42
109286|NCT01189201|261526|P1|STARTED|Overall Study||42
109287|NCT01189136|261582|P2|NOT COMPLETED|Overall Study||0
109288|NCT01189136|261583|P1|NOT COMPLETED|Overall Study||0
109289|NCT01189136|261582|P2|COMPLETED|Overall Study||42
109290|NCT01189136|261583|P1|COMPLETED|Overall Study||42
109291|NCT01189136|261582|P2|STARTED|Overall Study||42
109292|NCT01189136|261583|P1|STARTED|Overall Study||42
109293|NCT01189123|261597|P2|NOT COMPLETED|Overall Study||6
109294|NCT01189123|261598|P1|NOT COMPLETED|Overall Study||2
109295|NCT01189123|261597|P2|COMPLETED|Overall Study||47
109296|NCT01189123|261598|P1|COMPLETED|Overall Study||50
109297|NCT01189123|261597|P2|STARTED|Overall Study||53
109298|NCT01189123|261598|P1|STARTED|Overall Study||52
109299|NCT01189110|261608|P2|NOT COMPLETED|Overall Study||0
109300|NCT01189110|261609|P1|NOT COMPLETED|Overall Study||0
109301|NCT01189110|261608|P2|COMPLETED|Overall Study||61
109302|NCT01189110|261609|P1|COMPLETED|Overall Study|February, 2011|64
109303|NCT01189110|261608|P2|STARTED|Overall Study||61
109304|NCT01189110|261609|P1|STARTED|Overall Study|September, 2010|64
109305|NCT01189071|261617|P2|NOT COMPLETED|Overall Study||0
109306|NCT01189071|261618|P1|NOT COMPLETED|Overall Study||0
109307|NCT01189071|261617|P2|COMPLETED|Overall Study||0
109308|NCT01189071|261618|P1|COMPLETED|Overall Study||0
109309|NCT01189071|261617|P2|STARTED|Overall Study||0
109310|NCT01189071|261618|P1|STARTED|Overall Study||0
109311|NCT01189032|261629|P3|NOT COMPLETED|Overall Study||6
109312|NCT01189032|261630|P2|NOT COMPLETED|Overall Study||7
109313|NCT01189032|261631|P1|NOT COMPLETED|Overall Study||5
109314|NCT01189032|261629|P3|COMPLETED|Overall Study||90
109315|NCT01189032|261630|P2|COMPLETED|Overall Study||89
109316|NCT01189032|261631|P1|COMPLETED|Overall Study||89
109317|NCT01189032|261629|P3|STARTED|Overall Study||96
109318|NCT01189032|261630|P2|STARTED|Overall Study||96
109319|NCT01189032|261631|P1|STARTED|Overall Study||94
109320|NCT01188967|261641|P2|NOT COMPLETED|Overall Study||4
109321|NCT01188967|261642|P1|NOT COMPLETED|Overall Study||5
109322|NCT01188967|261641|P2|COMPLETED|Overall Study||4
109323|NCT01188967|261642|P1|COMPLETED|Overall Study||5
109324|NCT01188967|261641|P2|STARTED|Overall Study||8
109325|NCT01188967|261642|P1|STARTED|Overall Study||10
109326|NCT01188928|261658|P4|NOT COMPLETED|Overall Study||18
109327|NCT01188928|261659|P3|NOT COMPLETED|Overall Study||14
109328|NCT01188928|261660|P2|NOT COMPLETED|Overall Study||62
109329|NCT01188928|261661|P1|NOT COMPLETED|Overall Study||38
109330|NCT01188928|261658|P4|COMPLETED|Overall Study||77
109331|NCT01188928|261659|P3|COMPLETED|Overall Study||82
109332|NCT01188928|261660|P2|COMPLETED|Overall Study||417
109333|NCT01188928|261661|P1|COMPLETED|Overall Study||444
109334|NCT01188928|261658|P4|STARTED|Overall Study||95
109335|NCT01188928|261659|P3|STARTED|Overall Study||96
109336|NCT01188928|261660|P2|STARTED|Overall Study||479
109337|NCT01188928|261661|P1|STARTED|Overall Study||482
109338|NCT01188811|261685|P2|NOT COMPLETED|Overall Study||2
109339|NCT01188811|261686|P1|NOT COMPLETED|Overall Study||6
109340|NCT01188811|261685|P2|COMPLETED|Overall Study||24
109341|NCT01188811|261686|P1|COMPLETED|Overall Study||22
109342|NCT01188811|261685|P2|STARTED|Overall Study||26
109343|NCT01188811|261686|P1|STARTED|Overall Study||28
109344|NCT01188798|261698|P2|NOT COMPLETED|Overall Study||3
109345|NCT01188798|261699|P1|NOT COMPLETED|Overall Study||2
109346|NCT01188798|261698|P2|COMPLETED|Overall Study||1
109347|NCT01188798|261699|P1|COMPLETED|Overall Study||0
109348|NCT01188798|261698|P2|STARTED|Overall Study||4
109349|NCT01188798|261699|P1|STARTED|Overall Study||2
109350|NCT01188772|261711|P4|NOT COMPLETED|Overall Study||1
109351|NCT01188772|261712|P3|NOT COMPLETED|Overall Study||11
109352|NCT01188772|261713|P2|NOT COMPLETED|Overall Study||3
109353|NCT01188772|261714|P1|NOT COMPLETED|Overall Study||5
109354|NCT01188772|261711|P4|COMPLETED|Overall Study||24
109355|NCT01188772|261712|P3|COMPLETED|Overall Study||15
109356|NCT01188772|261713|P2|COMPLETED|Overall Study||45
109357|NCT01188772|261714|P1|COMPLETED|Overall Study||43
109358|NCT01188772|261711|P4|Randomized and Treated|Overall Study||25
109359|NCT01188772|261712|P3|Randomized and Treated|Overall Study||26
109360|NCT01188772|261713|P2|Randomized and Treated|Overall Study||47
109361|NCT01188772|261714|P1|Randomized and Treated|Overall Study||48
109362|NCT01188772|261711|P4|STARTED|Overall Study||25
109363|NCT01188772|261712|P3|STARTED|Overall Study||26
109364|NCT01188772|261713|P2|STARTED|Overall Study||48
109365|NCT01188772|261714|P1|STARTED|Overall Study||48
109366|NCT01188694|261772|P3|NOT COMPLETED|Overall Study||1
109367|NCT01188694|261773|P2|NOT COMPLETED|Overall Study||1
109368|NCT01188694|261774|P1|NOT COMPLETED|Overall Study||5
109369|NCT01188694|261772|P3|COMPLETED|Overall Study||10
109370|NCT01188694|261773|P2|COMPLETED|Overall Study||15
109371|NCT01188694|261774|P1|COMPLETED|Overall Study||10
109372|NCT01188694|261772|P3|STARTED|Overall Study||11
109373|NCT01188694|261773|P2|STARTED|Overall Study||16
109374|NCT01188694|261774|P1|STARTED|Overall Study||15
109375|NCT01188681|261786|P4|NOT COMPLETED|Overall Study||1
109376|NCT01188681|261787|P3|NOT COMPLETED|Overall Study||1
109377|NCT01188681|261788|P2|NOT COMPLETED|Overall Study||0
109378|NCT01188681|261789|P1|NOT COMPLETED|Overall Study||0
109379|NCT01188681|261786|P4|COMPLETED|Overall Study||33
109380|NCT01188681|261787|P3|COMPLETED|Overall Study||32
109381|NCT01188681|261788|P2|COMPLETED|Overall Study||6
109382|NCT01188681|261789|P1|COMPLETED|Overall Study||6
109383|NCT01188681|261786|P4|STARTED|Overall Study|34 patients enrolled, 33 patients treated. One patient withdrew consent and was not treated.|34
109384|NCT01188681|261787|P3|STARTED|Overall Study|33 patients enrolled, 32 patients treated. One patient had bladder cancer and was not treated.|33
109385|NCT01188681|261788|P2|STARTED|Overall Study||6
109386|NCT01188681|261789|P1|STARTED|Overall Study||6
109387|NCT01188668|261803|P1|NOT COMPLETED|Period 2: Coadministration ARIP + DVS SR||3
109388|NCT01188668|261803|P1|COMPLETED|Period 2: Coadministration ARIP + DVS SR||33
109389|NCT01188668|261803|P1|STARTED|Period 2: Coadministration ARIP + DVS SR||36
109390|NCT01188668|261803|P1|NOT COMPLETED|Period 1: ARIP Alone||2
109391|NCT01188668|261803|P1|COMPLETED|Period 1: ARIP Alone||36
109392|NCT01188668|261803|P1|STARTED|Period 1: ARIP Alone||38
109393|NCT01188655|261836|P1|NOT COMPLETED|Overall Study||13
109394|NCT01188655|261836|P1|COMPLETED|Overall Study||76
109395|NCT01188655|261836|P1|STARTED|Overall Study||89
109396|NCT01188603|261851|P1|NOT COMPLETED|Overall Study||0
109397|NCT01188603|261851|P1|COMPLETED|Overall Study||24
109398|NCT01188603|261851|P1|STARTED|Overall Study||24
109399|NCT01188577|261861|P2|NOT COMPLETED|Visit 2||0
109400|NCT01188577|261862|P1|NOT COMPLETED|Visit 2||0
109401|NCT01188577|261861|P2|COMPLETED|Visit 2||12
109402|NCT01188577|261862|P1|COMPLETED|Visit 2||11
109403|NCT01188577|261861|P2|STARTED|Visit 2||12
109404|NCT01188577|261862|P1|STARTED|Visit 2||11
109405|NCT01188577|261861|P2|NOT COMPLETED|3-14 Day Washout||0
109406|NCT01188577|261862|P1|NOT COMPLETED|3-14 Day Washout||0
109407|NCT01188577|261861|P2|COMPLETED|3-14 Day Washout||12
109408|NCT01188577|261862|P1|COMPLETED|3-14 Day Washout||11
109409|NCT01188577|261861|P2|STARTED|3-14 Day Washout||12
109410|NCT01188577|261862|P1|STARTED|3-14 Day Washout||11
109411|NCT01188577|261861|P2|NOT COMPLETED|Visit 1||0
109412|NCT01188577|261862|P1|NOT COMPLETED|Visit 1||0
109413|NCT01188577|261861|P2|COMPLETED|Visit 1||12
109414|NCT01188577|261862|P1|COMPLETED|Visit 1||11
109415|NCT01188577|261861|P2|STARTED|Visit 1||12
109416|NCT01188577|261862|P1|STARTED|Visit 1||11
109417|NCT01188564|261880|P2|NOT COMPLETED|Open Label Phase||0
109418|NCT01188564|261881|P1|NOT COMPLETED|Open Label Phase||0
109419|NCT01188564|261880|P2|COMPLETED|Open Label Phase||20
109420|NCT01188564|261881|P1|COMPLETED|Open Label Phase||24
109421|NCT01188564|261880|P2|STARTED|Open Label Phase|Not all Double Blind Phase participants went on to Open Label Phase|20
109422|NCT01188564|261881|P1|STARTED|Open Label Phase|Not all Double-Blind Phase participants went on to Open Label Phase|24
109423|NCT01188564|261880|P2|NOT COMPLETED|Double-blind Phase||0
109424|NCT01188564|261881|P1|NOT COMPLETED|Double-blind Phase||1
109425|NCT01188564|261880|P2|COMPLETED|Double-blind Phase||31
109426|NCT01188564|261881|P1|COMPLETED|Double-blind Phase||43
109427|NCT01188564|261880|P2|STARTED|Double-blind Phase||31
109428|NCT01188564|261881|P1|STARTED|Double-blind Phase||44
109429|NCT01188551|261893|P4|NOT COMPLETED|Overall Study||0
109430|NCT01188551|261894|P3|NOT COMPLETED|Overall Study||0
109431|NCT01188551|261895|P2|NOT COMPLETED|Overall Study||0
109432|NCT01188551|261896|P1|NOT COMPLETED|Overall Study||1
109433|NCT01188551|261893|P4|COMPLETED|Overall Study||25
109434|NCT01188551|261894|P3|COMPLETED|Overall Study||25
109435|NCT01188551|261895|P2|COMPLETED|Overall Study||25
109436|NCT01188551|261896|P1|COMPLETED|Overall Study||24
109437|NCT01188551|261893|P4|STARTED|Overall Study||25
109438|NCT01188551|261894|P3|STARTED|Overall Study||25
109439|NCT01188551|261895|P2|STARTED|Overall Study||25
109440|NCT01188551|261896|P1|STARTED|Overall Study||25
109441|NCT01188538|261912|P2|NOT COMPLETED|Overall Study||1
109442|NCT01188538|261913|P1|NOT COMPLETED|Overall Study||0
109443|NCT01188538|261912|P2|COMPLETED|Overall Study||19
109444|NCT01188538|261913|P1|COMPLETED|Overall Study||20
109445|NCT01188538|261912|P2|STARTED|Overall Study||20
109446|NCT01188538|261913|P1|STARTED|Overall Study||20
109447|NCT01188499|261926|P5|NOT COMPLETED|Overall Study||0
109448|NCT01188499|261927|P4|NOT COMPLETED|Overall Study||0
109449|NCT01188499|261928|P3|NOT COMPLETED|Overall Study||0
109450|NCT01188499|261929|P2|NOT COMPLETED|Overall Study||0
109451|NCT01188499|261930|P1|NOT COMPLETED|Overall Study||0
109452|NCT01188499|261926|P5|COMPLETED|Overall Study||18
109453|NCT01188499|261927|P4|COMPLETED|Overall Study||18
109454|NCT01188499|261928|P3|COMPLETED|Overall Study||33
109455|NCT01188499|261929|P2|COMPLETED|Overall Study||83
109456|NCT01188499|261930|P1|COMPLETED|Overall Study||24
109457|NCT01188499|261926|P5|STARTED|Overall Study||18
109458|NCT01188499|261927|P4|STARTED|Overall Study||18
109459|NCT01188499|261928|P3|STARTED|Overall Study||33
109460|NCT01188499|261929|P2|STARTED|Overall Study||83
109461|NCT01188499|261930|P1|STARTED|Overall Study||24
109462|NCT01188447|261947|P1|NOT COMPLETED|Overall Study||0
109463|NCT01188447|261947|P1|COMPLETED|Overall Study||4034
109464|NCT01188447|261947|P1|STARTED|Overall Study||4034
109465|NCT01188421|261958|P3|NOT COMPLETED|Overall Study||14
109466|NCT01188421|261959|P2|NOT COMPLETED|Overall Study||10
109467|NCT01188421|261960|P1|NOT COMPLETED|Overall Study||3
109468|NCT01188421|261958|P3|COMPLETED|Overall Study||22
109469|NCT01188421|261959|P2|COMPLETED|Overall Study||26
109470|NCT01188421|261960|P1|COMPLETED|Overall Study||28
109471|NCT01188421|261958|P3|STARTED|Overall Study||36
109472|NCT01188421|261959|P2|STARTED|Overall Study||36
109473|NCT01188421|261960|P1|STARTED|Overall Study||31
109474|NCT01188343|261971|P3|NOT COMPLETED|Overall Study||1
109475|NCT01188343|261972|P2|NOT COMPLETED|Overall Study||26
109476|NCT01188343|261973|P1|NOT COMPLETED|Overall Study||1
109477|NCT01188343|261971|P3|COMPLETED|Overall Study||220
109478|NCT01188343|261972|P2|COMPLETED|Overall Study||193
109479|NCT01188343|261973|P1|COMPLETED|Overall Study||101
109480|NCT01188343|261971|P3|STARTED|Overall Study||221
109481|NCT01188343|261972|P2|STARTED|Overall Study||219
109482|NCT01188343|261973|P1|STARTED|Overall Study||102
109483|NCT01188226|261999|P1|NOT COMPLETED|Overall Study||4
109484|NCT01188226|261999|P1|COMPLETED|Overall Study||6
109485|NCT01188226|261999|P1|STARTED|Overall Study||10
109486|NCT01188109|262038|P1|NOT COMPLETED|Overall Study||0
109487|NCT01188109|262038|P1|COMPLETED|Overall Study||22
109488|NCT01188109|262038|P1|STARTED|Overall Study||22
109489|NCT01187953|262045|P2|NOT COMPLETED|Overall Study||21
109490|NCT01187953|262046|P1|NOT COMPLETED|Overall Study||15
109491|NCT01187953|262045|P2|COMPLETED|Overall Study||254
109492|NCT01187953|262046|P1|COMPLETED|Overall Study||253
109493|NCT01187953|262045|P2|Dosed|Overall Study||271
109494|NCT01187953|262046|P1|Dosed|Overall Study||266
109495|NCT01187953|262045|P2|STARTED|Overall Study||275
109496|NCT01187953|262046|P1|STARTED|Overall Study||268
109497|NCT01187914|262054|P1|NOT COMPLETED|Overall Study||0
109498|NCT01187914|262054|P1|COMPLETED|Overall Study||40
109499|NCT01187914|262054|P1|STARTED|Overall Study||40
109500|NCT01187901|262060|P2|NOT COMPLETED|Overall Study||10
109501|NCT01187901|262061|P1|NOT COMPLETED|Overall Study||9
109502|NCT01187901|262060|P2|COMPLETED|Overall Study||36
109503|NCT01187901|262061|P1|COMPLETED|Overall Study||37
109504|NCT01187901|262060|P2|STARTED|Overall Study||46
109505|NCT01187901|262061|P1|STARTED|Overall Study||46
109506|NCT01187771|262079|P2|NOT COMPLETED|Overall Study||3
109507|NCT01187771|262080|P1|NOT COMPLETED|Overall Study||3
109508|NCT01187771|262079|P2|COMPLETED|Overall Study||18
109509|NCT01187771|262080|P1|COMPLETED|Overall Study||25
109510|NCT01187771|262079|P2|STARTED|Overall Study||21
109511|NCT01187771|262080|P1|STARTED|Overall Study||28
109512|NCT01187550|262102|P2|NOT COMPLETED|Overall Study||1
109513|NCT01187550|262103|P1|NOT COMPLETED|Overall Study||14
109514|NCT01187550|262102|P2|COMPLETED|Overall Study||29
109515|NCT01187550|262103|P1|COMPLETED|Overall Study||169
109516|NCT01187550|262102|P2|Treated|Overall Study||30
109517|NCT01187550|262103|P1|Treated|Overall Study||175
109518|NCT01187550|262102|P2|STARTED|Overall Study||30
109519|NCT01187550|262103|P1|STARTED|Overall Study||183
109520|NCT01187511|262121|P2|NOT COMPLETED|Overall Study||1
109521|NCT01187511|262122|P1|NOT COMPLETED|Overall Study||8
109522|NCT01187511|262121|P2|COMPLETED|Overall Study||21
109523|NCT01187511|262122|P1|COMPLETED|Overall Study||14
109524|NCT01187511|262121|P2|STARTED|Overall Study||22
109525|NCT01187511|262122|P1|STARTED|Overall Study||22
109526|NCT01187498|262230|P2|NOT COMPLETED|Overall Study||10
109527|NCT01187498|262231|P1|NOT COMPLETED|Overall Study||9
109528|NCT01187498|262230|P2|COMPLETED|Overall Study||60
109529|NCT01187498|262231|P1|COMPLETED|Overall Study||64
109530|NCT01187498|262230|P2|STARTED|Overall Study||70
109531|NCT01187498|262231|P1|STARTED|Overall Study||73
109532|NCT01187433|262259|P2|NOT COMPLETED|Overall Study||4
109533|NCT01187433|262260|P1|NOT COMPLETED|Overall Study||11
109534|NCT01187433|262259|P2|COMPLETED|Overall Study||46
109535|NCT01187433|262260|P1|COMPLETED|Overall Study||89
109536|NCT01187433|262259|P2|STARTED|Overall Study||50
109537|NCT01187433|262260|P1|STARTED|Overall Study||100
109538|NCT01187355|262288|P2|NOT COMPLETED|Overall Study||20
109539|NCT01187355|262289|P1|NOT COMPLETED|Overall Study||18
109540|NCT01187355|262288|P2|COMPLETED|Overall Study||277
109541|NCT01187355|262289|P1|COMPLETED|Overall Study||276
109542|NCT01187355|262288|P2|STARTED|Overall Study||297
109543|NCT01187355|262289|P1|STARTED|Overall Study||294
109544|NCT01187043|262304|P5|NOT COMPLETED|Overall Study||2
109545|NCT01187043|262305|P4|NOT COMPLETED|Overall Study||0
109546|NCT01187043|262306|P3|NOT COMPLETED|Overall Study||4
109547|NCT01187043|262307|P2|NOT COMPLETED|Overall Study||0
109548|NCT01187043|262308|P1|NOT COMPLETED|Overall Study||1
109549|NCT01187043|262304|P5|COMPLETED|Overall Study||10
109550|NCT01187043|262305|P4|COMPLETED|Overall Study||12
109551|NCT01187043|262306|P3|COMPLETED|Overall Study||8
109552|NCT01187043|262307|P2|COMPLETED|Overall Study||10
109553|NCT01187043|262308|P1|COMPLETED|Overall Study||11
109554|NCT01187043|262304|P5|STARTED|Overall Study||12
109555|NCT01187043|262305|P4|STARTED|Overall Study||12
109556|NCT01187043|262306|P3|STARTED|Overall Study||12
109557|NCT01187043|262307|P2|STARTED|Overall Study||10
109558|NCT01187043|262308|P1|STARTED|Overall Study||12
109559|NCT01187017|262320|P1|NOT COMPLETED|Overall Study||0
109560|NCT01187017|262320|P1|COMPLETED|Overall Study||1
109561|NCT01187017|262320|P1|STARTED|Overall Study||1
109562|NCT01187004|262326|P2|NOT COMPLETED|Overall Study||0
109563|NCT01187004|262327|P1|NOT COMPLETED|Overall Study||0
109564|NCT01187004|262326|P2|COMPLETED|Overall Study||144
109565|NCT01187004|262327|P1|COMPLETED|Overall Study||20
109566|NCT01187004|262326|P2|STARTED|Overall Study||144
109567|NCT01187004|262327|P1|STARTED|Overall Study||20
109568|NCT01186939|262334|P1|NOT COMPLETED|Overall Study||40
109569|NCT01186939|262334|P1|COMPLETED|Overall Study||0
109570|NCT01186939|262334|P1|STARTED|Overall Study||40
109571|NCT01186848|262338|P1|NOT COMPLETED|Overall Study||8
109572|NCT01186848|262338|P1|COMPLETED|Overall Study||22
109573|NCT01186848|262338|P1|STARTED|Overall Study||30
109574|NCT01186796|262346|P2|NOT COMPLETED|Overall Study||2
109575|NCT01186796|262347|P1|NOT COMPLETED|Overall Study||4
109576|NCT01186796|262346|P2|COMPLETED|Overall Study||14
109577|NCT01186796|262347|P1|COMPLETED|Overall Study||10
109578|NCT01186796|262346|P2|STARTED|Overall Study|1 subject was randomized but withdrew before study interventions.|16
109579|NCT01186796|262347|P1|STARTED|Overall Study||14
109580|NCT01186744|262367|P6|NOT COMPLETED|Overall Study||26
109581|NCT01186744|262368|P5|NOT COMPLETED|Overall Study||6
109582|NCT01186744|262369|P4|NOT COMPLETED|Overall Study||12
109583|NCT01186744|262370|P3|NOT COMPLETED|Overall Study||6
109584|NCT01186744|262371|P2|NOT COMPLETED|Overall Study||152
109585|NCT01186744|262372|P1|NOT COMPLETED|Overall Study||208
109586|NCT01186744|262367|P6|COMPLETED|Overall Study||107
109587|NCT01186744|262368|P5|COMPLETED|Overall Study||39
109588|NCT01186744|262369|P4|COMPLETED|Overall Study||70
109589|NCT01186744|262370|P3|COMPLETED|Overall Study||25
109590|NCT01186744|262371|P2|COMPLETED|Overall Study||5
109591|NCT01186744|262372|P1|COMPLETED|Overall Study||10
109592|NCT01186744|262367|P6|STARTED|Overall Study||133
109593|NCT01186744|262368|P5|STARTED|Overall Study||45
109594|NCT01186744|262369|P4|STARTED|Overall Study||82
109595|NCT01186744|262370|P3|STARTED|Overall Study||31
109596|NCT01186744|262371|P2|STARTED|Overall Study||157
109597|NCT01186744|262372|P1|STARTED|Overall Study||218
109598|NCT01186705|262788|P1|NOT COMPLETED|Overall Study||0
109599|NCT01186705|262788|P1|COMPLETED|Overall Study||1
109600|NCT01186705|262788|P1|STARTED|Overall Study||1
109601|NCT01186692|262792|P1|NOT COMPLETED|Overall Study||32
109602|NCT01186692|262792|P1|COMPLETED|Overall Study||99
109603|NCT01186692|262792|P1|STARTED|Overall Study||131
109604|NCT01186562|262802|P2|NOT COMPLETED|Overall Study||2
109605|NCT01186562|262803|P1|NOT COMPLETED|Overall Study||4
109606|NCT01186562|262802|P2|COMPLETED|Overall Study||27
109607|NCT01186562|262803|P1|COMPLETED|Overall Study||50
109608|NCT01186562|262802|P2|STARTED|Overall Study||29
109609|NCT01186562|262803|P1|STARTED|Overall Study||54
109610|NCT01186458|262819|P1|NOT COMPLETED|Overall Study||1
109611|NCT01186458|262819|P1|COMPLETED|Overall Study||3
109612|NCT01186458|262819|P1|STARTED|Overall Study||4
109613|NCT01186419|262828|P2|NOT COMPLETED|Overall Study||9
109614|NCT01186419|262829|P1|NOT COMPLETED|Overall Study||7
109615|NCT01186419|262828|P2|COMPLETED|Overall Study||18
109616|NCT01186419|262829|P1|COMPLETED|Overall Study||17
109617|NCT01186419|262828|P2|STARTED|Overall Study||27
109618|NCT01186419|262829|P1|STARTED|Overall Study||24
109619|NCT01186406|262836|P1|NOT COMPLETED|Overall Study||0
109620|NCT01186406|262836|P1|COMPLETED|Overall Study||41
109621|NCT01186406|262836|P1|STARTED|Overall Study||41
109622|NCT01186250|262845|P2|NOT COMPLETED|Overall Study||0
109623|NCT01186250|262846|P1|NOT COMPLETED|Overall Study||1
109624|NCT01186250|262845|P2|COMPLETED|Overall Study||9
109625|NCT01186250|262846|P1|COMPLETED|Overall Study||8
109626|NCT01186250|262845|P2|STARTED|Overall Study||9
109627|NCT01186250|262846|P1|STARTED|Overall Study||9
109628|NCT01185964|262867|P4|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||5
109629|NCT01185964|262868|P3|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
109630|NCT01185964|262869|P2|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
109631|NCT01185964|262870|P1|NOT COMPLETED|Optional Olaratumab Monotherapy on Dox||0
109632|NCT01185964|262867|P4|COMPLETED|Optional Olaratumab Monotherapy on Dox||25
109633|NCT01185964|262868|P3|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
109634|NCT01185964|262869|P2|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
109635|NCT01185964|262870|P1|COMPLETED|Optional Olaratumab Monotherapy on Dox||0
109636|NCT01185964|262867|P4|STARTED|Optional Olaratumab Monotherapy on Dox|Participants with disease progression after treatment received olaratumab.|30
109637|NCT01185964|262868|P3|STARTED|Optional Olaratumab Monotherapy on Dox||0
109638|NCT01185964|262869|P2|STARTED|Optional Olaratumab Monotherapy on Dox||0
109639|NCT01185964|262870|P1|STARTED|Optional Olaratumab Monotherapy on Dox||0
109640|NCT01185964|262867|P4|NOT COMPLETED|Phase 1b and Phase 2||0
109641|NCT01185964|262868|P3|NOT COMPLETED|Phase 1b and Phase 2||9
109642|NCT01185964|262869|P2|NOT COMPLETED|Phase 1b and Phase 2||10
109643|NCT01185964|262870|P1|NOT COMPLETED|Phase 1b and Phase 2||2
109644|NCT01185964|262867|P4|COMPLETED|Phase 1b and Phase 2||0
109645|NCT01185964|262868|P3|COMPLETED|Phase 1b and Phase 2||58
109646|NCT01185964|262869|P2|COMPLETED|Phase 1b and Phase 2||56
109647|NCT01185964|262870|P1|COMPLETED|Phase 1b and Phase 2||13
109648|NCT01185964|262867|P4|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||0
109649|NCT01185964|262868|P3|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||65
109650|NCT01185964|262869|P2|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||64
109651|NCT01185964|262870|P1|Received at Least 1 Dose of Study Drug|Phase 1b and Phase 2||15
109652|NCT01185964|262867|P4|STARTED|Phase 1b and Phase 2||0
109653|NCT01185964|262868|P3|STARTED|Phase 1b and Phase 2||67
109654|NCT01185964|262869|P2|STARTED|Phase 1b and Phase 2||66
109655|NCT01185964|262870|P1|STARTED|Phase 1b and Phase 2||15
109656|NCT01185834|262896|P1|NOT COMPLETED|Overall Study||14
109657|NCT01185834|262896|P1|COMPLETED|Overall Study||104
109658|NCT01185834|262896|P1|STARTED|Overall Study||118
109659|NCT01185782|262903|P2|NOT COMPLETED|Overall Study||11
109660|NCT01185782|262904|P1|NOT COMPLETED|Overall Study||6
109661|NCT01185782|262903|P2|COMPLETED|Overall Study||125
109662|NCT01185782|262904|P1|COMPLETED|Overall Study||123
109663|NCT01185782|262903|P2|Treated|Overall Study||132
109664|NCT01185782|262904|P1|Treated|Overall Study||129
109665|NCT01185782|262903|P2|STARTED|Overall Study||136
109666|NCT01185782|262904|P1|STARTED|Overall Study||129
109667|NCT01185704|262932|P2|NOT COMPLETED|Overall Study||8
109668|NCT01185704|262933|P1|NOT COMPLETED|Overall Study||13
109669|NCT01185704|262932|P2|COMPLETED|Overall Study||60
109670|NCT01185704|262933|P1|COMPLETED|Overall Study||55
109671|NCT01185704|262932|P2|Treated|Overall Study||65
109672|NCT01185704|262933|P1|Treated|Overall Study||65
109673|NCT01185704|262932|P2|STARTED|Overall Study||68
109674|NCT01185704|262933|P1|STARTED|Overall Study||68
109675|NCT01185600|262969|P2|NOT COMPLETED|Overall Study||45
109676|NCT01185600|262970|P1|NOT COMPLETED|Overall Study||32
109677|NCT01185600|262969|P2|COMPLETED|Overall Study||59
109678|NCT01185600|262970|P1|COMPLETED|Overall Study||41
109679|NCT01185600|262969|P2|STARTED|Overall Study||104
109680|NCT01185600|262970|P1|STARTED|Overall Study||73
109681|NCT01185561|262992|P2|NOT COMPLETED|Overall Study||12
109682|NCT01185561|262993|P1|NOT COMPLETED|Overall Study||2
109683|NCT01185561|262992|P2|COMPLETED|Overall Study||26
109684|NCT01185561|262993|P1|COMPLETED|Overall Study||34
109685|NCT01185561|262992|P2|STARTED|Overall Study||38
109686|NCT01185561|262993|P1|STARTED|Overall Study||36
109687|NCT01185522|263005|P1|NOT COMPLETED|Overall Study||108
109688|NCT01185522|263005|P1|COMPLETED|Overall Study||585
109689|NCT01185522|263005|P1|STARTED|Overall Study||693
109690|NCT01185509|263031|P2|NOT COMPLETED|Overall Study||20
109691|NCT01185509|263032|P1|NOT COMPLETED|Overall Study||11
109692|NCT01185509|263031|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
109693|NCT01185509|263032|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
109694|NCT01185509|263031|P2|STARTED|Overall Study||20
109695|NCT01185509|263032|P1|STARTED|Overall Study||11
109696|NCT01185353|263047|P10|NOT COMPLETED|Part D (Weeks 76 Through 128)||1
109697|NCT01185353|263048|P9|NOT COMPLETED|Part D (Weeks 76 Through 128)||7
109698|NCT01185353|263049|P8|NOT COMPLETED|Part D (Weeks 76 Through 128)||3
109699|NCT01185353|263050|P7|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
109700|NCT01185353|263051|P6|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
109701|NCT01185353|263052|P5|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
109702|NCT01185353|263053|P4|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
109703|NCT01185353|263054|P3|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
109704|NCT01185353|263055|P2|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
109705|NCT01185353|263056|P1|NOT COMPLETED|Part D (Weeks 76 Through 128)||0
109706|NCT01185353|263047|P10|COMPLETED|Part D (Weeks 76 Through 128)||17
109707|NCT01185353|263048|P9|COMPLETED|Part D (Weeks 76 Through 128)||40
109708|NCT01185353|263049|P8|COMPLETED|Part D (Weeks 76 Through 128)||76
109709|NCT01185353|263050|P7|COMPLETED|Part D (Weeks 76 Through 128)||0
109710|NCT01185353|263051|P6|COMPLETED|Part D (Weeks 76 Through 128)||0
109711|NCT01185353|263052|P5|COMPLETED|Part D (Weeks 76 Through 128)||0
109712|NCT01185353|263053|P4|COMPLETED|Part D (Weeks 76 Through 128)||0
109713|NCT01185353|263054|P3|COMPLETED|Part D (Weeks 76 Through 128)||0
109714|NCT01185353|263055|P2|COMPLETED|Part D (Weeks 76 Through 128)||0
109715|NCT01185353|263056|P1|COMPLETED|Part D (Weeks 76 Through 128)||0
109716|NCT01185353|263047|P10|STARTED|Part D (Weeks 76 Through 128)||18
109717|NCT01185353|263048|P9|STARTED|Part D (Weeks 76 Through 128)||47
109718|NCT01185353|263049|P8|STARTED|Part D (Weeks 76 Through 128)||79
109719|NCT01185353|263050|P7|STARTED|Part D (Weeks 76 Through 128)||0
109720|NCT01185353|263051|P6|STARTED|Part D (Weeks 76 Through 128)||0
109721|NCT01185353|263052|P5|STARTED|Part D (Weeks 76 Through 128)||0
109722|NCT01185353|263053|P4|STARTED|Part D (Weeks 76 Through 128)||0
109723|NCT01185353|263054|P3|STARTED|Part D (Weeks 76 Through 128)||0
109724|NCT01185353|263055|P2|STARTED|Part D (Weeks 76 Through 128)||0
109725|NCT01185353|263056|P1|STARTED|Part D (Weeks 76 Through 128)||0
109726|NCT01185353|263047|P10|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
109727|NCT01185353|263048|P9|NOT COMPLETED|Part C (Weeks 24 Through 76)||8
109728|NCT01185353|263049|P8|NOT COMPLETED|Part C (Weeks 24 Through 76)||16
109729|NCT01185353|263050|P7|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
109730|NCT01185353|263051|P6|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
109731|NCT01185353|263052|P5|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
109732|NCT01185353|263053|P4|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
109733|NCT01185353|263054|P3|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
109734|NCT01185353|263055|P2|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
109735|NCT01185353|263056|P1|NOT COMPLETED|Part C (Weeks 24 Through 76)||0
109736|NCT01185353|263047|P10|COMPLETED|Part C (Weeks 24 Through 76)||24
109737|NCT01185353|263048|P9|COMPLETED|Part C (Weeks 24 Through 76)||53
109738|NCT01185353|263049|P8|COMPLETED|Part C (Weeks 24 Through 76)||92
109739|NCT01185353|263050|P7|COMPLETED|Part C (Weeks 24 Through 76)||0
109740|NCT01185353|263051|P6|COMPLETED|Part C (Weeks 24 Through 76)||0
109741|NCT01185353|263052|P5|COMPLETED|Part C (Weeks 24 Through 76)||0
109742|NCT01185353|263053|P4|COMPLETED|Part C (Weeks 24 Through 76)||0
109743|NCT01185353|263054|P3|COMPLETED|Part C (Weeks 24 Through 76)||0
109744|NCT01185353|263055|P2|COMPLETED|Part C (Weeks 24 Through 76)||0
109745|NCT01185353|263056|P1|COMPLETED|Part C (Weeks 24 Through 76)||0
109746|NCT01185353|263047|P10|STARTED|Part C (Weeks 24 Through 76)||32
109747|NCT01185353|263048|P9|STARTED|Part C (Weeks 24 Through 76)||61
109748|NCT01185353|263049|P8|STARTED|Part C (Weeks 24 Through 76)||108
109749|NCT01185353|263050|P7|STARTED|Part C (Weeks 24 Through 76)||0
109750|NCT01185353|263051|P6|STARTED|Part C (Weeks 24 Through 76)||0
109751|NCT01185353|263052|P5|STARTED|Part C (Weeks 24 Through 76)||0
109752|NCT01185353|263053|P4|STARTED|Part C (Weeks 24 Through 76)||0
109753|NCT01185353|263054|P3|STARTED|Part C (Weeks 24 Through 76)||0
109754|NCT01185353|263055|P2|STARTED|Part C (Weeks 24 Through 76)||0
109755|NCT01185353|263056|P1|STARTED|Part C (Weeks 24 Through 76)||0
109756|NCT01185353|263047|P10|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
109757|NCT01185353|263048|P9|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
109758|NCT01185353|263049|P8|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
109759|NCT01185353|263050|P7|NOT COMPLETED|Part B (Weeks 12 Through 24)||6
109760|NCT01185353|263051|P6|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
109761|NCT01185353|263052|P5|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
109762|NCT01185353|263053|P4|NOT COMPLETED|Part B (Weeks 12 Through 24)||4
109763|NCT01185353|263054|P3|NOT COMPLETED|Part B (Weeks 12 Through 24)||2
109764|NCT01185353|263055|P2|NOT COMPLETED|Part B (Weeks 12 Through 24)||1
109765|NCT01185353|263056|P1|NOT COMPLETED|Part B (Weeks 12 Through 24)||0
109766|NCT01185353|263047|P10|COMPLETED|Part B (Weeks 12 Through 24)||0
109767|NCT01185353|263048|P9|COMPLETED|Part B (Weeks 12 Through 24)||0
109768|NCT01185353|263049|P8|COMPLETED|Part B (Weeks 12 Through 24)||0
109769|NCT01185353|263050|P7|COMPLETED|Part B (Weeks 12 Through 24)||57
109770|NCT01185353|263051|P6|COMPLETED|Part B (Weeks 12 Through 24)||59
109771|NCT01185353|263052|P5|COMPLETED|Part B (Weeks 12 Through 24)||0
109772|NCT01185353|263053|P4|COMPLETED|Part B (Weeks 12 Through 24)||45
109773|NCT01185353|263054|P3|COMPLETED|Part B (Weeks 12 Through 24)||48
109774|NCT01185353|263055|P2|COMPLETED|Part B (Weeks 12 Through 24)||50
109775|NCT01185353|263056|P1|COMPLETED|Part B (Weeks 12 Through 24)||0
109776|NCT01185353|263047|P10|STARTED|Part B (Weeks 12 Through 24)||0
109777|NCT01185353|263048|P9|STARTED|Part B (Weeks 12 Through 24)||0
109778|NCT01185353|263049|P8|STARTED|Part B (Weeks 12 Through 24)||0
109779|NCT01185353|263050|P7|STARTED|Part B (Weeks 12 Through 24)||63
109780|NCT01185353|263051|P6|STARTED|Part B (Weeks 12 Through 24)||63
109781|NCT01185353|263052|P5|STARTED|Part B (Weeks 12 Through 24)||0
109782|NCT01185353|263053|P4|STARTED|Part B (Weeks 12 Through 24)||49
109783|NCT01185353|263054|P3|STARTED|Part B (Weeks 12 Through 24)||50
109784|NCT01185353|263055|P2|STARTED|Part B (Weeks 12 Through 24)||51
109785|NCT01185353|263056|P1|STARTED|Part B (Weeks 12 Through 24)||0
109786|NCT01185353|263047|P10|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
109787|NCT01185353|263048|P9|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
109788|NCT01185353|263049|P8|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
109789|NCT01185353|263050|P7|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
109790|NCT01185353|263051|P6|NOT COMPLETED|Part A (Weeks 0 Through 12)||0
109791|NCT01185353|263052|P5|NOT COMPLETED|Part A (Weeks 0 Through 12)||16
109792|NCT01185353|263053|P4|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
109793|NCT01185353|263054|P3|NOT COMPLETED|Part A (Weeks 0 Through 12)||2
109794|NCT01185353|263055|P2|NOT COMPLETED|Part A (Weeks 0 Through 12)||1
109795|NCT01185353|263056|P1|NOT COMPLETED|Part A (Weeks 0 Through 12)||5
109796|NCT01185353|263047|P10|COMPLETED|Part A (Weeks 0 Through 12)||0
109797|NCT01185353|263048|P9|COMPLETED|Part A (Weeks 0 Through 12)||0
109798|NCT01185353|263049|P8|COMPLETED|Part A (Weeks 0 Through 12)||0
109799|NCT01185353|263050|P7|COMPLETED|Part A (Weeks 0 Through 12)||0
109800|NCT01185353|263051|P6|COMPLETED|Part A (Weeks 0 Through 12)||0
109801|NCT01185353|263052|P5|COMPLETED|Part A (Weeks 0 Through 12)||82
109802|NCT01185353|263053|P4|COMPLETED|Part A (Weeks 0 Through 12)||49
109803|NCT01185353|263054|P3|COMPLETED|Part A (Weeks 0 Through 12)||50
109804|NCT01185353|263055|P2|COMPLETED|Part A (Weeks 0 Through 12)||51
109805|NCT01185353|263056|P1|COMPLETED|Part A (Weeks 0 Through 12)||44
109806|NCT01185353|263047|P10|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
109807|NCT01185353|263048|P9|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
109808|NCT01185353|263049|P8|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
109809|NCT01185353|263050|P7|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
109810|NCT01185353|263051|P6|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||0
109811|NCT01185353|263052|P5|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||98
109812|NCT01185353|263053|P4|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||50
109813|NCT01185353|263054|P3|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
109814|NCT01185353|263055|P2|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||52
109815|NCT01185353|263056|P1|Received at Least 1 Dose of Study Drug|Part A (Weeks 0 Through 12)||49
109816|NCT01185353|263047|P10|STARTED|Part A (Weeks 0 Through 12)||0
109817|NCT01185353|263048|P9|STARTED|Part A (Weeks 0 Through 12)||0
109818|NCT01185353|263049|P8|STARTED|Part A (Weeks 0 Through 12)||0
109819|NCT01185353|263050|P7|STARTED|Part A (Weeks 0 Through 12)||0
109820|NCT01185353|263051|P6|STARTED|Part A (Weeks 0 Through 12)||0
109821|NCT01185353|263052|P5|STARTED|Part A (Weeks 0 Through 12)||98
109822|NCT01185353|263053|P4|STARTED|Part A (Weeks 0 Through 12)||50
109823|NCT01185353|263054|P3|STARTED|Part A (Weeks 0 Through 12)||52
109824|NCT01185353|263055|P2|STARTED|Part A (Weeks 0 Through 12)||52
109825|NCT01185353|263056|P1|STARTED|Part A (Weeks 0 Through 12)||49
109826|NCT01185301|263218|P4|NOT COMPLETED|Overall Study||9
109827|NCT01185301|263219|P3|NOT COMPLETED|Overall Study||6
109828|NCT01185301|263220|P2|NOT COMPLETED|Overall Study||7
109829|NCT01185301|263221|P1|NOT COMPLETED|Overall Study||15
109830|NCT01185301|263218|P4|COMPLETED|Overall Study||89
109831|NCT01185301|263219|P3|COMPLETED|Overall Study||93
109832|NCT01185301|263220|P2|COMPLETED|Overall Study||93
109833|NCT01185301|263221|P1|COMPLETED|Overall Study||83
109834|NCT01185301|263218|P4|STARTED|Overall Study||98
109835|NCT01185301|263219|P3|STARTED|Overall Study||99
109836|NCT01185301|263220|P2|STARTED|Overall Study||100
109837|NCT01185301|263221|P1|STARTED|Overall Study||98
109838|NCT01185288|263281|P2|NOT COMPLETED|Overall Study||16
109839|NCT01185288|263282|P1|NOT COMPLETED|Overall Study||19
109840|NCT01185288|263281|P2|COMPLETED|Overall Study||139
109841|NCT01185288|263282|P1|COMPLETED|Overall Study||135
109842|NCT01185288|263281|P2|STARTED|Overall Study||155
109843|NCT01185288|263282|P1|STARTED|Overall Study||154
109844|NCT01185249|263300|P1|NOT COMPLETED|Overall Study||42
109845|NCT01185249|263300|P1|COMPLETED|Overall Study|Data was analyzed for patients with three consecutive days of data.|24
109846|NCT01185249|263300|P1|STARTED|Overall Study|Total number of patients consented to participate.|66
109847|NCT01185080|263308|P3|NOT COMPLETED|Overall Study||1
109848|NCT01185080|263309|P2|NOT COMPLETED|Overall Study||1
109849|NCT01185080|263310|P1|NOT COMPLETED|Overall Study||1
109850|NCT01185080|263308|P3|COMPLETED|Overall Study||16
109851|NCT01185080|263309|P2|COMPLETED|Overall Study||15
109852|NCT01185080|263310|P1|COMPLETED|Overall Study||49
109853|NCT01185080|263308|P3|STARTED|Overall Study||17
109854|NCT01185080|263309|P2|STARTED|Overall Study||16
109855|NCT01185080|263310|P1|STARTED|Overall Study||50
109856|NCT01185028|263357|P1|NOT COMPLETED|Overall Study||4
109857|NCT01185028|263357|P1|COMPLETED|Overall Study||4
109858|NCT01185028|263357|P1|STARTED|Overall Study||8
109859|NCT01184989|263362|P1|NOT COMPLETED|Overall Study||12
109860|NCT01184989|263362|P1|COMPLETED|Overall Study||100
109861|NCT01184989|263362|P1|STARTED|Overall Study|Treated Patients|112
109862|NCT01184898|263368|P1|NOT COMPLETED|Overall Study||0
109863|NCT01184898|263368|P1|COMPLETED|Overall Study||36
109864|NCT01184898|263368|P1|STARTED|Overall Study||36
109865|NCT01184885|263375|P1|NOT COMPLETED|Overall Study||0
109866|NCT01184885|263375|P1|COMPLETED|Overall Study||7
109867|NCT01184885|263375|P1|STARTED|Overall Study||7
109868|NCT01184872|263382|P2|NOT COMPLETED|Overall Study||8
109869|NCT01184872|263383|P1|NOT COMPLETED|Overall Study||10
109870|NCT01184872|263382|P2|COMPLETED|Overall Study||31
109871|NCT01184872|263383|P1|COMPLETED|Overall Study||71
109872|NCT01184872|263382|P2|Microbiologically Evaluable Set (MES)|Overall Study||27
109873|NCT01184872|263383|P1|Microbiologically Evaluable Set (MES)|Overall Study||65
109874|NCT01184872|263382|P2|Clinical Evaluable Set (CES)|Overall Study||30
109875|NCT01184872|263383|P1|Clinical Evaluable Set (CES)|Overall Study||73
109876|NCT01184872|263382|P2|Safety Set|Overall Study||40
109877|NCT01184872|263383|P1|Safety Set|Overall Study|One patient randomized to Daptomycin received Vancomycin.|80
109878|NCT01184872|263382|P2|STARTED|Overall Study||39
109879|NCT01184872|263383|P1|STARTED|Overall Study|"Started indicates randomized and full analysis set."|81
109880|NCT01184859|263402|P5|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
109881|NCT01184859|263403|P4|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
109882|NCT01184859|263404|P3|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
109883|NCT01184859|263405|P2|NOT COMPLETED|Period 2: Daily Dose for 28 Days||0
109884|NCT01184859|263406|P1|NOT COMPLETED|Period 2: Daily Dose for 28 Days||1
109885|NCT01184859|263402|P5|COMPLETED|Period 2: Daily Dose for 28 Days||22
109886|NCT01184859|263403|P4|COMPLETED|Period 2: Daily Dose for 28 Days||22
109887|NCT01184859|263404|P3|COMPLETED|Period 2: Daily Dose for 28 Days||22
109888|NCT01184859|263405|P2|COMPLETED|Period 2: Daily Dose for 28 Days||23
109889|NCT01184859|263406|P1|COMPLETED|Period 2: Daily Dose for 28 Days||22
109890|NCT01184859|263402|P5|STARTED|Period 2: Daily Dose for 28 Days||23
109891|NCT01184859|263403|P4|STARTED|Period 2: Daily Dose for 28 Days||22
109892|NCT01184859|263404|P3|STARTED|Period 2: Daily Dose for 28 Days||22
109893|NCT01184859|263405|P2|STARTED|Period 2: Daily Dose for 28 Days||23
109894|NCT01184859|263406|P1|STARTED|Period 2: Daily Dose for 28 Days||23
109895|NCT01184859|263402|P5|NOT COMPLETED|Washout Period||0
109896|NCT01184859|263403|P4|NOT COMPLETED|Washout Period||0
109897|NCT01184859|263404|P3|NOT COMPLETED|Washout Period||0
109898|NCT01184859|263405|P2|NOT COMPLETED|Washout Period||0
109899|NCT01184859|263406|P1|NOT COMPLETED|Washout Period||0
109900|NCT01184859|263402|P5|COMPLETED|Washout Period||23
109901|NCT01184859|263403|P4|COMPLETED|Washout Period||22
109902|NCT01184859|263404|P3|COMPLETED|Washout Period||22
109903|NCT01184859|263405|P2|COMPLETED|Washout Period||23
109904|NCT01184859|263406|P1|COMPLETED|Washout Period||23
109905|NCT01184859|263402|P5|STARTED|Washout Period||23
109906|NCT01184859|263403|P4|STARTED|Washout Period||22
109907|NCT01184859|263404|P3|STARTED|Washout Period||22
109908|NCT01184859|263405|P2|STARTED|Washout Period||23
109909|NCT01184859|263406|P1|STARTED|Washout Period||23
109910|NCT01184859|263402|P5|NOT COMPLETED|Period 1: Single Dose||1
109911|NCT01184859|263403|P4|NOT COMPLETED|Period 1: Single Dose||0
109912|NCT01184859|263404|P3|NOT COMPLETED|Period 1: Single Dose||0
109913|NCT01184859|263405|P2|NOT COMPLETED|Period 1: Single Dose||2
109914|NCT01184859|263406|P1|NOT COMPLETED|Period 1: Single Dose||0
109915|NCT01184859|263402|P5|COMPLETED|Period 1: Single Dose||23
109916|NCT01184859|263403|P4|COMPLETED|Period 1: Single Dose||22
109917|NCT01184859|263404|P3|COMPLETED|Period 1: Single Dose||22
109918|NCT01184859|263405|P2|COMPLETED|Period 1: Single Dose||23
109919|NCT01184859|263406|P1|COMPLETED|Period 1: Single Dose||23
109920|NCT01184859|263402|P5|Per Protocol (PP)|Period 1: Single Dose|1 additional participant disqualified due to 'other'.|23
109921|NCT01184859|263403|P4|Per Protocol (PP)|Period 1: Single Dose||21
109922|NCT01184859|263404|P3|Per Protocol (PP)|Period 1: Single Dose||22
109923|NCT01184859|263405|P2|Per Protocol (PP)|Period 1: Single Dose||23
109924|NCT01184859|263406|P1|Per Protocol (PP)|Period 1: Single Dose||23
109925|NCT01184859|263402|P5|Full Analysis Set (FAS)|Period 1: Single Dose||24
109926|NCT01184859|263403|P4|Full Analysis Set (FAS)|Period 1: Single Dose|1 participant disqualified due to major entry criteria violation|21
109927|NCT01184859|263404|P3|Full Analysis Set (FAS)|Period 1: Single Dose||22
109928|NCT01184859|263405|P2|Full Analysis Set (FAS)|Period 1: Single Dose|2 participants disqualified due to no post-baseline primary efficacy data, and/or 'other'.|23
109929|NCT01184859|263406|P1|Full Analysis Set (FAS)|Period 1: Single Dose||23
109930|NCT01184859|263402|P5|STARTED|Period 1: Single Dose||24
109931|NCT01184859|263403|P4|STARTED|Period 1: Single Dose||22
109932|NCT01184859|263404|P3|STARTED|Period 1: Single Dose||22
109933|NCT01184859|263405|P2|STARTED|Period 1: Single Dose||25
109934|NCT01184859|263406|P1|STARTED|Period 1: Single Dose||23
109935|NCT01184846|263498|P1|NOT COMPLETED|Overall Study||3
109936|NCT01184846|263498|P1|COMPLETED|Overall Study||25
109937|NCT01184846|263498|P1|STARTED|Overall Study||28
109938|NCT01184755|263519|P3|NOT COMPLETED|Overall Study||6
109939|NCT01184755|263520|P2|NOT COMPLETED|Overall Study||11
109940|NCT01184755|263521|P1|NOT COMPLETED|Overall Study||25
109941|NCT01184755|263519|P3|COMPLETED|Overall Study||56
109942|NCT01184755|263520|P2|COMPLETED|Overall Study||54
109943|NCT01184755|263521|P1|COMPLETED|Overall Study||101
109944|NCT01184755|263519|P3|STARTED|Overall Study||62
109945|NCT01184755|263520|P2|STARTED|Overall Study||65
109946|NCT01184755|263521|P1|STARTED|Overall Study||126
109947|NCT01184417|263531|P2|NOT COMPLETED|Overall Study||0
109948|NCT01184417|263532|P1|NOT COMPLETED|Overall Study||0
109949|NCT01184417|263531|P2|COMPLETED|Overall Study||51
109950|NCT01184417|263532|P1|COMPLETED|Overall Study||51
109951|NCT01184417|263531|P2|STARTED|Overall Study||51
109952|NCT01184417|263532|P1|STARTED|Overall Study||51
109953|NCT01184118|263552|P1|NOT COMPLETED|Overall Study||18
109954|NCT01184118|263552|P1|COMPLETED|Overall Study||18
109955|NCT01184118|263552|P1|FP MDI as Indicated (2 Weeks)|Overall Study||18
109956|NCT01184118|263552|P1|FP MDI 880 mcg/Day (2 Weeks)|Overall Study||18
109957|NCT01184118|263552|P1|FP MDI 1,760 mcg/Day (16 Weeks)|Overall Study||18
109958|NCT01184118|263552|P1|STARTED|Overall Study||36
109959|NCT01184079|263560|P2|NOT COMPLETED|Overall Study||2
109960|NCT01184079|263561|P1|NOT COMPLETED|Overall Study||14
109961|NCT01184079|263560|P2|COMPLETED|Overall Study||107
109962|NCT01184079|263561|P1|COMPLETED|Overall Study||97
109963|NCT01184079|263560|P2|Final Blood Draw|Overall Study||107
109964|NCT01184079|263561|P1|Final Blood Draw|Overall Study||97
109965|NCT01184079|263560|P2|Dose 3|Overall Study||107
109966|NCT01184079|263561|P1|Dose 3|Overall Study||101
109967|NCT01184079|263560|P2|Dose 2|Overall Study||108
109968|NCT01184079|263561|P1|Dose 2|Overall Study||110
109969|NCT01184079|263560|P2|STARTED|Overall Study||109
109970|NCT01184079|263561|P1|STARTED|Overall Study||111
109971|NCT01184053|263571|P1|NOT COMPLETED|Overall Study||3
109972|NCT01184053|263571|P1|COMPLETED|Overall Study||0
109973|NCT01184053|263571|P1|STARTED|Overall Study||3
109974|NCT01184014|263580|P2|NOT COMPLETED|Overall Study||6
109975|NCT01184014|263581|P1|NOT COMPLETED|Overall Study||5
109976|NCT01184014|263580|P2|COMPLETED|Overall Study||31
109977|NCT01184014|263581|P1|COMPLETED|Overall Study||30
109978|NCT01184014|263580|P2|STARTED|Overall Study||37
109979|NCT01184014|263581|P1|STARTED|Overall Study||35
109980|NCT01183975|263587|P1|NOT COMPLETED|Overall Study||73
109981|NCT01183975|263587|P1|COMPLETED|Overall Study||444
109982|NCT01183975|263587|P1|STARTED|Overall Study||517
109983|NCT01183858|263594|P2|NOT COMPLETED|Overall Study||156
109984|NCT01183858|263595|P1|NOT COMPLETED|Overall Study||153
109985|NCT01183858|263594|P2|COMPLETED|Overall Study||3
109986|NCT01183858|263595|P1|COMPLETED|Overall Study||1
109987|NCT01183858|263594|P2|Safety Population|Overall Study||158
109988|NCT01183858|263595|P1|Safety Population|Overall Study||154
109989|NCT01183858|263594|P2|STARTED|Overall Study||159
109990|NCT01183858|263595|P1|STARTED|Overall Study||154
109991|NCT01183780|263617|P2|NOT COMPLETED|Overall Study||25
109992|NCT01183780|263618|P1|NOT COMPLETED|Overall Study||31
109993|NCT01183780|263617|P2|COMPLETED|Overall Study||511
109994|NCT01183780|263618|P1|COMPLETED|Overall Study||505
109995|NCT01183780|263617|P2|Received at Least 1 Dose of Study Drug|Overall Study||529
109996|NCT01183780|263618|P1|Received at Least 1 Dose of Study Drug|Overall Study||528
109997|NCT01183780|263617|P2|STARTED|Overall Study||536
109998|NCT01183780|263618|P1|STARTED|Overall Study||536
109999|NCT01183728|263635|P1|NOT COMPLETED|Overall Study||0
110000|NCT01183728|263635|P1|COMPLETED|Overall Study||12
110001|NCT01183728|263635|P1|STARTED|Overall Study||12
110002|NCT01183650|263642|P2|NOT COMPLETED|Overall Study||0
110003|NCT01183650|263643|P1|NOT COMPLETED|Overall Study||0
110004|NCT01183650|263642|P2|COMPLETED|Overall Study||12
110005|NCT01183650|263643|P1|COMPLETED|Overall Study||12
110006|NCT01183650|263642|P2|STARTED|Overall Study||12
110007|NCT01183650|263643|P1|STARTED|Overall Study||12
110008|NCT01183546|263653|P1|NOT COMPLETED|Overall Study||0
110009|NCT01183546|263653|P1|COMPLETED|Overall Study||53
110010|NCT01183546|263653|P1|STARTED|Overall Study||53
110011|NCT01183533|263660|P1|NOT COMPLETED|Overall Study||0
110012|NCT01183533|263660|P1|COMPLETED|Overall Study|- all pre-planned 40 patients received the study medication.|40
110013|NCT01183533|263660|P1|STARTED|Overall Study|Between Oct 2010 and Oct 2013.|40
110014|NCT01183481|263666|P1|NOT COMPLETED|Overall Study||0
110015|NCT01183481|263666|P1|COMPLETED|Overall Study||19
110016|NCT01183481|263666|P1|STARTED|Overall Study||19
110017|NCT01183468|263678|P4|NOT COMPLETED|Overall Study||0
110018|NCT01183468|263679|P3|NOT COMPLETED|Overall Study||0
110019|NCT01183468|263680|P2|NOT COMPLETED|Overall Study||2
110020|NCT01183468|263681|P1|NOT COMPLETED|Overall Study||3
110021|NCT01183468|263678|P4|COMPLETED|Overall Study||0
110022|NCT01183468|263679|P3|COMPLETED|Overall Study||0
110023|NCT01183468|263680|P2|COMPLETED|Overall Study||7
110024|NCT01183468|263681|P1|COMPLETED|Overall Study||5
110025|NCT01183468|263678|P4|STARTED|Overall Study||0
110026|NCT01183468|263679|P3|STARTED|Overall Study||0
110027|NCT01183468|263680|P2|STARTED|Overall Study||9
110028|NCT01183468|263681|P1|STARTED|Overall Study||8
110029|NCT01183390|263691|P2|NOT COMPLETED|Second Intervention||0
110030|NCT01183390|263692|P1|NOT COMPLETED|Second Intervention||0
110031|NCT01183390|263691|P2|COMPLETED|Second Intervention||10
110032|NCT01183390|263692|P1|COMPLETED|Second Intervention||11
110033|NCT01183390|263691|P2|STARTED|Second Intervention||10
110034|NCT01183390|263692|P1|STARTED|Second Intervention||11
110035|NCT01183390|263691|P2|NOT COMPLETED|Washout of 21 Days||0
110036|NCT01183390|263692|P1|NOT COMPLETED|Washout of 21 Days||0
110037|NCT01183390|263691|P2|COMPLETED|Washout of 21 Days||10
110038|NCT01183390|263692|P1|COMPLETED|Washout of 21 Days||11
110039|NCT01183390|263691|P2|STARTED|Washout of 21 Days||10
110040|NCT01183390|263692|P1|STARTED|Washout of 21 Days||11
110041|NCT01183390|263691|P2|NOT COMPLETED|First Intervention||1
110042|NCT01183390|263692|P1|NOT COMPLETED|First Intervention||0
110043|NCT01183390|263691|P2|COMPLETED|First Intervention||10
110044|NCT01183390|263692|P1|COMPLETED|First Intervention||11
110045|NCT01183390|263691|P2|STARTED|First Intervention||11
110046|NCT01183390|263692|P1|STARTED|First Intervention||11
110047|NCT01183312|263702|P2|NOT COMPLETED|Second Intervention Day||0
110048|NCT01183312|263703|P1|NOT COMPLETED|Second Intervention Day||0
110049|NCT01183312|263702|P2|COMPLETED|Second Intervention Day||5
110050|NCT01183312|263703|P1|COMPLETED|Second Intervention Day||5
110051|NCT01183312|263702|P2|STARTED|Second Intervention Day||5
110052|NCT01183312|263703|P1|STARTED|Second Intervention Day||5
110053|NCT01183312|263702|P2|NOT COMPLETED|Washout Period of at Least 1 Week||0
110054|NCT01183312|263703|P1|NOT COMPLETED|Washout Period of at Least 1 Week||0
110055|NCT01183312|263702|P2|COMPLETED|Washout Period of at Least 1 Week||5
110056|NCT01183312|263703|P1|COMPLETED|Washout Period of at Least 1 Week||5
110057|NCT01183312|263702|P2|STARTED|Washout Period of at Least 1 Week||5
110058|NCT01183312|263703|P1|STARTED|Washout Period of at Least 1 Week||5
110059|NCT01183312|263702|P2|NOT COMPLETED|First Intervention Day||0
110060|NCT01183312|263703|P1|NOT COMPLETED|First Intervention Day||0
110061|NCT01183312|263702|P2|COMPLETED|First Intervention Day||5
110062|NCT01183312|263703|P1|COMPLETED|First Intervention Day||5
110063|NCT01183312|263702|P2|STARTED|First Intervention Day||5
110064|NCT01183312|263703|P1|STARTED|First Intervention Day||5
110065|NCT01183234|263723|P2|NOT COMPLETED|Second Intervention||0
110066|NCT01183234|263724|P1|NOT COMPLETED|Second Intervention||0
110067|NCT01183234|263723|P2|COMPLETED|Second Intervention||14
110068|NCT01183234|263724|P1|COMPLETED|Second Intervention||13
110069|NCT01183234|263723|P2|STARTED|Second Intervention||14
110070|NCT01183234|263724|P1|STARTED|Second Intervention||13
110071|NCT01183234|263723|P2|NOT COMPLETED|Washout||0
110072|NCT01183234|263724|P1|NOT COMPLETED|Washout||0
110073|NCT01183234|263723|P2|COMPLETED|Washout||14
110074|NCT01183234|263724|P1|COMPLETED|Washout||13
110075|NCT01183234|263723|P2|STARTED|Washout||14
110076|NCT01183234|263724|P1|STARTED|Washout||13
110077|NCT01183234|263723|P2|NOT COMPLETED|First Intervention||0
110078|NCT01183234|263724|P1|NOT COMPLETED|First Intervention||1
110079|NCT01183234|263723|P2|COMPLETED|First Intervention||14
110080|NCT01183234|263724|P1|COMPLETED|First Intervention||13
110081|NCT01183234|263723|P2|STARTED|First Intervention||14
110082|NCT01183234|263724|P1|STARTED|First Intervention||14
110083|NCT01183169|263738|P7|NOT COMPLETED|Post-switch Phase||9
110084|NCT01183169|263739|P6|NOT COMPLETED|Post-switch Phase||14
110085|NCT01183169|263740|P5|NOT COMPLETED|Post-switch Phase||0
110086|NCT01183169|263741|P4|NOT COMPLETED|Post-switch Phase||0
110087|NCT01183169|263742|P3|NOT COMPLETED|Post-switch Phase||0
110088|NCT01183169|263743|P2|NOT COMPLETED|Post-switch Phase||0
110089|NCT01183169|263744|P1|NOT COMPLETED|Post-switch Phase||0
110090|NCT01183169|263738|P7|COMPLETED|Post-switch Phase||21
110091|NCT01183169|263739|P6|COMPLETED|Post-switch Phase||21
110092|NCT01183169|263740|P5|COMPLETED|Post-switch Phase||0
110093|NCT01183169|263741|P4|COMPLETED|Post-switch Phase||0
110094|NCT01183169|263742|P3|COMPLETED|Post-switch Phase||0
110095|NCT01183169|263743|P2|COMPLETED|Post-switch Phase||0
110096|NCT01183169|263744|P1|COMPLETED|Post-switch Phase||0
110097|NCT01183169|263738|P7|Completed Treatment|Post-switch Phase||13
110098|NCT01183169|263739|P6|Completed Treatment|Post-switch Phase||12
110099|NCT01183169|263740|P5|Completed Treatment|Post-switch Phase||0
110100|NCT01183169|263741|P4|Completed Treatment|Post-switch Phase||0
110101|NCT01183169|263742|P3|Completed Treatment|Post-switch Phase||0
110102|NCT01183169|263743|P2|Completed Treatment|Post-switch Phase||0
110103|NCT01183169|263744|P1|Completed Treatment|Post-switch Phase||0
110104|NCT01183169|263738|P7|STARTED|Post-switch Phase|Participants in Treatment C2 who switched to active ALV|30
110105|NCT01183169|263739|P6|STARTED|Post-switch Phase|Participants in Treatment C1 who switched to active ALV|35
110106|NCT01183169|263740|P5|STARTED|Post-switch Phase|Not a post-switch group|0
110107|NCT01183169|263741|P4|STARTED|Post-switch Phase|Not a post-switch group|0
110108|NCT01183169|263742|P3|STARTED|Post-switch Phase|Not a post-switch group|0
110109|NCT01183169|263743|P2|STARTED|Post-switch Phase|Not a post-switch group|0
110110|NCT01183169|263744|P1|STARTED|Post-switch Phase|Not a post-switch group|0
110111|NCT01183169|263738|P7|NOT COMPLETED|Main Phase||0
110112|NCT01183169|263739|P6|NOT COMPLETED|Main Phase||0
110113|NCT01183169|263740|P5|NOT COMPLETED|Main Phase||26
110114|NCT01183169|263741|P4|NOT COMPLETED|Main Phase||37
110115|NCT01183169|263742|P3|NOT COMPLETED|Main Phase||41
110116|NCT01183169|263743|P2|NOT COMPLETED|Main Phase||22
110117|NCT01183169|263744|P1|NOT COMPLETED|Main Phase||27
110118|NCT01183169|263738|P7|COMPLETED|Main Phase||0
110119|NCT01183169|263739|P6|COMPLETED|Main Phase||0
110120|NCT01183169|263740|P5|COMPLETED|Main Phase||83
110121|NCT01183169|263741|P4|COMPLETED|Main Phase||18
110122|NCT01183169|263742|P3|COMPLETED|Main Phase||18
110123|NCT01183169|263743|P2|COMPLETED|Main Phase||93
110124|NCT01183169|263744|P1|COMPLETED|Main Phase||94
110125|NCT01183169|263738|P7|Switched to ALV|Main Phase||0
110126|NCT01183169|263739|P6|Switched to ALV|Main Phase||0
110127|NCT01183169|263740|P5|Switched to ALV|Main Phase||0
110128|NCT01183169|263741|P4|Switched to ALV|Main Phase||30
110129|NCT01183169|263742|P3|Switched to ALV|Main Phase||35
110130|NCT01183169|263743|P2|Switched to ALV|Main Phase||0
110131|NCT01183169|263744|P1|Switched to ALV|Main Phase||0
110132|NCT01183169|263738|P7|Completed Treatment|Main Phase||0
110133|NCT01183169|263739|P6|Completed Treatment|Main Phase||0
110134|NCT01183169|263740|P5|Completed Treatment|Main Phase||77
110135|NCT01183169|263741|P4|Completed Treatment|Main Phase||17
110136|NCT01183169|263742|P3|Completed Treatment|Main Phase||17
110137|NCT01183169|263743|P2|Completed Treatment|Main Phase||78
110138|NCT01183169|263744|P1|Completed Treatment|Main Phase||72
110139|NCT01183169|263738|P7|STARTED|Main Phase||0
110140|NCT01183169|263739|P6|STARTED|Main Phase||0
110141|NCT01183169|263740|P5|STARTED|Main Phase||109
110142|NCT01183169|263741|P4|STARTED|Main Phase||55
110143|NCT01183169|263742|P3|STARTED|Main Phase||59
110144|NCT01183169|263743|P2|STARTED|Main Phase||115
110145|NCT01183169|263744|P1|STARTED|Main Phase||121
110146|NCT01183104|263818|P2|NOT COMPLETED|Overall Study||92
110147|NCT01183104|263819|P1|NOT COMPLETED|Overall Study||77
110148|NCT01183104|263818|P2|COMPLETED|Overall Study||60
110149|NCT01183104|263819|P1|COMPLETED|Overall Study||76
110150|NCT01183104|263818|P2|Enrolled in Extension Study|Overall Study||61
110151|NCT01183104|263819|P1|Enrolled in Extension Study|Overall Study||80
110152|NCT01183104|263818|P2|Completed 52-week Treatment|Overall Study||111
110153|NCT01183104|263819|P1|Completed 52-week Treatment|Overall Study||119
110154|NCT01183104|263818|P2|Continued Treatment for 12 Weeks|Overall Study||129
110155|NCT01183104|263819|P1|Continued Treatment for 12 Weeks|Overall Study||143
110156|NCT01183104|263818|P2|Received Study Drug|Overall Study||143
110157|NCT01183104|263819|P1|Received Study Drug|Overall Study||148
110158|NCT01183104|263818|P2|STARTED|Overall Study||152
110159|NCT01183104|263819|P1|STARTED|Overall Study||153
110160|NCT01183065|263835|P1|NOT COMPLETED|Overall Study||1
110161|NCT01183065|263835|P1|COMPLETED|Overall Study||12
110162|NCT01183065|263835|P1|STARTED|Overall Study||13
110163|NCT01183013|263846|P7|NOT COMPLETED|Overall Study||37
110164|NCT01183013|263847|P6|NOT COMPLETED|Overall Study||45
110165|NCT01183013|263848|P5|NOT COMPLETED|Overall Study||36
110166|NCT01183013|263849|P4|NOT COMPLETED|Overall Study||30
110167|NCT01183013|263850|P3|NOT COMPLETED|Overall Study||41
110168|NCT01183013|263851|P2|NOT COMPLETED|Overall Study||39
110169|NCT01183013|263852|P1|NOT COMPLETED|Overall Study||45
110170|NCT01183013|263846|P7|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|96
110171|NCT01183013|263847|P6|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|88
110172|NCT01183013|263848|P5|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|90
110173|NCT01183013|263849|P4|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|105
110174|NCT01183013|263850|P3|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|97
110175|NCT01183013|263851|P2|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|101
110176|NCT01183013|263852|P1|COMPLETED|Overall Study|Completed is first 30 weeks (Part A) or up to 84 weeks in relation to Protocol Amendment #5|86
110177|NCT01183013|263846|P7|STARTED|Overall Study||133
110178|NCT01183013|263847|P6|STARTED|Overall Study||133
110179|NCT01183013|263848|P5|STARTED|Overall Study||126
110180|NCT01183013|263849|P4|STARTED|Overall Study||135
110181|NCT01183013|263850|P3|STARTED|Overall Study||138
110182|NCT01183013|263851|P2|STARTED|Overall Study||140
110183|NCT01183013|263852|P1|STARTED|Overall Study||131
110184|NCT01182805|263931|P1|NOT COMPLETED|Overall Study||0
110185|NCT01182805|263931|P1|COMPLETED|Overall Study||50
110186|NCT01182805|263931|P1|STARTED|Overall Study||50
110187|NCT01182727|263940|P1|NOT COMPLETED|Overall Study||0
110188|NCT01182727|263940|P1|COMPLETED|Overall Study||10
110189|NCT01182727|263940|P1|STARTED|Overall Study||10
110190|NCT01182675|263946|P2|NOT COMPLETED|Overall Study||0
110191|NCT01182675|263947|P1|NOT COMPLETED|Overall Study||0
110192|NCT01182675|263946|P2|COMPLETED|Overall Study||0
110193|NCT01182675|263947|P1|COMPLETED|Overall Study||7
110194|NCT01182675|263946|P2|STARTED|Overall Study||0
110195|NCT01182675|263947|P1|STARTED|Overall Study||7
110196|NCT01182610|263953|P1|NOT COMPLETED|Overall Study||0
110197|NCT01182610|263953|P1|COMPLETED|Overall Study||1
110198|NCT01182610|263953|P1|STARTED|Overall Study||1
110199|NCT01182493|263963|P2|NOT COMPLETED|Overall Study||7
110200|NCT01182493|263964|P1|NOT COMPLETED|Overall Study||16
110201|NCT01182493|263963|P2|COMPLETED|Overall Study||156
110202|NCT01182493|263964|P1|COMPLETED|Overall Study||152
110203|NCT01182493|263963|P2|STARTED|Overall Study||163
110204|NCT01182493|263964|P1|STARTED|Overall Study||168
110205|NCT01182480|263970|P1|NOT COMPLETED|Overall Study||0
110206|NCT01182480|263970|P1|COMPLETED|Overall Study||47
110207|NCT01182480|263970|P1|STARTED|Overall Study||47
110208|NCT01182428|263976|P2|NOT COMPLETED|Overall Study||1
110209|NCT01182428|263977|P1|NOT COMPLETED|Overall Study||11
110210|NCT01182428|263976|P2|COMPLETED|Overall Study||150
110211|NCT01182428|263977|P1|COMPLETED|Overall Study||293
110212|NCT01182428|263976|P2|STARTED|Overall Study||151
110213|NCT01182428|263977|P1|STARTED|Overall Study||304
110214|NCT01182376|264043|P2|NOT COMPLETED|Overall Study||5
110215|NCT01182376|264044|P1|NOT COMPLETED|Overall Study||11
110216|NCT01182376|264043|P2|COMPLETED|Overall Study||13
110217|NCT01182376|264044|P1|COMPLETED|Overall Study||4
110218|NCT01182376|264043|P2|STARTED|Overall Study||18
110219|NCT01182376|264044|P1|STARTED|Overall Study||15
110220|NCT01182337|264052|P2|NOT COMPLETED|Overall Study||2
110221|NCT01182337|264053|P1|NOT COMPLETED|Overall Study||3
110222|NCT01182337|264052|P2|COMPLETED|Overall Study||7
110223|NCT01182337|264053|P1|COMPLETED|Overall Study||19
110224|NCT01182337|264052|P2|STARTED|Overall Study||9
110225|NCT01182337|264053|P1|STARTED|Overall Study||22
110226|NCT01182298|264071|P1|NOT COMPLETED|Overall Study||6
110227|NCT01182298|264071|P1|COMPLETED|Overall Study||4
110228|NCT01182298|264071|P1|STARTED|Overall Study||10
110229|NCT01182285|264075|P3|NOT COMPLETED|Third Intervention Week 11-52||8
110230|NCT01182285|264076|P2|NOT COMPLETED|Third Intervention Week 11-52||0
110231|NCT01182285|264077|P1|NOT COMPLETED|Third Intervention Week 11-52||0
110232|NCT01182285|264075|P3|COMPLETED|Third Intervention Week 11-52||0
110233|NCT01182285|264076|P2|COMPLETED|Third Intervention Week 11-52||0
110234|NCT01182285|264077|P1|COMPLETED|Third Intervention Week 11-52||0
110235|NCT01182285|264075|P3|STARTED|Third Intervention Week 11-52|2 subj. taken off study after completing ph 1: 1 due to a negative uptake scan & one off due to PD.|8
110236|NCT01182285|264076|P2|STARTED|Third Intervention Week 11-52||0
110237|NCT01182285|264077|P1|STARTED|Third Intervention Week 11-52||0
110238|NCT01182285|264075|P3|NOT COMPLETED|Second Intervention Week 11-17||0
110239|NCT01182285|264076|P2|NOT COMPLETED|Second Intervention Week 11-17||0
110240|NCT01182285|264077|P1|NOT COMPLETED|Second Intervention Week 11-17||0
110241|NCT01182285|264075|P3|COMPLETED|Second Intervention Week 11-17||0
110242|NCT01182285|264076|P2|COMPLETED|Second Intervention Week 11-17||0
110243|NCT01182285|264077|P1|COMPLETED|Second Intervention Week 11-17||0
110244|NCT01182285|264075|P3|STARTED|Second Intervention Week 11-17||0
110245|NCT01182285|264076|P2|STARTED|Second Intervention Week 11-17||0
110246|NCT01182285|264077|P1|STARTED|Second Intervention Week 11-17||0
110247|NCT01182285|264075|P3|NOT COMPLETED|First Intervention Week 1-10||0
110248|NCT01182285|264076|P2|NOT COMPLETED|First Intervention Week 1-10||0
110249|NCT01182285|264077|P1|NOT COMPLETED|First Intervention Week 1-10||3
110250|NCT01182285|264075|P3|COMPLETED|First Intervention Week 1-10||0
110251|NCT01182285|264076|P2|COMPLETED|First Intervention Week 1-10||0
110252|NCT01182285|264077|P1|COMPLETED|First Intervention Week 1-10||10
110253|NCT01182285|264075|P3|STARTED|First Intervention Week 1-10||0
110254|NCT01182285|264076|P2|STARTED|First Intervention Week 1-10||0
110255|NCT01182285|264077|P1|STARTED|First Intervention Week 1-10||13
110256|NCT01182207|264087|P2|NOT COMPLETED|Second Intervention||0
110257|NCT01182207|264088|P1|NOT COMPLETED|Second Intervention||1
110258|NCT01182207|264087|P2|COMPLETED|Second Intervention||14
110259|NCT01182207|264088|P1|COMPLETED|Second Intervention||17
110260|NCT01182207|264087|P2|STARTED|Second Intervention||14
110261|NCT01182207|264088|P1|STARTED|Second Intervention||18
110262|NCT01182207|264087|P2|NOT COMPLETED|Washout of 28 Days||0
110263|NCT01182207|264088|P1|NOT COMPLETED|Washout of 28 Days||0
110264|NCT01182207|264087|P2|COMPLETED|Washout of 28 Days||14
110265|NCT01182207|264088|P1|COMPLETED|Washout of 28 Days||18
110266|NCT01182207|264087|P2|STARTED|Washout of 28 Days||14
110267|NCT01182207|264088|P1|STARTED|Washout of 28 Days||18
110268|NCT01182207|264087|P2|NOT COMPLETED|First Intervention||1
110269|NCT01182207|264088|P1|NOT COMPLETED|First Intervention||0
110270|NCT01182207|264087|P2|COMPLETED|First Intervention||14
110271|NCT01182207|264088|P1|COMPLETED|First Intervention||18
110272|NCT01182207|264087|P2|STARTED|First Intervention||15
110273|NCT01182207|264088|P1|STARTED|First Intervention||18
110274|NCT01182194|264106|P2|NOT COMPLETED|Second Intervention||0
110275|NCT01182194|264107|P1|NOT COMPLETED|Second Intervention||0
110276|NCT01182194|264106|P2|COMPLETED|Second Intervention||16
110277|NCT01182194|264107|P1|COMPLETED|Second Intervention||15
110278|NCT01182194|264106|P2|STARTED|Second Intervention||16
110279|NCT01182194|264107|P1|STARTED|Second Intervention||15
110280|NCT01182194|264106|P2|NOT COMPLETED|Washout of 28 Days||0
110281|NCT01182194|264107|P1|NOT COMPLETED|Washout of 28 Days||1
110282|NCT01182194|264106|P2|COMPLETED|Washout of 28 Days||16
110283|NCT01182194|264107|P1|COMPLETED|Washout of 28 Days||15
110284|NCT01182194|264106|P2|STARTED|Washout of 28 Days||16
110285|NCT01182194|264107|P1|STARTED|Washout of 28 Days||16
110286|NCT01182194|264106|P2|NOT COMPLETED|First Intervention||0
110287|NCT01182194|264107|P1|NOT COMPLETED|First Intervention||0
110288|NCT01182194|264106|P2|COMPLETED|First Intervention||16
110289|NCT01182194|264107|P1|COMPLETED|First Intervention||16
110290|NCT01182194|264106|P2|STARTED|First Intervention||16
110291|NCT01182194|264107|P1|STARTED|First Intervention||16
110292|NCT01182181|264125|P2|NOT COMPLETED|Second Intervention||0
110293|NCT01182181|264126|P1|NOT COMPLETED|Second Intervention||0
110294|NCT01182181|264125|P2|COMPLETED|Second Intervention||10
110295|NCT01182181|264126|P1|COMPLETED|Second Intervention||10
110296|NCT01182181|264125|P2|STARTED|Second Intervention||10
110297|NCT01182181|264126|P1|STARTED|Second Intervention||10
110298|NCT01182181|264125|P2|NOT COMPLETED|Washout of 21 Days||1
110299|NCT01182181|264126|P1|NOT COMPLETED|Washout of 21 Days||0
110300|NCT01182181|264125|P2|COMPLETED|Washout of 21 Days||10
110301|NCT01182181|264126|P1|COMPLETED|Washout of 21 Days||10
110302|NCT01182181|264125|P2|STARTED|Washout of 21 Days||11
110303|NCT01182181|264126|P1|STARTED|Washout of 21 Days||10
110304|NCT01182181|264125|P2|NOT COMPLETED|First Intervention||0
110305|NCT01182181|264126|P1|NOT COMPLETED|First Intervention||1
110306|NCT01182181|264125|P2|COMPLETED|First Intervention||11
110307|NCT01182181|264126|P1|COMPLETED|First Intervention||10
110308|NCT01182181|264125|P2|STARTED|First Intervention||11
110309|NCT01182181|264126|P1|STARTED|First Intervention||11
110310|NCT01182103|264136|P2|NOT COMPLETED|Overall Study||0
110311|NCT01182103|264137|P1|NOT COMPLETED|Overall Study||0
110312|NCT01182103|264136|P2|COMPLETED|Overall Study||62
110313|NCT01182103|264137|P1|COMPLETED|Overall Study||48
110314|NCT01182103|264136|P2|STARTED|Overall Study||62
110315|NCT01182103|264137|P1|STARTED|Overall Study||48
110316|NCT01181986|264151|P3|NOT COMPLETED|Phase 2||0
110317|NCT01181986|264152|P2|NOT COMPLETED|Phase 2||4
110318|NCT01181986|264153|P1|NOT COMPLETED|Phase 2||0
110319|NCT01181986|264151|P3|COMPLETED|Phase 2||0
110320|NCT01181986|264152|P2|COMPLETED|Phase 2||18
110321|NCT01181986|264153|P1|COMPLETED|Phase 2||18
110322|NCT01181986|264151|P3|STARTED|Phase 2|N/A for Sub-study 2|0
110323|NCT01181986|264152|P2|STARTED|Phase 2||22
110324|NCT01181986|264153|P1|STARTED|Phase 2||18
110325|NCT01181986|264151|P3|NOT COMPLETED|Phase 1||2
110326|NCT01181986|264152|P2|NOT COMPLETED|Phase 1||1
110327|NCT01181986|264153|P1|NOT COMPLETED|Phase 1||1
110328|NCT01181986|264151|P3|COMPLETED|Phase 1||32
110329|NCT01181986|264152|P2|COMPLETED|Phase 1||22
110330|NCT01181986|264153|P1|COMPLETED|Phase 1||18
110331|NCT01181986|264151|P3|Exendin-9+Exenatide|Phase 1||33
110332|NCT01181986|264152|P2|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
110333|NCT01181986|264153|P1|Exendin-9+Exenatide|Phase 1|N/A for this arm|0
110334|NCT01181986|264151|P3|Saline+Placebo|Phase 1||33
110335|NCT01181986|264152|P2|Saline+Placebo|Phase 1|N/A for this arm|0
110336|NCT01181986|264153|P1|Saline+Placebo|Phase 1|N/A for this arm|0
110337|NCT01181986|264151|P3|Saline+Exenatide|Phase 1||32
110338|NCT01181986|264152|P2|Saline+Exenatide|Phase 1|N/A for this arm|0
110339|NCT01181986|264153|P1|Saline+Exenatide|Phase 1|N/A for this arm|0
110340|NCT01181986|264151|P3|STARTED|Phase 1||34
110341|NCT01181986|264152|P2|STARTED|Phase 1||23
110342|NCT01181986|264153|P1|STARTED|Phase 1||19
110343|NCT01181947|264169|P1|NOT COMPLETED|Overall Study||0
110344|NCT01181947|264169|P1|COMPLETED|Overall Study||100
110345|NCT01181947|264169|P1|STARTED|Overall Study||100
110346|NCT01181921|264174|P1|NOT COMPLETED|Overall Study||1
110347|NCT01181921|264174|P1|COMPLETED|Overall Study||0
110348|NCT01181921|264174|P1|STARTED|Overall Study||1
110349|NCT01181895|264181|P3|NOT COMPLETED|Overall Study||18
110350|NCT01181895|264182|P2|NOT COMPLETED|Overall Study||14
110351|NCT01181895|264183|P1|NOT COMPLETED|Overall Study||17
110352|NCT01181895|264181|P3|COMPLETED|Overall Study||98
110353|NCT01181895|264182|P2|COMPLETED|Overall Study||101
110354|NCT01181895|264183|P1|COMPLETED|Overall Study||99
110355|NCT01181895|264181|P3|STARTED|Overall Study||116
110356|NCT01181895|264182|P2|STARTED|Overall Study||115
110357|NCT01181895|264183|P1|STARTED|Overall Study||116
110358|NCT01181804|264216|P4|NOT COMPLETED|Period 4, Fasted (Part 2)||0
110359|NCT01181804|264217|P3|NOT COMPLETED|Period 4, Fasted (Part 2)||1
110360|NCT01181804|264218|P2|NOT COMPLETED|Period 4, Fasted (Part 2)||0
110361|NCT01181804|264219|P1|NOT COMPLETED|Period 4, Fasted (Part 2)||0
110362|NCT01181804|264216|P4|COMPLETED|Period 4, Fasted (Part 2)||58
110363|NCT01181804|264217|P3|COMPLETED|Period 4, Fasted (Part 2)||58
110364|NCT01181804|264218|P2|COMPLETED|Period 4, Fasted (Part 2)||0
110365|NCT01181804|264219|P1|COMPLETED|Period 4, Fasted (Part 2)||0
110366|NCT01181804|264216|P4|STARTED|Period 4, Fasted (Part 2)||58
110367|NCT01181804|264217|P3|STARTED|Period 4, Fasted (Part 2)||59
110368|NCT01181804|264218|P2|STARTED|Period 4, Fasted (Part 2)||0
110369|NCT01181804|264219|P1|STARTED|Period 4, Fasted (Part 2)||0
110370|NCT01181804|264216|P4|NOT COMPLETED|Period 3, Fasted (Part 2)||0
110371|NCT01181804|264217|P3|NOT COMPLETED|Period 3, Fasted (Part 2)||0
110372|NCT01181804|264218|P2|NOT COMPLETED|Period 3, Fasted (Part 2)||0
110373|NCT01181804|264219|P1|NOT COMPLETED|Period 3, Fasted (Part 2)||0
110374|NCT01181804|264216|P4|COMPLETED|Period 3, Fasted (Part 2)||58
110375|NCT01181804|264217|P3|COMPLETED|Period 3, Fasted (Part 2)||59
110376|NCT01181804|264218|P2|COMPLETED|Period 3, Fasted (Part 2)||0
110377|NCT01181804|264219|P1|COMPLETED|Period 3, Fasted (Part 2)||0
110378|NCT01181804|264216|P4|STARTED|Period 3, Fasted (Part 2)||58
110379|NCT01181804|264217|P3|STARTED|Period 3, Fasted (Part 2)||59
110380|NCT01181804|264218|P2|STARTED|Period 3, Fasted (Part 2)||0
110381|NCT01181804|264219|P1|STARTED|Period 3, Fasted (Part 2)||0
110382|NCT01181804|264216|P4|NOT COMPLETED|Period 2, Fed (Part 1)||0
110383|NCT01181804|264217|P3|NOT COMPLETED|Period 2, Fed (Part 1)||0
110384|NCT01181804|264218|P2|NOT COMPLETED|Period 2, Fed (Part 1)||0
110385|NCT01181804|264219|P1|NOT COMPLETED|Period 2, Fed (Part 1)||0
110386|NCT01181804|264216|P4|COMPLETED|Period 2, Fed (Part 1)||0
110387|NCT01181804|264217|P3|COMPLETED|Period 2, Fed (Part 1)||0
110388|NCT01181804|264218|P2|COMPLETED|Period 2, Fed (Part 1)||30
110389|NCT01181804|264219|P1|COMPLETED|Period 2, Fed (Part 1)||30
110390|NCT01181804|264216|P4|STARTED|Period 2, Fed (Part 1)||0
110391|NCT01181804|264217|P3|STARTED|Period 2, Fed (Part 1)||0
110392|NCT01181804|264218|P2|STARTED|Period 2, Fed (Part 1)||30
110393|NCT01181804|264219|P1|STARTED|Period 2, Fed (Part 1)||30
110394|NCT01181804|264216|P4|NOT COMPLETED|Period 1, Fed (Part 1)||0
110395|NCT01181804|264217|P3|NOT COMPLETED|Period 1, Fed (Part 1)||0
110396|NCT01181804|264218|P2|NOT COMPLETED|Period 1, Fed (Part 1)||0
110397|NCT01181804|264219|P1|NOT COMPLETED|Period 1, Fed (Part 1)||0
110398|NCT01181804|264216|P4|COMPLETED|Period 1, Fed (Part 1)||0
110399|NCT01181804|264217|P3|COMPLETED|Period 1, Fed (Part 1)||0
110400|NCT01181804|264218|P2|COMPLETED|Period 1, Fed (Part 1)||30
110401|NCT01181804|264219|P1|COMPLETED|Period 1, Fed (Part 1)||30
110402|NCT01181804|264216|P4|STARTED|Period 1, Fed (Part 1)||0
110403|NCT01181804|264217|P3|STARTED|Period 1, Fed (Part 1)||0
110404|NCT01181804|264218|P2|STARTED|Period 1, Fed (Part 1)||30
110405|NCT01181804|264219|P1|STARTED|Period 1, Fed (Part 1)||30
110406|NCT01181778|264241|P1|NOT COMPLETED|Overall Study||48
110407|NCT01181778|264241|P1|COMPLETED|Overall Study||1871
110408|NCT01181778|264241|P1|STARTED|Overall Study||1919
110409|NCT01181726|264249|P2|NOT COMPLETED|Second Intervention||0
110410|NCT01181726|264250|P1|NOT COMPLETED|Second Intervention||0
110411|NCT01181726|264249|P2|COMPLETED|Second Intervention||20
110412|NCT01181726|264250|P1|COMPLETED|Second Intervention||19
110413|NCT01181726|264249|P2|STARTED|Second Intervention||20
110414|NCT01181726|264250|P1|STARTED|Second Intervention||19
110415|NCT01181726|264249|P2|NOT COMPLETED|Washout of 28 Days||0
110416|NCT01181726|264250|P1|NOT COMPLETED|Washout of 28 Days||0
110417|NCT01181726|264249|P2|COMPLETED|Washout of 28 Days||20
110418|NCT01181726|264250|P1|COMPLETED|Washout of 28 Days||19
110419|NCT01181726|264249|P2|STARTED|Washout of 28 Days||20
110420|NCT01181726|264250|P1|STARTED|Washout of 28 Days||19
110421|NCT01181726|264249|P2|NOT COMPLETED|First Intervention||0
110422|NCT01181726|264250|P1|NOT COMPLETED|First Intervention||1
110423|NCT01181726|264249|P2|COMPLETED|First Intervention||20
110424|NCT01181726|264250|P1|COMPLETED|First Intervention||19
110425|NCT01181726|264249|P2|STARTED|First Intervention||20
110426|NCT01181726|264250|P1|STARTED|First Intervention||20
110427|NCT01181609|264296|P1|NOT COMPLETED|Overall Study||53
110428|NCT01181609|264296|P1|COMPLETED|Overall Study||1
110429|NCT01181609|264296|P1|STARTED|Overall Study||54
110430|NCT01181531|264309|P2|NOT COMPLETED|Overall Study||53
110431|NCT01181531|264310|P1|NOT COMPLETED|Overall Study||61
110432|NCT01181531|264309|P2|COMPLETED|Overall Study||102
110433|NCT01181531|264310|P1|COMPLETED|Overall Study||96
110434|NCT01181531|264309|P2|Received Investigational Product|Overall Study||153
110435|NCT01181531|264310|P1|Received Investigational Product|Overall Study||155
110436|NCT01181531|264309|P2|STARTED|Overall Study|Subjects are randomized after washout.|155
110437|NCT01181531|264310|P1|STARTED|Overall Study|Subjects are randomized after washout.|157
110438|NCT01181492|264323|P3|NOT COMPLETED|Overall Study||0
110439|NCT01181492|264324|P2|NOT COMPLETED|Overall Study||0
110440|NCT01181492|264325|P1|NOT COMPLETED|Overall Study||0
110441|NCT01181492|264323|P3|COMPLETED|Overall Study||7
110442|NCT01181492|264324|P2|COMPLETED|Overall Study||66
110443|NCT01181492|264325|P1|COMPLETED|Overall Study||103
110444|NCT01181492|264323|P3|STARTED|Overall Study||7
110445|NCT01181492|264324|P2|STARTED|Overall Study||66
110446|NCT01181492|264325|P1|STARTED|Overall Study||103
110447|NCT01181349|264339|P1|NOT COMPLETED|Overall Study||0
110448|NCT01181349|264339|P1|COMPLETED|Overall Study||350
110449|NCT01181349|264339|P1|STARTED|Overall Study||350
110450|NCT01181323|264355|P4|NOT COMPLETED|Overall Study||3
110451|NCT01181323|264356|P3|NOT COMPLETED|Overall Study||1
110452|NCT01181323|264357|P2|NOT COMPLETED|Overall Study||3
110453|NCT01181323|264358|P1|NOT COMPLETED|Overall Study||1
110454|NCT01181323|264355|P4|COMPLETED|Overall Study||122
110455|NCT01181323|264356|P3|COMPLETED|Overall Study||123
110456|NCT01181323|264357|P2|COMPLETED|Overall Study||121
110457|NCT01181323|264358|P1|COMPLETED|Overall Study||123
110458|NCT01181323|264355|P4|STARTED|Overall Study||125
110459|NCT01181323|264356|P3|STARTED|Overall Study||124
110460|NCT01181323|264357|P2|STARTED|Overall Study||124
110461|NCT01181323|264358|P1|STARTED|Overall Study||124
110462|NCT01181271|264433|P1|NOT COMPLETED|Allogeneic Transplant||0
110463|NCT01181271|264433|P1|COMPLETED|Allogeneic Transplant||29
110464|NCT01181271|264433|P1|STARTED|Allogeneic Transplant||29
110465|NCT01181271|264433|P1|NOT COMPLETED|Evaluation for Allogeneic Transplant||13
110466|NCT01181271|264433|P1|COMPLETED|Evaluation for Allogeneic Transplant||29
110467|NCT01181271|264433|P1|STARTED|Evaluation for Allogeneic Transplant||42
110468|NCT01181271|264433|P1|NOT COMPLETED|Autologous Transplant||0
110469|NCT01181271|264433|P1|COMPLETED|Autologous Transplant||42
110470|NCT01181271|264433|P1|STARTED|Autologous Transplant||42
110471|NCT01181258|264448|P1|NOT COMPLETED|Overall Study||0
110472|NCT01181258|264448|P1|COMPLETED|Overall Study||16
110473|NCT01181258|264448|P1|STARTED|Overall Study||16
110474|NCT01181167|264457|P2|NOT COMPLETED|Overall Study||32
110475|NCT01181167|264458|P1|NOT COMPLETED|Overall Study||23
110476|NCT01181167|264457|P2|COMPLETED|Overall Study||271
110477|NCT01181167|264458|P1|COMPLETED|Overall Study||284
110478|NCT01181167|264457|P2|Efficacy Analysis Population|Overall Study||248
110479|NCT01181167|264458|P1|Efficacy Analysis Population|Overall Study||255
110480|NCT01181167|264457|P2|STARTED|Overall Study||303
110481|NCT01181167|264458|P1|STARTED|Overall Study||307
110482|NCT01181141|264468|P2|NOT COMPLETED|Overall Study||4
110483|NCT01181141|264469|P1|NOT COMPLETED|Overall Study||12
110484|NCT01181141|264468|P2|COMPLETED|Overall Study||26
110485|NCT01181141|264469|P1|COMPLETED|Overall Study||50
110486|NCT01181141|264468|P2|Safety Analysis Population|Overall Study||29
110487|NCT01181141|264469|P1|Safety Analysis Population|Overall Study||59
110488|NCT01181141|264468|P2|STARTED|Overall Study||30
110489|NCT01181141|264469|P1|STARTED|Overall Study||62
110490|NCT01181128|264478|P3|NOT COMPLETED|Overall Study||1
110491|NCT01181128|264479|P2|NOT COMPLETED|Overall Study||5
110492|NCT01181128|264480|P1|NOT COMPLETED|Overall Study||6
110493|NCT01181128|264478|P3|COMPLETED|Overall Study||22
110494|NCT01181128|264479|P2|COMPLETED|Overall Study||19
110495|NCT01181128|264480|P1|COMPLETED|Overall Study||112
110496|NCT01181128|264478|P3|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|0
110497|NCT01181128|264479|P2|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|1
110498|NCT01181128|264480|P1|Perioperative Management Subgroup|Overall Study|Participants who underwent major surgery.|8
110499|NCT01181128|264478|P3|Pharmacokinetic (PK) Subgroup|Overall Study||0
110500|NCT01181128|264479|P2|Pharmacokinetic (PK) Subgroup|Overall Study||0
110501|NCT01181128|264480|P1|Pharmacokinetic (PK) Subgroup|Overall Study||30
110502|NCT01181128|264478|P3|STARTED|Overall Study||23
110503|NCT01181128|264479|P2|STARTED|Overall Study||24
110504|NCT01181128|264480|P1|STARTED|Overall Study||118
110505|NCT01181102|264568|P2|NOT COMPLETED|Overall Study||46
110506|NCT01181102|264569|P1|NOT COMPLETED|Overall Study||51
110507|NCT01181102|264568|P2|COMPLETED|Overall Study||310
110508|NCT01181102|264569|P1|COMPLETED|Overall Study||309
110509|NCT01181102|264568|P2|Efficacy Analysis Population|Overall Study||295
110510|NCT01181102|264569|P1|Efficacy Analysis Population|Overall Study||299
110511|NCT01181102|264568|P2|Safety Analysis Set|Overall Study||349
110512|NCT01181102|264569|P1|Safety Analysis Set|Overall Study||354
110513|NCT01181102|264568|P2|STARTED|Overall Study||356
110514|NCT01181102|264569|P1|STARTED|Overall Study||360
110515|NCT01181050|264579|P2|NOT COMPLETED|Overall Study||0
110516|NCT01181050|264580|P1|NOT COMPLETED|Overall Study||0
110517|NCT01181050|264579|P2|COMPLETED|Overall Study||22
110518|NCT01181050|264580|P1|COMPLETED|Overall Study||41
110519|NCT01181050|264579|P2|STARTED|Overall Study||22
110520|NCT01181050|264580|P1|STARTED|Overall Study||41
110521|NCT01181011|264590|P1|NOT COMPLETED|Overall Study||3
110522|NCT01181011|264590|P1|COMPLETED|Overall Study||25
110523|NCT01181011|264590|P1|Received Amlodipine 5mg|Overall Study||26
110524|NCT01181011|264590|P1|Received Telmisartan 80mg,Amlodipine 5mg|Overall Study||27
110525|NCT01181011|264590|P1|Received Telmisartan 80mg|Overall Study||27
110526|NCT01181011|264590|P1|STARTED|Overall Study||28
110527|NCT01180998|264640|P3|NOT COMPLETED|Overall Study||10
110528|NCT01180998|264641|P2|NOT COMPLETED|Overall Study||4
110529|NCT01180998|264642|P1|NOT COMPLETED|Overall Study||4
110530|NCT01180998|264640|P3|COMPLETED|Overall Study||51
110531|NCT01180998|264641|P2|COMPLETED|Overall Study||68
110532|NCT01180998|264642|P1|COMPLETED|Overall Study||63
110533|NCT01180998|264640|P3|STARTED|Overall Study||61
110534|NCT01180998|264641|P2|STARTED|Overall Study||72
110535|NCT01180998|264642|P1|STARTED|Overall Study||67
110536|NCT01180985|264656|P2|NOT COMPLETED|Period 2 (7 +/- 1 Days)||0
110537|NCT01180985|264657|P1|NOT COMPLETED|Period 2 (7 +/- 1 Days)||1
110538|NCT01180985|264656|P2|COMPLETED|Period 2 (7 +/- 1 Days)||26
110539|NCT01180985|264657|P1|COMPLETED|Period 2 (7 +/- 1 Days)||26
110540|NCT01180985|264656|P2|STARTED|Period 2 (7 +/- 1 Days)||26
110541|NCT01180985|264657|P1|STARTED|Period 2 (7 +/- 1 Days)||27
110542|NCT01180985|264656|P2|NOT COMPLETED|Period 1 (7 +/- Days)||0
110543|NCT01180985|264657|P1|NOT COMPLETED|Period 1 (7 +/- Days)||0
110544|NCT01180985|264656|P2|COMPLETED|Period 1 (7 +/- Days)||26
110545|NCT01180985|264657|P1|COMPLETED|Period 1 (7 +/- Days)||27
110546|NCT01180985|264656|P2|STARTED|Period 1 (7 +/- Days)||26
110547|NCT01180985|264657|P1|STARTED|Period 1 (7 +/- Days)||27
110548|NCT01180894|264676|P2|NOT COMPLETED|Overall Study||0
110549|NCT01180894|264677|P1|NOT COMPLETED|Overall Study||0
110550|NCT01180894|264676|P2|COMPLETED|Overall Study||75
110551|NCT01180894|264677|P1|COMPLETED|Overall Study||75
110552|NCT01180894|264676|P2|STARTED|Overall Study||75
110553|NCT01180894|264677|P1|STARTED|Overall Study||75
110554|NCT01180790|264696|P7|NOT COMPLETED|Overall Study||1
110555|NCT01180790|264697|P6|NOT COMPLETED|Overall Study||7
110556|NCT01180790|264698|P5|NOT COMPLETED|Overall Study||5
110557|NCT01180790|264699|P4|NOT COMPLETED|Overall Study||9
110558|NCT01180790|264700|P3|NOT COMPLETED|Overall Study||13
110559|NCT01180790|264701|P2|NOT COMPLETED|Overall Study||5
110560|NCT01180790|264702|P1|NOT COMPLETED|Overall Study||9
110561|NCT01180790|264696|P7|COMPLETED|Overall Study||18
110562|NCT01180790|264697|P6|COMPLETED|Overall Study||13
110563|NCT01180790|264698|P5|COMPLETED|Overall Study||14
110564|NCT01180790|264699|P4|COMPLETED|Overall Study||6
110565|NCT01180790|264700|P3|COMPLETED|Overall Study||4
110566|NCT01180790|264701|P2|COMPLETED|Overall Study||11
110567|NCT01180790|264702|P1|COMPLETED|Overall Study||7
110568|NCT01180790|264696|P7|STARTED|Overall Study||19
110569|NCT01180790|264697|P6|STARTED|Overall Study||20
110570|NCT01180790|264698|P5|STARTED|Overall Study||19
110571|NCT01180790|264699|P4|STARTED|Overall Study||15
110572|NCT01180790|264700|P3|STARTED|Overall Study||17
110573|NCT01180790|264701|P2|STARTED|Overall Study||16
110574|NCT01180790|264702|P1|STARTED|Overall Study||16
110575|NCT01180777|264767|P1|NOT COMPLETED|Overall Study||12
110576|NCT01180777|264767|P1|COMPLETED|Overall Study||80
110577|NCT01180777|264767|P1|STARTED|Overall Study||92
110578|NCT01180660|264781|P2|NOT COMPLETED|Overall Study||0
110579|NCT01180660|264782|P1|NOT COMPLETED|Overall Study||1
110580|NCT01180660|264781|P2|COMPLETED|Overall Study||26
110581|NCT01180660|264782|P1|COMPLETED|Overall Study||24
110582|NCT01180660|264781|P2|STARTED|Overall Study||26
110583|NCT01180660|264782|P1|STARTED|Overall Study||25
110584|NCT01180647|264792|P2|NOT COMPLETED|Overall Study||6
110585|NCT01180647|264793|P1|NOT COMPLETED|Overall Study||5
110586|NCT01180647|264792|P2|COMPLETED|Overall Study||11
110587|NCT01180647|264793|P1|COMPLETED|Overall Study||12
110588|NCT01180647|264792|P2|STARTED|Overall Study||17
110589|NCT01180647|264793|P1|STARTED|Overall Study||17
110590|NCT01180400|264811|P2|NOT COMPLETED|Overall Study||27
110591|NCT01180400|264812|P1|NOT COMPLETED|Overall Study||25
110592|NCT01180400|264811|P2|COMPLETED|Overall Study||121
110593|NCT01180400|264812|P1|COMPLETED|Overall Study||122
110594|NCT01180400|264811|P2|Received Treatment|Overall Study||146
110595|NCT01180400|264812|P1|Received Treatment|Overall Study||147
110596|NCT01180400|264811|P2|STARTED|Overall Study||148
110597|NCT01180400|264812|P1|STARTED|Overall Study||147
110598|NCT01180296|264860|P2|NOT COMPLETED|Overall Study||2
110599|NCT01180296|264861|P1|NOT COMPLETED|Overall Study||1
110600|NCT01180296|264860|P2|COMPLETED|Overall Study||14
110601|NCT01180296|264861|P1|COMPLETED|Overall Study||19
110602|NCT01180296|264860|P2|STARTED|Overall Study||16
110603|NCT01180296|264861|P1|STARTED|Overall Study||20
110604|NCT01180244|264869|P2|NOT COMPLETED|Overall Study||8
110605|NCT01180244|264870|P1|NOT COMPLETED|Overall Study||6
110606|NCT01180244|264869|P2|COMPLETED|Overall Study|Number of placebo group patients who completed all study visits and are evaluable|38
110607|NCT01180244|264870|P1|COMPLETED|Overall Study|Number of active treatment patients who completed all study visits and are evaluable|39
110608|NCT01180244|264869|P2|Received Treatment|Overall Study|Number of patients in the placebo group that received at least one sham treatment|45
110609|NCT01180244|264870|P1|Received Treatment|Overall Study|Number of patients in the active treatment group that received at least one study treatment|40
110610|NCT01180244|264869|P2|STARTED|Overall Study|Number of enrolled patients initially randomized to placebo group|46
110611|NCT01180244|264870|P1|STARTED|Overall Study|Number of enrolled patients initially randomized to active treatment group|45
110612|NCT01180127|264888|P4|NOT COMPLETED|Overall Study||1
110613|NCT01180127|264889|P3|NOT COMPLETED|Overall Study||1
110614|NCT01180127|264890|P2|NOT COMPLETED|Overall Study||0
110615|NCT01180127|264891|P1|NOT COMPLETED|Overall Study||2
110616|NCT01180127|264888|P4|COMPLETED|Overall Study||9
110617|NCT01180127|264889|P3|COMPLETED|Overall Study||9
110618|NCT01180127|264890|P2|COMPLETED|Overall Study||11
110619|NCT01180127|264891|P1|COMPLETED|Overall Study||8
110620|NCT01180127|264888|P4|STARTED|Overall Study||10
110621|NCT01180127|264889|P3|STARTED|Overall Study||10
110622|NCT01180127|264890|P2|STARTED|Overall Study||11
110623|NCT01180127|264891|P1|STARTED|Overall Study||10
110624|NCT01180049|264915|P2|NOT COMPLETED|Overall Study||43
110625|NCT01180049|264916|P1|NOT COMPLETED|Overall Study||47
110626|NCT01180049|264915|P2|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
110627|NCT01180049|264916|P1|COMPLETED|Overall Study|This is an ongoing study. Date for data cut-off is 12 November 2015.|0
110628|NCT01180049|264915|P2|Treated|Overall Study||42
110629|NCT01180049|264916|P1|Treated|Overall Study||47
110630|NCT01180049|264915|P2|STARTED|Overall Study||43
110631|NCT01180049|264916|P1|STARTED|Overall Study||47
110632|NCT01179984|264936|P1|NOT COMPLETED|Overall Study||18
110633|NCT01179984|264936|P1|COMPLETED|Overall Study||58
110634|NCT01179984|264936|P1|STARTED|Overall Study||76
110635|NCT01179919|264942|P1|NOT COMPLETED|Overall Study||2
110636|NCT01179919|264942|P1|COMPLETED|Overall Study||19
110637|NCT01179919|264942|P1|STARTED|Overall Study||21
110638|NCT01179737|264951|P4|NOT COMPLETED|Extension||0
110639|NCT01179737|264952|P3|NOT COMPLETED|Extension||0
110640|NCT01179737|264953|P2|NOT COMPLETED|Extension||0
110641|NCT01179737|264954|P1|NOT COMPLETED|Extension||3
110642|NCT01179737|264951|P4|COMPLETED|Extension||0
110643|NCT01179737|264952|P3|COMPLETED|Extension||0
110644|NCT01179737|264953|P2|COMPLETED|Extension||0
110645|NCT01179737|264954|P1|COMPLETED|Extension||0
110646|NCT01179737|264951|P4|STARTED|Extension||0
110647|NCT01179737|264952|P3|STARTED|Extension||0
110648|NCT01179737|264953|P2|STARTED|Extension|One patient did not enrol in the extension|0
110649|NCT01179737|264954|P1|STARTED|Extension|Two patients did not enrol in the extension|3
110650|NCT01179737|264951|P4|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
110651|NCT01179737|264952|P3|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
110652|NCT01179737|264953|P2|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||0
110653|NCT01179737|264954|P1|NOT COMPLETED|Cohort 1 & Cohort 2 Expansion||1
110654|NCT01179737|264951|P4|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
110655|NCT01179737|264952|P3|COMPLETED|Cohort 1 & Cohort 2 Expansion||0
110656|NCT01179737|264953|P2|COMPLETED|Cohort 1 & Cohort 2 Expansion||1
110657|NCT01179737|264954|P1|COMPLETED|Cohort 1 & Cohort 2 Expansion||4
110658|NCT01179737|264951|P4|STARTED|Cohort 1 & Cohort 2 Expansion||0
110659|NCT01179737|264952|P3|STARTED|Cohort 1 & Cohort 2 Expansion||0
110660|NCT01179737|264953|P2|STARTED|Cohort 1 & Cohort 2 Expansion||1
110661|NCT01179737|264954|P1|STARTED|Cohort 1 & Cohort 2 Expansion|2 participants did not enroll in extension|5
110662|NCT01179737|264951|P4|NOT COMPLETED|Cohort 1 & Cohort 2||4
110663|NCT01179737|264952|P3|NOT COMPLETED|Cohort 1 & Cohort 2||4
110664|NCT01179737|264953|P2|NOT COMPLETED|Cohort 1 & Cohort 2||2
110665|NCT01179737|264954|P1|NOT COMPLETED|Cohort 1 & Cohort 2||5
110666|NCT01179737|264951|P4|COMPLETED|Cohort 1 & Cohort 2||0
110667|NCT01179737|264952|P3|COMPLETED|Cohort 1 & Cohort 2||0
110668|NCT01179737|264953|P2|COMPLETED|Cohort 1 & Cohort 2||1
110669|NCT01179737|264954|P1|COMPLETED|Cohort 1 & Cohort 2||7
110670|NCT01179737|264951|P4|STARTED|Cohort 1 & Cohort 2||4
110671|NCT01179737|264952|P3|STARTED|Cohort 1 & Cohort 2||4
110672|NCT01179737|264953|P2|STARTED|Cohort 1 & Cohort 2|One patient was missing the end of study evaluation|3
110673|NCT01179737|264954|P1|STARTED|Cohort 1 & Cohort 2||12
110674|NCT00000371|264965|P2|NOT COMPLETED|Overall Study||16
110675|NCT00000371|264966|P1|NOT COMPLETED|Overall Study||13
110676|NCT00000371|264965|P2|COMPLETED|Overall Study||12
110677|NCT00000371|264966|P1|COMPLETED|Overall Study||14
110678|NCT00000371|264965|P2|STARTED|Overall Study||28
110679|NCT00000371|264966|P1|STARTED|Overall Study||27
110680|NCT00000378|264974|P2|NOT COMPLETED|Overall Study||14
110681|NCT00000378|264975|P1|NOT COMPLETED|Overall Study||16
110682|NCT00000378|264974|P2|COMPLETED|Overall Study||38
110683|NCT00000378|264975|P1|COMPLETED|Overall Study||42
110684|NCT00000378|264974|P2|STARTED|Overall Study||52
110685|NCT00000378|264975|P1|STARTED|Overall Study||58
110686|NCT00000392|264983|P2|NOT COMPLETED|Overall Study||32
110687|NCT00000392|264984|P1|NOT COMPLETED|Overall Study||40
110688|NCT00000392|264983|P2|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|77
110689|NCT00000392|264984|P1|COMPLETED|Overall Study|provided complete NP outcome data constituted the sample for the primary efficacy analyses|66
110690|NCT00000392|264983|P2|STARTED|Overall Study||109
110691|NCT00000392|264984|P1|STARTED|Overall Study||106
110692|NCT00000575|264995|P3|NOT COMPLETED|Overall Study||0
110693|NCT00000575|264996|P2|NOT COMPLETED|Overall Study||0
110694|NCT00000575|264997|P1|NOT COMPLETED|Overall Study||0
110695|NCT00000575|264995|P3|COMPLETED|Overall Study||418
110696|NCT00000575|264996|P2|COMPLETED|Overall Study||312
110697|NCT00000575|264997|P1|COMPLETED|Overall Study||311
110698|NCT00000575|264995|P3|STARTED|Overall Study||418
110699|NCT00000575|264996|P2|STARTED|Overall Study||312
110700|NCT00000575|264997|P1|STARTED|Overall Study||311
110701|NCT00000620|265025|P8|NOT COMPLETED|Overall Study||146
110702|NCT00000620|265026|P7|NOT COMPLETED|Overall Study||149
110703|NCT00000620|265027|P6|NOT COMPLETED|Overall Study||152
110704|NCT00000620|265028|P5|NOT COMPLETED|Overall Study||135
110705|NCT00000620|265029|P4|NOT COMPLETED|Overall Study||178
110706|NCT00000620|265030|P3|NOT COMPLETED|Overall Study||170
110707|NCT00000620|265031|P2|NOT COMPLETED|Overall Study||136
110708|NCT00000620|265032|P1|NOT COMPLETED|Overall Study||162
110709|NCT00000620|265025|P8|COMPLETED|Overall Study||1224
110710|NCT00000620|265026|P7|COMPLETED|Overall Study||1242
110711|NCT00000620|265027|P6|COMPLETED|Overall Study||1026
110712|NCT00000620|265028|P5|COMPLETED|Overall Study||1049
110713|NCT00000620|265029|P4|COMPLETED|Overall Study||1205
110714|NCT00000620|265030|P3|COMPLETED|Overall Study||1204
110715|NCT00000620|265031|P2|COMPLETED|Overall Study||1057
110716|NCT00000620|265032|P1|COMPLETED|Overall Study||1016
110717|NCT00000620|265025|P8|STARTED|Overall Study||1370
110718|NCT00000620|265026|P7|STARTED|Overall Study||1391
110719|NCT00000620|265027|P6|STARTED|Overall Study||1178
110720|NCT00000620|265028|P5|STARTED|Overall Study||1184
110721|NCT00000620|265029|P4|STARTED|Overall Study||1383
110722|NCT00000620|265030|P3|STARTED|Overall Study||1374
110723|NCT00000620|265031|P2|STARTED|Overall Study||1193
110724|NCT00000620|265032|P1|STARTED|Overall Study||1178
110725|NCT00000125|265050|P2|NOT COMPLETED|Overall Study||238
110726|NCT00000125|265051|P1|NOT COMPLETED|Overall Study||239
110727|NCT00000125|265050|P2|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|579
110728|NCT00000125|265051|P1|COMPLETED|Overall Study|Completed OHTS Phase 2, through March 2009|580
110729|NCT00000125|265050|P2|Completed OHTS Phase I, June 2002|Overall Study||702
110730|NCT00000125|265051|P1|Completed OHTS Phase I, June 2002|Overall Study||706
110731|NCT00000125|265050|P2|STARTED|Overall Study||817
110732|NCT00000125|265051|P1|STARTED|Overall Study||819
110733|NCT00000134|265060|P3|NOT COMPLETED|Overall Study||0
110734|NCT00000134|265061|P2|NOT COMPLETED|Overall Study||0
110735|NCT00000134|265062|P1|NOT COMPLETED|Overall Study||0
110736|NCT00000134|265060|P3|COMPLETED|Overall Study||96
110737|NCT00000134|265061|P2|COMPLETED|Overall Study||94
110738|NCT00000134|265062|P1|COMPLETED|Overall Study||89
110739|NCT00000134|265060|P3|STARTED|Overall Study||96
110740|NCT00000134|265061|P2|STARTED|Overall Study||94
110741|NCT00000134|265062|P1|STARTED|Overall Study||89
110742|NCT00000135|265072|P2|NOT COMPLETED|Overall Study||14
110743|NCT00000135|265073|P1|NOT COMPLETED|Overall Study||27
110744|NCT00000135|265072|P2|COMPLETED|Overall Study||91
110745|NCT00000135|265073|P1|COMPLETED|Overall Study||77
110746|NCT00000135|265072|P2|STARTED|Overall Study||105
110747|NCT00000135|265073|P1|STARTED|Overall Study||104
110748|NCT00000136|265081|P2|NOT COMPLETED|Overall Study||0
110749|NCT00000136|265082|P1|NOT COMPLETED|Overall Study||0
110750|NCT00000136|265081|P2|COMPLETED|Overall Study||127
110751|NCT00000136|265082|P1|COMPLETED|Overall Study||107
110752|NCT00000136|265081|P2|STARTED|Overall Study||127
110753|NCT00000136|265082|P1|STARTED|Overall Study||107
110754|NCT00000142|265091|P3|NOT COMPLETED|Overall Study||0
110755|NCT00000142|265092|P2|NOT COMPLETED|Overall Study||0
110756|NCT00000142|265093|P1|NOT COMPLETED|Overall Study||0
110757|NCT00000142|265091|P3|COMPLETED|Overall Study||12
110758|NCT00000142|265092|P2|COMPLETED|Overall Study||26
110759|NCT00000142|265093|P1|COMPLETED|Overall Study||26
110760|NCT00000142|265091|P3|STARTED|Overall Study||12
110761|NCT00000142|265092|P2|STARTED|Overall Study||26
110762|NCT00000142|265093|P1|STARTED|Overall Study||26
110763|NCT00000143|265103|P2|NOT COMPLETED|Overall Study||0
110764|NCT00000143|265104|P1|NOT COMPLETED|Overall Study||0
110765|NCT00000143|265103|P2|COMPLETED|Overall Study||30
110766|NCT00000143|265104|P1|COMPLETED|Overall Study||31
110767|NCT00000143|265103|P2|STARTED|Overall Study||30
110768|NCT00000143|265104|P1|STARTED|Overall Study||31
110769|NCT00000479|265114|P4|NOT COMPLETED|Overall Study||0
110770|NCT00000479|265115|P3|NOT COMPLETED|Overall Study||0
110771|NCT00000479|265116|P2|NOT COMPLETED|Overall Study||0
110772|NCT00000479|265117|P1|NOT COMPLETED|Overall Study||0
110773|NCT00000479|265114|P4|COMPLETED|Overall Study||9971
110774|NCT00000479|265115|P3|COMPLETED|Overall Study||9966
110775|NCT00000479|265116|P2|COMPLETED|Overall Study||9971
110776|NCT00000479|265117|P1|COMPLETED|Overall Study||9968
110777|NCT00000479|265114|P4|STARTED|Overall Study||9971
110778|NCT00000479|265115|P3|STARTED|Overall Study||9966
110779|NCT00000479|265116|P2|STARTED|Overall Study||9971
110780|NCT00000479|265117|P1|STARTED|Overall Study||9968
110781|NCT00001151|265131|P1|NOT COMPLETED|Overall Study||5
110782|NCT00001151|265131|P1|COMPLETED|Overall Study||1
110783|NCT00001151|265131|P1|STARTED|Overall Study||6
110784|NCT00001213|265135|P1|NOT COMPLETED|Overall Study||18
110785|NCT00001213|265135|P1|COMPLETED|Overall Study||310
110786|NCT00001213|265135|P1|STARTED|Overall Study||328
110787|NCT00001262|265143|P3|NOT COMPLETED|Overall Study||0
110788|NCT00001262|265144|P2|NOT COMPLETED|Overall Study||14
110789|NCT00001262|265145|P1|NOT COMPLETED|Overall Study||10
110790|NCT00001262|265143|P3|COMPLETED|Overall Study||3
110791|NCT00001262|265144|P2|COMPLETED|Overall Study||8
110792|NCT00001262|265145|P1|COMPLETED|Overall Study||25
110793|NCT00001262|265143|P3|STARTED|Overall Study||3
110794|NCT00001262|265144|P2|STARTED|Overall Study||22
110795|NCT00001262|265145|P1|STARTED|Overall Study||35
110796|NCT00001304|265173|P2|NOT COMPLETED|Overall Study||0
110797|NCT00001304|265174|P1|NOT COMPLETED|Overall Study||0
110798|NCT00001304|265173|P2|COMPLETED|Overall Study||14
110799|NCT00001304|265174|P1|COMPLETED|Overall Study||13
110800|NCT00001304|265173|P2|STARTED|Overall Study||14
110801|NCT00001304|265174|P1|STARTED|Overall Study||13
110802|NCT00001566|265192|P1|NOT COMPLETED|Overall Study||19
110803|NCT00001566|265192|P1|COMPLETED|Overall Study||23
110804|NCT00001566|265192|P1|Completed Immunotherapy|Overall Study||23
110805|NCT00001566|265192|P1|STARTED|Overall Study||42
110806|NCT00001575|265204|P1|NOT COMPLETED|Overall Study||45
110807|NCT00001575|265204|P1|COMPLETED|Overall Study||42
110808|NCT00001575|265204|P1|Treated|Overall Study||65
110809|NCT00001575|265204|P1|STARTED|Overall Study||87
110810|NCT00001586|265212|P2|NOT COMPLETED|Overall Study||0
110811|NCT00001586|265213|P1|NOT COMPLETED|Overall Study||0
110812|NCT00001586|265212|P2|COMPLETED|Overall Study||56
110813|NCT00001586|265213|P1|COMPLETED|Overall Study||49
110814|NCT00001586|265212|P2|STARTED|Overall Study||56
110815|NCT00001586|265213|P1|STARTED|Overall Study||49
110816|NCT00001596|265223|P2|NOT COMPLETED|Overall Study||10
110817|NCT00001596|265224|P1|NOT COMPLETED|Overall Study||17
110818|NCT00001596|265223|P2|COMPLETED|Overall Study||2
110819|NCT00001596|265224|P1|COMPLETED|Overall Study||6
110820|NCT00001596|265223|P2|STARTED|Overall Study||12
110821|NCT00001596|265224|P1|STARTED|Overall Study||23
110822|NCT00001832|265258|P15|NOT COMPLETED|Treatment Period||0
110823|NCT00001832|265259|P14|NOT COMPLETED|Treatment Period||0
110824|NCT00001832|265260|P13|NOT COMPLETED|Treatment Period||0
110825|NCT00001832|265261|P12|NOT COMPLETED|Treatment Period||0
110826|NCT00001832|265262|P11|NOT COMPLETED|Treatment Period||0
110827|NCT00001832|265263|P10|NOT COMPLETED|Treatment Period||0
110828|NCT00001832|265264|P9|NOT COMPLETED|Treatment Period||0
110829|NCT00001832|265265|P8|NOT COMPLETED|Treatment Period||1
110830|NCT00001832|265266|P7|NOT COMPLETED|Treatment Period||0
110831|NCT00001832|265267|P6|NOT COMPLETED|Treatment Period||1
110832|NCT00001832|265268|P5|NOT COMPLETED|Treatment Period||0
110833|NCT00001832|265269|P4|NOT COMPLETED|Treatment Period||0
110834|NCT00001832|265270|P3|NOT COMPLETED|Treatment Period||0
110835|NCT00001832|265271|P2|NOT COMPLETED|Treatment Period||0
110836|NCT00001832|265272|P1|NOT COMPLETED|Treatment Period||0
110837|NCT00001832|265258|P15|COMPLETED|Treatment Period||2
110838|NCT00001832|265259|P14|COMPLETED|Treatment Period||3
110839|NCT00001832|265260|P13|COMPLETED|Treatment Period||6
110840|NCT00001832|265261|P12|COMPLETED|Treatment Period||7
110841|NCT00001832|265262|P11|COMPLETED|Treatment Period||1
110842|NCT00001832|265263|P10|COMPLETED|Treatment Period||6
110843|NCT00001832|265264|P9|COMPLETED|Treatment Period||8
110844|NCT00001832|265265|P8|COMPLETED|Treatment Period||6
110845|NCT00001832|265266|P7|COMPLETED|Treatment Period||4
110846|NCT00001832|265267|P6|COMPLETED|Treatment Period||50
110847|NCT00001832|265268|P5|COMPLETED|Treatment Period||6
110848|NCT00001832|265269|P4|COMPLETED|Treatment Period||3
110849|NCT00001832|265270|P3|COMPLETED|Treatment Period||3
110850|NCT00001832|265271|P2|COMPLETED|Treatment Period||3
110851|NCT00001832|265272|P1|COMPLETED|Treatment Period||0
110852|NCT00001832|265258|P15|STARTED|Treatment Period||2
110853|NCT00001832|265259|P14|STARTED|Treatment Period||3
110854|NCT00001832|265260|P13|STARTED|Treatment Period||6
110855|NCT00001832|265261|P12|STARTED|Treatment Period||7
110856|NCT00001832|265262|P11|STARTED|Treatment Period||1
110857|NCT00001832|265263|P10|STARTED|Treatment Period||6
110858|NCT00001832|265264|P9|STARTED|Treatment Period||8
110859|NCT00001832|265265|P8|STARTED|Treatment Period||7
110860|NCT00001832|265266|P7|STARTED|Treatment Period||4
110861|NCT00001832|265267|P6|STARTED|Treatment Period||51
110862|NCT00001832|265268|P5|STARTED|Treatment Period||6
110863|NCT00001832|265269|P4|STARTED|Treatment Period||3
110864|NCT00001832|265270|P3|STARTED|Treatment Period||3
110865|NCT00001832|265271|P2|STARTED|Treatment Period||3
110866|NCT00001832|265272|P1|STARTED|Treatment Period||0
110867|NCT00001832|265258|P15|NOT COMPLETED|Apheresis Period||0
110868|NCT00001832|265259|P14|NOT COMPLETED|Apheresis Period||0
110869|NCT00001832|265260|P13|NOT COMPLETED|Apheresis Period||0
110870|NCT00001832|265261|P12|NOT COMPLETED|Apheresis Period||0
110871|NCT00001832|265262|P11|NOT COMPLETED|Apheresis Period||0
110872|NCT00001832|265263|P10|NOT COMPLETED|Apheresis Period||0
110873|NCT00001832|265264|P9|NOT COMPLETED|Apheresis Period||0
110874|NCT00001832|265265|P8|NOT COMPLETED|Apheresis Period||0
110875|NCT00001832|265266|P7|NOT COMPLETED|Apheresis Period||0
110876|NCT00001832|265267|P6|NOT COMPLETED|Apheresis Period||0
110877|NCT00001832|265268|P5|NOT COMPLETED|Apheresis Period||0
110878|NCT00001832|265269|P4|NOT COMPLETED|Apheresis Period||0
110879|NCT00001832|265270|P3|NOT COMPLETED|Apheresis Period||0
110880|NCT00001832|265271|P2|NOT COMPLETED|Apheresis Period||0
110881|NCT00001832|265272|P1|NOT COMPLETED|Apheresis Period||60
110882|NCT00001832|265258|P15|COMPLETED|Apheresis Period||0
110883|NCT00001832|265259|P14|COMPLETED|Apheresis Period||0
110884|NCT00001832|265260|P13|COMPLETED|Apheresis Period||0
110885|NCT00001832|265261|P12|COMPLETED|Apheresis Period||0
110886|NCT00001832|265262|P11|COMPLETED|Apheresis Period||0
110887|NCT00001832|265263|P10|COMPLETED|Apheresis Period||0
110888|NCT00001832|265264|P9|COMPLETED|Apheresis Period||0
110889|NCT00001832|265265|P8|COMPLETED|Apheresis Period||0
110890|NCT00001832|265266|P7|COMPLETED|Apheresis Period||0
110891|NCT00001832|265267|P6|COMPLETED|Apheresis Period||0
110892|NCT00001832|265268|P5|COMPLETED|Apheresis Period||0
110893|NCT00001832|265269|P4|COMPLETED|Apheresis Period||0
110894|NCT00001832|265270|P3|COMPLETED|Apheresis Period||0
110895|NCT00001832|265271|P2|COMPLETED|Apheresis Period||0
110896|NCT00001832|265272|P1|COMPLETED|Apheresis Period||110
110897|NCT00001832|265258|P15|STARTED|Apheresis Period||0
110898|NCT00001832|265259|P14|STARTED|Apheresis Period||0
110899|NCT00001832|265260|P13|STARTED|Apheresis Period||0
110900|NCT00001832|265261|P12|STARTED|Apheresis Period||0
110901|NCT00001832|265262|P11|STARTED|Apheresis Period||0
110902|NCT00001832|265263|P10|STARTED|Apheresis Period||0
110903|NCT00001832|265264|P9|STARTED|Apheresis Period||0
110904|NCT00001832|265265|P8|STARTED|Apheresis Period||0
110905|NCT00001832|265266|P7|STARTED|Apheresis Period||0
110906|NCT00001832|265267|P6|STARTED|Apheresis Period||0
110907|NCT00001832|265268|P5|STARTED|Apheresis Period||0
110908|NCT00001832|265269|P4|STARTED|Apheresis Period||0
110909|NCT00001832|265270|P3|STARTED|Apheresis Period||0
110910|NCT00001832|265271|P2|STARTED|Apheresis Period||0
110911|NCT00001832|265272|P1|STARTED|Apheresis Period||170
110912|NCT00001941|265316|P5|NOT COMPLETED|Overall Study||1
110913|NCT00001941|265317|P4|NOT COMPLETED|Overall Study||0
110914|NCT00001941|265318|P3|NOT COMPLETED|Overall Study||0
110915|NCT00001941|265319|P2|NOT COMPLETED|Overall Study||0
110916|NCT00001941|265320|P1|NOT COMPLETED|Overall Study||0
110917|NCT00001941|265316|P5|COMPLETED|Overall Study||19
110918|NCT00001941|265317|P4|COMPLETED|Overall Study||3
110919|NCT00001941|265318|P3|COMPLETED|Overall Study||3
110920|NCT00001941|265319|P2|COMPLETED|Overall Study||5
110921|NCT00001941|265320|P1|COMPLETED|Overall Study||3
110922|NCT00001941|265316|P5|STARTED|Overall Study||20
110923|NCT00001941|265317|P4|STARTED|Overall Study||3
110924|NCT00001941|265318|P3|STARTED|Overall Study||3
110925|NCT00001941|265319|P2|STARTED|Overall Study||5
110926|NCT00001941|265320|P1|STARTED|Overall Study||3
110927|NCT00001959|265327|P1|NOT COMPLETED|Overall Study||3
110928|NCT00001959|265327|P1|COMPLETED|Overall Study||18
110929|NCT00001959|265327|P1|STARTED|Overall Study||21
110930|NCT00001962|265333|P1|NOT COMPLETED|Overall Study||28
110931|NCT00001962|265333|P1|COMPLETED|Overall Study||72
110932|NCT00001962|265333|P1|STARTED|Overall Study||100
110933|NCT00001984|265337|P1|NOT COMPLETED|Overall Study||0
110934|NCT00001984|265337|P1|COMPLETED|Overall Study||5
110935|NCT00001984|265337|P1|STARTED|Overall Study||5
110936|NCT00002525|265349|P2|NOT COMPLETED|Overall Study||0
110937|NCT00002525|265350|P1|NOT COMPLETED|Overall Study||186
110938|NCT00002525|265349|P2|COMPLETED|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|428
110939|NCT00002525|265350|P1|COMPLETED|Overall Study||241
110940|NCT00002525|265349|P2|Dukes' B2 Stage|Overall Study||139
110941|NCT00002525|265350|P1|Dukes' B2 Stage|Overall Study||150
110942|NCT00002525|265349|P2|Dukes' B3 or C Stage|Overall Study||158
110943|NCT00002525|265350|P1|Dukes' B3 or C Stage|Overall Study|"Primary population: pts with Duke's B3, C disease. 158 such pts on No perioperative 5-FU arm"|156
110944|NCT00002525|265349|P2|Treated|Overall Study|"Patients on No perioperative 5-FU arm received no perioperative chemotherapy"|0
110945|NCT00002525|265350|P1|Treated|Overall Study||419
110946|NCT00002525|265349|P2|STARTED|Overall Study||428
110947|NCT00002525|265350|P1|STARTED|Overall Study|859 patients were enrolled to the study, but 4 patients were not randomized to any treatment arm|427
110948|NCT00002540|265366|P2|NOT COMPLETED|Overall Study||2464
110949|NCT00002540|265367|P1|NOT COMPLETED|Overall Study||801
110950|NCT00002540|265366|P2|COMPLETED|Overall Study||35876
110951|NCT00002540|265367|P1|COMPLETED|Overall Study||37544
110952|NCT00002540|265366|P2|STARTED|Overall Study||38340
110953|NCT00002540|265367|P1|STARTED|Overall Study||38345
110954|NCT00002558|265395|P2|NOT COMPLETED|Overall Study||1
110955|NCT00002558|265396|P1|NOT COMPLETED|Overall Study||0
110956|NCT00002558|265395|P2|COMPLETED|Overall Study||15
110957|NCT00002558|265396|P1|COMPLETED|Overall Study||92
110958|NCT00002558|265395|P2|STARTED|Overall Study||16
110959|NCT00002558|265396|P1|STARTED|Overall Study||92
110960|NCT00002597|265404|P2|NOT COMPLETED|Overall Study||23
110961|NCT00002597|265405|P1|NOT COMPLETED|Overall Study||26
110962|NCT00002597|265404|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|992
110963|NCT00002597|265405|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|987
110964|NCT00002597|265404|P2|STARTED|Overall Study||1015
110965|NCT00002597|265405|P1|STARTED|Overall Study||1013
110966|NCT00002601|265427|P1|NOT COMPLETED|Overall Study||0
110967|NCT00002601|265427|P1|COMPLETED|Overall Study||13
110968|NCT00002601|265427|P1|STARTED|Overall Study||13
110969|NCT00002651|265437|P3|NOT COMPLETED|Consolidation and Randomization||860
110970|NCT00002651|265438|P2|NOT COMPLETED|Consolidation and Randomization||838
110971|NCT00002651|265439|P1|NOT COMPLETED|Consolidation and Randomization||0
110972|NCT00002651|265437|P3|COMPLETED|Consolidation and Randomization||22
110973|NCT00002651|265438|P2|COMPLETED|Consolidation and Randomization||29
110974|NCT00002651|265439|P1|COMPLETED|Consolidation and Randomization||0
110975|NCT00002651|265437|P3|Assessable for Toxicity|Consolidation and Randomization||702
110976|NCT00002651|265438|P2|Assessable for Toxicity|Consolidation and Randomization||732
110977|NCT00002651|265439|P1|Assessable for Toxicity|Consolidation and Randomization||0
110978|NCT00002651|265437|P3|Eligible|Consolidation and Randomization||770
110979|NCT00002651|265438|P2|Eligible|Consolidation and Randomization||765
110980|NCT00002651|265439|P1|Eligible|Consolidation and Randomization||0
110981|NCT00002651|265437|P3|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|882
110982|NCT00002651|265438|P2|STARTED|Consolidation and Randomization|After induction,patients with stable or declining PSA (≤ 4.0 ng/mL) were eligible for randomization|867
110983|NCT00002651|265439|P1|STARTED|Consolidation and Randomization||0
110984|NCT00002651|265437|P3|NOT COMPLETED|Induction||0
110985|NCT00002651|265438|P2|NOT COMPLETED|Induction||0
110986|NCT00002651|265439|P1|NOT COMPLETED|Induction||1343
110987|NCT00002651|265437|P3|COMPLETED|Induction||0
110988|NCT00002651|265438|P2|COMPLETED|Induction||0
110989|NCT00002651|265439|P1|COMPLETED|Induction||1697
110990|NCT00002651|265437|P3|Eligible and Began Protocol Therapy|Induction||0
110991|NCT00002651|265438|P2|Eligible and Began Protocol Therapy|Induction||0
110992|NCT00002651|265439|P1|Eligible and Began Protocol Therapy|Induction||2950
110993|NCT00002651|265437|P3|Eligible|Induction||0
110994|NCT00002651|265438|P2|Eligible|Induction||0
110995|NCT00002651|265439|P1|Eligible|Induction||2950
110996|NCT00002651|265437|P3|STARTED|Induction||0
110997|NCT00002651|265438|P2|STARTED|Induction||0
110998|NCT00002651|265439|P1|STARTED|Induction||3040
110999|NCT00001656|265457|P2|NOT COMPLETED|Overall Study||0
111000|NCT00001656|265458|P1|NOT COMPLETED|Overall Study||1
111001|NCT00001656|265457|P2|COMPLETED|Overall Study||12
111002|NCT00001656|265458|P1|COMPLETED|Overall Study||12
111003|NCT00001656|265457|P2|STARTED|Overall Study||12
111004|NCT00001656|265458|P1|STARTED|Overall Study||13
111005|NCT00001703|265486|P1|NOT COMPLETED|Overall Study||5
111006|NCT00001703|265486|P1|COMPLETED|Overall Study||1
111007|NCT00001703|265486|P1|Peptide Stock Completed|Overall Study|off therapy reason for 3 patients|3
111008|NCT00001703|265486|P1|STARTED|Overall Study||6
111009|NCT00001723|265493|P2|NOT COMPLETED|Overall Study||16
111010|NCT00001723|265494|P1|NOT COMPLETED|Overall Study||13
111011|NCT00001723|265493|P2|COMPLETED|Overall Study||84
111012|NCT00001723|265494|P1|COMPLETED|Overall Study||87
111013|NCT00001723|265493|P2|STARTED|Overall Study||100
111014|NCT00001723|265494|P1|STARTED|Overall Study||100
111015|NCT00002766|265512|P2|NOT COMPLETED|Overall Study||4
111016|NCT00002766|265513|P1|NOT COMPLETED|Overall Study||3
111017|NCT00002766|265512|P2|COMPLETED|Overall Study||85
111018|NCT00002766|265513|P1|COMPLETED|Overall Study||78
111019|NCT00002766|265512|P2|STARTED|Overall Study||89
111020|NCT00002766|265513|P1|STARTED|Overall Study||81
111021|NCT00002842|265519|P1|NOT COMPLETED|Overall Study||27
111022|NCT00002842|265519|P1|COMPLETED|Overall Study||22
111023|NCT00002842|265519|P1|STARTED|Overall Study||49
111024|NCT00002850|265526|P3|NOT COMPLETED|Overall Study||4
111025|NCT00002850|265527|P2|NOT COMPLETED|Overall Study||2
111026|NCT00002850|265528|P1|NOT COMPLETED|Overall Study||5
111027|NCT00002850|265526|P3|COMPLETED|Overall Study||63
111028|NCT00002850|265527|P2|COMPLETED|Overall Study||74
111029|NCT00002850|265528|P1|COMPLETED|Overall Study||64
111030|NCT00002850|265526|P3|STARTED|Overall Study||67
111031|NCT00002850|265527|P2|STARTED|Overall Study||76
111032|NCT00002850|265528|P1|STARTED|Overall Study||69
111033|NCT00002874|265538|P2|NOT COMPLETED|Overall Study||35
111034|NCT00002874|265539|P1|NOT COMPLETED|Overall Study||45
111035|NCT00002874|265538|P2|COMPLETED|Overall Study||384
111036|NCT00002874|265539|P1|COMPLETED|Overall Study||376
111037|NCT00002874|265538|P2|STARTED|Overall Study||419
111038|NCT00002874|265539|P1|STARTED|Overall Study||421
111039|NCT00002931|265561|P1|NOT COMPLETED|Overall Study||2
111040|NCT00002931|265561|P1|COMPLETED|Overall Study||46
111041|NCT00002931|265561|P1|STARTED|Overall Study||48
111042|NCT00002975|265567|P1|NOT COMPLETED|Overall Study||5
111043|NCT00002975|265567|P1|COMPLETED|Overall Study||175
111044|NCT00002975|265567|P1|Treated With Study Therapy|Overall Study||175
111045|NCT00002975|265567|P1|STARTED|Overall Study||180
111046|NCT00003457|265571|P1|NOT COMPLETED|Overall Study||9
111047|NCT00003457|265571|P1|COMPLETED|Overall Study||31
111048|NCT00003457|265571|P1|STARTED|Overall Study||40
111049|NCT00003458|265576|P1|NOT COMPLETED|Overall Study||4
111050|NCT00003458|265576|P1|COMPLETED|Overall Study||30
111051|NCT00003458|265576|P1|STARTED|Overall Study||34
111052|NCT00003459|265581|P1|NOT COMPLETED|Overall Study||9
111053|NCT00003459|265581|P1|COMPLETED|Overall Study|Nine patients were not evaluable.|31
111054|NCT00003459|265581|P1|STARTED|Overall Study||40
111055|NCT00003460|265586|P1|NOT COMPLETED|Overall Study||1
111056|NCT00003460|265586|P1|COMPLETED|Overall Study|One patient was not evaluable.|12
111057|NCT00003460|265586|P1|STARTED|Overall Study||13
111058|NCT00003468|265591|P1|NOT COMPLETED|Overall Study||2
111059|NCT00003468|265591|P1|COMPLETED|Overall Study|Two patients were not evaluable.|9
111060|NCT00003468|265591|P1|STARTED|Overall Study||11
111061|NCT00003469|265596|P1|NOT COMPLETED|Overall Study||0
111062|NCT00003469|265596|P1|COMPLETED|Overall Study||4
111063|NCT00003469|265596|P1|STARTED|Overall Study||4
111064|NCT00003470|265601|P1|NOT COMPLETED|Overall Study||6
111065|NCT00003470|265601|P1|COMPLETED|Overall Study||21
111066|NCT00003470|265601|P1|STARTED|Overall Study||27
111067|NCT00003473|265606|P1|NOT COMPLETED|Overall Study||3
111068|NCT00003473|265606|P1|COMPLETED|Overall Study||17
111069|NCT00003473|265606|P1|STARTED|Overall Study||20
111070|NCT00003475|265611|P1|NOT COMPLETED|Overall Study||13
111071|NCT00003475|265611|P1|COMPLETED|Overall Study||27
111072|NCT00003475|265611|P1|STARTED|Overall Study||40
111073|NCT00003476|265616|P1|NOT COMPLETED|Overall Study||1
111074|NCT00003476|265616|P1|COMPLETED|Overall Study||7
111075|NCT00003476|265616|P1|STARTED|Overall Study||8
111076|NCT00003477|265621|P1|NOT COMPLETED|Overall Study||4
111077|NCT00003477|265621|P1|COMPLETED|Overall Study||8
111078|NCT00003477|265621|P1|STARTED|Overall Study||12
111079|NCT00003479|265626|P1|NOT COMPLETED|Overall Study||3
111080|NCT00003479|265626|P1|COMPLETED|Overall Study||6
111081|NCT00003479|265626|P1|STARTED|Overall Study||9
111082|NCT00003483|265631|P1|NOT COMPLETED|Overall Study||1
111083|NCT00003483|265631|P1|COMPLETED|Overall Study||2
111084|NCT00003483|265631|P1|STARTED|Overall Study||3
111085|NCT00003537|265636|P1|NOT COMPLETED|Overall Study||1
111086|NCT00003537|265636|P1|COMPLETED|Overall Study||18
111087|NCT00003537|265636|P1|STARTED|Overall Study||19
111088|NCT00003590|265641|P1|NOT COMPLETED|Overall Study||22
111089|NCT00003590|265641|P1|COMPLETED|Overall Study|Patients were to receive Hydroxyurea up to 2 years in absence of progressive disease.|7
111090|NCT00003590|265641|P1|Eligible and Began Protocol Therapy|Overall Study||28
111091|NCT00003590|265641|P1|Eligible|Overall Study||28
111092|NCT00003590|265641|P1|STARTED|Overall Study||29
111093|NCT00003631|265649|P3|NOT COMPLETED|Overall Study||9
111094|NCT00003631|265650|P2|NOT COMPLETED|Overall Study||1
111095|NCT00003631|265651|P1|NOT COMPLETED|Overall Study||3
111096|NCT00003631|265649|P3|COMPLETED|Overall Study||15
111097|NCT00003631|265650|P2|COMPLETED|Overall Study||43
111098|NCT00003631|265651|P1|COMPLETED|Overall Study||47
111099|NCT00003631|265649|P3|STARTED|Overall Study||24
111100|NCT00003631|265650|P2|STARTED|Overall Study||44
111101|NCT00003631|265651|P1|STARTED|Overall Study||50
111102|NCT00003726|265659|P1|NOT COMPLETED|Overall Study||1
111103|NCT00003726|265659|P1|COMPLETED|Overall Study|Funding was pulled on the trial and therefore no other participants were enrolled|0
111104|NCT00003726|265659|P1|STARTED|Overall Study||1
111105|NCT00003782|265666|P3|NOT COMPLETED|Overall Study||26
111106|NCT00003782|265667|P2|NOT COMPLETED|Overall Study||31
111107|NCT00003782|265668|P1|NOT COMPLETED|Overall Study||30
111108|NCT00003782|265666|P3|COMPLETED|Overall Study||1758
111109|NCT00003782|265667|P2|COMPLETED|Overall Study||1753
111110|NCT00003782|265668|P1|COMPLETED|Overall Study||1753
111111|NCT00003782|265666|P3|STARTED|Overall Study||1784
111112|NCT00003782|265667|P2|STARTED|Overall Study||1784
111113|NCT00003782|265668|P1|STARTED|Overall Study||1783
111114|NCT00003820|265676|P2|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
111115|NCT00003820|265677|P1|NOT COMPLETED|Cycle 4 (Maintenance Treatment)||0
111116|NCT00003820|265676|P2|COMPLETED|Cycle 4 (Maintenance Treatment)|Patients with treatment assessment at 24 months|16
111117|NCT00003820|265677|P1|COMPLETED|Cycle 4 (Maintenance Treatment)||0
111118|NCT00003820|265676|P2|STARTED|Cycle 4 (Maintenance Treatment)|Patients with treatment response/stable disease at 18 months|16
111119|NCT00003820|265677|P1|STARTED|Cycle 4 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
111120|NCT00003820|265676|P2|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
111121|NCT00003820|265677|P1|NOT COMPLETED|Cycle 3 (Maintenance Treatment)||0
111122|NCT00003820|265676|P2|COMPLETED|Cycle 3 (Maintenance Treatment)|Patients with treatment assessment at 18 months|16
111123|NCT00003820|265677|P1|COMPLETED|Cycle 3 (Maintenance Treatment)||0
111124|NCT00003820|265676|P2|STARTED|Cycle 3 (Maintenance Treatment)|Patients with treatment response/stable disease at 12 months|16
111125|NCT00003820|265677|P1|STARTED|Cycle 3 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
111126|NCT00003820|265676|P2|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
111127|NCT00003820|265677|P1|NOT COMPLETED|Cycle 2 (Maintenance Treatment)||0
111128|NCT00003820|265676|P2|COMPLETED|Cycle 2 (Maintenance Treatment)|Patients with treatment assessment at 12 months|16
111129|NCT00003820|265677|P1|COMPLETED|Cycle 2 (Maintenance Treatment)||0
111130|NCT00003820|265676|P2|STARTED|Cycle 2 (Maintenance Treatment)|Pts with treatment response/stable disease at 6 mos, & eligible to continue.|16
111131|NCT00003820|265677|P1|STARTED|Cycle 2 (Maintenance Treatment)|Initial Group of participants only received 1 cycle of treatment|0
111132|NCT00003820|265676|P2|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
111133|NCT00003820|265677|P1|NOT COMPLETED|Cycle 1 (Initial Treatment)||0
111134|NCT00003820|265676|P2|COMPLETED|Cycle 1 (Initial Treatment)||16
111135|NCT00003820|265677|P1|COMPLETED|Cycle 1 (Initial Treatment)||23
111136|NCT00003820|265676|P2|STARTED|Cycle 1 (Initial Treatment)||16
111137|NCT00003820|265677|P1|STARTED|Cycle 1 (Initial Treatment)||23
111138|NCT00003869|265685|P2|NOT COMPLETED|Overall Study||12
111139|NCT00003869|265686|P1|NOT COMPLETED|Overall Study||41
111140|NCT00003869|265685|P2|COMPLETED|Overall Study||80
111141|NCT00003869|265686|P1|COMPLETED|Overall Study||53
111142|NCT00003869|265685|P2|STARTED|Overall Study||92
111143|NCT00003869|265686|P1|STARTED|Overall Study||94
111144|NCT00003875|265702|P1|NOT COMPLETED|Overall Study||1
111145|NCT00003875|265702|P1|COMPLETED|Overall Study||29
111146|NCT00003875|265702|P1|STARTED|Overall Study||30
111147|NCT00003199|265709|P1|NOT COMPLETED|Overall Study||22
111148|NCT00003199|265709|P1|COMPLETED|Overall Study||28
111149|NCT00003199|265709|P1|STARTED|Overall Study||50
111150|NCT00003222|265717|P2|NOT COMPLETED|Overall Study||1
111151|NCT00003222|265718|P1|NOT COMPLETED|Overall Study||0
111152|NCT00003222|265717|P2|COMPLETED|Overall Study|Decline in performance status between enrollment and initiation of therapy.|27
111153|NCT00003222|265718|P1|COMPLETED|Overall Study||13
111154|NCT00003222|265717|P2|STARTED|Overall Study||28
111155|NCT00003222|265718|P1|STARTED|Overall Study||13
111156|NCT00003224|265734|P6|NOT COMPLETED|Overall Study||0
111157|NCT00003224|265735|P5|NOT COMPLETED|Overall Study||0
111158|NCT00003224|265736|P4|NOT COMPLETED|Overall Study||0
111159|NCT00003224|265737|P3|NOT COMPLETED|Overall Study||0
111160|NCT00003224|265738|P2|NOT COMPLETED|Overall Study||0
111161|NCT00003224|265739|P1|NOT COMPLETED|Overall Study||0
111162|NCT00003224|265734|P6|COMPLETED|Overall Study||3
111163|NCT00003224|265735|P5|COMPLETED|Overall Study||4
111164|NCT00003224|265736|P4|COMPLETED|Overall Study||2
111165|NCT00003224|265737|P3|COMPLETED|Overall Study||4
111166|NCT00003224|265738|P2|COMPLETED|Overall Study||5
111167|NCT00003224|265739|P1|COMPLETED|Overall Study||4
111168|NCT00003224|265734|P6|STARTED|Overall Study||3
111169|NCT00003224|265735|P5|STARTED|Overall Study||4
111170|NCT00003224|265736|P4|STARTED|Overall Study||2
111171|NCT00003224|265737|P3|STARTED|Overall Study||4
111172|NCT00003224|265738|P2|STARTED|Overall Study||5
111173|NCT00003224|265739|P1|STARTED|Overall Study||4
111174|NCT00003298|265757|P1|NOT COMPLETED|Step 2 (Adjuvant Therapy)||6
111175|NCT00003298|265757|P1|COMPLETED|Step 2 (Adjuvant Therapy)||4
111176|NCT00003298|265757|P1|Eligible and Treated on Step 2|Step 2 (Adjuvant Therapy)||7
111177|NCT00003298|265757|P1|STARTED|Step 2 (Adjuvant Therapy)||10
111178|NCT00003298|265757|P1|NOT COMPLETED|Re-register to Step 2 After Surgery||18
111179|NCT00003298|265757|P1|COMPLETED|Re-register to Step 2 After Surgery||10
111180|NCT00003298|265757|P1|STARTED|Re-register to Step 2 After Surgery||28
111181|NCT00003298|265757|P1|NOT COMPLETED|Surgery||7
111182|NCT00003298|265757|P1|COMPLETED|Surgery|1 patient did not complete neoadjuvant therapy but went to surgery anyway, not included here.|28
111183|NCT00003298|265757|P1|STARTED|Surgery||35
111184|NCT00003298|265757|P1|NOT COMPLETED|Step 1 (Neoadjuvant Therapy)||4
111185|NCT00003298|265757|P1|COMPLETED|Step 1 (Neoadjuvant Therapy)||35
111186|NCT00003298|265757|P1|Complete 3 Cycles of Neoadjuvant Therapy|Step 1 (Neoadjuvant Therapy)||35
111187|NCT00003298|265757|P1|Eligible and Treated|Step 1 (Neoadjuvant Therapy)||38
111188|NCT00003298|265757|P1|STARTED|Step 1 (Neoadjuvant Therapy)||39
111189|NCT00003377|265770|P5|NOT COMPLETED|Period II||1
111190|NCT00003377|265771|P4|NOT COMPLETED|Period II||0
111191|NCT00003377|265772|P3|NOT COMPLETED|Period II||0
111192|NCT00003377|265773|P2|NOT COMPLETED|Period II||0
111193|NCT00003377|265774|P1|NOT COMPLETED|Period II||0
111194|NCT00003377|265770|P5|COMPLETED|Period II||16
111195|NCT00003377|265771|P4|COMPLETED|Period II||0
111196|NCT00003377|265772|P3|COMPLETED|Period II||0
111197|NCT00003377|265773|P2|COMPLETED|Period II||0
111198|NCT00003377|265774|P1|COMPLETED|Period II||0
111199|NCT00003377|265770|P5|STARTED|Period II|All pts enrolled on Per II received cisplatin 40 mg/m2 & paclitaxel 40 mg/m2 concurrent w/ radiation|17
111200|NCT00003377|265771|P4|STARTED|Period II|Patients participated at this dose level only in Period I.|0
111201|NCT00003377|265772|P3|STARTED|Period II|Patients participated at this dose level only in Period I.|0
111202|NCT00003377|265773|P2|STARTED|Period II|Patients participated at this dose level only in Period I.|0
111203|NCT00003377|265774|P1|STARTED|Period II|Patients participated at this dose level only in Period I.|0
111204|NCT00003377|265770|P5|NOT COMPLETED|Period I||0
111205|NCT00003377|265771|P4|NOT COMPLETED|Period I||1
111206|NCT00003377|265772|P3|NOT COMPLETED|Period I||1
111207|NCT00003377|265773|P2|NOT COMPLETED|Period I||0
111208|NCT00003377|265774|P1|NOT COMPLETED|Period I||0
111209|NCT00003377|265770|P5|COMPLETED|Period I||0
111210|NCT00003377|265771|P4|COMPLETED|Period I||2
111211|NCT00003377|265772|P3|COMPLETED|Period I||2
111212|NCT00003377|265773|P2|COMPLETED|Period I||3
111213|NCT00003377|265774|P1|COMPLETED|Period I||3
111214|NCT00003377|265770|P5|STARTED|Period I||0
111215|NCT00003377|265771|P4|STARTED|Period I||3
111216|NCT00003377|265772|P3|STARTED|Period I||3
111217|NCT00003377|265773|P2|STARTED|Period I||3
111218|NCT00003377|265774|P1|STARTED|Period I||3
111219|NCT00003389|265790|P2|NOT COMPLETED|Overall Study||60
111220|NCT00003389|265791|P1|NOT COMPLETED|Overall Study||98
111221|NCT00003389|265790|P2|COMPLETED|Overall Study||366
111222|NCT00003389|265791|P1|COMPLETED|Overall Study||330
111223|NCT00003389|265790|P2|Eligible Patients|Overall Study||399
111224|NCT00003389|265791|P1|Eligible Patients|Overall Study||395
111225|NCT00003389|265790|P2|Treated Pts w/ Toxicity Data Available|Overall Study||422
111226|NCT00003389|265791|P1|Treated Pts w/ Toxicity Data Available|Overall Study||414
111227|NCT00003389|265790|P2|STARTED|Overall Study||426
111228|NCT00003389|265791|P1|STARTED|Overall Study||428
111229|NCT00003895|265803|P2|NOT COMPLETED|Overall Study||4
111230|NCT00003895|265804|P1|NOT COMPLETED|Overall Study||7
111231|NCT00003895|265803|P2|COMPLETED|Overall Study||14
111232|NCT00003895|265804|P1|COMPLETED|Overall Study||11
111233|NCT00003895|265803|P2|STARTED|Overall Study||18
111234|NCT00003895|265804|P1|STARTED|Overall Study||18
111235|NCT00003896|265810|P1|NOT COMPLETED|Overall Study||29
111236|NCT00003896|265810|P1|COMPLETED|Overall Study||39
111237|NCT00003896|265810|P1|Eligible|Overall Study|2 eligible patients did not have any toxicity assessments reported.|63
111238|NCT00003896|265810|P1|STARTED|Overall Study||68
111239|NCT00003901|265816|P1|NOT COMPLETED|Overall Study||17
111240|NCT00003901|265816|P1|COMPLETED|Overall Study||1030
111241|NCT00003901|265816|P1|STARTED|Overall Study||1047
111242|NCT00003907|265829|P2|NOT COMPLETED|Overall Study||23
111243|NCT00003907|265830|P1|NOT COMPLETED|Overall Study||13
111244|NCT00003907|265829|P2|COMPLETED|Overall Study||8
111245|NCT00003907|265830|P1|COMPLETED|Overall Study||6
111246|NCT00003907|265829|P2|Eligible and Treated|Overall Study||29
111247|NCT00003907|265830|P1|Eligible and Treated|Overall Study||17
111248|NCT00003907|265829|P2|Received Protocol Therapy (Treated)|Overall Study||31
111249|NCT00003907|265830|P1|Received Protocol Therapy (Treated)|Overall Study||18
111250|NCT00003907|265829|P2|Eligible|Overall Study||29
111251|NCT00003907|265830|P1|Eligible|Overall Study||18
111252|NCT00003907|265829|P2|STARTED|Overall Study||31
111253|NCT00003907|265830|P1|STARTED|Overall Study||19
111254|NCT00003910|265840|P2|NOT COMPLETED|Step 2||0
111255|NCT00003910|265841|P1|NOT COMPLETED|Step 2||0
111256|NCT00003910|265840|P2|COMPLETED|Step 2||16
111257|NCT00003910|265841|P1|COMPLETED|Step 2||0
111258|NCT00003910|265840|P2|STARTED|Step 2|The 16 includes 2 ineligible pts.|16
111259|NCT00003910|265841|P1|STARTED|Step 2||0
111260|NCT00003910|265840|P2|NOT COMPLETED|Step 1||0
111261|NCT00003910|265841|P1|NOT COMPLETED|Step 1||0
111262|NCT00003910|265840|P2|COMPLETED|Step 1||0
111263|NCT00003910|265841|P1|COMPLETED|Step 1||55
111264|NCT00003910|265840|P2|STARTED|Step 1||0
111265|NCT00003910|265841|P1|STARTED|Step 1|Of 59 (step 1), 4 pts were ineligible.|55
111266|NCT00004092|265848|P2|NOT COMPLETED|Overall Study||0
111267|NCT00004092|265849|P1|NOT COMPLETED|Overall Study||0
111268|NCT00004092|265848|P2|COMPLETED|Overall Study||51
111269|NCT00004092|265849|P1|COMPLETED|Overall Study||21
111270|NCT00004092|265848|P2|STARTED|Overall Study||51
111271|NCT00004092|265849|P1|STARTED|Overall Study||21
111272|NCT00004143|265857|P1|NOT COMPLETED|Overall Study||0
111273|NCT00004143|265857|P1|COMPLETED|Overall Study||2
111274|NCT00004143|265857|P1|STARTED|Overall Study||2
111275|NCT00004146|265866|P1|NOT COMPLETED|Overall Study||0
111276|NCT00004146|265866|P1|COMPLETED|Overall Study||55
111277|NCT00004146|265866|P1|STARTED|Overall Study||55
111278|NCT00004228|265880|P7|NOT COMPLETED|Overall Study||12
111279|NCT00004228|265881|P6|NOT COMPLETED|Overall Study||14
111280|NCT00004228|265882|P5|NOT COMPLETED|Overall Study||16
111281|NCT00004228|265883|P4|NOT COMPLETED|Overall Study||7
111282|NCT00004228|265884|P3|NOT COMPLETED|Overall Study||19
111283|NCT00004228|265885|P2|NOT COMPLETED|Overall Study||15
111284|NCT00004228|265886|P1|NOT COMPLETED|Overall Study||9
111285|NCT00004228|265880|P7|COMPLETED|Overall Study||45
111286|NCT00004228|265881|P6|COMPLETED|Overall Study||51
111287|NCT00004228|265882|P5|COMPLETED|Overall Study||51
111288|NCT00004228|265883|P4|COMPLETED|Overall Study||6
111289|NCT00004228|265884|P3|COMPLETED|Overall Study||46
111290|NCT00004228|265885|P2|COMPLETED|Overall Study||51
111291|NCT00004228|265886|P1|COMPLETED|Overall Study||51
111292|NCT00004228|265880|P7|STARTED|Overall Study||57
111293|NCT00004228|265881|P6|STARTED|Overall Study||65
111294|NCT00004228|265882|P5|STARTED|Overall Study||67
111295|NCT00004228|265883|P4|STARTED|Overall Study||13
111296|NCT00004228|265884|P3|STARTED|Overall Study||65
111297|NCT00004228|265885|P2|STARTED|Overall Study||66
111298|NCT00004228|265886|P1|STARTED|Overall Study||60
111299|NCT00003138|265911|P2|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||7
111300|NCT00003138|265912|P1|NOT COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||6
111301|NCT00003138|265911|P2|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
111302|NCT00003138|265912|P1|COMPLETED|Step 4 (EPO 300 Units/kg and G-CSF)||0
111303|NCT00003138|265911|P2|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||7
111304|NCT00003138|265912|P1|STARTED|Step 4 (EPO 300 Units/kg and G-CSF)||6
111305|NCT00003138|265911|P2|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||20
111306|NCT00003138|265912|P1|NOT COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||12
111307|NCT00003138|265911|P2|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
111308|NCT00003138|265912|P1|COMPLETED|Step 3 (EPO 150 Units/kg and G-CSF)||0
111309|NCT00003138|265911|P2|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||19
111310|NCT00003138|265912|P1|Treated|Step 3 (EPO 150 Units/kg and G-CSF)||12
111311|NCT00003138|265911|P2|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||20
111312|NCT00003138|265912|P1|STARTED|Step 3 (EPO 150 Units/kg and G-CSF)||12
111313|NCT00003138|265911|P2|NOT COMPLETED|Step 2 (Cross Over)||0
111314|NCT00003138|265912|P1|NOT COMPLETED|Step 2 (Cross Over)||26
111315|NCT00003138|265911|P2|COMPLETED|Step 2 (Cross Over)||0
111316|NCT00003138|265912|P1|COMPLETED|Step 2 (Cross Over)||0
111317|NCT00003138|265911|P2|STARTED|Step 2 (Cross Over)|Only patients in the supportive care arm are eligible to cross over to the Erythropoietin arm.|0
111318|NCT00003138|265912|P1|STARTED|Step 2 (Cross Over)||26
111319|NCT00003138|265911|P2|NOT COMPLETED|Step 1||57
111320|NCT00003138|265912|P1|NOT COMPLETED|Step 1||61
111321|NCT00003138|265911|P2|COMPLETED|Step 1||0
111322|NCT00003138|265912|P1|COMPLETED|Step 1||0
111323|NCT00003138|265911|P2|Patients With Transfusion Data|Step 1||42
111324|NCT00003138|265912|P1|Patients With Transfusion Data|Step 1||37
111325|NCT00003138|265911|P2|Patients With QOL Data at 4 Months|Step 1||42
111326|NCT00003138|265912|P1|Patients With QOL Data at 4 Months|Step 1||42
111327|NCT00003138|265911|P2|Eligible and Treated|Step 1||50
111328|NCT00003138|265912|P1|Eligible and Treated|Step 1||52
111329|NCT00003138|265911|P2|Treated|Step 1||53
111330|NCT00003138|265912|P1|Treated|Step 1||56
111331|NCT00003138|265911|P2|Patients With Complete Data|Step 1||53
111332|NCT00003138|265912|P1|Patients With Complete Data|Step 1||57
111333|NCT00003138|265911|P2|STARTED|Step 1||57
111334|NCT00003138|265912|P1|STARTED|Step 1||61
111335|NCT00003641|265927|P2|NOT COMPLETED|Overall Study||174
111336|NCT00003641|265928|P1|NOT COMPLETED|Overall Study||569
111337|NCT00003641|265927|P2|COMPLETED|Overall Study||407
111338|NCT00003641|265928|P1|COMPLETED|Overall Study||0
111339|NCT00003641|265927|P2|Toxicity Assessed|Overall Study||568
111340|NCT00003641|265928|P1|Toxicity Assessed|Overall Study|439 patients on arm I had their toxicity assessed even though they did not receive any treatment|439
111341|NCT00003641|265927|P2|Treated|Overall Study||569
111342|NCT00003641|265928|P1|Treated|Overall Study|Patients on arm I should undergo observation, but 2 patients received interferon therapy|2
111343|NCT00003641|265927|P2|STARTED|Overall Study||581
111344|NCT00003641|265928|P1|STARTED|Overall Study||569
111345|NCT00003659|265936|P1|NOT COMPLETED|Overall Study||3
111346|NCT00003659|265936|P1|COMPLETED|Overall Study||36
111347|NCT00003659|265936|P1|STARTED|Overall Study||39
111348|NCT00004732|265944|P2|NOT COMPLETED|Overall Study||111
111349|NCT00004732|265945|P1|NOT COMPLETED|Overall Study||69
111350|NCT00004732|265944|P2|COMPLETED|Overall Study||1129
111351|NCT00004732|265945|P1|COMPLETED|Overall Study||1193
111352|NCT00004732|265944|P2|STARTED|Overall Study||1240
111353|NCT00004732|265945|P1|STARTED|Overall Study||1262
111354|NCT00004859|265955|P2|NOT COMPLETED|Overall Study||282
111355|NCT00004859|265956|P1|NOT COMPLETED|Overall Study||118
111356|NCT00004859|265955|P2|COMPLETED|Overall Study||12
111357|NCT00004859|265956|P1|COMPLETED|Overall Study||177
111358|NCT00004859|265955|P2|Treated and Having Toxicity Data|Overall Study|1 patient had missing record for toxicity|288
111359|NCT00004859|265956|P1|Treated and Having Toxicity Data|Overall Study||289
111360|NCT00004859|265955|P2|Treated|Overall Study||289
111361|NCT00004859|265956|P1|Treated|Overall Study||289
111362|NCT00004859|265955|P2|Eligible|Overall Study||271
111363|NCT00004859|265956|P1|Eligible|Overall Study||275
111364|NCT00004859|265955|P2|STARTED|Overall Study||294
111365|NCT00004859|265956|P1|STARTED|Overall Study||295
111366|NCT00004888|265968|P2|NOT COMPLETED|Overall Study||24
111367|NCT00004888|265969|P1|NOT COMPLETED|Overall Study||11
111368|NCT00004888|265968|P2|COMPLETED|Overall Study||22
111369|NCT00004888|265969|P1|COMPLETED|Overall Study||27
111370|NCT00004888|265968|P2|STARTED|Overall Study|Of the 48 pts, 2 were ineligible.|46
111371|NCT00004888|265969|P1|STARTED|Overall Study|Of the 41 pts, 3 were ineligible.|38
111372|NCT00004978|265987|P2|NOT COMPLETED|Overall Study||270
111373|NCT00004978|265988|P1|NOT COMPLETED|Overall Study||244
111374|NCT00004978|265987|P2|COMPLETED|Overall Study||1790
111375|NCT00004978|265988|P1|COMPLETED|Overall Study||1846
111376|NCT00004978|265987|P2|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2060
111377|NCT00004978|265988|P1|STARTED|Overall Study|includes patients participating in Vanguard studies from the sites which participated in ESPRIT|2090
111378|NCT00004980|266014|P2|NOT COMPLETED|Overall Study||2
111379|NCT00004980|266015|P1|NOT COMPLETED|Overall Study||2
111380|NCT00004980|266014|P2|COMPLETED|Overall Study||21
111381|NCT00004980|266015|P1|COMPLETED|Overall Study||25
111382|NCT00004980|266014|P2|STARTED|Overall Study||23
111383|NCT00004980|266015|P1|STARTED|Overall Study||27
111384|NCT00004054|266029|P2|NOT COMPLETED|Overall Study||0
111385|NCT00004054|266030|P1|NOT COMPLETED|Overall Study||0
111386|NCT00004054|266029|P2|COMPLETED|Overall Study||200
111387|NCT00004054|266030|P1|COMPLETED|Overall Study||197
111388|NCT00004054|266029|P2|STARTED|Overall Study||200
111389|NCT00004054|266030|P1|STARTED|Overall Study||197
111390|NCT00004412|266039|P3|NOT COMPLETED|Crossover Period||0
111391|NCT00004412|266040|P2|NOT COMPLETED|Crossover Period||0
111392|NCT00004412|266041|P1|NOT COMPLETED|Crossover Period||0
111393|NCT00004412|266039|P3|COMPLETED|Crossover Period|Three subjects, from Arm I, who crossed- over to Arm II completed the study.|3
111394|NCT00004412|266040|P2|COMPLETED|Crossover Period|Twelve subjects in this arm completed the study.|12
111395|NCT00004412|266041|P1|COMPLETED|Crossover Period|Eight subjects in this arm completed study without crossing over.|8
111396|NCT00004412|266039|P3|STARTED|Crossover Period|Three of Randomized Period's Arm I elected to move to Crossover Period's Crossover Arm.|3
111397|NCT00004412|266040|P2|STARTED|Crossover Period|Twelve patients were randomized to the Arginine Butyrate plus Standard local care dressing Arm|12
111398|NCT00004412|266041|P1|STARTED|Crossover Period|Eight subjects were randomized to Standard of Care dressing Arm|8
111399|NCT00004412|266039|P3|NOT COMPLETED|Randomized Period||0
111400|NCT00004412|266040|P2|NOT COMPLETED|Randomized Period||0
111401|NCT00004412|266041|P1|NOT COMPLETED|Randomized Period||3
111402|NCT00004412|266039|P3|COMPLETED|Randomized Period||0
111403|NCT00004412|266040|P2|COMPLETED|Randomized Period||12
111404|NCT00004412|266041|P1|COMPLETED|Randomized Period||8
111405|NCT00004412|266039|P3|STARTED|Randomized Period||0
111406|NCT00004412|266040|P2|STARTED|Randomized Period||12
111407|NCT00004412|266041|P1|STARTED|Randomized Period||11
111408|NCT00004500|266051|P2|NOT COMPLETED|Overall Study||0
111409|NCT00004500|266052|P1|NOT COMPLETED|Overall Study||0
111410|NCT00004500|266051|P2|COMPLETED|Overall Study||31
111411|NCT00004500|266052|P1|COMPLETED|Overall Study||38
111412|NCT00004500|266051|P2|1 Year Follow-Up|Overall Study||24
111413|NCT00004500|266052|P1|1 Year Follow-Up|Overall Study||24
111414|NCT00004500|266051|P2|STARTED|Overall Study||31
111415|NCT00004500|266052|P1|STARTED|Overall Study||38
111416|NCT00004547|266065|P3|NOT COMPLETED|Overall Study||22
111417|NCT00004547|266066|P2|NOT COMPLETED|Overall Study||9
111418|NCT00004547|266067|P1|NOT COMPLETED|Overall Study||22
111419|NCT00004547|266065|P3|COMPLETED|Overall Study||35
111420|NCT00004547|266066|P2|COMPLETED|Overall Study||39
111421|NCT00004547|266067|P1|COMPLETED|Overall Study||61
111422|NCT00004547|266065|P3|Not Evaluable|Overall Study||23
111423|NCT00004547|266066|P2|Not Evaluable|Overall Study||9
111424|NCT00004547|266067|P1|Not Evaluable|Overall Study||21
111425|NCT00004547|266065|P3|STARTED|Overall Study||57
111426|NCT00004547|266066|P2|STARTED|Overall Study||48
111427|NCT00004547|266067|P1|STARTED|Overall Study||83
111428|NCT00004562|266087|P2|NOT COMPLETED|Overall Study||91
111429|NCT00004562|266088|P1|NOT COMPLETED|Overall Study||102
111430|NCT00004562|266087|P2|COMPLETED|Overall Study||1009
111431|NCT00004562|266088|P1|COMPLETED|Overall Study||999
111432|NCT00004562|266087|P2|STARTED|Overall Study||1100
111433|NCT00004562|266088|P1|STARTED|Overall Study||1101
111434|NCT00004563|266098|P2|NOT COMPLETED|Overall Study||24
111435|NCT00004563|266099|P1|NOT COMPLETED|Overall Study||25
111436|NCT00004563|266098|P2|COMPLETED|Overall Study||55
111437|NCT00004563|266099|P1|COMPLETED|Overall Study||54
111438|NCT00004563|266098|P2|STARTED|Overall Study||79
111439|NCT00004563|266099|P1|STARTED|Overall Study||79
111440|NCT00004635|266111|P2|NOT COMPLETED|Period Two||9
111441|NCT00004635|266112|P1|NOT COMPLETED|Period Two||6
111442|NCT00004635|266111|P2|COMPLETED|Period Two||50
111443|NCT00004635|266112|P1|COMPLETED|Period Two||38
111444|NCT00004635|266111|P2|STARTED|Period Two||59
111445|NCT00004635|266112|P1|STARTED|Period Two||44
111446|NCT00004635|266111|P2|NOT COMPLETED|Period One||6
111447|NCT00004635|266112|P1|NOT COMPLETED|Period One||6
111448|NCT00004635|266111|P2|COMPLETED|Period One||74
111449|NCT00004635|266112|P1|COMPLETED|Period One||73
111450|NCT00004635|266111|P2|Received Treatment|Period One||75
111451|NCT00004635|266112|P1|Received Treatment|Period One||73
111452|NCT00004635|266111|P2|STARTED|Period One||80
111453|NCT00004635|266112|P1|STARTED|Period One||79
111454|NCT00005879|266124|P2|NOT COMPLETED|Overall Study||10
111455|NCT00005879|266125|P1|NOT COMPLETED|Overall Study||8
111456|NCT00005879|266124|P2|COMPLETED|Overall Study||88
111457|NCT00005879|266125|P1|COMPLETED|Overall Study||93
111458|NCT00005879|266124|P2|STARTED|Overall Study||98
111459|NCT00005879|266125|P1|STARTED|Overall Study||101
111460|NCT00005901|266135|P2|NOT COMPLETED|Overall Study||0
111461|NCT00005901|266136|P1|NOT COMPLETED|Overall Study||0
111462|NCT00005901|266135|P2|COMPLETED|Overall Study||15
111463|NCT00005901|266136|P1|COMPLETED|Overall Study||19
111464|NCT00005901|266135|P2|STARTED|Overall Study||15
111465|NCT00005901|266136|P1|STARTED|Overall Study||19
111466|NCT00005906|266152|P1|NOT COMPLETED|Overall Study||3
111467|NCT00005906|266152|P1|COMPLETED|Overall Study||1
111468|NCT00005906|266152|P1|STARTED|Overall Study||4
111469|NCT00005908|266158|P2|NOT COMPLETED|Overall Study||0
111470|NCT00005908|266159|P1|NOT COMPLETED|Overall Study||1
111471|NCT00005908|266158|P2|COMPLETED|Overall Study||20
111472|NCT00005908|266159|P1|COMPLETED|Overall Study||9
111473|NCT00005908|266158|P2|STARTED|Overall Study||20
111474|NCT00005908|266159|P1|STARTED|Overall Study||10
111475|NCT00005937|266168|P1|NOT COMPLETED|Overall Study||5
111476|NCT00005937|266168|P1|COMPLETED|Overall Study||37
111477|NCT00005937|266168|P1|STARTED|Overall Study||42
111478|NCT00005947|266174|P2|NOT COMPLETED|Overall Study||41
111479|NCT00005947|266175|P1|NOT COMPLETED|Overall Study||57
111480|NCT00005947|266174|P2|COMPLETED|Overall Study||4
111481|NCT00005947|266175|P1|COMPLETED|Overall Study||25
111482|NCT00005947|266174|P2|STARTED|Overall Study||45
111483|NCT00005947|266175|P1|STARTED|Overall Study||82
111484|NCT00005957|266185|P2|NOT COMPLETED|Overall Study||28
111485|NCT00005957|266186|P1|NOT COMPLETED|Overall Study||8
111486|NCT00005957|266185|P2|COMPLETED|Overall Study||888
111487|NCT00005957|266186|P1|COMPLETED|Overall Study||908
111488|NCT00005957|266185|P2|STARTED|Overall Study||916
111489|NCT00005957|266186|P1|STARTED|Overall Study||916
111490|NCT00006237|266196|P2|NOT COMPLETED|Overall Study||61
111491|NCT00006237|266197|P1|NOT COMPLETED|Overall Study||125
111492|NCT00006237|266196|P2|COMPLETED|Overall Study||159
111493|NCT00006237|266197|P1|COMPLETED|Overall Study||87
111494|NCT00006237|266196|P2|Eligible and Treated|Overall Study||199
111495|NCT00006237|266197|P1|Eligible and Treated|Overall Study||203
111496|NCT00006237|266196|P2|Eligible|Overall Study||200
111497|NCT00006237|266197|P1|Eligible|Overall Study||203
111498|NCT00006237|266196|P2|STARTED|Overall Study||220
111499|NCT00006237|266197|P1|STARTED|Overall Study||212
111500|NCT00006244|266207|P1|NOT COMPLETED|Overall Study||0
111501|NCT00006244|266207|P1|COMPLETED|Overall Study||36
111502|NCT00006244|266207|P1|STARTED|Overall Study||36
111503|NCT00006289|266218|P2|NOT COMPLETED|Second Intervention (5 Weeks)||1
111504|NCT00006289|266219|P1|NOT COMPLETED|Second Intervention (5 Weeks)||1
111505|NCT00006289|266218|P2|COMPLETED|Second Intervention (5 Weeks)||9
111506|NCT00006289|266219|P1|COMPLETED|Second Intervention (5 Weeks)||9
111507|NCT00006289|266218|P2|STARTED|Second Intervention (5 Weeks)||10
111508|NCT00006289|266219|P1|STARTED|Second Intervention (5 Weeks)||10
111509|NCT00006289|266218|P2|NOT COMPLETED|Washout (>= 1 Week)||0
111510|NCT00006289|266219|P1|NOT COMPLETED|Washout (>= 1 Week)||0
111511|NCT00006289|266218|P2|COMPLETED|Washout (>= 1 Week)||10
111512|NCT00006289|266219|P1|COMPLETED|Washout (>= 1 Week)||10
111513|NCT00006289|266218|P2|STARTED|Washout (>= 1 Week)||10
111514|NCT00006289|266219|P1|STARTED|Washout (>= 1 Week)||10
111515|NCT00006289|266218|P2|NOT COMPLETED|First Intervention (5 Weeks)||0
111516|NCT00006289|266219|P1|NOT COMPLETED|First Intervention (5 Weeks)||1
111517|NCT00006289|266218|P2|COMPLETED|First Intervention (5 Weeks)||10
111518|NCT00006289|266219|P1|COMPLETED|First Intervention (5 Weeks)||10
111519|NCT00006289|266218|P2|STARTED|First Intervention (5 Weeks)||10
111520|NCT00006289|266219|P1|STARTED|First Intervention (5 Weeks)||11
111521|NCT00006305|266239|P4|NOT COMPLETED|Overall Study||14
111522|NCT00006305|266240|P3|NOT COMPLETED|Overall Study||15
111523|NCT00006305|266241|P2|NOT COMPLETED|Overall Study||10
111524|NCT00006305|266242|P1|NOT COMPLETED|Overall Study||17
111525|NCT00006305|266239|P4|COMPLETED|Overall Study||585
111526|NCT00006305|266240|P3|COMPLETED|Overall Study||578
111527|NCT00006305|266241|P2|COMPLETED|Overall Study||574
111528|NCT00006305|266242|P1|COMPLETED|Overall Study||575
111529|NCT00006305|266239|P4|STARTED|Overall Study||599
111530|NCT00006305|266240|P3|STARTED|Overall Study||593
111531|NCT00006305|266241|P2|STARTED|Overall Study||584
111532|NCT00006305|266242|P1|STARTED|Overall Study||592
111533|NCT00006389|266256|P1|NOT COMPLETED|Overall Study||1
111534|NCT00006389|266256|P1|COMPLETED|Overall Study||11
111535|NCT00006389|266256|P1|STARTED|Overall Study||12
111536|NCT00006392|266266|P4|NOT COMPLETED|Overall Study||160
111537|NCT00006392|266267|P3|NOT COMPLETED|Overall Study||160
111538|NCT00006392|266268|P2|NOT COMPLETED|Overall Study||158
111539|NCT00006392|266269|P1|NOT COMPLETED|Overall Study||167
111540|NCT00006392|266266|P4|COMPLETED|Overall Study||8696
111541|NCT00006392|266267|P3|COMPLETED|Overall Study||8703
111542|NCT00006392|266268|P2|COMPLETED|Overall Study||8752
111543|NCT00006392|266269|P1|COMPLETED|Overall Study||8737
111544|NCT00006392|266266|P4|STARTED|Overall Study||8856
111545|NCT00006392|266267|P3|STARTED|Overall Study||8863
111546|NCT00006392|266268|P2|STARTED|Overall Study||8910
111547|NCT00006392|266269|P1|STARTED|Overall Study||8904
111548|NCT00006409|266305|P6|NOT COMPLETED|Post-3 Year Intervention||62
111549|NCT00006409|266306|P5|NOT COMPLETED|Post-3 Year Intervention||62
111550|NCT00006409|266307|P4|NOT COMPLETED|Post-3 Year Intervention||0
111551|NCT00006409|266308|P3|NOT COMPLETED|Post-3 Year Intervention||0
111552|NCT00006409|266309|P2|NOT COMPLETED|Post-3 Year Intervention||0
111553|NCT00006409|266310|P1|NOT COMPLETED|Post-3 Year Intervention||0
111554|NCT00006409|266305|P6|COMPLETED|Post-3 Year Intervention||1714
111555|NCT00006409|266306|P5|COMPLETED|Post-3 Year Intervention||1664
111556|NCT00006409|266307|P4|COMPLETED|Post-3 Year Intervention||0
111557|NCT00006409|266308|P3|COMPLETED|Post-3 Year Intervention||0
111558|NCT00006409|266309|P2|COMPLETED|Post-3 Year Intervention||0
111559|NCT00006409|266310|P1|COMPLETED|Post-3 Year Intervention||0
111560|NCT00006409|266305|P6|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1776
111561|NCT00006409|266306|P5|STARTED|Post-3 Year Intervention|Sample is independent of 8th-grade/2005 sample that was measured post-2 year intervention|1726
111562|NCT00006409|266307|P4|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
111563|NCT00006409|266308|P3|STARTED|Post-3 Year Intervention|8th-grade/2005 sample was not followed over time|0
111564|NCT00006409|266309|P2|STARTED|Post-3 Year Intervention||0
111565|NCT00006409|266310|P1|STARTED|Post-3 Year Intervention||0
111566|NCT00006409|266305|P6|NOT COMPLETED|Post-2 Year Intervention||0
111567|NCT00006409|266306|P5|NOT COMPLETED|Post-2 Year Intervention||0
111568|NCT00006409|266307|P4|NOT COMPLETED|Post-2 Year Intervention||168
111569|NCT00006409|266308|P3|NOT COMPLETED|Post-2 Year Intervention||251
111570|NCT00006409|266309|P2|NOT COMPLETED|Post-2 Year Intervention||0
111571|NCT00006409|266310|P1|NOT COMPLETED|Post-2 Year Intervention||0
111572|NCT00006409|266305|P6|COMPLETED|Post-2 Year Intervention||0
111573|NCT00006409|266306|P5|COMPLETED|Post-2 Year Intervention||0
111574|NCT00006409|266307|P4|COMPLETED|Post-2 Year Intervention||1545
111575|NCT00006409|266308|P3|COMPLETED|Post-2 Year Intervention||1540
111576|NCT00006409|266309|P2|COMPLETED|Post-2 Year Intervention||0
111577|NCT00006409|266310|P1|COMPLETED|Post-2 Year Intervention||0
111578|NCT00006409|266305|P6|STARTED|Post-2 Year Intervention||0
111579|NCT00006409|266306|P5|STARTED|Post-2 Year Intervention||0
111580|NCT00006409|266307|P4|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1713
111581|NCT00006409|266308|P3|STARTED|Post-2 Year Intervention|Sample is independent of 6th-grade/2003 sample that was measured at baseline|1791
111582|NCT00006409|266309|P2|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
111583|NCT00006409|266310|P1|STARTED|Post-2 Year Intervention|6th grade/2003 sample was not followed over time|0
111584|NCT00006409|266305|P6|NOT COMPLETED|Baseline||0
111585|NCT00006409|266306|P5|NOT COMPLETED|Baseline||0
111586|NCT00006409|266307|P4|NOT COMPLETED|Baseline||0
111587|NCT00006409|266308|P3|NOT COMPLETED|Baseline||0
111588|NCT00006409|266309|P2|NOT COMPLETED|Baseline||70
111589|NCT00006409|266310|P1|NOT COMPLETED|Baseline||48
111590|NCT00006409|266305|P6|COMPLETED|Baseline||0
111591|NCT00006409|266306|P5|COMPLETED|Baseline||0
111592|NCT00006409|266307|P4|COMPLETED|Baseline||0
111593|NCT00006409|266308|P3|COMPLETED|Baseline||0
111594|NCT00006409|266309|P2|COMPLETED|Baseline||786
111595|NCT00006409|266310|P1|COMPLETED|Baseline||817
111596|NCT00006409|266305|P6|STARTED|Baseline||0
111597|NCT00006409|266306|P5|STARTED|Baseline||0
111598|NCT00006409|266307|P4|STARTED|Baseline||0
111599|NCT00006409|266308|P3|STARTED|Baseline||0
111600|NCT00006409|266309|P2|STARTED|Baseline||856
111601|NCT00006409|266310|P1|STARTED|Baseline||865
111602|NCT00005047|266334|P4|NOT COMPLETED|Overall Study||0
111603|NCT00005047|266335|P3|NOT COMPLETED|Overall Study||0
111604|NCT00005047|266336|P2|NOT COMPLETED|Overall Study||0
111605|NCT00005047|266337|P1|NOT COMPLETED|Overall Study||19
111606|NCT00005047|266334|P4|COMPLETED|Overall Study||158
111607|NCT00005047|266335|P3|COMPLETED|Overall Study||227
111608|NCT00005047|266336|P2|COMPLETED|Overall Study||56
111609|NCT00005047|266337|P1|COMPLETED|Overall Study||39
111610|NCT00005047|266334|P4|STARTED|Overall Study||158
111611|NCT00005047|266335|P3|STARTED|Overall Study||227
111612|NCT00005047|266336|P2|STARTED|Overall Study||56
111613|NCT00005047|266337|P1|STARTED|Overall Study||58
111614|NCT00005669|266353|P2|NOT COMPLETED|Overall Study||7
111615|NCT00005669|266354|P1|NOT COMPLETED|Overall Study||8
111616|NCT00005669|266353|P2|COMPLETED|Overall Study||40
111617|NCT00005669|266354|P1|COMPLETED|Overall Study||45
111618|NCT00005669|266353|P2|STARTED|Overall Study||47
111619|NCT00005669|266354|P1|STARTED|Overall Study||53
111620|NCT00006478|266368|P1|NOT COMPLETED|Overall Study||7
111621|NCT00006478|266368|P1|COMPLETED|Overall Study||12
111622|NCT00006478|266368|P1|STARTED|Overall Study||19
111623|NCT00006489|266376|P4|NOT COMPLETED|Overall Study||11
111624|NCT00006489|266377|P3|NOT COMPLETED|Overall Study||15
111625|NCT00006489|266378|P2|NOT COMPLETED|Overall Study||14
111626|NCT00006489|266379|P1|NOT COMPLETED|Overall Study||13
111627|NCT00006489|266376|P4|COMPLETED|Overall Study||32
111628|NCT00006489|266377|P3|COMPLETED|Overall Study||25
111629|NCT00006489|266378|P2|COMPLETED|Overall Study||26
111630|NCT00006489|266379|P1|COMPLETED|Overall Study||29
111631|NCT00006489|266376|P4|STARTED|Overall Study||43
111632|NCT00006489|266377|P3|STARTED|Overall Study||40
111633|NCT00006489|266378|P2|STARTED|Overall Study||40
111634|NCT00006489|266379|P1|STARTED|Overall Study||42
111635|NCT00006604|266404|P17|NOT COMPLETED|Overall Study||9
111636|NCT00006604|266405|P16|NOT COMPLETED|Overall Study||5
111637|NCT00006604|266406|P15|NOT COMPLETED|Overall Study||10
111638|NCT00006604|266407|P14|NOT COMPLETED|Overall Study||6
111639|NCT00006604|266408|P13|NOT COMPLETED|Overall Study||4
111640|NCT00006604|266409|P12|NOT COMPLETED|Overall Study||6
111641|NCT00006604|266410|P11|NOT COMPLETED|Overall Study||8
111642|NCT00006604|266411|P10|NOT COMPLETED|Overall Study||19
111643|NCT00006604|266412|P9|NOT COMPLETED|Overall Study||1
111644|NCT00006604|266413|P8|NOT COMPLETED|Overall Study||3
111645|NCT00006604|266414|P7|NOT COMPLETED|Overall Study||9
111646|NCT00006604|266415|P6|NOT COMPLETED|Overall Study||3
111647|NCT00006604|266416|P5|NOT COMPLETED|Overall Study||2
111648|NCT00006604|266417|P4|NOT COMPLETED|Overall Study||5
111649|NCT00006604|266418|P3|NOT COMPLETED|Overall Study||4
111650|NCT00006604|266419|P2|NOT COMPLETED|Overall Study||0
111651|NCT00006604|266420|P1|NOT COMPLETED|Overall Study||2
111652|NCT00006604|266404|P17|COMPLETED|Overall Study||6
111653|NCT00006604|266405|P16|COMPLETED|Overall Study||1
111654|NCT00006604|266406|P15|COMPLETED|Overall Study||14
111655|NCT00006604|266407|P14|COMPLETED|Overall Study||0
111656|NCT00006604|266408|P13|COMPLETED|Overall Study||22
111657|NCT00006604|266409|P12|COMPLETED|Overall Study||6
111658|NCT00006604|266410|P11|COMPLETED|Overall Study||13
111659|NCT00006604|266411|P10|COMPLETED|Overall Study||6
111660|NCT00006604|266412|P9|COMPLETED|Overall Study||4
111661|NCT00006604|266413|P8|COMPLETED|Overall Study||2
111662|NCT00006604|266414|P7|COMPLETED|Overall Study||12
111663|NCT00006604|266415|P6|COMPLETED|Overall Study||2
111664|NCT00006604|266416|P5|COMPLETED|Overall Study||3
111665|NCT00006604|266417|P4|COMPLETED|Overall Study||1
111666|NCT00006604|266418|P3|COMPLETED|Overall Study||1
111667|NCT00006604|266419|P2|COMPLETED|Overall Study||2
111668|NCT00006604|266420|P1|COMPLETED|Overall Study||4
111669|NCT00006604|266404|P17|STARTED|Overall Study||15
111670|NCT00006604|266405|P16|STARTED|Overall Study||6
111671|NCT00006604|266406|P15|STARTED|Overall Study||24
111672|NCT00006604|266407|P14|STARTED|Overall Study||6
111673|NCT00006604|266408|P13|STARTED|Overall Study||26
111674|NCT00006604|266409|P12|STARTED|Overall Study||12
111675|NCT00006604|266410|P11|STARTED|Overall Study||21
111676|NCT00006604|266411|P10|STARTED|Overall Study||25
111677|NCT00006604|266412|P9|STARTED|Overall Study||5
111678|NCT00006604|266413|P8|STARTED|Overall Study||5
111679|NCT00006604|266414|P7|STARTED|Overall Study||21
111680|NCT00006604|266415|P6|STARTED|Overall Study||5
111681|NCT00006604|266416|P5|STARTED|Overall Study||5
111682|NCT00006604|266417|P4|STARTED|Overall Study||6
111683|NCT00006604|266418|P3|STARTED|Overall Study||5
111684|NCT00006604|266419|P2|STARTED|Overall Study||2
111685|NCT00006604|266420|P1|STARTED|Overall Study||6
111686|NCT00006721|266537|P3|NOT COMPLETED|Overall Study||33
111687|NCT00006721|266538|P2|NOT COMPLETED|Overall Study||25
111688|NCT00006721|266539|P1|NOT COMPLETED|Overall Study||4
111689|NCT00006721|266537|P3|COMPLETED|Overall Study||242
111690|NCT00006721|266538|P2|COMPLETED|Overall Study||254
111691|NCT00006721|266539|P1|COMPLETED|Overall Study||13
111692|NCT00006721|266537|P3|Eligible and Began Protocol Therapy|Overall Study||265
111693|NCT00006721|266538|P2|Eligible and Began Protocol Therapy|Overall Study||267
111694|NCT00006721|266539|P1|Eligible and Began Protocol Therapy|Overall Study||14
111695|NCT00006721|266537|P3|Eligible|Overall Study||265
111696|NCT00006721|266538|P2|Eligible|Overall Study||267
111697|NCT00006721|266539|P1|Eligible|Overall Study||15
111698|NCT00006721|266537|P3|STARTED|Overall Study||275
111699|NCT00006721|266538|P2|STARTED|Overall Study||279
111700|NCT00006721|266539|P1|STARTED|Overall Study||17
111701|NCT00006903|266559|P3|NOT COMPLETED|Overall Study||6
111702|NCT00006903|266560|P2|NOT COMPLETED|Overall Study||4
111703|NCT00006903|266561|P1|NOT COMPLETED|Overall Study||10
111704|NCT00006903|266559|P3|COMPLETED|Overall Study||27
111705|NCT00006903|266560|P2|COMPLETED|Overall Study||20
111706|NCT00006903|266561|P1|COMPLETED|Overall Study||0
111707|NCT00006903|266559|P3|STARTED|Overall Study||33
111708|NCT00006903|266560|P2|STARTED|Overall Study||24
111709|NCT00006903|266561|P1|STARTED|Overall Study||10
111710|NCT00006916|266566|P1|NOT COMPLETED|Overall Study||5
111711|NCT00006916|266566|P1|COMPLETED|Overall Study|Subjects with survival data for the primary analysis are considered to have completed the study.|14
111712|NCT00006916|266566|P1|STARTED|Overall Study||19
111713|NCT00007345|266572|P2|NOT COMPLETED|Overall Study||11
111714|NCT00007345|266573|P1|NOT COMPLETED|Overall Study||2
111715|NCT00007345|266572|P2|COMPLETED|Overall Study||73
111716|NCT00007345|266573|P1|COMPLETED|Overall Study||45
111717|NCT00007345|266572|P2|STARTED|Overall Study||84
111718|NCT00007345|266573|P1|STARTED|Overall Study||47
111719|NCT00007475|266594|P4|NOT COMPLETED|Overall Study||0
111720|NCT00007475|266595|P3|NOT COMPLETED|Overall Study||0
111721|NCT00007475|266596|P2|NOT COMPLETED|Overall Study||0
111722|NCT00007475|266597|P1|NOT COMPLETED|Overall Study||4
111723|NCT00007475|266594|P4|COMPLETED|Overall Study||0
111724|NCT00007475|266595|P3|COMPLETED|Overall Study||2
111725|NCT00007475|266596|P2|COMPLETED|Overall Study||1
111726|NCT00007475|266597|P1|COMPLETED|Overall Study||8
111727|NCT00007475|266594|P4|Initiate Cyclophosphamide|Overall Study||0
111728|NCT00007475|266595|P3|Initiate Cyclophosphamide|Overall Study||2
111729|NCT00007475|266596|P2|Initiate Cyclophosphamide|Overall Study||1
111730|NCT00007475|266597|P1|Initiate Cyclophosphamide|Overall Study||12
111731|NCT00007475|266594|P4|Initial Plasma Exchange|Overall Study||0
111732|NCT00007475|266595|P3|Initial Plasma Exchange|Overall Study||2
111733|NCT00007475|266596|P2|Initial Plasma Exchange|Overall Study||1
111734|NCT00007475|266597|P1|Initial Plasma Exchange|Overall Study||12
111735|NCT00007475|266594|P4|Post-initial Transplant Proteinuria|Overall Study||0
111736|NCT00007475|266595|P3|Post-initial Transplant Proteinuria|Overall Study||2
111737|NCT00007475|266596|P2|Post-initial Transplant Proteinuria|Overall Study||1
111738|NCT00007475|266597|P1|Post-initial Transplant Proteinuria|Overall Study||12
111739|NCT00007475|266594|P4|Initial Transplant|Overall Study||0
111740|NCT00007475|266595|P3|Initial Transplant|Overall Study||2
111741|NCT00007475|266596|P2|Initial Transplant|Overall Study||1
111742|NCT00007475|266597|P1|Initial Transplant|Overall Study||12
111743|NCT00007475|266594|P4|FSGS Permeability Factor (FPF) Assayed|Overall Study||0
111744|NCT00007475|266595|P3|FSGS Permeability Factor (FPF) Assayed|Overall Study||2
111745|NCT00007475|266596|P2|FSGS Permeability Factor (FPF) Assayed|Overall Study||1
111746|NCT00007475|266597|P1|FSGS Permeability Factor (FPF) Assayed|Overall Study|FSGS Permeability Factor's provisional assay only applied to minority of early enrollees, by design.|0
111747|NCT00007475|266594|P4|STARTED|Overall Study||0
111748|NCT00007475|266595|P3|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|2
111749|NCT00007475|266596|P2|STARTED|Overall Study|[ arm reflects eventual participant disposition ]|1
111750|NCT00007475|266597|P1|STARTED|Overall Study|[ arm reflects un-assayed participants' disposition ]|12
111751|NCT00007644|266619|P2|NOT COMPLETED|Overall Study||0
111752|NCT00007644|266620|P1|NOT COMPLETED|Overall Study||0
111753|NCT00007644|266619|P2|COMPLETED|Overall Study||367
111754|NCT00007644|266620|P1|COMPLETED|Overall Study||364
111755|NCT00007644|266619|P2|STARTED|Overall Study||367
111756|NCT00007644|266620|P1|STARTED|Overall Study||364
111757|NCT00008138|266626|P1|NOT COMPLETED|Post-Cytoreduction Chemotherapy||8
111758|NCT00008138|266626|P1|COMPLETED|Post-Cytoreduction Chemotherapy||18
111759|NCT00008138|266626|P1|STARTED|Post-Cytoreduction Chemotherapy|Among 36 patients from previous period, 5 patients rejected and 5 patients are ineligible.|26
111760|NCT00008138|266626|P1|NOT COMPLETED|Interval Debulking||2
111761|NCT00008138|266626|P1|COMPLETED|Interval Debulking||36
111762|NCT00008138|266626|P1|Received Protocol Surgery|Interval Debulking||36
111763|NCT00008138|266626|P1|STARTED|Interval Debulking||38
111764|NCT00008138|266626|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||20
111765|NCT00008138|266626|P1|COMPLETED|Neoadjuvant Chemotherapy||38
111766|NCT00008138|266626|P1|Eligible|Neoadjuvant Chemotherapy||58
111767|NCT00008138|266626|P1|STARTED|Neoadjuvant Chemotherapy||58
111768|NCT00008385|266634|P2|NOT COMPLETED|Overall Study||802
111769|NCT00008385|266635|P1|NOT COMPLETED|Overall Study||387
111770|NCT00008385|266634|P2|COMPLETED|Overall Study||238
111771|NCT00008385|266635|P1|COMPLETED|Overall Study||134
111772|NCT00008385|266634|P2|Off Treatment Reasons Reported|Overall Study||795
111773|NCT00008385|266635|P1|Off Treatment Reasons Reported|Overall Study||398
111774|NCT00008385|266634|P2|Treated|Overall Study||865
111775|NCT00008385|266635|P1|Treated|Overall Study||477
111776|NCT00008385|266634|P2|STARTED|Overall Study||1040
111777|NCT00008385|266635|P1|STARTED|Overall Study||521
111778|NCT00006011|266648|P3|NOT COMPLETED|Overall Study||73
111779|NCT00006011|266649|P2|NOT COMPLETED|Overall Study||77
111780|NCT00006011|266650|P1|NOT COMPLETED|Overall Study||65
111781|NCT00006011|266648|P3|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|0
111782|NCT00006011|266649|P2|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|221
111783|NCT00006011|266650|P1|COMPLETED|Overall Study|total number of partipants that completed 6 cycles of chemotherapy.|223
111784|NCT00006011|266648|P3|STARTED|Overall Study|total number of participants enrolled, that only received radiation treatment.|73
111785|NCT00006011|266649|P2|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 2 of study.|298
111786|NCT00006011|266650|P1|STARTED|Overall Study|total number of participants enrolled, that received random treatment assignment to Arm 1 of study.|288
111787|NCT00006110|266658|P2|NOT COMPLETED|Overall Study||0
111788|NCT00006110|266659|P1|NOT COMPLETED|Overall Study||0
111789|NCT00006110|266658|P2|COMPLETED|Overall Study||30
111790|NCT00006110|266659|P1|COMPLETED|Overall Study||52
111791|NCT00006110|266658|P2|STARTED|Overall Study||30
111792|NCT00006110|266659|P1|STARTED|Overall Study||52
111793|NCT00006151|266673|P2|NOT COMPLETED|Overall Study||14
111794|NCT00006151|266674|P1|NOT COMPLETED|Overall Study||13
111795|NCT00006151|266673|P2|COMPLETED|Overall Study||16
111796|NCT00006151|266674|P1|COMPLETED|Overall Study||17
111797|NCT00006151|266673|P2|STARTED|Overall Study||30
111798|NCT00006151|266674|P1|STARTED|Overall Study||30
111799|NCT00006156|266682|P2|NOT COMPLETED|Overall Study||0
111800|NCT00006156|266683|P1|NOT COMPLETED|Overall Study||0
111801|NCT00006156|266682|P2|COMPLETED|Overall Study||7
111802|NCT00006156|266683|P1|COMPLETED|Overall Study||42
111803|NCT00006156|266682|P2|STARTED|Overall Study||7
111804|NCT00006156|266683|P1|STARTED|Overall Study||42
111805|NCT00006164|266692|P2|NOT COMPLETED|Overall Study||81
111806|NCT00006164|266693|P1|NOT COMPLETED|Overall Study||70
111807|NCT00006164|266692|P2|COMPLETED|Overall Study|81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol|452
111808|NCT00006164|266693|P1|COMPLETED|Overall Study|70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed|447
111809|NCT00006164|266692|P2|STARTED|Overall Study||533
111810|NCT00006164|266693|P1|STARTED|Overall Study||517
111811|NCT00006170|266721|P4|NOT COMPLETED|Overall Study||39
111812|NCT00006170|266722|P3|NOT COMPLETED|Overall Study||43
111813|NCT00006170|266723|P2|NOT COMPLETED|Overall Study||50
111814|NCT00006170|266724|P1|NOT COMPLETED|Overall Study||49
111815|NCT00006170|266721|P4|COMPLETED|Overall Study||28
111816|NCT00006170|266722|P3|COMPLETED|Overall Study||46
111817|NCT00006170|266723|P2|COMPLETED|Overall Study||37
111818|NCT00006170|266724|P1|COMPLETED|Overall Study||57
111819|NCT00006170|266721|P4|STARTED|Overall Study||67
111820|NCT00006170|266722|P3|STARTED|Overall Study||89
111821|NCT00006170|266723|P2|STARTED|Overall Study||87
111822|NCT00006170|266724|P1|STARTED|Overall Study||106
111823|NCT00006178|266742|P1|NOT COMPLETED|Overall Study||0
111824|NCT00006178|266742|P1|COMPLETED|Overall Study||12
111825|NCT00006178|266742|P1|STARTED|Overall Study||12
111826|NCT00006184|266751|P2|NOT COMPLETED|Overall Study||0
111827|NCT00006184|266752|P1|NOT COMPLETED|Overall Study||1
111828|NCT00006184|266751|P2|COMPLETED|Overall Study||10
111829|NCT00006184|266752|P1|COMPLETED|Overall Study||9
111830|NCT00006184|266751|P2|STARTED|Overall Study||10
111831|NCT00006184|266752|P1|STARTED|Overall Study||10
111832|NCT00014495|266763|P4|NOT COMPLETED|Overall Study||1
111833|NCT00014495|266764|P3|NOT COMPLETED|Overall Study||1
111834|NCT00014495|266765|P2|NOT COMPLETED|Overall Study||0
111835|NCT00014495|266766|P1|NOT COMPLETED|Overall Study||0
111836|NCT00014495|266763|P4|COMPLETED|Overall Study||5
111837|NCT00014495|266764|P3|COMPLETED|Overall Study||19
111838|NCT00014495|266765|P2|COMPLETED|Overall Study||3
111839|NCT00014495|266766|P1|COMPLETED|Overall Study||3
111840|NCT00014495|266763|P4|STARTED|Overall Study||6
111841|NCT00014495|266764|P3|STARTED|Overall Study||20
111842|NCT00014495|266765|P2|STARTED|Overall Study||3
111843|NCT00014495|266766|P1|STARTED|Overall Study||3
111844|NCT00014560|266773|P1|NOT COMPLETED|Overall Study||3
111845|NCT00014560|266773|P1|COMPLETED|Overall Study||0
111846|NCT00014560|266773|P1|STARTED|Overall Study||3
111847|NCT00014911|266777|P1|NOT COMPLETED|Overall Study||11
111848|NCT00014911|266777|P1|COMPLETED|Overall Study|One subject experienced pneumonia, myocardial infarction, and acute renal failure|25
111849|NCT00014911|266777|P1|STARTED|Overall Study||36
111850|NCT00015457|266786|P2|NOT COMPLETED|Second Intervention||0
111851|NCT00015457|266787|P1|NOT COMPLETED|Second Intervention||1
111852|NCT00015457|266786|P2|COMPLETED|Second Intervention||5
111853|NCT00015457|266787|P1|COMPLETED|Second Intervention||7
111854|NCT00015457|266786|P2|STARTED|Second Intervention||5
111855|NCT00015457|266787|P1|STARTED|Second Intervention||8
111856|NCT00015457|266786|P2|NOT COMPLETED|First Intervention||3
111857|NCT00015457|266787|P1|NOT COMPLETED|First Intervention||0
111858|NCT00015457|266786|P2|COMPLETED|First Intervention||5
111859|NCT00015457|266787|P1|COMPLETED|First Intervention||8
111860|NCT00015457|266786|P2|STARTED|First Intervention||8
111861|NCT00015457|266787|P1|STARTED|First Intervention||8
111862|NCT00015847|266795|P1|NOT COMPLETED|Overall Study||0
111863|NCT00015847|266795|P1|COMPLETED|Overall Study||25
111864|NCT00015847|266795|P1|STARTED|Overall Study||25
111865|NCT00016354|266801|P8|NOT COMPLETED|Overall Study||1
111866|NCT00016354|266802|P7|NOT COMPLETED|Overall Study||0
111867|NCT00016354|266803|P6|NOT COMPLETED|Overall Study||0
111868|NCT00016354|266804|P5|NOT COMPLETED|Overall Study||0
111869|NCT00016354|266805|P4|NOT COMPLETED|Overall Study||0
111870|NCT00016354|266806|P3|NOT COMPLETED|Overall Study||0
111871|NCT00016354|266807|P2|NOT COMPLETED|Overall Study||0
111872|NCT00016354|266808|P1|NOT COMPLETED|Overall Study||0
111873|NCT00016354|266801|P8|COMPLETED|Overall Study||6
111874|NCT00016354|266802|P7|COMPLETED|Overall Study||6
111875|NCT00016354|266803|P6|COMPLETED|Overall Study||1
111876|NCT00016354|266804|P5|COMPLETED|Overall Study||1
111877|NCT00016354|266805|P4|COMPLETED|Overall Study||1
111878|NCT00016354|266806|P3|COMPLETED|Overall Study||1
111879|NCT00016354|266807|P2|COMPLETED|Overall Study||1
111880|NCT00016354|266808|P1|COMPLETED|Overall Study||1
111881|NCT00016354|266801|P8|STARTED|Overall Study||7
111882|NCT00016354|266802|P7|STARTED|Overall Study||6
111883|NCT00016354|266803|P6|STARTED|Overall Study||1
111884|NCT00016354|266804|P5|STARTED|Overall Study||1
111885|NCT00016354|266805|P4|STARTED|Overall Study||1
111886|NCT00016354|266806|P3|STARTED|Overall Study||1
111887|NCT00016354|266807|P2|STARTED|Overall Study||1
111888|NCT00016354|266808|P1|STARTED|Overall Study||1
111889|NCT00016913|266812|P1|NOT COMPLETED|Overall Study||0
111890|NCT00016913|266812|P1|COMPLETED|Overall Study||27
111891|NCT00016913|266812|P1|STARTED|Overall Study||27
111892|NCT00018031|266818|P1|NOT COMPLETED|Overall Study||0
111893|NCT00018031|266818|P1|COMPLETED|Overall Study||36
111894|NCT00018031|266818|P1|STARTED|Overall Study||36
111895|NCT00019604|266822|P1|NOT COMPLETED|Overall Study||39
111896|NCT00019604|266822|P1|COMPLETED|Overall Study||5
111897|NCT00019604|266822|P1|STARTED|Overall Study||44
111898|NCT00019747|266837|P2|NOT COMPLETED|Overall Study||0
111899|NCT00019747|266838|P1|NOT COMPLETED|Overall Study||0
111900|NCT00019747|266837|P2|COMPLETED|Overall Study||16
111901|NCT00019747|266838|P1|COMPLETED|Overall Study||23
111902|NCT00019747|266837|P2|STARTED|Overall Study||16
111903|NCT00019747|266838|P1|STARTED|Overall Study||23
111904|NCT00020722|266844|P1|NOT COMPLETED|Overall Study||0
111905|NCT00020722|266844|P1|COMPLETED|Overall Study||7
111906|NCT00020722|266844|P1|STARTED|Overall Study||7
111907|NCT00009737|266851|P2|NOT COMPLETED|Overall Study||123
111908|NCT00009737|266852|P1|NOT COMPLETED|Overall Study||170
111909|NCT00009737|266851|P2|COMPLETED|Overall Study||860
111910|NCT00009737|266852|P1|COMPLETED|Overall Study||834
111911|NCT00009737|266851|P2|STARTED|Overall Study||983
111912|NCT00009737|266852|P1|STARTED|Overall Study||1004
111913|NCT00011986|266873|P5|NOT COMPLETED|Overall Study||0
111914|NCT00011986|266874|P4|NOT COMPLETED|Overall Study||0
111915|NCT00011986|266875|P3|NOT COMPLETED|Overall Study||0
111916|NCT00011986|266876|P2|NOT COMPLETED|Overall Study||0
111917|NCT00011986|266877|P1|NOT COMPLETED|Overall Study||0
111918|NCT00011986|266873|P5|COMPLETED|Overall Study||861
111919|NCT00011986|266874|P4|COMPLETED|Overall Study||861
111920|NCT00011986|266875|P3|COMPLETED|Overall Study||862
111921|NCT00011986|266876|P2|COMPLETED|Overall Study||864
111922|NCT00011986|266877|P1|COMPLETED|Overall Study||864
111923|NCT00011986|266873|P5|Initiated Treatment|Overall Study||851
111924|NCT00011986|266874|P4|Initiated Treatment|Overall Study||846
111925|NCT00011986|266875|P3|Initiated Treatment|Overall Study||854
111926|NCT00011986|266876|P2|Initiated Treatment|Overall Study||860
111927|NCT00011986|266877|P1|Initiated Treatment|Overall Study||862
111928|NCT00011986|266873|P5|STARTED|Overall Study||861
111929|NCT00011986|266874|P4|STARTED|Overall Study||861
111930|NCT00011986|266875|P3|STARTED|Overall Study||862
111931|NCT00011986|266876|P2|STARTED|Overall Study||864
111932|NCT00011986|266877|P1|STARTED|Overall Study||864
111933|NCT00012012|266891|P2|NOT COMPLETED|Overall Study||3
111934|NCT00012012|266892|P1|NOT COMPLETED|Overall Study||1
111935|NCT00012012|266891|P2|COMPLETED|Overall Study||15
111936|NCT00012012|266892|P1|COMPLETED|Overall Study||26
111937|NCT00012012|266891|P2|STARTED|Overall Study||18
111938|NCT00012012|266892|P1|STARTED|Overall Study||27
111939|NCT00012298|266905|P7|NOT COMPLETED|Overall Study||0
111940|NCT00012298|266906|P6|NOT COMPLETED|Overall Study||0
111941|NCT00012298|266907|P5|NOT COMPLETED|Overall Study||0
111942|NCT00012298|266908|P4|NOT COMPLETED|Overall Study||0
111943|NCT00012298|266909|P3|NOT COMPLETED|Overall Study||0
111944|NCT00012298|266910|P2|NOT COMPLETED|Overall Study||0
111945|NCT00012298|266911|P1|NOT COMPLETED|Overall Study||0
111946|NCT00012298|266905|P7|COMPLETED|Overall Study||39
111947|NCT00012298|266906|P6|COMPLETED|Overall Study||6
111948|NCT00012298|266907|P5|COMPLETED|Overall Study||5
111949|NCT00012298|266908|P4|COMPLETED|Overall Study||4
111950|NCT00012298|266909|P3|COMPLETED|Overall Study||9
111951|NCT00012298|266910|P2|COMPLETED|Overall Study||7
111952|NCT00012298|266911|P1|COMPLETED|Overall Study||11
111953|NCT00012298|266905|P7|STARTED|Overall Study||39
111954|NCT00012298|266906|P6|STARTED|Overall Study||6
111955|NCT00012298|266907|P5|STARTED|Overall Study||5
111956|NCT00012298|266908|P4|STARTED|Overall Study||4
111957|NCT00012298|266909|P3|STARTED|Overall Study||9
111958|NCT00012298|266910|P2|STARTED|Overall Study||7
111959|NCT00012298|266911|P1|STARTED|Overall Study||11
111960|NCT00013611|266935|P2|NOT COMPLETED|Overall Study||100
111961|NCT00013611|266936|P1|NOT COMPLETED|Overall Study||91
111962|NCT00013611|266935|P2|COMPLETED|Overall Study||746
111963|NCT00013611|266936|P1|COMPLETED|Overall Study||758
111964|NCT00013611|266935|P2|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|846
111965|NCT00013611|266936|P1|STARTED|Overall Study|138 were excluded from sites that did not re-consent 2/3 of patients to the amended protocol in 2003|849
111966|NCT00021229|266955|P3|NOT COMPLETED|Overall Study||16
111967|NCT00021229|266956|P2|NOT COMPLETED|Overall Study||33
111968|NCT00021229|266957|P1|NOT COMPLETED|Overall Study||35
111969|NCT00021229|266955|P3|COMPLETED|Overall Study||0
111970|NCT00021229|266956|P2|COMPLETED|Overall Study||0
111971|NCT00021229|266957|P1|COMPLETED|Overall Study|1 participant completed 13 courses of therapy|1
111972|NCT00021229|266955|P3|Enrolled in Phase II|Overall Study|Participants from stratum IIB did not participate in the phase II part of the study.|0
111973|NCT00021229|266956|P2|Enrolled in Phase II|Overall Study|Participants from stratum IIA did not participate in the phase II part of the study.|0
111974|NCT00021229|266957|P1|Enrolled in Phase II|Overall Study|Thirteen participants treated at the MTD in the phase I were also part of the phase II.|14
111975|NCT00021229|266955|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|4 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|12
111976|NCT00021229|266956|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study|13 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|20
111977|NCT00021229|266957|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|12 participants enrolled in the Phase I part did not complete the 8 week MTD estimation period.|23
111978|NCT00021229|266955|P3|Enrolled in Phase I|Overall Study||16
111979|NCT00021229|266956|P2|Enrolled in Phase I|Overall Study||33
111980|NCT00021229|266957|P1|Enrolled in Phase I|Overall Study||35
111981|NCT00021229|266955|P3|STARTED|Overall Study||16
111982|NCT00021229|266956|P2|STARTED|Overall Study||33
111983|NCT00021229|266957|P1|STARTED|Overall Study||36
111984|NCT00021255|266986|P3|NOT COMPLETED|Overall Study||149
111985|NCT00021255|266987|P2|NOT COMPLETED|Overall Study||270
111986|NCT00021255|266988|P1|NOT COMPLETED|Overall Study||121
111987|NCT00021255|266986|P3|COMPLETED|Overall Study||926
111988|NCT00021255|266987|P2|COMPLETED|Overall Study||804
111989|NCT00021255|266988|P1|COMPLETED|Overall Study||952
111990|NCT00021255|266986|P3|Safety Population|Overall Study|1056 participants received TCH.|1056
111991|NCT00021255|266987|P2|Safety Population|Overall Study|1100 participants received AC-TH (1066 from AC-TH arm, 33 from AC-T arm and 1 from TCH arm).|1100
111992|NCT00021255|266988|P1|Safety Population|Overall Study|1018 participants received AC-T (1012 from AC-T arm, 6 from AC-TH arm).|1018
111993|NCT00021255|266986|P3|Treated|Overall Study||1057
111994|NCT00021255|266987|P2|Treated|Overall Study||1072
111995|NCT00021255|266988|P1|Treated|Overall Study||1045
111996|NCT00021255|266986|P3|STARTED|Overall Study|Randomized|1075
111997|NCT00021255|266987|P2|STARTED|Overall Study|Randomized|1074
111998|NCT00021255|266988|P1|STARTED|Overall Study|Randomized|1073
111999|NCT00024258|267002|P1|NOT COMPLETED|Overall Study||9
112000|NCT00024258|267002|P1|COMPLETED|Overall Study||13
112001|NCT00024258|267002|P1|STARTED|Overall Study||22
112002|NCT00025155|267006|P1|NOT COMPLETED|Overall Study||2
112003|NCT00025155|267006|P1|COMPLETED|Overall Study|Patients who were eligible and received any study treatment.|49
112004|NCT00025155|267006|P1|STARTED|Overall Study||51
112005|NCT00025233|267012|P1|NOT COMPLETED|Overall Study||4
112006|NCT00025233|267012|P1|COMPLETED|Overall Study||46
112007|NCT00025233|267012|P1|STARTED|Overall Study||50
112008|NCT00025259|267025|P7|NOT COMPLETED|Overall Study||51
112009|NCT00025259|267026|P6|NOT COMPLETED|Overall Study||52
112010|NCT00025259|267027|P5|NOT COMPLETED|Overall Study||36
112011|NCT00025259|267028|P4|NOT COMPLETED|Overall Study||114
112012|NCT00025259|267029|P3|NOT COMPLETED|Overall Study||81
112013|NCT00025259|267030|P2|NOT COMPLETED|Overall Study||89
112014|NCT00025259|267031|P1|NOT COMPLETED|Overall Study||45
112015|NCT00025259|267025|P7|COMPLETED|Overall Study||102
112016|NCT00025259|267026|P6|COMPLETED|Overall Study||101
112017|NCT00025259|267027|P5|COMPLETED|Overall Study||6
112018|NCT00025259|267028|P4|COMPLETED|Overall Study||457
112019|NCT00025259|267029|P3|COMPLETED|Overall Study||301
112020|NCT00025259|267030|P2|COMPLETED|Overall Study||292
112021|NCT00025259|267031|P1|COMPLETED|Overall Study||7
112022|NCT00025259|267025|P7|STARTED|Overall Study||153
112023|NCT00025259|267026|P6|STARTED|Overall Study||153
112024|NCT00025259|267027|P5|STARTED|Overall Study||42
112025|NCT00025259|267028|P4|STARTED|Overall Study||571
112026|NCT00025259|267029|P3|STARTED|Overall Study||382
112027|NCT00025259|267030|P2|STARTED|Overall Study||381
112028|NCT00025259|267031|P1|STARTED|Overall Study||52
112029|NCT00025506|267067|P1|NOT COMPLETED|Overall Study||10
112030|NCT00025506|267067|P1|COMPLETED|Overall Study|Eligible and treated patients.|45
112031|NCT00025506|267067|P1|STARTED|Overall Study||55
112032|NCT00025662|267073|P1|NOT COMPLETED|Overall Study||3
112033|NCT00025662|267073|P1|COMPLETED|Overall Study|One patient who received a transplant did not meet eligibility and was a special exemption.|22
112034|NCT00025662|267073|P1|STARTED|Overall Study||25
112035|NCT00025883|267083|P1|NOT COMPLETED|Overall Study||17
112036|NCT00025883|267083|P1|COMPLETED|Overall Study||86
112037|NCT00025883|267083|P1|Partial Lipodystrophy|Overall Study||40
112038|NCT00025883|267083|P1|Generalized Lipodystrophy|Overall Study||63
112039|NCT00025883|267083|P1|STARTED|Overall Study||103
112040|NCT00026221|267093|P3|NOT COMPLETED|Overall Study||0
112041|NCT00026221|267094|P2|NOT COMPLETED|Overall Study||0
112042|NCT00026221|267095|P1|NOT COMPLETED|Overall Study||0
112043|NCT00026221|267093|P3|COMPLETED|Overall Study||25
112044|NCT00026221|267094|P2|COMPLETED|Overall Study||16
112045|NCT00026221|267095|P1|COMPLETED|Overall Study||16
112046|NCT00026221|267093|P3|STARTED|Overall Study||25
112047|NCT00026221|267094|P2|STARTED|Overall Study||16
112048|NCT00026221|267095|P1|STARTED|Overall Study||16
112049|NCT00026312|267114|P2|NOT COMPLETED|Overall Study||269
112050|NCT00026312|267115|P1|NOT COMPLETED|Overall Study||34
112051|NCT00026312|267114|P2|COMPLETED|Overall Study||1064
112052|NCT00026312|267115|P1|COMPLETED|Overall Study||82
112053|NCT00026312|267114|P2|STARTED|Overall Study||1333
112054|NCT00026312|267115|P1|STARTED|Overall Study||116
112055|NCT00026494|267134|P4|NOT COMPLETED|Overall Study||0
112056|NCT00026494|267135|P3|NOT COMPLETED|Overall Study||6
112057|NCT00026494|267136|P2|NOT COMPLETED|Overall Study||0
112058|NCT00026494|267137|P1|NOT COMPLETED|Overall Study||2
112059|NCT00026494|267134|P4|COMPLETED|Overall Study||16
112060|NCT00026494|267135|P3|COMPLETED|Overall Study||16
112061|NCT00026494|267136|P2|COMPLETED|Overall Study||4
112062|NCT00026494|267137|P1|COMPLETED|Overall Study||5
112063|NCT00026494|267134|P4|STARTED|Overall Study||16
112064|NCT00026494|267135|P3|STARTED|Overall Study||22
112065|NCT00026494|267136|P2|STARTED|Overall Study||4
112066|NCT00026494|267137|P1|STARTED|Overall Study||7
112067|NCT00010257|267149|P2|NOT COMPLETED|Overall Study||0
112068|NCT00010257|267150|P1|NOT COMPLETED|Overall Study||1
112069|NCT00010257|267149|P2|COMPLETED|Overall Study||21
112070|NCT00010257|267150|P1|COMPLETED|Overall Study||24
112071|NCT00010257|267149|P2|STARTED|Overall Study||21
112072|NCT00010257|267150|P1|STARTED|Overall Study||25
112073|NCT00010439|267158|P1|NOT COMPLETED|Overall Study||0
112074|NCT00010439|267158|P1|COMPLETED|Overall Study||10
112075|NCT00010439|267158|P1|6 Months|Overall Study||10
112076|NCT00010439|267158|P1|STARTED|Overall Study||10
112077|NCT00010803|267165|P2|NOT COMPLETED|Overall Study||98
112078|NCT00010803|267166|P1|NOT COMPLETED|Overall Study||97
112079|NCT00010803|267165|P2|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1426
112080|NCT00010803|267166|P1|COMPLETED|Overall Study|Reached endpoint of dementia, death or completion|1448
112081|NCT00010803|267165|P2|STARTED|Overall Study|Randomized|1524
112082|NCT00010803|267166|P1|STARTED|Overall Study|Randomized|1545
112083|NCT00017563|267176|P1|NOT COMPLETED|Overall Study||1
112084|NCT00017563|267176|P1|COMPLETED|Overall Study||56
112085|NCT00017563|267176|P1|STARTED|Overall Study||57
112086|NCT00027027|267185|P5|NOT COMPLETED|Overall Study||8
112087|NCT00027027|267186|P4|NOT COMPLETED|Overall Study||3
112088|NCT00027027|267187|P3|NOT COMPLETED|Overall Study||4
112089|NCT00027027|267188|P2|NOT COMPLETED|Overall Study||3
112090|NCT00027027|267189|P1|NOT COMPLETED|Overall Study||3
112091|NCT00027027|267185|P5|COMPLETED|Overall Study||0
112092|NCT00027027|267186|P4|COMPLETED|Overall Study||0
112093|NCT00027027|267187|P3|COMPLETED|Overall Study||0
112094|NCT00027027|267188|P2|COMPLETED|Overall Study||0
112095|NCT00027027|267189|P1|COMPLETED|Overall Study||0
112096|NCT00027027|267185|P5|Treated Beyond Cycle 2|Overall Study||4
112097|NCT00027027|267186|P4|Treated Beyond Cycle 2|Overall Study||2
112098|NCT00027027|267187|P3|Treated Beyond Cycle 2|Overall Study||2
112099|NCT00027027|267188|P2|Treated Beyond Cycle 2|Overall Study||1
112100|NCT00027027|267189|P1|Treated Beyond Cycle 2|Overall Study||1
112101|NCT00027027|267185|P5|Discontinued at Cycle 2|Overall Study||3
112102|NCT00027027|267186|P4|Discontinued at Cycle 2|Overall Study||1
112103|NCT00027027|267187|P3|Discontinued at Cycle 2|Overall Study||1
112104|NCT00027027|267188|P2|Discontinued at Cycle 2|Overall Study||2
112105|NCT00027027|267189|P1|Discontinued at Cycle 2|Overall Study||2
112106|NCT00027027|267185|P5|Completed 2 Cycles of Treatment|Overall Study||7
112107|NCT00027027|267186|P4|Completed 2 Cycles of Treatment|Overall Study||3
112108|NCT00027027|267187|P3|Completed 2 Cycles of Treatment|Overall Study||3
112109|NCT00027027|267188|P2|Completed 2 Cycles of Treatment|Overall Study||3
112110|NCT00027027|267189|P1|Completed 2 Cycles of Treatment|Overall Study||3
112111|NCT00027027|267185|P5|Discontinued Before 2 Treatment Cycles|Overall Study||1
112112|NCT00027027|267186|P4|Discontinued Before 2 Treatment Cycles|Overall Study||0
112113|NCT00027027|267187|P3|Discontinued Before 2 Treatment Cycles|Overall Study||1
112114|NCT00027027|267188|P2|Discontinued Before 2 Treatment Cycles|Overall Study||0
112115|NCT00027027|267189|P1|Discontinued Before 2 Treatment Cycles|Overall Study||0
112116|NCT00027027|267185|P5|STARTED|Overall Study||8
112117|NCT00027027|267186|P4|STARTED|Overall Study||3
112118|NCT00027027|267187|P3|STARTED|Overall Study||4
112119|NCT00027027|267188|P2|STARTED|Overall Study||3
112120|NCT00027027|267189|P1|STARTED|Overall Study||3
112121|NCT00027560|267234|P1|NOT COMPLETED|Overall Study||1
112122|NCT00027560|267234|P1|COMPLETED|Overall Study||50
112123|NCT00027560|267234|P1|STARTED|Overall Study||51
112124|NCT00027846|267246|P3|NOT COMPLETED|Overall Study||37
112125|NCT00027846|267247|P2|NOT COMPLETED|Overall Study||68
112126|NCT00027846|267248|P1|NOT COMPLETED|Overall Study||2
112127|NCT00027846|267246|P3|COMPLETED|Overall Study||41
112128|NCT00027846|267247|P2|COMPLETED|Overall Study||219
112129|NCT00027846|267248|P1|COMPLETED|Overall Study||11
112130|NCT00027846|267246|P3|STARTED|Overall Study||78
112131|NCT00027846|267247|P2|STARTED|Overall Study||287
112132|NCT00027846|267248|P1|STARTED|Overall Study||13
112133|NCT00028002|267266|P1|NOT COMPLETED|Overall Study||11
112134|NCT00028002|267266|P1|COMPLETED|Overall Study|Subjects comtributing data to the primary analysis are considered to have completed the study.|52
112135|NCT00028002|267266|P1|STARTED|Overall Study||63
112136|NCT00028093|267272|P2|NOT COMPLETED|Overall Study||0
112137|NCT00028093|267273|P1|NOT COMPLETED|Overall Study||0
112138|NCT00028093|267272|P2|COMPLETED|Overall Study||25
112139|NCT00028093|267273|P1|COMPLETED|Overall Study||25
112140|NCT00028093|267272|P2|STARTED|Overall Study||25
112141|NCT00028093|267273|P1|STARTED|Overall Study||25
112142|NCT00028262|267279|P1|NOT COMPLETED|Overall Study||1
112143|NCT00028262|267279|P1|COMPLETED|Overall Study||9
112144|NCT00028262|267279|P1|STARTED|Overall Study||10
112145|NCT00028769|267283|P1|NOT COMPLETED|Overall Study||41
112146|NCT00028769|267283|P1|COMPLETED|Overall Study|Patients receive protocol treatments until evidence of disease progression|0
112239|NCT00023309|267513|P2|COMPLETED|Overall Study||19
112147|NCT00028769|267283|P1|Eligible and Began Protocol Therapy|Overall Study|One patient refused all protocol treatment and was not evaluable for the present analysis|35
112148|NCT00028769|267283|P1|Eligible|Overall Study||36
112149|NCT00028769|267283|P1|STARTED|Overall Study||41
112150|NCT00029107|267291|P2|NOT COMPLETED|Overall Study||0
112151|NCT00029107|267292|P1|NOT COMPLETED|Overall Study||0
112152|NCT00029107|267291|P2|COMPLETED|Overall Study||12
112153|NCT00029107|267292|P1|COMPLETED|Overall Study||12
112154|NCT00029107|267291|P2|STARTED|Overall Study||12
112155|NCT00029107|267292|P1|STARTED|Overall Study||12
112156|NCT00029146|267300|P2|NOT COMPLETED|Overall Study||1
112157|NCT00029146|267301|P1|NOT COMPLETED|Overall Study||2
112158|NCT00029146|267300|P2|COMPLETED|Overall Study||97
112159|NCT00029146|267301|P1|COMPLETED|Overall Study||95
112160|NCT00029146|267300|P2|STARTED|Overall Study||98
112161|NCT00029146|267301|P1|STARTED|Overall Study||97
112162|NCT00029172|267328|P1|NOT COMPLETED|Overall Study||6
112163|NCT00029172|267328|P1|COMPLETED|Overall Study||182
112164|NCT00029172|267328|P1|STARTED|Overall Study||188
112165|NCT00029536|267336|P4|NOT COMPLETED|Overall Study||0
112166|NCT00029536|267337|P3|NOT COMPLETED|Overall Study||0
112167|NCT00029536|267338|P2|NOT COMPLETED|Overall Study||0
112168|NCT00029536|267339|P1|NOT COMPLETED|Overall Study||0
112169|NCT00029536|267336|P4|COMPLETED|Overall Study||59
112170|NCT00029536|267337|P3|COMPLETED|Overall Study||105
112171|NCT00029536|267338|P2|COMPLETED|Overall Study||45
112172|NCT00029536|267339|P1|COMPLETED|Overall Study||85
112173|NCT00029536|267336|P4|STARTED|Overall Study||59
112174|NCT00029536|267337|P3|STARTED|Overall Study||105
112175|NCT00029536|267338|P2|STARTED|Overall Study||45
112176|NCT00029536|267339|P1|STARTED|Overall Study||85
112177|NCT00030147|267367|P4|NOT COMPLETED|Overall Study||0
112178|NCT00030147|267368|P3|NOT COMPLETED|Overall Study||0
112179|NCT00030147|267369|P2|NOT COMPLETED|Overall Study||1
112180|NCT00030147|267370|P1|NOT COMPLETED|Overall Study||0
112181|NCT00030147|267367|P4|COMPLETED|Overall Study||11
112182|NCT00030147|267368|P3|COMPLETED|Overall Study||16
112183|NCT00030147|267369|P2|COMPLETED|Overall Study||18
112184|NCT00030147|267370|P1|COMPLETED|Overall Study||17
112185|NCT00030147|267367|P4|STARTED|Overall Study||11
112186|NCT00030147|267368|P3|STARTED|Overall Study||16
112187|NCT00030147|267369|P2|STARTED|Overall Study||19
112188|NCT00030147|267370|P1|STARTED|Overall Study||17
112189|NCT00022490|267384|P1|NOT COMPLETED|Overall Study||0
112190|NCT00022490|267384|P1|COMPLETED|Overall Study||24
112191|NCT00022490|267384|P1|STARTED|Overall Study||24
112192|NCT00022516|267390|P2|NOT COMPLETED|Overall Study||230
112193|NCT00022516|267391|P1|NOT COMPLETED|Overall Study||3
112194|NCT00022516|267390|P2|COMPLETED|Overall Study||314
112195|NCT00022516|267391|P1|COMPLETED|Overall Study||539
112196|NCT00022516|267390|P2|STARTED|Overall Study||544
112197|NCT00022516|267391|P1|STARTED|Overall Study||542
112198|NCT00022633|267405|P2|NOT COMPLETED|Overall Study||5
112199|NCT00022633|267406|P1|NOT COMPLETED|Overall Study||32
112200|NCT00022633|267405|P2|COMPLETED|Overall Study||5
112201|NCT00022633|267406|P1|COMPLETED|Overall Study||23
112202|NCT00022633|267405|P2|Eligible|Overall Study||10
112203|NCT00022633|267406|P1|Eligible|Overall Study||51
112204|NCT00022633|267405|P2|STARTED|Overall Study||10
112205|NCT00022633|267406|P1|STARTED|Overall Study||55
112206|NCT00022659|267417|P1|NOT COMPLETED|Overall Study||2
112207|NCT00022659|267417|P1|COMPLETED|Overall Study|Eligible and treated patients.|62
112208|NCT00022659|267417|P1|STARTED|Overall Study||64
112209|NCT00022672|267425|P2|NOT COMPLETED|Extension Phase||51
112210|NCT00022672|267426|P1|NOT COMPLETED|Extension Phase||3
112211|NCT00022672|267425|P2|COMPLETED|Extension Phase||7
112212|NCT00022672|267426|P1|COMPLETED|Extension Phase||11
112213|NCT00022672|267425|P2|Safety Set: Received Study Drug|Extension Phase||58
112214|NCT00022672|267426|P1|Safety Set: Received Study Drug|Extension Phase||14
112215|NCT00022672|267425|P2|STARTED|Extension Phase||58
112216|NCT00022672|267426|P1|STARTED|Extension Phase|2 patients completed Main Phase; but did not enter Extension (1-did not cooperate and 1-withdrew).|14
112217|NCT00022672|267425|P2|NOT COMPLETED|Main Phase: 24 Months||100
112218|NCT00022672|267426|P1|NOT COMPLETED|Main Phase: 24 Months||87
112219|NCT00022672|267425|P2|COMPLETED|Main Phase: 24 Months||4
112220|NCT00022672|267426|P1|COMPLETED|Main Phase: 24 Months||16
112221|NCT00022672|267425|P2|Safety Set: Received Study Drug|Main Phase: 24 Months||104
112222|NCT00022672|267426|P1|Safety Set: Received Study Drug|Main Phase: 24 Months||103
112223|NCT00022672|267425|P2|STARTED|Main Phase: 24 Months||104
112224|NCT00022672|267426|P1|STARTED|Main Phase: 24 Months||103
112225|NCT00022698|267461|P2|NOT COMPLETED|Overall Study||35
112226|NCT00022698|267462|P1|NOT COMPLETED|Overall Study||8
112227|NCT00022698|267461|P2|COMPLETED|Overall Study||17
112228|NCT00022698|267462|P1|COMPLETED|Overall Study||7
112229|NCT00022698|267461|P2|STARTED|Overall Study||52
112230|NCT00022698|267462|P1|STARTED|Overall Study||15
112231|NCT00022763|267487|P2|NOT COMPLETED|Overall Study||17
112232|NCT00022763|267488|P1|NOT COMPLETED|Overall Study||9
112233|NCT00022763|267487|P2|COMPLETED|Overall Study||11
112234|NCT00022763|267488|P1|COMPLETED|Overall Study||15
112235|NCT00022763|267487|P2|STARTED|Overall Study||28
112236|NCT00022763|267488|P1|STARTED|Overall Study||24
112237|NCT00023309|267513|P2|NOT COMPLETED|Overall Study||0
112238|NCT00023309|267514|P1|NOT COMPLETED|Overall Study||0
112240|NCT00023309|267514|P1|COMPLETED|Overall Study||22
112241|NCT00023309|267513|P2|STARTED|Overall Study||19
112242|NCT00023309|267514|P1|STARTED|Overall Study||22
112243|NCT00023322|267528|P1|NOT COMPLETED|Overall Study||1
112244|NCT00023322|267528|P1|COMPLETED|Overall Study||12
112245|NCT00023322|267528|P1|STARTED|Overall Study||13
112246|NCT00023452|267535|P2|NOT COMPLETED|Overall Study||872
112247|NCT00023452|267536|P1|NOT COMPLETED|Overall Study||1323
112248|NCT00023452|267535|P2|COMPLETED|Overall Study||3273
112249|NCT00023452|267536|P1|COMPLETED|Overall Study||2585
112250|NCT00023452|267535|P2|Completed Study|Overall Study||3475
112251|NCT00023452|267536|P1|Completed Study|Overall Study||3174
112252|NCT00023452|267535|P2|Not Treated|Overall Study||105
112253|NCT00023452|267536|P1|Not Treated|Overall Study||149
112254|NCT00023452|267535|P2|Completed Treatment|Overall Study||3273
112255|NCT00023452|267536|P1|Completed Treatment|Overall Study||2585
112256|NCT00023452|267535|P2|Enrolled as Part of a Cluster|Overall Study||971
112257|NCT00023452|267536|P1|Enrolled as Part of a Cluster|Overall Study||718
112258|NCT00023452|267535|P2|Randomized|Overall Study||3174
112259|NCT00023452|267536|P1|Randomized|Overall Study||3190
112260|NCT00023452|267535|P2|STARTED|Overall Study||4145
112261|NCT00023452|267536|P1|STARTED|Overall Study||3908
112262|NCT00023595|267565|P5|NOT COMPLETED|10 Year Follow up||0
112263|NCT00023595|267566|P4|NOT COMPLETED|10 Year Follow up||0
112264|NCT00023595|267567|P3|NOT COMPLETED|10 Year Follow up||3
112265|NCT00023595|267568|P2|NOT COMPLETED|10 Year Follow up||10
112266|NCT00023595|267569|P1|NOT COMPLETED|10 Year Follow up||12
112267|NCT00023595|267565|P5|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
112268|NCT00023595|267566|P4|COMPLETED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
112269|NCT00023595|267567|P3|COMPLETED|10 Year Follow up||73
112270|NCT00023595|267568|P2|COMPLETED|10 Year Follow up||524
112271|NCT00023595|267569|P1|COMPLETED|10 Year Follow up||590
112272|NCT00023595|267565|P5|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
112273|NCT00023595|267566|P4|STARTED|10 Year Follow up|H02 arm was not extended and ended at year 5|0
112274|NCT00023595|267567|P3|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|76
112275|NCT00023595|267568|P2|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|534
112276|NCT00023595|267569|P1|STARTED|10 Year Follow up|all participants who started H01 were counted as starting the 10 year follow up.|602
112277|NCT00023595|267565|P5|NOT COMPLETED|5 Year Follow up||3
112278|NCT00023595|267566|P4|NOT COMPLETED|5 Year Follow up||7
112279|NCT00023595|267567|P3|NOT COMPLETED|5 Year Follow up||1
112280|NCT00023595|267568|P2|NOT COMPLETED|5 Year Follow up||2
112281|NCT00023595|267569|P1|NOT COMPLETED|5 Year Follow up||2
112282|NCT00023595|267565|P5|COMPLETED|5 Year Follow up||498
112283|NCT00023595|267566|P4|COMPLETED|5 Year Follow up||416
112284|NCT00023595|267567|P3|COMPLETED|5 Year Follow up||75
112285|NCT00023595|267568|P2|COMPLETED|5 Year Follow up||532
112286|NCT00023595|267569|P1|COMPLETED|5 Year Follow up||600
112287|NCT00023595|267565|P5|STARTED|5 Year Follow up||501
112288|NCT00023595|267566|P4|STARTED|5 Year Follow up|76 of stratum B pts who were randomized to med therapy + CABG group belong to both H01 and H02.|423
112289|NCT00023595|267567|P3|STARTED|5 Year Follow up||76
112290|NCT00023595|267568|P2|STARTED|5 Year Follow up||534
112291|NCT00023595|267569|P1|STARTED|5 Year Follow up||602
112292|NCT00023673|267781|P4|NOT COMPLETED|Overall Study||2
112293|NCT00023673|267782|P3|NOT COMPLETED|Overall Study||0
112294|NCT00023673|267783|P2|NOT COMPLETED|Overall Study||0
112295|NCT00023673|267784|P1|NOT COMPLETED|Overall Study||0
112296|NCT00023673|267781|P4|COMPLETED|Overall Study|Phase II subjects contributing data to primary analysis are considered to have completed the study.|44
112297|NCT00023673|267782|P3|COMPLETED|Overall Study|This arm was not used since further de-escalation was not required.|0
112298|NCT00023673|267783|P2|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|9
112299|NCT00023673|267784|P1|COMPLETED|Overall Study|Phase I eligible patients starting protocol treatment are considered to have completed the study.|8
112300|NCT00023673|267781|P4|STARTED|Overall Study||46
112301|NCT00023673|267782|P3|STARTED|Overall Study||0
112302|NCT00023673|267783|P2|STARTED|Overall Study||9
112303|NCT00023673|267784|P1|STARTED|Overall Study||8
112304|NCT00023712|267793|P2|NOT COMPLETED|Overall Study||1
112305|NCT00023712|267794|P1|NOT COMPLETED|Overall Study||2
112306|NCT00023712|267793|P2|COMPLETED|Overall Study|total number of participants eligible and evaluable|29
112307|NCT00023712|267794|P1|COMPLETED|Overall Study|total number of participants eligible and evaluable|26
112308|NCT00023712|267793|P2|STARTED|Overall Study|total number of participants enrolled on study|30
112309|NCT00023712|267794|P1|STARTED|Overall Study|total number of participants enrolled on study|28
112310|NCT00023764|267806|P1|NOT COMPLETED|Overall Study||14
112311|NCT00023764|267806|P1|COMPLETED|Overall Study||89
112312|NCT00023764|267806|P1|STARTED|Overall Study||103
112313|NCT00024102|267813|P2|NOT COMPLETED|Overall Study||0
112314|NCT00024102|267814|P1|NOT COMPLETED|Overall Study||0
112315|NCT00024102|267813|P2|COMPLETED|Overall Study||307
112316|NCT00024102|267814|P1|COMPLETED|Overall Study||326
112317|NCT00024102|267813|P2|STARTED|Overall Study||307
112318|NCT00024102|267814|P1|STARTED|Overall Study||326
112319|NCT00024167|267829|P2|NOT COMPLETED|Overall Study||47
112320|NCT00024167|267830|P1|NOT COMPLETED|Overall Study||53
112321|NCT00024167|267829|P2|COMPLETED|Overall Study||15
112322|NCT00024167|267830|P1|COMPLETED|Overall Study||12
112323|NCT00024167|267829|P2|Induction Treatment Option 2 Completed|Overall Study||41
112324|NCT00024167|267830|P1|Induction Treatment Option 2 Completed|Overall Study||43
112325|NCT00024167|267829|P2|Induction Treatment Option 1 Completed|Overall Study||21
112326|NCT00024167|267830|P1|Induction Treatment Option 1 Completed|Overall Study||22
112327|NCT00024167|267829|P2|STARTED|Overall Study||62
112328|NCT00024167|267830|P1|STARTED|Overall Study||65
112329|NCT00036738|267839|P1|NOT COMPLETED|Overall Study||0
112330|NCT00036738|267839|P1|COMPLETED|Overall Study||28
112331|NCT00036738|267839|P1|STARTED|Overall Study||28
112332|NCT00037830|267848|P3|NOT COMPLETED|Overall Study||1
112333|NCT00037830|267849|P2|NOT COMPLETED|Overall Study||7
112334|NCT00037830|267850|P1|NOT COMPLETED|Overall Study||10
112335|NCT00037830|267848|P3|COMPLETED|Overall Study||16
112336|NCT00037830|267849|P2|COMPLETED|Overall Study||31
112337|NCT00037830|267850|P1|COMPLETED|Overall Study||29
112338|NCT00037830|267848|P3|STARTED|Overall Study||17
112339|NCT00037830|267849|P2|STARTED|Overall Study||38
112340|NCT00037830|267850|P1|STARTED|Overall Study||39
112341|NCT00038103|267873|P2|NOT COMPLETED|Overall Study||56
112342|NCT00038103|267874|P1|NOT COMPLETED|Overall Study||55
112343|NCT00038103|267873|P2|COMPLETED|Overall Study||0
112344|NCT00038103|267874|P1|COMPLETED|Overall Study||0
112345|NCT00038103|267873|P2|End of Treatment|Overall Study|patients remained on treatment until discontinued|56
112346|NCT00038103|267874|P1|End of Treatment|Overall Study|patients remained on treatment until discontinued|53
112347|NCT00038103|267873|P2|STARTED|Overall Study||56
112348|NCT00038103|267874|P1|STARTED|Overall Study||55
112349|NCT00038467|267896|P2|NOT COMPLETED|Overall Study||542
112350|NCT00038467|267897|P1|NOT COMPLETED|Overall Study||542
112351|NCT00038467|267896|P2|COMPLETED|Overall Study||1830
112352|NCT00038467|267897|P1|COMPLETED|Overall Study||1810
112353|NCT00038467|267896|P2|Treated|Overall Study|7 participants randomized to receive tamoxifen, received exemestane. Reported as per randomization.|2337
112354|NCT00038467|267897|P1|Treated|Overall Study|8 participants randomized to receive exemestane, received tamoxifen. Reported as per randomization.|2321
112355|NCT00038467|267896|P2|STARTED|Overall Study||2372
112356|NCT00038467|267897|P1|STARTED|Overall Study||2352
112357|NCT00038610|267957|P1|NOT COMPLETED|Overall Study||0
112358|NCT00038610|267957|P1|COMPLETED|Overall Study||54
112359|NCT00038610|267957|P1|STARTED|Overall Study||54
112360|NCT00038857|267963|P1|NOT COMPLETED|Overall Study||1
112361|NCT00038857|267963|P1|COMPLETED|Overall Study||28
112362|NCT00038857|267963|P1|STARTED|Overall Study||29
112363|NCT00038948|267969|P2|NOT COMPLETED|Overall Study||77
112364|NCT00038948|267970|P1|NOT COMPLETED|Overall Study||169
112365|NCT00038948|267969|P2|COMPLETED|Overall Study||198
112366|NCT00038948|267970|P1|COMPLETED|Overall Study||386
112367|NCT00038948|267969|P2|STARTED|Overall Study||275
112368|NCT00038948|267970|P1|STARTED|Overall Study||555
112369|NCT00039130|267982|P1|NOT COMPLETED|Overall Study||30
112370|NCT00039130|267982|P1|COMPLETED|Overall Study||75
112371|NCT00039130|267982|P1|STARTED|Overall Study||105
112372|NCT00039195|267988|P1|NOT COMPLETED|Overall Study||0
112373|NCT00039195|267988|P1|COMPLETED|Overall Study||98
112374|NCT00039195|267988|P1|STARTED|Overall Study||98
112375|NCT00021541|267994|P2|NOT COMPLETED|Period 2-crossover||11
112376|NCT00021541|267995|P1|NOT COMPLETED|Period 2-crossover||10
112377|NCT00021541|267994|P2|COMPLETED|Period 2-crossover||12
112378|NCT00021541|267995|P1|COMPLETED|Period 2-crossover||10
112379|NCT00021541|267994|P2|STARTED|Period 2-crossover||23
112380|NCT00021541|267995|P1|STARTED|Period 2-crossover||20
112381|NCT00021541|267994|P2|NOT COMPLETED|Period 1-First Treatment||8
112382|NCT00021541|267995|P1|NOT COMPLETED|Period 1-First Treatment||11
112383|NCT00021541|267994|P2|COMPLETED|Period 1-First Treatment||23
112384|NCT00021541|267995|P1|COMPLETED|Period 1-First Treatment||20
112385|NCT00021541|267994|P2|Ineligible Patients|Period 1-First Treatment||2
112386|NCT00021541|267995|P1|Ineligible Patients|Period 1-First Treatment||0
112387|NCT00021541|267994|P2|Pts Who Progressed to Second Treatment|Period 1-First Treatment||23
112388|NCT00021541|267995|P1|Pts Who Progressed to Second Treatment|Period 1-First Treatment||20
112389|NCT00021541|267994|P2|STARTED|Period 1-First Treatment|These are the patients randomized to receive placebo. Two of these patients were deemed ineligible.|31
112390|NCT00021541|267995|P1|STARTED|Period 1-First Treatment||31
112391|NCT00027378|268003|P2|NOT COMPLETED|Overall Study||3
112392|NCT00027378|268004|P1|NOT COMPLETED|Overall Study||0
112393|NCT00027378|268003|P2|COMPLETED|Overall Study||23
112394|NCT00027378|268004|P1|COMPLETED|Overall Study||24
112395|NCT00027378|268003|P2|STARTED|Overall Study||26
112396|NCT00027378|268004|P1|STARTED|Overall Study||24
112397|NCT00039377|268012|P4|NOT COMPLETED|Course 5 (Transplant Assignments)||0
112398|NCT00039377|268013|P3|NOT COMPLETED|Course 5 (Transplant Assignments)||0
112399|NCT00039377|268014|P2|NOT COMPLETED|Course 5 (Transplant Assignments)||0
112400|NCT00039377|268015|P1|NOT COMPLETED|Course 5 (Transplant Assignments)||0
112401|NCT00039377|268012|P4|COMPLETED|Course 5 (Transplant Assignments)||1
112402|NCT00039377|268013|P3|COMPLETED|Course 5 (Transplant Assignments)||19
112403|NCT00039377|268014|P2|COMPLETED|Course 5 (Transplant Assignments)||15
112404|NCT00039377|268015|P1|COMPLETED|Course 5 (Transplant Assignments)||0
112405|NCT00039377|268012|P4|STARTED|Course 5 (Transplant Assignments)||1
112406|NCT00039377|268013|P3|STARTED|Course 5 (Transplant Assignments)||19
112407|NCT00039377|268014|P2|STARTED|Course 5 (Transplant Assignments)||15
112408|NCT00039377|268015|P1|STARTED|Course 5 (Transplant Assignments)|After Course I-IV, participants were grouped into autologous, allogeneic or no transplant arms.|0
112409|NCT00039377|268012|P4|NOT COMPLETED|Initial Registration||0
112410|NCT00039377|268013|P3|NOT COMPLETED|Initial Registration||0
112411|NCT00039377|268014|P2|NOT COMPLETED|Initial Registration||0
112412|NCT00039377|268015|P1|NOT COMPLETED|Initial Registration||22
112413|NCT00039377|268012|P4|COMPLETED|Initial Registration||0
112414|NCT00039377|268013|P3|COMPLETED|Initial Registration||0
112415|NCT00039377|268014|P2|COMPLETED|Initial Registration||0
112416|NCT00039377|268015|P1|COMPLETED|Initial Registration||35
112417|NCT00039377|268012|P4|STARTED|Initial Registration||0
112418|NCT00039377|268013|P3|STARTED|Initial Registration||0
112419|NCT00039377|268014|P2|STARTED|Initial Registration||0
112420|NCT00039377|268015|P1|STARTED|Initial Registration||57
112421|NCT00041392|268029|P2|NOT COMPLETED|Overall Study||0
112422|NCT00041392|268030|P1|NOT COMPLETED|Overall Study||0
112423|NCT00041392|268029|P2|COMPLETED|Overall Study||191
112424|NCT00041392|268030|P1|COMPLETED|Overall Study||198
112425|NCT00041392|268029|P2|STARTED|Overall Study||191
112426|NCT00041392|268030|P1|STARTED|Overall Study||198
112427|NCT00041470|268036|P1|NOT COMPLETED|Overall Study||38
112428|NCT00041470|268036|P1|COMPLETED|Overall Study||0
112429|NCT00041470|268036|P1|STARTED|Overall Study||38
112430|NCT00041717|268043|P2|NOT COMPLETED|Overall Study||12
112431|NCT00041717|268044|P1|NOT COMPLETED|Overall Study||33
112432|NCT00041717|268043|P2|COMPLETED|Overall Study||86
112433|NCT00041717|268044|P1|COMPLETED|Overall Study||81
112434|NCT00041717|268043|P2|STARTED|Overall Study||98
112435|NCT00041717|268044|P1|STARTED|Overall Study||114
112436|NCT00041756|268057|P5|NOT COMPLETED|Overall Study||60
112437|NCT00041756|268058|P4|NOT COMPLETED|Overall Study||16
112438|NCT00041756|268059|P3|NOT COMPLETED|Overall Study||13
112439|NCT00041756|268060|P2|NOT COMPLETED|Overall Study||15
112440|NCT00041756|268061|P1|NOT COMPLETED|Overall Study||8
112441|NCT00041756|268057|P5|COMPLETED|Overall Study||19
112442|NCT00041756|268058|P4|COMPLETED|Overall Study||64
112443|NCT00041756|268059|P3|COMPLETED|Overall Study||66
112444|NCT00041756|268060|P2|COMPLETED|Overall Study||65
112445|NCT00041756|268061|P1|COMPLETED|Overall Study||69
112446|NCT00041756|268057|P5|STARTED|Overall Study||79
112447|NCT00041756|268058|P4|STARTED|Overall Study||80
112448|NCT00041756|268059|P3|STARTED|Overall Study||79
112449|NCT00041756|268060|P2|STARTED|Overall Study||80
112450|NCT00041756|268061|P1|STARTED|Overall Study||77
112451|NCT00041938|268080|P2|NOT COMPLETED|Overall Study||31
112452|NCT00041938|268081|P1|NOT COMPLETED|Overall Study||38
112453|NCT00041938|268080|P2|COMPLETED|Overall Study||1111
112454|NCT00041938|268081|P1|COMPLETED|Overall Study||1125
112455|NCT00041938|268080|P2|Withdrew Consent|Overall Study||14
112456|NCT00041938|268081|P1|Withdrew Consent|Overall Study||20
112457|NCT00041938|268080|P2|Lost to Follow-up|Overall Study||17
112458|NCT00041938|268081|P1|Lost to Follow-up|Overall Study||18
112459|NCT00041938|268080|P2|Only Vital Status Known|Overall Study||46
112460|NCT00041938|268081|P1|Only Vital Status Known|Overall Study||44
112461|NCT00041938|268080|P2|Primary Endpoint|Overall Study||302
112462|NCT00041938|268081|P1|Primary Endpoint|Overall Study||320
112463|NCT00041938|268080|P2|Completed Follow-up|Overall Study||745
112464|NCT00041938|268081|P1|Completed Follow-up|Overall Study||761
112465|NCT00041938|268080|P2|STARTED|Overall Study||1142
112466|NCT00041938|268081|P1|STARTED|Overall Study||1163
112467|NCT00042224|268111|P2|NOT COMPLETED|Overall Study||3
112468|NCT00042224|268112|P1|NOT COMPLETED|Overall Study||3
112469|NCT00042224|268111|P2|COMPLETED|Overall Study||16
112470|NCT00042224|268112|P1|COMPLETED|Overall Study||17
112471|NCT00042224|268111|P2|STARTED|Overall Study||19
112472|NCT00042224|268112|P1|STARTED|Overall Study||20
112473|NCT00042432|268120|P2|NOT COMPLETED|Overall Study||7
112474|NCT00042432|268121|P1|NOT COMPLETED|Overall Study||9
112475|NCT00042432|268120|P2|COMPLETED|Overall Study||20
112476|NCT00042432|268121|P1|COMPLETED|Overall Study||18
112477|NCT00042432|268120|P2|STARTED|Overall Study||27
112478|NCT00042432|268121|P1|STARTED|Overall Study||27
112479|NCT00042939|268131|P2|NOT COMPLETED|Overall Study||21
112480|NCT00042939|268132|P1|NOT COMPLETED|Overall Study||24
112481|NCT00042939|268131|P2|COMPLETED|Overall Study||25
112482|NCT00042939|268132|P1|COMPLETED|Overall Study||24
112483|NCT00042939|268131|P2|Patients With EGFR Results Available|Overall Study||31
112484|NCT00042939|268132|P1|Patients With EGFR Results Available|Overall Study||30
112485|NCT00042939|268131|P2|Eligible and Began Protocol Therapy|Overall Study||43
112486|NCT00042939|268132|P1|Eligible and Began Protocol Therapy|Overall Study||44
112487|NCT00042939|268131|P2|Treated|Overall Study||45
112488|NCT00042939|268132|P1|Treated|Overall Study||46
112489|NCT00042939|268131|P2|STARTED|Overall Study||46
112490|NCT00042939|268132|P1|STARTED|Overall Study||48
112491|NCT00042991|268153|P7|NOT COMPLETED|Overall Study||2
112492|NCT00042991|268154|P6|NOT COMPLETED|Overall Study||5
112493|NCT00042991|268155|P5|NOT COMPLETED|Overall Study||3
112494|NCT00042991|268156|P4|NOT COMPLETED|Overall Study||2
112495|NCT00042991|268157|P3|NOT COMPLETED|Overall Study||6
112496|NCT00042991|268158|P2|NOT COMPLETED|Overall Study||40
112497|NCT00042991|268159|P1|NOT COMPLETED|Overall Study||6
112498|NCT00042991|268153|P7|COMPLETED|Overall Study||1
112499|NCT00042991|268154|P6|COMPLETED|Overall Study||0
112500|NCT00042991|268155|P5|COMPLETED|Overall Study||0
112501|NCT00042991|268156|P4|COMPLETED|Overall Study||0
112502|NCT00042991|268157|P3|COMPLETED|Overall Study||1
112503|NCT00042991|268158|P2|COMPLETED|Overall Study||3
112504|NCT00042991|268159|P1|COMPLETED|Overall Study||0
112505|NCT00042991|268153|P7|Phase-II Trial|Overall Study||0
112506|NCT00042991|268154|P6|Phase-II Trial|Overall Study||0
112507|NCT00042991|268155|P5|Phase-II Trial|Overall Study||0
112508|NCT00042991|268156|P4|Phase-II Trial|Overall Study||0
112509|NCT00042991|268157|P3|Phase-II Trial|Overall Study||0
112510|NCT00042991|268158|P2|Phase-II Trial|Overall Study||36
112511|NCT00042991|268159|P1|Phase-II Trial|Overall Study||0
112512|NCT00042991|268153|P7|Phase-I Trial|Overall Study||3
112513|NCT00042991|268154|P6|Phase-I Trial|Overall Study||5
112514|NCT00042991|268155|P5|Phase-I Trial|Overall Study||3
112515|NCT00042991|268156|P4|Phase-I Trial|Overall Study||2
112516|NCT00042991|268157|P3|Phase-I Trial|Overall Study||7
112517|NCT00042991|268158|P2|Phase-I Trial|Overall Study|These seven patients contributed to both Phase-I and Phase-II objectives.|7
112518|NCT00042991|268159|P1|Phase-I Trial|Overall Study||6
112519|NCT00042991|268153|P7|STARTED|Overall Study||3
112520|NCT00042991|268154|P6|STARTED|Overall Study||5
112521|NCT00042991|268155|P5|STARTED|Overall Study||3
112522|NCT00042991|268156|P4|STARTED|Overall Study||2
112523|NCT00042991|268157|P3|STARTED|Overall Study||7
112524|NCT00042991|268158|P2|STARTED|Overall Study|These 43 patients form the Phase-II cohort, seven contributing from the Phase-I trial.|43
112525|NCT00042991|268159|P1|STARTED|Overall Study||6
112526|NCT00043186|268209|P9|NOT COMPLETED|Overall Study||17
112527|NCT00043186|268210|P8|NOT COMPLETED|Overall Study||16
112528|NCT00043186|268211|P7|NOT COMPLETED|Overall Study||17
112529|NCT00043186|268212|P6|NOT COMPLETED|Overall Study||8
112530|NCT00043186|268213|P5|NOT COMPLETED|Overall Study||18
112531|NCT00043186|268214|P4|NOT COMPLETED|Overall Study||22
112532|NCT00043186|268215|P3|NOT COMPLETED|Overall Study||20
112533|NCT00043186|268216|P2|NOT COMPLETED|Overall Study||15
112534|NCT00043186|268217|P1|NOT COMPLETED|Overall Study||17
112535|NCT00043186|268209|P9|COMPLETED|Overall Study||30
112536|NCT00043186|268210|P8|COMPLETED|Overall Study||31
112537|NCT00043186|268211|P7|COMPLETED|Overall Study||25
112538|NCT00043186|268212|P6|COMPLETED|Overall Study||39
112539|NCT00043186|268213|P5|COMPLETED|Overall Study||36
112540|NCT00043186|268214|P4|COMPLETED|Overall Study||19
112541|NCT00043186|268215|P3|COMPLETED|Overall Study||24
112542|NCT00043186|268216|P2|COMPLETED|Overall Study||29
112543|NCT00043186|268217|P1|COMPLETED|Overall Study||29
112544|NCT00043186|268209|P9|STARTED|Overall Study||47
112545|NCT00043186|268210|P8|STARTED|Overall Study||47
112546|NCT00043186|268211|P7|STARTED|Overall Study||42
112547|NCT00043186|268212|P6|STARTED|Overall Study||47
112548|NCT00043186|268213|P5|STARTED|Overall Study||54
112549|NCT00043186|268214|P4|STARTED|Overall Study||41
112550|NCT00043186|268215|P3|STARTED|Overall Study||44
112551|NCT00043186|268216|P2|STARTED|Overall Study||44
112552|NCT00043186|268217|P1|STARTED|Overall Study||46
112553|NCT00043550|268546|P3|NOT COMPLETED|Overall Study||20
112554|NCT00043550|268547|P2|NOT COMPLETED|Overall Study||12
112555|NCT00043550|268548|P1|NOT COMPLETED|Overall Study||22
112556|NCT00043550|268546|P3|COMPLETED|Overall Study||30
112557|NCT00043550|268547|P2|COMPLETED|Overall Study||39
112558|NCT00043550|268548|P1|COMPLETED|Overall Study||33
112559|NCT00043550|268546|P3|Week 8 Completed|Overall Study||35
112560|NCT00043550|268547|P2|Week 8 Completed|Overall Study||40
112561|NCT00043550|268548|P1|Week 8 Completed|Overall Study||35
112562|NCT00043550|268546|P3|STARTED|Overall Study||50
112563|NCT00043550|268547|P2|STARTED|Overall Study||51
112564|NCT00043550|268548|P1|STARTED|Overall Study||55
112565|NCT00030901|268558|P3|NOT COMPLETED|Randomization||88
112566|NCT00030901|268559|P2|NOT COMPLETED|Randomization||101
112567|NCT00030901|268560|P1|NOT COMPLETED|Randomization||0
112568|NCT00030901|268558|P3|COMPLETED|Randomization||137
112569|NCT00030901|268559|P2|COMPLETED|Randomization||126
112570|NCT00030901|268560|P1|COMPLETED|Randomization||0
112571|NCT00030901|268558|P3|Eligible|Randomization||211
112572|NCT00030901|268559|P2|Eligible|Randomization||212
112573|NCT00030901|268560|P1|Eligible|Randomization||0
112574|NCT00030901|268558|P3|STARTED|Randomization||225
112575|NCT00030901|268559|P2|STARTED|Randomization||227
112576|NCT00030901|268560|P1|STARTED|Randomization||0
112577|NCT00030901|268558|P3|NOT COMPLETED|Initial Registration||0
112578|NCT00030901|268559|P2|NOT COMPLETED|Initial Registration||0
112579|NCT00030901|268560|P1|NOT COMPLETED|Initial Registration||167
112580|NCT00030901|268558|P3|COMPLETED|Initial Registration||0
112581|NCT00030901|268559|P2|COMPLETED|Initial Registration||0
112582|NCT00030901|268560|P1|COMPLETED|Initial Registration||452
112583|NCT00030901|268558|P3|STARTED|Initial Registration||0
112584|NCT00030901|268559|P2|STARTED|Initial Registration||0
112585|NCT00030901|268560|P1|STARTED|Initial Registration||619
112586|NCT00030992|268568|P1|NOT COMPLETED|Overall Study||0
112587|NCT00030992|268568|P1|COMPLETED|Overall Study||102
112588|NCT00030992|268568|P1|STARTED|Overall Study||102
112589|NCT00031447|268575|P2|NOT COMPLETED|Overall Study||7
112590|NCT00031447|268576|P1|NOT COMPLETED|Overall Study||10
112591|NCT00031447|268575|P2|COMPLETED|Overall Study||8
112592|NCT00031447|268576|P1|COMPLETED|Overall Study||4
112593|NCT00031447|268575|P2|STARTED|Overall Study||15
112594|NCT00031447|268576|P1|STARTED|Overall Study||14
112595|NCT00031460|268590|P2|NOT COMPLETED|Overall Study||14
112596|NCT00031460|268591|P1|NOT COMPLETED|Overall Study||9
112597|NCT00031460|268590|P2|COMPLETED|Overall Study||8
112598|NCT00031460|268591|P1|COMPLETED|Overall Study||15
112599|NCT00031460|268590|P2|STARTED|Overall Study||22
112600|NCT00031460|268591|P1|STARTED|Overall Study||24
112601|NCT00031486|268605|P2|NOT COMPLETED|Overall Study||12
112602|NCT00031486|268606|P1|NOT COMPLETED|Overall Study||7
112603|NCT00031486|268605|P2|COMPLETED|Overall Study||35
112604|NCT00031486|268606|P1|COMPLETED|Overall Study||33
112605|NCT00031486|268605|P2|STARTED|Overall Study||47
112606|NCT00031486|268606|P1|STARTED|Overall Study||40
112607|NCT00031551|268632|P2|NOT COMPLETED|Overall Study||0
112608|NCT00031551|268633|P1|NOT COMPLETED|Overall Study||2
112609|NCT00031551|268632|P2|COMPLETED|Overall Study||25
112610|NCT00031551|268633|P1|COMPLETED|Overall Study||0
112611|NCT00031551|268632|P2|STARTED|Overall Study||25
112612|NCT00031551|268633|P1|STARTED|Overall Study||2
112613|NCT00031694|268643|P1|NOT COMPLETED|Overall Study||19
112614|NCT00031694|268643|P1|COMPLETED|Overall Study||0
112615|NCT00031694|268643|P1|STARTED|Overall Study||19
112616|NCT00032487|268649|P2|NOT COMPLETED|Overall Study||120
112617|NCT00032487|268650|P1|NOT COMPLETED|Overall Study||139
112618|NCT00032487|268649|P2|COMPLETED|Overall Study||772
112619|NCT00032487|268650|P1|COMPLETED|Overall Study||760
112620|NCT00032487|268649|P2|STARTED|Overall Study||892
112621|NCT00032487|268650|P1|STARTED|Overall Study||899
112622|NCT00032591|268660|P2|NOT COMPLETED|Follow-up||5
112623|NCT00032591|268661|P1|NOT COMPLETED|Follow-up||2
112624|NCT00032591|268660|P2|COMPLETED|Follow-up|1452 were included in analysis with greater than 1 day of follow-up|1452
112625|NCT00032591|268661|P1|COMPLETED|Follow-up|1463 were included in analysis with greater than 1 day of follow-up|1463
112626|NCT00032591|268660|P2|STARTED|Follow-up|5 were lost to follow-up, all with Atrial Fibrillation, no Mechanical Heart Valves|1457
112627|NCT00032591|268661|P1|STARTED|Follow-up|2 were lost to follow-up, both with Atrial Fibrillation, no Mechanical Heart Valves|1465
112628|NCT00032591|268660|P2|NOT COMPLETED|Randomization||0
112629|NCT00032591|268661|P1|NOT COMPLETED|Randomization||0
112630|NCT00032591|268660|P2|COMPLETED|Randomization|1457 were assigned to clinic testing|1457
112631|NCT00032591|268661|P1|COMPLETED|Randomization|1465 were assigned to self-testing|1465
112632|NCT00032591|268660|P2|STARTED|Randomization||1457
112633|NCT00032591|268661|P1|STARTED|Randomization|2922 underwent randomization|1465
112634|NCT00032591|268660|P2|NOT COMPLETED|Screening||415
112635|NCT00032591|268661|P1|NOT COMPLETED|Screening||408
112636|NCT00032591|268660|P2|COMPLETED|Screening||1457
112637|NCT00032591|268661|P1|COMPLETED|Screening|823 were excluded from the study|1465
112638|NCT00032591|268660|P2|STARTED|Screening|Treatment assigned at randomization; screening counts by arm represent half of the total screened.|1872
112639|NCT00032591|268661|P1|STARTED|Screening|3745 patients provided informed consent and were screened for participation.|1873
112640|NCT00032630|268677|P2|NOT COMPLETED|Overall Study||43
112641|NCT00032630|268678|P1|NOT COMPLETED|Overall Study||49
112642|NCT00032630|268677|P2|COMPLETED|Overall Study||1061
112643|NCT00032630|268678|P1|COMPLETED|Overall Study||1050
112644|NCT00032630|268677|P2|STARTED|Overall Study||1104
112645|NCT00032630|268678|P1|STARTED|Overall Study||1099
112646|NCT00033293|268688|P2|NOT COMPLETED|Overall Study||18
112647|NCT00033293|268689|P1|NOT COMPLETED|Overall Study||10
112648|NCT00033293|268688|P2|COMPLETED|Overall Study||9
112649|NCT00033293|268689|P1|COMPLETED|Overall Study||16
112650|NCT00033293|268688|P2|STARTED|Overall Study||27
112651|NCT00033293|268689|P1|STARTED|Overall Study||26
112652|NCT00033371|268709|P2|NOT COMPLETED|Overall Study||10
112653|NCT00033371|268710|P1|NOT COMPLETED|Overall Study||6
112654|NCT00033371|268709|P2|COMPLETED|Overall Study||47
112655|NCT00033371|268710|P1|COMPLETED|Overall Study||49
112656|NCT00033371|268709|P2|STARTED|Overall Study||57
112657|NCT00033371|268710|P1|STARTED|Overall Study||55
112658|NCT00033514|268718|P2|NOT COMPLETED|Overall Study||4
112659|NCT00033514|268719|P1|NOT COMPLETED|Overall Study||1
112660|NCT00033514|268718|P2|COMPLETED|Overall Study||7
112661|NCT00033514|268719|P1|COMPLETED|Overall Study||15
112662|NCT00033514|268718|P2|STARTED|Overall Study||11
112663|NCT00033514|268719|P1|STARTED|Overall Study||16
112664|NCT00033540|268727|P1|NOT COMPLETED|Overall Study||57
112665|NCT00033540|268727|P1|COMPLETED|Overall Study||0
112666|NCT00033540|268727|P1|Eligible and Began Protocol Therapy|Overall Study|One patient went off study prior to any toxicity assessments and is not evaluable for toxicities.|52
112667|NCT00033540|268727|P1|Eligible|Overall Study||54
112668|NCT00033540|268727|P1|STARTED|Overall Study||57
112669|NCT00033631|268737|P2|NOT COMPLETED|Overall Study||15
112670|NCT00033631|268738|P1|NOT COMPLETED|Overall Study||18
112671|NCT00033631|268737|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|748
112672|NCT00033631|268738|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|751
112673|NCT00033631|268737|P2|STARTED|Overall Study||763
112674|NCT00033631|268738|P1|STARTED|Overall Study||769
112675|NCT00033657|268758|P2|NOT COMPLETED|Adjuvant Chemotherapy||17
112676|NCT00033657|268759|P1|NOT COMPLETED|Adjuvant Chemotherapy||18
112677|NCT00033657|268758|P2|COMPLETED|Adjuvant Chemotherapy||16
112678|NCT00033657|268759|P1|COMPLETED|Adjuvant Chemotherapy||18
112679|NCT00033657|268758|P2|STARTED|Adjuvant Chemotherapy||33
112680|NCT00033657|268759|P1|STARTED|Adjuvant Chemotherapy||36
112681|NCT00033657|268758|P2|NOT COMPLETED|Surgical Resection||3
112682|NCT00033657|268759|P1|NOT COMPLETED|Surgical Resection||0
112683|NCT00033657|268758|P2|COMPLETED|Surgical Resection||33
112684|NCT00033657|268759|P1|COMPLETED|Surgical Resection||36
112685|NCT00033657|268758|P2|STARTED|Surgical Resection||36
112686|NCT00033657|268759|P1|STARTED|Surgical Resection||36
112687|NCT00033657|268758|P2|NOT COMPLETED|Neoadjuvant Chemotherapy||11
112688|NCT00033657|268759|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||14
112689|NCT00033657|268758|P2|COMPLETED|Neoadjuvant Chemotherapy||36
112690|NCT00033657|268759|P1|COMPLETED|Neoadjuvant Chemotherapy||36
112691|NCT00033657|268758|P2|Eligible and Treated|Neoadjuvant Chemotherapy||42
112692|NCT00033657|268759|P1|Eligible and Treated|Neoadjuvant Chemotherapy||39
112693|NCT00033657|268758|P2|Eligible|Neoadjuvant Chemotherapy||43
112694|NCT00033657|268759|P1|Eligible|Neoadjuvant Chemotherapy||42
112695|NCT00033657|268758|P2|STARTED|Neoadjuvant Chemotherapy||47
112696|NCT00033657|268759|P1|STARTED|Neoadjuvant Chemotherapy||50
112697|NCT00035555|268774|P3|NOT COMPLETED|Overall Study||22
112698|NCT00035555|268775|P2|NOT COMPLETED|Overall Study||16
112699|NCT00035555|268776|P1|NOT COMPLETED|Overall Study||16
112700|NCT00035555|268774|P3|COMPLETED|Overall Study||51
112701|NCT00035555|268775|P2|COMPLETED|Overall Study||55
112702|NCT00035555|268776|P1|COMPLETED|Overall Study||58
112703|NCT00035555|268774|P3|Number Who Received Study Drug|Overall Study||71
112704|NCT00035555|268775|P2|Number Who Received Study Drug|Overall Study||71
112705|NCT00035555|268776|P1|Number Who Received Study Drug|Overall Study||74
112706|NCT00035555|268774|P3|Number Who Had Undergone Transplantation|Overall Study||73
112707|NCT00035555|268775|P2|Number Who Had Undergone Transplantation|Overall Study||71
112708|NCT00035555|268776|P1|Number Who Had Undergone Transplantation|Overall Study||74
112709|NCT00035555|268774|P3|STARTED|Overall Study|Randomized patients|73
112710|NCT00035555|268775|P2|STARTED|Overall Study|Randomized patients|71
112711|NCT00035555|268776|P1|STARTED|Overall Study|Randomized patients|74
112712|NCT00035815|268819|P2|NOT COMPLETED|Overall Study||11
112713|NCT00035815|268820|P1|NOT COMPLETED|Overall Study||17
112714|NCT00035815|268819|P2|COMPLETED|Overall Study||152
112715|NCT00035815|268820|P1|COMPLETED|Overall Study||150
112716|NCT00035815|268819|P2|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|163
112717|NCT00035815|268820|P1|STARTED|Overall Study|Enrollment began June 2003, accrual was for 2 years, follow-up period was 2 years.|167
112718|NCT00035932|268833|P3|NOT COMPLETED|Overall Study||49
112719|NCT00035932|268834|P2|NOT COMPLETED|Overall Study||60
112720|NCT00035932|268835|P1|NOT COMPLETED|Overall Study||56
112721|NCT00035932|268833|P3|COMPLETED|Overall Study|59 remained on treatment, 10 completed at Week 96|69
112722|NCT00035932|268834|P2|COMPLETED|Overall Study|50 remained on treatment, 0 completed at Week 96|50
112723|NCT00035932|268835|P1|COMPLETED|Overall Study|63 remained on treatment, 0 completed at Week 96|63
112724|NCT00035932|268833|P3|Discontinued on or After Week 96|Overall Study||6
112725|NCT00035932|268834|P2|Discontinued on or After Week 96|Overall Study||4
112726|NCT00035932|268835|P1|Discontinued on or After Week 96|Overall Study||4
112727|NCT00035932|268833|P3|Discontinued Between Weeks 48 and 96|Overall Study||30
112728|NCT00035932|268834|P2|Discontinued Between Weeks 48 and 96|Overall Study||27
112729|NCT00035932|268835|P1|Discontinued Between Weeks 48 and 96|Overall Study||26
112730|NCT00035932|268833|P3|Discontinued Prior to Week 48 Visit|Overall Study||13
112731|NCT00035932|268834|P2|Discontinued Prior to Week 48 Visit|Overall Study||29
112732|NCT00035932|268835|P1|Discontinued Prior to Week 48 Visit|Overall Study||26
112733|NCT00035932|268833|P3|STARTED|Overall Study|123 randomized, 118 treated|118
112734|NCT00035932|268834|P2|STARTED|Overall Study|115 randomized, 110 treated|110
112735|NCT00035932|268835|P1|STARTED|Overall Study|120 randomized, 119 treated|119
112736|NCT00036270|268961|P2|NOT COMPLETED|Study Treatment to 5 Year Report||3488
112737|NCT00036270|268962|P1|NOT COMPLETED|Study Treatment to 5 Year Report||2565
112738|NCT00036270|268961|P2|COMPLETED|Study Treatment to 5 Year Report||1380
112739|NCT00036270|268962|P1|COMPLETED|Study Treatment to 5 Year Report||2333
112740|NCT00036270|268961|P2|Treated|Study Treatment to 5 Year Report||4814
112741|NCT00036270|268962|P1|Treated|Study Treatment to 5 Year Report||4852
112742|NCT00036270|268961|P2|STARTED|Study Treatment to 5 Year Report||4868
112743|NCT00036270|268962|P1|STARTED|Study Treatment to 5 Year Report||4898
112744|NCT00036270|268961|P2|NOT COMPLETED|Randomized to Study Treatment||7
112745|NCT00036270|268962|P1|NOT COMPLETED|Randomized to Study Treatment||6
112746|NCT00036270|268961|P2|COMPLETED|Randomized to Study Treatment||4868
112747|NCT00036270|268962|P1|COMPLETED|Randomized to Study Treatment||4898
112748|NCT00036270|268961|P2|STARTED|Randomized to Study Treatment||4875
112749|NCT00036270|268962|P1|STARTED|Randomized to Study Treatment||4904
112750|NCT00036569|268978|P1|NOT COMPLETED|Overall Study||0
112751|NCT00036569|268978|P1|COMPLETED|Overall Study||32
112752|NCT00036569|268978|P1|STARTED|Overall Study||32
112753|NCT00030823|268987|P1|NOT COMPLETED|Overall Study||1
112754|NCT00030823|268987|P1|COMPLETED|Overall Study||13
112755|NCT00030823|268987|P1|STARTED|Overall Study||14
112756|NCT00043979|268993|P3|NOT COMPLETED|Period 2||0
112757|NCT00043979|268994|P2|NOT COMPLETED|Period 2||0
112758|NCT00043979|268995|P1|NOT COMPLETED|Period 2||0
112759|NCT00043979|268993|P3|COMPLETED|Period 2||10
112760|NCT00043979|268994|P2|COMPLETED|Period 2||13
112761|NCT00043979|268995|P1|COMPLETED|Period 2||0
112762|NCT00043979|268993|P3|STARTED|Period 2||10
112763|NCT00043979|268994|P2|STARTED|Period 2||13
112764|NCT00043979|268995|P1|STARTED|Period 2||0
112765|NCT00043979|268993|P3|NOT COMPLETED|Period 1||3
112766|NCT00043979|268994|P2|NOT COMPLETED|Period 1||4
112767|NCT00043979|268995|P1|NOT COMPLETED|Period 1||7
112768|NCT00043979|268993|P3|COMPLETED|Period 1||10
112769|NCT00043979|268994|P2|COMPLETED|Period 1||13
112770|NCT00043979|268995|P1|COMPLETED|Period 1||23
112771|NCT00043979|268993|P3|STARTED|Period 1||13
112772|NCT00043979|268994|P2|STARTED|Period 1||17
112773|NCT00043979|268995|P1|STARTED|Period 1||30
112774|NCT00044005|269016|P3|NOT COMPLETED|Overall Study||22
112775|NCT00044005|269017|P2|NOT COMPLETED|Overall Study||14
112776|NCT00044005|269018|P1|NOT COMPLETED|Overall Study||19
112777|NCT00044005|269016|P3|COMPLETED|Overall Study||11
112778|NCT00044005|269017|P2|COMPLETED|Overall Study||19
112779|NCT00044005|269018|P1|COMPLETED|Overall Study||13
112780|NCT00044005|269016|P3|STARTED|Overall Study||33
112781|NCT00044005|269017|P2|STARTED|Overall Study||33
112782|NCT00044005|269018|P1|STARTED|Overall Study||32
112783|NCT00044044|269031|P5|NOT COMPLETED|Overall Study||36
112784|NCT00044044|269032|P4|NOT COMPLETED|Overall Study||44
112785|NCT00044044|269033|P3|NOT COMPLETED|Overall Study||40
112786|NCT00044044|269034|P2|NOT COMPLETED|Overall Study||41
112787|NCT00044044|269035|P1|NOT COMPLETED|Overall Study||44
112788|NCT00044044|269031|P5|COMPLETED|Overall Study||36
112789|NCT00044044|269032|P4|COMPLETED|Overall Study||29
112790|NCT00044044|269033|P3|COMPLETED|Overall Study||31
112791|NCT00044044|269034|P2|COMPLETED|Overall Study||28
112792|NCT00044044|269035|P1|COMPLETED|Overall Study||27
112793|NCT00044044|269031|P5|STARTED|Overall Study||72
112794|NCT00044044|269032|P4|STARTED|Overall Study||73
112795|NCT00044044|269033|P3|STARTED|Overall Study||71
112796|NCT00044044|269034|P2|STARTED|Overall Study||69
112797|NCT00044044|269035|P1|STARTED|Overall Study||71
112798|NCT00044213|269066|P4|NOT COMPLETED|Overall Study||136
112799|NCT00044213|269067|P3|NOT COMPLETED|Overall Study||138
112800|NCT00044213|269068|P2|NOT COMPLETED|Overall Study||112
112801|NCT00044213|269069|P1|NOT COMPLETED|Overall Study||100
112802|NCT00044213|269066|P4|COMPLETED|Overall Study||301
112803|NCT00044213|269067|P3|COMPLETED|Overall Study||294
112804|NCT00044213|269068|P2|COMPLETED|Overall Study||306
112805|NCT00044213|269069|P1|COMPLETED|Overall Study||321
112806|NCT00044213|269066|P4|STARTED|Overall Study||437
112807|NCT00044213|269067|P3|STARTED|Overall Study||432
112808|NCT00044213|269068|P2|STARTED|Overall Study||418
112809|NCT00044213|269069|P1|STARTED|Overall Study||421
112810|NCT00046475|269085|P3|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
112811|NCT00046475|269086|P2|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||1
112812|NCT00046475|269087|P1|NOT COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
112813|NCT00046475|269085|P3|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||59
112814|NCT00046475|269086|P2|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||44
112815|NCT00046475|269087|P1|COMPLETED|Treatment Period 2 (Up to 2 Weeks)||0
112816|NCT00046475|269085|P3|STARTED|Treatment Period 2 (Up to 2 Weeks)||59
112817|NCT00046475|269086|P2|STARTED|Treatment Period 2 (Up to 2 Weeks)||45
112818|NCT00046475|269087|P1|STARTED|Treatment Period 2 (Up to 2 Weeks)||0
112819|NCT00046475|269085|P3|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||1
112820|NCT00046475|269086|P2|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
112821|NCT00046475|269087|P1|NOT COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
112822|NCT00046475|269085|P3|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||59
112823|NCT00046475|269086|P2|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||45
112824|NCT00046475|269087|P1|COMPLETED|Treatment Period 1 (Up to 2 Weeks)||0
112825|NCT00046475|269085|P3|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|60
112826|NCT00046475|269086|P2|STARTED|Treatment Period 1 (Up to 2 Weeks)|Patients did not meet the criteria for randomization, had an AE, or withdrew from the study.|45
112827|NCT00046475|269087|P1|STARTED|Treatment Period 1 (Up to 2 Weeks)||0
112828|NCT00046475|269085|P3|NOT COMPLETED|Titration (1 Week)||0
112829|NCT00046475|269086|P2|NOT COMPLETED|Titration (1 Week)||0
112830|NCT00046475|269087|P1|NOT COMPLETED|Titration (1 Week)||0
112831|NCT00046475|269085|P3|COMPLETED|Titration (1 Week)||0
112832|NCT00046475|269086|P2|COMPLETED|Titration (1 Week)||0
112833|NCT00046475|269087|P1|COMPLETED|Titration (1 Week)||136
112834|NCT00046475|269085|P3|STARTED|Titration (1 Week)||0
112835|NCT00046475|269086|P2|STARTED|Titration (1 Week)||0
112836|NCT00046475|269087|P1|STARTED|Titration (1 Week)||136
112837|NCT00046475|269085|P3|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
112838|NCT00046475|269086|P2|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
112839|NCT00046475|269087|P1|NOT COMPLETED|Screening/Washout Period (Up to 2 Weeks)||4
112840|NCT00046475|269085|P3|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
112841|NCT00046475|269086|P2|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||0
112842|NCT00046475|269087|P1|COMPLETED|Screening/Washout Period (Up to 2 Weeks)||136
112843|NCT00046475|269085|P3|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
112844|NCT00046475|269086|P2|STARTED|Screening/Washout Period (Up to 2 Weeks)||0
112845|NCT00046475|269087|P1|STARTED|Screening/Washout Period (Up to 2 Weeks)||140
112846|NCT00046566|269126|P3|NOT COMPLETED|Intervention 3 (8 Weeks)||0
112847|NCT00046566|269127|P2|NOT COMPLETED|Intervention 3 (8 Weeks)||0
112848|NCT00046566|269128|P1|NOT COMPLETED|Intervention 3 (8 Weeks)||0
112849|NCT00046566|269126|P3|COMPLETED|Intervention 3 (8 Weeks)||88
112850|NCT00046566|269127|P2|COMPLETED|Intervention 3 (8 Weeks)||92
112851|NCT00046566|269128|P1|COMPLETED|Intervention 3 (8 Weeks)||93
112852|NCT00046566|269126|P3|STARTED|Intervention 3 (8 Weeks)||88
112853|NCT00046566|269127|P2|STARTED|Intervention 3 (8 Weeks)||92
112854|NCT00046566|269128|P1|STARTED|Intervention 3 (8 Weeks)||93
112855|NCT00046566|269126|P3|NOT COMPLETED|Intervention 2 (8 Weeks)||13
112856|NCT00046566|269127|P2|NOT COMPLETED|Intervention 2 (8 Weeks)||12
112857|NCT00046566|269128|P1|NOT COMPLETED|Intervention 2 (8 Weeks)||8
112858|NCT00046566|269126|P3|COMPLETED|Intervention 2 (8 Weeks)||88
112859|NCT00046566|269127|P2|COMPLETED|Intervention 2 (8 Weeks)||92
112860|NCT00046566|269128|P1|COMPLETED|Intervention 2 (8 Weeks)||93
112861|NCT00046566|269126|P3|STARTED|Intervention 2 (8 Weeks)|Soy protein 8 weeks|101
112862|NCT00046566|269127|P2|STARTED|Intervention 2 (8 Weeks)|Carbohydrate 8 weeks|104
112863|NCT00046566|269128|P1|STARTED|Intervention 2 (8 Weeks)|Milk protein 8 weeks|101
112864|NCT00046566|269126|P3|NOT COMPLETED|Intervention 1 (8 Weeks)||17
112865|NCT00046566|269127|P2|NOT COMPLETED|Intervention 1 (8 Weeks)||13
112866|NCT00046566|269128|P1|NOT COMPLETED|Intervention 1 (8 Weeks)||16
112867|NCT00046566|269126|P3|COMPLETED|Intervention 1 (8 Weeks)||101
112868|NCT00046566|269127|P2|COMPLETED|Intervention 1 (8 Weeks)||104
112869|NCT00046566|269128|P1|COMPLETED|Intervention 1 (8 Weeks)||101
112870|NCT00046566|269126|P3|STARTED|Intervention 1 (8 Weeks)|Carbohydrate 8 weeks|118
112871|NCT00046566|269127|P2|STARTED|Intervention 1 (8 Weeks)|Milk protein 8 weeks|117
112872|NCT00046566|269128|P1|STARTED|Intervention 1 (8 Weeks)|Soy protein 8 weeks|117
112873|NCT00046839|269144|P2|NOT COMPLETED|Overall Study||2
112874|NCT00046839|269145|P1|NOT COMPLETED|Overall Study||1
112875|NCT00046839|269144|P2|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|11
112876|NCT00046839|269145|P1|COMPLETED|Overall Study|Subjects contributing data to either primary analysis are considered to have completed the study.|7
112877|NCT00046839|269144|P2|STARTED|Overall Study||13
112878|NCT00046839|269145|P1|STARTED|Overall Study||8
112879|NCT00046891|269154|P2|NOT COMPLETED|Overall Study||30
112880|NCT00046891|269155|P1|NOT COMPLETED|Overall Study||29
112881|NCT00046891|269154|P2|COMPLETED|Overall Study||83
112882|NCT00046891|269155|P1|COMPLETED|Overall Study||84
112883|NCT00046891|269154|P2|STARTED|Overall Study||113
112884|NCT00046891|269155|P1|STARTED|Overall Study||113
112885|NCT00046930|269175|P2|NOT COMPLETED|Overall Study||4
112886|NCT00046930|269176|P1|NOT COMPLETED|Overall Study||12
112887|NCT00046930|269175|P2|COMPLETED|Overall Study||221
112888|NCT00046930|269176|P1|COMPLETED|Overall Study||212
112889|NCT00046930|269175|P2|STARTED|Overall Study||225
112890|NCT00046930|269176|P1|STARTED|Overall Study||224
112891|NCT00047008|269191|P2|NOT COMPLETED|Overall Study||11
112892|NCT00047008|269192|P1|NOT COMPLETED|Overall Study||11
112893|NCT00047008|269191|P2|COMPLETED|Overall Study||360
112894|NCT00047008|269192|P1|COMPLETED|Overall Study||361
112895|NCT00047008|269191|P2|STARTED|Overall Study||371
112896|NCT00047008|269192|P1|STARTED|Overall Study||372
112897|NCT00047320|269198|P1|NOT COMPLETED|Overall Study||28
112898|NCT00047320|269198|P1|COMPLETED|Overall Study||76
112899|NCT00047320|269198|P1|STARTED|Overall Study||104
112900|NCT00047385|269204|P2|NOT COMPLETED|Overall Study||500
112901|NCT00047385|269205|P1|NOT COMPLETED|Overall Study||267
112902|NCT00047385|269204|P2|COMPLETED|Overall Study||26232
112903|NCT00047385|269205|P1|COMPLETED|Overall Study|Had at least one screening exam.|26455
112904|NCT00047385|269204|P2|STARTED|Overall Study||26732
112905|NCT00047385|269205|P1|STARTED|Overall Study||26722
112906|NCT00047463|269225|P2|NOT COMPLETED|Overall Study||3
112907|NCT00047463|269226|P1|NOT COMPLETED|Overall Study||0
112908|NCT00047463|269225|P2|COMPLETED|Overall Study||19
112909|NCT00047463|269226|P1|COMPLETED|Overall Study||13
112910|NCT00047463|269225|P2|STARTED|Overall Study||22
112911|NCT00047463|269226|P1|STARTED|Overall Study||13
112912|NCT00047619|269237|P2|NOT COMPLETED|Overall Study||0
112913|NCT00047619|269238|P1|NOT COMPLETED|Overall Study||0
112914|NCT00047619|269237|P2|COMPLETED|Overall Study||14
112915|NCT00047619|269238|P1|COMPLETED|Overall Study||14
112916|NCT00047619|269237|P2|STARTED|Overall Study||14
112917|NCT00047619|269238|P1|STARTED|Overall Study||14
112918|NCT00047879|269248|P2|NOT COMPLETED|Overall Study||3
112919|NCT00047879|269249|P1|NOT COMPLETED|Overall Study||4
112920|NCT00047879|269248|P2|COMPLETED|Overall Study||0
112921|NCT00047879|269249|P1|COMPLETED|Overall Study||0
112922|NCT00047879|269248|P2|STARTED|Overall Study||3
112923|NCT00047879|269249|P1|STARTED|Overall Study||4
112924|NCT00048035|269265|P8|NOT COMPLETED|Extension Year 2||3
112925|NCT00048035|269266|P7|NOT COMPLETED|Extension Year 2||3
112926|NCT00048035|269267|P6|NOT COMPLETED|Extension Year 2||0
112927|NCT00048035|269268|P5|NOT COMPLETED|Extension Year 2||0
112928|NCT00048035|269269|P4|NOT COMPLETED|Extension Year 2||0
112929|NCT00048035|269270|P3|NOT COMPLETED|Extension Year 2||0
112930|NCT00048035|269271|P2|NOT COMPLETED|Extension Year 2||0
112931|NCT00048035|269272|P1|NOT COMPLETED|Extension Year 2||0
112932|NCT00048035|269265|P8|COMPLETED|Extension Year 2||10
112933|NCT00048035|269266|P7|COMPLETED|Extension Year 2||11
112934|NCT00048035|269267|P6|COMPLETED|Extension Year 2||0
112935|NCT00048035|269268|P5|COMPLETED|Extension Year 2||0
112936|NCT00048035|269269|P4|COMPLETED|Extension Year 2||0
112937|NCT00048035|269270|P3|COMPLETED|Extension Year 2||0
112938|NCT00048035|269271|P2|COMPLETED|Extension Year 2||0
112939|NCT00048035|269272|P1|COMPLETED|Extension Year 2||0
112940|NCT00048035|269265|P8|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|13
112941|NCT00048035|269266|P7|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
112942|NCT00048035|269267|P6|STARTED|Extension Year 2||0
112943|NCT00048035|269268|P5|STARTED|Extension Year 2||0
112944|NCT00048035|269269|P4|STARTED|Extension Year 2||0
112945|NCT00048035|269270|P3|STARTED|Extension Year 2||0
112946|NCT00048035|269271|P2|STARTED|Extension Year 2||0
112947|NCT00048035|269272|P1|STARTED|Extension Year 2||0
112948|NCT00048035|269265|P8|NOT COMPLETED|Extension Year 1||11
112949|NCT00048035|269266|P7|NOT COMPLETED|Extension Year 1||11
112950|NCT00048035|269267|P6|NOT COMPLETED|Extension Year 1||0
112951|NCT00048035|269268|P5|NOT COMPLETED|Extension Year 1||0
112952|NCT00048035|269269|P4|NOT COMPLETED|Extension Year 1||0
112953|NCT00048035|269270|P3|NOT COMPLETED|Extension Year 1||0
112954|NCT00048035|269271|P2|NOT COMPLETED|Extension Year 1||0
112955|NCT00048035|269272|P1|NOT COMPLETED|Extension Year 1||0
112956|NCT00048035|269265|P8|COMPLETED|Extension Year 1||15
112957|NCT00048035|269266|P7|COMPLETED|Extension Year 1||16
112958|NCT00048035|269267|P6|COMPLETED|Extension Year 1||0
112959|NCT00048035|269268|P5|COMPLETED|Extension Year 1||0
112960|NCT00048035|269269|P4|COMPLETED|Extension Year 1||0
112961|NCT00048035|269270|P3|COMPLETED|Extension Year 1||0
112962|NCT00048035|269271|P2|COMPLETED|Extension Year 1||0
112963|NCT00048035|269272|P1|COMPLETED|Extension Year 1||0
112964|NCT00048035|269265|P8|STARTED|Extension Year 1|Participants (Cohorts 2, 4 and 6) who completed core, entered extension period (entry optional).|26
112965|NCT00048035|269266|P7|STARTED|Extension Year 1|Participants (Cohorts 1, 3, and 5) who completed core, entered extension period (entry optional).|27
112966|NCT00048035|269267|P6|STARTED|Extension Year 1||0
112967|NCT00048035|269268|P5|STARTED|Extension Year 1||0
112968|NCT00048035|269269|P4|STARTED|Extension Year 1||0
112969|NCT00048035|269270|P3|STARTED|Extension Year 1||0
112970|NCT00048035|269271|P2|STARTED|Extension Year 1||0
112971|NCT00048035|269272|P1|STARTED|Extension Year 1||0
112972|NCT00048035|269265|P8|NOT COMPLETED|Core Period||0
112973|NCT00048035|269266|P7|NOT COMPLETED|Core Period||0
112974|NCT00048035|269267|P6|NOT COMPLETED|Core Period||1
112975|NCT00048035|269268|P5|NOT COMPLETED|Core Period||1
112976|NCT00048035|269269|P4|NOT COMPLETED|Core Period||1
112977|NCT00048035|269270|P3|NOT COMPLETED|Core Period||1
112978|NCT00048035|269271|P2|NOT COMPLETED|Core Period||2
112979|NCT00048035|269272|P1|NOT COMPLETED|Core Period||4
112980|NCT00048035|269265|P8|COMPLETED|Core Period||0
112981|NCT00048035|269266|P7|COMPLETED|Core Period||0
112982|NCT00048035|269267|P6|COMPLETED|Core Period||14
112983|NCT00048035|269268|P5|COMPLETED|Core Period||15
112984|NCT00048035|269269|P4|COMPLETED|Core Period||14
112985|NCT00048035|269270|P3|COMPLETED|Core Period||14
112986|NCT00048035|269271|P2|COMPLETED|Core Period||13
112987|NCT00048035|269272|P1|COMPLETED|Core Period||11
112988|NCT00048035|269265|P8|STARTED|Core Period||0
112989|NCT00048035|269266|P7|STARTED|Core Period||0
112990|NCT00048035|269267|P6|STARTED|Core Period||15
112991|NCT00048035|269268|P5|STARTED|Core Period||16
112992|NCT00048035|269269|P4|STARTED|Core Period||15
112993|NCT00048035|269270|P3|STARTED|Core Period||15
112994|NCT00048035|269271|P2|STARTED|Core Period||15
112995|NCT00048035|269272|P1|STARTED|Core Period||15
112996|NCT00048061|269312|P4|NOT COMPLETED|Overall Study||79
112997|NCT00048061|269313|P3|NOT COMPLETED|Overall Study||84
112998|NCT00048061|269314|P2|NOT COMPLETED|Overall Study||73
112999|NCT00048061|269315|P1|NOT COMPLETED|Overall Study||75
113000|NCT00048061|269312|P4|COMPLETED|Overall Study||322
113001|NCT00048061|269313|P3|COMPLETED|Overall Study||316
113002|NCT00048061|269314|P2|COMPLETED|Overall Study||328
113003|NCT00048061|269315|P1|COMPLETED|Overall Study||325
113004|NCT00048061|269312|P4|STARTED|Overall Study||401
113005|NCT00048061|269313|P3|STARTED|Overall Study||400
113006|NCT00048061|269314|P2|STARTED|Overall Study||401
113007|NCT00048061|269315|P1|STARTED|Overall Study||400
113008|NCT00048074|269388|P3|NOT COMPLETED|Overall Study||97
113009|NCT00048074|269389|P2|NOT COMPLETED|Overall Study||87
113010|NCT00048074|269390|P1|NOT COMPLETED|Overall Study||81
113011|NCT00048074|269388|P3|COMPLETED|Overall Study||372
113012|NCT00048074|269389|P2|COMPLETED|Overall Study||361
113013|NCT00048074|269390|P1|COMPLETED|Overall Study||384
113014|NCT00048074|269388|P3|STARTED|Overall Study||469
113015|NCT00048074|269389|P2|STARTED|Overall Study||448
113016|NCT00048074|269390|P1|STARTED|Overall Study||465
113017|NCT00048165|269445|P2|NOT COMPLETED|Completed 12 Months Study||3
113018|NCT00048165|269446|P1|NOT COMPLETED|Completed 12 Months Study||3
113019|NCT00048165|269445|P2|COMPLETED|Completed 12 Months Study||167
113020|NCT00048165|269446|P1|COMPLETED|Completed 12 Months Study||162
113021|NCT00048165|269445|P2|STARTED|Completed 12 Months Study||170
113022|NCT00048165|269446|P1|STARTED|Completed 12 Months Study||165
113023|NCT00048165|269445|P2|NOT COMPLETED|Completed 6 Months Study||48
113024|NCT00048165|269446|P1|NOT COMPLETED|Completed 6 Months Study||51
113025|NCT00048165|269445|P2|COMPLETED|Completed 6 Months Study||170
113026|NCT00048165|269446|P1|COMPLETED|Completed 6 Months Study||165
113027|NCT00048165|269445|P2|STARTED|Completed 6 Months Study||218
113028|NCT00048165|269446|P1|STARTED|Completed 6 Months Study||216
113029|NCT00048347|269478|P1|NOT COMPLETED|Overall Study||2
113030|NCT00048347|269478|P1|COMPLETED|Overall Study||16
113031|NCT00048347|269478|P1|STARTED|Overall Study||18
113032|NCT00048542|269486|P8|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
113033|NCT00048542|269487|P7|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||22
113034|NCT00048542|269488|P6|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
113035|NCT00048542|269489|P5|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
113036|NCT00048542|269490|P4|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
113037|NCT00048542|269491|P3|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
113038|NCT00048542|269492|P2|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
113039|NCT00048542|269493|P1|NOT COMPLETED|Open-Label Extension Fixed Dose Phase||0
113040|NCT00048542|269486|P8|COMPLETED|Open-Label Extension Fixed Dose Phase||25
113041|NCT00048542|269487|P7|COMPLETED|Open-Label Extension Fixed Dose Phase||37
113042|NCT00048542|269488|P6|COMPLETED|Open-Label Extension Fixed Dose Phase||0
113043|NCT00048542|269489|P5|COMPLETED|Open-Label Extension Fixed Dose Phase||0
113044|NCT00048542|269490|P4|COMPLETED|Open-Label Extension Fixed Dose Phase||0
113045|NCT00048542|269491|P3|COMPLETED|Open-Label Extension Fixed Dose Phase||0
113046|NCT00048542|269492|P2|COMPLETED|Open-Label Extension Fixed Dose Phase||0
113047|NCT00048542|269493|P1|COMPLETED|Open-Label Extension Fixed Dose Phase||0
113048|NCT00048542|269486|P8|STARTED|Open-Label Extension Fixed Dose Phase||47
113049|NCT00048542|269487|P7|STARTED|Open-Label Extension Fixed Dose Phase||59
113050|NCT00048542|269488|P6|STARTED|Open-Label Extension Fixed Dose Phase||0
113051|NCT00048542|269489|P5|STARTED|Open-Label Extension Fixed Dose Phase||0
113052|NCT00048542|269490|P4|STARTED|Open-Label Extension Fixed Dose Phase||0
113053|NCT00048542|269491|P3|STARTED|Open-Label Extension Fixed Dose Phase||0
113054|NCT00048542|269492|P2|STARTED|Open-Label Extension Fixed Dose Phase||0
113055|NCT00048542|269493|P1|STARTED|Open-Label Extension Fixed Dose Phase||0
113056|NCT00048542|269486|P8|NOT COMPLETED|Open-Label Extension BSA Phase||0
113057|NCT00048542|269487|P7|NOT COMPLETED|Open-Label Extension BSA Phase||0
113058|NCT00048542|269488|P6|NOT COMPLETED|Open-Label Extension BSA Phase||10
113059|NCT00048542|269489|P5|NOT COMPLETED|Open-Label Extension BSA Phase||12
113060|NCT00048542|269490|P4|NOT COMPLETED|Open-Label Extension BSA Phase||0
113061|NCT00048542|269491|P3|NOT COMPLETED|Open-Label Extension BSA Phase||0
113062|NCT00048542|269492|P2|NOT COMPLETED|Open-Label Extension BSA Phase||0
113063|NCT00048542|269493|P1|NOT COMPLETED|Open-Label Extension BSA Phase||0
113064|NCT00048542|269486|P8|COMPLETED|Open-Label Extension BSA Phase||0
113065|NCT00048542|269487|P7|COMPLETED|Open-Label Extension BSA Phase||0
113066|NCT00048542|269488|P6|COMPLETED|Open-Label Extension BSA Phase||47
113067|NCT00048542|269489|P5|COMPLETED|Open-Label Extension BSA Phase||59
113068|NCT00048542|269490|P4|COMPLETED|Open-Label Extension BSA Phase||0
113069|NCT00048542|269491|P3|COMPLETED|Open-Label Extension BSA Phase||0
113070|NCT00048542|269492|P2|COMPLETED|Open-Label Extension BSA Phase||0
113071|NCT00048542|269493|P1|COMPLETED|Open-Label Extension BSA Phase||0
113072|NCT00048542|269486|P8|STARTED|Open-Label Extension BSA Phase||0
113073|NCT00048542|269487|P7|STARTED|Open-Label Extension BSA Phase||0
113074|NCT00048542|269488|P6|STARTED|Open-Label Extension BSA Phase||57
113075|NCT00048542|269489|P5|STARTED|Open-Label Extension BSA Phase||71
113076|NCT00048542|269490|P4|STARTED|Open-Label Extension BSA Phase||0
113077|NCT00048542|269491|P3|STARTED|Open-Label Extension BSA Phase||0
113078|NCT00048542|269492|P2|STARTED|Open-Label Extension BSA Phase||0
113079|NCT00048542|269493|P1|STARTED|Open-Label Extension BSA Phase||0
113080|NCT00048542|269486|P8|NOT COMPLETED|Double-Blind Phase||0
113081|NCT00048542|269487|P7|NOT COMPLETED|Double-Blind Phase||0
113082|NCT00048542|269488|P6|NOT COMPLETED|Double-Blind Phase||0
113083|NCT00048542|269489|P5|NOT COMPLETED|Double-Blind Phase||0
113084|NCT00048542|269490|P4|NOT COMPLETED|Double-Blind Phase||0
113085|NCT00048542|269491|P3|NOT COMPLETED|Double-Blind Phase||1
113086|NCT00048542|269492|P2|NOT COMPLETED|Double-Blind Phase||1
113087|NCT00048542|269493|P1|NOT COMPLETED|Double-Blind Phase||3
113088|NCT00048542|269486|P8|COMPLETED|Double-Blind Phase||0
113089|NCT00048542|269487|P7|COMPLETED|Double-Blind Phase||0
113090|NCT00048542|269488|P6|COMPLETED|Double-Blind Phase||0
113091|NCT00048542|269489|P5|COMPLETED|Double-Blind Phase||0
113092|NCT00048542|269490|P4|COMPLETED|Double-Blind Phase||28
113093|NCT00048542|269491|P3|COMPLETED|Double-Blind Phase||29
113094|NCT00048542|269492|P2|COMPLETED|Double-Blind Phase||36
113095|NCT00048542|269493|P1|COMPLETED|Double-Blind Phase||35
113096|NCT00048542|269486|P8|STARTED|Double-Blind Phase||0
113097|NCT00048542|269487|P7|STARTED|Double-Blind Phase||0
113098|NCT00048542|269488|P6|STARTED|Double-Blind Phase||0
113099|NCT00048542|269489|P5|STARTED|Double-Blind Phase||0
113100|NCT00048542|269490|P4|STARTED|Double-Blind Phase||28
113101|NCT00048542|269491|P3|STARTED|Double-Blind Phase||30
113102|NCT00048542|269492|P2|STARTED|Double-Blind Phase||37
113103|NCT00048542|269493|P1|STARTED|Double-Blind Phase|For all groups, started indicates when the subjects entered the double-blind treatment phase.|38
113104|NCT00048568|269561|P3|NOT COMPLETED|Open-Label Period||160
113105|NCT00048568|269562|P2|NOT COMPLETED|Open-Label Period||0
113106|NCT00048568|269563|P1|NOT COMPLETED|Open-Label Period||0
113107|NCT00048568|269561|P3|COMPLETED|Open-Label Period||379
113108|NCT00048568|269562|P2|COMPLETED|Open-Label Period||0
113109|NCT00048568|269563|P1|COMPLETED|Open-Label Period||0
113110|NCT00048568|269561|P3|STARTED|Open-Label Period||539
113111|NCT00048568|269562|P2|STARTED|Open-Label Period||0
113112|NCT00048568|269563|P1|STARTED|Open-Label Period||0
113113|NCT00048568|269561|P3|NOT COMPLETED|Double-Blind Period Days 170 to 365||0
113114|NCT00048568|269562|P2|NOT COMPLETED|Double-Blind Period Days 170 to 365||12
113115|NCT00048568|269563|P1|NOT COMPLETED|Double-Blind Period Days 170 to 365||16
113116|NCT00048568|269561|P3|COMPLETED|Double-Blind Period Days 170 to 365||0
113117|NCT00048568|269562|P2|COMPLETED|Double-Blind Period Days 170 to 365||162
113118|NCT00048568|269563|P1|COMPLETED|Double-Blind Period Days 170 to 365||385
113119|NCT00048568|269561|P3|STARTED|Double-Blind Period Days 170 to 365||0
113120|NCT00048568|269562|P2|STARTED|Double-Blind Period Days 170 to 365||174
113121|NCT00048568|269563|P1|STARTED|Double-Blind Period Days 170 to 365||401
113122|NCT00048568|269561|P3|NOT COMPLETED|Double-Blind Period Days 1 to 169||0
113123|NCT00048568|269562|P2|NOT COMPLETED|Double-Blind Period Days 1 to 169||45
113124|NCT00048568|269563|P1|NOT COMPLETED|Double-Blind Period Days 1 to 169||32
113125|NCT00048568|269561|P3|COMPLETED|Double-Blind Period Days 1 to 169||0
113126|NCT00048568|269562|P2|COMPLETED|Double-Blind Period Days 1 to 169||174
113127|NCT00048568|269563|P1|COMPLETED|Double-Blind Period Days 1 to 169||401
113128|NCT00048568|269561|P3|STARTED|Double-Blind Period Days 1 to 169||0
113129|NCT00048568|269562|P2|STARTED|Double-Blind Period Days 1 to 169||219
113130|NCT00048568|269563|P1|STARTED|Double-Blind Period Days 1 to 169||433
113131|NCT00048581|269853|P3|NOT COMPLETED|Open-Label Period||167
113132|NCT00048581|269854|P2|NOT COMPLETED|Open-Label Period||0
113133|NCT00048581|269855|P1|NOT COMPLETED|Open-Label Period||0
113134|NCT00048581|269853|P3|COMPLETED|Open-Label Period||150
113135|NCT00048581|269854|P2|COMPLETED|Open-Label Period||0
113136|NCT00048581|269855|P1|COMPLETED|Open-Label Period||0
113137|NCT00048581|269853|P3|STARTED|Open-Label Period||317
113138|NCT00048581|269854|P2|STARTED|Open-Label Period||0
113139|NCT00048581|269855|P1|STARTED|Open-Label Period||0
113140|NCT00048581|269853|P3|NOT COMPLETED|Double-Blind Period||0
113141|NCT00048581|269854|P2|NOT COMPLETED|Double-Blind Period||34
113142|NCT00048581|269855|P1|NOT COMPLETED|Double-Blind Period||35
113143|NCT00048581|269853|P3|COMPLETED|Double-Blind Period||0
113144|NCT00048581|269854|P2|COMPLETED|Double-Blind Period||99
113145|NCT00048581|269855|P1|COMPLETED|Double-Blind Period||223
113146|NCT00048581|269853|P3|STARTED|Double-Blind Period||0
113147|NCT00048581|269854|P2|STARTED|Double-Blind Period||133
113148|NCT00048581|269855|P1|STARTED|Double-Blind Period||258
113149|NCT00048724|270022|P2|NOT COMPLETED|Overall Study||118
113150|NCT00048724|270023|P1|NOT COMPLETED|Overall Study||116
113151|NCT00048724|270022|P2|COMPLETED|Overall Study||197
113152|NCT00048724|270023|P1|COMPLETED|Overall Study||195
113153|NCT00048724|270022|P2|STARTED|Overall Study||315
113154|NCT00048724|270023|P1|STARTED|Overall Study||311
113155|NCT00048737|270031|P1|NOT COMPLETED|Overall Study||0
113156|NCT00048737|270031|P1|COMPLETED|Overall Study||70
113157|NCT00048737|270031|P1|STARTED|Overall Study||70
113158|NCT00048893|270035|P1|NOT COMPLETED|Overall Study||0
113159|NCT00048893|270035|P1|COMPLETED|Overall Study||37
113160|NCT00048893|270035|P1|STARTED|Overall Study||37
113161|NCT00033917|270048|P2|NOT COMPLETED|Overall Study||0
113162|NCT00033917|270049|P1|NOT COMPLETED|Overall Study||0
113163|NCT00033917|270048|P2|COMPLETED|Overall Study||222
113164|NCT00033917|270049|P1|COMPLETED|Overall Study||209
113165|NCT00033917|270048|P2|STARTED|Overall Study||222
113166|NCT00033917|270049|P1|STARTED|Overall Study||209
113167|NCT00039741|270063|P4|NOT COMPLETED|Overall Study||14
113168|NCT00039741|270064|P3|NOT COMPLETED|Overall Study||11
113169|NCT00039741|270065|P2|NOT COMPLETED|Overall Study||12
113170|NCT00039741|270066|P1|NOT COMPLETED|Overall Study||15
113171|NCT00039741|270063|P4|COMPLETED|Overall Study||50
113172|NCT00039741|270064|P3|COMPLETED|Overall Study||54
113173|NCT00039741|270065|P2|COMPLETED|Overall Study||56
113174|NCT00039741|270066|P1|COMPLETED|Overall Study||51
113175|NCT00039741|270063|P4|Death|Overall Study||0
113176|NCT00039741|270064|P3|Death|Overall Study||0
113177|NCT00039741|270065|P2|Death|Overall Study||1
113178|NCT00039741|270066|P1|Death|Overall Study||0
113179|NCT00039741|270063|P4|STARTED|Overall Study||64
113180|NCT00039741|270064|P3|STARTED|Overall Study||65
113181|NCT00039741|270065|P2|STARTED|Overall Study||68
113182|NCT00039741|270066|P1|STARTED|Overall Study||66
113183|NCT00039871|270108|P1|NOT COMPLETED|Overall Study||1384
113184|NCT00039871|270108|P1|COMPLETED|Overall Study||928
113185|NCT00039871|270108|P1|STARTED|Overall Study|Enrolled 2333; 21 subjects excluded due to GCP non-compliance|2312
113186|NCT00040365|270114|P1|NOT COMPLETED|Overall Study||11
113187|NCT00040365|270114|P1|COMPLETED|Overall Study||19
113188|NCT00040365|270114|P1|Completed Follow Up Phase|Overall Study||19
113189|NCT00040365|270114|P1|STARTED|Overall Study||30
113190|NCT00040664|270123|P4|NOT COMPLETED|Overall Study||27
113191|NCT00040664|270124|P3|NOT COMPLETED|Overall Study||13
113192|NCT00040664|270125|P2|NOT COMPLETED|Overall Study||13
113193|NCT00040664|270126|P1|NOT COMPLETED|Overall Study||53
113194|NCT00040664|270123|P4|COMPLETED|Overall Study||8
113195|NCT00040664|270124|P3|COMPLETED|Overall Study||4
113196|NCT00040664|270125|P2|COMPLETED|Overall Study||4
113197|NCT00040664|270126|P1|COMPLETED|Overall Study||16
113198|NCT00040664|270123|P4|STARTED|Overall Study||35
113199|NCT00040664|270124|P3|STARTED|Overall Study||17
113200|NCT00040664|270125|P2|STARTED|Overall Study||17
113201|NCT00040664|270126|P1|STARTED|Overall Study|All (69) enrolled on QD; 10 switched to twice daily. Participant flow not collected for this group.|69
113202|NCT00040742|270178|P4|NOT COMPLETED|Overall Study||34
113203|NCT00040742|270179|P3|NOT COMPLETED|Overall Study||46
113204|NCT00040742|270180|P2|NOT COMPLETED|Overall Study||49
113205|NCT00040742|270181|P1|NOT COMPLETED|Overall Study||39
113206|NCT00040742|270178|P4|COMPLETED|Overall Study||152
113207|NCT00040742|270179|P3|COMPLETED|Overall Study||141
113208|NCT00040742|270180|P2|COMPLETED|Overall Study||134
113209|NCT00040742|270181|P1|COMPLETED|Overall Study||149
113210|NCT00040742|270178|P4|STARTED|Overall Study|One subject found to be ineligible after randomization. No baseline data collected.|186
113211|NCT00040742|270179|P3|STARTED|Overall Study||187
113212|NCT00040742|270180|P2|STARTED|Overall Study||183
113213|NCT00040742|270181|P1|STARTED|Overall Study||188
113214|NCT00040846|270201|P6|NOT COMPLETED|Overall Study||0
113215|NCT00040846|270202|P5|NOT COMPLETED|Overall Study||0
113216|NCT00040846|270203|P4|NOT COMPLETED|Overall Study||0
113217|NCT00040846|270204|P3|NOT COMPLETED|Overall Study||0
113218|NCT00040846|270205|P2|NOT COMPLETED|Overall Study||0
113219|NCT00040846|270206|P1|NOT COMPLETED|Overall Study||0
113220|NCT00040846|270201|P6|COMPLETED|Overall Study||0
113221|NCT00040846|270202|P5|COMPLETED|Overall Study||0
113222|NCT00040846|270203|P4|COMPLETED|Overall Study||0
113223|NCT00040846|270204|P3|COMPLETED|Overall Study||0
113224|NCT00040846|270205|P2|COMPLETED|Overall Study||0
113225|NCT00040846|270206|P1|COMPLETED|Overall Study||60
113226|NCT00040846|270201|P6|STARTED|Overall Study||0
113227|NCT00040846|270202|P5|STARTED|Overall Study||0
113228|NCT00040846|270203|P4|STARTED|Overall Study||0
113229|NCT00040846|270204|P3|STARTED|Overall Study||0
113230|NCT00040846|270205|P2|STARTED|Overall Study||0
113231|NCT00040846|270206|P1|STARTED|Overall Study||60
113232|NCT00040937|270244|P1|NOT COMPLETED|Maintenance||0
113233|NCT00040937|270244|P1|COMPLETED|Maintenance|Patients remained on protocol therapy until progression.|76
113234|NCT00040937|270244|P1|STARTED|Maintenance||76
113235|NCT00040937|270244|P1|NOT COMPLETED|Autologous PBSCT||31
113236|NCT00040937|270244|P1|COMPLETED|Autologous PBSCT||77
113237|NCT00040937|270244|P1|STARTED|Autologous PBSCT|108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.|108
113238|NCT00040937|270244|P1|NOT COMPLETED|Induction/PBSC Mobilization||37
113239|NCT00040937|270244|P1|COMPLETED|Induction/PBSC Mobilization||110
113240|NCT00040937|270244|P1|STARTED|Induction/PBSC Mobilization|147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.|147
113241|NCT00041067|270251|P1|NOT COMPLETED|Overall Study||76
113242|NCT00041067|270251|P1|COMPLETED|Overall Study||0
113243|NCT00041067|270251|P1|Eligible|Overall Study||74
113244|NCT00041067|270251|P1|STARTED|Overall Study||76
113245|NCT00041080|270260|P2|NOT COMPLETED|Overall Study||10
113246|NCT00041080|270261|P1|NOT COMPLETED|Overall Study||30
113247|NCT00041080|270260|P2|COMPLETED|Overall Study||60
113248|NCT00041080|270261|P1|COMPLETED|Overall Study||39
113249|NCT00041080|270260|P2|STARTED|Overall Study|number patients enrolled on study|70
113250|NCT00041080|270261|P1|STARTED|Overall Study|number patients enrolled on study|69
113251|NCT00041119|270271|P4|NOT COMPLETED|Overall Study||0
113252|NCT00041119|270272|P3|NOT COMPLETED|Overall Study||0
113253|NCT00041119|270273|P2|NOT COMPLETED|Overall Study||0
113254|NCT00041119|270274|P1|NOT COMPLETED|Overall Study||0
113255|NCT00041119|270271|P4|COMPLETED|Overall Study||789
113256|NCT00041119|270272|P3|COMPLETED|Overall Study||1151
113257|NCT00041119|270273|P2|COMPLETED|Overall Study||789
113258|NCT00041119|270274|P1|COMPLETED|Overall Study||1142
113259|NCT00041119|270271|P4|STARTED|Overall Study||789
113260|NCT00041119|270272|P3|STARTED|Overall Study||1151
113261|NCT00041119|270273|P2|STARTED|Overall Study||789
113262|NCT00041119|270274|P1|STARTED|Overall Study||1142
113263|NCT00041132|270294|P1|NOT COMPLETED|Overall Study||30
113264|NCT00041132|270294|P1|COMPLETED|Overall Study||26
113265|NCT00041132|270294|P1|Eligible and Began Protocol Therapy|Overall Study||49
113266|NCT00041132|270294|P1|Eligible|Overall Study||49
113267|NCT00041132|270294|P1|STARTED|Overall Study||56
113268|NCT00048932|270302|P3|NOT COMPLETED|Open Label Period (OL)||441
113269|NCT00048932|270303|P2|NOT COMPLETED|Open Label Period (OL)||0
113270|NCT00048932|270304|P1|NOT COMPLETED|Open Label Period (OL)||0
113271|NCT00048932|270302|P3|COMPLETED|Open Label Period (OL)||743
113272|NCT00048932|270303|P2|COMPLETED|Open Label Period (OL)||0
113273|NCT00048932|270304|P1|COMPLETED|Open Label Period (OL)||0
113274|NCT00048932|270302|P3|STARTED|Open Label Period (OL)|47 participants who completed the double-blind did not enter the open-label|1184
113275|NCT00048932|270303|P2|STARTED|Open Label Period (OL)||0
113276|NCT00048932|270304|P1|STARTED|Open Label Period (OL)||0
113277|NCT00048932|270302|P3|NOT COMPLETED|Double Blind Period (DB)||0
113278|NCT00048932|270303|P2|NOT COMPLETED|Double Blind Period (DB)||87
113279|NCT00048932|270304|P1|NOT COMPLETED|Double Blind Period (DB)||123
113280|NCT00048932|270302|P3|COMPLETED|Double Blind Period (DB)||0
113281|NCT00048932|270303|P2|COMPLETED|Double Blind Period (DB)||395
113282|NCT00048932|270304|P1|COMPLETED|Double Blind Period (DB)||836
113283|NCT00048932|270302|P3|STARTED|Double Blind Period (DB)||0
113284|NCT00048932|270303|P2|STARTED|Double Blind Period (DB)|Number Treated|482
113285|NCT00048932|270304|P1|STARTED|Double Blind Period (DB)|Number Treated|959
113286|NCT00048997|270330|P2|NOT COMPLETED|Overall Study||3
113287|NCT00048997|270331|P1|NOT COMPLETED|Overall Study||13
113288|NCT00048997|270330|P2|COMPLETED|Overall Study||177
113289|NCT00048997|270331|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|163
113290|NCT00048997|270330|P2|STARTED|Overall Study||180
113291|NCT00048997|270331|P1|STARTED|Overall Study||176
113292|NCT00049036|270338|P2|NOT COMPLETED|Overall Study||0
113293|NCT00049036|270339|P1|NOT COMPLETED|Overall Study||0
113294|NCT00049036|270338|P2|COMPLETED|Overall Study||55
113295|NCT00049036|270339|P1|COMPLETED|Overall Study||51
113296|NCT00049036|270338|P2|STARTED|Overall Study||55
113297|NCT00049036|270339|P1|STARTED|Overall Study||51
113298|NCT00049127|270350|P5|NOT COMPLETED|Overall Study||0
113299|NCT00049127|270351|P4|NOT COMPLETED|Overall Study||0
113300|NCT00049127|270352|P3|NOT COMPLETED|Overall Study||1
113301|NCT00049127|270353|P2|NOT COMPLETED|Overall Study||0
113302|NCT00049127|270354|P1|NOT COMPLETED|Overall Study||0
113303|NCT00049127|270350|P5|COMPLETED|Overall Study||12
113304|NCT00049127|270351|P4|COMPLETED|Overall Study||0
113305|NCT00049127|270352|P3|COMPLETED|Overall Study||39
113306|NCT00049127|270353|P2|COMPLETED|Overall Study||0
113307|NCT00049127|270354|P1|COMPLETED|Overall Study||12
113308|NCT00049127|270350|P5|STARTED|Overall Study||12
113309|NCT00049127|270351|P4|STARTED|Overall Study||0
113310|NCT00049127|270352|P3|STARTED|Overall Study||40
113311|NCT00049127|270353|P2|STARTED|Overall Study||0
113312|NCT00049127|270354|P1|STARTED|Overall Study||12
113313|NCT00049257|270381|P1|NOT COMPLETED|Follow-up Period for Survival Status||4
113314|NCT00049257|270381|P1|COMPLETED|Follow-up Period for Survival Status||41
113315|NCT00049257|270381|P1|STARTED|Follow-up Period for Survival Status||45
113316|NCT00049257|270381|P1|NOT COMPLETED|Carboplatin, Paclitaxel||13
113317|NCT00049257|270381|P1|COMPLETED|Carboplatin, Paclitaxel|13 participants did not complete treatment|45
113318|NCT00049257|270381|P1|STARTED|Carboplatin, Paclitaxel||58
113319|NCT00051025|270390|P2|NOT COMPLETED|Overall Study||4
113320|NCT00051025|270391|P1|NOT COMPLETED|Overall Study||2
113321|NCT00051025|270390|P2|COMPLETED|Overall Study||0
113322|NCT00051025|270391|P1|COMPLETED|Overall Study||3
113323|NCT00051025|270390|P2|STARTED|Overall Study||4
113324|NCT00051025|270391|P1|STARTED|Overall Study||5
113325|NCT00051168|270399|P1|NOT COMPLETED|Overall Study||135
113326|NCT00051168|270399|P1|COMPLETED|Overall Study||367
113327|NCT00051168|270399|P1|STARTED|Overall Study||502
113328|NCT00051363|270405|P2|NOT COMPLETED|Overall Study||144
113329|NCT00051363|270406|P1|NOT COMPLETED|Overall Study||115
113330|NCT00051363|270405|P2|COMPLETED|Overall Study||403
113331|NCT00051363|270406|P1|COMPLETED|Overall Study||443
113332|NCT00051363|270405|P2|Completed 6M Vist On-Study|Overall Study||403
113333|NCT00051363|270406|P1|Completed 6M Vist On-Study|Overall Study||443
113334|NCT00051363|270405|P2|Completed 6M Visit On-Treatment|Overall Study||372
113335|NCT00051363|270406|P1|Completed 6M Visit On-Treatment|Overall Study||427
113336|NCT00051363|270405|P2|Completed 2M Visit On-Study|Overall Study||432
113337|NCT00051363|270406|P1|Completed 2M Visit On-Study|Overall Study||468
113338|NCT00051363|270405|P2|Completed 2M Visit On-Treatment|Overall Study||417
113339|NCT00051363|270406|P1|Completed 2M Visit On-Treatment|Overall Study||456
113340|NCT00051363|270405|P2|Randomized & Analyzed|Overall Study||542
113341|NCT00051363|270406|P1|Randomized & Analyzed|Overall Study||556
113342|NCT00051363|270405|P2|STARTED|Overall Study||547
113343|NCT00051363|270406|P1|STARTED|Overall Study||558
113344|NCT00051558|270442|P2|NOT COMPLETED|Overall Study||96
113345|NCT00051558|270443|P1|NOT COMPLETED|Overall Study||91
113346|NCT00051558|270442|P2|COMPLETED|Overall Study||118
113347|NCT00051558|270443|P1|COMPLETED|Overall Study||123
113348|NCT00051558|270442|P2|STARTED|Overall Study||214
113349|NCT00051558|270443|P1|STARTED|Overall Study||214
113350|NCT00051636|270479|P2|NOT COMPLETED|Period 2- Extended Observation Period||30
113351|NCT00051636|270480|P1|NOT COMPLETED|Period 2- Extended Observation Period||70
113352|NCT00051636|270479|P2|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease|22
113353|NCT00051636|270480|P1|COMPLETED|Period 2- Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|5
113354|NCT00051636|270479|P2|STARTED|Period 2- Extended Observation Period||52
113355|NCT00051636|270480|P1|STARTED|Period 2- Extended Observation Period||75
113356|NCT00051636|270479|P2|NOT COMPLETED|Period 1 - Core||6
113357|NCT00051636|270480|P1|NOT COMPLETED|Period 1 - Core||4
113358|NCT00051636|270479|P2|COMPLETED|Period 1 - Core||76
113359|NCT00051636|270480|P1|COMPLETED|Period 1 - Core||86
113360|NCT00051636|270479|P2|STARTED|Period 1 - Core||82
113361|NCT00051636|270480|P1|STARTED|Period 1 - Core||90
113362|NCT00052078|270510|P4|NOT COMPLETED|Overall Study||15
113363|NCT00052078|270511|P3|NOT COMPLETED|Overall Study||13
113364|NCT00052078|270512|P2|NOT COMPLETED|Overall Study||6
113365|NCT00052078|270513|P1|NOT COMPLETED|Overall Study||23
113366|NCT00052078|270510|P4|COMPLETED|Overall Study||61
113367|NCT00052078|270511|P3|COMPLETED|Overall Study||127
113368|NCT00052078|270512|P2|COMPLETED|Overall Study||133
113369|NCT00052078|270513|P1|COMPLETED|Overall Study||110
113370|NCT00052078|270510|P4|STARTED|Overall Study||76
113371|NCT00052078|270511|P3|STARTED|Overall Study||140
113372|NCT00052078|270512|P2|STARTED|Overall Study||139
113373|NCT00052078|270513|P1|STARTED|Overall Study||133
113374|NCT00052429|270523|P1|NOT COMPLETED|Overall Study||0
113375|NCT00052429|270523|P1|COMPLETED|Overall Study||25
113376|NCT00052429|270523|P1|STARTED|Overall Study||25
113377|NCT00052715|270528|P1|NOT COMPLETED|Overall Study||1
113378|NCT00052715|270528|P1|COMPLETED|Overall Study||30
113379|NCT00052715|270528|P1|STARTED|Overall Study||31
113380|NCT00052962|270537|P2|NOT COMPLETED|Overall Study||2
113381|NCT00052962|270538|P1|NOT COMPLETED|Overall Study||1
113382|NCT00052962|270537|P2|COMPLETED|Overall Study||15
113383|NCT00052962|270538|P1|COMPLETED|Overall Study||12
113384|NCT00052962|270537|P2|STARTED|Overall Study||17
113385|NCT00052962|270538|P1|STARTED|Overall Study||13
113386|NCT00053014|270546|P1|NOT COMPLETED|Overall Study||0
113387|NCT00053014|270546|P1|COMPLETED|Overall Study||5
113388|NCT00053014|270546|P1|STARTED|Overall Study||5
113389|NCT00053365|270551|P1|NOT COMPLETED|Overall Study||6
113390|NCT00053365|270551|P1|COMPLETED|Overall Study||55
113391|NCT00053365|270551|P1|STARTED|Overall Study||61
113392|NCT00053417|270560|P4|NOT COMPLETED|Overall Study||6
113393|NCT00053417|270561|P3|NOT COMPLETED|Overall Study||1
113394|NCT00053417|270562|P2|NOT COMPLETED|Overall Study||2
113395|NCT00053417|270563|P1|NOT COMPLETED|Overall Study||2
113396|NCT00053417|270560|P4|COMPLETED|Overall Study||51
113397|NCT00053417|270561|P3|COMPLETED|Overall Study||49
113398|NCT00053417|270562|P2|COMPLETED|Overall Study||50
113399|NCT00053417|270563|P1|COMPLETED|Overall Study||45
113400|NCT00053417|270560|P4|STARTED|Overall Study||57
113401|NCT00053417|270561|P3|STARTED|Overall Study||50
113402|NCT00053417|270562|P2|STARTED|Overall Study||52
113403|NCT00053417|270563|P1|STARTED|Overall Study||47
113404|NCT00053482|270578|P5|NOT COMPLETED|Overall Study||0
113405|NCT00053482|270579|P4|NOT COMPLETED|Overall Study||0
113406|NCT00053482|270580|P3|NOT COMPLETED|Overall Study||0
113407|NCT00053482|270581|P2|NOT COMPLETED|Overall Study||0
113408|NCT00053482|270582|P1|NOT COMPLETED|Overall Study||0
113409|NCT00053482|270578|P5|COMPLETED|Overall Study||52
113410|NCT00053482|270579|P4|COMPLETED|Overall Study||50
113411|NCT00053482|270580|P3|COMPLETED|Overall Study||102
113412|NCT00053482|270581|P2|COMPLETED|Overall Study||102
113413|NCT00053482|270582|P1|COMPLETED|Overall Study||51
113414|NCT00053482|270578|P5|STARTED|Overall Study||52
113415|NCT00053482|270579|P4|STARTED|Overall Study||50
113416|NCT00053482|270580|P3|STARTED|Overall Study||102
113417|NCT00053482|270581|P2|STARTED|Overall Study||102
113418|NCT00053482|270582|P1|STARTED|Overall Study||51
113419|NCT00053495|270634|P5|NOT COMPLETED|Overall Study||0
113420|NCT00053495|270635|P4|NOT COMPLETED|Overall Study||0
113421|NCT00053495|270636|P3|NOT COMPLETED|Overall Study||0
113422|NCT00053495|270637|P2|NOT COMPLETED|Overall Study||0
113423|NCT00053495|270638|P1|NOT COMPLETED|Overall Study||0
113424|NCT00053495|270634|P5|COMPLETED|Overall Study||49
113425|NCT00053495|270635|P4|COMPLETED|Overall Study||51
113426|NCT00053495|270636|P3|COMPLETED|Overall Study||101
113427|NCT00053495|270637|P2|COMPLETED|Overall Study||101
113428|NCT00053495|270638|P1|COMPLETED|Overall Study||51
113429|NCT00053495|270634|P5|STARTED|Overall Study||49
113430|NCT00053495|270635|P4|STARTED|Overall Study||51
113431|NCT00053495|270636|P3|STARTED|Overall Study||101
113432|NCT00053495|270637|P2|STARTED|Overall Study||101
113433|NCT00053495|270638|P1|STARTED|Overall Study||51
113434|NCT00053703|270688|P3|NOT COMPLETED|Overall Study||15
113435|NCT00053703|270689|P2|NOT COMPLETED|Overall Study||13
113436|NCT00053703|270690|P1|NOT COMPLETED|Overall Study||18
113437|NCT00053703|270688|P3|COMPLETED|Overall Study||25
113438|NCT00053703|270689|P2|COMPLETED|Overall Study||28
113439|NCT00053703|270690|P1|COMPLETED|Overall Study||17
113440|NCT00053703|270688|P3|STARTED|Overall Study||40
113441|NCT00053703|270689|P2|STARTED|Overall Study||41
113442|NCT00053703|270690|P1|STARTED|Overall Study||35
113443|NCT00053846|270715|P2|NOT COMPLETED|Overall Study||27
113444|NCT00053846|270716|P1|NOT COMPLETED|Overall Study||26
113445|NCT00053846|270715|P2|COMPLETED|Overall Study||192
113446|NCT00053846|270716|P1|COMPLETED|Overall Study||187
113447|NCT00053846|270715|P2|STARTED|Overall Study||219
113448|NCT00053846|270716|P1|STARTED|Overall Study||213
113449|NCT00044512|270722|P1|NOT COMPLETED|Follow Up||2
113450|NCT00044512|270722|P1|COMPLETED|Follow Up||135
113451|NCT00044512|270722|P1|STARTED|Follow Up||137
113452|NCT00044512|270722|P1|NOT COMPLETED|Treatment||0
113453|NCT00044512|270722|P1|COMPLETED|Treatment||137
113454|NCT00044512|270722|P1|STARTED|Treatment||137
113455|NCT00044655|270735|P2|NOT COMPLETED|Overall Study||38
113456|NCT00044655|270736|P1|NOT COMPLETED|Overall Study||20
113457|NCT00044655|270735|P2|COMPLETED|Overall Study||79
113458|NCT00044655|270736|P1|COMPLETED|Overall Study||82
113459|NCT00044655|270735|P2|STARTED|Overall Study||117
113460|NCT00044655|270736|P1|STARTED|Overall Study||102
113461|NCT00045032|270745|P3|NOT COMPLETED|Overall Study||726
113462|NCT00045032|270746|P2|NOT COMPLETED|Overall Study||708
113463|NCT00045032|270747|P1|NOT COMPLETED|Overall Study||863
113464|NCT00045032|270745|P3|COMPLETED|Overall Study||974
113465|NCT00045032|270746|P2|COMPLETED|Overall Study||994
113466|NCT00045032|270747|P1|COMPLETED|Overall Study||834
113467|NCT00045032|270745|P3|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
113549|NCT00045487|270958|P1|NOT COMPLETED|Overall Study||11
113550|NCT00045487|270958|P1|COMPLETED|Overall Study||30
113468|NCT00045032|270746|P2|Crossover to Adjuvant Herceptin|Overall Study|This milestone is not applicable to participants who were already randomized to Herceptin.|0
113469|NCT00045032|270747|P1|Crossover to Adjuvant Herceptin|Overall Study||888
113470|NCT00045032|270745|P3|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1700
113471|NCT00045032|270746|P2|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1702
113472|NCT00045032|270747|P1|STARTED|Overall Study|Included all participants with available signed Informed Consent Form.|1697
113473|NCT00045110|270877|P3|NOT COMPLETED|775mg Dose Escalation||0
113474|NCT00045110|270878|P2|NOT COMPLETED|775mg Dose Escalation||0
113475|NCT00045110|270879|P1|NOT COMPLETED|775mg Dose Escalation||0
113476|NCT00045110|270877|P3|COMPLETED|775mg Dose Escalation||0
113477|NCT00045110|270878|P2|COMPLETED|775mg Dose Escalation||0
113478|NCT00045110|270879|P1|COMPLETED|775mg Dose Escalation||7
113479|NCT00045110|270877|P3|STARTED|775mg Dose Escalation||0
113480|NCT00045110|270878|P2|STARTED|775mg Dose Escalation||0
113481|NCT00045110|270879|P1|STARTED|775mg Dose Escalation||7
113482|NCT00045110|270877|P3|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
113483|NCT00045110|270878|P2|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
113484|NCT00045110|270879|P1|NOT COMPLETED|650mg Phase 1 Dose Escalation||0
113485|NCT00045110|270877|P3|COMPLETED|650mg Phase 1 Dose Escalation||0
113486|NCT00045110|270878|P2|COMPLETED|650mg Phase 1 Dose Escalation||0
113487|NCT00045110|270879|P1|COMPLETED|650mg Phase 1 Dose Escalation||6
113488|NCT00045110|270877|P3|STARTED|650mg Phase 1 Dose Escalation||0
113489|NCT00045110|270878|P2|STARTED|650mg Phase 1 Dose Escalation||0
113490|NCT00045110|270879|P1|STARTED|650mg Phase 1 Dose Escalation||6
113491|NCT00045110|270877|P3|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
113492|NCT00045110|270878|P2|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
113493|NCT00045110|270879|P1|NOT COMPLETED|525mg Phase 1 Dose Escalation||0
113494|NCT00045110|270877|P3|COMPLETED|525mg Phase 1 Dose Escalation||0
113495|NCT00045110|270878|P2|COMPLETED|525mg Phase 1 Dose Escalation||0
113496|NCT00045110|270879|P1|COMPLETED|525mg Phase 1 Dose Escalation||3
113497|NCT00045110|270877|P3|STARTED|525mg Phase 1 Dose Escalation||0
113498|NCT00045110|270878|P2|STARTED|525mg Phase 1 Dose Escalation||0
113499|NCT00045110|270879|P1|STARTED|525mg Phase 1 Dose Escalation||3
113500|NCT00045110|270877|P3|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
113501|NCT00045110|270878|P2|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
113502|NCT00045110|270879|P1|NOT COMPLETED|400mg Phase 1 Dose Escalation||0
113503|NCT00045110|270877|P3|COMPLETED|400mg Phase 1 Dose Escalation||0
113504|NCT00045110|270878|P2|COMPLETED|400mg Phase 1 Dose Escalation||0
113505|NCT00045110|270879|P1|COMPLETED|400mg Phase 1 Dose Escalation||3
113506|NCT00045110|270877|P3|STARTED|400mg Phase 1 Dose Escalation||0
113507|NCT00045110|270878|P2|STARTED|400mg Phase 1 Dose Escalation||0
113508|NCT00045110|270879|P1|STARTED|400mg Phase 1 Dose Escalation||3
113509|NCT00045110|270877|P3|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
113510|NCT00045110|270878|P2|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
113511|NCT00045110|270879|P1|NOT COMPLETED|275mg Phase 1 Dose Escalation||0
113512|NCT00045110|270877|P3|COMPLETED|275mg Phase 1 Dose Escalation||0
113513|NCT00045110|270878|P2|COMPLETED|275mg Phase 1 Dose Escalation||0
113514|NCT00045110|270879|P1|COMPLETED|275mg Phase 1 Dose Escalation||3
113515|NCT00045110|270877|P3|STARTED|275mg Phase 1 Dose Escalation||0
113516|NCT00045110|270878|P2|STARTED|275mg Phase 1 Dose Escalation||0
113517|NCT00045110|270879|P1|STARTED|275mg Phase 1 Dose Escalation||3
113518|NCT00045110|270877|P3|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
113519|NCT00045110|270878|P2|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
113520|NCT00045110|270879|P1|NOT COMPLETED|200mg Phase 1 Dose Escalation||0
113521|NCT00045110|270877|P3|COMPLETED|200mg Phase 1 Dose Escalation||0
113522|NCT00045110|270878|P2|COMPLETED|200mg Phase 1 Dose Escalation||0
113523|NCT00045110|270879|P1|COMPLETED|200mg Phase 1 Dose Escalation||4
113524|NCT00045110|270877|P3|STARTED|200mg Phase 1 Dose Escalation||0
113525|NCT00045110|270878|P2|STARTED|200mg Phase 1 Dose Escalation||0
113526|NCT00045110|270879|P1|STARTED|200mg Phase 1 Dose Escalation||4
113527|NCT00045110|270877|P3|NOT COMPLETED|100mg Phase 1 Dose Escalalation||2
113528|NCT00045110|270878|P2|NOT COMPLETED|100mg Phase 1 Dose Escalalation||6
113529|NCT00045110|270879|P1|NOT COMPLETED|100mg Phase 1 Dose Escalalation||0
113530|NCT00045110|270877|P3|COMPLETED|100mg Phase 1 Dose Escalalation||43
113531|NCT00045110|270878|P2|COMPLETED|100mg Phase 1 Dose Escalalation||53
113532|NCT00045110|270879|P1|COMPLETED|100mg Phase 1 Dose Escalalation||6
113533|NCT00045110|270877|P3|STARTED|100mg Phase 1 Dose Escalalation||45
113534|NCT00045110|270878|P2|STARTED|100mg Phase 1 Dose Escalalation||59
113535|NCT00045110|270879|P1|STARTED|100mg Phase 1 Dose Escalalation||6
113536|NCT00045162|270927|P2|NOT COMPLETED|Overall Study||118
113537|NCT00045162|270928|P1|NOT COMPLETED|Overall Study||142
113538|NCT00045162|270927|P2|COMPLETED|Overall Study||217
113539|NCT00045162|270928|P1|COMPLETED|Overall Study||194
113540|NCT00045162|270927|P2|STARTED|Overall Study||335
113541|NCT00045162|270928|P1|STARTED|Overall Study||336
113542|NCT00045305|270940|P1|NOT COMPLETED|Overall Study||14
113543|NCT00045305|270940|P1|COMPLETED|Overall Study||3
113544|NCT00045305|270940|P1|Eligible and Treated|Overall Study||17
113545|NCT00045305|270940|P1|STARTED|Overall Study||17
113546|NCT00045435|270949|P1|NOT COMPLETED|Overall Study||0
113547|NCT00045435|270949|P1|COMPLETED|Overall Study||17
113548|NCT00045435|270949|P1|STARTED|Overall Study||17
113551|NCT00045487|270958|P1|STARTED|Overall Study||41
113552|NCT00045630|270962|P1|NOT COMPLETED|Overall Study||6
113553|NCT00045630|270962|P1|COMPLETED|Overall Study||71
113554|NCT00045630|270962|P1|Eligible and Began Protocol Therapy|Overall Study||74
113555|NCT00045630|270962|P1|Eligible|Overall Study||75
113556|NCT00045630|270962|P1|STARTED|Overall Study||77
113557|NCT00045708|270971|P3|NOT COMPLETED|Phase 2||0
113558|NCT00045708|270972|P2|NOT COMPLETED|Phase 2||0
113559|NCT00045708|270973|P1|NOT COMPLETED|Phase 2||0
113560|NCT00045708|270971|P3|COMPLETED|Phase 2||19
113561|NCT00045708|270972|P2|COMPLETED|Phase 2||0
113562|NCT00045708|270973|P1|COMPLETED|Phase 2||0
113563|NCT00045708|270971|P3|STARTED|Phase 2||19
113564|NCT00045708|270972|P2|STARTED|Phase 2||0
113565|NCT00045708|270973|P1|STARTED|Phase 2||0
113566|NCT00045708|270971|P3|NOT COMPLETED|Phase 1||0
113567|NCT00045708|270972|P2|NOT COMPLETED|Phase 1||1
113568|NCT00045708|270973|P1|NOT COMPLETED|Phase 1||0
113569|NCT00045708|270971|P3|COMPLETED|Phase 1||0
113570|NCT00045708|270972|P2|COMPLETED|Phase 1||16
113571|NCT00045708|270973|P1|COMPLETED|Phase 1||21
113572|NCT00045708|270971|P3|STARTED|Phase 1||0
113573|NCT00045708|270972|P2|STARTED|Phase 1||17
113574|NCT00045708|270973|P1|STARTED|Phase 1||21
113575|NCT00045734|270996|P1|NOT COMPLETED|Overall Study||1
113576|NCT00045734|270996|P1|COMPLETED|Overall Study||22
113577|NCT00045734|270996|P1|STARTED|Overall Study||23
113578|NCT00045942|271017|P9|NOT COMPLETED|PKC412A2104E2||6
113579|NCT00045942|271018|P8|NOT COMPLETED|PKC412A2104E2||7
113580|NCT00045942|271019|P7|NOT COMPLETED|PKC412A2104E2||7
113581|NCT00045942|271020|P6|NOT COMPLETED|PKC412A2104E2||9
113582|NCT00045942|271021|P5|NOT COMPLETED|PKC412A2104E2||0
113583|NCT00045942|271022|P4|NOT COMPLETED|PKC412A2104E2||0
113584|NCT00045942|271023|P3|NOT COMPLETED|PKC412A2104E2||0
113585|NCT00045942|271024|P2|NOT COMPLETED|PKC412A2104E2||0
113586|NCT00045942|271025|P1|NOT COMPLETED|PKC412A2104E2||0
113587|NCT00045942|271017|P9|COMPLETED|PKC412A2104E2||0
113588|NCT00045942|271018|P8|COMPLETED|PKC412A2104E2||0
113589|NCT00045942|271019|P7|COMPLETED|PKC412A2104E2||0
113590|NCT00045942|271020|P6|COMPLETED|PKC412A2104E2||0
113591|NCT00045942|271021|P5|COMPLETED|PKC412A2104E2||0
113592|NCT00045942|271022|P4|COMPLETED|PKC412A2104E2||0
113593|NCT00045942|271023|P3|COMPLETED|PKC412A2104E2||0
113594|NCT00045942|271024|P2|COMPLETED|PKC412A2104E2||0
113595|NCT00045942|271025|P1|COMPLETED|PKC412A2104E2||0
113596|NCT00045942|271017|P9|Primary Efficacy|PKC412A2104E2||6
113597|NCT00045942|271018|P8|Primary Efficacy|PKC412A2104E2||7
113598|NCT00045942|271019|P7|Primary Efficacy|PKC412A2104E2||7
113599|NCT00045942|271020|P6|Primary Efficacy|PKC412A2104E2||9
113600|NCT00045942|271021|P5|Primary Efficacy|PKC412A2104E2||0
113601|NCT00045942|271022|P4|Primary Efficacy|PKC412A2104E2||0
113602|NCT00045942|271023|P3|Primary Efficacy|PKC412A2104E2||0
113603|NCT00045942|271024|P2|Primary Efficacy|PKC412A2104E2||0
113604|NCT00045942|271025|P1|Primary Efficacy|PKC412A2104E2||0
113605|NCT00045942|271017|P9|STARTED|PKC412A2104E2||6
113606|NCT00045942|271018|P8|STARTED|PKC412A2104E2||7
113607|NCT00045942|271019|P7|STARTED|PKC412A2104E2||7
113608|NCT00045942|271020|P6|STARTED|PKC412A2104E2||9
113609|NCT00045942|271021|P5|STARTED|PKC412A2104E2||0
113610|NCT00045942|271022|P4|STARTED|PKC412A2104E2||0
113611|NCT00045942|271023|P3|STARTED|PKC412A2104E2||0
113612|NCT00045942|271024|P2|STARTED|PKC412A2104E2||0
113613|NCT00045942|271025|P1|STARTED|PKC412A2104E2||0
113614|NCT00045942|271017|P9|NOT COMPLETED|PKC412A2104E1||0
113615|NCT00045942|271018|P8|NOT COMPLETED|PKC412A2104E1||0
113616|NCT00045942|271019|P7|NOT COMPLETED|PKC412A2104E1||0
113617|NCT00045942|271020|P6|NOT COMPLETED|PKC412A2104E1||0
113618|NCT00045942|271021|P5|NOT COMPLETED|PKC412A2104E1||27
113619|NCT00045942|271022|P4|NOT COMPLETED|PKC412A2104E1||33
113620|NCT00045942|271023|P3|NOT COMPLETED|PKC412A2104E1||17
113621|NCT00045942|271024|P2|NOT COMPLETED|PKC412A2104E1||18
113622|NCT00045942|271025|P1|NOT COMPLETED|PKC412A2104E1||0
113623|NCT00045942|271017|P9|COMPLETED|PKC412A2104E1||0
113624|NCT00045942|271018|P8|COMPLETED|PKC412A2104E1||0
113625|NCT00045942|271019|P7|COMPLETED|PKC412A2104E1||0
113626|NCT00045942|271020|P6|COMPLETED|PKC412A2104E1||0
113627|NCT00045942|271021|P5|COMPLETED|PKC412A2104E1||0
113628|NCT00045942|271022|P4|COMPLETED|PKC412A2104E1||0
113629|NCT00045942|271023|P3|COMPLETED|PKC412A2104E1||0
113630|NCT00045942|271024|P2|COMPLETED|PKC412A2104E1||0
113631|NCT00045942|271025|P1|COMPLETED|PKC412A2104E1||0
113632|NCT00045942|271017|P9|Primary Efficacy|PKC412A2104E1||0
113633|NCT00045942|271018|P8|Primary Efficacy|PKC412A2104E1||0
113634|NCT00045942|271019|P7|Primary Efficacy|PKC412A2104E1||0
113635|NCT00045942|271020|P6|Primary Efficacy|PKC412A2104E1||0
113636|NCT00045942|271021|P5|Primary Efficacy|PKC412A2104E1||25
113637|NCT00045942|271022|P4|Primary Efficacy|PKC412A2104E1||32
113638|NCT00045942|271023|P3|Primary Efficacy|PKC412A2104E1||17
113639|NCT00045942|271024|P2|Primary Efficacy|PKC412A2104E1||18
113640|NCT00045942|271025|P1|Primary Efficacy|PKC412A2104E1||0
113641|NCT00045942|271017|P9|STARTED|PKC412A2104E1||0
113642|NCT00045942|271018|P8|STARTED|PKC412A2104E1||0
113643|NCT00045942|271019|P7|STARTED|PKC412A2104E1||0
113644|NCT00045942|271020|P6|STARTED|PKC412A2104E1||0
113645|NCT00045942|271021|P5|STARTED|PKC412A2104E1||27
113646|NCT00045942|271022|P4|STARTED|PKC412A2104E1||33
113647|NCT00045942|271023|P3|STARTED|PKC412A2104E1||17
113648|NCT00045942|271024|P2|STARTED|PKC412A2104E1||18
113649|NCT00045942|271025|P1|STARTED|PKC412A2104E1||0
113650|NCT00045942|271017|P9|NOT COMPLETED|PKC412A2104 (Core)||0
113651|NCT00045942|271018|P8|NOT COMPLETED|PKC412A2104 (Core)||0
113652|NCT00045942|271019|P7|NOT COMPLETED|PKC412A2104 (Core)||0
113653|NCT00045942|271020|P6|NOT COMPLETED|PKC412A2104 (Core)||0
113654|NCT00045942|271021|P5|NOT COMPLETED|PKC412A2104 (Core)||0
113655|NCT00045942|271022|P4|NOT COMPLETED|PKC412A2104 (Core)||0
113656|NCT00045942|271023|P3|NOT COMPLETED|PKC412A2104 (Core)||0
113657|NCT00045942|271024|P2|NOT COMPLETED|PKC412A2104 (Core)||0
113658|NCT00045942|271025|P1|NOT COMPLETED|PKC412A2104 (Core)||20
113659|NCT00045942|271017|P9|COMPLETED|PKC412A2104 (Core)||0
113660|NCT00045942|271018|P8|COMPLETED|PKC412A2104 (Core)||0
113661|NCT00045942|271019|P7|COMPLETED|PKC412A2104 (Core)||0
113662|NCT00045942|271020|P6|COMPLETED|PKC412A2104 (Core)||0
113663|NCT00045942|271021|P5|COMPLETED|PKC412A2104 (Core)||0
113664|NCT00045942|271022|P4|COMPLETED|PKC412A2104 (Core)||0
113665|NCT00045942|271023|P3|COMPLETED|PKC412A2104 (Core)||0
113666|NCT00045942|271024|P2|COMPLETED|PKC412A2104 (Core)||0
113667|NCT00045942|271025|P1|COMPLETED|PKC412A2104 (Core)||0
113668|NCT00045942|271017|P9|Core Primary Efficacy|PKC412A2104 (Core)||0
113669|NCT00045942|271018|P8|Core Primary Efficacy|PKC412A2104 (Core)||0
113670|NCT00045942|271019|P7|Core Primary Efficacy|PKC412A2104 (Core)||0
113671|NCT00045942|271020|P6|Core Primary Efficacy|PKC412A2104 (Core)||0
113672|NCT00045942|271021|P5|Core Primary Efficacy|PKC412A2104 (Core)||0
113673|NCT00045942|271022|P4|Core Primary Efficacy|PKC412A2104 (Core)||0
113674|NCT00045942|271023|P3|Core Primary Efficacy|PKC412A2104 (Core)||0
113675|NCT00045942|271024|P2|Core Primary Efficacy|PKC412A2104 (Core)||0
113676|NCT00045942|271025|P1|Core Primary Efficacy|PKC412A2104 (Core)||20
113677|NCT00045942|271017|P9|STARTED|PKC412A2104 (Core)||0
113678|NCT00045942|271018|P8|STARTED|PKC412A2104 (Core)||0
113679|NCT00045942|271019|P7|STARTED|PKC412A2104 (Core)||0
113680|NCT00045942|271020|P6|STARTED|PKC412A2104 (Core)||0
113681|NCT00045942|271021|P5|STARTED|PKC412A2104 (Core)||0
113682|NCT00045942|271022|P4|STARTED|PKC412A2104 (Core)||0
113683|NCT00045942|271023|P3|STARTED|PKC412A2104 (Core)||0
113684|NCT00045942|271024|P2|STARTED|PKC412A2104 (Core)||0
113685|NCT00045942|271025|P1|STARTED|PKC412A2104 (Core)||20
113686|NCT00046228|271108|P3|NOT COMPLETED|1 Year||12
113687|NCT00046228|271109|P2|NOT COMPLETED|1 Year||14
113688|NCT00046228|271110|P1|NOT COMPLETED|1 Year||19
113689|NCT00046228|271108|P3|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window|816
113690|NCT00046228|271109|P2|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|804
113691|NCT00046228|271110|P1|COMPLETED|1 Year|The number completed includes subjects who died or were seen for a visit within specified window.|787
113692|NCT00046228|271108|P3|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|828
113693|NCT00046228|271109|P2|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|818
113694|NCT00046228|271110|P1|STARTED|1 Year|This is the number of participants that were originally randomized to the trial.|806
113695|NCT00046228|271108|P3|NOT COMPLETED|90 Days||15
113696|NCT00046228|271109|P2|NOT COMPLETED|90 Days||8
113697|NCT00046228|271110|P1|NOT COMPLETED|90 Days||13
113698|NCT00046228|271108|P3|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|813
113699|NCT00046228|271109|P2|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|810
113700|NCT00046228|271110|P1|COMPLETED|90 Days|The number completed includes subjects who died or were seen for a visit within specified window.|793
113701|NCT00046228|271108|P3|STARTED|90 Days||828
113702|NCT00046228|271109|P2|STARTED|90 Days||818
113703|NCT00046228|271110|P1|STARTED|90 Days||806
113704|NCT00054028|271147|P1|NOT COMPLETED|Overall Study||0
113705|NCT00054028|271147|P1|COMPLETED|Overall Study||31
113706|NCT00054028|271147|P1|Phase II|Overall Study||22
113707|NCT00054028|271147|P1|Phase I|Overall Study||9
113708|NCT00054028|271147|P1|STARTED|Overall Study||31
113709|NCT00054132|271153|P1|NOT COMPLETED|Overall Study||1
113710|NCT00054132|271153|P1|COMPLETED|Overall Study||37
113711|NCT00054132|271153|P1|STARTED|Overall Study||38
113712|NCT00056160|271164|P2|NOT COMPLETED|Final Follow-up||0
113713|NCT00056160|271165|P1|NOT COMPLETED|Final Follow-up||6
113714|NCT00056160|271164|P2|COMPLETED|Final Follow-up||0
113715|NCT00056160|271165|P1|COMPLETED|Final Follow-up||0
113716|NCT00056160|271164|P2|STARTED|Final Follow-up||0
113717|NCT00056160|271165|P1|STARTED|Final Follow-up||6
113718|NCT00056160|271164|P2|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
113719|NCT00056160|271165|P1|NOT COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||171
113720|NCT00056160|271164|P2|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||0
113721|NCT00056160|271165|P1|COMPLETED|Extended Follow-up Cutoff (23 Jul 2008)||6
113722|NCT00056160|271164|P2|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||0
113723|NCT00056160|271165|P1|STARTED|Extended Follow-up Cutoff (23 Jul 2008)||177
113724|NCT00056160|271164|P2|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||163
113725|NCT00056160|271165|P1|NOT COMPLETED|Up to Unblinding (07 Jun 2005)||113
113726|NCT00056160|271164|P2|COMPLETED|Up to Unblinding (07 Jun 2005)||13
113727|NCT00056160|271165|P1|COMPLETED|Up to Unblinding (07 Jun 2005)||64
113728|NCT00056160|271164|P2|STARTED|Up to Unblinding (07 Jun 2005)||176
113729|NCT00056160|271165|P1|STARTED|Up to Unblinding (07 Jun 2005)||177
113730|NCT00056316|271179|P2|NOT COMPLETED|Overall Study||3
113731|NCT00056316|271180|P1|NOT COMPLETED|Overall Study||3
113732|NCT00056316|271179|P2|COMPLETED|Overall Study||38
113733|NCT00056316|271180|P1|COMPLETED|Overall Study||30
113734|NCT00056316|271179|P2|STARTED|Overall Study|over-enrolled due to potential higher rates of drop-out.|41
113735|NCT00056316|271180|P1|STARTED|Overall Study||33
113736|NCT00056407|271194|P2|NOT COMPLETED|Overall Study||1193
113737|NCT00056407|271195|P1|NOT COMPLETED|Overall Study||1211
113738|NCT00056407|271194|P2|COMPLETED|Overall Study||2912
113739|NCT00056407|271195|P1|COMPLETED|Overall Study||2915
113740|NCT00056407|271194|P2|STARTED|Overall Study||4105
113741|NCT00056407|271195|P1|STARTED|Overall Study||4126
113742|NCT00056472|271253|P2|NOT COMPLETED|Overall Study||69
113743|NCT00056472|271254|P1|NOT COMPLETED|Overall Study||48
113744|NCT00056472|271253|P2|COMPLETED|Overall Study||61
113745|NCT00056472|271254|P1|COMPLETED|Overall Study||81
113746|NCT00056472|271253|P2|STARTED|Overall Study||130
113747|NCT00056472|271254|P1|STARTED|Overall Study||129
113748|NCT00056498|271266|P2|NOT COMPLETED|Overall Study||7
113749|NCT00056498|271267|P1|NOT COMPLETED|Overall Study||5
113750|NCT00056498|271266|P2|COMPLETED|Overall Study||28
113751|NCT00056498|271267|P1|COMPLETED|Overall Study||25
113752|NCT00056498|271266|P2|STARTED|Overall Study||35
113753|NCT00056498|271267|P1|STARTED|Overall Study||30
113754|NCT00056550|271273|P1|NOT COMPLETED|Overall Study||0
113755|NCT00056550|271273|P1|COMPLETED|Overall Study||14
113756|NCT00056550|271273|P1|STARTED|Overall Study||14
113757|NCT00056563|271280|P2|NOT COMPLETED|Overall Study||0
113758|NCT00056563|271281|P1|NOT COMPLETED|Overall Study||0
113759|NCT00056563|271280|P2|COMPLETED|Overall Study||134
113760|NCT00056563|271281|P1|COMPLETED|Overall Study||121
113761|NCT00056563|271280|P2|STARTED|Overall Study||134
113762|NCT00056563|271281|P1|STARTED|Overall Study||121
113763|NCT00056862|271291|P2|NOT COMPLETED|Overall Study||0
113764|NCT00056862|271292|P1|NOT COMPLETED|Overall Study||1
113765|NCT00056862|271291|P2|COMPLETED|Overall Study||27
113766|NCT00056862|271292|P1|COMPLETED|Overall Study||30
113767|NCT00056862|271291|P2|STARTED|Overall Study||27
113768|NCT00056862|271292|P1|STARTED|Overall Study||31
113769|NCT00057330|271308|P2|NOT COMPLETED|Overall Study||920
113770|NCT00057330|271309|P1|NOT COMPLETED|Overall Study||1132
113771|NCT00057330|271308|P2|COMPLETED|Overall Study||2826
113772|NCT00057330|271309|P1|COMPLETED|Overall Study||3445
113773|NCT00057330|271308|P2|STARTED|Overall Study||3746
113774|NCT00057330|271309|P1|STARTED|Overall Study||4577
113775|NCT00057551|271340|P3|NOT COMPLETED|Overall Study||16
113776|NCT00057551|271341|P2|NOT COMPLETED|Overall Study||27
113777|NCT00057551|271342|P1|NOT COMPLETED|Overall Study||25
113778|NCT00057551|271340|P3|COMPLETED|Overall Study||80
113779|NCT00057551|271341|P2|COMPLETED|Overall Study||168
113780|NCT00057551|271342|P1|COMPLETED|Overall Study||175
113781|NCT00057551|271340|P3|STARTED|Overall Study||96
113782|NCT00057551|271341|P2|STARTED|Overall Study||195
113783|NCT00057551|271342|P1|STARTED|Overall Study||200
113784|NCT00057577|271352|P2|NOT COMPLETED|Overall Study||0
113785|NCT00057577|271353|P1|NOT COMPLETED|Overall Study||0
113786|NCT00057577|271352|P2|COMPLETED|Overall Study||225
113787|NCT00057577|271353|P1|COMPLETED|Overall Study||227
113788|NCT00057577|271352|P2|STARTED|Overall Study||225
113789|NCT00057577|271353|P1|STARTED|Overall Study||227
113790|NCT00057681|271370|P3|NOT COMPLETED|Overall Study||34
113791|NCT00057681|271371|P2|NOT COMPLETED|Overall Study||72
113792|NCT00057681|271372|P1|NOT COMPLETED|Overall Study||65
113793|NCT00057681|271370|P3|COMPLETED|Overall Study||69
113794|NCT00057681|271371|P2|COMPLETED|Overall Study||67
113795|NCT00057681|271372|P1|COMPLETED|Overall Study||72
113796|NCT00057681|271370|P3|STARTED|Overall Study||103
113797|NCT00057681|271371|P2|STARTED|Overall Study||139
113798|NCT00057681|271372|P1|STARTED|Overall Study||137
113799|NCT00057746|271389|P3|NOT COMPLETED|Overall Study||1
113800|NCT00057746|271390|P2|NOT COMPLETED|Overall Study||0
113801|NCT00057746|271391|P1|NOT COMPLETED|Overall Study||0
113802|NCT00057746|271389|P3|COMPLETED|Overall Study||66
113803|NCT00057746|271390|P2|COMPLETED|Overall Study||67
113804|NCT00057746|271391|P1|COMPLETED|Overall Study||131
113805|NCT00057746|271389|P3|STARTED|Overall Study||67
113806|NCT00057746|271390|P2|STARTED|Overall Study||67
113807|NCT00057746|271391|P1|STARTED|Overall Study||131
113808|NCT00057785|271399|P1|NOT COMPLETED|Overall Study||0
113809|NCT00057785|271399|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|68
113810|NCT00057785|271399|P1|STARTED|Overall Study||68
113811|NCT00057811|271405|P2|NOT COMPLETED|Overall Study||12
113812|NCT00057811|271406|P1|NOT COMPLETED|Overall Study||10
113813|NCT00057811|271405|P2|COMPLETED|Overall Study||34
113814|NCT00057811|271406|P1|COMPLETED|Overall Study||41
113815|NCT00057811|271405|P2|STARTED|Overall Study||46
113816|NCT00057811|271406|P1|STARTED|Overall Study||51
113817|NCT00057837|271420|P2|NOT COMPLETED|Overall Study||39
113818|NCT00057837|271421|P1|NOT COMPLETED|Overall Study||31
113819|NCT00057837|271420|P2|COMPLETED|Overall Study||31
113820|NCT00057837|271421|P1|COMPLETED|Overall Study||39
113821|NCT00057837|271420|P2|Patients With Response|Overall Study||38
113822|NCT00057837|271421|P1|Patients With Response|Overall Study||46
113823|NCT00057837|271420|P2|Eligible and Treated|Overall Study||66
113824|NCT00057837|271421|P1|Eligible and Treated|Overall Study||66
113825|NCT00057837|271420|P2|Treated|Overall Study||68
113826|NCT00057837|271421|P1|Treated|Overall Study||69
113827|NCT00057837|271420|P2|STARTED|Overall Study||70
113828|NCT00057837|271421|P1|STARTED|Overall Study||70
113829|NCT00057863|271431|P1|NOT COMPLETED|Overall Study||3
113830|NCT00057863|271431|P1|COMPLETED|Overall Study||32
113831|NCT00057863|271431|P1|STARTED|Overall Study||35
113832|NCT00057876|271440|P2|NOT COMPLETED|Overall Study||27
113833|NCT00057876|271441|P1|NOT COMPLETED|Overall Study||29
113834|NCT00057876|271440|P2|COMPLETED|Overall Study||9
113835|NCT00057876|271441|P1|COMPLETED|Overall Study||9
113836|NCT00057876|271440|P2|Eligible and Treated|Overall Study||34
113837|NCT00057876|271441|P1|Eligible and Treated|Overall Study||34
113838|NCT00057876|271440|P2|Began Protocol Therapy|Overall Study||34
113839|NCT00057876|271441|P1|Began Protocol Therapy|Overall Study||35
113840|NCT00057876|271440|P2|Eligible|Overall Study||34
113841|NCT00057876|271441|P1|Eligible|Overall Study||37
113842|NCT00057876|271440|P2|STARTED|Overall Study||36
113843|NCT00057876|271441|P1|STARTED|Overall Study||38
113844|NCT00057941|271453|P2|NOT COMPLETED|Overall Study||74
113845|NCT00057941|271454|P1|NOT COMPLETED|Overall Study||74
113846|NCT00057941|271453|P2|COMPLETED|Overall Study||0
113847|NCT00057941|271454|P1|COMPLETED|Overall Study||0
113848|NCT00057941|271453|P2|Eligible|Overall Study||69
113849|NCT00057941|271454|P1|Eligible|Overall Study||72
113850|NCT00057941|271453|P2|Treated|Overall Study||74
113851|NCT00057941|271454|P1|Treated|Overall Study||74
113852|NCT00057941|271453|P2|STARTED|Overall Study||74
113853|NCT00057941|271454|P1|STARTED|Overall Study||74
113854|NCT00057954|271460|P1|NOT COMPLETED|Overall Study||2
113855|NCT00057954|271460|P1|COMPLETED|Overall Study||4
113856|NCT00057954|271460|P1|STARTED|Overall Study||6
113857|NCT00058019|271468|P2|NOT COMPLETED|Overall Study||0
113858|NCT00058019|271469|P1|NOT COMPLETED|Overall Study||0
113859|NCT00058019|271468|P2|COMPLETED|Overall Study||12
113860|NCT00058019|271469|P1|COMPLETED|Overall Study||39
113861|NCT00058019|271468|P2|STARTED|Overall Study||12
113862|NCT00058019|271469|P1|STARTED|Overall Study||39
113863|NCT00058214|271482|P1|NOT COMPLETED|Overall Study||1
113864|NCT00058214|271482|P1|COMPLETED|Overall Study||24
113865|NCT00058214|271482|P1|STARTED|Overall Study||25
113866|NCT00058240|271491|P4|NOT COMPLETED|Second Dose Level||0
113867|NCT00058240|271492|P3|NOT COMPLETED|Second Dose Level||0
113868|NCT00058240|271493|P2|NOT COMPLETED|Second Dose Level||0
113869|NCT00058240|271494|P1|NOT COMPLETED|Second Dose Level||0
113870|NCT00058240|271491|P4|COMPLETED|Second Dose Level||4
113871|NCT00058240|271492|P3|COMPLETED|Second Dose Level||2
113872|NCT00058240|271493|P2|COMPLETED|Second Dose Level||0
113873|NCT00058240|271494|P1|COMPLETED|Second Dose Level||0
113874|NCT00058240|271491|P4|STARTED|Second Dose Level|4 patients previously relapsed on a different Dose level and were retreated at Dose level 4.|4
113875|NCT00058240|271492|P3|STARTED|Second Dose Level|2 patients were previously treated at Dose level 1, relapsed, and retreated at Dose level 3.|2
113876|NCT00058240|271493|P2|STARTED|Second Dose Level||0
113877|NCT00058240|271494|P1|STARTED|Second Dose Level||0
113878|NCT00058240|271491|P4|NOT COMPLETED|First Dose Level||0
113879|NCT00058240|271492|P3|NOT COMPLETED|First Dose Level||0
113880|NCT00058240|271493|P2|NOT COMPLETED|First Dose Level||0
113881|NCT00058240|271494|P1|NOT COMPLETED|First Dose Level||0
113882|NCT00058240|271491|P4|COMPLETED|First Dose Level||12
113883|NCT00058240|271492|P3|COMPLETED|First Dose Level||17
113884|NCT00058240|271493|P2|COMPLETED|First Dose Level||3
113885|NCT00058240|271494|P1|COMPLETED|First Dose Level||20
113886|NCT00058240|271491|P4|Treated|First Dose Level||12
113887|NCT00058240|271492|P3|Treated|First Dose Level||17
113888|NCT00058240|271493|P2|Treated|First Dose Level||3
113889|NCT00058240|271494|P1|Treated|First Dose Level||20
113890|NCT00058240|271491|P4|STARTED|First Dose Level||12
113891|NCT00058240|271492|P3|STARTED|First Dose Level||17
113892|NCT00058240|271493|P2|STARTED|First Dose Level||3
113893|NCT00058240|271494|P1|STARTED|First Dose Level||20
113894|NCT00058539|271504|P1|NOT COMPLETED|Overall Study||42
113895|NCT00058539|271504|P1|COMPLETED|Overall Study||0
113896|NCT00058539|271504|P1|STARTED|Overall Study||42
113897|NCT00058552|271516|P2|NOT COMPLETED|Overall Study||62
113898|NCT00058552|271517|P1|NOT COMPLETED|Overall Study||65
113899|NCT00058552|271516|P2|COMPLETED|Overall Study||2
113900|NCT00058552|271517|P1|COMPLETED|Overall Study||0
113901|NCT00058552|271516|P2|STARTED|Overall Study||64
113902|NCT00058552|271517|P1|STARTED|Overall Study||65
113903|NCT00049322|271537|P2|NOT COMPLETED|Overall Study||6
113904|NCT00049322|271538|P1|NOT COMPLETED|Overall Study||1
113905|NCT00049322|271537|P2|COMPLETED|Overall Study||9
113906|NCT00049322|271538|P1|COMPLETED|Overall Study||14
113907|NCT00049322|271537|P2|STARTED|Overall Study||15
113908|NCT00049322|271538|P1|STARTED|Overall Study||15
113909|NCT00049504|271550|P1|NOT COMPLETED|Overall Study||0
113910|NCT00049504|271550|P1|COMPLETED|Overall Study||55
113911|NCT00049504|271550|P1|STARTED|Overall Study||55
113912|NCT00049517|271558|P6|NOT COMPLETED|Conditioning/Transplant||6
113913|NCT00049517|271559|P5|NOT COMPLETED|Conditioning/Transplant||6
113914|NCT00049517|271560|P4|NOT COMPLETED|Conditioning/Transplant||43
113915|NCT00049517|271561|P3|NOT COMPLETED|Conditioning/Transplant||38
113916|NCT00049517|271562|P2|NOT COMPLETED|Conditioning/Transplant||50
113917|NCT00049517|271563|P1|NOT COMPLETED|Conditioning/Transplant||52
113918|NCT00049517|271558|P6|COMPLETED|Conditioning/Transplant||18
113919|NCT00049517|271559|P5|COMPLETED|Conditioning/Transplant||15
113920|NCT00049517|271560|P4|COMPLETED|Conditioning/Transplant||32
113921|NCT00049517|271561|P3|COMPLETED|Conditioning/Transplant||25
113922|NCT00049517|271562|P2|COMPLETED|Conditioning/Transplant||40
113923|NCT00049517|271563|P1|COMPLETED|Conditioning/Transplant||27
113924|NCT00049517|271558|P6|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 24 patients received Allogeneic HCT without randomization.|0
113925|NCT00049517|271559|P5|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|These 21 patients received Allogeneic HCT without randomization.|0
113926|NCT00049517|271560|P4|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||75
113927|NCT00049517|271561|P3|Randomized to Autologous HCT +/- GO|Conditioning/Transplant||63
113928|NCT00049517|271562|P2|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 17 patients received Autologous HCT without randomization.|73
113929|NCT00049517|271563|P1|Randomized to Autologous HCT +/- GO|Conditioning/Transplant|Additional 20 patients received Autologous HCT without randomization.|59
113930|NCT00049517|271558|P6|STARTED|Conditioning/Transplant||24
113931|NCT00049517|271559|P5|STARTED|Conditioning/Transplant||21
113932|NCT00049517|271560|P4|STARTED|Conditioning/Transplant||75
113933|NCT00049517|271561|P3|STARTED|Conditioning/Transplant||63
113934|NCT00049517|271562|P2|STARTED|Conditioning/Transplant||90
113935|NCT00049517|271563|P1|STARTED|Conditioning/Transplant||79
113936|NCT00049517|271558|P6|NOT COMPLETED|Induction||54
113937|NCT00049517|271559|P5|NOT COMPLETED|Induction||60
113938|NCT00049517|271560|P4|NOT COMPLETED|Induction||0
113939|NCT00049517|271561|P3|NOT COMPLETED|Induction||0
113940|NCT00049517|271562|P2|NOT COMPLETED|Induction||0
113941|NCT00049517|271563|P1|NOT COMPLETED|Induction||0
113942|NCT00049517|271558|P6|COMPLETED|Induction||108
113943|NCT00049517|271559|P5|COMPLETED|Induction||128
113944|NCT00049517|271560|P4|COMPLETED|Induction||75
113945|NCT00049517|271561|P3|COMPLETED|Induction||63
113946|NCT00049517|271562|P2|COMPLETED|Induction||90
113947|NCT00049517|271563|P1|COMPLETED|Induction||79
113948|NCT00049517|271558|P6|Treated|Induction||160
113949|NCT00049517|271559|P5|Treated|Induction||186
113950|NCT00049517|271560|P4|Treated|Induction||75
113951|NCT00049517|271561|P3|Treated|Induction||63
113952|NCT00049517|271562|P2|Treated|Induction||90
113953|NCT00049517|271563|P1|Treated|Induction||79
113954|NCT00049517|271558|P6|STARTED|Induction||162
113955|NCT00049517|271559|P5|STARTED|Induction||188
113956|NCT00049517|271560|P4|STARTED|Induction||75
113957|NCT00049517|271561|P3|STARTED|Induction||63
113958|NCT00049517|271562|P2|STARTED|Induction||90
113959|NCT00049517|271563|P1|STARTED|Induction||79
113960|NCT00049530|271573|P1|NOT COMPLETED|Overall Study||32
113961|NCT00049530|271573|P1|COMPLETED|Overall Study||0
113962|NCT00049530|271573|P1|Eligible and Treated|Overall Study||29
113963|NCT00049530|271573|P1|STARTED|Overall Study||32
113964|NCT00049543|271582|P2|NOT COMPLETED|Overall Study||9
113965|NCT00049543|271583|P1|NOT COMPLETED|Overall Study||2
113966|NCT00049543|271582|P2|COMPLETED|Overall Study||243
113967|NCT00049543|271583|P1|COMPLETED|Overall Study||249
113968|NCT00049543|271582|P2|STARTED|Overall Study||252
113969|NCT00049543|271583|P1|STARTED|Overall Study||251
113970|NCT00049842|271595|P2|NOT COMPLETED|Follow-up Phase||5
113971|NCT00049842|271596|P1|NOT COMPLETED|Follow-up Phase||7
113972|NCT00049842|271595|P2|COMPLETED|Follow-up Phase||189
113973|NCT00049842|271596|P1|COMPLETED|Follow-up Phase||211
113974|NCT00049842|271595|P2|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|194
113975|NCT00049842|271596|P1|STARTED|Follow-up Phase|Population is all treatment phase completers plus some who discontinued the treatment phase.|218
113976|NCT00049842|271595|P2|NOT COMPLETED|Treatment Phase||78
113977|NCT00049842|271596|P1|NOT COMPLETED|Treatment Phase||93
113978|NCT00049842|271595|P2|COMPLETED|Treatment Phase||192
113979|NCT00049842|271596|P1|COMPLETED|Treatment Phase||177
113980|NCT00049842|271595|P2|STARTED|Treatment Phase||270
113981|NCT00049842|271596|P1|STARTED|Treatment Phase||270
113982|NCT00050011|271614|P2|NOT COMPLETED|Overall Study||126
113983|NCT00050011|271615|P1|NOT COMPLETED|Overall Study||121
113984|NCT00050011|271614|P2|COMPLETED|Overall Study||175
113985|NCT00050011|271615|P1|COMPLETED|Overall Study||180
113986|NCT00050011|271614|P2|Intent-to-treat Population|Overall Study||300
113987|NCT00050011|271615|P1|Intent-to-treat Population|Overall Study||300
113988|NCT00050011|271614|P2|STARTED|Overall Study||301
113989|NCT00050011|271615|P1|STARTED|Overall Study||301
113990|NCT00050089|271639|P4|NOT COMPLETED|Overall Study||0
113991|NCT00050089|271640|P3|NOT COMPLETED|Overall Study||0
113992|NCT00050089|271641|P2|NOT COMPLETED|Overall Study||0
113993|NCT00050089|271642|P1|NOT COMPLETED|Overall Study||0
113994|NCT00050089|271639|P4|COMPLETED|Overall Study|For primary outcome assessment|78
113995|NCT00050089|271640|P3|COMPLETED|Overall Study|For primary outcome assessment|86
113996|NCT00050089|271641|P2|COMPLETED|Overall Study|For primary outcome assessment|98
113997|NCT00050089|271642|P1|COMPLETED|Overall Study|For primary outcome assessment|106
113998|NCT00050089|271639|P4|Baseline|Overall Study||78
113999|NCT00050089|271640|P3|Baseline|Overall Study||86
114000|NCT00050089|271641|P2|Baseline|Overall Study|14 participants randomized in the UK Option scheme (not shown in 2X2 baseline data)|84
114001|NCT00050089|271642|P1|Baseline|Overall Study|15 participants randomized in the UK Option scheme (not displayed in the 2X2 baseline data)|91
114002|NCT00050089|271639|P4|STARTED|Overall Study||78
114003|NCT00050089|271640|P3|STARTED|Overall Study||86
114004|NCT00050089|271641|P2|STARTED|Overall Study||98
114005|NCT00050089|271642|P1|STARTED|Overall Study||106
114006|NCT00050167|271662|P2|NOT COMPLETED|Overall Study||1
114007|NCT00050167|271663|P1|NOT COMPLETED|Overall Study||1
114008|NCT00050167|271662|P2|COMPLETED|Overall Study||300
114009|NCT00050167|271663|P1|COMPLETED|Overall Study||301
114010|NCT00050167|271662|P2|STARTED|Overall Study||301
114011|NCT00050167|271663|P1|STARTED|Overall Study||302
114012|NCT00050622|271669|P1|NOT COMPLETED|Overall Study||1
114013|NCT00050622|271669|P1|COMPLETED|Overall Study||153
114014|NCT00050622|271669|P1|STARTED|Overall Study||154
114015|NCT00050778|271708|P3|NOT COMPLETED|Overall Study||18
114016|NCT00050778|271709|P2|NOT COMPLETED|Overall Study||21
114017|NCT00050778|271710|P1|NOT COMPLETED|Overall Study||45
114018|NCT00050778|271708|P3|COMPLETED|Overall Study||92
114019|NCT00050778|271709|P2|COMPLETED|Overall Study||92
114020|NCT00050778|271710|P1|COMPLETED|Overall Study||66
114021|NCT00050778|271708|P3|Treated|Overall Study||108
114022|NCT00050778|271709|P2|Treated|Overall Study||108
114023|NCT00050778|271710|P1|Treated|Overall Study||107
114024|NCT00050778|271708|P3|STARTED|Overall Study||110
114025|NCT00050778|271709|P2|STARTED|Overall Study||113
114026|NCT00050778|271710|P1|STARTED|Overall Study|Randomized.|111
114027|NCT00050960|271738|P2|NOT COMPLETED|Overall Study||304
114028|NCT00050960|271739|P1|NOT COMPLETED|Overall Study||302
114029|NCT00050960|271738|P2|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|2
114121|NCT00062439|271893|P1|COMPLETED|Surgery||22
114030|NCT00050960|271739|P1|COMPLETED|Overall Study|Represents number of patients with no primary reason for termination|4
114031|NCT00050960|271738|P2|STARTED|Overall Study||306
114032|NCT00050960|271739|P1|STARTED|Overall Study||306
114033|NCT00050986|271745|P1|NOT COMPLETED|Overall Study||2
114034|NCT00050986|271745|P1|COMPLETED|Overall Study|Two participants had withdrawn consents before the study treatment was initiated.|53
114035|NCT00050986|271745|P1|STARTED|Overall Study||55
114036|NCT00058825|271749|P1|NOT COMPLETED|Overall Study||22
114037|NCT00058825|271749|P1|COMPLETED|Overall Study||5
114038|NCT00058825|271749|P1|STARTED|Overall Study||27
114039|NCT00060333|271763|P1|NOT COMPLETED|Overall Study||0
114040|NCT00060333|271763|P1|COMPLETED|Overall Study||20
114041|NCT00060333|271763|P1|STARTED|Overall Study||20
114042|NCT00060346|271774|P1|NOT COMPLETED|Overall Study||0
114043|NCT00060346|271774|P1|COMPLETED|Overall Study||16
114044|NCT00060346|271774|P1|Eligible and Treated|Overall Study||16
114045|NCT00060346|271774|P1|STARTED|Overall Study||16
114046|NCT00060528|271778|P4|NOT COMPLETED|Overall Study||0
114047|NCT00060528|271779|P3|NOT COMPLETED|Overall Study||0
114048|NCT00060528|271780|P2|NOT COMPLETED|Overall Study||0
114049|NCT00060528|271781|P1|NOT COMPLETED|Overall Study||0
114050|NCT00060528|271778|P4|COMPLETED|Overall Study||8
114051|NCT00060528|271779|P3|COMPLETED|Overall Study||7
114052|NCT00060528|271780|P2|COMPLETED|Overall Study||9
114053|NCT00060528|271781|P1|COMPLETED|Overall Study||8
114054|NCT00060528|271778|P4|STARTED|Overall Study||8
114055|NCT00060528|271779|P3|STARTED|Overall Study||7
114056|NCT00060528|271780|P2|STARTED|Overall Study||9
114057|NCT00060528|271781|P1|STARTED|Overall Study|32 participants are reported for the phase II portion.|8
114058|NCT00060840|271797|P2|NOT COMPLETED|Overall Study||9
114059|NCT00060840|271798|P1|NOT COMPLETED|Overall Study||4
114060|NCT00060840|271797|P2|COMPLETED|Overall Study||68
114061|NCT00060840|271798|P1|COMPLETED|Overall Study||69
114062|NCT00060840|271797|P2|STARTED|Overall Study||77
114063|NCT00060840|271798|P1|STARTED|Overall Study||73
114064|NCT00060944|271806|P2|NOT COMPLETED|Overall Study||134
114065|NCT00060944|271807|P1|NOT COMPLETED|Overall Study||136
114066|NCT00060944|271806|P2|COMPLETED|Overall Study||0
114067|NCT00060944|271807|P1|COMPLETED|Overall Study||0
114068|NCT00060944|271806|P2|Treated|Overall Study||130
114069|NCT00060944|271807|P1|Treated|Overall Study||130
114070|NCT00060944|271806|P2|STARTED|Overall Study||134
114071|NCT00060944|271807|P1|STARTED|Overall Study||136
114072|NCT00061048|271821|P1|NOT COMPLETED|Overall Study||22
114073|NCT00061048|271821|P1|COMPLETED|Overall Study|Began protocol specified follow-up period.|7
114074|NCT00061048|271821|P1|STARTED|Overall Study||29
114075|NCT00061373|271831|P2|NOT COMPLETED|Overall Study||0
114076|NCT00061373|271832|P1|NOT COMPLETED|Overall Study||0
114077|NCT00061373|271831|P2|COMPLETED|Overall Study||3
114078|NCT00061373|271832|P1|COMPLETED|Overall Study||15
114079|NCT00061373|271831|P2|Aspirin and Tinzaparin|Overall Study||3
114080|NCT00061373|271832|P1|Aspirin and Tinzaparin|Overall Study||15
114081|NCT00061373|271831|P2|STARTED|Overall Study||3
114082|NCT00061373|271832|P1|STARTED|Overall Study||15
114083|NCT00061633|271850|P2|NOT COMPLETED|Overall Study||11
114084|NCT00061633|271851|P1|NOT COMPLETED|Overall Study||5
114085|NCT00061633|271850|P2|COMPLETED|Overall Study||74
114086|NCT00061633|271851|P1|COMPLETED|Overall Study||79
114087|NCT00061633|271850|P2|STARTED|Overall Study||85
114088|NCT00061633|271851|P1|STARTED|Overall Study||84
114089|NCT00061893|271857|P1|NOT COMPLETED|Overall Study||18
114090|NCT00061893|271857|P1|COMPLETED|Overall Study||20
114091|NCT00061893|271857|P1|STARTED|Overall Study||38
114092|NCT00061932|271864|P2|NOT COMPLETED|Overall Study||4
114093|NCT00061932|271865|P1|NOT COMPLETED|Overall Study||13
114094|NCT00061932|271864|P2|COMPLETED|Overall Study||8
114095|NCT00061932|271865|P1|COMPLETED|Overall Study||16
114096|NCT00061932|271864|P2|STARTED|Overall Study||12
114097|NCT00061932|271865|P1|STARTED|Overall Study||29
114098|NCT00061945|271873|P2|NOT COMPLETED|Course IV: Alemtuzumab||16
114099|NCT00061945|271874|P1|NOT COMPLETED|Course IV: Alemtuzumab||7
114100|NCT00061945|271873|P2|COMPLETED|Course IV: Alemtuzumab||50
114101|NCT00061945|271874|P1|COMPLETED|Course IV: Alemtuzumab||18
114102|NCT00061945|271873|P2|STARTED|Course IV: Alemtuzumab||66
114103|NCT00061945|271874|P1|STARTED|Course IV: Alemtuzumab||25
114104|NCT00061945|271873|P2|NOT COMPLETED|Registration Through Course 3||115
114105|NCT00061945|271874|P1|NOT COMPLETED|Registration Through Course 3||94
114106|NCT00061945|271873|P2|COMPLETED|Registration Through Course 3||66
114107|NCT00061945|271874|P1|COMPLETED|Registration Through Course 3||25
114108|NCT00061945|271873|P2|STARTED|Registration Through Course 3||181
114109|NCT00061945|271874|P1|STARTED|Registration Through Course 3||119
114110|NCT00062010|271882|P1|NOT COMPLETED|Overall Study||3
114111|NCT00062010|271882|P1|COMPLETED|Overall Study||34
114112|NCT00062010|271882|P1|Eligible and Treated|Overall Study||34
114113|NCT00062010|271882|P1|STARTED|Overall Study||37
114114|NCT00062374|271888|P1|NOT COMPLETED|Overall Study||12
114115|NCT00062374|271888|P1|COMPLETED|Overall Study||43
114116|NCT00062374|271888|P1|STARTED|Overall Study||55
114117|NCT00062439|271893|P1|NOT COMPLETED|Consolidation Chemotherapy||2
114118|NCT00062439|271893|P1|COMPLETED|Consolidation Chemotherapy||20
114119|NCT00062439|271893|P1|STARTED|Consolidation Chemotherapy||22
114120|NCT00062439|271893|P1|NOT COMPLETED|Surgery||7
114122|NCT00062439|271893|P1|STARTED|Surgery||29
114123|NCT00062439|271893|P1|NOT COMPLETED|Post Chemoradiation Assessment||9
114124|NCT00062439|271893|P1|COMPLETED|Post Chemoradiation Assessment||29
114125|NCT00062439|271893|P1|STARTED|Post Chemoradiation Assessment||38
114126|NCT00062439|271893|P1|NOT COMPLETED|Induction Chemotherapy + Radiotherapy||8
114127|NCT00062439|271893|P1|COMPLETED|Induction Chemotherapy + Radiotherapy||38
114128|NCT00062439|271893|P1|STARTED|Induction Chemotherapy + Radiotherapy||46
114129|NCT00062647|271907|P2|NOT COMPLETED|Overall Study||13
114130|NCT00062647|271908|P1|NOT COMPLETED|Overall Study||16
114131|NCT00062647|271907|P2|COMPLETED|Overall Study||17
114132|NCT00062647|271908|P1|COMPLETED|Overall Study||14
114133|NCT00062647|271907|P2|STARTED|Overall Study||30
114134|NCT00062647|271908|P1|STARTED|Overall Study||30
114135|NCT00062738|271917|P3|NOT COMPLETED|Overall Study||0
114136|NCT00062738|271918|P2|NOT COMPLETED|Overall Study||0
114137|NCT00062738|271919|P1|NOT COMPLETED|Overall Study||0
114138|NCT00062738|271917|P3|COMPLETED|Overall Study||17
114139|NCT00062738|271918|P2|COMPLETED|Overall Study||18
114140|NCT00062738|271919|P1|COMPLETED|Overall Study||17
114141|NCT00062738|271917|P3|STARTED|Overall Study||17
114142|NCT00062738|271918|P2|STARTED|Overall Study||18
114143|NCT00062738|271919|P1|STARTED|Overall Study||17
114144|NCT00062751|271935|P5|NOT COMPLETED|Overall Study||6
114145|NCT00062751|271936|P4|NOT COMPLETED|Overall Study||5
114146|NCT00062751|271937|P3|NOT COMPLETED|Overall Study||30
114147|NCT00062751|271938|P2|NOT COMPLETED|Overall Study||30
114148|NCT00062751|271939|P1|NOT COMPLETED|Overall Study||33
114149|NCT00062751|271935|P5|COMPLETED|Overall Study||0
114150|NCT00062751|271936|P4|COMPLETED|Overall Study||1
114151|NCT00062751|271937|P3|COMPLETED|Overall Study||3
114152|NCT00062751|271938|P2|COMPLETED|Overall Study||0
114153|NCT00062751|271939|P1|COMPLETED|Overall Study||0
114154|NCT00062751|271935|P5|STARTED|Overall Study||6
114155|NCT00062751|271936|P4|STARTED|Overall Study||6
114156|NCT00062751|271937|P3|STARTED|Overall Study||33
114157|NCT00062751|271938|P2|STARTED|Overall Study||30
114158|NCT00062751|271939|P1|STARTED|Overall Study||33
114159|NCT00062764|272007|P1|NOT COMPLETED|Overall Study||0
114160|NCT00062764|272007|P1|COMPLETED|Overall Study||18
114161|NCT00062764|272007|P1|STARTED|Overall Study||18
114162|NCT00054275|272015|P1|NOT COMPLETED|Overall Study||11
114163|NCT00054275|272015|P1|COMPLETED|Overall Study||28
114164|NCT00054275|272015|P1|STARTED|Overall Study||39
114165|NCT00054327|272027|P6|NOT COMPLETED|Overall Study||0
114166|NCT00054327|272028|P5|NOT COMPLETED|Overall Study||0
114167|NCT00054327|272029|P4|NOT COMPLETED|Overall Study||0
114168|NCT00054327|272030|P3|NOT COMPLETED|Overall Study||0
114169|NCT00054327|272031|P2|NOT COMPLETED|Overall Study||0
114170|NCT00054327|272032|P1|NOT COMPLETED|Overall Study||1
114171|NCT00054327|272027|P6|COMPLETED|Overall Study||2
114172|NCT00054327|272028|P5|COMPLETED|Overall Study||10
114173|NCT00054327|272029|P4|COMPLETED|Overall Study||4
114174|NCT00054327|272030|P3|COMPLETED|Overall Study||3
114175|NCT00054327|272031|P2|COMPLETED|Overall Study||4
114176|NCT00054327|272032|P1|COMPLETED|Overall Study||10
114177|NCT00054327|272027|P6|STARTED|Overall Study||2
114178|NCT00054327|272028|P5|STARTED|Overall Study||10
114179|NCT00054327|272029|P4|STARTED|Overall Study||4
114180|NCT00054327|272030|P3|STARTED|Overall Study||3
114181|NCT00054327|272031|P2|STARTED|Overall Study||4
114182|NCT00054327|272032|P1|STARTED|Overall Study||11
114183|NCT00054639|272070|P1|NOT COMPLETED|Overall Study||2
114184|NCT00054639|272070|P1|COMPLETED|Overall Study||46
114185|NCT00054639|272070|P1|STARTED|Overall Study||48
114186|NCT00054665|272074|P2|NOT COMPLETED|Part B||0
114187|NCT00054665|272075|P1|NOT COMPLETED|Part B||0
114188|NCT00054665|272074|P2|COMPLETED|Part B||44
114189|NCT00054665|272075|P1|COMPLETED|Part B||0
114190|NCT00054665|272074|P2|STARTED|Part B|26 participants received only Part B|44
114191|NCT00054665|272075|P1|STARTED|Part B||0
114192|NCT00054665|272074|P2|NOT COMPLETED|Part A||0
114193|NCT00054665|272075|P1|NOT COMPLETED|Part A||0
114194|NCT00054665|272074|P2|COMPLETED|Part A||0
114195|NCT00054665|272075|P1|COMPLETED|Part A||23
114196|NCT00054665|272074|P2|STARTED|Part A||0
114197|NCT00054665|272075|P1|STARTED|Part A|5 participants only received Part A and 18 participants received Part B after Part A.|23
114198|NCT00054691|272083|P1|NOT COMPLETED|Overall Study||3
114199|NCT00054691|272083|P1|COMPLETED|Overall Study||37
114200|NCT00054691|272083|P1|STARTED|Overall Study||40
114201|NCT00054704|272090|P2|NOT COMPLETED|Overall Study||5
114202|NCT00054704|272091|P1|NOT COMPLETED|Overall Study||5
114203|NCT00054704|272090|P2|COMPLETED|Overall Study||6
114204|NCT00054704|272091|P1|COMPLETED|Overall Study||4
114205|NCT00054704|272090|P2|STARTED|Overall Study||11
114206|NCT00054704|272091|P1|STARTED|Overall Study||9
114207|NCT00054717|272099|P2|NOT COMPLETED|Overall Study||299
114208|NCT00054717|272100|P1|NOT COMPLETED|Overall Study||262
114209|NCT00054717|272099|P2|COMPLETED|Overall Study||18
114210|NCT00054717|272100|P1|COMPLETED|Overall Study||51
114211|NCT00054717|272099|P2|STARTED|Overall Study||317
114212|NCT00054717|272100|P1|STARTED|Overall Study||313
114213|NCT00054847|272288|P2|NOT COMPLETED|Overall Study||100
114214|NCT00054847|272289|P1|NOT COMPLETED|Overall Study||98
114215|NCT00054847|272288|P2|COMPLETED|Overall Study||266
114216|NCT00054847|272289|P1|COMPLETED|Overall Study||269
114217|NCT00054847|272288|P2|STARTED|Overall Study||366
114218|NCT00054847|272289|P1|STARTED|Overall Study||367
114219|NCT00055237|272303|P2|NOT COMPLETED|Overall Study||0
114220|NCT00055237|272304|P1|NOT COMPLETED|Overall Study||0
114221|NCT00055237|272303|P2|COMPLETED|Overall Study||2
114222|NCT00055237|272304|P1|COMPLETED|Overall Study||17
114223|NCT00055237|272303|P2|STARTED|Overall Study||2
114224|NCT00055237|272304|P1|STARTED|Overall Study||17
114225|NCT00055471|272312|P3|NOT COMPLETED|Period 2: Extension Period||0
114226|NCT00055471|272313|P2|NOT COMPLETED|Period 2: Extension Period||0
114227|NCT00055471|272314|P1|NOT COMPLETED|Period 2: Extension Period||0
114228|NCT00055471|272312|P3|COMPLETED|Period 2: Extension Period||0
114229|NCT00055471|272313|P2|COMPLETED|Period 2: Extension Period||6
114230|NCT00055471|272314|P1|COMPLETED|Period 2: Extension Period||3
114231|NCT00055471|272312|P3|STARTED|Period 2: Extension Period||0
114232|NCT00055471|272313|P2|STARTED|Period 2: Extension Period|2 pts discontinued after completion of Period1,therefore 9 pts proceeded to participate in Period2|6
114233|NCT00055471|272314|P1|STARTED|Period 2: Extension Period|Period 2 - attend Pts who,in the opinion of the Investigator,show benefit from treatment with ZD4054|3
114234|NCT00055471|272312|P3|NOT COMPLETED|Period 1: Dose Escalation Period||3
114235|NCT00055471|272313|P2|NOT COMPLETED|Period 1: Dose Escalation Period||2
114236|NCT00055471|272314|P1|NOT COMPLETED|Period 1: Dose Escalation Period||0
114237|NCT00055471|272312|P3|COMPLETED|Period 1: Dose Escalation Period||0
114238|NCT00055471|272313|P2|COMPLETED|Period 1: Dose Escalation Period||8
114239|NCT00055471|272314|P1|COMPLETED|Period 1: Dose Escalation Period||3
114240|NCT00055471|272312|P3|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|3
114241|NCT00055471|272313|P2|STARTED|Period 1: Dose Escalation Period|Dose level given only after lower dose was successfully administered.|10
114242|NCT00055471|272314|P1|STARTED|Period 1: Dose Escalation Period||3
114243|NCT00055497|272344|P4|NOT COMPLETED|Overall Study||90
114244|NCT00055497|272345|P3|NOT COMPLETED|Overall Study||2
114245|NCT00055497|272346|P2|NOT COMPLETED|Overall Study||3
114246|NCT00055497|272347|P1|NOT COMPLETED|Overall Study||5
114247|NCT00055497|272344|P4|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|131
114248|NCT00055497|272345|P3|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
114249|NCT00055497|272346|P2|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|16
114250|NCT00055497|272347|P1|COMPLETED|Overall Study|Participants may have continued to the open-label extension study. See NCT01070303.|13
114251|NCT00055497|272344|P4|STARTED|Overall Study|17 participants who discontinued at/before Week 4 are counted here because they were not randomized.|221
114252|NCT00055497|272345|P3|STARTED|Overall Study||18
114253|NCT00055497|272346|P2|STARTED|Overall Study||19
114254|NCT00055497|272347|P1|STARTED|Overall Study||18
114255|NCT00055601|272391|P2|NOT COMPLETED|Overall Study||2
114256|NCT00055601|272392|P1|NOT COMPLETED|Overall Study||2
114257|NCT00055601|272391|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
114258|NCT00055601|272392|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|46
114259|NCT00055601|272391|P2|STARTED|Overall Study||49
114260|NCT00055601|272392|P1|STARTED|Overall Study||48
114261|NCT00055692|272402|P1|NOT COMPLETED|Overall Study||0
114262|NCT00055692|272402|P1|COMPLETED|Overall Study||46
114263|NCT00055692|272402|P1|STARTED|Overall Study||46
114264|NCT00063154|272411|P1|NOT COMPLETED|Overall Study||51
114265|NCT00063154|272411|P1|COMPLETED|Overall Study||0
114266|NCT00063154|272411|P1|STARTED|Overall Study||51
114267|NCT00063232|272418|P1|NOT COMPLETED|Overall Study||0
114268|NCT00063232|272418|P1|COMPLETED|Overall Study||26
114269|NCT00063232|272418|P1|STARTED|Overall Study||26
114270|NCT00063258|272426|P2|NOT COMPLETED|Overall Study||0
114271|NCT00063258|272427|P1|NOT COMPLETED|Overall Study||4
114272|NCT00063258|272426|P2|COMPLETED|Overall Study||0
114273|NCT00063258|272427|P1|COMPLETED|Overall Study||1
114274|NCT00063258|272426|P2|STARTED|Overall Study||0
114275|NCT00063258|272427|P1|STARTED|Overall Study||5
114276|NCT00063934|272433|P1|NOT COMPLETED|Overall Study||1
114277|NCT00063934|272433|P1|COMPLETED|Overall Study||30
114278|NCT00063934|272433|P1|STARTED|Overall Study||31
114279|NCT00063986|272439|P1|NOT COMPLETED|Overall Study||6
114280|NCT00063986|272439|P1|COMPLETED|Overall Study||104
114281|NCT00063986|272439|P1|Eligible and Treated|Overall Study||104
114282|NCT00063986|272439|P1|Treated|Overall Study||105
114283|NCT00063986|272439|P1|STARTED|Overall Study||110
114284|NCT00064025|272451|P1|NOT COMPLETED|Overall Study||7
114285|NCT00064025|272451|P1|COMPLETED|Overall Study||68
114286|NCT00064025|272451|P1|STARTED|Overall Study||75
114287|NCT00064038|272460|P3|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||2
114288|NCT00064038|272461|P2|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
114289|NCT00064038|272462|P1|NOT COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
114290|NCT00064038|272460|P3|COMPLETED|Crossover to Lenalidomide+Dexamethasone||40
114291|NCT00064038|272461|P2|COMPLETED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
114292|NCT00064038|272462|P1|COMPLETED|Crossover to Lenalidomide+Dexamethasone||0
114293|NCT00064038|272460|P3|Safety Population|Crossover to Lenalidomide+Dexamethasone||40
114294|NCT00064038|272461|P2|Safety Population|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
114295|NCT00064038|272462|P1|Safety Population|Crossover to Lenalidomide+Dexamethasone||0
114296|NCT00064038|272460|P3|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||40
114297|NCT00064038|272461|P2|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
114298|NCT00064038|272462|P1|Eligible and Analyzable|Crossover to Lenalidomide+Dexamethasone||0
114299|NCT00064038|272460|P3|STARTED|Crossover to Lenalidomide+Dexamethasone||42
114300|NCT00064038|272461|P2|STARTED|Crossover to Lenalidomide+Dexamethasone|See Crossover to Lenalidomide+Dexamethasone Arm.|0
114301|NCT00064038|272462|P1|STARTED|Crossover to Lenalidomide+Dexamethasone||0
114302|NCT00064038|272460|P3|NOT COMPLETED|Initial Randomization||0
114303|NCT00064038|272461|P2|NOT COMPLETED|Initial Randomization||98
114304|NCT00064038|272462|P1|NOT COMPLETED|Initial Randomization||100
114305|NCT00064038|272460|P3|COMPLETED|Initial Randomization||0
114306|NCT00064038|272461|P2|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
114307|NCT00064038|272462|P1|COMPLETED|Initial Randomization|The study was closed early per recommedation of the Data Safety Monitoring Committee.|0
114308|NCT00064038|272460|P3|Safety Population|Initial Randomization||0
114309|NCT00064038|272461|P2|Safety Population|Initial Randomization||94
114310|NCT00064038|272462|P1|Safety Population|Initial Randomization||96
114311|NCT00064038|272460|P3|Eligible and Analyzable|Initial Randomization||0
114312|NCT00064038|272461|P2|Eligible and Analyzable|Initial Randomization||95
114313|NCT00064038|272462|P1|Eligible and Analyzable|Initial Randomization||97
114314|NCT00064038|272460|P3|STARTED|Initial Randomization||0
114315|NCT00064038|272461|P2|STARTED|Initial Randomization||98
114316|NCT00064038|272462|P1|STARTED|Initial Randomization||100
114317|NCT00064259|272472|P4|NOT COMPLETED|Overall Study||1
114318|NCT00064259|272473|P3|NOT COMPLETED|Overall Study||0
114319|NCT00064259|272474|P2|NOT COMPLETED|Overall Study||0
114320|NCT00064259|272475|P1|NOT COMPLETED|Overall Study||1
114321|NCT00064259|272472|P4|COMPLETED|Overall Study||0
114322|NCT00064259|272473|P3|COMPLETED|Overall Study||6
114323|NCT00064259|272474|P2|COMPLETED|Overall Study||4
114324|NCT00064259|272475|P1|COMPLETED|Overall Study||3
114325|NCT00064259|272472|P4|STARTED|Overall Study||1
114326|NCT00064259|272473|P3|STARTED|Overall Study||6
114327|NCT00064259|272474|P2|STARTED|Overall Study||4
114328|NCT00064259|272475|P1|STARTED|Overall Study||4
114329|NCT00064298|272481|P2|NOT COMPLETED|Overall Study||5
114330|NCT00064298|272482|P1|NOT COMPLETED|Overall Study||6
114331|NCT00064298|272481|P2|COMPLETED|Overall Study||57
114332|NCT00064298|272482|P1|COMPLETED|Overall Study||66
114333|NCT00064298|272481|P2|STARTED|Overall Study||62
114334|NCT00064298|272482|P1|STARTED|Overall Study||72
114335|NCT00064350|272493|P3|NOT COMPLETED|Cross-Over||0
114336|NCT00064350|272494|P2|NOT COMPLETED|Cross-Over||14
114337|NCT00064350|272495|P1|NOT COMPLETED|Cross-Over||6
114338|NCT00064350|272493|P3|COMPLETED|Cross-Over||0
114339|NCT00064350|272494|P2|COMPLETED|Cross-Over||13
114340|NCT00064350|272495|P1|COMPLETED|Cross-Over||4
114341|NCT00064350|272493|P3|Eligible and Treated|Cross-Over||0
114342|NCT00064350|272494|P2|Eligible and Treated|Cross-Over||21
114343|NCT00064350|272495|P1|Eligible and Treated|Cross-Over||7
114344|NCT00064350|272493|P3|Treated|Cross-Over||0
114345|NCT00064350|272494|P2|Treated|Cross-Over||26
114346|NCT00064350|272495|P1|Treated|Cross-Over||9
114347|NCT00064350|272493|P3|STARTED|Cross-Over||0
114348|NCT00064350|272494|P2|STARTED|Cross-Over||27
114349|NCT00064350|272495|P1|STARTED|Cross-Over||10
114350|NCT00064350|272493|P3|NOT COMPLETED|Randomization||0
114351|NCT00064350|272494|P2|NOT COMPLETED|Randomization||18
114352|NCT00064350|272495|P1|NOT COMPLETED|Randomization||26
114353|NCT00064350|272493|P3|COMPLETED|Randomization||0
114354|NCT00064350|272494|P2|COMPLETED|Randomization||28
114355|NCT00064350|272495|P1|COMPLETED|Randomization||33
114356|NCT00064350|272493|P3|Eligible and Treated|Randomization||0
114357|NCT00064350|272494|P2|Eligible and Treated|Randomization||31
114358|NCT00064350|272495|P1|Eligible and Treated|Randomization||50
114359|NCT00064350|272493|P3|Treated|Randomization||0
114360|NCT00064350|272494|P2|Treated|Randomization||40
114361|NCT00064350|272495|P1|Treated|Randomization||55
114362|NCT00064350|272493|P3|STARTED|Randomization||0
114363|NCT00064350|272494|P2|STARTED|Randomization||46
114364|NCT00064350|272495|P1|STARTED|Randomization||59
114365|NCT00064350|272493|P3|NOT COMPLETED|Induction Treatment||236
114366|NCT00064350|272494|P2|NOT COMPLETED|Induction Treatment||9
114367|NCT00064350|272495|P1|NOT COMPLETED|Induction Treatment||8
114368|NCT00064350|272493|P3|COMPLETED|Induction Treatment||1
114369|NCT00064350|272494|P2|COMPLETED|Induction Treatment||37
114370|NCT00064350|272495|P1|COMPLETED|Induction Treatment||51
114371|NCT00064350|272493|P3|Eligible and Treated|Induction Treatment||194
114372|NCT00064350|272494|P2|Eligible and Treated|Induction Treatment||46
114373|NCT00064350|272495|P1|Eligible and Treated|Induction Treatment||59
114374|NCT00064350|272493|P3|Treated|Induction Treatment||228
114375|NCT00064350|272494|P2|Treated|Induction Treatment||46
114376|NCT00064350|272495|P1|Treated|Induction Treatment||59
114377|NCT00064350|272493|P3|STARTED|Induction Treatment||237
114378|NCT00064350|272494|P2|STARTED|Induction Treatment||46
114379|NCT00064350|272495|P1|STARTED|Induction Treatment||59
114380|NCT00064662|272512|P2|NOT COMPLETED|Overall Study||61
114381|NCT00064662|272513|P1|NOT COMPLETED|Overall Study||74
114382|NCT00064662|272512|P2|COMPLETED|Overall Study||265
114383|NCT00064662|272513|P1|COMPLETED|Overall Study||255
114384|NCT00064662|272512|P2|STARTED|Overall Study||326
114385|NCT00064662|272513|P1|STARTED|Overall Study||329
114386|NCT00064701|272524|P3|NOT COMPLETED|Clinical Continuation Phase||140
114387|NCT00064701|272525|P2|NOT COMPLETED|Clinical Continuation Phase||178
114388|NCT00064701|272526|P1|NOT COMPLETED|Clinical Continuation Phase||170
114389|NCT00064701|272524|P3|COMPLETED|Clinical Continuation Phase||11
114390|NCT00064701|272525|P2|COMPLETED|Clinical Continuation Phase||4
114391|NCT00064701|272526|P1|COMPLETED|Clinical Continuation Phase||9
114392|NCT00064701|272524|P3|STARTED|Clinical Continuation Phase||151
114393|NCT00064701|272525|P2|STARTED|Clinical Continuation Phase|One participant did not enter the Clinical Continuation phase|182
114394|NCT00064701|272526|P1|STARTED|Clinical Continuation Phase||179
114395|NCT00064701|272524|P3|NOT COMPLETED|One Year Post-transplant||72
114396|NCT00064701|272525|P2|NOT COMPLETED|One Year Post-transplant||43
114397|NCT00064701|272526|P1|NOT COMPLETED|One Year Post-transplant||40
114398|NCT00064701|272524|P3|COMPLETED|One Year Post-transplant||151
114399|NCT00064701|272525|P2|COMPLETED|One Year Post-transplant||183
114400|NCT00064701|272526|P1|COMPLETED|One Year Post-transplant||179
114401|NCT00064701|272524|P3|Received Study Drug|One Year Post-transplant||212
114402|NCT00064701|272525|P2|Received Study Drug|One Year Post-transplant||214
114403|NCT00064701|272526|P1|Received Study Drug|One Year Post-transplant||212
114404|NCT00064701|272524|P3|STARTED|One Year Post-transplant||223
114405|NCT00064701|272525|P2|STARTED|One Year Post-transplant||226
114406|NCT00064701|272526|P1|STARTED|One Year Post-transplant||219
114407|NCT00064753|272578|P2|NOT COMPLETED|Overall Study||648
114408|NCT00064753|272579|P1|NOT COMPLETED|Overall Study||674
114409|NCT00064753|272578|P2|COMPLETED|Overall Study||1406
114410|NCT00064753|272579|P1|COMPLETED|Overall Study||1382
114411|NCT00064753|272578|P2|STARTED|Overall Study||2054
114412|NCT00064753|272579|P1|STARTED|Overall Study||2056
114413|NCT00064792|272609|P2|NOT COMPLETED|Overall Study||0
114414|NCT00064792|272610|P1|NOT COMPLETED|Overall Study||5
114415|NCT00064792|272609|P2|COMPLETED|Overall Study||10
114416|NCT00064792|272610|P1|COMPLETED|Overall Study||8
114417|NCT00064792|272609|P2|STARTED|Overall Study||10
114418|NCT00064792|272610|P1|STARTED|Overall Study||13
114419|NCT00064844|272620|P2|NOT COMPLETED|Overall Study||19
114420|NCT00064844|272621|P1|NOT COMPLETED|Overall Study||8
114421|NCT00064844|272620|P2|COMPLETED|Overall Study||32
114422|NCT00064844|272621|P1|COMPLETED|Overall Study||37
114423|NCT00064844|272620|P2|12 Month Follow-up|Overall Study||32
114424|NCT00064844|272621|P1|12 Month Follow-up|Overall Study||37
114425|NCT00064844|272620|P2|6 Month Follow-up|Overall Study||40
114426|NCT00064844|272621|P1|6 Month Follow-up|Overall Study||39
114427|NCT00064844|272620|P2|3 Month Follow-up|Overall Study||47
114428|NCT00064844|272621|P1|3 Month Follow-up|Overall Study||40
114429|NCT00064844|272620|P2|2 Week Follow-up|Overall Study||51
114430|NCT00064844|272621|P1|2 Week Follow-up|Overall Study||45
114431|NCT00064844|272620|P2|STARTED|Overall Study||51
114432|NCT00064844|272621|P1|STARTED|Overall Study||45
114433|NCT00064987|272631|P2|NOT COMPLETED|Overall Study||0
114434|NCT00064987|272632|P1|NOT COMPLETED|Overall Study||3
114435|NCT00064987|272631|P2|COMPLETED|Overall Study||6
114436|NCT00064987|272632|P1|COMPLETED|Overall Study||7
114437|NCT00064987|272631|P2|STARTED|Overall Study||6
114438|NCT00064987|272632|P1|STARTED|Overall Study||10
114439|NCT00065065|272652|P2|NOT COMPLETED|Overall Study||20
114440|NCT00065065|272653|P1|NOT COMPLETED|Overall Study||10
114441|NCT00065065|272652|P2|COMPLETED|Overall Study||33
114442|NCT00065065|272653|P1|COMPLETED|Overall Study||42
114443|NCT00065065|272652|P2|STARTED|Overall Study||53
114444|NCT00065065|272653|P1|STARTED|Overall Study||52
114445|NCT00065156|272661|P1|NOT COMPLETED|Overall Study||124
114446|NCT00065156|272661|P1|COMPLETED|Overall Study|24 patients rolled over to free drug due to sponsor closure of study.|24
114447|NCT00065156|272661|P1|Modified Intent to Treat Population|Overall Study||94
114448|NCT00065156|272661|P1|STARTED|Overall Study||148
114449|NCT00065260|272678|P2|NOT COMPLETED|Overall Study||1
114450|NCT00065260|272679|P1|NOT COMPLETED|Overall Study||0
114451|NCT00065260|272678|P2|COMPLETED|Overall Study||26
114452|NCT00065260|272679|P1|COMPLETED|Overall Study||27
114453|NCT00065260|272678|P2|STARTED|Overall Study||27
114454|NCT00065260|272679|P1|STARTED|Overall Study||27
114455|NCT00065429|272692|P7|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114456|NCT00065429|272693|P6|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114457|NCT00065429|272694|P5|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||6
114458|NCT00065429|272695|P4|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114459|NCT00065429|272696|P3|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114460|NCT00065429|272697|P2|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114461|NCT00065429|272698|P1|NOT COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114462|NCT00065429|272692|P7|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114463|NCT00065429|272693|P6|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114464|NCT00065429|272694|P5|COMPLETED|Phase II - Apr 2003 - Aug 2008||26
114465|NCT00065429|272695|P4|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114466|NCT00065429|272696|P3|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114467|NCT00065429|272697|P2|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114468|NCT00065429|272698|P1|COMPLETED|Phase II - Apr 2003 - Aug 2008||0
114469|NCT00065429|272692|P7|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
114470|NCT00065429|272693|P6|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
114471|NCT00065429|272694|P5|STARTED|Phase II - Apr 2003 - Aug 2008|All 32 patients enrolled in Phase 2 were at 60 mg/m2.|32
114472|NCT00065429|272695|P4|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
114473|NCT00065429|272696|P3|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
114474|NCT00065429|272697|P2|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
114475|NCT00065429|272698|P1|STARTED|Phase II - Apr 2003 - Aug 2008|Patients participated at this dose level only in Phase 1.|0
114476|NCT00065429|272692|P7|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
114477|NCT00065429|272693|P6|NOT COMPLETED|Phase I - May 2001 - Oct 2002||2
114478|NCT00065429|272694|P5|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
114479|NCT00065429|272695|P4|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
114480|NCT00065429|272696|P3|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
114481|NCT00065429|272697|P2|NOT COMPLETED|Phase I - May 2001 - Oct 2002||0
114482|NCT00065429|272698|P1|NOT COMPLETED|Phase I - May 2001 - Oct 2002||1
114483|NCT00065429|272692|P7|COMPLETED|Phase I - May 2001 - Oct 2002||2
114484|NCT00065429|272693|P6|COMPLETED|Phase I - May 2001 - Oct 2002||2
114485|NCT00065429|272694|P5|COMPLETED|Phase I - May 2001 - Oct 2002||8
114486|NCT00065429|272695|P4|COMPLETED|Phase I - May 2001 - Oct 2002||3
114487|NCT00065429|272696|P3|COMPLETED|Phase I - May 2001 - Oct 2002||3
114488|NCT00065429|272697|P2|COMPLETED|Phase I - May 2001 - Oct 2002||3
114489|NCT00065429|272698|P1|COMPLETED|Phase I - May 2001 - Oct 2002||3
114490|NCT00065429|272692|P7|STARTED|Phase I - May 2001 - Oct 2002||4
114491|NCT00065429|272693|P6|STARTED|Phase I - May 2001 - Oct 2002||4
114492|NCT00065429|272694|P5|STARTED|Phase I - May 2001 - Oct 2002||9
114493|NCT00065429|272695|P4|STARTED|Phase I - May 2001 - Oct 2002||4
114494|NCT00065429|272696|P3|STARTED|Phase I - May 2001 - Oct 2002||4
114495|NCT00065429|272697|P2|STARTED|Phase I - May 2001 - Oct 2002||3
114496|NCT00065429|272698|P1|STARTED|Phase I - May 2001 - Oct 2002||4
114497|NCT00065442|272712|P2|NOT COMPLETED|Overall Study||220
114498|NCT00065442|272713|P1|NOT COMPLETED|Overall Study||125
114499|NCT00065442|272712|P2|COMPLETED|Overall Study||121
114500|NCT00065442|272713|P1|COMPLETED|Overall Study||46
114501|NCT00065442|272712|P2|STARTED|Overall Study||341
114502|NCT00065442|272713|P1|STARTED|Overall Study||171
114503|NCT00065468|272724|P3|NOT COMPLETED|Overall Study||210
114504|NCT00065468|272725|P2|NOT COMPLETED|Overall Study||209
114505|NCT00065468|272726|P1|NOT COMPLETED|Overall Study||207
114506|NCT00065468|272724|P3|COMPLETED|Overall Study||0
114507|NCT00065468|272725|P2|COMPLETED|Overall Study||0
114508|NCT00065468|272726|P1|COMPLETED|Overall Study||0
114509|NCT00065468|272724|P3|Received Treatment|Overall Study||208
114510|NCT00065468|272725|P2|Received Treatment|Overall Study||208
114511|NCT00065468|272726|P1|Received Treatment|Overall Study||200
114512|NCT00065468|272724|P3|STARTED|Overall Study||210
114513|NCT00065468|272725|P2|STARTED|Overall Study||209
114514|NCT00065468|272726|P1|STARTED|Overall Study||207
114515|NCT00065507|272757|P2|NOT COMPLETED|Overall Study||29
114516|NCT00065507|272758|P1|NOT COMPLETED|Overall Study||29
114517|NCT00065507|272757|P2|COMPLETED|Overall Study|Completed first 48 weeks of treatment|62
114518|NCT00065507|272758|P1|COMPLETED|Overall Study|Completed first 48 weeks of treatment|71
114519|NCT00065507|272757|P2|Treated, 24-Week Follow-Up Population|Overall Study||28
114520|NCT00065507|272758|P1|Treated, 24-Week Follow-Up Population|Overall Study||25
114693|NCT00066742|273118|P1|Eligible|Induction Chemoradiotherapy||69
114521|NCT00065507|272757|P2|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
114522|NCT00065507|272758|P1|Treated, Wk 48 (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
114523|NCT00065507|272757|P2|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|89
114524|NCT00065507|272758|P1|Treated (As-Treated Population)|Overall Study|2 subjects randomized to ADV were treated with ETV for the entire dosing period and included in ETV.|102
114525|NCT00065507|272757|P2|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|91
114526|NCT00065507|272758|P1|Treated (As-Randomized Population)|Overall Study|As-randomized population was used in efficacy analyses, unless otherwise noted.|100
114527|NCT00065507|272757|P2|STARTED|Overall Study|94 participants were randomized; 3 never treated.|91
114528|NCT00065507|272758|P1|STARTED|Overall Study|101 participants were randomized; 1 never treated.|100
114529|NCT00065611|272822|P2|NOT COMPLETED|Overall Study||1
114530|NCT00065611|272823|P1|NOT COMPLETED|Overall Study||0
114531|NCT00065611|272822|P2|COMPLETED|Overall Study||3
114532|NCT00065611|272823|P1|COMPLETED|Overall Study||4
114533|NCT00065611|272822|P2|STARTED|Overall Study||4
114534|NCT00065611|272823|P1|STARTED|Overall Study||4
114535|NCT00065806|272835|P2|NOT COMPLETED|Overall Study||19
114536|NCT00065806|272836|P1|NOT COMPLETED|Overall Study||20
114537|NCT00065806|272835|P2|COMPLETED|Overall Study||89
114538|NCT00065806|272836|P1|COMPLETED|Overall Study||93
114539|NCT00065806|272835|P2|STARTED|Overall Study||108
114540|NCT00065806|272836|P1|STARTED|Overall Study||113
114541|NCT00066066|272881|P6|NOT COMPLETED|Overall Study||5
114542|NCT00066066|272882|P5|NOT COMPLETED|Overall Study||3
114543|NCT00066066|272883|P4|NOT COMPLETED|Overall Study||4
114544|NCT00066066|272884|P3|NOT COMPLETED|Overall Study||7
114545|NCT00066066|272885|P2|NOT COMPLETED|Overall Study||4
114546|NCT00066066|272886|P1|NOT COMPLETED|Overall Study||6
114547|NCT00066066|272881|P6|COMPLETED|Overall Study|20 enrolled, 15 analyzed,9 subjects had complete data,6 subjects had data carried forward.|15
114548|NCT00066066|272882|P5|COMPLETED|Overall Study|27 enrolled, 24 analyzed,19 subjects had complete data,5 subjects had data carried forward.|24
114549|NCT00066066|272883|P4|COMPLETED|Overall Study|20 enrolled, 16 analyzed,11 subjects had complete data,5 subjects had data carried forward.|16
114550|NCT00066066|272884|P3|COMPLETED|Overall Study|30 enrolled, 23 analyzed,21 subjects had complete data,2 subjects had data carried forward.|23
114551|NCT00066066|272885|P2|COMPLETED|Overall Study|22 enrolled, 18 analyzed,11 subjects had complete data,7 subjects had data carried forward.|18
114552|NCT00066066|272886|P1|COMPLETED|Overall Study|27 enrolled, 21 analyzed,18 subjects had complete data,3 subjects had data carried forward.|21
114553|NCT00066066|272881|P6|12 Month|Overall Study||9
114554|NCT00066066|272882|P5|12 Month|Overall Study||19
114555|NCT00066066|272883|P4|12 Month|Overall Study||11
114556|NCT00066066|272884|P3|12 Month|Overall Study||21
114557|NCT00066066|272885|P2|12 Month|Overall Study||11
114558|NCT00066066|272886|P1|12 Month|Overall Study||18
114559|NCT00066066|272881|P6|6 Month|Overall Study||14
114560|NCT00066066|272882|P5|6 Month|Overall Study||21
114561|NCT00066066|272883|P4|6 Month|Overall Study||13
114562|NCT00066066|272884|P3|6 Month|Overall Study||23
114563|NCT00066066|272885|P2|6 Month|Overall Study||13
114564|NCT00066066|272886|P1|6 Month|Overall Study||19
114565|NCT00066066|272881|P6|3 Month|Overall Study||15
114566|NCT00066066|272882|P5|3 Month|Overall Study||22
114567|NCT00066066|272883|P4|3 Month|Overall Study||16
114568|NCT00066066|272884|P3|3 Month|Overall Study||23
114569|NCT00066066|272885|P2|3 Month|Overall Study||17
114570|NCT00066066|272886|P1|3 Month|Overall Study||21
114571|NCT00066066|272881|P6|Baseline|Overall Study||20
114572|NCT00066066|272882|P5|Baseline|Overall Study||27
114573|NCT00066066|272883|P4|Baseline|Overall Study||20
114574|NCT00066066|272884|P3|Baseline|Overall Study||30
114575|NCT00066066|272885|P2|Baseline|Overall Study||22
114576|NCT00066066|272886|P1|Baseline|Overall Study||27
114577|NCT00066066|272881|P6|STARTED|Overall Study||20
114578|NCT00066066|272882|P5|STARTED|Overall Study||27
114579|NCT00066066|272883|P4|STARTED|Overall Study||20
114580|NCT00066066|272884|P3|STARTED|Overall Study||30
114581|NCT00066066|272885|P2|STARTED|Overall Study||22
114582|NCT00066066|272886|P1|STARTED|Overall Study||27
114583|NCT00066170|272904|P4|NOT COMPLETED|Overall Study||9
114584|NCT00066170|272905|P3|NOT COMPLETED|Overall Study||4
114585|NCT00066170|272906|P2|NOT COMPLETED|Overall Study||10
114586|NCT00066170|272907|P1|NOT COMPLETED|Overall Study||7
114587|NCT00066170|272904|P4|COMPLETED|Overall Study||48
114588|NCT00066170|272905|P3|COMPLETED|Overall Study||59
114589|NCT00066170|272906|P2|COMPLETED|Overall Study||45
114590|NCT00066170|272907|P1|COMPLETED|Overall Study||49
114591|NCT00066170|272904|P4|Intent to Treat|Overall Study||54
114592|NCT00066170|272905|P3|Intent to Treat|Overall Study||63
114593|NCT00066170|272906|P2|Intent to Treat|Overall Study||50
114594|NCT00066170|272907|P1|Intent to Treat|Overall Study||55
114595|NCT00066170|272904|P4|STARTED|Overall Study||57
114596|NCT00066170|272905|P3|STARTED|Overall Study||63
114597|NCT00066170|272906|P2|STARTED|Overall Study||55
114598|NCT00066170|272907|P1|STARTED|Overall Study||56
114599|NCT00066222|272917|P1|NOT COMPLETED|Overall Study||1
114694|NCT00066742|273118|P1|STARTED|Induction Chemoradiotherapy||72
114600|NCT00066222|272917|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|71
114601|NCT00066222|272917|P1|STARTED|Overall Study||72
114602|NCT00066365|272923|P2|NOT COMPLETED|Overall Study||14
114603|NCT00066365|272924|P1|NOT COMPLETED|Overall Study||23
114604|NCT00066365|272923|P2|COMPLETED|Overall Study||4
114605|NCT00066365|272924|P1|COMPLETED|Overall Study||8
114606|NCT00066365|272923|P2|STARTED|Overall Study||18
114607|NCT00066365|272924|P1|STARTED|Overall Study||31
114608|NCT00059215|272956|P4|NOT COMPLETED|Overall Study||15
114609|NCT00059215|272957|P3|NOT COMPLETED|Overall Study||15
114610|NCT00059215|272958|P2|NOT COMPLETED|Overall Study||14
114611|NCT00059215|272959|P1|NOT COMPLETED|Overall Study||13
114612|NCT00059215|272956|P4|COMPLETED|Overall Study||239
114613|NCT00059215|272957|P3|COMPLETED|Overall Study||236
114614|NCT00059215|272958|P2|COMPLETED|Overall Study||186
114615|NCT00059215|272959|P1|COMPLETED|Overall Study|One subject discontinued before receiving treatment and is not included in the evaluable set.|187
114616|NCT00059215|272956|P4|STARTED|Overall Study||254
114617|NCT00059215|272957|P3|STARTED|Overall Study||251
114618|NCT00059215|272958|P2|STARTED|Overall Study||200
114619|NCT00059215|272959|P1|STARTED|Overall Study||200
114620|NCT00059332|272987|P2|NOT COMPLETED|Overall Study||2
114621|NCT00059332|272988|P1|NOT COMPLETED|Overall Study||3
114622|NCT00059332|272987|P2|COMPLETED|Overall Study||855
114623|NCT00059332|272988|P1|COMPLETED|Overall Study||840
114624|NCT00059332|272987|P2|STARTED|Overall Study||857
114625|NCT00059332|272988|P1|STARTED|Overall Study||843
114626|NCT00059475|273018|P8|NOT COMPLETED|Overall Study||0
114627|NCT00059475|273019|P7|NOT COMPLETED|Overall Study||0
114628|NCT00059475|273020|P6|NOT COMPLETED|Overall Study||0
114629|NCT00059475|273021|P5|NOT COMPLETED|Overall Study||0
114630|NCT00059475|273022|P4|NOT COMPLETED|Overall Study||0
114631|NCT00059475|273023|P3|NOT COMPLETED|Overall Study||0
114632|NCT00059475|273024|P2|NOT COMPLETED|Overall Study||0
114633|NCT00059475|273025|P1|NOT COMPLETED|Overall Study||0
114634|NCT00059475|273018|P8|COMPLETED|Overall Study||7
114635|NCT00059475|273019|P7|COMPLETED|Overall Study||34
114636|NCT00059475|273020|P6|COMPLETED|Overall Study||2
114637|NCT00059475|273021|P5|COMPLETED|Overall Study||33
114638|NCT00059475|273022|P4|COMPLETED|Overall Study||3
114639|NCT00059475|273023|P3|COMPLETED|Overall Study||24
114640|NCT00059475|273024|P2|COMPLETED|Overall Study||2
114641|NCT00059475|273025|P1|COMPLETED|Overall Study||33
114642|NCT00059475|273018|P8|STARTED|Overall Study||7
114643|NCT00059475|273019|P7|STARTED|Overall Study||34
114644|NCT00059475|273020|P6|STARTED|Overall Study||2
114645|NCT00059475|273021|P5|STARTED|Overall Study||33
114646|NCT00059475|273022|P4|STARTED|Overall Study||3
114647|NCT00059475|273023|P3|STARTED|Overall Study||24
114648|NCT00059475|273024|P2|STARTED|Overall Study||2
114649|NCT00059475|273025|P1|STARTED|Overall Study||33
114650|NCT00059787|273051|P1|NOT COMPLETED|Overall Study||20
114651|NCT00059787|273051|P1|COMPLETED|Overall Study||36
114652|NCT00059787|273051|P1|STARTED|Overall Study||56
114653|NCT00059839|273061|P2|NOT COMPLETED|Overall Study||17
114654|NCT00059839|273062|P1|NOT COMPLETED|Overall Study||12
114655|NCT00059839|273061|P2|COMPLETED|Overall Study||47
114656|NCT00059839|273062|P1|COMPLETED|Overall Study||53
114657|NCT00059839|273061|P2|STARTED|Overall Study||64
114658|NCT00059839|273062|P1|STARTED|Overall Study||65
114659|NCT00060008|273068|P1|NOT COMPLETED|Overall Study||0
114660|NCT00060008|273068|P1|COMPLETED|Overall Study||18
114661|NCT00060008|273068|P1|STARTED|Overall Study||18
114662|NCT00066469|273073|P1|NOT COMPLETED|Overall Study||16
114663|NCT00066469|273073|P1|COMPLETED|Overall Study||39
114664|NCT00066469|273073|P1|STARTED|Overall Study||55
114665|NCT00066573|273079|P2|NOT COMPLETED|Overall Study||28
114666|NCT00066573|273080|P1|NOT COMPLETED|Overall Study||28
114667|NCT00066573|273079|P2|COMPLETED|Overall Study||3759
114668|NCT00066573|273080|P1|COMPLETED|Overall Study||3761
114669|NCT00066573|273079|P2|STARTED|Overall Study||3787
114670|NCT00066573|273080|P1|STARTED|Overall Study||3789
114671|NCT00066690|273089|P3|NOT COMPLETED|Overall Study||564
114672|NCT00066690|273090|P2|NOT COMPLETED|Overall Study||522
114673|NCT00066690|273091|P1|NOT COMPLETED|Overall Study||598
114674|NCT00066690|273089|P3|COMPLETED|Overall Study||457
114675|NCT00066690|273090|P2|COMPLETED|Overall Study||502
114676|NCT00066690|273091|P1|COMPLETED|Overall Study||423
114677|NCT00066690|273089|P3|STARTED|Overall Study||1021
114678|NCT00066690|273090|P2|STARTED|Overall Study||1024
114679|NCT00066690|273091|P1|STARTED|Overall Study||1021
114680|NCT00066703|273107|P2|NOT COMPLETED|Overall Study||582
114681|NCT00066703|273108|P1|NOT COMPLETED|Overall Study||612
114682|NCT00066703|273107|P2|COMPLETED|Overall Study||756
114683|NCT00066703|273108|P1|COMPLETED|Overall Study||722
114684|NCT00066703|273107|P2|STARTED|Overall Study||1338
114685|NCT00066703|273108|P1|STARTED|Overall Study||1334
114686|NCT00066742|273118|P1|NOT COMPLETED|Consolidation Chemotherapy||3
114687|NCT00066742|273118|P1|COMPLETED|Consolidation Chemotherapy||39
114688|NCT00066742|273118|P1|Eligible|Consolidation Chemotherapy||40
114689|NCT00066742|273118|P1|STARTED|Consolidation Chemotherapy||42
114690|NCT00066742|273118|P1|NOT COMPLETED|Induction Chemoradiotherapy||29
114691|NCT00066742|273118|P1|COMPLETED|Induction Chemoradiotherapy||43
114692|NCT00066742|273118|P1|Began Protocol Treatment|Induction Chemoradiotherapy||68
114695|NCT00066781|273127|P2|NOT COMPLETED|Overall Study||0
114696|NCT00066781|273128|P1|NOT COMPLETED|Overall Study||0
114697|NCT00066781|273127|P2|COMPLETED|Overall Study||17
114698|NCT00066781|273128|P1|COMPLETED|Overall Study||14
114699|NCT00066781|273127|P2|STARTED|Overall Study||17
114700|NCT00066781|273128|P1|STARTED|Overall Study||14
114701|NCT00067470|273140|P2|NOT COMPLETED|Overall Study||1
114702|NCT00067470|273141|P1|NOT COMPLETED|Overall Study||0
114703|NCT00067470|273140|P2|COMPLETED|Overall Study||19
114704|NCT00067470|273141|P1|COMPLETED|Overall Study||19
114705|NCT00067470|273140|P2|STARTED|Overall Study||20
114706|NCT00067470|273141|P1|STARTED|Overall Study||19
114707|NCT00067808|273154|P3|NOT COMPLETED|Overall Study||0
114708|NCT00067808|273155|P2|NOT COMPLETED|Overall Study||0
114709|NCT00067808|273156|P1|NOT COMPLETED|Overall Study||0
114710|NCT00067808|273154|P3|COMPLETED|Overall Study||14
114711|NCT00067808|273155|P2|COMPLETED|Overall Study||93
114712|NCT00067808|273156|P1|COMPLETED|Overall Study||17
114713|NCT00067808|273154|P3|STARTED|Overall Study||14
114714|NCT00067808|273155|P2|STARTED|Overall Study||93
114715|NCT00067808|273156|P1|STARTED|Overall Study||17
114716|NCT00068107|273164|P1|NOT COMPLETED|Overall Study||9
114717|NCT00068107|273164|P1|COMPLETED|Overall Study||3
114718|NCT00068107|273164|P1|STARTED|Overall Study||12
114719|NCT00068237|273175|P1|NOT COMPLETED|Overall Study||5
114720|NCT00068237|273175|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
114721|NCT00068237|273175|P1|STARTED|Overall Study||49
114722|NCT00068341|273182|P3|NOT COMPLETED|Overall Study||0
114723|NCT00068341|273183|P2|NOT COMPLETED|Overall Study||0
114724|NCT00068341|273184|P1|NOT COMPLETED|Overall Study||0
114725|NCT00068341|273182|P3|COMPLETED|Overall Study||44
114726|NCT00068341|273183|P2|COMPLETED|Overall Study||15
114727|NCT00068341|273184|P1|COMPLETED|Overall Study||15
114728|NCT00068341|273182|P3|STARTED|Overall Study||44
114729|NCT00068341|273183|P2|STARTED|Overall Study||15
114730|NCT00068341|273184|P1|STARTED|Overall Study||15
114731|NCT00068380|273205|P1|NOT COMPLETED|Overall Study||5
114732|NCT00068380|273205|P1|COMPLETED|Overall Study||12
114733|NCT00068380|273205|P1|STARTED|Overall Study||17
114734|NCT00068393|273209|P1|NOT COMPLETED|Overall Study||10
114735|NCT00068393|273209|P1|COMPLETED|Overall Study||29
114736|NCT00068393|273209|P1|Eligible and Treated|Overall Study||38
114737|NCT00068393|273209|P1|STARTED|Overall Study||39
114738|NCT00068419|273215|P1|NOT COMPLETED|Overall Study||60
114739|NCT00068419|273215|P1|COMPLETED|Overall Study|Participant flow data reported here are for the period of protocol therapy.|10
114740|NCT00068419|273215|P1|STARTED|Overall Study||70
114741|NCT00068575|273219|P1|NOT COMPLETED|Overall Study||0
114742|NCT00068575|273219|P1|COMPLETED|Overall Study||28
114743|NCT00068575|273219|P1|STARTED|Overall Study||28
114744|NCT00068588|273226|P3|NOT COMPLETED|Overall Study||4
114745|NCT00068588|273227|P2|NOT COMPLETED|Overall Study||0
114746|NCT00068588|273228|P1|NOT COMPLETED|Overall Study||0
114747|NCT00068588|273226|P3|COMPLETED|Overall Study||17
114748|NCT00068588|273227|P2|COMPLETED|Overall Study||3
114749|NCT00068588|273228|P1|COMPLETED|Overall Study||0
114750|NCT00068588|273226|P3|STARTED|Overall Study||21
114751|NCT00068588|273227|P2|STARTED|Overall Study||3
114752|NCT00068588|273228|P1|STARTED|Overall Study||0
114753|NCT00068601|273240|P2|NOT COMPLETED|Overall Study||60
114754|NCT00068601|273241|P1|NOT COMPLETED|Overall Study||62
114755|NCT00068601|273240|P2|COMPLETED|Overall Study||66
114756|NCT00068601|273241|P1|COMPLETED|Overall Study||69
114757|NCT00068601|273240|P2|STARTED|Overall Study||126
114758|NCT00068601|273241|P1|STARTED|Overall Study||131
114759|NCT00068718|273251|P1|NOT COMPLETED|Overall Study||0
114760|NCT00068718|273251|P1|COMPLETED|Overall Study||35
114761|NCT00068718|273251|P1|STARTED|Overall Study||35
114762|NCT00068770|273263|P2|NOT COMPLETED|Overall Study||0
114763|NCT00068770|273264|P1|NOT COMPLETED|Overall Study||0
114764|NCT00068770|273263|P2|COMPLETED|Overall Study||22
114765|NCT00068770|273264|P1|COMPLETED|Overall Study||13
114766|NCT00068770|273263|P2|STARTED|Overall Study||22
114767|NCT00068770|273264|P1|STARTED|Overall Study||13
114768|NCT00068822|273274|P2|NOT COMPLETED|Optional Crossover Intervention||0
114769|NCT00068822|273275|P1|NOT COMPLETED|Optional Crossover Intervention||0
114770|NCT00068822|273274|P2|COMPLETED|Optional Crossover Intervention||29
114771|NCT00068822|273275|P1|COMPLETED|Optional Crossover Intervention||9
114772|NCT00068822|273274|P2|Crossover at Month 3|Optional Crossover Intervention||27
114773|NCT00068822|273275|P1|Crossover at Month 3|Optional Crossover Intervention||8
114774|NCT00068822|273274|P2|Crossover at Month 1|Optional Crossover Intervention||2
114775|NCT00068822|273275|P1|Crossover at Month 1|Optional Crossover Intervention||1
114776|NCT00068822|273274|P2|STARTED|Optional Crossover Intervention||29
114777|NCT00068822|273275|P1|STARTED|Optional Crossover Intervention||9
114778|NCT00068822|273274|P2|NOT COMPLETED|First Randomized Intervention||2
114779|NCT00068822|273275|P1|NOT COMPLETED|First Randomized Intervention||1
114780|NCT00068822|273274|P2|COMPLETED|First Randomized Intervention||61
114781|NCT00068822|273275|P1|COMPLETED|First Randomized Intervention||67
114782|NCT00068822|273274|P2|STARTED|First Randomized Intervention||63
114783|NCT00068822|273275|P1|STARTED|First Randomized Intervention||68
114784|NCT00069095|273291|P6|NOT COMPLETED|Follow-up Phase||101
114785|NCT00069095|273292|P5|NOT COMPLETED|Follow-up Phase||92
114786|NCT00069095|273293|P4|NOT COMPLETED|Follow-up Phase||112
114787|NCT00069095|273294|P3|NOT COMPLETED|Follow-up Phase||120
114788|NCT00069095|273295|P2|NOT COMPLETED|Follow-up Phase||206
114789|NCT00069095|273296|P1|NOT COMPLETED|Follow-up Phase||174
114790|NCT00069095|273291|P6|COMPLETED|Follow-up Phase||171
114791|NCT00069095|273292|P5|COMPLETED|Follow-up Phase||186
114792|NCT00069095|273293|P4|COMPLETED|Follow-up Phase||187
114793|NCT00069095|273294|P3|COMPLETED|Follow-up Phase||178
114794|NCT00069095|273295|P2|COMPLETED|Follow-up Phase||93
114795|NCT00069095|273296|P1|COMPLETED|Follow-up Phase||110
114796|NCT00069095|273291|P6|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|272
114797|NCT00069095|273292|P5|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|278
114798|NCT00069095|273293|P4|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
114799|NCT00069095|273294|P3|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|298
114800|NCT00069095|273295|P2|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|299
114801|NCT00069095|273296|P1|STARTED|Follow-up Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|284
114802|NCT00069095|273291|P6|NOT COMPLETED|Post-study Treatment Phase||29
114803|NCT00069095|273292|P5|NOT COMPLETED|Post-study Treatment Phase||36
114804|NCT00069095|273293|P4|NOT COMPLETED|Post-study Treatment Phase||17
114805|NCT00069095|273294|P3|NOT COMPLETED|Post-study Treatment Phase||21
114806|NCT00069095|273295|P2|NOT COMPLETED|Post-study Treatment Phase||13
114807|NCT00069095|273296|P1|NOT COMPLETED|Post-study Treatment Phase||8
114808|NCT00069095|273291|P6|COMPLETED|Post-study Treatment Phase||0
114809|NCT00069095|273292|P5|COMPLETED|Post-study Treatment Phase||0
114810|NCT00069095|273293|P4|COMPLETED|Post-study Treatment Phase||0
114811|NCT00069095|273294|P3|COMPLETED|Post-study Treatment Phase||0
114812|NCT00069095|273295|P2|COMPLETED|Post-study Treatment Phase||0
114813|NCT00069095|273296|P1|COMPLETED|Post-study Treatment Phase||0
114814|NCT00069095|273291|P6|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|29
114815|NCT00069095|273292|P5|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|36
114816|NCT00069095|273293|P4|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|17
114817|NCT00069095|273294|P3|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|21
114818|NCT00069095|273295|P2|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|13
114819|NCT00069095|273296|P1|STARTED|Post-study Treatment Phase|Participants could enter the follow-up phase even without entering the post-study treatment phase.|8
114820|NCT00069095|273291|P6|NOT COMPLETED|Primary Treatment Phase||301
114821|NCT00069095|273292|P5|NOT COMPLETED|Primary Treatment Phase||302
114822|NCT00069095|273293|P4|NOT COMPLETED|Primary Treatment Phase||320
114823|NCT00069095|273294|P3|NOT COMPLETED|Primary Treatment Phase||314
114824|NCT00069095|273295|P2|NOT COMPLETED|Primary Treatment Phase||302
114825|NCT00069095|273296|P1|NOT COMPLETED|Primary Treatment Phase||295
114826|NCT00069095|273291|P6|COMPLETED|Primary Treatment Phase||48
114827|NCT00069095|273292|P5|COMPLETED|Primary Treatment Phase||48
114828|NCT00069095|273293|P4|COMPLETED|Primary Treatment Phase||31
114829|NCT00069095|273294|P3|COMPLETED|Primary Treatment Phase||36
114830|NCT00069095|273295|P2|COMPLETED|Primary Treatment Phase||15
114831|NCT00069095|273296|P1|COMPLETED|Primary Treatment Phase||22
114832|NCT00069095|273291|P6|STARTED|Primary Treatment Phase||349
114833|NCT00069095|273292|P5|STARTED|Primary Treatment Phase||350
114834|NCT00069095|273293|P4|STARTED|Primary Treatment Phase||351
114835|NCT00069095|273294|P3|STARTED|Primary Treatment Phase||350
114836|NCT00069095|273295|P2|STARTED|Primary Treatment Phase||317
114837|NCT00069095|273296|P1|STARTED|Primary Treatment Phase||317
114838|NCT00069108|273350|P2|NOT COMPLETED|Overall Study||219
114839|NCT00069108|273351|P1|NOT COMPLETED|Overall Study||213
114840|NCT00069108|273350|P2|COMPLETED|Overall Study||95
114841|NCT00069108|273351|P1|COMPLETED|Overall Study||100
114842|NCT00069108|273350|P2|STARTED|Overall Study||314
114843|NCT00069108|273351|P1|STARTED|Overall Study||313
114844|NCT00069121|273379|P2|NOT COMPLETED|Overall Study||276
114845|NCT00069121|273380|P1|NOT COMPLETED|Overall Study||302
114846|NCT00069121|273379|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|668
114847|NCT00069121|273380|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|640
114848|NCT00069121|273379|P2|Received Treatment|Overall Study|Safety Population|938
114849|NCT00069121|273380|P1|Received Treatment|Overall Study|Safety Population|926
114850|NCT00069121|273379|P2|STARTED|Overall Study||944
114851|NCT00069121|273380|P1|STARTED|Overall Study||942
114852|NCT00069160|273402|P2|NOT COMPLETED|Overall Study||0
114853|NCT00069160|273403|P1|NOT COMPLETED|Overall Study||0
114854|NCT00069160|273402|P2|COMPLETED|Overall Study||25
114855|NCT00069160|273403|P1|COMPLETED|Overall Study||23
114856|NCT00069160|273402|P2|STARTED|Overall Study||25
114857|NCT00069160|273403|P1|STARTED|Overall Study||23
114858|NCT00069238|273416|P3|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||2
114859|NCT00069238|273417|P2|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
114860|NCT00069238|273418|P1|NOT COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
114861|NCT00069238|273416|P3|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||1
114862|NCT00069238|273417|P2|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
114863|NCT00069238|273418|P1|COMPLETED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
114864|NCT00069238|273416|P3|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||3
114865|NCT00069238|273417|P2|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
114866|NCT00069238|273418|P1|STARTED|Cohort 3 - Dose Level 3 (Weeks 1-18)||0
114867|NCT00069238|273416|P3|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
114868|NCT00069238|273417|P2|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||2
114869|NCT00069238|273418|P1|NOT COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
114870|NCT00069238|273416|P3|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
114871|NCT00069238|273417|P2|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||1
114872|NCT00069238|273418|P1|COMPLETED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
114873|NCT00069238|273416|P3|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
114874|NCT00069238|273417|P2|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||3
114875|NCT00069238|273418|P1|STARTED|Cohort 2 - Dose Level 2 (Weeks 1-18)||0
114876|NCT00069238|273416|P3|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
114877|NCT00069238|273417|P2|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
114878|NCT00069238|273418|P1|NOT COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||9
114879|NCT00069238|273416|P3|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
114880|NCT00069238|273417|P2|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
114881|NCT00069238|273418|P1|COMPLETED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||16
114882|NCT00069238|273416|P3|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
114883|NCT00069238|273417|P2|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||0
114884|NCT00069238|273418|P1|STARTED|Cohort 1 - Dose Level 1 (Weeks 1 - 18)||25
114885|NCT00069264|273423|P1|NOT COMPLETED|Overall Study||32
114886|NCT00069264|273423|P1|COMPLETED|Overall Study||0
114887|NCT00069264|273423|P1|STARTED|Overall Study||32
114888|NCT00069277|273427|P1|NOT COMPLETED|Overall Study||21
114889|NCT00069277|273427|P1|COMPLETED|Overall Study||0
114890|NCT00069277|273427|P1|STARTED|Overall Study||21
114891|NCT00069329|273431|P1|NOT COMPLETED|Overall Study||2
114892|NCT00069329|273431|P1|COMPLETED|Overall Study||41
114893|NCT00069329|273431|P1|STARTED|Overall Study||43
114894|NCT00069641|273458|P3|NOT COMPLETED|Overall Study||1
114895|NCT00069641|273459|P2|NOT COMPLETED|Overall Study||0
114896|NCT00069641|273460|P1|NOT COMPLETED|Overall Study||1
114897|NCT00069641|273458|P3|COMPLETED|Overall Study||31
114898|NCT00069641|273459|P2|COMPLETED|Overall Study||32
114899|NCT00069641|273460|P1|COMPLETED|Overall Study||31
114900|NCT00069641|273458|P3|STARTED|Overall Study||32
114901|NCT00069641|273459|P2|STARTED|Overall Study||32
114902|NCT00069641|273460|P1|STARTED|Overall Study||32
114903|NCT00069784|273487|P2|NOT COMPLETED|Overall Study||0
114904|NCT00069784|273488|P1|NOT COMPLETED|Overall Study||1212
114905|NCT00069784|273487|P2|COMPLETED|Overall Study|not applicable (no treatment)|6273
114906|NCT00069784|273488|P1|COMPLETED|Overall Study|completed study treatment|5052
114907|NCT00069784|273487|P2|Safety Population (Treated)|Overall Study|patients randomized to standard care arm|6273
114908|NCT00069784|273488|P1|Safety Population (Treated)|Overall Study|randomized patients who received at least one dose of insulin glargine|6231
114909|NCT00069784|273487|P2|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6273
114910|NCT00069784|273488|P1|STARTED|Overall Study|randomized participants = intent-to-treat (ITT) population|6264
114911|NCT00069823|273508|P2|NOT COMPLETED|Overall Study||3
114912|NCT00069823|273509|P1|NOT COMPLETED|Overall Study||6
114913|NCT00069823|273508|P2|COMPLETED|Overall Study||200
114914|NCT00069823|273509|P1|COMPLETED|Overall Study||193
114915|NCT00069823|273508|P2|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|203
114916|NCT00069823|273509|P1|STARTED|Overall Study|The design was for 200 participants per group, the study did not exactly meet the design.|199
114917|NCT00069953|273549|P1|NOT COMPLETED|Overall Study||2
114918|NCT00069953|273549|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study|41
114919|NCT00069953|273549|P1|STARTED|Overall Study||43
114920|NCT00070018|273553|P1|NOT COMPLETED|Overall Study||4
114921|NCT00070018|273553|P1|COMPLETED|Overall Study||42
114922|NCT00070018|273553|P1|Eligible and Began Protocol Therapy|Overall Study||46
114923|NCT00070018|273553|P1|Eligible|Overall Study||46
114924|NCT00070018|273553|P1|STARTED|Overall Study||46
114925|NCT00063362|273559|P2|NOT COMPLETED|Overall Study||4
114926|NCT00063362|273560|P1|NOT COMPLETED|Overall Study||4
114927|NCT00063362|273559|P2|COMPLETED|Overall Study||22
114928|NCT00063362|273560|P1|COMPLETED|Overall Study||19
114929|NCT00063362|273559|P2|STARTED|Overall Study||26
114930|NCT00063362|273560|P1|STARTED|Overall Study||23
114931|NCT00063570|273568|P2|NOT COMPLETED|Overall Study||0
114932|NCT00063570|273569|P1|NOT COMPLETED|Overall Study||0
114933|NCT00063570|273568|P2|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|21
114934|NCT00063570|273569|P1|COMPLETED|Overall Study|Completed for this study means patient received study drug and was eligible for efficacy analysis.|52
114935|NCT00063570|273568|P2|STARTED|Overall Study||21
114936|NCT00063570|273569|P1|STARTED|Overall Study||52
114937|NCT00063622|273586|P3|NOT COMPLETED|Overall Study||11
114938|NCT00063622|273587|P2|NOT COMPLETED|Overall Study||4
114939|NCT00063622|273588|P1|NOT COMPLETED|Overall Study||10
114940|NCT00063622|273586|P3|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|72
114941|NCT00063622|273587|P2|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|80
114942|NCT00063622|273588|P1|COMPLETED|Overall Study|All randomized patients were included in analysis of primary outcome|70
114943|NCT00063622|273586|P3|STARTED|Overall Study||83
114944|NCT00063622|273587|P2|STARTED|Overall Study||84
114945|NCT00063622|273588|P1|STARTED|Overall Study||80
114946|NCT00063635|273614|P3|NOT COMPLETED|Overall Study||9
114947|NCT00063635|273615|P2|NOT COMPLETED|Overall Study||8
114948|NCT00063635|273616|P1|NOT COMPLETED|Overall Study||6
114949|NCT00063635|273614|P3|COMPLETED|Overall Study||49
114950|NCT00063635|273615|P2|COMPLETED|Overall Study||50
114951|NCT00063635|273616|P1|COMPLETED|Overall Study||51
114952|NCT00063635|273614|P3|STARTED|Overall Study||58
114953|NCT00063635|273615|P2|STARTED|Overall Study||58
114954|NCT00063635|273616|P1|STARTED|Overall Study||57
114955|NCT00070109|273659|P5|NOT COMPLETED|Overall Study||8
114956|NCT00070109|273660|P4|NOT COMPLETED|Overall Study||20
114957|NCT00070109|273661|P3|NOT COMPLETED|Overall Study||8
114958|NCT00070109|273662|P2|NOT COMPLETED|Overall Study||6
114959|NCT00070109|273663|P1|NOT COMPLETED|Overall Study||8
114960|NCT00070109|273659|P5|COMPLETED|Overall Study||0
114961|NCT00070109|273660|P4|COMPLETED|Overall Study||0
114962|NCT00070109|273661|P3|COMPLETED|Overall Study||0
114963|NCT00070109|273662|P2|COMPLETED|Overall Study||0
114964|NCT00070109|273663|P1|COMPLETED|Overall Study||0
114965|NCT00070109|273659|P5|STARTED|Overall Study||8
114966|NCT00070109|273660|P4|STARTED|Overall Study||20
114967|NCT00070109|273661|P3|STARTED|Overall Study||8
114968|NCT00070109|273662|P2|STARTED|Overall Study||6
114969|NCT00070109|273663|P1|STARTED|Overall Study||8
114970|NCT00070135|273676|P1|NOT COMPLETED|Overall Study||0
114971|NCT00070135|273676|P1|COMPLETED|Overall Study||114
114972|NCT00070135|273676|P1|STARTED|Overall Study||114
114973|NCT00070291|273682|P1|NOT COMPLETED|Step 2||1
114974|NCT00070291|273682|P1|COMPLETED|Step 2||0
114975|NCT00070291|273682|P1|STARTED|Step 2|One patient completed step 1, but opted to get alternative therapy. One patient entered step 2.|1
114976|NCT00070291|273682|P1|NOT COMPLETED|Step 1||2
114977|NCT00070291|273682|P1|COMPLETED|Step 1||2
114978|NCT00070291|273682|P1|Treated|Step 1||3
114979|NCT00070291|273682|P1|STARTED|Step 1||4
114980|NCT00070499|273691|P4|NOT COMPLETED|Overall Study||110
114981|NCT00070499|273692|P3|NOT COMPLETED|Overall Study||120
114982|NCT00070499|273693|P2|NOT COMPLETED|Overall Study||26
114983|NCT00070499|273694|P1|NOT COMPLETED|Overall Study||38
114984|NCT00070499|273691|P4|COMPLETED|Overall Study||17
114985|NCT00070499|273692|P3|COMPLETED|Overall Study||6
114986|NCT00070499|273693|P2|COMPLETED|Overall Study||52
114987|NCT00070499|273694|P1|COMPLETED|Overall Study||37
114988|NCT00070499|273691|P4|Eligible and Treated|Overall Study||123
114989|NCT00070499|273692|P3|Eligible and Treated|Overall Study||123
114990|NCT00070499|273693|P2|Eligible and Treated|Overall Study||73
114991|NCT00070499|273694|P1|Eligible and Treated|Overall Study||72
114992|NCT00070499|273691|P4|Eligible|Overall Study||125
114993|NCT00070499|273692|P3|Eligible|Overall Study||123
114994|NCT00070499|273693|P2|Eligible|Overall Study||73
114995|NCT00070499|273694|P1|Eligible|Overall Study||73
114996|NCT00070499|273691|P4|STARTED|Overall Study||127
114997|NCT00070499|273692|P3|STARTED|Overall Study||126
114998|NCT00070499|273693|P2|STARTED|Overall Study||78
114999|NCT00070499|273694|P1|STARTED|Overall Study||75
115000|NCT00071487|273724|P4|NOT COMPLETED|24-Week Open-Label Extension Period||23
115001|NCT00071487|273725|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
115002|NCT00071487|273726|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
115003|NCT00071487|273727|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
115004|NCT00071487|273724|P4|COMPLETED|24-Week Open-Label Extension Period||279
115005|NCT00071487|273725|P3|COMPLETED|24-Week Open-Label Extension Period||23
115006|NCT00071487|273726|P2|COMPLETED|24-Week Open-Label Extension Period||19
115007|NCT00071487|273727|P1|COMPLETED|24-Week Open-Label Extension Period||0
115008|NCT00071487|273724|P4|STARTED|24-Week Open-Label Extension Period|Of 90: 85 continued with 10 mg/kg; 5 elected not to continue in the open-label extension period.|302
115009|NCT00071487|273725|P3|STARTED|24-Week Open-Label Extension Period|Of 94: 64 switched to 10 mg/kg; 6 elected not to continue in the open-label extension period.|24
115010|NCT00071487|273726|P2|STARTED|24-Week Open-Label Extension Period|Of 87: 65 switched to 10 mg/kg; 3 elected not to continue in the open-label extension period.|19
115011|NCT00071487|273727|P1|STARTED|24-Week Open-Label Extension Period|Of 93: 88 switched to 10 mg/kg; 5 elected not to continue in the open-label extension period.|0
115012|NCT00071487|273724|P4|NOT COMPLETED|52-Week Double-Blind Period||21
115013|NCT00071487|273725|P3|NOT COMPLETED|52-Week Double-Blind Period||17
115014|NCT00071487|273726|P2|NOT COMPLETED|52-Week Double-Blind Period||27
115015|NCT00071487|273727|P1|NOT COMPLETED|52-Week Double-Blind Period||20
115016|NCT00071487|273724|P4|COMPLETED|52-Week Double-Blind Period||90
115017|NCT00071487|273725|P3|COMPLETED|52-Week Double-Blind Period||94
115018|NCT00071487|273726|P2|COMPLETED|52-Week Double-Blind Period||87
115019|NCT00071487|273727|P1|COMPLETED|52-Week Double-Blind Period||93
115020|NCT00071487|273724|P4|STARTED|52-Week Double-Blind Period||111
115021|NCT00071487|273725|P3|STARTED|52-Week Double-Blind Period||111
115022|NCT00071487|273726|P2|STARTED|52-Week Double-Blind Period||114
115023|NCT00071487|273727|P1|STARTED|52-Week Double-Blind Period||113
115024|NCT00071513|273773|P2|NOT COMPLETED|Follow-up Assessment||6
115025|NCT00071513|273774|P1|NOT COMPLETED|Follow-up Assessment||6
115026|NCT00071513|273773|P2|COMPLETED|Follow-up Assessment||247
115027|NCT00071513|273774|P1|COMPLETED|Follow-up Assessment||233
115028|NCT00071513|273773|P2|STARTED|Follow-up Assessment||253
115029|NCT00071513|273774|P1|STARTED|Follow-up Assessment||239
115030|NCT00071513|273773|P2|NOT COMPLETED|Intervention Component||3
115031|NCT00071513|273774|P1|NOT COMPLETED|Intervention Component||2
115032|NCT00071513|273773|P2|COMPLETED|Intervention Component||253
115033|NCT00071513|273774|P1|COMPLETED|Intervention Component||239
115034|NCT00071513|273773|P2|STARTED|Intervention Component||256
115035|NCT00071513|273774|P1|STARTED|Intervention Component||241
115036|NCT00071721|273784|P2|NOT COMPLETED|Overall Study||91
115037|NCT00071721|273785|P1|NOT COMPLETED|Overall Study||72
115038|NCT00071721|273784|P2|COMPLETED|Overall Study||69
115039|NCT00071721|273785|P1|COMPLETED|Overall Study||81
115040|NCT00071721|273784|P2|STARTED|Overall Study||160
115041|NCT00071721|273785|P1|STARTED|Overall Study||153
115042|NCT00071760|273801|P1|NOT COMPLETED|Overall Study||54
115043|NCT00071760|273801|P1|COMPLETED|Overall Study||0
115044|NCT00071760|273801|P1|Ongoing|Overall Study||25
115045|NCT00071760|273801|P1|STARTED|Overall Study||54
115046|NCT00071799|273862|P2|NOT COMPLETED|Overall Study||98
115047|NCT00071799|273863|P1|NOT COMPLETED|Overall Study||70
115048|NCT00071799|273862|P2|COMPLETED|Overall Study|Includes patients who died or transformed to AML during treatment, or were still receiving drug.|81
115049|NCT00071799|273863|P1|COMPLETED|Overall Study|Includes those who died or transformed to AML, or receiving drug + eligible for extension period.|109
115050|NCT00071799|273862|P2|STARTED|Overall Study|Best supportive care: 105, Low-dose cytarabine: 49, Standard chemotherapy: 25 patients|179
115051|NCT00071799|273863|P1|STARTED|Overall Study||179
115052|NCT00071812|273907|P4|NOT COMPLETED|24-Week Open-Label Extension Period||40
115053|NCT00071812|273908|P3|NOT COMPLETED|24-Week Open-Label Extension Period||1
115054|NCT00071812|273909|P2|NOT COMPLETED|24-Week Open-Label Extension Period||0
115055|NCT00071812|273910|P1|NOT COMPLETED|24-Week Open-Label Extension Period||0
115056|NCT00071812|273907|P4|COMPLETED|24-Week Open-Label Extension Period||178
115057|NCT00071812|273908|P3|COMPLETED|24-Week Open-Label Extension Period||7
115058|NCT00071812|273909|P2|COMPLETED|24-Week Open-Label Extension Period||11
115059|NCT00071812|273910|P1|COMPLETED|24-Week Open-Label Extension Period||0
115060|NCT00071812|273907|P4|STARTED|24-Week Open-Label Extension Period|Of 60: 56 continued with 10 mg/kg; 4 elected not to continue in the open-label extension.|218
115061|NCT00071812|273908|P3|STARTED|24-Week Open-Label Extension Period|Of 63: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|8
115062|NCT00071812|273909|P2|STARTED|24-Week Open-Label Extension Period|Of 66: 53 switched to 10 mg/kg; 2 elected not continue in the open-label extension.|11
115063|NCT00071812|273910|P1|STARTED|24-Week Open-Label Extension Period|Of 59: 56 switched to 10 mg/kg; 3 elected not to continue in the open-label extension.|0
115064|NCT00071812|273907|P4|NOT COMPLETED|24-Week Double-Blind Period||11
115065|NCT00071812|273908|P3|NOT COMPLETED|24-Week Double-Blind Period||8
115066|NCT00071812|273909|P2|NOT COMPLETED|24-Week Double-Blind Period||6
115067|NCT00071812|273910|P1|NOT COMPLETED|24-Week Double-Blind Period||10
115068|NCT00071812|273907|P4|COMPLETED|24-Week Double-Blind Period||60
115069|NCT00071812|273908|P3|COMPLETED|24-Week Double-Blind Period||63
115070|NCT00071812|273909|P2|COMPLETED|24-Week Double-Blind Period||66
115071|NCT00071812|273910|P1|COMPLETED|24-Week Double-Blind Period||59
115072|NCT00071812|273907|P4|STARTED|24-Week Double-Blind Period||71
115073|NCT00071812|273908|P3|STARTED|24-Week Double-Blind Period||71
115074|NCT00071812|273909|P2|STARTED|24-Week Double-Blind Period||72
115075|NCT00071812|273910|P1|STARTED|24-Week Double-Blind Period||69
115076|NCT00071890|273952|P2|NOT COMPLETED|Overall Study||0
115077|NCT00071890|273953|P1|NOT COMPLETED|Overall Study||0
115078|NCT00071890|273952|P2|COMPLETED|Overall Study|"1 withdrawal
1 lost of follow-up
1 death 67 patients analysed"|67
115079|NCT00071890|273953|P1|COMPLETED|Overall Study|"1 withdrawal
1 death 81 patients analysed"|81
115080|NCT00071890|273952|P2|STARTED|Overall Study|1 patients stopped HAART at week 0|67
115081|NCT00071890|273953|P1|STARTED|Overall Study|3 patients did not received Interleukin-2|81
115082|NCT00071981|273967|P4|NOT COMPLETED|Overall Study||45
115083|NCT00071981|273968|P3|NOT COMPLETED|Overall Study||37
115084|NCT00071981|273969|P2|NOT COMPLETED|Overall Study||41
115085|NCT00071981|273970|P1|NOT COMPLETED|Overall Study||46
115086|NCT00071981|273967|P4|COMPLETED|Overall Study||3
115087|NCT00071981|273968|P3|COMPLETED|Overall Study||0
115088|NCT00071981|273969|P2|COMPLETED|Overall Study||2
115089|NCT00071981|273970|P1|COMPLETED|Overall Study||1
115090|NCT00071981|273967|P4|Have Helper T Cell Response Data|Overall Study||39
115091|NCT00071981|273968|P3|Have Helper T Cell Response Data|Overall Study||25
115092|NCT00071981|273969|P2|Have Helper T Cell Response Data|Overall Study||27
115093|NCT00071981|273970|P1|Have Helper T Cell Response Data|Overall Study||37
115094|NCT00071981|273967|P4|Have CTL Response Data|Overall Study||41
115095|NCT00071981|273968|P3|Have CTL Response Data|Overall Study||29
115096|NCT00071981|273969|P2|Have CTL Response Data|Overall Study||30
115097|NCT00071981|273970|P1|Have CTL Response Data|Overall Study||40
115098|NCT00071981|273967|P4|Eligible and Treated|Overall Study||42
115099|NCT00071981|273968|P3|Eligible and Treated|Overall Study||32
115100|NCT00071981|273969|P2|Eligible and Treated|Overall Study||33
115101|NCT00071981|273970|P1|Eligible and Treated|Overall Study||41
115102|NCT00071981|273967|P4|Treated|Overall Study||48
115103|NCT00071981|273968|P3|Treated|Overall Study||36
115104|NCT00071981|273969|P2|Treated|Overall Study||38
115105|NCT00071981|273970|P1|Treated|Overall Study||45
115106|NCT00071981|273967|P4|Eligible|Overall Study||42
115107|NCT00071981|273968|P3|Eligible|Overall Study||33
115108|NCT00071981|273969|P2|Eligible|Overall Study||36
115109|NCT00071981|273970|P1|Eligible|Overall Study||43
115110|NCT00071981|273967|P4|STARTED|Overall Study||48
115111|NCT00071981|273968|P3|STARTED|Overall Study||37
115112|NCT00071981|273969|P2|STARTED|Overall Study||43
115113|NCT00071981|273970|P1|STARTED|Overall Study||47
115114|NCT00072176|273998|P2|NOT COMPLETED|Overall Study||1
115115|NCT00072176|273999|P1|NOT COMPLETED|Overall Study||1
115116|NCT00072176|273998|P2|COMPLETED|Overall Study||27
115117|NCT00072176|273999|P1|COMPLETED|Overall Study||33
115118|NCT00072176|273998|P2|STARTED|Overall Study||28
115119|NCT00072176|273999|P1|STARTED|Overall Study||34
115120|NCT00072189|274007|P1|NOT COMPLETED|Overall Study||1
115121|NCT00072189|274007|P1|COMPLETED|Overall Study||16
115122|NCT00072189|274007|P1|STARTED|Overall Study||17
115123|NCT00072280|274015|P2|NOT COMPLETED|Follow-up||2
115124|NCT00072280|274016|P1|NOT COMPLETED|Follow-up||2
115125|NCT00072280|274015|P2|COMPLETED|Follow-up||0
115126|NCT00072280|274016|P1|COMPLETED|Follow-up||0
115127|NCT00072280|274015|P2|STARTED|Follow-up||2
115128|NCT00072280|274016|P1|STARTED|Follow-up||2
115129|NCT00072280|274015|P2|NOT COMPLETED|Treatment||2
115130|NCT00072280|274016|P1|NOT COMPLETED|Treatment||1
115131|NCT00072280|274015|P2|COMPLETED|Treatment||2
115132|NCT00072280|274016|P1|COMPLETED|Treatment||2
115133|NCT00072280|274015|P2|STARTED|Treatment||4
115134|NCT00072280|274016|P1|STARTED|Treatment||3
115135|NCT00072293|274023|P2|NOT COMPLETED|Overall Study||2
115136|NCT00072293|274024|P1|NOT COMPLETED|Overall Study||1
115137|NCT00072293|274023|P2|COMPLETED|Overall Study||467
115138|NCT00072293|274024|P1|COMPLETED|Overall Study||464
115139|NCT00072293|274023|P2|STARTED|Overall Study||469
115140|NCT00072293|274024|P1|STARTED|Overall Study||465
115141|NCT00072449|274034|P1|NOT COMPLETED|Overall Study||0
115142|NCT00072449|274034|P1|COMPLETED|Overall Study||12
115143|NCT00072449|274034|P1|STARTED|Overall Study||12
115144|NCT00072475|274041|P1|NOT COMPLETED|Overall Study||97
115145|NCT00072475|274041|P1|COMPLETED|Overall Study||45
115146|NCT00072475|274041|P1|STARTED|Overall Study||142
115147|NCT00072514|274049|P1|NOT COMPLETED|Overall Study||4
115148|NCT00072514|274049|P1|COMPLETED|Overall Study||51
115149|NCT00072514|274049|P1|STARTED|Overall Study||55
115150|NCT00072566|274056|P1|NOT COMPLETED|Overall Study||0
115151|NCT00072566|274056|P1|COMPLETED|Overall Study||70
115152|NCT00072566|274056|P1|STARTED|Overall Study||70
115153|NCT00072761|274064|P2|NOT COMPLETED|Overall Study||2
115154|NCT00072761|274065|P1|NOT COMPLETED|Overall Study||9
115155|NCT00072761|274064|P2|COMPLETED|Overall Study||95
115156|NCT00072761|274065|P1|COMPLETED|Overall Study||90
115157|NCT00072761|274064|P2|STARTED|Overall Study||97
115158|NCT00072761|274065|P1|STARTED|Overall Study||99
115159|NCT00073008|274073|P2|NOT COMPLETED|Overall Study||63
115160|NCT00073008|274074|P1|NOT COMPLETED|Overall Study||62
115161|NCT00073008|274073|P2|COMPLETED|Overall Study||3
115162|NCT00073008|274074|P1|COMPLETED|Overall Study||3
115163|NCT00073008|274073|P2|STARTED|Overall Study||66
115164|NCT00073008|274074|P1|STARTED|Overall Study||65
115165|NCT00073021|274106|P2|NOT COMPLETED|Overall Study||16
115166|NCT00073021|274107|P1|NOT COMPLETED|Overall Study||26
115167|NCT00073021|274106|P2|COMPLETED|Overall Study||113
115168|NCT00073021|274107|P1|COMPLETED|Overall Study||113
115169|NCT00073021|274106|P2|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|129
115170|NCT00073021|274107|P1|STARTED|Overall Study|Subjects with Moderate Disease [PGA = 2] at Baseline|139
115171|NCT00073073|274135|P1|NOT COMPLETED|Overall Study||4
115172|NCT00073073|274135|P1|COMPLETED|Overall Study||42
115173|NCT00073073|274135|P1|STARTED|Overall Study||46
115174|NCT00073307|274148|P3|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||156
115175|NCT00073307|274149|P2|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
115176|NCT00073307|274150|P1|NOT COMPLETED|Open Label-Sorafenib Only [30Jun2008]||134
115177|NCT00073307|274148|P3|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||143
115178|NCT00073307|274149|P2|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||0
115179|NCT00073307|274150|P1|COMPLETED|Open Label-Sorafenib Only [30Jun2008]||120
115180|NCT00073307|274148|P3|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||216
115181|NCT00073307|274149|P2|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||0
115182|NCT00073307|274150|P1|Entered OL With Sorafenib Only Phase|Open Label-Sorafenib Only [30Jun2008]||219
115183|NCT00073307|274148|P3|STARTED|Open Label-Sorafenib Only [30Jun2008]||299
115184|NCT00073307|274149|P2|STARTED|Open Label-Sorafenib Only [30Jun2008]|Placebo treatment ended ~ 31May2005. Those who continued, switched to receive Sorafenib.|0
115185|NCT00073307|274150|P1|STARTED|Open Label-Sorafenib Only [30Jun2008]||254
115186|NCT00073307|274148|P3|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||0
115187|NCT00073307|274149|P2|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||153
115188|NCT00073307|274150|P1|NOT COMPLETED|Double-Blind (DB, as of ~31May2005)||197
115189|NCT00073307|274148|P3|COMPLETED|Double-Blind (DB, as of ~31May2005)||0
115190|NCT00073307|274149|P2|COMPLETED|Double-Blind (DB, as of ~31May2005)||299
115191|NCT00073307|274150|P1|COMPLETED|Double-Blind (DB, as of ~31May2005)||254
115192|NCT00073307|274148|P3|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||0
115193|NCT00073307|274149|P2|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
115194|NCT00073307|274150|P1|Participants Received Treatment|Double-Blind (DB, as of ~31May2005)||451
115195|NCT00073307|274148|P3|STARTED|Double-Blind (DB, as of ~31May2005)||0
115196|NCT00073307|274149|P2|STARTED|Double-Blind (DB, as of ~31May2005)||452
115197|NCT00073307|274150|P1|STARTED|Double-Blind (DB, as of ~31May2005)||451
115198|NCT00073333|274171|P3|NOT COMPLETED|Overall Study||0
115199|NCT00073333|274172|P2|NOT COMPLETED|Overall Study||14
115200|NCT00073333|274173|P1|NOT COMPLETED|Overall Study||14
115201|NCT00073333|274171|P3|COMPLETED|Overall Study||19
115202|NCT00073333|274172|P2|COMPLETED|Overall Study||27
115203|NCT00073333|274173|P1|COMPLETED|Overall Study||32
115204|NCT00073333|274171|P3|STARTED|Overall Study||19
115205|NCT00073333|274172|P2|STARTED|Overall Study||41
115206|NCT00073333|274173|P1|STARTED|Overall Study||46
115207|NCT00073528|274183|P2|NOT COMPLETED|Overall Study||642
115208|NCT00073528|274184|P1|NOT COMPLETED|Overall Study||644
115209|NCT00073528|274183|P2|COMPLETED|Overall Study||0
115210|NCT00073528|274184|P1|COMPLETED|Overall Study||0
115211|NCT00073528|274183|P2|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|344
115212|NCT00073528|274184|P1|Ongoing|Overall Study|These participants are still on study and do not yet have end of study data available.|349
115213|NCT00073528|274183|P2|STARTED|Overall Study||642
115214|NCT00073528|274184|P1|STARTED|Overall Study||644
115215|NCT00073918|274258|P1|NOT COMPLETED|Overall Study||4
115216|NCT00073918|274258|P1|COMPLETED|Overall Study||107
115217|NCT00073918|274258|P1|STARTED|Overall Study||111
115218|NCT00073983|274265|P1|NOT COMPLETED|Overall Study||1
115219|NCT00073983|274265|P1|COMPLETED|Overall Study|One patient in the chondrosarcoma subtype was not evaluable.|53
115220|NCT00073983|274265|P1|STARTED|Overall Study||54
115221|NCT00074035|274280|P1|NOT COMPLETED|Overall Study||0
115222|NCT00074035|274280|P1|COMPLETED|Overall Study||38
115223|NCT00074035|274280|P1|STARTED|Overall Study||38
115224|NCT00066807|274289|P2|NOT COMPLETED|Overall Study||15
115225|NCT00066807|274290|P1|NOT COMPLETED|Overall Study||14
115226|NCT00066807|274289|P2|COMPLETED|Overall Study||0
115227|NCT00066807|274290|P1|COMPLETED|Overall Study||0
115228|NCT00066807|274289|P2|STARTED|Overall Study||15
115229|NCT00066807|274290|P1|STARTED|Overall Study||14
115230|NCT00066937|274306|P4|NOT COMPLETED|6 Month Follow-up||1
115231|NCT00066937|274307|P3|NOT COMPLETED|6 Month Follow-up||3
115232|NCT00066937|274308|P2|NOT COMPLETED|6 Month Follow-up||3
115233|NCT00066937|274309|P1|NOT COMPLETED|6 Month Follow-up||7
115234|NCT00066937|274306|P4|COMPLETED|6 Month Follow-up||14
115235|NCT00066937|274307|P3|COMPLETED|6 Month Follow-up||22
115236|NCT00066937|274308|P2|COMPLETED|6 Month Follow-up||29
115237|NCT00066937|274309|P1|COMPLETED|6 Month Follow-up||26
115238|NCT00066937|274306|P4|STARTED|6 Month Follow-up||15
115239|NCT00066937|274307|P3|STARTED|6 Month Follow-up||25
115240|NCT00066937|274308|P2|STARTED|6 Month Follow-up||32
115241|NCT00066937|274309|P1|STARTED|6 Month Follow-up||33
115242|NCT00066937|274306|P4|NOT COMPLETED|3 Month Follow-up||4
115243|NCT00066937|274307|P3|NOT COMPLETED|3 Month Follow-up||1
115244|NCT00066937|274308|P2|NOT COMPLETED|3 Month Follow-up||1
115245|NCT00066937|274309|P1|NOT COMPLETED|3 Month Follow-up||5
115246|NCT00066937|274306|P4|COMPLETED|3 Month Follow-up||15
115247|NCT00066937|274307|P3|COMPLETED|3 Month Follow-up||25
115248|NCT00066937|274308|P2|COMPLETED|3 Month Follow-up||32
115249|NCT00066937|274309|P1|COMPLETED|3 Month Follow-up||33
115250|NCT00066937|274306|P4|STARTED|3 Month Follow-up||19
115251|NCT00066937|274307|P3|STARTED|3 Month Follow-up||26
115252|NCT00066937|274308|P2|STARTED|3 Month Follow-up||33
115253|NCT00066937|274309|P1|STARTED|3 Month Follow-up||38
115254|NCT00066937|274306|P4|NOT COMPLETED|Treatment Phase||5
115255|NCT00066937|274307|P3|NOT COMPLETED|Treatment Phase||11
115256|NCT00066937|274308|P2|NOT COMPLETED|Treatment Phase||5
115257|NCT00066937|274309|P1|NOT COMPLETED|Treatment Phase||3
115258|NCT00066937|274306|P4|COMPLETED|Treatment Phase||19
115259|NCT00066937|274307|P3|COMPLETED|Treatment Phase||26
115260|NCT00066937|274308|P2|COMPLETED|Treatment Phase||33
115261|NCT00066937|274309|P1|COMPLETED|Treatment Phase||38
115262|NCT00066937|274306|P4|STARTED|Treatment Phase||24
115263|NCT00066937|274307|P3|STARTED|Treatment Phase||37
115264|NCT00066937|274308|P2|STARTED|Treatment Phase||38
115265|NCT00066937|274309|P1|STARTED|Treatment Phase||41
115266|NCT00066963|274334|P3|NOT COMPLETED|Overall Study||39
115267|NCT00066963|274335|P2|NOT COMPLETED|Overall Study||31
115268|NCT00066963|274336|P1|NOT COMPLETED|Overall Study||26
115269|NCT00066963|274334|P3|COMPLETED|Overall Study||87
115270|NCT00066963|274335|P2|COMPLETED|Overall Study||93
115271|NCT00066963|274336|P1|COMPLETED|Overall Study|any follow-up|100
115272|NCT00066963|274334|P3|STARTED|Overall Study||126
115273|NCT00066963|274335|P2|STARTED|Overall Study||124
115274|NCT00066963|274336|P1|STARTED|Overall Study||126
115275|NCT00067236|274346|P2|NOT COMPLETED|Overall Study||26
115276|NCT00067236|274347|P1|NOT COMPLETED|Overall Study||20
115277|NCT00067236|274346|P2|COMPLETED|Overall Study||99
115278|NCT00067236|274347|P1|COMPLETED|Overall Study||108
115279|NCT00067236|274346|P2|STARTED|Overall Study||125
115280|NCT00067236|274347|P1|STARTED|Overall Study||128
115281|NCT00074152|274355|P2|NOT COMPLETED|Overall Study||33
115282|NCT00074152|274356|P1|NOT COMPLETED|Overall Study||55
115283|NCT00074152|274355|P2|COMPLETED|Overall Study||52
115284|NCT00074152|274356|P1|COMPLETED|Overall Study||22
115285|NCT00074152|274355|P2|STARTED|Overall Study||85
115286|NCT00074152|274356|P1|STARTED|Overall Study||77
115287|NCT00074165|274366|P1|NOT COMPLETED|Overall Study||0
115288|NCT00074165|274366|P1|COMPLETED|Overall Study||17
115289|NCT00074165|274366|P1|STARTED|Overall Study||17
115290|NCT00074269|274371|P1|NOT COMPLETED|Overall Study||0
115291|NCT00074269|274371|P1|COMPLETED|Overall Study||5
115292|NCT00074269|274371|P1|STARTED|Overall Study||5
115293|NCT00074412|274377|P2|NOT COMPLETED|Overall Study||84
115294|NCT00074412|274378|P1|NOT COMPLETED|Overall Study||82
115295|NCT00074412|274377|P2|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|675
115296|NCT00074412|274378|P1|COMPLETED|Overall Study|Number of infants who completed final 18 month visit: out of 733 infants who were expected.|681
115297|NCT00074412|274377|P2|Month 12 Visit|Overall Study||735
115298|NCT00074412|274378|P1|Month 12 Visit|Overall Study||733
115299|NCT00074412|274377|P2|Month 9 Visit|Overall Study||741
115300|NCT00074412|274378|P1|Month 9 Visit|Overall Study||741
115301|NCT00074412|274377|P2|Month 6 Visit|Overall Study||748
115302|NCT00074412|274378|P1|Month 6 Visit|Overall Study||748
115303|NCT00074412|274377|P2|Month 5 Visit|Overall Study||750
115304|NCT00074412|274378|P1|Month 5 Visit|Overall Study||756
115305|NCT00074412|274377|P2|Month 4 Visit|Overall Study||752
115306|NCT00074412|274378|P1|Month 4 Visit|Overall Study||758
115307|NCT00074412|274377|P2|Month 3 Visit|Overall Study||755
115308|NCT00074412|274378|P1|Month 3 Visit|Overall Study||759
115309|NCT00074412|274377|P2|Week 8 Visit|Overall Study||759
115310|NCT00074412|274378|P1|Week 8 Visit|Overall Study||759
115311|NCT00074412|274377|P2|STARTED|Overall Study|Number of infants randomized at 6 weeks.|759
115312|NCT00074412|274378|P1|STARTED|Overall Study|Number of infants randomized at 6 weeks.|763
115313|NCT00074802|274394|P2|NOT COMPLETED|Overall Study||7
115314|NCT00074802|274395|P1|NOT COMPLETED|Overall Study||9
115315|NCT00074802|274394|P2|COMPLETED|Overall Study||25
115316|NCT00074802|274395|P1|COMPLETED|Overall Study||20
115317|NCT00074802|274394|P2|STARTED|Overall Study||32
115318|NCT00074802|274395|P1|STARTED|Overall Study||29
115319|NCT00074815|274416|P3|NOT COMPLETED|Overall Study||12
115320|NCT00074815|274417|P2|NOT COMPLETED|Overall Study||6
115321|NCT00074815|274418|P1|NOT COMPLETED|Overall Study||5
115322|NCT00074815|274416|P3|COMPLETED|Overall Study||30
115323|NCT00074815|274417|P2|COMPLETED|Overall Study||34
115324|NCT00074815|274418|P1|COMPLETED|Overall Study||37
115325|NCT00074815|274416|P3|STARTED|Overall Study||42
115326|NCT00074815|274417|P2|STARTED|Overall Study||40
115327|NCT00074815|274418|P1|STARTED|Overall Study||42
115328|NCT00074958|274426|P1|NOT COMPLETED|Overall Study||1
115329|NCT00074958|274426|P1|COMPLETED|Overall Study||15
115330|NCT00074958|274426|P1|STARTED|Overall Study||16
115331|NCT00074984|274433|P2|NOT COMPLETED|Overall Study||8
115332|NCT00074984|274434|P1|NOT COMPLETED|Overall Study||3
115333|NCT00074984|274433|P2|COMPLETED|Overall Study||43
115334|NCT00074984|274434|P1|COMPLETED|Overall Study||28
115335|NCT00074984|274433|P2|STARTED|Overall Study||51
115336|NCT00074984|274434|P1|STARTED|Overall Study||31
115337|NCT00075023|274451|P2|NOT COMPLETED|Part Two||0
115338|NCT00075023|274452|P1|NOT COMPLETED|Part Two||0
115339|NCT00075023|274451|P2|COMPLETED|Part Two||0
115340|NCT00075023|274452|P1|COMPLETED|Part Two||0
115341|NCT00075023|274451|P2|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
115342|NCT00075023|274452|P1|STARTED|Part Two|Study was terminated after the pilot study. No participants entered Part Two.|0
115343|NCT00075023|274451|P2|NOT COMPLETED|Pilot Study||2
115344|NCT00075023|274452|P1|NOT COMPLETED|Pilot Study||2
115345|NCT00075023|274451|P2|COMPLETED|Pilot Study||3
115346|NCT00075023|274452|P1|COMPLETED|Pilot Study||3
115347|NCT00075023|274451|P2|STARTED|Pilot Study||5
115348|NCT00075023|274452|P1|STARTED|Pilot Study||5
115349|NCT00075088|274461|P2|NOT COMPLETED|Overall Study||0
115350|NCT00075088|274462|P1|NOT COMPLETED|Overall Study||0
115351|NCT00075088|274461|P2|COMPLETED|Overall Study||391
115352|NCT00075088|274462|P1|COMPLETED|Overall Study||403
115353|NCT00075088|274461|P2|STARTED|Overall Study||391
115354|NCT00075088|274462|P1|STARTED|Overall Study||403
115355|NCT00075218|274475|P3|NOT COMPLETED|Open-Label Treatment||255
115356|NCT00075218|274476|P2|NOT COMPLETED|Open-Label Treatment||0
115357|NCT00075218|274477|P1|NOT COMPLETED|Open-Label Treatment||0
115358|NCT00075218|274475|P3|COMPLETED|Open-Label Treatment||0
115359|NCT00075218|274476|P2|COMPLETED|Open-Label Treatment||0
115360|NCT00075218|274477|P1|COMPLETED|Open-Label Treatment||0
115361|NCT00075218|274475|P3|STARTED|Open-Label Treatment||255
115362|NCT00075218|274476|P2|STARTED|Open-Label Treatment||0
115363|NCT00075218|274477|P1|STARTED|Open-Label Treatment||0
115364|NCT00075218|274475|P3|NOT COMPLETED|Double-Blind Treatment||0
115365|NCT00075218|274476|P2|NOT COMPLETED|Double-Blind Treatment||15
115366|NCT00075218|274477|P1|NOT COMPLETED|Double-Blind Treatment||91
115367|NCT00075218|274475|P3|COMPLETED|Double-Blind Treatment||0
115368|NCT00075218|274476|P2|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|103
115369|NCT00075218|274477|P1|COMPLETED|Double-Blind Treatment|Defined:subjects completed double-blind treatment phase and/or entered open-label treatment phase.|152
115370|NCT00075218|274475|P3|Crossed Over to Open-Label Treatment|Double-Blind Treatment||0
115371|NCT00075218|274476|P2|Crossed Over to Open-Label Treatment|Double-Blind Treatment||103
115372|NCT00075218|274477|P1|Crossed Over to Open-Label Treatment|Double-Blind Treatment||152
115373|NCT00075218|274475|P3|Received Double-Blind Treatment|Double-Blind Treatment||0
115374|NCT00075218|274476|P2|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|114
115375|NCT00075218|274477|P1|Received Double-Blind Treatment|Double-Blind Treatment|As Treated Population (AT)|228
115376|NCT00075218|274475|P3|STARTED|Double-Blind Treatment||0
115377|NCT00075218|274476|P2|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|118
115378|NCT00075218|274477|P1|STARTED|Double-Blind Treatment|Intent To Treat Population (ITT)|243
115379|NCT00075270|274512|P2|NOT COMPLETED|Overall Study||284
115380|NCT00075270|274513|P1|NOT COMPLETED|Overall Study||286
115381|NCT00075270|274512|P2|COMPLETED|Overall Study||4
115382|NCT00075270|274513|P1|COMPLETED|Overall Study||5
115383|NCT00075270|274512|P2|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|13
115384|NCT00075270|274513|P1|Missing|Overall Study|These participants have no completion status information recorded on the case report forms.|26
115385|NCT00075270|274512|P2|STARTED|Overall Study||288
115386|NCT00075270|274513|P1|STARTED|Overall Study||291
115387|NCT00075400|274557|P1|NOT COMPLETED|Overall Study||3
115388|NCT00075400|274557|P1|COMPLETED|Overall Study|Eligible and treated patients.|23
115389|NCT00075400|274557|P1|STARTED|Overall Study||26
115390|NCT00075478|274565|P2|NOT COMPLETED|Overall Study||1
115391|NCT00075478|274566|P1|NOT COMPLETED|Overall Study||1
115392|NCT00075478|274565|P2|COMPLETED|Overall Study||44
115393|NCT00075478|274566|P1|COMPLETED|Overall Study||41
115394|NCT00075478|274565|P2|STARTED|Overall Study||45
115395|NCT00075478|274566|P1|STARTED|Overall Study||42
115396|NCT00075504|274588|P2|NOT COMPLETED|Overall Study||7
115397|NCT00075504|274589|P1|NOT COMPLETED|Overall Study||9
115398|NCT00075504|274588|P2|COMPLETED|Overall Study||3
115399|NCT00075504|274589|P1|COMPLETED|Overall Study||14
115400|NCT00075504|274588|P2|STARTED|Overall Study||10
115401|NCT00075504|274589|P1|STARTED|Overall Study||23
115402|NCT00075582|274601|P2|NOT COMPLETED|Overall Study||35
115403|NCT00075582|274602|P1|NOT COMPLETED|Overall Study||50
115404|NCT00075582|274601|P2|COMPLETED|Overall Study||50
115405|NCT00075582|274602|P1|COMPLETED|Overall Study||255
115406|NCT00075582|274601|P2|STARTED|Overall Study||85
115407|NCT00075582|274602|P1|STARTED|Overall Study||305
115408|NCT00075608|274610|P1|NOT COMPLETED|Overall Study||0
115409|NCT00075608|274610|P1|COMPLETED|Overall Study||12
115410|NCT00075608|274610|P1|STARTED|Overall Study||12
115411|NCT00075725|274628|P12|NOT COMPLETED|Overall Study||18
115412|NCT00075725|274629|P11|NOT COMPLETED|Overall Study||9
115413|NCT00075725|274630|P10|NOT COMPLETED|Overall Study||18
115414|NCT00075725|274631|P9|NOT COMPLETED|Overall Study||117
115415|NCT00075725|274632|P8|NOT COMPLETED|Overall Study||295
115416|NCT00075725|274633|P7|NOT COMPLETED|Overall Study||75
115417|NCT00075725|274634|P6|NOT COMPLETED|Overall Study||313
115418|NCT00075725|274635|P5|NOT COMPLETED|Overall Study||66
115419|NCT00075725|274636|P4|NOT COMPLETED|Overall Study||78
115420|NCT00075725|274637|P3|NOT COMPLETED|Overall Study||121
115421|NCT00075725|274638|P2|NOT COMPLETED|Overall Study||49
115422|NCT00075725|274639|P1|NOT COMPLETED|Overall Study||74
115423|NCT00075725|274628|P12|COMPLETED|Overall Study||10
115424|NCT00075725|274629|P11|COMPLETED|Overall Study||3
115425|NCT00075725|274630|P10|COMPLETED|Overall Study||16
115426|NCT00075725|274631|P9|COMPLETED|Overall Study||185
115427|NCT00075725|274632|P8|COMPLETED|Overall Study||401
115428|NCT00075725|274633|P7|COMPLETED|Overall Study||171
115429|NCT00075725|274634|P6|COMPLETED|Overall Study||397
115430|NCT00075725|274635|P5|COMPLETED|Overall Study||166
115431|NCT00075725|274636|P4|COMPLETED|Overall Study||168
115432|NCT00075725|274637|P3|COMPLETED|Overall Study||175
115433|NCT00075725|274638|P2|COMPLETED|Overall Study||57
115434|NCT00075725|274639|P1|COMPLETED|Overall Study||172
115435|NCT00075725|274628|P12|STARTED|Overall Study||28
115436|NCT00075725|274629|P11|STARTED|Overall Study||12
115437|NCT00075725|274630|P10|STARTED|Overall Study||34
115438|NCT00075725|274631|P9|STARTED|Overall Study||302
115439|NCT00075725|274632|P8|STARTED|Overall Study||696
115440|NCT00075725|274633|P7|STARTED|Overall Study||246
115441|NCT00075725|274634|P6|STARTED|Overall Study||710
115442|NCT00075725|274635|P5|STARTED|Overall Study||232
115443|NCT00075725|274636|P4|STARTED|Overall Study||246
115444|NCT00075725|274637|P3|STARTED|Overall Study||296
115445|NCT00075725|274638|P2|STARTED|Overall Study||106
115446|NCT00075725|274639|P1|STARTED|Overall Study||246
115447|NCT00075764|274730|P2|NOT COMPLETED|Overall Study||349
115448|NCT00075764|274731|P1|NOT COMPLETED|Overall Study||345
115449|NCT00075764|274730|P2|COMPLETED|Overall Study||0
115450|NCT00075764|274731|P1|COMPLETED|Overall Study||0
115451|NCT00075764|274730|P2|STARTED|Overall Study||349
115452|NCT00075764|274731|P1|STARTED|Overall Study||345
115453|NCT00075803|274745|P2|NOT COMPLETED|Overall Study||0
115454|NCT00075803|274746|P1|NOT COMPLETED|Overall Study||0
115455|NCT00075803|274745|P2|COMPLETED|Overall Study||305
115456|NCT00075803|274746|P1|COMPLETED|Overall Study||295
115457|NCT00075803|274745|P2|STARTED|Overall Study||305
115458|NCT00075803|274746|P1|STARTED|Overall Study||295
115459|NCT00075816|274774|P2|NOT COMPLETED|Overall Study||11
115460|NCT00075816|274775|P1|NOT COMPLETED|Overall Study||14
115461|NCT00075816|274774|P2|COMPLETED|Overall Study||262
115462|NCT00075816|274775|P1|COMPLETED|Overall Study||264
115463|NCT00075816|274774|P2|STARTED|Overall Study||273
115464|NCT00075816|274775|P1|STARTED|Overall Study||278
115465|NCT00075829|274817|P4|NOT COMPLETED|Overall Study||24
115466|NCT00075829|274818|P3|NOT COMPLETED|Overall Study||34
115467|NCT00075829|274819|P2|NOT COMPLETED|Overall Study||118
115468|NCT00075829|274820|P1|NOT COMPLETED|Overall Study||258
115469|NCT00075829|274817|P4|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|13
115470|NCT00075829|274818|P3|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|14
115471|NCT00075829|274819|P2|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|71
115472|NCT00075829|274820|P1|COMPLETED|Overall Study|Participants that were alive and free of disease progression at the end of follow-up (3 years)|178
115473|NCT00075829|274817|P4|STARTED|Overall Study||37
115474|NCT00075829|274818|P3|STARTED|Overall Study||48
115475|NCT00075829|274819|P2|STARTED|Overall Study||189
115476|NCT00075829|274820|P1|STARTED|Overall Study||436
115477|NCT00075881|274848|P1|NOT COMPLETED|Overall Study||43
115478|NCT00075881|274848|P1|COMPLETED|Overall Study||1
115479|NCT00075881|274848|P1|Reinduction Treatment|Overall Study||7
115480|NCT00075881|274848|P1|Maintenance Treatment|Overall Study||15
115481|NCT00075881|274848|P1|Induction Treatment|Overall Study||42
115482|NCT00075881|274848|P1|Treated|Overall Study||42
115483|NCT00075881|274848|P1|Eligible|Overall Study||43
115484|NCT00075881|274848|P1|STARTED|Overall Study||44
115485|NCT00075946|274859|P5|NOT COMPLETED|Overall Study||188
115486|NCT00075946|274860|P4|NOT COMPLETED|Overall Study||30
115487|NCT00075946|274861|P3|NOT COMPLETED|Overall Study||28
115488|NCT00075946|274862|P2|NOT COMPLETED|Overall Study||151
115489|NCT00075946|274863|P1|NOT COMPLETED|Overall Study||148
115490|NCT00075946|274859|P5|COMPLETED|Overall Study||0
115491|NCT00075946|274860|P4|COMPLETED|Overall Study||0
115492|NCT00075946|274861|P3|COMPLETED|Overall Study||0
115493|NCT00075946|274862|P2|COMPLETED|Overall Study||0
115494|NCT00075946|274863|P1|COMPLETED|Overall Study||0
115495|NCT00075946|274859|P5|Included in Primary Analysis|Overall Study||0
115496|NCT00075946|274860|P4|Included in Primary Analysis|Overall Study||29
115497|NCT00075946|274861|P3|Included in Primary Analysis|Overall Study||23
115498|NCT00075946|274862|P2|Included in Primary Analysis|Overall Study||146
115499|NCT00075946|274863|P1|Included in Primary Analysis|Overall Study||143
115500|NCT00075946|274859|P5|Treated and With Toxicity Data Available|Overall Study||154
115501|NCT00075946|274860|P4|Treated and With Toxicity Data Available|Overall Study||29
115502|NCT00075946|274861|P3|Treated and With Toxicity Data Available|Overall Study||27
115503|NCT00075946|274862|P2|Treated and With Toxicity Data Available|Overall Study||148
115504|NCT00075946|274863|P1|Treated and With Toxicity Data Available|Overall Study||142
115505|NCT00075946|274859|P5|STARTED|Overall Study||188
115506|NCT00075946|274860|P4|STARTED|Overall Study||30
115507|NCT00075946|274861|P3|STARTED|Overall Study||28
115508|NCT00075946|274862|P2|STARTED|Overall Study||151
115509|NCT00075946|274863|P1|STARTED|Overall Study||148
115510|NCT00076011|274878|P1|NOT COMPLETED|Overall Study||52
115511|NCT00076011|274878|P1|COMPLETED|Overall Study||0
115512|NCT00076011|274878|P1|STARTED|Overall Study||52
115513|NCT00076024|274889|P4|NOT COMPLETED|Phase 2, Open-label||16
115514|NCT00076024|274890|P3|NOT COMPLETED|Phase 2, Open-label||0
115515|NCT00076024|274891|P2|NOT COMPLETED|Phase 2, Open-label||0
115516|NCT00076024|274892|P1|NOT COMPLETED|Phase 2, Open-label||0
115517|NCT00076024|274889|P4|COMPLETED|Phase 2, Open-label||0
115518|NCT00076024|274890|P3|COMPLETED|Phase 2, Open-label||0
115519|NCT00076024|274891|P2|COMPLETED|Phase 2, Open-label||0
115520|NCT00076024|274892|P1|COMPLETED|Phase 2, Open-label||0
115521|NCT00076024|274889|P4|STARTED|Phase 2, Open-label||16
115522|NCT00076024|274890|P3|STARTED|Phase 2, Open-label||0
115523|NCT00076024|274891|P2|STARTED|Phase 2, Open-label||0
115524|NCT00076024|274892|P1|STARTED|Phase 2, Open-label||0
115525|NCT00076024|274889|P4|NOT COMPLETED|Phase 2, Double-blind||0
115526|NCT00076024|274890|P3|NOT COMPLETED|Phase 2, Double-blind||56
115527|NCT00076024|274891|P2|NOT COMPLETED|Phase 2, Double-blind||112
115528|NCT00076024|274892|P1|NOT COMPLETED|Phase 2, Double-blind||0
115529|NCT00076024|274889|P4|COMPLETED|Phase 2, Double-blind||0
115530|NCT00076024|274890|P3|COMPLETED|Phase 2, Double-blind||0
115531|NCT00076024|274891|P2|COMPLETED|Phase 2, Double-blind||0
115532|NCT00076024|274892|P1|COMPLETED|Phase 2, Double-blind||0
115533|NCT00076024|274889|P4|Treated|Phase 2, Double-blind||0
115534|NCT00076024|274890|P3|Treated|Phase 2, Double-blind||56
115535|NCT00076024|274891|P2|Treated|Phase 2, Double-blind||111
115536|NCT00076024|274892|P1|Treated|Phase 2, Double-blind||0
115537|NCT00076024|274889|P4|STARTED|Phase 2, Double-blind||0
115538|NCT00076024|274890|P3|STARTED|Phase 2, Double-blind||56
115539|NCT00076024|274891|P2|STARTED|Phase 2, Double-blind||112
115540|NCT00076024|274892|P1|STARTED|Phase 2, Double-blind||0
115541|NCT00076024|274889|P4|NOT COMPLETED|Phase 1, Lead-in||0
115542|NCT00076024|274890|P3|NOT COMPLETED|Phase 1, Lead-in||0
115543|NCT00076024|274891|P2|NOT COMPLETED|Phase 1, Lead-in||0
115544|NCT00076024|274892|P1|NOT COMPLETED|Phase 1, Lead-in||6
115545|NCT00076024|274889|P4|COMPLETED|Phase 1, Lead-in||0
115546|NCT00076024|274890|P3|COMPLETED|Phase 1, Lead-in||0
115547|NCT00076024|274891|P2|COMPLETED|Phase 1, Lead-in||0
115548|NCT00076024|274892|P1|COMPLETED|Phase 1, Lead-in||0
115549|NCT00076024|274889|P4|STARTED|Phase 1, Lead-in||0
115550|NCT00076024|274890|P3|STARTED|Phase 1, Lead-in||0
115551|NCT00076024|274891|P2|STARTED|Phase 1, Lead-in||0
115552|NCT00076024|274892|P1|STARTED|Phase 1, Lead-in||6
115553|NCT00076050|274908|P2|NOT COMPLETED|Overall Study||43
115554|NCT00076050|274909|P1|NOT COMPLETED|Overall Study||23
115555|NCT00076050|274908|P2|COMPLETED|Overall Study||83
115556|NCT00076050|274909|P1|COMPLETED|Overall Study||99
115557|NCT00076050|274908|P2|STARTED|Overall Study||126
115558|NCT00076050|274909|P1|STARTED|Overall Study||122
115559|NCT00076102|274919|P1|NOT COMPLETED|Overall Study||0
115560|NCT00076102|274919|P1|COMPLETED|Overall Study||36
115561|NCT00076102|274919|P1|STARTED|Overall Study||36
115562|NCT00076219|274926|P2|NOT COMPLETED|Overall Study||11
115563|NCT00076219|274927|P1|NOT COMPLETED|Overall Study||18
115564|NCT00076219|274926|P2|COMPLETED|Overall Study||550
115565|NCT00076219|274927|P1|COMPLETED|Overall Study||545
115566|NCT00076219|274926|P2|STARTED|Overall Study||561
115567|NCT00076219|274927|P1|STARTED|Overall Study||563
115568|NCT00076245|274937|P4|NOT COMPLETED|Overall Study||1
115569|NCT00076245|274938|P3|NOT COMPLETED|Overall Study||0
115570|NCT00076245|274939|P2|NOT COMPLETED|Overall Study||0
115571|NCT00076245|274940|P1|NOT COMPLETED|Overall Study||0
115572|NCT00076245|274937|P4|COMPLETED|Overall Study||14
115573|NCT00076245|274938|P3|COMPLETED|Overall Study||15
115574|NCT00076245|274939|P2|COMPLETED|Overall Study||15
115575|NCT00076245|274940|P1|COMPLETED|Overall Study||16
115576|NCT00076245|274937|P4|STARTED|Overall Study||15
115577|NCT00076245|274938|P3|STARTED|Overall Study||15
115578|NCT00076245|274939|P2|STARTED|Overall Study||15
115579|NCT00076245|274940|P1|STARTED|Overall Study||16
115580|NCT00076258|274956|P2|NOT COMPLETED|Overall Study||3
115581|NCT00076258|274957|P1|NOT COMPLETED|Overall Study||1
115582|NCT00076258|274956|P2|COMPLETED|Overall Study||61
115583|NCT00076258|274957|P1|COMPLETED|Overall Study||61
115584|NCT00076258|274956|P2|STARTED|Overall Study||64
115585|NCT00076258|274957|P1|STARTED|Overall Study||62
115586|NCT00076336|274965|P2|NOT COMPLETED|Overall Study||56
115587|NCT00076336|274966|P1|NOT COMPLETED|Overall Study||52
115588|NCT00076336|274965|P2|COMPLETED|Overall Study||60
115589|NCT00076336|274966|P1|COMPLETED|Overall Study||64
115590|NCT00076336|274965|P2|Completed Week 104|Overall Study||62
115591|NCT00076336|274966|P1|Completed Week 104|Overall Study||70
115592|NCT00076336|274965|P2|Completed Week 52|Overall Study||94
115593|NCT00076336|274966|P1|Completed Week 52|Overall Study||97
115594|NCT00076336|274965|P2|Intent to Treat (ITT) Population|Overall Study|2 patients had no HBV DNA assessments after baseline and were excluded from ITT population.|114
115595|NCT00076336|274966|P1|Intent to Treat (ITT) Population|Overall Study|1 patient had no HBV DNA assessments after baseline and was excluded from ITT population.|114
115596|NCT00076336|274965|P2|Safety Population|Overall Study||116
115597|NCT00076336|274966|P1|Safety Population|Overall Study|1 patient was randomized but never received study drug and not included in safety population.|115
115598|NCT00076336|274965|P2|STARTED|Overall Study||116
115599|NCT00076336|274966|P1|STARTED|Overall Study||116
115600|NCT00076570|274982|P2|NOT COMPLETED|Overall Study||8
115601|NCT00076570|274983|P1|NOT COMPLETED|Overall Study||8
115602|NCT00076570|274982|P2|COMPLETED|Overall Study||8
115603|NCT00076570|274983|P1|COMPLETED|Overall Study||7
115604|NCT00076570|274982|P2|STARTED|Overall Study||16
115605|NCT00076570|274983|P1|STARTED|Overall Study||15
115606|NCT00076687|274994|P3|NOT COMPLETED|Overall Study||4
115607|NCT00076687|274995|P2|NOT COMPLETED|Overall Study||5
115608|NCT00076687|274996|P1|NOT COMPLETED|Overall Study||6
115609|NCT00076687|274994|P3|COMPLETED|Overall Study||51
115610|NCT00076687|274995|P2|COMPLETED|Overall Study||47
115611|NCT00076687|274996|P1|COMPLETED|Overall Study||42
115612|NCT00076687|274994|P3|STARTED|Overall Study||55
115613|NCT00076687|274995|P2|STARTED|Overall Study||52
115614|NCT00076687|274996|P1|STARTED|Overall Study||48
115615|NCT00076752|275013|P1|NOT COMPLETED|Overall Study||3
115616|NCT00076752|275013|P1|COMPLETED|Overall Study||6
115617|NCT00076752|275013|P1|STARTED|Overall Study||9
115618|NCT00076804|275034|P2|NOT COMPLETED|Overall Study||69
115619|NCT00076804|275035|P1|NOT COMPLETED|Overall Study||60
115620|NCT00076804|275034|P2|COMPLETED|Overall Study|102 completed week 48, 68 completed week 96|68
115621|NCT00076804|275035|P1|COMPLETED|Overall Study|111 completed week 48, 77 completed week 96.|77
115622|NCT00076804|275034|P2|STARTED|Overall Study||137
115623|NCT00076804|275035|P1|STARTED|Overall Study||137
115624|NCT00076999|275051|P5|NOT COMPLETED|Overall Study||25
115625|NCT00076999|275052|P4|NOT COMPLETED|Overall Study||1
115626|NCT00076999|275053|P3|NOT COMPLETED|Overall Study||17
115627|NCT00076999|275054|P2|NOT COMPLETED|Overall Study||24
115628|NCT00076999|275055|P1|NOT COMPLETED|Overall Study||12
115629|NCT00076999|275051|P5|COMPLETED|Overall Study||9
115630|NCT00076999|275052|P4|COMPLETED|Overall Study||5
115631|NCT00076999|275053|P3|COMPLETED|Overall Study||2
115632|NCT00076999|275054|P2|COMPLETED|Overall Study||7
115633|NCT00076999|275055|P1|COMPLETED|Overall Study||13
115634|NCT00076999|275051|P5|STARTED|Overall Study||34
115635|NCT00076999|275052|P4|STARTED|Overall Study||6
115636|NCT00076999|275053|P3|STARTED|Overall Study||19
115637|NCT00076999|275054|P2|STARTED|Overall Study||31
115638|NCT00076999|275055|P1|STARTED|Overall Study||25
115639|NCT00077207|275172|P1|NOT COMPLETED|Overall Study||30
115640|NCT00077207|275172|P1|COMPLETED|Overall Study||36
115641|NCT00077207|275172|P1|STARTED|Overall Study||66
115642|NCT00077376|275177|P1|NOT COMPLETED|Overall Study||22
115643|NCT00077376|275177|P1|COMPLETED|Overall Study||39
115644|NCT00077376|275177|P1|HER2+ in Central Testing|Overall Study||39
115645|NCT00077376|275177|P1|Treated|Overall Study||59
115646|NCT00077376|275177|P1|STARTED|Overall Study||61
115647|NCT00070564|275192|P6|NOT COMPLETED|Overall Study||52
115648|NCT00070564|275193|P5|NOT COMPLETED|Overall Study||79
115649|NCT00070564|275194|P4|NOT COMPLETED|Overall Study||167
115650|NCT00070564|275195|P3|NOT COMPLETED|Overall Study||171
115651|NCT00070564|275196|P2|NOT COMPLETED|Overall Study||203
115652|NCT00070564|275197|P1|NOT COMPLETED|Overall Study||200
115653|NCT00070564|275192|P6|COMPLETED|Overall Study||244
115654|NCT00070564|275193|P5|COMPLETED|Overall Study||203
115655|NCT00070564|275194|P4|COMPLETED|Overall Study||481
115656|NCT00070564|275195|P3|COMPLETED|Overall Study||526
115657|NCT00070564|275196|P2|COMPLETED|Overall Study||490
115658|NCT00070564|275197|P1|COMPLETED|Overall Study||478
115659|NCT00070564|275192|P6|STARTED|Overall Study||296
115660|NCT00070564|275193|P5|STARTED|Overall Study||282
115661|NCT00070564|275194|P4|STARTED|Overall Study||648
115662|NCT00070564|275195|P3|STARTED|Overall Study||697
115663|NCT00070564|275196|P2|STARTED|Overall Study||693
115664|NCT00070564|275197|P1|STARTED|Overall Study||678
115665|NCT00070941|275242|P3|NOT COMPLETED|Overall Study||4
115666|NCT00070941|275243|P2|NOT COMPLETED|Overall Study||8
115667|NCT00070941|275244|P1|NOT COMPLETED|Overall Study||10
115668|NCT00070941|275242|P3|COMPLETED|Overall Study||2
115669|NCT00070941|275243|P2|COMPLETED|Overall Study||3
115670|NCT00070941|275244|P1|COMPLETED|Overall Study||2
115671|NCT00070941|275242|P3|STARTED|Overall Study||6
115672|NCT00070941|275243|P2|STARTED|Overall Study||11
115673|NCT00070941|275244|P1|STARTED|Overall Study||12
115674|NCT00071006|275252|P1|NOT COMPLETED|Overall Study||12
115675|NCT00071006|275252|P1|COMPLETED|Overall Study||0
115676|NCT00071006|275252|P1|STARTED|Overall Study||12
115677|NCT00071032|275264|P2|NOT COMPLETED|Overall Study||8
115678|NCT00071032|275265|P1|NOT COMPLETED|Overall Study||9
115679|NCT00071032|275264|P2|COMPLETED|Overall Study||1001
115680|NCT00071032|275265|P1|COMPLETED|Overall Study||998
115681|NCT00071032|275264|P2|STARTED|Overall Study||1009
115682|NCT00071032|275265|P1|STARTED|Overall Study||1007
115683|NCT00071058|275273|P1|NOT COMPLETED|Overall Study||1
115684|NCT00071058|275273|P1|COMPLETED|Overall Study||49
115685|NCT00071058|275273|P1|STARTED|Overall Study||50
115686|NCT00071110|275280|P2|NOT COMPLETED|Overall Study||4
115687|NCT00071110|275281|P1|NOT COMPLETED|Overall Study||0
115688|NCT00071110|275280|P2|COMPLETED|Overall Study||25
115689|NCT00071110|275281|P1|COMPLETED|Overall Study||28
115690|NCT00071110|275280|P2|STARTED|Overall Study||29
115691|NCT00071110|275281|P1|STARTED|Overall Study||28
115692|NCT00071396|275293|P1|NOT COMPLETED|Overall Study||3
115693|NCT00071396|275293|P1|COMPLETED|Overall Study|Evaluable for response.|41
115694|NCT00071396|275293|P1|STARTED|Overall Study||44
115695|NCT00077610|275300|P3|NOT COMPLETED|Overall Study||46
115696|NCT00077610|275301|P2|NOT COMPLETED|Overall Study||56
115697|NCT00077610|275302|P1|NOT COMPLETED|Overall Study||54
115698|NCT00077610|275300|P3|COMPLETED|Overall Study||180
115699|NCT00077610|275301|P2|COMPLETED|Overall Study||168
115700|NCT00077610|275302|P1|COMPLETED|Overall Study||169
115701|NCT00077610|275300|P3|Started Treatment|Overall Study||225
115702|NCT00077610|275301|P2|Started Treatment|Overall Study||220
115703|NCT00077610|275302|P1|Started Treatment|Overall Study||221
115704|NCT00077610|275300|P3|STARTED|Overall Study||226
115705|NCT00077610|275301|P2|STARTED|Overall Study||224
115706|NCT00077610|275302|P1|STARTED|Overall Study||223
115707|NCT00077623|275334|P3|NOT COMPLETED|Overall Study||32
115708|NCT00077623|275335|P2|NOT COMPLETED|Overall Study||43
115709|NCT00077623|275336|P1|NOT COMPLETED|Overall Study||36
115710|NCT00077623|275334|P3|COMPLETED|Overall Study||159
115711|NCT00077623|275335|P2|COMPLETED|Overall Study||148
115712|NCT00077623|275336|P1|COMPLETED|Overall Study||154
115713|NCT00077623|275334|P3|STARTED|Overall Study||191
115714|NCT00077623|275335|P2|STARTED|Overall Study||191
115715|NCT00077623|275336|P1|STARTED|Overall Study||190
115716|NCT00077636|275370|P2|NOT COMPLETED|Overall Study||92
115717|NCT00077636|275371|P1|NOT COMPLETED|Overall Study||44
115718|NCT00077636|275370|P2|COMPLETED|Overall Study||641
115719|NCT00077636|275371|P1|COMPLETED|Overall Study||692
115720|NCT00077636|275370|P2|STARTED|Overall Study||733
115721|NCT00077636|275371|P1|STARTED|Overall Study||736
115722|NCT00077649|275393|P4|NOT COMPLETED|Overall Study||17
115723|NCT00077649|275394|P3|NOT COMPLETED|Overall Study||15
115724|NCT00077649|275395|P2|NOT COMPLETED|Overall Study||9
115725|NCT00077649|275396|P1|NOT COMPLETED|Overall Study||14
115726|NCT00077649|275393|P4|COMPLETED|Overall Study||30
115727|NCT00077649|275394|P3|COMPLETED|Overall Study||32
115728|NCT00077649|275395|P2|COMPLETED|Overall Study||38
115729|NCT00077649|275396|P1|COMPLETED|Overall Study||33
115730|NCT00077649|275393|P4|Completed 24 Weeks of Follow-up|Overall Study||31
115731|NCT00077649|275394|P3|Completed 24 Weeks of Follow-up|Overall Study||36
115732|NCT00077649|275395|P2|Completed 24 Weeks of Follow-up|Overall Study||40
115733|NCT00077649|275396|P1|Completed 24 Weeks of Follow-up|Overall Study||36
115734|NCT00077649|275393|P4|STARTED|Overall Study||47
115735|NCT00077649|275394|P3|STARTED|Overall Study||47
115736|NCT00077649|275395|P2|STARTED|Overall Study||47
115737|NCT00077649|275396|P1|STARTED|Overall Study||47
115738|NCT00077675|275444|P2|NOT COMPLETED|Overall Study||9
115739|NCT00077675|275445|P1|NOT COMPLETED|Overall Study||11
115740|NCT00077675|275444|P2|COMPLETED|Overall Study||89
115741|NCT00077675|275445|P1|COMPLETED|Overall Study||92
115742|NCT00077675|275444|P2|STARTED|Overall Study||98
115743|NCT00077675|275445|P1|STARTED|Overall Study||103
115744|NCT00077766|275453|P2|NOT COMPLETED|Overall Study||25
115745|NCT00077766|275454|P1|NOT COMPLETED|Overall Study||39
115746|NCT00077766|275453|P2|COMPLETED|Overall Study||131
115747|NCT00077766|275454|P1|COMPLETED|Overall Study||118
115748|NCT00077766|275453|P2|STARTED|Overall Study||156
115749|NCT00077766|275454|P1|STARTED|Overall Study||157
115750|NCT00078286|275474|P2|NOT COMPLETED|Overall Study||83
115751|NCT00078286|275475|P1|NOT COMPLETED|Overall Study||96
115752|NCT00078286|275474|P2|COMPLETED|Overall Study||152
115753|NCT00078286|275475|P1|COMPLETED|Overall Study||138
115754|NCT00078286|275474|P2|STARTED|Overall Study||235
115755|NCT00078286|275475|P1|STARTED|Overall Study||234
115756|NCT00078312|275483|P1|NOT COMPLETED|Overall Study||177
115757|NCT00078312|275483|P1|COMPLETED|Overall Study||151
115758|NCT00078312|275483|P1|STARTED|Overall Study||328
115759|NCT00078325|275490|P3|NOT COMPLETED|Overall Study||11
115760|NCT00078325|275491|P2|NOT COMPLETED|Overall Study||19
115761|NCT00078325|275492|P1|NOT COMPLETED|Overall Study||21
115762|NCT00078325|275490|P3|COMPLETED|Overall Study||120
115763|NCT00078325|275491|P2|COMPLETED|Overall Study||114
115764|NCT00078325|275492|P1|COMPLETED|Overall Study||110
115765|NCT00078325|275490|P3|STARTED|Overall Study||131
115766|NCT00078325|275491|P2|STARTED|Overall Study||133
115767|NCT00078325|275492|P1|STARTED|Overall Study||131
115768|NCT00078377|275506|P3|NOT COMPLETED|Overall Study||9
115769|NCT00078377|275507|P2|NOT COMPLETED|Overall Study||16
115770|NCT00078377|275508|P1|NOT COMPLETED|Overall Study||11
115771|NCT00078377|275506|P3|COMPLETED|Overall Study||55
115772|NCT00078377|275507|P2|COMPLETED|Overall Study||49
115773|NCT00078377|275508|P1|COMPLETED|Overall Study||56
115774|NCT00078377|275506|P3|STARTED|Overall Study||64
115775|NCT00078377|275507|P2|STARTED|Overall Study||65
115776|NCT00078377|275508|P1|STARTED|Overall Study||67
115777|NCT00078403|275524|P3|NOT COMPLETED|Overall Study||28
115778|NCT00078403|275525|P2|NOT COMPLETED|Overall Study||16
115779|NCT00078403|275526|P1|NOT COMPLETED|Overall Study||18
115780|NCT00078403|275524|P3|COMPLETED|Overall Study||141
115781|NCT00078403|275525|P2|COMPLETED|Overall Study||26
115782|NCT00078403|275526|P1|COMPLETED|Overall Study||26
115783|NCT00078403|275524|P3|STARTED|Overall Study||169
115784|NCT00078403|275525|P2|STARTED|Overall Study|Eligible at pre-assignment (40), direct (1), Arm C week 36 non-response (1).|42
115785|NCT00078403|275526|P1|STARTED|Overall Study|Eligible at pre-assignment (40), direct (2), Arm C week 36 non-response (1), EVR inadvertently (1).|44
115786|NCT00078559|275583|P1|NOT COMPLETED|Overall Study||0
115787|NCT00078559|275583|P1|COMPLETED|Overall Study|1 subject stopped study drug due to a severe but non-serious AE, and completed the trial|10
115788|NCT00078559|275583|P1|STARTED|Overall Study||10
115789|NCT00078715|275609|P2|NOT COMPLETED|Second Intervention||0
115790|NCT00078715|275610|P1|NOT COMPLETED|Second Intervention||0
115791|NCT00078715|275609|P2|COMPLETED|Second Intervention||4
115792|NCT00078715|275610|P1|COMPLETED|Second Intervention||2
115793|NCT00078715|275609|P2|STARTED|Second Intervention||4
115794|NCT00078715|275610|P1|STARTED|Second Intervention||2
115795|NCT00078715|275609|P2|NOT COMPLETED|First Intervention||0
115796|NCT00078715|275610|P1|NOT COMPLETED|First Intervention||0
115797|NCT00078715|275609|P2|COMPLETED|First Intervention||4
115798|NCT00078715|275610|P1|COMPLETED|First Intervention||2
115799|NCT00078715|275609|P2|STARTED|First Intervention||4
115800|NCT00078715|275610|P1|STARTED|First Intervention||2
115801|NCT00078728|275618|P2|NOT COMPLETED|Overall Study||3
115802|NCT00078728|275619|P1|NOT COMPLETED|Overall Study||4
115803|NCT00078728|275618|P2|COMPLETED|Overall Study||17
115804|NCT00078728|275619|P1|COMPLETED|Overall Study||16
115805|NCT00078728|275618|P2|STARTED|Overall Study||20
115806|NCT00078728|275619|P1|STARTED|Overall Study||20
115807|NCT00078754|275628|P3|NOT COMPLETED|Overall Study||15
115808|NCT00078754|275629|P2|NOT COMPLETED|Overall Study||19
115809|NCT00078754|275630|P1|NOT COMPLETED|Overall Study||15
115810|NCT00078754|275628|P3|COMPLETED|Overall Study||16
115811|NCT00078754|275629|P2|COMPLETED|Overall Study||11
115812|NCT00078754|275630|P1|COMPLETED|Overall Study||14
115813|NCT00078754|275628|P3|STARTED|Overall Study||31
115814|NCT00078754|275629|P2|STARTED|Overall Study||30
115815|NCT00078754|275630|P1|STARTED|Overall Study||29
115816|NCT00078767|275640|P2|NOT COMPLETED|Overall Study||1
115817|NCT00078767|275641|P1|NOT COMPLETED|Overall Study||1
115818|NCT00078767|275640|P2|COMPLETED|Overall Study||11
115819|NCT00078767|275641|P1|COMPLETED|Overall Study||11
115820|NCT00078767|275640|P2|STARTED|Overall Study||12
115821|NCT00078767|275641|P1|STARTED|Overall Study||12
115822|NCT00078949|275659|P4|NOT COMPLETED|Maintenance||3
115823|NCT00078949|275660|P3|NOT COMPLETED|Maintenance||3
115824|NCT00078949|275661|P2|NOT COMPLETED|Maintenance||0
115825|NCT00078949|275662|P1|NOT COMPLETED|Maintenance||0
115826|NCT00078949|275659|P4|COMPLETED|Maintenance||112
115827|NCT00078949|275660|P3|COMPLETED|Maintenance||112
115828|NCT00078949|275661|P2|COMPLETED|Maintenance||0
115829|NCT00078949|275662|P1|COMPLETED|Maintenance||0
115830|NCT00078949|275659|P4|STARTED|Maintenance||115
115831|NCT00078949|275660|P3|STARTED|Maintenance||115
115832|NCT00078949|275661|P2|STARTED|Maintenance||0
115833|NCT00078949|275662|P1|STARTED|Maintenance||0
115834|NCT00078949|275659|P4|NOT COMPLETED|Salvage||0
115835|NCT00078949|275660|P3|NOT COMPLETED|Salvage||0
115836|NCT00078949|275661|P2|NOT COMPLETED|Salvage||5
115837|NCT00078949|275662|P1|NOT COMPLETED|Salvage||4
115838|NCT00078949|275659|P4|COMPLETED|Salvage||0
115839|NCT00078949|275660|P3|COMPLETED|Salvage||0
115840|NCT00078949|275661|P2|COMPLETED|Salvage||304
115841|NCT00078949|275662|P1|COMPLETED|Salvage||306
115842|NCT00078949|275659|P4|STARTED|Salvage||0
115843|NCT00078949|275660|P3|STARTED|Salvage||0
115844|NCT00078949|275661|P2|STARTED|Salvage||309
115845|NCT00078949|275662|P1|STARTED|Salvage||310
115846|NCT00079001|275676|P2|NOT COMPLETED|Overall Study||0
115847|NCT00079001|275677|P1|NOT COMPLETED|Overall Study||0
115848|NCT00079001|275676|P2|COMPLETED|Overall Study||322
115849|NCT00079001|275677|P1|COMPLETED|Overall Study||323
115850|NCT00079001|275676|P2|STARTED|Overall Study||322
115851|NCT00079001|275677|P1|STARTED|Overall Study||323
115852|NCT00079040|275687|P1|NOT COMPLETED|Overall Study||2
115853|NCT00079040|275687|P1|COMPLETED|Overall Study||63
115854|NCT00079040|275687|P1|STARTED|Overall Study||65
115855|NCT00079183|275693|P1|NOT COMPLETED|Overall Study||7
115856|NCT00079183|275693|P1|COMPLETED|Overall Study||37
115857|NCT00079183|275693|P1|Drop Outs|Overall Study||7
115858|NCT00079183|275693|P1|STARTED|Overall Study||44
115859|NCT00079274|275715|P7|NOT COMPLETED|Overall Study||0
115860|NCT00079274|275716|P6|NOT COMPLETED|Overall Study||20
115861|NCT00079274|275717|P5|NOT COMPLETED|Overall Study||15
115862|NCT00079274|275718|P4|NOT COMPLETED|Overall Study||444
115863|NCT00079274|275719|P3|NOT COMPLETED|Overall Study||27
115864|NCT00079274|275720|P2|NOT COMPLETED|Overall Study||27
115865|NCT00079274|275721|P1|NOT COMPLETED|Overall Study||321
115866|NCT00079274|275715|P7|COMPLETED|Overall Study||332
115867|NCT00079274|275716|P6|COMPLETED|Overall Study||26
115868|NCT00079274|275717|P5|COMPLETED|Overall Study||30
115869|NCT00079274|275718|P4|COMPLETED|Overall Study||906
115870|NCT00079274|275719|P3|COMPLETED|Overall Study||84
115871|NCT00079274|275720|P2|COMPLETED|Overall Study||84
115872|NCT00079274|275721|P1|COMPLETED|Overall Study||1081
115873|NCT00079274|275715|P7|STARTED|Overall Study||332
115874|NCT00079274|275716|P6|STARTED|Overall Study||46
115875|NCT00079274|275717|P5|STARTED|Overall Study||45
115876|NCT00079274|275718|P4|STARTED|Overall Study||1350
115877|NCT00079274|275719|P3|STARTED|Overall Study||111
115878|NCT00079274|275720|P2|STARTED|Overall Study||111
115879|NCT00079274|275721|P1|STARTED|Overall Study||1402
115880|NCT00079326|275736|P2|NOT COMPLETED|Overall Study||0
115881|NCT00079326|275737|P1|NOT COMPLETED|Overall Study||0
115882|NCT00079326|275736|P2|COMPLETED|Overall Study||24
115883|NCT00079326|275737|P1|COMPLETED|Overall Study||15
115884|NCT00079326|275736|P2|STARTED|Overall Study||24
115885|NCT00079326|275737|P1|STARTED|Overall Study||15
115886|NCT00079339|275747|P3|NOT COMPLETED|Overall Study||6
115887|NCT00079339|275748|P2|NOT COMPLETED|Overall Study||39
115888|NCT00079339|275749|P1|NOT COMPLETED|Overall Study||5
115889|NCT00079339|275747|P3|COMPLETED|Overall Study||0
115890|NCT00079339|275748|P2|COMPLETED|Overall Study||1
115891|NCT00079339|275749|P1|COMPLETED|Overall Study||0
115892|NCT00079339|275747|P3|Enrolled in Phase II|Overall Study|Participants treated at the 150 mg/m2 dose level did not participate in the phase II part.|0
115893|NCT00079339|275748|P2|Enrolled in Phase II|Overall Study|This number includes the 6 patients enrolled on the phase I part.|40
115894|NCT00079339|275749|P1|Enrolled in Phase II|Overall Study|Participants treated at the 100 mg/m2 dose level did not participate in the phase II part.|0
115895|NCT00079339|275747|P3|Maximum Tolerated Dose (MTD) Estimation|Overall Study|One participant enrolled in the phase I part did not complete the 8 week MTD estimation period.|5
115896|NCT00079339|275748|P2|Maximum Tolerated Dose (MTD) Estimation|Overall Study||6
115897|NCT00079339|275749|P1|Maximum Tolerated Dose (MTD) Estimation|Overall Study|2 participants enrolled in the phase I part did not complete the 8 week MTD estimation period.|3
115898|NCT00079339|275747|P3|Enrolled in Phase I|Overall Study||6
115899|NCT00079339|275748|P2|Enrolled in Phase I|Overall Study||6
115900|NCT00079339|275749|P1|Enrolled in Phase I|Overall Study||5
115901|NCT00079339|275747|P3|STARTED|Overall Study||6
115902|NCT00079339|275748|P2|STARTED|Overall Study||40
115903|NCT00079339|275749|P1|STARTED|Overall Study||5
115904|NCT00079391|275763|P1|NOT COMPLETED|Overall Study||1
115905|NCT00079391|275763|P1|COMPLETED|Overall Study||49
115906|NCT00079391|275763|P1|STARTED|Overall Study|1 of these withdrew after consent.|50
115907|NCT00079417|275772|P1|NOT COMPLETED|Overall Study||9
115908|NCT00079417|275772|P1|COMPLETED|Overall Study||19
115909|NCT00079417|275772|P1|STARTED|Overall Study||28
115910|NCT00079677|275778|P2|NOT COMPLETED|Overall Study||14
115911|NCT00079677|275779|P1|NOT COMPLETED|Overall Study||20
115912|NCT00079677|275778|P2|COMPLETED|Overall Study||118
115913|NCT00079677|275779|P1|COMPLETED|Overall Study||111
115914|NCT00079677|275778|P2|STARTED|Overall Study||132
115915|NCT00079677|275779|P1|STARTED|Overall Study||131
115916|NCT00079781|275790|P3|NOT COMPLETED|Follow-up Period||2
115917|NCT00079781|275791|P2|NOT COMPLETED|Follow-up Period||0
115918|NCT00079781|275792|P1|NOT COMPLETED|Follow-up Period||4
115919|NCT00079781|275790|P3|COMPLETED|Follow-up Period||12
115920|NCT00079781|275791|P2|COMPLETED|Follow-up Period||9
115921|NCT00079781|275792|P1|COMPLETED|Follow-up Period||38
115922|NCT00079781|275790|P3|STARTED|Follow-up Period||14
115923|NCT00079781|275791|P2|STARTED|Follow-up Period||9
115924|NCT00079781|275792|P1|STARTED|Follow-up Period||42
115925|NCT00079781|275790|P3|NOT COMPLETED|Evaluation Period||0
115926|NCT00079781|275791|P2|NOT COMPLETED|Evaluation Period||0
115927|NCT00079781|275792|P1|NOT COMPLETED|Evaluation Period||0
115928|NCT00079781|275790|P3|COMPLETED|Evaluation Period||14
115929|NCT00079781|275791|P2|COMPLETED|Evaluation Period||9
115930|NCT00079781|275792|P1|COMPLETED|Evaluation Period||42
115931|NCT00079781|275790|P3|STARTED|Evaluation Period||14
115932|NCT00079781|275791|P2|STARTED|Evaluation Period||9
115933|NCT00079781|275792|P1|STARTED|Evaluation Period||42
115934|NCT00079781|275790|P3|NOT COMPLETED|Pre-implant Period||1
115935|NCT00079781|275791|P2|NOT COMPLETED|Pre-implant Period||1
115936|NCT00079781|275792|P1|NOT COMPLETED|Pre-implant Period||3
115937|NCT00079781|275790|P3|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|14
115938|NCT00079781|275791|P2|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|9
115939|NCT00079781|275792|P1|COMPLETED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|42
115940|NCT00079781|275790|P3|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|15
115941|NCT00079781|275791|P2|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|10
115942|NCT00079781|275792|P1|STARTED|Pre-implant Period|Subjects were not assigned to a group until after initial implant.|45
115943|NCT00079937|275801|P2|NOT COMPLETED|Overall Study||32
115944|NCT00079937|275802|P1|NOT COMPLETED|Overall Study||69
115945|NCT00079937|275801|P2|COMPLETED|Overall Study||175
115946|NCT00079937|275802|P1|COMPLETED|Overall Study||352
115947|NCT00079937|275801|P2|STARTED|Overall Study||207
115948|NCT00079937|275802|P1|STARTED|Overall Study||421
115949|NCT00080119|275822|P4|NOT COMPLETED|Overall Study||163
115950|NCT00080119|275823|P3|NOT COMPLETED|Overall Study||165
115951|NCT00080119|275824|P2|NOT COMPLETED|Overall Study||62
115952|NCT00080119|275825|P1|NOT COMPLETED|Overall Study||56
115953|NCT00080119|275822|P4|COMPLETED|Overall Study||111
115954|NCT00080119|275823|P3|COMPLETED|Overall Study||108
115955|NCT00080119|275824|P2|COMPLETED|Overall Study||339
115956|NCT00080119|275825|P1|COMPLETED|Overall Study||347
115957|NCT00080119|275822|P4|STARTED|Overall Study||274
115958|NCT00080119|275823|P3|STARTED|Overall Study||273
115959|NCT00080119|275824|P2|STARTED|Overall Study||401
115960|NCT00080119|275825|P1|STARTED|Overall Study||403
115961|NCT00080223|275857|P1|NOT COMPLETED|Overall Study||76
115962|NCT00080223|275857|P1|COMPLETED|Overall Study||7
115963|NCT00080223|275857|P1|STARTED|Overall Study||83
115964|NCT00080288|275867|P2|NOT COMPLETED|Overall Study||38
115965|NCT00080288|275868|P1|NOT COMPLETED|Overall Study||30
115966|NCT00080288|275867|P2|COMPLETED|Overall Study||89
115967|NCT00080288|275868|P1|COMPLETED|Overall Study||97
115968|NCT00080288|275867|P2|STARTED|Overall Study||127
115969|NCT00080288|275868|P1|STARTED|Overall Study||127
115970|NCT00080301|275878|P2|NOT COMPLETED|Overall Study||11
115971|NCT00080301|275879|P1|NOT COMPLETED|Overall Study||5
115972|NCT00080301|275878|P2|COMPLETED|Overall Study|Participants who are off treatment|366
115973|NCT00080301|275879|P1|COMPLETED|Overall Study|Participants who are off treatment|370
115974|NCT00080301|275878|P2|Still on Treatment|Overall Study||1
115975|NCT00080301|275879|P1|Still on Treatment|Overall Study||0
115976|NCT00080301|275878|P2|Never Treated|Overall Study||10
115977|NCT00080301|275879|P1|Never Treated|Overall Study||5
115978|NCT00080301|275878|P2|STARTED|Overall Study||377
115979|NCT00080301|275879|P1|STARTED|Overall Study||375
115980|NCT00080470|275899|P2|NOT COMPLETED|Overall Study||28
115981|NCT00080470|275900|P1|NOT COMPLETED|Overall Study||34
115982|NCT00080470|275899|P2|COMPLETED|Overall Study||14
115983|NCT00080470|275900|P1|COMPLETED|Overall Study||11
115984|NCT00080470|275899|P2|STARTED|Overall Study||42
115985|NCT00080470|275900|P1|STARTED|Overall Study||45
115986|NCT00080483|275910|P2|NOT COMPLETED|Overall Study||2
115987|NCT00080483|275911|P1|NOT COMPLETED|Overall Study||2
115988|NCT00080483|275910|P2|COMPLETED|Overall Study||16
115989|NCT00080483|275911|P1|COMPLETED|Overall Study||15
115990|NCT00080483|275910|P2|STARTED|Overall Study||18
115991|NCT00080483|275911|P1|STARTED|Overall Study||17
115992|NCT00080535|275917|P1|NOT COMPLETED|Overall Study||0
115993|NCT00080535|275917|P1|COMPLETED|Overall Study||10
115994|NCT00080535|275917|P1|STARTED|Overall Study||10
115995|NCT00080899|275922|P1|NOT COMPLETED|Overall Study||1
115996|NCT00080899|275922|P1|COMPLETED|Overall Study||22
115997|NCT00080899|275922|P1|STARTED|Overall Study||23
115998|NCT00074581|275929|P2|NOT COMPLETED|Overall Study||226
115999|NCT00074581|275930|P1|NOT COMPLETED|Overall Study||244
116000|NCT00074581|275929|P2|COMPLETED|Overall Study||1541
116001|NCT00074581|275930|P1|COMPLETED|Overall Study||1545
116002|NCT00074581|275929|P2|STARTED|Overall Study|877 HIV-infected index cases and 890 HIV-uninfected partners|1767
116003|NCT00074581|275930|P1|STARTED|Overall Study|886 HIV-infected index cases and 903 HIV-uninfected partners|1789
116004|NCT00074711|275940|P2|NOT COMPLETED|Overall Study||15
116005|NCT00074711|275941|P1|NOT COMPLETED|Overall Study||15
116006|NCT00074711|275940|P2|COMPLETED|Overall Study||106
116007|NCT00074711|275941|P1|COMPLETED|Overall Study||105
116008|NCT00074711|275940|P2|STARTED|Overall Study||121
116009|NCT00074711|275941|P1|STARTED|Overall Study||120
116010|NCT00080912|275959|P2|NOT COMPLETED|Overall Study||0
116011|NCT00080912|275960|P1|NOT COMPLETED|Overall Study||0
116012|NCT00080912|275959|P2|COMPLETED|Overall Study||425
116013|NCT00080912|275960|P1|COMPLETED|Overall Study||425
116014|NCT00080912|275959|P2|STARTED|Overall Study||425
116015|NCT00080912|275960|P1|STARTED|Overall Study||425
116016|NCT00080938|275966|P1|NOT COMPLETED|Overall Study||24
116017|NCT00080938|275966|P1|COMPLETED|Overall Study||2
116018|NCT00080938|275966|P1|Eligible and Treated|Overall Study||21
116019|NCT00080938|275966|P1|Began Protocol Therapy|Overall Study||25
116020|NCT00080938|275966|P1|STARTED|Overall Study||26
116021|NCT00081159|275975|P2|NOT COMPLETED|Overall Study||5
116022|NCT00081159|275976|P1|NOT COMPLETED|Overall Study||2
116023|NCT00081159|275975|P2|COMPLETED|Overall Study||35
116024|NCT00081159|275976|P1|COMPLETED|Overall Study||37
116025|NCT00081159|275975|P2|STARTED|Overall Study||40
116026|NCT00081159|275976|P1|STARTED|Overall Study||39
116027|NCT00081289|275988|P2|NOT COMPLETED|Overall Study||21
116028|NCT00081289|275989|P1|NOT COMPLETED|Overall Study||21
116029|NCT00081289|275988|P2|COMPLETED|Overall Study||52
116030|NCT00081289|275989|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
116031|NCT00081289|275988|P2|STARTED|Overall Study||73
116032|NCT00081289|275989|P1|STARTED|Overall Study||73
116033|NCT00081328|275998|P3|NOT COMPLETED|Overall Study||0
116034|NCT00081328|275999|P2|NOT COMPLETED|Overall Study||0
116035|NCT00081328|276000|P1|NOT COMPLETED|Overall Study||0
116036|NCT00081328|275998|P3|COMPLETED|Overall Study||234
116037|NCT00081328|275999|P2|COMPLETED|Overall Study||233
116038|NCT00081328|276000|P1|COMPLETED|Overall Study||232
116039|NCT00081328|275998|P3|STARTED|Overall Study||234
116040|NCT00081328|275999|P2|STARTED|Overall Study||233
116041|NCT00081328|276000|P1|STARTED|Overall Study||232
116042|NCT00081861|276038|P1|NOT COMPLETED|Overall Study||0
116043|NCT00081861|276038|P1|COMPLETED|Overall Study||13
116044|NCT00081861|276038|P1|STARTED|Overall Study||13
116045|NCT00081939|276042|P1|NOT COMPLETED|Overall Study||0
116046|NCT00081939|276042|P1|COMPLETED|Overall Study||303
116047|NCT00081939|276042|P1|STARTED|Overall Study||303
116048|NCT00082017|276046|P2|NOT COMPLETED|Overall Study||0
116049|NCT00082017|276047|P1|NOT COMPLETED|Overall Study||0
116050|NCT00082017|276046|P2|COMPLETED|Overall Study||9
116051|NCT00082017|276047|P1|COMPLETED|Overall Study||11
116052|NCT00082017|276046|P2|STARTED|Overall Study||9
116053|NCT00082017|276047|P1|STARTED|Overall Study||11
116054|NCT00082173|276065|P2|NOT COMPLETED|Overall Study||11
116055|NCT00082173|276066|P1|NOT COMPLETED|Overall Study||10
116056|NCT00082173|276065|P2|COMPLETED|Overall Study||61
116057|NCT00082173|276066|P1|COMPLETED|Overall Study||64
116058|NCT00082173|276065|P2|STARTED|Overall Study||72
116059|NCT00082173|276066|P1|STARTED|Overall Study||74
116060|NCT00082329|276074|P1|NOT COMPLETED|Overall Study||0
116061|NCT00082329|276074|P1|COMPLETED|Overall Study||9
116062|NCT00082329|276074|P1|STARTED|Overall Study||9
116063|NCT00082342|276080|P2|NOT COMPLETED|Overall Study||0
116064|NCT00082342|276081|P1|NOT COMPLETED|Overall Study||0
116065|NCT00082342|276080|P2|COMPLETED|Overall Study||12
116066|NCT00082342|276081|P1|COMPLETED|Overall Study||13
116067|NCT00082342|276080|P2|STARTED|Overall Study||12
116068|NCT00082342|276081|P1|STARTED|Overall Study||13
116069|NCT00082355|276101|P1|NOT COMPLETED|5 Year Recurrent Thromboembolism Rate||28
116070|NCT00082355|276101|P1|COMPLETED|5 Year Recurrent Thromboembolism Rate|data will not be complied until 2014|0
116071|NCT00082355|276101|P1|STARTED|5 Year Recurrent Thromboembolism Rate||28
116072|NCT00082355|276101|P1|NOT COMPLETED|Initial Results of Thrombolytic Therapy||2
116073|NCT00082355|276101|P1|COMPLETED|Initial Results of Thrombolytic Therapy||28
116074|NCT00082355|276101|P1|STARTED|Initial Results of Thrombolytic Therapy||30
116075|NCT00082368|276106|P1|NOT COMPLETED|Overall Study||1
116076|NCT00082368|276106|P1|COMPLETED|Overall Study||11
116077|NCT00082368|276106|P1|STARTED|Overall Study||12
116078|NCT00082381|276113|P2|NOT COMPLETED|Overall Study||26
116079|NCT00082381|276114|P1|NOT COMPLETED|Overall Study||55
116080|NCT00082381|276113|P2|COMPLETED|Overall Study||242
116081|NCT00082381|276114|P1|COMPLETED|Overall Study||228
116082|NCT00082381|276113|P2|Received Treatment (Intent to Treat)|Overall Study||267
116083|NCT00082381|276114|P1|Received Treatment (Intent to Treat)|Overall Study||282
116084|NCT00082381|276113|P2|STARTED|Overall Study||268
116085|NCT00082381|276114|P1|STARTED|Overall Study||283
116086|NCT00082407|276134|P2|NOT COMPLETED|Overall Study||27
116087|NCT00082407|276135|P1|NOT COMPLETED|Overall Study||56
116088|NCT00082407|276134|P2|COMPLETED|Overall Study||223
116089|NCT00082407|276135|P1|COMPLETED|Overall Study||199
116090|NCT00082407|276134|P2|Received Treatment (Intent to Treat)|Overall Study||248
116091|NCT00082407|276135|P1|Received Treatment (Intent to Treat)|Overall Study||253
116092|NCT00082407|276134|P2|STARTED|Overall Study||250
116093|NCT00082407|276135|P1|STARTED|Overall Study||255
116094|NCT00082433|276155|P2|NOT COMPLETED|Overall Study||597
116095|NCT00082433|276156|P1|NOT COMPLETED|Overall Study||594
116096|NCT00082433|276155|P2|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
116097|NCT00082433|276156|P1|COMPLETED|Overall Study|Participants who received 18 or more cycles of treatment.|15
116098|NCT00082433|276155|P2|STARTED|Overall Study||612
116099|NCT00082433|276156|P1|STARTED|Overall Study||609
116100|NCT00082758|276177|P3|NOT COMPLETED|Overall Study||0
116101|NCT00082758|276178|P2|NOT COMPLETED|Overall Study||17
116102|NCT00082758|276179|P1|NOT COMPLETED|Overall Study||15
116103|NCT00082758|276177|P3|COMPLETED|Overall Study||0
116104|NCT00082758|276178|P2|COMPLETED|Overall Study||7
116105|NCT00082758|276179|P1|COMPLETED|Overall Study||0
116106|NCT00082758|276177|P3|STARTED|Overall Study||0
116107|NCT00082758|276178|P2|STARTED|Overall Study||24
116108|NCT00082758|276179|P1|STARTED|Overall Study||15
116109|NCT00082810|276187|P1|NOT COMPLETED|Overall Study||31
116110|NCT00082810|276187|P1|COMPLETED|Overall Study||2
116111|NCT00082810|276187|P1|STARTED|Overall Study||33
116112|NCT00082888|276194|P1|NOT COMPLETED|Overall Study||22
116113|NCT00082888|276194|P1|COMPLETED|Overall Study||71
116114|NCT00082888|276194|P1|STARTED|Overall Study||93
116115|NCT00083122|276200|P2|NOT COMPLETED|Overall Study||0
116116|NCT00083122|276201|P1|NOT COMPLETED|Overall Study||0
116117|NCT00083122|276200|P2|COMPLETED|Overall Study||5
116118|NCT00083122|276201|P1|COMPLETED|Overall Study||40
116119|NCT00083122|276200|P2|STARTED|Overall Study||5
116120|NCT00083122|276201|P1|STARTED|Overall Study||40
116121|NCT00083174|276212|P2|NOT COMPLETED|Overall Study||0
116122|NCT00083174|276213|P1|NOT COMPLETED|Overall Study||0
116123|NCT00083174|276212|P2|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2275
116124|NCT00083174|276213|P1|COMPLETED|Overall Study|All women randomized were included in the analysis based on intent-to-treat principle.|2285
116125|NCT00083174|276212|P2|STARTED|Overall Study||2275
116126|NCT00083174|276213|P1|STARTED|Overall Study||2285
116127|NCT00083226|276231|P1|NOT COMPLETED|Overall Study||42
116128|NCT00083226|276231|P1|COMPLETED|Overall Study||0
116129|NCT00083226|276231|P1|STARTED|Overall Study||42
116130|NCT00083382|276237|P1|NOT COMPLETED|Overall Study||0
116131|NCT00083382|276237|P1|COMPLETED|Overall Study||83
116132|NCT00083382|276237|P1|STARTED|Overall Study||83
116133|NCT00083551|276243|P2|NOT COMPLETED|Overall Study||0
116134|NCT00083551|276244|P1|NOT COMPLETED|Overall Study||0
116135|NCT00083551|276243|P2|COMPLETED|Overall Study||345
116136|NCT00083551|276244|P1|COMPLETED|Overall Study||323
116137|NCT00083551|276243|P2|STARTED|Overall Study||345
116138|NCT00083551|276244|P1|STARTED|Overall Study||323
116139|NCT00083616|276250|P1|NOT COMPLETED|Overall Study||31
116140|NCT00083616|276250|P1|COMPLETED|Overall Study|Completed safety followup or died on study as of the data cut-off date of 22 December 2006|154
116141|NCT00083616|276250|P1|Received Study Medication|Overall Study||182
116142|NCT00083616|276250|P1|STARTED|Overall Study||185
116143|NCT00083720|276262|P1|NOT COMPLETED|Overall Study||0
116144|NCT00083720|276262|P1|COMPLETED|Overall Study|Two patients died prior to receiving cetuximab.|85
116145|NCT00083720|276262|P1|STARTED|Overall Study|Patients analyzed for efficacy who met the epidermal growth factor receptor (EGFR) negative criteria|85
116146|NCT00083759|276274|P2|NOT COMPLETED|Overall Study||83
116147|NCT00083759|276275|P1|NOT COMPLETED|Overall Study||84
116148|NCT00083759|276274|P2|COMPLETED|Overall Study||66
116149|NCT00083759|276275|P1|COMPLETED|Overall Study||66
116150|NCT00083759|276274|P2|STARTED|Overall Study|149 subjects enrolled, 136 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|149
116151|NCT00083759|276275|P1|STARTED|Overall Study|150 subjects enrolled, 137 (Modified Intention-to-Treat [MITT] Population) for efficacy analyses|150
116152|NCT00083889|276285|P2|NOT COMPLETED|Overall Study||375
116153|NCT00083889|276286|P1|NOT COMPLETED|Overall Study||375
116154|NCT00083889|276285|P2|COMPLETED|Overall Study|Discontinuation crossover subjects: AEs 5,consent withdrawn 2, lack efficacy 13, sponsor decision 5.|0
116155|NCT00083889|276286|P1|COMPLETED|Overall Study||0
116156|NCT00083889|276285|P2|Received Treatment|Overall Study|15 subjects randomized to IFN-α discontinued before receiving their first dose of study medication.|360
116157|NCT00083889|276286|P1|Received Treatment|Overall Study||375
116158|NCT00083889|276285|P2|STARTED|Overall Study||375
116159|NCT00083889|276286|P1|STARTED|Overall Study||375
116160|NCT00083915|276337|P2|NOT COMPLETED|Overall Study||37
116161|NCT00083915|276338|P1|NOT COMPLETED|Overall Study||50
116162|NCT00083915|276337|P2|COMPLETED|Overall Study||8
116163|NCT00083915|276338|P1|COMPLETED|Overall Study||2
116164|NCT00083915|276337|P2|STARTED|Overall Study||45
116165|NCT00083915|276338|P1|STARTED|Overall Study||52
116166|NCT00084084|276344|P1|NOT COMPLETED|Phase 2 (Transition to Replagal AF)||1
116167|NCT00084084|276344|P1|COMPLETED|Phase 2 (Transition to Replagal AF)||10
116168|NCT00084084|276344|P1|STARTED|Phase 2 (Transition to Replagal AF)|The 11 patients remaining in TKT029 at the time Replagal AF was made available continued to Phase 2.|11
116169|NCT00084084|276344|P1|NOT COMPLETED|Phase 1 (Treatment With Replagal RB)||1
116170|NCT00084084|276344|P1|COMPLETED|Phase 1 (Treatment With Replagal RB)||16
116171|NCT00084084|276344|P1|STARTED|Phase 1 (Treatment With Replagal RB)||17
116172|NCT00084136|276355|P3|NOT COMPLETED|NRTI Comparison||82
116173|NCT00084136|276356|P2|NOT COMPLETED|NRTI Comparison||0
116174|NCT00084136|276357|P1|NOT COMPLETED|NRTI Comparison||101
116175|NCT00084136|276355|P3|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|444
116176|NCT00084136|276356|P2|COMPLETED|NRTI Comparison||0
116177|NCT00084136|276357|P1|COMPLETED|NRTI Comparison|Follow-up though study closeout period (final visit between April 1 and May 31, 2010).|418
116178|NCT00084136|276355|P3|STARTED|NRTI Comparison||526
116179|NCT00084136|276356|P2|STARTED|NRTI Comparison||0
116180|NCT00084136|276357|P1|STARTED|NRTI Comparison||519
116181|NCT00084136|276355|P3|NOT COMPLETED|PI Comparison||0
116182|NCT00084136|276356|P2|NOT COMPLETED|PI Comparison||47
116183|NCT00084136|276357|P1|NOT COMPLETED|PI Comparison||55
116184|NCT00084136|276355|P3|COMPLETED|PI Comparison||0
116185|NCT00084136|276356|P2|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|479
116186|NCT00084136|276357|P1|COMPLETED|PI Comparison|Follow-up was until ddI+FTC+ATV arm was closed per DSMB recommendation on May 23, 2008.|464
116187|NCT00084136|276355|P3|STARTED|PI Comparison||0
116188|NCT00084136|276356|P2|STARTED|PI Comparison||526
116189|NCT00084136|276357|P1|STARTED|PI Comparison||519
116190|NCT00084266|276418|P2|NOT COMPLETED|Overall Study||423
116191|NCT00084266|276419|P1|NOT COMPLETED|Overall Study||441
116192|NCT00084266|276418|P2|COMPLETED|Overall Study||184
116193|NCT00084266|276419|P1|COMPLETED|Overall Study||177
116194|NCT00084266|276418|P2|Treated|Overall Study||587
116195|NCT00084266|276419|P1|Treated|Overall Study||597
116196|NCT00084266|276418|P2|STARTED|Overall Study||607
116197|NCT00084266|276419|P1|STARTED|Overall Study||618
116198|NCT00084318|276455|P2|NOT COMPLETED|Overall Study||13
116199|NCT00084318|276456|P1|NOT COMPLETED|Overall Study||22
116200|NCT00084318|276455|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|106
116201|NCT00084318|276456|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|97
116202|NCT00084318|276455|P2|STARTED|Overall Study||119
116203|NCT00084318|276456|P1|STARTED|Overall Study||119
116204|NCT00084383|276472|P1|NOT COMPLETED|Overall Study||47
116205|NCT00084383|276472|P1|COMPLETED|Overall Study||13
116206|NCT00084383|276472|P1|STARTED|Overall Study||60
116207|NCT00084409|276479|P2|NOT COMPLETED|Overall Study||12
116208|NCT00084409|276480|P1|NOT COMPLETED|Overall Study||15
116209|NCT00084409|276479|P2|COMPLETED|Overall Study|4 Current, 8 former|65
116210|NCT00084409|276480|P1|COMPLETED|Overall Study|9 current, 6 former|60
116211|NCT00084409|276479|P2|STARTED|Overall Study|41 current, 36 former|77
116212|NCT00084409|276480|P1|STARTED|Overall Study|40 Current, 35 former|75
116213|NCT00077857|276510|P2|NOT COMPLETED|Overall Study||204
116214|NCT00077857|276511|P1|NOT COMPLETED|Overall Study||201
116215|NCT00077857|276510|P2|COMPLETED|Overall Study||31
116216|NCT00077857|276511|P1|COMPLETED|Overall Study||34
116217|NCT00077857|276510|P2|Safety Population: Actual Dose Received|Overall Study||248
116218|NCT00077857|276511|P1|Safety Population: Actual Dose Received|Overall Study|14 patients in the 1250 dose arm received a lower dose and were included in the 825 arm for Safety.|217
116219|NCT00077857|276510|P2|Received Study Drug|Overall Study||234
116220|NCT00077857|276511|P1|Received Study Drug|Overall Study||231
116221|NCT00077857|276510|P2|STARTED|Overall Study||235
116222|NCT00077857|276511|P1|STARTED|Overall Study||235
116223|NCT00077922|276529|P1|NOT COMPLETED|Overall Study||0
116224|NCT00077922|276529|P1|COMPLETED|Overall Study||15
116225|NCT00077922|276529|P1|STARTED|Overall Study||15
116226|NCT00077974|276534|P1|NOT COMPLETED|Overall Study||104
116227|NCT00077974|276534|P1|COMPLETED|Overall Study||2
116228|NCT00077974|276534|P1|STARTED|Overall Study||106
116229|NCT00084487|276549|P1|NOT COMPLETED|Overall Study||1
116230|NCT00084487|276549|P1|COMPLETED|Overall Study||20
116231|NCT00084487|276549|P1|STARTED|Overall Study||21
116232|NCT00084617|276557|P1|NOT COMPLETED|Overall Study||9
116233|NCT00084617|276557|P1|COMPLETED|Overall Study||30
116234|NCT00084617|276557|P1|STARTED|Overall Study||39
116235|NCT00084682|276563|P1|NOT COMPLETED|Overall Study||1
116236|NCT00084682|276563|P1|COMPLETED|Overall Study||13
116237|NCT00084682|276563|P1|STARTED|Overall Study||14
116238|NCT00084747|276567|P1|NOT COMPLETED|Overall Study||13
116239|NCT00084747|276567|P1|COMPLETED|Overall Study||17
116240|NCT00084747|276567|P1|STARTED|Overall Study||30
116241|NCT00085202|276574|P2|NOT COMPLETED|Overall Study||24
116242|NCT00085202|276575|P1|NOT COMPLETED|Overall Study||18
116243|NCT00085202|276574|P2|COMPLETED|Overall Study||120
116244|NCT00085202|276575|P1|COMPLETED|Overall Study||251
116245|NCT00085202|276574|P2|STARTED|Overall Study||144
116246|NCT00085202|276575|P1|STARTED|Overall Study||269
116247|NCT00085254|276589|P3|NOT COMPLETED|Overall Study||0
116248|NCT00085254|276590|P2|NOT COMPLETED|Overall Study||0
116249|NCT00085254|276591|P1|NOT COMPLETED|Overall Study||0
116250|NCT00085254|276589|P3|COMPLETED|Overall Study||48
116251|NCT00085254|276590|P2|COMPLETED|Overall Study||46
116252|NCT00085254|276591|P1|COMPLETED|Overall Study||18
116253|NCT00085254|276589|P3|STARTED|Overall Study||48
116254|NCT00085254|276590|P2|STARTED|Overall Study||46
116255|NCT00085254|276591|P1|STARTED|Overall Study||18
116256|NCT00085293|276605|P1|NOT COMPLETED|Overall Study||0
116257|NCT00085293|276605|P1|COMPLETED|Overall Study||12
116258|NCT00085293|276605|P1|STARTED|Overall Study||12
116259|NCT00085410|276610|P1|NOT COMPLETED|Overall Study||0
116260|NCT00085410|276610|P1|COMPLETED|Overall Study||20
116261|NCT00085410|276610|P1|STARTED|Overall Study||20
116262|NCT00085423|276624|P1|NOT COMPLETED|Overall Study||2
116263|NCT00085423|276624|P1|COMPLETED|Overall Study||18
116264|NCT00085423|276624|P1|STARTED|Overall Study||20
116265|NCT00085436|276630|P1|NOT COMPLETED|Overall Study||0
116266|NCT00085436|276630|P1|COMPLETED|Overall Study||18
116267|NCT00085436|276630|P1|STARTED|Overall Study||18
116268|NCT00085540|276636|P2|NOT COMPLETED|Overall Study||2
116269|NCT00085540|276637|P1|NOT COMPLETED|Overall Study||0
116270|NCT00085540|276636|P2|COMPLETED|Overall Study||40
116271|NCT00085540|276637|P1|COMPLETED|Overall Study||8
116272|NCT00085540|276636|P2|STARTED|Overall Study||42
116273|NCT00085540|276637|P1|STARTED|Overall Study||8
116274|NCT00085566|276647|P3|NOT COMPLETED|Overall Study||14
116275|NCT00085566|276648|P2|NOT COMPLETED|Overall Study||0
116276|NCT00085566|276649|P1|NOT COMPLETED|Overall Study||0
116277|NCT00085566|276647|P3|COMPLETED|Overall Study||43
116278|NCT00085566|276648|P2|COMPLETED|Overall Study||3
116279|NCT00085566|276649|P1|COMPLETED|Overall Study||3
116280|NCT00085566|276647|P3|STARTED|Overall Study||57
116281|NCT00085566|276648|P2|STARTED|Overall Study||3
116282|NCT00085566|276649|P1|STARTED|Overall Study||3
116283|NCT00085631|276657|P3|NOT COMPLETED|Overall Study||7
116284|NCT00085631|276658|P2|NOT COMPLETED|Overall Study||11
116285|NCT00085631|276659|P1|NOT COMPLETED|Overall Study||4
116286|NCT00085631|276657|P3|COMPLETED|Overall Study||32
116287|NCT00085631|276658|P2|COMPLETED|Overall Study||38
116288|NCT00085631|276659|P1|COMPLETED|Overall Study||9
116289|NCT00085631|276657|P3|STARTED|Overall Study||39
116290|NCT00085631|276658|P2|STARTED|Overall Study||49
116291|NCT00085631|276659|P1|STARTED|Overall Study||13
116292|NCT00085644|276668|P3|NOT COMPLETED|Open-Label Period||109
116293|NCT00085644|276669|P2|NOT COMPLETED|Open-Label Period||0
116294|NCT00085644|276670|P1|NOT COMPLETED|Open-Label Period||0
116295|NCT00085644|276668|P3|COMPLETED|Open-Label Period||202
116296|NCT00085644|276669|P2|COMPLETED|Open-Label Period||0
116297|NCT00085644|276670|P1|COMPLETED|Open-Label Period||0
116298|NCT00085644|276668|P3|STARTED|Open-Label Period|1 subject who discontinued for personal reasons subsequently died 450 days after last dose.|311
116299|NCT00085644|276669|P2|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
116300|NCT00085644|276670|P1|STARTED|Open-Label Period|This treatment group is not applicable to the Open-Label Period.|0
116301|NCT00085644|276668|P3|NOT COMPLETED|Double-Blind Period||0
116302|NCT00085644|276669|P2|NOT COMPLETED|Double-Blind Period||6
116303|NCT00085644|276670|P1|NOT COMPLETED|Double-Blind Period||13
116304|NCT00085644|276668|P3|COMPLETED|Double-Blind Period||0
116305|NCT00085644|276669|P2|COMPLETED|Double-Blind Period||101
116306|NCT00085644|276670|P1|COMPLETED|Double-Blind Period||195
116307|NCT00085644|276668|P3|STARTED|Double-Blind Period|This treatment group is not applicable to the Double-Blind Period.|0
116308|NCT00085644|276669|P2|STARTED|Double-Blind Period||107
116309|NCT00085644|276670|P1|STARTED|Double-Blind Period||208
116310|NCT00085709|276713|P2|NOT COMPLETED|Overall Study||50
116311|NCT00085709|276714|P1|NOT COMPLETED|Overall Study||53
116312|NCT00085709|276713|P2|COMPLETED|Overall Study||270
116313|NCT00085709|276714|P1|COMPLETED|Overall Study||264
116314|NCT00085709|276713|P2|Eligible and Did Not Withdraw Consent|Overall Study||300
116315|NCT00085709|276714|P1|Eligible and Did Not Withdraw Consent|Overall Study||296
116316|NCT00085709|276713|P2|Eligible|Overall Study||301
116317|NCT00085709|276714|P1|Eligible|Overall Study||298
116318|NCT00085709|276713|P2|STARTED|Overall Study||320
116319|NCT00085709|276714|P1|STARTED|Overall Study||317
116320|NCT00085735|276734|P6|NOT COMPLETED|Overall Study||31
116321|NCT00085735|276735|P5|NOT COMPLETED|Overall Study||42
116322|NCT00085735|276736|P4|NOT COMPLETED|Overall Study||19
116323|NCT00085735|276737|P3|NOT COMPLETED|Overall Study||17
116324|NCT00085735|276738|P2|NOT COMPLETED|Overall Study||10
116325|NCT00085735|276739|P1|NOT COMPLETED|Overall Study||12
116326|NCT00085735|276734|P6|COMPLETED|Overall Study||115
116327|NCT00085735|276735|P5|COMPLETED|Overall Study||105
116328|NCT00085735|276736|P4|COMPLETED|Overall Study||46
116329|NCT00085735|276737|P3|COMPLETED|Overall Study||46
116330|NCT00085735|276738|P2|COMPLETED|Overall Study||54
116331|NCT00085735|276739|P1|COMPLETED|Overall Study||52
116332|NCT00085735|276734|P6|STARTED|Overall Study||146
116333|NCT00085735|276735|P5|STARTED|Overall Study||147
116334|NCT00085735|276736|P4|STARTED|Overall Study||65
116335|NCT00085735|276737|P3|STARTED|Overall Study||63
116336|NCT00085735|276738|P2|STARTED|Overall Study||64
116337|NCT00085735|276739|P1|STARTED|Overall Study||64
116338|NCT00085839|276767|P2|NOT COMPLETED|Overall Study||0
116339|NCT00085839|276768|P1|NOT COMPLETED|Overall Study||0
116340|NCT00085839|276767|P2|COMPLETED|Overall Study||51
116341|NCT00085839|276768|P1|COMPLETED|Overall Study||52
116342|NCT00085839|276767|P2|STARTED|Overall Study||51
116343|NCT00085839|276768|P1|STARTED|Overall Study||52
116344|NCT00085917|276780|P2|NOT COMPLETED|Overall Study||3
116345|NCT00085917|276781|P1|NOT COMPLETED|Overall Study||4
116346|NCT00085917|276780|P2|COMPLETED|Overall Study||11
116347|NCT00085917|276781|P1|COMPLETED|Overall Study||11
116348|NCT00085917|276780|P2|STARTED|Overall Study||14
116349|NCT00085917|276781|P1|STARTED|Overall Study||15
116350|NCT00086047|276793|P2|NOT COMPLETED|Overall Study||7
116351|NCT00086047|276794|P1|NOT COMPLETED|Overall Study||7
116352|NCT00086047|276793|P2|COMPLETED|Overall Study||50
116353|NCT00086047|276794|P1|COMPLETED|Overall Study||50
116354|NCT00086047|276793|P2|STARTED|Overall Study||57
116355|NCT00086047|276794|P1|STARTED|Overall Study||57
116356|NCT00086138|276802|P2|NOT COMPLETED|Overall Study||3
116357|NCT00086138|276803|P1|NOT COMPLETED|Overall Study||4
116358|NCT00086138|276802|P2|COMPLETED|Overall Study||64
116359|NCT00086138|276803|P1|COMPLETED|Overall Study||60
116360|NCT00086138|276802|P2|STARTED|Overall Study||67
116361|NCT00086138|276803|P1|STARTED|Overall Study||64
116362|NCT00086190|276814|P3|NOT COMPLETED|Overall Study||6
116363|NCT00086190|276815|P2|NOT COMPLETED|Overall Study||4
116364|NCT00086190|276816|P1|NOT COMPLETED|Overall Study||8
116365|NCT00086190|276814|P3|COMPLETED|Overall Study||33
116366|NCT00086190|276815|P2|COMPLETED|Overall Study||30
116367|NCT00086190|276816|P1|COMPLETED|Overall Study||34
116368|NCT00086190|276814|P3|STARTED|Overall Study||39
116369|NCT00086190|276815|P2|STARTED|Overall Study||34
116370|NCT00086190|276816|P1|STARTED|Overall Study||42
116371|NCT00086281|276887|P15|NOT COMPLETED|Phase 2||0
116372|NCT00086281|276888|P14|NOT COMPLETED|Phase 2||1
116373|NCT00086281|276889|P13|NOT COMPLETED|Phase 2||1
116374|NCT00086281|276890|P12|NOT COMPLETED|Phase 2||0
116375|NCT00086281|276891|P11|NOT COMPLETED|Phase 2||0
116376|NCT00086281|276892|P10|NOT COMPLETED|Phase 2||0
116377|NCT00086281|276893|P9|NOT COMPLETED|Phase 2||0
116378|NCT00086281|276894|P8|NOT COMPLETED|Phase 2||0
116379|NCT00086281|276895|P7|NOT COMPLETED|Phase 2||0
116380|NCT00086281|276896|P6|NOT COMPLETED|Phase 2||0
116381|NCT00086281|276897|P5|NOT COMPLETED|Phase 2||0
116382|NCT00086281|276898|P4|NOT COMPLETED|Phase 2||0
116383|NCT00086281|276899|P3|NOT COMPLETED|Phase 2||0
116384|NCT00086281|276900|P2|NOT COMPLETED|Phase 2||0
116385|NCT00086281|276901|P1|NOT COMPLETED|Phase 2||0
116386|NCT00086281|276887|P15|COMPLETED|Phase 2||0
116387|NCT00086281|276888|P14|COMPLETED|Phase 2||26
116388|NCT00086281|276889|P13|COMPLETED|Phase 2||22
116389|NCT00086281|276890|P12|COMPLETED|Phase 2||0
116390|NCT00086281|276891|P11|COMPLETED|Phase 2||0
116391|NCT00086281|276892|P10|COMPLETED|Phase 2||0
116392|NCT00086281|276893|P9|COMPLETED|Phase 2||0
116393|NCT00086281|276894|P8|COMPLETED|Phase 2||0
116394|NCT00086281|276895|P7|COMPLETED|Phase 2||0
116395|NCT00086281|276896|P6|COMPLETED|Phase 2||0
116396|NCT00086281|276897|P5|COMPLETED|Phase 2||0
116397|NCT00086281|276898|P4|COMPLETED|Phase 2||0
116398|NCT00086281|276899|P3|COMPLETED|Phase 2||0
116399|NCT00086281|276900|P2|COMPLETED|Phase 2||0
116400|NCT00086281|276901|P1|COMPLETED|Phase 2||0
116401|NCT00086281|276887|P15|STARTED|Phase 2||0
116402|NCT00086281|276888|P14|STARTED|Phase 2||27
116403|NCT00086281|276889|P13|STARTED|Phase 2||23
116404|NCT00086281|276890|P12|STARTED|Phase 2||0
116405|NCT00086281|276891|P11|STARTED|Phase 2||0
116406|NCT00086281|276892|P10|STARTED|Phase 2||0
116407|NCT00086281|276893|P9|STARTED|Phase 2||0
116408|NCT00086281|276894|P8|STARTED|Phase 2||0
116409|NCT00086281|276895|P7|STARTED|Phase 2||0
116410|NCT00086281|276896|P6|STARTED|Phase 2||0
116411|NCT00086281|276897|P5|STARTED|Phase 2||0
116412|NCT00086281|276898|P4|STARTED|Phase 2||0
116413|NCT00086281|276899|P3|STARTED|Phase 2||0
116414|NCT00086281|276900|P2|STARTED|Phase 2||0
116415|NCT00086281|276901|P1|STARTED|Phase 2||0
116416|NCT00086281|276887|P15|NOT COMPLETED|Phase 1||3
116417|NCT00086281|276888|P14|NOT COMPLETED|Phase 1||1
116418|NCT00086281|276889|P13|NOT COMPLETED|Phase 1||1
116419|NCT00086281|276890|P12|NOT COMPLETED|Phase 1||1
116420|NCT00086281|276891|P11|NOT COMPLETED|Phase 1||3
116421|NCT00086281|276892|P10|NOT COMPLETED|Phase 1||1
116422|NCT00086281|276893|P9|NOT COMPLETED|Phase 1||0
116423|NCT00086281|276894|P8|NOT COMPLETED|Phase 1||0
116424|NCT00086281|276895|P7|NOT COMPLETED|Phase 1||0
116425|NCT00086281|276896|P6|NOT COMPLETED|Phase 1||0
116426|NCT00086281|276897|P5|NOT COMPLETED|Phase 1||0
116427|NCT00086281|276898|P4|NOT COMPLETED|Phase 1||0
116428|NCT00086281|276899|P3|NOT COMPLETED|Phase 1||0
116429|NCT00086281|276900|P2|NOT COMPLETED|Phase 1||0
116430|NCT00086281|276901|P1|NOT COMPLETED|Phase 1||0
116431|NCT00086281|276887|P15|COMPLETED|Phase 1||0
116432|NCT00086281|276888|P14|COMPLETED|Phase 1||0
116433|NCT00086281|276889|P13|COMPLETED|Phase 1||0
116434|NCT00086281|276890|P12|COMPLETED|Phase 1||0
116435|NCT00086281|276891|P11|COMPLETED|Phase 1||0
116436|NCT00086281|276892|P10|COMPLETED|Phase 1||0
116437|NCT00086281|276893|P9|COMPLETED|Phase 1||2
116438|NCT00086281|276894|P8|COMPLETED|Phase 1||1
116439|NCT00086281|276895|P7|COMPLETED|Phase 1||1
116440|NCT00086281|276896|P6|COMPLETED|Phase 1||3
116441|NCT00086281|276897|P5|COMPLETED|Phase 1||1
116442|NCT00086281|276898|P4|COMPLETED|Phase 1||11
116443|NCT00086281|276899|P3|COMPLETED|Phase 1||8
116444|NCT00086281|276900|P2|COMPLETED|Phase 1||12
116445|NCT00086281|276901|P1|COMPLETED|Phase 1||11
116446|NCT00086281|276887|P15|STARTED|Phase 1||3
116447|NCT00086281|276888|P14|STARTED|Phase 1||1
116448|NCT00086281|276889|P13|STARTED|Phase 1||1
116449|NCT00086281|276890|P12|STARTED|Phase 1||1
116450|NCT00086281|276891|P11|STARTED|Phase 1||3
116451|NCT00086281|276892|P10|STARTED|Phase 1||1
116452|NCT00086281|276893|P9|STARTED|Phase 1||2
116453|NCT00086281|276894|P8|STARTED|Phase 1||1
116454|NCT00086281|276895|P7|STARTED|Phase 1||1
116455|NCT00086281|276896|P6|STARTED|Phase 1||3
116456|NCT00086281|276897|P5|STARTED|Phase 1||1
116457|NCT00086281|276898|P4|STARTED|Phase 1||11
116458|NCT00086281|276899|P3|STARTED|Phase 1||8
116459|NCT00086281|276900|P2|STARTED|Phase 1||12
116460|NCT00086281|276901|P1|STARTED|Phase 1||11
116461|NCT00086307|276914|P3|NOT COMPLETED|Overall Study||8
116462|NCT00086307|276915|P2|NOT COMPLETED|Overall Study||1
116463|NCT00086307|276916|P1|NOT COMPLETED|Overall Study||2
116464|NCT00086307|276914|P3|COMPLETED|Overall Study||5
116465|NCT00086307|276915|P2|COMPLETED|Overall Study||12
116466|NCT00086307|276916|P1|COMPLETED|Overall Study||11
116467|NCT00086307|276914|P3|STARTED|Overall Study||13
116468|NCT00086307|276915|P2|STARTED|Overall Study||13
116469|NCT00086307|276916|P1|STARTED|Overall Study||13
116470|NCT00086346|276926|P2|NOT COMPLETED|Patients Dosed With Test Article||23
116471|NCT00086346|276927|P1|NOT COMPLETED|Patients Dosed With Test Article||140
116472|NCT00086346|276926|P2|COMPLETED|Patients Dosed With Test Article||187
116473|NCT00086346|276927|P1|COMPLETED|Patients Dosed With Test Article||249
116474|NCT00086346|276926|P2|STARTED|Patients Dosed With Test Article||210
116475|NCT00086346|276927|P1|STARTED|Patients Dosed With Test Article||389
116476|NCT00086346|276926|P2|NOT COMPLETED|Randomization||4
116477|NCT00086346|276927|P1|NOT COMPLETED|Randomization||4
116478|NCT00086346|276926|P2|COMPLETED|Randomization||210
116479|NCT00086346|276927|P1|COMPLETED|Randomization||389
116480|NCT00086346|276926|P2|STARTED|Randomization||214
116481|NCT00086346|276927|P1|STARTED|Randomization||393
116482|NCT00086385|276943|P4|NOT COMPLETED|Overall Study||1
116483|NCT00086385|276944|P3|NOT COMPLETED|Overall Study||1
116484|NCT00086385|276945|P2|NOT COMPLETED|Overall Study||2
116485|NCT00086385|276946|P1|NOT COMPLETED|Overall Study||2
116486|NCT00086385|276943|P4|COMPLETED|Overall Study||98
116487|NCT00086385|276944|P3|COMPLETED|Overall Study||103
116488|NCT00086385|276945|P2|COMPLETED|Overall Study||97
116489|NCT00086385|276946|P1|COMPLETED|Overall Study||98
116490|NCT00086385|276943|P4|STARTED|Overall Study||99
116491|NCT00086385|276944|P3|STARTED|Overall Study||104
116492|NCT00086385|276945|P2|STARTED|Overall Study||99
116493|NCT00086385|276946|P1|STARTED|Overall Study||100
116494|NCT00086411|276960|P4|NOT COMPLETED|Overall Study||12
116495|NCT00086411|276961|P3|NOT COMPLETED|Overall Study||13
116496|NCT00086411|276962|P2|NOT COMPLETED|Overall Study||11
116497|NCT00086411|276963|P1|NOT COMPLETED|Overall Study||11
116498|NCT00086411|276960|P4|COMPLETED|Overall Study||53
116499|NCT00086411|276961|P3|COMPLETED|Overall Study||49
116500|NCT00086411|276962|P2|COMPLETED|Overall Study||52
116501|NCT00086411|276963|P1|COMPLETED|Overall Study||59
116502|NCT00086411|276960|P4|STARTED|Overall Study||65
116503|NCT00086411|276961|P3|STARTED|Overall Study||62
116504|NCT00086411|276962|P2|STARTED|Overall Study||63
116505|NCT00086411|276963|P1|STARTED|Overall Study||70
116506|NCT00086450|276975|P2|NOT COMPLETED|Overall Study||0
116507|NCT00086450|276976|P1|NOT COMPLETED|Overall Study||0
116508|NCT00086450|276975|P2|COMPLETED|Overall Study||947
116509|NCT00086450|276976|P1|COMPLETED|Overall Study||953
116510|NCT00086450|276975|P2|STARTED|Overall Study||947
116511|NCT00086450|276976|P1|STARTED|Overall Study||953
116512|NCT00086502|276990|P2|NOT COMPLETED|Overall Study||20
116513|NCT00086502|276991|P1|NOT COMPLETED|Overall Study||26
116514|NCT00086502|276990|P2|COMPLETED|Overall Study||158
116515|NCT00086502|276991|P1|COMPLETED|Overall Study||149
116516|NCT00086502|276990|P2|STARTED|Overall Study||178
116517|NCT00086502|276991|P1|STARTED|Overall Study||175
116518|NCT00086515|277001|P2|NOT COMPLETED|Phase B (Weeks 24-104)||55
116519|NCT00086515|277002|P1|NOT COMPLETED|Phase B (Weeks 24-104)||190
116520|NCT00086515|277001|P2|COMPLETED|Phase B (Weeks 24-104)||109
116521|NCT00086515|277002|P1|COMPLETED|Phase B (Weeks 24-104)||201
116522|NCT00086515|277001|P2|STARTED|Phase B (Weeks 24-104)||164
116523|NCT00086515|277002|P1|STARTED|Phase B (Weeks 24-104)||391
116524|NCT00086515|277001|P2|NOT COMPLETED|Phase A to Phase B Transition Period||28
116525|NCT00086515|277002|P1|NOT COMPLETED|Phase A to Phase B Transition Period||24
116526|NCT00086515|277001|P2|COMPLETED|Phase A to Phase B Transition Period||164
116527|NCT00086515|277002|P1|COMPLETED|Phase A to Phase B Transition Period||391
116528|NCT00086515|277001|P2|STARTED|Phase A to Phase B Transition Period||192
116529|NCT00086515|277002|P1|STARTED|Phase A to Phase B Transition Period||415
116530|NCT00086515|277001|P2|NOT COMPLETED|Phase A (Weeks 0-24)||45
116531|NCT00086515|277002|P1|NOT COMPLETED|Phase A (Weeks 0-24)||49
116532|NCT00086515|277001|P2|COMPLETED|Phase A (Weeks 0-24)||192
116533|NCT00086515|277002|P1|COMPLETED|Phase A (Weeks 0-24)||415
116534|NCT00086515|277001|P2|STARTED|Phase A (Weeks 0-24)||237
116535|NCT00086515|277002|P1|STARTED|Phase A (Weeks 0-24)||464
116536|NCT00086580|277014|P2|NOT COMPLETED|Observation Period||65
116537|NCT00086580|277015|P1|NOT COMPLETED|Observation Period||46
116538|NCT00086580|277014|P2|COMPLETED|Observation Period||56
116539|NCT00086580|277015|P1|COMPLETED|Observation Period||49
116540|NCT00086580|277014|P2|STARTED|Observation Period||121
116541|NCT00086580|277015|P1|STARTED|Observation Period||95
116542|NCT00086580|277014|P2|NOT COMPLETED|Follow-up Period||119
116543|NCT00086580|277015|P1|NOT COMPLETED|Follow-up Period||104
116544|NCT00086580|277014|P2|COMPLETED|Follow-up Period||18
116545|NCT00086580|277015|P1|COMPLETED|Follow-up Period||37
116546|NCT00086580|277014|P2|STARTED|Follow-up Period||137
116547|NCT00086580|277015|P1|STARTED|Follow-up Period||141
116548|NCT00086580|277014|P2|NOT COMPLETED|Treatment Period||60
116549|NCT00086580|277015|P1|NOT COMPLETED|Treatment Period||65
116638|NCT00087516|277175|P4|STARTED|Overall Study||123
116550|NCT00086580|277014|P2|COMPLETED|Treatment Period|Finished 6 cycles of study drug|107
116551|NCT00086580|277015|P1|COMPLETED|Treatment Period|Finished 6 cycles of study drugs|103
116552|NCT00086580|277014|P2|Safety Population|Treatment Period|Two participants did not receive treatment|165
116553|NCT00086580|277015|P1|Safety Population|Treatment Period|Four participants did not receive treatment|164
116554|NCT00086580|277014|P2|STARTED|Treatment Period||167
116555|NCT00086580|277015|P1|STARTED|Treatment Period||168
116556|NCT00086619|277061|P2|NOT COMPLETED|Overall Study||17
116557|NCT00086619|277062|P1|NOT COMPLETED|Overall Study||15
116558|NCT00086619|277061|P2|COMPLETED|Overall Study||23
116559|NCT00086619|277062|P1|COMPLETED|Overall Study||25
116560|NCT00086619|277061|P2|Completed 12 Month Visit|Overall Study||26
116561|NCT00086619|277062|P1|Completed 12 Month Visit|Overall Study||26
116562|NCT00086619|277061|P2|Completed Baseline Visit|Overall Study||36
116563|NCT00086619|277062|P1|Completed Baseline Visit|Overall Study||34
116564|NCT00086619|277061|P2|STARTED|Overall Study||40
116565|NCT00086619|277062|P1|STARTED|Overall Study||40
116566|NCT00086684|277073|P3|NOT COMPLETED|Overall Study||53
116567|NCT00086684|277074|P2|NOT COMPLETED|Overall Study||55
116568|NCT00086684|277075|P1|NOT COMPLETED|Overall Study||55
116569|NCT00086684|277073|P3|COMPLETED|Overall Study||69
116570|NCT00086684|277074|P2|COMPLETED|Overall Study||74
116571|NCT00086684|277075|P1|COMPLETED|Overall Study||63
116572|NCT00086684|277073|P3|STARTED|Overall Study||122
116573|NCT00086684|277074|P2|STARTED|Overall Study||129
116574|NCT00086684|277075|P1|STARTED|Overall Study||118
116575|NCT00086957|277086|P3|NOT COMPLETED|Overall Study||0
116576|NCT00086957|277087|P2|NOT COMPLETED|Overall Study||0
116577|NCT00086957|277088|P1|NOT COMPLETED|Overall Study||0
116578|NCT00086957|277086|P3|COMPLETED|Overall Study||22
116579|NCT00086957|277087|P2|COMPLETED|Overall Study||7
116580|NCT00086957|277088|P1|COMPLETED|Overall Study||2
116581|NCT00086957|277086|P3|STARTED|Overall Study||22
116582|NCT00086957|277087|P2|STARTED|Overall Study||7
116583|NCT00086957|277088|P1|STARTED|Overall Study||2
116584|NCT00086996|277098|P1|NOT COMPLETED|Overall Study||64
116585|NCT00086996|277098|P1|COMPLETED|Overall Study||34
116586|NCT00086996|277098|P1|Eligible and Began Protocol Therapy|Overall Study||93
116587|NCT00086996|277098|P1|Eligible|Overall Study||93
116588|NCT00086996|277098|P1|STARTED|Overall Study||98
116589|NCT00087139|277108|P3|NOT COMPLETED|Overall Study||36
116590|NCT00087139|277109|P2|NOT COMPLETED|Overall Study||49
116591|NCT00087139|277110|P1|NOT COMPLETED|Overall Study||39
116592|NCT00087139|277108|P3|COMPLETED|Overall Study||0
116593|NCT00087139|277109|P2|COMPLETED|Overall Study||0
116594|NCT00087139|277110|P1|COMPLETED|Overall Study||0
116595|NCT00087139|277108|P3|Patients w/ Measurable Disease Response|Overall Study||0
116596|NCT00087139|277109|P2|Patients w/ Measurable Disease Response|Overall Study||2
116597|NCT00087139|277110|P1|Patients w/ Measurable Disease Response|Overall Study||5
116598|NCT00087139|277108|P3|Patients With PSA Response|Overall Study||4
116599|NCT00087139|277109|P2|Patients With PSA Response|Overall Study||8
116600|NCT00087139|277110|P1|Patients With PSA Response|Overall Study||10
116601|NCT00087139|277108|P3|Patients With Measurable Disease|Overall Study||24
116602|NCT00087139|277109|P2|Patients With Measurable Disease|Overall Study||25
116603|NCT00087139|277110|P1|Patients With Measurable Disease|Overall Study||22
116604|NCT00087139|277108|P3|Patients for the Analysis of PSA Respons|Overall Study||22
116605|NCT00087139|277109|P2|Patients for the Analysis of PSA Respons|Overall Study||34
116606|NCT00087139|277110|P1|Patients for the Analysis of PSA Respons|Overall Study||30
116607|NCT00087139|277108|P3|Eligible and Treated|Overall Study||32
116608|NCT00087139|277109|P2|Eligible and Treated|Overall Study||42
116609|NCT00087139|277110|P1|Eligible and Treated|Overall Study||35
116610|NCT00087139|277108|P3|Treated|Overall Study||36
116611|NCT00087139|277109|P2|Treated|Overall Study||48
116612|NCT00087139|277110|P1|Treated|Overall Study||39
116613|NCT00087139|277108|P3|STARTED|Overall Study||36
116614|NCT00087139|277109|P2|STARTED|Overall Study||49
116615|NCT00087139|277110|P1|STARTED|Overall Study||39
116616|NCT00087152|277125|P1|NOT COMPLETED|Overall Study||6
116617|NCT00087152|277125|P1|COMPLETED|Overall Study||21
116618|NCT00087152|277125|P1|STARTED|Overall Study||27
116619|NCT00087438|277131|P1|NOT COMPLETED|Overall Study||4
116620|NCT00087438|277131|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|55
116621|NCT00087438|277131|P1|STARTED|Overall Study||59
116622|NCT00087490|277137|P2|NOT COMPLETED|Overall Study||269
116623|NCT00087490|277138|P1|NOT COMPLETED|Overall Study||258
116624|NCT00087490|277137|P2|COMPLETED|Overall Study||264
116625|NCT00087490|277138|P1|COMPLETED|Overall Study||286
116626|NCT00087490|277137|P2|Treated|Overall Study||515
116627|NCT00087490|277138|P1|Treated|Overall Study||537
116628|NCT00087490|277137|P2|STARTED|Overall Study||533
116629|NCT00087490|277138|P1|STARTED|Overall Study||544
116630|NCT00087516|277175|P4|NOT COMPLETED|Overall Study||85
116631|NCT00087516|277176|P3|NOT COMPLETED|Overall Study||97
116632|NCT00087516|277177|P2|NOT COMPLETED|Overall Study||169
116633|NCT00087516|277178|P1|NOT COMPLETED|Overall Study||161
116634|NCT00087516|277175|P4|COMPLETED|Overall Study||38
116635|NCT00087516|277176|P3|COMPLETED|Overall Study||33
116636|NCT00087516|277177|P2|COMPLETED|Overall Study||81
116637|NCT00087516|277178|P1|COMPLETED|Overall Study||77
116639|NCT00087516|277176|P3|STARTED|Overall Study||130
116640|NCT00087516|277177|P2|STARTED|Overall Study||250
116641|NCT00087516|277178|P1|STARTED|Overall Study||238
116642|NCT00087529|277207|P2|NOT COMPLETED|Overall Study||68
116643|NCT00087529|277208|P1|NOT COMPLETED|Overall Study||31
116644|NCT00087529|277207|P2|COMPLETED|Overall Study||224
116645|NCT00087529|277208|P1|COMPLETED|Overall Study||116
116646|NCT00087529|277207|P2|STARTED|Overall Study||292
116647|NCT00087529|277208|P1|STARTED|Overall Study||147
116648|NCT00087555|277223|P3|NOT COMPLETED|Overall Study||21
116649|NCT00087555|277224|P2|NOT COMPLETED|Overall Study||11
116650|NCT00087555|277225|P1|NOT COMPLETED|Overall Study||12
116651|NCT00087555|277223|P3|COMPLETED|Overall Study||46
116652|NCT00087555|277224|P2|COMPLETED|Overall Study||51
116653|NCT00087555|277225|P1|COMPLETED|Overall Study||54
116654|NCT00087555|277223|P3|Treated|Overall Study||67
116655|NCT00087555|277224|P2|Treated|Overall Study||60
116656|NCT00087555|277225|P1|Treated|Overall Study||65
116657|NCT00087555|277223|P3|STARTED|Overall Study||67
116658|NCT00087555|277224|P2|STARTED|Overall Study||62
116659|NCT00087555|277225|P1|STARTED|Overall Study||66
116660|NCT00087568|277235|P2|NOT COMPLETED|Overall Study||2
116661|NCT00087568|277236|P1|NOT COMPLETED|Overall Study||30
116662|NCT00087568|277235|P2|COMPLETED|Overall Study||23
116663|NCT00087568|277236|P1|COMPLETED|Overall Study||2
116664|NCT00087568|277235|P2|STARTED|Overall Study||25
116665|NCT00087568|277236|P1|STARTED|Overall Study||32
116666|NCT00087594|277262|P2|NOT COMPLETED|Overall Study||12
116667|NCT00087594|277263|P1|NOT COMPLETED|Overall Study||8
116668|NCT00087594|277262|P2|COMPLETED|Overall Study||12
116669|NCT00087594|277263|P1|COMPLETED|Overall Study||16
116670|NCT00087594|277262|P2|STARTED|Overall Study||24
116671|NCT00087594|277263|P1|STARTED|Overall Study||24
116672|NCT00087607|277297|P2|NOT COMPLETED|Overall Study||122
116673|NCT00087607|277298|P1|NOT COMPLETED|Overall Study||122
116674|NCT00087607|277297|P2|COMPLETED|Overall Study||71
116675|NCT00087607|277298|P1|COMPLETED|Overall Study||70
116676|NCT00087607|277297|P2|STARTED|Overall Study||193
116677|NCT00087607|277298|P1|STARTED|Overall Study||192
116678|NCT00087633|277338|P2|NOT COMPLETED|Overall Study||17
116679|NCT00087633|277339|P1|NOT COMPLETED|Overall Study||24
116680|NCT00087633|277338|P2|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|43
116681|NCT00087633|277339|P1|COMPLETED|Overall Study|Completed 48 weeks of treatment/observation|31
116682|NCT00087633|277338|P2|STARTED|Overall Study|Randomized|60
116683|NCT00087633|277339|P1|STARTED|Overall Study|Randomized|55
116684|NCT00087646|277351|P4|NOT COMPLETED|Overall Study||84
116685|NCT00087646|277352|P3|NOT COMPLETED|Overall Study||65
116686|NCT00087646|277353|P2|NOT COMPLETED|Overall Study||42
116687|NCT00087646|277354|P1|NOT COMPLETED|Overall Study||135
116688|NCT00087646|277351|P4|COMPLETED|Overall Study||229
116689|NCT00087646|277352|P3|COMPLETED|Overall Study||91
116690|NCT00087646|277353|P2|COMPLETED|Overall Study||114
116691|NCT00087646|277354|P1|COMPLETED|Overall Study||182
116692|NCT00087646|277351|P4|STARTED|Overall Study||313
116693|NCT00087646|277352|P3|STARTED|Overall Study||156
116694|NCT00087646|277353|P2|STARTED|Overall Study||156
116695|NCT00087646|277354|P1|STARTED|Overall Study||317
116696|NCT00087672|277380|P1|NOT COMPLETED|Overall Study||0
116697|NCT00087672|277380|P1|COMPLETED|Overall Study||41
116698|NCT00087672|277380|P1|STARTED|Overall Study||41
116699|NCT00087685|277384|P1|NOT COMPLETED|Overall Study||14
116700|NCT00087685|277384|P1|COMPLETED|Overall Study||21
116701|NCT00087685|277384|P1|STARTED|Overall Study||35
116702|NCT00087698|277389|P1|NOT COMPLETED|Overall Study||36
116703|NCT00087698|277389|P1|COMPLETED|Overall Study||41
116704|NCT00087698|277389|P1|STARTED|Overall Study||77
116705|NCT00081458|277401|P3|NOT COMPLETED|Overall Study||4
116706|NCT00081458|277402|P2|NOT COMPLETED|Overall Study||8
116707|NCT00081458|277403|P1|NOT COMPLETED|Overall Study||1
116708|NCT00081458|277401|P3|COMPLETED|Overall Study||29
116709|NCT00081458|277402|P2|COMPLETED|Overall Study||27
116710|NCT00081458|277403|P1|COMPLETED|Overall Study||15
116711|NCT00081458|277401|P3|Received Treatment|Overall Study|1 subject was randomized but did not receive the study drug|32
116712|NCT00081458|277402|P2|Received Treatment|Overall Study||35
116713|NCT00081458|277403|P1|Received Treatment|Overall Study||16
116714|NCT00081458|277401|P3|STARTED|Overall Study||33
116715|NCT00081458|277402|P2|STARTED|Overall Study||35
116716|NCT00081458|277403|P1|STARTED|Overall Study||16
116717|NCT00081497|277416|P2|NOT COMPLETED|Overall Study||2
116718|NCT00081497|277417|P1|NOT COMPLETED|Overall Study||3
116719|NCT00081497|277416|P2|COMPLETED|Overall Study||37
116720|NCT00081497|277417|P1|COMPLETED|Overall Study||25
116721|NCT00081497|277416|P2|STARTED|Overall Study|Patients who were randomized to Fabrazyme in AGAL-008-00 (NCT00074984).|39
116722|NCT00081497|277417|P1|STARTED|Overall Study|Patients who were randomized to placebo in AGAL-008-00 (NCT00074984).|28
116723|NCT00081653|277434|P2|NOT COMPLETED|Overall Study||37
116724|NCT00081653|277435|P1|NOT COMPLETED|Overall Study||47
116725|NCT00081653|277434|P2|COMPLETED|Overall Study|Completed 3 years of treatment|324
116726|NCT00081653|277435|P1|COMPLETED|Overall Study|Completed 3 years of treatment|311
116727|NCT00081653|277434|P2|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|361
116728|NCT00081653|277435|P1|STARTED|Overall Study|Patients entering Study MA17903 from Study BM16549|358
116729|NCT00081731|277453|P2|NOT COMPLETED|Overall Study||8
116730|NCT00081731|277454|P1|NOT COMPLETED|Overall Study||8
116731|NCT00081731|277453|P2|COMPLETED|Overall Study||459
116732|NCT00081731|277454|P1|COMPLETED|Overall Study||472
116733|NCT00081731|277453|P2|STARTED|Overall Study||467
116734|NCT00081731|277454|P1|STARTED|Overall Study||480
116735|NCT00081770|277475|P3|NOT COMPLETED|Overall Study||456
116736|NCT00081770|277476|P2|NOT COMPLETED|Overall Study||546
116737|NCT00081770|277477|P1|NOT COMPLETED|Overall Study||502
116738|NCT00081770|277475|P3|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|579
116739|NCT00081770|277476|P2|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|470
116740|NCT00081770|277477|P1|COMPLETED|Overall Study|Patients who discontinued treatment but continued in study are considered Not Completed|517
116741|NCT00081770|277475|P3|STARTED|Overall Study||1035
116742|NCT00081770|277476|P2|STARTED|Overall Study||1016
116743|NCT00081770|277477|P1|STARTED|Overall Study||1019
116744|NCT00088153|277496|P2|NOT COMPLETED|Overall Study||25
116745|NCT00088153|277497|P1|NOT COMPLETED|Overall Study||24
116746|NCT00088153|277496|P2|COMPLETED|Overall Study||30
116747|NCT00088153|277497|P1|COMPLETED|Overall Study||31
116748|NCT00088153|277496|P2|STARTED|Overall Study||55
116749|NCT00088153|277497|P1|STARTED|Overall Study||55
116750|NCT00088166|277509|P2|NOT COMPLETED|Overall Study||61
116751|NCT00088166|277510|P1|NOT COMPLETED|Overall Study||53
116752|NCT00088166|277509|P2|COMPLETED|Overall Study||39
116753|NCT00088166|277510|P1|COMPLETED|Overall Study||47
116754|NCT00088166|277509|P2|STARTED|Overall Study||100
116755|NCT00088166|277510|P1|STARTED|Overall Study||100
116756|NCT00088218|277534|P2|NOT COMPLETED|Overall Study||0
116757|NCT00088218|277535|P1|NOT COMPLETED|Overall Study||0
116758|NCT00088218|277534|P2|COMPLETED|Overall Study||79
116759|NCT00088218|277535|P1|COMPLETED|Overall Study||16
116760|NCT00088218|277534|P2|STARTED|Overall Study||79
116761|NCT00088218|277535|P1|STARTED|Overall Study||16
116762|NCT00090220|277543|P6|NOT COMPLETED|Long-term Follow-up (EXT2)||28
116763|NCT00090220|277544|P5|NOT COMPLETED|Long-term Follow-up (EXT2)||44
116764|NCT00090220|277545|P4|NOT COMPLETED|Long-term Follow-up (EXT2)||0
116765|NCT00090220|277546|P3|NOT COMPLETED|Long-term Follow-up (EXT2)||0
116766|NCT00090220|277547|P2|NOT COMPLETED|Long-term Follow-up (EXT2)||0
116767|NCT00090220|277548|P1|NOT COMPLETED|Long-term Follow-up (EXT2)||0
116768|NCT00090220|277543|P6|COMPLETED|Long-term Follow-up (EXT2)||623
116769|NCT00090220|277544|P5|COMPLETED|Long-term Follow-up (EXT2)||641
116770|NCT00090220|277545|P4|COMPLETED|Long-term Follow-up (EXT2)||0
116771|NCT00090220|277546|P3|COMPLETED|Long-term Follow-up (EXT2)||0
116772|NCT00090220|277547|P2|COMPLETED|Long-term Follow-up (EXT2)||0
116773|NCT00090220|277548|P1|COMPLETED|Long-term Follow-up (EXT2)||0
116774|NCT00090220|277543|P6|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|651
116775|NCT00090220|277544|P5|STARTED|Long-term Follow-up (EXT2)|Participation in LTFU was voluntary; not all participants eligible for LTFU enrolled.|685
116776|NCT00090220|277545|P4|STARTED|Long-term Follow-up (EXT2)||0
116777|NCT00090220|277546|P3|STARTED|Long-term Follow-up (EXT2)||0
116778|NCT00090220|277547|P2|STARTED|Long-term Follow-up (EXT2)||0
116779|NCT00090220|277548|P1|STARTED|Long-term Follow-up (EXT2)||0
116780|NCT00090220|277543|P6|NOT COMPLETED|Extension 1 (EXT1)||0
116781|NCT00090220|277544|P5|NOT COMPLETED|Extension 1 (EXT1)||0
116782|NCT00090220|277545|P4|NOT COMPLETED|Extension 1 (EXT1)||2
116783|NCT00090220|277546|P3|NOT COMPLETED|Extension 1 (EXT1)||55
116784|NCT00090220|277547|P2|NOT COMPLETED|Extension 1 (EXT1)||0
116785|NCT00090220|277548|P1|NOT COMPLETED|Extension 1 (EXT1)||0
116786|NCT00090220|277543|P6|COMPLETED|Extension 1 (EXT1)||0
116787|NCT00090220|277544|P5|COMPLETED|Extension 1 (EXT1)||0
116788|NCT00090220|277545|P4|COMPLETED|Extension 1 (EXT1)||5
116789|NCT00090220|277546|P3|COMPLETED|Extension 1 (EXT1)||1267
116790|NCT00090220|277547|P2|COMPLETED|Extension 1 (EXT1)||0
116791|NCT00090220|277548|P1|COMPLETED|Extension 1 (EXT1)||0
116792|NCT00090220|277543|P6|Vaccinated|Extension 1 (EXT1)||0
116793|NCT00090220|277544|P5|Vaccinated|Extension 1 (EXT1)||0
116794|NCT00090220|277545|P4|Vaccinated|Extension 1 (EXT1)||7
116795|NCT00090220|277546|P3|Vaccinated|Extension 1 (EXT1)||1321
116796|NCT00090220|277547|P2|Vaccinated|Extension 1 (EXT1)||0
116797|NCT00090220|277548|P1|Vaccinated|Extension 1 (EXT1)||0
116798|NCT00090220|277543|P6|STARTED|Extension 1 (EXT1)||0
116799|NCT00090220|277544|P5|STARTED|Extension 1 (EXT1)||0
116800|NCT00090220|277545|P4|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|7
116801|NCT00090220|277546|P3|STARTED|Extension 1 (EXT1)|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1322
116802|NCT00090220|277547|P2|STARTED|Extension 1 (EXT1)||0
116803|NCT00090220|277548|P1|STARTED|Extension 1 (EXT1)||0
116804|NCT00090220|277543|P6|NOT COMPLETED|Base Study Follow-up Period||0
116805|NCT00090220|277544|P5|NOT COMPLETED|Base Study Follow-up Period||0
116806|NCT00090220|277545|P4|NOT COMPLETED|Base Study Follow-up Period||0
116807|NCT00090220|277546|P3|NOT COMPLETED|Base Study Follow-up Period||0
116808|NCT00090220|277547|P2|NOT COMPLETED|Base Study Follow-up Period||164
116809|NCT00090220|277548|P1|NOT COMPLETED|Base Study Follow-up Period||160
116810|NCT00090220|277543|P6|COMPLETED|Base Study Follow-up Period||0
116811|NCT00090220|277544|P5|COMPLETED|Base Study Follow-up Period||0
116812|NCT00090220|277545|P4|COMPLETED|Base Study Follow-up Period||0
116813|NCT00090220|277546|P3|COMPLETED|Base Study Follow-up Period||0
116814|NCT00090220|277547|P2|COMPLETED|Base Study Follow-up Period||1687
116815|NCT00090220|277548|P1|COMPLETED|Base Study Follow-up Period||1695
116816|NCT00090220|277543|P6|STARTED|Base Study Follow-up Period||0
116817|NCT00090220|277544|P5|STARTED|Base Study Follow-up Period||0
116818|NCT00090220|277545|P4|STARTED|Base Study Follow-up Period||0
116819|NCT00090220|277546|P3|STARTED|Base Study Follow-up Period||0
116820|NCT00090220|277547|P2|STARTED|Base Study Follow-up Period|5 participants did not complete the Vaccination Period but entered the Follow-up Period.|1851
116821|NCT00090220|277548|P1|STARTED|Base Study Follow-up Period|8 participants did not complete the Vaccination Period but entered the Follow-up Period.|1855
116822|NCT00090220|277543|P6|NOT COMPLETED|Base Study Vaccination Period||0
116823|NCT00090220|277544|P5|NOT COMPLETED|Base Study Vaccination Period||0
116824|NCT00090220|277545|P4|NOT COMPLETED|Base Study Vaccination Period||0
116825|NCT00090220|277546|P3|NOT COMPLETED|Base Study Vaccination Period||0
116826|NCT00090220|277547|P2|NOT COMPLETED|Base Study Vaccination Period||63
116827|NCT00090220|277548|P1|NOT COMPLETED|Base Study Vaccination Period||64
116828|NCT00090220|277543|P6|COMPLETED|Base Study Vaccination Period||0
116829|NCT00090220|277544|P5|COMPLETED|Base Study Vaccination Period||0
116830|NCT00090220|277545|P4|COMPLETED|Base Study Vaccination Period||0
116831|NCT00090220|277546|P3|COMPLETED|Base Study Vaccination Period||0
116832|NCT00090220|277547|P2|COMPLETED|Base Study Vaccination Period||1845
116833|NCT00090220|277548|P1|COMPLETED|Base Study Vaccination Period||1847
116834|NCT00090220|277543|P6|Vaccinated|Base Study Vaccination Period||0
116835|NCT00090220|277544|P5|Vaccinated|Base Study Vaccination Period||0
116836|NCT00090220|277545|P4|Vaccinated|Base Study Vaccination Period||0
116837|NCT00090220|277546|P3|Vaccinated|Base Study Vaccination Period||0
116838|NCT00090220|277547|P2|Vaccinated|Base Study Vaccination Period||1907
116839|NCT00090220|277548|P1|Vaccinated|Base Study Vaccination Period||1910
116840|NCT00090220|277543|P6|STARTED|Base Study Vaccination Period||0
116841|NCT00090220|277544|P5|STARTED|Base Study Vaccination Period||0
116842|NCT00090220|277545|P4|STARTED|Base Study Vaccination Period||0
116843|NCT00090220|277546|P3|STARTED|Base Study Vaccination Period||0
116844|NCT00090220|277547|P2|STARTED|Base Study Vaccination Period||1908
116845|NCT00090220|277548|P1|STARTED|Base Study Vaccination Period||1911
116846|NCT00090233|277642|P2|NOT COMPLETED|Overall Study||5065
116847|NCT00090233|277643|P1|NOT COMPLETED|Overall Study||4999
116848|NCT00090233|277642|P2|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29565
116849|NCT00090233|277643|P1|COMPLETED|Overall Study|Does not include participants who discontinued prior to the 42 day safety follow-up|29645
116850|NCT00090233|277642|P2|Vaccinated at Visit 3|Overall Study||29598
116851|NCT00090233|277643|P1|Vaccinated at Visit 3|Overall Study||29667
116852|NCT00090233|277642|P2|Vaccinated at Visit 2|Overall Study||31066
116853|NCT00090233|277643|P1|Vaccinated at Visit 2|Overall Study||31052
116854|NCT00090233|277642|P2|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 627|34003
116855|NCT00090233|277643|P1|Vaccinated at Visit 1|Overall Study|Randomized Not vaccinated 609|34035
116856|NCT00090233|277642|P2|STARTED|Overall Study|Evaluated by data safety monitoring board when they recommended stopping enrollment|34630
116857|NCT00090233|277643|P1|STARTED|Overall Study|Evaluated by data safety monitoring board (DSMB) when they recommended stopping enrollment|34644
116858|NCT00090259|277667|P2|NOT COMPLETED|Overall Study||48
116859|NCT00090259|277668|P1|NOT COMPLETED|Overall Study||62
116860|NCT00090259|277667|P2|COMPLETED|Overall Study|Completed follow-up: 1005 on drug, 233 off drug,& 635 at death (death was considered an endpoint)|1873
116861|NCT00090259|277668|P1|COMPLETED|Overall Study|Completed follow-up: 963 on drug, 223 off drug, & 665 at death (death was considered an endpoint)|1851
116862|NCT00090259|277667|P2|STARTED|Overall Study||1921
116863|NCT00090259|277668|P1|STARTED|Overall Study||1913
116864|NCT00090285|277684|P4|NOT COMPLETED|Extension 1||1
116865|NCT00090285|277685|P3|NOT COMPLETED|Extension 1||57
116866|NCT00090285|277686|P2|NOT COMPLETED|Extension 1||0
116867|NCT00090285|277687|P1|NOT COMPLETED|Extension 1||0
116868|NCT00090285|277684|P4|COMPLETED|Extension 1||15
116869|NCT00090285|277685|P3|COMPLETED|Extension 1||1041
116870|NCT00090285|277686|P2|COMPLETED|Extension 1||0
116871|NCT00090285|277687|P1|COMPLETED|Extension 1||0
116872|NCT00090285|277684|P4|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|16
116873|NCT00090285|277685|P3|STARTED|Extension 1|Participation in EXT1 was voluntary; not all participants eligible for EXT1 enrolled.|1098
116874|NCT00090285|277686|P2|STARTED|Extension 1||0
116875|NCT00090285|277687|P1|STARTED|Extension 1||0
116876|NCT00090285|277684|P4|NOT COMPLETED|Base Study Follow-up Period||0
116877|NCT00090285|277685|P3|NOT COMPLETED|Base Study Follow-up Period||0
116878|NCT00090285|277686|P2|NOT COMPLETED|Base Study Follow-up Period||342
116879|NCT00090285|277687|P1|NOT COMPLETED|Base Study Follow-up Period||335
116880|NCT00090285|277684|P4|COMPLETED|Base Study Follow-up Period||0
116881|NCT00090285|277685|P3|COMPLETED|Base Study Follow-up Period||0
116882|NCT00090285|277686|P2|COMPLETED|Base Study Follow-up Period||1479
116883|NCT00090285|277687|P1|COMPLETED|Base Study Follow-up Period||1487
116884|NCT00090285|277684|P4|STARTED|Base Study Follow-up Period||0
116885|NCT00090285|277685|P3|STARTED|Base Study Follow-up Period||0
116886|NCT00090285|277686|P2|STARTED|Base Study Follow-up Period|7 subjects who did not receive 3 doses of placebo in base study continued into the Follow-up Period|1821
116887|NCT00090285|277687|P1|STARTED|Base Study Follow-up Period|4 subjects who did not receive 3 doses of vaccine in base study continued into the Follow-up Period|1822
116888|NCT00090285|277684|P4|NOT COMPLETED|Base Study Vaccination Period||0
116889|NCT00090285|277685|P3|NOT COMPLETED|Base Study Vaccination Period||0
116890|NCT00090285|277686|P2|NOT COMPLETED|Base Study Vaccination Period||219
116891|NCT00090285|277687|P1|NOT COMPLETED|Base Study Vaccination Period||214
116892|NCT00090285|277684|P4|COMPLETED|Base Study Vaccination Period||0
116893|NCT00090285|277685|P3|COMPLETED|Base Study Vaccination Period||0
116894|NCT00090285|277686|P2|COMPLETED|Base Study Vaccination Period||1814
116895|NCT00090285|277687|P1|COMPLETED|Base Study Vaccination Period||1818
116896|NCT00090285|277684|P4|Vaccinated|Base Study Vaccination Period||0
116897|NCT00090285|277685|P3|Vaccinated|Base Study Vaccination Period||0
116898|NCT00090285|277686|P2|Vaccinated|Base Study Vaccination Period||2030
116899|NCT00090285|277687|P1|Vaccinated|Base Study Vaccination Period||2025
116900|NCT00090285|277684|P4|STARTED|Base Study Vaccination Period||0
116901|NCT00090285|277685|P3|STARTED|Base Study Vaccination Period||0
116902|NCT00090285|277686|P2|STARTED|Base Study Vaccination Period||2033
116903|NCT00090285|277687|P1|STARTED|Base Study Vaccination Period||2032
116904|NCT00090363|277707|P3|NOT COMPLETED|Overall Study||96
116905|NCT00090363|277708|P2|NOT COMPLETED|Overall Study||107
116906|NCT00090363|277709|P1|NOT COMPLETED|Overall Study||106
116907|NCT00090363|277707|P3|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|2
116908|NCT00090363|277708|P2|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|0
116909|NCT00090363|277709|P1|COMPLETED|Overall Study|Number of patients receiving study treatment at data cut-off (18th December 2008).|1
116910|NCT00090363|277707|P3|Received Study Treatment.|Overall Study||98
116911|NCT00090363|277708|P2|Received Study Treatment.|Overall Study||107
116912|NCT00090363|277709|P1|Received Study Treatment.|Overall Study||107
116913|NCT00090363|277707|P3|STARTED|Overall Study||98
116914|NCT00090363|277708|P2|STARTED|Overall Study||107
116915|NCT00090363|277709|P1|STARTED|Overall Study||107
116916|NCT00090402|277732|P3|NOT COMPLETED|Overall Study||1
116917|NCT00090402|277733|P2|NOT COMPLETED|Overall Study||2
116918|NCT00090402|277734|P1|NOT COMPLETED|Overall Study||2
116919|NCT00090402|277732|P3|COMPLETED|Overall Study||12
116920|NCT00090402|277733|P2|COMPLETED|Overall Study||11
116921|NCT00090402|277734|P1|COMPLETED|Overall Study||11
116922|NCT00090402|277732|P3|STARTED|Overall Study||13
116923|NCT00090402|277733|P2|STARTED|Overall Study||13
116924|NCT00090402|277734|P1|STARTED|Overall Study||13
116925|NCT00090493|277748|P1|NOT COMPLETED|Overall Study||2
116926|NCT00090493|277748|P1|COMPLETED|Overall Study||2
116927|NCT00090493|277748|P1|STARTED|Overall Study||4
116928|NCT00090519|277754|P2|NOT COMPLETED|Overall Study||75
116929|NCT00090519|277755|P1|NOT COMPLETED|Overall Study||73
116930|NCT00090519|277754|P2|COMPLETED|Overall Study||285
116931|NCT00090519|277755|P1|COMPLETED|Overall Study||298
116932|NCT00090519|277754|P2|STARTED|Overall Study||360
116933|NCT00090519|277755|P1|STARTED|Overall Study||371
116934|NCT00090545|277781|P2|NOT COMPLETED|Overall Study||24
116935|NCT00090545|277782|P1|NOT COMPLETED|Overall Study||22
116936|NCT00090545|277781|P2|COMPLETED|Overall Study||0
116937|NCT00090545|277782|P1|COMPLETED|Overall Study||0
116938|NCT00090545|277781|P2|STARTED|Overall Study||24
116939|NCT00090545|277782|P1|STARTED|Overall Study||22
116940|NCT00090584|277792|P2|NOT COMPLETED|Baseline to 8 Months||41
116941|NCT00090584|277793|P1|NOT COMPLETED|Baseline to 8 Months||44
116942|NCT00090584|277792|P2|COMPLETED|Baseline to 8 Months||112
116943|NCT00090584|277793|P1|COMPLETED|Baseline to 8 Months||110
116944|NCT00090584|277792|P2|STARTED|Baseline to 8 Months||153
116945|NCT00090584|277793|P1|STARTED|Baseline to 8 Months||154
116946|NCT00090584|277792|P2|NOT COMPLETED|Baseline to 10 Weeks||12
116947|NCT00090584|277793|P1|NOT COMPLETED|Baseline to 10 Weeks||15
116948|NCT00090584|277792|P2|COMPLETED|Baseline to 10 Weeks||141
116949|NCT00090584|277793|P1|COMPLETED|Baseline to 10 Weeks||139
116950|NCT00090584|277792|P2|STARTED|Baseline to 10 Weeks||153
116951|NCT00090584|277793|P1|STARTED|Baseline to 10 Weeks||154
116952|NCT00090610|277825|P2|NOT COMPLETED|Overall Study||1
116953|NCT00090610|277826|P1|NOT COMPLETED|Overall Study||1
116954|NCT00090610|277825|P2|COMPLETED|Overall Study||74
116955|NCT00090610|277826|P1|COMPLETED|Overall Study||74
116956|NCT00090610|277825|P2|STARTED|Overall Study||75
116957|NCT00090610|277826|P1|STARTED|Overall Study||75
116958|NCT00090753|277842|P2|NOT COMPLETED|Extended Treatment Period||191
116959|NCT00090753|277843|P1|NOT COMPLETED|Extended Treatment Period||359
116960|NCT00090753|277842|P2|COMPLETED|Extended Treatment Period||59
116961|NCT00090753|277843|P1|COMPLETED|Extended Treatment Period||94
116962|NCT00090753|277842|P2|STARTED|Extended Treatment Period|52 patients who completed the first treatment period refused to enter the extended treatment period.|250
116963|NCT00090753|277843|P1|STARTED|Extended Treatment Period|39 patients who completed the first treatment period refused to enter the extended treatment period.|453
116964|NCT00090753|277842|P2|NOT COMPLETED|First Treatment Period||178
116965|NCT00090753|277843|P1|NOT COMPLETED|First Treatment Period||256
116966|NCT00090753|277842|P2|COMPLETED|First Treatment Period||302
116967|NCT00090753|277843|P1|COMPLETED|First Treatment Period||492
116968|NCT00090753|277842|P2|STARTED|First Treatment Period||480
116969|NCT00090753|277843|P1|STARTED|First Treatment Period||748
116970|NCT00090766|277854|P3|NOT COMPLETED|Overall Study||3
116971|NCT00090766|277855|P2|NOT COMPLETED|Overall Study||2
116972|NCT00090766|277856|P1|NOT COMPLETED|Overall Study||3
116973|NCT00090766|277854|P3|COMPLETED|Overall Study||22
116974|NCT00090766|277855|P2|COMPLETED|Overall Study||19
116975|NCT00090766|277856|P1|COMPLETED|Overall Study||14
116976|NCT00090766|277854|P3|STARTED|Overall Study||25
116977|NCT00090766|277855|P2|STARTED|Overall Study||21
116978|NCT00090766|277856|P1|STARTED|Overall Study||17
116979|NCT00090779|277898|P2|NOT COMPLETED|Step 3||5
116980|NCT00090779|277899|P1|NOT COMPLETED|Step 3||7
116981|NCT00090779|277898|P2|COMPLETED|Step 3||0
116982|NCT00090779|277899|P1|COMPLETED|Step 3||0
116983|NCT00090779|277898|P2|STARTED|Step 3||5
116984|NCT00090779|277899|P1|STARTED|Step 3||7
116985|NCT00090779|277898|P2|NOT COMPLETED|Step 2||18
116986|NCT00090779|277899|P1|NOT COMPLETED|Step 2||6
116987|NCT00090779|277898|P2|COMPLETED|Step 2||1
116988|NCT00090779|277899|P1|COMPLETED|Step 2||0
116989|NCT00090779|277898|P2|STARTED|Step 2|Three with two consecutive CD4<350cells/mm^3 and one with CDC category B event didn't enter step 2.|19
116990|NCT00090779|277899|P1|STARTED|Step 2|One subject who had two consecutive CD4<350cells/mm^3 did not enter step 2.|6
116991|NCT00090779|277898|P2|NOT COMPLETED|Step 1||15
116992|NCT00090779|277899|P1|NOT COMPLETED|Step 1||11
116993|NCT00090779|277898|P2|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|49
116994|NCT00090779|277899|P1|COMPLETED|Step 1|Results are based on the database frozen on July 2, 2009 per DSMB recommendation of study closure.|55
116995|NCT00090779|277898|P2|STARTED|Step 1||64
116996|NCT00090779|277899|P1|STARTED|Step 1||66
116997|NCT00090844|277922|P2|NOT COMPLETED|Overall Study||1
116998|NCT00090844|277923|P1|NOT COMPLETED|Overall Study||1
116999|NCT00090844|277922|P2|COMPLETED|Overall Study||21
117000|NCT00090844|277923|P1|COMPLETED|Overall Study||26
117001|NCT00090844|277922|P2|STARTED|Overall Study||22
117002|NCT00090844|277923|P1|STARTED|Overall Study||27
117003|NCT00090857|277931|P2|NOT COMPLETED|Overall Study||3
117004|NCT00090857|277932|P1|NOT COMPLETED|Overall Study||4
117005|NCT00090857|277931|P2|COMPLETED|Overall Study||13
117006|NCT00090857|277932|P1|COMPLETED|Overall Study||29
117007|NCT00090857|277931|P2|STARTED|Overall Study||16
117008|NCT00090857|277932|P1|STARTED|Overall Study||33
117009|NCT00090987|277960|P1|NOT COMPLETED|Overall Study||21
117010|NCT00090987|277960|P1|COMPLETED|Overall Study||9
117011|NCT00090987|277960|P1|STARTED|Overall Study||30
117012|NCT00091026|277966|P2|NOT COMPLETED|Overall Study||3
117013|NCT00091026|277967|P1|NOT COMPLETED|Overall Study||1
117014|NCT00091026|277966|P2|COMPLETED|Overall Study||68
117015|NCT00091026|277967|P1|COMPLETED|Overall Study||71
117016|NCT00091026|277966|P2|STARTED|Overall Study||71
117017|NCT00091026|277967|P1|STARTED|Overall Study||72
117018|NCT00091169|277979|P2|NOT COMPLETED|Overall Study||53
117019|NCT00091169|277980|P1|NOT COMPLETED|Overall Study||57
117020|NCT00091169|277979|P2|COMPLETED|Overall Study||134
117021|NCT00091169|277980|P1|COMPLETED|Overall Study||132
117022|NCT00091169|277979|P2|Treated|Overall Study||170
117023|NCT00091169|277980|P1|Treated|Overall Study||163
117024|NCT00091169|277979|P2|STARTED|Overall Study||187
117025|NCT00091169|277980|P1|STARTED|Overall Study||189
117026|NCT00091260|277996|P1|NOT COMPLETED|Overall Study||0
117027|NCT00091260|277996|P1|COMPLETED|Overall Study||82
117028|NCT00091260|277996|P1|STARTED|Overall Study||82
117029|NCT00091273|278002|P1|NOT COMPLETED|Overall Study||0
117030|NCT00091273|278002|P1|COMPLETED|Overall Study||9
117031|NCT00091273|278002|P1|STARTED|Overall Study||9
117032|NCT00091390|278008|P1|NOT COMPLETED|Overall Study||4
117033|NCT00091390|278008|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|125
117034|NCT00091390|278008|P1|STARTED|Overall Study||129
117035|NCT00091442|278014|P2|NOT COMPLETED|Overall Study||373
117036|NCT00091442|278015|P1|NOT COMPLETED|Overall Study||369
117037|NCT00091442|278014|P2|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|5
117038|NCT00091442|278015|P1|COMPLETED|Overall Study|Indicates number of participants on study treatment at time of the primary objective|4
117039|NCT00091442|278014|P2|STARTED|Overall Study||378
117040|NCT00091442|278015|P1|STARTED|Overall Study||373
117041|NCT00091507|278027|P2|NOT COMPLETED|Overall Study||19
117042|NCT00091507|278028|P1|NOT COMPLETED|Overall Study||21
117043|NCT00091507|278027|P2|COMPLETED|Overall Study||460
117044|NCT00091507|278028|P1|COMPLETED|Overall Study||411
117045|NCT00091507|278027|P2|STARTED|Overall Study||479
117046|NCT00091507|278028|P1|STARTED|Overall Study||432
117047|NCT00091572|278044|P2|NOT COMPLETED|Overall Study||82
117048|NCT00091572|278045|P1|NOT COMPLETED|Overall Study||95
117049|NCT00091572|278044|P2|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|348
117050|NCT00091572|278045|P1|COMPLETED|Overall Study|Progressive disease/relapse/death due to progressive disease|334
117051|NCT00091572|278044|P2|STARTED|Overall Study|9 subjects in dacarbazine group not treated.|430
117052|NCT00091572|278045|P1|STARTED|Overall Study|10 subjects in temozolomide group not treated.|429
117053|NCT00091793|278059|P2|NOT COMPLETED|Overall Study||22
117054|NCT00091793|278060|P1|NOT COMPLETED|Overall Study||24
117055|NCT00091793|278059|P2|COMPLETED|Overall Study||144
117056|NCT00091793|278060|P1|COMPLETED|Overall Study||142
117057|NCT00091793|278059|P2|STARTED|Overall Study||166
117058|NCT00091793|278060|P1|STARTED|Overall Study||166
117059|NCT00091819|278084|P2|NOT COMPLETED|Overall Study||46
117060|NCT00091819|278085|P1|NOT COMPLETED|Overall Study||42
117061|NCT00091819|278084|P2|COMPLETED|Overall Study||387
117062|NCT00091819|278085|P1|COMPLETED|Overall Study||387
117063|NCT00091819|278084|P2|STARTED|Overall Study||433
117064|NCT00091819|278085|P1|STARTED|Overall Study||429
117065|NCT00091832|278097|P6|NOT COMPLETED|Overall Study||11
117066|NCT00091832|278098|P5|NOT COMPLETED|Overall Study||15
117067|NCT00091832|278099|P4|NOT COMPLETED|Overall Study||14
117068|NCT00091832|278100|P3|NOT COMPLETED|Overall Study||12
117069|NCT00091832|278101|P2|NOT COMPLETED|Overall Study||11
117070|NCT00091832|278102|P1|NOT COMPLETED|Overall Study||14
117071|NCT00091832|278097|P6|COMPLETED|Overall Study||32
117072|NCT00091832|278098|P5|COMPLETED|Overall Study||27
117073|NCT00091832|278099|P4|COMPLETED|Overall Study||29
117074|NCT00091832|278100|P3|COMPLETED|Overall Study||30
117075|NCT00091832|278101|P2|COMPLETED|Overall Study||31
117076|NCT00091832|278102|P1|COMPLETED|Overall Study||29
117077|NCT00091832|278097|P6|Received Study Medication|Overall Study||43
117078|NCT00091832|278098|P5|Received Study Medication|Overall Study||42
117079|NCT00091832|278099|P4|Received Study Medication|Overall Study||43
117080|NCT00091832|278100|P3|Received Study Medication|Overall Study||41
117081|NCT00091832|278101|P2|Received Study Medication|Overall Study||42
117082|NCT00091832|278102|P1|Received Study Medication|Overall Study||43
117083|NCT00091832|278097|P6|STARTED|Overall Study||43
117084|NCT00091832|278098|P5|STARTED|Overall Study||42
117085|NCT00091832|278099|P4|STARTED|Overall Study||43
117086|NCT00091832|278100|P3|STARTED|Overall Study||42
117087|NCT00091832|278101|P2|STARTED|Overall Study||42
117088|NCT00091832|278102|P1|STARTED|Overall Study||43
117089|NCT00091949|278220|P2|NOT COMPLETED|Overall Study||151
117090|NCT00091949|278221|P1|NOT COMPLETED|Overall Study||175
117091|NCT00091949|278220|P2|COMPLETED|Overall Study||1786
117092|NCT00091949|278221|P1|COMPLETED|Overall Study||1764
117093|NCT00091949|278220|P2|STARTED|Overall Study||1937
117094|NCT00091949|278221|P1|STARTED|Overall Study||1939
117095|NCT00091962|278242|P3|NOT COMPLETED|Overall Study||0
117096|NCT00091962|278243|P2|NOT COMPLETED|Overall Study||0
117097|NCT00091962|278244|P1|NOT COMPLETED|Overall Study||0
117098|NCT00091962|278242|P3|COMPLETED|Overall Study||151
117099|NCT00091962|278243|P2|COMPLETED|Overall Study||152
117100|NCT00091962|278244|P1|COMPLETED|Overall Study||150
117101|NCT00091962|278242|P3|STARTED|Overall Study||151
117102|NCT00091962|278243|P2|STARTED|Overall Study||152
117103|NCT00091962|278244|P1|STARTED|Overall Study||150
117104|NCT00092118|278263|P2|NOT COMPLETED|Overall Study||89
117105|NCT00092118|278264|P1|NOT COMPLETED|Overall Study||84
117106|NCT00092118|278263|P2|COMPLETED|Overall Study||913
117107|NCT00092118|278264|P1|COMPLETED|Overall Study||906
117108|NCT00092118|278263|P2|STARTED|Overall Study|2 patients discontinued after randomization due to adverse experience that began pre-randomization.|1002
117109|NCT00092118|278264|P1|STARTED|Overall Study|1 patient discontinued after randomization due to a adverse experience that began pre-randomization.|990
117110|NCT00092131|278274|P2|NOT COMPLETED|Treatment Period II||1
117111|NCT00092131|278275|P1|NOT COMPLETED|Treatment Period II||0
117112|NCT00092131|278274|P2|COMPLETED|Treatment Period II||25
117113|NCT00092131|278275|P1|COMPLETED|Treatment Period II||24
117114|NCT00092131|278274|P2|STARTED|Treatment Period II|1 patient discontinued after taking Period II study medication, due to asthma exacerbation|26
117115|NCT00092131|278275|P1|STARTED|Treatment Period II||24
117116|NCT00092131|278274|P2|NOT COMPLETED|Treatment Period I||0
117117|NCT00092131|278275|P1|NOT COMPLETED|Treatment Period I||1
117118|NCT00092131|278274|P2|COMPLETED|Treatment Period I||26
117119|NCT00092131|278275|P1|COMPLETED|Treatment Period I||24
117120|NCT00092131|278274|P2|STARTED|Treatment Period I||26
117121|NCT00092131|278275|P1|STARTED|Treatment Period I|1 patient discontinued due to influenza which started in washout (11 days after Period I medication)|25
117122|NCT00092417|278305|P2|NOT COMPLETED|Overall Study||1
117123|NCT00092417|278306|P1|NOT COMPLETED|Overall Study||5
117124|NCT00092417|278305|P2|COMPLETED|Overall Study|Received the lower potency zoster vaccine & completed 42 days of safety follow-up post vaccination|233
117125|NCT00092417|278306|P1|COMPLETED|Overall Study|Received the higher potency zoster vaccine & completed 42 days of safety follow-up post vaccination|459
117126|NCT00092417|278305|P2|Vaccinated|Overall Study||234
117127|NCT00092417|278306|P1|Vaccinated|Overall Study|3 participants were allocated,not vaccinated; they are not reported in the Baseline Characteristics|461
117128|NCT00092417|278305|P2|STARTED|Overall Study|Started Period Group 2|234
117129|NCT00092417|278306|P1|STARTED|Overall Study|Started Period Group 1|464
117130|NCT00092443|278322|P2|NOT COMPLETED|Overall Study||54
117131|NCT00092443|278323|P1|NOT COMPLETED|Overall Study||58
117132|NCT00092443|278322|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|607
117133|NCT00092443|278323|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up 42 days after each dose, thru 1st rotavirus season post study|593
117134|NCT00092443|278322|P2|Vaccinated at Visit 3|Overall Study||608
117135|NCT00092443|278323|P1|Vaccinated at Visit 3|Overall Study||593
117136|NCT00092443|278322|P2|Vaccinated at Visit 2|Overall Study||627
117137|NCT00092443|278323|P1|Vaccinated at Visit 2|Overall Study||618
117138|NCT00092443|278322|P2|Vaccinated at Visit 1|Overall Study||660
117139|NCT00092443|278323|P1|Vaccinated at Visit 1|Overall Study||650
117140|NCT00092443|278322|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|661
117141|NCT00092443|278323|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|651
117142|NCT00092456|278343|P4|NOT COMPLETED|Overall Study||16
117143|NCT00092456|278344|P3|NOT COMPLETED|Overall Study||29
117144|NCT00092456|278345|P2|NOT COMPLETED|Overall Study||17
117145|NCT00092456|278346|P1|NOT COMPLETED|Overall Study||25
117146|NCT00092456|278343|P4|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|97
117147|NCT00092456|278344|P3|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|200
117148|NCT00092456|278345|P2|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|208
117149|NCT00092456|278346|P1|COMPLETED|Overall Study|Subjects who received 3 scheduled vaccinations; with up to 42 days safety follow-up after each dose|201
117150|NCT00092456|278343|P4|Vaccinated at Visit 3|Overall Study||98
117151|NCT00092456|278344|P3|Vaccinated at Visit 3|Overall Study||200
117152|NCT00092456|278345|P2|Vaccinated at Visit 3|Overall Study||210
117153|NCT00092456|278346|P1|Vaccinated at Visit 3|Overall Study||202
117154|NCT00092456|278343|P4|Vaccinated at Visit 2|Overall Study||104
117155|NCT00092456|278344|P3|Vaccinated at Visit 2|Overall Study||210
117156|NCT00092456|278345|P2|Vaccinated at Visit 2|Overall Study||217
117157|NCT00092456|278346|P1|Vaccinated at Visit 2|Overall Study||208
117158|NCT00092456|278343|P4|Vaccinated at Visit 1|Overall Study||113
117159|NCT00092456|278344|P3|Vaccinated at Visit 1|Overall Study||229
117160|NCT00092456|278345|P2|Vaccinated at Visit 1|Overall Study||225
117161|NCT00092456|278346|P1|Vaccinated at Visit 1|Overall Study||226
117162|NCT00092456|278343|P4|STARTED|Overall Study|Subjects assigned to Placebo-matching RotaTeq™|113
117163|NCT00092456|278344|P3|STARTED|Overall Study|Subject assigned to ~6.91 X 10^7 IU/Dose of RotaTeq™ - Lot 3|229
117164|NCT00092456|278345|P2|STARTED|Overall Study|Subject assigned to ~8.01 X 10^7 IU/Dose of RotaTeq™ - Lot 2|225
117165|NCT00092456|278346|P1|STARTED|Overall Study|Subject assigned to ~8.81 X 10^7 IU/Dose of RotaTeq™ - Lot 1|226
117166|NCT00092495|278396|P5|NOT COMPLETED|Extension Study||0
117167|NCT00092495|278397|P4|NOT COMPLETED|Extension Study||0
117168|NCT00092495|278398|P3|NOT COMPLETED|Extension Study||0
117169|NCT00092495|278399|P2|NOT COMPLETED|Extension Study||0
117170|NCT00092495|278400|P1|NOT COMPLETED|Extension Study||0
117171|NCT00092495|278396|P5|COMPLETED|Extension Study||12
117172|NCT00092495|278397|P4|COMPLETED|Extension Study||0
117173|NCT00092495|278398|P3|COMPLETED|Extension Study||0
117174|NCT00092495|278399|P2|COMPLETED|Extension Study||0
117175|NCT00092495|278400|P1|COMPLETED|Extension Study||0
117176|NCT00092495|278396|P5|STARTED|Extension Study||12
117177|NCT00092495|278397|P4|STARTED|Extension Study||0
117178|NCT00092495|278398|P3|STARTED|Extension Study||0
117179|NCT00092495|278399|P2|STARTED|Extension Study||0
117180|NCT00092495|278400|P1|STARTED|Extension Study||0
117181|NCT00092495|278396|P5|NOT COMPLETED|Base Study Follow-up Period||0
117182|NCT00092495|278397|P4|NOT COMPLETED|Base Study Follow-up Period||14
117183|NCT00092495|278398|P3|NOT COMPLETED|Base Study Follow-up Period||4
117184|NCT00092495|278399|P2|NOT COMPLETED|Base Study Follow-up Period||3
117185|NCT00092495|278400|P1|NOT COMPLETED|Base Study Follow-up Period||3
117186|NCT00092495|278396|P5|COMPLETED|Base Study Follow-up Period||0
117187|NCT00092495|278397|P4|COMPLETED|Base Study Follow-up Period||446
117188|NCT00092495|278398|P3|COMPLETED|Base Study Follow-up Period||126
117189|NCT00092495|278399|P2|COMPLETED|Base Study Follow-up Period||122
117190|NCT00092495|278400|P1|COMPLETED|Base Study Follow-up Period||112
117191|NCT00092495|278396|P5|STARTED|Base Study Follow-up Period||0
117192|NCT00092495|278397|P4|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|460
117193|NCT00092495|278398|P3|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|130
117194|NCT00092495|278399|P2|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|125
117195|NCT00092495|278400|P1|STARTED|Base Study Follow-up Period|Protocol amended to extend follow-up for 10-15 year old subjects to Month 12 (6 months Postdose 3)|115
117196|NCT00092495|278396|P5|NOT COMPLETED|Base Study Vaccination Period||0
117197|NCT00092495|278397|P4|NOT COMPLETED|Base Study Vaccination Period||88
117198|NCT00092495|278398|P3|NOT COMPLETED|Base Study Vaccination Period||34
117199|NCT00092495|278399|P2|NOT COMPLETED|Base Study Vaccination Period||22
117200|NCT00092495|278400|P1|NOT COMPLETED|Base Study Vaccination Period||37
117201|NCT00092495|278396|P5|COMPLETED|Base Study Vaccination Period||0
117202|NCT00092495|278397|P4|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|1441
117203|NCT00092495|278398|P3|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|474
117204|NCT00092495|278399|P2|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|492
117205|NCT00092495|278400|P1|COMPLETED|Base Study Vaccination Period|Completed 3 vaccinations; entered the long-term follow-up or completed the study per-protocol|467
117206|NCT00092495|278396|P5|Without Long-term Follow-up|Base Study Vaccination Period||0
117207|NCT00092495|278397|P4|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|73
117208|NCT00092495|278398|P3|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|28
117209|NCT00092495|278399|P2|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|20
117210|NCT00092495|278400|P1|Without Long-term Follow-up|Base Study Vaccination Period|Subjects discontinued on or before Month 7 and did not enter the long-term follow-up period|34
117211|NCT00092495|278396|P5|With Long-term Follow-up *|Base Study Vaccination Period||0
117212|NCT00092495|278397|P4|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|10
117213|NCT00092495|278398|P3|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|6
117214|NCT00092495|278399|P2|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
117215|NCT00092495|278400|P1|With Long-term Follow-up *|Base Study Vaccination Period|Subjects received fewer than 3 doses of vaccinations and entered the long-term follow-up period|2
117216|NCT00092495|278396|P5|STARTED|Base Study Vaccination Period||0
117217|NCT00092495|278397|P4|STARTED|Base Study Vaccination Period||1529
117218|NCT00092495|278398|P3|STARTED|Base Study Vaccination Period||508
117219|NCT00092495|278399|P2|STARTED|Base Study Vaccination Period||514
117220|NCT00092495|278400|P1|STARTED|Base Study Vaccination Period||504
117221|NCT00092521|278465|P4|NOT COMPLETED|Extension Study (Group 4)||209
117222|NCT00092521|278466|P3|NOT COMPLETED|Extension Study (Group 4)||0
117223|NCT00092521|278467|P2|NOT COMPLETED|Extension Study (Group 4)||0
117224|NCT00092521|278468|P1|NOT COMPLETED|Extension Study (Group 4)||0
117225|NCT00092521|278465|P4|COMPLETED|Extension Study (Group 4)||635
117226|NCT00092521|278466|P3|COMPLETED|Extension Study (Group 4)||0
117227|NCT00092521|278467|P2|COMPLETED|Extension Study (Group 4)||0
117228|NCT00092521|278468|P1|COMPLETED|Extension Study (Group 4)||0
117229|NCT00092521|278465|P4|Received >=1 Dose in Extension Study|Extension Study (Group 4)||801
117230|NCT00092521|278466|P3|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
117231|NCT00092521|278467|P2|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
117232|NCT00092521|278468|P1|Received >=1 Dose in Extension Study|Extension Study (Group 4)||0
117453|NCT00095173|278722|P5|COMPLETED|Double-Blind Phase (Period B)||0
117233|NCT00092521|278465|P4|Initiated Extension Study|Extension Study (Group 4)||829
117234|NCT00092521|278466|P3|Initiated Extension Study|Extension Study (Group 4)||0
117235|NCT00092521|278467|P2|Initiated Extension Study|Extension Study (Group 4)||0
117236|NCT00092521|278468|P1|Initiated Extension Study|Extension Study (Group 4)||0
117237|NCT00092521|278465|P4|STARTED|Extension Study (Group 4)||844
117238|NCT00092521|278466|P3|STARTED|Extension Study (Group 4)||0
117239|NCT00092521|278467|P2|STARTED|Extension Study (Group 4)||0
117240|NCT00092521|278468|P1|STARTED|Extension Study (Group 4)||0
117241|NCT00092521|278465|P4|NOT COMPLETED|Follow-Up (After Month 7)||0
117242|NCT00092521|278466|P3|NOT COMPLETED|Follow-Up (After Month 7)||648
117243|NCT00092521|278467|P2|NOT COMPLETED|Follow-Up (After Month 7)||136
117244|NCT00092521|278468|P1|NOT COMPLETED|Follow-Up (After Month 7)||246
117245|NCT00092521|278465|P4|COMPLETED|Follow-Up (After Month 7)||0
117246|NCT00092521|278466|P3|COMPLETED|Follow-Up (After Month 7)||1959
117247|NCT00092521|278467|P2|COMPLETED|Follow-Up (After Month 7)||155
117248|NCT00092521|278468|P1|COMPLETED|Follow-Up (After Month 7)||2353
117249|NCT00092521|278465|P4|STARTED|Follow-Up (After Month 7)||0
117250|NCT00092521|278466|P3|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2607
117251|NCT00092521|278467|P2|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|291
117252|NCT00092521|278468|P1|STARTED|Follow-Up (After Month 7)|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up|2599
117253|NCT00092521|278465|P4|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||0
117254|NCT00092521|278466|P3|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||146
117255|NCT00092521|278467|P2|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||14
117256|NCT00092521|278468|P1|NOT COMPLETED|Vaccination (Day 1 Through Month 7)||140
117257|NCT00092521|278465|P4|COMPLETED|Vaccination (Day 1 Through Month 7)||0
117258|NCT00092521|278466|P3|COMPLETED|Vaccination (Day 1 Through Month 7)||2586
117259|NCT00092521|278467|P2|COMPLETED|Vaccination (Day 1 Through Month 7)||290
117260|NCT00092521|278468|P1|COMPLETED|Vaccination (Day 1 Through Month 7)||2583
117261|NCT00092521|278465|P4|STARTED|Vaccination (Day 1 Through Month 7)||0
117262|NCT00092521|278466|P3|STARTED|Vaccination (Day 1 Through Month 7)||2732
117263|NCT00092521|278467|P2|STARTED|Vaccination (Day 1 Through Month 7)||304
117264|NCT00092521|278468|P1|STARTED|Vaccination (Day 1 Through Month 7)||2723
117265|NCT00092534|278480|P3|NOT COMPLETED|Extension Study||145
117266|NCT00092534|278481|P2|NOT COMPLETED|Extension Study||0
117267|NCT00092534|278482|P1|NOT COMPLETED|Extension Study||0
117268|NCT00092534|278480|P3|COMPLETED|Extension Study||449
117269|NCT00092534|278481|P2|COMPLETED|Extension Study||0
117270|NCT00092534|278482|P1|COMPLETED|Extension Study||0
117271|NCT00092534|278480|P3|STARTED|Extension Study||594
117272|NCT00092534|278481|P2|STARTED|Extension Study||0
117273|NCT00092534|278482|P1|STARTED|Extension Study||0
117274|NCT00092534|278480|P3|NOT COMPLETED|Base Study Follow Up Period||0
117275|NCT00092534|278481|P2|NOT COMPLETED|Base Study Follow Up Period||694
117276|NCT00092534|278482|P1|NOT COMPLETED|Base Study Follow Up Period||316
117277|NCT00092534|278480|P3|COMPLETED|Base Study Follow Up Period||0
117278|NCT00092534|278481|P2|COMPLETED|Base Study Follow Up Period||5277
117279|NCT00092534|278482|P1|COMPLETED|Base Study Follow Up Period||5626
117280|NCT00092534|278480|P3|STARTED|Base Study Follow Up Period||0
117281|NCT00092534|278481|P2|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5971
117282|NCT00092534|278482|P1|STARTED|Base Study Follow Up Period|Includes subjects who did not receive 3 doses of vaccine/placebo but continued into the follow-up.|5942
117283|NCT00092534|278480|P3|NOT COMPLETED|Base Study Vaccination Period||0
117284|NCT00092534|278481|P2|NOT COMPLETED|Base Study Vaccination Period||126
117285|NCT00092534|278482|P1|NOT COMPLETED|Base Study Vaccination Period||171
117286|NCT00092534|278480|P3|COMPLETED|Base Study Vaccination Period||0
117287|NCT00092534|278481|P2|COMPLETED|Base Study Vaccination Period||5954
117288|NCT00092534|278482|P1|COMPLETED|Base Study Vaccination Period||5916
117289|NCT00092534|278480|P3|STARTED|Base Study Vaccination Period||0
117290|NCT00092534|278481|P2|STARTED|Base Study Vaccination Period||6080
117291|NCT00092534|278482|P1|STARTED|Base Study Vaccination Period||6087
117292|NCT00092547|278499|P3|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
117293|NCT00092547|278500|P2|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
117294|NCT00092547|278501|P1|NOT COMPLETED|Long-term Follow-up (Month 126 Visit)||0
117295|NCT00092547|278499|P3|COMPLETED|Long-term Follow-up (Month 126 Visit)||211
117296|NCT00092547|278500|P2|COMPLETED|Long-term Follow-up (Month 126 Visit)||0
117297|NCT00092547|278501|P1|COMPLETED|Long-term Follow-up (Month 126 Visit)||454
117298|NCT00092547|278499|P3|STARTED|Long-term Follow-up (Month 126 Visit)||211
117299|NCT00092547|278500|P2|STARTED|Long-term Follow-up (Month 126 Visit)||0
117300|NCT00092547|278501|P1|STARTED|Long-term Follow-up (Month 126 Visit)||454
117301|NCT00092547|278499|P3|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
117302|NCT00092547|278500|P2|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
117303|NCT00092547|278501|P1|NOT COMPLETED|Long-term Follow-up (Month 96 Visit)||0
117304|NCT00092547|278499|P3|COMPLETED|Long-term Follow-up (Month 96 Visit)||267
117305|NCT00092547|278500|P2|COMPLETED|Long-term Follow-up (Month 96 Visit)||0
117306|NCT00092547|278501|P1|COMPLETED|Long-term Follow-up (Month 96 Visit)||508
117307|NCT00092547|278499|P3|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|267
117454|NCT00095173|278723|P4|COMPLETED|Double-Blind Phase (Period B)||0
117308|NCT00092547|278500|P2|STARTED|Long-term Follow-up (Month 96 Visit)||0
117309|NCT00092547|278501|P1|STARTED|Long-term Follow-up (Month 96 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|508
117310|NCT00092547|278499|P3|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
117311|NCT00092547|278500|P2|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
117312|NCT00092547|278501|P1|NOT COMPLETED|Long-term Follow-up (Month 72 Visit)||0
117313|NCT00092547|278499|P3|COMPLETED|Long-term Follow-up (Month 72 Visit)||276
117314|NCT00092547|278500|P2|COMPLETED|Long-term Follow-up (Month 72 Visit)||0
117315|NCT00092547|278501|P1|COMPLETED|Long-term Follow-up (Month 72 Visit)||550
117316|NCT00092547|278499|P3|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|276
117317|NCT00092547|278500|P2|STARTED|Long-term Follow-up (Month 72 Visit)||0
117318|NCT00092547|278501|P1|STARTED|Long-term Follow-up (Month 72 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|550
117319|NCT00092547|278499|P3|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
117320|NCT00092547|278500|P2|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||0
117321|NCT00092547|278501|P1|NOT COMPLETED|Long-term Follow-up (Month 42 Visit)||1
117322|NCT00092547|278499|P3|COMPLETED|Long-term Follow-up (Month 42 Visit)||308
117323|NCT00092547|278500|P2|COMPLETED|Long-term Follow-up (Month 42 Visit)||0
117324|NCT00092547|278501|P1|COMPLETED|Long-term Follow-up (Month 42 Visit)||611
117325|NCT00092547|278499|P3|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|308
117326|NCT00092547|278500|P2|STARTED|Long-term Follow-up (Month 42 Visit)||0
117327|NCT00092547|278501|P1|STARTED|Long-term Follow-up (Month 42 Visit)|Includes participants continuing and who previously discontinued who re-entered the study|612
117328|NCT00092547|278499|P3|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||16
117329|NCT00092547|278500|P2|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
117330|NCT00092547|278501|P1|NOT COMPLETED|Extension Vaccine Phase (Month 30 to 37)||23
117331|NCT00092547|278499|P3|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||469
117332|NCT00092547|278500|P2|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||0
117333|NCT00092547|278501|P1|COMPLETED|Extension Vaccine Phase (Month 30 to 37)||933
117334|NCT00092547|278499|P3|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||482
117335|NCT00092547|278500|P2|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
117336|NCT00092547|278501|P1|Vaccinated in Extension Study|Extension Vaccine Phase (Month 30 to 37)||0
117337|NCT00092547|278499|P3|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|485
117338|NCT00092547|278500|P2|STARTED|Extension Vaccine Phase (Month 30 to 37)||0
117339|NCT00092547|278501|P1|STARTED|Extension Vaccine Phase (Month 30 to 37)|Includes participants continuing and who previously discontinued who re-entered the study|956
117340|NCT00092547|278499|P3|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
117341|NCT00092547|278500|P2|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||5
117342|NCT00092547|278501|P1|NOT COMPLETED|Base Follow-up Phase (Month 18 to 30)||8
117343|NCT00092547|278499|P3|COMPLETED|Base Follow-up Phase (Month 18 to 30)||0
117344|NCT00092547|278500|P2|COMPLETED|Base Follow-up Phase (Month 18 to 30)||485
117345|NCT00092547|278501|P1|COMPLETED|Base Follow-up Phase (Month 18 to 30)||956
117346|NCT00092547|278499|P3|STARTED|Base Follow-up Phase (Month 18 to 30)||0
117347|NCT00092547|278500|P2|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|490
117348|NCT00092547|278501|P1|STARTED|Base Follow-up Phase (Month 18 to 30)|Includes participants continuing and who previously discontinued who re-entered the study|964
117349|NCT00092547|278499|P3|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
117350|NCT00092547|278500|P2|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||14
117351|NCT00092547|278501|P1|NOT COMPLETED|Base Follow-up Phase (Month 7 to 18)||20
117352|NCT00092547|278499|P3|COMPLETED|Base Follow-up Phase (Month 7 to 18)||0
117353|NCT00092547|278500|P2|COMPLETED|Base Follow-up Phase (Month 7 to 18)||551
117354|NCT00092547|278501|P1|COMPLETED|Base Follow-up Phase (Month 7 to 18)||1108
117355|NCT00092547|278499|P3|STARTED|Base Follow-up Phase (Month 7 to 18)||0
117356|NCT00092547|278500|P2|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|565
117357|NCT00092547|278501|P1|STARTED|Base Follow-up Phase (Month 7 to 18)|Includes participants continuing and who previously discontinued who re-entered the study|1128
117358|NCT00092547|278499|P3|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
117359|NCT00092547|278500|P2|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||36
117360|NCT00092547|278501|P1|NOT COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||63
117361|NCT00092547|278499|P3|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||0
117362|NCT00092547|278500|P2|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||561
117363|NCT00092547|278501|P1|COMPLETED|Base Vaccine Phase (Day 1 to Month 7)||1121
117364|NCT00092547|278499|P3|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||0
117365|NCT00092547|278500|P2|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||596
117366|NCT00092547|278501|P1|Vaccinated|Base Vaccine Phase (Day 1 to Month 7)||1179
117367|NCT00092547|278499|P3|STARTED|Base Vaccine Phase (Day 1 to Month 7)||0
117368|NCT00092547|278500|P2|STARTED|Base Vaccine Phase (Day 1 to Month 7)||597
117369|NCT00092547|278501|P1|STARTED|Base Vaccine Phase (Day 1 to Month 7)||1184
117370|NCT00092677|278545|P2|NOT COMPLETED|Overall Study||11
117371|NCT00092677|278546|P1|NOT COMPLETED|Overall Study||5
117372|NCT00092677|278545|P2|COMPLETED|Overall Study|Placebo: 698 (on drug), 120 (after drug discon), 100 (at death)|918
117373|NCT00092677|278546|P1|COMPLETED|Overall Study|EZ/Simva: 694 (on drug), 140 (after drug discon), 105 (at death)|939
117374|NCT00092677|278545|P2|STARTED|Overall Study||929
117375|NCT00092677|278546|P1|STARTED|Overall Study||944
117376|NCT00084838|278588|P1|NOT COMPLETED|Overall Study||13
117377|NCT00084838|278588|P1|COMPLETED|Overall Study||12
117378|NCT00084838|278588|P1|Eligible and Treated|Overall Study|4 ineligible pts upon central path review (n=3) and per DFCI IRB (n=1); 1 pt withdrew before rcv trt|20
117379|NCT00084838|278588|P1|STARTED|Overall Study||25
117380|NCT00084864|278614|P4|NOT COMPLETED|Overall Study||0
117381|NCT00084864|278615|P3|NOT COMPLETED|Overall Study||0
117382|NCT00084864|278616|P2|NOT COMPLETED|Overall Study||0
117383|NCT00084864|278617|P1|NOT COMPLETED|Overall Study||1
117384|NCT00084864|278614|P4|COMPLETED|Overall Study||4
117385|NCT00084864|278615|P3|COMPLETED|Overall Study||4
117386|NCT00084864|278616|P2|COMPLETED|Overall Study||7
117387|NCT00084864|278617|P1|COMPLETED|Overall Study||9
117388|NCT00084864|278614|P4|STARTED|Overall Study||4
117389|NCT00084864|278615|P3|STARTED|Overall Study||4
117390|NCT00084864|278616|P2|STARTED|Overall Study||7
117391|NCT00084864|278617|P1|STARTED|Overall Study||10
117392|NCT00085098|278645|P2|NOT COMPLETED|Overall Study||2
117393|NCT00085098|278646|P1|NOT COMPLETED|Overall Study||1
117394|NCT00085098|278645|P2|COMPLETED|Overall Study||11
117395|NCT00085098|278646|P1|COMPLETED|Overall Study||10
117396|NCT00085098|278645|P2|STARTED|Overall Study||13
117397|NCT00085098|278646|P1|STARTED|Overall Study||11
117398|NCT00093015|278654|P2|NOT COMPLETED|Overall Study||664
117399|NCT00093015|278655|P1|NOT COMPLETED|Overall Study||665
117400|NCT00093015|278654|P2|COMPLETED|Overall Study||1348
117401|NCT00093015|278655|P1|COMPLETED|Overall Study||1361
117402|NCT00093015|278654|P2|Received Study Medication|Overall Study||2004
117403|NCT00093015|278655|P1|Received Study Medication|Overall Study||2019
117404|NCT00093015|278654|P2|STARTED|Overall Study||2012
117405|NCT00093015|278655|P1|STARTED|Overall Study||2026
117406|NCT00093041|278687|P6|NOT COMPLETED|Overall Study||3
117407|NCT00093041|278688|P5|NOT COMPLETED|Overall Study||1
117408|NCT00093041|278689|P4|NOT COMPLETED|Overall Study||1
117409|NCT00093041|278690|P3|NOT COMPLETED|Overall Study||2
117410|NCT00093041|278691|P2|NOT COMPLETED|Overall Study||3
117411|NCT00093041|278692|P1|NOT COMPLETED|Overall Study||2
117412|NCT00093041|278687|P6|COMPLETED|Overall Study|Three discontinued during multiple dose period|4
117413|NCT00093041|278688|P5|COMPLETED|Overall Study|One discontinued during multiple dose period|3
117414|NCT00093041|278689|P4|COMPLETED|Overall Study|One discontinued during single dose period|3
117415|NCT00093041|278690|P3|COMPLETED|Overall Study|Two discontinued during single dose period|3
117416|NCT00093041|278691|P2|COMPLETED|Overall Study|Three discontinued during single dose period|1
117417|NCT00093041|278692|P1|COMPLETED|Overall Study|One discontinued during single dose period and one during multiple dose period|2
117418|NCT00093041|278687|P6|STARTED|Overall Study||7
117419|NCT00093041|278688|P5|STARTED|Overall Study||4
117420|NCT00093041|278689|P4|STARTED|Overall Study||4
117421|NCT00093041|278690|P3|STARTED|Overall Study||5
117422|NCT00093041|278691|P2|STARTED|Overall Study||4
117423|NCT00093041|278692|P1|STARTED|Overall Study||4
117424|NCT00093145|278712|P1|NOT COMPLETED|Overall Study||17
117425|NCT00093145|278712|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|15
117426|NCT00093145|278712|P1|At Least One Response Assessment|Overall Study||31
117427|NCT00093145|278712|P1|STARTED|Overall Study||32
117428|NCT00095173|278721|P6|NOT COMPLETED|Open-Label Extension Phase (Period C)||32
117429|NCT00095173|278722|P5|NOT COMPLETED|Open-Label Extension Phase (Period C)||29
117430|NCT00095173|278723|P4|NOT COMPLETED|Open-Label Extension Phase (Period C)||23
117431|NCT00095173|278724|P3|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
117432|NCT00095173|278725|P2|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
117433|NCT00095173|278726|P1|NOT COMPLETED|Open-Label Extension Phase (Period C)||0
117434|NCT00095173|278721|P6|COMPLETED|Open-Label Extension Phase (Period C)||27
117435|NCT00095173|278722|P5|COMPLETED|Open-Label Extension Phase (Period C)||29
117436|NCT00095173|278723|P4|COMPLETED|Open-Label Extension Phase (Period C)||13
117437|NCT00095173|278724|P3|COMPLETED|Open-Label Extension Phase (Period C)||0
117438|NCT00095173|278725|P2|COMPLETED|Open-Label Extension Phase (Period C)||0
117439|NCT00095173|278726|P1|COMPLETED|Open-Label Extension Phase (Period C)||0
117440|NCT00095173|278721|P6|STARTED|Open-Label Extension Phase (Period C)|Includes 33 who discontinued Period B due to a flare and 26 who completed Period B with no flare|59
117441|NCT00095173|278722|P5|STARTED|Open-Label Extension Phase (Period C)|Includes 47 who completed Period B with no flare and 11 who discontinued Period B due to a flare|58
117442|NCT00095173|278723|P4|STARTED|Open-Label Extension Phase (Period C)|Participants were non-responders from Period A who re-entered in Period C.|36
117443|NCT00095173|278724|P3|STARTED|Open-Label Extension Phase (Period C)||0
117444|NCT00095173|278725|P2|STARTED|Open-Label Extension Phase (Period C)||0
117445|NCT00095173|278726|P1|STARTED|Open-Label Extension Phase (Period C)||0
117446|NCT00095173|278721|P6|NOT COMPLETED|Double-Blind Phase (Period B)||0
117447|NCT00095173|278722|P5|NOT COMPLETED|Double-Blind Phase (Period B)||0
117448|NCT00095173|278723|P4|NOT COMPLETED|Double-Blind Phase (Period B)||0
117449|NCT00095173|278724|P3|NOT COMPLETED|Double-Blind Phase (Period B)||31
117450|NCT00095173|278725|P2|NOT COMPLETED|Double-Blind Phase (Period B)||11
117451|NCT00095173|278726|P1|NOT COMPLETED|Double-Blind Phase (Period B)||0
117452|NCT00095173|278721|P6|COMPLETED|Double-Blind Phase (Period B)||0
117455|NCT00095173|278724|P3|COMPLETED|Double-Blind Phase (Period B)||31
117456|NCT00095173|278725|P2|COMPLETED|Double-Blind Phase (Period B)||49
117457|NCT00095173|278726|P1|COMPLETED|Double-Blind Phase (Period B)||0
117458|NCT00095173|278721|P6|STARTED|Double-Blind Phase (Period B)||0
117459|NCT00095173|278722|P5|STARTED|Double-Blind Phase (Period B)||0
117460|NCT00095173|278723|P4|STARTED|Double-Blind Phase (Period B)||0
117461|NCT00095173|278724|P3|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|62
117462|NCT00095173|278725|P2|STARTED|Double-Blind Phase (Period B)|123 responders from Period A qualified;122 entered and were randomized to abatacept and placebo.|60
117463|NCT00095173|278726|P1|STARTED|Double-Blind Phase (Period B)|All participants did not continue; responders entered Period B; non-responders re-entered Period C.|0
117464|NCT00095173|278721|P6|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
117465|NCT00095173|278722|P5|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
117466|NCT00095173|278723|P4|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
117467|NCT00095173|278724|P3|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
117468|NCT00095173|278725|P2|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||0
117469|NCT00095173|278726|P1|NOT COMPLETED|Open-Label Lead-In Phase (Period A)||20
117470|NCT00095173|278721|P6|COMPLETED|Open-Label Lead-In Phase (Period A)||0
117471|NCT00095173|278722|P5|COMPLETED|Open-Label Lead-In Phase (Period A)||0
117472|NCT00095173|278723|P4|COMPLETED|Open-Label Lead-In Phase (Period A)||0
117473|NCT00095173|278724|P3|COMPLETED|Open-Label Lead-In Phase (Period A)||0
117474|NCT00095173|278725|P2|COMPLETED|Open-Label Lead-In Phase (Period A)||0
117475|NCT00095173|278726|P1|COMPLETED|Open-Label Lead-In Phase (Period A)||170
117476|NCT00095173|278721|P6|STARTED|Open-Label Lead-In Phase (Period A)||0
117477|NCT00095173|278722|P5|STARTED|Open-Label Lead-In Phase (Period A)||0
117478|NCT00095173|278723|P4|STARTED|Open-Label Lead-In Phase (Period A)||0
117479|NCT00095173|278724|P3|STARTED|Open-Label Lead-In Phase (Period A)||0
117480|NCT00095173|278725|P2|STARTED|Open-Label Lead-In Phase (Period A)||0
117481|NCT00095173|278726|P1|STARTED|Open-Label Lead-In Phase (Period A)||190
117482|NCT00095199|278765|P4|NOT COMPLETED|Overall Study||143
117483|NCT00095199|278766|P3|NOT COMPLETED|Overall Study||160
117484|NCT00095199|278767|P2|NOT COMPLETED|Overall Study||242
117485|NCT00095199|278768|P1|NOT COMPLETED|Overall Study||296
117486|NCT00095199|278765|P4|COMPLETED|Overall Study||23
117487|NCT00095199|278766|P3|COMPLETED|Overall Study||7
117488|NCT00095199|278767|P2|COMPLETED|Overall Study||62
117489|NCT00095199|278768|P1|COMPLETED|Overall Study||6
117490|NCT00095199|278765|P4|STARTED|Overall Study||166
117491|NCT00095199|278766|P3|STARTED|Overall Study||167
117492|NCT00095199|278767|P2|STARTED|Overall Study||304
117493|NCT00095199|278768|P1|STARTED|Overall Study|1 participant has no data in database; not included in analyses. Data was lost/destroyed at site.|302
117494|NCT00095212|278808|P2|NOT COMPLETED|Overall Study||3
117495|NCT00095212|278809|P1|NOT COMPLETED|Overall Study||1
117496|NCT00095212|278808|P2|COMPLETED|Overall Study||9
117497|NCT00095212|278809|P1|COMPLETED|Overall Study||12
117498|NCT00095212|278808|P2|STARTED|Overall Study||12
117499|NCT00095212|278809|P1|STARTED|Overall Study||13
117500|NCT00095238|278837|P2|NOT COMPLETED|Overall Study||852
117501|NCT00095238|278838|P1|NOT COMPLETED|Overall Study||857
117502|NCT00095238|278837|P2|COMPLETED|Overall Study|completed double-blind therapy|1209
117503|NCT00095238|278838|P1|COMPLETED|Overall Study|completed double-blind therapy|1210
117504|NCT00095238|278837|P2|Safety (Treated) Population|Overall Study|One participant randomized to irbesartan received placebo.|2062
117586|NCT00095940|279484|P3|STARTED|Lapatinib Continuation/Phase II||17
117505|NCT00095238|278838|P1|Safety (Treated) Population|Overall Study|Two participants were randomized but not treated; 1 randomized to irbesartan received placebo|2064
117506|NCT00095238|278837|P2|STARTED|Overall Study|number randomized|2061
117507|NCT00095238|278838|P1|STARTED|Overall Study|number randomized|2067
117508|NCT00095303|278900|P2|NOT COMPLETED|Follow Up Study||58
117509|NCT00095303|278901|P1|NOT COMPLETED|Follow Up Study||59
117510|NCT00095303|278900|P2|COMPLETED|Follow Up Study||121
117511|NCT00095303|278901|P1|COMPLETED|Follow Up Study||140
117512|NCT00095303|278900|P2|STARTED|Follow Up Study|179 (TAU) gave permission for future contact; not a requirement to finish Main to start Follow up|179
117513|NCT00095303|278901|P1|STARTED|Follow Up Study|199 (BSFT) gave permission for future contact; not a requirement to finish Main to start Follow up|199
117514|NCT00095303|278900|P2|NOT COMPLETED|Main Study||87
117515|NCT00095303|278901|P1|NOT COMPLETED|Main Study||91
117516|NCT00095303|278900|P2|COMPLETED|Main Study||148
117517|NCT00095303|278901|P1|COMPLETED|Main Study||154
117518|NCT00095303|278900|P2|STARTED|Main Study||235
117519|NCT00095303|278901|P1|STARTED|Main Study||245
117520|NCT00095498|278970|P3|NOT COMPLETED|Overall Study||39
117521|NCT00095498|278971|P2|NOT COMPLETED|Overall Study||35
117522|NCT00095498|278972|P1|NOT COMPLETED|Overall Study||37
117523|NCT00095498|278970|P3|COMPLETED|Overall Study||39
117524|NCT00095498|278971|P2|COMPLETED|Overall Study||38
117525|NCT00095498|278972|P1|COMPLETED|Overall Study||39
117526|NCT00095498|278970|P3|Received Investigational Product|Overall Study||75
117527|NCT00095498|278971|P2|Received Investigational Product|Overall Study||71
117528|NCT00095498|278972|P1|Received Investigational Product|Overall Study||72
117529|NCT00095498|278970|P3|STARTED|Overall Study||78
117530|NCT00095498|278971|P2|STARTED|Overall Study||73
117531|NCT00095498|278972|P1|STARTED|Overall Study||76
117532|NCT00095563|279397|P1|NOT COMPLETED|Overall Study||0
117533|NCT00095563|279397|P1|COMPLETED|Overall Study||39
117534|NCT00095563|279397|P1|STARTED|Overall Study||39
117535|NCT00095576|279408|P2|NOT COMPLETED|Overall Study||1481
117536|NCT00095576|279409|P1|NOT COMPLETED|Overall Study||1475
117537|NCT00095576|279408|P2|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|14
117538|NCT00095576|279409|P1|COMPLETED|Overall Study|Subjects not completing entire study were eligible for observational long term follow up in V520-030|9
117539|NCT00095576|279408|P2|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1361
117540|NCT00095576|279409|P1|VACCINATED AT VISIT 7 (Dose 3)|Overall Study||1328
117541|NCT00095576|279408|P2|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1443
117542|NCT00095576|279409|P1|VACCINATED AT VISIT 4 (Dose 2)|Overall Study||1426
117543|NCT00095576|279408|P2|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1495
117544|NCT00095576|279409|P1|VACCINATED AT VISIT 2 (Dose 1)|Overall Study||1484
117545|NCT00095576|279408|P2|STARTED|Overall Study||1495
117546|NCT00095576|279409|P1|STARTED|Overall Study||1484
117547|NCT00095628|279421|P1|NOT COMPLETED|Overall Study||1
117548|NCT00095628|279421|P1|COMPLETED|Overall Study||20
117549|NCT00095628|279421|P1|STARTED|Overall Study||21
117550|NCT00095784|279430|P1|NOT COMPLETED|Overall Study||0
117551|NCT00095784|279430|P1|COMPLETED|Overall Study||21
117552|NCT00095784|279430|P1|STARTED|Overall Study||21
117553|NCT00095836|279453|P1|NOT COMPLETED|Overall Study||4
117554|NCT00095836|279453|P1|COMPLETED|Overall Study||23
117555|NCT00095836|279453|P1|STARTED|Overall Study||27
117556|NCT00095875|279462|P2|NOT COMPLETED|Overall Study||9
117557|NCT00095875|279463|P1|NOT COMPLETED|Overall Study||14
117558|NCT00095875|279462|P2|COMPLETED|Overall Study||66
117559|NCT00095875|279463|P1|COMPLETED|Overall Study||56
117560|NCT00095875|279462|P2|STARTED|Overall Study||75
117561|NCT00095875|279463|P1|STARTED|Overall Study||70
117562|NCT00095940|279478|P9|NOT COMPLETED|Lapatinib Continuation/Phase II||13
117563|NCT00095940|279479|P8|NOT COMPLETED|Lapatinib Continuation/Phase II||2
117564|NCT00095940|279480|P7|NOT COMPLETED|Lapatinib Continuation/Phase II||2
117565|NCT00095940|279481|P6|NOT COMPLETED|Lapatinib Continuation/Phase II||13
117566|NCT00095940|279482|P5|NOT COMPLETED|Lapatinib Continuation/Phase II||0
117567|NCT00095940|279483|P4|NOT COMPLETED|Lapatinib Continuation/Phase II||0
117568|NCT00095940|279484|P3|NOT COMPLETED|Lapatinib Continuation/Phase II||16
117569|NCT00095940|279485|P2|NOT COMPLETED|Lapatinib Continuation/Phase II||2
117570|NCT00095940|279486|P1|NOT COMPLETED|Lapatinib Continuation/Phase II||2
117571|NCT00095940|279478|P9|COMPLETED|Lapatinib Continuation/Phase II||1
117572|NCT00095940|279479|P8|COMPLETED|Lapatinib Continuation/Phase II||0
117573|NCT00095940|279480|P7|COMPLETED|Lapatinib Continuation/Phase II||0
117574|NCT00095940|279481|P6|COMPLETED|Lapatinib Continuation/Phase II||0
117575|NCT00095940|279482|P5|COMPLETED|Lapatinib Continuation/Phase II||0
117576|NCT00095940|279483|P4|COMPLETED|Lapatinib Continuation/Phase II||0
117577|NCT00095940|279484|P3|COMPLETED|Lapatinib Continuation/Phase II||1
117578|NCT00095940|279485|P2|COMPLETED|Lapatinib Continuation/Phase II||0
117579|NCT00095940|279486|P1|COMPLETED|Lapatinib Continuation/Phase II||0
117580|NCT00095940|279478|P9|STARTED|Lapatinib Continuation/Phase II||14
117581|NCT00095940|279479|P8|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
117582|NCT00095940|279480|P7|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
117583|NCT00095940|279481|P6|STARTED|Lapatinib Continuation/Phase II||13
117584|NCT00095940|279482|P5|STARTED|Lapatinib Continuation/Phase II||0
117585|NCT00095940|279483|P4|STARTED|Lapatinib Continuation/Phase II||0
117587|NCT00095940|279485|P2|STARTED|Lapatinib Continuation/Phase II|No measurable disease post surgery - ineligible for the phase II. Continued to receive lapatinib.|2
117588|NCT00095940|279486|P1|STARTED|Lapatinib Continuation/Phase II|Continued to receive lapatinib but were ineligible for the phase II.|2
117589|NCT00095940|279478|P9|NOT COMPLETED|Molecular Biology Phase||0
117590|NCT00095940|279479|P8|NOT COMPLETED|Molecular Biology Phase||0
117591|NCT00095940|279480|P7|NOT COMPLETED|Molecular Biology Phase||0
117592|NCT00095940|279481|P6|NOT COMPLETED|Molecular Biology Phase||0
117593|NCT00095940|279482|P5|NOT COMPLETED|Molecular Biology Phase||0
117594|NCT00095940|279483|P4|NOT COMPLETED|Molecular Biology Phase||0
117595|NCT00095940|279484|P3|NOT COMPLETED|Molecular Biology Phase||0
117596|NCT00095940|279485|P2|NOT COMPLETED|Molecular Biology Phase||0
117597|NCT00095940|279486|P1|NOT COMPLETED|Molecular Biology Phase||0
117598|NCT00095940|279478|P9|COMPLETED|Molecular Biology Phase||0
117599|NCT00095940|279479|P8|COMPLETED|Molecular Biology Phase||2
117600|NCT00095940|279480|P7|COMPLETED|Molecular Biology Phase||2
117601|NCT00095940|279481|P6|COMPLETED|Molecular Biology Phase||0
117602|NCT00095940|279482|P5|COMPLETED|Molecular Biology Phase||0
117603|NCT00095940|279483|P4|COMPLETED|Molecular Biology Phase||0
117604|NCT00095940|279484|P3|COMPLETED|Molecular Biology Phase||0
117605|NCT00095940|279485|P2|COMPLETED|Molecular Biology Phase||2
117606|NCT00095940|279486|P1|COMPLETED|Molecular Biology Phase||2
117607|NCT00095940|279478|P9|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
117608|NCT00095940|279479|P8|STARTED|Molecular Biology Phase||2
117609|NCT00095940|279480|P7|STARTED|Molecular Biology Phase||2
117610|NCT00095940|279481|P6|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
117611|NCT00095940|279482|P5|STARTED|Molecular Biology Phase||0
117612|NCT00095940|279483|P4|STARTED|Molecular Biology Phase||0
117613|NCT00095940|279484|P3|STARTED|Molecular Biology Phase|No surgery prior to study enrollment; not eligible for the molecular biology phase|0
117614|NCT00095940|279485|P2|STARTED|Molecular Biology Phase||2
117615|NCT00095940|279486|P1|STARTED|Molecular Biology Phase||2
117616|NCT00095979|279508|P1|NOT COMPLETED|Overall Study||2
117617|NCT00095979|279508|P1|COMPLETED|Overall Study||50
117618|NCT00095979|279508|P1|STARTED|Overall Study||52
117619|NCT00096018|279516|P2|NOT COMPLETED|Overall Study||14
117620|NCT00096018|279517|P1|NOT COMPLETED|Overall Study||2
117621|NCT00096018|279516|P2|COMPLETED|Overall Study||16
117622|NCT00096018|279517|P1|COMPLETED|Overall Study||11
117623|NCT00096018|279516|P2|Treated With Study Therapy|Overall Study||25
117624|NCT00096018|279517|P1|Treated With Study Therapy|Overall Study||13
117625|NCT00096018|279516|P2|STARTED|Overall Study||30
117626|NCT00096018|279517|P1|STARTED|Overall Study||13
117627|NCT00096031|279525|P1|NOT COMPLETED|Overall Study||63
117628|NCT00096031|279525|P1|COMPLETED|Overall Study||0
117629|NCT00096031|279525|P1|Eligible and Began Protocol Therapy|Overall Study||55
117630|NCT00096031|279525|P1|Eligible|Overall Study||57
117631|NCT00096031|279525|P1|STARTED|Overall Study||63
117632|NCT00096044|279531|P1|NOT COMPLETED|Overall Study||34
117633|NCT00096044|279531|P1|COMPLETED|Overall Study||11
117634|NCT00096044|279531|P1|STARTED|Overall Study||45
117635|NCT00096109|279540|P1|NOT COMPLETED|Overall Study||0
117636|NCT00096109|279540|P1|COMPLETED|Overall Study||11
117637|NCT00096109|279540|P1|STARTED|Overall Study||11
117638|NCT00096122|279546|P1|NOT COMPLETED|Overall Study||0
117639|NCT00096122|279546|P1|COMPLETED|Overall Study||95
117640|NCT00096122|279546|P1|STARTED|Overall Study||95
117641|NCT00096135|279552|P2|NOT COMPLETED|Overall Study||15
117642|NCT00096135|279553|P1|NOT COMPLETED|Overall Study||63
117643|NCT00096135|279552|P2|COMPLETED|Overall Study||27
117644|NCT00096135|279553|P1|COMPLETED|Overall Study||63
117645|NCT00096135|279552|P2|STARTED|Overall Study||42
117646|NCT00096135|279553|P1|STARTED|Overall Study||126
117647|NCT00096161|279563|P4|NOT COMPLETED|Overall Study||0
117648|NCT00096161|279564|P3|NOT COMPLETED|Overall Study||0
117649|NCT00096161|279565|P2|NOT COMPLETED|Overall Study||0
117650|NCT00096161|279566|P1|NOT COMPLETED|Overall Study||0
117651|NCT00096161|279563|P4|COMPLETED|Overall Study||0
117652|NCT00096161|279564|P3|COMPLETED|Overall Study||6
117653|NCT00096161|279565|P2|COMPLETED|Overall Study||10
117654|NCT00096161|279566|P1|COMPLETED|Overall Study||20
117655|NCT00096161|279563|P4|STARTED|Overall Study||0
117656|NCT00096161|279564|P3|STARTED|Overall Study||6
117657|NCT00096161|279565|P2|STARTED|Overall Study||10
117658|NCT00096161|279566|P1|STARTED|Overall Study||20
117659|NCT00096174|279596|P1|NOT COMPLETED|Overall Study||62
117660|NCT00096174|279596|P1|COMPLETED|Overall Study||7
117661|NCT00096174|279596|P1|Eligible and Treated|Overall Study|6 treated patients were ineligible|60
117662|NCT00096174|279596|P1|Began Protocol Therapy|Overall Study|3 patients never started treatment|66
117663|NCT00096174|279596|P1|STARTED|Overall Study||69
117664|NCT00096200|279605|P3|NOT COMPLETED|Overall Study||0
117665|NCT00096200|279606|P2|NOT COMPLETED|Overall Study||7
117666|NCT00096200|279607|P1|NOT COMPLETED|Overall Study||1
117667|NCT00096200|279605|P3|COMPLETED|Overall Study||5
117668|NCT00096200|279606|P2|COMPLETED|Overall Study||23
117669|NCT00096200|279607|P1|COMPLETED|Overall Study||8
117670|NCT00096200|279605|P3|STARTED|Overall Study||5
117671|NCT00096200|279606|P2|STARTED|Overall Study||30
117672|NCT00096200|279607|P1|STARTED|Overall Study||9
117673|NCT00096226|279615|P1|NOT COMPLETED|Overall Study||17
117674|NCT00096226|279615|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
117675|NCT00096226|279615|P1|STARTED|Overall Study||60
117676|NCT00096265|279622|P3|NOT COMPLETED|Overall Study||0
117677|NCT00096265|279623|P2|NOT COMPLETED|Overall Study||0
117678|NCT00096265|279624|P1|NOT COMPLETED|Overall Study||1
117679|NCT00096265|279622|P3|COMPLETED|Overall Study||41
117680|NCT00096265|279623|P2|COMPLETED|Overall Study||40
117681|NCT00096265|279624|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
117682|NCT00096265|279622|P3|STARTED|Overall Study||41
117683|NCT00096265|279623|P2|STARTED|Overall Study||40
117684|NCT00096265|279624|P1|STARTED|Overall Study||45
117685|NCT00096278|279634|P2|NOT COMPLETED|Overall Study||20
117686|NCT00096278|279635|P1|NOT COMPLETED|Overall Study||18
117687|NCT00096278|279634|P2|COMPLETED|Overall Study||1334
117688|NCT00096278|279635|P1|COMPLETED|Overall Study||1338
117689|NCT00096278|279634|P2|STARTED|Overall Study||1354
117690|NCT00096278|279635|P1|STARTED|Overall Study||1356
117691|NCT00096356|279643|P2|NOT COMPLETED|Overall Study||53
117692|NCT00096356|279644|P1|NOT COMPLETED|Overall Study||44
117693|NCT00096356|279643|P2|COMPLETED|Overall Study||61
117694|NCT00096356|279644|P1|COMPLETED|Overall Study||78
117695|NCT00096356|279643|P2|STARTED|Overall Study||114
117696|NCT00096356|279644|P1|STARTED|Overall Study||122
117697|NCT00096382|279656|P2|NOT COMPLETED|Overall Study||0
117698|NCT00096382|279657|P1|NOT COMPLETED|Overall Study||2
117699|NCT00096382|279656|P2|COMPLETED|Overall Study||3
117700|NCT00096382|279657|P1|COMPLETED|Overall Study||21
117701|NCT00096382|279656|P2|STARTED|Overall Study||3
117702|NCT00096382|279657|P1|STARTED|Overall Study||23
117703|NCT00096447|279665|P1|NOT COMPLETED|Overall Study||1
117704|NCT00096447|279665|P1|COMPLETED|Overall Study|Eligible and treated patients.|30
117705|NCT00096447|279665|P1|STARTED|Overall Study||31
117706|NCT00096460|279673|P2|NOT COMPLETED|Overall Study||1
117707|NCT00096460|279674|P1|NOT COMPLETED|Overall Study||7
117708|NCT00096460|279673|P2|COMPLETED|Overall Study||7
117709|NCT00096460|279674|P1|COMPLETED|Overall Study||15
117710|NCT00096460|279673|P2|STARTED|Overall Study||8
117711|NCT00096460|279674|P1|STARTED|Overall Study||22
117712|NCT00096486|279684|P4|NOT COMPLETED|Overall Study||2
117713|NCT00096486|279685|P3|NOT COMPLETED|Overall Study||2
117714|NCT00096486|279686|P2|NOT COMPLETED|Overall Study||0
117715|NCT00096486|279687|P1|NOT COMPLETED|Overall Study||0
117716|NCT00096486|279684|P4|COMPLETED|Overall Study||36
117717|NCT00096486|279685|P3|COMPLETED|Overall Study||24
117718|NCT00096486|279686|P2|COMPLETED|Overall Study||6
117719|NCT00096486|279687|P1|COMPLETED|Overall Study||4
117720|NCT00096486|279684|P4|STARTED|Overall Study||38
117721|NCT00096486|279685|P3|STARTED|Overall Study||26
117722|NCT00096486|279686|P2|STARTED|Overall Study||6
117723|NCT00096486|279687|P1|STARTED|Overall Study||4
117724|NCT00096538|279697|P1|NOT COMPLETED|Overall Study||1
117725|NCT00096538|279697|P1|COMPLETED|Overall Study||5
117726|NCT00096538|279697|P1|STARTED|Overall Study||6
117727|NCT00096681|279701|P1|NOT COMPLETED|Overall Study||0
117728|NCT00096681|279701|P1|COMPLETED|Overall Study||762
117729|NCT00096681|279701|P1|STARTED|Overall Study||762
117730|NCT00096785|279708|P2|NOT COMPLETED|Overall Study||1
117731|NCT00096785|279709|P1|NOT COMPLETED|Overall Study||2
117732|NCT00096785|279708|P2|COMPLETED|Overall Study|As randomized cohort|33
117733|NCT00096785|279709|P1|COMPLETED|Overall Study|As randomized cohort|33
117734|NCT00096785|279708|P2|As-Treated Population|Overall Study||33
117735|NCT00096785|279709|P1|As-Treated Population|Overall Study||36
117736|NCT00096785|279708|P2|As-Randomized Population|Overall Study||34
117737|NCT00096785|279709|P1|As-Randomized Population|Overall Study||35
117738|NCT00096785|279708|P2|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 34; as treated=33)|34
117739|NCT00096785|279709|P1|STARTED|Overall Study|1 participant randomized to ADV, treated with ETV. (As randomized= 35; as treated=36)|35
117740|NCT00096941|279733|P1|NOT COMPLETED|Overall Study||3
117741|NCT00096941|279733|P1|COMPLETED|Overall Study||0
117742|NCT00096941|279733|P1|STARTED|Overall Study||3
117743|NCT00096954|279740|P2|NOT COMPLETED|Overall Study||20
117744|NCT00096954|279741|P1|NOT COMPLETED|Overall Study||24
117745|NCT00096954|279740|P2|COMPLETED|Overall Study||154
117746|NCT00096954|279741|P1|COMPLETED|Overall Study||135
117747|NCT00096954|279740|P2|Received Study Drug|Overall Study||171
117748|NCT00096954|279741|P1|Received Study Drug|Overall Study||157
117749|NCT00096954|279740|P2|STARTED|Overall Study||174
117750|NCT00096954|279741|P1|STARTED|Overall Study||159
117751|NCT00096993|279755|P2|NOT COMPLETED|Overall Study||65
117752|NCT00096993|279756|P1|NOT COMPLETED|Overall Study||65
117753|NCT00096993|279755|P2|COMPLETED|Overall Study||0
117754|NCT00096993|279756|P1|COMPLETED|Overall Study||1
117755|NCT00096993|279755|P2|STARTED|Overall Study||65
117756|NCT00096993|279756|P1|STARTED|Overall Study||66
117757|NCT00097253|279770|P1|NOT COMPLETED|Water (Control)||0
117758|NCT00097253|279770|P1|COMPLETED|Water (Control)||56
117759|NCT00097253|279770|P1|STARTED|Water (Control)||56
117760|NCT00097253|279770|P1|NOT COMPLETED|Lemon||0
117761|NCT00097253|279770|P1|COMPLETED|Lemon||56
117762|NCT00097253|279770|P1|STARTED|Lemon||56
117763|NCT00097253|279770|P1|NOT COMPLETED|Lavender||0
117764|NCT00097253|279770|P1|COMPLETED|Lavender||56
117765|NCT00097253|279770|P1|STARTED|Lavender||56
117766|NCT00097370|279785|P1|NOT COMPLETED|Stage 3||59
117767|NCT00097370|279785|P1|COMPLETED|Stage 3||0
117768|NCT00097370|279785|P1|STARTED|Stage 3|Participants continued from Stage 2.|59
117769|NCT00097370|279785|P1|NOT COMPLETED|Stage 2||13
117770|NCT00097370|279785|P1|COMPLETED|Stage 2||59
117771|NCT00097370|279785|P1|STARTED|Stage 2|41 participants entered from study MHE100185 and 31 participants continued from Stage 1.|72
117772|NCT00097370|279785|P1|NOT COMPLETED|Stage 1||6
117773|NCT00097370|279785|P1|COMPLETED|Stage 1||31
117774|NCT00097370|279785|P1|STARTED|Stage 1|Participants entered from study MHE100185.|37
117775|NCT00097448|279804|P2|NOT COMPLETED|Overall Study||1
117776|NCT00097448|279805|P1|NOT COMPLETED|Overall Study||4
117777|NCT00097448|279804|P2|COMPLETED|Overall Study||129
117778|NCT00097448|279805|P1|COMPLETED|Overall Study||121
117779|NCT00097448|279804|P2|STARTED|Overall Study||130
117780|NCT00097448|279805|P1|STARTED|Overall Study||125
117781|NCT00097500|279813|P2|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||4
117782|NCT00097500|279814|P1|NOT COMPLETED|Off-drug Period (Week 52 to Week 64)||5
117783|NCT00097500|279813|P2|COMPLETED|Off-drug Period (Week 52 to Week 64)||26
117784|NCT00097500|279814|P1|COMPLETED|Off-drug Period (Week 52 to Week 64)||25
117785|NCT00097500|279813|P2|STARTED|Off-drug Period (Week 52 to Week 64)|Insulin Glargine is discontinued, metformin is continued|30
117786|NCT00097500|279814|P1|STARTED|Off-drug Period (Week 52 to Week 64)|Exenatide is discontinued, metformin is continued|30
117787|NCT00097500|279813|P2|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||3
117788|NCT00097500|279814|P1|NOT COMPLETED|On-drug Period (Week 0 to Week 52)||6
117789|NCT00097500|279813|P2|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
117790|NCT00097500|279814|P1|COMPLETED|On-drug Period (Week 0 to Week 52)|Subjects experiencing loss of glucose control after Week 52 are considered to have completed study.|30
117791|NCT00097500|279813|P2|STARTED|On-drug Period (Week 0 to Week 52)||33
117792|NCT00097500|279814|P1|STARTED|On-drug Period (Week 0 to Week 52)||36
117793|NCT00097539|279843|P7|NOT COMPLETED|Overall Study||171
117794|NCT00097539|279844|P6|NOT COMPLETED|Overall Study||5892
117795|NCT00097539|279845|P5|NOT COMPLETED|Overall Study||1758
117796|NCT00097539|279846|P4|NOT COMPLETED|Overall Study||3585
117797|NCT00097539|279847|P3|NOT COMPLETED|Overall Study||9108
117798|NCT00097539|279848|P2|NOT COMPLETED|Overall Study||6531
117799|NCT00097539|279849|P1|NOT COMPLETED|Overall Study||19066
117800|NCT00097539|279843|P7|COMPLETED|Overall Study||68
117801|NCT00097539|279844|P6|COMPLETED|Overall Study||2118
117802|NCT00097539|279845|P5|COMPLETED|Overall Study||386
117803|NCT00097539|279846|P4|COMPLETED|Overall Study||2066
117804|NCT00097539|279847|P3|COMPLETED|Overall Study||3411
117805|NCT00097539|279848|P2|COMPLETED|Overall Study||2825
117806|NCT00097539|279849|P1|COMPLETED|Overall Study||8220
117807|NCT00097539|279843|P7|STARTED|Overall Study||239
117808|NCT00097539|279844|P6|STARTED|Overall Study||8010
117809|NCT00097539|279845|P5|STARTED|Overall Study||2144
117810|NCT00097539|279846|P4|STARTED|Overall Study||5651
117811|NCT00097539|279847|P3|STARTED|Overall Study||12519
117812|NCT00097539|279848|P2|STARTED|Overall Study||9356
117813|NCT00097539|279849|P1|STARTED|Overall Study||27286
117814|NCT00097591|279895|P2|NOT COMPLETED|Overall Study||394
117815|NCT00097591|279896|P1|NOT COMPLETED|Overall Study||410
117816|NCT00097591|279895|P2|COMPLETED|Overall Study||6401
117817|NCT00097591|279896|P1|COMPLETED|Overall Study||6403
117818|NCT00097591|279895|P2|STARTED|Overall Study|4 subjects randomized but not analyzed due to an incomplete informed consent document|6795
117819|NCT00097591|279896|P1|STARTED|Overall Study|7 subjects randomized but not analyzed due to an incomplete informed consent document|6813
117820|NCT00097695|279916|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||5
117821|NCT00097695|279917|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||2
117822|NCT00097695|279918|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||15
117823|NCT00097695|279919|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||13
117824|NCT00097695|279916|P4|COMPLETED|The Open Label Extension (OLE) Phase||15
117825|NCT00097695|279917|P3|COMPLETED|The Open Label Extension (OLE) Phase||1
117826|NCT00097695|279918|P2|COMPLETED|The Open Label Extension (OLE) Phase||11
117827|NCT00097695|279919|P1|COMPLETED|The Open Label Extension (OLE) Phase||10
117828|NCT00097695|279916|P4|STARTED|The Open Label Extension (OLE) Phase||20
117829|NCT00097695|279917|P3|STARTED|The Open Label Extension (OLE) Phase||3
117830|NCT00097695|279918|P2|STARTED|The Open Label Extension (OLE) Phase||26
117831|NCT00097695|279919|P1|STARTED|The Open Label Extension (OLE) Phase||23
117832|NCT00097695|279916|P4|NOT COMPLETED|The Controlled Phase||20
117833|NCT00097695|279917|P3|NOT COMPLETED|The Controlled Phase||5
117834|NCT00097695|279918|P2|NOT COMPLETED|The Controlled Phase||3
117835|NCT00097695|279919|P1|NOT COMPLETED|The Controlled Phase||4
117836|NCT00097695|279916|P4|COMPLETED|The Controlled Phase|Patients screened and found eligible but did not have HAE attack or attack was not severe enough|0
117837|NCT00097695|279917|P3|COMPLETED|The Controlled Phase||3
117838|NCT00097695|279918|P2|COMPLETED|The Controlled Phase||26
117839|NCT00097695|279919|P1|COMPLETED|The Controlled Phase||23
117840|NCT00097695|279916|P4|STARTED|The Controlled Phase||20
117841|NCT00097695|279917|P3|STARTED|The Controlled Phase||8
117842|NCT00097695|279918|P2|STARTED|The Controlled Phase||29
117843|NCT00097695|279919|P1|STARTED|The Controlled Phase||27
117844|NCT00097708|279936|P3|NOT COMPLETED|Overall Study||65
117845|NCT00097708|279937|P2|NOT COMPLETED|Overall Study||56
117846|NCT00097708|279938|P1|NOT COMPLETED|Overall Study||64
117847|NCT00097708|279936|P3|COMPLETED|Overall Study||97
117848|NCT00097708|279937|P2|COMPLETED|Overall Study||120
117849|NCT00097708|279938|P1|COMPLETED|Overall Study||109
117850|NCT00097708|279936|P3|Treated|Overall Study||160
117851|NCT00097708|279937|P2|Treated|Overall Study||176
117852|NCT00097708|279938|P1|Treated|Overall Study||171
117853|NCT00097708|279936|P3|Intent-to-Treat (ITT)|Overall Study||149
117854|NCT00097708|279937|P2|Intent-to-Treat (ITT)|Overall Study||169
117855|NCT00097708|279938|P1|Intent-to-Treat (ITT)|Overall Study||165
117856|NCT00097708|279936|P3|STARTED|Overall Study||162
117857|NCT00097708|279937|P2|STARTED|Overall Study||176
117858|NCT00097708|279938|P1|STARTED|Overall Study||173
117859|NCT00097721|279948|P2|NOT COMPLETED|Overall Study||33
117860|NCT00097721|279949|P1|NOT COMPLETED|Overall Study||71
117861|NCT00097721|279948|P2|COMPLETED|Overall Study||0
117862|NCT00097721|279949|P1|COMPLETED|Overall Study||0
117863|NCT00097721|279948|P2|STARTED|Overall Study||33
117864|NCT00097721|279949|P1|STARTED|Overall Study|The number started is all enrolled subjects.BL Characteristics consists of Safety Population.|71
117865|NCT00088374|279963|P1|NOT COMPLETED|Overall Study||2
117866|NCT00088374|279963|P1|COMPLETED|Overall Study||7
117867|NCT00088374|279963|P1|STARTED|Overall Study||9
117868|NCT00088465|279972|P1|NOT COMPLETED|Overall Study||561
117869|NCT00088465|279972|P1|COMPLETED|Overall Study||370
117870|NCT00088465|279972|P1|STARTED|Overall Study||931
117871|NCT00088530|279997|P2|NOT COMPLETED|Overall Study||54
117872|NCT00088530|279998|P1|NOT COMPLETED|Overall Study||50
117873|NCT00088530|279997|P2|COMPLETED|Overall Study||16
117874|NCT00088530|279998|P1|COMPLETED|Overall Study||20
117875|NCT00088530|279997|P2|STARTED|Overall Study||70
117876|NCT00088530|279998|P1|STARTED|Overall Study||70
117877|NCT00088595|280010|P1|NOT COMPLETED|Overall Study||28
117878|NCT00088595|280010|P1|COMPLETED|Overall Study||17
117879|NCT00088595|280010|P1|STARTED|Overall Study||45
117880|NCT00088621|280026|P1|NOT COMPLETED|Overall Study||54
117881|NCT00088621|280026|P1|COMPLETED|Overall Study||7
117882|NCT00088621|280026|P1|STARTED|Overall Study||61
117883|NCT00088634|280032|P2|NOT COMPLETED|Overall Study||43
117884|NCT00088634|280033|P1|NOT COMPLETED|Overall Study||38
117885|NCT00088634|280032|P2|COMPLETED|Overall Study||47
117886|NCT00088634|280033|P1|COMPLETED|Overall Study||52
117887|NCT00088634|280032|P2|STARTED|Overall Study||90
117888|NCT00088634|280033|P1|STARTED|Overall Study||90
117889|NCT00088881|280045|P1|NOT COMPLETED|Step 3 - Radiation Therapy||0
117890|NCT00088881|280045|P1|COMPLETED|Step 3 - Radiation Therapy||1
117891|NCT00088881|280045|P1|STARTED|Step 3 - Radiation Therapy||1
117892|NCT00088881|280045|P1|NOT COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||11
117893|NCT00088881|280045|P1|COMPLETED|Step 2 - Zevalin™ Radioimmunotherapy||45
117894|NCT00088881|280045|P1|Eligible and Treated|Step 2 - Zevalin™ Radioimmunotherapy||48
117895|NCT00088881|280045|P1|STARTED|Step 2 - Zevalin™ Radioimmunotherapy|This includes all patients who received step 2 treatment regardless of eligibility.|56
117896|NCT00088881|280045|P1|NOT COMPLETED|Step 1 - R-CHOP||14
117897|NCT00088881|280045|P1|COMPLETED|Step 1 - R-CHOP||48
117898|NCT00088881|280045|P1|Eligible and Treated|Step 1 - R-CHOP||53
117899|NCT00088881|280045|P1|STARTED|Step 1 - R-CHOP||62
117900|NCT00088907|280056|P2|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||0
117901|NCT00088907|280057|P1|NOT COMPLETED|Single Gefitinib Treatment (Step 2)||24
117902|NCT00088907|280056|P2|COMPLETED|Single Gefitinib Treatment (Step 2)||0
117903|NCT00088907|280057|P1|COMPLETED|Single Gefitinib Treatment (Step 2)||0
117904|NCT00088907|280056|P2|Treated|Single Gefitinib Treatment (Step 2)||0
117905|NCT00088907|280057|P1|Treated|Single Gefitinib Treatment (Step 2)||19
117906|NCT00088907|280056|P2|STARTED|Single Gefitinib Treatment (Step 2)|Cross over to single gefitinib therapy at progression was allowed for patients on Arm I only.|0
117907|NCT00088907|280057|P1|STARTED|Single Gefitinib Treatment (Step 2)|Patients on Arm I could cross over to gefitinib after disease progression on step 1.|24
117908|NCT00088907|280056|P2|NOT COMPLETED|Randomized Study (Step 1)||134
117909|NCT00088907|280057|P1|NOT COMPLETED|Randomized Study (Step 1)||136
117910|NCT00088907|280056|P2|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles|0
117911|NCT00088907|280057|P1|COMPLETED|Randomized Study (Step 1)|Treatment would continue until disease progression, no certain fixed number of cycles.|0
117912|NCT00088907|280056|P2|Eligible and Treated|Randomized Study (Step 1)||122
117913|NCT00088907|280057|P1|Eligible and Treated|Randomized Study (Step 1)||117
117914|NCT00088907|280056|P2|Eligible|Randomized Study (Step 1)||122
117915|NCT00088907|280057|P1|Eligible|Randomized Study (Step 1)||117
117916|NCT00088907|280056|P2|Treated|Randomized Study (Step 1)||124
117917|NCT00088907|280057|P1|Treated|Randomized Study (Step 1)||129
117918|NCT00088907|280056|P2|STARTED|Randomized Study (Step 1)||134
117919|NCT00088907|280057|P1|STARTED|Randomized Study (Step 1)||136
117920|NCT00088972|280070|P2|NOT COMPLETED|Overall Study||4
117921|NCT00088972|280071|P1|NOT COMPLETED|Overall Study||2
117922|NCT00088972|280070|P2|COMPLETED|Overall Study||1
117923|NCT00088972|280071|P1|COMPLETED|Overall Study||1
117924|NCT00088972|280070|P2|STARTED|Overall Study||5
117925|NCT00088972|280071|P1|STARTED|Overall Study||3
117926|NCT00088985|280077|P1|NOT COMPLETED|Overall Study||3
117927|NCT00088985|280077|P1|COMPLETED|Overall Study||4
117928|NCT00088985|280077|P1|STARTED|Overall Study||7
117929|NCT00089011|280084|P2|NOT COMPLETED|Overall Study||0
117930|NCT00089011|280085|P1|NOT COMPLETED|Overall Study||0
117931|NCT00089011|280084|P2|COMPLETED|Overall Study||50
117932|NCT00089011|280085|P1|COMPLETED|Overall Study||100
117933|NCT00089011|280084|P2|STARTED|Overall Study||50
117934|NCT00089011|280085|P1|STARTED|Overall Study||100
117935|NCT00089076|280105|P1|NOT COMPLETED|Overall Study||10
117936|NCT00089076|280105|P1|COMPLETED|Overall Study||8
117937|NCT00089076|280105|P1|STARTED|Overall Study||18
117938|NCT00089141|280118|P2|NOT COMPLETED|Overall Study||24
117939|NCT00089141|280119|P1|NOT COMPLETED|Overall Study||18
117940|NCT00089141|280118|P2|COMPLETED|Overall Study||53
117941|NCT00089141|280119|P1|COMPLETED|Overall Study||56
117942|NCT00089141|280118|P2|STARTED|Overall Study||77
117943|NCT00089141|280119|P1|STARTED|Overall Study||74
117944|NCT00089297|280141|P1|NOT COMPLETED|Overall Study||38
117945|NCT00089297|280141|P1|COMPLETED|Overall Study||36
117946|NCT00089297|280141|P1|Eligible|Overall Study||63
117947|NCT00089297|280141|P1|Treated|Overall Study||70
117948|NCT00089297|280141|P1|STARTED|Overall Study||74
117949|NCT00089414|280151|P3|NOT COMPLETED|Overall Study||0
117950|NCT00089414|280152|P2|NOT COMPLETED|Overall Study||0
117951|NCT00089414|280153|P1|NOT COMPLETED|Overall Study||0
117952|NCT00089414|280151|P3|COMPLETED|Overall Study||2
117953|NCT00089414|280152|P2|COMPLETED|Overall Study||1
117954|NCT00089414|280153|P1|COMPLETED|Overall Study||2
117955|NCT00089414|280151|P3|STARTED|Overall Study||2
117956|NCT00089414|280152|P2|STARTED|Overall Study||1
117957|NCT00089414|280153|P1|STARTED|Overall Study||2
117958|NCT00089479|280169|P2|NOT COMPLETED|Overall Study||289
117959|NCT00089479|280170|P1|NOT COMPLETED|Overall Study||331
117960|NCT00089479|280169|P2|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|1018
117961|NCT00089479|280170|P1|COMPLETED|Overall Study|total includes Completed and Alive in follow-up|973
117962|NCT00089479|280169|P2|Received Treatment|Overall Study|Safety Population (includes 5 patients randomized to ACT, who received ACXT)|1283
117963|NCT00089479|280170|P1|Received Treatment|Overall Study|Safety Population (includes 19 patients randomized to ACXT, who received ACT)|1305
117964|NCT00089479|280169|P2|STARTED|Overall Study||1307
117965|NCT00089479|280170|P1|STARTED|Overall Study||1304
117966|NCT00089505|280198|P4|NOT COMPLETED|Overall Study||21
117967|NCT00089505|280199|P3|NOT COMPLETED|Overall Study||21
117968|NCT00089505|280200|P2|NOT COMPLETED|Overall Study||2
117969|NCT00089505|280201|P1|NOT COMPLETED|Overall Study||9
117970|NCT00089505|280198|P4|COMPLETED|Overall Study||230
117971|NCT00089505|280199|P3|COMPLETED|Overall Study||228
117972|NCT00089505|280200|P2|COMPLETED|Overall Study|The results for NVP/LPV_r were through database cutoff for DSMB review (by 6 October 2008).|118
117973|NCT00089505|280201|P1|COMPLETED|Overall Study|The results for NVP/NVP were through database cutoff for DSMB review (by 6 October 2008).|112
117974|NCT00089505|280198|P4|STARTED|Overall Study||251
117975|NCT00089505|280199|P3|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|249
117976|NCT00089505|280200|P2|STARTED|Overall Study||120
117977|NCT00089505|280201|P1|STARTED|Overall Study|2 women never started treatment and per protocol, were not followed and not included in analysis.|121
117978|NCT00089544|280245|P2|NOT COMPLETED|Overall Study||0
117979|NCT00089544|280246|P1|NOT COMPLETED|Overall Study||1
117980|NCT00089544|280245|P2|COMPLETED|Overall Study||7
117981|NCT00089544|280246|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|15
117982|NCT00089544|280245|P2|STARTED|Overall Study||7
117983|NCT00089544|280246|P1|STARTED|Overall Study||16
117984|NCT00089583|280258|P2|NOT COMPLETED|Overall Study||38
117985|NCT00089583|280259|P1|NOT COMPLETED|Overall Study||7
117986|NCT00089583|280258|P2|COMPLETED|Overall Study||51
117987|NCT00089583|280259|P1|COMPLETED|Overall Study||13
117988|NCT00089583|280258|P2|STARTED|Overall Study||89
117989|NCT00089583|280259|P1|STARTED|Overall Study||20
117990|NCT00089609|280353|P2|NOT COMPLETED|Overall Study||1
117991|NCT00089609|280354|P1|NOT COMPLETED|Overall Study||3
117992|NCT00089609|280353|P2|COMPLETED|Overall Study||12
117993|NCT00089609|280354|P1|COMPLETED|Overall Study||57
117994|NCT00089609|280353|P2|STARTED|Overall Study||13
117995|NCT00089609|280354|P1|STARTED|Overall Study||60
117996|NCT00089635|280371|P1|NOT COMPLETED|Overall Study||43
117997|NCT00089635|280371|P1|COMPLETED|Overall Study||160
117998|NCT00089635|280371|P1|STARTED|Overall Study||203
117999|NCT00089648|280383|P1|NOT COMPLETED|Overall Study||41
118000|NCT00089648|280383|P1|COMPLETED|Overall Study||20
118001|NCT00089648|280383|P1|STARTED|Overall Study||61
118002|NCT00089661|280401|P2|NOT COMPLETED|Overall Study||26
118003|NCT00089661|280402|P1|NOT COMPLETED|Overall Study||21
118004|NCT00089661|280401|P2|COMPLETED|Overall Study||99
118005|NCT00089661|280402|P1|COMPLETED|Overall Study||106
118006|NCT00089661|280401|P2|STARTED|Overall Study||125
118007|NCT00089661|280402|P1|STARTED|Overall Study||127
118008|NCT00089674|280420|P2|NOT COMPLETED|Overall Study||267
118009|NCT00089674|280421|P1|NOT COMPLETED|Overall Study||289
118010|NCT00089674|280420|P2|COMPLETED|Overall Study||467
118011|NCT00089674|280421|P1|COMPLETED|Overall Study||445
118012|NCT00089674|280420|P2|Received Study Drug|Overall Study||726
118013|NCT00089674|280421|P1|Received Study Drug|Overall Study||730
118014|NCT00089674|280420|P2|STARTED|Overall Study||734
118015|NCT00089674|280421|P1|STARTED|Overall Study||734
118016|NCT00089752|280447|P2|NOT COMPLETED|Overall Study||22
118017|NCT00089752|280448|P1|NOT COMPLETED|Overall Study||20
118018|NCT00089752|280447|P2|COMPLETED|Overall Study||118
118019|NCT00089752|280448|P1|COMPLETED|Overall Study||121
118020|NCT00089752|280447|P2|STARTED|Overall Study||140
118021|NCT00089752|280448|P1|STARTED|Overall Study||141
118022|NCT00089778|280469|P3|NOT COMPLETED|Overall Study||1
118023|NCT00089778|280470|P2|NOT COMPLETED|Overall Study||0
118024|NCT00089778|280471|P1|NOT COMPLETED|Overall Study||0
118025|NCT00089778|280469|P3|COMPLETED|Overall Study||7
118026|NCT00089778|280470|P2|COMPLETED|Overall Study||1
118027|NCT00089778|280471|P1|COMPLETED|Overall Study||2
118028|NCT00089778|280469|P3|STARTED|Overall Study||8
118029|NCT00089778|280470|P2|STARTED|Overall Study||1
118030|NCT00089778|280471|P1|STARTED|Overall Study||2
118031|NCT00089791|280484|P2|NOT COMPLETED|Overall Study||630
118032|NCT00089791|280485|P1|NOT COMPLETED|Overall Study||700
118033|NCT00089791|280484|P2|COMPLETED|Overall Study||3272
118034|NCT00089791|280485|P1|COMPLETED|Overall Study||3206
118035|NCT00089791|280484|P2|Safety Analysis Set|Overall Study||3886
118036|NCT00089791|280485|P1|Safety Analysis Set|Overall Study|7 participants in the placebo arm received ≥1 dose of denosumab & were analyzed in the denosumab arm|3876
118037|NCT00089791|280484|P2|Received Study Medication|Overall Study||3879
118038|NCT00089791|280485|P1|Received Study Medication|Overall Study||3883
118039|NCT00089791|280484|P2|STARTED|Overall Study||3902
118040|NCT00089791|280485|P1|STARTED|Overall Study||3906
118041|NCT00089843|280499|P4|NOT COMPLETED|Overall Study||7
118042|NCT00089843|280500|P3|NOT COMPLETED|Overall Study||5
118043|NCT00089843|280501|P2|NOT COMPLETED|Overall Study||4
118044|NCT00089843|280502|P1|NOT COMPLETED|Overall Study||2
118045|NCT00089843|280499|P4|COMPLETED|Overall Study||11
118046|NCT00089843|280500|P3|COMPLETED|Overall Study||15
118047|NCT00089843|280501|P2|COMPLETED|Overall Study||16
118048|NCT00089843|280502|P1|COMPLETED|Overall Study||17
118049|NCT00089843|280499|P4|STARTED|Overall Study||18
118050|NCT00089843|280500|P3|STARTED|Overall Study||20
118051|NCT00089843|280501|P2|STARTED|Overall Study||20
118052|NCT00089843|280502|P1|STARTED|Overall Study||19
118053|NCT00089895|280514|P2|NOT COMPLETED|Overall Study||42
118054|NCT00089895|280515|P1|NOT COMPLETED|Overall Study||35
118055|NCT00089895|280514|P2|COMPLETED|Overall Study|Number of Subjects treated|4642
118056|NCT00089895|280515|P1|COMPLETED|Overall Study|Number of Subjects treated|4687
118057|NCT00089895|280514|P2|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4684
118058|NCT00089895|280515|P1|STARTED|Overall Study|Number of Subjects Randomized with Intent to Treat|4722
118059|NCT00089986|280526|P3|NOT COMPLETED|Overall Study||10
118060|NCT00089986|280527|P2|NOT COMPLETED|Overall Study||24
118061|NCT00089986|280528|P1|NOT COMPLETED|Overall Study||15
118062|NCT00089986|280526|P3|COMPLETED|Overall Study||172
118063|NCT00089986|280527|P2|COMPLETED|Overall Study||574
118064|NCT00089986|280528|P1|COMPLETED|Overall Study||584
118065|NCT00089986|280526|P3|STARTED|Overall Study||182
118066|NCT00089986|280527|P2|STARTED|Overall Study||598
118067|NCT00089986|280528|P1|STARTED|Overall Study||599
118068|NCT00089999|280547|P2|NOT COMPLETED|Overall Study||69
118069|NCT00089999|280548|P1|NOT COMPLETED|Overall Study||69
118070|NCT00089999|280547|P2|COMPLETED|Overall Study||0
118071|NCT00089999|280548|P1|COMPLETED|Overall Study||0
118072|NCT00089999|280547|P2|STARTED|Overall Study||69
118073|NCT00089999|280548|P1|STARTED|Overall Study||69
118074|NCT00090051|280570|P2|NOT COMPLETED|Overall Study||95
118075|NCT00090051|280571|P1|NOT COMPLETED|Overall Study||109
118076|NCT00090051|280570|P2|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|181
118077|NCT00090051|280571|P1|COMPLETED|Overall Study|Completed 6 Cycles of Treatment|167
118078|NCT00090051|280570|P2|Safety Population; Received Study Drug|Overall Study||274
118079|NCT00090051|280571|P1|Safety Population; Received Study Drug|Overall Study||272
118080|NCT00090051|280570|P2|STARTED|Overall Study||276
118081|NCT00090051|280571|P1|STARTED|Overall Study||276
118082|NCT00090103|280608|P3|NOT COMPLETED|16-Week Safety Follow-up Period||457
118083|NCT00090103|280609|P2|NOT COMPLETED|16-Week Safety Follow-up Period||410
118084|NCT00090103|280610|P1|NOT COMPLETED|16-Week Safety Follow-up Period||374
118085|NCT00090103|280608|P3|COMPLETED|16-Week Safety Follow-up Period||1143
118086|NCT00090103|280609|P2|COMPLETED|16-Week Safety Follow-up Period||1205
118087|NCT00090103|280610|P1|COMPLETED|16-Week Safety Follow-up Period||1224
118088|NCT00090103|280608|P3|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1600
118089|NCT00090103|280609|P2|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1615
118090|NCT00090103|280610|P1|STARTED|16-Week Safety Follow-up Period|Some par. didn't enter the Follow-up phase or dropped out before completing the treatment phase.|1598
118091|NCT00090103|280608|P3|NOT COMPLETED|Four-Year Double-Blind Treatment Period||622
118092|NCT00090103|280609|P2|NOT COMPLETED|Four-Year Double-Blind Treatment Period||530
118093|NCT00090103|280610|P1|NOT COMPLETED|Four-Year Double-Blind Treatment Period||497
118094|NCT00090103|280608|P3|COMPLETED|Four-Year Double-Blind Treatment Period||989
118095|NCT00090103|280609|P2|COMPLETED|Four-Year Double-Blind Treatment Period||1093
118096|NCT00090103|280610|P1|COMPLETED|Four-Year Double-Blind Treatment Period||1113
118097|NCT00090103|280608|P3|STARTED|Four-Year Double-Blind Treatment Period||1611
118098|NCT00090103|280609|P2|STARTED|Four-Year Double-Blind Treatment Period||1623
118099|NCT00090103|280610|P1|STARTED|Four-Year Double-Blind Treatment Period||1610
118100|NCT00090142|280708|P2|NOT COMPLETED|Treatment Period II||0
118101|NCT00090142|280709|P1|NOT COMPLETED|Treatment Period II||1
118102|NCT00090142|280708|P2|COMPLETED|Treatment Period II||28
118103|NCT00090142|280709|P1|COMPLETED|Treatment Period II||25
118104|NCT00090142|280708|P2|STARTED|Treatment Period II||28
118105|NCT00090142|280709|P1|STARTED|Treatment Period II||26
118106|NCT00090142|280708|P2|NOT COMPLETED|Treatment Period I||3
118107|NCT00090142|280709|P1|NOT COMPLETED|Treatment Period I||5
118108|NCT00090142|280708|P2|COMPLETED|Treatment Period I||28
118109|NCT00090142|280709|P1|COMPLETED|Treatment Period I||26
118110|NCT00090142|280708|P2|STARTED|Treatment Period I||31
118111|NCT00090142|280709|P1|STARTED|Treatment Period I|1 patient was lost to follow-up after randomization and did not receive any study drug.|31
118112|NCT00097773|280741|P4|NOT COMPLETED|Overall Study||3
118113|NCT00097773|280742|P3|NOT COMPLETED|Overall Study||8
118114|NCT00097773|280743|P2|NOT COMPLETED|Overall Study||8
118115|NCT00097773|280744|P1|NOT COMPLETED|Overall Study||8
118116|NCT00097773|280741|P4|COMPLETED|Overall Study||73
118117|NCT00097773|280742|P3|COMPLETED|Overall Study||68
118118|NCT00097773|280743|P2|COMPLETED|Overall Study||68
118119|NCT00097773|280744|P1|COMPLETED|Overall Study||68
118120|NCT00097773|280741|P4|STARTED|Overall Study||76
118121|NCT00097773|280742|P3|STARTED|Overall Study||76
118122|NCT00097773|280743|P2|STARTED|Overall Study||76
118123|NCT00097773|280744|P1|STARTED|Overall Study||76
118124|NCT00097786|280766|P4|NOT COMPLETED|Overall Study||310
118125|NCT00097786|280767|P3|NOT COMPLETED|Overall Study||313
118126|NCT00097786|280768|P2|NOT COMPLETED|Overall Study||292
118127|NCT00097786|280769|P1|NOT COMPLETED|Overall Study||296
118128|NCT00097786|280766|P4|COMPLETED|Overall Study||2036
118129|NCT00097786|280767|P3|COMPLETED|Overall Study||2016
118130|NCT00097786|280768|P2|COMPLETED|Overall Study||2023
118131|NCT00097786|280769|P1|COMPLETED|Overall Study|"Completed means completed follow up for all cause death."|2020
118132|NCT00097786|280766|P4|Complete Follow-up for Core CV EPs|Overall Study||1988
118133|NCT00097786|280767|P3|Complete Follow-up for Core CV EPs|Overall Study||1966
118134|NCT00097786|280768|P2|Complete Follow-up for Core CV EPs|Overall Study||1963
118135|NCT00097786|280769|P1|Complete Follow-up for Core CV EPs|Overall Study||1948
118136|NCT00097786|280766|P4|Complete Follow-up for Extended CV EPs|Overall Study||2015
118137|NCT00097786|280767|P3|Complete Follow-up for Extended CV EPs|Overall Study||1987
118138|NCT00097786|280768|P2|Complete Follow-up for Extended CV EPs|Overall Study||1985
118139|NCT00097786|280769|P1|Complete Follow-up for Extended CV EPs|Overall Study||1969
118140|NCT00097786|280766|P4|Complete FU for Progression to Diabetes|Overall Study||1762
118141|NCT00097786|280767|P3|Complete FU for Progression to Diabetes|Overall Study||1734
118142|NCT00097786|280768|P2|Complete FU for Progression to Diabetes|Overall Study||1712
118143|NCT00097786|280769|P1|Complete FU for Progression to Diabetes|Overall Study||1709
118144|NCT00097786|280766|P4|STARTED|Overall Study||2346
118145|NCT00097786|280767|P3|STARTED|Overall Study||2329
118146|NCT00097786|280768|P2|STARTED|Overall Study||2315
118147|NCT00097786|280769|P1|STARTED|Overall Study|"Started indicates Full Analysis Set (FAS) population. Initially enrolled 9518, 212 excluded."|2316
118148|NCT00097981|280789|P2|NOT COMPLETED|Overall Study||100
118149|NCT00097981|280790|P1|NOT COMPLETED|Overall Study||106
118150|NCT00097981|280789|P2|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|12
118151|NCT00097981|280790|P1|COMPLETED|Overall Study|Completion of 2 or more cycles after CR or nCR, or completion of 12 cycles.|7
118152|NCT00097981|280789|P2|Received Study Medication|Overall Study||106
118153|NCT00097981|280790|P1|Received Study Medication|Overall Study||110
118154|NCT00097981|280789|P2|STARTED|Overall Study|Enrollment at randomization|112
118155|NCT00097981|280790|P1|STARTED|Overall Study|Enrollment at randomization|113
118156|NCT00098059|280810|P2|NOT COMPLETED|Overall Study||1
118157|NCT00098059|280811|P1|NOT COMPLETED|Overall Study||0
118158|NCT00098059|280810|P2|COMPLETED|Overall Study||46
118159|NCT00098059|280811|P1|COMPLETED|Overall Study||27
118160|NCT00098059|280810|P2|STARTED|Overall Study||47
118161|NCT00098059|280811|P1|STARTED|Overall Study||27
118162|NCT00100659|280857|P2|NOT COMPLETED|Overall Study||2
118163|NCT00100659|280858|P1|NOT COMPLETED|Overall Study||3
118164|NCT00100659|280857|P2|COMPLETED|Overall Study||57
118165|NCT00100659|280858|P1|COMPLETED|Overall Study||52
118166|NCT00100659|280857|P2|STARTED|Overall Study||59
118167|NCT00100659|280858|P1|STARTED|Overall Study||55
118168|NCT00100698|280866|P2|NOT COMPLETED|Overall Study||2
118169|NCT00100698|280867|P1|NOT COMPLETED|Overall Study||6
118170|NCT00100698|280866|P2|COMPLETED|Overall Study||27
118171|NCT00100698|280867|P1|COMPLETED|Overall Study||21
118172|NCT00100698|280866|P2|STARTED|Overall Study||29
118173|NCT00100698|280867|P1|STARTED|Overall Study||27
118174|NCT00100789|280907|P1|NOT COMPLETED|Overall Study||64
118175|NCT00100789|280907|P1|COMPLETED|Overall Study||3
118176|NCT00100789|280907|P1|Eligible and Began Protocol Therapy|Overall Study||63
118177|NCT00100789|280907|P1|Eligible|Overall Study||64
118178|NCT00100789|280907|P1|STARTED|Overall Study||67
118179|NCT00100802|280914|P1|NOT COMPLETED|Overall Study||80
118180|NCT00100802|280914|P1|COMPLETED|Overall Study||38
118181|NCT00100802|280914|P1|STARTED|Overall Study||118
118182|NCT00100815|280919|P1|NOT COMPLETED|Overall Study||49
118183|NCT00100815|280919|P1|COMPLETED|Overall Study||1
118184|NCT00100815|280919|P1|STARTED|Overall Study||50
118185|NCT00100841|280927|P1|NOT COMPLETED|Overall Study||0
118186|NCT00100841|280927|P1|COMPLETED|Overall Study||66
118187|NCT00100841|280927|P1|STARTED|Overall Study||66
118188|NCT00100932|280934|P2|NOT COMPLETED|Overall Study||27
118189|NCT00100932|280935|P1|NOT COMPLETED|Overall Study||73
118190|NCT00100932|280934|P2|COMPLETED|Overall Study||1
118191|NCT00100932|280935|P1|COMPLETED|Overall Study||5
118192|NCT00100932|280934|P2|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|28
118193|NCT00100932|280935|P1|STARTED|Overall Study|Represents all enrolled pts; counts in demographic section represents ITT/Safety Population.|78
118194|NCT00101036|280947|P2|NOT COMPLETED|Overall Study||0
118195|NCT00101036|280948|P1|NOT COMPLETED|Overall Study||0
118196|NCT00101036|280947|P2|COMPLETED|Overall Study||40
118197|NCT00101036|280948|P1|COMPLETED|Overall Study||17
118198|NCT00101036|280947|P2|STARTED|Overall Study||40
118199|NCT00101036|280948|P1|STARTED|Overall Study||17
118200|NCT00101101|280958|P1|NOT COMPLETED|Overall Study||20
118201|NCT00101101|280958|P1|COMPLETED|Overall Study|Participants who received at least one vaccine injection.|23
118202|NCT00101101|280958|P1|STARTED|Overall Study||43
118203|NCT00101166|280964|P1|NOT COMPLETED|Overall Study||10
118204|NCT00101166|280964|P1|COMPLETED|Overall Study||18
118205|NCT00101166|280964|P1|STARTED|Overall Study||28
118206|NCT00101192|280972|P1|NOT COMPLETED|Overall Study||7
118207|NCT00101192|280972|P1|COMPLETED|Overall Study||69
118208|NCT00101192|280972|P1|STARTED|Overall Study||76
118209|NCT00101283|280978|P2|NOT COMPLETED|Overall Study||3
118210|NCT00101283|280979|P1|NOT COMPLETED|Overall Study||0
118211|NCT00101283|280978|P2|COMPLETED|Overall Study||13
118212|NCT00101283|280979|P1|COMPLETED|Overall Study||16
118213|NCT00101283|280978|P2|Began Treatment|Overall Study||13
118214|NCT00101283|280979|P1|Began Treatment|Overall Study||16
118215|NCT00101283|280978|P2|STARTED|Overall Study||16
118216|NCT00101283|280979|P1|STARTED|Overall Study||16
118217|NCT00101361|280991|P2|NOT COMPLETED|Overall Study||0
118218|NCT00101361|280992|P1|NOT COMPLETED|Overall Study||0
118219|NCT00101361|280991|P2|COMPLETED|Overall Study||104
118220|NCT00101361|280992|P1|COMPLETED|Overall Study||108
118221|NCT00101361|280991|P2|STARTED|Overall Study||104
118222|NCT00101361|280992|P1|STARTED|Overall Study||108
118223|NCT00101400|280998|P1|NOT COMPLETED|Survival Follow-Up||7
118224|NCT00101400|280998|P1|COMPLETED|Survival Follow-Up|44 subjects reached endpoint (death); 7 subjects were still alive|44
118225|NCT00101400|280998|P1|STARTED|Survival Follow-Up|3 subjects died during previous period (completion as defined in protocol)|51
118226|NCT00101400|280998|P1|NOT COMPLETED|Treatment||0
118227|NCT00101400|280998|P1|COMPLETED|Treatment|Reasons for treatment termination: 4 Adverse Events, 3 Deaths, 46 Progression, 1 Withdrawal.|54
118228|NCT00101400|280998|P1|STARTED|Treatment|Treated until disease progression, unacceptable sorafenib-related toxicity or withdrawal of consent.|54
118229|NCT00101413|281007|P1|NOT COMPLETED|Overall Study||0
118230|NCT00101413|281007|P1|COMPLETED|Overall Study|Safety data collected for 4 subjects after 30 Jun 2005 until 11 Apr 2008.|52
118231|NCT00101413|281007|P1|STARTED|Overall Study||52
118232|NCT00101439|281017|P2|NOT COMPLETED|Period 2||2
118233|NCT00101439|281018|P1|NOT COMPLETED|Period 2||0
118234|NCT00101439|281017|P2|COMPLETED|Period 2||28
118235|NCT00101439|281018|P1|COMPLETED|Period 2||28
118236|NCT00101439|281017|P2|STARTED|Period 2||30
118237|NCT00101439|281018|P1|STARTED|Period 2||28
118238|NCT00101439|281017|P2|NOT COMPLETED|Period 1||0
118239|NCT00101439|281018|P1|NOT COMPLETED|Period 1||0
118240|NCT00101439|281017|P2|COMPLETED|Period 1||30
118241|NCT00101439|281018|P1|COMPLETED|Period 1||28
118242|NCT00101439|281017|P2|STARTED|Period 1||30
118243|NCT00101439|281018|P1|STARTED|Period 1||28
118244|NCT00101452|281029|P3|NOT COMPLETED|Overall Study||43
118245|NCT00101452|281030|P2|NOT COMPLETED|Overall Study||43
118246|NCT00101452|281031|P1|NOT COMPLETED|Overall Study||44
118247|NCT00101452|281029|P3|COMPLETED|Overall Study||22
118248|NCT00101452|281030|P2|COMPLETED|Overall Study||26
118249|NCT00101452|281031|P1|COMPLETED|Overall Study||21
118250|NCT00101452|281029|P3|STARTED|Overall Study||65
118251|NCT00101452|281030|P2|STARTED|Overall Study||69
118252|NCT00101452|281031|P1|STARTED|Overall Study||65
118253|NCT00101582|281045|P2|NOT COMPLETED|Overall Study||15
118254|NCT00101582|281046|P1|NOT COMPLETED|Overall Study||11
118255|NCT00101582|281045|P2|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|79
118256|NCT00101582|281046|P1|COMPLETED|Overall Study|Participants who completed the acute oral mucositis evaluation phase|83
118257|NCT00101582|281045|P2|Received Study Drug|Overall Study||94
118258|NCT00101582|281046|P1|Received Study Drug|Overall Study||91
118259|NCT00101582|281045|P2|STARTED|Overall Study||94
118260|NCT00101582|281046|P1|STARTED|Overall Study||94
118261|NCT00101647|281068|P2|NOT COMPLETED|Overall Study||0
118262|NCT00101647|281069|P1|NOT COMPLETED|Overall Study||0
118263|NCT00101647|281068|P2|COMPLETED|Overall Study||161
118264|NCT00101647|281069|P1|COMPLETED|Overall Study||13
118265|NCT00101647|281068|P2|STARTED|Overall Study|Randomized|161
118266|NCT00101647|281069|P1|STARTED|Overall Study|Randomized|13
118267|NCT00101660|281119|P2|NOT COMPLETED|Overall Study||0
118268|NCT00101660|281120|P1|NOT COMPLETED|Overall Study||0
118269|NCT00101660|281119|P2|COMPLETED|Overall Study||288
118270|NCT00101660|281120|P1|COMPLETED|Overall Study||99
118271|NCT00101660|281119|P2|STARTED|Overall Study||288
118272|NCT00101660|281120|P1|STARTED|Overall Study||99
118273|NCT00101686|281146|P10|NOT COMPLETED|Overall Study||30
118274|NCT00101686|281147|P9|NOT COMPLETED|Overall Study||30
118275|NCT00101686|281148|P8|NOT COMPLETED|Overall Study||30
118276|NCT00101686|281149|P7|NOT COMPLETED|Overall Study||27
118277|NCT00101686|281150|P6|NOT COMPLETED|Overall Study||72
118278|NCT00101686|281151|P5|NOT COMPLETED|Overall Study||73
118279|NCT00101686|281152|P4|NOT COMPLETED|Overall Study||72
118280|NCT00101686|281153|P3|NOT COMPLETED|Overall Study||69
118281|NCT00101686|281154|P2|NOT COMPLETED|Overall Study||73
118282|NCT00101686|281155|P1|NOT COMPLETED|Overall Study||71
118283|NCT00101686|281146|P10|COMPLETED|Overall Study|Patients treated until disease progression.|0
118284|NCT00101686|281147|P9|COMPLETED|Overall Study|Patients treated until disease progression.|0
118285|NCT00101686|281148|P8|COMPLETED|Overall Study|Patients treated until disease progression.|0
118286|NCT00101686|281149|P7|COMPLETED|Overall Study|Patients treated until disease progression.|0
118287|NCT00101686|281150|P6|COMPLETED|Overall Study|Patients treated until disease progression.|0
118288|NCT00101686|281151|P5|COMPLETED|Overall Study|Patients treated until disease progression.|0
118289|NCT00101686|281152|P4|COMPLETED|Overall Study|Patients treated until disease progression.|0
118290|NCT00101686|281153|P3|COMPLETED|Overall Study|Patients treated until disease progression.|0
118291|NCT00101686|281154|P2|COMPLETED|Overall Study|Patients treated until disease progression.|0
118292|NCT00101686|281155|P1|COMPLETED|Overall Study|Patients treated until disease progression.|0
118293|NCT00101686|281146|P10|Received Treatment|Overall Study||29
118294|NCT00101686|281147|P9|Received Treatment|Overall Study||30
118295|NCT00101686|281148|P8|Received Treatment|Overall Study||29
118296|NCT00101686|281149|P7|Received Treatment|Overall Study||27
118297|NCT00101686|281150|P6|Received Treatment|Overall Study||70
118298|NCT00101686|281151|P5|Received Treatment|Overall Study||71
118299|NCT00101686|281152|P4|Received Treatment|Overall Study||70
118300|NCT00101686|281153|P3|Received Treatment|Overall Study||67
118301|NCT00101686|281154|P2|Received Treatment|Overall Study||67
118302|NCT00101686|281155|P1|Received Treatment|Overall Study||70
118303|NCT00101686|281146|P10|STARTED|Overall Study||30
118304|NCT00101686|281147|P9|STARTED|Overall Study||30
118305|NCT00101686|281148|P8|STARTED|Overall Study||30
118306|NCT00101686|281149|P7|STARTED|Overall Study||27
118307|NCT00101686|281150|P6|STARTED|Overall Study||72
118308|NCT00101686|281151|P5|STARTED|Overall Study||73
118309|NCT00101686|281152|P4|STARTED|Overall Study||72
118310|NCT00101686|281153|P3|STARTED|Overall Study||69
118311|NCT00101686|281154|P2|STARTED|Overall Study||73
118312|NCT00101686|281155|P1|STARTED|Overall Study||71
118313|NCT00101816|281202|P2|NOT COMPLETED|Overall Study||0
118314|NCT00101816|281203|P1|NOT COMPLETED|Overall Study||0
118315|NCT00101816|281202|P2|COMPLETED|Overall Study||99
118316|NCT00101816|281203|P1|COMPLETED|Overall Study||10
118317|NCT00101816|281202|P2|STARTED|Overall Study||99
118318|NCT00101816|281203|P1|STARTED|Overall Study||10
118319|NCT00101868|281252|P2|NOT COMPLETED|Overall Study||32
118320|NCT00101868|281253|P1|NOT COMPLETED|Overall Study||29
118321|NCT00101868|281252|P2|COMPLETED|Overall Study|zero hospital physician with zero patients lost to follow up|283
118322|NCT00101868|281253|P1|COMPLETED|Overall Study|1 hospital physician with zero patients lost to follow up|287
118323|NCT00101868|281252|P2|STARTED|Overall Study|35 hospital physicians allocated to usual care discharge|315
118324|NCT00101868|281253|P1|STARTED|Overall Study|35 hospital physicians allocated to discharge software|316
118325|NCT00101907|281269|P6|NOT COMPLETED|Overall Study||0
118326|NCT00101907|281270|P5|NOT COMPLETED|Overall Study||5
118327|NCT00101907|281271|P4|NOT COMPLETED|Overall Study||1
118328|NCT00101907|281272|P3|NOT COMPLETED|Overall Study||1
118329|NCT00101907|281273|P2|NOT COMPLETED|Overall Study||1
118330|NCT00101907|281274|P1|NOT COMPLETED|Overall Study||2
118331|NCT00101907|281269|P6|COMPLETED|Overall Study||2
118332|NCT00101907|281270|P5|COMPLETED|Overall Study||6
118333|NCT00101907|281271|P4|COMPLETED|Overall Study||5
118334|NCT00101907|281272|P3|COMPLETED|Overall Study||5
118335|NCT00101907|281273|P2|COMPLETED|Overall Study||7
118336|NCT00101907|281274|P1|COMPLETED|Overall Study||6
118337|NCT00101907|281269|P6|STARTED|Overall Study||2
118338|NCT00101907|281270|P5|STARTED|Overall Study||11
118339|NCT00101907|281271|P4|STARTED|Overall Study||6
118340|NCT00101907|281272|P3|STARTED|Overall Study||6
118341|NCT00101907|281273|P2|STARTED|Overall Study||8
118342|NCT00101907|281274|P1|STARTED|Overall Study||8
118343|NCT00101933|281316|P2|NOT COMPLETED|Overall Study||0
118344|NCT00101933|281317|P1|NOT COMPLETED|Overall Study||0
118345|NCT00101933|281316|P2|COMPLETED|Overall Study||55
118346|NCT00101933|281317|P1|COMPLETED|Overall Study||54
118347|NCT00101933|281316|P2|STARTED|Overall Study||55
118348|NCT00101933|281317|P1|STARTED|Overall Study||54
118349|NCT00102063|281340|P3|NOT COMPLETED|Overall Study||10
118350|NCT00102063|281341|P2|NOT COMPLETED|Overall Study||18
118351|NCT00102063|281342|P1|NOT COMPLETED|Overall Study||16
118352|NCT00102063|281340|P3|COMPLETED|Overall Study||90
118353|NCT00102063|281341|P2|COMPLETED|Overall Study||84
118354|NCT00102063|281342|P1|COMPLETED|Overall Study||84
118355|NCT00102063|281340|P3|STARTED|Overall Study||100
118356|NCT00102063|281341|P2|STARTED|Overall Study||102
118357|NCT00102063|281342|P1|STARTED|Overall Study||100
118358|NCT00102440|281374|P3|NOT COMPLETED|Overall Study||66
118359|NCT00102440|281375|P2|NOT COMPLETED|Overall Study||98
118360|NCT00102440|281376|P1|NOT COMPLETED|Overall Study||88
118361|NCT00102440|281374|P3|COMPLETED|Overall Study||187
118362|NCT00102440|281375|P2|COMPLETED|Overall Study||153
118363|NCT00102440|281376|P1|COMPLETED|Overall Study||168
118364|NCT00102440|281374|P3|STARTED|Overall Study||253
118365|NCT00102440|281375|P2|STARTED|Overall Study||251
118366|NCT00102440|281376|P1|STARTED|Overall Study||256
118367|NCT00102518|281423|P1|NOT COMPLETED|Overall Study||87
118368|NCT00102518|281423|P1|COMPLETED|Overall Study||238
118369|NCT00102518|281423|P1|STARTED|Overall Study||325
118370|NCT00102531|281431|P2|NOT COMPLETED|Overall Study||11
118371|NCT00102531|281432|P1|NOT COMPLETED|Overall Study||5
118372|NCT00102531|281431|P2|COMPLETED|Overall Study||1
118373|NCT00102531|281432|P1|COMPLETED|Overall Study||2
118374|NCT00102531|281431|P2|STARTED|Overall Study||12
118375|NCT00102531|281432|P1|STARTED|Overall Study||7
118376|NCT00102596|281438|P2|NOT COMPLETED|Part C||0
118377|NCT00102596|281439|P1|NOT COMPLETED|Part C||0
118378|NCT00102596|281438|P2|COMPLETED|Part C||2
118379|NCT00102596|281439|P1|COMPLETED|Part C||0
118380|NCT00102596|281438|P2|STARTED|Part C|Only 2 patients participated in Part C|2
118381|NCT00102596|281439|P1|STARTED|Part C||0
118382|NCT00102596|281438|P2|NOT COMPLETED|Part B||0
118383|NCT00102596|281439|P1|NOT COMPLETED|Part B||0
118384|NCT00102596|281438|P2|COMPLETED|Part B||10
118385|NCT00102596|281439|P1|COMPLETED|Part B||0
118386|NCT00102596|281438|P2|STARTED|Part B||10
118387|NCT00102596|281439|P1|STARTED|Part B|Participants from Part A did not continue to Part B|0
118388|NCT00102596|281438|P2|NOT COMPLETED|Part A||0
118389|NCT00102596|281439|P1|NOT COMPLETED|Part A||7
118390|NCT00102596|281438|P2|COMPLETED|Part A||0
118391|NCT00102596|281439|P1|COMPLETED|Part A||4
118392|NCT00102596|281438|P2|Participants Assigned Treatment|Part A||0
118393|NCT00102596|281439|P1|Participants Assigned Treatment|Part A||5
118394|NCT00102596|281438|P2|STARTED|Part A||0
118395|NCT00102596|281439|P1|STARTED|Part A||11
118396|NCT00102687|281451|P5|NOT COMPLETED|Maintenance Period||13
118397|NCT00102687|281452|P4|NOT COMPLETED|Maintenance Period||10
118398|NCT00102687|281453|P3|NOT COMPLETED|Maintenance Period||6
118399|NCT00102687|281454|P2|NOT COMPLETED|Maintenance Period||4
118400|NCT00102687|281455|P1|NOT COMPLETED|Maintenance Period||7
118401|NCT00102687|281451|P5|COMPLETED|Maintenance Period||8
118402|NCT00102687|281452|P4|COMPLETED|Maintenance Period||12
118403|NCT00102687|281453|P3|COMPLETED|Maintenance Period||2
118404|NCT00102687|281454|P2|COMPLETED|Maintenance Period||2
118405|NCT00102687|281455|P1|COMPLETED|Maintenance Period||6
118406|NCT00102687|281451|P5|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|21
118407|NCT00102687|281452|P4|STARTED|Maintenance Period|Second randomization to one of two maintenance regimens|22
118408|NCT00102687|281453|P3|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|8
118409|NCT00102687|281454|P2|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|6
118410|NCT00102687|281455|P1|STARTED|Maintenance Period|Remained on initial treatment in the maintenance period.|13
118411|NCT00102687|281451|P5|NOT COMPLETED|Initial Period||0
118412|NCT00102687|281452|P4|NOT COMPLETED|Initial Period||0
118413|NCT00102687|281453|P3|NOT COMPLETED|Initial Period||26
118414|NCT00102687|281454|P2|NOT COMPLETED|Initial Period||28
118415|NCT00102687|281455|P1|NOT COMPLETED|Initial Period||18
118416|NCT00102687|281451|P5|COMPLETED|Initial Period||0
118417|NCT00102687|281452|P4|COMPLETED|Initial Period||0
118418|NCT00102687|281453|P3|COMPLETED|Initial Period||25
118419|NCT00102687|281454|P2|COMPLETED|Initial Period||22
118420|NCT00102687|281455|P1|COMPLETED|Initial Period||32
118421|NCT00102687|281451|P5|STARTED|Initial Period||0
118422|NCT00102687|281452|P4|STARTED|Initial Period||0
118423|NCT00102687|281453|P3|STARTED|Initial Period|3 randomized participants did not receive treatment.|51
118424|NCT00102687|281454|P2|STARTED|Initial Period||50
118425|NCT00102687|281455|P1|STARTED|Initial Period||50
118426|NCT00102804|281521|P2|NOT COMPLETED|Overall Study||222
118427|NCT00102804|281522|P1|NOT COMPLETED|Overall Study||441
118428|NCT00102804|281521|P2|COMPLETED|Overall Study||0
118429|NCT00102804|281522|P1|COMPLETED|Overall Study||0
118430|NCT00102804|281521|P2|Received at Least 1 Dose of Study Drug|Overall Study|Four participants randomized to placebo received pemetrexed.|222
118431|NCT00102804|281522|P1|Received at Least 1 Dose of Study Drug|Overall Study||434
118432|NCT00102804|281521|P2|STARTED|Overall Study||222
118433|NCT00102804|281522|P1|STARTED|Overall Study||441
118434|NCT00103012|281543|P3|NOT COMPLETED|Overall Study||4
118435|NCT00103012|281544|P2|NOT COMPLETED|Overall Study||1
118436|NCT00103012|281545|P1|NOT COMPLETED|Overall Study||3
118437|NCT00103012|281543|P3|COMPLETED|Overall Study||12
118438|NCT00103012|281544|P2|COMPLETED|Overall Study||13
118439|NCT00103012|281545|P1|COMPLETED|Overall Study||14
118440|NCT00103012|281543|P3|STARTED|Overall Study||16
118441|NCT00103012|281544|P2|STARTED|Overall Study||14
118442|NCT00103012|281545|P1|STARTED|Overall Study||17
118443|NCT00103116|281553|P1|NOT COMPLETED|Overall Study||0
118444|NCT00103116|281553|P1|COMPLETED|Overall Study||32
118445|NCT00103116|281553|P1|STARTED|Overall Study||32
118446|NCT00103142|281560|P2|NOT COMPLETED|Overall Study||1
118447|NCT00103142|281561|P1|NOT COMPLETED|Overall Study||3
118448|NCT00103142|281560|P2|COMPLETED|Overall Study||36
118449|NCT00103142|281561|P1|COMPLETED|Overall Study||33
118450|NCT00103142|281560|P2|STARTED|Overall Study||37
118451|NCT00103142|281561|P1|STARTED|Overall Study||36
118452|NCT00093379|281569|P1|NOT COMPLETED|Overall Study||0
118453|NCT00093379|281569|P1|COMPLETED|Overall Study||20
118454|NCT00093379|281569|P1|STARTED|Overall Study||20
118455|NCT00093470|281577|P2|NOT COMPLETED|Overall Study||0
118456|NCT00093470|281578|P1|NOT COMPLETED|Overall Study||73
118457|NCT00093470|281577|P2|COMPLETED|Overall Study|Patients underwent observation only.|71
118458|NCT00093470|281578|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
118459|NCT00093470|281577|P2|Patients With Toxicity Assessment|Overall Study||69
118460|NCT00093470|281578|P1|Patients With Toxicity Assessment|Overall Study||72
118461|NCT00093470|281577|P2|Treated|Overall Study||71
118462|NCT00093470|281578|P1|Treated|Overall Study||72
118463|NCT00093470|281577|P2|STARTED|Overall Study||71
118464|NCT00093470|281578|P1|STARTED|Overall Study||73
118465|NCT00093496|281588|P2|NOT COMPLETED|Overall Study||3
118466|NCT00093496|281589|P1|NOT COMPLETED|Overall Study||1
118467|NCT00093496|281588|P2|COMPLETED|Overall Study||11
118468|NCT00093496|281589|P1|COMPLETED|Overall Study||14
118469|NCT00093496|281588|P2|STARTED|Overall Study||14
118470|NCT00093496|281589|P1|STARTED|Overall Study||15
118471|NCT00093756|281602|P2|NOT COMPLETED|Overall Study||0
118472|NCT00093756|281603|P1|NOT COMPLETED|Overall Study||0
118473|NCT00093756|281602|P2|COMPLETED|Overall Study||27
118474|NCT00093756|281603|P1|COMPLETED|Overall Study||21
118475|NCT00093756|281602|P2|STARTED|Overall Study||27
118476|NCT00093756|281603|P1|STARTED|Overall Study||21
118477|NCT00093782|281608|P1|NOT COMPLETED|Overall Study||0
118478|NCT00093782|281608|P1|COMPLETED|Overall Study||36
118479|NCT00093782|281608|P1|STARTED|Overall Study||36
118480|NCT00093808|281618|P1|NOT COMPLETED|Overall Study||2
118481|NCT00093808|281618|P1|COMPLETED|Overall Study||45
118482|NCT00093808|281618|P1|STARTED|Overall Study||47
118483|NCT00093847|281627|P2|NOT COMPLETED|Overall Study||10
118484|NCT00093847|281628|P1|NOT COMPLETED|Overall Study||8
118485|NCT00093847|281627|P2|COMPLETED|Overall Study||24
118486|NCT00093847|281628|P1|COMPLETED|Overall Study||31
118487|NCT00093847|281627|P2|STARTED|Overall Study||34
118488|NCT00093847|281628|P1|STARTED|Overall Study||39
118489|NCT00094055|281636|P1|NOT COMPLETED|Overall Study||60
118490|NCT00094055|281636|P1|COMPLETED|Overall Study||0
118491|NCT00094055|281636|P1|STARTED|Overall Study||60
118492|NCT00094094|281645|P1|NOT COMPLETED|Overall Study||32
118493|NCT00094094|281645|P1|COMPLETED|Overall Study||0
118494|NCT00094094|281645|P1|STARTED|Overall Study||32
118495|NCT00094107|281654|P1|NOT COMPLETED|Overall Study||32
118496|NCT00094107|281654|P1|COMPLETED|Overall Study||0
118497|NCT00094107|281654|P1|STARTED|Overall Study||32
118498|NCT00094172|281665|P2|NOT COMPLETED|Overall Study||7
118499|NCT00094172|281666|P1|NOT COMPLETED|Overall Study||14
118500|NCT00094172|281665|P2|COMPLETED|Overall Study||25
118501|NCT00094172|281666|P1|COMPLETED|Overall Study||36
118502|NCT00094172|281665|P2|STARTED|Overall Study|Safety Sample: 32; Intent-to-Treat Sample: 32; Per Protocol Sample: 28|32
118503|NCT00094172|281666|P1|STARTED|Overall Study|Safety Sample: 49; Intent-to-Treat Sample: 49; Per Protocol Sample: 39|50
118504|NCT00094302|281678|P2|NOT COMPLETED|Overall Study||406
118505|NCT00094302|281679|P1|NOT COMPLETED|Overall Study||417
118506|NCT00094302|281678|P2|COMPLETED|Overall Study||1316
118507|NCT00094302|281679|P1|COMPLETED|Overall Study||1306
118508|NCT00094302|281678|P2|STARTED|Overall Study||1722
118509|NCT00094302|281679|P1|STARTED|Overall Study||1723
118510|NCT00094328|281733|P1|NOT COMPLETED|Overall Study||1
118511|NCT00094328|281733|P1|COMPLETED|Overall Study|Completed 12 months on treatment|13
118512|NCT00094328|281733|P1|STARTED|Overall Study|Received treatment|14
118513|NCT00094458|281744|P6|NOT COMPLETED|OLE: Open-Label Extension||4
118514|NCT00094458|281745|P5|NOT COMPLETED|OLE: Open-Label Extension||5
118515|NCT00094458|281746|P4|NOT COMPLETED|OLE: Open-Label Extension||1
118516|NCT00094458|281747|P3|NOT COMPLETED|OLE: Open-Label Extension||0
118517|NCT00094458|281748|P2|NOT COMPLETED|OLE: Open-Label Extension||0
118518|NCT00094458|281749|P1|NOT COMPLETED|OLE: Open-Label Extension||0
118519|NCT00094458|281744|P6|COMPLETED|OLE: Open-Label Extension||13
118520|NCT00094458|281745|P5|COMPLETED|OLE: Open-Label Extension||13
118521|NCT00094458|281746|P4|COMPLETED|OLE: Open-Label Extension||7
118522|NCT00094458|281747|P3|COMPLETED|OLE: Open-Label Extension||0
118523|NCT00094458|281748|P2|COMPLETED|OLE: Open-Label Extension||0
118524|NCT00094458|281749|P1|COMPLETED|OLE: Open-Label Extension||0
118525|NCT00094458|281744|P6|STARTED|OLE: Open-Label Extension||17
118526|NCT00094458|281745|P5|STARTED|OLE: Open-Label Extension||18
118527|NCT00094458|281746|P4|STARTED|OLE: Open-Label Extension||8
118528|NCT00094458|281747|P3|STARTED|OLE: Open-Label Extension||0
118529|NCT00094458|281748|P2|STARTED|OLE: Open-Label Extension||0
118530|NCT00094458|281749|P1|STARTED|OLE: Open-Label Extension||0
118531|NCT00094458|281744|P6|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
118532|NCT00094458|281745|P5|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
118533|NCT00094458|281746|P4|NOT COMPLETED|Study Extension: Week 30 Through Week 50||0
118534|NCT00094458|281747|P3|NOT COMPLETED|Study Extension: Week 30 Through Week 50||18
118535|NCT00094458|281748|P2|NOT COMPLETED|Study Extension: Week 30 Through Week 50||12
118536|NCT00094458|281749|P1|NOT COMPLETED|Study Extension: Week 30 Through Week 50||8
118537|NCT00094458|281744|P6|COMPLETED|Study Extension: Week 30 Through Week 50||0
118538|NCT00094458|281745|P5|COMPLETED|Study Extension: Week 30 Through Week 50||0
118623|NCT00094770|281921|P2|STARTED|Year 1 ( Week 0 to Week 52)||584
118539|NCT00094458|281746|P4|COMPLETED|Study Extension: Week 30 Through Week 50||0
118540|NCT00094458|281747|P3|COMPLETED|Study Extension: Week 30 Through Week 50||90
118541|NCT00094458|281748|P2|COMPLETED|Study Extension: Week 30 Through Week 50||85
118542|NCT00094458|281749|P1|COMPLETED|Study Extension: Week 30 Through Week 50||67
118543|NCT00094458|281744|P6|STARTED|Study Extension: Week 30 Through Week 50||0
118544|NCT00094458|281745|P5|STARTED|Study Extension: Week 30 Through Week 50||0
118545|NCT00094458|281746|P4|STARTED|Study Extension: Week 30 Through Week 50||0
118546|NCT00094458|281747|P3|STARTED|Study Extension: Week 30 Through Week 50||108
118547|NCT00094458|281748|P2|STARTED|Study Extension: Week 30 Through Week 50||97
118548|NCT00094458|281749|P1|STARTED|Study Extension: Week 30 Through Week 50||75
118549|NCT00094458|281744|P6|NOT COMPLETED|Main Study: Through Week 30||0
118550|NCT00094458|281745|P5|NOT COMPLETED|Main Study: Through Week 30||0
118551|NCT00094458|281746|P4|NOT COMPLETED|Main Study: Through Week 30||0
118552|NCT00094458|281747|P3|NOT COMPLETED|Main Study: Through Week 30||48
118553|NCT00094458|281748|P2|NOT COMPLETED|Main Study: Through Week 30||58
118554|NCT00094458|281749|P1|NOT COMPLETED|Main Study: Through Week 30||84
118555|NCT00094458|281744|P6|COMPLETED|Main Study: Through Week 30||0
118556|NCT00094458|281745|P5|COMPLETED|Main Study: Through Week 30||0
118557|NCT00094458|281746|P4|COMPLETED|Main Study: Through Week 30||0
118558|NCT00094458|281747|P3|COMPLETED|Main Study: Through Week 30||121
118559|NCT00094458|281748|P2|COMPLETED|Main Study: Through Week 30||111
118560|NCT00094458|281749|P1|COMPLETED|Main Study: Through Week 30||86
118561|NCT00094458|281744|P6|STARTED|Main Study: Through Week 30||0
118562|NCT00094458|281745|P5|STARTED|Main Study: Through Week 30||0
118563|NCT00094458|281746|P4|STARTED|Main Study: Through Week 30||0
118564|NCT00094458|281747|P3|STARTED|Main Study: Through Week 30||169
118565|NCT00094458|281748|P2|STARTED|Main Study: Through Week 30||169
118566|NCT00094458|281749|P1|STARTED|Main Study: Through Week 30||170
118567|NCT00094497|281789|P2|NOT COMPLETED|Overall Study||0
118568|NCT00094497|281790|P1|NOT COMPLETED|Overall Study||0
118569|NCT00094497|281789|P2|COMPLETED|Overall Study||153
118570|NCT00094497|281790|P1|COMPLETED|Overall Study||151
118571|NCT00094497|281789|P2|Received Second Line Therapy|Overall Study||101
118572|NCT00094497|281790|P1|Received Second Line Therapy|Overall Study||84
118573|NCT00094497|281789|P2|Treated|Overall Study||149
118574|NCT00094497|281790|P1|Treated|Overall Study||148
118575|NCT00094497|281789|P2|STARTED|Overall Study||153
118576|NCT00094497|281790|P1|STARTED|Overall Study||151
118577|NCT00094536|281804|P1|NOT COMPLETED|Treatment and Follow-up||31
118578|NCT00094536|281804|P1|COMPLETED|Treatment and Follow-up|51 subjects successfully completed the study.|51
118579|NCT00094536|281804|P1|36 Month Follow-up|Treatment and Follow-up||51
118580|NCT00094536|281804|P1|24 Month Follow-up|Treatment and Follow-up||53
118581|NCT00094536|281804|P1|12 Month Follow-up|Treatment and Follow-up|69 subjects were evaluated at 1-year post-treatment for the primary endpoint of success.|69
118582|NCT00094536|281804|P1|STARTED|Treatment and Follow-up|82 subjects qualified for and underwent the study treatment.|82
118583|NCT00094536|281804|P1|NOT COMPLETED|Inclusion Exclusion Evaluation||24
118584|NCT00094536|281804|P1|COMPLETED|Inclusion Exclusion Evaluation||82
118585|NCT00094536|281804|P1|STARTED|Inclusion Exclusion Evaluation||106
118586|NCT00094575|281810|P2|NOT COMPLETED|Overall Study||146
118587|NCT00094575|281811|P1|NOT COMPLETED|Overall Study||146
118588|NCT00094575|281810|P2|COMPLETED|Overall Study||291
118589|NCT00094575|281811|P1|COMPLETED|Overall Study||298
118590|NCT00094575|281810|P2|STARTED|Overall Study||437
118591|NCT00094575|281811|P1|STARTED|Overall Study||444
118592|NCT00094653|281834|P3|NOT COMPLETED|Overall Study||126
118593|NCT00094653|281835|P2|NOT COMPLETED|Overall Study||106
118594|NCT00094653|281836|P1|NOT COMPLETED|Overall Study||321
118595|NCT00094653|281834|P3|COMPLETED|Overall Study||10
118596|NCT00094653|281835|P2|COMPLETED|Overall Study||31
118597|NCT00094653|281836|P1|COMPLETED|Overall Study||82
118598|NCT00094653|281834|P3|Treated|Overall Study||131
118599|NCT00094653|281835|P2|Treated|Overall Study||131
118600|NCT00094653|281836|P1|Treated|Overall Study||381
118601|NCT00094653|281834|P3|STARTED|Overall Study||136
118602|NCT00094653|281835|P2|STARTED|Overall Study||137
118603|NCT00094653|281836|P1|STARTED|Overall Study||403
118604|NCT00094757|281900|P3|NOT COMPLETED|Overall Study||30
118605|NCT00094757|281901|P2|NOT COMPLETED|Overall Study||62
118606|NCT00094757|281902|P1|NOT COMPLETED|Overall Study||53
118607|NCT00094757|281900|P3|COMPLETED|Overall Study||80
118608|NCT00094757|281901|P2|COMPLETED|Overall Study||144
118609|NCT00094757|281902|P1|COMPLETED|Overall Study||152
118610|NCT00094757|281900|P3|STARTED|Overall Study||110
118611|NCT00094757|281901|P2|STARTED|Overall Study||206
118612|NCT00094757|281902|P1|STARTED|Overall Study||205
118613|NCT00094770|281921|P2|NOT COMPLETED|Year 2 (Week 0 to Week 104)||320
118614|NCT00094770|281922|P1|NOT COMPLETED|Year 2 (Week 0 to Week 104)||333
118615|NCT00094770|281921|P2|COMPLETED|Year 2 (Week 0 to Week 104)||264
118616|NCT00094770|281922|P1|COMPLETED|Year 2 (Week 0 to Week 104)||255
118617|NCT00094770|281921|P2|STARTED|Year 2 (Week 0 to Week 104)||584
118618|NCT00094770|281922|P1|STARTED|Year 2 (Week 0 to Week 104)||588
118619|NCT00094770|281921|P2|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||172
118620|NCT00094770|281922|P1|NOT COMPLETED|Year 1 ( Week 0 to Week 52)||202
118621|NCT00094770|281921|P2|COMPLETED|Year 1 ( Week 0 to Week 52)|11 Participants who Completed Week 52, Did NOT Enter second year|412
118622|NCT00094770|281922|P1|COMPLETED|Year 1 ( Week 0 to Week 52)|4 Participants who Completed Week 52, Did NOT Enter second year|386
118624|NCT00094770|281922|P1|STARTED|Year 1 ( Week 0 to Week 52)||588
118625|NCT00094809|281952|P2|NOT COMPLETED|Overall Study||65
118626|NCT00094809|281953|P1|NOT COMPLETED|Overall Study||52
118627|NCT00094809|281952|P2|COMPLETED|Overall Study|Subjects who completed treatment and LTFU|61
118628|NCT00094809|281953|P1|COMPLETED|Overall Study|Subjects who completed treatment and Long term follow up (LTFU)|74
118629|NCT00094809|281952|P2|Completed All 4 Cycles of Treatment|Overall Study||90
118630|NCT00094809|281953|P1|Completed All 4 Cycles of Treatment|Overall Study||98
118631|NCT00094809|281952|P2|Properly Consented; Received Study Drug|Overall Study||118
118632|NCT00094809|281953|P1|Properly Consented; Received Study Drug|Overall Study||123
118633|NCT00094809|281952|P2|Received Study Drug|Overall Study||118
118634|NCT00094809|281953|P1|Received Study Drug|Overall Study||124
118635|NCT00094809|281952|P2|STARTED|Overall Study||126
118636|NCT00094809|281953|P1|STARTED|Overall Study||126
118637|NCT00094835|281984|P7|NOT COMPLETED|Overall Study||2
118638|NCT00094835|281985|P6|NOT COMPLETED|Overall Study||3
118639|NCT00094835|281986|P5|NOT COMPLETED|Overall Study||4
118640|NCT00094835|281987|P4|NOT COMPLETED|Overall Study||1
118641|NCT00094835|281988|P3|NOT COMPLETED|Overall Study||3
118642|NCT00094835|281989|P2|NOT COMPLETED|Overall Study||3
118643|NCT00094835|281990|P1|NOT COMPLETED|Overall Study||4
118644|NCT00094835|281984|P7|COMPLETED|Overall Study||4
118645|NCT00094835|281985|P6|COMPLETED|Overall Study||3
118646|NCT00094835|281986|P5|COMPLETED|Overall Study||3
118647|NCT00094835|281987|P4|COMPLETED|Overall Study||4
118648|NCT00094835|281988|P3|COMPLETED|Overall Study||4
118649|NCT00094835|281989|P2|COMPLETED|Overall Study||8
118650|NCT00094835|281990|P1|COMPLETED|Overall Study||5
118651|NCT00094835|281984|P7|Treated With Motesanib|Overall Study||6
118652|NCT00094835|281985|P6|Treated With Motesanib|Overall Study||5
118653|NCT00094835|281986|P5|Treated With Motesanib|Overall Study||7
118654|NCT00094835|281987|P4|Treated With Motesanib|Overall Study||4
118655|NCT00094835|281988|P3|Treated With Motesanib|Overall Study||6
118656|NCT00094835|281989|P2|Treated With Motesanib|Overall Study||11
118657|NCT00094835|281990|P1|Treated With Motesanib|Overall Study||6
118658|NCT00094835|281984|P7|STARTED|Overall Study||6
118659|NCT00094835|281985|P6|STARTED|Overall Study||6
118660|NCT00094835|281986|P5|STARTED|Overall Study||7
118661|NCT00094835|281987|P4|STARTED|Overall Study||5
118662|NCT00094835|281988|P3|STARTED|Overall Study||7
118663|NCT00094835|281989|P2|STARTED|Overall Study||11
118664|NCT00094835|281990|P1|STARTED|Overall Study||9
118665|NCT00094861|282068|P2|NOT COMPLETED|Overall Study||9
118666|NCT00094861|282069|P1|NOT COMPLETED|Overall Study||18
118667|NCT00094861|282068|P2|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|40
118668|NCT00094861|282069|P1|COMPLETED|Overall Study|Participants who completed the acute dysphagia evaluation phase|28
118669|NCT00094861|282068|P2|Participants Treated|Overall Study||48
118670|NCT00094861|282069|P1|Participants Treated|Overall Study||46
118671|NCT00094861|282068|P2|STARTED|Overall Study||49
118672|NCT00094861|282069|P1|STARTED|Overall Study||46
118673|NCT00094887|282091|P2|NOT COMPLETED|Overall Study||6
118674|NCT00094887|282092|P1|NOT COMPLETED|Overall Study||5
118675|NCT00094887|282091|P2|COMPLETED|Overall Study||69
118676|NCT00094887|282092|P1|COMPLETED|Overall Study||70
118677|NCT00094887|282091|P2|STARTED|Overall Study|75|75
118678|NCT00094887|282092|P1|STARTED|Overall Study|75|75
118679|NCT00094900|282098|P1|NOT COMPLETED|Overall Study||1
118680|NCT00094900|282098|P1|COMPLETED|Overall Study||10
118681|NCT00094900|282098|P1|STARTED|Overall Study||11
118682|NCT00095056|282200|P2|NOT COMPLETED|Phase B (Weeks 12-54)||5
118683|NCT00095056|282201|P1|NOT COMPLETED|Phase B (Weeks 12-54)||10
118684|NCT00095056|282200|P2|COMPLETED|Phase B (Weeks 12-54)||20
118685|NCT00095056|282201|P1|COMPLETED|Phase B (Weeks 12-54)||46
118686|NCT00095056|282200|P2|STARTED|Phase B (Weeks 12-54)||25
118687|NCT00095056|282201|P1|STARTED|Phase B (Weeks 12-54)|2 randomized patients completed Period 1 but did not enter Period 2.|56
118688|NCT00095056|282200|P2|NOT COMPLETED|Phase A (Weeks 0-12)||1
118689|NCT00095056|282201|P1|NOT COMPLETED|Phase A (Weeks 0-12)||7
118690|NCT00095056|282200|P2|COMPLETED|Phase A (Weeks 0-12)||25
118691|NCT00095056|282201|P1|COMPLETED|Phase A (Weeks 0-12)||58
118692|NCT00095056|282200|P2|STARTED|Phase A (Weeks 0-12)||26
118693|NCT00095056|282201|P1|STARTED|Phase A (Weeks 0-12)||65
118694|NCT00095121|282211|P2|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||19
118695|NCT00095121|282212|P1|NOT COMPLETED|Open-Label (Study Weeks 49 Through 240)||62
118696|NCT00095121|282211|P2|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|35
118697|NCT00095121|282212|P1|COMPLETED|Open-Label (Study Weeks 49 Through 240)|Completed the 240-week study period either on or off treatment at Week 240.|46
118698|NCT00095121|282211|P2|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||11
118699|NCT00095121|282212|P1|Received Lamivudine (LAM) After Week 96|Open-Label (Study Weeks 49 Through 240)||21
118700|NCT00095121|282211|P2|STARTED|Open-Label (Study Weeks 49 Through 240)||54
118701|NCT00095121|282212|P1|STARTED|Open-Label (Study Weeks 49 Through 240)||108
118702|NCT00095121|282211|P2|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||0
118703|NCT00095121|282212|P1|NOT COMPLETED|Double-Blind (Study Weeks 0 Through 48)||3
118704|NCT00095121|282211|P2|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||58
118705|NCT00095121|282212|P1|COMPLETED|Double-Blind (Study Weeks 0 Through 48)||112
118706|NCT00095121|282211|P2|STARTED|Double-Blind (Study Weeks 0 Through 48)||58
118707|NCT00095121|282212|P1|STARTED|Double-Blind (Study Weeks 0 Through 48)||115
118708|NCT00095147|282259|P5|NOT COMPLETED|Long-term Extension Period||45
118709|NCT00095147|282260|P4|NOT COMPLETED|Long-term Extension Period||0
118710|NCT00095147|282261|P3|NOT COMPLETED|Long-term Extension Period||0
118711|NCT00095147|282262|P2|NOT COMPLETED|Long-term Extension Period||0
118712|NCT00095147|282263|P1|NOT COMPLETED|Long-term Extension Period||0
118713|NCT00095147|282259|P5|COMPLETED|Long-term Extension Period||327
118714|NCT00095147|282260|P4|COMPLETED|Long-term Extension Period||0
118715|NCT00095147|282261|P3|COMPLETED|Long-term Extension Period||0
118716|NCT00095147|282262|P2|COMPLETED|Long-term Extension Period||0
118717|NCT00095147|282263|P1|COMPLETED|Long-term Extension Period||0
118718|NCT00095147|282259|P5|STARTED|Long-term Extension Period||372
118719|NCT00095147|282260|P4|STARTED|Long-term Extension Period||0
118720|NCT00095147|282261|P3|STARTED|Long-term Extension Period||0
118721|NCT00095147|282262|P2|STARTED|Long-term Extension Period||0
118722|NCT00095147|282263|P1|STARTED|Long-term Extension Period||0
118723|NCT00095147|282259|P5|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
118724|NCT00095147|282260|P4|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||3
118725|NCT00095147|282261|P3|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||0
118726|NCT00095147|282262|P2|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||11
118727|NCT00095147|282263|P1|NOT COMPLETED|Double-blind Period 2 (Days 198-365)||8
118728|NCT00095147|282259|P5|COMPLETED|Double-blind Period 2 (Days 198-365)||0
118729|NCT00095147|282260|P4|COMPLETED|Double-blind Period 2 (Days 198-365)||104
118730|NCT00095147|282261|P3|COMPLETED|Double-blind Period 2 (Days 198-365)||0
118731|NCT00095147|282262|P2|COMPLETED|Double-blind Period 2 (Days 198-365)||141
118732|NCT00095147|282263|P1|COMPLETED|Double-blind Period 2 (Days 198-365)||139
118733|NCT00095147|282259|P5|STARTED|Double-blind Period 2 (Days 198-365)||0
118734|NCT00095147|282260|P4|STARTED|Double-blind Period 2 (Days 198-365)||107
118735|NCT00095147|282261|P3|STARTED|Double-blind Period 2 (Days 198-365)||0
118736|NCT00095147|282262|P2|STARTED|Double-blind Period 2 (Days 198-365)||152
118737|NCT00095147|282263|P1|STARTED|Double-blind Period 2 (Days 198-365)||147
118738|NCT00095147|282259|P5|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
118739|NCT00095147|282260|P4|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||0
118740|NCT00095147|282261|P3|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||3
118741|NCT00095147|282262|P2|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||13
118742|NCT00095147|282263|P1|NOT COMPLETED|Double-blind Period 1 (Days 1-197)||9
118743|NCT00095147|282259|P5|COMPLETED|Double-blind Period 1 (Days 1-197)||0
118744|NCT00095147|282260|P4|COMPLETED|Double-blind Period 1 (Days 1-197)||0
118745|NCT00095147|282261|P3|COMPLETED|Double-blind Period 1 (Days 1-197)||107
118746|NCT00095147|282262|P2|COMPLETED|Double-blind Period 1 (Days 1-197)||152
118747|NCT00095147|282263|P1|COMPLETED|Double-blind Period 1 (Days 1-197)||147
118748|NCT00095147|282259|P5|STARTED|Double-blind Period 1 (Days 1-197)||0
118749|NCT00095147|282260|P4|STARTED|Double-blind Period 1 (Days 1-197)||0
118750|NCT00095147|282261|P3|STARTED|Double-blind Period 1 (Days 1-197)||110
118751|NCT00095147|282262|P2|STARTED|Double-blind Period 1 (Days 1-197)||165
118752|NCT00095147|282263|P1|STARTED|Double-blind Period 1 (Days 1-197)||156
118753|NCT00103194|282456|P1|NOT COMPLETED|Overall Study||31
118754|NCT00103194|282456|P1|COMPLETED|Overall Study||18
118755|NCT00103194|282456|P1|Eligible and Treated|Overall Study||35
118756|NCT00103194|282456|P1|Eligible|Overall Study||35
118757|NCT00103194|282456|P1|Treated|Overall Study||49
118758|NCT00103194|282456|P1|STARTED|Overall Study||49
118759|NCT00103207|282463|P1|NOT COMPLETED|Overall Study||38
118760|NCT00103207|282463|P1|COMPLETED|Overall Study||34
118761|NCT00103207|282463|P1|Eligible Patients w/ Smoking Status Data|Overall Study||37
118762|NCT00103207|282463|P1|Eligible Patients w/ Confirmed Diagnosis|Overall Study||41
118763|NCT00103207|282463|P1|STARTED|Overall Study||72
118764|NCT00103259|282475|P2|NOT COMPLETED|Overall Study||12
118765|NCT00103259|282476|P1|NOT COMPLETED|Overall Study||12
118766|NCT00103259|282475|P2|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.This number is for stage I.|32
118767|NCT00103259|282476|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|15
118768|NCT00103259|282475|P2|Eligible Patients Who Cross Over|Overall Study||10
118769|NCT00103259|282476|P1|Eligible Patients Who Cross Over|Overall Study||0
118770|NCT00103259|282475|P2|Cross Over to the Other Arm|Overall Study|11 patients who progressed on bortezomib crossed over to Arm I. 10 of them were eligible|11
118771|NCT00103259|282476|P1|Cross Over to the Other Arm|Overall Study||0
118772|NCT00103259|282475|P2|Eligible and Treated|Overall Study||38
118773|NCT00103259|282476|P1|Eligible and Treated|Overall Study||23
118774|NCT00103259|282475|P2|Treated|Overall Study||41
118775|NCT00103259|282476|P1|Treated|Overall Study||23
118776|NCT00103259|282475|P2|Eligible|Overall Study||41
118777|NCT00103259|282476|P1|Eligible|Overall Study||27
118778|NCT00103259|282475|P2|STARTED|Overall Study||44
118779|NCT00103259|282476|P1|STARTED|Overall Study||27
118780|NCT00103311|282490|P2|NOT COMPLETED|Overall Study||1
118781|NCT00103311|282491|P1|NOT COMPLETED|Overall Study||4
118782|NCT00103311|282490|P2|COMPLETED|Overall Study||30
118783|NCT00103311|282491|P1|COMPLETED|Overall Study||29
118784|NCT00103311|282490|P2|STARTED|Overall Study||31
118785|NCT00103311|282491|P1|STARTED|Overall Study||33
118786|NCT00103506|282503|P2|NOT COMPLETED|Overall Study||324
118787|NCT00103506|282504|P1|NOT COMPLETED|Overall Study||322
118788|NCT00103506|282503|P2|COMPLETED|Overall Study||0
118789|NCT00103506|282504|P1|COMPLETED|Overall Study||0
118790|NCT00103506|282503|P2|STARTED|Overall Study||324
118791|NCT00103506|282504|P1|STARTED|Overall Study||322
118792|NCT00103844|282516|P2|NOT COMPLETED|Overall Study||0
118793|NCT00103844|282517|P1|NOT COMPLETED|Overall Study||0
118794|NCT00103844|282516|P2|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|49
118795|NCT00103844|282517|P1|COMPLETED|Overall Study|Completed=no longer on treatment.Treatment continued until disease progression/intolerable toxicity.|101
118796|NCT00103844|282516|P2|Crossed Over|Overall Study|40 participants from the imatinib arm crossed over the dasatinib|40
118797|NCT00103844|282517|P1|Crossed Over|Overall Study|22 participants from the dasatinib arm crossed over to imatinib|22
118798|NCT00103844|282516|P2|STARTED|Overall Study||49
118799|NCT00103844|282517|P1|STARTED|Overall Study||101
118800|NCT00103857|282555|P7|NOT COMPLETED|50-Week Extension Study||0
118801|NCT00103857|282556|P6|NOT COMPLETED|50-Week Extension Study||20
118802|NCT00103857|282557|P5|NOT COMPLETED|50-Week Extension Study||21
118803|NCT00103857|282558|P4|NOT COMPLETED|50-Week Extension Study||36
118804|NCT00103857|282559|P3|NOT COMPLETED|50-Week Extension Study||26
118805|NCT00103857|282560|P2|NOT COMPLETED|50-Week Extension Study||27
118806|NCT00103857|282561|P1|NOT COMPLETED|50-Week Extension Study||38
118807|NCT00103857|282555|P7|COMPLETED|50-Week Extension Study||0
118808|NCT00103857|282556|P6|COMPLETED|50-Week Extension Study||78
118809|NCT00103857|282557|P5|COMPLETED|50-Week Extension Study||101
118810|NCT00103857|282558|P4|COMPLETED|50-Week Extension Study||98
118811|NCT00103857|282559|P3|COMPLETED|50-Week Extension Study||95
118812|NCT00103857|282560|P2|COMPLETED|50-Week Extension Study||80
118813|NCT00103857|282561|P1|COMPLETED|50-Week Extension Study||65
118814|NCT00103857|282555|P7|STARTED|50-Week Extension Study||0
118815|NCT00103857|282556|P6|STARTED|50-Week Extension Study|17 randomized patients completed Period 1 but did not enter Period 2.|98
118816|NCT00103857|282557|P5|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|122
118817|NCT00103857|282558|P4|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|134
118818|NCT00103857|282559|P3|STARTED|50-Week Extension Study|14 randomized patients completed Period 1 but did not enter Period 2.|121
118819|NCT00103857|282560|P2|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|107
118820|NCT00103857|282561|P1|STARTED|50-Week Extension Study|19 randomized patients completed Period 1 but did not enter Period 2.|103
118821|NCT00103857|282555|P7|NOT COMPLETED|54-Week Base Study||38
118822|NCT00103857|282556|P6|NOT COMPLETED|54-Week Base Study||61
118823|NCT00103857|282557|P5|NOT COMPLETED|54-Week Base Study||41
118824|NCT00103857|282558|P4|NOT COMPLETED|54-Week Base Study||42
118825|NCT00103857|282559|P3|NOT COMPLETED|54-Week Base Study||47
118826|NCT00103857|282560|P2|NOT COMPLETED|54-Week Base Study||56
118827|NCT00103857|282561|P1|NOT COMPLETED|54-Week Base Study||57
118828|NCT00103857|282555|P7|COMPLETED|54-Week Base Study||79
118829|NCT00103857|282556|P6|COMPLETED|54-Week Base Study||115
118830|NCT00103857|282557|P5|COMPLETED|54-Week Base Study||141
118831|NCT00103857|282558|P4|COMPLETED|54-Week Base Study||148
118832|NCT00103857|282559|P3|COMPLETED|54-Week Base Study||135
118833|NCT00103857|282560|P2|COMPLETED|54-Week Base Study||126
118834|NCT00103857|282561|P1|COMPLETED|54-Week Base Study||122
118835|NCT00103857|282555|P7|STARTED|54-Week Base Study|Results for the OLC are through Week 24. Results for the 6 randomized groups are through Week 54.|117
118836|NCT00103857|282556|P6|STARTED|54-Week Base Study||176
118837|NCT00103857|282557|P5|STARTED|54-Week Base Study||182
118838|NCT00103857|282558|P4|STARTED|54-Week Base Study||190
118839|NCT00103857|282559|P3|STARTED|54-Week Base Study||182
118840|NCT00103857|282560|P2|STARTED|54-Week Base Study||182
118841|NCT00103857|282561|P1|STARTED|54-Week Base Study||179
118842|NCT00104052|282624|P1|NOT COMPLETED|Overall Study||29
118843|NCT00104052|282624|P1|COMPLETED|Overall Study||78
118844|NCT00104052|282624|P1|STARTED|Overall Study||107
118845|NCT00104104|282630|P2|NOT COMPLETED|Overall Study||72
118846|NCT00104104|282631|P1|NOT COMPLETED|Overall Study||75
118847|NCT00104104|282630|P2|COMPLETED|Overall Study||17
118848|NCT00104104|282631|P1|COMPLETED|Overall Study||15
118849|NCT00104104|282630|P2|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 4 patients in this arm were excluded.|84
118850|NCT00104104|282631|P1|Safety Population (Excluding Site 74)|Overall Study|Because of GCP violations at Site 74, post-baseline data for 3 patients in this arm were excluded.|85
118851|NCT00104104|282630|P2|Safety Population (Including Site 74)|Overall Study||88
118852|NCT00104104|282631|P1|Safety Population (Including Site 74)|Overall Study||88
118853|NCT00104104|282630|P2|STARTED|Overall Study|1 Participants in the 30-minute infusion group did not receive study drug.|89
118854|NCT00104104|282631|P1|STARTED|Overall Study|2 Participants in the 15-minute infusion group did not receive study drug.|90
118855|NCT00104234|282647|P2|NOT COMPLETED|Overall Study||1
118856|NCT00104234|282648|P1|NOT COMPLETED|Overall Study||0
118857|NCT00104234|282647|P2|COMPLETED|Overall Study||19
118858|NCT00104234|282648|P1|COMPLETED|Overall Study||19
118859|NCT00104234|282647|P2|STARTED|Overall Study||20
118860|NCT00104234|282648|P1|STARTED|Overall Study||19
118861|NCT00104247|282658|P2|NOT COMPLETED|Overall Study||1
118862|NCT00104247|282659|P1|NOT COMPLETED|Overall Study||1
118863|NCT00104247|282658|P2|COMPLETED|Overall Study|One subject withdrew at Week 4, but is included in the data analysis|46
118864|NCT00104247|282659|P1|COMPLETED|Overall Study|Subject withdrew prior to dosing|41
118865|NCT00104247|282658|P2|STARTED|Overall Study||47
118866|NCT00104247|282659|P1|STARTED|Overall Study||42
118867|NCT00104299|282667|P2|NOT COMPLETED|Overall Study||10
118868|NCT00104299|282668|P1|NOT COMPLETED|Overall Study||9
118869|NCT00104299|282667|P2|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|88
118870|NCT00104299|282668|P1|COMPLETED|Overall Study|Number of participants who completed 18 months post-randomization|90
118871|NCT00104299|282667|P2|STARTED|Overall Study||98
118872|NCT00104299|282668|P1|STARTED|Overall Study||99
118873|NCT00104416|282690|P5|NOT COMPLETED|Continuation Phase||5
118874|NCT00104416|282691|P4|NOT COMPLETED|Continuation Phase||2
118875|NCT00104416|282692|P3|NOT COMPLETED|Continuation Phase||6
118876|NCT00104416|282693|P2|NOT COMPLETED|Continuation Phase||0
118877|NCT00104416|282694|P1|NOT COMPLETED|Continuation Phase||0
118878|NCT00104416|282690|P5|COMPLETED|Continuation Phase||27
118879|NCT00104416|282691|P4|COMPLETED|Continuation Phase||65
118880|NCT00104416|282692|P3|COMPLETED|Continuation Phase||63
118881|NCT00104416|282693|P2|COMPLETED|Continuation Phase||0
118882|NCT00104416|282694|P1|COMPLETED|Continuation Phase||0
118883|NCT00104416|282690|P5|STARTED|Continuation Phase||32
118884|NCT00104416|282691|P4|STARTED|Continuation Phase|One participant did not complete the Double-Blind Phase but was enrolled in the Continuation Phase.|67
118885|NCT00104416|282692|P3|STARTED|Continuation Phase||69
118886|NCT00104416|282693|P2|STARTED|Continuation Phase||0
118887|NCT00104416|282694|P1|STARTED|Continuation Phase||0
118888|NCT00104416|282690|P5|NOT COMPLETED|Double-Blind Phase||0
118889|NCT00104416|282691|P4|NOT COMPLETED|Double-Blind Phase||0
118890|NCT00104416|282692|P3|NOT COMPLETED|Double-Blind Phase||0
118891|NCT00104416|282693|P2|NOT COMPLETED|Double-Blind Phase||10
118892|NCT00104416|282694|P1|NOT COMPLETED|Double-Blind Phase||8
118893|NCT00104416|282690|P5|COMPLETED|Double-Blind Phase||0
118894|NCT00104416|282691|P4|COMPLETED|Double-Blind Phase||0
118895|NCT00104416|282692|P3|COMPLETED|Double-Blind Phase||0
118896|NCT00104416|282693|P2|COMPLETED|Double-Blind Phase||66
118897|NCT00104416|282694|P1|COMPLETED|Double-Blind Phase||69
118898|NCT00104416|282690|P5|STARTED|Double-Blind Phase||0
118899|NCT00104416|282691|P4|STARTED|Double-Blind Phase||0
118900|NCT00104416|282692|P3|STARTED|Double-Blind Phase||0
118901|NCT00104416|282693|P2|STARTED|Double-Blind Phase||76
118902|NCT00104416|282694|P1|STARTED|Double-Blind Phase||77
118903|NCT00104520|282739|P2|NOT COMPLETED|Overall Study||71
118904|NCT00104520|282740|P1|NOT COMPLETED|Overall Study||50
118905|NCT00104520|282739|P2|COMPLETED|Overall Study||64
118906|NCT00104520|282740|P1|COMPLETED|Overall Study||26
118907|NCT00104520|282739|P2|STARTED|Overall Study||135
118908|NCT00104520|282740|P1|STARTED|Overall Study||76
118909|NCT00104572|282761|P3|NOT COMPLETED|Overall Study||0
118910|NCT00104572|282762|P2|NOT COMPLETED|Overall Study||3
118911|NCT00104572|282763|P1|NOT COMPLETED|Overall Study||3
118912|NCT00104572|282761|P3|COMPLETED|Overall Study||9
118913|NCT00104572|282762|P2|COMPLETED|Overall Study||10
118914|NCT00104572|282763|P1|COMPLETED|Overall Study||10
118915|NCT00104572|282761|P3|STARTED|Overall Study|(N=11) in placebo, physician removed 2 men due to total testosterone>450 ng/DL, N=9 analysed.|9
118916|NCT00104572|282762|P2|STARTED|Overall Study|These are the analysed subjects|13
118917|NCT00104572|282763|P1|STARTED|Overall Study|These are the analysed subjects|13
118918|NCT00104637|282771|P2|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
118919|NCT00104637|282772|P1|NOT COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||0
118920|NCT00104637|282771|P2|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||4
118921|NCT00104637|282772|P1|COMPLETED|Period 3 ( TREATMENT: 4 Weeks)||5
118922|NCT00104637|282771|P2|STARTED|Period 3 ( TREATMENT: 4 Weeks)||4
118923|NCT00104637|282772|P1|STARTED|Period 3 ( TREATMENT: 4 Weeks)||5
118924|NCT00104637|282771|P2|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
118925|NCT00104637|282772|P1|NOT COMPLETED|Period 2 (WASHOUT: 1 Week)||0
118926|NCT00104637|282771|P2|COMPLETED|Period 2 (WASHOUT: 1 Week)||4
118927|NCT00104637|282772|P1|COMPLETED|Period 2 (WASHOUT: 1 Week)||5
118928|NCT00104637|282771|P2|STARTED|Period 2 (WASHOUT: 1 Week)||4
118929|NCT00104637|282772|P1|STARTED|Period 2 (WASHOUT: 1 Week)||5
118930|NCT00104637|282771|P2|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||0
118931|NCT00104637|282772|P1|NOT COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||1
118932|NCT00104637|282771|P2|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||4
118933|NCT00104637|282772|P1|COMPLETED|Period 1: ( TREATMENT: 4 Weeks)||5
118934|NCT00104637|282771|P2|STARTED|Period 1: ( TREATMENT: 4 Weeks)||4
118935|NCT00104637|282772|P1|STARTED|Period 1: ( TREATMENT: 4 Weeks)||6
118936|NCT00104650|282801|P3|NOT COMPLETED|Follow-up Period||10
118937|NCT00104650|282802|P2|NOT COMPLETED|Follow-up Period||13
118938|NCT00104650|282803|P1|NOT COMPLETED|Follow-up Period||11
118939|NCT00104650|282801|P3|COMPLETED|Follow-up Period||18
118940|NCT00104650|282802|P2|COMPLETED|Follow-up Period||12
118941|NCT00104650|282803|P1|COMPLETED|Follow-up Period||14
118942|NCT00104650|282801|P3|STARTED|Follow-up Period||28
118943|NCT00104650|282802|P2|STARTED|Follow-up Period||25
118944|NCT00104650|282803|P1|STARTED|Follow-up Period||25
118945|NCT00104650|282801|P3|NOT COMPLETED|Treatment Period (25 Weeks)||10
118946|NCT00104650|282802|P2|NOT COMPLETED|Treatment Period (25 Weeks)||11
118947|NCT00104650|282803|P1|NOT COMPLETED|Treatment Period (25 Weeks)||12
118948|NCT00104650|282801|P3|COMPLETED|Treatment Period (25 Weeks)||28
118949|NCT00104650|282802|P2|COMPLETED|Treatment Period (25 Weeks)||25
118950|NCT00104650|282803|P1|COMPLETED|Treatment Period (25 Weeks)||25
118951|NCT00104650|282801|P3|Received Investigational Product|Treatment Period (25 Weeks)||38
118952|NCT00104650|282802|P2|Received Investigational Product|Treatment Period (25 Weeks)||35
118953|NCT00104650|282803|P1|Received Investigational Product|Treatment Period (25 Weeks)||35
118954|NCT00104650|282801|P3|STARTED|Treatment Period (25 Weeks)||38
118955|NCT00104650|282802|P2|STARTED|Treatment Period (25 Weeks)||36
118956|NCT00104650|282803|P1|STARTED|Treatment Period (25 Weeks)||37
118957|NCT00104728|282835|P1|NOT COMPLETED|Overall Study||19
118958|NCT00104728|282835|P1|COMPLETED|Overall Study||23
118959|NCT00104728|282835|P1|STARTED|Overall Study|42 consented on study|42
118960|NCT00104871|282840|P1|NOT COMPLETED|Overall Study||1
118961|NCT00104871|282840|P1|COMPLETED|Overall Study||21
118962|NCT00104871|282840|P1|STARTED|Overall Study||22
118963|NCT00104884|282845|P1|NOT COMPLETED|Overall Study||4
118964|NCT00104884|282845|P1|COMPLETED|Overall Study||0
118965|NCT00104884|282845|P1|STARTED|Overall Study||4
118966|NCT00105001|282852|P3|NOT COMPLETED|Overall Study||0
118967|NCT00105001|282853|P2|NOT COMPLETED|Overall Study||0
118968|NCT00105001|282854|P1|NOT COMPLETED|Overall Study||0
118969|NCT00105001|282852|P3|COMPLETED|Overall Study||69
118970|NCT00105001|282853|P2|COMPLETED|Overall Study||71
118971|NCT00105001|282854|P1|COMPLETED|Overall Study||70
118972|NCT00105001|282852|P3|STARTED|Overall Study||69
118973|NCT00105001|282853|P2|STARTED|Overall Study||71
118974|NCT00105001|282854|P1|STARTED|Overall Study||70
118975|NCT00105027|282880|P6|NOT COMPLETED|Overall Study||13
118976|NCT00105027|282881|P5|NOT COMPLETED|Overall Study||15
118977|NCT00105027|282882|P4|NOT COMPLETED|Overall Study||16
118978|NCT00105027|282883|P3|NOT COMPLETED|Overall Study||9
118979|NCT00105027|282884|P2|NOT COMPLETED|Overall Study||9
118980|NCT00105027|282885|P1|NOT COMPLETED|Overall Study||15
118981|NCT00105027|282880|P6|COMPLETED|Overall Study||125
118982|NCT00105027|282881|P5|COMPLETED|Overall Study||121
118983|NCT00105027|282882|P4|COMPLETED|Overall Study||121
118984|NCT00105027|282883|P3|COMPLETED|Overall Study||82
118985|NCT00105027|282884|P2|COMPLETED|Overall Study||83
118986|NCT00105027|282885|P1|COMPLETED|Overall Study||73
118987|NCT00105027|282880|P6|STARTED|Overall Study||138
118988|NCT00105027|282881|P5|STARTED|Overall Study||136
118989|NCT00105027|282882|P4|STARTED|Overall Study||137
118990|NCT00105027|282883|P3|STARTED|Overall Study||91
118991|NCT00105027|282884|P2|STARTED|Overall Study||92
118992|NCT00105027|282885|P1|STARTED|Overall Study||88
118993|NCT00105066|282901|P2|NOT COMPLETED|Overall Study||5
118994|NCT00105066|282902|P1|NOT COMPLETED|Overall Study||2
118995|NCT00105066|282901|P2|COMPLETED|Overall Study||45
118996|NCT00105066|282902|P1|COMPLETED|Overall Study||25
118997|NCT00105066|282901|P2|STARTED|Overall Study||50
118998|NCT00105066|282902|P1|STARTED|Overall Study||27
118999|NCT00105079|282914|P2|NOT COMPLETED|Overall Study||35
119000|NCT00105079|282915|P1|NOT COMPLETED|Overall Study||39
119001|NCT00105079|282914|P2|COMPLETED|Overall Study||135
119002|NCT00105079|282915|P1|COMPLETED|Overall Study||128
119003|NCT00105079|282914|P2|Safety Population|Overall Study||168
119004|NCT00105079|282915|P1|Safety Population|Overall Study||163
119005|NCT00105079|282914|P2|STARTED|Overall Study||170
119006|NCT00105079|282915|P1|STARTED|Overall Study||167
119007|NCT00105157|282935|P4|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||18
119008|NCT00105157|282936|P3|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
119009|NCT00105157|282937|P2|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||6
119010|NCT00105157|282938|P1|NOT COMPLETED|Open-Label Post Virologic Failure(OLPVF)||9
119011|NCT00105157|282935|P4|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||19
119012|NCT00105157|282936|P3|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||5
119013|NCT00105157|282937|P2|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||7
119014|NCT00105157|282938|P1|COMPLETED|Open-Label Post Virologic Failure(OLPVF)||2
119015|NCT00105157|282935|P4|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|37
119016|NCT00105157|282936|P3|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
119017|NCT00105157|282937|P2|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|13
119018|NCT00105157|282938|P1|STARTED|Open-Label Post Virologic Failure(OLPVF)|Number of Patients appropriate for and who consented to enter the OLPVF|11
119019|NCT00105157|282935|P4|NOT COMPLETED|Open-Label Continuation of DB||1
119020|NCT00105157|282936|P3|NOT COMPLETED|Open-Label Continuation of DB||9
119021|NCT00105157|282937|P2|NOT COMPLETED|Open-Label Continuation of DB||10
119022|NCT00105157|282938|P1|NOT COMPLETED|Open-Label Continuation of DB||7
119023|NCT00105157|282935|P4|COMPLETED|Open-Label Continuation of DB||5
119024|NCT00105157|282936|P3|COMPLETED|Open-Label Continuation of DB||24
119025|NCT00105157|282937|P2|COMPLETED|Open-Label Continuation of DB||21
119026|NCT00105157|282938|P1|COMPLETED|Open-Label Continuation of DB||23
119027|NCT00105157|282935|P4|STARTED|Open-Label Continuation of DB||6
119028|NCT00105157|282936|P3|STARTED|Open-Label Continuation of DB||33
119029|NCT00105157|282937|P2|STARTED|Open-Label Continuation of DB||31
119030|NCT00105157|282938|P1|STARTED|Open-Label Continuation of DB||30
119031|NCT00105157|282935|P4|NOT COMPLETED|Double-Blind (DB)||39
119032|NCT00105157|282936|P3|NOT COMPLETED|Double-Blind (DB)||12
119033|NCT00105157|282937|P2|NOT COMPLETED|Double-Blind (DB)||14
119034|NCT00105157|282938|P1|NOT COMPLETED|Double-Blind (DB)||14
119035|NCT00105157|282935|P4|COMPLETED|Double-Blind (DB)||6
119036|NCT00105157|282936|P3|COMPLETED|Double-Blind (DB)||33
119037|NCT00105157|282937|P2|COMPLETED|Double-Blind (DB)||31
119038|NCT00105157|282938|P1|COMPLETED|Double-Blind (DB)||30
119039|NCT00105157|282935|P4|Treated|Double-Blind (DB)||45
119040|NCT00105157|282936|P3|Treated|Double-Blind (DB)||45
119041|NCT00105157|282937|P2|Treated|Double-Blind (DB)||45
119042|NCT00105157|282938|P1|Treated|Double-Blind (DB)||43
119043|NCT00105157|282935|P4|STARTED|Double-Blind (DB)||45
119044|NCT00105157|282936|P3|STARTED|Double-Blind (DB)||45
119045|NCT00105157|282937|P2|STARTED|Double-Blind (DB)||45
119046|NCT00105157|282938|P1|STARTED|Double-Blind (DB)||44
119047|NCT00105183|283133|P3|NOT COMPLETED|Overall Study||23
119048|NCT00105183|283134|P2|NOT COMPLETED|Overall Study||19
119049|NCT00105183|283135|P1|NOT COMPLETED|Overall Study||22
119050|NCT00105183|283133|P3|COMPLETED|Overall Study|Completed at least 12 months follow up|39
119051|NCT00105183|283134|P2|COMPLETED|Overall Study|Completed at least 12 months follow up|60
119052|NCT00105183|283135|P1|COMPLETED|Overall Study|Completed at least 12 months follow up|60
119053|NCT00105183|283133|P3|STARTED|Overall Study|Randomized|62
119054|NCT00105183|283134|P2|STARTED|Overall Study|Randomized|79
119055|NCT00105183|283135|P1|STARTED|Overall Study|Randomized|82
119056|NCT00105196|283169|P2|NOT COMPLETED|Overall Study||23
119057|NCT00105196|283170|P1|NOT COMPLETED|Overall Study||30
119058|NCT00105196|283169|P2|COMPLETED|Overall Study||149
119059|NCT00105196|283170|P1|COMPLETED|Overall Study||147
119060|NCT00105196|283169|P2|STARTED|Overall Study||172
119061|NCT00105196|283170|P1|STARTED|Overall Study||177
119062|NCT00105235|283190|P1|NOT COMPLETED|Overall Study||7
119063|NCT00105235|283190|P1|COMPLETED|Overall Study||20
119064|NCT00105235|283190|P1|STARTED|Overall Study||27
119065|NCT00105443|283203|P4|NOT COMPLETED|Follow-up and/or Open Label Nexavar||47
119066|NCT00105443|283204|P3|NOT COMPLETED|Follow-up and/or Open Label Nexavar||245
119067|NCT00105443|283205|P2|NOT COMPLETED|Follow-up and/or Open Label Nexavar||57
119068|NCT00105443|283206|P1|NOT COMPLETED|Follow-up and/or Open Label Nexavar||228
119069|NCT00105443|283203|P4|COMPLETED|Follow-up and/or Open Label Nexavar|47 participants in total (36 + 11) received Open Label Sorafenib treatment (Subjects at Risk)|0
119070|NCT00105443|283204|P3|COMPLETED|Follow-up and/or Open Label Nexavar||0
119071|NCT00105443|283205|P2|COMPLETED|Follow-up and/or Open Label Nexavar|57 participants in total (47 + 10) received Open Label Sorafenib treatment (Subjects at Risk)|0
119072|NCT00105443|283206|P1|COMPLETED|Follow-up and/or Open Label Nexavar||0
119073|NCT00105443|283203|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||11
119074|NCT00105443|283204|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
119075|NCT00105443|283205|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||10
119076|NCT00105443|283206|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Nexavar||0
119077|NCT00105443|283203|P4|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|36
119078|NCT00105443|283204|P3|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
119079|NCT00105443|283205|P2|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar|"In parallel to Follow-up only phase; participants received Sorafenib 400 mg bid"|47
119080|NCT00105443|283206|P1|Open Label Treatment Only (no Follow-up)|Follow-up and/or Open Label Nexavar||0
119081|NCT00105443|283203|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
119082|NCT00105443|283204|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|245
119083|NCT00105443|283205|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar||0
119084|NCT00105443|283206|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Nexavar|"In parallel to Open Label treatment only phase"|228
119085|NCT00105443|283203|P4|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 36 participants directly switched to Open Label (OL) Sorafenib treatment|47
119086|NCT00105443|283204|P3|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 245 participants directly switched to Follow-up (FU)|245
119087|NCT00105443|283205|P2|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 47 participants directly switched to Open Label (OL) Sorafenib treatment|57
119088|NCT00105443|283206|P1|STARTED|Follow-up and/or Open Label Nexavar|At start of period, 228 participants directly switched to Follow-up (FU)|228
119089|NCT00105443|283203|P4|NOT COMPLETED|Double-Blind Treatment||0
119090|NCT00105443|283204|P3|NOT COMPLETED|Double-Blind Treatment||11
119091|NCT00105443|283205|P2|NOT COMPLETED|Double-Blind Treatment||0
119092|NCT00105443|283206|P1|NOT COMPLETED|Double-Blind Treatment||14
119093|NCT00105443|283203|P4|COMPLETED|Double-Blind Treatment|36 participants switched to Sorafenib Open Label (OL); 11 first to FU prior to also switch to OL|47
119094|NCT00105443|283204|P3|COMPLETED|Double-Blind Treatment|245 participants directly switched to the Follow-up (FU) phase|245
119095|NCT00105443|283205|P2|COMPLETED|Double-Blind Treatment|47 participants continued with Sorafenib Open Label (OL); 10 first to FU prior to also switch to OL|57
119096|NCT00105443|283206|P1|COMPLETED|Double-Blind Treatment|228 participants directly switched to the Follow-up (FU) phase only|228
119097|NCT00105443|283203|P4|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4 as well as RG5|47
119098|NCT00105443|283204|P3|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG2 and RG4|255
119099|NCT00105443|283205|P2|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3|57
119100|NCT00105443|283206|P1|Received Treatment|Double-Blind Treatment|Subjects at Risk/Safety Population - partly in RG1 and RG3 (RG = Reporting Group for Safety Data)|240
119101|NCT00105443|283203|P4|STARTED|Double-Blind Treatment||47
119102|NCT00105443|283204|P3|STARTED|Double-Blind Treatment||256
119103|NCT00105443|283205|P2|STARTED|Double-Blind Treatment||57
119104|NCT00105443|283206|P1|STARTED|Double-Blind Treatment||242
119105|NCT00105469|283235|P2|NOT COMPLETED|Overall Study||11
119106|NCT00105469|283236|P1|NOT COMPLETED|Overall Study||22
119107|NCT00105469|283235|P2|COMPLETED|Overall Study||367
119108|NCT00105469|283236|P1|COMPLETED|Overall Study||343
119109|NCT00105469|283235|P2|STARTED|Overall Study||378
119110|NCT00105469|283236|P1|STARTED|Overall Study||365
119111|NCT00105482|283246|P2|NOT COMPLETED|Overall Study||55
119112|NCT00105482|283247|P1|NOT COMPLETED|Overall Study||59
119113|NCT00105482|283246|P2|COMPLETED|Overall Study||30
119114|NCT00105482|283247|P1|COMPLETED|Overall Study||28
119115|NCT00105482|283246|P2|STARTED|Overall Study||85
119116|NCT00105482|283247|P1|STARTED|Overall Study||87
119117|NCT00105534|283263|P2|NOT COMPLETED|Overall Study||33
119118|NCT00105534|283264|P1|NOT COMPLETED|Overall Study||22
119119|NCT00105534|283263|P2|COMPLETED|Overall Study||317
119120|NCT00105534|283264|P1|COMPLETED|Overall Study||313
119121|NCT00105534|283263|P2|STARTED|Overall Study||350
119122|NCT00105534|283264|P1|STARTED|Overall Study||335
119123|NCT00105560|283272|P1|NOT COMPLETED|Overall Study||1
119124|NCT00105560|283272|P1|COMPLETED|Overall Study||58
119125|NCT00105560|283272|P1|STARTED|Overall Study||59
119126|NCT00105586|283294|P2|NOT COMPLETED|Overall Study||16
119127|NCT00105586|283295|P1|NOT COMPLETED|Overall Study||17
119128|NCT00105586|283294|P2|COMPLETED|Overall Study||69
119129|NCT00105586|283295|P1|COMPLETED|Overall Study||75
119130|NCT00105586|283294|P2|STARTED|Overall Study||85
119131|NCT00105586|283295|P1|STARTED|Overall Study||92
119132|NCT00105989|283303|P2|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||69
119133|NCT00105989|283304|P1|NOT COMPLETED|Maintenance - Double-Blind:Week 34-86||50
119134|NCT00105989|283303|P2|COMPLETED|Maintenance - Double-Blind:Week 34-86||73
119135|NCT00105989|283304|P1|COMPLETED|Maintenance - Double-Blind:Week 34-86||96
119136|NCT00105989|283303|P2|STARTED|Maintenance - Double-Blind:Week 34-86||142
119137|NCT00105989|283304|P1|STARTED|Maintenance - Double-Blind:Week 34-86||146
119138|NCT00105989|283303|P2|NOT COMPLETED|Continuation - Open Label:Week 10-34||0
119139|NCT00105989|283304|P1|NOT COMPLETED|Continuation - Open Label:Week 10-34||125
119140|NCT00105989|283303|P2|COMPLETED|Continuation - Open Label:Week 10-34||0
119141|NCT00105989|283304|P1|COMPLETED|Continuation - Open Label:Week 10-34||288
119142|NCT00105989|283303|P2|STARTED|Continuation - Open Label:Week 10-34||0
119143|NCT00105989|283304|P1|STARTED|Continuation - Open Label:Week 10-34||413
119144|NCT00105989|283303|P2|NOT COMPLETED|Acute - Open Label: Week 0-10||0
119145|NCT00105989|283304|P1|NOT COMPLETED|Acute - Open Label: Week 0-10||101
119146|NCT00105989|283303|P2|COMPLETED|Acute - Open Label: Week 0-10||0
119147|NCT00105989|283304|P1|COMPLETED|Acute - Open Label: Week 0-10||413
119148|NCT00105989|283303|P2|STARTED|Acute - Open Label: Week 0-10||0
119149|NCT00105989|283304|P1|STARTED|Acute - Open Label: Week 0-10||514
119150|NCT00106002|283418|P1|NOT COMPLETED|Overall Study||2
119151|NCT00106002|283418|P1|COMPLETED|Overall Study|Completed means that the patient was evaluable for response.|35
119152|NCT00106002|283418|P1|STARTED|Overall Study||37
119153|NCT00106028|283428|P2|NOT COMPLETED|Overall Study||12
119154|NCT00106028|283429|P1|NOT COMPLETED|Overall Study||6
119155|NCT00106028|283428|P2|COMPLETED|Overall Study|Completed Month 36|82
119156|NCT00106028|283429|P1|COMPLETED|Overall Study|Completed Month 36|43
119157|NCT00106028|283428|P2|Month 12 Completed/Started Open Label|Overall Study||87
119158|NCT00106028|283429|P1|Month 12 Completed/Started Open Label|Overall Study||49
119159|NCT00106028|283428|P2|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|94
119160|NCT00106028|283429|P1|STARTED|Overall Study|ITT Population: Patients Randomized and Received at least 1 Dose of Study Drug|49
119161|NCT00106080|283525|P2|NOT COMPLETED|Overall Study||27
119162|NCT00106080|283526|P1|NOT COMPLETED|Overall Study||43
119163|NCT00106080|283525|P2|COMPLETED|Overall Study||155
119164|NCT00106080|283526|P1|COMPLETED|Overall Study||151
119165|NCT00106080|283525|P2|STARTED|Overall Study||182
119166|NCT00106080|283526|P1|STARTED|Overall Study||194
119167|NCT00106106|283536|P2|NOT COMPLETED|Overall Study||4
119168|NCT00106106|283537|P1|NOT COMPLETED|Overall Study||4
119169|NCT00106106|283536|P2|COMPLETED|Overall Study|Although 19 subjects completed all other assessments for the study, only 15 completed both MRS scans|19
119170|NCT00106106|283537|P1|COMPLETED|Overall Study|Although 22 subjects completed all other assessments for the study, only 18 completed both MRS scans|22
119171|NCT00106106|283536|P2|Completed Both MRS Scans|Overall Study||15
119172|NCT00106106|283537|P1|Completed Both MRS Scans|Overall Study||18
119173|NCT00106106|283536|P2|STARTED|Overall Study||23
119174|NCT00106106|283537|P1|STARTED|Overall Study||26
119175|NCT00106119|283545|P2|NOT COMPLETED|Second Intervention||0
119176|NCT00106119|283546|P1|NOT COMPLETED|Second Intervention||0
119177|NCT00106119|283545|P2|COMPLETED|Second Intervention||7
119178|NCT00106119|283546|P1|COMPLETED|Second Intervention||7
119179|NCT00106119|283545|P2|STARTED|Second Intervention||7
119180|NCT00106119|283546|P1|STARTED|Second Intervention||7
119181|NCT00106119|283545|P2|NOT COMPLETED|Washout Period of 30 Days||0
119182|NCT00106119|283546|P1|NOT COMPLETED|Washout Period of 30 Days||0
119183|NCT00106119|283545|P2|COMPLETED|Washout Period of 30 Days||7
119184|NCT00106119|283546|P1|COMPLETED|Washout Period of 30 Days||7
119185|NCT00106119|283545|P2|STARTED|Washout Period of 30 Days||7
119186|NCT00106119|283546|P1|STARTED|Washout Period of 30 Days||7
119187|NCT00106119|283545|P2|NOT COMPLETED|First Intervention||0
119188|NCT00106119|283546|P1|NOT COMPLETED|First Intervention||0
119189|NCT00106119|283545|P2|COMPLETED|First Intervention||7
119190|NCT00106119|283546|P1|COMPLETED|First Intervention||7
119191|NCT00106119|283545|P2|STARTED|First Intervention||7
119192|NCT00106119|283546|P1|STARTED|First Intervention||7
119193|NCT00106184|283566|P2|NOT COMPLETED|Overall Study||2
119194|NCT00106184|283567|P1|NOT COMPLETED|Overall Study||3
119195|NCT00106184|283566|P2|COMPLETED|Overall Study||102
119196|NCT00106184|283567|P1|COMPLETED|Overall Study||93
119197|NCT00106184|283566|P2|Treated|Overall Study|104 subjects were randomized.|102
119198|NCT00106184|283567|P1|Treated|Overall Study|96 subjects were randomized.|93
119199|NCT00106184|283566|P2|STARTED|Overall Study||104
119200|NCT00106184|283567|P1|STARTED|Overall Study||96
119201|NCT00106249|283579|P2|NOT COMPLETED|Overall Study||2
119202|NCT00106249|283580|P1|NOT COMPLETED|Overall Study||3
119203|NCT00106249|283579|P2|COMPLETED|Overall Study||11
119204|NCT00106249|283580|P1|COMPLETED|Overall Study||11
119205|NCT00106249|283579|P2|STARTED|Overall Study||13
119206|NCT00106249|283580|P1|STARTED|Overall Study||14
119207|NCT00106353|283592|P7|NOT COMPLETED|Part 2||16
119208|NCT00106353|283593|P6|NOT COMPLETED|Part 2||18
119209|NCT00106353|283594|P5|NOT COMPLETED|Part 2||16
119210|NCT00106353|283595|P4|NOT COMPLETED|Part 2||0
119211|NCT00106353|283596|P3|NOT COMPLETED|Part 2||0
119212|NCT00106353|283597|P2|NOT COMPLETED|Part 2||0
119213|NCT00106353|283598|P1|NOT COMPLETED|Part 2||0
119214|NCT00106353|283592|P7|COMPLETED|Part 2||0
119215|NCT00106353|283593|P6|COMPLETED|Part 2||1
119216|NCT00106353|283594|P5|COMPLETED|Part 2||1
119217|NCT00106353|283595|P4|COMPLETED|Part 2||0
119218|NCT00106353|283596|P3|COMPLETED|Part 2||0
119219|NCT00106353|283597|P2|COMPLETED|Part 2||0
119220|NCT00106353|283598|P1|COMPLETED|Part 2||0
119221|NCT00106353|283592|P7|STARTED|Part 2||16
119222|NCT00106353|283593|P6|STARTED|Part 2||19
119223|NCT00106353|283594|P5|STARTED|Part 2||17
119224|NCT00106353|283595|P4|STARTED|Part 2||0
119225|NCT00106353|283596|P3|STARTED|Part 2||0
119226|NCT00106353|283597|P2|STARTED|Part 2||0
119227|NCT00106353|283598|P1|STARTED|Part 2||0
119228|NCT00106353|283592|P7|NOT COMPLETED|Part 1||0
119229|NCT00106353|283593|P6|NOT COMPLETED|Part 1||0
119230|NCT00106353|283594|P5|NOT COMPLETED|Part 1||0
119231|NCT00106353|283595|P4|NOT COMPLETED|Part 1||7
119232|NCT00106353|283596|P3|NOT COMPLETED|Part 1||3
119233|NCT00106353|283597|P2|NOT COMPLETED|Part 1||5
119234|NCT00106353|283598|P1|NOT COMPLETED|Part 1||4
119235|NCT00106353|283592|P7|COMPLETED|Part 1||0
119236|NCT00106353|283593|P6|COMPLETED|Part 1||0
119237|NCT00106353|283594|P5|COMPLETED|Part 1||0
119238|NCT00106353|283595|P4|COMPLETED|Part 1||0
119239|NCT00106353|283596|P3|COMPLETED|Part 1||0
119240|NCT00106353|283597|P2|COMPLETED|Part 1||0
119241|NCT00106353|283598|P1|COMPLETED|Part 1||0
119242|NCT00106353|283592|P7|STARTED|Part 1||0
119243|NCT00106353|283593|P6|STARTED|Part 1||0
119244|NCT00106353|283594|P5|STARTED|Part 1||0
119245|NCT00106353|283595|P4|STARTED|Part 1||7
119246|NCT00106353|283596|P3|STARTED|Part 1||3
119247|NCT00106353|283597|P2|STARTED|Part 1||5
119248|NCT00106353|283598|P1|STARTED|Part 1||4
119249|NCT00106392|283725|P2|NOT COMPLETED|Overall Study||27
119250|NCT00106392|283726|P1|NOT COMPLETED|Overall Study||26
119251|NCT00106392|283725|P2|COMPLETED|Overall Study||42
119252|NCT00106392|283726|P1|COMPLETED|Overall Study||36
119253|NCT00106392|283725|P2|Full Analysis Set (FAS)|Overall Study||61
119254|NCT00106392|283726|P1|Full Analysis Set (FAS)|Overall Study||53
119255|NCT00106392|283725|P2|Baseline Participants|Overall Study|4 patients withdrew: all prior to surgery and study drug|65
119256|NCT00106392|283726|P1|Baseline Participants|Overall Study|3 patients withdrew: 2 prior to surgery and study drug; 1 took study drug but did not have surgery|59
119257|NCT00106392|283725|P2|STARTED|Overall Study||69
119258|NCT00106392|283726|P1|STARTED|Overall Study||62
119259|NCT00098254|283742|P1|NOT COMPLETED|Overall Study||3
119260|NCT00098254|283742|P1|COMPLETED|Overall Study||34
119261|NCT00098254|283742|P1|STARTED|Overall Study||37
119262|NCT00098293|283764|P5|NOT COMPLETED|Supplemental Phase (SP)||33
119263|NCT00098293|283765|P4|NOT COMPLETED|Supplemental Phase (SP)||0
119264|NCT00098293|283766|P3|NOT COMPLETED|Supplemental Phase (SP)||0
119265|NCT00098293|283767|P2|NOT COMPLETED|Supplemental Phase (SP)||0
119266|NCT00098293|283768|P1|NOT COMPLETED|Supplemental Phase (SP)||0
119267|NCT00098293|283764|P5|COMPLETED|Supplemental Phase (SP)||94
119268|NCT00098293|283765|P4|COMPLETED|Supplemental Phase (SP)||0
119269|NCT00098293|283766|P3|COMPLETED|Supplemental Phase (SP)||0
119270|NCT00098293|283767|P2|COMPLETED|Supplemental Phase (SP)||0
119271|NCT00098293|283768|P1|COMPLETED|Supplemental Phase (SP)||0
119272|NCT00098293|283764|P5|STARTED|Supplemental Phase (SP)||127
119273|NCT00098293|283765|P4|STARTED|Supplemental Phase (SP)||0
119274|NCT00098293|283766|P3|STARTED|Supplemental Phase (SP)||0
119275|NCT00098293|283767|P2|STARTED|Supplemental Phase (SP)||0
119276|NCT00098293|283768|P1|STARTED|Supplemental Phase (SP)||0
119277|NCT00098293|283764|P5|NOT COMPLETED|Open-label (OL) Phase||0
119278|NCT00098293|283765|P4|NOT COMPLETED|Open-label (OL) Phase||65
119279|NCT00098293|283766|P3|NOT COMPLETED|Open-label (OL) Phase||41
119280|NCT00098293|283767|P2|NOT COMPLETED|Open-label (OL) Phase||25
119281|NCT00098293|283768|P1|NOT COMPLETED|Open-label (OL) Phase||0
119282|NCT00098293|283764|P5|COMPLETED|Open-label (OL) Phase||0
119283|NCT00098293|283765|P4|COMPLETED|Open-label (OL) Phase||65
119284|NCT00098293|283766|P3|COMPLETED|Open-label (OL) Phase||158
119285|NCT00098293|283767|P2|COMPLETED|Open-label (OL) Phase||177
119286|NCT00098293|283768|P1|COMPLETED|Open-label (OL) Phase||0
119287|NCT00098293|283764|P5|STARTED|Open-label (OL) Phase||0
119288|NCT00098293|283765|P4|STARTED|Open-label (OL) Phase||130
119289|NCT00098293|283766|P3|STARTED|Open-label (OL) Phase||199
119290|NCT00098293|283767|P2|STARTED|Open-label (OL) Phase||202
119291|NCT00098293|283768|P1|STARTED|Open-label (OL) Phase||0
119292|NCT00098293|283764|P5|NOT COMPLETED|Between DB and OL Phase||0
119293|NCT00098293|283765|P4|NOT COMPLETED|Between DB and OL Phase||0
119294|NCT00098293|283766|P3|NOT COMPLETED|Between DB and OL Phase||3
119295|NCT00098293|283767|P2|NOT COMPLETED|Between DB and OL Phase||0
119296|NCT00098293|283768|P1|NOT COMPLETED|Between DB and OL Phase||0
119297|NCT00098293|283764|P5|COMPLETED|Between DB and OL Phase||0
119298|NCT00098293|283765|P4|COMPLETED|Between DB and OL Phase||0
119299|NCT00098293|283766|P3|COMPLETED|Between DB and OL Phase||199
119300|NCT00098293|283767|P2|COMPLETED|Between DB and OL Phase||202
119301|NCT00098293|283768|P1|COMPLETED|Between DB and OL Phase||0
119302|NCT00098293|283764|P5|STARTED|Between DB and OL Phase||0
119303|NCT00098293|283765|P4|STARTED|Between DB and OL Phase||0
119304|NCT00098293|283766|P3|STARTED|Between DB and OL Phase||202
119305|NCT00098293|283767|P2|STARTED|Between DB and OL Phase||202
119306|NCT00098293|283768|P1|STARTED|Between DB and OL Phase||0
119307|NCT00098293|283764|P5|NOT COMPLETED|Double-blind (DB) Phase||0
119308|NCT00098293|283765|P4|NOT COMPLETED|Double-blind (DB) Phase||0
119309|NCT00098293|283766|P3|NOT COMPLETED|Double-blind (DB) Phase||170
119310|NCT00098293|283767|P2|NOT COMPLETED|Double-blind (DB) Phase||166
119311|NCT00098293|283768|P1|NOT COMPLETED|Double-blind (DB) Phase||177
119312|NCT00098293|283764|P5|COMPLETED|Double-blind (DB) Phase||0
119313|NCT00098293|283765|P4|COMPLETED|Double-blind (DB) Phase||0
119314|NCT00098293|283766|P3|COMPLETED|Double-blind (DB) Phase||202
119315|NCT00098293|283767|P2|COMPLETED|Double-blind (DB) Phase||202
119316|NCT00098293|283768|P1|COMPLETED|Double-blind (DB) Phase||0
119317|NCT00098293|283764|P5|Treated|Double-blind (DB) Phase||0
119318|NCT00098293|283765|P4|Treated|Double-blind (DB) Phase||0
119319|NCT00098293|283766|P3|Treated|Double-blind (DB) Phase||361
119320|NCT00098293|283767|P2|Treated|Double-blind (DB) Phase||360
119321|NCT00098293|283768|P1|Treated|Double-blind (DB) Phase||174
119322|NCT00098293|283764|P5|STARTED|Double-blind (DB) Phase||0
119323|NCT00098293|283765|P4|STARTED|Double-blind (DB) Phase||0
119324|NCT00098293|283766|P3|STARTED|Double-blind (DB) Phase||372
119325|NCT00098293|283767|P2|STARTED|Double-blind (DB) Phase||368
119326|NCT00098293|283768|P1|STARTED|Double-blind (DB) Phase||177
119327|NCT00098306|283824|P7|NOT COMPLETED|Observational Phase||26
119328|NCT00098306|283825|P6|NOT COMPLETED|Observational Phase||46
119329|NCT00098306|283826|P5|NOT COMPLETED|Observational Phase||0
119330|NCT00098306|283827|P4|NOT COMPLETED|Observational Phase||0
119331|NCT00098306|283828|P3|NOT COMPLETED|Observational Phase||0
119332|NCT00098306|283829|P2|NOT COMPLETED|Observational Phase||0
119333|NCT00098306|283830|P1|NOT COMPLETED|Observational Phase||0
119334|NCT00098306|283824|P7|COMPLETED|Observational Phase||55
119335|NCT00098306|283825|P6|COMPLETED|Observational Phase||204
119336|NCT00098306|283826|P5|COMPLETED|Observational Phase||0
119337|NCT00098306|283827|P4|COMPLETED|Observational Phase||0
119338|NCT00098306|283828|P3|COMPLETED|Observational Phase||0
119339|NCT00098306|283829|P2|COMPLETED|Observational Phase||0
119340|NCT00098306|283830|P1|COMPLETED|Observational Phase||0
119341|NCT00098306|283824|P7|STARTED|Observational Phase||81
119342|NCT00098306|283825|P6|STARTED|Observational Phase||250
119343|NCT00098306|283826|P5|STARTED|Observational Phase||0
119344|NCT00098306|283827|P4|STARTED|Observational Phase||0
119345|NCT00098306|283828|P3|STARTED|Observational Phase||0
119346|NCT00098306|283829|P2|STARTED|Observational Phase||0
119347|NCT00098306|283830|P1|STARTED|Observational Phase||0
119348|NCT00098306|283824|P7|NOT COMPLETED|Open Label||0
119349|NCT00098306|283825|P6|NOT COMPLETED|Open Label||0
119350|NCT00098306|283826|P5|NOT COMPLETED|Open Label||62
119351|NCT00098306|283827|P4|NOT COMPLETED|Open Label||327
119352|NCT00098306|283828|P3|NOT COMPLETED|Open Label||0
119353|NCT00098306|283829|P2|NOT COMPLETED|Open Label||0
119354|NCT00098306|283830|P1|NOT COMPLETED|Open Label||0
119355|NCT00098306|283824|P7|COMPLETED|Open Label||0
119356|NCT00098306|283825|P6|COMPLETED|Open Label||0
119357|NCT00098306|283826|P5|COMPLETED|Open Label||0
119358|NCT00098306|283827|P4|COMPLETED|Open Label||0
119359|NCT00098306|283828|P3|COMPLETED|Open Label||0
119360|NCT00098306|283829|P2|COMPLETED|Open Label||0
119361|NCT00098306|283830|P1|COMPLETED|Open Label||0
119362|NCT00098306|283824|P7|STARTED|Open Label||0
119363|NCT00098306|283825|P6|STARTED|Open Label||0
119364|NCT00098306|283826|P5|STARTED|Open Label||62
119365|NCT00098306|283827|P4|STARTED|Open Label||327
119366|NCT00098306|283828|P3|STARTED|Open Label||0
119367|NCT00098306|283829|P2|STARTED|Open Label||0
119368|NCT00098306|283830|P1|STARTED|Open Label||0
119369|NCT00098306|283824|P7|NOT COMPLETED|Double Blind||0
119370|NCT00098306|283825|P6|NOT COMPLETED|Double Blind||0
119371|NCT00098306|283826|P5|NOT COMPLETED|Double Blind||0
119372|NCT00098306|283827|P4|NOT COMPLETED|Double Blind||0
119373|NCT00098306|283828|P3|NOT COMPLETED|Double Blind||120
119374|NCT00098306|283829|P2|NOT COMPLETED|Double Blind||240
119375|NCT00098306|283830|P1|NOT COMPLETED|Double Blind||241
119376|NCT00098306|283824|P7|COMPLETED|Double Blind||0
119377|NCT00098306|283825|P6|COMPLETED|Double Blind||0
119378|NCT00098306|283826|P5|COMPLETED|Double Blind||0
119379|NCT00098306|283827|P4|COMPLETED|Double Blind||0
119380|NCT00098306|283828|P3|COMPLETED|Double Blind||0
119381|NCT00098306|283829|P2|COMPLETED|Double Blind||0
119382|NCT00098306|283830|P1|COMPLETED|Double Blind||0
119383|NCT00098306|283824|P7|Treated|Double Blind||0
119384|NCT00098306|283825|P6|Treated|Double Blind||0
119385|NCT00098306|283826|P5|Treated|Double Blind||0
119386|NCT00098306|283827|P4|Treated|Double Blind||0
119387|NCT00098306|283828|P3|Treated|Double Blind||118
119388|NCT00098306|283829|P2|Treated|Double Blind||235
119389|NCT00098306|283830|P1|Treated|Double Blind||232
119390|NCT00098306|283824|P7|STARTED|Double Blind||0
119391|NCT00098306|283825|P6|STARTED|Double Blind||0
119392|NCT00098306|283826|P5|STARTED|Double Blind||0
119393|NCT00098306|283827|P4|STARTED|Double Blind||0
119394|NCT00098306|283828|P3|STARTED|Double Blind||120
119395|NCT00098306|283829|P2|STARTED|Double Blind||240
119396|NCT00098306|283830|P1|STARTED|Double Blind||241
119397|NCT00098345|283893|P1|NOT COMPLETED|Overall Study||13
119398|NCT00098345|283893|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|17
119399|NCT00098345|283893|P1|STARTED|Overall Study||30
119400|NCT00098371|283903|P1|NOT COMPLETED|Overall Study||0
119401|NCT00098371|283903|P1|COMPLETED|Overall Study||64
119402|NCT00098371|283903|P1|STARTED|Overall Study||64
119403|NCT00098475|283930|P4|NOT COMPLETED|Step 2||0
119404|NCT00098475|283931|P3|NOT COMPLETED|Step 2||0
119405|NCT00098475|283932|P2|NOT COMPLETED|Step 2||10
119406|NCT00098475|283933|P1|NOT COMPLETED|Step 2||5
119407|NCT00098475|283930|P4|COMPLETED|Step 2||0
119408|NCT00098475|283931|P3|COMPLETED|Step 2||0
119409|NCT00098475|283932|P2|COMPLETED|Step 2||5
119410|NCT00098475|283933|P1|COMPLETED|Step 2||0
119411|NCT00098475|283930|P4|Eligible|Step 2||0
119412|NCT00098475|283931|P3|Eligible|Step 2||0
119413|NCT00098475|283932|P2|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|9
119414|NCT00098475|283933|P1|Eligible|Step 2|Some patients were considered eligible at registration but found ineligible in the analysis.|2
119415|NCT00098475|283930|P4|Treated|Step 2||0
119416|NCT00098475|283931|P3|Treated|Step 2||0
119417|NCT00098475|283932|P2|Treated|Step 2||14
119418|NCT00098475|283933|P1|Treated|Step 2||4
119419|NCT00098475|283930|P4|STARTED|Step 2||0
119420|NCT00098475|283931|P3|STARTED|Step 2||0
119421|NCT00098475|283932|P2|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|15
119422|NCT00098475|283933|P1|STARTED|Step 2|Step 2 treatment was an option but not required for patients who ended step 1 treatment.|5
119423|NCT00098475|283930|P4|NOT COMPLETED|Step 1||3
119424|NCT00098475|283931|P3|NOT COMPLETED|Step 1||4
119425|NCT00098475|283932|P2|NOT COMPLETED|Step 1||173
119426|NCT00098475|283933|P1|NOT COMPLETED|Step 1||171
119427|NCT00098475|283930|P4|COMPLETED|Step 1||0
119428|NCT00098475|283931|P3|COMPLETED|Step 1||0
119429|NCT00098475|283932|P2|COMPLETED|Step 1||49
119430|NCT00098475|283933|P1|COMPLETED|Step 1||52
119431|NCT00098475|283930|P4|Eligible|Step 1||3
119432|NCT00098475|283931|P3|Eligible|Step 1||4
119433|NCT00098475|283932|P2|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|208
119434|NCT00098475|283933|P1|Eligible|Step 1|Some patients were considered eligible at registration but found ineligible in the analysis.|214
119435|NCT00098475|283930|P4|Treated|Step 1||3
119436|NCT00098475|283931|P3|Treated|Step 1||4
119437|NCT00098475|283932|P2|Treated|Step 1||220
119438|NCT00098475|283933|P1|Treated|Step 1||223
119439|NCT00098475|283930|P4|STARTED|Step 1||3
119440|NCT00098475|283931|P3|STARTED|Step 1||4
119441|NCT00098475|283932|P2|STARTED|Step 1||222
119442|NCT00098475|283933|P1|STARTED|Step 1||223
119443|NCT00098670|283945|P1|NOT COMPLETED|Overall Study||0
119444|NCT00098670|283945|P1|COMPLETED|Overall Study||102
119445|NCT00098670|283945|P1|STARTED|Overall Study||102
119446|NCT00098722|283957|P7|NOT COMPLETED|Observation Phase||17
119447|NCT00098722|283958|P6|NOT COMPLETED|Observation Phase||45
119448|NCT00098722|283959|P5|NOT COMPLETED|Observation Phase||0
119449|NCT00098722|283960|P4|NOT COMPLETED|Observation Phase||0
119450|NCT00098722|283961|P3|NOT COMPLETED|Observation Phase||0
119451|NCT00098722|283962|P2|NOT COMPLETED|Observation Phase||0
119452|NCT00098722|283963|P1|NOT COMPLETED|Observation Phase||0
119453|NCT00098722|283957|P7|COMPLETED|Observation Phase||48
119454|NCT00098722|283958|P6|COMPLETED|Observation Phase||160
119455|NCT00098722|283959|P5|COMPLETED|Observation Phase||0
119456|NCT00098722|283960|P4|COMPLETED|Observation Phase||0
119457|NCT00098722|283961|P3|COMPLETED|Observation Phase||0
119458|NCT00098722|283962|P2|COMPLETED|Observation Phase||0
119459|NCT00098722|283963|P1|COMPLETED|Observation Phase||0
119460|NCT00098722|283957|P7|STARTED|Observation Phase||65
119461|NCT00098722|283958|P6|STARTED|Observation Phase||205
119462|NCT00098722|283959|P5|STARTED|Observation Phase||0
119463|NCT00098722|283960|P4|STARTED|Observation Phase||0
119464|NCT00098722|283961|P3|STARTED|Observation Phase||0
119465|NCT00098722|283962|P2|STARTED|Observation Phase||0
119466|NCT00098722|283963|P1|STARTED|Observation Phase||0
119467|NCT00098722|283957|P7|NOT COMPLETED|Open Label Phase||0
119468|NCT00098722|283958|P6|NOT COMPLETED|Open Label Phase||0
119469|NCT00098722|283959|P5|NOT COMPLETED|Open Label Phase||50
119470|NCT00098722|283960|P4|NOT COMPLETED|Open Label Phase||272
119471|NCT00098722|283961|P3|NOT COMPLETED|Open Label Phase||0
119472|NCT00098722|283962|P2|NOT COMPLETED|Open Label Phase||0
119473|NCT00098722|283963|P1|NOT COMPLETED|Open Label Phase||0
119474|NCT00098722|283957|P7|COMPLETED|Open Label Phase||0
119475|NCT00098722|283958|P6|COMPLETED|Open Label Phase||0
119476|NCT00098722|283959|P5|COMPLETED|Open Label Phase||0
119477|NCT00098722|283960|P4|COMPLETED|Open Label Phase||0
119478|NCT00098722|283961|P3|COMPLETED|Open Label Phase||0
119479|NCT00098722|283962|P2|COMPLETED|Open Label Phase||0
119480|NCT00098722|283963|P1|COMPLETED|Open Label Phase||0
119481|NCT00098722|283957|P7|STARTED|Open Label Phase||0
119482|NCT00098722|283958|P6|STARTED|Open Label Phase||0
119483|NCT00098722|283959|P5|STARTED|Open Label Phase||50
119484|NCT00098722|283960|P4|STARTED|Open Label Phase||272
119485|NCT00098722|283961|P3|STARTED|Open Label Phase||0
119486|NCT00098722|283962|P2|STARTED|Open Label Phase||0
119487|NCT00098722|283963|P1|STARTED|Open Label Phase||0
119488|NCT00098722|283957|P7|NOT COMPLETED|Double Blind Phase||0
119489|NCT00098722|283958|P6|NOT COMPLETED|Double Blind Phase||0
119490|NCT00098722|283959|P5|NOT COMPLETED|Double Blind Phase||0
119491|NCT00098722|283960|P4|NOT COMPLETED|Double Blind Phase||0
119492|NCT00098722|283961|P3|NOT COMPLETED|Double Blind Phase||94
119493|NCT00098722|283962|P2|NOT COMPLETED|Double Blind Phase||194
119494|NCT00098722|283963|P1|NOT COMPLETED|Double Blind Phase||186
119495|NCT00098722|283957|P7|COMPLETED|Double Blind Phase||0
119496|NCT00098722|283958|P6|COMPLETED|Double Blind Phase||0
119497|NCT00098722|283959|P5|COMPLETED|Double Blind Phase||0
119498|NCT00098722|283960|P4|COMPLETED|Double Blind Phase||0
119499|NCT00098722|283961|P3|COMPLETED|Double Blind Phase||0
119500|NCT00098722|283962|P2|COMPLETED|Double Blind Phase||0
119501|NCT00098722|283963|P1|COMPLETED|Double Blind Phase||0
119502|NCT00098722|283957|P7|Treated|Double Blind Phase||0
119503|NCT00098722|283958|P6|Treated|Double Blind Phase||0
119504|NCT00098722|283959|P5|Treated|Double Blind Phase||0
119505|NCT00098722|283960|P4|Treated|Double Blind Phase||0
119506|NCT00098722|283961|P3|Treated|Double Blind Phase||91
119507|NCT00098722|283962|P2|Treated|Double Blind Phase||191
119508|NCT00098722|283963|P1|Treated|Double Blind Phase||182
119509|NCT00098722|283957|P7|STARTED|Double Blind Phase||0
119510|NCT00098722|283958|P6|STARTED|Double Blind Phase||0
119511|NCT00098722|283959|P5|STARTED|Double Blind Phase||0
119512|NCT00098722|283960|P4|STARTED|Double Blind Phase||0
119513|NCT00098722|283961|P3|STARTED|Double Blind Phase||94
119514|NCT00098722|283962|P2|STARTED|Double Blind Phase||194
119515|NCT00098722|283963|P1|STARTED|Double Blind Phase||186
119516|NCT00098748|284029|P3|NOT COMPLETED|Continued on Open-Label Treatment||0
119517|NCT00098748|284030|P2|NOT COMPLETED|Continued on Open-Label Treatment||15
119518|NCT00098748|284031|P1|NOT COMPLETED|Continued on Open-Label Treatment||8
119519|NCT00098748|284029|P3|COMPLETED|Continued on Open-Label Treatment||0
119520|NCT00098748|284030|P2|COMPLETED|Continued on Open-Label Treatment||10
119521|NCT00098748|284031|P1|COMPLETED|Continued on Open-Label Treatment||7
119522|NCT00098748|284029|P3|STARTED|Continued on Open-Label Treatment|Placebo group not offered open-label maraviroc due to study not reaching primary endpoint at Week 24|0
119523|NCT00098748|284030|P2|STARTED|Continued on Open-Label Treatment||25
119524|NCT00098748|284031|P1|STARTED|Continued on Open-Label Treatment||15
119525|NCT00098748|284029|P3|NOT COMPLETED|Received Study Treatment||44
119526|NCT00098748|284030|P2|NOT COMPLETED|Received Study Treatment||36
119527|NCT00098748|284031|P1|NOT COMPLETED|Received Study Treatment||48
119528|NCT00098748|284029|P3|COMPLETED|Received Study Treatment||18
119529|NCT00098748|284030|P2|COMPLETED|Received Study Treatment||25
119530|NCT00098748|284031|P1|COMPLETED|Received Study Treatment||15
119531|NCT00098748|284029|P3|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||58
119532|NCT00098748|284030|P2|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment||52
119533|NCT00098748|284031|P1|Dual-tropic Subjects by Phenotype Assay|Received Study Treatment|Dual-tropic: Virus capable of using both CCR5 and CXCR4 coreceptors for cell entry.|57
119534|NCT00098748|284029|P3|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, Placebo = 61 subjects in Adverse event tables.|62
119535|NCT00098748|284030|P2|STARTED|Received Study Treatment|Due to 1 placebo subject switched to maraviroc BID, BID = 62 subjects in Adverse event tables.|61
119536|NCT00098748|284031|P1|STARTED|Received Study Treatment||63
119537|NCT00098748|284029|P3|NOT COMPLETED|Assigned to Study Treatment||2
119538|NCT00098748|284030|P2|NOT COMPLETED|Assigned to Study Treatment||2
119539|NCT00098748|284031|P1|NOT COMPLETED|Assigned to Study Treatment||0
119540|NCT00098748|284029|P3|COMPLETED|Assigned to Study Treatment||62
119541|NCT00098748|284030|P2|COMPLETED|Assigned to Study Treatment||61
119542|NCT00098748|284031|P1|COMPLETED|Assigned to Study Treatment||63
119543|NCT00098748|284029|P3|STARTED|Assigned to Study Treatment||64
119544|NCT00098748|284030|P2|STARTED|Assigned to Study Treatment||63
119545|NCT00098748|284031|P1|STARTED|Assigned to Study Treatment||63
119546|NCT00098774|284084|P1|NOT COMPLETED|Overall Study||18
119547|NCT00098774|284084|P1|COMPLETED|Overall Study||26
119548|NCT00098774|284084|P1|STARTED|Overall Study||44
119549|NCT00098787|284094|P3|NOT COMPLETED|Overall Study||63
119550|NCT00098787|284095|P2|NOT COMPLETED|Overall Study||75
119551|NCT00098787|284096|P1|NOT COMPLETED|Overall Study||73
119552|NCT00098787|284094|P3|COMPLETED|Overall Study||0
119553|NCT00098787|284095|P2|COMPLETED|Overall Study||0
119554|NCT00098787|284096|P1|COMPLETED|Overall Study||0
119555|NCT00098787|284094|P3|Eligible and Treated|Overall Study||59
119556|NCT00098787|284095|P2|Eligible and Treated|Overall Study||66
119557|NCT00098787|284096|P1|Eligible and Treated|Overall Study||61
119558|NCT00098787|284094|P3|Treated|Overall Study||62
119559|NCT00098787|284095|P2|Treated|Overall Study||73
119560|NCT00098787|284096|P1|Treated|Overall Study||70
119561|NCT00098787|284094|P3|STARTED|Overall Study||63
119562|NCT00098787|284095|P2|STARTED|Overall Study||75
119563|NCT00098787|284096|P1|STARTED|Overall Study||73
119564|NCT00098813|284110|P1|NOT COMPLETED|Overall Study||19
119565|NCT00098813|284110|P1|COMPLETED|Overall Study||1
119566|NCT00098813|284110|P1|STARTED|Overall Study||20
119567|NCT00098839|284116|P2|NOT COMPLETED|Overall Study||33
119568|NCT00098839|284117|P1|NOT COMPLETED|Overall Study||32
119569|NCT00098839|284116|P2|COMPLETED|Overall Study||27
119570|NCT00098839|284117|P1|COMPLETED|Overall Study||24
119571|NCT00098839|284116|P2|STARTED|Overall Study||60
119572|NCT00098839|284117|P1|STARTED|Overall Study||56
119573|NCT00098865|284127|P1|NOT COMPLETED|Overall Study||9
119574|NCT00098865|284127|P1|COMPLETED|Overall Study||6
119575|NCT00098865|284127|P1|STARTED|Overall Study||15
119576|NCT00098956|284133|P1|NOT COMPLETED|Overall Study||0
119577|NCT00098956|284133|P1|COMPLETED|Overall Study||19
119578|NCT00098956|284133|P1|STARTED|Overall Study||19
119579|NCT00099021|284138|P1|NOT COMPLETED|Overall Study||0
119580|NCT00099021|284138|P1|COMPLETED|Overall Study||21
119581|NCT00099021|284138|P1|STARTED|Overall Study||21
119582|NCT00099047|284146|P2|NOT COMPLETED|Overall Study||0
119583|NCT00099047|284147|P1|NOT COMPLETED|Overall Study||0
119584|NCT00099047|284146|P2|COMPLETED|Overall Study||12
119585|NCT00099047|284147|P1|COMPLETED|Overall Study||11
119586|NCT00099047|284146|P2|STARTED|Overall Study||12
119587|NCT00099047|284147|P1|STARTED|Overall Study||11
119588|NCT00099268|284155|P2|NOT COMPLETED|Overall Study||82
119589|NCT00099268|284156|P1|NOT COMPLETED|Overall Study||92
119590|NCT00099268|284155|P2|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa group within 30 days of treatment discontinuation|291
119591|NCT00099268|284156|P1|COMPLETED|Overall Study|Plus 1 death in the carbidopa/levodopa/entacapone group within 30 days of treatment discontinuation|282
119592|NCT00099268|284155|P2|Intent-to-Treat|Overall Study||372
119593|NCT00099268|284156|P1|Intent-to-Treat|Overall Study|One patient from each group discontinued without receiving a single dose of study drug.|373
119594|NCT00099268|284155|P2|STARTED|Overall Study||373
119595|NCT00099268|284156|P1|STARTED|Overall Study||374
119596|NCT00099359|284175|P3|NOT COMPLETED|Overall Study||68
119597|NCT00099359|284176|P2|NOT COMPLETED|Overall Study||65
119598|NCT00099359|284177|P1|NOT COMPLETED|Overall Study||54
119599|NCT00099359|284175|P3|COMPLETED|Overall Study||506
119600|NCT00099359|284176|P2|COMPLETED|Overall Study||515
119601|NCT00099359|284177|P1|COMPLETED|Overall Study||527
119602|NCT00099359|284175|P3|STARTED|Overall Study||574
119603|NCT00099359|284176|P2|STARTED|Overall Study||580
119604|NCT00099359|284177|P1|STARTED|Overall Study||581
119605|NCT00099437|284200|P2|NOT COMPLETED|Overall Study||349
119606|NCT00099437|284201|P1|NOT COMPLETED|Overall Study||366
119607|NCT00099437|284200|P2|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|13
119608|NCT00099437|284201|P1|COMPLETED|Overall Study|ongoing study treatment at survival follow-up data cut-off|8
119609|NCT00099437|284200|P2|STARTED|Overall Study|randomised patients|362
119610|NCT00099437|284201|P1|STARTED|Overall Study|randomised patients|374
119611|NCT00099632|284227|P6|NOT COMPLETED|Overall Study||2
119612|NCT00099632|284228|P5|NOT COMPLETED|Overall Study||1
119613|NCT00099632|284229|P4|NOT COMPLETED|Overall Study||1
119614|NCT00099632|284230|P3|NOT COMPLETED|Overall Study||3
119615|NCT00099632|284231|P2|NOT COMPLETED|Overall Study||1
119616|NCT00099632|284232|P1|NOT COMPLETED|Overall Study||1
119617|NCT00099632|284227|P6|COMPLETED|Overall Study||66
119618|NCT00099632|284228|P5|COMPLETED|Overall Study||70
119619|NCT00099632|284229|P4|COMPLETED|Overall Study||66
119620|NCT00099632|284230|P3|COMPLETED|Overall Study||72
119621|NCT00099632|284231|P2|COMPLETED|Overall Study||67
119622|NCT00099632|284232|P1|COMPLETED|Overall Study||72
119623|NCT00099632|284227|P6|STARTED|Overall Study||68
119624|NCT00099632|284228|P5|STARTED|Overall Study||71
119625|NCT00099632|284229|P4|STARTED|Overall Study||67
119626|NCT00099632|284230|P3|STARTED|Overall Study||75
119627|NCT00099632|284231|P2|STARTED|Overall Study||68
119628|NCT00099632|284232|P1|STARTED|Overall Study||73
119629|NCT00099983|284272|P2|NOT COMPLETED|Overall Study||25
119630|NCT00099983|284273|P1|NOT COMPLETED|Overall Study||24
119631|NCT00099983|284272|P2|COMPLETED|Overall Study||124
119632|NCT00099983|284273|P1|COMPLETED|Overall Study||123
119633|NCT00099983|284272|P2|STARTED|Overall Study||149
119634|NCT00099983|284273|P1|STARTED|Overall Study||147
119635|NCT00100048|284284|P6|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
119636|NCT00100048|284285|P5|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||0
119637|NCT00100048|284286|P4|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||10
119638|NCT00100048|284287|P3|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||13
119639|NCT00100048|284288|P2|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||9
119640|NCT00100048|284289|P1|NOT COMPLETED|Cohort I & II-Combination Therapy Phase||14
119641|NCT00100048|284284|P6|COMPLETED|Cohort I & II-Combination Therapy Phase||26
119642|NCT00100048|284285|P5|COMPLETED|Cohort I & II-Combination Therapy Phase||0
119643|NCT00100048|284286|P4|COMPLETED|Cohort I & II-Combination Therapy Phase||30
119644|NCT00100048|284287|P3|COMPLETED|Cohort I & II-Combination Therapy Phase||28
119645|NCT00100048|284288|P2|COMPLETED|Cohort I & II-Combination Therapy Phase||31
119646|NCT00100048|284289|P1|COMPLETED|Cohort I & II-Combination Therapy Phase||27
119647|NCT00100048|284284|P6|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|1
119648|NCT00100048|284285|P5|Never Treated|Cohort I & II-Combination Therapy Phase||0
119649|NCT00100048|284286|P4|Never Treated|Cohort I & II-Combination Therapy Phase||0
119650|NCT00100048|284287|P3|Never Treated|Cohort I & II-Combination Therapy Phase||0
119651|NCT00100048|284288|P2|Never Treated|Cohort I & II-Combination Therapy Phase||0
119652|NCT00100048|284289|P1|Never Treated|Cohort I & II-Combination Therapy Phase|Randomised in Cohort II did not start Period|2
119653|NCT00100048|284284|P6|Treated|Cohort I & II-Combination Therapy Phase||38
119654|NCT00100048|284285|P5|Treated|Cohort I & II-Combination Therapy Phase||0
119655|NCT00100048|284286|P4|Treated|Cohort I & II-Combination Therapy Phase||40
119656|NCT00100048|284287|P3|Treated|Cohort I & II-Combination Therapy Phase||41
119657|NCT00100048|284288|P2|Treated|Cohort I & II-Combination Therapy Phase||40
119658|NCT00100048|284289|P1|Treated|Cohort I & II-Combination Therapy Phase||39
119659|NCT00100048|284284|P6|STARTED|Cohort I & II-Combination Therapy Phase|4 subjects from the Monotherapy Phase (Placebo)and 35 new subjects|39
119660|NCT00100048|284285|P5|STARTED|Cohort I & II-Combination Therapy Phase|participants only assigned Placebo in Cohort I-Monotherapy Phase.|0
119661|NCT00100048|284286|P4|STARTED|Cohort I & II-Combination Therapy Phase|8 subjects from the Monotherapy Phase and 32 new subjects|40
119662|NCT00100048|284287|P3|STARTED|Cohort I & II-Combination Therapy Phase|6 subjects from the Monotherapy Phase and 35 new subjects|41
119663|NCT00100048|284288|P2|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 33 new subjects|40
119664|NCT00100048|284289|P1|STARTED|Cohort I & II-Combination Therapy Phase|7 subjects from the Monotherapy Phase and 34 new subjects|41
119665|NCT00100048|284284|P6|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
119666|NCT00100048|284285|P5|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
119667|NCT00100048|284286|P4|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
119668|NCT00100048|284287|P3|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
119669|NCT00100048|284288|P2|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
119670|NCT00100048|284289|P1|NOT COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
119671|NCT00100048|284284|P6|COMPLETED|Cohort I-Monotherapy Phase 10 Days||0
119672|NCT00100048|284285|P5|COMPLETED|Cohort I-Monotherapy Phase 10 Days|4 Subjects Continued to Cohort II, as part of the Efavirenz 600 mg q.d. arm|7
119673|NCT00100048|284286|P4|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|8
119674|NCT00100048|284287|P3|COMPLETED|Cohort I-Monotherapy Phase 10 Days|6 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|6
119675|NCT00100048|284288|P2|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
119676|NCT00100048|284289|P1|COMPLETED|Cohort I-Monotherapy Phase 10 Days|7 Subjects Continued to Cohort II Combined-Combination Therapy Phase (48 Weeks)|7
119677|NCT00100048|284284|P6|Treated|Cohort I-Monotherapy Phase 10 Days||0
119678|NCT00100048|284285|P5|Treated|Cohort I-Monotherapy Phase 10 Days||7
119679|NCT00100048|284286|P4|Treated|Cohort I-Monotherapy Phase 10 Days||8
119680|NCT00100048|284287|P3|Treated|Cohort I-Monotherapy Phase 10 Days||6
119681|NCT00100048|284288|P2|Treated|Cohort I-Monotherapy Phase 10 Days||7
119682|NCT00100048|284289|P1|Treated|Cohort I-Monotherapy Phase 10 Days||7
119683|NCT00100048|284284|P6|STARTED|Cohort I-Monotherapy Phase 10 Days|participants only assigned Efavirenz 600 mg q.h.s in Cohort II Combined-Combination Therapy Phase|0
119684|NCT00100048|284285|P5|STARTED|Cohort I-Monotherapy Phase 10 Days||7
119685|NCT00100048|284286|P4|STARTED|Cohort I-Monotherapy Phase 10 Days||8
119686|NCT00100048|284287|P3|STARTED|Cohort I-Monotherapy Phase 10 Days||6
119687|NCT00100048|284288|P2|STARTED|Cohort I-Monotherapy Phase 10 Days||7
119688|NCT00100048|284289|P1|STARTED|Cohort I-Monotherapy Phase 10 Days||7
119689|NCT00100178|284399|P3|NOT COMPLETED|Overall Study||10
119690|NCT00100178|284400|P2|NOT COMPLETED|Overall Study||10
119691|NCT00100178|284401|P1|NOT COMPLETED|Overall Study||9
119692|NCT00100178|284399|P3|COMPLETED|Overall Study||32
119693|NCT00100178|284400|P2|COMPLETED|Overall Study||21
119694|NCT00100178|284401|P1|COMPLETED|Overall Study||32
119695|NCT00100178|284399|P3|STARTED|Overall Study||42
119696|NCT00100178|284400|P2|STARTED|Overall Study|12 subjects randomized to the MMF alone group were excluded from analysis due to randomization error|31
119697|NCT00100178|284401|P1|STARTED|Overall Study||41
119698|NCT00100230|284411|P2|NOT COMPLETED|Overall Study||15
119699|NCT00100230|284412|P1|NOT COMPLETED|Overall Study||12
119700|NCT00100230|284411|P2|COMPLETED|Overall Study||22
119701|NCT00100230|284412|P1|COMPLETED|Overall Study||29
119702|NCT00100230|284411|P2|STARTED|Overall Study||37
119703|NCT00100230|284412|P1|STARTED|Overall Study||41
119704|NCT00106431|284422|P1|NOT COMPLETED|Overall Study||65
119705|NCT00106431|284422|P1|COMPLETED|Overall Study|37 represents the number of patients who reached at least 6 months treatment|37
119706|NCT00106431|284422|P1|STARTED|Overall Study||102
119707|NCT00106535|284435|P4|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||190
119708|NCT00106535|284436|P3|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
119709|NCT00106535|284437|P2|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
119710|NCT00106535|284438|P1|NOT COMPLETED|Long-term Extension Period (Year 3 to 5)||0
119711|NCT00106535|284435|P4|COMPLETED|Long-term Extension Period (Year 3 to 5)|Completed the study.|704
119712|NCT00106535|284436|P3|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
119713|NCT00106535|284437|P2|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
119714|NCT00106535|284438|P1|COMPLETED|Long-term Extension Period (Year 3 to 5)||0
119715|NCT00106535|284435|P4|STARTED|Long-term Extension Period (Year 3 to 5)|Entered the Long-term Extension.|894
119716|NCT00106535|284436|P3|STARTED|Long-term Extension Period (Year 3 to 5)||0
119717|NCT00106535|284437|P2|STARTED|Long-term Extension Period (Year 3 to 5)||0
119718|NCT00106535|284438|P1|STARTED|Long-term Extension Period (Year 3 to 5)||0
119719|NCT00106535|284435|P4|NOT COMPLETED|2-year Placebo Controlled Period||0
119720|NCT00106535|284436|P3|NOT COMPLETED|2-year Placebo Controlled Period||91
119721|NCT00106535|284437|P2|NOT COMPLETED|2-year Placebo Controlled Period||92
119722|NCT00106535|284438|P1|NOT COMPLETED|2-year Placebo Controlled Period||107
119723|NCT00106535|284435|P4|COMPLETED|2-year Placebo Controlled Period||0
119724|NCT00106535|284436|P3|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 306 participants randomized to the TCZ 8 mg/kg arm entered the LTE period.|310
119725|NCT00106535|284437|P2|COMPLETED|2-year Placebo Controlled Period|Completed Week 104. 304 participants randomized to the TCZ 4 mg/kg arm entered the LTE period.|309
119726|NCT00106535|284438|P1|COMPLETED|2-year Placebo Controlled Period|Completed Week 104 (Year 2). 284 participants randomized to the Placebo arm entered the LTE period.|287
119727|NCT00106535|284435|P4|Completed Week 52|2-year Placebo Controlled Period||0
119728|NCT00106535|284436|P3|Completed Week 52|2-year Placebo Controlled Period||338
119729|NCT00106535|284437|P2|Completed Week 52|2-year Placebo Controlled Period||342
119730|NCT00106535|284438|P1|Completed Week 52|2-year Placebo Controlled Period||326
119731|NCT00106535|284435|P4|Completed Week 24|2-year Placebo Controlled Period||0
119732|NCT00106535|284436|P3|Completed Week 24|2-year Placebo Controlled Period||366
119733|NCT00106535|284437|P2|Completed Week 24|2-year Placebo Controlled Period||373
119734|NCT00106535|284438|P1|Completed Week 24|2-year Placebo Controlled Period||356
119735|NCT00106535|284435|P4|Safety: Actual Treatment Received|2-year Placebo Controlled Period||0
119736|NCT00106535|284436|P3|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
119737|NCT00106535|284437|P2|Safety: Actual Treatment Received|2-year Placebo Controlled Period||399
119738|NCT00106535|284438|P1|Safety: Actual Treatment Received|2-year Placebo Controlled Period||392
119739|NCT00106535|284435|P4|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||0
119740|NCT00106535|284436|P3|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||398
119741|NCT00106535|284437|P2|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||399
119742|NCT00106535|284438|P1|Intent-to-treat: Received Study Drug|2-year Placebo Controlled Period||393
119743|NCT00106535|284435|P4|STARTED|2-year Placebo Controlled Period||0
119744|NCT00106535|284436|P3|STARTED|2-year Placebo Controlled Period||401
119745|NCT00106535|284437|P2|STARTED|2-year Placebo Controlled Period||401
119746|NCT00106535|284438|P1|STARTED|2-year Placebo Controlled Period||394
119747|NCT00106626|284735|P4|NOT COMPLETED|Overall Study||13
119748|NCT00106626|284736|P3|NOT COMPLETED|Overall Study||12
119749|NCT00106626|284737|P2|NOT COMPLETED|Overall Study||6
119750|NCT00106626|284738|P1|NOT COMPLETED|Overall Study||10
119751|NCT00106626|284735|P4|COMPLETED|Overall Study||3
119752|NCT00106626|284736|P3|COMPLETED|Overall Study||2
119753|NCT00106626|284737|P2|COMPLETED|Overall Study||3
119754|NCT00106626|284738|P1|COMPLETED|Overall Study||3
119755|NCT00106626|284735|P4|STARTED|Overall Study||16
119756|NCT00106626|284736|P3|STARTED|Overall Study||14
119757|NCT00106626|284737|P2|STARTED|Overall Study||9
119758|NCT00106626|284738|P1|STARTED|Overall Study||13
119759|NCT00106639|284756|P3|NOT COMPLETED|Overall Study||2
119760|NCT00106639|284757|P2|NOT COMPLETED|Overall Study||7
119761|NCT00106639|284758|P1|NOT COMPLETED|Overall Study||3
119762|NCT00106639|284756|P3|COMPLETED|Overall Study||19
119763|NCT00106639|284757|P2|COMPLETED|Overall Study||13
119764|NCT00106639|284758|P1|COMPLETED|Overall Study||17
119765|NCT00106639|284756|P3|STARTED|Overall Study||21
119766|NCT00106639|284757|P2|STARTED|Overall Study||20
119767|NCT00106639|284758|P1|STARTED|Overall Study||20
119768|NCT00106704|284883|P2|NOT COMPLETED|Overall Study||151
119769|NCT00106704|284884|P1|NOT COMPLETED|Overall Study||131
119770|NCT00106704|284883|P2|COMPLETED|Overall Study||68
119771|NCT00106704|284884|P1|COMPLETED|Overall Study||91
119772|NCT00106704|284883|P2|STARTED|Overall Study||219
119773|NCT00106704|284884|P1|STARTED|Overall Study||222
119774|NCT00109343|284895|P3|NOT COMPLETED|Overall Study||30
119775|NCT00109343|284896|P2|NOT COMPLETED|Overall Study||37
119776|NCT00109343|284897|P1|NOT COMPLETED|Overall Study||64
119777|NCT00109343|284895|P3|COMPLETED|Overall Study||229
119778|NCT00109343|284896|P2|COMPLETED|Overall Study||221
119779|NCT00109343|284897|P1|COMPLETED|Overall Study||446
119780|NCT00109343|284895|P3|Vaccinated at Visit 4|Overall Study||240
119781|NCT00109343|284896|P2|Vaccinated at Visit 4|Overall Study||235
119782|NCT00109343|284897|P1|Vaccinated at Visit 4|Overall Study||466
119783|NCT00109343|284895|P3|Vaccinated at Visit 2|Overall Study||246
119784|NCT00109343|284896|P2|Vaccinated at Visit 2|Overall Study||246
119785|NCT00109343|284897|P1|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects in Group 1 were not vaccinated at Visit 2|0
119786|NCT00109343|284895|P3|Vaccinated at Visit 1|Overall Study||259
119787|NCT00109343|284896|P2|Vaccinated at Visit 1|Overall Study||258
119788|NCT00109343|284897|P1|Vaccinated at Visit 1|Overall Study||510
119789|NCT00109343|284895|P3|STARTED|Overall Study||259
119790|NCT00109343|284896|P2|STARTED|Overall Study||258
119791|NCT00109343|284897|P1|STARTED|Overall Study||510
119792|NCT00109473|284940|P2|NOT COMPLETED|52 Week Extension Phase||5
119793|NCT00109473|284941|P1|NOT COMPLETED|52 Week Extension Phase||4
119794|NCT00109473|284940|P2|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|3
119795|NCT00109473|284941|P1|COMPLETED|52 Week Extension Phase|Extension phase ends when subjects discontinue intervention due to active disease or reaches week 64|5
119796|NCT00109473|284940|P2|Analyzed|52 Week Extension Phase||8
119797|NCT00109473|284941|P1|Analyzed|52 Week Extension Phase||9
119798|NCT00109473|284940|P2|STARTED|52 Week Extension Phase||8
119799|NCT00109473|284941|P1|STARTED|52 Week Extension Phase||9
119800|NCT00109473|284940|P2|NOT COMPLETED|Week 12 to Week 24||0
119801|NCT00109473|284941|P1|NOT COMPLETED|Week 12 to Week 24||1
119802|NCT00109473|284940|P2|COMPLETED|Week 12 to Week 24|one subject discontinued intervention due to active disease requiring surgery|9
119803|NCT00109473|284941|P1|COMPLETED|Week 12 to Week 24|One subject withdrew consent|9
119804|NCT00109473|284940|P2|Analyzed|Week 12 to Week 24||9
119805|NCT00109473|284941|P1|Analyzed|Week 12 to Week 24||9
119806|NCT00109473|284940|P2|STARTED|Week 12 to Week 24||9
119807|NCT00109473|284941|P1|STARTED|Week 12 to Week 24||10
119808|NCT00109473|284940|P2|NOT COMPLETED|Baseline (0 Through 12 Weeks)||1
119809|NCT00109473|284941|P1|NOT COMPLETED|Baseline (0 Through 12 Weeks)||0
119810|NCT00109473|284940|P2|COMPLETED|Baseline (0 Through 12 Weeks)|One subject discontinued intervention because of active disease requiring imfliximab|9
119811|NCT00109473|284941|P1|COMPLETED|Baseline (0 Through 12 Weeks)||10
119812|NCT00109473|284940|P2|Analyzed|Baseline (0 Through 12 Weeks)||10
119813|NCT00109473|284941|P1|Analyzed|Baseline (0 Through 12 Weeks)||10
119814|NCT00109473|284940|P2|STARTED|Baseline (0 Through 12 Weeks)||10
119815|NCT00109473|284941|P1|STARTED|Baseline (0 Through 12 Weeks)|11 subjects allocated to Group A; one withdrew consent, only 10 receieved intervention.|10
119816|NCT00109577|284962|P2|NOT COMPLETED|Overall Study||3
119817|NCT00109577|284963|P1|NOT COMPLETED|Overall Study||3
119818|NCT00109577|284962|P2|COMPLETED|Overall Study||17
119819|NCT00109577|284963|P1|COMPLETED|Overall Study||17
119820|NCT00109577|284962|P2|STARTED|Overall Study||20
119821|NCT00109577|284963|P1|STARTED|Overall Study||20
119822|NCT00109590|284972|P3|NOT COMPLETED|Overall Study||4
119823|NCT00109590|284973|P2|NOT COMPLETED|Overall Study||2
119824|NCT00109590|284974|P1|NOT COMPLETED|Overall Study||2
119825|NCT00109590|284972|P3|COMPLETED|Overall Study||56
119826|NCT00109590|284973|P2|COMPLETED|Overall Study||56
119827|NCT00109590|284974|P1|COMPLETED|Overall Study||55
119828|NCT00109590|284972|P3|RECEIVED TREATMENT|Overall Study||57
119829|NCT00109590|284973|P2|RECEIVED TREATMENT|Overall Study||56
119830|NCT00109590|284974|P1|RECEIVED TREATMENT|Overall Study||56
119831|NCT00109590|284972|P3|STARTED|Overall Study||60
119832|NCT00109590|284973|P2|STARTED|Overall Study||58
119833|NCT00109590|284974|P1|STARTED|Overall Study||57
119834|NCT00109733|285016|P2|NOT COMPLETED|Overall Study||4
119835|NCT00109733|285017|P1|NOT COMPLETED|Overall Study||2
119836|NCT00109733|285016|P2|COMPLETED|Overall Study||12
119837|NCT00109733|285017|P1|COMPLETED|Overall Study||13
119838|NCT00109733|285016|P2|STARTED|Overall Study||16
119839|NCT00109733|285017|P1|STARTED|Overall Study||15
119840|NCT00109772|285033|P2|NOT COMPLETED|Open-label Extension||49
119841|NCT00109772|285034|P1|NOT COMPLETED|Open-label Extension||45
119842|NCT00109772|285033|P2|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|29
119843|NCT00109772|285034|P1|COMPLETED|Open-label Extension|Participants who were active in extension period when the sponsor terminated the study.|19
119844|NCT00109772|285033|P2|STARTED|Open-label Extension|One double-blind participant did not continue into the open-label extension|78
119845|NCT00109772|285034|P1|STARTED|Open-label Extension|Four double-blind participants did not continue into the open-label extension|64
119846|NCT00109772|285033|P2|NOT COMPLETED|Double-blind Treatment||15
119847|NCT00109772|285034|P1|NOT COMPLETED|Double-blind Treatment||22
119848|NCT00109772|285033|P2|COMPLETED|Double-blind Treatment||79
119849|NCT00109772|285034|P1|COMPLETED|Double-blind Treatment||68
119850|NCT00109772|285033|P2|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|93
119851|NCT00109772|285034|P1|Safety and ITT Population|Double-blind Treatment|Safety: at least one dose of study drug ITT: treated and at least one post dose diary measurement|87
119852|NCT00109772|285033|P2|STARTED|Double-blind Treatment||94
119853|NCT00109772|285034|P1|STARTED|Double-blind Treatment||90
119854|NCT00109837|285072|P1|NOT COMPLETED|Overall Study||23
119855|NCT00109837|285072|P1|COMPLETED|Overall Study||56
119856|NCT00109837|285072|P1|Eligible and Ph- and Treated|Overall Study||60
119857|NCT00109837|285072|P1|Eligible and Ph-|Overall Study||61
119858|NCT00109837|285072|P1|Eligible|Overall Study||78
119859|NCT00109837|285072|P1|STARTED|Overall Study||79
119860|NCT00109850|285080|P1|NOT COMPLETED|Overall Study||4
119861|NCT00109850|285080|P1|COMPLETED|Overall Study||18
119862|NCT00109850|285080|P1|Eligible and Began Protocol Therapy|Overall Study||21
119863|NCT00109850|285080|P1|Eligible|Overall Study||21
119864|NCT00109850|285080|P1|STARTED|Overall Study||22
119865|NCT00109876|285087|P1|NOT COMPLETED|Overall Study||0
119866|NCT00109876|285087|P1|COMPLETED|Overall Study||51
119867|NCT00109876|285087|P1|STARTED|Overall Study||51
119868|NCT00109928|285097|P1|NOT COMPLETED|Overall Study||13
119869|NCT00109928|285097|P1|COMPLETED|Overall Study||21
119870|NCT00109928|285097|P1|Eligible and Began Protocol Therapy|Overall Study||33
119871|NCT00109928|285097|P1|Eligible|Overall Study||33
119872|NCT00109928|285097|P1|STARTED|Overall Study||34
119873|NCT00109967|285106|P2|NOT COMPLETED|Overall Study||6
119874|NCT00109967|285107|P1|NOT COMPLETED|Overall Study||20
119875|NCT00109967|285106|P2|COMPLETED|Overall Study||15
119876|NCT00109967|285107|P1|COMPLETED|Overall Study||30
119877|NCT00109967|285106|P2|STARTED|Overall Study||21
119878|NCT00109967|285107|P1|STARTED|Overall Study||50
119879|NCT00110019|285123|P2|NOT COMPLETED|Overall Study||413
119880|NCT00110019|285124|P1|NOT COMPLETED|Overall Study||406
119881|NCT00110019|285123|P2|COMPLETED|Overall Study||0
119882|NCT00110019|285124|P1|COMPLETED|Overall Study||4
119883|NCT00110019|285123|P2|Treated|Overall Study||397
119884|NCT00110019|285124|P1|Treated|Overall Study||393
119885|NCT00110019|285123|P2|Eligible|Overall Study||398
119886|NCT00110019|285124|P1|Eligible|Overall Study||395
119887|NCT00110019|285123|P2|STARTED|Overall Study||413
119888|NCT00110019|285124|P1|STARTED|Overall Study||410
119889|NCT00110084|285134|P1|NOT COMPLETED|Overall Study||28
119890|NCT00110084|285134|P1|COMPLETED|Overall Study||22
119891|NCT00110084|285134|P1|STARTED|Overall Study||50
119892|NCT00110136|285141|P1|NOT COMPLETED|Overall Study||0
119893|NCT00110136|285141|P1|COMPLETED|Overall Study||9
119894|NCT00110136|285141|P1|STARTED|Overall Study||9
119895|NCT00110214|285152|P2|NOT COMPLETED|Overall Study||503
119896|NCT00110214|285153|P1|NOT COMPLETED|Overall Study||509
119897|NCT00110214|285152|P2|COMPLETED|Overall Study||21
119898|NCT00110214|285153|P1|COMPLETED|Overall Study||17
119899|NCT00110214|285152|P2|STARTED|Overall Study||524
119900|NCT00110214|285153|P1|STARTED|Overall Study||526
119901|NCT00110305|285169|P2|NOT COMPLETED|Overall Study||32
119902|NCT00110305|285170|P1|NOT COMPLETED|Overall Study||114
119903|NCT00110305|285169|P2|COMPLETED|Overall Study||57
119904|NCT00110305|285170|P1|COMPLETED|Overall Study||165
119905|NCT00110305|285169|P2|STARTED|Overall Study||89
119906|NCT00110305|285170|P1|STARTED|Overall Study||279
119907|NCT00110357|285223|P2|NOT COMPLETED|Overall Study||19
119908|NCT00110357|285224|P1|NOT COMPLETED|Overall Study||27
119909|NCT00110357|285223|P2|COMPLETED|Overall Study|Number Still on Study|0
119910|NCT00110357|285224|P1|COMPLETED|Overall Study|Number Still on Study|0
119911|NCT00110357|285223|P2|STARTED|Overall Study||19
119912|NCT00110357|285224|P1|STARTED|Overall Study||27
119913|NCT00110396|285308|P1|NOT COMPLETED|Overall Study||36
119914|NCT00110396|285308|P1|COMPLETED|Overall Study|260 participants included in the Safety Population.207 completed treatment. 224 completed the trial|224
119915|NCT00110396|285308|P1|STARTED|Overall Study||260
119916|NCT00110461|285317|P3|NOT COMPLETED|Acute Phase||23
119917|NCT00110461|285318|P2|NOT COMPLETED|Acute Phase||22
119918|NCT00110461|285319|P1|NOT COMPLETED|Acute Phase||14
119919|NCT00110461|285317|P3|COMPLETED|Acute Phase||76
119920|NCT00110461|285318|P2|COMPLETED|Acute Phase||77
119921|NCT00110461|285319|P1|COMPLETED|Acute Phase||84
119922|NCT00110461|285317|P3|STARTED|Acute Phase||99
119923|NCT00110461|285318|P2|STARTED|Acute Phase||99
119924|NCT00110461|285319|P1|STARTED|Acute Phase||98
119925|NCT00110461|285317|P3|NOT COMPLETED|30-Week, Double-blind Treatment Phase||87
119926|NCT00110461|285318|P2|NOT COMPLETED|30-Week, Double-blind Treatment Phase||77
119927|NCT00110461|285319|P1|NOT COMPLETED|30-Week, Double-blind Treatment Phase||64
119928|NCT00110461|285317|P3|COMPLETED|30-Week, Double-blind Treatment Phase||12
119929|NCT00110461|285318|P2|COMPLETED|30-Week, Double-blind Treatment Phase||22
119930|NCT00110461|285319|P1|COMPLETED|30-Week, Double-blind Treatment Phase||34
119931|NCT00110461|285317|P3|STARTED|30-Week, Double-blind Treatment Phase||99
119932|NCT00110461|285318|P2|STARTED|30-Week, Double-blind Treatment Phase||99
119933|NCT00110461|285319|P1|STARTED|30-Week, Double-blind Treatment Phase||98
119934|NCT00110513|285414|P1|NOT COMPLETED|Overall Study||0
119935|NCT00110513|285414|P1|COMPLETED|Overall Study||18
119936|NCT00110513|285414|P1|STARTED|Overall Study||18
119937|NCT00110617|285420|P2|NOT COMPLETED|Overall Study||29
119938|NCT00110617|285421|P1|NOT COMPLETED|Overall Study||39
119939|NCT00110617|285420|P2|COMPLETED|Overall Study||39
119940|NCT00110617|285421|P1|COMPLETED|Overall Study||96
119941|NCT00110617|285420|P2|On Going at Week 24|Overall Study||53
119942|NCT00110617|285421|P1|On Going at Week 24|Overall Study||126
119943|NCT00110617|285420|P2|Full Analysis 2; Received ICL670|Overall Study||53
119944|NCT00110617|285421|P1|Full Analysis 2; Received ICL670|Overall Study||135
119945|NCT00110617|285420|P2|Safety Set 1; Received Study Drug|Overall Study||56
119946|NCT00110617|285421|P1|Safety Set 1; Received Study Drug|Overall Study||135
119947|NCT00110617|285420|P2|STARTED|Overall Study|Full Analysis Set 1 does not include 9 participants who were excluded due to GCP violations.|68
119948|NCT00110617|285421|P1|STARTED|Overall Study||135
119949|NCT00110812|285437|P3|NOT COMPLETED|Extended Follow-up||4
119950|NCT00110812|285438|P2|NOT COMPLETED|Extended Follow-up||4
119951|NCT00110812|285439|P1|NOT COMPLETED|Extended Follow-up||2
119952|NCT00110812|285437|P3|COMPLETED|Extended Follow-up||69
119953|NCT00110812|285438|P2|COMPLETED|Extended Follow-up||65
119954|NCT00110812|285439|P1|COMPLETED|Extended Follow-up||78
119955|NCT00110812|285437|P3|STARTED|Extended Follow-up||73
119956|NCT00110812|285438|P2|STARTED|Extended Follow-up||69
119957|NCT00110812|285439|P1|STARTED|Extended Follow-up||80
119958|NCT00110812|285437|P3|NOT COMPLETED|Main Study||13
119959|NCT00110812|285438|P2|NOT COMPLETED|Main Study||11
119960|NCT00110812|285439|P1|NOT COMPLETED|Main Study||8
119961|NCT00110812|285437|P3|COMPLETED|Main Study||74
119962|NCT00110812|285438|P2|COMPLETED|Main Study||78
119963|NCT00110812|285439|P1|COMPLETED|Main Study||83
119964|NCT00110812|285437|P3|STARTED|Main Study||87
119965|NCT00110812|285438|P2|STARTED|Main Study||89
119966|NCT00110812|285439|P1|STARTED|Main Study||91
119967|NCT00110890|285484|P2|NOT COMPLETED|Overall Study||179
119968|NCT00110890|285485|P1|NOT COMPLETED|Overall Study||361
119969|NCT00110890|285484|P2|COMPLETED|Overall Study|Follow-up Phase|5
119970|NCT00110890|285485|P1|COMPLETED|Overall Study|Follow-up Phase|7
119971|NCT00110890|285484|P2|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|150
119972|NCT00110890|285485|P1|End of Efficacy Assessment Phase|Overall Study|Weeks 17 to 23|280
119973|NCT00110890|285484|P2|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|170
119974|NCT00110890|285485|P1|End of Dose Optimization Phase|Overall Study|Weeks 1 to 16|316
119975|NCT00110890|285484|P2|STARTED|Overall Study||184
119976|NCT00110890|285485|P1|STARTED|Overall Study||368
119977|NCT00110994|285501|P2|NOT COMPLETED|Long Term Follow-up||17
119978|NCT00110994|285502|P1|NOT COMPLETED|Long Term Follow-up||19
119979|NCT00110994|285501|P2|COMPLETED|Long Term Follow-up||30
119980|NCT00110994|285502|P1|COMPLETED|Long Term Follow-up||22
119981|NCT00110994|285501|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|47
119982|NCT00110994|285502|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|41
119983|NCT00110994|285501|P2|NOT COMPLETED|Active Follow-up||2
119984|NCT00110994|285502|P1|NOT COMPLETED|Active Follow-up||1
119985|NCT00110994|285501|P2|COMPLETED|Active Follow-up||0
119986|NCT00110994|285502|P1|COMPLETED|Active Follow-up||0
119987|NCT00110994|285501|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|2
119988|NCT00110994|285502|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|1
119989|NCT00110994|285501|P2|NOT COMPLETED|Double-blind (DB) Treatment||47
119990|NCT00110994|285502|P1|NOT COMPLETED|Double-blind (DB) Treatment||42
119991|NCT00110994|285501|P2|COMPLETED|Double-blind (DB) Treatment||3
119992|NCT00110994|285502|P1|COMPLETED|Double-blind (DB) Treatment||9
119993|NCT00110994|285501|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|50
119994|NCT00110994|285502|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|51
119995|NCT00110994|285501|P2|STARTED|Double-blind (DB) Treatment|ITT population|50
119996|NCT00110994|285502|P1|STARTED|Double-blind (DB) Treatment|ITT population|51
119997|NCT00111007|285528|P2|NOT COMPLETED|Long Term Follow-up||45
119998|NCT00111007|285529|P1|NOT COMPLETED|Long Term Follow-up||47
119999|NCT00111007|285528|P2|COMPLETED|Long Term Follow-up||62
120000|NCT00111007|285529|P1|COMPLETED|Long Term Follow-up||54
120001|NCT00111007|285528|P2|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|107
120002|NCT00111007|285529|P1|STARTED|Long Term Follow-up|Subjects discontinued DB treatment with DP entered this period.|101
120003|NCT00111007|285528|P2|NOT COMPLETED|Active Follow-up||2
120004|NCT00111007|285529|P1|NOT COMPLETED|Active Follow-up||6
120005|NCT00111007|285528|P2|COMPLETED|Active Follow-up||2
120006|NCT00111007|285529|P1|COMPLETED|Active Follow-up||0
120007|NCT00111007|285528|P2|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|4
120008|NCT00111007|285529|P1|STARTED|Active Follow-up|Subjects discontinued DB treatment with CR, PR and SD entered this period.|6
120009|NCT00111007|285528|P2|NOT COMPLETED|Double-blind (DB) Treatment||111
120010|NCT00111007|285529|P1|NOT COMPLETED|Double-blind (DB) Treatment||108
120011|NCT00111007|285528|P2|COMPLETED|Double-blind (DB) Treatment||24
120012|NCT00111007|285529|P1|COMPLETED|Double-blind (DB) Treatment||27
120013|NCT00111007|285528|P2|Received Treatment|Double-blind (DB) Treatment|Safety population|134
120014|NCT00111007|285529|P1|Received Treatment|Double-blind (DB) Treatment|Safety population|134
120015|NCT00111007|285528|P2|STARTED|Double-blind (DB) Treatment|ITT population|135
120016|NCT00111007|285529|P1|STARTED|Double-blind (DB) Treatment|ITT population|135
120017|NCT00111657|285543|P1|NOT COMPLETED|Overall Study||16
120018|NCT00111657|285543|P1|COMPLETED|Overall Study|Completed all intended doses.|21
120019|NCT00111657|285543|P1|STARTED|Overall Study|37 consented. 30 initiated treatment. 29 completed at least 1 dose.|37
120020|NCT00111761|285555|P2|NOT COMPLETED|Part 2||0
120021|NCT00111761|285556|P1|NOT COMPLETED|Part 2||8
120022|NCT00111761|285555|P2|COMPLETED|Part 2||0
120023|NCT00111761|285556|P1|COMPLETED|Part 2||16
120024|NCT00111761|285555|P2|STARTED|Part 2|This treatment group was used in Part 1 only|0
120025|NCT00111761|285556|P1|STARTED|Part 2||24
120026|NCT00111761|285555|P2|NOT COMPLETED|Part 1||5
120027|NCT00111761|285556|P1|NOT COMPLETED|Part 1||0
120028|NCT00111761|285555|P2|COMPLETED|Part 1|Completed through safety followup|14
120029|NCT00111761|285556|P1|COMPLETED|Part 1||0
120030|NCT00111761|285555|P2|STARTED|Part 1||19
120031|NCT00111761|285556|P1|STARTED|Part 1|This treatment group was not initiated until Part 2|0
120032|NCT00111813|285573|P6|NOT COMPLETED|Overall Study||6
120033|NCT00111813|285574|P5|NOT COMPLETED|Overall Study||6
120034|NCT00111813|285575|P4|NOT COMPLETED|Overall Study||5
120035|NCT00111813|285576|P3|NOT COMPLETED|Overall Study||10
120036|NCT00111813|285577|P2|NOT COMPLETED|Overall Study||3
120037|NCT00111813|285578|P1|NOT COMPLETED|Overall Study||3
120038|NCT00111813|285573|P6|COMPLETED|Overall Study||0
120039|NCT00111813|285574|P5|COMPLETED|Overall Study||0
120040|NCT00111813|285575|P4|COMPLETED|Overall Study||1
120041|NCT00111813|285576|P3|COMPLETED|Overall Study||0
120042|NCT00111813|285577|P2|COMPLETED|Overall Study||0
120043|NCT00111813|285578|P1|COMPLETED|Overall Study||0
120044|NCT00111813|285573|P6|STARTED|Overall Study||6
120045|NCT00111813|285574|P5|STARTED|Overall Study||6
120046|NCT00111813|285575|P4|STARTED|Overall Study||6
120047|NCT00111813|285576|P3|STARTED|Overall Study||10
120048|NCT00111813|285577|P2|STARTED|Overall Study||3
120049|NCT00111813|285578|P1|STARTED|Overall Study||3
120050|NCT00103610|285613|P2|NOT COMPLETED|Overall Study||80
120051|NCT00103610|285614|P1|NOT COMPLETED|Overall Study||38
120052|NCT00103610|285613|P2|COMPLETED|Overall Study||68
120053|NCT00103610|285614|P1|COMPLETED|Overall Study||112
120054|NCT00103610|285613|P2|STARTED|Overall Study||148
120055|NCT00103610|285614|P1|STARTED|Overall Study||150
120056|NCT00103662|285638|P2|NOT COMPLETED|Overall Study||33
120057|NCT00103662|285639|P1|NOT COMPLETED|Overall Study||19
120058|NCT00103662|285638|P2|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|121
120059|NCT00103662|285639|P1|COMPLETED|Overall Study|1 participant was wrongly terminated due to 'other'; the participant stayed on study until death.|129
120060|NCT00103662|285638|P2|STARTED|Overall Study||154
120061|NCT00103662|285639|P1|STARTED|Overall Study||148
120062|NCT00103740|285665|P2|NOT COMPLETED|Period 2 - Extended Observation Period||36
120063|NCT00103740|285666|P1|NOT COMPLETED|Period 2 - Extended Observation Period||69
120064|NCT00103740|285665|P2|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|27
120065|NCT00103740|285666|P1|COMPLETED|Period 2 - Extended Observation Period|Includes patients retreated for Paget's disease and patients discontinued when sponsor ended study|9
120066|NCT00103740|285665|P2|STARTED|Period 2 - Extended Observation Period||63
120067|NCT00103740|285666|P1|STARTED|Period 2 - Extended Observation Period||78
120068|NCT00103740|285665|P2|NOT COMPLETED|Period 1 - Core||4
120069|NCT00103740|285666|P1|NOT COMPLETED|Period 1 - Core||7
120070|NCT00103740|285665|P2|COMPLETED|Period 1 - Core||89
120071|NCT00103740|285666|P1|COMPLETED|Period 1 - Core||85
120072|NCT00103740|285665|P2|STARTED|Period 1 - Core||93
120073|NCT00103740|285666|P1|STARTED|Period 1 - Core||92
120074|NCT00111917|285694|P2|NOT COMPLETED|Overall Study||1
120075|NCT00111917|285695|P1|NOT COMPLETED|Overall Study||1
120076|NCT00111917|285694|P2|COMPLETED|Overall Study||3
120077|NCT00111917|285695|P1|COMPLETED|Overall Study||8
120078|NCT00111917|285694|P2|STARTED|Overall Study||4
120079|NCT00111917|285695|P1|STARTED|Overall Study||9
120080|NCT00112047|285709|P2|NOT COMPLETED|Atripla Phase||20
120081|NCT00112047|285710|P1|NOT COMPLETED|Atripla Phase||18
120082|NCT00112047|285709|P2|COMPLETED|Atripla Phase||106
120083|NCT00112047|285710|P1|COMPLETED|Atripla Phase||142
120084|NCT00112047|285709|P2|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|126
120085|NCT00112047|285710|P1|STARTED|Atripla Phase|Number of participants who completed randomized phase and opted to roll over to Atripla at Week 144|160
120086|NCT00112047|285709|P2|NOT COMPLETED|Randomized Phase||88
120087|NCT00112047|285710|P1|NOT COMPLETED|Randomized Phase||70
120088|NCT00112047|285709|P2|COMPLETED|Randomized Phase||166
120089|NCT00112047|285710|P1|COMPLETED|Randomized Phase||187
120090|NCT00112047|285709|P2|STARTED|Randomized Phase|ITT analysis population|254
120091|NCT00112047|285710|P1|STARTED|Randomized Phase|Intention to treat (ITT) population N=255 (2 participants had received prior antiretroviral therapy)|257
120092|NCT00112112|285810|P2|NOT COMPLETED|Overall Study||0
120093|NCT00112112|285811|P1|NOT COMPLETED|Overall Study||0
120094|NCT00112112|285810|P2|COMPLETED|Overall Study||10
120095|NCT00112112|285811|P1|COMPLETED|Overall Study||10
120096|NCT00112112|285810|P2|STARTED|Overall Study||10
120097|NCT00112112|285811|P1|STARTED|Overall Study||10
120098|NCT00112151|285957|P6|NOT COMPLETED|Overall Study||3
120099|NCT00112151|285958|P5|NOT COMPLETED|Overall Study||6
120100|NCT00112151|285959|P4|NOT COMPLETED|Overall Study||3
120101|NCT00112151|285960|P3|NOT COMPLETED|Overall Study||3
120102|NCT00112151|285961|P2|NOT COMPLETED|Overall Study||5
120103|NCT00112151|285962|P1|NOT COMPLETED|Overall Study||4
120104|NCT00112151|285957|P6|COMPLETED|Overall Study||25
120105|NCT00112151|285958|P5|COMPLETED|Overall Study||22
120106|NCT00112151|285959|P4|COMPLETED|Overall Study||24
120107|NCT00112151|285960|P3|COMPLETED|Overall Study||25
120108|NCT00112151|285961|P2|COMPLETED|Overall Study||23
120109|NCT00112151|285962|P1|COMPLETED|Overall Study||24
120110|NCT00112151|285957|P6|STARTED|Overall Study||28
120111|NCT00112151|285958|P5|STARTED|Overall Study||28
120112|NCT00112151|285959|P4|STARTED|Overall Study||27
120113|NCT00112151|285960|P3|STARTED|Overall Study||28
120114|NCT00112151|285961|P2|STARTED|Overall Study||28
120115|NCT00112151|285962|P1|STARTED|Overall Study||28
120116|NCT00114504|285993|P2|NOT COMPLETED|Overall Study||0
120117|NCT00114504|285994|P1|NOT COMPLETED|Overall Study||0
120118|NCT00114504|285993|P2|COMPLETED|Overall Study||22
120119|NCT00114504|285994|P1|COMPLETED|Overall Study||21
120120|NCT00114504|285993|P2|STARTED|Overall Study||22
120121|NCT00114504|285994|P1|STARTED|Overall Study||21
120122|NCT00114517|286008|P4|NOT COMPLETED|Overall Study||10
120123|NCT00114517|286009|P3|NOT COMPLETED|Overall Study||14
120124|NCT00114517|286010|P2|NOT COMPLETED|Overall Study||11
120125|NCT00114517|286011|P1|NOT COMPLETED|Overall Study||12
120126|NCT00114517|286008|P4|COMPLETED|Overall Study||176
120127|NCT00114517|286009|P3|COMPLETED|Overall Study||172
120128|NCT00114517|286010|P2|COMPLETED|Overall Study||123
120129|NCT00114517|286011|P1|COMPLETED|Overall Study||125
120130|NCT00114517|286008|P4|STARTED|Overall Study||186
120131|NCT00114517|286009|P3|STARTED|Overall Study||186
120132|NCT00114517|286010|P2|STARTED|Overall Study||134
120133|NCT00114517|286011|P1|STARTED|Overall Study||137
120134|NCT00114530|286023|P2|NOT COMPLETED|Overall Study||20
120135|NCT00114530|286024|P1|NOT COMPLETED|Overall Study||9
120136|NCT00114530|286023|P2|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|19
120137|NCT00114530|286024|P1|COMPLETED|Overall Study|Completed 72 mo, 54 mo after failure, or at least 54 mo at study end (last patient’s 54 mo visit)|27
120138|NCT00114530|286023|P2|STARTED|Overall Study||39
120139|NCT00114530|286024|P1|STARTED|Overall Study||36
120140|NCT00114634|286129|P1|NOT COMPLETED|Overall Study||3
120141|NCT00114634|286129|P1|COMPLETED|Overall Study|Assessment forms lost by one failure to complete and return forms by two|10
120142|NCT00114634|286129|P1|STARTED|Overall Study||13
120143|NCT00114777|286146|P3|NOT COMPLETED|Long-Term Extension to Month 84||30
120144|NCT00114777|286147|P2|NOT COMPLETED|Long-Term Extension to Month 84||29
120145|NCT00114777|286148|P1|NOT COMPLETED|Long-Term Extension to Month 84||30
120146|NCT00114777|286146|P3|COMPLETED|Long-Term Extension to Month 84||57
120147|NCT00114777|286147|P2|COMPLETED|Long-Term Extension to Month 84||84
120148|NCT00114777|286148|P1|COMPLETED|Long-Term Extension to Month 84||74
120149|NCT00114777|286146|P3|STARTED|Long-Term Extension to Month 84||87
120150|NCT00114777|286147|P2|STARTED|Long-Term Extension to Month 84||113
120151|NCT00114777|286148|P1|STARTED|Long-Term Extension to Month 84||104
120152|NCT00114777|286146|P3|NOT COMPLETED|Randomization to Month 36||84
120153|NCT00114777|286147|P2|NOT COMPLETED|Randomization to Month 36||61
120154|NCT00114777|286148|P1|NOT COMPLETED|Randomization to Month 36||75
120155|NCT00114777|286146|P3|COMPLETED|Randomization to Month 36||100
120156|NCT00114777|286147|P2|COMPLETED|Randomization to Month 36||114
120157|NCT00114777|286148|P1|COMPLETED|Randomization to Month 36||109
120158|NCT00114777|286146|P3|STARTED|Randomization to Month 36||184
120159|NCT00114777|286147|P2|STARTED|Randomization to Month 36||175
120160|NCT00114777|286148|P1|STARTED|Randomization to Month 36||184
120161|NCT00114959|286222|P1|NOT COMPLETED|Overall Study||8
120162|NCT00114959|286222|P1|COMPLETED|Overall Study|protocol definition of completed study is having received >= 4 cycles of treatment|7
120163|NCT00114959|286222|P1|STARTED|Overall Study||15
120164|NCT00114972|286231|P2|NOT COMPLETED|Overall Study||12
120165|NCT00114972|286232|P1|NOT COMPLETED|Overall Study||48
120166|NCT00114972|286231|P2|COMPLETED|Overall Study||891
120167|NCT00114972|286232|P1|COMPLETED|Overall Study||849
120168|NCT00114972|286231|P2|STARTED|Overall Study||903
120169|NCT00114972|286232|P1|STARTED|Overall Study||897
120170|NCT00115063|286254|P2|NOT COMPLETED|Overall Study||104
120171|NCT00115063|286255|P1|NOT COMPLETED|Overall Study||99
120172|NCT00115063|286254|P2|COMPLETED|Overall Study||86
120173|NCT00115063|286255|P1|COMPLETED|Overall Study||101
120174|NCT00115063|286254|P2|STARTED|Overall Study||190
120175|NCT00115063|286255|P1|STARTED|Overall Study||200
120176|NCT00115297|286273|P2|NOT COMPLETED|Overall Study||0
120177|NCT00115297|286274|P1|NOT COMPLETED|Overall Study||0
120178|NCT00115297|286273|P2|COMPLETED|Overall Study||32
120179|NCT00115297|286274|P1|COMPLETED|Overall Study||30
120180|NCT00115297|286273|P2|STARTED|Overall Study||32
120181|NCT00115297|286274|P1|STARTED|Overall Study||30
120182|NCT00115349|286286|P2|NOT COMPLETED|Overall Study||9
120183|NCT00115349|286287|P1|NOT COMPLETED|Overall Study||11
120184|NCT00115349|286286|P2|COMPLETED|Overall Study|study closed due to low enrollment.|0
120185|NCT00115349|286287|P1|COMPLETED|Overall Study|Study closed due to low enrollment.|0
120186|NCT00115349|286286|P2|STARTED|Overall Study|Target was 43 subjects in this arm.|9
120187|NCT00115349|286287|P1|STARTED|Overall Study|Target was 43 subjects in this arm.|11
120188|NCT00115739|286293|P1|NOT COMPLETED|Overall Study||3
120189|NCT00115739|286293|P1|COMPLETED|Overall Study||8
120190|NCT00115739|286293|P1|STARTED|Overall Study||11
120191|NCT00115765|286304|P4|NOT COMPLETED|Overall Study||31
120192|NCT00115765|286305|P3|NOT COMPLETED|Overall Study||121
120193|NCT00115765|286306|P2|NOT COMPLETED|Overall Study||100
120194|NCT00115765|286307|P1|NOT COMPLETED|Overall Study||35
120195|NCT00115765|286304|P4|COMPLETED|Overall Study|Participants who were on study at closure or died|84
120196|NCT00115765|286305|P3|COMPLETED|Overall Study|Participants who were on study at closure or died|289
120197|NCT00115765|286306|P2|COMPLETED|Overall Study|Participants who were on study at closure or died|313
120198|NCT00115765|286307|P1|COMPLETED|Overall Study|Participants who were on study at closure or died|80
120199|NCT00115765|286304|P4|STARTED|Overall Study||115
120200|NCT00115765|286305|P3|STARTED|Overall Study||410
120201|NCT00115765|286306|P2|STARTED|Overall Study||413
120202|NCT00115765|286307|P1|STARTED|Overall Study||115
120203|NCT00115804|286345|P1|NOT COMPLETED|Overall Study||2
120204|NCT00115804|286345|P1|COMPLETED|Overall Study||4
120205|NCT00115804|286345|P1|STARTED|Overall Study||6
120206|NCT00115869|286358|P2|NOT COMPLETED|Overall Study||296
120207|NCT00115869|286359|P1|NOT COMPLETED|Overall Study||317
120208|NCT00115869|286358|P2|COMPLETED|Overall Study|Follow-up at two years post high school.|3881
120209|NCT00115869|286359|P1|COMPLETED|Overall Study||3894
120210|NCT00115869|286358|P2|Completed Data Collection at 12th Grade|Overall Study||3847
120211|NCT00115869|286359|P1|Completed Data Collection at 12th Grade|Overall Study||3876
120212|NCT00115869|286358|P2|STARTED|Overall Study||4177
120213|NCT00115869|286359|P1|STARTED|Overall Study||4211
120214|NCT00115934|286369|P2|NOT COMPLETED|Overall Study||2
120215|NCT00115934|286370|P1|NOT COMPLETED|Overall Study||4
120216|NCT00115934|286369|P2|COMPLETED|Overall Study||274
120217|NCT00115934|286370|P1|COMPLETED|Overall Study||275
120218|NCT00115934|286369|P2|STARTED|Overall Study|276 randomized to RVPAS, but 2 did not have a Norwood surgery and were excluded from analyses.|276
120219|NCT00115934|286370|P1|STARTED|Overall Study|279 randomized to MBTS, but 3 did not have a Norwood surgery; one was withdrawn-with limited data.|279
120220|NCT00116168|286412|P4|NOT COMPLETED|Overall Study||0
120221|NCT00116168|286413|P3|NOT COMPLETED|Overall Study||0
120222|NCT00116168|286414|P2|NOT COMPLETED|Overall Study||5
120223|NCT00116168|286415|P1|NOT COMPLETED|Overall Study||6
120224|NCT00116168|286412|P4|COMPLETED|Overall Study||6
120225|NCT00116168|286413|P3|COMPLETED|Overall Study||6
120226|NCT00116168|286414|P2|COMPLETED|Overall Study||6
120227|NCT00116168|286415|P1|COMPLETED|Overall Study||0
120228|NCT00116168|286412|P4|STARTED|Overall Study||6
120229|NCT00116168|286413|P3|STARTED|Overall Study||6
120230|NCT00116168|286414|P2|STARTED|Overall Study||11
120231|NCT00116168|286415|P1|STARTED|Overall Study||6
120232|NCT00116207|286479|P2|NOT COMPLETED|Overall Study||4
120233|NCT00116207|286480|P1|NOT COMPLETED|Overall Study||9
120234|NCT00116207|286479|P2|COMPLETED|Overall Study||18
120235|NCT00116207|286480|P1|COMPLETED|Overall Study||13
120236|NCT00116207|286479|P2|STARTED|Overall Study||22
120237|NCT00116207|286480|P1|STARTED|Overall Study||22
120238|NCT00116272|286494|P2|NOT COMPLETED|Overall Study||6
120239|NCT00116272|286495|P1|NOT COMPLETED|Overall Study||11
120240|NCT00116272|286494|P2|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|158
120241|NCT00116272|286495|P1|COMPLETED|Overall Study|Indicates participants with a known outcome of pregnancy|359
120242|NCT00116272|286494|P2|STARTED|Overall Study||164
120243|NCT00116272|286495|P1|STARTED|Overall Study||370
120244|NCT00116428|286547|P2|NOT COMPLETED|Overall Study||5
120245|NCT00116428|286548|P1|NOT COMPLETED|Overall Study||3
120246|NCT00116428|286547|P2|COMPLETED|Overall Study||56
120247|NCT00116428|286548|P1|COMPLETED|Overall Study||103
120248|NCT00116428|286547|P2|STARTED|Overall Study||61
120249|NCT00116428|286548|P1|STARTED|Overall Study||106
120250|NCT00116649|286564|P1|NOT COMPLETED|Overall Study||155
120251|NCT00116649|286564|P1|COMPLETED|Overall Study||396
120252|NCT00116649|286564|P1|STARTED|Overall Study|586 screened (34 not eligible) 552 enrolled 551 study population (1 subject not treated)|551
120253|NCT00116688|286571|P2|NOT COMPLETED|Overall Study||4
120254|NCT00116688|286572|P1|NOT COMPLETED|Overall Study||92
120255|NCT00116688|286571|P2|COMPLETED|Overall Study||17
120256|NCT00116688|286572|P1|COMPLETED|Overall Study||200
120257|NCT00116688|286571|P2|Received Study Medication|Overall Study||20
120258|NCT00116688|286572|P1|Received Study Medication|Overall Study||291
120259|NCT00116688|286571|P2|STARTED|Overall Study||21
120260|NCT00116688|286572|P1|STARTED|Overall Study||292
120261|NCT00116753|286590|P3|NOT COMPLETED|Overall Study||24
120262|NCT00116753|286591|P2|NOT COMPLETED|Overall Study||30
120263|NCT00116753|286592|P1|NOT COMPLETED|Overall Study||32
120264|NCT00116753|286590|P3|COMPLETED|Overall Study||128
120265|NCT00116753|286591|P2|COMPLETED|Overall Study||125
120266|NCT00116753|286592|P1|COMPLETED|Overall Study||121
120267|NCT00116753|286590|P3|ITT Population|Overall Study||147
120268|NCT00116753|286591|P2|ITT Population|Overall Study||150
120269|NCT00116753|286592|P1|ITT Population|Overall Study||150
120270|NCT00116753|286590|P3|STARTED|Overall Study||152
120271|NCT00116753|286591|P2|STARTED|Overall Study||155
120272|NCT00116753|286592|P1|STARTED|Overall Study|Randomised.|153
120273|NCT00106938|286614|P2|NOT COMPLETED|Overall Study||71
120274|NCT00106938|286615|P1|NOT COMPLETED|Overall Study||176
120275|NCT00106938|286614|P2|COMPLETED|Overall Study||293
120276|NCT00106938|286615|P1|COMPLETED|Overall Study||913
120277|NCT00106938|286614|P2|STARTED|Overall Study||364
120278|NCT00106938|286615|P1|STARTED|Overall Study||1089
120279|NCT00106964|286685|P3|NOT COMPLETED|Overall Study||7
120280|NCT00106964|286686|P2|NOT COMPLETED|Overall Study||15
120281|NCT00106964|286687|P1|NOT COMPLETED|Overall Study||13
120282|NCT00106964|286685|P3|COMPLETED|Overall Study|The number of those who completed the vaccine series was 120.|120
120283|NCT00106964|286686|P2|COMPLETED|Overall Study|The number of those who completed the vaccine series was 111.|111
120284|NCT00106964|286687|P1|COMPLETED|Overall Study|The number of those those who completed the vaccine series was 105.|105
120285|NCT00106964|286685|P3|STARTED|Overall Study||127
120286|NCT00106964|286686|P2|STARTED|Overall Study||126
120287|NCT00106964|286687|P1|STARTED|Overall Study||118
120288|NCT00107042|286712|P2|NOT COMPLETED|Overall Study||16
120289|NCT00107042|286713|P1|NOT COMPLETED|Overall Study||22
120290|NCT00107042|286712|P2|COMPLETED|Overall Study||47
120291|NCT00107042|286713|P1|COMPLETED|Overall Study||38
120292|NCT00107042|286712|P2|STARTED|Overall Study||63
120293|NCT00107042|286713|P1|STARTED|Overall Study||60
120294|NCT00107120|286778|P2|NOT COMPLETED|Overall Study||24
120295|NCT00107120|286779|P1|NOT COMPLETED|Overall Study||29
120296|NCT00107120|286778|P2|COMPLETED|Overall Study||133
120297|NCT00107120|286779|P1|COMPLETED|Overall Study||126
120298|NCT00107120|286778|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|157
120299|NCT00107120|286779|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|155
120300|NCT00107172|286791|P2|NOT COMPLETED|Overall Study||5
120301|NCT00107172|286792|P1|NOT COMPLETED|Overall Study||5
120302|NCT00107172|286791|P2|COMPLETED|Overall Study||103
120303|NCT00107172|286792|P1|COMPLETED|Overall Study||109
120304|NCT00107172|286791|P2|STARTED|Overall Study||108
120305|NCT00107172|286792|P1|STARTED|Overall Study||114
120306|NCT00107198|286820|P1|NOT COMPLETED|Overall Study||52
120307|NCT00107198|286820|P1|COMPLETED|Overall Study||136
120308|NCT00107198|286820|P1|STARTED|Overall Study||188
120309|NCT00107276|286828|P1|NOT COMPLETED|Overall Study||72
120310|NCT00107276|286828|P1|COMPLETED|Overall Study||40
120311|NCT00107276|286828|P1|Eligible|Overall Study||96
120312|NCT00107276|286828|P1|STARTED|Overall Study||112
120313|NCT00107315|286834|P1|NOT COMPLETED|Overall Study||15
120314|NCT00107315|286834|P1|COMPLETED|Overall Study||1
120315|NCT00107315|286834|P1|STARTED|Overall Study||16
120316|NCT00107380|286841|P1|NOT COMPLETED|Overall Study||30
120317|NCT00107380|286841|P1|COMPLETED|Overall Study||56
120318|NCT00107380|286841|P1|Eligible|Overall Study||84
120319|NCT00107380|286841|P1|STARTED|Overall Study||86
120320|NCT00107536|286847|P1|NOT COMPLETED|Overall Study||0
120321|NCT00107536|286847|P1|COMPLETED|Overall Study||26
120322|NCT00107536|286847|P1|STARTED|Overall Study||26
120323|NCT00107575|286859|P2|NOT COMPLETED|Overall Study||10
120324|NCT00107575|286860|P1|NOT COMPLETED|Overall Study||11
120325|NCT00107575|286859|P2|COMPLETED|Overall Study||107
120326|NCT00107575|286860|P1|COMPLETED|Overall Study||108
120327|NCT00107575|286859|P2|STARTED|Overall Study||117
120328|NCT00107575|286860|P1|STARTED|Overall Study||119
120329|NCT00107614|286874|P1|NOT COMPLETED|Overall Study||12
120330|NCT00107614|286874|P1|COMPLETED|Overall Study||0
120331|NCT00107614|286874|P1|STARTED|Overall Study||12
120332|NCT00107653|286880|P2|NOT COMPLETED|Overall Study||76
120333|NCT00107653|286881|P1|NOT COMPLETED|Overall Study||79
120334|NCT00107653|286880|P2|COMPLETED|Overall Study||224
120335|NCT00107653|286881|P1|COMPLETED|Overall Study||190
120336|NCT00107653|286880|P2|STARTED|Overall Study||300
120337|NCT00107653|286881|P1|STARTED|Overall Study||269
120338|NCT00107783|286929|P2|NOT COMPLETED|Overall Study||4
120339|NCT00107783|286930|P1|NOT COMPLETED|Overall Study||3
120340|NCT00107783|286929|P2|COMPLETED|Overall Study||16
120341|NCT00107783|286930|P1|COMPLETED|Overall Study||17
120342|NCT00107783|286929|P2|STARTED|Overall Study||20
120343|NCT00107783|286930|P1|STARTED|Overall Study||20
120344|NCT00107900|286950|P6|NOT COMPLETED|Overall Study||9
120345|NCT00107900|286951|P5|NOT COMPLETED|Overall Study||21
120346|NCT00107900|286952|P4|NOT COMPLETED|Overall Study||12
120347|NCT00107900|286953|P3|NOT COMPLETED|Overall Study||25
120348|NCT00107900|286954|P2|NOT COMPLETED|Overall Study||3
120349|NCT00107900|286955|P1|NOT COMPLETED|Overall Study||10
120350|NCT00107900|286950|P6|COMPLETED|Overall Study||94
120351|NCT00107900|286951|P5|COMPLETED|Overall Study||94
120352|NCT00107900|286952|P4|COMPLETED|Overall Study||87
120353|NCT00107900|286953|P3|COMPLETED|Overall Study||104
120354|NCT00107900|286954|P2|COMPLETED|Overall Study||72
120355|NCT00107900|286955|P1|COMPLETED|Overall Study||75
120356|NCT00107900|286950|P6|STARTED|Overall Study||103
120357|NCT00107900|286951|P5|STARTED|Overall Study||115
120358|NCT00107900|286952|P4|STARTED|Overall Study||99
120359|NCT00107900|286953|P3|STARTED|Overall Study||129
120360|NCT00107900|286954|P2|STARTED|Overall Study||75
120361|NCT00107900|286955|P1|STARTED|Overall Study||85
120362|NCT00107952|286989|P2|NOT COMPLETED|Overall Study||81
120363|NCT00107952|286990|P1|NOT COMPLETED|Overall Study||95
120364|NCT00107952|286989|P2|COMPLETED|Overall Study||299
120365|NCT00107952|286990|P1|COMPLETED|Overall Study||286
120366|NCT00107952|286989|P2|STARTED|Overall Study||380
120367|NCT00107952|286990|P1|STARTED|Overall Study||381
120368|NCT00107978|286998|P2|NOT COMPLETED|Overall Study||50
120369|NCT00107978|286999|P1|NOT COMPLETED|Overall Study||33
120370|NCT00107978|286998|P2|COMPLETED|Overall Study||431
120371|NCT00107978|286999|P1|COMPLETED|Overall Study||425
120372|NCT00107978|286998|P2|STARTED|Overall Study||481
120373|NCT00107978|286999|P1|STARTED|Overall Study||458
120374|NCT00107991|287005|P1|NOT COMPLETED|18-Week Post Treatment Assessment||2
120375|NCT00107991|287005|P1|COMPLETED|18-Week Post Treatment Assessment||8
120376|NCT00107991|287005|P1|STARTED|18-Week Post Treatment Assessment||10
120377|NCT00107991|287005|P1|NOT COMPLETED|12 Week Treatment Period||5
120378|NCT00107991|287005|P1|COMPLETED|12 Week Treatment Period||10
120379|NCT00107991|287005|P1|STARTED|12 Week Treatment Period||15
120380|NCT00107991|287005|P1|NOT COMPLETED|Eligibility Assessment||23
120381|NCT00107991|287005|P1|COMPLETED|Eligibility Assessment||15
120382|NCT00107991|287005|P1|STARTED|Eligibility Assessment||38
120383|NCT00108069|287015|P2|NOT COMPLETED|Overall Study||13
120384|NCT00108069|287016|P1|NOT COMPLETED|Overall Study||30
120385|NCT00108069|287015|P2|COMPLETED|Overall Study||0
120386|NCT00108069|287016|P1|COMPLETED|Overall Study||0
120387|NCT00108069|287015|P2|STARTED|Overall Study||13
120388|NCT00108069|287016|P1|STARTED|Overall Study||30
120389|NCT00108082|287033|P3|NOT COMPLETED|Overall Study||43
120390|NCT00108082|287034|P2|NOT COMPLETED|Overall Study||32
120391|NCT00108082|287035|P1|NOT COMPLETED|Overall Study||38
120392|NCT00108082|287033|P3|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
120393|NCT00108082|287034|P2|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|68
120394|NCT00108082|287035|P1|COMPLETED|Overall Study|Per protocol Amendment 4, participants who had completed Month 12 prior to amendment were withdrawn.|53
120395|NCT00108082|287033|P3|STARTED|Overall Study||96
120396|NCT00108082|287034|P2|STARTED|Overall Study||100
120397|NCT00108082|287035|P1|STARTED|Overall Study||91
120398|NCT00108160|287084|P2|NOT COMPLETED|Overall Study||21
120399|NCT00108160|287085|P1|NOT COMPLETED|Overall Study||39
120400|NCT00108160|287084|P2|COMPLETED|Overall Study|Participants who completed 18 months of placebo or developed new (recurrent) S. aureus infection.|42
120401|NCT00108160|287085|P1|COMPLETED|Overall Study|Patients who completed 18 months of mupirocin or developed new (recurrent) S. aureus infection.|44
120402|NCT00108160|287084|P2|Completed Visit 7 (18 mo)|Overall Study||31
120403|NCT00108160|287085|P1|Completed Visit 7 (18 mo)|Overall Study||34
120404|NCT00108160|287084|P2|Completed Visit 6 (15 mo)|Overall Study||33
120405|NCT00108160|287085|P1|Completed Visit 6 (15 mo)|Overall Study||36
120406|NCT00108160|287084|P2|Completed Visit 5 (12 mo)|Overall Study||37
120407|NCT00108160|287085|P1|Completed Visit 5 (12 mo)|Overall Study||37
120408|NCT00108160|287084|P2|Completed Visit 4 (9 mo)|Overall Study||37
120409|NCT00108160|287085|P1|Completed Visit 4 (9 mo)|Overall Study||38
120410|NCT00108160|287084|P2|Completed Visit 3 (6 mo)|Overall Study||38
120411|NCT00108160|287085|P1|Completed Visit 3 (6 mo)|Overall Study||44
120412|NCT00108160|287084|P2|Completed Visit 2 (3 mo)|Overall Study||46
120413|NCT00108160|287085|P1|Completed Visit 2 (3 mo)|Overall Study||54
120414|NCT00108160|287084|P2|Completed Visit 1 (2 Wks)|Overall Study||54
120415|NCT00108160|287085|P1|Completed Visit 1 (2 Wks)|Overall Study||72
120416|NCT00108160|287084|P2|Completed Visit 0 (Baseline)|Overall Study|3 patients who signed a consent and were randomized did not complete the initial visit to start drug|60
120417|NCT00108160|287085|P1|Completed Visit 0 (Baseline)|Overall Study|4 patients who signed consent and were randomized did not complete the initial visit to start drug|79
120418|NCT00108160|287084|P2|STARTED|Overall Study||63
120419|NCT00108160|287085|P1|STARTED|Overall Study||83
120420|NCT00108277|287098|P3|NOT COMPLETED|Overall Study||16
120421|NCT00108277|287099|P2|NOT COMPLETED|Overall Study||12
120422|NCT00108277|287100|P1|NOT COMPLETED|Overall Study||10
120423|NCT00108277|287098|P3|COMPLETED|Overall Study||19
120424|NCT00108277|287099|P2|COMPLETED|Overall Study||16
120425|NCT00108277|287100|P1|COMPLETED|Overall Study||19
120426|NCT00108277|287098|P3|STARTED|Overall Study||35
120427|NCT00108277|287099|P2|STARTED|Overall Study||28
120428|NCT00108277|287100|P1|STARTED|Overall Study||29
120429|NCT00108303|287111|P3|NOT COMPLETED|Overall Study||0
120430|NCT00108303|287112|P2|NOT COMPLETED|Overall Study||0
120431|NCT00108303|287113|P1|NOT COMPLETED|Overall Study||0
120432|NCT00108303|287111|P3|COMPLETED|Overall Study||180
120433|NCT00108303|287112|P2|COMPLETED|Overall Study||179
120434|NCT00108303|287113|P1|COMPLETED|Overall Study||179
120435|NCT00108303|287111|P3|STARTED|Overall Study||180
120436|NCT00108303|287112|P2|STARTED|Overall Study||179
120437|NCT00108303|287113|P1|STARTED|Overall Study||179
120438|NCT00108342|287127|P2|NOT COMPLETED|Overall Study||0
120439|NCT00108342|287128|P1|NOT COMPLETED|Overall Study||1
120440|NCT00108342|287127|P2|COMPLETED|Overall Study||9
120441|NCT00108342|287128|P1|COMPLETED|Overall Study||7
120442|NCT00108342|287127|P2|STARTED|Overall Study||9
120443|NCT00108342|287128|P1|STARTED|Overall Study||8
120444|NCT00108355|287136|P2|NOT COMPLETED|Overall Study||2
120445|NCT00108355|287137|P1|NOT COMPLETED|Overall Study||2
120446|NCT00108355|287136|P2|COMPLETED|Overall Study||12
120447|NCT00108355|287137|P1|COMPLETED|Overall Study||13
120448|NCT00108355|287136|P2|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis, other loculated ascites.|14
120449|NCT00108355|287137|P1|STARTED|Overall Study|Two patients met inclusion criteria not randomized, one had peritonitis , other loculated ascites.|15
120450|NCT00108433|287147|P2|NOT COMPLETED|Overall Study||17
120451|NCT00108433|287148|P1|NOT COMPLETED|Overall Study||21
120452|NCT00108433|287147|P2|COMPLETED|Overall Study||14
120453|NCT00108433|287148|P1|COMPLETED|Overall Study||9
120454|NCT00108433|287147|P2|STARTED|Overall Study||31
120455|NCT00108433|287148|P1|STARTED|Overall Study||30
120456|NCT00108485|287164|P2|NOT COMPLETED|Overall Study||2
120457|NCT00108485|287165|P1|NOT COMPLETED|Overall Study||3
120458|NCT00108485|287164|P2|COMPLETED|Overall Study||2
120459|NCT00108485|287165|P1|COMPLETED|Overall Study||2
120460|NCT00108485|287164|P2|STARTED|Overall Study||4
120461|NCT00108485|287165|P1|STARTED|Overall Study||5
120462|NCT00108524|287173|P2|NOT COMPLETED|Overall Study||18
120463|NCT00108524|287174|P1|NOT COMPLETED|Overall Study||29
120464|NCT00108524|287173|P2|COMPLETED|Overall Study||61
120465|NCT00108524|287174|P1|COMPLETED|Overall Study||52
120466|NCT00108524|287173|P2|STARTED|Overall Study||79
120467|NCT00108524|287174|P1|STARTED|Overall Study||81
120468|NCT00108550|287186|P2|NOT COMPLETED|Overall Study||16
120469|NCT00108550|287187|P1|NOT COMPLETED|Overall Study||16
120470|NCT00108550|287186|P2|COMPLETED|Overall Study||37
120471|NCT00108550|287187|P1|COMPLETED|Overall Study||39
120472|NCT00108550|287186|P2|STARTED|Overall Study||53
120473|NCT00108550|287187|P1|STARTED|Overall Study||55
120474|NCT00108628|287197|P2|NOT COMPLETED|Overall Study||10
120475|NCT00108628|287198|P1|NOT COMPLETED|Overall Study||20
120476|NCT00108628|287197|P2|COMPLETED|Overall Study||53
120477|NCT00108628|287198|P1|COMPLETED|Overall Study||41
120478|NCT00108628|287197|P2|Completed Treatment|Overall Study||57
120479|NCT00108628|287198|P1|Completed Treatment|Overall Study||42
120480|NCT00108628|287197|P2|Received One or More Sessions|Overall Study||58
120481|NCT00108628|287198|P1|Received One or More Sessions|Overall Study||53
120482|NCT00108628|287197|P2|STARTED|Overall Study||63
120483|NCT00108628|287198|P1|STARTED|Overall Study||61
120484|NCT00108732|287222|P1|NOT COMPLETED|Step 2 (Androgen Ablation and Vaccine)||5
120485|NCT00108732|287222|P1|COMPLETED|Step 2 (Androgen Ablation and Vaccine)||26
120486|NCT00108732|287222|P1|STARTED|Step 2 (Androgen Ablation and Vaccine)||31
120487|NCT00108732|287222|P1|NOT COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||14
120488|NCT00108732|287222|P1|COMPLETED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||36
120489|NCT00108732|287222|P1|Eligible and Treated|Step 1 (Vaccinia/Fowlpox/GM-CSF)||40
120490|NCT00108732|287222|P1|STARTED|Step 1 (Vaccinia/Fowlpox/GM-CSF)||50
120491|NCT00108862|287231|P2|NOT COMPLETED|Overall Study||62
120492|NCT00108862|287232|P1|NOT COMPLETED|Overall Study||68
120493|NCT00108862|287231|P2|COMPLETED|Overall Study||339
120494|NCT00108862|287232|P1|COMPLETED|Overall Study||337
120495|NCT00108862|287231|P2|STARTED|Overall Study|Three participants who were deemed clinically ineligible and taken off study were omitted.|401
120496|NCT00108862|287232|P1|STARTED|Overall Study||405
120497|NCT00108953|287262|P2|NOT COMPLETED|Follow-up||33
120498|NCT00108953|287263|P1|NOT COMPLETED|Follow-up||29
120499|NCT00108953|287262|P2|COMPLETED|Follow-up||12
120500|NCT00108953|287263|P1|COMPLETED|Follow-up||11
120501|NCT00108953|287262|P2|STARTED|Follow-up|45 out of 49 patients were followed after end of double blind treatment|45
120502|NCT00108953|287263|P1|STARTED|Follow-up|40 out of 47 patients were followed after end of double blind treatment|40
120503|NCT00108953|287262|P2|NOT COMPLETED|Treatment Period||0
120504|NCT00108953|287263|P1|NOT COMPLETED|Treatment Period||0
120505|NCT00108953|287262|P2|COMPLETED|Treatment Period|No patient under study medication anymore|49
120506|NCT00108953|287263|P1|COMPLETED|Treatment Period|No patient under study medication anymore|47
120507|NCT00108953|287262|P2|STARTED|Treatment Period|ITT population|49
120508|NCT00108953|287263|P1|STARTED|Treatment Period|ITT population|47
120509|NCT00109005|287285|P2|NOT COMPLETED|Overall Study||0
120510|NCT00109005|287286|P1|NOT COMPLETED|Overall Study||0
120511|NCT00109005|287285|P2|COMPLETED|Overall Study||9
120512|NCT00109005|287286|P1|COMPLETED|Overall Study||8
120513|NCT00109005|287285|P2|STARTED|Overall Study||9
120514|NCT00109005|287286|P1|STARTED|Overall Study||8
120515|NCT00109031|287302|P4|NOT COMPLETED|Overall Study||0
120516|NCT00109031|287303|P3|NOT COMPLETED|Overall Study||2
120517|NCT00109031|287304|P2|NOT COMPLETED|Overall Study||2
120518|NCT00109031|287305|P1|NOT COMPLETED|Overall Study||0
120519|NCT00109031|287302|P4|COMPLETED|Overall Study||12
120520|NCT00109031|287303|P3|COMPLETED|Overall Study||12
120521|NCT00109031|287304|P2|COMPLETED|Overall Study||8
120522|NCT00109031|287305|P1|COMPLETED|Overall Study||11
120523|NCT00109031|287302|P4|STARTED|Overall Study||12
120524|NCT00109031|287303|P3|STARTED|Overall Study||14
120525|NCT00109031|287304|P2|STARTED|Overall Study||10
120526|NCT00109031|287305|P1|STARTED|Overall Study||11
120527|NCT00116779|287341|P2|NOT COMPLETED|Overall Study||19
120528|NCT00116779|287342|P1|NOT COMPLETED|Overall Study||21
120529|NCT00116779|287341|P2|COMPLETED|Overall Study||45
120530|NCT00116779|287342|P1|COMPLETED|Overall Study||42
120531|NCT00116779|287341|P2|STARTED|Overall Study|Randomized and treated; intent-to-treat population|64
120532|NCT00116779|287342|P1|STARTED|Overall Study|Randomized and treated; Intent-to-treat population|63
120533|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 433 - 480||0
120534|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 433 - 480||4
120535|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 433 - 480||29
120536|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 433 - 480||53
120537|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|29
120538|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 433 - 480||57
120539|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 385 - 432||0
120540|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 385 - 432||2
120541|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 385 - 432||30
120542|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 385 - 432||57
120543|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 385 - 432|26 participants completed 384 weeks but did not continue on study.|30
120544|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 385 - 432|31 participants completed 384 weeks but did not continue on study.|59
120545|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 337 - 384||1
120546|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 337 - 384||8
120547|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 337 - 384||56
120548|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 337 - 384||90
120549|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 337 - 384||57
120550|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 337 - 384||98
120551|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 289 - 336||7
120552|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 289 - 336||6
120553|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 289 - 336||57
120554|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 289 - 336||98
120555|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 289 - 336||64
120556|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 289 - 336||104
120557|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 241 - 288||0
120558|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 241 - 288||6
120559|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 241 - 288||64
120560|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 241 - 288||104
120561|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 241 - 288||64
120562|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 241 - 288||110
120563|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 193 - 240||4
120564|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 193 - 240||13
120565|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 193 - 240||64
120566|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 193 - 240||110
120567|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 193 - 240||68
120568|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 193 - 240||123
120569|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 145 - 192||6
120570|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 145 - 192||10
120571|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 145 - 192||68
120572|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 145 - 192||123
120573|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 145 - 192||74
120574|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 145 - 192||133
120575|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 97 - 144||9
120576|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 97 - 144||11
120577|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 97 - 144||74
120578|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 97 - 144||133
120579|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 97 - 144||83
120580|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 97 - 144||144
120581|NCT00116805|287374|P2|NOT COMPLETED|Open-label Period Weeks 49 - 96||1
120582|NCT00116805|287375|P1|NOT COMPLETED|Open-label Period Weeks 49 - 96||10
120583|NCT00116805|287374|P2|COMPLETED|Open-label Period Weeks 49 - 96||83
120584|NCT00116805|287375|P1|COMPLETED|Open-label Period Weeks 49 - 96||144
120585|NCT00116805|287374|P2|STARTED|Open-label Period Weeks 49 - 96|1 participant completed 48 weeks but did not continue on study.|84
120586|NCT00116805|287375|P1|STARTED|Open-label Period Weeks 49 - 96|11 participants completed 48 weeks but did not continue on study.|154
120587|NCT00116805|287374|P2|NOT COMPLETED|Double-blind Period Through Week 48||5
120588|NCT00116805|287375|P1|NOT COMPLETED|Double-blind Period Through Week 48||11
120589|NCT00116805|287374|P2|COMPLETED|Double-blind Period Through Week 48||85
120590|NCT00116805|287375|P1|COMPLETED|Double-blind Period Through Week 48||165
120591|NCT00116805|287374|P2|STARTED|Double-blind Period Through Week 48||90
120592|NCT00116805|287375|P1|STARTED|Double-blind Period Through Week 48||176
120593|NCT00116831|287468|P2|NOT COMPLETED|Overall Study||72
120594|NCT00116831|287469|P1|NOT COMPLETED|Overall Study||73
120595|NCT00116831|287468|P2|COMPLETED|Overall Study||259
120596|NCT00116831|287469|P1|COMPLETED|Overall Study||264
120597|NCT00116831|287468|P2|STARTED|Overall Study||331
120598|NCT00116831|287469|P1|STARTED|Overall Study||337
120599|NCT00116857|287547|P2|NOT COMPLETED|Overall Study||4
120600|NCT00116857|287548|P1|NOT COMPLETED|Overall Study||3
120601|NCT00116857|287547|P2|COMPLETED|Overall Study||56
120602|NCT00116857|287548|P1|COMPLETED|Overall Study||59
120603|NCT00116857|287547|P2|STARTED|Overall Study||60
120604|NCT00116857|287548|P1|STARTED|Overall Study||62
120605|NCT00118092|287554|P1|NOT COMPLETED|Overall Study||2
120606|NCT00118092|287554|P1|COMPLETED|Overall Study||15
120607|NCT00118092|287554|P1|STARTED|Overall Study||17
120608|NCT00118131|287562|P1|NOT COMPLETED|Overall Study||0
120609|NCT00118131|287562|P1|COMPLETED|Overall Study||49
120610|NCT00118131|287562|P1|STARTED|Overall Study||49
120611|NCT00118144|287569|P1|NOT COMPLETED|Overall Study||1
120612|NCT00118144|287569|P1|COMPLETED|Overall Study||41
120613|NCT00118144|287569|P1|STARTED|Overall Study||42
120614|NCT00118157|287575|P1|NOT COMPLETED|Overall Study||12
120615|NCT00118157|287575|P1|COMPLETED|Overall Study||7
120616|NCT00118157|287575|P1|STARTED|Overall Study||19
120617|NCT00118248|287581|P2|NOT COMPLETED|Overall Study||0
120618|NCT00118248|287582|P1|NOT COMPLETED|Overall Study||0
120619|NCT00118248|287581|P2|COMPLETED|Overall Study||24
120620|NCT00118248|287582|P1|COMPLETED|Overall Study||17
120621|NCT00118248|287581|P2|STARTED|Overall Study||24
120622|NCT00118248|287582|P1|STARTED|Overall Study||17
120623|NCT00118287|287595|P1|NOT COMPLETED|Overall Study||2
120624|NCT00118287|287595|P1|COMPLETED|Overall Study||30
120625|NCT00118287|287595|P1|STARTED|Overall Study||32
120626|NCT00118352|287602|P3|NOT COMPLETED|Overall Study||0
120627|NCT00118352|287603|P2|NOT COMPLETED|Overall Study||0
120628|NCT00118352|287604|P1|NOT COMPLETED|Overall Study||0
120629|NCT00118352|287602|P3|COMPLETED|Overall Study||0
120630|NCT00118352|287603|P2|COMPLETED|Overall Study||0
120631|NCT00118352|287604|P1|COMPLETED|Overall Study||12
120632|NCT00118352|287602|P3|STARTED|Overall Study||0
120633|NCT00118352|287603|P2|STARTED|Overall Study||0
120634|NCT00118352|287604|P1|STARTED|Overall Study||12
120635|NCT00118365|287632|P2|NOT COMPLETED|Overall Study||60
120636|NCT00118365|287633|P1|NOT COMPLETED|Overall Study||59
120637|NCT00118365|287632|P2|COMPLETED|Overall Study||124
120638|NCT00118365|287633|P1|COMPLETED|Overall Study||132
120639|NCT00118365|287632|P2|STARTED|Overall Study||184
120640|NCT00118365|287633|P1|STARTED|Overall Study||191
120641|NCT00118378|287701|P2|NOT COMPLETED|Overall Study||8
120642|NCT00118378|287702|P1|NOT COMPLETED|Overall Study||2
120643|NCT00118378|287701|P2|COMPLETED|Overall Study||45
120644|NCT00118378|287702|P1|COMPLETED|Overall Study||60
120645|NCT00118378|287701|P2|STARTED|Overall Study||53
120646|NCT00118378|287702|P1|STARTED|Overall Study||62
120647|NCT00118404|287717|P3|NOT COMPLETED|Overall Study||20
120648|NCT00118404|287718|P2|NOT COMPLETED|Overall Study||16
120649|NCT00118404|287719|P1|NOT COMPLETED|Overall Study||24
120650|NCT00118404|287717|P3|COMPLETED|Overall Study||49
120651|NCT00118404|287718|P2|COMPLETED|Overall Study||70
120652|NCT00118404|287719|P1|COMPLETED|Overall Study||62
120653|NCT00118404|287717|P3|STARTED|Overall Study||69
120654|NCT00118404|287718|P2|STARTED|Overall Study||86
120655|NCT00118404|287719|P1|STARTED|Overall Study||86
120656|NCT00118417|287733|P2|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
120657|NCT00118417|287734|P1|NOT COMPLETED|Phase III (Weeks 12 to 24)||1
120658|NCT00118417|287733|P2|COMPLETED|Phase III (Weeks 12 to 24)||9
120659|NCT00118417|287734|P1|COMPLETED|Phase III (Weeks 12 to 24)||8
120660|NCT00118417|287733|P2|STARTED|Phase III (Weeks 12 to 24)||10
120661|NCT00118417|287734|P1|STARTED|Phase III (Weeks 12 to 24)||9
120662|NCT00118417|287733|P2|NOT COMPLETED|Phase II (Weeks 6 to 12)||3
120663|NCT00118417|287734|P1|NOT COMPLETED|Phase II (Weeks 6 to 12)||2
120664|NCT00118417|287733|P2|COMPLETED|Phase II (Weeks 6 to 12)||10
120665|NCT00118417|287734|P1|COMPLETED|Phase II (Weeks 6 to 12)||9
120666|NCT00118417|287733|P2|STARTED|Phase II (Weeks 6 to 12)||13
120667|NCT00118417|287734|P1|STARTED|Phase II (Weeks 6 to 12)|Three new participants on Phase 1 endpoint doses of SSRIs entered at Phase 2.|11
120668|NCT00118417|287733|P2|NOT COMPLETED|Phase I (Weeks 0 to 6)||0
120669|NCT00118417|287734|P1|NOT COMPLETED|Phase I (Weeks 0 to 6)||18
120670|NCT00118417|287733|P2|COMPLETED|Phase I (Weeks 0 to 6)||0
120671|NCT00118417|287734|P1|COMPLETED|Phase I (Weeks 0 to 6)||21
120672|NCT00118417|287733|P2|STARTED|Phase I (Weeks 0 to 6)|In Phase 1, all participants received open label SSRI - no second treatment arm.|0
120673|NCT00118417|287734|P1|STARTED|Phase I (Weeks 0 to 6)||39
120674|NCT00118430|287747|P3|NOT COMPLETED|Overall Study||28
120675|NCT00118430|287748|P2|NOT COMPLETED|Overall Study||24
120676|NCT00118430|287749|P1|NOT COMPLETED|Overall Study||21
120677|NCT00118430|287747|P3|COMPLETED|Overall Study||222
120678|NCT00118430|287748|P2|COMPLETED|Overall Study|127 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|103
120679|NCT00118430|287749|P1|COMPLETED|Overall Study|123 included in primary analysis due to repeated measures and interim 1,3 and 6 month assessments|102
120680|NCT00118430|287747|P3|STARTED|Overall Study||250
120681|NCT00118430|287748|P2|STARTED|Overall Study||127
120682|NCT00118430|287749|P1|STARTED|Overall Study||123
120683|NCT00118482|287766|P2|NOT COMPLETED|Overall Study||29
120684|NCT00118482|287767|P1|NOT COMPLETED|Overall Study||30
120685|NCT00118482|287766|P2|COMPLETED|Overall Study||76
120686|NCT00118482|287767|P1|COMPLETED|Overall Study|210 in the Intention To Treat analysis|75
120687|NCT00118482|287766|P2|STARTED|Overall Study||105
120688|NCT00118482|287767|P1|STARTED|Overall Study|3 patients signed the consent but did not take the study medication.|105
120689|NCT00118534|287777|P2|NOT COMPLETED|Overall Study||0
120690|NCT00118534|287778|P1|NOT COMPLETED|Overall Study||0
120691|NCT00118534|287777|P2|COMPLETED|Overall Study||471
120692|NCT00118534|287778|P1|COMPLETED|Overall Study||472
120693|NCT00118534|287777|P2|STARTED|Overall Study||471
120694|NCT00118534|287778|P1|STARTED|Overall Study||472
120695|NCT00118703|287862|P2|NOT COMPLETED|Overall Study||9
120696|NCT00118703|287863|P1|NOT COMPLETED|Overall Study||5
120697|NCT00118703|287862|P2|COMPLETED|Overall Study||165
120698|NCT00118703|287863|P1|COMPLETED|Overall Study||168
120699|NCT00118703|287862|P2|STARTED|Overall Study||174
120700|NCT00118703|287863|P1|STARTED|Overall Study||173
120701|NCT00118742|287875|P2|NOT COMPLETED|Overall Study||66
120702|NCT00118742|287876|P1|NOT COMPLETED|Overall Study||49
120703|NCT00118742|287875|P2|COMPLETED|Overall Study||82
120704|NCT00118742|287876|P1|COMPLETED|Overall Study||96
120705|NCT00118742|287875|P2|STARTED|Overall Study||148
120706|NCT00118742|287876|P1|STARTED|Overall Study||145
120707|NCT00118755|287890|P2|NOT COMPLETED|Overall Study||215
120708|NCT00118755|287891|P1|NOT COMPLETED|Overall Study||210
120709|NCT00118755|287890|P2|COMPLETED|Overall Study||3
120710|NCT00118755|287891|P1|COMPLETED|Overall Study||7
120711|NCT00118755|287890|P2|Safety Population|Overall Study||211
120712|NCT00118755|287891|P1|Safety Population|Overall Study||208
120713|NCT00118755|287890|P2|STARTED|Overall Study||218
120714|NCT00118755|287891|P1|STARTED|Overall Study||217
120715|NCT00118898|287907|P4|NOT COMPLETED|Overall Study||141
120716|NCT00118898|287908|P3|NOT COMPLETED|Overall Study||123
120717|NCT00118898|287909|P2|NOT COMPLETED|Overall Study||141
120718|NCT00118898|287910|P1|NOT COMPLETED|Overall Study||121
120719|NCT00118898|287907|P4|COMPLETED|Overall Study||322
120720|NCT00118898|287908|P3|COMPLETED|Overall Study||342
120721|NCT00118898|287909|P2|COMPLETED|Overall Study||324
120722|NCT00118898|287910|P1|COMPLETED|Overall Study||343
120723|NCT00118898|287907|P4|Initiated Treatment|Overall Study||462
120724|NCT00118898|287908|P3|Initiated Treatment|Overall Study||464
120725|NCT00118898|287909|P2|Initiated Treatment|Overall Study||461
120726|NCT00118898|287910|P1|Initiated Treatment|Overall Study||461
120727|NCT00118898|287907|P4|STARTED|Overall Study||463
120728|NCT00118898|287908|P3|STARTED|Overall Study||465
120729|NCT00118898|287909|P2|STARTED|Overall Study||465
120730|NCT00118898|287910|P1|STARTED|Overall Study||464
120731|NCT00118911|288006|P2|NOT COMPLETED|Overall Study||5
120732|NCT00118911|288007|P1|NOT COMPLETED|Overall Study||2
120733|NCT00118911|288006|P2|COMPLETED|Overall Study||38
120734|NCT00118911|288007|P1|COMPLETED|Overall Study||41
120735|NCT00118911|288006|P2|12 Month Follow-up|Overall Study|2 participants did not complete the 6 month follow-up but did complete the 12 month follow-up|32
120736|NCT00118911|288007|P1|12 Month Follow-up|Overall Study|1 participant did not complete the 6 month follow-up but did complete the 12 month follow-up|38
120737|NCT00118911|288006|P2|6 Month Follow-up|Overall Study||30
120738|NCT00118911|288007|P1|6 Month Follow-up|Overall Study||37
120739|NCT00118911|288006|P2|Completed Post-Treatment Assessment|Overall Study||37
120740|NCT00118911|288007|P1|Completed Post-Treatment Assessment|Overall Study||41
120741|NCT00118911|288006|P2|Received Intervention as Assigned|Overall Study||38
120742|NCT00118911|288007|P1|Received Intervention as Assigned|Overall Study||41
120743|NCT00118911|288006|P2|STARTED|Overall Study||43
120744|NCT00118911|288007|P1|STARTED|Overall Study||43
120745|NCT00119015|288017|P3|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
120746|NCT00119015|288018|P2|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
120747|NCT00119015|288019|P1|NOT COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
120748|NCT00119015|288017|P3|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||26
120749|NCT00119015|288018|P2|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||28
120750|NCT00119015|288019|P1|COMPLETED|Double-Blind, Randomized Phase (2 Weeks)||0
120751|NCT00119015|288017|P3|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|26
120752|NCT00119015|288018|P2|STARTED|Double-Blind, Randomized Phase (2 Weeks)|Baseline Analysis Population|28
120753|NCT00119015|288019|P1|STARTED|Double-Blind, Randomized Phase (2 Weeks)||0
120754|NCT00119015|288017|P3|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
120755|NCT00119015|288018|P2|NOT COMPLETED|Open-Label Phase (2 Weeks)||0
120756|NCT00119015|288019|P1|NOT COMPLETED|Open-Label Phase (2 Weeks)||48
120757|NCT00119015|288017|P3|COMPLETED|Open-Label Phase (2 Weeks)||0
120758|NCT00119015|288018|P2|COMPLETED|Open-Label Phase (2 Weeks)||0
120759|NCT00119015|288019|P1|COMPLETED|Open-Label Phase (2 Weeks)||54
120760|NCT00119015|288017|P3|STARTED|Open-Label Phase (2 Weeks)||0
120761|NCT00119015|288018|P2|STARTED|Open-Label Phase (2 Weeks)||0
120762|NCT00119015|288019|P1|STARTED|Open-Label Phase (2 Weeks)||102
120763|NCT00119041|288036|P3|NOT COMPLETED|Overall Study||0
120764|NCT00119041|288037|P2|NOT COMPLETED|Overall Study||0
120765|NCT00119041|288038|P1|NOT COMPLETED|Overall Study||0
120766|NCT00119041|288036|P3|COMPLETED|Overall Study||22
120767|NCT00119041|288037|P2|COMPLETED|Overall Study||83
120768|NCT00119041|288038|P1|COMPLETED|Overall Study||199
120769|NCT00119041|288036|P3|STARTED|Overall Study||22
120770|NCT00119041|288037|P2|STARTED|Overall Study||83
120771|NCT00119041|288038|P1|STARTED|Overall Study||199
120772|NCT00119158|288049|P2|NOT COMPLETED|Placebo Treatment||0
120773|NCT00119158|288050|P1|NOT COMPLETED|Placebo Treatment||0
120774|NCT00119158|288049|P2|COMPLETED|Placebo Treatment||45
120775|NCT00119158|288050|P1|COMPLETED|Placebo Treatment||45
120776|NCT00119158|288049|P2|STARTED|Placebo Treatment||45
120777|NCT00119158|288050|P1|STARTED|Placebo Treatment||45
120778|NCT00119158|288049|P2|NOT COMPLETED|Active Treatment||0
120779|NCT00119158|288050|P1|NOT COMPLETED|Active Treatment||0
120780|NCT00119158|288049|P2|COMPLETED|Active Treatment||45
120781|NCT00119158|288050|P1|COMPLETED|Active Treatment||45
120782|NCT00119158|288049|P2|STARTED|Active Treatment||45
120783|NCT00119158|288050|P1|STARTED|Active Treatment|patients are self controls|45
120784|NCT00119262|288060|P2|NOT COMPLETED|Overall Study||58
120785|NCT00119262|288061|P1|NOT COMPLETED|Overall Study||46
120786|NCT00119262|288060|P2|COMPLETED|Overall Study||64
120787|NCT00119262|288061|P1|COMPLETED|Overall Study||58
120788|NCT00119262|288060|P2|Eligible and Treated|Overall Study||119
120789|NCT00119262|288061|P1|Eligible and Treated|Overall Study||102
120790|NCT00119262|288060|P2|Treated|Overall Study||120
120791|NCT00119262|288061|P1|Treated|Overall Study||103
120792|NCT00119262|288060|P2|Eligible|Overall Study||120
120793|NCT00119262|288061|P1|Eligible|Overall Study||103
120794|NCT00119262|288060|P2|STARTED|Overall Study||122
120795|NCT00119262|288061|P1|STARTED|Overall Study||104
120796|NCT00119379|288073|P2|NOT COMPLETED|Overall Study||1
120797|NCT00119379|288074|P1|NOT COMPLETED|Overall Study||4
120798|NCT00119379|288073|P2|COMPLETED|Overall Study||23
120799|NCT00119379|288074|P1|COMPLETED|Overall Study||22
120800|NCT00119379|288073|P2|STARTED|Overall Study||24
120801|NCT00119379|288074|P1|STARTED|Overall Study||26
120802|NCT00119392|288090|P1|NOT COMPLETED|Overall Study||5
120803|NCT00119392|288090|P1|COMPLETED|Overall Study||40
120804|NCT00119392|288090|P1|STARTED|Overall Study||45
120805|NCT00119405|288098|P1|NOT COMPLETED|Overall Study||1
120806|NCT00119405|288098|P1|COMPLETED|Overall Study||17
120807|NCT00119405|288098|P1|STARTED|Overall Study||18
120808|NCT00119678|288104|P2|NOT COMPLETED|Open-label Treatment Period||0
120809|NCT00119678|288105|P1|NOT COMPLETED|Open-label Treatment Period||110
120810|NCT00119678|288104|P2|COMPLETED|Open-label Treatment Period||0
120811|NCT00119678|288105|P1|COMPLETED|Open-label Treatment Period||0
120812|NCT00119678|288104|P2|STARTED|Open-label Treatment Period||0
120813|NCT00119678|288105|P1|STARTED|Open-label Treatment Period|Number of participants treated|110
120814|NCT00119678|288104|P2|NOT COMPLETED|Double-blind Treatment Period||26
120815|NCT00119678|288105|P1|NOT COMPLETED|Double-blind Treatment Period||41
120816|NCT00119678|288104|P2|COMPLETED|Double-blind Treatment Period||35
120817|NCT00119678|288105|P1|COMPLETED|Double-blind Treatment Period||81
120818|NCT00119678|288104|P2|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||57
120819|NCT00119678|288105|P1|RANDOMIZED,TREATED, AND ANALYZED|Double-blind Treatment Period||118
120820|NCT00119678|288104|P2|RANDOMIZED AND TREATED|Double-blind Treatment Period||59
120821|NCT00119678|288105|P1|RANDOMIZED AND TREATED|Double-blind Treatment Period||121
120822|NCT00119678|288104|P2|STARTED|Double-blind Treatment Period||61
120823|NCT00119678|288105|P1|STARTED|Double-blind Treatment Period||122
120824|NCT00120042|288154|P3|NOT COMPLETED|Overall Study||0
120825|NCT00120042|288155|P2|NOT COMPLETED|Overall Study||0
120826|NCT00120042|288156|P1|NOT COMPLETED|Overall Study||0
120827|NCT00120042|288154|P3|COMPLETED|Overall Study||83
120828|NCT00120042|288155|P2|COMPLETED|Overall Study||83
120829|NCT00120042|288156|P1|COMPLETED|Overall Study||85
120830|NCT00120042|288154|P3|STARTED|Overall Study||83
120831|NCT00120042|288155|P2|STARTED|Overall Study||83
120832|NCT00120042|288156|P1|STARTED|Overall Study||85
120833|NCT00120250|288164|P2|NOT COMPLETED|Overall Study||2
120834|NCT00120250|288165|P1|NOT COMPLETED|Overall Study||1
120835|NCT00120250|288164|P2|COMPLETED|Overall Study||12
120836|NCT00120250|288165|P1|COMPLETED|Overall Study||12
120837|NCT00120250|288164|P2|STARTED|Overall Study||14
120838|NCT00120250|288165|P1|STARTED|Overall Study||13
120839|NCT00120289|288180|P2|NOT COMPLETED|Overall Study||109
120840|NCT00120289|288181|P1|NOT COMPLETED|Overall Study||121
120841|NCT00120289|288180|P2|COMPLETED|Overall Study||1587
120842|NCT00120289|288181|P1|COMPLETED|Overall Study||1597
120843|NCT00120289|288180|P2|STARTED|Overall Study||1696
120844|NCT00120289|288181|P1|STARTED|Overall Study||1718
120845|NCT00120406|288195|P2|NOT COMPLETED|Overall Study||16
120846|NCT00120406|288196|P1|NOT COMPLETED|Overall Study||19
120847|NCT00120406|288195|P2|COMPLETED|Overall Study||222
120848|NCT00120406|288196|P1|COMPLETED|Overall Study||217
120849|NCT00120406|288195|P2|STARTED|Overall Study||238
120850|NCT00120406|288196|P1|STARTED|Overall Study||236
120851|NCT00120523|288206|P2|NOT COMPLETED|Follow-Up Period||24
120852|NCT00120523|288207|P1|NOT COMPLETED|Follow-Up Period||30
120853|NCT00120523|288206|P2|COMPLETED|Follow-Up Period||46
120854|NCT00120523|288207|P1|COMPLETED|Follow-Up Period||90
120855|NCT00120523|288206|P2|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|70
120856|NCT00120523|288207|P1|STARTED|Follow-Up Period|Patients discontinued due to lost to follow-up or who withdrew consent were not part of this period.|120
120857|NCT00120523|288206|P2|NOT COMPLETED|Treatment Period||339
120858|NCT00120523|288207|P1|NOT COMPLETED|Treatment Period||369
120859|NCT00120523|288206|P2|COMPLETED|Treatment Period||874
120860|NCT00120523|288207|P1|COMPLETED|Treatment Period||836
120861|NCT00120523|288206|P2|STARTED|Treatment Period||1213
120862|NCT00120523|288207|P1|STARTED|Treatment Period||1205
120863|NCT00120627|288231|P2|NOT COMPLETED|Overall Study||5
120864|NCT00120627|288232|P1|NOT COMPLETED|Overall Study||5
120865|NCT00120627|288231|P2|COMPLETED|Overall Study|Three people refused the post-assessments CAPS interview only.|70
120866|NCT00120627|288232|P1|COMPLETED|Overall Study||66
120867|NCT00120627|288231|P2|Did Not Complete Post-tx Assessments|Overall Study|Three people dropped out but no reason given.|3
120868|NCT00120627|288232|P1|Did Not Complete Post-tx Assessments|Overall Study|One person had a scheduling conflict and two people were incarcerated.|3
120869|NCT00120627|288231|P2|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and an unknown reason.|73
120870|NCT00120627|288232|P1|Began Interventions|Overall Study|Two people dropped due to scheduling conflict and illness.|69
120871|NCT00120627|288231|P2|STARTED|Overall Study|This was the number that enrolled and was randomly assigned to receive the control condition.|75
120872|NCT00120627|288232|P1|STARTED|Overall Study|This is the number who enrolled and was randomly assigned to receive the Mantram Repetition Program.|71
120873|NCT00112294|288258|P2|NOT COMPLETED|Overall Study||0
120874|NCT00112294|288259|P1|NOT COMPLETED|Overall Study||5
120875|NCT00112294|288258|P2|COMPLETED|Overall Study|Off all study therapies.|320
120876|NCT00112294|288259|P1|COMPLETED|Overall Study|Off all study therapies.|320
120877|NCT00112294|288258|P2|Never Treated|Overall Study|Number by randomized group = 20, but 2 participants received C/T/C instead of T/C.|18
120878|NCT00112294|288259|P1|Never Treated|Overall Study|Number by randomized group = 11, but 2 participants received C/T/C instead of T/C.|13
120879|NCT00112294|288258|P2|STARTED|Overall Study|338 randomized and 320 treated.|320
120880|NCT00112294|288259|P1|STARTED|Overall Study|338 randomized and 325 treated.|325
120881|NCT00112359|288299|P2|NOT COMPLETED|Overall Study||13
120882|NCT00112359|288300|P1|NOT COMPLETED|Overall Study||27
120883|NCT00112359|288299|P2|COMPLETED|Overall Study||67
120884|NCT00112359|288300|P1|COMPLETED|Overall Study||57
120885|NCT00112359|288299|P2|STARTED|Overall Study||80
120886|NCT00112359|288300|P1|STARTED|Overall Study||84
120887|NCT00112385|288326|P2|NOT COMPLETED|Overall Study||1
120888|NCT00112385|288327|P1|NOT COMPLETED|Overall Study||1
120889|NCT00112385|288326|P2|COMPLETED|Overall Study||4
120890|NCT00112385|288327|P1|COMPLETED|Overall Study||10
120891|NCT00112385|288326|P2|STARTED|Overall Study||5
120892|NCT00112385|288327|P1|STARTED|Overall Study||11
120893|NCT00112437|288420|P15|NOT COMPLETED|12 Month Extension (Year 3)||1
120894|NCT00112437|288421|P14|NOT COMPLETED|12 Month Extension (Year 3)||2
120895|NCT00112437|288422|P13|NOT COMPLETED|12 Month Extension (Year 3)||1
120896|NCT00112437|288423|P12|NOT COMPLETED|12 Month Extension (Year 3)||3
120897|NCT00112437|288424|P11|NOT COMPLETED|12 Month Extension (Year 3)||4
120898|NCT00112437|288425|P10|NOT COMPLETED|12 Month Extension (Year 3)||1
120899|NCT00112437|288426|P9|NOT COMPLETED|12 Month Extension (Year 3)||1
120900|NCT00112437|288427|P8|NOT COMPLETED|12 Month Extension (Year 3)||0
120901|NCT00112437|288428|P7|NOT COMPLETED|12 Month Extension (Year 3)||5
120902|NCT00112437|288429|P6|NOT COMPLETED|12 Month Extension (Year 3)||2
120903|NCT00112437|288430|P5|NOT COMPLETED|12 Month Extension (Year 3)||0
120904|NCT00112437|288431|P4|NOT COMPLETED|12 Month Extension (Year 3)||0
120905|NCT00112437|288432|P3|NOT COMPLETED|12 Month Extension (Year 3)||0
120906|NCT00112437|288433|P2|NOT COMPLETED|12 Month Extension (Year 3)||0
120907|NCT00112437|288434|P1|NOT COMPLETED|12 Month Extension (Year 3)||0
120908|NCT00112437|288420|P15|COMPLETED|12 Month Extension (Year 3)||19
120909|NCT00112437|288421|P14|COMPLETED|12 Month Extension (Year 3)||16
120910|NCT00112437|288422|P13|COMPLETED|12 Month Extension (Year 3)||20
120911|NCT00112437|288423|P12|COMPLETED|12 Month Extension (Year 3)||16
120912|NCT00112437|288424|P11|COMPLETED|12 Month Extension (Year 3)||13
120913|NCT00112437|288425|P10|COMPLETED|12 Month Extension (Year 3)||17
120914|NCT00112437|288426|P9|COMPLETED|12 Month Extension (Year 3)||16
120915|NCT00112437|288427|P8|COMPLETED|12 Month Extension (Year 3)||18
120916|NCT00112437|288428|P7|COMPLETED|12 Month Extension (Year 3)||17
120917|NCT00112437|288429|P6|COMPLETED|12 Month Extension (Year 3)||17
120918|NCT00112437|288430|P5|COMPLETED|12 Month Extension (Year 3)||0
120919|NCT00112437|288431|P4|COMPLETED|12 Month Extension (Year 3)||0
120920|NCT00112437|288432|P3|COMPLETED|12 Month Extension (Year 3)||0
120921|NCT00112437|288433|P2|COMPLETED|12 Month Extension (Year 3)||0
120922|NCT00112437|288434|P1|COMPLETED|12 Month Extension (Year 3)||0
120923|NCT00112437|288420|P15|STARTED|12 Month Extension (Year 3)||20
120924|NCT00112437|288421|P14|STARTED|12 Month Extension (Year 3)||18
120925|NCT00112437|288422|P13|STARTED|12 Month Extension (Year 3)||21
120926|NCT00112437|288423|P12|STARTED|12 Month Extension (Year 3)||19
120927|NCT00112437|288424|P11|STARTED|12 Month Extension (Year 3)||17
120928|NCT00112437|288425|P10|STARTED|12 Month Extension (Year 3)||18
120929|NCT00112437|288426|P9|STARTED|12 Month Extension (Year 3)||17
120930|NCT00112437|288427|P8|STARTED|12 Month Extension (Year 3)||18
120931|NCT00112437|288428|P7|STARTED|12 Month Extension (Year 3)||22
120932|NCT00112437|288429|P6|STARTED|12 Month Extension (Year 3)||19
120933|NCT00112437|288430|P5|STARTED|12 Month Extension (Year 3)||0
120934|NCT00112437|288431|P4|STARTED|12 Month Extension (Year 3)||0
120935|NCT00112437|288432|P3|STARTED|12 Month Extension (Year 3)||0
120936|NCT00112437|288433|P2|STARTED|12 Month Extension (Year 3)||0
120937|NCT00112437|288434|P1|STARTED|12 Month Extension (Year 3)||0
120938|NCT00112437|288420|P15|NOT COMPLETED|12 Month Extension||0
120939|NCT00112437|288421|P14|NOT COMPLETED|12 Month Extension||0
120940|NCT00112437|288422|P13|NOT COMPLETED|12 Month Extension||0
120941|NCT00112437|288423|P12|NOT COMPLETED|12 Month Extension||0
120942|NCT00112437|288424|P11|NOT COMPLETED|12 Month Extension||0
120943|NCT00112437|288425|P10|NOT COMPLETED|12 Month Extension||0
120944|NCT00112437|288426|P9|NOT COMPLETED|12 Month Extension||0
120945|NCT00112437|288427|P8|NOT COMPLETED|12 Month Extension||0
120946|NCT00112437|288428|P7|NOT COMPLETED|12 Month Extension||0
120947|NCT00112437|288429|P6|NOT COMPLETED|12 Month Extension||0
120948|NCT00112437|288430|P5|NOT COMPLETED|12 Month Extension||13
120949|NCT00112437|288431|P4|NOT COMPLETED|12 Month Extension||7
120950|NCT00112437|288432|P3|NOT COMPLETED|12 Month Extension||8
120951|NCT00112437|288433|P2|NOT COMPLETED|12 Month Extension||9
120952|NCT00112437|288434|P1|NOT COMPLETED|12 Month Extension||3
120953|NCT00112437|288420|P15|COMPLETED|12 Month Extension||0
120954|NCT00112437|288421|P14|COMPLETED|12 Month Extension||0
120955|NCT00112437|288422|P13|COMPLETED|12 Month Extension||0
120956|NCT00112437|288423|P12|COMPLETED|12 Month Extension||0
120957|NCT00112437|288424|P11|COMPLETED|12 Month Extension||0
120958|NCT00112437|288425|P10|COMPLETED|12 Month Extension||0
120959|NCT00112437|288426|P9|COMPLETED|12 Month Extension||0
120960|NCT00112437|288427|P8|COMPLETED|12 Month Extension||0
120961|NCT00112437|288428|P7|COMPLETED|12 Month Extension||0
120962|NCT00112437|288429|P6|COMPLETED|12 Month Extension||0
120963|NCT00112437|288430|P5|COMPLETED|12 Month Extension||50
120964|NCT00112437|288431|P4|COMPLETED|12 Month Extension||62
120965|NCT00112437|288432|P3|COMPLETED|12 Month Extension||55
120966|NCT00112437|288433|P2|COMPLETED|12 Month Extension||53
120967|NCT00112437|288434|P1|COMPLETED|12 Month Extension||60
120968|NCT00112437|288420|P15|STARTED|12 Month Extension||0
120969|NCT00112437|288421|P14|STARTED|12 Month Extension||0
120970|NCT00112437|288422|P13|STARTED|12 Month Extension||0
120971|NCT00112437|288423|P12|STARTED|12 Month Extension||0
120972|NCT00112437|288424|P11|STARTED|12 Month Extension||0
120973|NCT00112437|288425|P10|STARTED|12 Month Extension||0
120974|NCT00112437|288426|P9|STARTED|12 Month Extension||0
120975|NCT00112437|288427|P8|STARTED|12 Month Extension||0
120976|NCT00112437|288428|P7|STARTED|12 Month Extension||0
120977|NCT00112437|288429|P6|STARTED|12 Month Extension||0
120978|NCT00112437|288430|P5|STARTED|12 Month Extension||63
120979|NCT00112437|288431|P4|STARTED|12 Month Extension||69
120980|NCT00112437|288432|P3|STARTED|12 Month Extension||63
120981|NCT00112437|288433|P2|STARTED|12 Month Extension||62
120982|NCT00112437|288434|P1|STARTED|12 Month Extension||63
120983|NCT00112437|288420|P15|NOT COMPLETED|12 Month Base Study||0
120984|NCT00112437|288421|P14|NOT COMPLETED|12 Month Base Study||0
120985|NCT00112437|288422|P13|NOT COMPLETED|12 Month Base Study||0
120986|NCT00112437|288423|P12|NOT COMPLETED|12 Month Base Study||0
120987|NCT00112437|288424|P11|NOT COMPLETED|12 Month Base Study||0
120988|NCT00112437|288425|P10|NOT COMPLETED|12 Month Base Study||0
120989|NCT00112437|288426|P9|NOT COMPLETED|12 Month Base Study||0
120990|NCT00112437|288427|P8|NOT COMPLETED|12 Month Base Study||0
120991|NCT00112437|288428|P7|NOT COMPLETED|12 Month Base Study||0
120992|NCT00112437|288429|P6|NOT COMPLETED|12 Month Base Study||0
120993|NCT00112437|288430|P5|NOT COMPLETED|12 Month Base Study||12
120994|NCT00112437|288431|P4|NOT COMPLETED|12 Month Base Study||8
120995|NCT00112437|288432|P3|NOT COMPLETED|12 Month Base Study||12
120996|NCT00112437|288433|P2|NOT COMPLETED|12 Month Base Study||18
120997|NCT00112437|288434|P1|NOT COMPLETED|12 Month Base Study||15
120998|NCT00112437|288420|P15|COMPLETED|12 Month Base Study||0
120999|NCT00112437|288421|P14|COMPLETED|12 Month Base Study||0
121000|NCT00112437|288422|P13|COMPLETED|12 Month Base Study||0
121001|NCT00112437|288423|P12|COMPLETED|12 Month Base Study||0
121002|NCT00112437|288424|P11|COMPLETED|12 Month Base Study||0
121003|NCT00112437|288425|P10|COMPLETED|12 Month Base Study||0
121004|NCT00112437|288426|P9|COMPLETED|12 Month Base Study||0
121005|NCT00112437|288427|P8|COMPLETED|12 Month Base Study||0
121006|NCT00112437|288428|P7|COMPLETED|12 Month Base Study||0
121007|NCT00112437|288429|P6|COMPLETED|12 Month Base Study||0
121008|NCT00112437|288430|P5|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|66
121009|NCT00112437|288431|P4|COMPLETED|12 Month Base Study||71
121010|NCT00112437|288432|P3|COMPLETED|12 Month Base Study||65
121011|NCT00112437|288433|P2|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|64
121012|NCT00112437|288434|P1|COMPLETED|12 Month Base Study|1 patient completed the base study after Demcember 19, 2006 & is not included in the completed total|68
121013|NCT00112437|288420|P15|STARTED|12 Month Base Study||0
121014|NCT00112437|288421|P14|STARTED|12 Month Base Study||0
121015|NCT00112437|288422|P13|STARTED|12 Month Base Study||0
121016|NCT00112437|288423|P12|STARTED|12 Month Base Study||0
121017|NCT00112437|288424|P11|STARTED|12 Month Base Study||0
121018|NCT00112437|288425|P10|STARTED|12 Month Base Study||0
121019|NCT00112437|288426|P9|STARTED|12 Month Base Study||0
121020|NCT00112437|288427|P8|STARTED|12 Month Base Study||0
121021|NCT00112437|288428|P7|STARTED|12 Month Base Study||0
121022|NCT00112437|288429|P6|STARTED|12 Month Base Study||0
121023|NCT00112437|288430|P5|STARTED|12 Month Base Study||78
121024|NCT00112437|288431|P4|STARTED|12 Month Base Study||79
121025|NCT00112437|288432|P3|STARTED|12 Month Base Study||77
121026|NCT00112437|288433|P2|STARTED|12 Month Base Study||82
121027|NCT00112437|288434|P1|STARTED|12 Month Base Study||83
121028|NCT00112463|288691|P1|NOT COMPLETED|Overall Study||39
121029|NCT00112463|288691|P1|COMPLETED|Overall Study||1
121030|NCT00112463|288691|P1|STARTED|Overall Study||40
121031|NCT00112489|288698|P1|NOT COMPLETED|Overall Study||40
121032|NCT00112489|288698|P1|COMPLETED|Overall Study|Completed regimen due to progression|15
121033|NCT00112489|288698|P1|STARTED|Overall Study|All patients enrolled on study|55
121034|NCT00112593|288702|P1|NOT COMPLETED|Overall Study||0
121035|NCT00112593|288702|P1|COMPLETED|Overall Study||5
121036|NCT00112593|288702|P1|STARTED|Overall Study||5
121037|NCT00112671|288711|P1|NOT COMPLETED|Overall Study||0
121038|NCT00112671|288711|P1|COMPLETED|Overall Study||17
121039|NCT00112671|288711|P1|STARTED|Overall Study||17
121040|NCT00112723|288717|P3|NOT COMPLETED|Overall Study||2
121041|NCT00112723|288718|P2|NOT COMPLETED|Overall Study||7
121042|NCT00112723|288719|P1|NOT COMPLETED|Overall Study||2
121043|NCT00112723|288717|P3|COMPLETED|Overall Study||12
121044|NCT00112723|288718|P2|COMPLETED|Overall Study||12
121045|NCT00112723|288719|P1|COMPLETED|Overall Study||11
121046|NCT00112723|288717|P3|Patients Evaluable for Toxicity|Overall Study||12
121047|NCT00112723|288718|P2|Patients Evaluable for Toxicity|Overall Study||12
121048|NCT00112723|288719|P1|Patients Evaluable for Toxicity|Overall Study||11
121049|NCT00112723|288717|P3|STARTED|Overall Study||14
121050|NCT00112723|288718|P2|STARTED|Overall Study||19
121051|NCT00112723|288719|P1|STARTED|Overall Study||13
121052|NCT00112736|288747|P2|NOT COMPLETED|Overall Study||0
121053|NCT00112736|288748|P1|NOT COMPLETED|Overall Study||1
121054|NCT00112736|288747|P2|COMPLETED|Overall Study|12 additional pts from phase 1 study were used in analysis for Phase 2 as they were treated at MTD|47
121055|NCT00112736|288748|P1|COMPLETED|Overall Study|12 of Phase I pts treated at MTD and hence considered part of the Phase II analysis|21
121056|NCT00112736|288747|P2|STARTED|Overall Study||47
121057|NCT00112736|288748|P1|STARTED|Overall Study||22
121058|NCT00112840|288764|P3|NOT COMPLETED|Overall Study||6
121059|NCT00112840|288765|P2|NOT COMPLETED|Overall Study||0
121060|NCT00112840|288766|P1|NOT COMPLETED|Overall Study||2
121061|NCT00112840|288764|P3|COMPLETED|Overall Study||40
121062|NCT00112840|288765|P2|COMPLETED|Overall Study||6
121063|NCT00112840|288766|P1|COMPLETED|Overall Study||6
121064|NCT00112840|288764|P3|STARTED|Overall Study||46
121065|NCT00112840|288765|P2|STARTED|Overall Study||6
121066|NCT00112840|288766|P1|STARTED|Overall Study||8
121067|NCT00112866|288784|P2|NOT COMPLETED|Overall Study||2
121068|NCT00112866|288785|P1|NOT COMPLETED|Overall Study||2
121069|NCT00112866|288784|P2|COMPLETED|Overall Study||13
121070|NCT00112866|288785|P1|COMPLETED|Overall Study||13
121071|NCT00112866|288784|P2|STARTED|Overall Study||15
121072|NCT00112866|288785|P1|STARTED|Overall Study||15
121073|NCT00112905|288804|P1|NOT COMPLETED|Overall Study||12
121074|NCT00112905|288804|P1|COMPLETED|Overall Study||15
121075|NCT00112905|288804|P1|Eligible and Treated|Overall Study||22
121076|NCT00112905|288804|P1|STARTED|Overall Study||27
121077|NCT00112918|288814|P3|NOT COMPLETED|Overall Study||299
121078|NCT00112918|288815|P2|NOT COMPLETED|Overall Study||345
121079|NCT00112918|288816|P1|NOT COMPLETED|Overall Study||297
121080|NCT00112918|288814|P3|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|846
121081|NCT00112918|288815|P2|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|810
121082|NCT00112918|288816|P1|COMPLETED|Overall Study|Represents patients alive in follow-up at the time of final data cut-off (30 June 2012)|854
121083|NCT00112918|288814|P3|Stage III Disease Population|Overall Study||952
121084|NCT00112918|288815|P2|Stage III Disease Population|Overall Study||960
121085|NCT00112918|288816|P1|Stage III Disease Population|Overall Study||955
121086|NCT00112918|288814|P3|Received Treatment|Overall Study||1135
121087|NCT00112918|288815|P2|Received Treatment|Overall Study|Includes two patients from FOLFOX4 who received Bv and were assigned to FOLFOX4+Bv safety analysis|1145
121088|NCT00112918|288816|P1|Received Treatment|Overall Study||1126
121089|NCT00112918|288814|P3|STARTED|Overall Study||1145
121090|NCT00112918|288815|P2|STARTED|Overall Study||1155
121091|NCT00112918|288816|P1|STARTED|Overall Study||1151
121092|NCT00113022|288841|P2|NOT COMPLETED|Overall Study||2
121093|NCT00113022|288842|P1|NOT COMPLETED|Overall Study||3
121094|NCT00113022|288841|P2|COMPLETED|Overall Study||2
121095|NCT00113022|288842|P1|COMPLETED|Overall Study||2
121096|NCT00113022|288841|P2|STARTED|Overall Study||4
121097|NCT00113022|288842|P1|STARTED|Overall Study||5
121098|NCT00113087|288850|P2|NOT COMPLETED|Overall Study||21
121099|NCT00113087|288851|P1|NOT COMPLETED|Overall Study||24
121100|NCT00113087|288850|P2|COMPLETED|Overall Study||94
121101|NCT00113087|288851|P1|COMPLETED|Overall Study||91
121102|NCT00113087|288850|P2|STARTED|Overall Study||115
121103|NCT00113087|288851|P1|STARTED|Overall Study||115
121104|NCT00113217|288913|P1|NOT COMPLETED|Overall Study||0
121105|NCT00113217|288913|P1|COMPLETED|Overall Study||50
121106|NCT00113217|288913|P1|STARTED|Overall Study||50
121107|NCT00113230|288917|P1|NOT COMPLETED|Overall Study||0
121108|NCT00113230|288917|P1|COMPLETED|Overall Study||25
121109|NCT00113230|288917|P1|STARTED|Overall Study||25
121110|NCT00113269|288925|P4|NOT COMPLETED|Overall Study||40
121111|NCT00113269|288926|P3|NOT COMPLETED|Overall Study||41
121112|NCT00113269|288927|P2|NOT COMPLETED|Overall Study||22
121113|NCT00113269|288928|P1|NOT COMPLETED|Overall Study||25
121114|NCT00113269|288925|P4|COMPLETED|Overall Study||140
121115|NCT00113269|288926|P3|COMPLETED|Overall Study||134
121116|NCT00113269|288927|P2|COMPLETED|Overall Study||48
121117|NCT00113269|288928|P1|COMPLETED|Overall Study||51
121118|NCT00113269|288925|P4|Received Treatment|Overall Study||171
121119|NCT00113269|288926|P3|Received Treatment|Overall Study||164
121120|NCT00113269|288927|P2|Received Treatment|Overall Study||69
121121|NCT00113269|288928|P1|Received Treatment|Overall Study||70
121122|NCT00113269|288925|P4|STARTED|Overall Study||180
121123|NCT00113269|288926|P3|STARTED|Overall Study||175
121124|NCT00113269|288927|P2|STARTED|Overall Study||70
121125|NCT00113269|288928|P1|STARTED|Overall Study||76
121126|NCT00113295|288980|P2|NOT COMPLETED|Overall Study||1
121127|NCT00113295|288981|P1|NOT COMPLETED|Overall Study||5
121128|NCT00113295|288980|P2|COMPLETED|Overall Study||10
121129|NCT00113295|288981|P1|COMPLETED|Overall Study||6
121130|NCT00113295|288980|P2|STARTED|Overall Study||11
121131|NCT00113295|288981|P1|STARTED|Overall Study||11
121132|NCT00113321|288996|P1|NOT COMPLETED|Overall Study||0
121133|NCT00113321|288996|P1|COMPLETED|Overall Study||16
121134|NCT00113321|288996|P1|STARTED|Overall Study||16
121135|NCT00113334|289000|P1|NOT COMPLETED|Overall Study||0
121136|NCT00113334|289000|P1|COMPLETED|Overall Study||6
121137|NCT00113334|289000|P1|STARTED|Overall Study||6
121138|NCT00113360|289004|P1|NOT COMPLETED|Overall Study||7
121139|NCT00113360|289004|P1|COMPLETED|Overall Study||60
121140|NCT00113360|289004|P1|STARTED|Overall Study|67 participants were enrolled for screening.|67
121141|NCT00113373|289008|P1|NOT COMPLETED|Overall Study||3
121142|NCT00113373|289008|P1|COMPLETED|Overall Study|Eligible and treated patients.|25
121143|NCT00113373|289008|P1|STARTED|Overall Study||28
121144|NCT00113386|289016|P2|NOT COMPLETED|Overall Study||4
121145|NCT00113386|289017|P1|NOT COMPLETED|Overall Study||7
121146|NCT00113386|289016|P2|COMPLETED|Overall Study||5
121147|NCT00113386|289017|P1|COMPLETED|Overall Study||3
121148|NCT00113386|289016|P2|STARTED|Overall Study||9
121149|NCT00113386|289017|P1|STARTED|Overall Study||10
121150|NCT00113399|289025|P2|NOT COMPLETED|Overall Study||5
121151|NCT00113399|289026|P1|NOT COMPLETED|Overall Study||2
121152|NCT00113399|289025|P2|COMPLETED|Overall Study||3
121153|NCT00113399|289026|P1|COMPLETED|Overall Study||5
121154|NCT00113399|289025|P2|STARTED|Overall Study||8
121155|NCT00113399|289026|P1|STARTED|Overall Study||7
121156|NCT00113425|289032|P1|NOT COMPLETED|Overall Study||15
121157|NCT00113425|289032|P1|COMPLETED|Overall Study||29
121158|NCT00113425|289032|P1|STARTED|Overall Study||44
121159|NCT00113490|289052|P2|NOT COMPLETED|Overall Study||3
121160|NCT00113490|289053|P1|NOT COMPLETED|Overall Study||2
121161|NCT00113490|289052|P2|COMPLETED|Overall Study||67
121162|NCT00113490|289053|P1|COMPLETED|Overall Study||64
121163|NCT00113490|289052|P2|STARTED|Overall Study||70
121164|NCT00113490|289053|P1|STARTED|Overall Study||66
121165|NCT00113516|289066|P2|NOT COMPLETED|Part 2||66
121166|NCT00113516|289067|P1|NOT COMPLETED|Part 2||0
121167|NCT00113516|289066|P2|COMPLETED|Part 2||0
121168|NCT00113516|289067|P1|COMPLETED|Part 2||0
121169|NCT00113516|289066|P2|STARTED|Part 2||66
121170|NCT00113516|289067|P1|STARTED|Part 2||0
121171|NCT00113516|289066|P2|NOT COMPLETED|Part 1||0
121172|NCT00113516|289067|P1|NOT COMPLETED|Part 1||84
121173|NCT00113516|289066|P2|COMPLETED|Part 1||0
121174|NCT00113516|289067|P1|COMPLETED|Part 1|66 subjects continued into Part 2 of the study.|0
121175|NCT00113516|289066|P2|STARTED|Part 1||0
121176|NCT00113516|289067|P1|STARTED|Part 1||84
121177|NCT00113529|289108|P1|NOT COMPLETED|Overall Study||34
121178|NCT00113529|289108|P1|COMPLETED|Overall Study|Subject discontinued from the study and continued treatment on commercially available sunitinib.|1
121179|NCT00113529|289108|P1|STARTED|Overall Study|Phase 2 included 4 subjects from Phase 1 and 31 from Phase 2, for a total of 35 subjects.|35
121180|NCT00113568|289141|P1|NOT COMPLETED|Overall Study||545
121181|NCT00113568|289141|P1|COMPLETED|Overall Study||239
121182|NCT00113568|289141|P1|Intent to Treat Population|Overall Study||723
121183|NCT00113568|289141|P1|STARTED|Overall Study||784
121184|NCT00113607|289155|P2|NOT COMPLETED|Overall Study||337
121185|NCT00113607|289156|P1|NOT COMPLETED|Overall Study||335
121186|NCT00113607|289155|P2|COMPLETED|Overall Study||0
121187|NCT00113607|289156|P1|COMPLETED|Overall Study||0
121188|NCT00113607|289155|P2|STARTED|Overall Study|Number of randomized participants|337
121189|NCT00113607|289156|P1|STARTED|Overall Study|Number of randomized participants|335
121190|NCT00113763|289172|P2|NOT COMPLETED|Overall Study||26
121191|NCT00113763|289173|P1|NOT COMPLETED|Overall Study||73
121192|NCT00113763|289172|P2|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|206
121193|NCT00113763|289173|P1|COMPLETED|Overall Study|Defined as participants who completed safety follow-up visit or who died.|158
121194|NCT00113763|289172|P2|Received Study Drug|Overall Study||0
121195|NCT00113763|289173|P1|Received Study Drug|Overall Study||229
121196|NCT00113763|289172|P2|STARTED|Overall Study||232
121197|NCT00113763|289173|P1|STARTED|Overall Study||231
121198|NCT00113841|289199|P2|NOT COMPLETED|Overall Study||2
121199|NCT00113841|289200|P1|NOT COMPLETED|Overall Study||1
121200|NCT00113841|289199|P2|COMPLETED|Overall Study||15
121201|NCT00113841|289200|P1|COMPLETED|Overall Study||15
121202|NCT00113841|289199|P2|STARTED|Overall Study||17
121203|NCT00113841|289200|P1|STARTED|Overall Study||16
121204|NCT00113880|289209|P3|NOT COMPLETED|Overall Study||0
121205|NCT00113880|289210|P2|NOT COMPLETED|Overall Study||0
121206|NCT00113880|289211|P1|NOT COMPLETED|Overall Study||0
121207|NCT00113880|289209|P3|COMPLETED|Overall Study||62492
121208|NCT00113880|289210|P2|COMPLETED|Overall Study||71949
121209|NCT00113880|289211|P1|COMPLETED|Overall Study||63061
121210|NCT00113880|289209|P3|STARTED|Overall Study||62492
121211|NCT00113880|289210|P2|STARTED|Overall Study||71949
121212|NCT00113880|289211|P1|STARTED|Overall Study||63061
121213|NCT00113919|289268|P1|NOT COMPLETED|Overall Study||14
121214|NCT00113919|289268|P1|COMPLETED|Overall Study||0
121215|NCT00113919|289268|P1|STARTED|Overall Study||14
121216|NCT00114101|289274|P2|NOT COMPLETED|Overall Study||0
121217|NCT00114101|289275|P1|NOT COMPLETED|Overall Study||0
121218|NCT00114101|289274|P2|COMPLETED|Overall Study||229
121219|NCT00114101|289275|P1|COMPLETED|Overall Study||231
121220|NCT00114101|289274|P2|STARTED|Overall Study||229
121221|NCT00114101|289275|P1|STARTED|Overall Study||231
121222|NCT00114127|289289|P2|NOT COMPLETED|Overall Study||4
121223|NCT00114127|289290|P1|NOT COMPLETED|Overall Study||4
121224|NCT00114127|289289|P2|COMPLETED|Overall Study||11
121225|NCT00114127|289290|P1|COMPLETED|Overall Study||9
121226|NCT00114127|289289|P2|STARTED|Overall Study||15
121227|NCT00114127|289290|P1|STARTED|Overall Study||13
121228|NCT00114166|289298|P1|NOT COMPLETED|Overall Study||1
121229|NCT00114166|289298|P1|COMPLETED|Overall Study|total numbers of eligible and evaluable participants|80
121230|NCT00114166|289298|P1|Registered to Regimen II|Overall Study||65
121231|NCT00114166|289298|P1|Registered to Regimen I|Overall Study||15
121232|NCT00114166|289298|P1|STARTED|Overall Study|total number of participants enrolled|81
121233|NCT00114244|289306|P2|NOT COMPLETED|Overall Study||7
121234|NCT00114244|289307|P1|NOT COMPLETED|Overall Study||2
121235|NCT00114244|289306|P2|COMPLETED|Overall Study||30
121236|NCT00114244|289307|P1|COMPLETED|Overall Study||13
121237|NCT00114244|289306|P2|STARTED|Overall Study||37
121238|NCT00114244|289307|P1|STARTED|Overall Study||15
121239|NCT00120874|289319|P2|NOT COMPLETED|Overall Study||1
121240|NCT00120874|289320|P1|NOT COMPLETED|Overall Study||0
121241|NCT00120874|289319|P2|COMPLETED|Overall Study||9
121242|NCT00120874|289320|P1|COMPLETED|Overall Study||10
121243|NCT00120874|289319|P2|Completed Study; Started Extension Study|Overall Study||10
121244|NCT00120874|289320|P1|Completed Study; Started Extension Study|Overall Study||10
121245|NCT00120874|289319|P2|STARTED|Overall Study||10
121246|NCT00120874|289320|P1|STARTED|Overall Study||10
121247|NCT00121472|289356|P1|NOT COMPLETED|Overall Study||0
121248|NCT00121472|289356|P1|COMPLETED|Overall Study|Followed for at least 1 year after implantation of HM II LVAS.|194
121249|NCT00121472|289356|P1|STARTED|Overall Study||194
121250|NCT00121485|289369|P2|NOT COMPLETED|Overall Study||7
121251|NCT00121485|289370|P1|NOT COMPLETED|Overall Study||1
121252|NCT00121485|289369|P2|COMPLETED|Overall Study||59
121253|NCT00121485|289370|P1|COMPLETED|Overall Study||133
121254|NCT00121485|289369|P2|STARTED|Overall Study||66
121255|NCT00121485|289370|P1|STARTED|Overall Study||134
121256|NCT00121641|289408|P5|NOT COMPLETED|48-month Short Term + Long Term Period||58
121257|NCT00121641|289409|P4|NOT COMPLETED|48-month Short Term + Long Term Period||71
121258|NCT00121641|289410|P3|NOT COMPLETED|48-month Short Term + Long Term Period||70
121259|NCT00121641|289411|P2|NOT COMPLETED|48-month Short Term + Long Term Period||82
121260|NCT00121641|289412|P1|NOT COMPLETED|48-month Short Term + Long Term Period||79
121261|NCT00121641|289408|P5|COMPLETED|48-month Short Term + Long Term Period||8
121262|NCT00121641|289409|P4|COMPLETED|48-month Short Term + Long Term Period||24
121263|NCT00121641|289410|P3|COMPLETED|48-month Short Term + Long Term Period||28
121264|NCT00121641|289411|P2|COMPLETED|48-month Short Term + Long Term Period||24
121265|NCT00121641|289412|P1|COMPLETED|48-month Short Term + Long Term Period||23
121266|NCT00121641|289408|P5|STARTED|48-month Short Term + Long Term Period||66
121267|NCT00121641|289409|P4|STARTED|48-month Short Term + Long Term Period||95
121268|NCT00121641|289410|P3|STARTED|48-month Short Term + Long Term Period||98
121269|NCT00121641|289411|P2|STARTED|48-month Short Term + Long Term Period||106
121354|NCT00121719|289650|P2|STARTED|Overall Study||4
121270|NCT00121641|289412|P1|STARTED|48-month Short Term + Long Term Period||102
121271|NCT00121641|289408|P5|NOT COMPLETED|24-week Short-term Treatment Period||41
121272|NCT00121641|289409|P4|NOT COMPLETED|24-week Short-term Treatment Period||40
121273|NCT00121641|289410|P3|NOT COMPLETED|24-week Short-term Treatment Period||29
121274|NCT00121641|289411|P2|NOT COMPLETED|24-week Short-term Treatment Period||38
121275|NCT00121641|289412|P1|NOT COMPLETED|24-week Short-term Treatment Period||29
121276|NCT00121641|289408|P5|COMPLETED|24-week Short-term Treatment Period||25
121277|NCT00121641|289409|P4|COMPLETED|24-week Short-term Treatment Period||55
121278|NCT00121641|289410|P3|COMPLETED|24-week Short-term Treatment Period||69
121279|NCT00121641|289411|P2|COMPLETED|24-week Short-term Treatment Period||68
121280|NCT00121641|289412|P1|COMPLETED|24-week Short-term Treatment Period||73
121281|NCT00121641|289408|P5|STARTED|24-week Short-term Treatment Period||66
121282|NCT00121641|289409|P4|STARTED|24-week Short-term Treatment Period||95
121283|NCT00121641|289410|P3|STARTED|24-week Short-term Treatment Period||98
121284|NCT00121641|289411|P2|STARTED|24-week Short-term Treatment Period||106
121285|NCT00121641|289412|P1|STARTED|24-week Short-term Treatment Period||102
121286|NCT00121667|289527|P4|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||140
121287|NCT00121667|289528|P3|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||113
121288|NCT00121667|289529|P2|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||133
121289|NCT00121667|289530|P1|NOT COMPLETED|Short Term (ST) + Long Term (LT) Period||128
121290|NCT00121667|289527|P4|COMPLETED|Short Term (ST) + Long Term (LT) Period||39
121291|NCT00121667|289528|P3|COMPLETED|Short Term (ST) + Long Term (LT) Period||68
121292|NCT00121667|289529|P2|COMPLETED|Short Term (ST) + Long Term (LT) Period||58
121293|NCT00121667|289530|P1|COMPLETED|Short Term (ST) + Long Term (LT) Period||64
121294|NCT00121667|289527|P4|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||7
121295|NCT00121667|289528|P3|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||23
121296|NCT00121667|289529|P2|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||18
121297|NCT00121667|289530|P1|Completed Study Without Being Rescued|Short Term (ST) + Long Term (LT) Period||14
121298|NCT00121667|289527|P4|STARTED|Short Term (ST) + Long Term (LT) Period||179
121299|NCT00121667|289528|P3|STARTED|Short Term (ST) + Long Term (LT) Period||181
121300|NCT00121667|289529|P2|STARTED|Short Term (ST) + Long Term (LT) Period||191
121301|NCT00121667|289530|P1|STARTED|Short Term (ST) + Long Term (LT) Period||192
121302|NCT00121667|289527|P4|NOT COMPLETED|Short Term (ST) Period||67
121303|NCT00121667|289528|P3|NOT COMPLETED|Short Term (ST) Period||41
121304|NCT00121667|289529|P2|NOT COMPLETED|Short Term (ST) Period||48
121305|NCT00121667|289530|P1|NOT COMPLETED|Short Term (ST) Period||44
121306|NCT00121667|289527|P4|COMPLETED|Short Term (ST) Period||112
121307|NCT00121667|289528|P3|COMPLETED|Short Term (ST) Period||140
121308|NCT00121667|289529|P2|COMPLETED|Short Term (ST) Period||143
121309|NCT00121667|289530|P1|COMPLETED|Short Term (ST) Period||148
121310|NCT00121667|289527|P4|STARTED|Short Term (ST) Period||179
121311|NCT00121667|289528|P3|STARTED|Short Term (ST) Period||181
121312|NCT00121667|289529|P2|STARTED|Short Term (ST) Period||191
121313|NCT00121667|289530|P1|STARTED|Short Term (ST) Period||192
121314|NCT00121719|289638|P14|NOT COMPLETED|Overall Study||7
121315|NCT00121719|289639|P13|NOT COMPLETED|Overall Study||24
121316|NCT00121719|289640|P12|NOT COMPLETED|Overall Study||5
121317|NCT00121719|289641|P11|NOT COMPLETED|Overall Study||6
121318|NCT00121719|289642|P10|NOT COMPLETED|Overall Study||3
121319|NCT00121719|289643|P9|NOT COMPLETED|Overall Study||6
121320|NCT00121719|289644|P8|NOT COMPLETED|Overall Study||9
121321|NCT00121719|289645|P7|NOT COMPLETED|Overall Study||12
121322|NCT00121719|289646|P6|NOT COMPLETED|Overall Study||3
121323|NCT00121719|289647|P5|NOT COMPLETED|Overall Study||3
121324|NCT00121719|289648|P4|NOT COMPLETED|Overall Study||3
121325|NCT00121719|289649|P3|NOT COMPLETED|Overall Study||4
121326|NCT00121719|289650|P2|NOT COMPLETED|Overall Study||4
121327|NCT00121719|289651|P1|NOT COMPLETED|Overall Study||4
121328|NCT00121719|289638|P14|COMPLETED|Overall Study||0
121329|NCT00121719|289639|P13|COMPLETED|Overall Study||0
121330|NCT00121719|289640|P12|COMPLETED|Overall Study||0
121331|NCT00121719|289641|P11|COMPLETED|Overall Study||0
121332|NCT00121719|289642|P10|COMPLETED|Overall Study||0
121333|NCT00121719|289643|P9|COMPLETED|Overall Study||0
121334|NCT00121719|289644|P8|COMPLETED|Overall Study||0
121335|NCT00121719|289645|P7|COMPLETED|Overall Study||0
121336|NCT00121719|289646|P6|COMPLETED|Overall Study||0
121337|NCT00121719|289647|P5|COMPLETED|Overall Study||0
121338|NCT00121719|289648|P4|COMPLETED|Overall Study||0
121339|NCT00121719|289649|P3|COMPLETED|Overall Study||0
121340|NCT00121719|289650|P2|COMPLETED|Overall Study||0
121341|NCT00121719|289651|P1|COMPLETED|Overall Study||0
121342|NCT00121719|289638|P14|STARTED|Overall Study||7
121343|NCT00121719|289639|P13|STARTED|Overall Study||24
121344|NCT00121719|289640|P12|STARTED|Overall Study||5
121345|NCT00121719|289641|P11|STARTED|Overall Study||6
121346|NCT00121719|289642|P10|STARTED|Overall Study||3
121347|NCT00121719|289643|P9|STARTED|Overall Study||6
121348|NCT00121719|289644|P8|STARTED|Overall Study||9
121349|NCT00121719|289645|P7|STARTED|Overall Study||12
121350|NCT00121719|289646|P6|STARTED|Overall Study||3
121351|NCT00121719|289647|P5|STARTED|Overall Study||3
121352|NCT00121719|289648|P4|STARTED|Overall Study||3
121353|NCT00121719|289649|P3|STARTED|Overall Study||4
121355|NCT00121719|289651|P1|STARTED|Overall Study||4
121356|NCT00121810|289826|P2|NOT COMPLETED|Overall Study||39
121357|NCT00121810|289827|P1|NOT COMPLETED|Overall Study||30
121358|NCT00121810|289826|P2|COMPLETED|Overall Study||115
121359|NCT00121810|289827|P1|COMPLETED|Overall Study||121
121360|NCT00121810|289826|P2|Intent-to-Treat (ITT) Population|Overall Study||151
121361|NCT00121810|289827|P1|Intent-to-Treat (ITT) Population|Overall Study||148
121362|NCT00121810|289826|P2|Safety Population|Overall Study||153
121363|NCT00121810|289827|P1|Safety Population|Overall Study||148
121364|NCT00121810|289826|P2|STARTED|Overall Study||154
121365|NCT00121810|289827|P1|STARTED|Overall Study||151
121366|NCT00121836|289841|P1|NOT COMPLETED|Overall Study||55
121367|NCT00121836|289841|P1|COMPLETED|Overall Study||54
121368|NCT00121836|289841|P1|STARTED|Overall Study||109
121369|NCT00122109|289852|P2|NOT COMPLETED|Overall Study||7
121370|NCT00122109|289853|P1|NOT COMPLETED|Overall Study||6
121371|NCT00122109|289852|P2|COMPLETED|Overall Study||57
121372|NCT00122109|289853|P1|COMPLETED|Overall Study||55
121373|NCT00122109|289852|P2|STARTED|Overall Study|ITT|64
121374|NCT00122109|289853|P1|STARTED|Overall Study|ITT|61
121375|NCT00122135|289879|P2|NOT COMPLETED|Overall Study||0
121376|NCT00122135|289880|P1|NOT COMPLETED|Overall Study||3
121377|NCT00122135|289879|P2|COMPLETED|Overall Study||60
121378|NCT00122135|289880|P1|COMPLETED|Overall Study||57
121379|NCT00122135|289879|P2|STARTED|Overall Study||60
121380|NCT00122135|289880|P1|STARTED|Overall Study||60
121381|NCT00122187|289888|P2|NOT COMPLETED|Overall Study||2
121382|NCT00122187|289889|P1|NOT COMPLETED|Overall Study||2
121383|NCT00122187|289888|P2|COMPLETED|Overall Study||2
121384|NCT00122187|289889|P1|COMPLETED|Overall Study||2
121385|NCT00122187|289888|P2|Post-intervention Data Collection|Overall Study||2
121386|NCT00122187|289889|P1|Post-intervention Data Collection|Overall Study||2
121387|NCT00122187|289888|P2|Intervention Implemented|Overall Study||4
121388|NCT00122187|289889|P1|Intervention Implemented|Overall Study||3
121389|NCT00122187|289888|P2|Randomized to Intervention or Usual Care|Overall Study||4
121390|NCT00122187|289889|P1|Randomized to Intervention or Usual Care|Overall Study||4
121391|NCT00122187|289888|P2|Matched by Colonoscopy Volume|Overall Study||4
121392|NCT00122187|289889|P1|Matched by Colonoscopy Volume|Overall Study||4
121393|NCT00122187|289888|P2|STARTED|Overall Study||4
121394|NCT00122187|289889|P1|STARTED|Overall Study||4
121395|NCT00122317|289901|P1|NOT COMPLETED|Overall Study||11
121396|NCT00122317|289901|P1|COMPLETED|Overall Study||176
121397|NCT00122317|289901|P1|STARTED|Overall Study||187
121398|NCT00122369|289908|P3|NOT COMPLETED|Overall Study||0
121399|NCT00122369|289909|P2|NOT COMPLETED|Overall Study||0
121400|NCT00122369|289910|P1|NOT COMPLETED|Overall Study||0
121401|NCT00122369|289908|P3|COMPLETED|Overall Study||78
121402|NCT00122369|289909|P2|COMPLETED|Overall Study||82
121403|NCT00122369|289910|P1|COMPLETED|Overall Study||76
121404|NCT00122369|289908|P3|STARTED|Overall Study||78
121405|NCT00122369|289909|P2|STARTED|Overall Study||82
121406|NCT00122369|289910|P1|STARTED|Overall Study||76
121407|NCT00122382|290001|P3|NOT COMPLETED|Open-Label Study||26
121408|NCT00122382|290002|P2|NOT COMPLETED|Open-Label Study||0
121409|NCT00122382|290003|P1|NOT COMPLETED|Open-Label Study||0
121410|NCT00122382|290001|P3|COMPLETED|Open-Label Study||433
121411|NCT00122382|290002|P2|COMPLETED|Open-Label Study||0
121412|NCT00122382|290003|P1|COMPLETED|Open-Label Study||0
121413|NCT00122382|290001|P3|STARTED|Open-Label Study||459
121414|NCT00122382|290002|P2|STARTED|Open-Label Study||0
121415|NCT00122382|290003|P1|STARTED|Open-Label Study||0
121416|NCT00122382|290001|P3|NOT COMPLETED|Double-Blind Study||0
121417|NCT00122382|290002|P2|NOT COMPLETED|Double-Blind Study||28
121418|NCT00122382|290003|P1|NOT COMPLETED|Double-Blind Study||24
121419|NCT00122382|290001|P3|COMPLETED|Double-Blind Study||0
121420|NCT00122382|290002|P2|COMPLETED|Double-Blind Study||227
121421|NCT00122382|290003|P1|COMPLETED|Double-Blind Study||232
121422|NCT00122382|290001|P3|Treated|Double-Blind Study||0
121423|NCT00122382|290002|P2|Treated|Double-Blind Study||253
121424|NCT00122382|290003|P1|Treated|Double-Blind Study||256
121425|NCT00122382|290001|P3|STARTED|Double-Blind Study||0
121426|NCT00122382|290002|P2|STARTED|Double-Blind Study|participants randomized|255
121427|NCT00122382|290003|P1|STARTED|Double-Blind Study|participants randomized|256
121428|NCT00122447|290057|P4|NOT COMPLETED|Overall Study||3
121429|NCT00122447|290058|P3|NOT COMPLETED|Overall Study||1
121430|NCT00122447|290059|P2|NOT COMPLETED|Overall Study||5
121431|NCT00122447|290060|P1|NOT COMPLETED|Overall Study||1
121432|NCT00122447|290057|P4|COMPLETED|Overall Study||14
121433|NCT00122447|290058|P3|COMPLETED|Overall Study||16
121434|NCT00122447|290059|P2|COMPLETED|Overall Study||13
121435|NCT00122447|290060|P1|COMPLETED|Overall Study||17
121436|NCT00122447|290057|P4|STARTED|Overall Study||17
121437|NCT00122447|290058|P3|STARTED|Overall Study||17
121438|NCT00122447|290059|P2|STARTED|Overall Study||18
121439|NCT00122447|290060|P1|STARTED|Overall Study||18
121440|NCT00122460|290080|P2|NOT COMPLETED|Overall Study||1
121441|NCT00122460|290081|P1|NOT COMPLETED|Overall Study||7
121442|NCT00122460|290080|P2|COMPLETED|Overall Study||219
121443|NCT00122460|290081|P1|COMPLETED|Overall Study||215
121444|NCT00122460|290080|P2|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|220
121445|NCT00122460|290081|P1|STARTED|Overall Study|Intention To Treat population, treatment group as randomized|222
121446|NCT00122681|290105|P2|NOT COMPLETED|Overall Study||1521
121447|NCT00122681|290106|P1|NOT COMPLETED|Overall Study||1514
121448|NCT00122681|290105|P2|COMPLETED|Overall Study||7798
121449|NCT00122681|290106|P1|COMPLETED|Overall Study||7811
121450|NCT00122681|290105|P2|STARTED|Overall Study||9319
121451|NCT00122681|290106|P1|STARTED|Overall Study||9325
121452|NCT00122954|290180|P2|NOT COMPLETED|Overall Study||3
121453|NCT00122954|290181|P1|NOT COMPLETED|Overall Study||2
121454|NCT00122954|290180|P2|COMPLETED|Overall Study||18
121455|NCT00122954|290181|P1|COMPLETED|Overall Study||16
121456|NCT00122954|290180|P2|STARTED|Overall Study||21
121457|NCT00122954|290181|P1|STARTED|Overall Study||18
121458|NCT00122980|290191|P2|NOT COMPLETED|Overall Study||40
121459|NCT00122980|290192|P1|NOT COMPLETED|Overall Study||43
121460|NCT00122980|290191|P2|COMPLETED|Overall Study|Study terminated early|26
121461|NCT00122980|290192|P1|COMPLETED|Overall Study|Study terminated early|24
121462|NCT00122980|290191|P2|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 66|66
121463|NCT00122980|290192|P1|STARTED|Overall Study|Randomized sample: 67; Intent-to-treat sample: 67|67
121464|NCT00123123|290217|P3|NOT COMPLETED|Overall Study||0
121465|NCT00123123|290218|P2|NOT COMPLETED|Overall Study||0
121466|NCT00123123|290219|P1|NOT COMPLETED|Overall Study||0
121467|NCT00123123|290217|P3|COMPLETED|Overall Study||58
121468|NCT00123123|290218|P2|COMPLETED|Overall Study||58
121469|NCT00123123|290219|P1|COMPLETED|Overall Study||59
121470|NCT00123123|290217|P3|STARTED|Overall Study||58
121471|NCT00123123|290218|P2|STARTED|Overall Study||58
121472|NCT00123123|290219|P1|STARTED|Overall Study||59
121473|NCT00123162|290232|P2|NOT COMPLETED|Overall Study||0
121474|NCT00123162|290233|P1|NOT COMPLETED|Overall Study||0
121475|NCT00123162|290232|P2|COMPLETED|Overall Study||12
121476|NCT00123162|290233|P1|COMPLETED|Overall Study||13
121477|NCT00123162|290232|P2|STARTED|Overall Study||12
121478|NCT00123162|290233|P1|STARTED|Overall Study||13
121479|NCT00123409|290243|P2|NOT COMPLETED|Overall Study||3
121480|NCT00123409|290244|P1|NOT COMPLETED|Overall Study||4
121481|NCT00123409|290243|P2|COMPLETED|Overall Study||71
121482|NCT00123409|290244|P1|COMPLETED|Overall Study||68
121483|NCT00123409|290243|P2|STARTED|Overall Study||74
121484|NCT00123409|290244|P1|STARTED|Overall Study||72
121485|NCT00123422|290255|P3|NOT COMPLETED|Overall Study||10
121486|NCT00123422|290256|P2|NOT COMPLETED|Overall Study||6
121487|NCT00123422|290257|P1|NOT COMPLETED|Overall Study||4
121488|NCT00123422|290255|P3|COMPLETED|Overall Study||25
121489|NCT00123422|290256|P2|COMPLETED|Overall Study||27
121490|NCT00123422|290257|P1|COMPLETED|Overall Study||31
121491|NCT00123422|290255|P3|8-week Testing|Overall Study||27
121492|NCT00123422|290256|P2|8-week Testing|Overall Study||30
121493|NCT00123422|290257|P1|8-week Testing|Overall Study||32
121494|NCT00123422|290255|P3|STARTED|Overall Study||35
121495|NCT00123422|290256|P2|STARTED|Overall Study||33
121496|NCT00123422|290257|P1|STARTED|Overall Study||35
121497|NCT00123474|290272|P4|NOT COMPLETED|As Treated at Study Closure||167
121498|NCT00123474|290273|P3|NOT COMPLETED|As Treated at Study Closure||167
121499|NCT00123474|290274|P2|NOT COMPLETED|As Treated at Study Closure||163
121500|NCT00123474|290275|P1|NOT COMPLETED|As Treated at Study Closure||165
121501|NCT00123474|290272|P4|COMPLETED|As Treated at Study Closure||0
121502|NCT00123474|290273|P3|COMPLETED|As Treated at Study Closure|Randomized to 100 mg QD but received 50 mg BID.|0
121503|NCT00123474|290274|P2|COMPLETED|As Treated at Study Closure||0
121504|NCT00123474|290275|P1|COMPLETED|As Treated at Study Closure||0
121505|NCT00123474|290272|P4|STARTED|As Treated at Study Closure||167
121506|NCT00123474|290273|P3|STARTED|As Treated at Study Closure||167
121507|NCT00123474|290274|P2|STARTED|As Treated at Study Closure||163
121508|NCT00123474|290275|P1|STARTED|As Treated at Study Closure|Randomized to 50 mg BID but received 100 mg QD.|165
121509|NCT00123474|290272|P4|NOT COMPLETED|Randomized to Treatment||1
121510|NCT00123474|290273|P3|NOT COMPLETED|Randomized to Treatment||2
121511|NCT00123474|290274|P2|NOT COMPLETED|Randomized to Treatment||4
121512|NCT00123474|290275|P1|NOT COMPLETED|Randomized to Treatment||1
121513|NCT00123474|290272|P4|COMPLETED|Randomized to Treatment||167
121514|NCT00123474|290273|P3|COMPLETED|Randomized to Treatment||166
121515|NCT00123474|290274|P2|COMPLETED|Randomized to Treatment||163
121516|NCT00123474|290275|P1|COMPLETED|Randomized to Treatment||166
121517|NCT00123474|290272|P4|STARTED|Randomized to Treatment||168
121518|NCT00123474|290273|P3|STARTED|Randomized to Treatment||168
121519|NCT00123474|290274|P2|STARTED|Randomized to Treatment||167
121520|NCT00123474|290275|P1|STARTED|Randomized to Treatment||167
121521|NCT00123487|290368|P2|NOT COMPLETED|Treated With Study Drug||305
121522|NCT00123487|290369|P1|NOT COMPLETED|Treated With Study Drug||304
121523|NCT00123487|290368|P2|COMPLETED|Treated With Study Drug||0
121524|NCT00123487|290369|P1|COMPLETED|Treated With Study Drug||0
121525|NCT00123487|290368|P2|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 305 represents actual BID treatment.|305
121526|NCT00123487|290369|P1|STARTED|Treated With Study Drug|1 participant randomized to QD but received BID in error. 304 represents actual QD treatment.|304
121527|NCT00123487|290368|P2|NOT COMPLETED|Randomized||1
121528|NCT00123487|290369|P1|NOT COMPLETED|Randomized||1
121529|NCT00123487|290368|P2|COMPLETED|Randomized||304
121530|NCT00123487|290369|P1|COMPLETED|Randomized||305
121531|NCT00123487|290368|P2|STARTED|Randomized||305
121532|NCT00123487|290369|P1|STARTED|Randomized||306
121533|NCT00123604|290411|P2|NOT COMPLETED|Overall Study||1
121534|NCT00123604|290412|P1|NOT COMPLETED|Overall Study||1
121535|NCT00123604|290411|P2|COMPLETED|Overall Study||16
121536|NCT00123604|290412|P1|COMPLETED|Overall Study||18
121537|NCT00123604|290411|P2|STARTED|Overall Study||17
121538|NCT00123604|290412|P1|STARTED|Overall Study||19
121539|NCT00123630|290420|P2|NOT COMPLETED|Overall Study||0
121540|NCT00123630|290421|P1|NOT COMPLETED|Overall Study||0
121541|NCT00123630|290420|P2|COMPLETED|Overall Study||15
121542|NCT00123630|290421|P1|COMPLETED|Overall Study||15
121543|NCT00123630|290420|P2|STARTED|Overall Study||15
121544|NCT00123630|290421|P1|STARTED|Overall Study||15
121545|NCT00123643|290429|P2|NOT COMPLETED|Overall Study||0
121546|NCT00123643|290430|P1|NOT COMPLETED|Overall Study||0
121547|NCT00123643|290429|P2|COMPLETED|Overall Study||16
121548|NCT00123643|290430|P1|COMPLETED|Overall Study||20
121549|NCT00123643|290429|P2|STARTED|Overall Study||16
121550|NCT00123643|290430|P1|STARTED|Overall Study||20
121551|NCT00123682|290440|P4|NOT COMPLETED|Overall Study||95
121552|NCT00123682|290441|P3|NOT COMPLETED|Overall Study||154
121553|NCT00123682|290442|P2|NOT COMPLETED|Overall Study||203
121554|NCT00123682|290443|P1|NOT COMPLETED|Overall Study||320
121555|NCT00123682|290440|P4|COMPLETED|Overall Study||430
121556|NCT00123682|290441|P3|COMPLETED|Overall Study||438
121557|NCT00123682|290442|P2|COMPLETED|Overall Study||731
121558|NCT00123682|290443|P1|COMPLETED|Overall Study||749
121559|NCT00123682|290440|P4|STARTED|Overall Study||525
121560|NCT00123682|290441|P3|STARTED|Overall Study||592
121561|NCT00123682|290442|P2|STARTED|Overall Study||934
121562|NCT00123682|290443|P1|STARTED|Overall Study||1069
121563|NCT00123734|290461|P1|NOT COMPLETED|Overall Study||8
121564|NCT00123734|290461|P1|COMPLETED|Overall Study||74
121565|NCT00123734|290461|P1|STARTED|Overall Study||82
121566|NCT00123955|290494|P2|NOT COMPLETED|Overall Study||4
121567|NCT00123955|290495|P1|NOT COMPLETED|Overall Study||5
121568|NCT00123955|290494|P2|COMPLETED|Overall Study||34
121569|NCT00123955|290495|P1|COMPLETED|Overall Study||37
121570|NCT00123955|290494|P2|STARTED|Overall Study||38
121571|NCT00123955|290495|P1|STARTED|Overall Study||42
121572|NCT00117156|290501|P1|NOT COMPLETED|Overall Study||11
121573|NCT00117156|290501|P1|COMPLETED|Overall Study||15
121574|NCT00117156|290501|P1|STARTED|Overall Study||26
121575|NCT00117286|290511|P2|NOT COMPLETED|Overall Study||21
121576|NCT00117286|290512|P1|NOT COMPLETED|Overall Study||28
121577|NCT00117286|290511|P2|COMPLETED|Overall Study||6
121578|NCT00117286|290512|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|2
121579|NCT00117286|290511|P2|Switched to Higher Dose|Overall Study||17
121580|NCT00117286|290512|P1|Switched to Higher Dose|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL)|17
121581|NCT00117286|290511|P2|STARTED|Overall Study||27
121582|NCT00117286|290512|P1|STARTED|Overall Study|Safety analysis set|30
121583|NCT00117312|290524|P4|NOT COMPLETED|Overall Study||21
121584|NCT00117312|290525|P3|NOT COMPLETED|Overall Study||24
121585|NCT00117312|290526|P2|NOT COMPLETED|Overall Study||20
121586|NCT00117312|290527|P1|NOT COMPLETED|Overall Study||10
121587|NCT00117312|290524|P4|COMPLETED|Overall Study||3
121588|NCT00117312|290525|P3|COMPLETED|Overall Study||0
121589|NCT00117312|290526|P2|COMPLETED|Overall Study|Defined as those patients ongoing when the extension study was terminated|4
121590|NCT00117312|290527|P1|COMPLETED|Overall Study||0
121591|NCT00117312|290524|P4|Started FE200486 CS06A|Overall Study||9
121592|NCT00117312|290525|P3|Started FE200486 CS06A|Overall Study||16
121593|NCT00117312|290526|P2|Started FE200486 CS06A|Overall Study||11
121594|NCT00117312|290527|P1|Started FE200486 CS06A|Overall Study||1
121595|NCT00117312|290524|P4|STARTED|Overall Study||24
121596|NCT00117312|290525|P3|STARTED|Overall Study||24
121597|NCT00117312|290526|P2|STARTED|Overall Study||24
121598|NCT00117312|290527|P1|STARTED|Overall Study||10
121599|NCT00117338|290543|P2|NOT COMPLETED|Overall Study||4
121600|NCT00117338|290544|P1|NOT COMPLETED|Overall Study||5
121601|NCT00117338|290543|P2|COMPLETED|Overall Study||127
121602|NCT00117338|290544|P1|COMPLETED|Overall Study||140
121603|NCT00117338|290543|P2|STARTED|Overall Study||131
121604|NCT00117338|290544|P1|STARTED|Overall Study||145
121605|NCT00117559|290564|P2|NOT COMPLETED|Overall Study||1
121606|NCT00117559|290565|P1|NOT COMPLETED|Overall Study||1
121607|NCT00117559|290564|P2|COMPLETED|Overall Study||9
121608|NCT00117559|290565|P1|COMPLETED|Overall Study||8
121609|NCT00117559|290564|P2|STARTED|Overall Study||10
121610|NCT00117559|290565|P1|STARTED|Overall Study||9
121611|NCT00117585|290571|P1|NOT COMPLETED|Overall Study||0
121612|NCT00117585|290571|P1|COMPLETED|Overall Study||341
121613|NCT00117585|290571|P1|STARTED|Overall Study||341
121614|NCT00117598|290578|P5|NOT COMPLETED|After Treament Cross Over||4
121615|NCT00117598|290579|P4|NOT COMPLETED|After Treament Cross Over||3
121616|NCT00117598|290580|P3|NOT COMPLETED|After Treament Cross Over||0
121617|NCT00117598|290581|P2|NOT COMPLETED|After Treament Cross Over||0
121618|NCT00117598|290582|P1|NOT COMPLETED|After Treament Cross Over||0
121619|NCT00117598|290578|P5|COMPLETED|After Treament Cross Over||0
121620|NCT00117598|290579|P4|COMPLETED|After Treament Cross Over||0
121621|NCT00117598|290580|P3|COMPLETED|After Treament Cross Over||0
121622|NCT00117598|290581|P2|COMPLETED|After Treament Cross Over||0
121623|NCT00117598|290582|P1|COMPLETED|After Treament Cross Over||0
121624|NCT00117598|290578|P5|STARTED|After Treament Cross Over||4
121625|NCT00117598|290579|P4|STARTED|After Treament Cross Over||3
121626|NCT00117598|290580|P3|STARTED|After Treament Cross Over||0
121627|NCT00117598|290581|P2|STARTED|After Treament Cross Over||0
121628|NCT00117598|290582|P1|STARTED|After Treament Cross Over||0
121629|NCT00117598|290578|P5|NOT COMPLETED|Prior to Treatment Cross Over||0
121630|NCT00117598|290579|P4|NOT COMPLETED|Prior to Treatment Cross Over||0
121631|NCT00117598|290580|P3|NOT COMPLETED|Prior to Treatment Cross Over||52
121632|NCT00117598|290581|P2|NOT COMPLETED|Prior to Treatment Cross Over||53
121633|NCT00117598|290582|P1|NOT COMPLETED|Prior to Treatment Cross Over||57
121634|NCT00117598|290578|P5|COMPLETED|Prior to Treatment Cross Over||0
121635|NCT00117598|290579|P4|COMPLETED|Prior to Treatment Cross Over||0
121636|NCT00117598|290580|P3|COMPLETED|Prior to Treatment Cross Over||4
121637|NCT00117598|290581|P2|COMPLETED|Prior to Treatment Cross Over||3
121638|NCT00117598|290582|P1|COMPLETED|Prior to Treatment Cross Over||0
121639|NCT00117598|290578|P5|STARTED|Prior to Treatment Cross Over||0
121640|NCT00117598|290579|P4|STARTED|Prior to Treatment Cross Over||0
121641|NCT00117598|290580|P3|STARTED|Prior to Treatment Cross Over||56
121642|NCT00117598|290581|P2|STARTED|Prior to Treatment Cross Over||56
121643|NCT00117598|290582|P1|STARTED|Prior to Treatment Cross Over||57
121644|NCT00117637|290612|P2|NOT COMPLETED|Second Intervention (Period 2)||22
121645|NCT00117637|290613|P1|NOT COMPLETED|Second Intervention (Period 2)||10
121646|NCT00117637|290612|P2|COMPLETED|Second Intervention (Period 2)||39
121647|NCT00117637|290613|P1|COMPLETED|Second Intervention (Period 2)||39
121648|NCT00117637|290612|P2|Subjects Received Treatment|Second Intervention (Period 2)||61
121649|NCT00117637|290613|P1|Subjects Received Treatment|Second Intervention (Period 2)||49
121650|NCT00117637|290612|P2|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|61
121651|NCT00117637|290613|P1|STARTED|Second Intervention (Period 2)|Not all patients who completed Period 1 (first progression) enter into Period 2|49
121652|NCT00117637|290612|P2|NOT COMPLETED|First Intervention (Period 1)||25
121653|NCT00117637|290613|P1|NOT COMPLETED|First Intervention (Period 1)||18
121654|NCT00117637|290612|P2|COMPLETED|First Intervention (Period 1)||67
121655|NCT00117637|290613|P1|COMPLETED|First Intervention (Period 1)||79
121656|NCT00117637|290612|P2|Subjects Received Treatment|First Intervention (Period 1)||90
121657|NCT00117637|290613|P1|Subjects Received Treatment|First Intervention (Period 1)||97
121658|NCT00117637|290612|P2|STARTED|First Intervention (Period 1)||92
121659|NCT00117637|290613|P1|STARTED|First Intervention (Period 1)||97
121660|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
121661|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 433 - 480||2
121662|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 433 - 480||41
121663|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 433 - 480||80
121664|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 433 - 480|1 participant completed 432 weeks but did not continue on study.|43
121665|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 433 - 480||82
121666|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 385 - 432||2
121667|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 385 - 432||0
121668|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 385 - 432||44
121669|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 385 - 432||82
121670|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 385 - 432|44 participants completed 384 weeks but did not continue on study.|46
121671|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 385 - 432|94 participants completed 384 weeks but did not continue on study.|82
121672|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 337 - 384||3
121673|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 337 - 384||7
121674|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 337 - 384||90
121675|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 337 - 384||176
121676|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 337 - 384||93
121677|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 337 - 384||183
121678|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 289 - 336||7
121679|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 289 - 336||9
121680|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 289 - 336||93
121681|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 289 - 336||183
121682|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 289 - 336||100
121683|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 289 - 336||192
121684|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 241 - 288||3
121685|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 241 - 288||10
121686|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 241 - 288||100
121687|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 241 - 288||192
121688|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 241 - 288||103
121689|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 241 - 288||202
121690|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 193 - 240||3
121691|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 193 - 240||7
121692|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 193 - 240||103
121693|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 193 - 240||202
121694|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 193 - 240||106
121695|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 193 - 240||209
121696|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 145 - 192||3
121697|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 145 - 192||10
121698|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 145 - 192||106
121699|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 145 - 192||209
121700|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 145 - 192||109
121701|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 145 - 192||219
121702|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 97 - 144||1
121703|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 97 - 144||6
121704|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 97 - 144||109
121705|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 97 - 144||219
121706|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 97 - 144||110
121707|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 97 - 144||225
121708|NCT00117676|290687|P2|NOT COMPLETED|Open-label Period: Weeks 49 - 96||2
121709|NCT00117676|290688|P1|NOT COMPLETED|Open-label Period: Weeks 49 - 96||10
121710|NCT00117676|290687|P2|COMPLETED|Open-label Period: Weeks 49 - 96||110
121711|NCT00117676|290688|P1|COMPLETED|Open-label Period: Weeks 49 - 96||225
121712|NCT00117676|290687|P2|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|112
121713|NCT00117676|290688|P1|STARTED|Open-label Period: Weeks 49 - 96|9 participants completed 48 weeks but did not continue on study.|235
121714|NCT00117676|290687|P2|NOT COMPLETED|Double-blind Period Through Week 48||7
121715|NCT00117676|290688|P1|NOT COMPLETED|Double-blind Period Through Week 48||10
121716|NCT00117676|290687|P2|COMPLETED|Double-blind Period Through Week 48||121
121717|NCT00117676|290688|P1|COMPLETED|Double-blind Period Through Week 48||244
121718|NCT00117676|290687|P2|STARTED|Double-blind Period Through Week 48||128
121719|NCT00117676|290688|P1|STARTED|Double-blind Period Through Week 48||254
121720|NCT00117715|290775|P1|NOT COMPLETED|Overall Study||72
121721|NCT00117715|290775|P1|COMPLETED|Overall Study||49
121722|NCT00117715|290775|P1|5 Year|Overall Study||49
121723|NCT00117715|290775|P1|4.5 Year|Overall Study||55
121724|NCT00117715|290775|P1|4 Year|Overall Study||58
121725|NCT00117715|290775|P1|3.5 Year|Overall Study||60
121726|NCT00117715|290775|P1|3 Year|Overall Study||61
121727|NCT00117715|290775|P1|2.5 Year|Overall Study||70
121728|NCT00117715|290775|P1|2 Year|Overall Study||76
121729|NCT00117715|290775|P1|1.5 Year|Overall Study||85
121730|NCT00117715|290775|P1|1 Year|Overall Study||88
121731|NCT00117715|290775|P1|STARTED|Overall Study||121
121732|NCT00117793|290781|P1|NOT COMPLETED|Overall Study||12
121733|NCT00117793|290781|P1|COMPLETED|Overall Study||5
121734|NCT00117793|290781|P1|STARTED|Overall Study||17
121735|NCT00117806|290798|P2|NOT COMPLETED|Overall Study||16
121736|NCT00117806|290799|P1|NOT COMPLETED|Overall Study||38
121737|NCT00117806|290798|P2|COMPLETED|Overall Study||60
121738|NCT00117806|290799|P1|COMPLETED|Overall Study||43
121739|NCT00117806|290798|P2|STARTED|Overall Study||76
121740|NCT00117806|290799|P1|STARTED|Overall Study||81
121741|NCT00117845|290809|P1|NOT COMPLETED|Overall Study||1
121742|NCT00117845|290809|P1|COMPLETED|Overall Study||16
121743|NCT00117845|290809|P1|STARTED|Overall Study||17
121744|NCT00117949|290818|P4|NOT COMPLETED|Overall Study||24
121745|NCT00117949|290819|P3|NOT COMPLETED|Overall Study||24
121746|NCT00117949|290820|P2|NOT COMPLETED|Overall Study||24
121747|NCT00117949|290821|P1|NOT COMPLETED|Overall Study||10
121748|NCT00117949|290818|P4|COMPLETED|Overall Study||0
121749|NCT00117949|290819|P3|COMPLETED|Overall Study||0
121750|NCT00117949|290820|P2|COMPLETED|Overall Study||0
121751|NCT00117949|290821|P1|COMPLETED|Overall Study||0
121752|NCT00117949|290818|P4|STARTED|Overall Study||24
121753|NCT00117949|290819|P3|STARTED|Overall Study||24
121754|NCT00117949|290820|P2|STARTED|Overall Study||24
121755|NCT00117949|290821|P1|STARTED|Overall Study|Dose level terminated prematurely due to inadequate testosterone response|10
121756|NCT00117962|290857|P2|NOT COMPLETED|Overall Study||25
121757|NCT00117962|290858|P1|NOT COMPLETED|Overall Study||22
121758|NCT00117962|290857|P2|COMPLETED|Overall Study||28
121759|NCT00117962|290858|P1|COMPLETED|Overall Study||26
121760|NCT00117962|290857|P2|STARTED|Overall Study||53
121761|NCT00117962|290858|P1|STARTED|Overall Study||48
121762|NCT00117988|290870|P1|NOT COMPLETED|Overall Study||4
121763|NCT00117988|290870|P1|COMPLETED|Overall Study||18
121764|NCT00117988|290870|P1|STARTED|Overall Study||22
121765|NCT00118040|290877|P3|NOT COMPLETED|Overall Study||6
121766|NCT00118040|290878|P2|NOT COMPLETED|Overall Study||2
121767|NCT00118040|290879|P1|NOT COMPLETED|Overall Study||1
121768|NCT00118040|290877|P3|COMPLETED|Overall Study||14
121769|NCT00118040|290878|P2|COMPLETED|Overall Study||18
121770|NCT00118040|290879|P1|COMPLETED|Overall Study||19
121771|NCT00118040|290877|P3|STARTED|Overall Study||20
121772|NCT00118040|290878|P2|STARTED|Overall Study||20
121773|NCT00118040|290879|P1|STARTED|Overall Study||20
121774|NCT00118053|290940|P1|NOT COMPLETED|Overall Study||0
121775|NCT00118053|290940|P1|COMPLETED|Overall Study||5
121776|NCT00118053|290940|P1|STARTED|Overall Study||5
121777|NCT00124020|290949|P2|NOT COMPLETED|Overall Study||91
121778|NCT00124020|290950|P1|NOT COMPLETED|Overall Study||88
121779|NCT00124020|290949|P2|COMPLETED|Overall Study||289
121780|NCT00124020|290950|P1|COMPLETED|Overall Study||289
121781|NCT00124020|290949|P2|STARTED|Overall Study||380
121782|NCT00124020|290950|P1|STARTED|Overall Study||377
121783|NCT00124072|290960|P4|NOT COMPLETED|Overall Study||500
121784|NCT00124072|290961|P3|NOT COMPLETED|Overall Study||492
121785|NCT00124072|290962|P2|NOT COMPLETED|Overall Study||512
121786|NCT00124072|290963|P1|NOT COMPLETED|Overall Study||514
121787|NCT00124072|290960|P4|COMPLETED|Overall Study||2515
121788|NCT00124072|290961|P3|COMPLETED|Overall Study||2524
121789|NCT00124072|290962|P2|COMPLETED|Overall Study||2504
121790|NCT00124072|290963|P1|COMPLETED|Overall Study||2503
121791|NCT00124072|290960|P4|STARTED|Overall Study||3015
121792|NCT00124072|290961|P3|STARTED|Overall Study||3016
121793|NCT00124072|290962|P2|STARTED|Overall Study||3016
121794|NCT00124072|290963|P1|STARTED|Overall Study||3017
121795|NCT00124176|290975|P2|NOT COMPLETED|Overall Study||0
121796|NCT00124176|290976|P1|NOT COMPLETED|Overall Study||0
121797|NCT00124176|290975|P2|COMPLETED|Overall Study||41
121798|NCT00124176|290976|P1|COMPLETED|Overall Study||40
121799|NCT00124176|290975|P2|Received Study Drug|Overall Study||41
121800|NCT00124176|290976|P1|Received Study Drug|Overall Study|3 never started on drug due to improvement but were kept in the study by intention to treat.|37
121801|NCT00124176|290975|P2|STARTED|Overall Study||41
121802|NCT00124176|290976|P1|STARTED|Overall Study||40
121803|NCT00124579|290990|P1|NOT COMPLETED|Maintenance||2
121804|NCT00124579|290990|P1|COMPLETED|Maintenance||0
121805|NCT00124579|290990|P1|STARTED|Maintenance||2
121806|NCT00124579|290990|P1|NOT COMPLETED|Induction||5
121807|NCT00124579|290990|P1|COMPLETED|Induction||2
121808|NCT00124579|290990|P1|STARTED|Induction||7
121809|NCT00124618|290996|P1|NOT COMPLETED|Overall Study||1
121810|NCT00124618|290996|P1|COMPLETED|Overall Study||57
121811|NCT00124618|290996|P1|STARTED|Overall Study||58
121812|NCT00124657|291006|P3|NOT COMPLETED|Overall Study||32
121813|NCT00124657|291007|P2|NOT COMPLETED|Overall Study||5
121814|NCT00124657|291008|P1|NOT COMPLETED|Overall Study||16
121815|NCT00124657|291006|P3|COMPLETED|Overall Study||7
121816|NCT00124657|291007|P2|COMPLETED|Overall Study||0
121817|NCT00124657|291008|P1|COMPLETED|Overall Study||2
121818|NCT00124657|291006|P3|STARTED|Overall Study||39
121819|NCT00124657|291007|P2|STARTED|Overall Study||5
121820|NCT00124657|291008|P1|STARTED|Overall Study||18
121821|NCT00124709|291045|P2|NOT COMPLETED|Overall Study||272
121822|NCT00124709|291046|P1|NOT COMPLETED|Overall Study||255
121823|NCT00124709|291045|P2|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|273
121824|NCT00124709|291046|P1|COMPLETED|Overall Study|232 Participants entered the OL phase of the study.|291
121825|NCT00124709|291045|P2|Patients Who Received Study Medication|Overall Study||544
121826|NCT00124709|291046|P1|Patients Who Received Study Medication|Overall Study||543
121827|NCT00124709|291045|P2|STARTED|Overall Study||545
121828|NCT00124709|291046|P1|STARTED|Overall Study||546
121829|NCT00124735|291070|P10|NOT COMPLETED|Overall Study||2
121830|NCT00124735|291071|P9|NOT COMPLETED|Overall Study||3
121831|NCT00124735|291072|P8|NOT COMPLETED|Overall Study||1
121832|NCT00124735|291073|P7|NOT COMPLETED|Overall Study||0
121833|NCT00124735|291074|P6|NOT COMPLETED|Overall Study||2
121834|NCT00124735|291075|P5|NOT COMPLETED|Overall Study||2
121835|NCT00124735|291076|P4|NOT COMPLETED|Overall Study||3
121836|NCT00124735|291077|P3|NOT COMPLETED|Overall Study||0
121837|NCT00124735|291078|P2|NOT COMPLETED|Overall Study||2
121838|NCT00124735|291079|P1|NOT COMPLETED|Overall Study||1
121839|NCT00124735|291070|P10|COMPLETED|Overall Study||18
121840|NCT00124735|291071|P9|COMPLETED|Overall Study||22
121841|NCT00124735|291072|P8|COMPLETED|Overall Study||19
121842|NCT00124735|291073|P7|COMPLETED|Overall Study||6
121843|NCT00124735|291074|P6|COMPLETED|Overall Study||5
121844|NCT00124735|291075|P5|COMPLETED|Overall Study||17
121845|NCT00124735|291076|P4|COMPLETED|Overall Study||18
121846|NCT00124735|291077|P3|COMPLETED|Overall Study||18
121847|NCT00124735|291078|P2|COMPLETED|Overall Study||6
121848|NCT00124735|291079|P1|COMPLETED|Overall Study||4
121849|NCT00124735|291070|P10|STARTED|Overall Study||20
121850|NCT00124735|291071|P9|STARTED|Overall Study||25
121851|NCT00124735|291072|P8|STARTED|Overall Study||20
121852|NCT00124735|291073|P7|STARTED|Overall Study||6
121853|NCT00124735|291074|P6|STARTED|Overall Study||7
121854|NCT00124735|291075|P5|STARTED|Overall Study||19
121855|NCT00124735|291076|P4|STARTED|Overall Study||21
121856|NCT00124735|291077|P3|STARTED|Overall Study||18
121857|NCT00124735|291078|P2|STARTED|Overall Study||8
121858|NCT00124735|291079|P1|STARTED|Overall Study||5
121859|NCT00124748|291125|P2|NOT COMPLETED|Overall Study||284
121860|NCT00124748|291126|P1|NOT COMPLETED|Overall Study||143
121861|NCT00124748|291125|P2|COMPLETED|Overall Study||35
121862|NCT00124748|291126|P1|COMPLETED|Overall Study||14
121863|NCT00124748|291125|P2|Safety Population|Overall Study||316
121864|NCT00124748|291126|P1|Safety Population|Overall Study||157
121865|NCT00124748|291125|P2|STARTED|Overall Study||319
121866|NCT00124748|291126|P1|STARTED|Overall Study||157
121867|NCT00124943|291172|P4|NOT COMPLETED|Phase II||5
121868|NCT00124943|291173|P3|NOT COMPLETED|Phase II||0
121869|NCT00124943|291174|P2|NOT COMPLETED|Phase II||2
121870|NCT00124943|291175|P1|NOT COMPLETED|Phase II||0
121871|NCT00124943|291172|P4|COMPLETED|Phase II||50
121872|NCT00124943|291173|P3|COMPLETED|Phase II||3
121873|NCT00124943|291174|P2|COMPLETED|Phase II||49
121874|NCT00124943|291175|P1|COMPLETED|Phase II||3
121875|NCT00124943|291172|P4|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|55
121876|NCT00124943|291173|P3|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
121877|NCT00124943|291174|P2|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|51
121878|NCT00124943|291175|P1|STARTED|Phase II|Includes participants from Phase I who were followed for efficacy but not retreated in Phase II.|3
121879|NCT00124943|291172|P4|NOT COMPLETED|Phase I||0
121880|NCT00124943|291173|P3|NOT COMPLETED|Phase I||0
121881|NCT00124943|291174|P2|NOT COMPLETED|Phase I||0
121882|NCT00124943|291175|P1|NOT COMPLETED|Phase I||0
121883|NCT00124943|291172|P4|COMPLETED|Phase I||3
121884|NCT00124943|291173|P3|COMPLETED|Phase I||3
121885|NCT00124943|291174|P2|COMPLETED|Phase I||3
121886|NCT00124943|291175|P1|COMPLETED|Phase I||3
121887|NCT00124943|291172|P4|STARTED|Phase I||3
121888|NCT00124943|291173|P3|STARTED|Phase I||3
121889|NCT00124943|291174|P2|STARTED|Phase I||3
121890|NCT00124943|291175|P1|STARTED|Phase I||3
121891|NCT00124982|291215|P3|NOT COMPLETED|Long-term Period||89
121892|NCT00124982|291216|P2|NOT COMPLETED|Long-term Period||0
121893|NCT00124982|291217|P1|NOT COMPLETED|Long-term Period||0
121894|NCT00124982|291215|P3|COMPLETED|Long-term Period||441
121895|NCT00124982|291216|P2|COMPLETED|Long-term Period||0
121896|NCT00124982|291217|P1|COMPLETED|Long-term Period||0
121897|NCT00124982|291215|P3|STARTED|Long-term Period|A large number did not continue due to a rollover from study drug to commercially available drug.|530
121898|NCT00124982|291216|P2|STARTED|Long-term Period||0
121899|NCT00124982|291217|P1|STARTED|Long-term Period||0
121900|NCT00124982|291215|P3|NOT COMPLETED|Short-term Period||0
121901|NCT00124982|291216|P2|NOT COMPLETED|Short-term Period||114
121902|NCT00124982|291217|P1|NOT COMPLETED|Short-term Period||72
121903|NCT00124982|291215|P3|COMPLETED|Short-term Period||0
121904|NCT00124982|291216|P2|COMPLETED|Short-term Period||483
121905|NCT00124982|291217|P1|COMPLETED|Short-term Period||377
121906|NCT00124982|291215|P3|STARTED|Short-term Period||0
121907|NCT00124982|291216|P2|STARTED|Short-term Period||597
121908|NCT00124982|291217|P1|STARTED|Short-term Period||449
121909|NCT00125034|291297|P2|NOT COMPLETED|Overall Study||0
121910|NCT00125034|291298|P1|NOT COMPLETED|Overall Study||0
121911|NCT00125034|291297|P2|COMPLETED|Overall Study||168
121912|NCT00125034|291298|P1|COMPLETED|Overall Study||170
121913|NCT00125034|291297|P2|STARTED|Overall Study|Randomized & treated|168
121914|NCT00125034|291298|P1|STARTED|Overall Study|Randomized & treated. 1 subject was not randomized correctly and was excluded in the ITT population.|170
121915|NCT00125138|291332|P4|NOT COMPLETED|Overall Study||5
121916|NCT00125138|291333|P3|NOT COMPLETED|Overall Study||4
121917|NCT00125138|291334|P2|NOT COMPLETED|Overall Study||3
121918|NCT00125138|291335|P1|NOT COMPLETED|Overall Study||3
121919|NCT00125138|291332|P4|COMPLETED|Overall Study||25
121920|NCT00125138|291333|P3|COMPLETED|Overall Study||21
121921|NCT00125138|291334|P2|COMPLETED|Overall Study||17
121922|NCT00125138|291335|P1|COMPLETED|Overall Study||12
121923|NCT00125138|291332|P4|STARTED|Overall Study||30
121924|NCT00125138|291333|P3|STARTED|Overall Study||25
121925|NCT00125138|291334|P2|STARTED|Overall Study|One subject requested withdrawal prior to treatment; data for the subject are excluded from results.|20
121926|NCT00125138|291335|P1|STARTED|Overall Study||15
121927|NCT00125164|291353|P4|NOT COMPLETED|Overall Study||6
121928|NCT00125164|291354|P3|NOT COMPLETED|Overall Study||4
121929|NCT00125164|291355|P2|NOT COMPLETED|Overall Study||0
121930|NCT00125164|291356|P1|NOT COMPLETED|Overall Study||2
121931|NCT00125164|291353|P4|COMPLETED|Overall Study||45
121932|NCT00125164|291354|P3|COMPLETED|Overall Study||40
121933|NCT00125164|291355|P2|COMPLETED|Overall Study||16
121934|NCT00125164|291356|P1|COMPLETED|Overall Study||23
121935|NCT00125164|291353|P4|STARTED|Overall Study||51
121936|NCT00125164|291354|P3|STARTED|Overall Study||44
121937|NCT00125164|291355|P2|STARTED|Overall Study||16
121938|NCT00125164|291356|P1|STARTED|Overall Study||25
121939|NCT00125190|291406|P1|NOT COMPLETED|Overall Study||15
121940|NCT00125190|291406|P1|COMPLETED|Overall Study||30
121941|NCT00125190|291406|P1|STARTED|Overall Study||45
121942|NCT00125242|291422|P2|NOT COMPLETED|Overall Study||2
121943|NCT00125242|291423|P1|NOT COMPLETED|Overall Study||7
121944|NCT00125242|291422|P2|COMPLETED|Overall Study||14
121945|NCT00125242|291423|P1|COMPLETED|Overall Study||87
121946|NCT00125242|291422|P2|STARTED|Overall Study||16
121947|NCT00125242|291423|P1|STARTED|Overall Study||94
121948|NCT00125268|291430|P2|NOT COMPLETED|Overall Study||1
121949|NCT00125268|291431|P1|NOT COMPLETED|Overall Study||1
121950|NCT00125268|291430|P2|COMPLETED|Overall Study||13
121951|NCT00125268|291431|P1|COMPLETED|Overall Study||15
121952|NCT00125268|291430|P2|STARTED|Overall Study||14
121953|NCT00125268|291431|P1|STARTED|Overall Study||16
121954|NCT00125515|291444|P3|NOT COMPLETED|Overall Study||21
121955|NCT00125515|291445|P2|NOT COMPLETED|Overall Study||20
121956|NCT00125515|291446|P1|NOT COMPLETED|Overall Study||20
121957|NCT00125515|291444|P3|COMPLETED|Overall Study||6
121958|NCT00125515|291445|P2|COMPLETED|Overall Study||7
121959|NCT00125515|291446|P1|COMPLETED|Overall Study||7
121960|NCT00125515|291444|P3|STARTED|Overall Study||27
121961|NCT00125515|291445|P2|STARTED|Overall Study||27
121962|NCT00125515|291446|P1|STARTED|Overall Study||27
121963|NCT00125528|291456|P2|NOT COMPLETED|Overall Study||1
121964|NCT00125528|291457|P1|NOT COMPLETED|Overall Study||2
121965|NCT00125528|291456|P2|COMPLETED|Overall Study||20
121966|NCT00125528|291457|P1|COMPLETED|Overall Study||18
121967|NCT00125528|291456|P2|STARTED|Overall Study||21
121968|NCT00125528|291457|P1|STARTED|Overall Study||20
121969|NCT00125593|291467|P2|NOT COMPLETED|Overall Study||103
121970|NCT00125593|291468|P1|NOT COMPLETED|Overall Study||101
121971|NCT00125593|291467|P2|COMPLETED|Overall Study||4517
121972|NCT00125593|291468|P1|COMPLETED|Overall Study||4549
121973|NCT00125593|291467|P2|STARTED|Overall Study||4620
121974|NCT00125593|291468|P1|STARTED|Overall Study||4650
121975|NCT00125619|291488|P2|NOT COMPLETED|Overall Study||0
121976|NCT00125619|291489|P1|NOT COMPLETED|Overall Study||0
121977|NCT00125619|291488|P2|COMPLETED|Overall Study||8
121978|NCT00125619|291489|P1|COMPLETED|Overall Study||8
121979|NCT00125619|291488|P2|STARTED|Overall Study||8
121980|NCT00125619|291489|P1|STARTED|Overall Study||8
121981|NCT00125658|291509|P2|NOT COMPLETED|Overall Study||0
121982|NCT00125658|291510|P1|NOT COMPLETED|Overall Study||0
121983|NCT00125658|291509|P2|COMPLETED|Overall Study||6
121984|NCT00125658|291510|P1|COMPLETED|Overall Study||8
121985|NCT00125658|291509|P2|STARTED|Overall Study||6
121986|NCT00125658|291510|P1|STARTED|Overall Study||8
121987|NCT00125931|291528|P1|NOT COMPLETED|Overall Study||0
121988|NCT00125931|291528|P1|COMPLETED|Overall Study||10
121989|NCT00125931|291528|P1|STARTED|Overall Study||10
121990|NCT00125957|291535|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
121991|NCT00125957|291536|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
121992|NCT00125957|291535|P2|COMPLETED|Second Intervention (3 Weeks)||17
121993|NCT00125957|291536|P1|COMPLETED|Second Intervention (3 Weeks)||15
121994|NCT00125957|291535|P2|STARTED|Second Intervention (3 Weeks)||17
121995|NCT00125957|291536|P1|STARTED|Second Intervention (3 Weeks)||15
121996|NCT00125957|291535|P2|NOT COMPLETED|First Intervention (3 Weeks)||0
121997|NCT00125957|291536|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
121998|NCT00125957|291535|P2|COMPLETED|First Intervention (3 Weeks)||17
121999|NCT00125957|291536|P1|COMPLETED|First Intervention (3 Weeks)||15
122000|NCT00125957|291535|P2|STARTED|First Intervention (3 Weeks)||17
122001|NCT00125957|291536|P1|STARTED|First Intervention (3 Weeks)||15
122002|NCT00126113|291546|P2|NOT COMPLETED|Overall Study||2
122003|NCT00126113|291547|P1|NOT COMPLETED|Overall Study||3
122004|NCT00126113|291546|P2|COMPLETED|Overall Study||35
122005|NCT00126113|291547|P1|COMPLETED|Overall Study||34
122006|NCT00126113|291546|P2|STARTED|Overall Study||37
122007|NCT00126113|291547|P1|STARTED|Overall Study||37
122008|NCT00126126|291561|P2|NOT COMPLETED|Overall Study||2
122009|NCT00126126|291562|P1|NOT COMPLETED|Overall Study||0
122010|NCT00126126|291561|P2|COMPLETED|Overall Study||7
122011|NCT00126126|291562|P1|COMPLETED|Overall Study||9
122012|NCT00126126|291561|P2|STARTED|Overall Study||9
122013|NCT00126126|291562|P1|STARTED|Overall Study||9
122014|NCT00126191|291572|P2|NOT COMPLETED|Overall Study||2
122015|NCT00126191|291573|P1|NOT COMPLETED|Overall Study||0
122016|NCT00126191|291572|P2|COMPLETED|Overall Study|1 pt off study during cycle 1 due to toxicity|6
122017|NCT00126191|291573|P1|COMPLETED|Overall Study||2
122018|NCT00126191|291572|P2|STARTED|Overall Study||8
122019|NCT00126191|291573|P1|STARTED|Overall Study||2
122020|NCT00126425|291583|P2|NOT COMPLETED|Overall Study||11
122021|NCT00126425|291584|P1|NOT COMPLETED|Overall Study||41
122022|NCT00126425|291583|P2|COMPLETED|Overall Study||37
122023|NCT00126425|291584|P1|COMPLETED|Overall Study||498
122024|NCT00126425|291583|P2|STARTED|Overall Study||48
122025|NCT00126425|291584|P1|STARTED|Overall Study||539
122026|NCT00126438|291592|P2|NOT COMPLETED|Overall Study||10
122027|NCT00126438|291593|P1|NOT COMPLETED|Overall Study||34
122028|NCT00126438|291592|P2|COMPLETED|Overall Study||52
122029|NCT00126438|291593|P1|COMPLETED|Overall Study||419
122030|NCT00126438|291592|P2|STARTED|Overall Study||62
122031|NCT00126438|291593|P1|STARTED|Overall Study||453
122032|NCT00126490|291599|P1|NOT COMPLETED|Overall Study||1
122033|NCT00126490|291599|P1|COMPLETED|Overall Study||18
122034|NCT00126490|291599|P1|STARTED|Overall Study||19
122035|NCT00126503|291609|P2|NOT COMPLETED|Overall Study||21
122036|NCT00126503|291610|P1|NOT COMPLETED|Overall Study||47
122037|NCT00126503|291609|P2|COMPLETED|Overall Study||0
122038|NCT00126503|291610|P1|COMPLETED|Overall Study||1
122039|NCT00126503|291609|P2|STARTED|Overall Study||21
122040|NCT00126503|291610|P1|STARTED|Overall Study||48
122041|NCT00126555|291622|P1|NOT COMPLETED|Overall Study||6
122042|NCT00126555|291622|P1|COMPLETED|Overall Study||17
122043|NCT00126555|291622|P1|STARTED|Overall Study||23
122044|NCT00126568|291636|P1|NOT COMPLETED|Overall Study||2
122045|NCT00126568|291636|P1|COMPLETED|Overall Study|Disease progression at beginning of study, not evaluable|18
122046|NCT00126568|291636|P1|STARTED|Overall Study||20
122047|NCT00126581|291644|P2|NOT COMPLETED|Overall Study||20
122048|NCT00126581|291645|P1|NOT COMPLETED|Overall Study||13
122049|NCT00126581|291644|P2|COMPLETED|Overall Study||80
122050|NCT00126581|291645|P1|COMPLETED|Overall Study||68
122051|NCT00126581|291644|P2|STARTED|Overall Study||100
122052|NCT00126581|291645|P1|STARTED|Overall Study||81
122053|NCT00126594|291667|P2|NOT COMPLETED|Overall Study||37
122054|NCT00126594|291668|P1|NOT COMPLETED|Overall Study||39
122055|NCT00126594|291667|P2|COMPLETED|Overall Study||3
122056|NCT00126594|291668|P1|COMPLETED|Overall Study||1
122057|NCT00126594|291667|P2|STARTED|Overall Study||40
122058|NCT00126594|291668|P1|STARTED|Overall Study||40
122059|NCT00126659|291686|P3|NOT COMPLETED|Overall Study||2
122060|NCT00126659|291687|P2|NOT COMPLETED|Overall Study||0
122061|NCT00126659|291688|P1|NOT COMPLETED|Overall Study||0
122062|NCT00126659|291686|P3|COMPLETED|Overall Study||2
122063|NCT00126659|291687|P2|COMPLETED|Overall Study||3
122064|NCT00126659|291688|P1|COMPLETED|Overall Study||3
122065|NCT00126659|291686|P3|STARTED|Overall Study||4
122066|NCT00126659|291687|P2|STARTED|Overall Study||3
122067|NCT00126659|291688|P1|STARTED|Overall Study||3
122068|NCT00126737|291698|P4|NOT COMPLETED|Overall Study||7
122069|NCT00126737|291699|P3|NOT COMPLETED|Overall Study||6
122070|NCT00126737|291700|P2|NOT COMPLETED|Overall Study||3
122071|NCT00126737|291701|P1|NOT COMPLETED|Overall Study||6
122072|NCT00126737|291698|P4|COMPLETED|Overall Study||18
122073|NCT00126737|291699|P3|COMPLETED|Overall Study||24
122074|NCT00126737|291700|P2|COMPLETED|Overall Study||24
122075|NCT00126737|291701|P1|COMPLETED|Overall Study||22
122076|NCT00126737|291698|P4|STARTED|Overall Study||25
122077|NCT00126737|291699|P3|STARTED|Overall Study||30
122078|NCT00126737|291700|P2|STARTED|Overall Study||27
122079|NCT00126737|291701|P1|STARTED|Overall Study||28
122080|NCT00126750|291729|P2|NOT COMPLETED|Overall Study||266
122081|NCT00126750|291730|P1|NOT COMPLETED|Overall Study||180
122082|NCT00126750|291729|P2|COMPLETED|Overall Study|Total providers at clinic locations were given the option to 'enroll'.|196
122083|NCT00126750|291730|P1|COMPLETED|Overall Study|Total providers at participating clinic locations were given the option to 'enroll'.|205
122084|NCT00126750|291729|P2|STARTED|Overall Study|Number of providers from 84 clinics|462
122085|NCT00126750|291730|P1|STARTED|Overall Study|Number of providers from 84 clinics|385
122086|NCT00126776|291738|P2|NOT COMPLETED|Overall Study||0
122087|NCT00126776|291739|P1|NOT COMPLETED|Overall Study||0
122088|NCT00126776|291738|P2|COMPLETED|Overall Study||371
122089|NCT00126776|291739|P1|COMPLETED|Overall Study||372
122090|NCT00126776|291738|P2|STARTED|Overall Study||371
122091|NCT00126776|291739|P1|STARTED|Overall Study||372
122092|NCT00127036|291745|P2|NOT COMPLETED|Overall Study||11
122093|NCT00127036|291746|P1|NOT COMPLETED|Overall Study||8
122094|NCT00127036|291745|P2|COMPLETED|Overall Study|20 Participants were evaluable.|20
122095|NCT00127036|291746|P1|COMPLETED|Overall Study|26 Participants were evaluable.|26
122096|NCT00127036|291745|P2|STARTED|Overall Study||31
122097|NCT00127036|291746|P1|STARTED|Overall Study||34
122098|NCT00127101|291762|P6|NOT COMPLETED|Continuation Phase||3
122099|NCT00127101|291763|P5|NOT COMPLETED|Continuation Phase||3
122100|NCT00127101|291764|P4|NOT COMPLETED|Continuation Phase||0
122101|NCT00127101|291765|P3|NOT COMPLETED|Continuation Phase||1
122102|NCT00127101|291766|P2|NOT COMPLETED|Continuation Phase||0
122103|NCT00127101|291767|P1|NOT COMPLETED|Continuation Phase||0
122104|NCT00127101|291762|P6|COMPLETED|Continuation Phase||0
122105|NCT00127101|291763|P5|COMPLETED|Continuation Phase||0
122106|NCT00127101|291764|P4|COMPLETED|Continuation Phase||0
122107|NCT00127101|291765|P3|COMPLETED|Continuation Phase||0
122108|NCT00127101|291766|P2|COMPLETED|Continuation Phase||0
122109|NCT00127101|291767|P1|COMPLETED|Continuation Phase||0
122110|NCT00127101|291762|P6|STARTED|Continuation Phase||3
122111|NCT00127101|291763|P5|STARTED|Continuation Phase||3
122112|NCT00127101|291764|P4|STARTED|Continuation Phase|No patients from the 2b Cohort entered into the extension phase|0
122113|NCT00127101|291765|P3|STARTED|Continuation Phase||1
122114|NCT00127101|291766|P2|STARTED|Continuation Phase||0
122115|NCT00127101|291767|P1|STARTED|Continuation Phase||0
122116|NCT00127101|291762|P6|NOT COMPLETED|Base Protocol||1
122117|NCT00127101|291763|P5|NOT COMPLETED|Base Protocol||2
122118|NCT00127101|291764|P4|NOT COMPLETED|Base Protocol||0
122119|NCT00127101|291765|P3|NOT COMPLETED|Base Protocol||2
122120|NCT00127101|291766|P2|NOT COMPLETED|Base Protocol||4
122121|NCT00127101|291767|P1|NOT COMPLETED|Base Protocol||2
122122|NCT00127101|291762|P6|COMPLETED|Base Protocol||3
122123|NCT00127101|291763|P5|COMPLETED|Base Protocol||3
122124|NCT00127101|291764|P4|COMPLETED|Base Protocol||3
122125|NCT00127101|291765|P3|COMPLETED|Base Protocol||1
122126|NCT00127101|291766|P2|COMPLETED|Base Protocol||1
122127|NCT00127101|291767|P1|COMPLETED|Base Protocol||1
122128|NCT00127101|291762|P6|STARTED|Base Protocol||4
122129|NCT00127101|291763|P5|STARTED|Base Protocol||5
122130|NCT00127101|291764|P4|STARTED|Base Protocol||3
122131|NCT00127101|291765|P3|STARTED|Base Protocol||3
122132|NCT00127101|291766|P2|STARTED|Base Protocol||5
122133|NCT00127101|291767|P1|STARTED|Base Protocol||3
122134|NCT00121134|291791|P4|NOT COMPLETED|Overall Study||9
122135|NCT00121134|291792|P3|NOT COMPLETED|Overall Study||21
122136|NCT00121134|291793|P2|NOT COMPLETED|Overall Study||15
122137|NCT00121134|291794|P1|NOT COMPLETED|Overall Study||16
122138|NCT00121134|291791|P4|COMPLETED|Overall Study||31
122139|NCT00121134|291792|P3|COMPLETED|Overall Study||20
122140|NCT00121134|291793|P2|COMPLETED|Overall Study||26
122141|NCT00121134|291794|P1|COMPLETED|Overall Study||24
122142|NCT00121134|291791|P4|STARTED|Overall Study||40
122143|NCT00121134|291792|P3|STARTED|Overall Study||41
122144|NCT00121134|291793|P2|STARTED|Overall Study||41
122145|NCT00121134|291794|P1|STARTED|Overall Study||40
122146|NCT00121186|291804|P1|NOT COMPLETED|Overall Study||0
122147|NCT00121186|291804|P1|COMPLETED|Overall Study||1
122148|NCT00121186|291804|P1|STARTED|Overall Study||1
122149|NCT00121199|291809|P1|NOT COMPLETED|Overall Study||28
122150|NCT00121199|291809|P1|COMPLETED|Overall Study||45
122151|NCT00121199|291809|P1|Eligible and Began Protocol Therapy|Overall Study||64
122152|NCT00121199|291809|P1|Eligible|Overall Study||64
122153|NCT00121199|291809|P1|STARTED|Overall Study||73
122154|NCT00121225|291816|P1|NOT COMPLETED|Overall Study||0
122155|NCT00121225|291816|P1|COMPLETED|Overall Study||32
122156|NCT00121225|291816|P1|STARTED|Overall Study||32
122157|NCT00121238|291820|P1|NOT COMPLETED|Overall Study||3
122158|NCT00121238|291820|P1|COMPLETED|Overall Study|2 were later deemed ineligible (PSA rise), censored from efficacy but included for toxicity analysis|13
122159|NCT00121238|291820|P1|STARTED|Overall Study||16
122160|NCT00127166|291830|P2|NOT COMPLETED|Period II||0
122161|NCT00127166|291831|P1|NOT COMPLETED|Period II||3
122162|NCT00127166|291830|P2|COMPLETED|Period II||73
122163|NCT00127166|291831|P1|COMPLETED|Period II||72
122164|NCT00127166|291830|P2|STARTED|Period II||73
122165|NCT00127166|291831|P1|STARTED|Period II||75
122166|NCT00127166|291830|P2|NOT COMPLETED|Washout Period||1
122167|NCT00127166|291831|P1|NOT COMPLETED|Washout Period||0
122168|NCT00127166|291830|P2|COMPLETED|Washout Period||73
122169|NCT00127166|291831|P1|COMPLETED|Washout Period||75
122170|NCT00127166|291830|P2|STARTED|Washout Period||74
122171|NCT00127166|291831|P1|STARTED|Washout Period||75
122172|NCT00127166|291830|P2|NOT COMPLETED|Period I||2
122173|NCT00127166|291831|P1|NOT COMPLETED|Period I||3
122174|NCT00127166|291830|P2|COMPLETED|Period I||74
122175|NCT00127166|291831|P1|COMPLETED|Period I||75
122176|NCT00127166|291830|P2|STARTED|Period I||76
122177|NCT00127166|291831|P1|STARTED|Period I||78
122178|NCT00127192|291850|P5|NOT COMPLETED|Overall Study||5
122179|NCT00127192|291851|P4|NOT COMPLETED|Overall Study||1
122180|NCT00127192|291852|P3|NOT COMPLETED|Overall Study||2
122181|NCT00127192|291853|P2|NOT COMPLETED|Overall Study||1
122182|NCT00127192|291854|P1|NOT COMPLETED|Overall Study||3
122183|NCT00127192|291850|P5|COMPLETED|Overall Study||68
122184|NCT00127192|291851|P4|COMPLETED|Overall Study||67
122185|NCT00127192|291852|P3|COMPLETED|Overall Study||68
122186|NCT00127192|291853|P2|COMPLETED|Overall Study||71
122187|NCT00127192|291854|P1|COMPLETED|Overall Study||77
122188|NCT00127192|291850|P5|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|73
122189|NCT00127192|291851|P4|STARTED|Overall Study|Study enrolled slightly less than the target of N=70|68
122190|NCT00127192|291852|P3|STARTED|Overall Study|Study enrolled as per the target of N=70|70
122191|NCT00127192|291853|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|72
122192|NCT00127192|291854|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=70|80
122193|NCT00127218|291878|P2|NOT COMPLETED|Overall Study||15
122194|NCT00127218|291879|P1|NOT COMPLETED|Overall Study||13
122195|NCT00127218|291878|P2|COMPLETED|Overall Study||58
122196|NCT00127218|291879|P1|COMPLETED|Overall Study||59
122197|NCT00127218|291878|P2|STARTED|Overall Study||73
122198|NCT00127218|291879|P1|STARTED|Overall Study||72
122199|NCT00127413|291889|P4|NOT COMPLETED|Overall Study||2
122200|NCT00127413|291890|P3|NOT COMPLETED|Overall Study||8
122201|NCT00127413|291891|P2|NOT COMPLETED|Overall Study||4
122202|NCT00127413|291892|P1|NOT COMPLETED|Overall Study||6
122203|NCT00127413|291889|P4|COMPLETED|Overall Study||5
122204|NCT00127413|291890|P3|COMPLETED|Overall Study||5
122205|NCT00127413|291891|P2|COMPLETED|Overall Study||6
122206|NCT00127413|291892|P1|COMPLETED|Overall Study||6
122207|NCT00127413|291889|P4|STARTED|Overall Study||7
122208|NCT00127413|291890|P3|STARTED|Overall Study||13
122209|NCT00127413|291891|P2|STARTED|Overall Study||10
122210|NCT00127413|291892|P1|STARTED|Overall Study||12
122211|NCT00129220|291905|P3|NOT COMPLETED|Study Period III||10
122212|NCT00129220|291906|P2|NOT COMPLETED|Study Period III||1
122213|NCT00129220|291907|P1|NOT COMPLETED|Study Period III||13
122214|NCT00129220|291905|P3|COMPLETED|Study Period III||42
122215|NCT00129220|291906|P2|COMPLETED|Study Period III||7
122216|NCT00129220|291907|P1|COMPLETED|Study Period III||59
122217|NCT00129220|291905|P3|STARTED|Study Period III||52
122218|NCT00129220|291906|P2|STARTED|Study Period III||8
122219|NCT00129220|291907|P1|STARTED|Study Period III||72
122220|NCT00129220|291905|P3|NOT COMPLETED|Study Period II||47
122221|NCT00129220|291906|P2|NOT COMPLETED|Study Period II||12
122222|NCT00129220|291907|P1|NOT COMPLETED|Study Period II||33
122223|NCT00129220|291905|P3|COMPLETED|Study Period II||52
122224|NCT00129220|291906|P2|COMPLETED|Study Period II||8
122225|NCT00129220|291907|P1|COMPLETED|Study Period II||72
122226|NCT00129220|291905|P3|Received at Least One Dose of Study Drug|Study Period II||97
122227|NCT00129220|291906|P2|Received at Least One Dose of Study Drug|Study Period II||20
122228|NCT00129220|291907|P1|Received at Least One Dose of Study Drug|Study Period II||104
122229|NCT00129220|291905|P3|STARTED|Study Period II||99
122230|NCT00129220|291906|P2|STARTED|Study Period II||20
122231|NCT00129220|291907|P1|STARTED|Study Period II||105
122232|NCT00129246|291946|P2|NOT COMPLETED|Overall Study||0
122233|NCT00129246|291947|P1|NOT COMPLETED|Overall Study||0
122234|NCT00129246|291946|P2|COMPLETED|Overall Study||20
122235|NCT00129246|291947|P1|COMPLETED|Overall Study||20
122236|NCT00129246|291946|P2|STARTED|Overall Study||20
122237|NCT00129246|291947|P1|STARTED|Overall Study||20
122238|NCT00129259|291961|P2|NOT COMPLETED|Overall Study||3
122239|NCT00129259|291962|P1|NOT COMPLETED|Overall Study||3
122240|NCT00129259|291961|P2|COMPLETED|Overall Study||22
122241|NCT00129259|291962|P1|COMPLETED|Overall Study||49
122242|NCT00129259|291961|P2|Received All or Part of Cycle 2|Overall Study||0
122243|NCT00129259|291962|P1|Received All or Part of Cycle 2|Overall Study||40
122244|NCT00129259|291961|P2|Received All or Part of Cycle 1|Overall Study||0
122245|NCT00129259|291962|P1|Received All or Part of Cycle 1|Overall Study||52
122246|NCT00129259|291961|P2|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|25
122247|NCT00129259|291962|P1|STARTED|Overall Study|Subjects not in the Intent-to-treat group did not have a baseline visit and are not included here|52
122248|NCT00129272|291974|P2|NOT COMPLETED|Overall Study||22
122249|NCT00129272|291975|P1|NOT COMPLETED|Overall Study||17
122250|NCT00129272|291974|P2|COMPLETED|Overall Study||51
122251|NCT00129272|291975|P1|COMPLETED|Overall Study||54
122252|NCT00129272|291974|P2|STARTED|Overall Study||73
122253|NCT00129272|291975|P1|STARTED|Overall Study||71
122254|NCT00129311|291985|P2|NOT COMPLETED|Overall Study||19
122255|NCT00129311|291986|P1|NOT COMPLETED|Overall Study||12
122256|NCT00129311|291985|P2|COMPLETED|Overall Study||31
122257|NCT00129311|291986|P1|COMPLETED|Overall Study||39
122258|NCT00129311|291985|P2|STARTED|Overall Study||50
122259|NCT00129311|291986|P1|STARTED|Overall Study||51
122260|NCT00129402|291996|P7|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||6
122261|NCT00129402|291997|P6|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122262|NCT00129402|291998|P5|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122263|NCT00129402|291999|P4|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122264|NCT00129402|292000|P3|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122265|NCT00129402|292001|P2|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122266|NCT00129402|292002|P1|NOT COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122267|NCT00129402|291996|P7|COMPLETED|Start Period3 to End Period3(Week 34-53)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|222
122268|NCT00129402|291997|P6|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122269|NCT00129402|291998|P5|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122270|NCT00129402|291999|P4|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122271|NCT00129402|292000|P3|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122272|NCT00129402|292001|P2|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122273|NCT00129402|292002|P1|COMPLETED|Start Period3 to End Period3(Week 34-53)||0
122274|NCT00129402|291996|P7|STARTED|Start Period3 to End Period3(Week 34-53)|In Period 3, all subjects from Period 1 and Period 2 were combined into one treatment group.|228
122275|NCT00129402|291997|P6|STARTED|Start Period3 to End Period3(Week 34-53)||0
122276|NCT00129402|291998|P5|STARTED|Start Period3 to End Period3(Week 34-53)||0
122277|NCT00129402|291999|P4|STARTED|Start Period3 to End Period3(Week 34-53)||0
122278|NCT00129402|292000|P3|STARTED|Start Period3 to End Period3(Week 34-53)||0
122279|NCT00129402|292001|P2|STARTED|Start Period3 to End Period3(Week 34-53)||0
122280|NCT00129402|292002|P1|STARTED|Start Period3 to End Period3(Week 34-53)||0
122281|NCT00129402|291996|P7|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122282|NCT00129402|291997|P6|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||5
122283|NCT00129402|291998|P5|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122284|NCT00129402|291999|P4|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122285|NCT00129402|292000|P3|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||8
122286|NCT00129402|292001|P2|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122287|NCT00129402|292002|P1|NOT COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122288|NCT00129402|291996|P7|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122289|NCT00129402|291997|P6|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|113
122290|NCT00129402|291998|P5|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122291|NCT00129402|291999|P4|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122292|NCT00129402|292000|P3|COMPLETED|Start Period2 to End Period2 (Week 7-33)|One subject who completed Period 1, did not enter Period 2, but entered and completed Period 3.|114
122293|NCT00129402|292001|P2|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122294|NCT00129402|292002|P1|COMPLETED|Start Period2 to End Period2 (Week 7-33)||0
122295|NCT00129402|291996|P7|STARTED|Start Period2 to End Period2 (Week 7-33)||0
122296|NCT00129402|291997|P6|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received simvastatin monotherapy|118
122297|NCT00129402|291998|P5|STARTED|Start Period2 to End Period2 (Week 7-33)||0
122298|NCT00129402|291999|P4|STARTED|Start Period2 to End Period2 (Week 7-33)||0
122299|NCT00129402|292000|P3|STARTED|Start Period2 to End Period2 (Week 7-33)|# of subjects were combined from the 3 arms in Period 1 who received ezetimibe with simvastatin|122
122300|NCT00129402|292001|P2|STARTED|Start Period2 to End Period2 (Week 7-33)||0
122301|NCT00129402|292002|P1|STARTED|Start Period2 to End Period2 (Week 7-33)||0
122302|NCT00129402|291996|P7|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
122303|NCT00129402|291997|P6|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
122304|NCT00129402|291998|P5|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
122305|NCT00129402|291999|P4|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
122306|NCT00129402|292000|P3|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||2
122307|NCT00129402|292001|P2|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||1
122308|NCT00129402|292002|P1|NOT COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
122309|NCT00129402|291996|P7|COMPLETED|Start Period1 to End Period1 (Week 1-6)||0
122310|NCT00129402|291997|P6|COMPLETED|Start Period1 to End Period1 (Week 1-6)||40
122311|NCT00129402|291998|P5|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
122312|NCT00129402|291999|P4|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
122313|NCT00129402|292000|P3|COMPLETED|Start Period1 to End Period1 (Week 1-6)||41
122314|NCT00129402|292001|P2|COMPLETED|Start Period1 to End Period1 (Week 1-6)||39
122315|NCT00129402|292002|P1|COMPLETED|Start Period1 to End Period1 (Week 1-6)||43
122316|NCT00129402|291996|P7|STARTED|Start Period1 to End Period1 (Week 1-6)||0
122317|NCT00129402|291997|P6|STARTED|Start Period1 to End Period1 (Week 1-6)||42
122318|NCT00129402|291998|P5|STARTED|Start Period1 to End Period1 (Week 1-6)||40
122319|NCT00129402|291999|P4|STARTED|Start Period1 to End Period1 (Week 1-6)||40
122320|NCT00129402|292000|P3|STARTED|Start Period1 to End Period1 (Week 1-6)||43
122321|NCT00129402|292001|P2|STARTED|Start Period1 to End Period1 (Week 1-6)||40
122322|NCT00129402|292002|P1|STARTED|Start Period1 to End Period1 (Week 1-6)||43
122323|NCT00129441|292021|P2|NOT COMPLETED|Overall Study||0
122324|NCT00129441|292022|P1|NOT COMPLETED|Overall Study||0
122325|NCT00129441|292021|P2|COMPLETED|Overall Study||6
122326|NCT00129441|292022|P1|COMPLETED|Overall Study||9
122327|NCT00129441|292021|P2|Year 1, Visit 8|Overall Study||6
122328|NCT00129441|292022|P1|Year 1, Visit 8|Overall Study||9
122329|NCT00129441|292021|P2|Week 26, Visit 7|Overall Study||6
122330|NCT00129441|292022|P1|Week 26, Visit 7|Overall Study||9
122331|NCT00129441|292021|P2|Week 5, Visit 6|Overall Study||6
122332|NCT00129441|292022|P1|Week 5, Visit 6|Overall Study||9
122333|NCT00129441|292021|P2|Week 4, Visit 5|Overall Study||6
122334|NCT00129441|292022|P1|Week 4, Visit 5|Overall Study||9
122335|NCT00129441|292021|P2|Week 3, Visit 4|Overall Study||6
122336|NCT00129441|292022|P1|Week 3, Visit 4|Overall Study||9
122337|NCT00129441|292021|P2|Week 2, Visit 3|Overall Study||6
122338|NCT00129441|292022|P1|Week 2, Visit 3|Overall Study||9
122339|NCT00129441|292021|P2|Week 1, Visit 2|Overall Study||6
122340|NCT00129441|292022|P1|Week 1, Visit 2|Overall Study||9
122341|NCT00129441|292021|P2|Baseline, Visit 1|Overall Study||6
122342|NCT00129441|292022|P1|Baseline, Visit 1|Overall Study|Baseline # only includes those who completed 4-week trial (one L-830982 subject did not complete).|9
122343|NCT00129441|292021|P2|STARTED|Overall Study||6
122344|NCT00129441|292022|P1|STARTED|Overall Study||9
122345|NCT00129467|292044|P2|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
122346|NCT00129467|292045|P1|NOT COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
122347|NCT00129467|292044|P2|COMPLETED|Open Label for SSRI+Methylphenidate Arm||0
122348|NCT00129467|292045|P1|COMPLETED|Open Label for SSRI+Methylphenidate Arm||2
122349|NCT00129467|292044|P2|STARTED|Open Label for SSRI+Methylphenidate Arm||0
122350|NCT00129467|292045|P1|STARTED|Open Label for SSRI+Methylphenidate Arm|Eligible if in methylphenidate arm & had 50% reduction in Montgomery-Asberg Depression Rating score|4
122351|NCT00129467|292044|P2|NOT COMPLETED|Received Intervention||4
122352|NCT00129467|292045|P1|NOT COMPLETED|Received Intervention||6
122353|NCT00129467|292044|P2|COMPLETED|Received Intervention||13
122354|NCT00129467|292045|P1|COMPLETED|Received Intervention||9
122355|NCT00129467|292044|P2|STARTED|Received Intervention||17
122356|NCT00129467|292045|P1|STARTED|Received Intervention||15
122357|NCT00129480|292053|P2|NOT COMPLETED|Overall Study||0
122358|NCT00129480|292054|P1|NOT COMPLETED|Overall Study||0
122359|NCT00129480|292053|P2|COMPLETED|Overall Study||214
122360|NCT00129480|292054|P1|COMPLETED|Overall Study||187
122361|NCT00129480|292053|P2|STARTED|Overall Study||214
122362|NCT00129480|292054|P1|STARTED|Overall Study||187
122363|NCT00129545|292063|P3|NOT COMPLETED|Overall Study||111
122364|NCT00129545|292064|P2|NOT COMPLETED|Overall Study||164
122365|NCT00129545|292065|P1|NOT COMPLETED|Overall Study||26
122366|NCT00129545|292063|P3|COMPLETED|Overall Study||133
122367|NCT00129545|292064|P2|COMPLETED|Overall Study||299
122368|NCT00129545|292065|P1|COMPLETED|Overall Study||67
122369|NCT00129545|292063|P3|STARTED|Overall Study||244
122370|NCT00129545|292064|P2|STARTED|Overall Study|2:1 randomization WATCHMAN to warfarin|463
122371|NCT00129545|292065|P1|STARTED|Overall Study||93
122372|NCT00129623|292077|P2|NOT COMPLETED|Overall Study||12
122373|NCT00129623|292078|P1|NOT COMPLETED|Overall Study||10
122374|NCT00129623|292077|P2|COMPLETED|Overall Study||65
122375|NCT00129623|292078|P1|COMPLETED|Overall Study||73
122376|NCT00129623|292077|P2|Intent-to-treat (ITT)/ Safety Population|Overall Study||77
122377|NCT00129623|292078|P1|Intent-to-treat (ITT)/ Safety Population|Overall Study||83
122378|NCT00129623|292077|P2|STARTED|Overall Study||77
122379|NCT00129623|292078|P1|STARTED|Overall Study||83
122380|NCT00129727|292100|P1|NOT COMPLETED|Overall Study||5
122381|NCT00129727|292100|P1|COMPLETED|Overall Study||57
122382|NCT00129727|292100|P1|STARTED|Overall Study||62
122383|NCT00129766|292108|P2|NOT COMPLETED|Overall Study||59
122384|NCT00129766|292109|P1|NOT COMPLETED|Overall Study||60
122385|NCT00129766|292108|P2|COMPLETED|Overall Study||3270
122386|NCT00129766|292109|P1|COMPLETED|Overall Study||3246
122387|NCT00129766|292108|P2|STARTED|Overall Study||3329
122388|NCT00129766|292109|P1|STARTED|Overall Study||3306
122389|NCT00129961|292149|P2|NOT COMPLETED|Overall Study||23
122390|NCT00129961|292150|P1|NOT COMPLETED|Overall Study||19
122391|NCT00129961|292149|P2|COMPLETED|Overall Study||24
122392|NCT00129961|292150|P1|COMPLETED|Overall Study||20
122393|NCT00129961|292149|P2|STARTED|Overall Study||47
122394|NCT00129961|292150|P1|STARTED|Overall Study||39
122395|NCT00129974|292184|P1|NOT COMPLETED|Overall Study||1
122396|NCT00129974|292184|P1|COMPLETED|Overall Study||0
122397|NCT00129974|292184|P1|STARTED|Overall Study||1
122398|NCT00130039|292191|P2|NOT COMPLETED|Overall Study||18
122399|NCT00130039|292192|P1|NOT COMPLETED|Overall Study||30
122400|NCT00130039|292191|P2|COMPLETED|Overall Study|full analysis set|207
122401|NCT00130039|292192|P1|COMPLETED|Overall Study|full analysis set|202
122402|NCT00130039|292191|P2|STARTED|Overall Study||225
122403|NCT00130039|292192|P1|STARTED|Overall Study||232
122404|NCT00130117|292210|P2|NOT COMPLETED|Overall Study||3
122405|NCT00130117|292211|P1|NOT COMPLETED|Overall Study||4
122406|NCT00130117|292210|P2|COMPLETED|Overall Study||6
122407|NCT00130117|292211|P1|COMPLETED|Overall Study||7
122408|NCT00130117|292210|P2|STARTED|Overall Study||9
122409|NCT00130117|292211|P1|STARTED|Overall Study||11
122410|NCT00130247|292234|P2|NOT COMPLETED|Overall Study||4
122411|NCT00130247|292235|P1|NOT COMPLETED|Overall Study||2
122412|NCT00130247|292234|P2|COMPLETED|Overall Study||194
122413|NCT00130247|292235|P1|COMPLETED|Overall Study||194
122414|NCT00130247|292234|P2|STARTED|Overall Study||198
122415|NCT00130247|292235|P1|STARTED|Overall Study||196
122416|NCT00130286|292255|P4|NOT COMPLETED|Overall Study||2
122417|NCT00130286|292256|P3|NOT COMPLETED|Overall Study||4
122418|NCT00130286|292257|P2|NOT COMPLETED|Overall Study||3
122419|NCT00130286|292258|P1|NOT COMPLETED|Overall Study||0
122420|NCT00130286|292255|P4|COMPLETED|Overall Study||17
122421|NCT00130286|292256|P3|COMPLETED|Overall Study||13
122422|NCT00130286|292257|P2|COMPLETED|Overall Study||16
122423|NCT00130286|292258|P1|COMPLETED|Overall Study||22
122424|NCT00130286|292255|P4|STARTED|Overall Study||19
122425|NCT00130286|292256|P3|STARTED|Overall Study||17
122426|NCT00130286|292257|P2|STARTED|Overall Study||19
122427|NCT00130286|292258|P1|STARTED|Overall Study||22
122428|NCT00130520|292276|P1|NOT COMPLETED|Overall Study||39
122429|NCT00130520|292276|P1|COMPLETED|Overall Study||1
122430|NCT00130520|292276|P1|Completion of at Least One Cycle|Overall Study||39
122431|NCT00130520|292276|P1|STARTED|Overall Study|85 women were screened for eligibility, 56 consented, 40 treated.|40
122432|NCT00130637|292282|P1|NOT COMPLETED|Overall Study||3
122433|NCT00130637|292282|P1|COMPLETED|Overall Study||3
122434|NCT00130637|292282|P1|STARTED|Overall Study||6
122435|NCT00130689|292287|P1|NOT COMPLETED|Overall Study||43
122436|NCT00130689|292287|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
122437|NCT00130689|292287|P1|Treated|Overall Study||35
122438|NCT00130689|292287|P1|Eligible|Overall Study||37
122439|NCT00130689|292287|P1|STARTED|Overall Study||43
122440|NCT00130728|292293|P2|NOT COMPLETED|Overall Study||213
122441|NCT00130728|292294|P1|NOT COMPLETED|Overall Study||211
122442|NCT00130728|292293|P2|COMPLETED|Overall Study||104
122443|NCT00130728|292294|P1|COMPLETED|Overall Study||108
122444|NCT00130728|292293|P2|Received Study Drug (Safety Population)|Overall Study||313
122445|NCT00130728|292294|P1|Received Study Drug (Safety Population)|Overall Study||313
122446|NCT00130728|292293|P2|STARTED|Overall Study||317
122447|NCT00130728|292294|P1|STARTED|Overall Study||319
122448|NCT00130780|292308|P2|NOT COMPLETED|Overall Study||0
122449|NCT00130780|292309|P1|NOT COMPLETED|Overall Study||0
122450|NCT00130780|292308|P2|COMPLETED|Overall Study||20
122451|NCT00130780|292309|P1|COMPLETED|Overall Study||51
122452|NCT00130780|292308|P2|STARTED|Overall Study||20
122453|NCT00130780|292309|P1|STARTED|Overall Study||51
122454|NCT00130793|292317|P2|NOT COMPLETED|Overall Study||4
122455|NCT00130793|292318|P1|NOT COMPLETED|Overall Study||3
122456|NCT00130793|292317|P2|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned VRC at Week 4|181
122457|NCT00130793|292318|P1|COMPLETED|Overall Study|Subject received vaccine, completed blood draws, returned vaccination report card (VRC) at Week 4|180
122458|NCT00130793|292317|P2|Vaccinated|Overall Study||185
122459|NCT00130793|292318|P1|Vaccinated|Overall Study|One subject was allocated but not vaccinated.|182
122460|NCT00130793|292317|P2|STARTED|Overall Study||185
122461|NCT00130793|292318|P1|STARTED|Overall Study||183
122462|NCT00130832|292330|P2|NOT COMPLETED|Overall Study||17
122463|NCT00130832|292331|P1|NOT COMPLETED|Overall Study||16
122464|NCT00130832|292330|P2|COMPLETED|Overall Study|Those who received all 3 doses; last 2 blood draws ~42 days postdose 3 of RotaTeq™ and postdose OPV|346
122465|NCT00130832|292331|P1|COMPLETED|Overall Study|Those who received all 3 doses of concomitant RotaTeq™/ OPV with blood draw ~42 days postdose 3|356
122466|NCT00130832|292330|P2|STARTED|Overall Study||363
122467|NCT00130832|292331|P1|STARTED|Overall Study||372
122468|NCT00130923|292343|P2|NOT COMPLETED|Overall Study||14
122469|NCT00130923|292344|P1|NOT COMPLETED|Overall Study||13
122470|NCT00130923|292343|P2|COMPLETED|Overall Study||32
122471|NCT00130923|292344|P1|COMPLETED|Overall Study||36
122472|NCT00130923|292343|P2|STARTED|Overall Study||46
122473|NCT00130923|292344|P1|STARTED|Overall Study||49
122474|NCT00131248|292350|P2|NOT COMPLETED|Intervention 3 (4-day Course)||0
122475|NCT00131248|292351|P1|NOT COMPLETED|Intervention 3 (4-day Course)||0
122476|NCT00131248|292350|P2|COMPLETED|Intervention 3 (4-day Course)||9
122477|NCT00131248|292351|P1|COMPLETED|Intervention 3 (4-day Course)||8
122478|NCT00131248|292350|P2|STARTED|Intervention 3 (4-day Course)||9
122479|NCT00131248|292351|P1|STARTED|Intervention 3 (4-day Course)||8
122480|NCT00131248|292350|P2|NOT COMPLETED|Washout 2 (24 Hours)||0
122481|NCT00131248|292351|P1|NOT COMPLETED|Washout 2 (24 Hours)||0
122482|NCT00131248|292350|P2|COMPLETED|Washout 2 (24 Hours)||9
122483|NCT00131248|292351|P1|COMPLETED|Washout 2 (24 Hours)||8
122484|NCT00131248|292350|P2|STARTED|Washout 2 (24 Hours)||9
122485|NCT00131248|292351|P1|STARTED|Washout 2 (24 Hours)||8
122486|NCT00131248|292350|P2|NOT COMPLETED|Intervention 2 (7-day Course)||0
122487|NCT00131248|292351|P1|NOT COMPLETED|Intervention 2 (7-day Course)||0
122488|NCT00131248|292350|P2|COMPLETED|Intervention 2 (7-day Course)||9
122489|NCT00131248|292351|P1|COMPLETED|Intervention 2 (7-day Course)||8
122490|NCT00131248|292350|P2|STARTED|Intervention 2 (7-day Course)||9
122491|NCT00131248|292351|P1|STARTED|Intervention 2 (7-day Course)||8
122492|NCT00131248|292350|P2|NOT COMPLETED|Washout (24 Hour)||0
122493|NCT00131248|292351|P1|NOT COMPLETED|Washout (24 Hour)||0
122494|NCT00131248|292350|P2|COMPLETED|Washout (24 Hour)||9
122495|NCT00131248|292351|P1|COMPLETED|Washout (24 Hour)||8
122496|NCT00131248|292350|P2|STARTED|Washout (24 Hour)||9
122497|NCT00131248|292351|P1|STARTED|Washout (24 Hour)||8
122498|NCT00131248|292350|P2|NOT COMPLETED|Intervention 1 (3-day Course)||0
122499|NCT00131248|292351|P1|NOT COMPLETED|Intervention 1 (3-day Course)||1
122500|NCT00131248|292350|P2|COMPLETED|Intervention 1 (3-day Course)||9
122501|NCT00131248|292351|P1|COMPLETED|Intervention 1 (3-day Course)||8
122502|NCT00131248|292350|P2|STARTED|Intervention 1 (3-day Course)||9
122503|NCT00131248|292351|P1|STARTED|Intervention 1 (3-day Course)||9
122504|NCT00131352|292359|P2|NOT COMPLETED|Repeat Treatment Period||0
122505|NCT00131352|292360|P1|NOT COMPLETED|Repeat Treatment Period||2
122506|NCT00131352|292359|P2|COMPLETED|Repeat Treatment Period||0
122507|NCT00131352|292360|P1|COMPLETED|Repeat Treatment Period||158
122508|NCT00131352|292359|P2|STARTED|Repeat Treatment Period||0
122509|NCT00131352|292360|P1|STARTED|Repeat Treatment Period|Safety population: 77 Synvisc + 83 Saline Control participants from the Initial Treatment period.|160
122510|NCT00131352|292359|P2|NOT COMPLETED|Initial Treatment Period||12
122511|NCT00131352|292360|P1|NOT COMPLETED|Initial Treatment Period||9
122512|NCT00131352|292359|P2|COMPLETED|Initial Treatment Period||118
122513|NCT00131352|292360|P1|COMPLETED|Initial Treatment Period||114
122514|NCT00131352|292359|P2|Intent to Treat Population|Initial Treatment Period||129
122515|NCT00131352|292360|P1|Intent to Treat Population|Initial Treatment Period||124
122516|NCT00131352|292359|P2|STARTED|Initial Treatment Period|Safety population|130
122517|NCT00131352|292360|P1|STARTED|Initial Treatment Period|Safety population|123
122518|NCT00131378|292386|P4|NOT COMPLETED|Overall Study||9
122519|NCT00131378|292387|P3|NOT COMPLETED|Overall Study||10
122520|NCT00131378|292388|P2|NOT COMPLETED|Overall Study||18
122521|NCT00131378|292389|P1|NOT COMPLETED|Overall Study||11
122522|NCT00131378|292386|P4|COMPLETED|Overall Study||21
122523|NCT00131378|292387|P3|COMPLETED|Overall Study||22
122524|NCT00131378|292388|P2|COMPLETED|Overall Study||22
122525|NCT00131378|292389|P1|COMPLETED|Overall Study||29
122526|NCT00131378|292386|P4|STARTED|Overall Study||30
122527|NCT00131378|292387|P3|STARTED|Overall Study||32
122528|NCT00131378|292388|P2|STARTED|Overall Study||40
122529|NCT00131378|292389|P1|STARTED|Overall Study||40
122530|NCT00131456|292413|P2|NOT COMPLETED|Overall Study||20
122531|NCT00131456|292414|P1|NOT COMPLETED|Overall Study||19
122532|NCT00131456|292413|P2|COMPLETED|Overall Study||31
122533|NCT00131456|292414|P1|COMPLETED|Overall Study||33
122534|NCT00131456|292413|P2|STARTED|Overall Study||51
122535|NCT00131456|292414|P1|STARTED|Overall Study||52
122536|NCT00131508|292422|P2|NOT COMPLETED|Overall Study||8
122537|NCT00131508|292423|P1|NOT COMPLETED|Overall Study||3
122538|NCT00131508|292422|P2|COMPLETED|Overall Study||5
122539|NCT00131508|292423|P1|COMPLETED|Overall Study||9
122540|NCT00131508|292422|P2|STARTED|Overall Study||13
122541|NCT00131508|292423|P1|STARTED|Overall Study||12
122542|NCT00131573|292447|P2|NOT COMPLETED|Overall Study||26
122543|NCT00131573|292448|P1|NOT COMPLETED|Overall Study||33
122544|NCT00131573|292447|P2|COMPLETED|Overall Study||13
122545|NCT00131573|292448|P1|COMPLETED|Overall Study||13
122546|NCT00131573|292447|P2|STARTED|Overall Study||39
122547|NCT00131573|292448|P1|STARTED|Overall Study||46
122548|NCT00124449|292458|P2|NOT COMPLETED|18-Month Untreated Observation Period||13
122549|NCT00124449|292459|P1|NOT COMPLETED|18-Month Untreated Observation Period||15
122550|NCT00124449|292458|P2|COMPLETED|18-Month Untreated Observation Period||4
122551|NCT00124449|292459|P1|COMPLETED|18-Month Untreated Observation Period||7
122552|NCT00124449|292458|P2|Completed Year 1 of Study|18-Month Untreated Observation Period||9
122553|NCT00124449|292459|P1|Completed Year 1 of Study|18-Month Untreated Observation Period||14
122554|NCT00124449|292458|P2|STARTED|18-Month Untreated Observation Period||17
122555|NCT00124449|292459|P1|STARTED|18-Month Untreated Observation Period||22
122556|NCT00124449|292458|P2|NOT COMPLETED|6-month Double-Blind Treatment Period||11
122557|NCT00124449|292459|P1|NOT COMPLETED|6-month Double-Blind Treatment Period||6
122558|NCT00124449|292458|P2|COMPLETED|6-month Double-Blind Treatment Period||17
122559|NCT00124449|292459|P1|COMPLETED|6-month Double-Blind Treatment Period||22
122560|NCT00124449|292458|P2|STARTED|6-month Double-Blind Treatment Period||28
122561|NCT00124449|292459|P1|STARTED|6-month Double-Blind Treatment Period||28
122562|NCT00124462|292494|P2|NOT COMPLETED|Overall Study||13
122563|NCT00124462|292495|P1|NOT COMPLETED|Overall Study||11
122564|NCT00124462|292494|P2|COMPLETED|Overall Study||27
122565|NCT00124462|292495|P1|COMPLETED|Overall Study||29
122566|NCT00124462|292494|P2|STARTED|Overall Study||40
122567|NCT00124462|292495|P1|STARTED|Overall Study||40
122568|NCT00131664|292506|P6|NOT COMPLETED|Second Period (Additional Drug Added)||3
122569|NCT00131664|292507|P5|NOT COMPLETED|Second Period (Additional Drug Added)||1
122570|NCT00131664|292508|P4|NOT COMPLETED|Second Period (Additional Drug Added)||2
122571|NCT00131664|292509|P3|NOT COMPLETED|Second Period (Additional Drug Added)||3
122572|NCT00131664|292510|P2|NOT COMPLETED|Second Period (Additional Drug Added)||4
122573|NCT00131664|292511|P1|NOT COMPLETED|Second Period (Additional Drug Added)||9
122574|NCT00131664|292506|P6|COMPLETED|Second Period (Additional Drug Added)||22
122575|NCT00131664|292507|P5|COMPLETED|Second Period (Additional Drug Added)||15
122576|NCT00131664|292508|P4|COMPLETED|Second Period (Additional Drug Added)||19
122577|NCT00131664|292509|P3|COMPLETED|Second Period (Additional Drug Added)||76
122578|NCT00131664|292510|P2|COMPLETED|Second Period (Additional Drug Added)||97
122579|NCT00131664|292511|P1|COMPLETED|Second Period (Additional Drug Added)||81
122580|NCT00131664|292506|P6|STARTED|Second Period (Additional Drug Added)||25
122581|NCT00131664|292507|P5|STARTED|Second Period (Additional Drug Added)||16
122582|NCT00131664|292508|P4|STARTED|Second Period (Additional Drug Added)||21
122583|NCT00131664|292509|P3|STARTED|Second Period (Additional Drug Added)|25 had added Amaryl at Month 6|79
122584|NCT00131664|292510|P2|STARTED|Second Period (Additional Drug Added)|16 had added Amaryl at Month 6|101
122585|NCT00131664|292511|P1|STARTED|Second Period (Additional Drug Added)|21 had added Metformin at Month 6|90
122586|NCT00131664|292506|P6|NOT COMPLETED|First Period (First 6 Months)||0
122587|NCT00131664|292507|P5|NOT COMPLETED|First Period (First 6 Months)||0
122588|NCT00131664|292508|P4|NOT COMPLETED|First Period (First 6 Months)||0
122589|NCT00131664|292509|P3|NOT COMPLETED|First Period (First 6 Months)||16
122590|NCT00131664|292510|P2|NOT COMPLETED|First Period (First 6 Months)||18
122591|NCT00131664|292511|P1|NOT COMPLETED|First Period (First 6 Months)||25
122592|NCT00131664|292506|P6|COMPLETED|First Period (First 6 Months)||0
122593|NCT00131664|292507|P5|COMPLETED|First Period (First 6 Months)||0
122594|NCT00131664|292508|P4|COMPLETED|First Period (First 6 Months)||0
122595|NCT00131664|292509|P3|COMPLETED|First Period (First 6 Months)||104
122596|NCT00131664|292510|P2|COMPLETED|First Period (First 6 Months)||117
122597|NCT00131664|292511|P1|COMPLETED|First Period (First 6 Months)||111
122598|NCT00131664|292506|P6|STARTED|First Period (First 6 Months)||0
122599|NCT00131664|292507|P5|STARTED|First Period (First 6 Months)||0
122600|NCT00131664|292508|P4|STARTED|First Period (First 6 Months)||0
122601|NCT00131664|292509|P3|STARTED|First Period (First 6 Months)||120
122602|NCT00131664|292510|P2|STARTED|First Period (First 6 Months)||135
122603|NCT00131664|292511|P1|STARTED|First Period (First 6 Months)||136
122604|NCT00131677|292572|P2|NOT COMPLETED|Overall Study||39
122605|NCT00131677|292573|P1|NOT COMPLETED|Overall Study||30
122606|NCT00131677|292572|P2|COMPLETED|Overall Study||160
122607|NCT00131677|292573|P1|COMPLETED|Overall Study||171
122608|NCT00131677|292572|P2|STARTED|Overall Study|199 randomized to placebo; 99 to start immediately and 100 after a 9 month delay.|199
122609|NCT00131677|292573|P1|STARTED|Overall Study|201 randomized to active drug; 101 to start immediately and 100 after a 9 month delay.|201
122610|NCT00131885|292591|P4|NOT COMPLETED|Time 2: Second Intervention||0
122611|NCT00131885|292592|P3|NOT COMPLETED|Time 2: Second Intervention||0
122612|NCT00131885|292593|P2|NOT COMPLETED|Time 2: Second Intervention||0
122613|NCT00131885|292594|P1|NOT COMPLETED|Time 2: Second Intervention||0
122614|NCT00131885|292591|P4|COMPLETED|Time 2: Second Intervention||9
122615|NCT00131885|292592|P3|COMPLETED|Time 2: Second Intervention||9
122616|NCT00131885|292593|P2|COMPLETED|Time 2: Second Intervention||9
122617|NCT00131885|292594|P1|COMPLETED|Time 2: Second Intervention||9
122618|NCT00131885|292591|P4|STARTED|Time 2: Second Intervention||9
122619|NCT00131885|292592|P3|STARTED|Time 2: Second Intervention||9
122620|NCT00131885|292593|P2|STARTED|Time 2: Second Intervention||9
122621|NCT00131885|292594|P1|STARTED|Time 2: Second Intervention||9
122622|NCT00131885|292591|P4|NOT COMPLETED|Time 1: First Intervention||0
122623|NCT00131885|292592|P3|NOT COMPLETED|Time 1: First Intervention||0
122624|NCT00131885|292593|P2|NOT COMPLETED|Time 1: First Intervention||0
122625|NCT00131885|292594|P1|NOT COMPLETED|Time 1: First Intervention||0
122626|NCT00131885|292591|P4|COMPLETED|Time 1: First Intervention||9
122627|NCT00131885|292592|P3|COMPLETED|Time 1: First Intervention||9
122628|NCT00131885|292593|P2|COMPLETED|Time 1: First Intervention||9
122629|NCT00131885|292594|P1|COMPLETED|Time 1: First Intervention||9
122630|NCT00131885|292591|P4|STARTED|Time 1: First Intervention||9
122631|NCT00131885|292592|P3|STARTED|Time 1: First Intervention||9
122632|NCT00131885|292593|P2|STARTED|Time 1: First Intervention||9
122633|NCT00131885|292594|P1|STARTED|Time 1: First Intervention||9
122634|NCT00131911|292626|P2|NOT COMPLETED|Overall Study||0
122635|NCT00131911|292627|P1|NOT COMPLETED|Overall Study||1
122636|NCT00131911|292626|P2|COMPLETED|Overall Study||42
122637|NCT00131911|292627|P1|COMPLETED|Overall Study||50
122638|NCT00131911|292626|P2|STARTED|Overall Study||42
122639|NCT00131911|292627|P1|STARTED|Overall Study||51
122640|NCT00131937|292640|P1|NOT COMPLETED|Overall Study||14
122641|NCT00131937|292640|P1|COMPLETED|Overall Study||0
122642|NCT00131937|292640|P1|STARTED|Overall Study||14
122643|NCT00132314|292648|P2|NOT COMPLETED|Overall Study||72
122644|NCT00132314|292649|P1|NOT COMPLETED|Overall Study||73
122645|NCT00132314|292648|P2|COMPLETED|Overall Study||120
122646|NCT00132314|292649|P1|COMPLETED|Overall Study||117
122647|NCT00132314|292648|P2|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort.|182
122648|NCT00132314|292649|P1|Completed Baseline Visit, Provided SSN|Overall Study|This is the ITT cohort|187
122649|NCT00132314|292648|P2|Received Treatment|Overall Study||185
122650|NCT00132314|292649|P1|Received Treatment|Overall Study||188
122651|NCT00132314|292648|P2|STARTED|Overall Study||192
122652|NCT00132314|292649|P1|STARTED|Overall Study||190
122653|NCT00132496|292659|P2|NOT COMPLETED|Overall Study||2
122654|NCT00132496|292660|P1|NOT COMPLETED|Overall Study||2
122655|NCT00132496|292659|P2|COMPLETED|Overall Study||55
122656|NCT00132496|292660|P1|COMPLETED|Overall Study||52
122657|NCT00132496|292659|P2|STARTED|Overall Study||57
122658|NCT00132496|292660|P1|STARTED|Overall Study||54
122659|NCT00132678|292668|P3|NOT COMPLETED|Period IV (Double-Blind Treatment)||0
122660|NCT00132678|292669|P2|NOT COMPLETED|Period IV (Double-Blind Treatment)||40
122661|NCT00132678|292670|P1|NOT COMPLETED|Period IV (Double-Blind Treatment)||37
122662|NCT00132678|292668|P3|COMPLETED|Period IV (Double-Blind Treatment)||0
122663|NCT00132678|292669|P2|COMPLETED|Period IV (Double-Blind Treatment)||109
122664|NCT00132678|292670|P1|COMPLETED|Period IV (Double-Blind Treatment)||117
122665|NCT00132678|292668|P3|STARTED|Period IV (Double-Blind Treatment)||0
122666|NCT00132678|292669|P2|STARTED|Period IV (Double-Blind Treatment)||149
122667|NCT00132678|292670|P1|STARTED|Period IV (Double-Blind Treatment)||154
122668|NCT00132678|292668|P3|NOT COMPLETED|Period III (Open-Label Stabilization)||0
122669|NCT00132678|292669|P2|NOT COMPLETED|Period III (Open-Label Stabilization)||0
122670|NCT00132678|292670|P1|NOT COMPLETED|Period III (Open-Label Stabilization)||198
122671|NCT00132678|292668|P3|COMPLETED|Period III (Open-Label Stabilization)||0
122672|NCT00132678|292669|P2|COMPLETED|Period III (Open-Label Stabilization)||0
122673|NCT00132678|292670|P1|COMPLETED|Period III (Open-Label Stabilization)||303
122674|NCT00132678|292668|P3|STARTED|Period III (Open-Label Stabilization)||0
122675|NCT00132678|292669|P2|STARTED|Period III (Open-Label Stabilization)||0
122676|NCT00132678|292670|P1|STARTED|Period III (Open-Label Stabilization)||501
122677|NCT00132678|292668|P3|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||58
122678|NCT00132678|292669|P2|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
122679|NCT00132678|292670|P1|NOT COMPLETED|Period II (Open-Label Oral Risperidone)||0
122680|NCT00132678|292668|P3|COMPLETED|Period II (Open-Label Oral Risperidone)||382
122681|NCT00132678|292669|P2|COMPLETED|Period II (Open-Label Oral Risperidone)||0
122682|NCT00132678|292670|P1|COMPLETED|Period II (Open-Label Oral Risperidone)||0
122683|NCT00132678|292668|P3|STARTED|Period II (Open-Label Oral Risperidone)||440
122684|NCT00132678|292669|P2|STARTED|Period II (Open-Label Oral Risperidone)||0
122685|NCT00132678|292670|P1|STARTED|Period II (Open-Label Oral Risperidone)||0
122686|NCT00132691|292684|P2|NOT COMPLETED|Overall Study||12
122687|NCT00132691|292685|P1|NOT COMPLETED|Overall Study||11
122688|NCT00132691|292684|P2|COMPLETED|Overall Study|114 participants completed the 2-year anniversary visit|114
122689|NCT00132691|292685|P1|COMPLETED|Overall Study|118 participants completed the 2-year anniversary visit|118
122690|NCT00132691|292684|P2|STARTED|Overall Study|126 participants were assigned to systemic treatment; 121 received systemic therapy|126
122691|NCT00132691|292685|P1|STARTED|Overall Study|129 participants were assigned to implant; 122 received implant|129
122692|NCT00132730|292727|P6|NOT COMPLETED|Period V - Open-label Extension (EXT2)||2
122693|NCT00132730|292728|P5|NOT COMPLETED|Period V - Open-label Extension (EXT2)||7
122694|NCT00132730|292729|P4|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
122695|NCT00132730|292730|P3|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
122696|NCT00132730|292731|P2|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
122697|NCT00132730|292732|P1|NOT COMPLETED|Period V - Open-label Extension (EXT2)||0
122698|NCT00132730|292727|P6|COMPLETED|Period V - Open-label Extension (EXT2)||0
122699|NCT00132730|292728|P5|COMPLETED|Period V - Open-label Extension (EXT2)||0
122700|NCT00132730|292729|P4|COMPLETED|Period V - Open-label Extension (EXT2)||0
122701|NCT00132730|292730|P3|COMPLETED|Period V - Open-label Extension (EXT2)||0
122702|NCT00132730|292731|P2|COMPLETED|Period V - Open-label Extension (EXT2)||0
122703|NCT00132730|292732|P1|COMPLETED|Period V - Open-label Extension (EXT2)||0
122704|NCT00132730|292727|P6|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|2
122705|NCT00132730|292728|P5|STARTED|Period V - Open-label Extension (EXT2)|Not all participants who completed Period IV entered Period V|7
122706|NCT00132730|292729|P4|STARTED|Period V - Open-label Extension (EXT2)||0
122707|NCT00132730|292730|P3|STARTED|Period V - Open-label Extension (EXT2)||0
122708|NCT00132730|292731|P2|STARTED|Period V - Open-label Extension (EXT2)||0
122709|NCT00132730|292732|P1|STARTED|Period V - Open-label Extension (EXT2)||0
122710|NCT00132730|292727|P6|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||68
122711|NCT00132730|292728|P5|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||179
122712|NCT00132730|292729|P4|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
122713|NCT00132730|292730|P3|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
122714|NCT00132730|292731|P2|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
122715|NCT00132730|292732|P1|NOT COMPLETED|Period IV - Open-label Extension (EXT2)||0
122716|NCT00132730|292727|P6|COMPLETED|Period IV - Open-label Extension (EXT2)||3
122717|NCT00132730|292728|P5|COMPLETED|Period IV - Open-label Extension (EXT2)||8
122718|NCT00132730|292729|P4|COMPLETED|Period IV - Open-label Extension (EXT2)||0
122719|NCT00132730|292730|P3|COMPLETED|Period IV - Open-label Extension (EXT2)||0
122720|NCT00132730|292731|P2|COMPLETED|Period IV - Open-label Extension (EXT2)||0
122721|NCT00132730|292732|P1|COMPLETED|Period IV - Open-label Extension (EXT2)||0
122722|NCT00132730|292727|P6|STARTED|Period IV - Open-label Extension (EXT2)|Includes paricipants from Period III. Not all eligible participants entered EXT2|71
122723|NCT00132730|292728|P5|STARTED|Period IV - Open-label Extension (EXT2)|Includes participants from Period III. Not all eligible participants entered EXT2|187
122724|NCT00132730|292729|P4|STARTED|Period IV - Open-label Extension (EXT2)||0
122725|NCT00132730|292730|P3|STARTED|Period IV - Open-label Extension (EXT2)||0
122726|NCT00132730|292731|P2|STARTED|Period IV - Open-label Extension (EXT2)||0
122727|NCT00132730|292732|P1|STARTED|Period IV - Open-label Extension (EXT2)||0
122728|NCT00132730|292727|P6|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
122729|NCT00132730|292728|P5|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
122730|NCT00132730|292729|P4|NOT COMPLETED|Period III - Blinded Extension (EXT1)||25
122731|NCT00132730|292730|P3|NOT COMPLETED|Period III - Blinded Extension (EXT1)||82
122732|NCT00132730|292731|P2|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
122733|NCT00132730|292732|P1|NOT COMPLETED|Period III - Blinded Extension (EXT1)||0
122734|NCT00132730|292727|P6|COMPLETED|Period III - Blinded Extension (EXT1)||0
122735|NCT00132730|292728|P5|COMPLETED|Period III - Blinded Extension (EXT1)||0
122736|NCT00132730|292729|P4|COMPLETED|Period III - Blinded Extension (EXT1)||82
122737|NCT00132730|292730|P3|COMPLETED|Period III - Blinded Extension (EXT1)||235
122738|NCT00132730|292731|P2|COMPLETED|Period III - Blinded Extension (EXT1)||0
122739|NCT00132730|292732|P1|COMPLETED|Period III - Blinded Extension (EXT1)||0
122740|NCT00132730|292727|P6|STARTED|Period III - Blinded Extension (EXT1)||0
122741|NCT00132730|292728|P5|STARTED|Period III - Blinded Extension (EXT1)||0
122742|NCT00132730|292729|P4|STARTED|Period III - Blinded Extension (EXT1)|Not all eligible participants entered EXT1|107
122743|NCT00132730|292730|P3|STARTED|Period III - Blinded Extension (EXT1)|Includes all MK-0873 participants from Period II. Not all eligible participants entered EXT1|317
122744|NCT00132730|292731|P2|STARTED|Period III - Blinded Extension (EXT1)||0
122745|NCT00132730|292732|P1|STARTED|Period III - Blinded Extension (EXT1)||0
122746|NCT00132730|292727|P6|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
122747|NCT00132730|292728|P5|NOT COMPLETED|Period II - 12-week Treatment (Base)||0
122748|NCT00132730|292729|P4|NOT COMPLETED|Period II - 12-week Treatment (Base)||22
122749|NCT00132730|292730|P3|NOT COMPLETED|Period II - 12-week Treatment (Base)||18
122750|NCT00132730|292731|P2|NOT COMPLETED|Period II - 12-week Treatment (Base)||15
122751|NCT00132730|292732|P1|NOT COMPLETED|Period II - 12-week Treatment (Base)||23
122752|NCT00132730|292727|P6|COMPLETED|Period II - 12-week Treatment (Base)||0
122753|NCT00132730|292728|P5|COMPLETED|Period II - 12-week Treatment (Base)||0
122754|NCT00132730|292729|P4|COMPLETED|Period II - 12-week Treatment (Base)||131
122755|NCT00132730|292730|P3|COMPLETED|Period II - 12-week Treatment (Base)||135
122756|NCT00132730|292731|P2|COMPLETED|Period II - 12-week Treatment (Base)||133
122757|NCT00132730|292732|P1|COMPLETED|Period II - 12-week Treatment (Base)||127
122758|NCT00132730|292727|P6|STARTED|Period II - 12-week Treatment (Base)||0
122759|NCT00132730|292728|P5|STARTED|Period II - 12-week Treatment (Base)||0
122760|NCT00132730|292729|P4|STARTED|Period II - 12-week Treatment (Base)||153
122761|NCT00132730|292730|P3|STARTED|Period II - 12-week Treatment (Base)||153
122762|NCT00132730|292731|P2|STARTED|Period II - 12-week Treatment (Base)||148
122763|NCT00132730|292732|P1|STARTED|Period II - 12-week Treatment (Base)||150
122764|NCT00132730|292727|P6|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
122765|NCT00132730|292728|P5|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
122766|NCT00132730|292729|P4|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
122767|NCT00132730|292730|P3|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
122768|NCT00132730|292731|P2|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
122769|NCT00132730|292732|P1|NOT COMPLETED|Period I - Placebo Run-in (Base)||0
122770|NCT00132730|292727|P6|COMPLETED|Period I - Placebo Run-in (Base)||0
122771|NCT00132730|292728|P5|COMPLETED|Period I - Placebo Run-in (Base)||0
122772|NCT00132730|292729|P4|COMPLETED|Period I - Placebo Run-in (Base)||153
122773|NCT00132730|292730|P3|COMPLETED|Period I - Placebo Run-in (Base)||153
122774|NCT00132730|292731|P2|COMPLETED|Period I - Placebo Run-in (Base)||148
122775|NCT00132730|292732|P1|COMPLETED|Period I - Placebo Run-in (Base)||150
122776|NCT00132730|292727|P6|STARTED|Period I - Placebo Run-in (Base)||0
122777|NCT00132730|292728|P5|STARTED|Period I - Placebo Run-in (Base)||0
122778|NCT00132730|292729|P4|STARTED|Period I - Placebo Run-in (Base)||153
122779|NCT00132730|292730|P3|STARTED|Period I - Placebo Run-in (Base)||153
122780|NCT00132730|292731|P2|STARTED|Period I - Placebo Run-in (Base)||148
122781|NCT00132730|292732|P1|STARTED|Period I - Placebo Run-in (Base)||150
122782|NCT00132769|292776|P2|NOT COMPLETED|Overall Study||11
122783|NCT00132769|292777|P1|NOT COMPLETED|Overall Study||11
122784|NCT00132769|292776|P2|COMPLETED|Overall Study||42
122785|NCT00132769|292777|P1|COMPLETED|Overall Study||42
122786|NCT00132769|292776|P2|STARTED|Overall Study||53
122787|NCT00132769|292777|P1|STARTED|Overall Study||53
122788|NCT00132808|292802|P3|NOT COMPLETED|Stratum II||9
122789|NCT00132808|292803|P2|NOT COMPLETED|Stratum II||15
122790|NCT00132808|292804|P1|NOT COMPLETED|Stratum II||8
122791|NCT00132808|292802|P3|COMPLETED|Stratum II||116
122792|NCT00132808|292803|P2|COMPLETED|Stratum II||96
122793|NCT00132808|292804|P1|COMPLETED|Stratum II||113
122794|NCT00132808|292802|P3|STARTED|Stratum II||125
122795|NCT00132808|292803|P2|STARTED|Stratum II||111
122796|NCT00132808|292804|P1|STARTED|Stratum II||121
122797|NCT00132808|292802|P3|NOT COMPLETED|Stratum I||5
122798|NCT00132808|292803|P2|NOT COMPLETED|Stratum I||12
122799|NCT00132808|292804|P1|NOT COMPLETED|Stratum I||9
122800|NCT00132808|292802|P3|COMPLETED|Stratum I||72
122801|NCT00132808|292803|P2|COMPLETED|Stratum I||58
122802|NCT00132808|292804|P1|COMPLETED|Stratum I||68
122803|NCT00132808|292802|P3|STARTED|Stratum I||77
122804|NCT00132808|292803|P2|STARTED|Stratum I||70
122805|NCT00132808|292804|P1|STARTED|Stratum I||77
122806|NCT00132873|292827|P1|NOT COMPLETED|Overall Study||9
122807|NCT00132873|292827|P1|COMPLETED|Overall Study||50
122808|NCT00132873|292827|P1|STARTED|Overall Study||59
122809|NCT00133575|292839|P7|NOT COMPLETED|Overall Study||3
122810|NCT00133575|292840|P6|NOT COMPLETED|Overall Study||1
122811|NCT00133575|292841|P5|NOT COMPLETED|Overall Study||4
122812|NCT00133575|292842|P4|NOT COMPLETED|Overall Study||1
122813|NCT00133575|292843|P3|NOT COMPLETED|Overall Study||2
122814|NCT00133575|292844|P2|NOT COMPLETED|Overall Study||0
122815|NCT00133575|292845|P1|NOT COMPLETED|Overall Study||0
122816|NCT00133575|292839|P7|COMPLETED|Overall Study||9
122817|NCT00133575|292840|P6|COMPLETED|Overall Study||9
122818|NCT00133575|292841|P5|COMPLETED|Overall Study||6
122819|NCT00133575|292842|P4|COMPLETED|Overall Study||9
122820|NCT00133575|292843|P3|COMPLETED|Overall Study||8
122821|NCT00133575|292844|P2|COMPLETED|Overall Study||10
122822|NCT00133575|292845|P1|COMPLETED|Overall Study||10
122823|NCT00133575|292839|P7|STARTED|Overall Study||12
122824|NCT00133575|292840|P6|STARTED|Overall Study||10
122825|NCT00133575|292841|P5|STARTED|Overall Study||10
122826|NCT00133575|292842|P4|STARTED|Overall Study||10
122827|NCT00133575|292843|P3|STARTED|Overall Study||10
122828|NCT00133575|292844|P2|STARTED|Overall Study||10
122829|NCT00133575|292845|P1|STARTED|Overall Study||10
122830|NCT00133705|292954|P2|NOT COMPLETED|Overall Study||3
122831|NCT00133705|292955|P1|NOT COMPLETED|Overall Study||2
122832|NCT00133705|292954|P2|COMPLETED|Overall Study||17
122833|NCT00133705|292955|P1|COMPLETED|Overall Study||20
122834|NCT00133705|292954|P2|STARTED|Overall Study||20
122835|NCT00133705|292955|P1|STARTED|Overall Study||22
122836|NCT00133809|292961|P1|NOT COMPLETED|Overall Study||0
122837|NCT00133809|292961|P1|COMPLETED|Overall Study||8
122838|NCT00133809|292961|P1|STARTED|Overall Study||8
122839|NCT00133952|292970|P2|NOT COMPLETED|Overall Study||28
122840|NCT00133952|292971|P1|NOT COMPLETED|Overall Study||42
122841|NCT00133952|292970|P2|COMPLETED|Overall Study||124
122842|NCT00133952|292971|P1|COMPLETED|Overall Study||115
122843|NCT00133952|292970|P2|Received at Least One Dose of Study Drug|Overall Study||149
122844|NCT00133952|292971|P1|Received at Least One Dose of Study Drug|Overall Study||153
122845|NCT00133952|292970|P2|STARTED|Overall Study||152
122846|NCT00133952|292971|P1|STARTED|Overall Study||157
122847|NCT00133978|292997|P4|NOT COMPLETED|Overall Study||2
122848|NCT00133978|292998|P3|NOT COMPLETED|Overall Study||0
122849|NCT00133978|292999|P2|NOT COMPLETED|Overall Study||1
122850|NCT00133978|293000|P1|NOT COMPLETED|Overall Study||2
122851|NCT00133978|292997|P4|COMPLETED|Overall Study||300
122852|NCT00133978|292998|P3|COMPLETED|Overall Study||310
122853|NCT00133978|292999|P2|COMPLETED|Overall Study||307
122854|NCT00133978|293000|P1|COMPLETED|Overall Study||301
122855|NCT00133978|292997|P4|STARTED|Overall Study||302
122856|NCT00133978|292998|P3|STARTED|Overall Study||310
122857|NCT00133978|292999|P2|STARTED|Overall Study||308
122858|NCT00133978|293000|P1|STARTED|Overall Study||303
122859|NCT00134004|293022|P1|NOT COMPLETED|Overall Study||0
122860|NCT00134004|293022|P1|COMPLETED|Overall Study||210
122861|NCT00134004|293022|P1|STARTED|Overall Study||210
122862|NCT00134043|293032|P2|NOT COMPLETED|Overall Study||0
122863|NCT00134043|293033|P1|NOT COMPLETED|Overall Study||0
122864|NCT00134043|293032|P2|COMPLETED|Overall Study||3
122865|NCT00134043|293033|P1|COMPLETED|Overall Study||16
122866|NCT00134043|293032|P2|STARTED|Overall Study||3
122867|NCT00134043|293033|P1|STARTED|Overall Study||16
122868|NCT00134056|293040|P2|NOT COMPLETED|Eligible for Protocol Assigned Treatment||315
122869|NCT00134056|293041|P1|NOT COMPLETED|Eligible for Protocol Assigned Treatment||327
122870|NCT00134056|293040|P2|COMPLETED|Eligible for Protocol Assigned Treatment||185
122871|NCT00134056|293041|P1|COMPLETED|Eligible for Protocol Assigned Treatment||169
122872|NCT00134056|293040|P2|STARTED|Eligible for Protocol Assigned Treatment||500
122873|NCT00134056|293041|P1|STARTED|Eligible for Protocol Assigned Treatment||496
122874|NCT00134056|293040|P2|NOT COMPLETED|Randomization||20
122875|NCT00134056|293041|P1|NOT COMPLETED|Randomization||22
122876|NCT00134056|293040|P2|COMPLETED|Randomization||500
122877|NCT00134056|293041|P1|COMPLETED|Randomization||496
122878|NCT00134056|293040|P2|STARTED|Randomization||520
122879|NCT00134056|293041|P1|STARTED|Randomization||518
122880|NCT00134563|293064|P3|NOT COMPLETED|Overall Study||96
122881|NCT00134563|293065|P2|NOT COMPLETED|Overall Study||92
122882|NCT00134563|293066|P1|NOT COMPLETED|Overall Study||104
122883|NCT00134563|293064|P3|COMPLETED|Overall Study|completed treatment period|263
122884|NCT00134563|293065|P2|COMPLETED|Overall Study|completed treatment period|274
122885|NCT00134563|293066|P1|COMPLETED|Overall Study|completed treatment period|259
122886|NCT00134563|293064|P3|Treated|Overall Study|one participant received doses of Teriflunomide 7 mg|358
122887|NCT00134563|293065|P2|Treated|Overall Study||365
122888|NCT00134563|293066|P1|Treated|Overall Study|Two participants received doses of Teriflunomide 7 mg, one participant doses of Teriflunomide 14 mg|363
122889|NCT00134563|293064|P3|STARTED|Overall Study|Randomized|359
122890|NCT00134563|293065|P2|STARTED|Overall Study|Randomized|366
122891|NCT00134563|293066|P1|STARTED|Overall Study|Randomized|363
122892|NCT00134719|293092|P3|NOT COMPLETED|Fourth Dose Vaccination Phase||1
122893|NCT00134719|293093|P2|NOT COMPLETED|Fourth Dose Vaccination Phase||3
122894|NCT00134719|293094|P1|NOT COMPLETED|Fourth Dose Vaccination Phase||2
122895|NCT00134719|293092|P3|COMPLETED|Fourth Dose Vaccination Phase||203
122896|NCT00134719|293093|P2|COMPLETED|Fourth Dose Vaccination Phase||203
122897|NCT00134719|293094|P1|COMPLETED|Fourth Dose Vaccination Phase||623
122898|NCT00134719|293092|P3|STARTED|Fourth Dose Vaccination Phase||204
122899|NCT00134719|293093|P2|STARTED|Fourth Dose Vaccination Phase||206
122900|NCT00134719|293094|P1|STARTED|Fourth Dose Vaccination Phase||625
122901|NCT00134719|293092|P3|NOT COMPLETED|Primary Vaccination Phase||5
122902|NCT00134719|293093|P2|NOT COMPLETED|Primary Vaccination Phase||6
122903|NCT00134719|293094|P1|NOT COMPLETED|Primary Vaccination Phase||14
122904|NCT00134719|293092|P3|COMPLETED|Primary Vaccination Phase||216
122905|NCT00134719|293093|P2|COMPLETED|Primary Vaccination Phase||215
122906|NCT00134719|293094|P1|COMPLETED|Primary Vaccination Phase||647
122907|NCT00134719|293092|P3|STARTED|Primary Vaccination Phase||221
122908|NCT00134719|293093|P2|STARTED|Primary Vaccination Phase||221
122909|NCT00134719|293094|P1|STARTED|Primary Vaccination Phase||661
122910|NCT00134784|293226|P4|NOT COMPLETED|Overall Study||1
122911|NCT00134784|293227|P3|NOT COMPLETED|Overall Study||2
122912|NCT00134784|293228|P2|NOT COMPLETED|Overall Study||2
122913|NCT00134784|293229|P1|NOT COMPLETED|Overall Study||2
122914|NCT00134784|293226|P4|COMPLETED|Overall Study||37
122915|NCT00134784|293227|P3|COMPLETED|Overall Study||35
122916|NCT00134784|293228|P2|COMPLETED|Overall Study||36
122917|NCT00134784|293229|P1|COMPLETED|Overall Study||27
122918|NCT00134784|293226|P4|STARTED|Overall Study||38
122919|NCT00134784|293227|P3|STARTED|Overall Study||37
122920|NCT00134784|293228|P2|STARTED|Overall Study||38
122921|NCT00134784|293229|P1|STARTED|Overall Study||29
122922|NCT00127530|293238|P2|NOT COMPLETED|Overall Study||21
122923|NCT00127530|293239|P1|NOT COMPLETED|Overall Study||1
122924|NCT00127530|293238|P2|COMPLETED|Overall Study||207
122925|NCT00127530|293239|P1|COMPLETED|Overall Study||71
122926|NCT00127530|293238|P2|STARTED|Overall Study||228
122927|NCT00127530|293239|P1|STARTED|Overall Study||72
122940|NCT00127712|293264|P2|NOT COMPLETED|Overall Study||0
122941|NCT00127712|293265|P1|NOT COMPLETED|Overall Study||5
122942|NCT00127712|293264|P2|COMPLETED|Overall Study||65
122943|NCT00127712|293265|P1|COMPLETED|Overall Study||60
122944|NCT00127712|293264|P2|STARTED|Overall Study||65
122945|NCT00127712|293265|P1|STARTED|Overall Study||65
122946|NCT00127790|293281|P4|NOT COMPLETED|Post-Treatment||0
122947|NCT00127790|293282|P3|NOT COMPLETED|Post-Treatment||0
122948|NCT00127790|293283|P2|NOT COMPLETED|Post-Treatment||0
122949|NCT00127790|293284|P1|NOT COMPLETED|Post-Treatment||0
122950|NCT00127790|293281|P4|COMPLETED|Post-Treatment||4
122951|NCT00127790|293282|P3|COMPLETED|Post-Treatment||6
122952|NCT00127790|293283|P2|COMPLETED|Post-Treatment||5
122953|NCT00127790|293284|P1|COMPLETED|Post-Treatment||6
122954|NCT00127790|293281|P4|STARTED|Post-Treatment||4
122955|NCT00127790|293282|P3|STARTED|Post-Treatment||6
122956|NCT00127790|293283|P2|STARTED|Post-Treatment||5
122957|NCT00127790|293284|P1|STARTED|Post-Treatment||6
122958|NCT00127790|293281|P4|NOT COMPLETED|Pre-Treatment||0
122959|NCT00127790|293282|P3|NOT COMPLETED|Pre-Treatment||0
122960|NCT00127790|293283|P2|NOT COMPLETED|Pre-Treatment||0
122961|NCT00127790|293284|P1|NOT COMPLETED|Pre-Treatment||0
122962|NCT00127790|293281|P4|COMPLETED|Pre-Treatment||4
122963|NCT00127790|293282|P3|COMPLETED|Pre-Treatment||6
122964|NCT00127790|293283|P2|COMPLETED|Pre-Treatment||5
122965|NCT00127790|293284|P1|COMPLETED|Pre-Treatment||6
122966|NCT00127790|293281|P4|STARTED|Pre-Treatment||4
122967|NCT00127790|293282|P3|STARTED|Pre-Treatment||6
122968|NCT00127790|293283|P2|STARTED|Pre-Treatment||5
122969|NCT00127790|293284|P1|STARTED|Pre-Treatment|7 enrolled subjects were withdrawn prior to randomization; 21 of 28 enrolled were randomized.|6
122970|NCT00127803|293310|P4|NOT COMPLETED|Overall Study||1
122971|NCT00127803|293311|P3|NOT COMPLETED|Overall Study||0
122972|NCT00127803|293312|P2|NOT COMPLETED|Overall Study||0
122973|NCT00127803|293313|P1|NOT COMPLETED|Overall Study||3
122974|NCT00127803|293310|P4|COMPLETED|Overall Study||11
122975|NCT00127803|293311|P3|COMPLETED|Overall Study||12
122976|NCT00127803|293312|P2|COMPLETED|Overall Study||13
122977|NCT00127803|293313|P1|COMPLETED|Overall Study||10
122978|NCT00127803|293310|P4|STARTED|Overall Study||12
122979|NCT00127803|293311|P3|STARTED|Overall Study||12
122980|NCT00127803|293312|P2|STARTED|Overall Study||13
122981|NCT00127803|293313|P1|STARTED|Overall Study||13
122982|NCT00127842|293331|P1|NOT COMPLETED|Overall Study||39
122983|NCT00127842|293331|P1|COMPLETED|Overall Study||71
122984|NCT00127842|293331|P1|STARTED|Overall Study||110
122985|NCT00127855|293350|P5|NOT COMPLETED|Polysaccharide Challenge Dose||0
122986|NCT00127855|293351|P4|NOT COMPLETED|Polysaccharide Challenge Dose||0
122987|NCT00127855|293352|P3|NOT COMPLETED|Polysaccharide Challenge Dose||0
122988|NCT00127855|293353|P2|NOT COMPLETED|Polysaccharide Challenge Dose||0
122989|NCT00127855|293354|P1|NOT COMPLETED|Polysaccharide Challenge Dose||0
122990|NCT00127855|293350|P5|COMPLETED|Polysaccharide Challenge Dose||77
122991|NCT00127855|293351|P4|COMPLETED|Polysaccharide Challenge Dose||81
122992|NCT00127855|293352|P3|COMPLETED|Polysaccharide Challenge Dose||77
122993|NCT00127855|293353|P2|COMPLETED|Polysaccharide Challenge Dose||79
122994|NCT00127855|293354|P1|COMPLETED|Polysaccharide Challenge Dose||80
122995|NCT00127855|293350|P5|STARTED|Polysaccharide Challenge Dose||77
122996|NCT00127855|293351|P4|STARTED|Polysaccharide Challenge Dose||81
122997|NCT00127855|293352|P3|STARTED|Polysaccharide Challenge Dose||77
122998|NCT00127855|293353|P2|STARTED|Polysaccharide Challenge Dose||79
122999|NCT00127855|293354|P1|STARTED|Polysaccharide Challenge Dose||80
123000|NCT00127855|293350|P5|NOT COMPLETED|Primary Vaccination Course||4
123001|NCT00127855|293351|P4|NOT COMPLETED|Primary Vaccination Course||0
123002|NCT00127855|293352|P3|NOT COMPLETED|Primary Vaccination Course||2
123003|NCT00127855|293353|P2|NOT COMPLETED|Primary Vaccination Course||1
123004|NCT00127855|293354|P1|NOT COMPLETED|Primary Vaccination Course||2
123005|NCT00127855|293350|P5|COMPLETED|Primary Vaccination Course||78
123006|NCT00127855|293351|P4|COMPLETED|Primary Vaccination Course||81
123007|NCT00127855|293352|P3|COMPLETED|Primary Vaccination Course||78
123008|NCT00127855|293353|P2|COMPLETED|Primary Vaccination Course||81
123009|NCT00127855|293354|P1|COMPLETED|Primary Vaccination Course||80
123010|NCT00127855|293350|P5|STARTED|Primary Vaccination Course||82
123011|NCT00127855|293351|P4|STARTED|Primary Vaccination Course||81
123012|NCT00127855|293352|P3|STARTED|Primary Vaccination Course||80
123013|NCT00127855|293353|P2|STARTED|Primary Vaccination Course||82
123014|NCT00127855|293354|P1|STARTED|Primary Vaccination Course||82
123015|NCT00127933|293538|P2|NOT COMPLETED|Overall Study||0
123016|NCT00127933|293539|P1|NOT COMPLETED|Overall Study||1
123017|NCT00127933|293538|P2|COMPLETED|Overall Study||34
123018|NCT00127933|293539|P1|COMPLETED|Overall Study||122
123019|NCT00127933|293538|P2|Postoperative|Overall Study||27
123020|NCT00127933|293539|P1|Postoperative|Overall Study||98
123021|NCT00127933|293538|P2|Quality of Life Population|Overall Study||33
123022|NCT00127933|293539|P1|Quality of Life Population|Overall Study||118
123023|NCT00127933|293538|P2|Safety Population|Overall Study||34
123024|NCT00127933|293539|P1|Safety Population|Overall Study||122
123025|NCT00127933|293538|P2|Clinical Response|Overall Study||34
123026|NCT00127933|293539|P1|Clinical Response|Overall Study||122
123027|NCT00127933|293538|P2|Pathological Response|Overall Study||28
123028|NCT00127933|293539|P1|Pathological Response|Overall Study||101
123029|NCT00127933|293538|P2|STARTED|Overall Study||34
123030|NCT00127933|293539|P1|STARTED|Overall Study||123
123031|NCT00128180|293557|P2|NOT COMPLETED|Overall Study||0
123032|NCT00128180|293558|P1|NOT COMPLETED|Overall Study||0
123033|NCT00128180|293557|P2|COMPLETED|Overall Study||34
123034|NCT00128180|293558|P1|COMPLETED|Overall Study||32
123035|NCT00128180|293557|P2|STARTED|Overall Study||34
123036|NCT00128180|293558|P1|STARTED|Overall Study||32
123037|NCT00128193|293594|P12|NOT COMPLETED|Overall Study||2
123038|NCT00128193|293595|P11|NOT COMPLETED|Overall Study||3
123039|NCT00128193|293596|P10|NOT COMPLETED|Overall Study||2
123040|NCT00128193|293597|P9|NOT COMPLETED|Overall Study||2
123041|NCT00128193|293598|P8|NOT COMPLETED|Overall Study||0
123042|NCT00128193|293599|P7|NOT COMPLETED|Overall Study||4
123043|NCT00128193|293600|P6|NOT COMPLETED|Overall Study||3
123044|NCT00128193|293601|P5|NOT COMPLETED|Overall Study||2
123045|NCT00128193|293602|P4|NOT COMPLETED|Overall Study||1
123046|NCT00128193|293603|P3|NOT COMPLETED|Overall Study||3
123047|NCT00128193|293604|P2|NOT COMPLETED|Overall Study||0
123048|NCT00128193|293605|P1|NOT COMPLETED|Overall Study||0
123049|NCT00128193|293594|P12|COMPLETED|Overall Study||18
123050|NCT00128193|293595|P11|COMPLETED|Overall Study||17
123051|NCT00128193|293596|P10|COMPLETED|Overall Study||18
123052|NCT00128193|293597|P9|COMPLETED|Overall Study||18
123053|NCT00128193|293598|P8|COMPLETED|Overall Study||20
123054|NCT00128193|293599|P7|COMPLETED|Overall Study||16
123055|NCT00128193|293600|P6|COMPLETED|Overall Study||17
123056|NCT00128193|293601|P5|COMPLETED|Overall Study||18
123057|NCT00128193|293602|P4|COMPLETED|Overall Study||44
123058|NCT00128193|293603|P3|COMPLETED|Overall Study||42
123059|NCT00128193|293604|P2|COMPLETED|Overall Study||5
123060|NCT00128193|293605|P1|COMPLETED|Overall Study||5
123061|NCT00128193|293594|P12|STARTED|Overall Study||20
123062|NCT00128193|293595|P11|STARTED|Overall Study||20
123063|NCT00128193|293596|P10|STARTED|Overall Study||20
123064|NCT00128193|293597|P9|STARTED|Overall Study||20
123065|NCT00128193|293598|P8|STARTED|Overall Study||20
123066|NCT00128193|293599|P7|STARTED|Overall Study||20
123067|NCT00128193|293600|P6|STARTED|Overall Study||20
123068|NCT00128193|293601|P5|STARTED|Overall Study||20
123069|NCT00128193|293602|P4|STARTED|Overall Study||45
123070|NCT00128193|293603|P3|STARTED|Overall Study||45
123071|NCT00128193|293604|P2|STARTED|Overall Study||5
123072|NCT00128193|293605|P1|STARTED|Overall Study||5
123073|NCT00128206|293841|P2|NOT COMPLETED|Overall Study||120
123074|NCT00128206|293842|P1|NOT COMPLETED|Overall Study||137
123075|NCT00128206|293841|P2|COMPLETED|Overall Study||60
123076|NCT00128206|293842|P1|COMPLETED|Overall Study||47
123077|NCT00128206|293841|P2|STARTED|Overall Study||180
123078|NCT00128206|293842|P1|STARTED|Overall Study||184
123079|NCT00128219|293850|P2|NOT COMPLETED|Overall Study||71
123080|NCT00128219|293851|P1|NOT COMPLETED|Overall Study||69
123081|NCT00128219|293850|P2|COMPLETED|Overall Study||263
123082|NCT00128219|293851|P1|COMPLETED|Overall Study||264
123083|NCT00128219|293850|P2|STARTED|Overall Study||334
123084|NCT00128219|293851|P1|STARTED|Overall Study||333
123085|NCT00128401|293935|P2|NOT COMPLETED|Overall Study||4
123086|NCT00128401|293936|P1|NOT COMPLETED|Overall Study||6
123087|NCT00128401|293935|P2|COMPLETED|Overall Study||15
123088|NCT00128401|293936|P1|COMPLETED|Overall Study||14
123089|NCT00128401|293935|P2|STARTED|Overall Study||19
123090|NCT00128401|293936|P1|STARTED|Overall Study||20
123091|NCT00128492|293947|P2|NOT COMPLETED|Overall Study||59
123092|NCT00128492|293948|P1|NOT COMPLETED|Overall Study||20
123093|NCT00128492|293947|P2|COMPLETED|Overall Study||130
123094|NCT00128492|293948|P1|COMPLETED|Overall Study||65
123095|NCT00128492|293947|P2|STARTED|Overall Study||189
123096|NCT00128492|293948|P1|STARTED|Overall Study||85
123097|NCT00128661|294008|P2|NOT COMPLETED|Overall Study||258
123098|NCT00128661|294009|P1|NOT COMPLETED|Overall Study||274
123099|NCT00128661|294008|P2|COMPLETED|Overall Study||3481
123100|NCT00128661|294009|P1|COMPLETED|Overall Study||3453
123101|NCT00128661|294008|P2|STARTED|Overall Study||3739
123102|NCT00128661|294009|P1|STARTED|Overall Study||3727
123103|NCT00128713|294056|P3|NOT COMPLETED|Overall Study||0
123104|NCT00128713|294057|P2|NOT COMPLETED|Overall Study||0
123105|NCT00128713|294058|P1|NOT COMPLETED|Overall Study||0
123106|NCT00128713|294056|P3|COMPLETED|Overall Study||449
123107|NCT00128713|294057|P2|COMPLETED|Overall Study||449
123108|NCT00128713|294058|P1|COMPLETED|Overall Study||453
123109|NCT00128713|294056|P3|STARTED|Overall Study||449
123110|NCT00128713|294057|P2|STARTED|Overall Study||449
123111|NCT00128713|294058|P1|STARTED|Overall Study||453
123112|NCT00128830|294078|P1|NOT COMPLETED|Overall Study||72
123113|NCT00128830|294078|P1|COMPLETED|Overall Study||139
123114|NCT00128830|294078|P1|STARTED|Overall Study||211
123115|NCT00128921|294096|P3|NOT COMPLETED|Overall Study||0
123116|NCT00128921|294097|P2|NOT COMPLETED|Overall Study||5
123117|NCT00128921|294098|P1|NOT COMPLETED|Overall Study||5
123118|NCT00128921|294096|P3|COMPLETED|Overall Study||0
123119|NCT00128921|294097|P2|COMPLETED|Overall Study||3
123120|NCT00128921|294098|P1|COMPLETED|Overall Study||5
123121|NCT00128921|294096|P3|Received Bortezomib|Overall Study||0
123122|NCT00128921|294097|P2|Received Bortezomib|Overall Study||6
123123|NCT00128921|294098|P1|Received Bortezomib|Overall Study||10
123124|NCT00128921|294096|P3|STARTED|Overall Study||0
123125|NCT00128921|294097|P2|STARTED|Overall Study||8
123126|NCT00128921|294098|P1|STARTED|Overall Study||10
123127|NCT00129116|294120|P5|NOT COMPLETED|Booster Phase||1
123128|NCT00129116|294121|P4|NOT COMPLETED|Booster Phase||0
123129|NCT00129116|294122|P3|NOT COMPLETED|Booster Phase||0
123130|NCT00129116|294123|P2|NOT COMPLETED|Booster Phase||0
123131|NCT00129116|294124|P1|NOT COMPLETED|Booster Phase||2
123132|NCT00129116|294120|P5|COMPLETED|Booster Phase||43
123133|NCT00129116|294121|P4|COMPLETED|Booster Phase||44
123134|NCT00129116|294122|P3|COMPLETED|Booster Phase||44
123135|NCT00129116|294123|P2|COMPLETED|Booster Phase||42
123136|NCT00129116|294124|P1|COMPLETED|Booster Phase||45
123137|NCT00129116|294120|P5|STARTED|Booster Phase||44
123138|NCT00129116|294121|P4|STARTED|Booster Phase||44
123139|NCT00129116|294122|P3|STARTED|Booster Phase||44
123140|NCT00129116|294123|P2|STARTED|Booster Phase||42
123141|NCT00129116|294124|P1|STARTED|Booster Phase||47
123142|NCT00129116|294120|P5|NOT COMPLETED|Primary Phase||1
123143|NCT00129116|294121|P4|NOT COMPLETED|Primary Phase||1
123144|NCT00129116|294122|P3|NOT COMPLETED|Primary Phase||1
123145|NCT00129116|294123|P2|NOT COMPLETED|Primary Phase||4
123146|NCT00129116|294124|P1|NOT COMPLETED|Primary Phase||2
123147|NCT00129116|294120|P5|COMPLETED|Primary Phase||76
123148|NCT00129116|294121|P4|COMPLETED|Primary Phase||77
123149|NCT00129116|294122|P3|COMPLETED|Primary Phase||77
123150|NCT00129116|294123|P2|COMPLETED|Primary Phase||73
123151|NCT00129116|294124|P1|COMPLETED|Primary Phase||76
123152|NCT00129116|294120|P5|STARTED|Primary Phase||77
123153|NCT00129116|294121|P4|STARTED|Primary Phase||78
123154|NCT00129116|294122|P3|STARTED|Primary Phase||78
123155|NCT00129116|294123|P2|STARTED|Primary Phase||77
123156|NCT00129116|294124|P1|STARTED|Primary Phase||78
123157|NCT00129129|294389|P5|NOT COMPLETED|Fourth Dose Phase||6
123158|NCT00129129|294390|P4|NOT COMPLETED|Fourth Dose Phase||4
123159|NCT00129129|294391|P3|NOT COMPLETED|Fourth Dose Phase||0
123160|NCT00129129|294392|P2|NOT COMPLETED|Fourth Dose Phase||0
123161|NCT00129129|294393|P1|NOT COMPLETED|Fourth Dose Phase||4
123162|NCT00129129|294389|P5|COMPLETED|Fourth Dose Phase||124
123163|NCT00129129|294390|P4|COMPLETED|Fourth Dose Phase||128
123164|NCT00129129|294391|P3|COMPLETED|Fourth Dose Phase||0
123165|NCT00129129|294392|P2|COMPLETED|Fourth Dose Phase||0
123166|NCT00129129|294393|P1|COMPLETED|Fourth Dose Phase||232
123167|NCT00129129|294389|P5|STARTED|Fourth Dose Phase||130
123168|NCT00129129|294390|P4|STARTED|Fourth Dose Phase||132
123169|NCT00129129|294391|P3|STARTED|Fourth Dose Phase||0
123170|NCT00129129|294392|P2|STARTED|Fourth Dose Phase||0
123171|NCT00129129|294393|P1|STARTED|Fourth Dose Phase||236
123172|NCT00129129|294389|P5|NOT COMPLETED|Primary Phase||0
123173|NCT00129129|294390|P4|NOT COMPLETED|Primary Phase||0
123174|NCT00129129|294391|P3|NOT COMPLETED|Primary Phase||0
123175|NCT00129129|294392|P2|NOT COMPLETED|Primary Phase||25
123176|NCT00129129|294393|P1|NOT COMPLETED|Primary Phase||25
123177|NCT00129129|294389|P5|COMPLETED|Primary Phase||0
123178|NCT00129129|294390|P4|COMPLETED|Primary Phase||0
123179|NCT00129129|294391|P3|COMPLETED|Primary Phase||150
123180|NCT00129129|294392|P2|COMPLETED|Primary Phase||294
123181|NCT00129129|294393|P1|COMPLETED|Primary Phase||262
123182|NCT00129129|294389|P5|STARTED|Primary Phase||0
123183|NCT00129129|294390|P4|STARTED|Primary Phase||0
123184|NCT00129129|294391|P3|STARTED|Primary Phase||150
123185|NCT00129129|294392|P2|STARTED|Primary Phase||319
123186|NCT00129129|294393|P1|STARTED|Primary Phase||287
123187|NCT00134901|294597|P2|NOT COMPLETED|Overall Study||15
123188|NCT00134901|294598|P1|NOT COMPLETED|Overall Study||17
123189|NCT00134901|294597|P2|COMPLETED|Overall Study||27
123190|NCT00134901|294598|P1|COMPLETED|Overall Study||22
123191|NCT00134901|294597|P2|STARTED|Overall Study||42
123192|NCT00134901|294598|P1|STARTED|Overall Study||39
123193|NCT00137267|294608|P2|NOT COMPLETED|Overall Study||21
123194|NCT00137267|294609|P1|NOT COMPLETED|Overall Study||15
123195|NCT00137267|294608|P2|COMPLETED|Overall Study||26
123196|NCT00137267|294609|P1|COMPLETED|Overall Study||40
123197|NCT00137267|294608|P2|STARTED|Overall Study||47
123198|NCT00137267|294609|P1|STARTED|Overall Study||55
123199|NCT00137280|294619|P2|NOT COMPLETED|Overall Study||55
123200|NCT00137280|294620|P1|NOT COMPLETED|Overall Study||84
123201|NCT00137280|294619|P2|COMPLETED|Overall Study||357
123202|NCT00137280|294620|P1|COMPLETED|Overall Study||305
123203|NCT00137280|294619|P2|STARTED|Overall Study||412
123204|NCT00137280|294620|P1|STARTED|Overall Study||389
123205|NCT00137423|294634|P2|NOT COMPLETED|Overall Study||44
123206|NCT00137423|294635|P1|NOT COMPLETED|Overall Study||39
123207|NCT00137423|294634|P2|COMPLETED|Overall Study||9
123208|NCT00137423|294635|P1|COMPLETED|Overall Study||15
123209|NCT00137423|294634|P2|STARTED|Overall Study||53
123210|NCT00137423|294635|P1|STARTED|Overall Study||54
123211|NCT00137436|294655|P1|NOT COMPLETED|Overall Study||43
123212|NCT00137436|294655|P1|COMPLETED|Overall Study||12
123213|NCT00137436|294655|P1|STARTED|Overall Study|Phase 2 did not include 38 participants from Phase 1.|55
123214|NCT00137449|294674|P2|NOT COMPLETED|Overall Study||18
123215|NCT00137449|294675|P1|NOT COMPLETED|Overall Study||16
123216|NCT00137449|294674|P2|COMPLETED|Overall Study||12
123217|NCT00137449|294675|P1|COMPLETED|Overall Study||14
123218|NCT00137449|294674|P2|STARTED|Overall Study||30
123219|NCT00137449|294675|P1|STARTED|Overall Study||30
123220|NCT00137631|294714|P2|NOT COMPLETED|Overall Study||41
123221|NCT00137631|294715|P1|NOT COMPLETED|Overall Study||37
123222|NCT00137631|294714|P2|COMPLETED|Overall Study||133
123223|NCT00137631|294715|P1|COMPLETED|Overall Study||127
123224|NCT00137631|294714|P2|Completed 6-month Follow-up|Overall Study|8 participants who were lost to follow-up at 3-months were retained at 6-months|133
123225|NCT00137631|294715|P1|Completed 6-month Follow-up|Overall Study|7 participants who were lost to follow-up at 3-months were retained at 6-months|127
123226|NCT00137631|294714|P2|Complete 3-month Follow-up|Overall Study||125
123227|NCT00137631|294715|P1|Complete 3-month Follow-up|Overall Study||120
123228|NCT00137631|294714|P2|STARTED|Overall Study||174
123229|NCT00137631|294715|P1|STARTED|Overall Study||164
123230|NCT00137969|294731|P2|NOT COMPLETED|Overall Study||21
123231|NCT00137969|294732|P1|NOT COMPLETED|Overall Study||67
123232|NCT00137969|294731|P2|COMPLETED|Overall Study||67
123233|NCT00137969|294732|P1|COMPLETED|Overall Study||107
123234|NCT00137969|294731|P2|Received Study Drug|Overall Study||88
123235|NCT00137969|294732|P1|Received Study Drug|Overall Study||169
123236|NCT00137969|294731|P2|STARTED|Overall Study||88
123237|NCT00137969|294732|P1|STARTED|Overall Study||174
123238|NCT00138034|294754|P2|NOT COMPLETED|Overall Study||3
123239|NCT00138034|294755|P1|NOT COMPLETED|Overall Study||3
123240|NCT00138034|294754|P2|COMPLETED|Overall Study||20
123241|NCT00138034|294755|P1|COMPLETED|Overall Study||23
123242|NCT00138034|294754|P2|STARTED|Overall Study||23
123243|NCT00138034|294755|P1|STARTED|Overall Study||26
123244|NCT00138073|294763|P1|NOT COMPLETED|Overall Study||55
123245|NCT00138073|294763|P1|COMPLETED|Overall Study||0
123246|NCT00138073|294763|P1|Pre-intervention Testing|Overall Study||55
123247|NCT00138073|294763|P1|STARTED|Overall Study||55
123248|NCT00138125|294768|P1|NOT COMPLETED|Overall Study||0
123249|NCT00138125|294768|P1|COMPLETED|Overall Study||2
123250|NCT00138125|294768|P1|STARTED|Overall Study||2
123251|NCT00138151|294772|P1|NOT COMPLETED|Overall Study||4
123252|NCT00138151|294772|P1|COMPLETED|Overall Study||29
123253|NCT00138151|294772|P1|STARTED|Overall Study||33
123254|NCT00138203|294778|P1|NOT COMPLETED|Overall Study||0
123255|NCT00138203|294778|P1|COMPLETED|Overall Study||16
123256|NCT00138203|294778|P1|STARTED|Overall Study||16
123257|NCT00138294|294784|P1|NOT COMPLETED|Overall Study||0
123258|NCT00138294|294784|P1|COMPLETED|Overall Study||29255
123259|NCT00138294|294784|P1|STARTED|Overall Study||29255
123260|NCT00138424|294798|P4|NOT COMPLETED|Overall Study||0
123261|NCT00138424|294799|P3|NOT COMPLETED|Overall Study||0
123262|NCT00138424|294800|P2|NOT COMPLETED|Overall Study||1
123263|NCT00138424|294801|P1|NOT COMPLETED|Overall Study||0
123264|NCT00138424|294798|P4|COMPLETED|Overall Study||3
123265|NCT00138424|294799|P3|COMPLETED|Overall Study||5
123266|NCT00138424|294800|P2|COMPLETED|Overall Study||4
123267|NCT00138424|294801|P1|COMPLETED|Overall Study||9
123268|NCT00138424|294798|P4|STARTED|Overall Study||3
123269|NCT00138424|294799|P3|STARTED|Overall Study||5
123270|NCT00138424|294800|P2|STARTED|Overall Study||5
123271|NCT00138424|294801|P1|STARTED|Overall Study||9
123272|NCT00138645|294869|P2|NOT COMPLETED|Overall Study||7
123273|NCT00138645|294870|P1|NOT COMPLETED|Overall Study||6
123274|NCT00138645|294869|P2|COMPLETED|Overall Study||23
123275|NCT00138645|294870|P1|COMPLETED|Overall Study||24
123276|NCT00138645|294869|P2|STARTED|Overall Study||30
123277|NCT00138645|294870|P1|STARTED|Overall Study||30
123278|NCT00138658|294876|P1|NOT COMPLETED|Overall Study||61
123279|NCT00138658|294876|P1|COMPLETED|Overall Study||20
123280|NCT00138658|294876|P1|STARTED|Overall Study||81
123281|NCT00138671|294888|P2|NOT COMPLETED|Overall Study||16
123282|NCT00138671|294889|P1|NOT COMPLETED|Overall Study||13
123283|NCT00138671|294888|P2|COMPLETED|Overall Study||30
123284|NCT00138671|294889|P1|COMPLETED|Overall Study||46
123285|NCT00138671|294888|P2|STARTED|Overall Study||46
123286|NCT00138671|294889|P1|STARTED|Overall Study||59
123287|NCT00139477|294941|P2|NOT COMPLETED|Second Intervention -6Months to 12Months||5
123288|NCT00139477|294942|P1|NOT COMPLETED|Second Intervention -6Months to 12Months||5
123289|NCT00139477|294941|P2|COMPLETED|Second Intervention -6Months to 12Months||18
123290|NCT00139477|294942|P1|COMPLETED|Second Intervention -6Months to 12Months||14
123291|NCT00139477|294941|P2|STARTED|Second Intervention -6Months to 12Months||23
123292|NCT00139477|294942|P1|STARTED|Second Intervention -6Months to 12Months||19
123293|NCT00139477|294941|P2|NOT COMPLETED|First Intervention -Baseline to 6Months||12
123294|NCT00139477|294942|P1|NOT COMPLETED|First Intervention -Baseline to 6Months||12
123295|NCT00139477|294941|P2|COMPLETED|First Intervention -Baseline to 6Months||23
123296|NCT00139477|294942|P1|COMPLETED|First Intervention -Baseline to 6Months||19
123297|NCT00139477|294941|P2|STARTED|First Intervention -Baseline to 6Months||35
123298|NCT00139477|294942|P1|STARTED|First Intervention -Baseline to 6Months||31
123299|NCT00139659|294964|P2|NOT COMPLETED|Overall Study||18
123300|NCT00139659|294965|P1|NOT COMPLETED|Overall Study||40
123301|NCT00139659|294964|P2|COMPLETED|Overall Study||123
123302|NCT00139659|294965|P1|COMPLETED|Overall Study||106
123303|NCT00139659|294964|P2|STARTED|Overall Study|1 subject randomized DC'd before receiving subcutaneous insulin and is not included in # of subjects|141
123304|NCT00139659|294965|P1|STARTED|Overall Study|1 subject randomized was DC'd prior to receiving inhaled insulin but received subcutaneous insulin|146
123305|NCT00132002|295041|P1|NOT COMPLETED|Overall Study||0
123306|NCT00132002|295041|P1|COMPLETED|Overall Study||14
123307|NCT00132002|295041|P1|STARTED|Overall Study||14
123308|NCT00132028|295047|P1|NOT COMPLETED|Overall Study||27
123309|NCT00132028|295047|P1|COMPLETED|Overall Study|"Since there was no maximum number of cycles, patients could not complete treatment."|0
123310|NCT00132028|295047|P1|Eligible and Began Protocol Therapy|Overall Study||25
123311|NCT00132028|295047|P1|Eligible|Overall Study||25
123312|NCT00132028|295047|P1|STARTED|Overall Study||27
123313|NCT00132132|295055|P2|NOT COMPLETED|Overall Study||2
123314|NCT00132132|295056|P1|NOT COMPLETED|Overall Study||7
123315|NCT00132132|295055|P2|COMPLETED|Overall Study||13
123316|NCT00132132|295056|P1|COMPLETED|Overall Study||8
123317|NCT00132132|295055|P2|STARTED|Overall Study||15
123318|NCT00132132|295056|P1|STARTED|Overall Study||15
123319|NCT00139737|295064|P1|NOT COMPLETED|Overall Study||341
123320|NCT00139737|295064|P1|COMPLETED|Overall Study||3
123321|NCT00139737|295064|P1|Received Treatment|Overall Study||331
123322|NCT00139737|295064|P1|STARTED|Overall Study||344
123323|NCT00139776|295070|P4|NOT COMPLETED|Period III||106
123324|NCT00139776|295071|P3|NOT COMPLETED|Period III||76
123325|NCT00139776|295072|P2|NOT COMPLETED|Period III||0
123326|NCT00139776|295073|P1|NOT COMPLETED|Period III||0
123327|NCT00139776|295070|P4|COMPLETED|Period III||321
123328|NCT00139776|295071|P3|COMPLETED|Period III||355
123329|NCT00139776|295072|P2|COMPLETED|Period III||0
123330|NCT00139776|295073|P1|COMPLETED|Period III||0
123331|NCT00139776|295070|P4|STARTED|Period III|Randomized 435: 8 participants not treated|427
123332|NCT00139776|295071|P3|STARTED|Period III|Randomized 440: 9 participants not treated|431
123333|NCT00139776|295072|P2|STARTED|Period III||0
123334|NCT00139776|295073|P1|STARTED|Period III||0
123335|NCT00139776|295070|P4|NOT COMPLETED|Period II||0
123336|NCT00139776|295071|P3|NOT COMPLETED|Period II||0
123337|NCT00139776|295072|P2|NOT COMPLETED|Period II||322
123338|NCT00139776|295073|P1|NOT COMPLETED|Period II||0
123339|NCT00139776|295070|P4|COMPLETED|Period II||0
123340|NCT00139776|295071|P3|COMPLETED|Period II||0
123341|NCT00139776|295072|P2|COMPLETED|Period II||875
123342|NCT00139776|295073|P1|COMPLETED|Period II||0
123343|NCT00139776|295070|P4|STARTED|Period II||0
123344|NCT00139776|295071|P3|STARTED|Period II||0
123345|NCT00139776|295072|P2|STARTED|Period II||1197
123346|NCT00139776|295073|P1|STARTED|Period II||0
123347|NCT00139776|295070|P4|NOT COMPLETED|Period I||0
123348|NCT00139776|295071|P3|NOT COMPLETED|Period I||0
123349|NCT00139776|295072|P2|NOT COMPLETED|Period I||0
123350|NCT00139776|295073|P1|NOT COMPLETED|Period I||575
123351|NCT00139776|295070|P4|COMPLETED|Period I||0
123352|NCT00139776|295071|P3|COMPLETED|Period I||0
123353|NCT00139776|295072|P2|COMPLETED|Period I||0
123354|NCT00139776|295073|P1|COMPLETED|Period I||1197
123355|NCT00139776|295070|P4|STARTED|Period I||0
123356|NCT00139776|295071|P3|STARTED|Period I||0
123357|NCT00139776|295072|P2|STARTED|Period I||0
123358|NCT00139776|295073|P1|STARTED|Period I||1772
123359|NCT00139997|295110|P2|NOT COMPLETED|Overall Study||2
123360|NCT00139997|295111|P1|NOT COMPLETED|Overall Study||1
123361|NCT00139997|295110|P2|COMPLETED|Overall Study||9
123362|NCT00139997|295111|P1|COMPLETED|Overall Study||14
123363|NCT00139997|295110|P2|STARTED|Overall Study||11
123364|NCT00139997|295111|P1|STARTED|Overall Study||15
123365|NCT00140556|295119|P1|NOT COMPLETED|Chemoradiotherapy Period||0
123366|NCT00140556|295119|P1|COMPLETED|Chemoradiotherapy Period||28
123367|NCT00140556|295119|P1|STARTED|Chemoradiotherapy Period||28
123368|NCT00140556|295119|P1|NOT COMPLETED|Pre Radiation Period: Avastin / Tarceva||0
123369|NCT00140556|295119|P1|COMPLETED|Pre Radiation Period: Avastin / Tarceva||28
123370|NCT00140556|295119|P1|STARTED|Pre Radiation Period: Avastin / Tarceva||28
123371|NCT00140621|295123|P1|NOT COMPLETED|Overall Study||0
123372|NCT00140621|295123|P1|COMPLETED|Overall Study||6
123373|NCT00140621|295123|P1|STARTED|Overall Study||6
123374|NCT00140842|295135|P2|NOT COMPLETED|Overall Study||0
123375|NCT00140842|295136|P1|NOT COMPLETED|Overall Study||0
123376|NCT00140842|295135|P2|COMPLETED|Overall Study||15
123377|NCT00140842|295136|P1|COMPLETED|Overall Study||15
123378|NCT00140842|295135|P2|STARTED|Overall Study||15
123379|NCT00140842|295136|P1|STARTED|Overall Study||15
123380|NCT00141037|295146|P2|NOT COMPLETED|Overall Study||18
123381|NCT00141037|295147|P1|NOT COMPLETED|Overall Study||10
123382|NCT00141037|295146|P2|COMPLETED|Overall Study|8 subjects had reduced follow-up|52
123383|NCT00141037|295147|P1|COMPLETED|Overall Study|16 subjects had reduced follow-up|50
123384|NCT00141037|295146|P2|STARTED|Overall Study||70
123385|NCT00141037|295147|P1|STARTED|Overall Study||60
123386|NCT00141102|295157|P2|NOT COMPLETED|Overall Study||625
123387|NCT00141102|295158|P1|NOT COMPLETED|Overall Study||508
123388|NCT00141102|295157|P2|COMPLETED|Overall Study||1621
123389|NCT00141102|295158|P1|COMPLETED|Overall Study||1730
123390|NCT00141102|295157|P2|Received Treatment|Overall Study||2237
123391|NCT00141102|295158|P1|Received Treatment|Overall Study||2223
123392|NCT00141102|295157|P2|STARTED|Overall Study||2246
123393|NCT00141102|295158|P1|STARTED|Overall Study||2238
123394|NCT00141219|295198|P2|NOT COMPLETED|Overall Study||16
123395|NCT00141219|295199|P1|NOT COMPLETED|Overall Study||24
123396|NCT00141219|295198|P2|COMPLETED|Overall Study||62
123397|NCT00141219|295199|P1|COMPLETED|Overall Study||138
123398|NCT00141219|295198|P2|STARTED|Overall Study||78
123399|NCT00141219|295199|P1|STARTED|Overall Study||162
123400|NCT00141271|295252|P3|NOT COMPLETED|Overall Study||57
123401|NCT00141271|295253|P2|NOT COMPLETED|Overall Study||63
123402|NCT00141271|295254|P1|NOT COMPLETED|Overall Study||80
123403|NCT00141271|295252|P3|COMPLETED|Overall Study||111
123404|NCT00141271|295253|P2|COMPLETED|Overall Study||102
123405|NCT00141271|295254|P1|COMPLETED|Overall Study||91
123406|NCT00141271|295252|P3|STARTED|Overall Study||168
123407|NCT00141271|295253|P2|STARTED|Overall Study||165
123408|NCT00141271|295254|P1|STARTED|Overall Study||171
123409|NCT00141297|295375|P10|NOT COMPLETED|Overall Study||6
123410|NCT00141297|295376|P9|NOT COMPLETED|Overall Study||20
123411|NCT00141297|295377|P8|NOT COMPLETED|Overall Study||4
123412|NCT00141297|295378|P7|NOT COMPLETED|Overall Study||3
123413|NCT00141297|295379|P6|NOT COMPLETED|Overall Study||3
123414|NCT00141297|295380|P5|NOT COMPLETED|Overall Study||22
123415|NCT00141297|295381|P4|NOT COMPLETED|Overall Study||3
123416|NCT00141297|295382|P3|NOT COMPLETED|Overall Study||7
123417|NCT00141297|295383|P2|NOT COMPLETED|Overall Study||3
123418|NCT00141297|295384|P1|NOT COMPLETED|Overall Study||3
123419|NCT00141297|295375|P10|COMPLETED|Overall Study||0
123420|NCT00141297|295376|P9|COMPLETED|Overall Study||0
123421|NCT00141297|295377|P8|COMPLETED|Overall Study||0
123422|NCT00141297|295378|P7|COMPLETED|Overall Study||0
123423|NCT00141297|295379|P6|COMPLETED|Overall Study||0
123424|NCT00141297|295380|P5|COMPLETED|Overall Study||0
123425|NCT00141297|295381|P4|COMPLETED|Overall Study||0
123426|NCT00141297|295382|P3|COMPLETED|Overall Study||0
123427|NCT00141297|295383|P2|COMPLETED|Overall Study||0
123428|NCT00141297|295384|P1|COMPLETED|Overall Study||0
123429|NCT00141297|295375|P10|STARTED|Overall Study||6
123430|NCT00141297|295376|P9|STARTED|Overall Study||20
123431|NCT00141297|295377|P8|STARTED|Overall Study||4
123432|NCT00141297|295378|P7|STARTED|Overall Study||3
123433|NCT00141297|295379|P6|STARTED|Overall Study||3
123434|NCT00141297|295380|P5|STARTED|Overall Study||22
123435|NCT00141297|295381|P4|STARTED|Overall Study||3
123436|NCT00141297|295382|P3|STARTED|Overall Study||7
123437|NCT00141297|295383|P2|STARTED|Overall Study||3
123438|NCT00141297|295384|P1|STARTED|Overall Study||3
123439|NCT00141453|295661|P2|NOT COMPLETED|Overall Study||5
123440|NCT00141453|295662|P1|NOT COMPLETED|Overall Study||6
123441|NCT00141453|295661|P2|COMPLETED|Overall Study||284
123442|NCT00141453|295662|P1|COMPLETED|Overall Study||282
123443|NCT00141453|295661|P2|STARTED|Overall Study||289
123444|NCT00141453|295662|P1|STARTED|Overall Study||288
123445|NCT00141518|295677|P3|NOT COMPLETED|Overall Study||6
123446|NCT00141518|295678|P2|NOT COMPLETED|Overall Study||6
123447|NCT00141518|295679|P1|NOT COMPLETED|Overall Study||16
123448|NCT00141518|295677|P3|COMPLETED|Overall Study||12
123449|NCT00141518|295678|P2|COMPLETED|Overall Study||16
123450|NCT00141518|295679|P1|COMPLETED|Overall Study||21
123451|NCT00141518|295677|P3|Full Analysis Sample|Overall Study||18
123452|NCT00141518|295678|P2|Full Analysis Sample|Overall Study||22
123453|NCT00141518|295679|P1|Full Analysis Sample|Overall Study||27
123454|NCT00141518|295677|P3|Safety Sample|Overall Study||18
123455|NCT00141518|295678|P2|Safety Sample|Overall Study||22
123456|NCT00141518|295679|P1|Safety Sample|Overall Study||36
123457|NCT00141518|295677|P3|STARTED|Overall Study||18
123458|NCT00141518|295678|P2|STARTED|Overall Study||22
123459|NCT00141518|295679|P1|STARTED|Overall Study||37
123460|NCT00141726|295866|P1|NOT COMPLETED|Overall Study||3
123461|NCT00141726|295866|P1|COMPLETED|Overall Study||31
123462|NCT00141726|295866|P1|STARTED|Overall Study||34
123463|NCT00141739|295871|P1|NOT COMPLETED|Overall Study||0
123464|NCT00141739|295871|P1|COMPLETED|Overall Study||100
123465|NCT00141739|295871|P1|STARTED|Overall Study|Number of evaluable patients|100
123466|NCT00141765|295882|P1|NOT COMPLETED|Overall Study||0
123467|NCT00141765|295882|P1|COMPLETED|Overall Study||25
123468|NCT00141765|295882|P1|STARTED|Overall Study||25
123469|NCT00141778|295889|P3|NOT COMPLETED|Started Study Medication||4
123470|NCT00141778|295890|P2|NOT COMPLETED|Started Study Medication||7
123471|NCT00141778|295891|P1|NOT COMPLETED|Started Study Medication||2
123472|NCT00141778|295889|P3|COMPLETED|Started Study Medication||143
123473|NCT00141778|295890|P2|COMPLETED|Started Study Medication||144
123474|NCT00141778|295891|P1|COMPLETED|Started Study Medication||145
123475|NCT00141778|295889|P3|STARTED|Started Study Medication||147
123476|NCT00141778|295890|P2|STARTED|Started Study Medication||151
123477|NCT00141778|295891|P1|STARTED|Started Study Medication||147
123478|NCT00141778|295889|P3|NOT COMPLETED|Randomization Prior to Study Med||6
123479|NCT00141778|295890|P2|NOT COMPLETED|Randomization Prior to Study Med||2
123480|NCT00141778|295891|P1|NOT COMPLETED|Randomization Prior to Study Med||5
123481|NCT00141778|295889|P3|COMPLETED|Randomization Prior to Study Med||147
123482|NCT00141778|295890|P2|COMPLETED|Randomization Prior to Study Med||151
123483|NCT00141778|295891|P1|COMPLETED|Randomization Prior to Study Med||147
123484|NCT00141778|295889|P3|STARTED|Randomization Prior to Study Med||153
123485|NCT00141778|295890|P2|STARTED|Randomization Prior to Study Med||153
123486|NCT00141778|295891|P1|STARTED|Randomization Prior to Study Med||152
123487|NCT00141817|295933|P4|NOT COMPLETED|Overall Study||0
123488|NCT00141817|295934|P3|NOT COMPLETED|Overall Study||1
123489|NCT00141817|295935|P2|NOT COMPLETED|Overall Study||0
123490|NCT00141817|295936|P1|NOT COMPLETED|Overall Study||1
123491|NCT00141817|295933|P4|COMPLETED|Overall Study||13
123492|NCT00141817|295934|P3|COMPLETED|Overall Study||10
123493|NCT00141817|295935|P2|COMPLETED|Overall Study||10
123494|NCT00141817|295936|P1|COMPLETED|Overall Study||6
123495|NCT00141817|295933|P4|STARTED|Overall Study||13
123496|NCT00141817|295934|P3|STARTED|Overall Study||11
123497|NCT00141817|295935|P2|STARTED|Overall Study||10
123498|NCT00141817|295936|P1|STARTED|Overall Study||7
123499|NCT00141921|295974|P1|NOT COMPLETED|Overall Study||141
123500|NCT00141921|295974|P1|COMPLETED|Overall Study||41
123501|NCT00141921|295974|P1|Received Treatment|Overall Study||181
123502|NCT00141921|295974|P1|STARTED|Overall Study||182
123503|NCT00142116|295996|P1|NOT COMPLETED|Overall Study||0
123504|NCT00142116|295996|P1|COMPLETED|Overall Study||25
123505|NCT00142116|295996|P1|STARTED|Overall Study||25
123506|NCT00142168|296001|P1|NOT COMPLETED|Overall Study||0
123507|NCT00142168|296001|P1|COMPLETED|Overall Study||16
123508|NCT00142168|296001|P1|STARTED|Overall Study||16
123509|NCT00142298|296018|P10|NOT COMPLETED|Overall Study||0
123510|NCT00142298|296019|P9|NOT COMPLETED|Overall Study||5
123511|NCT00142298|296020|P8|NOT COMPLETED|Overall Study||8
123512|NCT00142298|296021|P7|NOT COMPLETED|Overall Study||8
123513|NCT00142298|296022|P6|NOT COMPLETED|Overall Study||16
123514|NCT00142298|296023|P5|NOT COMPLETED|Overall Study||10
123515|NCT00142298|296024|P4|NOT COMPLETED|Overall Study||85
123516|NCT00142298|296025|P3|NOT COMPLETED|Overall Study||33
123517|NCT00142298|296026|P2|NOT COMPLETED|Overall Study||176
123518|NCT00142298|296027|P1|NOT COMPLETED|Overall Study||160
123519|NCT00142298|296018|P10|COMPLETED|Overall Study||13
123520|NCT00142298|296019|P9|COMPLETED|Overall Study||52
123521|NCT00142298|296020|P8|COMPLETED|Overall Study||58
123522|NCT00142298|296021|P7|COMPLETED|Overall Study||15
123523|NCT00142298|296022|P6|COMPLETED|Overall Study||10
123524|NCT00142298|296023|P5|COMPLETED|Overall Study||46
123525|NCT00142298|296024|P4|COMPLETED|Overall Study||121
123526|NCT00142298|296025|P3|COMPLETED|Overall Study||90
123527|NCT00142298|296026|P2|COMPLETED|Overall Study||456
123528|NCT00142298|296027|P1|COMPLETED|Overall Study|Completed week 104/week 208.|507
123529|NCT00142298|296018|P10|Per Protocol Population|Overall Study||13
123530|NCT00142298|296019|P9|Per Protocol Population|Overall Study||56
123531|NCT00142298|296020|P8|Per Protocol Population|Overall Study||64
123532|NCT00142298|296021|P7|Per Protocol Population|Overall Study||19
123533|NCT00142298|296022|P6|Per Protocol Population|Overall Study||25
123534|NCT00142298|296023|P5|Per Protocol Population|Overall Study||50
123535|NCT00142298|296024|P4|Per Protocol Population|Overall Study||202
123536|NCT00142298|296025|P3|Per Protocol Population|Overall Study||120
123537|NCT00142298|296026|P2|Per Protocol Population|Overall Study||606
123538|NCT00142298|296027|P1|Per Protocol Population|Overall Study||635
123539|NCT00142298|296018|P10|Safety Population|Overall Study||13
123540|NCT00142298|296019|P9|Safety Population|Overall Study||57
123541|NCT00142298|296020|P8|Safety Population|Overall Study||66
123542|NCT00142298|296021|P7|Safety Population|Overall Study||23
123543|NCT00142298|296022|P6|Safety Population|Overall Study||26
123544|NCT00142298|296023|P5|Safety Population|Overall Study||50
123545|NCT00142298|296024|P4|Safety Population|Overall Study||206
123546|NCT00142298|296025|P3|Safety Population|Overall Study||122
123547|NCT00142298|296026|P2|Safety Population|Overall Study||626
123548|NCT00142298|296027|P1|Safety Population|Overall Study||655
123549|NCT00142298|296018|P10|STARTED|Overall Study||13
123550|NCT00142298|296019|P9|STARTED|Overall Study||57
123551|NCT00142298|296020|P8|STARTED|Overall Study||66
123552|NCT00142298|296021|P7|STARTED|Overall Study||23
123553|NCT00142298|296022|P6|STARTED|Overall Study||26
123554|NCT00142298|296023|P5|STARTED|Overall Study||56
123555|NCT00142298|296024|P4|STARTED|Overall Study||206
123556|NCT00142298|296025|P3|STARTED|Overall Study||123
123557|NCT00142298|296026|P2|STARTED|Overall Study||632
123558|NCT00142298|296027|P1|STARTED|Overall Study||667
123559|NCT00142415|296055|P6|NOT COMPLETED|Overall Study||2
123560|NCT00142415|296056|P5|NOT COMPLETED|Overall Study||1
123561|NCT00142415|296057|P4|NOT COMPLETED|Overall Study||0
123562|NCT00142415|296058|P3|NOT COMPLETED|Overall Study||0
123563|NCT00142415|296059|P2|NOT COMPLETED|Overall Study||0
123564|NCT00142415|296060|P1|NOT COMPLETED|Overall Study||0
123565|NCT00142415|296055|P6|COMPLETED|Overall Study||6
123566|NCT00142415|296056|P5|COMPLETED|Overall Study||2
123567|NCT00142415|296057|P4|COMPLETED|Overall Study||3
123568|NCT00142415|296058|P3|COMPLETED|Overall Study||6
123569|NCT00142415|296059|P2|COMPLETED|Overall Study||3
123570|NCT00142415|296060|P1|COMPLETED|Overall Study||3
123571|NCT00142415|296055|P6|STARTED|Overall Study||8
123572|NCT00142415|296056|P5|STARTED|Overall Study||3
123573|NCT00142415|296057|P4|STARTED|Overall Study||3
123574|NCT00142415|296058|P3|STARTED|Overall Study||6
123575|NCT00142415|296059|P2|STARTED|Overall Study||3
123576|NCT00142415|296060|P1|STARTED|Overall Study||3
123577|NCT00142597|296090|P2|NOT COMPLETED|Overall Study||1
123578|NCT00142597|296091|P1|NOT COMPLETED|Overall Study||3
123579|NCT00142597|296090|P2|COMPLETED|Overall Study|N=10 completed PET imaging|22
123580|NCT00142597|296091|P1|COMPLETED|Overall Study|N=10 completed PET imaging|20
123581|NCT00142597|296090|P2|STARTED|Overall Study|N=10 underwent PET imaging|23
123582|NCT00142597|296091|P1|STARTED|Overall Study|N=10 underwent PET imaging|23
123583|NCT00142818|296101|P4|NOT COMPLETED|Overall Study||22
123584|NCT00142818|296102|P3|NOT COMPLETED|Overall Study||13
123585|NCT00142818|296103|P2|NOT COMPLETED|Overall Study||21
123586|NCT00142818|296104|P1|NOT COMPLETED|Overall Study||17
123587|NCT00142818|296101|P4|COMPLETED|Overall Study||20
123588|NCT00142818|296102|P3|COMPLETED|Overall Study||24
123589|NCT00142818|296103|P2|COMPLETED|Overall Study||19
123590|NCT00142818|296104|P1|COMPLETED|Overall Study||28
123591|NCT00142818|296101|P4|STARTED|Overall Study||42
123592|NCT00142818|296102|P3|STARTED|Overall Study||37
123593|NCT00142818|296103|P2|STARTED|Overall Study||40
123594|NCT00142818|296104|P1|STARTED|Overall Study||45
123595|NCT00142909|296116|P2|NOT COMPLETED|Medications Begin||3
123596|NCT00142909|296117|P1|NOT COMPLETED|Medications Begin||9
123597|NCT00142909|296116|P2|COMPLETED|Medications Begin||31
123598|NCT00142909|296117|P1|COMPLETED|Medications Begin||26
123599|NCT00142909|296116|P2|STARTED|Medications Begin||34
123600|NCT00142909|296117|P1|STARTED|Medications Begin||35
123601|NCT00142909|296116|P2|NOT COMPLETED|Randomization||10
123602|NCT00142909|296117|P1|NOT COMPLETED|Randomization||7
123603|NCT00142909|296116|P2|COMPLETED|Randomization||34
123604|NCT00142909|296117|P1|COMPLETED|Randomization||35
123605|NCT00142909|296116|P2|STARTED|Randomization||44
123606|NCT00142909|296117|P1|STARTED|Randomization||42
123607|NCT00142935|296136|P3|NOT COMPLETED|Overall Study||7
123608|NCT00142935|296137|P2|NOT COMPLETED|Overall Study||8
123609|NCT00142935|296138|P1|NOT COMPLETED|Overall Study||3
123610|NCT00142935|296136|P3|COMPLETED|Overall Study||23
123611|NCT00142935|296137|P2|COMPLETED|Overall Study||20
123612|NCT00142935|296138|P1|COMPLETED|Overall Study||26
123613|NCT00142935|296136|P3|STARTED|Overall Study||30
123614|NCT00142935|296137|P2|STARTED|Overall Study||28
123615|NCT00142935|296138|P1|STARTED|Overall Study||29
123616|NCT00135200|296161|P1|NOT COMPLETED|Overall Study||0
123617|NCT00135200|296161|P1|COMPLETED|Overall Study||16
123618|NCT00135200|296161|P1|STARTED|Overall Study||16
123619|NCT00135330|296169|P3|NOT COMPLETED|Overall Study||11
123620|NCT00135330|296170|P2|NOT COMPLETED|Overall Study||13
123621|NCT00135330|296171|P1|NOT COMPLETED|Overall Study||12
123622|NCT00135330|296169|P3|COMPLETED|Overall Study||34
123623|NCT00135330|296170|P2|COMPLETED|Overall Study||34
123624|NCT00135330|296171|P1|COMPLETED|Overall Study||33
123625|NCT00135330|296169|P3|STARTED|Overall Study||45
123626|NCT00135330|296170|P2|STARTED|Overall Study||47
123627|NCT00135330|296171|P1|STARTED|Overall Study||45
123628|NCT00135356|296265|P2|NOT COMPLETED|Overall Study||9
123629|NCT00135356|296266|P1|NOT COMPLETED|Overall Study||17
123630|NCT00135356|296265|P2|COMPLETED|Overall Study||60
123631|NCT00135356|296266|P1|COMPLETED|Overall Study||114
123632|NCT00135356|296265|P2|Discontinued on or After Week 96 Visit|Overall Study||0
123633|NCT00135356|296266|P1|Discontinued on or After Week 96 Visit|Overall Study||1
123634|NCT00135356|296265|P2|Discontinued Prior to Week 96 Visit|Overall Study||9
123635|NCT00135356|296266|P1|Discontinued Prior to Week 96 Visit|Overall Study||16
123636|NCT00135356|296265|P2|STARTED|Overall Study|Number randomized and treated(1 randomized and never treated subject not included in this number.)|69
123637|NCT00135356|296266|P1|STARTED|Overall Study|Number randomized and treated|131
123638|NCT00135694|296309|P3|NOT COMPLETED|Overall Study||7
123639|NCT00135694|296310|P2|NOT COMPLETED|Overall Study||21
123640|NCT00135694|296311|P1|NOT COMPLETED|Overall Study||180
123641|NCT00135694|296309|P3|COMPLETED|Overall Study||11
123642|NCT00135694|296310|P2|COMPLETED|Overall Study||56
123643|NCT00135694|296311|P1|COMPLETED|Overall Study|Subjects were assessed as ineligible for random assignment and subsequently terminated per protocol.|0
123644|NCT00135694|296309|P3|STARTED|Overall Study||18
123645|NCT00135694|296310|P2|STARTED|Overall Study||77
123646|NCT00135694|296311|P1|STARTED|Overall Study||180
123647|NCT00135798|296332|P3|NOT COMPLETED|Overall Study||0
123648|NCT00135798|296333|P2|NOT COMPLETED|Overall Study||0
123649|NCT00135798|296334|P1|NOT COMPLETED|Overall Study||0
123650|NCT00135798|296332|P3|COMPLETED|Overall Study||32
123651|NCT00135798|296333|P2|COMPLETED|Overall Study||31
123652|NCT00135798|296334|P1|COMPLETED|Overall Study||16
123653|NCT00135798|296332|P3|STARTED|Overall Study||32
123654|NCT00135798|296333|P2|STARTED|Overall Study||31
123655|NCT00135798|296334|P1|STARTED|Overall Study||16
123656|NCT00136084|296352|P2|NOT COMPLETED|Overall Study||42
123657|NCT00136084|296353|P1|NOT COMPLETED|Overall Study||48
123658|NCT00136084|296352|P2|COMPLETED|Overall Study||72
123659|NCT00136084|296353|P1|COMPLETED|Overall Study||61
123660|NCT00136084|296352|P2|STARTED|Overall Study||114
123661|NCT00136084|296353|P1|STARTED|Overall Study||109
123662|NCT00136318|296368|P2|NOT COMPLETED|Overall Study||7
123663|NCT00136318|296369|P1|NOT COMPLETED|Overall Study||7
123664|NCT00136318|296368|P2|COMPLETED|Overall Study||84
123665|NCT00136318|296369|P1|COMPLETED|Overall Study|reached end-point of antiviral treatment|83
123666|NCT00136318|296368|P2|STARTED|Overall Study|Took first dose of study medication|91
123667|NCT00136318|296369|P1|STARTED|Overall Study|Took first dose of study medication|90
123668|NCT00136357|296385|P2|NOT COMPLETED|Overall Study||2
123669|NCT00136357|296386|P1|NOT COMPLETED|Overall Study||3
123670|NCT00136357|296385|P2|COMPLETED|Overall Study||39
123671|NCT00136357|296386|P1|COMPLETED|Overall Study||38
123672|NCT00136357|296385|P2|STARTED|Overall Study||41
123673|NCT00136357|296386|P1|STARTED|Overall Study||41
123674|NCT00136695|296394|P2|NOT COMPLETED|Overall Study||8
123675|NCT00136695|296395|P1|NOT COMPLETED|Overall Study||11
123676|NCT00136695|296394|P2|COMPLETED|Overall Study||35
123677|NCT00136695|296395|P1|COMPLETED|Overall Study||34
123678|NCT00136695|296394|P2|STARTED|Overall Study||43
123679|NCT00136695|296395|P1|STARTED|Overall Study||45
123680|NCT00136760|296405|P4|NOT COMPLETED|Overall Study||0
123681|NCT00136760|296406|P3|NOT COMPLETED|Overall Study||0
123682|NCT00136760|296407|P2|NOT COMPLETED|Overall Study||0
123683|NCT00136760|296408|P1|NOT COMPLETED|Overall Study||0
123684|NCT00136760|296405|P4|COMPLETED|Overall Study||13
123685|NCT00136760|296406|P3|COMPLETED|Overall Study||11
123686|NCT00136760|296407|P2|COMPLETED|Overall Study||16
123687|NCT00136760|296408|P1|COMPLETED|Overall Study||12
123688|NCT00136760|296405|P4|STARTED|Overall Study||13
123689|NCT00136760|296406|P3|STARTED|Overall Study||11
123690|NCT00136760|296407|P2|STARTED|Overall Study||16
123691|NCT00136760|296408|P1|STARTED|Overall Study||12
123692|NCT00136812|296424|P2|NOT COMPLETED|Overall Study||0
123693|NCT00136812|296425|P1|NOT COMPLETED|Overall Study||0
123694|NCT00136812|296424|P2|COMPLETED|Overall Study||113
123695|NCT00136812|296425|P1|COMPLETED|Overall Study||111
123696|NCT00136812|296424|P2|STARTED|Overall Study||113
123697|NCT00136812|296425|P1|STARTED|Overall Study||111
123698|NCT00136838|296431|P2|NOT COMPLETED|Second Intervention ( 5 Days)||0
123699|NCT00136838|296432|P1|NOT COMPLETED|Second Intervention ( 5 Days)||0
123700|NCT00136838|296431|P2|COMPLETED|Second Intervention ( 5 Days)||6
123701|NCT00136838|296432|P1|COMPLETED|Second Intervention ( 5 Days)||6
123702|NCT00136838|296431|P2|STARTED|Second Intervention ( 5 Days)||6
123703|NCT00136838|296432|P1|STARTED|Second Intervention ( 5 Days)||6
123704|NCT00136838|296431|P2|NOT COMPLETED|First Intervention ( 5 Days)||0
123705|NCT00136838|296432|P1|NOT COMPLETED|First Intervention ( 5 Days)||0
123706|NCT00136838|296431|P2|COMPLETED|First Intervention ( 5 Days)||6
123707|NCT00136838|296432|P1|COMPLETED|First Intervention ( 5 Days)||6
123708|NCT00136838|296431|P2|STARTED|First Intervention ( 5 Days)||6
123709|NCT00136838|296432|P1|STARTED|First Intervention ( 5 Days)||6
123710|NCT00136916|296442|P2|NOT COMPLETED|Overall Study||104
123711|NCT00136916|296443|P1|NOT COMPLETED|Overall Study||125
123712|NCT00136916|296442|P2|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|212
123713|NCT00136916|296443|P1|COMPLETED|Overall Study|At study termination, active subjects completed end-of-study assessment and 3-month follow-up visit|194
123714|NCT00136916|296442|P2|Received Treatment|Overall Study||311
123715|NCT00136916|296443|P1|Received Treatment|Overall Study||316
123716|NCT00136916|296442|P2|STARTED|Overall Study||316
123717|NCT00136916|296443|P1|STARTED|Overall Study||319
123718|NCT00136955|296497|P1|NOT COMPLETED|Overall Study||23
123719|NCT00136955|296497|P1|COMPLETED|Overall Study||18
123720|NCT00136955|296497|P1|STARTED|Overall Study||41
123721|NCT00137046|296506|P2|NOT COMPLETED|Overall Study||93
123722|NCT00137046|296507|P1|NOT COMPLETED|Overall Study||99
123723|NCT00137046|296506|P2|COMPLETED|Overall Study||198
123724|NCT00137046|296507|P1|COMPLETED|Overall Study|Completed subjects were those subjects who did not discontinue while on active drug.|192
123725|NCT00137046|296506|P2|Received Study Treatment|Overall Study||290
123726|NCT00137046|296507|P1|Received Study Treatment|Overall Study||290
123727|NCT00137046|296506|P2|STARTED|Overall Study|One subject was randomized to subcutaneous insulin but never received treatment.|291
123728|NCT00137046|296507|P1|STARTED|Overall Study|One subject was randomized to inhaled insulin but never received treatment.|291
123729|NCT00137111|296559|P4|NOT COMPLETED|Total Therapy||0
123730|NCT00137111|296560|P3|NOT COMPLETED|Total Therapy||0
123731|NCT00137111|296561|P2|NOT COMPLETED|Total Therapy||0
123732|NCT00137111|296562|P1|NOT COMPLETED|Total Therapy||40
123733|NCT00137111|296559|P4|COMPLETED|Total Therapy||0
123734|NCT00137111|296560|P3|COMPLETED|Total Therapy||0
123735|NCT00137111|296561|P2|COMPLETED|Total Therapy||0
123736|NCT00137111|296562|P1|COMPLETED|Total Therapy||458
123737|NCT00137111|296559|P4|STARTED|Total Therapy||0
123738|NCT00137111|296560|P3|STARTED|Total Therapy||0
123739|NCT00137111|296561|P2|STARTED|Total Therapy||0
123740|NCT00137111|296562|P1|STARTED|Total Therapy||498
123741|NCT00137111|296559|P4|NOT COMPLETED|Window Therapy||0
123742|NCT00137111|296560|P3|NOT COMPLETED|Window Therapy||0
123743|NCT00137111|296561|P2|NOT COMPLETED|Window Therapy||0
123744|NCT00137111|296562|P1|NOT COMPLETED|Window Therapy||0
123745|NCT00137111|296559|P4|COMPLETED|Window Therapy||142
123746|NCT00137111|296560|P3|COMPLETED|Window Therapy||180
123747|NCT00137111|296561|P2|COMPLETED|Window Therapy||176
123748|NCT00137111|296562|P1|COMPLETED|Window Therapy||0
123749|NCT00137111|296559|P4|STARTED|Window Therapy||142
123750|NCT00137111|296560|P3|STARTED|Window Therapy||180
123751|NCT00137111|296561|P2|STARTED|Window Therapy||176
123752|NCT00137111|296562|P1|STARTED|Window Therapy||0
123753|NCT00143247|296574|P1|NOT COMPLETED|Overall Study||156
123754|NCT00143247|296574|P1|COMPLETED|Overall Study||17
123755|NCT00143247|296574|P1|STARTED|Overall Study|173=total subjects of current + 3 previous protocols|173
123756|NCT00143312|296588|P1|NOT COMPLETED|Overall Study||16
123757|NCT00143312|296588|P1|COMPLETED|Overall Study||29
123758|NCT00143312|296588|P1|STARTED|Overall Study||45
123759|NCT00143455|296602|P4|NOT COMPLETED|Cohort 2||93
123760|NCT00143455|296603|P3|NOT COMPLETED|Cohort 2||106
123761|NCT00143455|296604|P2|NOT COMPLETED|Cohort 2||0
123762|NCT00143455|296605|P1|NOT COMPLETED|Cohort 2||0
123763|NCT00143455|296602|P4|COMPLETED|Cohort 2||111
123764|NCT00143455|296603|P3|COMPLETED|Cohort 2||97
123765|NCT00143455|296604|P2|COMPLETED|Cohort 2||0
123766|NCT00143455|296605|P1|COMPLETED|Cohort 2||0
123767|NCT00143455|296602|P4|Received Treatment|Cohort 2||203
123768|NCT00143455|296603|P3|Received Treatment|Cohort 2||202
123769|NCT00143455|296604|P2|Received Treatment|Cohort 2||0
123770|NCT00143455|296605|P1|Received Treatment|Cohort 2||0
123771|NCT00143455|296602|P4|STARTED|Cohort 2||204
123772|NCT00143455|296603|P3|STARTED|Cohort 2||203
123773|NCT00143455|296604|P2|STARTED|Cohort 2||0
123774|NCT00143455|296605|P1|STARTED|Cohort 2||0
123775|NCT00143455|296602|P4|NOT COMPLETED|Cohort 1||0
123776|NCT00143455|296603|P3|NOT COMPLETED|Cohort 1||0
123777|NCT00143455|296604|P2|NOT COMPLETED|Cohort 1||17
123778|NCT00143455|296605|P1|NOT COMPLETED|Cohort 1||14
123779|NCT00143455|296602|P4|COMPLETED|Cohort 1||0
123780|NCT00143455|296603|P3|COMPLETED|Cohort 1||0
123781|NCT00143455|296604|P2|COMPLETED|Cohort 1||22
123782|NCT00143455|296605|P1|COMPLETED|Cohort 1||25
123783|NCT00143455|296602|P4|Received Treatment|Cohort 1||0
123784|NCT00143455|296603|P3|Received Treatment|Cohort 1||0
123785|NCT00143455|296604|P2|Received Treatment|Cohort 1||38
123786|NCT00143455|296605|P1|Received Treatment|Cohort 1||39
123787|NCT00143455|296602|P4|STARTED|Cohort 1||0
123788|NCT00143455|296603|P3|STARTED|Cohort 1||0
123789|NCT00143455|296604|P2|STARTED|Cohort 1||39
123790|NCT00143455|296605|P1|STARTED|Cohort 1||39
123791|NCT00143507|296639|P2|NOT COMPLETED|Overall Study||652
123792|NCT00143507|296640|P1|NOT COMPLETED|Overall Study||687
123793|NCT00143507|296639|P2|COMPLETED|Overall Study||4786
123794|NCT00143507|296640|P1|COMPLETED|Overall Study||4792
123795|NCT00143507|296639|P2|STARTED|Overall Study||5438
123796|NCT00143507|296640|P1|STARTED|Overall Study||5479
123797|NCT00143598|296672|P2|NOT COMPLETED|Overall Study||94
123798|NCT00143598|296673|P1|NOT COMPLETED|Overall Study||92
123799|NCT00143598|296672|P2|COMPLETED|Overall Study||302
123800|NCT00143598|296673|P1|COMPLETED|Overall Study||318
123801|NCT00143598|296672|P2|STARTED|Overall Study||396
123802|NCT00143598|296673|P1|STARTED|Overall Study||410
123803|NCT00143819|296687|P2|NOT COMPLETED|Overall Study||3
123804|NCT00143819|296688|P1|NOT COMPLETED|Overall Study||2
123805|NCT00143819|296687|P2|COMPLETED|Overall Study||5
123806|NCT00143819|296688|P1|COMPLETED|Overall Study||3
123807|NCT00143819|296687|P2|STARTED|Overall Study||8
123808|NCT00143819|296688|P1|STARTED|Overall Study||5
123809|NCT00143845|296701|P1|NOT COMPLETED|Overall Study||0
123810|NCT00143845|296701|P1|COMPLETED|Overall Study||54
123811|NCT00143845|296701|P1|STARTED|Overall Study||54
123812|NCT00144027|296709|P2|NOT COMPLETED|Overall Study||11
123813|NCT00144027|296710|P1|NOT COMPLETED|Overall Study||3
123814|NCT00144027|296709|P2|COMPLETED|Overall Study|participants who completed 12-month follow-up|25
123815|NCT00144027|296710|P1|COMPLETED|Overall Study|participants who completed 12-month follow-up|36
123816|NCT00144027|296709|P2|Completed 6 Month Assessment|Overall Study||24
123817|NCT00144027|296710|P1|Completed 6 Month Assessment|Overall Study||37
123818|NCT00144027|296709|P2|Completed Baseline Assessment|Overall Study||29
123819|NCT00144027|296710|P1|Completed Baseline Assessment|Overall Study||39
123820|NCT00144027|296709|P2|STARTED|Overall Study|participants who consented|36
123821|NCT00144027|296710|P1|STARTED|Overall Study|participants who consented|39
123822|NCT00144170|296718|P2|NOT COMPLETED|Overall Study||396
123823|NCT00144170|296719|P1|NOT COMPLETED|Overall Study||352
123824|NCT00144170|296718|P2|COMPLETED|Overall Study||32
123825|NCT00144170|296719|P1|COMPLETED|Overall Study||86
123826|NCT00144170|296718|P2|STARTED|Overall Study||428
123827|NCT00144170|296719|P1|STARTED|Overall Study||438
123828|NCT00144300|296909|P2|NOT COMPLETED|Overall Study||28
123829|NCT00144300|296910|P1|NOT COMPLETED|Overall Study||29
123830|NCT00144300|296909|P2|COMPLETED|Overall Study||97
123831|NCT00144300|296910|P1|COMPLETED|Overall Study||92
123832|NCT00144300|296909|P2|STARTED|Overall Study||125
123833|NCT00144300|296910|P1|STARTED|Overall Study||121
123834|NCT00144339|296958|P2|NOT COMPLETED|Overall Study||1099
123835|NCT00144339|296959|P1|NOT COMPLETED|Overall Study||1358
123836|NCT00144339|296958|P2|COMPLETED|Overall Study||1887
123837|NCT00144339|296959|P1|COMPLETED|Overall Study||1648
123838|NCT00144339|296958|P2|STARTED|Overall Study||2986
123839|NCT00144339|296959|P1|STARTED|Overall Study||3006
123840|NCT00144391|297167|P2|NOT COMPLETED|Overall Study||0
123841|NCT00144391|297168|P1|NOT COMPLETED|Overall Study||0
123842|NCT00144391|297167|P2|COMPLETED|Overall Study||9
123843|NCT00144391|297168|P1|COMPLETED|Overall Study||11
123844|NCT00144391|297167|P2|STARTED|Overall Study||9
123845|NCT00144391|297168|P1|STARTED|Overall Study||11
123846|NCT00144781|297178|P4|NOT COMPLETED|Overall Study||0
123847|NCT00144781|297179|P3|NOT COMPLETED|Overall Study||0
123848|NCT00144781|297180|P2|NOT COMPLETED|Overall Study||2
123849|NCT00144781|297181|P1|NOT COMPLETED|Overall Study||0
123850|NCT00144781|297178|P4|COMPLETED|Overall Study||9
123851|NCT00144781|297179|P3|COMPLETED|Overall Study||8
123852|NCT00144781|297180|P2|COMPLETED|Overall Study||7
123853|NCT00144781|297181|P1|COMPLETED|Overall Study||8
123854|NCT00144781|297178|P4|STARTED|Overall Study||9
123855|NCT00144781|297179|P3|STARTED|Overall Study||8
123856|NCT00144781|297180|P2|STARTED|Overall Study||9
123857|NCT00144781|297181|P1|STARTED|Overall Study||8
123858|NCT00144963|297199|P1|NOT COMPLETED|Overall Study||0
123859|NCT00144963|297199|P1|COMPLETED|Overall Study||36
123860|NCT00144963|297199|P1|STARTED|Overall Study||36
123861|NCT00145041|297203|P1|NOT COMPLETED|Overall Study||0
123862|NCT00145041|297203|P1|COMPLETED|Overall Study||7
123863|NCT00145041|297203|P1|STARTED|Overall Study||7
123864|NCT00145119|297209|P1|NOT COMPLETED|Overall Study||45
123865|NCT00145119|297209|P1|COMPLETED|Overall Study||267
123866|NCT00145119|297209|P1|STARTED|Overall Study||312
123867|NCT00145249|297216|P3|NOT COMPLETED|Overall Study||17
123868|NCT00145249|297217|P2|NOT COMPLETED|Overall Study||15
123869|NCT00145249|297218|P1|NOT COMPLETED|Overall Study||11
123870|NCT00145249|297216|P3|COMPLETED|Overall Study||31
123871|NCT00145249|297217|P2|COMPLETED|Overall Study||33
123872|NCT00145249|297218|P1|COMPLETED|Overall Study||36
123873|NCT00145249|297216|P3|STARTED|Overall Study|48 subjects randomized; 49 treated-3 subjects randomized to AmphoB+Fluc400 rec'd AmphoB+Fluc800|48
123874|NCT00145249|297217|P2|STARTED|Overall Study|48 subjects randomized; 47 subjects treated-2 subjects randomized to AmphoB rec'd AmphoB+Fluc400|48
123875|NCT00145249|297218|P1|STARTED|Overall Study|47 subjects randomized; 45 subjects treated|47
123876|NCT00145327|297262|P3|NOT COMPLETED|Overall Study||248
123877|NCT00145327|297263|P2|NOT COMPLETED|Overall Study||124
123878|NCT00145327|297264|P1|NOT COMPLETED|Overall Study||142
123879|NCT00145327|297262|P3|COMPLETED|Overall Study||975
123880|NCT00145327|297263|P2|COMPLETED|Overall Study||493
123881|NCT00145327|297264|P1|COMPLETED|Overall Study||474
123882|NCT00145327|297262|P3|STARTED|Overall Study|Group P3Z3 have non-randomized participants|1223
123883|NCT00145327|297263|P2|STARTED|Overall Study||617
123884|NCT00145327|297264|P1|STARTED|Overall Study|Group Z6 and Group Z3P3 have randomized participants.|616
123885|NCT00145418|297317|P1|NOT COMPLETED|Overall Study||0
123886|NCT00145418|297317|P1|COMPLETED|Overall Study||15
123887|NCT00145418|297317|P1|STARTED|Overall Study||15
123888|NCT00145496|297326|P2|NOT COMPLETED|Overall Study||81
123889|NCT00145496|297327|P1|NOT COMPLETED|Overall Study||123
123890|NCT00145496|297326|P2|COMPLETED|Overall Study||143
123891|NCT00145496|297327|P1|COMPLETED|Overall Study||121
123892|NCT00145496|297326|P2|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|224
123893|NCT00145496|297327|P1|STARTED|Overall Study|Subjects who received randomized treatment assignment and at least one dose of study medication.|244
123894|NCT00145509|297339|P2|NOT COMPLETED|Overall Study||21
123895|NCT00145509|297340|P1|NOT COMPLETED|Overall Study||22
123896|NCT00145509|297339|P2|COMPLETED|Overall Study||15
123897|NCT00145509|297340|P1|COMPLETED|Overall Study||19
123898|NCT00145509|297339|P2|STARTED|Overall Study||36
123899|NCT00145509|297340|P1|STARTED|Overall Study||41
123900|NCT00145574|297355|P3|NOT COMPLETED|Open Label Long-term Extension||11
123901|NCT00145574|297356|P2|NOT COMPLETED|Open Label Long-term Extension||0
123902|NCT00145574|297357|P1|NOT COMPLETED|Open Label Long-term Extension||0
123903|NCT00145574|297355|P3|COMPLETED|Open Label Long-term Extension||173
123904|NCT00145574|297356|P2|COMPLETED|Open Label Long-term Extension||0
123905|NCT00145574|297357|P1|COMPLETED|Open Label Long-term Extension||0
123906|NCT00145574|297355|P3|STARTED|Open Label Long-term Extension|2 participants discontinued after completing double-blind but before starting open label.|184
123907|NCT00145574|297356|P2|STARTED|Open Label Long-term Extension||0
123908|NCT00145574|297357|P1|STARTED|Open Label Long-term Extension||0
123909|NCT00145574|297355|P3|NOT COMPLETED|Double Blind||2
123910|NCT00145574|297356|P2|NOT COMPLETED|Double Blind||5
123911|NCT00145574|297357|P1|NOT COMPLETED|Double Blind||1
123912|NCT00145574|297355|P3|COMPLETED|Double Blind||62
123913|NCT00145574|297356|P2|COMPLETED|Double Blind||60
123914|NCT00145574|297357|P1|COMPLETED|Double Blind||64
123915|NCT00145574|297355|P3|STARTED|Double Blind||64
123916|NCT00145574|297356|P2|STARTED|Double Blind||65
123917|NCT00145574|297357|P1|STARTED|Double Blind||65
123918|NCT00145587|297414|P2|NOT COMPLETED|Overall Study||0
123919|NCT00145587|297415|P1|NOT COMPLETED|Overall Study||0
123920|NCT00145587|297414|P2|COMPLETED|Overall Study||1
123921|NCT00145587|297415|P1|COMPLETED|Overall Study||5
123922|NCT00145587|297414|P2|STARTED|Overall Study||1
123923|NCT00145587|297415|P1|STARTED|Overall Study||5
123924|NCT00145600|297425|P4|NOT COMPLETED|Overall Study||16
123925|NCT00145600|297426|P3|NOT COMPLETED|Overall Study||5
123926|NCT00145600|297427|P2|NOT COMPLETED|Overall Study||10
123927|NCT00145600|297428|P1|NOT COMPLETED|Overall Study||8
123928|NCT00145600|297425|P4|COMPLETED|Overall Study||130
123929|NCT00145600|297426|P3|COMPLETED|Overall Study||8
123930|NCT00145600|297427|P2|COMPLETED|Overall Study||36
123931|NCT00145600|297428|P1|COMPLETED|Overall Study||83
123932|NCT00145600|297425|P4|STARTED|Overall Study||146
123933|NCT00145600|297426|P3|STARTED|Overall Study||13
123934|NCT00145600|297427|P2|STARTED|Overall Study||46
123935|NCT00145600|297428|P1|STARTED|Overall Study||91
123936|NCT00145626|297542|P1|NOT COMPLETED|Overall Study||5
123937|NCT00145626|297542|P1|COMPLETED|Overall Study||14
123938|NCT00145626|297542|P1|STARTED|Overall Study||19
123939|NCT00145704|297586|P2|NOT COMPLETED|Overall Study||3
123940|NCT00145704|297587|P1|NOT COMPLETED|Overall Study||3
123941|NCT00145704|297586|P2|COMPLETED|Overall Study||0
123942|NCT00145704|297587|P1|COMPLETED|Overall Study||0
123943|NCT00145704|297586|P2|STARTED|Overall Study||3
123944|NCT00145704|297587|P1|STARTED|Overall Study||3
123945|NCT00145795|297595|P2|NOT COMPLETED|Overall Study||0
123946|NCT00145795|297596|P1|NOT COMPLETED|Overall Study||1
123947|NCT00145795|297595|P2|COMPLETED|Overall Study||10
123948|NCT00145795|297596|P1|COMPLETED|Overall Study|1 patient discontinued early due to grade II gastrointestinal symptoms.|9
123949|NCT00145795|297595|P2|STARTED|Overall Study||10
123950|NCT00145795|297596|P1|STARTED|Overall Study||10
123951|NCT00140140|297623|P3|NOT COMPLETED|Overall Study||2
123952|NCT00140140|297624|P2|NOT COMPLETED|Overall Study||2
123953|NCT00140140|297625|P1|NOT COMPLETED|Overall Study||2
123954|NCT00140140|297623|P3|COMPLETED|Overall Study|Progressive disease|4
123955|NCT00140140|297624|P2|COMPLETED|Overall Study|Progressive disease|4
123956|NCT00140140|297625|P1|COMPLETED|Overall Study|Progressive disease|2
123957|NCT00140140|297623|P3|STARTED|Overall Study||6
123958|NCT00140140|297624|P2|STARTED|Overall Study||6
123959|NCT00140140|297625|P1|STARTED|Overall Study||4
123960|NCT00140231|297664|P2|NOT COMPLETED|Fasting State With Leptin and Crossover||0
123961|NCT00140231|297665|P1|NOT COMPLETED|Fasting State With Leptin and Crossover||0
123962|NCT00140231|297664|P2|COMPLETED|Fasting State With Leptin and Crossover||6
123963|NCT00140231|297665|P1|COMPLETED|Fasting State With Leptin and Crossover||7
123964|NCT00140231|297664|P2|STARTED|Fasting State With Leptin and Crossover||6
123965|NCT00140231|297665|P1|STARTED|Fasting State With Leptin and Crossover||7
123966|NCT00140231|297664|P2|NOT COMPLETED|Washout 8 Weeks||0
123967|NCT00140231|297665|P1|NOT COMPLETED|Washout 8 Weeks||0
123968|NCT00140231|297664|P2|COMPLETED|Washout 8 Weeks||6
123969|NCT00140231|297665|P1|COMPLETED|Washout 8 Weeks||7
123970|NCT00140231|297664|P2|STARTED|Washout 8 Weeks||6
123971|NCT00140231|297665|P1|STARTED|Washout 8 Weeks||7
123972|NCT00140231|297664|P2|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
123973|NCT00140231|297665|P1|NOT COMPLETED|First Fasting State 3 Days With Placebo||0
123974|NCT00140231|297664|P2|COMPLETED|First Fasting State 3 Days With Placebo||6
123975|NCT00140231|297665|P1|COMPLETED|First Fasting State 3 Days With Placebo||7
123976|NCT00140231|297664|P2|STARTED|First Fasting State 3 Days With Placebo||6
123977|NCT00140231|297665|P1|STARTED|First Fasting State 3 Days With Placebo||7
123978|NCT00140231|297664|P2|NOT COMPLETED|Washout 8weeks||0
123979|NCT00140231|297665|P1|NOT COMPLETED|Washout 8weeks||0
123980|NCT00140231|297664|P2|COMPLETED|Washout 8weeks||6
123981|NCT00140231|297665|P1|COMPLETED|Washout 8weeks||7
123982|NCT00140231|297664|P2|STARTED|Washout 8weeks||6
123983|NCT00140231|297665|P1|STARTED|Washout 8weeks||7
123984|NCT00140231|297664|P2|NOT COMPLETED|Fed State 1 Day- day5||0
123985|NCT00140231|297665|P1|NOT COMPLETED|Fed State 1 Day- day5||0
123986|NCT00140231|297664|P2|COMPLETED|Fed State 1 Day- day5||6
123987|NCT00140231|297665|P1|COMPLETED|Fed State 1 Day- day5||7
123988|NCT00140231|297664|P2|STARTED|Fed State 1 Day- day5||6
123989|NCT00140231|297665|P1|STARTED|Fed State 1 Day- day5||7
123990|NCT00140244|297681|P2|NOT COMPLETED|Intervention 2||2
123991|NCT00140244|297682|P1|NOT COMPLETED|Intervention 2||0
123992|NCT00140244|297681|P2|COMPLETED|Intervention 2||2
123993|NCT00140244|297682|P1|COMPLETED|Intervention 2||3
123994|NCT00140244|297681|P2|STARTED|Intervention 2||4
123995|NCT00140244|297682|P1|STARTED|Intervention 2||3
123996|NCT00140244|297681|P2|NOT COMPLETED|Washout||0
123997|NCT00140244|297682|P1|NOT COMPLETED|Washout||0
123998|NCT00140244|297681|P2|COMPLETED|Washout||4
123999|NCT00140244|297682|P1|COMPLETED|Washout||3
124000|NCT00140244|297681|P2|STARTED|Washout||4
124001|NCT00140244|297682|P1|STARTED|Washout||3
124002|NCT00140244|297681|P2|NOT COMPLETED|Intervention 1||0
124003|NCT00140244|297682|P1|NOT COMPLETED|Intervention 1||0
124004|NCT00140244|297681|P2|COMPLETED|Intervention 1||4
124005|NCT00140244|297682|P1|COMPLETED|Intervention 1||3
124006|NCT00140244|297681|P2|STARTED|Intervention 1||4
124007|NCT00140244|297682|P1|STARTED|Intervention 1||3
124008|NCT00140413|297715|P2|NOT COMPLETED|Overall Study||0
124009|NCT00140413|297716|P1|NOT COMPLETED|Overall Study||3
124010|NCT00140413|297715|P2|COMPLETED|Overall Study|Crossed over subjects were treated as controls for purpose of intent to treat analysis.|7
124011|NCT00140413|297716|P1|COMPLETED|Overall Study||10
124012|NCT00140413|297715|P2|Received at Least One Dose of GH|Overall Study|Controls were crossed over to GH if they met criteria for growth deceleration during the study.|3
124013|NCT00140413|297716|P1|Received at Least One Dose of GH|Overall Study||13
124014|NCT00140413|297715|P2|STARTED|Overall Study||7
124015|NCT00140413|297716|P1|STARTED|Overall Study||13
124016|NCT00140426|297725|P2|NOT COMPLETED|Overall Study||3
124017|NCT00140426|297726|P1|NOT COMPLETED|Overall Study||0
124018|NCT00140426|297725|P2|COMPLETED|Overall Study||16
124019|NCT00140426|297726|P1|COMPLETED|Overall Study||22
124020|NCT00140426|297725|P2|STARTED|Overall Study||19
124021|NCT00140426|297726|P1|STARTED|Overall Study||22
124022|NCT00149630|297758|P2|NOT COMPLETED|Overall Study||5
124023|NCT00149630|297759|P1|NOT COMPLETED|Overall Study||8
124024|NCT00149630|297758|P2|COMPLETED|Overall Study||35
124025|NCT00149630|297759|P1|COMPLETED|Overall Study||26
124026|NCT00149630|297758|P2|STARTED|Overall Study||40
124027|NCT00149630|297759|P1|STARTED|Overall Study||34
124028|NCT00149643|297771|P2|NOT COMPLETED|Overall Study||36
124029|NCT00149643|297772|P1|NOT COMPLETED|Overall Study||34
124030|NCT00149643|297771|P2|COMPLETED|Overall Study||0
124031|NCT00149643|297772|P1|COMPLETED|Overall Study||0
124032|NCT00149643|297771|P2|STARTED|Overall Study||36
124033|NCT00149643|297772|P1|STARTED|Overall Study||34
124034|NCT00149669|297784|P2|NOT COMPLETED|Overall Study||5
124035|NCT00149669|297785|P1|NOT COMPLETED|Overall Study||3
124036|NCT00149669|297784|P2|COMPLETED|Overall Study||30
124037|NCT00149669|297785|P1|COMPLETED|Overall Study||29
124038|NCT00149669|297784|P2|STARTED|Overall Study||35
124039|NCT00149669|297785|P1|STARTED|Overall Study||32
124040|NCT00149747|297805|P2|NOT COMPLETED|Overall Study||3
124041|NCT00149747|297806|P1|NOT COMPLETED|Overall Study||4
124042|NCT00149747|297805|P2|COMPLETED|Overall Study||27
124043|NCT00149747|297806|P1|COMPLETED|Overall Study||32
124044|NCT00149747|297805|P2|STARTED|Overall Study||30
124045|NCT00149747|297806|P1|STARTED|Overall Study||36
124046|NCT00149799|297818|P3|NOT COMPLETED|Discontinuation (Phase II)||9
124047|NCT00149799|297819|P2|NOT COMPLETED|Discontinuation (Phase II)||3
124048|NCT00149799|297820|P1|NOT COMPLETED|Discontinuation (Phase II)||0
124049|NCT00149799|297818|P3|COMPLETED|Discontinuation (Phase II)||21
124050|NCT00149799|297819|P2|COMPLETED|Discontinuation (Phase II)||25
124051|NCT00149799|297820|P1|COMPLETED|Discontinuation (Phase II)||0
124052|NCT00149799|297818|P3|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|30
124053|NCT00149799|297819|P2|STARTED|Discontinuation (Phase II)|Only responders who completed Phase I were randomized in Phase II|28
124054|NCT00149799|297820|P1|STARTED|Discontinuation (Phase II)||0
124055|NCT00149799|297818|P3|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
124056|NCT00149799|297819|P2|NOT COMPLETED|Open Label Escitalopram (Phase I)||0
124057|NCT00149799|297820|P1|NOT COMPLETED|Open Label Escitalopram (Phase I)||26
124058|NCT00149799|297818|P3|COMPLETED|Open Label Escitalopram (Phase I)||0
124059|NCT00149799|297819|P2|COMPLETED|Open Label Escitalopram (Phase I)||0
124060|NCT00149799|297820|P1|COMPLETED|Open Label Escitalopram (Phase I)|14 completers were non-responders and 2 responders terminated the study after completing Phase I|74
124061|NCT00149799|297818|P3|STARTED|Open Label Escitalopram (Phase I)||0
124062|NCT00149799|297819|P2|STARTED|Open Label Escitalopram (Phase I)||0
124063|NCT00149799|297820|P1|STARTED|Open Label Escitalopram (Phase I)||100
124064|NCT00149825|297830|P2|NOT COMPLETED|Overall Study||3
124065|NCT00149825|297831|P1|NOT COMPLETED|Overall Study||5
124066|NCT00149825|297830|P2|COMPLETED|Overall Study||12
124067|NCT00149825|297831|P1|COMPLETED|Overall Study||10
124068|NCT00149825|297830|P2|STARTED|Overall Study||15
124069|NCT00149825|297831|P1|STARTED|Overall Study||15
124070|NCT00149890|297841|P2|NOT COMPLETED|Overall Study||18
124071|NCT00149890|297842|P1|NOT COMPLETED|Overall Study||13
124072|NCT00149890|297841|P2|COMPLETED|Overall Study||20
124073|NCT00149890|297842|P1|COMPLETED|Overall Study||26
124074|NCT00149890|297841|P2|STARTED|Overall Study||38
124075|NCT00149890|297842|P1|STARTED|Overall Study|"Started indicates all screened and treated participants."|39
124076|NCT00149994|297862|P2|NOT COMPLETED|Overall Study||1
124077|NCT00149994|297863|P1|NOT COMPLETED|Overall Study||1
124078|NCT00149994|297862|P2|COMPLETED|Overall Study||85
124079|NCT00149994|297863|P1|COMPLETED|Overall Study|"Completed indicates intention to treat (ITT) population."|84
124080|NCT00149994|297862|P2|STARTED|Overall Study||86
124081|NCT00149994|297863|P1|STARTED|Overall Study|"Started indicates Safety population."|85
124082|NCT00150176|297871|P2|NOT COMPLETED|Overall Study||120
124083|NCT00150176|297872|P1|NOT COMPLETED|Overall Study||59
124084|NCT00150176|297871|P2|COMPLETED|Overall Study||72
124085|NCT00150176|297872|P1|COMPLETED|Overall Study||135
124086|NCT00150176|297871|P2|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|192
124087|NCT00150176|297872|P1|STARTED|Overall Study|subjects who were screened and received at least one dose of double-blind trial medication|194
124088|NCT00150345|297883|P2|NOT COMPLETED|Overall Study||32
124089|NCT00150345|297884|P1|NOT COMPLETED|Overall Study||34
124090|NCT00150345|297883|P2|COMPLETED|Overall Study||34
124091|NCT00150345|297884|P1|COMPLETED|Overall Study||47
124092|NCT00150345|297883|P2|STARTED|Overall Study||66
124093|NCT00150345|297884|P1|STARTED|Overall Study||81
124094|NCT00150462|297957|P11|NOT COMPLETED|Overall Study||3
124095|NCT00150462|297958|P10|NOT COMPLETED|Overall Study||6
124096|NCT00150462|297959|P9|NOT COMPLETED|Overall Study||6
124097|NCT00150462|297960|P8|NOT COMPLETED|Overall Study||8
124098|NCT00150462|297961|P7|NOT COMPLETED|Overall Study||3
124099|NCT00150462|297962|P6|NOT COMPLETED|Overall Study||4
124100|NCT00150462|297963|P5|NOT COMPLETED|Overall Study||3
124101|NCT00150462|297964|P4|NOT COMPLETED|Overall Study||3
124102|NCT00150462|297965|P3|NOT COMPLETED|Overall Study||4
124103|NCT00150462|297966|P2|NOT COMPLETED|Overall Study||3
124104|NCT00150462|297967|P1|NOT COMPLETED|Overall Study||3
124105|NCT00150462|297957|P11|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
124106|NCT00150462|297958|P10|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of treatment.|1
124107|NCT00150462|297959|P9|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124108|NCT00150462|297960|P8|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124109|NCT00150462|297961|P7|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124110|NCT00150462|297962|P6|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124111|NCT00150462|297963|P5|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124112|NCT00150462|297964|P4|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124113|NCT00150462|297965|P3|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124114|NCT00150462|297966|P2|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124115|NCT00150462|297967|P1|COMPLETED|Overall Study|Indicates participants remaining on study treatment|0
124116|NCT00150462|297957|P11|STARTED|Overall Study||4
124117|NCT00150462|297958|P10|STARTED|Overall Study||7
124118|NCT00150462|297959|P9|STARTED|Overall Study||6
124119|NCT00150462|297960|P8|STARTED|Overall Study||8
124120|NCT00150462|297961|P7|STARTED|Overall Study||3
124121|NCT00150462|297962|P6|STARTED|Overall Study||4
124122|NCT00150462|297963|P5|STARTED|Overall Study||3
124123|NCT00150462|297964|P4|STARTED|Overall Study||3
124124|NCT00150462|297965|P3|STARTED|Overall Study||4
124125|NCT00150462|297966|P2|STARTED|Overall Study||3
124126|NCT00150462|297967|P1|STARTED|Overall Study||3
124127|NCT00150592|298077|P2|NOT COMPLETED|Overall Study||3
124128|NCT00150592|298078|P1|NOT COMPLETED|Overall Study||7
124129|NCT00150592|298077|P2|COMPLETED|Overall Study||54
124130|NCT00150592|298078|P1|COMPLETED|Overall Study||114
124131|NCT00150592|298077|P2|STARTED|Overall Study||57
124132|NCT00150592|298078|P1|STARTED|Overall Study||121
124133|NCT00150618|298103|P5|NOT COMPLETED|Overall Study||25
124134|NCT00150618|298104|P4|NOT COMPLETED|Overall Study||26
124135|NCT00150618|298105|P3|NOT COMPLETED|Overall Study||27
124136|NCT00150618|298106|P2|NOT COMPLETED|Overall Study||18
124137|NCT00150618|298107|P1|NOT COMPLETED|Overall Study||17
124138|NCT00150618|298103|P5|COMPLETED|Overall Study||41
124139|NCT00150618|298104|P4|COMPLETED|Overall Study||40
124140|NCT00150618|298105|P3|COMPLETED|Overall Study||38
124141|NCT00150618|298106|P2|COMPLETED|Overall Study||47
124142|NCT00150618|298107|P1|COMPLETED|Overall Study||45
124143|NCT00150618|298103|P5|STARTED|Overall Study||66
124144|NCT00150618|298104|P4|STARTED|Overall Study||66
124145|NCT00150618|298105|P3|STARTED|Overall Study||65
124146|NCT00150618|298106|P2|STARTED|Overall Study||65
124147|NCT00150618|298107|P1|STARTED|Overall Study||62
124148|NCT00150969|298141|P2|NOT COMPLETED|24-48 Month Extension||100
124149|NCT00150969|298142|P1|NOT COMPLETED|24-48 Month Extension||88
124150|NCT00150969|298141|P2|COMPLETED|24-48 Month Extension||40
124151|NCT00150969|298142|P1|COMPLETED|24-48 Month Extension||33
124152|NCT00150969|298141|P2|STARTED|24-48 Month Extension||140
124153|NCT00150969|298142|P1|STARTED|24-48 Month Extension||121
124154|NCT00150969|298141|P2|NOT COMPLETED|24 Month Main Study||21
124155|NCT00150969|298142|P1|NOT COMPLETED|24 Month Main Study||19
124156|NCT00150969|298141|P2|COMPLETED|24 Month Main Study||202
124157|NCT00150969|298142|P1|COMPLETED|24 Month Main Study||198
124158|NCT00150969|298141|P2|STARTED|24 Month Main Study||223
124159|NCT00150969|298142|P1|STARTED|24 Month Main Study||217
124160|NCT00151320|298176|P1|NOT COMPLETED|Overall Study||0
124161|NCT00151320|298176|P1|COMPLETED|Overall Study||76
124162|NCT00151320|298176|P1|STARTED|Overall Study||76
124163|NCT00151372|298183|P2|NOT COMPLETED|Overall Study||29
124164|NCT00151372|298184|P1|NOT COMPLETED|Overall Study||29
124165|NCT00151372|298183|P2|COMPLETED|Overall Study||45
124166|NCT00151372|298184|P1|COMPLETED|Overall Study||38
124167|NCT00151372|298183|P2|STARTED|Overall Study||74
124168|NCT00151372|298184|P1|STARTED|Overall Study||67
124169|NCT00151411|298194|P2|NOT COMPLETED|Overall Study||43
124170|NCT00151411|298195|P1|NOT COMPLETED|Overall Study||33
124171|NCT00151411|298194|P2|COMPLETED|Overall Study||16
124172|NCT00151411|298195|P1|COMPLETED|Overall Study||22
124173|NCT00151411|298194|P2|STARTED|Overall Study||59
124174|NCT00151411|298195|P1|STARTED|Overall Study||55
124175|NCT00151476|298204|P2|NOT COMPLETED|FAP Analyzed Subjects||3
124176|NCT00151476|298205|P1|NOT COMPLETED|FAP Analyzed Subjects||0
124177|NCT00151476|298204|P2|COMPLETED|FAP Analyzed Subjects||51
124178|NCT00151476|298205|P1|COMPLETED|FAP Analyzed Subjects||13
124179|NCT00151476|298204|P2|STARTED|FAP Analyzed Subjects||54
124180|NCT00151476|298205|P1|STARTED|FAP Analyzed Subjects||13
124181|NCT00151476|298204|P2|NOT COMPLETED|FAP Identified Subjects||1
124182|NCT00151476|298205|P1|NOT COMPLETED|FAP Identified Subjects||0
124183|NCT00151476|298204|P2|COMPLETED|FAP Identified Subjects||54
124184|NCT00151476|298205|P1|COMPLETED|FAP Identified Subjects||13
124185|NCT00151476|298204|P2|STARTED|FAP Identified Subjects||55
124186|NCT00151476|298205|P1|STARTED|FAP Identified Subjects||13
124187|NCT00143390|298262|P2|NOT COMPLETED|Overall Study||149
124188|NCT00143390|298263|P1|NOT COMPLETED|Overall Study||149
124189|NCT00143390|298262|P2|COMPLETED|Overall Study||0
124190|NCT00143390|298263|P1|COMPLETED|Overall Study||0
124191|NCT00143390|298262|P2|STARTED|Overall Study||149
124192|NCT00143390|298263|P1|STARTED|Overall Study||149
124193|NCT00143403|298281|P2|NOT COMPLETED|Overall Study||46
124194|NCT00143403|298282|P1|NOT COMPLETED|Overall Study||35
124195|NCT00143403|298281|P2|COMPLETED|Overall Study|Received maximum number of cycles.|115
124196|NCT00143403|298282|P1|COMPLETED|Overall Study|Received maximum number of cycles.|125
124197|NCT00143403|298281|P2|Treated|Overall Study||153
124198|NCT00143403|298282|P1|Treated|Overall Study||153
124199|NCT00143403|298281|P2|STARTED|Overall Study||161
124200|NCT00143403|298282|P1|STARTED|Overall Study||160
124201|NCT00151775|298295|P12|NOT COMPLETED|Period 4: Open Label||0
124202|NCT00151775|298296|P11|NOT COMPLETED|Period 4: Open Label||0
124203|NCT00151775|298297|P10|NOT COMPLETED|Period 4: Open Label||21
124204|NCT00151775|298298|P9|NOT COMPLETED|Period 4: Open Label||0
124205|NCT00151775|298299|P8|NOT COMPLETED|Period 4: Open Label||0
124206|NCT00151775|298300|P7|NOT COMPLETED|Period 4: Open Label||0
124207|NCT00151775|298301|P6|NOT COMPLETED|Period 4: Open Label||0
124208|NCT00151775|298302|P5|NOT COMPLETED|Period 4: Open Label||30
124209|NCT00151775|298303|P4|NOT COMPLETED|Period 4: Open Label||0
124210|NCT00151775|298304|P3|NOT COMPLETED|Period 4: Open Label||0
124211|NCT00151775|298305|P2|NOT COMPLETED|Period 4: Open Label||0
124212|NCT00151775|298306|P1|NOT COMPLETED|Period 4: Open Label||0
124213|NCT00151775|298295|P12|COMPLETED|Period 4: Open Label||0
124214|NCT00151775|298296|P11|COMPLETED|Period 4: Open Label||57
124215|NCT00151775|298297|P10|COMPLETED|Period 4: Open Label||83
124216|NCT00151775|298298|P9|COMPLETED|Period 4: Open Label||0
124217|NCT00151775|298299|P8|COMPLETED|Period 4: Open Label||0
124218|NCT00151775|298300|P7|COMPLETED|Period 4: Open Label||0
124219|NCT00151775|298301|P6|COMPLETED|Period 4: Open Label||0
124220|NCT00151775|298302|P5|COMPLETED|Period 4: Open Label||149
124221|NCT00151775|298303|P4|COMPLETED|Period 4: Open Label||0
124222|NCT00151775|298304|P3|COMPLETED|Period 4: Open Label||0
124223|NCT00151775|298305|P2|COMPLETED|Period 4: Open Label||0
124224|NCT00151775|298306|P1|COMPLETED|Period 4: Open Label||0
124225|NCT00151775|298295|P12|STARTED|Period 4: Open Label||0
124226|NCT00151775|298296|P11|STARTED|Period 4: Open Label||57
124227|NCT00151775|298297|P10|STARTED|Period 4: Open Label||104
124228|NCT00151775|298298|P9|STARTED|Period 4: Open Label||0
124229|NCT00151775|298299|P8|STARTED|Period 4: Open Label||0
124230|NCT00151775|298300|P7|STARTED|Period 4: Open Label||0
124231|NCT00151775|298301|P6|STARTED|Period 4: Open Label||0
124232|NCT00151775|298302|P5|STARTED|Period 4: Open Label||179
124233|NCT00151775|298303|P4|STARTED|Period 4: Open Label||0
124234|NCT00151775|298304|P3|STARTED|Period 4: Open Label||0
124235|NCT00151775|298305|P2|STARTED|Period 4: Open Label||0
124236|NCT00151775|298306|P1|STARTED|Period 4: Open Label||0
124237|NCT00151775|298295|P12|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
124238|NCT00151775|298296|P11|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
124239|NCT00151775|298297|P10|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
124240|NCT00151775|298298|P9|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
124241|NCT00151775|298299|P8|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
124242|NCT00151775|298300|P7|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
124243|NCT00151775|298301|P6|NOT COMPLETED|Period 3: Double-blind, Withdrawal||1
124244|NCT00151775|298302|P5|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
124245|NCT00151775|298303|P4|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
124246|NCT00151775|298304|P3|NOT COMPLETED|Period 3: Double-blind, Withdrawal||3
124247|NCT00151775|298305|P2|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
124248|NCT00151775|298306|P1|NOT COMPLETED|Period 3: Double-blind, Withdrawal||0
124249|NCT00151775|298295|P12|COMPLETED|Period 3: Double-blind, Withdrawal||28
124250|NCT00151775|298296|P11|COMPLETED|Period 3: Double-blind, Withdrawal||29
124251|NCT00151775|298297|P10|COMPLETED|Period 3: Double-blind, Withdrawal||0
124252|NCT00151775|298298|P9|COMPLETED|Period 3: Double-blind, Withdrawal||26
124253|NCT00151775|298299|P8|COMPLETED|Period 3: Double-blind, Withdrawal||27
124254|NCT00151775|298300|P7|COMPLETED|Period 3: Double-blind, Withdrawal||26
124255|NCT00151775|298301|P6|COMPLETED|Period 3: Double-blind, Withdrawal||25
124256|NCT00151775|298302|P5|COMPLETED|Period 3: Double-blind, Withdrawal||0
124257|NCT00151775|298303|P4|COMPLETED|Period 3: Double-blind, Withdrawal||44
124258|NCT00151775|298304|P3|COMPLETED|Period 3: Double-blind, Withdrawal||42
124259|NCT00151775|298305|P2|COMPLETED|Period 3: Double-blind, Withdrawal||45
124260|NCT00151775|298306|P1|COMPLETED|Period 3: Double-blind, Withdrawal||48
124261|NCT00151775|298295|P12|STARTED|Period 3: Double-blind, Withdrawal||29
124262|NCT00151775|298296|P11|STARTED|Period 3: Double-blind, Withdrawal||29
124263|NCT00151775|298297|P10|STARTED|Period 3: Double-blind, Withdrawal||0
124264|NCT00151775|298298|P9|STARTED|Period 3: Double-blind, Withdrawal||26
124265|NCT00151775|298299|P8|STARTED|Period 3: Double-blind, Withdrawal||28
124266|NCT00151775|298300|P7|STARTED|Period 3: Double-blind, Withdrawal||27
124267|NCT00151775|298301|P6|STARTED|Period 3: Double-blind, Withdrawal||26
124268|NCT00151775|298302|P5|STARTED|Period 3: Double-blind, Withdrawal||0
124269|NCT00151775|298303|P4|STARTED|Period 3: Double-blind, Withdrawal||44
124270|NCT00151775|298304|P3|STARTED|Period 3: Double-blind, Withdrawal||45
124271|NCT00151775|298305|P2|STARTED|Period 3: Double-blind, Withdrawal||45
124272|NCT00151775|298306|P1|STARTED|Period 3: Double-blind, Withdrawal||48
124273|NCT00151775|298295|P12|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
124274|NCT00151775|298296|P11|NOT COMPLETED|Period 2 - Double-Blind Dose Response||1
124275|NCT00151775|298297|P10|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
124276|NCT00151775|298298|P9|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
124277|NCT00151775|298299|P8|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
124278|NCT00151775|298300|P7|NOT COMPLETED|Period 2 - Double-Blind Dose Response||3
124279|NCT00151775|298301|P6|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
124280|NCT00151775|298302|P5|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
124281|NCT00151775|298303|P4|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
124282|NCT00151775|298304|P3|NOT COMPLETED|Period 2 - Double-Blind Dose Response||0
124283|NCT00151775|298305|P2|NOT COMPLETED|Period 2 - Double-Blind Dose Response||6
124284|NCT00151775|298306|P1|NOT COMPLETED|Period 2 - Double-Blind Dose Response||2
124285|NCT00151775|298295|P12|COMPLETED|Period 2 - Double-Blind Dose Response||0
124286|NCT00151775|298296|P11|COMPLETED|Period 2 - Double-Blind Dose Response||59
124287|NCT00151775|298297|P10|COMPLETED|Period 2 - Double-Blind Dose Response||0
124288|NCT00151775|298298|P9|COMPLETED|Period 2 - Double-Blind Dose Response||0
124289|NCT00151775|298299|P8|COMPLETED|Period 2 - Double-Blind Dose Response||0
124290|NCT00151775|298300|P7|COMPLETED|Period 2 - Double-Blind Dose Response||53
124291|NCT00151775|298301|P6|COMPLETED|Period 2 - Double-Blind Dose Response||54
124292|NCT00151775|298302|P5|COMPLETED|Period 2 - Double-Blind Dose Response||0
124293|NCT00151775|298303|P4|COMPLETED|Period 2 - Double-Blind Dose Response||0
124294|NCT00151775|298304|P3|COMPLETED|Period 2 - Double-Blind Dose Response||0
124295|NCT00151775|298305|P2|COMPLETED|Period 2 - Double-Blind Dose Response||89
124296|NCT00151775|298306|P1|COMPLETED|Period 2 - Double-Blind Dose Response||93
124297|NCT00151775|298295|P12|STARTED|Period 2 - Double-Blind Dose Response||0
124298|NCT00151775|298296|P11|STARTED|Period 2 - Double-Blind Dose Response||60
124299|NCT00151775|298297|P10|STARTED|Period 2 - Double-Blind Dose Response||0
124300|NCT00151775|298298|P9|STARTED|Period 2 - Double-Blind Dose Response||0
124301|NCT00151775|298299|P8|STARTED|Period 2 - Double-Blind Dose Response||0
124302|NCT00151775|298300|P7|STARTED|Period 2 - Double-Blind Dose Response||56
124303|NCT00151775|298301|P6|STARTED|Period 2 - Double-Blind Dose Response||56
124304|NCT00151775|298302|P5|STARTED|Period 2 - Double-Blind Dose Response||0
124305|NCT00151775|298303|P4|STARTED|Period 2 - Double-Blind Dose Response||0
124306|NCT00151775|298304|P3|STARTED|Period 2 - Double-Blind Dose Response||0
124307|NCT00151775|298305|P2|STARTED|Period 2 - Double-Blind Dose Response||95
124308|NCT00151775|298306|P1|STARTED|Period 2 - Double-Blind Dose Response||95
124309|NCT00151814|298350|P3|NOT COMPLETED|Overall Study||0
124310|NCT00151814|298351|P2|NOT COMPLETED|Overall Study||0
124311|NCT00151814|298352|P1|NOT COMPLETED|Overall Study||0
124312|NCT00151814|298350|P3|COMPLETED|Overall Study||10
124313|NCT00151814|298351|P2|COMPLETED|Overall Study||10
124314|NCT00151814|298352|P1|COMPLETED|Overall Study||4
124315|NCT00151814|298350|P3|STARTED|Overall Study||10
124316|NCT00151814|298351|P2|STARTED|Overall Study||10
124317|NCT00151814|298352|P1|STARTED|Overall Study||4
124318|NCT00151892|298375|P2|NOT COMPLETED|Overall Study||83
124319|NCT00151892|298376|P1|NOT COMPLETED|Overall Study||76
124320|NCT00151892|298375|P2|COMPLETED|Overall Study||330
124321|NCT00151892|298376|P1|COMPLETED|Overall Study||340
124322|NCT00151892|298375|P2|STARTED|Overall Study||413
124323|NCT00151892|298376|P1|STARTED|Overall Study||416
124324|NCT00151996|298392|P2|NOT COMPLETED|Overall Study||7
124325|NCT00151996|298393|P1|NOT COMPLETED|Overall Study||5
124326|NCT00151996|298392|P2|COMPLETED|Overall Study||26
124327|NCT00151996|298393|P1|COMPLETED|Overall Study||37
124328|NCT00151996|298392|P2|STARTED|Overall Study||33
124329|NCT00151996|298393|P1|STARTED|Overall Study||42
124330|NCT00152009|298411|P4|NOT COMPLETED|Overall Study||33
124331|NCT00152009|298412|P3|NOT COMPLETED|Overall Study||37
124332|NCT00152009|298413|P2|NOT COMPLETED|Overall Study||31
124333|NCT00152009|298414|P1|NOT COMPLETED|Overall Study||29
124334|NCT00152009|298411|P4|COMPLETED|Overall Study||53
124335|NCT00152009|298412|P3|COMPLETED|Overall Study||49
124336|NCT00152009|298413|P2|COMPLETED|Overall Study||55
124337|NCT00152009|298414|P1|COMPLETED|Overall Study||58
124338|NCT00152009|298411|P4|STARTED|Overall Study||86
124339|NCT00152009|298412|P3|STARTED|Overall Study||86
124340|NCT00152009|298413|P2|STARTED|Overall Study||86
124341|NCT00152009|298414|P1|STARTED|Overall Study||87
124342|NCT00153816|298450|P6|NOT COMPLETED|Overall Study||27
124343|NCT00153816|298451|P5|NOT COMPLETED|Overall Study||17
124344|NCT00153816|298452|P4|NOT COMPLETED|Overall Study||31
124345|NCT00153816|298453|P3|NOT COMPLETED|Overall Study||32
124346|NCT00153816|298454|P2|NOT COMPLETED|Overall Study||32
124347|NCT00153816|298455|P1|NOT COMPLETED|Overall Study||32
124348|NCT00153816|298450|P6|COMPLETED|Overall Study||262
124349|NCT00153816|298451|P5|COMPLETED|Overall Study||278
124350|NCT00153816|298452|P4|COMPLETED|Overall Study||390
124351|NCT00153816|298453|P3|COMPLETED|Overall Study||388
124352|NCT00153816|298454|P2|COMPLETED|Overall Study||387
124353|NCT00153816|298455|P1|COMPLETED|Overall Study||383
124354|NCT00153816|298450|P6|STARTED|Overall Study||289
124355|NCT00153816|298451|P5|STARTED|Overall Study||295
124356|NCT00153816|298452|P4|STARTED|Overall Study||421
124357|NCT00153816|298453|P3|STARTED|Overall Study||420
124358|NCT00153816|298454|P2|STARTED|Overall Study||419
124359|NCT00153816|298455|P1|STARTED|Overall Study||415
124360|NCT00153920|298475|P1|NOT COMPLETED|Overall Study||30
124361|NCT00153920|298475|P1|COMPLETED|Overall Study||36
124362|NCT00153920|298475|P1|Eligible and Treated|Overall Study||64
124363|NCT00153920|298475|P1|STARTED|Overall Study||66
124364|NCT00153985|298484|P1|NOT COMPLETED|Overall Study||0
124365|NCT00153985|298484|P1|COMPLETED|Overall Study||2
124366|NCT00153985|298484|P1|STARTED|Overall Study||2
124367|NCT00154063|298492|P2|NOT COMPLETED|Overall Study||22
124368|NCT00154063|298493|P1|NOT COMPLETED|Overall Study||12
124369|NCT00154063|298492|P2|COMPLETED|Overall Study||80
124370|NCT00154063|298493|P1|COMPLETED|Overall Study||92
124371|NCT00154063|298492|P2|STARTED|Overall Study||102
124372|NCT00154063|298493|P1|STARTED|Overall Study||104
124373|NCT00154102|298551|P2|NOT COMPLETED|Overall Study||2
124374|NCT00154102|298552|P1|NOT COMPLETED|Overall Study||7
124375|NCT00154102|298551|P2|COMPLETED|Overall Study||597
124376|NCT00154102|298552|P1|COMPLETED|Overall Study||592
124377|NCT00154102|298551|P2|STARTED|Overall Study|Randomized and treated subjects; 3 additional subjects were treated but not randomised|599
124378|NCT00154102|298552|P1|STARTED|Overall Study|Randomized and treated subjects; 1 additional subject was treated but not randomised|599
124379|NCT00154284|298588|P2|NOT COMPLETED|Overall Study||13
124380|NCT00154284|298589|P1|NOT COMPLETED|Overall Study||7
124381|NCT00154284|298588|P2|COMPLETED|Overall Study||42
124382|NCT00154284|298589|P1|COMPLETED|Overall Study|"Completed means patients completed on study medication.All patients of both arms completed study."|52
124383|NCT00154284|298588|P2|Intent to Treat (ITT) Population|Overall Study||53
124384|NCT00154284|298589|P1|Intent to Treat (ITT) Population|Overall Study||57
124385|NCT00154284|298588|P2|STARTED|Overall Study||55
124386|NCT00154284|298589|P1|STARTED|Overall Study|"Started indicates Safety Population (randomized patients and treated after randomization.)"|59
124387|NCT00154297|298603|P2|NOT COMPLETED|Overall Study||7
124388|NCT00154297|298604|P1|NOT COMPLETED|Overall Study||8
124389|NCT00154297|298603|P2|COMPLETED|Overall Study|Completed study by 12 month.|67
124390|NCT00154297|298604|P1|COMPLETED|Overall Study|Completed study by 12 month.|57
124391|NCT00154297|298603|P2|STARTED|Overall Study|Randomized population.|74
124392|NCT00154297|298604|P1|STARTED|Overall Study|Randomized population.|65
124393|NCT00154310|298622|P2|NOT COMPLETED|Overall Study||28
124394|NCT00154310|298623|P1|NOT COMPLETED|Overall Study||37
124395|NCT00154310|298622|P2|COMPLETED|Overall Study||117
124396|NCT00154310|298623|P1|COMPLETED|Overall Study||118
124397|NCT00154310|298622|P2|STARTED|Overall Study||145
124398|NCT00154310|298623|P1|STARTED|Overall Study|"Started indicates enrolled participants. Randomized participants for two arms are 154 and 146."|155
124399|NCT00154375|298639|P2|NOT COMPLETED|Overall Study||106
124400|NCT00154375|298640|P1|NOT COMPLETED|Overall Study||113
124401|NCT00154375|298639|P2|COMPLETED|Overall Study||14
124402|NCT00154375|298640|P1|COMPLETED|Overall Study||7
124403|NCT00154375|298639|P2|Not Exposed to Study Treatment|Overall Study||2
124404|NCT00154375|298640|P1|Not Exposed to Study Treatment|Overall Study|4 randomized patients didn't receive study treatment were excluded from the safety analyses.|2
124405|NCT00154375|298639|P2|Discontinued Study Treatment|Overall Study||104
124406|NCT00154375|298640|P1|Discontinued Study Treatment|Overall Study||111
124407|NCT00154375|298639|P2|STARTED|Overall Study||120
124408|NCT00154375|298640|P1|STARTED|Overall Study||120
124409|NCT00154466|298652|P3|NOT COMPLETED|Overall Study||0
124410|NCT00154466|298653|P2|NOT COMPLETED|Overall Study||0
124411|NCT00154466|298654|P1|NOT COMPLETED|Overall Study||0
124412|NCT00154466|298652|P3|COMPLETED|Overall Study||19
124413|NCT00154466|298653|P2|COMPLETED|Overall Study||19
124414|NCT00154466|298654|P1|COMPLETED|Overall Study||20
124415|NCT00154466|298652|P3|STARTED|Overall Study|Healthy controls underwent the test of myocardial perfusion only at baseline.|19
124416|NCT00154466|298653|P2|STARTED|Overall Study||19
124417|NCT00154466|298654|P1|STARTED|Overall Study||20
124418|NCT00156013|298664|P1|NOT COMPLETED|Overall Study||2
124419|NCT00156013|298664|P1|COMPLETED|Overall Study||31
124420|NCT00156013|298664|P1|STARTED|Overall Study||33
124421|NCT00156065|298671|P3|NOT COMPLETED|Overall Study||27
124422|NCT00156065|298672|P2|NOT COMPLETED|Overall Study||63
124423|NCT00156065|298673|P1|NOT COMPLETED|Overall Study||31
124424|NCT00156065|298671|P3|COMPLETED|Overall Study||16
124425|NCT00156065|298672|P2|COMPLETED|Overall Study||30
124426|NCT00156065|298673|P1|COMPLETED|Overall Study||20
124427|NCT00156065|298671|P3|STARTED|Overall Study||43
124428|NCT00156065|298672|P2|STARTED|Overall Study||93
124429|NCT00156065|298673|P1|STARTED|Overall Study||51
124430|NCT00146328|298687|P3|NOT COMPLETED|Overall Study||291
124431|NCT00146328|298688|P2|NOT COMPLETED|Overall Study||154
124432|NCT00146328|298689|P1|NOT COMPLETED|Overall Study||141
124433|NCT00146328|298687|P3|COMPLETED|Overall Study||158
124434|NCT00146328|298688|P2|COMPLETED|Overall Study||101
124435|NCT00146328|298689|P1|COMPLETED|Overall Study||150
124436|NCT00146328|298687|P3|STARTED|Overall Study||449
124437|NCT00146328|298688|P2|STARTED|Overall Study||255
124438|NCT00146328|298689|P1|STARTED|Overall Study||291
124439|NCT00146757|298772|P2|NOT COMPLETED|Overall Study||0
124440|NCT00146757|298773|P1|NOT COMPLETED|Overall Study||2
124441|NCT00146757|298772|P2|COMPLETED|Overall Study||4
124442|NCT00146757|298773|P1|COMPLETED|Overall Study||14
124443|NCT00146757|298772|P2|STARTED|Overall Study||4
124444|NCT00146757|298773|P1|STARTED|Overall Study||16
124445|NCT00146770|298792|P2|NOT COMPLETED|Overall Study||0
124446|NCT00146770|298793|P1|NOT COMPLETED|Overall Study||5
124447|NCT00146770|298792|P2|COMPLETED|Overall Study||22
124448|NCT00146770|298793|P1|COMPLETED|Overall Study||18
124449|NCT00146770|298792|P2|STARTED|Overall Study||22
124450|NCT00146770|298793|P1|STARTED|Overall Study||23
124451|NCT00146848|298814|P3|NOT COMPLETED|Post-randomization||39
124452|NCT00146848|298815|P2|NOT COMPLETED|Post-randomization||47
124453|NCT00146848|298816|P1|NOT COMPLETED|Post-randomization||38
124454|NCT00146848|298814|P3|COMPLETED|Post-randomization||431
124455|NCT00146848|298815|P2|COMPLETED|Post-randomization||441
124456|NCT00146848|298816|P1|COMPLETED|Post-randomization||437
124457|NCT00146848|298814|P3|STARTED|Post-randomization||470
124458|NCT00146848|298815|P2|STARTED|Post-randomization||488
124459|NCT00146848|298816|P1|STARTED|Post-randomization||475
124460|NCT00146848|298814|P3|NOT COMPLETED|Pre-randomization||0
124461|NCT00146848|298815|P2|NOT COMPLETED|Pre-randomization||0
124462|NCT00146848|298816|P1|NOT COMPLETED|Pre-randomization||309
124463|NCT00146848|298814|P3|COMPLETED|Pre-randomization||0
124464|NCT00146848|298815|P2|COMPLETED|Pre-randomization||0
124465|NCT00146848|298816|P1|COMPLETED|Pre-randomization|Reached 6-week visit and were randomized|1433
124466|NCT00146848|298814|P3|STARTED|Pre-randomization||0
124467|NCT00146848|298815|P2|STARTED|Pre-randomization||0
124468|NCT00146848|298816|P1|STARTED|Pre-randomization|Registered|1742
124469|NCT00147030|298832|P2|NOT COMPLETED|Overall Study||0
124470|NCT00147030|298833|P1|NOT COMPLETED|Overall Study||0
124471|NCT00147030|298832|P2|COMPLETED|Overall Study||162
124472|NCT00147030|298833|P1|COMPLETED|Overall Study||163
124473|NCT00147030|298832|P2|STARTED|Overall Study||162
124474|NCT00147030|298833|P1|STARTED|Overall Study||163
124475|NCT00147199|298883|P2|NOT COMPLETED|Overall Study||10
124476|NCT00147199|298884|P1|NOT COMPLETED|Overall Study||13
124477|NCT00147199|298883|P2|COMPLETED|Overall Study||110
124478|NCT00147199|298884|P1|COMPLETED|Overall Study||102
124479|NCT00147199|298883|P2|STARTED|Overall Study||120
124480|NCT00147199|298884|P1|STARTED|Overall Study||115
124481|NCT00147212|298906|P1|NOT COMPLETED|Overall Study||0
124482|NCT00147212|298906|P1|COMPLETED|Overall Study||50
124483|NCT00147212|298906|P1|STARTED|Overall Study||50
124484|NCT00147225|298916|P6|NOT COMPLETED|Overall Study||2
124485|NCT00147225|298917|P5|NOT COMPLETED|Overall Study||1
124486|NCT00147225|298918|P4|NOT COMPLETED|Overall Study||1
124487|NCT00147225|298919|P3|NOT COMPLETED|Overall Study||2
124488|NCT00147225|298920|P2|NOT COMPLETED|Overall Study||0
124489|NCT00147225|298921|P1|NOT COMPLETED|Overall Study||1
124490|NCT00147225|298916|P6|COMPLETED|Overall Study||10
124491|NCT00147225|298917|P5|COMPLETED|Overall Study||10
124492|NCT00147225|298918|P4|COMPLETED|Overall Study||10
124493|NCT00147225|298919|P3|COMPLETED|Overall Study||6
124494|NCT00147225|298920|P2|COMPLETED|Overall Study||6
124495|NCT00147225|298921|P1|COMPLETED|Overall Study||6
124496|NCT00147225|298916|P6|STARTED|Overall Study||12
124497|NCT00147225|298917|P5|STARTED|Overall Study||11
124498|NCT00147225|298918|P4|STARTED|Overall Study||11
124499|NCT00147225|298919|P3|STARTED|Overall Study||8
124500|NCT00147225|298920|P2|STARTED|Overall Study||6
124501|NCT00147225|298921|P1|STARTED|Overall Study||7
124502|NCT00147238|298941|P1|NOT COMPLETED|Overall Study||8
124503|NCT00147238|298941|P1|COMPLETED|Overall Study||2
124504|NCT00147238|298941|P1|STARTED|Overall Study||10
124505|NCT00147277|298947|P2|NOT COMPLETED|Overall Study||0
124506|NCT00147277|298948|P1|NOT COMPLETED|Overall Study||0
124507|NCT00147277|298947|P2|COMPLETED|Overall Study||450
124508|NCT00147277|298948|P1|COMPLETED|Overall Study||475
124509|NCT00147277|298947|P2|STARTED|Overall Study||450
124510|NCT00147277|298948|P1|STARTED|Overall Study||475
124511|NCT00147290|298954|P2|NOT COMPLETED|Overall Study||0
124512|NCT00147290|298955|P1|NOT COMPLETED|Overall Study||0
124513|NCT00147290|298954|P2|COMPLETED|Overall Study||260
124514|NCT00147290|298955|P1|COMPLETED|Overall Study||266
124515|NCT00147290|298954|P2|STARTED|Overall Study||260
124516|NCT00147290|298955|P1|STARTED|Overall Study||266
124517|NCT00147316|298959|P1|NOT COMPLETED|Overall Study||0
124518|NCT00147316|298959|P1|COMPLETED|Overall Study||103
124519|NCT00147316|298959|P1|STARTED|Overall Study||103
124520|NCT00147446|298966|P2|NOT COMPLETED|Overall Study||0
124521|NCT00147446|298967|P1|NOT COMPLETED|Overall Study||0
124522|NCT00147446|298966|P2|COMPLETED|Overall Study||61
124523|NCT00147446|298967|P1|COMPLETED|Overall Study||60
124524|NCT00147446|298966|P2|STARTED|Overall Study||61
124525|NCT00147446|298967|P1|STARTED|Overall Study||60
124526|NCT00147498|298979|P4|NOT COMPLETED|Overall Study||17
124527|NCT00147498|298980|P3|NOT COMPLETED|Overall Study||17
124528|NCT00147498|298981|P2|NOT COMPLETED|Overall Study||9
124529|NCT00147498|298982|P1|NOT COMPLETED|Overall Study||3
124530|NCT00147498|298979|P4|COMPLETED|Overall Study||48
124531|NCT00147498|298980|P3|COMPLETED|Overall Study||52
124532|NCT00147498|298981|P2|COMPLETED|Overall Study||60
124533|NCT00147498|298982|P1|COMPLETED|Overall Study||58
124534|NCT00147498|298979|P4|STARTED|Overall Study||65
124535|NCT00147498|298980|P3|STARTED|Overall Study||69
124536|NCT00147498|298981|P2|STARTED|Overall Study||69
124537|NCT00147498|298982|P1|STARTED|Overall Study||61
124538|NCT00147537|299080|P11|NOT COMPLETED|Phase 2||52
124539|NCT00147537|299081|P10|NOT COMPLETED|Phase 2||161
124540|NCT00147537|299082|P9|NOT COMPLETED|Phase 2||0
124541|NCT00147537|299083|P8|NOT COMPLETED|Phase 2||0
124542|NCT00147537|299084|P7|NOT COMPLETED|Phase 2||0
124543|NCT00147537|299085|P6|NOT COMPLETED|Phase 2||0
124544|NCT00147537|299086|P5|NOT COMPLETED|Phase 2||0
124545|NCT00147537|299087|P4|NOT COMPLETED|Phase 2||0
124546|NCT00147537|299088|P3|NOT COMPLETED|Phase 2||0
124547|NCT00147537|299089|P2|NOT COMPLETED|Phase 2||0
124548|NCT00147537|299090|P1|NOT COMPLETED|Phase 2||0
124549|NCT00147537|299080|P11|COMPLETED|Phase 2||3
124550|NCT00147537|299081|P10|COMPLETED|Phase 2||5
124551|NCT00147537|299082|P9|COMPLETED|Phase 2||0
124552|NCT00147537|299083|P8|COMPLETED|Phase 2||0
124553|NCT00147537|299084|P7|COMPLETED|Phase 2||0
124554|NCT00147537|299085|P6|COMPLETED|Phase 2||0
124555|NCT00147537|299086|P5|COMPLETED|Phase 2||0
124556|NCT00147537|299087|P4|COMPLETED|Phase 2||0
124557|NCT00147537|299088|P3|COMPLETED|Phase 2||0
124558|NCT00147537|299089|P2|COMPLETED|Phase 2||0
124559|NCT00147537|299090|P1|COMPLETED|Phase 2||0
124560|NCT00147537|299080|P11|STARTED|Phase 2|55 randomized; 56 treated-1 randomized but not treated, 2 randomized to F+P+C rec'd P+C|55
124561|NCT00147537|299081|P10|STARTED|Phase 2|166 particpants randomized; 163 participants treated|166
124562|NCT00147537|299082|P9|STARTED|Phase 2||0
124563|NCT00147537|299083|P8|STARTED|Phase 2||0
124564|NCT00147537|299084|P7|STARTED|Phase 2||0
124565|NCT00147537|299085|P6|STARTED|Phase 2||0
124566|NCT00147537|299086|P5|STARTED|Phase 2||0
124567|NCT00147537|299087|P4|STARTED|Phase 2||0
124568|NCT00147537|299088|P3|STARTED|Phase 2||0
124569|NCT00147537|299089|P2|STARTED|Phase 2||0
124570|NCT00147537|299090|P1|STARTED|Phase 2||0
124571|NCT00147537|299080|P11|NOT COMPLETED|Phase 1b||0
124572|NCT00147537|299081|P10|NOT COMPLETED|Phase 1b||0
124573|NCT00147537|299082|P9|NOT COMPLETED|Phase 1b||17
124574|NCT00147537|299083|P8|NOT COMPLETED|Phase 1b||7
124575|NCT00147537|299084|P7|NOT COMPLETED|Phase 1b||18
124576|NCT00147537|299085|P6|NOT COMPLETED|Phase 1b||3
124577|NCT00147537|299086|P5|NOT COMPLETED|Phase 1b||3
124578|NCT00147537|299087|P4|NOT COMPLETED|Phase 1b||2
124579|NCT00147537|299088|P3|NOT COMPLETED|Phase 1b||4
124580|NCT00147537|299089|P2|NOT COMPLETED|Phase 1b||2
124581|NCT00147537|299090|P1|NOT COMPLETED|Phase 1b||2
124582|NCT00147537|299080|P11|COMPLETED|Phase 1b||0
124583|NCT00147537|299081|P10|COMPLETED|Phase 1b||0
124584|NCT00147537|299082|P9|COMPLETED|Phase 1b||1
124585|NCT00147537|299083|P8|COMPLETED|Phase 1b||0
124586|NCT00147537|299084|P7|COMPLETED|Phase 1b||0
124587|NCT00147537|299085|P6|COMPLETED|Phase 1b||0
124588|NCT00147537|299086|P5|COMPLETED|Phase 1b||0
124589|NCT00147537|299087|P4|COMPLETED|Phase 1b||1
124590|NCT00147537|299088|P3|COMPLETED|Phase 1b||0
124591|NCT00147537|299089|P2|COMPLETED|Phase 1b||0
124592|NCT00147537|299090|P1|COMPLETED|Phase 1b||1
124593|NCT00147537|299080|P11|STARTED|Phase 1b||0
124594|NCT00147537|299081|P10|STARTED|Phase 1b||0
124595|NCT00147537|299082|P9|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
124596|NCT00147537|299083|P8|STARTED|Phase 1b||7
124597|NCT00147537|299084|P7|STARTED|Phase 1b|18 participants randomized; 17 participants treated|18
124598|NCT00147537|299085|P6|STARTED|Phase 1b||3
124599|NCT00147537|299086|P5|STARTED|Phase 1b||3
124600|NCT00147537|299087|P4|STARTED|Phase 1b||3
124601|NCT00147537|299088|P3|STARTED|Phase 1b||4
124602|NCT00147537|299089|P2|STARTED|Phase 1b||2
124603|NCT00147537|299090|P1|STARTED|Phase 1b||3
124604|NCT00147745|299272|P3|NOT COMPLETED|Overall Study||0
124605|NCT00147745|299273|P2|NOT COMPLETED|Overall Study||0
124606|NCT00147745|299274|P1|NOT COMPLETED|Overall Study||1
124607|NCT00147745|299272|P3|COMPLETED|Overall Study||6
124608|NCT00147745|299273|P2|COMPLETED|Overall Study||14
124609|NCT00147745|299274|P1|COMPLETED|Overall Study||15
124610|NCT00147745|299272|P3|STARTED|Overall Study||6
124611|NCT00147745|299273|P2|STARTED|Overall Study||14
124612|NCT00147745|299274|P1|STARTED|Overall Study||16
124613|NCT00147823|299294|P2|NOT COMPLETED|Overall Study||15
124614|NCT00147823|299295|P1|NOT COMPLETED|Overall Study||13
124615|NCT00147823|299294|P2|COMPLETED|Overall Study||16
124616|NCT00147823|299295|P1|COMPLETED|Overall Study||19
124617|NCT00147823|299294|P2|Month 24 Visit|Overall Study||18
124618|NCT00147823|299295|P1|Month 24 Visit|Overall Study||21
124619|NCT00147823|299294|P2|Month 18 Visit|Overall Study||20
124620|NCT00147823|299295|P1|Month 18 Visit|Overall Study|As stated previously ea. subject is counted at each milestone, as data is collected at ea. timepoint|21
124621|NCT00147823|299294|P2|Month 12 CT Scan|Overall Study||25
124622|NCT00147823|299295|P1|Month 12 CT Scan|Overall Study||20
124623|NCT00147823|299294|P2|Month 12 Visit|Overall Study|Subjects are counted at each milestone as that is when data is collectec|25
124624|NCT00147823|299295|P1|Month 12 Visit|Overall Study||21
124625|NCT00147823|299294|P2|Month 6 Visit|Overall Study||21
124626|NCT00147823|299295|P1|Month 6 Visit|Overall Study||25
124627|NCT00147823|299294|P2|Month 3 Visit|Overall Study||24
124628|NCT00147823|299295|P1|Month 3 Visit|Overall Study||25
124629|NCT00147823|299294|P2|Week 6 Visit|Overall Study||28
124630|NCT00147823|299295|P1|Week 6 Visit|Overall Study||26
124631|NCT00147823|299294|P2|STARTED|Overall Study||31
124632|NCT00147823|299295|P1|STARTED|Overall Study||32
124633|NCT00147966|299323|P1|NOT COMPLETED|Overall Study||0
124634|NCT00147966|299323|P1|COMPLETED|Overall Study||24
124635|NCT00147966|299323|P1|STARTED|Overall Study||24
124636|NCT00148109|299329|P2|NOT COMPLETED|Overall Study||20
124637|NCT00148109|299330|P1|NOT COMPLETED|Overall Study||12
124638|NCT00148109|299329|P2|COMPLETED|Overall Study||1
124639|NCT00148109|299330|P1|COMPLETED|Overall Study||3
124640|NCT00148109|299329|P2|STARTED|Overall Study||21
124641|NCT00148109|299330|P1|STARTED|Overall Study||15
124642|NCT00148122|299340|P1|NOT COMPLETED|Overall Study||2
124643|NCT00148122|299340|P1|COMPLETED|Overall Study||38
124644|NCT00148122|299340|P1|STARTED|Overall Study||40
124645|NCT00148317|299346|P1|NOT COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||11
124646|NCT00148317|299346|P1|COMPLETED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||27
124647|NCT00148317|299346|P1|STARTED|Mobilization (VEL+CYTOXAN+FILGRASTIM)||38
124648|NCT00148317|299346|P1|NOT COMPLETED|Consolidation (VEL + DEX)||0
124649|NCT00148317|299346|P1|COMPLETED|Consolidation (VEL + DEX)||38
124650|NCT00148317|299346|P1|no DOXIL Added|Consolidation (VEL + DEX)||10
124651|NCT00148317|299346|P1|DOXIL Added at Cycle 5|Consolidation (VEL + DEX)||12
124652|NCT00148317|299346|P1|DOXIL Added at Cycle 3|Consolidation (VEL + DEX)||16
124653|NCT00148317|299346|P1|STARTED|Consolidation (VEL + DEX)||38
124654|NCT00148668|299355|P2|NOT COMPLETED|Overall Study||0
124655|NCT00148668|299356|P1|NOT COMPLETED|Overall Study||0
124656|NCT00148668|299355|P2|COMPLETED|Overall Study||40
124657|NCT00148668|299356|P1|COMPLETED|Overall Study||41
124658|NCT00148668|299355|P2|STARTED|Overall Study||40
124659|NCT00148668|299356|P1|STARTED|Overall Study||41
124660|NCT00148733|299364|P2|NOT COMPLETED|Overall Study||15
124661|NCT00148733|299365|P1|NOT COMPLETED|Overall Study||14
124662|NCT00148733|299364|P2|COMPLETED|Overall Study||1299
124663|NCT00148733|299365|P1|COMPLETED|Overall Study||1300
124664|NCT00148733|299364|P2|STARTED|Overall Study||1314
124665|NCT00148733|299365|P1|STARTED|Overall Study||1314
124666|NCT00148759|299373|P2|NOT COMPLETED|Overall Study||1
124667|NCT00148759|299374|P1|NOT COMPLETED|Overall Study||2
124668|NCT00148759|299373|P2|COMPLETED|Overall Study||11
124669|NCT00148759|299374|P1|COMPLETED|Overall Study||9
124670|NCT00148759|299373|P2|24-hr PK Sampling|Overall Study||11
124671|NCT00148759|299374|P1|24-hr PK Sampling|Overall Study||9
124672|NCT00148759|299373|P2|STARTED|Overall Study||12
124673|NCT00148759|299374|P1|STARTED|Overall Study||11
124674|NCT00148798|299384|P2|NOT COMPLETED|Overall Study||0
124675|NCT00148798|299385|P1|NOT COMPLETED|Overall Study||0
124676|NCT00148798|299384|P2|COMPLETED|Overall Study||568
124677|NCT00148798|299385|P1|COMPLETED|Overall Study||557
124678|NCT00148798|299384|P2|STARTED|Overall Study|ITT Population|568
124679|NCT00148798|299385|P1|STARTED|Overall Study|Intent To Treat (ITT) Population|557
124680|NCT00148954|299407|P2|NOT COMPLETED|Overall Study||300
124681|NCT00148954|299408|P1|NOT COMPLETED|Overall Study||307
124682|NCT00148954|299407|P2|COMPLETED|Overall Study||677
124683|NCT00148954|299408|P1|COMPLETED|Overall Study||678
124684|NCT00148954|299407|P2|STARTED|Overall Study||977
124685|NCT00148954|299408|P1|STARTED|Overall Study||985
124686|NCT00149214|299416|P2|NOT COMPLETED|Overall Study||17
124687|NCT00149214|299417|P1|NOT COMPLETED|Overall Study||26
124688|NCT00149214|299416|P2|COMPLETED|Overall Study||105
124689|NCT00149214|299417|P1|COMPLETED|Overall Study|The patient treated with Cyclophosphamide (C) was included in that arm (C) for safety analysis.|109
124690|NCT00149214|299416|P2|STARTED|Overall Study||122
124691|NCT00149214|299417|P1|STARTED|Overall Study|One patient randomized to Pemetrexed (P) was treated with Cyclophosphamide (C).|135
124692|NCT00149227|299433|P2|NOT COMPLETED|Overall Study||0
124693|NCT00149227|299434|P1|NOT COMPLETED|Overall Study||0
124694|NCT00149227|299433|P2|COMPLETED|Overall Study||1514
124695|NCT00149227|299434|P1|COMPLETED|Overall Study||1517
124696|NCT00149227|299433|P2|STARTED|Overall Study||1514
124697|NCT00149227|299434|P1|STARTED|Overall Study||1517
124698|NCT00156247|299458|P1|NOT COMPLETED|Overall Study||4
124699|NCT00156247|299458|P1|COMPLETED|Overall Study||5
124700|NCT00156247|299458|P1|STARTED|Overall Study||9
124701|NCT00156390|299466|P2|NOT COMPLETED|Overall Study||8
124702|NCT00156390|299467|P1|NOT COMPLETED|Overall Study||14
124703|NCT00156390|299466|P2|COMPLETED|Overall Study||69
124704|NCT00156390|299467|P1|COMPLETED|Overall Study||96
124705|NCT00156390|299466|P2|STARTED|Overall Study||77
124706|NCT00156390|299467|P1|STARTED|Overall Study||110
124707|NCT00156819|299476|P3|NOT COMPLETED|Overall Study||3
124708|NCT00156819|299477|P2|NOT COMPLETED|Overall Study||1
124709|NCT00156819|299478|P1|NOT COMPLETED|Overall Study||1
124710|NCT00156819|299476|P3|COMPLETED|Overall Study||162
124711|NCT00156819|299477|P2|COMPLETED|Overall Study||165
124712|NCT00156819|299478|P1|COMPLETED|Overall Study||168
124713|NCT00156819|299476|P3|STARTED|Overall Study||165
124714|NCT00156819|299477|P2|STARTED|Overall Study||166
124715|NCT00156819|299478|P1|STARTED|Overall Study||169
124716|NCT00156910|299488|P2|NOT COMPLETED|Open-Label Phase (OL)||55
124717|NCT00156910|299489|P1|NOT COMPLETED|Open-Label Phase (OL)||33
124718|NCT00156910|299488|P2|COMPLETED|Open-Label Phase (OL)||231
124719|NCT00156910|299489|P1|COMPLETED|Open-Label Phase (OL)||252
124720|NCT00156910|299488|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL Phase|286
124810|NCT00157820|299806|P2|NOT COMPLETED|1 Month Wash Out Period||0
124721|NCT00156910|299489|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|285
124722|NCT00156910|299488|P2|NOT COMPLETED|Double-Blind Phase (DB)||43
124723|NCT00156910|299489|P1|NOT COMPLETED|Double-Blind Phase (DB)||45
124724|NCT00156910|299488|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|295
124725|NCT00156910|299489|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|296
124726|NCT00156910|299488|P2|STARTED|Double-Blind Phase (DB)||338
124727|NCT00156910|299489|P1|STARTED|Double-Blind Phase (DB)||341
124728|NCT00156923|299505|P2|NOT COMPLETED|Overall Study||32
124729|NCT00156923|299506|P1|NOT COMPLETED|Overall Study||34
124730|NCT00156923|299505|P2|COMPLETED|Overall Study||20
124731|NCT00156923|299506|P1|COMPLETED|Overall Study||22
124732|NCT00156923|299505|P2|STARTED|Overall Study||52
124733|NCT00156923|299506|P1|STARTED|Overall Study||56
124734|NCT00156936|299514|P2|NOT COMPLETED|Overall Study||11
124735|NCT00156936|299515|P1|NOT COMPLETED|Overall Study||72
124736|NCT00156936|299514|P2|COMPLETED|Overall Study||5
124737|NCT00156936|299515|P1|COMPLETED|Overall Study||20
124738|NCT00156936|299514|P2|STARTED|Overall Study||16
124739|NCT00156936|299515|P1|STARTED|Overall Study||92
124740|NCT00157014|299525|P4|NOT COMPLETED|Overall Study||1
124741|NCT00157014|299526|P3|NOT COMPLETED|Overall Study||1
124742|NCT00157014|299527|P2|NOT COMPLETED|Overall Study||5
124743|NCT00157014|299528|P1|NOT COMPLETED|Overall Study||7
124744|NCT00157014|299525|P4|COMPLETED|Overall Study||5
124745|NCT00157014|299526|P3|COMPLETED|Overall Study||4
124746|NCT00157014|299527|P2|COMPLETED|Overall Study||41
124747|NCT00157014|299528|P1|COMPLETED|Overall Study||45
124748|NCT00157014|299525|P4|STARTED|Overall Study||6
124749|NCT00157014|299526|P3|STARTED|Overall Study||5
124750|NCT00157014|299527|P2|STARTED|Overall Study||46
124751|NCT00157014|299528|P1|STARTED|Overall Study||52
124752|NCT00157157|299606|P1|NOT COMPLETED|Overall Study||11
124753|NCT00157157|299606|P1|COMPLETED|Overall Study||44
124754|NCT00157157|299606|P1|STARTED|Overall Study||55
124755|NCT00157196|299629|P1|NOT COMPLETED|Overall Study||9
124756|NCT00157196|299629|P1|COMPLETED|Overall Study||13
124757|NCT00157196|299629|P1|STARTED|Overall Study||22
124758|NCT00157209|299637|P2|NOT COMPLETED|Overall Study||0
124759|NCT00157209|299638|P1|NOT COMPLETED|Overall Study||10
124760|NCT00157209|299637|P2|COMPLETED|Overall Study||83
124761|NCT00157209|299638|P1|COMPLETED|Overall Study||78
124762|NCT00157209|299637|P2|STARTED|Overall Study||83
124763|NCT00157209|299638|P1|STARTED|Overall Study||88
124764|NCT00157248|299656|P4|NOT COMPLETED|Overall Study||47
124765|NCT00157248|299657|P3|NOT COMPLETED|Overall Study||21
124766|NCT00157248|299658|P2|NOT COMPLETED|Overall Study||37
124767|NCT00157248|299659|P1|NOT COMPLETED|Overall Study||48
124768|NCT00157248|299656|P4|COMPLETED|Overall Study||77
124769|NCT00157248|299657|P3|COMPLETED|Overall Study||29
124770|NCT00157248|299658|P2|COMPLETED|Overall Study||52
124771|NCT00157248|299659|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation of study medication.|50
124772|NCT00157248|299656|P4|STARTED|Overall Study||124
124773|NCT00157248|299657|P3|STARTED|Overall Study||50
124774|NCT00157248|299658|P2|STARTED|Overall Study||89
124775|NCT00157248|299659|P1|STARTED|Overall Study|Started: Participant completed previous trial on Dabigatran and took study drug of present trial.|98
124776|NCT00157573|299763|P2|NOT COMPLETED|Overall Study||0
124777|NCT00157573|299764|P1|NOT COMPLETED|Overall Study||0
124778|NCT00157573|299763|P2|COMPLETED|Overall Study||37
124779|NCT00157573|299764|P1|COMPLETED|Overall Study||35
124780|NCT00157573|299763|P2|STARTED|Overall Study||37
124781|NCT00157573|299764|P1|STARTED|Overall Study||35
124782|NCT00157755|299775|P6|NOT COMPLETED|Overall Study||5
124783|NCT00157755|299776|P5|NOT COMPLETED|Overall Study||2
124784|NCT00157755|299777|P4|NOT COMPLETED|Overall Study||4
124785|NCT00157755|299778|P3|NOT COMPLETED|Overall Study||7
124786|NCT00157755|299779|P2|NOT COMPLETED|Overall Study||4
124787|NCT00157755|299780|P1|NOT COMPLETED|Overall Study||2
124788|NCT00157755|299775|P6|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|0
124789|NCT00157755|299776|P5|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|10
124790|NCT00157755|299777|P4|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|11
124791|NCT00157755|299778|P3|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|3
124792|NCT00157755|299779|P2|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|15
124793|NCT00157755|299780|P1|COMPLETED|Overall Study|Subjects finished 12-month follow-up.|24
124794|NCT00157755|299775|P6|STARTED|Overall Study||5
124795|NCT00157755|299776|P5|STARTED|Overall Study||12
124796|NCT00157755|299777|P4|STARTED|Overall Study||15
124797|NCT00157755|299778|P3|STARTED|Overall Study||10
124798|NCT00157755|299779|P2|STARTED|Overall Study||19
124799|NCT00157755|299780|P1|STARTED|Overall Study||26
124800|NCT00157820|299805|P3|NOT COMPLETED|2nd 8 Months||14
124801|NCT00157820|299806|P2|NOT COMPLETED|2nd 8 Months||13
124802|NCT00157820|299807|P1|NOT COMPLETED|2nd 8 Months||5
124803|NCT00157820|299805|P3|COMPLETED|2nd 8 Months||94
124804|NCT00157820|299806|P2|COMPLETED|2nd 8 Months||88
124805|NCT00157820|299807|P1|COMPLETED|2nd 8 Months||98
124806|NCT00157820|299805|P3|STARTED|2nd 8 Months||108
124807|NCT00157820|299806|P2|STARTED|2nd 8 Months||101
124808|NCT00157820|299807|P1|STARTED|2nd 8 Months||103
124809|NCT00157820|299805|P3|NOT COMPLETED|1 Month Wash Out Period||0
124811|NCT00157820|299807|P1|NOT COMPLETED|1 Month Wash Out Period||0
124812|NCT00157820|299805|P3|COMPLETED|1 Month Wash Out Period||108
124813|NCT00157820|299806|P2|COMPLETED|1 Month Wash Out Period||101
124814|NCT00157820|299807|P1|COMPLETED|1 Month Wash Out Period||103
124815|NCT00157820|299805|P3|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in DC true period, that are now carried to SC sim period|108
124816|NCT00157820|299806|P2|STARTED|1 Month Wash Out Period|2 patients had crossed over prematurely in SC sim period, that are now carried to DC true period|101
124817|NCT00157820|299807|P1|STARTED|1 Month Wash Out Period||103
124818|NCT00157820|299805|P3|NOT COMPLETED|1st 8 Month||6
124819|NCT00157820|299806|P2|NOT COMPLETED|1st 8 Month||12
124820|NCT00157820|299807|P1|NOT COMPLETED|1st 8 Month||8
124821|NCT00157820|299805|P3|COMPLETED|1st 8 Month||106
124822|NCT00157820|299806|P2|COMPLETED|1st 8 Month||99
124823|NCT00157820|299807|P1|COMPLETED|1st 8 Month||103
124824|NCT00157820|299805|P3|STARTED|1st 8 Month||112
124825|NCT00157820|299806|P2|STARTED|1st 8 Month||111
124826|NCT00157820|299807|P1|STARTED|1st 8 Month||111
124827|NCT00157820|299805|P3|NOT COMPLETED|Randomized||8
124828|NCT00157820|299806|P2|NOT COMPLETED|Randomized||5
124829|NCT00157820|299807|P1|NOT COMPLETED|Randomized||7
124830|NCT00157820|299805|P3|COMPLETED|Randomized||112
124831|NCT00157820|299806|P2|COMPLETED|Randomized||111
124832|NCT00157820|299807|P1|COMPLETED|Randomized||111
124833|NCT00157820|299805|P3|STARTED|Randomized||120
124834|NCT00157820|299806|P2|STARTED|Randomized||116
124835|NCT00157820|299807|P1|STARTED|Randomized||118
124836|NCT00157950|299820|P2|NOT COMPLETED|Overall Study||0
124837|NCT00157950|299821|P1|NOT COMPLETED|Overall Study||1
124838|NCT00157950|299820|P2|COMPLETED|Overall Study||59
124839|NCT00157950|299821|P1|COMPLETED|Overall Study||116
124840|NCT00157950|299820|P2|Vaccinated at Dose 3|Overall Study||59
124841|NCT00157950|299821|P1|Vaccinated at Dose 3|Overall Study||116
124842|NCT00157950|299820|P2|Vaccinated at Dose 2|Overall Study||59
124843|NCT00157950|299821|P1|Vaccinated at Dose 2|Overall Study||117
124844|NCT00157950|299820|P2|Vaccinated at Dose 1|Overall Study||59
124845|NCT00157950|299821|P1|Vaccinated at Dose 1|Overall Study||117
124846|NCT00157950|299820|P2|STARTED|Overall Study||59
124847|NCT00157950|299821|P1|STARTED|Overall Study||117
124848|NCT00158054|299837|P2|NOT COMPLETED|Overall Study||3
124849|NCT00158054|299838|P1|NOT COMPLETED|Overall Study||10
124850|NCT00158054|299837|P2|COMPLETED|Overall Study||74
124851|NCT00158054|299838|P1|COMPLETED|Overall Study||70
124852|NCT00158054|299837|P2|STARTED|Overall Study||77
124853|NCT00158054|299838|P1|STARTED|Overall Study||80
124854|NCT00158184|299852|P2|NOT COMPLETED|Overall Study||2
124855|NCT00158184|299853|P1|NOT COMPLETED|Overall Study||6
124856|NCT00158184|299852|P2|COMPLETED|Overall Study||9
124857|NCT00158184|299853|P1|COMPLETED|Overall Study||10
124858|NCT00158184|299852|P2|STARTED|Overall Study||11
124859|NCT00158184|299853|P1|STARTED|Overall Study||16
124860|NCT00158197|299865|P4|NOT COMPLETED|Overall Study||0
124861|NCT00158197|299866|P3|NOT COMPLETED|Overall Study||0
124862|NCT00158197|299867|P2|NOT COMPLETED|Overall Study||0
124863|NCT00158197|299868|P1|NOT COMPLETED|Overall Study||0
124864|NCT00158197|299865|P4|COMPLETED|Overall Study||29
124865|NCT00158197|299866|P3|COMPLETED|Overall Study||28
124866|NCT00158197|299867|P2|COMPLETED|Overall Study||30
124867|NCT00158197|299868|P1|COMPLETED|Overall Study||32
124868|NCT00158197|299865|P4|STARTED|Overall Study||29
124869|NCT00158197|299866|P3|STARTED|Overall Study||28
124870|NCT00158197|299867|P2|STARTED|Overall Study||30
124871|NCT00158197|299868|P1|STARTED|Overall Study||32
124872|NCT00158223|299888|P2|NOT COMPLETED|Overall Study||3
124873|NCT00158223|299889|P1|NOT COMPLETED|Overall Study||5
124874|NCT00158223|299888|P2|COMPLETED|Overall Study||22
124875|NCT00158223|299889|P1|COMPLETED|Overall Study||23
124876|NCT00158223|299888|P2|STARTED|Overall Study||25
124877|NCT00158223|299889|P1|STARTED|Overall Study||28
124878|NCT00158249|299901|P2|NOT COMPLETED|Overall Study||0
124879|NCT00158249|299902|P1|NOT COMPLETED|Overall Study||2
124880|NCT00158249|299901|P2|COMPLETED|Overall Study||10
124881|NCT00158249|299902|P1|COMPLETED|Overall Study||9
124882|NCT00158249|299901|P2|STARTED|Overall Study||10
124883|NCT00158249|299902|P1|STARTED|Overall Study||11
124884|NCT00158262|299912|P2|NOT COMPLETED|Overall Study||1
124885|NCT00158262|299913|P1|NOT COMPLETED|Overall Study||1
124886|NCT00158262|299912|P2|COMPLETED|Overall Study||21
124887|NCT00158262|299913|P1|COMPLETED|Overall Study||20
124888|NCT00158262|299912|P2|STARTED|Overall Study||22
124889|NCT00158262|299913|P1|STARTED|Overall Study||21
124890|NCT00158379|299923|P1|NOT COMPLETED|Overall Study||0
124891|NCT00158379|299923|P1|COMPLETED|Overall Study||105
124892|NCT00158379|299923|P1|STARTED|Overall Study||105
124893|NCT00158600|299930|P2|NOT COMPLETED|Overall Study||4
124894|NCT00158600|299931|P1|NOT COMPLETED|Overall Study||5
124895|NCT00158600|299930|P2|COMPLETED|Overall Study||26
124896|NCT00158600|299931|P1|COMPLETED|Overall Study||55
124897|NCT00158600|299930|P2|STARTED|Overall Study||30
124898|NCT00158600|299931|P1|STARTED|Overall Study||60
124899|NCT00158743|299951|P2|NOT COMPLETED|Overall Study||7
124900|NCT00158743|299952|P1|NOT COMPLETED|Overall Study||9
124901|NCT00158743|299951|P2|COMPLETED|Overall Study||20
124902|NCT00158743|299952|P1|COMPLETED|Overall Study||15
124903|NCT00158743|299951|P2|STARTED|Overall Study||27
124904|NCT00158743|299952|P1|STARTED|Overall Study||24
124905|NCT00158756|299963|P5|NOT COMPLETED|Overall Study||3
124906|NCT00158756|299964|P4|NOT COMPLETED|Overall Study||1
124907|NCT00158756|299965|P3|NOT COMPLETED|Overall Study||8
124908|NCT00158756|299966|P2|NOT COMPLETED|Overall Study||0
124909|NCT00158756|299967|P1|NOT COMPLETED|Overall Study||5
124910|NCT00158756|299963|P5|COMPLETED|Overall Study||96
124911|NCT00158756|299964|P4|COMPLETED|Overall Study||22
124912|NCT00158756|299965|P3|COMPLETED|Overall Study||73
124913|NCT00158756|299966|P2|COMPLETED|Overall Study||25
124914|NCT00158756|299967|P1|COMPLETED|Overall Study||75
124915|NCT00158756|299963|P5|STARTED|Overall Study||99
124916|NCT00158756|299964|P4|STARTED|Overall Study||23
124917|NCT00158756|299965|P3|STARTED|Overall Study||81
124918|NCT00158756|299966|P2|STARTED|Overall Study||25
124919|NCT00158756|299967|P1|STARTED|Overall Study||80
124920|NCT00158925|300062|P1|NOT COMPLETED|Overall Study||12
124921|NCT00158925|300062|P1|COMPLETED|Overall Study||84
124922|NCT00158925|300062|P1|STARTED|Overall Study|96 subjects were implanted or attempted with the study lead|96
124923|NCT00152516|300070|P1|NOT COMPLETED|Overall Study||75
124924|NCT00152516|300070|P1|COMPLETED|Overall Study|Subjects ongoing until study close-out|180
124925|NCT00152516|300070|P1|STARTED|Overall Study|Subjects that were dispensed at least 1 dose of study medication|255
124926|NCT00152763|300098|P4|NOT COMPLETED|Overall Study||14
124927|NCT00152763|300099|P3|NOT COMPLETED|Overall Study||4
124928|NCT00152763|300100|P2|NOT COMPLETED|Overall Study||5
124929|NCT00152763|300101|P1|NOT COMPLETED|Overall Study||10
124930|NCT00152763|300098|P4|COMPLETED|Overall Study||63
124931|NCT00152763|300099|P3|COMPLETED|Overall Study||16
124932|NCT00152763|300100|P2|COMPLETED|Overall Study||14
124933|NCT00152763|300101|P1|COMPLETED|Overall Study||67
124934|NCT00152763|300098|P4|STARTED|Overall Study||77
124935|NCT00152763|300099|P3|STARTED|Overall Study||20
124936|NCT00152763|300100|P2|STARTED|Overall Study||19
124937|NCT00152763|300101|P1|STARTED|Overall Study||77
124938|NCT00152971|300220|P3|NOT COMPLETED|Treatment||80
124939|NCT00152971|300221|P2|NOT COMPLETED|Treatment||63
124940|NCT00152971|300222|P1|NOT COMPLETED|Treatment||71
124941|NCT00152971|300220|P3|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|788
124942|NCT00152971|300221|P2|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|808
124943|NCT00152971|300222|P1|COMPLETED|Treatment|Non-completers in 'treatment' table may have completed study but not treatment, and vice versa|786
124944|NCT00152971|300220|P3|STARTED|Treatment||868
124945|NCT00152971|300221|P2|STARTED|Treatment||871
124946|NCT00152971|300222|P1|STARTED|Treatment||857
124947|NCT00152971|300220|P3|NOT COMPLETED|Overall Study||49
124948|NCT00152971|300221|P2|NOT COMPLETED|Overall Study||48
124949|NCT00152971|300222|P1|NOT COMPLETED|Overall Study||51
124950|NCT00152971|300220|P3|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|819
125040|NCT00159822|300434|P1|NOT COMPLETED|Voriconazole Treatment Period||22
124951|NCT00152971|300221|P2|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|823
124952|NCT00152971|300222|P1|COMPLETED|Overall Study|Non-completers in 'overall study' table may have completed treatment but not study, and vice versa|806
124953|NCT00152971|300220|P3|STARTED|Overall Study||868
124954|NCT00152971|300221|P2|STARTED|Overall Study||871
124955|NCT00152971|300222|P1|STARTED|Overall Study||857
124956|NCT00153062|300258|P4|NOT COMPLETED|Overall Study||411
124957|NCT00153062|300259|P3|NOT COMPLETED|Overall Study||415
124958|NCT00153062|300260|P2|NOT COMPLETED|Overall Study||406
124959|NCT00153062|300261|P1|NOT COMPLETED|Overall Study||387
124960|NCT00153062|300258|P4|COMPLETED|Overall Study||4680
124961|NCT00153062|300259|P3|COMPLETED|Overall Study||4645
124962|NCT00153062|300260|P2|COMPLETED|Overall Study||4689
124963|NCT00153062|300261|P1|COMPLETED|Overall Study||4699
124964|NCT00153062|300258|P4|STARTED|Overall Study||5091
124965|NCT00153062|300259|P3|STARTED|Overall Study||5060
124966|NCT00153062|300260|P2|STARTED|Overall Study||5095
124967|NCT00153062|300261|P1|STARTED|Overall Study||5086
124968|NCT00153101|300282|P5|NOT COMPLETED|Overall Study||10
124969|NCT00153101|300283|P4|NOT COMPLETED|Overall Study||8
124970|NCT00153101|300284|P3|NOT COMPLETED|Overall Study||15
124971|NCT00153101|300285|P2|NOT COMPLETED|Overall Study||18
124972|NCT00153101|300286|P1|NOT COMPLETED|Overall Study||17
124973|NCT00153101|300282|P5|COMPLETED|Overall Study||2962
124974|NCT00153101|300283|P4|COMPLETED|Overall Study||2946
124975|NCT00153101|300284|P3|COMPLETED|Overall Study||8561
124976|NCT00153101|300285|P2|COMPLETED|Overall Study||8524
124977|NCT00153101|300286|P1|COMPLETED|Overall Study||8485
124978|NCT00153101|300282|P5|STARTED|Overall Study||2972
124979|NCT00153101|300283|P4|STARTED|Overall Study||2954
124980|NCT00153101|300284|P3|STARTED|Overall Study||8576
124981|NCT00153101|300285|P2|STARTED|Overall Study||8542
124982|NCT00153101|300286|P1|STARTED|Overall Study||8502
124983|NCT00153166|300393|P3|NOT COMPLETED|Overall Study||0
124984|NCT00153166|300394|P2|NOT COMPLETED|Overall Study||0
124985|NCT00153166|300395|P1|NOT COMPLETED|Overall Study||0
124986|NCT00153166|300393|P3|COMPLETED|Overall Study||28
124987|NCT00153166|300394|P2|COMPLETED|Overall Study||37
124988|NCT00153166|300395|P1|COMPLETED|Overall Study||11
124989|NCT00153166|300393|P3|Received Placebo and Placebo|Overall Study||7
124990|NCT00153166|300394|P2|Received Placebo and Placebo|Overall Study||9
124991|NCT00153166|300395|P1|Received Placebo and Placebo|Overall Study||3
124992|NCT00153166|300393|P3|Received Placebo and Pioglitazone|Overall Study||7
124993|NCT00153166|300394|P2|Received Placebo and Pioglitazone|Overall Study||10
124994|NCT00153166|300395|P1|Received Placebo and Pioglitazone|Overall Study||3
124995|NCT00153166|300393|P3|Received Atorvastatin and Placebo|Overall Study||7
124996|NCT00153166|300394|P2|Received Atorvastatin and Placebo|Overall Study||9
124997|NCT00153166|300395|P1|Received Atorvastatin and Placebo|Overall Study||2
124998|NCT00153166|300393|P3|Received Atorvastatin and Pioglitazone|Overall Study||7
124999|NCT00153166|300394|P2|Received Atorvastatin and Pioglitazone|Overall Study||9
125000|NCT00153166|300395|P1|Received Atorvastatin and Pioglitazone|Overall Study||3
125001|NCT00153166|300393|P3|STARTED|Overall Study||28
125002|NCT00153166|300394|P2|STARTED|Overall Study||37
125003|NCT00153166|300395|P1|STARTED|Overall Study||11
125004|NCT00153179|300409|P4|NOT COMPLETED|Study Visit Day 2||0
125005|NCT00153179|300410|P3|NOT COMPLETED|Study Visit Day 2||0
125006|NCT00153179|300411|P2|NOT COMPLETED|Study Visit Day 2||0
125007|NCT00153179|300412|P1|NOT COMPLETED|Study Visit Day 2||0
125008|NCT00153179|300409|P4|COMPLETED|Study Visit Day 2||7
125009|NCT00153179|300410|P3|COMPLETED|Study Visit Day 2||11
125010|NCT00153179|300411|P2|COMPLETED|Study Visit Day 2||8
125011|NCT00153179|300412|P1|COMPLETED|Study Visit Day 2||9
125012|NCT00153179|300409|P4|STARTED|Study Visit Day 2||7
125013|NCT00153179|300410|P3|STARTED|Study Visit Day 2||11
125014|NCT00153179|300411|P2|STARTED|Study Visit Day 2||8
125015|NCT00153179|300412|P1|STARTED|Study Visit Day 2||9
125016|NCT00153179|300409|P4|NOT COMPLETED|Study Visit Day 1||0
125017|NCT00153179|300410|P3|NOT COMPLETED|Study Visit Day 1||0
125018|NCT00153179|300411|P2|NOT COMPLETED|Study Visit Day 1||0
125019|NCT00153179|300412|P1|NOT COMPLETED|Study Visit Day 1||0
125020|NCT00153179|300409|P4|COMPLETED|Study Visit Day 1||9
125021|NCT00153179|300410|P3|COMPLETED|Study Visit Day 1||13
125022|NCT00153179|300411|P2|COMPLETED|Study Visit Day 1||8
125023|NCT00153179|300412|P1|COMPLETED|Study Visit Day 1||10
125024|NCT00153179|300409|P4|STARTED|Study Visit Day 1||9
125025|NCT00153179|300410|P3|STARTED|Study Visit Day 1||13
125026|NCT00153179|300411|P2|STARTED|Study Visit Day 1||8
125027|NCT00153179|300412|P1|STARTED|Study Visit Day 1||10
125028|NCT00159419|300422|P2|NOT COMPLETED|Overall Study||0
125029|NCT00159419|300423|P1|NOT COMPLETED|Overall Study||0
125030|NCT00159419|300422|P2|COMPLETED|Overall Study||9
125031|NCT00159419|300423|P1|COMPLETED|Overall Study||9
125032|NCT00159419|300422|P2|STARTED|Overall Study||9
125033|NCT00159419|300423|P1|STARTED|Overall Study||9
125034|NCT00159432|300429|P1|NOT COMPLETED|Overall Study||10
125035|NCT00159432|300429|P1|COMPLETED|Overall Study||53
125036|NCT00159432|300429|P1|STARTED|Overall Study||63
125037|NCT00159822|300434|P1|NOT COMPLETED|Post-treatment Follow-up Period||3
125038|NCT00159822|300434|P1|COMPLETED|Post-treatment Follow-up Period||23
125039|NCT00159822|300434|P1|STARTED|Post-treatment Follow-up Period||26
125041|NCT00159822|300434|P1|COMPLETED|Voriconazole Treatment Period|Number of subjects completed treatment: 36 up to month 6 (M6); 26 after M6.|26
125042|NCT00159822|300434|P1|STARTED|Voriconazole Treatment Period||48
125043|NCT00159861|300451|P2|NOT COMPLETED|Extension Study - up to 3 Years||71
125044|NCT00159861|300452|P1|NOT COMPLETED|Extension Study - up to 3 Years||62
125045|NCT00159861|300451|P2|COMPLETED|Extension Study - up to 3 Years||56
125046|NCT00159861|300452|P1|COMPLETED|Extension Study - up to 3 Years||53
125047|NCT00159861|300451|P2|Treated|Extension Study - up to 3 Years||127
125048|NCT00159861|300452|P1|Treated|Extension Study - up to 3 Years||115
125049|NCT00159861|300451|P2|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|127
125050|NCT00159861|300452|P1|STARTED|Extension Study - up to 3 Years|Subjects may have entered extension study after 4 weeks in core study (prior to completion).|115
125051|NCT00159861|300451|P2|NOT COMPLETED|Core Study - 16 Weeks||12
125052|NCT00159861|300452|P1|NOT COMPLETED|Core Study - 16 Weeks||25
125053|NCT00159861|300451|P2|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 127; Did not enter A1481153: 7|122
125054|NCT00159861|300452|P1|COMPLETED|Core Study - 16 Weeks|Entered A1481153: 115; Did not enter A1481153: 16|108
125055|NCT00159861|300451|P2|Treated|Core Study - 16 Weeks||134
125056|NCT00159861|300452|P1|Treated|Core Study - 16 Weeks||131
125057|NCT00159861|300451|P2|STARTED|Core Study - 16 Weeks||134
125058|NCT00159861|300452|P1|STARTED|Core Study - 16 Weeks||133
125059|NCT00159874|300480|P7|NOT COMPLETED|Overall Study||5
125060|NCT00159874|300481|P6|NOT COMPLETED|Overall Study||12
125061|NCT00159874|300482|P5|NOT COMPLETED|Overall Study||8
125062|NCT00159874|300483|P4|NOT COMPLETED|Overall Study||6
125063|NCT00159874|300484|P3|NOT COMPLETED|Overall Study||43
125064|NCT00159874|300485|P2|NOT COMPLETED|Overall Study||30
125065|NCT00159874|300486|P1|NOT COMPLETED|Overall Study||20
125066|NCT00159874|300480|P7|COMPLETED|Overall Study||0
125067|NCT00159874|300481|P6|COMPLETED|Overall Study||11
125068|NCT00159874|300482|P5|COMPLETED|Overall Study||11
125069|NCT00159874|300483|P4|COMPLETED|Overall Study||7
125070|NCT00159874|300484|P3|COMPLETED|Overall Study||34
125071|NCT00159874|300485|P2|COMPLETED|Overall Study||25
125072|NCT00159874|300486|P1|COMPLETED|Overall Study||22
125073|NCT00159874|300480|P7|Treated|Overall Study||5
125074|NCT00159874|300481|P6|Treated|Overall Study||23
125075|NCT00159874|300482|P5|Treated|Overall Study||19
125076|NCT00159874|300483|P4|Treated|Overall Study||13
125077|NCT00159874|300484|P3|Treated|Overall Study||77
125078|NCT00159874|300485|P2|Treated|Overall Study||55
125079|NCT00159874|300486|P1|Treated|Overall Study||42
125080|NCT00159874|300480|P7|STARTED|Overall Study||5
125081|NCT00159874|300481|P6|STARTED|Overall Study||23
125082|NCT00159874|300482|P5|STARTED|Overall Study||19
125083|NCT00159874|300483|P4|STARTED|Overall Study||13
125084|NCT00159874|300484|P3|STARTED|Overall Study||77
125085|NCT00159874|300485|P2|STARTED|Overall Study||55
125086|NCT00159874|300486|P1|STARTED|Overall Study||42
125087|NCT00159913|300658|P4|NOT COMPLETED|Overall Study||2
125088|NCT00159913|300659|P3|NOT COMPLETED|Overall Study||2
125089|NCT00159913|300660|P2|NOT COMPLETED|Overall Study||0
125090|NCT00159913|300661|P1|NOT COMPLETED|Overall Study||2
125091|NCT00159913|300658|P4|COMPLETED|Overall Study||58
125092|NCT00159913|300659|P3|COMPLETED|Overall Study||75
125093|NCT00159913|300660|P2|COMPLETED|Overall Study||55
125094|NCT00159913|300661|P1|COMPLETED|Overall Study||40
125095|NCT00159913|300658|P4|STARTED|Overall Study||60
125096|NCT00159913|300659|P3|STARTED|Overall Study||77
125097|NCT00159913|300660|P2|STARTED|Overall Study||55
125098|NCT00159913|300661|P1|STARTED|Overall Study||42
125099|NCT00159965|300730|P2|NOT COMPLETED|Overall Study||5
125100|NCT00159965|300731|P1|NOT COMPLETED|Overall Study||7
125101|NCT00159965|300730|P2|COMPLETED|Overall Study||14
125102|NCT00159965|300731|P1|COMPLETED|Overall Study||12
125103|NCT00159965|300730|P2|STARTED|Overall Study||19
125104|NCT00159965|300731|P1|STARTED|Overall Study||19
125105|NCT00160199|300765|P2|NOT COMPLETED|Overall Study||37
125106|NCT00160199|300766|P1|NOT COMPLETED|Overall Study||24
125107|NCT00160199|300765|P2|COMPLETED|Overall Study||81
125108|NCT00160199|300766|P1|COMPLETED|Overall Study||98
125109|NCT00160199|300765|P2|STARTED|Overall Study||118
125110|NCT00160199|300766|P1|STARTED|Overall Study||122
125111|NCT00160251|300790|P8|NOT COMPLETED|Post-amendment 2||55
125112|NCT00160251|300791|P7|NOT COMPLETED|Post-amendment 2||0
125113|NCT00160251|300792|P6|NOT COMPLETED|Post-amendment 2||0
125114|NCT00160251|300793|P5|NOT COMPLETED|Post-amendment 2||0
125115|NCT00160251|300794|P4|NOT COMPLETED|Post-amendment 2||0
125116|NCT00160251|300795|P3|NOT COMPLETED|Post-amendment 2||0
125117|NCT00160251|300796|P2|NOT COMPLETED|Post-amendment 2||0
125118|NCT00160251|300797|P1|NOT COMPLETED|Post-amendment 2||0
125119|NCT00160251|300790|P8|COMPLETED|Post-amendment 2||88
125120|NCT00160251|300791|P7|COMPLETED|Post-amendment 2||0
125121|NCT00160251|300792|P6|COMPLETED|Post-amendment 2||0
125122|NCT00160251|300793|P5|COMPLETED|Post-amendment 2||0
125123|NCT00160251|300794|P4|COMPLETED|Post-amendment 2||0
125124|NCT00160251|300795|P3|COMPLETED|Post-amendment 2||0
125125|NCT00160251|300796|P2|COMPLETED|Post-amendment 2||0
125126|NCT00160251|300797|P1|COMPLETED|Post-amendment 2||0
125127|NCT00160251|300790|P8|STARTED|Post-amendment 2||143
125128|NCT00160251|300791|P7|STARTED|Post-amendment 2||0
125129|NCT00160251|300792|P6|STARTED|Post-amendment 2||0
125130|NCT00160251|300793|P5|STARTED|Post-amendment 2||0
125131|NCT00160251|300794|P4|STARTED|Post-amendment 2||0
125132|NCT00160251|300795|P3|STARTED|Post-amendment 2||0
125133|NCT00160251|300796|P2|STARTED|Post-amendment 2||0
125134|NCT00160251|300797|P1|STARTED|Post-amendment 2||0
125135|NCT00160251|300790|P8|NOT COMPLETED|Prior to Amendment 2||0
125136|NCT00160251|300791|P7|NOT COMPLETED|Prior to Amendment 2||4
125137|NCT00160251|300792|P6|NOT COMPLETED|Prior to Amendment 2||83
125138|NCT00160251|300793|P5|NOT COMPLETED|Prior to Amendment 2||28
125139|NCT00160251|300794|P4|NOT COMPLETED|Prior to Amendment 2||40
125140|NCT00160251|300795|P3|NOT COMPLETED|Prior to Amendment 2||44
125141|NCT00160251|300796|P2|NOT COMPLETED|Prior to Amendment 2||6
125142|NCT00160251|300797|P1|NOT COMPLETED|Prior to Amendment 2||9
125143|NCT00160251|300790|P8|COMPLETED|Prior to Amendment 2||0
125144|NCT00160251|300791|P7|COMPLETED|Prior to Amendment 2||61
125145|NCT00160251|300792|P6|COMPLETED|Prior to Amendment 2||14
125146|NCT00160251|300793|P5|COMPLETED|Prior to Amendment 2||21
125147|NCT00160251|300794|P4|COMPLETED|Prior to Amendment 2||9
125148|NCT00160251|300795|P3|COMPLETED|Prior to Amendment 2||4
125149|NCT00160251|300796|P2|COMPLETED|Prior to Amendment 2||28
125150|NCT00160251|300797|P1|COMPLETED|Prior to Amendment 2||6
125151|NCT00160251|300790|P8|STARTED|Prior to Amendment 2||0
125152|NCT00160251|300791|P7|STARTED|Prior to Amendment 2||65
125153|NCT00160251|300792|P6|STARTED|Prior to Amendment 2||97
125154|NCT00160251|300793|P5|STARTED|Prior to Amendment 2||49
125155|NCT00160251|300794|P4|STARTED|Prior to Amendment 2||49
125156|NCT00160251|300795|P3|STARTED|Prior to Amendment 2||48
125157|NCT00160251|300796|P2|STARTED|Prior to Amendment 2||34
125158|NCT00160251|300797|P1|STARTED|Prior to Amendment 2||15
125159|NCT00160524|300871|P1|NOT COMPLETED|Overall Study||478
125160|NCT00160524|300871|P1|COMPLETED|Overall Study||117
125161|NCT00160524|300871|P1|STARTED|Overall Study|One subject was enrolled erroneously and has no data in the database.|595
125162|NCT00160563|300885|P3|NOT COMPLETED|Overall Study||90
125163|NCT00160563|300886|P2|NOT COMPLETED|Overall Study||45
125164|NCT00160563|300887|P1|NOT COMPLETED|Overall Study||51
125165|NCT00160563|300885|P3|COMPLETED|Overall Study||11
125166|NCT00160563|300886|P2|COMPLETED|Overall Study||2
125167|NCT00160563|300887|P1|COMPLETED|Overall Study||8
125168|NCT00160563|300885|P3|STARTED|Overall Study||101
125169|NCT00160563|300886|P2|STARTED|Overall Study||47
125170|NCT00160563|300887|P1|STARTED|Overall Study||59
125171|NCT00160641|300899|P1|NOT COMPLETED|Overall Study||221
125172|NCT00160641|300899|P1|COMPLETED|Overall Study||346
125173|NCT00160641|300899|P1|STARTED|Overall Study||567
125174|NCT00160693|300930|P1|NOT COMPLETED|Overall Study||235
125175|NCT00160693|300930|P1|COMPLETED|Overall Study||167
125176|NCT00160693|300930|P1|STARTED|Overall Study||402
125177|NCT00160706|300947|P1|NOT COMPLETED|Overall Study||286
125178|NCT00160706|300947|P1|COMPLETED|Overall Study||24
125179|NCT00160706|300947|P1|STARTED|Overall Study||310
125180|NCT00161213|300959|P1|NOT COMPLETED|Overall Study||2
125181|NCT00161213|300959|P1|COMPLETED|Overall Study||42
125182|NCT00161213|300959|P1|STARTED|Overall Study||44
125183|NCT00161382|300968|P2|NOT COMPLETED|Overall Study||289
125184|NCT00161382|300969|P1|NOT COMPLETED|Overall Study||249
125185|NCT00161382|300968|P2|COMPLETED|Overall Study|Number of control students included in the analyzed cohort (i.e., completed 9th-grade survey)|558
125186|NCT00161382|300969|P1|COMPLETED|Overall Study|Number of intervention students included in the analyzed cohort (i.e., completed 9th-grade survey)|349
125187|NCT00161382|300968|P2|STARTED|Overall Study|Number of students allocated to comparison group|847
125188|NCT00161382|300969|P1|STARTED|Overall Study|Number of students allocated to intervention group|598
125189|NCT00161473|300977|P2|NOT COMPLETED|Overall Study||6
125190|NCT00161473|300978|P1|NOT COMPLETED|Overall Study||5
125191|NCT00161473|300977|P2|COMPLETED|Overall Study||6
125192|NCT00161473|300978|P1|COMPLETED|Overall Study||7
125193|NCT00161473|300977|P2|STARTED|Overall Study||12
125194|NCT00161473|300978|P1|STARTED|Overall Study||12
125195|NCT00161616|300992|P2|NOT COMPLETED|Overall Study||19
125196|NCT00161616|300993|P1|NOT COMPLETED|Overall Study||26
125197|NCT00161616|300992|P2|COMPLETED|Overall Study||119
125198|NCT00161616|300993|P1|COMPLETED|Overall Study||113
125199|NCT00161616|300992|P2|STARTED|Overall Study||138
125200|NCT00161616|300993|P1|STARTED|Overall Study||139
125201|NCT00162032|301003|P2|NOT COMPLETED|Overall Study||2
125202|NCT00162032|301004|P1|NOT COMPLETED|Overall Study||5
125203|NCT00162032|301003|P2|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|114
125204|NCT00162032|301004|P1|COMPLETED|Overall Study|Completed is all subjects who completed 3 yr FU whether or not they were seen in the previous year.|324
125205|NCT00162032|301003|P2|STARTED|Overall Study||116
125206|NCT00162032|301004|P1|STARTED|Overall Study||329
125207|NCT00162097|301016|P4|NOT COMPLETED|Overall Study||1
125208|NCT00162097|301017|P3|NOT COMPLETED|Overall Study||0
125209|NCT00162097|301018|P2|NOT COMPLETED|Overall Study||0
125210|NCT00162097|301019|P1|NOT COMPLETED|Overall Study||0
125211|NCT00162097|301016|P4|COMPLETED|Overall Study||6
125212|NCT00162097|301017|P3|COMPLETED|Overall Study||1
125213|NCT00162097|301018|P2|COMPLETED|Overall Study||2
125214|NCT00162097|301019|P1|COMPLETED|Overall Study||6
125215|NCT00162097|301016|P4|STARTED|Overall Study|Treated on Day 1. One participant enrolled twice in the study and is hence counted twice|7
125216|NCT00162097|301017|P3|STARTED|Overall Study|Treated on Day 1|1
125217|NCT00162097|301018|P2|STARTED|Overall Study|Treated on Day 1|2
125218|NCT00162097|301019|P1|STARTED|Overall Study|Treated on Day 1|6
125219|NCT00162123|301087|P8|NOT COMPLETED|Overall Study||58
125220|NCT00162123|301088|P7|NOT COMPLETED|Overall Study||4
125221|NCT00162123|301089|P6|NOT COMPLETED|Overall Study||9
125222|NCT00162123|301090|P5|NOT COMPLETED|Overall Study||31
125223|NCT00162123|301091|P4|NOT COMPLETED|Overall Study||8
125224|NCT00162123|301092|P3|NOT COMPLETED|Overall Study||21
125225|NCT00162123|301093|P2|NOT COMPLETED|Overall Study||29
125226|NCT00162123|301094|P1|NOT COMPLETED|Overall Study||44
125227|NCT00162123|301087|P8|COMPLETED|Overall Study|Still on treatment|0
125228|NCT00162123|301088|P7|COMPLETED|Overall Study|Still on treatment|0
125229|NCT00162123|301089|P6|COMPLETED|Overall Study|Still on treatment|4
125230|NCT00162123|301090|P5|COMPLETED|Overall Study|Still on treatment|14
125231|NCT00162123|301091|P4|COMPLETED|Overall Study|Still on treatment|3
125232|NCT00162123|301092|P3|COMPLETED|Overall Study|Still on treatment|3
125233|NCT00162123|301093|P2|COMPLETED|Overall Study|Still on treatment|5
125234|NCT00162123|301094|P1|COMPLETED|Overall Study|Still on treatment|9
125235|NCT00162123|301087|P8|Received Treatment|Overall Study||0
125236|NCT00162123|301088|P7|Received Treatment|Overall Study||4
125237|NCT00162123|301089|P6|Received Treatment|Overall Study||12
125238|NCT00162123|301090|P5|Received Treatment|Overall Study||33
125239|NCT00162123|301091|P4|Received Treatment|Overall Study||11
125240|NCT00162123|301092|P3|Received Treatment|Overall Study||24
125241|NCT00162123|301093|P2|Received Treatment|Overall Study||34
125242|NCT00162123|301094|P1|Received Treatment|Overall Study||53
125243|NCT00162123|301087|P8|STARTED|Overall Study|Enrolled|58
125244|NCT00162123|301088|P7|STARTED|Overall Study|Enrolled|4
125245|NCT00162123|301089|P6|STARTED|Overall Study|Enrolled|13
125246|NCT00162123|301090|P5|STARTED|Overall Study|Enrolled|45
125247|NCT00162123|301091|P4|STARTED|Overall Study|Enrolled|11
125248|NCT00162123|301092|P3|STARTED|Overall Study|Enrolled|24
125249|NCT00162123|301093|P2|STARTED|Overall Study|Enrolled|34
125250|NCT00162123|301094|P1|STARTED|Overall Study|Enrolled|53
125251|NCT00162136|301129|P1|NOT COMPLETED|Overall Study||35
125252|NCT00162136|301129|P1|COMPLETED|Overall Study|Number of Participants still on treatment at study termination|0
125253|NCT00162136|301129|P1|STARTED|Overall Study||35
125254|NCT00162266|301156|P4|NOT COMPLETED|Open-Label Period||137
125255|NCT00162266|301157|P3|NOT COMPLETED|Open-Label Period||0
125256|NCT00162266|301158|P2|NOT COMPLETED|Open-Label Period||0
125257|NCT00162266|301159|P1|NOT COMPLETED|Open-Label Period||0
125258|NCT00162266|301156|P4|COMPLETED|Open-Label Period||82
125259|NCT00162266|301157|P3|COMPLETED|Open-Label Period||0
125260|NCT00162266|301158|P2|COMPLETED|Open-Label Period||0
125261|NCT00162266|301159|P1|COMPLETED|Open-Label Period||0
125262|NCT00162266|301156|P4|STARTED|Open-Label Period||219
125263|NCT00162266|301157|P3|STARTED|Open-Label Period||0
125264|NCT00162266|301158|P2|STARTED|Open-Label Period||0
125265|NCT00162266|301159|P1|STARTED|Open-Label Period||0
125266|NCT00162266|301156|P4|NOT COMPLETED|Double-Blind Period||0
125267|NCT00162266|301157|P3|NOT COMPLETED|Double-Blind Period||48
125268|NCT00162266|301158|P2|NOT COMPLETED|Double-Blind Period||31
125269|NCT00162266|301159|P1|NOT COMPLETED|Double-Blind Period||25
125270|NCT00162266|301156|P4|COMPLETED|Double-Blind Period||0
125271|NCT00162266|301157|P3|COMPLETED|Double-Blind Period||71
125272|NCT00162266|301158|P2|COMPLETED|Double-Blind Period||74
125273|NCT00162266|301159|P1|COMPLETED|Double-Blind Period||90
125274|NCT00162266|301156|P4|Completed Day 1 to Day 181|Double-Blind Period||0
125275|NCT00162266|301157|P3|Completed Day 1 to Day 181|Double-Blind Period||78
125276|NCT00162266|301158|P2|Completed Day 1 to Day 181|Double-Blind Period||80
125277|NCT00162266|301159|P1|Completed Day 1 to Day 181|Double-Blind Period||98
125278|NCT00162266|301156|P4|STARTED|Double-Blind Period||0
125279|NCT00162266|301157|P3|STARTED|Double-Blind Period||119
125280|NCT00162266|301158|P2|STARTED|Double-Blind Period||105
125281|NCT00162266|301159|P1|STARTED|Double-Blind Period||115
125282|NCT00156533|301358|P4|NOT COMPLETED|Overall Study||2
125283|NCT00156533|301359|P3|NOT COMPLETED|Overall Study||2
125284|NCT00156533|301360|P2|NOT COMPLETED|Overall Study||2
125285|NCT00156533|301361|P1|NOT COMPLETED|Overall Study||2
125286|NCT00156533|301358|P4|COMPLETED|Overall Study||3
125287|NCT00156533|301359|P3|COMPLETED|Overall Study||3
125288|NCT00156533|301360|P2|COMPLETED|Overall Study||3
125289|NCT00156533|301361|P1|COMPLETED|Overall Study||3
125290|NCT00156533|301358|P4|STARTED|Overall Study||5
125291|NCT00156533|301359|P3|STARTED|Overall Study||5
125292|NCT00156533|301360|P2|STARTED|Overall Study||5
125293|NCT00156533|301361|P1|STARTED|Overall Study||5
125294|NCT00156715|301375|P1|NOT COMPLETED|Overall Study||7
125295|NCT00156715|301375|P1|COMPLETED|Overall Study||16
125296|NCT00156715|301375|P1|STARTED|Overall Study||23
125297|NCT00162370|301380|P1|NOT COMPLETED|Efficacy Population||51
125298|NCT00162370|301380|P1|COMPLETED|Efficacy Population|Efficacy population, completed rest/stress echo with Definity & completed 2 and/or 5 year follow up|315
125299|NCT00162370|301380|P1|STARTED|Efficacy Population||366
125300|NCT00162370|301380|P1|NOT COMPLETED|Completed Echocardiography Imaging||0
125301|NCT00162370|301380|P1|COMPLETED|Completed Echocardiography Imaging|number of subjects who under went Definity-enhanced rest and stress echocardiogram|366
125302|NCT00162370|301380|P1|STARTED|Completed Echocardiography Imaging|Received at least one dose of Definity|366
125303|NCT00163293|301388|P3|NOT COMPLETED|Overall Study||19
125304|NCT00163293|301389|P2|NOT COMPLETED|Overall Study||7
125305|NCT00163293|301390|P1|NOT COMPLETED|Overall Study||13
125306|NCT00163293|301388|P3|COMPLETED|Overall Study||66
125307|NCT00163293|301389|P2|COMPLETED|Overall Study||69
125308|NCT00163293|301390|P1|COMPLETED|Overall Study||66
125309|NCT00163293|301388|P3|STARTED|Overall Study||85
125310|NCT00163293|301389|P2|STARTED|Overall Study||76
125311|NCT00163293|301390|P1|STARTED|Overall Study||79
125312|NCT00163657|301467|P3|NOT COMPLETED|Overall Study||37
125313|NCT00163657|301468|P2|NOT COMPLETED|Overall Study||23
125314|NCT00163657|301469|P1|NOT COMPLETED|Overall Study||20
125315|NCT00163657|301467|P3|COMPLETED|Overall Study||116
125316|NCT00163657|301468|P2|COMPLETED|Overall Study||56
125317|NCT00163657|301469|P1|COMPLETED|Overall Study||60
125318|NCT00163657|301467|P3|STARTED|Overall Study||153
125319|NCT00163657|301468|P2|STARTED|Overall Study||79
125320|NCT00163657|301469|P1|STARTED|Overall Study||80
125321|NCT00165503|301480|P1|NOT COMPLETED|Overall Study||16
125322|NCT00165503|301480|P1|COMPLETED|Overall Study||0
125323|NCT00165503|301480|P1|STARTED|Overall Study||16
125324|NCT00165646|301487|P3|NOT COMPLETED|Overall Study||4
125325|NCT00165646|301488|P2|NOT COMPLETED|Overall Study||5
125326|NCT00165646|301489|P1|NOT COMPLETED|Overall Study||5
125327|NCT00165646|301487|P3|COMPLETED|Overall Study||98
125328|NCT00165646|301488|P2|COMPLETED|Overall Study||88
125329|NCT00165646|301489|P1|COMPLETED|Overall Study||88
125330|NCT00165646|301487|P3|STARTED|Overall Study||102
125331|NCT00165646|301488|P2|STARTED|Overall Study||93
125332|NCT00165646|301489|P1|STARTED|Overall Study||93
125333|NCT00165672|301499|P2|NOT COMPLETED|Overall Study||1
125334|NCT00165672|301500|P1|NOT COMPLETED|Overall Study||0
125335|NCT00165672|301499|P2|COMPLETED|Overall Study||12
125336|NCT00165672|301500|P1|COMPLETED|Overall Study||13
125337|NCT00165672|301499|P2|STARTED|Overall Study||13
125338|NCT00165672|301500|P1|STARTED|Overall Study||13
125339|NCT00165698|301508|P2|NOT COMPLETED|Overall Study||15
125340|NCT00165698|301509|P1|NOT COMPLETED|Overall Study||8
125341|NCT00165698|301508|P2|COMPLETED|Overall Study||105
125342|NCT00165698|301509|P1|COMPLETED|Overall Study||112
125343|NCT00165698|301508|P2|STARTED|Overall Study||120
125344|NCT00165698|301509|P1|STARTED|Overall Study||120
125345|NCT00165776|301537|P4|NOT COMPLETED|Overall Study||2
125346|NCT00165776|301538|P3|NOT COMPLETED|Overall Study||2
125347|NCT00165776|301539|P2|NOT COMPLETED|Overall Study||1
125348|NCT00165776|301540|P1|NOT COMPLETED|Overall Study||4
125349|NCT00165776|301537|P4|COMPLETED|Overall Study||29
125350|NCT00165776|301538|P3|COMPLETED|Overall Study||31
125351|NCT00165776|301539|P2|COMPLETED|Overall Study||33
125352|NCT00165776|301540|P1|COMPLETED|Overall Study||31
125353|NCT00165776|301537|P4|STARTED|Overall Study||31
125354|NCT00165776|301538|P3|STARTED|Overall Study||33
125355|NCT00165776|301539|P2|STARTED|Overall Study||34
125356|NCT00165776|301540|P1|STARTED|Overall Study||35
125357|NCT00165789|301578|P4|NOT COMPLETED|Overall Study||14
125358|NCT00165789|301579|P3|NOT COMPLETED|Overall Study||1
125359|NCT00165789|301580|P2|NOT COMPLETED|Overall Study||4
125360|NCT00165789|301581|P1|NOT COMPLETED|Overall Study||0
125361|NCT00165789|301578|P4|COMPLETED|Overall Study||21
125362|NCT00165789|301579|P3|COMPLETED|Overall Study||11
125363|NCT00165789|301580|P2|COMPLETED|Overall Study||16
125364|NCT00165789|301581|P1|COMPLETED|Overall Study||8
125365|NCT00165789|301578|P4|STARTED|Overall Study||35
125366|NCT00165789|301579|P3|STARTED|Overall Study||12
125367|NCT00165789|301580|P2|STARTED|Overall Study||20
125368|NCT00165789|301581|P1|STARTED|Overall Study||8
125369|NCT00159783|301634|P3|NOT COMPLETED|Overall Study||39
125370|NCT00159783|301635|P2|NOT COMPLETED|Overall Study||27
125371|NCT00159783|301636|P1|NOT COMPLETED|Overall Study||19
125372|NCT00159783|301634|P3|COMPLETED|Overall Study||68
125373|NCT00159783|301635|P2|COMPLETED|Overall Study||52
125374|NCT00159783|301636|P1|COMPLETED|Overall Study||13
125375|NCT00159783|301634|P3|STARTED|Overall Study||107
125376|NCT00159783|301635|P2|STARTED|Overall Study||79
125377|NCT00159783|301636|P1|STARTED|Overall Study||32
125378|NCT00165841|301668|P2|NOT COMPLETED|Overall Study||62
125379|NCT00165841|301669|P1|NOT COMPLETED|Overall Study||30
125380|NCT00165841|301668|P2|COMPLETED|Overall Study||35
125381|NCT00165841|301669|P1|COMPLETED|Overall Study||73
125382|NCT00165841|301668|P2|STARTED|Overall Study||97
125383|NCT00165841|301669|P1|STARTED|Overall Study||103
125384|NCT00165958|301677|P2|NOT COMPLETED|Overall Study||2
125385|NCT00165958|301678|P1|NOT COMPLETED|Overall Study||1
125386|NCT00165958|301677|P2|COMPLETED|Overall Study||19
125387|NCT00165958|301678|P1|COMPLETED|Overall Study||18
125388|NCT00165958|301677|P2|STARTED|Overall Study||21
125389|NCT00165958|301678|P1|STARTED|Overall Study||19
125390|NCT00165984|301684|P1|NOT COMPLETED|Overall Study||15
125391|NCT00165984|301684|P1|COMPLETED|Overall Study||150
125392|NCT00165984|301684|P1|STARTED|Overall Study||165
125393|NCT00166036|301693|P2|NOT COMPLETED|Overall Study||0
125394|NCT00166036|301694|P1|NOT COMPLETED|Overall Study||0
125395|NCT00166036|301693|P2|COMPLETED|Overall Study||19
125396|NCT00166036|301694|P1|COMPLETED|Overall Study||17
125397|NCT00166036|301693|P2|STARTED|Overall Study||19
125398|NCT00166036|301694|P1|STARTED|Overall Study||17
125399|NCT00166114|301704|P2|NOT COMPLETED|Overall Study||6
125400|NCT00166114|301705|P1|NOT COMPLETED|Overall Study||14
125401|NCT00166114|301704|P2|COMPLETED|Overall Study||13
125402|NCT00166114|301705|P1|COMPLETED|Overall Study||7
125403|NCT00166114|301704|P2|STARTED|Overall Study||19
125404|NCT00166114|301705|P1|STARTED|Overall Study||21
125405|NCT00168038|301711|P1|NOT COMPLETED|Overall Study||2
125406|NCT00168038|301711|P1|COMPLETED|Overall Study||55
125407|NCT00168038|301711|P1|STARTED|Overall Study||57
125408|NCT00168064|301725|P2|NOT COMPLETED|Overall Study||44
125409|NCT00168064|301726|P1|NOT COMPLETED|Overall Study||49
125410|NCT00168064|301725|P2|COMPLETED|Overall Study||86
125411|NCT00168064|301726|P1|COMPLETED|Overall Study||81
125412|NCT00168064|301725|P2|STARTED|Overall Study|127 participants received AP formulation|130
125413|NCT00168064|301726|P1|STARTED|Overall Study|128 participants received PG formulation|130
125414|NCT00168103|301737|P4|NOT COMPLETED|Overall Study||0
125415|NCT00168103|301738|P3|NOT COMPLETED|Overall Study||1
125416|NCT00168103|301739|P2|NOT COMPLETED|Overall Study||5
125417|NCT00168103|301740|P1|NOT COMPLETED|Overall Study||2
125418|NCT00168103|301737|P4|COMPLETED|Overall Study||1
125419|NCT00168103|301738|P3|COMPLETED|Overall Study||41
125420|NCT00168103|301739|P2|COMPLETED|Overall Study||38
125421|NCT00168103|301740|P1|COMPLETED|Overall Study|1 randomized subject received open-label rescue medication before receiving randomized treatment.|38
125422|NCT00168103|301737|P4|STARTED|Overall Study||1
125423|NCT00168103|301738|P3|STARTED|Overall Study||42
125424|NCT00168103|301739|P2|STARTED|Overall Study||43
125425|NCT00168103|301740|P1|STARTED|Overall Study||40
125426|NCT00168298|301763|P3|NOT COMPLETED|Open-Label Period||8
125427|NCT00168298|301764|P2|NOT COMPLETED|Open-Label Period||5
125428|NCT00168298|301765|P1|NOT COMPLETED|Open-Label Period||7
125429|NCT00168298|301763|P3|COMPLETED|Open-Label Period||160
125430|NCT00168298|301764|P2|COMPLETED|Open-Label Period||168
125431|NCT00168298|301765|P1|COMPLETED|Open-Label Period||172
125432|NCT00168298|301763|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|168
125433|NCT00168298|301764|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|173
125434|NCT00168298|301765|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|179
125435|NCT00168298|301763|P3|NOT COMPLETED|Double-Blind Period||15
125436|NCT00168298|301764|P2|NOT COMPLETED|Double-Blind Period||12
125437|NCT00168298|301765|P1|NOT COMPLETED|Double-Blind Period||12
125438|NCT00168298|301763|P3|COMPLETED|Double-Blind Period||209
125439|NCT00168298|301764|P2|COMPLETED|Double-Blind Period||206
125440|NCT00168298|301765|P1|COMPLETED|Double-Blind Period||214
125441|NCT00168298|301763|P3|STARTED|Double-Blind Period||224
125442|NCT00168298|301764|P2|STARTED|Double-Blind Period||218
125443|NCT00168298|301765|P1|STARTED|Double-Blind Period||226
125444|NCT00168311|301784|P2|NOT COMPLETED|Overall Study||2
125445|NCT00168311|301785|P1|NOT COMPLETED|Overall Study||0
125446|NCT00168311|301784|P2|COMPLETED|Overall Study||8
125447|NCT00168311|301785|P1|COMPLETED|Overall Study||12
125448|NCT00168311|301784|P2|STARTED|Overall Study||10
125449|NCT00168311|301785|P1|STARTED|Overall Study||12
125450|NCT00168324|301794|P3|NOT COMPLETED|Open-Label Period||6
125451|NCT00168324|301795|P2|NOT COMPLETED|Open-Label Period||8
125452|NCT00168324|301796|P1|NOT COMPLETED|Open-Label Period||4
125453|NCT00168324|301794|P3|COMPLETED|Open-Label Period||152
125454|NCT00168324|301795|P2|COMPLETED|Open-Label Period||147
125455|NCT00168324|301796|P1|COMPLETED|Open-Label Period||160
125456|NCT00168324|301794|P3|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|158
125457|NCT00168324|301795|P2|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|155
125458|NCT00168324|301796|P1|STARTED|Open-Label Period|Not all patients who completed the double-blind period entered the open-label period.|164
125459|NCT00168324|301794|P3|NOT COMPLETED|Double-Blind Period||13
125460|NCT00168324|301795|P2|NOT COMPLETED|Double-Blind Period||7
125461|NCT00168324|301796|P1|NOT COMPLETED|Double-Blind Period||12
125462|NCT00168324|301794|P3|COMPLETED|Double-Blind Period||189
125463|NCT00168324|301795|P2|COMPLETED|Double-Blind Period||189
125464|NCT00168324|301796|P1|COMPLETED|Double-Blind Period||189
125465|NCT00168324|301794|P3|STARTED|Double-Blind Period||202
125466|NCT00168324|301795|P2|STARTED|Double-Blind Period||196
125467|NCT00168324|301796|P1|STARTED|Double-Blind Period||201
125468|NCT00168337|301819|P3|NOT COMPLETED|Overall Study||103
125469|NCT00168337|301820|P2|NOT COMPLETED|Overall Study||69
125470|NCT00168337|301821|P1|NOT COMPLETED|Overall Study||70
125471|NCT00168337|301819|P3|COMPLETED|Overall Study||82
125472|NCT00168337|301820|P2|COMPLETED|Overall Study||112
125473|NCT00168337|301821|P1|COMPLETED|Overall Study||118
125474|NCT00168337|301819|P3|STARTED|Overall Study||185
125475|NCT00168337|301820|P2|STARTED|Overall Study||181
125476|NCT00168337|301821|P1|STARTED|Overall Study||188
125477|NCT00168389|301850|P3|NOT COMPLETED|Overall Study||95
125478|NCT00168389|301851|P2|NOT COMPLETED|Overall Study||48
125479|NCT00168389|301852|P1|NOT COMPLETED|Overall Study||56
125480|NCT00168389|301850|P3|COMPLETED|Overall Study||70
125481|NCT00168389|301851|P2|COMPLETED|Overall Study||118
125482|NCT00168389|301852|P1|COMPLETED|Overall Study||107
125483|NCT00168389|301850|P3|STARTED|Overall Study||165
125484|NCT00168389|301851|P2|STARTED|Overall Study||166
125485|NCT00168389|301852|P1|STARTED|Overall Study||163
125486|NCT00168428|301880|P2|NOT COMPLETED|Open-Label Phase (OL)||68
125487|NCT00168428|301881|P1|NOT COMPLETED|Open-Label Phase (OL)||44
125488|NCT00168428|301880|P2|COMPLETED|Open-Label Phase (OL)||261
125489|NCT00168428|301881|P1|COMPLETED|Open-Label Phase (OL)||261
125490|NCT00168428|301880|P2|STARTED|Open-Label Phase (OL)|Number of DB Placebo patients who rolled into OL phase|329
125491|NCT00168428|301881|P1|STARTED|Open-Label Phase (OL)|Number of DB Botulinum toxin type A patients who rolled into OL phase|305
125492|NCT00168428|301880|P2|NOT COMPLETED|Double-Blind Phase (DB)||24
125493|NCT00168428|301881|P1|NOT COMPLETED|Double-Blind Phase (DB)||36
125494|NCT00168428|301880|P2|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|334
125495|NCT00168428|301881|P1|COMPLETED|Double-Blind Phase (DB)|Completed Week 24|311
125496|NCT00168428|301880|P2|STARTED|Double-Blind Phase (DB)||358
125497|NCT00168428|301881|P1|STARTED|Double-Blind Phase (DB)||347
125498|NCT00168454|301903|P6|NOT COMPLETED|Overall Study||6
125499|NCT00168454|301904|P5|NOT COMPLETED|Overall Study||6
125500|NCT00168454|301905|P4|NOT COMPLETED|Overall Study||9
125501|NCT00168454|301906|P3|NOT COMPLETED|Overall Study||6
125502|NCT00168454|301907|P2|NOT COMPLETED|Overall Study||7
125503|NCT00168454|301908|P1|NOT COMPLETED|Overall Study||7
125504|NCT00168454|301903|P6|COMPLETED|Overall Study||50
125505|NCT00168454|301904|P5|COMPLETED|Overall Study||47
125506|NCT00168454|301905|P4|COMPLETED|Overall Study||40
125507|NCT00168454|301906|P3|COMPLETED|Overall Study||48
125508|NCT00168454|301907|P2|COMPLETED|Overall Study||50
125509|NCT00168454|301908|P1|COMPLETED|Overall Study||37
125510|NCT00168454|301903|P6|STARTED|Overall Study||56
125511|NCT00168454|301904|P5|STARTED|Overall Study||53
125512|NCT00168454|301905|P4|STARTED|Overall Study||49
125513|NCT00168454|301906|P3|STARTED|Overall Study||54
125514|NCT00168454|301907|P2|STARTED|Overall Study||57
125515|NCT00168454|301908|P1|STARTED|Overall Study||44
125516|NCT00168805|301955|P3|NOT COMPLETED|Treatment||62
125517|NCT00168805|301956|P2|NOT COMPLETED|Treatment||56
125518|NCT00168805|301957|P1|NOT COMPLETED|Treatment||49
125519|NCT00168805|301955|P3|COMPLETED|Treatment||632
125520|NCT00168805|301956|P2|COMPLETED|Treatment||647
125521|NCT00168805|301957|P1|COMPLETED|Treatment||630
125522|NCT00168805|301955|P3|STARTED|Treatment||694
125523|NCT00168805|301956|P2|STARTED|Treatment||703
125524|NCT00168805|301957|P1|STARTED|Treatment||679
125525|NCT00168805|301955|P3|NOT COMPLETED|Overall Study||78
125526|NCT00168805|301956|P2|NOT COMPLETED|Overall Study||78
125527|NCT00168805|301957|P1|NOT COMPLETED|Overall Study||71
125528|NCT00168805|301955|P3|COMPLETED|Overall Study||616
125529|NCT00168805|301956|P2|COMPLETED|Overall Study||625
125530|NCT00168805|301957|P1|COMPLETED|Overall Study||608
125531|NCT00168805|301955|P3|STARTED|Overall Study||694
125532|NCT00168805|301956|P2|STARTED|Overall Study||703
125533|NCT00168805|301957|P1|STARTED|Overall Study||679
125534|NCT00168818|302001|P3|NOT COMPLETED|Treatment||133
125535|NCT00168818|302002|P2|NOT COMPLETED|Treatment||151
125536|NCT00168818|302003|P1|NOT COMPLETED|Treatment||133
125537|NCT00168818|302001|P3|COMPLETED|Treatment||1021
125538|NCT00168818|302002|P2|COMPLETED|Treatment||1012
125539|NCT00168818|302003|P1|COMPLETED|Treatment||1013
125540|NCT00168818|302001|P3|STARTED|Treatment||1154
125541|NCT00168818|302002|P2|STARTED|Treatment||1163
125542|NCT00168818|302003|P1|STARTED|Treatment||1146
125543|NCT00168818|302001|P3|NOT COMPLETED|Overall Study||124
125544|NCT00168818|302002|P2|NOT COMPLETED|Overall Study||109
125545|NCT00168818|302003|P1|NOT COMPLETED|Overall Study||117
125546|NCT00168818|302001|P3|COMPLETED|Overall Study||1030
125547|NCT00168818|302002|P2|COMPLETED|Overall Study||1054
125548|NCT00168818|302003|P1|COMPLETED|Overall Study||1029
125549|NCT00168818|302001|P3|STARTED|Overall Study||1154
125550|NCT00168818|302002|P2|STARTED|Overall Study||1163
125551|NCT00168818|302003|P1|STARTED|Overall Study||1146
125552|NCT00168831|302047|P3|NOT COMPLETED|Overall Study||114
125553|NCT00168831|302048|P2|NOT COMPLETED|Overall Study||81
125554|NCT00168831|302049|P1|NOT COMPLETED|Overall Study||60
125555|NCT00168831|302047|P3|COMPLETED|Overall Study||220
125556|NCT00168831|302048|P2|COMPLETED|Overall Study||254
125557|NCT00168831|302049|P1|COMPLETED|Overall Study||278
125558|NCT00168831|302047|P3|STARTED|Overall Study||334
125559|NCT00168831|302048|P2|STARTED|Overall Study||335
125560|NCT00168831|302049|P1|STARTED|Overall Study||338
125561|NCT00168844|302231|P3|NOT COMPLETED|Overall Study||91
125562|NCT00168844|302232|P2|NOT COMPLETED|Overall Study||55
125563|NCT00168844|302233|P1|NOT COMPLETED|Overall Study||55
125564|NCT00168844|302231|P3|COMPLETED|Overall Study||228
125565|NCT00168844|302232|P2|COMPLETED|Overall Study||277
125566|NCT00168844|302233|P1|COMPLETED|Overall Study||277
125567|NCT00168844|302231|P3|STARTED|Overall Study||319
125568|NCT00168844|302232|P2|STARTED|Overall Study||332
125569|NCT00168844|302233|P1|STARTED|Overall Study||332
125570|NCT00169442|302418|P6|NOT COMPLETED|Overall Study||2
125571|NCT00169442|302419|P5|NOT COMPLETED|Overall Study||1
125572|NCT00169442|302420|P4|NOT COMPLETED|Overall Study||0
125573|NCT00169442|302421|P3|NOT COMPLETED|Overall Study||1
125574|NCT00169442|302422|P2|NOT COMPLETED|Overall Study||1
125575|NCT00169442|302423|P1|NOT COMPLETED|Overall Study||0
125576|NCT00169442|302418|P6|COMPLETED|Overall Study||41
125577|NCT00169442|302419|P5|COMPLETED|Overall Study||41
125578|NCT00169442|302420|P4|COMPLETED|Overall Study||250
125579|NCT00169442|302421|P3|COMPLETED|Overall Study||166
125580|NCT00169442|302422|P2|COMPLETED|Overall Study||123
125581|NCT00169442|302423|P1|COMPLETED|Overall Study||119
125582|NCT00169442|302418|P6|STARTED|Overall Study||43
125583|NCT00169442|302419|P5|STARTED|Overall Study||42
125584|NCT00169442|302420|P4|STARTED|Overall Study||250
125585|NCT00169442|302421|P3|STARTED|Overall Study||167
125586|NCT00169442|302422|P2|STARTED|Overall Study||124
125587|NCT00169442|302423|P1|STARTED|Overall Study||119
125588|NCT00170157|302530|P2|NOT COMPLETED|Treatment Period 2 Crossover||0
125589|NCT00170157|302531|P1|NOT COMPLETED|Treatment Period 2 Crossover||0
125590|NCT00170157|302530|P2|COMPLETED|Treatment Period 2 Crossover||41
125591|NCT00170157|302531|P1|COMPLETED|Treatment Period 2 Crossover||0
125592|NCT00170157|302530|P2|STARTED|Treatment Period 2 Crossover||41
125593|NCT00170157|302531|P1|STARTED|Treatment Period 2 Crossover|Participants initially randomized to this arm were not eligible for crossover.|0
125594|NCT00170157|302530|P2|NOT COMPLETED|Washout Period of 14 Days||17
125595|NCT00170157|302531|P1|NOT COMPLETED|Washout Period of 14 Days||0
125596|NCT00170157|302530|P2|COMPLETED|Washout Period of 14 Days||41
125597|NCT00170157|302531|P1|COMPLETED|Washout Period of 14 Days||0
125598|NCT00170157|302530|P2|STARTED|Washout Period of 14 Days||58
125599|NCT00170157|302531|P1|STARTED|Washout Period of 14 Days|Participants initially randomized to this arm were not eligible for crossover.|0
125600|NCT00170157|302530|P2|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
125601|NCT00170157|302531|P1|NOT COMPLETED|Treatment Period 1 Initial Randomization||0
125602|NCT00170157|302530|P2|COMPLETED|Treatment Period 1 Initial Randomization||58
125603|NCT00170157|302531|P1|COMPLETED|Treatment Period 1 Initial Randomization||54
125604|NCT00170157|302530|P2|STARTED|Treatment Period 1 Initial Randomization||58
125605|NCT00170157|302531|P1|STARTED|Treatment Period 1 Initial Randomization||54
125606|NCT00162773|302537|P1|NOT COMPLETED|Overall Study||22
125607|NCT00162773|302537|P1|COMPLETED|Overall Study||7
125608|NCT00162773|302537|P1|STARTED|Overall Study||29
125609|NCT00162942|302543|P2|NOT COMPLETED|Overall Study||52
125610|NCT00162942|302544|P1|NOT COMPLETED|Overall Study||106
125611|NCT00162942|302543|P2|COMPLETED|Overall Study||26
125612|NCT00162942|302544|P1|COMPLETED|Overall Study||51
125613|NCT00162942|302543|P2|Week 12|Overall Study||61
125614|NCT00162942|302544|P1|Week 12|Overall Study||127
125615|NCT00162942|302543|P2|STARTED|Overall Study||78
125616|NCT00162942|302544|P1|STARTED|Overall Study||157
125617|NCT00162981|302594|P2|NOT COMPLETED|Overall Study||6
125618|NCT00162981|302595|P1|NOT COMPLETED|Overall Study||4
125619|NCT00162981|302594|P2|COMPLETED|Overall Study||30
125620|NCT00162981|302595|P1|COMPLETED|Overall Study||28
125621|NCT00162981|302594|P2|STARTED|Overall Study||36
125622|NCT00162981|302595|P1|STARTED|Overall Study||32
125623|NCT00163020|302611|P2|NOT COMPLETED|Overall Study||2
125624|NCT00163020|302612|P1|NOT COMPLETED|Overall Study||0
125625|NCT00163020|302611|P2|COMPLETED|Overall Study|Twins = 78 Triplets = 25|103
125626|NCT00163020|302612|P1|COMPLETED|Overall Study|Twins = 160 Triplets = 56|216
125627|NCT00163020|302611|P2|STARTED|Overall Study|Twins = 80 Triplets = 25|105
125628|NCT00163020|302612|P1|STARTED|Overall Study|Twins = 160 Triplets = 56|216
125629|NCT00163189|302650|P1|NOT COMPLETED|Overall Study||63
125630|NCT00163189|302650|P1|COMPLETED|Overall Study||35
125631|NCT00163189|302650|P1|STARTED|Overall Study||98
125632|NCT00163215|302672|P1|NOT COMPLETED|Overall Study||15
125633|NCT00163215|302672|P1|COMPLETED|Overall Study||31
125634|NCT00163215|302672|P1|STARTED|Overall Study||46
125635|NCT00170625|302692|P1|NOT COMPLETED|Overall Study||0
125636|NCT00170625|302692|P1|COMPLETED|Overall Study||26
125637|NCT00170625|302692|P1|STARTED|Overall Study||26
125638|NCT00174187|302699|P3|NOT COMPLETED|Period 2 (After 3 Years)||8
125639|NCT00174187|302700|P2|NOT COMPLETED|Period 2 (After 3 Years)||0
125640|NCT00174187|302701|P1|NOT COMPLETED|Period 2 (After 3 Years)||0
125641|NCT00174187|302699|P3|COMPLETED|Period 2 (After 3 Years)||13
125642|NCT00174187|302700|P2|COMPLETED|Period 2 (After 3 Years)||0
125643|NCT00174187|302701|P1|COMPLETED|Period 2 (After 3 Years)||0
125644|NCT00174187|302699|P3|STARTED|Period 2 (After 3 Years)||21
125645|NCT00174187|302700|P2|STARTED|Period 2 (After 3 Years)||0
125646|NCT00174187|302701|P1|STARTED|Period 2 (After 3 Years)||0
125647|NCT00174187|302699|P3|NOT COMPLETED|Between Period 1 and Period 2||5
125648|NCT00174187|302700|P2|NOT COMPLETED|Between Period 1 and Period 2||0
125649|NCT00174187|302701|P1|NOT COMPLETED|Between Period 1 and Period 2||0
125650|NCT00174187|302699|P3|COMPLETED|Between Period 1 and Period 2||21
125651|NCT00174187|302700|P2|COMPLETED|Between Period 1 and Period 2||0
125652|NCT00174187|302701|P1|COMPLETED|Between Period 1 and Period 2||0
125653|NCT00174187|302699|P3|Consented|Between Period 1 and Period 2||24
125654|NCT00174187|302700|P2|Consented|Between Period 1 and Period 2||0
125655|NCT00174187|302701|P1|Consented|Between Period 1 and Period 2||0
125656|NCT00174187|302699|P3|STARTED|Between Period 1 and Period 2||26
125657|NCT00174187|302700|P2|STARTED|Between Period 1 and Period 2||0
125658|NCT00174187|302701|P1|STARTED|Between Period 1 and Period 2||0
125659|NCT00174187|302699|P3|NOT COMPLETED|Period 1 (up to 3 Years)||0
125660|NCT00174187|302700|P2|NOT COMPLETED|Period 1 (up to 3 Years)||4
125661|NCT00174187|302701|P1|NOT COMPLETED|Period 1 (up to 3 Years)||0
125662|NCT00174187|302699|P3|COMPLETED|Period 1 (up to 3 Years)||0
125663|NCT00174187|302700|P2|COMPLETED|Period 1 (up to 3 Years)||11
125664|NCT00174187|302701|P1|COMPLETED|Period 1 (up to 3 Years)||15
125665|NCT00174187|302699|P3|STARTED|Period 1 (up to 3 Years)||0
125666|NCT00174187|302700|P2|STARTED|Period 1 (up to 3 Years)||15
125667|NCT00174187|302701|P1|STARTED|Period 1 (up to 3 Years)||15
125668|NCT00174252|302762|P1|NOT COMPLETED|Overall Study||2
125669|NCT00174252|302762|P1|COMPLETED|Overall Study||55
125670|NCT00174252|302762|P1|STARTED|Overall Study||57
125671|NCT00174265|302797|P2|NOT COMPLETED|Overall Study||21
125672|NCT00174265|302798|P1|NOT COMPLETED|Overall Study||29
125673|NCT00174265|302797|P2|COMPLETED|Overall Study||89
125674|NCT00174265|302798|P1|COMPLETED|Overall Study||57
125675|NCT00174265|302797|P2|STARTED|Overall Study||110
125676|NCT00174265|302798|P1|STARTED|Overall Study|85 participants received randomized treatment assignment and at least one dose of study medication.|86
125677|NCT00174291|302808|P2|NOT COMPLETED|Overall Study||6
125678|NCT00174291|302809|P1|NOT COMPLETED|Overall Study||5
125679|NCT00174291|302808|P2|COMPLETED|Overall Study||4
125680|NCT00174291|302809|P1|COMPLETED|Overall Study||6
125681|NCT00174291|302808|P2|STARTED|Overall Study||10
125682|NCT00174291|302809|P1|STARTED|Overall Study||11
125683|NCT00174382|302837|P1|NOT COMPLETED|Overall Study||33
125684|NCT00174382|302837|P1|COMPLETED|Overall Study||116
125685|NCT00174382|302837|P1|STARTED|Overall Study|148 are summarized below: 1 subject entered the study but was lost to follow up.|149
125686|NCT00174447|302854|P1|NOT COMPLETED|Overall Study||38
125687|NCT00174447|302854|P1|COMPLETED|Overall Study||5
125688|NCT00174447|302854|P1|STARTED|Overall Study||43
125689|NCT00174460|302865|P2|NOT COMPLETED|Overall Study||1
125690|NCT00174460|302866|P1|NOT COMPLETED|Overall Study||0
125691|NCT00174460|302865|P2|COMPLETED|Overall Study||14
125692|NCT00174460|302866|P1|COMPLETED|Overall Study||18
125693|NCT00174460|302865|P2|Received Study Treatment|Overall Study||14
125694|NCT00174460|302866|P1|Received Study Treatment|Overall Study||18
125695|NCT00174460|302865|P2|STARTED|Overall Study||15
125696|NCT00174460|302866|P1|STARTED|Overall Study||18
125697|NCT00174785|302914|P2|NOT COMPLETED|Overall Study||716
125698|NCT00174785|302915|P1|NOT COMPLETED|Overall Study||696
125699|NCT00174785|302914|P2|COMPLETED|Overall Study|completed study drug|1611
125700|NCT00174785|302915|P1|COMPLETED|Overall Study|completed study drug|1605
125701|NCT00174785|302914|P2|STARTED|Overall Study|randomized patients; among them, 14 patients did not receive any study drug in the placebo group|2327
125702|NCT00174785|302915|P1|STARTED|Overall Study|randomized patients; among them, 10 patients did not receive any study drug in the dronedarone group|2301
125703|NCT00174915|302934|P5|NOT COMPLETED|Overall Study||33
125704|NCT00174915|302935|P4|NOT COMPLETED|Overall Study||57
125705|NCT00174915|302936|P3|NOT COMPLETED|Overall Study||48
125706|NCT00174915|302937|P2|NOT COMPLETED|Overall Study||69
125707|NCT00174915|302938|P1|NOT COMPLETED|Overall Study||93
125708|NCT00174915|302934|P5|COMPLETED|Overall Study||101
125709|NCT00174915|302935|P4|COMPLETED|Overall Study||211
125710|NCT00174915|302936|P3|COMPLETED|Overall Study||86
125711|NCT00174915|302937|P2|COMPLETED|Overall Study||200
125712|NCT00174915|302938|P1|COMPLETED|Overall Study||174
125713|NCT00174915|302934|P5|STARTED|Overall Study||134
125714|NCT00174915|302935|P4|STARTED|Overall Study||268
125715|NCT00174915|302936|P3|STARTED|Overall Study||134
125716|NCT00174915|302937|P2|STARTED|Overall Study||269
125717|NCT00174915|302938|P1|STARTED|Overall Study||267
125718|NCT00174941|302998|P4|NOT COMPLETED|Overall Study||58
125719|NCT00174941|302999|P3|NOT COMPLETED|Overall Study||18
125720|NCT00174941|303000|P2|NOT COMPLETED|Overall Study||38
125721|NCT00174941|303001|P1|NOT COMPLETED|Overall Study||2
125722|NCT00174941|302998|P4|COMPLETED|Overall Study||58
125723|NCT00174941|302999|P3|COMPLETED|Overall Study||11
125724|NCT00174941|303000|P2|COMPLETED|Overall Study||41
125725|NCT00174941|303001|P1|COMPLETED|Overall Study||6
125726|NCT00174941|302998|P4|STARTED|Overall Study||116
125727|NCT00174941|302999|P3|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|29
125728|NCT00174941|303000|P2|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|79
125729|NCT00174941|303001|P1|STARTED|Overall Study|Subjects started on febuxostat 80mg. Number of subjects based on Final Stable Dose after titration.|8
125730|NCT00174954|303071|P1|NOT COMPLETED|Overall Study||4
125731|NCT00174954|303071|P1|COMPLETED|Overall Study||28
125732|NCT00174954|303071|P1|STARTED|Overall Study||32
125733|NCT00174967|303080|P4|NOT COMPLETED|Overall Study||2
125734|NCT00174967|303081|P3|NOT COMPLETED|Overall Study||2
125735|NCT00174967|303082|P2|NOT COMPLETED|Overall Study||3
125736|NCT00174967|303083|P1|NOT COMPLETED|Overall Study||1
125737|NCT00174967|303080|P4|COMPLETED|Overall Study||36
125738|NCT00174967|303081|P3|COMPLETED|Overall Study||36
125739|NCT00174967|303082|P2|COMPLETED|Overall Study||37
125740|NCT00174967|303083|P1|COMPLETED|Overall Study||36
125741|NCT00174967|303080|P4|STARTED|Overall Study||38
125742|NCT00174967|303081|P3|STARTED|Overall Study||38
125743|NCT00174967|303082|P2|STARTED|Overall Study||40
125744|NCT00174967|303083|P1|STARTED|Overall Study||37
125745|NCT00175006|303129|P1|NOT COMPLETED|Overall Study||0
125746|NCT00175006|303129|P1|COMPLETED|Overall Study||13
125747|NCT00175006|303129|P1|STARTED|Overall Study||13
125748|NCT00175019|303137|P3|NOT COMPLETED|Overall Study||57
125749|NCT00175019|303138|P2|NOT COMPLETED|Overall Study||171
125750|NCT00175019|303139|P1|NOT COMPLETED|Overall Study||194
125751|NCT00175019|303137|P3|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|35
125752|NCT00175019|303138|P2|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|217
125753|NCT00175019|303139|P1|COMPLETED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|412
125754|NCT00175019|303137|P3|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|92
125755|NCT00175019|303138|P2|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|388
125756|NCT00175019|303139|P1|STARTED|Overall Study|Based on final stable treatment in C02-021, defined as after dose switch not allowed.|606
125757|NCT00175877|303183|P1|NOT COMPLETED|Overall Study||349
125758|NCT00175877|303183|P1|COMPLETED|Overall Study||497
125759|NCT00175877|303183|P1|STARTED|Overall Study||846
125760|NCT00176202|303216|P2|NOT COMPLETED|Overall Study||16
125761|NCT00176202|303217|P1|NOT COMPLETED|Overall Study||5
125762|NCT00176202|303216|P2|COMPLETED|Overall Study||17
125763|NCT00176202|303217|P1|COMPLETED|Overall Study||27
125764|NCT00176202|303216|P2|STARTED|Overall Study||33
125765|NCT00176202|303217|P1|STARTED|Overall Study||32
125766|NCT00176228|303229|P1|NOT COMPLETED|Overall Study||2
125767|NCT00176228|303229|P1|COMPLETED|Overall Study|Study ended|46
125768|NCT00176228|303229|P1|STARTED|Overall Study|When study began|48
125769|NCT00176254|303234|P1|NOT COMPLETED|Overall Study||1
125770|NCT00176254|303234|P1|COMPLETED|Overall Study|1 patient only received 1 cycle and refused further induction, another progressed in neck nodes|39
125771|NCT00176254|303234|P1|STARTED|Overall Study||40
125772|NCT00176306|303242|P1|NOT COMPLETED|Overall Study||0
125773|NCT00176306|303242|P1|COMPLETED|Overall Study||15
125774|NCT00176306|303242|P1|STARTED|Overall Study||15
125775|NCT00166166|303248|P2|NOT COMPLETED|Overall Study||0
125776|NCT00166166|303249|P1|NOT COMPLETED|Overall Study||0
125777|NCT00166166|303248|P2|COMPLETED|Overall Study||71
125778|NCT00166166|303249|P1|COMPLETED|Overall Study||103
125779|NCT00166166|303248|P2|STARTED|Overall Study||71
125780|NCT00166166|303249|P1|STARTED|Overall Study||103
125781|NCT00166205|303270|P1|NOT COMPLETED|Overall Study||48
125782|NCT00166205|303270|P1|COMPLETED|Overall Study||228
125783|NCT00166205|303270|P1|Intervention - SAGB Surgery|Overall Study||276
125784|NCT00166205|303270|P1|STARTED|Overall Study||276
125785|NCT00166296|303286|P2|NOT COMPLETED|Overall Study||9
125786|NCT00166296|303287|P1|NOT COMPLETED|Overall Study||7
125787|NCT00166296|303286|P2|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|57
125788|NCT00166296|303287|P1|COMPLETED|Overall Study|Patients who completed both trial medication and interferon+ribavirin treatment for 12 weeks|60
125873|NCT00167388|303415|P1|STARTED|Overall Study||5
125874|NCT00167544|303425|P2|NOT COMPLETED|Overall Study||0
125789|NCT00166296|303286|P2|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|63
125790|NCT00166296|303287|P1|ANALYZED|Overall Study|Patients who did receive at least the first dose of study medications, included in the analysis|66
125791|NCT00166296|303286|P2|STARTED|Overall Study|Randomized patients|66
125792|NCT00166296|303287|P1|STARTED|Overall Study|Randomized patients|67
125793|NCT00166361|303301|P2|NOT COMPLETED|Overall Study||0
125794|NCT00166361|303302|P1|NOT COMPLETED|Overall Study||0
125795|NCT00166361|303301|P2|COMPLETED|Overall Study||10
125796|NCT00166361|303302|P1|COMPLETED|Overall Study||14
125797|NCT00166361|303301|P2|STARTED|Overall Study||10
125798|NCT00166361|303302|P1|STARTED|Overall Study||14
125799|NCT00166504|303310|P2|NOT COMPLETED|Overall Study||4
125800|NCT00166504|303311|P1|NOT COMPLETED|Overall Study||5
125801|NCT00166504|303310|P2|COMPLETED|Overall Study||91
125802|NCT00166504|303311|P1|COMPLETED|Overall Study||103
125803|NCT00166504|303310|P2|STARTED|Overall Study||95
125804|NCT00166504|303311|P1|STARTED|Overall Study||108
125805|NCT00166517|303319|P2|NOT COMPLETED|Overall Study||2
125806|NCT00166517|303320|P1|NOT COMPLETED|Overall Study||5
125807|NCT00166517|303319|P2|COMPLETED|Overall Study||61
125808|NCT00166517|303320|P1|COMPLETED|Overall Study||110
125809|NCT00166517|303319|P2|Vaccinated at Visit 3|Overall Study||61
125810|NCT00166517|303320|P1|Vaccinated at Visit 3|Overall Study||110
125811|NCT00166517|303319|P2|Vaccinated at Visit 2|Overall Study||61
125812|NCT00166517|303320|P1|Vaccinated at Visit 2|Overall Study||112
125813|NCT00166517|303319|P2|Vaccinated at Visit 1|Overall Study||63
125814|NCT00166517|303320|P1|Vaccinated at Visit 1|Overall Study||115
125815|NCT00166517|303319|P2|STARTED|Overall Study||63
125816|NCT00166517|303320|P1|STARTED|Overall Study||115
125817|NCT00166712|303330|P2|NOT COMPLETED|Overall Study||5
125818|NCT00166712|303331|P1|NOT COMPLETED|Overall Study||2
125819|NCT00166712|303330|P2|COMPLETED|Overall Study|Completed study participation.|11
125820|NCT00166712|303331|P1|COMPLETED|Overall Study|Completed study participation.|22
125821|NCT00166712|303330|P2|Phase 3|Overall Study|# weaned off Sirolimus at 12 months post-transplant.|0
125822|NCT00166712|303331|P1|Phase 3|Overall Study|Subjects from Phase 2b who were weaned off Sirolimus @ 12 months post-transplant.|0
125823|NCT00166712|303330|P2|Phase 2b|Overall Study|Subjects weaned off Sirolimus|0
125824|NCT00166712|303331|P1|Phase 2b|Overall Study|Subjects converted to Sirolimus post-transplant.|3
125825|NCT00166712|303330|P2|Phase 2a|Overall Study|Subject who remained on Sirolimus at 6 months post-transplant.|12
125826|NCT00166712|303331|P1|Phase 2a|Overall Study|Subjects who remained on Prograf at 6mo post-transplant.|19
125827|NCT00166712|303330|P2|Phase 1|Overall Study|Evaluated at 6 month post-transplant to potentially be weaned off Sirolimus.|12
125828|NCT00166712|303331|P1|Phase 1|Overall Study|Evaluated for rejection at 6months post-transplant|22
125829|NCT00166712|303330|P2|STARTED|Overall Study|Consented: Randomized-Group 2. Given Sirolimus & MMF prior to surgery, Alemtuzumab day of surgery.|16
125830|NCT00166712|303331|P1|STARTED|Overall Study|Consented:Randomized-Group 1. Given MMF prior to surgery, Alemtuzumab & TAC (Prograf) day of surgery|24
125831|NCT00167102|303348|P2|NOT COMPLETED|Overall Study||0
125832|NCT00167102|303349|P1|NOT COMPLETED|Overall Study||0
125833|NCT00167102|303348|P2|COMPLETED|Overall Study||22
125834|NCT00167102|303349|P1|COMPLETED|Overall Study||23
125835|NCT00167102|303348|P2|STARTED|Overall Study||22
125836|NCT00167102|303349|P1|STARTED|Overall Study||23
125837|NCT00167180|303359|P2|NOT COMPLETED|Overall Study||0
125838|NCT00167180|303360|P1|NOT COMPLETED|Overall Study||0
125839|NCT00167180|303359|P2|COMPLETED|Overall Study||57
125840|NCT00167180|303360|P1|COMPLETED|Overall Study||0
125841|NCT00167180|303359|P2|STARTED|Overall Study||57
125842|NCT00167180|303360|P1|STARTED|Overall Study||0
125843|NCT00167206|303374|P1|NOT COMPLETED|Overall Study||0
125844|NCT00167206|303374|P1|COMPLETED|Overall Study||16
125845|NCT00167206|303374|P1|STARTED|Overall Study||16
125846|NCT00167245|303388|P2|NOT COMPLETED|Overall Study||41
125847|NCT00167245|303389|P1|NOT COMPLETED|Overall Study||29
125848|NCT00167245|303388|P2|COMPLETED|Overall Study||46
125849|NCT00167245|303389|P1|COMPLETED|Overall Study||54
125850|NCT00167245|303388|P2|STARTED|Overall Study||87
125851|NCT00167245|303389|P1|STARTED|Overall Study||83
125852|NCT00167310|303399|P2|NOT COMPLETED|Overall Study||10
125853|NCT00167310|303400|P1|NOT COMPLETED|Overall Study||8
125854|NCT00167310|303399|P2|COMPLETED|Overall Study||18
125855|NCT00167310|303400|P1|COMPLETED|Overall Study||21
125856|NCT00167310|303399|P2|STARTED|Overall Study||28
125857|NCT00167310|303400|P1|STARTED|Overall Study||29
125858|NCT00167388|303412|P4|NOT COMPLETED|Overall Study||0
125859|NCT00167388|303413|P3|NOT COMPLETED|Overall Study||0
125860|NCT00167388|303414|P2|NOT COMPLETED|Overall Study||0
125861|NCT00167388|303415|P1|NOT COMPLETED|Overall Study||0
125862|NCT00167388|303412|P4|COMPLETED|Overall Study||6
125863|NCT00167388|303413|P3|COMPLETED|Overall Study||6
125864|NCT00167388|303414|P2|COMPLETED|Overall Study||5
125865|NCT00167388|303415|P1|COMPLETED|Overall Study||5
125866|NCT00167388|303412|P4|Completed Doppler Study|Overall Study||6
125867|NCT00167388|303413|P3|Completed Doppler Study|Overall Study||6
125868|NCT00167388|303414|P2|Completed Doppler Study|Overall Study||5
125869|NCT00167388|303415|P1|Completed Doppler Study|Overall Study||5
125870|NCT00167388|303412|P4|STARTED|Overall Study||6
125871|NCT00167388|303413|P3|STARTED|Overall Study||6
125872|NCT00167388|303414|P2|STARTED|Overall Study||5
125875|NCT00167544|303426|P1|NOT COMPLETED|Overall Study||1
125876|NCT00167544|303425|P2|COMPLETED|Overall Study||33
125877|NCT00167544|303426|P1|COMPLETED|Overall Study||30
125878|NCT00167544|303425|P2|STARTED|Overall Study||33
125879|NCT00167544|303426|P1|STARTED|Overall Study||31
125880|NCT00167778|303440|P1|NOT COMPLETED|Overall Study||1
125881|NCT00167778|303440|P1|COMPLETED|Overall Study||10
125882|NCT00167778|303440|P1|STARTED|Overall Study||11
125883|NCT00176436|303491|P2|NOT COMPLETED|Overall Study||5
125884|NCT00176436|303492|P1|NOT COMPLETED|Overall Study||6
125885|NCT00176436|303491|P2|COMPLETED|Overall Study||12
125886|NCT00176436|303492|P1|COMPLETED|Overall Study||14
125887|NCT00176436|303491|P2|STARTED|Overall Study||17
125888|NCT00176436|303492|P1|STARTED|Overall Study||20
125889|NCT00176462|303500|P2|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
125890|NCT00176462|303501|P1|NOT COMPLETED|Continuation -up to 30mos Post Remission||0
125891|NCT00176462|303500|P2|COMPLETED|Continuation -up to 30mos Post Remission||26
125892|NCT00176462|303501|P1|COMPLETED|Continuation -up to 30mos Post Remission||19
125893|NCT00176462|303500|P2|STARTED|Continuation -up to 30mos Post Remission||26
125894|NCT00176462|303501|P1|STARTED|Continuation -up to 30mos Post Remission||19
125895|NCT00176462|303500|P2|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||3
125896|NCT00176462|303501|P1|NOT COMPLETED|Intensive Continuation (8X8-week Cycles)||1
125897|NCT00176462|303500|P2|COMPLETED|Intensive Continuation (8X8-week Cycles)||26
125898|NCT00176462|303501|P1|COMPLETED|Intensive Continuation (8X8-week Cycles)||19
125899|NCT00176462|303500|P2|STARTED|Intensive Continuation (8X8-week Cycles)||29
125900|NCT00176462|303501|P1|STARTED|Intensive Continuation (8X8-week Cycles)||20
125901|NCT00176462|303500|P2|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
125902|NCT00176462|303501|P1|NOT COMPLETED|Delayed Intensification (8 Weeks)||0
125903|NCT00176462|303500|P2|COMPLETED|Delayed Intensification (8 Weeks)||29
125904|NCT00176462|303501|P1|COMPLETED|Delayed Intensification (8 Weeks)||20
125905|NCT00176462|303500|P2|STARTED|Delayed Intensification (8 Weeks)||29
125906|NCT00176462|303501|P1|STARTED|Delayed Intensification (8 Weeks)||20
125907|NCT00176462|303500|P2|NOT COMPLETED|Consolidation (12 Weeks)||5
125908|NCT00176462|303501|P1|NOT COMPLETED|Consolidation (12 Weeks)||0
125909|NCT00176462|303500|P2|COMPLETED|Consolidation (12 Weeks)||29
125910|NCT00176462|303501|P1|COMPLETED|Consolidation (12 Weeks)||20
125911|NCT00176462|303500|P2|STARTED|Consolidation (12 Weeks)||34
125912|NCT00176462|303501|P1|STARTED|Consolidation (12 Weeks)||20
125913|NCT00176462|303500|P2|NOT COMPLETED|Induction (4 Weeks)||5
125914|NCT00176462|303501|P1|NOT COMPLETED|Induction (4 Weeks)||1
125915|NCT00176462|303500|P2|COMPLETED|Induction (4 Weeks)||34
125916|NCT00176462|303501|P1|COMPLETED|Induction (4 Weeks)||20
125917|NCT00176462|303500|P2|STARTED|Induction (4 Weeks)||39
125918|NCT00176462|303501|P1|STARTED|Induction (4 Weeks)||21
125919|NCT00176488|303508|P1|NOT COMPLETED|Overall Study||1
125920|NCT00176488|303508|P1|COMPLETED|Overall Study||30
125921|NCT00176488|303508|P1|STARTED|Overall Study||31
125922|NCT00176501|303514|P1|NOT COMPLETED|Overall Study||0
125923|NCT00176501|303514|P1|COMPLETED|Overall Study||3
125924|NCT00176501|303514|P1|STARTED|Overall Study||3
125925|NCT00176605|303520|P1|NOT COMPLETED|Overall Study||2
125926|NCT00176605|303520|P1|COMPLETED|Overall Study||13
125927|NCT00176605|303520|P1|STARTED|Overall Study||15
125928|NCT00176631|303525|P1|NOT COMPLETED|Overall Study||0
125929|NCT00176631|303525|P1|COMPLETED|Overall Study||10
125930|NCT00176631|303525|P1|STARTED|Overall Study||10
125931|NCT00176644|303530|P1|NOT COMPLETED|Overall Study||1
125932|NCT00176644|303530|P1|COMPLETED|Overall Study||22
125933|NCT00176644|303530|P1|STARTED|Overall Study||23
125934|NCT00177164|303540|P2|NOT COMPLETED|Overall Study||16
125935|NCT00177164|303541|P1|NOT COMPLETED|Overall Study||9
125936|NCT00177164|303540|P2|COMPLETED|Overall Study||9
125937|NCT00177164|303541|P1|COMPLETED|Overall Study||14
125938|NCT00177164|303540|P2|STARTED|Overall Study||25
125939|NCT00177164|303541|P1|STARTED|Overall Study||23
125940|NCT00177216|303556|P3|NOT COMPLETED|Overall Study||1
125941|NCT00177216|303557|P2|NOT COMPLETED|Overall Study||3
125942|NCT00177216|303558|P1|NOT COMPLETED|Overall Study||6
125943|NCT00177216|303556|P3|COMPLETED|Overall Study||19
125944|NCT00177216|303557|P2|COMPLETED|Overall Study||20
125945|NCT00177216|303558|P1|COMPLETED|Overall Study||20
125946|NCT00177216|303556|P3|STARTED|Overall Study||20
125947|NCT00177216|303557|P2|STARTED|Overall Study||23
125948|NCT00177216|303558|P1|STARTED|Overall Study||26
125949|NCT00177255|303572|P1|NOT COMPLETED|Overall Study||0
125950|NCT00177255|303572|P1|COMPLETED|Overall Study||39
125951|NCT00177255|303572|P1|STARTED|Overall Study||39
125952|NCT00177294|303579|P2|NOT COMPLETED|Overall Study||5
125953|NCT00177294|303580|P1|NOT COMPLETED|Overall Study||7
125954|NCT00177294|303579|P2|COMPLETED|Overall Study||59
125955|NCT00177294|303580|P1|COMPLETED|Overall Study||53
125956|NCT00177294|303579|P2|STARTED|Overall Study||64
125957|NCT00177294|303580|P1|STARTED|Overall Study||60
125958|NCT00177307|303586|P1|NOT COMPLETED|Overall Study||1
125959|NCT00177307|303586|P1|COMPLETED|Overall Study||39
125960|NCT00177307|303586|P1|STARTED|Overall Study||40
125961|NCT00177671|303595|P2|NOT COMPLETED|Overall Study||14
125962|NCT00177671|303596|P1|NOT COMPLETED|Overall Study||25
125963|NCT00177671|303595|P2|COMPLETED|Overall Study||49
125964|NCT00177671|303596|P1|COMPLETED|Overall Study||42
125965|NCT00177671|303595|P2|Month 24|Overall Study||49
125966|NCT00177671|303596|P1|Month 24|Overall Study||42
125967|NCT00177671|303595|P2|Month 12|Overall Study||57
125968|NCT00177671|303596|P1|Month 12|Overall Study||45
125969|NCT00177671|303595|P2|STARTED|Overall Study||63
125970|NCT00177671|303596|P1|STARTED|Overall Study||67
125971|NCT00177866|303610|P2|NOT COMPLETED|Overall Study||0
125972|NCT00177866|303611|P1|NOT COMPLETED|Overall Study||0
125973|NCT00177866|303610|P2|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
125974|NCT00177866|303611|P1|COMPLETED|Overall Study|No results or publication, data destroyed due to age of study.|0
125975|NCT00177866|303610|P2|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
125976|NCT00177866|303611|P1|STARTED|Overall Study|No results or publication, data destroyed due to age of study.|0
125977|NCT00177970|303621|P2|NOT COMPLETED|Overall Study||0
125978|NCT00177970|303622|P1|NOT COMPLETED|Overall Study||0
125979|NCT00177970|303621|P2|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
125980|NCT00177970|303622|P1|COMPLETED|Overall Study|No results available record destroyed due to age of study. no publications|0
125981|NCT00177970|303621|P2|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
125982|NCT00177970|303622|P1|STARTED|Overall Study|No results available record destroyed due to age of study. no publications|0
125983|NCT00178126|303644|P2|NOT COMPLETED|Overall Study||27
125984|NCT00178126|303645|P1|NOT COMPLETED|Overall Study||25
125985|NCT00178126|303644|P2|COMPLETED|Overall Study||86
125986|NCT00178126|303645|P1|COMPLETED|Overall Study||94
125987|NCT00178126|303644|P2|STARTED|Overall Study||113
125988|NCT00178126|303645|P1|STARTED|Overall Study||119
125989|NCT00178178|303655|P4|NOT COMPLETED|Overall Study||0
125990|NCT00178178|303656|P3|NOT COMPLETED|Overall Study||0
125991|NCT00178178|303657|P2|NOT COMPLETED|Overall Study||0
125992|NCT00178178|303658|P1|NOT COMPLETED|Overall Study||0
125993|NCT00178178|303655|P4|COMPLETED|Overall Study||24
125994|NCT00178178|303656|P3|COMPLETED|Overall Study||24
125995|NCT00178178|303657|P2|COMPLETED|Overall Study||24
125996|NCT00178178|303658|P1|COMPLETED|Overall Study||24
125997|NCT00178178|303655|P4|STARTED|Overall Study||24
125998|NCT00178178|303656|P3|STARTED|Overall Study||24
125999|NCT00178178|303657|P2|STARTED|Overall Study||24
126000|NCT00178178|303658|P1|STARTED|Overall Study||24
126001|NCT00178191|303671|P3|NOT COMPLETED|Overall Study||0
126002|NCT00178191|303672|P2|NOT COMPLETED|Overall Study||0
126003|NCT00178191|303673|P1|NOT COMPLETED|Overall Study||0
126004|NCT00178191|303671|P3|COMPLETED|Overall Study||7
126005|NCT00178191|303672|P2|COMPLETED|Overall Study||10
126006|NCT00178191|303673|P1|COMPLETED|Overall Study||11
126007|NCT00178191|303671|P3|STARTED|Overall Study||7
126008|NCT00178191|303672|P2|STARTED|Overall Study||10
126009|NCT00178191|303673|P1|STARTED|Overall Study||11
126010|NCT00178256|303681|P4|NOT COMPLETED|Overall Study||2
126011|NCT00178256|303682|P3|NOT COMPLETED|Overall Study||0
126012|NCT00178256|303683|P2|NOT COMPLETED|Overall Study||1
126013|NCT00178256|303684|P1|NOT COMPLETED|Overall Study||4
126014|NCT00178256|303681|P4|COMPLETED|Overall Study||16
126015|NCT00178256|303682|P3|COMPLETED|Overall Study||6
126016|NCT00178256|303683|P2|COMPLETED|Overall Study||6
126017|NCT00178256|303684|P1|COMPLETED|Overall Study||6
126018|NCT00178256|303681|P4|STARTED|Overall Study||18
126019|NCT00178256|303682|P3|STARTED|Overall Study||6
126020|NCT00178256|303683|P2|STARTED|Overall Study||7
126021|NCT00178256|303684|P1|STARTED|Overall Study||10
126022|NCT00178464|303691|P1|NOT COMPLETED|Overall Study||2
126023|NCT00178464|303691|P1|COMPLETED|Overall Study||9
126024|NCT00178464|303691|P1|STARTED|Overall Study||11
126025|NCT00178477|303696|P1|NOT COMPLETED|Overall Study||5
126026|NCT00178477|303696|P1|COMPLETED|Overall Study||5
126027|NCT00178477|303696|P1|STARTED|Overall Study||10
126028|NCT00178503|303700|P1|NOT COMPLETED|MPH Trial: High Dose||0
126029|NCT00178503|303700|P1|COMPLETED|MPH Trial: High Dose||24
126030|NCT00178503|303700|P1|STARTED|MPH Trial: High Dose||24
126031|NCT00178503|303700|P1|NOT COMPLETED|MPH Trial: Med Dose||0
126032|NCT00178503|303700|P1|COMPLETED|MPH Trial: Med Dose||24
126033|NCT00178503|303700|P1|STARTED|MPH Trial: Med Dose||24
126034|NCT00178503|303700|P1|NOT COMPLETED|MPH Trial: Low Dose||0
126035|NCT00178503|303700|P1|COMPLETED|MPH Trial: Low Dose||24
126036|NCT00178503|303700|P1|STARTED|MPH Trial: Low Dose||24
126037|NCT00178503|303700|P1|NOT COMPLETED|MPH Trial: Placebo||0
126038|NCT00178503|303700|P1|COMPLETED|MPH Trial: Placebo||24
126039|NCT00178503|303700|P1|STARTED|MPH Trial: Placebo||24
126040|NCT00178633|303718|P1|NOT COMPLETED|Overall Study||6
126041|NCT00178633|303718|P1|COMPLETED|Overall Study||37
126042|NCT00178633|303718|P1|STARTED|Overall Study||43
126043|NCT00178685|303729|P3|NOT COMPLETED|Overall Study||196
126044|NCT00178685|303730|P2|NOT COMPLETED|Overall Study||204
126045|NCT00178685|303731|P1|NOT COMPLETED|Overall Study||111
126046|NCT00178685|303729|P3|COMPLETED|Overall Study||128
126047|NCT00178685|303730|P2|COMPLETED|Overall Study||120
126048|NCT00178685|303731|P1|COMPLETED|Overall Study||61
126049|NCT00178685|303729|P3|STARTED|Overall Study||324
126050|NCT00178685|303730|P2|STARTED|Overall Study||324
126051|NCT00178685|303731|P1|STARTED|Overall Study||172
126052|NCT00178711|303744|P2|NOT COMPLETED|Overall Study||0
126053|NCT00178711|303745|P1|NOT COMPLETED|Overall Study||0
126054|NCT00178711|303744|P2|COMPLETED|Overall Study||45
126055|NCT00178711|303745|P1|COMPLETED|Overall Study||52
126056|NCT00178711|303744|P2|STARTED|Overall Study||45
126057|NCT00178711|303745|P1|STARTED|Overall Study||52
126058|NCT00178841|303753|P1|NOT COMPLETED|Overall Study||0
126059|NCT00178841|303753|P1|COMPLETED|Overall Study||4
126060|NCT00178841|303753|P1|STARTED|Overall Study||4
126061|NCT00178919|303761|P2|NOT COMPLETED|Overall Study||25
126062|NCT00178919|303762|P1|NOT COMPLETED|Overall Study||0
126063|NCT00178919|303761|P2|COMPLETED|Overall Study||68
126064|NCT00178919|303762|P1|COMPLETED|Overall Study||19
126065|NCT00178919|303761|P2|STARTED|Overall Study||93
126066|NCT00178919|303762|P1|STARTED|Overall Study||19
126067|NCT00179309|303772|P2|NOT COMPLETED|Crossover||0
126068|NCT00179309|303773|P1|NOT COMPLETED|Crossover||0
126069|NCT00179309|303772|P2|COMPLETED|Crossover||3
126070|NCT00179309|303773|P1|COMPLETED|Crossover||0
126071|NCT00179309|303772|P2|STARTED|Crossover|Crossover was allowed so that patients randomized to B could receive the vaccine upon progression.|3
126072|NCT00179309|303773|P1|STARTED|Crossover||0
126073|NCT00179309|303772|P2|NOT COMPLETED|Treatment||5
126074|NCT00179309|303773|P1|NOT COMPLETED|Treatment||4
126075|NCT00179309|303772|P2|COMPLETED|Treatment||18
126076|NCT00179309|303773|P1|COMPLETED|Treatment||21
126077|NCT00179309|303772|P2|STARTED|Treatment||23
126078|NCT00179309|303773|P1|STARTED|Treatment||25
126079|NCT00179413|303783|P2|NOT COMPLETED|Overall Study||115
126080|NCT00179413|303784|P1|NOT COMPLETED|Overall Study||125
126081|NCT00179413|303783|P2|COMPLETED|Overall Study||152
126082|NCT00179413|303784|P1|COMPLETED|Overall Study||157
126083|NCT00179413|303783|P2|STARTED|Overall Study||267
126084|NCT00179413|303784|P1|STARTED|Overall Study||282
126085|NCT00171704|303796|P2|NOT COMPLETED|Overall Study||49
126086|NCT00171704|303797|P1|NOT COMPLETED|Overall Study||44
126087|NCT00171704|303796|P2|COMPLETED|Overall Study||81
126088|NCT00171704|303797|P1|COMPLETED|Overall Study||89
126089|NCT00171704|303796|P2|STARTED|Overall Study||130
126090|NCT00171704|303797|P1|STARTED|Overall Study||133
126091|NCT00171834|303824|P7|NOT COMPLETED|Overall Study||4
126092|NCT00171834|303825|P6|NOT COMPLETED|Overall Study||35
126093|NCT00171834|303826|P5|NOT COMPLETED|Overall Study||8
126094|NCT00171834|303827|P4|NOT COMPLETED|Overall Study||12
126095|NCT00171834|303828|P3|NOT COMPLETED|Overall Study||12
126096|NCT00171834|303829|P2|NOT COMPLETED|Overall Study||12
126097|NCT00171834|303830|P1|NOT COMPLETED|Overall Study||6
126098|NCT00171834|303824|P7|COMPLETED|Overall Study||0
126099|NCT00171834|303825|P6|COMPLETED|Overall Study||0
126100|NCT00171834|303826|P5|COMPLETED|Overall Study||0
126101|NCT00171834|303827|P4|COMPLETED|Overall Study||0
126102|NCT00171834|303828|P3|COMPLETED|Overall Study||0
126103|NCT00171834|303829|P2|COMPLETED|Overall Study||0
126104|NCT00171834|303830|P1|COMPLETED|Overall Study||0
126105|NCT00171834|303824|P7|Completed 6 Cycles of Treatment|Overall Study||0
126106|NCT00171834|303825|P6|Completed 6 Cycles of Treatment|Overall Study||1
126107|NCT00171834|303826|P5|Completed 6 Cycles of Treatment|Overall Study||2
126108|NCT00171834|303827|P4|Completed 6 Cycles of Treatment|Overall Study||0
126109|NCT00171834|303828|P3|Completed 6 Cycles of Treatment|Overall Study||1
126110|NCT00171834|303829|P2|Completed 6 Cycles of Treatment|Overall Study||0
126111|NCT00171834|303830|P1|Completed 6 Cycles of Treatment|Overall Study||0
126112|NCT00171834|303824|P7|STARTED|Overall Study||4
126113|NCT00171834|303825|P6|STARTED|Overall Study||35
126114|NCT00171834|303826|P5|STARTED|Overall Study||8
126115|NCT00171834|303827|P4|STARTED|Overall Study||12
126116|NCT00171834|303828|P3|STARTED|Overall Study||12
126117|NCT00171834|303829|P2|STARTED|Overall Study||12
126118|NCT00171834|303830|P1|STARTED|Overall Study||6
126119|NCT00171873|303870|P2|NOT COMPLETED|Overall Study||3
126120|NCT00171873|303871|P1|NOT COMPLETED|Overall Study||9
126121|NCT00171873|303870|P2|COMPLETED|Overall Study||40
126122|NCT00171873|303871|P1|COMPLETED|Overall Study||33
126123|NCT00171873|303870|P2|STARTED|Overall Study||43
126124|NCT00171873|303871|P1|STARTED|Overall Study||42
126125|NCT00171925|303879|P2|NOT COMPLETED|Overall Study||31
126126|NCT00171925|303880|P1|NOT COMPLETED|Overall Study||30
126127|NCT00171925|303879|P2|COMPLETED|Overall Study||40
126128|NCT00171925|303880|P1|COMPLETED|Overall Study||42
126129|NCT00171925|303879|P2|STARTED|Overall Study||71
126130|NCT00171925|303880|P1|STARTED|Overall Study||72
126131|NCT00172042|303892|P2|NOT COMPLETED|Overall Study||125
126132|NCT00172042|303893|P1|NOT COMPLETED|Overall Study||158
126133|NCT00172042|303892|P2|COMPLETED|Overall Study||86
126134|NCT00172042|303893|P1|COMPLETED|Overall Study||68
126135|NCT00172042|303892|P2|STARTED|Overall Study||211
126136|NCT00172042|303893|P1|STARTED|Overall Study||226
126137|NCT00172185|303917|P4|NOT COMPLETED|Overall Study||4
126138|NCT00172185|303918|P3|NOT COMPLETED|Overall Study||5
126139|NCT00172185|303919|P2|NOT COMPLETED|Overall Study||2
126140|NCT00172185|303920|P1|NOT COMPLETED|Overall Study||0
126141|NCT00172185|303917|P4|COMPLETED|Overall Study||23
126142|NCT00172185|303918|P3|COMPLETED|Overall Study||20
126143|NCT00172185|303919|P2|COMPLETED|Overall Study||5
126144|NCT00172185|303920|P1|COMPLETED|Overall Study||6
126145|NCT00172185|303917|P4|STARTED|Overall Study||27
126146|NCT00172185|303918|P3|STARTED|Overall Study||25
126147|NCT00172185|303919|P2|STARTED|Overall Study||7
126148|NCT00172185|303920|P1|STARTED|Overall Study||6
126149|NCT00179517|303936|P2|NOT COMPLETED|Overall Study||1
126150|NCT00179517|303937|P1|NOT COMPLETED|Overall Study||2
126151|NCT00179517|303936|P2|COMPLETED|Overall Study||19
126152|NCT00179517|303937|P1|COMPLETED|Overall Study||18
126153|NCT00179517|303936|P2|STARTED|Overall Study||20
126154|NCT00179517|303937|P1|STARTED|Overall Study||20
126155|NCT00179621|303962|P4|NOT COMPLETED|Open-Label Period||43
126156|NCT00179621|303963|P3|NOT COMPLETED|Open-Label Period||28
126157|NCT00179621|303964|P2|NOT COMPLETED|Open-Label Period||28
126158|NCT00179621|303965|P1|NOT COMPLETED|Open-Label Period||0
126159|NCT00179621|303962|P4|COMPLETED|Open-Label Period||13
126160|NCT00179621|303963|P3|COMPLETED|Open-Label Period||19
126161|NCT00179621|303964|P2|COMPLETED|Open-Label Period||14
126162|NCT00179621|303965|P1|COMPLETED|Open-Label Period||0
126163|NCT00179621|303962|P4|STARTED|Open-Label Period|'Started' includes 1 participant who completed double-blind and 55 who discontinued double-blind.|56
126164|NCT00179621|303963|P3|STARTED|Open-Label Period|'Started' includes 39 participants who completed double-blind and 8 who discontinued double-blind.|47
126165|NCT00179621|303964|P2|STARTED|Open-Label Period|'Started' includes 23 participants who completed double-blind and 19 who discontinued double-blind.|42
126166|NCT00179621|303965|P1|STARTED|Open-Label Period||0
126167|NCT00179621|303962|P4|NOT COMPLETED|Double-Blind Period||0
126168|NCT00179621|303963|P3|NOT COMPLETED|Double-Blind Period||30
126169|NCT00179621|303964|P2|NOT COMPLETED|Double-Blind Period||46
126170|NCT00179621|303965|P1|NOT COMPLETED|Double-Blind Period||64
126171|NCT00179621|303962|P4|COMPLETED|Double-Blind Period||0
126172|NCT00179621|303963|P3|COMPLETED|Double-Blind Period||39
126173|NCT00179621|303964|P2|COMPLETED|Double-Blind Period||23
126174|NCT00179621|303965|P1|COMPLETED|Double-Blind Period||3
126175|NCT00179621|303962|P4|STARTED|Double-Blind Period||0
126176|NCT00179621|303963|P3|STARTED|Double-Blind Period||69
126177|NCT00179621|303964|P2|STARTED|Double-Blind Period||69
126178|NCT00179621|303965|P1|STARTED|Double-Blind Period||67
126179|NCT00179647|304016|P1|NOT COMPLETED|Overall Study||1913
126180|NCT00179647|304016|P1|COMPLETED|Overall Study|Subjects participated in study until they presented with reason for discontinuation.|0
126181|NCT00179647|304016|P1|STARTED|Overall Study||1913
126182|NCT00179660|304020|P1|NOT COMPLETED|Overall Study||50
126183|NCT00179660|304020|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
126184|NCT00179660|304020|P1|Completed 12 Cycles of Treatment|Overall Study||12
126185|NCT00179660|304020|P1|Received Study Drug|Overall Study||49
126186|NCT00179660|304020|P1|STARTED|Overall Study||50
126187|NCT00179673|304029|P1|NOT COMPLETED|Overall Study||43
126188|NCT00179673|304029|P1|COMPLETED|Overall Study|Completed refers to participants ongoing in the study at the time of analysis.|0
126189|NCT00179673|304029|P1|Received Study Drug|Overall Study||43
126190|NCT00179673|304029|P1|STARTED|Overall Study||43
126191|NCT00180687|304041|P4|NOT COMPLETED|Overall Study||0
126192|NCT00180687|304042|P3|NOT COMPLETED|Overall Study||0
126193|NCT00180687|304043|P2|NOT COMPLETED|Overall Study||0
126194|NCT00180687|304044|P1|NOT COMPLETED|Overall Study||0
126195|NCT00180687|304041|P4|COMPLETED|Overall Study||20
126196|NCT00180687|304042|P3|COMPLETED|Overall Study||20
126197|NCT00180687|304043|P2|COMPLETED|Overall Study||20
126198|NCT00180687|304044|P1|COMPLETED|Overall Study||20
126199|NCT00180687|304041|P4|STARTED|Overall Study||20
126200|NCT00180687|304042|P3|STARTED|Overall Study||20
126201|NCT00180687|304043|P2|STARTED|Overall Study||20
126202|NCT00180687|304044|P1|STARTED|Overall Study||20
126203|NCT00181155|304066|P2|NOT COMPLETED|Overall Study||0
126204|NCT00181155|304067|P1|NOT COMPLETED|Overall Study||2
126205|NCT00181155|304066|P2|COMPLETED|Overall Study||3
126206|NCT00181155|304067|P1|COMPLETED|Overall Study||13
126207|NCT00181155|304066|P2|STARTED|Overall Study||3
126208|NCT00181155|304067|P1|STARTED|Overall Study||15
126209|NCT00181610|304078|P3|NOT COMPLETED|Overall Study||0
126210|NCT00181610|304079|P2|NOT COMPLETED|Overall Study||1
126211|NCT00181610|304080|P1|NOT COMPLETED|Overall Study||0
126212|NCT00181610|304078|P3|COMPLETED|Overall Study||3
126213|NCT00181610|304079|P2|COMPLETED|Overall Study||3
126214|NCT00181610|304080|P1|COMPLETED|Overall Study||4
126215|NCT00181610|304078|P3|STARTED|Overall Study||3
126216|NCT00181610|304079|P2|STARTED|Overall Study||4
126217|NCT00181610|304080|P1|STARTED|Overall Study||4
126218|NCT00181623|304088|P1|NOT COMPLETED|Overall Study||1
126219|NCT00181623|304088|P1|COMPLETED|Overall Study||5
126220|NCT00181623|304088|P1|STARTED|Overall Study||6
126221|NCT00181714|304092|P1|NOT COMPLETED|Began Treatment With OROS-MPH||124
126222|NCT00181714|304092|P1|COMPLETED|Began Treatment With OROS-MPH||30
126223|NCT00181714|304092|P1|STARTED|Began Treatment With OROS-MPH||154
126224|NCT00181714|304092|P1|NOT COMPLETED|Signed Consent/Enrolled||49
126225|NCT00181714|304092|P1|COMPLETED|Signed Consent/Enrolled||154
126226|NCT00181714|304092|P1|STARTED|Signed Consent/Enrolled||203
126227|NCT00181766|304096|P1|NOT COMPLETED|Overall Study||12
126228|NCT00181766|304096|P1|COMPLETED|Overall Study|Completed the trial.|33
126229|NCT00181766|304096|P1|STARTED|Overall Study|Number of subjects enrolled and treated with Atomoxetine.|45
126230|NCT00181844|304101|P1|NOT COMPLETED|Exposed to Study Medication||17
126231|NCT00181844|304101|P1|COMPLETED|Exposed to Study Medication||22
126232|NCT00181844|304101|P1|STARTED|Exposed to Study Medication||39
126233|NCT00181844|304101|P1|NOT COMPLETED|Signed Consent||12
126234|NCT00181844|304101|P1|COMPLETED|Signed Consent||39
126235|NCT00181844|304101|P1|STARTED|Signed Consent||51
126236|NCT00181883|304105|P1|NOT COMPLETED|Overall Study||10
126237|NCT00181883|304105|P1|COMPLETED|Overall Study||20
126238|NCT00181883|304105|P1|STARTED|Overall Study||30
126239|NCT00182000|304111|P2|NOT COMPLETED|Overall Study||2
126240|NCT00182000|304112|P1|NOT COMPLETED|Overall Study||5
126241|NCT00182000|304111|P2|COMPLETED|Overall Study||13
126242|NCT00182000|304112|P1|COMPLETED|Overall Study||9
126243|NCT00182000|304111|P2|STARTED|Overall Study||15
126244|NCT00182000|304112|P1|STARTED|Overall Study||14
126245|NCT00182078|304120|P2|NOT COMPLETED|Overall Study||0
126246|NCT00182078|304121|P1|NOT COMPLETED|Overall Study||1
126247|NCT00182078|304120|P2|COMPLETED|Overall Study||17
126248|NCT00182078|304121|P1|COMPLETED|Overall Study||8
126249|NCT00182078|304120|P2|STARTED|Overall Study||17
126250|NCT00182078|304121|P1|STARTED|Overall Study||9
126251|NCT00182091|304135|P4|NOT COMPLETED|Overall Study||0
126252|NCT00182091|304136|P3|NOT COMPLETED|Overall Study||0
126253|NCT00182091|304137|P2|NOT COMPLETED|Overall Study||0
126254|NCT00182091|304138|P1|NOT COMPLETED|Overall Study||1
126255|NCT00182091|304135|P4|COMPLETED|Overall Study||20
126256|NCT00182091|304136|P3|COMPLETED|Overall Study||25
126257|NCT00182091|304137|P2|COMPLETED|Overall Study||15
126258|NCT00182091|304138|P1|COMPLETED|Overall Study||14
126259|NCT00182091|304135|P4|STARTED|Overall Study||20
126260|NCT00182091|304136|P3|STARTED|Overall Study||25
126261|NCT00182091|304137|P2|STARTED|Overall Study||15
126262|NCT00182091|304138|P1|STARTED|Overall Study||15
126263|NCT00182637|304152|P1|NOT COMPLETED|Overall Study||3
126264|NCT00182637|304152|P1|COMPLETED|Overall Study|off study date|2
126265|NCT00182637|304152|P1|STARTED|Overall Study|active/on treatment date|5
126266|NCT00182689|304160|P2|NOT COMPLETED|Overall Study||49
126267|NCT00182689|304161|P1|NOT COMPLETED|Overall Study||40
126268|NCT00182689|304160|P2|COMPLETED|Overall Study||0
126269|NCT00182689|304161|P1|COMPLETED|Overall Study||0
126270|NCT00182689|304160|P2|Eligible and Began Protocol Therapy|Overall Study||45
126271|NCT00182689|304161|P1|Eligible and Began Protocol Therapy|Overall Study||38
126272|NCT00182689|304160|P2|Eligible|Overall Study||45
126273|NCT00182689|304161|P1|Eligible|Overall Study||39
126274|NCT00182689|304160|P2|STARTED|Overall Study||49
126275|NCT00182689|304161|P1|STARTED|Overall Study||40
126276|NCT00182728|304171|P1|NOT COMPLETED|Overall Study||0
126277|NCT00182728|304171|P1|COMPLETED|Overall Study||71
126278|NCT00182728|304171|P1|STARTED|Overall Study||71
126279|NCT00182754|304183|P2|NOT COMPLETED|Overall Study||0
126280|NCT00182754|304184|P1|NOT COMPLETED|Overall Study||0
126281|NCT00182754|304183|P2|COMPLETED|Overall Study||17
126282|NCT00182754|304184|P1|COMPLETED|Overall Study||16
126283|NCT00182754|304183|P2|STARTED|Overall Study||17
126284|NCT00182754|304184|P1|STARTED|Overall Study||16
126285|NCT00182767|304194|P5|NOT COMPLETED|Overall Study||0
126286|NCT00182767|304195|P4|NOT COMPLETED|Overall Study||0
126287|NCT00182767|304196|P3|NOT COMPLETED|Overall Study||0
126288|NCT00182767|304197|P2|NOT COMPLETED|Overall Study||0
126289|NCT00182767|304198|P1|NOT COMPLETED|Overall Study||0
126290|NCT00182767|304194|P5|COMPLETED|Overall Study||24
126291|NCT00182767|304195|P4|COMPLETED|Overall Study||3
126292|NCT00182767|304196|P3|COMPLETED|Overall Study||6
126293|NCT00182767|304197|P2|COMPLETED|Overall Study||6
126294|NCT00182767|304198|P1|COMPLETED|Overall Study||6
126295|NCT00182767|304194|P5|STARTED|Overall Study||24
126296|NCT00182767|304195|P4|STARTED|Overall Study||3
126297|NCT00182767|304196|P3|STARTED|Overall Study||6
126298|NCT00182767|304197|P2|STARTED|Overall Study||6
126299|NCT00182767|304198|P1|STARTED|Overall Study||6
126300|NCT00182793|304213|P1|NOT COMPLETED|Overall Study||0
126301|NCT00182793|304213|P1|COMPLETED|Overall Study||32
126302|NCT00182793|304213|P1|STARTED|Overall Study||32
126303|NCT00183092|304220|P4|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
126304|NCT00183092|304221|P3|NOT COMPLETED|Open-label Period (Month 2 Until Death)||1
126305|NCT00183092|304222|P2|NOT COMPLETED|Open-label Period (Month 2 Until Death)||14
126306|NCT00183092|304223|P1|NOT COMPLETED|Open-label Period (Month 2 Until Death)||10
126307|NCT00183092|304220|P4|COMPLETED|Open-label Period (Month 2 Until Death)||0
126308|NCT00183092|304221|P3|COMPLETED|Open-label Period (Month 2 Until Death)||0
126309|NCT00183092|304222|P2|COMPLETED|Open-label Period (Month 2 Until Death)||0
126310|NCT00183092|304223|P1|COMPLETED|Open-label Period (Month 2 Until Death)||0
126311|NCT00183092|304220|P4|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Placebo opted to continue assigned drug during open-label period|1
126312|NCT00183092|304221|P3|STARTED|Open-label Period (Month 2 Until Death)|Participants assigned to Quinacrine opted to continue assigned drug during open-label period|1
126313|NCT00183092|304222|P2|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Placebo opted to begin open-label Quinacrine at Month 2|14
126314|NCT00183092|304223|P1|STARTED|Open-label Period (Month 2 Until Death)|Participants initially assigned to Quinacrine opted to begin open-label Quinacrine at Month 2|10
126315|NCT00183092|304220|P4|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
126316|NCT00183092|304221|P3|NOT COMPLETED|Double-blind (Baseline - Month 2)||0
126317|NCT00183092|304222|P2|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
126318|NCT00183092|304223|P1|NOT COMPLETED|Double-blind (Baseline - Month 2)||12
126319|NCT00183092|304220|P4|COMPLETED|Double-blind (Baseline - Month 2)||0
126320|NCT00183092|304221|P3|COMPLETED|Double-blind (Baseline - Month 2)||0
126321|NCT00183092|304222|P2|COMPLETED|Double-blind (Baseline - Month 2)||16
126322|NCT00183092|304223|P1|COMPLETED|Double-blind (Baseline - Month 2)||11
126323|NCT00183092|304220|P4|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
126324|NCT00183092|304221|P3|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||0
126325|NCT00183092|304222|P2|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||16
126326|NCT00183092|304223|P1|Came in for Month 2 Visit|Double-blind (Baseline - Month 2)||10
126327|NCT00183092|304220|P4|Alive at Month 2|Double-blind (Baseline - Month 2)||0
126328|NCT00183092|304221|P3|Alive at Month 2|Double-blind (Baseline - Month 2)||0
126329|NCT00183092|304222|P2|Alive at Month 2|Double-blind (Baseline - Month 2)||19
126330|NCT00183092|304223|P1|Alive at Month 2|Double-blind (Baseline - Month 2)||13
126331|NCT00183092|304220|P4|STARTED|Double-blind (Baseline - Month 2)||0
126332|NCT00183092|304221|P3|STARTED|Double-blind (Baseline - Month 2)||0
126333|NCT00183092|304222|P2|STARTED|Double-blind (Baseline - Month 2)||28
126334|NCT00183092|304223|P1|STARTED|Double-blind (Baseline - Month 2)||23
126335|NCT00183196|304247|P3|NOT COMPLETED|Overall Study||18
126336|NCT00183196|304248|P2|NOT COMPLETED|Overall Study||15
126337|NCT00183196|304249|P1|NOT COMPLETED|Overall Study||20
126338|NCT00183196|304247|P3|COMPLETED|Overall Study||32
126339|NCT00183196|304248|P2|COMPLETED|Overall Study||35
126340|NCT00183196|304249|P1|COMPLETED|Overall Study||30
126341|NCT00183196|304247|P3|STARTED|Overall Study|1 subject had no post-randomization data|50
126342|NCT00183196|304248|P2|STARTED|Overall Study|1 subject had no post-randomization data|50
126343|NCT00183196|304249|P1|STARTED|Overall Study|2 subjects had no post-randomization data|50
126344|NCT00183248|304259|P2|NOT COMPLETED|Overall Study||1
126345|NCT00183248|304260|P1|NOT COMPLETED|Overall Study||1
126346|NCT00183248|304259|P2|COMPLETED|Overall Study||4
126347|NCT00183248|304260|P1|COMPLETED|Overall Study||3
126348|NCT00183248|304259|P2|STARTED|Overall Study||5
126349|NCT00183248|304260|P1|STARTED|Overall Study||4
126350|NCT00183274|304278|P6|NOT COMPLETED|Phase 3: Double-Blind||4
126351|NCT00183274|304279|P5|NOT COMPLETED|Phase 3: Double-Blind||20
126352|NCT00183274|304280|P4|NOT COMPLETED|Phase 3: Double-Blind||2
126353|NCT00183274|304281|P3|NOT COMPLETED|Phase 3: Double-Blind||0
126354|NCT00183274|304282|P2|NOT COMPLETED|Phase 3: Double-Blind||0
126355|NCT00183274|304283|P1|NOT COMPLETED|Phase 3: Double-Blind||0
126356|NCT00183274|304278|P6|COMPLETED|Phase 3: Double-Blind|2 lost to relapse and 2 lost to dropout|6
126357|NCT00183274|304279|P5|COMPLETED|Phase 3: Double-Blind|11 lost to relapse and 9 lost to dropout|14
126358|NCT00183274|304280|P4|COMPLETED|Phase 3: Double-Blind|1 lost to relapse and 1 lost to dropout|13
126359|NCT00183274|304281|P3|COMPLETED|Phase 3: Double-Blind||0
126360|NCT00183274|304282|P2|COMPLETED|Phase 3: Double-Blind||0
126361|NCT00183274|304283|P1|COMPLETED|Phase 3: Double-Blind||0
126362|NCT00183274|304278|P6|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|10
126363|NCT00183274|304279|P5|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|34
126364|NCT00183274|304280|P4|STARTED|Phase 3: Double-Blind|8 completed Phase 2 but did not enter phase 3|15
126365|NCT00183274|304281|P3|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
126366|NCT00183274|304282|P2|STARTED|Phase 3: Double-Blind|Phase 2 ended at the end of 12 months of study.|0
126367|NCT00183274|304283|P1|STARTED|Phase 3: Double-Blind||0
126368|NCT00183274|304278|P6|NOT COMPLETED|Phase 2: Double-Blind||0
126369|NCT00183274|304279|P5|NOT COMPLETED|Phase 2: Double-Blind||0
126370|NCT00183274|304280|P4|NOT COMPLETED|Phase 2: Double-Blind||0
126371|NCT00183274|304281|P3|NOT COMPLETED|Phase 2: Double-Blind||43
126372|NCT00183274|304282|P2|NOT COMPLETED|Phase 2: Double-Blind||26
126373|NCT00183274|304283|P1|NOT COMPLETED|Phase 2: Double-Blind||0
126374|NCT00183274|304278|P6|COMPLETED|Phase 2: Double-Blind||0
126375|NCT00183274|304279|P5|COMPLETED|Phase 2: Double-Blind||0
126376|NCT00183274|304280|P4|COMPLETED|Phase 2: Double-Blind||0
126377|NCT00183274|304281|P3|COMPLETED|Phase 2: Double-Blind|29 lost to relapse, 14 lost to dropout|11
126378|NCT00183274|304282|P2|COMPLETED|Phase 2: Double-Blind|8 lost to relapse, 18 lost to dropout|56
126379|NCT00183274|304283|P1|COMPLETED|Phase 2: Double-Blind||0
126380|NCT00183274|304278|P6|STARTED|Phase 2: Double-Blind||0
126381|NCT00183274|304279|P5|STARTED|Phase 2: Double-Blind||0
126382|NCT00183274|304280|P4|STARTED|Phase 2: Double-Blind||0
126383|NCT00183274|304281|P3|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|54
126384|NCT00183274|304282|P2|STARTED|Phase 2: Double-Blind|22 did not enter phase 2 due to lack of efficacy and withdrawal of consent|82
126385|NCT00183274|304283|P1|STARTED|Phase 2: Double-Blind|This phase ended after 6 months. There were no longer participants in this phase.|0
126386|NCT00183274|304278|P6|NOT COMPLETED|Phase 1: Open-Label||0
126387|NCT00183274|304279|P5|NOT COMPLETED|Phase 1: Open-Label||0
126388|NCT00183274|304280|P4|NOT COMPLETED|Phase 1: Open-Label||0
126389|NCT00183274|304281|P3|NOT COMPLETED|Phase 1: Open-Label||0
126390|NCT00183274|304282|P2|NOT COMPLETED|Phase 1: Open-Label||0
126391|NCT00183274|304283|P1|NOT COMPLETED|Phase 1: Open-Label||110
126392|NCT00183274|304278|P6|COMPLETED|Phase 1: Open-Label||0
126393|NCT00183274|304279|P5|COMPLETED|Phase 1: Open-Label||0
126394|NCT00183274|304280|P4|COMPLETED|Phase 1: Open-Label||0
126395|NCT00183274|304281|P3|COMPLETED|Phase 1: Open-Label||0
126396|NCT00183274|304282|P2|COMPLETED|Phase 1: Open-Label||0
126397|NCT00183274|304283|P1|COMPLETED|Phase 1: Open-Label|110 dropouts during phase 1|158
126398|NCT00183274|304278|P6|STARTED|Phase 1: Open-Label||0
126399|NCT00183274|304279|P5|STARTED|Phase 1: Open-Label||0
126400|NCT00183274|304280|P4|STARTED|Phase 1: Open-Label||0
126401|NCT00183274|304281|P3|STARTED|Phase 1: Open-Label||0
126402|NCT00183274|304282|P2|STARTED|Phase 1: Open-Label||0
126403|NCT00183274|304283|P1|STARTED|Phase 1: Open-Label||268
126404|NCT00170846|304301|P3|NOT COMPLETED|Overall Study||13
126405|NCT00170846|304302|P2|NOT COMPLETED|Overall Study||19
126406|NCT00170846|304303|P1|NOT COMPLETED|Overall Study||11
126407|NCT00170846|304301|P3|COMPLETED|Overall Study||131
126408|NCT00170846|304302|P2|COMPLETED|Overall Study||108
126409|NCT00170846|304303|P1|COMPLETED|Overall Study||112
126410|NCT00170846|304301|P3|STARTED|Overall Study||144
126411|NCT00170846|304302|P2|STARTED|Overall Study||127
126412|NCT00170846|304303|P1|STARTED|Overall Study||123
126413|NCT00170950|304319|P2|NOT COMPLETED|Overall Study||910
126414|NCT00170950|304320|P1|NOT COMPLETED|Overall Study||885
126415|NCT00170950|304319|P2|COMPLETED|Overall Study||4852
126416|NCT00170950|304320|P1|COMPLETED|Overall Study||4859
126417|NCT00170950|304319|P2|STARTED|Overall Study||5762
126418|NCT00170950|304320|P1|STARTED|Overall Study||5744
126419|NCT00171054|304332|P2|NOT COMPLETED|Overall Study||12
126420|NCT00171054|304333|P1|NOT COMPLETED|Overall Study||10
126421|NCT00171054|304332|P2|COMPLETED|Overall Study||50
126422|NCT00171054|304333|P1|COMPLETED|Overall Study||53
126423|NCT00171054|304332|P2|STARTED|Overall Study||62
126424|NCT00171054|304333|P1|STARTED|Overall Study||63
126425|NCT00171210|304365|P2|NOT COMPLETED|Overall Study||115
126426|NCT00171210|304366|P1|NOT COMPLETED|Overall Study||69
126427|NCT00171210|304365|P2|COMPLETED|Overall Study||181
126428|NCT00171210|304366|P1|COMPLETED|Overall Study||190
126429|NCT00171210|304365|P2|STARTED EXTENSION STUDY|Overall Study||247
126430|NCT00171210|304366|P1|STARTED EXTENSION STUDY|Overall Study||259
126431|NCT00171210|304365|P2|STARTED|Overall Study||296
126432|NCT00171210|304366|P1|STARTED|Overall Study||259
126433|NCT00171301|304396|P2|NOT COMPLETED|Overall Study||9
126434|NCT00171301|304397|P1|NOT COMPLETED|Overall Study||8
126435|NCT00171301|304396|P2|COMPLETED|Overall Study||62
126436|NCT00171301|304397|P1|COMPLETED|Overall Study||154
126437|NCT00171301|304396|P2|Received Deferasirox|Overall Study||69
126438|NCT00171301|304397|P1|Received Deferasirox|Overall Study||162
126439|NCT00171301|304396|P2|STARTED|Overall Study|2 participants in this group never received deferasirox.|71
126440|NCT00171301|304397|P1|STARTED|Overall Study||162
126441|NCT00171314|304410|P2|NOT COMPLETED|Overall Study||78
126442|NCT00171314|304411|P1|NOT COMPLETED|Overall Study||91
126443|NCT00171314|304410|P2|COMPLETED|Overall Study||186
126444|NCT00171314|304411|P1|COMPLETED|Overall Study||172
126445|NCT00171314|304410|P2|Safety Population|Overall Study|"Treatment Actually Received = 10 from upfront Arm and 259 from delayed Arm"|269
126446|NCT00171314|304411|P1|Safety Population|Overall Study|"Treatment Actually Received = 251 from upfront Arm and 3 from delayed Arm"|254
126447|NCT00171314|304410|P2|STARTED|Overall Study||264
126448|NCT00171314|304411|P1|STARTED|Overall Study|2 patients in each arm were randomized but not treated.|263
126449|NCT00171340|304427|P2|NOT COMPLETED|Overall Study||135
126450|NCT00171340|304428|P1|NOT COMPLETED|Overall Study||124
126451|NCT00171340|304427|P2|COMPLETED|Overall Study||398
126452|NCT00171340|304428|P1|COMPLETED|Overall Study||408
126453|NCT00171340|304427|P2|STARTED|Overall Study||533
126454|NCT00171340|304428|P1|STARTED|Overall Study||532
126455|NCT00176800|304442|P1|NOT COMPLETED|Overall Study||0
126456|NCT00176800|304442|P1|COMPLETED|Overall Study||69
126457|NCT00176800|304442|P1|STARTED|Overall Study||69
126458|NCT00176826|304448|P1|NOT COMPLETED|Overall Study||0
126459|NCT00176826|304448|P1|COMPLETED|Overall Study||22
126460|NCT00176826|304448|P1|STARTED|Overall Study||22
126461|NCT00176839|304458|P1|NOT COMPLETED|Overall Study||0
126462|NCT00176839|304458|P1|COMPLETED|Overall Study||11
126463|NCT00176839|304458|P1|STARTED|Overall Study||11
126464|NCT00176852|304470|P3|NOT COMPLETED|Overall Study||0
126465|NCT00176852|304471|P2|NOT COMPLETED|Overall Study||0
126466|NCT00176852|304472|P1|NOT COMPLETED|Overall Study||0
126467|NCT00176852|304470|P3|COMPLETED|Overall Study||14
126468|NCT00176852|304471|P2|COMPLETED|Overall Study||5
126469|NCT00176852|304472|P1|COMPLETED|Overall Study||3
126470|NCT00176852|304470|P3|STARTED|Overall Study||14
126471|NCT00176852|304471|P2|STARTED|Overall Study||5
126472|NCT00176852|304472|P1|STARTED|Overall Study||3
126473|NCT00176865|304534|P3|NOT COMPLETED|Overall Study||0
126474|NCT00176865|304535|P2|NOT COMPLETED|Overall Study||0
126475|NCT00176865|304536|P1|NOT COMPLETED|Overall Study||0
126476|NCT00176865|304534|P3|COMPLETED|Overall Study||6
126477|NCT00176865|304535|P2|COMPLETED|Overall Study||10
126478|NCT00176865|304536|P1|COMPLETED|Overall Study||3
126479|NCT00176865|304534|P3|STARTED|Overall Study||6
126480|NCT00176865|304535|P2|STARTED|Overall Study||10
126481|NCT00176865|304536|P1|STARTED|Overall Study||3
126482|NCT00176878|304571|P1|NOT COMPLETED|Overall Study||0
126483|NCT00176878|304571|P1|COMPLETED|Overall Study||10
126484|NCT00176878|304571|P1|STARTED|Overall Study||10
126485|NCT00176904|304580|P1|NOT COMPLETED|Overall Study||0
126486|NCT00176904|304580|P1|COMPLETED|Overall Study||135
126487|NCT00176904|304580|P1|STARTED|Overall Study||135
126488|NCT00176917|304588|P1|NOT COMPLETED|Overall Study||0
126489|NCT00176917|304588|P1|COMPLETED|Overall Study||41
126490|NCT00176917|304588|P1|STARTED|Overall Study||41
126491|NCT00183339|304597|P2|NOT COMPLETED|Overall Study||4
126492|NCT00183339|304598|P1|NOT COMPLETED|Overall Study||6
126493|NCT00183339|304597|P2|COMPLETED|Overall Study||4
126494|NCT00183339|304598|P1|COMPLETED|Overall Study||4
126495|NCT00183339|304597|P2|STARTED|Overall Study||8
126496|NCT00183339|304598|P1|STARTED|Overall Study||10
126497|NCT00183430|304612|P2|NOT COMPLETED|Overall Study||0
126498|NCT00183430|304613|P1|NOT COMPLETED|Overall Study||6
126499|NCT00183430|304612|P2|COMPLETED|Overall Study||11
126500|NCT00183430|304613|P1|COMPLETED|Overall Study||3
126501|NCT00183430|304612|P2|STARTED|Overall Study||11
126502|NCT00183430|304613|P1|STARTED|Overall Study||9
126503|NCT00183456|304627|P4|NOT COMPLETED|Overall Study||28
126504|NCT00183456|304628|P3|NOT COMPLETED|Overall Study||16
126505|NCT00183456|304629|P2|NOT COMPLETED|Overall Study||1
126506|NCT00183456|304630|P1|NOT COMPLETED|Overall Study||3
126507|NCT00183456|304627|P4|COMPLETED|Overall Study|total # of non-randomized index participants that completed any follow-up|220
126508|NCT00183456|304628|P3|COMPLETED|Overall Study|total # of network participants that completed any follow-up|313
126509|NCT00183456|304629|P2|COMPLETED|Overall Study|total # of comparison condition participants that completed any follow-up|83
126510|NCT00183456|304630|P1|COMPLETED|Overall Study|total # of intervention participants that completed any follow-up (6, 12, or 18 month Follow-up)|82
126511|NCT00183456|304627|P4|18 Month Follow-up|Overall Study||207
126512|NCT00183456|304628|P3|18 Month Follow-up|Overall Study||303
126513|NCT00183456|304629|P2|18 Month Follow-up|Overall Study||81
126514|NCT00183456|304630|P1|18 Month Follow-up|Overall Study||80
126515|NCT00183456|304627|P4|12 Month Follow-up|Overall Study||186
126516|NCT00183456|304628|P3|12 Month Follow-up|Overall Study||267
126517|NCT00183456|304629|P2|12 Month Follow-up|Overall Study||74
126518|NCT00183456|304630|P1|12 Month Follow-up|Overall Study||76
126519|NCT00183456|304627|P4|6 Month Follow-up|Overall Study||175
126520|NCT00183456|304628|P3|6 Month Follow-up|Overall Study||278
126521|NCT00183456|304629|P2|6 Month Follow-up|Overall Study||77
126522|NCT00183456|304630|P1|6 Month Follow-up|Overall Study||74
126523|NCT00183456|304627|P4|STARTED|Overall Study||248
126524|NCT00183456|304628|P3|STARTED|Overall Study||329
126525|NCT00183456|304629|P2|STARTED|Overall Study||84
126526|NCT00183456|304630|P1|STARTED|Overall Study||85
126527|NCT00183469|304678|P2|NOT COMPLETED|Overall Study||29
126528|NCT00183469|304679|P1|NOT COMPLETED|Overall Study||28
126529|NCT00183469|304678|P2|COMPLETED|Overall Study||16
126530|NCT00183469|304679|P1|COMPLETED|Overall Study||13
126531|NCT00183469|304678|P2|STARTED|Overall Study||45
126532|NCT00183469|304679|P1|STARTED|Overall Study||41
126533|NCT00183625|304687|P4|NOT COMPLETED|Overall Study||14
126534|NCT00183625|304688|P3|NOT COMPLETED|Overall Study||19
126535|NCT00183625|304689|P2|NOT COMPLETED|Overall Study||18
126536|NCT00183625|304690|P1|NOT COMPLETED|Overall Study||18
126537|NCT00183625|304687|P4|COMPLETED|Overall Study||10
126538|NCT00183625|304688|P3|COMPLETED|Overall Study||9
126539|NCT00183625|304689|P2|COMPLETED|Overall Study||10
126540|NCT00183625|304690|P1|COMPLETED|Overall Study||9
126541|NCT00183625|304687|P4|Obtained Employment|Overall Study||14
126542|NCT00183625|304688|P3|Obtained Employment|Overall Study||14
126543|NCT00183625|304689|P2|Obtained Employment|Overall Study||18
126544|NCT00183625|304690|P1|Obtained Employment|Overall Study||21
126545|NCT00183625|304687|P4|STARTED|Overall Study||24
126546|NCT00183625|304688|P3|STARTED|Overall Study||28
126547|NCT00183625|304689|P2|STARTED|Overall Study||28
126548|NCT00183625|304690|P1|STARTED|Overall Study||27
126549|NCT00183677|304698|P1|NOT COMPLETED|Overall Study||44
126550|NCT00183677|304698|P1|COMPLETED|Overall Study||53
126551|NCT00183677|304698|P1|STARTED|Overall Study||97
126552|NCT00189098|304704|P2|NOT COMPLETED|Overall Study||6
126553|NCT00189098|304705|P1|NOT COMPLETED|Overall Study||5
126554|NCT00189098|304704|P2|COMPLETED|Overall Study||44
126555|NCT00189098|304705|P1|COMPLETED|Overall Study||46
126556|NCT00189098|304704|P2|STARTED|Overall Study||50
126557|NCT00189098|304705|P1|STARTED|Overall Study||51
126558|NCT00189137|304723|P2|NOT COMPLETED|Overall Study||0
126559|NCT00189137|304724|P1|NOT COMPLETED|Overall Study||0
126560|NCT00189137|304723|P2|COMPLETED|Overall Study||43
126561|NCT00189137|304724|P1|COMPLETED|Overall Study||37
126562|NCT00189137|304723|P2|STARTED|Overall Study||43
126563|NCT00189137|304724|P1|STARTED|Overall Study||37
126564|NCT00189202|304732|P1|NOT COMPLETED|Overall Study||5
126565|NCT00189202|304732|P1|COMPLETED|Overall Study||44
126566|NCT00189202|304732|P1|STARTED|Overall Study||49
126567|NCT00189306|304741|P1|NOT COMPLETED|Long-Term Follow-up||38
126568|NCT00189306|304741|P1|COMPLETED|Long-Term Follow-up||119
126569|NCT00189306|304741|P1|STARTED|Long-Term Follow-up||157
126570|NCT00189306|304741|P1|NOT COMPLETED|Posttreatment Period||12
126571|NCT00189306|304741|P1|COMPLETED|Posttreatment Period|11 subjects discontinued during the 12-week Posttreatment Period|157
126572|NCT00189306|304741|P1|STARTED|Posttreatment Period|5 of the 169 discontinued, but 4 returned for the Posttreatment Period|169
126573|NCT00189306|304741|P1|NOT COMPLETED|Treatment Period||5
126574|NCT00189306|304741|P1|COMPLETED|Treatment Period|5 subjects discontinued during treatment - 4 subjects returned for the Posttreatment Period|164
126575|NCT00189306|304741|P1|STARTED|Treatment Period||169
126576|NCT00189423|304748|P2|NOT COMPLETED|Overall Study||766
126577|NCT00189423|304749|P1|NOT COMPLETED|Overall Study||765
126578|NCT00189423|304748|P2|COMPLETED|Overall Study||74
126579|NCT00189423|304749|P1|COMPLETED|Overall Study||48
126580|NCT00189423|304748|P2|STARTED|Overall Study||840
126581|NCT00189423|304749|P1|STARTED|Overall Study||813
126582|NCT00189436|304771|P2|NOT COMPLETED|Overall Study||5
126583|NCT00189436|304772|P1|NOT COMPLETED|Overall Study||8
126584|NCT00189436|304771|P2|COMPLETED|Overall Study||25
126585|NCT00189436|304772|P1|COMPLETED|Overall Study||23
126586|NCT00189436|304771|P2|STARTED|Overall Study||30
126587|NCT00189436|304772|P1|STARTED|Overall Study||31
126588|NCT00189462|304780|P2|NOT COMPLETED|Overall Study||21
126589|NCT00189462|304781|P1|NOT COMPLETED|Overall Study||23
126590|NCT00189462|304780|P2|COMPLETED|Overall Study||28
126591|NCT00189462|304781|P1|COMPLETED|Overall Study||27
126592|NCT00189462|304780|P2|STARTED|Overall Study||49
126593|NCT00189462|304781|P1|STARTED|Overall Study||50
126594|NCT00189475|304789|P2|NOT COMPLETED|Overall Study||0
126595|NCT00189475|304790|P1|NOT COMPLETED|Overall Study||0
126596|NCT00189475|304789|P2|COMPLETED|Overall Study||42
126597|NCT00189475|304790|P1|COMPLETED|Overall Study||42
126598|NCT00189475|304789|P2|STARTED|Overall Study||42
126599|NCT00189475|304790|P1|STARTED|Overall Study||42
126600|NCT00189488|304798|P2|NOT COMPLETED|Overall Study||22
126601|NCT00189488|304799|P1|NOT COMPLETED|Overall Study||15
126602|NCT00189488|304798|P2|COMPLETED|Overall Study||55
126603|NCT00189488|304799|P1|COMPLETED|Overall Study||63
126604|NCT00189488|304798|P2|Received Palifermin/Placebo|Overall Study||76
126605|NCT00189488|304799|P1|Received Palifermin/Placebo|Overall Study||75
126606|NCT00189488|304798|P2|STARTED|Overall Study||77
126607|NCT00189488|304799|P1|STARTED|Overall Study||78
126608|NCT00189540|304821|P2|NOT COMPLETED|Overall Study||1
126609|NCT00189540|304822|P1|NOT COMPLETED|Overall Study||7
126610|NCT00189540|304821|P2|COMPLETED|Overall Study||5
126611|NCT00189540|304822|P1|COMPLETED|Overall Study||14
126612|NCT00189540|304821|P2|STARTED|Overall Study||6
126613|NCT00189540|304822|P1|STARTED|Overall Study||21
126614|NCT00190671|304840|P2|NOT COMPLETED|Overall Study||42
126615|NCT00190671|304841|P1|NOT COMPLETED|Overall Study||27
126616|NCT00190671|304840|P2|COMPLETED|Overall Study||19
126617|NCT00190671|304841|P1|COMPLETED|Overall Study||15
126618|NCT00190671|304840|P2|STARTED|Overall Study||61
126619|NCT00190671|304841|P1|STARTED|Overall Study||42
126620|NCT00190684|304859|P1|NOT COMPLETED|Overall Study||1489
126621|NCT00190684|304859|P1|COMPLETED|Overall Study|Number of patients that completed overall study (through Period VI)|64
126622|NCT00190684|304859|P1|Received at Least 1 Dose of Study Drug|Overall Study|1553 patients entered the study; 1551 were enrolled and received study drug.|1551
126623|NCT00190684|304859|P1|STARTED|Overall Study||1553
126624|NCT00190749|304880|P2|NOT COMPLETED|Overall Study||31
126625|NCT00190749|304881|P1|NOT COMPLETED|Overall Study||26
126626|NCT00190749|304880|P2|COMPLETED|Overall Study||31
126627|NCT00190749|304881|P1|COMPLETED|Overall Study||42
126628|NCT00190749|304880|P2|STARTED|Overall Study||62
126629|NCT00190749|304881|P1|STARTED|Overall Study||68
126630|NCT00190775|304947|P2|NOT COMPLETED|Overall Study||100
126631|NCT00190775|304948|P1|NOT COMPLETED|Overall Study||149
126632|NCT00190775|304947|P2|COMPLETED|Overall Study||134
126633|NCT00190775|304948|P1|COMPLETED|Overall Study||119
126634|NCT00190775|304947|P2|Received Study Drug|Overall Study||234
126635|NCT00190775|304948|P1|Received Study Drug|Overall Study||266
126636|NCT00190775|304947|P2|STARTED|Overall Study||234
126637|NCT00190775|304948|P1|STARTED|Overall Study||268
126638|NCT00190983|305017|P1|NOT COMPLETED|Overall Study||2
126639|NCT00190983|305017|P1|COMPLETED|Overall Study|Completed means patient received treatment and was evaluable for response.|27
126640|NCT00190983|305017|P1|STARTED|Overall Study||29
126641|NCT00191100|305026|P2|NOT COMPLETED|Overall Study||12
126642|NCT00191100|305027|P1|NOT COMPLETED|Overall Study||42
126643|NCT00191100|305026|P2|COMPLETED|Overall Study||244
126644|NCT00191100|305027|P1|COMPLETED|Overall Study||217
126645|NCT00191100|305026|P2|STARTED|Overall Study||256
126646|NCT00191100|305027|P1|STARTED|Overall Study||259
126647|NCT00191113|305045|P2|NOT COMPLETED|Addendum 3||0
126648|NCT00191113|305046|P1|NOT COMPLETED|Addendum 3||0
126649|NCT00191113|305045|P2|COMPLETED|Addendum 3||37
126650|NCT00191113|305046|P1|COMPLETED|Addendum 3||20
126651|NCT00191113|305045|P2|STARTED|Addendum 3||37
126652|NCT00191113|305046|P1|STARTED|Addendum 3||20
126653|NCT00191113|305045|P2|NOT COMPLETED|Addendum 2||17
126654|NCT00191113|305046|P1|NOT COMPLETED|Addendum 2||10
126655|NCT00191113|305045|P2|COMPLETED|Addendum 2||31
126656|NCT00191113|305046|P1|COMPLETED|Addendum 2||18
126657|NCT00191113|305045|P2|STARTED|Addendum 2||48
126658|NCT00191113|305046|P1|STARTED|Addendum 2||28
126659|NCT00191113|305045|P2|NOT COMPLETED|Addendum 1||0
126660|NCT00191113|305046|P1|NOT COMPLETED|Addendum 1||0
126661|NCT00191113|305045|P2|COMPLETED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
126662|NCT00191113|305046|P1|COMPLETED|Addendum 1||2
126663|NCT00191113|305045|P2|STARTED|Addendum 1|Not Applicable -- only Control patients were eligible for Addendum 1|0
126664|NCT00191113|305046|P1|STARTED|Addendum 1||2
126665|NCT00191113|305045|P2|NOT COMPLETED|Core Study||15
126666|NCT00191113|305046|P1|NOT COMPLETED|Core Study||35
126667|NCT00191113|305045|P2|COMPLETED|Core Study||61
126668|NCT00191113|305046|P1|COMPLETED|Core Study||43
126669|NCT00191113|305045|P2|STARTED|Core Study||76
126670|NCT00191113|305046|P1|STARTED|Core Study||78
126671|NCT00191139|305088|P2|NOT COMPLETED|Overall Study||12
126672|NCT00191139|305089|P1|NOT COMPLETED|Overall Study||5
126673|NCT00191139|305088|P2|COMPLETED|Overall Study||20
126674|NCT00191139|305089|P1|COMPLETED|Overall Study||27
126675|NCT00191139|305088|P2|STARTED|Overall Study||32
126676|NCT00191139|305089|P1|STARTED|Overall Study||32
126677|NCT00191152|305105|P2|NOT COMPLETED|Crossover Treatment||28
126678|NCT00191152|305106|P1|NOT COMPLETED|Crossover Treatment||27
126679|NCT00191152|305105|P2|COMPLETED|Crossover Treatment||53
126680|NCT00191152|305106|P1|COMPLETED|Crossover Treatment||50
126681|NCT00191152|305105|P2|Received Treatment|Crossover Treatment||80
126682|NCT00191152|305106|P1|Received Treatment|Crossover Treatment||76
126683|NCT00191152|305105|P2|STARTED|Crossover Treatment||81
126684|NCT00191152|305106|P1|STARTED|Crossover Treatment||77
126685|NCT00191152|305105|P2|NOT COMPLETED|Initial Treatment||153
126686|NCT00191152|305106|P1|NOT COMPLETED|Initial Treatment||141
126687|NCT00191152|305105|P2|COMPLETED|Initial Treatment||83
126688|NCT00191152|305106|P1|COMPLETED|Initial Treatment||98
126689|NCT00191152|305105|P2|Received Initial Treatment|Initial Treatment||227
126690|NCT00191152|305106|P1|Received Initial Treatment|Initial Treatment||236
126691|NCT00191152|305105|P2|STARTED|Initial Treatment||236
126692|NCT00191152|305106|P1|STARTED|Initial Treatment||239
126693|NCT00191165|305138|P2|NOT COMPLETED|Overall Study||2
126694|NCT00191165|305139|P1|NOT COMPLETED|Overall Study||2
126695|NCT00191165|305138|P2|COMPLETED|Overall Study||11
126696|NCT00191165|305139|P1|COMPLETED|Overall Study||12
126697|NCT00191165|305138|P2|STARTED|Overall Study||13
126698|NCT00191165|305139|P1|STARTED|Overall Study||14
126699|NCT00191191|305151|P2|NOT COMPLETED|Overall Study||112
126700|NCT00191191|305152|P1|NOT COMPLETED|Overall Study||114
126701|NCT00191191|305151|P2|COMPLETED|Overall Study||0
126702|NCT00191191|305152|P1|COMPLETED|Overall Study||0
126703|NCT00191191|305151|P2|Full Analysis Set Population|Overall Study||108
126704|NCT00191191|305152|P1|Full Analysis Set Population|Overall Study||108
126705|NCT00191191|305151|P2|Safety Analysis Population|Overall Study||111
126706|NCT00191191|305152|P1|Safety Analysis Population|Overall Study||114
126707|NCT00191191|305151|P2|STARTED|Overall Study||112
126708|NCT00191191|305152|P1|STARTED|Overall Study||114
126709|NCT00191269|305168|P2|NOT COMPLETED|Overall Study||58
126710|NCT00191269|305169|P1|NOT COMPLETED|Overall Study||6
126711|NCT00191269|305168|P2|COMPLETED|Overall Study||4
126712|NCT00191269|305169|P1|COMPLETED|Overall Study||0
126713|NCT00191269|305168|P2|STARTED|Overall Study||62
126714|NCT00191269|305169|P1|STARTED|Overall Study||6
126715|NCT00191282|305185|P2|NOT COMPLETED|Overall Study||212
126716|NCT00191282|305186|P1|NOT COMPLETED|Overall Study||220
126717|NCT00191282|305185|P2|COMPLETED|Overall Study||346
126718|NCT00191282|305186|P1|COMPLETED|Overall Study||338
126719|NCT00191282|305185|P2|STARTED|Overall Study||558
126720|NCT00191282|305186|P1|STARTED|Overall Study||558
126721|NCT00191308|305244|P1|NOT COMPLETED|Overall Study||1
126722|NCT00191308|305244|P1|COMPLETED|Overall Study||29
126723|NCT00191308|305244|P1|STARTED|Overall Study||30
126724|NCT00179959|305254|P2|NOT COMPLETED|Overall Study||3
126725|NCT00179959|305255|P1|NOT COMPLETED|Overall Study||6
126726|NCT00179959|305254|P2|COMPLETED|Overall Study||13
126727|NCT00179959|305255|P1|COMPLETED|Overall Study||9
126728|NCT00179959|305254|P2|STARTED|Overall Study||16
126729|NCT00179959|305255|P1|STARTED|Overall Study||15
126730|NCT00180271|305263|P2|NOT COMPLETED|Overall Study||0
126731|NCT00180271|305264|P1|NOT COMPLETED|Overall Study||0
126732|NCT00180271|305263|P2|COMPLETED|Overall Study||731
126733|NCT00180271|305264|P1|COMPLETED|Overall Study||1089
126734|NCT00180271|305263|P2|STARTED|Overall Study||731
126735|NCT00180271|305264|P1|STARTED|Overall Study||1089
126736|NCT00180323|305270|P1|NOT COMPLETED|Overall Study||0
126737|NCT00180323|305270|P1|COMPLETED|Overall Study||43
126738|NCT00180323|305270|P1|STARTED|Overall Study||43
126739|NCT00180479|305279|P2|NOT COMPLETED|Overall Study||13
126740|NCT00180479|305280|P1|NOT COMPLETED|Overall Study||16
126741|NCT00180479|305279|P2|COMPLETED|Overall Study||320
126742|NCT00180479|305280|P1|COMPLETED|Overall Study||653
126743|NCT00180479|305279|P2|STARTED|Overall Study|1 patient randomized never signed consent, therefore no data collected. Analysis group = 332.|333
126744|NCT00180479|305280|P1|STARTED|Overall Study||669
126745|NCT00191334|305372|P1|NOT COMPLETED|Overall Study||17
126746|NCT00191334|305372|P1|COMPLETED|Overall Study||33
126747|NCT00191334|305372|P1|STARTED|Overall Study||50
126748|NCT00191386|305380|P1|NOT COMPLETED|Overall Study||160
126749|NCT00191386|305380|P1|COMPLETED|Overall Study||68
126750|NCT00191386|305380|P1|3 Years|Overall Study||65
126751|NCT00191386|305380|P1|2 Years|Overall Study||105
126752|NCT00191386|305380|P1|12 Months|Overall Study||149
126753|NCT00191386|305380|P1|6 Months|Overall Study||183
126754|NCT00191386|305380|P1|STARTED|Overall Study||228
126755|NCT00191451|305390|P3|NOT COMPLETED|Overall Study||14
126756|NCT00191451|305391|P2|NOT COMPLETED|Overall Study||14
126757|NCT00191451|305392|P1|NOT COMPLETED|Overall Study||7
126758|NCT00191451|305390|P3|COMPLETED|Overall Study||35
126759|NCT00191451|305391|P2|COMPLETED|Overall Study||37
126760|NCT00191451|305392|P1|COMPLETED|Overall Study||43
126761|NCT00191451|305390|P3|Received at Least One Dose of Study Drug|Overall Study||47
126762|NCT00191451|305391|P2|Received at Least One Dose of Study Drug|Overall Study||48
126763|NCT00191451|305392|P1|Received at Least One Dose of Study Drug|Overall Study||50
126764|NCT00191451|305390|P3|STARTED|Overall Study||49
126765|NCT00191451|305391|P2|STARTED|Overall Study||51
126766|NCT00191451|305392|P1|STARTED|Overall Study||50
126767|NCT00191477|305414|P2|NOT COMPLETED|Overall Study||129
126768|NCT00191477|305415|P1|NOT COMPLETED|Overall Study||138
126769|NCT00191477|305414|P2|COMPLETED|Overall Study||47
126770|NCT00191477|305415|P1|COMPLETED|Overall Study||41
126771|NCT00191477|305414|P2|Received Study Drug|Overall Study||162
126772|NCT00191477|305415|P1|Received Study Drug|Overall Study||166
126773|NCT00191477|305414|P2|STARTED|Overall Study||176
126774|NCT00191477|305415|P1|STARTED|Overall Study||179
126775|NCT00191646|305433|P2|NOT COMPLETED|Overall Study||153
126776|NCT00191646|305434|P1|NOT COMPLETED|Overall Study||171
126777|NCT00191646|305433|P2|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|261
126778|NCT00191646|305434|P1|COMPLETED|Overall Study|Completed was defined as the patients treated in either consolidation therapy or crossover therapy.|246
126779|NCT00191646|305433|P2|Received Crossover Therapy|Overall Study||78
126780|NCT00191646|305434|P1|Received Crossover Therapy|Overall Study||77
126781|NCT00191646|305433|P2|Received Consolidation Therapy|Overall Study||183
126782|NCT00191646|305434|P1|Received Consolidation Therapy|Overall Study||169
126783|NCT00191646|305433|P2|Received Induction Therapy|Overall Study||409
126784|NCT00191646|305434|P1|Received Induction Therapy|Overall Study||411
126785|NCT00191646|305433|P2|STARTED|Overall Study||414
126786|NCT00191646|305434|P1|STARTED|Overall Study||417
126787|NCT00194532|305454|P2|NOT COMPLETED|Overall Study||0
126788|NCT00194532|305455|P1|NOT COMPLETED|Overall Study||0
126789|NCT00194532|305454|P2|COMPLETED|Overall Study||150
126790|NCT00194532|305455|P1|COMPLETED|Overall Study||150
126791|NCT00194532|305454|P2|STARTED|Overall Study||150
126792|NCT00194532|305455|P1|STARTED|Overall Study||150
126793|NCT00194610|305465|P2|NOT COMPLETED|Overall Study||0
126794|NCT00194610|305466|P1|NOT COMPLETED|Overall Study||0
126795|NCT00194610|305465|P2|COMPLETED|Overall Study||9
126796|NCT00194610|305466|P1|COMPLETED|Overall Study||11
126797|NCT00194610|305465|P2|STARTED|Overall Study||9
126798|NCT00194610|305466|P1|STARTED|Overall Study||11
126799|NCT00194675|305474|P2|NOT COMPLETED|Overall Study||2
126800|NCT00194675|305475|P1|NOT COMPLETED|Overall Study||5
126801|NCT00194675|305474|P2|COMPLETED|Overall Study||24
126802|NCT00194675|305475|P1|COMPLETED|Overall Study||22
126803|NCT00194675|305474|P2|STARTED|Overall Study||26
126804|NCT00194675|305475|P1|STARTED|Overall Study||27
126805|NCT00194792|305491|P1|NOT COMPLETED|Overall Study||1
126806|NCT00194792|305491|P1|COMPLETED|Overall Study||27
126807|NCT00194792|305491|P1|STARTED|Overall Study||28
126808|NCT00194896|305505|P4|NOT COMPLETED|Overall Study||12
126809|NCT00194896|305506|P3|NOT COMPLETED|Overall Study||6
126810|NCT00194896|305507|P2|NOT COMPLETED|Overall Study||5
126811|NCT00194896|305508|P1|NOT COMPLETED|Overall Study||11
126812|NCT00194896|305505|P4|COMPLETED|Overall Study||9
126813|NCT00194896|305506|P3|COMPLETED|Overall Study||7
126814|NCT00194896|305507|P2|COMPLETED|Overall Study||10
126815|NCT00194896|305508|P1|COMPLETED|Overall Study||4
126816|NCT00194896|305505|P4|STARTED|Overall Study||21
126817|NCT00194896|305506|P3|STARTED|Overall Study||13
126818|NCT00194896|305507|P2|STARTED|Overall Study||15
126819|NCT00194896|305508|P1|STARTED|Overall Study||15
126820|NCT00195013|305524|P2|NOT COMPLETED|Overall Study||1
126821|NCT00195013|305525|P1|NOT COMPLETED|Overall Study||2
126822|NCT00195013|305524|P2|COMPLETED|Overall Study||15
126823|NCT00195013|305525|P1|COMPLETED|Overall Study||12
126824|NCT00195013|305524|P2|STARTED|Overall Study||16
126825|NCT00195013|305525|P1|STARTED|Overall Study||14
126826|NCT00195260|305533|P11|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||23
126827|NCT00195260|305534|P10|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||38
126828|NCT00195260|305535|P9|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||33
126829|NCT00195260|305536|P8|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126830|NCT00195260|305537|P7|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126831|NCT00195260|305538|P6|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126832|NCT00195260|305539|P5|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126833|NCT00195260|305540|P4|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126834|NCT00195260|305541|P3|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126835|NCT00195260|305542|P2|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126836|NCT00195260|305543|P1|NOT COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126837|NCT00195260|305533|P11|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||2
126838|NCT00195260|305534|P10|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126839|NCT00195260|305535|P9|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||4
126840|NCT00195260|305536|P8|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126841|NCT00195260|305537|P7|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126842|NCT00195260|305538|P6|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126843|NCT00195260|305539|P5|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126844|NCT00195260|305540|P4|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126845|NCT00195260|305541|P3|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126846|NCT00195260|305542|P2|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126847|NCT00195260|305543|P1|COMPLETED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126848|NCT00195260|305533|P11|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||25
126849|NCT00195260|305534|P10|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||38
126850|NCT00195260|305535|P9|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||37
126851|NCT00195260|305536|P8|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126852|NCT00195260|305537|P7|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126853|NCT00195260|305538|P6|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126854|NCT00195260|305539|P5|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126855|NCT00195260|305540|P4|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126856|NCT00195260|305541|P3|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126857|NCT00195260|305542|P2|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126858|NCT00195260|305543|P1|STARTED|Part 2: Recommended Phase 2 Dose (RP2D)||0
126859|NCT00195260|305533|P11|NOT COMPLETED|Part 1: Dose Escalation||0
126860|NCT00195260|305534|P10|NOT COMPLETED|Part 1: Dose Escalation||0
126861|NCT00195260|305535|P9|NOT COMPLETED|Part 1: Dose Escalation||0
126862|NCT00195260|305536|P8|NOT COMPLETED|Part 1: Dose Escalation||6
126863|NCT00195260|305537|P7|NOT COMPLETED|Part 1: Dose Escalation||10
126864|NCT00195260|305538|P6|NOT COMPLETED|Part 1: Dose Escalation||7
126865|NCT00195260|305539|P5|NOT COMPLETED|Part 1: Dose Escalation||7
126866|NCT00195260|305540|P4|NOT COMPLETED|Part 1: Dose Escalation||7
126867|NCT00195260|305541|P3|NOT COMPLETED|Part 1: Dose Escalation||6
126868|NCT00195260|305542|P2|NOT COMPLETED|Part 1: Dose Escalation||4
126869|NCT00195260|305543|P1|NOT COMPLETED|Part 1: Dose Escalation||4
126870|NCT00195260|305533|P11|COMPLETED|Part 1: Dose Escalation||0
126871|NCT00195260|305534|P10|COMPLETED|Part 1: Dose Escalation||0
126872|NCT00195260|305535|P9|COMPLETED|Part 1: Dose Escalation||0
126873|NCT00195260|305536|P8|COMPLETED|Part 1: Dose Escalation||0
126874|NCT00195260|305537|P7|COMPLETED|Part 1: Dose Escalation||0
126875|NCT00195260|305538|P6|COMPLETED|Part 1: Dose Escalation||0
126876|NCT00195260|305539|P5|COMPLETED|Part 1: Dose Escalation||0
126877|NCT00195260|305540|P4|COMPLETED|Part 1: Dose Escalation||0
126878|NCT00195260|305541|P3|COMPLETED|Part 1: Dose Escalation||0
126879|NCT00195260|305542|P2|COMPLETED|Part 1: Dose Escalation||0
126880|NCT00195260|305543|P1|COMPLETED|Part 1: Dose Escalation||0
126881|NCT00195260|305533|P11|STARTED|Part 1: Dose Escalation||0
126882|NCT00195260|305534|P10|STARTED|Part 1: Dose Escalation||0
126883|NCT00195260|305535|P9|STARTED|Part 1: Dose Escalation||0
126884|NCT00195260|305536|P8|STARTED|Part 1: Dose Escalation||6
126885|NCT00195260|305537|P7|STARTED|Part 1: Dose Escalation||10
126886|NCT00195260|305538|P6|STARTED|Part 1: Dose Escalation||7
126887|NCT00195260|305539|P5|STARTED|Part 1: Dose Escalation||7
126888|NCT00195260|305540|P4|STARTED|Part 1: Dose Escalation||7
126889|NCT00195260|305541|P3|STARTED|Part 1: Dose Escalation||6
126890|NCT00195260|305542|P2|STARTED|Part 1: Dose Escalation||4
126891|NCT00195260|305543|P1|STARTED|Part 1: Dose Escalation||4
126892|NCT00195273|305691|P2|NOT COMPLETED|Overall Study||14
126893|NCT00195273|305692|P1|NOT COMPLETED|Overall Study||21
126894|NCT00195273|305691|P2|COMPLETED|Overall Study||16
126895|NCT00195273|305692|P1|COMPLETED|Overall Study||10
126896|NCT00195273|305691|P2|STARTED|Overall Study||30
126897|NCT00195273|305692|P1|STARTED|Overall Study||31
126898|NCT00195338|305704|P1|NOT COMPLETED|Overall Study||12
126899|NCT00195338|305704|P1|COMPLETED|Overall Study||13
126900|NCT00195338|305704|P1|STARTED|Overall Study||25
126901|NCT00195351|305714|P2|NOT COMPLETED|Overall Study||16
126902|NCT00195351|305715|P1|NOT COMPLETED|Overall Study||21
126903|NCT00195351|305714|P2|COMPLETED|Overall Study||215
126904|NCT00195351|305715|P1|COMPLETED|Overall Study||215
126905|NCT00195351|305714|P2|STARTED|Overall Study||231
126906|NCT00195351|305715|P1|STARTED|Overall Study||236
126907|NCT00195403|305725|P1|NOT COMPLETED|Overall Study||0
126908|NCT00195403|305725|P1|COMPLETED|Overall Study||1014
126909|NCT00195403|305725|P1|STARTED|Overall Study||1014
126910|NCT00195429|305733|P2|NOT COMPLETED|Overall Study||5
126911|NCT00195429|305734|P1|NOT COMPLETED|Overall Study||5
126912|NCT00195429|305733|P2|COMPLETED|Overall Study||18
126913|NCT00195429|305734|P1|COMPLETED|Overall Study||19
126914|NCT00195429|305733|P2|STARTED|Overall Study||23
126915|NCT00195429|305734|P1|STARTED|Overall Study||24
126916|NCT00195442|305742|P1|NOT COMPLETED|Overall Study||136
126917|NCT00195442|305742|P1|COMPLETED|Overall Study||152
126918|NCT00195442|305742|P1|STARTED|Overall Study||288
126919|NCT00195494|305761|P6|NOT COMPLETED|Year 2||0
126920|NCT00195494|305762|P5|NOT COMPLETED|Year 2||0
126921|NCT00195494|305763|P4|NOT COMPLETED|Year 2||23
126922|NCT00195494|305764|P3|NOT COMPLETED|Year 2||18
126923|NCT00195494|305765|P2|NOT COMPLETED|Year 2||16
126924|NCT00195494|305766|P1|NOT COMPLETED|Year 2||7
126925|NCT00195494|305761|P6|COMPLETED|Year 2||0
126926|NCT00195494|305762|P5|COMPLETED|Year 2||0
126927|NCT00195494|305763|P4|COMPLETED|Year 2||76
126928|NCT00195494|305764|P3|COMPLETED|Year 2||93
126929|NCT00195494|305765|P2|COMPLETED|Year 2||74
126930|NCT00195494|305766|P1|COMPLETED|Year 2||104
126931|NCT00195494|305761|P6|STARTED|Year 2||0
126932|NCT00195494|305762|P5|STARTED|Year 2||0
126933|NCT00195494|305763|P4|STARTED|Year 2||99
126934|NCT00195494|305764|P3|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
126935|NCT00195494|305765|P2|STARTED|Year 2||90
126936|NCT00195494|305766|P1|STARTED|Year 2|A patient with Year 1 termination had taken drug briefly during Year 2 and thus counted in the data.|111
126937|NCT00195494|305761|P6|NOT COMPLETED|Year 1||53
126938|NCT00195494|305762|P5|NOT COMPLETED|Year 1||79
126939|NCT00195494|305763|P4|NOT COMPLETED|Year 1||0
126940|NCT00195494|305764|P3|NOT COMPLETED|Year 1||0
126941|NCT00195494|305765|P2|NOT COMPLETED|Year 1||0
126942|NCT00195494|305766|P1|NOT COMPLETED|Year 1||0
126943|NCT00195494|305761|P6|COMPLETED|Year 1||221
126944|NCT00195494|305762|P5|COMPLETED|Year 1||189
126945|NCT00195494|305763|P4|COMPLETED|Year 1||0
126946|NCT00195494|305764|P3|COMPLETED|Year 1||0
126947|NCT00195494|305765|P2|COMPLETED|Year 1||0
126948|NCT00195494|305766|P1|COMPLETED|Year 1||0
126949|NCT00195494|305761|P6|STARTED|Year 1||274
126950|NCT00195494|305762|P5|STARTED|Year 1||268
126951|NCT00195494|305763|P4|STARTED|Year 1||0
126952|NCT00195494|305764|P3|STARTED|Year 1||0
126953|NCT00195494|305765|P2|STARTED|Year 1||0
126954|NCT00195494|305766|P1|STARTED|Year 1||0
126955|NCT00195507|305786|P2|NOT COMPLETED|Overall Study||118
126956|NCT00195507|305787|P1|NOT COMPLETED|Overall Study||99
126957|NCT00195507|305786|P2|COMPLETED|Overall Study||245
126958|NCT00195507|305787|P1|COMPLETED|Overall Study||258
126959|NCT00195507|305786|P2|STARTED|Overall Study||363
126960|NCT00195507|305787|P1|STARTED|Overall Study||357
126961|NCT00195650|305799|P1|NOT COMPLETED|Overall Study||525
126962|NCT00195650|305799|P1|COMPLETED|Overall Study||321
126963|NCT00195650|305799|P1|STARTED|Overall Study|Participants who received at least 1 adalimumab dose in study;3 enrolled did not receive adalimumab.|846
126964|NCT00195663|305816|P3|NOT COMPLETED|Open-Label Extension Period||97
126965|NCT00195663|305817|P2|NOT COMPLETED|Open-Label Extension Period||74
126966|NCT00195663|305818|P1|NOT COMPLETED|Open-Label Extension Period||76
126967|NCT00195663|305816|P3|COMPLETED|Open-Label Extension Period||86
126968|NCT00195663|305817|P2|COMPLETED|Open-Label Extension Period||85
126969|NCT00195663|305818|P1|COMPLETED|Open-Label Extension Period||79
126970|NCT00195663|305816|P3|STARTED|Open-Label Extension Period||183
126971|NCT00195663|305817|P2|STARTED|Open-Label Extension Period||159
126972|NCT00195663|305818|P1|STARTED|Open-Label Extension Period||155
126973|NCT00195663|305816|P3|NOT COMPLETED|2-year Double-blind Treatment Period||72
126974|NCT00195663|305817|P2|NOT COMPLETED|2-year Double-blind Treatment Period||108
126975|NCT00195663|305818|P1|NOT COMPLETED|2-year Double-blind Treatment Period||93
126976|NCT00195663|305816|P3|COMPLETED|2-year Double-blind Treatment Period||196
126977|NCT00195663|305817|P2|COMPLETED|2-year Double-blind Treatment Period||166
126978|NCT00195663|305818|P1|COMPLETED|2-year Double-blind Treatment Period||164
126979|NCT00195663|305816|P3|STARTED|2-year Double-blind Treatment Period||268
126980|NCT00195663|305817|P2|STARTED|2-year Double-blind Treatment Period||274
126981|NCT00195663|305818|P1|STARTED|2-year Double-blind Treatment Period||257
126982|NCT00195676|305912|P1|NOT COMPLETED|Period R - Retreatment 16 Weeks||35
126983|NCT00195676|305912|P1|COMPLETED|Period R - Retreatment 16 Weeks||490
126984|NCT00195676|305912|P1|STARTED|Period R - Retreatment 16 Weeks|Number who entered from Period W, including those who did and did not relapse in that period.|525
126985|NCT00195676|305912|P1|NOT COMPLETED|Period W (Withdrawal) - No Treatment||608
126986|NCT00195676|305912|P1|COMPLETED|Period W (Withdrawal) - No Treatment|Non-completers may have entered Period R, whether or not they relapsed (PGA >= 3).|0
126987|NCT00195676|305912|P1|STARTED|Period W (Withdrawal) - No Treatment|Period O completers with a Physician's Global Assessment =<2 who continued into Periods W and R.|608
126988|NCT00195676|305912|P1|NOT COMPLETED|Period O - Open-label Treatment||606
126989|NCT00195676|305912|P1|COMPLETED|Period O - Open-label Treatment|254 Period O completers did not consent or were not eligible to continue into Period W and Period R.|862
126990|NCT00195676|305912|P1|STARTED|Period O - Open-label Treatment|Number receiving adalimumab in Period O (1 additional participant enrolled but did not receive drug)|1468
126991|NCT00195702|305926|P6|NOT COMPLETED|Open-label Extension Phase||78
126992|NCT00195702|305927|P5|NOT COMPLETED|Open-label Extension Phase||78
126993|NCT00195702|305928|P4|NOT COMPLETED|Open-label Extension Phase||99
126994|NCT00195702|305929|P3|NOT COMPLETED|Open-label Extension Phase||0
126995|NCT00195702|305930|P2|NOT COMPLETED|Open-label Extension Phase||0
126996|NCT00195702|305931|P1|NOT COMPLETED|Open-label Extension Phase||0
126997|NCT00195702|305926|P6|COMPLETED|Open-label Extension Phase||56
126998|NCT00195702|305927|P5|COMPLETED|Open-label Extension Phase||80
126999|NCT00195702|305928|P4|COMPLETED|Open-label Extension Phase||66
127000|NCT00195702|305929|P3|COMPLETED|Open-label Extension Phase||0
127001|NCT00195702|305930|P2|COMPLETED|Open-label Extension Phase||0
127002|NCT00195702|305931|P1|COMPLETED|Open-label Extension Phase||0
127003|NCT00195702|305926|P6|STARTED|Open-label Extension Phase|6 subjects completed the double-blind phase but did not enter the open-label extension phase.|134
127004|NCT00195702|305927|P5|STARTED|Open-label Extension Phase|1 subject completed the double-blind phase but did not enter the open-label extension phase.|158
127005|NCT00195702|305928|P4|STARTED|Open-label Extension Phase|3 subjects completed the double-blind phase but did not enter the open-label extension phase.|165
127006|NCT00195702|305929|P3|STARTED|Open-label Extension Phase||0
127007|NCT00195702|305930|P2|STARTED|Open-label Extension Phase||0
127008|NCT00195702|305931|P1|STARTED|Open-label Extension Phase||0
127009|NCT00195702|305926|P6|NOT COMPLETED|Double-blind Phase||0
127010|NCT00195702|305927|P5|NOT COMPLETED|Double-blind Phase||0
127011|NCT00195702|305928|P4|NOT COMPLETED|Double-blind Phase||0
127012|NCT00195702|305929|P3|NOT COMPLETED|Double-blind Phase||60
127013|NCT00195702|305930|P2|NOT COMPLETED|Double-blind Phase||48
127014|NCT00195702|305931|P1|NOT COMPLETED|Double-blind Phase||44
127015|NCT00195702|305926|P6|COMPLETED|Double-blind Phase||0
127016|NCT00195702|305927|P5|COMPLETED|Double-blind Phase||0
127017|NCT00195702|305928|P4|COMPLETED|Double-blind Phase||0
127018|NCT00195702|305929|P3|COMPLETED|Double-blind Phase||140
127019|NCT00195702|305930|P2|COMPLETED|Double-blind Phase||159
127020|NCT00195702|305931|P1|COMPLETED|Double-blind Phase||168
127021|NCT00195702|305926|P6|STARTED|Double-blind Phase||0
127022|NCT00195702|305927|P5|STARTED|Double-blind Phase||0
127023|NCT00195702|305928|P4|STARTED|Double-blind Phase||0
127024|NCT00195702|305929|P3|STARTED|Double-blind Phase||200
127025|NCT00195702|305930|P2|STARTED|Double-blind Phase||207
127026|NCT00195702|305931|P1|STARTED|Double-blind Phase|For all groups, started indicates when the subjects entered the 52-week double-blind phase.|212
127027|NCT00195715|305995|P1|NOT COMPLETED|Overall Study||377
127028|NCT00195715|305995|P1|COMPLETED|Overall Study||400
127029|NCT00195715|305995|P1|STARTED|Overall Study||777
127030|NCT00195819|306023|P2|NOT COMPLETED|Open-label||20
127031|NCT00195819|306024|P1|NOT COMPLETED|Open-label||0
127032|NCT00195819|306023|P2|COMPLETED|Open-label||62
127033|NCT00195819|306024|P1|COMPLETED|Open-label||0
127034|NCT00195819|306023|P2|STARTED|Open-label||82
127035|NCT00195819|306024|P1|STARTED|Open-label||0
127036|NCT00195819|306023|P2|NOT COMPLETED|Double-Blind||0
127037|NCT00195819|306024|P1|NOT COMPLETED|Double-Blind||2
127038|NCT00195819|306023|P2|COMPLETED|Double-Blind||38
127039|NCT00195819|306024|P1|COMPLETED|Double-Blind||42
127040|NCT00195819|306023|P2|STARTED|Double-Blind||38
127041|NCT00195819|306024|P1|STARTED|Double-Blind||44
127042|NCT00196105|306077|P3|NOT COMPLETED|Overall Study||7
127043|NCT00196105|306078|P2|NOT COMPLETED|Overall Study||5
127044|NCT00196105|306079|P1|NOT COMPLETED|Overall Study||4
127045|NCT00196105|306077|P3|COMPLETED|Overall Study||82
127046|NCT00196105|306078|P2|COMPLETED|Overall Study||83
127047|NCT00196105|306079|P1|COMPLETED|Overall Study||60
127048|NCT00196105|306077|P3|STARTED|Overall Study||89
127049|NCT00196105|306078|P2|STARTED|Overall Study||88
127050|NCT00196105|306079|P1|STARTED|Overall Study||64
127051|NCT00196196|306099|P1|NOT COMPLETED|Overall Study||7
127052|NCT00196196|306099|P1|COMPLETED|Overall Study||267
127053|NCT00196196|306099|P1|STARTED|Overall Study||274
127054|NCT00196313|306106|P2|NOT COMPLETED|Overall Study||8
127055|NCT00196313|306107|P1|NOT COMPLETED|Overall Study||11
127056|NCT00196313|306106|P2|COMPLETED|Overall Study||40
127057|NCT00196313|306107|P1|COMPLETED|Overall Study||36
127058|NCT00196313|306106|P2|STARTED|Overall Study||48
127059|NCT00196313|306107|P1|STARTED|Overall Study||47
127060|NCT00196326|306121|P1|NOT COMPLETED|Overall Study||986
127061|NCT00196326|306121|P1|COMPLETED|Overall Study||1249
127062|NCT00196326|306121|P1|Pregnancy Intent-to-treat Cohort (PITT)|Overall Study|Completed one cycle and 18-35 years old|1735
127063|NCT00196326|306121|P1|Safety Population|Overall Study|Treated participants|2185
127064|NCT00196326|306121|P1|STARTED|Overall Study|Took at least one dose of study medication|2235
127065|NCT00183729|306129|P2|NOT COMPLETED|Overall Study||5
127066|NCT00183729|306130|P1|NOT COMPLETED|Overall Study||3
127067|NCT00183729|306129|P2|COMPLETED|Overall Study||13
127068|NCT00183729|306130|P1|COMPLETED|Overall Study||14
127069|NCT00183729|306129|P2|STARTED|Overall Study||18
127070|NCT00183729|306130|P1|STARTED|Overall Study||17
127071|NCT00183794|306136|P1|NOT COMPLETED|Overall Study||0
127072|NCT00183794|306136|P1|COMPLETED|Overall Study||20
127073|NCT00183794|306136|P1|STARTED|Overall Study||20
127074|NCT00183963|306145|P4|NOT COMPLETED|Overall Study||1
127075|NCT00183963|306146|P3|NOT COMPLETED|Overall Study||1
127076|NCT00183963|306147|P2|NOT COMPLETED|Overall Study||1
127077|NCT00183963|306148|P1|NOT COMPLETED|Overall Study||1
127078|NCT00183963|306145|P4|COMPLETED|Overall Study||0
127079|NCT00183963|306146|P3|COMPLETED|Overall Study||0
127080|NCT00183963|306147|P2|COMPLETED|Overall Study||0
127081|NCT00183963|306148|P1|COMPLETED|Overall Study||0
127082|NCT00183963|306145|P4|STARTED|Overall Study||1
127083|NCT00183963|306146|P3|STARTED|Overall Study||1
127084|NCT00183963|306147|P2|STARTED|Overall Study||1
127085|NCT00183963|306148|P1|STARTED|Overall Study||1
127086|NCT00184002|306162|P1|NOT COMPLETED|Overall Study||17
127087|NCT00184002|306162|P1|COMPLETED|Overall Study||51
127088|NCT00184002|306162|P1|STARTED|Overall Study||68
127089|NCT00184028|306167|P1|NOT COMPLETED|Overall Study||10
127090|NCT00184028|306167|P1|COMPLETED|Overall Study||2
127091|NCT00184028|306167|P1|STARTED|Overall Study||12
127092|NCT00184054|306172|P1|NOT COMPLETED|Overall Study||1
127093|NCT00184054|306172|P1|COMPLETED|Overall Study||10
127094|NCT00184054|306172|P1|STARTED|Overall Study||11
127095|NCT00184093|306177|P1|NOT COMPLETED|Overall Study||9
127096|NCT00184093|306177|P1|COMPLETED|Overall Study||26
127097|NCT00184093|306177|P1|STARTED|Overall Study|Phase 1 participants = 6 Phase 2 participants = 29|35
127098|NCT00184548|306186|P4|NOT COMPLETED|Overall Study||7
127099|NCT00184548|306187|P3|NOT COMPLETED|Overall Study||3
127100|NCT00184548|306188|P2|NOT COMPLETED|Overall Study||13
127101|NCT00184548|306189|P1|NOT COMPLETED|Overall Study||8
127102|NCT00184548|306186|P4|COMPLETED|Overall Study||38
127103|NCT00184548|306187|P3|COMPLETED|Overall Study||44
127104|NCT00184548|306188|P2|COMPLETED|Overall Study||242
127105|NCT00184548|306189|P1|COMPLETED|Overall Study||218
127106|NCT00184548|306186|P4|Exposed|Overall Study|Four subjects withdrew due to ineligibility, one subject died. Excluded from safety analysis set|40
127107|NCT00184548|306187|P3|Exposed|Overall Study|One subject withdrew due to ineligibility. Excluded from safety analysis set|46
127108|NCT00184548|306188|P2|Exposed|Overall Study|Three subjects withdrew due to ineligibility, two subjects died. Excluded from safety analysis set|250
127109|NCT00184548|306189|P1|Exposed|Overall Study|Two subjects withdrew due to ineligibility. Excluded from safety analysis set|224
127110|NCT00184548|306186|P4|STARTED|Overall Study||45
127111|NCT00184548|306187|P3|STARTED|Overall Study||47
127112|NCT00184548|306188|P2|STARTED|Overall Study||255
127113|NCT00184548|306189|P1|STARTED|Overall Study||226
127114|NCT00184600|306226|P3|NOT COMPLETED|Overall Study||34
127115|NCT00184600|306227|P2|NOT COMPLETED|Overall Study||51
127116|NCT00184600|306228|P1|NOT COMPLETED|Overall Study||45
127117|NCT00184600|306226|P3|COMPLETED|Overall Study||201
127118|NCT00184600|306227|P2|COMPLETED|Overall Study||188
127119|NCT00184600|306228|P1|COMPLETED|Overall Study||189
127120|NCT00184600|306226|P3|STARTED|Overall Study||235
127121|NCT00184600|306227|P2|STARTED|Overall Study||239
127122|NCT00184600|306228|P1|STARTED|Overall Study||234
127123|NCT00184717|306281|P5|NOT COMPLETED|Extension Period (GHLIQUID-1517)||5
127124|NCT00184717|306282|P4|NOT COMPLETED|Extension Period (GHLIQUID-1517)||3
127125|NCT00184717|306283|P3|NOT COMPLETED|Extension Period (GHLIQUID-1517)||0
127126|NCT00184717|306284|P2|NOT COMPLETED|Extension Period (GHLIQUID-1517)||6
127127|NCT00184717|306285|P1|NOT COMPLETED|Extension Period (GHLIQUID-1517)||10
127128|NCT00184717|306281|P5|COMPLETED|Extension Period (GHLIQUID-1517)||5
127129|NCT00184717|306282|P4|COMPLETED|Extension Period (GHLIQUID-1517)||7
127130|NCT00184717|306283|P3|COMPLETED|Extension Period (GHLIQUID-1517)||0
127131|NCT00184717|306284|P2|COMPLETED|Extension Period (GHLIQUID-1517)||27
127132|NCT00184717|306285|P1|COMPLETED|Extension Period (GHLIQUID-1517)||23
127133|NCT00184717|306281|P5|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
127134|NCT00184717|306282|P4|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised from No treatment group|10
127135|NCT00184717|306283|P3|STARTED|Extension Period (GHLIQUID-1517)|Re-randomised to receive 0.033 or 0.067 mg|0
127136|NCT00184717|306284|P2|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
127137|NCT00184717|306285|P1|STARTED|Extension Period (GHLIQUID-1517)|Three subjects did not continue in extension period|33
127138|NCT00184717|306281|P5|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
127139|NCT00184717|306282|P4|NOT COMPLETED|Main Period (GHLIQUID-1516)||0
127140|NCT00184717|306283|P3|NOT COMPLETED|Main Period (GHLIQUID-1516)||1
127141|NCT00184717|306284|P2|NOT COMPLETED|Main Period (GHLIQUID-1516)||2
127142|NCT00184717|306285|P1|NOT COMPLETED|Main Period (GHLIQUID-1516)||3
127143|NCT00184717|306281|P5|COMPLETED|Main Period (GHLIQUID-1516)||0
127144|NCT00184717|306282|P4|COMPLETED|Main Period (GHLIQUID-1516)||0
127145|NCT00184717|306283|P3|COMPLETED|Main Period (GHLIQUID-1516)||20
127146|NCT00184717|306284|P2|COMPLETED|Main Period (GHLIQUID-1516)||36
127147|NCT00184717|306285|P1|COMPLETED|Main Period (GHLIQUID-1516)||36
127148|NCT00184717|306281|P5|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
127149|NCT00184717|306282|P4|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||0
127150|NCT00184717|306283|P3|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||21
127151|NCT00184717|306284|P2|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
127152|NCT00184717|306285|P1|Exposed to Trial Drug|Main Period (GHLIQUID-1516)||38
127153|NCT00184717|306281|P5|STARTED|Main Period (GHLIQUID-1516)||0
127154|NCT00184717|306282|P4|STARTED|Main Period (GHLIQUID-1516)||0
127155|NCT00184717|306283|P3|STARTED|Main Period (GHLIQUID-1516)||21
127156|NCT00184717|306284|P2|STARTED|Main Period (GHLIQUID-1516)||38
127157|NCT00184717|306285|P1|STARTED|Main Period (GHLIQUID-1516)||39
127158|NCT00186446|306323|P1|NOT COMPLETED|Overall Study||9
127159|NCT00186446|306323|P1|COMPLETED|Overall Study||11
127160|NCT00186446|306323|P1|STARTED|Overall Study||20
127161|NCT00186485|306329|P1|NOT COMPLETED|Overall Study||3
127162|NCT00186485|306329|P1|COMPLETED|Overall Study||25
127163|NCT00186485|306329|P1|STARTED|Overall Study||28
127164|NCT00186537|306338|P3|NOT COMPLETED|Overall Study||3
127165|NCT00186537|306339|P2|NOT COMPLETED|Overall Study||0
127166|NCT00186537|306340|P1|NOT COMPLETED|Overall Study||7
127167|NCT00186537|306338|P3|COMPLETED|Overall Study||13
127168|NCT00186537|306339|P2|COMPLETED|Overall Study||12
127169|NCT00186537|306340|P1|COMPLETED|Overall Study||12
127170|NCT00186537|306338|P3|STARTED|Overall Study||16
127171|NCT00186537|306339|P2|STARTED|Overall Study||12
127172|NCT00186537|306340|P1|STARTED|Overall Study||19
127173|NCT00186875|306356|P2|NOT COMPLETED|Overall Study||0
127174|NCT00186875|306357|P1|NOT COMPLETED|Overall Study||0
127175|NCT00186875|306356|P2|COMPLETED|Overall Study||14
127176|NCT00186875|306357|P1|COMPLETED|Overall Study||26
127177|NCT00186875|306356|P2|STARTED|Overall Study||14
127178|NCT00186875|306357|P1|STARTED|Overall Study||26
127179|NCT00186888|306374|P3|NOT COMPLETED|Overall Study||0
127180|NCT00186888|306375|P2|NOT COMPLETED|Overall Study||3
127181|NCT00186888|306376|P1|NOT COMPLETED|Overall Study||4
127182|NCT00186888|306374|P3|COMPLETED|Overall Study||55
127183|NCT00186888|306375|P2|COMPLETED|Overall Study||24
127184|NCT00186888|306376|P1|COMPLETED|Overall Study||19
127185|NCT00186888|306374|P3|Window Therapy|Overall Study||0
127186|NCT00186888|306375|P2|Window Therapy|Overall Study||27
127187|NCT00186888|306376|P1|Window Therapy|Overall Study||0
127188|NCT00186888|306374|P3|STARTED|Overall Study||55
127189|NCT00186888|306375|P2|STARTED|Overall Study||27
127190|NCT00186888|306376|P1|STARTED|Overall Study||23
127191|NCT00186901|306443|P3|NOT COMPLETED|Overall Study||149
127192|NCT00186901|306444|P2|NOT COMPLETED|Overall Study||45
127193|NCT00186901|306445|P1|NOT COMPLETED|Overall Study||49
127194|NCT00186901|306443|P3|COMPLETED|Overall Study||0
127195|NCT00186901|306444|P2|COMPLETED|Overall Study||96
127196|NCT00186901|306445|P1|COMPLETED|Overall Study||85
127197|NCT00186901|306443|P3|24 Month Follow-up|Overall Study||0
127198|NCT00186901|306444|P2|24 Month Follow-up|Overall Study||107
127199|NCT00186901|306445|P1|24 Month Follow-up|Overall Study||106
127200|NCT00186901|306443|P3|12 Month Follow-up|Overall Study||0
127201|NCT00186901|306444|P2|12 Month Follow-up|Overall Study||122
127202|NCT00186901|306445|P1|12 Month Follow-up|Overall Study||117
127203|NCT00186901|306443|P3|Baseline|Overall Study||0
127204|NCT00186901|306444|P2|Baseline|Overall Study||141
127205|NCT00186901|306445|P1|Baseline|Overall Study||134
127206|NCT00186901|306443|P3|STARTED|Overall Study||149
127207|NCT00186901|306444|P2|STARTED|Overall Study||141
127208|NCT00186901|306445|P1|STARTED|Overall Study||134
127209|NCT00187096|306485|P3|NOT COMPLETED|Overall Study||1
127210|NCT00187096|306486|P2|NOT COMPLETED|Overall Study||0
127211|NCT00187096|306487|P1|NOT COMPLETED|Overall Study||0
127212|NCT00187096|306485|P3|COMPLETED|Overall Study||11
127213|NCT00187096|306486|P2|COMPLETED|Overall Study||3
127214|NCT00187096|306487|P1|COMPLETED|Overall Study||10
127215|NCT00187096|306485|P3|STARTED|Overall Study||12
127216|NCT00187096|306486|P2|STARTED|Overall Study||3
127217|NCT00187096|306487|P1|STARTED|Overall Study||10
127218|NCT00187135|306528|P6|NOT COMPLETED|Visit Three||6
127219|NCT00187135|306529|P5|NOT COMPLETED|Visit Three||8
127220|NCT00187135|306530|P4|NOT COMPLETED|Visit Three||9
127221|NCT00187135|306531|P3|NOT COMPLETED|Visit Three||9
127222|NCT00187135|306532|P2|NOT COMPLETED|Visit Three||7
127223|NCT00187135|306533|P1|NOT COMPLETED|Visit Three||7
127224|NCT00187135|306528|P6|COMPLETED|Visit Three||12
127225|NCT00187135|306529|P5|COMPLETED|Visit Three||11
127226|NCT00187135|306530|P4|COMPLETED|Visit Three||9
127227|NCT00187135|306531|P3|COMPLETED|Visit Three||14
127228|NCT00187135|306532|P2|COMPLETED|Visit Three||17
127229|NCT00187135|306533|P1|COMPLETED|Visit Three||14
127230|NCT00187135|306528|P6|STARTED|Visit Three||18
127231|NCT00187135|306529|P5|STARTED|Visit Three||19
127232|NCT00187135|306530|P4|STARTED|Visit Three||18
127233|NCT00187135|306531|P3|STARTED|Visit Three||23
127234|NCT00187135|306532|P2|STARTED|Visit Three||24
127235|NCT00187135|306533|P1|STARTED|Visit Three||21
127236|NCT00187135|306528|P6|NOT COMPLETED|Visit Two||8
127237|NCT00187135|306529|P5|NOT COMPLETED|Visit Two||6
127238|NCT00187135|306530|P4|NOT COMPLETED|Visit Two||8
127239|NCT00187135|306531|P3|NOT COMPLETED|Visit Two||2
127240|NCT00187135|306532|P2|NOT COMPLETED|Visit Two||3
127241|NCT00187135|306533|P1|NOT COMPLETED|Visit Two||5
127242|NCT00187135|306528|P6|COMPLETED|Visit Two||18
127243|NCT00187135|306529|P5|COMPLETED|Visit Two||19
127244|NCT00187135|306530|P4|COMPLETED|Visit Two||18
127245|NCT00187135|306531|P3|COMPLETED|Visit Two||23
127246|NCT00187135|306532|P2|COMPLETED|Visit Two||24
127247|NCT00187135|306533|P1|COMPLETED|Visit Two||21
127248|NCT00187135|306528|P6|STARTED|Visit Two||26
127249|NCT00187135|306529|P5|STARTED|Visit Two||25
127250|NCT00187135|306530|P4|STARTED|Visit Two||26
127251|NCT00187135|306531|P3|STARTED|Visit Two||25
127252|NCT00187135|306532|P2|STARTED|Visit Two||27
127253|NCT00187135|306533|P1|STARTED|Visit Two||26
127254|NCT00187135|306528|P6|NOT COMPLETED|Visit One||2
127255|NCT00187135|306529|P5|NOT COMPLETED|Visit One||0
127256|NCT00187135|306530|P4|NOT COMPLETED|Visit One||0
127257|NCT00187135|306531|P3|NOT COMPLETED|Visit One||0
127258|NCT00187135|306532|P2|NOT COMPLETED|Visit One||1
127259|NCT00187135|306533|P1|NOT COMPLETED|Visit One||4
127260|NCT00187135|306528|P6|COMPLETED|Visit One||26
127261|NCT00187135|306529|P5|COMPLETED|Visit One||25
127262|NCT00187135|306530|P4|COMPLETED|Visit One||26
127263|NCT00187135|306531|P3|COMPLETED|Visit One||25
127264|NCT00187135|306532|P2|COMPLETED|Visit One||27
127265|NCT00187135|306533|P1|COMPLETED|Visit One||26
127266|NCT00187135|306528|P6|STARTED|Visit One||28
127267|NCT00187135|306529|P5|STARTED|Visit One||25
127268|NCT00187135|306530|P4|STARTED|Visit One||26
127269|NCT00187135|306531|P3|STARTED|Visit One||25
127270|NCT00187135|306532|P2|STARTED|Visit One||28
127271|NCT00187135|306533|P1|STARTED|Visit One||30
127272|NCT00187200|306555|P2|NOT COMPLETED|Overall Study||18
127273|NCT00187200|306556|P1|NOT COMPLETED|Overall Study||18
127274|NCT00187200|306555|P2|COMPLETED|Overall Study||26
127275|NCT00187200|306556|P1|COMPLETED|Overall Study||31
127276|NCT00187200|306555|P2|STARTED|Overall Study||44
127277|NCT00187200|306556|P1|STARTED|Overall Study||49
127278|NCT00187226|306574|P6|NOT COMPLETED|Overall Study||0
127279|NCT00187226|306575|P5|NOT COMPLETED|Overall Study||0
127280|NCT00187226|306576|P4|NOT COMPLETED|Overall Study||0
127281|NCT00187226|306577|P3|NOT COMPLETED|Overall Study||0
127282|NCT00187226|306578|P2|NOT COMPLETED|Overall Study||0
127283|NCT00187226|306579|P1|NOT COMPLETED|Overall Study||0
127284|NCT00187226|306574|P6|COMPLETED|Overall Study||1
127285|NCT00187226|306575|P5|COMPLETED|Overall Study||34
127286|NCT00187226|306576|P4|COMPLETED|Overall Study||2
127287|NCT00187226|306577|P3|COMPLETED|Overall Study||28
127288|NCT00187226|306578|P2|COMPLETED|Overall Study||49
127289|NCT00187226|306579|P1|COMPLETED|Overall Study||88
127290|NCT00187226|306574|P6|STARTED|Overall Study||1
127291|NCT00187226|306575|P5|STARTED|Overall Study||34
127292|NCT00187226|306576|P4|STARTED|Overall Study||2
127293|NCT00187226|306577|P3|STARTED|Overall Study||28
127294|NCT00187226|306578|P2|STARTED|Overall Study||49
127295|NCT00187226|306579|P1|STARTED|Overall Study||88
127296|NCT00187486|306593|P1|NOT COMPLETED|Overall Study||1
127297|NCT00187486|306593|P1|COMPLETED|Overall Study||65
127298|NCT00187486|306593|P1|STARTED|Overall Study||66
127299|NCT00187655|306598|P1|NOT COMPLETED|Overall Study||0
127300|NCT00187655|306598|P1|COMPLETED|Overall Study||24
127301|NCT00187655|306598|P1|STARTED|Overall Study||24
127302|NCT00187681|306605|P2|NOT COMPLETED|Overall Study||0
127303|NCT00187681|306606|P1|NOT COMPLETED|Overall Study||0
127304|NCT00187681|306605|P2|COMPLETED|Overall Study||8
127305|NCT00187681|306606|P1|COMPLETED|Overall Study||12
127306|NCT00187681|306605|P2|STARTED|Overall Study||8
127307|NCT00187681|306606|P1|STARTED|Overall Study||12
127308|NCT00187720|306616|P2|NOT COMPLETED|Overall Study||0
127309|NCT00187720|306617|P1|NOT COMPLETED|Overall Study||0
127310|NCT00187720|306616|P2|COMPLETED|Overall Study||14
127311|NCT00187720|306617|P1|COMPLETED|Overall Study||9
127312|NCT00187720|306616|P2|STARTED|Overall Study||14
127313|NCT00187720|306617|P1|STARTED|Overall Study||9
127314|NCT00187876|306625|P2|NOT COMPLETED|Overall Study||0
127315|NCT00187876|306626|P1|NOT COMPLETED|Overall Study||0
127316|NCT00187876|306625|P2|COMPLETED|Overall Study||43
127317|NCT00187876|306626|P1|COMPLETED|Overall Study||24
127318|NCT00187876|306625|P2|STARTED|Overall Study||43
127319|NCT00187876|306626|P1|STARTED|Overall Study||24
127320|NCT00187889|306634|P2|NOT COMPLETED|Overall Study||4
127321|NCT00187889|306635|P1|NOT COMPLETED|Overall Study||6
127322|NCT00187889|306634|P2|COMPLETED|Overall Study||22
127323|NCT00187889|306635|P1|COMPLETED|Overall Study||19
127324|NCT00187889|306634|P2|STARTED|Overall Study||26
127325|NCT00187889|306635|P1|STARTED|Overall Study||25
127326|NCT00196716|306643|P1|NOT COMPLETED|0.3 mg/kg Period||0
127327|NCT00196716|306643|P1|COMPLETED|0.3 mg/kg Period||21
127328|NCT00196716|306643|P1|STARTED|0.3 mg/kg Period||21
127329|NCT00196716|306643|P1|NOT COMPLETED|1.0 mg/kg Period||0
127330|NCT00196716|306643|P1|COMPLETED|1.0 mg/kg Period||21
127331|NCT00196716|306643|P1|STARTED|1.0 mg/kg Period||21
127332|NCT00196937|306656|P3|NOT COMPLETED|Overall Study||7
127333|NCT00196937|306657|P2|NOT COMPLETED|Overall Study||5
127334|NCT00196937|306658|P1|NOT COMPLETED|Overall Study||9
127335|NCT00196937|306656|P3|COMPLETED|Overall Study||204
127336|NCT00196937|306657|P2|COMPLETED|Overall Study||221
127337|NCT00196937|306658|P1|COMPLETED|Overall Study||220
127338|NCT00196937|306656|P3|STARTED|Overall Study||211
127339|NCT00196937|306657|P2|STARTED|Overall Study||226
127340|NCT00196937|306658|P1|STARTED|Overall Study||229
127341|NCT00196976|306710|P14|NOT COMPLETED|Booster Study||0
127342|NCT00196976|306711|P13|NOT COMPLETED|Booster Study||0
127343|NCT00196976|306712|P12|NOT COMPLETED|Booster Study||2
127344|NCT00196976|306713|P11|NOT COMPLETED|Booster Study||2
127345|NCT00196976|306714|P10|NOT COMPLETED|Booster Study||0
127346|NCT00196976|306715|P9|NOT COMPLETED|Booster Study||0
127347|NCT00196976|306716|P8|NOT COMPLETED|Booster Study||0
127348|NCT00196976|306717|P7|NOT COMPLETED|Booster Study||0
127349|NCT00196976|306718|P6|NOT COMPLETED|Booster Study||0
127350|NCT00196976|306719|P5|NOT COMPLETED|Booster Study||0
127351|NCT00196976|306720|P4|NOT COMPLETED|Booster Study||0
127352|NCT00196976|306721|P3|NOT COMPLETED|Booster Study||0
127353|NCT00196976|306722|P2|NOT COMPLETED|Booster Study||0
127354|NCT00196976|306723|P1|NOT COMPLETED|Booster Study||0
127355|NCT00196976|306710|P14|COMPLETED|Booster Study||43
127356|NCT00196976|306711|P13|COMPLETED|Booster Study||45
127357|NCT00196976|306712|P12|COMPLETED|Booster Study||30
127358|NCT00196976|306713|P11|COMPLETED|Booster Study||31
127359|NCT00196976|306714|P10|COMPLETED|Booster Study||0
127360|NCT00196976|306715|P9|COMPLETED|Booster Study||0
127361|NCT00196976|306716|P8|COMPLETED|Booster Study||0
127362|NCT00196976|306717|P7|COMPLETED|Booster Study||0
127363|NCT00196976|306718|P6|COMPLETED|Booster Study||0
127364|NCT00196976|306719|P5|COMPLETED|Booster Study||0
127365|NCT00196976|306720|P4|COMPLETED|Booster Study||0
127366|NCT00196976|306721|P3|COMPLETED|Booster Study||0
127367|NCT00196976|306722|P2|COMPLETED|Booster Study||0
127368|NCT00196976|306723|P1|COMPLETED|Booster Study||0
127369|NCT00196976|306710|P14|STARTED|Booster Study||43
127370|NCT00196976|306711|P13|STARTED|Booster Study||45
127371|NCT00196976|306712|P12|STARTED|Booster Study||32
127372|NCT00196976|306713|P11|STARTED|Booster Study||33
127373|NCT00196976|306714|P10|STARTED|Booster Study||0
127374|NCT00196976|306715|P9|STARTED|Booster Study||0
127375|NCT00196976|306716|P8|STARTED|Booster Study||0
127376|NCT00196976|306717|P7|STARTED|Booster Study||0
127377|NCT00196976|306718|P6|STARTED|Booster Study||0
127378|NCT00196976|306719|P5|STARTED|Booster Study||0
127379|NCT00196976|306720|P4|STARTED|Booster Study||0
127380|NCT00196976|306721|P3|STARTED|Booster Study||0
127381|NCT00196976|306722|P2|STARTED|Booster Study||0
127382|NCT00196976|306723|P1|STARTED|Booster Study||0
127383|NCT00196976|306710|P14|NOT COMPLETED|Primary Study||0
127384|NCT00196976|306711|P13|NOT COMPLETED|Primary Study||0
127385|NCT00196976|306712|P12|NOT COMPLETED|Primary Study||0
127386|NCT00196976|306713|P11|NOT COMPLETED|Primary Study||0
127387|NCT00196976|306714|P10|NOT COMPLETED|Primary Study||1
127388|NCT00196976|306715|P9|NOT COMPLETED|Primary Study||0
127389|NCT00196976|306716|P8|NOT COMPLETED|Primary Study||3
127390|NCT00196976|306717|P7|NOT COMPLETED|Primary Study||0
127391|NCT00196976|306718|P6|NOT COMPLETED|Primary Study||2
127392|NCT00196976|306719|P5|NOT COMPLETED|Primary Study||3
127393|NCT00196976|306720|P4|NOT COMPLETED|Primary Study||1
127394|NCT00196976|306721|P3|NOT COMPLETED|Primary Study||4
127395|NCT00196976|306722|P2|NOT COMPLETED|Primary Study||1
127396|NCT00196976|306723|P1|NOT COMPLETED|Primary Study||1
127397|NCT00196976|306710|P14|COMPLETED|Primary Study||0
127398|NCT00196976|306711|P13|COMPLETED|Primary Study||0
127399|NCT00196976|306712|P12|COMPLETED|Primary Study||0
127400|NCT00196976|306713|P11|COMPLETED|Primary Study||0
127401|NCT00196976|306714|P10|COMPLETED|Primary Study||51
127402|NCT00196976|306715|P9|COMPLETED|Primary Study||52
127403|NCT00196976|306716|P8|COMPLETED|Primary Study||49
127404|NCT00196976|306717|P7|COMPLETED|Primary Study||50
127405|NCT00196976|306718|P6|COMPLETED|Primary Study||52
127406|NCT00196976|306719|P5|COMPLETED|Primary Study||37
127407|NCT00196976|306720|P4|COMPLETED|Primary Study||39
127408|NCT00196976|306721|P3|COMPLETED|Primary Study||37
127409|NCT00196976|306722|P2|COMPLETED|Primary Study||40
127410|NCT00196976|306723|P1|COMPLETED|Primary Study||38
127411|NCT00196976|306710|P14|STARTED|Primary Study||0
127412|NCT00196976|306711|P13|STARTED|Primary Study||0
127413|NCT00196976|306712|P12|STARTED|Primary Study||0
127414|NCT00196976|306713|P11|STARTED|Primary Study||0
127415|NCT00196976|306714|P10|STARTED|Primary Study||52
127416|NCT00196976|306715|P9|STARTED|Primary Study||52
127417|NCT00196976|306716|P8|STARTED|Primary Study||52
127418|NCT00196976|306717|P7|STARTED|Primary Study||50
127419|NCT00196976|306718|P6|STARTED|Primary Study||54
127420|NCT00196976|306719|P5|STARTED|Primary Study||40
127421|NCT00196976|306720|P4|STARTED|Primary Study||40
127422|NCT00196976|306721|P3|STARTED|Primary Study||41
127423|NCT00196976|306722|P2|STARTED|Primary Study||41
127424|NCT00196976|306723|P1|STARTED|Primary Study||39
127425|NCT00197002|306919|P3|NOT COMPLETED|Overall Study||17
127426|NCT00197002|306920|P2|NOT COMPLETED|Overall Study||18
127427|NCT00197002|306921|P1|NOT COMPLETED|Overall Study||22
127428|NCT00197002|306919|P3|COMPLETED|Overall Study||132
127429|NCT00197002|306920|P2|COMPLETED|Overall Study||119
127430|NCT00197002|306921|P1|COMPLETED|Overall Study||125
127431|NCT00197002|306919|P3|STARTED|Overall Study||149
127432|NCT00197002|306920|P2|STARTED|Overall Study||137
127433|NCT00197002|306921|P1|STARTED|Overall Study||147
127434|NCT00197015|306961|P3|NOT COMPLETED|Overall Study||77
127435|NCT00197015|306962|P2|NOT COMPLETED|Overall Study||89
127436|NCT00197015|306963|P1|NOT COMPLETED|Overall Study||50
127437|NCT00197015|306961|P3|COMPLETED|Overall Study||385
127438|NCT00197015|306962|P2|COMPLETED|Overall Study||366
127439|NCT00197015|306963|P1|COMPLETED|Overall Study||274
127440|NCT00197015|306961|P3|STARTED|Overall Study||462
127441|NCT00197015|306962|P2|STARTED|Overall Study||455
127442|NCT00197015|306963|P1|STARTED|Overall Study||324
127443|NCT00197028|307021|P2|NOT COMPLETED|Overall Study||21
127444|NCT00197028|307022|P1|NOT COMPLETED|Overall Study||16
127445|NCT00197028|307021|P2|COMPLETED|Overall Study||86
127446|NCT00197028|307022|P1|COMPLETED|Overall Study||91
127447|NCT00197028|307021|P2|STARTED|Overall Study||107
127448|NCT00197028|307022|P1|STARTED|Overall Study||107
127449|NCT00199381|307062|P1|NOT COMPLETED|Overall Study||504
127450|NCT00199381|307062|P1|COMPLETED|Overall Study|Premature study termination by the Sponsor.|0
127451|NCT00199381|307062|P1|STARTED|Overall Study||504
127452|NCT00199914|307068|P2|NOT COMPLETED|Overall Study||6
127453|NCT00199914|307069|P1|NOT COMPLETED|Overall Study||3
127454|NCT00199914|307068|P2|COMPLETED|Overall Study||54
127455|NCT00199914|307069|P1|COMPLETED|Overall Study||50
127456|NCT00199914|307068|P2|STARTED|Overall Study||60
127457|NCT00199914|307069|P1|STARTED|Overall Study||53
127458|NCT00200057|307075|P1|NOT COMPLETED|Overall Study||9
127459|NCT00200057|307075|P1|COMPLETED|Overall Study||111
127460|NCT00200057|307075|P1|12 Month Follow-up|Overall Study||111
127461|NCT00200057|307075|P1|6 Month Follow-up|Overall Study||114
127462|NCT00200057|307075|P1|3 Month Follow-up|Overall Study||116
127463|NCT00200057|307075|P1|1 Month Follow-up|Overall Study||117
127464|NCT00200057|307075|P1|STARTED|Overall Study||120
127465|NCT00200343|307088|P3|NOT COMPLETED|Overall Study||13
127466|NCT00200343|307089|P2|NOT COMPLETED|Overall Study||8
127467|NCT00200343|307090|P1|NOT COMPLETED|Overall Study||16
127468|NCT00200343|307088|P3|COMPLETED|Overall Study||184
127469|NCT00200343|307089|P2|COMPLETED|Overall Study||192
127470|NCT00200343|307090|P1|COMPLETED|Overall Study||183
127471|NCT00200343|307088|P3|STARTED|Overall Study||197
127472|NCT00200343|307089|P2|STARTED|Overall Study||200
127473|NCT00200343|307090|P1|STARTED|Overall Study||199
127474|NCT00200356|307115|P2|NOT COMPLETED|Overall Study||7
127475|NCT00200356|307116|P1|NOT COMPLETED|Overall Study||8
127476|NCT00200356|307115|P2|COMPLETED|Overall Study||195
127477|NCT00200356|307116|P1|COMPLETED|Overall Study||191
127478|NCT00200356|307115|P2|Safety Analysis Set|Overall Study||198
127479|NCT00200356|307116|P1|Safety Analysis Set|Overall Study||194
127480|NCT00200356|307115|P2|STARTED|Overall Study||202
127481|NCT00200356|307116|P1|STARTED|Overall Study||199
127482|NCT00200785|307142|P2|NOT COMPLETED|Second Intervention||0
127483|NCT00200785|307143|P1|NOT COMPLETED|Second Intervention||0
127484|NCT00200785|307142|P2|COMPLETED|Second Intervention||6
127485|NCT00200785|307143|P1|COMPLETED|Second Intervention||9
127486|NCT00200785|307142|P2|STARTED|Second Intervention||6
127487|NCT00200785|307143|P1|STARTED|Second Intervention||9
127488|NCT00200785|307142|P2|NOT COMPLETED|Washout Period of 1 Week||0
127489|NCT00200785|307143|P1|NOT COMPLETED|Washout Period of 1 Week||0
127490|NCT00200785|307142|P2|COMPLETED|Washout Period of 1 Week||6
127491|NCT00200785|307143|P1|COMPLETED|Washout Period of 1 Week||9
127492|NCT00200785|307142|P2|STARTED|Washout Period of 1 Week||6
127493|NCT00200785|307143|P1|STARTED|Washout Period of 1 Week||9
127494|NCT00200785|307142|P2|NOT COMPLETED|First Intervention||0
127495|NCT00200785|307143|P1|NOT COMPLETED|First Intervention||0
127496|NCT00200785|307142|P2|COMPLETED|First Intervention||6
127497|NCT00200785|307143|P1|COMPLETED|First Intervention||9
127498|NCT00200785|307142|P2|STARTED|First Intervention||6
127499|NCT00200785|307143|P1|STARTED|First Intervention||9
127500|NCT00200967|307153|P2|NOT COMPLETED|Run-out Period||0
127501|NCT00200967|307154|P1|NOT COMPLETED|Run-out Period||1
127502|NCT00200967|307153|P2|COMPLETED|Run-out Period||41
127503|NCT00200967|307154|P1|COMPLETED|Run-out Period||34
127504|NCT00200967|307153|P2|STARTED|Run-out Period||41
127505|NCT00200967|307154|P1|STARTED|Run-out Period||35
127506|NCT00200967|307153|P2|NOT COMPLETED|Second Treatment Period||2
127507|NCT00200967|307154|P1|NOT COMPLETED|Second Treatment Period||1
127508|NCT00200967|307153|P2|COMPLETED|Second Treatment Period||41
127509|NCT00200967|307154|P1|COMPLETED|Second Treatment Period||35
127510|NCT00200967|307153|P2|STARTED|Second Treatment Period||43
127511|NCT00200967|307154|P1|STARTED|Second Treatment Period||36
127512|NCT00200967|307153|P2|NOT COMPLETED|Wash-out Period||1
127513|NCT00200967|307154|P1|NOT COMPLETED|Wash-out Period||0
127514|NCT00200967|307153|P2|COMPLETED|Wash-out Period||43
127515|NCT00200967|307154|P1|COMPLETED|Wash-out Period||36
127516|NCT00200967|307153|P2|STARTED|Wash-out Period||44
127517|NCT00200967|307154|P1|STARTED|Wash-out Period||36
127518|NCT00200967|307153|P2|NOT COMPLETED|First Treatment Period||1
127519|NCT00200967|307154|P1|NOT COMPLETED|First Treatment Period||6
127520|NCT00200967|307153|P2|COMPLETED|First Treatment Period||44
127521|NCT00200967|307154|P1|COMPLETED|First Treatment Period||36
127522|NCT00200967|307153|P2|First Treatment Period|First Treatment Period||45
127523|NCT00200967|307154|P1|First Treatment Period|First Treatment Period||42
127524|NCT00200967|307153|P2|STARTED|First Treatment Period||45
127525|NCT00200967|307154|P1|STARTED|First Treatment Period||42
127526|NCT00201006|307185|P3|NOT COMPLETED|Overall Study||4
127527|NCT00201006|307186|P2|NOT COMPLETED|Overall Study||2
127528|NCT00201006|307187|P1|NOT COMPLETED|Overall Study||8
127529|NCT00201006|307185|P3|COMPLETED|Overall Study||75
127530|NCT00201006|307186|P2|COMPLETED|Overall Study||70
127531|NCT00201006|307187|P1|COMPLETED|Overall Study||75
127532|NCT00201006|307185|P3|STARTED|Overall Study||79
127533|NCT00201006|307186|P2|STARTED|Overall Study||72
127534|NCT00201006|307187|P1|STARTED|Overall Study||83
127535|NCT00201123|307198|P3|NOT COMPLETED|Overall Study||9
127536|NCT00201123|307199|P2|NOT COMPLETED|Overall Study||4
127537|NCT00201123|307200|P1|NOT COMPLETED|Overall Study||6
127538|NCT00201123|307198|P3|COMPLETED|Overall Study||23
127539|NCT00201123|307199|P2|COMPLETED|Overall Study||28
127540|NCT00201123|307200|P1|COMPLETED|Overall Study||26
127541|NCT00201123|307198|P3|Did Not Meet Continuation Criteria|Overall Study||5
127542|NCT00201123|307199|P2|Did Not Meet Continuation Criteria|Overall Study||0
127543|NCT00201123|307200|P1|Did Not Meet Continuation Criteria|Overall Study||2
127544|NCT00201123|307198|P3|STARTED|Overall Study||32
127545|NCT00201123|307199|P2|STARTED|Overall Study||32
127546|NCT00201123|307200|P1|STARTED|Overall Study||32
127547|NCT00201201|307216|P2|NOT COMPLETED|Overall Study||7
127548|NCT00201201|307217|P1|NOT COMPLETED|Overall Study||5
127549|NCT00201201|307216|P2|COMPLETED|Overall Study||66
127550|NCT00201201|307217|P1|COMPLETED|Overall Study||82
127551|NCT00201201|307216|P2|STARTED|Overall Study||73
127552|NCT00201201|307217|P1|STARTED|Overall Study||87
127553|NCT00201240|307233|P1|NOT COMPLETED|Overall Study||3
127554|NCT00201240|307233|P1|COMPLETED|Overall Study||44
127555|NCT00201240|307233|P1|STARTED|Overall Study||47
127556|NCT00201409|307251|P2|NOT COMPLETED|Overall Study||1
127557|NCT00201409|307252|P1|NOT COMPLETED|Overall Study||1
127558|NCT00201409|307251|P2|COMPLETED|Overall Study||66
127559|NCT00201409|307252|P1|COMPLETED|Overall Study||64
127560|NCT00201409|307251|P2|STARTED|Overall Study||67
127561|NCT00201409|307252|P1|STARTED|Overall Study||65
127562|NCT00185211|307264|P2|NOT COMPLETED|Follow-up Study (91031 - This Study)||34
127563|NCT00185211|307265|P1|NOT COMPLETED|Follow-up Study (91031 - This Study)||26
127564|NCT00185211|307264|P2|COMPLETED|Follow-up Study (91031 - This Study)||123
127565|NCT00185211|307265|P1|COMPLETED|Follow-up Study (91031 - This Study)||235
127566|NCT00185211|307264|P2|STARTED|Follow-up Study (91031 - This Study)|9 of the 166 subjects completing the placebo-controlled study did not consent to the Follow-up.|157
127567|NCT00185211|307265|P1|STARTED|Follow-up Study (91031 - This Study)|10 of the 271 subjects completing the placebo-controlled study did not consent to the Follow-up.|261
127568|NCT00185211|307264|P2|NOT COMPLETED|Placebo-controlled Study (92012)||10
127569|NCT00185211|307265|P1|NOT COMPLETED|Placebo-controlled Study (92012)||21
127570|NCT00185211|307264|P2|COMPLETED|Placebo-controlled Study (92012)||166
127571|NCT00185211|307265|P1|COMPLETED|Placebo-controlled Study (92012)||271
127572|NCT00185211|307264|P2|STARTED|Placebo-controlled Study (92012)||176
127573|NCT00185211|307265|P1|STARTED|Placebo-controlled Study (92012)||292
127574|NCT00191724|307295|P5|NOT COMPLETED|Overall Study||3
127575|NCT00191724|307296|P4|NOT COMPLETED|Overall Study||3
127576|NCT00191724|307297|P3|NOT COMPLETED|Overall Study||1
127577|NCT00191724|307298|P2|NOT COMPLETED|Overall Study||1
127578|NCT00191724|307299|P1|NOT COMPLETED|Overall Study||1
127579|NCT00191724|307295|P5|COMPLETED|Overall Study||12
127580|NCT00191724|307296|P4|COMPLETED|Overall Study||5
127581|NCT00191724|307297|P3|COMPLETED|Overall Study||8
127582|NCT00191724|307298|P2|COMPLETED|Overall Study||8
127583|NCT00191724|307299|P1|COMPLETED|Overall Study||5
127584|NCT00191724|307295|P5|STARTED|Overall Study||15
127585|NCT00191724|307296|P4|STARTED|Overall Study||8
127586|NCT00191724|307297|P3|STARTED|Overall Study||9
127587|NCT00191724|307298|P2|STARTED|Overall Study||9
127588|NCT00191724|307299|P1|STARTED|Overall Study||6
127589|NCT00191789|307326|P1|NOT COMPLETED|Overall Study||25
127590|NCT00191789|307326|P1|COMPLETED|Overall Study||40
127591|NCT00191789|307326|P1|STARTED|Overall Study||65
127592|NCT00191815|307338|P1|NOT COMPLETED|Overall Study||40
127593|NCT00191815|307338|P1|COMPLETED|Overall Study||30
127594|NCT00191815|307338|P1|Treated|Overall Study||67
127595|NCT00191815|307338|P1|STARTED|Overall Study||70
127596|NCT00191854|307353|P3|NOT COMPLETED|Overall Study||39
127597|NCT00191854|307354|P2|NOT COMPLETED|Overall Study||30
127598|NCT00191854|307355|P1|NOT COMPLETED|Overall Study||37
127599|NCT00191854|307353|P3|COMPLETED|Overall Study||12
127600|NCT00191854|307354|P2|COMPLETED|Overall Study||17
127601|NCT00191854|307355|P1|COMPLETED|Overall Study||12
127602|NCT00191854|307353|P3|Received at Least One Dose of Study Drug|Overall Study|Screen failure: discontinued prior to receiving study drug.|50
127603|NCT00191854|307354|P2|Received at Least One Dose of Study Drug|Overall Study||47
127604|NCT00191854|307355|P1|Received at Least One Dose of Study Drug|Overall Study||49
127605|NCT00191854|307353|P3|STARTED|Overall Study||51
127606|NCT00191854|307354|P2|STARTED|Overall Study||47
127607|NCT00191854|307355|P1|STARTED|Overall Study||49
127608|NCT00191906|307379|P4|NOT COMPLETED|Study Period III||0
127609|NCT00191906|307380|P3|NOT COMPLETED|Study Period III||0
127610|NCT00191906|307381|P2|NOT COMPLETED|Study Period III||4
127611|NCT00191906|307382|P1|NOT COMPLETED|Study Period III||5
127612|NCT00191906|307379|P4|COMPLETED|Study Period III||0
127613|NCT00191906|307380|P3|COMPLETED|Study Period III||0
127614|NCT00191906|307381|P2|COMPLETED|Study Period III||7
127615|NCT00191906|307382|P1|COMPLETED|Study Period III||9
127616|NCT00191906|307379|P4|STARTED|Study Period III||0
127617|NCT00191906|307380|P3|STARTED|Study Period III||0
127618|NCT00191906|307381|P2|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|11
127792|NCT00194129|307777|P2|NOT COMPLETED|Overall Study||13
127619|NCT00191906|307382|P1|STARTED|Study Period III|These are patients who continued in optional open-label period (1 country). All received atomoxetine|14
127620|NCT00191906|307379|P4|NOT COMPLETED|Study Period II||0
127621|NCT00191906|307380|P3|NOT COMPLETED|Study Period II||1
127622|NCT00191906|307381|P2|NOT COMPLETED|Study Period II||5
127623|NCT00191906|307382|P1|NOT COMPLETED|Study Period II||0
127624|NCT00191906|307379|P4|COMPLETED|Study Period II||18
127625|NCT00191906|307380|P3|COMPLETED|Study Period II||26
127626|NCT00191906|307381|P2|COMPLETED|Study Period II||32
127627|NCT00191906|307382|P1|COMPLETED|Study Period II||39
127628|NCT00191906|307379|P4|STARTED|Study Period II||18
127629|NCT00191906|307380|P3|STARTED|Study Period II||27
127630|NCT00191906|307381|P2|STARTED|Study Period II||37
127631|NCT00191906|307382|P1|STARTED|Study Period II||39
127632|NCT00191945|307424|P2|NOT COMPLETED|Open-Label Treatment Extension||0
127633|NCT00191945|307425|P1|NOT COMPLETED|Open-Label Treatment Extension||0
127634|NCT00191945|307424|P2|COMPLETED|Open-Label Treatment Extension||48
127635|NCT00191945|307425|P1|COMPLETED|Open-Label Treatment Extension||94
127636|NCT00191945|307424|P2|STARTED|Open-Label Treatment Extension||48
127637|NCT00191945|307425|P1|STARTED|Open-Label Treatment Extension||94
127638|NCT00191945|307424|P2|NOT COMPLETED|Double-Blind Acute Treatment||3
127639|NCT00191945|307425|P1|NOT COMPLETED|Double-Blind Acute Treatment||6
127640|NCT00191945|307424|P2|COMPLETED|Double-Blind Acute Treatment||48
127641|NCT00191945|307425|P1|COMPLETED|Double-Blind Acute Treatment||94
127642|NCT00191945|307424|P2|STARTED|Double-Blind Acute Treatment||51
127643|NCT00191945|307425|P1|STARTED|Double-Blind Acute Treatment||100
127644|NCT00191984|307457|P1|NOT COMPLETED|Overall Study||39
127645|NCT00191984|307457|P1|COMPLETED|Overall Study||7
127646|NCT00191984|307457|P1|STARTED|Overall Study||46
127647|NCT00192023|307467|P2|NOT COMPLETED|Period IV - Optional Open-Label||0
127648|NCT00192023|307468|P1|NOT COMPLETED|Period IV - Optional Open-Label||75
127649|NCT00192023|307467|P2|COMPLETED|Period IV - Optional Open-Label||0
127650|NCT00192023|307468|P1|COMPLETED|Period IV - Optional Open-Label||49
127651|NCT00192023|307467|P2|STARTED|Period IV - Optional Open-Label|Placebo patients received atomoxetine during the optional open-label period.|0
127652|NCT00192023|307468|P1|STARTED|Period IV - Optional Open-Label||124
127653|NCT00192023|307467|P2|NOT COMPLETED|Period III - Double-Blind||0
127654|NCT00192023|307468|P1|NOT COMPLETED|Period III - Double-Blind||7
127747|NCT00193453|307677|P1|STARTED|Overall Study||69
127655|NCT00192023|307467|P2|COMPLETED|Period III - Double-Blind|2 patients who completed the protocol did not enter the optional open-label period.|32
127656|NCT00192023|307468|P1|COMPLETED|Period III - Double-Blind|6 patients who completed the protocol did not enter optional open-label period.|100
127657|NCT00192023|307467|P2|STARTED|Period III - Double-Blind||32
127658|NCT00192023|307468|P1|STARTED|Period III - Double-Blind||107
127659|NCT00192036|307490|P1|NOT COMPLETED|Overall Study||21
127660|NCT00192036|307490|P1|COMPLETED|Overall Study||28
127661|NCT00192036|307490|P1|STARTED|Overall Study||49
127662|NCT00192075|307500|P2|NOT COMPLETED|Overall Study||19
127663|NCT00192075|307501|P1|NOT COMPLETED|Overall Study||39
127664|NCT00192075|307500|P2|COMPLETED|Overall Study||23
127665|NCT00192075|307501|P1|COMPLETED|Overall Study||3
127666|NCT00192075|307500|P2|STARTED|Overall Study||42
127667|NCT00192075|307501|P1|STARTED|Overall Study||42
127668|NCT00192296|307530|P4|NOT COMPLETED|Overall Study||0
127669|NCT00192296|307531|P3|NOT COMPLETED|Overall Study||0
127670|NCT00192296|307532|P2|NOT COMPLETED|Overall Study||1
127671|NCT00192296|307533|P1|NOT COMPLETED|Overall Study||0
127672|NCT00192296|307530|P4|COMPLETED|Overall Study||6
127673|NCT00192296|307531|P3|COMPLETED|Overall Study||6
127674|NCT00192296|307532|P2|COMPLETED|Overall Study||5
127675|NCT00192296|307533|P1|COMPLETED|Overall Study||6
127676|NCT00192296|307530|P4|STARTED|Overall Study||6
127677|NCT00192296|307531|P3|STARTED|Overall Study||6
127678|NCT00192296|307532|P2|STARTED|Overall Study||6
127679|NCT00192296|307533|P1|STARTED|Overall Study||6
127680|NCT00192647|307589|P2|NOT COMPLETED|Overall Study||146
127681|NCT00192647|307590|P1|NOT COMPLETED|Overall Study||128
127682|NCT00192647|307589|P2|COMPLETED|Overall Study||302
127683|NCT00192647|307590|P1|COMPLETED|Overall Study||320
127684|NCT00192647|307589|P2|Treated|Overall Study||438
127685|NCT00192647|307590|P1|Treated|Overall Study||433
127686|NCT00192647|307589|P2|STARTED|Overall Study||448
127687|NCT00192647|307590|P1|STARTED|Overall Study||448
127688|NCT00193037|307608|P2|NOT COMPLETED|Crossover Treatment||0
127689|NCT00193037|307609|P1|NOT COMPLETED|Crossover Treatment||0
127690|NCT00193037|307608|P2|COMPLETED|Crossover Treatment||24
127691|NCT00193037|307609|P1|COMPLETED|Crossover Treatment||32
127692|NCT00193037|307608|P2|STARTED|Crossover Treatment||24
127693|NCT00193037|307609|P1|STARTED|Crossover Treatment||32
127694|NCT00193037|307608|P2|NOT COMPLETED|Randomized Treatment||28
127695|NCT00193037|307609|P1|NOT COMPLETED|Randomized Treatment||18
127696|NCT00193037|307608|P2|COMPLETED|Randomized Treatment||24
127697|NCT00193037|307609|P1|COMPLETED|Randomized Treatment||32
127698|NCT00193037|307608|P2|STARTED|Randomized Treatment||52
127699|NCT00193037|307609|P1|STARTED|Randomized Treatment||50
127700|NCT00193050|307617|P1|NOT COMPLETED|Adjuvant||10
127701|NCT00193050|307617|P1|COMPLETED|Adjuvant||77
127702|NCT00193050|307617|P1|STARTED|Adjuvant|16 patients never initiated postoperative adjuvant therapy|87
127703|NCT00193050|307617|P1|NOT COMPLETED|Surgery||0
127704|NCT00193050|307617|P1|COMPLETED|Surgery||103
127705|NCT00193050|307617|P1|STARTED|Surgery|2 patients had surgery after 2 cycles of neoadjuvant treatment|103
127706|NCT00193050|307617|P1|NOT COMPLETED|Neoadjuvant Treatment||9
127707|NCT00193050|307617|P1|COMPLETED|Neoadjuvant Treatment||101
127708|NCT00193050|307617|P1|STARTED|Neoadjuvant Treatment||110
127709|NCT00193063|307621|P1|NOT COMPLETED|Overall Study||4
127710|NCT00193063|307621|P1|COMPLETED|Overall Study||37
127711|NCT00193063|307621|P1|STARTED|Overall Study||41
127712|NCT00193128|307629|P2|NOT COMPLETED|Overall Study||10
127713|NCT00193128|307630|P1|NOT COMPLETED|Overall Study||0
127714|NCT00193128|307629|P2|COMPLETED|Overall Study||39
127715|NCT00193128|307630|P1|COMPLETED|Overall Study||10
127716|NCT00193128|307629|P2|STARTED|Overall Study||49
127717|NCT00193128|307630|P1|STARTED|Overall Study||10
127718|NCT00193180|307636|P1|NOT COMPLETED|Overall Study||10
127719|NCT00193180|307636|P1|COMPLETED|Overall Study||27
127720|NCT00193180|307636|P1|STARTED|Overall Study||37
127721|NCT00193206|307642|P1|NOT COMPLETED|Postoperative Therapy||14
127722|NCT00193206|307642|P1|COMPLETED|Postoperative Therapy||102
127723|NCT00193206|307642|P1|STARTED|Postoperative Therapy||116
127724|NCT00193206|307642|P1|NOT COMPLETED|Surgery||0
127725|NCT00193206|307642|P1|COMPLETED|Surgery||116
127726|NCT00193206|307642|P1|STARTED|Surgery||116
127727|NCT00193206|307642|P1|NOT COMPLETED|Preoperative Therapy||7
127728|NCT00193206|307642|P1|COMPLETED|Preoperative Therapy||116
127729|NCT00193206|307642|P1|STARTED|Preoperative Therapy||123
127730|NCT00193219|307646|P1|NOT COMPLETED|Overall Study||30
127731|NCT00193219|307646|P1|COMPLETED|Overall Study||6
127732|NCT00193219|307646|P1|STARTED|Overall Study||36
127733|NCT00193258|307652|P1|NOT COMPLETED|Overall Study||0
127734|NCT00193258|307652|P1|COMPLETED|Overall Study||94
127735|NCT00193258|307652|P1|STARTED|Overall Study||94
127736|NCT00193375|307658|P1|NOT COMPLETED|Overall Study||19
127737|NCT00193375|307658|P1|COMPLETED|Overall Study||41
127738|NCT00193375|307658|P1|STARTED|Overall Study||60
127739|NCT00193414|307664|P1|NOT COMPLETED|Overall Study||58
127740|NCT00193414|307664|P1|COMPLETED|Overall Study||14
127741|NCT00193414|307664|P1|STARTED|Overall Study||72
127742|NCT00193427|307670|P1|NOT COMPLETED|Overall Study||49
127743|NCT00193427|307670|P1|COMPLETED|Overall Study||26
127744|NCT00193427|307670|P1|STARTED|Overall Study||75
127745|NCT00193453|307677|P1|NOT COMPLETED|Overall Study||48
127746|NCT00193453|307677|P1|COMPLETED|Overall Study||21
127748|NCT00193479|307683|P1|NOT COMPLETED|Maintenance Rituximab||0
127749|NCT00193479|307683|P1|COMPLETED|Maintenance Rituximab||44
127750|NCT00193479|307683|P1|STARTED|Maintenance Rituximab||44
127751|NCT00193479|307683|P1|NOT COMPLETED|Induction Chemotherapy||3
127752|NCT00193479|307683|P1|COMPLETED|Induction Chemotherapy||48
127753|NCT00193479|307683|P1|STARTED|Induction Chemotherapy||51
127754|NCT00193492|307689|P2|NOT COMPLETED|Overall Study||15
127755|NCT00193492|307690|P1|NOT COMPLETED|Overall Study||17
127756|NCT00193492|307689|P2|COMPLETED|Overall Study||14
127757|NCT00193492|307690|P1|COMPLETED|Overall Study||14
127758|NCT00193492|307689|P2|STARTED|Overall Study||29
127759|NCT00193492|307690|P1|STARTED|Overall Study||31
127760|NCT00193596|307700|P2|NOT COMPLETED|Overall Study||66
127761|NCT00193596|307701|P1|NOT COMPLETED|Overall Study||56
127762|NCT00193596|307700|P2|COMPLETED|Overall Study||39
127763|NCT00193596|307701|P1|COMPLETED|Overall Study||37
127764|NCT00193596|307700|P2|STARTED|Overall Study||105
127765|NCT00193596|307701|P1|STARTED|Overall Study||93
127766|NCT00193609|307709|P1|NOT COMPLETED|Overall Study||4
127767|NCT00193609|307709|P1|COMPLETED|Overall Study||44
127768|NCT00193609|307709|P1|STARTED|Overall Study||48
127769|NCT00194012|307716|P2|NOT COMPLETED|Open Label Extension (OLE)||6
127770|NCT00194012|307717|P1|NOT COMPLETED|Open Label Extension (OLE)||5
127771|NCT00194012|307716|P2|COMPLETED|Open Label Extension (OLE)||15
127772|NCT00194012|307717|P1|COMPLETED|Open Label Extension (OLE)||17
127773|NCT00194012|307716|P2|STARTED|Open Label Extension (OLE)|Participants from placebo group started OLE (eligible even if randomized period not completed).|21
127774|NCT00194012|307717|P1|STARTED|Open Label Extension (OLE)|Participants from aripiprazole group started OLE (eligible even if randomized period not completed).|22
127775|NCT00194012|307716|P2|NOT COMPLETED|Randomized Phase||25
127776|NCT00194012|307717|P1|NOT COMPLETED|Randomized Phase||16
127777|NCT00194012|307716|P2|COMPLETED|Randomized Phase||6
127778|NCT00194012|307717|P1|COMPLETED|Randomized Phase||15
127779|NCT00194012|307716|P2|Received More Than One Dose|Randomized Phase||29
127780|NCT00194012|307717|P1|Received More Than One Dose|Randomized Phase||30
127781|NCT00194012|307716|P2|STARTED|Randomized Phase||31
127782|NCT00194012|307717|P1|STARTED|Randomized Phase||31
127783|NCT00194025|307753|P1|NOT COMPLETED|Overall Study||5
127784|NCT00194025|307753|P1|COMPLETED|Overall Study|5 participants withdrew prematurely|15
127785|NCT00194025|307753|P1|STARTED|Overall Study|The intent-to-treat population received at least one dose of valproate semisodium.|20
127786|NCT00194077|307768|P2|NOT COMPLETED|Overall Study||30
127787|NCT00194077|307769|P1|NOT COMPLETED|Overall Study||24
127788|NCT00194077|307768|P2|COMPLETED|Overall Study|"Lack of efficacy:
hypomania n=17 Cycling n=6 Mania n=5 Mixed state n=1 Concern regarding tx n=1"|0
127789|NCT00194077|307769|P1|COMPLETED|Overall Study|"Lack of efficacy:
Hypomania n=12 Cycling n=5 Mixed state=4 Mania n=1"|6
127790|NCT00194077|307768|P2|STARTED|Overall Study||30
127791|NCT00194077|307769|P1|STARTED|Overall Study||30
127793|NCT00194129|307778|P1|NOT COMPLETED|Overall Study||10
127794|NCT00194129|307777|P2|COMPLETED|Overall Study||3
127795|NCT00194129|307778|P1|COMPLETED|Overall Study||5
127796|NCT00194129|307777|P2|STARTED|Overall Study||16
127797|NCT00194129|307778|P1|STARTED|Overall Study||15
127798|NCT00201448|307786|P2|NOT COMPLETED|Overall Study||0
127799|NCT00201448|307787|P1|NOT COMPLETED|Overall Study||0
127800|NCT00201448|307786|P2|COMPLETED|Overall Study||40
127801|NCT00201448|307787|P1|COMPLETED|Overall Study||42
127802|NCT00201448|307786|P2|STARTED|Overall Study||40
127803|NCT00201448|307787|P1|STARTED|Overall Study||42
127804|NCT00201643|307797|P2|NOT COMPLETED|Overall Study||4
127805|NCT00201643|307798|P1|NOT COMPLETED|Overall Study||5
127806|NCT00201643|307797|P2|COMPLETED|Overall Study||210
127807|NCT00201643|307798|P1|COMPLETED|Overall Study||218
127808|NCT00201643|307797|P2|STARTED|Overall Study||214
127809|NCT00201643|307798|P1|STARTED|Overall Study||223
127810|NCT00201734|307822|P2|NOT COMPLETED|Overall Study||0
127811|NCT00201734|307823|P1|NOT COMPLETED|Overall Study||3
127812|NCT00201734|307822|P2|COMPLETED|Overall Study||25
127813|NCT00201734|307823|P1|COMPLETED|Overall Study||29
127814|NCT00201734|307822|P2|Patients Not Evaluable|Overall Study||0
127815|NCT00201734|307823|P1|Patients Not Evaluable|Overall Study||3
127816|NCT00201734|307822|P2|STARTED|Overall Study||25
127817|NCT00201734|307823|P1|STARTED|Overall Study||32
127818|NCT00201773|307838|P1|NOT COMPLETED|Overall Study||6
127819|NCT00201773|307838|P1|COMPLETED|Overall Study||16
127820|NCT00201773|307838|P1|Stopped Exemestane After 4 Weeks|Overall Study||1
127821|NCT00201773|307838|P1|Received All Exemestane Therapy|Overall Study||5
127822|NCT00201773|307838|P1|Completed 8 Weeks of Planned Therapy|Overall Study||16
127823|NCT00201773|307838|P1|STARTED|Overall Study||22
127824|NCT00202449|307848|P3|NOT COMPLETED|Overall Study||12
127825|NCT00202449|307849|P2|NOT COMPLETED|Overall Study||11
127826|NCT00202449|307850|P1|NOT COMPLETED|Overall Study||11
127827|NCT00202449|307848|P3|COMPLETED|Overall Study||9
127828|NCT00202449|307849|P2|COMPLETED|Overall Study||9
127829|NCT00202449|307850|P1|COMPLETED|Overall Study||7
127830|NCT00202449|307848|P3|STARTED|Overall Study||21
127831|NCT00202449|307849|P2|STARTED|Overall Study||20
127832|NCT00202449|307850|P1|STARTED|Overall Study||18
127833|NCT00202722|307864|P1|NOT COMPLETED|Overall Study||0
127834|NCT00202722|307864|P1|COMPLETED|Overall Study||41
127835|NCT00202722|307864|P1|STARTED|Overall Study||41
127836|NCT00202839|307871|P2|NOT COMPLETED|Overall Study||10
127837|NCT00202839|307872|P1|NOT COMPLETED|Overall Study||24
127838|NCT00202839|307871|P2|COMPLETED|Overall Study||72
127839|NCT00202839|307872|P1|COMPLETED|Overall Study||54
127840|NCT00202839|307871|P2|STARTED|Overall Study||82
127841|NCT00202839|307872|P1|STARTED|Overall Study||78
127842|NCT00202878|307882|P2|NOT COMPLETED|Overall Study||2217
127843|NCT00202878|307883|P1|NOT COMPLETED|Overall Study||2199
127844|NCT00202878|307882|P2|COMPLETED|Overall Study||6860
127845|NCT00202878|307883|P1|COMPLETED|Overall Study||6868
127846|NCT00202878|307882|P2|STARTED|Overall Study||9077
127847|NCT00202878|307883|P1|STARTED|Overall Study||9067
127848|NCT00203047|307897|P2|NOT COMPLETED|Overall Study||203
127849|NCT00203047|307898|P1|NOT COMPLETED|Overall Study||191
127850|NCT00203047|307897|P2|COMPLETED|Overall Study||7
127851|NCT00203047|307898|P1|COMPLETED|Overall Study||13
127852|NCT00203047|307897|P2|In Database as of January 29, 2009|Overall Study||209
127853|NCT00203047|307898|P1|In Database as of January 29, 2009|Overall Study||199
127854|NCT00203047|307897|P2|STARTED|Overall Study||210
127855|NCT00203047|307898|P1|STARTED|Overall Study||204
127856|NCT00203203|307912|P2|NOT COMPLETED|Overall Study||0
127857|NCT00203203|307913|P1|NOT COMPLETED|Overall Study||1
127858|NCT00203203|307912|P2|COMPLETED|Overall Study||20
127859|NCT00203203|307913|P1|COMPLETED|Overall Study||9
127860|NCT00203203|307912|P2|STARTED|Overall Study||20
127861|NCT00203203|307913|P1|STARTED|Overall Study||10
127862|NCT00203216|307943|P1|NOT COMPLETED|Overall Study||4
127863|NCT00203216|307943|P1|COMPLETED|Overall Study||27
127864|NCT00203216|307943|P1|STARTED|Overall Study||31
127865|NCT00203229|307949|P2|NOT COMPLETED|Overall Study||3
127866|NCT00203229|307950|P1|NOT COMPLETED|Overall Study||3
127867|NCT00203229|307949|P2|COMPLETED|Overall Study||7
127868|NCT00203229|307950|P1|COMPLETED|Overall Study||7
127869|NCT00203229|307949|P2|STARTED|Overall Study||10
127870|NCT00203229|307950|P1|STARTED|Overall Study||10
127871|NCT00203242|307956|P1|NOT COMPLETED|Overall Study||1
127872|NCT00203242|307956|P1|COMPLETED|Overall Study||14
127873|NCT00203242|307956|P1|STARTED|Overall Study||15
127874|NCT00203268|307960|P1|NOT COMPLETED|Late Treatment||0
127875|NCT00203268|307960|P1|COMPLETED|Late Treatment||9
127876|NCT00203268|307960|P1|STARTED|Late Treatment||9
127877|NCT00203268|307960|P1|NOT COMPLETED|Early Treatment||4
127878|NCT00203268|307960|P1|COMPLETED|Early Treatment||9
127879|NCT00203268|307960|P1|STARTED|Early Treatment||13
127880|NCT00203294|307968|P2|NOT COMPLETED|Overall Study||13
127881|NCT00203294|307969|P1|NOT COMPLETED|Overall Study||8
127882|NCT00203294|307968|P2|COMPLETED|Overall Study||10
127883|NCT00203294|307969|P1|COMPLETED|Overall Study||14
127884|NCT00203294|307968|P2|STARTED|Overall Study||23
127885|NCT00203294|307969|P1|STARTED|Overall Study||22
127886|NCT00203307|307977|P2|NOT COMPLETED|Second Intervention||0
127887|NCT00203307|307978|P1|NOT COMPLETED|Second Intervention||0
127888|NCT00203307|307977|P2|COMPLETED|Second Intervention||0
127889|NCT00203307|307978|P1|COMPLETED|Second Intervention||1
127890|NCT00203307|307977|P2|STARTED|Second Intervention||0
127891|NCT00203307|307978|P1|STARTED|Second Intervention|2 subjects dropped out of the 1st intervention period, due to fatugue.|1
127892|NCT00203307|307977|P2|NOT COMPLETED|First Intervention||0
127893|NCT00203307|307978|P1|NOT COMPLETED|First Intervention||2
127894|NCT00203307|307977|P2|COMPLETED|First Intervention||0
127895|NCT00203307|307978|P1|COMPLETED|First Intervention||1
127896|NCT00203307|307977|P2|STARTED|First Intervention||0
127897|NCT00203307|307978|P1|STARTED|First Intervention|Double-blind cross-over design. Study terminated early. Results not analyzed.|3
127898|NCT00203411|307984|P1|NOT COMPLETED|Follow-up||4
127899|NCT00203411|307984|P1|COMPLETED|Follow-up||41
127900|NCT00203411|307984|P1|STARTED|Follow-up||45
127901|NCT00203411|307984|P1|NOT COMPLETED|Treatment Period||0
127902|NCT00203411|307984|P1|COMPLETED|Treatment Period||45
127903|NCT00203411|307984|P1|STARTED|Treatment Period||45
127904|NCT00203424|307991|P1|NOT COMPLETED|Follow-up Period||6
127905|NCT00203424|307991|P1|COMPLETED|Follow-up Period||10
127906|NCT00203424|307991|P1|STARTED|Follow-up Period|followup includes 11 pts that completed treatment + 5 pts who stopped treatment due to adverse event|16
127907|NCT00203424|307991|P1|NOT COMPLETED|Treatment Period||11
127908|NCT00203424|307991|P1|COMPLETED|Treatment Period|Of 11 pts that did not complete treatment,5 stopped due to adverse event and entered followup period|11
127909|NCT00203424|307991|P1|STARTED|Treatment Period|23 subjects registered for treatment, 1 withdrew consent after registration,22 received treatment.|22
127910|NCT00203476|308001|P3|NOT COMPLETED|Overall Study||0
127911|NCT00203476|308002|P2|NOT COMPLETED|Overall Study||1
127912|NCT00203476|308003|P1|NOT COMPLETED|Overall Study||1
127913|NCT00203476|308001|P3|COMPLETED|Overall Study||10
127914|NCT00203476|308002|P2|COMPLETED|Overall Study||9
127915|NCT00203476|308003|P1|COMPLETED|Overall Study||9
127916|NCT00203476|308001|P3|STARTED|Overall Study||10
127917|NCT00203476|308002|P2|STARTED|Overall Study||10
127918|NCT00203476|308003|P1|STARTED|Overall Study||10
127919|NCT00203502|308020|P1|NOT COMPLETED|Overall Study||1
127920|NCT00203502|308020|P1|COMPLETED|Overall Study||39
127921|NCT00203502|308020|P1|STARTED|Overall Study||40
127922|NCT00203892|308031|P3|NOT COMPLETED|Overall Study||0
127923|NCT00203892|308032|P2|NOT COMPLETED|Overall Study||2
127924|NCT00203892|308033|P1|NOT COMPLETED|Overall Study||2
127925|NCT00203892|308031|P3|COMPLETED|Overall Study||6
128274|NCT00211237|308621|P3|NOT COMPLETED|1 Month||0
127926|NCT00203892|308032|P2|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|8
127927|NCT00203892|308033|P1|COMPLETED|Overall Study|2 patients not completing study were randomized but never treated|5
127928|NCT00203892|308031|P3|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|4
127929|NCT00203892|308032|P2|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
127930|NCT00203892|308033|P1|Received at Least 3 Doses of CEA Vaccine|Overall Study|This group of patients were evaluable for the primary outcome.|5
127931|NCT00203892|308031|P3|STARTED|Overall Study||6
127932|NCT00203892|308032|P2|STARTED|Overall Study||10
127933|NCT00203892|308033|P1|STARTED|Overall Study||7
127934|NCT00203931|308046|P2|NOT COMPLETED|Overall Study||5
127935|NCT00203931|308047|P1|NOT COMPLETED|Overall Study||7
127936|NCT00203931|308046|P2|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|23
127937|NCT00203931|308047|P1|COMPLETED|Overall Study|These are the evaluable patients who received at least 3 doses of cetuximab.|20
127938|NCT00203931|308046|P2|STARTED|Overall Study||28
127939|NCT00203931|308047|P1|STARTED|Overall Study||27
127940|NCT00203996|308067|P10|NOT COMPLETED|Overall Study||1
127941|NCT00203996|308068|P9|NOT COMPLETED|Overall Study||0
127942|NCT00203996|308069|P8|NOT COMPLETED|Overall Study||2
127943|NCT00203996|308070|P7|NOT COMPLETED|Overall Study||0
127944|NCT00203996|308071|P6|NOT COMPLETED|Overall Study||0
127945|NCT00203996|308072|P5|NOT COMPLETED|Overall Study||1
127946|NCT00203996|308073|P4|NOT COMPLETED|Overall Study||10
127947|NCT00203996|308074|P3|NOT COMPLETED|Overall Study||0
127948|NCT00203996|308075|P2|NOT COMPLETED|Overall Study||0
127949|NCT00203996|308076|P1|NOT COMPLETED|Overall Study||0
127950|NCT00203996|308067|P10|COMPLETED|Overall Study||2
127951|NCT00203996|308068|P9|COMPLETED|Overall Study||2
127952|NCT00203996|308069|P8|COMPLETED|Overall Study||2
127953|NCT00203996|308070|P7|COMPLETED|Overall Study||2
127954|NCT00203996|308071|P6|COMPLETED|Overall Study||3
127955|NCT00203996|308072|P5|COMPLETED|Overall Study||3
127956|NCT00203996|308073|P4|COMPLETED|Overall Study||9
127957|NCT00203996|308074|P3|COMPLETED|Overall Study||0
127958|NCT00203996|308075|P2|COMPLETED|Overall Study||0
127959|NCT00203996|308076|P1|COMPLETED|Overall Study||0
127960|NCT00203996|308067|P10|Aim 3 Only: Third Intervention|Overall Study||2
127961|NCT00203996|308068|P9|Aim 3 Only: Third Intervention|Overall Study||2
127962|NCT00203996|308069|P8|Aim 3 Only: Third Intervention|Overall Study||2
127963|NCT00203996|308070|P7|Aim 3 Only: Third Intervention|Overall Study||2
127964|NCT00203996|308071|P6|Aim 3 Only: Third Intervention|Overall Study||3
127965|NCT00203996|308072|P5|Aim 3 Only: Third Intervention|Overall Study||0
127966|NCT00203996|308073|P4|Aim 3 Only: Third Intervention|Overall Study||0
127967|NCT00203996|308074|P3|Aim 3 Only: Third Intervention|Overall Study||0
127968|NCT00203996|308075|P2|Aim 3 Only: Third Intervention|Overall Study||0
127969|NCT00203996|308076|P1|Aim 3 Only: Third Intervention|Overall Study||0
127970|NCT00203996|308067|P10|Aim 3 Only: Second Washout|Overall Study||2
127971|NCT00203996|308068|P9|Aim 3 Only: Second Washout|Overall Study||2
127972|NCT00203996|308069|P8|Aim 3 Only: Second Washout|Overall Study||2
127973|NCT00203996|308070|P7|Aim 3 Only: Second Washout|Overall Study||2
127974|NCT00203996|308071|P6|Aim 3 Only: Second Washout|Overall Study||3
127975|NCT00203996|308072|P5|Aim 3 Only: Second Washout|Overall Study||0
127976|NCT00203996|308073|P4|Aim 3 Only: Second Washout|Overall Study||0
127977|NCT00203996|308074|P3|Aim 3 Only: Second Washout|Overall Study||0
127978|NCT00203996|308075|P2|Aim 3 Only: Second Washout|Overall Study||0
127979|NCT00203996|308076|P1|Aim 3 Only: Second Washout|Overall Study||0
127980|NCT00203996|308067|P10|Aim 3 Only: Second Intervention|Overall Study||2
127981|NCT00203996|308068|P9|Aim 3 Only: Second Intervention|Overall Study||2
127982|NCT00203996|308069|P8|Aim 3 Only: Second Intervention|Overall Study||2
127983|NCT00203996|308070|P7|Aim 3 Only: Second Intervention|Overall Study||2
127984|NCT00203996|308071|P6|Aim 3 Only: Second Intervention|Overall Study||3
127985|NCT00203996|308072|P5|Aim 3 Only: Second Intervention|Overall Study||0
127986|NCT00203996|308073|P4|Aim 3 Only: Second Intervention|Overall Study||0
127987|NCT00203996|308074|P3|Aim 3 Only: Second Intervention|Overall Study||0
127988|NCT00203996|308075|P2|Aim 3 Only: Second Intervention|Overall Study||0
127989|NCT00203996|308076|P1|Aim 3 Only: Second Intervention|Overall Study||0
127990|NCT00203996|308067|P10|Aim 3 Only: Washout|Overall Study||2
127991|NCT00203996|308068|P9|Aim 3 Only: Washout|Overall Study||2
127992|NCT00203996|308069|P8|Aim 3 Only: Washout|Overall Study||2
127993|NCT00203996|308070|P7|Aim 3 Only: Washout|Overall Study||2
127994|NCT00203996|308071|P6|Aim 3 Only: Washout|Overall Study||3
127995|NCT00203996|308072|P5|Aim 3 Only: Washout|Overall Study||0
127996|NCT00203996|308073|P4|Aim 3 Only: Washout|Overall Study||0
127997|NCT00203996|308074|P3|Aim 3 Only: Washout|Overall Study||0
127998|NCT00203996|308075|P2|Aim 3 Only: Washout|Overall Study||0
127999|NCT00203996|308076|P1|Aim 3 Only: Washout|Overall Study||0
128000|NCT00203996|308067|P10|Aim 3 Only: First Intervention|Overall Study||3
128001|NCT00203996|308068|P9|Aim 3 Only: First Intervention|Overall Study||2
128002|NCT00203996|308069|P8|Aim 3 Only: First Intervention|Overall Study||4
128003|NCT00203996|308070|P7|Aim 3 Only: First Intervention|Overall Study||2
128004|NCT00203996|308071|P6|Aim 3 Only: First Intervention|Overall Study||3
128005|NCT00203996|308072|P5|Aim 3 Only: First Intervention|Overall Study||0
128006|NCT00203996|308073|P4|Aim 3 Only: First Intervention|Overall Study||0
128007|NCT00203996|308074|P3|Aim 3 Only: First Intervention|Overall Study||0
128008|NCT00203996|308075|P2|Aim 3 Only: First Intervention|Overall Study||0
128009|NCT00203996|308076|P1|Aim 3 Only: First Intervention|Overall Study||0
128010|NCT00203996|308067|P10|STARTED|Overall Study||3
128011|NCT00203996|308068|P9|STARTED|Overall Study||2
128012|NCT00203996|308069|P8|STARTED|Overall Study||4
128013|NCT00203996|308070|P7|STARTED|Overall Study||2
128014|NCT00203996|308071|P6|STARTED|Overall Study||3
128015|NCT00203996|308072|P5|STARTED|Overall Study||4
128016|NCT00203996|308073|P4|STARTED|Overall Study||19
128017|NCT00203996|308074|P3|STARTED|Overall Study||0
128018|NCT00203996|308075|P2|STARTED|Overall Study||0
128019|NCT00203996|308076|P1|STARTED|Overall Study||0
128020|NCT00204373|308123|P1|NOT COMPLETED|Overall Study||0
128021|NCT00204373|308123|P1|COMPLETED|Overall Study||72
128022|NCT00204373|308123|P1|STARTED|Overall Study||72
128023|NCT00185588|308132|P4|NOT COMPLETED|Overall Study||4
128024|NCT00185588|308133|P3|NOT COMPLETED|Overall Study||6
128025|NCT00185588|308134|P2|NOT COMPLETED|Overall Study||2
128026|NCT00185588|308135|P1|NOT COMPLETED|Overall Study||3
128027|NCT00185588|308132|P4|COMPLETED|Overall Study||13
128028|NCT00185588|308133|P3|COMPLETED|Overall Study||0
128029|NCT00185588|308134|P2|COMPLETED|Overall Study||2
128030|NCT00185588|308135|P1|COMPLETED|Overall Study||3
128031|NCT00185588|308132|P4|STARTED|Overall Study||17
128032|NCT00185588|308133|P3|STARTED|Overall Study||6
128033|NCT00185588|308134|P2|STARTED|Overall Study||4
128034|NCT00185588|308135|P1|STARTED|Overall Study||6
128035|NCT00185679|308149|P1|NOT COMPLETED|Overall Study||0
128036|NCT00185679|308149|P1|COMPLETED|Overall Study||13
128037|NCT00185679|308149|P1|STARTED|Overall Study||13
128038|NCT00185692|308155|P1|NOT COMPLETED|Overall Study||16
128039|NCT00185692|308155|P1|COMPLETED|Overall Study||0
128040|NCT00185692|308155|P1|STARTED|Overall Study||16
128041|NCT00185965|308162|P2|NOT COMPLETED|Overall Study||1
128042|NCT00185965|308163|P1|NOT COMPLETED|Overall Study||0
128043|NCT00185965|308162|P2|COMPLETED|Overall Study||14
128044|NCT00185965|308163|P1|COMPLETED|Overall Study||15
128045|NCT00185965|308162|P2|STARTED|Overall Study||15
128046|NCT00185965|308163|P1|STARTED|Overall Study||15
128047|NCT00186017|308171|P2|NOT COMPLETED|Overall Study||3
128048|NCT00186017|308172|P1|NOT COMPLETED|Overall Study||2
128049|NCT00186017|308171|P2|COMPLETED|Overall Study||22
128050|NCT00186017|308172|P1|COMPLETED|Overall Study||23
128051|NCT00186017|308171|P2|STARTED|Overall Study||25
128052|NCT00186017|308172|P1|STARTED|Overall Study||25
128053|NCT00186056|308186|P2|NOT COMPLETED|Overall Study||1
128054|NCT00186056|308187|P1|NOT COMPLETED|Overall Study||2
128055|NCT00186056|308186|P2|COMPLETED|Overall Study||16
128056|NCT00186056|308187|P1|COMPLETED|Overall Study||12
128057|NCT00186056|308186|P2|STARTED|Overall Study||17
128058|NCT00186056|308187|P1|STARTED|Overall Study||14
128059|NCT00186069|308195|P2|NOT COMPLETED|Overall Study||0
128060|NCT00186069|308196|P1|NOT COMPLETED|Overall Study||0
128061|NCT00186069|308195|P2|COMPLETED|Overall Study||15
128062|NCT00186069|308196|P1|COMPLETED|Overall Study||15
128063|NCT00186069|308195|P2|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
128064|NCT00186069|308196|P1|STARTED|Overall Study|Enrollment goal was not reached due to the introduction of magnesium sulfate for neuroprotection|15
128065|NCT00186186|308206|P1|NOT COMPLETED|Overall Study||8
128066|NCT00186186|308206|P1|COMPLETED|Overall Study||20
128067|NCT00186186|308206|P1|STARTED|Overall Study||28
128068|NCT00197106|308213|P3|NOT COMPLETED|Overall Treatment Period||6
128069|NCT00197106|308214|P2|NOT COMPLETED|Overall Treatment Period||1
128070|NCT00197106|308215|P1|NOT COMPLETED|Overall Treatment Period||0
128071|NCT00197106|308213|P3|COMPLETED|Overall Treatment Period||74
128072|NCT00197106|308214|P2|COMPLETED|Overall Treatment Period||77
128073|NCT00197106|308215|P1|COMPLETED|Overall Treatment Period||0
128074|NCT00197106|308213|P3|STARTED|Overall Treatment Period||80
128075|NCT00197106|308214|P2|STARTED|Overall Treatment Period||78
128076|NCT00197106|308215|P1|STARTED|Overall Treatment Period||0
128077|NCT00197106|308213|P3|NOT COMPLETED|4-Week Run-In Period||0
128078|NCT00197106|308214|P2|NOT COMPLETED|4-Week Run-In Period||0
128079|NCT00197106|308215|P1|NOT COMPLETED|4-Week Run-In Period||99
128080|NCT00197106|308213|P3|COMPLETED|4-Week Run-In Period||0
128081|NCT00197106|308214|P2|COMPLETED|4-Week Run-In Period||0
128082|NCT00197106|308215|P1|COMPLETED|4-Week Run-In Period||158
128083|NCT00197106|308213|P3|STARTED|4-Week Run-In Period||0
128084|NCT00197106|308214|P2|STARTED|4-Week Run-In Period||0
128085|NCT00197106|308215|P1|STARTED|4-Week Run-In Period||257
128086|NCT00197119|308251|P2|NOT COMPLETED|Year 10||0
128087|NCT00197119|308252|P1|NOT COMPLETED|Year 10||0
128088|NCT00197119|308251|P2|COMPLETED|Year 10||108
128089|NCT00197119|308252|P1|COMPLETED|Year 10||120
128090|NCT00197119|308251|P2|STARTED|Year 10|Six subjects participating in the Year 9 time point did not return for the current time point.|108
128091|NCT00197119|308252|P1|STARTED|Year 10|One subject participating in the Year 9 time point did not return for the current time point.|120
128092|NCT00197119|308251|P2|NOT COMPLETED|Year 9||0
128093|NCT00197119|308252|P1|NOT COMPLETED|Year 9||0
128094|NCT00197119|308251|P2|COMPLETED|Year 9||114
128095|NCT00197119|308252|P1|COMPLETED|Year 9||121
128096|NCT00197119|308251|P2|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|114
128097|NCT00197119|308252|P1|STARTED|Year 9|One subject participating in the Year 8 time point did not return for the current time point.|121
128098|NCT00197119|308251|P2|NOT COMPLETED|Year 8||0
128099|NCT00197119|308252|P1|NOT COMPLETED|Year 8||0
128100|NCT00197119|308251|P2|COMPLETED|Year 8||115
128101|NCT00197119|308252|P1|COMPLETED|Year 8||122
128102|NCT00197119|308251|P2|STARTED|Year 8|One additional subject (compared to Year 7) participated in the current follow-up time point.|115
128103|NCT00197119|308252|P1|STARTED|Year 8||122
128104|NCT00197119|308251|P2|NOT COMPLETED|Year 7||0
128105|NCT00197119|308252|P1|NOT COMPLETED|Year 7||0
128106|NCT00197119|308251|P2|COMPLETED|Year 7||114
128107|NCT00197119|308252|P1|COMPLETED|Year 7||122
128108|NCT00197119|308251|P2|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|114
128109|NCT00197119|308252|P1|STARTED|Year 7|4 subjects who participated in the Year 6 follow-up time point did not return for this time point.|122
128110|NCT00197119|308251|P2|NOT COMPLETED|Year 6||0
128111|NCT00197119|308252|P1|NOT COMPLETED|Year 6||0
128112|NCT00197119|308251|P2|COMPLETED|Year 6||118
128113|NCT00197119|308252|P1|COMPLETED|Year 6||126
128114|NCT00197119|308251|P2|STARTED|Year 6||118
128115|NCT00197119|308252|P1|STARTED|Year 6||126
128116|NCT00197184|308264|P2|NOT COMPLETED|Overall Study||0
128117|NCT00197184|308265|P1|NOT COMPLETED|Overall Study||0
128118|NCT00197184|308264|P2|COMPLETED|Overall Study||137
128119|NCT00197184|308265|P1|COMPLETED|Overall Study||139
128120|NCT00197184|308264|P2|STARTED|Overall Study||137
128121|NCT00197184|308265|P1|STARTED|Overall Study||139
128122|NCT00197236|308290|P3|NOT COMPLETED|Overall Study||23
128123|NCT00197236|308291|P2|NOT COMPLETED|Overall Study||17
128124|NCT00197236|308292|P1|NOT COMPLETED|Overall Study||14
128125|NCT00197236|308290|P3|COMPLETED|Overall Study||109
128126|NCT00197236|308291|P2|COMPLETED|Overall Study||110
128127|NCT00197236|308292|P1|COMPLETED|Overall Study||121
128128|NCT00197236|308290|P3|STARTED|Overall Study||132
128129|NCT00197236|308291|P2|STARTED|Overall Study||127
128130|NCT00197236|308292|P1|STARTED|Overall Study||135
128131|NCT00197392|308341|P2|NOT COMPLETED|Overall Study||86
128132|NCT00197392|308342|P1|NOT COMPLETED|Overall Study||88
128133|NCT00197392|308341|P2|COMPLETED|Overall Study||134
128134|NCT00197392|308342|P1|COMPLETED|Overall Study||126
128135|NCT00197392|308341|P2|Per Protocol|Overall Study||134
128136|NCT00197392|308342|P1|Per Protocol|Overall Study||126
128137|NCT00197392|308341|P2|Evaluable|Overall Study||181
128138|NCT00197392|308342|P1|Evaluable|Overall Study||176
128139|NCT00197392|308341|P2|Modified Intent to Treat|Overall Study||210
128140|NCT00197392|308342|P1|Modified Intent to Treat|Overall Study||209
128141|NCT00197392|308341|P2|Safety Population|Overall Study||220
128142|NCT00197392|308342|P1|Safety Population|Overall Study||214
128143|NCT00197392|308341|P2|STARTED|Overall Study||220
128144|NCT00197392|308342|P1|STARTED|Overall Study||214
128145|NCT00197496|308373|P2|NOT COMPLETED|Follow-up||1
128146|NCT00197496|308374|P1|NOT COMPLETED|Follow-up||2
128147|NCT00197496|308373|P2|COMPLETED|Follow-up||4
128148|NCT00197496|308374|P1|COMPLETED|Follow-up||10
128149|NCT00197496|308373|P2|STARTED|Follow-up||5
128150|NCT00197496|308374|P1|STARTED|Follow-up||12
128151|NCT00197496|308373|P2|NOT COMPLETED|Baseline to Discharge||2
128152|NCT00197496|308374|P1|NOT COMPLETED|Baseline to Discharge||2
128153|NCT00197496|308373|P2|COMPLETED|Baseline to Discharge||5
128154|NCT00197496|308374|P1|COMPLETED|Baseline to Discharge||12
128155|NCT00197496|308373|P2|STARTED|Baseline to Discharge||7
128156|NCT00197496|308374|P1|STARTED|Baseline to Discharge||14
128157|NCT00198029|308387|P1|NOT COMPLETED|Overall Study||4
128158|NCT00198029|308387|P1|COMPLETED|Overall Study||28
128159|NCT00198029|308387|P1|STARTED|Overall Study||32
128160|NCT00198042|308392|P1|NOT COMPLETED|Overall Study||0
128161|NCT00198042|308392|P1|COMPLETED|Overall Study||18
128162|NCT00198042|308392|P1|STARTED|Overall Study||18
128163|NCT00198081|308398|P2|NOT COMPLETED|Overall Study||0
128164|NCT00198081|308399|P1|NOT COMPLETED|Overall Study||1
128165|NCT00198081|308398|P2|COMPLETED|Overall Study|No enrollment on this arm.|0
128166|NCT00198081|308399|P1|COMPLETED|Overall Study||4
128167|NCT00198081|308398|P2|STARTED|Overall Study|No enrollment on this arm.|0
128168|NCT00198081|308399|P1|STARTED|Overall Study|Eight (8) persons consented to participate but 3 withdrew prior to beginning protocol treatment.|5
128169|NCT00198133|308427|P2|NOT COMPLETED|Overall Study||8
128170|NCT00198133|308428|P1|NOT COMPLETED|Overall Study||5
128171|NCT00198133|308427|P2|COMPLETED|Overall Study||3
128172|NCT00198133|308428|P1|COMPLETED|Overall Study||11
128173|NCT00198133|308427|P2|STARTED|Overall Study||11
128174|NCT00198133|308428|P1|STARTED|Overall Study||16
128175|NCT00198822|308441|P3|NOT COMPLETED|Overall Study||21
128176|NCT00198822|308442|P2|NOT COMPLETED|Overall Study||20
128177|NCT00198822|308443|P1|NOT COMPLETED|Overall Study||14
128178|NCT00198822|308441|P3|COMPLETED|Overall Study|No. of consented pregnant women in beta-catorene arm with vital status known at 12 weeks postpartum|19998
128179|NCT00198822|308442|P2|COMPLETED|Overall Study|No. of consented pregnant women in vitamin A arm with vital status known at 12 weeks postpartum|19806
128180|NCT00198822|308443|P1|COMPLETED|Overall Study|No. of consented pregnant women in placebo arm with vital status known at 12 weeks postpartum|19862
128181|NCT00198822|308441|P3|STARTED|Overall Study|No. of consenting pregnant women in the beta-catorene arm of trial cohort|20019
128182|NCT00198822|308442|P2|STARTED|Overall Study|No. of consenting pregnant women in the vitamin A arm of trial cohort|19826
128183|NCT00198822|308443|P1|STARTED|Overall Study|No. of consenting pregnant women in the placebo arm of trial cohort|19876
128184|NCT00204932|308462|P2|NOT COMPLETED|Overall Study||6
128185|NCT00204932|308463|P1|NOT COMPLETED|Overall Study||2
128186|NCT00204932|308462|P2|COMPLETED|Overall Study||18
128187|NCT00204932|308463|P1|COMPLETED|Overall Study||22
128188|NCT00204932|308462|P2|STARTED|Overall Study||24
128189|NCT00204932|308463|P1|STARTED|Overall Study||24
128190|NCT00205049|308471|P2|NOT COMPLETED|Overall Study||0
128191|NCT00205049|308472|P1|NOT COMPLETED|Overall Study||0
128192|NCT00205049|308471|P2|COMPLETED|Overall Study||0
128193|NCT00205049|308472|P1|COMPLETED|Overall Study||0
128194|NCT00205049|308471|P2|STARTED|Overall Study||0
128195|NCT00205049|308472|P1|STARTED|Overall Study||0
128196|NCT00209339|308478|P1|NOT COMPLETED|At 5 Years Follow-up||8
128197|NCT00209339|308478|P1|COMPLETED|At 5 Years Follow-up||15
128198|NCT00209339|308478|P1|STARTED|At 5 Years Follow-up||23
128199|NCT00209339|308478|P1|NOT COMPLETED|At 4 Years Follow-up||5
128200|NCT00209339|308478|P1|COMPLETED|At 4 Years Follow-up||23
128201|NCT00209339|308478|P1|STARTED|At 4 Years Follow-up||28
128202|NCT00209339|308478|P1|NOT COMPLETED|At 3 Years Follow-up||1
128203|NCT00209339|308478|P1|COMPLETED|At 3 Years Follow-up||28
128204|NCT00209339|308478|P1|STARTED|At 3 Years Follow-up||29
128205|NCT00209339|308478|P1|NOT COMPLETED|At 24 Months Follow-up||11
128206|NCT00209339|308478|P1|COMPLETED|At 24 Months Follow-up||29
128207|NCT00209339|308478|P1|STARTED|At 24 Months Follow-up||40
128208|NCT00209339|308478|P1|NOT COMPLETED|At 12 Months Follow-up||15
128209|NCT00209339|308478|P1|COMPLETED|At 12 Months Follow-up||40
128210|NCT00209339|308478|P1|STARTED|At 12 Months Follow-up||55
128211|NCT00209417|308562|P2|NOT COMPLETED|Overall Study||0
128212|NCT00209417|308563|P1|NOT COMPLETED|Overall Study||0
128213|NCT00209417|308562|P2|COMPLETED|Overall Study||327
128214|NCT00209417|308563|P1|COMPLETED|Overall Study||321
128215|NCT00209417|308562|P2|STARTED|Overall Study||327
128216|NCT00209417|308563|P1|STARTED|Overall Study||321
128217|NCT00209560|308573|P2|NOT COMPLETED|Overall Study||0
128218|NCT00209560|308574|P1|NOT COMPLETED|Overall Study||1
128219|NCT00209560|308573|P2|COMPLETED|Overall Study||42
128220|NCT00209560|308574|P1|COMPLETED|Overall Study||120
128221|NCT00209560|308573|P2|STARTED|Overall Study||42
128222|NCT00209560|308574|P1|STARTED|Overall Study||121
128223|NCT00210470|308582|P1|NOT COMPLETED|Overall Study||1
128224|NCT00210470|308582|P1|COMPLETED|Overall Study||26
128225|NCT00210470|308582|P1|STARTED|Overall Study||27
128226|NCT00210626|308588|P2|NOT COMPLETED|Overall Study||45
128227|NCT00210626|308589|P1|NOT COMPLETED|Overall Study||48
128228|NCT00210626|308588|P2|COMPLETED|Overall Study||50
128229|NCT00210626|308589|P1|COMPLETED|Overall Study||49
128230|NCT00210626|308588|P2|STARTED|Overall Study||95
128231|NCT00210626|308589|P1|STARTED|Overall Study||97
128232|NCT00210639|308599|P2|NOT COMPLETED|Overall Study||42
128233|NCT00210639|308600|P1|NOT COMPLETED|Overall Study||63
128234|NCT00210639|308599|P2|COMPLETED|Overall Study||41
128235|NCT00210639|308600|P1|COMPLETED|Overall Study||61
128236|NCT00210639|308599|P2|STARTED|Overall Study||83
128237|NCT00210639|308600|P1|STARTED|Overall Study||124
128238|NCT00211081|308606|P1|NOT COMPLETED|Overall Study||2
128239|NCT00211081|308606|P1|COMPLETED|Overall Study|Study completed in 2008|10
128240|NCT00211081|308606|P1|STARTED|Overall Study|Study started in 2006|12
128241|NCT00211172|308612|P2|NOT COMPLETED|Overall Study||32
128242|NCT00211172|308613|P1|NOT COMPLETED|Overall Study||39
128243|NCT00211172|308612|P2|COMPLETED|Overall Study|32 patients died or lost health plan eligibility|426
128244|NCT00211172|308613|P1|COMPLETED|Overall Study|39 patients died or lost health plan eligibility|410
128245|NCT00211172|308612|P2|STARTED|Overall Study||458
128246|NCT00211172|308613|P1|STARTED|Overall Study||449
128247|NCT00211237|308621|P3|NOT COMPLETED|12 Months||6
128248|NCT00211237|308622|P2|NOT COMPLETED|12 Months||2
128249|NCT00211237|308623|P1|NOT COMPLETED|12 Months||9
128250|NCT00211237|308621|P3|COMPLETED|12 Months||28
128251|NCT00211237|308622|P2|COMPLETED|12 Months||6
128252|NCT00211237|308623|P1|COMPLETED|12 Months||40
128253|NCT00211237|308621|P3|STARTED|12 Months||34
128254|NCT00211237|308622|P2|STARTED|12 Months|1 patient crossed over Balloon Kyphoplasty|8
128255|NCT00211237|308623|P1|STARTED|12 Months||49
128256|NCT00211237|308621|P3|NOT COMPLETED|6 Months||3
128257|NCT00211237|308622|P2|NOT COMPLETED|6 Months||2
128258|NCT00211237|308623|P1|NOT COMPLETED|6 Months||8
128259|NCT00211237|308621|P3|COMPLETED|6 Months||33
128260|NCT00211237|308622|P2|COMPLETED|6 Months||9
128261|NCT00211237|308623|P1|COMPLETED|6 Months||49
128262|NCT00211237|308621|P3|STARTED|6 Months||36
128263|NCT00211237|308622|P2|STARTED|6 Months|3 patients crossed over Balloon Kyphoplasty|11
128264|NCT00211237|308623|P1|STARTED|6 Months||57
128265|NCT00211237|308621|P3|NOT COMPLETED|3 Months||1
128266|NCT00211237|308622|P2|NOT COMPLETED|3 Months||4
128267|NCT00211237|308623|P1|NOT COMPLETED|3 Months||8
128268|NCT00211237|308621|P3|COMPLETED|3 Months||33
128269|NCT00211237|308622|P2|COMPLETED|3 Months||14
128270|NCT00211237|308623|P1|COMPLETED|3 Months||57
128271|NCT00211237|308621|P3|STARTED|3 Months||34
128272|NCT00211237|308622|P2|STARTED|3 Months|34 patients crossed over to Balloon Kyphoplasty.|18
128273|NCT00211237|308623|P1|STARTED|3 Months||65
128275|NCT00211237|308622|P2|NOT COMPLETED|1 Month||9
128276|NCT00211237|308623|P1|NOT COMPLETED|1 Month||3
128277|NCT00211237|308621|P3|COMPLETED|1 Month||0
128278|NCT00211237|308622|P2|COMPLETED|1 Month||52
128279|NCT00211237|308623|P1|COMPLETED|1 Month||65
128280|NCT00211237|308621|P3|STARTED|1 Month||0
128281|NCT00211237|308622|P2|STARTED|1 Month||61
128282|NCT00211237|308623|P1|STARTED|1 Month||68
128283|NCT00211237|308621|P3|NOT COMPLETED|Baseline||0
128284|NCT00211237|308622|P2|NOT COMPLETED|Baseline||3
128285|NCT00211237|308623|P1|NOT COMPLETED|Baseline||2
128286|NCT00211237|308621|P3|COMPLETED|Baseline||0
128287|NCT00211237|308622|P2|COMPLETED|Baseline||61
128288|NCT00211237|308623|P1|COMPLETED|Baseline||68
128289|NCT00211237|308621|P3|STARTED|Baseline||0
128290|NCT00211237|308622|P2|STARTED|Baseline||64
128291|NCT00211237|308623|P1|STARTED|Baseline||70
128292|NCT00211510|308715|P2|NOT COMPLETED|Overall Study||2
128293|NCT00211510|308716|P1|NOT COMPLETED|Overall Study||6
128294|NCT00211510|308715|P2|COMPLETED|Overall Study||72
128295|NCT00211510|308716|P1|COMPLETED|Overall Study||66
128296|NCT00211510|308715|P2|STARTED|Overall Study||74
128297|NCT00211510|308716|P1|STARTED|Overall Study||72
128298|NCT00211536|308734|P2|NOT COMPLETED|Overall Study||7
128299|NCT00211536|308735|P1|NOT COMPLETED|Overall Study||4
128300|NCT00211536|308734|P2|COMPLETED|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|47
128301|NCT00211536|308735|P1|COMPLETED|Overall Study||49
128302|NCT00211536|308734|P2|As Treated Data Analysis Set|Overall Study||48
128303|NCT00211536|308735|P1|As Treated Data Analysis Set|Overall Study|This set includes all subjects followed to Visit 5 (90 days, first insulin refill for MIP group).|52
128304|NCT00211536|308734|P2|STARTED|Overall Study||54
128305|NCT00211536|308735|P1|STARTED|Overall Study||53
128306|NCT00211692|308751|P2|NOT COMPLETED|Overall Study||0
128307|NCT00211692|308752|P1|NOT COMPLETED|Overall Study||0
128308|NCT00211692|308751|P2|COMPLETED|Overall Study||31
128309|NCT00211692|308752|P1|COMPLETED|Overall Study||33
128310|NCT00211692|308751|P2|STARTED|Overall Study||31
128311|NCT00211692|308752|P1|STARTED|Overall Study||33
128312|NCT00185380|308763|P3|NOT COMPLETED|Overall Study||74
128313|NCT00185380|308764|P2|NOT COMPLETED|Overall Study||72
128314|NCT00185380|308765|P1|NOT COMPLETED|Overall Study||66
128315|NCT00185380|308763|P3|COMPLETED|Overall Study||182
128316|NCT00185380|308764|P2|COMPLETED|Overall Study||174
128317|NCT00185380|308765|P1|COMPLETED|Overall Study||174
128318|NCT00185380|308763|P3|Subjects Received Treatment|Overall Study||254
128319|NCT00185380|308764|P2|Subjects Received Treatment|Overall Study||245
128320|NCT00185380|308765|P1|Subjects Received Treatment|Overall Study||239
128321|NCT00185380|308763|P3|STARTED|Overall Study||256
128322|NCT00185380|308764|P2|STARTED|Overall Study||246
128323|NCT00185380|308765|P1|STARTED|Overall Study||240
128324|NCT00185458|308791|P1|NOT COMPLETED|HRT Phase||27
128325|NCT00185458|308791|P1|COMPLETED|HRT Phase||141
128326|NCT00185458|308791|P1|STARTED|HRT Phase|168 subjects were eligible for the HRT phase out 336 who completed contraception phase.|168
128327|NCT00185458|308791|P1|NOT COMPLETED|Contraception Phase||58
128328|NCT00185458|308791|P1|COMPLETED|Contraception Phase||336
128329|NCT00185458|308791|P1|STARTED|Contraception Phase||394
128330|NCT00201825|308851|P1|NOT COMPLETED|Overall Study||0
128331|NCT00201825|308851|P1|COMPLETED|Overall Study||29
128332|NCT00201825|308851|P1|STARTED|Overall Study||29
128333|NCT00201838|308860|P2|NOT COMPLETED|Overall Study||0
128334|NCT00201838|308861|P1|NOT COMPLETED|Overall Study||0
128335|NCT00201838|308860|P2|COMPLETED|Overall Study||8
128336|NCT00201838|308861|P1|COMPLETED|Overall Study||30
128337|NCT00201838|308860|P2|Treatment Cohort|Overall Study||8
128338|NCT00201838|308861|P1|Treatment Cohort|Overall Study||30
128339|NCT00201838|308860|P2|STARTED|Overall Study||8
128340|NCT00201838|308861|P1|STARTED|Overall Study||30
128341|NCT00201851|308878|P3|NOT COMPLETED|Overall Study||1
128342|NCT00201851|308879|P2|NOT COMPLETED|Overall Study||2
128343|NCT00201851|308880|P1|NOT COMPLETED|Overall Study||8
128344|NCT00201851|308878|P3|COMPLETED|Overall Study||230
128345|NCT00201851|308879|P2|COMPLETED|Overall Study||255
128346|NCT00201851|308880|P1|COMPLETED|Overall Study||244
128347|NCT00201851|308878|P3|STARTED|Overall Study||231
128348|NCT00201851|308879|P2|STARTED|Overall Study||257
128349|NCT00201851|308880|P1|STARTED|Overall Study||252
128350|NCT00201864|308888|P1|NOT COMPLETED|Overall Study||0
128351|NCT00201864|308888|P1|COMPLETED|Overall Study||40
128352|NCT00201864|308888|P1|STARTED|Overall Study||40
128353|NCT00201877|308896|P1|NOT COMPLETED|Overall Study||0
128354|NCT00201877|308896|P1|COMPLETED|Overall Study||25
128355|NCT00201877|308896|P1|STARTED|Overall Study||25
128356|NCT00211809|308902|P1|NOT COMPLETED|Overall Study||6
128357|NCT00211809|308902|P1|COMPLETED|Overall Study||11
128358|NCT00211809|308902|P1|STARTED|Overall Study||17
128359|NCT00211887|308919|P3|NOT COMPLETED|Overall Study||36
128360|NCT00211887|308920|P2|NOT COMPLETED|Overall Study||56
128361|NCT00211887|308921|P1|NOT COMPLETED|Overall Study||102
128362|NCT00211887|308919|P3|COMPLETED|Overall Study||223
128363|NCT00211887|308920|P2|COMPLETED|Overall Study||194
128364|NCT00211887|308921|P1|COMPLETED|Overall Study||397
128365|NCT00211887|308919|P3|STARTED|Overall Study||259
128366|NCT00211887|308920|P2|STARTED|Overall Study||250
128367|NCT00211887|308921|P1|STARTED|Overall Study||499
128368|NCT00212134|308940|P2|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||1
128369|NCT00212134|308941|P1|NOT COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||0
128370|NCT00212134|308940|P2|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)|Patient lost to follow-up.|56
128371|NCT00212134|308941|P1|COMPLETED|Phase 2 (Age 1 Year to Age 5 Years)||57
128372|NCT00212134|308940|P2|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
128373|NCT00212134|308941|P1|STARTED|Phase 2 (Age 1 Year to Age 5 Years)|Visual acuity assessment at Age 4.5 Years and final visit at Age 5 Years.|57
128374|NCT00212134|308940|P2|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
128375|NCT00212134|308941|P1|NOT COMPLETED|Phase 1 (to Age 1 Year)||0
128376|NCT00212134|308940|P2|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
128377|NCT00212134|308941|P1|COMPLETED|Phase 1 (to Age 1 Year)|Age 1 data collection visit|57
128378|NCT00212134|308940|P2|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
128379|NCT00212134|308941|P1|Complete First Endpoint at 1 Year|Phase 1 (to Age 1 Year)||57
128380|NCT00212134|308940|P2|STARTED|Phase 1 (to Age 1 Year)||57
128381|NCT00212134|308941|P1|STARTED|Phase 1 (to Age 1 Year)||57
128382|NCT00212758|308959|P2|NOT COMPLETED|Standard Therapy of GH (12 Months)||1
128383|NCT00212758|308960|P1|NOT COMPLETED|Standard Therapy of GH (12 Months)||2
128384|NCT00212758|308959|P2|COMPLETED|Standard Therapy of GH (12 Months)||8
128385|NCT00212758|308960|P1|COMPLETED|Standard Therapy of GH (12 Months)||6
128386|NCT00212758|308959|P2|STARTED|Standard Therapy of GH (12 Months)||9
128387|NCT00212758|308960|P1|STARTED|Standard Therapy of GH (12 Months)||8
128388|NCT00212758|308959|P2|NOT COMPLETED|Second Intervention (7 Days)||0
128389|NCT00212758|308960|P1|NOT COMPLETED|Second Intervention (7 Days)||0
128390|NCT00212758|308959|P2|COMPLETED|Second Intervention (7 Days)||9
128391|NCT00212758|308960|P1|COMPLETED|Second Intervention (7 Days)||8
128392|NCT00212758|308959|P2|STARTED|Second Intervention (7 Days)||9
128393|NCT00212758|308960|P1|STARTED|Second Intervention (7 Days)||8
128394|NCT00212758|308959|P2|NOT COMPLETED|Wash Out Period (2 Weeks)||0
128395|NCT00212758|308960|P1|NOT COMPLETED|Wash Out Period (2 Weeks)||0
128396|NCT00212758|308959|P2|COMPLETED|Wash Out Period (2 Weeks)||9
128397|NCT00212758|308960|P1|COMPLETED|Wash Out Period (2 Weeks)||8
128398|NCT00212758|308959|P2|STARTED|Wash Out Period (2 Weeks)||9
128399|NCT00212758|308960|P1|STARTED|Wash Out Period (2 Weeks)||8
128400|NCT00212758|308959|P2|NOT COMPLETED|First Intervention (7 Days)||0
128401|NCT00212758|308960|P1|NOT COMPLETED|First Intervention (7 Days)||0
128402|NCT00212758|308959|P2|COMPLETED|First Intervention (7 Days)||9
128403|NCT00212758|308960|P1|COMPLETED|First Intervention (7 Days)||8
128404|NCT00212758|308959|P2|STARTED|First Intervention (7 Days)||9
128405|NCT00212758|308960|P1|STARTED|First Intervention (7 Days)||8
128406|NCT00213135|308969|P3|NOT COMPLETED|Overall Study||57
128407|NCT00213135|308970|P2|NOT COMPLETED|Overall Study||35
128408|NCT00213135|308971|P1|NOT COMPLETED|Overall Study||50
128409|NCT00213135|308969|P3|COMPLETED|Overall Study||380
128410|NCT00213135|308970|P2|COMPLETED|Overall Study||398
128411|NCT00213135|308971|P1|COMPLETED|Overall Study||406
128412|NCT00213135|308969|P3|STARTED|Overall Study||437
128413|NCT00213135|308970|P2|STARTED|Overall Study||433
128414|NCT00213135|308971|P1|STARTED|Overall Study||456
128415|NCT00214019|308988|P1|NOT COMPLETED|Overall Study||30
128416|NCT00214019|308988|P1|COMPLETED|Overall Study||6
128417|NCT00214019|308988|P1|Fluticasone/Salmeterol Arm|Overall Study||6
128418|NCT00214019|308988|P1|Fluticasone/Placebo Arm|Overall Study||6
128419|NCT00214019|308988|P1|Placebo/Salmeterol Arm|Overall Study||6
128420|NCT00214019|308988|P1|Placebo/Placebo Arm|Overall Study||6
128421|NCT00214019|308988|P1|STARTED|Overall Study||36
128422|NCT00214201|308997|P2|NOT COMPLETED|Overall Study||2
128423|NCT00214201|308998|P1|NOT COMPLETED|Overall Study||2
128424|NCT00214201|308997|P2|COMPLETED|Overall Study||18
128425|NCT00214201|308998|P1|COMPLETED|Overall Study||18
128426|NCT00214201|308997|P2|STARTED|Overall Study||20
128427|NCT00214201|308998|P1|STARTED|Overall Study||20
128428|NCT00214383|309010|P2|NOT COMPLETED|Overall Study||26
128429|NCT00214383|309011|P1|NOT COMPLETED|Overall Study||16
128430|NCT00214383|309010|P2|COMPLETED|Overall Study||127
128431|NCT00214383|309011|P1|COMPLETED|Overall Study||132
128432|NCT00214383|309010|P2|STARTED|Overall Study||153
128433|NCT00214383|309011|P1|STARTED|Overall Study||148
128434|NCT00214461|309025|P4|NOT COMPLETED|Overall Study||1
128435|NCT00214461|309026|P3|NOT COMPLETED|Overall Study||2
128436|NCT00214461|309027|P2|NOT COMPLETED|Overall Study||0
128437|NCT00214461|309028|P1|NOT COMPLETED|Overall Study||0
128438|NCT00214461|309025|P4|COMPLETED|Overall Study||11
128439|NCT00214461|309026|P3|COMPLETED|Overall Study||10
128440|NCT00214461|309027|P2|COMPLETED|Overall Study||12
128441|NCT00214461|309028|P1|COMPLETED|Overall Study||12
128442|NCT00214461|309025|P4|STARTED|Overall Study||12
128443|NCT00214461|309026|P3|STARTED|Overall Study||12
128444|NCT00214461|309027|P2|STARTED|Overall Study||12
128445|NCT00214461|309028|P1|STARTED|Overall Study||12
128446|NCT00214487|309044|P2|NOT COMPLETED|Overall Study||3
128447|NCT00214487|309045|P1|NOT COMPLETED|Overall Study||5
128448|NCT00214487|309044|P2|COMPLETED|Overall Study||40
128449|NCT00214487|309045|P1|COMPLETED|Overall Study||38
128450|NCT00214487|309044|P2|STARTED|Overall Study||43
128451|NCT00214487|309045|P1|STARTED|Overall Study||43
128452|NCT00214526|309053|P2|NOT COMPLETED|Post-Treatment Period||0
128453|NCT00214526|309054|P1|NOT COMPLETED|Post-Treatment Period||1
128454|NCT00214526|309053|P2|COMPLETED|Post-Treatment Period||49
128455|NCT00214526|309054|P1|COMPLETED|Post-Treatment Period||52
128456|NCT00214526|309053|P2|STARTED|Post-Treatment Period||49
128457|NCT00214526|309054|P1|STARTED|Post-Treatment Period||53
128458|NCT00214526|309053|P2|NOT COMPLETED|Treatment Period||5
128459|NCT00214526|309054|P1|NOT COMPLETED|Treatment Period||2
128460|NCT00214526|309053|P2|COMPLETED|Treatment Period||49
128461|NCT00214526|309054|P1|COMPLETED|Treatment Period||53
128462|NCT00214526|309053|P2|STARTED|Treatment Period||54
128463|NCT00214526|309054|P1|STARTED|Treatment Period||55
128464|NCT00214526|309053|P2|NOT COMPLETED|Randomized||2
128465|NCT00214526|309054|P1|NOT COMPLETED|Randomized||1
128466|NCT00214526|309053|P2|COMPLETED|Randomized||54
128467|NCT00214526|309054|P1|COMPLETED|Randomized||55
128468|NCT00214526|309053|P2|STARTED|Randomized||56
128469|NCT00214526|309054|P1|STARTED|Randomized||56
128470|NCT00214539|309082|P2|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
128471|NCT00214539|309083|P1|NOT COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||0
128472|NCT00214539|309082|P2|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||17
128473|NCT00214539|309083|P1|COMPLETED|Reduced Steroid (Post-SS to 52-Weeks)||15
128474|NCT00214539|309082|P2|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||17
128475|NCT00214539|309083|P1|STARTED|Reduced Steroid (Post-SS to 52-Weeks)||15
128476|NCT00214539|309082|P2|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
128477|NCT00214539|309083|P1|NOT COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||0
128478|NCT00214539|309082|P2|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||17
128479|NCT00214539|309083|P1|COMPLETED|Steroid Stable (Post-Tx to 22-Weeks)||15
128480|NCT00214539|309082|P2|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||17
128481|NCT00214539|309083|P1|STARTED|Steroid Stable (Post-Tx to 22-Weeks)||15
128482|NCT00214539|309082|P2|NOT COMPLETED|Treatment Period||0
128483|NCT00214539|309083|P1|NOT COMPLETED|Treatment Period||0
128484|NCT00214539|309082|P2|COMPLETED|Treatment Period||17
128485|NCT00214539|309083|P1|COMPLETED|Treatment Period||15
128486|NCT00214539|309082|P2|STARTED|Treatment Period||17
128487|NCT00214539|309083|P1|STARTED|Treatment Period||15
128488|NCT00214539|309082|P2|NOT COMPLETED|Randomized||0
128489|NCT00214539|309083|P1|NOT COMPLETED|Randomized||2
128490|NCT00214539|309082|P2|COMPLETED|Randomized||17
128491|NCT00214539|309083|P1|COMPLETED|Randomized||15
128492|NCT00214539|309082|P2|STARTED|Randomized||17
128493|NCT00214539|309083|P1|STARTED|Randomized||17
128494|NCT00214786|309107|P1|NOT COMPLETED|Overall Study||3
128495|NCT00214786|309107|P1|COMPLETED|Overall Study||1
128496|NCT00214786|309107|P1|STARTED|Overall Study||4
128497|NCT00214903|309124|P4|NOT COMPLETED|Overall Study||0
128498|NCT00214903|309125|P3|NOT COMPLETED|Overall Study||0
128499|NCT00214903|309126|P2|NOT COMPLETED|Overall Study||0
128500|NCT00214903|309127|P1|NOT COMPLETED|Overall Study||0
128501|NCT00214903|309124|P4|COMPLETED|Overall Study||3057
128502|NCT00214903|309125|P3|COMPLETED|Overall Study||4113
128503|NCT00214903|309126|P2|COMPLETED|Overall Study||13384
128504|NCT00214903|309127|P1|COMPLETED|Overall Study||10043
128505|NCT00214903|309124|P4|STARTED|Overall Study||3057
128506|NCT00214903|309125|P3|STARTED|Overall Study||4113
128507|NCT00214903|309126|P2|STARTED|Overall Study||13384
128508|NCT00214903|309127|P1|STARTED|Overall Study||10043
128509|NCT00205374|309143|P2|NOT COMPLETED|Overall Study||0
128510|NCT00205374|309144|P1|NOT COMPLETED|Overall Study||0
128511|NCT00205374|309143|P2|COMPLETED|Overall Study||9
128512|NCT00205374|309144|P1|COMPLETED|Overall Study||10
128513|NCT00205374|309143|P2|STARTED|Overall Study||9
128514|NCT00205374|309144|P1|STARTED|Overall Study||10
128515|NCT00205504|309154|P2|NOT COMPLETED|Overall Study||0
128516|NCT00205504|309155|P1|NOT COMPLETED|Overall Study||7
128517|NCT00205504|309154|P2|COMPLETED|Overall Study||15
128518|NCT00205504|309155|P1|COMPLETED|Overall Study||14
128519|NCT00205504|309154|P2|STARTED|Overall Study||15
128520|NCT00205504|309155|P1|STARTED|Overall Study||21
128521|NCT00205712|309181|P2|NOT COMPLETED|Overall Study||1
128522|NCT00205712|309182|P1|NOT COMPLETED|Overall Study||0
128523|NCT00205712|309181|P2|COMPLETED|Overall Study||19
128524|NCT00205712|309182|P1|COMPLETED|Overall Study||20
128525|NCT00205712|309181|P2|STARTED|Overall Study||20
128526|NCT00205712|309182|P1|STARTED|Overall Study||20
128527|NCT00205777|309196|P6|NOT COMPLETED|Study Extension II||282
128528|NCT00205777|309197|P5|NOT COMPLETED|Study Extension II||0
128529|NCT00205777|309198|P4|NOT COMPLETED|Study Extension II||149
128530|NCT00205777|309199|P3|NOT COMPLETED|Study Extension II||0
128531|NCT00205777|309200|P2|NOT COMPLETED|Study Extension II||0
128532|NCT00205777|309201|P1|NOT COMPLETED|Study Extension II||0
128533|NCT00205777|309196|P6|COMPLETED|Study Extension II||860
128534|NCT00205777|309197|P5|COMPLETED|Study Extension II||0
128535|NCT00205777|309198|P4|COMPLETED|Study Extension II||441
128536|NCT00205777|309199|P3|COMPLETED|Study Extension II||0
128537|NCT00205777|309200|P2|COMPLETED|Study Extension II||0
128538|NCT00205777|309201|P1|COMPLETED|Study Extension II||0
128539|NCT00205777|309196|P6|TREATED|Study Extension II||1011
128540|NCT00205777|309197|P5|TREATED|Study Extension II||0
128541|NCT00205777|309198|P4|TREATED|Study Extension II||519
128542|NCT00205777|309199|P3|TREATED|Study Extension II||0
128543|NCT00205777|309200|P2|TREATED|Study Extension II||0
128544|NCT00205777|309201|P1|TREATED|Study Extension II||0
128545|NCT00205777|309196|P6|STARTED|Study Extension II||1142
128546|NCT00205777|309197|P5|STARTED|Study Extension II||0
128547|NCT00205777|309198|P4|STARTED|Study Extension II||590
128548|NCT00205777|309199|P3|STARTED|Study Extension II||0
128549|NCT00205777|309200|P2|STARTED|Study Extension II||0
128550|NCT00205777|309201|P1|STARTED|Study Extension II||0
128551|NCT00205777|309196|P6|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
128552|NCT00205777|309197|P5|NOT COMPLETED|Completed SE I, Entered Extension SE II||258
128553|NCT00205777|309198|P4|NOT COMPLETED|Completed SE I, Entered Extension SE II||240
128554|NCT00205777|309199|P3|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
128555|NCT00205777|309200|P2|NOT COMPLETED|Completed SE I, Entered Extension SE II||0
128556|NCT00205777|309201|P1|NOT COMPLETED|Completed SE I, Entered Extension SE II||273
128557|NCT00205777|309196|P6|COMPLETED|Completed SE I, Entered Extension SE II||0
128558|NCT00205777|309197|P5|COMPLETED|Completed SE I, Entered Extension SE II||582
128559|NCT00205777|309198|P4|COMPLETED|Completed SE I, Entered Extension SE II||590
128560|NCT00205777|309199|P3|COMPLETED|Completed SE I, Entered Extension SE II||0
128561|NCT00205777|309200|P2|COMPLETED|Completed SE I, Entered Extension SE II||0
128562|NCT00205777|309201|P1|COMPLETED|Completed SE I, Entered Extension SE II||560
128563|NCT00205777|309196|P6|STARTED|Completed SE I, Entered Extension SE II||0
128564|NCT00205777|309197|P5|STARTED|Completed SE I, Entered Extension SE II||840
128565|NCT00205777|309198|P4|STARTED|Completed SE I, Entered Extension SE II||830
128566|NCT00205777|309199|P3|STARTED|Completed SE I, Entered Extension SE II||0
128567|NCT00205777|309200|P2|STARTED|Completed SE I, Entered Extension SE II||0
128568|NCT00205777|309201|P1|STARTED|Completed SE I, Entered Extension SE II||833
128569|NCT00205777|309196|P6|NOT COMPLETED|Study Extension I||0
128570|NCT00205777|309197|P5|NOT COMPLETED|Study Extension I||201
128571|NCT00205777|309198|P4|NOT COMPLETED|Study Extension I||228
128572|NCT00205777|309199|P3|NOT COMPLETED|Study Extension I||1070
128573|NCT00205777|309200|P2|NOT COMPLETED|Study Extension I||0
128574|NCT00205777|309201|P1|NOT COMPLETED|Study Extension I||214
128575|NCT00205777|309196|P6|COMPLETED|Study Extension I||0
128576|NCT00205777|309197|P5|COMPLETED|Study Extension I||840
128577|NCT00205777|309198|P4|COMPLETED|Study Extension I||830
128578|NCT00205777|309199|P3|COMPLETED|Study Extension I||0
128579|NCT00205777|309200|P2|COMPLETED|Study Extension I||0
128580|NCT00205777|309201|P1|COMPLETED|Study Extension I||833
128581|NCT00205777|309196|P6|STARTED|Study Extension I||0
128582|NCT00205777|309197|P5|STARTED|Study Extension I||1041
128583|NCT00205777|309198|P4|STARTED|Study Extension I||1058
128584|NCT00205777|309199|P3|STARTED|Study Extension I||1070
128585|NCT00205777|309200|P2|STARTED|Study Extension I||0
128586|NCT00205777|309201|P1|STARTED|Study Extension I||1047
128587|NCT00205777|309196|P6|NOT COMPLETED|Completed Core Study, Entered SE I||0
128588|NCT00205777|309197|P5|NOT COMPLETED|Completed Core Study, Entered SE I||0
128589|NCT00205777|309198|P4|NOT COMPLETED|Completed Core Study, Entered SE I||224
128590|NCT00205777|309199|P3|NOT COMPLETED|Completed Core Study, Entered SE I||207
128591|NCT00205777|309200|P2|NOT COMPLETED|Completed Core Study, Entered SE I||204
128592|NCT00205777|309201|P1|NOT COMPLETED|Completed Core Study, Entered SE I||232
128593|NCT00205777|309196|P6|COMPLETED|Completed Core Study, Entered SE I||0
128594|NCT00205777|309197|P5|COMPLETED|Completed Core Study, Entered SE I||0
128595|NCT00205777|309198|P4|COMPLETED|Completed Core Study, Entered SE I||1058
128596|NCT00205777|309199|P3|COMPLETED|Completed Core Study, Entered SE I||1070
128597|NCT00205777|309200|P2|COMPLETED|Completed Core Study, Entered SE I||1041
128598|NCT00205777|309201|P1|COMPLETED|Completed Core Study, Entered SE I||1047
128599|NCT00205777|309196|P6|STARTED|Completed Core Study, Entered SE I||0
128600|NCT00205777|309197|P5|STARTED|Completed Core Study, Entered SE I||0
128601|NCT00205777|309198|P4|STARTED|Completed Core Study, Entered SE I||1282
128602|NCT00205777|309199|P3|STARTED|Completed Core Study, Entered SE I||1277
128603|NCT00205777|309200|P2|STARTED|Completed Core Study, Entered SE I||1245
128604|NCT00205777|309201|P1|STARTED|Completed Core Study, Entered SE I||1279
128605|NCT00205777|309196|P6|NOT COMPLETED|Core Study (Up to 3 Years)||0
128606|NCT00205777|309197|P5|NOT COMPLETED|Core Study (Up to 3 Years)||0
128607|NCT00205777|309198|P4|NOT COMPLETED|Core Study (Up to 3 Years)||632
128608|NCT00205777|309199|P3|NOT COMPLETED|Core Study (Up to 3 Years)||607
128609|NCT00205777|309200|P2|NOT COMPLETED|Core Study (Up to 3 Years)||659
128610|NCT00205777|309201|P1|NOT COMPLETED|Core Study (Up to 3 Years)||628
128611|NCT00205777|309196|P6|COMPLETED|Core Study (Up to 3 Years)||0
128612|NCT00205777|309197|P5|COMPLETED|Core Study (Up to 3 Years)||0
128613|NCT00205777|309198|P4|COMPLETED|Core Study (Up to 3 Years)||1282
128614|NCT00205777|309199|P3|COMPLETED|Core Study (Up to 3 Years)||1277
128615|NCT00205777|309200|P2|COMPLETED|Core Study (Up to 3 Years)||1245
128616|NCT00205777|309201|P1|COMPLETED|Core Study (Up to 3 Years)||1279
128617|NCT00205777|309196|P6|TREATED|Core Study (Up to 3 Years)||0
128618|NCT00205777|309197|P5|TREATED|Core Study (Up to 3 Years)||0
128619|NCT00205777|309198|P4|TREATED|Core Study (Up to 3 Years)||1885
128620|NCT00205777|309199|P3|TREATED|Core Study (Up to 3 Years)||1849
128621|NCT00205777|309200|P2|TREATED|Core Study (Up to 3 Years)||1872
128622|NCT00205777|309201|P1|TREATED|Core Study (Up to 3 Years)||1886
128623|NCT00205777|309196|P6|STARTED|Core Study (Up to 3 Years)||0
128624|NCT00205777|309197|P5|STARTED|Core Study (Up to 3 Years)||0
128625|NCT00205777|309198|P4|STARTED|Core Study (Up to 3 Years)||1914
128626|NCT00205777|309199|P3|STARTED|Core Study (Up to 3 Years)||1884
128627|NCT00205777|309200|P2|STARTED|Core Study (Up to 3 Years)||1904
128628|NCT00205777|309201|P1|STARTED|Core Study (Up to 3 Years)||1907
128629|NCT00205803|309410|P2|NOT COMPLETED|Toddler Dose||3
128630|NCT00205803|309411|P1|NOT COMPLETED|Toddler Dose||2
128631|NCT00205803|309410|P2|COMPLETED|Toddler Dose||100
128632|NCT00205803|309411|P1|COMPLETED|Toddler Dose||84
128633|NCT00205803|309410|P2|STARTED|Toddler Dose||103
128634|NCT00205803|309411|P1|STARTED|Toddler Dose||86
128635|NCT00205803|309410|P2|NOT COMPLETED|After Infant Series||13
128636|NCT00205803|309411|P1|NOT COMPLETED|After Infant Series||18
128637|NCT00205803|309410|P2|COMPLETED|After Infant Series||103
128638|NCT00205803|309411|P1|COMPLETED|After Infant Series||86
128639|NCT00205803|309410|P2|STARTED|After Infant Series||116
128640|NCT00205803|309411|P1|STARTED|After Infant Series||104
128641|NCT00205803|309410|P2|NOT COMPLETED|Infant Series||11
128642|NCT00205803|309411|P1|NOT COMPLETED|Infant Series||18
128643|NCT00205803|309410|P2|COMPLETED|Infant Series||116
128644|NCT00205803|309411|P1|COMPLETED|Infant Series||104
128645|NCT00205803|309410|P2|Vaccinated Dose 3|Infant Series||118
128646|NCT00205803|309411|P1|Vaccinated Dose 3|Infant Series||110
128647|NCT00205803|309410|P2|Vaccinated Dose 2|Infant Series||122
128648|NCT00205803|309411|P1|Vaccinated Dose 2|Infant Series||115
128649|NCT00205803|309410|P2|Vaccinated Dose 1|Infant Series||126
128650|NCT00205803|309411|P1|Vaccinated Dose 1|Infant Series||121
128651|NCT00205803|309410|P2|STARTED|Infant Series||127
128652|NCT00205803|309411|P1|STARTED|Infant Series||122
128653|NCT00205855|309463|P1|NOT COMPLETED|Overall Study||21
128654|NCT00205855|309463|P1|COMPLETED|Overall Study||44
128655|NCT00205855|309463|P1|STARTED|Overall Study||65
128656|NCT00205881|309467|P1|NOT COMPLETED|Overall Study||16
128657|NCT00205881|309467|P1|COMPLETED|Overall Study|32 enrolled. 1 unilateral. 25 bilateral for data analysis at 8 months. 16 completed study.|16
128658|NCT00205881|309467|P1|STARTED|Overall Study||32
128659|NCT00206076|309474|P2|NOT COMPLETED|Overall Study||1
128660|NCT00206076|309475|P1|NOT COMPLETED|Overall Study||3
128661|NCT00206076|309474|P2|COMPLETED|Overall Study||9
128662|NCT00206076|309475|P1|COMPLETED|Overall Study||6
128663|NCT00206076|309474|P2|STARTED|Overall Study||10
128664|NCT00206076|309475|P1|STARTED|Overall Study||9
128665|NCT00206102|309487|P2|NOT COMPLETED|Overall Study||315
128666|NCT00206102|309488|P1|NOT COMPLETED|Overall Study||408
128667|NCT00206102|309487|P2|COMPLETED|Overall Study||187
128668|NCT00206102|309488|P1|COMPLETED|Overall Study||188
128669|NCT00206102|309487|P2|STARTED|Overall Study||502
128670|NCT00206102|309488|P1|STARTED|Overall Study||596
128671|NCT00207090|309522|P1|NOT COMPLETED|Overall Study||7
128672|NCT00207090|309522|P1|COMPLETED|Overall Study||8
128673|NCT00207090|309522|P1|STARTED|Overall Study|Number of participants treated|15
128674|NCT00207142|309554|P4|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
128759|NCT00208325|309731|P1|COMPLETED|Overall Study||142
128675|NCT00207142|309555|P3|NOT COMPLETED|Maintenance Phase/Rescue Phase||13
128676|NCT00207142|309556|P2|NOT COMPLETED|Maintenance Phase/Rescue Phase||9
128677|NCT00207142|309557|P1|NOT COMPLETED|Maintenance Phase/Rescue Phase||0
128678|NCT00207142|309554|P4|COMPLETED|Maintenance Phase/Rescue Phase||41
128679|NCT00207142|309555|P3|COMPLETED|Maintenance Phase/Rescue Phase||72
128680|NCT00207142|309556|P2|COMPLETED|Maintenance Phase/Rescue Phase||78
128681|NCT00207142|309557|P1|COMPLETED|Maintenance Phase/Rescue Phase||0
128682|NCT00207142|309554|P4|STARTED|Maintenance Phase/Rescue Phase||50
128683|NCT00207142|309555|P3|STARTED|Maintenance Phase/Rescue Phase||85
128684|NCT00207142|309556|P2|STARTED|Maintenance Phase/Rescue Phase||87
128685|NCT00207142|309557|P1|STARTED|Maintenance Phase/Rescue Phase||0
128686|NCT00207142|309554|P4|NOT COMPLETED|Induction Phase||0
128687|NCT00207142|309555|P3|NOT COMPLETED|Induction Phase||0
128688|NCT00207142|309556|P2|NOT COMPLETED|Induction Phase||0
128689|NCT00207142|309557|P1|NOT COMPLETED|Induction Phase||30
128690|NCT00207142|309554|P4|COMPLETED|Induction Phase||0
128691|NCT00207142|309555|P3|COMPLETED|Induction Phase||0
128692|NCT00207142|309556|P2|COMPLETED|Induction Phase||0
128693|NCT00207142|309557|P1|COMPLETED|Induction Phase|Subjects randomized into Maintenance Phase=172 (87 ATV +85 ATV/RTV); Rescue Phase subjects=50|222
128694|NCT00207142|309554|P4|STARTED|Induction Phase||0
128695|NCT00207142|309555|P3|STARTED|Induction Phase||0
128696|NCT00207142|309556|P2|STARTED|Induction Phase||0
128697|NCT00207142|309557|P1|STARTED|Induction Phase||252
128698|NCT00207714|309599|P5|NOT COMPLETED|Overall Study||5
128699|NCT00207714|309600|P4|NOT COMPLETED|Overall Study||8
128700|NCT00207714|309601|P3|NOT COMPLETED|Overall Study||10
128701|NCT00207714|309602|P2|NOT COMPLETED|Overall Study||7
128702|NCT00207714|309603|P1|NOT COMPLETED|Overall Study||14
128703|NCT00207714|309599|P5|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|29
128704|NCT00207714|309600|P4|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|26
128705|NCT00207714|309601|P3|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|24
128706|NCT00207714|309602|P2|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|28
128707|NCT00207714|309603|P1|COMPLETED|Overall Study|Indicates number of participants who continued subcutaneous study agent at Wk 16|21
128708|NCT00207714|309599|P5|STARTED|Overall Study||34
128709|NCT00207714|309600|P4|STARTED|Overall Study||34
128710|NCT00207714|309601|P3|STARTED|Overall Study||34
128711|NCT00207714|309602|P2|STARTED|Overall Study||35
128712|NCT00207714|309603|P1|STARTED|Overall Study||35
128713|NCT00207727|309627|P5|NOT COMPLETED|Overall Study||34
128714|NCT00207727|309628|P4|NOT COMPLETED|Overall Study||37
128715|NCT00207727|309629|P3|NOT COMPLETED|Overall Study||41
128716|NCT00207727|309630|P2|NOT COMPLETED|Overall Study||42
128717|NCT00207727|309631|P1|NOT COMPLETED|Overall Study||38
128718|NCT00207727|309627|P5|COMPLETED|Overall Study||16
128719|NCT00207727|309628|P4|COMPLETED|Overall Study||13
128720|NCT00207727|309629|P3|COMPLETED|Overall Study||9
128721|NCT00207727|309630|P2|COMPLETED|Overall Study||8
128722|NCT00207727|309631|P1|COMPLETED|Overall Study||11
128723|NCT00207727|309627|P5|STARTED|Overall Study||50
128724|NCT00207727|309628|P4|STARTED|Overall Study||50
128725|NCT00207727|309629|P3|STARTED|Overall Study||50
128726|NCT00207727|309630|P2|STARTED|Overall Study||50
128727|NCT00207727|309631|P1|STARTED|Overall Study||49
128728|NCT00207740|309657|P4|NOT COMPLETED|Overall Study||43
128729|NCT00207740|309658|P3|NOT COMPLETED|Overall Study||40
128730|NCT00207740|309659|P2|NOT COMPLETED|Overall Study||41
128731|NCT00207740|309660|P1|NOT COMPLETED|Overall Study||29
128732|NCT00207740|309657|P4|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|35
128733|NCT00207740|309658|P3|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
128734|NCT00207740|309659|P2|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|36
128735|NCT00207740|309660|P1|COMPLETED|Overall Study|Indicates number of patients who received subcutaneous study medication through Week 52|49
128736|NCT00207740|309657|P4|STARTED|Overall Study||78
128737|NCT00207740|309658|P3|STARTED|Overall Study||76
128738|NCT00207740|309659|P2|STARTED|Overall Study||77
128739|NCT00207740|309660|P1|STARTED|Overall Study||78
128740|NCT00207883|309703|P2|NOT COMPLETED|Overall Study||0
128741|NCT00207883|309704|P1|NOT COMPLETED|Overall Study||0
128742|NCT00207883|309703|P2|COMPLETED|Overall Study||119
128743|NCT00207883|309704|P1|COMPLETED|Overall Study||93
128744|NCT00207883|309703|P2|STARTED|Overall Study||119
128745|NCT00207883|309704|P1|STARTED|Overall Study||93
128746|NCT00208026|309712|P1|NOT COMPLETED|Overall Study||0
128747|NCT00208026|309712|P1|COMPLETED|Overall Study||3
128748|NCT00208026|309712|P1|STARTED|Overall Study||3
128749|NCT00208091|309716|P1|NOT COMPLETED|Overall Study||0
128750|NCT00208091|309716|P1|COMPLETED|Overall Study||16
128751|NCT00208091|309716|P1|STARTED|Overall Study||16
128752|NCT00208325|309728|P4|NOT COMPLETED|Overall Study||14
128753|NCT00208325|309729|P3|NOT COMPLETED|Overall Study||14
128754|NCT00208325|309730|P2|NOT COMPLETED|Overall Study||54
128755|NCT00208325|309731|P1|NOT COMPLETED|Overall Study||51
128756|NCT00208325|309728|P4|COMPLETED|Overall Study||147
128757|NCT00208325|309729|P3|COMPLETED|Overall Study||156
128758|NCT00208325|309730|P2|COMPLETED|Overall Study||142
128760|NCT00208325|309728|P4|STARTED|Overall Study||161
128761|NCT00208325|309729|P3|STARTED|Overall Study||170
128762|NCT00208325|309730|P2|STARTED|Overall Study||196
128763|NCT00208325|309731|P1|STARTED|Overall Study||193
128764|NCT00208494|309841|P2|NOT COMPLETED|Overall Study||34
128765|NCT00208494|309842|P1|NOT COMPLETED|Overall Study||30
128766|NCT00208494|309841|P2|COMPLETED|Overall Study||162
128767|NCT00208494|309842|P1|COMPLETED|Overall Study||164
128768|NCT00208494|309841|P2|STARTED|Overall Study||196
128769|NCT00208494|309842|P1|STARTED|Overall Study||194
128770|NCT00208507|309850|P2|NOT COMPLETED|Overall Study||8
128771|NCT00208507|309851|P1|NOT COMPLETED|Overall Study||14
128772|NCT00208507|309850|P2|COMPLETED|Overall Study||79
128773|NCT00208507|309851|P1|COMPLETED|Overall Study||163
128774|NCT00208507|309850|P2|STARTED|Overall Study||87
128775|NCT00208507|309851|P1|STARTED|Overall Study||177
128776|NCT00208767|309859|P2|NOT COMPLETED|Overall Study||7
128777|NCT00208767|309860|P1|NOT COMPLETED|Overall Study||27
128778|NCT00208767|309859|P2|COMPLETED|Overall Study||33
128779|NCT00208767|309860|P1|COMPLETED|Overall Study||53
128780|NCT00208767|309859|P2|STARTED|Overall Study||40
128781|NCT00208767|309860|P1|STARTED|Overall Study||80
128782|NCT00208949|309868|P2|NOT COMPLETED|Overall Study||0
128783|NCT00208949|309869|P1|NOT COMPLETED|Overall Study||0
128784|NCT00208949|309868|P2|COMPLETED|Overall Study||25
128785|NCT00208949|309869|P1|COMPLETED|Overall Study||25
128786|NCT00208949|309868|P2|STARTED|Overall Study||25
128787|NCT00208949|309869|P1|STARTED|Overall Study||25
128788|NCT00208975|309877|P1|NOT COMPLETED|Overall Study||0
128789|NCT00208975|309877|P1|COMPLETED|Overall Study||15
128790|NCT00208975|309877|P1|STARTED|Overall Study||15
128791|NCT00209027|309884|P2|NOT COMPLETED|Overall Study||0
128792|NCT00209027|309885|P1|NOT COMPLETED|Overall Study||10
128793|NCT00209027|309884|P2|COMPLETED|Overall Study||10
128794|NCT00209027|309885|P1|COMPLETED|Overall Study||0
128795|NCT00209027|309884|P2|STARTED|Overall Study||10
128796|NCT00209027|309885|P1|STARTED|Overall Study||10
128797|NCT00209092|309893|P2|NOT COMPLETED|Overall Study||2
128798|NCT00209092|309894|P1|NOT COMPLETED|Overall Study||8
128799|NCT00209092|309893|P2|COMPLETED|Overall Study||24
128800|NCT00209092|309894|P1|COMPLETED|Overall Study||17
128801|NCT00209092|309893|P2|STARTED|Overall Study||26
128802|NCT00209092|309894|P1|STARTED|Overall Study||25
128803|NCT00209131|309904|P2|NOT COMPLETED|Overall Study||11
128804|NCT00209131|309905|P1|NOT COMPLETED|Overall Study||15
128805|NCT00209131|309904|P2|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
128806|NCT00209131|309905|P1|COMPLETED|Overall Study|Lack of personnel for adequate followup and data collection.|0
128807|NCT00209131|309904|P2|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|11
128808|NCT00209131|309905|P1|STARTED|Overall Study|Patients enrolled for participation but did not complete the study.|15
128809|NCT00209170|309915|P2|NOT COMPLETED|Overall Study||3
128810|NCT00209170|309916|P1|NOT COMPLETED|Overall Study||2
128811|NCT00209170|309915|P2|COMPLETED|Overall Study||4
128812|NCT00209170|309916|P1|COMPLETED|Overall Study||5
128813|NCT00209170|309915|P2|STARTED|Overall Study||7
128814|NCT00209170|309916|P1|STARTED|Overall Study||7
128815|NCT00215137|309922|P3|NOT COMPLETED|Randomization Period||0
128816|NCT00215137|309923|P2|NOT COMPLETED|Randomization Period||2
128817|NCT00215137|309924|P1|NOT COMPLETED|Randomization Period||0
128818|NCT00215137|309922|P3|COMPLETED|Randomization Period||5
128819|NCT00215137|309923|P2|COMPLETED|Randomization Period||5
128820|NCT00215137|309924|P1|COMPLETED|Randomization Period||0
128821|NCT00215137|309922|P3|STARTED|Randomization Period||5
128822|NCT00215137|309923|P2|STARTED|Randomization Period||7
128823|NCT00215137|309924|P1|STARTED|Randomization Period||0
128824|NCT00215137|309922|P3|NOT COMPLETED|Open Label Escitalopram||0
128825|NCT00215137|309923|P2|NOT COMPLETED|Open Label Escitalopram||0
128826|NCT00215137|309924|P1|NOT COMPLETED|Open Label Escitalopram||1
128827|NCT00215137|309922|P3|COMPLETED|Open Label Escitalopram||0
128828|NCT00215137|309923|P2|COMPLETED|Open Label Escitalopram||0
128829|NCT00215137|309924|P1|COMPLETED|Open Label Escitalopram||13
128830|NCT00215137|309922|P3|STARTED|Open Label Escitalopram||0
128831|NCT00215137|309923|P2|STARTED|Open Label Escitalopram||0
128832|NCT00215137|309924|P1|STARTED|Open Label Escitalopram||14
128833|NCT00215150|309932|P1|NOT COMPLETED|Randomization Phase Placebo||1
128834|NCT00215150|309932|P1|COMPLETED|Randomization Phase Placebo||10
128835|NCT00215150|309932|P1|STARTED|Randomization Phase Placebo||11
128836|NCT00215150|309932|P1|NOT COMPLETED|Randomization Phase Ziprasidone||3
128837|NCT00215150|309932|P1|COMPLETED|Randomization Phase Ziprasidone||7
128838|NCT00215150|309932|P1|STARTED|Randomization Phase Ziprasidone||10
128839|NCT00215150|309932|P1|NOT COMPLETED|Open Label Phase||30
128840|NCT00215150|309932|P1|COMPLETED|Open Label Phase||21
128841|NCT00215150|309932|P1|STARTED|Open Label Phase|Number of subjects consented|51
128842|NCT00215930|309940|P1|NOT COMPLETED|Overall Study||0
128843|NCT00215930|309940|P1|COMPLETED|Overall Study||53
128844|NCT00215930|309940|P1|STARTED|Overall Study||53
128845|NCT00215943|309948|P2|NOT COMPLETED|Overall Study||14
128846|NCT00215943|309949|P1|NOT COMPLETED|Overall Study||9
128847|NCT00215943|309948|P2|COMPLETED|Overall Study||23
128848|NCT00215943|309949|P1|COMPLETED|Overall Study||27
128849|NCT00215943|309948|P2|STARTED|Overall Study||37
128850|NCT00215943|309949|P1|STARTED|Overall Study||36
128851|NCT00216060|309963|P2|NOT COMPLETED|Overall Study||0
128852|NCT00216060|309964|P1|NOT COMPLETED|Overall Study||0
128853|NCT00216060|309963|P2|COMPLETED|Overall Study||31
128854|NCT00216060|309964|P1|COMPLETED|Overall Study||32
128855|NCT00216060|309963|P2|STARTED|Overall Study||31
128856|NCT00216060|309964|P1|STARTED|Overall Study||32
128857|NCT00216086|309984|P1|NOT COMPLETED|Overall Study||4
128858|NCT00216086|309984|P1|COMPLETED|Overall Study||18
128859|NCT00216086|309984|P1|STARTED|Overall Study||22
128860|NCT00216099|309991|P1|NOT COMPLETED|Overall Study||1
128861|NCT00216099|309991|P1|COMPLETED|Overall Study||48
128862|NCT00216099|309991|P1|Response Analysis|Overall Study||48
128863|NCT00216099|309991|P1|Toxicity Analysis|Overall Study||49
128864|NCT00216099|309991|P1|STARTED|Overall Study||49
128865|NCT00216125|310002|P3|NOT COMPLETED|Randomization Phase||8
128866|NCT00216125|310003|P2|NOT COMPLETED|Randomization Phase||11
128867|NCT00216125|310004|P1|NOT COMPLETED|Randomization Phase||0
128868|NCT00216125|310002|P3|COMPLETED|Randomization Phase||74
128869|NCT00216125|310003|P2|COMPLETED|Randomization Phase||73
128870|NCT00216125|310004|P1|COMPLETED|Randomization Phase||0
128871|NCT00216125|310002|P3|DSMB Cohort for Futility|Randomization Phase||74
128872|NCT00216125|310003|P2|DSMB Cohort for Futility|Randomization Phase||73
128873|NCT00216125|310004|P1|DSMB Cohort for Futility|Randomization Phase||0
128874|NCT00216125|310002|P3|STARTED|Randomization Phase||82
128875|NCT00216125|310003|P2|STARTED|Randomization Phase||84
128876|NCT00216125|310004|P1|STARTED|Randomization Phase||0
128877|NCT00216125|310002|P3|NOT COMPLETED|Pre-Randomization Phase||0
128878|NCT00216125|310003|P2|NOT COMPLETED|Pre-Randomization Phase||0
128879|NCT00216125|310004|P1|NOT COMPLETED|Pre-Randomization Phase||77
128880|NCT00216125|310002|P3|COMPLETED|Pre-Randomization Phase||0
128881|NCT00216125|310003|P2|COMPLETED|Pre-Randomization Phase||0
128882|NCT00216125|310004|P1|COMPLETED|Pre-Randomization Phase||166
128883|NCT00216125|310002|P3|DSMB Cohort for Futility|Pre-Randomization Phase||0
128884|NCT00216125|310003|P2|DSMB Cohort for Futility|Pre-Randomization Phase||0
128885|NCT00216125|310004|P1|DSMB Cohort for Futility|Pre-Randomization Phase||203
128886|NCT00216125|310002|P3|STARTED|Pre-Randomization Phase||0
128887|NCT00216125|310003|P2|STARTED|Pre-Randomization Phase||0
128888|NCT00216125|310004|P1|STARTED|Pre-Randomization Phase||243
128889|NCT00216203|310013|P1|NOT COMPLETED|Overall Study||2
128890|NCT00216203|310013|P1|COMPLETED|Overall Study||34
128891|NCT00216203|310013|P1|STARTED|Overall Study||36
128892|NCT00216320|310024|P3|NOT COMPLETED|Phase 2 (Weeks 6 -12)||1
128893|NCT00216320|310025|P2|NOT COMPLETED|Phase 2 (Weeks 6 -12)||4
128894|NCT00216320|310026|P1|NOT COMPLETED|Phase 2 (Weeks 6 -12)||5
128895|NCT00216320|310024|P3|COMPLETED|Phase 2 (Weeks 6 -12)||24
128896|NCT00216320|310025|P2|COMPLETED|Phase 2 (Weeks 6 -12)||31
128897|NCT00216320|310026|P1|COMPLETED|Phase 2 (Weeks 6 -12)||38
128898|NCT00216320|310024|P3|STARTED|Phase 2 (Weeks 6 -12)||25
128899|NCT00216320|310025|P2|STARTED|Phase 2 (Weeks 6 -12)||35
128900|NCT00216320|310026|P1|STARTED|Phase 2 (Weeks 6 -12)||43
128901|NCT00216320|310024|P3|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||5
128902|NCT00216320|310025|P2|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||4
128903|NCT00216320|310026|P1|NOT COMPLETED|Phase 1 (Weeks 0 - 6)||0
128904|NCT00216320|310024|P3|COMPLETED|Phase 1 (Weeks 0 - 6)||25
128905|NCT00216320|310025|P2|COMPLETED|Phase 1 (Weeks 0 - 6)||35
128906|NCT00216320|310026|P1|COMPLETED|Phase 1 (Weeks 0 - 6)||43
128907|NCT00216320|310024|P3|STARTED|Phase 1 (Weeks 0 - 6)||30
128908|NCT00216320|310025|P2|STARTED|Phase 1 (Weeks 0 - 6)||39
128909|NCT00216320|310026|P1|STARTED|Phase 1 (Weeks 0 - 6)||43
128910|NCT00216476|310043|P3|NOT COMPLETED|Overall Study||17
128911|NCT00216476|310044|P2|NOT COMPLETED|Overall Study||107
128912|NCT00216476|310045|P1|NOT COMPLETED|Overall Study||105
128913|NCT00216476|310043|P3|COMPLETED|Overall Study||28
128914|NCT00216476|310044|P2|COMPLETED|Overall Study||230
128915|NCT00216476|310045|P1|COMPLETED|Overall Study||224
128916|NCT00216476|310043|P3|STARTED|Overall Study||45
128917|NCT00216476|310044|P2|STARTED|Overall Study||337
128918|NCT00216476|310045|P1|STARTED|Overall Study||329
128919|NCT00216671|310064|P2|NOT COMPLETED|Overall Study||50
128920|NCT00216671|310065|P1|NOT COMPLETED|Overall Study||35
128921|NCT00216671|310064|P2|COMPLETED|Overall Study||60
128922|NCT00216671|310065|P1|COMPLETED|Overall Study||75
128923|NCT00216671|310064|P2|STARTED|Overall Study||110
128924|NCT00216671|310065|P1|STARTED|Overall Study||110
128925|NCT00216736|310083|P2|NOT COMPLETED|Overall Study||1
128926|NCT00216736|310084|P1|NOT COMPLETED|Overall Study||1
128927|NCT00216736|310083|P2|COMPLETED|Overall Study||30
128928|NCT00216736|310084|P1|COMPLETED|Overall Study||31
128929|NCT00216736|310083|P2|STARTED|Overall Study||31
128930|NCT00216736|310084|P1|STARTED|Overall Study||32
128931|NCT00217022|310098|P2|NOT COMPLETED|Overall Study||1
128932|NCT00217022|310099|P1|NOT COMPLETED|Overall Study||1
128933|NCT00217022|310098|P2|COMPLETED|Overall Study||3
128934|NCT00217022|310099|P1|COMPLETED|Overall Study||11
128935|NCT00217022|310098|P2|STARTED|Overall Study||4
128936|NCT00217022|310099|P1|STARTED|Overall Study||12
128937|NCT00217087|310109|P2|NOT COMPLETED|Overall Study||20
128938|NCT00217087|310110|P1|NOT COMPLETED|Overall Study||11
128939|NCT00217087|310109|P2|COMPLETED|Overall Study||17
128940|NCT00217087|310110|P1|COMPLETED|Overall Study||25
128941|NCT00217087|310109|P2|STARTED|Overall Study||37
128942|NCT00217087|310110|P1|STARTED|Overall Study||36
128943|NCT00217399|310122|P1|NOT COMPLETED|Overall Study||0
128944|NCT00217399|310122|P1|COMPLETED|Overall Study||35
128945|NCT00217399|310122|P1|STARTED|Overall Study||35
128946|NCT00217425|310128|P1|NOT COMPLETED|Overall Study||37
128947|NCT00217425|310128|P1|COMPLETED|Overall Study||9
128948|NCT00217425|310128|P1|Eligible and Treated|Overall Study||39
128949|NCT00217425|310128|P1|Treated|Overall Study||44
128950|NCT00217425|310128|P1|STARTED|Overall Study||46
128951|NCT00217438|310136|P2|NOT COMPLETED|Overall Study||1
128952|NCT00217438|310137|P1|NOT COMPLETED|Overall Study||0
128953|NCT00217438|310136|P2|COMPLETED|Overall Study|One patient did not complete Day 80-120 evaluation tests after returning to referring physician.|63
128954|NCT00217438|310137|P1|COMPLETED|Overall Study||66
128955|NCT00217438|310136|P2|STARTED|Overall Study||64
128956|NCT00217438|310137|P1|STARTED|Overall Study||66
128957|NCT00217464|310145|P1|NOT COMPLETED|Overall Study||17
128958|NCT00217464|310145|P1|COMPLETED|Overall Study||0
128959|NCT00217464|310145|P1|STARTED|Overall Study||17
128960|NCT00217490|310154|P4|NOT COMPLETED|Overall Study||23
128961|NCT00217490|310155|P3|NOT COMPLETED|Overall Study||24
128962|NCT00217490|310156|P2|NOT COMPLETED|Overall Study||25
128963|NCT00217490|310157|P1|NOT COMPLETED|Overall Study||17
128964|NCT00217490|310154|P4|COMPLETED|Overall Study||130
128965|NCT00217490|310155|P3|COMPLETED|Overall Study||131
128966|NCT00217490|310156|P2|COMPLETED|Overall Study||128
128967|NCT00217490|310157|P1|COMPLETED|Overall Study||137
128968|NCT00217490|310154|P4|STARTED|Overall Study||153
128969|NCT00217490|310155|P3|STARTED|Overall Study||155
128970|NCT00217490|310156|P2|STARTED|Overall Study||153
128971|NCT00217490|310157|P1|STARTED|Overall Study||154
128972|NCT00217581|310171|P1|NOT COMPLETED|Overall Study||1
128973|NCT00217581|310171|P1|COMPLETED|Overall Study||38
128974|NCT00217581|310171|P1|STARTED|Overall Study||39
128975|NCT00217620|310175|P1|NOT COMPLETED|Overall Study||51
128976|NCT00217620|310175|P1|COMPLETED|Overall Study||0
128977|NCT00217620|310175|P1|Eligible and Began Protocol Therapy|Overall Study||37
128978|NCT00217620|310175|P1|Eligible|Overall Study||38
128979|NCT00217620|310175|P1|STARTED|Overall Study||51
128980|NCT00217672|310186|P2|NOT COMPLETED|Follow-up||0
128981|NCT00217672|310187|P1|NOT COMPLETED|Follow-up||5
128982|NCT00217672|310186|P2|COMPLETED|Follow-up||0
128983|NCT00217672|310187|P1|COMPLETED|Follow-up||69
128984|NCT00217672|310186|P2|STARTED|Follow-up||0
129072|NCT00218335|310290|P2|6 Month Follow-up|Overall Study||99
128985|NCT00217672|310187|P1|STARTED|Follow-up|when bevacizumab became available, converted to a 1-arm open-label trial (67+7=74)|74
128986|NCT00217672|310186|P2|NOT COMPLETED|Treatment||7
128987|NCT00217672|310187|P1|NOT COMPLETED|Treatment||67
128988|NCT00217672|310186|P2|COMPLETED|Treatment||0
128989|NCT00217672|310187|P1|COMPLETED|Treatment||0
128990|NCT00217672|310186|P2|STARTED|Treatment|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
128991|NCT00217672|310187|P1|STARTED|Treatment||67
128992|NCT00217672|310186|P2|NOT COMPLETED|Allocation||0
128993|NCT00217672|310187|P1|NOT COMPLETED|Allocation||2
128994|NCT00217672|310186|P2|COMPLETED|Allocation||7
128995|NCT00217672|310187|P1|COMPLETED|Allocation||67
128996|NCT00217672|310186|P2|STARTED|Allocation|When bevacizumab became available, study converted to a 1-arm open-label trial with just bevacizumab|7
128997|NCT00217672|310187|P1|STARTED|Allocation||69
128998|NCT00217724|310193|P2|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||0
128999|NCT00217724|310194|P1|NOT COMPLETED|Course 2, (Glutamine/Placebo Crossover)||1
129000|NCT00217724|310193|P2|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||5
129001|NCT00217724|310194|P1|COMPLETED|Course 2, (Glutamine/Placebo Crossover)||8
129002|NCT00217724|310193|P2|STARTED|Course 2, (Glutamine/Placebo Crossover)||5
129003|NCT00217724|310194|P1|STARTED|Course 2, (Glutamine/Placebo Crossover)||9
129004|NCT00217724|310193|P2|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||1
129005|NCT00217724|310194|P1|NOT COMPLETED|Course 1, (Glutamine/Placebo Arms)||3
129006|NCT00217724|310193|P2|COMPLETED|Course 1, (Glutamine/Placebo Arms)||9
129007|NCT00217724|310194|P1|COMPLETED|Course 1, (Glutamine/Placebo Arms)||5
129008|NCT00217724|310193|P2|STARTED|Course 1, (Glutamine/Placebo Arms)||10
129009|NCT00217724|310194|P1|STARTED|Course 1, (Glutamine/Placebo Arms)||8
129010|NCT00217971|310204|P2|NOT COMPLETED|Overall Study||33
129011|NCT00217971|310205|P1|NOT COMPLETED|Overall Study||24
129012|NCT00217971|310204|P2|COMPLETED|Overall Study||44
129013|NCT00217971|310205|P1|COMPLETED|Overall Study||55
129014|NCT00217971|310204|P2|STARTED|Overall Study||77
129015|NCT00217971|310205|P1|STARTED|Overall Study||79
129016|NCT00218023|310215|P4|NOT COMPLETED|Overall Study||7
129017|NCT00218023|310216|P3|NOT COMPLETED|Overall Study||10
129018|NCT00218023|310217|P2|NOT COMPLETED|Overall Study||15
129019|NCT00218023|310218|P1|NOT COMPLETED|Overall Study||13
129020|NCT00218023|310215|P4|COMPLETED|Overall Study||11
129021|NCT00218023|310216|P3|COMPLETED|Overall Study||6
129022|NCT00218023|310217|P2|COMPLETED|Overall Study||10
129023|NCT00218023|310218|P1|COMPLETED|Overall Study||9
129024|NCT00218023|310215|P4|Received Drug or Placebo in Phase II|Overall Study||18
129025|NCT00218023|310216|P3|Received Drug or Placebo in Phase II|Overall Study||15
129026|NCT00218023|310217|P2|Received Drug or Placebo in Phase II|Overall Study||24
129027|NCT00218023|310218|P1|Received Drug or Placebo in Phase II|Overall Study||18
129028|NCT00218023|310215|P4|STARTED|Overall Study||18
129029|NCT00218023|310216|P3|STARTED|Overall Study||16
129030|NCT00218023|310217|P2|STARTED|Overall Study||25
129031|NCT00218023|310218|P1|STARTED|Overall Study||22
129032|NCT00218062|310236|P4|NOT COMPLETED|Overall Study||13
129033|NCT00218062|310237|P3|NOT COMPLETED|Overall Study||12
129034|NCT00218062|310238|P2|NOT COMPLETED|Overall Study||16
129035|NCT00218062|310239|P1|NOT COMPLETED|Overall Study||15
129036|NCT00218062|310236|P4|COMPLETED|Overall Study||3
129037|NCT00218062|310237|P3|COMPLETED|Overall Study||3
129038|NCT00218062|310238|P2|COMPLETED|Overall Study||4
129039|NCT00218062|310239|P1|COMPLETED|Overall Study||7
129040|NCT00218062|310236|P4|Received First Dose of Study Medication|Overall Study||12
129041|NCT00218062|310237|P3|Received First Dose of Study Medication|Overall Study||10
129042|NCT00218062|310238|P2|Received First Dose of Study Medication|Overall Study||11
129043|NCT00218062|310239|P1|Received First Dose of Study Medication|Overall Study||16
129044|NCT00218062|310236|P4|STARTED|Overall Study||16
129045|NCT00218062|310237|P3|STARTED|Overall Study||15
129046|NCT00218062|310238|P2|STARTED|Overall Study||20
129047|NCT00218062|310239|P1|STARTED|Overall Study||22
129048|NCT00218296|310267|P2|NOT COMPLETED|Overall Study||121
129049|NCT00218296|310268|P1|NOT COMPLETED|Overall Study||111
129050|NCT00218296|310267|P2|COMPLETED|Overall Study||48
129051|NCT00218296|310268|P1|COMPLETED|Overall Study||52
129052|NCT00218296|310267|P2|STARTED|Overall Study||169
129053|NCT00218296|310268|P1|STARTED|Overall Study||163
129054|NCT00218335|310288|P4|NOT COMPLETED|Overall Study||36
129055|NCT00218335|310289|P3|NOT COMPLETED|Overall Study||54
129056|NCT00218335|310290|P2|NOT COMPLETED|Overall Study||3
129057|NCT00218335|310291|P1|NOT COMPLETED|Overall Study||6
129058|NCT00218335|310288|P4|COMPLETED|Overall Study||388
129059|NCT00218335|310289|P3|COMPLETED|Overall Study||319
129060|NCT00218335|310290|P2|COMPLETED|Overall Study||110
129061|NCT00218335|310291|P1|COMPLETED|Overall Study||108
129062|NCT00218335|310288|P4|18 Month Follow-up|Overall Study||368
129063|NCT00218335|310289|P3|18 Month Follow-up|Overall Study||296
129064|NCT00218335|310290|P2|18 Month Follow-up|Overall Study||108
129065|NCT00218335|310291|P1|18 Month Follow-up|Overall Study||101
129066|NCT00218335|310288|P4|12 Month Follow-up|Overall Study||303
129067|NCT00218335|310289|P3|12 Month Follow-up|Overall Study||244
129068|NCT00218335|310290|P2|12 Month Follow-up|Overall Study||102
129069|NCT00218335|310291|P1|12 Month Follow-up|Overall Study||95
129070|NCT00218335|310288|P4|6 Month Follow-up|Overall Study||301
129071|NCT00218335|310289|P3|6 Month Follow-up|Overall Study||219
129073|NCT00218335|310291|P1|6 Month Follow-up|Overall Study||103
129074|NCT00218335|310288|P4|STARTED|Overall Study||424
129075|NCT00218335|310289|P3|STARTED|Overall Study||373
129076|NCT00218335|310290|P2|STARTED|Overall Study||113
129077|NCT00218335|310291|P1|STARTED|Overall Study||114
129078|NCT00206427|310353|P1|NOT COMPLETED|Overall Study||2
129079|NCT00206427|310353|P1|COMPLETED|Overall Study|Complete 6-week therapy|47
129080|NCT00206427|310353|P1|STARTED|Overall Study|Received First Dose|49
129081|NCT00206440|310359|P2|NOT COMPLETED|Overall Study||4
129082|NCT00206440|310360|P1|NOT COMPLETED|Overall Study||5
129083|NCT00206440|310359|P2|COMPLETED|Overall Study||18
129084|NCT00206440|310360|P1|COMPLETED|Overall Study||16
129085|NCT00206440|310359|P2|STARTED|Overall Study||22
129086|NCT00206440|310360|P1|STARTED|Overall Study||21
129087|NCT00206518|310368|P2|NOT COMPLETED|Overall Study||6
129088|NCT00206518|310369|P1|NOT COMPLETED|Overall Study||10
129089|NCT00206518|310368|P2|COMPLETED|Overall Study||78
129090|NCT00206518|310369|P1|COMPLETED|Overall Study||73
129091|NCT00206518|310368|P2|STARTED|Overall Study||84
129092|NCT00206518|310369|P1|STARTED|Overall Study||83
129093|NCT00206726|310379|P1|NOT COMPLETED|Overall Study||51
129094|NCT00206726|310379|P1|COMPLETED|Overall Study|4-6 cycles of treatment with assessments at 2, 6, and 9 months post last dose|9
129095|NCT00206726|310379|P1|4 Cycles Completed|Overall Study|per protocol population|41
129096|NCT00206726|310379|P1|Treatment Started|Overall Study|Safety population (3 withdrew consent prior to receiving study drug)|57
129097|NCT00206726|310379|P1|STARTED|Overall Study||60
129098|NCT00212264|310391|P3|NOT COMPLETED|Overall Study||4
129099|NCT00212264|310392|P2|NOT COMPLETED|Overall Study||16
129100|NCT00212264|310393|P1|NOT COMPLETED|Overall Study||12
129101|NCT00212264|310391|P3|COMPLETED|Overall Study||64
129102|NCT00212264|310392|P2|COMPLETED|Overall Study||54
129103|NCT00212264|310393|P1|COMPLETED|Overall Study||58
129104|NCT00212264|310391|P3|STARTED|Overall Study||68
129105|NCT00212264|310392|P2|STARTED|Overall Study||70
129106|NCT00212264|310393|P1|STARTED|Overall Study||70
129107|NCT00212355|310403|P1|NOT COMPLETED|Overall Study||3
129108|NCT00212355|310403|P1|COMPLETED|Overall Study||34
129109|NCT00212355|310403|P1|STARTED|Overall Study||37
129110|NCT00218439|310409|P2|NOT COMPLETED|Second Intervention (4 Weeks)||5
129111|NCT00218439|310410|P1|NOT COMPLETED|Second Intervention (4 Weeks)||7
129112|NCT00218439|310409|P2|COMPLETED|Second Intervention (4 Weeks)||30
129113|NCT00218439|310410|P1|COMPLETED|Second Intervention (4 Weeks)||33
129114|NCT00218439|310409|P2|STARTED|Second Intervention (4 Weeks)||35
129115|NCT00218439|310410|P1|STARTED|Second Intervention (4 Weeks)||40
129116|NCT00218439|310409|P2|NOT COMPLETED|First Intervention (4 Weeks)||12
129117|NCT00218439|310410|P1|NOT COMPLETED|First Intervention (4 Weeks)||18
129118|NCT00218439|310409|P2|COMPLETED|First Intervention (4 Weeks)||35
129119|NCT00218439|310410|P1|COMPLETED|First Intervention (4 Weeks)||40
129120|NCT00218439|310409|P2|STARTED|First Intervention (4 Weeks)||47
129121|NCT00218439|310410|P1|STARTED|First Intervention (4 Weeks)||58
129122|NCT00218465|310426|P2|NOT COMPLETED|Overall Study||18
129123|NCT00218465|310427|P1|NOT COMPLETED|Overall Study||17
129124|NCT00218465|310426|P2|COMPLETED|Overall Study||30
129125|NCT00218465|310427|P1|COMPLETED|Overall Study||33
129126|NCT00218465|310426|P2|STARTED|Overall Study||48
129127|NCT00218465|310427|P1|STARTED|Overall Study||50
129128|NCT00218543|310437|P1|NOT COMPLETED|Overall Study||15
129129|NCT00218543|310437|P1|COMPLETED|Overall Study|13 reached the maintenance dose phase of treatment; 9 completed at least six weeks of treatment.|5
129130|NCT00218543|310437|P1|STARTED|Overall Study||20
129131|NCT00218634|310444|P2|NOT COMPLETED|Overall Study||15
129132|NCT00218634|310445|P1|NOT COMPLETED|Overall Study||8
129133|NCT00218634|310444|P2|COMPLETED|Overall Study||30
129134|NCT00218634|310445|P1|COMPLETED|Overall Study||36
129135|NCT00218634|310444|P2|STARTED|Overall Study||45
129136|NCT00218634|310445|P1|STARTED|Overall Study||44
129137|NCT00222105|310465|P1|NOT COMPLETED|Overall Study||14
129138|NCT00222105|310465|P1|COMPLETED|Overall Study||11
129139|NCT00222105|310465|P1|STARTED|Overall Study||25
129140|NCT00222729|310470|P1|NOT COMPLETED|Overall Study||3
129141|NCT00222729|310470|P1|COMPLETED|Overall Study||37
129142|NCT00222729|310470|P1|STARTED|Overall Study||40
129143|NCT00223236|310479|P2|NOT COMPLETED|Overall Study||14
129144|NCT00223236|310480|P1|NOT COMPLETED|Overall Study||7
129145|NCT00223236|310479|P2|COMPLETED|Overall Study|4 completed 12 week trial.|4
129146|NCT00223236|310480|P1|COMPLETED|Overall Study|9 completed 12 week trial.|9
129147|NCT00223236|310479|P2|STARTED|Overall Study|21 completed baseline assessment but 18 completed at least one treatment visit.|18
129148|NCT00223236|310480|P1|STARTED|Overall Study|23 completed baseline assessment but 16 completed at least one treatment visit.|16
129149|NCT00223496|310492|P1|NOT COMPLETED|Overall Study||22
129150|NCT00223496|310492|P1|COMPLETED|Overall Study||10
129151|NCT00223496|310492|P1|STARTED|Overall Study|32 people consented, 19 were baselined|32
129152|NCT00223652|310498|P2|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||4
129153|NCT00223652|310499|P1|NOT COMPLETED|T-CBT and TAU 6 Month Follow-up||1
129154|NCT00223652|310498|P2|COMPLETED|T-CBT and TAU 6 Month Follow-up||37
129155|NCT00223652|310499|P1|COMPLETED|T-CBT and TAU 6 Month Follow-up||39
129156|NCT00223652|310498|P2|STARTED|T-CBT and TAU 6 Month Follow-up||41
129157|NCT00223652|310499|P1|STARTED|T-CBT and TAU 6 Month Follow-up||40
129158|NCT00223652|310498|P2|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
129159|NCT00223652|310499|P1|NOT COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||0
129160|NCT00223652|310498|P2|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||41
129161|NCT00223652|310499|P1|COMPLETED|T-CBT 20 Weeks, TAU 20 Weeks||40
129162|NCT00223652|310498|P2|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||41
129163|NCT00223652|310499|P1|STARTED|T-CBT 20 Weeks, TAU 20 Weeks||40
129164|NCT00223652|310498|P2|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||3
129165|NCT00223652|310499|P1|NOT COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||1
129166|NCT00223652|310498|P2|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||41
129167|NCT00223652|310499|P1|COMPLETED|T-CBT 12 Weeks, TAU 20 Weeks||40
129168|NCT00223652|310498|P2|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||44
129169|NCT00223652|310499|P1|STARTED|T-CBT 12 Weeks, TAU 20 Weeks||41
129170|NCT00223678|310517|P2|NOT COMPLETED|Overall Study||0
129171|NCT00223678|310518|P1|NOT COMPLETED|Overall Study||0
129172|NCT00223678|310517|P2|COMPLETED|Overall Study||7
129173|NCT00223678|310518|P1|COMPLETED|Overall Study||13
129174|NCT00223678|310517|P2|STARTED|Overall Study||7
129175|NCT00223678|310518|P1|STARTED|Overall Study||13
129176|NCT00223704|310527|P3|NOT COMPLETED|Overall Study||0
129177|NCT00223704|310528|P2|NOT COMPLETED|Overall Study||0
129178|NCT00223704|310529|P1|NOT COMPLETED|Overall Study||0
129179|NCT00223704|310527|P3|COMPLETED|Overall Study||40
129180|NCT00223704|310528|P2|COMPLETED|Overall Study||37
129181|NCT00223704|310529|P1|COMPLETED|Overall Study||38
129182|NCT00223704|310527|P3|STARTED|Overall Study||40
129183|NCT00223704|310528|P2|STARTED|Overall Study||37
129184|NCT00223704|310529|P1|STARTED|Overall Study||38
129185|NCT00223795|310549|P2|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
129186|NCT00223795|310550|P1|NOT COMPLETED|Second Intervention - All Use Canes 4 mo||1
129187|NCT00223795|310549|P2|COMPLETED|Second Intervention - All Use Canes 4 mo||17
129188|NCT00223795|310550|P1|COMPLETED|Second Intervention - All Use Canes 4 mo||18
129189|NCT00223795|310549|P2|STARTED|Second Intervention - All Use Canes 4 mo||18
129190|NCT00223795|310550|P1|STARTED|Second Intervention - All Use Canes 4 mo||19
129191|NCT00223795|310549|P2|NOT COMPLETED|First Intervention - Eight Weeks||9
129192|NCT00223795|310550|P1|NOT COMPLETED|First Intervention - Eight Weeks||7
129193|NCT00223795|310549|P2|COMPLETED|First Intervention - Eight Weeks||18
129194|NCT00223795|310550|P1|COMPLETED|First Intervention - Eight Weeks||19
129195|NCT00223795|310549|P2|STARTED|First Intervention - Eight Weeks||27
129196|NCT00223795|310550|P1|STARTED|First Intervention - Eight Weeks||26
129197|NCT00223808|310560|P3|NOT COMPLETED|Overall Study||5
129198|NCT00223808|310561|P2|NOT COMPLETED|Overall Study||5
129199|NCT00223808|310562|P1|NOT COMPLETED|Overall Study||3
129200|NCT00223808|310560|P3|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|18
129201|NCT00223808|310561|P2|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|17
129202|NCT00223808|310562|P1|COMPLETED|Overall Study|Completed at least the immediate post-treatment testing with 5 or more hours of treatment.|19
129203|NCT00223808|310560|P3|STARTED|Overall Study||23
129204|NCT00223808|310561|P2|STARTED|Overall Study||22
129205|NCT00223808|310562|P1|STARTED|Overall Study||22
129206|NCT00223821|310581|P2|NOT COMPLETED|Overall Study||10
129207|NCT00223821|310582|P1|NOT COMPLETED|Overall Study||4
129208|NCT00223821|310581|P2|COMPLETED|Overall Study||22
129209|NCT00223821|310582|P1|COMPLETED|Overall Study||28
129210|NCT00223821|310581|P2|Completed 6-month Follow-up|Overall Study||25
129211|NCT00223821|310582|P1|Completed 6-month Follow-up|Overall Study||28
129212|NCT00223821|310581|P2|Completed Post-treatment Assessment|Overall Study||27
129213|NCT00223821|310582|P1|Completed Post-treatment Assessment|Overall Study||31
129214|NCT00223821|310581|P2|Completed Therapy|Overall Study||28
129215|NCT00223821|310582|P1|Completed Therapy|Overall Study||31
129216|NCT00223821|310581|P2|STARTED|Overall Study||32
129217|NCT00223821|310582|P1|STARTED|Overall Study||32
129218|NCT00223977|310593|P3|NOT COMPLETED|Overall Study||3
129219|NCT00223977|310594|P2|NOT COMPLETED|Overall Study||11
129220|NCT00223977|310595|P1|NOT COMPLETED|Overall Study||9
129221|NCT00223977|310593|P3|COMPLETED|Overall Study||39
129222|NCT00223977|310594|P2|COMPLETED|Overall Study||47
129223|NCT00223977|310595|P1|COMPLETED|Overall Study||37
129224|NCT00223977|310593|P3|STARTED|Overall Study||42
129225|NCT00223977|310594|P2|STARTED|Overall Study||58
129226|NCT00223977|310595|P1|STARTED|Overall Study||46
129227|NCT00224003|310615|P1|NOT COMPLETED|Overall Study||7
129228|NCT00224003|310615|P1|COMPLETED|Overall Study|Last patient out: March 31, 2004|16
129229|NCT00224003|310615|P1|STARTED|Overall Study|First patient in: April 2, 2003|23
129230|NCT00224016|310621|P2|NOT COMPLETED|Follow-Up Period||0
129231|NCT00224016|310622|P1|NOT COMPLETED|Follow-Up Period||0
129232|NCT00224016|310621|P2|COMPLETED|Follow-Up Period||0
129233|NCT00224016|310622|P1|COMPLETED|Follow-Up Period||35
129234|NCT00224016|310621|P2|STARTED|Follow-Up Period|This group of subjects did not proceed to follow-up period.|0
129235|NCT00224016|310622|P1|STARTED|Follow-Up Period||35
129236|NCT00224016|310621|P2|NOT COMPLETED|Maintenance Period||1
129237|NCT00224016|310622|P1|NOT COMPLETED|Maintenance Period||2
129238|NCT00224016|310621|P2|COMPLETED|Maintenance Period||14
129239|NCT00224016|310622|P1|COMPLETED|Maintenance Period||36
129240|NCT00224016|310621|P2|STARTED|Maintenance Period||15
129241|NCT00224016|310622|P1|STARTED|Maintenance Period||38
129242|NCT00224016|310621|P2|NOT COMPLETED|Titration Period||1
129243|NCT00224016|310622|P1|NOT COMPLETED|Titration Period||1
129244|NCT00224016|310621|P2|COMPLETED|Titration Period||15
129245|NCT00224016|310622|P1|COMPLETED|Titration Period||38
129246|NCT00224016|310621|P2|STARTED|Titration Period||16
129247|NCT00224016|310622|P1|STARTED|Titration Period||39
129248|NCT00224029|310630|P1|NOT COMPLETED|Overall Study||6
129249|NCT00224029|310630|P1|COMPLETED|Overall Study||18
129250|NCT00224029|310630|P1|STARTED|Overall Study||24
129251|NCT00224042|310636|P2|NOT COMPLETED|Overall Study||6
129252|NCT00224042|310637|P1|NOT COMPLETED|Overall Study||6
129253|NCT00224042|310636|P2|COMPLETED|Overall Study||20
129254|NCT00224042|310637|P1|COMPLETED|Overall Study||20
129255|NCT00224042|310636|P2|STARTED|Overall Study||26
129256|NCT00224042|310637|P1|STARTED|Overall Study||26
129257|NCT00224055|310651|P2|NOT COMPLETED|Overall Study||14
129258|NCT00224055|310652|P1|NOT COMPLETED|Overall Study||15
129259|NCT00224055|310651|P2|COMPLETED|Overall Study||31
129260|NCT00224055|310652|P1|COMPLETED|Overall Study||29
129261|NCT00224055|310651|P2|STARTED|Overall Study||45
129262|NCT00224055|310652|P1|STARTED|Overall Study||44
129263|NCT00224107|310662|P2|NOT COMPLETED|Overall Study||14
129264|NCT00224107|310663|P1|NOT COMPLETED|Overall Study||31
129265|NCT00224107|310662|P2|COMPLETED|Overall Study||214
129266|NCT00224107|310663|P1|COMPLETED|Overall Study||202
129267|NCT00224107|310662|P2|STARTED|Overall Study||228
129268|NCT00224107|310663|P1|STARTED|Overall Study||233
129269|NCT00215540|310674|P3|NOT COMPLETED|Overall Study||0
129270|NCT00215540|310675|P2|NOT COMPLETED|Overall Study||0
129271|NCT00215540|310676|P1|NOT COMPLETED|Overall Study||1
129272|NCT00215540|310674|P3|COMPLETED|Overall Study||44
129273|NCT00215540|310675|P2|COMPLETED|Overall Study||47
129274|NCT00215540|310676|P1|COMPLETED|Overall Study||44
129275|NCT00215540|310674|P3|STARTED|Overall Study||44
129276|NCT00215540|310675|P2|STARTED|Overall Study||47
129277|NCT00215540|310676|P1|STARTED|Overall Study||45
129278|NCT00215553|310718|P7|NOT COMPLETED|Overall Study||0
129279|NCT00215553|310719|P6|NOT COMPLETED|Overall Study||6
129280|NCT00215553|310720|P5|NOT COMPLETED|Overall Study||2
129281|NCT00215553|310721|P4|NOT COMPLETED|Overall Study||1
129282|NCT00215553|310722|P3|NOT COMPLETED|Overall Study||2
129283|NCT00215553|310723|P2|NOT COMPLETED|Overall Study||1
129284|NCT00215553|310724|P1|NOT COMPLETED|Overall Study||0
129285|NCT00215553|310718|P7|COMPLETED|Overall Study||36
129286|NCT00215553|310719|P6|COMPLETED|Overall Study|6 Subjects discontinued due to AE|32
129287|NCT00215553|310720|P5|COMPLETED|Overall Study|2 Subjects discontinued due to AE|26
129288|NCT00215553|310721|P4|COMPLETED|Overall Study|1 Subject discontinued due to AE|4
129289|NCT00215553|310722|P3|COMPLETED|Overall Study|2 Subjects discontinued due to AE|4
129290|NCT00215553|310723|P2|COMPLETED|Overall Study|1 Subject discontinued due to AE|5
129291|NCT00215553|310724|P1|COMPLETED|Overall Study||5
129292|NCT00215553|310718|P7|STARTED|Overall Study||36
129293|NCT00215553|310719|P6|STARTED|Overall Study||38
129294|NCT00215553|310720|P5|STARTED|Overall Study||28
129295|NCT00215553|310721|P4|STARTED|Overall Study||5
129296|NCT00215553|310722|P3|STARTED|Overall Study||6
129297|NCT00215553|310723|P2|STARTED|Overall Study||6
129298|NCT00215553|310724|P1|STARTED|Overall Study||5
129299|NCT00215657|310762|P8|NOT COMPLETED|Overall Study||16
129300|NCT00215657|310763|P7|NOT COMPLETED|Overall Study||23
129301|NCT00215657|310764|P6|NOT COMPLETED|Overall Study||20
129302|NCT00215657|310765|P5|NOT COMPLETED|Overall Study||23
129303|NCT00215657|310766|P4|NOT COMPLETED|Overall Study||18
129304|NCT00215657|310767|P3|NOT COMPLETED|Overall Study||11
129305|NCT00215657|310768|P2|NOT COMPLETED|Overall Study||11
129306|NCT00215657|310769|P1|NOT COMPLETED|Overall Study||22
129307|NCT00215657|310762|P8|COMPLETED|Overall Study||11
129308|NCT00215657|310763|P7|COMPLETED|Overall Study||4
129309|NCT00215657|310764|P6|COMPLETED|Overall Study||4
129310|NCT00215657|310765|P5|COMPLETED|Overall Study||4
129311|NCT00215657|310766|P4|COMPLETED|Overall Study||6
129312|NCT00215657|310767|P3|COMPLETED|Overall Study||2
129313|NCT00215657|310768|P2|COMPLETED|Overall Study||1
129314|NCT00215657|310769|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study.|4
129315|NCT00215657|310762|P8|Started FE200486 CS07A|Overall Study||23
129316|NCT00215657|310763|P7|Started FE200486 CS07A|Overall Study||14
129317|NCT00215657|310764|P6|Started FE200486 CS07A|Overall Study||20
129318|NCT00215657|310765|P5|Started FE200486 CS07A|Overall Study||17
129319|NCT00215657|310766|P4|Started FE200486 CS07A|Overall Study||24
129320|NCT00215657|310767|P3|Started FE200486 CS07A|Overall Study||7
129321|NCT00215657|310768|P2|Started FE200486 CS07A|Overall Study||6
129322|NCT00215657|310769|P1|Started FE200486 CS07A|Overall Study||20
129323|NCT00215657|310762|P8|Intention-to-treat Population|Overall Study||27
129324|NCT00215657|310763|P7|Intention-to-treat Population|Overall Study||24
129325|NCT00215657|310764|P6|Intention-to-treat Population|Overall Study||24
129326|NCT00215657|310765|P5|Intention-to-treat Population|Overall Study||24
129327|NCT00215657|310766|P4|Intention-to-treat Population|Overall Study||24
129328|NCT00215657|310767|P3|Intention-to-treat Population|Overall Study||12
129329|NCT00215657|310768|P2|Intention-to-treat Population|Overall Study||12
129330|NCT00215657|310769|P1|Intention-to-treat Population|Overall Study||25
129331|NCT00215657|310762|P8|STARTED|Overall Study||27
129332|NCT00215657|310763|P7|STARTED|Overall Study||27
129333|NCT00215657|310764|P6|STARTED|Overall Study||24
129334|NCT00215657|310765|P5|STARTED|Overall Study||27
129335|NCT00215657|310766|P4|STARTED|Overall Study||24
129336|NCT00215657|310767|P3|STARTED|Overall Study||13
129337|NCT00215657|310768|P2|STARTED|Overall Study||12
129338|NCT00215657|310769|P1|STARTED|Overall Study||26
129339|NCT00215683|310798|P3|NOT COMPLETED|Overall Study||32
129340|NCT00215683|310799|P2|NOT COMPLETED|Overall Study||26
129341|NCT00215683|310800|P1|NOT COMPLETED|Overall Study||29
129342|NCT00215683|310798|P3|COMPLETED|Overall Study||12
129343|NCT00215683|310799|P2|COMPLETED|Overall Study||22
129344|NCT00215683|310800|P1|COMPLETED|Overall Study|Participants ongoing at the time of study closure were considered to have completed the study|16
129345|NCT00215683|310798|P3|Switched to 160 mg|Overall Study||36
129346|NCT00215683|310799|P2|Switched to 160 mg|Overall Study||41
129347|NCT00215683|310800|P1|Switched to 160 mg|Overall Study|A protocol amendment changed the dosage to 160 mg (40 mg/mL) for all participants|32
129348|NCT00215683|310798|P3|STARTED|Overall Study||44
129349|NCT00215683|310799|P2|STARTED|Overall Study||48
129350|NCT00215683|310800|P1|STARTED|Overall Study|Safety analysis set|45
129351|NCT00215787|310811|P1|NOT COMPLETED|Overall Study||0
129352|NCT00215787|310811|P1|COMPLETED|Overall Study||20
129353|NCT00215787|310811|P1|STARTED|Overall Study||20
129354|NCT00224120|310817|P2|NOT COMPLETED|Overall Study||24
129355|NCT00224120|310818|P1|NOT COMPLETED|Overall Study||22
129356|NCT00224120|310817|P2|COMPLETED|Overall Study||205
129357|NCT00224120|310818|P1|COMPLETED|Overall Study||211
129358|NCT00224120|310817|P2|STARTED|Overall Study||229
129359|NCT00224120|310818|P1|STARTED|Overall Study||233
129360|NCT00224133|310826|P1|NOT COMPLETED|Overall Study||226
129361|NCT00224133|310826|P1|COMPLETED|Overall Study||435
129362|NCT00224133|310826|P1|STARTED|Overall Study||661
129363|NCT00224289|310830|P1|NOT COMPLETED|Overall Study||0
129364|NCT00224289|310830|P1|COMPLETED|Overall Study||17
129365|NCT00224289|310830|P1|STARTED|Overall Study||17
129366|NCT00226239|310835|P1|NOT COMPLETED|Maintenance Cetuximab||14
129367|NCT00226239|310835|P1|COMPLETED|Maintenance Cetuximab||17
129368|NCT00226239|310835|P1|STARTED|Maintenance Cetuximab||31
129369|NCT00226239|310835|P1|NOT COMPLETED|XPE, Definitive Therapy||4
129370|NCT00226239|310835|P1|COMPLETED|XPE, Definitive Therapy||33
129371|NCT00226239|310835|P1|STARTED|XPE, Definitive Therapy||37
129372|NCT00226239|310835|P1|NOT COMPLETED|TPE, Induction Therapy||2
129373|NCT00226239|310835|P1|COMPLETED|TPE, Induction Therapy||37
129374|NCT00226239|310835|P1|STARTED|TPE, Induction Therapy||39
129375|NCT00226577|310844|P1|NOT COMPLETED|Overall Study||0
129376|NCT00226577|310844|P1|COMPLETED|Overall Study||52
129377|NCT00226577|310844|P1|STARTED|Overall Study||52
129378|NCT00226590|310852|P1|NOT COMPLETED|Overall Study||0
129379|NCT00226590|310852|P1|COMPLETED|Overall Study||39
129380|NCT00226590|310852|P1|STARTED|Overall Study||39
129381|NCT00226655|310859|P1|NOT COMPLETED|Overall Study||79
129382|NCT00226655|310859|P1|COMPLETED|Overall Study||33
129383|NCT00226655|310859|P1|STARTED|Overall Study||112
129384|NCT00226811|310863|P1|NOT COMPLETED|Overall Study||76
129385|NCT00226811|310863|P1|COMPLETED|Overall Study||2
129386|NCT00226811|310863|P1|STARTED|Overall Study||78
129387|NCT00227019|310873|P1|NOT COMPLETED|Overall Study||0
129388|NCT00227019|310873|P1|COMPLETED|Overall Study||16
129389|NCT00227019|310873|P1|STARTED|Overall Study||16
129390|NCT00227266|310882|P3|NOT COMPLETED|Overall Study||4
129391|NCT00227266|310883|P2|NOT COMPLETED|Overall Study||0
129392|NCT00227266|310884|P1|NOT COMPLETED|Overall Study||1
129393|NCT00227266|310882|P3|COMPLETED|Overall Study||29
129394|NCT00227266|310883|P2|COMPLETED|Overall Study||30
129395|NCT00227266|310884|P1|COMPLETED|Overall Study||30
129396|NCT00227266|310882|P3|STARTED|Overall Study||33
129397|NCT00227266|310883|P2|STARTED|Overall Study||30
129398|NCT00227266|310884|P1|STARTED|Overall Study||31
129399|NCT00227305|310904|P1|NOT COMPLETED|Overall Study||144
129400|NCT00227305|310904|P1|COMPLETED|Overall Study|Completed 26 weeks|237
129401|NCT00227305|310904|P1|Drug Received|Overall Study|safety population|380
129402|NCT00227305|310904|P1|STARTED|Overall Study|enrolled|381
129403|NCT00227344|310920|P2|NOT COMPLETED|Overall Study||5
129404|NCT00227344|310921|P1|NOT COMPLETED|Overall Study||12
129405|NCT00227344|310920|P2|COMPLETED|Overall Study||37
129406|NCT00227344|310921|P1|COMPLETED|Overall Study||75
129407|NCT00227344|310920|P2|STARTED|Overall Study||42
129408|NCT00227344|310921|P1|STARTED|Overall Study||87
129409|NCT00227370|310943|P2|NOT COMPLETED|Overall Study||24
129410|NCT00227370|310944|P1|NOT COMPLETED|Overall Study||21
129411|NCT00227370|310943|P2|COMPLETED|Overall Study||46
129412|NCT00227370|310944|P1|COMPLETED|Overall Study||45
129413|NCT00227370|310943|P2|STARTED|Overall Study|Treatment Group|70
129414|NCT00227370|310944|P1|STARTED|Overall Study|Placebo Group|66
129415|NCT00227539|310962|P1|NOT COMPLETED|Overall Study||1
129416|NCT00227539|310962|P1|COMPLETED|Overall Study||24
129417|NCT00227539|310962|P1|STARTED|Overall Study||25
129418|NCT00227591|310968|P1|NOT COMPLETED|Overall Study||1
129419|NCT00227591|310968|P1|COMPLETED|Overall Study||47
129420|NCT00227591|310968|P1|Began Treatment|Overall Study||47
129421|NCT00227591|310968|P1|STARTED|Overall Study|48 pts registered to the study|48
129422|NCT00227721|310972|P1|NOT COMPLETED|Overall Study||1
129423|NCT00227721|310972|P1|COMPLETED|Overall Study||29
129424|NCT00227721|310972|P1|STARTED|Overall Study||30
129425|NCT00227760|310976|P1|NOT COMPLETED|Overall Study||0
129426|NCT00227760|310976|P1|COMPLETED|Overall Study||44
129427|NCT00227760|310976|P1|STARTED|Overall Study||44
129428|NCT00227903|310984|P2|NOT COMPLETED|Overall Study||10
129429|NCT00227903|310985|P1|NOT COMPLETED|Overall Study||5
129430|NCT00227903|310984|P2|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|82
129431|NCT00227903|310985|P1|COMPLETED|Overall Study|Participants with at least 1 follow-up assessment were analyzed|86
129432|NCT00227903|310984|P2|Received ≥ 1 Follow-up Assessment|Overall Study|4 participants did not receive any treatment sessions.|82
129433|NCT00227903|310985|P1|Received ≥ 1 Follow-up Assessment|Overall Study|1 participant did not receive any treatment sessions.|86
129434|NCT00227903|310984|P2|STARTED|Overall Study||92
129435|NCT00227903|310985|P1|STARTED|Overall Study||91
129436|NCT00227994|311047|P2|NOT COMPLETED|Overall Study||7
129437|NCT00227994|311048|P1|NOT COMPLETED|Overall Study||7
129438|NCT00227994|311047|P2|COMPLETED|Overall Study||13
129439|NCT00227994|311048|P1|COMPLETED|Overall Study||13
129440|NCT00227994|311047|P2|STARTED|Overall Study||20
129441|NCT00227994|311048|P1|STARTED|Overall Study||20
129442|NCT00228384|311058|P2|NOT COMPLETED|Overall Study||29
129443|NCT00228384|311059|P1|NOT COMPLETED|Overall Study||29
129444|NCT00228384|311058|P2|COMPLETED|Overall Study||47
129445|NCT00228384|311059|P1|COMPLETED|Overall Study||43
129446|NCT00228384|311058|P2|Three Year Follow-up (Final)|Overall Study||47
129447|NCT00228384|311059|P1|Three Year Follow-up (Final)|Overall Study||43
129448|NCT00228384|311058|P2|30-Day Follow-up (Safety Outcome)|Overall Study||72
129449|NCT00228384|311059|P1|30-Day Follow-up (Safety Outcome)|Overall Study||69
129450|NCT00228384|311058|P2|Baseline|Overall Study||76
129451|NCT00228384|311059|P1|Baseline|Overall Study||72
129452|NCT00228384|311058|P2|STARTED|Overall Study||76
129453|NCT00228384|311059|P1|STARTED|Overall Study||72
129454|NCT00228553|311097|P1|NOT COMPLETED|Overall Study||430
129455|NCT00228553|311097|P1|COMPLETED|Overall Study||313
129456|NCT00228553|311097|P1|STARTED|Overall Study||743
129457|NCT00228566|311101|P1|NOT COMPLETED|Overall Study||71
129458|NCT00228566|311101|P1|COMPLETED|Overall Study||176
129459|NCT00228566|311101|P1|STARTED|Overall Study||247
129460|NCT00219141|311108|P3|NOT COMPLETED|Overall Study||12
129461|NCT00219141|311109|P2|NOT COMPLETED|Overall Study||21
129462|NCT00219141|311110|P1|NOT COMPLETED|Overall Study||14
129463|NCT00219141|311108|P3|COMPLETED|Overall Study||142
129464|NCT00219141|311109|P2|COMPLETED|Overall Study||131
129465|NCT00219141|311110|P1|COMPLETED|Overall Study||140
129466|NCT00219141|311108|P3|STARTED|Overall Study||154
129467|NCT00219141|311109|P2|STARTED|Overall Study||152
129468|NCT00219141|311110|P1|STARTED|Overall Study||154
129469|NCT00219284|311156|P2|NOT COMPLETED|Extension Phase - 8 Weeks||7
129470|NCT00219284|311157|P1|NOT COMPLETED|Extension Phase - 8 Weeks||2
129471|NCT00219284|311156|P2|COMPLETED|Extension Phase - 8 Weeks||99
129472|NCT00219284|311157|P1|COMPLETED|Extension Phase - 8 Weeks||112
129473|NCT00219284|311156|P2|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|106
129474|NCT00219284|311157|P1|STARTED|Extension Phase - 8 Weeks|Not all subjects who completed the treatment phase chose to enter this optional extension phase.|114
129475|NCT00219284|311156|P2|NOT COMPLETED|Treatment Phase - 16 Weeks||51
129476|NCT00219284|311157|P1|NOT COMPLETED|Treatment Phase - 16 Weeks||44
129477|NCT00219284|311156|P2|COMPLETED|Treatment Phase - 16 Weeks||128
129478|NCT00219284|311157|P1|COMPLETED|Treatment Phase - 16 Weeks||136
129479|NCT00219284|311156|P2|STARTED|Treatment Phase - 16 Weeks||179
129480|NCT00219284|311157|P1|STARTED|Treatment Phase - 16 Weeks||180
129481|NCT00219349|311179|P1|NOT COMPLETED|Escitalopram Phase||11
129482|NCT00219349|311179|P1|COMPLETED|Escitalopram Phase||4
129483|NCT00219349|311179|P1|STARTED|Escitalopram Phase|7 responders to CBT were ineligible to start and 1 declined, leaving 7 who started escitalopram|15
129484|NCT00219349|311179|P1|NOT COMPLETED|Cognitive Behavioral Therapy Phase||10
129485|NCT00219349|311179|P1|COMPLETED|Cognitive Behavioral Therapy Phase||15
129486|NCT00219349|311179|P1|STARTED|Cognitive Behavioral Therapy Phase||25
129487|NCT00219544|311183|P2|NOT COMPLETED|Double Blind Treatment Period||0
129488|NCT00219544|311184|P1|NOT COMPLETED|Double Blind Treatment Period||0
129489|NCT00219544|311183|P2|COMPLETED|Double Blind Treatment Period||77
129490|NCT00219544|311184|P1|COMPLETED|Double Blind Treatment Period||80
129491|NCT00219544|311183|P2|STARTED|Double Blind Treatment Period||77
129492|NCT00219544|311184|P1|STARTED|Double Blind Treatment Period||80
129493|NCT00219544|311183|P2|NOT COMPLETED|Single Blind Treatment Period||0
129494|NCT00219544|311184|P1|NOT COMPLETED|Single Blind Treatment Period||22
129495|NCT00219544|311183|P2|COMPLETED|Single Blind Treatment Period||0
129496|NCT00219544|311184|P1|COMPLETED|Single Blind Treatment Period||234
129497|NCT00219544|311183|P2|STARTED|Single Blind Treatment Period||0
129498|NCT00219544|311184|P1|STARTED|Single Blind Treatment Period||256
129499|NCT00219557|311225|P3|NOT COMPLETED|Phase 2||33
129500|NCT00219557|311226|P2|NOT COMPLETED|Phase 2||69
129501|NCT00219557|311227|P1|NOT COMPLETED|Phase 2||0
129502|NCT00219557|311225|P3|COMPLETED|Phase 2||1
129503|NCT00219557|311226|P2|COMPLETED|Phase 2||0
129504|NCT00219557|311227|P1|COMPLETED|Phase 2||0
129505|NCT00219557|311225|P3|Treated|Phase 2||31
129506|NCT00219557|311226|P2|Treated|Phase 2||68
129507|NCT00219557|311227|P1|Treated|Phase 2||0
129508|NCT00219557|311225|P3|STARTED|Phase 2||34
129509|NCT00219557|311226|P2|STARTED|Phase 2||69
129510|NCT00219557|311227|P1|STARTED|Phase 2||0
129511|NCT00219557|311225|P3|NOT COMPLETED|Phase 1||0
129512|NCT00219557|311226|P2|NOT COMPLETED|Phase 1||0
129513|NCT00219557|311227|P1|NOT COMPLETED|Phase 1||7
129514|NCT00219557|311225|P3|COMPLETED|Phase 1||0
129515|NCT00219557|311226|P2|COMPLETED|Phase 1||0
129516|NCT00219557|311227|P1|COMPLETED|Phase 1||1
129517|NCT00219557|311225|P3|STARTED|Phase 1||0
129518|NCT00219557|311226|P2|STARTED|Phase 1||0
129519|NCT00219557|311227|P1|STARTED|Phase 1||8
129520|NCT00220636|311255|P1|NOT COMPLETED|Overall Study||4
129521|NCT00220636|311255|P1|COMPLETED|Overall Study||11
129522|NCT00220636|311255|P1|STARTED|Overall Study||15
129523|NCT00220701|311264|P2|NOT COMPLETED|Overall Study||4
129524|NCT00220701|311265|P1|NOT COMPLETED|Overall Study||5
129525|NCT00220701|311264|P2|COMPLETED|Overall Study||13
129526|NCT00220701|311265|P1|COMPLETED|Overall Study||12
129527|NCT00220701|311264|P2|STARTED|Overall Study||17
129528|NCT00220701|311265|P1|STARTED|Overall Study||17
129529|NCT00220727|311283|P2|NOT COMPLETED|Second Infusion (Week <6)||0
129530|NCT00220727|311284|P1|NOT COMPLETED|Second Infusion (Week <6)||1
129531|NCT00220727|311283|P2|COMPLETED|Second Infusion (Week <6)||4
129532|NCT00220727|311284|P1|COMPLETED|Second Infusion (Week <6)||3
129533|NCT00220727|311283|P2|STARTED|Second Infusion (Week <6)||4
129534|NCT00220727|311284|P1|STARTED|Second Infusion (Week <6)||4
129535|NCT00220727|311283|P2|NOT COMPLETED|First Infusion (Week 0)||0
129536|NCT00220727|311284|P1|NOT COMPLETED|First Infusion (Week 0)||0
129537|NCT00220727|311283|P2|COMPLETED|First Infusion (Week 0)||4
129538|NCT00220727|311284|P1|COMPLETED|First Infusion (Week 0)||4
129539|NCT00220727|311283|P2|STARTED|First Infusion (Week 0)||4
129540|NCT00220727|311284|P1|STARTED|First Infusion (Week 0)||4
129541|NCT00220740|311300|P2|NOT COMPLETED|Withdrawal Period||15
129542|NCT00220740|311301|P1|NOT COMPLETED|Withdrawal Period||6
129543|NCT00220740|311300|P2|COMPLETED|Withdrawal Period||16
129544|NCT00220740|311301|P1|COMPLETED|Withdrawal Period||37
129545|NCT00220740|311300|P2|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|31
129546|NCT00220740|311301|P1|STARTED|Withdrawal Period|The subjects who were success in Efficacy or Rescue Period were re-randomized to Withdrawal period.|43
129547|NCT00220740|311300|P2|NOT COMPLETED|Rescue Treatment||18
129548|NCT00220740|311301|P1|NOT COMPLETED|Rescue Treatment||19
129549|NCT00220740|311300|P2|COMPLETED|Rescue Treatment||5
129550|NCT00220740|311301|P1|COMPLETED|Rescue Treatment||26
129551|NCT00220740|311300|P2|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|23
129552|NCT00220740|311301|P1|STARTED|Rescue Treatment|Only the subjects who failed the treatment in the Efficacy period entered the Rescue period.|45
129553|NCT00220740|311300|P2|NOT COMPLETED|Efficacy Period||46
129554|NCT00220740|311301|P1|NOT COMPLETED|Efficacy Period||26
129555|NCT00220740|311300|P2|COMPLETED|Efficacy Period||12
129556|NCT00220740|311301|P1|COMPLETED|Efficacy Period||33
129557|NCT00220740|311300|P2|STARTED|Efficacy Period||58
129558|NCT00220740|311301|P1|STARTED|Efficacy Period||59
129559|NCT00220779|311316|P3|NOT COMPLETED|Overall Study||4
129560|NCT00220779|311317|P2|NOT COMPLETED|Overall Study||4
129561|NCT00220779|311318|P1|NOT COMPLETED|Overall Study||7
129562|NCT00220779|311316|P3|COMPLETED|Overall Study||37
129563|NCT00220779|311317|P2|COMPLETED|Overall Study||38
129564|NCT00220779|311318|P1|COMPLETED|Overall Study||38
129565|NCT00220779|311316|P3|STARTED|Overall Study||41
129566|NCT00220779|311317|P2|STARTED|Overall Study||42
129567|NCT00220779|311318|P1|STARTED|Overall Study||45
129568|NCT00220805|311328|P2|NOT COMPLETED|Overall Study||11
129569|NCT00220805|311329|P1|NOT COMPLETED|Overall Study||8
129570|NCT00220805|311328|P2|COMPLETED|Overall Study||16
129571|NCT00220805|311329|P1|COMPLETED|Overall Study||22
129572|NCT00220805|311328|P2|STARTED|Overall Study||27
129573|NCT00220805|311329|P1|STARTED|Overall Study||30
129574|NCT00220961|311349|P2|NOT COMPLETED|Overall Study||90
129575|NCT00220961|311350|P1|NOT COMPLETED|Overall Study||71
129576|NCT00220961|311349|P2|COMPLETED|Overall Study||213
129577|NCT00220961|311350|P1|COMPLETED|Overall Study||228
129578|NCT00220961|311349|P2|STARTED|Overall Study||303
129579|NCT00220961|311350|P1|STARTED|Overall Study||299
129580|NCT00221195|311366|P2|NOT COMPLETED|Overall Study||3
129581|NCT00221195|311367|P1|NOT COMPLETED|Overall Study||5
129582|NCT00221195|311366|P2|COMPLETED|Overall Study||14
129583|NCT00221195|311367|P1|COMPLETED|Overall Study||12
129584|NCT00221195|311366|P2|STARTED|Overall Study||17
129585|NCT00221195|311367|P1|STARTED|Overall Study||17
129586|NCT00221299|311377|P4|NOT COMPLETED|Overall Study||1
129587|NCT00221299|311378|P3|NOT COMPLETED|Overall Study||0
129588|NCT00221299|311379|P2|NOT COMPLETED|Overall Study||2
129589|NCT00221299|311380|P1|NOT COMPLETED|Overall Study||1
129590|NCT00221299|311377|P4|COMPLETED|Overall Study||10
129591|NCT00221299|311378|P3|COMPLETED|Overall Study||14
129592|NCT00221299|311379|P2|COMPLETED|Overall Study||11
129593|NCT00221299|311380|P1|COMPLETED|Overall Study||10
129594|NCT00221299|311377|P4|STARTED|Overall Study||11
129595|NCT00221299|311378|P3|STARTED|Overall Study||14
129596|NCT00221299|311379|P2|STARTED|Overall Study||13
129597|NCT00221299|311380|P1|STARTED|Overall Study||11
129598|NCT00228813|311388|P1|NOT COMPLETED|Overall Study||4
129599|NCT00228813|311388|P1|COMPLETED|Overall Study||4
129600|NCT00228813|311388|P1|STARTED|Overall Study||8
129601|NCT00228917|311398|P4|NOT COMPLETED|Overall Study||0
129602|NCT00228917|311399|P3|NOT COMPLETED|Overall Study||0
129603|NCT00228917|311400|P2|NOT COMPLETED|Overall Study||3
129604|NCT00228917|311401|P1|NOT COMPLETED|Overall Study||1
129605|NCT00228917|311398|P4|COMPLETED|Overall Study||107
129606|NCT00228917|311399|P3|COMPLETED|Overall Study||213
129607|NCT00228917|311400|P2|COMPLETED|Overall Study||320
129608|NCT00228917|311401|P1|COMPLETED|Overall Study||646
129609|NCT00228917|311398|P4|STARTED|Overall Study||107
129610|NCT00228917|311399|P3|STARTED|Overall Study||213
129611|NCT00228917|311400|P2|STARTED|Overall Study||323
129612|NCT00228917|311401|P1|STARTED|Overall Study||647
129613|NCT00228943|311427|P1|NOT COMPLETED|Week 2||1
129614|NCT00228943|311427|P1|COMPLETED|Week 2||27
129615|NCT00228943|311427|P1|STARTED|Week 2||28
129616|NCT00228943|311427|P1|NOT COMPLETED|Week 1||0
129617|NCT00228943|311427|P1|COMPLETED|Week 1||28
129618|NCT00228943|311427|P1|STARTED|Week 1||28
129619|NCT00229619|311435|P1|NOT COMPLETED|Overall Study||0
129620|NCT00229619|311435|P1|COMPLETED|Overall Study||11
129621|NCT00229619|311435|P1|STARTED|Overall Study||11
129622|NCT00229658|311441|P2|NOT COMPLETED|Overall Study||167
129623|NCT00229658|311442|P1|NOT COMPLETED|Overall Study||225
129624|NCT00229658|311441|P2|COMPLETED|Overall Study||364
129625|NCT00229658|311442|P1|COMPLETED|Overall Study||541
129626|NCT00229658|311441|P2|STARTED|Overall Study||531
129627|NCT00229658|311442|P1|STARTED|Overall Study||766
129628|NCT00229723|311477|P7|NOT COMPLETED|Maintenance Phase||10
129629|NCT00229723|311478|P6|NOT COMPLETED|Maintenance Phase||19
129630|NCT00229723|311479|P5|NOT COMPLETED|Maintenance Phase||15
129631|NCT00229723|311480|P4|NOT COMPLETED|Maintenance Phase||17
129632|NCT00229723|311481|P3|NOT COMPLETED|Maintenance Phase||9
129633|NCT00229723|311482|P2|NOT COMPLETED|Maintenance Phase||14
129634|NCT00229723|311483|P1|NOT COMPLETED|Maintenance Phase||25
129635|NCT00229723|311477|P7|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
129636|NCT00229723|311478|P6|COMPLETED|Maintenance Phase|Completed study on randomized treatment|12
129637|NCT00229723|311479|P5|COMPLETED|Maintenance Phase|Completed study on randomized treatment|7
129638|NCT00229723|311480|P4|COMPLETED|Maintenance Phase|Completed study on randomized treatment|9
129639|NCT00229723|311481|P3|COMPLETED|Maintenance Phase|Completed study on randomized treatment|16
129640|NCT00229723|311482|P2|COMPLETED|Maintenance Phase|Completed study on randomized treatment|5
129641|NCT00229723|311483|P1|COMPLETED|Maintenance Phase|Completed study on randomized treatment|25
129642|NCT00229723|311477|P7|STARTED|Maintenance Phase||19
129643|NCT00229723|311478|P6|STARTED|Maintenance Phase||31
129644|NCT00229723|311479|P5|STARTED|Maintenance Phase||22
129645|NCT00229723|311480|P4|STARTED|Maintenance Phase||26
129646|NCT00229723|311481|P3|STARTED|Maintenance Phase||25
129647|NCT00229723|311482|P2|STARTED|Maintenance Phase||19
129648|NCT00229723|311483|P1|STARTED|Maintenance Phase||50
129649|NCT00229723|311477|P7|NOT COMPLETED|Concomitant Phase||3
129650|NCT00229723|311478|P6|NOT COMPLETED|Concomitant Phase||3
129651|NCT00229723|311479|P5|NOT COMPLETED|Concomitant Phase||2
129652|NCT00229723|311480|P4|NOT COMPLETED|Concomitant Phase||5
129653|NCT00229723|311481|P3|NOT COMPLETED|Concomitant Phase||6
129654|NCT00229723|311482|P2|NOT COMPLETED|Concomitant Phase||5
129655|NCT00229723|311483|P1|NOT COMPLETED|Concomitant Phase||10
129656|NCT00229723|311477|P7|COMPLETED|Concomitant Phase||19
129657|NCT00229723|311478|P6|COMPLETED|Concomitant Phase||31
129658|NCT00229723|311479|P5|COMPLETED|Concomitant Phase||22
129659|NCT00229723|311480|P4|COMPLETED|Concomitant Phase||26
129660|NCT00229723|311481|P3|COMPLETED|Concomitant Phase||25
129661|NCT00229723|311482|P2|COMPLETED|Concomitant Phase||19
129662|NCT00229723|311483|P1|COMPLETED|Concomitant Phase||50
129663|NCT00229723|311477|P7|STARTED|Concomitant Phase|Received randomized treatment|22
129664|NCT00229723|311478|P6|STARTED|Concomitant Phase|Received randomized treatment|34
129665|NCT00229723|311479|P5|STARTED|Concomitant Phase|Received randomized treatment|24
129666|NCT00229723|311480|P4|STARTED|Concomitant Phase|Received randomized treatment|31
129667|NCT00229723|311481|P3|STARTED|Concomitant Phase|Received randomized treatment|31
129668|NCT00229723|311482|P2|STARTED|Concomitant Phase|Received randomized treatment|24
129669|NCT00229723|311483|P1|STARTED|Concomitant Phase|Received randomized treatment|60
129670|NCT00229931|311536|P2|NOT COMPLETED|Overall Study||2
129671|NCT00229931|311537|P1|NOT COMPLETED|Overall Study||4
129672|NCT00229931|311536|P2|COMPLETED|Overall Study||3
129673|NCT00229931|311537|P1|COMPLETED|Overall Study||2
129674|NCT00229931|311536|P2|STARTED|Overall Study||5
129675|NCT00229931|311537|P1|STARTED|Overall Study||6
129676|NCT00229957|311547|P2|NOT COMPLETED|Overall Study||12
129677|NCT00229957|311548|P1|NOT COMPLETED|Overall Study||20
129678|NCT00229957|311547|P2|COMPLETED|Overall Study||139
129679|NCT00229957|311548|P1|COMPLETED|Overall Study||132
129680|NCT00229957|311547|P2|STARTED|Overall Study||151
129681|NCT00229957|311548|P1|STARTED|Overall Study||152
129682|NCT00229970|311557|P3|NOT COMPLETED|Overall Study||0
129683|NCT00229970|311558|P2|NOT COMPLETED|Overall Study||0
129684|NCT00229970|311559|P1|NOT COMPLETED|Overall Study||0
129685|NCT00229970|311557|P3|COMPLETED|Overall Study||75
129686|NCT00229970|311558|P2|COMPLETED|Overall Study||72
129687|NCT00229970|311559|P1|COMPLETED|Overall Study||78
129688|NCT00229970|311557|P3|STARTED|Overall Study||75
129689|NCT00229970|311558|P2|STARTED|Overall Study||72
129690|NCT00229970|311559|P1|STARTED|Overall Study||78
129691|NCT00230009|311569|P2|NOT COMPLETED|Follow-up||26
129692|NCT00230009|311570|P1|NOT COMPLETED|Follow-up||31
129693|NCT00230009|311569|P2|COMPLETED|Follow-up||24
129694|NCT00230009|311570|P1|COMPLETED|Follow-up||19
129695|NCT00230009|311569|P2|STARTED|Follow-up||50
129696|NCT00230009|311570|P1|STARTED|Follow-up||50
129697|NCT00230009|311569|P2|NOT COMPLETED|Single Session Intervention/Control||0
129698|NCT00230009|311570|P1|NOT COMPLETED|Single Session Intervention/Control||0
129699|NCT00230009|311569|P2|COMPLETED|Single Session Intervention/Control||50
129700|NCT00230009|311570|P1|COMPLETED|Single Session Intervention/Control||50
129701|NCT00230009|311569|P2|STARTED|Single Session Intervention/Control||50
129702|NCT00230009|311570|P1|STARTED|Single Session Intervention/Control||50
129703|NCT00230022|311586|P2|NOT COMPLETED|Overall Study||0
129704|NCT00230022|311587|P1|NOT COMPLETED|Overall Study||0
129705|NCT00230022|311586|P2|COMPLETED|Overall Study||15
129706|NCT00230022|311587|P1|COMPLETED|Overall Study||15
129707|NCT00230022|311586|P2|STARTED|Overall Study||15
129708|NCT00230022|311587|P1|STARTED|Overall Study||15
129709|NCT00230048|311595|P2|NOT COMPLETED|Overall Study||18
129710|NCT00230048|311596|P1|NOT COMPLETED|Overall Study||13
129711|NCT00230048|311595|P2|COMPLETED|Overall Study||37
129712|NCT00230048|311596|P1|COMPLETED|Overall Study||39
129713|NCT00230048|311595|P2|Completed Intervention/Control Session|Overall Study||55
129714|NCT00230048|311596|P1|Completed Intervention/Control Session|Overall Study||52
129715|NCT00230048|311595|P2|STARTED|Overall Study||55
129716|NCT00230048|311596|P1|STARTED|Overall Study||52
129717|NCT00230100|311606|P2|NOT COMPLETED|Overall Study||0
129718|NCT00230100|311607|P1|NOT COMPLETED|Overall Study||0
129719|NCT00230100|311606|P2|COMPLETED|Overall Study||17
129720|NCT00230100|311607|P1|COMPLETED|Overall Study||29
129721|NCT00230100|311606|P2|STARTED|Overall Study||17
129722|NCT00230100|311607|P1|STARTED|Overall Study||29
129723|NCT00230126|311629|P2|NOT COMPLETED|Overall Study||1
129724|NCT00230126|311630|P1|NOT COMPLETED|Overall Study||2
129725|NCT00230126|311629|P2|COMPLETED|Overall Study||27
129726|NCT00230126|311630|P1|COMPLETED|Overall Study||28
129727|NCT00230126|311629|P2|STARTED|Overall Study||28
129728|NCT00230126|311630|P1|STARTED|Overall Study||30
129729|NCT00230178|311643|P3|NOT COMPLETED|Overall Study||7
129730|NCT00230178|311644|P2|NOT COMPLETED|Overall Study||7
129731|NCT00230178|311645|P1|NOT COMPLETED|Overall Study||4
129732|NCT00230178|311643|P3|COMPLETED|Overall Study||86
129733|NCT00230178|311644|P2|COMPLETED|Overall Study||86
129734|NCT00230178|311645|P1|COMPLETED|Overall Study||90
129735|NCT00230178|311643|P3|Treated|Overall Study||91
129736|NCT00230178|311644|P2|Treated|Overall Study||92
129737|NCT00230178|311645|P1|Treated|Overall Study|Modified ITT population: ITT patients with at least 1 dose of study drug|92
129738|NCT00230178|311643|P3|STARTED|Overall Study||93
129739|NCT00230178|311644|P2|STARTED|Overall Study||93
129740|NCT00230178|311645|P1|STARTED|Overall Study|Intent-to-treat (ITT)population: randomized patients|94
129741|NCT00230282|311659|P1|NOT COMPLETED|Maintanence Therapy With Alemtuzumab||0
129742|NCT00230282|311659|P1|COMPLETED|Maintanence Therapy With Alemtuzumab||17
129743|NCT00230282|311659|P1|STARTED|Maintanence Therapy With Alemtuzumab||17
129744|NCT00230282|311659|P1|NOT COMPLETED|Fludarabine + Cyclophosphamide||8
129745|NCT00230282|311659|P1|COMPLETED|Fludarabine + Cyclophosphamide||17
129746|NCT00230282|311659|P1|STARTED|Fludarabine + Cyclophosphamide||25
129747|NCT00230737|311667|P3|NOT COMPLETED|Overall Study||0
129748|NCT00230737|311668|P2|NOT COMPLETED|Overall Study||0
129749|NCT00230737|311669|P1|NOT COMPLETED|Overall Study||0
129750|NCT00230737|311667|P3|COMPLETED|Overall Study||8
129751|NCT00230737|311668|P2|COMPLETED|Overall Study||10
129752|NCT00230737|311669|P1|COMPLETED|Overall Study||9
129753|NCT00230737|311667|P3|STARTED|Overall Study||8
129754|NCT00230737|311668|P2|STARTED|Overall Study||10
129755|NCT00230737|311669|P1|STARTED|Overall Study||9
129756|NCT00230802|311679|P2|NOT COMPLETED|Overall Study||0
129757|NCT00230802|311680|P1|NOT COMPLETED|Overall Study||0
129758|NCT00230802|311679|P2|COMPLETED|Overall Study||23
129759|NCT00230802|311680|P1|COMPLETED|Overall Study||25
129760|NCT00230802|311679|P2|STARTED|Overall Study||23
129761|NCT00230802|311680|P1|STARTED|Overall Study||25
129762|NCT00230971|311692|P2|NOT COMPLETED|Baseline Participants||19
129763|NCT00230971|311693|P1|NOT COMPLETED|Baseline Participants||22
129764|NCT00230971|311692|P2|COMPLETED|Baseline Participants||216
129765|NCT00230971|311693|P1|COMPLETED|Baseline Participants||210
129766|NCT00230971|311692|P2|STARTED|Baseline Participants||235
129767|NCT00230971|311693|P1|STARTED|Baseline Participants||232
129768|NCT00230971|311692|P2|NOT COMPLETED|Randomization||3
129769|NCT00230971|311693|P1|NOT COMPLETED|Randomization||3
129770|NCT00230971|311692|P2|COMPLETED|Randomization||235
129771|NCT00230971|311693|P1|COMPLETED|Randomization||232
129772|NCT00230971|311692|P2|STARTED|Randomization||238
129773|NCT00230971|311693|P1|STARTED|Randomization||235
129774|NCT00231062|311705|P1|NOT COMPLETED|Overall Study||6
129775|NCT00231062|311705|P1|COMPLETED|Overall Study||109
129776|NCT00231062|311705|P1|STARTED|Overall Study||115
129777|NCT00231114|311713|P2|NOT COMPLETED|Post-Treatment Period||1
129778|NCT00231114|311714|P1|NOT COMPLETED|Post-Treatment Period||8
129779|NCT00231114|311713|P2|COMPLETED|Post-Treatment Period||97
129780|NCT00231114|311714|P1|COMPLETED|Post-Treatment Period||181
129781|NCT00231114|311713|P2|STARTED|Post-Treatment Period||98
129782|NCT00231114|311714|P1|STARTED|Post-Treatment Period||189
129783|NCT00231114|311713|P2|NOT COMPLETED|Treatment Period||0
129784|NCT00231114|311714|P1|NOT COMPLETED|Treatment Period||1
129785|NCT00231114|311713|P2|COMPLETED|Treatment Period||98
129786|NCT00231114|311714|P1|COMPLETED|Treatment Period||189
129787|NCT00231114|311713|P2|STARTED|Treatment Period||98
129788|NCT00231114|311714|P1|STARTED|Treatment Period||190
129789|NCT00231114|311713|P2|NOT COMPLETED|Randomized||3
129790|NCT00231114|311714|P1|NOT COMPLETED|Randomized||6
129791|NCT00231114|311713|P2|COMPLETED|Randomized||98
129792|NCT00231114|311714|P1|COMPLETED|Randomized||190
129793|NCT00231114|311713|P2|STARTED|Randomized||101
129794|NCT00231114|311714|P1|STARTED|Randomized||196
129795|NCT00231153|311752|P2|NOT COMPLETED|Overall Study||188
129796|NCT00231153|311753|P1|NOT COMPLETED|Overall Study||217
129797|NCT00231153|311752|P2|COMPLETED|Overall Study||720
129798|NCT00231153|311753|P1|COMPLETED|Overall Study||690
129799|NCT00231153|311752|P2|STARTED|Overall Study|Subjects randomized to povidone-iodine who received at least one dose of study treatment.|908
129800|NCT00231153|311753|P1|STARTED|Overall Study|Subjects randomized to omiganan 1% gel who received at least one dose of study treatment.|907
129801|NCT00231179|311763|P2|NOT COMPLETED|Overall Study||24
129802|NCT00231179|311764|P1|NOT COMPLETED|Overall Study||24
129803|NCT00231179|311763|P2|COMPLETED|Overall Study|126 (93%) in the control group completed the five year follow-up visit.|126
129804|NCT00231179|311764|P1|COMPLETED|Overall Study|128 (95%) in intervention group completed the five year follow-up visit.|128
129805|NCT00231179|311763|P2|STARTED|Overall Study||150
129806|NCT00231179|311764|P1|STARTED|Overall Study||152
129807|NCT00231283|311778|P1|NOT COMPLETED|Overall Study||5
129808|NCT00231283|311778|P1|COMPLETED|Overall Study||95
129809|NCT00231283|311778|P1|STARTED|Overall Study||100
129810|NCT00231309|311785|P1|NOT COMPLETED|Overall Study||0
129811|NCT00231309|311785|P1|COMPLETED|Overall Study||10
129812|NCT00231309|311785|P1|STARTED|Overall Study||10
129813|NCT00231465|311790|P1|NOT COMPLETED|Overall Study||2
129814|NCT00231465|311790|P1|COMPLETED|Overall Study||42
129815|NCT00231465|311790|P1|STARTED|Overall Study||44
129816|NCT00231478|311798|P2|NOT COMPLETED|Overall Study||6
129817|NCT00231478|311799|P1|NOT COMPLETED|Overall Study||8
129818|NCT00231478|311798|P2|COMPLETED|Overall Study||78
129819|NCT00231478|311799|P1|COMPLETED|Overall Study||79
129820|NCT00231478|311798|P2|STARTED|Overall Study||84
129821|NCT00231478|311799|P1|STARTED|Overall Study||87
129822|NCT00231777|311813|P2|NOT COMPLETED|Overall Study||2
129823|NCT00231777|311814|P1|NOT COMPLETED|Overall Study||6
129824|NCT00231777|311813|P2|COMPLETED|Overall Study||44
129825|NCT00231777|311814|P1|COMPLETED|Overall Study||164
129826|NCT00231777|311813|P2|STARTED|Overall Study||46
129827|NCT00231777|311814|P1|STARTED|Overall Study||170
129828|NCT00224484|311829|P3|NOT COMPLETED|Overall Study||62
129829|NCT00224484|311830|P2|NOT COMPLETED|Overall Study||65
129830|NCT00224484|311831|P1|NOT COMPLETED|Overall Study||146
129831|NCT00224484|311829|P3|COMPLETED|Overall Study||1425
129832|NCT00224484|311830|P2|COMPLETED|Overall Study||1426
129833|NCT00224484|311831|P1|COMPLETED|Overall Study||2831
129834|NCT00224484|311829|P3|STARTED|Overall Study||1487
129835|NCT00224484|311830|P2|STARTED|Overall Study||1491
129836|NCT00224484|311831|P1|STARTED|Overall Study||2977
129837|NCT00224770|311893|P3|NOT COMPLETED|Overall Study||0
129838|NCT00224770|311894|P2|NOT COMPLETED|Overall Study||2
129839|NCT00224770|311895|P1|NOT COMPLETED|Overall Study||4
129840|NCT00224770|311893|P3|COMPLETED|Overall Study||14
129841|NCT00224770|311894|P2|COMPLETED|Overall Study||52
129842|NCT00224770|311895|P1|COMPLETED|Overall Study||38
129843|NCT00224770|311893|P3|STARTED|Overall Study||14
129844|NCT00224770|311894|P2|STARTED|Overall Study||54
129845|NCT00224770|311895|P1|STARTED|Overall Study||42
129846|NCT00224874|311931|P4|NOT COMPLETED|Overall Study||0
129847|NCT00224874|311932|P3|NOT COMPLETED|Overall Study||1
129848|NCT00224874|311933|P2|NOT COMPLETED|Overall Study||0
129849|NCT00224874|311934|P1|NOT COMPLETED|Overall Study||0
129850|NCT00224874|311931|P4|COMPLETED|Overall Study||42
129851|NCT00224874|311932|P3|COMPLETED|Overall Study||46
129852|NCT00224874|311933|P2|COMPLETED|Overall Study||45
129853|NCT00224874|311934|P1|COMPLETED|Overall Study||46
129854|NCT00224874|311931|P4|STARTED|Overall Study||42
129855|NCT00224874|311932|P3|STARTED|Overall Study||47
129856|NCT00224874|311933|P2|STARTED|Overall Study||45
129857|NCT00224874|311934|P1|STARTED|Overall Study||46
129858|NCT00224952|311979|P3|NOT COMPLETED|Overall Study||0
129859|NCT00224952|311980|P2|NOT COMPLETED|Overall Study||0
129860|NCT00224952|311981|P1|NOT COMPLETED|Overall Study||0
129861|NCT00224952|311979|P3|COMPLETED|Overall Study||134
129862|NCT00224952|311980|P2|COMPLETED|Overall Study||87
129863|NCT00224952|311981|P1|COMPLETED|Overall Study||53
129864|NCT00224952|311979|P3|STARTED|Overall Study||134
129865|NCT00224952|311980|P2|STARTED|Overall Study||87
129866|NCT00224952|311981|P1|STARTED|Overall Study||53
129867|NCT00225017|311994|P2|NOT COMPLETED|Overall Study||1
129868|NCT00225017|311995|P1|NOT COMPLETED|Overall Study||0
129869|NCT00225017|311994|P2|COMPLETED|Overall Study|1 subject did not complete week 24 assessments|23
129870|NCT00225017|311995|P1|COMPLETED|Overall Study||26
129871|NCT00225017|311994|P2|STARTED|Overall Study||24
129872|NCT00225017|311995|P1|STARTED|Overall Study||26
129873|NCT00225147|312009|P4|NOT COMPLETED|Open-label Phase||10
129874|NCT00225147|312010|P3|NOT COMPLETED|Open-label Phase||0
129875|NCT00225147|312011|P2|NOT COMPLETED|Open-label Phase||0
129876|NCT00225147|312012|P1|NOT COMPLETED|Open-label Phase||0
129877|NCT00225147|312009|P4|COMPLETED|Open-label Phase||52
129878|NCT00225147|312010|P3|COMPLETED|Open-label Phase||0
129879|NCT00225147|312011|P2|COMPLETED|Open-label Phase||0
129880|NCT00225147|312012|P1|COMPLETED|Open-label Phase||0
129881|NCT00225147|312009|P4|STARTED|Open-label Phase||62
129882|NCT00225147|312010|P3|STARTED|Open-label Phase||0
129883|NCT00225147|312011|P2|STARTED|Open-label Phase||0
129884|NCT00225147|312012|P1|STARTED|Open-label Phase||0
129885|NCT00225147|312009|P4|NOT COMPLETED|Double-blind Phase||0
129886|NCT00225147|312010|P3|NOT COMPLETED|Double-blind Phase||0
129887|NCT00225147|312011|P2|NOT COMPLETED|Double-blind Phase||0
129888|NCT00225147|312012|P1|NOT COMPLETED|Double-blind Phase||0
129889|NCT00225147|312009|P4|COMPLETED|Double-blind Phase||0
129890|NCT00225147|312010|P3|COMPLETED|Double-blind Phase||13
129891|NCT00225147|312011|P2|COMPLETED|Double-blind Phase||12
129892|NCT00225147|312012|P1|COMPLETED|Double-blind Phase||13
129893|NCT00225147|312009|P4|STARTED|Double-blind Phase||0
129894|NCT00225147|312010|P3|STARTED|Double-blind Phase||13
129895|NCT00225147|312011|P2|STARTED|Double-blind Phase||12
129896|NCT00225147|312012|P1|STARTED|Double-blind Phase||13
129897|NCT00225212|312026|P1|NOT COMPLETED|Overall Study||6
129898|NCT00225212|312026|P1|COMPLETED|Overall Study||29
129899|NCT00225212|312026|P1|STARTED|Overall Study||35
129900|NCT00225251|312033|P2|NOT COMPLETED|Overall Study||1
129901|NCT00225251|312034|P1|NOT COMPLETED|Overall Study||1
129902|NCT00225251|312033|P2|COMPLETED|Overall Study||6
129903|NCT00225251|312034|P1|COMPLETED|Overall Study||10
129904|NCT00225251|312033|P2|STARTED|Overall Study||7
129905|NCT00225251|312034|P1|STARTED|Overall Study||11
129906|NCT00225277|312050|P2|NOT COMPLETED|Overall Study||95
129907|NCT00225277|312051|P1|NOT COMPLETED|Overall Study||97
129908|NCT00225277|312050|P2|COMPLETED|Overall Study||178
129909|NCT00225277|312051|P1|COMPLETED|Overall Study||177
129910|NCT00225277|312050|P2|STARTED|Overall Study|Mean treatment durations were 56.3 weeks (glimepiride) and 56.5 weeks (pioglitazone).|273
129911|NCT00225277|312051|P1|STARTED|Overall Study|274 subjects randomized, but four subjects did not receive drug.|274
129912|NCT00225420|312067|P3|NOT COMPLETED|Overall Study||0
129913|NCT00225420|312068|P2|NOT COMPLETED|Overall Study||0
129914|NCT00225420|312069|P1|NOT COMPLETED|Overall Study||0
129915|NCT00225420|312067|P3|COMPLETED|Overall Study||3
129916|NCT00225420|312068|P2|COMPLETED|Overall Study||6
129917|NCT00225420|312069|P1|COMPLETED|Overall Study||9
129918|NCT00225420|312067|P3|STARTED|Overall Study||3
129919|NCT00225420|312068|P2|STARTED|Overall Study||6
129920|NCT00225420|312069|P1|STARTED|Overall Study||9
129921|NCT00225498|312076|P1|NOT COMPLETED|Overall Study||0
129922|NCT00225498|312076|P1|COMPLETED|Overall Study|The only analyses with adequate statistical power were of the 10 ziprasidone nonresponders.|10
129923|NCT00225498|312076|P1|STARTED|Overall Study||10
129924|NCT00225732|312082|P2|NOT COMPLETED|Overall Study||0
129925|NCT00225732|312083|P1|NOT COMPLETED|Overall Study||0
129926|NCT00225732|312082|P2|COMPLETED|Overall Study||166
129927|NCT00225732|312083|P1|COMPLETED|Overall Study||153
129928|NCT00225732|312082|P2|STARTED|Overall Study||166
129929|NCT00225732|312083|P1|STARTED|Overall Study||153
129930|NCT00225784|312089|P1|NOT COMPLETED|Overall Study||4
129931|NCT00225784|312089|P1|COMPLETED|Overall Study||33
129932|NCT00225784|312089|P1|STARTED|Overall Study||37
129933|NCT00231816|312102|P2|NOT COMPLETED|Overall Study||12
129934|NCT00231816|312103|P1|NOT COMPLETED|Overall Study||16
129935|NCT00231816|312102|P2|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|369
129936|NCT00231816|312103|P1|COMPLETED|Overall Study|Participant received required vaccines and returned completed vaccination report cards at Visits 2&3|366
129937|NCT00231816|312102|P2|Vaccinated at Visit 2|Overall Study||371
129938|NCT00231816|312103|P1|Vaccinated at Visit 2|Overall Study||369
129939|NCT00231816|312102|P2|Vaccinated at Visit 1|Overall Study|One participant was randomized but not vaccinated|380
129940|NCT00231816|312103|P1|Vaccinated at Visit 1|Overall Study||382
129941|NCT00231816|312102|P2|STARTED|Overall Study||381
129942|NCT00231816|312103|P1|STARTED|Overall Study||382
129943|NCT00233064|312118|P2|NOT COMPLETED|Overall Study||12
129944|NCT00233064|312119|P1|NOT COMPLETED|Overall Study||14
129945|NCT00233064|312118|P2|COMPLETED|Overall Study||190
129946|NCT00233064|312119|P1|COMPLETED|Overall Study||197
129947|NCT00233064|312118|P2|STARTED|Overall Study||202
129948|NCT00233064|312119|P1|STARTED|Overall Study||211
129949|NCT00233090|312128|P2|NOT COMPLETED|Overall Study||0
129950|NCT00233090|312129|P1|NOT COMPLETED|Overall Study||0
129951|NCT00233090|312128|P2|COMPLETED|Overall Study||9
129952|NCT00233090|312129|P1|COMPLETED|Overall Study||12
129953|NCT00233090|312128|P2|STARTED|Overall Study||9
129954|NCT00233090|312129|P1|STARTED|Overall Study||12
129955|NCT00233103|312151|P2|NOT COMPLETED|Overall Study||6
129956|NCT00233103|312152|P1|NOT COMPLETED|Overall Study||5
129957|NCT00233103|312151|P2|COMPLETED|Overall Study||19
129958|NCT00233103|312152|P1|COMPLETED|Overall Study||22
129959|NCT00233103|312151|P2|STARTED|Overall Study||25
129960|NCT00233103|312152|P1|STARTED|Overall Study||27
129961|NCT00233324|312168|P4|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||11
129962|NCT00233324|312169|P3|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||18
129963|NCT00233324|312170|P2|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||14
129964|NCT00233324|312171|P1|NOT COMPLETED|Follow up at 18-22 Months Corrected Age||13
129965|NCT00233324|312168|P4|COMPLETED|Follow up at 18-22 Months Corrected Age||269
129966|NCT00233324|312169|P3|COMPLETED|Follow up at 18-22 Months Corrected Age||256
129967|NCT00233324|312170|P2|COMPLETED|Follow up at 18-22 Months Corrected Age||261
129968|NCT00233324|312171|P1|COMPLETED|Follow up at 18-22 Months Corrected Age||237
129969|NCT00233324|312168|P4|STARTED|Follow up at 18-22 Months Corrected Age||280
129970|NCT00233324|312169|P3|STARTED|Follow up at 18-22 Months Corrected Age||274
129971|NCT00233324|312170|P2|STARTED|Follow up at 18-22 Months Corrected Age||275
129972|NCT00233324|312171|P1|STARTED|Follow up at 18-22 Months Corrected Age||250
129973|NCT00233324|312168|P4|NOT COMPLETED|Main Study||47
129974|NCT00233324|312169|P3|NOT COMPLETED|Main Study||62
129975|NCT00233324|312170|P2|NOT COMPLETED|Main Study||60
129976|NCT00233324|312171|P1|NOT COMPLETED|Main Study||68
129977|NCT00233324|312168|P4|COMPLETED|Main Study||280
129978|NCT00233324|312169|P3|COMPLETED|Main Study||274
129979|NCT00233324|312170|P2|COMPLETED|Main Study||275
129980|NCT00233324|312171|P1|COMPLETED|Main Study||250
129981|NCT00233324|312168|P4|STARTED|Main Study||327
129982|NCT00233324|312169|P3|STARTED|Main Study||336
129983|NCT00233324|312170|P2|STARTED|Main Study||335
129984|NCT00233324|312171|P1|STARTED|Main Study||318
129985|NCT00233402|312187|P2|NOT COMPLETED|Overall Study||124
129986|NCT00233402|312188|P1|NOT COMPLETED|Overall Study||104
129987|NCT00233402|312187|P2|COMPLETED|Overall Study||271
129988|NCT00233402|312188|P1|COMPLETED|Overall Study||280
129989|NCT00233402|312187|P2|STARTED|Overall Study||395
129990|NCT00233402|312188|P1|STARTED|Overall Study||384
129991|NCT00233454|312199|P1|NOT COMPLETED|Overall Study||6
129992|NCT00233454|312199|P1|COMPLETED|Overall Study||20
129993|NCT00233454|312199|P1|2 Months (for Response Rate)|Overall Study||26
129994|NCT00233454|312199|P1|STARTED|Overall Study||26
129995|NCT00233519|312206|P2|NOT COMPLETED|Overall Study||1
129996|NCT00233519|312207|P1|NOT COMPLETED|Overall Study||1
129997|NCT00233519|312206|P2|COMPLETED|Overall Study||9
129998|NCT00233519|312207|P1|COMPLETED|Overall Study||6
129999|NCT00233519|312206|P2|STARTED|Overall Study||10
130000|NCT00233519|312207|P1|STARTED|Overall Study||7
130001|NCT00233948|312215|P6|NOT COMPLETED|Overall Study||0
130002|NCT00233948|312216|P5|NOT COMPLETED|Overall Study||0
130003|NCT00233948|312217|P4|NOT COMPLETED|Overall Study||0
130004|NCT00233948|312218|P3|NOT COMPLETED|Overall Study||0
130005|NCT00233948|312219|P2|NOT COMPLETED|Overall Study||0
130006|NCT00233948|312220|P1|NOT COMPLETED|Overall Study||1
130007|NCT00233948|312215|P6|COMPLETED|Overall Study||12
130008|NCT00233948|312216|P5|COMPLETED|Overall Study||4
130009|NCT00233948|312217|P4|COMPLETED|Overall Study||3
130010|NCT00233948|312218|P3|COMPLETED|Overall Study||3
130011|NCT00233948|312219|P2|COMPLETED|Overall Study||3
130012|NCT00233948|312220|P1|COMPLETED|Overall Study||3
130013|NCT00233948|312215|P6|STARTED|Overall Study||12
130014|NCT00233948|312216|P5|STARTED|Overall Study||4
130015|NCT00233948|312217|P4|STARTED|Overall Study||3
130016|NCT00233948|312218|P3|STARTED|Overall Study||3
130017|NCT00233948|312219|P2|STARTED|Overall Study||3
130018|NCT00233948|312220|P1|STARTED|Overall Study||4
130019|NCT00233987|312235|P1|NOT COMPLETED|Overall Study||15
130020|NCT00233987|312235|P1|COMPLETED|Overall Study||83
130021|NCT00233987|312235|P1|Eligible and Treated|Overall Study||92
130022|NCT00233987|312235|P1|Eligible|Overall Study||94
130023|NCT00233987|312235|P1|STARTED|Overall Study||98
130024|NCT00234039|312242|P1|NOT COMPLETED|Overall Study||50
130025|NCT00234039|312242|P1|COMPLETED|Overall Study||8
130026|NCT00234039|312242|P1|Eligible and Began Protocol Therapy|Overall Study||47
130027|NCT00234039|312242|P1|Eligible|Overall Study||49
130028|NCT00234039|312242|P1|STARTED|Overall Study||58
130029|NCT00234065|312251|P2|NOT COMPLETED|Overall Study||356
130030|NCT00234065|312252|P1|NOT COMPLETED|Overall Study||475
130031|NCT00234065|312251|P2|COMPLETED|Overall Study||1004
130032|NCT00234065|312252|P1|COMPLETED|Overall Study||881
130033|NCT00234065|312251|P2|STARTED|Overall Study||1360
130034|NCT00234065|312252|P1|STARTED|Overall Study||1356
130035|NCT00234078|312272|P4|NOT COMPLETED|Overall Study||4
130036|NCT00234078|312273|P3|NOT COMPLETED|Overall Study||10
130037|NCT00234078|312274|P2|NOT COMPLETED|Overall Study||9
130038|NCT00234078|312275|P1|NOT COMPLETED|Overall Study||6
130039|NCT00234078|312272|P4|COMPLETED|Overall Study||68
130040|NCT00234078|312273|P3|COMPLETED|Overall Study||64
130041|NCT00234078|312274|P2|COMPLETED|Overall Study||63
130042|NCT00234078|312275|P1|COMPLETED|Overall Study||66
130043|NCT00234078|312272|P4|STARTED|Overall Study||72
130044|NCT00234078|312273|P3|STARTED|Overall Study||74
130045|NCT00234078|312274|P2|STARTED|Overall Study||72
130046|NCT00234078|312275|P1|STARTED|Overall Study||72
130047|NCT00234104|312301|P4|NOT COMPLETED|Overall Study||8
130048|NCT00234104|312302|P3|NOT COMPLETED|Overall Study||5
130049|NCT00234104|312303|P2|NOT COMPLETED|Overall Study||1
130050|NCT00234104|312304|P1|NOT COMPLETED|Overall Study||4
130051|NCT00234104|312301|P4|COMPLETED|Overall Study||21
130052|NCT00234104|312302|P3|COMPLETED|Overall Study||29
130053|NCT00234104|312303|P2|COMPLETED|Overall Study||28
130054|NCT00234104|312304|P1|COMPLETED|Overall Study||26
130055|NCT00234104|312301|P4|STARTED|Overall Study||29
130056|NCT00234104|312302|P3|STARTED|Overall Study||34
130057|NCT00234104|312303|P2|STARTED|Overall Study||29
130058|NCT00234104|312304|P1|STARTED|Overall Study||30
130059|NCT00234286|312314|P1|NOT COMPLETED|Overall Study||0
130060|NCT00234286|312314|P1|COMPLETED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
130061|NCT00234286|312314|P1|STARTED|Overall Study|We reviewed eletronic health records for 6066 deceased individuals within 6 VA Hospitals|6066
130062|NCT00234494|312349|P1|NOT COMPLETED|Overall Study||2
130063|NCT00234494|312349|P1|COMPLETED|Overall Study||43
130064|NCT00234494|312349|P1|STARTED|Overall Study||45
130065|NCT00234832|312358|P2|NOT COMPLETED|Overall Study||996
130066|NCT00234832|312359|P1|NOT COMPLETED|Overall Study||1016
130067|NCT00234832|312358|P2|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3902
130068|NCT00234832|312359|P1|COMPLETED|Overall Study|Subjects completed the Randomization Phase.|3890
130069|NCT00234832|312358|P2|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4898
130070|NCT00234832|312359|P1|STARTED|Overall Study|Subjects completed the 6-week Lead-in Period and were dispensed randomized study drug.|4906
130071|NCT00234884|312384|P1|NOT COMPLETED|Overall Study||1630
130072|NCT00234884|312384|P1|COMPLETED|Overall Study||1805
130073|NCT00234884|312384|P1|STARTED|Overall Study||3435
130074|NCT00235326|312394|P2|NOT COMPLETED|Overall Study||1400
130075|NCT00235326|312395|P1|NOT COMPLETED|Overall Study||746
130076|NCT00235326|312394|P2|COMPLETED|Overall Study||1586
130077|NCT00235326|312395|P1|COMPLETED|Overall Study||829
130078|NCT00235326|312394|P2|STARTED|Overall Study||2986
130079|NCT00235326|312395|P1|STARTED|Overall Study||1575
130080|NCT00235391|312405|P6|NOT COMPLETED|Overall Study||4
130081|NCT00235391|312406|P5|NOT COMPLETED|Overall Study||12
130082|NCT00235391|312407|P4|NOT COMPLETED|Overall Study||220
130083|NCT00235391|312408|P3|NOT COMPLETED|Overall Study||24
130084|NCT00235391|312409|P2|NOT COMPLETED|Overall Study||18
130085|NCT00235391|312410|P1|NOT COMPLETED|Overall Study||12
130086|NCT00235391|312405|P6|COMPLETED|Overall Study||3
130087|NCT00235391|312406|P5|COMPLETED|Overall Study||31
130088|NCT00235391|312407|P4|COMPLETED|Overall Study||944
130089|NCT00235391|312408|P3|COMPLETED|Overall Study||148
130090|NCT00235391|312409|P2|COMPLETED|Overall Study||182
130091|NCT00235391|312410|P1|COMPLETED|Overall Study||85
130092|NCT00235391|312405|P6|Deferasirox Treatment|Overall Study||7
130093|NCT00235391|312406|P5|Deferasirox Treatment|Overall Study||43
130094|NCT00235391|312407|P4|Deferasirox Treatment|Overall Study||1164
130095|NCT00235391|312408|P3|Deferasirox Treatment|Overall Study||172
130096|NCT00235391|312409|P2|Deferasirox Treatment|Overall Study||200
130097|NCT00235391|312410|P1|Deferasirox Treatment|Overall Study||97
130098|NCT00235391|312405|P6|STARTED|Overall Study||7
130099|NCT00235391|312406|P5|STARTED|Overall Study||43
130100|NCT00235391|312407|P4|STARTED|Overall Study||1164
130101|NCT00235391|312408|P3|STARTED|Overall Study||172
130102|NCT00235391|312409|P2|STARTED|Overall Study||200
130103|NCT00235391|312410|P1|STARTED|Overall Study||97
130104|NCT00235443|312431|P6|NOT COMPLETED|Overall Study||45
130105|NCT00235443|312432|P5|NOT COMPLETED|Overall Study||30
130106|NCT00235443|312433|P4|NOT COMPLETED|Overall Study||97
130107|NCT00235443|312434|P3|NOT COMPLETED|Overall Study||62
130108|NCT00235443|312435|P2|NOT COMPLETED|Overall Study||38
130109|NCT00235443|312436|P1|NOT COMPLETED|Overall Study||8
130110|NCT00235443|312431|P6|COMPLETED|Overall Study||9
130111|NCT00235443|312432|P5|COMPLETED|Overall Study||9
130112|NCT00235443|312433|P4|COMPLETED|Overall Study||108
130113|NCT00235443|312434|P3|COMPLETED|Overall Study||23
130114|NCT00235443|312435|P2|COMPLETED|Overall Study||19
130115|NCT00235443|312436|P1|COMPLETED|Overall Study||3
130116|NCT00235443|312431|P6|STARTED|Overall Study||54
130117|NCT00235443|312432|P5|STARTED|Overall Study||39
130118|NCT00235443|312433|P4|STARTED|Overall Study||205
130119|NCT00235443|312434|P3|STARTED|Overall Study||85
130120|NCT00235443|312435|P2|STARTED|Overall Study||57
130121|NCT00235443|312436|P1|STARTED|Overall Study||11
130122|NCT00235456|312573|P2|NOT COMPLETED|Overall Study||7
130123|NCT00235456|312574|P1|NOT COMPLETED|Overall Study||2
130124|NCT00235456|312573|P2|COMPLETED|Overall Study||143
130125|NCT00235456|312574|P1|COMPLETED|Overall Study||148
130126|NCT00235456|312573|P2|STARTED|Overall Study||150
130127|NCT00235456|312574|P1|STARTED|Overall Study||150
130128|NCT00229203|312592|P2|NOT COMPLETED|Overall Study||19
130129|NCT00229203|312593|P1|NOT COMPLETED|Overall Study||32
130130|NCT00229203|312592|P2|COMPLETED|Overall Study||0
130131|NCT00229203|312593|P1|COMPLETED|Overall Study||0
130132|NCT00229203|312592|P2|STARTED|Overall Study||19
130133|NCT00229203|312593|P1|STARTED|Overall Study||32
130134|NCT00235573|312605|P1|NOT COMPLETED|Overall Study||0
130135|NCT00235573|312605|P1|COMPLETED|Overall Study||21
130136|NCT00235573|312605|P1|STARTED|Overall Study|35 subjects screened; 14 not eligible; 21 started and completed study|21
130137|NCT00235716|312613|P4|NOT COMPLETED|Overall Study||62
130138|NCT00235716|312614|P3|NOT COMPLETED|Overall Study||65
130139|NCT00235716|312615|P2|NOT COMPLETED|Overall Study||67
130140|NCT00235716|312616|P1|NOT COMPLETED|Overall Study||62
130141|NCT00235716|312613|P4|COMPLETED|Overall Study||90
130142|NCT00235716|312614|P3|COMPLETED|Overall Study||89
130143|NCT00235716|312615|P2|COMPLETED|Overall Study||88
130144|NCT00235716|312616|P1|COMPLETED|Overall Study||90
130145|NCT00235716|312613|P4|STARTED|Overall Study||152
130146|NCT00235716|312614|P3|STARTED|Overall Study||154
130147|NCT00235716|312615|P2|STARTED|Overall Study||155
130148|NCT00235716|312616|P1|STARTED|Overall Study||152
130149|NCT00235755|312653|P3|NOT COMPLETED|12-Week Maintenance Phase||31
130150|NCT00235755|312654|P2|NOT COMPLETED|12-Week Maintenance Phase||27
130151|NCT00235755|312655|P1|NOT COMPLETED|12-Week Maintenance Phase||16
130152|NCT00235755|312653|P3|COMPLETED|12-Week Maintenance Phase||122
130153|NCT00235755|312654|P2|COMPLETED|12-Week Maintenance Phase||135
130154|NCT00235755|312655|P1|COMPLETED|12-Week Maintenance Phase||152
130155|NCT00235755|312653|P3|STARTED|12-Week Maintenance Phase||153
130156|NCT00235755|312654|P2|STARTED|12-Week Maintenance Phase||162
130157|NCT00235755|312655|P1|STARTED|12-Week Maintenance Phase||168
130158|NCT00235755|312653|P3|NOT COMPLETED|4-Week Titration Phase||26
130159|NCT00235755|312654|P2|NOT COMPLETED|4-Week Titration Phase||19
130160|NCT00235755|312655|P1|NOT COMPLETED|4-Week Titration Phase||11
130161|NCT00235755|312653|P3|COMPLETED|4-Week Titration Phase||153
130162|NCT00235755|312654|P2|COMPLETED|4-Week Titration Phase||162
130163|NCT00235755|312655|P1|COMPLETED|4-Week Titration Phase||168
130164|NCT00235755|312653|P3|STARTED|4-Week Titration Phase||179
130165|NCT00235755|312654|P2|STARTED|4-Week Titration Phase||181
130166|NCT00235755|312655|P1|STARTED|4-Week Titration Phase||179
130167|NCT00235833|312729|P1|NOT COMPLETED|Overall Study||16
130168|NCT00235833|312729|P1|COMPLETED|Overall Study||9
130169|NCT00235833|312729|P1|STARTED|Overall Study||25
130170|NCT00235872|312742|P1|NOT COMPLETED|Overall Study||147
130171|NCT00235872|312742|P1|COMPLETED|Overall Study||162
130172|NCT00235872|312742|P1|STARTED|Overall Study||309
130173|NCT00236080|312762|P5|NOT COMPLETED|Overall Study||1
130174|NCT00236080|312763|P4|NOT COMPLETED|Overall Study||2
130175|NCT00236080|312764|P3|NOT COMPLETED|Overall Study||5
130176|NCT00236080|312765|P2|NOT COMPLETED|Overall Study||1
130177|NCT00236080|312766|P1|NOT COMPLETED|Overall Study||2
130178|NCT00236080|312762|P5|COMPLETED|Overall Study||26
130179|NCT00236080|312763|P4|COMPLETED|Overall Study||23
130180|NCT00236080|312764|P3|COMPLETED|Overall Study||22
130181|NCT00236080|312765|P2|COMPLETED|Overall Study||27
130182|NCT00236080|312766|P1|COMPLETED|Overall Study||27
130183|NCT00236080|312762|P5|STARTED|Overall Study||27
130184|NCT00236080|312763|P4|STARTED|Overall Study||25
130185|NCT00236080|312764|P3|STARTED|Overall Study||27
130186|NCT00236080|312765|P2|STARTED|Overall Study||28
130187|NCT00236080|312766|P1|STARTED|Overall Study||29
130188|NCT00236184|312785|P2|NOT COMPLETED|Overall Study||11
130189|NCT00236184|312786|P1|NOT COMPLETED|Overall Study||18
130190|NCT00236184|312785|P2|COMPLETED|Overall Study||308
130191|NCT00236184|312786|P1|COMPLETED|Overall Study||292
130192|NCT00236184|312785|P2|STARTED|Overall Study||319
130193|NCT00236184|312786|P1|STARTED|Overall Study||310
130194|NCT00236197|312794|P2|NOT COMPLETED|Overall Study||14
130195|NCT00236197|312795|P1|NOT COMPLETED|Overall Study||5
130196|NCT00236197|312794|P2|COMPLETED|Overall Study||293
130197|NCT00236197|312795|P1|COMPLETED|Overall Study||307
130198|NCT00236197|312794|P2|STARTED|Overall Study||307
130199|NCT00236197|312795|P1|STARTED|Overall Study||312
130200|NCT00236899|312805|P4|NOT COMPLETED|Overall Study||40
130201|NCT00236899|312806|P3|NOT COMPLETED|Overall Study||44
130202|NCT00236899|312807|P2|NOT COMPLETED|Overall Study||40
130203|NCT00236899|312808|P1|NOT COMPLETED|Overall Study||42
130204|NCT00236899|312805|P4|COMPLETED|Overall Study||19
130205|NCT00236899|312806|P3|COMPLETED|Overall Study||14
130206|NCT00236899|312807|P2|COMPLETED|Overall Study||24
130207|NCT00236899|312808|P1|COMPLETED|Overall Study||18
130208|NCT00236899|312805|P4|STARTED|Overall Study||59
130209|NCT00236899|312806|P3|STARTED|Overall Study||58
130210|NCT00236899|312807|P2|STARTED|Overall Study||64
130211|NCT00236899|312808|P1|STARTED|Overall Study||60
130212|NCT00236938|312840|P2|NOT COMPLETED|Overall Study||20
130213|NCT00236938|312841|P1|NOT COMPLETED|Overall Study||13
130214|NCT00236938|312840|P2|COMPLETED|Overall Study||26
130215|NCT00236938|312841|P1|COMPLETED|Overall Study||62
130216|NCT00236938|312840|P2|STARTED|Overall Study||46
130217|NCT00236938|312841|P1|STARTED|Overall Study||75
130218|NCT00236951|312857|P4|NOT COMPLETED|Overall Study||31
130219|NCT00236951|312858|P3|NOT COMPLETED|Overall Study||19
130220|NCT00236951|312859|P2|NOT COMPLETED|Overall Study||31
130221|NCT00236951|312860|P1|NOT COMPLETED|Overall Study||26
130222|NCT00236951|312857|P4|COMPLETED|Overall Study||17
130223|NCT00236951|312858|P3|COMPLETED|Overall Study||21
130224|NCT00236951|312859|P2|COMPLETED|Overall Study||46
130225|NCT00236951|312860|P1|COMPLETED|Overall Study||33
130226|NCT00236951|312857|P4|STARTED|Overall Study||48
130227|NCT00236951|312858|P3|STARTED|Overall Study||40
130228|NCT00236951|312859|P2|STARTED|Overall Study||77
130229|NCT00236951|312860|P1|STARTED|Overall Study||59
130230|NCT00236977|312872|P2|NOT COMPLETED|Overall Study||19
130231|NCT00236977|312873|P1|NOT COMPLETED|Overall Study||21
130232|NCT00236977|312872|P2|COMPLETED|Overall Study||72
130233|NCT00236977|312873|P1|COMPLETED|Overall Study||70
130234|NCT00236977|312872|P2|STARTED|Overall Study||91
130235|NCT00236977|312873|P1|STARTED|Overall Study||91
130236|NCT00237042|312894|P3|NOT COMPLETED|Long Term (12 Month) Follow up||9
130237|NCT00237042|312895|P2|NOT COMPLETED|Long Term (12 Month) Follow up||9
130238|NCT00237042|312896|P1|NOT COMPLETED|Long Term (12 Month) Follow up||11
130239|NCT00237042|312894|P3|COMPLETED|Long Term (12 Month) Follow up||48
130240|NCT00237042|312895|P2|COMPLETED|Long Term (12 Month) Follow up||46
130241|NCT00237042|312896|P1|COMPLETED|Long Term (12 Month) Follow up||48
130242|NCT00237042|312894|P3|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
130243|NCT00237042|312895|P2|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
130244|NCT00237042|312896|P1|STARTED|Long Term (12 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
130245|NCT00237042|312894|P3|NOT COMPLETED|Short Term (6 Month) Follow up||11
130246|NCT00237042|312895|P2|NOT COMPLETED|Short Term (6 Month) Follow up||8
130247|NCT00237042|312896|P1|NOT COMPLETED|Short Term (6 Month) Follow up||9
130248|NCT00237042|312894|P3|COMPLETED|Short Term (6 Month) Follow up||46
130249|NCT00237042|312895|P2|COMPLETED|Short Term (6 Month) Follow up||47
130250|NCT00237042|312896|P1|COMPLETED|Short Term (6 Month) Follow up||50
130251|NCT00237042|312894|P3|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|57
130252|NCT00237042|312895|P2|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|55
130253|NCT00237042|312896|P1|STARTED|Short Term (6 Month) Follow up|Greater than number completing treatment: intent to treat analysis|59
130254|NCT00237042|312894|P3|NOT COMPLETED|Treatment||38
130255|NCT00237042|312895|P2|NOT COMPLETED|Treatment||7
130256|NCT00237042|312896|P1|NOT COMPLETED|Treatment||6
130257|NCT00237042|312894|P3|COMPLETED|Treatment||36
130258|NCT00237042|312895|P2|COMPLETED|Treatment||50
130259|NCT00237042|312896|P1|COMPLETED|Treatment||54
130260|NCT00237042|312894|P3|STARTED|Treatment||74
130261|NCT00237042|312895|P2|STARTED|Treatment||57
130262|NCT00237042|312896|P1|STARTED|Treatment||60
130263|NCT00237185|312915|P2|NOT COMPLETED|Extension||19
130264|NCT00237185|312916|P1|NOT COMPLETED|Extension||16
130265|NCT00237185|312915|P2|COMPLETED|Extension||13
130266|NCT00237185|312916|P1|COMPLETED|Extension||8
130267|NCT00237185|312915|P2|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|32
130268|NCT00237185|312916|P1|STARTED|Extension|A portion of the participants, who completed the core, entered the extension.|24
130269|NCT00237185|312915|P2|NOT COMPLETED|Core||37
130270|NCT00237185|312916|P1|NOT COMPLETED|Core||44
130271|NCT00237185|312915|P2|COMPLETED|Core||37
130272|NCT00237185|312916|P1|COMPLETED|Core||30
130273|NCT00237185|312915|P2|Treated Participants|Core||74
130274|NCT00237185|312916|P1|Treated Participants|Core||73
130275|NCT00237185|312915|P2|STARTED|Core||74
130276|NCT00237185|312916|P1|STARTED|Core||74
130277|NCT00237458|312944|P1|NOT COMPLETED|Overall Study||3
130278|NCT00237458|312944|P1|COMPLETED|Overall Study||4
130279|NCT00237458|312944|P1|STARTED|Overall Study||7
130280|NCT00237666|312960|P1|NOT COMPLETED|Overall Study||6
130281|NCT00237666|312960|P1|COMPLETED|Overall Study||24
130282|NCT00237666|312960|P1|STARTED|Overall Study||30
130283|NCT00237692|312974|P4|NOT COMPLETED|Overall Study||19
130284|NCT00237692|312975|P3|NOT COMPLETED|Overall Study||22
130285|NCT00237692|312976|P2|NOT COMPLETED|Overall Study||14
130286|NCT00237692|312977|P1|NOT COMPLETED|Overall Study||18
130287|NCT00237692|312974|P4|COMPLETED|Overall Study||128
130288|NCT00237692|312975|P3|COMPLETED|Overall Study||127
130289|NCT00237692|312976|P2|COMPLETED|Overall Study||134
130290|NCT00237692|312977|P1|COMPLETED|Overall Study||129
130291|NCT00237692|312974|P4|18 Month f/u|Overall Study||122
130292|NCT00237692|312975|P3|18 Month f/u|Overall Study||126
130293|NCT00237692|312976|P2|18 Month f/u|Overall Study||131
130294|NCT00237692|312977|P1|18 Month f/u|Overall Study||124
130295|NCT00237692|312974|P4|12 Month f/u|Overall Study||127
130296|NCT00237692|312975|P3|12 Month f/u|Overall Study||132
130297|NCT00237692|312976|P2|12 Month f/u|Overall Study||127
130298|NCT00237692|312977|P1|12 Month f/u|Overall Study||137
130299|NCT00237692|312974|P4|6 Month f/u|Overall Study||134
130300|NCT00237692|312975|P3|6 Month f/u|Overall Study||135
130301|NCT00237692|312976|P2|6 Month f/u|Overall Study||134
130302|NCT00237692|312977|P1|6 Month f/u|Overall Study||132
130303|NCT00237692|312974|P4|STARTED|Overall Study||147
130304|NCT00237692|312975|P3|STARTED|Overall Study||149
130305|NCT00237692|312976|P2|STARTED|Overall Study||148
130306|NCT00237692|312977|P1|STARTED|Overall Study||147
130307|NCT00237718|313009|P2|NOT COMPLETED|Overall Study||41
130308|NCT00237718|313010|P1|NOT COMPLETED|Overall Study||46
130309|NCT00237718|313009|P2|COMPLETED|Overall Study||124
130310|NCT00237718|313010|P1|COMPLETED|Overall Study||114
130311|NCT00237718|313009|P2|STARTED|Overall Study||165
130312|NCT00237718|313010|P1|STARTED|Overall Study||160
130313|NCT00237744|313021|P3|NOT COMPLETED|Overall Study||0
130314|NCT00237744|313022|P2|NOT COMPLETED|Overall Study||1
130315|NCT00237744|313023|P1|NOT COMPLETED|Overall Study||3
130316|NCT00237744|313021|P3|COMPLETED|Overall Study||18
130317|NCT00237744|313022|P2|COMPLETED|Overall Study||10
130318|NCT00237744|313023|P1|COMPLETED|Overall Study||8
130319|NCT00237744|313021|P3|STARTED|Overall Study||18
130320|NCT00237744|313022|P2|STARTED|Overall Study||11
130321|NCT00237744|313023|P1|STARTED|Overall Study||11
130322|NCT00237770|313036|P2|NOT COMPLETED|Overall Study||0
130323|NCT00237770|313037|P1|NOT COMPLETED|Overall Study||0
130324|NCT00237770|313036|P2|COMPLETED|Overall Study||7
130325|NCT00237770|313037|P1|COMPLETED|Overall Study||9
130326|NCT00237770|313036|P2|STARTED|Overall Study||7
130327|NCT00237770|313037|P1|STARTED|Overall Study||9
130328|NCT00237796|313049|P2|NOT COMPLETED|Overall Study||5
130329|NCT00237796|313050|P1|NOT COMPLETED|Overall Study||10
130330|NCT00237796|313049|P2|COMPLETED|Overall Study||33
130331|NCT00237796|313050|P1|COMPLETED|Overall Study||31
130332|NCT00237796|313049|P2|STARTED|Overall Study||38
130333|NCT00237796|313050|P1|STARTED|Overall Study||41
130334|NCT00237809|313072|P4|NOT COMPLETED|Overall Study||9
130335|NCT00237809|313073|P3|NOT COMPLETED|Overall Study||9
130336|NCT00237809|313074|P2|NOT COMPLETED|Overall Study||10
130337|NCT00237809|313075|P1|NOT COMPLETED|Overall Study||11
130338|NCT00237809|313072|P4|COMPLETED|Overall Study||17
130339|NCT00237809|313073|P3|COMPLETED|Overall Study||15
130340|NCT00237809|313074|P2|COMPLETED|Overall Study||17
130341|NCT00237809|313075|P1|COMPLETED|Overall Study||16
130342|NCT00237809|313072|P4|STARTED|Overall Study||26
130343|NCT00237809|313073|P3|STARTED|Overall Study||24
130344|NCT00237809|313074|P2|STARTED|Overall Study||27
130345|NCT00237809|313075|P1|STARTED|Overall Study||27
130346|NCT00238108|313111|P2|NOT COMPLETED|Overall Study||0
130347|NCT00238108|313112|P1|NOT COMPLETED|Overall Study||0
130348|NCT00238108|313111|P2|COMPLETED|Overall Study||8
130349|NCT00238108|313112|P1|COMPLETED|Overall Study||8
130350|NCT00238108|313111|P2|STARTED|Overall Study||8
130351|NCT00238108|313112|P1|STARTED|Overall Study||8
130352|NCT00238121|313120|P2|NOT COMPLETED|Overall Study||2
130353|NCT00238121|313121|P1|NOT COMPLETED|Overall Study||3
130354|NCT00238121|313120|P2|COMPLETED|Overall Study||14
130355|NCT00238121|313121|P1|COMPLETED|Overall Study||37
130356|NCT00238121|313120|P2|STARTED|Overall Study||16
130357|NCT00238121|313121|P1|STARTED|Overall Study||40
130358|NCT00238238|313135|P3|NOT COMPLETED|Overall Study||0
130359|NCT00238238|313136|P2|NOT COMPLETED|Overall Study||3
130360|NCT00238238|313137|P1|NOT COMPLETED|Overall Study||0
130361|NCT00238238|313135|P3|COMPLETED|Overall Study||46
130362|NCT00238238|313136|P2|COMPLETED|Overall Study||45
130363|NCT00238238|313137|P1|COMPLETED|Overall Study||3
130364|NCT00238238|313135|P3|STARTED|Overall Study||46
130365|NCT00238238|313136|P2|STARTED|Overall Study||48
130366|NCT00238238|313137|P1|STARTED|Overall Study||3
130367|NCT00238264|313148|P1|NOT COMPLETED|Overall Study||36
130368|NCT00238264|313148|P1|COMPLETED|Overall Study||56
130369|NCT00238264|313148|P1|STARTED|Overall Study||92
130370|NCT00238303|313161|P3|NOT COMPLETED|Overall Study||9
130371|NCT00238303|313162|P2|NOT COMPLETED|Overall Study||2
130372|NCT00238303|313163|P1|NOT COMPLETED|Overall Study||15
130373|NCT00238303|313161|P3|COMPLETED|Overall Study||11
130374|NCT00238303|313162|P2|COMPLETED|Overall Study||13
130375|NCT00238303|313163|P1|COMPLETED|Overall Study||53
130376|NCT00238303|313161|P3|STARTED|Overall Study||20
130377|NCT00238303|313162|P2|STARTED|Overall Study||15
130378|NCT00238303|313163|P1|STARTED|Overall Study||68
130379|NCT00238355|313180|P1|NOT COMPLETED|Overall Study||3
130380|NCT00238355|313180|P1|COMPLETED|Overall Study||10
130381|NCT00238355|313180|P1|STARTED|Overall Study||13
130382|NCT00238420|313186|P2|NOT COMPLETED|Overall Study||1
130383|NCT00238420|313187|P1|NOT COMPLETED|Overall Study||1
130384|NCT00238420|313186|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|47
130385|NCT00238420|313187|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|21
130386|NCT00238420|313186|P2|STARTED|Overall Study||48
130387|NCT00238420|313187|P1|STARTED|Overall Study||22
130388|NCT00238433|313197|P1|NOT COMPLETED|Overall Study||3
130389|NCT00238433|313197|P1|COMPLETED|Overall Study||34
130390|NCT00238433|313197|P1|STARTED|Overall Study||37
130391|NCT00232141|313204|P2|NOT COMPLETED|Overall Study||26
130392|NCT00232141|313205|P1|NOT COMPLETED|Overall Study||31
130393|NCT00232141|313204|P2|COMPLETED|Overall Study||125
130394|NCT00232141|313205|P1|COMPLETED|Overall Study||120
130395|NCT00232141|313204|P2|STARTED|Overall Study||151
130396|NCT00232141|313205|P1|STARTED|Overall Study||151
130397|NCT00232180|313275|P3|NOT COMPLETED|Open Label Phase||148
130398|NCT00232180|313276|P2|NOT COMPLETED|Open Label Phase||0
130399|NCT00232180|313277|P1|NOT COMPLETED|Open Label Phase||0
130400|NCT00232180|313275|P3|COMPLETED|Open Label Phase||1098
130401|NCT00232180|313276|P2|COMPLETED|Open Label Phase||0
130402|NCT00232180|313277|P1|COMPLETED|Open Label Phase||0
130403|NCT00232180|313275|P3|Treated|Open Label Phase||1245
130404|NCT00232180|313276|P2|Treated|Open Label Phase||0
130405|NCT00232180|313277|P1|Treated|Open Label Phase||0
130406|NCT00232180|313275|P3|STARTED|Open Label Phase||1246
130407|NCT00232180|313276|P2|STARTED|Open Label Phase||0
130408|NCT00232180|313277|P1|STARTED|Open Label Phase||0
130409|NCT00232180|313275|P3|NOT COMPLETED|Double-blind (DB) Phase||0
130410|NCT00232180|313276|P2|NOT COMPLETED|Double-blind (DB) Phase||605
130411|NCT00232180|313277|P1|NOT COMPLETED|Double-blind (DB) Phase||541
130412|NCT00232180|313275|P3|COMPLETED|Double-blind (DB) Phase||0
130413|NCT00232180|313276|P2|COMPLETED|Double-blind (DB) Phase||771
130414|NCT00232180|313277|P1|COMPLETED|Double-blind (DB) Phase||826
130415|NCT00232180|313275|P3|Treated|Double-blind (DB) Phase||0
130416|NCT00232180|313276|P2|Treated|Double-blind (DB) Phase||1372
130417|NCT00232180|313277|P1|Treated|Double-blind (DB) Phase||1364
130418|NCT00232180|313275|P3|STARTED|Double-blind (DB) Phase||0
130419|NCT00232180|313276|P2|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1376
130420|NCT00232180|313277|P1|STARTED|Double-blind (DB) Phase|Three participants in each arm were enrolled after data cut-off.|1367
130421|NCT00232479|313320|P1|NOT COMPLETED|Overall Study||0
130422|NCT00232479|313320|P1|COMPLETED|Overall Study||44
130423|NCT00232479|313320|P1|STARTED|Overall Study||44
130424|NCT00232505|313327|P2|NOT COMPLETED|Overall Study||11
130425|NCT00232505|313328|P1|NOT COMPLETED|Overall Study||5
130426|NCT00232505|313327|P2|COMPLETED|Overall Study||60
130427|NCT00232505|313328|P1|COMPLETED|Overall Study||26
130428|NCT00232505|313327|P2|Off Protocol|Overall Study||0
130429|NCT00232505|313328|P1|Off Protocol|Overall Study||5
130430|NCT00232505|313327|P2|Early Progressors|Overall Study||5
130431|NCT00232505|313328|P1|Early Progressors|Overall Study||2
130432|NCT00232505|313327|P2|Not Evaluable|Overall Study||6
130433|NCT00232505|313328|P1|Not Evaluable|Overall Study||0
130434|NCT00232505|313327|P2|STARTED|Overall Study||71
130435|NCT00232505|313328|P1|STARTED|Overall Study||31
130436|NCT00232544|313343|P2|NOT COMPLETED|Overall Study||15
130437|NCT00232544|313344|P1|NOT COMPLETED|Overall Study||20
130438|NCT00232544|313343|P2|COMPLETED|Overall Study||111
130439|NCT00232544|313344|P1|COMPLETED|Overall Study||104
130440|NCT00232544|313343|P2|STARTED|Overall Study||126
130441|NCT00232544|313344|P1|STARTED|Overall Study||124
130442|NCT00232557|313354|P2|NOT COMPLETED|Overall Study||5
130443|NCT00232557|313355|P1|NOT COMPLETED|Overall Study||3
130444|NCT00232557|313354|P2|COMPLETED|Overall Study||60
130445|NCT00232557|313355|P1|COMPLETED|Overall Study||68
130446|NCT00232557|313354|P2|STARTED|Overall Study||65
130447|NCT00232557|313355|P1|STARTED|Overall Study||71
130448|NCT00232583|313365|P2|NOT COMPLETED|Overall Study||13
130449|NCT00232583|313366|P1|NOT COMPLETED|Overall Study||10
130450|NCT00232583|313365|P2|COMPLETED|Overall Study||16
130451|NCT00232583|313366|P1|COMPLETED|Overall Study||19
130452|NCT00232583|313365|P2|STARTED|Overall Study||29
130453|NCT00232583|313366|P1|STARTED|Overall Study||29
130454|NCT00232596|313374|P2|NOT COMPLETED|12-Week Maintenance Phase||28
130455|NCT00232596|313375|P1|NOT COMPLETED|12-Week Maintenance Phase||12
130456|NCT00232596|313374|P2|COMPLETED|12-Week Maintenance Phase||97
130457|NCT00232596|313375|P1|COMPLETED|12-Week Maintenance Phase|One participant withdrew after being considered a “completer” and is listed as an early withdraw.|126
130458|NCT00232596|313374|P2|STARTED|12-Week Maintenance Phase||125
130459|NCT00232596|313375|P1|STARTED|12-Week Maintenance Phase||138
130460|NCT00232596|313374|P2|NOT COMPLETED|6-Week Titration Phase||29
130461|NCT00232596|313375|P1|NOT COMPLETED|6-Week Titration Phase||14
130462|NCT00232596|313374|P2|COMPLETED|6-Week Titration Phase||125
130463|NCT00232596|313375|P1|COMPLETED|6-Week Titration Phase||138
130464|NCT00232596|313374|P2|STARTED|6-Week Titration Phase||154
130465|NCT00232596|313375|P1|STARTED|6-Week Titration Phase||152
130466|NCT00232739|313425|P1|NOT COMPLETED|Overall Study||9
130467|NCT00232739|313425|P1|COMPLETED|Overall Study||91
130468|NCT00232739|313425|P1|STARTED|Overall Study||100
130469|NCT00238615|313442|P1|NOT COMPLETED|Overall Study||0
130470|NCT00238615|313442|P1|COMPLETED|Overall Study||13
130471|NCT00238615|313442|P1|STARTED|Overall Study||13
130472|NCT00240487|313450|P2|NOT COMPLETED|Overall Study||0
130473|NCT00240487|313451|P1|NOT COMPLETED|Overall Study||0
130474|NCT00240487|313450|P2|COMPLETED|Overall Study||28
130475|NCT00240487|313451|P1|COMPLETED|Overall Study||24
130476|NCT00240487|313450|P2|STARTED|Overall Study||28
130477|NCT00240487|313451|P1|STARTED|Overall Study||24
130478|NCT00240500|313463|P6|NOT COMPLETED|Overall Study||1
130479|NCT00240500|313464|P5|NOT COMPLETED|Overall Study||3
130480|NCT00240500|313465|P4|NOT COMPLETED|Overall Study||4
130481|NCT00240500|313466|P3|NOT COMPLETED|Overall Study||3
130482|NCT00240500|313467|P2|NOT COMPLETED|Overall Study||3
130483|NCT00240500|313468|P1|NOT COMPLETED|Overall Study||1
130484|NCT00240500|313463|P6|COMPLETED|Overall Study||2
130485|NCT00240500|313464|P5|COMPLETED|Overall Study||26
130486|NCT00240500|313465|P4|COMPLETED|Overall Study||19
130487|NCT00240500|313466|P3|COMPLETED|Overall Study||14
130488|NCT00240500|313467|P2|COMPLETED|Overall Study||17
130489|NCT00240500|313468|P1|COMPLETED|Overall Study||16
130490|NCT00240500|313463|P6|STARTED|Overall Study||3
130491|NCT00240500|313464|P5|STARTED|Overall Study||29
130492|NCT00240500|313465|P4|STARTED|Overall Study||23
130493|NCT00240500|313466|P3|STARTED|Overall Study||17
130494|NCT00240500|313467|P2|STARTED|Overall Study||20
130495|NCT00240500|313468|P1|STARTED|Overall Study||17
130496|NCT00240526|313492|P4|NOT COMPLETED|Year 20||0
130497|NCT00240526|313493|P3|NOT COMPLETED|Year 20||0
130498|NCT00240526|313494|P2|NOT COMPLETED|Year 20||0
130499|NCT00240526|313495|P1|NOT COMPLETED|Year 20||0
130500|NCT00240526|313492|P4|COMPLETED|Year 20||20
130501|NCT00240526|313493|P3|COMPLETED|Year 20||13
130502|NCT00240526|313494|P2|COMPLETED|Year 20||17
130503|NCT00240526|313495|P1|COMPLETED|Year 20||19
130504|NCT00240526|313492|P4|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|20
130505|NCT00240526|313493|P3|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|13
130506|NCT00240526|313494|P2|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|17
130507|NCT00240526|313495|P1|STARTED|Year 20|Number of subjects who come back at Year 20 (Month 240) time-point|19
130508|NCT00240526|313492|P4|NOT COMPLETED|Year 19||0
130509|NCT00240526|313493|P3|NOT COMPLETED|Year 19||0
130510|NCT00240526|313494|P2|NOT COMPLETED|Year 19||0
130511|NCT00240526|313495|P1|NOT COMPLETED|Year 19||0
130512|NCT00240526|313492|P4|COMPLETED|Year 19||18
130513|NCT00240526|313493|P3|COMPLETED|Year 19||12
130514|NCT00240526|313494|P2|COMPLETED|Year 19||16
130515|NCT00240526|313495|P1|COMPLETED|Year 19||17
130516|NCT00240526|313492|P4|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|18
130517|NCT00240526|313493|P3|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|12
130518|NCT00240526|313494|P2|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|16
130519|NCT00240526|313495|P1|STARTED|Year 19|Number of subjects who come back at Year 19 (Month 228) time-point|17
130520|NCT00240526|313492|P4|NOT COMPLETED|Year 18||0
130521|NCT00240526|313493|P3|NOT COMPLETED|Year 18||0
130522|NCT00240526|313494|P2|NOT COMPLETED|Year 18||0
130523|NCT00240526|313495|P1|NOT COMPLETED|Year 18||0
130524|NCT00240526|313492|P4|COMPLETED|Year 18||20
130525|NCT00240526|313493|P3|COMPLETED|Year 18||14
130526|NCT00240526|313494|P2|COMPLETED|Year 18||17
130527|NCT00240526|313495|P1|COMPLETED|Year 18||16
130528|NCT00240526|313492|P4|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|20
130529|NCT00240526|313493|P3|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|14
130530|NCT00240526|313494|P2|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|17
130531|NCT00240526|313495|P1|STARTED|Year 18|Number of subjects who come back at Year 18 (Month 216) time-point|16
130532|NCT00240526|313492|P4|NOT COMPLETED|Year 17||0
130533|NCT00240526|313493|P3|NOT COMPLETED|Year 17||0
130534|NCT00240526|313494|P2|NOT COMPLETED|Year 17||0
130535|NCT00240526|313495|P1|NOT COMPLETED|Year 17||0
130536|NCT00240526|313492|P4|COMPLETED|Year 17||20
130537|NCT00240526|313493|P3|COMPLETED|Year 17||13
130538|NCT00240526|313494|P2|COMPLETED|Year 17||17
130539|NCT00240526|313495|P1|COMPLETED|Year 17||19
130540|NCT00240526|313492|P4|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|20
130541|NCT00240526|313493|P3|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|13
130542|NCT00240526|313494|P2|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|17
130543|NCT00240526|313495|P1|STARTED|Year 17|Number of subjects who come back at Year 17 (Month 204) time-point|19
130544|NCT00240526|313492|P4|NOT COMPLETED|Year 16||0
130545|NCT00240526|313493|P3|NOT COMPLETED|Year 16||0
130546|NCT00240526|313494|P2|NOT COMPLETED|Year 16||0
130547|NCT00240526|313495|P1|NOT COMPLETED|Year 16||0
130548|NCT00240526|313492|P4|COMPLETED|Year 16||22
130549|NCT00240526|313493|P3|COMPLETED|Year 16||16
130550|NCT00240526|313494|P2|COMPLETED|Year 16||19
130551|NCT00240526|313495|P1|COMPLETED|Year 16||17
130552|NCT00240526|313492|P4|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|22
130553|NCT00240526|313493|P3|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|16
130554|NCT00240526|313494|P2|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|19
130555|NCT00240526|313495|P1|STARTED|Year 16|Number of subjects who come back at Year 16 (Month 192) time-point|17
130556|NCT00240526|313492|P4|NOT COMPLETED|Year 15||0
130557|NCT00240526|313493|P3|NOT COMPLETED|Year 15||0
130558|NCT00240526|313494|P2|NOT COMPLETED|Year 15||0
130559|NCT00240526|313495|P1|NOT COMPLETED|Year 15||0
130560|NCT00240526|313492|P4|COMPLETED|Year 15||21
130561|NCT00240526|313493|P3|COMPLETED|Year 15||14
130562|NCT00240526|313494|P2|COMPLETED|Year 15||19
130563|NCT00240526|313495|P1|COMPLETED|Year 15||19
130564|NCT00240526|313492|P4|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|21
130565|NCT00240526|313493|P3|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|14
130566|NCT00240526|313494|P2|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
130567|NCT00240526|313495|P1|STARTED|Year 15|Number of subjects who come back at Year 15 (Month 180) time-point|19
130568|NCT00240539|313529|P4|NOT COMPLETED|Overall Study||0
130569|NCT00240539|313530|P3|NOT COMPLETED|Overall Study||0
130570|NCT00240539|313531|P2|NOT COMPLETED|Overall Study||0
130571|NCT00240539|313532|P1|NOT COMPLETED|Overall Study||0
130572|NCT00240539|313529|P4|COMPLETED|Overall Study||1
130573|NCT00240539|313530|P3|COMPLETED|Overall Study||31
130574|NCT00240539|313531|P2|COMPLETED|Overall Study||2
130575|NCT00240539|313532|P1|COMPLETED|Overall Study||2
130576|NCT00240539|313529|P4|STARTED|Overall Study||1
130577|NCT00240539|313530|P3|STARTED|Overall Study||31
130578|NCT00240539|313531|P2|STARTED|Overall Study||2
130579|NCT00240539|313532|P1|STARTED|Overall Study||2
130580|NCT00240981|313552|P2|NOT COMPLETED|Overall Study||33
130581|NCT00240981|313553|P1|NOT COMPLETED|Overall Study||38
130582|NCT00240981|313552|P2|COMPLETED|Overall Study||70
130583|NCT00240981|313553|P1|COMPLETED|Overall Study||68
130584|NCT00240981|313552|P2|Intent to Treat Sample|Overall Study||83
130585|NCT00240981|313553|P1|Intent to Treat Sample|Overall Study||82
130586|NCT00240981|313552|P2|STARTED|Overall Study||103
130587|NCT00240981|313553|P1|STARTED|Overall Study||106
130588|NCT00240994|313577|P1|NOT COMPLETED|Overall Study||3
130589|NCT00240994|313577|P1|COMPLETED|Overall Study||32
130590|NCT00240994|313577|P1|STARTED|Overall Study||35
130591|NCT00241176|313581|P1|NOT COMPLETED|Overall Study||0
130592|NCT00241176|313581|P1|COMPLETED|Overall Study||11
130593|NCT00241176|313581|P1|STARTED|Overall Study||11
130594|NCT00241280|313590|P2|NOT COMPLETED|Overall Study||68
130595|NCT00241280|313591|P1|NOT COMPLETED|Overall Study||48
130596|NCT00241280|313590|P2|COMPLETED|Overall Study||186
130597|NCT00241280|313591|P1|COMPLETED|Overall Study||199
130598|NCT00241280|313590|P2|STARTED|Overall Study||254
130599|NCT00241280|313591|P1|STARTED|Overall Study||247
130600|NCT00241358|313602|P3|NOT COMPLETED|Overall Study||1
130601|NCT00241358|313603|P2|NOT COMPLETED|Overall Study||1
130602|NCT00241358|313604|P1|NOT COMPLETED|Overall Study||0
130603|NCT00241358|313602|P3|COMPLETED|Overall Study||20
130604|NCT00241358|313603|P2|COMPLETED|Overall Study||45
130605|NCT00241358|313604|P1|COMPLETED|Overall Study||25
130606|NCT00241358|313602|P3|STARTED|Overall Study||21
130607|NCT00241358|313603|P2|STARTED|Overall Study||46
130608|NCT00241358|313604|P1|STARTED|Overall Study||25
130609|NCT00241644|313639|P4|NOT COMPLETED|Second Efficacy Period (Year 2)||118
130610|NCT00241644|313640|P3|NOT COMPLETED|Second Efficacy Period (Year 2)||64
130611|NCT00241644|313641|P2|NOT COMPLETED|Second Efficacy Period (Year 2)||57
130612|NCT00241644|313642|P1|NOT COMPLETED|Second Efficacy Period (Year 2)||61
130613|NCT00241644|313639|P4|COMPLETED|Second Efficacy Period (Year 2)||1407
130614|NCT00241644|313640|P3|COMPLETED|Second Efficacy Period (Year 2)||682
130615|NCT00241644|313641|P2|COMPLETED|Second Efficacy Period (Year 2)||697
130616|NCT00241644|313642|P1|COMPLETED|Second Efficacy Period (Year 2)||710
130617|NCT00241644|313639|P4|STARTED|Second Efficacy Period (Year 2)||1525
130618|NCT00241644|313640|P3|STARTED|Second Efficacy Period (Year 2)||746
130619|NCT00241644|313641|P2|STARTED|Second Efficacy Period (Year 2)||754
130620|NCT00241644|313642|P1|STARTED|Second Efficacy Period (Year 2)||771
130621|NCT00241644|313639|P4|NOT COMPLETED|First Efficacy Period (Year 1)||495
130622|NCT00241644|313640|P3|NOT COMPLETED|First Efficacy Period (Year 1)||249
130623|NCT00241644|313641|P2|NOT COMPLETED|First Efficacy Period (Year 1)||268
130624|NCT00241644|313642|P1|NOT COMPLETED|First Efficacy Period (Year 1)||227
130625|NCT00241644|313639|P4|COMPLETED|First Efficacy Period (Year 1)||2803
130626|NCT00241644|313640|P3|COMPLETED|First Efficacy Period (Year 1)||1392
130627|NCT00241644|313641|P2|COMPLETED|First Efficacy Period (Year 1)||1383
130628|NCT00241644|313642|P1|COMPLETED|First Efficacy Period (Year 1)||1420
130629|NCT00241644|313639|P4|STARTED|First Efficacy Period (Year 1)||3298
130630|NCT00241644|313640|P3|STARTED|First Efficacy Period (Year 1)||1641
130631|NCT00241644|313641|P2|STARTED|First Efficacy Period (Year 1)||1651
130632|NCT00241644|313642|P1|STARTED|First Efficacy Period (Year 1)||1647
130633|NCT00241839|313726|P2|NOT COMPLETED|Overall Study||18
130634|NCT00241839|313727|P1|NOT COMPLETED|Overall Study||19
130635|NCT00241839|313726|P2|COMPLETED|Overall Study|N=53 represents number with both baseline and 8-10 week data. N<53 implies missing data.|53
130636|NCT00241839|313727|P1|COMPLETED|Overall Study|N=52 represents number with both baseline and 8-10 week data. N<52 implies missing data.|52
130637|NCT00241839|313726|P2|STARTED|Overall Study||71
130638|NCT00241839|313727|P1|STARTED|Overall Study||71
130639|NCT00242216|313741|P2|NOT COMPLETED|Overall Study||22
130640|NCT00242216|313742|P1|NOT COMPLETED|Overall Study||18
130641|NCT00242216|313741|P2|COMPLETED|Overall Study||15
130642|NCT00242216|313742|P1|COMPLETED|Overall Study||21
130643|NCT00242216|313741|P2|STARTED|Overall Study||37
130644|NCT00242216|313742|P1|STARTED|Overall Study||39
130645|NCT00242385|313750|P2|NOT COMPLETED|Period 2||0
130646|NCT00242385|313751|P1|NOT COMPLETED|Period 2||0
130647|NCT00242385|313750|P2|COMPLETED|Period 2||11
130648|NCT00242385|313751|P1|COMPLETED|Period 2||14
130649|NCT00242385|313750|P2|STARTED|Period 2||11
130650|NCT00242385|313751|P1|STARTED|Period 2||14
130651|NCT00242385|313750|P2|NOT COMPLETED|Period 1||0
130652|NCT00242385|313751|P1|NOT COMPLETED|Period 1||0
130653|NCT00242385|313750|P2|COMPLETED|Period 1||11
130654|NCT00242385|313751|P1|COMPLETED|Period 1||14
130655|NCT00242385|313750|P2|STARTED|Period 1||11
130656|NCT00242385|313751|P1|STARTED|Period 1||14
130657|NCT00242502|313775|P1|NOT COMPLETED|Overall Study||0
130658|NCT00242502|313775|P1|COMPLETED|Overall Study||59
130659|NCT00242502|313775|P1|STARTED|Overall Study||59
130660|NCT00242567|313781|P2|NOT COMPLETED|Overall Study||140
130661|NCT00242567|313782|P1|NOT COMPLETED|Overall Study||166
130662|NCT00242567|313781|P2|COMPLETED|Overall Study||123
130663|NCT00242567|313782|P1|COMPLETED|Overall Study||93
130664|NCT00242567|313781|P2|Never Received Study Drug|Overall Study||191
130665|NCT00242567|313782|P1|Never Received Study Drug|Overall Study||0
130666|NCT00242567|313781|P2|Received at Least 1 Dose of Study Drug|Overall Study||72
130667|NCT00242567|313782|P1|Received at Least 1 Dose of Study Drug|Overall Study||259
130668|NCT00242567|313781|P2|STARTED|Overall Study||263
130669|NCT00242567|313782|P1|STARTED|Overall Study||259
130670|NCT00242580|313801|P3|NOT COMPLETED|Overall Study||14
130671|NCT00242580|313802|P2|NOT COMPLETED|Overall Study||12
130672|NCT00242580|313803|P1|NOT COMPLETED|Overall Study||10
130673|NCT00242580|313801|P3|COMPLETED|Overall Study||24
130674|NCT00242580|313802|P2|COMPLETED|Overall Study||29
130675|NCT00242580|313803|P1|COMPLETED|Overall Study|"Completed indicates 12 month data."|22
130676|NCT00242580|313801|P3|STARTED|Overall Study||38
130677|NCT00242580|313802|P2|STARTED|Overall Study||41
130678|NCT00242580|313803|P1|STARTED|Overall Study||32
130679|NCT00242619|313828|P2|NOT COMPLETED|Overall Study||0
130680|NCT00242619|313829|P1|NOT COMPLETED|Overall Study||0
130681|NCT00242619|313828|P2|COMPLETED|Overall Study||4
130682|NCT00242619|313829|P1|COMPLETED|Overall Study||8
130683|NCT00242619|313828|P2|STARTED|Overall Study||4
130684|NCT00242619|313829|P1|STARTED|Overall Study||8
130685|NCT00242632|313839|P2|NOT COMPLETED|Overall Study||0
130686|NCT00242632|313840|P1|NOT COMPLETED|Overall Study||0
130687|NCT00242632|313839|P2|COMPLETED|Overall Study||11
130688|NCT00242632|313840|P1|COMPLETED|Overall Study||11
130689|NCT00242632|313839|P2|STARTED|Overall Study||11
130690|NCT00242632|313840|P1|STARTED|Overall Study||11
130691|NCT00242658|313848|P2|NOT COMPLETED|Overall Study||19
130692|NCT00242658|313849|P1|NOT COMPLETED|Overall Study||22
130693|NCT00242658|313848|P2|COMPLETED|Overall Study||188
130694|NCT00242658|313849|P1|COMPLETED|Overall Study||165
130695|NCT00242658|313848|P2|STARTED|Overall Study||207
130696|NCT00242658|313849|P1|STARTED|Overall Study||187
130697|NCT00242684|313857|P1|NOT COMPLETED|Overall Study||0
130698|NCT00242684|313857|P1|COMPLETED|Overall Study||446
130699|NCT00242684|313857|P1|STARTED|Overall Study||446
130700|NCT00242710|313866|P4|NOT COMPLETED|Study Extension (up to Year 2)||10
130701|NCT00242710|313867|P3|NOT COMPLETED|Study Extension (up to Year 2)||15
130702|NCT00242710|313868|P2|NOT COMPLETED|Study Extension (up to Year 2)||29
130703|NCT00242710|313869|P1|NOT COMPLETED|Study Extension (up to Year 2)||27
130704|NCT00242710|313866|P4|COMPLETED|Study Extension (up to Year 2)||84
130705|NCT00242710|313867|P3|COMPLETED|Study Extension (up to Year 2)||69
130706|NCT00242710|313868|P2|COMPLETED|Study Extension (up to Year 2)||148
130707|NCT00242710|313869|P1|COMPLETED|Study Extension (up to Year 2)||141
130708|NCT00242710|313866|P4|STARTED|Study Extension (up to Year 2)||94
130709|NCT00242710|313867|P3|STARTED|Study Extension (up to Year 2)||84
130710|NCT00242710|313868|P2|STARTED|Study Extension (up to Year 2)||177
130711|NCT00242710|313869|P1|STARTED|Study Extension (up to Year 2)||168
130712|NCT00242710|313866|P4|NOT COMPLETED|Period Between Core Study and Extension||49
130713|NCT00242710|313867|P3|NOT COMPLETED|Period Between Core Study and Extension||48
130714|NCT00242710|313868|P2|NOT COMPLETED|Period Between Core Study and Extension||112
130715|NCT00242710|313869|P1|NOT COMPLETED|Period Between Core Study and Extension||119
130716|NCT00242710|313866|P4|COMPLETED|Period Between Core Study and Extension||94
130717|NCT00242710|313867|P3|COMPLETED|Period Between Core Study and Extension||84
130718|NCT00242710|313868|P2|COMPLETED|Period Between Core Study and Extension||177
130719|NCT00242710|313869|P1|COMPLETED|Period Between Core Study and Extension||168
130720|NCT00242710|313866|P4|STARTED|Period Between Core Study and Extension||143
130721|NCT00242710|313867|P3|STARTED|Period Between Core Study and Extension||132
130722|NCT00242710|313868|P2|STARTED|Period Between Core Study and Extension||289
130723|NCT00242710|313869|P1|STARTED|Period Between Core Study and Extension||287
130724|NCT00242710|313866|P4|NOT COMPLETED|Core Study (up to Year 1)||31
130725|NCT00242710|313867|P3|NOT COMPLETED|Core Study (up to Year 1)||51
130726|NCT00242710|313868|P2|NOT COMPLETED|Core Study (up to Year 1)||64
130727|NCT00242710|313869|P1|NOT COMPLETED|Core Study (up to Year 1)||86
130728|NCT00242710|313866|P4|COMPLETED|Core Study (up to Year 1)||143
130729|NCT00242710|313867|P3|COMPLETED|Core Study (up to Year 1)||132
130730|NCT00242710|313868|P2|COMPLETED|Core Study (up to Year 1)||289
130731|NCT00242710|313869|P1|COMPLETED|Core Study (up to Year 1)||287
130732|NCT00242710|313866|P4|Treated|Core Study (up to Year 1)||172
130733|NCT00242710|313867|P3|Treated|Core Study (up to Year 1)||179
130734|NCT00242710|313868|P2|Treated|Core Study (up to Year 1)||349
130735|NCT00242710|313869|P1|Treated|Core Study (up to Year 1)||361
130736|NCT00242710|313866|P4|STARTED|Core Study (up to Year 1)||174
130737|NCT00242710|313867|P3|STARTED|Core Study (up to Year 1)||183
130738|NCT00242710|313868|P2|STARTED|Core Study (up to Year 1)||353
130739|NCT00242710|313869|P1|STARTED|Core Study (up to Year 1)||373
130740|NCT00235989|313923|P6|NOT COMPLETED|Extension Treatment Period (ET)||0
130741|NCT00235989|313924|P5|NOT COMPLETED|Extension Treatment Period (ET)||0
130742|NCT00235989|313925|P4|NOT COMPLETED|Extension Treatment Period (ET)||6
130743|NCT00235989|313926|P3|NOT COMPLETED|Extension Treatment Period (ET)||5
130744|NCT00235989|313927|P2|NOT COMPLETED|Extension Treatment Period (ET)||4
130745|NCT00235989|313928|P1|NOT COMPLETED|Extension Treatment Period (ET)||8
130746|NCT00235989|313923|P6|COMPLETED|Extension Treatment Period (ET)||0
130747|NCT00235989|313924|P5|COMPLETED|Extension Treatment Period (ET)||0
130748|NCT00235989|313925|P4|COMPLETED|Extension Treatment Period (ET)||14
130749|NCT00235989|313926|P3|COMPLETED|Extension Treatment Period (ET)||14
130750|NCT00235989|313927|P2|COMPLETED|Extension Treatment Period (ET)||2
130751|NCT00235989|313928|P1|COMPLETED|Extension Treatment Period (ET)||8
130752|NCT00235989|313923|P6|STARTED|Extension Treatment Period (ET)||0
130753|NCT00235989|313924|P5|STARTED|Extension Treatment Period (ET)||0
130754|NCT00235989|313925|P4|STARTED|Extension Treatment Period (ET)||20
130755|NCT00235989|313926|P3|STARTED|Extension Treatment Period (ET)||19
130756|NCT00235989|313927|P2|STARTED|Extension Treatment Period (ET)||6
130757|NCT00235989|313928|P1|STARTED|Extension Treatment Period (ET)||16
130758|NCT00235989|313923|P6|NOT COMPLETED|Core Treatment Period (CT)||2
130759|NCT00235989|313924|P5|NOT COMPLETED|Core Treatment Period (CT)||0
130760|NCT00235989|313925|P4|NOT COMPLETED|Core Treatment Period (CT)||0
130761|NCT00235989|313926|P3|NOT COMPLETED|Core Treatment Period (CT)||0
130762|NCT00235989|313927|P2|NOT COMPLETED|Core Treatment Period (CT)||0
130763|NCT00235989|313928|P1|NOT COMPLETED|Core Treatment Period (CT)||0
130764|NCT00235989|313923|P6|COMPLETED|Core Treatment Period (CT)||25
130765|NCT00235989|313924|P5|COMPLETED|Core Treatment Period (CT)||36
130766|NCT00235989|313925|P4|COMPLETED|Core Treatment Period (CT)||0
130767|NCT00235989|313926|P3|COMPLETED|Core Treatment Period (CT)||0
130768|NCT00235989|313927|P2|COMPLETED|Core Treatment Period (CT)||0
130769|NCT00235989|313928|P1|COMPLETED|Core Treatment Period (CT)||0
130770|NCT00235989|313923|P6|STARTED|Core Treatment Period (CT)||27
130771|NCT00235989|313924|P5|STARTED|Core Treatment Period (CT)||36
130772|NCT00235989|313925|P4|STARTED|Core Treatment Period (CT)||0
130773|NCT00235989|313926|P3|STARTED|Core Treatment Period (CT)||0
130774|NCT00235989|313927|P2|STARTED|Core Treatment Period (CT)||0
130775|NCT00235989|313928|P1|STARTED|Core Treatment Period (CT)||0
130776|NCT00243022|313944|P2|NOT COMPLETED|Overall Study||1
130777|NCT00243022|313945|P1|NOT COMPLETED|Overall Study||2
130778|NCT00243022|313944|P2|COMPLETED|Overall Study||4
130779|NCT00243022|313945|P1|COMPLETED|Overall Study||5
130780|NCT00243022|313944|P2|STARTED|Overall Study||5
130781|NCT00243022|313945|P1|STARTED|Overall Study||7
130782|NCT00243061|313963|P1|NOT COMPLETED|Overall Study||0
130783|NCT00243061|313963|P1|COMPLETED|Overall Study||24
130784|NCT00243061|313963|P1|STARTED|Overall Study||24
130785|NCT00243074|313972|P1|NOT COMPLETED|Overall Study||54
130786|NCT00243074|313972|P1|COMPLETED|Overall Study||0
130787|NCT00243074|313972|P1|STARTED|Overall Study||54
130788|NCT00243191|313981|P1|NOT COMPLETED|Overall Study||0
130789|NCT00243191|313981|P1|COMPLETED|Overall Study||18
130790|NCT00243191|313981|P1|STARTED|Overall Study||18
130791|NCT00243243|313987|P2|NOT COMPLETED|Overall Study||0
130792|NCT00243243|313988|P1|NOT COMPLETED|Overall Study||0
130793|NCT00243243|313987|P2|COMPLETED|Overall Study||10
130794|NCT00243243|313988|P1|COMPLETED|Overall Study||10
130795|NCT00243243|313987|P2|STARTED|Overall Study||10
130796|NCT00243243|313988|P1|STARTED|Overall Study||10
130797|NCT00243269|313998|P4|NOT COMPLETED|Overall Study||4
130798|NCT00243269|313999|P3|NOT COMPLETED|Overall Study||1
130799|NCT00243269|314000|P2|NOT COMPLETED|Overall Study||1
130800|NCT00243269|314001|P1|NOT COMPLETED|Overall Study||3
130801|NCT00243269|313998|P4|COMPLETED|Overall Study||25
130802|NCT00243269|313999|P3|COMPLETED|Overall Study||11
130803|NCT00243269|314000|P2|COMPLETED|Overall Study||10
130804|NCT00243269|314001|P1|COMPLETED|Overall Study||28
130805|NCT00243269|313998|P4|STARTED|Overall Study||29
130806|NCT00243269|313999|P3|STARTED|Overall Study||12
130807|NCT00243269|314000|P2|STARTED|Overall Study||11
130808|NCT00243269|314001|P1|STARTED|Overall Study||31
130809|NCT00243919|314018|P3|NOT COMPLETED|Overall Study||11
130810|NCT00243919|314019|P2|NOT COMPLETED|Overall Study||18
130811|NCT00243919|314020|P1|NOT COMPLETED|Overall Study||17
130812|NCT00243919|314018|P3|COMPLETED|Overall Study||115
130813|NCT00243919|314019|P2|COMPLETED|Overall Study||125
130814|NCT00243919|314020|P1|COMPLETED|Overall Study||122
130815|NCT00243919|314018|P3|STARTED|Overall Study||126
130816|NCT00243919|314019|P2|STARTED|Overall Study||143
130817|NCT00243919|314020|P1|STARTED|Overall Study||139
130818|NCT00243932|314064|P3|NOT COMPLETED|Stage 2: Efficacy||0
130819|NCT00243932|314065|P2|NOT COMPLETED|Stage 2: Efficacy||0
130820|NCT00243932|314066|P1|NOT COMPLETED|Stage 2: Efficacy||0
130821|NCT00243932|314064|P3|COMPLETED|Stage 2: Efficacy||0
130822|NCT00243932|314065|P2|COMPLETED|Stage 2: Efficacy||40
130823|NCT00243932|314066|P1|COMPLETED|Stage 2: Efficacy||40
130824|NCT00243932|314064|P3|STARTED|Stage 2: Efficacy|No new pts. randomized because selection procedure in Stage 1 selected the 2,700 mg dose.|0
130825|NCT00243932|314065|P2|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
130826|NCT00243932|314066|P1|STARTED|Stage 2: Efficacy|40 newly randomized pts. Efficacy analysis included Stage 1 + Stage 2 patients|40
130827|NCT00243932|314064|P3|NOT COMPLETED|Stage 1: Dose Selection||0
130828|NCT00243932|314065|P2|NOT COMPLETED|Stage 1: Dose Selection||0
130829|NCT00243932|314066|P1|NOT COMPLETED|Stage 1: Dose Selection||2
130830|NCT00243932|314064|P3|COMPLETED|Stage 1: Dose Selection||35
130831|NCT00243932|314065|P2|COMPLETED|Stage 1: Dose Selection||35
130832|NCT00243932|314066|P1|COMPLETED|Stage 1: Dose Selection||33
130833|NCT00243932|314064|P3|STARTED|Stage 1: Dose Selection||35
130834|NCT00243932|314065|P2|STARTED|Stage 1: Dose Selection||35
130835|NCT00243932|314066|P1|STARTED|Stage 1: Dose Selection||35
130836|NCT00244010|314076|P2|NOT COMPLETED|Overall Study||0
130837|NCT00244010|314077|P1|NOT COMPLETED|Overall Study||0
130838|NCT00244010|314076|P2|COMPLETED|Overall Study||2
130839|NCT00244010|314077|P1|COMPLETED|Overall Study||2
130840|NCT00244010|314076|P2|STARTED|Overall Study||2
130841|NCT00244010|314077|P1|STARTED|Overall Study||2
130842|NCT00244101|314086|P3|NOT COMPLETED|Overall Study||0
130843|NCT00244101|314087|P2|NOT COMPLETED|Overall Study||0
130844|NCT00244101|314088|P1|NOT COMPLETED|Overall Study||0
130845|NCT00244101|314086|P3|COMPLETED|Overall Study||216
130846|NCT00244101|314087|P2|COMPLETED|Overall Study||223
130847|NCT00244101|314088|P1|COMPLETED|Overall Study||209
130848|NCT00244101|314086|P3|STARTED|Overall Study||216
130849|NCT00244101|314087|P2|STARTED|Overall Study||223
130850|NCT00244101|314088|P1|STARTED|Overall Study||209
130851|NCT00244140|314098|P2|NOT COMPLETED|Overall Study||0
130852|NCT00244140|314099|P1|NOT COMPLETED|Overall Study||0
130853|NCT00244140|314098|P2|COMPLETED|Overall Study||22
130854|NCT00244140|314099|P1|COMPLETED|Overall Study||412
130855|NCT00244140|314098|P2|STARTED|Overall Study||22
130856|NCT00244140|314099|P1|STARTED|Overall Study||412
130857|NCT00244374|314111|P5|NOT COMPLETED|Vaccine Adherence Cohort||0
130858|NCT00244374|314112|P4|NOT COMPLETED|Vaccine Adherence Cohort||0
130859|NCT00244374|314113|P3|NOT COMPLETED|Vaccine Adherence Cohort||0
130860|NCT00244374|314114|P2|NOT COMPLETED|Vaccine Adherence Cohort||0
130861|NCT00244374|314115|P1|NOT COMPLETED|Vaccine Adherence Cohort||0
130862|NCT00244374|314111|P5|COMPLETED|Vaccine Adherence Cohort||41
130863|NCT00244374|314112|P4|COMPLETED|Vaccine Adherence Cohort||36
130864|NCT00244374|314113|P3|COMPLETED|Vaccine Adherence Cohort||43
130865|NCT00244374|314114|P2|COMPLETED|Vaccine Adherence Cohort||47
130866|NCT00244374|314115|P1|COMPLETED|Vaccine Adherence Cohort||0
130867|NCT00244374|314111|P5|STARTED|Vaccine Adherence Cohort||41
130868|NCT00244374|314112|P4|STARTED|Vaccine Adherence Cohort||36
130869|NCT00244374|314113|P3|STARTED|Vaccine Adherence Cohort||43
130870|NCT00244374|314114|P2|STARTED|Vaccine Adherence Cohort||47
130871|NCT00244374|314115|P1|STARTED|Vaccine Adherence Cohort|Eligible and willing cross-sectional study participants progressed to adherence cohort randomization|0
130872|NCT00244374|314111|P5|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130873|NCT00244374|314112|P4|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130874|NCT00244374|314113|P3|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130875|NCT00244374|314114|P2|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130876|NCT00244374|314115|P1|NOT COMPLETED|Evaluation for Vaccine Adherence Cohort||273
130877|NCT00244374|314111|P5|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130878|NCT00244374|314112|P4|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130879|NCT00244374|314113|P3|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130880|NCT00244374|314114|P2|COMPLETED|Evaluation for Vaccine Adherence Cohort||0
130881|NCT00244374|314115|P1|COMPLETED|Evaluation for Vaccine Adherence Cohort||167
130882|NCT00244374|314111|P5|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
130883|NCT00244374|314112|P4|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
130884|NCT00244374|314113|P3|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
130885|NCT00244374|314114|P2|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||0
130886|NCT00244374|314115|P1|Eligible for Vaccine Adherence Cohort|Evaluation for Vaccine Adherence Cohort||217
130887|NCT00244374|314111|P5|STARTED|Evaluation for Vaccine Adherence Cohort||0
130888|NCT00244374|314112|P4|STARTED|Evaluation for Vaccine Adherence Cohort||0
130889|NCT00244374|314113|P3|STARTED|Evaluation for Vaccine Adherence Cohort||0
130890|NCT00244374|314114|P2|STARTED|Evaluation for Vaccine Adherence Cohort||0
130891|NCT00244374|314115|P1|STARTED|Evaluation for Vaccine Adherence Cohort|440 study participants enrolled prior to 3/31/2007 were evaluated for vaccine adherence cohort|440
130892|NCT00244374|314111|P5|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
130893|NCT00244374|314112|P4|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
130894|NCT00244374|314113|P3|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
130895|NCT00244374|314114|P2|NOT COMPLETED|Pre-Randomization Cross-sectional Study||0
130896|NCT00244374|314115|P1|NOT COMPLETED|Pre-Randomization Cross-sectional Study||137
130897|NCT00244374|314111|P5|COMPLETED|Pre-Randomization Cross-sectional Study||0
130898|NCT00244374|314112|P4|COMPLETED|Pre-Randomization Cross-sectional Study||0
130899|NCT00244374|314113|P3|COMPLETED|Pre-Randomization Cross-sectional Study||0
130900|NCT00244374|314114|P2|COMPLETED|Pre-Randomization Cross-sectional Study||0
130901|NCT00244374|314115|P1|COMPLETED|Pre-Randomization Cross-sectional Study||409
130902|NCT00244374|314111|P5|STARTED|Pre-Randomization Cross-sectional Study||0
130903|NCT00244374|314112|P4|STARTED|Pre-Randomization Cross-sectional Study||0
130904|NCT00244374|314113|P3|STARTED|Pre-Randomization Cross-sectional Study||0
130905|NCT00244374|314114|P2|STARTED|Pre-Randomization Cross-sectional Study||0
130906|NCT00244374|314115|P1|STARTED|Pre-Randomization Cross-sectional Study||546
130907|NCT00244621|314134|P3|NOT COMPLETED|Open-label Treatment Period||2
130908|NCT00244621|314135|P2|NOT COMPLETED|Open-label Treatment Period||1
130909|NCT00244621|314136|P1|NOT COMPLETED|Open-label Treatment Period||1
130910|NCT00244621|314134|P3|COMPLETED|Open-label Treatment Period||28
130911|NCT00244621|314135|P2|COMPLETED|Open-label Treatment Period||28
130912|NCT00244621|314136|P1|COMPLETED|Open-label Treatment Period||25
130913|NCT00244621|314134|P3|STARTED|Open-label Treatment Period||30
130914|NCT00244621|314135|P2|STARTED|Open-label Treatment Period||29
130915|NCT00244621|314136|P1|STARTED|Open-label Treatment Period|One participant discontinued study due to Adverse Event after completing the double-blind period.|26
130916|NCT00244621|314134|P3|NOT COMPLETED|Double-blind Treatment Period||2
130917|NCT00244621|314135|P2|NOT COMPLETED|Double-blind Treatment Period||3
130918|NCT00244621|314136|P1|NOT COMPLETED|Double-blind Treatment Period||2
130919|NCT00244621|314134|P3|COMPLETED|Double-blind Treatment Period||30
130920|NCT00244621|314135|P2|COMPLETED|Double-blind Treatment Period||29
130921|NCT00244621|314136|P1|COMPLETED|Double-blind Treatment Period||27
130922|NCT00244621|314134|P3|STARTED|Double-blind Treatment Period||32
130923|NCT00244621|314135|P2|STARTED|Double-blind Treatment Period||32
130924|NCT00244621|314136|P1|STARTED|Double-blind Treatment Period||29
130925|NCT00244712|314155|P2|NOT COMPLETED|Overall Study||124
130926|NCT00244712|314156|P1|NOT COMPLETED|Overall Study||109
130927|NCT00244712|314155|P2|COMPLETED|Overall Study||221
130928|NCT00244712|314156|P1|COMPLETED|Overall Study||234
130929|NCT00244712|314155|P2|STARTED|Overall Study||345
130930|NCT00244712|314156|P1|STARTED|Overall Study||343
130931|NCT00244725|314192|P4|NOT COMPLETED|Overall Study||21
130932|NCT00244725|314193|P3|NOT COMPLETED|Overall Study||24
130933|NCT00244725|314194|P2|NOT COMPLETED|Overall Study||19
130934|NCT00244725|314195|P1|NOT COMPLETED|Overall Study||23
130935|NCT00244725|314192|P4|COMPLETED|Overall Study||216
130936|NCT00244725|314193|P3|COMPLETED|Overall Study||215
130937|NCT00244725|314194|P2|COMPLETED|Overall Study||226
130938|NCT00244725|314195|P1|COMPLETED|Overall Study||214
130939|NCT00244725|314192|P4|STARTED|Overall Study||237
130940|NCT00244725|314193|P3|STARTED|Overall Study||239
130941|NCT00244725|314194|P2|STARTED|Overall Study||245
130942|NCT00244725|314195|P1|STARTED|Overall Study||237
130943|NCT00244764|314249|P1|NOT COMPLETED|Overall Study||96
130944|NCT00244764|314249|P1|COMPLETED|Overall Study||129
130945|NCT00244764|314249|P1|STARTED|Overall Study||225
130946|NCT00244855|314258|P2|NOT COMPLETED|Overall Study||1
130947|NCT00244855|314259|P1|NOT COMPLETED|Overall Study||0
130948|NCT00244855|314258|P2|COMPLETED|Overall Study||24
130949|NCT00244855|314259|P1|COMPLETED|Overall Study||7
130950|NCT00244855|314258|P2|STARTED|Overall Study||25
130951|NCT00244855|314259|P1|STARTED|Overall Study||7
130952|NCT00244881|314267|P1|NOT COMPLETED|Overall Study||3
130953|NCT00244881|314267|P1|COMPLETED|Overall Study||23
130954|NCT00244881|314267|P1|STARTED|Overall Study||26
130955|NCT00244933|314273|P1|NOT COMPLETED|Overall Study||2
130956|NCT00244933|314273|P1|COMPLETED|Overall Study||17
130957|NCT00244933|314273|P1|STARTED|Overall Study||19
130958|NCT00244985|314277|P1|NOT COMPLETED|Overall Study||0
130959|NCT00244985|314277|P1|COMPLETED|Overall Study||42
130960|NCT00244985|314277|P1|STARTED|Overall Study||42
130961|NCT00245011|314285|P1|NOT COMPLETED|Overall Study||1
130962|NCT00245011|314285|P1|COMPLETED|Overall Study|Subject had disease progression prior to completing study.|10
130963|NCT00245011|314285|P1|STARTED|Overall Study||11
130964|NCT00245037|314289|P1|NOT COMPLETED|Overall Study||17
130965|NCT00245037|314289|P1|COMPLETED|Overall Study|17 participants died from infectious complications.|130
130966|NCT00245037|314289|P1|STARTED|Overall Study||147
130967|NCT00245050|314301|P2|NOT COMPLETED|Overall Study||2
130968|NCT00245050|314302|P1|NOT COMPLETED|Overall Study||3
130969|NCT00245050|314301|P2|COMPLETED|Overall Study||14
130970|NCT00245050|314302|P1|COMPLETED|Overall Study||15
130971|NCT00245050|314301|P2|STARTED|Overall Study||16
130972|NCT00245050|314302|P1|STARTED|Overall Study||18
130973|NCT00245063|314312|P2|NOT COMPLETED|Overall Study||5
130974|NCT00245063|314313|P1|NOT COMPLETED|Overall Study||7
130975|NCT00245063|314312|P2|COMPLETED|Overall Study||8
130976|NCT00245063|314313|P1|COMPLETED|Overall Study||5
130977|NCT00245063|314312|P2|STARTED|Overall Study||13
130978|NCT00245063|314313|P1|STARTED|Overall Study||12
130979|NCT00245102|314325|P6|NOT COMPLETED|Overall Study||4
130980|NCT00245102|314326|P5|NOT COMPLETED|Overall Study||0
130981|NCT00245102|314327|P4|NOT COMPLETED|Overall Study||3
130982|NCT00245102|314328|P3|NOT COMPLETED|Overall Study||7
130983|NCT00245102|314329|P2|NOT COMPLETED|Overall Study||4
130984|NCT00245102|314330|P1|NOT COMPLETED|Overall Study||7
130985|NCT00245102|314325|P6|COMPLETED|Overall Study||19
130986|NCT00245102|314326|P5|COMPLETED|Overall Study||5
130987|NCT00245102|314327|P4|COMPLETED|Overall Study||10
130988|NCT00245102|314328|P3|COMPLETED|Overall Study||39
130989|NCT00245102|314329|P2|COMPLETED|Overall Study||12
130990|NCT00245102|314330|P1|COMPLETED|Overall Study||37
130991|NCT00245102|314325|P6|STARTED|Overall Study||23
130992|NCT00245102|314326|P5|STARTED|Overall Study||5
130993|NCT00245102|314327|P4|STARTED|Overall Study||13
130994|NCT00245102|314328|P3|STARTED|Overall Study||46
130995|NCT00245102|314329|P2|STARTED|Overall Study||16
130996|NCT00245102|314330|P1|STARTED|Overall Study||44
130997|NCT00245128|314344|P1|NOT COMPLETED|Overall Study||10
130998|NCT00245128|314344|P1|COMPLETED|Overall Study||0
130999|NCT00245128|314344|P1|STARTED|Overall Study||10
131000|NCT00245219|314351|P3|NOT COMPLETED|Overall Study||2
131001|NCT00245219|314352|P2|NOT COMPLETED|Overall Study||6
131002|NCT00245219|314353|P1|NOT COMPLETED|Overall Study||6
131003|NCT00245219|314351|P3|COMPLETED|Overall Study||58
131004|NCT00245219|314352|P2|COMPLETED|Overall Study||88
131005|NCT00245219|314353|P1|COMPLETED|Overall Study||85
131006|NCT00245219|314351|P3|STARTED|Overall Study||60
131007|NCT00245219|314352|P2|STARTED|Overall Study||94
131008|NCT00245219|314353|P1|STARTED|Overall Study||91
131009|NCT00245466|314370|P3|NOT COMPLETED|Overall Study||37
131010|NCT00245466|314371|P2|NOT COMPLETED|Overall Study||44
131011|NCT00245466|314372|P1|NOT COMPLETED|Overall Study||36
131012|NCT00245466|314370|P3|COMPLETED|Overall Study||3
131013|NCT00245466|314371|P2|COMPLETED|Overall Study||2
131014|NCT00245466|314372|P1|COMPLETED|Overall Study|Defined as those participants ongoing when the extension study was terminated|7
131015|NCT00245466|314370|P3|Started FE200486 CS02A|Overall Study||26
131016|NCT00245466|314371|P2|Started FE200486 CS02A|Overall Study||30
131017|NCT00245466|314372|P1|Started FE200486 CS02A|Overall Study||32
131018|NCT00245466|314370|P3|STARTED|Overall Study||40
131019|NCT00245466|314371|P2|STARTED|Overall Study||46
131020|NCT00245466|314372|P1|STARTED|Overall Study||43
131021|NCT00245557|314388|P2|NOT COMPLETED|Overall Study||16
131022|NCT00245557|314389|P1|NOT COMPLETED|Overall Study||6
131023|NCT00245557|314388|P2|COMPLETED|Overall Study||10
131024|NCT00245557|314389|P1|COMPLETED|Overall Study||11
131025|NCT00245557|314388|P2|STARTED|Overall Study||26
131026|NCT00245557|314389|P1|STARTED|Overall Study||17
131027|NCT00245570|314400|P6|NOT COMPLETED|Treatment Period IV||0
131028|NCT00245570|314401|P5|NOT COMPLETED|Treatment Period IV||0
131029|NCT00245570|314402|P4|NOT COMPLETED|Treatment Period IV||0
131030|NCT00245570|314403|P3|NOT COMPLETED|Treatment Period IV||0
131031|NCT00245570|314404|P2|NOT COMPLETED|Treatment Period IV||0
131032|NCT00245570|314405|P1|NOT COMPLETED|Treatment Period IV||0
131033|NCT00245570|314400|P6|COMPLETED|Treatment Period IV||8
131034|NCT00245570|314401|P5|COMPLETED|Treatment Period IV||8
131035|NCT00245570|314402|P4|COMPLETED|Treatment Period IV||8
131036|NCT00245570|314403|P3|COMPLETED|Treatment Period IV||8
131037|NCT00245570|314404|P2|COMPLETED|Treatment Period IV||7
131038|NCT00245570|314405|P1|COMPLETED|Treatment Period IV||7
131039|NCT00245570|314400|P6|STARTED|Treatment Period IV||8
131040|NCT00245570|314401|P5|STARTED|Treatment Period IV||8
131041|NCT00245570|314402|P4|STARTED|Treatment Period IV||8
131042|NCT00245570|314403|P3|STARTED|Treatment Period IV||8
131043|NCT00245570|314404|P2|STARTED|Treatment Period IV||7
131044|NCT00245570|314405|P1|STARTED|Treatment Period IV||7
131045|NCT00245570|314400|P6|NOT COMPLETED|Washout Between Periods III and IV||0
131046|NCT00245570|314401|P5|NOT COMPLETED|Washout Between Periods III and IV||0
131047|NCT00245570|314402|P4|NOT COMPLETED|Washout Between Periods III and IV||0
131048|NCT00245570|314403|P3|NOT COMPLETED|Washout Between Periods III and IV||0
131049|NCT00245570|314404|P2|NOT COMPLETED|Washout Between Periods III and IV||1
131050|NCT00245570|314405|P1|NOT COMPLETED|Washout Between Periods III and IV||0
131051|NCT00245570|314400|P6|COMPLETED|Washout Between Periods III and IV||8
131052|NCT00245570|314401|P5|COMPLETED|Washout Between Periods III and IV||8
131053|NCT00245570|314402|P4|COMPLETED|Washout Between Periods III and IV||8
131054|NCT00245570|314403|P3|COMPLETED|Washout Between Periods III and IV||8
131055|NCT00245570|314404|P2|COMPLETED|Washout Between Periods III and IV||7
131056|NCT00245570|314405|P1|COMPLETED|Washout Between Periods III and IV||7
131057|NCT00245570|314400|P6|STARTED|Washout Between Periods III and IV||8
131058|NCT00245570|314401|P5|STARTED|Washout Between Periods III and IV||8
131059|NCT00245570|314402|P4|STARTED|Washout Between Periods III and IV||8
131060|NCT00245570|314403|P3|STARTED|Washout Between Periods III and IV||8
131061|NCT00245570|314404|P2|STARTED|Washout Between Periods III and IV|1 pt in the montelukast/placebo/salmeterol group discontinued during washout period 2 after placebo|8
131062|NCT00245570|314405|P1|STARTED|Washout Between Periods III and IV||7
131063|NCT00245570|314400|P6|NOT COMPLETED|Treatment Period III||0
131064|NCT00245570|314401|P5|NOT COMPLETED|Treatment Period III||0
131065|NCT00245570|314402|P4|NOT COMPLETED|Treatment Period III||0
131066|NCT00245570|314403|P3|NOT COMPLETED|Treatment Period III||0
131067|NCT00245570|314404|P2|NOT COMPLETED|Treatment Period III||0
131068|NCT00245570|314405|P1|NOT COMPLETED|Treatment Period III||0
131069|NCT00245570|314400|P6|COMPLETED|Treatment Period III||8
131070|NCT00245570|314401|P5|COMPLETED|Treatment Period III||8
131071|NCT00245570|314402|P4|COMPLETED|Treatment Period III||8
131072|NCT00245570|314403|P3|COMPLETED|Treatment Period III||8
131073|NCT00245570|314404|P2|COMPLETED|Treatment Period III||8
131074|NCT00245570|314405|P1|COMPLETED|Treatment Period III||7
131075|NCT00245570|314400|P6|STARTED|Treatment Period III||8
131076|NCT00245570|314401|P5|STARTED|Treatment Period III||8
131077|NCT00245570|314402|P4|STARTED|Treatment Period III||8
131078|NCT00245570|314403|P3|STARTED|Treatment Period III||8
131079|NCT00245570|314404|P2|STARTED|Treatment Period III||8
131080|NCT00245570|314405|P1|STARTED|Treatment Period III||7
131081|NCT00245570|314400|P6|NOT COMPLETED|Washout Between Periods II and III||0
131082|NCT00245570|314401|P5|NOT COMPLETED|Washout Between Periods II and III||0
131083|NCT00245570|314402|P4|NOT COMPLETED|Washout Between Periods II and III||0
131084|NCT00245570|314403|P3|NOT COMPLETED|Washout Between Periods II and III||0
131085|NCT00245570|314404|P2|NOT COMPLETED|Washout Between Periods II and III||0
131086|NCT00245570|314405|P1|NOT COMPLETED|Washout Between Periods II and III||0
131087|NCT00245570|314400|P6|COMPLETED|Washout Between Periods II and III||8
131088|NCT00245570|314401|P5|COMPLETED|Washout Between Periods II and III||8
131089|NCT00245570|314402|P4|COMPLETED|Washout Between Periods II and III||8
131090|NCT00245570|314403|P3|COMPLETED|Washout Between Periods II and III||8
131091|NCT00245570|314404|P2|COMPLETED|Washout Between Periods II and III||8
131092|NCT00245570|314405|P1|COMPLETED|Washout Between Periods II and III||7
131093|NCT00245570|314400|P6|STARTED|Washout Between Periods II and III||8
131094|NCT00245570|314401|P5|STARTED|Washout Between Periods II and III||8
131095|NCT00245570|314402|P4|STARTED|Washout Between Periods II and III||8
131096|NCT00245570|314403|P3|STARTED|Washout Between Periods II and III||8
131097|NCT00245570|314404|P2|STARTED|Washout Between Periods II and III||8
131098|NCT00245570|314405|P1|STARTED|Washout Between Periods II and III||7
131099|NCT00245570|314400|P6|NOT COMPLETED|Treatment Period II||0
131100|NCT00245570|314401|P5|NOT COMPLETED|Treatment Period II||0
131101|NCT00245570|314402|P4|NOT COMPLETED|Treatment Period II||0
131102|NCT00245570|314403|P3|NOT COMPLETED|Treatment Period II||0
131103|NCT00245570|314404|P2|NOT COMPLETED|Treatment Period II||0
131104|NCT00245570|314405|P1|NOT COMPLETED|Treatment Period II||0
131105|NCT00245570|314400|P6|COMPLETED|Treatment Period II||8
131106|NCT00245570|314401|P5|COMPLETED|Treatment Period II||8
131107|NCT00245570|314402|P4|COMPLETED|Treatment Period II||8
131108|NCT00245570|314403|P3|COMPLETED|Treatment Period II||8
131109|NCT00245570|314404|P2|COMPLETED|Treatment Period II||8
131110|NCT00245570|314405|P1|COMPLETED|Treatment Period II||7
131111|NCT00245570|314400|P6|STARTED|Treatment Period II||8
131112|NCT00245570|314401|P5|STARTED|Treatment Period II||8
131113|NCT00245570|314402|P4|STARTED|Treatment Period II||8
131114|NCT00245570|314403|P3|STARTED|Treatment Period II||8
131115|NCT00245570|314404|P2|STARTED|Treatment Period II||8
131116|NCT00245570|314405|P1|STARTED|Treatment Period II||7
131117|NCT00245635|314451|P2|NOT COMPLETED|Overall Study||0
131118|NCT00245635|314452|P1|NOT COMPLETED|Overall Study||0
131119|NCT00245635|314451|P2|COMPLETED|Overall Study||18
131120|NCT00245635|314452|P1|COMPLETED|Overall Study||25
131121|NCT00245635|314451|P2|STARTED|Overall Study||18
131122|NCT00245635|314452|P1|STARTED|Overall Study||25
131123|NCT00245856|314458|P2|NOT COMPLETED|Period Two||1
131124|NCT00245856|314459|P1|NOT COMPLETED|Period Two||0
131125|NCT00245856|314458|P2|COMPLETED|Period Two||38
131126|NCT00245856|314459|P1|COMPLETED|Period Two||0
131127|NCT00245856|314458|P2|STARTED|Period Two||39
131128|NCT00245856|314459|P1|STARTED|Period Two||0
131129|NCT00245856|314458|P2|NOT COMPLETED|Period One||0
131130|NCT00245856|314459|P1|NOT COMPLETED|Period One||0
131131|NCT00245856|314458|P2|COMPLETED|Period One||0
131132|NCT00245856|314459|P1|COMPLETED|Period One||28
131133|NCT00245856|314458|P2|STARTED|Period One||0
131134|NCT00245856|314459|P1|STARTED|Period One||28
131135|NCT00245960|314468|P2|NOT COMPLETED|Overall Study||28
131136|NCT00245960|314469|P1|NOT COMPLETED|Overall Study||29
131137|NCT00245960|314468|P2|COMPLETED|Overall Study||345
131138|NCT00245960|314469|P1|COMPLETED|Overall Study||350
131139|NCT00245960|314468|P2|STARTED|Overall Study||373
131140|NCT00245960|314469|P1|STARTED|Overall Study||379
131141|NCT00246012|314486|P9|NOT COMPLETED|Overall Study||28
131142|NCT00246012|314487|P8|NOT COMPLETED|Overall Study||28
131143|NCT00246012|314488|P7|NOT COMPLETED|Overall Study||31
131144|NCT00246012|314489|P6|NOT COMPLETED|Overall Study||28
131145|NCT00246012|314490|P5|NOT COMPLETED|Overall Study||3
131146|NCT00246012|314491|P4|NOT COMPLETED|Overall Study||3
131147|NCT00246012|314492|P3|NOT COMPLETED|Overall Study||2
131148|NCT00246012|314493|P2|NOT COMPLETED|Overall Study||1
131149|NCT00246012|314494|P1|NOT COMPLETED|Overall Study||3
131150|NCT00246012|314486|P9|COMPLETED|Overall Study||4
131151|NCT00246012|314487|P8|COMPLETED|Overall Study||5
131152|NCT00246012|314488|P7|COMPLETED|Overall Study||1
131153|NCT00246012|314489|P6|COMPLETED|Overall Study||4
131154|NCT00246012|314490|P5|COMPLETED|Overall Study||0
131155|NCT00246012|314491|P4|COMPLETED|Overall Study||0
131156|NCT00246012|314492|P3|COMPLETED|Overall Study||1
131157|NCT00246012|314493|P2|COMPLETED|Overall Study||2
131158|NCT00246012|314494|P1|COMPLETED|Overall Study||0
131159|NCT00246012|314486|P9|Treated|Overall Study||32
131160|NCT00246012|314487|P8|Treated|Overall Study||33
131161|NCT00246012|314488|P7|Treated|Overall Study||31
131162|NCT00246012|314489|P6|Treated|Overall Study||31
131163|NCT00246012|314490|P5|Treated|Overall Study||3
131164|NCT00246012|314491|P4|Treated|Overall Study||3
131165|NCT00246012|314492|P3|Treated|Overall Study||3
131166|NCT00246012|314493|P2|Treated|Overall Study||3
131167|NCT00246012|314494|P1|Treated|Overall Study||3
131168|NCT00246012|314486|P9|STARTED|Overall Study||32
131169|NCT00246012|314487|P8|STARTED|Overall Study||33
131170|NCT00246012|314488|P7|STARTED|Overall Study||32
131171|NCT00246012|314489|P6|STARTED|Overall Study||32
131172|NCT00246012|314490|P5|STARTED|Overall Study||3
131173|NCT00246012|314491|P4|STARTED|Overall Study||3
131174|NCT00246012|314492|P3|STARTED|Overall Study||3
131175|NCT00246012|314493|P2|STARTED|Overall Study||3
131176|NCT00246012|314494|P1|STARTED|Overall Study||3
131177|NCT00246025|314591|P4|NOT COMPLETED|Overall Study||13
131178|NCT00246025|314592|P3|NOT COMPLETED|Overall Study||10
131179|NCT00246025|314593|P2|NOT COMPLETED|Overall Study||9
131180|NCT00246025|314594|P1|NOT COMPLETED|Overall Study||10
131181|NCT00246025|314591|P4|COMPLETED|Overall Study||116
131182|NCT00246025|314592|P3|COMPLETED|Overall Study||116
131183|NCT00246025|314593|P2|COMPLETED|Overall Study||124
131184|NCT00246025|314594|P1|COMPLETED|Overall Study||114
131185|NCT00246025|314591|P4|STARTED|Overall Study||129
131186|NCT00246025|314592|P3|STARTED|Overall Study||126
131187|NCT00246025|314593|P2|STARTED|Overall Study||133
131188|NCT00246025|314594|P1|STARTED|Overall Study||124
131189|NCT00246090|314644|P1|NOT COMPLETED|Overall Study||295
131190|NCT00246090|314644|P1|COMPLETED|Overall Study||3
131191|NCT00246090|314644|P1|STARTED|Overall Study||298
131192|NCT00246259|314651|P2|NOT COMPLETED|Overall Study||26
131193|NCT00246259|314652|P1|NOT COMPLETED|Overall Study||28
131194|NCT00246259|314651|P2|COMPLETED|Overall Study||15
131195|NCT00246259|314652|P1|COMPLETED|Overall Study||16
131196|NCT00246259|314651|P2|Eligible for Intent-to-treat (ITT)|Overall Study||35
131197|NCT00246259|314652|P1|Eligible for Intent-to-treat (ITT)|Overall Study||42
131198|NCT00246259|314651|P2|STARTED|Overall Study||41
131199|NCT00246259|314652|P1|STARTED|Overall Study||44
131200|NCT00246324|314686|P1|NOT COMPLETED|Overall Study||1
131201|NCT00246324|314686|P1|COMPLETED|Overall Study||15
131202|NCT00246324|314686|P1|STARTED|Overall Study||16
131203|NCT00246337|314700|P9|NOT COMPLETED|Overall Study||11
131204|NCT00246337|314701|P8|NOT COMPLETED|Overall Study||13
131205|NCT00246337|314702|P7|NOT COMPLETED|Overall Study||9
131206|NCT00246337|314703|P6|NOT COMPLETED|Overall Study||15
131207|NCT00246337|314704|P5|NOT COMPLETED|Overall Study||4
131208|NCT00246337|314705|P4|NOT COMPLETED|Overall Study||1
131209|NCT00246337|314706|P3|NOT COMPLETED|Overall Study||3
131210|NCT00246337|314707|P2|NOT COMPLETED|Overall Study||2
131211|NCT00246337|314708|P1|NOT COMPLETED|Overall Study||32
131212|NCT00246337|314700|P9|COMPLETED|Overall Study||34
131213|NCT00246337|314701|P8|COMPLETED|Overall Study||40
131214|NCT00246337|314702|P7|COMPLETED|Overall Study||45
131215|NCT00246337|314703|P6|COMPLETED|Overall Study||39
131216|NCT00246337|314704|P5|COMPLETED|Overall Study||12
131217|NCT00246337|314705|P4|COMPLETED|Overall Study||16
131218|NCT00246337|314706|P3|COMPLETED|Overall Study||15
131219|NCT00246337|314707|P2|COMPLETED|Overall Study||14
131220|NCT00246337|314708|P1|COMPLETED|Overall Study||115
131221|NCT00246337|314700|P9|Completed Period (Both Doses)|Overall Study||15
131222|NCT00246337|314701|P8|Completed Period (Both Doses)|Overall Study||13
131223|NCT00246337|314702|P7|Completed Period (Both Doses)|Overall Study||16
131224|NCT00246337|314703|P6|Completed Period (Both Doses)|Overall Study||10
131225|NCT00246337|314704|P5|Completed Period (Both Doses)|Overall Study||4
131226|NCT00246337|314705|P4|Completed Period (Both Doses)|Overall Study||11
131227|NCT00246337|314706|P3|Completed Period (Both Doses)|Overall Study||6
131228|NCT00246337|314707|P2|Completed Period (Both Doses)|Overall Study||10
131229|NCT00246337|314708|P1|Completed Period (Both Doses)|Overall Study||69
131230|NCT00246337|314700|P9|Completed Period (Initial Dose)|Overall Study||19
131231|NCT00246337|314701|P8|Completed Period (Initial Dose)|Overall Study||27
131232|NCT00246337|314702|P7|Completed Period (Initial Dose)|Overall Study||29
131233|NCT00246337|314703|P6|Completed Period (Initial Dose)|Overall Study||29
131234|NCT00246337|314704|P5|Completed Period (Initial Dose)|Overall Study||8
131235|NCT00246337|314705|P4|Completed Period (Initial Dose)|Overall Study||5
131236|NCT00246337|314706|P3|Completed Period (Initial Dose)|Overall Study||9
131237|NCT00246337|314707|P2|Completed Period (Initial Dose)|Overall Study||4
131238|NCT00246337|314708|P1|Completed Period (Initial Dose)|Overall Study||46
131239|NCT00246337|314700|P9|STARTED|Overall Study||45
131240|NCT00246337|314701|P8|STARTED|Overall Study||53
131241|NCT00246337|314702|P7|STARTED|Overall Study||54
131242|NCT00246337|314703|P6|STARTED|Overall Study||54
131243|NCT00246337|314704|P5|STARTED|Overall Study||16
131244|NCT00246337|314705|P4|STARTED|Overall Study||17
131245|NCT00246337|314706|P3|STARTED|Overall Study||18
131246|NCT00246337|314707|P2|STARTED|Overall Study||16
131247|NCT00246337|314708|P1|STARTED|Overall Study||147
131248|NCT00239005|314757|P2|NOT COMPLETED|Overall Study||12
131249|NCT00239005|314758|P1|NOT COMPLETED|Overall Study||12
131250|NCT00239005|314757|P2|COMPLETED|Overall Study||53
131251|NCT00239005|314758|P1|COMPLETED|Overall Study||57
131252|NCT00239005|314757|P2|Intention-to-treat Population (ITT)|Overall Study||61
131253|NCT00239005|314758|P1|Intention-to-treat Population (ITT)|Overall Study||68
131254|NCT00239005|314757|P2|STARTED|Overall Study||65
131255|NCT00239005|314758|P1|STARTED|Overall Study||69
131256|NCT00239226|314772|P4|NOT COMPLETED|Overall Study||3
131257|NCT00239226|314773|P3|NOT COMPLETED|Overall Study||1
131258|NCT00239226|314774|P2|NOT COMPLETED|Overall Study||0
131259|NCT00239226|314775|P1|NOT COMPLETED|Overall Study||1
131260|NCT00239226|314772|P4|COMPLETED|Overall Study||14
131261|NCT00239226|314773|P3|COMPLETED|Overall Study||36
131262|NCT00239226|314774|P2|COMPLETED|Overall Study||18
131263|NCT00239226|314775|P1|COMPLETED|Overall Study||29
131264|NCT00239226|314772|P4|STARTED|Overall Study||17
131265|NCT00239226|314773|P3|STARTED|Overall Study||37
131266|NCT00239226|314774|P2|STARTED|Overall Study||18
131267|NCT00239226|314775|P1|STARTED|Overall Study||30
131268|NCT00239356|314787|P2|NOT COMPLETED|Overall Study||9
131269|NCT00239356|314788|P1|NOT COMPLETED|Overall Study||39
131270|NCT00239356|314787|P2|COMPLETED|Overall Study||11
131271|NCT00239356|314788|P1|COMPLETED|Overall Study||58
131272|NCT00239356|314787|P2|STARTED|Overall Study||20
131273|NCT00239356|314788|P1|STARTED|Overall Study||97
131274|NCT00239642|314809|P3|NOT COMPLETED|Overall Study||2
131275|NCT00239642|314810|P2|NOT COMPLETED|Overall Study||0
131276|NCT00239642|314811|P1|NOT COMPLETED|Overall Study||2
131277|NCT00239642|314809|P3|COMPLETED|Overall Study||47
131278|NCT00239642|314810|P2|COMPLETED|Overall Study||47
131279|NCT00239642|314811|P1|COMPLETED|Overall Study||47
131280|NCT00239642|314809|P3|STARTED|Overall Study||49
131281|NCT00239642|314810|P2|STARTED|Overall Study||47
131282|NCT00239642|314811|P1|STARTED|Overall Study||49
131283|NCT00239681|314845|P2|NOT COMPLETED|Overall Study||715
131284|NCT00239681|314846|P1|NOT COMPLETED|Overall Study||693
131285|NCT00239681|314845|P2|COMPLETED|Overall Study||8186
131286|NCT00239681|314846|P1|COMPLETED|Overall Study||8208
131287|NCT00239681|314845|P2|Randomized and Treated (Safety Pop)|Overall Study||8864
131288|NCT00239681|314846|P1|Randomized and Treated (Safety Pop)|Overall Study||8869
131289|NCT00239681|314845|P2|STARTED|Overall Study||8901
131290|NCT00239681|314846|P1|STARTED|Overall Study||8901
131291|NCT00239720|314864|P2|NOT COMPLETED|Overall Study||1
131292|NCT00239720|314865|P1|NOT COMPLETED|Overall Study||1
131293|NCT00239720|314864|P2|COMPLETED|Overall Study|One participant lost to follow-up|0
131294|NCT00239720|314865|P1|COMPLETED|Overall Study|One participant discontinued due to an adverse event|2
131295|NCT00239720|314864|P2|STARTED|Overall Study||1
131296|NCT00239720|314865|P1|STARTED|Overall Study||3
131297|NCT00239733|314871|P1|NOT COMPLETED|Overall Study||0
131298|NCT00239733|314871|P1|COMPLETED|Overall Study||6
131299|NCT00239733|314871|P1|STARTED|Overall Study||6
131300|NCT00239837|314878|P2|NOT COMPLETED|Overall Study||7
131301|NCT00239837|314879|P1|NOT COMPLETED|Overall Study||3
131302|NCT00239837|314878|P2|COMPLETED|Overall Study|3-year follow-up|45
131303|NCT00239837|314879|P1|COMPLETED|Overall Study|3-year follow-up|45
131304|NCT00239837|314878|P2|6 Months|Overall Study||50
131305|NCT00239837|314879|P1|6 Months|Overall Study||48
131306|NCT00239837|314878|P2|STARTED|Overall Study||52
131307|NCT00239837|314879|P1|STARTED|Overall Study||48
131308|NCT00239928|314899|P1|NOT COMPLETED|Overall Study||10
131309|NCT00239928|314899|P1|COMPLETED|Overall Study||51
131310|NCT00239928|314899|P1|STARTED|Overall Study||61
131311|NCT00240071|314909|P1|NOT COMPLETED|Overall Study||3
131312|NCT00240071|314909|P1|COMPLETED|Overall Study|3 patients withdrew consent after 29, 5 and 3 1/2 months on study.|27
131313|NCT00240071|314909|P1|STARTED|Overall Study||30
131314|NCT00240097|314913|P1|NOT COMPLETED|Part II||23
131315|NCT00240097|314913|P1|COMPLETED|Part II||3
131316|NCT00240097|314913|P1|STARTED|Part II||26
131317|NCT00240097|314913|P1|NOT COMPLETED|Part I||4
131318|NCT00240097|314913|P1|COMPLETED|Part I||26
131319|NCT00240097|314913|P1|STARTED|Part I||30
131320|NCT00240110|314925|P2|NOT COMPLETED|Overall Study||7
131321|NCT00240110|314926|P1|NOT COMPLETED|Overall Study||6
131322|NCT00240110|314925|P2|COMPLETED|Overall Study||6
131323|NCT00240110|314926|P1|COMPLETED|Overall Study||7
131324|NCT00240110|314925|P2|STARTED|Overall Study||13
131325|NCT00240110|314926|P1|STARTED|Overall Study||13
131326|NCT00240162|314934|P1|NOT COMPLETED|Overall Study||0
131327|NCT00240162|314934|P1|COMPLETED|Overall Study||21
131328|NCT00240162|314934|P1|STARTED|Overall Study||21
131329|NCT00240227|314941|P1|NOT COMPLETED|Overall Study||0
131330|NCT00240227|314941|P1|COMPLETED|Overall Study||8
131331|NCT00240227|314941|P1|STARTED|Overall Study||8
131332|NCT00240331|314949|P2|NOT COMPLETED|Overall Study||134
131333|NCT00240331|314950|P1|NOT COMPLETED|Overall Study||126
131334|NCT00240331|314949|P2|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1250
131335|NCT00240331|314950|P1|COMPLETED|Overall Study|Vital status was obtained for all randomised patients at the end of the study|1263
131336|NCT00240331|314949|P2|STARTED|Overall Study|One patient was incorrectly randomised and not included in the analyses|1384
131337|NCT00240331|314950|P1|STARTED|Overall Study|Two patients were incorrectly randomised and not included in the analyses.|1389
131338|NCT00246376|314973|P5|NOT COMPLETED|Overall Study||17
131339|NCT00246376|314974|P4|NOT COMPLETED|Overall Study||26
131340|NCT00246376|314975|P3|NOT COMPLETED|Overall Study||16
131341|NCT00246376|314976|P2|NOT COMPLETED|Overall Study||19
131342|NCT00246376|314977|P1|NOT COMPLETED|Overall Study||15
131343|NCT00246376|314973|P5|COMPLETED|Overall Study||28
131344|NCT00246376|314974|P4|COMPLETED|Overall Study||21
131345|NCT00246376|314975|P3|COMPLETED|Overall Study||29
131346|NCT00246376|314976|P2|COMPLETED|Overall Study||24
131347|NCT00246376|314977|P1|COMPLETED|Overall Study||26
131348|NCT00246376|314973|P5|After Dietary run-in at Two Weeks|Overall Study||42
131349|NCT00246376|314974|P4|After Dietary run-in at Two Weeks|Overall Study||40
131350|NCT00246376|314975|P3|After Dietary run-in at Two Weeks|Overall Study||41
131351|NCT00246376|314976|P2|After Dietary run-in at Two Weeks|Overall Study||38
131352|NCT00246376|314977|P1|After Dietary run-in at Two Weeks|Overall Study||30
131353|NCT00246376|314973|P5|STARTED|Overall Study||45
131354|NCT00246376|314974|P4|STARTED|Overall Study||47
131355|NCT00246376|314975|P3|STARTED|Overall Study||45
131356|NCT00246376|314976|P2|STARTED|Overall Study||43
131357|NCT00246376|314977|P1|STARTED|Overall Study||41
131358|NCT00246519|315021|P2|NOT COMPLETED|Overall Study||64
131359|NCT00246519|315022|P1|NOT COMPLETED|Overall Study||56
131360|NCT00246519|315021|P2|COMPLETED|Overall Study||382
131361|NCT00246519|315022|P1|COMPLETED|Overall Study||386
131362|NCT00246519|315021|P2|STARTED|Overall Study||446
131363|NCT00246519|315022|P1|STARTED|Overall Study||442
131364|NCT00246571|315030|P2|NOT COMPLETED|Overall Study||104
131365|NCT00246571|315031|P1|NOT COMPLETED|Overall Study||113
131366|NCT00246571|315030|P2|COMPLETED|Overall Study||0
131367|NCT00246571|315031|P1|COMPLETED|Overall Study||0
131368|NCT00246571|315030|P2|Randomized But Not Treated|Overall Study||1
131369|NCT00246571|315031|P1|Randomized But Not Treated|Overall Study||3
131370|NCT00246571|315030|P2|STARTED|Overall Study||104
131371|NCT00246571|315031|P1|STARTED|Overall Study||113
131372|NCT00247611|315071|P2|NOT COMPLETED|On Protocol Sample||125
131373|NCT00247611|315072|P1|NOT COMPLETED|On Protocol Sample||111
131374|NCT00247611|315071|P2|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|152
131375|NCT00247611|315072|P1|COMPLETED|On Protocol Sample|Participants with no interruptions in ART receipt and completing 6 or more LifeWindows assessments|176
131376|NCT00247611|315071|P2|STARTED|On Protocol Sample|ITT sample participants|277
131377|NCT00247611|315072|P1|STARTED|On Protocol Sample|ITT sample participants|287
131378|NCT00247611|315071|P2|NOT COMPLETED|Intention to Treat Sample||13
131379|NCT00247611|315072|P1|NOT COMPLETED|Intention to Treat Sample||17
131380|NCT00247611|315071|P2|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|277
131381|NCT00247611|315072|P1|COMPLETED|Intention to Treat Sample|Randomized participants who completed at least 2 adherence assessments/sessions|287
131382|NCT00247611|315071|P2|STARTED|Intention to Treat Sample|Participants randomized|290
131383|NCT00247611|315072|P1|STARTED|Intention to Treat Sample|Participants randomized|304
131384|NCT00247611|315071|P2|NOT COMPLETED|Baselined||13
131385|NCT00247611|315072|P1|NOT COMPLETED|Baselined||17
131386|NCT00247611|315071|P2|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|277
131387|NCT00247611|315072|P1|COMPLETED|Baselined|Randomized participants who completed at least 2 adherence assessments/sessions|287
131388|NCT00247611|315071|P2|STARTED|Baselined|Participants randomized|290
131389|NCT00247611|315072|P1|STARTED|Baselined|Participants randomized|304
131390|NCT00247676|315088|P1|NOT COMPLETED|Overall Study||36
131391|NCT00247676|315088|P1|COMPLETED|Overall Study||1
131392|NCT00247676|315088|P1|STARTED|Overall Study||37
131393|NCT00247962|315118|P2|NOT COMPLETED|Overall Study||19
131394|NCT00247962|315119|P1|NOT COMPLETED|Overall Study||26
131395|NCT00247962|315118|P2|COMPLETED|Overall Study||168
131396|NCT00247962|315119|P1|COMPLETED|Overall Study||353
131397|NCT00247962|315118|P2|STARTED|Overall Study||187
131398|NCT00247962|315119|P1|STARTED|Overall Study||379
131399|NCT00248170|315129|P2|NOT COMPLETED|Overall Study||808
131400|NCT00248170|315130|P1|NOT COMPLETED|Overall Study||761
131401|NCT00248170|315129|P2|COMPLETED|Overall Study||1286
131402|NCT00248170|315130|P1|COMPLETED|Overall Study||1317
131403|NCT00248170|315129|P2|Safety Set|Overall Study||2062
131404|NCT00248170|315130|P1|Safety Set|Overall Study||2049
131405|NCT00248170|315129|P2|Intent-to-treat (ITT)|Overall Study||2075
131406|NCT00248170|315130|P1|Intent-to-treat (ITT)|Overall Study||2061
131407|NCT00248170|315129|P2|STARTED|Overall Study||2094
131408|NCT00248170|315130|P1|STARTED|Overall Study||2078
131409|NCT00248287|315152|P2|NOT COMPLETED|Overall Study||19
131410|NCT00248287|315153|P1|NOT COMPLETED|Overall Study||24
131411|NCT00248287|315152|P2|COMPLETED|Overall Study||60
131412|NCT00248287|315153|P1|COMPLETED|Overall Study||51
131413|NCT00248287|315152|P2|STARTED|Overall Study||79
131414|NCT00248287|315153|P1|STARTED|Overall Study||75
131415|NCT00248495|315165|P1|NOT COMPLETED|Overall Study||1
131416|NCT00248495|315165|P1|COMPLETED|Overall Study||37
131417|NCT00248495|315165|P1|STARTED|Overall Study||38
131418|NCT00248547|315176|P2|NOT COMPLETED|Overall Study||0
131419|NCT00248547|315177|P1|NOT COMPLETED|Overall Study||0
131420|NCT00248547|315176|P2|COMPLETED|Overall Study||20
131421|NCT00248547|315177|P1|COMPLETED|Overall Study||20
131422|NCT00248547|315176|P2|STARTED|Overall Study||20
131423|NCT00248547|315177|P1|STARTED|Overall Study||20
131424|NCT00248560|315183|P1|NOT COMPLETED|Overall Study||0
131425|NCT00248560|315183|P1|COMPLETED|Overall Study||36
131426|NCT00248560|315183|P1|STARTED|Overall Study||36
131427|NCT00248612|315191|P4|NOT COMPLETED|Overall Study||0
131428|NCT00248612|315192|P3|NOT COMPLETED|Overall Study||0
131429|NCT00248612|315193|P2|NOT COMPLETED|Overall Study||0
131430|NCT00248612|315194|P1|NOT COMPLETED|Overall Study||0
131431|NCT00248612|315191|P4|COMPLETED|Overall Study||22
131432|NCT00248612|315192|P3|COMPLETED|Overall Study||14
131433|NCT00248612|315193|P2|COMPLETED|Overall Study||21
131434|NCT00248612|315194|P1|COMPLETED|Overall Study||24
131435|NCT00248612|315191|P4|STARTED|Overall Study||22
131436|NCT00248612|315192|P3|STARTED|Overall Study||14
131437|NCT00248612|315193|P2|STARTED|Overall Study||21
131438|NCT00248612|315194|P1|STARTED|Overall Study||24
131439|NCT00248625|315238|P2|NOT COMPLETED|Overall Study||2
131440|NCT00248625|315239|P1|NOT COMPLETED|Overall Study||0
131441|NCT00248625|315238|P2|COMPLETED|Overall Study||90
131442|NCT00248625|315239|P1|COMPLETED|Overall Study||92
131443|NCT00248625|315238|P2|STARTED|Overall Study||92
131444|NCT00248625|315239|P1|STARTED|Overall Study||92
131445|NCT00248638|315261|P2|NOT COMPLETED|Overall Study||0
131446|NCT00248638|315262|P1|NOT COMPLETED|Overall Study||0
131447|NCT00248638|315261|P2|COMPLETED|Overall Study||75
131448|NCT00248638|315262|P1|COMPLETED|Overall Study||75
131449|NCT00248638|315261|P2|STARTED|Overall Study||75
131450|NCT00248638|315262|P1|STARTED|Overall Study||75
131451|NCT00248651|315273|P3|NOT COMPLETED|Overall Study||32
131452|NCT00248651|315274|P2|NOT COMPLETED|Overall Study||40
131453|NCT00248651|315275|P1|NOT COMPLETED|Overall Study||28
131454|NCT00248651|315273|P3|COMPLETED|Overall Study||65
131455|NCT00248651|315274|P2|COMPLETED|Overall Study||58
131456|NCT00248651|315275|P1|COMPLETED|Overall Study||69
131457|NCT00248651|315273|P3|Completed 12 Weeks of Treatment|Overall Study||75
131458|NCT00248651|315274|P2|Completed 12 Weeks of Treatment|Overall Study||66
131459|NCT00248651|315275|P1|Completed 12 Weeks of Treatment|Overall Study||78
131460|NCT00248651|315273|P3|STARTED|Overall Study||97
131461|NCT00248651|315274|P2|STARTED|Overall Study||98
131462|NCT00248651|315275|P1|STARTED|Overall Study||97
131463|NCT00248781|315294|P2|NOT COMPLETED|Overall Study||4
131464|NCT00248781|315295|P1|NOT COMPLETED|Overall Study||10
131465|NCT00248781|315294|P2|COMPLETED|Overall Study||47
131466|NCT00248781|315295|P1|COMPLETED|Overall Study||42
131467|NCT00248781|315294|P2|STARTED|Overall Study||51
131468|NCT00248781|315295|P1|STARTED|Overall Study||52
131469|NCT00248794|315322|P3|NOT COMPLETED|Overall Study||3
131470|NCT00248794|315323|P2|NOT COMPLETED|Overall Study||8
131471|NCT00248794|315324|P1|NOT COMPLETED|Overall Study||6
131472|NCT00248794|315322|P3|COMPLETED|Overall Study||7
131473|NCT00248794|315323|P2|COMPLETED|Overall Study||16
131474|NCT00248794|315324|P1|COMPLETED|Overall Study||19
131475|NCT00248794|315322|P3|STARTED|Overall Study||10
131476|NCT00248794|315323|P2|STARTED|Overall Study||24
131477|NCT00248794|315324|P1|STARTED|Overall Study||25
131478|NCT00248807|315346|P2|NOT COMPLETED|Overall Study||0
131479|NCT00248807|315347|P1|NOT COMPLETED|Overall Study||0
131480|NCT00248807|315346|P2|COMPLETED|Overall Study||11
131481|NCT00248807|315347|P1|COMPLETED|Overall Study||19
131482|NCT00248807|315346|P2|STARTED|Overall Study||11
131483|NCT00248807|315347|P1|STARTED|Overall Study||19
131484|NCT00249002|315361|P1|NOT COMPLETED|Overall Study||7
131485|NCT00249002|315361|P1|COMPLETED|Overall Study||2
131486|NCT00249002|315361|P1|STARTED|Overall Study||9
131487|NCT00249249|315381|P4|NOT COMPLETED|Overall Study||3
131488|NCT00249249|315382|P3|NOT COMPLETED|Overall Study||15
131489|NCT00249249|315383|P2|NOT COMPLETED|Overall Study||5
131490|NCT00249249|315384|P1|NOT COMPLETED|Overall Study||20
131491|NCT00249249|315381|P4|COMPLETED|Overall Study||100
131492|NCT00249249|315382|P3|COMPLETED|Overall Study||288
131493|NCT00249249|315383|P2|COMPLETED|Overall Study||98
131494|NCT00249249|315384|P1|COMPLETED|Overall Study||301
131495|NCT00249249|315381|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|103
131496|NCT00249249|315382|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|300
131497|NCT00249249|315383|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|102
131498|NCT00249249|315384|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|316
131499|NCT00249249|315381|P4|STARTED|Overall Study||103
131500|NCT00249249|315382|P3|STARTED|Overall Study||303
131501|NCT00249249|315383|P2|STARTED|Overall Study||103
131502|NCT00249249|315384|P1|STARTED|Overall Study||321
131503|NCT00249288|315440|P2|NOT COMPLETED|Overall Study||5
131504|NCT00249288|315441|P1|NOT COMPLETED|Overall Study||5
131505|NCT00249288|315440|P2|COMPLETED|Overall Study||14
131506|NCT00249288|315441|P1|COMPLETED|Overall Study||14
131507|NCT00249288|315440|P2|Initiated Treatment|Overall Study||15
131508|NCT00249288|315441|P1|Initiated Treatment|Overall Study||17
131509|NCT00249288|315440|P2|STARTED|Overall Study||19
131510|NCT00249288|315441|P1|STARTED|Overall Study||19
131511|NCT00249379|315449|P2|NOT COMPLETED|Overall Study||8
131512|NCT00249379|315450|P1|NOT COMPLETED|Overall Study||8
131513|NCT00249379|315449|P2|COMPLETED|Overall Study||4
131514|NCT00249379|315450|P1|COMPLETED|Overall Study||6
131515|NCT00249379|315449|P2|STARTED|Overall Study||12
131516|NCT00249379|315450|P1|STARTED|Overall Study||14
131517|NCT00249470|315464|P2|NOT COMPLETED|Overall Study||0
131518|NCT00249470|315465|P1|NOT COMPLETED|Overall Study||0
131519|NCT00249470|315464|P2|COMPLETED|Overall Study||28
131520|NCT00249470|315465|P1|COMPLETED|Overall Study||28
131521|NCT00249470|315464|P2|STARTED|Overall Study||28
131522|NCT00249470|315465|P1|STARTED|Overall Study||28
131523|NCT00249496|315473|P2|NOT COMPLETED|Overall Study||1
131524|NCT00249496|315474|P1|NOT COMPLETED|Overall Study||0
131525|NCT00249496|315473|P2|COMPLETED|Overall Study||26
131526|NCT00249496|315474|P1|COMPLETED|Overall Study||24
131527|NCT00249496|315473|P2|STARTED|Overall Study||27
131528|NCT00249496|315474|P1|STARTED|Overall Study||24
131529|NCT00249613|315490|P2|NOT COMPLETED|12 Month Follow-up||15
131530|NCT00249613|315491|P1|NOT COMPLETED|12 Month Follow-up||17
131531|NCT00249613|315490|P2|COMPLETED|12 Month Follow-up||124
131532|NCT00249613|315491|P1|COMPLETED|12 Month Follow-up||135
131533|NCT00249613|315490|P2|STARTED|12 Month Follow-up||139
131534|NCT00249613|315491|P1|STARTED|12 Month Follow-up||152
131535|NCT00249613|315490|P2|NOT COMPLETED|Baseline||0
131536|NCT00249613|315491|P1|NOT COMPLETED|Baseline||0
131537|NCT00249613|315490|P2|COMPLETED|Baseline||139
131538|NCT00249613|315491|P1|COMPLETED|Baseline||152
131539|NCT00249613|315490|P2|STARTED|Baseline||139
131540|NCT00249613|315491|P1|STARTED|Baseline||152
131541|NCT00249795|315502|P2|NOT COMPLETED|Overall Study||1390
131542|NCT00249795|315503|P1|NOT COMPLETED|Overall Study||1394
131543|NCT00249795|315502|P2|COMPLETED|Overall Study|started and completed study drug|3108
131544|NCT00249795|315503|P1|COMPLETED|Overall Study|started and completed study drug|3124
131545|NCT00249795|315502|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4498
131546|NCT00249795|315503|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|4518
131547|NCT00249821|315523|P2|NOT COMPLETED|Overall Study||1
131548|NCT00249821|315524|P1|NOT COMPLETED|Overall Study||0
131549|NCT00249821|315523|P2|COMPLETED|Overall Study||11
131550|NCT00249821|315524|P1|COMPLETED|Overall Study||10
131551|NCT00249821|315523|P2|STARTED|Overall Study||12
131552|NCT00249821|315524|P1|STARTED|Overall Study||10
131553|NCT00249873|315546|P2|NOT COMPLETED|Overall Study||1254
131554|NCT00249873|315547|P1|NOT COMPLETED|Overall Study||1330
131555|NCT00249873|315546|P2|COMPLETED|Overall Study|started and completed study drug|2528
131556|NCT00249873|315547|P1|COMPLETED|Overall Study|started and completed study drug|2442
131557|NCT00249873|315546|P2|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3782
131558|NCT00249873|315547|P1|STARTED|Overall Study|randomized patients: patients remained in the study whether treated or not until planned study end|3772
131559|NCT00243347|315559|P1|NOT COMPLETED|Overall Study||19
131560|NCT00243347|315559|P1|COMPLETED|Overall Study|Completed study|0
131561|NCT00243347|315559|P1|STARTED|Overall Study|Treated|19
131562|NCT00243386|315564|P3|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
131563|NCT00243386|315565|P2|NOT COMPLETED|PK-Driven or Standard Prophylaxis||3
131564|NCT00243386|315566|P1|NOT COMPLETED|PK-Driven or Standard Prophylaxis||0
131565|NCT00243386|315564|P3|COMPLETED|PK-Driven or Standard Prophylaxis||32
131566|NCT00243386|315565|P2|COMPLETED|PK-Driven or Standard Prophylaxis||31
131567|NCT00243386|315566|P1|COMPLETED|PK-Driven or Standard Prophylaxis||0
131568|NCT00243386|315564|P3|STARTED|PK-Driven or Standard Prophylaxis||32
131569|NCT00243386|315565|P2|STARTED|PK-Driven or Standard Prophylaxis||34
131570|NCT00243386|315566|P1|STARTED|PK-Driven or Standard Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
131571|NCT00243386|315564|P3|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
131572|NCT00243386|315565|P2|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||0
131573|NCT00243386|315566|P1|NOT COMPLETED|End of Part 1, But Prior to Prophylaxis||3
131574|NCT00243386|315564|P3|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
131575|NCT00243386|315565|P2|COMPLETED|End of Part 1, But Prior to Prophylaxis||0
131576|NCT00243386|315566|P1|COMPLETED|End of Part 1, But Prior to Prophylaxis||66
131577|NCT00243386|315564|P3|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
131578|NCT00243386|315565|P2|STARTED|End of Part 1, But Prior to Prophylaxis|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
131579|NCT00243386|315566|P1|STARTED|End of Part 1, But Prior to Prophylaxis||69
131580|NCT00243386|315564|P3|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
131581|NCT00243386|315565|P2|NOT COMPLETED|On-Demand Regimen (Study Part 1)||0
131582|NCT00243386|315566|P1|NOT COMPLETED|On-Demand Regimen (Study Part 1)||4
131583|NCT00243386|315564|P3|COMPLETED|On-Demand Regimen (Study Part 1)||0
131584|NCT00243386|315565|P2|COMPLETED|On-Demand Regimen (Study Part 1)||0
131585|NCT00243386|315566|P1|COMPLETED|On-Demand Regimen (Study Part 1)||69
131586|NCT00243386|315564|P3|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
131587|NCT00243386|315565|P2|STARTED|On-Demand Regimen (Study Part 1)|Participants were randomized to PK-Driven or Standard Prophylaxis after Part 1 (On-Demand Regimen)|0
131588|NCT00243386|315566|P1|STARTED|On-Demand Regimen (Study Part 1)||73
131589|NCT00243412|315633|P2|NOT COMPLETED|Overall Study||11
131590|NCT00243412|315634|P1|NOT COMPLETED|Overall Study||10
131591|NCT00243412|315633|P2|COMPLETED|Overall Study|Completed Week 104|10
131592|NCT00243412|315634|P1|COMPLETED|Overall Study|Completed Week 104|11
131593|NCT00243412|315633|P2|Safety Evaluable|Overall Study||20
131594|NCT00243412|315634|P1|Safety Evaluable|Overall Study||21
131595|NCT00243412|315633|P2|STARTED|Overall Study|Intent to treat|21
131596|NCT00243412|315634|P1|STARTED|Overall Study|Intent to treat|21
131597|NCT00243503|315660|P1|NOT COMPLETED|Overall Study||58
131598|NCT00243503|315660|P1|COMPLETED|Overall Study||2
131689|NCT00251225|315996|P1|COMPLETED|Overall Study||49
131599|NCT00243503|315660|P1|STARTED|Overall Study|3 participants discontinued and only took Trastuzumab.|60
131600|NCT00243659|315677|P2|NOT COMPLETED|Overall Study||3
131601|NCT00243659|315678|P1|NOT COMPLETED|Overall Study||2
131602|NCT00243659|315677|P2|COMPLETED|Overall Study||5
131603|NCT00243659|315678|P1|COMPLETED|Overall Study||20
131604|NCT00243659|315677|P2|STARTED|Overall Study||8
131605|NCT00243659|315678|P1|STARTED|Overall Study||22
131606|NCT00250276|315690|P4|NOT COMPLETED|Overall Study||19
131607|NCT00250276|315691|P3|NOT COMPLETED|Overall Study||19
131608|NCT00250276|315692|P2|NOT COMPLETED|Overall Study||21
131609|NCT00250276|315693|P1|NOT COMPLETED|Overall Study||17
131610|NCT00250276|315690|P4|COMPLETED|Overall Study||181
131611|NCT00250276|315691|P3|COMPLETED|Overall Study||182
131612|NCT00250276|315692|P2|COMPLETED|Overall Study||177
131613|NCT00250276|315693|P1|COMPLETED|Overall Study||182
131614|NCT00250276|315690|P4|STARTED|Overall Study||200
131615|NCT00250276|315691|P3|STARTED|Overall Study||201
131616|NCT00250276|315692|P2|STARTED|Overall Study||198
131617|NCT00250276|315693|P1|STARTED|Overall Study||199
131618|NCT00250432|315773|P2|NOT COMPLETED|Overall Study||47
131619|NCT00250432|315774|P1|NOT COMPLETED|Overall Study||45
131620|NCT00250432|315773|P2|COMPLETED|Overall Study||53
131621|NCT00250432|315774|P1|COMPLETED|Overall Study||59
131622|NCT00250432|315773|P2|STARTED|Overall Study||100
131623|NCT00250432|315774|P1|STARTED|Overall Study||104
131624|NCT00250458|315784|P2|NOT COMPLETED|Overall Study||17
131625|NCT00250458|315785|P1|NOT COMPLETED|Overall Study||32
131626|NCT00250458|315784|P2|COMPLETED|Overall Study||97
131627|NCT00250458|315785|P1|COMPLETED|Overall Study||200
131628|NCT00250458|315784|P2|STARTED|Overall Study||114
131629|NCT00250458|315785|P1|STARTED|Overall Study||232
131630|NCT00250484|315795|P2|NOT COMPLETED|Overall Study||0
131631|NCT00250484|315796|P1|NOT COMPLETED|Overall Study||0
131632|NCT00250484|315795|P2|COMPLETED|Overall Study||8
131633|NCT00250484|315796|P1|COMPLETED|Overall Study||9
131634|NCT00250484|315795|P2|STARTED|Overall Study||8
131635|NCT00250484|315796|P1|STARTED|Overall Study||9
131636|NCT00250497|315806|P2|NOT COMPLETED|Overall Study||15
131637|NCT00250497|315807|P1|NOT COMPLETED|Overall Study||5
131638|NCT00250497|315806|P2|COMPLETED|Overall Study||159
131639|NCT00250497|315807|P1|COMPLETED|Overall Study||177
131640|NCT00250497|315806|P2|STARTED|Overall Study||174
131641|NCT00250497|315807|P1|STARTED|Overall Study||182
131642|NCT00250588|315826|P3|NOT COMPLETED|Overall Study||13
131643|NCT00250588|315827|P2|NOT COMPLETED|Overall Study||19
131644|NCT00250588|315828|P1|NOT COMPLETED|Overall Study||9
131645|NCT00250588|315826|P3|COMPLETED|Overall Study||74
131646|NCT00250588|315827|P2|COMPLETED|Overall Study||65
131647|NCT00250588|315828|P1|COMPLETED|Overall Study||72
131648|NCT00250588|315826|P3|STARTED|Overall Study||87
131649|NCT00250588|315827|P2|STARTED|Overall Study||84
131650|NCT00250588|315828|P1|STARTED|Overall Study||81
131651|NCT00250679|315845|P3|NOT COMPLETED|Overall Study||44
131652|NCT00250679|315846|P2|NOT COMPLETED|Overall Study||49
131653|NCT00250679|315847|P1|NOT COMPLETED|Overall Study||39
131654|NCT00250679|315845|P3|COMPLETED|Overall Study||103
131655|NCT00250679|315846|P2|COMPLETED|Overall Study||100
131656|NCT00250679|315847|P1|COMPLETED|Overall Study||108
131657|NCT00250679|315845|P3|STARTED|Overall Study||147
131658|NCT00250679|315846|P2|STARTED|Overall Study||149
131659|NCT00250679|315847|P1|STARTED|Overall Study||147
131660|NCT00250705|315945|P1|NOT COMPLETED|Overall Study||2
131661|NCT00250705|315945|P1|COMPLETED|Overall Study||10
131662|NCT00250705|315945|P1|STARTED|Overall Study||12
131663|NCT00250718|315953|P1|NOT COMPLETED|Overall Study||3
131664|NCT00250718|315953|P1|COMPLETED|Overall Study||14
131665|NCT00250718|315953|P1|Received Treatment|Overall Study||16
131666|NCT00250718|315953|P1|STARTED|Overall Study||17
131667|NCT00250835|315958|P1|NOT COMPLETED|Overall Study||1
131668|NCT00250835|315958|P1|COMPLETED|Overall Study||37
131669|NCT00250835|315958|P1|STARTED|Overall Study||38
131670|NCT00250926|315967|P1|NOT COMPLETED|Overall Study||0
131671|NCT00250926|315967|P1|COMPLETED|Overall Study||23
131672|NCT00250926|315967|P1|STARTED|Overall Study||23
131673|NCT00251004|315977|P3|NOT COMPLETED|Overall Study||31
131674|NCT00251004|315978|P2|NOT COMPLETED|Overall Study||41
131675|NCT00251004|315979|P1|NOT COMPLETED|Overall Study||45
131676|NCT00251004|315977|P3|COMPLETED|Overall Study||246
131677|NCT00251004|315978|P2|COMPLETED|Overall Study||238
131678|NCT00251004|315979|P1|COMPLETED|Overall Study||232
131679|NCT00251004|315977|P3|24 Month Analysis|Overall Study|Under 24 month analysis under group 3, 185 Completed study medication.|246
131680|NCT00251004|315978|P2|24 Month Analysis|Overall Study|Under 24 month analysis under group 2, 161 Completed study medication.|238
131681|NCT00251004|315979|P1|24 Month Analysis|Overall Study|Under 24 month analysis under group 1, 167 Completed study medication.|232
131682|NCT00251004|315977|P3|12 Month Analysis|Overall Study|Under 12 month analysis under group 3, 200 Completed study medication.|253
131683|NCT00251004|315978|P2|12 Month Analysis|Overall Study|Under 12 month analysis under group 2, 175 Completed study medication.|249
131684|NCT00251004|315979|P1|12 Month Analysis|Overall Study|Under 12 month analysis under group 1, 179 Completed study medication.|241
131685|NCT00251004|315977|P3|STARTED|Overall Study||277
131686|NCT00251004|315978|P2|STARTED|Overall Study||279
131687|NCT00251004|315979|P1|STARTED|Overall Study||277
131688|NCT00251225|315996|P1|NOT COMPLETED|Overall Study||0
131690|NCT00251225|315996|P1|STARTED|Overall Study||49
131691|NCT00251238|316004|P2|NOT COMPLETED|Overall Study||0
131692|NCT00251238|316005|P1|NOT COMPLETED|Overall Study||0
131693|NCT00251238|316004|P2|COMPLETED|Overall Study||20
131694|NCT00251238|316005|P1|COMPLETED|Overall Study||21
131695|NCT00251238|316004|P2|STARTED|Overall Study||20
131696|NCT00251238|316005|P1|STARTED|Overall Study||21
131697|NCT00251303|316017|P2|NOT COMPLETED|Overall Study||1
131698|NCT00251303|316018|P1|NOT COMPLETED|Overall Study||8
131699|NCT00251303|316017|P2|COMPLETED|Overall Study||29
131700|NCT00251303|316018|P1|COMPLETED|Overall Study||22
131701|NCT00251303|316017|P2|STARTED|Overall Study||30
131702|NCT00251303|316018|P1|STARTED|Overall Study|78 subjects signed any consent. 60 started drug (30 riluzole & 30 placebo).|30
131703|NCT00251316|316028|P2|NOT COMPLETED|Overall Study||3
131704|NCT00251316|316029|P1|NOT COMPLETED|Overall Study||2
131705|NCT00251316|316028|P2|COMPLETED|Overall Study||14
131706|NCT00251316|316029|P1|COMPLETED|Overall Study||15
131707|NCT00251316|316028|P2|STARTED|Overall Study||17
131708|NCT00251316|316029|P1|STARTED|Overall Study||17
131709|NCT00251589|316039|P4|NOT COMPLETED|Overall Study||2
131710|NCT00251589|316040|P3|NOT COMPLETED|Overall Study||2
131711|NCT00251589|316041|P2|NOT COMPLETED|Overall Study||3
131712|NCT00251589|316042|P1|NOT COMPLETED|Overall Study||15
131713|NCT00251589|316039|P4|COMPLETED|Overall Study||0
131714|NCT00251589|316040|P3|COMPLETED|Overall Study||0
131715|NCT00251589|316041|P2|COMPLETED|Overall Study||0
131716|NCT00251589|316042|P1|COMPLETED|Overall Study||1
131717|NCT00251589|316039|P4|STARTED|Overall Study||2
131718|NCT00251589|316040|P3|STARTED|Overall Study||2
131719|NCT00251589|316041|P2|STARTED|Overall Study||3
131720|NCT00251589|316042|P1|STARTED|Overall Study|4 of the 16 patients participated in Phase I and II portions. 12 participated in Phase II only.|16
131721|NCT00251641|316079|P2|NOT COMPLETED|Overall Study||88
131722|NCT00251641|316080|P1|NOT COMPLETED|Overall Study||112
131723|NCT00251641|316079|P2|COMPLETED|Overall Study||127
131724|NCT00251641|316080|P1|COMPLETED|Overall Study||541
131725|NCT00251641|316079|P2|STARTED|Overall Study||215
131726|NCT00251641|316080|P1|STARTED|Overall Study||653
131727|NCT00251693|316097|P3|NOT COMPLETED|Overall Study||46
131728|NCT00251693|316098|P2|NOT COMPLETED|Overall Study||44
131729|NCT00251693|316099|P1|NOT COMPLETED|Overall Study||51
131730|NCT00251693|316097|P3|COMPLETED|Overall Study||644
131731|NCT00251693|316098|P2|COMPLETED|Overall Study||624
131732|NCT00251693|316099|P1|COMPLETED|Overall Study||629
131733|NCT00251693|316097|P3|STARTED|Overall Study||690
131734|NCT00251693|316098|P2|STARTED|Overall Study||668
131735|NCT00251693|316099|P1|STARTED|Overall Study||680
131736|NCT00251719|316125|P3|NOT COMPLETED|Overall Study||30
131737|NCT00251719|316126|P2|NOT COMPLETED|Overall Study||45
131738|NCT00251719|316127|P1|NOT COMPLETED|Overall Study||53
131739|NCT00251719|316125|P3|COMPLETED|Overall Study||643
131740|NCT00251719|316126|P2|COMPLETED|Overall Study||642
131741|NCT00251719|316127|P1|COMPLETED|Overall Study||641
131742|NCT00251719|316125|P3|STARTED|Overall Study||673
131743|NCT00251719|316126|P2|STARTED|Overall Study||687
131744|NCT00251719|316127|P1|STARTED|Overall Study||694
131745|NCT00251745|316153|P3|NOT COMPLETED|Overall Study||27
131746|NCT00251745|316154|P2|NOT COMPLETED|Overall Study||27
131747|NCT00251745|316155|P1|NOT COMPLETED|Overall Study||28
131748|NCT00251745|316153|P3|COMPLETED|Overall Study||277
131749|NCT00251745|316154|P2|COMPLETED|Overall Study||285
131750|NCT00251745|316155|P1|COMPLETED|Overall Study||264
131751|NCT00251745|316153|P3|STARTED|Overall Study||304
131752|NCT00251745|316154|P2|STARTED|Overall Study||312
131753|NCT00251745|316155|P1|STARTED|Overall Study||292
131754|NCT00251758|316175|P3|NOT COMPLETED|Overall Study||27
131755|NCT00251758|316176|P2|NOT COMPLETED|Overall Study||27
131756|NCT00251758|316177|P1|NOT COMPLETED|Overall Study||28
131757|NCT00251758|316175|P3|COMPLETED|Overall Study||277
131758|NCT00251758|316176|P2|COMPLETED|Overall Study||285
131759|NCT00251758|316177|P1|COMPLETED|Overall Study||264
131760|NCT00251758|316175|P3|STARTED|Overall Study||304
131761|NCT00251758|316176|P2|STARTED|Overall Study||312
131762|NCT00251758|316177|P1|STARTED|Overall Study||292
131763|NCT00251862|316197|P3|NOT COMPLETED|Overall Study||0
131764|NCT00251862|316198|P2|NOT COMPLETED|Overall Study||0
131765|NCT00251862|316199|P1|NOT COMPLETED|Overall Study||0
131766|NCT00251862|316197|P3|COMPLETED|Overall Study||276
131767|NCT00251862|316198|P2|COMPLETED|Overall Study||269
131768|NCT00251862|316199|P1|COMPLETED|Overall Study||280
131769|NCT00251862|316197|P3|STARTED|Overall Study||276
131770|NCT00251862|316198|P2|STARTED|Overall Study||269
131771|NCT00251862|316199|P1|STARTED|Overall Study||280
131772|NCT00251927|316218|P2|NOT COMPLETED|Overall Study||74
131773|NCT00251927|316219|P1|NOT COMPLETED|Overall Study||108
131774|NCT00251927|316218|P2|COMPLETED|Overall Study|Completed 5 year visit|192
131775|NCT00251927|316219|P1|COMPLETED|Overall Study|Completed 5 year visit|180
131776|NCT00251927|316218|P2|STARTED|Overall Study|Randomised|266
131777|NCT00251927|316219|P1|STARTED|Overall Study|Randomised|288
131778|NCT00251979|316248|P2|NOT COMPLETED|Overall Study||40
131779|NCT00251979|316249|P1|NOT COMPLETED|Overall Study||38
131780|NCT00251979|316248|P2|COMPLETED|Overall Study||349
131781|NCT00251979|316249|P1|COMPLETED|Overall Study||337
131782|NCT00251979|316248|P2|STARTED|Overall Study|ITT population|389
131783|NCT00251979|316249|P1|STARTED|Overall Study|ITT population|375
131784|NCT00252057|316281|P2|NOT COMPLETED|Overall Study||8
131785|NCT00252057|316282|P1|NOT COMPLETED|Overall Study||3
131786|NCT00252057|316281|P2|COMPLETED|Overall Study||368
131787|NCT00252057|316282|P1|COMPLETED|Overall Study||370
131788|NCT00252057|316281|P2|STARTED|Overall Study||376
131789|NCT00252057|316282|P1|STARTED|Overall Study||373
131790|NCT00252174|316291|P3|NOT COMPLETED|Overall Study||0
131791|NCT00252174|316292|P2|NOT COMPLETED|Overall Study||1
131792|NCT00252174|316293|P1|NOT COMPLETED|Overall Study||0
131793|NCT00252174|316291|P3|COMPLETED|Overall Study||0
131794|NCT00252174|316292|P2|COMPLETED|Overall Study||1
131795|NCT00252174|316293|P1|COMPLETED|Overall Study||0
131796|NCT00252174|316291|P3|STARTED|Overall Study|No subjects entered Stage 2|0
131797|NCT00252174|316292|P2|STARTED|Overall Study|2 subjects entered the control arm in total|2
131798|NCT00252174|316293|P1|STARTED|Overall Study|No subjects were randomized into Active Arm as only 2 subjects were randomized into the Control Arm.|0
131799|NCT00252187|316330|P2|NOT COMPLETED|Overall Study||1
131800|NCT00252187|316331|P1|NOT COMPLETED|Overall Study||4
131801|NCT00252187|316330|P2|COMPLETED|Overall Study||20
131802|NCT00252187|316331|P1|COMPLETED|Overall Study||20
131803|NCT00252187|316330|P2|STARTED|Overall Study||21
131804|NCT00252187|316331|P1|STARTED|Overall Study||24
131805|NCT00252239|316355|P4|NOT COMPLETED|Overall Study||1
131806|NCT00252239|316356|P3|NOT COMPLETED|Overall Study||2
131807|NCT00252239|316357|P2|NOT COMPLETED|Overall Study||0
131808|NCT00252239|316358|P1|NOT COMPLETED|Overall Study||1
131809|NCT00252239|316355|P4|COMPLETED|Overall Study||30
131810|NCT00252239|316356|P3|COMPLETED|Overall Study||17
131811|NCT00252239|316357|P2|COMPLETED|Overall Study||31
131812|NCT00252239|316358|P1|COMPLETED|Overall Study||30
131813|NCT00252239|316355|P4|STARTED|Overall Study||31
131814|NCT00252239|316356|P3|STARTED|Overall Study||19
131815|NCT00252239|316357|P2|STARTED|Overall Study||31
131816|NCT00252239|316358|P1|STARTED|Overall Study||31
131817|NCT00252382|316368|P1|NOT COMPLETED|Overall Study||26
131818|NCT00252382|316368|P1|COMPLETED|Overall Study||5
131819|NCT00252382|316368|P1|STARTED|Overall Study||31
131820|NCT00252499|316376|P3|NOT COMPLETED|Overall Study||0
131821|NCT00252499|316377|P2|NOT COMPLETED|Overall Study||0
131822|NCT00252499|316378|P1|NOT COMPLETED|Overall Study||1
131823|NCT00252499|316376|P3|COMPLETED|Overall Study||6
131824|NCT00252499|316377|P2|COMPLETED|Overall Study||2
131825|NCT00252499|316378|P1|COMPLETED|Overall Study||4
131826|NCT00252499|316376|P3|STARTED|Overall Study||6
131827|NCT00252499|316377|P2|STARTED|Overall Study||2
131828|NCT00252499|316378|P1|STARTED|Overall Study||5
131829|NCT00252512|316403|P2|NOT COMPLETED|12 Month Follow up||1
131830|NCT00252512|316404|P1|NOT COMPLETED|12 Month Follow up||9
131831|NCT00252512|316403|P2|COMPLETED|12 Month Follow up||121
131832|NCT00252512|316404|P1|COMPLETED|12 Month Follow up||123
131833|NCT00252512|316403|P2|STARTED|12 Month Follow up||122
131834|NCT00252512|316404|P1|STARTED|12 Month Follow up||132
131835|NCT00252512|316403|P2|NOT COMPLETED|Six Month Follow up||12
131836|NCT00252512|316404|P1|NOT COMPLETED|Six Month Follow up||4
131837|NCT00252512|316403|P2|COMPLETED|Six Month Follow up||122
131838|NCT00252512|316404|P1|COMPLETED|Six Month Follow up||132
131839|NCT00252512|316403|P2|STARTED|Six Month Follow up||134
131840|NCT00252512|316404|P1|STARTED|Six Month Follow up||136
131841|NCT00252512|316403|P2|NOT COMPLETED|Intervention||31
131842|NCT00252512|316404|P1|NOT COMPLETED|Intervention||29
131843|NCT00252512|316403|P2|COMPLETED|Intervention||134
131844|NCT00252512|316404|P1|COMPLETED|Intervention||136
131845|NCT00252512|316403|P2|STARTED|Intervention||165
131846|NCT00252512|316404|P1|STARTED|Intervention||165
131847|NCT00252538|316410|P2|NOT COMPLETED|Overall Study||0
131848|NCT00252538|316411|P1|NOT COMPLETED|Overall Study||0
131849|NCT00252538|316410|P2|COMPLETED|Overall Study||114
131850|NCT00252538|316411|P1|COMPLETED|Overall Study||19
131851|NCT00252538|316410|P2|STARTED|Overall Study||114
131852|NCT00252538|316411|P1|STARTED|Overall Study||19
131853|NCT00252564|316418|P2|NOT COMPLETED|Overall Study||44
131854|NCT00252564|316419|P1|NOT COMPLETED|Overall Study||39
131855|NCT00252564|316418|P2|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|79
131856|NCT00252564|316419|P1|COMPLETED|Overall Study|Received 6+ cycles OR had response (RECIST criteria, CR or PR)|85
131857|NCT00252564|316418|P2|STARTED|Overall Study|From randomization|123
131858|NCT00252564|316419|P1|STARTED|Overall Study|From randomization|124
131859|NCT00252590|316434|P3|NOT COMPLETED|Overall Study||3
131860|NCT00252590|316435|P2|NOT COMPLETED|Overall Study||2
131861|NCT00252590|316436|P1|NOT COMPLETED|Overall Study||2
131862|NCT00252590|316434|P3|COMPLETED|Overall Study||31
131863|NCT00252590|316435|P2|COMPLETED|Overall Study||28
131864|NCT00252590|316436|P1|COMPLETED|Overall Study||33
131865|NCT00252590|316434|P3|STARTED|Overall Study||34
131866|NCT00252590|316435|P2|STARTED|Overall Study||30
131867|NCT00252590|316436|P1|STARTED|Overall Study||35
131868|NCT00252629|316450|P3|NOT COMPLETED|Overall Study||0
131869|NCT00252629|316451|P2|NOT COMPLETED|Overall Study||0
131870|NCT00252629|316452|P1|NOT COMPLETED|Overall Study||1
131871|NCT00252629|316450|P3|COMPLETED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
131872|NCT00252629|316451|P2|COMPLETED|Overall Study||9
131873|NCT00252629|316452|P1|COMPLETED|Overall Study|One participant assigned to therapeutic CPAP was excluded from the trial before starting treatment.|8
131874|NCT00252629|316450|P3|STARTED|Overall Study|We used data from the 18 veterans with GWS in addition to the 11 control|11
131875|NCT00252629|316451|P2|STARTED|Overall Study||9
131876|NCT00252629|316452|P1|STARTED|Overall Study||9
131877|NCT00252694|316467|P2|NOT COMPLETED|Overall Study||154
131878|NCT00252694|316468|P1|NOT COMPLETED|Overall Study||144
131879|NCT00252694|316467|P2|COMPLETED|Overall Study||800
131880|NCT00252694|316468|P1|COMPLETED|Overall Study||807
131881|NCT00252694|316467|P2|STARTED|Overall Study||954
131882|NCT00252694|316468|P1|STARTED|Overall Study||951
131883|NCT00252720|316482|P2|NOT COMPLETED|Overall Study||165
131884|NCT00252720|316483|P1|NOT COMPLETED|Overall Study||132
131885|NCT00252720|316482|P2|COMPLETED|Overall Study||789
131886|NCT00252720|316483|P1|COMPLETED|Overall Study||819
131887|NCT00252720|316482|P2|STARTED|Overall Study||954
131888|NCT00252720|316483|P1|STARTED|Overall Study||951
131889|NCT00252733|316497|P2|NOT COMPLETED|Overall Study||92
131890|NCT00252733|316498|P1|NOT COMPLETED|Overall Study||106
131891|NCT00252733|316497|P2|COMPLETED|Overall Study||618
131892|NCT00252733|316498|P1|COMPLETED|Overall Study||605
131893|NCT00252733|316497|P2|STARTED|Overall Study||710
131894|NCT00252733|316498|P1|STARTED|Overall Study||711
131895|NCT00252967|316508|P2|NOT COMPLETED|Overall Study||0
131896|NCT00252967|316509|P1|NOT COMPLETED|Overall Study||0
131897|NCT00252967|316508|P2|COMPLETED|Overall Study||33
131898|NCT00252967|316509|P1|COMPLETED|Overall Study||31
131899|NCT00252967|316508|P2|STARTED|Overall Study||33
131900|NCT00252967|316509|P1|STARTED|Overall Study||31
131901|NCT00253019|316534|P3|NOT COMPLETED|Overall Study||18
131902|NCT00253019|316535|P2|NOT COMPLETED|Overall Study||31
131903|NCT00253019|316536|P1|NOT COMPLETED|Overall Study||29
131904|NCT00253019|316534|P3|COMPLETED|Overall Study||83
131905|NCT00253019|316535|P2|COMPLETED|Overall Study||78
131906|NCT00253019|316536|P1|COMPLETED|Overall Study||82
131907|NCT00253019|316534|P3|STARTED|Overall Study||101
131908|NCT00253019|316535|P2|STARTED|Overall Study||109
131909|NCT00253019|316536|P1|STARTED|Overall Study||111
131910|NCT00246753|316544|P1|NOT COMPLETED|Overall Study||8
131911|NCT00246753|316544|P1|COMPLETED|Overall Study||21
131912|NCT00246753|316544|P1|STARTED|Overall Study||29
131913|NCT00246805|316552|P2|NOT COMPLETED|Phase 2||0
131914|NCT00246805|316553|P1|NOT COMPLETED|Phase 2||0
131915|NCT00246805|316552|P2|COMPLETED|Phase 2||33
131916|NCT00246805|316553|P1|COMPLETED|Phase 2||33
131917|NCT00246805|316552|P2|STARTED|Phase 2||33
131918|NCT00246805|316553|P1|STARTED|Phase 2||33
131919|NCT00246805|316552|P2|NOT COMPLETED|Phase 1||0
131920|NCT00246805|316553|P1|NOT COMPLETED|Phase 1||1
131921|NCT00246805|316552|P2|COMPLETED|Phase 1||33
131922|NCT00246805|316553|P1|COMPLETED|Phase 1||33
131923|NCT00246805|316552|P2|STARTED|Phase 1||33
131924|NCT00246805|316553|P1|STARTED|Phase 1||34
131925|NCT00247273|316561|P2|NOT COMPLETED|Overall Study||137
131926|NCT00247273|316562|P1|NOT COMPLETED|Overall Study||146
131927|NCT00247273|316561|P2|COMPLETED|Overall Study||513
131928|NCT00247273|316562|P1|COMPLETED|Overall Study||498
131929|NCT00247273|316561|P2|Intent to Treat Population|Overall Study||650
131930|NCT00247273|316562|P1|Intent to Treat Population|Overall Study|Two subjects not included as they did not take any study medication.|642
131931|NCT00247273|316561|P2|STARTED|Overall Study||650
131932|NCT00247273|316562|P1|STARTED|Overall Study||644
131933|NCT00247377|316608|P2|NOT COMPLETED|Overall Study||0
131934|NCT00247377|316609|P1|NOT COMPLETED|Overall Study||0
131935|NCT00247377|316608|P2|COMPLETED|Overall Study||86
131936|NCT00247377|316609|P1|COMPLETED|Overall Study||111
131937|NCT00247377|316608|P2|STARTED|Overall Study||86
131938|NCT00247377|316609|P1|STARTED|Overall Study||111
131939|NCT00247416|316635|P2|NOT COMPLETED|Overall Study||2
131940|NCT00247416|316636|P1|NOT COMPLETED|Overall Study||1
131941|NCT00247416|316635|P2|COMPLETED|Overall Study||31
131942|NCT00247416|316636|P1|COMPLETED|Overall Study||25
131943|NCT00247416|316635|P2|STARTED|Overall Study||33
131944|NCT00247416|316636|P1|STARTED|Overall Study||26
131945|NCT00253747|316650|P2|NOT COMPLETED|Overall Study||27
131946|NCT00253747|316651|P1|NOT COMPLETED|Overall Study||24
131947|NCT00253747|316650|P2|COMPLETED|Overall Study||101
131948|NCT00253747|316651|P1|COMPLETED|Overall Study||103
131949|NCT00253747|316650|P2|STARTED|Overall Study||128
131950|NCT00253747|316651|P1|STARTED|Overall Study||127
131951|NCT00253890|316671|P2|NOT COMPLETED|Overall Study||7
131952|NCT00253890|316672|P1|NOT COMPLETED|Overall Study||7
131953|NCT00253890|316671|P2|COMPLETED|Overall Study||61
131954|NCT00253890|316672|P1|COMPLETED|Overall Study||62
131955|NCT00253890|316671|P2|STARTED|Overall Study||68
131956|NCT00253890|316672|P1|STARTED|Overall Study||69
131957|NCT00253981|316680|P2|NOT COMPLETED|Overall Study||0
131958|NCT00253981|316681|P1|NOT COMPLETED|Overall Study||0
131959|NCT00253981|316680|P2|COMPLETED|Overall Study||14
131960|NCT00253981|316681|P1|COMPLETED|Overall Study||16
131961|NCT00253981|316680|P2|STARTED|Overall Study||14
131962|NCT00253981|316681|P1|STARTED|Overall Study||16
131963|NCT00254072|316689|P2|NOT COMPLETED|Overall Study||0
131964|NCT00254072|316690|P1|NOT COMPLETED|Overall Study||0
131965|NCT00254072|316689|P2|COMPLETED|Overall Study||175
131966|NCT00254072|316690|P1|COMPLETED|Overall Study||180
131967|NCT00254072|316689|P2|STARTED|Overall Study||175
131968|NCT00254072|316690|P1|STARTED|Overall Study||180
131969|NCT00254163|316698|P2|NOT COMPLETED|Overall Study||46
131970|NCT00254163|316699|P1|NOT COMPLETED|Overall Study||45
131971|NCT00254163|316698|P2|COMPLETED|Overall Study||46
131972|NCT00254163|316699|P1|COMPLETED|Overall Study||47
131973|NCT00254163|316698|P2|STARTED|Overall Study||92
131974|NCT00254163|316699|P1|STARTED|Overall Study||92
131975|NCT00254293|316727|P7|NOT COMPLETED|LTE Open Label Fixed Dosing||13
131976|NCT00254293|316728|P6|NOT COMPLETED|LTE Open Label Fixed Dosing||0
131977|NCT00254293|316729|P5|NOT COMPLETED|LTE Open Label Fixed Dosing||0
131978|NCT00254293|316730|P4|NOT COMPLETED|LTE Open Label Fixed Dosing||0
131979|NCT00254293|316731|P3|NOT COMPLETED|LTE Open Label Fixed Dosing||0
131980|NCT00254293|316732|P2|NOT COMPLETED|LTE Open Label Fixed Dosing||0
131981|NCT00254293|316733|P1|NOT COMPLETED|LTE Open Label Fixed Dosing||0
131982|NCT00254293|316727|P7|COMPLETED|LTE Open Label Fixed Dosing||35
131983|NCT00254293|316728|P6|COMPLETED|LTE Open Label Fixed Dosing||0
131984|NCT00254293|316729|P5|COMPLETED|LTE Open Label Fixed Dosing||0
131985|NCT00254293|316730|P4|COMPLETED|LTE Open Label Fixed Dosing||0
131986|NCT00254293|316731|P3|COMPLETED|LTE Open Label Fixed Dosing||0
131987|NCT00254293|316732|P2|COMPLETED|LTE Open Label Fixed Dosing||0
131988|NCT00254293|316733|P1|COMPLETED|LTE Open Label Fixed Dosing||0
131989|NCT00254293|316727|P7|STARTED|LTE Open Label Fixed Dosing||48
131990|NCT00254293|316728|P6|STARTED|LTE Open Label Fixed Dosing||0
131991|NCT00254293|316729|P5|STARTED|LTE Open Label Fixed Dosing||0
131992|NCT00254293|316730|P4|STARTED|LTE Open Label Fixed Dosing||0
131993|NCT00254293|316731|P3|STARTED|LTE Open Label Fixed Dosing||0
131994|NCT00254293|316732|P2|STARTED|LTE Open Label Fixed Dosing||0
131995|NCT00254293|316733|P1|STARTED|LTE Open Label Fixed Dosing||0
131996|NCT00254293|316727|P7|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
131997|NCT00254293|316728|P6|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
131998|NCT00254293|316729|P5|NOT COMPLETED|LTE Open Label Variable SC Dosing||2
131999|NCT00254293|316730|P4|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
132000|NCT00254293|316731|P3|NOT COMPLETED|LTE Open Label Variable SC Dosing||10
132001|NCT00254293|316732|P2|NOT COMPLETED|LTE Open Label Variable SC Dosing||0
132002|NCT00254293|316733|P1|NOT COMPLETED|LTE Open Label Variable SC Dosing||3
132003|NCT00254293|316727|P7|COMPLETED|LTE Open Label Variable SC Dosing||0
132004|NCT00254293|316728|P6|COMPLETED|LTE Open Label Variable SC Dosing||0
132005|NCT00254293|316729|P5|COMPLETED|LTE Open Label Variable SC Dosing||8
132006|NCT00254293|316730|P4|COMPLETED|LTE Open Label Variable SC Dosing||0
132007|NCT00254293|316731|P3|COMPLETED|LTE Open Label Variable SC Dosing||32
132008|NCT00254293|316732|P2|COMPLETED|LTE Open Label Variable SC Dosing||0
132009|NCT00254293|316733|P1|COMPLETED|LTE Open Label Variable SC Dosing||8
132087|NCT00255008|316938|P2|STARTED|Overall Study||9
132010|NCT00254293|316727|P7|STARTED|LTE Open Label Variable SC Dosing|Participant rolled over from LTE (Variable Dose Period) to LTE (Fixed Dose Period).|0
132011|NCT00254293|316728|P6|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to a variable SC dose group of 75, 125 or 200 mg Weekly by body weight.|0
132012|NCT00254293|316729|P5|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to variable SC dose group (by body weight, >100kg).|10
132013|NCT00254293|316730|P4|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
132014|NCT00254293|316731|P3|STARTED|LTE Open Label Variable SC Dosing|Variable SC dose group: 125 mg Weekly, body weight <60 to >100kg (Groups 2, 3, 4 in ST Period).|42
132015|NCT00254293|316732|P2|STARTED|LTE Open Label Variable SC Dosing|Participants rolled over to 125mg dose group summarized as one group (body weight <60 to >100 kg).|0
132016|NCT00254293|316733|P1|STARTED|LTE Open Label Variable SC Dosing|Participants who received ST placebo rolled over to 75mg SC dose group (by body weight, <60kg).|11
132017|NCT00254293|316727|P7|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
132018|NCT00254293|316728|P6|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
132019|NCT00254293|316729|P5|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
132020|NCT00254293|316730|P4|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
132021|NCT00254293|316731|P3|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||3
132022|NCT00254293|316732|P2|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||1
132023|NCT00254293|316733|P1|NOT COMPLETED|Short Term (12 Week) Randomized Dosing||0
132024|NCT00254293|316727|P7|COMPLETED|Short Term (12 Week) Randomized Dosing||0
132025|NCT00254293|316728|P6|COMPLETED|Short Term (12 Week) Randomized Dosing||17
132026|NCT00254293|316729|P5|COMPLETED|Short Term (12 Week) Randomized Dosing||5
132027|NCT00254293|316730|P4|COMPLETED|Short Term (12 Week) Randomized Dosing||5
132028|NCT00254293|316731|P3|COMPLETED|Short Term (12 Week) Randomized Dosing||26
132029|NCT00254293|316732|P2|COMPLETED|Short Term (12 Week) Randomized Dosing||3
132030|NCT00254293|316733|P1|COMPLETED|Short Term (12 Week) Randomized Dosing||7
132031|NCT00254293|316727|P7|STARTED|Short Term (12 Week) Randomized Dosing||0
132032|NCT00254293|316728|P6|STARTED|Short Term (12 Week) Randomized Dosing|2, 2, 9, 2, and 2 were randomized to placebo in body weight Groups 1, 2, 3, 4, 5, respectively.|17
132033|NCT00254293|316729|P5|STARTED|Short Term (12 Week) Randomized Dosing||5
132034|NCT00254293|316730|P4|STARTED|Short Term (12 Week) Randomized Dosing||6
132035|NCT00254293|316731|P3|STARTED|Short Term (12 Week) Randomized Dosing||29
132036|NCT00254293|316732|P2|STARTED|Short Term (12 Week) Randomized Dosing||4
132037|NCT00254293|316733|P1|STARTED|Short Term (12 Week) Randomized Dosing||7
132038|NCT00254462|316816|P2|NOT COMPLETED|Overall Study||10
132039|NCT00254462|316817|P1|NOT COMPLETED|Overall Study||8
132040|NCT00254462|316816|P2|COMPLETED|Overall Study||39
132041|NCT00254462|316817|P1|COMPLETED|Overall Study||36
132042|NCT00254462|316816|P2|STARTED|Overall Study||49
132043|NCT00254462|316817|P1|STARTED|Overall Study||44
132044|NCT00254501|316827|P2|NOT COMPLETED|Overall Study||1
132045|NCT00254501|316828|P1|NOT COMPLETED|Overall Study||1
132046|NCT00254501|316827|P2|COMPLETED|Overall Study||36
132047|NCT00254501|316828|P1|COMPLETED|Overall Study||31
132048|NCT00254501|316827|P2|STARTED|Overall Study||37
132049|NCT00254501|316828|P1|STARTED|Overall Study||32
132050|NCT00254540|316842|P2|NOT COMPLETED|Overall Study||22
132051|NCT00254540|316843|P1|NOT COMPLETED|Overall Study||19
132052|NCT00254540|316842|P2|COMPLETED|Overall Study||4
132053|NCT00254540|316843|P1|COMPLETED|Overall Study||6
132054|NCT00254540|316842|P2|STARTED|Overall Study|All 26 subjects enrolled were included in Intent-To Treat population.|26
132055|NCT00254540|316843|P1|STARTED|Overall Study|All 25 subjects enrolled were included in Intent-To Treat population.|25
132056|NCT00254566|316872|P2|NOT COMPLETED|Overall Study||26
132057|NCT00254566|316873|P1|NOT COMPLETED|Overall Study||31
132058|NCT00254566|316872|P2|COMPLETED|Overall Study||172
132059|NCT00254566|316873|P1|COMPLETED|Overall Study||167
132060|NCT00254566|316872|P2|STARTED|Overall Study||198
132061|NCT00254566|316873|P1|STARTED|Overall Study||198
132062|NCT00254592|316895|P1|NOT COMPLETED|Overall Study||2
132063|NCT00254592|316895|P1|COMPLETED|Overall Study||41
132064|NCT00254592|316895|P1|STARTED|Overall Study||43
132065|NCT00254982|316901|P2|NOT COMPLETED|Overall Study||31
132066|NCT00254982|316902|P1|NOT COMPLETED|Overall Study||36
132067|NCT00254982|316901|P2|COMPLETED|Overall Study||265
132068|NCT00254982|316902|P1|COMPLETED|Overall Study||261
132069|NCT00254982|316901|P2|STARTED|Overall Study||296
132070|NCT00254982|316902|P1|STARTED|Overall Study||297
132071|NCT00254995|316910|P2|NOT COMPLETED|Overall Study||0
132072|NCT00254995|316911|P1|NOT COMPLETED|Overall Study||0
132073|NCT00254995|316910|P2|COMPLETED|Overall Study||31065
132074|NCT00254995|316911|P1|COMPLETED|Overall Study||31561
132075|NCT00254995|316910|P2|STARTED|Overall Study||31065
132076|NCT00254995|316911|P1|STARTED|Overall Study||31561
132077|NCT00255008|316936|P4|NOT COMPLETED|Overall Study||22
132078|NCT00255008|316937|P3|NOT COMPLETED|Overall Study||16
132079|NCT00255008|316938|P2|NOT COMPLETED|Overall Study||9
132080|NCT00255008|316939|P1|NOT COMPLETED|Overall Study||32
132081|NCT00255008|316936|P4|COMPLETED|Overall Study||12
132082|NCT00255008|316937|P3|COMPLETED|Overall Study||17
132083|NCT00255008|316938|P2|COMPLETED|Overall Study||0
132084|NCT00255008|316939|P1|COMPLETED|Overall Study|The study was terminated early and as a result only 42 patients completed the study.|13
132085|NCT00255008|316936|P4|STARTED|Overall Study||34
132086|NCT00255008|316937|P3|STARTED|Overall Study||33
132088|NCT00255008|316939|P1|STARTED|Overall Study||45
132089|NCT00255034|316951|P2|NOT COMPLETED|Overall Study||38
132090|NCT00255034|316952|P1|NOT COMPLETED|Overall Study||15
132091|NCT00255034|316951|P2|COMPLETED|Overall Study||26
132092|NCT00255034|316952|P1|COMPLETED|Overall Study||64
132093|NCT00255034|316951|P2|STARTED|Overall Study||64
132094|NCT00255034|316952|P1|STARTED|Overall Study||79
132095|NCT00255047|316962|P4|NOT COMPLETED|Overall Study||46
132096|NCT00255047|316963|P3|NOT COMPLETED|Overall Study||50
132097|NCT00255047|316964|P2|NOT COMPLETED|Overall Study||48
132098|NCT00255047|316965|P1|NOT COMPLETED|Overall Study||48
132099|NCT00255047|316962|P4|COMPLETED|Overall Study||502
132100|NCT00255047|316963|P3|COMPLETED|Overall Study||496
132101|NCT00255047|316964|P2|COMPLETED|Overall Study||487
132102|NCT00255047|316965|P1|COMPLETED|Overall Study||490
132103|NCT00255047|316962|P4|STARTED|Overall Study||548
132104|NCT00255047|316963|P3|STARTED|Overall Study||546
132105|NCT00255047|316964|P2|STARTED|Overall Study||535
132106|NCT00255047|316965|P1|STARTED|Overall Study||538
132107|NCT00255086|316989|P2|NOT COMPLETED|Overall Study||2
132108|NCT00255086|316990|P1|NOT COMPLETED|Overall Study||2
132109|NCT00255086|316989|P2|COMPLETED|Overall Study||6
132110|NCT00255086|316990|P1|COMPLETED|Overall Study||7
132111|NCT00255086|316989|P2|STARTED|Overall Study||8
132112|NCT00255086|316990|P1|STARTED|Overall Study||9
132113|NCT00255125|317000|P2|NOT COMPLETED|Overall Study||0
132114|NCT00255125|317001|P1|NOT COMPLETED|Overall Study||0
132115|NCT00255125|317000|P2|COMPLETED|Overall Study||42
132116|NCT00255125|317001|P1|COMPLETED|Overall Study||44
132117|NCT00255125|317000|P2|STARTED|Overall Study||42
132118|NCT00255125|317001|P1|STARTED|Overall Study||44
132119|NCT00255151|317010|P3|NOT COMPLETED|Overall Study||49
132120|NCT00255151|317011|P2|NOT COMPLETED|Overall Study||49
132121|NCT00255151|317012|P1|NOT COMPLETED|Overall Study||123
132122|NCT00255151|317010|P3|COMPLETED|Overall Study||103
132123|NCT00255151|317011|P2|COMPLETED|Overall Study||110
132124|NCT00255151|317012|P1|COMPLETED|Overall Study||17
132125|NCT00255151|317010|P3|STARTED|Overall Study||152
132126|NCT00255151|317011|P2|STARTED|Overall Study||159
132127|NCT00255151|317012|P1|STARTED|Overall Study||140
132128|NCT00255164|317038|P3|NOT COMPLETED|Overall Study||49
132129|NCT00255164|317039|P2|NOT COMPLETED|Overall Study||49
132130|NCT00255164|317040|P1|NOT COMPLETED|Overall Study||123
132131|NCT00255164|317038|P3|COMPLETED|Overall Study||103
132132|NCT00255164|317039|P2|COMPLETED|Overall Study||110
132133|NCT00255164|317040|P1|COMPLETED|Overall Study||17
132134|NCT00255164|317038|P3|STARTED|Overall Study||152
132135|NCT00255164|317039|P2|STARTED|Overall Study||159
132136|NCT00255164|317040|P1|STARTED|Overall Study||140
132137|NCT00255177|317067|P4|NOT COMPLETED|Overall Study||2
132138|NCT00255177|317068|P3|NOT COMPLETED|Overall Study||1
132139|NCT00255177|317069|P2|NOT COMPLETED|Overall Study||1
132140|NCT00255177|317070|P1|NOT COMPLETED|Overall Study||2
132141|NCT00255177|317067|P4|COMPLETED|Overall Study||4
132142|NCT00255177|317068|P3|COMPLETED|Overall Study||12
132143|NCT00255177|317069|P2|COMPLETED|Overall Study||13
132144|NCT00255177|317070|P1|COMPLETED|Overall Study||9
132145|NCT00255177|317067|P4|STARTED|Overall Study||6
132146|NCT00255177|317068|P3|STARTED|Overall Study||13
132147|NCT00255177|317069|P2|STARTED|Overall Study||14
132148|NCT00255177|317070|P1|STARTED|Overall Study||11
132149|NCT00255190|317082|P2|NOT COMPLETED|Overall Study||157
132150|NCT00255190|317083|P1|NOT COMPLETED|Overall Study||50
132151|NCT00255190|317082|P2|COMPLETED|Overall Study||281
132152|NCT00255190|317083|P1|COMPLETED|Overall Study||103
132153|NCT00255190|317082|P2|STARTED|Overall Study||438
132154|NCT00255190|317083|P1|STARTED|Overall Study||153
132155|NCT00255684|317147|P1|NOT COMPLETED|Overall Study||0
132156|NCT00255684|317147|P1|COMPLETED|Overall Study||16
132157|NCT00255684|317147|P1|STARTED|Overall Study||16
132158|NCT00255723|317154|P2|NOT COMPLETED|Overall Study||2
132159|NCT00255723|317155|P1|NOT COMPLETED|Overall Study||2
132160|NCT00255723|317154|P2|COMPLETED|Overall Study||39
132161|NCT00255723|317155|P1|COMPLETED|Overall Study||54
132162|NCT00255723|317154|P2|STARTED|Overall Study||41
132163|NCT00255723|317155|P1|STARTED|Overall Study||56
132164|NCT00255840|317163|P2|NOT COMPLETED|Overall Study||70
132165|NCT00255840|317164|P1|NOT COMPLETED|Overall Study||63
132166|NCT00255840|317163|P2|COMPLETED|Overall Study||334
132167|NCT00255840|317164|P1|COMPLETED|Overall Study||345
132168|NCT00255840|317163|P2|STARTED|Overall Study||404
132169|NCT00255840|317164|P1|STARTED|Overall Study||408
132170|NCT00255970|317172|P2|NOT COMPLETED|Overall Study||0
132171|NCT00255970|317173|P1|NOT COMPLETED|Overall Study||0
132172|NCT00255970|317172|P2|COMPLETED|Overall Study||19
132173|NCT00255970|317173|P1|COMPLETED|Overall Study||21
132174|NCT00255970|317172|P2|Final Visit Week 24|Overall Study||19
132175|NCT00255970|317173|P1|Final Visit Week 24|Overall Study||21
132176|NCT00255970|317172|P2|Screening Visit|Overall Study||19
132177|NCT00255970|317173|P1|Screening Visit|Overall Study||21
132178|NCT00255970|317172|P2|STARTED|Overall Study||19
132179|NCT00255970|317173|P1|STARTED|Overall Study||21
132180|NCT00256204|317195|P4|NOT COMPLETED|Overall Study||49
132181|NCT00256204|317196|P3|NOT COMPLETED|Overall Study||54
132182|NCT00256204|317197|P2|NOT COMPLETED|Overall Study||50
132183|NCT00256204|317198|P1|NOT COMPLETED|Overall Study||67
132184|NCT00256204|317195|P4|COMPLETED|Overall Study||244
132185|NCT00256204|317196|P3|COMPLETED|Overall Study||241
132186|NCT00256204|317197|P2|COMPLETED|Overall Study||238
132187|NCT00256204|317198|P1|COMPLETED|Overall Study||231
132188|NCT00256204|317195|P4|STARTED|Overall Study||293
132189|NCT00256204|317196|P3|STARTED|Overall Study||295
132190|NCT00256204|317197|P2|STARTED|Overall Study||288
132191|NCT00256204|317198|P1|STARTED|Overall Study||298
132192|NCT00256243|317211|P1|NOT COMPLETED|Overall Study||10
132193|NCT00256243|317211|P1|COMPLETED|Overall Study||38
132194|NCT00256243|317211|P1|STARTED|Overall Study||48
132195|NCT00256295|317216|P1|NOT COMPLETED|Overall Study||4
132196|NCT00256295|317216|P1|COMPLETED|Overall Study||3
132197|NCT00256295|317216|P1|STARTED|Overall Study|Of the 8 subjects consented, 1 withdrew prior to treatment.|7
132198|NCT00257309|317224|P2|NOT COMPLETED|Overall Study||2
132199|NCT00257309|317225|P1|NOT COMPLETED|Overall Study||2
132200|NCT00257309|317224|P2|COMPLETED|Overall Study||130
132201|NCT00257309|317225|P1|COMPLETED|Overall Study||132
132202|NCT00257309|317224|P2|STARTED|Overall Study||132
132203|NCT00257309|317225|P1|STARTED|Overall Study||134
132204|NCT00257322|317233|P1|NOT COMPLETED|Overall Study||4
132205|NCT00257322|317233|P1|COMPLETED|Overall Study|4 subjects withdrew from this study.|16
132206|NCT00257322|317233|P1|STARTED|Overall Study|20 subjects accrued.|20
132207|NCT00257556|317240|P2|NOT COMPLETED|Overall Study||10
132208|NCT00257556|317241|P1|NOT COMPLETED|Overall Study||14
132209|NCT00257556|317240|P2|COMPLETED|Overall Study||32
132210|NCT00257556|317241|P1|COMPLETED|Overall Study||24
132211|NCT00257556|317240|P2|All Patients Treated Population|Overall Study|Also the safety population. Three randomized patients did not receive study medication.|39
132212|NCT00257556|317241|P1|All Patients Treated Population|Overall Study|Also the safety population. One randomized patient did not receive study medication.|37
132213|NCT00257556|317240|P2|STARTED|Overall Study||42
132214|NCT00257556|317241|P1|STARTED|Overall Study||38
132215|NCT00257608|317269|P3|NOT COMPLETED|Post Chemotherapy Phase||244
132216|NCT00257608|317270|P2|NOT COMPLETED|Post Chemotherapy Phase||264
132217|NCT00257608|317271|P1|NOT COMPLETED|Post Chemotherapy Phase||0
132218|NCT00257608|317269|P3|COMPLETED|Post Chemotherapy Phase||126
132219|NCT00257608|317270|P2|COMPLETED|Post Chemotherapy Phase||109
132220|NCT00257608|317271|P1|COMPLETED|Post Chemotherapy Phase||0
132221|NCT00257608|317269|P3|STARTED|Post Chemotherapy Phase||370
132222|NCT00257608|317270|P2|STARTED|Post Chemotherapy Phase||373
132223|NCT00257608|317271|P1|STARTED|Post Chemotherapy Phase||0
132224|NCT00257608|317269|P3|NOT COMPLETED|Chemotherapy Phase||0
132225|NCT00257608|317270|P2|NOT COMPLETED|Chemotherapy Phase||0
132226|NCT00257608|317271|P1|NOT COMPLETED|Chemotherapy Phase||376
132227|NCT00257608|317269|P3|COMPLETED|Chemotherapy Phase||0
132228|NCT00257608|317270|P2|COMPLETED|Chemotherapy Phase||0
132229|NCT00257608|317271|P1|COMPLETED|Chemotherapy Phase||769
132230|NCT00257608|317269|P3|STARTED|Chemotherapy Phase||0
132231|NCT00257608|317270|P2|STARTED|Chemotherapy Phase||0
132232|NCT00257608|317271|P1|STARTED|Chemotherapy Phase||1145
132233|NCT00257660|317297|P2|NOT COMPLETED|Overall Study||23
132234|NCT00257660|317298|P1|NOT COMPLETED|Overall Study||10
132235|NCT00257660|317297|P2|COMPLETED|Overall Study||38
132236|NCT00257660|317298|P1|COMPLETED|Overall Study||45
132237|NCT00257660|317297|P2|STARTED|Overall Study||61
132238|NCT00257660|317298|P1|STARTED|Overall Study||55
132239|NCT00257686|317332|P6|NOT COMPLETED|Overall Study||9
132240|NCT00257686|317333|P5|NOT COMPLETED|Overall Study||22
132241|NCT00257686|317334|P4|NOT COMPLETED|Overall Study||11
132242|NCT00257686|317335|P3|NOT COMPLETED|Overall Study||18
132243|NCT00257686|317336|P2|NOT COMPLETED|Overall Study||19
132244|NCT00257686|317337|P1|NOT COMPLETED|Overall Study||21
132245|NCT00257686|317332|P6|COMPLETED|Overall Study||95
132246|NCT00257686|317333|P5|COMPLETED|Overall Study||194
132247|NCT00257686|317334|P4|COMPLETED|Overall Study||88
132248|NCT00257686|317335|P3|COMPLETED|Overall Study||208
132249|NCT00257686|317336|P2|COMPLETED|Overall Study||89
132250|NCT00257686|317337|P1|COMPLETED|Overall Study||188
132251|NCT00257686|317332|P6|Safety Population|Overall Study|Subjects who received at least one dose of study medication|102
132252|NCT00257686|317333|P5|Safety Population|Overall Study|Subjects who received at least one dose of study medication|210
132253|NCT00257686|317334|P4|Safety Population|Overall Study|Subjects who received at least one dose of study medication|96
132254|NCT00257686|317335|P3|Safety Population|Overall Study|Subjects who received at least one dose of study medication|224
132255|NCT00257686|317336|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|103
132256|NCT00257686|317337|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|207
132257|NCT00257686|317332|P6|STARTED|Overall Study||104
132258|NCT00257686|317333|P5|STARTED|Overall Study||216
132259|NCT00257686|317334|P4|STARTED|Overall Study||99
132260|NCT00257686|317335|P3|STARTED|Overall Study||226
132261|NCT00257686|317336|P2|STARTED|Overall Study||108
132262|NCT00257686|317337|P1|STARTED|Overall Study||209
132263|NCT00257894|317359|P2|NOT COMPLETED|Overall Study||5
132264|NCT00257894|317360|P1|NOT COMPLETED|Overall Study||4
132265|NCT00257894|317359|P2|COMPLETED|Overall Study||15
132266|NCT00257894|317360|P1|COMPLETED|Overall Study||17
132267|NCT00257894|317359|P2|STARTED|Overall Study||20
132268|NCT00257894|317360|P1|STARTED|Overall Study||21
132269|NCT00257920|317374|P2|NOT COMPLETED|Period: Second Intervention||1
132270|NCT00257920|317375|P1|NOT COMPLETED|Period: Second Intervention||2
132271|NCT00257920|317374|P2|COMPLETED|Period: Second Intervention||18
132272|NCT00257920|317375|P1|COMPLETED|Period: Second Intervention||19
132273|NCT00257920|317374|P2|STARTED|Period: Second Intervention||19
132274|NCT00257920|317375|P1|STARTED|Period: Second Intervention||21
132275|NCT00257920|317374|P2|NOT COMPLETED|Period: Washout Period of Two Weeks||1
132276|NCT00257920|317375|P1|NOT COMPLETED|Period: Washout Period of Two Weeks||0
132277|NCT00257920|317374|P2|COMPLETED|Period: Washout Period of Two Weeks||19
132278|NCT00257920|317375|P1|COMPLETED|Period: Washout Period of Two Weeks||21
132279|NCT00257920|317374|P2|STARTED|Period: Washout Period of Two Weeks||20
132280|NCT00257920|317375|P1|STARTED|Period: Washout Period of Two Weeks||21
132281|NCT00257920|317374|P2|NOT COMPLETED|Period: First Intervention||0
132282|NCT00257920|317375|P1|NOT COMPLETED|Period: First Intervention||0
132283|NCT00257920|317374|P2|COMPLETED|Period: First Intervention||20
132284|NCT00257920|317375|P1|COMPLETED|Period: First Intervention||21
132285|NCT00257920|317374|P2|STARTED|Period: First Intervention||20
132286|NCT00257920|317375|P1|STARTED|Period: First Intervention||21
132287|NCT00257933|317385|P2|NOT COMPLETED|Overall Study||0
132288|NCT00257933|317386|P1|NOT COMPLETED|Overall Study||0
132289|NCT00257933|317385|P2|COMPLETED|Overall Study||78
132290|NCT00257933|317386|P1|COMPLETED|Overall Study||74
132291|NCT00257933|317385|P2|STARTED|Overall Study||78
132292|NCT00257933|317386|P1|STARTED|Overall Study||74
132293|NCT00258011|317392|P1|NOT COMPLETED|Overall Study||0
132294|NCT00258011|317392|P1|COMPLETED|Overall Study||3
132295|NCT00258011|317392|P1|STARTED|Overall Study||3
132296|NCT00258154|317399|P2|NOT COMPLETED|Overall Study||7
132297|NCT00258154|317400|P1|NOT COMPLETED|Overall Study||9
132298|NCT00258154|317399|P2|COMPLETED|Overall Study|Subjects who completed the study.|195
132299|NCT00258154|317400|P1|COMPLETED|Overall Study|Subjects who completed the study.|192
132300|NCT00258154|317399|P2|Vaccinated at Visit 3|Overall Study||197
132301|NCT00258154|317400|P1|Vaccinated at Visit 3|Overall Study||195
132302|NCT00258154|317399|P2|Vaccinated at Visit 2|Overall Study||198
132303|NCT00258154|317400|P1|Vaccinated at Visit 2|Overall Study||198
132304|NCT00258154|317399|P2|Vaccinated at Visit 1|Overall Study||202
132305|NCT00258154|317400|P1|Vaccinated at Visit 1|Overall Study||201
132306|NCT00258154|317399|P2|STARTED|Overall Study|Healthy infants who started in the Placebo concomitantly with INFANRIX™ hexa group.|202
132307|NCT00258154|317400|P1|STARTED|Overall Study|Healthy infants who started in the RotaTeq™ concomitantly with INFANRIX™ hexa group.|201
132308|NCT00258206|317468|P1|NOT COMPLETED|Overall Study||0
132309|NCT00258206|317468|P1|COMPLETED|Overall Study||21
132310|NCT00258206|317468|P1|STARTED|Overall Study||21
132311|NCT00258310|317472|P1|NOT COMPLETED|Overall Study||0
132312|NCT00258310|317472|P1|COMPLETED|Overall Study||35
132313|NCT00258310|317472|P1|STARTED|Overall Study||35
132314|NCT00258349|317476|P1|NOT COMPLETED|Overall Study||0
132315|NCT00258349|317476|P1|COMPLETED|Overall Study||16
132316|NCT00258349|317476|P1|HER2-positive by Central Review|Overall Study||10
132317|NCT00258349|317476|P1|STARTED|Overall Study||16
132318|NCT00258362|317483|P1|NOT COMPLETED|Overall Study||0
132319|NCT00258362|317483|P1|COMPLETED|Overall Study||41
132320|NCT00258362|317483|P1|STARTED|Overall Study||41
132321|NCT00258440|317491|P3|NOT COMPLETED|Overall Study||1
132322|NCT00258440|317492|P2|NOT COMPLETED|Overall Study||0
132323|NCT00258440|317493|P1|NOT COMPLETED|Overall Study||0
132324|NCT00258440|317491|P3|COMPLETED|Overall Study||5
132325|NCT00258440|317492|P2|COMPLETED|Overall Study||0
132326|NCT00258440|317493|P1|COMPLETED|Overall Study||1
132327|NCT00258440|317491|P3|STARTED|Overall Study||6
132328|NCT00258440|317492|P2|STARTED|Overall Study||0
132329|NCT00258440|317493|P1|STARTED|Overall Study||1
132330|NCT00258674|317507|P3|NOT COMPLETED|Overall Study||34
132331|NCT00258674|317508|P2|NOT COMPLETED|Overall Study||53
132332|NCT00258674|317509|P1|NOT COMPLETED|Overall Study||32
132333|NCT00258674|317507|P3|COMPLETED|Overall Study||568
132334|NCT00258674|317508|P2|COMPLETED|Overall Study||758
132335|NCT00258674|317509|P1|COMPLETED|Overall Study||565
132336|NCT00258674|317507|P3|STARTED|Overall Study||602
132337|NCT00258674|317508|P2|STARTED|Overall Study||811
132338|NCT00258674|317509|P1|STARTED|Overall Study||597
132339|NCT00258817|317567|P2|NOT COMPLETED|Overall Study||0
132340|NCT00258817|317568|P1|NOT COMPLETED|Overall Study||0
132341|NCT00258817|317567|P2|COMPLETED|Overall Study||15
132342|NCT00258817|317568|P1|COMPLETED|Overall Study||15
132343|NCT00258817|317567|P2|STARTED|Overall Study||15
132344|NCT00258817|317568|P1|STARTED|Overall Study||15
132345|NCT00258830|317580|P2|NOT COMPLETED|Overall Study||0
132346|NCT00258830|317581|P1|NOT COMPLETED|Overall Study||0
132347|NCT00258830|317580|P2|COMPLETED|Overall Study||60
132348|NCT00258830|317581|P1|COMPLETED|Overall Study||60
132349|NCT00258830|317580|P2|STARTED|Overall Study||60
132350|NCT00258830|317581|P1|STARTED|Overall Study||60
132351|NCT00258856|317597|P4|NOT COMPLETED|Overall Study||1
132352|NCT00258856|317598|P3|NOT COMPLETED|Overall Study||2
132353|NCT00258856|317599|P2|NOT COMPLETED|Overall Study||0
132354|NCT00258856|317600|P1|NOT COMPLETED|Overall Study||3
132355|NCT00258856|317597|P4|COMPLETED|Overall Study||58
132356|NCT00258856|317598|P3|COMPLETED|Overall Study||56
132357|NCT00258856|317599|P2|COMPLETED|Overall Study||58
132358|NCT00258856|317600|P1|COMPLETED|Overall Study||56
132359|NCT00258856|317597|P4|STARTED|Overall Study||59
132360|NCT00258856|317598|P3|STARTED|Overall Study||58
132361|NCT00258856|317599|P2|STARTED|Overall Study||58
132362|NCT00258856|317600|P1|STARTED|Overall Study||59
132363|NCT00258882|317612|P2|NOT COMPLETED|Pregnancy Surveillance||0
132364|NCT00258882|317613|P1|NOT COMPLETED|Pregnancy Surveillance||0
132365|NCT00258882|317612|P2|COMPLETED|Pregnancy Surveillance||675
132366|NCT00258882|317613|P1|COMPLETED|Pregnancy Surveillance||225
132367|NCT00258882|317612|P2|STARTED|Pregnancy Surveillance|Non-vaccinated age-matched subjects with first positive pregnancy test in the same month (± 1 month)|675
132368|NCT00258882|317613|P1|STARTED|Pregnancy Surveillance|Adacel recipients who were pregnant at the time of vaccination or within 28 days thereafter.|225
132369|NCT00258882|317612|P2|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
132370|NCT00258882|317613|P1|NOT COMPLETED|Adacel Recipients-Risk Interval Method||0
132371|NCT00258882|317612|P2|COMPLETED|Adacel Recipients-Risk Interval Method||0
132372|NCT00258882|317613|P1|COMPLETED|Adacel Recipients-Risk Interval Method||124139
132373|NCT00258882|317612|P2|STARTED|Adacel Recipients-Risk Interval Method|Study participants served as their own controls for this analysis|0
132374|NCT00258882|317613|P1|STARTED|Adacel Recipients-Risk Interval Method||124139
132375|NCT00258882|317612|P2|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
132376|NCT00258882|317613|P1|NOT COMPLETED|Adacel Recipients Historic Cohort Method||0
132377|NCT00258882|317612|P2|COMPLETED|Adacel Recipients Historic Cohort Method||203154
132378|NCT00258882|317613|P1|COMPLETED|Adacel Recipients Historic Cohort Method||124139
132379|NCT00258882|317612|P2|STARTED|Adacel Recipients Historic Cohort Method||203154
132380|NCT00258882|317613|P1|STARTED|Adacel Recipients Historic Cohort Method||124139
132381|NCT00258895|317630|P2|NOT COMPLETED|Overall Study||3
132382|NCT00258895|317631|P1|NOT COMPLETED|Overall Study||10
132383|NCT00258895|317630|P2|COMPLETED|Overall Study||159
132384|NCT00258895|317631|P1|COMPLETED|Overall Study||477
132385|NCT00258895|317630|P2|STARTED|Overall Study||162
132386|NCT00258895|317631|P1|STARTED|Overall Study||487
132387|NCT00258908|317645|P1|NOT COMPLETED|Overall Study||0
132388|NCT00258908|317645|P1|COMPLETED|Overall Study||112
132389|NCT00258908|317645|P1|STARTED|Overall Study|3 participants were not vaccinated and were not included in the final analysis and in this report.|112
132390|NCT00259012|317653|P2|NOT COMPLETED|Overall Study||4
132391|NCT00259012|317654|P1|NOT COMPLETED|Overall Study||2
132392|NCT00259012|317653|P2|COMPLETED|Overall Study||30
132393|NCT00259012|317654|P1|COMPLETED|Overall Study||31
132394|NCT00259012|317653|P2|STARTED|Overall Study||34
132395|NCT00259012|317654|P1|STARTED|Overall Study||33
132396|NCT00259090|317689|P3|NOT COMPLETED|Overall Study||0
132397|NCT00259090|317690|P2|NOT COMPLETED|Overall Study||0
132398|NCT00259090|317691|P1|NOT COMPLETED|Overall Study||0
132399|NCT00259090|317689|P3|COMPLETED|Overall Study||37
132400|NCT00259090|317690|P2|COMPLETED|Overall Study||31
132401|NCT00259090|317691|P1|COMPLETED|Overall Study||35
132402|NCT00259090|317689|P3|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|37
132403|NCT00259090|317690|P2|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|31
132404|NCT00259090|317691|P1|STARTED|Overall Study|Doesn't include protocol deviators, those who didn't complete the study or had missing tumor samples|35
132405|NCT00259272|317709|P4|NOT COMPLETED|Overall Study||21
132406|NCT00259272|317710|P3|NOT COMPLETED|Overall Study||5
132407|NCT00259272|317711|P2|NOT COMPLETED|Overall Study||7
132408|NCT00259272|317712|P1|NOT COMPLETED|Overall Study||15
132409|NCT00259272|317709|P4|COMPLETED|Overall Study||27
132410|NCT00259272|317710|P3|COMPLETED|Overall Study||21
132411|NCT00259272|317711|P2|COMPLETED|Overall Study||24
132412|NCT00259272|317712|P1|COMPLETED|Overall Study||21
132413|NCT00259272|317709|P4|STARTED|Overall Study||48
132414|NCT00259272|317710|P3|STARTED|Overall Study||26
132415|NCT00259272|317711|P2|STARTED|Overall Study||31
132416|NCT00259272|317712|P1|STARTED|Overall Study||36
132417|NCT00259285|317787|P1|NOT COMPLETED|Overall Study||0
132418|NCT00259285|317787|P1|COMPLETED|Overall Study||10
132419|NCT00259285|317787|P1|STARTED|Overall Study||10
132420|NCT00259298|317793|P1|NOT COMPLETED|Overall Study||3
132421|NCT00259298|317793|P1|COMPLETED|Overall Study||9
132422|NCT00259298|317793|P1|Received at Least 1 Dose of Study Drug|Overall Study||10
132423|NCT00259298|317793|P1|STARTED|Overall Study||12
132424|NCT00259610|317805|P4|NOT COMPLETED|Overall Study||43
132425|NCT00259610|317806|P3|NOT COMPLETED|Overall Study||73
132426|NCT00259610|317807|P2|NOT COMPLETED|Overall Study||46
132427|NCT00259610|317808|P1|NOT COMPLETED|Overall Study||76
132428|NCT00259610|317805|P4|COMPLETED|Overall Study||81
132429|NCT00259610|317806|P3|COMPLETED|Overall Study||182
132430|NCT00259610|317807|P2|COMPLETED|Overall Study||86
132431|NCT00259610|317808|P1|COMPLETED|Overall Study||168
132432|NCT00259610|317805|P4|STARTED|Overall Study||124
132433|NCT00259610|317806|P3|STARTED|Overall Study||255
132434|NCT00259610|317807|P2|STARTED|Overall Study||132
132435|NCT00259610|317808|P1|STARTED|Overall Study||244
132436|NCT00259649|317822|P1|NOT COMPLETED|Overall Study||10
132437|NCT00259649|317822|P1|COMPLETED|Overall Study||61
132438|NCT00259649|317822|P1|STARTED|Overall Study||71
132439|NCT00259740|317828|P2|NOT COMPLETED|Overall Study||53
132440|NCT00259740|317829|P1|NOT COMPLETED|Overall Study||43
132441|NCT00259740|317828|P2|COMPLETED|Overall Study||0
132442|NCT00259740|317829|P1|COMPLETED|Overall Study||0
132443|NCT00259740|317828|P2|Received Study Medication|Overall Study||53
132444|NCT00259740|317829|P1|Received Study Medication|Overall Study||42
132445|NCT00259740|317828|P2|STARTED|Overall Study||53
132446|NCT00259740|317829|P1|STARTED|Overall Study||43
132447|NCT00253370|317839|P1|NOT COMPLETED|Overall Study||43
132448|NCT00253370|317839|P1|COMPLETED|Overall Study||1
132449|NCT00253370|317839|P1|STARTED|Overall Study||44
132450|NCT00253435|317847|P2|NOT COMPLETED|Overall Study||0
132451|NCT00253435|317848|P1|NOT COMPLETED|Overall Study||0
132452|NCT00253435|317847|P2|COMPLETED|Overall Study|Eight evaluable patients enrolled.|8
132453|NCT00253435|317848|P1|COMPLETED|Overall Study|Forty-two evaluable poor risk patients enrolled.|42
132454|NCT00253435|317847|P2|3rd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
132455|NCT00253435|317848|P1|3rd Interim Analysis|Overall Study|Third interim analysis: need 4+ responses in first 35 patients. Goal met study continued.|10
132456|NCT00253435|317847|P2|2nd Interim Analysis|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|0
132457|NCT00253435|317848|P1|2nd Interim Analysis|Overall Study|Second interim analysis: need 3+ responses in first 25 patients. Goal met study continued.|10
132458|NCT00253435|317847|P2|1st Interim Analysis|Overall Study|Only interim analysis: need 1+ response in first 10 patients.|8
132459|NCT00253435|317848|P1|1st Interim Analysis|Overall Study|First interim analysis: need 2+ responses in first 15 patients. Goal met study continued.|15
132460|NCT00253435|317847|P2|STARTED|Overall Study|This cohort opened as long as the poor risk group is open to accrual.|8
132461|NCT00253435|317848|P1|STARTED|Overall Study|Total number is 42|42
132462|NCT00253448|317860|P1|NOT COMPLETED|Overall Study||1
132463|NCT00253448|317860|P1|COMPLETED|Overall Study||34
132464|NCT00253448|317860|P1|STARTED|Overall Study||35
132465|NCT00253513|317864|P1|NOT COMPLETED|Overall Study||0
132466|NCT00253513|317864|P1|COMPLETED|Overall Study||60
132467|NCT00253513|317864|P1|STARTED|Overall Study||60
132468|NCT00253643|317875|P4|NOT COMPLETED|Overall Study||3
132469|NCT00253643|317876|P3|NOT COMPLETED|Overall Study||1
132470|NCT00253643|317877|P2|NOT COMPLETED|Overall Study||0
132471|NCT00253643|317878|P1|NOT COMPLETED|Overall Study||0
132472|NCT00253643|317875|P4|COMPLETED|Overall Study||28
132473|NCT00253643|317876|P3|COMPLETED|Overall Study||28
132474|NCT00253643|317877|P2|COMPLETED|Overall Study||15
132475|NCT00253643|317878|P1|COMPLETED|Overall Study||14
132476|NCT00253643|317875|P4|STARTED|Overall Study||31
132477|NCT00253643|317876|P3|STARTED|Overall Study||29
132478|NCT00253643|317877|P2|STARTED|Overall Study||15
132479|NCT00253643|317878|P1|STARTED|Overall Study||14
132480|NCT00253708|317895|P3|NOT COMPLETED|Overall Study||1
132481|NCT00253708|317896|P2|NOT COMPLETED|Overall Study||0
132482|NCT00253708|317897|P1|NOT COMPLETED|Overall Study||0
132483|NCT00253708|317895|P3|COMPLETED|Overall Study||8
132484|NCT00253708|317896|P2|COMPLETED|Overall Study||10
132485|NCT00253708|317897|P1|COMPLETED|Overall Study||20
132486|NCT00253708|317895|P3|STARTED|Overall Study||9
132487|NCT00253708|317896|P2|STARTED|Overall Study||10
132488|NCT00253708|317897|P1|STARTED|Overall Study||20
132489|NCT00259857|317925|P2|NOT COMPLETED|24 Months Treatment||3
132490|NCT00259857|317926|P1|NOT COMPLETED|24 Months Treatment||0
132491|NCT00259857|317925|P2|COMPLETED|24 Months Treatment||6
132492|NCT00259857|317926|P1|COMPLETED|24 Months Treatment||10
132493|NCT00259857|317925|P2|STARTED|24 Months Treatment||9
132494|NCT00259857|317926|P1|STARTED|24 Months Treatment||10
132495|NCT00259857|317925|P2|NOT COMPLETED|12 Months Treatment||2
132496|NCT00259857|317926|P1|NOT COMPLETED|12 Months Treatment||1
132497|NCT00259857|317925|P2|COMPLETED|12 Months Treatment||9
132498|NCT00259857|317926|P1|COMPLETED|12 Months Treatment||10
132499|NCT00259857|317925|P2|STARTED|12 Months Treatment||11
132500|NCT00259857|317926|P1|STARTED|12 Months Treatment||11
132501|NCT00260065|317942|P1|NOT COMPLETED|Overall Study||93
132502|NCT00260065|317942|P1|COMPLETED|Overall Study||6
132503|NCT00260065|317942|P1|STARTED|Overall Study||99
132504|NCT00262730|317947|P1|NOT COMPLETED|Overall Study||0
132505|NCT00262730|317947|P1|COMPLETED|Overall Study||97
132506|NCT00262730|317947|P1|STARTED|Overall Study||97
132507|NCT00262743|317953|P2|NOT COMPLETED|Overall Study||12
132508|NCT00262743|317954|P1|NOT COMPLETED|Overall Study||0
132509|NCT00262743|317953|P2|COMPLETED|Overall Study||30
132510|NCT00262743|317954|P1|COMPLETED|Overall Study||27
132511|NCT00262743|317953|P2|STARTED|Overall Study||42
132512|NCT00262743|317954|P1|STARTED|Overall Study||27
132513|NCT00262821|317963|P2|NOT COMPLETED|Overall Study||19
132514|NCT00262821|317964|P1|NOT COMPLETED|Overall Study||4
132515|NCT00262821|317963|P2|COMPLETED|Overall Study||185
132516|NCT00262821|317964|P1|COMPLETED|Overall Study||194
132517|NCT00262821|317963|P2|STARTED|Overall Study||204
132518|NCT00262821|317964|P1|STARTED|Overall Study||198
132519|NCT00262834|317976|P2|NOT COMPLETED|Overall Study||4
132520|NCT00262834|317977|P1|NOT COMPLETED|Overall Study||1
132521|NCT00262834|317976|P2|COMPLETED|Overall Study||25
132522|NCT00262834|317977|P1|COMPLETED|Overall Study||24
132523|NCT00262834|317976|P2|STARTED|Overall Study||29
132524|NCT00262834|317977|P1|STARTED|Overall Study||25
132525|NCT00262847|317988|P3|NOT COMPLETED|Overall Study||396
132526|NCT00262847|317989|P2|NOT COMPLETED|Overall Study||513
132527|NCT00262847|317990|P1|NOT COMPLETED|Overall Study||518
132528|NCT00262847|317988|P3|COMPLETED|Overall Study||227
132529|NCT00262847|317989|P2|COMPLETED|Overall Study||112
132530|NCT00262847|317990|P1|COMPLETED|Overall Study||107
132531|NCT00262847|317988|P3|STARTED|Overall Study|Total enrolled and included in efficacy analysis|623
132532|NCT00262847|317989|P2|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
132533|NCT00262847|317990|P1|STARTED|Overall Study|Total enrolled and included in efficacy analysis|625
132534|NCT00262860|318004|P1|NOT COMPLETED|Overall Study||2
132535|NCT00262860|318004|P1|COMPLETED|Overall Study||16
132536|NCT00262860|318004|P1|STARTED|Overall Study||18
132537|NCT00262873|318010|P1|NOT COMPLETED|Overall Study||8
132538|NCT00262873|318010|P1|COMPLETED|Overall Study||0
132539|NCT00262873|318010|P1|STARTED|Overall Study||8
132540|NCT00262925|318021|P1|NOT COMPLETED|Overall Study||11
132541|NCT00262925|318021|P1|COMPLETED|Overall Study||1
132542|NCT00262925|318021|P1|STARTED|Overall Study|7 patients were enrolled to step 1, and 5 patients were enrolled to step 2|12
132543|NCT00262951|318027|P1|NOT COMPLETED|Overall Study||16
132544|NCT00262951|318027|P1|COMPLETED|Overall Study||7
132545|NCT00262951|318027|P1|STARTED|Overall Study||23
132546|NCT00262964|318034|P4|NOT COMPLETED|Overall Study||0
132547|NCT00262964|318035|P3|NOT COMPLETED|Overall Study||0
132548|NCT00262964|318036|P2|NOT COMPLETED|Overall Study||0
132549|NCT00262964|318037|P1|NOT COMPLETED|Overall Study||0
132550|NCT00262964|318034|P4|COMPLETED|Overall Study||12
132551|NCT00262964|318035|P3|COMPLETED|Overall Study||17
132552|NCT00262964|318036|P2|COMPLETED|Overall Study||11
132553|NCT00262964|318037|P1|COMPLETED|Overall Study||11
132554|NCT00262964|318034|P4|STARTED|Overall Study||12
132555|NCT00262964|318035|P3|STARTED|Overall Study||17
132556|NCT00262964|318036|P2|STARTED|Overall Study||11
132557|NCT00262964|318037|P1|STARTED|Overall Study||11
132558|NCT00263211|318069|P2|NOT COMPLETED|Overall Study||1
132559|NCT00263211|318070|P1|NOT COMPLETED|Overall Study||5
132560|NCT00263211|318069|P2|COMPLETED|Overall Study||23
132561|NCT00263211|318070|P1|COMPLETED|Overall Study||19
132562|NCT00263211|318069|P2|STARTED|Overall Study||24
132563|NCT00263211|318070|P1|STARTED|Overall Study||24
132564|NCT00263328|318089|P3|NOT COMPLETED|Overall Study||7
132565|NCT00263328|318090|P2|NOT COMPLETED|Overall Study||2
132566|NCT00263328|318091|P1|NOT COMPLETED|Overall Study||8
132567|NCT00263328|318089|P3|COMPLETED|Overall Study||6
132568|NCT00263328|318090|P2|COMPLETED|Overall Study||12
132569|NCT00263328|318091|P1|COMPLETED|Overall Study||10
132570|NCT00263328|318089|P3|STARTED|Overall Study||13
132571|NCT00263328|318090|P2|STARTED|Overall Study||14
132572|NCT00263328|318091|P1|STARTED|Overall Study||18
132573|NCT00263666|318249|P2|NOT COMPLETED|Overall Study||11
132574|NCT00263666|318250|P1|NOT COMPLETED|Overall Study||7
132575|NCT00263666|318249|P2|COMPLETED|Overall Study||39
132576|NCT00263666|318250|P1|COMPLETED|Overall Study||43
132577|NCT00263666|318249|P2|STARTED|Overall Study||50
132578|NCT00263666|318250|P1|STARTED|Overall Study||50
132579|NCT00263757|318303|P2|NOT COMPLETED|Overall Study||8
132580|NCT00263757|318304|P1|NOT COMPLETED|Overall Study||8
132581|NCT00263757|318303|P2|COMPLETED|Overall Study||5
132582|NCT00263757|318304|P1|COMPLETED|Overall Study||4
132583|NCT00263757|318303|P2|STARTED|Overall Study||13
132584|NCT00263757|318304|P1|STARTED|Overall Study||12
132585|NCT00263887|318316|P2|NOT COMPLETED|Overall Study||7
132586|NCT00263887|318317|P1|NOT COMPLETED|Overall Study||3
132587|NCT00263887|318316|P2|COMPLETED|Overall Study||32
132588|NCT00263887|318317|P1|COMPLETED|Overall Study||35
132589|NCT00263887|318316|P2|STARTED|Overall Study||39
132590|NCT00263887|318317|P1|STARTED|Overall Study||38
132591|NCT00264004|318327|P4|NOT COMPLETED|Overall Study||15
132592|NCT00264004|318328|P3|NOT COMPLETED|Overall Study||14
132593|NCT00264004|318329|P2|NOT COMPLETED|Overall Study||11
132594|NCT00264004|318330|P1|NOT COMPLETED|Overall Study||17
132595|NCT00264004|318327|P4|COMPLETED|Overall Study|Completed 12 weeks treatment|19
132596|NCT00264004|318328|P3|COMPLETED|Overall Study|Completed 12 weeks treatment|16
132597|NCT00264004|318329|P2|COMPLETED|Overall Study|Completed 12 weeks treatment|21
132598|NCT00264004|318330|P1|COMPLETED|Overall Study|Completed 12 weeks treatment|13
132599|NCT00264004|318327|P4|STARTED|Overall Study|Randomised|34
132600|NCT00264004|318328|P3|STARTED|Overall Study|Randomised|30
132601|NCT00264004|318329|P2|STARTED|Overall Study|Randomised|32
132602|NCT00264004|318330|P1|STARTED|Overall Study|Randomised|30
132603|NCT00264147|318361|P6|NOT COMPLETED|Treatment II Period||33
132604|NCT00264147|318362|P5|NOT COMPLETED|Treatment II Period||33
132605|NCT00264147|318363|P4|NOT COMPLETED|Treatment II Period||0
132606|NCT00264147|318364|P3|NOT COMPLETED|Treatment II Period||0
132607|NCT00264147|318365|P2|NOT COMPLETED|Treatment II Period||0
132608|NCT00264147|318366|P1|NOT COMPLETED|Treatment II Period||0
132609|NCT00264147|318361|P6|COMPLETED|Treatment II Period||116
132610|NCT00264147|318362|P5|COMPLETED|Treatment II Period||147
132611|NCT00264147|318363|P4|COMPLETED|Treatment II Period||0
132612|NCT00264147|318364|P3|COMPLETED|Treatment II Period||0
132613|NCT00264147|318365|P2|COMPLETED|Treatment II Period||0
132614|NCT00264147|318366|P1|COMPLETED|Treatment II Period||0
132615|NCT00264147|318361|P6|STARTED|Treatment II Period|Etoricoxib 10 mg (34), 30 mg (37), 60 mg (29), and placebo (49) reassigned to diclofenac (149)|149
132616|NCT00264147|318362|P5|STARTED|Treatment II Period|Etoricoxib 10 mg (38), 30 mg (28), 60 mg (33), 90 mg (45) and placebo (36) reassigned to 90 mg (180)|180
132617|NCT00264147|318363|P4|STARTED|Treatment II Period||0
132618|NCT00264147|318364|P3|STARTED|Treatment II Period||0
132619|NCT00264147|318365|P2|STARTED|Treatment II Period||0
132620|NCT00264147|318366|P1|STARTED|Treatment II Period||0
132621|NCT00264147|318361|P6|NOT COMPLETED|Treatment I Period||0
132622|NCT00264147|318362|P5|NOT COMPLETED|Treatment I Period||56
132623|NCT00264147|318363|P4|NOT COMPLETED|Treatment I Period||72
132624|NCT00264147|318364|P3|NOT COMPLETED|Treatment I Period||77
132625|NCT00264147|318365|P2|NOT COMPLETED|Treatment I Period||83
132626|NCT00264147|318366|P1|NOT COMPLETED|Treatment I Period||98
132627|NCT00264147|318361|P6|COMPLETED|Treatment I Period||0
132628|NCT00264147|318362|P5|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|99
132629|NCT00264147|318363|P4|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|68
132630|NCT00264147|318364|P3|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|74
132631|NCT00264147|318365|P2|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|71
132632|NCT00264147|318366|P1|COMPLETED|Treatment I Period|Randomized to Treatment I period and remained on Treatment I period during course of study|63
132633|NCT00264147|318361|P6|STARTED|Treatment I Period||0
132634|NCT00264147|318362|P5|STARTED|Treatment I Period||155
132635|NCT00264147|318363|P4|STARTED|Treatment I Period||140
132636|NCT00264147|318364|P3|STARTED|Treatment I Period||151
132637|NCT00264147|318365|P2|STARTED|Treatment I Period||154
132638|NCT00264147|318366|P1|STARTED|Treatment I Period||161
132639|NCT00264238|318405|P1|NOT COMPLETED|Overall Study||1
132640|NCT00264238|318405|P1|COMPLETED|Overall Study||14
132641|NCT00264238|318405|P1|STARTED|Overall Study||15
132642|NCT00264290|318414|P2|NOT COMPLETED|Observation (4 Weeks)||0
132643|NCT00264290|318415|P1|NOT COMPLETED|Observation (4 Weeks)||0
132644|NCT00264290|318414|P2|COMPLETED|Observation (4 Weeks)||14
132645|NCT00264290|318415|P1|COMPLETED|Observation (4 Weeks)||15
132646|NCT00264290|318414|P2|STARTED|Observation (4 Weeks)||14
132647|NCT00264290|318415|P1|STARTED|Observation (4 Weeks)||15
132648|NCT00264290|318414|P2|NOT COMPLETED|Intervention (8 Weeks)||0
132649|NCT00264290|318415|P1|NOT COMPLETED|Intervention (8 Weeks)||1
132650|NCT00264290|318414|P2|COMPLETED|Intervention (8 Weeks)||14
132651|NCT00264290|318415|P1|COMPLETED|Intervention (8 Weeks)||15
132652|NCT00264290|318414|P2|STARTED|Intervention (8 Weeks)||14
132653|NCT00264290|318415|P1|STARTED|Intervention (8 Weeks)||16
132654|NCT00264303|318423|P2|NOT COMPLETED|Overall Study||29
132655|NCT00264303|318424|P1|NOT COMPLETED|Overall Study||25
132656|NCT00264303|318423|P2|COMPLETED|Overall Study||419
132657|NCT00264303|318424|P1|COMPLETED|Overall Study||413
132658|NCT00264303|318423|P2|STARTED|Overall Study||448
132659|NCT00264303|318424|P1|STARTED|Overall Study||438
132660|NCT00264381|318442|P2|NOT COMPLETED|Overall Study||0
132661|NCT00264381|318443|P1|NOT COMPLETED|Overall Study||0
132662|NCT00264381|318442|P2|COMPLETED|Overall Study||37
132663|NCT00264381|318443|P1|COMPLETED|Overall Study||35
132664|NCT00264381|318442|P2|STARTED|Overall Study||37
132665|NCT00264381|318443|P1|STARTED|Overall Study||35
132666|NCT00264498|318457|P2|NOT COMPLETED|Crossover Treatment||9
132667|NCT00264498|318458|P1|NOT COMPLETED|Crossover Treatment||6
132668|NCT00264498|318457|P2|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
132669|NCT00264498|318458|P1|COMPLETED|Crossover Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
132670|NCT00264498|318457|P2|STARTED|Crossover Treatment||9
132671|NCT00264498|318458|P1|STARTED|Crossover Treatment||6
132672|NCT00264498|318457|P2|NOT COMPLETED|Randomized Treatment||18
132673|NCT00264498|318458|P1|NOT COMPLETED|Randomized Treatment||17
132674|NCT00264498|318457|P2|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
132675|NCT00264498|318458|P1|COMPLETED|Randomized Treatment|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
132676|NCT00264498|318457|P2|STARTED|Randomized Treatment||18
132677|NCT00264498|318458|P1|STARTED|Randomized Treatment||17
132678|NCT00264537|318468|P4|NOT COMPLETED|Overall Study||60
132679|NCT00264537|318469|P3|NOT COMPLETED|Overall Study||50
132680|NCT00264537|318470|P2|NOT COMPLETED|Overall Study||58
132681|NCT00264537|318471|P1|NOT COMPLETED|Overall Study||50
132682|NCT00264537|318468|P4|COMPLETED|Overall Study||99
132683|NCT00264537|318469|P3|COMPLETED|Overall Study||109
132684|NCT00264537|318470|P2|COMPLETED|Overall Study||101
132685|NCT00264537|318471|P1|COMPLETED|Overall Study||110
132686|NCT00264537|318468|P4|STARTED|Overall Study||159
132687|NCT00264537|318469|P3|STARTED|Overall Study||159
132688|NCT00264537|318470|P2|STARTED|Overall Study||159
132689|NCT00264537|318471|P1|STARTED|Overall Study||160
132690|NCT00264550|318505|P4|NOT COMPLETED|Overall Study||30
132691|NCT00264550|318506|P3|NOT COMPLETED|Overall Study||17
132692|NCT00264550|318507|P2|NOT COMPLETED|Overall Study||41
132693|NCT00264550|318508|P1|NOT COMPLETED|Overall Study||43
132694|NCT00264550|318505|P4|COMPLETED|Overall Study||59
132695|NCT00264550|318506|P3|COMPLETED|Overall Study||72
132696|NCT00264550|318507|P2|COMPLETED|Overall Study||92
132697|NCT00264550|318508|P1|COMPLETED|Overall Study||90
132698|NCT00264550|318505|P4|STARTED|Overall Study||89
132699|NCT00264550|318506|P3|STARTED|Overall Study||89
132700|NCT00264550|318507|P2|STARTED|Overall Study||133
132701|NCT00264550|318508|P1|STARTED|Overall Study||133
132702|NCT00264576|318545|P2|NOT COMPLETED|Overall Study||1
132703|NCT00264576|318546|P1|NOT COMPLETED|Overall Study||1
132704|NCT00264576|318545|P2|COMPLETED|Overall Study||304
132705|NCT00264576|318546|P1|COMPLETED|Overall Study||307
132706|NCT00264576|318545|P2|STARTED|Overall Study||305
132707|NCT00264576|318546|P1|STARTED|Overall Study||308
132708|NCT00264641|318568|P2|NOT COMPLETED|Overall Study||0
132709|NCT00264641|318569|P1|NOT COMPLETED|Overall Study||0
132710|NCT00264641|318568|P2|COMPLETED|Overall Study||10
132711|NCT00264641|318569|P1|COMPLETED|Overall Study||10
132712|NCT00264641|318568|P2|Initiation of the Study|Overall Study||10
132713|NCT00264641|318569|P1|Initiation of the Study|Overall Study||10
132714|NCT00264641|318568|P2|STARTED|Overall Study||10
132715|NCT00264641|318569|P1|STARTED|Overall Study||10
132716|NCT00264797|318576|P2|NOT COMPLETED|Overall Study||43
132717|NCT00264797|318577|P1|NOT COMPLETED|Overall Study||33
132718|NCT00264797|318576|P2|COMPLETED|Overall Study||109
132719|NCT00264797|318577|P1|COMPLETED|Overall Study||118
132720|NCT00264797|318576|P2|STARTED|Overall Study||152
132721|NCT00264797|318577|P1|STARTED|Overall Study||151
132722|NCT00264810|318591|P2|NOT COMPLETED|Open Label Evaluation Period||6
132723|NCT00264810|318592|P1|NOT COMPLETED|Open Label Evaluation Period||6
132724|NCT00264810|318591|P2|COMPLETED|Open Label Evaluation Period||86
132725|NCT00264810|318592|P1|COMPLETED|Open Label Evaluation Period||89
132726|NCT00264810|318591|P2|1-year Post-implant|Open Label Evaluation Period||90
132727|NCT00264810|318592|P1|1-year Post-implant|Open Label Evaluation Period||92
132728|NCT00264810|318591|P2|STARTED|Open Label Evaluation Period||92
132729|NCT00264810|318592|P1|STARTED|Open Label Evaluation Period||95
132730|NCT00264810|318591|P2|NOT COMPLETED|Blinded Evaluation Period||1
132731|NCT00264810|318592|P1|NOT COMPLETED|Blinded Evaluation Period||1
132732|NCT00264810|318591|P2|COMPLETED|Blinded Evaluation Period||92
132733|NCT00264810|318592|P1|COMPLETED|Blinded Evaluation Period||95
132734|NCT00264810|318591|P2|STARTED|Blinded Evaluation Period||93
132735|NCT00264810|318592|P1|STARTED|Blinded Evaluation Period||96
132736|NCT00264810|318591|P2|NOT COMPLETED|Stimulation Optimization Period||1
132737|NCT00264810|318592|P1|NOT COMPLETED|Stimulation Optimization Period||1
132738|NCT00264810|318591|P2|COMPLETED|Stimulation Optimization Period||93
132739|NCT00264810|318592|P1|COMPLETED|Stimulation Optimization Period||96
132740|NCT00264810|318591|P2|STARTED|Stimulation Optimization Period||94
132741|NCT00264810|318592|P1|STARTED|Stimulation Optimization Period||97
132742|NCT00264810|318591|P2|NOT COMPLETED|Post-Operative Stabilization Period||0
132743|NCT00264810|318592|P1|NOT COMPLETED|Post-Operative Stabilization Period||0
132744|NCT00264810|318591|P2|COMPLETED|Post-Operative Stabilization Period||94
132745|NCT00264810|318592|P1|COMPLETED|Post-Operative Stabilization Period||97
132822|NCT00265200|318738|P1|STARTED|Overall Study||28
132746|NCT00264810|318591|P2|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
132747|NCT00264810|318592|P1|STARTED|Post-Operative Stabilization Period|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
132748|NCT00264810|318591|P2|NOT COMPLETED|Baseline||26
132749|NCT00264810|318592|P1|NOT COMPLETED|Baseline||23
132750|NCT00264810|318591|P2|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|94
132751|NCT00264810|318592|P1|COMPLETED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|97
132752|NCT00264810|318591|P2|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
132753|NCT00264810|318592|P1|STARTED|Baseline|Subjects were not assigned to a group until the end of the Post-Operative Stabilization Period.|120
132754|NCT00264849|318602|P2|NOT COMPLETED|Overall Study||25
132755|NCT00264849|318603|P1|NOT COMPLETED|Overall Study||22
132756|NCT00264849|318602|P2|COMPLETED|Overall Study||106
132757|NCT00264849|318603|P1|COMPLETED|Overall Study||253
132758|NCT00264849|318602|P2|STARTED|Overall Study||131
132759|NCT00264849|318603|P1|STARTED|Overall Study||275
132760|NCT00264875|318637|P1|NOT COMPLETED|Overall Study||30
132761|NCT00264875|318637|P1|COMPLETED|Overall Study||190
132762|NCT00264875|318637|P1|STARTED|Overall Study||220
132763|NCT00265083|318644|P3|NOT COMPLETED|Overall Study||42
132764|NCT00265083|318645|P2|NOT COMPLETED|Overall Study||42
132765|NCT00265083|318646|P1|NOT COMPLETED|Overall Study||17
132766|NCT00265083|318644|P3|COMPLETED|Overall Study||98
132767|NCT00265083|318645|P2|COMPLETED|Overall Study|One patient did not receive study agent.|96
132768|NCT00265083|318646|P1|COMPLETED|Overall Study||61
132769|NCT00265083|318644|P3|STARTED|Overall Study||140
132770|NCT00265083|318645|P2|STARTED|Overall Study|One patient did not receive study agent.|138
132771|NCT00265083|318646|P1|STARTED|Overall Study||78
132772|NCT00265096|318670|P3|NOT COMPLETED|Overall Study||39
132773|NCT00265096|318671|P2|NOT COMPLETED|Overall Study||51
132774|NCT00265096|318672|P1|NOT COMPLETED|Overall Study||36
132775|NCT00265096|318670|P3|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|107
132776|NCT00265096|318671|P2|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|95
132777|NCT00265096|318672|P1|COMPLETED|Overall Study|Indicates number of patients that were continuing SC study agent at Wk 24|77
132778|NCT00265096|318670|P3|STARTED|Overall Study||146
132779|NCT00265096|318671|P2|STARTED|Overall Study||146
132780|NCT00265096|318672|P1|STARTED|Overall Study||113
132781|NCT00265109|318701|P1|NOT COMPLETED|Overall Study||6
132782|NCT00265109|318701|P1|COMPLETED|Overall Study||11
132783|NCT00265109|318701|P1|STARTED|Overall Study||17
132784|NCT00265122|318711|P6|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
132785|NCT00265122|318712|P5|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||5
132786|NCT00265122|318713|P4|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
132787|NCT00265122|318714|P3|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||4
132788|NCT00265122|318715|P2|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||1
132789|NCT00265122|318716|P1|NOT COMPLETED|Intervention Period 2 (Weeks 8 to 28):||7
132790|NCT00265122|318711|P6|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||12
132791|NCT00265122|318712|P5|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||8
132792|NCT00265122|318713|P4|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||20
132793|NCT00265122|318714|P3|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||18
132794|NCT00265122|318715|P2|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||22
132795|NCT00265122|318716|P1|COMPLETED|Intervention Period 2 (Weeks 8 to 28):||17
132796|NCT00265122|318711|P6|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
132797|NCT00265122|318712|P5|STARTED|Intervention Period 2 (Weeks 8 to 28):||13
132798|NCT00265122|318713|P4|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
132799|NCT00265122|318714|P3|STARTED|Intervention Period 2 (Weeks 8 to 28):||22
132800|NCT00265122|318715|P2|STARTED|Intervention Period 2 (Weeks 8 to 28):||23
132801|NCT00265122|318716|P1|STARTED|Intervention Period 2 (Weeks 8 to 28):||24
132802|NCT00265122|318711|P6|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||0
132803|NCT00265122|318712|P5|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||1
132804|NCT00265122|318713|P4|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
132805|NCT00265122|318714|P3|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||5
132806|NCT00265122|318715|P2|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
132807|NCT00265122|318716|P1|NOT COMPLETED|Intervention Period 1 (Weeks 0 to 8):||2
132808|NCT00265122|318711|P6|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
132809|NCT00265122|318712|P5|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||13
132810|NCT00265122|318713|P4|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
132811|NCT00265122|318714|P3|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||22
132812|NCT00265122|318715|P2|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||23
132813|NCT00265122|318716|P1|COMPLETED|Intervention Period 1 (Weeks 0 to 8):||24
132814|NCT00265122|318711|P6|STARTED|Intervention Period 1 (Weeks 0 to 8):||13
132815|NCT00265122|318712|P5|STARTED|Intervention Period 1 (Weeks 0 to 8):||14
132816|NCT00265122|318713|P4|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
132817|NCT00265122|318714|P3|STARTED|Intervention Period 1 (Weeks 0 to 8):||27
132818|NCT00265122|318715|P2|STARTED|Intervention Period 1 (Weeks 0 to 8):||25
132819|NCT00265122|318716|P1|STARTED|Intervention Period 1 (Weeks 0 to 8):||26
132820|NCT00265200|318738|P1|NOT COMPLETED|Overall Study||4
132821|NCT00265200|318738|P1|COMPLETED|Overall Study||24
132823|NCT00265239|318744|P2|NOT COMPLETED|Overall Study||1
132824|NCT00265239|318745|P1|NOT COMPLETED|Overall Study||2
132825|NCT00265239|318744|P2|COMPLETED|Overall Study||51
132826|NCT00265239|318745|P1|COMPLETED|Overall Study||50
132827|NCT00265239|318744|P2|STARTED|Overall Study||52
132828|NCT00265239|318745|P1|STARTED|Overall Study||52
132829|NCT00256698|318759|P2|NOT COMPLETED|Overall Study||172
132830|NCT00256698|318760|P1|NOT COMPLETED|Overall Study||167
132831|NCT00256698|318759|P2|COMPLETED|Overall Study||84
132832|NCT00256698|318760|P1|COMPLETED|Overall Study||91
132833|NCT00256698|318759|P2|STARTED|Overall Study||256
132834|NCT00256698|318760|P1|STARTED|Overall Study||258
132835|NCT00256724|318780|P2|NOT COMPLETED|Overall Study||8
132836|NCT00256724|318781|P1|NOT COMPLETED|Overall Study||5
132837|NCT00256724|318780|P2|COMPLETED|Overall Study||16
132838|NCT00256724|318781|P1|COMPLETED|Overall Study||18
132839|NCT00256724|318780|P2|STARTED|Overall Study||24
132840|NCT00256724|318781|P1|STARTED|Overall Study||23
132841|NCT00256750|318792|P3|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||28
132842|NCT00256750|318793|P2|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||30
132843|NCT00256750|318794|P1|NOT COMPLETED|Long Term Extension (LTE; 84 Months)||47
132844|NCT00256750|318792|P3|COMPLETED|Long Term Extension (LTE; 84 Months)||127
132845|NCT00256750|318793|P2|COMPLETED|Long Term Extension (LTE; 84 Months)||136
132846|NCT00256750|318794|P1|COMPLETED|Long Term Extension (LTE; 84 Months)||89
132847|NCT00256750|318792|P3|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 3 withdrew or refused.|155
132848|NCT00256750|318793|P2|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 were eligible to enroll in LTE; 4 withdrew or refused.|166
132849|NCT00256750|318794|P1|STARTED|Long Term Extension (LTE; 84 Months)|Participants on drug through month 36 eligible to enroll in LTE; 2 ineligible, 5 withdrew or refused|136
132850|NCT00256750|318792|P3|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
132851|NCT00256750|318793|P2|NOT COMPLETED|Post-Transplant Treated (36 Months)||6
132852|NCT00256750|318794|P1|NOT COMPLETED|Post-Transplant Treated (36 Months)||10
132853|NCT00256750|318792|P3|COMPLETED|Post-Transplant Treated (36 Months)||158
132854|NCT00256750|318793|P2|COMPLETED|Post-Transplant Treated (36 Months)||170
132855|NCT00256750|318794|P1|COMPLETED|Post-Transplant Treated (36 Months)||143
132856|NCT00256750|318792|P3|STARTED|Post-Transplant Treated (36 Months)||164
132857|NCT00256750|318793|P2|STARTED|Post-Transplant Treated (36 Months)||176
132858|NCT00256750|318794|P1|STARTED|Post-Transplant Treated (36 Months)||153
132859|NCT00256750|318792|P3|NOT COMPLETED|Post-Transplant Treated (24 Months)||9
132860|NCT00256750|318793|P2|NOT COMPLETED|Post-Transplant Treated (24 Months)||7
132861|NCT00256750|318794|P1|NOT COMPLETED|Post-Transplant Treated (24 Months)||21
132862|NCT00256750|318792|P3|COMPLETED|Post-Transplant Treated (24 Months)||164
132863|NCT00256750|318793|P2|COMPLETED|Post-Transplant Treated (24 Months)||176
132864|NCT00256750|318794|P1|COMPLETED|Post-Transplant Treated (24 Months)||153
132865|NCT00256750|318792|P3|STARTED|Post-Transplant Treated (24 Months)||173
132866|NCT00256750|318793|P2|STARTED|Post-Transplant Treated (24 Months)||183
132867|NCT00256750|318794|P1|STARTED|Post-Transplant Treated (24 Months)||174
132868|NCT00256750|318792|P3|NOT COMPLETED|Post-Transplant Treated (12 Months)||46
132869|NCT00256750|318793|P2|NOT COMPLETED|Post-Transplant Treated (12 Months)||43
132870|NCT00256750|318794|P1|NOT COMPLETED|Post-Transplant Treated (12 Months)||41
132871|NCT00256750|318792|P3|COMPLETED|Post-Transplant Treated (12 Months)||173
132872|NCT00256750|318793|P2|COMPLETED|Post-Transplant Treated (12 Months)||183
132873|NCT00256750|318794|P1|COMPLETED|Post-Transplant Treated (12 Months)||174
132874|NCT00256750|318792|P3|STARTED|Post-Transplant Treated (12 Months)||219
132875|NCT00256750|318793|P2|STARTED|Post-Transplant Treated (12 Months)||226
132876|NCT00256750|318794|P1|STARTED|Post-Transplant Treated (12 Months)||215
132877|NCT00256750|318792|P3|NOT COMPLETED|Transplanted Pre-Treatment||0
132878|NCT00256750|318793|P2|NOT COMPLETED|Transplanted Pre-Treatment||0
132879|NCT00256750|318794|P1|NOT COMPLETED|Transplanted Pre-Treatment||6
132880|NCT00256750|318792|P3|COMPLETED|Transplanted Pre-Treatment||219
132881|NCT00256750|318793|P2|COMPLETED|Transplanted Pre-Treatment||226
132882|NCT00256750|318794|P1|COMPLETED|Transplanted Pre-Treatment||215
132883|NCT00256750|318792|P3|STARTED|Transplanted Pre-Treatment||219
132884|NCT00256750|318793|P2|STARTED|Transplanted Pre-Treatment||226
132885|NCT00256750|318794|P1|STARTED|Transplanted Pre-Treatment||221
132886|NCT00256984|318928|P1|NOT COMPLETED|Overall Study||16
132887|NCT00256984|318928|P1|COMPLETED|Overall Study||59
132888|NCT00256984|318928|P1|STARTED|Overall Study||75
132889|NCT00256997|318940|P2|NOT COMPLETED|Overall Study||55
132890|NCT00256997|318941|P1|NOT COMPLETED|Overall Study||48
132891|NCT00256997|318940|P2|COMPLETED|Overall Study||31
132892|NCT00256997|318941|P1|COMPLETED|Overall Study||33
132893|NCT00256997|318940|P2|Treated|Overall Study||86
132894|NCT00256997|318941|P1|Treated|Overall Study||79
132895|NCT00256997|318940|P2|STARTED|Overall Study||86
132896|NCT00256997|318941|P1|STARTED|Overall Study||81
132897|NCT00257010|318965|P1|NOT COMPLETED|Overall Study||128
132898|NCT00257010|318965|P1|COMPLETED|Overall Study||319
132899|NCT00257010|318965|P1|STARTED|Overall Study||447
132900|NCT00257166|318976|P2|NOT COMPLETED|Overall Study||37
132901|NCT00257166|318977|P1|NOT COMPLETED|Overall Study||53
132902|NCT00257166|318976|P2|COMPLETED|Overall Study||51
132903|NCT00257166|318977|P1|COMPLETED|Overall Study||97
132904|NCT00257166|318976|P2|Treated|Overall Study||88
132905|NCT00257166|318977|P1|Treated|Overall Study||149
132906|NCT00257166|318976|P2|STARTED|Overall Study||88
132907|NCT00257166|318977|P1|STARTED|Overall Study||150
132908|NCT00257192|318991|P2|NOT COMPLETED|Overall Study||39
132909|NCT00257192|318992|P1|NOT COMPLETED|Overall Study||58
132910|NCT00257192|318991|P2|COMPLETED|Overall Study||52
132911|NCT00257192|318992|P1|COMPLETED|Overall Study||135
132912|NCT00257192|318991|P2|Received Study Treatment|Overall Study||90
132913|NCT00257192|318992|P1|Received Study Treatment|Overall Study||193
132914|NCT00257192|318991|P2|STARTED|Overall Study|Includes 1 subject randomized but not treated|91
132915|NCT00257192|318992|P1|STARTED|Overall Study||193
132916|NCT00265317|319038|P4|NOT COMPLETED|Phase 2||65
132917|NCT00265317|319039|P3|NOT COMPLETED|Phase 2||64
132918|NCT00265317|319040|P2|NOT COMPLETED|Phase 2||0
132919|NCT00265317|319041|P1|NOT COMPLETED|Phase 2||0
132920|NCT00265317|319038|P4|COMPLETED|Phase 2||2
132921|NCT00265317|319039|P3|COMPLETED|Phase 2||1
132922|NCT00265317|319040|P2|COMPLETED|Phase 2||0
132923|NCT00265317|319041|P1|COMPLETED|Phase 2||0
132924|NCT00265317|319038|P4|STARTED|Phase 2||67
132925|NCT00265317|319039|P3|STARTED|Phase 2||65
132926|NCT00265317|319040|P2|STARTED|Phase 2||0
132927|NCT00265317|319041|P1|STARTED|Phase 2||0
132928|NCT00265317|319038|P4|NOT COMPLETED|Lead-In||0
132929|NCT00265317|319039|P3|NOT COMPLETED|Lead-In||0
132930|NCT00265317|319040|P2|NOT COMPLETED|Lead-In||17
132931|NCT00265317|319041|P1|NOT COMPLETED|Lead-In||12
132932|NCT00265317|319038|P4|COMPLETED|Lead-In||0
132933|NCT00265317|319039|P3|COMPLETED|Lead-In||0
132934|NCT00265317|319040|P2|COMPLETED|Lead-In||0
132935|NCT00265317|319041|P1|COMPLETED|Lead-In||1
132936|NCT00265317|319038|P4|STARTED|Lead-In||0
132937|NCT00265317|319039|P3|STARTED|Lead-In||0
132938|NCT00265317|319040|P2|STARTED|Lead-In||17
132939|NCT00265317|319041|P1|STARTED|Lead-In||13
132940|NCT00265330|319154|P1|NOT COMPLETED|Overall Study||95
132941|NCT00265330|319154|P1|COMPLETED|Overall Study||67
132942|NCT00265330|319154|P1|STARTED|Overall Study||162
132943|NCT00265343|319178|P2|NOT COMPLETED|Overall Study||19
132944|NCT00265343|319179|P1|NOT COMPLETED|Overall Study||21
132945|NCT00265343|319178|P2|COMPLETED|Overall Study||153
132946|NCT00265343|319179|P1|COMPLETED|Overall Study||113
132947|NCT00265343|319178|P2|STARTED|Overall Study||172
132948|NCT00265343|319179|P1|STARTED|Overall Study||134
132949|NCT00265382|319187|P1|NOT COMPLETED|Overall Study||145
132950|NCT00265382|319187|P1|COMPLETED|Overall Study||76
132951|NCT00265382|319187|P1|STARTED|Overall Study||221
132952|NCT00265395|319207|P2|NOT COMPLETED|Overall Study||17
132953|NCT00265395|319208|P1|NOT COMPLETED|Overall Study||8
132954|NCT00265395|319207|P2|COMPLETED|Overall Study||56
132955|NCT00265395|319208|P1|COMPLETED|Overall Study||78
132956|NCT00265395|319207|P2|STARTED|Overall Study||73
132957|NCT00265395|319208|P1|STARTED|Overall Study||86
132958|NCT00265473|319213|P1|NOT COMPLETED|Overall Study||0
132959|NCT00265473|319213|P1|COMPLETED|Overall Study||5
132960|NCT00265473|319213|P1|STARTED|Overall Study||5
132961|NCT00265512|319223|P2|NOT COMPLETED|Overall Study||95
132962|NCT00265512|319224|P1|NOT COMPLETED|Overall Study||45
132963|NCT00265512|319223|P2|COMPLETED|Overall Study||359
132964|NCT00265512|319224|P1|COMPLETED|Overall Study||168
132965|NCT00265512|319223|P2|STARTED|Overall Study||454
132966|NCT00265512|319224|P1|STARTED|Overall Study||213
132967|NCT00267046|319232|P2|NOT COMPLETED|Overall Study||11
132968|NCT00267046|319233|P1|NOT COMPLETED|Overall Study||12
132969|NCT00267046|319232|P2|COMPLETED|Overall Study||5
132970|NCT00267046|319233|P1|COMPLETED|Overall Study||20
132971|NCT00267046|319232|P2|STARTED|Overall Study||16
132972|NCT00267046|319233|P1|STARTED|Overall Study||32
132973|NCT00267059|319241|P1|NOT COMPLETED|Overall Study||0
132974|NCT00267059|319241|P1|COMPLETED|Overall Study||44
132975|NCT00267059|319241|P1|STARTED|Overall Study||44
132976|NCT00267085|319245|P1|NOT COMPLETED|Overall Study||0
132977|NCT00267085|319245|P1|COMPLETED|Overall Study||10
132978|NCT00267085|319245|P1|STARTED|Overall Study||10
132979|NCT00267098|319257|P8|NOT COMPLETED|Overall Study||15
132980|NCT00267098|319258|P7|NOT COMPLETED|Overall Study||46
132981|NCT00267098|319259|P6|NOT COMPLETED|Overall Study||40
132982|NCT00267098|319260|P5|NOT COMPLETED|Overall Study||37
132983|NCT00267098|319261|P4|NOT COMPLETED|Overall Study||106
132984|NCT00267098|319262|P3|NOT COMPLETED|Overall Study||94
132985|NCT00267098|319263|P2|NOT COMPLETED|Overall Study||51
132986|NCT00267098|319264|P1|NOT COMPLETED|Overall Study||109
132987|NCT00267098|319257|P8|COMPLETED|Overall Study||5
132988|NCT00267098|319258|P7|COMPLETED|Overall Study||55
132989|NCT00267098|319259|P6|COMPLETED|Overall Study||66
132990|NCT00267098|319260|P5|COMPLETED|Overall Study||10
132991|NCT00267098|319261|P4|COMPLETED|Overall Study||135
132992|NCT00267098|319262|P3|COMPLETED|Overall Study||149
132993|NCT00267098|319263|P2|COMPLETED|Overall Study||0
132994|NCT00267098|319264|P1|COMPLETED|Overall Study||0
132995|NCT00267098|319257|P8|STARTED|Overall Study||20
132996|NCT00267098|319258|P7|STARTED|Overall Study||101
132997|NCT00267098|319259|P6|STARTED|Overall Study||106
132998|NCT00267098|319260|P5|STARTED|Overall Study||47
132999|NCT00267098|319261|P4|STARTED|Overall Study||241
133000|NCT00267098|319262|P3|STARTED|Overall Study||243
133001|NCT00267098|319263|P2|STARTED|Overall Study||51
133002|NCT00267098|319264|P1|STARTED|Overall Study||109
133003|NCT00267111|319399|P2|NOT COMPLETED|Overall Study||0
133004|NCT00267111|319400|P1|NOT COMPLETED|Overall Study||0
133005|NCT00267111|319399|P2|COMPLETED|Overall Study||55
133006|NCT00267111|319400|P1|COMPLETED|Overall Study||55
133007|NCT00267111|319399|P2|STARTED|Overall Study||55
133008|NCT00267111|319400|P1|STARTED|Overall Study||55
133009|NCT00267150|319408|P1|NOT COMPLETED|Overall Study||1
133010|NCT00267150|319408|P1|COMPLETED|Overall Study||30
133011|NCT00267150|319408|P1|STARTED|Overall Study||31
133012|NCT00267189|319415|P2|NOT COMPLETED|Overall Study||1
133013|NCT00267189|319416|P1|NOT COMPLETED|Overall Study||5
133014|NCT00267189|319415|P2|COMPLETED|Overall Study||72
133015|NCT00267189|319416|P1|COMPLETED|Overall Study|"Completed indicates completed study."|67
133016|NCT00267189|319415|P2|Completed Study Medication|Overall Study||72
133017|NCT00267189|319416|P1|Completed Study Medication|Overall Study||54
133018|NCT00267189|319415|P2|STARTED|Overall Study||73
133019|NCT00267189|319416|P1|STARTED|Overall Study|Intention to treat (ITT) population.|72
133020|NCT00267202|319428|P2|NOT COMPLETED|Overall Study||34
133021|NCT00267202|319429|P1|NOT COMPLETED|Overall Study||53
133022|NCT00267202|319428|P2|COMPLETED|Overall Study||105
133023|NCT00267202|319429|P1|COMPLETED|Overall Study||83
133024|NCT00267202|319428|P2|STARTED|Overall Study||139
133025|NCT00267202|319429|P1|STARTED|Overall Study||136
133026|NCT00267293|319451|P3|NOT COMPLETED|Overall Study||0
133027|NCT00267293|319452|P2|NOT COMPLETED|Overall Study||0
133028|NCT00267293|319453|P1|NOT COMPLETED|Overall Study||0
133029|NCT00267293|319451|P3|COMPLETED|Overall Study||20
133030|NCT00267293|319452|P2|COMPLETED|Overall Study||20
133031|NCT00267293|319453|P1|COMPLETED|Overall Study||20
133032|NCT00267293|319451|P3|STARTED|Overall Study||20
133033|NCT00267293|319452|P2|STARTED|Overall Study||20
133034|NCT00267293|319453|P1|STARTED|Overall Study||20
133035|NCT00267488|319461|P1|NOT COMPLETED|Overall Study||11
133036|NCT00267488|319461|P1|COMPLETED|Overall Study||26
133037|NCT00267488|319461|P1|STARTED|Overall Study||37
133038|NCT00267631|319472|P2|NOT COMPLETED|Overall Study||0
133039|NCT00267631|319473|P1|NOT COMPLETED|Overall Study||0
133040|NCT00267631|319472|P2|COMPLETED|Overall Study||3031
133041|NCT00267631|319473|P1|COMPLETED|Overall Study||2361
133042|NCT00267631|319472|P2|STARTED|Overall Study||3031
133043|NCT00267631|319473|P1|STARTED|Overall Study||2361
133044|NCT00267644|319481|P2|NOT COMPLETED|Overall Study||0
133045|NCT00267644|319482|P1|NOT COMPLETED|Overall Study||0
133046|NCT00267644|319481|P2|COMPLETED|Overall Study||63
133047|NCT00267644|319482|P1|COMPLETED|Overall Study||13
133048|NCT00267644|319481|P2|STARTED|Overall Study||63
133049|NCT00267644|319482|P1|STARTED|Overall Study||13
133050|NCT00267670|319492|P2|NOT COMPLETED|Overall Study||0
133051|NCT00267670|319493|P1|NOT COMPLETED|Overall Study||4
133052|NCT00267670|319492|P2|COMPLETED|Overall Study||7
133053|NCT00267670|319493|P1|COMPLETED|Overall Study||15
133054|NCT00267670|319492|P2|STARTED|Overall Study||7
133055|NCT00267670|319493|P1|STARTED|Overall Study||19
133056|NCT00267696|319505|P1|NOT COMPLETED|Overall Study||0
133057|NCT00267696|319505|P1|COMPLETED|Overall Study||45
133058|NCT00267696|319505|P1|STARTED|Overall Study||45
133059|NCT00267748|319513|P3|NOT COMPLETED|Randomized Period||132
133060|NCT00267748|319514|P2|NOT COMPLETED|Randomized Period||127
133061|NCT00267748|319515|P1|NOT COMPLETED|Randomized Period||0
133062|NCT00267748|319513|P3|COMPLETED|Randomized Period||14
133063|NCT00267748|319514|P2|COMPLETED|Randomized Period||19
133064|NCT00267748|319515|P1|COMPLETED|Randomized Period||0
133065|NCT00267748|319513|P3|Treated|Randomized Period||143
133066|NCT00267748|319514|P2|Treated|Randomized Period||146
133067|NCT00267748|319515|P1|Treated|Randomized Period||0
133068|NCT00267748|319513|P3|STARTED|Randomized Period||146
133069|NCT00267748|319514|P2|STARTED|Randomized Period||146
133070|NCT00267748|319515|P1|STARTED|Randomized Period||0
133071|NCT00267748|319513|P3|NOT COMPLETED|Non-randomized Period||0
133072|NCT00267748|319514|P2|NOT COMPLETED|Non-randomized Period||0
133073|NCT00267748|319515|P1|NOT COMPLETED|Non-randomized Period||23
133074|NCT00267748|319513|P3|COMPLETED|Non-randomized Period||0
133075|NCT00267748|319514|P2|COMPLETED|Non-randomized Period||0
133076|NCT00267748|319515|P1|COMPLETED|Non-randomized Period||2
133077|NCT00267748|319513|P3|STARTED|Non-randomized Period||0
133078|NCT00267748|319514|P2|STARTED|Non-randomized Period||0
133079|NCT00267748|319515|P1|STARTED|Non-randomized Period||25
133080|NCT00267774|319534|P2|NOT COMPLETED|Overall Study||0
133081|NCT00267774|319535|P1|NOT COMPLETED|Overall Study||0
133082|NCT00267774|319534|P2|COMPLETED|Overall Study||496
133083|NCT00267774|319535|P1|COMPLETED|Overall Study||509
133084|NCT00267774|319534|P2|STARTED|Overall Study||496
133085|NCT00267774|319535|P1|STARTED|Overall Study||509
133086|NCT00267956|319543|P4|NOT COMPLETED|After Controlled Period||2
133087|NCT00267956|319544|P3|NOT COMPLETED|After Controlled Period||5
133088|NCT00267956|319545|P2|NOT COMPLETED|After Controlled Period||0
133089|NCT00267956|319546|P1|NOT COMPLETED|After Controlled Period||0
133090|NCT00267956|319543|P4|COMPLETED|After Controlled Period||70
133091|NCT00267956|319544|P3|COMPLETED|After Controlled Period||52
133092|NCT00267956|319545|P2|COMPLETED|After Controlled Period||0
133093|NCT00267956|319546|P1|COMPLETED|After Controlled Period||0
133094|NCT00267956|319543|P4|STARTED|After Controlled Period||72
133095|NCT00267956|319544|P3|STARTED|After Controlled Period||57
133096|NCT00267956|319545|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
133097|NCT00267956|319546|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
133098|NCT00267956|319543|P4|NOT COMPLETED|Controlled Period||0
133099|NCT00267956|319544|P3|NOT COMPLETED|Controlled Period||0
133100|NCT00267956|319545|P2|NOT COMPLETED|Controlled Period||4
133101|NCT00267956|319546|P1|NOT COMPLETED|Controlled Period||13
133102|NCT00267956|319543|P4|COMPLETED|Controlled Period||0
133103|NCT00267956|319544|P3|COMPLETED|Controlled Period||0
133104|NCT00267956|319545|P2|COMPLETED|Controlled Period||72
133105|NCT00267956|319546|P1|COMPLETED|Controlled Period||57
133106|NCT00267956|319543|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
133107|NCT00267956|319544|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
133108|NCT00267956|319545|P2|STARTED|Controlled Period||76
133109|NCT00267956|319546|P1|STARTED|Controlled Period||70
133110|NCT00267969|319567|P7|NOT COMPLETED|After Controlled Period||72
133111|NCT00267969|319568|P6|NOT COMPLETED|After Controlled Period||82
133112|NCT00267969|319569|P5|NOT COMPLETED|After Controlled Period||35
133113|NCT00267969|319570|P4|NOT COMPLETED|After Controlled Period||36
133114|NCT00267969|319571|P3|NOT COMPLETED|After Controlled Period||0
133115|NCT00267969|319572|P2|NOT COMPLETED|After Controlled Period||0
133116|NCT00267969|319573|P1|NOT COMPLETED|After Controlled Period||0
133117|NCT00267969|319567|P7|COMPLETED|After Controlled Period||173
133118|NCT00267969|319568|P6|COMPLETED|After Controlled Period||172
133119|NCT00267969|319569|P5|COMPLETED|After Controlled Period||85
133120|NCT00267969|319570|P4|COMPLETED|After Controlled Period||87
133121|NCT00267969|319571|P3|COMPLETED|After Controlled Period||0
133122|NCT00267969|319572|P2|COMPLETED|After Controlled Period||0
133123|NCT00267969|319573|P1|COMPLETED|After Controlled Period||0
133124|NCT00267969|319567|P7|STARTED|After Controlled Period||245
133125|NCT00267969|319568|P6|STARTED|After Controlled Period||254
133126|NCT00267969|319569|P5|STARTED|After Controlled Period||120
133127|NCT00267969|319570|P4|STARTED|After Controlled Period||123
133128|NCT00267969|319571|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
133129|NCT00267969|319572|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
133130|NCT00267969|319573|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
133131|NCT00267969|319567|P7|NOT COMPLETED|Controlled Period||0
133132|NCT00267969|319568|P6|NOT COMPLETED|Controlled Period||0
133133|NCT00267969|319569|P5|NOT COMPLETED|Controlled Period||0
133134|NCT00267969|319570|P4|NOT COMPLETED|Controlled Period||0
133135|NCT00267969|319571|P3|NOT COMPLETED|Controlled Period||11
133136|NCT00267969|319572|P2|NOT COMPLETED|Controlled Period||1
133137|NCT00267969|319573|P1|NOT COMPLETED|Controlled Period||12
133138|NCT00267969|319567|P7|COMPLETED|Controlled Period||0
133139|NCT00267969|319568|P6|COMPLETED|Controlled Period||0
133140|NCT00267969|319569|P5|COMPLETED|Controlled Period||0
133141|NCT00267969|319570|P4|COMPLETED|Controlled Period||0
133142|NCT00267969|319571|P3|COMPLETED|Controlled Period||245
133143|NCT00267969|319572|P2|COMPLETED|Controlled Period||254
133144|NCT00267969|319573|P1|COMPLETED|Controlled Period||243
133145|NCT00267969|319567|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
133146|NCT00267969|319568|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
133147|NCT00267969|319569|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
133148|NCT00267969|319570|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
133149|NCT00267969|319571|P3|STARTED|Controlled Period|Number of patients randomized|256
133150|NCT00267969|319572|P2|STARTED|Controlled Period|Number of patients randomized|255
133151|NCT00267969|319573|P1|STARTED|Controlled Period|Number of patients randomized|255
133152|NCT00268203|319597|P1|NOT COMPLETED|Overall Study||647
133153|NCT00268203|319597|P1|COMPLETED|Overall Study|These participants completed 10 years of follow-up.|118
133154|NCT00268203|319597|P1|Completed 2 Years of Follow-up|Overall Study||62
133155|NCT00268203|319597|P1|STARTED|Overall Study||765
133156|NCT00268242|319608|P1|NOT COMPLETED|Overall Study||1
133157|NCT00268242|319608|P1|COMPLETED|Overall Study||23
133158|NCT00268242|319608|P1|STARTED|Overall Study||24
133159|NCT00268346|319619|P2|NOT COMPLETED|Overall Study||3
133160|NCT00268346|319620|P1|NOT COMPLETED|Overall Study||0
133161|NCT00268346|319619|P2|COMPLETED|Overall Study||37
133162|NCT00268346|319620|P1|COMPLETED|Overall Study||18
133163|NCT00268346|319619|P2|Started Treatment|Overall Study||40
133164|NCT00268346|319620|P1|Started Treatment|Overall Study||18
133165|NCT00268346|319619|P2|STARTED|Overall Study||40
133166|NCT00268346|319620|P1|STARTED|Overall Study||18
133167|NCT00268437|319626|P1|NOT COMPLETED|Overall Study||1
133168|NCT00268437|319626|P1|COMPLETED|Overall Study||26
133169|NCT00268437|319626|P1|STARTED|Overall Study||27
133170|NCT00268463|319633|P2|NOT COMPLETED|Overall Study||12
133171|NCT00268463|319634|P1|NOT COMPLETED|Overall Study||10
133172|NCT00268463|319633|P2|COMPLETED|Overall Study||0
133173|NCT00268463|319634|P1|COMPLETED|Overall Study||0
133174|NCT00268463|319633|P2|STARTED|Overall Study||12
133175|NCT00268463|319634|P1|STARTED|Overall Study||10
133176|NCT00268762|319640|P1|NOT COMPLETED|Overall Study||0
133177|NCT00268762|319640|P1|COMPLETED|Overall Study||65
133178|NCT00268762|319640|P1|STARTED|Overall Study||65
133179|NCT00268892|319649|P3|NOT COMPLETED|Overall Study||39
133180|NCT00268892|319650|P2|NOT COMPLETED|Overall Study||42
133181|NCT00268892|319651|P1|NOT COMPLETED|Overall Study||39
133182|NCT00268892|319649|P3|COMPLETED|Overall Study||54
133183|NCT00268892|319650|P2|COMPLETED|Overall Study||53
133184|NCT00268892|319651|P1|COMPLETED|Overall Study||51
133185|NCT00268892|319649|P3|Switched to Higher Dose|Overall Study||76
133186|NCT00268892|319650|P2|Switched to Higher Dose|Overall Study||68
133187|NCT00268892|319651|P1|Switched to Higher Dose|Overall Study||59
133188|NCT00268892|319649|P3|STARTED|Overall Study||93
133189|NCT00268892|319650|P2|STARTED|Overall Study||95
133190|NCT00268892|319651|P1|STARTED|Overall Study||90
133191|NCT00268905|319665|P3|NOT COMPLETED|Overall Study||12
133192|NCT00268905|319666|P2|NOT COMPLETED|Overall Study||9
133193|NCT00268905|319667|P1|NOT COMPLETED|Overall Study||43
133194|NCT00268905|319665|P3|COMPLETED|Overall Study||0
133195|NCT00268905|319666|P2|COMPLETED|Overall Study||0
133196|NCT00268905|319667|P1|COMPLETED|Overall Study||0
133197|NCT00268905|319665|P3|STARTED|Overall Study||12
133198|NCT00268905|319666|P2|STARTED|Overall Study||9
133199|NCT00268905|319667|P1|STARTED|Overall Study||43
133200|NCT00268983|319683|P2|NOT COMPLETED|Overall Study||0
133201|NCT00268983|319684|P1|NOT COMPLETED|Overall Study||3
133202|NCT00268983|319683|P2|COMPLETED|Overall Study||8
133203|NCT00268983|319684|P1|COMPLETED|Overall Study||3
133204|NCT00268983|319683|P2|STARTED|Overall Study||8
133205|NCT00268983|319684|P1|STARTED|Overall Study||6
133206|NCT00269113|319726|P2|NOT COMPLETED|Overall Study||37
133207|NCT00269113|319727|P1|NOT COMPLETED|Overall Study||74
133208|NCT00269113|319726|P2|COMPLETED|Overall Study||146
133209|NCT00269113|319727|P1|COMPLETED|Overall Study||103
133210|NCT00269113|319726|P2|STARTED|Overall Study||183
133211|NCT00269113|319727|P1|STARTED|Overall Study||177
133212|NCT00269152|319747|P2|NOT COMPLETED|Overall Study||10
133213|NCT00269152|319748|P1|NOT COMPLETED|Overall Study||18
133214|NCT00269152|319747|P2|COMPLETED|Overall Study||49
133215|NCT00269152|319748|P1|COMPLETED|Overall Study||45
133216|NCT00269152|319747|P2|STARTED|Overall Study|4 were randomized without receiving any study drug.|59
133217|NCT00269152|319748|P1|STARTED|Overall Study|One participant in Pemetrexed+Carboplatin actually received Pemetrexed+Cisplatin|63
133218|NCT00269477|319766|P4|NOT COMPLETED|Overall Study||0
133219|NCT00269477|319767|P3|NOT COMPLETED|Overall Study||1
133220|NCT00269477|319768|P2|NOT COMPLETED|Overall Study||6
133221|NCT00269477|319769|P1|NOT COMPLETED|Overall Study||5
133222|NCT00269477|319766|P4|COMPLETED|Overall Study||60
133223|NCT00269477|319767|P3|COMPLETED|Overall Study||57
133224|NCT00269477|319768|P2|COMPLETED|Overall Study||12
133225|NCT00269477|319769|P1|COMPLETED|Overall Study||4
133226|NCT00269477|319766|P4|STARTED|Overall Study||60
133227|NCT00269477|319767|P3|STARTED|Overall Study||58
133228|NCT00269477|319768|P2|STARTED|Overall Study||18
133229|NCT00269477|319769|P1|STARTED|Overall Study||9
133230|NCT00260195|319785|P2|NOT COMPLETED|Overall Study||0
133231|NCT00260195|319786|P1|NOT COMPLETED|Overall Study||0
133232|NCT00260195|319785|P2|COMPLETED|Overall Study||37
133233|NCT00260195|319786|P1|COMPLETED|Overall Study||39
133234|NCT00260195|319785|P2|STARTED|Overall Study||37
133235|NCT00260195|319786|P1|STARTED|Overall Study||39
133236|NCT00260208|319800|P2|NOT COMPLETED|Overall Study||34
133237|NCT00260208|319801|P1|NOT COMPLETED|Overall Study||47
133238|NCT00260208|319800|P2|COMPLETED|Overall Study||138
133239|NCT00260208|319801|P1|COMPLETED|Overall Study||137
133240|NCT00260208|319800|P2|Modified ITT|Overall Study||96
133241|NCT00260208|319801|P1|Modified ITT|Overall Study||101
133242|NCT00260208|319800|P2|Intent to Treat (ITT) Population|Overall Study||169
133243|NCT00260208|319801|P1|Intent to Treat (ITT) Population|Overall Study||182
133244|NCT00260208|319800|P2|STARTED|Overall Study||172
133245|NCT00260208|319801|P1|STARTED|Overall Study|"Started indicates safety population."|184
133246|NCT00260429|319831|P2|NOT COMPLETED|Overall Study||0
133247|NCT00260429|319832|P1|NOT COMPLETED|Overall Study||2
133248|NCT00260429|319831|P2|COMPLETED|Overall Study||12
133249|NCT00260429|319832|P1|COMPLETED|Overall Study||21
133250|NCT00260429|319831|P2|STARTED|Overall Study||12
133251|NCT00260429|319832|P1|STARTED|Overall Study||23
133252|NCT00260533|319840|P2|NOT COMPLETED|Overall Study||3
133253|NCT00260533|319841|P1|NOT COMPLETED|Overall Study||3
133254|NCT00260533|319840|P2|COMPLETED|Overall Study||10
133255|NCT00260533|319841|P1|COMPLETED|Overall Study||11
133256|NCT00260533|319840|P2|STARTED|Overall Study||13
133257|NCT00260533|319841|P1|STARTED|Overall Study||14
133258|NCT00260689|319850|P3|NOT COMPLETED|Overall Study||15
133259|NCT00260689|319851|P2|NOT COMPLETED|Overall Study||49
133260|NCT00260689|319852|P1|NOT COMPLETED|Overall Study||41
133261|NCT00260689|319850|P3|COMPLETED|Overall Study||1
133262|NCT00260689|319851|P2|COMPLETED|Overall Study||11
133263|NCT00260689|319852|P1|COMPLETED|Overall Study||19
133264|NCT00260689|319850|P3|STARTED|Overall Study||16
133265|NCT00260689|319851|P2|STARTED|Overall Study||60
133266|NCT00260689|319852|P1|STARTED|Overall Study||60
133267|NCT00260832|319868|P2|NOT COMPLETED|Overall Study||211
133268|NCT00260832|319869|P1|NOT COMPLETED|Overall Study||228
133350|NCT00261846|320380|P7|NOT COMPLETED|Period 2: Part 2 (Efficacy)||22
133269|NCT00260832|319868|P2|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|31
133270|NCT00260832|319869|P1|COMPLETED|Overall Study|At study completion, these subjects chose to remain on treatment|15
133271|NCT00260832|319868|P2|STARTED|Overall Study||242
133272|NCT00260832|319869|P1|STARTED|Overall Study||243
133273|NCT00260962|319877|P2|NOT COMPLETED|Overall Study||2
133274|NCT00260962|319878|P1|NOT COMPLETED|Overall Study||4
133275|NCT00260962|319877|P2|COMPLETED|Overall Study||14
133276|NCT00260962|319878|P1|COMPLETED|Overall Study||14
133277|NCT00260962|319877|P2|STARTED|Overall Study||16
133278|NCT00260962|319878|P1|STARTED|Overall Study||18
133279|NCT00261443|319888|P3|NOT COMPLETED|4: Extension Phase||2
133280|NCT00261443|319889|P2|NOT COMPLETED|4: Extension Phase||3
133281|NCT00261443|319890|P1|NOT COMPLETED|4: Extension Phase||0
133282|NCT00261443|319888|P3|COMPLETED|4: Extension Phase||21
133283|NCT00261443|319889|P2|COMPLETED|4: Extension Phase||16
133284|NCT00261443|319890|P1|COMPLETED|4: Extension Phase||0
133285|NCT00261443|319888|P3|STARTED|4: Extension Phase||23
133286|NCT00261443|319889|P2|STARTED|4: Extension Phase||19
133287|NCT00261443|319890|P1|STARTED|4: Extension Phase||0
133288|NCT00261443|319888|P3|NOT COMPLETED|3: Assessment of Relapse||65
133289|NCT00261443|319889|P2|NOT COMPLETED|3: Assessment of Relapse||80
133290|NCT00261443|319890|P1|NOT COMPLETED|3: Assessment of Relapse||0
133291|NCT00261443|319888|P3|COMPLETED|3: Assessment of Relapse||103
133292|NCT00261443|319889|P2|COMPLETED|3: Assessment of Relapse||89
133293|NCT00261443|319890|P1|COMPLETED|3: Assessment of Relapse||0
133294|NCT00261443|319888|P3|STARTED|3: Assessment of Relapse||168
133295|NCT00261443|319889|P2|STARTED|3: Assessment of Relapse||169
133296|NCT00261443|319890|P1|STARTED|3: Assessment of Relapse||0
133297|NCT00261443|319888|P3|NOT COMPLETED|2: Stability & Maintenance of Stability||0
133298|NCT00261443|319889|P2|NOT COMPLETED|2: Stability & Maintenance of Stability||0
133299|NCT00261443|319890|P1|NOT COMPLETED|2: Stability & Maintenance of Stability||340
133300|NCT00261443|319888|P3|COMPLETED|2: Stability & Maintenance of Stability||0
133301|NCT00261443|319889|P2|COMPLETED|2: Stability & Maintenance of Stability||0
133302|NCT00261443|319890|P1|COMPLETED|2: Stability & Maintenance of Stability||346
133303|NCT00261443|319888|P3|STARTED|2: Stability & Maintenance of Stability||0
133304|NCT00261443|319889|P2|STARTED|2: Stability & Maintenance of Stability||0
133305|NCT00261443|319890|P1|STARTED|2: Stability & Maintenance of Stability||686
133306|NCT00261443|319888|P3|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
133307|NCT00261443|319889|P2|NOT COMPLETED|1: Confirmation of Partial Nonresponse||0
133308|NCT00261443|319890|P1|NOT COMPLETED|1: Confirmation of Partial Nonresponse||584
133309|NCT00261443|319888|P3|COMPLETED|1: Confirmation of Partial Nonresponse||0
133310|NCT00261443|319889|P2|COMPLETED|1: Confirmation of Partial Nonresponse||0
133311|NCT00261443|319890|P1|COMPLETED|1: Confirmation of Partial Nonresponse||686
133312|NCT00261443|319888|P3|STARTED|1: Confirmation of Partial Nonresponse||0
133313|NCT00261443|319889|P2|STARTED|1: Confirmation of Partial Nonresponse||0
133314|NCT00261443|319890|P1|STARTED|1: Confirmation of Partial Nonresponse||1270
133315|NCT00261495|320147|P2|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||5
133316|NCT00261495|320148|P1|NOT COMPLETED|Extension Phase (Weeks 24 to 52)||10
133317|NCT00261495|320147|P2|COMPLETED|Extension Phase (Weeks 24 to 52)||47
133318|NCT00261495|320148|P1|COMPLETED|Extension Phase (Weeks 24 to 52)||50
133319|NCT00261495|320147|P2|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (85 subjects).|52
133320|NCT00261495|320148|P1|STARTED|Extension Phase (Weeks 24 to 52)|Number started is different to number completed maintenance phase owing to drop outs (80 subjects).|60
133321|NCT00261495|320147|P2|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||48
133322|NCT00261495|320148|P1|NOT COMPLETED|Maintenance Phase (Weeks 4 to 24)||66
133323|NCT00261495|320147|P2|COMPLETED|Maintenance Phase (Weeks 4 to 24)||137
133324|NCT00261495|320148|P1|COMPLETED|Maintenance Phase (Weeks 4 to 24)||140
133325|NCT00261495|320147|P2|STARTED|Maintenance Phase (Weeks 4 to 24)||185
133326|NCT00261495|320148|P1|STARTED|Maintenance Phase (Weeks 4 to 24)||206
133327|NCT00261495|320147|P2|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||65
133328|NCT00261495|320148|P1|NOT COMPLETED|Titration Phase (Weeks 0 to 4)||48
133329|NCT00261495|320147|P2|COMPLETED|Titration Phase (Weeks 0 to 4)||185
133330|NCT00261495|320148|P1|COMPLETED|Titration Phase (Weeks 0 to 4)||206
133331|NCT00261495|320147|P2|STARTED|Titration Phase (Weeks 0 to 4)||250
133332|NCT00261495|320148|P1|STARTED|Titration Phase (Weeks 0 to 4)||254
133333|NCT00261716|320312|P2|NOT COMPLETED|Overall Study||10
133334|NCT00261716|320313|P1|NOT COMPLETED|Overall Study||6
133335|NCT00261716|320312|P2|COMPLETED|Overall Study||11
133336|NCT00261716|320313|P1|COMPLETED|Overall Study||11
133337|NCT00261716|320312|P2|STARTED|Overall Study||21
133338|NCT00261716|320313|P1|STARTED|Overall Study||17
133339|NCT00261833|320333|P2|NOT COMPLETED|Overall Study||18
133340|NCT00261833|320334|P1|NOT COMPLETED|Overall Study||9
133341|NCT00261833|320333|P2|COMPLETED|Overall Study||69
133342|NCT00261833|320334|P1|COMPLETED|Overall Study||84
133343|NCT00261833|320333|P2|STARTED|Overall Study||87
133344|NCT00261833|320334|P1|STARTED|Overall Study||93
133345|NCT00261846|320375|P12|NOT COMPLETED|Period 2: Part 2 (Efficacy)||23
133346|NCT00261846|320376|P11|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
133347|NCT00261846|320377|P10|NOT COMPLETED|Period 2: Part 2 (Efficacy)||49
133348|NCT00261846|320378|P9|NOT COMPLETED|Period 2: Part 2 (Efficacy)||14
133349|NCT00261846|320379|P8|NOT COMPLETED|Period 2: Part 2 (Efficacy)||29
133351|NCT00261846|320381|P6|NOT COMPLETED|Period 2: Part 2 (Efficacy)||2
133352|NCT00261846|320382|P5|NOT COMPLETED|Period 2: Part 2 (Efficacy)||50
133353|NCT00261846|320383|P4|NOT COMPLETED|Period 2: Part 2 (Efficacy)||135
133354|NCT00261846|320384|P3|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
133355|NCT00261846|320385|P2|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
133356|NCT00261846|320386|P1|NOT COMPLETED|Period 2: Part 2 (Efficacy)||0
133357|NCT00261846|320375|P12|COMPLETED|Period 2: Part 2 (Efficacy)||1
133358|NCT00261846|320376|P11|COMPLETED|Period 2: Part 2 (Efficacy)||15
133359|NCT00261846|320377|P10|COMPLETED|Period 2: Part 2 (Efficacy)||30
133360|NCT00261846|320378|P9|COMPLETED|Period 2: Part 2 (Efficacy)||12
133361|NCT00261846|320379|P8|COMPLETED|Period 2: Part 2 (Efficacy)||21
133362|NCT00261846|320380|P7|COMPLETED|Period 2: Part 2 (Efficacy)||16
133363|NCT00261846|320381|P6|COMPLETED|Period 2: Part 2 (Efficacy)||3
133364|NCT00261846|320382|P5|COMPLETED|Period 2: Part 2 (Efficacy)||39
133365|NCT00261846|320383|P4|COMPLETED|Period 2: Part 2 (Efficacy)||60
133366|NCT00261846|320384|P3|COMPLETED|Period 2: Part 2 (Efficacy)||0
133367|NCT00261846|320385|P2|COMPLETED|Period 2: Part 2 (Efficacy)||0
133368|NCT00261846|320386|P1|COMPLETED|Period 2: Part 2 (Efficacy)||0
133369|NCT00261846|320375|P12|STARTED|Period 2: Part 2 (Efficacy)||24
133370|NCT00261846|320376|P11|STARTED|Period 2: Part 2 (Efficacy)||64
133371|NCT00261846|320377|P10|STARTED|Period 2: Part 2 (Efficacy)|1 participant from Part 1 (Bosutinib 600mg cohort) continued in Part 2 of the study.|79
133372|NCT00261846|320378|P9|STARTED|Period 2: Part 2 (Efficacy)||26
133373|NCT00261846|320379|P8|STARTED|Period 2: Part 2 (Efficacy)||50
133374|NCT00261846|320380|P7|STARTED|Period 2: Part 2 (Efficacy)||38
133375|NCT00261846|320381|P6|STARTED|Period 2: Part 2 (Efficacy)||5
133376|NCT00261846|320382|P5|STARTED|Period 2: Part 2 (Efficacy)||89
133377|NCT00261846|320383|P4|STARTED|Period 2: Part 2 (Efficacy)|17 participants from Part 1 (Bosutinib 400mg, 500mg, 600mg cohort) continued in Part 2 of the study.|195
133378|NCT00261846|320384|P3|STARTED|Period 2: Part 2 (Efficacy)||0
133379|NCT00261846|320385|P2|STARTED|Period 2: Part 2 (Efficacy)||0
133380|NCT00261846|320386|P1|STARTED|Period 2: Part 2 (Efficacy)||0
133381|NCT00261846|320375|P12|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133382|NCT00261846|320376|P11|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133383|NCT00261846|320377|P10|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133384|NCT00261846|320378|P9|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133385|NCT00261846|320379|P8|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133386|NCT00261846|320380|P7|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133387|NCT00261846|320381|P6|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133478|NCT00262067|320868|P3|NOT COMPLETED|Overall Study||216
133388|NCT00261846|320382|P5|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133389|NCT00261846|320383|P4|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133390|NCT00261846|320384|P3|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||12
133391|NCT00261846|320385|P2|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
133392|NCT00261846|320386|P1|NOT COMPLETED|Period 1: Part 1 (Dose Escalation)||3
133393|NCT00261846|320375|P12|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133394|NCT00261846|320376|P11|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133395|NCT00261846|320377|P10|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133396|NCT00261846|320378|P9|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133397|NCT00261846|320379|P8|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133398|NCT00261846|320380|P7|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133399|NCT00261846|320381|P6|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133400|NCT00261846|320382|P5|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133401|NCT00261846|320383|P4|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133402|NCT00261846|320384|P3|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133403|NCT00261846|320385|P2|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133404|NCT00261846|320386|P1|COMPLETED|Period 1: Part 1 (Dose Escalation)||0
133405|NCT00261846|320375|P12|STARTED|Period 1: Part 1 (Dose Escalation)||0
133406|NCT00261846|320376|P11|STARTED|Period 1: Part 1 (Dose Escalation)||0
133407|NCT00261846|320377|P10|STARTED|Period 1: Part 1 (Dose Escalation)||0
133408|NCT00261846|320378|P9|STARTED|Period 1: Part 1 (Dose Escalation)||0
133409|NCT00261846|320379|P8|STARTED|Period 1: Part 1 (Dose Escalation)||0
133410|NCT00261846|320380|P7|STARTED|Period 1: Part 1 (Dose Escalation)||0
133411|NCT00261846|320381|P6|STARTED|Period 1: Part 1 (Dose Escalation)||0
133412|NCT00261846|320382|P5|STARTED|Period 1: Part 1 (Dose Escalation)||0
133413|NCT00261846|320383|P4|STARTED|Period 1: Part 1 (Dose Escalation)||0
133414|NCT00261846|320384|P3|STARTED|Period 1: Part 1 (Dose Escalation)||12
133415|NCT00261846|320385|P2|STARTED|Period 1: Part 1 (Dose Escalation)||3
133416|NCT00261846|320386|P1|STARTED|Period 1: Part 1 (Dose Escalation)||3
133417|NCT00261950|320643|P1|NOT COMPLETED|Overall Study||26
133418|NCT00261950|320643|P1|COMPLETED|Overall Study||84
133419|NCT00261950|320643|P1|STARTED|Overall Study||110
133420|NCT00262002|320666|P7|NOT COMPLETED|Overall Study||6
133421|NCT00262002|320667|P6|NOT COMPLETED|Overall Study||7
133422|NCT00262002|320668|P5|NOT COMPLETED|Overall Study||7
133423|NCT00262002|320669|P4|NOT COMPLETED|Overall Study||5
133424|NCT00262002|320670|P3|NOT COMPLETED|Overall Study||0
133425|NCT00262002|320671|P2|NOT COMPLETED|Overall Study||6
133426|NCT00262002|320672|P1|NOT COMPLETED|Overall Study||11
133427|NCT00262002|320666|P7|COMPLETED|Overall Study||84
133428|NCT00262002|320667|P6|COMPLETED|Overall Study||83
133429|NCT00262002|320668|P5|COMPLETED|Overall Study||91
133430|NCT00262002|320669|P4|COMPLETED|Overall Study||93
133431|NCT00262002|320670|P3|COMPLETED|Overall Study||45
133432|NCT00262002|320671|P2|COMPLETED|Overall Study||84
133433|NCT00262002|320672|P1|COMPLETED|Overall Study||79
133434|NCT00262002|320666|P7|STARTED|Overall Study||90
133435|NCT00262002|320667|P6|STARTED|Overall Study||90
133436|NCT00262002|320668|P5|STARTED|Overall Study||98
133437|NCT00262002|320669|P4|STARTED|Overall Study||98
133438|NCT00262002|320670|P3|STARTED|Overall Study||45
133439|NCT00262002|320671|P2|STARTED|Overall Study||90
133440|NCT00262002|320672|P1|STARTED|Overall Study||90
133441|NCT00262028|320774|P9|NOT COMPLETED|Overall Study||19
133442|NCT00262028|320775|P8|NOT COMPLETED|Overall Study||18
133443|NCT00262028|320776|P7|NOT COMPLETED|Overall Study||12
133444|NCT00262028|320777|P6|NOT COMPLETED|Overall Study||13
133445|NCT00262028|320778|P5|NOT COMPLETED|Overall Study||12
133446|NCT00262028|320779|P4|NOT COMPLETED|Overall Study||23
133447|NCT00262028|320780|P3|NOT COMPLETED|Overall Study||20
133448|NCT00262028|320781|P2|NOT COMPLETED|Overall Study||27
133449|NCT00262028|320782|P1|NOT COMPLETED|Overall Study||24
133450|NCT00262028|320774|P9|COMPLETED|Overall Study||81
133451|NCT00262028|320775|P8|COMPLETED|Overall Study||55
133452|NCT00262028|320776|P7|COMPLETED|Overall Study||59
133453|NCT00262028|320777|P6|COMPLETED|Overall Study||60
133454|NCT00262028|320778|P5|COMPLETED|Overall Study||62
133455|NCT00262028|320779|P4|COMPLETED|Overall Study||134
133456|NCT00262028|320780|P3|COMPLETED|Overall Study||137
133457|NCT00262028|320781|P2|COMPLETED|Overall Study||126
133458|NCT00262028|320782|P1|COMPLETED|Overall Study||128
133459|NCT00262028|320774|P9|STARTED|Overall Study||100
133460|NCT00262028|320775|P8|STARTED|Overall Study||73
133461|NCT00262028|320776|P7|STARTED|Overall Study||71
133462|NCT00262028|320777|P6|STARTED|Overall Study||73
133463|NCT00262028|320778|P5|STARTED|Overall Study||74
133464|NCT00262028|320779|P4|STARTED|Overall Study||157
133465|NCT00262028|320780|P3|STARTED|Overall Study||157
133466|NCT00262028|320781|P2|STARTED|Overall Study||153
133467|NCT00262028|320782|P1|STARTED|Overall Study||152
133468|NCT00262041|320841|P3|NOT COMPLETED|Overall Study||6
133469|NCT00262041|320842|P2|NOT COMPLETED|Overall Study||4
133470|NCT00262041|320843|P1|NOT COMPLETED|Overall Study||2
133471|NCT00262041|320841|P3|COMPLETED|Overall Study||203
133472|NCT00262041|320842|P2|COMPLETED|Overall Study||147
133473|NCT00262041|320843|P1|COMPLETED|Overall Study||162
133474|NCT00262041|320841|P3|STARTED|Overall Study||209
133475|NCT00262041|320842|P2|STARTED|Overall Study||151
133476|NCT00262041|320843|P1|STARTED|Overall Study||164
133477|NCT00262067|320867|P4|NOT COMPLETED|Overall Study||113
133479|NCT00262067|320869|P2|NOT COMPLETED|Overall Study||100
133480|NCT00262067|320870|P1|NOT COMPLETED|Overall Study||219
133481|NCT00262067|320867|P4|COMPLETED|Overall Study||93
133482|NCT00262067|320868|P3|COMPLETED|Overall Study||193
133483|NCT00262067|320869|P2|COMPLETED|Overall Study||107
133484|NCT00262067|320870|P1|COMPLETED|Overall Study||196
133485|NCT00262067|320867|P4|STARTED|Overall Study||206
133486|NCT00262067|320868|P3|STARTED|Overall Study||409
133487|NCT00262067|320869|P2|STARTED|Overall Study||207
133488|NCT00262067|320870|P1|STARTED|Overall Study||415
133489|NCT00262080|320903|P3|NOT COMPLETED|Repeat Dose Treatment Period||5
133490|NCT00262080|320904|P2|NOT COMPLETED|Repeat Dose Treatment Period||1
133491|NCT00262080|320905|P1|NOT COMPLETED|Repeat Dose Treatment Period||4
133492|NCT00262080|320903|P3|COMPLETED|Repeat Dose Treatment Period||14
133493|NCT00262080|320904|P2|COMPLETED|Repeat Dose Treatment Period||25
133494|NCT00262080|320905|P1|COMPLETED|Repeat Dose Treatment Period|Some patients participated in only the double-blind or the open label phase.|18
133495|NCT00262080|320903|P3|STARTED|Repeat Dose Treatment Period|This arm represents new patients, not treated in the double-blind part of the study.|19
133496|NCT00262080|320904|P2|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|26
133497|NCT00262080|320905|P1|STARTED|Repeat Dose Treatment Period|Not all patients treated in the double-blind part came for treatment in the repeat-dose part.|22
133498|NCT00262080|320903|P3|NOT COMPLETED|Double Blind Treatment Period||0
133499|NCT00262080|320904|P2|NOT COMPLETED|Double Blind Treatment Period||0
133500|NCT00262080|320905|P1|NOT COMPLETED|Double Blind Treatment Period||1
133501|NCT00262080|320903|P3|COMPLETED|Double Blind Treatment Period||0
133502|NCT00262080|320904|P2|COMPLETED|Double Blind Treatment Period||36
133503|NCT00262080|320905|P1|COMPLETED|Double Blind Treatment Period||35
133504|NCT00262080|320903|P3|STARTED|Double Blind Treatment Period||0
133505|NCT00262080|320904|P2|STARTED|Double Blind Treatment Period|One patient was randomized to receive placebo but was treated with ecallantide.|36
133506|NCT00262080|320905|P1|STARTED|Double Blind Treatment Period|One patient was randomized to receive ecallantide but was treated with placebo.|36
133507|NCT00262119|320924|P3|NOT COMPLETED|Overall Study||58
133508|NCT00262119|320925|P2|NOT COMPLETED|Overall Study||70
133509|NCT00262119|320926|P1|NOT COMPLETED|Overall Study||58
133510|NCT00262119|320924|P3|COMPLETED|Overall Study||325
133511|NCT00262119|320925|P2|COMPLETED|Overall Study||328
133512|NCT00262119|320926|P1|COMPLETED|Overall Study||327
133513|NCT00262119|320924|P3|STARTED|Overall Study||383
133514|NCT00262119|320925|P2|STARTED|Overall Study||398
133515|NCT00262119|320926|P1|STARTED|Overall Study||385
133516|NCT00262223|320945|P2|NOT COMPLETED|12-month Post-treatment Follow-up||7
133517|NCT00262223|320946|P1|NOT COMPLETED|12-month Post-treatment Follow-up||7
133518|NCT00262223|320945|P2|COMPLETED|12-month Post-treatment Follow-up||22
133519|NCT00262223|320946|P1|COMPLETED|12-month Post-treatment Follow-up||21
133520|NCT00262223|320945|P2|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
133521|NCT00262223|320946|P1|STARTED|12-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
133522|NCT00262223|320945|P2|NOT COMPLETED|6-month Post-treatment Follow-up||1
133523|NCT00262223|320946|P1|NOT COMPLETED|6-month Post-treatment Follow-up||6
133524|NCT00262223|320945|P2|COMPLETED|6-month Post-treatment Follow-up||28
133525|NCT00262223|320946|P1|COMPLETED|6-month Post-treatment Follow-up||22
133526|NCT00262223|320945|P2|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|29
133527|NCT00262223|320946|P1|STARTED|6-month Post-treatment Follow-up|Subjects were included in subsequent follow-ups even if lost to contact during previous follow-up.|28
133528|NCT00262223|320945|P2|NOT COMPLETED|1-week Post-treatment Follow-up||4
133529|NCT00262223|320946|P1|NOT COMPLETED|1-week Post-treatment Follow-up||4
133530|NCT00262223|320945|P2|COMPLETED|1-week Post-treatment Follow-up||25
133531|NCT00262223|320946|P1|COMPLETED|1-week Post-treatment Follow-up||24
133532|NCT00262223|320945|P2|STARTED|1-week Post-treatment Follow-up||29
133533|NCT00262223|320946|P1|STARTED|1-week Post-treatment Follow-up||28
133534|NCT00262223|320945|P2|NOT COMPLETED|Treatment Phase||8
133535|NCT00262223|320946|P1|NOT COMPLETED|Treatment Phase||4
133536|NCT00262223|320945|P2|COMPLETED|Treatment Phase||29
133537|NCT00262223|320946|P1|COMPLETED|Treatment Phase||28
133538|NCT00262223|320945|P2|STARTED|Treatment Phase||37
133539|NCT00262223|320946|P1|STARTED|Treatment Phase||32
133540|NCT00262301|320957|P3|NOT COMPLETED|Open-label Phase||0
133541|NCT00262301|320958|P2|NOT COMPLETED|Open-label Phase||0
133542|NCT00262301|320959|P1|NOT COMPLETED|Open-label Phase||0
133543|NCT00262301|320957|P3|COMPLETED|Open-label Phase||57
133544|NCT00262301|320958|P2|COMPLETED|Open-label Phase||0
133545|NCT00262301|320959|P1|COMPLETED|Open-label Phase||0
133546|NCT00262301|320957|P3|STARTED|Open-label Phase|"14/57 patients crossed over from the double-blind phase (7/14 were treated with 100 U/kg rhC1INH)"|57
133547|NCT00262301|320958|P2|STARTED|Open-label Phase||0
133548|NCT00262301|320959|P1|STARTED|Open-label Phase||0
133549|NCT00262301|320957|P3|NOT COMPLETED|Double-blind Phase||0
133550|NCT00262301|320958|P2|NOT COMPLETED|Double-blind Phase||1
133551|NCT00262301|320959|P1|NOT COMPLETED|Double-blind Phase||1
133552|NCT00262301|320957|P3|COMPLETED|Double-blind Phase||0
133553|NCT00262301|320958|P2|COMPLETED|Double-blind Phase||15
133554|NCT00262301|320959|P1|COMPLETED|Double-blind Phase||15
133555|NCT00262301|320957|P3|STARTED|Double-blind Phase||0
133556|NCT00262301|320958|P2|STARTED|Double-blind Phase||16
133557|NCT00262301|320959|P1|STARTED|Double-blind Phase||16
133558|NCT00262314|320970|P1|NOT COMPLETED|Overall Study||337
133559|NCT00262314|320970|P1|COMPLETED|Overall Study|Patients in the study for 5 years +/-3 months are considered to have completed the 5-year study|172
133560|NCT00262314|320970|P1|STARTED|Overall Study|Patients with validated data who received at least 1 dose of Novantrone®|509
133561|NCT00262509|320987|P2|NOT COMPLETED|Overall Study||0
133562|NCT00262509|320988|P1|NOT COMPLETED|Overall Study||0
133563|NCT00262509|320987|P2|COMPLETED|Overall Study||9
133564|NCT00262509|320988|P1|COMPLETED|Overall Study||8
133565|NCT00262509|320987|P2|STARTED|Overall Study||9
133566|NCT00262509|320988|P1|STARTED|Overall Study||8
133567|NCT00262522|320998|P4|NOT COMPLETED|Study Start Through 96 Weeks||0
133568|NCT00262522|320999|P3|NOT COMPLETED|Study Start Through 96 Weeks||77
133569|NCT00262522|321000|P2|NOT COMPLETED|Study Start Through 96 Weeks||0
133570|NCT00262522|321001|P1|NOT COMPLETED|Study Start Through 96 Weeks||77
133571|NCT00262522|320998|P4|COMPLETED|Study Start Through 96 Weeks||0
133572|NCT00262522|320999|P3|COMPLETED|Study Start Through 96 Weeks||254
133573|NCT00262522|321000|P2|COMPLETED|Study Start Through 96 Weeks||0
133574|NCT00262522|321001|P1|COMPLETED|Study Start Through 96 Weeks||256
133575|NCT00262522|320998|P4|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
133576|NCT00262522|320999|P3|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|331
133577|NCT00262522|321000|P2|STARTED|Study Start Through 96 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
133578|NCT00262522|321001|P1|STARTED|Study Start Through 96 Weeks|Number of subjects who started the study, not the number who completed the first 48 weeks.|333
133579|NCT00262522|320998|P4|NOT COMPLETED|Study Start Through 48 Weeks||0
133580|NCT00262522|320999|P3|NOT COMPLETED|Study Start Through 48 Weeks||55
133581|NCT00262522|321000|P2|NOT COMPLETED|Study Start Through 48 Weeks||0
133582|NCT00262522|321001|P1|NOT COMPLETED|Study Start Through 48 Weeks||49
133583|NCT00262522|320998|P4|COMPLETED|Study Start Through 48 Weeks||0
133584|NCT00262522|320999|P3|COMPLETED|Study Start Through 48 Weeks||276
133585|NCT00262522|321000|P2|COMPLETED|Study Start Through 48 Weeks||0
133586|NCT00262522|321001|P1|COMPLETED|Study Start Through 48 Weeks||284
133587|NCT00262522|320998|P4|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation twice daily through the end of study.|0
133588|NCT00262522|320999|P3|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|331
133589|NCT00262522|321000|P2|STARTED|Study Start Through 48 Weeks|After Week 8, these subjects received the tablet formulation once daily through the end of study.|0
133670|NCT00272961|321294|P5|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
133590|NCT00262522|321001|P1|STARTED|Study Start Through 48 Weeks|Number of subjects who started the study, not the number who completed the first 8 weeks.|333
133591|NCT00262522|320998|P4|NOT COMPLETED|Study Start Through 8 Weeks||5
133592|NCT00262522|320999|P3|NOT COMPLETED|Study Start Through 8 Weeks||11
133593|NCT00262522|321000|P2|NOT COMPLETED|Study Start Through 8 Weeks||5
133594|NCT00262522|321001|P1|NOT COMPLETED|Study Start Through 8 Weeks||4
133595|NCT00262522|320998|P4|COMPLETED|Study Start Through 8 Weeks||160
133596|NCT00262522|320999|P3|COMPLETED|Study Start Through 8 Weeks||155
133597|NCT00262522|321000|P2|COMPLETED|Study Start Through 8 Weeks||161
133598|NCT00262522|321001|P1|COMPLETED|Study Start Through 8 Weeks||163
133599|NCT00262522|320998|P4|STARTED|Study Start Through 8 Weeks||165
133600|NCT00262522|320999|P3|STARTED|Study Start Through 8 Weeks||166
133601|NCT00262522|321000|P2|STARTED|Study Start Through 8 Weeks||166
133602|NCT00262522|321001|P1|STARTED|Study Start Through 8 Weeks||167
133603|NCT00262600|321024|P3|NOT COMPLETED|Overall Study||266
133604|NCT00262600|321025|P2|NOT COMPLETED|Overall Study||252
133605|NCT00262600|321026|P1|NOT COMPLETED|Overall Study||235
133606|NCT00262600|321024|P3|COMPLETED|Overall Study||5756
133607|NCT00262600|321025|P2|COMPLETED|Overall Study||5824
133608|NCT00262600|321026|P1|COMPLETED|Overall Study||5780
133609|NCT00262600|321024|P3|STARTED|Overall Study||6022
133610|NCT00262600|321025|P2|STARTED|Overall Study||6076
133611|NCT00262600|321026|P1|STARTED|Overall Study||6015
133612|NCT00262639|321053|P4|NOT COMPLETED|Overall Study||0
133613|NCT00262639|321054|P3|NOT COMPLETED|Overall Study||0
133614|NCT00262639|321055|P2|NOT COMPLETED|Overall Study||0
133615|NCT00262639|321056|P1|NOT COMPLETED|Overall Study||0
133616|NCT00262639|321053|P4|COMPLETED|Overall Study||7
133617|NCT00262639|321054|P3|COMPLETED|Overall Study||9
133618|NCT00262639|321055|P2|COMPLETED|Overall Study||26
133619|NCT00262639|321056|P1|COMPLETED|Overall Study||18
133620|NCT00262639|321053|P4|STARTED|Overall Study||7
133621|NCT00262639|321054|P3|STARTED|Overall Study||9
133622|NCT00262639|321055|P2|STARTED|Overall Study||26
133623|NCT00262639|321056|P1|STARTED|Overall Study||18
133624|NCT00269633|321072|P2|NOT COMPLETED|Overall Study||0
133625|NCT00269633|321073|P1|NOT COMPLETED|Overall Study||1
133626|NCT00269633|321072|P2|COMPLETED|Overall Study||5
133627|NCT00269633|321073|P1|COMPLETED|Overall Study||3
133628|NCT00269633|321072|P2|STARTED|Overall Study||5
133629|NCT00269633|321073|P1|STARTED|Overall Study||4
133630|NCT00269919|321079|P1|NOT COMPLETED|Overall Study||27
133631|NCT00269919|321079|P1|COMPLETED|Overall Study||13
133632|NCT00269919|321079|P1|Treated|Overall Study||39
133633|NCT00269919|321079|P1|STARTED|Overall Study||40
133634|NCT00272779|321098|P2|NOT COMPLETED|Baseline Through Week 96||136
133635|NCT00272779|321099|P1|NOT COMPLETED|Baseline Through Week 96||139
133636|NCT00272779|321098|P2|COMPLETED|Baseline Through Week 96||307
133637|NCT00272779|321099|P1|COMPLETED|Baseline Through Week 96||301
133638|NCT00272779|321098|P2|RECEIVED ANY TREATMENT|Baseline Through Week 96|3 participants received ATV instead of LPV (treatment error) and 3 participants never treated|437
133639|NCT00272779|321099|P1|RECEIVED ANY TREATMENT|Baseline Through Week 96|1 participant randomized to LPV received ATV instead (treatment error)|441
133640|NCT00272779|321098|P2|STARTED|Baseline Through Week 96|Number randomized to LPV|443
133641|NCT00272779|321099|P1|STARTED|Baseline Through Week 96|Number randomized to ATV|440
133642|NCT00272779|321098|P2|NOT COMPLETED|Baseline Through Week 48||443
133643|NCT00272779|321099|P1|NOT COMPLETED|Baseline Through Week 48||440
133644|NCT00272779|321098|P2|COMPLETED|Baseline Through Week 48||0
133645|NCT00272779|321099|P1|COMPLETED|Baseline Through Week 48||0
133646|NCT00272779|321098|P2|STILL ON TREATMENT|Baseline Through Week 48||368
133647|NCT00272779|321099|P1|STILL ON TREATMENT|Baseline Through Week 48||385
133648|NCT00272779|321098|P2|Discontinued on or After Week 48|Baseline Through Week 48||14
133649|NCT00272779|321099|P1|Discontinued on or After Week 48|Baseline Through Week 48||14
133650|NCT00272779|321098|P2|Discontinued Before Week 48|Baseline Through Week 48||58
133651|NCT00272779|321099|P1|Discontinued Before Week 48|Baseline Through Week 48||39
133652|NCT00272779|321098|P2|TREATED AS RANDOMIZED|Baseline Through Week 48||440
133653|NCT00272779|321099|P1|TREATED AS RANDOMIZED|Baseline Through Week 48||438
133654|NCT00272779|321098|P2|RECEIVED ANY TREATMENT|Baseline Through Week 48|3 participants received ATV instead of LPV (treatment error), 3 participants never treated with LPV|437
133655|NCT00272779|321099|P1|RECEIVED ANY TREATMENT|Baseline Through Week 48|1 participant randomized to LPV received ATV instead (treatment error)|441
133656|NCT00272779|321098|P2|STARTED|Baseline Through Week 48|Number of participants randomized to LPV|443
133657|NCT00272779|321099|P1|STARTED|Baseline Through Week 48|Number of participants randomized to ATV|440
133658|NCT00272792|321280|P2|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||3
133659|NCT00272792|321281|P1|NOT COMPLETED|Part 2: Blinded, Placebo Control Period||1
133660|NCT00272792|321280|P2|COMPLETED|Part 2: Blinded, Placebo Control Period||9
133661|NCT00272792|321281|P1|COMPLETED|Part 2: Blinded, Placebo Control Period||32
133662|NCT00272792|321280|P2|STARTED|Part 2: Blinded, Placebo Control Period||12
133663|NCT00272792|321281|P1|STARTED|Part 2: Blinded, Placebo Control Period||33
133664|NCT00272792|321280|P2|NOT COMPLETED|Part 1: Responsiveness||0
133665|NCT00272792|321281|P1|NOT COMPLETED|Part 1: Responsiveness||1
133666|NCT00272792|321280|P2|COMPLETED|Part 1: Responsiveness||0
133667|NCT00272792|321281|P1|COMPLETED|Part 1: Responsiveness||89
133668|NCT00272792|321280|P2|STARTED|Part 1: Responsiveness||0
133669|NCT00272792|321281|P1|STARTED|Part 1: Responsiveness||90
133671|NCT00272961|321295|P4|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||3
133672|NCT00272961|321296|P3|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
133673|NCT00272961|321297|P2|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
133674|NCT00272961|321298|P1|NOT COMPLETED|Treatment Phase: Week 3 Up to Week 12||2
133675|NCT00272961|321294|P5|COMPLETED|Treatment Phase: Week 3 Up to Week 12||6
133676|NCT00272961|321295|P4|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
133677|NCT00272961|321296|P3|COMPLETED|Treatment Phase: Week 3 Up to Week 12||7
133678|NCT00272961|321297|P2|COMPLETED|Treatment Phase: Week 3 Up to Week 12||4
133679|NCT00272961|321298|P1|COMPLETED|Treatment Phase: Week 3 Up to Week 12||8
133680|NCT00272961|321294|P5|STARTED|Treatment Phase: Week 3 Up to Week 12||10
133681|NCT00272961|321295|P4|STARTED|Treatment Phase: Week 3 Up to Week 12||10
133682|NCT00272961|321296|P3|STARTED|Treatment Phase: Week 3 Up to Week 12||11
133683|NCT00272961|321297|P2|STARTED|Treatment Phase: Week 3 Up to Week 12||8
133684|NCT00272961|321298|P1|STARTED|Treatment Phase: Week 3 Up to Week 12||10
133685|NCT00272961|321294|P5|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133686|NCT00272961|321295|P4|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133687|NCT00272961|321296|P3|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133688|NCT00272961|321297|P2|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133689|NCT00272961|321298|P1|NOT COMPLETED|Placebo Run-in Phase: Up to Week 2||11
133690|NCT00272961|321294|P5|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133691|NCT00272961|321295|P4|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133692|NCT00272961|321296|P3|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133693|NCT00272961|321297|P2|COMPLETED|Placebo Run-in Phase: Up to Week 2||0
133694|NCT00272961|321298|P1|COMPLETED|Placebo Run-in Phase: Up to Week 2||49
133695|NCT00272961|321294|P5|STARTED|Placebo Run-in Phase: Up to Week 2||0
133696|NCT00272961|321295|P4|STARTED|Placebo Run-in Phase: Up to Week 2||0
133697|NCT00272961|321296|P3|STARTED|Placebo Run-in Phase: Up to Week 2||0
133698|NCT00272961|321297|P2|STARTED|Placebo Run-in Phase: Up to Week 2||0
133699|NCT00272961|321298|P1|STARTED|Placebo Run-in Phase: Up to Week 2||60
133700|NCT00272987|321358|P3|NOT COMPLETED|Overall Study||19
133701|NCT00272987|321359|P2|NOT COMPLETED|Overall Study||14
133702|NCT00272987|321360|P1|NOT COMPLETED|Overall Study||21
133703|NCT00272987|321358|P3|COMPLETED|Overall Study||1
133704|NCT00272987|321359|P2|COMPLETED|Overall Study||0
133705|NCT00272987|321360|P1|COMPLETED|Overall Study||8
133706|NCT00272987|321358|P3|Ongoing|Overall Study||15
133707|NCT00272987|321359|P2|Ongoing|Overall Study||14
133708|NCT00272987|321360|P1|Ongoing|Overall Study||20
133709|NCT00272987|321358|P3|STARTED|Overall Study||20
133710|NCT00272987|321359|P2|STARTED|Overall Study||14
133711|NCT00272987|321360|P1|STARTED|Overall Study||29
133712|NCT00273052|321421|P2|NOT COMPLETED|Overall Study||88
133713|NCT00273052|321422|P1|NOT COMPLETED|Overall Study||69
133714|NCT00273052|321421|P2|COMPLETED|Overall Study||190
133715|NCT00273052|321422|P1|COMPLETED|Overall Study||221
133716|NCT00273052|321421|P2|STARTED|Overall Study||278
133717|NCT00273052|321422|P1|STARTED|Overall Study||290
133718|NCT00273182|321454|P1|NOT COMPLETED|Overall Study||985
133719|NCT00273182|321454|P1|COMPLETED|Overall Study||1014
133720|NCT00273182|321454|P1|STARTED|Overall Study||1999
133721|NCT00273754|321464|P2|NOT COMPLETED|Overall Study||0
133722|NCT00273754|321465|P1|NOT COMPLETED|Overall Study||0
133723|NCT00273754|321464|P2|COMPLETED|Overall Study||36
133724|NCT00273754|321465|P1|COMPLETED|Overall Study||36
133725|NCT00273754|321464|P2|STARTED|Overall Study||36
133726|NCT00273754|321465|P1|STARTED|Overall Study||36
133727|NCT00273793|321487|P6|NOT COMPLETED|Overall Study||0
133728|NCT00273793|321488|P5|NOT COMPLETED|Overall Study||0
133729|NCT00273793|321489|P4|NOT COMPLETED|Overall Study||0
133730|NCT00273793|321490|P3|NOT COMPLETED|Overall Study||0
133731|NCT00273793|321491|P2|NOT COMPLETED|Overall Study||0
133732|NCT00273793|321492|P1|NOT COMPLETED|Overall Study||0
133733|NCT00273793|321487|P6|COMPLETED|Overall Study||29
133734|NCT00273793|321488|P5|COMPLETED|Overall Study||58
133735|NCT00273793|321489|P4|COMPLETED|Overall Study||60
133736|NCT00273793|321490|P3|COMPLETED|Overall Study||18
133737|NCT00273793|321491|P2|COMPLETED|Overall Study||38
133738|NCT00273793|321492|P1|COMPLETED|Overall Study||36
133739|NCT00273793|321487|P6|STARTED|Overall Study||29
133740|NCT00273793|321488|P5|STARTED|Overall Study||58
133741|NCT00273793|321489|P4|STARTED|Overall Study||60
133742|NCT00273793|321490|P3|STARTED|Overall Study||18
133743|NCT00273793|321491|P2|STARTED|Overall Study||38
133744|NCT00273793|321492|P1|STARTED|Overall Study||36
133745|NCT00273858|321512|P1|NOT COMPLETED|Overall Study||537
133746|NCT00273858|321512|P1|COMPLETED|Overall Study||343
133747|NCT00273858|321512|P1|STARTED|Overall Study||880
133748|NCT00273910|321527|P6|NOT COMPLETED|Overall Study||0
133749|NCT00273910|321528|P5|NOT COMPLETED|Overall Study||0
133750|NCT00273910|321529|P4|NOT COMPLETED|Overall Study||0
133751|NCT00273910|321530|P3|NOT COMPLETED|Overall Study||0
133752|NCT00273910|321531|P2|NOT COMPLETED|Overall Study||0
133753|NCT00273910|321532|P1|NOT COMPLETED|Overall Study||0
133754|NCT00273910|321527|P6|COMPLETED|Overall Study||14
133755|NCT00273910|321528|P5|COMPLETED|Overall Study||15
133756|NCT00273910|321529|P4|COMPLETED|Overall Study||19
133757|NCT00273910|321530|P3|COMPLETED|Overall Study||18
133758|NCT00273910|321531|P2|COMPLETED|Overall Study||19
133759|NCT00273910|321532|P1|COMPLETED|Overall Study||19
133760|NCT00273910|321527|P6|STARTED|Overall Study||14
133761|NCT00273910|321528|P5|STARTED|Overall Study||15
133762|NCT00273910|321529|P4|STARTED|Overall Study||19
133763|NCT00273910|321530|P3|STARTED|Overall Study||18
133764|NCT00273910|321531|P2|STARTED|Overall Study||19
133765|NCT00273910|321532|P1|STARTED|Overall Study||19
133766|NCT00274261|321554|P2|NOT COMPLETED|Overall Study||337
133767|NCT00274261|321555|P1|NOT COMPLETED|Overall Study||489
133768|NCT00274261|321554|P2|COMPLETED|Overall Study||296
133769|NCT00274261|321555|P1|COMPLETED|Overall Study||443
133770|NCT00274261|321554|P2|STARTED|Overall Study||633
133771|NCT00274261|321555|P1|STARTED|Overall Study||932
133772|NCT00274287|321561|P1|NOT COMPLETED|Overall Study||2
133773|NCT00274287|321561|P1|COMPLETED|Overall Study||13
133774|NCT00274287|321561|P1|STARTED|Overall Study||15
133775|NCT00274456|321569|P4|NOT COMPLETED|Overall Study||45
133776|NCT00274456|321570|P3|NOT COMPLETED|Overall Study||35
133777|NCT00274456|321571|P2|NOT COMPLETED|Overall Study||27
133778|NCT00274456|321572|P1|NOT COMPLETED|Overall Study||37
133779|NCT00274456|321569|P4|COMPLETED|Overall Study|Treatment completed upon progressive disease|29
133780|NCT00274456|321570|P3|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
133781|NCT00274456|321571|P2|COMPLETED|Overall Study|Treatment completed upon progressive disease|49
133782|NCT00274456|321572|P1|COMPLETED|Overall Study|Treatment completed upon progressive disease|39
133783|NCT00274456|321569|P4|At Least One Response Assessment|Overall Study||70
133784|NCT00274456|321570|P3|At Least One Response Assessment|Overall Study||73
133785|NCT00274456|321571|P2|At Least One Response Assessment|Overall Study||76
133786|NCT00274456|321572|P1|At Least One Response Assessment|Overall Study||73
133787|NCT00274456|321569|P4|STARTED|Overall Study||74
133788|NCT00274456|321570|P3|STARTED|Overall Study||74
133789|NCT00274456|321571|P2|STARTED|Overall Study||76
133790|NCT00274456|321572|P1|STARTED|Overall Study||76
133791|NCT00274469|321616|P2|NOT COMPLETED|Overall Study||50
133792|NCT00274469|321617|P1|NOT COMPLETED|Overall Study||38
133793|NCT00274469|321616|P2|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|53
133794|NCT00274469|321617|P1|COMPLETED|Overall Study|Number of patients ongoing study treatment at data cut-off|64
133795|NCT00274469|321616|P2|STARTED|Overall Study|Number of patients randomized|103
133796|NCT00274469|321617|P1|STARTED|Overall Study|Number of patients randomized|102
133797|NCT00274625|321633|P2|NOT COMPLETED|Overall Study||62
133798|NCT00274625|321634|P1|NOT COMPLETED|Overall Study||60
133799|NCT00274625|321633|P2|COMPLETED|Overall Study||141
133800|NCT00274625|321634|P1|COMPLETED|Overall Study||139
133801|NCT00274625|321633|P2|STARTED|Overall Study||203
133802|NCT00274625|321634|P1|STARTED|Overall Study||199
133803|NCT00274651|321642|P2|NOT COMPLETED|Overall Study||20
133804|NCT00274651|321643|P1|NOT COMPLETED|Overall Study||28
133805|NCT00274651|321642|P2|COMPLETED|Overall Study||4
133806|NCT00274651|321643|P1|COMPLETED|Overall Study||1
133807|NCT00274651|321642|P2|STARTED|Overall Study||24
133808|NCT00274651|321643|P1|STARTED|Overall Study||29
133809|NCT00274716|321662|P6|NOT COMPLETED|Phase B||1
133810|NCT00274716|321663|P5|NOT COMPLETED|Phase B||0
133811|NCT00274716|321664|P4|NOT COMPLETED|Phase B||1
133812|NCT00274716|321665|P3|NOT COMPLETED|Phase B||3
133813|NCT00274716|321666|P2|NOT COMPLETED|Phase B||4
133814|NCT00274716|321667|P1|NOT COMPLETED|Phase B||1
133815|NCT00274716|321662|P6|COMPLETED|Phase B||14
133816|NCT00274716|321663|P5|COMPLETED|Phase B||16
133817|NCT00274716|321664|P4|COMPLETED|Phase B||41
133818|NCT00274716|321665|P3|COMPLETED|Phase B||41
133819|NCT00274716|321666|P2|COMPLETED|Phase B||40
133820|NCT00274716|321667|P1|COMPLETED|Phase B||42
133821|NCT00274716|321662|P6|STARTED|Phase B||15
133822|NCT00274716|321663|P5|STARTED|Phase B||16
133823|NCT00274716|321664|P4|STARTED|Phase B||42
133824|NCT00274716|321665|P3|STARTED|Phase B||44
133825|NCT00274716|321666|P2|STARTED|Phase B||44
133826|NCT00274716|321667|P1|STARTED|Phase B||43
133827|NCT00274716|321662|P6|NOT COMPLETED|Phase A||4
133828|NCT00274716|321663|P5|NOT COMPLETED|Phase A||3
133829|NCT00274716|321664|P4|NOT COMPLETED|Phase A||9
133830|NCT00274716|321665|P3|NOT COMPLETED|Phase A||8
133831|NCT00274716|321666|P2|NOT COMPLETED|Phase A||10
133832|NCT00274716|321667|P1|NOT COMPLETED|Phase A||11
133833|NCT00274716|321662|P6|COMPLETED|Phase A||15
133834|NCT00274716|321663|P5|COMPLETED|Phase A||16
133835|NCT00274716|321664|P4|COMPLETED|Phase A||42
133836|NCT00274716|321665|P3|COMPLETED|Phase A||44
133837|NCT00274716|321666|P2|COMPLETED|Phase A||44
133838|NCT00274716|321667|P1|COMPLETED|Phase A||43
133839|NCT00274716|321662|P6|STARTED|Phase A||19
133840|NCT00274716|321663|P5|STARTED|Phase A||19
133841|NCT00274716|321664|P4|STARTED|Phase A||51
133842|NCT00274716|321665|P3|STARTED|Phase A||52
133843|NCT00274716|321666|P2|STARTED|Phase A||54
133844|NCT00274716|321667|P1|STARTED|Phase A||54
133845|NCT00274742|321733|P6|NOT COMPLETED|Overall Study||3
133846|NCT00274742|321734|P5|NOT COMPLETED|Overall Study||16
133847|NCT00274742|321735|P4|NOT COMPLETED|Overall Study||5
133848|NCT00274742|321736|P3|NOT COMPLETED|Overall Study||2
133849|NCT00274742|321737|P2|NOT COMPLETED|Overall Study||8
133850|NCT00274742|321738|P1|NOT COMPLETED|Overall Study||0
133851|NCT00274742|321733|P6|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|1
133852|NCT00274742|321734|P5|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|16
133853|NCT00274742|321735|P4|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
133854|NCT00274742|321736|P3|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|4
133855|NCT00274742|321737|P2|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|5
133856|NCT00274742|321738|P1|COMPLETED|Overall Study|Participants completed the first treatment and 4-week follow-up.|12
133857|NCT00274742|321733|P6|STARTED|Overall Study||4
133858|NCT00274742|321734|P5|STARTED|Overall Study||32
133859|NCT00274742|321735|P4|STARTED|Overall Study||9
133860|NCT00274742|321736|P3|STARTED|Overall Study||6
133861|NCT00274742|321737|P2|STARTED|Overall Study||13
133862|NCT00274742|321738|P1|STARTED|Overall Study||12
133863|NCT00274768|321770|P1|NOT COMPLETED|Overall Study||0
133864|NCT00274768|321770|P1|COMPLETED|Overall Study||26
133865|NCT00274768|321770|P1|STARTED|Overall Study||26
133866|NCT00274781|321774|P1|NOT COMPLETED|Overall Study||0
133867|NCT00274781|321774|P1|COMPLETED|Overall Study||30
133868|NCT00274781|321774|P1|STARTED|Overall Study||30
133869|NCT00274846|321780|P1|NOT COMPLETED|Overall Study||1
133870|NCT00274846|321780|P1|COMPLETED|Overall Study|Evaluable patients - received adequate natural killer (NK) cells|20
133871|NCT00274846|321780|P1|STARTED|Overall Study||21
133872|NCT00265616|321790|P2|NOT COMPLETED|Overall Study||0
133873|NCT00265616|321791|P1|NOT COMPLETED|Overall Study||0
133874|NCT00265616|321790|P2|COMPLETED|Overall Study||9
133875|NCT00265616|321791|P1|COMPLETED|Overall Study||14
133876|NCT00265616|321790|P2|STARTED|Overall Study||9
133877|NCT00265616|321791|P1|STARTED|Overall Study||14
133878|NCT00265759|321813|P4|NOT COMPLETED|Overall Study||9
133879|NCT00265759|321814|P3|NOT COMPLETED|Overall Study||2
133880|NCT00265759|321815|P2|NOT COMPLETED|Overall Study||1
133881|NCT00265759|321816|P1|NOT COMPLETED|Overall Study||0
133882|NCT00265759|321813|P4|COMPLETED|Overall Study||236
133883|NCT00265759|321814|P3|COMPLETED|Overall Study||123
133884|NCT00265759|321815|P2|COMPLETED|Overall Study||127
133885|NCT00265759|321816|P1|COMPLETED|Overall Study||124
133886|NCT00265759|321813|P4|STARTED|Overall Study||245
133887|NCT00265759|321814|P3|STARTED|Overall Study||125
133888|NCT00265759|321815|P2|STARTED|Overall Study||128
133889|NCT00265759|321816|P1|STARTED|Overall Study||124
133890|NCT00265785|321845|P1|NOT COMPLETED|Overall Study||27
133891|NCT00265785|321845|P1|COMPLETED|Overall Study||0
133892|NCT00265785|321845|P1|Eligible and Began Protocol Treatment|Overall Study||24
133893|NCT00265785|321845|P1|Eligible|Overall Study||26
133894|NCT00265785|321845|P1|STARTED|Overall Study||27
133895|NCT00265798|321852|P1|NOT COMPLETED|Overall Study||0
133896|NCT00265798|321852|P1|COMPLETED|Overall Study||38
133897|NCT00265798|321852|P1|STARTED|Overall Study||38
133898|NCT00265850|321861|P3|NOT COMPLETED|Overall Study||0
133899|NCT00265850|321862|P2|NOT COMPLETED|Overall Study||0
133900|NCT00265850|321863|P1|NOT COMPLETED|Overall Study||0
133901|NCT00265850|321861|P3|COMPLETED|Overall Study||533
133902|NCT00265850|321862|P2|COMPLETED|Overall Study||902
133903|NCT00265850|321863|P1|COMPLETED|Overall Study||899
133904|NCT00265850|321861|P3|STARTED|Overall Study||533
133905|NCT00265850|321862|P2|STARTED|Overall Study||902
133906|NCT00265850|321863|P1|STARTED|Overall Study||899
133907|NCT00265889|321873|P1|NOT COMPLETED|Overall Study||5
133908|NCT00265889|321873|P1|COMPLETED|Overall Study||37
133909|NCT00265889|321873|P1|Cycle 2: 2nd Regimen/Transplant|Overall Study||37
133910|NCT00265889|321873|P1|Cycle 1: 1st Regimen/Transplant|Overall Study||37
133911|NCT00265889|321873|P1|STARTED|Overall Study||42
133912|NCT00266032|321882|P3|NOT COMPLETED|Open-label Safety Extension||25
133913|NCT00266032|321883|P2|NOT COMPLETED|Open-label Safety Extension||14
133914|NCT00266032|321884|P1|NOT COMPLETED|Open-label Safety Extension||41
133915|NCT00266032|321882|P3|COMPLETED|Open-label Safety Extension||140
133916|NCT00266032|321883|P2|COMPLETED|Open-label Safety Extension||115
133917|NCT00266032|321884|P1|COMPLETED|Open-label Safety Extension||448
133918|NCT00266032|321882|P3|STARTED|Open-label Safety Extension|21 subjects continued their treatment in second period (safety extension)|165
133919|NCT00266032|321883|P2|STARTED|Open-label Safety Extension|7 subjects continued their treatment in second period (safety extension)|129
133920|NCT00266032|321884|P1|STARTED|Open-label Safety Extension|treatment for subjects of all 3 treatment groups in 2nd period, except for 28 in subgroups|489
133921|NCT00266032|321882|P3|NOT COMPLETED|Treatment||47
133922|NCT00266032|321883|P2|NOT COMPLETED|Treatment||64
133923|NCT00266032|321884|P1|NOT COMPLETED|Treatment||111
133924|NCT00266032|321882|P3|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|192
133925|NCT00266032|321883|P2|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|172
133926|NCT00266032|321884|P1|COMPLETED|Treatment|not all entered period 2 (open-label safety extension)|580
133927|NCT00266032|321882|P3|Patients Treated and in FAS|Treatment|FAS|216
133928|NCT00266032|321883|P2|Patients Treated and in FAS|Treatment|FAS|209
133929|NCT00266032|321884|P1|Patients Treated and in FAS|Treatment|FAS|642
133930|NCT00266032|321882|P3|Patients Treated|Treatment||229
133931|NCT00266032|321883|P2|Patients Treated|Treatment||221
133932|NCT00266032|321884|P1|Patients Treated|Treatment||684
133933|NCT00266032|321882|P3|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|239
133934|NCT00266032|321883|P2|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|236
133935|NCT00266032|321884|P1|STARTED|Treatment|all randomized subjects, baseline data for full analysis set (FAS) only|691
133936|NCT00266110|321912|P1|NOT COMPLETED|Overall Study||7
133937|NCT00266110|321912|P1|COMPLETED|Overall Study||10
133938|NCT00266110|321912|P1|STARTED|Overall Study||17
133939|NCT00266227|321918|P3|NOT COMPLETED|Retreatment: Week 48 to Week 72||0
133940|NCT00266227|321919|P2|NOT COMPLETED|Retreatment: Week 48 to Week 72||42
133941|NCT00266227|321920|P1|NOT COMPLETED|Retreatment: Week 48 to Week 72||64
133942|NCT00266227|321918|P3|COMPLETED|Retreatment: Week 48 to Week 72||0
133943|NCT00266227|321919|P2|COMPLETED|Retreatment: Week 48 to Week 72||92
133944|NCT00266227|321920|P1|COMPLETED|Retreatment: Week 48 to Week 72||227
133945|NCT00266227|321918|P3|STARTED|Retreatment: Week 48 to Week 72||0
133946|NCT00266227|321919|P2|STARTED|Retreatment: Week 48 to Week 72||134
133947|NCT00266227|321920|P1|STARTED|Retreatment: Week 48 to Week 72||291
133948|NCT00266227|321918|P3|NOT COMPLETED|Retreatment: Up to Week 48||0
133949|NCT00266227|321919|P2|NOT COMPLETED|Retreatment: Up to Week 48||23
133950|NCT00266227|321920|P1|NOT COMPLETED|Retreatment: Up to Week 48||27
133951|NCT00266227|321918|P3|COMPLETED|Retreatment: Up to Week 48||0
133952|NCT00266227|321919|P2|COMPLETED|Retreatment: Up to Week 48||134
133953|NCT00266227|321920|P1|COMPLETED|Retreatment: Up to Week 48||291
133954|NCT00266227|321918|P3|STARTED|Retreatment: Up to Week 48||0
133955|NCT00266227|321919|P2|STARTED|Retreatment: Up to Week 48||157
133956|NCT00266227|321920|P1|STARTED|Retreatment: Up to Week 48||318
133957|NCT00266227|321918|P3|NOT COMPLETED|Initial Treatment||77
133958|NCT00266227|321919|P2|NOT COMPLETED|Initial Treatment||0
133959|NCT00266227|321920|P1|NOT COMPLETED|Initial Treatment||0
133960|NCT00266227|321918|P3|COMPLETED|Initial Treatment||482
133961|NCT00266227|321919|P2|COMPLETED|Initial Treatment||0
133962|NCT00266227|321920|P1|COMPLETED|Initial Treatment||0
133963|NCT00266227|321918|P3|STARTED|Initial Treatment||559
133964|NCT00266227|321919|P2|STARTED|Initial Treatment||0
133965|NCT00266227|321920|P1|STARTED|Initial Treatment||0
133966|NCT00266279|321965|P1|NOT COMPLETED|Overall Study||2
133967|NCT00266279|321965|P1|COMPLETED|Overall Study||15
133968|NCT00266279|321965|P1|STARTED|Overall Study||17
133969|NCT00266409|321973|P4|NOT COMPLETED|Overall Study||22
133970|NCT00266409|321974|P3|NOT COMPLETED|Overall Study||17
133971|NCT00266409|321975|P2|NOT COMPLETED|Overall Study||46
133972|NCT00266409|321976|P1|NOT COMPLETED|Overall Study||45
133973|NCT00266409|321973|P4|COMPLETED|Overall Study||49
133974|NCT00266409|321974|P3|COMPLETED|Overall Study||55
133975|NCT00266409|321975|P2|COMPLETED|Overall Study||92
133976|NCT00266409|321976|P1|COMPLETED|Overall Study||92
133977|NCT00266409|321973|P4|STARTED|Overall Study||71
133978|NCT00266409|321974|P3|STARTED|Overall Study||72
133979|NCT00266409|321975|P2|STARTED|Overall Study||138
133980|NCT00266409|321976|P1|STARTED|Overall Study||137
133981|NCT00266630|322260|P2|NOT COMPLETED|Overall Study||28
133982|NCT00266630|322261|P1|NOT COMPLETED|Overall Study||42
133983|NCT00266630|322260|P2|COMPLETED|Overall Study||11
133984|NCT00266630|322261|P1|COMPLETED|Overall Study||58
133985|NCT00266630|322260|P2|STARTED|Overall Study||39
133986|NCT00266630|322261|P1|STARTED|Overall Study||100
133987|NCT00266656|322301|P2|NOT COMPLETED|Overall Study||13
133988|NCT00266656|322302|P1|NOT COMPLETED|Overall Study||14
133989|NCT00266656|322301|P2|COMPLETED|Overall Study||20
133990|NCT00266656|322302|P1|COMPLETED|Overall Study||22
133991|NCT00266656|322301|P2|STARTED|Overall Study||33
133992|NCT00266656|322302|P1|STARTED|Overall Study||36
133993|NCT00266695|322324|P1|NOT COMPLETED|Overall Study||29
133994|NCT00266695|322324|P1|COMPLETED|Overall Study||174
133995|NCT00266695|322324|P1|STARTED|Overall Study||203
133996|NCT00266799|322336|P2|NOT COMPLETED|Overall Study||34
133997|NCT00266799|322337|P1|NOT COMPLETED|Overall Study||36
133998|NCT00266799|322336|P2|COMPLETED|Overall Study||68
133999|NCT00266799|322337|P1|COMPLETED|Overall Study||62
134000|NCT00266799|322336|P2|STARTED|Overall Study||102
134001|NCT00266799|322337|P1|STARTED|Overall Study||98
134002|NCT00266812|322353|P2|NOT COMPLETED|Overall Study||11
134003|NCT00266812|322354|P1|NOT COMPLETED|Overall Study||21
134004|NCT00266812|322353|P2|COMPLETED|Overall Study||2
134005|NCT00266812|322354|P1|COMPLETED|Overall Study||1
134006|NCT00266812|322353|P2|STARTED|Overall Study||13
134007|NCT00266812|322354|P1|STARTED|Overall Study||22
134008|NCT00266825|322362|P2|NOT COMPLETED|Completed Follow-Up||24
134009|NCT00266825|322363|P1|NOT COMPLETED|Completed Follow-Up||25
134010|NCT00266825|322362|P2|COMPLETED|Completed Follow-Up||154
134011|NCT00266825|322363|P1|COMPLETED|Completed Follow-Up||147
134012|NCT00266825|322362|P2|STARTED|Completed Follow-Up||178
134013|NCT00266825|322363|P1|STARTED|Completed Follow-Up||172
134014|NCT00266825|322362|P2|NOT COMPLETED|Enrolled and Allocated Intervention||0
134015|NCT00266825|322363|P1|NOT COMPLETED|Enrolled and Allocated Intervention||0
134016|NCT00266825|322362|P2|COMPLETED|Enrolled and Allocated Intervention||178
134017|NCT00266825|322363|P1|COMPLETED|Enrolled and Allocated Intervention||172
134018|NCT00266825|322362|P2|STARTED|Enrolled and Allocated Intervention||178
134019|NCT00266825|322363|P1|STARTED|Enrolled and Allocated Intervention||172
134020|NCT00266864|322389|P2|NOT COMPLETED|Overall Study||2
134021|NCT00266864|322390|P1|NOT COMPLETED|Overall Study||5
134022|NCT00266864|322389|P2|COMPLETED|Overall Study||11
134023|NCT00266864|322390|P1|COMPLETED|Overall Study||13
134024|NCT00266864|322389|P2|STARTED|Overall Study||13
134025|NCT00266864|322390|P1|STARTED|Overall Study||18
134026|NCT00267007|322399|P2|NOT COMPLETED|Overall Study||1
134027|NCT00267007|322400|P1|NOT COMPLETED|Overall Study||8
134028|NCT00267007|322399|P2|COMPLETED|Overall Study||10
134029|NCT00267007|322400|P1|COMPLETED|Overall Study||11
134030|NCT00267007|322399|P2|STARTED|Overall Study||11
134031|NCT00267007|322400|P1|STARTED|Overall Study|2 additional patients were randomized but never received study medication and no data were collected|19
134032|NCT00274924|322411|P3|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
134033|NCT00274924|322412|P2|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||18
134034|NCT00274924|322413|P1|NOT COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||7
134035|NCT00274924|322411|P3|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||0
134036|NCT00274924|322412|P2|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||58
134037|NCT00274924|322413|P1|COMPLETED|Step 2 (Tx Based on Mid-treatment PET)||10
134038|NCT00274924|322411|P3|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||0
134039|NCT00274924|322412|P2|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||61
134040|NCT00274924|322413|P1|Eligible and Treated|Step 2 (Tx Based on Mid-treatment PET)||13
134041|NCT00274924|322411|P3|STARTED|Step 2 (Tx Based on Mid-treatment PET)||0
134042|NCT00274924|322412|P2|STARTED|Step 2 (Tx Based on Mid-treatment PET)|One patient withdrew from the study after step 1 treatment.|76
134043|NCT00274924|322413|P1|STARTED|Step 2 (Tx Based on Mid-treatment PET)|All patients who started step 2 therapy were included regardless of eligibility.|17
134044|NCT00274924|322411|P3|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||6
134045|NCT00274924|322412|P2|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||14
134046|NCT00274924|322413|P1|NOT COMPLETED|Step 1 (R-CHOP X 3 Cycles)||4
134047|NCT00274924|322411|P3|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||0
134048|NCT00274924|322412|P2|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||63
134049|NCT00274924|322413|P1|COMPLETED|Step 1 (R-CHOP X 3 Cycles)||13
134050|NCT00274924|322411|P3|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||4
134051|NCT00274924|322412|P2|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||63
134052|NCT00274924|322413|P1|Eligible and Treated|Step 1 (R-CHOP X 3 Cycles)||13
134053|NCT00274924|322411|P3|Treated|Step 1 (R-CHOP X 3 Cycles)||5
134054|NCT00274924|322412|P2|Treated|Step 1 (R-CHOP X 3 Cycles)||77
134055|NCT00274924|322413|P1|Treated|Step 1 (R-CHOP X 3 Cycles)||17
134056|NCT00274924|322411|P3|STARTED|Step 1 (R-CHOP X 3 Cycles)||6
134057|NCT00274924|322412|P2|STARTED|Step 1 (R-CHOP X 3 Cycles)||77
134058|NCT00274924|322413|P1|STARTED|Step 1 (R-CHOP X 3 Cycles)||17
134059|NCT00274937|322422|P1|NOT COMPLETED|Overall Study||20
134060|NCT00274937|322422|P1|COMPLETED|Overall Study||91
134061|NCT00274937|322422|P1|STARTED|Overall Study||111
134062|NCT00275002|322431|P2|NOT COMPLETED|Overall Study||16
134063|NCT00275002|322432|P1|NOT COMPLETED|Overall Study||22
134064|NCT00275002|322431|P2|COMPLETED|Overall Study||0
134065|NCT00275002|322432|P1|COMPLETED|Overall Study||3
134066|NCT00275002|322431|P2|STARTED|Overall Study||16
134067|NCT00275002|322432|P1|STARTED|Overall Study||25
134068|NCT00275028|322440|P1|NOT COMPLETED|Overall Study||47
134069|NCT00275028|322440|P1|COMPLETED|Overall Study|Participants are treated until one of the below milestones is reached. Completion is N/A.|0
134070|NCT00275028|322440|P1|STARTED|Overall Study||47
134071|NCT00276016|322451|P6|NOT COMPLETED|Intervention 3||0
134072|NCT00276016|322452|P5|NOT COMPLETED|Intervention 3||0
134073|NCT00276016|322453|P4|NOT COMPLETED|Intervention 3||0
134074|NCT00276016|322454|P3|NOT COMPLETED|Intervention 3||0
134075|NCT00276016|322455|P2|NOT COMPLETED|Intervention 3||0
134076|NCT00276016|322456|P1|NOT COMPLETED|Intervention 3||0
134077|NCT00276016|322451|P6|COMPLETED|Intervention 3||6
134078|NCT00276016|322452|P5|COMPLETED|Intervention 3||6
134079|NCT00276016|322453|P4|COMPLETED|Intervention 3||6
134080|NCT00276016|322454|P3|COMPLETED|Intervention 3||7
134081|NCT00276016|322455|P2|COMPLETED|Intervention 3||6
134082|NCT00276016|322456|P1|COMPLETED|Intervention 3||7
134083|NCT00276016|322451|P6|STARTED|Intervention 3||6
134084|NCT00276016|322452|P5|STARTED|Intervention 3||6
134085|NCT00276016|322453|P4|STARTED|Intervention 3||6
134086|NCT00276016|322454|P3|STARTED|Intervention 3||7
134087|NCT00276016|322455|P2|STARTED|Intervention 3||6
134088|NCT00276016|322456|P1|STARTED|Intervention 3||7
134089|NCT00276016|322451|P6|NOT COMPLETED|Wash Out 2||0
134090|NCT00276016|322452|P5|NOT COMPLETED|Wash Out 2||0
134091|NCT00276016|322453|P4|NOT COMPLETED|Wash Out 2||0
134092|NCT00276016|322454|P3|NOT COMPLETED|Wash Out 2||0
134093|NCT00276016|322455|P2|NOT COMPLETED|Wash Out 2||0
134094|NCT00276016|322456|P1|NOT COMPLETED|Wash Out 2||0
134095|NCT00276016|322451|P6|COMPLETED|Wash Out 2||6
134096|NCT00276016|322452|P5|COMPLETED|Wash Out 2||6
134097|NCT00276016|322453|P4|COMPLETED|Wash Out 2||6
134098|NCT00276016|322454|P3|COMPLETED|Wash Out 2||7
134099|NCT00276016|322455|P2|COMPLETED|Wash Out 2||6
134100|NCT00276016|322456|P1|COMPLETED|Wash Out 2||7
134101|NCT00276016|322451|P6|STARTED|Wash Out 2||6
134102|NCT00276016|322452|P5|STARTED|Wash Out 2||6
134103|NCT00276016|322453|P4|STARTED|Wash Out 2||6
134104|NCT00276016|322454|P3|STARTED|Wash Out 2||7
134105|NCT00276016|322455|P2|STARTED|Wash Out 2||6
134106|NCT00276016|322456|P1|STARTED|Wash Out 2||7
134107|NCT00276016|322451|P6|NOT COMPLETED|Intervention 2||0
134108|NCT00276016|322452|P5|NOT COMPLETED|Intervention 2||0
134109|NCT00276016|322453|P4|NOT COMPLETED|Intervention 2||0
134110|NCT00276016|322454|P3|NOT COMPLETED|Intervention 2||0
134111|NCT00276016|322455|P2|NOT COMPLETED|Intervention 2||0
134112|NCT00276016|322456|P1|NOT COMPLETED|Intervention 2||0
134113|NCT00276016|322451|P6|COMPLETED|Intervention 2||6
134114|NCT00276016|322452|P5|COMPLETED|Intervention 2||6
134115|NCT00276016|322453|P4|COMPLETED|Intervention 2||6
134116|NCT00276016|322454|P3|COMPLETED|Intervention 2||7
134117|NCT00276016|322455|P2|COMPLETED|Intervention 2||6
134118|NCT00276016|322456|P1|COMPLETED|Intervention 2||7
134119|NCT00276016|322451|P6|STARTED|Intervention 2||6
134120|NCT00276016|322452|P5|STARTED|Intervention 2||6
134121|NCT00276016|322453|P4|STARTED|Intervention 2||6
134122|NCT00276016|322454|P3|STARTED|Intervention 2||7
134123|NCT00276016|322455|P2|STARTED|Intervention 2||6
134124|NCT00276016|322456|P1|STARTED|Intervention 2||7
134125|NCT00276016|322451|P6|NOT COMPLETED|Wash Out 1||0
134126|NCT00276016|322452|P5|NOT COMPLETED|Wash Out 1||0
134127|NCT00276016|322453|P4|NOT COMPLETED|Wash Out 1||0
134128|NCT00276016|322454|P3|NOT COMPLETED|Wash Out 1||0
134129|NCT00276016|322455|P2|NOT COMPLETED|Wash Out 1||0
134130|NCT00276016|322456|P1|NOT COMPLETED|Wash Out 1||0
134131|NCT00276016|322451|P6|COMPLETED|Wash Out 1||6
134132|NCT00276016|322452|P5|COMPLETED|Wash Out 1||6
134133|NCT00276016|322453|P4|COMPLETED|Wash Out 1||6
134134|NCT00276016|322454|P3|COMPLETED|Wash Out 1||7
134135|NCT00276016|322455|P2|COMPLETED|Wash Out 1||6
134136|NCT00276016|322456|P1|COMPLETED|Wash Out 1||7
134137|NCT00276016|322451|P6|STARTED|Wash Out 1||6
134138|NCT00276016|322452|P5|STARTED|Wash Out 1||6
134139|NCT00276016|322453|P4|STARTED|Wash Out 1||6
134140|NCT00276016|322454|P3|STARTED|Wash Out 1||7
134141|NCT00276016|322455|P2|STARTED|Wash Out 1||6
134142|NCT00276016|322456|P1|STARTED|Wash Out 1||7
134143|NCT00276016|322451|P6|NOT COMPLETED|Intervention 1||0
134144|NCT00276016|322452|P5|NOT COMPLETED|Intervention 1||0
134145|NCT00276016|322453|P4|NOT COMPLETED|Intervention 1||0
134146|NCT00276016|322454|P3|NOT COMPLETED|Intervention 1||0
134147|NCT00276016|322455|P2|NOT COMPLETED|Intervention 1||1
134148|NCT00276016|322456|P1|NOT COMPLETED|Intervention 1||0
134149|NCT00276016|322451|P6|COMPLETED|Intervention 1||6
134150|NCT00276016|322452|P5|COMPLETED|Intervention 1||6
134151|NCT00276016|322453|P4|COMPLETED|Intervention 1||6
134152|NCT00276016|322454|P3|COMPLETED|Intervention 1||7
134153|NCT00276016|322455|P2|COMPLETED|Intervention 1||6
134154|NCT00276016|322456|P1|COMPLETED|Intervention 1||7
134155|NCT00276016|322451|P6|STARTED|Intervention 1||6
134156|NCT00276016|322452|P5|STARTED|Intervention 1||6
134157|NCT00276016|322453|P4|STARTED|Intervention 1||6
134158|NCT00276016|322454|P3|STARTED|Intervention 1||7
134159|NCT00276016|322455|P2|STARTED|Intervention 1||7
134160|NCT00276016|322456|P1|STARTED|Intervention 1||7
134161|NCT00276094|322468|P3|NOT COMPLETED|Overall Study||38
134162|NCT00276094|322469|P2|NOT COMPLETED|Overall Study||42
134163|NCT00276094|322470|P1|NOT COMPLETED|Overall Study||57
134164|NCT00276094|322468|P3|COMPLETED|Overall Study||230
134165|NCT00276094|322469|P2|COMPLETED|Overall Study||234
134166|NCT00276094|322470|P1|COMPLETED|Overall Study||225
134167|NCT00276094|322468|P3|STARTED|Overall Study||268
134168|NCT00276094|322469|P2|STARTED|Overall Study||276
134169|NCT00276094|322470|P1|STARTED|Overall Study||282
134170|NCT00276159|322517|P1|NOT COMPLETED|Overall Study||6
134171|NCT00276159|322517|P1|COMPLETED|Overall Study||0
134172|NCT00276159|322517|P1|STARTED|Overall Study||6
134173|NCT00276250|322527|P3|NOT COMPLETED|Overall Study||0
134174|NCT00276250|322528|P2|NOT COMPLETED|Overall Study||0
134175|NCT00276250|322529|P1|NOT COMPLETED|Overall Study||0
134176|NCT00276250|322527|P3|COMPLETED|Overall Study||0
134177|NCT00276250|322528|P2|COMPLETED|Overall Study||1
134178|NCT00276250|322529|P1|COMPLETED|Overall Study||4
134179|NCT00276250|322527|P3|STARTED|Overall Study||0
134180|NCT00276250|322528|P2|STARTED|Overall Study||1
134181|NCT00276250|322529|P1|STARTED|Overall Study||4
134182|NCT00276406|322563|P2|NOT COMPLETED|Overall Study||0
134183|NCT00276406|322564|P1|NOT COMPLETED|Overall Study||0
134184|NCT00276406|322563|P2|COMPLETED|Overall Study||14
134185|NCT00276406|322564|P1|COMPLETED|Overall Study|14 of 16 subjects tolerated 360mg daily, while 2 of 16 tolerated 180mg daily.|16
134186|NCT00276406|322563|P2|STARTED|Overall Study||14
134187|NCT00276406|322564|P1|STARTED|Overall Study||16
134188|NCT00276419|322594|P2|NOT COMPLETED|Second Intervention||0
134189|NCT00276419|322595|P1|NOT COMPLETED|Second Intervention||0
134190|NCT00276419|322594|P2|COMPLETED|Second Intervention||8
134191|NCT00276419|322595|P1|COMPLETED|Second Intervention||7
134192|NCT00276419|322594|P2|STARTED|Second Intervention||8
134193|NCT00276419|322595|P1|STARTED|Second Intervention||7
134194|NCT00276419|322594|P2|NOT COMPLETED|Wash-out Phase||0
134195|NCT00276419|322595|P1|NOT COMPLETED|Wash-out Phase||0
134196|NCT00276419|322594|P2|COMPLETED|Wash-out Phase||8
134197|NCT00276419|322595|P1|COMPLETED|Wash-out Phase||7
134198|NCT00276419|322594|P2|STARTED|Wash-out Phase||8
134199|NCT00276419|322595|P1|STARTED|Wash-out Phase||7
134200|NCT00276419|322594|P2|NOT COMPLETED|First Intervention||2
134201|NCT00276419|322595|P1|NOT COMPLETED|First Intervention||1
134202|NCT00276419|322594|P2|COMPLETED|First Intervention||8
134203|NCT00276419|322595|P1|COMPLETED|First Intervention||7
134204|NCT00276419|322594|P2|STARTED|First Intervention||10
134205|NCT00276419|322595|P1|STARTED|First Intervention||8
134206|NCT00276458|322607|P2|NOT COMPLETED|Overall Study||7
134207|NCT00276458|322608|P1|NOT COMPLETED|Overall Study||6
134208|NCT00276458|322607|P2|COMPLETED|Overall Study||91
134209|NCT00276458|322608|P1|COMPLETED|Overall Study||92
134210|NCT00276458|322607|P2|STARTED|Overall Study||98
134211|NCT00276458|322608|P1|STARTED|Overall Study||98
134212|NCT00276484|322642|P2|NOT COMPLETED|Overall Study||13
134213|NCT00276484|322643|P1|NOT COMPLETED|Overall Study||9
134214|NCT00276484|322642|P2|COMPLETED|Overall Study||278
134215|NCT00276484|322643|P1|COMPLETED|Overall Study||279
134216|NCT00276484|322642|P2|STARTED|Overall Study||291
134217|NCT00276484|322643|P1|STARTED|Overall Study||288
134218|NCT00276549|322673|P1|NOT COMPLETED|Overall Study||0
134219|NCT00276549|322673|P1|COMPLETED|Overall Study||35
134220|NCT00276549|322673|P1|STARTED|Overall Study||35
134221|NCT00276614|322678|P1|NOT COMPLETED|Overall Study||3
134222|NCT00276614|322678|P1|COMPLETED|Overall Study||1
134223|NCT00276614|322678|P1|STARTED|Overall Study||4
134224|NCT00276861|322682|P1|NOT COMPLETED|Overall Study||0
134225|NCT00276861|322682|P1|COMPLETED|Overall Study||10
134226|NCT00276861|322682|P1|STARTED|Overall Study||10
134227|NCT00277095|322687|P1|NOT COMPLETED|Overall Study||21
134228|NCT00277095|322687|P1|COMPLETED|Overall Study|Details of patients who did not complete study are given below.|103
134229|NCT00277095|322687|P1|STARTED|Overall Study|Anatomy of 1 patient did not allow ProACT to be implanted, hence only 123 patients were implanted.|124
134230|NCT00277212|322691|P3|NOT COMPLETED|Phase 2 - Double-Blind Treatment||113
134231|NCT00277212|322692|P2|NOT COMPLETED|Phase 2 - Double-Blind Treatment||120
134232|NCT00277212|322693|P1|NOT COMPLETED|Phase 2 - Double-Blind Treatment||0
134233|NCT00277212|322691|P3|COMPLETED|Phase 2 - Double-Blind Treatment||65
134234|NCT00277212|322692|P2|COMPLETED|Phase 2 - Double-Blind Treatment||53
134235|NCT00277212|322693|P1|COMPLETED|Phase 2 - Double-Blind Treatment||0
134236|NCT00277212|322691|P3|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||174
134237|NCT00277212|322692|P2|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||164
134238|NCT00277212|322693|P1|Phase 2 Efficacy Sample|Phase 2 - Double-Blind Treatment||0
134239|NCT00277212|322691|P3|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||176
134240|NCT00277212|322692|P2|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||165
134241|NCT00277212|322693|P1|Phase 2 Safety Sample|Phase 2 - Double-Blind Treatment||0
134242|NCT00277212|322691|P3|STARTED|Phase 2 - Double-Blind Treatment|1 participant did not want to continue in the study for personal reasons, and did not enter Phase 2.|178
134243|NCT00277212|322692|P2|STARTED|Phase 2 - Double-Blind Treatment||173
134244|NCT00277212|322693|P1|STARTED|Phase 2 - Double-Blind Treatment||0
134245|NCT00277212|322691|P3|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
134246|NCT00277212|322692|P2|NOT COMPLETED|Phase 1 - Single-Blind Treatment||0
134247|NCT00277212|322693|P1|NOT COMPLETED|Phase 1 - Single-Blind Treatment||435
134248|NCT00277212|322691|P3|COMPLETED|Phase 1 - Single-Blind Treatment||0
134249|NCT00277212|322692|P2|COMPLETED|Phase 1 - Single-Blind Treatment||0
134250|NCT00277212|322693|P1|COMPLETED|Phase 1 - Single-Blind Treatment||352
134251|NCT00277212|322691|P3|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
134252|NCT00277212|322692|P2|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||0
134253|NCT00277212|322693|P1|Phase 1 Efficacy Sample|Phase 1 - Single-Blind Treatment||756
134254|NCT00277212|322691|P3|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
134255|NCT00277212|322692|P2|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||0
134256|NCT00277212|322693|P1|Phase 1 Safety Sample|Phase 1 - Single-Blind Treatment||787
134257|NCT00277212|322691|P3|STARTED|Phase 1 - Single-Blind Treatment||0
134258|NCT00277212|322692|P2|STARTED|Phase 1 - Single-Blind Treatment||0
134259|NCT00277212|322693|P1|STARTED|Phase 1 - Single-Blind Treatment||787
134260|NCT00277355|322733|P2|NOT COMPLETED|Overall Study||5
134261|NCT00277355|322734|P1|NOT COMPLETED|Overall Study||14
134262|NCT00277355|322733|P2|COMPLETED|Overall Study||22
134263|NCT00277355|322734|P1|COMPLETED|Overall Study||73
134264|NCT00277355|322733|P2|STARTED|Overall Study||27
134265|NCT00277355|322734|P1|STARTED|Overall Study||87
134266|NCT00277394|322744|P2|NOT COMPLETED|Overall Study||24
134267|NCT00277394|322745|P1|NOT COMPLETED|Overall Study||37
134268|NCT00277394|322744|P2|COMPLETED|Overall Study||246
134269|NCT00277394|322745|P1|COMPLETED|Overall Study||232
134270|NCT00277394|322744|P2|STARTED|Overall Study||270
134271|NCT00277394|322745|P1|STARTED|Overall Study||269
134272|NCT00277446|322755|P1|NOT COMPLETED|Overall Study||0
134273|NCT00277446|322755|P1|COMPLETED|Overall Study||13
134274|NCT00277446|322755|P1|STARTED|Overall Study||13
134275|NCT00277524|322761|P4|NOT COMPLETED|Overall Study||0
134276|NCT00277524|322762|P3|NOT COMPLETED|Overall Study||0
134277|NCT00277524|322763|P2|NOT COMPLETED|Overall Study||0
134278|NCT00277524|322764|P1|NOT COMPLETED|Overall Study||0
134279|NCT00277524|322761|P4|COMPLETED|Overall Study||850
134280|NCT00277524|322762|P3|COMPLETED|Overall Study||1088
134281|NCT00277524|322763|P2|COMPLETED|Overall Study||324
134282|NCT00277524|322764|P1|COMPLETED|Overall Study||621
134283|NCT00277524|322761|P4|STARTED|Overall Study||850
134284|NCT00277524|322762|P3|STARTED|Overall Study||1088
134285|NCT00277524|322763|P2|STARTED|Overall Study||324
134286|NCT00277524|322764|P1|STARTED|Overall Study||621
134287|NCT00278343|322782|P1|NOT COMPLETED|Overall Study||0
134288|NCT00278343|322782|P1|COMPLETED|Overall Study||74
134289|NCT00278343|322782|P1|STARTED|Overall Study||74
134290|NCT00278395|322789|P1|NOT COMPLETED|Overall Study||3
134291|NCT00278395|322789|P1|COMPLETED|Overall Study||11
134292|NCT00278395|322789|P1|STARTED|Overall Study||14
134293|NCT00278473|322795|P2|NOT COMPLETED|Overall Study||3
134294|NCT00278473|322796|P1|NOT COMPLETED|Overall Study||4
134295|NCT00278473|322795|P2|COMPLETED|Overall Study||40
134296|NCT00278473|322796|P1|COMPLETED|Overall Study||41
134297|NCT00278473|322795|P2|STARTED|Overall Study||43
134298|NCT00278473|322796|P1|STARTED|Overall Study||45
134299|NCT00270205|322816|P4|NOT COMPLETED|Overall Study||1
134300|NCT00270205|322817|P3|NOT COMPLETED|Overall Study||0
134301|NCT00270205|322818|P2|NOT COMPLETED|Overall Study||0
134302|NCT00270205|322819|P1|NOT COMPLETED|Overall Study||1
134303|NCT00270205|322816|P4|COMPLETED|Overall Study||6
134304|NCT00270205|322817|P3|COMPLETED|Overall Study||6
134305|NCT00270205|322818|P2|COMPLETED|Overall Study||6
134306|NCT00270205|322819|P1|COMPLETED|Overall Study||5
134307|NCT00270205|322816|P4|STARTED|Overall Study||7
134308|NCT00270205|322817|P3|STARTED|Overall Study||6
134309|NCT00270205|322818|P2|STARTED|Overall Study|7 participants enrolled. One never started study vaccination and was excluded from all analyses.|6
134310|NCT00270205|322819|P1|STARTED|Overall Study||6
134311|NCT00270231|322929|P2|NOT COMPLETED|Second Intervention||1
134312|NCT00270231|322930|P1|NOT COMPLETED|Second Intervention||0
134313|NCT00270231|322929|P2|COMPLETED|Second Intervention||30
134314|NCT00270231|322930|P1|COMPLETED|Second Intervention||30
134315|NCT00270231|322929|P2|STARTED|Second Intervention||31
134316|NCT00270231|322930|P1|STARTED|Second Intervention||30
134317|NCT00270231|322929|P2|NOT COMPLETED|Washout Period||0
134318|NCT00270231|322930|P1|NOT COMPLETED|Washout Period||1
134319|NCT00270231|322929|P2|COMPLETED|Washout Period||31
134320|NCT00270231|322930|P1|COMPLETED|Washout Period||30
134321|NCT00270231|322929|P2|STARTED|Washout Period||31
134322|NCT00270231|322930|P1|STARTED|Washout Period||31
134323|NCT00270231|322929|P2|NOT COMPLETED|First Intervention||1
134324|NCT00270231|322930|P1|NOT COMPLETED|First Intervention||1
134325|NCT00270231|322929|P2|COMPLETED|First Intervention||31
134326|NCT00270231|322930|P1|COMPLETED|First Intervention||31
134327|NCT00270231|322929|P2|STARTED|First Intervention||32
134328|NCT00270231|322930|P1|STARTED|First Intervention||32
134329|NCT00270257|322938|P2|NOT COMPLETED|Overall Study||424
134330|NCT00270257|322939|P1|NOT COMPLETED|Overall Study||412
134331|NCT00270257|322938|P2|COMPLETED|Overall Study||204
134332|NCT00270257|322939|P1|COMPLETED|Overall Study||211
134333|NCT00270257|322938|P2|Visit 104|Overall Study||204
134334|NCT00270257|322939|P1|Visit 104|Overall Study||211
134335|NCT00270257|322938|P2|Week 78|Overall Study||285
134336|NCT00270257|322939|P1|Week 78|Overall Study||283
134337|NCT00270257|322938|P2|Week 52|Overall Study||340
134338|NCT00270257|322939|P1|Week 52|Overall Study||362
134339|NCT00270257|322938|P2|Week 26|Overall Study||440
134340|NCT00270257|322939|P1|Week 26|Overall Study||460
134341|NCT00270257|322938|P2|Week 8|Overall Study||443
134342|NCT00270257|322939|P1|Week 8|Overall Study||510
134343|NCT00270257|322938|P2|STARTED|Overall Study|1 excluded from analysis (enrollment date exceeded eligibility window by 13 days)|628
134344|NCT00270257|322939|P1|STARTED|Overall Study||623
134345|NCT00270296|322960|P3|NOT COMPLETED|Overall Study||61
134346|NCT00270296|322961|P2|NOT COMPLETED|Overall Study||90
134347|NCT00270296|322962|P1|NOT COMPLETED|Overall Study||99
134348|NCT00270296|322960|P3|COMPLETED|Overall Study||109
134349|NCT00270296|322961|P2|COMPLETED|Overall Study||185
134350|NCT00270296|322962|P1|COMPLETED|Overall Study||186
134351|NCT00270296|322960|P3|STARTED|Overall Study||170
134352|NCT00270296|322961|P2|STARTED|Overall Study||275
134353|NCT00270296|322962|P1|STARTED|Overall Study||285
134354|NCT00270634|322977|P4|NOT COMPLETED|Overall Study||5
134355|NCT00270634|322978|P3|NOT COMPLETED|Overall Study||22
134356|NCT00270634|322979|P2|NOT COMPLETED|Overall Study||13
134357|NCT00270634|322980|P1|NOT COMPLETED|Overall Study||17
134358|NCT00270634|322977|P4|COMPLETED|Overall Study||81
134359|NCT00270634|322978|P3|COMPLETED|Overall Study||62
134360|NCT00270634|322979|P2|COMPLETED|Overall Study||64
134361|NCT00270634|322980|P1|COMPLETED|Overall Study||70
134362|NCT00270634|322977|P4|STARTED|Overall Study||86
134363|NCT00270634|322978|P3|STARTED|Overall Study||84
134364|NCT00270634|322979|P2|STARTED|Overall Study||77
134365|NCT00270634|322980|P1|STARTED|Overall Study||87
134366|NCT00270790|323014|P1|NOT COMPLETED|Overall Study||5
134367|NCT00270790|323014|P1|COMPLETED|Overall Study||16
134368|NCT00270790|323014|P1|STARTED|Overall Study||21
134369|NCT00270842|323022|P3|NOT COMPLETED|Overall Study||16
134370|NCT00270842|323023|P2|NOT COMPLETED|Overall Study||16
134371|NCT00270842|323024|P1|NOT COMPLETED|Overall Study||15
134372|NCT00270842|323022|P3|COMPLETED|Overall Study||18
134373|NCT00270842|323023|P2|COMPLETED|Overall Study||18
134374|NCT00270842|323024|P1|COMPLETED|Overall Study||18
134375|NCT00270842|323022|P3|STARTED|Overall Study||34
134376|NCT00270842|323023|P2|STARTED|Overall Study||34
134377|NCT00270842|323024|P1|STARTED|Overall Study||33
134378|NCT00270894|323035|P1|NOT COMPLETED|Overall Study||2
134379|NCT00270894|323035|P1|COMPLETED|Overall Study||28
134380|NCT00270894|323035|P1|STARTED|Overall Study||30
134381|NCT00270998|323048|P3|NOT COMPLETED|12 Month Follow-up||21
134382|NCT00270998|323049|P2|NOT COMPLETED|12 Month Follow-up||25
134383|NCT00270998|323050|P1|NOT COMPLETED|12 Month Follow-up||14
134384|NCT00270998|323048|P3|COMPLETED|12 Month Follow-up||111
134385|NCT00270998|323049|P2|COMPLETED|12 Month Follow-up||99
134386|NCT00270998|323050|P1|COMPLETED|12 Month Follow-up||96
134387|NCT00270998|323048|P3|STARTED|12 Month Follow-up||132
134388|NCT00270998|323049|P2|STARTED|12 Month Follow-up||124
134389|NCT00270998|323050|P1|STARTED|12 Month Follow-up||110
134390|NCT00270998|323048|P3|NOT COMPLETED|3 Month Follow-up||18
134391|NCT00270998|323049|P2|NOT COMPLETED|3 Month Follow-up||22
134392|NCT00270998|323050|P1|NOT COMPLETED|3 Month Follow-up||39
134393|NCT00270998|323048|P3|COMPLETED|3 Month Follow-up||132
134394|NCT00270998|323049|P2|COMPLETED|3 Month Follow-up||124
134395|NCT00270998|323050|P1|COMPLETED|3 Month Follow-up||110
134396|NCT00270998|323048|P3|STARTED|3 Month Follow-up|1 participant randomized to combined found ineligible at first treatment visit, removed from study.|150
134397|NCT00270998|323049|P2|STARTED|3 Month Follow-up||146
134398|NCT00270998|323050|P1|STARTED|3 Month Follow-up||149
134399|NCT00271011|323079|P1|NOT COMPLETED|Overall Study||0
134400|NCT00271011|323079|P1|COMPLETED|Overall Study||13
134401|NCT00271011|323079|P1|STARTED|Overall Study||13
134402|NCT00271024|323088|P4|NOT COMPLETED|Overall Study||24
134403|NCT00271024|323089|P3|NOT COMPLETED|Overall Study||23
134404|NCT00271024|323090|P2|NOT COMPLETED|Overall Study||26
134405|NCT00271024|323091|P1|NOT COMPLETED|Overall Study||22
134406|NCT00271024|323088|P4|COMPLETED|Overall Study|Discontinued: 9 smoking related, 2 reaction to tablet, 4 time commitment, 1 other, 3 unspecified|64
134407|NCT00271024|323089|P3|COMPLETED|Overall Study|Discontinued: 5 smoking related, 4 reaction to tablet, 4 time commitment, 3 other, 4 unspecified|65
134408|NCT00271024|323090|P2|COMPLETED|Overall Study|Discontinued: 5 smoking related, 3 reaction to tablet, 2 time commitment, 1 other, 9 unspecified|51
134409|NCT00271024|323091|P1|COMPLETED|Overall Study|Discontinued: 1 smoking related, 1 reaction to tablet, 6 time commitment, 2 other, 8 unspecified|58
134410|NCT00271024|323088|P4|Received Study Treatment|Overall Study|n=5 did not start treatment (2 health problems, 1 wanted diff. treatment method, 2 lost interest)|83
134411|NCT00271024|323089|P3|Received Study Treatment|Overall Study|n=3 did not start treatment (2 lost interest, 1 unknown)|85
134412|NCT00271024|323090|P2|Received Study Treatment|Overall Study|n=6 did not start treatment (1 diff treat. desired, 3 lost interest, 1 began psych meds, 1 unknown)|71
134413|NCT00271024|323091|P1|Received Study Treatment|Overall Study|n=4 did not start treatment (3 lost interest, 1 unknown)|76
134414|NCT00271024|323088|P4|STARTED|Overall Study||88
134415|NCT00271024|323089|P3|STARTED|Overall Study||88
134416|NCT00271024|323090|P2|STARTED|Overall Study||77
134417|NCT00271024|323091|P1|STARTED|Overall Study||80
134418|NCT00271154|323135|P2|NOT COMPLETED|Overall Study||0
134419|NCT00271154|323136|P1|NOT COMPLETED|Overall Study||0
134420|NCT00271154|323135|P2|COMPLETED|Overall Study||419
134421|NCT00271154|323136|P1|COMPLETED|Overall Study||191
134422|NCT00271154|323135|P2|STARTED|Overall Study||419
134423|NCT00271154|323136|P1|STARTED|Overall Study||191
134424|NCT00271219|323147|P2|NOT COMPLETED|Overall Study||28
134425|NCT00271219|323148|P1|NOT COMPLETED|Overall Study||16
134426|NCT00271219|323147|P2|COMPLETED|Overall Study||58
134427|NCT00271219|323148|P1|COMPLETED|Overall Study||73
134428|NCT00271219|323147|P2|STARTED|Overall Study||86
134429|NCT00271219|323148|P1|STARTED|Overall Study||89
134430|NCT00271375|323175|P3|NOT COMPLETED|Overall Study||0
134431|NCT00271375|323176|P2|NOT COMPLETED|Overall Study||0
134432|NCT00271375|323177|P1|NOT COMPLETED|Overall Study||0
134433|NCT00271375|323175|P3|COMPLETED|Overall Study||57
134434|NCT00271375|323176|P2|COMPLETED|Overall Study||83
134435|NCT00271375|323177|P1|COMPLETED|Overall Study||114
134436|NCT00271375|323175|P3|STARTED|Overall Study||57
134437|NCT00271375|323176|P2|STARTED|Overall Study||83
134438|NCT00271375|323177|P1|STARTED|Overall Study||114
134439|NCT00271544|323213|P1|NOT COMPLETED|Overall Study||20
134440|NCT00271544|323213|P1|COMPLETED|Overall Study|Total number subjects successfully implanted 4196 lead.|170
134441|NCT00271544|323213|P1|Model 4196 Lead Attempted|Overall Study|Total number of subjects attempted Model 4196 lead.|177
134442|NCT00271544|323213|P1|Implant Attempted|Overall Study|Total number of subjects completed baseline and underwent system implant attempt.|186
134443|NCT00271544|323213|P1|STARTED|Overall Study|Total number of subjects enrolled.|190
134444|NCT00271570|323236|P2|NOT COMPLETED|Overall Study||0
134445|NCT00271570|323237|P1|NOT COMPLETED|Overall Study||0
134446|NCT00271570|323236|P2|COMPLETED|Overall Study||12
134447|NCT00271570|323237|P1|COMPLETED|Overall Study||12
134448|NCT00271570|323236|P2|STARTED|Overall Study||12
134449|NCT00271570|323237|P1|STARTED|Overall Study||12
134450|NCT00271596|323247|P2|NOT COMPLETED|Overall Study||1
134451|NCT00271596|323248|P1|NOT COMPLETED|Overall Study||1
134452|NCT00271596|323247|P2|COMPLETED|Overall Study||15
134453|NCT00271596|323248|P1|COMPLETED|Overall Study||16
134454|NCT00271596|323247|P2|STARTED|Overall Study||16
134455|NCT00271596|323248|P1|STARTED|Overall Study||17
134456|NCT00271609|323274|P2|NOT COMPLETED|Overall Study||3
134457|NCT00271609|323275|P1|NOT COMPLETED|Overall Study||13
134458|NCT00271609|323274|P2|COMPLETED|Overall Study||29
134459|NCT00271609|323275|P1|COMPLETED|Overall Study||43
134460|NCT00271609|323274|P2|STARTED|Overall Study||32
134461|NCT00271609|323275|P1|STARTED|Overall Study||56
134462|NCT00271739|323285|P2|NOT COMPLETED|Overall Study||105
134463|NCT00271739|323286|P1|NOT COMPLETED|Overall Study||115
134464|NCT00271739|323285|P2|COMPLETED|Overall Study||716
134465|NCT00271739|323286|P1|COMPLETED|Overall Study||729
134466|NCT00271739|323285|P2|STARTED|Overall Study||821
134467|NCT00271739|323286|P1|STARTED|Overall Study||844
134468|NCT00271817|323299|P3|NOT COMPLETED|Part 2||84
134469|NCT00271817|323300|P2|NOT COMPLETED|Part 2||32
134470|NCT00271817|323301|P1|NOT COMPLETED|Part 2||0
134471|NCT00271817|323299|P3|COMPLETED|Part 2||401
134472|NCT00271817|323300|P2|COMPLETED|Part 2||234
134473|NCT00271817|323301|P1|COMPLETED|Part 2||0
134474|NCT00271817|323299|P3|STARTED|Part 2|Includes 105 patients re-allocated from the niacin group in Part 1|485
134475|NCT00271817|323300|P2|STARTED|Part 2|Includes 54 patients re-allocated from the niacin group in Part 1|266
134476|NCT00271817|323301|P1|STARTED|Part 2|Patients completing the niacin group in Part 1, were re-allocated to one of the two arms in Part 2|0
134477|NCT00271817|323299|P3|NOT COMPLETED|Part 1||285
134478|NCT00271817|323300|P2|NOT COMPLETED|Part 1||59
134479|NCT00271817|323301|P1|NOT COMPLETED|Part 1||106
134480|NCT00271817|323299|P3|COMPLETED|Part 1|11 patients who completed Part 1 did not continue to Part 2|391
134481|NCT00271817|323300|P2|COMPLETED|Part 1|1 patient who completed Part 1 did not continue to Part 2|213
134482|NCT00271817|323301|P1|COMPLETED|Part 1|6 patients who completed Part 1 did not continue to Part 2; 1 patient never received drug in Part 2|166
134483|NCT00271817|323299|P3|STARTED|Part 1||676
134484|NCT00271817|323300|P2|STARTED|Part 1||272
134485|NCT00271817|323301|P1|STARTED|Part 1||272
134486|NCT00271856|323330|P2|NOT COMPLETED|Overall Study||18
134487|NCT00271856|323331|P1|NOT COMPLETED|Overall Study||11
134488|NCT00271856|323330|P2|COMPLETED|Overall Study||70
134489|NCT00271856|323331|P1|COMPLETED|Overall Study||78
134490|NCT00271856|323330|P2|STARTED|Overall Study||88
134491|NCT00271856|323331|P1|STARTED|Overall Study||89
134492|NCT00271947|323347|P1|NOT COMPLETED|Overall Study||1
134493|NCT00271947|323347|P1|COMPLETED|Overall Study||0
134494|NCT00271947|323347|P1|STARTED|Overall Study||1
134495|NCT00272038|323351|P1|NOT COMPLETED|Overall Study||7
134496|NCT00272038|323351|P1|COMPLETED|Overall Study||22
134497|NCT00272038|323351|P1|STARTED|Overall Study||29
134498|NCT00272168|323359|P2|NOT COMPLETED|Overall Study||10
134499|NCT00272168|323360|P1|NOT COMPLETED|Overall Study||10
134500|NCT00272168|323359|P2|COMPLETED|Overall Study||31
134501|NCT00272168|323360|P1|COMPLETED|Overall Study||37
134502|NCT00272168|323359|P2|STARTED|Overall Study||41
134503|NCT00272168|323360|P1|STARTED|Overall Study||47
134504|NCT00272311|323381|P5|NOT COMPLETED|Overall Study||0
134505|NCT00272311|323382|P4|NOT COMPLETED|Overall Study||0
134506|NCT00272311|323383|P3|NOT COMPLETED|Overall Study||0
134507|NCT00272311|323384|P2|NOT COMPLETED|Overall Study||0
134508|NCT00272311|323385|P1|NOT COMPLETED|Overall Study||0
134509|NCT00272311|323381|P5|COMPLETED|Overall Study||14
134510|NCT00272311|323382|P4|COMPLETED|Overall Study||14
134511|NCT00272311|323383|P3|COMPLETED|Overall Study||14
134512|NCT00272311|323384|P2|COMPLETED|Overall Study||14
134513|NCT00272311|323385|P1|COMPLETED|Overall Study||14
134514|NCT00272311|323381|P5|STARTED|Overall Study||14
134515|NCT00272311|323382|P4|STARTED|Overall Study||14
134516|NCT00272311|323383|P3|STARTED|Overall Study||14
134517|NCT00272311|323384|P2|STARTED|Overall Study||14
134518|NCT00272311|323385|P1|STARTED|Overall Study||14
134519|NCT00272337|323402|P5|NOT COMPLETED|Overall Study||0
134520|NCT00272337|323403|P4|NOT COMPLETED|Overall Study||0
134521|NCT00272337|323404|P3|NOT COMPLETED|Overall Study||0
134522|NCT00272337|323405|P2|NOT COMPLETED|Overall Study||0
134523|NCT00272337|323406|P1|NOT COMPLETED|Overall Study||0
134524|NCT00272337|323402|P5|COMPLETED|Overall Study||8
134525|NCT00272337|323403|P4|COMPLETED|Overall Study||7
134526|NCT00272337|323404|P3|COMPLETED|Overall Study||7
134527|NCT00272337|323405|P2|COMPLETED|Overall Study||7
134528|NCT00272337|323406|P1|COMPLETED|Overall Study||8
134529|NCT00272337|323402|P5|STARTED|Overall Study||8
134530|NCT00272337|323403|P4|STARTED|Overall Study||7
134531|NCT00272337|323404|P3|STARTED|Overall Study||7
134532|NCT00272337|323405|P2|STARTED|Overall Study||7
134533|NCT00272337|323406|P1|STARTED|Overall Study||8
134534|NCT00278525|323420|P2|NOT COMPLETED|Overall Study||0
134535|NCT00278525|323421|P1|NOT COMPLETED|Overall Study||0
134536|NCT00278525|323420|P2|COMPLETED|Overall Study|7 participant crossed over to the HSCT arm and underwent HSCT, in accordance with the protocol.|10
134537|NCT00278525|323421|P1|COMPLETED|Overall Study|7 participants crossed to HSCT arm in accordance with the protocol|9
134538|NCT00278525|323420|P2|STARTED|Overall Study||10
134539|NCT00278525|323421|P1|STARTED|Overall Study||9
134540|NCT00278655|323429|P1|NOT COMPLETED|Overall Study||0
134541|NCT00278655|323429|P1|COMPLETED|Overall Study||21
134542|NCT00278655|323429|P1|STARTED|Overall Study||21
134543|NCT00282815|323436|P2|NOT COMPLETED|Overall Study||6
134544|NCT00282815|323437|P1|NOT COMPLETED|Overall Study||7
134545|NCT00282815|323436|P2|COMPLETED|Overall Study||11
134546|NCT00282815|323437|P1|COMPLETED|Overall Study||8
134547|NCT00282815|323436|P2|STARTED|Overall Study||17
134548|NCT00282815|323437|P1|STARTED|Overall Study||15
134549|NCT00282828|323449|P3|NOT COMPLETED|Overall Study||9
134550|NCT00282828|323450|P2|NOT COMPLETED|Overall Study||12
134551|NCT00282828|323451|P1|NOT COMPLETED|Overall Study||6
134552|NCT00282828|323449|P3|COMPLETED|Overall Study||50
134553|NCT00282828|323450|P2|COMPLETED|Overall Study||47
134554|NCT00282828|323451|P1|COMPLETED|Overall Study||57
134555|NCT00282828|323449|P3|STARTED|Overall Study||59
134556|NCT00282828|323450|P2|STARTED|Overall Study||59
134557|NCT00282828|323451|P1|STARTED|Overall Study||63
134558|NCT00282867|323465|P3|NOT COMPLETED|Overall Study||0
134559|NCT00282867|323466|P2|NOT COMPLETED|Overall Study||1
134560|NCT00282867|323467|P1|NOT COMPLETED|Overall Study||1
134561|NCT00282867|323465|P3|COMPLETED|Overall Study||25
134562|NCT00282867|323466|P2|COMPLETED|Overall Study||24
134563|NCT00282867|323467|P1|COMPLETED|Overall Study||23
134564|NCT00282867|323465|P3|STARTED|Overall Study||25
134565|NCT00282867|323466|P2|STARTED|Overall Study||25
134566|NCT00282867|323467|P1|STARTED|Overall Study||24
134567|NCT00282919|323481|P1|NOT COMPLETED|Overall Study||7
134568|NCT00282919|323481|P1|COMPLETED|Overall Study||103
134569|NCT00282919|323481|P1|STARTED|Overall Study||110
134570|NCT00282971|323495|P2|NOT COMPLETED|Overall Study||22
134571|NCT00282971|323496|P1|NOT COMPLETED|Overall Study||34
134572|NCT00282971|323495|P2|COMPLETED|Overall Study||149
134573|NCT00282971|323496|P1|COMPLETED|Overall Study||146
134574|NCT00282971|323495|P2|STARTED|Overall Study||171
134575|NCT00282971|323496|P1|STARTED|Overall Study||180
134576|NCT00282984|323508|P2|NOT COMPLETED|Overall Study||61
134577|NCT00282984|323509|P1|NOT COMPLETED|Overall Study||51
134578|NCT00282984|323508|P2|COMPLETED|Overall Study||289
134579|NCT00282984|323509|P1|COMPLETED|Overall Study||302
134580|NCT00282984|323508|P2|STARTED|Overall Study||350
134581|NCT00282984|323509|P1|STARTED|Overall Study||353
134582|NCT00283049|323536|P3|NOT COMPLETED|Overall Study||54
134583|NCT00283049|323537|P2|NOT COMPLETED|Overall Study||45
134584|NCT00283049|323538|P1|NOT COMPLETED|Overall Study||58
134585|NCT00283049|323536|P3|COMPLETED|Overall Study||76
134586|NCT00283049|323537|P2|COMPLETED|Overall Study||83
134587|NCT00283049|323538|P1|COMPLETED|Overall Study||70
134588|NCT00283049|323536|P3|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|130
134589|NCT00283049|323537|P2|STARTED|Overall Study|1 randomized patient did not receive study drug and was not included in the safety population|128
134590|NCT00283049|323538|P1|STARTED|Overall Study|2 randomized patients did not receive study drug and were not included in the safety population|128
134591|NCT00283062|323568|P4|NOT COMPLETED|Overall Study||49
134592|NCT00283062|323569|P3|NOT COMPLETED|Overall Study||41
134593|NCT00283062|323570|P2|NOT COMPLETED|Overall Study||7
134594|NCT00283062|323571|P1|NOT COMPLETED|Overall Study||12
134595|NCT00283062|323568|P4|COMPLETED|Overall Study||13
134596|NCT00283062|323569|P3|COMPLETED|Overall Study||15
134597|NCT00283062|323570|P2|COMPLETED|Overall Study||48
134598|NCT00283062|323571|P1|COMPLETED|Overall Study||43
134599|NCT00283062|323568|P4|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
134600|NCT00283062|323569|P3|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||15
134601|NCT00283062|323570|P2|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study|Not applicable, since participants in this arm did not receive chemotherapy.|0
134602|NCT00283062|323571|P1|COMPLETED CHEMOTHERAPY (6 Cycles)|Overall Study||43
134603|NCT00283062|323568|P4|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||13
134604|NCT00283062|323569|P3|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||15
134605|NCT00283062|323570|P2|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||48
134606|NCT00283062|323571|P1|COMPLETED HORMONAL THERAPY (6 Cycles)|Overall Study||44
134607|NCT00283062|323568|P4|ADMINISTERED STUDY TREATMENT|Overall Study||17
134608|NCT00283062|323569|P3|ADMINISTERED STUDY TREATMENT|Overall Study||20
134609|NCT00283062|323570|P2|ADMINISTERED STUDY TREATMENT|Overall Study||51
134610|NCT00283062|323571|P1|ADMINISTERED STUDY TREATMENT|Overall Study||50
134611|NCT00283062|323568|P4|STARTED|Overall Study||62
134612|NCT00283062|323569|P3|STARTED|Overall Study||56
134613|NCT00283062|323570|P2|STARTED|Overall Study||55
134614|NCT00283062|323571|P1|STARTED|Overall Study||55
134615|NCT00283075|323601|P2|NOT COMPLETED|Overall Study||0
134616|NCT00283075|323602|P1|NOT COMPLETED|Overall Study||0
134617|NCT00283075|323601|P2|COMPLETED|Overall Study||6
134618|NCT00283075|323602|P1|COMPLETED|Overall Study||25
134619|NCT00283075|323601|P2|STARTED|Overall Study||6
134620|NCT00283075|323602|P1|STARTED|Overall Study||25
134621|NCT00283244|323616|P3|NOT COMPLETED|Overall Study||51
134622|NCT00283244|323617|P2|NOT COMPLETED|Overall Study||51
134623|NCT00283244|323618|P1|NOT COMPLETED|Overall Study||18
134624|NCT00283244|323616|P3|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 9 patients received 2nd line therapy|0
134625|NCT00283244|323617|P2|COMPLETED|Overall Study|Patients treated until progression or unacceptable toxicity; 12 patients received 2nd line therapy|0
134626|NCT00283244|323618|P1|COMPLETED|Overall Study|19 patients went on to receive second line Erlotinib|26
134627|NCT00283244|323616|P3|STARTED|Overall Study||51
134628|NCT00283244|323617|P2|STARTED|Overall Study||51
134629|NCT00283244|323618|P1|STARTED|Overall Study||44
134630|NCT00283296|323638|P1|NOT COMPLETED|Overall Study||5
134631|NCT00283296|323638|P1|COMPLETED|Overall Study|Completed in-lab and in-home trial.|9
134632|NCT00283296|323638|P1|STARTED|Overall Study||14
134633|NCT00283387|323644|P2|NOT COMPLETED|Second Intervention||0
134634|NCT00283387|323645|P1|NOT COMPLETED|Second Intervention||0
134635|NCT00283387|323644|P2|COMPLETED|Second Intervention||5
134636|NCT00283387|323645|P1|COMPLETED|Second Intervention||5
134637|NCT00283387|323644|P2|STARTED|Second Intervention||5
134638|NCT00283387|323645|P1|STARTED|Second Intervention||5
134639|NCT00283387|323644|P2|NOT COMPLETED|Washout Period of 2 Months||0
134640|NCT00283387|323645|P1|NOT COMPLETED|Washout Period of 2 Months||0
134641|NCT00283387|323644|P2|COMPLETED|Washout Period of 2 Months||5
134642|NCT00283387|323645|P1|COMPLETED|Washout Period of 2 Months||5
134643|NCT00283387|323644|P2|STARTED|Washout Period of 2 Months||5
134644|NCT00283387|323645|P1|STARTED|Washout Period of 2 Months||5
134645|NCT00283387|323644|P2|NOT COMPLETED|First Intervention||2
134646|NCT00283387|323645|P1|NOT COMPLETED|First Intervention||1
134647|NCT00283387|323644|P2|COMPLETED|First Intervention||5
134648|NCT00283387|323645|P1|COMPLETED|First Intervention||5
134649|NCT00283387|323644|P2|STARTED|First Intervention||7
134650|NCT00283387|323645|P1|STARTED|First Intervention||6
134651|NCT00283400|323655|P4|NOT COMPLETED|Overall Study||0
134652|NCT00283400|323656|P3|NOT COMPLETED|Overall Study||1
134653|NCT00283400|323657|P2|NOT COMPLETED|Overall Study||1
134654|NCT00283400|323658|P1|NOT COMPLETED|Overall Study||2
134655|NCT00283400|323655|P4|COMPLETED|Overall Study||0
134656|NCT00283400|323656|P3|COMPLETED|Overall Study||6
134657|NCT00283400|323657|P2|COMPLETED|Overall Study||19
134658|NCT00283400|323658|P1|COMPLETED|Overall Study||18
134659|NCT00283400|323655|P4|STARTED|Overall Study||0
134660|NCT00283400|323656|P3|STARTED|Overall Study||7
134661|NCT00283400|323657|P2|STARTED|Overall Study||20
134662|NCT00283400|323658|P1|STARTED|Overall Study||20
134663|NCT00283439|323680|P4|NOT COMPLETED|Overall Study||9
134664|NCT00283439|323681|P3|NOT COMPLETED|Overall Study||11
134665|NCT00283439|323682|P2|NOT COMPLETED|Overall Study||11
134666|NCT00283439|323683|P1|NOT COMPLETED|Overall Study||8
134667|NCT00283439|323680|P4|COMPLETED|Overall Study||0
134668|NCT00283439|323681|P3|COMPLETED|Overall Study||0
134669|NCT00283439|323682|P2|COMPLETED|Overall Study||0
134670|NCT00283439|323683|P1|COMPLETED|Overall Study||0
134671|NCT00283439|323680|P4|STARTED|Overall Study||9
134672|NCT00283439|323681|P3|STARTED|Overall Study||11
134673|NCT00283439|323682|P2|STARTED|Overall Study||11
134674|NCT00283439|323683|P1|STARTED|Overall Study||8
134675|NCT00283595|323707|P2|NOT COMPLETED|Overall Study||2
134676|NCT00283595|323708|P1|NOT COMPLETED|Overall Study||1
134677|NCT00283595|323707|P2|COMPLETED|Overall Study||9
134678|NCT00283595|323708|P1|COMPLETED|Overall Study||9
134679|NCT00283595|323707|P2|STARTED|Overall Study||11
134680|NCT00283595|323708|P1|STARTED|Overall Study||10
134681|NCT00283686|323720|P4|NOT COMPLETED|Overall Study||32
134682|NCT00283686|323721|P3|NOT COMPLETED|Overall Study||33
134683|NCT00283686|323722|P2|NOT COMPLETED|Overall Study||41
134684|NCT00283686|323723|P1|NOT COMPLETED|Overall Study||29
134685|NCT00283686|323720|P4|COMPLETED|Overall Study||109
134686|NCT00283686|323721|P3|COMPLETED|Overall Study||111
134687|NCT00283686|323722|P2|COMPLETED|Overall Study||92
134688|NCT00283686|323723|P1|COMPLETED|Overall Study||111
134689|NCT00283686|323720|P4|STARTED|Overall Study||141
134690|NCT00283686|323721|P3|STARTED|Overall Study||144
134691|NCT00283686|323722|P2|STARTED|Overall Study||133
134692|NCT00283686|323723|P1|STARTED|Overall Study||140
134693|NCT00283712|323767|P2|NOT COMPLETED|Overall Study||1
134694|NCT00283712|323768|P1|NOT COMPLETED|Overall Study||0
134695|NCT00283712|323767|P2|COMPLETED|Overall Study|One subject in placebo arm died prior to study completion.|9
134696|NCT00283712|323768|P1|COMPLETED|Overall Study||10
134697|NCT00283712|323767|P2|Per-Protocol Sample|Overall Study||7
134698|NCT00283712|323768|P1|Per-Protocol Sample|Overall Study||6
134699|NCT00283712|323767|P2|Safety Sample|Overall Study||10
134700|NCT00283712|323768|P1|Safety Sample|Overall Study||10
134701|NCT00283712|323767|P2|Intent-to-treat Sample|Overall Study||10
134702|NCT00283712|323768|P1|Intent-to-treat Sample|Overall Study||10
134703|NCT00283712|323767|P2|STARTED|Overall Study||10
134704|NCT00283712|323768|P1|STARTED|Overall Study||10
134705|NCT00283816|323804|P2|NOT COMPLETED|Overall Study||2
134706|NCT00283816|323805|P1|NOT COMPLETED|Overall Study||2
134707|NCT00283816|323804|P2|COMPLETED|Overall Study||16
134708|NCT00283816|323805|P1|COMPLETED|Overall Study||16
134709|NCT00283816|323804|P2|STARTED|Overall Study||18
134710|NCT00283816|323805|P1|STARTED|Overall Study||18
134711|NCT00283842|323822|P5|NOT COMPLETED|Overall Study||15
134712|NCT00283842|323823|P4|NOT COMPLETED|Overall Study||27
134713|NCT00283842|323824|P3|NOT COMPLETED|Overall Study||31
134714|NCT00283842|323825|P2|NOT COMPLETED|Overall Study||18
134715|NCT00283842|323826|P1|NOT COMPLETED|Overall Study||12
134716|NCT00283842|323822|P5|COMPLETED|Overall Study||75
134717|NCT00283842|323823|P4|COMPLETED|Overall Study||42
134718|NCT00283842|323824|P3|COMPLETED|Overall Study||68
134719|NCT00283842|323825|P2|COMPLETED|Overall Study||69
134720|NCT00283842|323826|P1|COMPLETED|Overall Study||51
134721|NCT00283842|323822|P5|STARTED|Overall Study||90
134722|NCT00283842|323823|P4|STARTED|Overall Study||69
134723|NCT00283842|323824|P3|STARTED|Overall Study||99
134724|NCT00283842|323825|P2|STARTED|Overall Study||87
134725|NCT00283842|323826|P1|STARTED|Overall Study||63
134726|NCT00283868|323845|P2|NOT COMPLETED|Overall Study||8
134727|NCT00283868|323846|P1|NOT COMPLETED|Overall Study||7
134728|NCT00283868|323845|P2|COMPLETED|Overall Study||103
134729|NCT00283868|323846|P1|COMPLETED|Overall Study||104
134730|NCT00283868|323845|P2|STARTED|Overall Study||111
134731|NCT00283868|323846|P1|STARTED|Overall Study||111
134732|NCT00284050|323861|P3|NOT COMPLETED|Overall Study||9
134733|NCT00284050|323862|P2|NOT COMPLETED|Overall Study||5
134734|NCT00284050|323863|P1|NOT COMPLETED|Overall Study||5
134735|NCT00284050|323861|P3|COMPLETED|Overall Study||40
134736|NCT00284050|323862|P2|COMPLETED|Overall Study||46
134737|NCT00284050|323863|P1|COMPLETED|Overall Study||46
134738|NCT00284050|323861|P3|STARTED|Overall Study||49
134739|NCT00284050|323862|P2|STARTED|Overall Study||51
134740|NCT00284050|323863|P1|STARTED|Overall Study||51
134741|NCT00284089|323881|P4|NOT COMPLETED|Extension Phase||12
134742|NCT00284089|323882|P3|NOT COMPLETED|Extension Phase||6
134743|NCT00284089|323883|P2|NOT COMPLETED|Extension Phase||0
134744|NCT00284089|323884|P1|NOT COMPLETED|Extension Phase||2
134745|NCT00284089|323881|P4|COMPLETED|Extension Phase||21
134746|NCT00284089|323882|P3|COMPLETED|Extension Phase||22
134747|NCT00284089|323883|P2|COMPLETED|Extension Phase||6
134748|NCT00284089|323884|P1|COMPLETED|Extension Phase||1
134749|NCT00284089|323881|P4|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|33
134750|NCT00284089|323882|P3|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|28
134751|NCT00284089|323883|P2|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|6
134752|NCT00284089|323884|P1|STARTED|Extension Phase|Patients providing written consent & satisfying eligibility criteria could enter the extension phase|3
134753|NCT00284089|323881|P4|NOT COMPLETED|Multiple Dose Phase||4
134754|NCT00284089|323882|P3|NOT COMPLETED|Multiple Dose Phase||4
134755|NCT00284089|323883|P2|NOT COMPLETED|Multiple Dose Phase||0
134756|NCT00284089|323884|P1|NOT COMPLETED|Multiple Dose Phase||1
134757|NCT00284089|323881|P4|COMPLETED|Multiple Dose Phase||37
134758|NCT00284089|323882|P3|COMPLETED|Multiple Dose Phase||31
134759|NCT00284089|323883|P2|COMPLETED|Multiple Dose Phase||6
134760|NCT00284089|323884|P1|COMPLETED|Multiple Dose Phase||4
134761|NCT00284089|323881|P4|STARTED|Multiple Dose Phase||41
134762|NCT00284089|323882|P3|STARTED|Multiple Dose Phase||35
134763|NCT00284089|323883|P2|STARTED|Multiple Dose Phase||6
134764|NCT00284089|323884|P1|STARTED|Multiple Dose Phase|1 subject chose to receive other treatment & discontinued before starting the multiple dose phase.|5
134765|NCT00284089|323881|P4|NOT COMPLETED|Single Dose Phase||0
134766|NCT00284089|323882|P3|NOT COMPLETED|Single Dose Phase||0
134767|NCT00284089|323883|P2|NOT COMPLETED|Single Dose Phase||0
134768|NCT00284089|323884|P1|NOT COMPLETED|Single Dose Phase||0
134769|NCT00284089|323881|P4|COMPLETED|Single Dose Phase||0
134770|NCT00284089|323882|P3|COMPLETED|Single Dose Phase||0
134771|NCT00284089|323883|P2|COMPLETED|Single Dose Phase||6
134772|NCT00284089|323884|P1|COMPLETED|Single Dose Phase||6
134773|NCT00284089|323881|P4|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
134774|NCT00284089|323882|P3|STARTED|Single Dose Phase|Group B patients did not participate in the Single Dose Phase of the study.|0
134775|NCT00284089|323883|P2|STARTED|Single Dose Phase||6
134776|NCT00284089|323884|P1|STARTED|Single Dose Phase||6
134777|NCT00284141|323910|P1|NOT COMPLETED|Overall Study||98
134861|NCT00275262|324087|P1|STARTED|Overall Study||12
134778|NCT00284141|323910|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were still ongoing treatment.|0
134779|NCT00284141|323910|P1|ONGOING TREATMENT|Overall Study|Participants were still on study treatment at the clinical database cut-off date.|2
134780|NCT00284141|323910|P1|TREATED|Overall Study|Participants received at least part of one dose of Aflibercept.|96
134781|NCT00284141|323910|P1|STARTED|Overall Study||98
134782|NCT00284154|323929|P1|NOT COMPLETED|Overall Study||42
134783|NCT00284154|323929|P1|COMPLETED|Overall Study||9
134784|NCT00284154|323929|P1|STARTED|Overall Study||51
134785|NCT00284180|323938|P2|NOT COMPLETED|Overall Study||4
134786|NCT00284180|323939|P1|NOT COMPLETED|Overall Study||0
134787|NCT00284180|323938|P2|COMPLETED|Overall Study||17
134788|NCT00284180|323939|P1|COMPLETED|Overall Study||11
134789|NCT00284180|323938|P2|STARTED|Overall Study||21
134790|NCT00284180|323939|P1|STARTED|Overall Study||11
134791|NCT00284518|323949|P4|NOT COMPLETED|Overall Study||33
134792|NCT00284518|323950|P3|NOT COMPLETED|Overall Study||28
134793|NCT00284518|323951|P2|NOT COMPLETED|Overall Study||28
134794|NCT00284518|323952|P1|NOT COMPLETED|Overall Study||26
134795|NCT00284518|323949|P4|COMPLETED|Overall Study||61
134796|NCT00284518|323950|P3|COMPLETED|Overall Study||67
134797|NCT00284518|323951|P2|COMPLETED|Overall Study||66
134798|NCT00284518|323952|P1|COMPLETED|Overall Study||71
134799|NCT00284518|323949|P4|STARTED|Overall Study||94
134800|NCT00284518|323950|P3|STARTED|Overall Study||95
134801|NCT00284518|323951|P2|STARTED|Overall Study||94
134802|NCT00284518|323952|P1|STARTED|Overall Study||97
134803|NCT00284557|323992|P2|NOT COMPLETED|Overall Study||13
134804|NCT00284557|323993|P1|NOT COMPLETED|Overall Study||9
134805|NCT00284557|323992|P2|COMPLETED|Overall Study||50
134806|NCT00284557|323993|P1|COMPLETED|Overall Study||58
134807|NCT00284557|323992|P2|STARTED|Overall Study||63
134808|NCT00284557|323993|P1|STARTED|Overall Study||67
134809|NCT00284739|324003|P2|NOT COMPLETED|Overall Study||0
134810|NCT00284739|324004|P1|NOT COMPLETED|Overall Study||0
134811|NCT00284739|324003|P2|COMPLETED|Overall Study||9
134812|NCT00284739|324004|P1|COMPLETED|Overall Study||11
134813|NCT00284739|324003|P2|STARTED|Overall Study||9
134814|NCT00284739|324004|P1|STARTED|Overall Study||11
134815|NCT00284856|324017|P3|NOT COMPLETED|Overall Study||60
134816|NCT00284856|324018|P2|NOT COMPLETED|Overall Study||50
134817|NCT00284856|324019|P1|NOT COMPLETED|Overall Study||51
134818|NCT00284856|324017|P3|COMPLETED|Overall Study||276
134819|NCT00284856|324018|P2|COMPLETED|Overall Study||286
134820|NCT00284856|324019|P1|COMPLETED|Overall Study||296
134821|NCT00284856|324017|P3|STARTED|Overall Study||336
134822|NCT00284856|324018|P2|STARTED|Overall Study||336
134823|NCT00284856|324019|P1|STARTED|Overall Study||347
134824|NCT00284934|324035|P2|NOT COMPLETED|Overall Study||3
134825|NCT00284934|324036|P1|NOT COMPLETED|Overall Study||4
134826|NCT00284934|324035|P2|COMPLETED|Overall Study||43
134827|NCT00284934|324036|P1|COMPLETED|Overall Study||44
134828|NCT00284934|324035|P2|Intent-to-treat Population (ITT)|Overall Study||45
134829|NCT00284934|324036|P1|Intent-to-treat Population (ITT)|Overall Study||47
134830|NCT00284934|324035|P2|STARTED|Overall Study||46
134831|NCT00284934|324036|P1|STARTED|Overall Study||48
134832|NCT00285012|324050|P2|NOT COMPLETED|Received Study Tx||94
134833|NCT00285012|324051|P1|NOT COMPLETED|Received Study Tx||72
134834|NCT00285012|324050|P2|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|157
134835|NCT00285012|324051|P1|COMPLETED|Received Study Tx|Completed study through nontreatment follow-up phase Week 13 to Week 52|176
134836|NCT00285012|324050|P2|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=14 AE;3 Lack of efficacy;10 Lost to follow up;25 subject withdrawal;6 other, unknown|58
134837|NCT00285012|324051|P1|Discontinued Tx (May Continue in Study)|Received Study Tx|Discontinued Tx=12 Adverse Event (AE); 10 Lost to follow up; 13 subject withdrawal; 6 other, unknown|41
134838|NCT00285012|324050|P2|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|193
134839|NCT00285012|324051|P1|Completed Tx (May Continue in Study)|Received Study Tx|After treatment completion at Wk 12, subjects may continue in nontreatment follow-up phase|207
134840|NCT00285012|324050|P2|STARTED|Received Study Tx||251
134841|NCT00285012|324051|P1|STARTED|Received Study Tx||248
134842|NCT00285012|324050|P2|NOT COMPLETED|Assigned to Study Treatment (Tx)||3
134843|NCT00285012|324051|P1|NOT COMPLETED|Assigned to Study Treatment (Tx)||2
134844|NCT00285012|324050|P2|COMPLETED|Assigned to Study Treatment (Tx)||251
134845|NCT00285012|324051|P1|COMPLETED|Assigned to Study Treatment (Tx)||248
134846|NCT00285012|324050|P2|STARTED|Assigned to Study Treatment (Tx)||254
134847|NCT00285012|324051|P1|STARTED|Assigned to Study Treatment (Tx)||250
134848|NCT00285207|324077|P2|NOT COMPLETED|Overall Study||6
134849|NCT00285207|324078|P1|NOT COMPLETED|Overall Study||9
134850|NCT00285207|324077|P2|COMPLETED|Overall Study||71
134851|NCT00285207|324078|P1|COMPLETED|Overall Study||61
134852|NCT00285207|324077|P2|Treated|Overall Study||75
134853|NCT00285207|324078|P1|Treated|Overall Study||63
134854|NCT00285207|324077|P2|STARTED|Overall Study||77
134855|NCT00285207|324078|P1|STARTED|Overall Study||70
134856|NCT00275262|324086|P2|NOT COMPLETED|Overall Study||9
134857|NCT00275262|324087|P1|NOT COMPLETED|Overall Study||6
134858|NCT00275262|324086|P2|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|4
134859|NCT00275262|324087|P1|COMPLETED|Overall Study|Patients who completed the entire 12 month study period|6
134860|NCT00275262|324086|P2|STARTED|Overall Study||13
134862|NCT00275275|324104|P3|NOT COMPLETED|Overall Study||6
134863|NCT00275275|324105|P2|NOT COMPLETED|Overall Study||2
134864|NCT00275275|324106|P1|NOT COMPLETED|Overall Study||6
134865|NCT00275275|324104|P3|COMPLETED|Overall Study||15
134866|NCT00275275|324105|P2|COMPLETED|Overall Study||18
134867|NCT00275275|324106|P1|COMPLETED|Overall Study||14
134868|NCT00275275|324104|P3|STARTED|Overall Study|One participant was removed after enrollment and before any data was collected for him.|21
134869|NCT00275275|324105|P2|STARTED|Overall Study||20
134870|NCT00275275|324106|P1|STARTED|Overall Study||20
134871|NCT00275301|324114|P1|NOT COMPLETED|Overall Study||5
134872|NCT00275301|324114|P1|COMPLETED|Overall Study||14
134873|NCT00275301|324114|P1|STARTED|Overall Study||19
134874|NCT00275340|324120|P2|NOT COMPLETED|Overall Study||4
134875|NCT00275340|324121|P1|NOT COMPLETED|Overall Study||2
134876|NCT00275340|324120|P2|COMPLETED|Overall Study||45
134877|NCT00275340|324121|P1|COMPLETED|Overall Study||50
134878|NCT00275340|324120|P2|STARTED|Overall Study||49
134879|NCT00275340|324121|P1|STARTED|Overall Study||52
134880|NCT00275392|324127|P2|NOT COMPLETED|Overall Study||2
134881|NCT00275392|324128|P1|NOT COMPLETED|Overall Study||0
134882|NCT00275392|324127|P2|COMPLETED|Overall Study||17
134883|NCT00275392|324128|P1|COMPLETED|Overall Study||20
134884|NCT00275392|324127|P2|STARTED|Overall Study||19
134885|NCT00275392|324128|P1|STARTED|Overall Study||20
134886|NCT00275561|324138|P2|NOT COMPLETED|Overall Study||6
134887|NCT00275561|324139|P1|NOT COMPLETED|Overall Study||2
134888|NCT00275561|324138|P2|COMPLETED|Overall Study||15
134889|NCT00275561|324139|P1|COMPLETED|Overall Study||19
134890|NCT00275561|324138|P2|STARTED|Overall Study||21
134891|NCT00275561|324139|P1|STARTED|Overall Study||21
134892|NCT00275821|324152|P3|NOT COMPLETED|Overall Study||12
134893|NCT00275821|324153|P2|NOT COMPLETED|Overall Study||23
134894|NCT00275821|324154|P1|NOT COMPLETED|Overall Study||14
134895|NCT00275821|324152|P3|COMPLETED|Overall Study||103
134896|NCT00275821|324153|P2|COMPLETED|Overall Study||95
134897|NCT00275821|324154|P1|COMPLETED|Overall Study||106
134898|NCT00275821|324152|P3|STARTED|Overall Study||115
134899|NCT00275821|324153|P2|STARTED|Overall Study||118
134900|NCT00275821|324154|P1|STARTED|Overall Study||120
134901|NCT00275834|324174|P3|NOT COMPLETED|Overall Study||1
134902|NCT00275834|324175|P2|NOT COMPLETED|Overall Study||3
134903|NCT00275834|324176|P1|NOT COMPLETED|Overall Study||3
134904|NCT00275834|324174|P3|COMPLETED|Overall Study||74
134905|NCT00275834|324175|P2|COMPLETED|Overall Study||73
134906|NCT00275834|324176|P1|COMPLETED|Overall Study||71
134907|NCT00275834|324174|P3|Completed Study While on Study Drug|Overall Study||62
134908|NCT00275834|324175|P2|Completed Study While on Study Drug|Overall Study||51
134909|NCT00275834|324176|P1|Completed Study While on Study Drug|Overall Study||54
134910|NCT00275834|324174|P3|STARTED|Overall Study||75
134911|NCT00275834|324175|P2|STARTED|Overall Study||76
134912|NCT00275834|324176|P1|STARTED|Overall Study||74
134913|NCT00285246|324205|P1|NOT COMPLETED|Overall Study||48
134914|NCT00285246|324205|P1|COMPLETED|Overall Study|Number of participants who were eligible and completed at least one phase of data collection|790
134915|NCT00285246|324205|P1|STARTED|Overall Study||838
134916|NCT00285467|324214|P2|NOT COMPLETED|Overall Study||0
134917|NCT00285467|324215|P1|NOT COMPLETED|Overall Study||0
134918|NCT00285467|324214|P2|COMPLETED|Overall Study||22
134919|NCT00285467|324215|P1|COMPLETED|Overall Study||25
134920|NCT00285467|324214|P2|STARTED|Overall Study||22
134921|NCT00285467|324215|P1|STARTED|Overall Study||25
134922|NCT00285584|324225|P2|NOT COMPLETED|Month 9||3
134923|NCT00285584|324226|P1|NOT COMPLETED|Month 9||1
134924|NCT00285584|324225|P2|COMPLETED|Month 9||14
134925|NCT00285584|324226|P1|COMPLETED|Month 9||15
134926|NCT00285584|324225|P2|STARTED|Month 9||17
134927|NCT00285584|324226|P1|STARTED|Month 9||16
134928|NCT00285584|324225|P2|NOT COMPLETED|Month 6||1
134929|NCT00285584|324226|P1|NOT COMPLETED|Month 6||0
134930|NCT00285584|324225|P2|COMPLETED|Month 6||17
134931|NCT00285584|324226|P1|COMPLETED|Month 6||16
134932|NCT00285584|324225|P2|STARTED|Month 6||18
134933|NCT00285584|324226|P1|STARTED|Month 6||16
134934|NCT00285584|324225|P2|NOT COMPLETED|Month 3||3
134935|NCT00285584|324226|P1|NOT COMPLETED|Month 3||4
134936|NCT00285584|324225|P2|COMPLETED|Month 3||18
134937|NCT00285584|324226|P1|COMPLETED|Month 3||16
134938|NCT00285584|324225|P2|STARTED|Month 3||21
134939|NCT00285584|324226|P1|STARTED|Month 3||20
134940|NCT00285584|324225|P2|NOT COMPLETED|Enrollment (Month 0)||0
134941|NCT00285584|324226|P1|NOT COMPLETED|Enrollment (Month 0)||0
134942|NCT00285584|324225|P2|COMPLETED|Enrollment (Month 0)||21
134943|NCT00285584|324226|P1|COMPLETED|Enrollment (Month 0)||20
134944|NCT00285584|324225|P2|STARTED|Enrollment (Month 0)||21
134945|NCT00285584|324226|P1|STARTED|Enrollment (Month 0)||20
134946|NCT00285779|324240|P2|NOT COMPLETED|Follow-up Period (wk 24-32)||0
134947|NCT00285779|324241|P1|NOT COMPLETED|Follow-up Period (wk 24-32)||1
134948|NCT00285779|324240|P2|COMPLETED|Follow-up Period (wk 24-32)||10
134949|NCT00285779|324241|P1|COMPLETED|Follow-up Period (wk 24-32)||8
134950|NCT00285779|324240|P2|STARTED|Follow-up Period (wk 24-32)||10
134951|NCT00285779|324241|P1|STARTED|Follow-up Period (wk 24-32)||9
134952|NCT00285779|324240|P2|NOT COMPLETED|Open Label Period (wk 12-24)||2
134953|NCT00285779|324241|P1|NOT COMPLETED|Open Label Period (wk 12-24)||2
134954|NCT00285779|324240|P2|COMPLETED|Open Label Period (wk 12-24)||10
134955|NCT00285779|324241|P1|COMPLETED|Open Label Period (wk 12-24)||9
134956|NCT00285779|324240|P2|STARTED|Open Label Period (wk 12-24)||12
134957|NCT00285779|324241|P1|STARTED|Open Label Period (wk 12-24)||11
134958|NCT00285779|324240|P2|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||1
134959|NCT00285779|324241|P1|NOT COMPLETED|Placebo-controlled Period (wk 1-12)||3
134960|NCT00285779|324240|P2|COMPLETED|Placebo-controlled Period (wk 1-12)||12
134961|NCT00285779|324241|P1|COMPLETED|Placebo-controlled Period (wk 1-12)||11
134962|NCT00285779|324240|P2|STARTED|Placebo-controlled Period (wk 1-12)||13
134963|NCT00285779|324241|P1|STARTED|Placebo-controlled Period (wk 1-12)||14
134964|NCT00285818|324249|P2|NOT COMPLETED|Overall Study||2
134965|NCT00285818|324250|P1|NOT COMPLETED|Overall Study||4
134966|NCT00285818|324249|P2|COMPLETED|Overall Study||3
134967|NCT00285818|324250|P1|COMPLETED|Overall Study||2
134968|NCT00285818|324249|P2|STARTED|Overall Study||5
134969|NCT00285818|324250|P1|STARTED|Overall Study||6
134970|NCT00285857|324256|P1|NOT COMPLETED|Overall Study||4
134971|NCT00285857|324256|P1|COMPLETED|Overall Study||26
134972|NCT00285857|324256|P1|STARTED|Overall Study||30
134973|NCT00286078|324269|P2|NOT COMPLETED|Overall Study||34
134974|NCT00286078|324270|P1|NOT COMPLETED|Overall Study||32
134975|NCT00286078|324269|P2|COMPLETED|Overall Study||34
134976|NCT00286078|324270|P1|COMPLETED|Overall Study||40
134977|NCT00286078|324269|P2|12 Weeks|Overall Study||62
134978|NCT00286078|324270|P1|12 Weeks|Overall Study||63
134979|NCT00286078|324269|P2|STARTED|Overall Study||68
134980|NCT00286078|324270|P1|STARTED|Overall Study||72
134981|NCT00286091|324280|P2|NOT COMPLETED|Open-label Treatment Phase||71
134982|NCT00286091|324281|P1|NOT COMPLETED|Open-label Treatment Phase||77
134983|NCT00286091|324280|P2|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
134984|NCT00286091|324281|P1|COMPLETED|Open-label Treatment Phase|Completed 3 years of open-label treatment|33
134985|NCT00286091|324280|P2|Received Treatment|Open-label Treatment Phase||101
134986|NCT00286091|324281|P1|Received Treatment|Open-label Treatment Phase||109
134987|NCT00286091|324280|P2|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|104
134988|NCT00286091|324281|P1|STARTED|Open-label Treatment Phase|Participants in the Czech Republic and UK are reported separately (Study 20080585; NCT01824342)|110
134989|NCT00286091|324280|P2|NOT COMPLETED|Double-blind Treatment Phase||593
134990|NCT00286091|324281|P1|NOT COMPLETED|Double-blind Treatment Phase||584
134991|NCT00286091|324280|P2|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|123
134992|NCT00286091|324281|P1|COMPLETED|Double-blind Treatment Phase|On study through blinded treatment cutoff date of 09 January 2011|132
134993|NCT00286091|324280|P2|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|174
134994|NCT00286091|324281|P1|On Study at Primary Data Analysis Cutoff|Double-blind Treatment Phase|Primary analysis cut-off date was 30 July 2010|164
134995|NCT00286091|324280|P2|Received Treatment|Double-blind Treatment Phase||716
134996|NCT00286091|324281|P1|Received Treatment|Double-blind Treatment Phase|4 participants received ≥ 1 dose of denosumab in error|709
134997|NCT00286091|324280|P2|STARTED|Double-blind Treatment Phase||716
134998|NCT00286091|324281|P1|STARTED|Double-blind Treatment Phase||716
134999|NCT00286156|324296|P3|NOT COMPLETED|Overall Study||1
135000|NCT00286156|324297|P2|NOT COMPLETED|Overall Study||1
135001|NCT00286156|324298|P1|NOT COMPLETED|Overall Study||2
135002|NCT00286156|324296|P3|COMPLETED|Overall Study||9
135003|NCT00286156|324297|P2|COMPLETED|Overall Study||9
135004|NCT00286156|324298|P1|COMPLETED|Overall Study||8
135005|NCT00286156|324296|P3|STARTED|Overall Study||10
135006|NCT00286156|324297|P2|STARTED|Overall Study||10
135007|NCT00286156|324298|P1|STARTED|Overall Study||10
135008|NCT00286182|324311|P2|NOT COMPLETED|Overall Study||3
135009|NCT00286182|324312|P1|NOT COMPLETED|Overall Study||5
135010|NCT00286182|324311|P2|COMPLETED|Overall Study||25
135011|NCT00286182|324312|P1|COMPLETED|Overall Study||23
135012|NCT00286182|324311|P2|STARTED|Overall Study||28
135013|NCT00286182|324312|P1|STARTED|Overall Study||28
135014|NCT00286325|324318|P1|NOT COMPLETED|Overall Study||0
135015|NCT00286325|324318|P1|COMPLETED|Overall Study||8
135016|NCT00286325|324318|P1|STARTED|Overall Study||8
135017|NCT00286429|324329|P3|NOT COMPLETED|Overall Study||52
135018|NCT00286429|324330|P2|NOT COMPLETED|Overall Study||48
135019|NCT00286429|324331|P1|NOT COMPLETED|Overall Study||75
135020|NCT00286429|324329|P3|COMPLETED|Overall Study||77
135021|NCT00286429|324330|P2|COMPLETED|Overall Study||83
135022|NCT00286429|324331|P1|COMPLETED|Overall Study||55
135023|NCT00286429|324329|P3|STARTED|Overall Study||129
135024|NCT00286429|324330|P2|STARTED|Overall Study||131
135025|NCT00286429|324331|P1|STARTED|Overall Study||130
135026|NCT00286442|324438|P3|NOT COMPLETED|Overall Study||32
135027|NCT00286442|324439|P2|NOT COMPLETED|Overall Study||45
135028|NCT00286442|324440|P1|NOT COMPLETED|Overall Study||37
135029|NCT00286442|324438|P3|COMPLETED|Overall Study||72
135030|NCT00286442|324439|P2|COMPLETED|Overall Study||165
135031|NCT00286442|324440|P1|COMPLETED|Overall Study||176
135032|NCT00286442|324438|P3|STARTED|Overall Study||104
135033|NCT00286442|324439|P2|STARTED|Overall Study||210
135034|NCT00286442|324440|P1|STARTED|Overall Study||213
135035|NCT00286455|324601|P3|NOT COMPLETED|Overall Study||24
135036|NCT00286455|324602|P2|NOT COMPLETED|Overall Study||28
135037|NCT00286455|324603|P1|NOT COMPLETED|Overall Study||25
135038|NCT00286455|324601|P3|COMPLETED|Overall Study||107
135039|NCT00286455|324602|P2|COMPLETED|Overall Study||105
135040|NCT00286455|324603|P1|COMPLETED|Overall Study||40
135041|NCT00286455|324601|P3|STARTED|Overall Study||131
135042|NCT00286455|324602|P2|STARTED|Overall Study||133
135043|NCT00286455|324603|P1|STARTED|Overall Study||65
135044|NCT00286468|324782|P3|NOT COMPLETED|Overall Study||50
135045|NCT00286468|324783|P2|NOT COMPLETED|Overall Study||50
135046|NCT00286468|324784|P1|NOT COMPLETED|Overall Study||37
135047|NCT00286468|324782|P3|COMPLETED|Overall Study||148
135048|NCT00286468|324783|P2|COMPLETED|Overall Study||153
135049|NCT00286468|324784|P1|COMPLETED|Overall Study||62
135050|NCT00286468|324782|P3|STARTED|Overall Study||198
135051|NCT00286468|324783|P2|STARTED|Overall Study||203
135052|NCT00286468|324784|P1|STARTED|Overall Study||99
135053|NCT00286494|324945|P3|NOT COMPLETED|Overall Study||39
135054|NCT00286494|324946|P2|NOT COMPLETED|Overall Study||44
135055|NCT00286494|324947|P1|NOT COMPLETED|Overall Study||26
135056|NCT00286494|324945|P3|COMPLETED|Overall Study||160
135057|NCT00286494|324946|P2|COMPLETED|Overall Study||153
135058|NCT00286494|324947|P1|COMPLETED|Overall Study||71
135059|NCT00286494|324945|P3|STARTED|Overall Study||199
135060|NCT00286494|324946|P2|STARTED|Overall Study||197
135061|NCT00286494|324947|P1|STARTED|Overall Study||97
135062|NCT00286728|325107|P2|NOT COMPLETED|Overall Study||29
135063|NCT00286728|325108|P1|NOT COMPLETED|Overall Study||36
135064|NCT00286728|325107|P2|COMPLETED|Overall Study||116
135065|NCT00286728|325108|P1|COMPLETED|Overall Study||106
135066|NCT00286728|325107|P2|STARTED|Overall Study||145
135067|NCT00286728|325108|P1|STARTED|Overall Study||142
135068|NCT00286741|325116|P2|NOT COMPLETED|Overall Study||17
135069|NCT00286741|325117|P1|NOT COMPLETED|Overall Study||11
135070|NCT00286741|325116|P2|COMPLETED|Overall Study||89
135071|NCT00286741|325117|P1|COMPLETED|Overall Study||122
135072|NCT00286741|325116|P2|STARTED|Overall Study||106
135073|NCT00286741|325117|P1|STARTED|Overall Study||133
135074|NCT00286754|325128|P3|NOT COMPLETED|Overall Study||10
135075|NCT00286754|325129|P2|NOT COMPLETED|Overall Study||18
135076|NCT00286754|325130|P1|NOT COMPLETED|Overall Study||20
135077|NCT00286754|325128|P3|COMPLETED|Overall Study||170
135078|NCT00286754|325129|P2|COMPLETED|Overall Study||159
135079|NCT00286754|325130|P1|COMPLETED|Overall Study||156
135080|NCT00286754|325128|P3|STARTED|Overall Study||180
135081|NCT00286754|325129|P2|STARTED|Overall Study||177
135082|NCT00286754|325130|P1|STARTED|Overall Study||176
135083|NCT00287053|325164|P2|NOT COMPLETED|Overall Study||1
135084|NCT00287053|325165|P1|NOT COMPLETED|Overall Study||4
135085|NCT00287053|325164|P2|COMPLETED|Overall Study||26
135086|NCT00287053|325165|P1|COMPLETED|Overall Study||26
135087|NCT00287053|325164|P2|STARTED|Overall Study||27
135088|NCT00287053|325165|P1|STARTED|Overall Study||30
135089|NCT00287079|325173|P2|NOT COMPLETED|Overall Study||1
135090|NCT00287079|325174|P1|NOT COMPLETED|Overall Study||22
135091|NCT00287079|325173|P2|COMPLETED|Overall Study||2
135092|NCT00287079|325174|P1|COMPLETED|Overall Study||10
135093|NCT00287079|325173|P2|STARTED|Overall Study||3
135094|NCT00287079|325174|P1|STARTED|Overall Study||32
135095|NCT00287222|325184|P1|NOT COMPLETED|Overall Study||0
135096|NCT00287222|325184|P1|COMPLETED|Overall Study||21
135097|NCT00287222|325184|P1|STARTED|Overall Study||21
135098|NCT00287339|325190|P2|NOT COMPLETED|Overall Study||0
135099|NCT00287339|325191|P1|NOT COMPLETED|Overall Study||0
135100|NCT00287339|325190|P2|COMPLETED|Overall Study||18
135101|NCT00287339|325191|P1|COMPLETED|Overall Study||22
135102|NCT00287339|325190|P2|STARTED|Overall Study||18
135103|NCT00287339|325191|P1|STARTED|Overall Study||22
135104|NCT00287365|325197|P1|NOT COMPLETED|Overall Study||13
135105|NCT00287365|325197|P1|COMPLETED|Overall Study||12
135106|NCT00287365|325197|P1|STARTED|Overall Study||25
135107|NCT00287586|325206|P2|NOT COMPLETED|Overall Study||52
135108|NCT00287586|325207|P1|NOT COMPLETED|Overall Study||45
135109|NCT00287586|325206|P2|COMPLETED|Overall Study||100
135110|NCT00287586|325207|P1|COMPLETED|Overall Study||111
135111|NCT00287586|325206|P2|Intent-to-treat: Received Study Drug|Overall Study||151
135112|NCT00287586|325207|P1|Intent-to-treat: Received Study Drug|Overall Study||155
135113|NCT00287586|325206|P2|STARTED|Overall Study||152
135114|NCT00287586|325207|P1|STARTED|Overall Study||156
135115|NCT00287716|325246|P3|NOT COMPLETED|Overall Study||31
135116|NCT00287716|325247|P2|NOT COMPLETED|Overall Study||17
135117|NCT00287716|325248|P1|NOT COMPLETED|Overall Study||38
135118|NCT00287716|325246|P3|COMPLETED|Overall Study||143
135119|NCT00287716|325247|P2|COMPLETED|Overall Study||70
135120|NCT00287716|325248|P1|COMPLETED|Overall Study||136
135121|NCT00287716|325246|P3|STARTED|Overall Study||174
135122|NCT00287716|325247|P2|STARTED|Overall Study||87
135123|NCT00287716|325248|P1|STARTED|Overall Study||174
135124|NCT00287729|325279|P2|NOT COMPLETED|Overall Study||31
135125|NCT00287729|325280|P1|NOT COMPLETED|Overall Study||34
135126|NCT00287729|325279|P2|COMPLETED|Overall Study||142
135127|NCT00287729|325280|P1|COMPLETED|Overall Study||137
135128|NCT00287729|325279|P2|STARTED|Overall Study||173
135129|NCT00287729|325280|P1|STARTED|Overall Study||171
135130|NCT00287872|325300|P1|NOT COMPLETED|Overall Study||0
135131|NCT00287872|325300|P1|COMPLETED|Overall Study||30
135132|NCT00287872|325300|P1|STARTED|Overall Study||30
135133|NCT00288054|325305|P1|NOT COMPLETED|Overall Study||24
135134|NCT00288054|325305|P1|COMPLETED|Overall Study||0
135135|NCT00288054|325305|P1|STARTED|Overall Study||24
135136|NCT00288067|325313|P1|NOT COMPLETED|Overall Study||0
135137|NCT00288067|325313|P1|COMPLETED|Overall Study||32
135138|NCT00288067|325313|P1|STARTED|Overall Study||32
135139|NCT00288080|325321|P2|NOT COMPLETED|Overall Study||23
135140|NCT00288080|325322|P1|NOT COMPLETED|Overall Study||26
135141|NCT00288080|325321|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|282
135142|NCT00288080|325322|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|281
135143|NCT00288080|325321|P2|STARTED|Overall Study||305
135144|NCT00288080|325322|P1|STARTED|Overall Study||307
135145|NCT00278863|325340|P2|NOT COMPLETED|Overall Study||2
135146|NCT00278863|325341|P1|NOT COMPLETED|Overall Study||5
135147|NCT00278863|325340|P2|COMPLETED|Overall Study||45
135148|NCT00278863|325341|P1|COMPLETED|Overall Study||44
135149|NCT00278863|325340|P2|STARTED|Overall Study||47
135150|NCT00278863|325341|P1|STARTED|Overall Study||49
135151|NCT00278876|325349|P1|NOT COMPLETED|Overall Study||9
135152|NCT00278876|325349|P1|COMPLETED|Overall Study||38
135153|NCT00278876|325349|P1|STARTED|Overall Study||47
135154|NCT00278889|325358|P3|NOT COMPLETED|Overall Study||20
135155|NCT00278889|325359|P2|NOT COMPLETED|Overall Study||27
135156|NCT00278889|325360|P1|NOT COMPLETED|Overall Study||25
135157|NCT00278889|325358|P3|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
135158|NCT00278889|325359|P2|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|47
135159|NCT00278889|325360|P1|COMPLETED|Overall Study|Ongoing at data cut-off for PFS analysis (November 2007)|48
135160|NCT00278889|325358|P3|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|19
135161|NCT00278889|325359|P2|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|20
135162|NCT00278889|325360|P1|Overall Survival Analysis|Overall Study|Ongoing at data cut-off for OS analysis (30 January 2009)|16
135163|NCT00278889|325358|P3|STARTED|Overall Study|Randomised|68
135164|NCT00278889|325359|P2|STARTED|Overall Study|Randomised|74
135165|NCT00278889|325360|P1|STARTED|Overall Study|Randomised|73
135166|NCT00278915|325386|P1|NOT COMPLETED|Overall Study||1
135167|NCT00278915|325386|P1|COMPLETED|Overall Study||29
135168|NCT00278915|325386|P1|STARTED|Overall Study|First 6 patients were dosed at 2mg/kg then increased to 4 mg/kg. Remaining 24 were dosed at 4mg/kg.|30
135169|NCT00278954|325419|P1|NOT COMPLETED|Overall Study||5
135170|NCT00278954|325419|P1|COMPLETED|Overall Study||45
135171|NCT00278954|325419|P1|STARTED|Overall Study||50
135172|NCT00278993|325427|P1|NOT COMPLETED|Overall Study||107
135173|NCT00278993|325427|P1|COMPLETED|Overall Study||1
135174|NCT00278993|325427|P1|STARTED|Overall Study||108
135175|NCT00279201|325437|P6|NOT COMPLETED|Intensification Addendum||37
135176|NCT00279201|325438|P5|NOT COMPLETED|Intensification Addendum||29
135177|NCT00279201|325439|P4|NOT COMPLETED|Intensification Addendum||28
135178|NCT00279201|325440|P3|NOT COMPLETED|Intensification Addendum||23
135179|NCT00279201|325441|P2|NOT COMPLETED|Intensification Addendum||0
135180|NCT00279201|325442|P1|NOT COMPLETED|Intensification Addendum||0
135181|NCT00279201|325437|P6|COMPLETED|Intensification Addendum||162
135182|NCT00279201|325438|P5|COMPLETED|Intensification Addendum||142
135183|NCT00279201|325439|P4|COMPLETED|Intensification Addendum||172
135184|NCT00279201|325440|P3|COMPLETED|Intensification Addendum||151
135185|NCT00279201|325441|P2|COMPLETED|Intensification Addendum||0
135186|NCT00279201|325442|P1|COMPLETED|Intensification Addendum||0
135187|NCT00279201|325437|P6|STARTED|Intensification Addendum||199
135188|NCT00279201|325438|P5|STARTED|Intensification Addendum||171
135189|NCT00279201|325439|P4|STARTED|Intensification Addendum||200
135190|NCT00279201|325440|P3|STARTED|Intensification Addendum||174
135191|NCT00279201|325441|P2|STARTED|Intensification Addendum||0
135192|NCT00279201|325442|P1|STARTED|Intensification Addendum||0
135193|NCT00279201|325437|P6|NOT COMPLETED|Maintenance||0
135194|NCT00279201|325438|P5|NOT COMPLETED|Maintenance||0
135195|NCT00279201|325439|P4|NOT COMPLETED|Maintenance||0
135196|NCT00279201|325440|P3|NOT COMPLETED|Maintenance||0
135197|NCT00279201|325441|P2|NOT COMPLETED|Maintenance||234
135198|NCT00279201|325442|P1|NOT COMPLETED|Maintenance||231
135199|NCT00279201|325437|P6|COMPLETED|Maintenance||0
135200|NCT00279201|325438|P5|COMPLETED|Maintenance||0
135201|NCT00279201|325439|P4|COMPLETED|Maintenance||0
135202|NCT00279201|325440|P3|COMPLETED|Maintenance||0
135203|NCT00279201|325441|P2|COMPLETED|Maintenance||239
135204|NCT00279201|325442|P1|COMPLETED|Maintenance||188
135205|NCT00279201|325437|P6|STARTED|Maintenance||0
135206|NCT00279201|325438|P5|STARTED|Maintenance||0
135207|NCT00279201|325439|P4|STARTED|Maintenance||0
135208|NCT00279201|325440|P3|STARTED|Maintenance||0
135209|NCT00279201|325441|P2|STARTED|Maintenance|82 left the study after initiation. 345 had HbA1c>7% and enrolled in intensification addendum.|473
135210|NCT00279201|325442|P1|STARTED|Maintenance|100 left the study after initiation. 399 had HbA1c>7% and enrolled in intensification addendum.|419
135211|NCT00279201|325437|P6|NOT COMPLETED|Initiation||0
135212|NCT00279201|325438|P5|NOT COMPLETED|Initiation||0
135213|NCT00279201|325439|P4|NOT COMPLETED|Initiation||0
135214|NCT00279201|325440|P3|NOT COMPLETED|Initiation||0
135215|NCT00279201|325441|P2|NOT COMPLETED|Initiation||145
135216|NCT00279201|325442|P1|NOT COMPLETED|Initiation||128
135217|NCT00279201|325437|P6|COMPLETED|Initiation||0
135218|NCT00279201|325438|P5|COMPLETED|Initiation||0
135219|NCT00279201|325439|P4|COMPLETED|Initiation||0
135220|NCT00279201|325440|P3|COMPLETED|Initiation||0
135221|NCT00279201|325441|P2|COMPLETED|Initiation||900
135222|NCT00279201|325442|P1|COMPLETED|Initiation||918
135223|NCT00279201|325437|P6|STARTED|Initiation||0
135224|NCT00279201|325438|P5|STARTED|Initiation||0
135225|NCT00279201|325439|P4|STARTED|Initiation||0
135226|NCT00279201|325440|P3|STARTED|Initiation||0
135227|NCT00279201|325441|P2|STARTED|Initiation||1045
135228|NCT00279201|325442|P1|STARTED|Initiation||1046
135229|NCT00279214|325588|P2|NOT COMPLETED|Overall Study||2
135230|NCT00279214|325589|P1|NOT COMPLETED|Overall Study||3
135231|NCT00279214|325588|P2|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
135232|NCT00279214|325589|P1|COMPLETED|Overall Study|Completed means the number of per-protocol patients in the study|19
135233|NCT00279214|325588|P2|STARTED|Overall Study||21
135234|NCT00279214|325589|P1|STARTED|Overall Study||22
135235|NCT00279305|325619|P2|NOT COMPLETED|Overall Study||1
135236|NCT00279305|325620|P1|NOT COMPLETED|Overall Study||8
135237|NCT00279305|325619|P2|COMPLETED|Overall Study||29
135238|NCT00279305|325620|P1|COMPLETED|Overall Study||49
135239|NCT00279305|325619|P2|STARTED|Overall Study||30
135240|NCT00279305|325620|P1|STARTED|Overall Study||57
135241|NCT00279591|325628|P2|NOT COMPLETED|Overall Study||0
135242|NCT00279591|325629|P1|NOT COMPLETED|Overall Study||0
135243|NCT00279591|325628|P2|COMPLETED|Overall Study||46
135244|NCT00279591|325629|P1|COMPLETED|Overall Study||48
135245|NCT00279591|325628|P2|STARTED|Overall Study||46
135246|NCT00279591|325629|P1|STARTED|Overall Study||48
135247|NCT00279708|325645|P2|NOT COMPLETED|Overall Study||4
135248|NCT00279708|325646|P1|NOT COMPLETED|Overall Study||3
135249|NCT00279708|325645|P2|COMPLETED|Overall Study||24
135250|NCT00279708|325646|P1|COMPLETED|Overall Study||24
135251|NCT00279708|325645|P2|STARTED|Overall Study||28
135252|NCT00279708|325646|P1|STARTED|Overall Study|"Started meaning randomized"|27
135253|NCT00279916|325654|P2|NOT COMPLETED|Overall Study||5
135254|NCT00279916|325655|P1|NOT COMPLETED|Overall Study||7
135255|NCT00279916|325654|P2|COMPLETED|Overall Study||41
135256|NCT00279916|325655|P1|COMPLETED|Overall Study||38
135257|NCT00279916|325654|P2|STARTED|Overall Study||46
135258|NCT00279916|325655|P1|STARTED|Overall Study||45
135259|NCT00280241|325675|P1|NOT COMPLETED|Overall Study||10
135260|NCT00280241|325675|P1|COMPLETED|Overall Study||55
135261|NCT00280241|325675|P1|STARTED|Overall Study||65
135262|NCT00280293|325684|P2|NOT COMPLETED|Overall Study||23
135263|NCT00280293|325685|P1|NOT COMPLETED|Overall Study||26
135264|NCT00280293|325684|P2|COMPLETED|Overall Study||34
135265|NCT00280293|325685|P1|COMPLETED|Overall Study||29
135266|NCT00280293|325684|P2|STARTED|Overall Study||57
135267|NCT00280293|325685|P1|STARTED|Overall Study||55
135268|NCT00280384|325705|P8|NOT COMPLETED|Overall Study||0
135269|NCT00280384|325706|P7|NOT COMPLETED|Overall Study||0
135270|NCT00280384|325707|P6|NOT COMPLETED|Overall Study||0
135271|NCT00280384|325708|P5|NOT COMPLETED|Overall Study||0
135272|NCT00280384|325709|P4|NOT COMPLETED|Overall Study||0
135273|NCT00280384|325710|P3|NOT COMPLETED|Overall Study||0
135274|NCT00280384|325711|P2|NOT COMPLETED|Overall Study||0
135275|NCT00280384|325712|P1|NOT COMPLETED|Overall Study||0
135276|NCT00280384|325705|P8|COMPLETED|Overall Study||6
135277|NCT00280384|325706|P7|COMPLETED|Overall Study||6
135278|NCT00280384|325707|P6|COMPLETED|Overall Study||6
135279|NCT00280384|325708|P5|COMPLETED|Overall Study||6
135280|NCT00280384|325709|P4|COMPLETED|Overall Study||6
135281|NCT00280384|325710|P3|COMPLETED|Overall Study||6
135282|NCT00280384|325711|P2|COMPLETED|Overall Study||6
135283|NCT00280384|325712|P1|COMPLETED|Overall Study||6
135284|NCT00280384|325705|P8|STARTED|Overall Study||6
135285|NCT00280384|325706|P7|STARTED|Overall Study||6
135286|NCT00280384|325707|P6|STARTED|Overall Study||6
135287|NCT00280384|325708|P5|STARTED|Overall Study||6
135288|NCT00280384|325709|P4|STARTED|Overall Study||6
135289|NCT00280384|325710|P3|STARTED|Overall Study||6
135290|NCT00280384|325711|P2|STARTED|Overall Study||6
135291|NCT00280384|325712|P1|STARTED|Overall Study||6
135292|NCT00280397|325754|P1|NOT COMPLETED|Overall Study||1
135293|NCT00280397|325754|P1|COMPLETED|Overall Study||26
135294|NCT00280397|325754|P1|STARTED|Overall Study||27
135295|NCT00280566|325763|P3|NOT COMPLETED|Period 2 Double Blind||57
135296|NCT00280566|325764|P2|NOT COMPLETED|Period 2 Double Blind||43
135297|NCT00280566|325765|P1|NOT COMPLETED|Period 2 Double Blind||0
135298|NCT00280566|325763|P3|COMPLETED|Period 2 Double Blind||54
135299|NCT00280566|325764|P2|COMPLETED|Period 2 Double Blind||84
135300|NCT00280566|325765|P1|COMPLETED|Period 2 Double Blind||0
135301|NCT00280566|325763|P3|STARTED|Period 2 Double Blind||111
135302|NCT00280566|325764|P2|STARTED|Period 2 Double Blind||127
135303|NCT00280566|325765|P1|STARTED|Period 2 Double Blind|1 subject in Period 1 did not want to be randomized into Period 2|0
135304|NCT00280566|325763|P3|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
135305|NCT00280566|325764|P2|NOT COMPLETED|Period 1 Open Label Ziprasidone||0
135306|NCT00280566|325765|P1|NOT COMPLETED|Period 1 Open Label Ziprasidone||343
135307|NCT00280566|325763|P3|COMPLETED|Period 1 Open Label Ziprasidone||0
135308|NCT00280566|325764|P2|COMPLETED|Period 1 Open Label Ziprasidone||0
135309|NCT00280566|325765|P1|COMPLETED|Period 1 Open Label Ziprasidone|Subject excluded as described above is counted as 2; enrolled in 2 sites (2 identification numbers)|241
135310|NCT00280566|325763|P3|STARTED|Period 1 Open Label Ziprasidone||0
135311|NCT00280566|325764|P2|STARTED|Period 1 Open Label Ziprasidone||0
135312|NCT00280566|325765|P1|STARTED|Period 1 Open Label Ziprasidone|1 subject inappropriately randomized into 2 different sites. Data from this subject was excluded.|584
135313|NCT00280683|325792|P2|NOT COMPLETED|Overall Study||3
135314|NCT00280683|325793|P1|NOT COMPLETED|Overall Study||2
135315|NCT00280683|325792|P2|COMPLETED|Overall Study||7
135316|NCT00280683|325793|P1|COMPLETED|Overall Study|Reasons for subjects discontinuing included inability to adhere to the schedule or adverse event.|8
135317|NCT00280683|325792|P2|STARTED|Overall Study||10
135318|NCT00280683|325793|P1|STARTED|Overall Study||10
135319|NCT00280735|325801|P1|NOT COMPLETED|Overall Study||18
135320|NCT00280735|325801|P1|COMPLETED|Overall Study||57
135321|NCT00280735|325801|P1|Received Adequate Exposure|Overall Study||57
135322|NCT00280735|325801|P1|Received Treatment|Overall Study||72
135323|NCT00280735|325801|P1|STARTED|Overall Study||75
135324|NCT00280748|325811|P1|NOT COMPLETED|Overall Study||4
135325|NCT00280748|325811|P1|COMPLETED|Overall Study||6
135326|NCT00280748|325811|P1|STARTED|Overall Study||10
135327|NCT00280826|325821|P1|NOT COMPLETED|Overall Study||0
135328|NCT00280826|325821|P1|COMPLETED|Overall Study||6
135329|NCT00280826|325821|P1|STARTED|Overall Study||6
135330|NCT00280904|325829|P1|NOT COMPLETED|Overall Study||0
135331|NCT00280904|325829|P1|COMPLETED|Overall Study||433
135332|NCT00280904|325829|P1|STARTED|Overall Study||433
135333|NCT00280917|325838|P4|NOT COMPLETED|Overall Study||2
135334|NCT00280917|325839|P3|NOT COMPLETED|Overall Study||6
135335|NCT00280917|325840|P2|NOT COMPLETED|Overall Study||6
135336|NCT00280917|325841|P1|NOT COMPLETED|Overall Study||2
135337|NCT00280917|325838|P4|COMPLETED|Overall Study||61
135338|NCT00280917|325839|P3|COMPLETED|Overall Study||57
135339|NCT00280917|325840|P2|COMPLETED|Overall Study||57
135340|NCT00280917|325841|P1|COMPLETED|Overall Study||63
135341|NCT00280917|325838|P4|STARTED|Overall Study||63
135342|NCT00280917|325839|P3|STARTED|Overall Study||63
135343|NCT00280917|325840|P2|STARTED|Overall Study||63
135344|NCT00280917|325841|P1|STARTED|Overall Study||65
135345|NCT00281021|325851|P1|NOT COMPLETED|Overall Study||2
135346|NCT00281021|325851|P1|COMPLETED|Overall Study||24
135347|NCT00281021|325851|P1|STARTED|Overall Study||26
135348|NCT00281099|325857|P2|NOT COMPLETED|Overall Study||222
135349|NCT00281099|325858|P1|NOT COMPLETED|Overall Study||205
135350|NCT00281099|325857|P2|COMPLETED|Overall Study||296
135351|NCT00281099|325858|P1|COMPLETED|Overall Study||308
135352|NCT00281099|325857|P2|STARTED|Overall Study||518
135353|NCT00281099|325858|P1|STARTED|Overall Study||513
135354|NCT00281320|325901|P2|NOT COMPLETED|Overall Study||21
135355|NCT00281320|325902|P1|NOT COMPLETED|Overall Study||25
135356|NCT00281320|325901|P2|COMPLETED|Overall Study||40
135357|NCT00281320|325902|P1|COMPLETED|Overall Study||36
135358|NCT00281320|325901|P2|STARTED|Overall Study||61
135359|NCT00281320|325902|P1|STARTED|Overall Study||61
135360|NCT00281463|325922|P1|NOT COMPLETED|Overall Study||0
135361|NCT00281463|325922|P1|COMPLETED|Overall Study||45
135362|NCT00281463|325922|P1|STARTED|Overall Study||45
135363|NCT00281528|325930|P3|NOT COMPLETED|Overall Study||79
135364|NCT00281528|325931|P2|NOT COMPLETED|Overall Study||54
135365|NCT00281528|325932|P1|NOT COMPLETED|Overall Study||75
135366|NCT00281528|325930|P3|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
135367|NCT00281528|325931|P2|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
135368|NCT00281528|325932|P1|COMPLETED|Overall Study|No participants completed because they continued in the study until disease progression|0
135369|NCT00281528|325930|P3|STARTED|Overall Study||79
135370|NCT00281528|325931|P2|STARTED|Overall Study||54
135371|NCT00281528|325932|P1|STARTED|Overall Study||75
135372|NCT00281580|325992|P16|NOT COMPLETED|Overall Study||13
135373|NCT00281580|325993|P15|NOT COMPLETED|Overall Study||7
135374|NCT00281580|325994|P14|NOT COMPLETED|Overall Study||7
135375|NCT00281580|325995|P13|NOT COMPLETED|Overall Study||13
135376|NCT00281580|325996|P12|NOT COMPLETED|Overall Study||10
135377|NCT00281580|325997|P11|NOT COMPLETED|Overall Study||4
135378|NCT00281580|325998|P10|NOT COMPLETED|Overall Study||12
135379|NCT00281580|325999|P9|NOT COMPLETED|Overall Study||8
135380|NCT00281580|326000|P8|NOT COMPLETED|Overall Study||1
135381|NCT00281580|326001|P7|NOT COMPLETED|Overall Study||5
135382|NCT00281580|326002|P6|NOT COMPLETED|Overall Study||3
135383|NCT00281580|326003|P5|NOT COMPLETED|Overall Study||4
135384|NCT00281580|326004|P4|NOT COMPLETED|Overall Study||17
135385|NCT00281580|326005|P3|NOT COMPLETED|Overall Study||5
135386|NCT00281580|326006|P2|NOT COMPLETED|Overall Study||1
135387|NCT00281580|326007|P1|NOT COMPLETED|Overall Study||7
135388|NCT00281580|325992|P16|COMPLETED|Overall Study||116
135389|NCT00281580|325993|P15|COMPLETED|Overall Study||133
135390|NCT00281580|325994|P14|COMPLETED|Overall Study||43
135391|NCT00281580|325995|P13|COMPLETED|Overall Study||129
135392|NCT00281580|325996|P12|COMPLETED|Overall Study||136
135393|NCT00281580|325997|P11|COMPLETED|Overall Study||44
135394|NCT00281580|325998|P10|COMPLETED|Overall Study||117
135395|NCT00281580|325999|P9|COMPLETED|Overall Study||135
135396|NCT00281580|326000|P8|COMPLETED|Overall Study||46
135397|NCT00281580|326001|P7|COMPLETED|Overall Study||39
135398|NCT00281580|326002|P6|COMPLETED|Overall Study||43
135399|NCT00281580|326003|P5|COMPLETED|Overall Study||40
135400|NCT00281580|326004|P4|COMPLETED|Overall Study||118
135401|NCT00281580|326005|P3|COMPLETED|Overall Study||125
135402|NCT00281580|326006|P2|COMPLETED|Overall Study||41
135403|NCT00281580|326007|P1|COMPLETED|Overall Study||39
135404|NCT00281580|325992|P16|STARTED|Overall Study||129
135405|NCT00281580|325993|P15|STARTED|Overall Study||140
135406|NCT00281580|325994|P14|STARTED|Overall Study||50
135407|NCT00281580|325995|P13|STARTED|Overall Study||142
135408|NCT00281580|325996|P12|STARTED|Overall Study||146
135409|NCT00281580|325997|P11|STARTED|Overall Study||48
135410|NCT00281580|325998|P10|STARTED|Overall Study||129
135411|NCT00281580|325999|P9|STARTED|Overall Study||143
135412|NCT00281580|326000|P8|STARTED|Overall Study||47
135413|NCT00281580|326001|P7|STARTED|Overall Study||44
135414|NCT00281580|326002|P6|STARTED|Overall Study||46
135415|NCT00281580|326003|P5|STARTED|Overall Study||44
135416|NCT00281580|326004|P4|STARTED|Overall Study||135
135417|NCT00281580|326005|P3|STARTED|Overall Study||130
135418|NCT00281580|326006|P2|STARTED|Overall Study||42
135419|NCT00281580|326007|P1|STARTED|Overall Study||46
135420|NCT00281632|326351|P1|NOT COMPLETED|Overall Study||36
135421|NCT00281632|326351|P1|COMPLETED|Overall Study|Three participants were ongoing in the study at the time of the data cut-off (30 Apr 2008).|0
135422|NCT00281632|326351|P1|STARTED|Overall Study||36
135423|NCT00281658|326379|P3|NOT COMPLETED|Open-label Monotherapy Extension Phase||101
135424|NCT00281658|326380|P2|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
135425|NCT00281658|326381|P1|NOT COMPLETED|Open-label Monotherapy Extension Phase||0
135426|NCT00281658|326379|P3|COMPLETED|Open-label Monotherapy Extension Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|48
135427|NCT00281658|326380|P2|COMPLETED|Open-label Monotherapy Extension Phase||0
135428|NCT00281658|326381|P1|COMPLETED|Open-label Monotherapy Extension Phase||0
135429|NCT00281658|326379|P3|STARTED|Open-label Monotherapy Extension Phase||149
135430|NCT00281658|326380|P2|STARTED|Open-label Monotherapy Extension Phase||0
135431|NCT00281658|326381|P1|STARTED|Open-label Monotherapy Extension Phase||0
135432|NCT00281658|326379|P3|NOT COMPLETED|Double-blind, Randomized Phase||0
135433|NCT00281658|326380|P2|NOT COMPLETED|Double-blind, Randomized Phase||54
135434|NCT00281658|326381|P1|NOT COMPLETED|Double-blind, Randomized Phase||137
135435|NCT00281658|326379|P3|COMPLETED|Double-blind, Randomized Phase||0
135436|NCT00281658|326380|P2|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|168
135437|NCT00281658|326381|P1|COMPLETED|Double-blind, Randomized Phase|For the purposes of this report, completed pts are pts ongoing at the time of the analysis.|85
135438|NCT00281658|326379|P3|STARTED|Double-blind, Randomized Phase||0
135439|NCT00281658|326380|P2|STARTED|Double-blind, Randomized Phase|Of these participants, 149 entered the open-label extension phase.|222
135440|NCT00281658|326381|P1|STARTED|Double-blind, Randomized Phase||222
135441|NCT00281697|326400|P2|NOT COMPLETED|Overall Study||197
135442|NCT00281697|326401|P1|NOT COMPLETED|Overall Study||401
135443|NCT00281697|326400|P2|COMPLETED|Overall Study||28
135444|NCT00281697|326401|P1|COMPLETED|Overall Study||58
135445|NCT00281697|326400|P2|STARTED|Overall Study||225
135446|NCT00281697|326401|P1|STARTED|Overall Study||459
135447|NCT00281827|326417|P1|NOT COMPLETED|Overall Study||0
135448|NCT00281827|326417|P1|COMPLETED|Overall Study|All patients received 3 cycles of therapy; 2 did not receive all 3 thalidomide cycles|22
135449|NCT00281827|326417|P1|STARTED|Overall Study||22
135450|NCT00281840|326426|P1|NOT COMPLETED|Overall Study||25
135451|NCT00281840|326426|P1|COMPLETED|Overall Study||5
135452|NCT00281840|326426|P1|STARTED|Overall Study||30
135453|NCT00281879|326439|P8|NOT COMPLETED|Overall Study||1
135454|NCT00281879|326440|P7|NOT COMPLETED|Overall Study||0
135455|NCT00281879|326441|P6|NOT COMPLETED|Overall Study||9
135456|NCT00281879|326442|P5|NOT COMPLETED|Overall Study||6
135457|NCT00281879|326443|P4|NOT COMPLETED|Overall Study||0
135458|NCT00281879|326444|P3|NOT COMPLETED|Overall Study||20
135459|NCT00281879|326445|P2|NOT COMPLETED|Overall Study||36
135460|NCT00281879|326446|P1|NOT COMPLETED|Overall Study||128
135461|NCT00281879|326439|P8|COMPLETED|Overall Study||0
135462|NCT00281879|326440|P7|COMPLETED|Overall Study||0
135463|NCT00281879|326441|P6|COMPLETED|Overall Study||0
135464|NCT00281879|326442|P5|COMPLETED|Overall Study||0
135465|NCT00281879|326443|P4|COMPLETED|Overall Study||0
135466|NCT00281879|326444|P3|COMPLETED|Overall Study||0
135467|NCT00281879|326445|P2|COMPLETED|Overall Study||0
135468|NCT00281879|326446|P1|COMPLETED|Overall Study||0
135469|NCT00281879|326439|P8|STARTED|Overall Study||1
135470|NCT00281879|326440|P7|STARTED|Overall Study||0
135471|NCT00281879|326441|P6|STARTED|Overall Study||9
135472|NCT00281879|326442|P5|STARTED|Overall Study||6
135473|NCT00281879|326443|P4|STARTED|Overall Study||0
135474|NCT00281879|326444|P3|STARTED|Overall Study||20
135475|NCT00281879|326445|P2|STARTED|Overall Study||36
135476|NCT00281879|326446|P1|STARTED|Overall Study||128
135477|NCT00281918|326466|P2|NOT COMPLETED|Overall Study||108
135478|NCT00281918|326467|P1|NOT COMPLETED|Overall Study||142
135479|NCT00281918|326466|P2|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|300
135480|NCT00281918|326467|P1|COMPLETED|Overall Study|Completed all 6 cycles of study medication.|267
135481|NCT00281918|326466|P2|Safety Population; Received Study Drug|Overall Study||402
135482|NCT00281918|326467|P1|Safety Population; Received Study Drug|Overall Study||398
135647|NCT00282672|326833|P4|STARTED|1 Year||42
135483|NCT00281918|326466|P2|STARTED|Overall Study|Informed consent unavailable for 5 patients at time of analysis; intent-to-treat population was 403.|408
135484|NCT00281918|326467|P1|STARTED|Overall Study|Informed consent unavailable for 2 patients at time of analysis; intent-to-treat population was 407.|409
135485|NCT00281957|326495|P2|NOT COMPLETED|Overall Study||42
135486|NCT00281957|326496|P1|NOT COMPLETED|Overall Study||67
135487|NCT00281957|326495|P2|COMPLETED|Overall Study||0
135488|NCT00281957|326496|P1|COMPLETED|Overall Study||0
135489|NCT00281957|326495|P2|Eligible and Received Treatment|Overall Study||39
135490|NCT00281957|326496|P1|Eligible and Received Treatment|Overall Study||63
135491|NCT00281957|326495|P2|Eligible|Overall Study||40
135492|NCT00281957|326496|P1|Eligible|Overall Study||66
135493|NCT00281957|326495|P2|STARTED|Overall Study||42
135494|NCT00281957|326496|P1|STARTED|Overall Study||67
135495|NCT00282048|326508|P1|NOT COMPLETED|Overall Study||62
135496|NCT00282048|326508|P1|COMPLETED|Overall Study||0
135497|NCT00282048|326508|P1|STARTED|Overall Study||62
135498|NCT00282087|326520|P1|NOT COMPLETED|Overall Study||1
135499|NCT00282087|326520|P1|COMPLETED|Overall Study|One patient died during cycle 1 of treatment because of infectious complications of AIDS.|46
135500|NCT00282087|326520|P1|STARTED|Overall Study||47
135501|NCT00282113|326536|P3|NOT COMPLETED|Overall Study||0
135502|NCT00282113|326537|P2|NOT COMPLETED|Overall Study||0
135503|NCT00282113|326538|P1|NOT COMPLETED|Overall Study||1
135504|NCT00282113|326536|P3|COMPLETED|Overall Study||29
135505|NCT00282113|326537|P2|COMPLETED|Overall Study||30
135506|NCT00282113|326538|P1|COMPLETED|Overall Study||30
135507|NCT00282113|326536|P3|STARTED|Overall Study||29
135508|NCT00282113|326537|P2|STARTED|Overall Study||30
135509|NCT00282113|326538|P1|STARTED|Overall Study||31
135510|NCT00282152|326554|P2|NOT COMPLETED|Overall Study||0
135511|NCT00282152|326555|P1|NOT COMPLETED|Overall Study||1
135512|NCT00282152|326554|P2|COMPLETED|Overall Study||15
135513|NCT00282152|326555|P1|COMPLETED|Overall Study||14
135514|NCT00282152|326554|P2|STARTED|Overall Study||15
135515|NCT00282152|326555|P1|STARTED|Overall Study||15
135516|NCT00282243|326573|P1|NOT COMPLETED|Extension Treatment Period||22
135517|NCT00282243|326573|P1|COMPLETED|Extension Treatment Period||43
135518|NCT00282243|326573|P1|STARTED|Extension Treatment Period||65
135519|NCT00282243|326573|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||5
135520|NCT00282243|326573|P1|COMPLETED|Pharmacokinetic Treatment Period||65
135521|NCT00282243|326573|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||69
135522|NCT00282243|326573|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||70
135523|NCT00282243|326573|P1|STARTED|Pharmacokinetic Treatment Period||70
135524|NCT00282256|326597|P1|NOT COMPLETED|Extension Treatment Period||2
135525|NCT00282256|326597|P1|COMPLETED|Extension Treatment Period||16
135526|NCT00282256|326597|P1|STARTED|Extension Treatment Period||18
135527|NCT00282256|326597|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||1
135528|NCT00282256|326597|P1|COMPLETED|Pharmacokinetic Treatment Period||18
135529|NCT00282256|326597|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||18
135530|NCT00282256|326597|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||19
135531|NCT00282256|326597|P1|STARTED|Pharmacokinetic Treatment Period||19
135532|NCT00282282|326618|P1|NOT COMPLETED|Overall Study||0
135533|NCT00282282|326618|P1|COMPLETED|Overall Study||29
135534|NCT00282282|326618|P1|STARTED|Overall Study|31 patients enrolled but 2 patients did not go through with transplant|29
135535|NCT00282295|326627|P3|NOT COMPLETED|Overall Study||8
135536|NCT00282295|326628|P2|NOT COMPLETED|Overall Study||17
135537|NCT00282295|326629|P1|NOT COMPLETED|Overall Study||3
135538|NCT00282295|326627|P3|COMPLETED|Overall Study||441
135539|NCT00282295|326628|P2|COMPLETED|Overall Study||429
135540|NCT00282295|326629|P1|COMPLETED|Overall Study||443
135541|NCT00282295|326627|P3|STARTED|Overall Study||449
135542|NCT00282295|326628|P2|STARTED|Overall Study||446
135543|NCT00282295|326629|P1|STARTED|Overall Study||446
135544|NCT00282308|326680|P3|NOT COMPLETED|Safety Follow-up Period||19
135545|NCT00282308|326681|P2|NOT COMPLETED|Safety Follow-up Period||0
135546|NCT00282308|326682|P1|NOT COMPLETED|Safety Follow-up Period||0
135547|NCT00282308|326680|P3|COMPLETED|Safety Follow-up Period||81
135548|NCT00282308|326681|P2|COMPLETED|Safety Follow-up Period||0
135549|NCT00282308|326682|P1|COMPLETED|Safety Follow-up Period||0
135550|NCT00282308|326680|P3|STARTED|Safety Follow-up Period|Some patients entered this Safety Follow-up Period directly from the Treatment Period.|100
135551|NCT00282308|326681|P2|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
135552|NCT00282308|326682|P1|STARTED|Safety Follow-up Period|Participant Flow is reported for the combined treatment groups for this Period.|0
135553|NCT00282308|326680|P3|NOT COMPLETED|Optional Extension Re-treatment Period||6
135554|NCT00282308|326681|P2|NOT COMPLETED|Optional Extension Re-treatment Period||0
135555|NCT00282308|326682|P1|NOT COMPLETED|Optional Extension Re-treatment Period||0
135556|NCT00282308|326680|P3|COMPLETED|Optional Extension Re-treatment Period||72
135557|NCT00282308|326681|P2|COMPLETED|Optional Extension Re-treatment Period||0
135558|NCT00282308|326682|P1|COMPLETED|Optional Extension Re-treatment Period||0
135559|NCT00282308|326680|P3|STARTED|Optional Extension Re-treatment Period|Not all patients who completed the Treatment Period entered this Optional Re-treatment Period.|78
135560|NCT00282308|326681|P2|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
135648|NCT00282672|326834|P3|STARTED|1 Year||21
135649|NCT00282672|326835|P2|STARTED|1 Year||42
135561|NCT00282308|326682|P1|STARTED|Optional Extension Re-treatment Period|Participant Flow is reported for the combined treatment groups for this Period.|0
135562|NCT00282308|326680|P3|NOT COMPLETED|Treatment Period||0
135563|NCT00282308|326681|P2|NOT COMPLETED|Treatment Period||6
135564|NCT00282308|326682|P1|NOT COMPLETED|Treatment Period||4
135565|NCT00282308|326680|P3|COMPLETED|Treatment Period||0
135566|NCT00282308|326681|P2|COMPLETED|Treatment Period||28
135567|NCT00282308|326682|P1|COMPLETED|Treatment Period||65
135568|NCT00282308|326680|P3|STARTED|Treatment Period|Participant Flow is reported separately for the treatment groups for this Period.|0
135569|NCT00282308|326681|P2|STARTED|Treatment Period||34
135570|NCT00282308|326682|P1|STARTED|Treatment Period||69
135571|NCT00282334|326711|P2|NOT COMPLETED|Overall Study||5
135572|NCT00282334|326712|P1|NOT COMPLETED|Overall Study||8
135573|NCT00282334|326711|P2|COMPLETED|Overall Study||118
135574|NCT00282334|326712|P1|COMPLETED|Overall Study||105
135575|NCT00282334|326711|P2|STARTED|Overall Study||123
135576|NCT00282334|326712|P1|STARTED|Overall Study||113
135577|NCT00282347|326720|P2|NOT COMPLETED|B Cell Follow-up Period||0
135578|NCT00282347|326721|P1|NOT COMPLETED|B Cell Follow-up Period||5
135579|NCT00282347|326720|P2|COMPLETED|B Cell Follow-up Period||4
135580|NCT00282347|326721|P1|COMPLETED|B Cell Follow-up Period||15
135581|NCT00282347|326720|P2|STARTED|B Cell Follow-up Period||4
135582|NCT00282347|326721|P1|STARTED|B Cell Follow-up Period||20
135583|NCT00282347|326720|P2|NOT COMPLETED|Safety Follow-up Period||6
135584|NCT00282347|326721|P1|NOT COMPLETED|Safety Follow-up Period||3
135585|NCT00282347|326720|P2|COMPLETED|Safety Follow-up Period||57
135586|NCT00282347|326721|P1|COMPLETED|Safety Follow-up Period||64
135587|NCT00282347|326720|P2|STARTED|Safety Follow-up Period||63
135588|NCT00282347|326721|P1|STARTED|Safety Follow-up Period||67
135589|NCT00282347|326720|P2|NOT COMPLETED|Treatment Period||9
135590|NCT00282347|326721|P1|NOT COMPLETED|Treatment Period||5
135591|NCT00282347|326720|P2|COMPLETED|Treatment Period||63
135592|NCT00282347|326721|P1|COMPLETED|Treatment Period||67
135593|NCT00282347|326720|P2|STARTED|Treatment Period||72
135594|NCT00282347|326721|P1|STARTED|Treatment Period||72
135595|NCT00282438|326747|P2|NOT COMPLETED|Overall Study||1
135596|NCT00282438|326748|P1|NOT COMPLETED|Overall Study||1
135597|NCT00282438|326747|P2|COMPLETED|Overall Study||0
135598|NCT00282438|326748|P1|COMPLETED|Overall Study||0
135599|NCT00282438|326747|P2|STARTED|Overall Study||1
135600|NCT00282438|326748|P1|STARTED|Overall Study||1
135601|NCT00282464|326756|P2|NOT COMPLETED|Overall Study||62
135602|NCT00282464|326757|P1|NOT COMPLETED|Overall Study||73
135603|NCT00282464|326756|P2|COMPLETED|Overall Study||134
135604|NCT00282464|326757|P1|COMPLETED|Overall Study||112
135605|NCT00282464|326756|P2|STARTED|Overall Study||196
135606|NCT00282464|326757|P1|STARTED|Overall Study||185
135607|NCT00282568|326805|P1|NOT COMPLETED|Extended Treatment Period||24
135608|NCT00282568|326805|P1|COMPLETED|Extended Treatment Period||42
135609|NCT00282568|326805|P1|STARTED|Extended Treatment Period|One patient who completed the PK period did not enter the extended treatment period.|66
135610|NCT00282568|326805|P1|NOT COMPLETED|Pharmacokinetic Treatment Period||3
135611|NCT00282568|326805|P1|COMPLETED|Pharmacokinetic Treatment Period||67
135612|NCT00282568|326805|P1|Received Tacrolimus MR|Pharmacokinetic Treatment Period||67
135613|NCT00282568|326805|P1|Received Tacrolimus|Pharmacokinetic Treatment Period||68
135614|NCT00282568|326805|P1|STARTED|Pharmacokinetic Treatment Period||70
135615|NCT00282672|326833|P4|NOT COMPLETED|5 Year: Follow up||5
135616|NCT00282672|326834|P3|NOT COMPLETED|5 Year: Follow up||0
135617|NCT00282672|326835|P2|NOT COMPLETED|5 Year: Follow up||5
135618|NCT00282672|326836|P1|NOT COMPLETED|5 Year: Follow up||1
135619|NCT00282672|326833|P4|COMPLETED|5 Year: Follow up||20
135620|NCT00282672|326834|P3|COMPLETED|5 Year: Follow up||12
135621|NCT00282672|326835|P2|COMPLETED|5 Year: Follow up||27
135622|NCT00282672|326836|P1|COMPLETED|5 Year: Follow up||14
135623|NCT00282672|326833|P4|STARTED|5 Year: Follow up|11 withdrew|25
135624|NCT00282672|326834|P3|STARTED|5 Year: Follow up|3 withdrew|12
135625|NCT00282672|326835|P2|STARTED|5 Year: Follow up|7 withdrew|32
135626|NCT00282672|326836|P1|STARTED|5 Year: Follow up|1 withdrew|15
135627|NCT00282672|326833|P4|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||2
135628|NCT00282672|326834|P3|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
135629|NCT00282672|326835|P2|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||1
135630|NCT00282672|326836|P1|NOT COMPLETED|2 Year: Sham Crossed Over to RFA||3
135631|NCT00282672|326833|P4|COMPLETED|2 Year: Sham Crossed Over to RFA||36
135632|NCT00282672|326834|P3|COMPLETED|2 Year: Sham Crossed Over to RFA||15
135633|NCT00282672|326835|P2|COMPLETED|2 Year: Sham Crossed Over to RFA||39
135634|NCT00282672|326836|P1|COMPLETED|2 Year: Sham Crossed Over to RFA||16
135635|NCT00282672|326833|P4|STARTED|2 Year: Sham Crossed Over to RFA||38
135636|NCT00282672|326834|P3|STARTED|2 Year: Sham Crossed Over to RFA|16 Crossed over to RFA treatment|16
135637|NCT00282672|326835|P2|STARTED|2 Year: Sham Crossed Over to RFA||40
135638|NCT00282672|326836|P1|STARTED|2 Year: Sham Crossed Over to RFA|19 crossed over to RFA treatment|19
135639|NCT00282672|326833|P4|NOT COMPLETED|1 Year||4
135640|NCT00282672|326834|P3|NOT COMPLETED|1 Year||1
135641|NCT00282672|326835|P2|NOT COMPLETED|1 Year||2
135642|NCT00282672|326836|P1|NOT COMPLETED|1 Year||3
135643|NCT00282672|326833|P4|COMPLETED|1 Year||38
135644|NCT00282672|326834|P3|COMPLETED|1 Year||20
135645|NCT00282672|326835|P2|COMPLETED|1 Year||40
135646|NCT00282672|326836|P1|COMPLETED|1 Year||19
135650|NCT00282672|326836|P1|STARTED|1 Year||22
135651|NCT00288509|326882|P1|NOT COMPLETED|Treatment Cycle 4||8
135652|NCT00288509|326882|P1|COMPLETED|Treatment Cycle 4||80
135653|NCT00288509|326882|P1|STARTED|Treatment Cycle 4|3 subjects completed Cycle 3 but withdrew before Cycle 4, treatment stopped according to protocol|88
135654|NCT00288509|326882|P1|NOT COMPLETED|Treatment Cycle 3||5
135655|NCT00288509|326882|P1|COMPLETED|Treatment Cycle 3||91
135656|NCT00288509|326882|P1|STARTED|Treatment Cycle 3|One subject completed Cycle 2 but withdrew before Cycle 3 due to insufficient clinical response|96
135657|NCT00288509|326882|P1|NOT COMPLETED|Treatment Cycle 2||3
135658|NCT00288509|326882|P1|COMPLETED|Treatment Cycle 2||97
135659|NCT00288509|326882|P1|STARTED|Treatment Cycle 2|2 subjects completed Cycle 1 but withdrew before Cycle 2 due to insufficient clinical response|100
135660|NCT00288509|326882|P1|NOT COMPLETED|Treatment Cycle 1||6
135661|NCT00288509|326882|P1|COMPLETED|Treatment Cycle 1||102
135662|NCT00288509|326882|P1|STARTED|Treatment Cycle 1||108
135663|NCT00288574|326891|P2|NOT COMPLETED|Overall Study||0
135664|NCT00288574|326892|P1|NOT COMPLETED|Overall Study||0
135665|NCT00288574|326891|P2|COMPLETED|Overall Study||44
135666|NCT00288574|326892|P1|COMPLETED|Overall Study||49
135667|NCT00288574|326891|P2|STARTED|Overall Study||44
135668|NCT00288574|326892|P1|STARTED|Overall Study||49
135669|NCT00291135|326898|P1|NOT COMPLETED|Overall Study||0
135670|NCT00291135|326898|P1|COMPLETED|Overall Study||42
135671|NCT00291135|326898|P1|STARTED|Overall Study||42
135672|NCT00291161|326906|P4|NOT COMPLETED|Overall Study||65
135673|NCT00291161|326907|P3|NOT COMPLETED|Overall Study||93
135674|NCT00291161|326908|P2|NOT COMPLETED|Overall Study||58
135675|NCT00291161|326909|P1|NOT COMPLETED|Overall Study||81
135676|NCT00291161|326906|P4|COMPLETED|Overall Study||122
135677|NCT00291161|326907|P3|COMPLETED|Overall Study||206
135678|NCT00291161|326908|P2|COMPLETED|Overall Study||134
135679|NCT00291161|326909|P1|COMPLETED|Overall Study||235
135680|NCT00291161|326906|P4|STARTED|Overall Study||187
135681|NCT00291161|326907|P3|STARTED|Overall Study||299
135682|NCT00291161|326908|P2|STARTED|Overall Study||192
135683|NCT00291161|326909|P1|STARTED|Overall Study||316
135684|NCT00291187|326921|P4|NOT COMPLETED|Overall Study||0
135685|NCT00291187|326922|P3|NOT COMPLETED|Overall Study||1
135686|NCT00291187|326923|P2|NOT COMPLETED|Overall Study||0
135687|NCT00291187|326924|P1|NOT COMPLETED|Overall Study||0
135688|NCT00291187|326921|P4|COMPLETED|Overall Study||106
135689|NCT00291187|326922|P3|COMPLETED|Overall Study||102
135690|NCT00291187|326923|P2|COMPLETED|Overall Study||100
135691|NCT00291187|326924|P1|COMPLETED|Overall Study||103
135692|NCT00291187|326921|P4|STARTED|Overall Study||106
135693|NCT00291187|326922|P3|STARTED|Overall Study||103
135694|NCT00291187|326923|P2|STARTED|Overall Study||100
135695|NCT00291187|326924|P1|STARTED|Overall Study||103
135696|NCT00291226|326948|P2|NOT COMPLETED|Overall Study||1
135697|NCT00291226|326949|P1|NOT COMPLETED|Overall Study||1
135698|NCT00291226|326948|P2|COMPLETED|Overall Study||3
135699|NCT00291226|326949|P1|COMPLETED|Overall Study||3
135700|NCT00291226|326948|P2|STARTED|Overall Study||4
135701|NCT00291226|326949|P1|STARTED|Overall Study||4
135702|NCT00291317|326957|P1|NOT COMPLETED|Overall Study||0
135703|NCT00291317|326957|P1|COMPLETED|Overall Study||6
135704|NCT00291317|326957|P1|STARTED|Overall Study||6
135705|NCT00291330|326964|P2|NOT COMPLETED|Overall Study||97
135706|NCT00291330|326965|P1|NOT COMPLETED|Overall Study||101
135707|NCT00291330|326964|P2|COMPLETED|Overall Study|Completed planned observation time|1169
135708|NCT00291330|326965|P1|COMPLETED|Overall Study|Completed planned observation time|1172
135709|NCT00291330|326964|P2|STARTED|Overall Study|Started Treatment|1266
135710|NCT00291330|326965|P1|STARTED|Overall Study|Started Treatment|1273
135711|NCT00291343|326989|P2|NOT COMPLETED|Overall Study||0
135712|NCT00291343|326990|P1|NOT COMPLETED|Overall Study||0
135713|NCT00291343|326989|P2|COMPLETED|Overall Study||93
135714|NCT00291343|326990|P1|COMPLETED|Overall Study||203
135715|NCT00291343|326989|P2|STARTED|Overall Study||93
135716|NCT00291343|326990|P1|STARTED|Overall Study||203
135717|NCT00291551|327018|P1|NOT COMPLETED|Overall Study||13
135718|NCT00291551|327018|P1|COMPLETED|Overall Study||26
135719|NCT00291551|327018|P1|STARTED|Overall Study||39
135720|NCT00291577|327033|P1|NOT COMPLETED|Overall Study||21
135721|NCT00291577|327033|P1|COMPLETED|Overall Study|Subject End of Study=Completed; not per protocol reason. PI reason=withdrawn during active treatment|1
135722|NCT00291577|327033|P1|STARTED|Overall Study||22
135723|NCT00291655|327052|P1|NOT COMPLETED|Overall Study||15
135724|NCT00291655|327052|P1|COMPLETED|Overall Study||115
135725|NCT00291655|327052|P1|STARTED|Overall Study||130
135726|NCT00291694|327059|P2|NOT COMPLETED|Overall Study||5
135727|NCT00291694|327060|P1|NOT COMPLETED|Overall Study||3
135728|NCT00291694|327059|P2|COMPLETED|Overall Study||43
135729|NCT00291694|327060|P1|COMPLETED|Overall Study||21
135730|NCT00291694|327059|P2|STARTED|Overall Study||48
135731|NCT00291694|327060|P1|STARTED|Overall Study||24
135732|NCT00291876|327074|P1|NOT COMPLETED|Overall Study||0
135733|NCT00291876|327074|P1|COMPLETED|Overall Study||135
135734|NCT00291876|327074|P1|STARTED|Overall Study||135
135735|NCT00292162|327088|P2|NOT COMPLETED|Overall Study||2
135736|NCT00292162|327089|P1|NOT COMPLETED|Overall Study||1
135737|NCT00292162|327088|P2|COMPLETED|Overall Study||20
135738|NCT00292162|327089|P1|COMPLETED|Overall Study||18
135739|NCT00292162|327088|P2|STARTED|Overall Study||22
135740|NCT00292162|327089|P1|STARTED|Overall Study||19
135741|NCT00292188|327107|P3|NOT COMPLETED|Double-Blind||29
135742|NCT00292188|327108|P2|NOT COMPLETED|Double-Blind||31
135743|NCT00292188|327109|P1|NOT COMPLETED|Double-Blind||0
135744|NCT00292188|327107|P3|COMPLETED|Double-Blind||98
135745|NCT00292188|327108|P2|COMPLETED|Double-Blind||96
135746|NCT00292188|327109|P1|COMPLETED|Double-Blind||0
135747|NCT00292188|327107|P3|STARTED|Double-Blind||127
135748|NCT00292188|327108|P2|STARTED|Double-Blind||127
135749|NCT00292188|327109|P1|STARTED|Double-Blind||0
135750|NCT00292188|327107|P3|NOT COMPLETED|Single-Blind||0
135751|NCT00292188|327108|P2|NOT COMPLETED|Single-Blind||0
135752|NCT00292188|327109|P1|NOT COMPLETED|Single-Blind||114
135753|NCT00292188|327107|P3|COMPLETED|Single-Blind||0
135754|NCT00292188|327108|P2|COMPLETED|Single-Blind||0
135755|NCT00292188|327109|P1|COMPLETED|Single-Blind||254
135756|NCT00292188|327107|P3|Received Treatment|Single-Blind||0
135757|NCT00292188|327108|P2|Received Treatment|Single-Blind||0
135758|NCT00292188|327109|P1|Received Treatment|Single-Blind||367
135759|NCT00292188|327107|P3|STARTED|Single-Blind||0
135760|NCT00292188|327108|P2|STARTED|Single-Blind||0
135761|NCT00292188|327109|P1|STARTED|Single-Blind||368
135762|NCT00292227|327170|P3|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
135763|NCT00292227|327171|P2|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
135764|NCT00292227|327172|P1|NOT COMPLETED|Cross-over Period 2 (Day 39)||0
135765|NCT00292227|327170|P3|COMPLETED|Cross-over Period 2 (Day 39)||30
135766|NCT00292227|327171|P2|COMPLETED|Cross-over Period 2 (Day 39)||31
135767|NCT00292227|327172|P1|COMPLETED|Cross-over Period 2 (Day 39)||65
135768|NCT00292227|327170|P3|STARTED|Cross-over Period 2 (Day 39)||30
135769|NCT00292227|327171|P2|STARTED|Cross-over Period 2 (Day 39)||31
135770|NCT00292227|327172|P1|STARTED|Cross-over Period 2 (Day 39)||65
135771|NCT00292227|327170|P3|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
135772|NCT00292227|327171|P2|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
135773|NCT00292227|327172|P1|NOT COMPLETED|Cross-over Period 1 (Day 32)||0
135774|NCT00292227|327170|P3|COMPLETED|Cross-over Period 1 (Day 32)||30
135775|NCT00292227|327171|P2|COMPLETED|Cross-over Period 1 (Day 32)||31
135776|NCT00292227|327172|P1|COMPLETED|Cross-over Period 1 (Day 32)||65
135777|NCT00292227|327170|P3|STARTED|Cross-over Period 1 (Day 32)||30
135778|NCT00292227|327171|P2|STARTED|Cross-over Period 1 (Day 32)||31
135779|NCT00292227|327172|P1|STARTED|Cross-over Period 1 (Day 32)||65
135780|NCT00292227|327170|P3|NOT COMPLETED|Patch Period||3
135781|NCT00292227|327171|P2|NOT COMPLETED|Patch Period||0
135782|NCT00292227|327172|P1|NOT COMPLETED|Patch Period||1
135783|NCT00292227|327170|P3|COMPLETED|Patch Period||30
135784|NCT00292227|327171|P2|COMPLETED|Patch Period||31
135785|NCT00292227|327172|P1|COMPLETED|Patch Period||65
135786|NCT00292227|327170|P3|STARTED|Patch Period||33
135787|NCT00292227|327171|P2|STARTED|Patch Period||31
135788|NCT00292227|327172|P1|STARTED|Patch Period||66
135789|NCT00292318|327254|P2|NOT COMPLETED|Overall Study||1
135790|NCT00292318|327255|P1|NOT COMPLETED|Overall Study||2
135791|NCT00292318|327254|P2|COMPLETED|Overall Study||2
135792|NCT00292318|327255|P1|COMPLETED|Overall Study||2
135793|NCT00292318|327254|P2|STARTED|Overall Study||3
135794|NCT00292318|327255|P1|STARTED|Overall Study||4
135795|NCT00292370|327266|P3|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||7
135796|NCT00292370|327267|P2|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||4
135797|NCT00292370|327268|P1|NOT COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
135798|NCT00292370|327266|P3|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||18
135799|NCT00292370|327267|P2|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||21
135800|NCT00292370|327268|P1|COMPLETED|Phase II: OLP + DB Quetiapine or Placebo||0
135801|NCT00292370|327266|P3|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
135802|NCT00292370|327267|P2|STARTED|Phase II: OLP + DB Quetiapine or Placebo|25 out of 50 in Arm I PhI, eligible for Ph II|25
135803|NCT00292370|327268|P1|STARTED|Phase II: OLP + DB Quetiapine or Placebo|"78 Completed Ph I
28 Excluded Ph II:
20 responded
7 declined
1 medical
50 to Arm 2 & 3"|0
135804|NCT00292370|327266|P3|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
135805|NCT00292370|327267|P2|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
135806|NCT00292370|327268|P1|NOT COMPLETED|Phase I - Open-Label Paroxetine (OLP)||46
135807|NCT00292370|327266|P3|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
135808|NCT00292370|327267|P2|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||0
135809|NCT00292370|327268|P1|COMPLETED|Phase I - Open-Label Paroxetine (OLP)||78
135810|NCT00292370|327266|P3|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
135811|NCT00292370|327267|P2|STARTED|Phase I - Open-Label Paroxetine (OLP)||0
135812|NCT00292370|327268|P1|STARTED|Phase I - Open-Label Paroxetine (OLP)||124
135813|NCT00292461|327277|P2|NOT COMPLETED|Overall Study||6
135814|NCT00292461|327278|P1|NOT COMPLETED|Overall Study||10
135815|NCT00292461|327277|P2|COMPLETED|Overall Study||24
135816|NCT00292461|327278|P1|COMPLETED|Overall Study||24
135817|NCT00292461|327277|P2|STARTED|Overall Study||30
135818|NCT00292461|327278|P1|STARTED|Overall Study||34
135819|NCT00292591|327293|P3|NOT COMPLETED|Overall Study||58
135820|NCT00292591|327294|P2|NOT COMPLETED|Overall Study||56
135821|NCT00292591|327295|P1|NOT COMPLETED|Overall Study||64
135822|NCT00292591|327293|P3|COMPLETED|Overall Study||110
135823|NCT00292591|327294|P2|COMPLETED|Overall Study||111
135824|NCT00292591|327295|P1|COMPLETED|Overall Study||102
135825|NCT00292591|327293|P3|STARTED|Overall Study||168
135826|NCT00292591|327294|P2|STARTED|Overall Study||167
135827|NCT00292591|327295|P1|STARTED|Overall Study||166
135828|NCT00292981|327303|P1|NOT COMPLETED|Overall Study||39
135829|NCT00292981|327303|P1|COMPLETED|Overall Study||18
135830|NCT00292981|327303|P1|STARTED|Overall Study||57
135831|NCT00293020|327310|P1|NOT COMPLETED|Overall Study||162
135832|NCT00293020|327310|P1|COMPLETED|Overall Study||82
135833|NCT00293020|327310|P1|STARTED|Overall Study||244
135834|NCT00293059|327316|P2|NOT COMPLETED|Overall Study||19
135835|NCT00293059|327317|P1|NOT COMPLETED|Overall Study||35
135836|NCT00293059|327316|P2|COMPLETED|Overall Study||51
135837|NCT00293059|327317|P1|COMPLETED|Overall Study||85
135838|NCT00293059|327316|P2|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|62
135839|NCT00293059|327317|P1|Cycle 7/Treatment Day 196|Overall Study|Includes participants that prematurely discontinued and may not be counted in earlier visits.|113
135840|NCT00293059|327316|P2|Cycle 3/Treatment Day 84|Overall Study||55
135841|NCT00293059|327317|P1|Cycle 3/Treatment Day 84|Overall Study||100
135842|NCT00293059|327316|P2|Cycle 1/Treatment Day 28|Overall Study||64
135843|NCT00293059|327317|P1|Cycle 1/Treatment Day 28|Overall Study||115
135844|NCT00293059|327316|P2|Subjects Received Treatment|Overall Study||66
135845|NCT00293059|327317|P1|Subjects Received Treatment|Overall Study||119
135846|NCT00293059|327316|P2|STARTED|Overall Study||70
135847|NCT00293059|327317|P1|STARTED|Overall Study||120
135848|NCT00293241|327431|P2|NOT COMPLETED|Overall Study||41
135849|NCT00293241|327432|P1|NOT COMPLETED|Overall Study||36
135850|NCT00293241|327431|P2|COMPLETED|Overall Study||265
135851|NCT00293241|327432|P1|COMPLETED|Overall Study||263
135852|NCT00293241|327431|P2|STARTED|Overall Study||306
135853|NCT00293241|327432|P1|STARTED|Overall Study||299
135854|NCT00293254|327476|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||27
135855|NCT00293254|327477|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||31
135856|NCT00293254|327476|P2|COMPLETED|Open-Label Post Virologic Failure Phase||37
135857|NCT00293254|327477|P1|COMPLETED|Open-Label Post Virologic Failure Phase||19
135858|NCT00293254|327476|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|64
135859|NCT00293254|327477|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|50
135860|NCT00293254|327476|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||1
135861|NCT00293254|327477|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||10
135862|NCT00293254|327476|P2|COMPLETED|Extension - Open-Label Week 157-240||18
135863|NCT00293254|327477|P1|COMPLETED|Extension - Open-Label Week 157-240||110
135937|NCT00279955|327635|P3|NOT COMPLETED|Overall Study||0
135864|NCT00293254|327476|P2|STARTED|Extension - Open-Label Week 157-240|6 of 25 participants who completed the double-blind phase did not enter this open-label phase.|19
135865|NCT00293254|327477|P1|STARTED|Extension - Open-Label Week 157-240||120
135866|NCT00293254|327476|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||29
135867|NCT00293254|327477|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||57
135868|NCT00293254|327476|P2|COMPLETED|Extension - Double-Blind Week 49-156||25
135869|NCT00293254|327477|P1|COMPLETED|Extension - Double-Blind Week 49-156||120
135870|NCT00293254|327476|P2|STARTED|Extension - Double-Blind Week 49-156|1 of 55 participants who completed Week 48 did not enter the extension study.|54
135871|NCT00293254|327477|P1|STARTED|Extension - Double-Blind Week 49-156||177
135872|NCT00293254|327476|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||64
135873|NCT00293254|327477|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||55
135874|NCT00293254|327476|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||55
135875|NCT00293254|327477|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||177
135876|NCT00293254|327476|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the OLPVF phase|55
135877|NCT00293254|327477|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the Open-Label Post-Virologic Failure (OLPVF) Phase|177
135878|NCT00293254|327476|P2|Treated|Primary Study - Double-Blind Week 0-48||119
135879|NCT00293254|327477|P1|Treated|Primary Study - Double-Blind Week 0-48||230
135880|NCT00293254|327476|P2|STARTED|Primary Study - Double-Blind Week 0-48||119
135881|NCT00293254|327477|P1|STARTED|Primary Study - Double-Blind Week 0-48||232
135882|NCT00293267|327517|P2|NOT COMPLETED|Open-Label Post Virologic Failure Phase||37
135883|NCT00293267|327518|P1|NOT COMPLETED|Open-Label Post Virologic Failure Phase||33
135884|NCT00293267|327517|P2|COMPLETED|Open-Label Post Virologic Failure Phase||29
135885|NCT00293267|327518|P1|COMPLETED|Open-Label Post Virologic Failure Phase||15
135886|NCT00293267|327517|P2|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|66
135887|NCT00293267|327518|P1|STARTED|Open-Label Post Virologic Failure Phase|Number of participants who failed treatment and consented to enter the OLPVF phase|48
135888|NCT00293267|327517|P2|NOT COMPLETED|Extension - Open-Label Week 157-240||2
135889|NCT00293267|327518|P1|NOT COMPLETED|Extension - Open-Label Week 157-240||20
135890|NCT00293267|327517|P2|COMPLETED|Extension - Open-Label Week 157-240||26
135891|NCT00293267|327518|P1|COMPLETED|Extension - Open-Label Week 157-240||111
135892|NCT00293267|327517|P2|STARTED|Extension - Open-Label Week 157-240|7 of 35 participants who completed the double-blind phase did not enter this open-label phase|28
135893|NCT00293267|327518|P1|STARTED|Extension - Open-Label Week 157-240|8 of 139 participants who completed the double-blind phase did not enter this open-label phase|131
135894|NCT00293267|327517|P2|NOT COMPLETED|Extension - Double-Blind Week 49-156||15
135895|NCT00293267|327518|P1|NOT COMPLETED|Extension - Double-Blind Week 49-156||52
135896|NCT00293267|327517|P2|COMPLETED|Extension - Double-Blind Week 49-156||35
135897|NCT00293267|327518|P1|COMPLETED|Extension - Double-Blind Week 49-156||139
135898|NCT00293267|327517|P2|STARTED|Extension - Double-Blind Week 49-156||50
135899|NCT00293267|327518|P1|STARTED|Extension - Double-Blind Week 49-156|2 participants who completed Week 48 did not enter the extension study|191
135900|NCT00293267|327517|P2|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||68
135901|NCT00293267|327518|P1|NOT COMPLETED|Primary Study - Double-Blind Week 0-48||41
135902|NCT00293267|327517|P2|COMPLETED|Primary Study - Double-Blind Week 0-48||50
135903|NCT00293267|327518|P1|COMPLETED|Primary Study - Double-Blind Week 0-48||193
135904|NCT00293267|327517|P2|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48||50
135905|NCT00293267|327518|P1|Continuing in Double-Blind|Primary Study - Double-Blind Week 0-48|Excludes participants who entered the open-label post virological failure (OLPVF) phase|193
135906|NCT00293267|327517|P2|Treated|Primary Study - Double-Blind Week 0-48||118
135907|NCT00293267|327518|P1|Treated|Primary Study - Double-Blind Week 0-48||232
135908|NCT00293267|327517|P2|STARTED|Primary Study - Double-Blind Week 0-48||118
135909|NCT00293267|327518|P1|STARTED|Primary Study - Double-Blind Week 0-48||234
135910|NCT00293293|327558|P2|NOT COMPLETED|Overall Study||2
135911|NCT00293293|327559|P1|NOT COMPLETED|Overall Study||2
135912|NCT00293293|327558|P2|COMPLETED|Overall Study||21
135913|NCT00293293|327559|P1|COMPLETED|Overall Study||18
135914|NCT00293293|327558|P2|STARTED|Overall Study||23
135915|NCT00293293|327559|P1|STARTED|Overall Study||20
135916|NCT00293384|327585|P1|NOT COMPLETED|Overall Study||5
135917|NCT00293384|327585|P1|COMPLETED|Overall Study||35
135918|NCT00293384|327585|P1|STARTED|Overall Study||40
135919|NCT00293462|327595|P3|NOT COMPLETED|Overall Study||10
135920|NCT00293462|327596|P2|NOT COMPLETED|Overall Study||8
135921|NCT00293462|327597|P1|NOT COMPLETED|Overall Study||7
135922|NCT00293462|327595|P3|COMPLETED|Overall Study||21
135923|NCT00293462|327596|P2|COMPLETED|Overall Study||21
135924|NCT00293462|327597|P1|COMPLETED|Overall Study||24
135925|NCT00293462|327595|P3|STARTED|Overall Study||31
135926|NCT00293462|327596|P2|STARTED|Overall Study||29
135927|NCT00293462|327597|P1|STARTED|Overall Study||31
135928|NCT00293540|327618|P2|NOT COMPLETED|Overall Study||8
135929|NCT00293540|327619|P1|NOT COMPLETED|Overall Study||7
135930|NCT00293540|327618|P2|COMPLETED|Overall Study||119
135931|NCT00293540|327619|P1|COMPLETED|Overall Study||115
135932|NCT00293540|327618|P2|STARTED|Overall Study||127
135933|NCT00293540|327619|P1|STARTED|Overall Study||122
135934|NCT00293579|327625|P1|NOT COMPLETED|Overall Study||1
135935|NCT00293579|327625|P1|COMPLETED|Overall Study||4
135936|NCT00293579|327625|P1|STARTED|Overall Study||5
135938|NCT00279955|327636|P2|NOT COMPLETED|Overall Study||0
135939|NCT00279955|327637|P1|NOT COMPLETED|Overall Study||0
135940|NCT00279955|327635|P3|COMPLETED|Overall Study|They are still counted as completes, though they are never used for the analyses of objectives.|358
135941|NCT00279955|327636|P2|COMPLETED|Overall Study||486
135942|NCT00279955|327637|P1|COMPLETED|Overall Study||157
135943|NCT00279955|327635|P3|STARTED|Overall Study||358
135944|NCT00279955|327636|P2|STARTED|Overall Study||486
135945|NCT00279955|327637|P1|STARTED|Overall Study||157
135946|NCT00280059|327650|P2|NOT COMPLETED|Extension Phase||38
135947|NCT00280059|327651|P1|NOT COMPLETED|Extension Phase||49
135948|NCT00280059|327650|P2|COMPLETED|Extension Phase||177
135949|NCT00280059|327651|P1|COMPLETED|Extension Phase||145
135950|NCT00280059|327650|P2|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|215
135951|NCT00280059|327651|P1|STARTED|Extension Phase|Optional phase; number entered was less than the number who completed the efficacy assessment phase.|194
135952|NCT00280059|327650|P2|NOT COMPLETED|Efficacy Assessment Phase||80
135953|NCT00280059|327651|P1|NOT COMPLETED|Efficacy Assessment Phase||94
135954|NCT00280059|327650|P2|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|250
135955|NCT00280059|327651|P1|COMPLETED|Efficacy Assessment Phase|Week 56: up to end of efficacy assessment phase (excluding extension phase).|236
135956|NCT00280059|327650|P2|STARTED|Efficacy Assessment Phase||330
135957|NCT00280059|327651|P1|STARTED|Efficacy Assessment Phase||330
135958|NCT00280150|327701|P4|NOT COMPLETED|Overall Study||10
135959|NCT00280150|327702|P3|NOT COMPLETED|Overall Study||5
135960|NCT00280150|327703|P2|NOT COMPLETED|Overall Study||1
135961|NCT00280150|327704|P1|NOT COMPLETED|Overall Study||3
135962|NCT00280150|327701|P4|COMPLETED|Overall Study||20
135963|NCT00280150|327702|P3|COMPLETED|Overall Study||1
135964|NCT00280150|327703|P2|COMPLETED|Overall Study||4
135965|NCT00280150|327704|P1|COMPLETED|Overall Study||2
135966|NCT00280150|327701|P4|Consolidation Therapy|Overall Study|Phase II participants did not receive consolidation therapy.|0
135967|NCT00280150|327702|P3|Consolidation Therapy|Overall Study||3
135968|NCT00280150|327703|P2|Consolidation Therapy|Overall Study||5
135969|NCT00280150|327704|P1|Consolidation Therapy|Overall Study||2
135970|NCT00280150|327701|P4|Cohort Induction|Overall Study||30
135971|NCT00280150|327702|P3|Cohort Induction|Overall Study||6
135972|NCT00280150|327703|P2|Cohort Induction|Overall Study||5
135973|NCT00280150|327704|P1|Cohort Induction|Overall Study||5
135974|NCT00280150|327701|P4|STARTED|Overall Study||30
135975|NCT00280150|327702|P3|STARTED|Overall Study||6
135976|NCT00280150|327703|P2|STARTED|Overall Study||5
135977|NCT00280150|327704|P1|STARTED|Overall Study||5
135978|NCT00285649|327720|P3|NOT COMPLETED|Overall Study||6
135979|NCT00285649|327721|P2|NOT COMPLETED|Overall Study||6
135980|NCT00285649|327722|P1|NOT COMPLETED|Overall Study||9
135981|NCT00285649|327720|P3|COMPLETED|Overall Study||42
135982|NCT00285649|327721|P2|COMPLETED|Overall Study||66
135983|NCT00285649|327722|P1|COMPLETED|Overall Study||63
135984|NCT00285649|327720|P3|STARTED|Overall Study||48
135985|NCT00285649|327721|P2|STARTED|Overall Study||72
135986|NCT00285649|327722|P1|STARTED|Overall Study||72
135987|NCT00293709|327730|P1|NOT COMPLETED|Overall Study||47
135988|NCT00293709|327730|P1|COMPLETED|Overall Study||102
135989|NCT00293709|327730|P1|STARTED|Overall Study||149
135990|NCT00293722|327744|P1|NOT COMPLETED|Overall Study||427
135991|NCT00293722|327744|P1|COMPLETED|Overall Study||864
135992|NCT00293722|327744|P1|STARTED|Overall Study||1291
135993|NCT00293813|327761|P3|NOT COMPLETED|Overall Study||8
135994|NCT00293813|327762|P2|NOT COMPLETED|Overall Study||9
135995|NCT00293813|327763|P1|NOT COMPLETED|Overall Study||13
135996|NCT00293813|327761|P3|COMPLETED|Overall Study||74
135997|NCT00293813|327762|P2|COMPLETED|Overall Study||74
135998|NCT00293813|327763|P1|COMPLETED|Overall Study||69
135999|NCT00293813|327761|P3|STARTED|Overall Study||82
136000|NCT00293813|327762|P2|STARTED|Overall Study||83
136001|NCT00293813|327763|P1|STARTED|Overall Study||82
136002|NCT00294398|327776|P2|NOT COMPLETED|Overall Study||26
136003|NCT00294398|327777|P1|NOT COMPLETED|Overall Study||21
136004|NCT00294398|327776|P2|COMPLETED|Overall Study||48
136005|NCT00294398|327777|P1|COMPLETED|Overall Study||57
136006|NCT00294398|327776|P2|STARTED|Overall Study||74
136007|NCT00294398|327777|P1|STARTED|Overall Study||78
136008|NCT00294515|327787|P2|NOT COMPLETED|Overall Study||28
136009|NCT00294515|327788|P1|NOT COMPLETED|Overall Study||34
136010|NCT00294515|327787|P2|COMPLETED|Overall Study||132
136011|NCT00294515|327788|P1|COMPLETED|Overall Study||132
136012|NCT00294515|327787|P2|STARTED|Overall Study|Randomized|160
136013|NCT00294515|327788|P1|STARTED|Overall Study|Randomized|166
136014|NCT00294645|327804|P2|NOT COMPLETED|Overall Study||92
136015|NCT00294645|327805|P1|NOT COMPLETED|Overall Study||48
136016|NCT00294645|327804|P2|COMPLETED|Overall Study||510
136017|NCT00294645|327805|P1|COMPLETED|Overall Study||247
136018|NCT00294645|327804|P2|STARTED|Overall Study||602
136019|NCT00294645|327805|P1|STARTED|Overall Study||295
136020|NCT00294658|327839|P2|NOT COMPLETED|Overall Study||9
136021|NCT00294658|327840|P1|NOT COMPLETED|Overall Study||6
136022|NCT00294658|327839|P2|COMPLETED|Overall Study||51
136023|NCT00294658|327840|P1|COMPLETED|Overall Study||60
136024|NCT00294658|327839|P2|STARTED|Overall Study||60
136025|NCT00294658|327840|P1|STARTED|Overall Study||66
136026|NCT00294671|327904|P2|NOT COMPLETED|Overall Study||40
136027|NCT00294671|327905|P1|NOT COMPLETED|Overall Study||27
136028|NCT00294671|327904|P2|COMPLETED|Overall Study||26
136029|NCT00294671|327905|P1|COMPLETED|Overall Study||37
136030|NCT00294671|327904|P2|STARTED|Overall Study||66
136031|NCT00294671|327905|P1|STARTED|Overall Study||64
136032|NCT00294684|327921|P2|NOT COMPLETED|Overall Study||8
136033|NCT00294684|327922|P1|NOT COMPLETED|Overall Study||5
136034|NCT00294684|327921|P2|COMPLETED|Overall Study||62
136035|NCT00294684|327922|P1|COMPLETED|Overall Study||65
136036|NCT00294684|327921|P2|STARTED|Overall Study||70
136037|NCT00294684|327922|P1|STARTED|Overall Study||70
136038|NCT00294723|327963|P3|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||20
136039|NCT00294723|327964|P2|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||21
136040|NCT00294723|327965|P1|NOT COMPLETED|Additional Open-Label Extension 91 Weeks||28
136041|NCT00294723|327963|P3|COMPLETED|Additional Open-Label Extension 91 Weeks||8
136042|NCT00294723|327964|P2|COMPLETED|Additional Open-Label Extension 91 Weeks||32
136043|NCT00294723|327965|P1|COMPLETED|Additional Open-Label Extension 91 Weeks||34
136044|NCT00294723|327963|P3|STARTED|Additional Open-Label Extension 91 Weeks|69 subjects did not continue into the extension period|28
136045|NCT00294723|327964|P2|STARTED|Additional Open-Label Extension 91 Weeks|57 subjects did not continue into the extension period|53
136046|NCT00294723|327965|P1|STARTED|Additional Open-Label Extension 91 Weeks|52 subjects did not continue into the extension period|62
136047|NCT00294723|327963|P3|NOT COMPLETED|Open-Label Extension 52 Weeks||40
136048|NCT00294723|327964|P2|NOT COMPLETED|Open-Label Extension 52 Weeks||39
136049|NCT00294723|327965|P1|NOT COMPLETED|Open-Label Extension 52 Weeks||40
136050|NCT00294723|327963|P3|COMPLETED|Open-Label Extension 52 Weeks||97
136051|NCT00294723|327964|P2|COMPLETED|Open-Label Extension 52 Weeks||110
136052|NCT00294723|327965|P1|COMPLETED|Open-Label Extension 52 Weeks||114
136053|NCT00294723|327963|P3|STARTED|Open-Label Extension 52 Weeks|15 subjects did not continue into the extension period|137
136054|NCT00294723|327964|P2|STARTED|Open-Label Extension 52 Weeks|13 subjects did not continue into the extension period|149
136055|NCT00294723|327965|P1|STARTED|Open-Label Extension 52 Weeks|19 subjects did not continue into the extension period|154
136056|NCT00294723|327963|P3|NOT COMPLETED|Double-Blind Period 52 Weeks||96
136057|NCT00294723|327964|P2|NOT COMPLETED|Double-Blind Period 52 Weeks||89
136058|NCT00294723|327965|P1|NOT COMPLETED|Double-Blind Period 52 Weeks||74
136059|NCT00294723|327963|P3|COMPLETED|Double-Blind Period 52 Weeks||152
136060|NCT00294723|327964|P2|COMPLETED|Double-Blind Period 52 Weeks||162
136061|NCT00294723|327965|P1|COMPLETED|Double-Blind Period 52 Weeks||173
136062|NCT00294723|327963|P3|Exposed to Study Drug|Double-Blind Period 52 Weeks||248
136063|NCT00294723|327964|P2|Exposed to Study Drug|Double-Blind Period 52 Weeks||251
136064|NCT00294723|327965|P1|Exposed to Study Drug|Double-Blind Period 52 Weeks|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|246
136065|NCT00294723|327963|P3|STARTED|Double-Blind Period 52 Weeks|Randomised|248
136066|NCT00294723|327964|P2|STARTED|Double-Blind Period 52 Weeks|Randomised|251
136067|NCT00294723|327965|P1|STARTED|Double-Blind Period 52 Weeks|Randomised|247
136068|NCT00294762|328026|P2|NOT COMPLETED|Overall Study||3
136069|NCT00294762|328027|P1|NOT COMPLETED|Overall Study||3
136070|NCT00294762|328026|P2|COMPLETED|Overall Study||68
136071|NCT00294762|328027|P1|COMPLETED|Overall Study||69
136072|NCT00294762|328026|P2|STARTED|Overall Study||71
136073|NCT00294762|328027|P1|STARTED|Overall Study||72
136074|NCT00295009|328049|P6|NOT COMPLETED|Overall Study||269
136075|NCT00295009|328050|P5|NOT COMPLETED|Overall Study||58
136076|NCT00295009|328051|P4|NOT COMPLETED|Overall Study||25
136077|NCT00295009|328052|P3|NOT COMPLETED|Overall Study||12
136078|NCT00295009|328053|P2|NOT COMPLETED|Overall Study||49
136079|NCT00295009|328054|P1|NOT COMPLETED|Overall Study||41
136080|NCT00295009|328049|P6|COMPLETED|Overall Study|Continued Access patients were only followed out to 24 months|0
136081|NCT00295009|328050|P5|COMPLETED|Overall Study|Completed 60 month visit|116
136082|NCT00295009|328051|P4|COMPLETED|Overall Study|Completed 60 month visit|57
136083|NCT00295009|328052|P3|COMPLETED|Overall Study|Completed 60 month visit|39
136084|NCT00295009|328053|P2|COMPLETED|Overall Study|Completed 60 month visit|134
136085|NCT00295009|328054|P1|COMPLETED|Overall Study|Completed 60 month visit|52
136086|NCT00295009|328049|P6|Completed 24 Month Analysis|Overall Study||198
136087|NCT00295009|328050|P5|Completed 24 Month Analysis|Overall Study||133
136088|NCT00295009|328051|P4|Completed 24 Month Analysis|Overall Study||60
136089|NCT00295009|328052|P3|Completed 24 Month Analysis|Overall Study||45
136090|NCT00295009|328053|P2|Completed 24 Month Analysis|Overall Study||148
136091|NCT00295009|328054|P1|Completed 24 Month Analysis|Overall Study||71
136092|NCT00295009|328049|P6|Treated|Overall Study||259
136093|NCT00295009|328050|P5|Treated|Overall Study||165
136094|NCT00295009|328051|P4|Treated|Overall Study||72
136095|NCT00295009|328052|P3|Treated|Overall Study||50
136096|NCT00295009|328053|P2|Treated|Overall Study||162
136097|NCT00295009|328054|P1|Treated|Overall Study||80
136098|NCT00295009|328049|P6|STARTED|Overall Study||269
136099|NCT00295009|328050|P5|STARTED|Overall Study||174
136100|NCT00295009|328051|P4|STARTED|Overall Study||82
136101|NCT00295009|328052|P3|STARTED|Overall Study||51
136102|NCT00295009|328053|P2|STARTED|Overall Study||183
136103|NCT00295009|328054|P1|STARTED|Overall Study||93
136104|NCT00295061|328076|P2|NOT COMPLETED|Overall Study||0
136105|NCT00295061|328077|P1|NOT COMPLETED|Overall Study||0
136106|NCT00295061|328076|P2|COMPLETED|Overall Study||12
136107|NCT00295061|328077|P1|COMPLETED|Overall Study||12
136108|NCT00295061|328076|P2|STARTED|Overall Study||12
136109|NCT00295061|328077|P1|STARTED|Overall Study||12
136110|NCT00295490|328087|P4|NOT COMPLETED|Overall Study||5
136111|NCT00295490|328088|P3|NOT COMPLETED|Overall Study||4
136112|NCT00295490|328089|P2|NOT COMPLETED|Overall Study||4
136113|NCT00295490|328090|P1|NOT COMPLETED|Overall Study||1
136114|NCT00295490|328087|P4|COMPLETED|Overall Study||12
136115|NCT00295490|328088|P3|COMPLETED|Overall Study||12
136116|NCT00295490|328089|P2|COMPLETED|Overall Study||15
136117|NCT00295490|328090|P1|COMPLETED|Overall Study||14
136118|NCT00295490|328087|P4|STARTED|Overall Study||17
136119|NCT00295490|328088|P3|STARTED|Overall Study||16
136120|NCT00295490|328089|P2|STARTED|Overall Study||19
136121|NCT00295490|328090|P1|STARTED|Overall Study||15
136122|NCT00295503|328128|P1|NOT COMPLETED|Overall Study||0
136123|NCT00295503|328128|P1|COMPLETED|Overall Study||53
136124|NCT00295503|328128|P1|STARTED|Overall Study||53
136125|NCT00295633|328137|P3|NOT COMPLETED|Overall Study||76
136126|NCT00295633|328138|P2|NOT COMPLETED|Overall Study||67
136127|NCT00295633|328139|P1|NOT COMPLETED|Overall Study||62
136128|NCT00295633|328137|P3|COMPLETED|Overall Study||108
136129|NCT00295633|328138|P2|COMPLETED|Overall Study||119
136130|NCT00295633|328139|P1|COMPLETED|Overall Study||133
136131|NCT00295633|328137|P3|Completed Study Without Being Rescued|Overall Study||51
136132|NCT00295633|328138|P2|Completed Study Without Being Rescued|Overall Study||82
136133|NCT00295633|328139|P1|Completed Study Without Being Rescued|Overall Study||88
136134|NCT00295633|328137|P3|STARTED|Overall Study||184
136135|NCT00295633|328138|P2|STARTED|Overall Study||186
136136|NCT00295633|328139|P1|STARTED|Overall Study||195
136137|NCT00295750|328159|P3|NOT COMPLETED|Overall Study||32
136138|NCT00295750|328160|P2|NOT COMPLETED|Overall Study||41
136139|NCT00295750|328161|P1|NOT COMPLETED|Overall Study||43
136140|NCT00295750|328159|P3|COMPLETED|Overall Study||172
136141|NCT00295750|328160|P2|COMPLETED|Overall Study||169
136142|NCT00295750|328161|P1|COMPLETED|Overall Study||163
136143|NCT00295750|328159|P3|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|201
136144|NCT00295750|328160|P2|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|207
136145|NCT00295750|328161|P1|Intent-to-treat (ITT) Population|Overall Study|randomized and exposed patients|202
136146|NCT00295750|328159|P3|STARTED|Overall Study|randomized|204
136147|NCT00295750|328160|P2|STARTED|Overall Study|randomized|210
136148|NCT00295750|328161|P1|STARTED|Overall Study|randomized|206
136149|NCT00295854|328196|P3|NOT COMPLETED|Overall Study||15
136150|NCT00295854|328197|P2|NOT COMPLETED|Overall Study||21
136151|NCT00295854|328198|P1|NOT COMPLETED|Overall Study||18
136152|NCT00295854|328196|P3|COMPLETED|Overall Study||87
136153|NCT00295854|328197|P2|COMPLETED|Overall Study||87
136154|NCT00295854|328198|P1|COMPLETED|Overall Study||77
136155|NCT00295854|328196|P3|ITT Population (N=296)|Overall Study||99
136156|NCT00295854|328197|P2|ITT Population (N=296)|Overall Study||105
136157|NCT00295854|328198|P1|ITT Population (N=296)|Overall Study||92
136158|NCT00295854|328196|P3|Safety Population (N=304)|Overall Study||101
136159|NCT00295854|328197|P2|Safety Population (N=304)|Overall Study||108
136160|NCT00295854|328198|P1|Safety Population (N=304)|Overall Study||95
136161|NCT00295854|328196|P3|STARTED|Overall Study||102
136162|NCT00295854|328197|P2|STARTED|Overall Study||108
136163|NCT00295854|328198|P1|STARTED|Overall Study||95
136164|NCT00295880|328209|P1|NOT COMPLETED|Overall Study||2
136165|NCT00295880|328209|P1|COMPLETED|Overall Study||10
136166|NCT00295880|328209|P1|STARTED|Overall Study||12
136167|NCT00296036|328222|P6|NOT COMPLETED|Overall Study||4
136168|NCT00296036|328223|P5|NOT COMPLETED|Overall Study||2
136169|NCT00296036|328224|P4|NOT COMPLETED|Overall Study||1
136170|NCT00296036|328225|P3|NOT COMPLETED|Overall Study||2
136171|NCT00296036|328226|P2|NOT COMPLETED|Overall Study||0
136172|NCT00296036|328227|P1|NOT COMPLETED|Overall Study||1
136173|NCT00296036|328222|P6|COMPLETED|Overall Study||28
136174|NCT00296036|328223|P5|COMPLETED|Overall Study||31
136175|NCT00296036|328224|P4|COMPLETED|Overall Study||16
136176|NCT00296036|328225|P3|COMPLETED|Overall Study||16
136177|NCT00296036|328226|P2|COMPLETED|Overall Study||18
136178|NCT00296036|328227|P1|COMPLETED|Overall Study||18
136179|NCT00296036|328222|P6|STARTED|Overall Study||32
136180|NCT00296036|328223|P5|STARTED|Overall Study||33
136181|NCT00296036|328224|P4|STARTED|Overall Study||17
136182|NCT00296036|328225|P3|STARTED|Overall Study||18
136183|NCT00296036|328226|P2|STARTED|Overall Study||18
136184|NCT00296036|328227|P1|STARTED|Overall Study||19
136185|NCT00296192|328258|P5|NOT COMPLETED|Overall Study||0
136186|NCT00296192|328259|P4|NOT COMPLETED|Overall Study||0
136187|NCT00296192|328260|P3|NOT COMPLETED|Overall Study||0
136188|NCT00296192|328261|P2|NOT COMPLETED|Overall Study||0
136189|NCT00296192|328262|P1|NOT COMPLETED|Overall Study||0
136190|NCT00296192|328258|P5|COMPLETED|Overall Study||16
136191|NCT00296192|328259|P4|COMPLETED|Overall Study||17
136192|NCT00296192|328260|P3|COMPLETED|Overall Study||16
136193|NCT00296192|328261|P2|COMPLETED|Overall Study||16
136194|NCT00296192|328262|P1|COMPLETED|Overall Study||17
136195|NCT00296192|328258|P5|STARTED|Overall Study||16
136196|NCT00296192|328259|P4|STARTED|Overall Study||17
136197|NCT00296192|328260|P3|STARTED|Overall Study||16
136198|NCT00296192|328261|P2|STARTED|Overall Study||16
136199|NCT00296192|328262|P1|STARTED|Overall Study||17
136200|NCT00296231|328294|P1|NOT COMPLETED|Overall Study||0
136201|NCT00296231|328294|P1|COMPLETED|Overall Study||14
136202|NCT00296231|328294|P1|STARTED|Overall Study||14
136203|NCT00296244|328301|P2|NOT COMPLETED|Overall Study||1
136204|NCT00296244|328302|P1|NOT COMPLETED|Overall Study||0
136205|NCT00296244|328301|P2|COMPLETED|Overall Study||19
136206|NCT00296244|328302|P1|COMPLETED|Overall Study||20
136207|NCT00296244|328301|P2|STARTED|Overall Study||20
136208|NCT00296244|328302|P1|STARTED|Overall Study||20
136209|NCT00296322|328320|P2|NOT COMPLETED|Overall Study||79
136210|NCT00296322|328321|P1|NOT COMPLETED|Overall Study||21
136211|NCT00296322|328320|P2|COMPLETED|Overall Study||184
136212|NCT00296322|328321|P1|COMPLETED|Overall Study||237
136213|NCT00296322|328320|P2|STARTED|Overall Study||263
136214|NCT00296322|328321|P1|STARTED|Overall Study||258
136215|NCT00296335|328333|P2|NOT COMPLETED|Overall Study||122
136216|NCT00296335|328334|P1|NOT COMPLETED|Overall Study||30
136217|NCT00296335|328333|P2|COMPLETED|Overall Study||309
136218|NCT00296335|328334|P1|COMPLETED|Overall Study||394
136219|NCT00296335|328333|P2|STARTED|Overall Study||431
136220|NCT00296335|328334|P1|STARTED|Overall Study||424
136221|NCT00296374|328347|P3|NOT COMPLETED|Overall Study||29
136222|NCT00296374|328348|P2|NOT COMPLETED|Overall Study||23
136223|NCT00296374|328349|P1|NOT COMPLETED|Overall Study||25
136224|NCT00296374|328347|P3|COMPLETED|Overall Study||82
136225|NCT00296374|328348|P2|COMPLETED|Overall Study||101
136226|NCT00296374|328349|P1|COMPLETED|Overall Study||93
136227|NCT00296374|328347|P3|STARTED|Overall Study||111
136228|NCT00296374|328348|P2|STARTED|Overall Study||124
136229|NCT00296374|328349|P1|STARTED|Overall Study||118
136230|NCT00296400|328573|P3|NOT COMPLETED|Overall Study||13
136231|NCT00296400|328574|P2|NOT COMPLETED|Overall Study||18
136232|NCT00296400|328575|P1|NOT COMPLETED|Overall Study||17
136233|NCT00296400|328573|P3|COMPLETED|Overall Study||67
136234|NCT00296400|328574|P2|COMPLETED|Overall Study||69
136235|NCT00296400|328575|P1|COMPLETED|Overall Study||53
136236|NCT00296400|328573|P3|STARTED|Overall Study||80
136237|NCT00296400|328574|P2|STARTED|Overall Study||87
136238|NCT00296400|328575|P1|STARTED|Overall Study||70
136239|NCT00296491|328800|P4|NOT COMPLETED|Overall Study||43
136240|NCT00296491|328801|P3|NOT COMPLETED|Overall Study||43
136241|NCT00296491|328802|P2|NOT COMPLETED|Overall Study||53
136242|NCT00296491|328803|P1|NOT COMPLETED|Overall Study||42
136243|NCT00296491|328800|P4|COMPLETED|Overall Study||138
136244|NCT00296491|328801|P3|COMPLETED|Overall Study||137
136245|NCT00296491|328802|P2|COMPLETED|Overall Study||129
136246|NCT00296491|328803|P1|COMPLETED|Overall Study||140
136247|NCT00296491|328800|P4|STARTED|Overall Study||181
136248|NCT00296491|328801|P3|STARTED|Overall Study||180
136249|NCT00296491|328802|P2|STARTED|Overall Study||182
136250|NCT00296491|328803|P1|STARTED|Overall Study|Please note: Outcome Measures generally conducts analysis of 2 of the 4 Arms at a time.|182
136251|NCT00296504|328837|P9|NOT COMPLETED|Final Analysis||21
136252|NCT00296504|328838|P8|NOT COMPLETED|Final Analysis||0
136253|NCT00296504|328839|P7|NOT COMPLETED|Final Analysis||0
136254|NCT00296504|328840|P6|NOT COMPLETED|Final Analysis||0
136255|NCT00296504|328841|P5|NOT COMPLETED|Final Analysis||0
136256|NCT00296504|328842|P4|NOT COMPLETED|Final Analysis||0
136257|NCT00296504|328843|P3|NOT COMPLETED|Final Analysis||0
136258|NCT00296504|328844|P2|NOT COMPLETED|Final Analysis||0
136259|NCT00296504|328845|P1|NOT COMPLETED|Final Analysis||0
136260|NCT00296504|328837|P9|COMPLETED|Final Analysis||90
136261|NCT00296504|328838|P8|COMPLETED|Final Analysis||0
136262|NCT00296504|328839|P7|COMPLETED|Final Analysis||0
136263|NCT00296504|328840|P6|COMPLETED|Final Analysis||0
136264|NCT00296504|328841|P5|COMPLETED|Final Analysis||0
136265|NCT00296504|328842|P4|COMPLETED|Final Analysis||0
136266|NCT00296504|328843|P3|COMPLETED|Final Analysis||0
136267|NCT00296504|328844|P2|COMPLETED|Final Analysis||0
136268|NCT00296504|328845|P1|COMPLETED|Final Analysis||0
136269|NCT00296504|328837|P9|STARTED|Final Analysis|Continued in study; commercial supplies of FPV were unavailable locally at end of Interim Analysis.|111
136270|NCT00296504|328838|P8|STARTED|Final Analysis||0
136271|NCT00296504|328839|P7|STARTED|Final Analysis||0
136272|NCT00296504|328840|P6|STARTED|Final Analysis||0
136273|NCT00296504|328841|P5|STARTED|Final Analysis||0
136274|NCT00296504|328842|P4|STARTED|Final Analysis||0
136275|NCT00296504|328843|P3|STARTED|Final Analysis||0
136276|NCT00296504|328844|P2|STARTED|Final Analysis||0
136277|NCT00296504|328845|P1|STARTED|Final Analysis||0
136278|NCT00296504|328837|P9|NOT COMPLETED|Interim Analysis||0
136279|NCT00296504|328838|P8|NOT COMPLETED|Interim Analysis||49
136280|NCT00296504|328839|P7|NOT COMPLETED|Interim Analysis||74
136281|NCT00296504|328840|P6|NOT COMPLETED|Interim Analysis||37
136282|NCT00296504|328841|P5|NOT COMPLETED|Interim Analysis||37
136283|NCT00296504|328842|P4|NOT COMPLETED|Interim Analysis||43
136284|NCT00296504|328843|P3|NOT COMPLETED|Interim Analysis||105
136285|NCT00296504|328844|P2|NOT COMPLETED|Interim Analysis||18
136286|NCT00296504|328845|P1|NOT COMPLETED|Interim Analysis||76
136287|NCT00296504|328837|P9|COMPLETED|Interim Analysis||0
136288|NCT00296504|328838|P8|COMPLETED|Interim Analysis||37
136289|NCT00296504|328839|P7|COMPLETED|Interim Analysis||30
136290|NCT00296504|328840|P6|COMPLETED|Interim Analysis||41
136291|NCT00296504|328841|P5|COMPLETED|Interim Analysis||36
136292|NCT00296504|328842|P4|COMPLETED|Interim Analysis||11
136293|NCT00296504|328843|P3|COMPLETED|Interim Analysis||116
136294|NCT00296504|328844|P2|COMPLETED|Interim Analysis||0
136295|NCT00296504|328845|P1|COMPLETED|Interim Analysis||43
136296|NCT00296504|328837|P9|Ongoing|Interim Analysis||0
136297|NCT00296504|328838|P8|Ongoing|Interim Analysis||1
136298|NCT00296504|328839|P7|Ongoing|Interim Analysis||30
136299|NCT00296504|328840|P6|Ongoing|Interim Analysis||0
136300|NCT00296504|328841|P5|Ongoing|Interim Analysis||0
136301|NCT00296504|328842|P4|Ongoing|Interim Analysis||22
136302|NCT00296504|328843|P3|Ongoing|Interim Analysis||16
136303|NCT00296504|328844|P2|Ongoing|Interim Analysis||12
136304|NCT00296504|328845|P1|Ongoing|Interim Analysis||32
136305|NCT00296504|328837|P9|STARTED|Interim Analysis||0
136306|NCT00296504|328838|P8|STARTED|Interim Analysis||86
136307|NCT00296504|328839|P7|STARTED|Interim Analysis||104
136308|NCT00296504|328840|P6|STARTED|Interim Analysis||78
136309|NCT00296504|328841|P5|STARTED|Interim Analysis||73
136310|NCT00296504|328842|P4|STARTED|Interim Analysis||54
136311|NCT00296504|328843|P3|STARTED|Interim Analysis||221
136312|NCT00296504|328844|P2|STARTED|Interim Analysis||18
136313|NCT00296504|328845|P1|STARTED|Interim Analysis||119
136314|NCT00296517|328936|P2|NOT COMPLETED|Dose Level 3 - Weeks 3-12||62
136315|NCT00296517|328937|P1|NOT COMPLETED|Dose Level 3 - Weeks 3-12||45
136316|NCT00296517|328936|P2|COMPLETED|Dose Level 3 - Weeks 3-12||99
136317|NCT00296517|328937|P1|COMPLETED|Dose Level 3 - Weeks 3-12||112
136318|NCT00296517|328936|P2|STARTED|Dose Level 3 - Weeks 3-12||161
136319|NCT00296517|328937|P1|STARTED|Dose Level 3 - Weeks 3-12||157
136320|NCT00296517|328936|P2|NOT COMPLETED|Dose Level 2 - Week 2||5
136321|NCT00296517|328937|P1|NOT COMPLETED|Dose Level 2 - Week 2||2
136322|NCT00296517|328936|P2|COMPLETED|Dose Level 2 - Week 2||161
136323|NCT00296517|328937|P1|COMPLETED|Dose Level 2 - Week 2||157
136324|NCT00296517|328936|P2|STARTED|Dose Level 2 - Week 2||166
136325|NCT00296517|328937|P1|STARTED|Dose Level 2 - Week 2||159
136326|NCT00296517|328936|P2|NOT COMPLETED|Dose Level 1 - Week 1||0
136327|NCT00296517|328937|P1|NOT COMPLETED|Dose Level 1 - Week 1||0
136328|NCT00296517|328936|P2|COMPLETED|Dose Level 1 - Week 1||166
136329|NCT00296517|328937|P1|COMPLETED|Dose Level 1 - Week 1||159
136330|NCT00296517|328936|P2|STARTED|Dose Level 1 - Week 1||166
136331|NCT00296517|328937|P1|STARTED|Dose Level 1 - Week 1||159
136332|NCT00296647|328970|P5|NOT COMPLETED|Overall Study||20
136333|NCT00296647|328971|P4|NOT COMPLETED|Overall Study||17
136334|NCT00296647|328972|P3|NOT COMPLETED|Overall Study||34
136335|NCT00296647|328973|P2|NOT COMPLETED|Overall Study||28
136336|NCT00296647|328974|P1|NOT COMPLETED|Overall Study||32
136337|NCT00296647|328970|P5|COMPLETED|Overall Study||248
136338|NCT00296647|328971|P4|COMPLETED|Overall Study||262
136339|NCT00296647|328972|P3|COMPLETED|Overall Study||222
136340|NCT00296647|328973|P2|COMPLETED|Overall Study||233
136341|NCT00296647|328974|P1|COMPLETED|Overall Study||250
136342|NCT00296647|328970|P5|STARTED|Overall Study||268
136343|NCT00296647|328971|P4|STARTED|Overall Study||279
136344|NCT00296647|328972|P3|STARTED|Overall Study||256
136345|NCT00296647|328973|P2|STARTED|Overall Study||261
136346|NCT00296647|328974|P1|STARTED|Overall Study||282
136347|NCT00288587|328988|P2|NOT COMPLETED|Overall Study||10
136348|NCT00288587|328989|P1|NOT COMPLETED|Overall Study||5
136349|NCT00288587|328988|P2|COMPLETED|Overall Study||7
136350|NCT00288587|328989|P1|COMPLETED|Overall Study||14
136351|NCT00288587|328988|P2|STARTED|Overall Study||17
136352|NCT00288587|328989|P1|STARTED|Overall Study||19
136353|NCT00288600|329005|P2|NOT COMPLETED|Overall Study||0
136354|NCT00288600|329006|P1|NOT COMPLETED|Overall Study||0
136355|NCT00288600|329005|P2|COMPLETED|Overall Study||46
136356|NCT00288600|329006|P1|COMPLETED|Overall Study||46
136357|NCT00288600|329005|P2|STARTED|Overall Study||46
136358|NCT00288600|329006|P1|STARTED|Overall Study||46
136359|NCT00288626|329012|P1|NOT COMPLETED|Overall Study||7
136360|NCT00288626|329012|P1|COMPLETED|Overall Study||17
136361|NCT00288626|329012|P1|STARTED|Overall Study||24
136362|NCT00288639|329035|P1|NOT COMPLETED|Overall Study||12
136363|NCT00288639|329035|P1|COMPLETED|Overall Study||86
136364|NCT00288639|329035|P1|STARTED|Overall Study||98
136365|NCT00288704|329055|P3|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||20
136366|NCT00288704|329056|P2|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
136367|NCT00288704|329057|P1|NOT COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
136368|NCT00288704|329055|P3|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||81
136369|NCT00288704|329056|P2|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
136370|NCT00288704|329057|P1|COMPLETED|Open-Label Extension (OLE) Weeks 24-117||0
136371|NCT00288704|329055|P3|STARTED|Open-Label Extension (OLE) Weeks 24-117||101
136372|NCT00288704|329056|P2|STARTED|Open-Label Extension (OLE) Weeks 24-117||0
136373|NCT00288704|329057|P1|STARTED|Open-Label Extension (OLE) Weeks 24-117|After week 24, all subjects are treated with Open label rilonacept.|0
136374|NCT00288704|329055|P3|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
136375|NCT00288704|329056|P2|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||1
136376|NCT00288704|329057|P1|NOT COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
136377|NCT00288704|329055|P3|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||0
136378|NCT00288704|329056|P2|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||21
136379|NCT00288704|329057|P1|COMPLETED|Part B, Randomized Withdrawal, Wks 15-24||23
136380|NCT00288704|329055|P3|STARTED|Part B, Randomized Withdrawal, Wks 15-24||0
136381|NCT00288704|329056|P2|STARTED|Part B, Randomized Withdrawal, Wks 15-24||22
136382|NCT00288704|329057|P1|STARTED|Part B, Randomized Withdrawal, Wks 15-24|1 subject discontinued during weeks 6-14 due to non-compliance with study drug dosing procedures.|23
136383|NCT00288704|329055|P3|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
136384|NCT00288704|329056|P2|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||1
136385|NCT00288704|329057|P1|NOT COMPLETED|Part A, Double Blind, Weeks 1-6||0
136386|NCT00288704|329055|P3|COMPLETED|Part A, Double Blind, Weeks 1-6||0
136387|NCT00288704|329056|P2|COMPLETED|Part A, Double Blind, Weeks 1-6||22
136388|NCT00288704|329057|P1|COMPLETED|Part A, Double Blind, Weeks 1-6||24
136389|NCT00288704|329055|P3|STARTED|Part A, Double Blind, Weeks 1-6|Subjects enrolled into the open-label phase do not complete this part of the study.|0
136390|NCT00288704|329056|P2|STARTED|Part A, Double Blind, Weeks 1-6||23
136391|NCT00288704|329057|P1|STARTED|Part A, Double Blind, Weeks 1-6||24
136392|NCT00288860|329086|P2|NOT COMPLETED|Overall Study||97
136393|NCT00288860|329087|P1|NOT COMPLETED|Overall Study||102
136394|NCT00288860|329086|P2|COMPLETED|Overall Study|328 completed 4 or 12 month survey. Used all with intake (n=417) in intent to treat.|328
136395|NCT00288860|329087|P1|COMPLETED|Overall Study|310 completed either 4 or 12 month survey. Used all with intake (n = 408) in intent-to-treat.|310
136396|NCT00288860|329086|P2|Completed 12 Month fu Survey|Overall Study||281
136397|NCT00288860|329087|P1|Completed 12 Month fu Survey|Overall Study||257
136398|NCT00288860|329086|P2|Completed 4 Month fu Survey|Overall Study||299
136399|NCT00288860|329087|P1|Completed 4 Month fu Survey|Overall Study||275
136400|NCT00288860|329086|P2|Completed Intake Survey|Overall Study||417
136401|NCT00288860|329087|P1|Completed Intake Survey|Overall Study||408
136402|NCT00288860|329086|P2|STARTED|Overall Study||425
136403|NCT00288860|329087|P1|STARTED|Overall Study||412
136404|NCT00288886|329099|P2|NOT COMPLETED|Overall Study||11
136405|NCT00288886|329100|P1|NOT COMPLETED|Overall Study||11
136406|NCT00288886|329099|P2|COMPLETED|Overall Study||81
136407|NCT00288886|329100|P1|COMPLETED|Overall Study||80
136408|NCT00288886|329099|P2|12-month Follow Up|Overall Study||81
136409|NCT00288886|329100|P1|12-month Follow Up|Overall Study||80
136410|NCT00288886|329099|P2|6-month Follow Up|Overall Study||84
136411|NCT00288886|329100|P1|6-month Follow Up|Overall Study||85
136412|NCT00288886|329099|P2|3-month Follow Up|Overall Study||85
136413|NCT00288886|329100|P1|3-month Follow Up|Overall Study||82
136414|NCT00288886|329099|P2|STARTED|Overall Study||92
136415|NCT00288886|329100|P1|STARTED|Overall Study||91
136416|NCT00288912|329121|P3|NOT COMPLETED|Overall Study||28
136417|NCT00288912|329122|P2|NOT COMPLETED|Overall Study||17
136418|NCT00288912|329123|P1|NOT COMPLETED|Overall Study||17
136419|NCT00288912|329121|P3|COMPLETED|Overall Study||146
136420|NCT00288912|329122|P2|COMPLETED|Overall Study||157
136421|NCT00288912|329123|P1|COMPLETED|Overall Study||158
136422|NCT00288912|329121|P3|STARTED|Overall Study||174
136423|NCT00288912|329122|P2|STARTED|Overall Study||174
136424|NCT00288912|329123|P1|STARTED|Overall Study||175
136425|NCT00289016|329140|P1|NOT COMPLETED|Overall Study||37
136426|NCT00289016|329140|P1|COMPLETED|Overall Study||13
136427|NCT00289016|329140|P1|STARTED|Overall Study||50
136428|NCT00289094|329151|P2|NOT COMPLETED|Overall Study||47
136429|NCT00289094|329152|P1|NOT COMPLETED|Overall Study||47
136430|NCT00289094|329151|P2|COMPLETED|Overall Study||2
136431|NCT00289094|329152|P1|COMPLETED|Overall Study||3
136432|NCT00289094|329151|P2|STARTED|Overall Study||49
136433|NCT00289094|329152|P1|STARTED|Overall Study||50
136434|NCT00289107|329160|P2|NOT COMPLETED|Overall Study||44
136435|NCT00289107|329161|P1|NOT COMPLETED|Overall Study||53
136436|NCT00289107|329160|P2|COMPLETED|Overall Study||28
136437|NCT00289107|329161|P1|COMPLETED|Overall Study||24
136438|NCT00289107|329160|P2|STARTED|Overall Study||72
136439|NCT00289107|329161|P1|STARTED|Overall Study||77
136440|NCT00289120|329167|P1|NOT COMPLETED|Overall Study||0
136441|NCT00289120|329167|P1|COMPLETED|Overall Study||13
136442|NCT00289120|329167|P1|STARTED|Overall Study||13
136443|NCT00289133|329185|P2|NOT COMPLETED|Overall Study||298
136444|NCT00289133|329186|P1|NOT COMPLETED|Overall Study||272
136445|NCT00289133|329185|P2|COMPLETED|Overall Study||179
136446|NCT00289133|329186|P1|COMPLETED|Overall Study||189
136447|NCT00289133|329185|P2|STARTED|Overall Study||477
136448|NCT00289133|329186|P1|STARTED|Overall Study||461
136449|NCT00289185|329210|P2|NOT COMPLETED|Overall Study||26
136450|NCT00289185|329211|P1|NOT COMPLETED|Overall Study||28
136451|NCT00289185|329210|P2|COMPLETED|Overall Study||144
136452|NCT00289185|329211|P1|COMPLETED|Overall Study||142
136453|NCT00289185|329210|P2|STARTED|Overall Study||170
136454|NCT00289185|329211|P1|STARTED|Overall Study||170
136455|NCT00289211|329259|P3|NOT COMPLETED|Overall Study||10
136456|NCT00289211|329260|P2|NOT COMPLETED|Overall Study||1
136457|NCT00289211|329261|P1|NOT COMPLETED|Overall Study||0
136458|NCT00289211|329259|P3|COMPLETED|Overall Study||2
136459|NCT00289211|329260|P2|COMPLETED|Overall Study||34
136460|NCT00289211|329261|P1|COMPLETED|Overall Study||36
136461|NCT00289211|329259|P3|STARTED|Overall Study||12
136462|NCT00289211|329260|P2|STARTED|Overall Study||35
136463|NCT00289211|329261|P1|STARTED|Overall Study||36
136464|NCT00289276|329279|P2|NOT COMPLETED|Second Part of FAST Study (Expansion)||3
136465|NCT00289276|329280|P1|NOT COMPLETED|Second Part of FAST Study (Expansion)||0
136466|NCT00289276|329279|P2|COMPLETED|Second Part of FAST Study (Expansion)||106
136467|NCT00289276|329280|P1|COMPLETED|Second Part of FAST Study (Expansion)||0
136468|NCT00289276|329279|P2|STARTED|Second Part of FAST Study (Expansion)||109
136469|NCT00289276|329280|P1|STARTED|Second Part of FAST Study (Expansion)||0
136470|NCT00289276|329279|P2|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
136471|NCT00289276|329280|P1|NOT COMPLETED|First Part of FAST Study (Pivotal)||0
136472|NCT00289276|329279|P2|COMPLETED|First Part of FAST Study (Pivotal)||0
136473|NCT00289276|329280|P1|COMPLETED|First Part of FAST Study (Pivotal)||47
136474|NCT00289276|329279|P2|STARTED|First Part of FAST Study (Pivotal)||0
136475|NCT00289276|329280|P1|STARTED|First Part of FAST Study (Pivotal)|11 patients were re-consented under version 7 of the CIP, but are included in Pivotal results only|47
136476|NCT00289289|329295|P3|NOT COMPLETED|Overall Study||49
136477|NCT00289289|329296|P2|NOT COMPLETED|Overall Study||10
136478|NCT00289289|329297|P1|NOT COMPLETED|Overall Study||19
136479|NCT00289289|329295|P3|COMPLETED|Overall Study||95
136480|NCT00289289|329296|P2|COMPLETED|Overall Study||114
136481|NCT00289289|329297|P1|COMPLETED|Overall Study||113
136482|NCT00289289|329295|P3|STARTED|Overall Study||144
136483|NCT00289289|329296|P2|STARTED|Overall Study||124
136484|NCT00289289|329297|P1|STARTED|Overall Study||132
136485|NCT00289341|329312|P2|NOT COMPLETED|Overall Study||0
136486|NCT00289341|329313|P1|NOT COMPLETED|Overall Study||0
136487|NCT00289341|329312|P2|COMPLETED|Overall Study||12
136488|NCT00289341|329313|P1|COMPLETED|Overall Study||12
136489|NCT00289341|329312|P2|STARTED|Overall Study||12
136490|NCT00289341|329313|P1|STARTED|Overall Study||12
136491|NCT00289458|329326|P3|NOT COMPLETED|Overall Study||6
136492|NCT00289458|329327|P2|NOT COMPLETED|Overall Study||6
136493|NCT00289458|329328|P1|NOT COMPLETED|Overall Study||6
136494|NCT00289458|329326|P3|COMPLETED|Overall Study||22
136495|NCT00289458|329327|P2|COMPLETED|Overall Study||20
136496|NCT00289458|329328|P1|COMPLETED|Overall Study||19
136497|NCT00289458|329326|P3|STARTED|Overall Study||28
136498|NCT00289458|329327|P2|STARTED|Overall Study||26
136499|NCT00289458|329328|P1|STARTED|Overall Study||25
136500|NCT00289471|329351|P1|NOT COMPLETED|Overall Study||0
136501|NCT00289471|329351|P1|COMPLETED|Overall Study||630
136502|NCT00289471|329351|P1|STARTED|Overall Study||630
136503|NCT00289536|329355|P3|NOT COMPLETED|Period 3||1
136504|NCT00289536|329356|P2|NOT COMPLETED|Period 3||0
136505|NCT00289536|329357|P1|NOT COMPLETED|Period 3||0
136506|NCT00289536|329355|P3|COMPLETED|Period 3||9
136507|NCT00289536|329356|P2|COMPLETED|Period 3||9
136508|NCT00289536|329357|P1|COMPLETED|Period 3||7
136509|NCT00289536|329355|P3|STARTED|Period 3|5 participants received Low Dose and 5 participants received Medium Dose in Period 2|10
136510|NCT00289536|329356|P2|STARTED|Period 3|5 participants received Low Dose and 4 participants received High Dose in Period 2|9
136511|NCT00289536|329357|P1|STARTED|Period 3|3 participants received Medium Dose and 4 participants received High Dose in Period 2|7
136512|NCT00289536|329355|P3|NOT COMPLETED|Period 2||0
136513|NCT00289536|329356|P2|NOT COMPLETED|Period 2||0
136514|NCT00289536|329357|P1|NOT COMPLETED|Period 2||0
136515|NCT00289536|329355|P3|COMPLETED|Period 2||7
136516|NCT00289536|329356|P2|COMPLETED|Period 2||9
136517|NCT00289536|329357|P1|COMPLETED|Period 2||10
136518|NCT00289536|329355|P3|STARTED|Period 2|4 participants received Low Dose and 3 participants received Medium Dose in Period 1|7
136519|NCT00289536|329356|P2|STARTED|Period 2|5 participants received Low Dose and 4 participants received High Dose in Period 1|9
136520|NCT00289536|329357|P1|STARTED|Period 2|5 participants received Medium Dose and 5 participants received High Dose in Period 1|10
136521|NCT00289536|329355|P3|NOT COMPLETED|Period 1||0
136522|NCT00289536|329356|P2|NOT COMPLETED|Period 1||0
136523|NCT00289536|329357|P1|NOT COMPLETED|Period 1||0
136524|NCT00289536|329355|P3|COMPLETED|Period 1||9
136525|NCT00289536|329356|P2|COMPLETED|Period 1||8
136526|NCT00289536|329357|P1|COMPLETED|Period 1||9
136527|NCT00289536|329355|P3|STARTED|Period 1||9
136528|NCT00289536|329356|P2|STARTED|Period 1||8
136529|NCT00289536|329357|P1|STARTED|Period 1||9
136530|NCT00289718|329396|P1|NOT COMPLETED|Overall Study||0
136531|NCT00289718|329396|P1|COMPLETED|Overall Study||51
136532|NCT00289718|329396|P1|STARTED|Overall Study||51
136533|NCT00289744|329408|P3|NOT COMPLETED|Additional Dose Phase||0
136534|NCT00289744|329409|P2|NOT COMPLETED|Additional Dose Phase||0
136535|NCT00289744|329410|P1|NOT COMPLETED|Additional Dose Phase||0
136536|NCT00289744|329408|P3|COMPLETED|Additional Dose Phase||6
136537|NCT00289744|329409|P2|COMPLETED|Additional Dose Phase||19
136538|NCT00289744|329410|P1|COMPLETED|Additional Dose Phase||0
136539|NCT00289744|329408|P3|STARTED|Additional Dose Phase||6
136540|NCT00289744|329409|P2|STARTED|Additional Dose Phase||19
136541|NCT00289744|329410|P1|STARTED|Additional Dose Phase||0
136542|NCT00289744|329408|P3|NOT COMPLETED|Year 10 Long-term Follow-up||0
136543|NCT00289744|329409|P2|NOT COMPLETED|Year 10 Long-term Follow-up||0
136544|NCT00289744|329410|P1|NOT COMPLETED|Year 10 Long-term Follow-up||0
136545|NCT00289744|329408|P3|COMPLETED|Year 10 Long-term Follow-up||0
136546|NCT00289744|329409|P2|COMPLETED|Year 10 Long-term Follow-up||0
136547|NCT00289744|329410|P1|COMPLETED|Year 10 Long-term Follow-up||171
136548|NCT00289744|329408|P3|STARTED|Year 10 Long-term Follow-up||0
136549|NCT00289744|329409|P2|STARTED|Year 10 Long-term Follow-up||0
136550|NCT00289744|329410|P1|STARTED|Year 10 Long-term Follow-up|Subjects who came back at Year 10 blood sampling time-point|171
136551|NCT00289744|329408|P3|NOT COMPLETED|Year 9 Long-term Follow-up||0
136552|NCT00289744|329409|P2|NOT COMPLETED|Year 9 Long-term Follow-up||0
136553|NCT00289744|329410|P1|NOT COMPLETED|Year 9 Long-term Follow-up||0
136554|NCT00289744|329408|P3|COMPLETED|Year 9 Long-term Follow-up||0
136555|NCT00289744|329409|P2|COMPLETED|Year 9 Long-term Follow-up||0
136556|NCT00289744|329410|P1|COMPLETED|Year 9 Long-term Follow-up||173
136557|NCT00289744|329408|P3|STARTED|Year 9 Long-term Follow-up||0
136558|NCT00289744|329409|P2|STARTED|Year 9 Long-term Follow-up||0
136559|NCT00289744|329410|P1|STARTED|Year 9 Long-term Follow-up|Subjects who came back at Year 9 blood sampling time-point|173
136560|NCT00289744|329408|P3|NOT COMPLETED|Year 8 Long-term Follow-up||0
136561|NCT00289744|329409|P2|NOT COMPLETED|Year 8 Long-term Follow-up||0
136562|NCT00289744|329410|P1|NOT COMPLETED|Year 8 Long-term Follow-up||0
136563|NCT00289744|329408|P3|COMPLETED|Year 8 Long-term Follow-up||0
136564|NCT00289744|329409|P2|COMPLETED|Year 8 Long-term Follow-up||0
136565|NCT00289744|329410|P1|COMPLETED|Year 8 Long-term Follow-up||174
136566|NCT00289744|329408|P3|STARTED|Year 8 Long-term Follow-up||0
136567|NCT00289744|329409|P2|STARTED|Year 8 Long-term Follow-up||0
136568|NCT00289744|329410|P1|STARTED|Year 8 Long-term Follow-up|Subjects who came back at Year 8 blood sampling time-point|174
136569|NCT00289744|329408|P3|NOT COMPLETED|Year 7 Long-term Follow-up||0
136570|NCT00289744|329409|P2|NOT COMPLETED|Year 7 Long-term Follow-up||0
136571|NCT00289744|329410|P1|NOT COMPLETED|Year 7 Long-term Follow-up||0
136572|NCT00289744|329408|P3|COMPLETED|Year 7 Long-term Follow-up||0
136573|NCT00289744|329409|P2|COMPLETED|Year 7 Long-term Follow-up||0
136574|NCT00289744|329410|P1|COMPLETED|Year 7 Long-term Follow-up||175
136575|NCT00289744|329408|P3|STARTED|Year 7 Long-term Follow-up||0
136576|NCT00289744|329409|P2|STARTED|Year 7 Long-term Follow-up||0
136577|NCT00289744|329410|P1|STARTED|Year 7 Long-term Follow-up|Subjects who came back at Year 7 blood sampling time-point|175
136578|NCT00289744|329408|P3|NOT COMPLETED|Year 6 Long-term Follow-up||0
136579|NCT00289744|329409|P2|NOT COMPLETED|Year 6 Long-term Follow-up||0
136580|NCT00289744|329410|P1|NOT COMPLETED|Year 6 Long-term Follow-up||0
136581|NCT00289744|329408|P3|COMPLETED|Year 6 Long-term Follow-up||0
136582|NCT00289744|329409|P2|COMPLETED|Year 6 Long-term Follow-up||0
136583|NCT00289744|329410|P1|COMPLETED|Year 6 Long-term Follow-up||178
136584|NCT00289744|329408|P3|STARTED|Year 6 Long-term Follow-up||0
136585|NCT00289744|329409|P2|STARTED|Year 6 Long-term Follow-up||0
136586|NCT00289744|329410|P1|STARTED|Year 6 Long-term Follow-up|Number of subjects who come back at Year 6 blood sampling time-point|178
136587|NCT00289757|329428|P1|NOT COMPLETED|Overall Study||0
136588|NCT00289757|329428|P1|COMPLETED|Overall Study||78
136589|NCT00289757|329428|P1|STARTED|Overall Study||78
136590|NCT00289770|329439|P1|NOT COMPLETED|Year 15||1
136591|NCT00289770|329439|P1|COMPLETED|Year 15||49
136592|NCT00289770|329439|P1|STARTED|Year 15||50
136593|NCT00289770|329439|P1|NOT COMPLETED|Year 14||0
136594|NCT00289770|329439|P1|COMPLETED|Year 14||43
136595|NCT00289770|329439|P1|STARTED|Year 14||43
136596|NCT00289770|329439|P1|NOT COMPLETED|Year 13||0
136597|NCT00289770|329439|P1|COMPLETED|Year 13||37
136598|NCT00289770|329439|P1|STARTED|Year 13||37
136599|NCT00289770|329439|P1|NOT COMPLETED|Year 12||0
136600|NCT00289770|329439|P1|COMPLETED|Year 12||40
136601|NCT00289770|329439|P1|STARTED|Year 12||40
136602|NCT00289770|329439|P1|NOT COMPLETED|Year 11||0
136603|NCT00289770|329439|P1|COMPLETED|Year 11||37
136604|NCT00289770|329439|P1|STARTED|Year 11||37
136605|NCT00289783|329453|P2|NOT COMPLETED|Fourth Dose Phase||24
136606|NCT00289783|329454|P1|NOT COMPLETED|Fourth Dose Phase||87
136607|NCT00289783|329453|P2|COMPLETED|Fourth Dose Phase||899
136608|NCT00289783|329454|P1|COMPLETED|Fourth Dose Phase||2682
136609|NCT00289783|329453|P2|STARTED|Fourth Dose Phase||923
136610|NCT00289783|329454|P1|STARTED|Fourth Dose Phase||2769
136611|NCT00289783|329453|P2|NOT COMPLETED|Primary Phase||83
136612|NCT00289783|329454|P1|NOT COMPLETED|Primary Phase||248
136613|NCT00289783|329453|P2|COMPLETED|Primary Phase||961
136614|NCT00289783|329454|P1|COMPLETED|Primary Phase||2888
136615|NCT00289783|329453|P2|STARTED|Primary Phase||1044
136616|NCT00289783|329454|P1|STARTED|Primary Phase||3136
136617|NCT00289848|329634|P2|NOT COMPLETED|Overall Study||45
136618|NCT00289848|329635|P1|NOT COMPLETED|Overall Study||46
136619|NCT00289848|329634|P2|COMPLETED|Overall Study||133
136620|NCT00289848|329635|P1|COMPLETED|Overall Study||306
136621|NCT00289848|329634|P2|STARTED|Overall Study||178
136622|NCT00289848|329635|P1|STARTED|Overall Study||352
136623|NCT00289874|329647|P2|NOT COMPLETED|Overall Study||8
136624|NCT00289874|329648|P1|NOT COMPLETED|Overall Study||6
136625|NCT00289874|329647|P2|COMPLETED|Overall Study||210
136626|NCT00289874|329648|P1|COMPLETED|Overall Study||197
136627|NCT00289874|329647|P2|STARTED|Overall Study||218
136628|NCT00289874|329648|P1|STARTED|Overall Study||203
136629|NCT00289887|329658|P2|NOT COMPLETED|Overall Study||29
136630|NCT00289887|329659|P1|NOT COMPLETED|Overall Study||22
136631|NCT00289887|329658|P2|COMPLETED|Overall Study||105
136632|NCT00289887|329659|P1|COMPLETED|Overall Study||105
136633|NCT00289887|329658|P2|STARTED|Overall Study||134
136634|NCT00289887|329659|P1|STARTED|Overall Study||127
136635|NCT00289900|329681|P6|NOT COMPLETED|Overall Study||61
136636|NCT00289900|329682|P5|NOT COMPLETED|Overall Study||45
136637|NCT00289900|329683|P4|NOT COMPLETED|Overall Study||59
136638|NCT00289900|329684|P3|NOT COMPLETED|Overall Study||33
136639|NCT00289900|329685|P2|NOT COMPLETED|Overall Study||120
136640|NCT00289900|329686|P1|NOT COMPLETED|Overall Study||68
136641|NCT00289900|329681|P6|COMPLETED|Overall Study||372
136642|NCT00289900|329682|P5|COMPLETED|Overall Study||392
136643|NCT00289900|329683|P4|COMPLETED|Overall Study||380
136644|NCT00289900|329684|P3|COMPLETED|Overall Study||265
136645|NCT00289900|329685|P2|COMPLETED|Overall Study||316
136646|NCT00289900|329686|P1|COMPLETED|Overall Study||229
136647|NCT00289900|329681|P6|Treated|Overall Study||433
136648|NCT00289900|329682|P5|Treated|Overall Study||437
136649|NCT00289900|329683|P4|Treated|Overall Study||439
136650|NCT00289900|329684|P3|Treated|Overall Study||298
136651|NCT00289900|329685|P2|Treated|Overall Study||435
136652|NCT00289900|329686|P1|Treated|Overall Study||297
136653|NCT00289900|329681|P6|STARTED|Overall Study||433
136654|NCT00289900|329682|P5|STARTED|Overall Study||437
136655|NCT00289900|329683|P4|STARTED|Overall Study||439
136656|NCT00289900|329684|P3|STARTED|Overall Study||298
136657|NCT00289900|329685|P2|STARTED|Overall Study||436
136658|NCT00289900|329686|P1|STARTED|Overall Study||297
136659|NCT00289913|329793|P5|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
136660|NCT00289913|329794|P4|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
136661|NCT00289913|329795|P3|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
136662|NCT00289913|329796|P2|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
136663|NCT00289913|329797|P1|NOT COMPLETED|Visit 4 (Stage I and Stage II)||0
136664|NCT00289913|329793|P5|COMPLETED|Visit 4 (Stage I and Stage II)||597
136665|NCT00289913|329794|P4|COMPLETED|Visit 4 (Stage I and Stage II)||131
136666|NCT00289913|329795|P3|COMPLETED|Visit 4 (Stage I and Stage II)||138
136667|NCT00289913|329796|P2|COMPLETED|Visit 4 (Stage I and Stage II)||106
136668|NCT00289913|329797|P1|COMPLETED|Visit 4 (Stage I and Stage II)||122
136669|NCT00289913|329793|P5|STARTED|Visit 4 (Stage I and Stage II)||597
136670|NCT00289913|329794|P4|STARTED|Visit 4 (Stage I and Stage II)||131
136671|NCT00289913|329795|P3|STARTED|Visit 4 (Stage I and Stage II)||138
136672|NCT00289913|329796|P2|STARTED|Visit 4 (Stage I and Stage II)||106
136673|NCT00289913|329797|P1|STARTED|Visit 4 (Stage I and Stage II)||122
136674|NCT00289913|329793|P5|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
136675|NCT00289913|329794|P4|NOT COMPLETED|Visit 3 (Stage I and Stage II)||4
136676|NCT00289913|329795|P3|NOT COMPLETED|Visit 3 (Stage I and Stage II)||2
136677|NCT00289913|329796|P2|NOT COMPLETED|Visit 3 (Stage I and Stage II)||8
136678|NCT00289913|329797|P1|NOT COMPLETED|Visit 3 (Stage I and Stage II)||9
136679|NCT00289913|329793|P5|COMPLETED|Visit 3 (Stage I and Stage II)||597
136680|NCT00289913|329794|P4|COMPLETED|Visit 3 (Stage I and Stage II)||131
136681|NCT00289913|329795|P3|COMPLETED|Visit 3 (Stage I and Stage II)||138
136682|NCT00289913|329796|P2|COMPLETED|Visit 3 (Stage I and Stage II)||106
136683|NCT00289913|329797|P1|COMPLETED|Visit 3 (Stage I and Stage II)||122
136684|NCT00289913|329793|P5|STARTED|Visit 3 (Stage I and Stage II)||605
136685|NCT00289913|329794|P4|STARTED|Visit 3 (Stage I and Stage II)||135
136686|NCT00289913|329795|P3|STARTED|Visit 3 (Stage I and Stage II)||140
136687|NCT00289913|329796|P2|STARTED|Visit 3 (Stage I and Stage II)||114
136688|NCT00289913|329797|P1|STARTED|Visit 3 (Stage I and Stage II)||131
136689|NCT00289913|329793|P5|NOT COMPLETED|Visit 2 (Stage I and Stage II)||40
136690|NCT00289913|329794|P4|NOT COMPLETED|Visit 2 (Stage I and Stage II)||6
136691|NCT00289913|329795|P3|NOT COMPLETED|Visit 2 (Stage I and Stage II)||10
136692|NCT00289913|329796|P2|NOT COMPLETED|Visit 2 (Stage I and Stage II)||21
136693|NCT00289913|329797|P1|NOT COMPLETED|Visit 2 (Stage I and Stage II)||15
136694|NCT00289913|329793|P5|COMPLETED|Visit 2 (Stage I and Stage II)||605
136695|NCT00289913|329794|P4|COMPLETED|Visit 2 (Stage I and Stage II)||135
136696|NCT00289913|329795|P3|COMPLETED|Visit 2 (Stage I and Stage II)||140
136697|NCT00289913|329796|P2|COMPLETED|Visit 2 (Stage I and Stage II)||114
136698|NCT00289913|329797|P1|COMPLETED|Visit 2 (Stage I and Stage II)||131
136699|NCT00289913|329793|P5|STARTED|Visit 2 (Stage I and Stage II)|No vaccine administered at Visit 2 (Stage II), therefore there was no safety F/U period.|645
136700|NCT00289913|329794|P4|STARTED|Visit 2 (Stage I and Stage II)||141
136701|NCT00289913|329795|P3|STARTED|Visit 2 (Stage I and Stage II)||150
136702|NCT00289913|329796|P2|STARTED|Visit 2 (Stage I and Stage II)||135
136703|NCT00289913|329797|P1|STARTED|Visit 2 (Stage I and Stage II)||146
136704|NCT00289913|329793|P5|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
136705|NCT00289913|329794|P4|NOT COMPLETED|Visit 1 (Stage I and Stage II)||11
136706|NCT00289913|329795|P3|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
136707|NCT00289913|329796|P2|NOT COMPLETED|Visit 1 (Stage I and Stage II)||16
136708|NCT00289913|329797|P1|NOT COMPLETED|Visit 1 (Stage I and Stage II)||9
136709|NCT00289913|329793|P5|COMPLETED|Visit 1 (Stage I and Stage II)||645
136710|NCT00289913|329794|P4|COMPLETED|Visit 1 (Stage I and Stage II)||141
136711|NCT00289913|329795|P3|COMPLETED|Visit 1 (Stage I and Stage II)||150
136712|NCT00289913|329796|P2|COMPLETED|Visit 1 (Stage I and Stage II)||135
136713|NCT00289913|329797|P1|COMPLETED|Visit 1 (Stage I and Stage II)||146
136714|NCT00289913|329793|P5|STARTED|Visit 1 (Stage I and Stage II)|Participants were enrolled during Stage II.|654
136715|NCT00289913|329794|P4|STARTED|Visit 1 (Stage I and Stage II)||152
136716|NCT00289913|329795|P3|STARTED|Visit 1 (Stage I and Stage II)||159
136717|NCT00289913|329796|P2|STARTED|Visit 1 (Stage I and Stage II)||151
136718|NCT00289913|329797|P1|STARTED|Visit 1 (Stage I and Stage II)||155
136719|NCT00289978|329825|P3|NOT COMPLETED|Overall Study||86
136720|NCT00289978|329826|P2|NOT COMPLETED|Overall Study||56
136721|NCT00289978|329827|P1|NOT COMPLETED|Overall Study||97
136722|NCT00289978|329825|P3|COMPLETED|Overall Study|303 completed on study drug, 29 completed off study drug.|332
136723|NCT00289978|329826|P2|COMPLETED|Overall Study|345 completed on study drug, 24 completed off study drug.|369
136724|NCT00289978|329827|P1|COMPLETED|Overall Study|296 completed on study drug, 35 completed off study drug.|332
136725|NCT00289978|329825|P3|STARTED|Overall Study||418
136726|NCT00289978|329826|P2|STARTED|Overall Study||425
136727|NCT00289978|329827|P1|STARTED|Overall Study||429
136728|NCT00289991|329843|P2|NOT COMPLETED|Overall Study||80
136729|NCT00289991|329844|P1|NOT COMPLETED|Overall Study||58
136730|NCT00289991|329843|P2|COMPLETED|Overall Study||175
136731|NCT00289991|329844|P1|COMPLETED|Overall Study||176
136732|NCT00289991|329843|P2|STARTED|Overall Study||255
136733|NCT00289991|329844|P1|STARTED|Overall Study||234
136734|NCT00290147|329868|P2|NOT COMPLETED|Overall Study||0
136735|NCT00290147|329869|P1|NOT COMPLETED|Overall Study||0
136736|NCT00290147|329868|P2|COMPLETED|Overall Study||12
136737|NCT00290147|329869|P1|COMPLETED|Overall Study||10
136738|NCT00290147|329868|P2|STARTED|Overall Study||12
136739|NCT00290147|329869|P1|STARTED|Overall Study||10
136740|NCT00290186|329879|P2|NOT COMPLETED|Overall Study||5
136741|NCT00290186|329880|P1|NOT COMPLETED|Overall Study||5
136742|NCT00290186|329879|P2|COMPLETED|Overall Study||19
136743|NCT00290186|329880|P1|COMPLETED|Overall Study||20
136744|NCT00290186|329879|P2|Completed 6-month Followup Assessments|Overall Study||19
136745|NCT00290186|329880|P1|Completed 6-month Followup Assessments|Overall Study||20
136746|NCT00290186|329879|P2|Completed 3-month Followup Assessments|Overall Study||21
136747|NCT00290186|329880|P1|Completed 3-month Followup Assessments|Overall Study||20
136748|NCT00290186|329879|P2|Completed Post-treatment Assessments|Overall Study||22
136749|NCT00290186|329880|P1|Completed Post-treatment Assessments|Overall Study||24
136750|NCT00290186|329879|P2|Completed 8 Weeks of Treatment|Overall Study||22
136751|NCT00290186|329880|P1|Completed 8 Weeks of Treatment|Overall Study||24
136752|NCT00290186|329879|P2|Completed Baseline Assessments|Overall Study||24
136753|NCT00290186|329880|P1|Completed Baseline Assessments|Overall Study||25
136754|NCT00290186|329879|P2|STARTED|Overall Study||24
136755|NCT00290186|329880|P1|STARTED|Overall Study||25
136756|NCT00290199|329920|P2|NOT COMPLETED|Overall Study||0
136757|NCT00290199|329921|P1|NOT COMPLETED|Overall Study||0
136758|NCT00290199|329920|P2|COMPLETED|Overall Study||82
136759|NCT00290199|329921|P1|COMPLETED|Overall Study||87
136760|NCT00290199|329920|P2|STARTED|Overall Study||82
136761|NCT00290199|329921|P1|STARTED|Overall Study||87
136762|NCT00290238|329935|P2|NOT COMPLETED|Overall Study||41
136763|NCT00290238|329936|P1|NOT COMPLETED|Overall Study||42
136764|NCT00290238|329935|P2|COMPLETED|Overall Study||24
136765|NCT00290238|329936|P1|COMPLETED|Overall Study||15
136766|NCT00290238|329935|P2|STARTED|Overall Study|One subject had an invalid birth date and was excluded from the Age Categorical counts.|65
136767|NCT00290238|329936|P1|STARTED|Overall Study||57
136768|NCT00290251|329944|P3|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
136769|NCT00290251|329945|P2|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
136770|NCT00290251|329946|P1|NOT COMPLETED|Elective Extension (to 12 Months no Rx)||0
136771|NCT00290251|329944|P3|COMPLETED|Elective Extension (to 12 Months no Rx)||5
136772|NCT00290251|329945|P2|COMPLETED|Elective Extension (to 12 Months no Rx)||3
136773|NCT00290251|329946|P1|COMPLETED|Elective Extension (to 12 Months no Rx)||5
136774|NCT00290251|329944|P3|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
136775|NCT00290251|329945|P2|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|3
136776|NCT00290251|329946|P1|STARTED|Elective Extension (to 12 Months no Rx)|Extension study was elective and observational only; treatment arm given as last study drug group|5
136777|NCT00290251|329944|P3|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
136778|NCT00290251|329945|P2|NOT COMPLETED|Treatment 2 (Months 4 - 6)||0
136779|NCT00290251|329946|P1|NOT COMPLETED|Treatment 2 (Months 4 - 6)||2
136780|NCT00290251|329944|P3|COMPLETED|Treatment 2 (Months 4 - 6)||0
136781|NCT00290251|329945|P2|COMPLETED|Treatment 2 (Months 4 - 6)||5
136782|NCT00290251|329946|P1|COMPLETED|Treatment 2 (Months 4 - 6)||6
136783|NCT00290251|329944|P3|STARTED|Treatment 2 (Months 4 - 6)|Women were randomized from PLC to ulipristal acetate or continued same dose ulipristal acetate|0
136784|NCT00290251|329945|P2|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 10 grp did not continue|5
136785|NCT00290251|329946|P1|STARTED|Treatment 2 (Months 4 - 6)|2 crossed over from placebo; others in treatment 1 PLC or ulipristal acetate 20 did not continue|8
136786|NCT00290251|329944|P3|NOT COMPLETED|Treatment 1 (Months 1 - 3)||2
136787|NCT00290251|329945|P2|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
136788|NCT00290251|329946|P1|NOT COMPLETED|Treatment 1 (Months 1 - 3)||1
136789|NCT00290251|329944|P3|COMPLETED|Treatment 1 (Months 1 - 3)||12
136790|NCT00290251|329945|P2|COMPLETED|Treatment 1 (Months 1 - 3)||13
136791|NCT00290251|329946|P1|COMPLETED|Treatment 1 (Months 1 - 3)||13
136792|NCT00290251|329944|P3|STARTED|Treatment 1 (Months 1 - 3)||14
136793|NCT00290251|329945|P2|STARTED|Treatment 1 (Months 1 - 3)||14
136794|NCT00290251|329946|P1|STARTED|Treatment 1 (Months 1 - 3)||14
136795|NCT00290290|329958|P2|NOT COMPLETED|Overall Study||18
136796|NCT00290290|329959|P1|NOT COMPLETED|Overall Study||18
136797|NCT00290290|329958|P2|COMPLETED|Overall Study||391
136798|NCT00290290|329959|P1|COMPLETED|Overall Study||422
136799|NCT00290290|329958|P2|STARTED|Overall Study||409
136800|NCT00290290|329959|P1|STARTED|Overall Study||440
136801|NCT00290329|329968|P3|NOT COMPLETED|Overall Study||0
136802|NCT00290329|329969|P2|NOT COMPLETED|Overall Study||0
136803|NCT00290329|329970|P1|NOT COMPLETED|Overall Study||0
136804|NCT00290329|329968|P3|COMPLETED|Overall Study||61
136805|NCT00290329|329969|P2|COMPLETED|Overall Study||86
136806|NCT00290329|329970|P1|COMPLETED|Overall Study||102
136807|NCT00290329|329968|P3|STARTED|Overall Study||61
136808|NCT00290329|329969|P2|STARTED|Overall Study||86
136809|NCT00290329|329970|P1|STARTED|Overall Study||102
136810|NCT00290407|329990|P1|NOT COMPLETED|Overall Study||0
136811|NCT00290407|329990|P1|COMPLETED|Overall Study||2
136812|NCT00290407|329990|P1|STARTED|Overall Study||2
136813|NCT00290472|329997|P3|NOT COMPLETED|Overall Study||0
136814|NCT00290472|329998|P2|NOT COMPLETED|Overall Study||0
136815|NCT00290472|329999|P1|NOT COMPLETED|Overall Study||0
136816|NCT00290472|329997|P3|COMPLETED|Overall Study||18
136817|NCT00290472|329998|P2|COMPLETED|Overall Study||39
136818|NCT00290472|329999|P1|COMPLETED|Overall Study||32
136819|NCT00290472|329997|P3|STARTED|Overall Study||18
136820|NCT00290472|329998|P2|STARTED|Overall Study||39
136821|NCT00290472|329999|P1|STARTED|Overall Study||32
136822|NCT00290537|330011|P2|NOT COMPLETED|Overall Study||0
136823|NCT00290537|330012|P1|NOT COMPLETED|Overall Study||0
136824|NCT00290537|330011|P2|COMPLETED|Overall Study||0
136825|NCT00290537|330012|P1|COMPLETED|Overall Study||4
136826|NCT00290537|330011|P2|STARTED|Overall Study||0
136827|NCT00290537|330012|P1|STARTED|Overall Study||4
136828|NCT00290615|330017|P1|NOT COMPLETED|Overall Study||0
136829|NCT00290615|330017|P1|COMPLETED|Overall Study||30
136830|NCT00290615|330017|P1|STARTED|Overall Study||30
136831|NCT00290654|330024|P1|NOT COMPLETED|Overall Study||0
136832|NCT00290654|330024|P1|COMPLETED|Overall Study||41
136833|NCT00290654|330024|P1|STARTED|Overall Study||41
136834|NCT00290693|330035|P1|NOT COMPLETED|Overall Study||0
136835|NCT00290693|330035|P1|COMPLETED|Overall Study||24
136836|NCT00290693|330035|P1|STARTED|Overall Study||24
136837|NCT00290732|330042|P5|NOT COMPLETED|Overall Study||0
136838|NCT00290732|330043|P4|NOT COMPLETED|Overall Study||0
136839|NCT00290732|330044|P3|NOT COMPLETED|Overall Study||1
136840|NCT00290732|330045|P2|NOT COMPLETED|Overall Study||1
136841|NCT00290732|330046|P1|NOT COMPLETED|Overall Study||0
136842|NCT00290732|330042|P5|COMPLETED|Overall Study||3
136843|NCT00290732|330043|P4|COMPLETED|Overall Study||6
136844|NCT00290732|330044|P3|COMPLETED|Overall Study||3
136845|NCT00290732|330045|P2|COMPLETED|Overall Study||3
136846|NCT00290732|330046|P1|COMPLETED|Overall Study||3
136847|NCT00290732|330042|P5|STARTED|Overall Study||3
136848|NCT00290732|330043|P4|STARTED|Overall Study||6
136849|NCT00290732|330044|P3|STARTED|Overall Study||4
136850|NCT00290732|330045|P2|STARTED|Overall Study||4
136851|NCT00290732|330046|P1|STARTED|Overall Study||3
136852|NCT00290758|330066|P2|NOT COMPLETED|Post Intervention rFNA||5
136853|NCT00290758|330067|P1|NOT COMPLETED|Post Intervention rFNA||6
136854|NCT00290758|330066|P2|COMPLETED|Post Intervention rFNA||49
136855|NCT00290758|330067|P1|COMPLETED|Post Intervention rFNA||49
136856|NCT00290758|330066|P2|STARTED|Post Intervention rFNA||54
136857|NCT00290758|330067|P1|STARTED|Post Intervention rFNA||55
136858|NCT00290758|330066|P2|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||10
136859|NCT00290758|330067|P1|NOT COMPLETED|Pre-Intervention rFNA Through Follow-Up||7
136860|NCT00290758|330066|P2|COMPLETED|Pre-Intervention rFNA Through Follow-Up||54
136861|NCT00290758|330067|P1|COMPLETED|Pre-Intervention rFNA Through Follow-Up||55
136862|NCT00290758|330066|P2|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||54
136863|NCT00290758|330067|P1|Post Intervention Follow-Up|Pre-Intervention rFNA Through Follow-Up||55
136864|NCT00290758|330066|P2|Treatment|Pre-Intervention rFNA Through Follow-Up||64
136865|NCT00290758|330067|P1|Treatment|Pre-Intervention rFNA Through Follow-Up||61
136866|NCT00290758|330066|P2|Randomization|Pre-Intervention rFNA Through Follow-Up||62
136867|NCT00290758|330067|P1|Randomization|Pre-Intervention rFNA Through Follow-Up||62
136868|NCT00290758|330066|P2|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||64
136869|NCT00290758|330067|P1|First rFNA Tissue Collection|Pre-Intervention rFNA Through Follow-Up||62
136870|NCT00290758|330066|P2|STARTED|Pre-Intervention rFNA Through Follow-Up||64
136871|NCT00290758|330067|P1|STARTED|Pre-Intervention rFNA Through Follow-Up||62
136872|NCT00290771|330089|P2|NOT COMPLETED|Overall Study||97
136873|NCT00290771|330090|P1|NOT COMPLETED|Overall Study||127
136874|NCT00290771|330089|P2|COMPLETED|Overall Study||3
136875|NCT00290771|330090|P1|COMPLETED|Overall Study||4
136876|NCT00290771|330089|P2|STARTED|Overall Study||100
136877|NCT00290771|330090|P1|STARTED|Overall Study||131
136878|NCT00290810|330112|P1|NOT COMPLETED|Overall Study||0
136879|NCT00290810|330112|P1|COMPLETED|Overall Study||12
136880|NCT00290810|330112|P1|STARTED|Overall Study||12
136881|NCT00290888|330121|P2|NOT COMPLETED|Overall Study||1
136882|NCT00290888|330122|P1|NOT COMPLETED|Overall Study||3
136883|NCT00290888|330121|P2|COMPLETED|Overall Study||44
136884|NCT00290888|330122|P1|COMPLETED|Overall Study||38
136885|NCT00290888|330121|P2|STARTED|Overall Study||45
136886|NCT00290888|330122|P1|STARTED|Overall Study||41
136887|NCT00291018|330133|P3|NOT COMPLETED|Overall Study||43
136888|NCT00291018|330134|P2|NOT COMPLETED|Overall Study||42
136889|NCT00291018|330135|P1|NOT COMPLETED|Overall Study||25
136890|NCT00291018|330133|P3|COMPLETED|Overall Study|Evaluated at 84 Months|93
136891|NCT00291018|330134|P2|COMPLETED|Overall Study|Evaluated at 84 Months|64
136892|NCT00291018|330135|P1|COMPLETED|Overall Study|Evaluated at 84 Months|78
136893|NCT00291018|330133|P3|Evaluated at 24 Months|Overall Study||105
136894|NCT00291018|330134|P2|Evaluated at 24 Months|Overall Study||92
136895|NCT00291018|330135|P1|Evaluated at 24 Months|Overall Study||99
136896|NCT00291018|330133|P3|STARTED|Overall Study|Started =Subjects Enrolled and Treated. 140 PDC-CA subjects were Enrolled but only 136 were Treated|136
136897|NCT00291018|330134|P2|STARTED|Overall Study|Started = Subjects Enrolled and Treated. 117 ACDF subjects were Enrolled but only 106 were Treated|106
136898|NCT00291018|330135|P1|STARTED|Overall Study|Started = Subjects Enrolled and Treated. 111 PDC subjects were Enrolled but only 103 were Treated|103
136899|NCT00296816|330175|P1|NOT COMPLETED|Overall Study||74
136900|NCT00296816|330175|P1|COMPLETED|Overall Study|Completed study treatment for a minimum of three years|58
136901|NCT00296816|330175|P1|STARTED|Overall Study||132
136902|NCT00297037|330189|P2|NOT COMPLETED|Overall Study||0
136903|NCT00297037|330190|P1|NOT COMPLETED|Overall Study||2
136904|NCT00297037|330189|P2|COMPLETED|Overall Study||11
136905|NCT00297037|330190|P1|COMPLETED|Overall Study||8
136906|NCT00297037|330189|P2|STARTED|Overall Study||11
136907|NCT00297037|330190|P1|STARTED|Overall Study||10
136908|NCT00297102|330202|P2|NOT COMPLETED|Overall Study||233
136909|NCT00297102|330203|P1|NOT COMPLETED|Overall Study||263
136910|NCT00297102|330202|P2|COMPLETED|Overall Study||525
136911|NCT00297102|330203|P1|COMPLETED|Overall Study||502
136912|NCT00297102|330202|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|758
136913|NCT00297102|330203|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|765
136914|NCT00300677|330219|P1|NOT COMPLETED|Overall Study||0
136915|NCT00300677|330219|P1|COMPLETED|Overall Study||12
136916|NCT00300677|330219|P1|STARTED|Overall Study||12
136917|NCT00300742|330226|P1|NOT COMPLETED|Overall Study||2
136918|NCT00300742|330226|P1|COMPLETED|Overall Study||3
136919|NCT00300742|330226|P1|STARTED|Overall Study||5
136920|NCT00300755|330237|P3|NOT COMPLETED|Overall Study||2
136921|NCT00300755|330238|P2|NOT COMPLETED|Overall Study||4
136922|NCT00300755|330239|P1|NOT COMPLETED|Overall Study||1
136923|NCT00300755|330237|P3|COMPLETED|Overall Study||19
136924|NCT00300755|330238|P2|COMPLETED|Overall Study||17
136925|NCT00300755|330239|P1|COMPLETED|Overall Study||17
136926|NCT00300755|330237|P3|STARTED|Overall Study||21
136927|NCT00300755|330238|P2|STARTED|Overall Study||21
136928|NCT00300755|330239|P1|STARTED|Overall Study||18
136929|NCT00300885|330258|P2|NOT COMPLETED|Follow-up||195
136930|NCT00300885|330259|P1|NOT COMPLETED|Follow-up||178
136931|NCT00300885|330258|P2|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|174
136932|NCT00300885|330259|P1|COMPLETED|Follow-up|Subjects still in Follow up period at data cut-off date.|176
136933|NCT00300885|330258|P2|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|369
136934|NCT00300885|330259|P1|STARTED|Follow-up|Subjects entered Follow-up period after termination of Treatment period due to any reason.|354
136935|NCT00300885|330258|P2|NOT COMPLETED|Treatment||374
136936|NCT00300885|330259|P1|NOT COMPLETED|Treatment||373
136937|NCT00300885|330258|P2|COMPLETED|Treatment||88
136938|NCT00300885|330259|P1|COMPLETED|Treatment||91
136939|NCT00300885|330258|P2|Received Treatment|Treatment||459
136940|NCT00300885|330259|P1|Received Treatment|Treatment||463
136941|NCT00300885|330258|P2|STARTED|Treatment|ongoing in double -blind treatment at data cut-off|462
136942|NCT00300885|330259|P1|STARTED|Treatment||464
136943|NCT00301028|330275|P1|NOT COMPLETED|Overall Study||0
136944|NCT00301028|330275|P1|COMPLETED|Overall Study||47
136945|NCT00301028|330275|P1|STARTED|Overall Study||47
136946|NCT00301080|330279|P5|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136947|NCT00301080|330280|P4|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136948|NCT00301080|330281|P3|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136949|NCT00301080|330282|P2|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136950|NCT00301080|330283|P1|NOT COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136951|NCT00301080|330279|P5|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136952|NCT00301080|330280|P4|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136953|NCT00301080|330281|P3|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136954|NCT00301080|330282|P2|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136955|NCT00301080|330283|P1|COMPLETED|Revised Version (3 Arms & 12 Weeks)||0
136956|NCT00301080|330279|P5|STARTED|Revised Version (3 Arms & 12 Weeks)||0
136957|NCT00301080|330280|P4|STARTED|Revised Version (3 Arms & 12 Weeks)||0
136958|NCT00301080|330281|P3|STARTED|Revised Version (3 Arms & 12 Weeks)||0
136959|NCT00301080|330282|P2|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
136960|NCT00301080|330283|P1|STARTED|Revised Version (3 Arms & 12 Weeks)|This arm was not a part of the revised study design.|0
136961|NCT00301080|330279|P5|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
136962|NCT00301080|330280|P4|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
136963|NCT00301080|330281|P3|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
136964|NCT00301080|330282|P2|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||0
136965|NCT00301080|330283|P1|NOT COMPLETED|Original Version (2 Arms & 4 Weeks)||1
136966|NCT00301080|330279|P5|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
136967|NCT00301080|330280|P4|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
136968|NCT00301080|330281|P3|COMPLETED|Original Version (2 Arms & 4 Weeks)||0
136969|NCT00301080|330282|P2|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
136970|NCT00301080|330283|P1|COMPLETED|Original Version (2 Arms & 4 Weeks)||3
136971|NCT00301080|330279|P5|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
136972|NCT00301080|330280|P4|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
136973|NCT00301080|330281|P3|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||0
136974|NCT00301080|330282|P2|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
136975|NCT00301080|330283|P1|Completed 4 Week Intervention|Original Version (2 Arms & 4 Weeks)||3
136976|NCT00301080|330279|P5|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
136977|NCT00301080|330280|P4|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
136978|NCT00301080|330281|P3|Received an Intervention|Original Version (2 Arms & 4 Weeks)||0
136979|NCT00301080|330282|P2|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
136980|NCT00301080|330283|P1|Received an Intervention|Original Version (2 Arms & 4 Weeks)||3
136981|NCT00301080|330279|P5|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
136982|NCT00301080|330280|P4|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
136983|NCT00301080|330281|P3|STARTED|Original Version (2 Arms & 4 Weeks)|This arm not part of the original version.|0
136984|NCT00301080|330282|P2|STARTED|Original Version (2 Arms & 4 Weeks)||3
136985|NCT00301080|330283|P1|STARTED|Original Version (2 Arms & 4 Weeks)||4
136986|NCT00301262|330314|P2|NOT COMPLETED|Open Label Phase (OL)||2
136987|NCT00301262|330315|P1|NOT COMPLETED|Open Label Phase (OL)||4
136988|NCT00301262|330314|P2|COMPLETED|Open Label Phase (OL)||67
136989|NCT00301262|330315|P1|COMPLETED|Open Label Phase (OL)||79
136990|NCT00301262|330314|P2|STARTED|Open Label Phase (OL)||69
136991|NCT00301262|330315|P1|STARTED|Open Label Phase (OL)||83
136992|NCT00301262|330314|P2|NOT COMPLETED|Double Blind Phase (DB)||13
136993|NCT00301262|330315|P1|NOT COMPLETED|Double Blind Phase (DB)||10
136994|NCT00301262|330314|P2|COMPLETED|Double Blind Phase (DB)||69
136995|NCT00301262|330315|P1|COMPLETED|Double Blind Phase (DB)||84
136996|NCT00301262|330314|P2|STARTED|Double Blind Phase (DB)||82
136997|NCT00301262|330315|P1|STARTED|Double Blind Phase (DB)||94
136998|NCT00301366|330473|P1|NOT COMPLETED|Overall Study||1
136999|NCT00301366|330473|P1|COMPLETED|Overall Study||37
137000|NCT00301366|330473|P1|STARTED|Overall Study||38
137001|NCT00301418|330477|P1|NOT COMPLETED|Overall Study||0
137002|NCT00301418|330477|P1|COMPLETED|Overall Study||11
137003|NCT00301418|330477|P1|STARTED|Overall Study||11
137004|NCT00301756|330483|P1|NOT COMPLETED|Overall Study||0
137005|NCT00301756|330483|P1|COMPLETED|Overall Study||32
137006|NCT00301756|330483|P1|STARTED|Overall Study||32
137007|NCT00301808|330492|P1|NOT COMPLETED|Overall Study||12
137008|NCT00301808|330492|P1|COMPLETED|Overall Study||17
137009|NCT00301808|330492|P1|STARTED|Overall Study||29
137010|NCT00301821|330496|P1|NOT COMPLETED|Overall Study||26
137011|NCT00301821|330496|P1|COMPLETED|Overall Study||81
137012|NCT00301821|330496|P1|STARTED|Overall Study||107
137013|NCT00301834|330503|P1|NOT COMPLETED|Overall Study||1
137014|NCT00301834|330503|P1|COMPLETED|Overall Study||34
137015|NCT00301834|330503|P1|STARTED|Overall Study||35
137016|NCT00301873|330512|P1|NOT COMPLETED|Overall Study||0
137017|NCT00301873|330512|P1|COMPLETED|Overall Study||59
137018|NCT00301873|330512|P1|STARTED|Overall Study||59
137019|NCT00301964|330518|P1|NOT COMPLETED|Overall Study||4
137020|NCT00301964|330518|P1|COMPLETED|Overall Study|Total number of eligible and evaluable participants|52
137021|NCT00301964|330518|P1|STARTED|Overall Study||56
137022|NCT00302003|330523|P1|NOT COMPLETED|Overall Study||80
137023|NCT00302003|330523|P1|COMPLETED|Overall Study||207
137024|NCT00302003|330523|P1|STARTED|Overall Study||287
137025|NCT00302042|330532|P2|NOT COMPLETED|Overall Study||8
137026|NCT00302042|330533|P1|NOT COMPLETED|Overall Study||7
137027|NCT00302042|330532|P2|COMPLETED|Overall Study||38
137028|NCT00302042|330533|P1|COMPLETED|Overall Study||39
137029|NCT00302042|330532|P2|STARTED|Overall Study||46
137030|NCT00302042|330533|P1|STARTED|Overall Study||46
137031|NCT00302055|330541|P2|NOT COMPLETED|Overall Study||13
137032|NCT00302055|330542|P1|NOT COMPLETED|Overall Study||9
137033|NCT00302055|330541|P2|COMPLETED|Overall Study||36
137034|NCT00302055|330542|P1|COMPLETED|Overall Study||14
137035|NCT00302055|330541|P2|STARTED|Overall Study||49
137036|NCT00302055|330542|P1|STARTED|Overall Study||23
137037|NCT00302068|330551|P3|NOT COMPLETED|Overall Study||1
137038|NCT00302068|330552|P2|NOT COMPLETED|Overall Study||4
137039|NCT00302068|330553|P1|NOT COMPLETED|Overall Study||1
137040|NCT00302068|330551|P3|COMPLETED|Overall Study||23
137041|NCT00302068|330552|P2|COMPLETED|Overall Study||36
137042|NCT00302068|330553|P1|COMPLETED|Overall Study||36
137043|NCT00302068|330551|P3|STARTED|Overall Study||24
137044|NCT00302068|330552|P2|STARTED|Overall Study||40
137045|NCT00302068|330553|P1|STARTED|Overall Study||37
137046|NCT00302081|330582|P3|NOT COMPLETED|Overall Study||52
137047|NCT00302081|330583|P2|NOT COMPLETED|Overall Study||43
137048|NCT00302081|330584|P1|NOT COMPLETED|Overall Study||56
137049|NCT00302081|330582|P3|COMPLETED|Overall Study||178
137050|NCT00302081|330583|P2|COMPLETED|Overall Study||186
137051|NCT00302081|330584|P1|COMPLETED|Overall Study||181
137052|NCT00302081|330582|P3|STARTED|Overall Study||230
137053|NCT00302081|330583|P2|STARTED|Overall Study||229
137054|NCT00302081|330584|P1|STARTED|Overall Study||237
137055|NCT00302107|330594|P2|NOT COMPLETED|Overall Study||9
137056|NCT00302107|330595|P1|NOT COMPLETED|Overall Study||8
137057|NCT00302107|330594|P2|COMPLETED|Overall Study||30
137058|NCT00302107|330595|P1|COMPLETED|Overall Study||31
137059|NCT00302107|330594|P2|STARTED|Overall Study||39
137060|NCT00302107|330595|P1|STARTED|Overall Study||39
137061|NCT00302133|330603|P2|NOT COMPLETED|Overall Study||4
137062|NCT00302133|330604|P1|NOT COMPLETED|Overall Study||4
137063|NCT00302133|330603|P2|COMPLETED|Overall Study||5
137064|NCT00302133|330604|P1|COMPLETED|Overall Study||5
137065|NCT00302133|330603|P2|STARTED|Overall Study||9
137066|NCT00302133|330604|P1|STARTED|Overall Study||9
137067|NCT00302159|330612|P1|NOT COMPLETED|Overall Study||2
137068|NCT00302159|330612|P1|COMPLETED|Overall Study||41
137069|NCT00302159|330612|P1|STARTED|Overall Study||43
137070|NCT00302211|330624|P5|NOT COMPLETED|Open Label-Patients From Double-Blind||8
137071|NCT00302211|330625|P4|NOT COMPLETED|Open Label-Patients From Double-Blind||8
137072|NCT00302211|330626|P3|NOT COMPLETED|Open Label-Patients From Double-Blind||0
137073|NCT00302211|330627|P2|NOT COMPLETED|Open Label-Patients From Double-Blind||0
137074|NCT00302211|330628|P1|NOT COMPLETED|Open Label-Patients From Double-Blind||0
137075|NCT00302211|330624|P5|COMPLETED|Open Label-Patients From Double-Blind||24
137076|NCT00302211|330625|P4|COMPLETED|Open Label-Patients From Double-Blind||18
137077|NCT00302211|330626|P3|COMPLETED|Open Label-Patients From Double-Blind||0
137078|NCT00302211|330627|P2|COMPLETED|Open Label-Patients From Double-Blind||0
137079|NCT00302211|330628|P1|COMPLETED|Open Label-Patients From Double-Blind||0
137080|NCT00302211|330624|P5|STARTED|Open Label-Patients From Double-Blind|26 pts in 4x/day + placebo 2x/day DB phase & 6 pts in placebo 6x/day DB phase enrolled in OL 4x/day|32
137081|NCT00302211|330625|P4|STARTED|Open Label-Patients From Double-Blind|21 patients (pts) in 6x/day DB phase & 5 patients in placebo 6x/day DB phase enrolled in OL 6x/day|26
137082|NCT00302211|330626|P3|STARTED|Open Label-Patients From Double-Blind||0
137083|NCT00302211|330627|P2|STARTED|Open Label-Patients From Double-Blind||0
137084|NCT00302211|330628|P1|STARTED|Open Label-Patients From Double-Blind||0
137085|NCT00302211|330624|P5|NOT COMPLETED|Double Blind Period (New Patients)||0
137086|NCT00302211|330625|P4|NOT COMPLETED|Double Blind Period (New Patients)||0
137087|NCT00302211|330626|P3|NOT COMPLETED|Double Blind Period (New Patients)||4
137088|NCT00302211|330627|P2|NOT COMPLETED|Double Blind Period (New Patients)||2
137089|NCT00302211|330628|P1|NOT COMPLETED|Double Blind Period (New Patients)||3
137090|NCT00302211|330624|P5|COMPLETED|Double Blind Period (New Patients)||0
137091|NCT00302211|330625|P4|COMPLETED|Double Blind Period (New Patients)||0
137092|NCT00302211|330626|P3|COMPLETED|Double Blind Period (New Patients)||10
137093|NCT00302211|330627|P2|COMPLETED|Double Blind Period (New Patients)||25
137094|NCT00302211|330628|P1|COMPLETED|Double Blind Period (New Patients)||23
137095|NCT00302211|330624|P5|STARTED|Double Blind Period (New Patients)||0
137096|NCT00302211|330625|P4|STARTED|Double Blind Period (New Patients)||0
137097|NCT00302211|330626|P3|STARTED|Double Blind Period (New Patients)|placebo plus sildenafil with or without bosentan|14
137098|NCT00302211|330627|P2|STARTED|Double Blind Period (New Patients)|iloprost 4x/day plus sildenafil with or without bosentan|27
137099|NCT00302211|330628|P1|STARTED|Double Blind Period (New Patients)|iloprost 6x/day plus sildenafil with or without bosentan|26
137100|NCT00302328|330643|P3|NOT COMPLETED|Overall Study||0
137101|NCT00302328|330644|P2|NOT COMPLETED|Overall Study||1
137102|NCT00302328|330645|P1|NOT COMPLETED|Overall Study||0
137103|NCT00302328|330643|P3|COMPLETED|Overall Study||18
137104|NCT00302328|330644|P2|COMPLETED|Overall Study|developed cancer during the study|34
137105|NCT00302328|330645|P1|COMPLETED|Overall Study||25
137106|NCT00302328|330643|P3|STARTED|Overall Study||18
137107|NCT00302328|330644|P2|STARTED|Overall Study||35
137108|NCT00302328|330645|P1|STARTED|Overall Study||25
137109|NCT00302458|330659|P1|NOT COMPLETED|Overall Study||3
137110|NCT00302458|330659|P1|COMPLETED|Overall Study||26
137111|NCT00302458|330659|P1|STARTED|Overall Study||29
137112|NCT00302718|330671|P4|NOT COMPLETED|Overall Study||2
137113|NCT00302718|330672|P3|NOT COMPLETED|Overall Study||2
137114|NCT00302718|330673|P2|NOT COMPLETED|Overall Study||1
137115|NCT00302718|330674|P1|NOT COMPLETED|Overall Study||1
137116|NCT00302718|330671|P4|COMPLETED|Overall Study||19
137117|NCT00302718|330672|P3|COMPLETED|Overall Study||19
137118|NCT00302718|330673|P2|COMPLETED|Overall Study||20
137119|NCT00302718|330674|P1|COMPLETED|Overall Study||19
137120|NCT00302718|330671|P4|STARTED|Overall Study||21
137121|NCT00302718|330672|P3|STARTED|Overall Study||21
137122|NCT00302718|330673|P2|STARTED|Overall Study||21
137123|NCT00302718|330674|P1|STARTED|Overall Study||20
137124|NCT00302848|330709|P3|NOT COMPLETED|Overall Study||579
137125|NCT00302848|330710|P2|NOT COMPLETED|Overall Study||419
137126|NCT00302848|330711|P1|NOT COMPLETED|Overall Study||401
137127|NCT00302848|330709|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|25762
137128|NCT00302848|330710|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|15009
137129|NCT00302848|330711|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 1.5 and 5.0 years.|16133
137130|NCT00302848|330709|P3|STARTED|Overall Study||26341
137131|NCT00302848|330710|P2|STARTED|Overall Study||15428
137132|NCT00302848|330711|P1|STARTED|Overall Study||16534
137133|NCT00302952|330720|P2|NOT COMPLETED|Overall Study||5
137134|NCT00302952|330721|P1|NOT COMPLETED|Overall Study||3
137135|NCT00302952|330720|P2|COMPLETED|Overall Study||25
137136|NCT00302952|330721|P1|COMPLETED|Overall Study||31
137222|NCT00305162|331009|P2|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|504
137137|NCT00302952|330720|P2|Completed Intent-to-Treat (ITT)|Overall Study|One participant did not have a baseline C-reactive Protein and was excluded from the ITT population.|29
137138|NCT00302952|330721|P1|Completed Intent-to-Treat (ITT)|Overall Study||34
137139|NCT00302952|330720|P2|Started Intent-to-Treat (ITT)|Overall Study||30
137140|NCT00302952|330721|P1|Started Intent-to-Treat (ITT)|Overall Study||34
137141|NCT00302952|330720|P2|STARTED|Overall Study||30
137142|NCT00302952|330721|P1|STARTED|Overall Study||34
137143|NCT00303069|330759|P4|NOT COMPLETED|Overall Study||2
137144|NCT00303069|330760|P3|NOT COMPLETED|Overall Study||1
137145|NCT00303069|330761|P2|NOT COMPLETED|Overall Study||0
137146|NCT00303069|330762|P1|NOT COMPLETED|Overall Study||2
137147|NCT00303069|330759|P4|COMPLETED|Overall Study||29
137148|NCT00303069|330760|P3|COMPLETED|Overall Study||33
137149|NCT00303069|330761|P2|COMPLETED|Overall Study||28
137150|NCT00303069|330762|P1|COMPLETED|Overall Study||29
137151|NCT00303069|330759|P4|STARTED|Overall Study||31
137152|NCT00303069|330760|P3|STARTED|Overall Study||34
137153|NCT00303069|330761|P2|STARTED|Overall Study||28
137154|NCT00303069|330762|P1|STARTED|Overall Study||31
137155|NCT00294047|330782|P2|NOT COMPLETED|Month 84||989
137156|NCT00294047|330783|P1|NOT COMPLETED|Month 84||973
137157|NCT00294047|330782|P2|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Aluminium Hydroxide Group = 2116|1881
137158|NCT00294047|330783|P1|COMPLETED|Month 84|The number of subjects who remained up to Month 48 in the Cervarix Group = 2146|1904
137159|NCT00294047|330782|P2|STARTED|Month 84||2870
137160|NCT00294047|330783|P1|STARTED|Month 84||2877
137161|NCT00294047|330782|P2|NOT COMPLETED|Month 48||433
137162|NCT00294047|330783|P1|NOT COMPLETED|Month 48||425
137163|NCT00294047|330782|P2|COMPLETED|Month 48||2438
137164|NCT00294047|330783|P1|COMPLETED|Month 48||2456
137165|NCT00294047|330782|P2|Participated up to Month 48|Month 48||2281
137166|NCT00294047|330783|P1|Participated up to Month 48|Month 48||2305
137167|NCT00294047|330782|P2|STARTED|Month 48||2871
137168|NCT00294047|330783|P1|STARTED|Month 48||2881
137169|NCT00294060|330885|P1|NOT COMPLETED|Overall Study||1173
137170|NCT00294060|330885|P1|COMPLETED|Overall Study||840
137171|NCT00294060|330885|P1|STARTED|Overall Study||2013
137172|NCT00303108|330894|P3|NOT COMPLETED|Overall Study||16
137173|NCT00303108|330895|P2|NOT COMPLETED|Overall Study||9
137174|NCT00303108|330896|P1|NOT COMPLETED|Overall Study||12
137175|NCT00303108|330894|P3|COMPLETED|Overall Study||31
137176|NCT00303108|330895|P2|COMPLETED|Overall Study||37
137177|NCT00303108|330896|P1|COMPLETED|Overall Study||31
137178|NCT00303108|330894|P3|STARTED|Overall Study||47
137179|NCT00303108|330895|P2|STARTED|Overall Study||46
137180|NCT00303108|330896|P1|STARTED|Overall Study||43
137181|NCT00303186|330912|P1|NOT COMPLETED|Overall Study||52
137182|NCT00303186|330912|P1|COMPLETED|Overall Study||55
137183|NCT00303186|330912|P1|STARTED|Overall Study||107
137184|NCT00303316|330945|P2|NOT COMPLETED|Overall Study||3
137185|NCT00303316|330946|P1|NOT COMPLETED|Overall Study||2
137186|NCT00303316|330945|P2|COMPLETED|Overall Study||223
137187|NCT00303316|330946|P1|COMPLETED|Overall Study||230
137188|NCT00303316|330945|P2|STARTED|Overall Study||226
137189|NCT00303316|330946|P1|STARTED|Overall Study||232
137190|NCT00303329|330960|P2|NOT COMPLETED|Overall Study||62
137191|NCT00303329|330961|P1|NOT COMPLETED|Overall Study||35
137192|NCT00303329|330960|P2|COMPLETED|Overall Study||37
137193|NCT00303329|330961|P1|COMPLETED|Overall Study||50
137194|NCT00303329|330960|P2|STARTED|Overall Study||99
137195|NCT00303329|330961|P1|STARTED|Overall Study||85
137196|NCT00304915|330975|P2|NOT COMPLETED|Overall Study||16
137197|NCT00304915|330976|P1|NOT COMPLETED|Overall Study||18
137198|NCT00304915|330975|P2|COMPLETED|Overall Study||110
137199|NCT00304915|330976|P1|COMPLETED|Overall Study||105
137200|NCT00304915|330975|P2|STARTED|Overall Study||126
137201|NCT00304915|330976|P1|STARTED|Overall Study||123
137202|NCT00304954|330986|P4|NOT COMPLETED|Overall Study||0
137203|NCT00304954|330987|P3|NOT COMPLETED|Overall Study||1
137204|NCT00304954|330988|P2|NOT COMPLETED|Overall Study||0
137205|NCT00304954|330989|P1|NOT COMPLETED|Overall Study||1
137206|NCT00304954|330986|P4|COMPLETED|Overall Study||3
137207|NCT00304954|330987|P3|COMPLETED|Overall Study||2
137208|NCT00304954|330988|P2|COMPLETED|Overall Study||3
137209|NCT00304954|330989|P1|COMPLETED|Overall Study||3
137210|NCT00304954|330986|P4|STARTED|Overall Study||3
137211|NCT00304954|330987|P3|STARTED|Overall Study||3
137212|NCT00304954|330988|P2|STARTED|Overall Study||3
137213|NCT00304954|330989|P1|STARTED|Overall Study||4
137214|NCT00305162|331009|P2|NOT COMPLETED|1 Year Follow-up Period||65
137215|NCT00305162|331010|P1|NOT COMPLETED|1 Year Follow-up Period||55
137216|NCT00305162|331009|P2|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4382
137217|NCT00305162|331010|P1|COMPLETED|1 Year Follow-up Period|intent-to-treat (ITT) completers at 1-year follow-up|4380
137218|NCT00305162|331009|P2|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|444
137219|NCT00305162|331010|P1|Modified ITT (mITT): STEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|446
137220|NCT00305162|331009|P2|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3818
137221|NCT00305162|331010|P1|Modified ITT (mITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year; Excludes those who did not receive study drug or undergo index PCI.|3851
137223|NCT00305162|331010|P1|Intent-to-treat (ITT): STEMI|1 Year Follow-up Period|Completed through 1 year|480
137224|NCT00305162|331009|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3878
137225|NCT00305162|331010|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|1 Year Follow-up Period|Completed through 1 year|3900
137226|NCT00305162|331009|P2|STARTED|1 Year Follow-up Period||4447
137227|NCT00305162|331010|P1|STARTED|1 Year Follow-up Period||4435
137228|NCT00305162|331009|P2|NOT COMPLETED|30-day Follow-up Period||63
137229|NCT00305162|331010|P1|NOT COMPLETED|30-day Follow-up Period||62
137230|NCT00305162|331009|P2|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4384
137231|NCT00305162|331010|P1|COMPLETED|30-day Follow-up Period|intent-to-treat (ITT) completers at 30-day follow-up|4373
137232|NCT00305162|331009|P2|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|444
137233|NCT00305162|331010|P1|Modified ITT (mITT): STEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|438
137234|NCT00305162|331009|P2|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3827
137235|NCT00305162|331010|P1|Modified ITT (mITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days; Excludes those who did not receive study drug or undergo index PCI.|3860
137236|NCT00305162|331009|P2|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|501
137237|NCT00305162|331010|P1|Intent-to-treat (ITT): STEMI|30-day Follow-up Period|Completed through 30-days|471
137238|NCT00305162|331009|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3883
137239|NCT00305162|331010|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|30-day Follow-up Period|Completed through 30-days|3902
137240|NCT00305162|331009|P2|STARTED|30-day Follow-up Period||4447
137241|NCT00305162|331010|P1|STARTED|30-day Follow-up Period||4435
137242|NCT00305162|331009|P2|NOT COMPLETED|48 Hour Follow-up Period||16
137243|NCT00305162|331010|P1|NOT COMPLETED|48 Hour Follow-up Period||20
137244|NCT00305162|331009|P2|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4431
137245|NCT00305162|331010|P1|COMPLETED|48 Hour Follow-up Period|intent-to-treat (ITT) completers at 48 hour follow-up|4415
137246|NCT00305162|331009|P2|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4365
137247|NCT00305162|331010|P1|Safety Population|48 Hour Follow-up Period|Patients who received at least 1 dose of study drug, according to the actual treatment received.|4374
137248|NCT00305162|331009|P2|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|447
137249|NCT00305162|331010|P1|Modified ITT (mITT): STEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|446
137250|NCT00305162|331009|P2|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3865
137338|NCT00305864|331278|P1|STARTED|Overall Study||7
137251|NCT00305162|331010|P1|Modified ITT (mITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Completed through 48 hours; Excludes those who did not receive study drug or undergo index PCI.|3889
137252|NCT00305162|331009|P2|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|507
137253|NCT00305162|331010|P1|Intent-to-treat (ITT): STEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|482
137254|NCT00305162|331009|P2|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3924
137255|NCT00305162|331010|P1|Intent-to-treat (ITT): SA/UA/NSTEMI|48 Hour Follow-up Period|Patients who completed through 48 hours|3933
137256|NCT00305162|331009|P2|STARTED|48 Hour Follow-up Period||4447
137257|NCT00305162|331010|P1|STARTED|48 Hour Follow-up Period||4435
137258|NCT00305227|331050|P2|NOT COMPLETED|Overall Study||6
137259|NCT00305227|331051|P1|NOT COMPLETED|Overall Study||7
137260|NCT00305227|331050|P2|COMPLETED|Overall Study|with at least 8 weeks of observation|44
137261|NCT00305227|331051|P1|COMPLETED|Overall Study|with at least 8 weeks of observation|43
137262|NCT00305227|331050|P2|STARTED|Overall Study||50
137263|NCT00305227|331051|P1|STARTED|Overall Study||50
137264|NCT00305253|331059|P2|NOT COMPLETED|Overall Study||1
137265|NCT00305253|331060|P1|NOT COMPLETED|Overall Study||0
137266|NCT00305253|331059|P2|COMPLETED|Overall Study||558
137267|NCT00305253|331060|P1|COMPLETED|Overall Study||432
137268|NCT00305253|331059|P2|STARTED|Overall Study||559
137269|NCT00305253|331060|P1|STARTED|Overall Study||432
137270|NCT00305344|331070|P1|NOT COMPLETED|Overall Study||0
137271|NCT00305344|331070|P1|COMPLETED|Overall Study||23
137272|NCT00305344|331070|P1|STARTED|Overall Study||23
137273|NCT00305448|331077|P3|NOT COMPLETED|Overall Study||33
137274|NCT00305448|331078|P2|NOT COMPLETED|Overall Study||34
137275|NCT00305448|331079|P1|NOT COMPLETED|Overall Study||31
137276|NCT00305448|331077|P3|COMPLETED|Overall Study||14
137277|NCT00305448|331078|P2|COMPLETED|Overall Study||17
137278|NCT00305448|331079|P1|COMPLETED|Overall Study||14
137279|NCT00305448|331077|P3|STARTED|Overall Study||47
137280|NCT00305448|331078|P2|STARTED|Overall Study||51
137281|NCT00305448|331079|P1|STARTED|Overall Study||45
137282|NCT00305565|331098|P3|NOT COMPLETED|Overall Study (ITT Population)||5
137283|NCT00305565|331099|P2|NOT COMPLETED|Overall Study (ITT Population)||11
137284|NCT00305565|331100|P1|NOT COMPLETED|Overall Study (ITT Population)||13
137285|NCT00305565|331098|P3|COMPLETED|Overall Study (ITT Population)||102
137286|NCT00305565|331099|P2|COMPLETED|Overall Study (ITT Population)||90
137287|NCT00305565|331100|P1|COMPLETED|Overall Study (ITT Population)||89
137288|NCT00305565|331098|P3|STARTED|Overall Study (ITT Population)||107
137289|NCT00305565|331099|P2|STARTED|Overall Study (ITT Population)||101
137290|NCT00305565|331100|P1|STARTED|Overall Study (ITT Population)||102
137291|NCT00305565|331098|P3|NOT COMPLETED|Overall Study (Safety Population)||7
137292|NCT00305565|331099|P2|NOT COMPLETED|Overall Study (Safety Population)||12
137293|NCT00305565|331100|P1|NOT COMPLETED|Overall Study (Safety Population)||14
137294|NCT00305565|331098|P3|COMPLETED|Overall Study (Safety Population)||106
137295|NCT00305565|331099|P2|COMPLETED|Overall Study (Safety Population)||95
137296|NCT00305565|331100|P1|COMPLETED|Overall Study (Safety Population)||97
137297|NCT00305565|331098|P3|STARTED|Overall Study (Safety Population)||113
137298|NCT00305565|331099|P2|STARTED|Overall Study (Safety Population)||107
137299|NCT00305565|331100|P1|STARTED|Overall Study (Safety Population)||111
137300|NCT00305578|331217|P2|NOT COMPLETED|Overall Study||2
137301|NCT00305578|331218|P1|NOT COMPLETED|Overall Study||3
137302|NCT00305578|331217|P2|COMPLETED|Overall Study||12
137303|NCT00305578|331218|P1|COMPLETED|Overall Study||12
137304|NCT00305578|331217|P2|STARTED|Overall Study||14
137305|NCT00305578|331218|P1|STARTED|Overall Study||15
137306|NCT00305604|331226|P2|NOT COMPLETED|Overall Study||47
137307|NCT00305604|331227|P1|NOT COMPLETED|Overall Study||32
137308|NCT00305604|331226|P2|COMPLETED|Overall Study||57
137309|NCT00305604|331227|P1|COMPLETED|Overall Study||70
137310|NCT00305604|331226|P2|STARTED|Overall Study||104
137311|NCT00305604|331227|P1|STARTED|Overall Study||102
137312|NCT00305643|331241|P2|NOT COMPLETED|Overall Study||0
137313|NCT00305643|331242|P1|NOT COMPLETED|Overall Study||0
137314|NCT00305643|331241|P2|COMPLETED|Overall Study||5
137315|NCT00305643|331242|P1|COMPLETED|Overall Study||6
137316|NCT00305643|331241|P2|STARTED|Overall Study||5
137317|NCT00305643|331242|P1|STARTED|Overall Study||6
137318|NCT00305760|331250|P1|NOT COMPLETED|Overall Study||47
137319|NCT00305760|331250|P1|COMPLETED|Overall Study||13
137320|NCT00305760|331250|P1|STARTED|Overall Study||60
137321|NCT00305773|331256|P2|NOT COMPLETED|Overall Study||18
137322|NCT00305773|331257|P1|NOT COMPLETED|Overall Study||14
137323|NCT00305773|331256|P2|COMPLETED|Overall Study||4
137324|NCT00305773|331257|P1|COMPLETED|Overall Study||1
137325|NCT00305773|331256|P2|STARTED|Overall Study||22
137326|NCT00305773|331257|P1|STARTED|Overall Study||15
137327|NCT00305864|331275|P4|NOT COMPLETED|Overall Study||13
137328|NCT00305864|331276|P3|NOT COMPLETED|Overall Study||1
137329|NCT00305864|331277|P2|NOT COMPLETED|Overall Study||1
137330|NCT00305864|331278|P1|NOT COMPLETED|Overall Study||0
137331|NCT00305864|331275|P4|COMPLETED|Overall Study||81
137332|NCT00305864|331276|P3|COMPLETED|Overall Study||6
137333|NCT00305864|331277|P2|COMPLETED|Overall Study||9
137334|NCT00305864|331278|P1|COMPLETED|Overall Study||7
137335|NCT00305864|331275|P4|STARTED|Overall Study||94
137336|NCT00305864|331276|P3|STARTED|Overall Study||7
137337|NCT00305864|331277|P2|STARTED|Overall Study||10
137339|NCT00305877|331290|P2|NOT COMPLETED|Overall Study||34
137340|NCT00305877|331291|P1|NOT COMPLETED|Overall Study||24
137341|NCT00305877|331290|P2|COMPLETED|Overall Study||34
137342|NCT00305877|331291|P1|COMPLETED|Overall Study||45
137343|NCT00305877|331290|P2|Included in Efficacy Analysis|Overall Study||62
137344|NCT00305877|331291|P1|Included in Efficacy Analysis|Overall Study||65
137345|NCT00305877|331290|P2|Eligible|Overall Study||66
137346|NCT00305877|331291|P1|Eligible|Overall Study||66
137347|NCT00305877|331290|P2|Treated|Overall Study||63
137348|NCT00305877|331291|P1|Treated|Overall Study||67
137349|NCT00305877|331290|P2|STARTED|Overall Study||68
137350|NCT00305877|331291|P1|STARTED|Overall Study||69
137351|NCT00305942|331301|P1|NOT COMPLETED|Overall Study||38
137352|NCT00305942|331301|P1|COMPLETED|Overall Study||23
137353|NCT00305942|331301|P1|STARTED|Overall Study||61
137354|NCT00306163|331309|P2|NOT COMPLETED|Overall Study||0
137355|NCT00306163|331310|P1|NOT COMPLETED|Overall Study||0
137356|NCT00306163|331309|P2|COMPLETED|Overall Study||18
137357|NCT00306163|331310|P1|COMPLETED|Overall Study||19
137358|NCT00306163|331309|P2|STARTED|Overall Study||18
137359|NCT00306163|331310|P1|STARTED|Overall Study||19
137360|NCT00306189|331320|P4|NOT COMPLETED|Overall Study||5
137361|NCT00306189|331321|P3|NOT COMPLETED|Overall Study||11
137362|NCT00306189|331322|P2|NOT COMPLETED|Overall Study||6
137363|NCT00306189|331323|P1|NOT COMPLETED|Overall Study||9
137364|NCT00306189|331320|P4|COMPLETED|Overall Study||52
137365|NCT00306189|331321|P3|COMPLETED|Overall Study||45
137366|NCT00306189|331322|P2|COMPLETED|Overall Study||50
137367|NCT00306189|331323|P1|COMPLETED|Overall Study||48
137368|NCT00306189|331320|P4|STARTED|Overall Study||57
137369|NCT00306189|331321|P3|STARTED|Overall Study||56
137370|NCT00306189|331322|P2|STARTED|Overall Study||56
137371|NCT00306189|331323|P1|STARTED|Overall Study||57
137372|NCT00306202|331336|P3|NOT COMPLETED|Overall Study||0
137373|NCT00306202|331337|P2|NOT COMPLETED|Overall Study||1
137374|NCT00306202|331338|P1|NOT COMPLETED|Overall Study||6
137375|NCT00306202|331336|P3|COMPLETED|Overall Study|Completed = Off-treatment|24
137376|NCT00306202|331337|P2|COMPLETED|Overall Study|Completed = Off-treatment|16
137377|NCT00306202|331338|P1|COMPLETED|Overall Study|Completed = Off-treatment|11
137378|NCT00306202|331336|P3|STARTED|Overall Study|Started = Treated. 24 were enrolled; 1 no longer met study criteria and was never treated|24
137379|NCT00306202|331337|P2|STARTED|Overall Study|Started=Treated. 20 were enrolled;3 never treated(2 no longer met study criteria;1 withdrew consent)|17
137464|NCT00306891|331663|P3|COMPLETED|Part A||0
137380|NCT00306202|331338|P1|STARTED|Overall Study|Started = Treated. 18 were enrolled; 1 no longer met study criteria and was never treated|17
137381|NCT00306384|331497|P3|NOT COMPLETED|Overall Study||277
137382|NCT00306384|331498|P2|NOT COMPLETED|Overall Study||508
137383|NCT00306384|331499|P1|NOT COMPLETED|Overall Study||542
137384|NCT00306384|331497|P3|COMPLETED|Overall Study||251
137385|NCT00306384|331498|P2|COMPLETED|Overall Study||891
137386|NCT00306384|331499|P1|COMPLETED|Overall Study||854
137387|NCT00306384|331497|P3|Safety Set|Overall Study|Patients who received at least one dose of study drug|527
137388|NCT00306384|331498|P2|Safety Set|Overall Study|Patients who received at least one dose of study drug|1398
137389|NCT00306384|331499|P1|Safety Set|Overall Study|Patients who received at least one dose of study drug|1395
137390|NCT00306384|331497|P3|STARTED|Overall Study||528
137391|NCT00306384|331498|P2|STARTED|Overall Study||1399
137392|NCT00306384|331499|P1|STARTED|Overall Study||1396
137393|NCT00306488|331531|P2|NOT COMPLETED|Overall Study||1
137394|NCT00306488|331532|P1|NOT COMPLETED|Overall Study||1
137395|NCT00306488|331531|P2|COMPLETED|Overall Study||10
137396|NCT00306488|331532|P1|COMPLETED|Overall Study||10
137397|NCT00306488|331531|P2|STARTED|Overall Study||11
137398|NCT00306488|331532|P1|STARTED|Overall Study||11
137399|NCT00306527|331547|P4|NOT COMPLETED|Overall Study||6
137400|NCT00306527|331548|P3|NOT COMPLETED|Overall Study||5
137401|NCT00306527|331549|P2|NOT COMPLETED|Overall Study||7
137402|NCT00306527|331550|P1|NOT COMPLETED|Overall Study||6
137403|NCT00306527|331547|P4|COMPLETED|Overall Study||590
137404|NCT00306527|331548|P3|COMPLETED|Overall Study|Additional death has been reported post study. Please refer to outcome measure-2.|567
137405|NCT00306527|331549|P2|COMPLETED|Overall Study||527
137406|NCT00306527|331550|P1|COMPLETED|Overall Study||527
137407|NCT00306527|331547|P4|STARTED|Overall Study||596
137408|NCT00306527|331548|P3|STARTED|Overall Study||572
137409|NCT00306527|331549|P2|STARTED|Overall Study||534
137410|NCT00306527|331550|P1|STARTED|Overall Study||533
137411|NCT00306592|331604|P2|NOT COMPLETED|Overall Study||58
137412|NCT00306592|331605|P1|NOT COMPLETED|Overall Study||31
137413|NCT00306592|331604|P2|COMPLETED|Overall Study||632
137414|NCT00306592|331605|P1|COMPLETED|Overall Study||373
137415|NCT00306592|331604|P2|Entered 101-MS-321 Extension Study|Overall Study|pertains to participants transitioning from 101-MS-322 (NCT00306592) study only|0
137416|NCT00306592|331605|P1|Entered 101-MS-321 Extension Study|Overall Study||22
137417|NCT00306592|331604|P2|Completed at 48 Weeks|Overall Study||632
137418|NCT00306592|331605|P1|Completed at 48 Weeks|Overall Study||81
137419|NCT00306592|331604|P2|Completed Between 24 and 48 Weeks|Overall Study||0
137420|NCT00306592|331605|P1|Completed Between 24 and 48 Weeks|Overall Study||85
137421|NCT00306592|331604|P2|Completed at 24 Weeks|Overall Study||0
137422|NCT00306592|331605|P1|Completed at 24 Weeks|Overall Study||207
137423|NCT00306592|331604|P2|STARTED|Overall Study||690
137424|NCT00306592|331605|P1|STARTED|Overall Study||404
137425|NCT00306670|331613|P2|NOT COMPLETED|Overall Study||2
137426|NCT00306670|331614|P1|NOT COMPLETED|Overall Study||0
137427|NCT00306670|331613|P2|COMPLETED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued study before treatment initiated|0
137428|NCT00306670|331614|P1|COMPLETED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
137429|NCT00306670|331613|P2|STARTED|Overall Study|2 patients recruited; Genentech, the study sponsor, discontinued trial before treatment started|2
137430|NCT00306670|331614|P1|STARTED|Overall Study|no patients recruited; Genentech, the study sponsor, pulled funding and discontinued the protocol|0
137431|NCT00306787|331622|P2|NOT COMPLETED|Overall Study||241
137432|NCT00306787|331623|P1|NOT COMPLETED|Overall Study||234
137433|NCT00306787|331622|P2|COMPLETED|Overall Study||359
137434|NCT00306787|331623|P1|COMPLETED|Overall Study||345
137435|NCT00306787|331622|P2|Intent to Treat (ITT) Population|Overall Study||381
137436|NCT00306787|331623|P1|Intent to Treat (ITT) Population|Overall Study||370
137437|NCT00306787|331622|P2|Received Study Drug (Safety Population)|Overall Study||385
137438|NCT00306787|331623|P1|Received Study Drug (Safety Population)|Overall Study||371
137439|NCT00306787|331622|P2|STARTED|Overall Study||600
137440|NCT00306787|331623|P1|STARTED|Overall Study||579
137441|NCT00306852|331641|P2|NOT COMPLETED|Overall Study||38
137442|NCT00306852|331642|P1|NOT COMPLETED|Overall Study||29
137443|NCT00306852|331641|P2|COMPLETED|Overall Study||69
137444|NCT00306852|331642|P1|COMPLETED|Overall Study||76
137445|NCT00306852|331641|P2|STARTED|Overall Study||107
137446|NCT00306852|331642|P1|STARTED|Overall Study||105
137447|NCT00306891|331662|P4|NOT COMPLETED|Part B||17
137448|NCT00306891|331663|P3|NOT COMPLETED|Part B||11
137449|NCT00306891|331664|P2|NOT COMPLETED|Part B||0
137450|NCT00306891|331665|P1|NOT COMPLETED|Part B||0
137451|NCT00306891|331662|P4|COMPLETED|Part B||14
137452|NCT00306891|331663|P3|COMPLETED|Part B||5
137453|NCT00306891|331664|P2|COMPLETED|Part B||0
137454|NCT00306891|331665|P1|COMPLETED|Part B||0
137455|NCT00306891|331662|P4|STARTED|Part B|in Part B: Cediranib Dose Escalation 11 new patients were randomized.|31
137456|NCT00306891|331663|P3|STARTED|Part B|In Part B: Cediranib 45 mg Fixed Dose 4 new patients were randomized|16
137457|NCT00306891|331664|P2|STARTED|Part B||0
137458|NCT00306891|331665|P1|STARTED|Part B||0
137459|NCT00306891|331662|P4|NOT COMPLETED|Part A||0
137460|NCT00306891|331663|P3|NOT COMPLETED|Part A||0
137461|NCT00306891|331664|P2|NOT COMPLETED|Part A||6
137462|NCT00306891|331665|P1|NOT COMPLETED|Part A||5
137463|NCT00306891|331662|P4|COMPLETED|Part A||0
137465|NCT00306891|331664|P2|COMPLETED|Part A||16
137466|NCT00306891|331665|P1|COMPLETED|Part A||18
137467|NCT00306891|331662|P4|STARTED|Part A||0
137468|NCT00306891|331663|P3|STARTED|Part A||0
137469|NCT00306891|331664|P2|STARTED|Part A||22
137470|NCT00306891|331665|P1|STARTED|Part A||23
137471|NCT00306917|331688|P2|NOT COMPLETED|Overall Study||109
137472|NCT00306917|331689|P1|NOT COMPLETED|Overall Study||108
137473|NCT00306917|331688|P2|COMPLETED|Overall Study||15
137474|NCT00306917|331689|P1|COMPLETED|Overall Study||13
137475|NCT00306917|331688|P2|60 Month Follow up|Overall Study||15
137476|NCT00306917|331689|P1|60 Month Follow up|Overall Study||13
137477|NCT00306917|331688|P2|48 Month Follow up|Overall Study||22
137478|NCT00306917|331689|P1|48 Month Follow up|Overall Study||29
137479|NCT00306917|331688|P2|36 Month Follow up|Overall Study||42
137480|NCT00306917|331689|P1|36 Month Follow up|Overall Study||56
137481|NCT00306917|331688|P2|24 Month Follow up|Overall Study||71
137482|NCT00306917|331689|P1|24 Month Follow up|Overall Study||60
137483|NCT00306917|331688|P2|12 Month Follow|Overall Study||94
137484|NCT00306917|331689|P1|12 Month Follow|Overall Study||86
137485|NCT00306917|331688|P2|Postoperative to 6 Month Follow up|Overall Study||100
137486|NCT00306917|331689|P1|Postoperative to 6 Month Follow up|Overall Study||93
137487|NCT00306917|331688|P2|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|124
137488|NCT00306917|331689|P1|STARTED|Overall Study|400 subjects were to be followed for 5 years; due to slow enrollment study closed early with 245.|121
137489|NCT00307034|331697|P2|NOT COMPLETED|Overall Study||7
137490|NCT00307034|331698|P1|NOT COMPLETED|Overall Study||2
137491|NCT00307034|331697|P2|COMPLETED|Overall Study||169
137492|NCT00307034|331698|P1|COMPLETED|Overall Study||173
137493|NCT00307034|331697|P2|STARTED|Overall Study||176
137494|NCT00307034|331698|P1|STARTED|Overall Study||175
137495|NCT00307047|331738|P2|NOT COMPLETED|Overall Study||49
137496|NCT00307047|331739|P1|NOT COMPLETED|Overall Study||69
137497|NCT00307047|331738|P2|COMPLETED|Overall Study||1180
137498|NCT00307047|331739|P1|COMPLETED|Overall Study||2389
137499|NCT00307047|331738|P2|STARTED|Overall Study||1229
137500|NCT00307047|331739|P1|STARTED|Overall Study||2458
137501|NCT00307086|331875|P1|NOT COMPLETED|Overall Study||5
137502|NCT00307086|331875|P1|COMPLETED|Overall Study||25
137503|NCT00307086|331875|P1|STARTED|Overall Study||30
137504|NCT00307125|331881|P3|NOT COMPLETED|Pilot Phase||1
137505|NCT00307125|331882|P2|NOT COMPLETED|Pilot Phase||2
137506|NCT00307125|331883|P1|NOT COMPLETED|Pilot Phase||0
137507|NCT00307125|331881|P3|COMPLETED|Pilot Phase|1 participant had reduced follow-up|6
137508|NCT00307125|331882|P2|COMPLETED|Pilot Phase|2 participants had reduced follow-up|13
137509|NCT00307125|331883|P1|COMPLETED|Pilot Phase||0
137510|NCT00307125|331881|P3|STARTED|Pilot Phase||7
137511|NCT00307125|331882|P2|STARTED|Pilot Phase||15
137512|NCT00307125|331883|P1|STARTED|Pilot Phase||0
137513|NCT00307125|331881|P3|NOT COMPLETED|Screening Phase||0
137514|NCT00307125|331882|P2|NOT COMPLETED|Screening Phase||0
137515|NCT00307125|331883|P1|NOT COMPLETED|Screening Phase||454
137516|NCT00307125|331881|P3|COMPLETED|Screening Phase||0
137517|NCT00307125|331882|P2|COMPLETED|Screening Phase||0
137518|NCT00307125|331883|P1|COMPLETED|Screening Phase||303
137519|NCT00307125|331881|P3|STARTED|Screening Phase||0
137520|NCT00307125|331882|P2|STARTED|Screening Phase||0
137521|NCT00307125|331883|P1|STARTED|Screening Phase||757
137522|NCT00307151|331909|P4|NOT COMPLETED|Overall Study||11
137523|NCT00307151|331910|P3|NOT COMPLETED|Overall Study||20
137524|NCT00307151|331911|P2|NOT COMPLETED|Overall Study||7
137525|NCT00307151|331912|P1|NOT COMPLETED|Overall Study||11
137526|NCT00307151|331909|P4|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|129
137527|NCT00307151|331910|P3|COMPLETED|Overall Study|Results are through date DSMB recommended Cohort II results be unblinded (October 27, 2010)|127
137528|NCT00307151|331911|P2|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|75
137529|NCT00307151|331912|P1|COMPLETED|Overall Study|Results are through date DSMB closed Cohort I to accrual (April 20, 2009)|71
137530|NCT00307151|331909|P4|STARTED|Overall Study|One participant never started treatment, were not followed and not included in analysis.|140
137531|NCT00307151|331910|P3|STARTED|Overall Study||147
137532|NCT00307151|331911|P2|STARTED|Overall Study||82
137533|NCT00307151|331912|P1|STARTED|Overall Study||82
137534|NCT00307164|331956|P2|NOT COMPLETED|Overall Study||14
137535|NCT00307164|331957|P1|NOT COMPLETED|Overall Study||15
137536|NCT00307164|331956|P2|COMPLETED|Overall Study||68
137537|NCT00307164|331957|P1|COMPLETED|Overall Study||68
137538|NCT00307164|331956|P2|STARTED|Overall Study||82
137539|NCT00307164|331957|P1|STARTED|Overall Study||83
137540|NCT00307294|331993|P1|NOT COMPLETED|Overall Study||30
137541|NCT00307294|331993|P1|COMPLETED|Overall Study||9
137542|NCT00307294|331993|P1|STARTED|Overall Study||39
137543|NCT00297115|331999|P2|NOT COMPLETED|Overall Study||246
137544|NCT00297115|332000|P1|NOT COMPLETED|Overall Study||245
137545|NCT00297115|331999|P2|COMPLETED|Overall Study||550
137546|NCT00297115|332000|P1|COMPLETED|Overall Study||527
137547|NCT00297115|331999|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|796
137548|NCT00297115|332000|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|772
137549|NCT00297167|332016|P3|NOT COMPLETED|Open-label Dose Normalization Period 2||0
137550|NCT00297167|332017|P2|NOT COMPLETED|Open-label Dose Normalization Period 2||0
137551|NCT00297167|332018|P1|NOT COMPLETED|Open-label Dose Normalization Period 2||0
137552|NCT00297167|332016|P3|COMPLETED|Open-label Dose Normalization Period 2||31
137553|NCT00297167|332017|P2|COMPLETED|Open-label Dose Normalization Period 2||0
137554|NCT00297167|332018|P1|COMPLETED|Open-label Dose Normalization Period 2||0
137555|NCT00297167|332016|P3|STARTED|Open-label Dose Normalization Period 2||31
137556|NCT00297167|332017|P2|STARTED|Open-label Dose Normalization Period 2||0
137557|NCT00297167|332018|P1|STARTED|Open-label Dose Normalization Period 2||0
137558|NCT00297167|332016|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
137559|NCT00297167|332017|P2|NOT COMPLETED|Second Double-blind Intervention Period||0
137560|NCT00297167|332018|P1|NOT COMPLETED|Second Double-blind Intervention Period||1
137561|NCT00297167|332016|P3|COMPLETED|Second Double-blind Intervention Period||0
137562|NCT00297167|332017|P2|COMPLETED|Second Double-blind Intervention Period||15
137563|NCT00297167|332018|P1|COMPLETED|Second Double-blind Intervention Period||16
137564|NCT00297167|332016|P3|STARTED|Second Double-blind Intervention Period||0
137565|NCT00297167|332017|P2|STARTED|Second Double-blind Intervention Period||15
137566|NCT00297167|332018|P1|STARTED|Second Double-blind Intervention Period||17
137567|NCT00297167|332016|P3|NOT COMPLETED|Open-label Dose Normalization Period 1||1
137568|NCT00297167|332017|P2|NOT COMPLETED|Open-label Dose Normalization Period 1||0
137569|NCT00297167|332018|P1|NOT COMPLETED|Open-label Dose Normalization Period 1||0
137570|NCT00297167|332016|P3|COMPLETED|Open-label Dose Normalization Period 1||32
137571|NCT00297167|332017|P2|COMPLETED|Open-label Dose Normalization Period 1||0
137572|NCT00297167|332018|P1|COMPLETED|Open-label Dose Normalization Period 1||0
137573|NCT00297167|332016|P3|STARTED|Open-label Dose Normalization Period 1||33
137574|NCT00297167|332017|P2|STARTED|Open-label Dose Normalization Period 1||0
137575|NCT00297167|332018|P1|STARTED|Open-label Dose Normalization Period 1||0
137576|NCT00297167|332016|P3|NOT COMPLETED|First Double-blind Intervention Period||0
137577|NCT00297167|332017|P2|NOT COMPLETED|First Double-blind Intervention Period||0
137578|NCT00297167|332018|P1|NOT COMPLETED|First Double-blind Intervention Period||0
137579|NCT00297167|332016|P3|COMPLETED|First Double-blind Intervention Period||0
137580|NCT00297167|332017|P2|COMPLETED|First Double-blind Intervention Period||16
137581|NCT00297167|332018|P1|COMPLETED|First Double-blind Intervention Period||17
137582|NCT00297167|332016|P3|STARTED|First Double-blind Intervention Period||0
137583|NCT00297167|332017|P2|STARTED|First Double-blind Intervention Period||16
137584|NCT00297167|332018|P1|STARTED|First Double-blind Intervention Period||17
137585|NCT00297232|332042|P1|NOT COMPLETED|Overall Study||605
137586|NCT00297232|332042|P1|COMPLETED|Overall Study||489
137587|NCT00297232|332042|P1|STARTED|Overall Study||1094
137588|NCT00297258|332048|P1|NOT COMPLETED|Overall Study||142
137589|NCT00297258|332048|P1|COMPLETED|Overall Study||0
137590|NCT00297258|332048|P1|STARTED|Overall Study||142
137591|NCT00297427|332069|P2|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||0
137592|NCT00297427|332070|P1|NOT COMPLETED|Phase 3: Follow-up Post-True Acupuncture||34
137593|NCT00297427|332069|P2|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
137594|NCT00297427|332070|P1|COMPLETED|Phase 3: Follow-up Post-True Acupuncture|Subjects who completed=/>1 follow-up visits and were evaluated for booster acupuncture|60
137595|NCT00297427|332069|P2|STARTED|Phase 3: Follow-up Post-True Acupuncture|Only subjects who received true acupuncture initially or after cross-over entered follow-up|0
137596|NCT00297427|332070|P1|STARTED|Phase 3: Follow-up Post-True Acupuncture||94
137597|NCT00297427|332069|P2|NOT COMPLETED|Phase 2: Optional Crossover for Sham||0
137598|NCT00297427|332070|P1|NOT COMPLETED|Phase 2: Optional Crossover for Sham||16
137599|NCT00297427|332069|P2|COMPLETED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
137600|NCT00297427|332070|P1|COMPLETED|Phase 2: Optional Crossover for Sham||38
137601|NCT00297427|332069|P2|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
137602|NCT00297427|332070|P1|Crossed Over to True Acupuncture|Phase 2: Optional Crossover for Sham|54 subjects completed the sham acupuncture & were offered the opportunity to cross-over; 12 declined|42
137603|NCT00297427|332069|P2|STARTED|Phase 2: Optional Crossover for Sham|There was no cross-over to sham acupuncture as this was a wait list control design|0
137604|NCT00297427|332070|P1|STARTED|Phase 2: Optional Crossover for Sham||54
137605|NCT00297427|332069|P2|NOT COMPLETED|Phase 1: Initial Intervention||9
137606|NCT00297427|332070|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
137607|NCT00297427|332069|P2|COMPLETED|Phase 1: Initial Intervention||54
137608|NCT00297427|332070|P1|COMPLETED|Phase 1: Initial Intervention||56
137609|NCT00297427|332069|P2|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|63
137610|NCT00297427|332070|P1|STARTED|Phase 1: Initial Intervention|Intention-to-treat analysis; all randomized subjects were included in analysis|64
137611|NCT00297492|332114|P3|NOT COMPLETED|6 Month Follow-up||27
137612|NCT00297492|332115|P2|NOT COMPLETED|6 Month Follow-up||49
137613|NCT00297492|332116|P1|NOT COMPLETED|6 Month Follow-up||63
137614|NCT00297492|332114|P3|COMPLETED|6 Month Follow-up||118
137615|NCT00297492|332115|P2|COMPLETED|6 Month Follow-up||237
137616|NCT00297492|332116|P1|COMPLETED|6 Month Follow-up||227
137617|NCT00297492|332114|P3|STARTED|6 Month Follow-up||145
137618|NCT00297492|332115|P2|STARTED|6 Month Follow-up||286
137619|NCT00297492|332116|P1|STARTED|6 Month Follow-up||290
137620|NCT00297492|332114|P3|NOT COMPLETED|Set Quit Date||5
137621|NCT00297492|332115|P2|NOT COMPLETED|Set Quit Date||13
137622|NCT00297492|332116|P1|NOT COMPLETED|Set Quit Date||7
137623|NCT00297492|332114|P3|COMPLETED|Set Quit Date||145
137624|NCT00297492|332115|P2|COMPLETED|Set Quit Date||286
137625|NCT00297492|332116|P1|COMPLETED|Set Quit Date||290
137626|NCT00297492|332114|P3|STARTED|Set Quit Date||150
137627|NCT00297492|332115|P2|STARTED|Set Quit Date||299
137628|NCT00297492|332116|P1|STARTED|Set Quit Date||297
137629|NCT00297596|332124|P1|NOT COMPLETED|Overall Study||0
137630|NCT00297596|332124|P1|COMPLETED|Overall Study||25
137631|NCT00297596|332124|P1|STARTED|Overall Study||25
137632|NCT00298090|332128|P1|NOT COMPLETED|Overall Study||18
137633|NCT00298090|332128|P1|COMPLETED|Overall Study|Eighteen subjects were not included in final analysis due to incomplete data sets|29
137634|NCT00298090|332128|P1|STARTED|Overall Study||47
137635|NCT00298155|332135|P3|NOT COMPLETED|Overall Study||0
137636|NCT00298155|332136|P2|NOT COMPLETED|Overall Study||0
137637|NCT00298155|332137|P1|NOT COMPLETED|Overall Study||0
137638|NCT00298155|332135|P3|COMPLETED|Overall Study||13
137639|NCT00298155|332136|P2|COMPLETED|Overall Study||10
137640|NCT00298155|332137|P1|COMPLETED|Overall Study||12
137641|NCT00298155|332135|P3|STARTED|Overall Study||13
137642|NCT00298155|332136|P2|STARTED|Overall Study||10
137643|NCT00298155|332137|P1|STARTED|Overall Study||12
137644|NCT00298233|332150|P4|NOT COMPLETED|Overall Study||0
137645|NCT00298233|332151|P3|NOT COMPLETED|Overall Study||0
137646|NCT00298233|332152|P2|NOT COMPLETED|Overall Study||0
137647|NCT00298233|332153|P1|NOT COMPLETED|Overall Study||0
137648|NCT00298233|332150|P4|COMPLETED|Overall Study||124
137649|NCT00298233|332151|P3|COMPLETED|Overall Study||122
137650|NCT00298233|332152|P2|COMPLETED|Overall Study||41
137651|NCT00298233|332153|P1|COMPLETED|Overall Study||39
137652|NCT00298233|332150|P4|STARTED|Overall Study||124
137653|NCT00298233|332151|P3|STARTED|Overall Study||122
137654|NCT00298233|332152|P2|STARTED|Overall Study||41
137655|NCT00298233|332153|P1|STARTED|Overall Study||39
137656|NCT00298272|332171|P2|NOT COMPLETED|Safety Follow-up Phase||4
137657|NCT00298272|332172|P1|NOT COMPLETED|Safety Follow-up Phase||4
137658|NCT00298272|332171|P2|COMPLETED|Safety Follow-up Phase||13
137659|NCT00298272|332172|P1|COMPLETED|Safety Follow-up Phase||18
137660|NCT00298272|332171|P2|STARTED|Safety Follow-up Phase||17
137661|NCT00298272|332172|P1|STARTED|Safety Follow-up Phase||22
137662|NCT00298272|332171|P2|NOT COMPLETED|Open Label Retreatment Phase||4
137663|NCT00298272|332172|P1|NOT COMPLETED|Open Label Retreatment Phase||9
137664|NCT00298272|332171|P2|COMPLETED|Open Label Retreatment Phase||12
137665|NCT00298272|332172|P1|COMPLETED|Open Label Retreatment Phase||13
137666|NCT00298272|332171|P2|Completed to Week 56|Open Label Retreatment Phase||12
137667|NCT00298272|332172|P1|Completed to Week 56|Open Label Retreatment Phase||13
137668|NCT00298272|332171|P2|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|15
137669|NCT00298272|332172|P1|Completed to Week 24|Open Label Retreatment Phase|received full course of open-label rituximab therapy|22
137670|NCT00298272|332171|P2|STARTED|Open Label Retreatment Phase||16
137671|NCT00298272|332172|P1|STARTED|Open Label Retreatment Phase||22
137672|NCT00298272|332171|P2|NOT COMPLETED|Double-blind Phase||0
137673|NCT00298272|332172|P1|NOT COMPLETED|Double-blind Phase||8
137674|NCT00298272|332171|P2|COMPLETED|Double-blind Phase||18
137675|NCT00298272|332172|P1|COMPLETED|Double-blind Phase||28
137676|NCT00298272|332171|P2|Completed to Week 56|Double-blind Phase||3
137677|NCT00298272|332172|P1|Completed to Week 56|Double-blind Phase||8
137678|NCT00298272|332171|P2|Completed to Week 24|Double-blind Phase|received full course of placebo therapy|18
137679|NCT00298272|332172|P1|Completed to Week 24|Double-blind Phase|received full course of rituximab therapy|31
137680|NCT00298272|332171|P2|Safety Population|Double-blind Phase||18
137681|NCT00298272|332172|P1|Safety Population|Double-blind Phase|received treatment|33
137682|NCT00298272|332171|P2|STARTED|Double-blind Phase||18
137683|NCT00298272|332172|P1|STARTED|Double-blind Phase|enrolled and randomized (2:1 scheme)|36
137684|NCT00298363|332196|P3|NOT COMPLETED|Overall Study||6
137685|NCT00298363|332197|P2|NOT COMPLETED|Overall Study||8
137686|NCT00298363|332198|P1|NOT COMPLETED|Overall Study||17
137687|NCT00298363|332196|P3|COMPLETED|Overall Study|13 completed while taking DB ETV; 3 completed following switch from DB ETV to OL FTC/TDF.|16
137688|NCT00298363|332197|P2|COMPLETED|Overall Study|34 completed while taking DB FTC/TDF; 3 completed following switch from DB TDF to OL FTC/TDF.|37
137689|NCT00298363|332198|P1|COMPLETED|Overall Study|22 completed while taking DB TDF; 6 completed following switch from DB TDF to OL FTC/TDF.|28
137690|NCT00298363|332196|P3|STARTED|Overall Study||22
137691|NCT00298363|332197|P2|STARTED|Overall Study||45
137692|NCT00298363|332198|P1|STARTED|Overall Study||45
137693|NCT00298558|332358|P4|NOT COMPLETED|10th Annual (A10)||163
137694|NCT00298558|332359|P3|NOT COMPLETED|10th Annual (A10)||171
137695|NCT00298558|332360|P2|NOT COMPLETED|10th Annual (A10)||153
137696|NCT00298558|332361|P1|NOT COMPLETED|10th Annual (A10)||172
137697|NCT00298558|332358|P4|COMPLETED|10th Annual (A10)||285
137698|NCT00298558|332359|P3|COMPLETED|10th Annual (A10)||319
137699|NCT00298558|332360|P2|COMPLETED|10th Annual (A10)||316
137700|NCT00298558|332361|P1|COMPLETED|10th Annual (A10)||300
137701|NCT00298558|332358|P4|STARTED|10th Annual (A10)||448
137702|NCT00298558|332359|P3|STARTED|10th Annual (A10)||490
137703|NCT00298558|332360|P2|STARTED|10th Annual (A10)||469
137704|NCT00298558|332361|P1|STARTED|10th Annual (A10)||472
137705|NCT00298558|332358|P4|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||104
137706|NCT00298558|332359|P3|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||84
137707|NCT00298558|332360|P2|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||86
137708|NCT00298558|332361|P1|NOT COMPLETED|3rd Annual (A3) and 5th Annual (A5)||91
137709|NCT00298558|332358|P4|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||448
137710|NCT00298558|332359|P3|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||490
137711|NCT00298558|332360|P2|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||469
137712|NCT00298558|332361|P1|COMPLETED|3rd Annual (A3) and 5th Annual (A5)||472
137713|NCT00298558|332358|P4|STARTED|3rd Annual (A3) and 5th Annual (A5)||552
137714|NCT00298558|332359|P3|STARTED|3rd Annual (A3) and 5th Annual (A5)||574
137715|NCT00298558|332360|P2|STARTED|3rd Annual (A3) and 5th Annual (A5)||555
137716|NCT00298558|332361|P1|STARTED|3rd Annual (A3) and 5th Annual (A5)||563
137717|NCT00298558|332358|P4|NOT COMPLETED|3rd Annual Booster||0
137718|NCT00298558|332359|P3|NOT COMPLETED|3rd Annual Booster||140
137719|NCT00298558|332360|P2|NOT COMPLETED|3rd Annual Booster||128
137720|NCT00298558|332361|P1|NOT COMPLETED|3rd Annual Booster||122
137721|NCT00298558|332358|P4|COMPLETED|3rd Annual Booster||0
137722|NCT00298558|332359|P3|COMPLETED|3rd Annual Booster||230
137723|NCT00298558|332360|P2|COMPLETED|3rd Annual Booster||243
137724|NCT00298558|332361|P1|COMPLETED|3rd Annual Booster||250
137725|NCT00298558|332358|P4|STARTED|3rd Annual Booster||0
137726|NCT00298558|332359|P3|STARTED|3rd Annual Booster||370
137727|NCT00298558|332360|P2|STARTED|3rd Annual Booster||371
137728|NCT00298558|332361|P1|STARTED|3rd Annual Booster||372
137729|NCT00298558|332358|P4|NOT COMPLETED|2nd Annual (A2)||32
137730|NCT00298558|332359|P3|NOT COMPLETED|2nd Annual (A2)||27
137731|NCT00298558|332360|P2|NOT COMPLETED|2nd Annual (A2)||11
137732|NCT00298558|332361|P1|NOT COMPLETED|2nd Annual (A2)||22
137733|NCT00298558|332358|P4|COMPLETED|2nd Annual (A2)||552
137734|NCT00298558|332359|P3|COMPLETED|2nd Annual (A2)||574
137735|NCT00298558|332360|P2|COMPLETED|2nd Annual (A2)||555
137736|NCT00298558|332361|P1|COMPLETED|2nd Annual (A2)||563
137737|NCT00298558|332358|P4|STARTED|2nd Annual (A2)||584
137738|NCT00298558|332359|P3|STARTED|2nd Annual (A2)||601
137739|NCT00298558|332360|P2|STARTED|2nd Annual (A2)||566
137740|NCT00298558|332361|P1|STARTED|2nd Annual (A2)||585
137741|NCT00298558|332358|P4|NOT COMPLETED|1st Annual (A1)||55
137742|NCT00298558|332359|P3|NOT COMPLETED|1st Annual (A1)||52
137743|NCT00298558|332360|P2|NOT COMPLETED|1st Annual (A1)||63
137744|NCT00298558|332361|P1|NOT COMPLETED|1st Annual (A1)||55
137745|NCT00298558|332358|P4|COMPLETED|1st Annual (A1)||584
137746|NCT00298558|332359|P3|COMPLETED|1st Annual (A1)||601
137747|NCT00298558|332360|P2|COMPLETED|1st Annual (A1)||566
137748|NCT00298558|332361|P1|COMPLETED|1st Annual (A1)||585
137749|NCT00298558|332358|P4|STARTED|1st Annual (A1)||639
137750|NCT00298558|332359|P3|STARTED|1st Annual (A1)||653
137751|NCT00298558|332360|P2|STARTED|1st Annual (A1)||629
137752|NCT00298558|332361|P1|STARTED|1st Annual (A1)||640
137753|NCT00298558|332358|P4|NOT COMPLETED|Booster||0
137754|NCT00298558|332359|P3|NOT COMPLETED|Booster||75
137755|NCT00298558|332360|P2|NOT COMPLETED|Booster||70
137756|NCT00298558|332361|P1|NOT COMPLETED|Booster||89
137757|NCT00298558|332358|P4|COMPLETED|Booster||0
137758|NCT00298558|332359|P3|COMPLETED|Booster||295
137759|NCT00298558|332360|P2|COMPLETED|Booster||301
137760|NCT00298558|332361|P1|COMPLETED|Booster||283
137761|NCT00298558|332358|P4|STARTED|Booster||0
137762|NCT00298558|332359|P3|STARTED|Booster||370
137763|NCT00298558|332360|P2|STARTED|Booster||371
137764|NCT00298558|332361|P1|STARTED|Booster||372
137765|NCT00298558|332358|P4|NOT COMPLETED|Immediate Post Test||65
137766|NCT00298558|332359|P3|NOT COMPLETED|Immediate Post Test||59
137767|NCT00298558|332360|P2|NOT COMPLETED|Immediate Post Test||76
137768|NCT00298558|332361|P1|NOT COMPLETED|Immediate Post Test||71
137769|NCT00298558|332358|P4|COMPLETED|Immediate Post Test||639
137770|NCT00298558|332359|P3|COMPLETED|Immediate Post Test||653
137771|NCT00298558|332360|P2|COMPLETED|Immediate Post Test||629
137772|NCT00298558|332361|P1|COMPLETED|Immediate Post Test||640
137773|NCT00298558|332358|P4|STARTED|Immediate Post Test||704
137774|NCT00298558|332359|P3|STARTED|Immediate Post Test||712
137775|NCT00298558|332360|P2|STARTED|Immediate Post Test||705
137776|NCT00298558|332361|P1|STARTED|Immediate Post Test||711
137777|NCT00298558|332358|P4|NOT COMPLETED|Intervention||419
137778|NCT00298558|332359|P3|NOT COMPLETED|Intervention||75
137779|NCT00298558|332360|P2|NOT COMPLETED|Intervention||78
137780|NCT00298558|332361|P1|NOT COMPLETED|Intervention||91
137781|NCT00298558|332358|P4|COMPLETED|Intervention||285
137782|NCT00298558|332359|P3|COMPLETED|Intervention||637
137783|NCT00298558|332360|P2|COMPLETED|Intervention||627
137784|NCT00298558|332361|P1|COMPLETED|Intervention||620
137785|NCT00298558|332358|P4|STARTED|Intervention||704
137786|NCT00298558|332359|P3|STARTED|Intervention||712
137787|NCT00298558|332360|P2|STARTED|Intervention||705
137788|NCT00298558|332361|P1|STARTED|Intervention||711
137789|NCT00298558|332358|P4|NOT COMPLETED|Baseline||0
137790|NCT00298558|332359|P3|NOT COMPLETED|Baseline||0
137791|NCT00298558|332360|P2|NOT COMPLETED|Baseline||0
137792|NCT00298558|332361|P1|NOT COMPLETED|Baseline||0
137793|NCT00298558|332358|P4|COMPLETED|Baseline||704
137794|NCT00298558|332359|P3|COMPLETED|Baseline||712
137795|NCT00298558|332360|P2|COMPLETED|Baseline||705
137796|NCT00298558|332361|P1|COMPLETED|Baseline||711
137797|NCT00298558|332358|P4|STARTED|Baseline||704
137798|NCT00298558|332359|P3|STARTED|Baseline||712
137799|NCT00298558|332360|P2|STARTED|Baseline||705
137800|NCT00298558|332361|P1|STARTED|Baseline||711
137801|NCT00298610|332391|P1|NOT COMPLETED|Overall Study||0
137802|NCT00298610|332391|P1|COMPLETED|Overall Study||30
137803|NCT00298610|332391|P1|STARTED|Overall Study||30
137804|NCT00298766|332401|P1|NOT COMPLETED|Overall Study||46
137805|NCT00298766|332401|P1|COMPLETED|Overall Study||24
137806|NCT00298766|332401|P1|STARTED|Overall Study||70
137807|NCT00299000|332412|P2|NOT COMPLETED|Overall Study||0
137808|NCT00299000|332413|P1|NOT COMPLETED|Overall Study||0
137809|NCT00299000|332412|P2|COMPLETED|Overall Study||2
137810|NCT00299000|332413|P1|COMPLETED|Overall Study||2
137811|NCT00299000|332412|P2|STARTED|Overall Study||2
137812|NCT00299000|332413|P1|STARTED|Overall Study||2
137813|NCT00299104|332428|P3|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||12
137814|NCT00299104|332429|P2|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||9
137815|NCT00299104|332430|P1|NOT COMPLETED|Extended Safety Follow-Up (ESFU) Period||5
137816|NCT00299104|332428|P3|COMPLETED|Extended Safety Follow-Up (ESFU) Period||39
137817|NCT00299104|332429|P2|COMPLETED|Extended Safety Follow-Up (ESFU) Period||31
137818|NCT00299104|332430|P1|COMPLETED|Extended Safety Follow-Up (ESFU) Period||29
137819|NCT00299104|332428|P3|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|51
137820|NCT00299104|332429|P2|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|40
137821|NCT00299104|332430|P1|STARTED|Extended Safety Follow-Up (ESFU) Period|Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.|34
137822|NCT00299104|332428|P3|NOT COMPLETED|Safety Follow-Up (SFU) Period||37
137823|NCT00299104|332429|P2|NOT COMPLETED|Safety Follow-Up (SFU) Period||41
137824|NCT00299104|332430|P1|NOT COMPLETED|Safety Follow-Up (SFU) Period||55
137825|NCT00299104|332428|P3|COMPLETED|Safety Follow-Up (SFU) Period||176
137826|NCT00299104|332429|P2|COMPLETED|Safety Follow-Up (SFU) Period||171
137827|NCT00299104|332430|P1|COMPLETED|Safety Follow-Up (SFU) Period||129
137828|NCT00299104|332428|P3|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|213
137829|NCT00299104|332429|P2|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|212
137830|NCT00299104|332430|P1|STARTED|Safety Follow-Up (SFU) Period|All participants who received treatment were to enter SFU even if withdrawn during treatment period.|184
137831|NCT00299104|332428|P3|NOT COMPLETED|Treatment Period||172
137832|NCT00299104|332429|P2|NOT COMPLETED|Treatment Period||175
137833|NCT00299104|332430|P1|NOT COMPLETED|Treatment Period||189
137834|NCT00299104|332428|P3|COMPLETED|Treatment Period||80
137835|NCT00299104|332429|P2|COMPLETED|Treatment Period||77
137836|NCT00299104|332430|P1|COMPLETED|Treatment Period|Completed Week 152|62
137837|NCT00299104|332428|P3|Completed Week 104|Treatment Period||216
137838|NCT00299104|332429|P2|Completed Week 104|Treatment Period||213
137839|NCT00299104|332430|P1|Completed Week 104|Treatment Period||178
137840|NCT00299104|332428|P3|Completed Week 52|Treatment Period||232
137841|NCT00299104|332429|P2|Completed Week 52|Treatment Period||227
137842|NCT00299104|332430|P1|Completed Week 52|Treatment Period||213
137843|NCT00299104|332428|P3|Completed Week 24|Treatment Period||241
137844|NCT00299104|332429|P2|Completed Week 24|Treatment Period||240
137845|NCT00299104|332430|P1|Completed Week 24|Treatment Period||227
137846|NCT00299104|332428|P3|Safety/ITT: Received Study Drug|Treatment Period||250
137847|NCT00299104|332429|P2|Safety/ITT: Received Study Drug|Treatment Period||249
137848|NCT00299104|332430|P1|Safety/ITT: Received Study Drug|Treatment Period||249
137849|NCT00299104|332428|P3|STARTED|Treatment Period||252
137850|NCT00299104|332429|P2|STARTED|Treatment Period||252
137851|NCT00299104|332430|P1|STARTED|Treatment Period||251
137852|NCT00299130|332528|P3|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||6
137853|NCT00299130|332529|P2|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||8
137854|NCT00299130|332530|P1|NOT COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
137855|NCT00299130|332528|P3|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||38
137856|NCT00299130|332529|P2|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||74
137857|NCT00299130|332530|P1|COMPLETED|Extended SFU (ESFU) (up to 5.1 Years)||0
137858|NCT00299130|332528|P3|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||44
137859|NCT00299130|332529|P2|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||82
137860|NCT00299130|332530|P1|STARTED|Extended SFU (ESFU) (up to 5.1 Years)||0
137861|NCT00299130|332528|P3|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
137862|NCT00299130|332529|P2|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
137863|NCT00299130|332530|P1|NOT COMPLETED|Safety Follow-up (SFU) (48 Weeks)||45
137864|NCT00299130|332528|P3|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||123
137865|NCT00299130|332529|P2|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||120
137866|NCT00299130|332530|P1|COMPLETED|Safety Follow-up (SFU) (48 Weeks)||122
137867|NCT00299130|332528|P3|STARTED|Safety Follow-up (SFU) (48 Weeks)||168
137868|NCT00299130|332529|P2|STARTED|Safety Follow-up (SFU) (48 Weeks)||165
137869|NCT00299130|332530|P1|STARTED|Safety Follow-up (SFU) (48 Weeks)||167
137870|NCT00299130|332528|P3|NOT COMPLETED|Treatment Period (up to 5 Years)||50
137871|NCT00299130|332529|P2|NOT COMPLETED|Treatment Period (up to 5 Years)||43
137872|NCT00299130|332530|P1|NOT COMPLETED|Treatment Period (up to 5 Years)||53
137873|NCT00299130|332528|P3|COMPLETED|Treatment Period (up to 5 Years)||121
137874|NCT00299130|332529|P2|COMPLETED|Treatment Period (up to 5 Years)||125
137875|NCT00299130|332530|P1|COMPLETED|Treatment Period (up to 5 Years)||119
137876|NCT00299130|332528|P3|Completed 144 Weeks|Treatment Period (up to 5 Years)||132
137877|NCT00299130|332529|P2|Completed 144 Weeks|Treatment Period (up to 5 Years)||138
137878|NCT00299130|332530|P1|Completed 144 Weeks|Treatment Period (up to 5 Years)||133
137879|NCT00299130|332528|P3|Completed 48 Weeks|Treatment Period (up to 5 Years)||158
137880|NCT00299130|332529|P2|Completed 48 Weeks|Treatment Period (up to 5 Years)||157
137881|NCT00299130|332530|P1|Completed 48 Weeks|Treatment Period (up to 5 Years)||155
137882|NCT00299130|332528|P3|Completed 24 Weeks|Treatment Period (up to 5 Years)||166
137883|NCT00299130|332529|P2|Completed 24 Weeks|Treatment Period (up to 5 Years)||162
137884|NCT00299130|332530|P1|Completed 24 Weeks|Treatment Period (up to 5 Years)||159
137885|NCT00299130|332528|P3|Treated|Treatment Period (up to 5 Years)||170
137886|NCT00299130|332529|P2|Treated|Treatment Period (up to 5 Years)||167
137887|NCT00299130|332530|P1|Treated|Treatment Period (up to 5 Years)|155 participants in placebo arm switched to active therapy (rituximab 2 x 0.5g) between Weeks 16-48.|172
137888|NCT00299130|332528|P3|STARTED|Treatment Period (up to 5 Years)||171
137889|NCT00299130|332529|P2|STARTED|Treatment Period (up to 5 Years)||168
137890|NCT00299130|332530|P1|STARTED|Treatment Period (up to 5 Years)||172
137891|NCT00299156|332635|P3|NOT COMPLETED|Period 2 (Randomized)||0
137892|NCT00299156|332636|P2|NOT COMPLETED|Period 2 (Randomized)||1
137893|NCT00299156|332637|P1|NOT COMPLETED|Period 2 (Randomized)||0
137894|NCT00299156|332635|P3|COMPLETED|Period 2 (Randomized)||16
137895|NCT00299156|332636|P2|COMPLETED|Period 2 (Randomized)||16
137896|NCT00299156|332637|P1|COMPLETED|Period 2 (Randomized)||0
137897|NCT00299156|332635|P3|STARTED|Period 2 (Randomized)||16
137898|NCT00299156|332636|P2|STARTED|Period 2 (Randomized)||17
137899|NCT00299156|332637|P1|STARTED|Period 2 (Randomized)||0
137900|NCT00299156|332635|P3|NOT COMPLETED|Period 1 (Non-Randomized)||0
137901|NCT00299156|332636|P2|NOT COMPLETED|Period 1 (Non-Randomized)||0
137902|NCT00299156|332637|P1|NOT COMPLETED|Period 1 (Non-Randomized)||0
137903|NCT00299156|332635|P3|COMPLETED|Period 1 (Non-Randomized)||0
137904|NCT00299156|332636|P2|COMPLETED|Period 1 (Non-Randomized)||0
137905|NCT00299156|332637|P1|COMPLETED|Period 1 (Non-Randomized)||32
137906|NCT00299156|332635|P3|STARTED|Period 1 (Non-Randomized)||0
137907|NCT00299156|332636|P2|STARTED|Period 1 (Non-Randomized)||0
137908|NCT00299156|332637|P1|STARTED|Period 1 (Non-Randomized)||32
137909|NCT00299221|332647|P2|NOT COMPLETED|Overall Study||0
137910|NCT00299221|332648|P1|NOT COMPLETED|Overall Study||0
137911|NCT00299221|332647|P2|COMPLETED|Overall Study||71
137912|NCT00299221|332648|P1|COMPLETED|Overall Study||79
137913|NCT00299221|332647|P2|STARTED|Overall Study||71
137914|NCT00299221|332648|P1|STARTED|Overall Study||79
137915|NCT00299416|332662|P1|NOT COMPLETED|Overall Study||0
137916|NCT00299416|332662|P1|COMPLETED|Overall Study||30
137917|NCT00299416|332662|P1|STARTED|Overall Study||30
137918|NCT00299546|332671|P3|NOT COMPLETED|Overall Study||86
137919|NCT00299546|332672|P2|NOT COMPLETED|Overall Study||92
137920|NCT00299546|332673|P1|NOT COMPLETED|Overall Study||100
137921|NCT00299546|332671|P3|COMPLETED|Overall Study||67
137922|NCT00299546|332672|P2|COMPLETED|Overall Study||61
137923|NCT00299546|332673|P1|COMPLETED|Overall Study||55
137924|NCT00299546|332671|P3|STARTED|Overall Study||153
137925|NCT00299546|332672|P2|STARTED|Overall Study||153
137926|NCT00299546|332673|P1|STARTED|Overall Study||155
137927|NCT00299689|332698|P1|NOT COMPLETED|Overall Study||0
137928|NCT00299689|332698|P1|COMPLETED|Overall Study||69
137929|NCT00299689|332698|P1|STARTED|Overall Study||69
137930|NCT00299702|332704|P2|NOT COMPLETED|Overall Study||50
137931|NCT00299702|332705|P1|NOT COMPLETED|Overall Study||53
137932|NCT00299702|332704|P2|COMPLETED|Overall Study||126
137933|NCT00299702|332705|P1|COMPLETED|Overall Study||126
137934|NCT00299702|332704|P2|STARTED|Overall Study||176
137935|NCT00299702|332705|P1|STARTED|Overall Study||179
137936|NCT00299741|332713|P1|NOT COMPLETED|Overall Study||0
137937|NCT00299741|332713|P1|COMPLETED|Overall Study||36
137938|NCT00299741|332713|P1|STARTED|Overall Study||36
137939|NCT00299975|332721|P3|NOT COMPLETED|Overall Study||8
137940|NCT00299975|332722|P2|NOT COMPLETED|Overall Study||1
137941|NCT00299975|332723|P1|NOT COMPLETED|Overall Study||3
137942|NCT00299975|332721|P3|COMPLETED|Overall Study||25
137943|NCT00299975|332722|P2|COMPLETED|Overall Study||31
137944|NCT00299975|332723|P1|COMPLETED|Overall Study||29
137945|NCT00299975|332721|P3|Received Allocated Intervention|Overall Study||32
137946|NCT00299975|332722|P2|Received Allocated Intervention|Overall Study||32
137947|NCT00299975|332723|P1|Received Allocated Intervention|Overall Study||32
137948|NCT00299975|332721|P3|STARTED|Overall Study||33
137949|NCT00299975|332722|P2|STARTED|Overall Study||32
137950|NCT00299975|332723|P1|STARTED|Overall Study||32
137951|NCT00300235|332778|P5|NOT COMPLETED|Overall Study||0
137952|NCT00300235|332779|P4|NOT COMPLETED|Overall Study||0
137953|NCT00300235|332780|P3|NOT COMPLETED|Overall Study||0
137954|NCT00300235|332781|P2|NOT COMPLETED|Overall Study||0
137955|NCT00300235|332782|P1|NOT COMPLETED|Overall Study||0
137956|NCT00300235|332778|P5|COMPLETED|Overall Study||251
137957|NCT00300235|332779|P4|COMPLETED|Overall Study||362
137958|NCT00300235|332780|P3|COMPLETED|Overall Study||398
137959|NCT00300235|332781|P2|COMPLETED|Overall Study||240
137960|NCT00300235|332782|P1|COMPLETED|Overall Study||208
137961|NCT00300235|332778|P5|STARTED|Overall Study||251
137962|NCT00300235|332779|P4|STARTED|Overall Study||362
137963|NCT00300235|332780|P3|STARTED|Overall Study||398
137964|NCT00300235|332781|P2|STARTED|Overall Study||240
137965|NCT00300235|332782|P1|STARTED|Overall Study||208
137966|NCT00300274|332797|P3|NOT COMPLETED|Overall Study||45
137967|NCT00300274|332798|P2|NOT COMPLETED|Overall Study||27
137968|NCT00300274|332799|P1|NOT COMPLETED|Overall Study||46
137969|NCT00300274|332797|P3|COMPLETED|Overall Study||226
137970|NCT00300274|332798|P2|COMPLETED|Overall Study||141
137971|NCT00300274|332799|P1|COMPLETED|Overall Study||236
137972|NCT00300274|332797|P3|Completed 12 Month|Overall Study||248
137973|NCT00300274|332798|P2|Completed 12 Month|Overall Study||149
137974|NCT00300274|332799|P1|Completed 12 Month|Overall Study||250
137975|NCT00300274|332797|P3|STARTED|Overall Study||271
137976|NCT00300274|332798|P2|STARTED|Overall Study||168
137977|NCT00300274|332799|P1|STARTED|Overall Study||282
137978|NCT00300365|332836|P2|NOT COMPLETED|Overall Study||2
137979|NCT00300365|332837|P1|NOT COMPLETED|Overall Study||4
137980|NCT00300365|332836|P2|COMPLETED|Overall Study||38
137981|NCT00300365|332837|P1|COMPLETED|Overall Study||34
137982|NCT00300365|332836|P2|STARTED|Overall Study||40
137983|NCT00300365|332837|P1|STARTED|Overall Study||38
137984|NCT00300430|332846|P3|NOT COMPLETED|Overall Study||151
137985|NCT00300430|332847|P2|NOT COMPLETED|Overall Study||169
137986|NCT00300430|332848|P1|NOT COMPLETED|Overall Study||367
137987|NCT00300430|332846|P3|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|350
137988|NCT00300430|332847|P2|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|345
137989|NCT00300430|332848|P1|COMPLETED|Overall Study|"Completed = completed both the double-blind and open-label studies."|819
137990|NCT00300430|332846|P3|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|501
137991|NCT00300430|332847|P2|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|514
137992|NCT00300430|332848|P1|STARTED|Overall Study|"Started = received combo therapy in double-blind and/or open-label study."|1186
137993|NCT00300456|332886|P6|NOT COMPLETED|Overall Study||11
137994|NCT00300456|332887|P5|NOT COMPLETED|Overall Study||17
137995|NCT00300456|332888|P4|NOT COMPLETED|Overall Study||14
137996|NCT00300456|332889|P3|NOT COMPLETED|Overall Study||21
137997|NCT00300456|332890|P2|NOT COMPLETED|Overall Study||16
137998|NCT00300456|332891|P1|NOT COMPLETED|Overall Study||16
137999|NCT00300456|332886|P6|COMPLETED|Overall Study||48
138000|NCT00300456|332887|P5|COMPLETED|Overall Study||99
138001|NCT00300456|332888|P4|COMPLETED|Overall Study||105
138002|NCT00300456|332889|P3|COMPLETED|Overall Study||98
138003|NCT00300456|332890|P2|COMPLETED|Overall Study||102
138004|NCT00300456|332891|P1|COMPLETED|Overall Study||103
138005|NCT00300456|332886|P6|STARTED|Overall Study||59
138006|NCT00300456|332887|P5|STARTED|Overall Study||116
138007|NCT00300456|332888|P4|STARTED|Overall Study||119
138008|NCT00300456|332889|P3|STARTED|Overall Study||119
138009|NCT00300456|332890|P2|STARTED|Overall Study||118
138010|NCT00300456|332891|P1|STARTED|Overall Study|"For all arms, started means treated."|119
138011|NCT00300469|332953|P6|NOT COMPLETED|Overall Study||9
138012|NCT00300469|332954|P5|NOT COMPLETED|Overall Study||14
138013|NCT00300469|332955|P4|NOT COMPLETED|Overall Study||9
138014|NCT00300469|332956|P3|NOT COMPLETED|Overall Study||17
138015|NCT00300469|332957|P2|NOT COMPLETED|Overall Study||21
138016|NCT00300469|332958|P1|NOT COMPLETED|Overall Study||21
138017|NCT00300469|332953|P6|COMPLETED|Overall Study||46
138018|NCT00300469|332954|P5|COMPLETED|Overall Study||95
138019|NCT00300469|332955|P4|COMPLETED|Overall Study||104
138020|NCT00300469|332956|P3|COMPLETED|Overall Study||95
138021|NCT00300469|332957|P2|COMPLETED|Overall Study||89
138022|NCT00300469|332958|P1|COMPLETED|Overall Study||89
138023|NCT00300469|332953|P6|STARTED|Overall Study||55
138024|NCT00300469|332954|P5|STARTED|Overall Study||109
138025|NCT00300469|332955|P4|STARTED|Overall Study||113
138026|NCT00300469|332956|P3|STARTED|Overall Study||112
138027|NCT00300469|332957|P2|STARTED|Overall Study||110
138028|NCT00300469|332958|P1|STARTED|Overall Study|"For all arms, started means treated."|110
138029|NCT00300482|333020|P6|NOT COMPLETED|Overall Study||16
138030|NCT00300482|333021|P5|NOT COMPLETED|Overall Study||23
138031|NCT00300482|333022|P4|NOT COMPLETED|Overall Study||24
138032|NCT00300482|333023|P3|NOT COMPLETED|Overall Study||51
138033|NCT00300482|333024|P2|NOT COMPLETED|Overall Study||41
138034|NCT00300482|333025|P1|NOT COMPLETED|Overall Study||41
138035|NCT00300482|333020|P6|COMPLETED|Overall Study||115
138036|NCT00300482|333021|P5|COMPLETED|Overall Study||243
138037|NCT00300482|333022|P4|COMPLETED|Overall Study||237
138038|NCT00300482|333023|P3|COMPLETED|Overall Study||208
138039|NCT00300482|333024|P2|COMPLETED|Overall Study||220
138040|NCT00300482|333025|P1|COMPLETED|Overall Study||220
138041|NCT00300482|333020|P6|STARTED|Overall Study||131
138042|NCT00300482|333021|P5|STARTED|Overall Study||266
138043|NCT00300482|333022|P4|STARTED|Overall Study||261
138044|NCT00300482|333023|P3|STARTED|Overall Study||259
138045|NCT00300482|333024|P2|STARTED|Overall Study||261
138046|NCT00300482|333025|P1|STARTED|Overall Study|"For all arms, started means treated."|261
138047|NCT00300495|333083|P2|NOT COMPLETED|Overall Study||1
138048|NCT00300495|333084|P1|NOT COMPLETED|Overall Study||4
138049|NCT00300495|333083|P2|COMPLETED|Overall Study||8
138050|NCT00300495|333084|P1|COMPLETED|Overall Study||6
138051|NCT00300495|333083|P2|STARTED|Overall Study||9
138052|NCT00300495|333084|P1|STARTED|Overall Study||10
138053|NCT00307333|333094|P2|NOT COMPLETED|Overall Study||3
138054|NCT00307333|333095|P1|NOT COMPLETED|Overall Study||11
138055|NCT00307333|333094|P2|COMPLETED|Overall Study||1489
138056|NCT00307333|333095|P1|COMPLETED|Overall Study||1500
138057|NCT00307333|333094|P2|STARTED|Overall Study||1492
138058|NCT00307333|333095|P1|STARTED|Overall Study||1511
138059|NCT00307437|333110|P7|NOT COMPLETED|After Controlled Period||113
138060|NCT00307437|333111|P6|NOT COMPLETED|After Controlled Period||122
138061|NCT00307437|333112|P5|NOT COMPLETED|After Controlled Period||55
138062|NCT00307437|333113|P4|NOT COMPLETED|After Controlled Period||58
138063|NCT00307437|333114|P3|NOT COMPLETED|After Controlled Period||0
138064|NCT00307437|333115|P2|NOT COMPLETED|After Controlled Period||0
138065|NCT00307437|333116|P1|NOT COMPLETED|After Controlled Period||0
138066|NCT00307437|333110|P7|COMPLETED|After Controlled Period||289
138067|NCT00307437|333111|P6|COMPLETED|After Controlled Period||281
138068|NCT00307437|333112|P5|COMPLETED|After Controlled Period||140
138069|NCT00307437|333113|P4|COMPLETED|After Controlled Period||139
138070|NCT00307437|333114|P3|COMPLETED|After Controlled Period||0
138071|NCT00307437|333115|P2|COMPLETED|After Controlled Period||0
138072|NCT00307437|333116|P1|COMPLETED|After Controlled Period||0
138073|NCT00307437|333110|P7|STARTED|After Controlled Period||402
138074|NCT00307437|333111|P6|STARTED|After Controlled Period||403
138075|NCT00307437|333112|P5|STARTED|After Controlled Period|2 participants from placebo group in CP did not crossover to this group after CP.|195
138076|NCT00307437|333113|P4|STARTED|After Controlled Period||197
138077|NCT00307437|333114|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
138078|NCT00307437|333115|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
138079|NCT00307437|333116|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
138080|NCT00307437|333110|P7|NOT COMPLETED|Controlled Period||0
138081|NCT00307437|333111|P6|NOT COMPLETED|Controlled Period||0
138082|NCT00307437|333112|P5|NOT COMPLETED|Controlled Period||0
138083|NCT00307437|333113|P4|NOT COMPLETED|Controlled Period||0
138084|NCT00307437|333114|P3|NOT COMPLETED|Controlled Period||9
138085|NCT00307437|333115|P2|NOT COMPLETED|Controlled Period||6
138086|NCT00307437|333116|P1|NOT COMPLETED|Controlled Period||16
138087|NCT00307437|333110|P7|COMPLETED|Controlled Period||0
138088|NCT00307437|333111|P6|COMPLETED|Controlled Period||0
138089|NCT00307437|333112|P5|COMPLETED|Controlled Period||0
138090|NCT00307437|333113|P4|COMPLETED|Controlled Period||0
138091|NCT00307437|333114|P3|COMPLETED|Controlled Period||402
138092|NCT00307437|333115|P2|COMPLETED|Controlled Period||403
138093|NCT00307437|333116|P1|COMPLETED|Controlled Period||394
138094|NCT00307437|333110|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
138175|NCT00308581|333338|P2|STARTED|Randomized Maintenance Phase||186
138095|NCT00307437|333111|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
138096|NCT00307437|333112|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
138097|NCT00307437|333113|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
138098|NCT00307437|333114|P3|STARTED|Controlled Period||411
138099|NCT00307437|333115|P2|STARTED|Controlled Period||409
138100|NCT00307437|333116|P1|STARTED|Controlled Period||410
138101|NCT00307489|333142|P2|NOT COMPLETED|Week 48 Through Week 168||6
138102|NCT00307489|333143|P1|NOT COMPLETED|Week 48 Through Week 168||6
138103|NCT00307489|333142|P2|COMPLETED|Week 48 Through Week 168|5 of the 44 subjects switched to open-label FTC/TDF prior to Week 168.|44
138104|NCT00307489|333143|P1|COMPLETED|Week 48 Through Week 168|11 of the 46 subjects switched to open-label FTC/TDF prior to Week 168.|46
138105|NCT00307489|333142|P2|STARTED|Week 48 Through Week 168||50
138106|NCT00307489|333143|P1|STARTED|Week 48 Through Week 168||52
138107|NCT00307489|333142|P2|NOT COMPLETED|Baseline Through Week 48||2
138108|NCT00307489|333143|P1|NOT COMPLETED|Baseline Through Week 48||1
138109|NCT00307489|333142|P2|COMPLETED|Baseline Through Week 48|9 of the 50 subjects switched to open-label FTC/TDF prior to Week 48.|50
138110|NCT00307489|333143|P1|COMPLETED|Baseline Through Week 48|16 of the 52 subjects switched to open-label FTC/TDF prior to Week 48.|52
138111|NCT00307489|333142|P2|STARTED|Baseline Through Week 48||52
138112|NCT00307489|333143|P1|STARTED|Baseline Through Week 48||53
138113|NCT00308113|333189|P4|NOT COMPLETED|Overall Study||1
138114|NCT00308113|333190|P3|NOT COMPLETED|Overall Study||0
138115|NCT00308113|333191|P2|NOT COMPLETED|Overall Study||0
138116|NCT00308113|333192|P1|NOT COMPLETED|Overall Study||0
138117|NCT00308113|333189|P4|COMPLETED|Overall Study||1
138118|NCT00308113|333190|P3|COMPLETED|Overall Study||1
138119|NCT00308113|333191|P2|COMPLETED|Overall Study||0
138120|NCT00308113|333192|P1|COMPLETED|Overall Study||0
138121|NCT00308113|333189|P4|STARTED|Overall Study||2
138122|NCT00308113|333190|P3|STARTED|Overall Study||1
138123|NCT00308113|333191|P2|STARTED|Overall Study||0
138124|NCT00308113|333192|P1|STARTED|Overall Study||0
138125|NCT00308139|333212|P2|NOT COMPLETED|Overall Study||87
138126|NCT00308139|333213|P1|NOT COMPLETED|Overall Study||94
138127|NCT00308139|333212|P2|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|64
138128|NCT00308139|333213|P1|COMPLETED|Overall Study|Subjects who completed 364 weeks of assessment|58
138129|NCT00308139|333212|P2|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|130
138130|NCT00308139|333213|P1|30-Week Completed|Overall Study|Subjects who completed 30 weeks of assessment|128
138131|NCT00308139|333212|P2|Evaluable Meal Tolerance Cohort|Overall Study||24
138132|NCT00308139|333213|P1|Evaluable Meal Tolerance Cohort|Overall Study||27
138133|NCT00308139|333212|P2|Pharmacokinetics Population|Overall Study||0
138134|NCT00308139|333213|P1|Pharmacokinetics Population|Overall Study||129
138135|NCT00308139|333212|P2|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|145
138136|NCT00308139|333213|P1|ITT in the 30-Week Assessment|Overall Study|ITT Subjects who received at least one injection of randomized dose.|148
138137|NCT00308139|333212|P2|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|147
138138|NCT00308139|333213|P1|Intent to Treat (ITT)|Overall Study|Subjects who received at least one injection of lead-in exenatide 5 mcg.|148
138139|NCT00308139|333212|P2|STARTED|Overall Study||151
138140|NCT00308139|333213|P1|STARTED|Overall Study||152
138141|NCT00308230|333286|P3|NOT COMPLETED|Overall Study||0
138142|NCT00308230|333287|P2|NOT COMPLETED|Overall Study||0
138143|NCT00308230|333288|P1|NOT COMPLETED|Overall Study||0
138144|NCT00308230|333286|P3|COMPLETED|Overall Study||20
138145|NCT00308230|333287|P2|COMPLETED|Overall Study||8
138146|NCT00308230|333288|P1|COMPLETED|Overall Study||6
138147|NCT00308230|333286|P3|STARTED|Overall Study||20
138148|NCT00308230|333287|P2|STARTED|Overall Study||8
138149|NCT00308230|333288|P1|STARTED|Overall Study||6
138150|NCT00308308|333298|P2|NOT COMPLETED|Overall Study||68
138151|NCT00308308|333299|P1|NOT COMPLETED|Overall Study||103
138152|NCT00308308|333298|P2|COMPLETED|Overall Study||220
138153|NCT00308308|333299|P1|COMPLETED|Overall Study||198
138154|NCT00308308|333298|P2|STARTED|Overall Study||288
138155|NCT00308308|333299|P1|STARTED|Overall Study||301
138156|NCT00308516|333321|P2|NOT COMPLETED|Overall Study||21
138157|NCT00308516|333322|P1|NOT COMPLETED|Overall Study||29
138158|NCT00308516|333321|P2|COMPLETED|Overall Study||10
138159|NCT00308516|333322|P1|COMPLETED|Overall Study||6
138160|NCT00308516|333321|P2|STARTED|Overall Study||31
138161|NCT00308516|333322|P1|STARTED|Overall Study||35
138162|NCT00308555|333330|P2|NOT COMPLETED|Overall Study||0
138163|NCT00308555|333331|P1|NOT COMPLETED|Overall Study||3
138164|NCT00308555|333330|P2|COMPLETED|Overall Study||11
138165|NCT00308555|333331|P1|COMPLETED|Overall Study||10
138166|NCT00308555|333330|P2|STARTED|Overall Study||11
138167|NCT00308555|333331|P1|STARTED|Overall Study||13
138168|NCT00308581|333337|P3|NOT COMPLETED|Randomized Maintenance Phase||0
138169|NCT00308581|333338|P2|NOT COMPLETED|Randomized Maintenance Phase||103
138170|NCT00308581|333339|P1|NOT COMPLETED|Randomized Maintenance Phase||105
138171|NCT00308581|333337|P3|COMPLETED|Randomized Maintenance Phase||0
138172|NCT00308581|333338|P2|COMPLETED|Randomized Maintenance Phase||83
138173|NCT00308581|333339|P1|COMPLETED|Randomized Maintenance Phase||82
138174|NCT00308581|333337|P3|STARTED|Randomized Maintenance Phase||0
138176|NCT00308581|333339|P1|STARTED|Randomized Maintenance Phase||187
138177|NCT00308581|333337|P3|NOT COMPLETED|Induction Phase||166
138178|NCT00308581|333338|P2|NOT COMPLETED|Induction Phase||0
138179|NCT00308581|333339|P1|NOT COMPLETED|Induction Phase||0
138180|NCT00308581|333337|P3|COMPLETED|Induction Phase||373
138181|NCT00308581|333338|P2|COMPLETED|Induction Phase|Not applicable in this period|0
138182|NCT00308581|333339|P1|COMPLETED|Induction Phase|Not applicable in this period|0
138183|NCT00308581|333337|P3|STARTED|Induction Phase||539
138184|NCT00308581|333338|P2|STARTED|Induction Phase|Not applicable in this period|0
138185|NCT00308581|333339|P1|STARTED|Induction Phase|Not applicable in this period|0
138186|NCT00308620|333466|P3|NOT COMPLETED|Overall Study||1
138187|NCT00308620|333467|P2|NOT COMPLETED|Overall Study||1
138188|NCT00308620|333468|P1|NOT COMPLETED|Overall Study||1
138189|NCT00308620|333466|P3|COMPLETED|Overall Study||5
138190|NCT00308620|333467|P2|COMPLETED|Overall Study||3
138191|NCT00308620|333468|P1|COMPLETED|Overall Study||2
138192|NCT00308620|333466|P3|STARTED|Overall Study||6
138193|NCT00308620|333467|P2|STARTED|Overall Study||4
138194|NCT00308620|333468|P1|STARTED|Overall Study||3
138195|NCT00308711|333480|P3|NOT COMPLETED|Overall Study||5
138196|NCT00308711|333481|P2|NOT COMPLETED|Overall Study||4
138197|NCT00308711|333482|P1|NOT COMPLETED|Overall Study||2
138198|NCT00308711|333480|P3|COMPLETED|Overall Study||431
138199|NCT00308711|333481|P2|COMPLETED|Overall Study||440
138200|NCT00308711|333482|P1|COMPLETED|Overall Study||426
138201|NCT00308711|333480|P3|STARTED|Overall Study||436
138202|NCT00308711|333481|P2|STARTED|Overall Study||444
138203|NCT00308711|333482|P1|STARTED|Overall Study||428
138204|NCT00308737|333517|P3|NOT COMPLETED|Overall Study||37
138205|NCT00308737|333518|P2|NOT COMPLETED|Overall Study||289
138206|NCT00308737|333519|P1|NOT COMPLETED|Overall Study||463
138207|NCT00308737|333517|P3|COMPLETED|Overall Study||127
138208|NCT00308737|333518|P2|COMPLETED|Overall Study||662
138209|NCT00308737|333519|P1|COMPLETED|Overall Study||475
138210|NCT00308737|333517|P3|STARTED|Overall Study||164
138211|NCT00308737|333518|P2|STARTED|Overall Study||951
138212|NCT00308737|333519|P1|STARTED|Overall Study||938
138213|NCT00308997|333558|P2|NOT COMPLETED|Overall Study||1
138214|NCT00308997|333559|P1|NOT COMPLETED|Overall Study||1
138215|NCT00308997|333558|P2|COMPLETED|Overall Study||28
138216|NCT00308997|333559|P1|COMPLETED|Overall Study||55
138217|NCT00308997|333558|P2|STARTED|Overall Study||29
138218|NCT00308997|333559|P1|STARTED|Overall Study||56
138219|NCT00309244|333577|P2|NOT COMPLETED|Overall Study||97
138220|NCT00309244|333578|P1|NOT COMPLETED|Overall Study||118
138221|NCT00309244|333577|P2|COMPLETED|Overall Study||246
138222|NCT00309244|333578|P1|COMPLETED|Overall Study||216
138223|NCT00309244|333577|P2|STARTED|Overall Study||343
138224|NCT00309244|333578|P1|STARTED|Overall Study||334
138225|NCT00309387|333600|P2|NOT COMPLETED|Overall Study||159
138226|NCT00309387|333601|P1|NOT COMPLETED|Overall Study||142
138227|NCT00309387|333600|P2|COMPLETED|Overall Study||351
138228|NCT00309387|333601|P1|COMPLETED|Overall Study||368
138229|NCT00309387|333600|P2|STARTED|Overall Study||510
138230|NCT00309387|333601|P1|STARTED|Overall Study||510
138231|NCT00309452|333619|P2|NOT COMPLETED|Overall Study||0
138232|NCT00309452|333620|P1|NOT COMPLETED|Overall Study||3
138233|NCT00309452|333619|P2|COMPLETED|Overall Study||60
138234|NCT00309452|333620|P1|COMPLETED|Overall Study||57
138235|NCT00309452|333619|P2|STARTED|Overall Study||60
138236|NCT00309452|333620|P1|STARTED|Overall Study||60
138237|NCT00309465|333652|P6|NOT COMPLETED|Overall Study||0
138238|NCT00309465|333653|P5|NOT COMPLETED|Overall Study||0
138239|NCT00309465|333654|P4|NOT COMPLETED|Overall Study||1
138240|NCT00309465|333655|P3|NOT COMPLETED|Overall Study||0
138241|NCT00309465|333656|P2|NOT COMPLETED|Overall Study||0
138242|NCT00309465|333657|P1|NOT COMPLETED|Overall Study||0
138243|NCT00309465|333652|P6|COMPLETED|Overall Study||76
138244|NCT00309465|333653|P5|COMPLETED|Overall Study||76
138245|NCT00309465|333654|P4|COMPLETED|Overall Study|One subject was excluded due to eligibility error.|75
138246|NCT00309465|333655|P3|COMPLETED|Overall Study||58
138247|NCT00309465|333656|P2|COMPLETED|Overall Study||58
138248|NCT00309465|333657|P1|COMPLETED|Overall Study||58
138249|NCT00309465|333652|P6|STARTED|Overall Study||76
138250|NCT00309465|333653|P5|STARTED|Overall Study||76
138251|NCT00309465|333654|P4|STARTED|Overall Study||76
138252|NCT00309465|333655|P3|STARTED|Overall Study||58
138253|NCT00309465|333656|P2|STARTED|Overall Study||58
138254|NCT00309465|333657|P1|STARTED|Overall Study||58
138255|NCT00309608|333676|P5|NOT COMPLETED|Overall Study||4
138256|NCT00309608|333677|P4|NOT COMPLETED|Overall Study||6
138257|NCT00309608|333678|P3|NOT COMPLETED|Overall Study||10
138258|NCT00309608|333679|P2|NOT COMPLETED|Overall Study||13
138259|NCT00309608|333680|P1|NOT COMPLETED|Overall Study||14
138260|NCT00309608|333676|P5|COMPLETED|Overall Study||61
138261|NCT00309608|333677|P4|COMPLETED|Overall Study||60
138262|NCT00309608|333678|P3|COMPLETED|Overall Study||56
138263|NCT00309608|333679|P2|COMPLETED|Overall Study||52
138264|NCT00309608|333680|P1|COMPLETED|Overall Study||57
138265|NCT00309608|333676|P5|STARTED|Overall Study||65
138266|NCT00309608|333677|P4|STARTED|Overall Study||66
138267|NCT00309608|333678|P3|STARTED|Overall Study||66
138268|NCT00309608|333679|P2|STARTED|Overall Study||65
138269|NCT00309608|333680|P1|STARTED|Overall Study||71
138270|NCT00309738|333703|P2|NOT COMPLETED|Overall Study||12
138271|NCT00309738|333704|P1|NOT COMPLETED|Overall Study||13
138272|NCT00309738|333703|P2|COMPLETED|Overall Study||107
138273|NCT00309738|333704|P1|COMPLETED|Overall Study||223
138274|NCT00309738|333703|P2|Safety Population|Overall Study|Subjects who received at least one dose of study medication|119
138275|NCT00309738|333704|P1|Safety Population|Overall Study|Subjects who received at least one dose of study medication|233
138276|NCT00309738|333703|P2|STARTED|Overall Study||119
138277|NCT00309738|333704|P1|STARTED|Overall Study||236
138278|NCT00309751|333714|P2|NOT COMPLETED|Overall Study||15
138279|NCT00309751|333715|P1|NOT COMPLETED|Overall Study||31
138280|NCT00309751|333714|P2|COMPLETED|Overall Study||124
138281|NCT00309751|333715|P1|COMPLETED|Overall Study||248
138282|NCT00309751|333714|P2|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|137
138283|NCT00309751|333715|P1|Safety Population|Overall Study|Subjects who received at least 1 dose of study drug|275
138284|NCT00309751|333714|P2|STARTED|Overall Study||139
138285|NCT00309751|333715|P1|STARTED|Overall Study||279
138286|NCT00309777|333727|P4|NOT COMPLETED|Overall Study||4
138287|NCT00309777|333728|P3|NOT COMPLETED|Overall Study||19
138288|NCT00309777|333729|P2|NOT COMPLETED|Overall Study||9
138289|NCT00309777|333730|P1|NOT COMPLETED|Overall Study||23
138290|NCT00309777|333727|P4|COMPLETED|Overall Study||107
138291|NCT00309777|333728|P3|COMPLETED|Overall Study||304
138292|NCT00309777|333729|P2|COMPLETED|Overall Study||99
138293|NCT00309777|333730|P1|COMPLETED|Overall Study||292
138294|NCT00309777|333727|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|110
138295|NCT00309777|333728|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|320
138296|NCT00309777|333729|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|107
138297|NCT00309777|333730|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of study treatment.|311
138298|NCT00309777|333727|P4|STARTED|Overall Study||111
138299|NCT00309777|333728|P3|STARTED|Overall Study||323
138300|NCT00309777|333729|P2|STARTED|Overall Study||108
138301|NCT00309777|333730|P1|STARTED|Overall Study||315
138302|NCT00309907|333744|P1|NOT COMPLETED|Overall Study||20
138303|NCT00309907|333744|P1|COMPLETED|Overall Study||19
138304|NCT00309907|333744|P1|STARTED|Overall Study||39
138305|NCT00309946|333748|P1|NOT COMPLETED|Overall Study||1
138306|NCT00309946|333748|P1|COMPLETED|Overall Study||50
138307|NCT00309946|333748|P1|STARTED|Overall Study||51
138308|NCT00309985|333756|P2|NOT COMPLETED|Overall Study||1
138309|NCT00309985|333757|P1|NOT COMPLETED|Overall Study||62
138310|NCT00309985|333756|P2|COMPLETED|Overall Study|"Arm B tx info was not collected so only 1 patient w/o follow-up data was considered not completed."|392
138311|NCT00309985|333757|P1|COMPLETED|Overall Study||335
138312|NCT00309985|333756|P2|Both Baseline and 3-month FACT-P Evals|Overall Study||299
138313|NCT00309985|333757|P1|Both Baseline and 3-month FACT-P Evals|Overall Study||334
138314|NCT00309985|333756|P2|Toxicity Analysis|Overall Study||392
138315|NCT00309985|333757|P1|Toxicity Analysis|Overall Study||390
138316|NCT00309985|333756|P2|STARTED|Overall Study||393
138317|NCT00309985|333757|P1|STARTED|Overall Study||397
138318|NCT00310076|333773|P1|NOT COMPLETED|Overall Study||3
138319|NCT00310076|333773|P1|COMPLETED|Overall Study||26
138320|NCT00310076|333773|P1|STARTED|Overall Study||29
138321|NCT00310310|333779|P2|NOT COMPLETED|Overall Study||20
138322|NCT00310310|333780|P1|NOT COMPLETED|Overall Study||30
138323|NCT00310310|333779|P2|COMPLETED|Overall Study||100
138324|NCT00310310|333780|P1|COMPLETED|Overall Study||90
138325|NCT00310310|333779|P2|STARTED|Overall Study||120
138326|NCT00310310|333780|P1|STARTED|Overall Study||120
138327|NCT00310362|333807|P3|NOT COMPLETED|Overall Study||0
138328|NCT00310362|333808|P2|NOT COMPLETED|Overall Study||0
138329|NCT00310362|333809|P1|NOT COMPLETED|Overall Study||0
138330|NCT00310362|333807|P3|COMPLETED|Overall Study||1206
138331|NCT00310362|333808|P2|COMPLETED|Overall Study||1205
138332|NCT00310362|333809|P1|COMPLETED|Overall Study||1199
138333|NCT00310362|333807|P3|STARTED|Overall Study||1206
138334|NCT00310362|333808|P2|STARTED|Overall Study||1205
138335|NCT00310362|333809|P1|STARTED|Overall Study||1199
138336|NCT00310375|333819|P2|NOT COMPLETED|Overall Study||68
138337|NCT00310375|333820|P1|NOT COMPLETED|Overall Study||91
138338|NCT00310375|333819|P2|COMPLETED|Overall Study||11
138339|NCT00310375|333820|P1|COMPLETED|Overall Study||11
138340|NCT00310375|333819|P2|STARTED|Overall Study||79
138341|NCT00310375|333820|P1|STARTED|Overall Study||102
138342|NCT00310401|333860|P2|NOT COMPLETED|Overall Study||0
138343|NCT00310401|333861|P1|NOT COMPLETED|Overall Study||0
138344|NCT00310401|333860|P2|COMPLETED|Overall Study||246
138345|NCT00310401|333861|P1|COMPLETED|Overall Study||260
138346|NCT00310401|333860|P2|STARTED|Overall Study||246
138347|NCT00310401|333861|P1|STARTED|Overall Study||260
138348|NCT00310427|333869|P2|NOT COMPLETED|Overall Study||1
138349|NCT00310427|333870|P1|NOT COMPLETED|Overall Study||2
138350|NCT00310427|333869|P2|COMPLETED|Overall Study||25
138351|NCT00310427|333870|P1|COMPLETED|Overall Study||25
138352|NCT00310427|333869|P2|STARTED|Overall Study||26
138353|NCT00310427|333870|P1|STARTED|Overall Study||27
138354|NCT00310440|333892|P2|NOT COMPLETED|Overall Study||13
138355|NCT00310440|333893|P1|NOT COMPLETED|Overall Study||26
138356|NCT00310440|333892|P2|COMPLETED|Overall Study||141
138357|NCT00310440|333893|P1|COMPLETED|Overall Study||139
138358|NCT00310440|333892|P2|STARTED|Overall Study||154
138359|NCT00310440|333893|P1|STARTED|Overall Study||165
138360|NCT00310466|333919|P2|NOT COMPLETED|Overall Study||12
138361|NCT00310466|333920|P1|NOT COMPLETED|Overall Study||18
138362|NCT00310466|333919|P2|COMPLETED|Overall Study||101
138363|NCT00310466|333920|P1|COMPLETED|Overall Study||95
138364|NCT00310466|333919|P2|STARTED|Overall Study||113
138365|NCT00310466|333920|P1|STARTED|Overall Study||113
138366|NCT00297648|333932|P1|NOT COMPLETED|Overall Study||36
138367|NCT00297648|333932|P1|COMPLETED|Overall Study||53
138368|NCT00297648|333932|P1|STARTED|Overall Study||89
138369|NCT00297778|333973|P2|NOT COMPLETED|Overall Study||20
138370|NCT00297778|333974|P1|NOT COMPLETED|Overall Study||19
138371|NCT00297778|333973|P2|COMPLETED|Overall Study||124
138372|NCT00297778|333974|P1|COMPLETED|Overall Study||133
138373|NCT00297778|333973|P2|STARTED|Overall Study||144
138374|NCT00297778|333974|P1|STARTED|Overall Study||152
138375|NCT00297830|334011|P3|NOT COMPLETED|12 Month Visit||0
138376|NCT00297830|334012|P2|NOT COMPLETED|12 Month Visit||6
138377|NCT00297830|334013|P1|NOT COMPLETED|12 Month Visit||1
138378|NCT00297830|334011|P3|COMPLETED|12 Month Visit||24
138379|NCT00297830|334012|P2|COMPLETED|12 Month Visit||35
138380|NCT00297830|334013|P1|COMPLETED|12 Month Visit||37
138381|NCT00297830|334011|P3|STARTED|12 Month Visit||24
138382|NCT00297830|334012|P2|STARTED|12 Month Visit||41
138383|NCT00297830|334013|P1|STARTED|12 Month Visit||38
138384|NCT00297830|334011|P3|NOT COMPLETED|6 Month Visit||3
138385|NCT00297830|334012|P2|NOT COMPLETED|6 Month Visit||2
138386|NCT00297830|334013|P1|NOT COMPLETED|6 Month Visit||3
138387|NCT00297830|334011|P3|COMPLETED|6 Month Visit||24
138388|NCT00297830|334012|P2|COMPLETED|6 Month Visit||41
138389|NCT00297830|334013|P1|COMPLETED|6 Month Visit||38
138390|NCT00297830|334011|P3|STARTED|6 Month Visit||27
138391|NCT00297830|334012|P2|STARTED|6 Month Visit||43
138392|NCT00297830|334013|P1|STARTED|6 Month Visit||41
138393|NCT00297830|334011|P3|NOT COMPLETED|Baseline||0
138394|NCT00297830|334012|P2|NOT COMPLETED|Baseline||0
138395|NCT00297830|334013|P1|NOT COMPLETED|Baseline||0
138396|NCT00297830|334011|P3|COMPLETED|Baseline||27
138397|NCT00297830|334012|P2|COMPLETED|Baseline||43
138398|NCT00297830|334013|P1|COMPLETED|Baseline||41
138399|NCT00297830|334011|P3|STARTED|Baseline||27
138400|NCT00297830|334012|P2|STARTED|Baseline||43
138401|NCT00297830|334013|P1|STARTED|Baseline||41
138402|NCT00303446|334032|P2|NOT COMPLETED|Overall Study||4
138403|NCT00303446|334033|P1|NOT COMPLETED|Overall Study||2
138404|NCT00303446|334032|P2|COMPLETED|Overall Study||21
138405|NCT00303446|334033|P1|COMPLETED|Overall Study||23
138406|NCT00303446|334032|P2|STARTED|Overall Study||25
138407|NCT00303446|334033|P1|STARTED|Overall Study||25
138408|NCT00303459|334069|P2|NOT COMPLETED|Overall Study||89
138409|NCT00303459|334070|P1|NOT COMPLETED|Overall Study||83
138410|NCT00303459|334069|P2|COMPLETED|Overall Study||86
138411|NCT00303459|334070|P1|COMPLETED|Overall Study||76
138412|NCT00303459|334069|P2|STARTED|Overall Study|One subject randomized to placebo did not receive study treatment|175
138413|NCT00303459|334070|P1|STARTED|Overall Study||159
138414|NCT00303472|334101|P7|NOT COMPLETED|Treatment Extension (Optional)||0
138415|NCT00303472|334102|P6|NOT COMPLETED|Treatment Extension (Optional)||1
138416|NCT00303472|334103|P5|NOT COMPLETED|Treatment Extension (Optional)||4
138417|NCT00303472|334104|P4|NOT COMPLETED|Treatment Extension (Optional)||8
138418|NCT00303472|334105|P3|NOT COMPLETED|Treatment Extension (Optional)||9
138419|NCT00303472|334106|P2|NOT COMPLETED|Treatment Extension (Optional)||6
138420|NCT00303472|334107|P1|NOT COMPLETED|Treatment Extension (Optional)||5
138421|NCT00303472|334101|P7|COMPLETED|Treatment Extension (Optional)||1
138422|NCT00303472|334102|P6|COMPLETED|Treatment Extension (Optional)||4
138423|NCT00303472|334103|P5|COMPLETED|Treatment Extension (Optional)||1
138424|NCT00303472|334104|P4|COMPLETED|Treatment Extension (Optional)||5
138425|NCT00303472|334105|P3|COMPLETED|Treatment Extension (Optional)||2
138426|NCT00303472|334106|P2|COMPLETED|Treatment Extension (Optional)||5
138427|NCT00303472|334107|P1|COMPLETED|Treatment Extension (Optional)||1
138428|NCT00303472|334101|P7|STARTED|Treatment Extension (Optional)||1
138429|NCT00303472|334102|P6|STARTED|Treatment Extension (Optional)||5
138430|NCT00303472|334103|P5|STARTED|Treatment Extension (Optional)||5
138431|NCT00303472|334104|P4|STARTED|Treatment Extension (Optional)||13
138432|NCT00303472|334105|P3|STARTED|Treatment Extension (Optional)||11
138433|NCT00303472|334106|P2|STARTED|Treatment Extension (Optional)||11
138434|NCT00303472|334107|P1|STARTED|Treatment Extension (Optional)||6
138435|NCT00303472|334101|P7|NOT COMPLETED|Treatment Period||2
138436|NCT00303472|334102|P6|NOT COMPLETED|Treatment Period||1
138437|NCT00303472|334103|P5|NOT COMPLETED|Treatment Period||3
138438|NCT00303472|334104|P4|NOT COMPLETED|Treatment Period||2
138439|NCT00303472|334105|P3|NOT COMPLETED|Treatment Period||0
138440|NCT00303472|334106|P2|NOT COMPLETED|Treatment Period||0
138441|NCT00303472|334107|P1|NOT COMPLETED|Treatment Period||0
138442|NCT00303472|334101|P7|COMPLETED|Treatment Period||3
138443|NCT00303472|334102|P6|COMPLETED|Treatment Period||11
138444|NCT00303472|334103|P5|COMPLETED|Treatment Period||8
138445|NCT00303472|334104|P4|COMPLETED|Treatment Period||14
138446|NCT00303472|334105|P3|COMPLETED|Treatment Period||11
138447|NCT00303472|334106|P2|COMPLETED|Treatment Period||11
138448|NCT00303472|334107|P1|COMPLETED|Treatment Period||6
138449|NCT00303472|334101|P7|STARTED|Treatment Period||5
138450|NCT00303472|334102|P6|STARTED|Treatment Period||12
138451|NCT00303472|334103|P5|STARTED|Treatment Period||11
138452|NCT00303472|334104|P4|STARTED|Treatment Period||16
138453|NCT00303472|334105|P3|STARTED|Treatment Period||11
138454|NCT00303472|334106|P2|STARTED|Treatment Period||11
138455|NCT00303472|334107|P1|STARTED|Treatment Period||6
138456|NCT00303485|334167|P2|NOT COMPLETED|Overall Study||2
138457|NCT00303485|334168|P1|NOT COMPLETED|Overall Study||1
138458|NCT00303485|334167|P2|COMPLETED|Overall Study||15
138459|NCT00303485|334168|P1|COMPLETED|Overall Study||48
138460|NCT00303485|334167|P2|STARTED|Overall Study||17
138461|NCT00303485|334168|P1|STARTED|Overall Study||49
138462|NCT00303511|334192|P1|NOT COMPLETED|Overall Study||0
138463|NCT00303511|334192|P1|COMPLETED|Overall Study||10
138464|NCT00303511|334192|P1|STARTED|Overall Study||10
138465|NCT00303602|334198|P2|NOT COMPLETED|Overall Study||15
138466|NCT00303602|334199|P1|NOT COMPLETED|Overall Study||19
138467|NCT00303602|334198|P2|COMPLETED|Overall Study||50
138468|NCT00303602|334199|P1|COMPLETED|Overall Study||65
138469|NCT00303602|334198|P2|STARTED|Overall Study||65
138470|NCT00303602|334199|P1|STARTED|Overall Study||84
138471|NCT00303628|334241|P2|NOT COMPLETED|Overall Study||73
138472|NCT00303628|334242|P1|NOT COMPLETED|Overall Study||50
138473|NCT00303628|334241|P2|COMPLETED|Overall Study||106
138474|NCT00303628|334242|P1|COMPLETED|Overall Study||126
138475|NCT00303628|334241|P2|Treated|Overall Study||174
138476|NCT00303628|334242|P1|Treated|Overall Study||173
138477|NCT00303628|334241|P2|Eligible|Overall Study||177
138478|NCT00303628|334242|P1|Eligible|Overall Study||171
138479|NCT00303628|334241|P2|STARTED|Overall Study||179
138480|NCT00303628|334242|P1|STARTED|Overall Study||176
138481|NCT00303667|334260|P2|NOT COMPLETED|Overall Study||4
138482|NCT00303667|334261|P1|NOT COMPLETED|Overall Study||0
138483|NCT00303667|334260|P2|COMPLETED|Overall Study|Completed = remained alive and on study through Day 0 (day of transplant)|35
138484|NCT00303667|334261|P1|COMPLETED|Overall Study||8
138485|NCT00303667|334260|P2|STARTED|Overall Study||39
138486|NCT00303667|334261|P1|STARTED|Overall Study||8
138487|NCT00303823|334285|P2|NOT COMPLETED|Overall Study||10
138488|NCT00303823|334286|P1|NOT COMPLETED|Overall Study||15
138489|NCT00303823|334285|P2|COMPLETED|Overall Study||38
138490|NCT00303823|334286|P1|COMPLETED|Overall Study||35
138491|NCT00303823|334285|P2|STARTED|Overall Study||48
138492|NCT00303823|334286|P1|STARTED|Overall Study||50
138493|NCT00303862|334298|P1|NOT COMPLETED|Overall Study||0
138494|NCT00303862|334298|P1|COMPLETED|Overall Study||10
138495|NCT00303862|334298|P1|STARTED|Overall Study||10
138496|NCT00303901|334305|P1|NOT COMPLETED|Overall Study||0
138497|NCT00303901|334305|P1|COMPLETED|Overall Study||40
138498|NCT00303901|334305|P1|STARTED|Overall Study||40
138499|NCT00303953|334310|P1|NOT COMPLETED|Overall Study||19
138500|NCT00303953|334310|P1|COMPLETED|Overall Study||3
138501|NCT00303953|334310|P1|Eligible and Treated|Overall Study||20
138502|NCT00303953|334310|P1|Eligible|Overall Study||21
138503|NCT00303953|334310|P1|STARTED|Overall Study||22
138504|NCT00303966|334316|P1|NOT COMPLETED|Overall Study||0
138505|NCT00303966|334316|P1|COMPLETED|Overall Study||5
138506|NCT00303966|334316|P1|STARTED|Overall Study||5
138507|NCT00303979|334328|P3|NOT COMPLETED|Single Time Point (18 Month)||0
138508|NCT00303979|334329|P2|NOT COMPLETED|Single Time Point (18 Month)||0
138509|NCT00303979|334330|P1|NOT COMPLETED|Single Time Point (18 Month)||0
138510|NCT00303979|334328|P3|COMPLETED|Single Time Point (18 Month)||9641
138511|NCT00303979|334329|P2|COMPLETED|Single Time Point (18 Month)||0
138512|NCT00303979|334330|P1|COMPLETED|Single Time Point (18 Month)||0
138513|NCT00303979|334328|P3|STARTED|Single Time Point (18 Month)||9641
138514|NCT00303979|334329|P2|STARTED|Single Time Point (18 Month)||0
138515|NCT00303979|334330|P1|STARTED|Single Time Point (18 Month)||0
138516|NCT00303979|334328|P3|NOT COMPLETED|Single Time Point (6 Month)||0
138517|NCT00303979|334329|P2|NOT COMPLETED|Single Time Point (6 Month)||0
138518|NCT00303979|334330|P1|NOT COMPLETED|Single Time Point (6 Month)||0
138519|NCT00303979|334328|P3|COMPLETED|Single Time Point (6 Month)||0
138520|NCT00303979|334329|P2|COMPLETED|Single Time Point (6 Month)||9992
138521|NCT00303979|334330|P1|COMPLETED|Single Time Point (6 Month)||0
138522|NCT00303979|334328|P3|STARTED|Single Time Point (6 Month)||0
138523|NCT00303979|334329|P2|STARTED|Single Time Point (6 Month)||9992
138524|NCT00303979|334330|P1|STARTED|Single Time Point (6 Month)||0
138525|NCT00303979|334328|P3|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
138526|NCT00303979|334329|P2|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
138527|NCT00303979|334330|P1|NOT COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||7572
138528|NCT00303979|334328|P3|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
138529|NCT00303979|334329|P2|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)||0
138530|NCT00303979|334330|P1|COMPLETED|Longitudinal (Baseline, 12 and 24 Month)|at 24 Month|7605
138531|NCT00303979|334328|P3|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
138532|NCT00303979|334329|P2|STARTED|Longitudinal (Baseline, 12 and 24 Month)||0
138533|NCT00303979|334330|P1|STARTED|Longitudinal (Baseline, 12 and 24 Month)|at Baseline|15177
138534|NCT00304031|334343|P3|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||2
138535|NCT00304031|334344|P2|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
138536|NCT00304031|334345|P1|NOT COMPLETED|Randomization to Adjuvant TMZ Arm||0
138537|NCT00304031|334343|P3|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study|420
138538|NCT00304031|334344|P2|COMPLETED|Randomization to Adjuvant TMZ Arm|Subjects contributing data to the primary analysis are considered to have completed the study.|411
138539|NCT00304031|334345|P1|COMPLETED|Randomization to Adjuvant TMZ Arm||0
138540|NCT00304031|334343|P3|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|422
138541|NCT00304031|334344|P2|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|411
138542|NCT00304031|334345|P1|STARTED|Randomization to Adjuvant TMZ Arm|Patients who met requirements were randomized to an adjuvant TMZ arm after concomitant treatment.|0
138543|NCT00304031|334343|P3|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
138544|NCT00304031|334344|P2|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||0
138545|NCT00304031|334345|P1|NOT COMPLETED|Concomitant Radiation Therapy and TMZ||292
138546|NCT00304031|334343|P3|COMPLETED|Concomitant Radiation Therapy and TMZ||0
138547|NCT00304031|334344|P2|COMPLETED|Concomitant Radiation Therapy and TMZ||0
138548|NCT00304031|334345|P1|COMPLETED|Concomitant Radiation Therapy and TMZ|These patients successfully completed concomitant treatment and met requirements for randomization.|833
138549|NCT00304031|334343|P3|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
138550|NCT00304031|334344|P2|STARTED|Concomitant Radiation Therapy and TMZ|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
138551|NCT00304031|334345|P1|STARTED|Concomitant Radiation Therapy and TMZ|All patients were registered to concomitant treatment; randomized after completing this treatment.|1125
138552|NCT00304031|334343|P3|NOT COMPLETED|Registration||0
138553|NCT00304031|334344|P2|NOT COMPLETED|Registration||0
138554|NCT00304031|334345|P1|NOT COMPLETED|Registration||48
138555|NCT00304031|334343|P3|COMPLETED|Registration||0
138556|NCT00304031|334344|P2|COMPLETED|Registration||0
138557|NCT00304031|334345|P1|COMPLETED|Registration|Patients determined to be ineligible after registration were excluded.|1125
138558|NCT00304031|334343|P3|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
138559|NCT00304031|334344|P2|STARTED|Registration|Patients were not randomized to adjuvant TMZ until after completion of concomitant treatment.|0
138560|NCT00304031|334345|P1|STARTED|Registration|All patients were registered to concomitant treatment; randomized after completing this treatment.|1173
138561|NCT00304070|334355|P3|NOT COMPLETED|Overall Study||12
138562|NCT00304070|334356|P2|NOT COMPLETED|Overall Study||7
138563|NCT00304070|334357|P1|NOT COMPLETED|Overall Study||3
138564|NCT00304070|334355|P3|COMPLETED|Overall Study||27
138565|NCT00304070|334356|P2|COMPLETED|Overall Study||8
138566|NCT00304070|334357|P1|COMPLETED|Overall Study||21
138567|NCT00304070|334355|P3|STARTED|Overall Study||39
138568|NCT00304070|334356|P2|STARTED|Overall Study||15
138569|NCT00304070|334357|P1|STARTED|Overall Study||24
138570|NCT00304096|334371|P2|NOT COMPLETED|Overall Study||0
138571|NCT00304096|334372|P1|NOT COMPLETED|Overall Study||0
138572|NCT00304096|334371|P2|COMPLETED|Overall Study|6 patients enrolled, 1 not treated|5
138573|NCT00304096|334372|P1|COMPLETED|Overall Study||6
138574|NCT00304096|334371|P2|STARTED|Overall Study||5
138575|NCT00304096|334372|P1|STARTED|Overall Study||6
138576|NCT00304161|334382|P2|NOT COMPLETED|Overall Study||6
138577|NCT00304161|334383|P1|NOT COMPLETED|Overall Study||6
138578|NCT00304161|334382|P2|COMPLETED|Overall Study||21
138579|NCT00304161|334383|P1|COMPLETED|Overall Study||22
138580|NCT00304161|334382|P2|STARTED|Overall Study||27
138581|NCT00304161|334383|P1|STARTED|Overall Study||28
138582|NCT00304187|334393|P2|NOT COMPLETED|Overall Study||1
138583|NCT00304187|334394|P1|NOT COMPLETED|Overall Study||2
138584|NCT00304187|334393|P2|COMPLETED|Overall Study||13
138585|NCT00304187|334394|P1|COMPLETED|Overall Study||13
138586|NCT00304187|334393|P2|STARTED|Overall Study||14
138587|NCT00304187|334394|P1|STARTED|Overall Study||15
138588|NCT00304265|334402|P2|NOT COMPLETED|Overall Study||0
138589|NCT00304265|334403|P1|NOT COMPLETED|Overall Study||0
138590|NCT00304265|334402|P2|COMPLETED|Overall Study||98
138591|NCT00304265|334403|P1|COMPLETED|Overall Study||117
138592|NCT00304265|334402|P2|STARTED|Overall Study||98
138593|NCT00304265|334403|P1|STARTED|Overall Study||117
138594|NCT00304278|334409|P1|NOT COMPLETED|Overall Study||2
138595|NCT00304278|334409|P1|COMPLETED|Overall Study||19
138596|NCT00304278|334409|P1|STARTED|Overall Study||21
138597|NCT00304707|334416|P2|NOT COMPLETED|Overall Study||6
138598|NCT00304707|334417|P1|NOT COMPLETED|Overall Study||7
138599|NCT00304707|334416|P2|COMPLETED|Overall Study||64
138600|NCT00304707|334417|P1|COMPLETED|Overall Study||66
138601|NCT00304707|334416|P2|STARTED|Overall Study||70
138602|NCT00304707|334417|P1|STARTED|Overall Study||73
138603|NCT00304746|334425|P2|NOT COMPLETED|Overall Study||0
138604|NCT00304746|334426|P1|NOT COMPLETED|Overall Study||0
138605|NCT00304746|334425|P2|COMPLETED|Overall Study||50
138606|NCT00304746|334426|P1|COMPLETED|Overall Study||50
138607|NCT00304746|334425|P2|STARTED|Overall Study||50
138608|NCT00304746|334426|P1|STARTED|Overall Study||50
138609|NCT00310791|334436|P2|NOT COMPLETED|Overall Study||10
138610|NCT00310791|334437|P1|NOT COMPLETED|Overall Study||10
138611|NCT00310791|334436|P2|COMPLETED|Overall Study||30
138612|NCT00310791|334437|P1|COMPLETED|Overall Study||30
138613|NCT00310791|334436|P2|STARTED|Overall Study||40
138614|NCT00310791|334437|P1|STARTED|Overall Study||40
138615|NCT00310804|334445|P2|NOT COMPLETED|Overall Study||0
138616|NCT00310804|334446|P1|NOT COMPLETED|Overall Study||5
138617|NCT00310804|334445|P2|COMPLETED|Overall Study||171
138618|NCT00310804|334446|P1|COMPLETED|Overall Study||1024
138619|NCT00310804|334445|P2|STARTED|Overall Study||171
138620|NCT00310804|334446|P1|STARTED|Overall Study||1029
138621|NCT00310817|334483|P4|NOT COMPLETED|Overall Study||8
138622|NCT00310817|334484|P3|NOT COMPLETED|Overall Study||8
138623|NCT00310817|334485|P2|NOT COMPLETED|Overall Study||8
138624|NCT00310817|334486|P1|NOT COMPLETED|Overall Study||11
138625|NCT00310817|334483|P4|COMPLETED|Overall Study||74
138626|NCT00310817|334484|P3|COMPLETED|Overall Study||120
138627|NCT00310817|334485|P2|COMPLETED|Overall Study||198
138628|NCT00310817|334486|P1|COMPLETED|Overall Study||196
138629|NCT00310817|334483|P4|STARTED|Overall Study||82
138630|NCT00310817|334484|P3|STARTED|Overall Study||128
138631|NCT00310817|334485|P2|STARTED|Overall Study||206
138632|NCT00310817|334486|P1|STARTED|Overall Study||207
138633|NCT00310856|334575|P3|NOT COMPLETED|Overall Study||8
138634|NCT00310856|334576|P2|NOT COMPLETED|Overall Study||5
138635|NCT00310856|334577|P1|NOT COMPLETED|Overall Study||5
138636|NCT00310856|334575|P3|COMPLETED|Overall Study||42
138637|NCT00310856|334576|P2|COMPLETED|Overall Study||56
138638|NCT00310856|334577|P1|COMPLETED|Overall Study||59
138639|NCT00310856|334575|P3|STARTED|Overall Study||50
138640|NCT00310856|334576|P2|STARTED|Overall Study||61
138641|NCT00310856|334577|P1|STARTED|Overall Study||64
138642|NCT00318812|334599|P2|NOT COMPLETED|Overall Study||0
138643|NCT00318812|334600|P1|NOT COMPLETED|Overall Study||0
138644|NCT00318812|334599|P2|COMPLETED|Overall Study||22
138645|NCT00318812|334600|P1|COMPLETED|Overall Study||18
138646|NCT00318812|334599|P2|STARTED|Overall Study||22
138647|NCT00318812|334600|P1|STARTED|Overall Study||18
138648|NCT00318929|334610|P1|NOT COMPLETED|Overall Study||0
138649|NCT00318929|334610|P1|COMPLETED|Overall Study||14
138650|NCT00318929|334610|P1|STARTED|Overall Study||14
138651|NCT00319020|334616|P2|NOT COMPLETED|Overall Study||13
138652|NCT00319020|334617|P1|NOT COMPLETED|Overall Study||7
138653|NCT00319020|334616|P2|COMPLETED|Overall Study||8
138654|NCT00319020|334617|P1|COMPLETED|Overall Study||8
138655|NCT00319020|334616|P2|Enrollment in FUTURE 2 (F-2)|Overall Study||20
138656|NCT00319020|334617|P1|Enrollment in FUTURE 2 (F-2)|Overall Study||13
138657|NCT00319020|334616|P2|STARTED|Overall Study||21
138658|NCT00319020|334617|P1|STARTED|Overall Study||15
138659|NCT00319046|334646|P1|NOT COMPLETED|Overall Study||8
138660|NCT00319046|334646|P1|COMPLETED|Overall Study||34
138842|NCT00320528|335239|P2|NOT COMPLETED|Study Period III||31
138661|NCT00319046|334646|P1|STARTED|Overall Study|One patient was excluded from analysis as the baseline liver volume not available|42
138662|NCT00319098|334657|P2|NOT COMPLETED|Overall Study||32
138663|NCT00319098|334658|P1|NOT COMPLETED|Overall Study||135
138664|NCT00319098|334657|P2|COMPLETED|Overall Study||1237
138665|NCT00319098|334658|P1|COMPLETED|Overall Study||3667
138666|NCT00319098|334657|P2|STARTED|Overall Study||1269
138667|NCT00319098|334658|P1|STARTED|Overall Study||3802
138668|NCT00319111|334716|P1|NOT COMPLETED|Overall Study||47
138669|NCT00319111|334716|P1|COMPLETED|Overall Study||104
138670|NCT00319111|334716|P1|STARTED|Overall Study|148 patients enrolled in BENEFIT OL & 3 prematurely discontinued from BENEFIT (NCT00313222)|151
138671|NCT00319254|334726|P1|NOT COMPLETED|Overall Study||54
138672|NCT00319254|334726|P1|COMPLETED|Overall Study||21
138673|NCT00319254|334726|P1|Treated|Overall Study||73
138674|NCT00319254|334726|P1|STARTED|Overall Study||75
138675|NCT00319436|334741|P2|NOT COMPLETED|Overall Study||7
138676|NCT00319436|334742|P1|NOT COMPLETED|Overall Study||6
138677|NCT00319436|334741|P2|COMPLETED|Overall Study||17
138678|NCT00319436|334742|P1|COMPLETED|Overall Study||17
138679|NCT00319436|334741|P2|STARTED|Overall Study||24
138680|NCT00319436|334742|P1|STARTED|Overall Study||23
138681|NCT00319449|334762|P2|NOT COMPLETED|Overall Study||0
138682|NCT00319449|334763|P1|NOT COMPLETED|Overall Study||2
138683|NCT00319449|334762|P2|COMPLETED|Overall Study||12
138684|NCT00319449|334763|P1|COMPLETED|Overall Study||8
138685|NCT00319449|334762|P2|STARTED|Overall Study||12
138686|NCT00319449|334763|P1|STARTED|Overall Study||10
138687|NCT00319501|334775|P2|NOT COMPLETED|Open-label Extension Period||0
138688|NCT00319501|334776|P1|NOT COMPLETED|Open-label Extension Period||51
138689|NCT00319501|334775|P2|COMPLETED|Open-label Extension Period||0
138690|NCT00319501|334776|P1|COMPLETED|Open-label Extension Period||0
138691|NCT00319501|334775|P2|Received Treatment|Open-label Extension Period||0
138692|NCT00319501|334776|P1|Received Treatment|Open-label Extension Period||33
138693|NCT00319501|334775|P2|STARTED|Open-label Extension Period||0
138694|NCT00319501|334776|P1|STARTED|Open-label Extension Period|Eligible participants who chose to continue treatment|51
138695|NCT00319501|334775|P2|NOT COMPLETED|Open-label Period||0
138696|NCT00319501|334776|P1|NOT COMPLETED|Open-label Period||116
138697|NCT00319501|334775|P2|COMPLETED|Open-label Period||0
138698|NCT00319501|334776|P1|COMPLETED|Open-label Period|Competed=continuing treatment|45
138699|NCT00319501|334775|P2|Received Treatment|Open-label Period||0
138700|NCT00319501|334776|P1|Received Treatment|Open-label Period||128
138701|NCT00319501|334775|P2|STARTED|Open-label Period||0
138702|NCT00319501|334776|P1|STARTED|Open-label Period|Participants who continued to meet eligibility requirements|161
138703|NCT00319501|334775|P2|NOT COMPLETED|Double-blind Period||32
138704|NCT00319501|334776|P1|NOT COMPLETED|Double-blind Period||43
138705|NCT00319501|334775|P2|COMPLETED|Double-blind Period||78
138706|NCT00319501|334776|P1|COMPLETED|Double-blind Period||81
138707|NCT00319501|334775|P2|Received Treatment|Double-blind Period||81
138708|NCT00319501|334776|P1|Received Treatment|Double-blind Period||82
138709|NCT00319501|334775|P2|STARTED|Double-blind Period|Randomized participants|110
138710|NCT00319501|334776|P1|STARTED|Double-blind Period|Randomized participants|124
138711|NCT00319553|334802|P2|NOT COMPLETED|Overall Study||4
138712|NCT00319553|334803|P1|NOT COMPLETED|Overall Study||4
138713|NCT00319553|334802|P2|COMPLETED|Overall Study||317
138714|NCT00319553|334803|P1|COMPLETED|Overall Study||319
138715|NCT00319553|334802|P2|STARTED|Overall Study||321
138716|NCT00319553|334803|P1|STARTED|Overall Study||323
138717|NCT00319592|334817|P2|NOT COMPLETED|Overall Study||1
138718|NCT00319592|334818|P1|NOT COMPLETED|Overall Study||1
138719|NCT00319592|334817|P2|COMPLETED|Overall Study||29
138720|NCT00319592|334818|P1|COMPLETED|Overall Study||29
138721|NCT00319592|334817|P2|STARTED|Overall Study||30
138722|NCT00319592|334818|P1|STARTED|Overall Study||30
138723|NCT00319644|334834|P2|NOT COMPLETED|Overall Study||0
138724|NCT00319644|334835|P1|NOT COMPLETED|Overall Study||0
138725|NCT00319644|334834|P2|COMPLETED|Overall Study||16
138726|NCT00319644|334835|P1|COMPLETED|Overall Study||21
138727|NCT00319644|334834|P2|STARTED|Overall Study||16
138728|NCT00319644|334835|P1|STARTED|Overall Study||21
138729|NCT00319696|334843|P1|NOT COMPLETED|Overall Study||60
138730|NCT00319696|334843|P1|COMPLETED|Overall Study||56
138731|NCT00319696|334843|P1|STARTED|Overall Study||116
138732|NCT00319735|334867|P1|NOT COMPLETED|Overall Study||2
138733|NCT00319735|334867|P1|COMPLETED|Overall Study||39
138734|NCT00319735|334867|P1|STARTED|Overall Study||41
138735|NCT00319748|334880|P1|NOT COMPLETED|Overall Study||0
138736|NCT00319748|334880|P1|COMPLETED|Overall Study||13
138737|NCT00319748|334880|P1|STARTED|Overall Study||13
138738|NCT00319982|334892|P2|NOT COMPLETED|Overall Study||0
138739|NCT00319982|334893|P1|NOT COMPLETED|Overall Study||1
138740|NCT00319982|334892|P2|COMPLETED|Overall Study||20
138741|NCT00319982|334893|P1|COMPLETED|Overall Study||18
138742|NCT00319982|334892|P2|STARTED|Overall Study||20
138743|NCT00319982|334893|P1|STARTED|Overall Study||19
138744|NCT00320112|334913|P2|NOT COMPLETED|Overall Study||5
138745|NCT00320112|334914|P1|NOT COMPLETED|Overall Study||8
138746|NCT00320112|334913|P2|COMPLETED|Overall Study||114
138747|NCT00320112|334914|P1|COMPLETED|Overall Study||117
138748|NCT00320112|334913|P2|STARTED|Overall Study||119
138749|NCT00320112|334914|P1|STARTED|Overall Study||125
138750|NCT00320190|334928|P2|NOT COMPLETED|Long-term (12-month) Extension||2
138751|NCT00320190|334929|P1|NOT COMPLETED|Long-term (12-month) Extension||9
138752|NCT00320190|334928|P2|COMPLETED|Long-term (12-month) Extension||1
138753|NCT00320190|334929|P1|COMPLETED|Long-term (12-month) Extension||2
138754|NCT00320190|334928|P2|STARTED|Long-term (12-month) Extension||3
138755|NCT00320190|334929|P1|STARTED|Long-term (12-month) Extension||11
138756|NCT00320190|334928|P2|NOT COMPLETED|First 12 Months||10
138757|NCT00320190|334929|P1|NOT COMPLETED|First 12 Months||8
138758|NCT00320190|334928|P2|COMPLETED|First 12 Months||3
138759|NCT00320190|334929|P1|COMPLETED|First 12 Months||11
138760|NCT00320190|334928|P2|STARTED|First 12 Months||13
138761|NCT00320190|334929|P1|STARTED|First 12 Months||19
138762|NCT00320216|334952|P5|NOT COMPLETED|Overall Study||6
138763|NCT00320216|334953|P4|NOT COMPLETED|Overall Study||3
138764|NCT00320216|334954|P3|NOT COMPLETED|Overall Study||6
138765|NCT00320216|334955|P2|NOT COMPLETED|Overall Study||10
138766|NCT00320216|334956|P1|NOT COMPLETED|Overall Study||16
138767|NCT00320216|334952|P5|COMPLETED|Overall Study||58
138768|NCT00320216|334953|P4|COMPLETED|Overall Study||61
138769|NCT00320216|334954|P3|COMPLETED|Overall Study||58
138770|NCT00320216|334955|P2|COMPLETED|Overall Study||54
138771|NCT00320216|334956|P1|COMPLETED|Overall Study||48
138772|NCT00320216|334952|P5|STARTED|Overall Study||64
138773|NCT00320216|334953|P4|STARTED|Overall Study||64
138774|NCT00320216|334954|P3|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
138775|NCT00320216|334955|P2|STARTED|Overall Study|1 patient randomized but not treated was included as discontinued due to Other reason.|64
138776|NCT00320216|334956|P1|STARTED|Overall Study||64
138777|NCT00320242|334988|P2|NOT COMPLETED|Overall Study||4
138778|NCT00320242|334989|P1|NOT COMPLETED|Overall Study||2
138779|NCT00320242|334988|P2|COMPLETED|Overall Study||12
138780|NCT00320242|334989|P1|COMPLETED|Overall Study||14
138781|NCT00320242|334988|P2|STARTED|Overall Study||16
138782|NCT00320242|334989|P1|STARTED|Overall Study||16
138783|NCT00320255|335002|P6|NOT COMPLETED|Overall Study||0
138784|NCT00320255|335003|P5|NOT COMPLETED|Overall Study||0
138785|NCT00320255|335004|P4|NOT COMPLETED|Overall Study||8
138786|NCT00320255|335005|P3|NOT COMPLETED|Overall Study||6
138787|NCT00320255|335006|P2|NOT COMPLETED|Overall Study||7
138788|NCT00320255|335007|P1|NOT COMPLETED|Overall Study||11
138789|NCT00320255|335002|P6|COMPLETED|Overall Study||3
138790|NCT00320255|335003|P5|COMPLETED|Overall Study||2
138791|NCT00320255|335004|P4|COMPLETED|Overall Study||25
138792|NCT00320255|335005|P3|COMPLETED|Overall Study||24
138793|NCT00320255|335006|P2|COMPLETED|Overall Study||25
138794|NCT00320255|335007|P1|COMPLETED|Overall Study||19
138795|NCT00320255|335002|P6|Received Treatment|Overall Study||3
138796|NCT00320255|335003|P5|Received Treatment|Overall Study||2
138797|NCT00320255|335004|P4|Received Treatment|Overall Study||32
138798|NCT00320255|335005|P3|Received Treatment|Overall Study||29
138799|NCT00320255|335006|P2|Received Treatment|Overall Study||32
138800|NCT00320255|335007|P1|Received Treatment|Overall Study||29
138801|NCT00320255|335002|P6|STARTED|Overall Study||3
138802|NCT00320255|335003|P5|STARTED|Overall Study||2
138803|NCT00320255|335004|P4|STARTED|Overall Study||33
138804|NCT00320255|335005|P3|STARTED|Overall Study||30
138805|NCT00320255|335006|P2|STARTED|Overall Study||32
138806|NCT00320255|335007|P1|STARTED|Overall Study||30
138807|NCT00320281|335089|P2|NOT COMPLETED|Overall Study||0
138808|NCT00320281|335090|P1|NOT COMPLETED|Overall Study||0
138809|NCT00320281|335089|P2|COMPLETED|Overall Study||9
138810|NCT00320281|335090|P1|COMPLETED|Overall Study||10
138811|NCT00320281|335089|P2|STARTED|Overall Study||9
138812|NCT00320281|335090|P1|STARTED|Overall Study||10
138813|NCT00320372|335099|P2|NOT COMPLETED|Overall Study||163
138814|NCT00320372|335100|P1|NOT COMPLETED|Overall Study||195
138815|NCT00320372|335099|P2|COMPLETED|Overall Study||138
138816|NCT00320372|335100|P1|COMPLETED|Overall Study||299
138817|NCT00320372|335099|P2|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||0
138818|NCT00320372|335100|P1|VNS Therapy D-21 (NCT00305565) Rollovers|Overall Study||159
138819|NCT00320372|335099|P2|VNS Therapy D-23 Original|Overall Study||0
138820|NCT00320372|335100|P1|VNS Therapy D-23 Original|Overall Study||335
138821|NCT00320372|335099|P2|STARTED|Overall Study||301
138822|NCT00320372|335100|P1|STARTED|Overall Study||494
138823|NCT00320385|335127|P2|NOT COMPLETED|Overall Study||22
138824|NCT00320385|335128|P1|NOT COMPLETED|Overall Study||18
138825|NCT00320385|335127|P2|COMPLETED|Overall Study||126
138826|NCT00320385|335128|P1|COMPLETED|Overall Study||130
138827|NCT00320385|335127|P2|STARTED|Overall Study||148
138828|NCT00320385|335128|P1|STARTED|Overall Study||148
138829|NCT00320411|335148|P1|NOT COMPLETED|Overall Study||4
138830|NCT00320411|335148|P1|COMPLETED|Overall Study||58
138831|NCT00320411|335148|P1|STARTED|Overall Study||62
138832|NCT00320489|335171|P2|NOT COMPLETED|Overall Study||136
138833|NCT00320489|335172|P1|NOT COMPLETED|Overall Study||145
138834|NCT00320489|335171|P2|COMPLETED|Overall Study||124
138835|NCT00320489|335172|P1|COMPLETED|Overall Study||119
138836|NCT00320489|335171|P2|STARTED|Overall Study||260
138837|NCT00320489|335172|P1|STARTED|Overall Study||264
138838|NCT00320515|335228|P1|NOT COMPLETED|Overall Study||49
138839|NCT00320515|335228|P1|COMPLETED|Overall Study||20
138840|NCT00320515|335228|P1|STARTED|Overall Study||69
138841|NCT00320528|335238|P3|NOT COMPLETED|Study Period III||106
138843|NCT00320528|335240|P1|NOT COMPLETED|Study Period III||87
138844|NCT00320528|335238|P3|COMPLETED|Study Period III||2
138845|NCT00320528|335239|P2|COMPLETED|Study Period III||0
138846|NCT00320528|335240|P1|COMPLETED|Study Period III||0
138847|NCT00320528|335238|P3|STARTED|Study Period III||108
138848|NCT00320528|335239|P2|STARTED|Study Period III||31
138849|NCT00320528|335240|P1|STARTED|Study Period III||87
138850|NCT00320528|335238|P3|NOT COMPLETED|Study Period II||22
138851|NCT00320528|335239|P2|NOT COMPLETED|Study Period II||10
138852|NCT00320528|335240|P1|NOT COMPLETED|Study Period II||11
138853|NCT00320528|335238|P3|COMPLETED|Study Period II||108
138854|NCT00320528|335239|P2|COMPLETED|Study Period II||31
138855|NCT00320528|335240|P1|COMPLETED|Study Period II||87
138856|NCT00320528|335238|P3|Received at Least One Dose of Study Drug|Study Period II||128
138857|NCT00320528|335239|P2|Received at Least One Dose of Study Drug|Study Period II||38
138858|NCT00320528|335240|P1|Received at Least One Dose of Study Drug|Study Period II||97
138859|NCT00320528|335238|P3|STARTED|Study Period II||130
138860|NCT00320528|335239|P2|STARTED|Study Period II||41
138861|NCT00320528|335240|P1|STARTED|Study Period II||98
138862|NCT00320541|335277|P2|NOT COMPLETED|Overall Study||57
138863|NCT00320541|335278|P1|NOT COMPLETED|Overall Study||50
138864|NCT00320541|335277|P2|COMPLETED|Overall Study||36
138865|NCT00320541|335278|P1|COMPLETED|Overall Study||44
138866|NCT00320541|335277|P2|STARTED|Overall Study||93
138867|NCT00320541|335278|P1|STARTED|Overall Study||94
138868|NCT00320593|335304|P2|NOT COMPLETED|Overall Study||1
138869|NCT00320593|335305|P1|NOT COMPLETED|Overall Study||7
138870|NCT00320593|335304|P2|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|58
138871|NCT00320593|335305|P1|COMPLETED|Overall Study|Completed defined as completing the 3 year primary outcome exam|52
138872|NCT00320593|335304|P2|STARTED|Overall Study||59
138873|NCT00320593|335305|P1|STARTED|Overall Study||59
138874|NCT00320606|335327|P1|NOT COMPLETED|Overall Study||14
138875|NCT00320606|335327|P1|COMPLETED|Overall Study|2 discontinued early, 12 ongoing in study|6
138876|NCT00320606|335327|P1|STARTED|Overall Study||20
138877|NCT00320671|335333|P2|NOT COMPLETED|Overall Study||38
138878|NCT00320671|335334|P1|NOT COMPLETED|Overall Study||33
138879|NCT00320671|335333|P2|COMPLETED|Overall Study||58
138880|NCT00320671|335334|P1|COMPLETED|Overall Study||69
138881|NCT00320671|335333|P2|STARTED|Overall Study||96
138882|NCT00320671|335334|P1|STARTED|Overall Study||102
138883|NCT00320710|335343|P3|NOT COMPLETED|Overall Study||5
138884|NCT00320710|335344|P2|NOT COMPLETED|Overall Study||76
138885|NCT00320710|335345|P1|NOT COMPLETED|Overall Study||94
138886|NCT00320710|335343|P3|COMPLETED|Overall Study||8
138887|NCT00320710|335344|P2|COMPLETED|Overall Study||127
138888|NCT00320710|335345|P1|COMPLETED|Overall Study||106
138889|NCT00320710|335343|P3|Treated (Safety Set)|Overall Study||13
138890|NCT00320710|335344|P2|Treated (Safety Set)|Overall Study||202
138891|NCT00320710|335345|P1|Treated (Safety Set)|Overall Study||198
138892|NCT00320710|335343|P3|STARTED|Overall Study||13
138893|NCT00320710|335344|P2|STARTED|Overall Study||203
138894|NCT00320710|335345|P1|STARTED|Overall Study||200
138895|NCT00320749|335366|P3|NOT COMPLETED|Overall Study||9
138896|NCT00320749|335367|P2|NOT COMPLETED|Overall Study||2
138897|NCT00320749|335368|P1|NOT COMPLETED|Overall Study||0
138898|NCT00320749|335366|P3|COMPLETED|Overall Study||1
138899|NCT00320749|335367|P2|COMPLETED|Overall Study||6
138900|NCT00320749|335368|P1|COMPLETED|Overall Study||3
138901|NCT00320749|335366|P3|STARTED|Overall Study||10
138902|NCT00320749|335367|P2|STARTED|Overall Study||8
138903|NCT00320749|335368|P1|STARTED|Overall Study||3
138904|NCT00320788|335379|P5|NOT COMPLETED|Overall Study||5
138905|NCT00320788|335380|P4|NOT COMPLETED|Overall Study||5
138906|NCT00320788|335381|P3|NOT COMPLETED|Overall Study||3
138907|NCT00320788|335382|P2|NOT COMPLETED|Overall Study||6
138908|NCT00320788|335383|P1|NOT COMPLETED|Overall Study||6
138909|NCT00320788|335379|P5|COMPLETED|Overall Study||26
138910|NCT00320788|335380|P4|COMPLETED|Overall Study||27
138911|NCT00320788|335381|P3|COMPLETED|Overall Study||29
138912|NCT00320788|335382|P2|COMPLETED|Overall Study||26
138913|NCT00320788|335383|P1|COMPLETED|Overall Study||26
138914|NCT00320788|335379|P5|Participants Received Treatment (SAF)|Overall Study||31
138915|NCT00320788|335380|P4|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
138916|NCT00320788|335381|P3|Participants Received Treatment (SAF)|Overall Study|One participant in this group did not receive treatment and was not included in the SAF and FAS|31
138917|NCT00320788|335382|P2|Participants Received Treatment (SAF)|Overall Study||32
138918|NCT00320788|335383|P1|Participants Received Treatment (SAF)|Overall Study||32
138919|NCT00320788|335379|P5|STARTED|Overall Study||31
138920|NCT00320788|335380|P4|STARTED|Overall Study|Participants Randomized|32
138921|NCT00320788|335381|P3|STARTED|Overall Study||32
138922|NCT00320788|335382|P2|STARTED|Overall Study||32
138923|NCT00320788|335383|P1|STARTED|Overall Study||32
138924|NCT00320801|335428|P4|NOT COMPLETED|Extension Phase||48
138925|NCT00320801|335429|P3|NOT COMPLETED|Extension Phase||0
138926|NCT00320801|335430|P2|NOT COMPLETED|Extension Phase||0
138927|NCT00320801|335431|P1|NOT COMPLETED|Extension Phase||0
138928|NCT00320801|335428|P4|COMPLETED|Extension Phase||7
138929|NCT00320801|335429|P3|COMPLETED|Extension Phase||0
138930|NCT00320801|335430|P2|COMPLETED|Extension Phase||0
138931|NCT00320801|335431|P1|COMPLETED|Extension Phase||0
138932|NCT00320801|335428|P4|STARTED|Extension Phase||55
138933|NCT00320801|335429|P3|STARTED|Extension Phase||0
138934|NCT00320801|335430|P2|STARTED|Extension Phase||0
138935|NCT00320801|335431|P1|STARTED|Extension Phase||0
138936|NCT00320801|335428|P4|NOT COMPLETED|Double-blind Phase||0
138937|NCT00320801|335429|P3|NOT COMPLETED|Double-blind Phase||14
138938|NCT00320801|335430|P2|NOT COMPLETED|Double-blind Phase||11
138939|NCT00320801|335431|P1|NOT COMPLETED|Double-blind Phase||0
138940|NCT00320801|335428|P4|COMPLETED|Double-blind Phase||0
138941|NCT00320801|335429|P3|COMPLETED|Double-blind Phase||35
138942|NCT00320801|335430|P2|COMPLETED|Double-blind Phase||36
138943|NCT00320801|335431|P1|COMPLETED|Double-blind Phase||0
138944|NCT00320801|335428|P4|STARTED|Double-blind Phase||0
138945|NCT00320801|335429|P3|STARTED|Double-blind Phase||49
138946|NCT00320801|335430|P2|STARTED|Double-blind Phase||47
138947|NCT00320801|335431|P1|STARTED|Double-blind Phase||0
138948|NCT00320801|335428|P4|NOT COMPLETED|Open-label Run-in Period||0
138949|NCT00320801|335429|P3|NOT COMPLETED|Open-label Run-in Period||0
138950|NCT00320801|335430|P2|NOT COMPLETED|Open-label Run-in Period||0
138951|NCT00320801|335431|P1|NOT COMPLETED|Open-label Run-in Period||92
138952|NCT00320801|335428|P4|COMPLETED|Open-label Run-in Period||0
138953|NCT00320801|335429|P3|COMPLETED|Open-label Run-in Period||0
138954|NCT00320801|335430|P2|COMPLETED|Open-label Run-in Period||0
138955|NCT00320801|335431|P1|COMPLETED|Open-label Run-in Period||96
138956|NCT00320801|335428|P4|STARTED|Open-label Run-in Period||0
138957|NCT00320801|335429|P3|STARTED|Open-label Run-in Period||0
138958|NCT00320801|335430|P2|STARTED|Open-label Run-in Period||0
138959|NCT00320801|335431|P1|STARTED|Open-label Run-in Period||188
138960|NCT00321269|335443|P2|NOT COMPLETED|Overall Study||6
138961|NCT00321269|335444|P1|NOT COMPLETED|Overall Study||8
138962|NCT00321269|335443|P2|COMPLETED|Overall Study||68
138963|NCT00321269|335444|P1|COMPLETED|Overall Study||66
138964|NCT00321269|335443|P2|STARTED|Overall Study||74
138965|NCT00321269|335444|P1|STARTED|Overall Study||74
138966|NCT00307684|335452|P3|NOT COMPLETED|Double Blind Phase||0
138967|NCT00307684|335453|P2|NOT COMPLETED|Double Blind Phase||5
138968|NCT00307684|335454|P1|NOT COMPLETED|Double Blind Phase||2
138969|NCT00307684|335452|P3|COMPLETED|Double Blind Phase||0
138970|NCT00307684|335453|P2|COMPLETED|Double Blind Phase||17
138971|NCT00307684|335454|P1|COMPLETED|Double Blind Phase||21
138972|NCT00307684|335452|P3|STARTED|Double Blind Phase||0
138973|NCT00307684|335453|P2|STARTED|Double Blind Phase||22
138974|NCT00307684|335454|P1|STARTED|Double Blind Phase||23
138975|NCT00307684|335452|P3|NOT COMPLETED|Open Label Phase||56
138976|NCT00307684|335453|P2|NOT COMPLETED|Open Label Phase||0
138977|NCT00307684|335454|P1|NOT COMPLETED|Open Label Phase||0
138978|NCT00307684|335452|P3|COMPLETED|Open Label Phase||99
138979|NCT00307684|335453|P2|COMPLETED|Open Label Phase||0
138980|NCT00307684|335454|P1|COMPLETED|Open Label Phase||0
138981|NCT00307684|335452|P3|STARTED|Open Label Phase|1 screening failure|155
138982|NCT00307684|335453|P2|STARTED|Open Label Phase||0
138983|NCT00307684|335454|P1|STARTED|Open Label Phase||0
138984|NCT00307736|335480|P4|NOT COMPLETED|Overall Study||3
138985|NCT00307736|335481|P3|NOT COMPLETED|Overall Study||3
138986|NCT00307736|335482|P2|NOT COMPLETED|Overall Study||0
138987|NCT00307736|335483|P1|NOT COMPLETED|Overall Study||0
138988|NCT00307736|335480|P4|COMPLETED|Overall Study||20
138989|NCT00307736|335481|P3|COMPLETED|Overall Study||0
138990|NCT00307736|335482|P2|COMPLETED|Overall Study||3
138991|NCT00307736|335483|P1|COMPLETED|Overall Study||3
138992|NCT00307736|335480|P4|STARTED|Overall Study||23
138993|NCT00307736|335481|P3|STARTED|Overall Study||3
138994|NCT00307736|335482|P2|STARTED|Overall Study||3
138995|NCT00307736|335483|P1|STARTED|Overall Study||3
138996|NCT00307801|335496|P2|NOT COMPLETED|Overall Study||17
138997|NCT00307801|335497|P1|NOT COMPLETED|Overall Study||32
138998|NCT00307801|335496|P2|COMPLETED|Overall Study||65
138999|NCT00307801|335497|P1|COMPLETED|Overall Study||117
139000|NCT00307801|335496|P2|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|77
139001|NCT00307801|335497|P1|Cycle 7, Treatment Day 196|Overall Study|Includes subjects that prematurely discontinued the study and may not be counted in earlier visits.|141
139002|NCT00307801|335496|P2|Cycle 3, Visit 7, Treatment Day 84|Overall Study||71
139003|NCT00307801|335497|P1|Cycle 3, Visit 7, Treatment Day 84|Overall Study||130
139004|NCT00307801|335496|P2|Cycle 1, Visit 5, Baseline|Overall Study||81
139005|NCT00307801|335497|P1|Cycle 1, Visit 5, Baseline|Overall Study||145
139006|NCT00307801|335496|P2|Subjects Received Treatment|Overall Study||81
139007|NCT00307801|335497|P1|Subjects Received Treatment|Overall Study||145
139008|NCT00307801|335496|P2|STARTED|Overall Study||82
139009|NCT00307801|335497|P1|STARTED|Overall Study||149
139010|NCT00307931|335609|P1|NOT COMPLETED|Overall Study||1
139011|NCT00307931|335609|P1|COMPLETED|Overall Study|Number of subjects who completed the Week 12 visit|15
139012|NCT00307931|335609|P1|STARTED|Overall Study|Number of subjects who entered the study and have been treated|16
139013|NCT00308061|335626|P2|NOT COMPLETED|Overall Study||0
139014|NCT00308061|335627|P1|NOT COMPLETED|Overall Study||0
139015|NCT00308061|335626|P2|COMPLETED|Overall Study||20
139016|NCT00308061|335627|P1|COMPLETED|Overall Study||20
139017|NCT00308061|335626|P2|STARTED|Overall Study||20
139018|NCT00308061|335627|P1|STARTED|Overall Study||20
139019|NCT00308074|335634|P1|NOT COMPLETED|Overall Study||1
139020|NCT00308074|335634|P1|COMPLETED|Overall Study||13
139021|NCT00308074|335634|P1|STARTED|Overall Study||14
139022|NCT00308087|335643|P2|NOT COMPLETED|Overall Study||37
139023|NCT00308087|335644|P1|NOT COMPLETED|Overall Study||36
139024|NCT00308087|335643|P2|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
139025|NCT00308087|335644|P1|COMPLETED|Overall Study|Completers finished treatment and the 24 month follow-up.|1
139026|NCT00308087|335643|P2|STARTED|Overall Study||38
139027|NCT00308087|335644|P1|STARTED|Overall Study||37
139028|NCT00321321|335660|P1|NOT COMPLETED|Overall Study||0
139029|NCT00321321|335660|P1|COMPLETED|Overall Study||12
139030|NCT00321321|335660|P1|STARTED|Overall Study||12
139031|NCT00321373|335667|P3|NOT COMPLETED|Overall Study||3
139032|NCT00321373|335668|P2|NOT COMPLETED|Overall Study||0
139033|NCT00321373|335669|P1|NOT COMPLETED|Overall Study||2
139034|NCT00321373|335667|P3|COMPLETED|Overall Study||404
139035|NCT00321373|335668|P2|COMPLETED|Overall Study||406
139036|NCT00321373|335669|P1|COMPLETED|Overall Study||405
139037|NCT00321373|335667|P3|STARTED|Overall Study||407
139038|NCT00321373|335668|P2|STARTED|Overall Study||406
139039|NCT00321373|335669|P1|STARTED|Overall Study||407
139040|NCT00321464|335694|P2|NOT COMPLETED|Overall Study||558
139041|NCT00321464|335695|P1|NOT COMPLETED|Overall Study||559
139042|NCT00321464|335694|P2|COMPLETED|Overall Study||468
139043|NCT00321464|335695|P1|COMPLETED|Overall Study||461
139044|NCT00321464|335694|P2|Received Investigational Product|Overall Study||1019
139045|NCT00321464|335695|P1|Received Investigational Product|Overall Study||1014
139046|NCT00321464|335694|P2|STARTED|Overall Study||1026
139047|NCT00321464|335695|P1|STARTED|Overall Study||1020
139048|NCT00321620|335707|P2|NOT COMPLETED|Overall Study||722
139049|NCT00321620|335708|P1|NOT COMPLETED|Overall Study||743
139050|NCT00321620|335707|P2|COMPLETED|Overall Study||228
139051|NCT00321620|335708|P1|COMPLETED|Overall Study||208
139052|NCT00321620|335707|P2|Received Investigational Product|Overall Study||942
139053|NCT00321620|335708|P1|Received Investigational Product|Overall Study||946
139054|NCT00321620|335707|P2|STARTED|Overall Study||950
139055|NCT00321620|335708|P1|STARTED|Overall Study||951
139056|NCT00327392|335718|P1|NOT COMPLETED|Overall Study||0
139057|NCT00327392|335718|P1|COMPLETED|Overall Study||123
139058|NCT00327392|335718|P1|STARTED|Overall Study||123
139059|NCT00327444|335724|P2|NOT COMPLETED|Open Label Treatment (OL) Period||10
139060|NCT00327444|335725|P1|NOT COMPLETED|Open Label Treatment (OL) Period||11
139061|NCT00327444|335724|P2|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
139062|NCT00327444|335725|P1|COMPLETED|Open Label Treatment (OL) Period|All participants were treated till they met treatment discontinuation criteria|0
139063|NCT00327444|335724|P2|ONGOING TREATMENT|Open Label Treatment (OL) Period||0
139064|NCT00327444|335725|P1|ONGOING TREATMENT|Open Label Treatment (OL) Period||1
139065|NCT00327444|335724|P2|STARTED|Open Label Treatment (OL) Period||10
139066|NCT00327444|335725|P1|STARTED|Open Label Treatment (OL) Period||11
139067|NCT00327444|335724|P2|NOT COMPLETED|Double Blind Treatment (DB) Period||29
139068|NCT00327444|335725|P1|NOT COMPLETED|Double Blind Treatment (DB) Period||26
139069|NCT00327444|335724|P2|COMPLETED|Double Blind Treatment (DB) Period||0
139070|NCT00327444|335725|P1|COMPLETED|Double Blind Treatment (DB) Period||0
139071|NCT00327444|335724|P2|SAFETY|Double Blind Treatment (DB) Period|Includes 1 from Placebo who received aflibercept in DB period|30
139072|NCT00327444|335725|P1|SAFETY|Double Blind Treatment (DB) Period|Excludes one participant from the Placebo arm who received aflibercept in error in the DB period.|25
139073|NCT00327444|335724|P2|STARTED|Double Blind Treatment (DB) Period||29
139074|NCT00327444|335725|P1|STARTED|Double Blind Treatment (DB) Period||26
139075|NCT00327470|335739|P2|NOT COMPLETED|Overall Study||63
139076|NCT00327470|335740|P1|NOT COMPLETED|Overall Study||29
139077|NCT00327470|335739|P2|COMPLETED|Overall Study||118
139078|NCT00327470|335740|P1|COMPLETED|Overall Study||78
139079|NCT00327470|335739|P2|Treated|Overall Study||179
139080|NCT00327470|335740|P1|Treated|Overall Study||107
139081|NCT00327470|335739|P2|STARTED|Overall Study||181
139082|NCT00327470|335740|P1|STARTED|Overall Study||107
139083|NCT00327717|335760|P2|NOT COMPLETED|Overall Study||14
139084|NCT00327717|335761|P1|NOT COMPLETED|Overall Study||9
139085|NCT00327717|335760|P2|COMPLETED|Overall Study||106
139086|NCT00327717|335761|P1|COMPLETED|Overall Study||111
139087|NCT00327717|335760|P2|STARTED|Overall Study||120
139088|NCT00327717|335761|P1|STARTED|Overall Study||120
139089|NCT00328016|335787|P2|NOT COMPLETED|Overall Study||0
139090|NCT00328016|335788|P1|NOT COMPLETED|Overall Study||0
139091|NCT00328016|335787|P2|COMPLETED|Overall Study||21
139092|NCT00328016|335788|P1|COMPLETED|Overall Study||23
139093|NCT00328016|335787|P2|STARTED|Overall Study||21
139094|NCT00328016|335788|P1|STARTED|Overall Study||23
139095|NCT00328042|335800|P2|NOT COMPLETED|Overall Study||2
139096|NCT00328042|335801|P1|NOT COMPLETED|Overall Study||0
139097|NCT00328042|335800|P2|COMPLETED|Overall Study||63
139098|NCT00328042|335801|P1|COMPLETED|Overall Study||69
139099|NCT00328042|335800|P2|STARTED|Overall Study||65
139100|NCT00328042|335801|P1|STARTED|Overall Study||69
139101|NCT00328094|335811|P2|NOT COMPLETED|Overall Study||3
139102|NCT00328094|335812|P1|NOT COMPLETED|Overall Study||3
139103|NCT00328094|335811|P2|COMPLETED|Overall Study|3 did not receive interevention. 1 post induction arrest. 1 case cancelled.|122
139104|NCT00328094|335812|P1|COMPLETED|Overall Study|2 did not receive intervention. 1 patient refusal|114
139105|NCT00328094|335811|P2|STARTED|Overall Study||125
139106|NCT00328094|335812|P1|STARTED|Overall Study||117
139107|NCT00328172|335825|P5|NOT COMPLETED|Overall Study||5
139108|NCT00328172|335826|P4|NOT COMPLETED|Overall Study||13
139109|NCT00328172|335827|P3|NOT COMPLETED|Overall Study||10
139110|NCT00328172|335828|P2|NOT COMPLETED|Overall Study||14
139111|NCT00328172|335829|P1|NOT COMPLETED|Overall Study||22
139112|NCT00328172|335825|P5|COMPLETED|Overall Study||60
139113|NCT00328172|335826|P4|COMPLETED|Overall Study||42
139114|NCT00328172|335827|P3|COMPLETED|Overall Study||47
139115|NCT00328172|335828|P2|COMPLETED|Overall Study||44
139116|NCT00328172|335829|P1|COMPLETED|Overall Study||45
139117|NCT00328172|335825|P5|STARTED|Overall Study||65
139118|NCT00328172|335826|P4|STARTED|Overall Study||55
139119|NCT00328172|335827|P3|STARTED|Overall Study||57
139120|NCT00328172|335828|P2|STARTED|Overall Study||58
139121|NCT00328172|335829|P1|STARTED|Overall Study||67
139122|NCT00328198|335851|P1|NOT COMPLETED|Follow-up||35
139123|NCT00328198|335851|P1|COMPLETED|Follow-up||43
139124|NCT00328198|335851|P1|STARTED|Follow-up|Eight participants did not enter Follow-up|78
139125|NCT00328198|335851|P1|NOT COMPLETED|Treatment||38
139126|NCT00328198|335851|P1|COMPLETED|Treatment|Depending upon protocol version, completed treatment was either 12 or 18 weeks in duration.|48
139127|NCT00328198|335851|P1|STARTED|Treatment|16 participants escalated the dose. 70 participants started at the 30 mg target dose.|86
139128|NCT00328263|335863|P2|NOT COMPLETED|Overall Study||4
139129|NCT00328263|335864|P1|NOT COMPLETED|Overall Study||3
139130|NCT00328263|335863|P2|COMPLETED|Overall Study|4 deaths occured during the study. None of the deaths were causally related to the study product.|217
139131|NCT00328263|335864|P1|COMPLETED|Overall Study|3 deaths occured during the study. None of the deaths were causally related to the study product.|213
139132|NCT00328263|335863|P2|STARTED|Overall Study||221
139133|NCT00328263|335864|P1|STARTED|Overall Study||216
139134|NCT00328510|335872|P2|NOT COMPLETED|Overall Study||4
139135|NCT00328510|335873|P1|NOT COMPLETED|Overall Study||10
139136|NCT00328510|335872|P2|COMPLETED|Overall Study||37
139137|NCT00328510|335873|P1|COMPLETED|Overall Study||32
139138|NCT00328510|335872|P2|STARTED|Overall Study||41
139139|NCT00328510|335873|P1|STARTED|Overall Study||42
139140|NCT00328562|335879|P1|NOT COMPLETED|Overall Study||1
139141|NCT00328562|335879|P1|COMPLETED|Overall Study||12
139142|NCT00328562|335879|P1|STARTED|Overall Study||13
139143|NCT00328614|335892|P6|NOT COMPLETED|Overall Study||1
139144|NCT00328614|335893|P5|NOT COMPLETED|Overall Study||1
139145|NCT00328614|335894|P4|NOT COMPLETED|Overall Study||1
139146|NCT00328614|335895|P3|NOT COMPLETED|Overall Study||0
139147|NCT00328614|335896|P2|NOT COMPLETED|Overall Study||0
139148|NCT00328614|335897|P1|NOT COMPLETED|Overall Study||0
139149|NCT00328614|335892|P6|COMPLETED|Overall Study||5
139150|NCT00328614|335893|P5|COMPLETED|Overall Study||5
139151|NCT00328614|335894|P4|COMPLETED|Overall Study||5
139152|NCT00328614|335895|P3|COMPLETED|Overall Study||6
139153|NCT00328614|335896|P2|COMPLETED|Overall Study||4
139154|NCT00328614|335897|P1|COMPLETED|Overall Study||4
139155|NCT00328614|335892|P6|STARTED|Overall Study||6
139156|NCT00328614|335893|P5|STARTED|Overall Study||6
139157|NCT00328614|335894|P4|STARTED|Overall Study||6
139158|NCT00328614|335895|P3|STARTED|Overall Study||6
139159|NCT00328614|335896|P2|STARTED|Overall Study||4
139160|NCT00328614|335897|P1|STARTED|Overall Study||4
139161|NCT00328627|335918|P12|NOT COMPLETED|Overall Study||16
139162|NCT00328627|335919|P11|NOT COMPLETED|Overall Study||18
139163|NCT00328627|335920|P10|NOT COMPLETED|Overall Study||32
139164|NCT00328627|335921|P9|NOT COMPLETED|Overall Study||17
139165|NCT00328627|335922|P8|NOT COMPLETED|Overall Study||14
139166|NCT00328627|335923|P7|NOT COMPLETED|Overall Study||35
139167|NCT00328627|335924|P6|NOT COMPLETED|Overall Study||20
139168|NCT00328627|335925|P5|NOT COMPLETED|Overall Study||15
139169|NCT00328627|335926|P4|NOT COMPLETED|Overall Study||37
139170|NCT00328627|335927|P3|NOT COMPLETED|Overall Study||28
139171|NCT00328627|335928|P2|NOT COMPLETED|Overall Study||31
139172|NCT00328627|335929|P1|NOT COMPLETED|Overall Study||59
139173|NCT00328627|335918|P12|COMPLETED|Overall Study||114
139174|NCT00328627|335919|P11|COMPLETED|Overall Study||112
139175|NCT00328627|335920|P10|COMPLETED|Overall Study||97
139176|NCT00328627|335921|P9|COMPLETED|Overall Study||113
139177|NCT00328627|335922|P8|COMPLETED|Overall Study||116
139178|NCT00328627|335923|P7|COMPLETED|Overall Study||94
139179|NCT00328627|335924|P6|COMPLETED|Overall Study||110
139180|NCT00328627|335925|P5|COMPLETED|Overall Study||115
139181|NCT00328627|335926|P4|COMPLETED|Overall Study||93
139182|NCT00328627|335927|P3|COMPLETED|Overall Study||101
139183|NCT00328627|335928|P2|COMPLETED|Overall Study||97
139184|NCT00328627|335929|P1|COMPLETED|Overall Study||70
139185|NCT00328627|335918|P12|Safety Set|Overall Study||130
139186|NCT00328627|335919|P11|Safety Set|Overall Study||130
139187|NCT00328627|335920|P10|Safety Set|Overall Study||129
139188|NCT00328627|335921|P9|Safety Set|Overall Study||130
139189|NCT00328627|335922|P8|Safety Set|Overall Study||130
139190|NCT00328627|335923|P7|Safety Set|Overall Study||129
139191|NCT00328627|335924|P6|Safety Set|Overall Study||130
139192|NCT00328627|335925|P5|Safety Set|Overall Study||130
139193|NCT00328627|335926|P4|Safety Set|Overall Study||129
139194|NCT00328627|335927|P3|Safety Set|Overall Study||129
139195|NCT00328627|335928|P2|Safety Set|Overall Study||128
139282|NCT00329524|337971|P1|STARTED|Overall Study||5
139196|NCT00328627|335929|P1|Safety Set|Overall Study|All patients who took at least 1 dose of double-blind study drug.|129
139197|NCT00328627|335918|P12|STARTED|Overall Study||130
139198|NCT00328627|335919|P11|STARTED|Overall Study||130
139199|NCT00328627|335920|P10|STARTED|Overall Study||129
139200|NCT00328627|335921|P9|STARTED|Overall Study||130
139201|NCT00328627|335922|P8|STARTED|Overall Study||130
139202|NCT00328627|335923|P7|STARTED|Overall Study||129
139203|NCT00328627|335924|P6|STARTED|Overall Study||130
139204|NCT00328627|335925|P5|STARTED|Overall Study||130
139205|NCT00328627|335926|P4|STARTED|Overall Study||130
139206|NCT00328627|335927|P3|STARTED|Overall Study||129
139207|NCT00328627|335928|P2|STARTED|Overall Study||128
139208|NCT00328627|335929|P1|STARTED|Overall Study||129
139209|NCT00328770|337446|P1|NOT COMPLETED|Overall Study||0
139210|NCT00328770|337446|P1|COMPLETED|Overall Study||70
139211|NCT00328770|337446|P1|STARTED|Overall Study||70
139212|NCT00328783|337452|P1|NOT COMPLETED|Overall Study||26
139213|NCT00328783|337452|P1|COMPLETED|Overall Study||86
139214|NCT00328783|337452|P1|STARTED|Overall Study||112
139215|NCT00328861|337459|P2|NOT COMPLETED|Overall Study||0
139216|NCT00328861|337460|P1|NOT COMPLETED|Overall Study||0
139217|NCT00328861|337459|P2|COMPLETED|Overall Study||1
139218|NCT00328861|337460|P1|COMPLETED|Overall Study||7
139219|NCT00328861|337459|P2|STARTED|Overall Study||1
139220|NCT00328861|337460|P1|STARTED|Overall Study||7
139221|NCT00328926|337471|P3|NOT COMPLETED|Overall Study||2
139222|NCT00328926|337472|P2|NOT COMPLETED|Overall Study||3
139223|NCT00328926|337473|P1|NOT COMPLETED|Overall Study||2
139224|NCT00328926|337471|P3|COMPLETED|Overall Study||1
139225|NCT00328926|337472|P2|COMPLETED|Overall Study||0
139226|NCT00328926|337473|P1|COMPLETED|Overall Study||3
139227|NCT00328926|337471|P3|STARTED|Overall Study||3
139228|NCT00328926|337472|P2|STARTED|Overall Study||3
139229|NCT00328926|337473|P1|STARTED|Overall Study||5
139230|NCT00329030|337489|P2|NOT COMPLETED|Overall Study||6
139231|NCT00329030|337490|P1|NOT COMPLETED|Overall Study||8
139232|NCT00329030|337489|P2|COMPLETED|Overall Study||107
139233|NCT00329030|337490|P1|COMPLETED|Overall Study||103
139234|NCT00329030|337489|P2|STARTED|Overall Study||113
139235|NCT00329030|337490|P1|STARTED|Overall Study||111
139236|NCT00329108|337520|P2|NOT COMPLETED|Overall Study||12
139237|NCT00329108|337521|P1|NOT COMPLETED|Overall Study||10
139238|NCT00329108|337520|P2|COMPLETED|Overall Study||2
139239|NCT00329108|337521|P1|COMPLETED|Overall Study||5
139240|NCT00329108|337520|P2|STARTED|Overall Study|study terminated due to poor recruitment|14
139241|NCT00329108|337521|P1|STARTED|Overall Study|study terminated due to poor recruitment|15
139242|NCT00329160|337527|P1|NOT COMPLETED|Overall Study||88
139243|NCT00329160|337527|P1|COMPLETED|Overall Study||126
139244|NCT00329160|337527|P1|Treatment Period|Overall Study||214
139245|NCT00329160|337527|P1|Observation Period|Overall Study||214
139246|NCT00329160|337527|P1|STARTED|Overall Study||214
139247|NCT00329238|337536|P2|NOT COMPLETED|Overall Study||281
139248|NCT00329238|337537|P1|NOT COMPLETED|Overall Study||276
139249|NCT00329238|337536|P2|COMPLETED|Overall Study||1145
139250|NCT00329238|337537|P1|COMPLETED|Overall Study||1154
139251|NCT00329238|337536|P2|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1426
139252|NCT00329238|337537|P1|STARTED|Overall Study|2866 were randomized. A total of ten did not receive treatment resulting in 2856 starting study.|1430
139253|NCT00329407|337573|P1|NOT COMPLETED|Overall Study||1
139254|NCT00329407|337573|P1|COMPLETED|Overall Study||9
139255|NCT00329407|337573|P1|STARTED|Overall Study||10
139256|NCT00329420|337581|P3|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||1
139257|NCT00329420|337582|P2|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||2
139258|NCT00329420|337583|P1|NOT COMPLETED|4-weekly Dosing Phase (Responders Only)||4
139259|NCT00329420|337581|P3|COMPLETED|4-weekly Dosing Phase (Responders Only)||6
139260|NCT00329420|337582|P2|COMPLETED|4-weekly Dosing Phase (Responders Only)||5
139261|NCT00329420|337583|P1|COMPLETED|4-weekly Dosing Phase (Responders Only)||8
139262|NCT00329420|337581|P3|STARTED|4-weekly Dosing Phase (Responders Only)||7
139263|NCT00329420|337582|P2|STARTED|4-weekly Dosing Phase (Responders Only)||7
139264|NCT00329420|337583|P1|STARTED|4-weekly Dosing Phase (Responders Only)||12
139265|NCT00329420|337581|P3|NOT COMPLETED|Re-induction Phase||8
139266|NCT00329420|337582|P2|NOT COMPLETED|Re-induction Phase||6
139267|NCT00329420|337583|P1|NOT COMPLETED|Re-induction Phase||6
139268|NCT00329420|337581|P3|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
139269|NCT00329420|337582|P2|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|7
139270|NCT00329420|337583|P1|COMPLETED|Re-induction Phase|Completed = Reached Week 14 (end of re-induction phase) and responded to re-induction at that time.|12
139271|NCT00329420|337581|P3|STARTED|Re-induction Phase||15
139272|NCT00329420|337582|P2|STARTED|Re-induction Phase||13
139273|NCT00329420|337583|P1|STARTED|Re-induction Phase||18
139274|NCT00329433|337964|P2|NOT COMPLETED|Overall Study||0
139275|NCT00329433|337965|P1|NOT COMPLETED|Overall Study||0
139276|NCT00329433|337964|P2|COMPLETED|Overall Study||59
139277|NCT00329433|337965|P1|COMPLETED|Overall Study||61
139278|NCT00329433|337964|P2|STARTED|Overall Study||59
139279|NCT00329433|337965|P1|STARTED|Overall Study||61
139280|NCT00329524|337971|P1|NOT COMPLETED|Overall Study||0
139281|NCT00329524|337971|P1|COMPLETED|Overall Study||5
139283|NCT00329550|337980|P3|NOT COMPLETED|Overall Study||4
139284|NCT00329550|337981|P2|NOT COMPLETED|Overall Study||4
139285|NCT00329550|337982|P1|NOT COMPLETED|Overall Study||4
139286|NCT00329550|337980|P3|COMPLETED|Overall Study||12
139287|NCT00329550|337981|P2|COMPLETED|Overall Study||11
139288|NCT00329550|337982|P1|COMPLETED|Overall Study||5
139289|NCT00329550|337980|P3|STARTED|Overall Study|1 subject in Safety Set is not in Full Analysis Set due to Good Clinical Practice non-compliance.|16
139290|NCT00329550|337981|P2|STARTED|Overall Study||15
139291|NCT00329550|337982|P1|STARTED|Overall Study||9
139292|NCT00329602|338231|P3|NOT COMPLETED|40-Week Open-Label Treatment Phase||36
139293|NCT00329602|338232|P2|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
139294|NCT00329602|338233|P1|NOT COMPLETED|40-Week Open-Label Treatment Phase||0
139295|NCT00329602|338231|P3|COMPLETED|40-Week Open-Label Treatment Phase||233
139296|NCT00329602|338232|P2|COMPLETED|40-Week Open-Label Treatment Phase||0
139297|NCT00329602|338233|P1|COMPLETED|40-Week Open-Label Treatment Phase||0
139298|NCT00329602|338231|P3|STARTED|40-Week Open-Label Treatment Phase|148 and 121 par. randomized to DB placebo and ropinirole IR, respectively, entered the OL phase.|269
139299|NCT00329602|338232|P2|STARTED|40-Week Open-Label Treatment Phase||0
139300|NCT00329602|338233|P1|STARTED|40-Week Open-Label Treatment Phase||0
139301|NCT00329602|338231|P3|NOT COMPLETED|26-Week Double-Blind Treatment Phase||0
139302|NCT00329602|338232|P2|NOT COMPLETED|26-Week Double-Blind Treatment Phase||99
139303|NCT00329602|338233|P1|NOT COMPLETED|26-Week Double-Blind Treatment Phase||119
139304|NCT00329602|338231|P3|COMPLETED|26-Week Double-Blind Treatment Phase||0
139305|NCT00329602|338232|P2|COMPLETED|26-Week Double-Blind Treatment Phase||98
139306|NCT00329602|338233|P1|COMPLETED|26-Week Double-Blind Treatment Phase||88
139307|NCT00329602|338231|P3|STARTED|26-Week Double-Blind Treatment Phase||0
139308|NCT00329602|338232|P2|STARTED|26-Week Double-Blind Treatment Phase||197
139309|NCT00329602|338233|P1|STARTED|26-Week Double-Blind Treatment Phase|"Numbers of participants in the Participant Flow section are based on the Safety Population."|207
139310|NCT00329641|338268|P1|NOT COMPLETED|Overall Study||6
139311|NCT00329641|338268|P1|COMPLETED|Overall Study||19
139312|NCT00329641|338268|P1|Eligible and Received Treatment|Overall Study||24
139313|NCT00329641|338268|P1|Eligible|Overall Study||25
139314|NCT00329641|338268|P1|STARTED|Overall Study||25
139315|NCT00329719|338279|P4|NOT COMPLETED|Overall Study||1
139316|NCT00329719|338280|P3|NOT COMPLETED|Overall Study||0
139317|NCT00329719|338281|P2|NOT COMPLETED|Overall Study||0
139318|NCT00329719|338282|P1|NOT COMPLETED|Overall Study||0
139319|NCT00329719|338279|P4|COMPLETED|Overall Study||44
139320|NCT00329719|338280|P3|COMPLETED|Overall Study||9
139321|NCT00329719|338281|P2|COMPLETED|Overall Study||49
139322|NCT00329719|338282|P1|COMPLETED|Overall Study||12
139323|NCT00329719|338279|P4|STARTED|Overall Study||45
139324|NCT00329719|338280|P3|STARTED|Overall Study||9
139325|NCT00329719|338281|P2|STARTED|Overall Study||49
139326|NCT00329719|338282|P1|STARTED|Overall Study||12
139327|NCT00329732|338306|P2|NOT COMPLETED|Overall Study||0
139328|NCT00329732|338307|P1|NOT COMPLETED|Overall Study||0
139329|NCT00329732|338306|P2|COMPLETED|Overall Study||0
139330|NCT00329732|338307|P1|COMPLETED|Overall Study||2
139331|NCT00329732|338306|P2|STARTED|Overall Study||0
139332|NCT00329732|338307|P1|STARTED|Overall Study||2
139333|NCT00329745|338314|P2|NOT COMPLETED|Overall Study||102
139334|NCT00329745|338315|P1|NOT COMPLETED|Overall Study||87
139335|NCT00329745|338314|P2|COMPLETED|Overall Study||4226
139336|NCT00329745|338315|P1|COMPLETED|Overall Study||4272
139337|NCT00329745|338314|P2|STARTED|Overall Study||4328
139338|NCT00329745|338315|P1|STARTED|Overall Study||4359
139339|NCT00329771|338323|P1|NOT COMPLETED|Overall Study||3
139340|NCT00329771|338323|P1|COMPLETED|Overall Study|3 subjects withdrew or were lost to follow-up|25
139341|NCT00329771|338323|P1|STARTED|Overall Study||28
139342|NCT00329784|338331|P4|NOT COMPLETED|Overall Study||0
139343|NCT00329784|338332|P3|NOT COMPLETED|Overall Study||0
139344|NCT00329784|338333|P2|NOT COMPLETED|Overall Study||5
139345|NCT00329784|338334|P1|NOT COMPLETED|Overall Study||5
139346|NCT00329784|338331|P4|COMPLETED|Overall Study||47
139347|NCT00329784|338332|P3|COMPLETED|Overall Study||51
139348|NCT00329784|338333|P2|COMPLETED|Overall Study||267
139349|NCT00329784|338334|P1|COMPLETED|Overall Study||265
139350|NCT00329784|338331|P4|STARTED|Overall Study||47
139351|NCT00329784|338332|P3|STARTED|Overall Study||51
139352|NCT00329784|338333|P2|STARTED|Overall Study||272
139353|NCT00329784|338334|P1|STARTED|Overall Study||270
139354|NCT00329836|338356|P1|NOT COMPLETED|Overall Study||0
139355|NCT00329836|338356|P1|COMPLETED|Overall Study||41
139356|NCT00329836|338356|P1|STARTED|Overall Study||41
139357|NCT00329849|338362|P2|NOT COMPLETED|Overall Study||4
139358|NCT00329849|338363|P1|NOT COMPLETED|Overall Study||6
139359|NCT00329849|338362|P2|COMPLETED|Overall Study||546
139360|NCT00329849|338363|P1|COMPLETED|Overall Study||944
139361|NCT00329849|338362|P2|STARTED|Overall Study||550
139362|NCT00329849|338363|P1|STARTED|Overall Study||950
139363|NCT00329901|338386|P3|NOT COMPLETED|Overall Study||4
139364|NCT00329901|338387|P2|NOT COMPLETED|Overall Study||5
139365|NCT00329901|338388|P1|NOT COMPLETED|Overall Study||9
139366|NCT00329901|338386|P3|COMPLETED|Overall Study||353
139367|NCT00329901|338387|P2|COMPLETED|Overall Study||349
139368|NCT00329901|338388|P1|COMPLETED|Overall Study||352
139369|NCT00329901|338386|P3|STARTED|Overall Study||357
139370|NCT00329901|338387|P2|STARTED|Overall Study||354
139371|NCT00329901|338388|P1|STARTED|Overall Study||361
139372|NCT00311155|338416|P1|NOT COMPLETED|Overall Study||93
139373|NCT00311155|338416|P1|COMPLETED|Overall Study|Some participants had multiple reasons for discontinuation|601
139374|NCT00311155|338416|P1|STARTED|Overall Study||694
139375|NCT00311181|338425|P1|NOT COMPLETED|Overall Study||96
139376|NCT00311181|338425|P1|COMPLETED|Overall Study||121
139377|NCT00311181|338425|P1|STARTED|Overall Study||217
139378|NCT00311311|338433|P2|NOT COMPLETED|Overall Study||9
139379|NCT00311311|338434|P1|NOT COMPLETED|Overall Study||8
139380|NCT00311311|338433|P2|COMPLETED|Overall Study||26
139381|NCT00311311|338434|P1|COMPLETED|Overall Study||29
139382|NCT00311311|338433|P2|STARTED|Overall Study||35
139383|NCT00311311|338434|P1|STARTED|Overall Study||37
139384|NCT00311363|338487|P3|NOT COMPLETED|12-Week Double-Blind Treatment Period||12
139385|NCT00311363|338488|P2|NOT COMPLETED|12-Week Double-Blind Treatment Period||14
139386|NCT00311363|338489|P1|NOT COMPLETED|12-Week Double-Blind Treatment Period||0
139387|NCT00311363|338487|P3|COMPLETED|12-Week Double-Blind Treatment Period||84
139388|NCT00311363|338488|P2|COMPLETED|12-Week Double-Blind Treatment Period||84
139389|NCT00311363|338489|P1|COMPLETED|12-Week Double-Blind Treatment Period||0
139390|NCT00311363|338487|P3|STARTED|12-Week Double-Blind Treatment Period||96
139391|NCT00311363|338488|P2|STARTED|12-Week Double-Blind Treatment Period||98
139392|NCT00311363|338489|P1|STARTED|12-Week Double-Blind Treatment Period||0
139393|NCT00311363|338487|P3|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
139394|NCT00311363|338488|P2|NOT COMPLETED|24-Week Single-Blind Treatment Period||0
139395|NCT00311363|338489|P1|NOT COMPLETED|24-Week Single-Blind Treatment Period||106
139396|NCT00311363|338487|P3|COMPLETED|24-Week Single-Blind Treatment Period||0
139397|NCT00311363|338488|P2|COMPLETED|24-Week Single-Blind Treatment Period||0
139398|NCT00311363|338489|P1|COMPLETED|24-Week Single-Blind Treatment Period||221
139399|NCT00311363|338487|P3|STARTED|24-Week Single-Blind Treatment Period||0
139400|NCT00311363|338488|P2|STARTED|24-Week Single-Blind Treatment Period||0
139401|NCT00311363|338489|P1|STARTED|24-Week Single-Blind Treatment Period||327
139402|NCT00311376|338550|P3|NOT COMPLETED|Treatment Cycle 2||0
139403|NCT00311376|338551|P2|NOT COMPLETED|Treatment Cycle 2||13
139404|NCT00311376|338552|P1|NOT COMPLETED|Treatment Cycle 2||9
139405|NCT00311376|338550|P3|COMPLETED|Treatment Cycle 2||0
139406|NCT00311376|338551|P2|COMPLETED|Treatment Cycle 2||112
139407|NCT00311376|338552|P1|COMPLETED|Treatment Cycle 2||106
139408|NCT00311376|338550|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200U in Cycle 2|0
139409|NCT00311376|338551|P2|STARTED|Treatment Cycle 2|74 from the 200U group + 51 from the Placebo group entered Cycle 2|125
139410|NCT00311376|338552|P1|STARTED|Treatment Cycle 2|69 from the 300U group + 46 from the Placebo group entered Cycle 2|115
139411|NCT00311376|338550|P3|NOT COMPLETED|Treatment Cycle 1||17
139412|NCT00311376|338551|P2|NOT COMPLETED|Treatment Cycle 1||17
139413|NCT00311376|338552|P1|NOT COMPLETED|Treatment Cycle 1||27
139414|NCT00311376|338550|P3|COMPLETED|Treatment Cycle 1||132
139415|NCT00311376|338551|P2|COMPLETED|Treatment Cycle 1||118
139416|NCT00311376|338552|P1|COMPLETED|Treatment Cycle 1||105
139417|NCT00311376|338550|P3|STARTED|Treatment Cycle 1||149
139418|NCT00311376|338551|P2|STARTED|Treatment Cycle 1||135
139419|NCT00311376|338552|P1|STARTED|Treatment Cycle 1||132
139420|NCT00311402|338571|P2|NOT COMPLETED|Overall Study||177
139421|NCT00311402|338572|P1|NOT COMPLETED|Overall Study||210
139422|NCT00311402|338571|P2|COMPLETED|Overall Study||462
139423|NCT00311402|338572|P1|COMPLETED|Overall Study||445
139424|NCT00311402|338571|P2|STARTED|Overall Study||639
139425|NCT00311402|338572|P1|STARTED|Overall Study||655
139426|NCT00311584|338598|P2|NOT COMPLETED|Overall Study||23
139427|NCT00311584|338599|P1|NOT COMPLETED|Overall Study||20
139428|NCT00311584|338598|P2|COMPLETED|Overall Study||7
139429|NCT00311584|338599|P1|COMPLETED|Overall Study||9
139430|NCT00311584|338598|P2|STARTED|Overall Study||30
139431|NCT00311584|338599|P1|STARTED|Overall Study||29
139432|NCT00311766|338607|P2|NOT COMPLETED|Overall Study||5
139433|NCT00311766|338608|P1|NOT COMPLETED|Overall Study||0
139434|NCT00311766|338607|P2|COMPLETED|Overall Study||17
139435|NCT00311766|338608|P1|COMPLETED|Overall Study||8
139436|NCT00311766|338607|P2|STARTED|Overall Study||22
139437|NCT00311766|338608|P1|STARTED|Overall Study||8
139438|NCT00312195|338618|P2|NOT COMPLETED|Overall Study||6
139439|NCT00312195|338619|P1|NOT COMPLETED|Overall Study||6
139440|NCT00312195|338618|P2|COMPLETED|Overall Study||123
139441|NCT00312195|338619|P1|COMPLETED|Overall Study||132
139442|NCT00312195|338618|P2|STARTED|Overall Study||129
139443|NCT00312195|338619|P1|STARTED|Overall Study||138
139444|NCT00312208|338635|P2|NOT COMPLETED|Overall Study||123
139445|NCT00312208|338636|P1|NOT COMPLETED|Overall Study||172
139446|NCT00312208|338635|P2|COMPLETED|Overall Study||1526
139447|NCT00312208|338636|P1|COMPLETED|Overall Study||1477
139448|NCT00312208|338635|P2|STARTED|Overall Study|1649 patients randomized 1635 patients treated|1649
139449|NCT00312208|338636|P1|STARTED|Overall Study|1649 patients randomized, 1634 patients treated|1649
139450|NCT00312221|338647|P4|NOT COMPLETED|Double-blind Phase||70
139451|NCT00312221|338648|P3|NOT COMPLETED|Double-blind Phase||72
139452|NCT00312221|338649|P2|NOT COMPLETED|Double-blind Phase||59
139453|NCT00312221|338650|P1|NOT COMPLETED|Double-blind Phase||0
139454|NCT00312221|338647|P4|COMPLETED|Double-blind Phase||63
139455|NCT00312221|338648|P3|COMPLETED|Double-blind Phase||77
139456|NCT00312221|338649|P2|COMPLETED|Double-blind Phase||77
139457|NCT00312221|338650|P1|COMPLETED|Double-blind Phase||0
139458|NCT00312221|338647|P4|STARTED|Double-blind Phase||133
139459|NCT00312221|338648|P3|STARTED|Double-blind Phase||149
139460|NCT00312221|338649|P2|STARTED|Double-blind Phase||136
139461|NCT00312221|338650|P1|STARTED|Double-blind Phase||0
139462|NCT00312221|338647|P4|NOT COMPLETED|Open-label Run-in Period||0
139463|NCT00312221|338648|P3|NOT COMPLETED|Open-label Run-in Period||0
139464|NCT00312221|338649|P2|NOT COMPLETED|Open-label Run-in Period||0
139465|NCT00312221|338650|P1|NOT COMPLETED|Open-label Run-in Period||234
139466|NCT00312221|338647|P4|COMPLETED|Open-label Run-in Period||0
139467|NCT00312221|338648|P3|COMPLETED|Open-label Run-in Period||0
139468|NCT00312221|338649|P2|COMPLETED|Open-label Run-in Period||0
139469|NCT00312221|338650|P1|COMPLETED|Open-label Run-in Period||418
139470|NCT00312221|338647|P4|STARTED|Open-label Run-in Period||0
139471|NCT00312221|338648|P3|STARTED|Open-label Run-in Period||0
139472|NCT00312221|338649|P2|STARTED|Open-label Run-in Period||0
139473|NCT00312221|338650|P1|STARTED|Open-label Run-in Period||652
139474|NCT00313300|338673|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
139475|NCT00313300|338674|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||5
139476|NCT00313300|338675|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||2
139477|NCT00313300|338676|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||0
139478|NCT00313300|338677|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase B||3
139479|NCT00313300|338673|P5|COMPLETED|Follow-Up(30days)-Randomized Phase B||199
139480|NCT00313300|338674|P4|COMPLETED|Follow-Up(30days)-Randomized Phase B||217
139481|NCT00313300|338675|P3|COMPLETED|Follow-Up(30days)-Randomized Phase B||117
139482|NCT00313300|338676|P2|COMPLETED|Follow-Up(30days)-Randomized Phase B||123
139483|NCT00313300|338677|P1|COMPLETED|Follow-Up(30days)-Randomized Phase B||380
139484|NCT00313300|338673|P5|STARTED|Follow-Up(30days)-Randomized Phase B||201
139485|NCT00313300|338674|P4|STARTED|Follow-Up(30days)-Randomized Phase B||222
139486|NCT00313300|338675|P3|STARTED|Follow-Up(30days)-Randomized Phase B||119
139487|NCT00313300|338676|P2|STARTED|Follow-Up(30days)-Randomized Phase B||123
139488|NCT00313300|338677|P1|STARTED|Follow-Up(30days)-Randomized Phase B||383
139489|NCT00313300|338673|P5|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
139490|NCT00313300|338674|P4|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||0
139491|NCT00313300|338675|P3|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||2
139492|NCT00313300|338676|P2|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||6
139493|NCT00313300|338677|P1|NOT COMPLETED|Follow-Up(30days)-Randomized Phase A||5
139494|NCT00313300|338673|P5|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
139495|NCT00313300|338674|P4|COMPLETED|Follow-Up(30days)-Randomized Phase A||0
139496|NCT00313300|338675|P3|COMPLETED|Follow-Up(30days)-Randomized Phase A||172
139497|NCT00313300|338676|P2|COMPLETED|Follow-Up(30days)-Randomized Phase A||156
139498|NCT00313300|338677|P1|COMPLETED|Follow-Up(30days)-Randomized Phase A||158
139499|NCT00313300|338673|P5|STARTED|Follow-Up(30days)-Randomized Phase A||0
139500|NCT00313300|338674|P4|STARTED|Follow-Up(30days)-Randomized Phase A||0
139501|NCT00313300|338675|P3|STARTED|Follow-Up(30days)-Randomized Phase A||174
139502|NCT00313300|338676|P2|STARTED|Follow-Up(30days)-Randomized Phase A||162
139503|NCT00313300|338677|P1|STARTED|Follow-Up(30days)-Randomized Phase A||163
139504|NCT00313300|338673|P5|NOT COMPLETED|Randomized in Phase B (26 Weeks)||208
139505|NCT00313300|338674|P4|NOT COMPLETED|Randomized in Phase B (26 Weeks)||233
139506|NCT00313300|338675|P3|NOT COMPLETED|Randomized in Phase B (26 Weeks)||40
139507|NCT00313300|338676|P2|NOT COMPLETED|Randomized in Phase B (26 Weeks)||33
139508|NCT00313300|338677|P1|NOT COMPLETED|Randomized in Phase B (26 Weeks)||94
139509|NCT00313300|338673|P5|COMPLETED|Randomized in Phase B (26 Weeks)||13
139510|NCT00313300|338674|P4|COMPLETED|Randomized in Phase B (26 Weeks)||15
139511|NCT00313300|338675|P3|COMPLETED|Randomized in Phase B (26 Weeks)||94
139512|NCT00313300|338676|P2|COMPLETED|Randomized in Phase B (26 Weeks)||105
139513|NCT00313300|338677|P1|COMPLETED|Randomized in Phase B (26 Weeks)||333
139514|NCT00313300|338673|P5|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||221
139515|NCT00313300|338674|P4|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||248
139516|NCT00313300|338675|P3|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||110
139517|NCT00313300|338676|P2|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||120
139518|NCT00313300|338677|P1|Start of Phase B to High Dose Terminated|Randomized in Phase B (26 Weeks)||368
139519|NCT00313300|338673|P5|STARTED|Randomized in Phase B (26 Weeks)||221
139520|NCT00313300|338674|P4|STARTED|Randomized in Phase B (26 Weeks)||248
139521|NCT00313300|338675|P3|STARTED|Randomized in Phase B (26 Weeks)||134
139522|NCT00313300|338676|P2|STARTED|Randomized in Phase B (26 Weeks)||138
139523|NCT00313300|338677|P1|STARTED|Randomized in Phase B (26 Weeks)||427
139524|NCT00313300|338673|P5|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
139525|NCT00313300|338674|P4|NOT COMPLETED|Randomized in Phase A (26 Weeks)||0
139526|NCT00313300|338675|P3|NOT COMPLETED|Randomized in Phase A (26 Weeks)||35
139527|NCT00313300|338676|P2|NOT COMPLETED|Randomized in Phase A (26 Weeks)||39
139528|NCT00313300|338677|P1|NOT COMPLETED|Randomized in Phase A (26 Weeks)||54
139529|NCT00313300|338673|P5|COMPLETED|Randomized in Phase A (26 Weeks)||0
139530|NCT00313300|338674|P4|COMPLETED|Randomized in Phase A (26 Weeks)||0
139531|NCT00313300|338675|P3|COMPLETED|Randomized in Phase A (26 Weeks)||149
139532|NCT00313300|338676|P2|COMPLETED|Randomized in Phase A (26 Weeks)||140
139533|NCT00313300|338677|P1|COMPLETED|Randomized in Phase A (26 Weeks)||130
139534|NCT00313300|338673|P5|STARTED|Randomized in Phase A (26 Weeks)||0
139535|NCT00313300|338674|P4|STARTED|Randomized in Phase A (26 Weeks)||0
139536|NCT00313300|338675|P3|STARTED|Randomized in Phase A (26 Weeks)||184
139537|NCT00313300|338676|P2|STARTED|Randomized in Phase A (26 Weeks)||179
139538|NCT00313300|338677|P1|STARTED|Randomized in Phase A (26 Weeks)||184
139539|NCT00313313|338730|P3|NOT COMPLETED|Overall Study||82
139540|NCT00313313|338731|P2|NOT COMPLETED|Overall Study||66
139541|NCT00313313|338732|P1|NOT COMPLETED|Overall Study||63
139542|NCT00313313|338730|P3|COMPLETED|Overall Study|26 subjects completed the study without being rescued|185
139543|NCT00313313|338731|P2|COMPLETED|Overall Study|55 subjects completed the study without being rescued|187
139544|NCT00313313|338732|P1|COMPLETED|Overall Study|61 subjects completed the study without being rescued|185
139545|NCT00313313|338730|P3|STARTED|Overall Study||267
139546|NCT00313313|338731|P2|STARTED|Overall Study||253
139547|NCT00313313|338732|P1|STARTED|Overall Study||248
139548|NCT00313443|338749|P1|NOT COMPLETED|Overall Study||0
139549|NCT00313443|338749|P1|COMPLETED|Overall Study||30
139550|NCT00313443|338749|P1|STARTED|Overall Study||30
139551|NCT00313586|338761|P4|NOT COMPLETED|Overall Study||23
139552|NCT00313586|338762|P3|NOT COMPLETED|Overall Study||24
139553|NCT00313586|338763|P2|NOT COMPLETED|Overall Study||70
139554|NCT00313586|338764|P1|NOT COMPLETED|Overall Study||70
139555|NCT00313586|338761|P4|COMPLETED|Overall Study||0
139556|NCT00313586|338762|P3|COMPLETED|Overall Study||0
139557|NCT00313586|338763|P2|COMPLETED|Overall Study||5
139558|NCT00313586|338764|P1|COMPLETED|Overall Study||5
139559|NCT00313586|338761|P4|Treated|Overall Study||23
139560|NCT00313586|338762|P3|Treated|Overall Study||24
139561|NCT00313586|338763|P2|Treated|Overall Study||75
139562|NCT00313586|338764|P1|Treated|Overall Study||74
139563|NCT00313586|338761|P4|STARTED|Overall Study||23
139564|NCT00313586|338762|P3|STARTED|Overall Study||24
139565|NCT00313586|338763|P2|STARTED|Overall Study||75
139566|NCT00313586|338764|P1|STARTED|Overall Study||75
139567|NCT00313612|338774|P2|NOT COMPLETED|Overall Study||1
139568|NCT00313612|338775|P1|NOT COMPLETED|Overall Study||0
139569|NCT00313612|338774|P2|COMPLETED|Overall Study||19
139570|NCT00313612|338775|P1|COMPLETED|Overall Study||19
139571|NCT00313612|338774|P2|STARTED|Overall Study||20
139572|NCT00313612|338775|P1|STARTED|Overall Study||19
139573|NCT00313703|338787|P4|NOT COMPLETED|Overall Study||12
139574|NCT00313703|338788|P3|NOT COMPLETED|Overall Study||5
139575|NCT00313703|338789|P2|NOT COMPLETED|Overall Study||2
139576|NCT00313703|338790|P1|NOT COMPLETED|Overall Study||11
139577|NCT00313703|338787|P4|COMPLETED|Overall Study|Outcomes not reported due to heterogeneity of this group|0
139578|NCT00313703|338788|P3|COMPLETED|Overall Study|Some subjects lost-to-follow-up|72
139579|NCT00313703|338789|P2|COMPLETED|Overall Study|Some subjects lost-to follow-up|32
139580|NCT00313703|338790|P1|COMPLETED|Overall Study|Some subjects lost to follow-up|175
139581|NCT00313703|338787|P4|STARTED|Overall Study||12
139582|NCT00313703|338788|P3|STARTED|Overall Study||77
139583|NCT00313703|338789|P2|STARTED|Overall Study||34
139584|NCT00313703|338790|P1|STARTED|Overall Study||186
139585|NCT00313716|338810|P6|NOT COMPLETED|Overall Study||13
139586|NCT00313716|338811|P5|NOT COMPLETED|Overall Study||6
139587|NCT00313716|338812|P4|NOT COMPLETED|Overall Study||4
139588|NCT00313716|338813|P3|NOT COMPLETED|Overall Study||12
139589|NCT00313716|338814|P2|NOT COMPLETED|Overall Study||8
139590|NCT00313716|338815|P1|NOT COMPLETED|Overall Study||5
139591|NCT00313716|338810|P6|COMPLETED|Overall Study||35
139592|NCT00313716|338811|P5|COMPLETED|Overall Study||27
139593|NCT00313716|338812|P4|COMPLETED|Overall Study||16
139594|NCT00313716|338813|P3|COMPLETED|Overall Study||38
139595|NCT00313716|338814|P2|COMPLETED|Overall Study||23
139596|NCT00313716|338815|P1|COMPLETED|Overall Study||13
139597|NCT00313716|338810|P6|STARTED|Overall Study||48
139598|NCT00313716|338811|P5|STARTED|Overall Study||33
139599|NCT00313716|338812|P4|STARTED|Overall Study||20
139600|NCT00313716|338813|P3|STARTED|Overall Study||50
139601|NCT00313716|338814|P2|STARTED|Overall Study||31
139602|NCT00313716|338815|P1|STARTED|Overall Study||18
139603|NCT00313781|338840|P3|NOT COMPLETED|After Crossover||27
139604|NCT00313781|338841|P2|NOT COMPLETED|After Crossover||0
139605|NCT00313781|338842|P1|NOT COMPLETED|After Crossover||0
139606|NCT00313781|338840|P3|COMPLETED|After Crossover||10
139607|NCT00313781|338841|P2|COMPLETED|After Crossover||0
139608|NCT00313781|338842|P1|COMPLETED|After Crossover||0
139609|NCT00313781|338840|P3|STARTED|After Crossover||37
139610|NCT00313781|338841|P2|STARTED|After Crossover||0
139611|NCT00313781|338842|P1|STARTED|After Crossover||0
139612|NCT00313781|338840|P3|NOT COMPLETED|Before Crossover||0
139613|NCT00313781|338841|P2|NOT COMPLETED|Before Crossover||79
139614|NCT00313781|338842|P1|NOT COMPLETED|Before Crossover||75
139615|NCT00313781|338840|P3|COMPLETED|Before Crossover||0
139616|NCT00313781|338841|P2|COMPLETED|Before Crossover||23
139617|NCT00313781|338842|P1|COMPLETED|Before Crossover||27
139618|NCT00313781|338840|P3|Treated|Before Crossover||0
139619|NCT00313781|338841|P2|Treated|Before Crossover||102
139620|NCT00313781|338842|P1|Treated|Before Crossover||97
139621|NCT00313781|338840|P3|STARTED|Before Crossover||0
139622|NCT00313781|338841|P2|STARTED|Before Crossover||102
139623|NCT00313781|338842|P1|STARTED|Before Crossover||102
139624|NCT00313820|338878|P2|NOT COMPLETED|Pregabalin or Placebo Treatment Period||19
139625|NCT00313820|338879|P1|NOT COMPLETED|Pregabalin or Placebo Treatment Period||17
139626|NCT00313820|338878|P2|COMPLETED|Pregabalin or Placebo Treatment Period||90
139627|NCT00313820|338879|P1|COMPLETED|Pregabalin or Placebo Treatment Period||93
139628|NCT00313820|338878|P2|STARTED|Pregabalin or Placebo Treatment Period||109
139629|NCT00313820|338879|P1|STARTED|Pregabalin or Placebo Treatment Period||110
139630|NCT00313820|338878|P2|NOT COMPLETED|Assigned to Treatment||0
139631|NCT00313820|338879|P1|NOT COMPLETED|Assigned to Treatment||1
139632|NCT00313820|338878|P2|COMPLETED|Assigned to Treatment||109
139633|NCT00313820|338879|P1|COMPLETED|Assigned to Treatment||110
139634|NCT00313820|338878|P2|STARTED|Assigned to Treatment||109
139635|NCT00313820|338879|P1|STARTED|Assigned to Treatment||111
139636|NCT00313846|338917|P2|NOT COMPLETED|Overall Study||11
139637|NCT00313846|338918|P1|NOT COMPLETED|Overall Study||5
139638|NCT00313846|338917|P2|COMPLETED|Overall Study||153
139639|NCT00313846|338918|P1|COMPLETED|Overall Study||157
139640|NCT00313846|338917|P2|STARTED|Overall Study|327 subjects were randomized: 1 subject was lost to follow-up (N = 326).|164
139641|NCT00313846|338918|P1|STARTED|Overall Study||162
139642|NCT00313911|338929|P2|NOT COMPLETED|Overall Study||41
139643|NCT00313911|338930|P1|NOT COMPLETED|Overall Study||94
139644|NCT00313911|338929|P2|COMPLETED|Overall Study||670
139645|NCT00313911|338930|P1|COMPLETED|Overall Study||1328
139646|NCT00313911|338929|P2|STARTED|Overall Study|A participant in this group mistakenly got Group 1 vaccine. N in outcomes adjusted accordingly.|711
139647|NCT00313911|338930|P1|STARTED|Overall Study|N for outcomes adjusted to include participant in Group 2 that got vaccine assigned to this group.|1422
139648|NCT00314106|338944|P2|NOT COMPLETED|Overall Study||0
139649|NCT00314106|338945|P1|NOT COMPLETED|Overall Study||0
139650|NCT00314106|338944|P2|COMPLETED|Overall Study||8
139651|NCT00314106|338945|P1|COMPLETED|Overall Study||18
139652|NCT00314106|338944|P2|STARTED|Overall Study||8
139653|NCT00314106|338945|P1|STARTED|Overall Study||18
139654|NCT00314132|338955|P2|NOT COMPLETED|Overall Study||18
139655|NCT00314132|338956|P1|NOT COMPLETED|Overall Study||8
139656|NCT00314132|338955|P2|COMPLETED|Overall Study||1583
139657|NCT00314132|338956|P1|COMPLETED|Overall Study||395
139658|NCT00314132|338955|P2|STARTED|Overall Study||1601
139659|NCT00314132|338956|P1|STARTED|Overall Study||403
139660|NCT00314145|338966|P2|NOT COMPLETED|Overall Study||29
139661|NCT00314145|338967|P1|NOT COMPLETED|Overall Study||21
139662|NCT00314145|338966|P2|COMPLETED|Overall Study||381
139663|NCT00314145|338967|P1|COMPLETED|Overall Study||389
139664|NCT00314145|338966|P2|STARTED|Overall Study||410
139665|NCT00314145|338967|P1|STARTED|Overall Study||410
139666|NCT00314236|338981|P2|NOT COMPLETED|Overall Study||2
139667|NCT00314236|338982|P1|NOT COMPLETED|Overall Study||0
139668|NCT00314236|338981|P2|COMPLETED|Overall Study||37
139669|NCT00314236|338982|P1|COMPLETED|Overall Study||41
139670|NCT00314236|338981|P2|STARTED|Overall Study||39
139671|NCT00314236|338982|P1|STARTED|Overall Study||41
139672|NCT00314249|338996|P2|NOT COMPLETED|Overall Study||163
139673|NCT00314249|338997|P1|NOT COMPLETED|Overall Study||152
139674|NCT00314249|338996|P2|COMPLETED|Overall Study||353
139675|NCT00314249|338997|P1|COMPLETED|Overall Study||357
139676|NCT00314249|338996|P2|STARTED|Overall Study||516
139677|NCT00314249|338997|P1|STARTED|Overall Study||509
139678|NCT00314262|339013|P1|NOT COMPLETED|Overall Study||5
139679|NCT00314262|339013|P1|COMPLETED|Overall Study||7
139680|NCT00314262|339013|P1|STARTED|Overall Study||12
139681|NCT00314327|339019|P1|NOT COMPLETED|Overall Study||1
139682|NCT00314327|339019|P1|COMPLETED|Overall Study||0
139683|NCT00314327|339019|P1|STARTED|Overall Study||1
139684|NCT00314340|339023|P1|NOT COMPLETED|Overall Study||1
139685|NCT00314340|339023|P1|COMPLETED|Overall Study||11
139686|NCT00314340|339023|P1|Placebo|Overall Study||12
139687|NCT00314340|339023|P1|Hydrocodone Plus APAP|Overall Study||12
139688|NCT00314340|339023|P1|ER Morphine|Overall Study||11
139689|NCT00314340|339023|P1|STARTED|Overall Study||12
139690|NCT00314353|339031|P2|NOT COMPLETED|Follow-up||0
139691|NCT00314353|339032|P1|NOT COMPLETED|Follow-up||0
139692|NCT00314353|339031|P2|COMPLETED|Follow-up||0
139693|NCT00314353|339032|P1|COMPLETED|Follow-up||3
139694|NCT00314353|339031|P2|STARTED|Follow-up||0
139695|NCT00314353|339032|P1|STARTED|Follow-up|2 participants who completed 8 cycles plus 1 participant who did not complete 8 cycles therapy.|3
139696|NCT00314353|339031|P2|NOT COMPLETED|Protocol Therapy (8 Cycles)||3
139697|NCT00314353|339032|P1|NOT COMPLETED|Protocol Therapy (8 Cycles)||2
139698|NCT00314353|339031|P2|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|0
139699|NCT00314353|339032|P1|COMPLETED|Protocol Therapy (8 Cycles)|COMPLETED refers to the participants completing 8 cycles of therapy.|2
139700|NCT00314353|339031|P2|STARTED|Protocol Therapy (8 Cycles)||3
139701|NCT00314353|339032|P1|STARTED|Protocol Therapy (8 Cycles)||4
139702|NCT00314366|339040|P2|NOT COMPLETED|Overall Study||0
139703|NCT00314366|339041|P1|NOT COMPLETED|Overall Study||1
139704|NCT00314366|339040|P2|COMPLETED|Overall Study||10
139705|NCT00314366|339041|P1|COMPLETED|Overall Study||10
139706|NCT00314366|339040|P2|STARTED|Overall Study||10
139707|NCT00314366|339041|P1|STARTED|Overall Study||11
139708|NCT00314574|339071|P2|NOT COMPLETED|Overall Study||83
139709|NCT00314574|339072|P1|NOT COMPLETED|Overall Study||94
139710|NCT00314574|339071|P2|COMPLETED|Overall Study||344
139711|NCT00314574|339072|P1|COMPLETED|Overall Study||329
139712|NCT00314574|339071|P2|Safety Population|Overall Study||428
139793|NCT00315302|339216|P4|STARTED|Overall Study||34
139713|NCT00314574|339072|P1|Safety Population|Overall Study|1 patient in the placebo arm received Xolair and was added to the Xolair arm for Safety analyses.|420
139714|NCT00314574|339071|P2|Received at Least One Dose of Study Drug|Overall Study||427
139715|NCT00314574|339072|P1|Received at Least One Dose of Study Drug|Overall Study||421
139716|NCT00314574|339071|P2|STARTED|Overall Study||427
139717|NCT00314574|339072|P1|STARTED|Overall Study||423
139718|NCT00314808|339086|P1|NOT COMPLETED|Overall Study||8
139719|NCT00314808|339086|P1|COMPLETED|Overall Study|Completed 2 cycles of Dronabinol or terminated early due to treatment-related adverse events (AE)|25
139720|NCT00314808|339086|P1|STARTED|Overall Study||33
139721|NCT00314951|339096|P2|NOT COMPLETED|Follow-up||34
139722|NCT00314951|339097|P1|NOT COMPLETED|Follow-up||44
139723|NCT00314951|339096|P2|COMPLETED|Follow-up||255
139724|NCT00314951|339097|P1|COMPLETED|Follow-up||263
139725|NCT00314951|339096|P2|STARTED|Follow-up||289
139726|NCT00314951|339097|P1|STARTED|Follow-up||307
139727|NCT00314951|339096|P2|NOT COMPLETED|Treatment||11
139728|NCT00314951|339097|P1|NOT COMPLETED|Treatment||16
139729|NCT00314951|339096|P2|COMPLETED|Treatment||289
139730|NCT00314951|339097|P1|COMPLETED|Treatment||307
139731|NCT00314951|339096|P2|STARTED|Treatment||300
139732|NCT00314951|339097|P1|STARTED|Treatment||323
139733|NCT00314951|339096|P2|NOT COMPLETED|Enrollment||6
139734|NCT00314951|339097|P1|NOT COMPLETED|Enrollment||0
139735|NCT00314951|339096|P2|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|300
139736|NCT00314951|339097|P1|COMPLETED|Enrollment|6 subjects took incorrect treatment assignment, 6 subjects didn't take drug|323
139737|NCT00314951|339096|P2|STARTED|Enrollment||306
139738|NCT00314951|339097|P1|STARTED|Enrollment||323
139739|NCT00315055|339109|P2|NOT COMPLETED|Overall Study||5
139740|NCT00315055|339110|P1|NOT COMPLETED|Overall Study||3
139741|NCT00315055|339109|P2|COMPLETED|Overall Study||150
139742|NCT00315055|339110|P1|COMPLETED|Overall Study||152
139743|NCT00315055|339109|P2|STARTED|Overall Study||155
139744|NCT00315055|339110|P1|STARTED|Overall Study||155
139745|NCT00315120|339130|P4|NOT COMPLETED|Overall Study||0
139746|NCT00315120|339131|P3|NOT COMPLETED|Overall Study||0
139747|NCT00315120|339132|P2|NOT COMPLETED|Overall Study||0
139748|NCT00315120|339133|P1|NOT COMPLETED|Overall Study||0
139749|NCT00315120|339130|P4|COMPLETED|Overall Study||107
139750|NCT00315120|339131|P3|COMPLETED|Overall Study||115
139751|NCT00315120|339132|P2|COMPLETED|Overall Study||118
139752|NCT00315120|339133|P1|COMPLETED|Overall Study||115
139753|NCT00315120|339130|P4|STARTED|Overall Study||107
139754|NCT00315120|339131|P3|STARTED|Overall Study||115
139755|NCT00315120|339132|P2|STARTED|Overall Study||118
139756|NCT00315120|339133|P1|STARTED|Overall Study||115
139757|NCT00315146|339195|P4|NOT COMPLETED|Overall Study||0
139758|NCT00315146|339196|P3|NOT COMPLETED|Overall Study||2
139759|NCT00315146|339197|P2|NOT COMPLETED|Overall Study||3
139760|NCT00315146|339198|P1|NOT COMPLETED|Overall Study||2
139761|NCT00315146|339195|P4|COMPLETED|Overall Study||22
139762|NCT00315146|339196|P3|COMPLETED|Overall Study||20
139763|NCT00315146|339197|P2|COMPLETED|Overall Study||19
139764|NCT00315146|339198|P1|COMPLETED|Overall Study||20
139765|NCT00315146|339195|P4|STARTED|Overall Study||22
139766|NCT00315146|339196|P3|STARTED|Overall Study||22
139767|NCT00315146|339197|P2|STARTED|Overall Study||22
139768|NCT00315146|339198|P1|STARTED|Overall Study||22
139769|NCT00315302|339216|P4|NOT COMPLETED|Overall Study||3
139770|NCT00315302|339217|P3|NOT COMPLETED|Overall Study||2
139771|NCT00315302|339218|P2|NOT COMPLETED|Overall Study||2
139772|NCT00315302|339219|P1|NOT COMPLETED|Overall Study||6
139773|NCT00315302|339216|P4|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|31
139774|NCT00315302|339217|P3|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|24
139775|NCT00315302|339218|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|88
139776|NCT00315302|339219|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|84
139777|NCT00315302|339216|P4|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|11
139778|NCT00315302|339217|P3|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|9
139779|NCT00315302|339218|P2|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|13
139780|NCT00315302|339219|P1|Partial Responder Phase (Post 18 Weeks)|Overall Study|Those who improved in the amblyopic eye at 18wk outcome continued on treatment w/ visits every 8wks.|16
139781|NCT00315302|339216|P4|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|31
139782|NCT00315302|339217|P3|18 Week Primary Outcome Visit|Overall Study||24
139783|NCT00315302|339218|P2|18 Week Primary Outcome Visit|Overall Study|Can be higher as includes subjects who may have missed the 10 week or other visit|88
139784|NCT00315302|339219|P1|18 Week Primary Outcome Visit|Overall Study||84
139785|NCT00315302|339216|P4|10 Week Visit|Overall Study||29
139786|NCT00315302|339217|P3|10 Week Visit|Overall Study||24
139787|NCT00315302|339218|P2|10 Week Visit|Overall Study||85
139788|NCT00315302|339219|P1|10 Week Visit|Overall Study|Can be higher as includes subjects who may have missed the 5 week visit|86
139789|NCT00315302|339216|P4|5 Week Visit|Overall Study||30
139790|NCT00315302|339217|P3|5 Week Visit|Overall Study||26
139791|NCT00315302|339218|P2|5 Week Visit|Overall Study||86
139792|NCT00315302|339219|P1|5 Week Visit|Overall Study||85
139794|NCT00315302|339217|P3|STARTED|Overall Study||26
139795|NCT00315302|339218|P2|STARTED|Overall Study||90
139796|NCT00315302|339219|P1|STARTED|Overall Study||90
139797|NCT00315328|339265|P4|NOT COMPLETED|Overall Study||2
139798|NCT00315328|339266|P3|NOT COMPLETED|Overall Study||5
139799|NCT00315328|339267|P2|NOT COMPLETED|Overall Study||7
139800|NCT00315328|339268|P1|NOT COMPLETED|Overall Study||14
139801|NCT00315328|339265|P4|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|20
139802|NCT00315328|339266|P3|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|13
139803|NCT00315328|339267|P2|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|88
139804|NCT00315328|339268|P1|COMPLETED|Overall Study|Completed defined as completing 17 week primary outcome exam|84
139805|NCT00315328|339265|P4|5 Week Visit|Overall Study||19
139806|NCT00315328|339266|P3|5 Week Visit|Overall Study||17
139807|NCT00315328|339267|P2|5 Week Visit|Overall Study||89
139808|NCT00315328|339268|P1|5 Week Visit|Overall Study||91
139809|NCT00315328|339265|P4|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|22
139810|NCT00315328|339266|P3|STARTED|Overall Study|Includes subjects with severe amblyopia only (20/125 to 20/400 at baseline)|18
139811|NCT00315328|339267|P2|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|95
139812|NCT00315328|339268|P1|STARTED|Overall Study|Includes subjects with moderate amblyopia only (20/40 to 20/100 at baseline)|98
139813|NCT00315341|339336|P2|NOT COMPLETED|Overall Study||138
139814|NCT00315341|339337|P1|NOT COMPLETED|Overall Study||400
139815|NCT00315341|339336|P2|COMPLETED|Overall Study||391
139816|NCT00315341|339337|P1|COMPLETED|Overall Study||340
139817|NCT00315341|339336|P2|STARTED|Overall Study||529
139818|NCT00315341|339337|P1|STARTED|Overall Study||740
139819|NCT00315445|339346|P3|NOT COMPLETED|Overall Study||24
139820|NCT00315445|339347|P2|NOT COMPLETED|Overall Study||16
139821|NCT00315445|339348|P1|NOT COMPLETED|Overall Study||27
139822|NCT00315445|339346|P3|COMPLETED|Overall Study||22
139823|NCT00315445|339347|P2|COMPLETED|Overall Study||27
139824|NCT00315445|339348|P1|COMPLETED|Overall Study||18
139825|NCT00315445|339346|P3|STARTED|Overall Study||46
139826|NCT00315445|339347|P2|STARTED|Overall Study||43
139827|NCT00315445|339348|P1|STARTED|Overall Study||45
139828|NCT00315458|339421|P4|NOT COMPLETED|Overall Study||29
139829|NCT00315458|339422|P3|NOT COMPLETED|Overall Study||52
139830|NCT00315458|339423|P2|NOT COMPLETED|Overall Study||12
139831|NCT00315458|339424|P1|NOT COMPLETED|Overall Study||3
139832|NCT00315458|339421|P4|COMPLETED|Overall Study||10
139833|NCT00315458|339422|P3|COMPLETED|Overall Study||107
139834|NCT00315458|339423|P2|COMPLETED|Overall Study||44
139835|NCT00315458|339424|P1|COMPLETED|Overall Study||48
139836|NCT00315458|339421|P4|STARTED|Overall Study||39
139837|NCT00315458|339422|P3|STARTED|Overall Study||159
139838|NCT00315458|339423|P2|STARTED|Overall Study||56
139839|NCT00315458|339424|P1|STARTED|Overall Study||51
139840|NCT00315588|339434|P1|NOT COMPLETED|Overall Study||0
139841|NCT00315588|339434|P1|COMPLETED|Overall Study||7
139842|NCT00315588|339434|P1|STARTED|Overall Study||7
139843|NCT00315614|339441|P1|NOT COMPLETED|Overall Study||0
139844|NCT00315614|339441|P1|COMPLETED|Overall Study||3
139845|NCT00315614|339441|P1|STARTED|Overall Study||3
139846|NCT00315627|339448|P1|NOT COMPLETED|Overall Study||0
139847|NCT00315627|339448|P1|COMPLETED|Overall Study||3
139848|NCT00315627|339448|P1|STARTED|Overall Study||3
139849|NCT00315705|339458|P1|NOT COMPLETED|Phase 2||25
139850|NCT00315705|339458|P1|COMPLETED|Phase 2|No Phase 2 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
139851|NCT00315705|339458|P1|STARTED|Phase 2|Phase 1 and phase 2 are separate populations|25
139852|NCT00315705|339458|P1|NOT COMPLETED|Phase 1||25
139853|NCT00315705|339458|P1|COMPLETED|Phase 1|No Phase 1 participants completed the treatment period (i.e. all 8 cycles and follow-up)|0
139854|NCT00315705|339458|P1|STARTED|Phase 1||25
139855|NCT00315731|339495|P1|NOT COMPLETED|Overall Study||6
139856|NCT00315731|339495|P1|COMPLETED|Overall Study||9
139857|NCT00315731|339495|P1|STARTED|Overall Study||15
139858|NCT00315822|339523|P2|NOT COMPLETED|Overall Study||0
139859|NCT00315822|339524|P1|NOT COMPLETED|Overall Study||0
139860|NCT00315822|339523|P2|COMPLETED|Overall Study||202
139861|NCT00315822|339524|P1|COMPLETED|Overall Study||198
139862|NCT00315822|339523|P2|STARTED|Overall Study||202
139863|NCT00315822|339524|P1|STARTED|Overall Study||198
139864|NCT00315939|339532|P2|NOT COMPLETED|Admission 3 (3 Months)||2
139865|NCT00315939|339533|P1|NOT COMPLETED|Admission 3 (3 Months)||4
139866|NCT00315939|339532|P2|COMPLETED|Admission 3 (3 Months)||49
139867|NCT00315939|339533|P1|COMPLETED|Admission 3 (3 Months)||48
139868|NCT00315939|339532|P2|STARTED|Admission 3 (3 Months)||51
139869|NCT00315939|339533|P1|STARTED|Admission 3 (3 Months)||52
139870|NCT00315939|339532|P2|NOT COMPLETED|Admission 2 (3 Months)||4
139871|NCT00315939|339533|P1|NOT COMPLETED|Admission 2 (3 Months)||4
139872|NCT00315939|339532|P2|COMPLETED|Admission 2 (3 Months)||51
139873|NCT00315939|339533|P1|COMPLETED|Admission 2 (3 Months)||52
139874|NCT00315939|339532|P2|STARTED|Admission 2 (3 Months)||55
139875|NCT00315939|339533|P1|STARTED|Admission 2 (3 Months)||56
139876|NCT00315939|339532|P2|NOT COMPLETED|Admission 1 (3 Months)||6
139877|NCT00315939|339533|P1|NOT COMPLETED|Admission 1 (3 Months)||3
139878|NCT00315939|339532|P2|COMPLETED|Admission 1 (3 Months)||55
139879|NCT00315939|339533|P1|COMPLETED|Admission 1 (3 Months)||56
139880|NCT00315939|339532|P2|STARTED|Admission 1 (3 Months)||61
139881|NCT00315939|339533|P1|STARTED|Admission 1 (3 Months)||59
139882|NCT00316004|339542|P3|NOT COMPLETED|Overall Study||21
139883|NCT00316004|339543|P2|NOT COMPLETED|Overall Study||14
139884|NCT00316004|339544|P1|NOT COMPLETED|Overall Study||14
139885|NCT00316004|339542|P3|COMPLETED|Overall Study||582
139886|NCT00316004|339543|P2|COMPLETED|Overall Study||341
139887|NCT00316004|339544|P1|COMPLETED|Overall Study||359
139888|NCT00316004|339542|P3|STARTED|Overall Study||603
139889|NCT00316004|339543|P2|STARTED|Overall Study||355
139890|NCT00316004|339544|P1|STARTED|Overall Study||373
139891|NCT00316017|339600|P3|NOT COMPLETED|Overall Study||19
139892|NCT00316017|339601|P2|NOT COMPLETED|Overall Study||13
139893|NCT00316017|339602|P1|NOT COMPLETED|Overall Study||11
139894|NCT00316017|339600|P3|COMPLETED|Overall Study||376
139895|NCT00316017|339601|P2|COMPLETED|Overall Study||256
139896|NCT00316017|339602|P1|COMPLETED|Overall Study||220
139897|NCT00316017|339600|P3|STARTED|Overall Study|19 of 19 not complete due to BONG|395
139898|NCT00316017|339601|P2|STARTED|Overall Study|12 of 13 not completed due to BONG; 1 not completed was a prisoner who was excluded|269
139899|NCT00316017|339602|P1|STARTED|Overall Study|"11 of 11 not completed due to Bag Opened Not Given (BONG)"|231
139900|NCT00316303|339675|P2|NOT COMPLETED|Overall Study||16
139901|NCT00316303|339676|P1|NOT COMPLETED|Overall Study||11
139902|NCT00316303|339675|P2|COMPLETED|Overall Study||102
139903|NCT00316303|339676|P1|COMPLETED|Overall Study||107
139904|NCT00316303|339675|P2|STARTED|Overall Study||118
139905|NCT00316303|339676|P1|STARTED|Overall Study||118
139906|NCT00316355|339692|P2|NOT COMPLETED|Overall Study||7
139907|NCT00316355|339693|P1|NOT COMPLETED|Overall Study||5
139908|NCT00316355|339692|P2|COMPLETED|Overall Study||12
139909|NCT00316355|339693|P1|COMPLETED|Overall Study||10
139910|NCT00316355|339692|P2|Started Treatment|Overall Study||18
139911|NCT00316355|339693|P1|Started Treatment|Overall Study||12
139912|NCT00316355|339692|P2|STARTED|Overall Study||19
139913|NCT00316355|339693|P1|STARTED|Overall Study||15
139914|NCT00316693|339703|P2|NOT COMPLETED|Overall Study||85
139915|NCT00316693|339704|P1|NOT COMPLETED|Overall Study||77
139916|NCT00316693|339703|P2|COMPLETED|Overall Study||436
139917|NCT00316693|339704|P1|COMPLETED|Overall Study||442
139918|NCT00316693|339703|P2|STARTED|Overall Study||521
139919|NCT00316693|339704|P1|STARTED|Overall Study||519
139920|NCT00316706|339746|P2|NOT COMPLETED|Overall Study||48
139921|NCT00316706|339747|P1|NOT COMPLETED|Overall Study||38
139922|NCT00316706|339746|P2|COMPLETED|Overall Study|Subjects in Havrix group that completed the study at Month 24|571
139923|NCT00316706|339747|P1|COMPLETED|Overall Study|Subjects in Cervarix group that completed the study at Month 48|588
139924|NCT00316706|339746|P2|STARTED|Overall Study||619
139925|NCT00316706|339747|P1|STARTED|Overall Study||626
139926|NCT00316719|339763|P2|NOT COMPLETED|Overall Study||6
139927|NCT00316719|339764|P1|NOT COMPLETED|Overall Study||2
139928|NCT00316719|339763|P2|COMPLETED|Overall Study||47
139929|NCT00316719|339764|P1|COMPLETED|Overall Study||50
139930|NCT00316719|339763|P2|STARTED|Overall Study||53
139931|NCT00316719|339764|P1|STARTED|Overall Study||52
139932|NCT00316862|339788|P1|NOT COMPLETED|Overall Study||0
139933|NCT00316862|339788|P1|COMPLETED|Overall Study||82
139934|NCT00316862|339788|P1|STARTED|Overall Study||82
139935|NCT00316888|339796|P2|NOT COMPLETED|Overall Study||8
139936|NCT00316888|339797|P1|NOT COMPLETED|Overall Study||6
139937|NCT00316888|339796|P2|COMPLETED|Overall Study||27
139938|NCT00316888|339797|P1|COMPLETED|Overall Study||22
139939|NCT00316888|339796|P2|Started Chemo+Radiation+Cetuximab|Overall Study||34
139940|NCT00316888|339797|P1|Started Chemo+Radiation+Cetuximab|Overall Study|One patient did not start chemo+radiation therapy after completing induction therapy|27
139941|NCT00316888|339796|P2|Started Induction Chemotherapy|Overall Study|Induction chemotherapy was removed for patients on this arm|0
139942|NCT00316888|339797|P1|Started Induction Chemotherapy|Overall Study||28
139943|NCT00316888|339796|P2|Treated|Overall Study||34
139944|NCT00316888|339797|P1|Treated|Overall Study|Received induction and/or chemo+radiation therapy|28
139945|NCT00316888|339796|P2|Eligible|Overall Study||35
139946|NCT00316888|339797|P1|Eligible|Overall Study||28
139947|NCT00316888|339796|P2|STARTED|Overall Study||35
139948|NCT00316888|339797|P1|STARTED|Overall Study||28
139949|NCT00316914|339813|P2|NOT COMPLETED|Overall Study||36
139950|NCT00316914|339814|P1|NOT COMPLETED|Overall Study||33
139951|NCT00316914|339813|P2|COMPLETED|Overall Study||16
139952|NCT00316914|339814|P1|COMPLETED|Overall Study||17
139953|NCT00316914|339813|P2|STARTED|Overall Study||52
139954|NCT00316914|339814|P1|STARTED|Overall Study||50
139955|NCT00317044|339845|P3|NOT COMPLETED|Overall Study||45
139956|NCT00317044|339846|P2|NOT COMPLETED|Overall Study||40
139957|NCT00317044|339847|P1|NOT COMPLETED|Overall Study||48
139958|NCT00317044|339845|P3|COMPLETED|Overall Study||283
139959|NCT00317044|339846|P2|COMPLETED|Overall Study||273
139960|NCT00317044|339847|P1|COMPLETED|Overall Study||272
139961|NCT00317044|339845|P3|STARTED|Overall Study||328
139962|NCT00317044|339846|P2|STARTED|Overall Study||313
139963|NCT00317044|339847|P1|STARTED|Overall Study||320
139964|NCT00317109|339893|P2|NOT COMPLETED|Overall Study||0
139965|NCT00317109|339894|P1|NOT COMPLETED|Overall Study||3
139966|NCT00317109|339893|P2|COMPLETED|Overall Study||84
139967|NCT00317109|339894|P1|COMPLETED|Overall Study||81
139968|NCT00317109|339893|P2|STARTED|Overall Study||84
139969|NCT00317109|339894|P1|STARTED|Overall Study||84
139970|NCT00317226|339928|P1|NOT COMPLETED|Overall Study||23
139971|NCT00317226|339928|P1|COMPLETED|Overall Study||104
139972|NCT00317226|339928|P1|STARTED|Overall Study||127
139973|NCT00317239|339934|P2|NOT COMPLETED|Overall Study||19
139974|NCT00317239|339935|P1|NOT COMPLETED|Overall Study||13
139975|NCT00317239|339934|P2|COMPLETED|Overall Study||84
139976|NCT00317239|339935|P1|COMPLETED|Overall Study||134
139977|NCT00317239|339934|P2|STARTED|Overall Study||103
139978|NCT00317239|339935|P1|STARTED|Overall Study||147
139979|NCT00317642|339943|P2|NOT COMPLETED|Overall Study||135
139980|NCT00317642|339944|P1|NOT COMPLETED|Overall Study||122
139981|NCT00317642|339943|P2|COMPLETED|Overall Study|achieved remission and completed consolidation|28
139982|NCT00317642|339944|P1|COMPLETED|Overall Study|achieved remission and completed consolidation|41
139983|NCT00317642|339943|P2|Received >= 1 Study Drug (Safety Set)|Overall Study||155
139984|NCT00317642|339944|P1|Received >= 1 Study Drug (Safety Set)|Overall Study||161
139985|NCT00317642|339943|P2|Full Analysis Set|Overall Study|AML Centrally Confirmed|158
139986|NCT00317642|339944|P1|Full Analysis Set|Overall Study|AML Centrally Confirmed|162
139987|NCT00317642|339943|P2|STARTED|Overall Study||163
139988|NCT00317642|339944|P1|STARTED|Overall Study||163
139989|NCT00317720|340017|P2|NOT COMPLETED|Overall Study||0
139990|NCT00317720|340018|P1|NOT COMPLETED|Overall Study||0
139991|NCT00317720|340017|P2|COMPLETED|Overall Study||7
139992|NCT00317720|340018|P1|COMPLETED|Overall Study||40
139993|NCT00317720|340017|P2|STARTED|Overall Study||7
139994|NCT00317720|340018|P1|STARTED|Overall Study||40
139995|NCT00317941|340025|P3|NOT COMPLETED|Overall Study||8
139996|NCT00317941|340026|P2|NOT COMPLETED|Overall Study||5
139997|NCT00317941|340027|P1|NOT COMPLETED|Overall Study||7
139998|NCT00317941|340025|P3|COMPLETED|Overall Study||60
139999|NCT00317941|340026|P2|COMPLETED|Overall Study||74
140000|NCT00317941|340027|P1|COMPLETED|Overall Study||66
140001|NCT00317941|340025|P3|Fulfilled Requirements PP Population|Overall Study||63
140002|NCT00317941|340026|P2|Fulfilled Requirements PP Population|Overall Study||76
140003|NCT00317941|340027|P1|Fulfilled Requirements PP Population|Overall Study||66
140004|NCT00317941|340025|P3|Fulfilled Requirement Safety Population|Overall Study||65
140005|NCT00317941|340026|P2|Fulfilled Requirement Safety Population|Overall Study||77
140006|NCT00317941|340027|P1|Fulfilled Requirement Safety Population|Overall Study||73
140007|NCT00317941|340025|P3|Participants Received Treatment|Overall Study||68
140008|NCT00317941|340026|P2|Participants Received Treatment|Overall Study||79
140009|NCT00317941|340027|P1|Participants Received Treatment|Overall Study||73
140010|NCT00317941|340025|P3|STARTED|Overall Study||68
140011|NCT00317941|340026|P2|STARTED|Overall Study||79
140012|NCT00317941|340027|P1|STARTED|Overall Study||73
140013|NCT00318136|340068|P1|NOT COMPLETED|Overall Study||45
140014|NCT00318136|340068|P1|COMPLETED|Overall Study||2
140015|NCT00318136|340068|P1|STARTED|Overall Study||47
140016|NCT00318292|340077|P2|NOT COMPLETED|Overall Study||0
140017|NCT00318292|340078|P1|NOT COMPLETED|Overall Study||0
140018|NCT00318292|340077|P2|COMPLETED|Overall Study||45
140019|NCT00318292|340078|P1|COMPLETED|Overall Study||45
140020|NCT00318292|340077|P2|STARTED|Overall Study||45
140021|NCT00318292|340078|P1|STARTED|Overall Study||45
140022|NCT00318370|340084|P3|NOT COMPLETED|Period 3||33
140023|NCT00318370|340085|P2|NOT COMPLETED|Period 3||0
140024|NCT00318370|340086|P1|NOT COMPLETED|Period 3||0
140025|NCT00318370|340084|P3|COMPLETED|Period 3||3
140026|NCT00318370|340085|P2|COMPLETED|Period 3||0
140027|NCT00318370|340086|P1|COMPLETED|Period 3||0
140028|NCT00318370|340084|P3|STARTED|Period 3||36
140029|NCT00318370|340085|P2|STARTED|Period 3||0
140030|NCT00318370|340086|P1|STARTED|Period 3||0
140031|NCT00318370|340084|P3|NOT COMPLETED|Period 2||0
140032|NCT00318370|340085|P2|NOT COMPLETED|Period 2||11
140033|NCT00318370|340086|P1|NOT COMPLETED|Period 2||0
140034|NCT00318370|340084|P3|COMPLETED|Period 2||0
140035|NCT00318370|340085|P2|COMPLETED|Period 2||36
140036|NCT00318370|340086|P1|COMPLETED|Period 2||0
140037|NCT00318370|340084|P3|STARTED|Period 2||0
140038|NCT00318370|340085|P2|STARTED|Period 2|26 participants enrolled directly into Chemo Plus Far plus 21 participants from Far Only.|47
140039|NCT00318370|340086|P1|STARTED|Period 2||0
140040|NCT00318370|340084|P3|NOT COMPLETED|Period 1||0
140041|NCT00318370|340085|P2|NOT COMPLETED|Period 1||0
140042|NCT00318370|340086|P1|NOT COMPLETED|Period 1||7
140043|NCT00318370|340084|P3|COMPLETED|Period 1||0
140044|NCT00318370|340085|P2|COMPLETED|Period 1||0
140045|NCT00318370|340086|P1|COMPLETED|Period 1|21 participants proceeded from Far Only to Chemo Plus Far.|21
140046|NCT00318370|340084|P3|STARTED|Period 1||0
140047|NCT00318370|340085|P2|STARTED|Period 1||0
140048|NCT00318370|340086|P1|STARTED|Period 1||28
140049|NCT00318409|340098|P2|NOT COMPLETED|Overall Study||1
140050|NCT00318409|340099|P1|NOT COMPLETED|Overall Study||2
140051|NCT00318409|340098|P2|COMPLETED|Overall Study||9
140052|NCT00318409|340099|P1|COMPLETED|Overall Study||18
140053|NCT00318409|340098|P2|STARTED|Overall Study||10
140054|NCT00318409|340099|P1|STARTED|Overall Study||20
140055|NCT00318461|340123|P5|NOT COMPLETED|Open-Label Extension, 18 Months||97
140056|NCT00318461|340124|P4|NOT COMPLETED|Open-Label Extension, 18 Months||43
140057|NCT00318461|340125|P3|NOT COMPLETED|Open-Label Extension, 18 Months||73
140058|NCT00318461|340126|P2|NOT COMPLETED|Open-Label Extension, 18 Months||60
140059|NCT00318461|340127|P1|NOT COMPLETED|Open-Label Extension, 18 Months||78
140060|NCT00318461|340123|P5|COMPLETED|Open-Label Extension, 18 Months||113
140061|NCT00318461|340124|P4|COMPLETED|Open-Label Extension, 18 Months||31
140062|NCT00318461|340125|P3|COMPLETED|Open-Label Extension, 18 Months||118
140063|NCT00318461|340126|P2|COMPLETED|Open-Label Extension, 18 Months||137
140064|NCT00318461|340127|P1|COMPLETED|Open-Label Extension, 18 Months||130
140065|NCT00318461|340123|P5|STARTED|Open-Label Extension, 18 Months||210
140066|NCT00318461|340124|P4|STARTED|Open-Label Extension, 18 Months||74
140067|NCT00318461|340125|P3|STARTED|Open-Label Extension, 18 Months||191
140068|NCT00318461|340126|P2|STARTED|Open-Label Extension, 18 Months||197
140069|NCT00318461|340127|P1|STARTED|Open-Label Extension, 18 Months||208
140070|NCT00318461|340123|P5|NOT COMPLETED|Double-Blind, 6 Months||34
140071|NCT00318461|340124|P4|NOT COMPLETED|Double-Blind, 6 Months||48
140072|NCT00318461|340125|P3|NOT COMPLETED|Double-Blind, 6 Months||51
140073|NCT00318461|340126|P2|NOT COMPLETED|Double-Blind, 6 Months||44
140074|NCT00318461|340127|P1|NOT COMPLETED|Double-Blind, 6 Months||34
140075|NCT00318461|340123|P5|COMPLETED|Double-Blind, 6 Months||210
140076|NCT00318461|340124|P4|COMPLETED|Double-Blind, 6 Months||74
140077|NCT00318461|340125|P3|COMPLETED|Double-Blind, 6 Months||191
140078|NCT00318461|340126|P2|COMPLETED|Double-Blind, 6 Months||197
140079|NCT00318461|340127|P1|COMPLETED|Double-Blind, 6 Months||208
140080|NCT00318461|340123|P5|Exposed to Study Drug|Double-Blind, 6 Months|Subjects withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|242
140081|NCT00318461|340124|P4|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|121
140082|NCT00318461|340125|P3|Exposed to Study Drug|Double-Blind, 6 Months||242
140083|NCT00318461|340126|P2|Exposed to Study Drug|Double-Blind, 6 Months|Subject withdrew before exposure to drug, and thus not included in the safety and ITT analysis sets|240
140084|NCT00318461|340127|P1|Exposed to Study Drug|Double-Blind, 6 Months||242
140085|NCT00318461|340123|P5|STARTED|Double-Blind, 6 Months|Randomised|244
140086|NCT00318461|340124|P4|STARTED|Double-Blind, 6 Months|Randomised|122
140087|NCT00318461|340125|P3|STARTED|Double-Blind, 6 Months|Randomised|242
140088|NCT00318461|340126|P2|STARTED|Double-Blind, 6 Months|Randomised|241
140089|NCT00318461|340127|P1|STARTED|Double-Blind, 6 Months|Randomised|242
140090|NCT00318474|340206|P2|NOT COMPLETED|Overall Study||17
140091|NCT00318474|340207|P1|NOT COMPLETED|Overall Study||18
140092|NCT00318474|340206|P2|COMPLETED|Overall Study||10
140093|NCT00318474|340207|P1|COMPLETED|Overall Study||7
140094|NCT00318474|340206|P2|STARTED|Overall Study||27
140095|NCT00318474|340207|P1|STARTED|Overall Study||25
140096|NCT00318565|340213|P1|NOT COMPLETED|Overall Study||24
140097|NCT00318565|340213|P1|COMPLETED|Overall Study||267
140098|NCT00318565|340213|P1|STARTED|Overall Study||291
140099|NCT00318591|340220|P2|NOT COMPLETED|Overall Study||45
140100|NCT00318591|340221|P1|NOT COMPLETED|Overall Study||60
140101|NCT00318591|340220|P2|COMPLETED|Overall Study||69
140102|NCT00318591|340221|P1|COMPLETED|Overall Study||45
140103|NCT00318591|340220|P2|STARTED|Overall Study||114
140104|NCT00318591|340221|P1|STARTED|Overall Study||105
140105|NCT00318656|340241|P2|NOT COMPLETED|Overall Study||2
140106|NCT00318656|340242|P1|NOT COMPLETED|Overall Study||0
140107|NCT00318656|340241|P2|COMPLETED|Overall Study|1 patient received by error avandamet treatment and 1 patient did not receive any treatment.|9
140108|NCT00318656|340242|P1|COMPLETED|Overall Study||12
140109|NCT00318656|340241|P2|STARTED|Overall Study||11
140110|NCT00318656|340242|P1|STARTED|Overall Study||12
140111|NCT00318708|340280|P2|NOT COMPLETED|Overall Study||5
140112|NCT00318708|340281|P1|NOT COMPLETED|Overall Study||8
140113|NCT00318708|340280|P2|COMPLETED|Overall Study||40
140114|NCT00318708|340281|P1|COMPLETED|Overall Study||39
140115|NCT00318708|340280|P2|8-week Milestone|Overall Study||42
140116|NCT00318708|340281|P1|8-week Milestone|Overall Study||42
140117|NCT00318708|340280|P2|STARTED|Overall Study||45
140118|NCT00318708|340281|P1|STARTED|Overall Study||47
140119|NCT00312338|340289|P2|NOT COMPLETED|Overall Study||3
140120|NCT00312338|340290|P1|NOT COMPLETED|Overall Study||22
140121|NCT00312338|340289|P2|COMPLETED|Overall Study||54
140122|NCT00312338|340290|P1|COMPLETED|Overall Study||83
140123|NCT00312338|340289|P2|STARTED|Overall Study||57
140124|NCT00312338|340290|P1|STARTED|Overall Study||105
140125|NCT00312377|340302|P2|NOT COMPLETED|Overall Study||668
140126|NCT00312377|340303|P1|NOT COMPLETED|Overall Study||644
140127|NCT00312377|340302|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|29
140128|NCT00312377|340303|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|50
140129|NCT00312377|340302|P2|STARTED|Overall Study|randomised patients|697
140130|NCT00312377|340303|P1|STARTED|Overall Study|randomised patients|694
140131|NCT00312494|340328|P3|NOT COMPLETED|Overall Study||43
140132|NCT00312494|340329|P2|NOT COMPLETED|Overall Study||58
140133|NCT00312494|340330|P1|NOT COMPLETED|Overall Study||71
140134|NCT00312494|340328|P3|COMPLETED|Overall Study||179
140135|NCT00312494|340329|P2|COMPLETED|Overall Study||168
140136|NCT00312494|340330|P1|COMPLETED|Overall Study|1 subject randomized to higher dose; received lower dose baseline and/or week 1; higher dose week 2.|161
140137|NCT00312494|340328|P3|Received Study Treatment|Overall Study||217
140138|NCT00312494|340329|P2|Received Study Treatment|Overall Study||216
140139|NCT00312494|340330|P1|Received Study Treatment|Overall Study|1 subject randomized to higher dose; received lower dose at baseline, higher dose weeks 1 and 2.|223
140140|NCT00312494|340328|P3|STARTED|Overall Study||222
140141|NCT00312494|340329|P2|STARTED|Overall Study||226
140142|NCT00312494|340330|P1|STARTED|Overall Study||232
140143|NCT00312572|340364|P2|NOT COMPLETED|Overall Study||21
140144|NCT00312572|340365|P1|NOT COMPLETED|Overall Study||16
140145|NCT00312572|340364|P2|COMPLETED|Overall Study||82
140146|NCT00312572|340365|P1|COMPLETED|Overall Study||85
140147|NCT00312572|340364|P2|STARTED|Overall Study||103
140148|NCT00312572|340365|P1|STARTED|Overall Study||101
140149|NCT00312728|340373|P1|NOT COMPLETED|Overall Study||110
140150|NCT00312728|340373|P1|COMPLETED|Overall Study||5
140151|NCT00312728|340373|P1|STARTED|Overall Study||115
140152|NCT00312845|340384|P2|NOT COMPLETED|Overall Study||95
140153|NCT00312845|340385|P1|NOT COMPLETED|Overall Study||99
140154|NCT00312845|340384|P2|COMPLETED|Overall Study||245
140155|NCT00312845|340385|P1|COMPLETED|Overall Study||237
140156|NCT00312845|340384|P2|STARTED|Overall Study||340
140157|NCT00312845|340385|P1|STARTED|Overall Study||336
140158|NCT00312858|340395|P2|NOT COMPLETED|Overall Study||93
140159|NCT00312858|340396|P1|NOT COMPLETED|Overall Study||68
140160|NCT00312858|340395|P2|COMPLETED|Overall Study||230
140161|NCT00312858|340396|P1|COMPLETED|Overall Study||262
140162|NCT00312858|340395|P2|Visit 4|Overall Study||240
140163|NCT00312858|340396|P1|Visit 4|Overall Study||262
140164|NCT00312858|340395|P2|Visit 3|Overall Study||261
140165|NCT00312858|340396|P1|Visit 3|Overall Study||273
140166|NCT00312858|340395|P2|Visit 2|Overall Study||294
140167|NCT00312858|340396|P1|Visit 2|Overall Study||305
140168|NCT00312858|340395|P2|Visit 1|Overall Study||323
140169|NCT00312858|340396|P1|Visit 1|Overall Study||330
140170|NCT00312858|340395|P2|STARTED|Overall Study||323
140171|NCT00312858|340396|P1|STARTED|Overall Study||330
140172|NCT00312884|340450|P2|NOT COMPLETED|Overall Study||12
140173|NCT00312884|340451|P1|NOT COMPLETED|Overall Study||17
140174|NCT00312884|340450|P2|COMPLETED|Overall Study||79
140175|NCT00312884|340451|P1|COMPLETED|Overall Study||74
140176|NCT00312884|340450|P2|STARTED|Overall Study||91
140177|NCT00312884|340451|P1|STARTED|Overall Study||91
140178|NCT00312923|340465|P2|NOT COMPLETED|Overall Study||6
140179|NCT00312923|340466|P1|NOT COMPLETED|Overall Study||9
140180|NCT00312923|340465|P2|COMPLETED|Overall Study||20
140181|NCT00312923|340466|P1|COMPLETED|Overall Study||19
140182|NCT00312923|340465|P2|STARTED|Overall Study||26
140183|NCT00312923|340466|P1|STARTED|Overall Study||28
140184|NCT00313014|340477|P3|NOT COMPLETED|Overall Study||61
140185|NCT00313014|340478|P2|NOT COMPLETED|Overall Study||73
140186|NCT00313014|340479|P1|NOT COMPLETED|Overall Study||93
140187|NCT00313014|340477|P3|COMPLETED|Overall Study||159
140188|NCT00313014|340478|P2|COMPLETED|Overall Study||146
140189|NCT00313014|340479|P1|COMPLETED|Overall Study||128
140190|NCT00313014|340477|P3|STARTED|Overall Study||220
140191|NCT00313014|340478|P2|STARTED|Overall Study||219
140192|NCT00313014|340479|P1|STARTED|Overall Study||221
140193|NCT00313144|340497|P1|NOT COMPLETED|Overall Study||110
140194|NCT00313144|340497|P1|COMPLETED|Overall Study||17
140195|NCT00313144|340497|P1|STARTED|Overall Study||127
140196|NCT00313170|340584|P3|NOT COMPLETED|Overall Study||32
140197|NCT00313170|340585|P2|NOT COMPLETED|Overall Study||35
140198|NCT00313170|340586|P1|NOT COMPLETED|Overall Study||36
140199|NCT00313170|340584|P3|COMPLETED|Overall Study||14
140200|NCT00313170|340585|P2|COMPLETED|Overall Study||16
140201|NCT00313170|340586|P1|COMPLETED|Overall Study||11
140202|NCT00313170|340584|P3|STARTED|Overall Study||46
140203|NCT00313170|340585|P2|STARTED|Overall Study||51
140204|NCT00313170|340586|P1|STARTED|Overall Study||47
140205|NCT00313209|340604|P2|NOT COMPLETED|Overall Study||82
140206|NCT00313209|340605|P1|NOT COMPLETED|Overall Study||107
140207|NCT00313209|340604|P2|COMPLETED|Overall Study||385
140208|NCT00313209|340605|P1|COMPLETED|Overall Study||359
140209|NCT00313209|340604|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|467
140210|NCT00313209|340605|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|466
140211|NCT00330161|340619|P1|NOT COMPLETED|Overall Study||0
140212|NCT00330161|340619|P1|COMPLETED|Overall Study||29
140213|NCT00330161|340619|P1|STARTED|Overall Study||29
140214|NCT00330174|340630|P2|NOT COMPLETED|Overall Study||19
140215|NCT00330174|340631|P1|NOT COMPLETED|Overall Study||22
140216|NCT00330174|340630|P2|COMPLETED|Overall Study||26
140217|NCT00330174|340631|P1|COMPLETED|Overall Study||23
140218|NCT00330174|340630|P2|STARTED|Overall Study||45
140219|NCT00330174|340631|P1|STARTED|Overall Study||45
140220|NCT00330421|340643|P2|NOT COMPLETED|Overall Study||0
140221|NCT00330421|340644|P1|NOT COMPLETED|Overall Study||0
140222|NCT00330421|340643|P2|COMPLETED|Overall Study||0
140223|NCT00330421|340644|P1|COMPLETED|Overall Study||15
140224|NCT00330421|340643|P2|STARTED|Overall Study||0
140225|NCT00330421|340644|P1|STARTED|Overall Study||15
140226|NCT00330460|340650|P2|NOT COMPLETED|Overall Study||33
140227|NCT00330460|340651|P1|NOT COMPLETED|Overall Study||42
140228|NCT00330460|340650|P2|COMPLETED|Overall Study||561
140229|NCT00330460|340651|P1|COMPLETED|Overall Study||553
140230|NCT00330460|340650|P2|STARTED|Overall Study||594
140231|NCT00330460|340651|P1|STARTED|Overall Study||595
140232|NCT00330564|340665|P1|NOT COMPLETED|Overall Study||0
140233|NCT00330564|340665|P1|COMPLETED|Overall Study||15
140234|NCT00330564|340665|P1|STARTED|Overall Study||15
140235|NCT00330616|340670|P1|NOT COMPLETED|Overall Study||21
140236|NCT00330616|340670|P1|COMPLETED|Overall Study||14
140237|NCT00330616|340670|P1|STARTED|Overall Study||35
140238|NCT00330668|340689|P1|NOT COMPLETED|Overall Study||114
140239|NCT00330668|340689|P1|COMPLETED|Overall Study||0
140240|NCT00330668|340689|P1|STARTED|Overall Study||114
140241|NCT00330681|340698|P2|NOT COMPLETED|Overall Study||14
140242|NCT00330681|340699|P1|NOT COMPLETED|Overall Study||9
140243|NCT00330681|340698|P2|COMPLETED|Overall Study||90
140244|NCT00330681|340699|P1|COMPLETED|Overall Study||93
140245|NCT00330681|340698|P2|STARTED|Overall Study||104
140246|NCT00330681|340699|P1|STARTED|Overall Study||102
140247|NCT00330733|340723|P2|NOT COMPLETED|Overall Study||5
140248|NCT00330733|340724|P1|NOT COMPLETED|Overall Study||7
140249|NCT00330733|340723|P2|COMPLETED|Overall Study||29
140250|NCT00330733|340724|P1|COMPLETED|Overall Study||30
140251|NCT00330733|340723|P2|Received Study Medication|Overall Study||34
140252|NCT00330733|340724|P1|Received Study Medication|Overall Study||36
140253|NCT00330733|340723|P2|STARTED|Overall Study||34
140254|NCT00330733|340724|P1|STARTED|Overall Study||37
140255|NCT00330759|340732|P2|NOT COMPLETED|Overall Study||706
140256|NCT00330759|340733|P1|NOT COMPLETED|Overall Study||712
140257|NCT00330759|340732|P2|COMPLETED|Overall Study||180
140258|NCT00330759|340733|P1|COMPLETED|Overall Study||178
140259|NCT00330759|340732|P2|Received Investigational Product|Overall Study||878
140260|NCT00330759|340733|P1|Received Investigational Product|Overall Study||878
140261|NCT00330759|340732|P2|STARTED|Overall Study||886
140262|NCT00330759|340733|P1|STARTED|Overall Study||890
140263|NCT00330876|340743|P2|NOT COMPLETED|Overall Study||13
140264|NCT00330876|340744|P1|NOT COMPLETED|Overall Study||71
140265|NCT00330876|340743|P2|COMPLETED|Overall Study||77
140266|NCT00330876|340744|P1|COMPLETED|Overall Study||378
140267|NCT00330876|340743|P2|STARTED|Overall Study||90
140268|NCT00330876|340744|P1|STARTED|Overall Study||449
140269|NCT00330915|340752|P1|NOT COMPLETED|Overall Study||0
140270|NCT00330915|340752|P1|COMPLETED|Overall Study||37
140271|NCT00330915|340752|P1|STARTED|Overall Study||37
140272|NCT00330928|340759|P1|NOT COMPLETED|Overall Study||17
140273|NCT00330928|340759|P1|COMPLETED|Overall Study||89
140274|NCT00330928|340759|P1|1 Year Phone Contact|Overall Study||89
140275|NCT00330928|340759|P1|7 Day Phone Contact|Overall Study||99
140276|NCT00330928|340759|P1|STARTED|Overall Study|Subjects that signed consent and were subject to research procedures.|106
140277|NCT00330967|340766|P2|NOT COMPLETED|Overall Study||14
140278|NCT00330967|340767|P1|NOT COMPLETED|Overall Study||0
140279|NCT00330967|340766|P2|COMPLETED|Overall Study||11
140280|NCT00330967|340767|P1|COMPLETED|Overall Study||0
140281|NCT00330967|340766|P2|STARTED|Overall Study||25
140282|NCT00330967|340767|P1|STARTED|Overall Study||0
140283|NCT00331006|340778|P1|NOT COMPLETED|Follow-Up Phase II||3
140284|NCT00331006|340778|P1|COMPLETED|Follow-Up Phase II||11
140285|NCT00331006|340778|P1|STARTED|Follow-Up Phase II||14
140286|NCT00331006|340778|P1|NOT COMPLETED|Follow-Up Phase I||1
140287|NCT00331006|340778|P1|COMPLETED|Follow-Up Phase I||14
140288|NCT00331006|340778|P1|STARTED|Follow-Up Phase I||15
140289|NCT00331006|340778|P1|NOT COMPLETED|Treatment Phase||1
140290|NCT00331006|340778|P1|COMPLETED|Treatment Phase||15
140291|NCT00331006|340778|P1|STARTED|Treatment Phase||16
140292|NCT00331006|340778|P1|NOT COMPLETED|Screening Phase||7
140293|NCT00331006|340778|P1|COMPLETED|Screening Phase|subjects eligible for the treatment phase if inhibitor titer following Factor VIII was at least 5 BU|16
140294|NCT00331006|340778|P1|STARTED|Screening Phase||23
140295|NCT00331409|340789|P1|NOT COMPLETED|Overall Study||4
140296|NCT00331409|340789|P1|COMPLETED|Overall Study|15 patients accrued to the first stage;if>9 were progression-free at 3 months,enrollment continued.|15
140297|NCT00331409|340789|P1|STARTED|Overall Study|19 patients were enrolled in the first stage due to 4 patients who withdrew early.|19
140298|NCT00331422|340796|P1|NOT COMPLETED|Overall Study||5
140299|NCT00331422|340796|P1|COMPLETED|Overall Study|Completed all 6 courses of chemotherapy and had surgery to remove all tumor lesions.|2
140300|NCT00331422|340796|P1|STARTED|Overall Study|Patients who met study criteria and received at least one dose of study drug.|7
140301|NCT00331552|340807|P2|NOT COMPLETED|Period 3: Phase II||0
140302|NCT00331552|340808|P1|NOT COMPLETED|Period 3: Phase II||2
140303|NCT00331552|340807|P2|COMPLETED|Period 3: Phase II||0
140304|NCT00331552|340808|P1|COMPLETED|Period 3: Phase II||22
140305|NCT00331552|340807|P2|STARTED|Period 3: Phase II||0
140306|NCT00331552|340808|P1|STARTED|Period 3: Phase II||24
140307|NCT00331552|340807|P2|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
140308|NCT00331552|340808|P1|NOT COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
140309|NCT00331552|340807|P2|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
140310|NCT00331552|340808|P1|COMPLETED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
140311|NCT00331552|340807|P2|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||3
140312|NCT00331552|340808|P1|STARTED|Period 2: Doxil 35 mg/m^2 (Phase I)||0
140313|NCT00331552|340807|P2|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
140314|NCT00331552|340808|P1|NOT COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
140315|NCT00331552|340807|P2|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
140316|NCT00331552|340808|P1|COMPLETED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
140317|NCT00331552|340807|P2|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||0
140318|NCT00331552|340808|P1|STARTED|Period 1: Doxil 30 mg/m^2 (Phase I)||3
140319|NCT00331682|340822|P1|NOT COMPLETED|Overall Study||1
140320|NCT00331682|340822|P1|COMPLETED|Overall Study||9
140321|NCT00331682|340822|P1|STARTED|Overall Study||10
140322|NCT00331760|340830|P2|NOT COMPLETED|Overall Study||8
140323|NCT00331760|340831|P1|NOT COMPLETED|Overall Study||15
140324|NCT00331760|340830|P2|COMPLETED|Overall Study||40
140325|NCT00331760|340831|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|43
140326|NCT00331760|340830|P2|STARTED|Overall Study||48
140327|NCT00331760|340831|P1|STARTED|Overall Study||58
140328|NCT00331773|340839|P2|NOT COMPLETED|Overall Study||7
140329|NCT00331773|340840|P1|NOT COMPLETED|Overall Study||16
140330|NCT00331773|340839|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|550
140331|NCT00331773|340840|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|542
140332|NCT00331773|340839|P2|STARTED|Overall Study||557
140333|NCT00331773|340840|P1|STARTED|Overall Study||558
140334|NCT00331799|340866|P1|NOT COMPLETED|Overall Study||3
140335|NCT00331799|340866|P1|COMPLETED|Overall Study||15
140336|NCT00331799|340866|P1|STARTED|Overall Study||18
140337|NCT00331864|340872|P2|NOT COMPLETED|Overall Study||4
140338|NCT00331864|340873|P1|NOT COMPLETED|Overall Study||58
140339|NCT00331864|340872|P2|COMPLETED|Overall Study||14
140340|NCT00331864|340873|P1|COMPLETED|Overall Study||455
140341|NCT00331864|340872|P2|STARTED|Overall Study||18
140342|NCT00331864|340873|P1|STARTED|Overall Study||513
140343|NCT00332163|340894|P2|NOT COMPLETED|Overall Study||0
140344|NCT00332163|340895|P1|NOT COMPLETED|Overall Study||0
140345|NCT00332163|340894|P2|COMPLETED|Overall Study||47
140346|NCT00332163|340895|P1|COMPLETED|Overall Study||48
140347|NCT00332163|340894|P2|Received Treatment|Overall Study||47
140348|NCT00332163|340895|P1|Received Treatment|Overall Study||48
140349|NCT00332163|340894|P2|STARTED|Overall Study||47
140350|NCT00332163|340895|P1|STARTED|Overall Study||48
140351|NCT00332189|340927|P1|NOT COMPLETED|Overall Study||21
140352|NCT00332189|340927|P1|COMPLETED|Overall Study|Subjects in this extension study continued until there was market approval in their region.|90
140353|NCT00332189|340927|P1|STARTED|Overall Study||111
140354|NCT00332241|340934|P2|NOT COMPLETED|Overall Study||8
140355|NCT00332241|340935|P1|NOT COMPLETED|Overall Study||15
140356|NCT00332241|340934|P2|COMPLETED|Overall Study||39
140357|NCT00332241|340935|P1|COMPLETED|Overall Study||36
140358|NCT00332241|340934|P2|STARTED|Overall Study||47
140359|NCT00332241|340935|P1|STARTED|Overall Study||51
140360|NCT00332332|340955|P1|NOT COMPLETED|Overall Study||68
140361|NCT00332332|340955|P1|COMPLETED|Overall Study||178
140362|NCT00332332|340955|P1|Received Study Medication|Overall Study||230
140363|NCT00332332|340955|P1|STARTED|Overall Study||246
140364|NCT00332462|340962|P1|NOT COMPLETED|Overall Study||16
140365|NCT00332462|340962|P1|COMPLETED|Overall Study||18
140366|NCT00332462|340962|P1|Patients Treated With Sandimmun® Optoral|Overall Study||29
140367|NCT00332462|340962|P1|Patients Treated With Sandimmun® i.v.|Overall Study||34
140368|NCT00332462|340962|P1|STARTED|Overall Study|Safety and Intention to treat population.|34
140369|NCT00332488|340972|P3|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||21
140370|NCT00332488|340973|P2|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
140371|NCT00332488|340974|P1|NOT COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||2
140372|NCT00332488|340972|P3|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||233
140373|NCT00332488|340973|P2|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||70
140374|NCT00332488|340974|P1|COMPLETED|Transfer Treatment Phase (Weeks 12 – 24)||27
140375|NCT00332488|340972|P3|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects in this arm who met HbA1c criteria + subjects from other arms who did not|254
140376|NCT00332488|340973|P2|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on treatment who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|72
140377|NCT00332488|340974|P1|STARTED|Transfer Treatment Phase (Weeks 12 – 24)|Subjects on TI who achieved an HbA1c < 7.5% or had an HbA1c decrease from baseline >= 1.0%|29
140378|NCT00332488|340972|P3|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||56
140379|NCT00332488|340973|P2|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||18
140380|NCT00332488|340974|P1|NOT COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||50
140381|NCT00332488|340972|P3|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||119
140382|NCT00332488|340973|P2|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||152
140383|NCT00332488|340974|P1|COMPLETED|Initial Treatment Phase (Weeks 0 - 12)||133
140384|NCT00332488|340972|P3|STARTED|Initial Treatment Phase (Weeks 0 - 12)||175
140385|NCT00332488|340973|P2|STARTED|Initial Treatment Phase (Weeks 0 - 12)||170
140386|NCT00332488|340974|P1|STARTED|Initial Treatment Phase (Weeks 0 - 12)||183
140387|NCT00332579|340988|P2|NOT COMPLETED|Overall Study||1
140388|NCT00332579|340989|P1|NOT COMPLETED|Overall Study||1
140389|NCT00332579|340988|P2|COMPLETED|Overall Study||12
140390|NCT00332579|340989|P1|COMPLETED|Overall Study||11
140391|NCT00332579|340988|P2|STARTED|Overall Study||13
140392|NCT00332579|340989|P1|STARTED|Overall Study||12
140393|NCT00332605|340998|P3|NOT COMPLETED|Overall Study||8
140394|NCT00332605|340999|P2|NOT COMPLETED|Overall Study||2
140395|NCT00332605|341000|P1|NOT COMPLETED|Overall Study||2
140396|NCT00332605|340998|P3|COMPLETED|Overall Study||9
140397|NCT00332605|340999|P2|COMPLETED|Overall Study||12
140398|NCT00332605|341000|P1|COMPLETED|Overall Study||12
140399|NCT00332605|340998|P3|STARTED|Overall Study||17
140400|NCT00332605|340999|P2|STARTED|Overall Study||14
140401|NCT00332605|341000|P1|STARTED|Overall Study||14
140402|NCT00332644|341014|P6|NOT COMPLETED|Overall Study||15
140403|NCT00332644|341015|P5|NOT COMPLETED|Overall Study||12
140404|NCT00332644|341016|P4|NOT COMPLETED|Overall Study||20
140405|NCT00332644|341017|P3|NOT COMPLETED|Overall Study||9
140406|NCT00332644|341018|P2|NOT COMPLETED|Overall Study||22
140407|NCT00332644|341019|P1|NOT COMPLETED|Overall Study||12
140408|NCT00332644|341014|P6|COMPLETED|Overall Study||174
140409|NCT00332644|341015|P5|COMPLETED|Overall Study||250
140410|NCT00332644|341016|P4|COMPLETED|Overall Study||244
140411|NCT00332644|341017|P3|COMPLETED|Overall Study||258
140412|NCT00332644|341018|P2|COMPLETED|Overall Study||238
140413|NCT00332644|341019|P1|COMPLETED|Overall Study||250
140414|NCT00332644|341014|P6|STARTED|Overall Study||189
140415|NCT00332644|341015|P5|STARTED|Overall Study||262
140416|NCT00332644|341016|P4|STARTED|Overall Study||264
140417|NCT00332644|341017|P3|STARTED|Overall Study||267
140418|NCT00332644|341018|P2|STARTED|Overall Study||260
140419|NCT00332644|341019|P1|STARTED|Overall Study||262
140420|NCT00332696|341035|P2|NOT COMPLETED|Overall Study||30
140421|NCT00332696|341036|P1|NOT COMPLETED|Overall Study||30
140422|NCT00332696|341035|P2|COMPLETED|Overall Study||2
140423|NCT00332696|341036|P1|COMPLETED|Overall Study|Completed Month 3 Visit|2
140424|NCT00332696|341035|P2|Completed Day 14 Visit|Overall Study||15
140425|NCT00332696|341036|P1|Completed Day 14 Visit|Overall Study|Primary Endpoint|21
140426|NCT00332696|341035|P2|STARTED|Overall Study||32
140427|NCT00332696|341036|P1|STARTED|Overall Study||32
140428|NCT00332709|341064|P2|NOT COMPLETED|Overall Study||20
140429|NCT00332709|341065|P1|NOT COMPLETED|Overall Study||16
140430|NCT00332709|341064|P2|COMPLETED|Overall Study||21
140431|NCT00332709|341065|P1|COMPLETED|Overall Study||24
140432|NCT00332709|341064|P2|STARTED|Overall Study||41
140433|NCT00332709|341065|P1|STARTED|Overall Study||40
140434|NCT00332722|341089|P2|NOT COMPLETED|Overall Study||0
140435|NCT00332722|341090|P1|NOT COMPLETED|Overall Study||0
140436|NCT00332722|341089|P2|COMPLETED|Overall Study||60
140437|NCT00332722|341090|P1|COMPLETED|Overall Study||60
140438|NCT00332722|341089|P2|STARTED|Overall Study||60
140439|NCT00332722|341090|P1|STARTED|Overall Study||60
140440|NCT00332839|341100|P2|NOT COMPLETED|Follow-up (Months 12 - 60)||3
140441|NCT00332839|341101|P1|NOT COMPLETED|Follow-up (Months 12 - 60)||4
140442|NCT00332839|341100|P2|COMPLETED|Follow-up (Months 12 - 60)||31
140443|NCT00332839|341101|P1|COMPLETED|Follow-up (Months 12 - 60)||29
140444|NCT00332839|341100|P2|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|34
140445|NCT00332839|341101|P1|STARTED|Follow-up (Months 12 - 60)|Follow-up included core participants (completed or discontinued) who wished to be followed.|33
140446|NCT00332839|341100|P2|NOT COMPLETED|Core (Months 0 - 12)||18
140447|NCT00332839|341101|P1|NOT COMPLETED|Core (Months 0 - 12)||10
140448|NCT00332839|341100|P2|COMPLETED|Core (Months 0 - 12)||28
140449|NCT00332839|341101|P1|COMPLETED|Core (Months 0 - 12)||37
140450|NCT00332839|341100|P2|Safety Set|Core (Months 0 - 12)||46
140451|NCT00332839|341101|P1|Safety Set|Core (Months 0 - 12)||47
140452|NCT00332839|341100|P2|STARTED|Core (Months 0 - 12)||46
140453|NCT00332839|341101|P1|STARTED|Core (Months 0 - 12)||47
140454|NCT00316082|341124|P5|NOT COMPLETED|Overall Study||26
140455|NCT00316082|341125|P4|NOT COMPLETED|Overall Study||26
140456|NCT00316082|341126|P3|NOT COMPLETED|Overall Study||27
140457|NCT00316082|341127|P2|NOT COMPLETED|Overall Study||22
140458|NCT00316082|341128|P1|NOT COMPLETED|Overall Study||33
140459|NCT00316082|341124|P5|COMPLETED|Overall Study||48
140460|NCT00316082|341125|P4|COMPLETED|Overall Study||46
140461|NCT00316082|341126|P3|COMPLETED|Overall Study||44
140462|NCT00316082|341127|P2|COMPLETED|Overall Study||52
140463|NCT00316082|341128|P1|COMPLETED|Overall Study||41
140464|NCT00316082|341124|P5|Completed Study Without Being Rescued|Overall Study||31
140465|NCT00316082|341125|P4|Completed Study Without Being Rescued|Overall Study||27
140466|NCT00316082|341126|P3|Completed Study Without Being Rescued|Overall Study||29
140467|NCT00316082|341127|P2|Completed Study Without Being Rescued|Overall Study||35
140468|NCT00316082|341128|P1|Completed Study Without Being Rescued|Overall Study||25
140469|NCT00316082|341124|P5|STARTED|Overall Study||74
140470|NCT00316082|341125|P4|STARTED|Overall Study||72
140471|NCT00316082|341126|P3|STARTED|Overall Study||71
140472|NCT00316082|341127|P2|STARTED|Overall Study||74
140473|NCT00316082|341128|P1|STARTED|Overall Study||74
140474|NCT00316121|341158|P2|NOT COMPLETED|Overall Study||9
140475|NCT00316121|341159|P1|NOT COMPLETED|Overall Study||22
140476|NCT00316121|341158|P2|COMPLETED|Overall Study||37
140477|NCT00316121|341159|P1|COMPLETED|Overall Study||70
140478|NCT00316121|341158|P2|STARTED|Overall Study||46
140479|NCT00316121|341159|P1|STARTED|Overall Study||92
140480|NCT00316173|341167|P2|NOT COMPLETED|Treatment Phase||42
140481|NCT00316173|341168|P1|NOT COMPLETED|Treatment Phase||0
140482|NCT00316173|341167|P2|COMPLETED|Treatment Phase||13
140483|NCT00316173|341168|P1|COMPLETED|Treatment Phase||0
140484|NCT00316173|341167|P2|STARTED|Treatment Phase||55
140485|NCT00316173|341168|P1|STARTED|Treatment Phase||0
140486|NCT00316173|341167|P2|NOT COMPLETED|Run-in Phase||0
140487|NCT00316173|341168|P1|NOT COMPLETED|Run-in Phase||7
140488|NCT00316173|341167|P2|COMPLETED|Run-in Phase||0
140489|NCT00316173|341168|P1|COMPLETED|Run-in Phase||15
140490|NCT00316173|341167|P2|STARTED|Run-in Phase||0
140491|NCT00316173|341168|P1|STARTED|Run-in Phase||22
140492|NCT00316186|341179|P1|NOT COMPLETED|Overall Study||12
140493|NCT00316186|341179|P1|COMPLETED|Overall Study||21
140494|NCT00316186|341179|P1|STARTED|Overall Study||33
140495|NCT00316199|341191|P1|NOT COMPLETED|Overall Study||12
140496|NCT00316199|341191|P1|COMPLETED|Overall Study||48
140497|NCT00316199|341191|P1|STARTED|Overall Study||60
140498|NCT00316225|341199|P1|NOT COMPLETED|Overall Study||25
140499|NCT00316225|341199|P1|COMPLETED|Overall Study||6
140500|NCT00316225|341199|P1|STARTED|Overall Study||31
140501|NCT00316264|341211|P3|NOT COMPLETED|Overall Study||6
140502|NCT00316264|341212|P2|NOT COMPLETED|Overall Study||7
140503|NCT00316264|341213|P1|NOT COMPLETED|Overall Study||6
140504|NCT00316264|341211|P3|COMPLETED|Overall Study||87
140505|NCT00316264|341212|P2|COMPLETED|Overall Study||77
140506|NCT00316264|341213|P1|COMPLETED|Overall Study||77
140507|NCT00316264|341211|P3|STARTED|Overall Study||93
140508|NCT00316264|341212|P2|STARTED|Overall Study||84
140509|NCT00316264|341213|P1|STARTED|Overall Study||83
140510|NCT00316277|341283|P2|NOT COMPLETED|Phase 2 (24 Weeks)||19
140511|NCT00316277|341284|P1|NOT COMPLETED|Phase 2 (24 Weeks)||19
140512|NCT00316277|341283|P2|COMPLETED|Phase 2 (24 Weeks)||161
140513|NCT00316277|341284|P1|COMPLETED|Phase 2 (24 Weeks)||161
140514|NCT00316277|341283|P2|STARTED|Phase 2 (24 Weeks)||180
140515|NCT00316277|341284|P1|STARTED|Phase 2 (24 Weeks)||180
140516|NCT00316277|341283|P2|NOT COMPLETED|Phase 1 (12 Weeks)||300
140517|NCT00316277|341284|P1|NOT COMPLETED|Phase 1 (12 Weeks)||310
140518|NCT00316277|341283|P2|COMPLETED|Phase 1 (12 Weeks)||24
140519|NCT00316277|341284|P1|COMPLETED|Phase 1 (12 Weeks)||19
140520|NCT00316277|341283|P2|STARTED|Phase 1 (12 Weeks)||324
140521|NCT00316277|341284|P1|STARTED|Phase 1 (12 Weeks)||329
140522|NCT00321646|341302|P1|NOT COMPLETED|Prostatectomy||0
140523|NCT00321646|341302|P1|COMPLETED|Prostatectomy||37
140524|NCT00321646|341302|P1|STARTED|Prostatectomy||37
140525|NCT00321646|341302|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||4
140526|NCT00321646|341302|P1|COMPLETED|Neoadjuvant Chemotherapy|1 pt withdrew before start of therapy, 38 completed 6 cycles neoadjuvant therapy.|38
140527|NCT00321646|341302|P1|STARTED|Neoadjuvant Chemotherapy||42
140528|NCT00321672|341311|P4|NOT COMPLETED|Overall Study||2
140529|NCT00321672|341312|P3|NOT COMPLETED|Overall Study||11
140530|NCT00321672|341313|P2|NOT COMPLETED|Overall Study||8
140531|NCT00321672|341314|P1|NOT COMPLETED|Overall Study||12
140532|NCT00321672|341311|P4|COMPLETED|Overall Study||71
140533|NCT00321672|341312|P3|COMPLETED|Overall Study||156
140534|NCT00321672|341313|P2|COMPLETED|Overall Study||81
140535|NCT00321672|341314|P1|COMPLETED|Overall Study||153
140536|NCT00321672|341311|P4|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|73
140537|NCT00321672|341312|P3|STARTED|Overall Study||167
140538|NCT00321672|341313|P2|STARTED|Overall Study|One randomized to 30 minutes received 60 minutes. Under 30 for efficacy and under 60 for safety.|89
140539|NCT00321672|341314|P1|STARTED|Overall Study||165
140540|NCT00321685|341340|P1|NOT COMPLETED|Overall Study||39
140541|NCT00321685|341340|P1|COMPLETED|Overall Study||18
140542|NCT00321685|341340|P1|Eligible and Treated|Overall Study||53
140543|NCT00321685|341340|P1|Started Protocol Therapy|Overall Study||55
140544|NCT00321685|341340|P1|Eligible|Overall Study||55
140545|NCT00321685|341340|P1|STARTED|Overall Study||57
140546|NCT00321698|341353|P5|NOT COMPLETED|Phase II, MTD Dose||0
140547|NCT00321698|341354|P4|NOT COMPLETED|Phase II, MTD Dose||0
140548|NCT00321698|341355|P3|NOT COMPLETED|Phase II, MTD Dose||0
140549|NCT00321698|341356|P2|NOT COMPLETED|Phase II, MTD Dose||0
140550|NCT00321698|341357|P1|NOT COMPLETED|Phase II, MTD Dose||0
140551|NCT00321698|341353|P5|COMPLETED|Phase II, MTD Dose||13
140552|NCT00321698|341354|P4|COMPLETED|Phase II, MTD Dose||0
140553|NCT00321698|341355|P3|COMPLETED|Phase II, MTD Dose||0
140554|NCT00321698|341356|P2|COMPLETED|Phase II, MTD Dose||0
140555|NCT00321698|341357|P1|COMPLETED|Phase II, MTD Dose||0
140556|NCT00321698|341353|P5|STARTED|Phase II, MTD Dose|+1 screen failure|13
140557|NCT00321698|341354|P4|STARTED|Phase II, MTD Dose||0
140558|NCT00321698|341355|P3|STARTED|Phase II, MTD Dose||0
140559|NCT00321698|341356|P2|STARTED|Phase II, MTD Dose||0
140560|NCT00321698|341357|P1|STARTED|Phase II, MTD Dose||0
140561|NCT00321698|341353|P5|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
140562|NCT00321698|341354|P4|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
140563|NCT00321698|341355|P3|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
140564|NCT00321698|341356|P2|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
140565|NCT00321698|341357|P1|NOT COMPLETED|Phase I, Rad Only & Dose 1-3||0
140566|NCT00321698|341353|P5|COMPLETED|Phase I, Rad Only & Dose 1-3||0
140567|NCT00321698|341354|P4|COMPLETED|Phase I, Rad Only & Dose 1-3||3
140568|NCT00321698|341355|P3|COMPLETED|Phase I, Rad Only & Dose 1-3||3
140569|NCT00321698|341356|P2|COMPLETED|Phase I, Rad Only & Dose 1-3||3
140570|NCT00321698|341357|P1|COMPLETED|Phase I, Rad Only & Dose 1-3||3
140571|NCT00321698|341353|P5|STARTED|Phase I, Rad Only & Dose 1-3||0
140572|NCT00321698|341354|P4|STARTED|Phase I, Rad Only & Dose 1-3||3
140573|NCT00321698|341355|P3|STARTED|Phase I, Rad Only & Dose 1-3||3
140574|NCT00321698|341356|P2|STARTED|Phase I, Rad Only & Dose 1-3||3
140575|NCT00321698|341357|P1|STARTED|Phase I, Rad Only & Dose 1-3||3
140576|NCT00321711|341376|P5|NOT COMPLETED|Part B||5
140577|NCT00321711|341377|P4|NOT COMPLETED|Part B||6
140578|NCT00321711|341378|P3|NOT COMPLETED|Part B||0
140579|NCT00321711|341379|P2|NOT COMPLETED|Part B||0
140580|NCT00321711|341380|P1|NOT COMPLETED|Part B||0
140581|NCT00321711|341376|P5|COMPLETED|Part B||10
140582|NCT00321711|341377|P4|COMPLETED|Part B||8
140583|NCT00321711|341378|P3|COMPLETED|Part B||0
140584|NCT00321711|341379|P2|COMPLETED|Part B||0
140585|NCT00321711|341380|P1|COMPLETED|Part B||0
140586|NCT00321711|341376|P5|STARTED|Part B||15
140587|NCT00321711|341377|P4|STARTED|Part B||14
140588|NCT00321711|341378|P3|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
140589|NCT00321711|341379|P2|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
140590|NCT00321711|341380|P1|STARTED|Part B|Participants in Part A were not eligible for enrollment in Part B|0
140591|NCT00321711|341376|P5|NOT COMPLETED|Part A||0
140592|NCT00321711|341377|P4|NOT COMPLETED|Part A||0
140593|NCT00321711|341378|P3|NOT COMPLETED|Part A||11
140594|NCT00321711|341379|P2|NOT COMPLETED|Part A||10
140595|NCT00321711|341380|P1|NOT COMPLETED|Part A||5
140596|NCT00321711|341376|P5|COMPLETED|Part A||0
140597|NCT00321711|341377|P4|COMPLETED|Part A||0
140598|NCT00321711|341378|P3|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
140599|NCT00321711|341379|P2|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|3
140600|NCT00321711|341380|P1|COMPLETED|Part A|Participants in Part A were not eligible for enrollment in Part B|8
140601|NCT00321711|341376|P5|STARTED|Part A||0
140602|NCT00321711|341377|P4|STARTED|Part A||0
140603|NCT00321711|341378|P3|STARTED|Part A||14
140604|NCT00321711|341379|P2|STARTED|Part A||13
140605|NCT00321711|341380|P1|STARTED|Part A||13
140606|NCT00321737|341410|P3|NOT COMPLETED|Overall Study||54
140607|NCT00321737|341411|P2|NOT COMPLETED|Overall Study||48
140608|NCT00321737|341412|P1|NOT COMPLETED|Overall Study||122
140609|NCT00321737|341410|P3|COMPLETED|Overall Study||104
140610|NCT00321737|341411|P2|COMPLETED|Overall Study||92
140611|NCT00321737|341412|P1|COMPLETED|Overall Study||25
140612|NCT00321737|341410|P3|STARTED|Overall Study||158
140613|NCT00321737|341411|P2|STARTED|Overall Study||140
140614|NCT00321737|341412|P1|STARTED|Overall Study||147
140615|NCT00321763|341439|P4|NOT COMPLETED|Overall Study||5
140616|NCT00321763|341440|P3|NOT COMPLETED|Overall Study||6
140617|NCT00321763|341441|P2|NOT COMPLETED|Overall Study||2
140618|NCT00321763|341442|P1|NOT COMPLETED|Overall Study||6
140619|NCT00321763|341439|P4|COMPLETED|Overall Study||565
140620|NCT00321763|341440|P3|COMPLETED|Overall Study||848
140621|NCT00321763|341441|P2|COMPLETED|Overall Study||848
140622|NCT00321763|341442|P1|COMPLETED|Overall Study||844
140623|NCT00321763|341439|P4|STARTED|Overall Study||570
140624|NCT00321763|341440|P3|STARTED|Overall Study||854
140625|NCT00321763|341441|P2|STARTED|Overall Study||850
140626|NCT00321763|341442|P1|STARTED|Overall Study||850
140627|NCT00321789|341501|P2|NOT COMPLETED|Overall Study||16
140628|NCT00321789|341502|P1|NOT COMPLETED|Overall Study||15
140629|NCT00321789|341501|P2|COMPLETED|Overall Study||112
140630|NCT00321789|341502|P1|COMPLETED|Overall Study||112
140631|NCT00321789|341501|P2|STARTED|Overall Study||128
140632|NCT00321789|341502|P1|STARTED|Overall Study||127
140633|NCT00321828|341530|P1|NOT COMPLETED|Overall Study||4
140634|NCT00321828|341530|P1|COMPLETED|Overall Study||86
140635|NCT00321828|341530|P1|STARTED|Overall Study||90
140636|NCT00321854|341536|P2|NOT COMPLETED|Overall Study||82
140637|NCT00321854|341537|P1|NOT COMPLETED|Overall Study||63
140638|NCT00321854|341536|P2|COMPLETED|Overall Study||192
140639|NCT00321854|341537|P1|COMPLETED|Overall Study||198
140640|NCT00321854|341536|P2|STARTED|Overall Study||274
140641|NCT00321854|341537|P1|STARTED|Overall Study||261
140642|NCT00321893|341657|P2|NOT COMPLETED|Overall Study||14
140643|NCT00321893|341658|P1|NOT COMPLETED|Overall Study||24
140644|NCT00321893|341657|P2|COMPLETED|Overall Study||87
140645|NCT00321893|341658|P1|COMPLETED|Overall Study||77
140646|NCT00321893|341657|P2|STARTED|Overall Study||101
140647|NCT00321893|341658|P1|STARTED|Overall Study||101
140648|NCT00321906|341672|P2|NOT COMPLETED|Overall Study||56
140649|NCT00321906|341673|P1|NOT COMPLETED|Overall Study||46
140650|NCT00321906|341672|P2|COMPLETED|Overall Study||31
140651|NCT00321906|341673|P1|COMPLETED|Overall Study||48
140652|NCT00321906|341672|P2|STARTED|Overall Study||87
140653|NCT00321906|341673|P1|STARTED|Overall Study||94
140654|NCT00321919|341695|P2|NOT COMPLETED|Overall Study||52
140655|NCT00321919|341696|P1|NOT COMPLETED|Overall Study||75
140656|NCT00321919|341695|P2|COMPLETED|Overall Study||250
140657|NCT00321919|341696|P1|COMPLETED|Overall Study||226
140658|NCT00321919|341695|P2|STARTED|Overall Study||302
140659|NCT00321919|341696|P1|STARTED|Overall Study||301
140660|NCT00321932|341738|P2|NOT COMPLETED|Overall Study||21
140661|NCT00321932|341739|P1|NOT COMPLETED|Overall Study||10
140662|NCT00321932|341738|P2|COMPLETED|Overall Study||11
140663|NCT00321932|341739|P1|COMPLETED|Overall Study||19
140664|NCT00321932|341738|P2|STARTED|Overall Study||32
140665|NCT00321932|341739|P1|STARTED|Overall Study||29
140666|NCT00321984|341764|P3|NOT COMPLETED|Overall Study||26
140667|NCT00321984|341765|P2|NOT COMPLETED|Overall Study||21
140668|NCT00321984|341766|P1|NOT COMPLETED|Overall Study||27
140669|NCT00321984|341764|P3|COMPLETED|Overall Study||289
140670|NCT00321984|341765|P2|COMPLETED|Overall Study||294
140671|NCT00321984|341766|P1|COMPLETED|Overall Study||290
140672|NCT00321984|341764|P3|STARTED|Overall Study||315
140673|NCT00321984|341765|P2|STARTED|Overall Study||315
140674|NCT00321984|341766|P1|STARTED|Overall Study||317
140675|NCT00322049|341787|P4|NOT COMPLETED|Overall Study||1
140676|NCT00322049|341788|P3|NOT COMPLETED|Overall Study||0
140677|NCT00322049|341789|P2|NOT COMPLETED|Overall Study||1
140678|NCT00322049|341790|P1|NOT COMPLETED|Overall Study||0
140679|NCT00322049|341787|P4|COMPLETED|Overall Study||16
140680|NCT00322049|341788|P3|COMPLETED|Overall Study||20
140681|NCT00322049|341789|P2|COMPLETED|Overall Study||9
140682|NCT00322049|341790|P1|COMPLETED|Overall Study||4
140683|NCT00322049|341787|P4|STARTED|Overall Study||17
140684|NCT00322049|341788|P3|STARTED|Overall Study||20
140685|NCT00322049|341789|P2|STARTED|Overall Study||10
140686|NCT00322049|341790|P1|STARTED|Overall Study||4
140687|NCT00322101|341822|P2|NOT COMPLETED|Overall Study||0
140688|NCT00322101|341823|P1|NOT COMPLETED|Overall Study||0
140689|NCT00322101|341822|P2|COMPLETED|Overall Study||11
140690|NCT00322101|341823|P1|COMPLETED|Overall Study||14
140691|NCT00322101|341822|P2|STARTED|Overall Study||11
140692|NCT00322101|341823|P1|STARTED|Overall Study||14
140693|NCT00322153|341841|P2|NOT COMPLETED|Overall Study||69
140694|NCT00322153|341842|P1|NOT COMPLETED|Overall Study||63
140695|NCT00322153|341841|P2|COMPLETED|Overall Study||273
140696|NCT00322153|341842|P1|COMPLETED|Overall Study||272
140697|NCT00322153|341841|P2|SAFETY POPULATION|Overall Study|Safety population: one patient was randomized but did not receive double-blind study drug.|341
140698|NCT00322153|341842|P1|SAFETY POPULATION|Overall Study|Safety population defined as all patients who took at least one dose of double-blind study drug.|335
140699|NCT00322153|341841|P2|STARTED|Overall Study|Randomized to Memantine ER|342
140700|NCT00322153|341842|P1|STARTED|Overall Study|Randomized to placebo|335
140701|NCT00322231|341854|P2|NOT COMPLETED|Period 2||0
140702|NCT00322231|341855|P1|NOT COMPLETED|Period 2||0
140703|NCT00322231|341854|P2|COMPLETED|Period 2||49
140704|NCT00322231|341855|P1|COMPLETED|Period 2||51
140705|NCT00322231|341854|P2|STARTED|Period 2|One participant was lost between Period 1 and Period 2|49
140706|NCT00322231|341855|P1|STARTED|Period 2||51
140707|NCT00322231|341854|P2|NOT COMPLETED|Period 1||0
140708|NCT00322231|341855|P1|NOT COMPLETED|Period 1||0
140709|NCT00322231|341854|P2|COMPLETED|Period 1||50
140710|NCT00322231|341855|P1|COMPLETED|Period 1||51
140711|NCT00322231|341854|P2|STARTED|Period 1||50
140712|NCT00322231|341855|P1|STARTED|Period 1||51
140713|NCT00322309|341867|P2|NOT COMPLETED|Overall Study||4
140714|NCT00322309|341868|P1|NOT COMPLETED|Overall Study||2
140715|NCT00322309|341867|P2|COMPLETED|Overall Study||9
140716|NCT00322309|341868|P1|COMPLETED|Overall Study||9
140717|NCT00322309|341867|P2|STARTED|Overall Study||13
140718|NCT00322309|341868|P1|STARTED|Overall Study||11
140719|NCT00322335|341885|P3|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
140720|NCT00322335|341886|P2|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
140721|NCT00322335|341887|P1|NOT COMPLETED|Subjects 66 Months After Booster Dose||0
140722|NCT00322335|341885|P3|COMPLETED|Subjects 66 Months After Booster Dose||53
140723|NCT00322335|341886|P2|COMPLETED|Subjects 66 Months After Booster Dose||104
140724|NCT00322335|341887|P1|COMPLETED|Subjects 66 Months After Booster Dose||48
140725|NCT00322335|341885|P3|STARTED|Subjects 66 Months After Booster Dose||53
140726|NCT00322335|341886|P2|STARTED|Subjects 66 Months After Booster Dose||104
140727|NCT00322335|341887|P1|STARTED|Subjects 66 Months After Booster Dose||48
140728|NCT00322335|341885|P3|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
140729|NCT00322335|341886|P2|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
140730|NCT00322335|341887|P1|NOT COMPLETED|Subjects 54 Months After Booster Dose||0
140731|NCT00322335|341885|P3|COMPLETED|Subjects 54 Months After Booster Dose||56
140732|NCT00322335|341886|P2|COMPLETED|Subjects 54 Months After Booster Dose||108
140733|NCT00322335|341887|P1|COMPLETED|Subjects 54 Months After Booster Dose||50
140734|NCT00322335|341885|P3|STARTED|Subjects 54 Months After Booster Dose||56
140735|NCT00322335|341886|P2|STARTED|Subjects 54 Months After Booster Dose||108
140736|NCT00322335|341887|P1|STARTED|Subjects 54 Months After Booster Dose||50
140737|NCT00322335|341885|P3|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
140738|NCT00322335|341886|P2|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
140739|NCT00322335|341887|P1|NOT COMPLETED|Subjects 42 Months After Booster Dose||0
140740|NCT00322335|341885|P3|COMPLETED|Subjects 42 Months After Booster Dose||56
140741|NCT00322335|341886|P2|COMPLETED|Subjects 42 Months After Booster Dose||113
140742|NCT00322335|341887|P1|COMPLETED|Subjects 42 Months After Booster Dose||51
140743|NCT00322335|341885|P3|STARTED|Subjects 42 Months After Booster Dose||56
140744|NCT00322335|341886|P2|STARTED|Subjects 42 Months After Booster Dose||113
140745|NCT00322335|341887|P1|STARTED|Subjects 42 Months After Booster Dose||51
140746|NCT00322335|341885|P3|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
140747|NCT00322335|341886|P2|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
140748|NCT00322335|341887|P1|NOT COMPLETED|Subjects 30 Months After Booster Dose||0
140749|NCT00322335|341885|P3|COMPLETED|Subjects 30 Months After Booster Dose||57
140750|NCT00322335|341886|P2|COMPLETED|Subjects 30 Months After Booster Dose||119
140751|NCT00322335|341887|P1|COMPLETED|Subjects 30 Months After Booster Dose||54
140752|NCT00322335|341885|P3|STARTED|Subjects 30 Months After Booster Dose|Subjects eliminated from previous timepoint were included again from this timepoint onwards|57
140753|NCT00322335|341886|P2|STARTED|Subjects 30 Months After Booster Dose||119
140754|NCT00322335|341887|P1|STARTED|Subjects 30 Months After Booster Dose||54
140755|NCT00322335|341885|P3|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
140756|NCT00322335|341886|P2|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
140757|NCT00322335|341887|P1|NOT COMPLETED|Subjects 18 Months After Booster Dose||0
140758|NCT00322335|341885|P3|COMPLETED|Subjects 18 Months After Booster Dose||3
140759|NCT00322335|341886|P2|COMPLETED|Subjects 18 Months After Booster Dose||123
140760|NCT00322335|341887|P1|COMPLETED|Subjects 18 Months After Booster Dose||58
140761|NCT00322335|341885|P3|STARTED|Subjects 18 Months After Booster Dose|Subjects who received Meningitec booster outside scope study NCT00323050 eliminated from this period|3
140762|NCT00322335|341886|P2|STARTED|Subjects 18 Months After Booster Dose||123
140763|NCT00322335|341887|P1|STARTED|Subjects 18 Months After Booster Dose||58
140764|NCT00322348|341927|P2|NOT COMPLETED|Overall Study||33
140765|NCT00322348|341928|P1|NOT COMPLETED|Overall Study||37
140766|NCT00322348|341927|P2|COMPLETED|Overall Study|Number of participants completed up to Week 96|16
140767|NCT00322348|341928|P1|COMPLETED|Overall Study|Number of participants completed up to Week 96|12
140768|NCT00322348|341927|P2|Received Study Treatment|Overall Study||48
140769|NCT00322348|341928|P1|Received Study Treatment|Overall Study||50
140770|NCT00322348|341927|P2|STARTED|Overall Study||49
140771|NCT00322348|341928|P1|STARTED|Overall Study||49
140772|NCT00322374|341947|P4|NOT COMPLETED|Second Escalation||0
140773|NCT00322374|341948|P3|NOT COMPLETED|Second Escalation||6
140774|NCT00322374|341949|P2|NOT COMPLETED|Second Escalation||0
140775|NCT00322374|341950|P1|NOT COMPLETED|Second Escalation||0
140776|NCT00322374|341947|P4|COMPLETED|Second Escalation||0
140777|NCT00322374|341948|P3|COMPLETED|Second Escalation||0
140778|NCT00322374|341949|P2|COMPLETED|Second Escalation||0
140779|NCT00322374|341950|P1|COMPLETED|Second Escalation||0
140780|NCT00322374|341947|P4|STARTED|Second Escalation||0
140781|NCT00322374|341948|P3|STARTED|Second Escalation||6
140782|NCT00322374|341949|P2|STARTED|Second Escalation||0
140783|NCT00322374|341950|P1|STARTED|Second Escalation||0
140784|NCT00322374|341947|P4|NOT COMPLETED|First Escalation||0
140785|NCT00322374|341948|P3|NOT COMPLETED|First Escalation||0
140786|NCT00322374|341949|P2|NOT COMPLETED|First Escalation||30
140787|NCT00322374|341950|P1|NOT COMPLETED|First Escalation||0
140788|NCT00322374|341947|P4|COMPLETED|First Escalation||0
140789|NCT00322374|341948|P3|COMPLETED|First Escalation||0
140790|NCT00322374|341949|P2|COMPLETED|First Escalation||0
140791|NCT00322374|341950|P1|COMPLETED|First Escalation||0
140792|NCT00322374|341947|P4|STARTED|First Escalation||0
140793|NCT00322374|341948|P3|STARTED|First Escalation||0
140794|NCT00322374|341949|P2|STARTED|First Escalation||30
140795|NCT00322374|341950|P1|STARTED|First Escalation||0
140796|NCT00322374|341947|P4|NOT COMPLETED|Starting Dose||0
140797|NCT00322374|341948|P3|NOT COMPLETED|Starting Dose||0
140798|NCT00322374|341949|P2|NOT COMPLETED|Starting Dose||0
140799|NCT00322374|341950|P1|NOT COMPLETED|Starting Dose||6
140800|NCT00322374|341947|P4|COMPLETED|Starting Dose||0
140801|NCT00322374|341948|P3|COMPLETED|Starting Dose||0
140802|NCT00322374|341949|P2|COMPLETED|Starting Dose||0
140803|NCT00322374|341950|P1|COMPLETED|Starting Dose||0
140804|NCT00322374|341947|P4|STARTED|Starting Dose||0
140805|NCT00322374|341948|P3|STARTED|Starting Dose||0
140806|NCT00322374|341949|P2|STARTED|Starting Dose||0
140807|NCT00322374|341950|P1|STARTED|Starting Dose||6
140808|NCT00322374|341947|P4|NOT COMPLETED|Enrollment||0
140809|NCT00322374|341948|P3|NOT COMPLETED|Enrollment||0
140810|NCT00322374|341949|P2|NOT COMPLETED|Enrollment||0
140811|NCT00322374|341950|P1|NOT COMPLETED|Enrollment||0
140812|NCT00322374|341947|P4|COMPLETED|Enrollment||42
140813|NCT00322374|341948|P3|COMPLETED|Enrollment||0
140814|NCT00322374|341949|P2|COMPLETED|Enrollment||0
140815|NCT00322374|341950|P1|COMPLETED|Enrollment||0
140816|NCT00322374|341947|P4|STARTED|Enrollment||42
140817|NCT00322374|341948|P3|STARTED|Enrollment||0
140818|NCT00322374|341949|P2|STARTED|Enrollment||0
140819|NCT00322374|341950|P1|STARTED|Enrollment||0
140820|NCT00322387|342000|P2|NOT COMPLETED|Follow-up Period||3
140821|NCT00322387|342001|P1|NOT COMPLETED|Follow-up Period||2
140822|NCT00322387|342000|P2|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|23
140823|NCT00322387|342001|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|12
140824|NCT00322387|342000|P2|STARTED|Follow-up Period|Participants who had transplants. One participant did not complete therapy but had a transplant.|26
140825|NCT00322387|342001|P1|STARTED|Follow-up Period|Participants who had transplants|14
140826|NCT00322387|342000|P2|NOT COMPLETED|Treatment Period||1
140827|NCT00322387|342001|P1|NOT COMPLETED|Treatment Period||0
140828|NCT00322387|342000|P2|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|25
140829|NCT00322387|342001|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|14
140830|NCT00322387|342000|P2|STARTED|Treatment Period|Plerixafor PM=12, Plerixafor AM=9, Low CD34+ Count/Plerixafor PM=1, and Plerixafor After Chemo=4|26
140831|NCT00322387|342001|P1|STARTED|Treatment Period|Plerixafor PM=7, Plerixafor AM=6, Low CD34+ Count/Plerixafor PM=0, and Plerixafor After Chemo=1|14
140832|NCT00322439|342032|P1|NOT COMPLETED|Overall Study||1056
140833|NCT00322439|342032|P1|COMPLETED|Overall Study||1455
140834|NCT00322439|342032|P1|Received at Least 1 Dose of Etanercept|Overall Study||2510
140835|NCT00322439|342032|P1|STARTED|Overall Study||2511
140836|NCT00322452|342047|P2|NOT COMPLETED|Overall Study||276
140837|NCT00322452|342048|P1|NOT COMPLETED|Overall Study||247
140838|NCT00322452|342047|P2|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 84 remained at OS DCO (14 June 2010)|332
140839|NCT00322452|342048|P1|COMPLETED|Overall Study|Patients still in study at PFS Data Cut Off (14 April 2008), 97 remained at OS DCO (14 June 2010)|362
140840|NCT00322452|342047|P2|STARTED|Overall Study|Number of patients randomized|608
140841|NCT00322452|342048|P1|STARTED|Overall Study|Number of patients randomized|609
140842|NCT00322465|342088|P4|NOT COMPLETED|Overall Study||26
140843|NCT00322465|342089|P3|NOT COMPLETED|Overall Study||26
140844|NCT00322465|342090|P2|NOT COMPLETED|Overall Study||24
140845|NCT00322465|342091|P1|NOT COMPLETED|Overall Study||20
140846|NCT00322465|342088|P4|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|53
140847|NCT00322465|342089|P3|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|51
140848|NCT00322465|342090|P2|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|49
140849|NCT00322465|342091|P1|COMPLETED|Overall Study|Second follow-up visit or clinical failure at first follow-up visit|56
140850|NCT00322465|342088|P4|STARTED|Overall Study|Randomized|79
140851|NCT00322465|342089|P3|STARTED|Overall Study|Randomized|77
140852|NCT00322465|342090|P2|STARTED|Overall Study|Randomized|73
140853|NCT00322465|342091|P1|STARTED|Overall Study|Randomized|76
140854|NCT00322491|342152|P2|NOT COMPLETED|Overall Study||2
140855|NCT00322491|342153|P1|NOT COMPLETED|Overall Study||2
140856|NCT00322491|342152|P2|COMPLETED|Overall Study||24
140857|NCT00322491|342153|P1|COMPLETED|Overall Study||21
140858|NCT00322491|342152|P2|STARTED|Overall Study||26
140859|NCT00322491|342153|P1|STARTED|Overall Study||23
140860|NCT00322556|342175|P1|NOT COMPLETED|Overall Study||12
140861|NCT00322556|342175|P1|COMPLETED|Overall Study||43
140862|NCT00322556|342175|P1|STARTED|Overall Study||55
140863|NCT00322621|342189|P3|NOT COMPLETED|Period III - Maintenance / Rescue Phase||36
140864|NCT00322621|342190|P2|NOT COMPLETED|Period III - Maintenance / Rescue Phase||29
140865|NCT00322621|342191|P1|NOT COMPLETED|Period III - Maintenance / Rescue Phase||0
140866|NCT00322621|342189|P3|COMPLETED|Period III - Maintenance / Rescue Phase||33
140867|NCT00322621|342190|P2|COMPLETED|Period III - Maintenance / Rescue Phase||86
140868|NCT00322621|342191|P1|COMPLETED|Period III - Maintenance / Rescue Phase||0
140869|NCT00322621|342189|P3|STARTED|Period III - Maintenance / Rescue Phase||69
140870|NCT00322621|342190|P2|STARTED|Period III - Maintenance / Rescue Phase||115
140871|NCT00322621|342191|P1|STARTED|Period III - Maintenance / Rescue Phase||0
140872|NCT00322621|342189|P3|NOT COMPLETED|Period II - Acute Therapy Phase||0
140873|NCT00322621|342190|P2|NOT COMPLETED|Period II - Acute Therapy Phase||0
140874|NCT00322621|342191|P1|NOT COMPLETED|Period II - Acute Therapy Phase||32
140875|NCT00322621|342189|P3|COMPLETED|Period II - Acute Therapy Phase||0
140876|NCT00322621|342190|P2|COMPLETED|Period II - Acute Therapy Phase||0
140877|NCT00322621|342191|P1|COMPLETED|Period II - Acute Therapy Phase||184
140878|NCT00322621|342189|P3|STARTED|Period II - Acute Therapy Phase||0
140879|NCT00322621|342190|P2|STARTED|Period II - Acute Therapy Phase||0
140880|NCT00322621|342191|P1|STARTED|Period II - Acute Therapy Phase||216
140881|NCT00322712|342243|P1|NOT COMPLETED|Overall Study||1
140882|NCT00322712|342243|P1|COMPLETED|Overall Study||11
140883|NCT00322712|342243|P1|STARTED|Overall Study||12
140884|NCT00322777|342249|P2|NOT COMPLETED|Overall Study||0
140885|NCT00322777|342250|P1|NOT COMPLETED|Overall Study||0
140886|NCT00322777|342249|P2|COMPLETED|Overall Study||45
140887|NCT00322777|342250|P1|COMPLETED|Overall Study||39
140888|NCT00322777|342249|P2|Data Collection at Week 24|Overall Study||45
140889|NCT00322777|342250|P1|Data Collection at Week 24|Overall Study||39
140890|NCT00322777|342249|P2|Data Collection at Week 16|Overall Study||45
140891|NCT00322777|342250|P1|Data Collection at Week 16|Overall Study||39
140892|NCT00322777|342249|P2|Data Collection at Week 8|Overall Study||45
140893|NCT00322777|342250|P1|Data Collection at Week 8|Overall Study||39
140894|NCT00322777|342249|P2|"Data Collection at BASELINE|"|Overall Study||45
140895|NCT00322777|342250|P1|"Data Collection at BASELINE|"|Overall Study||39
140896|NCT00322777|342249|P2|STARTED|Overall Study||45
140897|NCT00322777|342250|P1|STARTED|Overall Study||39
140898|NCT00322842|342262|P2|NOT COMPLETED|Overall Study||2
140899|NCT00322842|342263|P1|NOT COMPLETED|Overall Study||2
140900|NCT00322842|342262|P2|COMPLETED|Overall Study|One participant d/c treatment early, received a transplant, and was lost to follow-up after 6 months|29
140901|NCT00322842|342263|P1|COMPLETED|Overall Study|One participant discontinued (d/c) treatment early, received a transplant, and completed the study.|2
140902|NCT00322842|342262|P2|STARTED|Overall Study||31
140903|NCT00322842|342263|P1|STARTED|Overall Study||4
140904|NCT00322855|342288|P1|NOT COMPLETED|Overall Study||0
140905|NCT00322855|342288|P1|COMPLETED|Overall Study||1
140906|NCT00322855|342288|P1|STARTED|Overall Study||1
140907|NCT00322881|342292|P1|NOT COMPLETED|Overall Study||5
140908|NCT00322881|342292|P1|COMPLETED|Overall Study||7
140909|NCT00322881|342292|P1|STARTED|Overall Study||12
140910|NCT00323037|342298|P2|NOT COMPLETED|Overall Study||27
140911|NCT00323037|342299|P1|NOT COMPLETED|Overall Study||33
140912|NCT00323037|342298|P2|COMPLETED|Overall Study||126
140913|NCT00323037|342299|P1|COMPLETED|Overall Study||132
140914|NCT00323037|342298|P2|STARTED|Overall Study|Number randomized|153
140915|NCT00323037|342299|P1|STARTED|Overall Study|Number randomized|165
140916|NCT00323115|342303|P1|NOT COMPLETED|Adjuvant Therapy & Survival Follow-Up||8
140917|NCT00323115|342303|P1|COMPLETED|Adjuvant Therapy & Survival Follow-Up||2
140918|NCT00323115|342303|P1|STARTED|Adjuvant Therapy & Survival Follow-Up||10
140919|NCT00323115|342303|P1|NOT COMPLETED|Vaccine Administration||1
140920|NCT00323115|342303|P1|COMPLETED|Vaccine Administration||10
140921|NCT00323115|342303|P1|STARTED|Vaccine Administration||11
140922|NCT00323193|342310|P2|NOT COMPLETED|Overall Study||15
140923|NCT00323193|342311|P1|NOT COMPLETED|Overall Study||23
140924|NCT00323193|342310|P2|COMPLETED|Overall Study||41
140925|NCT00323193|342311|P1|COMPLETED|Overall Study||30
140926|NCT00323193|342310|P2|STARTED|Overall Study||56
140927|NCT00323193|342311|P1|STARTED|Overall Study||53
140928|NCT00323258|342321|P2|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
140929|NCT00323258|342322|P1|NOT COMPLETED|Secondary Outcome (6 Mon Refill Records)||14
140930|NCT00323258|342321|P2|COMPLETED|Secondary Outcome (6 Mon Refill Records)||58
140931|NCT00323258|342322|P1|COMPLETED|Secondary Outcome (6 Mon Refill Records)||57
140932|NCT00323258|342321|P2|STARTED|Secondary Outcome (6 Mon Refill Records)||72
140933|NCT00323258|342322|P1|STARTED|Secondary Outcome (6 Mon Refill Records)||71
140934|NCT00323258|342321|P2|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||19
140935|NCT00323258|342322|P1|NOT COMPLETED|Primary Outcome (Phone Call at 6 Months)||16
140936|NCT00323258|342321|P2|COMPLETED|Primary Outcome (Phone Call at 6 Months)||53
140937|NCT00323258|342322|P1|COMPLETED|Primary Outcome (Phone Call at 6 Months)||55
140938|NCT00323258|342321|P2|STARTED|Primary Outcome (Phone Call at 6 Months)||72
140939|NCT00323258|342322|P1|STARTED|Primary Outcome (Phone Call at 6 Months)||71
140940|NCT00323271|342338|P2|NOT COMPLETED|Overall Study||3
140941|NCT00323271|342339|P1|NOT COMPLETED|Overall Study||2
140942|NCT00323271|342338|P2|COMPLETED|Overall Study||9
140943|NCT00323271|342339|P1|COMPLETED|Overall Study||11
140944|NCT00323271|342338|P2|STARTED|Overall Study||12
140945|NCT00323271|342339|P1|STARTED|Overall Study||13
140946|NCT00323284|342349|P2|NOT COMPLETED|24 Months Follow-up||22
140947|NCT00323284|342350|P1|NOT COMPLETED|24 Months Follow-up||18
140948|NCT00323284|342349|P2|COMPLETED|24 Months Follow-up||101
140949|NCT00323284|342350|P1|COMPLETED|24 Months Follow-up||98
140950|NCT00323284|342349|P2|STARTED|24 Months Follow-up||123
140951|NCT00323284|342350|P1|STARTED|24 Months Follow-up||116
140952|NCT00323284|342349|P2|NOT COMPLETED|12 Months Follow-up||9
140953|NCT00323284|342350|P1|NOT COMPLETED|12 Months Follow-up||5
140954|NCT00323284|342349|P2|COMPLETED|12 Months Follow-up||114
140955|NCT00323284|342350|P1|COMPLETED|12 Months Follow-up||111
140956|NCT00323284|342349|P2|STARTED|12 Months Follow-up||123
140957|NCT00323284|342350|P1|STARTED|12 Months Follow-up||116
140958|NCT00323297|342360|P2|NOT COMPLETED|Part B (Open-label)||12
140959|NCT00323297|342361|P1|NOT COMPLETED|Part B (Open-label)||9
140960|NCT00323297|342360|P2|COMPLETED|Part B (Open-label)||31
140961|NCT00323297|342361|P1|COMPLETED|Part B (Open-label)||39
140962|NCT00323297|342360|P2|STARTED|Part B (Open-label)||43
140963|NCT00323297|342361|P1|STARTED|Part B (Open-label)||48
140964|NCT00323297|342360|P2|NOT COMPLETED|Part A (Double Blind Randomized)||7
140965|NCT00323297|342361|P1|NOT COMPLETED|Part A (Double Blind Randomized)||5
140966|NCT00323297|342360|P2|COMPLETED|Part A (Double Blind Randomized)||43
140967|NCT00323297|342361|P1|COMPLETED|Part A (Double Blind Randomized)||48
140968|NCT00323297|342360|P2|STARTED|Part A (Double Blind Randomized)||50
140969|NCT00323297|342361|P1|STARTED|Part A (Double Blind Randomized)||53
140970|NCT00323310|342377|P1|NOT COMPLETED|Overall Study||3
140971|NCT00323310|342377|P1|COMPLETED|Overall Study||89
140972|NCT00323310|342377|P1|STARTED|Overall Study||92
140973|NCT00323362|342390|P1|NOT COMPLETED|Overall Study||0
140974|NCT00323362|342390|P1|COMPLETED|Overall Study||17
140975|NCT00323362|342390|P1|STARTED|Overall Study||17
140976|NCT00323427|342398|P2|NOT COMPLETED|Overall Study||23
140977|NCT00323427|342399|P1|NOT COMPLETED|Overall Study||31
140978|NCT00323427|342398|P2|COMPLETED|Overall Study||43
140979|NCT00323427|342399|P1|COMPLETED|Overall Study||38
140980|NCT00323427|342398|P2|STARTED|Overall Study||66
140981|NCT00323427|342399|P1|STARTED|Overall Study||69
140982|NCT00323479|342409|P1|NOT COMPLETED|Overall Study||8
140983|NCT00323479|342409|P1|COMPLETED|Overall Study|with at least 1 evaluation for primary efficacy endpoint|106
140984|NCT00323479|342409|P1|Safety Population|Overall Study|Patients who taken at least one dose of treatment|110
140985|NCT00323479|342409|P1|STARTED|Overall Study||114
140986|NCT00323492|342420|P3|NOT COMPLETED|Study Phase 2||1
140987|NCT00323492|342421|P2|NOT COMPLETED|Study Phase 2||1
140988|NCT00323492|342422|P1|NOT COMPLETED|Study Phase 2||4
140989|NCT00323492|342420|P3|COMPLETED|Study Phase 2||24
140990|NCT00323492|342421|P2|COMPLETED|Study Phase 2||17
140991|NCT00323492|342422|P1|COMPLETED|Study Phase 2||40
140992|NCT00323492|342420|P3|STARTED|Study Phase 2|N=25 switched to Truvada in Phase 2.|25
140993|NCT00323492|342421|P2|STARTED|Study Phase 2|2/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=20 (no switch to Truvada)|18
140994|NCT00323492|342422|P1|STARTED|Study Phase 2|1/45 subjects completed Phase 1 but did not start Phase 2. Week 48 ITT N=46|44
140995|NCT00323492|342420|P3|NOT COMPLETED|Study Phase 1||0
140996|NCT00323492|342421|P2|NOT COMPLETED|Study Phase 1||0
140997|NCT00323492|342422|P1|NOT COMPLETED|Study Phase 1||2
140998|NCT00323492|342420|P3|COMPLETED|Study Phase 1||0
140999|NCT00323492|342421|P2|COMPLETED|Study Phase 1||45
141000|NCT00323492|342422|P1|COMPLETED|Study Phase 1||45
141001|NCT00323492|342420|P3|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||0
141002|NCT00323492|342421|P2|Intent-to-Treat (ITT) Analysis Set|Study Phase 1||45
141003|NCT00323492|342422|P1|Intent-to-Treat (ITT) Analysis Set|Study Phase 1|One subject was excluded from ITT analysis set due to protocol violation.|46
141004|NCT00323492|342420|P3|STARTED|Study Phase 1|Not applicable to Phase 1.|0
141005|NCT00323492|342421|P2|STARTED|Study Phase 1||45
141006|NCT00323492|342422|P1|STARTED|Study Phase 1||47
141007|NCT00323557|342455|P2|NOT COMPLETED|Overall Study||0
141008|NCT00323557|342456|P1|NOT COMPLETED|Overall Study||1
141009|NCT00323557|342455|P2|COMPLETED|Overall Study||7
141010|NCT00323557|342456|P1|COMPLETED|Overall Study||24
141011|NCT00323557|342455|P2|STARTED|Overall Study||7
141012|NCT00323557|342456|P1|STARTED|Overall Study|GM-CSF pre and post vaccine.|25
141013|NCT00323609|342465|P4|NOT COMPLETED|Overall Study||15
141014|NCT00323609|342466|P3|NOT COMPLETED|Overall Study||8
141015|NCT00323609|342467|P2|NOT COMPLETED|Overall Study||99
141016|NCT00323609|342468|P1|NOT COMPLETED|Overall Study||91
141017|NCT00323609|342465|P4|COMPLETED|Overall Study||0
141018|NCT00323609|342466|P3|COMPLETED|Overall Study||0
141019|NCT00323609|342467|P2|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|91
141020|NCT00323609|342468|P1|COMPLETED|Overall Study|Revision retains subjects with follow-up data in a visit window when terminated in same visit window|100
141021|NCT00323609|342465|P4|STARTED|Overall Study||15
141022|NCT00323609|342466|P3|STARTED|Overall Study||8
141023|NCT00323609|342467|P2|STARTED|Overall Study||190
141024|NCT00323609|342468|P1|STARTED|Overall Study||191
141025|NCT00323622|342510|P8|NOT COMPLETED|Overall Study||15
141026|NCT00323622|342511|P7|NOT COMPLETED|Overall Study||5
141027|NCT00323622|342512|P6|NOT COMPLETED|Overall Study||74
141028|NCT00323622|342513|P5|NOT COMPLETED|Overall Study||39
141029|NCT00323622|342514|P4|NOT COMPLETED|Overall Study||12
141030|NCT00323622|342515|P3|NOT COMPLETED|Overall Study||4
141031|NCT00323622|342516|P2|NOT COMPLETED|Overall Study||92
141032|NCT00323622|342517|P1|NOT COMPLETED|Overall Study||31
141033|NCT00323622|342510|P8|COMPLETED|Overall Study||125
141034|NCT00323622|342511|P7|COMPLETED|Overall Study||38
141035|NCT00323622|342512|P6|COMPLETED|Overall Study||454
141036|NCT00323622|342513|P5|COMPLETED|Overall Study||120
141037|NCT00323622|342514|P4|COMPLETED|Overall Study||122
141038|NCT00323622|342515|P3|COMPLETED|Overall Study||38
141039|NCT00323622|342516|P2|COMPLETED|Overall Study||423
141040|NCT00323622|342517|P1|COMPLETED|Overall Study||145
141041|NCT00323622|342510|P8|STARTED|Overall Study||140
141042|NCT00323622|342511|P7|STARTED|Overall Study||43
141043|NCT00323622|342512|P6|STARTED|Overall Study||528
141044|NCT00323622|342513|P5|STARTED|Overall Study||159
141045|NCT00323622|342514|P4|STARTED|Overall Study||134
141046|NCT00323622|342515|P3|STARTED|Overall Study||42
141047|NCT00323622|342516|P2|STARTED|Overall Study||515
141048|NCT00323622|342517|P1|STARTED|Overall Study||176
141049|NCT00323635|342559|P2|NOT COMPLETED|Overall Study||0
141050|NCT00323635|342560|P1|NOT COMPLETED|Overall Study||0
141051|NCT00323635|342559|P2|COMPLETED|Overall Study||9
141052|NCT00323635|342560|P1|COMPLETED|Overall Study||10
141053|NCT00323635|342559|P2|STARTED|Overall Study||9
141054|NCT00323635|342560|P1|STARTED|Overall Study||10
141055|NCT00323739|342576|P1|NOT COMPLETED|Overall Study||0
141056|NCT00323739|342576|P1|COMPLETED|Overall Study||80
141057|NCT00323739|342576|P1|STARTED|Overall Study||80
141058|NCT00324857|342585|P4|NOT COMPLETED|Overall Study||5
141059|NCT00324857|342586|P3|NOT COMPLETED|Overall Study||7
141060|NCT00324857|342587|P2|NOT COMPLETED|Overall Study||6
141061|NCT00324857|342588|P1|NOT COMPLETED|Overall Study||6
141062|NCT00324857|342585|P4|COMPLETED|Overall Study||158
141063|NCT00324857|342586|P3|COMPLETED|Overall Study||158
141064|NCT00324857|342587|P2|COMPLETED|Overall Study||162
141065|NCT00324857|342588|P1|COMPLETED|Overall Study||161
141066|NCT00324857|342585|P4|STARTED|Overall Study||163
141067|NCT00324857|342586|P3|STARTED|Overall Study||165
141068|NCT00324857|342587|P2|STARTED|Overall Study||168
141069|NCT00324857|342588|P1|STARTED|Overall Study||167
141070|NCT00324870|342598|P1|NOT COMPLETED|Overall Study||0
141071|NCT00324870|342598|P1|COMPLETED|Overall Study||37
141072|NCT00324870|342598|P1|STARTED|Overall Study||37
141073|NCT00324896|342604|P2|NOT COMPLETED|Overall Study||8
141074|NCT00324896|342605|P1|NOT COMPLETED|Overall Study||3
141075|NCT00324896|342604|P2|COMPLETED|Overall Study||7
141076|NCT00324896|342605|P1|COMPLETED|Overall Study||12
141077|NCT00324896|342604|P2|STARTED|Overall Study||15
141078|NCT00324896|342605|P1|STARTED|Overall Study||15
141079|NCT00324961|342613|P1|NOT COMPLETED|Overall Study||43
141080|NCT00324961|342613|P1|COMPLETED|Overall Study||490
141081|NCT00324961|342613|P1|STARTED|Overall Study||533
141082|NCT00325039|342628|P2|NOT COMPLETED|Overall Study||14
141083|NCT00325039|342629|P1|NOT COMPLETED|Overall Study||18
141084|NCT00325039|342628|P2|COMPLETED|Overall Study||285
141085|NCT00325039|342629|P1|COMPLETED|Overall Study||280
141086|NCT00325039|342628|P2|STARTED|Overall Study||299
141087|NCT00325039|342629|P1|STARTED|Overall Study||298
141088|NCT00325078|342646|P3|NOT COMPLETED|Overall Study||2
141089|NCT00325078|342647|P2|NOT COMPLETED|Overall Study||5
141090|NCT00325078|342648|P1|NOT COMPLETED|Overall Study||5
141091|NCT00325078|342646|P3|COMPLETED|Overall Study||23
141092|NCT00325078|342647|P2|COMPLETED|Overall Study||2
141093|NCT00325078|342648|P1|COMPLETED|Overall Study||3
141094|NCT00325078|342646|P3|STARTED|Overall Study||25
141095|NCT00325078|342647|P2|STARTED|Overall Study||7
141096|NCT00325078|342648|P1|STARTED|Overall Study||8
141097|NCT00325130|342660|P2|NOT COMPLETED|Overall Study||30
141098|NCT00325130|342661|P1|NOT COMPLETED|Overall Study||19
141099|NCT00325130|342660|P2|COMPLETED|Overall Study||494
141100|NCT00325130|342661|P1|COMPLETED|Overall Study||499
141101|NCT00325130|342660|P2|STARTED|Overall Study||524
141102|NCT00325130|342661|P1|STARTED|Overall Study||518
141103|NCT00325143|342701|P1|NOT COMPLETED|Overall Study||26
141104|NCT00325143|342701|P1|COMPLETED|Overall Study||676
141105|NCT00325143|342701|P1|STARTED|Overall Study||702
141106|NCT00325156|342708|P1|NOT COMPLETED|Overall Study||112
141107|NCT00325156|342708|P1|COMPLETED|Overall Study||2478
141108|NCT00325156|342708|P1|STARTED|Overall Study||2590
141109|NCT00325195|342718|P3|NOT COMPLETED|Received Intervention: ITT Population||4
141110|NCT00325195|342719|P2|NOT COMPLETED|Received Intervention: ITT Population||25
141111|NCT00325195|342720|P1|NOT COMPLETED|Received Intervention: ITT Population||26
141112|NCT00325195|342718|P3|COMPLETED|Received Intervention: ITT Population||39
141113|NCT00325195|342719|P2|COMPLETED|Received Intervention: ITT Population||59
141114|NCT00325195|342720|P1|COMPLETED|Received Intervention: ITT Population||59
141115|NCT00325195|342718|P3|STARTED|Received Intervention: ITT Population||43
141116|NCT00325195|342719|P2|STARTED|Received Intervention: ITT Population||84
141117|NCT00325195|342720|P1|STARTED|Received Intervention: ITT Population||85
141118|NCT00325195|342718|P3|NOT COMPLETED|Randomized||3
141119|NCT00325195|342719|P2|NOT COMPLETED|Randomized||5
141120|NCT00325195|342720|P1|NOT COMPLETED|Randomized||5
141121|NCT00325195|342718|P3|COMPLETED|Randomized||43
141122|NCT00325195|342719|P2|COMPLETED|Randomized||84
141123|NCT00325195|342720|P1|COMPLETED|Randomized||85
141124|NCT00325195|342718|P3|STARTED|Randomized||46
141125|NCT00325195|342719|P2|STARTED|Randomized||89
141126|NCT00325195|342720|P1|STARTED|Randomized||90
141127|NCT00325234|342745|P2|NOT COMPLETED|Overall Study||66
141128|NCT00325234|342746|P1|NOT COMPLETED|Overall Study||69
141129|NCT00325234|342745|P2|COMPLETED|Overall Study||0
141130|NCT00325234|342746|P1|COMPLETED|Overall Study||0
141131|NCT00325234|342745|P2|Received At Least 1 Dose of Study Drug|Overall Study||66
141132|NCT00325234|342746|P1|Received At Least 1 Dose of Study Drug|Overall Study||65
141133|NCT00325234|342745|P2|STARTED|Overall Study||66
141134|NCT00325234|342746|P1|STARTED|Overall Study||69
141135|NCT00325403|342764|P2|NOT COMPLETED|Overall Study||51
141136|NCT00325403|342765|P1|NOT COMPLETED|Overall Study||18
141137|NCT00325403|342764|P2|COMPLETED|Overall Study|182 subjects receiving oral treprostinil completed the study on study drug|182
141138|NCT00325403|342765|P1|COMPLETED|Overall Study|98 subjects receiving placebo completed the study on study drug|98
141139|NCT00325403|342764|P2|STARTED|Overall Study||233
141140|NCT00325403|342765|P1|STARTED|Overall Study||116
141141|NCT00325416|342803|P2|NOT COMPLETED|Phase II: Treatment at MTD||2
141142|NCT00325416|342804|P1|NOT COMPLETED|Phase II: Treatment at MTD||0
141143|NCT00325416|342803|P2|COMPLETED|Phase II: Treatment at MTD||40
141144|NCT00325416|342804|P1|COMPLETED|Phase II: Treatment at MTD||78
141145|NCT00325416|342803|P2|Enrolled During Phase II|Phase II: Treatment at MTD||8
141146|NCT00325416|342804|P1|Enrolled During Phase II|Phase II: Treatment at MTD||40
141147|NCT00325416|342803|P2|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||34
141148|NCT00325416|342804|P1|Proceeded From Phase I to Phase II|Phase II: Treatment at MTD||38
141149|NCT00325416|342803|P2|STARTED|Phase II: Treatment at MTD||42
141150|NCT00325416|342804|P1|STARTED|Phase II: Treatment at MTD||78
141151|NCT00325416|342803|P2|NOT COMPLETED|Phase I: Dose Escalation||16
141152|NCT00325416|342804|P1|NOT COMPLETED|Phase I: Dose Escalation||22
141153|NCT00325416|342803|P2|COMPLETED|Phase I: Dose Escalation||44
141154|NCT00325416|342804|P1|COMPLETED|Phase I: Dose Escalation||48
141155|NCT00325416|342803|P2|STARTED|Phase I: Dose Escalation||60
141156|NCT00325416|342804|P1|STARTED|Phase I: Dose Escalation||70
141157|NCT00325442|342818|P2|NOT COMPLETED|Overall Study||21
141158|NCT00325442|342819|P1|NOT COMPLETED|Overall Study||9
141159|NCT00325442|342818|P2|COMPLETED|Overall Study||153
141160|NCT00325442|342819|P1|COMPLETED|Overall Study||167
141161|NCT00325442|342818|P2|STARTED|Overall Study||174
141162|NCT00325442|342819|P1|STARTED|Overall Study||176
141163|NCT00325468|342869|P5|NOT COMPLETED|Overall Study||8
141164|NCT00325468|342870|P4|NOT COMPLETED|Overall Study||34
141165|NCT00325468|342871|P3|NOT COMPLETED|Overall Study||4
141166|NCT00325468|342872|P2|NOT COMPLETED|Overall Study||5
141167|NCT00325468|342873|P1|NOT COMPLETED|Overall Study||11
141168|NCT00325468|342869|P5|COMPLETED|Overall Study||14
141169|NCT00325468|342870|P4|COMPLETED|Overall Study||90
141170|NCT00325468|342871|P3|COMPLETED|Overall Study||10
141171|NCT00325468|342872|P2|COMPLETED|Overall Study||12
141172|NCT00325468|342873|P1|COMPLETED|Overall Study||12
141173|NCT00325468|342869|P5|STARTED|Overall Study||22
141174|NCT00325468|342870|P4|STARTED|Overall Study||124
141175|NCT00325468|342871|P3|STARTED|Overall Study||14
141176|NCT00325468|342872|P2|STARTED|Overall Study||17
141177|NCT00325468|342873|P1|STARTED|Overall Study||23
141178|NCT00325598|342908|P2|NOT COMPLETED|Overall Study||0
141179|NCT00325598|342909|P1|NOT COMPLETED|Overall Study||0
141180|NCT00325598|342908|P2|COMPLETED|Overall Study||50
141181|NCT00325598|342909|P1|COMPLETED|Overall Study||50
141182|NCT00325598|342908|P2|STARTED|Overall Study||50
141183|NCT00325598|342909|P1|STARTED|Overall Study||50
141184|NCT00325754|342921|P2|NOT COMPLETED|Overall Study||1
141185|NCT00325754|342922|P1|NOT COMPLETED|Overall Study||4
141186|NCT00325754|342921|P2|COMPLETED|Overall Study||10
141187|NCT00325754|342922|P1|COMPLETED|Overall Study||7
141188|NCT00325754|342921|P2|STARTED|Overall Study||11
141189|NCT00325754|342922|P1|STARTED|Overall Study||11
141190|NCT00325780|342936|P1|NOT COMPLETED|Overall Study||155
141191|NCT00325780|342936|P1|COMPLETED|Overall Study||1200
141192|NCT00325780|342936|P1|Safety Population|Overall Study|Patients who received at least one dose of study treatment in this extension study.|1353
141193|NCT00325780|342936|P1|STARTED|Overall Study||1355
141194|NCT00325819|342943|P2|NOT COMPLETED|Overall Study||13
141195|NCT00325819|342944|P1|NOT COMPLETED|Overall Study||9
141196|NCT00325819|342943|P2|COMPLETED|Overall Study||176
141197|NCT00325819|342944|P1|COMPLETED|Overall Study||176
141198|NCT00325819|342943|P2|STARTED|Overall Study||189
141199|NCT00325819|342944|P1|STARTED|Overall Study||185
141200|NCT00325897|342966|P2|NOT COMPLETED|Overall Study||13
141201|NCT00325897|342967|P1|NOT COMPLETED|Overall Study||12
141202|NCT00325897|342966|P2|COMPLETED|Overall Study||559
141203|NCT00325897|342967|P1|COMPLETED|Overall Study||558
141204|NCT00325897|342966|P2|STARTED|Overall Study||572
141205|NCT00325897|342967|P1|STARTED|Overall Study||570
141206|NCT00326001|342987|P2|NOT COMPLETED|Overall Study||8
141207|NCT00326001|342988|P1|NOT COMPLETED|Overall Study||7
141208|NCT00326001|342987|P2|COMPLETED|Overall Study||219
141209|NCT00326001|342988|P1|COMPLETED|Overall Study||229
141210|NCT00326001|342987|P2|STARTED|Overall Study||227
141211|NCT00326001|342988|P1|STARTED|Overall Study||236
141212|NCT00326118|343002|P2|NOT COMPLETED|Year 5 Follow up||0
141213|NCT00326118|343003|P1|NOT COMPLETED|Year 5 Follow up||0
141214|NCT00326118|343002|P2|COMPLETED|Year 5 Follow up||78
141215|NCT00326118|343003|P1|COMPLETED|Year 5 Follow up||217
141216|NCT00326118|343002|P2|STARTED|Year 5 Follow up||78
141217|NCT00326118|343003|P1|STARTED|Year 5 Follow up||217
141218|NCT00326118|343002|P2|NOT COMPLETED|Year 4 Follow-up||0
141219|NCT00326118|343003|P1|NOT COMPLETED|Year 4 Follow-up||0
141220|NCT00326118|343002|P2|COMPLETED|Year 4 Follow-up||80
141221|NCT00326118|343003|P1|COMPLETED|Year 4 Follow-up||228
141222|NCT00326118|343002|P2|STARTED|Year 4 Follow-up||80
141223|NCT00326118|343003|P1|STARTED|Year 4 Follow-up||228
141224|NCT00326118|343002|P2|NOT COMPLETED|Year 3 Follow-up||0
141225|NCT00326118|343003|P1|NOT COMPLETED|Year 3 Follow-up||0
141226|NCT00326118|343002|P2|COMPLETED|Year 3 Follow-up||89
141227|NCT00326118|343003|P1|COMPLETED|Year 3 Follow-up||256
141228|NCT00326118|343002|P2|STARTED|Year 3 Follow-up||89
141229|NCT00326118|343003|P1|STARTED|Year 3 Follow-up||256
141230|NCT00326118|343002|P2|NOT COMPLETED|Year 2 Follow-up||0
141231|NCT00326118|343003|P1|NOT COMPLETED|Year 2 Follow-up||0
141232|NCT00326118|343002|P2|COMPLETED|Year 2 Follow-up||92
141233|NCT00326118|343003|P1|COMPLETED|Year 2 Follow-up||270
141234|NCT00326118|343002|P2|STARTED|Year 2 Follow-up||92
141235|NCT00326118|343003|P1|STARTED|Year 2 Follow-up||270
141236|NCT00326118|343002|P2|NOT COMPLETED|Year 1 Follow-up||0
141237|NCT00326118|343003|P1|NOT COMPLETED|Year 1 Follow-up||0
141238|NCT00326118|343002|P2|COMPLETED|Year 1 Follow-up||100
141239|NCT00326118|343003|P1|COMPLETED|Year 1 Follow-up||295
141240|NCT00326118|343002|P2|STARTED|Year 1 Follow-up||100
141241|NCT00326118|343003|P1|STARTED|Year 1 Follow-up||295
141242|NCT00326118|343002|P2|NOT COMPLETED|Active Phase||1
141243|NCT00326118|343003|P1|NOT COMPLETED|Active Phase||4
141244|NCT00326118|343002|P2|COMPLETED|Active Phase||108
141245|NCT00326118|343003|P1|COMPLETED|Active Phase||320
141246|NCT00326118|343002|P2|STARTED|Active Phase||109
141247|NCT00326118|343003|P1|STARTED|Active Phase||324
141248|NCT00326170|343037|P1|NOT COMPLETED|Overall Study||0
141249|NCT00326170|343037|P1|COMPLETED|Overall Study||34
141250|NCT00326170|343037|P1|STARTED|Overall Study||34
141251|NCT00326183|343043|P2|NOT COMPLETED|Overall Study||83
141252|NCT00326183|343044|P1|NOT COMPLETED|Overall Study||200
141253|NCT00326183|343043|P2|COMPLETED|Overall Study||264
141254|NCT00326183|343044|P1|COMPLETED|Overall Study||1253
141255|NCT00326183|343043|P2|Postvaccination 2 Post-safety Follow-up|Overall Study||271
141256|NCT00326183|343044|P1|Postvaccination 2 Post-safety Follow-up|Overall Study||1265
141257|NCT00326183|343043|P2|Vaccination 2 + Safety Follow-up|Overall Study||292
141258|NCT00326183|343044|P1|Vaccination 2 + Safety Follow-up|Overall Study||1301
141259|NCT00326183|343043|P2|Postvaccination 1 Post-safety Follow-up|Overall Study||325
141260|NCT00326183|343044|P1|Postvaccination 1 Post-safety Follow-up|Overall Study||1393
141261|NCT00326183|343043|P2|Vaccination 1 + Safety Follow-up|Overall Study||347
141262|NCT00326183|343044|P1|Vaccination 1 + Safety Follow-up|Overall Study||1453
141263|NCT00326183|343043|P2|STARTED|Overall Study||347
141264|NCT00326183|343044|P1|STARTED|Overall Study||1453
141265|NCT00326196|343072|P2|NOT COMPLETED|Overall Study||0
141266|NCT00326196|343073|P1|NOT COMPLETED|Overall Study||0
141267|NCT00326196|343072|P2|COMPLETED|Overall Study||97
141268|NCT00326196|343073|P1|COMPLETED|Overall Study||101
141269|NCT00326196|343072|P2|STARTED|Overall Study||97
141270|NCT00326196|343073|P1|STARTED|Overall Study||101
141271|NCT00326417|343081|P4|NOT COMPLETED|Overall Study||3
141272|NCT00326417|343082|P3|NOT COMPLETED|Overall Study||1
141273|NCT00326417|343083|P2|NOT COMPLETED|Overall Study||0
141274|NCT00326417|343084|P1|NOT COMPLETED|Overall Study||14
141275|NCT00326417|343081|P4|COMPLETED|Overall Study|Arm was closed to accrual after 3 patients experienced graft failure.|0
141276|NCT00326417|343082|P3|COMPLETED|Overall Study||38
141277|NCT00326417|343083|P2|COMPLETED|Overall Study||41
141278|NCT00326417|343084|P1|COMPLETED|Overall Study|Dose level was closed for excessive toxicity after 8 patients in Phase II accrued.|0
141279|NCT00326417|343081|P4|Phase II|Overall Study||0
141280|NCT00326417|343082|P3|Phase II|Overall Study||33
141281|NCT00326417|343083|P2|Phase II|Overall Study||35
141282|NCT00326417|343084|P1|Phase II|Overall Study||8
141283|NCT00326417|343081|P4|Phase I|Overall Study||3
141284|NCT00326417|343082|P3|Phase I|Overall Study||6
141285|NCT00326417|343083|P2|Phase I|Overall Study||6
141286|NCT00326417|343084|P1|Phase I|Overall Study||6
141287|NCT00326417|343081|P4|STARTED|Overall Study||3
141288|NCT00326417|343082|P3|STARTED|Overall Study||39
141289|NCT00326417|343083|P2|STARTED|Overall Study||41
141290|NCT00326417|343084|P1|STARTED|Overall Study||14
141291|NCT00326495|343100|P1|NOT COMPLETED|Overall Study||5
141292|NCT00326495|343100|P1|COMPLETED|Overall Study||46
141293|NCT00326495|343100|P1|STARTED|Overall Study||51
141294|NCT00326599|343109|P4|NOT COMPLETED|Overall Study||19
141295|NCT00326599|343110|P3|NOT COMPLETED|Overall Study||53
141296|NCT00326599|343111|P2|NOT COMPLETED|Overall Study||1
141297|NCT00326599|343112|P1|NOT COMPLETED|Overall Study||6
141298|NCT00326599|343109|P4|COMPLETED|Overall Study||10
141299|NCT00326599|343110|P3|COMPLETED|Overall Study||5
141300|NCT00326599|343111|P2|COMPLETED|Overall Study||2
141301|NCT00326599|343112|P1|COMPLETED|Overall Study||0
141302|NCT00326599|343109|P4|STARTED|Overall Study||29
141303|NCT00326599|343110|P3|STARTED|Overall Study||58
141304|NCT00326599|343111|P2|STARTED|Overall Study||3
141305|NCT00326599|343112|P1|STARTED|Overall Study||6
141306|NCT00326612|343133|P2|NOT COMPLETED|Overall Study||137
141307|NCT00326612|343134|P1|NOT COMPLETED|Overall Study||129
141308|NCT00326612|343133|P2|COMPLETED|Overall Study||42
141309|NCT00326612|343134|P1|COMPLETED|Overall Study||50
141310|NCT00326612|343133|P2|STARTED|Overall Study||179
141311|NCT00326612|343134|P1|STARTED|Overall Study||179
141312|NCT00326716|343154|P4|NOT COMPLETED|Infants||0
141313|NCT00326716|343155|P3|NOT COMPLETED|Infants||0
141314|NCT00326716|343156|P2|NOT COMPLETED|Infants||0
141315|NCT00326716|343157|P1|NOT COMPLETED|Infants||0
141316|NCT00326716|343154|P4|COMPLETED|Infants||20
141317|NCT00326716|343155|P3|COMPLETED|Infants||20
141318|NCT00326716|343156|P2|COMPLETED|Infants||0
141319|NCT00326716|343157|P1|COMPLETED|Infants||0
141320|NCT00326716|343154|P4|STARTED|Infants|All infants were followed. One mother withdrew consent pre-delivery and her infant was not followed.|20
141321|NCT00326716|343155|P3|STARTED|Infants|All infants were followed.|20
141322|NCT00326716|343156|P2|STARTED|Infants||0
141323|NCT00326716|343157|P1|STARTED|Infants||0
141324|NCT00326716|343154|P4|NOT COMPLETED|Pre-Natal Mothers||0
141325|NCT00326716|343155|P3|NOT COMPLETED|Pre-Natal Mothers||0
141326|NCT00326716|343156|P2|NOT COMPLETED|Pre-Natal Mothers||2
141327|NCT00326716|343157|P1|NOT COMPLETED|Pre-Natal Mothers||1
141328|NCT00326716|343154|P4|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
141329|NCT00326716|343155|P3|COMPLETED|Pre-Natal Mothers|Completion was defined as completing all follow up visits through 6 months.|0
141330|NCT00326716|343156|P2|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
141331|NCT00326716|343157|P1|COMPLETED|Pre-Natal Mothers|Completion was defined as completing the study.|19
141332|NCT00326716|343154|P4|STARTED|Pre-Natal Mothers||0
141333|NCT00326716|343155|P3|STARTED|Pre-Natal Mothers||0
141334|NCT00326716|343156|P2|STARTED|Pre-Natal Mothers||21
141335|NCT00326716|343157|P1|STARTED|Pre-Natal Mothers||20
141336|NCT00326781|343229|P2|NOT COMPLETED|Overall Study||32
141337|NCT00326781|343230|P1|NOT COMPLETED|Overall Study||42
141338|NCT00326781|343229|P2|COMPLETED|Overall Study||298
141339|NCT00326781|343230|P1|COMPLETED|Overall Study||302
141340|NCT00326781|343229|P2|STARTED|Overall Study||330
141341|NCT00326781|343230|P1|STARTED|Overall Study||344
141342|NCT00326872|343238|P1|NOT COMPLETED|Overall Study||0
141343|NCT00326872|343238|P1|COMPLETED|Overall Study||26
141344|NCT00326872|343238|P1|STARTED|Overall Study||26
141345|NCT00326885|343247|P1|NOT COMPLETED|Overall Study||7
141346|NCT00326885|343247|P1|COMPLETED|Overall Study||25
141347|NCT00326885|343247|P1|STARTED|Overall Study||32
141348|NCT00326898|343259|P3|NOT COMPLETED|Overall Study||203
141349|NCT00326898|343260|P2|NOT COMPLETED|Overall Study||343
141350|NCT00326898|343261|P1|NOT COMPLETED|Overall Study||351
141351|NCT00326898|343259|P3|COMPLETED|Overall Study||444
141352|NCT00326898|343260|P2|COMPLETED|Overall Study||306
141353|NCT00326898|343261|P1|COMPLETED|Overall Study||296
141354|NCT00326898|343259|P3|Patients With >=1 Follow-up MUGA Scan|Overall Study||580
141355|NCT00326898|343260|P2|Patients With >=1 Follow-up MUGA Scan|Overall Study||510
141356|NCT00326898|343261|P1|Patients With >=1 Follow-up MUGA Scan|Overall Study||513
141357|NCT00326898|343259|P3|Patients With Clear Cell Histology|Overall Study||540
141358|NCT00326898|343260|P2|Patients With Clear Cell Histology|Overall Study||540
141359|NCT00326898|343261|P1|Patients With Clear Cell Histology|Overall Study||542
141360|NCT00326898|343259|P3|Patients With Toxicity Data|Overall Study||626
141361|NCT00326898|343260|P2|Patients With Toxicity Data|Overall Study||628
141362|NCT00326898|343261|P1|Patients With Toxicity Data|Overall Study||625
141363|NCT00326898|343259|P3|STARTED|Overall Study||647
141364|NCT00326898|343260|P2|STARTED|Overall Study||649
141365|NCT00326898|343261|P1|STARTED|Overall Study||647
141366|NCT00326911|343280|P2|NOT COMPLETED|Overall Study||2
141367|NCT00326911|343281|P1|NOT COMPLETED|Overall Study||1
141368|NCT00326911|343280|P2|COMPLETED|Overall Study|This number reflects all treated patients.|29
141369|NCT00326911|343281|P1|COMPLETED|Overall Study|This number reflects all treated patients.|29
141370|NCT00326911|343280|P2|STARTED|Overall Study|This number reflects all randomized patients.|31
141371|NCT00326911|343281|P1|STARTED|Overall Study|This number reflects all randomized patients.|30
141372|NCT00326950|343331|P1|NOT COMPLETED|Overall Study||1
141373|NCT00326950|343331|P1|COMPLETED|Overall Study||14
141374|NCT00326950|343331|P1|STARTED|Overall Study||15
141375|NCT00326963|343336|P1|NOT COMPLETED|Overall Study||33
141376|NCT00326963|343336|P1|COMPLETED|Overall Study||107
141377|NCT00326963|343336|P1|STARTED|Overall Study||140
141378|NCT00327015|343360|P4|NOT COMPLETED|Overall Study||109
141379|NCT00327015|343361|P3|NOT COMPLETED|Overall Study||126
141380|NCT00327015|343362|P2|NOT COMPLETED|Overall Study||92
141381|NCT00327015|343363|P1|NOT COMPLETED|Overall Study||91
141382|NCT00327015|343360|P4|COMPLETED|Overall Study||219
141383|NCT00327015|343361|P3|COMPLETED|Overall Study||209
141384|NCT00327015|343362|P2|COMPLETED|Overall Study||231
141385|NCT00327015|343363|P1|COMPLETED|Overall Study||229
141386|NCT00327015|343360|P4|Completed Study Without Being Rescued|Overall Study||144
141387|NCT00327015|343361|P3|Completed Study Without Being Rescued|Overall Study||113
141388|NCT00327015|343362|P2|Completed Study Without Being Rescued|Overall Study||177
141389|NCT00327015|343363|P1|Completed Study Without Being Rescued|Overall Study||179
141390|NCT00327015|343360|P4|STARTED|Overall Study||328
141391|NCT00327015|343361|P3|STARTED|Overall Study||335
141392|NCT00327015|343362|P2|STARTED|Overall Study||323
141393|NCT00327015|343363|P1|STARTED|Overall Study||320
141394|NCT00327171|343407|P2|NOT COMPLETED|Overall Study||109
141395|NCT00327171|343408|P1|NOT COMPLETED|Overall Study||108
141396|NCT00327171|343407|P2|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|0
141397|NCT00327171|343408|P1|COMPLETED|Overall Study|Participants received treatment until they met treatment discontinuation criteria|1
141398|NCT00327171|343407|P2|STARTED|Overall Study||109
141399|NCT00327171|343408|P1|STARTED|Overall Study||109
141400|NCT00327340|343438|P2|NOT COMPLETED|Overall Study||30
141401|NCT00327340|343439|P1|NOT COMPLETED|Overall Study||15
141402|NCT00327340|343438|P2|COMPLETED|Overall Study||16
141403|NCT00327340|343439|P1|COMPLETED|Overall Study||8
141404|NCT00327340|343438|P2|STARTED|Overall Study||46
141405|NCT00327340|343439|P1|STARTED|Overall Study||23
141406|NCT00333138|343454|P3|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
141407|NCT00333138|343455|P2|NOT COMPLETED|Extension Study (Month6 to End of Study)||42
141408|NCT00333138|343456|P1|NOT COMPLETED|Extension Study (Month6 to End of Study)||43
141409|NCT00333138|343454|P3|COMPLETED|Extension Study (Month6 to End of Study)||37
141410|NCT00333138|343455|P2|COMPLETED|Extension Study (Month6 to End of Study)||45
141411|NCT00333138|343456|P1|COMPLETED|Extension Study (Month6 to End of Study)||40
141412|NCT00333138|343454|P3|STARTED|Extension Study (Month6 to End of Study)||80
141413|NCT00333138|343455|P2|STARTED|Extension Study (Month6 to End of Study)||87
141414|NCT00333138|343456|P1|STARTED|Extension Study (Month6 to End of Study)||83
141415|NCT00333138|343454|P3|NOT COMPLETED|Core Study (6 Months)||12
141416|NCT00333138|343455|P2|NOT COMPLETED|Core Study (6 Months)||6
141417|NCT00333138|343456|P1|NOT COMPLETED|Core Study (6 Months)||7
141418|NCT00333138|343454|P3|COMPLETED|Core Study (6 Months)||82
141419|NCT00333138|343455|P2|COMPLETED|Core Study (6 Months)||88
141420|NCT00333138|343456|P1|COMPLETED|Core Study (6 Months)||86
141421|NCT00333138|343454|P3|STARTED|Core Study (6 Months)||94
141422|NCT00333138|343455|P2|STARTED|Core Study (6 Months)||94
141423|NCT00333138|343456|P1|STARTED|Core Study (6 Months)||93
141424|NCT00333229|343495|P2|NOT COMPLETED|Overall Study||1
141425|NCT00333229|343496|P1|NOT COMPLETED|Overall Study||0
141426|NCT00333229|343495|P2|COMPLETED|Overall Study||4
141427|NCT00333229|343496|P1|COMPLETED|Overall Study||6
141428|NCT00333229|343495|P2|STARTED|Overall Study||5
141429|NCT00333229|343496|P1|STARTED|Overall Study||6
141430|NCT00333359|343512|P2|NOT COMPLETED|Overall Study||122
141431|NCT00333359|343513|P1|NOT COMPLETED|Overall Study||73
141432|NCT00333359|343512|P2|COMPLETED|Overall Study||260
141433|NCT00333359|343513|P1|COMPLETED|Overall Study||126
141434|NCT00333359|343512|P2|STARTED|Overall Study||382
141435|NCT00333359|343513|P1|STARTED|Overall Study||199
141436|NCT00334061|343554|P1|NOT COMPLETED|Overall Study||0
141437|NCT00334061|343554|P1|COMPLETED|Overall Study|November 2007|125
141438|NCT00334061|343554|P1|STARTED|Overall Study|June 2006|125
141439|NCT00334074|343563|P1|NOT COMPLETED|Overall Study||0
141440|NCT00334074|343563|P1|COMPLETED|Overall Study||30
141441|NCT00334074|343563|P1|STARTED|Overall Study||30
141442|NCT00334113|343570|P2|NOT COMPLETED|Overall Study||3
141443|NCT00334113|343571|P1|NOT COMPLETED|Overall Study||2
141444|NCT00334113|343570|P2|COMPLETED|Overall Study||31
141445|NCT00334113|343571|P1|COMPLETED|Overall Study||30
141446|NCT00334113|343570|P2|STARTED|Overall Study||34
141447|NCT00334113|343571|P1|STARTED|Overall Study||32
141448|NCT00334204|343577|P1|NOT COMPLETED|Overall Study||2
141449|NCT00334204|343577|P1|COMPLETED|Overall Study||56
141450|NCT00334204|343577|P1|STARTED|Overall Study||58
141451|NCT00334282|343585|P2|NOT COMPLETED|Overall Study||108
141452|NCT00334282|343586|P1|NOT COMPLETED|Overall Study||222
141453|NCT00334282|343585|P2|COMPLETED|Overall Study||37
141454|NCT00334282|343586|P1|COMPLETED|Overall Study||68
141455|NCT00334282|343585|P2|STARTED|Overall Study||145
141456|NCT00334282|343586|P1|STARTED|Overall Study||290
141457|NCT00334295|343609|P1|NOT COMPLETED|Overall Study||5
141458|NCT00334295|343609|P1|COMPLETED|Overall Study||30
141459|NCT00334295|343609|P1|STARTED|Overall Study||35
141460|NCT00334542|343617|P1|NOT COMPLETED|Overall Study||5
141461|NCT00334542|343617|P1|COMPLETED|Overall Study||45
141462|NCT00334542|343617|P1|STARTED|Overall Study||50
141463|NCT00334633|343625|P3|NOT COMPLETED|Overall Study||82
141464|NCT00334633|343626|P2|NOT COMPLETED|Overall Study||82
141465|NCT00334633|343627|P1|NOT COMPLETED|Overall Study||80
141466|NCT00334633|343625|P3|COMPLETED|Overall Study||114
141467|NCT00334633|343626|P2|COMPLETED|Overall Study||118
141468|NCT00334633|343627|P1|COMPLETED|Overall Study||117
141469|NCT00334633|343625|P3|STARTED|Overall Study||196
141470|NCT00334633|343626|P2|STARTED|Overall Study||200
141471|NCT00334633|343627|P1|STARTED|Overall Study||197
141472|NCT00334802|343637|P2|NOT COMPLETED|Overall Study||40
141473|NCT00334802|343638|P1|NOT COMPLETED|Overall Study||6
141474|NCT00334802|343637|P2|COMPLETED|Overall Study||16
141475|NCT00334802|343638|P1|COMPLETED|Overall Study||0
141476|NCT00334802|343637|P2|STARTED|Overall Study||56
141477|NCT00334802|343638|P1|STARTED|Overall Study||6
141478|NCT00334815|343657|P2|NOT COMPLETED|Overall Study||10
141479|NCT00334815|343658|P1|NOT COMPLETED|Overall Study||7
141480|NCT00334815|343657|P2|COMPLETED|Overall Study||3
141481|NCT00334815|343658|P1|COMPLETED|Overall Study||9
141482|NCT00334815|343657|P2|STARTED|Overall Study||13
141483|NCT00334815|343658|P1|STARTED|Overall Study||16
141484|NCT00334893|343672|P2|NOT COMPLETED|Overall Study||0
141485|NCT00334893|343673|P1|NOT COMPLETED|Overall Study||1
141486|NCT00334893|343672|P2|COMPLETED|Overall Study||37
141487|NCT00334893|343673|P1|COMPLETED|Overall Study||36
141488|NCT00334893|343672|P2|STARTED|Overall Study||37
141489|NCT00334893|343673|P1|STARTED|Overall Study||37
141490|NCT00334958|343681|P2|NOT COMPLETED|Overall Study||24
141491|NCT00334958|343682|P1|NOT COMPLETED|Overall Study||37
141492|NCT00334958|343681|P2|COMPLETED|Overall Study||156
141493|NCT00334958|343682|P1|COMPLETED|Overall Study||139
141494|NCT00334958|343681|P2|STARTED|Overall Study|1 subject withdrawn prior to study drug dosing due to not obtaining labs|180
141495|NCT00334958|343682|P1|STARTED|Overall Study||176
141496|NCT00335140|343694|P1|NOT COMPLETED|Overall Study||1
141497|NCT00335140|343694|P1|COMPLETED|Overall Study||25
141498|NCT00335140|343694|P1|Treated|Overall Study||25
141499|NCT00335140|343694|P1|Eligible|Overall Study||25
141500|NCT00335140|343694|P1|STARTED|Overall Study||26
141501|NCT00335153|343698|P1|NOT COMPLETED|Post-PEG-J Long-Term Treatment Period||52
141502|NCT00335153|343698|P1|COMPLETED|Post-PEG-J Long-Term Treatment Period||272
141503|NCT00335153|343698|P1|STARTED|Post-PEG-J Long-Term Treatment Period||324
141504|NCT00335153|343698|P1|NOT COMPLETED|Nasojejunal (NJ) Test Period||30
141505|NCT00335153|343698|P1|COMPLETED|Nasojejunal (NJ) Test Period||324
141506|NCT00335153|343698|P1|STARTED|Nasojejunal (NJ) Test Period||354
141507|NCT00335257|343738|P3|NOT COMPLETED|Overall Study||0
141508|NCT00335257|343739|P2|NOT COMPLETED|Overall Study||0
141509|NCT00335257|343740|P1|NOT COMPLETED|Overall Study||0
141510|NCT00335257|343738|P3|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|60190
141511|NCT00335257|343739|P2|COMPLETED|Overall Study||9377
141512|NCT00335257|343740|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 6.0 years.|15542
141513|NCT00335257|343738|P3|STARTED|Overall Study||60190
141514|NCT00335257|343739|P2|STARTED|Overall Study||9377
141515|NCT00335257|343740|P1|STARTED|Overall Study||15542
141516|NCT00335283|343759|P2|NOT COMPLETED|Overall Study||5
141517|NCT00335283|343760|P1|NOT COMPLETED|Overall Study||6
141518|NCT00335283|343759|P2|COMPLETED|Overall Study||34
141519|NCT00335283|343760|P1|COMPLETED|Overall Study||30
141520|NCT00335283|343759|P2|STARTED|Overall Study||39
141521|NCT00335283|343760|P1|STARTED|Overall Study||36
141522|NCT00335322|343775|P3|NOT COMPLETED|Overall Study||2
141523|NCT00335322|343776|P2|NOT COMPLETED|Overall Study||2
141524|NCT00335322|343777|P1|NOT COMPLETED|Overall Study||1
141525|NCT00335322|343775|P3|COMPLETED|Overall Study||103
141526|NCT00335322|343776|P2|COMPLETED|Overall Study||105
141527|NCT00335322|343777|P1|COMPLETED|Overall Study||114
141528|NCT00335322|343775|P3|STARTED|Overall Study||105
141529|NCT00335322|343776|P2|STARTED|Overall Study||107
141530|NCT00335322|343777|P1|STARTED|Overall Study||115
141531|NCT00335452|343789|P4|NOT COMPLETED|Overall Study||131
141532|NCT00335452|343790|P3|NOT COMPLETED|Overall Study||159
141533|NCT00335452|343791|P2|NOT COMPLETED|Overall Study||147
141534|NCT00335452|343792|P1|NOT COMPLETED|Overall Study||158
141535|NCT00335452|343789|P4|COMPLETED|Overall Study|Completed 30 days follow-up period|6122
141536|NCT00335452|343790|P3|COMPLETED|Overall Study|Completed 30 days follow-up period|6108
141537|NCT00335452|343791|P2|COMPLETED|Overall Study|Completed 30 days follow-up period|6107
141538|NCT00335452|343792|P1|COMPLETED|Overall Study|Completed 30 days follow-up period|6154
141539|NCT00335452|343789|P4|TREATED WITH ASA|Overall Study||6247
141540|NCT00335452|343790|P3|TREATED WITH ASA|Overall Study||6261
141541|NCT00335452|343791|P2|TREATED WITH ASA|Overall Study||6251
141542|NCT00335452|343792|P1|TREATED WITH ASA|Overall Study||6302
141543|NCT00335452|343789|P4|TREATED WITH CLOPIDOGREL|Overall Study||6217
141544|NCT00335452|343790|P3|TREATED WITH CLOPIDOGREL|Overall Study||6228
141545|NCT00335452|343791|P2|TREATED WITH CLOPIDOGREL|Overall Study||6218
141546|NCT00335452|343792|P1|TREATED WITH CLOPIDOGREL|Overall Study||6271
141547|NCT00335452|343789|P4|STARTED|Overall Study|Randomized|6253
141548|NCT00335452|343790|P3|STARTED|Overall Study|Randomized|6267
141549|NCT00335452|343791|P2|STARTED|Overall Study|Randomized|6254
141550|NCT00335452|343792|P1|STARTED|Overall Study|Randomized|6312
141551|NCT00335478|343814|P1|NOT COMPLETED|Overall Study||24
141552|NCT00335478|343814|P1|COMPLETED|Overall Study||30
141553|NCT00335478|343814|P1|STARTED|Overall Study||54
141554|NCT00335504|343822|P4|NOT COMPLETED|Overall Study||0
141555|NCT00335504|343823|P3|NOT COMPLETED|Overall Study||0
141556|NCT00335504|343824|P2|NOT COMPLETED|Overall Study||0
141557|NCT00335504|343825|P1|NOT COMPLETED|Overall Study||0
141558|NCT00335504|343822|P4|COMPLETED|Overall Study||22
141559|NCT00335504|343823|P3|COMPLETED|Overall Study||20
141560|NCT00335504|343824|P2|COMPLETED|Overall Study||21
141561|NCT00335504|343825|P1|COMPLETED|Overall Study||22
141562|NCT00335504|343822|P4|STARTED|Overall Study||22
141563|NCT00335504|343823|P3|STARTED|Overall Study||20
141564|NCT00335504|343824|P2|STARTED|Overall Study||21
141565|NCT00335504|343825|P1|STARTED|Overall Study||22
141566|NCT00335517|343847|P1|NOT COMPLETED|Overall Study||2
141567|NCT00335517|343847|P1|COMPLETED|Overall Study|Due to pharmacy error two patients were enolled and recieved EREM, but were not included in analysis|98
141568|NCT00335517|343847|P1|STARTED|Overall Study||100
141569|NCT00335556|343857|P6|NOT COMPLETED|Overall Study||1
141570|NCT00335556|343858|P5|NOT COMPLETED|Overall Study||1
141571|NCT00335556|343859|P4|NOT COMPLETED|Overall Study||5
141572|NCT00335556|343860|P3|NOT COMPLETED|Overall Study||5
141573|NCT00335556|343861|P2|NOT COMPLETED|Overall Study||34
141574|NCT00335556|343862|P1|NOT COMPLETED|Overall Study||2
141575|NCT00335556|343857|P6|COMPLETED|Overall Study||29
141576|NCT00335556|343858|P5|COMPLETED|Overall Study||77
141577|NCT00335556|343859|P4|COMPLETED|Overall Study||5
141578|NCT00335556|343860|P3|COMPLETED|Overall Study||2
141579|NCT00335556|343861|P2|COMPLETED|Overall Study||64
141580|NCT00335556|343862|P1|COMPLETED|Overall Study||66
141581|NCT00335556|343857|P6|STARTED|Overall Study||30
141582|NCT00335556|343858|P5|STARTED|Overall Study||78
141583|NCT00335556|343859|P4|STARTED|Overall Study||10
141584|NCT00335556|343860|P3|STARTED|Overall Study||7
141585|NCT00335556|343861|P2|STARTED|Overall Study||98
141586|NCT00335556|343862|P1|STARTED|Overall Study||68
141587|NCT00335725|343885|P2|NOT COMPLETED|Overall Study||5
141588|NCT00335725|343886|P1|NOT COMPLETED|Overall Study||4
141589|NCT00335725|343885|P2|COMPLETED|Overall Study||71
141590|NCT00335725|343886|P1|COMPLETED|Overall Study||71
141591|NCT00335725|343885|P2|STARTED|Overall Study||76
141592|NCT00335725|343886|P1|STARTED|Overall Study||75
141593|NCT00335777|343894|P1|NOT COMPLETED|Treated 2 Headaches Per Protocol||13
141594|NCT00335777|343894|P1|COMPLETED|Treated 2 Headaches Per Protocol||22
141595|NCT00335777|343894|P1|STARTED|Treated 2 Headaches Per Protocol||35
141596|NCT00335777|343894|P1|NOT COMPLETED|Enrolled and Dispensed Study Medication||29
141597|NCT00335777|343894|P1|COMPLETED|Enrolled and Dispensed Study Medication||35
141598|NCT00335777|343894|P1|STARTED|Enrolled and Dispensed Study Medication|64 subjects enrolled. 35 treated 2 headaches, but 22/35 at appropriate times, as per protocol.|64
141599|NCT00335829|343899|P1|NOT COMPLETED|Overall Study||3
141600|NCT00335829|343899|P1|COMPLETED|Overall Study||23
141601|NCT00335829|343899|P1|Received First TACE|Overall Study|1 patient left after receiving bevacizumab but prior to first TACE|25
141602|NCT00335829|343899|P1|Received Bevacizumab|Overall Study||26
141603|NCT00335829|343899|P1|STARTED|Overall Study||26
141604|NCT00335959|343913|P1|NOT COMPLETED|Overall Study||3
141605|NCT00335959|343913|P1|COMPLETED|Overall Study||4
141606|NCT00335959|343913|P1|Eligible and Began Protocol Therapy|Overall Study||6
141607|NCT00335959|343913|P1|Eligible|Overall Study||6
141608|NCT00335959|343913|P1|STARTED|Overall Study||7
141609|NCT00335972|343920|P2|NOT COMPLETED|Overall Study||3
141610|NCT00335972|343921|P1|NOT COMPLETED|Overall Study||0
141611|NCT00335972|343920|P2|COMPLETED|Overall Study||68
141612|NCT00335972|343921|P1|COMPLETED|Overall Study||71
141613|NCT00335972|343920|P2|STARTED|Overall Study||71
141614|NCT00335972|343921|P1|STARTED|Overall Study||71
141615|NCT00336232|343931|P1|NOT COMPLETED|High Vitamin K (500mcg Daily)||0
141616|NCT00336232|343931|P1|COMPLETED|High Vitamin K (500mcg Daily)||42
141617|NCT00336232|343931|P1|STARTED|High Vitamin K (500mcg Daily)||42
141618|NCT00336232|343931|P1|NOT COMPLETED|Low Vitamin K (10mcg Daily)||0
141619|NCT00336232|343931|P1|COMPLETED|Low Vitamin K (10mcg Daily)||42
141620|NCT00336232|343931|P1|STARTED|Low Vitamin K (10mcg Daily)||42
141621|NCT00336232|343931|P1|NOT COMPLETED|Baseline (200mcg Daily)||17
141622|NCT00336232|343931|P1|COMPLETED|Baseline (200mcg Daily)||42
141623|NCT00336232|343931|P1|STARTED|Baseline (200mcg Daily)||59
141624|NCT00336284|343937|P2|NOT COMPLETED|Overall Study||151
141625|NCT00336284|343938|P1|NOT COMPLETED|Overall Study||236
141626|NCT00336284|343937|P2|COMPLETED|Overall Study||322
141627|NCT00336284|343938|P1|COMPLETED|Overall Study||741
141628|NCT00336284|343937|P2|STARTED|Overall Study||473
141629|NCT00336284|343938|P1|STARTED|Overall Study||977
141630|NCT00336323|343955|P5|NOT COMPLETED|Overall Study||3
141631|NCT00336323|343956|P4|NOT COMPLETED|Overall Study||0
141632|NCT00336323|343957|P3|NOT COMPLETED|Overall Study||1
141633|NCT00336323|343958|P2|NOT COMPLETED|Overall Study||1
141634|NCT00336323|343959|P1|NOT COMPLETED|Overall Study||0
141635|NCT00336323|343955|P5|COMPLETED|Overall Study||19
141636|NCT00336323|343956|P4|COMPLETED|Overall Study||22
141637|NCT00336323|343957|P3|COMPLETED|Overall Study||23
141638|NCT00336323|343958|P2|COMPLETED|Overall Study||21
141639|NCT00336323|343959|P1|COMPLETED|Overall Study||19
141640|NCT00336323|343955|P5|24 Week Visit|Overall Study||19
141641|NCT00336323|343956|P4|24 Week Visit|Overall Study||22
141642|NCT00336323|343957|P3|24 Week Visit|Overall Study|1 patient was dropped from the study|22
141643|NCT00336323|343958|P2|24 Week Visit|Overall Study|1 patient was dropped from the study|20
141644|NCT00336323|343959|P1|24 Week Visit|Overall Study||18
141645|NCT00336323|343955|P5|18 Week Visit|Overall Study|1 patient was dropped from the study|18
141646|NCT00336323|343956|P4|18 Week Visit|Overall Study||21
141647|NCT00336323|343957|P3|18 Week Visit|Overall Study||23
141648|NCT00336323|343958|P2|18 Week Visit|Overall Study||22
141649|NCT00336323|343959|P1|18 Week Visit|Overall Study||19
141650|NCT00336323|343955|P5|12 Week Visit|Overall Study|1 patient was dropped from study|20
141651|NCT00336323|343956|P4|12 Week Visit|Overall Study||22
141652|NCT00336323|343957|P3|12 Week Visit|Overall Study||24
141653|NCT00336323|343958|P2|12 Week Visit|Overall Study||21
141654|NCT00336323|343959|P1|12 Week Visit|Overall Study||19
141655|NCT00336323|343955|P5|9 Week Visit|Overall Study||19
141656|NCT00336323|343956|P4|9 Week Visit|Overall Study||21
141657|NCT00336323|343957|P3|9 Week Visit|Overall Study||23
141658|NCT00336323|343958|P2|9 Week Visit|Overall Study||21
141659|NCT00336323|343959|P1|9 Week Visit|Overall Study||18
141660|NCT00336323|343955|P5|6 Week Visit|Overall Study|1 patient was dropped - injection was given late at 9 wks for one patient|20
141661|NCT00336323|343956|P4|6 Week Visit|Overall Study||22
141662|NCT00336323|343957|P3|6 Week Visit|Overall Study||24
141663|NCT00336323|343958|P2|6 Week Visit|Overall Study||22
141664|NCT00336323|343959|P1|6 Week Visit|Overall Study||18
141665|NCT00336323|343955|P5|3 Week Visit|Overall Study|Laser given late at six weeks for one patient|20
141666|NCT00336323|343956|P4|3 Week Visit|Overall Study||22
141667|NCT00336323|343957|P3|3 Week Visit|Overall Study||24
141668|NCT00336323|343958|P2|3 Week Visit|Overall Study||21
141669|NCT00336323|343959|P1|3 Week Visit|Overall Study||18
141670|NCT00336323|343955|P5|STARTED|Overall Study||22
141671|NCT00336323|343956|P4|STARTED|Overall Study||22
141672|NCT00336323|343957|P3|STARTED|Overall Study||24
141673|NCT00336323|343958|P2|STARTED|Overall Study||22
141674|NCT00336323|343959|P1|STARTED|Overall Study||19
141675|NCT00336479|344018|P4|NOT COMPLETED|Overall Study||4
141676|NCT00336479|344019|P3|NOT COMPLETED|Overall Study||26
141677|NCT00336479|344020|P2|NOT COMPLETED|Overall Study||25
141678|NCT00336479|344021|P1|NOT COMPLETED|Overall Study||37
141679|NCT00336479|344018|P4|COMPLETED|Overall Study||13
141680|NCT00336479|344019|P3|COMPLETED|Overall Study||53
141681|NCT00336479|344020|P2|COMPLETED|Overall Study||54
141682|NCT00336479|344021|P1|COMPLETED|Overall Study||38
141683|NCT00336479|344018|P4|STARTED|Overall Study||17
141684|NCT00336479|344019|P3|STARTED|Overall Study||79
141685|NCT00336479|344020|P2|STARTED|Overall Study||79
141686|NCT00336479|344021|P1|STARTED|Overall Study||75
141687|NCT00336492|344047|P3|NOT COMPLETED|Overall Study||11
141688|NCT00336492|344048|P2|NOT COMPLETED|Overall Study||4
141689|NCT00336492|344049|P1|NOT COMPLETED|Overall Study||15
141690|NCT00336492|344047|P3|COMPLETED|Overall Study||12
141691|NCT00336492|344048|P2|COMPLETED|Overall Study||18
141692|NCT00336492|344049|P1|COMPLETED|Overall Study||0
141693|NCT00336492|344047|P3|STARTED|Overall Study||23
141694|NCT00336492|344048|P2|STARTED|Overall Study||22
141695|NCT00336492|344049|P1|STARTED|Overall Study||15
141696|NCT00336505|344059|P2|NOT COMPLETED|Overall Study||27
141697|NCT00336505|344060|P1|NOT COMPLETED|Overall Study||37
141698|NCT00336505|344059|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|264
141699|NCT00336505|344060|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|254
141700|NCT00336505|344059|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|291
141701|NCT00336505|344060|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|291
141702|NCT00336544|344074|P2|NOT COMPLETED|Overall Study||22
141703|NCT00336544|344075|P1|NOT COMPLETED|Overall Study||19
141704|NCT00336544|344074|P2|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|238
141705|NCT00336544|344075|P1|COMPLETED|Overall Study|Number of subjects completing the test of cure (TOC) visit.|242
141706|NCT00336544|344074|P2|STARTED|Overall Study|All subjects who were randomized and dosed.|260
141707|NCT00336544|344075|P1|STARTED|Overall Study|All subjects who were randomized and dosed.|261
141708|NCT00336583|344087|P1|NOT COMPLETED|Overall Study||2
141709|NCT00336583|344087|P1|COMPLETED|Overall Study||25
141710|NCT00336583|344087|P1|STARTED|Overall Study||27
141711|NCT00323869|344092|P1|NOT COMPLETED|Overall Study||1
141712|NCT00323869|344092|P1|COMPLETED|Overall Study||47
141713|NCT00323869|344092|P1|Treatment Initiation|Overall Study|One participant died before receiving therapy, not included in analysis|47
141714|NCT00323869|344092|P1|STARTED|Overall Study|Enrollment|48
141715|NCT00323882|344109|P5|NOT COMPLETED|Overall Study||32
141716|NCT00323882|344110|P4|NOT COMPLETED|Overall Study||7
141717|NCT00323882|344111|P3|NOT COMPLETED|Overall Study||13
141718|NCT00323882|344112|P2|NOT COMPLETED|Overall Study||6
141719|NCT00323882|344113|P1|NOT COMPLETED|Overall Study||8
141720|NCT00323882|344109|P5|COMPLETED|Overall Study||2
141721|NCT00323882|344110|P4|COMPLETED|Overall Study||0
141722|NCT00323882|344111|P3|COMPLETED|Overall Study||3
141723|NCT00323882|344112|P2|COMPLETED|Overall Study||0
141724|NCT00323882|344113|P1|COMPLETED|Overall Study||0
141725|NCT00323882|344109|P5|STARTED|Overall Study||34
141726|NCT00323882|344110|P4|STARTED|Overall Study||7
141727|NCT00323882|344111|P3|STARTED|Overall Study||16
141728|NCT00323882|344112|P2|STARTED|Overall Study||6
141729|NCT00323882|344113|P1|STARTED|Overall Study||8
141730|NCT00324038|344186|P2|NOT COMPLETED|Overall Study||51
141731|NCT00324038|344187|P1|NOT COMPLETED|Overall Study||49
141732|NCT00324038|344186|P2|COMPLETED|Overall Study||58
141733|NCT00324038|344187|P1|COMPLETED|Overall Study||61
141734|NCT00324038|344186|P2|STARTED|Overall Study||109
141735|NCT00324038|344187|P1|STARTED|Overall Study||110
141736|NCT00324116|344193|P1|NOT COMPLETED|Overall Study||32
141737|NCT00324116|344193|P1|COMPLETED|Overall Study||49
141738|NCT00324116|344193|P1|STARTED|Overall Study|subjects received treatment|81
141739|NCT00324155|344205|P2|NOT COMPLETED|Follow-up Phase||6
141740|NCT00324155|344206|P1|NOT COMPLETED|Follow-up Phase||11
141741|NCT00324155|344205|P2|COMPLETED|Follow-up Phase||245
141742|NCT00324155|344206|P1|COMPLETED|Follow-up Phase||236
141743|NCT00324155|344205|P2|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|251
141744|NCT00324155|344206|P1|STARTED|Follow-up Phase|All participants received study drug. Follow-up was performed for those leaving earlier phases.|247
141745|NCT00324155|344205|P2|NOT COMPLETED|Received Treatment in Maintenance Phase||47
141746|NCT00324155|344206|P1|NOT COMPLETED|Received Treatment in Maintenance Phase||32
141747|NCT00324155|344205|P2|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure. 6 participants in Maintenance Phase not yet summarized.|6
141748|NCT00324155|344206|P1|COMPLETED|Received Treatment in Maintenance Phase|Study is in closure at this time. 11 in Maintenance Phase not yet summarized.|11
141749|NCT00324155|344205|P2|STARTED|Received Treatment in Maintenance Phase|1 completed Induction Phase but did not enter Maintenance Phase|53
141750|NCT00324155|344206|P1|STARTED|Received Treatment in Maintenance Phase|2 completed Induction Phase but did not enter Maintenance Phase|43
141751|NCT00324155|344205|P2|NOT COMPLETED|Received Treatment in Induction Phase||197
141752|NCT00324155|344206|P1|NOT COMPLETED|Received Treatment in Induction Phase||202
141753|NCT00324155|344205|P2|COMPLETED|Received Treatment in Induction Phase|54 participants on treatment at end of Induction Phase. Study undergoing closure.|54
141754|NCT00324155|344206|P1|COMPLETED|Received Treatment in Induction Phase|45 participants on treatment at end of Induction Phase. Study undergoing closure.|45
141755|NCT00324155|344205|P2|STARTED|Received Treatment in Induction Phase||251
141756|NCT00324155|344206|P1|STARTED|Received Treatment in Induction Phase||247
141757|NCT00324155|344205|P2|NOT COMPLETED|Enrolled and Randomized||1
141758|NCT00324155|344206|P1|NOT COMPLETED|Enrolled and Randomized||3
141759|NCT00324155|344205|P2|COMPLETED|Enrolled and Randomized|1 randomized but who did not receive treatment (lost to follow-up).|251
141760|NCT00324155|344206|P1|COMPLETED|Enrolled and Randomized|3 randomized but who did not receive treatment (no longer met study criteria).|247
141761|NCT00324155|344205|P2|STARTED|Enrolled and Randomized||252
141762|NCT00324155|344206|P1|STARTED|Enrolled and Randomized||250
141763|NCT00324168|344238|P2|NOT COMPLETED|Overall Study||30
141764|NCT00324168|344239|P1|NOT COMPLETED|Overall Study||28
141765|NCT00324168|344238|P2|COMPLETED|Overall Study||220
141766|NCT00324168|344239|P1|COMPLETED|Overall Study||222
141767|NCT00324168|344238|P2|STARTED|Overall Study||250
141768|NCT00324168|344239|P1|STARTED|Overall Study||250
141769|NCT00324233|344267|P2|NOT COMPLETED|Second Period||7
141770|NCT00324233|344268|P1|NOT COMPLETED|Second Period||5
141771|NCT00324233|344267|P2|COMPLETED|Second Period||11
141772|NCT00324233|344268|P1|COMPLETED|Second Period||12
141773|NCT00324233|344267|P2|STARTED|Second Period||18
141774|NCT00324233|344268|P1|STARTED|Second Period||17
141775|NCT00324233|344267|P2|NOT COMPLETED|First Period||0
141776|NCT00324233|344268|P1|NOT COMPLETED|First Period||1
141777|NCT00324233|344267|P2|COMPLETED|First Period||18
141778|NCT00324233|344268|P1|COMPLETED|First Period||17
141779|NCT00324233|344267|P2|STARTED|First Period||18
141780|NCT00324233|344268|P1|STARTED|First Period||18
141781|NCT00324259|344276|P2|NOT COMPLETED|Overall Study||0
141782|NCT00324259|344277|P1|NOT COMPLETED|Overall Study||0
141783|NCT00324259|344276|P2|COMPLETED|Overall Study||32
141784|NCT00324259|344277|P1|COMPLETED|Overall Study||34
141785|NCT00324259|344276|P2|STARTED|Overall Study||32
141786|NCT00324259|344277|P1|STARTED|Overall Study||34
141787|NCT00324272|344300|P4|NOT COMPLETED|Overall Study||0
141788|NCT00324272|344301|P3|NOT COMPLETED|Overall Study||0
141789|NCT00324272|344302|P2|NOT COMPLETED|Overall Study||0
141790|NCT00324272|344303|P1|NOT COMPLETED|Overall Study||0
141791|NCT00324272|344300|P4|COMPLETED|Overall Study||18
141792|NCT00324272|344301|P3|COMPLETED|Overall Study||18
141793|NCT00324272|344302|P2|COMPLETED|Overall Study||20
141794|NCT00324272|344303|P1|COMPLETED|Overall Study||18
141795|NCT00324272|344300|P4|STARTED|Overall Study||18
141796|NCT00324272|344301|P3|STARTED|Overall Study||18
141797|NCT00324272|344302|P2|STARTED|Overall Study||20
141798|NCT00324272|344303|P1|STARTED|Overall Study||18
141799|NCT00324350|344339|P2|NOT COMPLETED|Overall Study||0
141800|NCT00324350|344340|P1|NOT COMPLETED|Overall Study||0
141801|NCT00324350|344339|P2|COMPLETED|Overall Study||3632
141802|NCT00324350|344340|P1|COMPLETED|Overall Study||3655
141803|NCT00324350|344339|P2|Falls Follow-Up|Overall Study||3418
141804|NCT00324350|344340|P1|Falls Follow-Up|Overall Study||3364
141805|NCT00324350|344339|P2|Non-Vertebral Fracture Follow-Up|Overall Study||3632
141806|NCT00324350|344340|P1|Non-Vertebral Fracture Follow-Up|Overall Study||3655
141807|NCT00324350|344339|P2|STARTED|Overall Study||3632
141808|NCT00324350|344340|P1|STARTED|Overall Study||3655
141809|NCT00324415|344350|P1|NOT COMPLETED|Overall Study||0
141810|NCT00324415|344350|P1|COMPLETED|Overall Study||45
141811|NCT00324415|344350|P1|STARTED|Overall Study||45
141812|NCT00324649|344365|P2|NOT COMPLETED|Overall Study||5
141813|NCT00324649|344366|P1|NOT COMPLETED|Overall Study||2
141814|NCT00324649|344365|P2|COMPLETED|Overall Study||36
141815|NCT00324649|344366|P1|COMPLETED|Overall Study||37
141816|NCT00324649|344365|P2|STARTED|Overall Study||41
141817|NCT00324649|344366|P1|STARTED|Overall Study||39
141818|NCT00324675|344408|P2|NOT COMPLETED|Overall Study||0
141819|NCT00324675|344409|P1|NOT COMPLETED|Overall Study||1
141820|NCT00324675|344408|P2|COMPLETED|Overall Study||14
141821|NCT00324675|344409|P1|COMPLETED|Overall Study||13
141822|NCT00324675|344408|P2|STARTED|Overall Study||14
141823|NCT00324675|344409|P1|STARTED|Overall Study||14
141824|NCT00324701|344417|P2|NOT COMPLETED|Overall Study||17
141825|NCT00324701|344418|P1|NOT COMPLETED|Overall Study||20
141826|NCT00324701|344417|P2|COMPLETED|Overall Study||104
141827|NCT00324701|344418|P1|COMPLETED|Overall Study||100
141828|NCT00324701|344417|P2|Week 8 Assessment|Overall Study||107
141829|NCT00324701|344418|P1|Week 8 Assessment|Overall Study||108
141830|NCT00324701|344417|P2|STARTED|Overall Study||121
141831|NCT00324701|344418|P1|STARTED|Overall Study||120
141832|NCT00324740|344426|P3|NOT COMPLETED|Overall Study||1
141833|NCT00324740|344427|P2|NOT COMPLETED|Overall Study||0
141834|NCT00324740|344428|P1|NOT COMPLETED|Overall Study||1
141835|NCT00324740|344426|P3|COMPLETED|Overall Study||3
141836|NCT00324740|344427|P2|COMPLETED|Overall Study||3
141837|NCT00324740|344428|P1|COMPLETED|Overall Study||6
141838|NCT00324740|344426|P3|STARTED|Overall Study||4
141839|NCT00324740|344427|P2|STARTED|Overall Study||3
141840|NCT00324740|344428|P1|STARTED|Overall Study||7
141841|NCT00330343|344435|P1|NOT COMPLETED|Overall Study||5
141842|NCT00330343|344435|P1|COMPLETED|Overall Study||59
141843|NCT00330343|344435|P1|STARTED|Overall Study||64
141844|NCT00330382|344441|P2|NOT COMPLETED|Overall Study||17
141845|NCT00330382|344442|P1|NOT COMPLETED|Overall Study||24
141846|NCT00330382|344441|P2|COMPLETED|Overall Study||48
141847|NCT00330382|344442|P1|COMPLETED|Overall Study||43
141848|NCT00330382|344441|P2|STARTED|Overall Study||65
141849|NCT00330382|344442|P1|STARTED|Overall Study||67
141850|NCT00336700|344463|P1|NOT COMPLETED|Overall Study||0
141851|NCT00336700|344463|P1|COMPLETED|Overall Study||25
141852|NCT00336700|344463|P1|STARTED|Overall Study||25
141853|NCT00336817|344474|P2|NOT COMPLETED|Overall Study||2
141854|NCT00336817|344475|P1|NOT COMPLETED|Overall Study||1
141855|NCT00336817|344474|P2|COMPLETED|Overall Study||13
141856|NCT00336817|344475|P1|COMPLETED|Overall Study||14
141857|NCT00336817|344474|P2|STARTED|Overall Study||15
141858|NCT00336817|344475|P1|STARTED|Overall Study||15
141859|NCT00336856|344505|P1|NOT COMPLETED|Overall Study||4
141860|NCT00336856|344505|P1|COMPLETED|Overall Study||31
141861|NCT00336856|344505|P1|STARTED|Overall Study|Number of patients consented and registered for the study|35
141862|NCT00336895|344511|P1|NOT COMPLETED|Overall Study||4
141863|NCT00336895|344511|P1|COMPLETED|Overall Study||26
141864|NCT00336895|344511|P1|STARTED|Overall Study||30
141865|NCT00342355|344521|P4|NOT COMPLETED|Overall Study||0
141866|NCT00342355|344522|P3|NOT COMPLETED|Overall Study||0
141867|NCT00342355|344523|P2|NOT COMPLETED|Overall Study||0
141868|NCT00342355|344524|P1|NOT COMPLETED|Overall Study||0
141869|NCT00342355|344521|P4|COMPLETED|Overall Study||443
141870|NCT00342355|344522|P3|COMPLETED|Overall Study||444
141871|NCT00342355|344523|P2|COMPLETED|Overall Study||440
141872|NCT00342355|344524|P1|COMPLETED|Overall Study||444
141873|NCT00342355|344521|P4|STARTED|Overall Study||443
141874|NCT00342355|344522|P3|STARTED|Overall Study||444
141875|NCT00342355|344523|P2|STARTED|Overall Study||440
141876|NCT00342355|344524|P1|STARTED|Overall Study||444
141877|NCT00342563|344542|P4|NOT COMPLETED|Overall Study||6
141878|NCT00342563|344543|P3|NOT COMPLETED|Overall Study||14
141879|NCT00342563|344544|P2|NOT COMPLETED|Overall Study||8
141880|NCT00342563|344545|P1|NOT COMPLETED|Overall Study||6
141881|NCT00342563|344542|P4|COMPLETED|Overall Study||22
141882|NCT00342563|344543|P3|COMPLETED|Overall Study||26
141883|NCT00342563|344544|P2|COMPLETED|Overall Study||19
141884|NCT00342563|344545|P1|COMPLETED|Overall Study||35
141885|NCT00342563|344542|P4|STARTED|Overall Study||28
141886|NCT00342563|344543|P3|STARTED|Overall Study||40
141887|NCT00342563|344544|P2|STARTED|Overall Study||27
141888|NCT00342563|344545|P1|STARTED|Overall Study||41
141889|NCT00342628|344564|P3|NOT COMPLETED|Overall Study||19
141890|NCT00342628|344565|P2|NOT COMPLETED|Overall Study||21
141891|NCT00342628|344566|P1|NOT COMPLETED|Overall Study||20
141892|NCT00342628|344564|P3|COMPLETED|Overall Study|97 completed 3 injections of DTP alone, 16 were lost-to-followup for blood drawing at 12 months.|81
141893|NCT00342628|344565|P2|COMPLETED|Overall Study|83 completed 4 injections, 3 were lost-to-followup after 4th injection|80
141894|NCT00342628|344566|P1|COMPLETED|Overall Study|84 completed 4 injections, 4 were lost-to-followup after the 4th injection|80
141895|NCT00342628|344564|P3|STARTED|Overall Study||100
141896|NCT00342628|344565|P2|STARTED|Overall Study||101
141897|NCT00342628|344566|P1|STARTED|Overall Study||100
141898|NCT00343044|344583|P1|NOT COMPLETED|Overall Study||0
141899|NCT00343044|344583|P1|COMPLETED|Overall Study||40
141900|NCT00343044|344583|P1|STARTED|Overall Study||40
141901|NCT00343083|344590|P1|NOT COMPLETED|Overall Study||21
141902|NCT00343083|344590|P1|COMPLETED|Overall Study||22
141903|NCT00343083|344590|P1|STARTED|Overall Study||43
141904|NCT00343252|344601|P2|NOT COMPLETED|18 Months (All Treated Participants)||81
141905|NCT00343252|344602|P1|NOT COMPLETED|18 Months (All Treated Participants)||101
141906|NCT00343252|344601|P2|COMPLETED|18 Months (All Treated Participants)||269
141907|NCT00343252|344602|P1|COMPLETED|18 Months (All Treated Participants)||259
141908|NCT00343252|344601|P2|STARTED|18 Months (All Treated Participants)||350
141909|NCT00343252|344602|P1|STARTED|18 Months (All Treated Participants)||360
141910|NCT00343252|344601|P2|NOT COMPLETED|12 Months (All Treated Participants)||69
141911|NCT00343252|344602|P1|NOT COMPLETED|12 Months (All Treated Participants)||86
141912|NCT00343252|344601|P2|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|281
141913|NCT00343252|344602|P1|COMPLETED|12 Months (All Treated Participants)|Completed 12 Months.|274
141914|NCT00343252|344601|P2|STARTED|12 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
141915|NCT00343252|344602|P1|STARTED|12 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
141916|NCT00343252|344601|P2|NOT COMPLETED|6 Months (All Treated Participants)||44
141917|NCT00343252|344602|P1|NOT COMPLETED|6 Months (All Treated Participants)||56
141918|NCT00343252|344601|P2|COMPLETED|6 Months (All Treated Participants)||306
141919|NCT00343252|344602|P1|COMPLETED|6 Months (All Treated Participants)||304
141920|NCT00343252|344601|P2|STARTED|6 Months (All Treated Participants)|351 participants were randomized but 1 did not receive study drug and was not analyzed.|350
141921|NCT00343252|344602|P1|STARTED|6 Months (All Treated Participants)|361 participants were randomized but 1 did not receive study drug and was not analyzed.|360
141922|NCT00343252|344601|P2|NOT COMPLETED|All Randomized Participants||82
141923|NCT00343252|344602|P1|NOT COMPLETED|All Randomized Participants||102
141924|NCT00343252|344601|P2|COMPLETED|All Randomized Participants||269
141925|NCT00343252|344602|P1|COMPLETED|All Randomized Participants||259
141926|NCT00343252|344601|P2|STARTED|All Randomized Participants||351
141927|NCT00343252|344602|P1|STARTED|All Randomized Participants||361
141928|NCT00343291|344650|P2|NOT COMPLETED|Overall Study||56
141929|NCT00343291|344651|P1|NOT COMPLETED|Overall Study||57
141930|NCT00343291|344650|P2|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|5
141931|NCT00343291|344651|P1|COMPLETED|Overall Study|Participants completed 6 cycles of treatment. Did not start subsequent weekly cetuximab monotherapy.|3
141932|NCT00343291|344650|P2|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
141933|NCT00343291|344651|P1|RECEIVED AT LEAST ONE DOSE OF STUDY DRUG|Overall Study||58
141934|NCT00343291|344650|P2|STARTED|Overall Study||61
141935|NCT00343291|344651|P1|STARTED|Overall Study||60
141936|NCT00343382|344668|P3|NOT COMPLETED|Overall Study||17
141937|NCT00343382|344669|P2|NOT COMPLETED|Overall Study||14
141938|NCT00343382|344670|P1|NOT COMPLETED|Overall Study||4
141939|NCT00343382|344668|P3|COMPLETED|Overall Study||49
141940|NCT00343382|344669|P2|COMPLETED|Overall Study||51
141941|NCT00343382|344670|P1|COMPLETED|Overall Study||60
141942|NCT00343382|344668|P3|STARTED|Overall Study||66
141943|NCT00343382|344669|P2|STARTED|Overall Study||65
141944|NCT00343382|344670|P1|STARTED|Overall Study||64
141945|NCT00343460|344693|P3|NOT COMPLETED|Cycle 2 - 4||0
141946|NCT00343460|344694|P2|NOT COMPLETED|Cycle 2 - 4||50
141947|NCT00343460|344695|P1|NOT COMPLETED|Cycle 2 - 4||56
141948|NCT00343460|344693|P3|COMPLETED|Cycle 2 - 4||0
141949|NCT00343460|344694|P2|COMPLETED|Cycle 2 - 4||515
141950|NCT00343460|344695|P1|COMPLETED|Cycle 2 - 4||528
141951|NCT00343460|344693|P3|STARTED|Cycle 2 - 4||0
141952|NCT00343460|344694|P2|STARTED|Cycle 2 - 4||565
141953|NCT00343460|344695|P1|STARTED|Cycle 2 - 4||584
141954|NCT00343460|344693|P3|NOT COMPLETED|Cycle 1||18
141955|NCT00343460|344694|P2|NOT COMPLETED|Cycle 1||22
141956|NCT00343460|344695|P1|NOT COMPLETED|Cycle 1||22
141957|NCT00343460|344693|P3|COMPLETED|Cycle 1||454
141958|NCT00343460|344694|P2|COMPLETED|Cycle 1||459
141959|NCT00343460|344695|P1|COMPLETED|Cycle 1||453
141960|NCT00343460|344693|P3|STARTED|Cycle 1||472
141961|NCT00343460|344694|P2|STARTED|Cycle 1||481
141962|NCT00343460|344695|P1|STARTED|Cycle 1||475
141963|NCT00343512|344766|P1|NOT COMPLETED|Overall Study||2
141964|NCT00343512|344766|P1|COMPLETED|Overall Study||32
141965|NCT00343512|344766|P1|STARTED|Overall Study||34
141966|NCT00343564|344783|P11|NOT COMPLETED|Overall Study||0
141967|NCT00343564|344784|P10|NOT COMPLETED|Overall Study||0
141968|NCT00343564|344785|P9|NOT COMPLETED|Overall Study||0
141969|NCT00343564|344786|P8|NOT COMPLETED|Overall Study||0
141970|NCT00343564|344787|P7|NOT COMPLETED|Overall Study||0
141971|NCT00343564|344788|P6|NOT COMPLETED|Overall Study||0
141972|NCT00343564|344789|P5|NOT COMPLETED|Overall Study||0
141973|NCT00343564|344790|P4|NOT COMPLETED|Overall Study||0
141974|NCT00343564|344791|P3|NOT COMPLETED|Overall Study||0
141975|NCT00343564|344792|P2|NOT COMPLETED|Overall Study||0
141976|NCT00343564|344793|P1|NOT COMPLETED|Overall Study||0
141977|NCT00343564|344783|P11|COMPLETED|Overall Study||8
141978|NCT00343564|344784|P10|COMPLETED|Overall Study||8
141979|NCT00343564|344785|P9|COMPLETED|Overall Study||3
141980|NCT00343564|344786|P8|COMPLETED|Overall Study||3
141981|NCT00343564|344787|P7|COMPLETED|Overall Study||4
141982|NCT00343564|344788|P6|COMPLETED|Overall Study||9
141983|NCT00343564|344789|P5|COMPLETED|Overall Study||10
141984|NCT00343564|344790|P4|COMPLETED|Overall Study||7
141985|NCT00343564|344791|P3|COMPLETED|Overall Study||3
141986|NCT00343564|344792|P2|COMPLETED|Overall Study||7
141987|NCT00343564|344793|P1|COMPLETED|Overall Study||6
141988|NCT00343564|344783|P11|STARTED|Overall Study||8
141989|NCT00343564|344784|P10|STARTED|Overall Study||8
141990|NCT00343564|344785|P9|STARTED|Overall Study||3
141991|NCT00343564|344786|P8|STARTED|Overall Study||3
141992|NCT00343564|344787|P7|STARTED|Overall Study||4
141993|NCT00343564|344788|P6|STARTED|Overall Study||9
141994|NCT00343564|344789|P5|STARTED|Overall Study||10
141995|NCT00343564|344790|P4|STARTED|Overall Study||7
141996|NCT00343564|344791|P3|STARTED|Overall Study||3
141997|NCT00343564|344792|P2|STARTED|Overall Study||7
141998|NCT00343564|344793|P1|STARTED|Overall Study||6
141999|NCT00343785|344808|P1|NOT COMPLETED|Overall Study||0
142000|NCT00343785|344808|P1|COMPLETED|Overall Study||21
142001|NCT00343785|344808|P1|STARTED|Overall Study||21
142002|NCT00343863|344816|P2|NOT COMPLETED|Overall Study||0
142003|NCT00343863|344817|P1|NOT COMPLETED|Overall Study||0
142004|NCT00343863|344816|P2|COMPLETED|Overall Study||34
142005|NCT00343863|344817|P1|COMPLETED|Overall Study||7
142006|NCT00343863|344816|P2|STARTED|Overall Study||34
142007|NCT00343863|344817|P1|STARTED|Overall Study||7
142008|NCT00343889|344841|P2|NOT COMPLETED|Overall Study||1
142009|NCT00343889|344842|P1|NOT COMPLETED|Overall Study||3
142010|NCT00343889|344841|P2|COMPLETED|Overall Study||188
142011|NCT00343889|344842|P1|COMPLETED|Overall Study||187
142012|NCT00343889|344841|P2|STARTED|Overall Study||189
142013|NCT00343889|344842|P1|STARTED|Overall Study||190
142014|NCT00343915|344860|P2|NOT COMPLETED|Month 66 Follow-up||0
142015|NCT00343915|344861|P1|NOT COMPLETED|Month 66 Follow-up||0
142016|NCT00343915|344860|P2|COMPLETED|Month 66 Follow-up||76
142017|NCT00343915|344861|P1|COMPLETED|Month 66 Follow-up||158
142018|NCT00343915|344860|P2|STARTED|Month 66 Follow-up||76
142019|NCT00343915|344861|P1|STARTED|Month 66 Follow-up|Subjects, previously vaccinated, that returned for the Month 66 follow-up.|158
142020|NCT00343915|344860|P2|NOT COMPLETED|Month 54 Follow-up||0
142021|NCT00343915|344861|P1|NOT COMPLETED|Month 54 Follow-up||0
142022|NCT00343915|344860|P2|COMPLETED|Month 54 Follow-up||79
142023|NCT00343915|344861|P1|COMPLETED|Month 54 Follow-up||166
142024|NCT00343915|344860|P2|STARTED|Month 54 Follow-up||79
142025|NCT00343915|344861|P1|STARTED|Month 54 Follow-up|Subjects, previously vaccinated, that returned for the Month 54 follow-up.|166
142026|NCT00343915|344860|P2|NOT COMPLETED|Month 42 Follow-up||0
142027|NCT00343915|344861|P1|NOT COMPLETED|Month 42 Follow-up||0
142028|NCT00343915|344860|P2|COMPLETED|Month 42 Follow-up||84
142029|NCT00343915|344861|P1|COMPLETED|Month 42 Follow-up||174
142030|NCT00343915|344860|P2|STARTED|Month 42 Follow-up||84
142123|NCT00333840|345062|P1|NOT COMPLETED|Second-line Treatment Period||0
142031|NCT00343915|344861|P1|STARTED|Month 42 Follow-up|Subjects, previously vaccinated, that returned for the Month 42 follow-up.|174
142032|NCT00343915|344860|P2|NOT COMPLETED|Month 30 Follow-up||0
142033|NCT00343915|344861|P1|NOT COMPLETED|Month 30 Follow-up||0
142034|NCT00343915|344860|P2|COMPLETED|Month 30 Follow-up||88
142035|NCT00343915|344861|P1|COMPLETED|Month 30 Follow-up||179
142036|NCT00343915|344860|P2|STARTED|Month 30 Follow-up||88
142037|NCT00343915|344861|P1|STARTED|Month 30 Follow-up|Subjects, previously vaccinated, that returned for the Month 30 follow-up.|179
142038|NCT00343915|344860|P2|NOT COMPLETED|Primary Study||3
142039|NCT00343915|344861|P1|NOT COMPLETED|Primary Study||4
142040|NCT00343915|344860|P2|COMPLETED|Primary Study||123
142041|NCT00343915|344861|P1|COMPLETED|Primary Study||254
142042|NCT00343915|344860|P2|STARTED|Primary Study||126
142043|NCT00343915|344861|P1|STARTED|Primary Study||258
142044|NCT00344019|344888|P3|NOT COMPLETED|Overall Study||74
142045|NCT00344019|344889|P2|NOT COMPLETED|Overall Study||0
142046|NCT00344019|344890|P1|NOT COMPLETED|Overall Study||0
142047|NCT00344019|344888|P3|COMPLETED|Overall Study||0
142048|NCT00344019|344889|P2|COMPLETED|Overall Study||11
142049|NCT00344019|344890|P1|COMPLETED|Overall Study||12
142050|NCT00344019|344888|P3|STARTED|Overall Study||74
142051|NCT00344019|344889|P2|STARTED|Overall Study||11
142052|NCT00344019|344890|P1|STARTED|Overall Study||12
142053|NCT00344032|344899|P2|NOT COMPLETED|Overall Study||10
142054|NCT00344032|344900|P1|NOT COMPLETED|Overall Study||14
142055|NCT00344032|344899|P2|COMPLETED|Overall Study||168
142056|NCT00344032|344900|P1|COMPLETED|Overall Study||162
142057|NCT00344032|344899|P2|STARTED|Overall Study||178
142058|NCT00344032|344900|P1|STARTED|Overall Study||176
142059|NCT00344175|344918|P2|NOT COMPLETED|Overall Study||10
142060|NCT00344175|344919|P1|NOT COMPLETED|Overall Study||12
142061|NCT00344175|344918|P2|COMPLETED|Overall Study||47
142062|NCT00344175|344919|P1|COMPLETED|Overall Study||109
142063|NCT00344175|344918|P2|STARTED|Overall Study||57
142064|NCT00344175|344919|P1|STARTED|Overall Study||121
142065|NCT00333437|344929|P1|NOT COMPLETED|Overall Study||0
142066|NCT00333437|344929|P1|COMPLETED|Overall Study||7
142067|NCT00333437|344929|P1|STARTED|Overall Study||7
142068|NCT00333619|344939|P2|NOT COMPLETED|Overall Study||10
142069|NCT00333619|344940|P1|NOT COMPLETED|Overall Study||21
142070|NCT00333619|344939|P2|COMPLETED|Overall Study||99
142071|NCT00333619|344940|P1|COMPLETED|Overall Study||89
142072|NCT00333619|344939|P2|3-month Follow-up|Overall Study||105
142073|NCT00333619|344940|P1|3-month Follow-up|Overall Study||101
142074|NCT00333619|344939|P2|Post-treatment|Overall Study||109
142075|NCT00333619|344940|P1|Post-treatment|Overall Study||109
142076|NCT00333619|344939|P2|STARTED|Overall Study||109
142077|NCT00333619|344940|P1|STARTED|Overall Study||110
142078|NCT00333710|344951|P3|NOT COMPLETED|Overall Study||1
142079|NCT00333710|344952|P2|NOT COMPLETED|Overall Study||4
142080|NCT00333710|344953|P1|NOT COMPLETED|Overall Study||11
142081|NCT00333710|344951|P3|COMPLETED|Overall Study||15
142082|NCT00333710|344952|P2|COMPLETED|Overall Study||14
142083|NCT00333710|344953|P1|COMPLETED|Overall Study||8
142084|NCT00333710|344951|P3|STARTED|Overall Study||16
142085|NCT00333710|344952|P2|STARTED|Overall Study||18
142086|NCT00333710|344953|P1|STARTED|Overall Study||19
142087|NCT00333762|344961|P1|NOT COMPLETED|Overall Study||4
142088|NCT00333762|344961|P1|COMPLETED|Overall Study||0
142089|NCT00333762|344961|P1|STARTED|Overall Study||4
142090|NCT00333775|344968|P3|NOT COMPLETED|Overall Study||247
142091|NCT00333775|344969|P2|NOT COMPLETED|Overall Study||248
142092|NCT00333775|344970|P1|NOT COMPLETED|Overall Study||241
142093|NCT00333775|344968|P3|COMPLETED|Overall Study||0
142094|NCT00333775|344969|P2|COMPLETED|Overall Study||0
142095|NCT00333775|344970|P1|COMPLETED|Overall Study||0
142096|NCT00333775|344968|P3|Received Treatment|Overall Study||245
142097|NCT00333775|344969|P2|Received Treatment|Overall Study||247
142098|NCT00333775|344970|P1|Received Treatment|Overall Study||238
142099|NCT00333775|344968|P3|STARTED|Overall Study||247
142100|NCT00333775|344969|P2|STARTED|Overall Study||248
142101|NCT00333775|344970|P1|STARTED|Overall Study||241
142102|NCT00333788|344990|P1|NOT COMPLETED|Overall Study||162
142103|NCT00333788|344990|P1|COMPLETED|Overall Study||71
142104|NCT00333788|344990|P1|STARTED|Overall Study|Participant flow based on All Subjects population; Baseline characteristics based on ITT population.|233
142105|NCT00333801|345019|P2|NOT COMPLETED|Overall Study||6
142106|NCT00333801|345020|P1|NOT COMPLETED|Overall Study||8
142107|NCT00333801|345019|P2|COMPLETED|Overall Study||36
142108|NCT00333801|345020|P1|COMPLETED|Overall Study||35
142109|NCT00333801|345019|P2|STARTED|Overall Study||42
142110|NCT00333801|345020|P1|STARTED|Overall Study||43
142111|NCT00333814|345041|P3|NOT COMPLETED|Overall Study||5
142112|NCT00333814|345042|P2|NOT COMPLETED|Overall Study||4
142113|NCT00333814|345043|P1|NOT COMPLETED|Overall Study||3
142114|NCT00333814|345041|P3|COMPLETED|Overall Study||71
142115|NCT00333814|345042|P2|COMPLETED|Overall Study||73
142116|NCT00333814|345043|P1|COMPLETED|Overall Study||73
142117|NCT00333814|345041|P3|STARTED|Overall Study||76
142118|NCT00333814|345042|P2|STARTED|Overall Study||77
142119|NCT00333814|345043|P1|STARTED|Overall Study||76
142120|NCT00333840|345059|P4|NOT COMPLETED|Second-line Treatment Period||188
142121|NCT00333840|345060|P3|NOT COMPLETED|Second-line Treatment Period||14
142122|NCT00333840|345061|P2|NOT COMPLETED|Second-line Treatment Period||0
142124|NCT00333840|345059|P4|COMPLETED|Second-line Treatment Period||175
142125|NCT00333840|345060|P3|COMPLETED|Second-line Treatment Period||0
142126|NCT00333840|345061|P2|COMPLETED|Second-line Treatment Period||0
142127|NCT00333840|345062|P1|COMPLETED|Second-line Treatment Period||0
142128|NCT00333840|345059|P4|STARTED|Second-line Treatment Period||363
142129|NCT00333840|345060|P3|STARTED|Second-line Treatment Period||14
142130|NCT00333840|345061|P2|STARTED|Second-line Treatment Period||0
142131|NCT00333840|345062|P1|STARTED|Second-line Treatment Period||0
142132|NCT00333840|345059|P4|NOT COMPLETED|First-line Treatment Period||0
142133|NCT00333840|345060|P3|NOT COMPLETED|First-line Treatment Period||0
142134|NCT00333840|345061|P2|NOT COMPLETED|First-line Treatment Period||546
142135|NCT00333840|345062|P1|NOT COMPLETED|First-line Treatment Period||286
142136|NCT00333840|345059|P4|COMPLETED|First-line Treatment Period||0
142137|NCT00333840|345060|P3|COMPLETED|First-line Treatment Period||0
142138|NCT00333840|345061|P2|COMPLETED|First-line Treatment Period||7
142139|NCT00333840|345062|P1|COMPLETED|First-line Treatment Period||267
142140|NCT00333840|345059|P4|Safety Population; Received Study Drug|First-line Treatment Period||0
142141|NCT00333840|345060|P3|Safety Population; Received Study Drug|First-line Treatment Period||0
142142|NCT00333840|345061|P2|Safety Population; Received Study Drug|First-line Treatment Period||533
142143|NCT00333840|345062|P1|Safety Population; Received Study Drug|First-line Treatment Period||551
142144|NCT00333840|345059|P4|STARTED|First-line Treatment Period||0
142145|NCT00333840|345060|P3|STARTED|First-line Treatment Period||0
142146|NCT00333840|345061|P2|STARTED|First-line Treatment Period||553
142147|NCT00333840|345062|P1|STARTED|First-line Treatment Period||553
142148|NCT00333866|345091|P4|NOT COMPLETED|Overall Study||66
142149|NCT00333866|345092|P3|NOT COMPLETED|Overall Study||51
142150|NCT00333866|345093|P2|NOT COMPLETED|Overall Study||64
142151|NCT00333866|345094|P1|NOT COMPLETED|Overall Study||48
142152|NCT00333866|345091|P4|COMPLETED|Overall Study||121
142153|NCT00333866|345092|P3|COMPLETED|Overall Study||133
142154|NCT00333866|345093|P2|COMPLETED|Overall Study||123
142155|NCT00333866|345094|P1|COMPLETED|Overall Study||141
142156|NCT00333866|345091|P4|TREATED|Overall Study||186
142157|NCT00333866|345092|P3|TREATED|Overall Study||182
142158|NCT00333866|345093|P2|TREATED|Overall Study||184
142159|NCT00333866|345094|P1|TREATED|Overall Study||184
142160|NCT00333866|345091|P4|STARTED|Overall Study||187
142161|NCT00333866|345092|P3|STARTED|Overall Study||184
142162|NCT00333866|345093|P2|STARTED|Overall Study||187
142163|NCT00333866|345094|P1|STARTED|Overall Study||189
142164|NCT00333879|345152|P1|NOT COMPLETED|Overall Study||0
142165|NCT00333879|345152|P1|COMPLETED|Overall Study||4
142166|NCT00333879|345152|P1|STARTED|Overall Study||4
142167|NCT00333970|345159|P2|NOT COMPLETED|Overall Study||7
142168|NCT00333970|345160|P1|NOT COMPLETED|Overall Study||13
142169|NCT00333970|345159|P2|COMPLETED|Overall Study||18
142170|NCT00333970|345160|P1|COMPLETED|Overall Study||37
142171|NCT00333970|345159|P2|STARTED|Overall Study||25
142172|NCT00333970|345160|P1|STARTED|Overall Study||50
142173|NCT00333983|345169|P3|NOT COMPLETED|Overall Study||2
142174|NCT00333983|345170|P2|NOT COMPLETED|Overall Study||5
142175|NCT00333983|345171|P1|NOT COMPLETED|Overall Study||3
142176|NCT00333983|345169|P3|COMPLETED|Overall Study||19
142177|NCT00333983|345170|P2|COMPLETED|Overall Study||16
142178|NCT00333983|345171|P1|COMPLETED|Overall Study||17
142179|NCT00333983|345169|P3|STARTED|Overall Study||21
142180|NCT00333983|345170|P2|STARTED|Overall Study||21
142181|NCT00333983|345171|P1|STARTED|Overall Study||20
142182|NCT00344305|345181|P2|NOT COMPLETED|Overall Study||1
142183|NCT00344305|345182|P1|NOT COMPLETED|Overall Study||2
142184|NCT00344305|345181|P2|COMPLETED|Overall Study||99
142185|NCT00344305|345182|P1|COMPLETED|Overall Study||98
142186|NCT00344305|345181|P2|STARTED|Overall Study||100
142187|NCT00344305|345182|P1|STARTED|Overall Study||100
142188|NCT00344370|345219|P2|NOT COMPLETED|Overall Study||3
142189|NCT00344370|345220|P1|NOT COMPLETED|Overall Study||15
142190|NCT00344370|345219|P2|COMPLETED|Overall Study||68
142191|NCT00344370|345220|P1|COMPLETED|Overall Study||128
142192|NCT00344370|345219|P2|STARTED|Overall Study||71
142193|NCT00344370|345220|P1|STARTED|Overall Study||143
142194|NCT00344448|345230|P2|NOT COMPLETED|Open Label||1
142195|NCT00344448|345231|P1|NOT COMPLETED|Open Label||2
142196|NCT00344448|345230|P2|COMPLETED|Open Label||2
142197|NCT00344448|345231|P1|COMPLETED|Open Label||2
142198|NCT00344448|345230|P2|STARTED|Open Label||3
142199|NCT00344448|345231|P1|STARTED|Open Label||4
142200|NCT00344448|345230|P2|NOT COMPLETED|Double Blind, Placebo Controlled||0
142201|NCT00344448|345231|P1|NOT COMPLETED|Double Blind, Placebo Controlled||2
142202|NCT00344448|345230|P2|COMPLETED|Double Blind, Placebo Controlled||3
142203|NCT00344448|345231|P1|COMPLETED|Double Blind, Placebo Controlled||4
142204|NCT00344448|345230|P2|STARTED|Double Blind, Placebo Controlled||3
142205|NCT00344448|345231|P1|STARTED|Double Blind, Placebo Controlled||6
142206|NCT00344448|345230|P2|NOT COMPLETED|Screening||1
142207|NCT00344448|345231|P1|NOT COMPLETED|Screening||0
142208|NCT00344448|345230|P2|COMPLETED|Screening||3
142209|NCT00344448|345231|P1|COMPLETED|Screening||6
142210|NCT00344448|345230|P2|STARTED|Screening||4
142211|NCT00344448|345231|P1|STARTED|Screening|No randomization during the screening phase|6
142212|NCT00344487|345237|P1|NOT COMPLETED|Overall Study||1
142306|NCT00346632|345488|P1|COMPLETED|Overall Study||0
142213|NCT00344487|345237|P1|COMPLETED|Overall Study|One subject was withdrawn at month 9 because he was considered an immunologic failure on study.|2
142214|NCT00344487|345237|P1|STARTED|Overall Study||3
142215|NCT00344500|345243|P3|NOT COMPLETED|Overall Study||2
142216|NCT00344500|345244|P2|NOT COMPLETED|Overall Study||35
142217|NCT00344500|345245|P1|NOT COMPLETED|Overall Study||23
142218|NCT00344500|345243|P3|COMPLETED|Overall Study||12
142219|NCT00344500|345244|P2|COMPLETED|Overall Study||25
142220|NCT00344500|345245|P1|COMPLETED|Overall Study||25
142221|NCT00344500|345243|P3|STARTED|Overall Study||14
142222|NCT00344500|345244|P2|STARTED|Overall Study||60
142223|NCT00344500|345245|P1|STARTED|Overall Study||48
142224|NCT00345631|345259|P3|NOT COMPLETED|Overall Study||6
142225|NCT00345631|345260|P2|NOT COMPLETED|Overall Study||8
142226|NCT00345631|345261|P1|NOT COMPLETED|Overall Study||4
142227|NCT00345631|345259|P3|COMPLETED|Overall Study||128
142228|NCT00345631|345260|P2|COMPLETED|Overall Study||259
142229|NCT00345631|345261|P1|COMPLETED|Overall Study||83
142230|NCT00345631|345259|P3|STARTED|Overall Study||134
142231|NCT00345631|345260|P2|STARTED|Overall Study||267
142232|NCT00345631|345261|P1|STARTED|Overall Study||87
142233|NCT00345683|345295|P2|NOT COMPLETED|Overall Study||9
142234|NCT00345683|345296|P1|NOT COMPLETED|Overall Study||25
142235|NCT00345683|345295|P2|COMPLETED|Overall Study||1001
142236|NCT00345683|345296|P1|COMPLETED|Overall Study||2985
142237|NCT00345683|345295|P2|STARTED|Overall Study||1010
142238|NCT00345683|345296|P1|STARTED|Overall Study||3010
142239|NCT00345839|345318|P2|NOT COMPLETED|Overall Study||159
142240|NCT00345839|345319|P1|NOT COMPLETED|Overall Study||149
142241|NCT00345839|345318|P2|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1776
142242|NCT00345839|345319|P1|COMPLETED|Overall Study|Participants who completed study includes those with ended study due to death.|1799
142243|NCT00345839|345318|P2|STARTED|Overall Study|Randomized to placebo|1935
142244|NCT00345839|345319|P1|STARTED|Overall Study|Randomized to cinacalcet|1948
142245|NCT00345878|345345|P2|NOT COMPLETED|Overall Study||1
142246|NCT00345878|345346|P1|NOT COMPLETED|Overall Study||4
142247|NCT00345878|345345|P2|COMPLETED|Overall Study||135
142248|NCT00345878|345346|P1|COMPLETED|Overall Study||131
142249|NCT00345878|345345|P2|STARTED|Overall Study||136
142250|NCT00345878|345346|P1|STARTED|Overall Study||135
142251|NCT00346034|345362|P1|NOT COMPLETED|Overall Study||57
142252|NCT00346034|345362|P1|COMPLETED|Overall Study||300
142253|NCT00346034|345362|P1|STARTED|Overall Study||357
142254|NCT00346151|345367|P1|NOT COMPLETED|Overall Study||3
142255|NCT00346151|345367|P1|COMPLETED|Overall Study||2
142256|NCT00346151|345367|P1|STARTED|Overall Study||5
142257|NCT00346216|345388|P3|NOT COMPLETED|Overall Study||2348
142258|NCT00346216|345389|P2|NOT COMPLETED|Overall Study||2460
142259|NCT00346216|345390|P1|NOT COMPLETED|Overall Study||2408
142260|NCT00346216|345388|P3|COMPLETED|Overall Study||5621
142261|NCT00346216|345389|P2|COMPLETED|Overall Study||5580
142262|NCT00346216|345390|P1|COMPLETED|Overall Study||5664
142263|NCT00346216|345388|P3|STARTED|Overall Study||7969
142264|NCT00346216|345389|P2|STARTED|Overall Study||8040
142265|NCT00346216|345390|P1|STARTED|Overall Study||8072
142266|NCT00346268|345409|P2|NOT COMPLETED|Overall Study||3
142267|NCT00346268|345410|P1|NOT COMPLETED|Overall Study||2
142268|NCT00346268|345409|P2|COMPLETED|Overall Study||50
142269|NCT00346268|345410|P1|COMPLETED|Overall Study||50
142270|NCT00346268|345409|P2|STARTED|Overall Study||53
142271|NCT00346268|345410|P1|STARTED|Overall Study||52
142272|NCT00346333|345444|P2|NOT COMPLETED|Overall Study||8
142273|NCT00346333|345445|P1|NOT COMPLETED|Overall Study||5
142274|NCT00346333|345444|P2|COMPLETED|Overall Study||111
142275|NCT00346333|345445|P1|COMPLETED|Overall Study||116
142276|NCT00346333|345444|P2|STARTED|Overall Study||119
142277|NCT00346333|345445|P1|STARTED|Overall Study||121
142278|NCT00346398|345461|P2|NOT COMPLETED|Overall Study||2
142279|NCT00346398|345462|P1|NOT COMPLETED|Overall Study||3
142280|NCT00346398|345461|P2|COMPLETED|Overall Study||24
142281|NCT00346398|345462|P1|COMPLETED|Overall Study||22
142282|NCT00346398|345461|P2|STARTED|Overall Study||26
142283|NCT00346398|345462|P1|STARTED|Overall Study||25
142284|NCT00346476|345472|P1|NOT COMPLETED|Overall Study||0
142285|NCT00346476|345472|P1|COMPLETED|Overall Study||1250
142286|NCT00346476|345472|P1|STARTED|Overall Study||1250
142287|NCT00346632|345479|P10|NOT COMPLETED|Overall Study||3
142288|NCT00346632|345480|P9|NOT COMPLETED|Overall Study||4
142289|NCT00346632|345481|P8|NOT COMPLETED|Overall Study||4
142290|NCT00346632|345482|P7|NOT COMPLETED|Overall Study||5
142291|NCT00346632|345483|P6|NOT COMPLETED|Overall Study||2
142292|NCT00346632|345484|P5|NOT COMPLETED|Overall Study||4
142293|NCT00346632|345485|P4|NOT COMPLETED|Overall Study||3
142294|NCT00346632|345486|P3|NOT COMPLETED|Overall Study||6
142295|NCT00346632|345487|P2|NOT COMPLETED|Overall Study||3
142296|NCT00346632|345488|P1|NOT COMPLETED|Overall Study||3
142297|NCT00346632|345479|P10|COMPLETED|Overall Study||0
142298|NCT00346632|345480|P9|COMPLETED|Overall Study||0
142299|NCT00346632|345481|P8|COMPLETED|Overall Study||0
142300|NCT00346632|345482|P7|COMPLETED|Overall Study||0
142301|NCT00346632|345483|P6|COMPLETED|Overall Study||0
142302|NCT00346632|345484|P5|COMPLETED|Overall Study||0
142303|NCT00346632|345485|P4|COMPLETED|Overall Study||0
142304|NCT00346632|345486|P3|COMPLETED|Overall Study||0
142305|NCT00346632|345487|P2|COMPLETED|Overall Study||0
142307|NCT00346632|345479|P10|STARTED|Overall Study||3
142308|NCT00346632|345480|P9|STARTED|Overall Study||4
142309|NCT00346632|345481|P8|STARTED|Overall Study||4
142310|NCT00346632|345482|P7|STARTED|Overall Study||5
142311|NCT00346632|345483|P6|STARTED|Overall Study||2
142312|NCT00346632|345484|P5|STARTED|Overall Study||4
142313|NCT00346632|345485|P4|STARTED|Overall Study||3
142314|NCT00346632|345486|P3|STARTED|Overall Study||6
142315|NCT00346632|345487|P2|STARTED|Overall Study||3
142316|NCT00346632|345488|P1|STARTED|Overall Study||3
142317|NCT00346697|345633|P2|NOT COMPLETED|Overall Study||1
142318|NCT00346697|345634|P1|NOT COMPLETED|Overall Study||0
142319|NCT00346697|345633|P2|COMPLETED|Overall Study||23
142320|NCT00346697|345634|P1|COMPLETED|Overall Study||24
142321|NCT00346697|345633|P2|STARTED|Overall Study||24
142322|NCT00346697|345634|P1|STARTED|Overall Study||24
142323|NCT00346905|345668|P1|NOT COMPLETED|Overall Study||4
142324|NCT00346905|345668|P1|COMPLETED|Overall Study||12
142325|NCT00346905|345668|P1|STARTED|Overall Study||16
142326|NCT00347009|345672|P1|NOT COMPLETED|Overall Study||27
142327|NCT00347009|345672|P1|COMPLETED|Overall Study||128
142328|NCT00347009|345672|P1|STARTED|Overall Study||155
142329|NCT00347022|345691|P2|NOT COMPLETED|Overall Study||5
142330|NCT00347022|345692|P1|NOT COMPLETED|Overall Study||12
142331|NCT00347022|345691|P2|COMPLETED|Overall Study||66
142332|NCT00347022|345692|P1|COMPLETED|Overall Study||62
142333|NCT00347022|345691|P2|STARTED|Overall Study||71
142334|NCT00347022|345692|P1|STARTED|Overall Study||74
142335|NCT00347269|345700|P2|NOT COMPLETED|Overall Study||106
142336|NCT00347269|345701|P1|NOT COMPLETED|Overall Study||94
142337|NCT00347269|345700|P2|COMPLETED|Overall Study||395
142338|NCT00347269|345701|P1|COMPLETED|Overall Study||409
142339|NCT00347269|345700|P2|STARTED|Overall Study||501
142340|NCT00347269|345701|P1|STARTED|Overall Study||503
142341|NCT00347308|345707|P1|NOT COMPLETED|Overall Study||0
142342|NCT00347308|345707|P1|COMPLETED|Overall Study||40
142343|NCT00347308|345707|P1|STARTED|Overall Study||40
142344|NCT00347360|345726|P15|NOT COMPLETED|Overall Study||4
142345|NCT00347360|345727|P14|NOT COMPLETED|Overall Study||8
142346|NCT00347360|345728|P13|NOT COMPLETED|Overall Study||10
142347|NCT00347360|345729|P12|NOT COMPLETED|Overall Study||6
142348|NCT00347360|345730|P11|NOT COMPLETED|Overall Study||5
142349|NCT00347360|345731|P10|NOT COMPLETED|Overall Study||9
142350|NCT00347360|345732|P9|NOT COMPLETED|Overall Study||6
142351|NCT00347360|345733|P8|NOT COMPLETED|Overall Study||3
142352|NCT00347360|345734|P7|NOT COMPLETED|Overall Study||7
142353|NCT00347360|345735|P6|NOT COMPLETED|Overall Study||8
142354|NCT00347360|345736|P5|NOT COMPLETED|Overall Study||5
142355|NCT00347360|345737|P4|NOT COMPLETED|Overall Study||13
142356|NCT00347360|345738|P3|NOT COMPLETED|Overall Study||6
142357|NCT00347360|345739|P2|NOT COMPLETED|Overall Study||8
142358|NCT00347360|345740|P1|NOT COMPLETED|Overall Study||5
142359|NCT00347360|345726|P15|COMPLETED|Overall Study||39
142360|NCT00347360|345727|P14|COMPLETED|Overall Study||36
142361|NCT00347360|345728|P13|COMPLETED|Overall Study||34
142362|NCT00347360|345729|P12|COMPLETED|Overall Study||37
142363|NCT00347360|345730|P11|COMPLETED|Overall Study||39
142364|NCT00347360|345731|P10|COMPLETED|Overall Study||35
142365|NCT00347360|345732|P9|COMPLETED|Overall Study||38
142366|NCT00347360|345733|P8|COMPLETED|Overall Study||40
142367|NCT00347360|345734|P7|COMPLETED|Overall Study||37
142368|NCT00347360|345735|P6|COMPLETED|Overall Study||36
142369|NCT00347360|345736|P5|COMPLETED|Overall Study||39
142370|NCT00347360|345737|P4|COMPLETED|Overall Study||30
142371|NCT00347360|345738|P3|COMPLETED|Overall Study||37
142372|NCT00347360|345739|P2|COMPLETED|Overall Study||35
142373|NCT00347360|345740|P1|COMPLETED|Overall Study||39
142374|NCT00347360|345726|P15|STARTED|Overall Study||43
142375|NCT00347360|345727|P14|STARTED|Overall Study||44
142376|NCT00347360|345728|P13|STARTED|Overall Study||44
142377|NCT00347360|345729|P12|STARTED|Overall Study||43
142378|NCT00347360|345730|P11|STARTED|Overall Study||44
142379|NCT00347360|345731|P10|STARTED|Overall Study||44
142380|NCT00347360|345732|P9|STARTED|Overall Study||44
142381|NCT00347360|345733|P8|STARTED|Overall Study||43
142382|NCT00347360|345734|P7|STARTED|Overall Study||44
142383|NCT00347360|345735|P6|STARTED|Overall Study||44
142384|NCT00347360|345736|P5|STARTED|Overall Study||44
142385|NCT00347360|345737|P4|STARTED|Overall Study||43
142386|NCT00347360|345738|P3|STARTED|Overall Study||43
142387|NCT00347360|345739|P2|STARTED|Overall Study||43
142388|NCT00347360|345740|P1|STARTED|Overall Study||44
142389|NCT00347438|345922|P1|NOT COMPLETED|Overall Study||2
142390|NCT00347438|345922|P1|COMPLETED|Overall Study||16
142391|NCT00347438|345922|P1|STARTED|Overall Study||18
142392|NCT00347776|345932|P3|NOT COMPLETED|12 Month Follow-up||19
142393|NCT00347776|345933|P2|NOT COMPLETED|12 Month Follow-up||16
142394|NCT00347776|345934|P1|NOT COMPLETED|12 Month Follow-up||23
142395|NCT00347776|345932|P3|COMPLETED|12 Month Follow-up||436
142396|NCT00347776|345933|P2|COMPLETED|12 Month Follow-up||446
142397|NCT00347776|345934|P1|COMPLETED|12 Month Follow-up||425
142398|NCT00347776|345932|P3|STARTED|12 Month Follow-up||455
142399|NCT00347776|345933|P2|STARTED|12 Month Follow-up||462
142400|NCT00347776|345934|P1|STARTED|12 Month Follow-up||448
142401|NCT00347776|345932|P3|NOT COMPLETED|6 Month Follow-up||18
142402|NCT00347776|345933|P2|NOT COMPLETED|6 Month Follow-up||13
142403|NCT00347776|345934|P1|NOT COMPLETED|6 Month Follow-up||22
142404|NCT00347776|345932|P3|COMPLETED|6 Month Follow-up|452 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|455
142405|NCT00347776|345933|P2|COMPLETED|6 Month Follow-up|459 had no recurrence.3 were lost to follow-up but were still eligible for follow-up at next visits|462
142406|NCT00347776|345934|P1|COMPLETED|6 Month Follow-up|440 had no recurrence.8 were lost to follow-up but were still eligible for follow-up at next visits|448
142407|NCT00347776|345932|P3|STARTED|6 Month Follow-up||473
142408|NCT00347776|345933|P2|STARTED|6 Month Follow-up||475
142409|NCT00347776|345934|P1|STARTED|6 Month Follow-up||470
142410|NCT00347776|345932|P3|NOT COMPLETED|1.5 Month Follow-up||12
142411|NCT00347776|345933|P2|NOT COMPLETED|1.5 Month Follow-up||8
142412|NCT00347776|345934|P1|NOT COMPLETED|1.5 Month Follow-up||14
142413|NCT00347776|345932|P3|COMPLETED|1.5 Month Follow-up|472 had no recurrence.1 was lost to follow-up but was still eligible for follow-up at next visits|473
142414|NCT00347776|345933|P2|COMPLETED|1.5 Month Follow-up|473 had no recurrence.2 were lost to follow-up but were still eligible for follow-up at next visits|475
142415|NCT00347776|345934|P1|COMPLETED|1.5 Month Follow-up||470
142416|NCT00347776|345932|P3|STARTED|1.5 Month Follow-up||485
142417|NCT00347776|345933|P2|STARTED|1.5 Month Follow-up||483
142418|NCT00347776|345934|P1|STARTED|1.5 Month Follow-up||484
142419|NCT00347919|345949|P3|NOT COMPLETED|Overall Study||38
142420|NCT00347919|345950|P2|NOT COMPLETED|Overall Study||76
142421|NCT00347919|345951|P1|NOT COMPLETED|Overall Study||71
142422|NCT00347919|345949|P3|COMPLETED|Overall Study||2
142423|NCT00347919|345950|P2|COMPLETED|Overall Study||0
142424|NCT00347919|345951|P1|COMPLETED|Overall Study||2
142425|NCT00347919|345949|P3|STARTED|Overall Study|Safety Population|40
142426|NCT00347919|345950|P2|STARTED|Overall Study|Safety Population|76
142427|NCT00347919|345951|P1|STARTED|Overall Study|Safety Population|73
142428|NCT00347932|345973|P2|NOT COMPLETED|Overall Study||52
142429|NCT00347932|345974|P1|NOT COMPLETED|Overall Study||31
142430|NCT00347932|345973|P2|COMPLETED|Overall Study||430
142431|NCT00347932|345974|P1|COMPLETED|Overall Study||444
142432|NCT00347932|345973|P2|STARTED|Overall Study|As Randomized Population - received at least one dose of study medication|482
142433|NCT00347932|345974|P1|STARTED|Overall Study|As Randomized population - received at least one dose of study medication|475
142434|NCT00347958|345986|P1|NOT COMPLETED|Overall Study||4
142435|NCT00347958|345986|P1|COMPLETED|Overall Study||540
142436|NCT00347958|345986|P1|STARTED|Overall Study||544
142437|NCT00336973|345993|P1|NOT COMPLETED|Overall Study||33
142438|NCT00336973|345993|P1|COMPLETED|Overall Study||33
142439|NCT00336973|345993|P1|STARTED|Overall Study||66
142440|NCT00337077|346002|P3|NOT COMPLETED|Overall Study||25
142441|NCT00337077|346003|P2|NOT COMPLETED|Overall Study||53
142442|NCT00337077|346004|P1|NOT COMPLETED|Overall Study||43
142443|NCT00337077|346002|P3|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
142444|NCT00337077|346003|P2|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
142445|NCT00337077|346004|P1|COMPLETED|Overall Study|No completion of treatment because treatment was given until PD or unacceptable toxicity.|0
142446|NCT00337077|346002|P3|Patients With Measurable Disease|Overall Study||13
142447|NCT00337077|346003|P2|Patients With Measurable Disease|Overall Study||38
142448|NCT00337077|346004|P1|Patients With Measurable Disease|Overall Study||26
142449|NCT00337077|346002|P3|Eligible and Treated|Overall Study||24
142450|NCT00337077|346003|P2|Eligible and Treated|Overall Study||51
142451|NCT00337077|346004|P1|Eligible and Treated|Overall Study||41
142452|NCT00337077|346002|P3|Toxicity Assessed|Overall Study||25
142453|NCT00337077|346003|P2|Toxicity Assessed|Overall Study||51
142454|NCT00337077|346004|P1|Toxicity Assessed|Overall Study||42
142455|NCT00337077|346002|P3|Treated|Overall Study||25
142456|NCT00337077|346003|P2|Treated|Overall Study||52
142457|NCT00337077|346004|P1|Treated|Overall Study||42
142458|NCT00337077|346002|P3|STARTED|Overall Study||25
142459|NCT00337077|346003|P2|STARTED|Overall Study||53
142460|NCT00337077|346004|P1|STARTED|Overall Study||43
142461|NCT00337103|346015|P2|NOT COMPLETED|Overall Study||543
142462|NCT00337103|346016|P1|NOT COMPLETED|Overall Study||549
142463|NCT00337103|346015|P2|COMPLETED|Overall Study||5
142464|NCT00337103|346016|P1|COMPLETED|Overall Study||5
142465|NCT00337103|346015|P2|STARTED|Overall Study||548
142466|NCT00337103|346016|P1|STARTED|Overall Study||554
142467|NCT00337129|346024|P1|NOT COMPLETED|Overall Study||40
142468|NCT00337129|346024|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until discontinuation criterion is met.|0
142469|NCT00337129|346024|P1|STARTED|Overall Study||40
142470|NCT00337168|346031|P1|NOT COMPLETED|Overall Study||8
142471|NCT00337168|346031|P1|COMPLETED|Overall Study||29
142472|NCT00337168|346031|P1|Eligible and Treated|Overall Study||36
142473|NCT00337168|346031|P1|Eligible|Overall Study||37
142474|NCT00337168|346031|P1|STARTED|Overall Study||37
142475|NCT00337194|346040|P2|NOT COMPLETED|Overall Study||4
142476|NCT00337194|346041|P1|NOT COMPLETED|Overall Study||12
142477|NCT00337194|346040|P2|COMPLETED|Overall Study||3
142478|NCT00337194|346041|P1|COMPLETED|Overall Study||11
142479|NCT00337194|346040|P2|STARTED|Overall Study||7
142480|NCT00337194|346041|P1|STARTED|Overall Study||23
142481|NCT00337207|346056|P1|NOT COMPLETED|Overall Study||3
142482|NCT00337207|346056|P1|COMPLETED|Overall Study||52
142483|NCT00337207|346056|P1|STARTED|Overall Study||55
142484|NCT00337272|346062|P2|NOT COMPLETED|Withdrawal Period||1
142485|NCT00337272|346063|P1|NOT COMPLETED|Withdrawal Period||0
142486|NCT00337272|346062|P2|COMPLETED|Withdrawal Period||6
142487|NCT00337272|346063|P1|COMPLETED|Withdrawal Period||6
142488|NCT00337272|346062|P2|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|7
142489|NCT00337272|346063|P1|STARTED|Withdrawal Period|Subjects in both groups received placebo for one week.|6
142490|NCT00337272|346062|P2|NOT COMPLETED|Treatment Period||2
142491|NCT00337272|346063|P1|NOT COMPLETED|Treatment Period||1
142492|NCT00337272|346062|P2|COMPLETED|Treatment Period||7
142493|NCT00337272|346063|P1|COMPLETED|Treatment Period||6
142494|NCT00337272|346062|P2|Randomization|Treatment Period||9
142495|NCT00337272|346063|P1|Randomization|Treatment Period||7
142496|NCT00337272|346062|P2|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|9
142497|NCT00337272|346063|P1|STARTED|Treatment Period|16 subjects were randomized to either placebo or ramelteon before starting treatment period.|7
142498|NCT00337272|346062|P2|NOT COMPLETED|Screening Period (Pre-randomization)||0
142499|NCT00337272|346063|P1|NOT COMPLETED|Screening Period (Pre-randomization)||6
142500|NCT00337272|346062|P2|COMPLETED|Screening Period (Pre-randomization)||0
142501|NCT00337272|346063|P1|COMPLETED|Screening Period (Pre-randomization)|16 subjects completed the screening period and were eligible for randomization.|16
142502|NCT00337272|346062|P2|STARTED|Screening Period (Pre-randomization)||0
142503|NCT00337272|346063|P1|STARTED|Screening Period (Pre-randomization)|22 subjects were consented. All subjects received placebo during the 2 week screening period.|22
142504|NCT00337285|346083|P1|NOT COMPLETED|Overall Study||158
142505|NCT00337285|346083|P1|COMPLETED|Overall Study||191
142506|NCT00337285|346083|P1|STARTED|Overall Study||349
142507|NCT00337350|346091|P2|NOT COMPLETED|Overall Study||1
142508|NCT00337350|346092|P1|NOT COMPLETED|Overall Study||1
142509|NCT00337350|346091|P2|COMPLETED|Overall Study||10
142510|NCT00337350|346092|P1|COMPLETED|Overall Study||8
142511|NCT00337350|346091|P2|STARTED|Overall Study||11
142512|NCT00337350|346092|P1|STARTED|Overall Study||9
142513|NCT00337428|346104|P2|NOT COMPLETED|Overall Study||3
142514|NCT00337428|346105|P1|NOT COMPLETED|Overall Study||4
142515|NCT00337428|346104|P2|COMPLETED|Overall Study||421
142516|NCT00337428|346105|P1|COMPLETED|Overall Study||415
142517|NCT00337428|346104|P2|STARTED|Overall Study||424
142518|NCT00337428|346105|P1|STARTED|Overall Study||419
142519|NCT00337467|346143|P1|NOT COMPLETED|Overall Study||10
142520|NCT00337467|346143|P1|COMPLETED|Overall Study||51
142521|NCT00337467|346143|P1|Discontinued Prior to Week 96|Overall Study|5 of these participants discontinued prior to Week 48|10
142522|NCT00337467|346143|P1|STARTED|Overall Study||61
142523|NCT00337571|346164|P4|NOT COMPLETED|Overall Study||7
142524|NCT00337571|346165|P3|NOT COMPLETED|Overall Study||10
142525|NCT00337571|346166|P2|NOT COMPLETED|Overall Study||9
142526|NCT00337571|346167|P1|NOT COMPLETED|Overall Study||14
142527|NCT00337571|346164|P4|COMPLETED|Overall Study||47
142528|NCT00337571|346165|P3|COMPLETED|Overall Study||49
142529|NCT00337571|346166|P2|COMPLETED|Overall Study||44
142530|NCT00337571|346167|P1|COMPLETED|Overall Study||38
142531|NCT00337571|346164|P4|STARTED|Overall Study||54
142532|NCT00337571|346165|P3|STARTED|Overall Study||59
142533|NCT00337571|346166|P2|STARTED|Overall Study||53
142534|NCT00337571|346167|P1|STARTED|Overall Study||52
142535|NCT00337610|346207|P2|NOT COMPLETED|Overall Study||14
142536|NCT00337610|346208|P1|NOT COMPLETED|Overall Study||17
142537|NCT00337610|346207|P2|COMPLETED|Overall Study||80
142538|NCT00337610|346208|P1|COMPLETED|Overall Study||79
142539|NCT00337610|346207|P2|Completed Week 18|Overall Study||82
142540|NCT00337610|346208|P1|Completed Week 18|Overall Study||89
142541|NCT00337610|346207|P2|STARTED|Overall Study||94
142542|NCT00337610|346208|P1|STARTED|Overall Study||96
142543|NCT00337662|346223|P4|NOT COMPLETED|Study Period III||0
142544|NCT00337662|346224|P3|NOT COMPLETED|Study Period III||44
142545|NCT00337662|346225|P2|NOT COMPLETED|Study Period III||58
142546|NCT00337662|346226|P1|NOT COMPLETED|Study Period III||60
142547|NCT00337662|346223|P4|COMPLETED|Study Period III||0
142548|NCT00337662|346224|P3|COMPLETED|Study Period III||100
142549|NCT00337662|346225|P2|COMPLETED|Study Period III||134
142550|NCT00337662|346226|P1|COMPLETED|Study Period III||126
142551|NCT00337662|346223|P4|STARTED|Study Period III||0
142552|NCT00337662|346224|P3|STARTED|Study Period III||144
142553|NCT00337662|346225|P2|STARTED|Study Period III||192
142554|NCT00337662|346226|P1|STARTED|Study Period III||186
142555|NCT00337662|346223|P4|NOT COMPLETED|Study Period II||106
142556|NCT00337662|346224|P3|NOT COMPLETED|Study Period II||0
142557|NCT00337662|346225|P2|NOT COMPLETED|Study Period II||0
142558|NCT00337662|346226|P1|NOT COMPLETED|Study Period II||0
142559|NCT00337662|346223|P4|COMPLETED|Study Period II||522
142560|NCT00337662|346224|P3|COMPLETED|Study Period II||0
142561|NCT00337662|346225|P2|COMPLETED|Study Period II||0
142562|NCT00337662|346226|P1|COMPLETED|Study Period II||0
142563|NCT00337662|346223|P4|STARTED|Study Period II||628
142564|NCT00337662|346224|P3|STARTED|Study Period II||0
142565|NCT00337662|346225|P2|STARTED|Study Period II||0
142566|NCT00337662|346226|P1|STARTED|Study Period II||0
142567|NCT00337675|346281|P3|NOT COMPLETED|Overall Study||99
142568|NCT00337675|346282|P2|NOT COMPLETED|Overall Study||103
142569|NCT00337675|346283|P1|NOT COMPLETED|Overall Study||97
142570|NCT00337675|346281|P3|COMPLETED|Overall Study||492
142571|NCT00337675|346282|P2|COMPLETED|Overall Study||488
142572|NCT00337675|346283|P1|COMPLETED|Overall Study||492
142573|NCT00337675|346281|P3|STARTED|Overall Study||591
142574|NCT00337675|346282|P2|STARTED|Overall Study||591
142575|NCT00337675|346283|P1|STARTED|Overall Study||589
142576|NCT00337727|346299|P2|NOT COMPLETED|Overall Study||12
142577|NCT00337727|346300|P1|NOT COMPLETED|Overall Study||18
142578|NCT00337727|346299|P2|COMPLETED|Overall Study||406
142579|NCT00337727|346300|P1|COMPLETED|Overall Study||412
142580|NCT00337727|346299|P2|STARTED|Overall Study||418
142581|NCT00337727|346300|P1|STARTED|Overall Study||430
142582|NCT00337779|346310|P2|NOT COMPLETED|Overall Study||79
142583|NCT00337779|346311|P1|NOT COMPLETED|Overall Study||52
142584|NCT00337779|346310|P2|COMPLETED|Overall Study||490
142585|NCT00337779|346311|P1|COMPLETED|Overall Study||534
142586|NCT00337779|346310|P2|STARTED|Overall Study||569
142587|NCT00337779|346311|P1|STARTED|Overall Study||586
142588|NCT00337818|346324|P3|NOT COMPLETED|Overall Study||107
142589|NCT00337818|346325|P2|NOT COMPLETED|Overall Study||91
142590|NCT00337818|346326|P1|NOT COMPLETED|Overall Study||289
142591|NCT00337818|346324|P3|COMPLETED|Overall Study||51
142592|NCT00337818|346325|P2|COMPLETED|Overall Study||63
142593|NCT00337818|346326|P1|COMPLETED|Overall Study||169
142594|NCT00337818|346324|P3|STARTED|Overall Study||158
142595|NCT00337818|346325|P2|STARTED|Overall Study||154
142596|NCT00337818|346326|P1|STARTED|Overall Study||458
142597|NCT00337935|346348|P2|NOT COMPLETED|Overall Study||27
142598|NCT00337935|346349|P1|NOT COMPLETED|Overall Study||10
142599|NCT00337935|346348|P2|COMPLETED|Overall Study||91
142600|NCT00337935|346349|P1|COMPLETED|Overall Study||29
142601|NCT00337935|346348|P2|STARTED|Overall Study||118
142602|NCT00337935|346349|P1|STARTED|Overall Study||39
142603|NCT00337987|346359|P1|NOT COMPLETED|Overall Study||0
142604|NCT00337987|346359|P1|COMPLETED|Overall Study||49
142605|NCT00337987|346359|P1|STARTED|Overall Study||49
142606|NCT00338039|346364|P1|NOT COMPLETED|Overall Study||0
142607|NCT00338039|346364|P1|COMPLETED|Overall Study||69
142608|NCT00338039|346364|P1|STARTED|Overall Study||69
142609|NCT00338104|346372|P3|NOT COMPLETED|Overall Study||3
142610|NCT00338104|346373|P2|NOT COMPLETED|Overall Study||1
142611|NCT00338104|346374|P1|NOT COMPLETED|Overall Study||2
142612|NCT00338104|346372|P3|COMPLETED|Overall Study||22
142613|NCT00338104|346373|P2|COMPLETED|Overall Study||24
142614|NCT00338104|346374|P1|COMPLETED|Overall Study||23
142615|NCT00338104|346372|P3|STARTED|Overall Study||25
142616|NCT00338104|346373|P2|STARTED|Overall Study||25
142617|NCT00338104|346374|P1|STARTED|Overall Study||25
142618|NCT00338286|346387|P2|NOT COMPLETED|Overall Study||370
142619|NCT00338286|346388|P1|NOT COMPLETED|Overall Study||393
142620|NCT00338286|346387|P2|COMPLETED|Overall Study||680
142621|NCT00338286|346388|P1|COMPLETED|Overall Study||655
142622|NCT00338286|346387|P2|STARTED|Overall Study||1050
142623|NCT00338286|346388|P1|STARTED|Overall Study||1048
142624|NCT00338962|346406|P4|NOT COMPLETED|Overall Study||3
142625|NCT00338962|346407|P3|NOT COMPLETED|Overall Study||6
142626|NCT00338962|346408|P2|NOT COMPLETED|Overall Study||4
142627|NCT00338962|346409|P1|NOT COMPLETED|Overall Study||8
142628|NCT00338962|346406|P4|COMPLETED|Overall Study||21
142629|NCT00338962|346407|P3|COMPLETED|Overall Study||16
142630|NCT00338962|346408|P2|COMPLETED|Overall Study||16
142631|NCT00338962|346409|P1|COMPLETED|Overall Study||14
142632|NCT00338962|346406|P4|STARTED|Overall Study||24
142633|NCT00338962|346407|P3|STARTED|Overall Study||22
142634|NCT00338962|346408|P2|STARTED|Overall Study||20
142635|NCT00338962|346409|P1|STARTED|Overall Study||22
142636|NCT00338988|346431|P1|NOT COMPLETED|Overall Study||1
142637|NCT00338988|346431|P1|COMPLETED|Overall Study||43
142638|NCT00338988|346431|P1|STARTED|Overall Study||44
142639|NCT00339040|346438|P2|NOT COMPLETED|Stage II||2
142640|NCT00339040|346439|P1|NOT COMPLETED|Stage II||10
142641|NCT00339040|346438|P2|COMPLETED|Stage II||27
142642|NCT00339040|346439|P1|COMPLETED|Stage II||84
142643|NCT00339040|346438|P2|Vaccination 6 at Week 120|Stage II||27
142644|NCT00339040|346439|P1|Vaccination 6 at Week 120|Stage II||0
142645|NCT00339040|346438|P2|Vaccination 5 at Week 104|Stage II||28
142646|NCT00339040|346439|P1|Vaccination 5 at Week 104|Stage II||0
142647|NCT00339040|346438|P2|Vaccination 4 at Week 96|Stage II||29
142648|NCT00339040|346439|P1|Vaccination 4 at Week 96|Stage II||84
142649|NCT00339040|346438|P2|STARTED|Stage II||29
142650|NCT00339040|346439|P1|STARTED|Stage II||94
142651|NCT00339040|346438|P2|NOT COMPLETED|Stage I||1
142652|NCT00339040|346439|P1|NOT COMPLETED|Stage I||2
142653|NCT00339040|346438|P2|COMPLETED|Stage I||29
142654|NCT00339040|346439|P1|COMPLETED|Stage I||94
142655|NCT00339040|346438|P2|Vaccination 3 at Week 24|Stage I||30
142656|NCT00339040|346439|P1|Vaccination 3 at Week 24|Stage I||94
142657|NCT00339040|346438|P2|Vaccination 2 at Week 8|Stage I||30
142658|NCT00339040|346439|P1|Vaccination 2 at Week 8|Stage I||95
142659|NCT00339040|346438|P2|Vaccination 1 at Week 0|Stage I||30
142660|NCT00339040|346439|P1|Vaccination 1 at Week 0|Stage I||96
142661|NCT00339040|346438|P2|STARTED|Stage I||30
142662|NCT00339040|346439|P1|STARTED|Stage I||96
142663|NCT00339079|346461|P4|NOT COMPLETED|Overall Study||24
142664|NCT00339079|346462|P3|NOT COMPLETED|Overall Study||18
142665|NCT00339079|346463|P2|NOT COMPLETED|Overall Study||23
142666|NCT00339079|346464|P1|NOT COMPLETED|Overall Study||33
142667|NCT00339079|346461|P4|COMPLETED|Overall Study||29
142668|NCT00339079|346462|P3|COMPLETED|Overall Study||27
142669|NCT00339079|346463|P2|COMPLETED|Overall Study||21
142670|NCT00339079|346464|P1|COMPLETED|Overall Study||20
142671|NCT00339079|346461|P4|STARTED|Overall Study||53
142672|NCT00339079|346462|P3|STARTED|Overall Study||45
142673|NCT00339079|346463|P2|STARTED|Overall Study||44
142674|NCT00339079|346464|P1|STARTED|Overall Study||53
142675|NCT00339144|346481|P3|NOT COMPLETED|Overall Study||4
142676|NCT00339144|346482|P2|NOT COMPLETED|Overall Study||3
142677|NCT00339144|346483|P1|NOT COMPLETED|Overall Study||9
142678|NCT00339144|346481|P3|COMPLETED|Overall Study||0
142679|NCT00339144|346482|P2|COMPLETED|Overall Study||0
142680|NCT00339144|346483|P1|COMPLETED|Overall Study||0
142681|NCT00339144|346481|P3|STARTED|Overall Study|Number of participants enrolled and treated|4
142682|NCT00339144|346482|P2|STARTED|Overall Study|Number of participants enrolled and treated|3
142683|NCT00339144|346483|P1|STARTED|Overall Study|Number of participants enrolled and treated|9
142684|NCT00339183|346567|P2|NOT COMPLETED|Overall Study||105
142685|NCT00339183|346568|P1|NOT COMPLETED|Overall Study||121
142686|NCT00339183|346567|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|490
142687|NCT00339183|346568|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|470
142688|NCT00339183|346567|P2|Received Study Drug|Overall Study||593
142689|NCT00339183|346568|P1|Received Study Drug|Overall Study|Includes one participant who received FOLFIRI Alone|588
142690|NCT00339183|346567|P2|STARTED|Overall Study||595
142691|NCT00339183|346568|P1|STARTED|Overall Study||591
142692|NCT00339833|346596|P2|NOT COMPLETED|Overall Study||8
142693|NCT00339833|346597|P1|NOT COMPLETED|Overall Study||6
142694|NCT00339833|346596|P2|COMPLETED|Overall Study||18
142695|NCT00339833|346597|P1|COMPLETED|Overall Study||22
142696|NCT00339833|346596|P2|STARTED|Overall Study||26
142697|NCT00339833|346597|P1|STARTED|Overall Study||28
142698|NCT00340379|346607|P2|NOT COMPLETED|Overall Study||9
142699|NCT00340379|346608|P1|NOT COMPLETED|Overall Study||8
142700|NCT00340379|346607|P2|COMPLETED|Overall Study||28
142701|NCT00340379|346608|P1|COMPLETED|Overall Study||27
142702|NCT00340379|346607|P2|STARTED|Overall Study||37
142703|NCT00340379|346608|P1|STARTED|Overall Study||35
142704|NCT00340678|346622|P4|NOT COMPLETED|Overall Study||0
142705|NCT00340678|346623|P3|NOT COMPLETED|Overall Study||0
142706|NCT00340678|346624|P2|NOT COMPLETED|Overall Study||0
142707|NCT00340678|346625|P1|NOT COMPLETED|Overall Study||1
142708|NCT00340678|346622|P4|COMPLETED|Overall Study||39
142709|NCT00340678|346623|P3|COMPLETED|Overall Study||39
142710|NCT00340678|346624|P2|COMPLETED|Overall Study||46
142711|NCT00340678|346625|P1|COMPLETED|Overall Study||45
142712|NCT00340678|346622|P4|STARTED|Overall Study||39
142713|NCT00340678|346623|P3|STARTED|Overall Study||39
142714|NCT00340678|346624|P2|STARTED|Overall Study||46
142715|NCT00340678|346625|P1|STARTED|Overall Study||46
142716|NCT00340704|346646|P9|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||29
142717|NCT00340704|346647|P8|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||12
142718|NCT00340704|346648|P7|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||53
142719|NCT00340704|346649|P6|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||7
142720|NCT00340704|346650|P5|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||5
142721|NCT00340704|346651|P4|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||2
142722|NCT00340704|346652|P3|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
142723|NCT00340704|346653|P2|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
142724|NCT00340704|346654|P1|NOT COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
142725|NCT00340704|346646|P9|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
142726|NCT00340704|346647|P8|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
142727|NCT00340704|346648|P7|COMPLETED|Group D- Denovo & 527.51 Rollover Study||1
142728|NCT00340704|346649|P6|COMPLETED|Group D- Denovo & 527.51 Rollover Study||30
142729|NCT00340704|346650|P5|COMPLETED|Group D- Denovo & 527.51 Rollover Study||16
142730|NCT00340704|346651|P4|COMPLETED|Group D- Denovo & 527.51 Rollover Study||27
142731|NCT00340704|346652|P3|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
142732|NCT00340704|346653|P2|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
142733|NCT00340704|346654|P1|COMPLETED|Group D- Denovo & 527.51 Rollover Study||0
142734|NCT00340704|346646|P9|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
142735|NCT00340704|346647|P8|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
142736|NCT00340704|346648|P7|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
142737|NCT00340704|346649|P6|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||18
142738|NCT00340704|346650|P5|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||5
142739|NCT00340704|346651|P4|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||7
142740|NCT00340704|346652|P3|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
142741|NCT00340704|346653|P2|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
142742|NCT00340704|346654|P1|PK Study Subjects Entered Group D-Denovo|Group D- Denovo & 527.51 Rollover Study||0
142743|NCT00340704|346646|P9|STARTED|Group D- Denovo & 527.51 Rollover Study||29
142744|NCT00340704|346647|P8|STARTED|Group D- Denovo & 527.51 Rollover Study||13
142745|NCT00340704|346648|P7|STARTED|Group D- Denovo & 527.51 Rollover Study||54
142746|NCT00340704|346649|P6|STARTED|Group D- Denovo & 527.51 Rollover Study||37
142747|NCT00340704|346650|P5|STARTED|Group D- Denovo & 527.51 Rollover Study||21
142748|NCT00340704|346651|P4|STARTED|Group D- Denovo & 527.51 Rollover Study||29
142749|NCT00340704|346652|P3|STARTED|Group D- Denovo & 527.51 Rollover Study||0
142750|NCT00340704|346653|P2|STARTED|Group D- Denovo & 527.51 Rollover Study||0
142751|NCT00340704|346654|P1|STARTED|Group D- Denovo & 527.51 Rollover Study||0
142752|NCT00340704|346646|P9|NOT COMPLETED|PK Study||0
142753|NCT00340704|346647|P8|NOT COMPLETED|PK Study||0
142754|NCT00340704|346648|P7|NOT COMPLETED|PK Study||0
142755|NCT00340704|346649|P6|NOT COMPLETED|PK Study||0
142756|NCT00340704|346650|P5|NOT COMPLETED|PK Study||0
142757|NCT00340704|346651|P4|NOT COMPLETED|PK Study||0
142758|NCT00340704|346652|P3|NOT COMPLETED|PK Study||1
142759|NCT00340704|346653|P2|NOT COMPLETED|PK Study||1
142760|NCT00340704|346654|P1|NOT COMPLETED|PK Study||0
142761|NCT00340704|346646|P9|COMPLETED|PK Study||0
142762|NCT00340704|346647|P8|COMPLETED|PK Study||0
142763|NCT00340704|346648|P7|COMPLETED|PK Study||0
142764|NCT00340704|346649|P6|COMPLETED|PK Study||0
142765|NCT00340704|346650|P5|COMPLETED|PK Study||0
142766|NCT00340704|346651|P4|COMPLETED|PK Study||0
142767|NCT00340704|346652|P3|COMPLETED|PK Study||10
142768|NCT00340704|346653|P2|COMPLETED|PK Study||9
142769|NCT00340704|346654|P1|COMPLETED|PK Study||10
142770|NCT00340704|346646|P9|STARTED|PK Study||0
142771|NCT00340704|346647|P8|STARTED|PK Study||0
142772|NCT00340704|346648|P7|STARTED|PK Study||0
142773|NCT00340704|346649|P6|STARTED|PK Study||0
142774|NCT00340704|346650|P5|STARTED|PK Study||0
142775|NCT00340704|346651|P4|STARTED|PK Study||0
142776|NCT00340704|346652|P3|STARTED|PK Study||11
142777|NCT00340704|346653|P2|STARTED|PK Study||10
142778|NCT00340704|346654|P1|STARTED|PK Study||10
142779|NCT00340834|346761|P5|NOT COMPLETED|Extension Phase of Study||44
142780|NCT00340834|346762|P4|NOT COMPLETED|Extension Phase of Study||53
142781|NCT00340834|346763|P3|NOT COMPLETED|Extension Phase of Study||0
142782|NCT00340834|346764|P2|NOT COMPLETED|Extension Phase of Study||76
142783|NCT00340834|346765|P1|NOT COMPLETED|Extension Phase of Study||85
142784|NCT00340834|346761|P5|COMPLETED|Extension Phase of Study||123
142785|NCT00340834|346762|P4|COMPLETED|Extension Phase of Study||123
142786|NCT00340834|346763|P3|COMPLETED|Extension Phase of Study||0
142787|NCT00340834|346764|P2|COMPLETED|Extension Phase of Study||281
142788|NCT00340834|346765|P1|COMPLETED|Extension Phase of Study||245
142789|NCT00340834|346761|P5|Received Study Drug|Extension Phase of Study||167
142790|NCT00340834|346762|P4|Received Study Drug|Extension Phase of Study||174
142791|NCT00340834|346763|P3|Received Study Drug|Extension Phase of Study||0
142792|NCT00340834|346764|P2|Received Study Drug|Extension Phase of Study||356
142793|NCT00340834|346765|P1|Received Study Drug|Extension Phase of Study||330
142794|NCT00340834|346761|P5|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|167
142795|NCT00340834|346762|P4|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|176
142796|NCT00340834|346763|P3|STARTED|Extension Phase of Study|This group did not exist in the extension phase of the study.|0
142797|NCT00340834|346764|P2|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|357
142798|NCT00340834|346765|P1|STARTED|Extension Phase of Study|Entry into the extension phase of the study was optional.|330
142799|NCT00340834|346761|P5|NOT COMPLETED|Core Phase of Study||0
142800|NCT00340834|346762|P4|NOT COMPLETED|Core Phase of Study||0
142801|NCT00340834|346763|P3|NOT COMPLETED|Core Phase of Study||49
142802|NCT00340834|346764|P2|NOT COMPLETED|Core Phase of Study||33
142803|NCT00340834|346765|P1|NOT COMPLETED|Core Phase of Study||57
142804|NCT00340834|346761|P5|COMPLETED|Core Phase of Study||0
142805|NCT00340834|346762|P4|COMPLETED|Core Phase of Study||0
142806|NCT00340834|346763|P3|COMPLETED|Core Phase of Study|On study drug: 380, Off study drug: 6|386
142807|NCT00340834|346764|P2|COMPLETED|Core Phase of Study|On study drug: 385, Off study drug: 13|398
142808|NCT00340834|346765|P1|COMPLETED|Core Phase of Study|On study drug: 358, Off study drug: 11|369
142809|NCT00340834|346761|P5|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
142810|NCT00340834|346762|P4|STARTED|Core Phase of Study|This group was formed at the beginning of the extension phase of the study.|0
142811|NCT00340834|346763|P3|STARTED|Core Phase of Study||435
142812|NCT00340834|346764|P2|STARTED|Core Phase of Study||431
142813|NCT00340834|346765|P1|STARTED|Core Phase of Study||426
142814|NCT00348283|346792|P2|NOT COMPLETED|Open Label||34
142815|NCT00348283|346793|P1|NOT COMPLETED|Open Label||0
142816|NCT00348283|346792|P2|COMPLETED|Open Label||66
142817|NCT00348283|346793|P1|COMPLETED|Open Label||0
142818|NCT00348283|346792|P2|STARTED|Open Label|14 subjects completed the Double Blind portion of the study but did not enter the Open Label period.|100
142819|NCT00348283|346793|P1|STARTED|Open Label|No comparator was used in the Open Label portion of the study.|0
142820|NCT00348283|346792|P2|NOT COMPLETED|Double Blind||10
142821|NCT00348283|346793|P1|NOT COMPLETED|Double Blind||5
142822|NCT00348283|346792|P2|COMPLETED|Double Blind||54
142823|NCT00348283|346793|P1|COMPLETED|Double Blind||60
142824|NCT00348283|346792|P2|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|64
142825|NCT00348283|346793|P1|STARTED|Double Blind|At Week 4, subjects were randomized to either adalimumab 40 mg eow or placebo eow.|65
142826|NCT00348283|346792|P2|NOT COMPLETED|Induction||6
142827|NCT00348283|346793|P1|NOT COMPLETED|Induction||0
142828|NCT00348283|346792|P2|COMPLETED|Induction|Subjects provided more than one reason for discontinuing during induction.|129
142829|NCT00348283|346793|P1|COMPLETED|Induction||0
142830|NCT00348283|346792|P2|STARTED|Induction|Subjects received an open- label dose of 80 mg adalimumab at Week 2 (induction dose).|135
142831|NCT00348283|346793|P1|STARTED|Induction||0
142832|NCT00348348|346811|P2|NOT COMPLETED|Overall Study||27
142833|NCT00348348|346812|P1|NOT COMPLETED|Overall Study||25
142834|NCT00348348|346811|P2|COMPLETED|Overall Study||555
142835|NCT00348348|346812|P1|COMPLETED|Overall Study||554
142836|NCT00348348|346811|P2|STARTED|Overall Study|Received at least one drop of study medication(Safety Population)|582
142837|NCT00348348|346812|P1|STARTED|Overall Study|Received at least one drop of study medication (Safety Population)|579
142838|NCT00348374|346826|P2|NOT COMPLETED|Overall Study||32
142839|NCT00348374|346827|P1|NOT COMPLETED|Overall Study||19
142840|NCT00348374|346826|P2|COMPLETED|Overall Study||71
142841|NCT00348374|346827|P1|COMPLETED|Overall Study||69
142842|NCT00348374|346826|P2|Received Study Treatment|Overall Study||96
142843|NCT00348374|346827|P1|Received Study Treatment|Overall Study||88
142844|NCT00348374|346826|P2|STARTED|Overall Study||103
142845|NCT00348374|346827|P1|STARTED|Overall Study||88
142846|NCT00349336|346874|P2|NOT COMPLETED|Overall Study||14
142847|NCT00349336|346875|P1|NOT COMPLETED|Overall Study||13
142848|NCT00349336|346874|P2|COMPLETED|Overall Study||18
142849|NCT00349336|346875|P1|COMPLETED|Overall Study||19
142850|NCT00349336|346874|P2|STARTED|Overall Study||32
142851|NCT00349336|346875|P1|STARTED|Overall Study||32
142852|NCT00349349|346900|P3|NOT COMPLETED|Overall Study||6
142853|NCT00349349|346901|P2|NOT COMPLETED|Overall Study||62
142854|NCT00349349|346902|P1|NOT COMPLETED|Overall Study||53
142855|NCT00349349|346900|P3|COMPLETED|Overall Study||10
142856|NCT00349349|346901|P2|COMPLETED|Overall Study||50
142857|NCT00349349|346902|P1|COMPLETED|Overall Study||42
142858|NCT00349349|346900|P3|STARTED|Overall Study||16
142859|NCT00349349|346901|P2|STARTED|Overall Study||112
142860|NCT00349349|346902|P1|STARTED|Overall Study||95
142861|NCT00349388|346968|P2|NOT COMPLETED|Overall Study||0
142862|NCT00349388|346969|P1|NOT COMPLETED|Overall Study||0
142863|NCT00349388|346968|P2|COMPLETED|Overall Study||1
142864|NCT00349388|346969|P1|COMPLETED|Overall Study|no patients enrolled , therefore no patients completed|0
142865|NCT00349388|346968|P2|STARTED|Overall Study||1
142866|NCT00349388|346969|P1|STARTED|Overall Study|no patients enrolled|0
142867|NCT00349466|346977|P2|NOT COMPLETED|Overall Study||3
142868|NCT00349466|346978|P1|NOT COMPLETED|Overall Study||9
142869|NCT00349466|346977|P2|COMPLETED|Overall Study||35
142870|NCT00349466|346978|P1|COMPLETED|Overall Study||33
142871|NCT00349466|346977|P2|STARTED|Overall Study||38
142872|NCT00349466|346978|P1|STARTED|Overall Study||42
142873|NCT00349622|346986|P2|NOT COMPLETED|Overall Study||96
142874|NCT00349622|346987|P1|NOT COMPLETED|Overall Study||178
142875|NCT00349622|346986|P2|COMPLETED|Overall Study||77
142876|NCT00349622|346987|P1|COMPLETED|Overall Study||162
142877|NCT00349622|346986|P2|STARTED|Overall Study||173
142878|NCT00349622|346987|P1|STARTED|Overall Study||340
142879|NCT00349713|347006|P3|NOT COMPLETED|Overall Study||0
142880|NCT00349713|347007|P2|NOT COMPLETED|Overall Study||0
142881|NCT00349713|347008|P1|NOT COMPLETED|Overall Study||0
142882|NCT00349713|347006|P3|COMPLETED|Overall Study||20
142883|NCT00349713|347007|P2|COMPLETED|Overall Study||20
142884|NCT00349713|347008|P1|COMPLETED|Overall Study||20
142885|NCT00349713|347006|P3|STARTED|Overall Study||20
142886|NCT00349713|347007|P2|STARTED|Overall Study||20
142887|NCT00349713|347008|P1|STARTED|Overall Study||20
142888|NCT00349752|347030|P2|NOT COMPLETED|Overall Study||64
142889|NCT00349752|347031|P1|NOT COMPLETED|Overall Study||59
142890|NCT00349752|347030|P2|COMPLETED|Overall Study||23
142891|NCT00349752|347031|P1|COMPLETED|Overall Study||28
142892|NCT00349752|347030|P2|STARTED|Overall Study||87
142893|NCT00349752|347031|P1|STARTED|Overall Study||87
142894|NCT00349908|347059|P2|NOT COMPLETED|Overall Study||4
142895|NCT00349908|347060|P1|NOT COMPLETED|Overall Study||0
142896|NCT00349908|347059|P2|COMPLETED|Overall Study|9 returned for 30 day follow-up, 7 returned for 6 month and 6/7 had 6 month angiogram|6
142897|NCT00349908|347060|P1|COMPLETED|Overall Study||10
142898|NCT00349908|347059|P2|STARTED|Overall Study||10
142899|NCT00349908|347060|P1|STARTED|Overall Study||10
142900|NCT00349921|347082|P4|NOT COMPLETED|Second Spinal Injection||0
142901|NCT00349921|347083|P3|NOT COMPLETED|Second Spinal Injection||0
142902|NCT00349921|347084|P2|NOT COMPLETED|Second Spinal Injection||0
142903|NCT00349921|347085|P1|NOT COMPLETED|Second Spinal Injection||0
142904|NCT00349921|347082|P4|COMPLETED|Second Spinal Injection||1
142905|NCT00349921|347083|P3|COMPLETED|Second Spinal Injection||0
142906|NCT00349921|347084|P2|COMPLETED|Second Spinal Injection||10
142907|NCT00349921|347085|P1|COMPLETED|Second Spinal Injection||9
142908|NCT00349921|347082|P4|STARTED|Second Spinal Injection||1
142909|NCT00349921|347083|P3|STARTED|Second Spinal Injection||0
142910|NCT00349921|347084|P2|STARTED|Second Spinal Injection||10
142911|NCT00349921|347085|P1|STARTED|Second Spinal Injection|One patient experienced an adverse event after period one and did not participate in period two|9
142912|NCT00349921|347082|P4|NOT COMPLETED|First Spinal Injection||0
142913|NCT00349921|347083|P3|NOT COMPLETED|First Spinal Injection||1
142914|NCT00349921|347084|P2|NOT COMPLETED|First Spinal Injection||0
142915|NCT00349921|347085|P1|NOT COMPLETED|First Spinal Injection||1
142916|NCT00349921|347082|P4|COMPLETED|First Spinal Injection||1
142917|NCT00349921|347083|P3|COMPLETED|First Spinal Injection||0
142918|NCT00349921|347084|P2|COMPLETED|First Spinal Injection||10
142919|NCT00349921|347085|P1|COMPLETED|First Spinal Injection||9
142920|NCT00349921|347082|P4|STARTED|First Spinal Injection||1
142921|NCT00349921|347083|P3|STARTED|First Spinal Injection||1
142922|NCT00349921|347084|P2|STARTED|First Spinal Injection||10
142923|NCT00349921|347085|P1|STARTED|First Spinal Injection||10
142924|NCT00350025|347096|P2|NOT COMPLETED|Overall Study||2
142925|NCT00350025|347097|P1|NOT COMPLETED|Overall Study||0
142926|NCT00350025|347096|P2|COMPLETED|Overall Study||28
142927|NCT00350025|347097|P1|COMPLETED|Overall Study||11
142928|NCT00350025|347096|P2|STARTED|Overall Study||30
142929|NCT00350025|347097|P1|STARTED|Overall Study||11
142930|NCT00350142|347105|P1|NOT COMPLETED|Overall Study||0
142931|NCT00350142|347105|P1|COMPLETED|Overall Study||20
142932|NCT00350142|347105|P1|STARTED|Overall Study||20
142933|NCT00350207|347113|P3|NOT COMPLETED|Overall Study||7
142934|NCT00350207|347114|P2|NOT COMPLETED|Overall Study||6
142935|NCT00350207|347115|P1|NOT COMPLETED|Overall Study||8
142936|NCT00350207|347113|P3|COMPLETED|Overall Study||119
142937|NCT00350207|347114|P2|COMPLETED|Overall Study||128
142938|NCT00350207|347115|P1|COMPLETED|Overall Study||120
142939|NCT00350207|347113|P3|STARTED|Overall Study||126
142940|NCT00350207|347114|P2|STARTED|Overall Study||134
142941|NCT00350207|347115|P1|STARTED|Overall Study||128
142942|NCT00350220|347311|P2|NOT COMPLETED|Overall Study||0
142943|NCT00350220|347312|P1|NOT COMPLETED|Overall Study||0
142944|NCT00350220|347311|P2|COMPLETED|Overall Study||30
142945|NCT00350220|347312|P1|COMPLETED|Overall Study||30
142946|NCT00350220|347311|P2|STARTED|Overall Study||30
142947|NCT00350220|347312|P1|STARTED|Overall Study||30
142948|NCT00350272|347322|P2|NOT COMPLETED|Open-Label 84 Week Treatment||8
142949|NCT00350272|347323|P1|NOT COMPLETED|Open-Label 84 Week Treatment||9
142950|NCT00350272|347322|P2|COMPLETED|Open-Label 84 Week Treatment||27
142951|NCT00350272|347323|P1|COMPLETED|Open-Label 84 Week Treatment||21
142952|NCT00350272|347322|P2|STARTED|Open-Label 84 Week Treatment||35
142953|NCT00350272|347323|P1|STARTED|Open-Label 84 Week Treatment||30
142954|NCT00350272|347322|P2|NOT COMPLETED|Blinded 12 Week Treatment||2
142955|NCT00350272|347323|P1|NOT COMPLETED|Blinded 12 Week Treatment||9
142956|NCT00350272|347322|P2|COMPLETED|Blinded 12 Week Treatment||35
142957|NCT00350272|347323|P1|COMPLETED|Blinded 12 Week Treatment||30
142958|NCT00350272|347322|P2|STARTED|Blinded 12 Week Treatment||37
142959|NCT00350272|347323|P1|STARTED|Blinded 12 Week Treatment||39
142960|NCT00350363|347331|P1|NOT COMPLETED|Overall Study||0
142961|NCT00350363|347331|P1|COMPLETED|Overall Study||60
142962|NCT00350363|347331|P1|STARTED|Overall Study||60
142963|NCT00350402|347337|P2|NOT COMPLETED|Overall Study||1
142964|NCT00350402|347338|P1|NOT COMPLETED|Overall Study||1
142965|NCT00350402|347337|P2|COMPLETED|Overall Study||20
142966|NCT00350402|347338|P1|COMPLETED|Overall Study||20
142967|NCT00350402|347337|P2|STARTED|Overall Study||21
142968|NCT00350402|347338|P1|STARTED|Overall Study||21
142969|NCT00350519|347352|P2|NOT COMPLETED|Overall Study||6
142970|NCT00350519|347353|P1|NOT COMPLETED|Overall Study||4
142971|NCT00350519|347352|P2|COMPLETED|Overall Study||13
142972|NCT00350519|347353|P1|COMPLETED|Overall Study||14
142973|NCT00350519|347352|P2|STARTED|Overall Study||19
142974|NCT00350519|347353|P1|STARTED|Overall Study||18
142975|NCT00350532|347367|P2|NOT COMPLETED|Overall Study||0
142976|NCT00350532|347368|P1|NOT COMPLETED|Overall Study||0
142977|NCT00350532|347367|P2|COMPLETED|Overall Study||19
142978|NCT00350532|347368|P1|COMPLETED|Overall Study||24
142979|NCT00350532|347367|P2|STARTED|Overall Study||19
142980|NCT00350532|347368|P1|STARTED|Overall Study||24
142981|NCT00350623|347377|P3|NOT COMPLETED|Overall Study||6
142982|NCT00350623|347378|P2|NOT COMPLETED|Overall Study||4
142983|NCT00350623|347379|P1|NOT COMPLETED|Overall Study||8
142984|NCT00350623|347377|P3|COMPLETED|Overall Study||62
142985|NCT00350623|347378|P2|COMPLETED|Overall Study||67
142986|NCT00350623|347379|P1|COMPLETED|Overall Study||63
142987|NCT00350623|347377|P3|STARTED|Overall Study||68
142988|NCT00350623|347378|P2|STARTED|Overall Study||71
142989|NCT00350623|347379|P1|STARTED|Overall Study||71
142990|NCT00350636|347389|P2|NOT COMPLETED|Overall Study||45
142991|NCT00350636|347390|P1|NOT COMPLETED|Overall Study||43
142992|NCT00350636|347389|P2|COMPLETED|Overall Study||355
142993|NCT00350636|347390|P1|COMPLETED|Overall Study||346
142994|NCT00350636|347389|P2|STARTED|Overall Study||400
142995|NCT00350636|347390|P1|STARTED|Overall Study||389
142996|NCT00350727|347409|P3|NOT COMPLETED|Phase II||22
142997|NCT00350727|347410|P2|NOT COMPLETED|Phase II||19
142998|NCT00350727|347411|P1|NOT COMPLETED|Phase II||0
142999|NCT00350727|347409|P3|COMPLETED|Phase II||0
143000|NCT00350727|347410|P2|COMPLETED|Phase II||0
143001|NCT00350727|347411|P1|COMPLETED|Phase II||0
143002|NCT00350727|347409|P3|STARTED|Phase II||22
143003|NCT00350727|347410|P2|STARTED|Phase II||19
143004|NCT00350727|347411|P1|STARTED|Phase II||0
143005|NCT00350727|347409|P3|NOT COMPLETED|Phase I: Dose Escalation||0
143006|NCT00350727|347410|P2|NOT COMPLETED|Phase I: Dose Escalation||0
143007|NCT00350727|347411|P1|NOT COMPLETED|Phase I: Dose Escalation||34
143008|NCT00350727|347409|P3|COMPLETED|Phase I: Dose Escalation||0
143009|NCT00350727|347410|P2|COMPLETED|Phase I: Dose Escalation||0
143010|NCT00350727|347411|P1|COMPLETED|Phase I: Dose Escalation||0
143011|NCT00350727|347409|P3|STARTED|Phase I: Dose Escalation||0
143012|NCT00350727|347410|P2|STARTED|Phase I: Dose Escalation||0
143013|NCT00350727|347411|P1|STARTED|Phase I: Dose Escalation||34
143014|NCT00350779|347555|P2|NOT COMPLETED|Overall Study||21
143015|NCT00350779|347556|P1|NOT COMPLETED|Overall Study||22
143016|NCT00350779|347555|P2|COMPLETED|Overall Study||71
143017|NCT00350779|347556|P1|COMPLETED|Overall Study||148
143018|NCT00350779|347555|P2|STARTED|Overall Study||92
143019|NCT00350779|347556|P1|STARTED|Overall Study||170
143020|NCT00350792|347574|P1|NOT COMPLETED|Overall Study||33
143021|NCT00350792|347574|P1|COMPLETED|Overall Study||29
143022|NCT00350792|347574|P1|STARTED|Overall Study||62
143023|NCT00350844|347582|P1|NOT COMPLETED|Overall Study||1
143024|NCT00350844|347582|P1|COMPLETED|Overall Study||5
143025|NCT00350844|347582|P1|STARTED|Overall Study||6
143026|NCT00350870|347590|P4|NOT COMPLETED|Overall Study||15
143027|NCT00350870|347591|P3|NOT COMPLETED|Overall Study||16
143028|NCT00350870|347592|P2|NOT COMPLETED|Overall Study||17
143029|NCT00350870|347593|P1|NOT COMPLETED|Overall Study||22
143030|NCT00350870|347590|P4|COMPLETED|Overall Study||7
143031|NCT00350870|347591|P3|COMPLETED|Overall Study||6
143032|NCT00350870|347592|P2|COMPLETED|Overall Study||11
143033|NCT00350870|347593|P1|COMPLETED|Overall Study||5
143034|NCT00350870|347590|P4|Had at Least 1 Day of Med|Overall Study||19
143035|NCT00350870|347591|P3|Had at Least 1 Day of Med|Overall Study||18
143036|NCT00350870|347592|P2|Had at Least 1 Day of Med|Overall Study||24
143037|NCT00350870|347593|P1|Had at Least 1 Day of Med|Overall Study||19
143038|NCT00350870|347590|P4|STARTED|Overall Study||22
143039|NCT00350870|347591|P3|STARTED|Overall Study||22
143040|NCT00350870|347592|P2|STARTED|Overall Study||28
143041|NCT00350870|347593|P1|STARTED|Overall Study||27
143042|NCT00351000|347607|P1|NOT COMPLETED|Overall Study||3
143043|NCT00351000|347607|P1|COMPLETED|Overall Study||21
143044|NCT00351000|347607|P1|STARTED|Overall Study||24
143045|NCT00351039|347614|P1|NOT COMPLETED|Overall Study||0
143046|NCT00351039|347614|P1|COMPLETED|Overall Study|The study was halted before Phase II was initiated.|8
143047|NCT00351039|347614|P1|STARTED|Overall Study||8
143048|NCT00351273|347626|P3|NOT COMPLETED|Overall Study||5
143049|NCT00351273|347627|P2|NOT COMPLETED|Overall Study||2
143050|NCT00351273|347628|P1|NOT COMPLETED|Overall Study||1
143051|NCT00351273|347626|P3|COMPLETED|Overall Study||10
143052|NCT00351273|347627|P2|COMPLETED|Overall Study||10
143053|NCT00351273|347628|P1|COMPLETED|Overall Study||14
143054|NCT00351273|347626|P3|STARTED|Overall Study||15
143055|NCT00351273|347627|P2|STARTED|Overall Study||12
143056|NCT00351273|347628|P1|STARTED|Overall Study||15
143057|NCT00351299|347638|P2|NOT COMPLETED|Overall Study||0
143058|NCT00351299|347639|P1|NOT COMPLETED|Overall Study||0
143059|NCT00351299|347638|P2|COMPLETED|Overall Study||28
143060|NCT00351299|347639|P1|COMPLETED|Overall Study||25
143061|NCT00351299|347638|P2|STARTED|Overall Study||28
143062|NCT00351299|347639|P1|STARTED|Overall Study||25
143063|NCT00351351|347655|P2|NOT COMPLETED|Overall Study||4
143064|NCT00351351|347656|P1|NOT COMPLETED|Overall Study||9
143065|NCT00351351|347655|P2|COMPLETED|Overall Study||32
143066|NCT00351351|347656|P1|COMPLETED|Overall Study||25
143067|NCT00351351|347655|P2|STARTED|Overall Study||36
143068|NCT00351351|347656|P1|STARTED|Overall Study||34
143069|NCT00351377|347662|P1|NOT COMPLETED|Overall Study||7
143070|NCT00351377|347662|P1|COMPLETED|Overall Study||104
143071|NCT00351377|347662|P1|STARTED|Overall Study||111
143072|NCT00351416|347676|P2|NOT COMPLETED|Overall Study||0
143073|NCT00351416|347677|P1|NOT COMPLETED|Overall Study||0
143074|NCT00351416|347676|P2|COMPLETED|Overall Study||9
143075|NCT00351416|347677|P1|COMPLETED|Overall Study||6
143076|NCT00351416|347676|P2|STARTED|Overall Study||9
143077|NCT00351416|347677|P1|STARTED|Overall Study||6
143078|NCT00351468|347683|P1|NOT COMPLETED|Overall Study||167
143079|NCT00351468|347683|P1|COMPLETED|Overall Study||135
143080|NCT00351468|347683|P1|Unknown - Not From Previous Trial|Overall Study|Mistakenly enrolled (not in any of the 3 trials) On 50 mg/d eltrombopag for 18 days and withdrawn|1
143081|NCT00351468|347683|P1|Subjects From TRA108057 Repeat|Overall Study||43
143082|NCT00351468|347683|P1|Subjects From TRA102537 Raise|Overall Study||146
143083|NCT00351468|347683|P1|Subjects From TRA100773B|Overall Study||61
143084|NCT00351468|347683|P1|Subjects From TRA100773A|Overall Study||51
143085|NCT00351468|347683|P1|STARTED|Overall Study||302
143086|NCT00351533|347700|P2|NOT COMPLETED|Overall Study||5
143087|NCT00351533|347701|P1|NOT COMPLETED|Overall Study||2
143088|NCT00351533|347700|P2|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|44
143089|NCT00351533|347701|P1|COMPLETED|Overall Study|Pts did not undergo BALs if not intubated|39
143090|NCT00351533|347700|P2|STARTED|Overall Study||49
143091|NCT00351533|347701|P1|STARTED|Overall Study||41
143092|NCT00338455|347763|P2|NOT COMPLETED|Overall Study||1
143093|NCT00338455|347764|P1|NOT COMPLETED|Overall Study||3
143094|NCT00338455|347763|P2|COMPLETED|Overall Study||6
143095|NCT00338455|347764|P1|COMPLETED|Overall Study||6
143096|NCT00338455|347763|P2|Administered Study Drug|Overall Study||7
143097|NCT00338455|347764|P1|Administered Study Drug|Overall Study||8
143098|NCT00338455|347763|P2|STARTED|Overall Study||7
143099|NCT00338455|347764|P1|STARTED|Overall Study||9
143100|NCT00338598|347778|P2|NOT COMPLETED|Overall Study||2
143101|NCT00338598|347779|P1|NOT COMPLETED|Overall Study||0
143102|NCT00338598|347778|P2|COMPLETED|Overall Study||8
143103|NCT00338598|347779|P1|COMPLETED|Overall Study||10
143104|NCT00338598|347778|P2|STARTED|Overall Study||10
143105|NCT00338598|347779|P1|STARTED|Overall Study||10
143106|NCT00338741|347799|P2|NOT COMPLETED|Overall Study||0
143107|NCT00338741|347800|P1|NOT COMPLETED|Overall Study||2
143108|NCT00338741|347799|P2|COMPLETED|Overall Study||2
143109|NCT00338741|347800|P1|COMPLETED|Overall Study||32
143110|NCT00338741|347799|P2|STARTED|Overall Study||2
143111|NCT00338741|347800|P1|STARTED|Overall Study|2 subjects signed a consent form but no data were received for either subject|34
143112|NCT00338806|347810|P2|NOT COMPLETED|Follow-up||3
143113|NCT00338806|347811|P1|NOT COMPLETED|Follow-up||1
143114|NCT00338806|347810|P2|COMPLETED|Follow-up||1
143115|NCT00338806|347811|P1|COMPLETED|Follow-up||1
143116|NCT00338806|347810|P2|STARTED|Follow-up||4
143117|NCT00338806|347811|P1|STARTED|Follow-up||2
143118|NCT00338806|347810|P2|NOT COMPLETED|Acute Phase||1
143119|NCT00338806|347811|P1|NOT COMPLETED|Acute Phase||0
143120|NCT00338806|347810|P2|COMPLETED|Acute Phase||4
143121|NCT00338806|347811|P1|COMPLETED|Acute Phase||2
143122|NCT00338806|347810|P2|STARTED|Acute Phase||5
143123|NCT00338806|347811|P1|STARTED|Acute Phase||2
143124|NCT00338884|347871|P1|NOT COMPLETED|Overall Study||78
143125|NCT00338884|347871|P1|COMPLETED|Overall Study||42
143126|NCT00338884|347871|P1|Received Treatment|Overall Study||119
143127|NCT00338884|347871|P1|STARTED|Overall Study||120
143128|NCT00344682|347905|P2|NOT COMPLETED|Overall Study||1
143129|NCT00344682|347906|P1|NOT COMPLETED|Overall Study||4
143130|NCT00344682|347905|P2|COMPLETED|Overall Study||14
143131|NCT00344682|347906|P1|COMPLETED|Overall Study||12
143132|NCT00344682|347905|P2|STARTED|Overall Study||15
143133|NCT00344682|347906|P1|STARTED|Overall Study||16
143134|NCT00344773|347918|P1|NOT COMPLETED|Overall Study||21
143135|NCT00344773|347918|P1|COMPLETED|Overall Study||25
143136|NCT00344773|347918|P1|STARTED|Overall Study||46
143137|NCT00344968|347927|P3|NOT COMPLETED|Overall Study||116
143138|NCT00344968|347928|P2|NOT COMPLETED|Overall Study||102
143139|NCT00344968|347929|P1|NOT COMPLETED|Overall Study||59
143140|NCT00344968|347927|P3|COMPLETED|Overall Study||279
143141|NCT00344968|347928|P2|COMPLETED|Overall Study||274
143142|NCT00344968|347929|P1|COMPLETED|Overall Study||126
143143|NCT00344968|347927|P3|STARTED|Overall Study||395
143144|NCT00344968|347928|P2|STARTED|Overall Study||376
143145|NCT00344968|347929|P1|STARTED|Overall Study||185
143146|NCT00345033|347942|P2|NOT COMPLETED|Overall Study||4
143147|NCT00345033|347943|P1|NOT COMPLETED|Overall Study||4
143148|NCT00345033|347942|P2|COMPLETED|Overall Study||14
143149|NCT00345033|347943|P1|COMPLETED|Overall Study||16
143150|NCT00345033|347942|P2|STARTED|Overall Study||18
143151|NCT00345033|347943|P1|STARTED|Overall Study||20
143152|NCT00345046|347962|P3|NOT COMPLETED|Overall Study||2
143153|NCT00345046|347963|P2|NOT COMPLETED|Overall Study||1
143154|NCT00345046|347964|P1|NOT COMPLETED|Overall Study||1
143155|NCT00345046|347962|P3|COMPLETED|Overall Study||14
143156|NCT00345046|347963|P2|COMPLETED|Overall Study||21
143157|NCT00345046|347964|P1|COMPLETED|Overall Study||17
143158|NCT00345046|347962|P3|STARTED|Overall Study||16
143159|NCT00345046|347963|P2|STARTED|Overall Study||22
143160|NCT00345046|347964|P1|STARTED|Overall Study||18
143161|NCT00345176|347976|P4|NOT COMPLETED|Overall Study||10
143162|NCT00345176|347977|P3|NOT COMPLETED|Overall Study||6
143163|NCT00345176|347978|P2|NOT COMPLETED|Overall Study||6
143164|NCT00345176|347979|P1|NOT COMPLETED|Overall Study||5
143165|NCT00345176|347976|P4|COMPLETED|Overall Study||1069
143166|NCT00345176|347977|P3|COMPLETED|Overall Study||1062
143167|NCT00345176|347978|P2|COMPLETED|Overall Study||1038
143168|NCT00345176|347979|P1|COMPLETED|Overall Study||1007
143169|NCT00345176|347976|P4|STARTED|Overall Study||1079
143170|NCT00345176|347977|P3|STARTED|Overall Study||1068
143171|NCT00345176|347978|P2|STARTED|Overall Study||1044
143172|NCT00345176|347979|P1|STARTED|Overall Study||1012
143173|NCT00345254|348001|P2|NOT COMPLETED|Overall Study||0
143174|NCT00345254|348002|P1|NOT COMPLETED|Overall Study||0
143175|NCT00345254|348001|P2|COMPLETED|Overall Study||30
143176|NCT00345254|348002|P1|COMPLETED|Overall Study||30
143177|NCT00345254|348001|P2|STARTED|Overall Study||30
143178|NCT00345254|348002|P1|STARTED|Overall Study||30
143179|NCT00345293|348008|P2|NOT COMPLETED|Overall Study||0
143180|NCT00345293|348009|P1|NOT COMPLETED|Overall Study||2
143181|NCT00345293|348008|P2|COMPLETED|Overall Study||3
143182|NCT00345293|348009|P1|COMPLETED|Overall Study||8
143183|NCT00345293|348008|P2|STARTED|Overall Study||3
143184|NCT00345293|348009|P1|STARTED|Overall Study||10
143185|NCT00345332|348018|P2|NOT COMPLETED|Overall Study||0
143186|NCT00345332|348019|P1|NOT COMPLETED|Overall Study||0
143187|NCT00345332|348018|P2|COMPLETED|Overall Study||20
143188|NCT00345332|348019|P1|COMPLETED|Overall Study||11
143189|NCT00345332|348018|P2|STARTED|Overall Study||20
143190|NCT00345332|348019|P1|STARTED|Overall Study||11
143191|NCT00345371|348029|P2|NOT COMPLETED|Overall Study||33
143192|NCT00345371|348030|P1|NOT COMPLETED|Overall Study||30
143193|NCT00345371|348029|P2|COMPLETED|Overall Study||38
143194|NCT00345371|348030|P1|COMPLETED|Overall Study||39
143195|NCT00345371|348029|P2|STARTED|Overall Study||71
143196|NCT00345371|348030|P1|STARTED|Overall Study||69
143197|NCT00345384|348040|P2|NOT COMPLETED|Overall Study||0
143198|NCT00345384|348041|P1|NOT COMPLETED|Overall Study||0
143199|NCT00345384|348040|P2|COMPLETED|Overall Study||19
143200|NCT00345384|348041|P1|COMPLETED|Overall Study||19
143201|NCT00345384|348040|P2|STARTED|Overall Study||19
143202|NCT00345384|348041|P1|STARTED|Overall Study||19
143203|NCT00345397|348049|P1|NOT COMPLETED|Overall Study||1
143204|NCT00345397|348049|P1|COMPLETED|Overall Study||6
143205|NCT00345397|348049|P1|STARTED|Overall Study||7
143206|NCT00345540|348054|P1|NOT COMPLETED|Overall Study||1
143207|NCT00345540|348054|P1|COMPLETED|Overall Study||15
143208|NCT00345540|348054|P1|STARTED|Overall Study|1 subject enrolled but not treated (off-trial for patient discretion)|16
143209|NCT00345579|348062|P2|NOT COMPLETED|Overall Study||65
143210|NCT00345579|348063|P1|NOT COMPLETED|Overall Study||164
143211|NCT00345579|348062|P2|COMPLETED|Overall Study||1048
143212|NCT00345579|348063|P1|COMPLETED|Overall Study||3114
143213|NCT00345579|348062|P2|STARTED|Overall Study||1113
143214|NCT00345579|348063|P1|STARTED|Overall Study||3278
143215|NCT00345592|348085|P2|NOT COMPLETED|Overall Study||24
143216|NCT00345592|348086|P1|NOT COMPLETED|Overall Study||25
143217|NCT00345592|348085|P2|COMPLETED|Overall Study||173
143218|NCT00345592|348086|P1|COMPLETED|Overall Study||174
143219|NCT00345592|348085|P2|STARTED|Overall Study||197
143220|NCT00345592|348086|P1|STARTED|Overall Study||199
143221|NCT00345605|348092|P2|NOT COMPLETED|Arm 2, Opposite Treatment||0
143222|NCT00345605|348093|P1|NOT COMPLETED|Arm 2, Opposite Treatment||1
143223|NCT00345605|348092|P2|COMPLETED|Arm 2, Opposite Treatment||6
143224|NCT00345605|348093|P1|COMPLETED|Arm 2, Opposite Treatment||5
143225|NCT00345605|348092|P2|STARTED|Arm 2, Opposite Treatment||6
143226|NCT00345605|348093|P1|STARTED|Arm 2, Opposite Treatment||6
143227|NCT00345605|348092|P2|NOT COMPLETED|Crossover Wash-out||0
143228|NCT00345605|348093|P1|NOT COMPLETED|Crossover Wash-out||0
143229|NCT00345605|348092|P2|COMPLETED|Crossover Wash-out||6
143230|NCT00345605|348093|P1|COMPLETED|Crossover Wash-out||6
143231|NCT00345605|348092|P2|STARTED|Crossover Wash-out||6
143232|NCT00345605|348093|P1|STARTED|Crossover Wash-out||6
143233|NCT00345605|348092|P2|NOT COMPLETED|Interval||0
143234|NCT00345605|348093|P1|NOT COMPLETED|Interval||0
143235|NCT00345605|348092|P2|COMPLETED|Interval||6
143236|NCT00345605|348093|P1|COMPLETED|Interval||6
143237|NCT00345605|348092|P2|STARTED|Interval||6
143238|NCT00345605|348093|P1|STARTED|Interval||6
143239|NCT00345605|348092|P2|NOT COMPLETED|Arm 1||1
143240|NCT00345605|348093|P1|NOT COMPLETED|Arm 1||0
143241|NCT00345605|348092|P2|COMPLETED|Arm 1||5
143242|NCT00345605|348093|P1|COMPLETED|Arm 1||6
143243|NCT00345605|348092|P2|STARTED|Arm 1||6
143244|NCT00345605|348093|P1|STARTED|Arm 1||6
143245|NCT00345605|348092|P2|NOT COMPLETED|Initial Washout||0
143246|NCT00345605|348093|P1|NOT COMPLETED|Initial Washout||0
143247|NCT00345605|348092|P2|COMPLETED|Initial Washout||6
143248|NCT00345605|348093|P1|COMPLETED|Initial Washout||6
143249|NCT00345605|348092|P2|STARTED|Initial Washout||6
143250|NCT00345605|348093|P1|STARTED|Initial Washout||6
143251|NCT00351741|348113|P2|NOT COMPLETED|Overall Study||0
143252|NCT00351741|348114|P1|NOT COMPLETED|Overall Study||0
143253|NCT00351741|348113|P2|COMPLETED|Overall Study||31
143254|NCT00351741|348114|P1|COMPLETED|Overall Study||31
143255|NCT00351741|348113|P2|STARTED|Overall Study||31
143256|NCT00351741|348114|P1|STARTED|Overall Study||31
143257|NCT00351819|348134|P2|NOT COMPLETED|Overall Study||12
143258|NCT00351819|348135|P1|NOT COMPLETED|Overall Study||7
143259|NCT00351819|348134|P2|COMPLETED|Overall Study||29
143260|NCT00351819|348135|P1|COMPLETED|Overall Study||36
143261|NCT00351819|348134|P2|STARTED|Overall Study||41
143262|NCT00351819|348135|P1|STARTED|Overall Study||43
143263|NCT00352365|348183|P1|NOT COMPLETED|Maintenance Therapy||12
143264|NCT00352365|348183|P1|COMPLETED|Maintenance Therapy||0
143265|NCT00352365|348183|P1|Eligible and Began Protocol Therapy|Maintenance Therapy||8
143266|NCT00352365|348183|P1|STARTED|Maintenance Therapy||12
143267|NCT00352365|348183|P1|NOT COMPLETED|Induction Therapy||27
143268|NCT00352365|348183|P1|COMPLETED|Induction Therapy||14
143269|NCT00352365|348183|P1|Eligible and Began Protocol Therapy|Induction Therapy||37
143270|NCT00352365|348183|P1|Eligible|Induction Therapy||38
143271|NCT00352365|348183|P1|STARTED|Induction Therapy||41
143272|NCT00352417|348195|P2|NOT COMPLETED|Overall Study||5
143273|NCT00352417|348196|P1|NOT COMPLETED|Overall Study||5
143274|NCT00352417|348195|P2|COMPLETED|Overall Study||21
143275|NCT00352417|348196|P1|COMPLETED|Overall Study||19
143276|NCT00352417|348195|P2|STARTED|Overall Study||26
143277|NCT00352417|348196|P1|STARTED|Overall Study||24
143278|NCT00352534|348212|P7|NOT COMPLETED|Final Risk Group Assignment||39
143279|NCT00352534|348213|P6|NOT COMPLETED|Final Risk Group Assignment||45
143280|NCT00352534|348214|P5|NOT COMPLETED|Final Risk Group Assignment||1
143281|NCT00352534|348215|P4|NOT COMPLETED|Final Risk Group Assignment||3
143282|NCT00352534|348216|P3|NOT COMPLETED|Final Risk Group Assignment||3
143283|NCT00352534|348217|P2|NOT COMPLETED|Final Risk Group Assignment||0
143284|NCT00352534|348218|P1|NOT COMPLETED|Final Risk Group Assignment||0
143285|NCT00352534|348212|P7|COMPLETED|Final Risk Group Assignment||1
143286|NCT00352534|348213|P6|COMPLETED|Final Risk Group Assignment||503
143287|NCT00352534|348214|P5|COMPLETED|Final Risk Group Assignment||31
143288|NCT00352534|348215|P4|COMPLETED|Final Risk Group Assignment||49
143289|NCT00352534|348216|P3|COMPLETED|Final Risk Group Assignment||116
143290|NCT00352534|348217|P2|COMPLETED|Final Risk Group Assignment||0
143291|NCT00352534|348218|P1|COMPLETED|Final Risk Group Assignment||0
143292|NCT00352534|348212|P7|STARTED|Final Risk Group Assignment||40
143293|NCT00352534|348213|P6|STARTED|Final Risk Group Assignment||548
143294|NCT00352534|348214|P5|STARTED|Final Risk Group Assignment||32
143295|NCT00352534|348215|P4|STARTED|Final Risk Group Assignment||52
143296|NCT00352534|348216|P3|STARTED|Final Risk Group Assignment||119
143297|NCT00352534|348217|P2|STARTED|Final Risk Group Assignment||0
143298|NCT00352534|348218|P1|STARTED|Final Risk Group Assignment||0
143299|NCT00352534|348212|P7|NOT COMPLETED|Initial Staging||0
143300|NCT00352534|348213|P6|NOT COMPLETED|Initial Staging||0
143301|NCT00352534|348214|P5|NOT COMPLETED|Initial Staging||0
143302|NCT00352534|348215|P4|NOT COMPLETED|Initial Staging||0
143303|NCT00352534|348216|P3|NOT COMPLETED|Initial Staging||0
143304|NCT00352534|348217|P2|NOT COMPLETED|Initial Staging||9
143305|NCT00352534|348218|P1|NOT COMPLETED|Initial Staging||8
143306|NCT00352534|348212|P7|COMPLETED|Initial Staging||0
143307|NCT00352534|348213|P6|COMPLETED|Initial Staging||0
143308|NCT00352534|348214|P5|COMPLETED|Initial Staging||0
143309|NCT00352534|348215|P4|COMPLETED|Initial Staging||0
143310|NCT00352534|348216|P3|COMPLETED|Initial Staging||0
143311|NCT00352534|348217|P2|COMPLETED|Initial Staging||588
143312|NCT00352534|348218|P1|COMPLETED|Initial Staging||203
143313|NCT00352534|348212|P7|STARTED|Initial Staging||0
143314|NCT00352534|348213|P6|STARTED|Initial Staging||0
143315|NCT00352534|348214|P5|STARTED|Initial Staging||0
143316|NCT00352534|348215|P4|STARTED|Initial Staging||0
143317|NCT00352534|348216|P3|STARTED|Initial Staging||0
143318|NCT00352534|348217|P2|STARTED|Initial Staging||597
143319|NCT00352534|348218|P1|STARTED|Initial Staging||211
143320|NCT00352612|348235|P2|NOT COMPLETED|Overall Study||0
143321|NCT00352612|348236|P1|NOT COMPLETED|Overall Study||0
143322|NCT00352612|348235|P2|COMPLETED|Overall Study||100
143323|NCT00352612|348236|P1|COMPLETED|Overall Study||100
143324|NCT00352612|348235|P2|STARTED|Overall Study||100
143325|NCT00352612|348236|P1|STARTED|Overall Study||100
143326|NCT00352664|348244|P2|NOT COMPLETED|Overall Study||0
143327|NCT00352664|348245|P1|NOT COMPLETED|Overall Study||7
143328|NCT00352664|348244|P2|COMPLETED|Overall Study||0
143329|NCT00352664|348245|P1|COMPLETED|Overall Study||20
143330|NCT00352664|348244|P2|STARTED|Overall Study||0
143331|NCT00352664|348245|P1|STARTED|Overall Study||27
143332|NCT00352690|348253|P2|NOT COMPLETED|Overall Study||0
143333|NCT00352690|348254|P1|NOT COMPLETED|Overall Study||2
143334|NCT00352690|348253|P2|COMPLETED|Overall Study||0
143335|NCT00352690|348254|P1|COMPLETED|Overall Study||8
143336|NCT00352690|348253|P2|STARTED|Overall Study||0
143337|NCT00352690|348254|P1|STARTED|Overall Study||10
143338|NCT00352755|348272|P1|NOT COMPLETED|Overall Study||2
143339|NCT00352755|348272|P1|COMPLETED|Overall Study||16
143340|NCT00352755|348272|P1|STARTED|Overall Study||18
143341|NCT00352781|348280|P1|NOT COMPLETED|Overall Study||883
143342|NCT00352781|348280|P1|COMPLETED|Overall Study||884
143343|NCT00352781|348280|P1|STARTED|Overall Study||1767
143344|NCT00352846|348287|P2|NOT COMPLETED|Overall Study||13
143345|NCT00352846|348288|P1|NOT COMPLETED|Overall Study||8
143346|NCT00352846|348287|P2|COMPLETED|Overall Study||24
143347|NCT00352846|348288|P1|COMPLETED|Overall Study||29
143348|NCT00352846|348287|P2|STARTED|Overall Study||37
143349|NCT00352846|348288|P1|STARTED|Overall Study||37
143350|NCT00352885|348296|P2|NOT COMPLETED|Overall Study||8
143351|NCT00352885|348297|P1|NOT COMPLETED|Overall Study||5
143352|NCT00352885|348296|P2|COMPLETED|Overall Study||3
143353|NCT00352885|348297|P1|COMPLETED|Overall Study||4
143354|NCT00352885|348296|P2|STARTED|Overall Study||11
143355|NCT00352885|348297|P1|STARTED|Overall Study||9
143356|NCT00352911|348305|P2|NOT COMPLETED|300mg Twice Daily (14 Days)||0
143357|NCT00352911|348306|P1|NOT COMPLETED|300mg Twice Daily (14 Days)||1
143358|NCT00352911|348305|P2|COMPLETED|300mg Twice Daily (14 Days)||3
143359|NCT00352911|348306|P1|COMPLETED|300mg Twice Daily (14 Days)||15
143360|NCT00352911|348305|P2|STARTED|300mg Twice Daily (14 Days)||3
143361|NCT00352911|348306|P1|STARTED|300mg Twice Daily (14 Days)||16
143362|NCT00352911|348305|P2|NOT COMPLETED|150mg Twice Daily (14 Days)||0
143363|NCT00352911|348306|P1|NOT COMPLETED|150mg Twice Daily (14 Days)||0
143364|NCT00352911|348305|P2|COMPLETED|150mg Twice Daily (14 Days)||3
143365|NCT00352911|348306|P1|COMPLETED|150mg Twice Daily (14 Days)||16
143366|NCT00352911|348305|P2|STARTED|150mg Twice Daily (14 Days)||3
143367|NCT00352911|348306|P1|STARTED|150mg Twice Daily (14 Days)||16
143368|NCT00353119|348314|P2|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
143369|NCT00353119|348315|P1|NOT COMPLETED|Second Intervention Week 12 to Week 28||0
143370|NCT00353119|348314|P2|COMPLETED|Second Intervention Week 12 to Week 28||10
143371|NCT00353119|348315|P1|COMPLETED|Second Intervention Week 12 to Week 28||5
143372|NCT00353119|348314|P2|STARTED|Second Intervention Week 12 to Week 28||10
143373|NCT00353119|348315|P1|STARTED|Second Intervention Week 12 to Week 28||5
143374|NCT00353119|348314|P2|NOT COMPLETED|First Intervention Day 0 to Week 12||0
143375|NCT00353119|348315|P1|NOT COMPLETED|First Intervention Day 0 to Week 12||0
143376|NCT00353119|348314|P2|COMPLETED|First Intervention Day 0 to Week 12||10
143377|NCT00353119|348315|P1|COMPLETED|First Intervention Day 0 to Week 12||5
143378|NCT00353119|348314|P2|STARTED|First Intervention Day 0 to Week 12||10
143379|NCT00353119|348315|P1|STARTED|First Intervention Day 0 to Week 12||5
143380|NCT00353262|348325|P1|NOT COMPLETED|Overall Study||29
143381|NCT00353262|348325|P1|COMPLETED|Overall Study||7
143382|NCT00353262|348325|P1|STARTED|Overall Study||36
143383|NCT00353275|348344|P2|NOT COMPLETED|Overall Study||0
143384|NCT00353275|348345|P1|NOT COMPLETED|Overall Study||0
143385|NCT00353275|348344|P2|COMPLETED|Overall Study||3
143386|NCT00353275|348345|P1|COMPLETED|Overall Study||2
143387|NCT00353275|348344|P2|STARTED|Overall Study||3
143388|NCT00353275|348345|P1|STARTED|Overall Study||2
143389|NCT00353301|348351|P1|NOT COMPLETED|Overall Study||0
143390|NCT00353301|348351|P1|COMPLETED|Overall Study||25
143391|NCT00353301|348351|P1|STARTED|Overall Study||25
143392|NCT00353366|348356|P1|NOT COMPLETED|Overall Study||143
143393|NCT00353366|348356|P1|COMPLETED|Overall Study||1289
143394|NCT00353366|348356|P1|STARTED|Overall Study||1432
143395|NCT00353418|348365|P2|NOT COMPLETED|Overall Study||158
143396|NCT00353418|348366|P1|NOT COMPLETED|Overall Study||83
143397|NCT00353418|348365|P2|COMPLETED|Overall Study||119
143398|NCT00353418|348366|P1|COMPLETED|Overall Study||55
143399|NCT00353418|348365|P2|STARTED|Overall Study||277
143400|NCT00353418|348366|P1|STARTED|Overall Study||138
143401|NCT00353431|348386|P2|NOT COMPLETED|Overall Study||0
143402|NCT00353431|348387|P1|NOT COMPLETED|Overall Study||0
143403|NCT00353431|348386|P2|COMPLETED|Overall Study||67
143404|NCT00353431|348387|P1|COMPLETED|Overall Study||63
143405|NCT00353431|348386|P2|STARTED|Overall Study||67
143406|NCT00353431|348387|P1|STARTED|Overall Study||63
143407|NCT00353496|348403|P2|NOT COMPLETED|Overall Study||17
143408|NCT00353496|348404|P1|NOT COMPLETED|Overall Study||16
143409|NCT00353496|348403|P2|COMPLETED|Overall Study||86
143410|NCT00353496|348404|P1|COMPLETED|Overall Study|Patients who completed specified assessments or met primary efficacy endpoint criteria for an event.|85
143411|NCT00353496|348403|P2|STARTED|Overall Study||103
143412|NCT00353496|348404|P1|STARTED|Overall Study||101
143413|NCT00353652|348425|P6|NOT COMPLETED|Overall Study||5
143414|NCT00353652|348426|P5|NOT COMPLETED|Overall Study||5
143415|NCT00353652|348427|P4|NOT COMPLETED|Overall Study||0
143416|NCT00353652|348428|P3|NOT COMPLETED|Overall Study||0
143417|NCT00353652|348429|P2|NOT COMPLETED|Overall Study||0
143418|NCT00353652|348430|P1|NOT COMPLETED|Overall Study||0
143419|NCT00353652|348425|P6|COMPLETED|Overall Study||18
143420|NCT00353652|348426|P5|COMPLETED|Overall Study||18
143421|NCT00353652|348427|P4|COMPLETED|Overall Study||7
143422|NCT00353652|348428|P3|COMPLETED|Overall Study||17
143423|NCT00353652|348429|P2|COMPLETED|Overall Study||17
143424|NCT00353652|348430|P1|COMPLETED|Overall Study||17
143425|NCT00353652|348425|P6|STARTED|Overall Study||23
143426|NCT00353652|348426|P5|STARTED|Overall Study||23
143427|NCT00353652|348427|P4|STARTED|Overall Study||7
143428|NCT00353652|348428|P3|STARTED|Overall Study||17
143429|NCT00353652|348429|P2|STARTED|Overall Study||17
143430|NCT00353652|348430|P1|STARTED|Overall Study||17
143431|NCT00353704|348446|P2|NOT COMPLETED|Overall Study||1
143432|NCT00353704|348447|P1|NOT COMPLETED|Overall Study||3
143433|NCT00353704|348446|P2|COMPLETED|Overall Study||24
143434|NCT00353704|348447|P1|COMPLETED|Overall Study||22
143435|NCT00353704|348446|P2|STARTED|Overall Study||25
143436|NCT00353704|348447|P1|STARTED|Overall Study||25
143437|NCT00353795|348455|P1|NOT COMPLETED|Overall Study||0
143438|NCT00353795|348455|P1|COMPLETED|Overall Study||179
143439|NCT00353795|348455|P1|STARTED|Overall Study||179
143440|NCT00353873|348461|P2|NOT COMPLETED|Overall Study||3
143441|NCT00353873|348462|P1|NOT COMPLETED|Overall Study||6
143442|NCT00353873|348461|P2|COMPLETED|Overall Study||147
143443|NCT00353873|348462|P1|COMPLETED|Overall Study||147
143444|NCT00353873|348461|P2|STARTED|Overall Study||150
143445|NCT00353873|348462|P1|STARTED|Overall Study||153
143446|NCT00353977|348474|P1|NOT COMPLETED|Overall Study||0
143447|NCT00353977|348474|P1|COMPLETED|Overall Study||38
143448|NCT00353977|348474|P1|STARTED|Overall Study||38
143449|NCT00354029|348480|P2|NOT COMPLETED|Overall Study||2
143450|NCT00354029|348481|P1|NOT COMPLETED|Overall Study||4
143451|NCT00354029|348480|P2|COMPLETED|Overall Study||38
143452|NCT00354029|348481|P1|COMPLETED|Overall Study||39
143453|NCT00354029|348480|P2|STARTED|Overall Study||40
143454|NCT00354029|348481|P1|STARTED|Overall Study||43
143455|NCT00354107|348487|P1|NOT COMPLETED|Overall Study||5
143456|NCT00354107|348487|P1|COMPLETED|Overall Study||0
143457|NCT00354107|348487|P1|STARTED|Overall Study||5
143458|NCT00354159|348493|P2|NOT COMPLETED|Long-term Follow-up||176
143459|NCT00354159|348494|P1|NOT COMPLETED|Long-term Follow-up||180
143460|NCT00354159|348493|P2|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
143461|NCT00354159|348494|P1|COMPLETED|Long-term Follow-up|All subjects were exited at the time of study closure|0
143462|NCT00354159|348493|P2|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|176
143463|NCT00354159|348494|P1|STARTED|Long-term Follow-up|Number entering post 12-month non-randomized long-term follow-up period|180
143464|NCT00354159|348493|P2|NOT COMPLETED|Randomized Study Period||22
143465|NCT00354159|348494|P1|NOT COMPLETED|Randomized Study Period||22
143466|NCT00354159|348493|P2|COMPLETED|Randomized Study Period||176
143467|NCT00354159|348494|P1|COMPLETED|Randomized Study Period||180
143468|NCT00354159|348493|P2|STARTED|Randomized Study Period||198
143469|NCT00354159|348494|P1|STARTED|Randomized Study Period||202
143470|NCT00354172|348537|P1|NOT COMPLETED|Overall Study||1
143471|NCT00354172|348537|P1|COMPLETED|Overall Study|1 patient did not reach umbilical cord blood transplant|15
143472|NCT00354172|348537|P1|STARTED|Overall Study||16
143473|NCT00354341|348557|P2|NOT COMPLETED|Overall Study||7
143474|NCT00354341|348558|P1|NOT COMPLETED|Overall Study||3
143475|NCT00354341|348557|P2|COMPLETED|Overall Study||75
143476|NCT00354341|348558|P1|COMPLETED|Overall Study||85
143477|NCT00354341|348557|P2|STARTED|Overall Study||82
143478|NCT00354341|348558|P1|STARTED|Overall Study||88
143479|NCT00354432|348578|P4|NOT COMPLETED|Overall Study||10
143480|NCT00354432|348579|P3|NOT COMPLETED|Overall Study||10
143481|NCT00354432|348580|P2|NOT COMPLETED|Overall Study||8
143482|NCT00354432|348581|P1|NOT COMPLETED|Overall Study||6
143483|NCT00354432|348578|P4|COMPLETED|Overall Study||20
143484|NCT00354432|348579|P3|COMPLETED|Overall Study||20
143485|NCT00354432|348580|P2|COMPLETED|Overall Study||22
143486|NCT00354432|348581|P1|COMPLETED|Overall Study||24
143487|NCT00354432|348578|P4|STARTED|Overall Study||30
143488|NCT00354432|348579|P3|STARTED|Overall Study||30
143489|NCT00354432|348580|P2|STARTED|Overall Study||30
143490|NCT00354432|348581|P1|STARTED|Overall Study||30
143491|NCT00354484|348597|P2|NOT COMPLETED|Overall Study||3
143492|NCT00354484|348598|P1|NOT COMPLETED|Overall Study||4
143493|NCT00354484|348597|P2|COMPLETED|Overall Study||144
143494|NCT00354484|348598|P1|COMPLETED|Overall Study||138
143495|NCT00354484|348597|P2|STARTED|Overall Study||147
143496|NCT00354484|348598|P1|STARTED|Overall Study||142
143497|NCT00354601|348604|P1|NOT COMPLETED|Overall Study||2
143498|NCT00354601|348604|P1|COMPLETED|Overall Study||0
143499|NCT00354601|348604|P1|STARTED|Overall Study||2
143500|NCT00354614|348611|P1|NOT COMPLETED|Overall Study||28
143501|NCT00354614|348611|P1|COMPLETED|Overall Study||53
143502|NCT00354614|348611|P1|STARTED|Overall Study||81
143503|NCT00354640|348615|P1|NOT COMPLETED|Overall Study||0
143504|NCT00354640|348615|P1|COMPLETED|Overall Study||11
143505|NCT00354640|348615|P1|STARTED|Overall Study||11
143506|NCT00354679|348620|P1|NOT COMPLETED|Overall Study||1
143507|NCT00354679|348620|P1|COMPLETED|Overall Study||33
143508|NCT00354679|348620|P1|STARTED|Overall Study||34
143509|NCT00348556|348624|P1|NOT COMPLETED|Overall Study||1
143510|NCT00348556|348624|P1|COMPLETED|Overall Study||3
143511|NCT00348556|348624|P1|STARTED|Overall Study||4
143512|NCT00348673|348637|P9|NOT COMPLETED|Stage 2||0
143513|NCT00348673|348638|P8|NOT COMPLETED|Stage 2||0
143514|NCT00348673|348639|P7|NOT COMPLETED|Stage 2||0
143515|NCT00348673|348640|P6|NOT COMPLETED|Stage 2||0
143516|NCT00348673|348641|P5|NOT COMPLETED|Stage 2||0
143517|NCT00348673|348642|P4|NOT COMPLETED|Stage 2||0
143518|NCT00348673|348643|P3|NOT COMPLETED|Stage 2||0
143519|NCT00348673|348644|P2|NOT COMPLETED|Stage 2||0
143520|NCT00348673|348645|P1|NOT COMPLETED|Stage 2||0
143521|NCT00348673|348637|P9|COMPLETED|Stage 2||2
143522|NCT00348673|348638|P8|COMPLETED|Stage 2||6
143523|NCT00348673|348639|P7|COMPLETED|Stage 2||6
143524|NCT00348673|348640|P6|COMPLETED|Stage 2||6
143525|NCT00348673|348641|P5|COMPLETED|Stage 2||0
143526|NCT00348673|348642|P4|COMPLETED|Stage 2||0
143527|NCT00348673|348643|P3|COMPLETED|Stage 2||0
143528|NCT00348673|348644|P2|COMPLETED|Stage 2||0
143529|NCT00348673|348645|P1|COMPLETED|Stage 2||0
143530|NCT00348673|348637|P9|STARTED|Stage 2||2
143531|NCT00348673|348638|P8|STARTED|Stage 2||6
143532|NCT00348673|348639|P7|STARTED|Stage 2||6
143533|NCT00348673|348640|P6|STARTED|Stage 2||6
143534|NCT00348673|348641|P5|STARTED|Stage 2||0
143535|NCT00348673|348642|P4|STARTED|Stage 2||0
143536|NCT00348673|348643|P3|STARTED|Stage 2||0
143537|NCT00348673|348644|P2|STARTED|Stage 2||0
143538|NCT00348673|348645|P1|STARTED|Stage 2||0
143539|NCT00348673|348637|P9|NOT COMPLETED|Stage 1||0
143540|NCT00348673|348638|P8|NOT COMPLETED|Stage 1||0
143541|NCT00348673|348639|P7|NOT COMPLETED|Stage 1||0
143542|NCT00348673|348640|P6|NOT COMPLETED|Stage 1||0
143543|NCT00348673|348641|P5|NOT COMPLETED|Stage 1||0
143544|NCT00348673|348642|P4|NOT COMPLETED|Stage 1||0
143545|NCT00348673|348643|P3|NOT COMPLETED|Stage 1||1
143546|NCT00348673|348644|P2|NOT COMPLETED|Stage 1||0
143547|NCT00348673|348645|P1|NOT COMPLETED|Stage 1||0
143548|NCT00348673|348637|P9|COMPLETED|Stage 1||0
143549|NCT00348673|348638|P8|COMPLETED|Stage 1||0
143550|NCT00348673|348639|P7|COMPLETED|Stage 1||0
143551|NCT00348673|348640|P6|COMPLETED|Stage 1||0
143552|NCT00348673|348641|P5|COMPLETED|Stage 1||4
143553|NCT00348673|348642|P4|COMPLETED|Stage 1||6
143554|NCT00348673|348643|P3|COMPLETED|Stage 1||6
143555|NCT00348673|348644|P2|COMPLETED|Stage 1||6
143556|NCT00348673|348645|P1|COMPLETED|Stage 1||6
143557|NCT00348673|348637|P9|Treated|Stage 1||0
143558|NCT00348673|348638|P8|Treated|Stage 1||0
143559|NCT00348673|348639|P7|Treated|Stage 1||0
143560|NCT00348673|348640|P6|Treated|Stage 1||0
143561|NCT00348673|348641|P5|Treated|Stage 1||4
143562|NCT00348673|348642|P4|Treated|Stage 1||6
143563|NCT00348673|348643|P3|Treated|Stage 1||6
143564|NCT00348673|348644|P2|Treated|Stage 1||6
143565|NCT00348673|348645|P1|Treated|Stage 1||6
143566|NCT00348673|348637|P9|STARTED|Stage 1||0
143567|NCT00348673|348638|P8|STARTED|Stage 1||0
143568|NCT00348673|348639|P7|STARTED|Stage 1||0
143569|NCT00348673|348640|P6|STARTED|Stage 1||0
143570|NCT00348673|348641|P5|STARTED|Stage 1||4
143571|NCT00348673|348642|P4|STARTED|Stage 1||6
143572|NCT00348673|348643|P3|STARTED|Stage 1||7
143573|NCT00348673|348644|P2|STARTED|Stage 1||6
143574|NCT00348673|348645|P1|STARTED|Stage 1||6
143575|NCT00348686|348692|P1|NOT COMPLETED|Overall Study||66
143576|NCT00348686|348692|P1|COMPLETED|Overall Study||249
143577|NCT00348686|348692|P1|STARTED|Overall Study||315
143578|NCT00348790|348701|P1|NOT COMPLETED|Completed Treatment||25
143579|NCT00348790|348701|P1|COMPLETED|Completed Treatment||0
143580|NCT00348790|348701|P1|STARTED|Completed Treatment||25
143581|NCT00348790|348701|P1|NOT COMPLETED|Began Treatment||0
143582|NCT00348790|348701|P1|COMPLETED|Began Treatment||25
143583|NCT00348790|348701|P1|STARTED|Began Treatment||25
143584|NCT00348816|348706|P1|NOT COMPLETED|Overall Study||1
143585|NCT00348816|348706|P1|COMPLETED|Overall Study||19
143586|NCT00348816|348706|P1|STARTED|Overall Study||20
143587|NCT00348881|348713|P2|NOT COMPLETED|Overall Study||12
143588|NCT00348881|348714|P1|NOT COMPLETED|Overall Study||17
143589|NCT00348881|348713|P2|COMPLETED|Overall Study||697
143590|NCT00348881|348714|P1|COMPLETED|Overall Study||1407
143591|NCT00348881|348713|P2|STARTED|Overall Study||709
143592|NCT00348881|348714|P1|STARTED|Overall Study||1424
143593|NCT00348933|348726|P1|NOT COMPLETED|Overall Study||25
143594|NCT00348933|348726|P1|COMPLETED|Overall Study||65
143595|NCT00348933|348726|P1|STARTED|Overall Study||90
143596|NCT00354744|348732|P1|NOT COMPLETED|Overall Study||42
143597|NCT00354744|348732|P1|COMPLETED|Overall Study||67
143598|NCT00354744|348732|P1|STARTED|Overall Study||109
143599|NCT00354770|348739|P2|NOT COMPLETED|Overall Study||3
143600|NCT00354770|348740|P1|NOT COMPLETED|Overall Study||3
143601|NCT00354770|348739|P2|COMPLETED|Overall Study||22
143602|NCT00354770|348740|P1|COMPLETED|Overall Study||22
143603|NCT00354770|348739|P2|STARTED|Overall Study||25
143604|NCT00354770|348740|P1|STARTED|Overall Study||25
143605|NCT00354835|348748|P2|NOT COMPLETED|Overall Study||61
143606|NCT00354835|348749|P1|NOT COMPLETED|Overall Study||52
143607|NCT00354835|348748|P2|COMPLETED|Overall Study||181
143608|NCT00354835|348749|P1|COMPLETED|Overall Study||187
143609|NCT00354835|348748|P2|STARTED|Overall Study||242
143610|NCT00354835|348749|P1|STARTED|Overall Study||239
143611|NCT00354887|348779|P1|NOT COMPLETED|Overall Study||1
143612|NCT00354887|348779|P1|COMPLETED|Overall Study||29
143613|NCT00354887|348779|P1|STARTED|Overall Study||30
143614|NCT00354913|348783|P1|NOT COMPLETED|Overall Study||0
143615|NCT00354913|348783|P1|COMPLETED|Overall Study||21
143616|NCT00354913|348783|P1|STARTED|Overall Study||21
143617|NCT00354978|348790|P1|NOT COMPLETED|Overall Study||0
143618|NCT00354978|348790|P1|COMPLETED|Overall Study||43
143619|NCT00354978|348790|P1|STARTED|Overall Study||43
143788|NCT00358449|349269|P1|COMPLETED|Overall Study||15
143620|NCT00355030|348796|P2|NOT COMPLETED|Study Period 2 Long Term Follow-Up||2
143621|NCT00355030|348797|P1|NOT COMPLETED|Study Period 2 Long Term Follow-Up||1
143622|NCT00355030|348796|P2|COMPLETED|Study Period 2 Long Term Follow-Up||17
143623|NCT00355030|348797|P1|COMPLETED|Study Period 2 Long Term Follow-Up||19
143624|NCT00355030|348796|P2|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|19
143625|NCT00355030|348797|P1|STARTED|Study Period 2 Long Term Follow-Up|Participants from France were given the option to re-consent for Study Period 2.|20
143626|NCT00355030|348796|P2|NOT COMPLETED|Study Period 1 Treatment||44
143627|NCT00355030|348797|P1|NOT COMPLETED|Study Period 1 Treatment||45
143628|NCT00355030|348796|P2|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
143629|NCT00355030|348797|P1|COMPLETED|Study Period 1 Treatment|Participants from the Netherlands exited the study after Study Period 1.|1
143630|NCT00355030|348796|P2|Received At Least One Dose of Study Drug|Study Period 1 Treatment|2 non-eligible participants received somatropin from previous control group|43
143631|NCT00355030|348797|P1|Received At Least One Dose of Study Drug|Study Period 1 Treatment|1 non-eligible participant received somatropin from previous control group|45
143632|NCT00355030|348796|P2|STARTED|Study Period 1 Treatment||45
143633|NCT00355030|348797|P1|STARTED|Study Period 1 Treatment||46
143634|NCT00357110|348821|P2|NOT COMPLETED|Overall Study||5
143635|NCT00357110|348822|P1|NOT COMPLETED|Overall Study||5
143636|NCT00357110|348821|P2|COMPLETED|Overall Study||2
143637|NCT00357110|348822|P1|COMPLETED|Overall Study||1
143638|NCT00357110|348821|P2|STARTED|Overall Study||7
143639|NCT00357110|348822|P1|STARTED|Overall Study||6
143640|NCT00357162|348828|P1|NOT COMPLETED|Overall Study||0
143641|NCT00357162|348828|P1|COMPLETED|Overall Study||21
143642|NCT00357162|348828|P1|STARTED|Overall Study||21
143643|NCT00357331|348838|P2|NOT COMPLETED|Overall Study||0
143644|NCT00357331|348839|P1|NOT COMPLETED|Overall Study||0
143645|NCT00357331|348838|P2|COMPLETED|Overall Study||41
143646|NCT00357331|348839|P1|COMPLETED|Overall Study||42
143647|NCT00357331|348838|P2|STARTED|Overall Study||41
143648|NCT00357331|348839|P1|STARTED|Overall Study||42
143649|NCT00357370|348852|P3|NOT COMPLETED|Cohort 2||2
143650|NCT00357370|348853|P2|NOT COMPLETED|Cohort 2||7
143651|NCT00357370|348854|P1|NOT COMPLETED|Cohort 2||2
143652|NCT00357370|348852|P3|COMPLETED|Cohort 2||22
143653|NCT00357370|348853|P2|COMPLETED|Cohort 2||16
143654|NCT00357370|348854|P1|COMPLETED|Cohort 2||22
143655|NCT00357370|348852|P3|STARTED|Cohort 2||24
143656|NCT00357370|348853|P2|STARTED|Cohort 2||23
143657|NCT00357370|348854|P1|STARTED|Cohort 2||24
143658|NCT00357370|348852|P3|NOT COMPLETED|Cohort 1||0
143659|NCT00357370|348853|P2|NOT COMPLETED|Cohort 1||0
143660|NCT00357370|348854|P1|NOT COMPLETED|Cohort 1||0
143661|NCT00357370|348852|P3|COMPLETED|Cohort 1||0
143662|NCT00357370|348853|P2|COMPLETED|Cohort 1||0
143663|NCT00357370|348854|P1|COMPLETED|Cohort 1||4
143664|NCT00357370|348852|P3|STARTED|Cohort 1||0
143665|NCT00357370|348853|P2|STARTED|Cohort 1||0
143666|NCT00357370|348854|P1|STARTED|Cohort 1||4
143667|NCT00357396|348879|P2|NOT COMPLETED|Overall Study||0
143668|NCT00357396|348880|P1|NOT COMPLETED|Overall Study||1
143669|NCT00357396|348879|P2|COMPLETED|Overall Study||4
143670|NCT00357396|348880|P1|COMPLETED|Overall Study||5
143671|NCT00357396|348879|P2|STARTED|Overall Study||4
143672|NCT00357396|348880|P1|STARTED|Overall Study||6
143673|NCT00357500|348885|P1|NOT COMPLETED|Overall Study||77
143674|NCT00357500|348885|P1|COMPLETED|Overall Study||24
143675|NCT00357500|348885|P1|Began Protocol Therapy|Overall Study|4 pts did not start treatment due either to removal of consent or inability to get insurance.|97
143676|NCT00357500|348885|P1|STARTED|Overall Study||101
143677|NCT00357552|348892|P1|NOT COMPLETED|Weeks 24 to 104||5
143678|NCT00357552|348892|P1|COMPLETED|Weeks 24 to 104||117
143679|NCT00357552|348892|P1|STARTED|Weeks 24 to 104||122
143680|NCT00357552|348892|P1|NOT COMPLETED|Weeks 0 to 24||1
143681|NCT00357552|348892|P1|COMPLETED|Weeks 0 to 24|One subject died prior to week 24.|122
143682|NCT00357552|348892|P1|STARTED|Weeks 0 to 24||123
143683|NCT00357552|348892|P1|NOT COMPLETED|Screening||84
143684|NCT00357552|348892|P1|COMPLETED|Screening|The number of participants who completed this period, is the number of participants who enrolled.|123
143685|NCT00357552|348892|P1|STARTED|Screening|The number of participants who started this period, is the number of participants who screened.|207
143686|NCT00357656|348909|P2|NOT COMPLETED|Overall Study||3
143687|NCT00357656|348910|P1|NOT COMPLETED|Overall Study||0
143688|NCT00357656|348909|P2|COMPLETED|Overall Study||29
143689|NCT00357656|348910|P1|COMPLETED|Overall Study||31
143690|NCT00357656|348909|P2|STARTED|Overall Study||32
143691|NCT00357656|348910|P1|STARTED|Overall Study||31
143692|NCT00357734|348961|P1|NOT COMPLETED|Overall Study||4
143693|NCT00357734|348961|P1|COMPLETED|Overall Study||10
143694|NCT00357734|348961|P1|Patient Received 500 mg of ZD1839|Overall Study||1
143695|NCT00357734|348961|P1|Patients Received 250 mg of ZD1839|Overall Study||13
143696|NCT00357734|348961|P1|STARTED|Overall Study||14
143697|NCT00357760|348972|P2|NOT COMPLETED|Overall Study||35
143698|NCT00357760|348973|P1|NOT COMPLETED|Overall Study||59
143699|NCT00357760|348972|P2|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
143700|NCT00357760|348973|P1|COMPLETED|Overall Study|Patients continued receiving protocol treatment until progressive disease or unacceptable toxicity.|0
143701|NCT00357760|348972|P2|Patients Who Undergo Dose Escalation|Overall Study||16
143702|NCT00357760|348973|P1|Patients Who Undergo Dose Escalation|Overall Study|Only patients who progressed on the low dose (Arm B) had the opportunity to undergo dose escalation.|0
143703|NCT00357760|348972|P2|Eligible and Treated Patients|Overall Study||32
143704|NCT00357760|348973|P1|Eligible and Treated Patients|Overall Study||57
143705|NCT00357760|348972|P2|Patients Who Started Treatment|Overall Study||34
143706|NCT00357760|348973|P1|Patients Who Started Treatment|Overall Study||57
143707|NCT00357760|348972|P2|STARTED|Overall Study||35
143708|NCT00357760|348973|P1|STARTED|Overall Study||59
143709|NCT00357877|348985|P2|NOT COMPLETED|Overall Study||30
143710|NCT00357877|348986|P1|NOT COMPLETED|Overall Study||26
143711|NCT00357877|348985|P2|COMPLETED|Overall Study||460
143712|NCT00357877|348986|P1|COMPLETED|Overall Study||467
143713|NCT00357877|348985|P2|STARTED|Overall Study||490
143714|NCT00357877|348986|P1|STARTED|Overall Study||493
143715|NCT00357903|349000|P2|NOT COMPLETED|Overall Study||43
143716|NCT00357903|349001|P1|NOT COMPLETED|Overall Study||363
143717|NCT00357903|349000|P2|COMPLETED|Overall Study||15
143718|NCT00357903|349001|P1|COMPLETED|Overall Study||218
143719|NCT00357903|349000|P2|STARTED|Overall Study||58
143720|NCT00357903|349001|P1|STARTED|Overall Study||581
143721|NCT00357955|349041|P2|NOT COMPLETED|Overall Study||3
143722|NCT00357955|349042|P1|NOT COMPLETED|Overall Study||6
143723|NCT00357955|349041|P2|COMPLETED|Overall Study||51
143724|NCT00357955|349042|P1|COMPLETED|Overall Study||58
143725|NCT00357955|349041|P2|STARTED|Overall Study||54
143726|NCT00357955|349042|P1|STARTED|Overall Study||64
143727|NCT00357968|349050|P2|NOT COMPLETED|Crossover Maintenance Dose Phase||0
143728|NCT00357968|349051|P1|NOT COMPLETED|Crossover Maintenance Dose Phase||0
143729|NCT00357968|349050|P2|COMPLETED|Crossover Maintenance Dose Phase||55
143730|NCT00357968|349051|P1|COMPLETED|Crossover Maintenance Dose Phase||54
143731|NCT00357968|349050|P2|STARTED|Crossover Maintenance Dose Phase||55
143732|NCT00357968|349051|P1|STARTED|Crossover Maintenance Dose Phase|1 subject discontinued study drug-did not take clopidogrel during the 2nd phase but completed study|54
143733|NCT00357968|349050|P2|NOT COMPLETED|First Maintenance Dose Phase||44
143734|NCT00357968|349051|P1|NOT COMPLETED|First Maintenance Dose Phase||48
143735|NCT00357968|349050|P2|COMPLETED|First Maintenance Dose Phase||55
143736|NCT00357968|349051|P1|COMPLETED|First Maintenance Dose Phase||54
143737|NCT00357968|349050|P2|Started Maintenance Dose|First Maintenance Dose Phase||55
143738|NCT00357968|349051|P1|Started Maintenance Dose|First Maintenance Dose Phase||55
143739|NCT00357968|349050|P2|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||57
143740|NCT00357968|349051|P1|Percutaneous Coronary Intervention (PCI)|First Maintenance Dose Phase||55
143741|NCT00357968|349050|P2|Received Loading Dose|First Maintenance Dose Phase||99
143742|NCT00357968|349051|P1|Received Loading Dose|First Maintenance Dose Phase||102
143743|NCT00357968|349050|P2|STARTED|First Maintenance Dose Phase||99
143744|NCT00357968|349051|P1|STARTED|First Maintenance Dose Phase||102
143745|NCT00357994|349095|P2|NOT COMPLETED|Overall Study||3
143746|NCT00357994|349096|P1|NOT COMPLETED|Overall Study||2
143747|NCT00357994|349095|P2|COMPLETED|Overall Study||31
143748|NCT00357994|349096|P1|COMPLETED|Overall Study||35
143749|NCT00357994|349095|P2|STARTED|Overall Study||34
143750|NCT00357994|349096|P1|STARTED|Overall Study||37
143751|NCT00358007|349148|P1|NOT COMPLETED|Overall Study||2
143752|NCT00358007|349148|P1|COMPLETED|Overall Study||28
143753|NCT00358007|349148|P1|STARTED|Overall Study||30
143754|NCT00358150|349153|P1|NOT COMPLETED|Overall Study||7
143755|NCT00358150|349153|P1|COMPLETED|Overall Study||19
143756|NCT00358150|349153|P1|STARTED|Overall Study||26
143757|NCT00358215|349177|P2|NOT COMPLETED|Overall Study||652
143758|NCT00358215|349178|P1|NOT COMPLETED|Overall Study||679
143759|NCT00358215|349177|P2|COMPLETED|Overall Study|Participants who completed investigational product|484
143760|NCT00358215|349178|P1|COMPLETED|Overall Study|Participants who completed investigational product|463
143761|NCT00358215|349177|P2|Received Investigational Product|Overall Study||1133
143762|NCT00358215|349178|P1|Received Investigational Product|Overall Study||1140
143763|NCT00358215|349177|P2|STARTED|Overall Study||1136
143764|NCT00358215|349178|P1|STARTED|Overall Study||1142
143765|NCT00358332|349196|P4|NOT COMPLETED|Overall Study||0
143766|NCT00358332|349197|P3|NOT COMPLETED|Overall Study||1
143767|NCT00358332|349198|P2|NOT COMPLETED|Overall Study||3
143768|NCT00358332|349199|P1|NOT COMPLETED|Overall Study||0
143769|NCT00358332|349196|P4|COMPLETED|Overall Study||25
143770|NCT00358332|349197|P3|COMPLETED|Overall Study||29
143771|NCT00358332|349198|P2|COMPLETED|Overall Study||27
143772|NCT00358332|349199|P1|COMPLETED|Overall Study||15
143773|NCT00358332|349196|P4|STARTED|Overall Study||25
143774|NCT00358332|349197|P3|STARTED|Overall Study||30
143775|NCT00358332|349198|P2|STARTED|Overall Study||30
143776|NCT00358332|349199|P1|STARTED|Overall Study||15
143777|NCT00358436|349251|P2|NOT COMPLETED|Overall Study||86
143778|NCT00358436|349252|P1|NOT COMPLETED|Overall Study||154
143779|NCT00358436|349251|P2|COMPLETED|Overall Study||118
143780|NCT00358436|349252|P1|COMPLETED|Overall Study||446
143781|NCT00358436|349251|P2|STARTED|Overall Study||204
143782|NCT00358436|349252|P1|STARTED|Overall Study||600
143783|NCT00358449|349267|P3|NOT COMPLETED|Overall Study||2
143784|NCT00358449|349268|P2|NOT COMPLETED|Overall Study||1
143785|NCT00358449|349269|P1|NOT COMPLETED|Overall Study||4
143786|NCT00358449|349267|P3|COMPLETED|Overall Study||18
143787|NCT00358449|349268|P2|COMPLETED|Overall Study||19
143789|NCT00358449|349267|P3|STARTED|Overall Study||20
143790|NCT00358449|349268|P2|STARTED|Overall Study||20
143791|NCT00358449|349269|P1|STARTED|Overall Study||19
143792|NCT00358462|349372|P2|NOT COMPLETED|Overall Study||64
143793|NCT00358462|349373|P1|NOT COMPLETED|Overall Study||59
143794|NCT00358462|349372|P2|COMPLETED|Overall Study||238
143795|NCT00358462|349373|P1|COMPLETED|Overall Study||245
143796|NCT00358462|349372|P2|STARTED|Overall Study||302
143797|NCT00358462|349373|P1|STARTED|Overall Study||304
143798|NCT00358501|349383|P2|NOT COMPLETED|Overall Study||0
143799|NCT00358501|349384|P1|NOT COMPLETED|Overall Study||0
143800|NCT00358501|349383|P2|COMPLETED|Overall Study||32
143801|NCT00358501|349384|P1|COMPLETED|Overall Study||102
143802|NCT00358501|349383|P2|STARTED|Overall Study||32
143803|NCT00358501|349384|P1|STARTED|Overall Study||102
143804|NCT00358527|349399|P2|NOT COMPLETED|Overall Study||3
143805|NCT00358527|349400|P1|NOT COMPLETED|Overall Study||13
143806|NCT00358527|349399|P2|COMPLETED|Overall Study||131
143807|NCT00358527|349400|P1|COMPLETED|Overall Study||254
143808|NCT00358527|349399|P2|STARTED|Overall Study||134
143809|NCT00358527|349400|P1|STARTED|Overall Study||267
143810|NCT00358579|349410|P2|NOT COMPLETED|Overall Study||0
143811|NCT00358579|349411|P1|NOT COMPLETED|Overall Study||0
143812|NCT00358579|349410|P2|COMPLETED|Overall Study||374
143813|NCT00358579|349411|P1|COMPLETED|Overall Study||353
143814|NCT00358579|349410|P2|STARTED|Overall Study||374
143815|NCT00358579|349411|P1|STARTED|Overall Study||353
143816|NCT00358644|349425|P1|NOT COMPLETED|Overall Study||50
143817|NCT00358644|349425|P1|COMPLETED|Overall Study||5
143818|NCT00358644|349425|P1|STARTED|Overall Study||55
143819|NCT00358670|349431|P2|NOT COMPLETED|Overall Study||219
143820|NCT00358670|349432|P1|NOT COMPLETED|Overall Study||222
143821|NCT00358670|349431|P2|COMPLETED|Overall Study||0
143822|NCT00358670|349432|P1|COMPLETED|Overall Study||0
143823|NCT00358670|349431|P2|STARTED|Overall Study||219
143824|NCT00358670|349432|P1|STARTED|Overall Study||222
143825|NCT00358735|349448|P2|NOT COMPLETED|Overall Study||17
143826|NCT00358735|349449|P1|NOT COMPLETED|Overall Study||8
143827|NCT00358735|349448|P2|COMPLETED|Overall Study|Efficacy|190
143828|NCT00358735|349449|P1|COMPLETED|Overall Study|Efficacy|196
143829|NCT00358735|349448|P2|Not Completed Safety|Overall Study||13
143830|NCT00358735|349449|P1|Not Completed Safety|Overall Study||6
143831|NCT00358735|349448|P2|Completed Safety|Overall Study||194
143832|NCT00358735|349449|P1|Completed Safety|Overall Study||198
143833|NCT00358735|349448|P2|STARTED|Overall Study||207
143834|NCT00358735|349449|P1|STARTED|Overall Study||204
143835|NCT00358826|349481|P8|NOT COMPLETED|MDCT Substudy||0
143836|NCT00358826|349482|P7|NOT COMPLETED|MDCT Substudy||0
143837|NCT00358826|349483|P6|NOT COMPLETED|MDCT Substudy||2
143838|NCT00358826|349484|P5|NOT COMPLETED|MDCT Substudy||1
143839|NCT00358826|349485|P4|NOT COMPLETED|MDCT Substudy||0
143840|NCT00358826|349486|P3|NOT COMPLETED|MDCT Substudy||0
143841|NCT00358826|349487|P2|NOT COMPLETED|MDCT Substudy||0
143842|NCT00358826|349488|P1|NOT COMPLETED|MDCT Substudy||0
143843|NCT00358826|349481|P8|COMPLETED|MDCT Substudy||27
143844|NCT00358826|349482|P7|COMPLETED|MDCT Substudy||19
143845|NCT00358826|349483|P6|COMPLETED|MDCT Substudy||20
143846|NCT00358826|349484|P5|COMPLETED|MDCT Substudy||24
143847|NCT00358826|349485|P4|COMPLETED|MDCT Substudy||0
143848|NCT00358826|349486|P3|COMPLETED|MDCT Substudy||0
143849|NCT00358826|349487|P2|COMPLETED|MDCT Substudy||0
143850|NCT00358826|349488|P1|COMPLETED|MDCT Substudy||0
143851|NCT00358826|349481|P8|STARTED|MDCT Substudy||27
143852|NCT00358826|349482|P7|STARTED|MDCT Substudy||19
143853|NCT00358826|349483|P6|STARTED|MDCT Substudy||22
143854|NCT00358826|349484|P5|STARTED|MDCT Substudy||25
143855|NCT00358826|349485|P4|STARTED|MDCT Substudy||0
143856|NCT00358826|349486|P3|STARTED|MDCT Substudy||0
143857|NCT00358826|349487|P2|STARTED|MDCT Substudy||0
143858|NCT00358826|349488|P1|STARTED|MDCT Substudy||0
143859|NCT00358826|349481|P8|NOT COMPLETED|Core Study||0
143860|NCT00358826|349482|P7|NOT COMPLETED|Core Study||0
143861|NCT00358826|349483|P6|NOT COMPLETED|Core Study||0
143862|NCT00358826|349484|P5|NOT COMPLETED|Core Study||0
143863|NCT00358826|349485|P4|NOT COMPLETED|Core Study||2
143864|NCT00358826|349486|P3|NOT COMPLETED|Core Study||2
143865|NCT00358826|349487|P2|NOT COMPLETED|Core Study||5
143866|NCT00358826|349488|P1|NOT COMPLETED|Core Study||3
143867|NCT00358826|349481|P8|COMPLETED|Core Study||0
143868|NCT00358826|349482|P7|COMPLETED|Core Study||0
143869|NCT00358826|349483|P6|COMPLETED|Core Study||0
143870|NCT00358826|349484|P5|COMPLETED|Core Study||0
143871|NCT00358826|349485|P4|COMPLETED|Core Study||50
143872|NCT00358826|349486|P3|COMPLETED|Core Study||42
143873|NCT00358826|349487|P2|COMPLETED|Core Study||41
143874|NCT00358826|349488|P1|COMPLETED|Core Study||46
143875|NCT00358826|349481|P8|STARTED|Core Study||0
143876|NCT00358826|349482|P7|STARTED|Core Study||0
143877|NCT00358826|349483|P6|STARTED|Core Study||0
143878|NCT00358826|349484|P5|STARTED|Core Study||0
143879|NCT00358826|349485|P4|STARTED|Core Study||52
143880|NCT00358826|349486|P3|STARTED|Core Study||44
143881|NCT00358826|349487|P2|STARTED|Core Study||46
143882|NCT00358826|349488|P1|STARTED|Core Study||49
143883|NCT00358917|349524|P2|NOT COMPLETED|Overall Study||69
143884|NCT00358917|349525|P1|NOT COMPLETED|Overall Study||66
143885|NCT00358917|349524|P2|COMPLETED|Overall Study||230
143886|NCT00358917|349525|P1|COMPLETED|Overall Study||234
143887|NCT00358917|349524|P2|STARTED|Overall Study||299
143888|NCT00358917|349525|P1|STARTED|Overall Study||300
143889|NCT00358956|349539|P1|NOT COMPLETED|Overall Study||8
143890|NCT00358956|349539|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|11
143891|NCT00358956|349539|P1|STARTED|Overall Study||19
143892|NCT00359021|349551|P2|NOT COMPLETED|Overall Study||52
143893|NCT00359021|349552|P1|NOT COMPLETED|Overall Study||81
143894|NCT00359021|349551|P2|COMPLETED|Overall Study||195
143895|NCT00359021|349552|P1|COMPLETED|Overall Study||175
143896|NCT00359021|349551|P2|STARTED|Overall Study||247
143897|NCT00359021|349552|P1|STARTED|Overall Study||256
143898|NCT00359138|349567|P3|NOT COMPLETED|Overall Study||0
143899|NCT00359138|349568|P2|NOT COMPLETED|Overall Study||0
143900|NCT00359138|349569|P1|NOT COMPLETED|Overall Study||0
143901|NCT00359138|349567|P3|COMPLETED|Overall Study||12
143902|NCT00359138|349568|P2|COMPLETED|Overall Study||12
143903|NCT00359138|349569|P1|COMPLETED|Overall Study||12
143904|NCT00359138|349567|P3|STARTED|Overall Study||12
143905|NCT00359138|349568|P2|STARTED|Overall Study||12
143906|NCT00359138|349569|P1|STARTED|Overall Study||12
143907|NCT00359203|349579|P2|NOT COMPLETED|Overall Study||0
143908|NCT00359203|349580|P1|NOT COMPLETED|Overall Study||0
143909|NCT00359203|349579|P2|COMPLETED|Overall Study||38
143910|NCT00359203|349580|P1|COMPLETED|Overall Study||39
143911|NCT00359203|349579|P2|STARTED|Overall Study||38
143912|NCT00359203|349580|P1|STARTED|Overall Study||39
143913|NCT00359216|349588|P2|NOT COMPLETED|Overall Study||1
143914|NCT00359216|349589|P1|NOT COMPLETED|Overall Study||0
143915|NCT00359216|349588|P2|COMPLETED|Overall Study|Completed treatment but simultaneously partaking in other study,final study procedures not performed|9
143916|NCT00359216|349589|P1|COMPLETED|Overall Study||20
143917|NCT00359216|349588|P2|STARTED|Overall Study||10
143918|NCT00359216|349589|P1|STARTED|Overall Study||20
143919|NCT00359281|349604|P9|NOT COMPLETED|Overall Study||0
143920|NCT00359281|349605|P8|NOT COMPLETED|Overall Study||0
143921|NCT00359281|349606|P7|NOT COMPLETED|Overall Study||2
143922|NCT00359281|349607|P6|NOT COMPLETED|Overall Study||0
143923|NCT00359281|349608|P5|NOT COMPLETED|Overall Study||0
143924|NCT00359281|349609|P4|NOT COMPLETED|Overall Study||0
143925|NCT00359281|349610|P3|NOT COMPLETED|Overall Study||0
143926|NCT00359281|349611|P2|NOT COMPLETED|Overall Study||0
143927|NCT00359281|349612|P1|NOT COMPLETED|Overall Study||1
143928|NCT00359281|349604|P9|COMPLETED|Overall Study||20
143929|NCT00359281|349605|P8|COMPLETED|Overall Study||15
143930|NCT00359281|349606|P7|COMPLETED|Overall Study||16
143931|NCT00359281|349607|P6|COMPLETED|Overall Study||15
143932|NCT00359281|349608|P5|COMPLETED|Overall Study||10
143933|NCT00359281|349609|P4|COMPLETED|Overall Study||10
143934|NCT00359281|349610|P3|COMPLETED|Overall Study||10
143935|NCT00359281|349611|P2|COMPLETED|Overall Study||15
143936|NCT00359281|349612|P1|COMPLETED|Overall Study||15
143937|NCT00359281|349604|P9|STARTED|Overall Study||20
143938|NCT00359281|349605|P8|STARTED|Overall Study||15
143939|NCT00359281|349606|P7|STARTED|Overall Study||18
143940|NCT00359281|349607|P6|STARTED|Overall Study||15
143941|NCT00359281|349608|P5|STARTED|Overall Study||10
143942|NCT00359281|349609|P4|STARTED|Overall Study||10
143943|NCT00359281|349610|P3|STARTED|Overall Study||10
143944|NCT00359281|349611|P2|STARTED|Overall Study||15
143945|NCT00359281|349612|P1|STARTED|Overall Study||16
143946|NCT00359424|349644|P2|NOT COMPLETED|Overall Study||67
143947|NCT00359424|349645|P1|NOT COMPLETED|Overall Study||130
143948|NCT00359424|349644|P2|COMPLETED|Overall Study||155
143949|NCT00359424|349645|P1|COMPLETED|Overall Study||304
143950|NCT00359424|349644|P2|270 Day Follow up|Overall Study||159
143951|NCT00359424|349645|P1|270 Day Follow up|Overall Study||313
143952|NCT00359424|349644|P2|180 Day Follow up|Overall Study||167
143953|NCT00359424|349645|P1|180 Day Follow up|Overall Study||325
143954|NCT00359424|349644|P2|90 Day Follow up|Overall Study||172
143955|NCT00359424|349645|P1|90 Day Follow up|Overall Study||343
143956|NCT00359424|349644|P2|STARTED|Overall Study||222
143957|NCT00359424|349645|P1|STARTED|Overall Study||434
143958|NCT00351936|349675|P1|NOT COMPLETED|Overall Study||0
143959|NCT00351936|349675|P1|COMPLETED|Overall Study||15
143960|NCT00351936|349675|P1|STARTED|Overall Study||15
143961|NCT00352027|349692|P1|NOT COMPLETED|Overall Study||3
143962|NCT00352027|349692|P1|COMPLETED|Overall Study||77
143963|NCT00352027|349692|P1|STARTED|Overall Study||80
143964|NCT00352053|349963|P2|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||2
143965|NCT00352053|349964|P1|NOT COMPLETED|Third Extension Phase (Weeks 240-294)||1
143966|NCT00352053|349963|P2|COMPLETED|Third Extension Phase (Weeks 240-294)||2
143967|NCT00352053|349964|P1|COMPLETED|Third Extension Phase (Weeks 240-294)||0
143968|NCT00352053|349963|P2|STARTED|Third Extension Phase (Weeks 240-294)|5 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|4
143969|NCT00352053|349964|P1|STARTED|Third Extension Phase (Weeks 240-294)|3 participants completed the 2nd extension phase but did not enroll in the 3rd extension phase.|1
143970|NCT00352053|349963|P2|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
143971|NCT00352053|349964|P1|NOT COMPLETED|Second Extension Phase (Weeks 144-240)||5
143972|NCT00352053|349963|P2|COMPLETED|Second Extension Phase (Weeks 144-240)||9
143973|NCT00352053|349964|P1|COMPLETED|Second Extension Phase (Weeks 144-240)||4
144060|NCT00359762|350317|P2|Extension ITT Safety Population|Period III||74
143974|NCT00352053|349963|P2|STARTED|Second Extension Phase (Weeks 144-240)|5 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|14
143975|NCT00352053|349964|P1|STARTED|Second Extension Phase (Weeks 144-240)|3 participants completed the 1st extension phase but did not enroll in the 2nd extension phase.|9
143976|NCT00352053|349963|P2|NOT COMPLETED|First Extension Phase (Weeks 48-144)||17
143977|NCT00352053|349964|P1|NOT COMPLETED|First Extension Phase (Weeks 48-144)||12
143978|NCT00352053|349963|P2|COMPLETED|First Extension Phase (Weeks 48-144)||19
143979|NCT00352053|349964|P1|COMPLETED|First Extension Phase (Weeks 48-144)||12
143980|NCT00352053|349963|P2|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|36
143981|NCT00352053|349964|P1|STARTED|First Extension Phase (Weeks 48-144)|3 participants completed the double-blind phase but did not enroll in the 1st extension phase.|24
143982|NCT00352053|349963|P2|NOT COMPLETED|Double-Blind Phase (Through Week 48)||13
143983|NCT00352053|349964|P1|NOT COMPLETED|Double-Blind Phase (Through Week 48)||18
143984|NCT00352053|349963|P2|COMPLETED|Double-Blind Phase (Through Week 48)|The 10 participants discontinued for virologic failure enrolled early in the open-label extension.|29
143985|NCT00352053|349964|P1|COMPLETED|Double-Blind Phase (Through Week 48)||27
143986|NCT00352053|349963|P2|STARTED|Double-Blind Phase (Through Week 48)||42
143987|NCT00352053|349964|P1|STARTED|Double-Blind Phase (Through Week 48)||45
143988|NCT00352105|350131|P1|NOT COMPLETED|Overall Study||40
143989|NCT00352105|350131|P1|COMPLETED|Overall Study||20
143990|NCT00352105|350131|P1|STARTED|Overall Study||60
143991|NCT00352118|350140|P1|NOT COMPLETED|Overall Study||4
143992|NCT00352118|350140|P1|COMPLETED|Overall Study||0
143993|NCT00352118|350140|P1|STARTED|Overall Study||4
143994|NCT00359619|350157|P7|NOT COMPLETED|Overall Study||4
143995|NCT00359619|350158|P6|NOT COMPLETED|Overall Study||5
143996|NCT00359619|350159|P5|NOT COMPLETED|Overall Study||3
143997|NCT00359619|350160|P4|NOT COMPLETED|Overall Study||3
143998|NCT00359619|350161|P3|NOT COMPLETED|Overall Study||7
143999|NCT00359619|350162|P2|NOT COMPLETED|Overall Study||5
144000|NCT00359619|350163|P1|NOT COMPLETED|Overall Study||8
144001|NCT00359619|350157|P7|COMPLETED|Overall Study||46
144002|NCT00359619|350158|P6|COMPLETED|Overall Study||45
144003|NCT00359619|350159|P5|COMPLETED|Overall Study||45
144004|NCT00359619|350160|P4|COMPLETED|Overall Study||45
144005|NCT00359619|350161|P3|COMPLETED|Overall Study||42
144006|NCT00359619|350162|P2|COMPLETED|Overall Study||45
144007|NCT00359619|350163|P1|COMPLETED|Overall Study||80
144008|NCT00359619|350157|P7|STARTED|Overall Study||50
144009|NCT00359619|350158|P6|STARTED|Overall Study||50
144010|NCT00359619|350159|P5|STARTED|Overall Study||48
144011|NCT00359619|350160|P4|STARTED|Overall Study||48
144012|NCT00359619|350161|P3|STARTED|Overall Study||49
144013|NCT00359619|350162|P2|STARTED|Overall Study||50
144014|NCT00359619|350163|P1|STARTED|Overall Study||88
144015|NCT00359632|350293|P2|NOT COMPLETED|Overall Study||0
144016|NCT00359632|350294|P1|NOT COMPLETED|Overall Study||4
144017|NCT00359632|350293|P2|COMPLETED|Overall Study||9
144018|NCT00359632|350294|P1|COMPLETED|Overall Study||20
144019|NCT00359632|350293|P2|STARTED|Overall Study||9
144020|NCT00359632|350294|P1|STARTED|Overall Study||24
144021|NCT00359736|350303|P2|NOT COMPLETED|Overall Study||0
144022|NCT00359736|350304|P1|NOT COMPLETED|Overall Study||0
144023|NCT00359736|350303|P2|COMPLETED|Overall Study||15
144024|NCT00359736|350304|P1|COMPLETED|Overall Study||14
144025|NCT00359736|350303|P2|STARTED|Overall Study||15
144026|NCT00359736|350304|P1|STARTED|Overall Study||14
144027|NCT00359762|350314|P5|NOT COMPLETED|Period I||0
144028|NCT00359762|350315|P4|NOT COMPLETED|Period I||0
144029|NCT00359762|350316|P3|NOT COMPLETED|Period I||0
144030|NCT00359762|350317|P2|NOT COMPLETED|Period I||0
144031|NCT00359762|350318|P1|NOT COMPLETED|Period I||0
144032|NCT00359762|350314|P5|COMPLETED|Period I||0
144033|NCT00359762|350315|P4|COMPLETED|Period I||0
144034|NCT00359762|350316|P3|COMPLETED|Period I||0
144035|NCT00359762|350317|P2|COMPLETED|Period I||0
144036|NCT00359762|350318|P1|COMPLETED|Period I||0
144037|NCT00359762|350314|P5|STARTED|Period I||0
144038|NCT00359762|350315|P4|STARTED|Period I||0
144039|NCT00359762|350316|P3|STARTED|Period I||0
144040|NCT00359762|350317|P2|STARTED|Period I||0
144041|NCT00359762|350318|P1|STARTED|Period I||0
144042|NCT00359762|350314|P5|NOT COMPLETED|Period III||0
144043|NCT00359762|350315|P4|NOT COMPLETED|Period III||65
144044|NCT00359762|350316|P3|NOT COMPLETED|Period III||30
144045|NCT00359762|350317|P2|NOT COMPLETED|Period III||29
144046|NCT00359762|350318|P1|NOT COMPLETED|Period III||0
144047|NCT00359762|350314|P5|COMPLETED|Period III||0
144048|NCT00359762|350315|P4|COMPLETED|Period III||101
144049|NCT00359762|350316|P3|COMPLETED|Period III||47
144050|NCT00359762|350317|P2|COMPLETED|Period III||48
144051|NCT00359762|350318|P1|COMPLETED|Period III||0
144052|NCT00359762|350314|P5|Extension ITT Efficacy Population|Period III||0
144053|NCT00359762|350315|P4|Extension ITT Efficacy Population|Period III||164
144054|NCT00359762|350316|P3|Extension ITT Efficacy Population|Period III||75
144055|NCT00359762|350317|P2|Extension ITT Efficacy Population|Period III||73
144056|NCT00359762|350318|P1|Extension ITT Efficacy Population|Period III||0
144057|NCT00359762|350314|P5|Extension ITT Safety Population|Period III||0
144058|NCT00359762|350315|P4|Extension ITT Safety Population|Period III||166
144059|NCT00359762|350316|P3|Extension ITT Safety Population|Period III||76
144061|NCT00359762|350318|P1|Extension ITT Safety Population|Period III||0
144062|NCT00359762|350314|P5|STARTED|Period III||0
144063|NCT00359762|350315|P4|STARTED|Period III||166
144064|NCT00359762|350316|P3|STARTED|Period III||77
144065|NCT00359762|350317|P2|STARTED|Period III||77
144066|NCT00359762|350318|P1|STARTED|Period III||0
144067|NCT00359762|350314|P5|NOT COMPLETED|Period II||174
144068|NCT00359762|350315|P4|NOT COMPLETED|Period II||0
144069|NCT00359762|350316|P3|NOT COMPLETED|Period II||0
144070|NCT00359762|350317|P2|NOT COMPLETED|Period II||0
144071|NCT00359762|350318|P1|NOT COMPLETED|Period II||128
144072|NCT00359762|350314|P5|COMPLETED|Period II||341
144073|NCT00359762|350315|P4|COMPLETED|Period II||0
144074|NCT00359762|350316|P3|COMPLETED|Period II||0
144075|NCT00359762|350317|P2|COMPLETED|Period II||0
144076|NCT00359762|350318|P1|COMPLETED|Period II||386
144077|NCT00359762|350314|P5|Without Treatment Failure|Period II||138
144078|NCT00359762|350315|P4|Without Treatment Failure|Period II||0
144079|NCT00359762|350316|P3|Without Treatment Failure|Period II||0
144080|NCT00359762|350317|P2|Without Treatment Failure|Period II||0
144081|NCT00359762|350318|P1|Without Treatment Failure|Period II||124
144082|NCT00359762|350314|P5|Met Primary Endpoint|Period II||203
144083|NCT00359762|350315|P4|Met Primary Endpoint|Period II||0
144084|NCT00359762|350316|P3|Met Primary Endpoint|Period II||0
144085|NCT00359762|350317|P2|Met Primary Endpoint|Period II||0
144086|NCT00359762|350318|P1|Met Primary Endpoint|Period II||262
144087|NCT00359762|350314|P5|ITT Efficacy Population|Period II||490
144088|NCT00359762|350315|P4|ITT Efficacy Population|Period II||0
144089|NCT00359762|350316|P3|ITT Efficacy Population|Period II||0
144090|NCT00359762|350317|P2|ITT Efficacy Population|Period II||0
144091|NCT00359762|350318|P1|ITT Efficacy Population|Period II||487
144092|NCT00359762|350314|P5|Intent to Treat (ITT) Safety Population|Period II||511
144093|NCT00359762|350315|P4|Intent to Treat (ITT) Safety Population|Period II||0
144094|NCT00359762|350316|P3|Intent to Treat (ITT) Safety Population|Period II||0
144095|NCT00359762|350317|P2|Intent to Treat (ITT) Safety Population|Period II||0
144096|NCT00359762|350318|P1|Intent to Treat (ITT) Safety Population|Period II||508
144097|NCT00359762|350314|P5|STARTED|Period II||515
144098|NCT00359762|350315|P4|STARTED|Period II||0
144099|NCT00359762|350316|P3|STARTED|Period II||0
144100|NCT00359762|350317|P2|STARTED|Period II||0
144101|NCT00359762|350318|P1|STARTED|Period II||514
144102|NCT00359788|350381|P2|NOT COMPLETED|Overall Study||17
144103|NCT00359788|350382|P1|NOT COMPLETED|Overall Study||23
144104|NCT00359788|350381|P2|COMPLETED|Overall Study||159
144105|NCT00359788|350382|P1|COMPLETED|Overall Study||150
144106|NCT00359788|350381|P2|STARTED|Overall Study||176
144107|NCT00359788|350382|P1|STARTED|Overall Study||173
144108|NCT00359801|350616|P2|NOT COMPLETED|Overall Study||220
144109|NCT00359801|350617|P1|NOT COMPLETED|Overall Study||305
144110|NCT00359801|350616|P2|COMPLETED|Overall Study|4 additional subjects had missing data and final status (completed/discontinued) is unknown.|769
144111|NCT00359801|350617|P1|COMPLETED|Overall Study|7 additional subjects had missing data and final status (completed/discontinued) is unknown.|682
144112|NCT00359801|350616|P2|STARTED|Overall Study||989
144113|NCT00359801|350617|P1|STARTED|Overall Study||987
144114|NCT00359944|350652|P3|NOT COMPLETED|Overall Study||19
144115|NCT00359944|350653|P2|NOT COMPLETED|Overall Study||19
144116|NCT00359944|350654|P1|NOT COMPLETED|Overall Study||16
144117|NCT00359944|350652|P3|COMPLETED|Overall Study||38
144118|NCT00359944|350653|P2|COMPLETED|Overall Study||28
144119|NCT00359944|350654|P1|COMPLETED|Overall Study||34
144120|NCT00359944|350652|P3|STARTED|Overall Study||57
144121|NCT00359944|350653|P2|STARTED|Overall Study||47
144122|NCT00359944|350654|P1|STARTED|Overall Study||50
144123|NCT00361972|350670|P2|NOT COMPLETED|Overall Study||0
144124|NCT00361972|350671|P1|NOT COMPLETED|Overall Study||0
144125|NCT00361972|350670|P2|COMPLETED|Overall Study||9
144126|NCT00361972|350671|P1|COMPLETED|Overall Study||8
144127|NCT00361972|350670|P2|STARTED|Overall Study||9
144128|NCT00361972|350671|P1|STARTED|Overall Study||8
144129|NCT00362115|350686|P7|NOT COMPLETED|Overall Study||12
144130|NCT00362115|350687|P6|NOT COMPLETED|Overall Study||7
144131|NCT00362115|350688|P5|NOT COMPLETED|Overall Study||7
144132|NCT00362115|350689|P4|NOT COMPLETED|Overall Study||4
144133|NCT00362115|350690|P3|NOT COMPLETED|Overall Study||7
144134|NCT00362115|350691|P2|NOT COMPLETED|Overall Study||6
144135|NCT00362115|350692|P1|NOT COMPLETED|Overall Study||2
144136|NCT00362115|350686|P7|COMPLETED|Overall Study||52
144137|NCT00362115|350687|P6|COMPLETED|Overall Study||57
144138|NCT00362115|350688|P5|COMPLETED|Overall Study||57
144139|NCT00362115|350689|P4|COMPLETED|Overall Study||59
144140|NCT00362115|350690|P3|COMPLETED|Overall Study||57
144141|NCT00362115|350691|P2|COMPLETED|Overall Study||59
144142|NCT00362115|350692|P1|COMPLETED|Overall Study||63
144143|NCT00362115|350686|P7|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
144144|NCT00362115|350687|P6|STARTED|Overall Study|1 participant failed to receive double-blind medication.|64
144145|NCT00362115|350688|P5|STARTED|Overall Study||64
144146|NCT00362115|350689|P4|STARTED|Overall Study|1 participant failed to receive double-blind medication.|63
144147|NCT00362115|350690|P3|STARTED|Overall Study||64
144148|NCT00362115|350691|P2|STARTED|Overall Study|1 participant failed to receive double-blind medication.|65
144149|NCT00362115|350692|P1|STARTED|Overall Study||65
144150|NCT00362128|350841|P1|NOT COMPLETED|Overall Study||0
144151|NCT00362128|350841|P1|COMPLETED|Overall Study|Enrollment was completed in October 2009.|2072
144152|NCT00362128|350841|P1|STARTED|Overall Study|Enrollment was initiated in 2007.|2072
144153|NCT00362180|350854|P9|NOT COMPLETED|20 Week Safety Follow-up||0
144154|NCT00362180|350855|P8|NOT COMPLETED|20 Week Safety Follow-up||0
144155|NCT00362180|350856|P7|NOT COMPLETED|20 Week Safety Follow-up||0
144156|NCT00362180|350857|P6|NOT COMPLETED|20 Week Safety Follow-up||0
144157|NCT00362180|350858|P5|NOT COMPLETED|20 Week Safety Follow-up||0
144158|NCT00362180|350859|P4|NOT COMPLETED|20 Week Safety Follow-up||0
144159|NCT00362180|350860|P3|NOT COMPLETED|20 Week Safety Follow-up||0
144160|NCT00362180|350861|P2|NOT COMPLETED|20 Week Safety Follow-up||0
144161|NCT00362180|350862|P1|NOT COMPLETED|20 Week Safety Follow-up||0
144162|NCT00362180|350854|P9|COMPLETED|20 Week Safety Follow-up||1
144163|NCT00362180|350855|P8|COMPLETED|20 Week Safety Follow-up||3
144164|NCT00362180|350856|P7|COMPLETED|20 Week Safety Follow-up||0
144165|NCT00362180|350857|P6|COMPLETED|20 Week Safety Follow-up||9
144166|NCT00362180|350858|P5|COMPLETED|20 Week Safety Follow-up||11
144167|NCT00362180|350859|P4|COMPLETED|20 Week Safety Follow-up||0
144168|NCT00362180|350860|P3|COMPLETED|20 Week Safety Follow-up||1
144169|NCT00362180|350861|P2|COMPLETED|20 Week Safety Follow-up||2
144170|NCT00362180|350862|P1|COMPLETED|20 Week Safety Follow-up||3
144171|NCT00362180|350854|P9|STARTED|20 Week Safety Follow-up||1
144172|NCT00362180|350855|P8|STARTED|20 Week Safety Follow-up||3
144173|NCT00362180|350856|P7|STARTED|20 Week Safety Follow-up|This observational cohort did not include a safety follow-up period.|0
144174|NCT00362180|350857|P6|STARTED|20 Week Safety Follow-up||9
144175|NCT00362180|350858|P5|STARTED|20 Week Safety Follow-up||11
144176|NCT00362180|350859|P4|STARTED|20 Week Safety Follow-up||0
144177|NCT00362180|350860|P3|STARTED|20 Week Safety Follow-up||1
144178|NCT00362180|350861|P2|STARTED|20 Week Safety Follow-up||2
144179|NCT00362180|350862|P1|STARTED|20 Week Safety Follow-up||3
144180|NCT00362180|350854|P9|NOT COMPLETED|Treated Period||0
144181|NCT00362180|350855|P8|NOT COMPLETED|Treated Period||1
144182|NCT00362180|350856|P7|NOT COMPLETED|Treated Period||0
144183|NCT00362180|350857|P6|NOT COMPLETED|Treated Period||1
144184|NCT00362180|350858|P5|NOT COMPLETED|Treated Period||0
144185|NCT00362180|350859|P4|NOT COMPLETED|Treated Period||0
144186|NCT00362180|350860|P3|NOT COMPLETED|Treated Period||0
144187|NCT00362180|350861|P2|NOT COMPLETED|Treated Period||0
144188|NCT00362180|350862|P1|NOT COMPLETED|Treated Period||1
144189|NCT00362180|350854|P9|COMPLETED|Treated Period||1
144190|NCT00362180|350855|P8|COMPLETED|Treated Period||2
144191|NCT00362180|350856|P7|COMPLETED|Treated Period||6
144192|NCT00362180|350857|P6|COMPLETED|Treated Period||9
144193|NCT00362180|350858|P5|COMPLETED|Treated Period||11
144194|NCT00362180|350859|P4|COMPLETED|Treated Period||0
144195|NCT00362180|350860|P3|COMPLETED|Treated Period||1
144196|NCT00362180|350861|P2|COMPLETED|Treated Period||2
144197|NCT00362180|350862|P1|COMPLETED|Treated Period||3
144198|NCT00362180|350854|P9|STARTED|Treated Period||1
144199|NCT00362180|350855|P8|STARTED|Treated Period||3
144200|NCT00362180|350856|P7|STARTED|Treated Period||6
144201|NCT00362180|350857|P6|STARTED|Treated Period||10
144202|NCT00362180|350858|P5|STARTED|Treated Period||11
144203|NCT00362180|350859|P4|STARTED|Treated Period||0
144204|NCT00362180|350860|P3|STARTED|Treated Period||1
144205|NCT00362180|350861|P2|STARTED|Treated Period||2
144206|NCT00362180|350862|P1|STARTED|Treated Period||4
144207|NCT00362232|350925|P2|NOT COMPLETED|Follow-up (30 (+ 5) Days)||39
144208|NCT00362232|350926|P1|NOT COMPLETED|Follow-up (30 (+ 5) Days)||38
144209|NCT00362232|350925|P2|COMPLETED|Follow-up (30 (+ 5) Days)||1416
144210|NCT00362232|350926|P1|COMPLETED|Follow-up (30 (+ 5) Days)||1433
144211|NCT00362232|350925|P2|STARTED|Follow-up (30 (+ 5) Days)||1455
144212|NCT00362232|350926|P1|STARTED|Follow-up (30 (+ 5) Days)||1471
144213|NCT00362232|350925|P2|NOT COMPLETED|Treatment (12 +/- 2 Days)||151
144214|NCT00362232|350926|P1|NOT COMPLETED|Treatment (12 +/- 2 Days)||159
144215|NCT00362232|350925|P2|COMPLETED|Treatment (12 +/- 2 Days)||1413
144216|NCT00362232|350926|P1|COMPLETED|Treatment (12 +/- 2 Days)||1425
144217|NCT00362232|350925|P2|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1508
144218|NCT00362232|350926|P1|Received Treatment|Treatment (12 +/- 2 Days)|Safety population|1526
144219|NCT00362232|350925|P2|STARTED|Treatment (12 +/- 2 Days)||1564
144220|NCT00362232|350926|P1|STARTED|Treatment (12 +/- 2 Days)||1584
144221|NCT00362297|350964|P2|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
144222|NCT00362297|350965|P1|NOT COMPLETED|Arm 2 (Cross-over to Other Dose)||0
144223|NCT00362297|350964|P2|COMPLETED|Arm 2 (Cross-over to Other Dose)||11
144224|NCT00362297|350965|P1|COMPLETED|Arm 2 (Cross-over to Other Dose)||16
144225|NCT00362297|350964|P2|STARTED|Arm 2 (Cross-over to Other Dose)||11
144226|NCT00362297|350965|P1|STARTED|Arm 2 (Cross-over to Other Dose)||16
144227|NCT00362297|350964|P2|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||4
144228|NCT00362297|350965|P1|NOT COMPLETED|Arm 1 (Initial Drug Assignment)||0
144229|NCT00362297|350964|P2|COMPLETED|Arm 1 (Initial Drug Assignment)||11
144230|NCT00362297|350965|P1|COMPLETED|Arm 1 (Initial Drug Assignment)||16
144231|NCT00362297|350964|P2|STARTED|Arm 1 (Initial Drug Assignment)||15
144232|NCT00362297|350965|P1|STARTED|Arm 1 (Initial Drug Assignment)||16
144233|NCT00362336|350974|P3|NOT COMPLETED|Overall Study||3
144234|NCT00362336|350975|P2|NOT COMPLETED|Overall Study||7
144235|NCT00362336|350976|P1|NOT COMPLETED|Overall Study||10
144236|NCT00362336|350974|P3|COMPLETED|Overall Study||134
144237|NCT00362336|350975|P2|COMPLETED|Overall Study||235
144238|NCT00362336|350976|P1|COMPLETED|Overall Study||233
144239|NCT00362336|350974|P3|STARTED|Overall Study||137
144240|NCT00362336|350975|P2|STARTED|Overall Study||242
144241|NCT00362336|350976|P1|STARTED|Overall Study||243
144242|NCT00362375|351004|P2|NOT COMPLETED|Overall Study||35
144243|NCT00362375|351005|P1|NOT COMPLETED|Overall Study||40
144244|NCT00362375|351004|P2|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|117
144245|NCT00362375|351005|P1|COMPLETED|Overall Study|Number completed 6-month follow-up assessment|121
144246|NCT00362375|351004|P2|STARTED|Overall Study|Number eligible and randomized|152
144247|NCT00362375|351005|P1|STARTED|Overall Study|Number eligible and randomized|161
144248|NCT00362401|351022|P3|NOT COMPLETED|Overall Study||0
144249|NCT00362401|351023|P2|NOT COMPLETED|Overall Study||0
144250|NCT00362401|351024|P1|NOT COMPLETED|Overall Study||0
144251|NCT00362401|351022|P3|COMPLETED|Overall Study||40
144252|NCT00362401|351023|P2|COMPLETED|Overall Study||29
144253|NCT00362401|351024|P1|COMPLETED|Overall Study||15
144254|NCT00362401|351022|P3|STARTED|Overall Study||40
144255|NCT00362401|351023|P2|STARTED|Overall Study||29
144256|NCT00362401|351024|P1|STARTED|Overall Study||15
144257|NCT00362414|351029|P1|NOT COMPLETED|Overall Study||3
144258|NCT00362414|351029|P1|COMPLETED|Overall Study||12
144259|NCT00362414|351029|P1|STARTED|Overall Study||15
144260|NCT00362440|351048|P2|NOT COMPLETED|Overall Study||1
144261|NCT00362440|351049|P1|NOT COMPLETED|Overall Study||2
144262|NCT00362440|351048|P2|COMPLETED|Overall Study||3
144263|NCT00362440|351049|P1|COMPLETED|Overall Study||3
144264|NCT00362440|351048|P2|STARTED|Overall Study||4
144265|NCT00362440|351049|P1|STARTED|Overall Study||5
144266|NCT00362453|351061|P2|NOT COMPLETED|Overall Study||0
144267|NCT00362453|351062|P1|NOT COMPLETED|Overall Study||0
144268|NCT00362453|351061|P2|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
144269|NCT00362453|351062|P1|COMPLETED|Overall Study|No patient withdrew from the study (20/20 participants completed follow-ups at 12, 24 and 48 weeks).|20
144270|NCT00362453|351061|P2|STARTED|Overall Study||20
144271|NCT00362453|351062|P1|STARTED|Overall Study||20
144272|NCT00362466|351094|P2|NOT COMPLETED|Overall Study||0
144273|NCT00362466|351095|P1|NOT COMPLETED|Overall Study||0
144274|NCT00362466|351094|P2|COMPLETED|Overall Study||1
144275|NCT00362466|351095|P1|COMPLETED|Overall Study||2
144276|NCT00362466|351094|P2|STARTED|Overall Study||1
144277|NCT00362466|351095|P1|STARTED|Overall Study||2
144278|NCT00362609|351117|P2|NOT COMPLETED|Overall Study||2
144279|NCT00362609|351118|P1|NOT COMPLETED|Overall Study||0
144280|NCT00362609|351117|P2|COMPLETED|Overall Study||38
144281|NCT00362609|351118|P1|COMPLETED|Overall Study||19
144282|NCT00362609|351117|P2|STARTED|Overall Study||40
144283|NCT00362609|351118|P1|STARTED|Overall Study||19
144284|NCT00362648|351134|P4|NOT COMPLETED|Overall Study||11
144285|NCT00362648|351135|P3|NOT COMPLETED|Overall Study||9
144286|NCT00362648|351136|P2|NOT COMPLETED|Overall Study||134
144287|NCT00362648|351137|P1|NOT COMPLETED|Overall Study||126
144288|NCT00362648|351134|P4|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1007
144289|NCT00362648|351135|P3|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|1009
144290|NCT00362648|351136|P2|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2601
144291|NCT00362648|351137|P1|COMPLETED|Overall Study|Subjects vaccinated and followed up to 14 days after each dose|2607
144292|NCT00362648|351134|P4|Vaccinated at Visit 3|Overall Study||1007
144293|NCT00362648|351135|P3|Vaccinated at Visit 3|Overall Study||1009
144294|NCT00362648|351136|P2|Vaccinated at Visit 3|Overall Study||2612
144295|NCT00362648|351137|P1|Vaccinated at Visit 3|Overall Study||2613
144296|NCT00362648|351134|P4|Vaccinated at Visit 2|Overall Study||1009
144297|NCT00362648|351135|P3|Vaccinated at Visit 2|Overall Study||1013
144298|NCT00362648|351136|P2|Vaccinated at Visit 2|Overall Study||2666
144299|NCT00362648|351137|P1|Vaccinated at Visit 2|Overall Study||2657
144300|NCT00362648|351134|P4|Vaccinated at Visit 1|Overall Study||1018
144301|NCT00362648|351135|P3|Vaccinated at Visit 1|Overall Study||1018
144302|NCT00362648|351136|P2|Vaccinated at Visit 1|Overall Study||2735
144303|NCT00362648|351137|P1|Vaccinated at Visit 1|Overall Study||2733
144304|NCT00362648|351134|P4|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
144305|NCT00362648|351135|P3|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|1018
144306|NCT00362648|351136|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2735
144307|NCT00362648|351137|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized in to the study|2733
144308|NCT00362817|351153|P1|NOT COMPLETED|Overall Study||0
144309|NCT00362817|351153|P1|COMPLETED|Overall Study||17
144310|NCT00362817|351153|P1|STARTED|Overall Study||17
144311|NCT00362882|351164|P2|NOT COMPLETED|Overall Study||0
144312|NCT00362882|351165|P1|NOT COMPLETED|Overall Study||0
144313|NCT00362882|351164|P2|COMPLETED|Overall Study||41
144314|NCT00362882|351165|P1|COMPLETED|Overall Study||40
144315|NCT00362882|351164|P2|STARTED|Overall Study||41
144316|NCT00362882|351165|P1|STARTED|Overall Study||40
144317|NCT00363038|351175|P1|NOT COMPLETED|Overall Study||0
144318|NCT00363038|351175|P1|COMPLETED|Overall Study||16
144319|NCT00363038|351175|P1|STARTED|Overall Study||16
144320|NCT00363051|351181|P2|NOT COMPLETED|Overall Study||22
144321|NCT00363051|351182|P1|NOT COMPLETED|Overall Study||38
144322|NCT00363051|351181|P2|COMPLETED|Overall Study||23
144323|NCT00363051|351182|P1|COMPLETED|Overall Study|Patients with documented disease progression per RECIST criteria|77
144324|NCT00363051|351181|P2|STARTED|Overall Study||45
144325|NCT00363051|351182|P1|STARTED|Overall Study||115
144326|NCT00363077|351201|P2|NOT COMPLETED|Overall Study||0
144327|NCT00363077|351202|P1|NOT COMPLETED|Overall Study||0
144328|NCT00363077|351201|P2|COMPLETED|Overall Study||75
144329|NCT00363077|351202|P1|COMPLETED|Overall Study||75
144330|NCT00363077|351201|P2|STARTED|Overall Study||75
144331|NCT00363077|351202|P1|STARTED|Overall Study||75
144332|NCT00363129|351228|P2|NOT COMPLETED|Overall Study||33
144333|NCT00363129|351229|P1|NOT COMPLETED|Overall Study||29
144334|NCT00363129|351228|P2|COMPLETED|Overall Study||60
144335|NCT00363129|351229|P1|COMPLETED|Overall Study||67
144336|NCT00363129|351228|P2|STARTED|Overall Study||93
144337|NCT00363129|351229|P1|STARTED|Overall Study||96
144338|NCT00363142|351245|P2|NOT COMPLETED|Overall Study||3
144339|NCT00363142|351246|P1|NOT COMPLETED|Overall Study||7
144340|NCT00363142|351245|P2|COMPLETED|Overall Study||66
144341|NCT00363142|351246|P1|COMPLETED|Overall Study||133
144342|NCT00363142|351245|P2|STARTED|Overall Study||69
144343|NCT00363142|351246|P1|STARTED|Overall Study||140
144344|NCT00363168|351275|P2|NOT COMPLETED|Overall Study||0
144345|NCT00363168|351276|P1|NOT COMPLETED|Overall Study||0
144346|NCT00363168|351275|P2|COMPLETED|Overall Study||2
144347|NCT00363168|351276|P1|COMPLETED|Overall Study||5
144348|NCT00363168|351275|P2|STARTED|Overall Study||2
144349|NCT00363168|351276|P1|STARTED|Overall Study||5
144350|NCT00363246|351284|P1|NOT COMPLETED|Overall Study||97
144351|NCT00363246|351284|P1|COMPLETED|Overall Study||669
144352|NCT00363246|351284|P1|STARTED|Overall Study||766
144353|NCT00363298|351291|P2|NOT COMPLETED|4-week Study Continuation Phase||0
144354|NCT00363298|351292|P1|NOT COMPLETED|4-week Study Continuation Phase||1
144355|NCT00363298|351291|P2|COMPLETED|4-week Study Continuation Phase||7
144356|NCT00363298|351292|P1|COMPLETED|4-week Study Continuation Phase||5
144357|NCT00363298|351291|P2|STARTED|4-week Study Continuation Phase||7
144358|NCT00363298|351292|P1|STARTED|4-week Study Continuation Phase||6
144359|NCT00363298|351291|P2|NOT COMPLETED|First Study Week||5
144360|NCT00363298|351292|P1|NOT COMPLETED|First Study Week||6
144361|NCT00363298|351291|P2|COMPLETED|First Study Week|At end of week 1, 7/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|7
144362|NCT00363298|351292|P1|COMPLETED|First Study Week|At end of week 1, 6/12 subjects met Y-BOCS response criterion and began 4-week continuation phase|6
144363|NCT00363298|351291|P2|STARTED|First Study Week||12
144364|NCT00363298|351292|P1|STARTED|First Study Week||12
144365|NCT00363311|351302|P2|NOT COMPLETED|Overall Study||45
144366|NCT00363311|351303|P1|NOT COMPLETED|Overall Study||76
144367|NCT00363311|351302|P2|COMPLETED|Overall Study||102
144368|NCT00363311|351303|P1|COMPLETED|Overall Study||79
144369|NCT00363311|351302|P2|STARTED|Overall Study||147
144370|NCT00363311|351303|P1|STARTED|Overall Study||155
144371|NCT00363415|351369|P2|NOT COMPLETED|Overall Study||249
144372|NCT00363415|351370|P1|NOT COMPLETED|Overall Study||361
144373|NCT00363415|351369|P2|COMPLETED|Overall Study||206
144374|NCT00363415|351370|P1|COMPLETED|Overall Study||92
144375|NCT00363415|351369|P2|Received at Least One Dose of Study Drug|Overall Study||447
144376|NCT00363415|351370|P1|Received at Least One Dose of Study Drug|Overall Study||433
144377|NCT00363415|351369|P2|STARTED|Overall Study||455
144378|NCT00363415|351370|P1|STARTED|Overall Study||453
144379|NCT00363467|351386|P1|NOT COMPLETED|Overall Study||1
144380|NCT00363467|351386|P1|COMPLETED|Overall Study||2
144381|NCT00363467|351386|P1|STARTED|Overall Study||3
144382|NCT00363545|351396|P2|NOT COMPLETED|Overall Study||57
144383|NCT00363545|351397|P1|NOT COMPLETED|Overall Study||44
144384|NCT00363545|351396|P2|COMPLETED|Overall Study||581
144385|NCT00363545|351397|P1|COMPLETED|Overall Study||592
144386|NCT00363545|351396|P2|STARTED|Overall Study||638
144387|NCT00363545|351397|P1|STARTED|Overall Study||636
144388|NCT00363675|351415|P1|NOT COMPLETED|Overall Study||0
144389|NCT00363675|351415|P1|COMPLETED|Overall Study||3
144390|NCT00363675|351415|P1|Completed Testing|Overall Study||3
144391|NCT00363675|351415|P1|STARTED|Overall Study||3
144392|NCT00363779|351422|P1|NOT COMPLETED|Overall Study||0
144393|NCT00363779|351422|P1|COMPLETED|Overall Study||5
144394|NCT00363779|351422|P1|STARTED|Overall Study||5
144395|NCT00363805|351430|P3|NOT COMPLETED|Overall Study||3
144396|NCT00363805|351431|P2|NOT COMPLETED|Overall Study||6
144397|NCT00363805|351432|P1|NOT COMPLETED|Overall Study||4
144398|NCT00363805|351430|P3|COMPLETED|Overall Study||70
144399|NCT00363805|351431|P2|COMPLETED|Overall Study||57
144400|NCT00363805|351432|P1|COMPLETED|Overall Study||38
144401|NCT00363805|351430|P3|STARTED|Overall Study||73
144402|NCT00363805|351431|P2|STARTED|Overall Study||63
144403|NCT00363805|351432|P1|STARTED|Overall Study||42
144404|NCT00363883|351443|P1|NOT COMPLETED|Overall Study||0
144405|NCT00363883|351443|P1|COMPLETED|Overall Study||14
144406|NCT00363883|351443|P1|STARTED|Overall Study||14
144407|NCT00363896|351451|P2|NOT COMPLETED|Overall Study||47
144408|NCT00363896|351452|P1|NOT COMPLETED|Overall Study||89
144409|NCT00363896|351451|P2|COMPLETED|Overall Study||169
144410|NCT00363896|351452|P1|COMPLETED|Overall Study||538
144411|NCT00363896|351451|P2|STARTED|Overall Study||216
144412|NCT00363896|351452|P1|STARTED|Overall Study||627
144413|NCT00364013|351466|P2|NOT COMPLETED|Overall Study||95
144414|NCT00364013|351467|P1|NOT COMPLETED|Overall Study||101
144415|NCT00364013|351466|P2|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|495
144416|NCT00364013|351467|P1|COMPLETED|Overall Study|Indicates participants who had completed the safety visit 30 days after last dose or had died|492
144417|NCT00364013|351466|P2|Received Study Drug|Overall Study||583
144418|NCT00364013|351467|P1|Received Study Drug|Overall Study|One participant randomized to this group did not receive any panitumumab|586
144419|NCT00364013|351466|P2|STARTED|Overall Study||590
144420|NCT00364013|351467|P1|STARTED|Overall Study||593
144421|NCT00364130|351495|P2|NOT COMPLETED|Post Intervention Follow-up Period||11
144422|NCT00364130|351496|P1|NOT COMPLETED|Post Intervention Follow-up Period||5
144423|NCT00364130|351495|P2|COMPLETED|Post Intervention Follow-up Period||50
144424|NCT00364130|351496|P1|COMPLETED|Post Intervention Follow-up Period||55
144425|NCT00364130|351495|P2|STARTED|Post Intervention Follow-up Period||61
144426|NCT00364130|351496|P1|STARTED|Post Intervention Follow-up Period||60
144427|NCT00364130|351495|P2|NOT COMPLETED|Intervention Period||8
144428|NCT00364130|351496|P1|NOT COMPLETED|Intervention Period||9
144429|NCT00364130|351495|P2|COMPLETED|Intervention Period||61
144430|NCT00364130|351496|P1|COMPLETED|Intervention Period||60
144431|NCT00364130|351495|P2|STARTED|Intervention Period||69
144432|NCT00364130|351496|P1|STARTED|Intervention Period||69
144433|NCT00364156|351518|P2|NOT COMPLETED|Overall Study||81
144434|NCT00364156|351519|P1|NOT COMPLETED|Overall Study||79
144435|NCT00364156|351518|P2|COMPLETED|Overall Study||205
144436|NCT00364156|351519|P1|COMPLETED|Overall Study||203
144437|NCT00364156|351518|P2|STARTED|Overall Study||286
144438|NCT00364156|351519|P1|STARTED|Overall Study||282
144439|NCT00364182|351528|P3|NOT COMPLETED|Fourth Intervention||0
144440|NCT00364182|351529|P2|NOT COMPLETED|Fourth Intervention||0
144441|NCT00364182|351530|P1|NOT COMPLETED|Fourth Intervention||0
144442|NCT00364182|351528|P3|COMPLETED|Fourth Intervention||22
144443|NCT00364182|351529|P2|COMPLETED|Fourth Intervention||19
144444|NCT00364182|351530|P1|COMPLETED|Fourth Intervention||0
144445|NCT00364182|351528|P3|STARTED|Fourth Intervention||22
144446|NCT00364182|351529|P2|STARTED|Fourth Intervention||19
144447|NCT00364182|351530|P1|STARTED|Fourth Intervention||0
144448|NCT00364182|351528|P3|NOT COMPLETED|Third Intervention||1
144449|NCT00364182|351529|P2|NOT COMPLETED|Third Intervention||1
144450|NCT00364182|351530|P1|NOT COMPLETED|Third Intervention||0
144451|NCT00364182|351528|P3|COMPLETED|Third Intervention||22
144452|NCT00364182|351529|P2|COMPLETED|Third Intervention||19
144453|NCT00364182|351530|P1|COMPLETED|Third Intervention||0
144454|NCT00364182|351528|P3|STARTED|Third Intervention||23
144455|NCT00364182|351529|P2|STARTED|Third Intervention||20
144456|NCT00364182|351530|P1|STARTED|Third Intervention||0
144457|NCT00364182|351528|P3|NOT COMPLETED|Second Intervention||2
144458|NCT00364182|351529|P2|NOT COMPLETED|Second Intervention||2
144459|NCT00364182|351530|P1|NOT COMPLETED|Second Intervention||0
144460|NCT00364182|351528|P3|COMPLETED|Second Intervention||23
144461|NCT00364182|351529|P2|COMPLETED|Second Intervention||20
144462|NCT00364182|351530|P1|COMPLETED|Second Intervention||0
144463|NCT00364182|351528|P3|Randomized|Second Intervention||25
144464|NCT00364182|351529|P2|Randomized|Second Intervention||22
144465|NCT00364182|351530|P1|Randomized|Second Intervention||0
144466|NCT00364182|351528|P3|STARTED|Second Intervention||25
144467|NCT00364182|351529|P2|STARTED|Second Intervention||22
144468|NCT00364182|351530|P1|STARTED|Second Intervention||0
144469|NCT00364182|351528|P3|NOT COMPLETED|First Intervention||0
144470|NCT00364182|351529|P2|NOT COMPLETED|First Intervention||0
144471|NCT00364182|351530|P1|NOT COMPLETED|First Intervention||3
144472|NCT00364182|351528|P3|COMPLETED|First Intervention||25
144473|NCT00364182|351529|P2|COMPLETED|First Intervention||22
144474|NCT00364182|351530|P1|COMPLETED|First Intervention||0
144475|NCT00364182|351528|P3|STARTED|First Intervention||25
144476|NCT00364182|351529|P2|STARTED|First Intervention||22
144477|NCT00364182|351530|P1|STARTED|First Intervention||3
144478|NCT00364286|351562|P1|NOT COMPLETED|Overall Study||0
144479|NCT00364286|351562|P1|COMPLETED|Overall Study||17
144480|NCT00364286|351562|P1|STARTED|Overall Study||17
144481|NCT00355082|351568|P3|NOT COMPLETED|Continuation Phase||3
144482|NCT00355082|351569|P2|NOT COMPLETED|Continuation Phase||0
144483|NCT00355082|351570|P1|NOT COMPLETED|Continuation Phase||24
144484|NCT00355082|351568|P3|COMPLETED|Continuation Phase||8
144485|NCT00355082|351569|P2|COMPLETED|Continuation Phase||0
144486|NCT00355082|351570|P1|COMPLETED|Continuation Phase||160
144487|NCT00355082|351568|P3|STARTED|Continuation Phase|"See Pre-assign. Details for reasons why number starting CP does not equal number completing TP."|11
144488|NCT00355082|351569|P2|STARTED|Continuation Phase||0
144489|NCT00355082|351570|P1|STARTED|Continuation Phase|83 and 101 participants from the 250 and 300 mg groups (DB Phase), respectively, entered the CP.|184
144490|NCT00355082|351568|P3|NOT COMPLETED|Double-Blind (DB) Treatment Phase||0
144491|NCT00355082|351569|P2|NOT COMPLETED|Double-Blind (DB) Treatment Phase||34
144492|NCT00355082|351570|P1|NOT COMPLETED|Double-Blind (DB) Treatment Phase||19
144493|NCT00355082|351568|P3|COMPLETED|Double-Blind (DB) Treatment Phase||0
144494|NCT00355082|351569|P2|COMPLETED|Double-Blind (DB) Treatment Phase||79
144495|NCT00355082|351570|P1|COMPLETED|Double-Blind (DB) Treatment Phase||94
144496|NCT00355082|351568|P3|STARTED|Double-Blind (DB) Treatment Phase||0
144497|NCT00355082|351569|P2|STARTED|Double-Blind (DB) Treatment Phase|111 participants have baseline data; 2 participants did not receive study drug.|113
144498|NCT00355082|351570|P1|STARTED|Double-Blind (DB) Treatment Phase|112 participants have baseline data; 1 participant did not receive study drug.|113
144499|NCT00355121|351593|P3|NOT COMPLETED|Overall Study||5
144500|NCT00355121|351594|P2|NOT COMPLETED|Overall Study||29
144501|NCT00355121|351595|P1|NOT COMPLETED|Overall Study||21
144502|NCT00355121|351593|P3|COMPLETED|Overall Study||170
144503|NCT00355121|351594|P2|COMPLETED|Overall Study||324
144504|NCT00355121|351595|P1|COMPLETED|Overall Study||332
144505|NCT00355121|351593|P3|STARTED|Overall Study||175
144506|NCT00355121|351594|P2|STARTED|Overall Study||353
144507|NCT00355121|351595|P1|STARTED|Overall Study||353
144508|NCT00355134|351629|P5|NOT COMPLETED|Extension Phase||19
144509|NCT00355134|351630|P4|NOT COMPLETED|Extension Phase||16
144510|NCT00355134|351631|P3|NOT COMPLETED|Extension Phase||0
144511|NCT00355134|351632|P2|NOT COMPLETED|Extension Phase||37
144512|NCT00355134|351633|P1|NOT COMPLETED|Extension Phase||31
144513|NCT00355134|351629|P5|COMPLETED|Extension Phase||88
144514|NCT00355134|351630|P4|COMPLETED|Extension Phase||89
144515|NCT00355134|351631|P3|COMPLETED|Extension Phase||0
144516|NCT00355134|351632|P2|COMPLETED|Extension Phase||180
144517|NCT00355134|351633|P1|COMPLETED|Extension Phase||172
144518|NCT00355134|351629|P5|STARTED|Extension Phase||107
144519|NCT00355134|351630|P4|STARTED|Extension Phase||105
144520|NCT00355134|351631|P3|STARTED|Extension Phase||0
144521|NCT00355134|351632|P2|STARTED|Extension Phase||217
144522|NCT00355134|351633|P1|STARTED|Extension Phase||203
144523|NCT00355134|351629|P5|NOT COMPLETED|Core Phase||0
144524|NCT00355134|351630|P4|NOT COMPLETED|Core Phase||0
144525|NCT00355134|351631|P3|NOT COMPLETED|Core Phase||100
144526|NCT00355134|351632|P2|NOT COMPLETED|Core Phase||86
144527|NCT00355134|351633|P1|NOT COMPLETED|Core Phase||119
144528|NCT00355134|351629|P5|COMPLETED|Core Phase||0
144529|NCT00355134|351630|P4|COMPLETED|Core Phase||0
144530|NCT00355134|351631|P3|COMPLETED|Core Phase||255
144531|NCT00355134|351632|P2|COMPLETED|Core Phase||272
144532|NCT00355134|351633|P1|COMPLETED|Core Phase||251
144533|NCT00355134|351629|P5|STARTED|Core Phase||0
144534|NCT00355134|351630|P4|STARTED|Core Phase||0
144535|NCT00355134|351631|P3|STARTED|Core Phase||355
144536|NCT00355134|351632|P2|STARTED|Core Phase||358
144537|NCT00355134|351633|P1|STARTED|Core Phase||370
144538|NCT00355147|351675|P2|NOT COMPLETED|Overall Study||20
144539|NCT00355147|351676|P1|NOT COMPLETED|Overall Study||18
144540|NCT00355147|351675|P2|COMPLETED|Overall Study||67
144541|NCT00355147|351676|P1|COMPLETED|Overall Study||69
144542|NCT00355147|351675|P2|STARTED|Overall Study||87
144543|NCT00355147|351676|P1|STARTED|Overall Study||87
144544|NCT00355199|351692|P2|NOT COMPLETED|Overall Study||4
144545|NCT00355199|351693|P1|NOT COMPLETED|Overall Study||7
144546|NCT00355199|351692|P2|COMPLETED|Overall Study||122
144547|NCT00355199|351693|P1|COMPLETED|Overall Study||113
144548|NCT00355199|351692|P2|STARTED|Overall Study||126
144549|NCT00355199|351693|P1|STARTED|Overall Study||120
144550|NCT00355368|351709|P2|NOT COMPLETED|Overall Study||9
144551|NCT00355368|351710|P1|NOT COMPLETED|Overall Study||10
144552|NCT00355368|351709|P2|COMPLETED|Overall Study||201
144553|NCT00355368|351710|P1|COMPLETED|Overall Study||200
144554|NCT00355368|351709|P2|STARTED|Overall Study||210
144555|NCT00355368|351710|P1|STARTED|Overall Study||210
144556|NCT00355394|351724|P2|NOT COMPLETED|Overall Study||0
144557|NCT00355394|351725|P1|NOT COMPLETED|Overall Study||0
144558|NCT00355394|351724|P2|COMPLETED|Overall Study||16
144559|NCT00355394|351725|P1|COMPLETED|Overall Study||15
144560|NCT00355394|351724|P2|STARTED|Overall Study||16
144561|NCT00355394|351725|P1|STARTED|Overall Study||15
144562|NCT00355472|351741|P1|NOT COMPLETED|Overall Study||1
144563|NCT00355472|351741|P1|COMPLETED|Overall Study||15
144564|NCT00355472|351741|P1|STARTED|Overall Study||16
144565|NCT00355615|351770|P5|NOT COMPLETED|40-week Rosuvastatin Open Label Period||9
144566|NCT00355615|351771|P4|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
144567|NCT00355615|351772|P3|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
144568|NCT00355615|351773|P2|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
144569|NCT00355615|351774|P1|NOT COMPLETED|40-week Rosuvastatin Open Label Period||0
144570|NCT00355615|351770|P5|COMPLETED|40-week Rosuvastatin Open Label Period||164
144571|NCT00355615|351771|P4|COMPLETED|40-week Rosuvastatin Open Label Period||0
144572|NCT00355615|351772|P3|COMPLETED|40-week Rosuvastatin Open Label Period||0
144573|NCT00355615|351773|P2|COMPLETED|40-week Rosuvastatin Open Label Period||0
144574|NCT00355615|351774|P1|COMPLETED|40-week Rosuvastatin Open Label Period||0
144575|NCT00355615|351770|P5|STARTED|40-week Rosuvastatin Open Label Period||173
144576|NCT00355615|351771|P4|STARTED|40-week Rosuvastatin Open Label Period||0
144577|NCT00355615|351772|P3|STARTED|40-week Rosuvastatin Open Label Period||0
144578|NCT00355615|351773|P2|STARTED|40-week Rosuvastatin Open Label Period||0
144579|NCT00355615|351774|P1|STARTED|40-week Rosuvastatin Open Label Period||0
144580|NCT00355615|351770|P5|NOT COMPLETED|Randomized Double Blind Period||0
144581|NCT00355615|351771|P4|NOT COMPLETED|Randomized Double Blind Period||1
144582|NCT00355615|351772|P3|NOT COMPLETED|Randomized Double Blind Period||1
144583|NCT00355615|351773|P2|NOT COMPLETED|Randomized Double Blind Period||0
144584|NCT00355615|351774|P1|NOT COMPLETED|Randomized Double Blind Period||1
144585|NCT00355615|351770|P5|COMPLETED|Randomized Double Blind Period||0
144586|NCT00355615|351771|P4|COMPLETED|Randomized Double Blind Period|1 dropped out due to an adverse event|45
144587|NCT00355615|351772|P3|COMPLETED|Randomized Double Blind Period|45 were randomized but 1 never received drug|44
144588|NCT00355615|351773|P2|COMPLETED|Randomized Double Blind Period||44
144589|NCT00355615|351774|P1|COMPLETED|Randomized Double Blind Period|1 dropped out due to adverse event|41
144590|NCT00355615|351770|P5|STARTED|Randomized Double Blind Period|open label phase followed the randomized phase|0
144591|NCT00355615|351771|P4|STARTED|Randomized Double Blind Period||46
144592|NCT00355615|351772|P3|STARTED|Randomized Double Blind Period||45
144593|NCT00355615|351773|P2|STARTED|Randomized Double Blind Period||44
144594|NCT00355615|351774|P1|STARTED|Randomized Double Blind Period||42
144595|NCT00355706|351835|P2|NOT COMPLETED|Overall Study||0
144596|NCT00355706|351836|P1|NOT COMPLETED|Overall Study||0
144597|NCT00355706|351835|P2|COMPLETED|Overall Study||50
144598|NCT00355706|351836|P1|COMPLETED|Overall Study||50
144599|NCT00355706|351835|P2|STARTED|Overall Study||50
144600|NCT00355706|351836|P1|STARTED|Overall Study||50
144601|NCT00355784|351849|P3|NOT COMPLETED|Overall Study||2
144602|NCT00355784|351850|P2|NOT COMPLETED|Overall Study||0
144603|NCT00355784|351851|P1|NOT COMPLETED|Overall Study||0
144604|NCT00355784|351849|P3|COMPLETED|Overall Study||5
144605|NCT00355784|351850|P2|COMPLETED|Overall Study||8
144606|NCT00355784|351851|P1|COMPLETED|Overall Study||9
144607|NCT00355784|351849|P3|STARTED|Overall Study||7
144608|NCT00355784|351850|P2|STARTED|Overall Study||8
144609|NCT00355784|351851|P1|STARTED|Overall Study||9
144610|NCT00355797|351886|P3|NOT COMPLETED|Overall Study||142
144611|NCT00355797|351887|P2|NOT COMPLETED|Overall Study||148
144612|NCT00355797|351888|P1|NOT COMPLETED|Overall Study||240
144613|NCT00355797|351886|P3|COMPLETED|Overall Study||239
144614|NCT00355797|351887|P2|COMPLETED|Overall Study||221
144615|NCT00355797|351888|P1|COMPLETED|Overall Study||501
144616|NCT00355797|351886|P3|STARTED|Overall Study||381
144617|NCT00355797|351887|P2|STARTED|Overall Study||369
144618|NCT00355797|351888|P1|STARTED|Overall Study||741
144619|NCT00355914|351919|P2|NOT COMPLETED|Overall Study||0
144620|NCT00355914|351920|P1|NOT COMPLETED|Overall Study||0
144621|NCT00355914|351919|P2|COMPLETED|Overall Study||60
144622|NCT00355914|351920|P1|COMPLETED|Overall Study||60
144623|NCT00355914|351919|P2|STARTED|Overall Study||60
144624|NCT00355914|351920|P1|STARTED|Overall Study||60
144625|NCT00356031|351928|P1|NOT COMPLETED|Overall Study||0
144626|NCT00356031|351928|P1|COMPLETED|Overall Study||20
144627|NCT00356031|351928|P1|STARTED|Overall Study||20
144628|NCT00356057|351940|P3|NOT COMPLETED|Overall Study||12
144629|NCT00356057|351941|P2|NOT COMPLETED|Overall Study||14
144630|NCT00356057|351942|P1|NOT COMPLETED|Overall Study||13
144631|NCT00356057|351940|P3|COMPLETED|Overall Study||22
144632|NCT00356057|351941|P2|COMPLETED|Overall Study||47
144633|NCT00356057|351942|P1|COMPLETED|Overall Study||45
144634|NCT00356057|351940|P3|IMPLANTED|Overall Study||25
144635|NCT00356057|351941|P2|IMPLANTED|Overall Study||52
144636|NCT00356057|351942|P1|IMPLANTED|Overall Study||49
144637|NCT00356057|351940|P3|STARTED|Overall Study||34
144638|NCT00356057|351941|P2|STARTED|Overall Study||61
144639|NCT00356057|351942|P1|STARTED|Overall Study||58
144640|NCT00356122|351948|P1|NOT COMPLETED|FOLLOW-UP||41
144641|NCT00356122|351948|P1|COMPLETED|FOLLOW-UP||12
144642|NCT00356122|351948|P1|STARTED|FOLLOW-UP||53
144643|NCT00356122|351948|P1|NOT COMPLETED|TREATMENT||45
144644|NCT00356122|351948|P1|COMPLETED|TREATMENT||8
144645|NCT00356122|351948|P1|STARTED|TREATMENT||53
144646|NCT00356135|351959|P3|NOT COMPLETED|Overall Study||5
144647|NCT00356135|351960|P2|NOT COMPLETED|Overall Study||2
144648|NCT00356135|351961|P1|NOT COMPLETED|Overall Study||4
144649|NCT00356135|351959|P3|COMPLETED|Overall Study||39
144650|NCT00356135|351960|P2|COMPLETED|Overall Study||46
144651|NCT00356135|351961|P1|COMPLETED|Overall Study||43
144652|NCT00356135|351959|P3|STARTED|Overall Study||44
144653|NCT00356135|351960|P2|STARTED|Overall Study||48
144654|NCT00356135|351961|P1|STARTED|Overall Study||47
144655|NCT00356148|351985|P2|NOT COMPLETED|Overall Study||1
144656|NCT00356148|351986|P1|NOT COMPLETED|Overall Study||2
144657|NCT00356148|351985|P2|COMPLETED|Overall Study||182
144658|NCT00356148|351986|P1|COMPLETED|Overall Study||187
144659|NCT00356148|351985|P2|STARTED|Overall Study||183
144660|NCT00356148|351986|P1|STARTED|Overall Study||189
144661|NCT00356200|351996|P2|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||2
144662|NCT00356200|351997|P1|NOT COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
144663|NCT00356200|351996|P2|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||3
144664|NCT00356200|351997|P1|COMPLETED|Cohort 2: 100 ug/ml (New Patients)||0
144665|NCT00356200|351996|P2|STARTED|Cohort 2: 100 ug/ml (New Patients)||5
144666|NCT00356200|351997|P1|STARTED|Cohort 2: 100 ug/ml (New Patients)||0
144667|NCT00356200|351996|P2|NOT COMPLETED|Cohort 1: 10 ug/ml||0
144668|NCT00356200|351997|P1|NOT COMPLETED|Cohort 1: 10 ug/ml||1
144669|NCT00356200|351996|P2|COMPLETED|Cohort 1: 10 ug/ml||0
144670|NCT00356200|351997|P1|COMPLETED|Cohort 1: 10 ug/ml||4
144671|NCT00356200|351996|P2|STARTED|Cohort 1: 10 ug/ml||0
144672|NCT00356200|351997|P1|STARTED|Cohort 1: 10 ug/ml||5
144673|NCT00356278|352012|P3|NOT COMPLETED|Overall Study||19
144674|NCT00356278|352013|P2|NOT COMPLETED|Overall Study||15
144675|NCT00356278|352014|P1|NOT COMPLETED|Overall Study||25
144676|NCT00356278|352012|P3|COMPLETED|Overall Study||34
144677|NCT00356278|352013|P2|COMPLETED|Overall Study||35
144678|NCT00356278|352014|P1|COMPLETED|Overall Study||28
144679|NCT00356278|352012|P3|STARTED|Overall Study||53
144680|NCT00356278|352013|P2|STARTED|Overall Study||50
144681|NCT00356278|352014|P1|STARTED|Overall Study||53
144682|NCT00356304|352051|P2|NOT COMPLETED|Overall Study||4
144683|NCT00356304|352052|P1|NOT COMPLETED|Overall Study||2
144684|NCT00356304|352051|P2|COMPLETED|Overall Study||20
144685|NCT00356304|352052|P1|COMPLETED|Overall Study||24
144686|NCT00356304|352051|P2|STARTED|Overall Study||24
144687|NCT00356304|352052|P1|STARTED|Overall Study||26
144688|NCT00356408|352064|P1|NOT COMPLETED|Overall Study||60
144689|NCT00356408|352064|P1|COMPLETED|Overall Study||43
144690|NCT00356408|352064|P1|STARTED|Overall Study|106 subjects enrolled, however only 103 were included in the Intent to Treat (ITT) population.|103
144691|NCT00356421|352081|P2|NOT COMPLETED|Overall Study||17
144692|NCT00356421|352082|P1|NOT COMPLETED|Overall Study||32
144693|NCT00356421|352081|P2|COMPLETED|Overall Study||3
144694|NCT00356421|352082|P1|COMPLETED|Overall Study||6
144695|NCT00356421|352081|P2|STARTED|Overall Study||20
144696|NCT00356421|352082|P1|STARTED|Overall Study||38
144697|NCT00356434|352120|P2|NOT COMPLETED|Overall Study||0
144698|NCT00356434|352121|P1|NOT COMPLETED|Overall Study||0
144699|NCT00356434|352120|P2|COMPLETED|Overall Study||7
144700|NCT00356434|352121|P1|COMPLETED|Overall Study||4
144701|NCT00356434|352120|P2|STARTED|Overall Study||7
144702|NCT00356434|352121|P1|STARTED|Overall Study||4
144703|NCT00356525|352135|P4|NOT COMPLETED|Overall Study||9
144704|NCT00356525|352136|P3|NOT COMPLETED|Overall Study||7
144705|NCT00356525|352137|P2|NOT COMPLETED|Overall Study||11
144706|NCT00356525|352138|P1|NOT COMPLETED|Overall Study||14
144707|NCT00356525|352135|P4|COMPLETED|Overall Study||0
144708|NCT00356525|352136|P3|COMPLETED|Overall Study||0
144709|NCT00356525|352137|P2|COMPLETED|Overall Study||0
144710|NCT00356525|352138|P1|COMPLETED|Overall Study||0
144711|NCT00356525|352135|P4|STARTED|Overall Study||9
144712|NCT00356525|352136|P3|STARTED|Overall Study||7
144713|NCT00356525|352137|P2|STARTED|Overall Study||11
144714|NCT00356525|352138|P1|STARTED|Overall Study||14
144715|NCT00356590|352164|P1|NOT COMPLETED|Overall Study||274
144716|NCT00356590|352164|P1|COMPLETED|Overall Study||194
144717|NCT00356590|352164|P1|STARTED|Overall Study||468
144718|NCT00356811|352196|P1|NOT COMPLETED|Overall Study||49
144719|NCT00356811|352196|P1|COMPLETED|Overall Study||8
144720|NCT00356811|352196|P1|STARTED|Overall Study||57
144721|NCT00356863|352211|P2|NOT COMPLETED|Overall Study||75
144722|NCT00356863|352212|P1|NOT COMPLETED|Overall Study||92
144723|NCT00356863|352211|P2|COMPLETED|Overall Study||445
144724|NCT00356863|352212|P1|COMPLETED|Overall Study||412
144725|NCT00356863|352211|P2|STARTED|Overall Study||520
144726|NCT00356863|352212|P1|STARTED|Overall Study||504
144727|NCT00356889|352238|P1|NOT COMPLETED|Overall Study||3
144728|NCT00356889|352238|P1|COMPLETED|Overall Study||53
144729|NCT00356889|352238|P1|STARTED|Overall Study||56
144730|NCT00356915|352248|P3|NOT COMPLETED|Overall Study||42
144731|NCT00356915|352249|P2|NOT COMPLETED|Overall Study||94
144732|NCT00356915|352250|P1|NOT COMPLETED|Overall Study||76
144733|NCT00356915|352248|P3|COMPLETED|Overall Study||156
144734|NCT00356915|352249|P2|COMPLETED|Overall Study||496
144735|NCT00356915|352250|P1|COMPLETED|Overall Study||517
144736|NCT00356915|352248|P3|STARTED|Overall Study||198
144737|NCT00356915|352249|P2|STARTED|Overall Study||590
144738|NCT00356915|352250|P1|STARTED|Overall Study||593
144739|NCT00357006|352270|P3|NOT COMPLETED|Overall Study||3
144740|NCT00357006|352271|P2|NOT COMPLETED|Overall Study||5
144741|NCT00357006|352272|P1|NOT COMPLETED|Overall Study||2
144742|NCT00357006|352270|P3|COMPLETED|Overall Study||59
144743|NCT00357006|352271|P2|COMPLETED|Overall Study||51
144744|NCT00357006|352272|P1|COMPLETED|Overall Study||60
144745|NCT00357006|352270|P3|STARTED|Overall Study||62
144746|NCT00357006|352271|P2|STARTED|Overall Study||56
144747|NCT00357006|352272|P1|STARTED|Overall Study||62
144748|NCT00357032|352280|P1|NOT COMPLETED|Overall Study||0
144749|NCT00357032|352280|P1|COMPLETED|Overall Study||12
144750|NCT00357032|352280|P1|STARTED|Overall Study||12
144751|NCT00357097|352287|P2|NOT COMPLETED|Overall Study||29
144752|NCT00357097|352288|P1|NOT COMPLETED|Overall Study||54
144753|NCT00357097|352287|P2|COMPLETED|Overall Study||38
144754|NCT00357097|352288|P1|COMPLETED|Overall Study||145
144755|NCT00357097|352287|P2|STARTED|Overall Study||67
144756|NCT00357097|352288|P1|STARTED|Overall Study|199 were randomized. Only 198 took investigational product.|199
144757|NCT00364351|352334|P2|NOT COMPLETED|Overall Study||583
144758|NCT00364351|352335|P1|NOT COMPLETED|Overall Study||592
144759|NCT00364351|352334|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|34
144760|NCT00364351|352335|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|31
144761|NCT00364351|352334|P2|STARTED|Overall Study|randomised patients|617
144762|NCT00364351|352335|P1|STARTED|Overall Study|randomised patients|623
144763|NCT00364377|352355|P2|NOT COMPLETED|Overall Study||0
144764|NCT00364377|352356|P1|NOT COMPLETED|Overall Study||0
144765|NCT00364377|352355|P2|COMPLETED|Overall Study||11
144766|NCT00364377|352356|P1|COMPLETED|Overall Study||11
144767|NCT00364377|352355|P2|STARTED|Overall Study||11
144768|NCT00364377|352356|P1|STARTED|Overall Study||11
144769|NCT00364533|352367|P5|NOT COMPLETED|Overall Study||51
144770|NCT00364533|352368|P4|NOT COMPLETED|Overall Study||31
144771|NCT00364533|352369|P3|NOT COMPLETED|Overall Study||45
144772|NCT00364533|352370|P2|NOT COMPLETED|Overall Study||40
144773|NCT00364533|352371|P1|NOT COMPLETED|Overall Study||42
144774|NCT00364533|352367|P5|COMPLETED|Overall Study||24
144775|NCT00364533|352368|P4|COMPLETED|Overall Study||36
144776|NCT00364533|352369|P3|COMPLETED|Overall Study||30
144777|NCT00364533|352370|P2|COMPLETED|Overall Study||31
144778|NCT00364533|352371|P1|COMPLETED|Overall Study||35
144779|NCT00364533|352367|P5|STARTED|Overall Study||75
144780|NCT00364533|352368|P4|STARTED|Overall Study||67
144781|NCT00364533|352369|P3|STARTED|Overall Study||75
144782|NCT00364533|352370|P2|STARTED|Overall Study||71
144783|NCT00364533|352371|P1|STARTED|Overall Study||77
144784|NCT00364611|352395|P2|NOT COMPLETED|Overall Study||21
144785|NCT00364611|352396|P1|NOT COMPLETED|Overall Study||51
144786|NCT00364611|352395|P2|COMPLETED|Overall Study||0
144787|NCT00364611|352396|P1|COMPLETED|Overall Study|Ongoing treatment (June 2011-initial analysis). Continued treatment till March 2012 (study closed).|1
144788|NCT00364611|352395|P2|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|20
144789|NCT00364611|352396|P1|TREATED (SAFTEY POPULATION)|Overall Study|Received at least one dose of study medication|52
144790|NCT00364611|352395|P2|STARTED|Overall Study||21
144791|NCT00364611|352396|P1|STARTED|Overall Study||52
144792|NCT00365716|352419|P7|NOT COMPLETED|Extension 2||10
144793|NCT00365716|352420|P6|NOT COMPLETED|Extension 2||0
144794|NCT00365716|352421|P5|NOT COMPLETED|Extension 2||0
144795|NCT00365716|352422|P4|NOT COMPLETED|Extension 2||0
144796|NCT00365716|352423|P3|NOT COMPLETED|Extension 2||0
144797|NCT00365716|352424|P2|NOT COMPLETED|Extension 2||0
144798|NCT00365716|352425|P1|NOT COMPLETED|Extension 2||0
144799|NCT00365716|352419|P7|COMPLETED|Extension 2||7
144800|NCT00365716|352420|P6|COMPLETED|Extension 2||0
144801|NCT00365716|352421|P5|COMPLETED|Extension 2||0
144802|NCT00365716|352422|P4|COMPLETED|Extension 2||0
144803|NCT00365716|352423|P3|COMPLETED|Extension 2||0
144804|NCT00365716|352424|P2|COMPLETED|Extension 2||0
144805|NCT00365716|352425|P1|COMPLETED|Extension 2||0
144806|NCT00365716|352419|P7|STARTED|Extension 2|17 Participants continued into Extension 2 from Extension 1|17
144807|NCT00365716|352420|P6|STARTED|Extension 2||0
144808|NCT00365716|352421|P5|STARTED|Extension 2||0
144809|NCT00365716|352422|P4|STARTED|Extension 2||0
144810|NCT00365716|352423|P3|STARTED|Extension 2||0
144811|NCT00365716|352424|P2|STARTED|Extension 2||0
144812|NCT00365716|352425|P1|STARTED|Extension 2||0
144813|NCT00365716|352419|P7|NOT COMPLETED|Extension 1||0
144814|NCT00365716|352420|P6|NOT COMPLETED|Extension 1||22
144815|NCT00365716|352421|P5|NOT COMPLETED|Extension 1||0
144816|NCT00365716|352422|P4|NOT COMPLETED|Extension 1||0
144817|NCT00365716|352423|P3|NOT COMPLETED|Extension 1||0
144818|NCT00365716|352424|P2|NOT COMPLETED|Extension 1||0
144819|NCT00365716|352425|P1|NOT COMPLETED|Extension 1||0
144820|NCT00365716|352419|P7|COMPLETED|Extension 1||0
144821|NCT00365716|352420|P6|COMPLETED|Extension 1||219
144822|NCT00365716|352421|P5|COMPLETED|Extension 1||0
144823|NCT00365716|352422|P4|COMPLETED|Extension 1||0
144824|NCT00365716|352423|P3|COMPLETED|Extension 1||0
144825|NCT00365716|352424|P2|COMPLETED|Extension 1||0
144826|NCT00365716|352425|P1|COMPLETED|Extension 1||0
144827|NCT00365716|352419|P7|STARTED|Extension 1||0
144828|NCT00365716|352420|P6|STARTED|Extension 1||241
144829|NCT00365716|352421|P5|STARTED|Extension 1||0
144830|NCT00365716|352422|P4|STARTED|Extension 1||0
144831|NCT00365716|352423|P3|STARTED|Extension 1||0
144832|NCT00365716|352424|P2|STARTED|Extension 1||0
144833|NCT00365716|352425|P1|STARTED|Extension 1||0
144834|NCT00365716|352419|P7|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
144835|NCT00365716|352420|P6|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
144836|NCT00365716|352421|P5|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||82
144837|NCT00365716|352422|P4|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||79
144838|NCT00365716|352423|P3|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||20
144839|NCT00365716|352424|P2|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||15
144840|NCT00365716|352425|P1|NOT COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||132
144841|NCT00365716|352419|P7|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
144842|NCT00365716|352420|P6|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||0
144843|NCT00365716|352421|P5|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
144844|NCT00365716|352422|P4|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||57
144845|NCT00365716|352423|P3|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||251
144846|NCT00365716|352424|P2|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||245
144847|NCT00365716|352425|P1|COMPLETED|Long Term Follow-up (Month 7 toMonth 36)||137
144848|NCT00365716|352419|P7|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
144849|NCT00365716|352420|P6|STARTED|Long Term Follow-up (Month 7 toMonth 36)||0
144850|NCT00365716|352421|P5|STARTED|Long Term Follow-up (Month 7 toMonth 36)||139
144851|NCT00365716|352422|P4|STARTED|Long Term Follow-up (Month 7 toMonth 36)||136
144852|NCT00365716|352423|P3|STARTED|Long Term Follow-up (Month 7 toMonth 36)||271
144853|NCT00365716|352424|P2|STARTED|Long Term Follow-up (Month 7 toMonth 36)||260
144854|NCT00365716|352425|P1|STARTED|Long Term Follow-up (Month 7 toMonth 36)||269
144855|NCT00365716|352419|P7|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
144856|NCT00365716|352420|P6|NOT COMPLETED|Base Study (Day 1 to Month 7)||0
144857|NCT00365716|352421|P5|NOT COMPLETED|Base Study (Day 1 to Month 7)||7
144858|NCT00365716|352422|P4|NOT COMPLETED|Base Study (Day 1 to Month 7)||10
144859|NCT00365716|352423|P3|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
144860|NCT00365716|352424|P2|NOT COMPLETED|Base Study (Day 1 to Month 7)||24
144861|NCT00365716|352425|P1|NOT COMPLETED|Base Study (Day 1 to Month 7)||21
144862|NCT00365716|352419|P7|COMPLETED|Base Study (Day 1 to Month 7)||0
144863|NCT00365716|352420|P6|COMPLETED|Base Study (Day 1 to Month 7)||0
144864|NCT00365716|352421|P5|COMPLETED|Base Study (Day 1 to Month 7)||139
144865|NCT00365716|352422|P4|COMPLETED|Base Study (Day 1 to Month 7)||136
144866|NCT00365716|352423|P3|COMPLETED|Base Study (Day 1 to Month 7)||271
144867|NCT00365716|352424|P2|COMPLETED|Base Study (Day 1 to Month 7)||260
144868|NCT00365716|352425|P1|COMPLETED|Base Study (Day 1 to Month 7)||269
144869|NCT00365716|352419|P7|STARTED|Base Study (Day 1 to Month 7)||0
144870|NCT00365716|352420|P6|STARTED|Base Study (Day 1 to Month 7)||0
144871|NCT00365716|352421|P5|STARTED|Base Study (Day 1 to Month 7)||146
144872|NCT00365716|352422|P4|STARTED|Base Study (Day 1 to Month 7)||146
144873|NCT00365716|352423|P3|STARTED|Base Study (Day 1 to Month 7)||292
144874|NCT00365716|352424|P2|STARTED|Base Study (Day 1 to Month 7)||284
144875|NCT00365716|352425|P1|STARTED|Base Study (Day 1 to Month 7)||290
144876|NCT00365768|352442|P2|NOT COMPLETED|Overall Study||0
144877|NCT00365768|352443|P1|NOT COMPLETED|Overall Study||0
144878|NCT00365768|352442|P2|COMPLETED|Overall Study||25
144879|NCT00365768|352443|P1|COMPLETED|Overall Study||24
144880|NCT00365768|352442|P2|STARTED|Overall Study||25
144881|NCT00365768|352443|P1|STARTED|Overall Study||24
144882|NCT00365846|352451|P1|NOT COMPLETED|Overall Study||1
144883|NCT00365846|352451|P1|COMPLETED|Overall Study||28
144884|NCT00365846|352451|P1|STARTED|Overall Study||29
144885|NCT00365859|352463|P4|NOT COMPLETED|Overall Study||131
144886|NCT00365859|352464|P3|NOT COMPLETED|Overall Study||67
144887|NCT00365859|352465|P2|NOT COMPLETED|Overall Study||33
144888|NCT00365859|352466|P1|NOT COMPLETED|Overall Study||31
144889|NCT00365859|352463|P4|COMPLETED|Overall Study||199
144890|NCT00365859|352464|P3|COMPLETED|Overall Study||107
144891|NCT00365859|352465|P2|COMPLETED|Overall Study||37
144892|NCT00365859|352466|P1|COMPLETED|Overall Study||55
144893|NCT00365859|352463|P4|Efficacy Population|Overall Study||322
144894|NCT00365859|352464|P3|Efficacy Population|Overall Study|3 lost to follow-up, 1 not included due to mild increased appetite, 1 to family emergency (total=5)|169
144895|NCT00365859|352465|P2|Efficacy Population|Overall Study|1 not included due to increased alanine aminotransferase (ALT) prior to treatment with aripiprazole|69
144896|NCT00365859|352466|P1|Efficacy Population|Overall Study|1 patient was lost to follow-up and 1 not included due to moderate sedation (total=2)|84
144897|NCT00365859|352463|P4|Safety Population|Overall Study||330
144898|NCT00365859|352464|P3|Safety Population|Overall Study||174
144899|NCT00365859|352465|P2|Safety Population|Overall Study||70
144900|NCT00365859|352466|P1|Safety Population|Overall Study||86
144901|NCT00365859|352463|P4|STARTED|Overall Study||330
144902|NCT00365859|352464|P3|STARTED|Overall Study||174
144903|NCT00365859|352465|P2|STARTED|Overall Study||70
144904|NCT00365859|352466|P1|STARTED|Overall Study||86
144905|NCT00365872|352558|P3|NOT COMPLETED|Overall Study||0
144906|NCT00365872|352559|P2|NOT COMPLETED|Overall Study||0
144907|NCT00365872|352560|P1|NOT COMPLETED|Overall Study||0
144908|NCT00365872|352558|P3|COMPLETED|Overall Study||6
144909|NCT00365872|352559|P2|COMPLETED|Overall Study||6
144910|NCT00365872|352560|P1|COMPLETED|Overall Study||5
144911|NCT00365872|352558|P3|STARTED|Overall Study||6
144912|NCT00365872|352559|P2|STARTED|Overall Study||6
144913|NCT00365872|352560|P1|STARTED|Overall Study||5
144914|NCT00365976|352572|P2|NOT COMPLETED|Overall Study||5
144915|NCT00365976|352573|P1|NOT COMPLETED|Overall Study||1
144916|NCT00365976|352572|P2|COMPLETED|Overall Study||20
144917|NCT00365976|352573|P1|COMPLETED|Overall Study||32
144918|NCT00365976|352572|P2|STARTED|Overall Study||25
144919|NCT00365976|352573|P1|STARTED|Overall Study||33
144920|NCT00366028|352603|P2|NOT COMPLETED|Overall Study||0
144921|NCT00366028|352604|P1|NOT COMPLETED|Overall Study||0
144922|NCT00366028|352603|P2|COMPLETED|Overall Study||735
144923|NCT00366028|352604|P1|COMPLETED|Overall Study||889
144924|NCT00366028|352603|P2|STARTED|Overall Study||735
144925|NCT00366028|352604|P1|STARTED|Overall Study||889
144926|NCT00366106|352612|P1|NOT COMPLETED|Overall Study||0
144927|NCT00366106|352612|P1|COMPLETED|Overall Study||32
144928|NCT00366106|352612|P1|STARTED|Overall Study||32
144929|NCT00366249|352621|P2|NOT COMPLETED|Overall Study||78
144930|NCT00366249|352622|P1|NOT COMPLETED|Overall Study||131
144931|NCT00366249|352621|P2|COMPLETED|Overall Study||430
144932|NCT00366249|352622|P1|COMPLETED|Overall Study||422
144933|NCT00366249|352621|P2|STARTED|Overall Study||508
144934|NCT00366249|352622|P1|STARTED|Overall Study||553
144935|NCT00366275|352636|P1|NOT COMPLETED|Overall Study||6
144936|NCT00366275|352636|P1|COMPLETED|Overall Study||58
144937|NCT00366275|352636|P1|STARTED|Overall Study||64
144938|NCT00366301|352644|P4|NOT COMPLETED|Overall Study||8
144939|NCT00366301|352645|P3|NOT COMPLETED|Overall Study||4
144940|NCT00366301|352646|P2|NOT COMPLETED|Overall Study||6
144941|NCT00366301|352647|P1|NOT COMPLETED|Overall Study||8
144942|NCT00366301|352644|P4|COMPLETED|Overall Study||116
144943|NCT00366301|352645|P3|COMPLETED|Overall Study||122
144944|NCT00366301|352646|P2|COMPLETED|Overall Study||120
144945|NCT00366301|352647|P1|COMPLETED|Overall Study||116
144946|NCT00366301|352644|P4|Either 6W or 14W CRP Obtained|Overall Study||119
144947|NCT00366301|352645|P3|Either 6W or 14W CRP Obtained|Overall Study||124
144948|NCT00366301|352646|P2|Either 6W or 14W CRP Obtained|Overall Study||124
144949|NCT00366301|352647|P1|Either 6W or 14W CRP Obtained|Overall Study||120
144950|NCT00366301|352644|P4|STARTED|Overall Study||124
144951|NCT00366301|352645|P3|STARTED|Overall Study||126
144952|NCT00366301|352646|P2|STARTED|Overall Study||126
144953|NCT00366301|352647|P1|STARTED|Overall Study||124
144954|NCT00366340|352659|P2|NOT COMPLETED|Toddler Dose||1
144955|NCT00366340|352660|P1|NOT COMPLETED|Toddler Dose||1
144956|NCT00366340|352659|P2|COMPLETED|Toddler Dose||286
144957|NCT00366340|352660|P1|COMPLETED|Toddler Dose||289
144958|NCT00366340|352659|P2|STARTED|Toddler Dose||287
144959|NCT00366340|352660|P1|STARTED|Toddler Dose||290
144960|NCT00366340|352659|P2|NOT COMPLETED|After the Infant Series||6
144961|NCT00366340|352660|P1|NOT COMPLETED|After the Infant Series||3
144962|NCT00366340|352659|P2|COMPLETED|After the Infant Series||287
144963|NCT00366340|352660|P1|COMPLETED|After the Infant Series||290
144964|NCT00366340|352659|P2|STARTED|After the Infant Series||293
144965|NCT00366340|352660|P1|STARTED|After the Infant Series||293
144966|NCT00366340|352659|P2|NOT COMPLETED|Infant Series||10
144967|NCT00366340|352660|P1|NOT COMPLETED|Infant Series||8
144968|NCT00366340|352659|P2|COMPLETED|Infant Series||293
144969|NCT00366340|352660|P1|COMPLETED|Infant Series||293
144970|NCT00366340|352659|P2|Vaccinated Dose 3|Infant Series||293
144971|NCT00366340|352660|P1|Vaccinated Dose 3|Infant Series||294
144972|NCT00366340|352659|P2|Vaccinated Dose 2|Infant Series||297
144973|NCT00366340|352660|P1|Vaccinated Dose 2|Infant Series||296
144974|NCT00366340|352659|P2|Vaccinated Dose 1|Infant Series||303
144975|NCT00366340|352660|P1|Vaccinated Dose 1|Infant Series||300
144976|NCT00366340|352659|P2|STARTED|Infant Series||303
144977|NCT00366340|352660|P1|STARTED|Infant Series||301
144978|NCT00366444|352716|P2|NOT COMPLETED|Overall Study||2
144979|NCT00366444|352717|P1|NOT COMPLETED|Overall Study||1
144980|NCT00366444|352716|P2|COMPLETED|Overall Study||97
144981|NCT00366444|352717|P1|COMPLETED|Overall Study||101
144982|NCT00366444|352716|P2|STARTED|Overall Study||99
144983|NCT00366444|352717|P1|STARTED|Overall Study||102
144984|NCT00366457|352743|P1|NOT COMPLETED|Overall Study||2
144985|NCT00366457|352743|P1|COMPLETED|Overall Study||30
144986|NCT00366457|352743|P1|STARTED|Overall Study||32
144987|NCT00366548|352752|P2|NOT COMPLETED|Toddler Dose||0
144988|NCT00366548|352753|P1|NOT COMPLETED|Toddler Dose||0
144989|NCT00366548|352752|P2|COMPLETED|Toddler Dose||244
144990|NCT00366548|352753|P1|COMPLETED|Toddler Dose||240
144991|NCT00366548|352752|P2|STARTED|Toddler Dose||244
144992|NCT00366548|352753|P1|STARTED|Toddler Dose||240
144993|NCT00366548|352752|P2|NOT COMPLETED|After Infant Series||1
144994|NCT00366548|352753|P1|NOT COMPLETED|After Infant Series||6
144995|NCT00366548|352752|P2|COMPLETED|After Infant Series||244
144996|NCT00366548|352753|P1|COMPLETED|After Infant Series||240
144997|NCT00366548|352752|P2|STARTED|After Infant Series||245
144998|NCT00366548|352753|P1|STARTED|After Infant Series||246
144999|NCT00366548|352752|P2|NOT COMPLETED|Infant Series||5
145000|NCT00366548|352753|P1|NOT COMPLETED|Infant Series||4
145001|NCT00366548|352752|P2|COMPLETED|Infant Series||245
145002|NCT00366548|352753|P1|COMPLETED|Infant Series||246
145003|NCT00366548|352752|P2|Vaccinated Dose 3|Infant Series||247
145004|NCT00366548|352753|P1|Vaccinated Dose 3|Infant Series||246
145005|NCT00366548|352752|P2|Vaccinated Dose 2|Infant Series||249
145006|NCT00366548|352753|P1|Vaccinated Dose 2|Infant Series||246
145007|NCT00366548|352752|P2|Vaccinated Dose 1|Infant Series||250
145008|NCT00366548|352753|P1|Vaccinated Dose 1|Infant Series||250
145009|NCT00366548|352752|P2|STARTED|Infant Series||250
145010|NCT00366548|352753|P1|STARTED|Infant Series||250
145011|NCT00366626|352789|P2|NOT COMPLETED|Overall Study||0
145012|NCT00366626|352790|P1|NOT COMPLETED|Overall Study||0
145013|NCT00366626|352789|P2|COMPLETED|Overall Study||45
145014|NCT00366626|352790|P1|COMPLETED|Overall Study||38
145015|NCT00366626|352789|P2|STARTED|Overall Study||45
145016|NCT00366626|352790|P1|STARTED|Overall Study||38
145017|NCT00366678|352804|P3|NOT COMPLETED|Toddler Dose||0
145018|NCT00366678|352805|P2|NOT COMPLETED|Toddler Dose||1
145019|NCT00366678|352806|P1|NOT COMPLETED|Toddler Dose||5
145020|NCT00366678|352804|P3|COMPLETED|Toddler Dose||137
145021|NCT00366678|352805|P2|COMPLETED|Toddler Dose||151
145022|NCT00366678|352806|P1|COMPLETED|Toddler Dose||268
145023|NCT00366678|352804|P3|STARTED|Toddler Dose||137
145024|NCT00366678|352805|P2|STARTED|Toddler Dose||152
145025|NCT00366678|352806|P1|STARTED|Toddler Dose||273
145026|NCT00366678|352804|P3|NOT COMPLETED|After Infant||0
145027|NCT00366678|352805|P2|NOT COMPLETED|After Infant||10
145028|NCT00366678|352806|P1|NOT COMPLETED|After Infant||17
145029|NCT00366678|352804|P3|COMPLETED|After Infant||0
145030|NCT00366678|352805|P2|COMPLETED|After Infant||289
145031|NCT00366678|352806|P1|COMPLETED|After Infant||273
145032|NCT00366678|352804|P3|STARTED|After Infant||0
145033|NCT00366678|352805|P2|STARTED|After Infant||299
145034|NCT00366678|352806|P1|STARTED|After Infant||290
145035|NCT00366678|352804|P3|NOT COMPLETED|Infant Series||0
145036|NCT00366678|352805|P2|NOT COMPLETED|Infant Series||10
145037|NCT00366678|352806|P1|NOT COMPLETED|Infant Series||14
145038|NCT00366678|352804|P3|COMPLETED|Infant Series||0
145039|NCT00366678|352805|P2|COMPLETED|Infant Series||299
145040|NCT00366678|352806|P1|COMPLETED|Infant Series||290
145041|NCT00366678|352804|P3|Vaccinated Dose 3|Infant Series||0
145042|NCT00366678|352805|P2|Vaccinated Dose 3|Infant Series||302
145043|NCT00366678|352806|P1|Vaccinated Dose 3|Infant Series||291
145044|NCT00366678|352804|P3|Vaccinated Dose 2|Infant Series||0
145045|NCT00366678|352805|P2|Vaccinated Dose 2|Infant Series||304
145046|NCT00366678|352806|P1|Vaccinated Dose 2|Infant Series||295
145047|NCT00366678|352804|P3|Vaccinated Dose 1|Infant Series||0
145048|NCT00366678|352805|P2|Vaccinated Dose 1|Infant Series||309
145049|NCT00366678|352806|P1|Vaccinated Dose 1|Infant Series||302
145050|NCT00366678|352804|P3|STARTED|Infant Series||0
145051|NCT00366678|352805|P2|STARTED|Infant Series||309
145052|NCT00366678|352806|P1|STARTED|Infant Series||304
145053|NCT00366899|352873|P2|NOT COMPLETED|Toddler Dose||1
145054|NCT00366899|352874|P1|NOT COMPLETED|Toddler Dose||2
145055|NCT00366899|352873|P2|COMPLETED|Toddler Dose||281
145056|NCT00366899|352874|P1|COMPLETED|Toddler Dose||285
145057|NCT00366899|352873|P2|STARTED|Toddler Dose||282
145058|NCT00366899|352874|P1|STARTED|Toddler Dose||287
145059|NCT00366899|352873|P2|NOT COMPLETED|After Infant Series||9
145060|NCT00366899|352874|P1|NOT COMPLETED|After Infant Series||7
145061|NCT00366899|352873|P2|COMPLETED|After Infant Series||282
145062|NCT00366899|352874|P1|COMPLETED|After Infant Series||287
145063|NCT00366899|352873|P2|STARTED|After Infant Series||291
145064|NCT00366899|352874|P1|STARTED|After Infant Series||294
145065|NCT00366899|352873|P2|NOT COMPLETED|Infant Series||12
145066|NCT00366899|352874|P1|NOT COMPLETED|Infant Series||9
145067|NCT00366899|352873|P2|COMPLETED|Infant Series||291
145068|NCT00366899|352874|P1|COMPLETED|Infant Series||294
145069|NCT00366899|352873|P2|Vaccinated Dose 2|Infant Series||293
145070|NCT00366899|352874|P1|Vaccinated Dose 2|Infant Series|1 participant randomized to 13vPnC, incorrectly received 7vPnC|296
145071|NCT00366899|352873|P2|Vaccinated Dose 1|Infant Series||302
145072|NCT00366899|352874|P1|Vaccinated Dose 1|Infant Series|2 participants randomized to 13vPnC, incorrectly received 7vPnC|302
145073|NCT00366899|352873|P2|STARTED|Infant Series|1 participant randomized to 7vPnC but never vaccinated|303
145074|NCT00366899|352874|P1|STARTED|Infant Series|1 participant was counted twice, 1 participant randomized to 13vPnC, incorrectly received 7vPnC|303
145075|NCT00367055|352934|P2|NOT COMPLETED|Overall Study||11
145076|NCT00367055|352935|P1|NOT COMPLETED|Overall Study||11
145077|NCT00367055|352934|P2|COMPLETED|Overall Study||30
145078|NCT00367055|352935|P1|COMPLETED|Overall Study||32
145079|NCT00367055|352934|P2|STARTED|Overall Study||41
145080|NCT00367055|352935|P1|STARTED|Overall Study||43
145081|NCT00367133|352952|P3|NOT COMPLETED|3 Years||18
145082|NCT00367133|352953|P2|NOT COMPLETED|3 Years||23
145083|NCT00367133|352954|P1|NOT COMPLETED|3 Years||28
145084|NCT00367133|352952|P3|COMPLETED|3 Years||98
145085|NCT00367133|352953|P2|COMPLETED|3 Years||93
145086|NCT00367133|352954|P1|COMPLETED|3 Years||115
145087|NCT00367133|352952|P3|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
145088|NCT00367133|352953|P2|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|116
145089|NCT00367133|352954|P1|STARTED|3 Years|Since trial ended early, includes only those with potential for 3 year follow-up -excludes deaths|143
145090|NCT00367133|352952|P3|NOT COMPLETED|2 Years||49
145091|NCT00367133|352953|P2|NOT COMPLETED|2 Years||36
145092|NCT00367133|352954|P1|NOT COMPLETED|2 Years||58
145093|NCT00367133|352952|P3|COMPLETED|2 Years||205
145094|NCT00367133|352953|P2|COMPLETED|2 Years||220
145095|NCT00367133|352954|P1|COMPLETED|2 Years||272
145096|NCT00367133|352952|P3|STARTED|2 Years|Number of Eyes|254
145097|NCT00367133|352953|P2|STARTED|2 Years|Number of Eyes|256
145098|NCT00367133|352954|P1|STARTED|2 Years|Number of Eyes|330
145099|NCT00367237|353006|P2|NOT COMPLETED|Overall Study||11
145100|NCT00367237|353007|P1|NOT COMPLETED|Overall Study||10
145101|NCT00367237|353006|P2|COMPLETED|Overall Study||47
145102|NCT00367237|353007|P1|COMPLETED|Overall Study||47
145103|NCT00367237|353006|P2|STARTED|Overall Study|Number of subjects randomized|58
145104|NCT00367237|353007|P1|STARTED|Overall Study|Number of subjects randomized|57
145105|NCT00367341|353015|P2|NOT COMPLETED|Overall Study||0
145106|NCT00367341|353016|P1|NOT COMPLETED|Overall Study||2
145107|NCT00367341|353015|P2|COMPLETED|Overall Study||40
145108|NCT00367341|353016|P1|COMPLETED|Overall Study||40
145109|NCT00367341|353015|P2|STARTED|Overall Study||40
145110|NCT00367341|353016|P1|STARTED|Overall Study||42
145111|NCT00367380|353027|P3|NOT COMPLETED|Overall Study||0
145112|NCT00367380|353028|P2|NOT COMPLETED|Overall Study||0
145113|NCT00367380|353029|P1|NOT COMPLETED|Overall Study||0
145114|NCT00367380|353027|P3|COMPLETED|Overall Study||6
145115|NCT00367380|353028|P2|COMPLETED|Overall Study||6
145116|NCT00367380|353029|P1|COMPLETED|Overall Study||6
145117|NCT00367380|353027|P3|STARTED|Overall Study||6
145118|NCT00367380|353028|P2|STARTED|Overall Study||6
145119|NCT00367380|353029|P1|STARTED|Overall Study||6
145120|NCT00367432|353037|P2|NOT COMPLETED|Second Period (up to 54 Months)||16
145121|NCT00367432|353038|P1|NOT COMPLETED|Second Period (up to 54 Months)||87
145122|NCT00367432|353037|P2|COMPLETED|Second Period (up to 54 Months)||69
145123|NCT00367432|353038|P1|COMPLETED|Second Period (up to 54 Months)||188
145124|NCT00367432|353037|P2|STARTED|Second Period (up to 54 Months)|85 subjects from N01020 [NCT00160615] entered Second Period of N01222|85
145212|NCT00359983|353195|P1|COMPLETED|Year 1 Persistence Follow-up||138
145125|NCT00367432|353038|P1|STARTED|Second Period (up to 54 Months)|275 subjects from N01221 [NCT00280696] completed First Period and entered Second Period of N01222|275
145126|NCT00367432|353037|P2|NOT COMPLETED|First Period (16 Weeks)||0
145127|NCT00367432|353038|P1|NOT COMPLETED|First Period (16 Weeks)||38
145128|NCT00367432|353037|P2|COMPLETED|First Period (16 Weeks)||0
145129|NCT00367432|353038|P1|COMPLETED|First Period (16 Weeks)||275
145130|NCT00367432|353037|P2|STARTED|First Period (16 Weeks)||0
145131|NCT00367432|353038|P1|STARTED|First Period (16 Weeks)|Eligible subjects from preceding study N01221 [NCT00280696] entered the First Period of N01222|313
145132|NCT00367484|353050|P1|NOT COMPLETED|Overall Study||17
145133|NCT00367484|353050|P1|COMPLETED|Overall Study|Safety population = 460 Intent To Treat (ITT) population = 458|443
145134|NCT00367484|353050|P1|STARTED|Overall Study||460
145135|NCT00367601|353054|P1|NOT COMPLETED|Overall Study||0
145136|NCT00367601|353054|P1|COMPLETED|Overall Study||25
145137|NCT00367601|353054|P1|STARTED|Overall Study||25
145138|NCT00367640|353064|P4|NOT COMPLETED|Overall Study||10
145139|NCT00367640|353065|P3|NOT COMPLETED|Overall Study||19
145140|NCT00367640|353066|P2|NOT COMPLETED|Overall Study||22
145141|NCT00367640|353067|P1|NOT COMPLETED|Overall Study||18
145142|NCT00367640|353064|P4|COMPLETED|Overall Study||146
145143|NCT00367640|353065|P3|COMPLETED|Overall Study||141
145144|NCT00367640|353066|P2|COMPLETED|Overall Study||133
145145|NCT00367640|353067|P1|COMPLETED|Overall Study||139
145146|NCT00367640|353064|P4|STARTED|Overall Study||156
145147|NCT00367640|353065|P3|STARTED|Overall Study||160
145148|NCT00367640|353066|P2|STARTED|Overall Study||155
145149|NCT00367640|353067|P1|STARTED|Overall Study||157
145150|NCT00367679|353077|P1|NOT COMPLETED|Overall Study||0
145151|NCT00367679|353077|P1|COMPLETED|Overall Study||35
145152|NCT00367679|353077|P1|STARTED|Overall Study||35
145153|NCT00367744|353096|P2|NOT COMPLETED|Overall Study||5
145154|NCT00367744|353097|P1|NOT COMPLETED|Overall Study||4
145155|NCT00367744|353096|P2|COMPLETED|Overall Study||32
145156|NCT00367744|353097|P1|COMPLETED|Overall Study||30
145157|NCT00367744|353096|P2|STARTED|Overall Study||37
145158|NCT00367744|353097|P1|STARTED|Overall Study||34
145159|NCT00367770|353105|P1|NOT COMPLETED|Overall Study||2
145160|NCT00367770|353105|P1|COMPLETED|Overall Study||35
145161|NCT00367770|353105|P1|STARTED|Overall Study||37
145162|NCT00367835|353113|P2|NOT COMPLETED|Overall Study||31
145163|NCT00367835|353114|P1|NOT COMPLETED|Overall Study||29
145164|NCT00367835|353113|P2|COMPLETED|Overall Study||48
145165|NCT00367835|353114|P1|COMPLETED|Overall Study||109
145166|NCT00367835|353113|P2|STARTED|Overall Study||79
145167|NCT00367835|353114|P1|STARTED|Overall Study||138
145168|NCT00367991|353142|P2|NOT COMPLETED|Overall Study||2
145169|NCT00367991|353143|P1|NOT COMPLETED|Overall Study||2
145170|NCT00367991|353142|P2|COMPLETED|Overall Study||13
145171|NCT00367991|353143|P1|COMPLETED|Overall Study||27
145172|NCT00367991|353142|P2|STARTED|Overall Study||15
145173|NCT00367991|353143|P1|STARTED|Overall Study||29
145174|NCT00368069|353151|P2|NOT COMPLETED|Overall Study||7
145175|NCT00368069|353152|P1|NOT COMPLETED|Overall Study||8
145176|NCT00368069|353151|P2|COMPLETED|Overall Study||72
145177|NCT00368069|353152|P1|COMPLETED|Overall Study||71
145178|NCT00368069|353151|P2|STARTED|Overall Study||79
145179|NCT00368069|353152|P1|STARTED|Overall Study||79
145180|NCT00368108|353171|P3|NOT COMPLETED|Overall Study||68
145181|NCT00368108|353172|P2|NOT COMPLETED|Overall Study||53
145182|NCT00368108|353173|P1|NOT COMPLETED|Overall Study||64
145183|NCT00368108|353171|P3|COMPLETED|Overall Study||182
145184|NCT00368108|353172|P2|COMPLETED|Overall Study||198
145185|NCT00368108|353173|P1|COMPLETED|Overall Study||187
145186|NCT00368108|353171|P3|STARTED|Overall Study||250
145187|NCT00368108|353172|P2|STARTED|Overall Study||251
145188|NCT00368108|353173|P1|STARTED|Overall Study|One subject had stopped medication prior to notifying staff. Remaining results will have 250.|251
145189|NCT00359983|353193|P3|NOT COMPLETED|Year 5 Persistence Follow-up||0
145190|NCT00359983|353194|P2|NOT COMPLETED|Year 5 Persistence Follow-up||0
145191|NCT00359983|353195|P1|NOT COMPLETED|Year 5 Persistence Follow-up||0
145192|NCT00359983|353193|P3|COMPLETED|Year 5 Persistence Follow-up||42
145193|NCT00359983|353194|P2|COMPLETED|Year 5 Persistence Follow-up||44
145194|NCT00359983|353195|P1|COMPLETED|Year 5 Persistence Follow-up||95
145195|NCT00359983|353193|P3|STARTED|Year 5 Persistence Follow-up||42
145196|NCT00359983|353194|P2|STARTED|Year 5 Persistence Follow-up||44
145197|NCT00359983|353195|P1|STARTED|Year 5 Persistence Follow-up||95
145198|NCT00359983|353193|P3|NOT COMPLETED|Year 3 Persistence Follow-up||0
145199|NCT00359983|353194|P2|NOT COMPLETED|Year 3 Persistence Follow-up||0
145200|NCT00359983|353195|P1|NOT COMPLETED|Year 3 Persistence Follow-up||0
145201|NCT00359983|353193|P3|COMPLETED|Year 3 Persistence Follow-up||51
145202|NCT00359983|353194|P2|COMPLETED|Year 3 Persistence Follow-up||47
145203|NCT00359983|353195|P1|COMPLETED|Year 3 Persistence Follow-up||103
145204|NCT00359983|353193|P3|STARTED|Year 3 Persistence Follow-up||51
145205|NCT00359983|353194|P2|STARTED|Year 3 Persistence Follow-up||47
145206|NCT00359983|353195|P1|STARTED|Year 3 Persistence Follow-up||103
145207|NCT00359983|353193|P3|NOT COMPLETED|Year 1 Persistence Follow-up||0
145208|NCT00359983|353194|P2|NOT COMPLETED|Year 1 Persistence Follow-up||0
145209|NCT00359983|353195|P1|NOT COMPLETED|Year 1 Persistence Follow-up||0
145210|NCT00359983|353193|P3|COMPLETED|Year 1 Persistence Follow-up||62
145211|NCT00359983|353194|P2|COMPLETED|Year 1 Persistence Follow-up||70
145213|NCT00359983|353193|P3|STARTED|Year 1 Persistence Follow-up||62
145214|NCT00359983|353194|P2|STARTED|Year 1 Persistence Follow-up||70
145215|NCT00359983|353195|P1|STARTED|Year 1 Persistence Follow-up||138
145216|NCT00360009|353230|P3|NOT COMPLETED|Overall Study||3
145217|NCT00360009|353231|P2|NOT COMPLETED|Overall Study||4
145218|NCT00360009|353232|P1|NOT COMPLETED|Overall Study||0
145219|NCT00360009|353230|P3|COMPLETED|Overall Study||23
145220|NCT00360009|353231|P2|COMPLETED|Overall Study||22
145221|NCT00360009|353232|P1|COMPLETED|Overall Study||10
145222|NCT00360009|353230|P3|STARTED|Overall Study||26
145223|NCT00360009|353231|P2|STARTED|Overall Study||26
145224|NCT00360009|353232|P1|STARTED|Overall Study||10
145225|NCT00360126|353270|P1|NOT COMPLETED|Overall Study||0
145226|NCT00360126|353270|P1|COMPLETED|Overall Study||11
145227|NCT00360126|353270|P1|STARTED|Overall Study||11
145228|NCT00360243|353278|P4|NOT COMPLETED|Overall Study||125
145229|NCT00360243|353279|P3|NOT COMPLETED|Overall Study||156
145230|NCT00360243|353280|P2|NOT COMPLETED|Overall Study||120
145231|NCT00360243|353281|P1|NOT COMPLETED|Overall Study||102
145232|NCT00360243|353278|P4|COMPLETED|Overall Study||224
145233|NCT00360243|353279|P3|COMPLETED|Overall Study||180
145234|NCT00360243|353280|P2|COMPLETED|Overall Study||243
145235|NCT00360243|353281|P1|COMPLETED|Overall Study||235
145236|NCT00360243|353278|P4|STARTED|Overall Study||349
145237|NCT00360243|353279|P3|STARTED|Overall Study||336
145238|NCT00360243|353280|P2|STARTED|Overall Study||363
145239|NCT00360243|353281|P1|STARTED|Overall Study||337
145240|NCT00360269|353297|P2|NOT COMPLETED|Overall Study||12
145241|NCT00360269|353298|P1|NOT COMPLETED|Overall Study||10
145242|NCT00360269|353297|P2|COMPLETED|Overall Study||7
145243|NCT00360269|353298|P1|COMPLETED|Overall Study||9
145244|NCT00360269|353297|P2|STARTED|Overall Study||19
145245|NCT00360269|353298|P1|STARTED|Overall Study||19
145246|NCT00360282|353312|P4|NOT COMPLETED|Second Intervention||0
145247|NCT00360282|353313|P3|NOT COMPLETED|Second Intervention||0
145248|NCT00360282|353314|P2|NOT COMPLETED|Second Intervention||1
145249|NCT00360282|353315|P1|NOT COMPLETED|Second Intervention||0
145250|NCT00360282|353312|P4|COMPLETED|Second Intervention||6
145251|NCT00360282|353313|P3|COMPLETED|Second Intervention||6
145252|NCT00360282|353314|P2|COMPLETED|Second Intervention||7
145253|NCT00360282|353315|P1|COMPLETED|Second Intervention||6
145254|NCT00360282|353312|P4|STARTED|Second Intervention||6
145255|NCT00360282|353313|P3|STARTED|Second Intervention||6
145256|NCT00360282|353314|P2|STARTED|Second Intervention||8
145257|NCT00360282|353315|P1|STARTED|Second Intervention||6
145258|NCT00360282|353312|P4|NOT COMPLETED|Washout 1-3 Weeks||0
145259|NCT00360282|353313|P3|NOT COMPLETED|Washout 1-3 Weeks||1
145260|NCT00360282|353314|P2|NOT COMPLETED|Washout 1-3 Weeks||0
145261|NCT00360282|353315|P1|NOT COMPLETED|Washout 1-3 Weeks||0
145262|NCT00360282|353312|P4|COMPLETED|Washout 1-3 Weeks||6
145263|NCT00360282|353313|P3|COMPLETED|Washout 1-3 Weeks||6
145264|NCT00360282|353314|P2|COMPLETED|Washout 1-3 Weeks||8
145265|NCT00360282|353315|P1|COMPLETED|Washout 1-3 Weeks||6
145266|NCT00360282|353312|P4|STARTED|Washout 1-3 Weeks||6
145267|NCT00360282|353313|P3|STARTED|Washout 1-3 Weeks||7
145268|NCT00360282|353314|P2|STARTED|Washout 1-3 Weeks||8
145269|NCT00360282|353315|P1|STARTED|Washout 1-3 Weeks||6
145270|NCT00360282|353312|P4|NOT COMPLETED|First Intervention||0
145271|NCT00360282|353313|P3|NOT COMPLETED|First Intervention||0
145272|NCT00360282|353314|P2|NOT COMPLETED|First Intervention||0
145273|NCT00360282|353315|P1|NOT COMPLETED|First Intervention||0
145274|NCT00360282|353312|P4|COMPLETED|First Intervention||6
145275|NCT00360282|353313|P3|COMPLETED|First Intervention||7
145276|NCT00360282|353314|P2|COMPLETED|First Intervention||8
145277|NCT00360282|353315|P1|COMPLETED|First Intervention||6
145278|NCT00360282|353312|P4|STARTED|First Intervention||6
145279|NCT00360282|353313|P3|STARTED|First Intervention||7
145280|NCT00360282|353314|P2|STARTED|First Intervention||8
145281|NCT00360282|353315|P1|STARTED|First Intervention||6
145282|NCT00360308|353328|P3|NOT COMPLETED|Overall Study||88
145283|NCT00360308|353329|P2|NOT COMPLETED|Overall Study||79
145284|NCT00360308|353330|P1|NOT COMPLETED|Overall Study||76
145285|NCT00360308|353328|P3|COMPLETED|Overall Study||154
145286|NCT00360308|353329|P2|COMPLETED|Overall Study||155
145287|NCT00360308|353330|P1|COMPLETED|Overall Study||171
145288|NCT00360308|353328|P3|STARTED|Overall Study||242
145289|NCT00360308|353329|P2|STARTED|Overall Study||234
145290|NCT00360308|353330|P1|STARTED|Overall Study||247
145291|NCT00360334|353349|P2|NOT COMPLETED|Overall Study||13
145292|NCT00360334|353350|P1|NOT COMPLETED|Overall Study||19
145293|NCT00360334|353349|P2|COMPLETED|Overall Study||104
145294|NCT00360334|353350|P1|COMPLETED|Overall Study||99
145295|NCT00360334|353349|P2|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|116
145296|NCT00360334|353350|P1|Full Analysis Set (FAS)|Overall Study|FAS = received ≥ 1 dose of study drug|118
145297|NCT00360334|353349|P2|STARTED|Overall Study||117
145298|NCT00360334|353350|P1|STARTED|Overall Study||118
145299|NCT00360360|353410|P1|NOT COMPLETED|Overall Study||6
145300|NCT00360360|353410|P1|COMPLETED|Overall Study||54
145301|NCT00360360|353410|P1|STARTED|Overall Study||60
145302|NCT00360399|353418|P3|NOT COMPLETED|Overall Study||46
145303|NCT00360399|353419|P2|NOT COMPLETED|Overall Study||36
145304|NCT00360399|353420|P1|NOT COMPLETED|Overall Study||28
145305|NCT00360399|353418|P3|COMPLETED|Overall Study||69
145306|NCT00360399|353419|P2|COMPLETED|Overall Study||79
145307|NCT00360399|353420|P1|COMPLETED|Overall Study||86
145308|NCT00360399|353418|P3|Had Post-randomization Assessment|Overall Study||105
145309|NCT00360399|353419|P2|Had Post-randomization Assessment|Overall Study||106
145310|NCT00360399|353420|P1|Had Post-randomization Assessment|Overall Study||105
145311|NCT00360399|353418|P3|STARTED|Overall Study||115
145312|NCT00360399|353419|P2|STARTED|Overall Study||115
145313|NCT00360399|353420|P1|STARTED|Overall Study||114
145314|NCT00360412|353445|P2|NOT COMPLETED|Overall Study||662
145315|NCT00360412|353446|P1|NOT COMPLETED|Overall Study||333
145316|NCT00360412|353445|P2|COMPLETED|Overall Study||2
145317|NCT00360412|353446|P1|COMPLETED|Overall Study||0
145318|NCT00360412|353445|P2|STARTED|Overall Study||664
145319|NCT00360412|353446|P1|STARTED|Overall Study||333
145320|NCT00360490|353460|P2|NOT COMPLETED|Overall Study||11
145321|NCT00360490|353461|P1|NOT COMPLETED|Overall Study||9
145322|NCT00360490|353460|P2|COMPLETED|Overall Study||72
145323|NCT00360490|353461|P1|COMPLETED|Overall Study||73
145324|NCT00360490|353460|P2|STARTED|Overall Study||83
145325|NCT00360490|353461|P1|STARTED|Overall Study||82
145326|NCT00360529|353497|P3|NOT COMPLETED|Overall Study||91
145327|NCT00360529|353498|P2|NOT COMPLETED|Overall Study||65
145328|NCT00360529|353499|P1|NOT COMPLETED|Overall Study||61
145329|NCT00360529|353497|P3|COMPLETED|Overall Study||199
145330|NCT00360529|353498|P2|COMPLETED|Overall Study||230
145331|NCT00360529|353499|P1|COMPLETED|Overall Study||234
145332|NCT00360529|353497|P3|STARTED|Overall Study||290
145333|NCT00360529|353498|P2|STARTED|Overall Study||295
145334|NCT00360529|353499|P1|STARTED|Overall Study||295
145335|NCT00360555|353529|P4|NOT COMPLETED|Overall Study||112
145336|NCT00360555|353530|P3|NOT COMPLETED|Overall Study||145
145337|NCT00360555|353531|P2|NOT COMPLETED|Overall Study||134
145338|NCT00360555|353532|P1|NOT COMPLETED|Overall Study||122
145339|NCT00360555|353529|P4|COMPLETED|Overall Study||287
145340|NCT00360555|353530|P3|COMPLETED|Overall Study||251
145341|NCT00360555|353531|P2|COMPLETED|Overall Study||259
145342|NCT00360555|353532|P1|COMPLETED|Overall Study||274
145343|NCT00360555|353529|P4|STARTED|Overall Study||399
145344|NCT00360555|353530|P3|STARTED|Overall Study||396
145345|NCT00360555|353531|P2|STARTED|Overall Study||393
145346|NCT00360555|353532|P1|STARTED|Overall Study||396
145347|NCT00360568|353548|P2|NOT COMPLETED|Overall Study||5
145348|NCT00360568|353549|P1|NOT COMPLETED|Overall Study||2
145349|NCT00360568|353548|P2|COMPLETED|Overall Study||24
145350|NCT00360568|353549|P1|COMPLETED|Overall Study||31
145351|NCT00360568|353548|P2|STARTED|Overall Study||29
145352|NCT00360568|353549|P1|STARTED|Overall Study||33
145353|NCT00360672|353656|P1|NOT COMPLETED|Overall Study||0
145354|NCT00360672|353656|P1|COMPLETED|Overall Study||27
145355|NCT00360672|353656|P1|STARTED|Overall Study||27
145356|NCT00360685|353662|P2|NOT COMPLETED|Overall Study||0
145357|NCT00360685|353663|P1|NOT COMPLETED|Overall Study||0
145358|NCT00360685|353662|P2|COMPLETED|Overall Study||42
145359|NCT00360685|353663|P1|COMPLETED|Overall Study||47
145360|NCT00360685|353662|P2|STARTED|Overall Study||42
145361|NCT00360685|353663|P1|STARTED|Overall Study||47
145362|NCT00360698|353675|P2|NOT COMPLETED|Treatment Period||1
145363|NCT00360698|353676|P1|NOT COMPLETED|Treatment Period||1
145364|NCT00360698|353675|P2|COMPLETED|Treatment Period||56
145365|NCT00360698|353676|P1|COMPLETED|Treatment Period||48
145366|NCT00360698|353675|P2|STARTED|Treatment Period||57
145367|NCT00360698|353676|P1|STARTED|Treatment Period||49
145368|NCT00360698|353675|P2|NOT COMPLETED|Run-In||10
145369|NCT00360698|353676|P1|NOT COMPLETED|Run-In||0
145370|NCT00360698|353675|P2|COMPLETED|Run-In|19 patients completed the run-in but were not eligible for randomization in the treatment period|125
145371|NCT00360698|353676|P1|COMPLETED|Run-In||0
145372|NCT00360698|353675|P2|STARTED|Run-In||135
145373|NCT00360698|353676|P1|STARTED|Run-In||0
145374|NCT00360724|353704|P2|NOT COMPLETED|Overall Study||4
145375|NCT00360724|353705|P1|NOT COMPLETED|Overall Study||4
145376|NCT00360724|353704|P2|COMPLETED|Overall Study||28
145377|NCT00360724|353705|P1|COMPLETED|Overall Study||29
145378|NCT00360724|353704|P2|STARTED|Overall Study||32
145379|NCT00360724|353705|P1|STARTED|Overall Study||33
145380|NCT00360828|353731|P1|NOT COMPLETED|Overall Study||1
145381|NCT00360828|353731|P1|COMPLETED|Overall Study||9
145382|NCT00360828|353731|P1|STARTED|Overall Study||10
145383|NCT00360971|353741|P2|NOT COMPLETED|Overall Study||0
145384|NCT00360971|353742|P1|NOT COMPLETED|Overall Study||0
145385|NCT00360971|353741|P2|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|11
145386|NCT00360971|353742|P1|COMPLETED|Overall Study|Subjects with data for planned primary analysis are considered to have completed the study.|10
145387|NCT00360971|353741|P2|STARTED|Overall Study||11
145388|NCT00360971|353742|P1|STARTED|Overall Study||10
145389|NCT00361140|353751|P3|NOT COMPLETED|Overall Study||0
145390|NCT00361140|353752|P2|NOT COMPLETED|Overall Study||0
145391|NCT00361140|353753|P1|NOT COMPLETED|Overall Study||0
145392|NCT00361140|353751|P3|COMPLETED|Overall Study||3
145393|NCT00361140|353752|P2|COMPLETED|Overall Study||29
145394|NCT00361140|353753|P1|COMPLETED|Overall Study||40
145395|NCT00361140|353751|P3|STARTED|Overall Study||3
145396|NCT00361140|353752|P2|STARTED|Overall Study||29
145397|NCT00361140|353753|P1|STARTED|Overall Study||40
145398|NCT00361218|353764|P1|NOT COMPLETED|Overall Study||23
145399|NCT00361218|353764|P1|COMPLETED|Overall Study||30
145400|NCT00361218|353764|P1|Completed Baseline Assessment|Overall Study||47
145401|NCT00361218|353764|P1|STARTED|Overall Study|met eligibility criteria and enrolled in the study|53
145402|NCT00361231|353768|P1|NOT COMPLETED|Overall Study||34
145403|NCT00361231|353768|P1|COMPLETED|Overall Study||1
145404|NCT00361231|353768|P1|STARTED|Overall Study||35
145405|NCT00361257|353775|P2|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
145406|NCT00361257|353776|P1|NOT COMPLETED|Step 2: Minocycline(Open Label) for All||15
145407|NCT00361257|353775|P2|COMPLETED|Step 2: Minocycline(Open Label) for All||19
145408|NCT00361257|353776|P1|COMPLETED|Step 2: Minocycline(Open Label) for All||13
145409|NCT00361257|353775|P2|STARTED|Step 2: Minocycline(Open Label) for All|43 participants completed Step 1; however, 9 decided not to enroll Step 2,so 43-9=34 started Step 2.|34
145410|NCT00361257|353776|P1|STARTED|Step 2: Minocycline(Open Label) for All|40 participants completed Step 1; however,12 decided not to enroll Step 2,so 40-12=28 started Step 2|28
145411|NCT00361257|353775|P2|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
145412|NCT00361257|353776|P1|NOT COMPLETED|Step 1: Minocycline vs. Placebo||12
145413|NCT00361257|353775|P2|COMPLETED|Step 1: Minocycline vs. Placebo||43
145414|NCT00361257|353776|P1|COMPLETED|Step 1: Minocycline vs. Placebo||40
145415|NCT00361257|353775|P2|STARTED|Step 1: Minocycline vs. Placebo||55
145416|NCT00361257|353776|P1|STARTED|Step 1: Minocycline vs. Placebo||52
145417|NCT00361270|353832|P4|NOT COMPLETED|Overall Study||13
145418|NCT00361270|353833|P3|NOT COMPLETED|Overall Study||10
145419|NCT00361270|353834|P2|NOT COMPLETED|Overall Study||14
145420|NCT00361270|353835|P1|NOT COMPLETED|Overall Study||24
145421|NCT00361270|353832|P4|COMPLETED|Overall Study||25
145422|NCT00361270|353833|P3|COMPLETED|Overall Study||25
145423|NCT00361270|353834|P2|COMPLETED|Overall Study||25
145424|NCT00361270|353835|P1|COMPLETED|Overall Study||25
145425|NCT00361270|353832|P4|STARTED|Overall Study||38
145426|NCT00361270|353833|P3|STARTED|Overall Study||35
145427|NCT00361270|353834|P2|STARTED|Overall Study||39
145428|NCT00361270|353835|P1|STARTED|Overall Study||49
145429|NCT00361283|353853|P1|NOT COMPLETED|Overall Study||27
145430|NCT00361283|353853|P1|COMPLETED|Overall Study||81
145431|NCT00361283|353853|P1|STARTED|Overall Study||108
145432|NCT00361335|353862|P7|NOT COMPLETED|SC Period: Week E0 to Week E24||9
145433|NCT00361335|353863|P6|NOT COMPLETED|SC Period: Week E0 to Week E24||1
145434|NCT00361335|353864|P5|NOT COMPLETED|SC Period: Week E0 to Week E24||0
145435|NCT00361335|353865|P4|NOT COMPLETED|SC Period: Week E0 to Week E24||4
145436|NCT00361335|353866|P3|NOT COMPLETED|SC Period: Week E0 to Week E24||5
145437|NCT00361335|353867|P2|NOT COMPLETED|SC Period: Week E0 to Week E24||3
145438|NCT00361335|353868|P1|NOT COMPLETED|SC Period: Week E0 to Week E24||2
145439|NCT00361335|353862|P7|COMPLETED|SC Period: Week E0 to Week E24||164
145440|NCT00361335|353863|P6|COMPLETED|SC Period: Week E0 to Week E24||23
145441|NCT00361335|353864|P5|COMPLETED|SC Period: Week E0 to Week E24||3
145442|NCT00361335|353865|P4|COMPLETED|SC Period: Week E0 to Week E24||59
145443|NCT00361335|353866|P3|COMPLETED|SC Period: Week E0 to Week E24||99
145444|NCT00361335|353867|P2|COMPLETED|SC Period: Week E0 to Week E24||56
145445|NCT00361335|353868|P1|COMPLETED|SC Period: Week E0 to Week E24||80
145446|NCT00361335|353862|P7|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|173
145447|NCT00361335|353863|P6|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|24
145448|NCT00361335|353864|P5|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|3
145449|NCT00361335|353865|P4|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|63
145450|NCT00361335|353866|P3|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|104
145451|NCT00361335|353867|P2|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|59
145452|NCT00361335|353868|P1|STARTED|SC Period: Week E0 to Week E24|Reporting groups in the SC Period are determined by treatment assignment at Week 24|82
145453|NCT00361335|353862|P7|NOT COMPLETED|IV Period: Baseline to E0||0
145454|NCT00361335|353863|P6|NOT COMPLETED|IV Period: Baseline to E0||0
145455|NCT00361335|353864|P5|NOT COMPLETED|IV Period: Baseline to E0||24
145456|NCT00361335|353865|P4|NOT COMPLETED|IV Period: Baseline to E0||27
145457|NCT00361335|353866|P3|NOT COMPLETED|IV Period: Baseline to E0||21
145458|NCT00361335|353867|P2|NOT COMPLETED|IV Period: Baseline to E0||29
145459|NCT00361335|353868|P1|NOT COMPLETED|IV Period: Baseline to E0||20
145460|NCT00361335|353862|P7|COMPLETED|IV Period: Baseline to E0||0
145461|NCT00361335|353863|P6|COMPLETED|IV Period: Baseline to E0||0
145462|NCT00361335|353864|P5|COMPLETED|IV Period: Baseline to E0||105
145463|NCT00361335|353865|P4|COMPLETED|IV Period: Baseline to E0||102
145464|NCT00361335|353866|P3|COMPLETED|IV Period: Baseline to E0||107
145465|NCT00361335|353867|P2|COMPLETED|IV Period: Baseline to E0||99
145466|NCT00361335|353868|P1|COMPLETED|IV Period: Baseline to E0||109
145467|NCT00361335|353862|P7|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
145468|NCT00361335|353863|P6|STARTED|IV Period: Baseline to E0|"0 in column indicates this reporting group is not relevant to the IV Period."|0
145469|NCT00361335|353864|P5|STARTED|IV Period: Baseline to E0||129
145470|NCT00361335|353865|P4|STARTED|IV Period: Baseline to E0||129
145471|NCT00361335|353866|P3|STARTED|IV Period: Baseline to E0||128
145472|NCT00361335|353867|P2|STARTED|IV Period: Baseline to E0||128
145473|NCT00361335|353868|P1|STARTED|IV Period: Baseline to E0||129
145474|NCT00361374|353915|P3|NOT COMPLETED|Overall Study||12
145475|NCT00361374|353916|P2|NOT COMPLETED|Overall Study||15
145476|NCT00361374|353917|P1|NOT COMPLETED|Overall Study||15
145477|NCT00361374|353915|P3|COMPLETED|Overall Study||53
145478|NCT00361374|353916|P2|COMPLETED|Overall Study||50
145479|NCT00361374|353917|P1|COMPLETED|Overall Study||51
145480|NCT00361374|353915|P3|STARTED|Overall Study||65
145481|NCT00361374|353916|P2|STARTED|Overall Study||65
145482|NCT00361374|353917|P1|STARTED|Overall Study||66
145483|NCT00361439|353927|P2|NOT COMPLETED|Overall Study||0
145484|NCT00361439|353928|P1|NOT COMPLETED|Overall Study||0
145485|NCT00361439|353927|P2|COMPLETED|Overall Study||9
145486|NCT00361439|353928|P1|COMPLETED|Overall Study||8
145487|NCT00361439|353927|P2|STARTED|Overall Study||9
145488|NCT00361439|353928|P1|STARTED|Overall Study||8
145489|NCT00361504|353942|P2|NOT COMPLETED|Overall Study||145
145490|NCT00361504|353943|P1|NOT COMPLETED|Overall Study||481
145491|NCT00361504|353942|P2|COMPLETED|Overall Study||78
145492|NCT00361504|353943|P1|COMPLETED|Overall Study||413
145493|NCT00361504|353942|P2|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|223
145494|NCT00361504|353943|P1|STARTED|Overall Study|Number of participants who received at least 1 dose of study medication|894
145495|NCT00361569|353955|P4|NOT COMPLETED|Overall Study||21
145496|NCT00361569|353956|P3|NOT COMPLETED|Overall Study||18
145497|NCT00361569|353957|P2|NOT COMPLETED|Overall Study||11
145498|NCT00361569|353958|P1|NOT COMPLETED|Overall Study||12
145499|NCT00361569|353955|P4|COMPLETED|Overall Study||135
145500|NCT00361569|353956|P3|COMPLETED|Overall Study||137
145501|NCT00361569|353957|P2|COMPLETED|Overall Study||150
145502|NCT00361569|353958|P1|COMPLETED|Overall Study||138
145503|NCT00361569|353955|P4|STARTED|Overall Study||156
145504|NCT00361569|353956|P3|STARTED|Overall Study||155
145505|NCT00361569|353957|P2|STARTED|Overall Study||161
145506|NCT00361569|353958|P1|STARTED|Overall Study||150
145507|NCT00361595|353980|P1|NOT COMPLETED|Overall Study||0
145508|NCT00361595|353980|P1|COMPLETED|Overall Study||35
145509|NCT00361595|353980|P1|STARTED|Overall Study||35
145510|NCT00361634|353987|P1|NOT COMPLETED|Overall Study||2
145511|NCT00361634|353987|P1|COMPLETED|Overall Study||12
145512|NCT00361634|353987|P1|Treated|Overall Study|The safety analysis set consisted of all patients who received at least one dose of etanercept.|13
145513|NCT00361634|353987|P1|STARTED|Overall Study||14
145514|NCT00368251|354008|P3|NOT COMPLETED|Overall Study||1
145515|NCT00368251|354009|P2|NOT COMPLETED|Overall Study||0
145516|NCT00368251|354010|P1|NOT COMPLETED|Overall Study||1
145517|NCT00368251|354008|P3|COMPLETED|Overall Study||17
145518|NCT00368251|354009|P2|COMPLETED|Overall Study||20
145519|NCT00368251|354010|P1|COMPLETED|Overall Study||17
145520|NCT00368251|354008|P3|STARTED|Overall Study||18
145521|NCT00368251|354009|P2|STARTED|Overall Study||20
145522|NCT00368251|354010|P1|STARTED|Overall Study||18
145523|NCT00368277|354032|P2|NOT COMPLETED|Overall Study||108
145524|NCT00368277|354033|P1|NOT COMPLETED|Overall Study||113
145525|NCT00368277|354032|P2|COMPLETED|Overall Study||336
145526|NCT00368277|354033|P1|COMPLETED|Overall Study||344
145527|NCT00368277|354032|P2|STARTED|Overall Study||444
145528|NCT00368277|354033|P1|STARTED|Overall Study||457
145529|NCT00368290|354047|P2|NOT COMPLETED|Overall Study||10
145530|NCT00368290|354048|P1|NOT COMPLETED|Overall Study||13
145531|NCT00368290|354047|P2|COMPLETED|Overall Study||37
145532|NCT00368290|354048|P1|COMPLETED|Overall Study||34
145533|NCT00368290|354047|P2|STARTED|Overall Study||47
145534|NCT00368290|354048|P1|STARTED|Overall Study||47
145535|NCT00368316|354058|P2|NOT COMPLETED|Overall Study||46
145536|NCT00368316|354059|P1|NOT COMPLETED|Overall Study||42
145537|NCT00368316|354058|P2|COMPLETED|Overall Study||1319
145538|NCT00368316|354059|P1|COMPLETED|Overall Study||1392
145539|NCT00368316|354058|P2|STARTED|Overall Study||1365
145540|NCT00368316|354059|P1|STARTED|Overall Study||1434
145541|NCT00369681|354069|P1|NOT COMPLETED|Overall Study||1
145542|NCT00369681|354069|P1|COMPLETED|Overall Study||49
145543|NCT00369681|354069|P1|STARTED|Overall Study||50
145544|NCT00369746|354077|P2|NOT COMPLETED|Overall Study||0
145545|NCT00369746|354078|P1|NOT COMPLETED|Overall Study||0
145546|NCT00369746|354077|P2|COMPLETED|Overall Study||536
145547|NCT00369746|354078|P1|COMPLETED|Overall Study||138
145548|NCT00369746|354077|P2|STARTED|Overall Study||536
145549|NCT00369746|354078|P1|STARTED|Overall Study||138
145550|NCT00369785|354090|P2|NOT COMPLETED|Overall Study||25
145551|NCT00369785|354091|P1|NOT COMPLETED|Overall Study||27
145552|NCT00369785|354090|P2|COMPLETED|Overall Study||74
145553|NCT00369785|354091|P1|COMPLETED|Overall Study||72
145554|NCT00369785|354090|P2|STARTED|Overall Study||99
145555|NCT00369785|354091|P1|STARTED|Overall Study||99
145556|NCT00369824|354105|P6|NOT COMPLETED|Overall Study||11
145557|NCT00369824|354106|P5|NOT COMPLETED|Overall Study||18
145558|NCT00369824|354107|P4|NOT COMPLETED|Overall Study||15
145559|NCT00369824|354108|P3|NOT COMPLETED|Overall Study||12
145560|NCT00369824|354109|P2|NOT COMPLETED|Overall Study||19
145561|NCT00369824|354110|P1|NOT COMPLETED|Overall Study||15
145562|NCT00369824|354105|P6|COMPLETED|Overall Study||204
145563|NCT00369824|354106|P5|COMPLETED|Overall Study||196
145564|NCT00369824|354107|P4|COMPLETED|Overall Study||199
145565|NCT00369824|354108|P3|COMPLETED|Overall Study||202
145566|NCT00369824|354109|P2|COMPLETED|Overall Study||195
145567|NCT00369824|354110|P1|COMPLETED|Overall Study||197
145568|NCT00369824|354105|P6|STARTED|Overall Study||215
145569|NCT00369824|354106|P5|STARTED|Overall Study||214
145570|NCT00369824|354107|P4|STARTED|Overall Study||214
145571|NCT00369824|354108|P3|STARTED|Overall Study||214
145572|NCT00369824|354109|P2|STARTED|Overall Study||214
145573|NCT00369824|354110|P1|STARTED|Overall Study||212
145574|NCT00369915|354210|P2|NOT COMPLETED|Overall Study||3
145575|NCT00369915|354211|P1|NOT COMPLETED|Overall Study||6
145576|NCT00369915|354210|P2|COMPLETED|Overall Study||4
145577|NCT00369915|354211|P1|COMPLETED|Overall Study||4
145578|NCT00369915|354210|P2|STARTED|Overall Study||7
145579|NCT00369915|354211|P1|STARTED|Overall Study||10
145580|NCT00369928|354222|P3|NOT COMPLETED|Overall Study||20
145581|NCT00369928|354223|P2|NOT COMPLETED|Overall Study||16
145582|NCT00369928|354224|P1|NOT COMPLETED|Overall Study||8
145583|NCT00369928|354222|P3|COMPLETED|Overall Study||66
145584|NCT00369928|354223|P2|COMPLETED|Overall Study||69
145585|NCT00369928|354224|P1|COMPLETED|Overall Study||77
145586|NCT00369928|354222|P3|STARTED|Overall Study||86
145587|NCT00369928|354223|P2|STARTED|Overall Study||85
145588|NCT00369928|354224|P1|STARTED|Overall Study||85
145589|NCT00369941|354234|P2|NOT COMPLETED|Overall Study||100
145590|NCT00369941|354235|P1|NOT COMPLETED|Overall Study||72
145591|NCT00369941|354234|P2|COMPLETED|Overall Study||184
145592|NCT00369941|354235|P1|COMPLETED|Overall Study||210
145593|NCT00369941|354234|P2|Treated|Overall Study||282
145594|NCT00369941|354235|P1|Treated|Overall Study||281
145595|NCT00369941|354234|P2|STARTED|Overall Study||284
145596|NCT00369941|354235|P1|STARTED|Overall Study||282
145597|NCT00369967|354387|P2|NOT COMPLETED|Overall Study||12
145598|NCT00369967|354388|P1|NOT COMPLETED|Overall Study||23
145599|NCT00369967|354387|P2|COMPLETED|Overall Study||5
145600|NCT00369967|354388|P1|COMPLETED|Overall Study||8
145601|NCT00369967|354387|P2|STARTED|Overall Study||17
145602|NCT00369967|354388|P1|STARTED|Overall Study||31
145603|NCT00370032|354406|P2|NOT COMPLETED|Follow-up Period||0
145604|NCT00370032|354407|P1|NOT COMPLETED|Follow-up Period||1
145605|NCT00370032|354406|P2|COMPLETED|Follow-up Period||22
145606|NCT00370032|354407|P1|COMPLETED|Follow-up Period||22
145607|NCT00370032|354406|P2|STARTED|Follow-up Period||22
145608|NCT00370032|354407|P1|STARTED|Follow-up Period||23
145609|NCT00370032|354406|P2|NOT COMPLETED|Treatment Period 2||0
145610|NCT00370032|354407|P1|NOT COMPLETED|Treatment Period 2||0
145611|NCT00370032|354406|P2|COMPLETED|Treatment Period 2||22
145612|NCT00370032|354407|P1|COMPLETED|Treatment Period 2||23
145613|NCT00370032|354406|P2|STARTED|Treatment Period 2||22
145614|NCT00370032|354407|P1|STARTED|Treatment Period 2||23
145615|NCT00370032|354406|P2|NOT COMPLETED|Washout Period||2
145616|NCT00370032|354407|P1|NOT COMPLETED|Washout Period||1
145617|NCT00370032|354406|P2|COMPLETED|Washout Period||22
145618|NCT00370032|354407|P1|COMPLETED|Washout Period||23
145619|NCT00370032|354406|P2|STARTED|Washout Period||24
145620|NCT00370032|354407|P1|STARTED|Washout Period||24
145621|NCT00370032|354406|P2|NOT COMPLETED|Treatment Period 1||1
145622|NCT00370032|354407|P1|NOT COMPLETED|Treatment Period 1||0
145623|NCT00370032|354406|P2|COMPLETED|Treatment Period 1||24
145624|NCT00370032|354407|P1|COMPLETED|Treatment Period 1||24
145625|NCT00370032|354406|P2|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|25
145626|NCT00370032|354407|P1|STARTED|Treatment Period 1|Safety Population - all subjects who took at least one dose of study medication.|24
145627|NCT00370071|354425|P1|NOT COMPLETED|Overall Study||2
145628|NCT00370071|354425|P1|COMPLETED|Overall Study||37
145629|NCT00370071|354425|P1|STARTED|Overall Study||39
145630|NCT00370149|354442|P2|NOT COMPLETED|Overall Study||19
145631|NCT00370149|354443|P1|NOT COMPLETED|Overall Study||19
145632|NCT00370149|354442|P2|COMPLETED|Overall Study||142
145633|NCT00370149|354443|P1|COMPLETED|Overall Study||146
145634|NCT00370149|354442|P2|STARTED|Overall Study||161
145635|NCT00370149|354443|P1|STARTED|Overall Study||165
145636|NCT00370292|354455|P1|NOT COMPLETED|Overall Study||13
145637|NCT00370292|354455|P1|COMPLETED|Overall Study||6
145638|NCT00370292|354455|P1|STARTED|Overall Study||19
145639|NCT00370331|354468|P2|NOT COMPLETED|Overall Study||23
145640|NCT00370331|354469|P1|NOT COMPLETED|Overall Study||7
145641|NCT00370331|354468|P2|COMPLETED|Overall Study||112
145642|NCT00370331|354469|P1|COMPLETED|Overall Study||55
145643|NCT00370331|354468|P2|STARTED|Overall Study||135
145644|NCT00370331|354469|P1|STARTED|Overall Study||62
145645|NCT00370552|354496|P3|NOT COMPLETED|Overall Study||32
145646|NCT00370552|354497|P2|NOT COMPLETED|Overall Study||45
145647|NCT00370552|354498|P1|NOT COMPLETED|Overall Study||46
145648|NCT00370552|354496|P3|COMPLETED|Overall Study||0
145649|NCT00370552|354497|P2|COMPLETED|Overall Study||0
145650|NCT00370552|354498|P1|COMPLETED|Overall Study||0
145651|NCT00370552|354496|P3|STARTED|Overall Study|Randomized|32
145652|NCT00370552|354497|P2|STARTED|Overall Study|Randomized|45
145653|NCT00370552|354498|P1|STARTED|Overall Study|Randomized|46
145654|NCT00370682|354539|P3|NOT COMPLETED|Overall Study||1
145655|NCT00370682|354540|P2|NOT COMPLETED|Overall Study||3
145656|NCT00370682|354541|P1|NOT COMPLETED|Overall Study||0
145657|NCT00370682|354539|P3|COMPLETED|Overall Study||39
145658|NCT00370682|354540|P2|COMPLETED|Overall Study||37
145659|NCT00370682|354541|P1|COMPLETED|Overall Study||40
145660|NCT00370682|354539|P3|STARTED|Overall Study||40
145661|NCT00370682|354540|P2|STARTED|Overall Study||40
145662|NCT00370682|354541|P1|STARTED|Overall Study||40
145663|NCT00370838|354582|P2|NOT COMPLETED|Taper||0
145664|NCT00370838|354583|P1|NOT COMPLETED|Taper||0
145665|NCT00370838|354582|P2|COMPLETED|Taper||3
145666|NCT00370838|354583|P1|COMPLETED|Taper||7
145667|NCT00370838|354582|P2|STARTED|Taper||3
145668|NCT00370838|354583|P1|STARTED|Taper||7
145669|NCT00370838|354582|P2|NOT COMPLETED|Period 2 (Days 65-107)||0
145670|NCT00370838|354583|P1|NOT COMPLETED|Period 2 (Days 65-107)||0
145671|NCT00370838|354582|P2|COMPLETED|Period 2 (Days 65-107)||3
145672|NCT00370838|354583|P1|COMPLETED|Period 2 (Days 65-107)||7
145673|NCT00370838|354582|P2|STARTED|Period 2 (Days 65-107)||3
145674|NCT00370838|354583|P1|STARTED|Period 2 (Days 65-107)||7
145675|NCT00370838|354582|P2|NOT COMPLETED|Washout (Days 51-64)||0
145676|NCT00370838|354583|P1|NOT COMPLETED|Washout (Days 51-64)||0
145677|NCT00370838|354582|P2|COMPLETED|Washout (Days 51-64)||3
145678|NCT00370838|354583|P1|COMPLETED|Washout (Days 51-64)||7
145679|NCT00370838|354582|P2|STARTED|Washout (Days 51-64)||3
145680|NCT00370838|354583|P1|STARTED|Washout (Days 51-64)||7
145681|NCT00370838|354582|P2|NOT COMPLETED|Period 1 (Days 8-50)||0
145682|NCT00370838|354583|P1|NOT COMPLETED|Period 1 (Days 8-50)||0
145683|NCT00370838|354582|P2|COMPLETED|Period 1 (Days 8-50)||3
145684|NCT00370838|354583|P1|COMPLETED|Period 1 (Days 8-50)||7
145685|NCT00370838|354582|P2|STARTED|Period 1 (Days 8-50)||3
145686|NCT00370838|354583|P1|STARTED|Period 1 (Days 8-50)||7
145687|NCT00370994|354603|P2|NOT COMPLETED|Overall Study||0
145688|NCT00370994|354604|P1|NOT COMPLETED|Overall Study||0
145689|NCT00370994|354603|P2|COMPLETED|Overall Study||60
145690|NCT00370994|354604|P1|COMPLETED|Overall Study||60
145691|NCT00370994|354603|P2|STARTED|Overall Study||60
145692|NCT00370994|354604|P1|STARTED|Overall Study|Sample size was 200, due to the difficulties of recruiting we changed to 120|60
145693|NCT00371137|354615|P3|NOT COMPLETED|Overall Study||79
145694|NCT00371137|354616|P2|NOT COMPLETED|Overall Study||63
145695|NCT00371137|354617|P1|NOT COMPLETED|Overall Study||72
145696|NCT00371137|354615|P3|COMPLETED|Overall Study||104
145697|NCT00371137|354616|P2|COMPLETED|Overall Study||119
145698|NCT00371137|354617|P1|COMPLETED|Overall Study||111
145699|NCT00371137|354615|P3|Treated|Overall Study||182
145700|NCT00371137|354616|P2|Treated|Overall Study||182
145701|NCT00371137|354617|P1|Treated|Overall Study||183
145702|NCT00371137|354615|P3|STARTED|Overall Study||183
145703|NCT00371137|354616|P2|STARTED|Overall Study||182
145704|NCT00371137|354617|P1|STARTED|Overall Study||183
145705|NCT00371150|354627|P2|NOT COMPLETED|Overall Study||2
145706|NCT00371150|354628|P1|NOT COMPLETED|Overall Study||3
145707|NCT00371150|354627|P2|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|4
145708|NCT00371150|354628|P1|COMPLETED|Overall Study|"Completion of treatment” means received treatment through Week 52"|37
145709|NCT00371150|354627|P2|Discontinued at or After Week 48 Visit|Overall Study||1
145710|NCT00371150|354628|P1|Discontinued at or After Week 48 Visit|Overall Study||2
145711|NCT00371150|354627|P2|Discontinued Prior to Week 48 Visit|Overall Study||1
145712|NCT00371150|354628|P1|Discontinued Prior to Week 48 Visit|Overall Study||1
145713|NCT00371150|354627|P2|STARTED|Overall Study||6
145714|NCT00371150|354628|P1|STARTED|Overall Study||40
145715|NCT00371176|354662|P2|NOT COMPLETED|Overall Study||8
145716|NCT00371176|354663|P1|NOT COMPLETED|Overall Study||5
145717|NCT00371176|354662|P2|COMPLETED|Overall Study||5
145718|NCT00371176|354663|P1|COMPLETED|Overall Study||8
145719|NCT00371176|354662|P2|Completed Treatment|Overall Study||9
145720|NCT00371176|354663|P1|Completed Treatment|Overall Study||10
145721|NCT00371176|354662|P2|STARTED|Overall Study||13
145722|NCT00371176|354663|P1|STARTED|Overall Study||13
145723|NCT00371254|354693|P2|NOT COMPLETED|Overall Study||21
145724|NCT00371254|354694|P1|NOT COMPLETED|Overall Study||23
145725|NCT00371254|354693|P2|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
145726|NCT00371254|354694|P1|COMPLETED|Overall Study|Number of participants remained on study till the study drug could be tolerated|0
145727|NCT00371254|354693|P2|STARTED|Overall Study|Number of participants treated|21
145728|NCT00371254|354694|P1|STARTED|Overall Study|Number of participants treated|23
145729|NCT00371267|354746|P2|NOT COMPLETED|Overall Study||18
145730|NCT00371267|354747|P1|NOT COMPLETED|Overall Study||9
145731|NCT00371267|354746|P2|COMPLETED|Overall Study||32
145732|NCT00371267|354747|P1|COMPLETED|Overall Study||39
145733|NCT00371267|354746|P2|STARTED|Overall Study||50
145734|NCT00371267|354747|P1|STARTED|Overall Study||48
145735|NCT00371293|354764|P3|NOT COMPLETED|Overall Study||16
145736|NCT00371293|354765|P2|NOT COMPLETED|Overall Study||19
145737|NCT00371293|354766|P1|NOT COMPLETED|Overall Study||10
145738|NCT00371293|354764|P3|COMPLETED|Overall Study||46
145739|NCT00371293|354765|P2|COMPLETED|Overall Study||42
145740|NCT00371293|354766|P1|COMPLETED|Overall Study||48
145741|NCT00371293|354764|P3|STARTED|Overall Study||62
145742|NCT00371293|354765|P2|STARTED|Overall Study||61
145743|NCT00371293|354766|P1|STARTED|Overall Study||58
145744|NCT00371345|354788|P2|NOT COMPLETED|Overall Study||46
145745|NCT00371345|354789|P1|NOT COMPLETED|Overall Study||24
145746|NCT00371345|354788|P2|COMPLETED|Overall Study||0
145747|NCT00371345|354789|P1|COMPLETED|Overall Study||0
145748|NCT00371345|354788|P2|STARTED|Overall Study||46
145749|NCT00371345|354789|P1|STARTED|Overall Study||24
145750|NCT00371397|354846|P12|NOT COMPLETED|Session 3||0
145751|NCT00371397|354847|P11|NOT COMPLETED|Session 3||0
145752|NCT00371397|354848|P10|NOT COMPLETED|Session 3||0
145753|NCT00371397|354849|P9|NOT COMPLETED|Session 3||0
145754|NCT00371397|354850|P8|NOT COMPLETED|Session 3||0
145755|NCT00371397|354851|P7|NOT COMPLETED|Session 3||0
145756|NCT00371397|354852|P6|NOT COMPLETED|Session 3||0
145757|NCT00371397|354853|P5|NOT COMPLETED|Session 3||0
145758|NCT00371397|354854|P4|NOT COMPLETED|Session 3||0
145759|NCT00371397|354855|P3|NOT COMPLETED|Session 3||0
145760|NCT00371397|354856|P2|NOT COMPLETED|Session 3||0
145761|NCT00371397|354857|P1|NOT COMPLETED|Session 3||0
145762|NCT00371397|354846|P12|COMPLETED|Session 3||2
145763|NCT00371397|354847|P11|COMPLETED|Session 3||4
145764|NCT00371397|354848|P10|COMPLETED|Session 3||5
145765|NCT00371397|354849|P9|COMPLETED|Session 3||6
145766|NCT00371397|354850|P8|COMPLETED|Session 3||4
145767|NCT00371397|354851|P7|COMPLETED|Session 3||4
145768|NCT00371397|354852|P6|COMPLETED|Session 3||4
145769|NCT00371397|354853|P5|COMPLETED|Session 3||3
145770|NCT00371397|354854|P4|COMPLETED|Session 3||2
145771|NCT00371397|354855|P3|COMPLETED|Session 3||5
145772|NCT00371397|354856|P2|COMPLETED|Session 3||7
145773|NCT00371397|354857|P1|COMPLETED|Session 3||4
145774|NCT00371397|354846|P12|STARTED|Session 3||2
145775|NCT00371397|354847|P11|STARTED|Session 3||4
145776|NCT00371397|354848|P10|STARTED|Session 3||5
145777|NCT00371397|354849|P9|STARTED|Session 3||6
145778|NCT00371397|354850|P8|STARTED|Session 3||4
145779|NCT00371397|354851|P7|STARTED|Session 3||4
145780|NCT00371397|354852|P6|STARTED|Session 3||4
145781|NCT00371397|354853|P5|STARTED|Session 3||3
145782|NCT00371397|354854|P4|STARTED|Session 3||2
145783|NCT00371397|354855|P3|STARTED|Session 3||5
145784|NCT00371397|354856|P2|STARTED|Session 3||7
145785|NCT00371397|354857|P1|STARTED|Session 3||4
145786|NCT00371397|354846|P12|NOT COMPLETED|Session 2||0
145787|NCT00371397|354847|P11|NOT COMPLETED|Session 2||0
145788|NCT00371397|354848|P10|NOT COMPLETED|Session 2||0
145789|NCT00371397|354849|P9|NOT COMPLETED|Session 2||0
145790|NCT00371397|354850|P8|NOT COMPLETED|Session 2||0
145791|NCT00371397|354851|P7|NOT COMPLETED|Session 2||0
145792|NCT00371397|354852|P6|NOT COMPLETED|Session 2||0
145793|NCT00371397|354853|P5|NOT COMPLETED|Session 2||0
145794|NCT00371397|354854|P4|NOT COMPLETED|Session 2||0
145795|NCT00371397|354855|P3|NOT COMPLETED|Session 2||0
145796|NCT00371397|354856|P2|NOT COMPLETED|Session 2||0
145797|NCT00371397|354857|P1|NOT COMPLETED|Session 2||0
145798|NCT00371397|354846|P12|COMPLETED|Session 2||2
145799|NCT00371397|354847|P11|COMPLETED|Session 2||4
145800|NCT00371397|354848|P10|COMPLETED|Session 2||5
145801|NCT00371397|354849|P9|COMPLETED|Session 2||6
145802|NCT00371397|354850|P8|COMPLETED|Session 2||4
145803|NCT00371397|354851|P7|COMPLETED|Session 2||4
145804|NCT00371397|354852|P6|COMPLETED|Session 2||4
145805|NCT00371397|354853|P5|COMPLETED|Session 2||3
145806|NCT00371397|354854|P4|COMPLETED|Session 2||2
145807|NCT00371397|354855|P3|COMPLETED|Session 2||5
145808|NCT00371397|354856|P2|COMPLETED|Session 2||7
145809|NCT00371397|354857|P1|COMPLETED|Session 2||4
145810|NCT00371397|354846|P12|STARTED|Session 2||2
145811|NCT00371397|354847|P11|STARTED|Session 2||4
145812|NCT00371397|354848|P10|STARTED|Session 2||5
145813|NCT00371397|354849|P9|STARTED|Session 2||6
145814|NCT00371397|354850|P8|STARTED|Session 2||4
145815|NCT00371397|354851|P7|STARTED|Session 2||4
145816|NCT00371397|354852|P6|STARTED|Session 2||4
145817|NCT00371397|354853|P5|STARTED|Session 2||3
145818|NCT00371397|354854|P4|STARTED|Session 2||2
145819|NCT00371397|354855|P3|STARTED|Session 2||5
145820|NCT00371397|354856|P2|STARTED|Session 2||7
145821|NCT00371397|354857|P1|STARTED|Session 2||4
145822|NCT00371397|354846|P12|NOT COMPLETED|Session 1||0
145823|NCT00371397|354847|P11|NOT COMPLETED|Session 1||0
145824|NCT00371397|354848|P10|NOT COMPLETED|Session 1||0
145825|NCT00371397|354849|P9|NOT COMPLETED|Session 1||0
145826|NCT00371397|354850|P8|NOT COMPLETED|Session 1||1
145827|NCT00371397|354851|P7|NOT COMPLETED|Session 1||0
145828|NCT00371397|354852|P6|NOT COMPLETED|Session 1||0
145829|NCT00371397|354853|P5|NOT COMPLETED|Session 1||0
145830|NCT00371397|354854|P4|NOT COMPLETED|Session 1||0
145831|NCT00371397|354855|P3|NOT COMPLETED|Session 1||0
145832|NCT00371397|354856|P2|NOT COMPLETED|Session 1||0
145833|NCT00371397|354857|P1|NOT COMPLETED|Session 1||1
145834|NCT00371397|354846|P12|COMPLETED|Session 1||2
145835|NCT00371397|354847|P11|COMPLETED|Session 1||4
145836|NCT00371397|354848|P10|COMPLETED|Session 1||5
145837|NCT00371397|354849|P9|COMPLETED|Session 1||6
145838|NCT00371397|354850|P8|COMPLETED|Session 1||4
145839|NCT00371397|354851|P7|COMPLETED|Session 1||4
145840|NCT00371397|354852|P6|COMPLETED|Session 1||4
145841|NCT00371397|354853|P5|COMPLETED|Session 1||3
145842|NCT00371397|354854|P4|COMPLETED|Session 1||2
145843|NCT00371397|354855|P3|COMPLETED|Session 1||5
145844|NCT00371397|354856|P2|COMPLETED|Session 1||7
145845|NCT00371397|354857|P1|COMPLETED|Session 1||4
145846|NCT00371397|354846|P12|STARTED|Session 1||2
145847|NCT00371397|354847|P11|STARTED|Session 1||4
145848|NCT00371397|354848|P10|STARTED|Session 1||5
145849|NCT00371397|354849|P9|STARTED|Session 1||6
145850|NCT00371397|354850|P8|STARTED|Session 1||5
145851|NCT00371397|354851|P7|STARTED|Session 1||4
145852|NCT00371397|354852|P6|STARTED|Session 1||4
145853|NCT00371397|354853|P5|STARTED|Session 1||3
145854|NCT00371397|354854|P4|STARTED|Session 1||2
145855|NCT00371397|354855|P3|STARTED|Session 1||5
145856|NCT00371397|354856|P2|STARTED|Session 1||7
145857|NCT00371397|354857|P1|STARTED|Session 1||5
145858|NCT00371436|354865|P2|NOT COMPLETED|Overall Study||21
145859|NCT00371436|354866|P1|NOT COMPLETED|Overall Study||34
145860|NCT00371436|354865|P2|COMPLETED|Overall Study||68
145861|NCT00371436|354866|P1|COMPLETED|Overall Study||58
145862|NCT00371436|354865|P2|STARTED|Overall Study||89
145863|NCT00371436|354866|P1|STARTED|Overall Study||92
145864|NCT00371449|354872|P1|NOT COMPLETED|Overall Study||0
145865|NCT00371449|354872|P1|COMPLETED|Overall Study||120
145866|NCT00371449|354872|P1|STARTED|Overall Study||120
145867|NCT00371462|354883|P2|NOT COMPLETED|Overall Study||8
145868|NCT00371462|354884|P1|NOT COMPLETED|Overall Study||8
145869|NCT00371462|354883|P2|COMPLETED|Overall Study||27
145870|NCT00371462|354884|P1|COMPLETED|Overall Study||27
145871|NCT00371462|354883|P2|STARTED|Overall Study||35
145872|NCT00371462|354884|P1|STARTED|Overall Study||35
145873|NCT00371540|354892|P2|NOT COMPLETED|Overall Study||9
145874|NCT00371540|354893|P1|NOT COMPLETED|Overall Study||10
145875|NCT00371540|354892|P2|COMPLETED|Overall Study||87
145876|NCT00371540|354893|P1|COMPLETED|Overall Study||102
145877|NCT00371540|354892|P2|STARTED|Overall Study||96
145878|NCT00371540|354893|P1|STARTED|Overall Study||112
145879|NCT00371566|354905|P2|NOT COMPLETED|Follow Up Phase||7
145880|NCT00371566|354906|P1|NOT COMPLETED|Follow Up Phase||3
145881|NCT00371566|354905|P2|COMPLETED|Follow Up Phase||58
145882|NCT00371566|354906|P1|COMPLETED|Follow Up Phase||28
145883|NCT00371566|354905|P2|STARTED|Follow Up Phase||65
145884|NCT00371566|354906|P1|STARTED|Follow Up Phase||31
145885|NCT00371566|354905|P2|NOT COMPLETED|Chemoradiation Phase||3
145886|NCT00371566|354906|P1|NOT COMPLETED|Chemoradiation Phase||5
145887|NCT00371566|354905|P2|COMPLETED|Chemoradiation Phase||65
145888|NCT00371566|354906|P1|COMPLETED|Chemoradiation Phase||31
145889|NCT00371566|354905|P2|STARTED|Chemoradiation Phase||68
145890|NCT00371566|354906|P1|STARTED|Chemoradiation Phase||36
145891|NCT00371566|354905|P2|NOT COMPLETED|Treatment Phase||3
145892|NCT00371566|354906|P1|NOT COMPLETED|Treatment Phase||0
145893|NCT00371566|354905|P2|COMPLETED|Treatment Phase|1 screen failure included in the ITT population|68
145894|NCT00371566|354906|P1|COMPLETED|Treatment Phase||36
145895|NCT00371566|354905|P2|STARTED|Treatment Phase||71
145896|NCT00371566|354906|P1|STARTED|Treatment Phase||36
145897|NCT00371631|354976|P1|NOT COMPLETED|Overall Study||0
145898|NCT00371631|354976|P1|COMPLETED|Overall Study||13
145899|NCT00371631|354976|P1|STARTED|Overall Study||13
145900|NCT00371644|354983|P2|NOT COMPLETED|Overall Study||13
145901|NCT00371644|354984|P1|NOT COMPLETED|Overall Study||28
145902|NCT00371644|354983|P2|COMPLETED|Overall Study||44
145903|NCT00371644|354984|P1|COMPLETED|Overall Study||44
145904|NCT00371644|354983|P2|STARTED|Overall Study||57
145905|NCT00371644|354984|P1|STARTED|Overall Study||72
145906|NCT00371683|354992|P2|NOT COMPLETED|Follow-Up Period - Randomized Patients||72
145907|NCT00371683|354993|P1|NOT COMPLETED|Follow-Up Period - Randomized Patients||61
145908|NCT00371683|354992|P2|COMPLETED|Follow-Up Period - Randomized Patients||1461
145909|NCT00371683|354993|P1|COMPLETED|Follow-Up Period - Randomized Patients||1492
145910|NCT00371683|354992|P2|STARTED|Follow-Up Period - Randomized Patients||1533
145911|NCT00371683|354993|P1|STARTED|Follow-Up Period - Randomized Patients||1553
145912|NCT00371683|354992|P2|NOT COMPLETED|DB Treatment Period-Randomized Patients||107
145913|NCT00371683|354993|P1|NOT COMPLETED|DB Treatment Period-Randomized Patients||90
145914|NCT00371683|354992|P2|COMPLETED|DB Treatment Period-Randomized Patients||1489
145915|NCT00371683|354993|P1|COMPLETED|DB Treatment Period-Randomized Patients||1509
145916|NCT00371683|354992|P2|STARTED|DB Treatment Period-Randomized Patients||1596
145917|NCT00371683|354993|P1|STARTED|DB Treatment Period-Randomized Patients||1599
145918|NCT00371761|355047|P2|NOT COMPLETED|Overall Study||10
145919|NCT00371761|355048|P1|NOT COMPLETED|Overall Study||8
145920|NCT00371761|355047|P2|COMPLETED|Overall Study||2
145921|NCT00371761|355048|P1|COMPLETED|Overall Study||5
145922|NCT00371761|355047|P2|STARTED|Overall Study||12
145923|NCT00371761|355048|P1|STARTED|Overall Study||13
145924|NCT00371787|355056|P2|NOT COMPLETED|Overall Study||1
145925|NCT00371787|355057|P1|NOT COMPLETED|Overall Study||3
145926|NCT00371787|355056|P2|COMPLETED|Overall Study||11
145927|NCT00371787|355057|P1|COMPLETED|Overall Study||23
145928|NCT00371787|355056|P2|STARTED|Overall Study||12
145929|NCT00371787|355057|P1|STARTED|Overall Study||26
145930|NCT00371826|355072|P3|NOT COMPLETED|Extension Phase (24 Months)||2
145931|NCT00371826|355073|P2|NOT COMPLETED|Extension Phase (24 Months)||10
145932|NCT00371826|355074|P1|NOT COMPLETED|Extension Phase (24 Months)||5
145933|NCT00371826|355072|P3|COMPLETED|Extension Phase (24 Months)||3
145934|NCT00371826|355073|P2|COMPLETED|Extension Phase (24 Months)||29
145935|NCT00371826|355074|P1|COMPLETED|Extension Phase (24 Months)||18
145936|NCT00371826|355072|P3|Safety Set|Extension Phase (24 Months)|Patient withdrawn as per DMC suggestion had no efficacy data, but was included in safety set.|5
145937|NCT00371826|355073|P2|Safety Set|Extension Phase (24 Months)|One patient mis-randomised to 1st arm but treated in this arm, evaluated for safety in this arm.|40
145938|NCT00371826|355074|P1|Safety Set|Extension Phase (24 Months)|One patient randomized to this arm, was treated with the control regimen (CNI+MPA+Steroid)|22
145939|NCT00371826|355072|P3|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)|One patient entered extension, was withdrawn (no efficacy data in extension) due to DMC suggestion|4
145940|NCT00371826|355073|P2|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||39
145941|NCT00371826|355074|P1|Intention to Treat - Extenstion (ITT-Ex)|Extension Phase (24 Months)||23
145942|NCT00371826|355072|P3|STARTED|Extension Phase (24 Months)|One patient completed core, did not wish to continue to extension.|5
145943|NCT00371826|355073|P2|STARTED|Extension Phase (24 Months)||39
145944|NCT00371826|355074|P1|STARTED|Extension Phase (24 Months)|2 patients who completed 12 month core did not wish to continue in extension.|23
145945|NCT00371826|355072|P3|NOT COMPLETED|Core Phase (12 Months)||24
145946|NCT00371826|355073|P2|NOT COMPLETED|Core Phase (12 Months)||8
145947|NCT00371826|355074|P1|NOT COMPLETED|Core Phase (12 Months)||24
145948|NCT00371826|355072|P3|COMPLETED|Core Phase (12 Months)||6
145949|NCT00371826|355073|P2|COMPLETED|Core Phase (12 Months)||39
145950|NCT00371826|355074|P1|COMPLETED|Core Phase (12 Months)|"Completed means patients were still on study medication by month 12."|25
145951|NCT00371826|355072|P3|Modified Intent to Treat (mITT)|Core Phase (12 Months)||6
145952|NCT00371826|355073|P2|Modified Intent to Treat (mITT)|Core Phase (12 Months)||39
145953|NCT00371826|355074|P1|Modified Intent to Treat (mITT)|Core Phase (12 Months)||27
145954|NCT00371826|355072|P3|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||20
145955|NCT00371826|355073|P2|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||44
145956|NCT00371826|355074|P1|Modified Intent to Treat (mITT)- Add|Core Phase (12 Months)||46
145957|NCT00371826|355072|P3|STARTED|Core Phase (12 Months)||30
145958|NCT00371826|355073|P2|STARTED|Core Phase (12 Months)||47
145959|NCT00371826|355074|P1|STARTED|Core Phase (12 Months)|"Started indicates patients in Randomized, Intent to treat (ITT) and Safety set."|49
145960|NCT00371839|355199|P3|NOT COMPLETED|Overall Study||2
145961|NCT00371839|355200|P2|NOT COMPLETED|Overall Study||7
145962|NCT00371839|355201|P1|NOT COMPLETED|Overall Study||17
145963|NCT00371839|355199|P3|COMPLETED|Overall Study||7
145964|NCT00371839|355200|P2|COMPLETED|Overall Study||13
145965|NCT00371839|355201|P1|COMPLETED|Overall Study||32
145966|NCT00371839|355199|P3|STARTED|Overall Study||9
145967|NCT00371839|355200|P2|STARTED|Overall Study||20
145968|NCT00371839|355201|P1|STARTED|Overall Study||49
145969|NCT00371865|355209|P2|NOT COMPLETED|Overall Study||14
145970|NCT00371865|355210|P1|NOT COMPLETED|Overall Study||15
145971|NCT00371865|355209|P2|COMPLETED|Overall Study|8 withdrew before starting the intervention. 6 withdrew after starting the intervention.|43
145972|NCT00371865|355210|P1|COMPLETED|Overall Study|7 withdrew before starting the intervention. 8 withdrew after starting the intervention.|42
145973|NCT00371865|355209|P2|STARTED|Overall Study||57
145974|NCT00371865|355210|P1|STARTED|Overall Study||57
145975|NCT00372060|355226|P2|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||8
145976|NCT00372060|355227|P1|NOT COMPLETED|Period II - Open-label (Weeks 12-52)||14
145977|NCT00372060|355226|P2|COMPLETED|Period II - Open-label (Weeks 12-52)||59
145978|NCT00372060|355227|P1|COMPLETED|Period II - Open-label (Weeks 12-52)||49
145979|NCT00372060|355226|P2|STARTED|Period II - Open-label (Weeks 12-52)||67
145980|NCT00372060|355227|P1|STARTED|Period II - Open-label (Weeks 12-52)||63
145981|NCT00372060|355226|P2|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||1
145982|NCT00372060|355227|P1|NOT COMPLETED|Period I - Double-blind (Weeks 0-12)||3
145983|NCT00372060|355226|P2|COMPLETED|Period I - Double-blind (Weeks 0-12)||67
145984|NCT00372060|355227|P1|COMPLETED|Period I - Double-blind (Weeks 0-12)||63
145985|NCT00372060|355226|P2|STARTED|Period I - Double-blind (Weeks 0-12)||68
145986|NCT00372060|355227|P1|STARTED|Period I - Double-blind (Weeks 0-12)|The planned number of enrolled patients was 130. The actual number of enrolled patients was 134.|66
145987|NCT00372190|355242|P2|NOT COMPLETED|Overall Study||1
145988|NCT00372190|355243|P1|NOT COMPLETED|Overall Study||3
145989|NCT00372190|355242|P2|COMPLETED|Overall Study||96
145990|NCT00372190|355243|P1|COMPLETED|Overall Study||90
145991|NCT00372190|355242|P2|STARTED|Overall Study|99 were allocated to conventional arm, however 2 never underwent any surgery|97
145992|NCT00372190|355243|P1|STARTED|Overall Study|95 were allocated to mesh group, however 2 never underwent any surgery|93
145993|NCT00364793|355259|P4|NOT COMPLETED|Overall Study||3
145994|NCT00364793|355260|P3|NOT COMPLETED|Overall Study||4
145995|NCT00364793|355261|P2|NOT COMPLETED|Overall Study||5
145996|NCT00364793|355262|P1|NOT COMPLETED|Overall Study||8
145997|NCT00364793|355259|P4|COMPLETED|Overall Study||5
145998|NCT00364793|355260|P3|COMPLETED|Overall Study||0
145999|NCT00364793|355261|P2|COMPLETED|Overall Study||5
146000|NCT00364793|355262|P1|COMPLETED|Overall Study||7
146001|NCT00364793|355259|P4|STARTED|Overall Study||8
146002|NCT00364793|355260|P3|STARTED|Overall Study||4
146003|NCT00364793|355261|P2|STARTED|Overall Study||10
146004|NCT00364793|355262|P1|STARTED|Overall Study||15
146005|NCT00364819|355396|P1|NOT COMPLETED|Overall Study||0
146006|NCT00364819|355396|P1|COMPLETED|Overall Study||6
146007|NCT00364819|355396|P1|STARTED|Overall Study||6
146008|NCT00364832|355413|P12|NOT COMPLETED|Extension Year 2||3
146009|NCT00364832|355414|P11|NOT COMPLETED|Extension Year 2||5
146010|NCT00364832|355415|P10|NOT COMPLETED|Extension Year 2||5
146011|NCT00364832|355416|P9|NOT COMPLETED|Extension Year 2||0
146012|NCT00364832|355417|P8|NOT COMPLETED|Extension Year 2||0
146013|NCT00364832|355418|P7|NOT COMPLETED|Extension Year 2||0
146014|NCT00364832|355419|P6|NOT COMPLETED|Extension Year 2||0
146015|NCT00364832|355420|P5|NOT COMPLETED|Extension Year 2||0
146016|NCT00364832|355421|P4|NOT COMPLETED|Extension Year 2||0
146017|NCT00364832|355422|P3|NOT COMPLETED|Extension Year 2||0
146018|NCT00364832|355423|P2|NOT COMPLETED|Extension Year 2||0
146019|NCT00364832|355424|P1|NOT COMPLETED|Extension Year 2||0
146020|NCT00364832|355413|P12|COMPLETED|Extension Year 2||11
146021|NCT00364832|355414|P11|COMPLETED|Extension Year 2||9
146022|NCT00364832|355415|P10|COMPLETED|Extension Year 2||9
146023|NCT00364832|355416|P9|COMPLETED|Extension Year 2||0
146024|NCT00364832|355417|P8|COMPLETED|Extension Year 2||0
146025|NCT00364832|355418|P7|COMPLETED|Extension Year 2||0
146026|NCT00364832|355419|P6|COMPLETED|Extension Year 2||0
146027|NCT00364832|355420|P5|COMPLETED|Extension Year 2||0
146028|NCT00364832|355421|P4|COMPLETED|Extension Year 2||0
146029|NCT00364832|355422|P3|COMPLETED|Extension Year 2||0
146030|NCT00364832|355423|P2|COMPLETED|Extension Year 2||0
146031|NCT00364832|355424|P1|COMPLETED|Extension Year 2||0
146032|NCT00364832|355413|P12|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
146033|NCT00364832|355414|P11|STARTED|Extension Year 2|A portion of participants who completed Extension Year 1, entered Extension Year 2 (entry optional).|14
146034|NCT00364832|355415|P10|STARTED|Extension Year 2||14
146035|NCT00364832|355416|P9|STARTED|Extension Year 2||0
146036|NCT00364832|355417|P8|STARTED|Extension Year 2||0
146037|NCT00364832|355418|P7|STARTED|Extension Year 2||0
146038|NCT00364832|355419|P6|STARTED|Extension Year 2||0
146039|NCT00364832|355420|P5|STARTED|Extension Year 2||0
146040|NCT00364832|355421|P4|STARTED|Extension Year 2||0
146041|NCT00364832|355422|P3|STARTED|Extension Year 2||0
146042|NCT00364832|355423|P2|STARTED|Extension Year 2||0
146043|NCT00364832|355424|P1|STARTED|Extension Year 2||0
146044|NCT00364832|355413|P12|NOT COMPLETED|Extension Year 1||10
146045|NCT00364832|355414|P11|NOT COMPLETED|Extension Year 1||2
146046|NCT00364832|355415|P10|NOT COMPLETED|Extension Year 1||4
146047|NCT00364832|355416|P9|NOT COMPLETED|Extension Year 1||0
146048|NCT00364832|355417|P8|NOT COMPLETED|Extension Year 1||0
146049|NCT00364832|355418|P7|NOT COMPLETED|Extension Year 1||0
146050|NCT00364832|355419|P6|NOT COMPLETED|Extension Year 1||0
146051|NCT00364832|355420|P5|NOT COMPLETED|Extension Year 1||0
146052|NCT00364832|355421|P4|NOT COMPLETED|Extension Year 1||0
146053|NCT00364832|355422|P3|NOT COMPLETED|Extension Year 1||0
146054|NCT00364832|355423|P2|NOT COMPLETED|Extension Year 1||0
146055|NCT00364832|355424|P1|NOT COMPLETED|Extension Year 1||0
146056|NCT00364832|355413|P12|COMPLETED|Extension Year 1||17
146057|NCT00364832|355414|P11|COMPLETED|Extension Year 1||15
146058|NCT00364832|355415|P10|COMPLETED|Extension Year 1||14
146059|NCT00364832|355416|P9|COMPLETED|Extension Year 1||0
146060|NCT00364832|355417|P8|COMPLETED|Extension Year 1||0
146061|NCT00364832|355418|P7|COMPLETED|Extension Year 1||0
146062|NCT00364832|355419|P6|COMPLETED|Extension Year 1||0
146063|NCT00364832|355420|P5|COMPLETED|Extension Year 1||0
146064|NCT00364832|355421|P4|COMPLETED|Extension Year 1||0
146065|NCT00364832|355422|P3|COMPLETED|Extension Year 1||0
146066|NCT00364832|355423|P2|COMPLETED|Extension Year 1||0
146067|NCT00364832|355424|P1|COMPLETED|Extension Year 1||0
146068|NCT00364832|355413|P12|STARTED|Extension Year 1|Participants (Cohorts C, F, and I) who completed core, entered extension period (entry optional).|27
146069|NCT00364832|355414|P11|STARTED|Extension Year 1|Participants (Cohorts B, E, and H) who completed core, entered extension period (entry optional).|17
146070|NCT00364832|355415|P10|STARTED|Extension Year 1|Participants (Cohorts A, D, and G) who completed core, entered extension period (entry optional).|18
146071|NCT00364832|355416|P9|STARTED|Extension Year 1||0
146072|NCT00364832|355417|P8|STARTED|Extension Year 1||0
146073|NCT00364832|355418|P7|STARTED|Extension Year 1||0
146074|NCT00364832|355419|P6|STARTED|Extension Year 1||0
146075|NCT00364832|355420|P5|STARTED|Extension Year 1||0
146076|NCT00364832|355421|P4|STARTED|Extension Year 1||0
146077|NCT00364832|355422|P3|STARTED|Extension Year 1||0
146078|NCT00364832|355423|P2|STARTED|Extension Year 1||0
146079|NCT00364832|355424|P1|STARTED|Extension Year 1||0
146080|NCT00364832|355413|P12|NOT COMPLETED|Core Period||0
146081|NCT00364832|355414|P11|NOT COMPLETED|Core Period||0
146082|NCT00364832|355415|P10|NOT COMPLETED|Core Period||0
146083|NCT00364832|355416|P9|NOT COMPLETED|Core Period||0
146084|NCT00364832|355417|P8|NOT COMPLETED|Core Period||1
146085|NCT00364832|355418|P7|NOT COMPLETED|Core Period||4
146086|NCT00364832|355419|P6|NOT COMPLETED|Core Period||0
146087|NCT00364832|355420|P5|NOT COMPLETED|Core Period||0
146088|NCT00364832|355421|P4|NOT COMPLETED|Core Period||1
146089|NCT00364832|355422|P3|NOT COMPLETED|Core Period||1
146090|NCT00364832|355423|P2|NOT COMPLETED|Core Period||2
146091|NCT00364832|355424|P1|NOT COMPLETED|Core Period||2
146092|NCT00364832|355413|P12|COMPLETED|Core Period||0
146093|NCT00364832|355414|P11|COMPLETED|Core Period||0
146094|NCT00364832|355415|P10|COMPLETED|Core Period||0
146095|NCT00364832|355416|P9|COMPLETED|Core Period||16
146096|NCT00364832|355417|P8|COMPLETED|Core Period||14
146097|NCT00364832|355418|P7|COMPLETED|Core Period||12
146098|NCT00364832|355419|P6|COMPLETED|Core Period||12
146099|NCT00364832|355420|P5|COMPLETED|Core Period||16
146100|NCT00364832|355421|P4|COMPLETED|Core Period||15
146101|NCT00364832|355422|P3|COMPLETED|Core Period||14
146102|NCT00364832|355423|P2|COMPLETED|Core Period||13
146103|NCT00364832|355424|P1|COMPLETED|Core Period||14
146104|NCT00364832|355413|P12|STARTED|Core Period||0
146105|NCT00364832|355414|P11|STARTED|Core Period||0
146106|NCT00364832|355415|P10|STARTED|Core Period||0
146107|NCT00364832|355416|P9|STARTED|Core Period||16
146108|NCT00364832|355417|P8|STARTED|Core Period||15
146109|NCT00364832|355418|P7|STARTED|Core Period||16
146110|NCT00364832|355419|P6|STARTED|Core Period||12
146111|NCT00364832|355420|P5|STARTED|Core Period||16
146112|NCT00364832|355421|P4|STARTED|Core Period||16
146113|NCT00364832|355422|P3|STARTED|Core Period||15
146114|NCT00364832|355423|P2|STARTED|Core Period||15
146115|NCT00364832|355424|P1|STARTED|Core Period||16
146116|NCT00364845|355479|P2|NOT COMPLETED|Overall Study||11
146117|NCT00364845|355480|P1|NOT COMPLETED|Overall Study||11
146118|NCT00364845|355479|P2|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|12
146119|NCT00364845|355480|P1|COMPLETED|Overall Study|Completed 36-week titration/treatment phase|17
146120|NCT00364845|355479|P2|STARTED|Overall Study||23
146121|NCT00364845|355480|P1|STARTED|Overall Study||28
146122|NCT00364858|355494|P2|NOT COMPLETED|Overall Study||22
146123|NCT00364858|355495|P1|NOT COMPLETED|Overall Study||7
146124|NCT00364858|355494|P2|COMPLETED|Overall Study||40
146125|NCT00364858|355495|P1|COMPLETED|Overall Study||26
146126|NCT00364858|355494|P2|STARTED|Overall Study||62
146127|NCT00364858|355495|P1|STARTED|Overall Study||33
146128|NCT00364923|355508|P1|NOT COMPLETED|Survival Follow-up, After Pralatrexate||24
146129|NCT00364923|355508|P1|COMPLETED|Survival Follow-up, After Pralatrexate|Pts who completed follow-up either died, were followed for 24 months, or withdrew|83
146130|NCT00364923|355508|P1|STARTED|Survival Follow-up, After Pralatrexate|Patients (pts) who stop treatment with pralatrexate are followed for survival|107
146131|NCT00364923|355508|P1|NOT COMPLETED|Treatment With Pralatrexate||4
146132|NCT00364923|355508|P1|COMPLETED|Treatment With Pralatrexate|Treatment duration not limited. After treatment ends, patients attend survival follow-up visits.|107
146133|NCT00364923|355508|P1|STARTED|Treatment With Pralatrexate|Received at least one dose of pralatrexate.|111
146134|NCT00364949|355517|P2|NOT COMPLETED|Overall Study||0
146135|NCT00364949|355518|P1|NOT COMPLETED|Overall Study||0
146136|NCT00364949|355517|P2|COMPLETED|Overall Study||39
146137|NCT00364949|355518|P1|COMPLETED|Overall Study||31
146138|NCT00364949|355517|P2|STARTED|Overall Study||39
146139|NCT00364949|355518|P1|STARTED|Overall Study||31
146140|NCT00365053|355536|P1|NOT COMPLETED|Overall Study||0
146141|NCT00365053|355536|P1|COMPLETED|Overall Study||13
146142|NCT00365053|355536|P1|STARTED|Overall Study||13
146143|NCT00365105|355544|P2|NOT COMPLETED|Overall Study||4
146144|NCT00365105|355545|P1|NOT COMPLETED|Overall Study||6
146145|NCT00365105|355544|P2|COMPLETED|Overall Study||128
146146|NCT00365105|355545|P1|COMPLETED|Overall Study||123
146147|NCT00365105|355544|P2|STARTED|Overall Study||132
146148|NCT00365105|355545|P1|STARTED|Overall Study||129
146149|NCT00365144|355551|P1|NOT COMPLETED|Overall Study||0
146150|NCT00365144|355551|P1|COMPLETED|Overall Study||36
146151|NCT00365144|355551|P1|STARTED|Overall Study||36
146152|NCT00365209|355557|P1|NOT COMPLETED|Stage 2: Receiving 4g Curcumin||2
146153|NCT00365209|355557|P1|COMPLETED|Stage 2: Receiving 4g Curcumin||19
146154|NCT00365209|355557|P1|STARTED|Stage 2: Receiving 4g Curcumin||21
146155|NCT00365209|355557|P1|NOT COMPLETED|Stage 1: Receiving 2g Curcumin||2
146156|NCT00365209|355557|P1|COMPLETED|Stage 1: Receiving 2g Curcumin||21
146157|NCT00365209|355557|P1|STARTED|Stage 1: Receiving 2g Curcumin||23
146158|NCT00365261|355588|P2|NOT COMPLETED|Overall Study||3
146159|NCT00365261|355589|P1|NOT COMPLETED|Overall Study||3
146160|NCT00365261|355588|P2|COMPLETED|Overall Study||19
146161|NCT00365261|355589|P1|COMPLETED|Overall Study||20
146162|NCT00365261|355588|P2|STARTED|Overall Study||22
146163|NCT00365261|355589|P1|STARTED|Overall Study||23
146164|NCT00365274|355599|P1|NOT COMPLETED|Overall Study||0
146165|NCT00365274|355599|P1|COMPLETED|Overall Study||6
146166|NCT00365274|355599|P1|STARTED|Overall Study||6
146167|NCT00365300|355605|P2|NOT COMPLETED|Double-blind Phase||9
146168|NCT00365300|355606|P1|NOT COMPLETED|Double-blind Phase||11
146169|NCT00365300|355605|P2|COMPLETED|Double-blind Phase||45
146170|NCT00365300|355606|P1|COMPLETED|Double-blind Phase||43
146171|NCT00365300|355605|P2|STARTED|Double-blind Phase||54
146172|NCT00365300|355606|P1|STARTED|Double-blind Phase||54
146173|NCT00365300|355605|P2|NOT COMPLETED|Open-label Phase||0
146174|NCT00365300|355606|P1|NOT COMPLETED|Open-label Phase||22
146175|NCT00365300|355605|P2|COMPLETED|Open-label Phase||0
146176|NCT00365300|355606|P1|COMPLETED|Open-label Phase||107
146177|NCT00365300|355605|P2|STARTED|Open-label Phase||0
146178|NCT00365300|355606|P1|STARTED|Open-label Phase||129
146179|NCT00365352|355618|P3|NOT COMPLETED|Overall Study||15
146180|NCT00365352|355619|P2|NOT COMPLETED|Overall Study||11
146181|NCT00365352|355620|P1|NOT COMPLETED|Overall Study||20
146182|NCT00365352|355618|P3|COMPLETED|Overall Study||98
146183|NCT00365352|355619|P2|COMPLETED|Overall Study||104
146184|NCT00365352|355620|P1|COMPLETED|Overall Study||77
146185|NCT00365352|355618|P3|Modified Intent-to-Treat Population|Overall Study||111
146186|NCT00365352|355619|P2|Modified Intent-to-Treat Population|Overall Study||114
146187|NCT00365352|355620|P1|Modified Intent-to-Treat Population|Overall Study||96
146188|NCT00365352|355618|P3|Safety Population|Overall Study||111
146189|NCT00365352|355619|P2|Safety Population|Overall Study||115
146190|NCT00365352|355620|P1|Safety Population|Overall Study||96
146191|NCT00365352|355618|P3|STARTED|Overall Study||113
146192|NCT00365352|355619|P2|STARTED|Overall Study||115
146193|NCT00365352|355620|P1|STARTED|Overall Study||97
146194|NCT00365365|355705|P3|NOT COMPLETED|Overall Study||15
146195|NCT00365365|355706|P2|NOT COMPLETED|Overall Study||36
146196|NCT00365365|355707|P1|NOT COMPLETED|Overall Study||34
146197|NCT00365365|355705|P3|COMPLETED|Overall Study||44
146198|NCT00365365|355706|P2|COMPLETED|Overall Study||41
146199|NCT00365365|355707|P1|COMPLETED|Overall Study||44
146200|NCT00365365|355705|P3|COMPLETED TREATMENT|Overall Study||45
146201|NCT00365365|355706|P2|COMPLETED TREATMENT|Overall Study||36
146202|NCT00365365|355707|P1|COMPLETED TREATMENT|Overall Study||38
146203|NCT00365365|355705|P3|TREATED (SAFETY POPULATION)|Overall Study||59
146204|NCT00365365|355706|P2|TREATED (SAFETY POPULATION)|Overall Study||75
146205|NCT00365365|355707|P1|TREATED (SAFETY POPULATION)|Overall Study||78
146206|NCT00365365|355705|P3|STARTED|Overall Study||59
146207|NCT00365365|355706|P2|STARTED|Overall Study||77
146208|NCT00365365|355707|P1|STARTED|Overall Study||78
146209|NCT00365378|355723|P3|NOT COMPLETED|Extension||197
146210|NCT00365378|355724|P2|NOT COMPLETED|Extension||0
146211|NCT00365378|355725|P1|NOT COMPLETED|Extension||0
146212|NCT00365378|355723|P3|COMPLETED|Extension||203
146213|NCT00365378|355724|P2|COMPLETED|Extension||0
146214|NCT00365378|355725|P1|COMPLETED|Extension||0
146215|NCT00365378|355723|P3|STARTED|Extension||400
146216|NCT00365378|355724|P2|STARTED|Extension||0
146217|NCT00365378|355725|P1|STARTED|Extension||0
146218|NCT00365378|355723|P3|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||0
146219|NCT00365378|355724|P2|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||202
146220|NCT00365378|355725|P1|NOT COMPLETED|Follow-up (Month 7 Though Month 48)||158
146221|NCT00365378|355723|P3|COMPLETED|Follow-up (Month 7 Though Month 48)||0
146222|NCT00365378|355724|P2|COMPLETED|Follow-up (Month 7 Though Month 48)||836
146223|NCT00365378|355725|P1|COMPLETED|Follow-up (Month 7 Though Month 48)||835
146224|NCT00365378|355723|P3|STARTED|Follow-up (Month 7 Though Month 48)||0
146225|NCT00365378|355724|P2|STARTED|Follow-up (Month 7 Though Month 48)||1038
146226|NCT00365378|355725|P1|STARTED|Follow-up (Month 7 Though Month 48)||993
146227|NCT00365378|355723|P3|NOT COMPLETED|Vaccination (Day 1 to Month 7)||0
146228|NCT00365378|355724|P2|NOT COMPLETED|Vaccination (Day 1 to Month 7)||167
146229|NCT00365378|355725|P1|NOT COMPLETED|Vaccination (Day 1 to Month 7)||211
146230|NCT00365378|355723|P3|COMPLETED|Vaccination (Day 1 to Month 7)||0
146231|NCT00365378|355724|P2|COMPLETED|Vaccination (Day 1 to Month 7)||1038
146232|NCT00365378|355725|P1|COMPLETED|Vaccination (Day 1 to Month 7)||993
146233|NCT00365378|355723|P3|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||0
146234|NCT00365378|355724|P2|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1198
146235|NCT00365378|355725|P1|Entered Vaccination Period|Vaccination (Day 1 to Month 7)||1193
146236|NCT00365378|355723|P3|STARTED|Vaccination (Day 1 to Month 7)||0
146237|NCT00365378|355724|P2|STARTED|Vaccination (Day 1 to Month 7)||1205
146238|NCT00365378|355725|P1|STARTED|Vaccination (Day 1 to Month 7)||1204
146239|NCT00365391|355736|P1|NOT COMPLETED|Overall Study||0
146240|NCT00365391|355736|P1|COMPLETED|Overall Study||27
146241|NCT00365391|355736|P1|STARTED|Overall Study||27
146242|NCT00365417|355744|P1|NOT COMPLETED|Overall Study||0
146243|NCT00365417|355744|P1|COMPLETED|Overall Study||45
146244|NCT00365417|355744|P1|STARTED|Overall Study||45
146245|NCT00365456|355750|P2|NOT COMPLETED|Trial Period III (12 Months)||5
146246|NCT00365456|355751|P1|NOT COMPLETED|Trial Period III (12 Months)||18
146247|NCT00365456|355750|P2|COMPLETED|Trial Period III (12 Months)||127
146248|NCT00365456|355751|P1|COMPLETED|Trial Period III (12 Months)||118
146249|NCT00365456|355750|P2|STARTED|Trial Period III (12 Months)||132
146250|NCT00365456|355751|P1|STARTED|Trial Period III (12 Months)||136
146251|NCT00365456|355750|P2|NOT COMPLETED|Trial Period II (12 Months)||14
146252|NCT00365456|355751|P1|NOT COMPLETED|Trial Period II (12 Months)||0
146253|NCT00365456|355750|P2|COMPLETED|Trial Period II (12 Months)||268
146254|NCT00365456|355751|P1|COMPLETED|Trial Period II (12 Months)||0
146255|NCT00365456|355750|P2|STARTED|Trial Period II (12 Months)||282
146256|NCT00365456|355751|P1|STARTED|Trial Period II (12 Months)||0
146257|NCT00365456|355750|P2|NOT COMPLETED|Trial Period I (12 Months)||0
146258|NCT00365456|355751|P1|NOT COMPLETED|Trial Period I (12 Months)||125
146259|NCT00365456|355750|P2|COMPLETED|Trial Period I (12 Months)||0
146260|NCT00365456|355751|P1|COMPLETED|Trial Period I (12 Months)||282
146261|NCT00365456|355750|P2|STARTED|Trial Period I (12 Months)||0
146262|NCT00365456|355751|P1|STARTED|Trial Period I (12 Months)||407
146263|NCT00365508|355759|P2|NOT COMPLETED|Overall Study||154
146264|NCT00365508|355760|P1|NOT COMPLETED|Overall Study||139
146265|NCT00365508|355759|P2|COMPLETED|Overall Study||167
146266|NCT00365508|355760|P1|COMPLETED|Overall Study||182
146267|NCT00365508|355759|P2|STARTED|Overall Study||321
146268|NCT00365508|355760|P1|STARTED|Overall Study||321
146269|NCT00365547|355768|P1|NOT COMPLETED|Overall Study||3
146270|NCT00365547|355768|P1|COMPLETED|Overall Study||43
146271|NCT00365547|355768|P1|STARTED|Overall Study||46
146272|NCT00365599|355776|P1|NOT COMPLETED|Overall Study||0
146273|NCT00365599|355776|P1|COMPLETED|Overall Study||43
146274|NCT00365599|355776|P1|STARTED|Overall Study||43
146275|NCT00372385|355786|P4|NOT COMPLETED|Overall Study||8
146276|NCT00372385|355787|P3|NOT COMPLETED|Overall Study||10
146277|NCT00372385|355788|P2|NOT COMPLETED|Overall Study||20
146278|NCT00372385|355789|P1|NOT COMPLETED|Overall Study||33
146279|NCT00372385|355786|P4|COMPLETED|Overall Study||70
146280|NCT00372385|355787|P3|COMPLETED|Overall Study||72
146281|NCT00372385|355788|P2|COMPLETED|Overall Study||61
146282|NCT00372385|355789|P1|COMPLETED|Overall Study||49
146283|NCT00372385|355786|P4|STARTED|Overall Study||78
146284|NCT00372385|355787|P3|STARTED|Overall Study||82
146285|NCT00372385|355788|P2|STARTED|Overall Study||81
146286|NCT00372385|355789|P1|STARTED|Overall Study||82
146287|NCT00372411|355819|P3|NOT COMPLETED|Overall Study||3
146288|NCT00372411|355820|P2|NOT COMPLETED|Overall Study||8
146289|NCT00372411|355821|P1|NOT COMPLETED|Overall Study||5
146290|NCT00372411|355819|P3|COMPLETED|Overall Study||25
146291|NCT00372411|355820|P2|COMPLETED|Overall Study||42
146292|NCT00372411|355821|P1|COMPLETED|Overall Study||44
146293|NCT00372411|355819|P3|STARTED|Overall Study||28
146294|NCT00372411|355820|P2|STARTED|Overall Study||50
146295|NCT00372411|355821|P1|STARTED|Overall Study||49
146296|NCT00372424|355841|P1|NOT COMPLETED|Overall Study||26
146297|NCT00372424|355841|P1|COMPLETED|Overall Study||0
146298|NCT00372424|355841|P1|Treated|Overall Study||25
146299|NCT00372424|355841|P1|STARTED|Overall Study||26
146300|NCT00372489|355852|P1|NOT COMPLETED|Overall Study||79
146301|NCT00372489|355852|P1|COMPLETED|Overall Study||2
146302|NCT00372489|355852|P1|STARTED|Overall Study||81
146303|NCT00372528|355856|P1|NOT COMPLETED|Overall Study||21
146304|NCT00372528|355856|P1|COMPLETED|Overall Study||0
146305|NCT00372528|355856|P1|STARTED|Overall Study||21
146306|NCT00372593|355864|P3|NOT COMPLETED|Overall Study||4
146307|NCT00372593|355865|P2|NOT COMPLETED|Overall Study||198
146308|NCT00372593|355866|P1|NOT COMPLETED|Overall Study||204
146309|NCT00372593|355864|P3|COMPLETED|Overall Study||3
146310|NCT00372593|355865|P2|COMPLETED|Overall Study||334
146311|NCT00372593|355866|P1|COMPLETED|Overall Study||327
146312|NCT00372593|355864|P3|STARTED|Overall Study||7
146313|NCT00372593|355865|P2|STARTED|Overall Study||532
146314|NCT00372593|355866|P1|STARTED|Overall Study||531
146315|NCT00372619|355899|P7|NOT COMPLETED|Overall Study||0
146316|NCT00372619|355900|P6|NOT COMPLETED|Overall Study||3
146317|NCT00372619|355901|P5|NOT COMPLETED|Overall Study||0
146318|NCT00372619|355902|P4|NOT COMPLETED|Overall Study||0
146319|NCT00372619|355903|P3|NOT COMPLETED|Overall Study||0
146320|NCT00372619|355904|P2|NOT COMPLETED|Overall Study||0
146321|NCT00372619|355905|P1|NOT COMPLETED|Overall Study||0
146322|NCT00372619|355899|P7|COMPLETED|Overall Study||2
146323|NCT00372619|355900|P6|COMPLETED|Overall Study||39
146324|NCT00372619|355901|P5|COMPLETED|Overall Study||7
146325|NCT00372619|355902|P4|COMPLETED|Overall Study||10
146326|NCT00372619|355903|P3|COMPLETED|Overall Study||3
146327|NCT00372619|355904|P2|COMPLETED|Overall Study||2
146328|NCT00372619|355905|P1|COMPLETED|Overall Study||8
146329|NCT00372619|355899|P7|STARTED|Overall Study||2
146330|NCT00372619|355900|P6|STARTED|Overall Study||42
146331|NCT00372619|355901|P5|STARTED|Overall Study||7
146332|NCT00372619|355902|P4|STARTED|Overall Study||10
146333|NCT00372619|355903|P3|STARTED|Overall Study||3
146334|NCT00372619|355904|P2|STARTED|Overall Study||2
146335|NCT00372619|355905|P1|STARTED|Overall Study||8
146336|NCT00372697|355937|P2|NOT COMPLETED|Overall Study||1
146337|NCT00372697|355938|P1|NOT COMPLETED|Overall Study||1
146338|NCT00372697|355937|P2|COMPLETED|Overall Study||11
146339|NCT00372697|355938|P1|COMPLETED|Overall Study||15
146340|NCT00372697|355937|P2|STARTED|Overall Study||12
146341|NCT00372697|355938|P1|STARTED|Overall Study||16
146342|NCT00372775|355956|P1|NOT COMPLETED|Overall Study||63
146343|NCT00372775|355956|P1|COMPLETED|Overall Study||3
146344|NCT00372775|355956|P1|Received Treatment|Overall Study||64
146345|NCT00372775|355956|P1|STARTED|Overall Study||66
146346|NCT00372970|355978|P2|NOT COMPLETED|Overall Study||0
146347|NCT00372970|355979|P1|NOT COMPLETED|Overall Study||0
146348|NCT00372970|355978|P2|COMPLETED|Overall Study||16
146349|NCT00372970|355979|P1|COMPLETED|Overall Study||16
146350|NCT00372970|355978|P2|STARTED|Overall Study||16
146351|NCT00372970|355979|P1|STARTED|Overall Study||16
146352|NCT00372996|355987|P4|NOT COMPLETED|Overall Study||20
146353|NCT00372996|355988|P3|NOT COMPLETED|Overall Study||28
146354|NCT00372996|355989|P2|NOT COMPLETED|Overall Study||14
146355|NCT00372996|355990|P1|NOT COMPLETED|Overall Study||37
146356|NCT00372996|355987|P4|COMPLETED|Overall Study||23
146357|NCT00372996|355988|P3|COMPLETED|Overall Study||33
146358|NCT00372996|355989|P2|COMPLETED|Overall Study||22
146359|NCT00372996|355990|P1|COMPLETED|Overall Study||42
146360|NCT00372996|355987|P4|STARTED|Overall Study||43
146361|NCT00372996|355988|P3|STARTED|Overall Study||61
146362|NCT00372996|355989|P2|STARTED|Overall Study||36
146363|NCT00372996|355990|P1|STARTED|Overall Study||79
146364|NCT00373113|356016|P2|NOT COMPLETED|Overall Study||244
146365|NCT00373113|356017|P1|NOT COMPLETED|Overall Study||238
146366|NCT00373113|356016|P2|COMPLETED|Overall Study||0
146367|NCT00373113|356017|P1|COMPLETED|Overall Study||0
146368|NCT00373113|356016|P2|Received Treatment|Overall Study||240
146369|NCT00373113|356017|P1|Received Treatment|Overall Study||238
146370|NCT00373113|356016|P2|STARTED|Overall Study||244
146371|NCT00373113|356017|P1|STARTED|Overall Study||238
146372|NCT00373256|356039|P2|NOT COMPLETED|Overall Study||247
146373|NCT00373256|356040|P1|NOT COMPLETED|Overall Study||241
146374|NCT00373256|356039|P2|COMPLETED|Overall Study||0
146375|NCT00373256|356040|P1|COMPLETED|Overall Study||0
146376|NCT00373256|356039|P2|Treated|Overall Study||236
146377|NCT00373256|356040|P1|Treated|Overall Study||235
146378|NCT00373256|356039|P2|STARTED|Overall Study||247
146379|NCT00373256|356040|P1|STARTED|Overall Study||241
146380|NCT00373269|356066|P2|NOT COMPLETED|Overall Study||0
146381|NCT00373269|356067|P1|NOT COMPLETED|Overall Study||0
146382|NCT00373269|356066|P2|COMPLETED|Overall Study||10
146383|NCT00373269|356067|P1|COMPLETED|Overall Study||11
146384|NCT00373269|356066|P2|STARTED|Overall Study||10
146385|NCT00373269|356067|P1|STARTED|Overall Study||11
146386|NCT00373295|356075|P6|NOT COMPLETED|Intervention 3 (8 Days)||0
146387|NCT00373295|356076|P5|NOT COMPLETED|Intervention 3 (8 Days)||0
146388|NCT00373295|356077|P4|NOT COMPLETED|Intervention 3 (8 Days)||0
146389|NCT00373295|356078|P3|NOT COMPLETED|Intervention 3 (8 Days)||0
146390|NCT00373295|356079|P2|NOT COMPLETED|Intervention 3 (8 Days)||0
146391|NCT00373295|356080|P1|NOT COMPLETED|Intervention 3 (8 Days)||0
146392|NCT00373295|356075|P6|COMPLETED|Intervention 3 (8 Days)||2
146393|NCT00373295|356076|P5|COMPLETED|Intervention 3 (8 Days)||2
146394|NCT00373295|356077|P4|COMPLETED|Intervention 3 (8 Days)||2
146395|NCT00373295|356078|P3|COMPLETED|Intervention 3 (8 Days)||1
146396|NCT00373295|356079|P2|COMPLETED|Intervention 3 (8 Days)||1
146397|NCT00373295|356080|P1|COMPLETED|Intervention 3 (8 Days)||2
146398|NCT00373295|356075|P6|STARTED|Intervention 3 (8 Days)||2
146399|NCT00373295|356076|P5|STARTED|Intervention 3 (8 Days)||2
146400|NCT00373295|356077|P4|STARTED|Intervention 3 (8 Days)||2
146401|NCT00373295|356078|P3|STARTED|Intervention 3 (8 Days)||1
146402|NCT00373295|356079|P2|STARTED|Intervention 3 (8 Days)||1
146403|NCT00373295|356080|P1|STARTED|Intervention 3 (8 Days)||2
146404|NCT00373295|356075|P6|NOT COMPLETED|Intervention 2 (8 Days)||0
146405|NCT00373295|356076|P5|NOT COMPLETED|Intervention 2 (8 Days)||0
146406|NCT00373295|356077|P4|NOT COMPLETED|Intervention 2 (8 Days)||0
146407|NCT00373295|356078|P3|NOT COMPLETED|Intervention 2 (8 Days)||0
146408|NCT00373295|356079|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
146409|NCT00373295|356080|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
146410|NCT00373295|356075|P6|COMPLETED|Intervention 2 (8 Days)||2
146411|NCT00373295|356076|P5|COMPLETED|Intervention 2 (8 Days)||2
146412|NCT00373295|356077|P4|COMPLETED|Intervention 2 (8 Days)||2
146413|NCT00373295|356078|P3|COMPLETED|Intervention 2 (8 Days)||1
146414|NCT00373295|356079|P2|COMPLETED|Intervention 2 (8 Days)||1
146415|NCT00373295|356080|P1|COMPLETED|Intervention 2 (8 Days)||2
146416|NCT00373295|356075|P6|STARTED|Intervention 2 (8 Days)||2
146417|NCT00373295|356076|P5|STARTED|Intervention 2 (8 Days)||2
146418|NCT00373295|356077|P4|STARTED|Intervention 2 (8 Days)||2
146419|NCT00373295|356078|P3|STARTED|Intervention 2 (8 Days)||1
146420|NCT00373295|356079|P2|STARTED|Intervention 2 (8 Days)||1
146421|NCT00373295|356080|P1|STARTED|Intervention 2 (8 Days)||2
146422|NCT00373295|356075|P6|NOT COMPLETED|Intervention 1 (8 Days)||0
146423|NCT00373295|356076|P5|NOT COMPLETED|Intervention 1 (8 Days)||1
146424|NCT00373295|356077|P4|NOT COMPLETED|Intervention 1 (8 Days)||0
146425|NCT00373295|356078|P3|NOT COMPLETED|Intervention 1 (8 Days)||0
146426|NCT00373295|356079|P2|NOT COMPLETED|Intervention 1 (8 Days)||2
146427|NCT00373295|356080|P1|NOT COMPLETED|Intervention 1 (8 Days)||0
146428|NCT00373295|356075|P6|COMPLETED|Intervention 1 (8 Days)||2
146429|NCT00373295|356076|P5|COMPLETED|Intervention 1 (8 Days)||2
146430|NCT00373295|356077|P4|COMPLETED|Intervention 1 (8 Days)||2
146431|NCT00373295|356078|P3|COMPLETED|Intervention 1 (8 Days)||1
146432|NCT00373295|356079|P2|COMPLETED|Intervention 1 (8 Days)||1
146433|NCT00373295|356080|P1|COMPLETED|Intervention 1 (8 Days)||2
146434|NCT00373295|356075|P6|STARTED|Intervention 1 (8 Days)||2
146435|NCT00373295|356076|P5|STARTED|Intervention 1 (8 Days)||3
146436|NCT00373295|356077|P4|STARTED|Intervention 1 (8 Days)||2
146437|NCT00373295|356078|P3|STARTED|Intervention 1 (8 Days)||1
146438|NCT00373295|356079|P2|STARTED|Intervention 1 (8 Days)||3
146439|NCT00373295|356080|P1|STARTED|Intervention 1 (8 Days)||2
146440|NCT00373334|356091|P3|NOT COMPLETED|Overall Study||13
146441|NCT00373334|356092|P2|NOT COMPLETED|Overall Study||18
146442|NCT00373334|356093|P1|NOT COMPLETED|Overall Study||10
146443|NCT00373334|356091|P3|COMPLETED|Overall Study||32
146444|NCT00373334|356092|P2|COMPLETED|Overall Study||32
146445|NCT00373334|356093|P1|COMPLETED|Overall Study||33
146446|NCT00373334|356091|P3|STARTED|Overall Study||45
146447|NCT00373334|356092|P2|STARTED|Overall Study||50
146448|NCT00373334|356093|P1|STARTED|Overall Study||43
146449|NCT00373360|356107|P1|NOT COMPLETED|Overall Study||0
146450|NCT00373360|356107|P1|COMPLETED|Overall Study||10
146451|NCT00373360|356107|P1|STARTED|Overall Study||10
146452|NCT00373425|356140|P5|NOT COMPLETED|Overall Study||72
146453|NCT00373425|356141|P4|NOT COMPLETED|Overall Study||11
146454|NCT00373425|356142|P3|NOT COMPLETED|Overall Study||134
146455|NCT00373425|356143|P2|NOT COMPLETED|Overall Study||153
146456|NCT00373425|356144|P1|NOT COMPLETED|Overall Study||370
146457|NCT00373425|356140|P5|COMPLETED|Overall Study|Completed 2 years of study treatment|60
146458|NCT00373425|356141|P4|COMPLETED|Overall Study|Completed 2 years of study treatment|0
146459|NCT00373425|356142|P3|COMPLETED|Overall Study|Completed 2 years of study treatment|0
146460|NCT00373425|356143|P2|COMPLETED|Overall Study|Completed 2 years of study treatment|197
146461|NCT00373425|356144|P1|COMPLETED|Overall Study|Completed 2 years of study treatment|253
146462|NCT00373425|356140|P5|Received Treatment|Overall Study||132
146463|NCT00373425|356141|P4|Received Treatment|Overall Study||7
146464|NCT00373425|356142|P3|Received Treatment|Overall Study||134
146465|NCT00373425|356143|P2|Received Treatment|Overall Study||342
146466|NCT00373425|356144|P1|Received Treatment|Overall Study||612
146467|NCT00373425|356140|P5|STARTED|Overall Study||132
146468|NCT00373425|356141|P4|STARTED|Overall Study||11
146469|NCT00373425|356142|P3|STARTED|Overall Study||134
146470|NCT00373425|356143|P2|STARTED|Overall Study||350
146471|NCT00373425|356144|P1|STARTED|Overall Study||623
146472|NCT00373490|356171|P2|NOT COMPLETED|Overall Study||6
146473|NCT00373490|356172|P1|NOT COMPLETED|Overall Study||9
146474|NCT00373490|356171|P2|COMPLETED|Overall Study||0
146475|NCT00373490|356172|P1|COMPLETED|Overall Study||1
146476|NCT00373490|356171|P2|STARTED|Overall Study||6
146477|NCT00373490|356172|P1|STARTED|Overall Study||10
146478|NCT00373529|356190|P1|NOT COMPLETED|Overall Study||108
146479|NCT00373529|356190|P1|COMPLETED|Overall Study|Completed: initiated full 6 cycles of treatment. Not Completed: initiated <6 cycles of treatment|8
146480|NCT00373529|356190|P1|Full Analysis Set|Overall Study|3 Failed Independent Confirmation of AML; 1 consent violation|112
146481|NCT00373529|356190|P1|STARTED|Overall Study||116
146482|NCT00373685|356202|P2|NOT COMPLETED|Overall Study||1421
146483|NCT00373685|356203|P1|NOT COMPLETED|Overall Study||1439
146484|NCT00373685|356202|P2|COMPLETED|Overall Study||2611
146485|NCT00373685|356203|P1|COMPLETED|Overall Study||2596
146486|NCT00373685|356202|P2|Treated|Overall Study||3955
146487|NCT00373685|356203|P1|Treated|Overall Study||3984
146488|NCT00373685|356202|P2|STARTED|Overall Study||4032
146489|NCT00373685|356203|P1|STARTED|Overall Study||4035
146490|NCT00373698|356239|P2|NOT COMPLETED|Overall Study||0
146491|NCT00373698|356240|P1|NOT COMPLETED|Overall Study||11
146492|NCT00373698|356239|P2|COMPLETED|Overall Study||99
146493|NCT00373698|356240|P1|COMPLETED|Overall Study||85
146494|NCT00373698|356239|P2|STARTED|Overall Study||99
146495|NCT00373698|356240|P1|STARTED|Overall Study||96
146496|NCT00373958|356254|P2|NOT COMPLETED|Toddler Dose||38
146497|NCT00373958|356255|P1|NOT COMPLETED|Toddler Dose||30
146498|NCT00373958|356254|P2|COMPLETED|Toddler Dose||252
146499|NCT00373958|356255|P1|COMPLETED|Toddler Dose||264
146500|NCT00373958|356254|P2|Vaccinated Toddler Dose|Toddler Dose||265
146501|NCT00373958|356255|P1|Vaccinated Toddler Dose|Toddler Dose||272
146502|NCT00373958|356254|P2|Withdrawn After Infant Series|Toddler Dose||25
146503|NCT00373958|356255|P1|Withdrawn After Infant Series|Toddler Dose||22
146504|NCT00373958|356254|P2|STARTED|Toddler Dose||290
146505|NCT00373958|356255|P1|STARTED|Toddler Dose||294
146506|NCT00373958|356254|P2|NOT COMPLETED|Infant Series||42
146507|NCT00373958|356255|P1|NOT COMPLETED|Infant Series||40
146508|NCT00373958|356254|P2|COMPLETED|Infant Series||290
146509|NCT00373958|356255|P1|COMPLETED|Infant Series||294
146510|NCT00373958|356254|P2|Vaccinated Dose 3|Infant Series||300
146511|NCT00373958|356255|P1|Vaccinated Dose 3|Infant Series||298
146512|NCT00373958|356254|P2|Vaccinated Dose 2|Infant Series||305
146513|NCT00373958|356255|P1|Vaccinated Dose 2|Infant Series||309
146514|NCT00373958|356254|P2|Vaccinated Dose 1|Infant Series||331
146515|NCT00373958|356255|P1|Vaccinated Dose 1|Infant Series||332
146516|NCT00373958|356254|P2|STARTED|Infant Series||332
146517|NCT00373958|356255|P1|STARTED|Infant Series|One participant was prerandomized but not consented.|334
146518|NCT00374088|356305|P2|NOT COMPLETED|Overall Study||1
146519|NCT00374088|356306|P1|NOT COMPLETED|Overall Study||1
146520|NCT00374088|356305|P2|COMPLETED|Overall Study||10
146521|NCT00374088|356306|P1|COMPLETED|Overall Study||9
146522|NCT00374088|356305|P2|STARTED|Overall Study||11
146523|NCT00374088|356306|P1|STARTED|Overall Study||10
146524|NCT00374140|356316|P1|NOT COMPLETED|Overall Study||2
146525|NCT00374140|356316|P1|COMPLETED|Overall Study||38
146526|NCT00374140|356316|P1|STARTED|Overall Study||40
146527|NCT00374231|356320|P1|NOT COMPLETED|Overall Study||0
146528|NCT00374231|356320|P1|COMPLETED|Overall Study||40
146529|NCT00374231|356320|P1|STARTED|Overall Study||40
146530|NCT00374244|356328|P2|NOT COMPLETED|Overall Study||0
146531|NCT00374244|356329|P1|NOT COMPLETED|Overall Study||0
146532|NCT00374244|356328|P2|COMPLETED|Overall Study||14
146533|NCT00374244|356329|P1|COMPLETED|Overall Study||14
146534|NCT00374244|356328|P2|STARTED|Overall Study||14
146535|NCT00374244|356329|P1|STARTED|Overall Study||14
146536|NCT00374322|356377|P2|NOT COMPLETED|Overall Study||1304
146537|NCT00374322|356378|P1|NOT COMPLETED|Overall Study||1257
146538|NCT00374322|356377|P2|COMPLETED|Overall Study||278
146539|NCT00374322|356378|P1|COMPLETED|Overall Study||322
146540|NCT00374322|356377|P2|Received >=1 Dose of Study Treatment|Overall Study||1576
146541|NCT00374322|356378|P1|Received >=1 Dose of Study Treatment|Overall Study||1571
146542|NCT00374322|356377|P2|STARTED|Overall Study||1582
146543|NCT00374322|356378|P1|STARTED|Overall Study||1579
146544|NCT00374335|356414|P1|NOT COMPLETED|Overall Study||0
146545|NCT00374335|356414|P1|COMPLETED|Overall Study||261
146546|NCT00374335|356414|P1|STARTED|Overall Study||261
146547|NCT00374543|356421|P2|NOT COMPLETED|Overall Study||0
146548|NCT00374543|356422|P1|NOT COMPLETED|Overall Study||0
146549|NCT00374543|356421|P2|COMPLETED|Overall Study||1
146550|NCT00374543|356422|P1|COMPLETED|Overall Study||2
146551|NCT00374543|356421|P2|STARTED|Overall Study||1
146552|NCT00374543|356422|P1|STARTED|Overall Study||2
146553|NCT00374803|356430|P2|NOT COMPLETED|Overall Study||0
146554|NCT00374803|356431|P1|NOT COMPLETED|Overall Study||0
146555|NCT00374803|356430|P2|COMPLETED|Overall Study||23
146556|NCT00374803|356431|P1|COMPLETED|Overall Study||22
146557|NCT00374803|356430|P2|STARTED|Overall Study||23
146558|NCT00374803|356431|P1|STARTED|Overall Study||22
146559|NCT00374842|356448|P3|NOT COMPLETED|Overall Study||0
146560|NCT00374842|356449|P2|NOT COMPLETED|Overall Study||0
146561|NCT00374842|356450|P1|NOT COMPLETED|Overall Study||0
146562|NCT00374842|356448|P3|COMPLETED|Overall Study||100
146563|NCT00374842|356449|P2|COMPLETED|Overall Study||100
146564|NCT00374842|356450|P1|COMPLETED|Overall Study||100
146565|NCT00374842|356448|P3|STARTED|Overall Study||100
146566|NCT00374842|356449|P2|STARTED|Overall Study||100
146567|NCT00374842|356450|P1|STARTED|Overall Study||100
146568|NCT00374868|356479|P1|NOT COMPLETED|Overall Study||36
146569|NCT00374868|356479|P1|COMPLETED|Overall Study||2
146570|NCT00374868|356479|P1|STARTED|Overall Study||38
146571|NCT00374907|356492|P2|NOT COMPLETED|116-Week Short-term + Long-term Period||14
146572|NCT00374907|356493|P1|NOT COMPLETED|116-Week Short-term + Long-term Period||13
146573|NCT00374907|356492|P2|COMPLETED|116-Week Short-term + Long-term Period||2
146574|NCT00374907|356493|P1|COMPLETED|116-Week Short-term + Long-term Period||7
146575|NCT00374907|356492|P2|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||15
146576|NCT00374907|356493|P1|Completed 12-week Short Term Period|116-Week Short-term + Long-term Period||17
146577|NCT00374907|356492|P2|STARTED|116-Week Short-term + Long-term Period||16
146578|NCT00374907|356493|P1|STARTED|116-Week Short-term + Long-term Period||20
146579|NCT00374907|356492|P2|NOT COMPLETED|12-Week Short-term Period||1
146580|NCT00374907|356493|P1|NOT COMPLETED|12-Week Short-term Period||3
146581|NCT00374907|356492|P2|COMPLETED|12-Week Short-term Period||15
146582|NCT00374907|356493|P1|COMPLETED|12-Week Short-term Period||17
146583|NCT00374907|356492|P2|STARTED|12-Week Short-term Period||16
146584|NCT00374907|356493|P1|STARTED|12-Week Short-term Period||20
146585|NCT00368459|356507|P2|NOT COMPLETED|Overall Study||1
146586|NCT00368459|356508|P1|NOT COMPLETED|Overall Study||2
146587|NCT00368459|356507|P2|COMPLETED|Overall Study||20
146588|NCT00368459|356508|P1|COMPLETED|Overall Study||19
146589|NCT00368459|356507|P2|STARTED|Overall Study||21
146590|NCT00368459|356508|P1|STARTED|Overall Study||21
146591|NCT00368472|356532|P1|NOT COMPLETED|Overall Study||105
146592|NCT00368472|356532|P1|COMPLETED|Overall Study||33
146593|NCT00368472|356532|P1|STARTED|Overall Study||138
146594|NCT00368537|356540|P2|NOT COMPLETED|Baseline Participants||24
146595|NCT00368537|356541|P1|NOT COMPLETED|Baseline Participants||24
146596|NCT00368537|356540|P2|COMPLETED|Baseline Participants||239
146597|NCT00368537|356541|P1|COMPLETED|Baseline Participants||244
146598|NCT00368537|356540|P2|STARTED|Baseline Participants||263
146599|NCT00368537|356541|P1|STARTED|Baseline Participants||268
146600|NCT00368537|356540|P2|NOT COMPLETED|Randomization||6
146601|NCT00368537|356541|P1|NOT COMPLETED|Randomization||13
146602|NCT00368537|356540|P2|COMPLETED|Randomization||263
146603|NCT00368537|356541|P1|COMPLETED|Randomization||268
146604|NCT00368537|356540|P2|STARTED|Randomization||269
146605|NCT00368537|356541|P1|STARTED|Randomization||281
146606|NCT00368550|356557|P2|NOT COMPLETED|Overall Study||23
146607|NCT00368550|356558|P1|NOT COMPLETED|Overall Study||28
146608|NCT00368550|356557|P2|COMPLETED|Overall Study||48
146609|NCT00368550|356558|P1|COMPLETED|Overall Study||35
146610|NCT00368550|356557|P2|STARTED|Overall Study||71
146611|NCT00368550|356558|P1|STARTED|Overall Study||63
146612|NCT00368641|356570|P2|NOT COMPLETED|Overall Study||6
146613|NCT00368641|356571|P1|NOT COMPLETED|Overall Study||6
146614|NCT00368641|356570|P2|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
146615|NCT00368641|356571|P1|COMPLETED|Overall Study|study was terminated prior to completion of treatment period|0
146616|NCT00368641|356570|P2|STARTED|Overall Study||6
146617|NCT00368641|356571|P1|STARTED|Overall Study||6
146618|NCT00368745|356579|P2|NOT COMPLETED|Double-blind Treatment Period||31
146619|NCT00368745|356580|P1|NOT COMPLETED|Double-blind Treatment Period||26
146620|NCT00368745|356579|P2|COMPLETED|Double-blind Treatment Period||19
146621|NCT00368745|356580|P1|COMPLETED|Double-blind Treatment Period||30
146622|NCT00368745|356579|P2|STARTED|Double-blind Treatment Period||50
146623|NCT00368745|356580|P1|STARTED|Double-blind Treatment Period||56
146624|NCT00368745|356579|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
146625|NCT00368745|356580|P1|NOT COMPLETED|Randomized to Double-blind Treatment||1
146626|NCT00368745|356579|P2|COMPLETED|Randomized to Double-blind Treatment|One subject did not want to participate in study.|50
146627|NCT00368745|356580|P1|COMPLETED|Randomized to Double-blind Treatment|One subject did not return following randomization; study drug not dispensed.|56
146628|NCT00368745|356579|P2|STARTED|Randomized to Double-blind Treatment||51
146629|NCT00368745|356580|P1|STARTED|Randomized to Double-blind Treatment||57
146630|NCT00368849|356610|P2|NOT COMPLETED|Overall Study||2
146631|NCT00368849|356611|P1|NOT COMPLETED|Overall Study||0
146632|NCT00368849|356610|P2|COMPLETED|Overall Study||8
146633|NCT00368849|356611|P1|COMPLETED|Overall Study||10
146634|NCT00368849|356610|P2|STARTED|Overall Study||10
146635|NCT00368849|356611|P1|STARTED|Overall Study||10
146636|NCT00368875|356625|P2|NOT COMPLETED|Overall Study||48
146637|NCT00368875|356626|P1|NOT COMPLETED|Overall Study||6
146638|NCT00368875|356625|P2|COMPLETED|Overall Study||0
146639|NCT00368875|356626|P1|COMPLETED|Overall Study||0
146640|NCT00368875|356625|P2|STARTED|Overall Study||48
146641|NCT00368875|356626|P1|STARTED|Overall Study||6
146642|NCT00368927|356636|P2|NOT COMPLETED|Overall Study||3
146643|NCT00368927|356637|P1|NOT COMPLETED|Overall Study||5
146644|NCT00368927|356636|P2|COMPLETED|Overall Study||27
146645|NCT00368927|356637|P1|COMPLETED|Overall Study||26
146646|NCT00368927|356636|P2|STARTED|Overall Study||30
146647|NCT00368927|356637|P1|STARTED|Overall Study||31
146648|NCT00368940|356647|P2|NOT COMPLETED|Completed 12-wk Treatment||5
146649|NCT00368940|356648|P1|NOT COMPLETED|Completed 12-wk Treatment||6
146650|NCT00368940|356647|P2|COMPLETED|Completed 12-wk Treatment||32
146651|NCT00368940|356648|P1|COMPLETED|Completed 12-wk Treatment||31
146652|NCT00368940|356647|P2|STARTED|Completed 12-wk Treatment||37
146653|NCT00368940|356648|P1|STARTED|Completed 12-wk Treatment||37
146654|NCT00368940|356647|P2|NOT COMPLETED|Intention-to-Treat||0
146655|NCT00368940|356648|P1|NOT COMPLETED|Intention-to-Treat||0
146656|NCT00368940|356647|P2|COMPLETED|Intention-to-Treat||37
146657|NCT00368940|356648|P1|COMPLETED|Intention-to-Treat||37
146658|NCT00368940|356647|P2|STARTED|Intention-to-Treat||37
146659|NCT00368940|356648|P1|STARTED|Intention-to-Treat||37
146660|NCT00368966|356662|P2|NOT COMPLETED|Toddler Dose||3
146661|NCT00368966|356663|P1|NOT COMPLETED|Toddler Dose||1
146662|NCT00368966|356662|P2|COMPLETED|Toddler Dose||286
146663|NCT00368966|356663|P1|COMPLETED|Toddler Dose||292
146664|NCT00368966|356662|P2|STARTED|Toddler Dose||289
146665|NCT00368966|356663|P1|STARTED|Toddler Dose||293
146666|NCT00368966|356662|P2|NOT COMPLETED|After Infant||5
146667|NCT00368966|356663|P1|NOT COMPLETED|After Infant||6
146668|NCT00368966|356662|P2|COMPLETED|After Infant||289
146669|NCT00368966|356663|P1|COMPLETED|After Infant||293
146670|NCT00368966|356662|P2|STARTED|After Infant||294
146671|NCT00368966|356663|P1|STARTED|After Infant||299
146672|NCT00368966|356662|P2|NOT COMPLETED|Infant Series||10
146673|NCT00368966|356663|P1|NOT COMPLETED|Infant Series||16
146674|NCT00368966|356662|P2|COMPLETED|Infant Series||294
146675|NCT00368966|356663|P1|COMPLETED|Infant Series||299
146676|NCT00368966|356662|P2|Vaccinated Dose 3|Infant Series|1 randomized but incorrectly given 13vPnC|296
146677|NCT00368966|356663|P1|Vaccinated Dose 3|Infant Series||301
146678|NCT00368966|356662|P2|Vaccinated Dose 2|Infant Series||298
146679|NCT00368966|356663|P1|Vaccinated Dose 2|Infant Series|1 randomized but incorrectly given 7vPnC|307
146680|NCT00368966|356662|P2|Vaccinated Dose 1|Infant Series|1 randomized to 7vPnC but given 13vPnC vaccine; 1 was withdrawn before receiving 7vPnC vaccine|302
146681|NCT00368966|356663|P1|Vaccinated Dose 1|Infant Series||314
146682|NCT00368966|356662|P2|STARTED|Infant Series||304
146683|NCT00368966|356663|P1|STARTED|Infant Series||315
146684|NCT00368979|356719|P2|NOT COMPLETED|Overall Study||30
146685|NCT00368979|356720|P1|NOT COMPLETED|Overall Study||25
146686|NCT00368979|356719|P2|COMPLETED|Overall Study||163
146687|NCT00368979|356720|P1|COMPLETED|Overall Study||160
146688|NCT00368979|356719|P2|STARTED|Overall Study||193
146689|NCT00368979|356720|P1|STARTED|Overall Study||185
146690|NCT00368992|356734|P1|NOT COMPLETED|Overall Study||110
146691|NCT00368992|356734|P1|COMPLETED|Overall Study||0
146692|NCT00368992|356734|P1|STARTED|Overall Study||110
146693|NCT00369122|356741|P1|NOT COMPLETED|Overall Study||11
146694|NCT00369122|356741|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|49
146695|NCT00369122|356741|P1|STARTED|Overall Study||60
146696|NCT00369161|356747|P2|NOT COMPLETED|Overall Study||24
146697|NCT00369161|356748|P1|NOT COMPLETED|Overall Study||27
146698|NCT00369161|356747|P2|COMPLETED|Overall Study||95
146699|NCT00369161|356748|P1|COMPLETED|Overall Study||82
146700|NCT00369161|356747|P2|Intention to Treat (ITT)|Overall Study||117
146701|NCT00369161|356748|P1|Intention to Treat (ITT)|Overall Study||107
146702|NCT00369161|356747|P2|STARTED|Overall Study||119
146703|NCT00369161|356748|P1|STARTED|Overall Study|"Started indicates randomized and safety population."|109
146704|NCT00369226|356760|P2|NOT COMPLETED|Phase II (45 Days)||0
146705|NCT00369226|356761|P1|NOT COMPLETED|Phase II (45 Days)||0
146706|NCT00369226|356760|P2|COMPLETED|Phase II (45 Days)|This includes 10 patients treated at candidate MTD in Phase I.|32
146707|NCT00369226|356761|P1|COMPLETED|Phase II (45 Days)||0
146708|NCT00369226|356760|P2|STARTED|Phase II (45 Days)||32
146709|NCT00369226|356761|P1|STARTED|Phase II (45 Days)||0
146710|NCT00369226|356760|P2|NOT COMPLETED|Phase I (45 Days)||0
146711|NCT00369226|356761|P1|NOT COMPLETED|Phase I (45 Days)||0
146712|NCT00369226|356760|P2|COMPLETED|Phase I (45 Days)||0
146713|NCT00369226|356761|P1|COMPLETED|Phase I (45 Days)|Once MTD established, additional 10 patients were accrued at MTD to better estimate toxicity.|13
146714|NCT00369226|356760|P2|STARTED|Phase I (45 Days)||0
146715|NCT00369226|356761|P1|STARTED|Phase I (45 Days)||13
146716|NCT00369265|356773|P2|NOT COMPLETED|Overall Study||7
146717|NCT00369265|356774|P1|NOT COMPLETED|Overall Study||4
146718|NCT00369265|356773|P2|COMPLETED|Overall Study||0
146719|NCT00369265|356774|P1|COMPLETED|Overall Study||0
146720|NCT00369265|356773|P2|STARTED|Overall Study||7
146721|NCT00369265|356774|P1|STARTED|Overall Study||4
146722|NCT00369278|356782|P2|NOT COMPLETED|Overall Study||21
146723|NCT00369278|356783|P1|NOT COMPLETED|Overall Study||24
146724|NCT00369278|356782|P2|COMPLETED|Overall Study||44
146725|NCT00369278|356783|P1|COMPLETED|Overall Study||39
146726|NCT00369278|356782|P2|STARTED|Overall Study||65
146727|NCT00369278|356783|P1|STARTED|Overall Study||63
146728|NCT00369317|356797|P1|NOT COMPLETED|Overall Study||20
146729|NCT00369317|356797|P1|COMPLETED|Overall Study||185
146730|NCT00369317|356797|P1|STARTED|Overall Study||205
146731|NCT00369343|356813|P2|NOT COMPLETED|Open-label Phase||30
146732|NCT00369343|356814|P1|NOT COMPLETED|Open-label Phase||57
146733|NCT00369343|356813|P2|COMPLETED|Open-label Phase||79
146734|NCT00369343|356814|P1|COMPLETED|Open-label Phase||155
146735|NCT00369343|356813|P2|STARTED|Open-label Phase||109
146736|NCT00369343|356814|P1|STARTED|Open-label Phase||212
146737|NCT00369343|356813|P2|NOT COMPLETED|Double-blind Phase||16
146738|NCT00369343|356814|P1|NOT COMPLETED|Double-blind Phase||44
146739|NCT00369343|356813|P2|COMPLETED|Double-blind Phase||109
146740|NCT00369343|356814|P1|COMPLETED|Double-blind Phase||212
146741|NCT00369343|356813|P2|STARTED|Double-blind Phase||125
146742|NCT00369343|356814|P1|STARTED|Double-blind Phase||256
146743|NCT00369382|356849|P2|NOT COMPLETED|Overall Study||3
146744|NCT00369382|356850|P1|NOT COMPLETED|Overall Study||10
146745|NCT00369382|356849|P2|COMPLETED|Overall Study||54
146746|NCT00369382|356850|P1|COMPLETED|Overall Study||49
146747|NCT00369382|356849|P2|Completed Assigned Treatment Regimen|Overall Study||33
146748|NCT00369382|356850|P1|Completed Assigned Treatment Regimen|Overall Study||48
146749|NCT00369382|356849|P2|Received Treatment|Overall Study||57
146750|NCT00369382|356850|P1|Received Treatment|Overall Study||57
146751|NCT00369382|356849|P2|STARTED|Overall Study||57
146752|NCT00369382|356850|P1|STARTED|Overall Study||59
146753|NCT00369486|356886|P5|NOT COMPLETED|34-Week Visit||3
146754|NCT00369486|356887|P4|NOT COMPLETED|34-Week Visit||3
146755|NCT00369486|356888|P3|NOT COMPLETED|34-Week Visit||1
146756|NCT00369486|356889|P2|NOT COMPLETED|34-Week Visit||1
146757|NCT00369486|356890|P1|NOT COMPLETED|34-Week Visit||0
146758|NCT00369486|356886|P5|COMPLETED|34-Week Visit|Number of eyes|22
146759|NCT00369486|356887|P4|COMPLETED|34-Week Visit|Number of eyes|19
146760|NCT00369486|356888|P3|COMPLETED|34-Week Visit|Number of eyes|22
146761|NCT00369486|356889|P2|COMPLETED|34-Week Visit|Number of eyes|20
146762|NCT00369486|356890|P1|COMPLETED|34-Week Visit|Number of eyes|38
146763|NCT00369486|356886|P5|STARTED|34-Week Visit|Number of eyes that|25
146764|NCT00369486|356887|P4|STARTED|34-Week Visit|Number of eyes|22
146765|NCT00369486|356888|P3|STARTED|34-Week Visit|Number of eyes|23
146766|NCT00369486|356889|P2|STARTED|34-Week Visit|Number of eyes|21
146767|NCT00369486|356890|P1|STARTED|34-Week Visit|Number of eyes|38
146768|NCT00369486|356886|P5|NOT COMPLETED|17-Week Visit||1
146769|NCT00369486|356887|P4|NOT COMPLETED|17-Week Visit||1
146770|NCT00369486|356888|P3|NOT COMPLETED|17-Week Visit||1
146771|NCT00369486|356889|P2|NOT COMPLETED|17-Week Visit||0
146772|NCT00369486|356890|P1|NOT COMPLETED|17-Week Visit||0
146773|NCT00369486|356886|P5|COMPLETED|17-Week Visit|Number of eyes|24
146774|NCT00369486|356887|P4|COMPLETED|17-Week Visit|Number of eyes|21
146775|NCT00369486|356888|P3|COMPLETED|17-Week Visit|Number of eyes|22
146776|NCT00369486|356889|P2|COMPLETED|17-Week Visit|Number of eyes|21
146777|NCT00369486|356890|P1|COMPLETED|17-Week Visit|Number of eyes|38
146778|NCT00369486|356886|P5|STARTED|17-Week Visit|Number of eyes|25
146779|NCT00369486|356887|P4|STARTED|17-Week Visit|Number of eyes|22
146780|NCT00369486|356888|P3|STARTED|17-Week Visit|Number of eyes|23
146781|NCT00369486|356889|P2|STARTED|17-Week Visit|Number of eyes|21
146782|NCT00369486|356890|P1|STARTED|17-Week Visit|Number of eyes|38
146783|NCT00369486|356886|P5|NOT COMPLETED|8-Week Visit||1
146784|NCT00369486|356887|P4|NOT COMPLETED|8-Week Visit||1
146785|NCT00369486|356888|P3|NOT COMPLETED|8-Week Visit||0
146786|NCT00369486|356889|P2|NOT COMPLETED|8-Week Visit||1
146787|NCT00369486|356890|P1|NOT COMPLETED|8-Week Visit||0
146788|NCT00369486|356886|P5|COMPLETED|8-Week Visit|Number of eyes|24
146789|NCT00369486|356887|P4|COMPLETED|8-Week Visit|Number of eyes|21
146790|NCT00369486|356888|P3|COMPLETED|8-Week Visit|Number of eyes|22
146791|NCT00369486|356889|P2|COMPLETED|8-Week Visit|Number of eyes|20
146792|NCT00369486|356890|P1|COMPLETED|8-Week Visit|Number of eyes|38
146793|NCT00369486|356886|P5|STARTED|8-Week Visit|Number of eyes|25
146794|NCT00369486|356887|P4|STARTED|8-Week Visit|Number of eyes|22
146795|NCT00369486|356888|P3|STARTED|8-Week Visit|Number of eyes|22
146796|NCT00369486|356889|P2|STARTED|8-Week Visit|Number of eyes|21
146797|NCT00369486|356890|P1|STARTED|8-Week Visit|Number of eyes|38
146798|NCT00369486|356886|P5|NOT COMPLETED|4-Week Visit||1
146799|NCT00369486|356887|P4|NOT COMPLETED|4-Week Visit||2
146800|NCT00369486|356888|P3|NOT COMPLETED|4-Week Visit||1
146801|NCT00369486|356889|P2|NOT COMPLETED|4-Week Visit||2
146802|NCT00369486|356890|P1|NOT COMPLETED|4-Week Visit||2
146803|NCT00369486|356886|P5|COMPLETED|4-Week Visit|Number of eyes|24
146804|NCT00369486|356887|P4|COMPLETED|4-Week Visit|Number of eyes|20
146805|NCT00369486|356888|P3|COMPLETED|4-Week Visit|Number of eyes|22
146806|NCT00369486|356889|P2|COMPLETED|4-Week Visit|Number of eyes;|19
146807|NCT00369486|356890|P1|COMPLETED|4-Week Visit|Number of eyes|36
146808|NCT00369486|356886|P5|STARTED|4-Week Visit|Number of eyes|25
146809|NCT00369486|356887|P4|STARTED|4-Week Visit|Number of eyes|22
146810|NCT00369486|356888|P3|STARTED|4-Week Visit|Number of eyes|23
146811|NCT00369486|356889|P2|STARTED|4-Week Visit|Number of eyes|21
146812|NCT00369486|356890|P1|STARTED|4-Week Visit|Number of eyes|38
146813|NCT00369512|356927|P1|NOT COMPLETED|Overall Study||0
146814|NCT00369512|356927|P1|COMPLETED|Overall Study||15
146815|NCT00369512|356927|P1|STARTED|Overall Study||15
146816|NCT00369564|356935|P2|NOT COMPLETED|Overall Study||23
146817|NCT00369564|356936|P1|NOT COMPLETED|Overall Study||43
146818|NCT00369564|356935|P2|COMPLETED|Overall Study||100
146819|NCT00369564|356936|P1|COMPLETED|Overall Study||84
146820|NCT00369564|356935|P2|STARTED|Overall Study||123
146821|NCT00369564|356936|P1|STARTED|Overall Study||127
146822|NCT00369590|356944|P2|NOT COMPLETED|Overall Study||0
146823|NCT00369590|356945|P1|NOT COMPLETED|Overall Study||0
146824|NCT00369590|356944|P2|COMPLETED|Overall Study||42
146825|NCT00369590|356945|P1|COMPLETED|Overall Study||16
146826|NCT00369590|356944|P2|STARTED|Overall Study||42
146827|NCT00369590|356945|P1|STARTED|Overall Study||16
146828|NCT00369655|356960|P1|NOT COMPLETED|Overall Study||2
146829|NCT00369655|356960|P1|COMPLETED|Overall Study||19
146830|NCT00369655|356960|P1|STARTED|Overall Study||21
146831|NCT00369668|356972|P3|NOT COMPLETED|Overall Study||7
146832|NCT00369668|356973|P2|NOT COMPLETED|Overall Study||5
146833|NCT00369668|356974|P1|NOT COMPLETED|Overall Study||4
146834|NCT00369668|356972|P3|COMPLETED|Overall Study||3
146835|NCT00369668|356973|P2|COMPLETED|Overall Study||5
146836|NCT00369668|356974|P1|COMPLETED|Overall Study||6
146837|NCT00369668|356972|P3|STARTED|Overall Study||10
146838|NCT00369668|356973|P2|STARTED|Overall Study||10
146839|NCT00369668|356974|P1|STARTED|Overall Study|Original number of participants to be recruited for each group.|10
146840|NCT00375219|356991|P3|NOT COMPLETED|Overall Study||21
146841|NCT00375219|356992|P2|NOT COMPLETED|Overall Study||20
146842|NCT00375219|356993|P1|NOT COMPLETED|Overall Study||59
146843|NCT00375219|356991|P3|COMPLETED|Overall Study||0
146844|NCT00375219|356992|P2|COMPLETED|Overall Study||0
146845|NCT00375219|356993|P1|COMPLETED|Overall Study||3
146846|NCT00375219|356991|P3|STARTED|Overall Study||21
146847|NCT00375219|356992|P2|STARTED|Overall Study||20
146848|NCT00375219|356993|P1|STARTED|Overall Study||62
146849|NCT00375674|357061|P2|NOT COMPLETED|Overall Study||115
146850|NCT00375674|357062|P1|NOT COMPLETED|Overall Study||123
146851|NCT00375674|357061|P2|COMPLETED|Overall Study||191
146852|NCT00375674|357062|P1|COMPLETED|Overall Study||186
146853|NCT00375674|357061|P2|STARTED|Overall Study||306
146854|NCT00375674|357062|P1|STARTED|Overall Study||309
146855|NCT00375713|357090|P2|NOT COMPLETED|Overall Study||23
146856|NCT00375713|357091|P1|NOT COMPLETED|Overall Study||20
146857|NCT00375713|357090|P2|COMPLETED|Overall Study|23 Patients were not treated or discontinued after randomization in Cetirizine group.|211
146858|NCT00375713|357091|P1|COMPLETED|Overall Study|20 Patients were not treated or discontinued after randomization in Levocetirizine group.|212
146859|NCT00375713|357090|P2|STARTED|Overall Study|Randomized population (N=234).|234
146860|NCT00375713|357091|P1|STARTED|Overall Study|Randomized population (N=232).|232
146861|NCT00375752|357105|P2|NOT COMPLETED|Overall Study||15
146862|NCT00375752|357106|P1|NOT COMPLETED|Overall Study||12
146863|NCT00375752|357105|P2|COMPLETED|Overall Study||74
146864|NCT00375752|357106|P1|COMPLETED|Overall Study||67
146865|NCT00375752|357105|P2|STARTED|Overall Study||89
146866|NCT00375752|357106|P1|STARTED|Overall Study||79
146867|NCT00375934|357122|P2|NOT COMPLETED|Overall Study||6
146868|NCT00375934|357123|P1|NOT COMPLETED|Overall Study||3
146869|NCT00375934|357122|P2|COMPLETED|Overall Study||95
146870|NCT00375934|357123|P1|COMPLETED|Overall Study||96
146871|NCT00375934|357122|P2|STARTED|Overall Study||101
146872|NCT00375934|357123|P1|STARTED|Overall Study||99
146873|NCT00375973|357151|P2|NOT COMPLETED|Overall Study||2
146874|NCT00375973|357152|P1|NOT COMPLETED|Overall Study||10
146875|NCT00375973|357151|P2|COMPLETED|Overall Study||28
146876|NCT00375973|357152|P1|COMPLETED|Overall Study||20
146877|NCT00375973|357151|P2|STARTED|Overall Study||30
146878|NCT00375973|357152|P1|STARTED|Overall Study||30
146879|NCT00375999|357170|P1|NOT COMPLETED|Overall Study||2
146880|NCT00375999|357170|P1|COMPLETED|Overall Study||32
146881|NCT00375999|357170|P1|STARTED|Overall Study||34
146882|NCT00376168|357176|P2|NOT COMPLETED|Overall Study||1
146883|NCT00376168|357177|P1|NOT COMPLETED|Overall Study||2
146884|NCT00376168|357176|P2|COMPLETED|Overall Study||15
146885|NCT00376168|357177|P1|COMPLETED|Overall Study||14
146886|NCT00376168|357176|P2|STARTED|Overall Study|One patient randomized but not treated|16
146887|NCT00376168|357177|P1|STARTED|Overall Study||16
146888|NCT00376220|357193|P2|NOT COMPLETED|Overall Study||12
146889|NCT00376220|357194|P1|NOT COMPLETED|Overall Study||10
146890|NCT00376220|357193|P2|COMPLETED|Overall Study||35
146891|NCT00376220|357194|P1|COMPLETED|Overall Study||37
146892|NCT00376220|357193|P2|STARTED|Overall Study||47
146893|NCT00376220|357194|P1|STARTED|Overall Study||47
146894|NCT00376259|357202|P2|NOT COMPLETED|Overall Study||21
146895|NCT00376259|357203|P1|NOT COMPLETED|Overall Study||22
146896|NCT00376259|357202|P2|COMPLETED|Overall Study||0
146897|NCT00376259|357203|P1|COMPLETED|Overall Study||0
146898|NCT00376259|357202|P2|Received Study Drug|Overall Study||21
146899|NCT00376259|357203|P1|Received Study Drug|Overall Study||21
146900|NCT00376259|357202|P2|STARTED|Overall Study||21
146901|NCT00376259|357203|P1|STARTED|Overall Study||22
146902|NCT00376363|357217|P2|NOT COMPLETED|Overall Study||46
146903|NCT00376363|357218|P1|NOT COMPLETED|Overall Study||56
146904|NCT00376363|357217|P2|COMPLETED|Overall Study||87
146905|NCT00376363|357218|P1|COMPLETED|Overall Study||87
146906|NCT00376363|357217|P2|STARTED|Overall Study||133
146907|NCT00376363|357218|P1|STARTED|Overall Study||143
146908|NCT00376506|357230|P2|NOT COMPLETED|Overall Study||2
146909|NCT00376506|357231|P1|NOT COMPLETED|Overall Study||0
146910|NCT00376506|357230|P2|COMPLETED|Overall Study||4
146911|NCT00376506|357231|P1|COMPLETED|Overall Study||4
146912|NCT00376506|357230|P2|STARTED|Overall Study||6
146913|NCT00376506|357231|P1|STARTED|Overall Study||4
146914|NCT00376532|357249|P2|NOT COMPLETED|Overall Study||6
146915|NCT00376532|357250|P1|NOT COMPLETED|Overall Study||6
146916|NCT00376532|357249|P2|COMPLETED|Overall Study|Last non-event subject enrolled 3/18/2008.|26
146917|NCT00376532|357250|P1|COMPLETED|Overall Study|Last event subject enrolled 2/22/2008|25
146918|NCT00376532|357249|P2|STARTED|Overall Study|Subjects without an event were enrolled beginning 09/15/2006.|32
146919|NCT00376532|357250|P1|STARTED|Overall Study|Subjects with an event were enrolled beginning 09/14/2006.|31
146920|NCT00376558|357260|P2|NOT COMPLETED|Overall Study||0
146921|NCT00376558|357261|P1|NOT COMPLETED|Overall Study||0
146922|NCT00376558|357260|P2|COMPLETED|Overall Study||25
146923|NCT00376558|357261|P1|COMPLETED|Overall Study||25
146924|NCT00376558|357260|P2|STARTED|Overall Study||25
146925|NCT00376558|357261|P1|STARTED|Overall Study||25
146926|NCT00376675|357270|P2|NOT COMPLETED|Overall Study||14
146927|NCT00376675|357271|P1|NOT COMPLETED|Overall Study||20
146928|NCT00376675|357270|P2|COMPLETED|Overall Study||56
146929|NCT00376675|357271|P1|COMPLETED|Overall Study||49
146930|NCT00376675|357270|P2|STARTED|Overall Study||70
146931|NCT00376675|357271|P1|STARTED|Overall Study||69
146932|NCT00376688|357293|P1|NOT COMPLETED|Overall Study||4
146933|NCT00376688|357293|P1|COMPLETED|Overall Study||27
146934|NCT00376688|357293|P1|STARTED|Overall Study||31
146935|NCT00376805|357297|P1|NOT COMPLETED|Overall Study||0
146936|NCT00376805|357297|P1|COMPLETED|Overall Study||6
146937|NCT00376805|357297|P1|STARTED|Overall Study||6
146938|NCT00376935|357308|P4|NOT COMPLETED|Overall Study||0
146939|NCT00376935|357309|P3|NOT COMPLETED|Overall Study||0
146940|NCT00376935|357310|P2|NOT COMPLETED|Overall Study||0
146941|NCT00376935|357311|P1|NOT COMPLETED|Overall Study||0
146942|NCT00376935|357308|P4|COMPLETED|Overall Study||24
146943|NCT00376935|357309|P3|COMPLETED|Overall Study||25
146944|NCT00376935|357310|P2|COMPLETED|Overall Study||25
146945|NCT00376935|357311|P1|COMPLETED|Overall Study||25
146946|NCT00376935|357308|P4|STARTED|Overall Study||24
146947|NCT00376935|357309|P3|STARTED|Overall Study||25
146948|NCT00376935|357310|P2|STARTED|Overall Study||25
146949|NCT00376935|357311|P1|STARTED|Overall Study||25
146950|NCT00376948|357349|P1|NOT COMPLETED|Overall Study||0
146951|NCT00376948|357349|P1|COMPLETED|Overall Study||20
146952|NCT00376948|357349|P1|STARTED|Overall Study||20
146953|NCT00376961|357354|P2|NOT COMPLETED|Maintenance||23
146954|NCT00376961|357355|P1|NOT COMPLETED|Maintenance||0
146955|NCT00376961|357354|P2|COMPLETED|Maintenance||27
146956|NCT00376961|357355|P1|COMPLETED|Maintenance||0
146957|NCT00376961|357354|P2|Eligible|Maintenance||47
146958|NCT00376961|357355|P1|Eligible|Maintenance||0
146959|NCT00376961|357354|P2|STARTED|Maintenance||50
146960|NCT00376961|357355|P1|STARTED|Maintenance||0
146961|NCT00376961|357354|P2|NOT COMPLETED|Initial Registration||0
146962|NCT00376961|357355|P1|NOT COMPLETED|Initial Registration||7
146963|NCT00376961|357354|P2|COMPLETED|Initial Registration||0
146964|NCT00376961|357355|P1|COMPLETED|Initial Registration||61
146965|NCT00376961|357354|P2|Eligible|Initial Registration||0
146966|NCT00376961|357355|P1|Eligible|Initial Registration||65
146967|NCT00376961|357354|P2|STARTED|Initial Registration||0
146968|NCT00376961|357355|P1|STARTED|Initial Registration||68
146969|NCT00377156|357366|P2|NOT COMPLETED|Overall Study||54
146970|NCT00377156|357367|P1|NOT COMPLETED|Overall Study||48
146971|NCT00377156|357366|P2|COMPLETED|Overall Study||48
146972|NCT00377156|357367|P1|COMPLETED|Overall Study||63
146973|NCT00377156|357366|P2|STARTED|Overall Study||102
146974|NCT00377156|357367|P1|STARTED|Overall Study||111
146975|NCT00377234|357383|P2|NOT COMPLETED|Overall Study||31
146976|NCT00377234|357384|P1|NOT COMPLETED|Overall Study||34
146977|NCT00377234|357383|P2|COMPLETED|Overall Study||145
146978|NCT00377234|357384|P1|COMPLETED|Overall Study||146
146979|NCT00377234|357383|P2|Safety Analysis Set: Risedronate|Overall Study||174
146980|NCT00377234|357384|P1|Safety Analysis Set: Risedronate|Overall Study||153
146981|NCT00377234|357383|P2|Safety Analysis Set: Ibandronate|Overall Study||150
146982|NCT00377234|357384|P1|Safety Analysis Set: Ibandronate|Overall Study||177
146983|NCT00377234|357383|P2|Safety Analysis Set: Period 2|Overall Study||150
146984|NCT00377234|357384|P1|Safety Analysis Set: Period 2|Overall Study||153
146985|NCT00377234|357383|P2|Safety Analysis Set: Period 1|Overall Study||174
146986|NCT00377234|357384|P1|Safety Analysis Set: Period 1|Overall Study||177
146987|NCT00377234|357383|P2|Received Treatment|Overall Study||174
146988|NCT00377234|357384|P1|Received Treatment|Overall Study||177
146989|NCT00377234|357383|P2|Did Not Receive Study Treatment|Overall Study||2
146990|NCT00377234|357384|P1|Did Not Receive Study Treatment|Overall Study||3
146991|NCT00377234|357383|P2|Randomized|Overall Study||176
146992|NCT00377234|357384|P1|Randomized|Overall Study||180
146993|NCT00377234|357383|P2|STARTED|Overall Study||176
146994|NCT00377234|357384|P1|STARTED|Overall Study||180
146995|NCT00377260|357402|P2|NOT COMPLETED|Overall Study||5
146996|NCT00377260|357403|P1|NOT COMPLETED|Overall Study||2
146997|NCT00377260|357402|P2|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
146998|NCT00377260|357403|P1|COMPLETED|Overall Study|A child is considered a completer if he/she had at least one visit after the end of therapy.|142
146999|NCT00377260|357402|P2|STARTED|Overall Study||147
147000|NCT00377260|357403|P1|STARTED|Overall Study||144
147001|NCT00377299|357457|P2|NOT COMPLETED|Overall Study||24
147002|NCT00377299|357458|P1|NOT COMPLETED|Overall Study||19
147003|NCT00377299|357457|P2|COMPLETED|Overall Study||4
147004|NCT00377299|357458|P1|COMPLETED|Overall Study||13
147005|NCT00377299|357457|P2|STARTED|Overall Study||28
147006|NCT00377299|357458|P1|STARTED|Overall Study||32
147007|NCT00377312|357474|P2|NOT COMPLETED|Overall Study||1
147008|NCT00377312|357475|P1|NOT COMPLETED|Overall Study||1
147009|NCT00377312|357474|P2|COMPLETED|Overall Study||4
147010|NCT00377312|357475|P1|COMPLETED|Overall Study||5
147011|NCT00377312|357474|P2|STARTED|Overall Study||5
147012|NCT00377312|357475|P1|STARTED|Overall Study||6
147013|NCT00377364|357507|P2|NOT COMPLETED|Overall Study||0
147014|NCT00377364|357508|P1|NOT COMPLETED|Overall Study||2
147015|NCT00377364|357507|P2|COMPLETED|Overall Study||14
147016|NCT00377364|357508|P1|COMPLETED|Overall Study||14
147017|NCT00377364|357507|P2|STARTED|Overall Study||14
147018|NCT00377364|357508|P1|STARTED|Overall Study||16
147019|NCT00377403|357534|P2|NOT COMPLETED|Overall Study||7
147020|NCT00377403|357535|P1|NOT COMPLETED|Overall Study||4
147021|NCT00377403|357534|P2|COMPLETED|Overall Study|The number varied by day of follow-up from 71 to 77 in the symptomatic treatment only group.|74
147022|NCT00377403|357535|P1|COMPLETED|Overall Study|The number varied by day of follow-up from 80 to 82 in the intervention group.|81
147023|NCT00377403|357534|P2|Day 28 Assessment|Overall Study||77
147024|NCT00377403|357535|P1|Day 28 Assessment|Overall Study||82
147025|NCT00377403|357534|P2|Day 10 Assessment|Overall Study||71
147026|NCT00377403|357535|P1|Day 10 Assessment|Overall Study||81
147027|NCT00377403|357534|P2|Day 7 Assessment|Overall Study||75
147028|NCT00377403|357535|P1|Day 7 Assessment|Overall Study||80
147029|NCT00377403|357534|P2|Day -3 Assessment|Overall Study||74
147030|NCT00377403|357535|P1|Day -3 Assessment|Overall Study||81
147031|NCT00377403|357534|P2|STARTED|Overall Study||81
147032|NCT00377403|357535|P1|STARTED|Overall Study||85
147033|NCT00377429|357541|P1|NOT COMPLETED|Overall Study||15
147034|NCT00377429|357541|P1|COMPLETED|Overall Study|Completed main study|32
147035|NCT00377429|357541|P1|STARTED|Overall Study|Treated|47
147036|NCT00377455|357550|P1|NOT COMPLETED|Overall Study||1
147037|NCT00377455|357550|P1|COMPLETED|Overall Study||4
147038|NCT00377455|357550|P1|STARTED|Overall Study||5
147039|NCT00377520|357554|P1|NOT COMPLETED|Overall Study||1
147040|NCT00377520|357554|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|26
147041|NCT00377520|357554|P1|STARTED|Overall Study||27
147042|NCT00377572|357561|P2|NOT COMPLETED|Overall Study||54
147043|NCT00377572|357562|P1|NOT COMPLETED|Overall Study||53
147044|NCT00377572|357561|P2|COMPLETED|Overall Study||157
147045|NCT00377572|357562|P1|COMPLETED|Overall Study||155
147046|NCT00377572|357561|P2|STARTED|Overall Study||211
147047|NCT00377572|357562|P1|STARTED|Overall Study||208
147048|NCT00377637|357604|P4|NOT COMPLETED|Maintenance Phase||57
147049|NCT00377637|357605|P3|NOT COMPLETED|Maintenance Phase||43
147050|NCT00377637|357606|P2|NOT COMPLETED|Maintenance Phase||0
147051|NCT00377637|357607|P1|NOT COMPLETED|Maintenance Phase||0
147052|NCT00377637|357604|P4|COMPLETED|Maintenance Phase||54
147053|NCT00377637|357605|P3|COMPLETED|Maintenance Phase||73
147054|NCT00377637|357606|P2|COMPLETED|Maintenance Phase||0
147055|NCT00377637|357607|P1|COMPLETED|Maintenance Phase||0
147056|NCT00377637|357604|P4|STARTED|Maintenance Phase||111
147057|NCT00377637|357605|P3|STARTED|Maintenance Phase||116
147058|NCT00377637|357606|P2|STARTED|Maintenance Phase||0
147059|NCT00377637|357607|P1|STARTED|Maintenance Phase||0
147060|NCT00377637|357604|P4|NOT COMPLETED|Induction Phase||0
147061|NCT00377637|357605|P3|NOT COMPLETED|Induction Phase||0
147062|NCT00377637|357606|P2|NOT COMPLETED|Induction Phase||35
147063|NCT00377637|357607|P1|NOT COMPLETED|Induction Phase||29
147064|NCT00377637|357604|P4|COMPLETED|Induction Phase||0
147065|NCT00377637|357605|P3|COMPLETED|Induction Phase||0
147066|NCT00377637|357606|P2|COMPLETED|Induction Phase||150
147067|NCT00377637|357607|P1|COMPLETED|Induction Phase||156
147068|NCT00377637|357604|P4|Safety Population|Induction Phase||0
147069|NCT00377637|357605|P3|Safety Population|Induction Phase||0
147070|NCT00377637|357606|P2|Safety Population|Induction Phase||184
147071|NCT00377637|357607|P1|Safety Population|Induction Phase||180
147072|NCT00377637|357604|P4|STARTED|Induction Phase||0
147073|NCT00377637|357605|P3|STARTED|Induction Phase||0
147074|NCT00377637|357606|P2|STARTED|Induction Phase|Intent-To-Treat|185
147075|NCT00377637|357607|P1|STARTED|Induction Phase|Intent-To-Treat|185
147076|NCT00377676|357643|P2|NOT COMPLETED|Overall Study||322
147077|NCT00377676|357644|P1|NOT COMPLETED|Overall Study||961
147078|NCT00377676|357643|P2|COMPLETED|Overall Study||694
147079|NCT00377676|357644|P1|COMPLETED|Overall Study||1093
147080|NCT00377676|357643|P2|STARTED|Overall Study||1016
147081|NCT00377676|357644|P1|STARTED|Overall Study|25 subjects did not receive study drug - thus 3070 were randomized and received drug|2054
147082|NCT00377741|357658|P2|NOT COMPLETED|Overall Study||0
147083|NCT00377741|357659|P1|NOT COMPLETED|Overall Study||0
147084|NCT00377741|357658|P2|COMPLETED|Overall Study||15
147085|NCT00377741|357659|P1|COMPLETED|Overall Study||16
147086|NCT00377741|357658|P2|STARTED|Overall Study||15
147087|NCT00377741|357659|P1|STARTED|Overall Study||16
147088|NCT00377819|357675|P2|NOT COMPLETED|Overall Study||10
147089|NCT00377819|357676|P1|NOT COMPLETED|Overall Study||13
147090|NCT00377819|357675|P2|COMPLETED|Overall Study||243
147091|NCT00377819|357676|P1|COMPLETED|Overall Study||238
147092|NCT00377819|357675|P2|Received Study Medication|Overall Study||253
147093|NCT00377819|357676|P1|Received Study Medication|Overall Study||249
147094|NCT00377819|357675|P2|STARTED|Overall Study||253
147095|NCT00377819|357676|P1|STARTED|Overall Study||251
147096|NCT00377832|357688|P2|NOT COMPLETED|Overall Study||0
147097|NCT00377832|357689|P1|NOT COMPLETED|Overall Study||0
147098|NCT00377832|357688|P2|COMPLETED|Overall Study||6
147099|NCT00377832|357689|P1|COMPLETED|Overall Study||7
147100|NCT00377832|357688|P2|STARTED|Overall Study||6
147101|NCT00377832|357689|P1|STARTED|Overall Study||7
147102|NCT00377858|357711|P2|NOT COMPLETED|Overall Study||27
147103|NCT00377858|357712|P1|NOT COMPLETED|Overall Study||31
147104|NCT00377858|357711|P2|COMPLETED|Overall Study||215
147105|NCT00377858|357712|P1|COMPLETED|Overall Study||211
147106|NCT00377858|357711|P2|Had at Least One Post-Baseline Value|Overall Study||240
147107|NCT00377858|357712|P1|Had at Least One Post-Baseline Value|Overall Study||239
147108|NCT00377858|357711|P2|STARTED|Overall Study||242
147109|NCT00377858|357712|P1|STARTED|Overall Study||242
147110|NCT00377962|357742|P2|NOT COMPLETED|Extension Study: 12-24 Months||4
147111|NCT00377962|357743|P1|NOT COMPLETED|Extension Study: 12-24 Months||10
147112|NCT00377962|357742|P2|COMPLETED|Extension Study: 12-24 Months||123
147113|NCT00377962|357743|P1|COMPLETED|Extension Study: 12-24 Months||98
147114|NCT00377962|357742|P2|STARTED|Extension Study: 12-24 Months||127
147115|NCT00377962|357743|P1|STARTED|Extension Study: 12-24 Months||108
147116|NCT00377962|357742|P2|NOT COMPLETED|Core Study: 0-12 Months||9
147117|NCT00377962|357743|P1|NOT COMPLETED|Core Study: 0-12 Months||28
147118|NCT00377962|357742|P2|COMPLETED|Core Study: 0-12 Months||133
147119|NCT00377962|357743|P1|COMPLETED|Core Study: 0-12 Months||112
147120|NCT00377962|357742|P2|STARTED|Core Study: 0-12 Months||142
147121|NCT00377962|357743|P1|STARTED|Core Study: 0-12 Months||140
147122|NCT00378014|357779|P2|NOT COMPLETED|Extension (Month 12 to Month 59)||14
147123|NCT00378014|357780|P1|NOT COMPLETED|Extension (Month 12 to Month 59)||14
147124|NCT00378014|357779|P2|COMPLETED|Extension (Month 12 to Month 59)||26
147125|NCT00378014|357780|P1|COMPLETED|Extension (Month 12 to Month 59)||27
147126|NCT00378014|357779|P2|STARTED|Extension (Month 12 to Month 59)||40
147127|NCT00378014|357780|P1|STARTED|Extension (Month 12 to Month 59)||41
147128|NCT00378014|357779|P2|NOT COMPLETED|Core (Randomization to Month 11)||12
147129|NCT00378014|357780|P1|NOT COMPLETED|Core (Randomization to Month 11)||14
147130|NCT00378014|357779|P2|COMPLETED|Core (Randomization to Month 11)||90
147131|NCT00378014|357780|P1|COMPLETED|Core (Randomization to Month 11)||87
147132|NCT00378014|357779|P2|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|98
147133|NCT00378014|357780|P1|Intent-to-treat (ITT) Population|Core (Randomization to Month 11)|ITT contained all randomized patients who had at least one post baseline GFR measurement.|96
147134|NCT00378014|357779|P2|STARTED|Core (Randomization to Month 11)||102
147135|NCT00378014|357780|P1|STARTED|Core (Randomization to Month 11)||101
147136|NCT00378079|357807|P3|NOT COMPLETED|Overall Study||0
147137|NCT00378079|357808|P2|NOT COMPLETED|Overall Study||1
147138|NCT00378079|357809|P1|NOT COMPLETED|Overall Study||6
147139|NCT00378079|357807|P3|COMPLETED|Overall Study||71
147140|NCT00378079|357808|P2|COMPLETED|Overall Study||69
147141|NCT00378079|357809|P1|COMPLETED|Overall Study||64
147142|NCT00378079|357807|P3|STARTED|Overall Study||71
147143|NCT00378079|357808|P2|STARTED|Overall Study||70
147144|NCT00378079|357809|P1|STARTED|Overall Study||70
147145|NCT00378105|357831|P2|NOT COMPLETED|Overall Study||30
147146|NCT00378105|357832|P1|NOT COMPLETED|Overall Study||20
147147|NCT00378105|357831|P2|COMPLETED|Overall Study||5
147148|NCT00378105|357832|P1|COMPLETED|Overall Study||11
147149|NCT00378105|357831|P2|STARTED|Overall Study||35
147150|NCT00378105|357832|P1|STARTED|Overall Study|Out of 33 enrolled, two patients went off study before start of therapy.|31
147151|NCT00372567|357844|P3|NOT COMPLETED|Phase 3 Study||12
147152|NCT00372567|357845|P2|NOT COMPLETED|Phase 3 Study||26
147153|NCT00372567|357846|P1|NOT COMPLETED|Phase 3 Study||31
147154|NCT00372567|357844|P3|COMPLETED|Phase 3 Study||0
147155|NCT00372567|357845|P2|COMPLETED|Phase 3 Study||0
147156|NCT00372567|357846|P1|COMPLETED|Phase 3 Study||0
147157|NCT00372567|357844|P3|Received Treatment|Phase 3 Study||12
147158|NCT00372567|357845|P2|Received Treatment|Phase 3 Study||25
147159|NCT00372567|357846|P1|Received Treatment|Phase 3 Study||31
147160|NCT00372567|357844|P3|STARTED|Phase 3 Study||12
147161|NCT00372567|357845|P2|STARTED|Phase 3 Study||26
147162|NCT00372567|357846|P1|STARTED|Phase 3 Study||31
147163|NCT00372567|357844|P3|NOT COMPLETED|Phase 1 Sub-study||0
147164|NCT00372567|357845|P2|NOT COMPLETED|Phase 1 Sub-study||0
147165|NCT00372567|357846|P1|NOT COMPLETED|Phase 1 Sub-study||0
147166|NCT00372567|357844|P3|COMPLETED|Phase 1 Sub-study||12
147167|NCT00372567|357845|P2|COMPLETED|Phase 1 Sub-study||0
147168|NCT00372567|357846|P1|COMPLETED|Phase 1 Sub-study||0
147169|NCT00372567|357844|P3|STARTED|Phase 1 Sub-study||12
147170|NCT00372567|357845|P2|STARTED|Phase 1 Sub-study||0
147171|NCT00372567|357846|P1|STARTED|Phase 1 Sub-study||0
147172|NCT00378209|357874|P1|NOT COMPLETED|Overall Study||22
147173|NCT00378209|357874|P1|COMPLETED|Overall Study|This included patients who completed at least 8 cycles of combination therapy with all drugs.|42
147174|NCT00378209|357874|P1|STARTED|Overall Study|1 patient who never started treatment was excluded in the analysis.|64
147175|NCT00378326|357882|P1|NOT COMPLETED|Overall Study||0
147176|NCT00378326|357882|P1|COMPLETED|Overall Study||26
147177|NCT00378326|357882|P1|STARTED|Overall Study||26
147178|NCT00378352|357890|P6|NOT COMPLETED|Efficacy Phase||7
147179|NCT00378352|357891|P5|NOT COMPLETED|Efficacy Phase||11
147180|NCT00378352|357892|P4|NOT COMPLETED|Efficacy Phase||0
147181|NCT00378352|357893|P3|NOT COMPLETED|Efficacy Phase||0
147182|NCT00378352|357894|P2|NOT COMPLETED|Efficacy Phase||0
147183|NCT00378352|357895|P1|NOT COMPLETED|Efficacy Phase||0
147184|NCT00378352|357890|P6|COMPLETED|Efficacy Phase||59
147185|NCT00378352|357891|P5|COMPLETED|Efficacy Phase||54
147186|NCT00378352|357892|P4|COMPLETED|Efficacy Phase||0
147187|NCT00378352|357893|P3|COMPLETED|Efficacy Phase||0
147188|NCT00378352|357894|P2|COMPLETED|Efficacy Phase||0
147189|NCT00378352|357895|P1|COMPLETED|Efficacy Phase||0
147190|NCT00378352|357890|P6|Safety Analysis|Efficacy Phase||64
147191|NCT00378352|357891|P5|Safety Analysis|Efficacy Phase|Two participants randomized to placebo received 60,000 units Epoetin alfa|67
147192|NCT00378352|357892|P4|Safety Analysis|Efficacy Phase||0
147193|NCT00378352|357893|P3|Safety Analysis|Efficacy Phase||0
147194|NCT00378352|357894|P2|Safety Analysis|Efficacy Phase||0
147195|NCT00378352|357895|P1|Safety Analysis|Efficacy Phase||0
147196|NCT00378352|357890|P6|STARTED|Efficacy Phase||66
147197|NCT00378352|357891|P5|STARTED|Efficacy Phase||65
147198|NCT00378352|357892|P4|STARTED|Efficacy Phase||0
147199|NCT00378352|357893|P3|STARTED|Efficacy Phase||0
147200|NCT00378352|357894|P2|STARTED|Efficacy Phase||0
147201|NCT00378352|357895|P1|STARTED|Efficacy Phase||0
147202|NCT00378352|357890|P6|NOT COMPLETED|Dose Escalation 60,000 Units||0
147203|NCT00378352|357891|P5|NOT COMPLETED|Dose Escalation 60,000 Units||0
147204|NCT00378352|357892|P4|NOT COMPLETED|Dose Escalation 60,000 Units||1
147205|NCT00378352|357893|P3|NOT COMPLETED|Dose Escalation 60,000 Units||3
147206|NCT00378352|357894|P2|NOT COMPLETED|Dose Escalation 60,000 Units||0
147207|NCT00378352|357895|P1|NOT COMPLETED|Dose Escalation 60,000 Units||0
147208|NCT00378352|357890|P6|COMPLETED|Dose Escalation 60,000 Units||0
147209|NCT00378352|357891|P5|COMPLETED|Dose Escalation 60,000 Units||0
147210|NCT00378352|357892|P4|COMPLETED|Dose Escalation 60,000 Units||10
147211|NCT00378352|357893|P3|COMPLETED|Dose Escalation 60,000 Units||17
147212|NCT00378352|357894|P2|COMPLETED|Dose Escalation 60,000 Units||0
147213|NCT00378352|357895|P1|COMPLETED|Dose Escalation 60,000 Units||0
147214|NCT00378352|357890|P6|Safety Analysis|Dose Escalation 60,000 Units||0
147215|NCT00378352|357891|P5|Safety Analysis|Dose Escalation 60,000 Units||0
147216|NCT00378352|357892|P4|Safety Analysis|Dose Escalation 60,000 Units||11
147217|NCT00378352|357893|P3|Safety Analysis|Dose Escalation 60,000 Units||19
147218|NCT00378352|357894|P2|Safety Analysis|Dose Escalation 60,000 Units||0
147219|NCT00378352|357895|P1|Safety Analysis|Dose Escalation 60,000 Units||0
147220|NCT00378352|357890|P6|STARTED|Dose Escalation 60,000 Units||0
147221|NCT00378352|357891|P5|STARTED|Dose Escalation 60,000 Units||0
147222|NCT00378352|357892|P4|STARTED|Dose Escalation 60,000 Units||11
147223|NCT00378352|357893|P3|STARTED|Dose Escalation 60,000 Units||20
147224|NCT00378352|357894|P2|STARTED|Dose Escalation 60,000 Units||0
147225|NCT00378352|357895|P1|STARTED|Dose Escalation 60,000 Units||0
147226|NCT00378352|357890|P6|NOT COMPLETED|Dose Escalation 30,000 Units||0
147227|NCT00378352|357891|P5|NOT COMPLETED|Dose Escalation 30,000 Units||0
147228|NCT00378352|357892|P4|NOT COMPLETED|Dose Escalation 30,000 Units||2
147229|NCT00378352|357893|P3|NOT COMPLETED|Dose Escalation 30,000 Units||0
147230|NCT00378352|357894|P2|NOT COMPLETED|Dose Escalation 30,000 Units||3
147231|NCT00378352|357895|P1|NOT COMPLETED|Dose Escalation 30,000 Units||0
147232|NCT00378352|357890|P6|COMPLETED|Dose Escalation 30,000 Units||0
147233|NCT00378352|357891|P5|COMPLETED|Dose Escalation 30,000 Units||0
147234|NCT00378352|357892|P4|COMPLETED|Dose Escalation 30,000 Units||9
147235|NCT00378352|357893|P3|COMPLETED|Dose Escalation 30,000 Units||0
147236|NCT00378352|357894|P2|COMPLETED|Dose Escalation 30,000 Units||16
147237|NCT00378352|357895|P1|COMPLETED|Dose Escalation 30,000 Units||0
147238|NCT00378352|357890|P6|Safety Analysis|Dose Escalation 30,000 Units||0
147239|NCT00378352|357891|P5|Safety Analysis|Dose Escalation 30,000 Units||0
147240|NCT00378352|357892|P4|Safety Analysis|Dose Escalation 30,000 Units||11
147241|NCT00378352|357893|P3|Safety Analysis|Dose Escalation 30,000 Units||0
147242|NCT00378352|357894|P2|Safety Analysis|Dose Escalation 30,000 Units|One participant randomized to 60,000 units received 30,000 units|20
147243|NCT00378352|357895|P1|Safety Analysis|Dose Escalation 30,000 Units||0
147244|NCT00378352|357890|P6|STARTED|Dose Escalation 30,000 Units||0
147245|NCT00378352|357891|P5|STARTED|Dose Escalation 30,000 Units||0
147246|NCT00378352|357892|P4|STARTED|Dose Escalation 30,000 Units||11
147247|NCT00378352|357893|P3|STARTED|Dose Escalation 30,000 Units||0
147248|NCT00378352|357894|P2|STARTED|Dose Escalation 30,000 Units||19
147249|NCT00378352|357895|P1|STARTED|Dose Escalation 30,000 Units||0
147250|NCT00378352|357890|P6|NOT COMPLETED|Dose Escalation 15,000 Units||0
147251|NCT00378352|357891|P5|NOT COMPLETED|Dose Escalation 15,000 Units||0
147252|NCT00378352|357892|P4|NOT COMPLETED|Dose Escalation 15,000 Units||1
147253|NCT00378352|357893|P3|NOT COMPLETED|Dose Escalation 15,000 Units||0
147254|NCT00378352|357894|P2|NOT COMPLETED|Dose Escalation 15,000 Units||0
147255|NCT00378352|357895|P1|NOT COMPLETED|Dose Escalation 15,000 Units||5
147256|NCT00378352|357890|P6|COMPLETED|Dose Escalation 15,000 Units||0
147257|NCT00378352|357891|P5|COMPLETED|Dose Escalation 15,000 Units||0
147258|NCT00378352|357892|P4|COMPLETED|Dose Escalation 15,000 Units||10
147259|NCT00378352|357893|P3|COMPLETED|Dose Escalation 15,000 Units||0
147260|NCT00378352|357894|P2|COMPLETED|Dose Escalation 15,000 Units||0
147261|NCT00378352|357895|P1|COMPLETED|Dose Escalation 15,000 Units||15
147262|NCT00378352|357890|P6|Safety Analysis|Dose Escalation 15,000 Units||0
147263|NCT00378352|357891|P5|Safety Analysis|Dose Escalation 15,000 Units||0
147264|NCT00378352|357892|P4|Safety Analysis|Dose Escalation 15,000 Units||11
147265|NCT00378352|357893|P3|Safety Analysis|Dose Escalation 15,000 Units||0
147266|NCT00378352|357894|P2|Safety Analysis|Dose Escalation 15,000 Units||0
147267|NCT00378352|357895|P1|Safety Analysis|Dose Escalation 15,000 Units||19
147268|NCT00378352|357890|P6|STARTED|Dose Escalation 15,000 Units||0
147269|NCT00378352|357891|P5|STARTED|Dose Escalation 15,000 Units||0
147270|NCT00378352|357892|P4|STARTED|Dose Escalation 15,000 Units||11
147271|NCT00378352|357893|P3|STARTED|Dose Escalation 15,000 Units||0
147272|NCT00378352|357894|P2|STARTED|Dose Escalation 15,000 Units||0
147273|NCT00378352|357895|P1|STARTED|Dose Escalation 15,000 Units||20
147274|NCT00378378|357920|P3|NOT COMPLETED|Overall Study||2
147275|NCT00378378|357921|P2|NOT COMPLETED|Overall Study||1
147276|NCT00378378|357922|P1|NOT COMPLETED|Overall Study||0
147277|NCT00378378|357920|P3|COMPLETED|Overall Study||24
147278|NCT00378378|357921|P2|COMPLETED|Overall Study||49
147279|NCT00378378|357922|P1|COMPLETED|Overall Study||51
147280|NCT00378378|357920|P3|STARTED|Overall Study||26
147281|NCT00378378|357921|P2|STARTED|Overall Study||50
147282|NCT00378378|357922|P1|STARTED|Overall Study||51
147283|NCT00378703|357937|P4|NOT COMPLETED|Overall Study||91
147284|NCT00378703|357938|P3|NOT COMPLETED|Overall Study||90
147285|NCT00378703|357939|P2|NOT COMPLETED|Overall Study||91
147286|NCT00378703|357940|P1|NOT COMPLETED|Overall Study||89
147287|NCT00378703|357937|P4|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
147288|NCT00378703|357938|P3|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
147289|NCT00378703|357939|P2|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
147290|NCT00378703|357940|P1|COMPLETED|Overall Study|There is no limit to the number of treatment cycles allowed on any treatment arm.|0
147291|NCT00378703|357937|P4|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
147292|NCT00378703|357938|P3|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|83
147293|NCT00378703|357939|P2|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|80
147294|NCT00378703|357940|P1|Eligible and Treated|Overall Study|Number of patients included in the primary analysis.|84
147295|NCT00378703|357937|P4|Treated|Overall Study|Number of patients included in the toxicity analysis.|91
147296|NCT00378703|357938|P3|Treated|Overall Study|Number of patients included in the toxicity analysis.|90
147297|NCT00378703|357939|P2|Treated|Overall Study|Number of patients included in the toxicity analysis.|86
147298|NCT00378703|357940|P1|Treated|Overall Study|Number of patients included in the toxicity analysis.|88
147299|NCT00378703|357937|P4|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
147300|NCT00378703|357938|P3|STARTED|Overall Study|Number of patients randomized to this treatment arm.|90
147301|NCT00378703|357939|P2|STARTED|Overall Study|Number of patients randomized to this treatment arm.|91
147302|NCT00378703|357940|P1|STARTED|Overall Study|Number of patients randomized to this treatment arm.|89
147303|NCT00378898|357964|P2|NOT COMPLETED|Overall Study||6
147304|NCT00378898|357965|P1|NOT COMPLETED|Overall Study||11
147305|NCT00378898|357964|P2|COMPLETED|Overall Study||11
147306|NCT00378898|357965|P1|COMPLETED|Overall Study||11
147307|NCT00378898|357964|P2|STARTED|Overall Study||17
147308|NCT00378898|357965|P1|STARTED|Overall Study||22
147309|NCT00379080|357976|P3|NOT COMPLETED|Overall Study||0
147310|NCT00379080|357977|P2|NOT COMPLETED|Overall Study||4
147311|NCT00379080|357978|P1|NOT COMPLETED|Overall Study||0
147312|NCT00379080|357976|P3|COMPLETED|Overall Study||31
147313|NCT00379080|357977|P2|COMPLETED|Overall Study||15
147314|NCT00379080|357978|P1|COMPLETED|Overall Study||6
147315|NCT00379080|357976|P3|STARTED|Overall Study||31
147316|NCT00379080|357977|P2|STARTED|Overall Study||19
147317|NCT00379080|357978|P1|STARTED|Overall Study||6
147318|NCT00379197|358021|P1|NOT COMPLETED|Overall Study||5
147319|NCT00379197|358021|P1|COMPLETED|Overall Study||8
147320|NCT00379197|358021|P1|STARTED|Overall Study||13
147321|NCT00379210|358028|P2|NOT COMPLETED|Overall Study||7
147322|NCT00379210|358029|P1|NOT COMPLETED|Overall Study||10
147323|NCT00379210|358028|P2|COMPLETED|Overall Study||23
147324|NCT00379210|358029|P1|COMPLETED|Overall Study||20
147325|NCT00379210|358028|P2|STARTED|Overall Study||30
147326|NCT00379210|358029|P1|STARTED|Overall Study||30
147327|NCT00379236|358037|P3|NOT COMPLETED|Open-label Extension||55
147328|NCT00379236|358038|P2|NOT COMPLETED|Open-label Extension||0
147329|NCT00379236|358039|P1|NOT COMPLETED|Open-label Extension||0
147330|NCT00379236|358037|P3|COMPLETED|Open-label Extension||378
147331|NCT00379236|358038|P2|COMPLETED|Open-label Extension||0
147332|NCT00379236|358039|P1|COMPLETED|Open-label Extension||0
147333|NCT00379236|358037|P3|STARTED|Open-label Extension||433
147334|NCT00379236|358038|P2|STARTED|Open-label Extension||0
147335|NCT00379236|358039|P1|STARTED|Open-label Extension||0
147336|NCT00379236|358037|P3|NOT COMPLETED|Double-blind||0
147337|NCT00379236|358038|P2|NOT COMPLETED|Double-blind||36
147338|NCT00379236|358039|P1|NOT COMPLETED|Double-blind||36
147339|NCT00379236|358037|P3|COMPLETED|Double-blind||0
147340|NCT00379236|358038|P2|COMPLETED|Double-blind|Data could not be retrieved for two participants|259
147341|NCT00379236|358039|P1|COMPLETED|Double-blind|Data could not be retrieved for two participants|257
147342|NCT00379236|358037|P3|STARTED|Double-blind||0
147343|NCT00379236|358038|P2|STARTED|Double-blind||295
147344|NCT00379236|358039|P1|STARTED|Double-blind||293
147345|NCT00379288|358086|P4|NOT COMPLETED|Overall Study||8
147346|NCT00379288|358087|P3|NOT COMPLETED|Overall Study||10
147347|NCT00379288|358088|P2|NOT COMPLETED|Overall Study||22
147348|NCT00379288|358089|P1|NOT COMPLETED|Overall Study||19
147349|NCT00379288|358086|P4|COMPLETED|Overall Study||57
147350|NCT00379288|358087|P3|COMPLETED|Overall Study||58
147351|NCT00379288|358088|P2|COMPLETED|Overall Study||108
147352|NCT00379288|358089|P1|COMPLETED|Overall Study||122
147353|NCT00379288|358086|P4|STARTED|Overall Study||65
147354|NCT00379288|358087|P3|STARTED|Overall Study||68
147355|NCT00379288|358088|P2|STARTED|Overall Study||130
147356|NCT00379288|358089|P1|STARTED|Overall Study||141
147357|NCT00379340|358104|P5|NOT COMPLETED|Overall Study||14
147358|NCT00379340|358105|P4|NOT COMPLETED|Overall Study||13
147359|NCT00379340|358106|P3|NOT COMPLETED|Overall Study||2
147360|NCT00379340|358107|P2|NOT COMPLETED|Overall Study||3
147361|NCT00379340|358108|P1|NOT COMPLETED|Overall Study||13
147362|NCT00379340|358104|P5|COMPLETED|Overall Study||9
147363|NCT00379340|358105|P4|COMPLETED|Overall Study||37
147364|NCT00379340|358106|P3|COMPLETED|Overall Study||50
147365|NCT00379340|358107|P2|COMPLETED|Overall Study||132
147366|NCT00379340|358108|P1|COMPLETED|Overall Study||107
147367|NCT00379340|358104|P5|STARTED|Overall Study||23
147368|NCT00379340|358105|P4|STARTED|Overall Study||50
147369|NCT00379340|358106|P3|STARTED|Overall Study||52
147370|NCT00379340|358107|P2|STARTED|Overall Study||135
147371|NCT00379340|358108|P1|STARTED|Overall Study||120
147372|NCT00379353|358123|P2|NOT COMPLETED|Overall Study||6
147373|NCT00379353|358124|P1|NOT COMPLETED|Overall Study||11
147374|NCT00379353|358123|P2|COMPLETED|Overall Study||9
147375|NCT00379353|358124|P1|COMPLETED|Overall Study||5
147376|NCT00379353|358123|P2|STARTED|Overall Study||15
147377|NCT00379353|358124|P1|STARTED|Overall Study||16
147378|NCT00379574|358154|P1|NOT COMPLETED|Overall Study||0
147379|NCT00379574|358154|P1|COMPLETED|Overall Study|Phase I (9) + Phase II (40)|49
147380|NCT00379574|358154|P1|STARTED|Overall Study|Phase I (9) + Phase II (40)|49
147381|NCT00379587|358159|P1|NOT COMPLETED|Overall Study||2
147382|NCT00379587|358159|P1|COMPLETED|Overall Study||63
147383|NCT00379587|358159|P1|STARTED|Overall Study||65
147384|NCT00379639|358171|P5|NOT COMPLETED|Overall Study||6
147385|NCT00379639|358172|P4|NOT COMPLETED|Overall Study||6
147386|NCT00379639|358173|P3|NOT COMPLETED|Overall Study||9
147387|NCT00379639|358174|P2|NOT COMPLETED|Overall Study||5
147388|NCT00379639|358175|P1|NOT COMPLETED|Overall Study||3
147389|NCT00379639|358171|P5|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
147390|NCT00379639|358172|P4|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|0
147391|NCT00379639|358173|P3|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|1
147392|NCT00379639|358174|P2|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|2
147393|NCT00379639|358175|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6|4
147394|NCT00379639|358171|P5|Completed 6 Cycles of Therapy|Overall Study||0
147395|NCT00379639|358172|P4|Completed 6 Cycles of Therapy|Overall Study||0
147396|NCT00379639|358173|P3|Completed 6 Cycles of Therapy|Overall Study||1
147397|NCT00379639|358174|P2|Completed 6 Cycles of Therapy|Overall Study||2
147398|NCT00379639|358175|P1|Completed 6 Cycles of Therapy|Overall Study||4
147399|NCT00379639|358171|P5|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|3
147400|NCT00379639|358172|P4|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|4
147401|NCT00379639|358173|P3|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
147402|NCT00379639|358174|P2|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|7
147403|NCT00379639|358175|P1|Efficacy Evaluable Population|Overall Study|Completed ≥2 consecutive treatment cycles, had ≥1 efficacy assessment & no major protocol violations|6
147404|NCT00379639|358171|P5|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
147405|NCT00379639|358172|P4|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|6
147406|NCT00379639|358173|P3|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|10
147407|NCT00379639|358174|P2|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
147408|NCT00379639|358175|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|7
147409|NCT00379769|358201|P6|NOT COMPLETED|Observational Follow-up||148
147410|NCT00379769|358202|P5|NOT COMPLETED|Observational Follow-up||149
147411|NCT00379769|358203|P4|NOT COMPLETED|Observational Follow-up||0
147412|NCT00379769|358204|P3|NOT COMPLETED|Observational Follow-up||0
147413|NCT00379769|358205|P2|NOT COMPLETED|Observational Follow-up||0
147414|NCT00379769|358206|P1|NOT COMPLETED|Observational Follow-up||0
147415|NCT00379769|358201|P6|COMPLETED|Observational Follow-up||1102
147416|NCT00379769|358202|P5|COMPLETED|Observational Follow-up||1131
147417|NCT00379769|358203|P4|COMPLETED|Observational Follow-up||0
147418|NCT00379769|358204|P3|COMPLETED|Observational Follow-up||0
147419|NCT00379769|358205|P2|COMPLETED|Observational Follow-up||0
147420|NCT00379769|358206|P1|COMPLETED|Observational Follow-up||0
147421|NCT00379769|358201|P6|STARTED|Observational Follow-up|647 from “SU in Addition to Background MET” arm; 603 from “MET in Addition to Background SU” arm.|1250
147422|NCT00379769|358202|P5|STARTED|Observational Follow-up|665 from “RSG in Addition to Background MET” arm; 615 from “RGS in Addition to Background SU” arm.|1280
147423|NCT00379769|358203|P4|STARTED|Observational Follow-up||0
147424|NCT00379769|358204|P3|STARTED|Observational Follow-up||0
147425|NCT00379769|358205|P2|STARTED|Observational Follow-up||0
147426|NCT00379769|358206|P1|STARTED|Observational Follow-up||0
147427|NCT00379769|358201|P6|NOT COMPLETED|Main Study||0
147428|NCT00379769|358202|P5|NOT COMPLETED|Main Study||0
147429|NCT00379769|358203|P4|NOT COMPLETED|Main Study||230
147430|NCT00379769|358204|P3|NOT COMPLETED|Main Study||207
147431|NCT00379769|358205|P2|NOT COMPLETED|Main Study||199
147432|NCT00379769|358206|P1|NOT COMPLETED|Main Study||178
147433|NCT00379769|358201|P6|COMPLETED|Main Study||0
147434|NCT00379769|358202|P5|COMPLETED|Main Study||0
147435|NCT00379769|358203|P4|COMPLETED|Main Study||892
147436|NCT00379769|358204|P3|COMPLETED|Main Study||896
147437|NCT00379769|358205|P2|COMPLETED|Main Study||906
147438|NCT00379769|358206|P1|COMPLETED|Main Study||939
147439|NCT00379769|358201|P6|STARTED|Main Study||0
147440|NCT00379769|358202|P5|STARTED|Main Study||0
147441|NCT00379769|358203|P4|STARTED|Main Study||1122
147442|NCT00379769|358204|P3|STARTED|Main Study||1103
147443|NCT00379769|358205|P2|STARTED|Main Study||1105
147444|NCT00379769|358206|P1|STARTED|Main Study||1117
147445|NCT00379795|358365|P5|NOT COMPLETED|Overall Study||49
147446|NCT00379795|358366|P4|NOT COMPLETED|Overall Study||68
147447|NCT00379795|358367|P3|NOT COMPLETED|Overall Study||93
147448|NCT00379795|358368|P2|NOT COMPLETED|Overall Study||51
147449|NCT00379795|358369|P1|NOT COMPLETED|Overall Study||476
147450|NCT00379795|358365|P5|COMPLETED|Overall Study||14
147451|NCT00379795|358366|P4|COMPLETED|Overall Study||6
147452|NCT00379795|358367|P3|COMPLETED|Overall Study||23
147453|NCT00379795|358368|P2|COMPLETED|Overall Study||23
147454|NCT00379795|358369|P1|COMPLETED|Overall Study||50
147455|NCT00379795|358365|P5|Received Ranibizumab in Extension Study|Overall Study||0
147456|NCT00379795|358366|P4|Received Ranibizumab in Extension Study|Overall Study||55
147457|NCT00379795|358367|P3|Received Ranibizumab in Extension Study|Overall Study||113
147458|NCT00379795|358368|P2|Received Ranibizumab in Extension Study|Overall Study||41
147459|NCT00379795|358369|P1|Received Ranibizumab in Extension Study|Overall Study||377
147460|NCT00379795|358365|P5|STARTED|Overall Study||63
147461|NCT00379795|358366|P4|STARTED|Overall Study||74
147462|NCT00379795|358367|P3|STARTED|Overall Study||116
147463|NCT00379795|358368|P2|STARTED|Overall Study||74
147464|NCT00379795|358369|P1|STARTED|Overall Study||526
147465|NCT00379808|358395|P2|NOT COMPLETED|Intervention Period 2 (4 Weeks)||1
147466|NCT00379808|358396|P1|NOT COMPLETED|Intervention Period 2 (4 Weeks)||0
147467|NCT00379808|358395|P2|COMPLETED|Intervention Period 2 (4 Weeks)||10
147468|NCT00379808|358396|P1|COMPLETED|Intervention Period 2 (4 Weeks)||11
147469|NCT00379808|358395|P2|STARTED|Intervention Period 2 (4 Weeks)||11
147470|NCT00379808|358396|P1|STARTED|Intervention Period 2 (4 Weeks)||11
147471|NCT00379808|358395|P2|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
147472|NCT00379808|358396|P1|NOT COMPLETED|Intervention Period 1 (4 Weeks)||0
147473|NCT00379808|358395|P2|COMPLETED|Intervention Period 1 (4 Weeks)||11
147474|NCT00379808|358396|P1|COMPLETED|Intervention Period 1 (4 Weeks)||11
147475|NCT00379808|358395|P2|STARTED|Intervention Period 1 (4 Weeks)||11
147476|NCT00379808|358396|P1|STARTED|Intervention Period 1 (4 Weeks)||11
147477|NCT00379821|358416|P4|NOT COMPLETED|Overall Study||79
147478|NCT00379821|358417|P3|NOT COMPLETED|Overall Study||67
147479|NCT00379821|358418|P2|NOT COMPLETED|Overall Study||89
147480|NCT00379821|358419|P1|NOT COMPLETED|Overall Study||73
147481|NCT00379821|358416|P4|COMPLETED|Overall Study||81
147482|NCT00379821|358417|P3|COMPLETED|Overall Study||93
147483|NCT00379821|358418|P2|COMPLETED|Overall Study||71
147484|NCT00379821|358419|P1|COMPLETED|Overall Study||87
147485|NCT00379821|358416|P4|STARTED|Overall Study||160
147486|NCT00379821|358417|P3|STARTED|Overall Study||160
147487|NCT00379821|358418|P2|STARTED|Overall Study||160
147488|NCT00379821|358419|P1|STARTED|Overall Study||160
147489|NCT00379834|358560|P1|NOT COMPLETED|Overall Study||2
147490|NCT00379834|358560|P1|COMPLETED|Overall Study||8
147491|NCT00379834|358560|P1|STARTED|Overall Study||10
147492|NCT00379899|358566|P2|NOT COMPLETED|Overall Study||40
147493|NCT00379899|358567|P1|NOT COMPLETED|Overall Study||40
147494|NCT00379899|358566|P2|COMPLETED|Overall Study||140
147495|NCT00379899|358567|P1|COMPLETED|Overall Study||140
147496|NCT00379899|358566|P2|STARTED|Overall Study||180
147497|NCT00379899|358567|P1|STARTED|Overall Study||180
147498|NCT00379912|358597|P2|NOT COMPLETED|Overall Study||0
147499|NCT00379912|358598|P1|NOT COMPLETED|Overall Study||1
147500|NCT00379912|358597|P2|COMPLETED|Overall Study||8
147501|NCT00379912|358598|P1|COMPLETED|Overall Study||6
147502|NCT00379912|358597|P2|STARTED|Overall Study||8
147503|NCT00379912|358598|P1|STARTED|Overall Study||7
147504|NCT00380029|358616|P1|NOT COMPLETED|Overall Study||0
147505|NCT00380029|358616|P1|COMPLETED|Overall Study||20
147506|NCT00380029|358616|P1|STARTED|Overall Study||20
147507|NCT00380068|358626|P1|NOT COMPLETED|Overall Study||69
147508|NCT00380068|358626|P1|COMPLETED|Overall Study||155
147509|NCT00380068|358626|P1|STARTED|Overall Study||224
147510|NCT00380081|358652|P6|NOT COMPLETED|Overall Study||1
147511|NCT00380081|358653|P5|NOT COMPLETED|Overall Study||1
147512|NCT00380081|358654|P4|NOT COMPLETED|Overall Study||0
147513|NCT00380081|358655|P3|NOT COMPLETED|Overall Study||0
147514|NCT00380081|358656|P2|NOT COMPLETED|Overall Study||0
147515|NCT00380081|358657|P1|NOT COMPLETED|Overall Study||0
147516|NCT00380081|358652|P6|COMPLETED|Overall Study||13
147517|NCT00380081|358653|P5|COMPLETED|Overall Study||12
147518|NCT00380081|358654|P4|COMPLETED|Overall Study||15
147519|NCT00380081|358655|P3|COMPLETED|Overall Study||13
147520|NCT00380081|358656|P2|COMPLETED|Overall Study||13
147521|NCT00380081|358657|P1|COMPLETED|Overall Study||14
147522|NCT00380081|358652|P6|STARTED|Overall Study||14
147523|NCT00380081|358653|P5|STARTED|Overall Study||13
147524|NCT00380081|358654|P4|STARTED|Overall Study||15
147525|NCT00380081|358655|P3|STARTED|Overall Study||13
147526|NCT00380081|358656|P2|STARTED|Overall Study||13
147527|NCT00380081|358657|P1|STARTED|Overall Study||14
147528|NCT00380250|358709|P2|NOT COMPLETED|Overall Study||55
147529|NCT00380250|358710|P1|NOT COMPLETED|Overall Study||99
147530|NCT00380250|358709|P2|COMPLETED|Overall Study||139
147531|NCT00380250|358710|P1|COMPLETED|Overall Study||297
147532|NCT00380250|358709|P2|STARTED|Overall Study||194
147533|NCT00380250|358710|P1|STARTED|Overall Study||396
147534|NCT00380367|358772|P1|NOT COMPLETED|Overall Study||2
147535|NCT00380367|358772|P1|COMPLETED|Overall Study||108
147536|NCT00380367|358772|P1|STARTED|Overall Study||110
147537|NCT00380588|358779|P2|NOT COMPLETED|Overall Study||40
147538|NCT00380588|358780|P1|NOT COMPLETED|Overall Study||39
147539|NCT00380588|358779|P2|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|2
147540|NCT00380588|358780|P1|COMPLETED|Overall Study|Treatment period reached 48 week maximum.|3
147541|NCT00380588|358779|P2|Received at Least One Dose of Study Drug|Overall Study||42
147542|NCT00380588|358780|P1|Received at Least One Dose of Study Drug|Overall Study||41
147543|NCT00380588|358779|P2|STARTED|Overall Study||42
147544|NCT00380588|358780|P1|STARTED|Overall Study||42
147545|NCT00380692|358794|P2|NOT COMPLETED|Study Period III - Open Label||12
147546|NCT00380692|358795|P1|NOT COMPLETED|Study Period III - Open Label||6
147547|NCT00380692|358794|P2|COMPLETED|Study Period III - Open Label||34
147548|NCT00380692|358795|P1|COMPLETED|Study Period III - Open Label||36
147549|NCT00380692|358794|P2|STARTED|Study Period III - Open Label||46
147550|NCT00380692|358795|P1|STARTED|Study Period III - Open Label|One patient who completed Study Period II did not enter Study Period III.|42
147551|NCT00380692|358794|P2|NOT COMPLETED|Study Period II - Double Blind||3
147552|NCT00380692|358795|P1|NOT COMPLETED|Study Period II - Double Blind||5
147553|NCT00380692|358794|P2|COMPLETED|Study Period II - Double Blind||46
147554|NCT00380692|358795|P1|COMPLETED|Study Period II - Double Blind||43
147555|NCT00380692|358794|P2|STARTED|Study Period II - Double Blind||49
147556|NCT00380692|358795|P1|STARTED|Study Period II - Double Blind||48
147557|NCT00380718|358841|P1|NOT COMPLETED|Overall Study||18
147558|NCT00380718|358841|P1|COMPLETED|Overall Study||15
147559|NCT00380718|358841|P1|Received Escalated Dose in Cycle 2|Overall Study||25
147560|NCT00380718|358841|P1|Received at Least One Dose of Study Drug|Overall Study||33
147561|NCT00380718|358841|P1|STARTED|Overall Study||33
147562|NCT00380861|358853|P2|NOT COMPLETED|Overall Study||17
147563|NCT00380861|358854|P1|NOT COMPLETED|Overall Study||18
147564|NCT00380861|358853|P2|COMPLETED|Overall Study||74
147565|NCT00380861|358854|P1|COMPLETED|Overall Study||75
147566|NCT00380861|358853|P2|STARTED|Overall Study|Two subjects received the PFC Sigma RP-F device but not the RP and their results are not included.|91
147567|NCT00380861|358854|P1|STARTED|Overall Study||93
147568|NCT00380874|358862|P2|NOT COMPLETED|Overall Study||10
147569|NCT00380874|358863|P1|NOT COMPLETED|Overall Study||13
147570|NCT00380874|358862|P2|COMPLETED|Overall Study||19
147571|NCT00380874|358863|P1|COMPLETED|Overall Study||19
147572|NCT00380874|358862|P2|STARTED|Overall Study||29
147573|NCT00380874|358863|P1|STARTED|Overall Study||32
147574|NCT00380978|358881|P2|NOT COMPLETED|Overall Study||10
147575|NCT00380978|358882|P1|NOT COMPLETED|Overall Study||2
147576|NCT00380978|358881|P2|COMPLETED|Overall Study||400
147577|NCT00380978|358882|P1|COMPLETED|Overall Study||406
147578|NCT00380978|358881|P2|STARTED|Overall Study||410
147579|NCT00380978|358882|P1|STARTED|Overall Study||408
147580|NCT00381004|358902|P1|NOT COMPLETED|Overall Study||0
147581|NCT00381004|358902|P1|COMPLETED|Overall Study||60
147582|NCT00381004|358902|P1|STARTED|Overall Study||60
147583|NCT00381043|358910|P2|NOT COMPLETED|Overall Study||8
147584|NCT00381043|358911|P1|NOT COMPLETED|Overall Study||12
147585|NCT00381043|358910|P2|COMPLETED|Overall Study||41
147586|NCT00381043|358911|P1|COMPLETED|Overall Study||39
147587|NCT00381043|358910|P2|STARTED|Overall Study||49
147588|NCT00381043|358911|P1|STARTED|Overall Study||51
147589|NCT00381095|358931|P2|NOT COMPLETED|Overall Study||21
147590|NCT00381095|358932|P1|NOT COMPLETED|Overall Study||13
147591|NCT00381095|358931|P2|COMPLETED|Overall Study||59
147592|NCT00381095|358932|P1|COMPLETED|Overall Study||59
147593|NCT00381095|358931|P2|STARTED|Overall Study||80
147594|NCT00381095|358932|P1|STARTED|Overall Study||72
147595|NCT00375427|358964|P2|NOT COMPLETED|Overall Study||74
147596|NCT00375427|358965|P1|NOT COMPLETED|Overall Study||60
147597|NCT00375427|358964|P2|COMPLETED|Overall Study||142
147598|NCT00375427|358965|P1|COMPLETED|Overall Study||149
147599|NCT00375427|358964|P2|STARTED|Overall Study||216
147690|NCT00382785|359252|P1|STARTED|Overall Study||25
147600|NCT00375427|358965|P1|STARTED|Overall Study|Total enrollment was 430 but five patients were screened but not treated.|209
147601|NCT00375492|358989|P2|NOT COMPLETED|Overall Study||26
147602|NCT00375492|358990|P1|NOT COMPLETED|Overall Study||26
147603|NCT00375492|358989|P2|COMPLETED|Overall Study||72
147604|NCT00375492|358990|P1|COMPLETED|Overall Study||70
147605|NCT00375492|358989|P2|STARTED|Overall Study||98
147606|NCT00375492|358990|P1|STARTED|Overall Study||96
147607|NCT00375505|359020|P2|NOT COMPLETED|Overall Study||2
147608|NCT00375505|359021|P1|NOT COMPLETED|Overall Study||1
147609|NCT00375505|359020|P2|COMPLETED|Overall Study||32
147610|NCT00375505|359021|P1|COMPLETED|Overall Study||35
147611|NCT00375505|359020|P2|STARTED|Overall Study||34
147612|NCT00375505|359021|P1|STARTED|Overall Study||36
147613|NCT00375518|359065|P2|NOT COMPLETED|Overall Study||17
147614|NCT00375518|359066|P1|NOT COMPLETED|Overall Study||8
147615|NCT00375518|359065|P2|COMPLETED|Overall Study||65
147616|NCT00375518|359066|P1|COMPLETED|Overall Study||72
147617|NCT00375518|359065|P2|STARTED|Overall Study||82
147618|NCT00375518|359066|P1|STARTED|Overall Study||80
147619|NCT00381238|359072|P1|NOT COMPLETED|Overall Study||12
147620|NCT00381238|359072|P1|COMPLETED|Overall Study||21
147621|NCT00381238|359072|P1|STARTED|Overall Study||33
147622|NCT00381303|359088|P2|NOT COMPLETED|Overall Study||33
147623|NCT00381303|359089|P1|NOT COMPLETED|Overall Study||94
147624|NCT00381303|359088|P2|COMPLETED|Overall Study||109
147625|NCT00381303|359089|P1|COMPLETED|Overall Study||193
147626|NCT00381303|359088|P2|STARTED|Overall Study||142
147627|NCT00381303|359089|P1|STARTED|Overall Study||287
147628|NCT00381381|359149|P1|NOT COMPLETED|Overall Study||64
147629|NCT00381381|359149|P1|COMPLETED|Overall Study||135
147630|NCT00381381|359149|P1|STARTED|Overall Study||199
147631|NCT00382291|359159|P3|NOT COMPLETED|Overall Study||8
147632|NCT00382291|359160|P2|NOT COMPLETED|Overall Study||7
147633|NCT00382291|359161|P1|NOT COMPLETED|Overall Study||4
147634|NCT00382291|359159|P3|COMPLETED|Overall Study||13
147635|NCT00382291|359160|P2|COMPLETED|Overall Study||10
147636|NCT00382291|359161|P1|COMPLETED|Overall Study||14
147637|NCT00382291|359159|P3|STARTED|Overall Study||21
147638|NCT00382291|359160|P2|STARTED|Overall Study||17
147639|NCT00382291|359161|P1|STARTED|Overall Study||18
147640|NCT00382408|359174|P2|NOT COMPLETED|Overall Study||54
147641|NCT00382408|359175|P1|NOT COMPLETED|Overall Study||144
147642|NCT00382408|359174|P2|COMPLETED|Overall Study||955
147643|NCT00382408|359175|P1|COMPLETED|Overall Study||2887
147644|NCT00382408|359174|P2|STARTED|Overall Study||1009
147645|NCT00382408|359175|P1|STARTED|Overall Study||3031
147646|NCT00382590|359201|P2|NOT COMPLETED|Overall Study||0
147647|NCT00382590|359202|P1|NOT COMPLETED|Overall Study||0
147648|NCT00382590|359201|P2|COMPLETED|Overall Study||6
147649|NCT00382590|359202|P1|COMPLETED|Overall Study||4
147650|NCT00382590|359201|P2|STARTED|Overall Study||6
147651|NCT00382590|359202|P1|STARTED|Overall Study||4
147652|NCT00382720|359211|P3|NOT COMPLETED|Overall Study||86
147653|NCT00382720|359212|P2|NOT COMPLETED|Overall Study||89
147654|NCT00382720|359213|P1|NOT COMPLETED|Overall Study||79
147655|NCT00382720|359211|P3|COMPLETED|Overall Study||0
147656|NCT00382720|359212|P2|COMPLETED|Overall Study||0
147657|NCT00382720|359213|P1|COMPLETED|Overall Study||0
147658|NCT00382720|359211|P3|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|82
147659|NCT00382720|359212|P2|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|88
147660|NCT00382720|359213|P1|Full Analysis Population (FAP)|Overall Study|ITT who received at least one dose of study medication|78
147661|NCT00382720|359211|P3|Administered Optimal Dose (Parts I & II)|Overall Study||82
147662|NCT00382720|359212|P2|Administered Optimal Dose (Parts I & II)|Overall Study||88
147663|NCT00382720|359213|P1|Administered Optimal Dose (Parts I & II)|Overall Study||78
147664|NCT00382720|359211|P3|Administered Non-Optimal Dose (Part I)|Overall Study||0
147665|NCT00382720|359212|P2|Administered Non-Optimal Dose (Part I)|Overall Study||11
147666|NCT00382720|359213|P1|Administered Non-Optimal Dose (Part I)|Overall Study||10
147667|NCT00382720|359211|P3|STARTED|Overall Study||86
147668|NCT00382720|359212|P2|STARTED|Overall Study||89
147669|NCT00382720|359213|P1|STARTED|Overall Study||79
147670|NCT00382733|359227|P5|NOT COMPLETED|Overall Study||0
147671|NCT00382733|359228|P4|NOT COMPLETED|Overall Study||0
147672|NCT00382733|359229|P3|NOT COMPLETED|Overall Study||0
147673|NCT00382733|359230|P2|NOT COMPLETED|Overall Study||1
147674|NCT00382733|359231|P1|NOT COMPLETED|Overall Study||0
147675|NCT00382733|359227|P5|COMPLETED|Overall Study||2
147676|NCT00382733|359228|P4|COMPLETED|Overall Study||14
147677|NCT00382733|359229|P3|COMPLETED|Overall Study||3
147678|NCT00382733|359230|P2|COMPLETED|Overall Study|1 subject withdrew consent before completing Cycle 1 - that subject was replaced|3
147679|NCT00382733|359231|P1|COMPLETED|Overall Study||3
147680|NCT00382733|359227|P5|STARTED|Overall Study||2
147681|NCT00382733|359228|P4|STARTED|Overall Study||14
147682|NCT00382733|359229|P3|STARTED|Overall Study||3
147683|NCT00382733|359230|P2|STARTED|Overall Study||4
147684|NCT00382733|359231|P1|STARTED|Overall Study||3
147685|NCT00382785|359251|P2|NOT COMPLETED|Overall Study||0
147686|NCT00382785|359252|P1|NOT COMPLETED|Overall Study||0
147687|NCT00382785|359251|P2|COMPLETED|Overall Study||26
147688|NCT00382785|359252|P1|COMPLETED|Overall Study||25
147689|NCT00382785|359251|P2|STARTED|Overall Study||26
147691|NCT00382863|359264|P2|NOT COMPLETED|Overall Study||36
147692|NCT00382863|359265|P1|NOT COMPLETED|Overall Study||15
147693|NCT00382863|359264|P2|COMPLETED|Overall Study||78
147694|NCT00382863|359265|P1|COMPLETED|Overall Study||81
147695|NCT00382863|359264|P2|STARTED|Overall Study||114
147696|NCT00382863|359265|P1|STARTED|Overall Study||96
147697|NCT00382928|359321|P2|NOT COMPLETED|Overall Study||0
147698|NCT00382928|359322|P1|NOT COMPLETED|Overall Study||0
147699|NCT00382928|359321|P2|COMPLETED|Overall Study||95
147700|NCT00382928|359322|P1|COMPLETED|Overall Study||97
147701|NCT00382928|359321|P2|STARTED|Overall Study||95
147702|NCT00382928|359322|P1|STARTED|Overall Study||97
147703|NCT00382967|359336|P2|NOT COMPLETED|Overall Study||1
147704|NCT00382967|359337|P1|NOT COMPLETED|Overall Study||1
147705|NCT00382967|359336|P2|COMPLETED|Overall Study|Subject dosed in error, should not have received Datscan product|137
147706|NCT00382967|359337|P1|COMPLETED|Overall Study|Patient lost to followup and the data was not recorded.|121
147707|NCT00382967|359336|P2|STARTED|Overall Study||138
147708|NCT00382967|359337|P1|STARTED|Overall Study|135 subjects enrolled at the start of the study, however, 13 subjects withdrew prior to dosing.|122
147709|NCT00382993|359345|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||4
147710|NCT00382993|359346|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
147711|NCT00382993|359345|P2|COMPLETED|Migraine Attack 2 (Period 2)||63
147712|NCT00382993|359346|P1|COMPLETED|Migraine Attack 2 (Period 2)||68
147713|NCT00382993|359345|P2|STARTED|Migraine Attack 2 (Period 2)||67
147714|NCT00382993|359346|P1|STARTED|Migraine Attack 2 (Period 2)||70
147715|NCT00382993|359345|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||18
147716|NCT00382993|359346|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||14
147717|NCT00382993|359345|P2|COMPLETED|Migraine Attack 1 (Period 1)||67
147718|NCT00382993|359346|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participant considered to have completed period if treated a migraine with investigational product.|70
147719|NCT00382993|359345|P2|STARTED|Migraine Attack 1 (Period 1)||85
147720|NCT00382993|359346|P1|STARTED|Migraine Attack 1 (Period 1)||84
147721|NCT00383019|359390|P2|NOT COMPLETED|Overall Study||2
147722|NCT00383019|359391|P1|NOT COMPLETED|Overall Study||5
147723|NCT00383019|359390|P2|COMPLETED|Overall Study||143
147724|NCT00383019|359391|P1|COMPLETED|Overall Study||139
147725|NCT00383019|359390|P2|STARTED|Overall Study||145
147726|NCT00383019|359391|P1|STARTED|Overall Study||144
147727|NCT00383071|359417|P4|NOT COMPLETED|Overall Study||3
147728|NCT00383071|359418|P3|NOT COMPLETED|Overall Study||7
147729|NCT00383071|359419|P2|NOT COMPLETED|Overall Study||4
147730|NCT00383071|359420|P1|NOT COMPLETED|Overall Study||0
147731|NCT00383071|359417|P4|COMPLETED|Overall Study||22
147732|NCT00383071|359418|P3|COMPLETED|Overall Study||44
147733|NCT00383071|359419|P2|COMPLETED|Overall Study||21
147734|NCT00383071|359420|P1|COMPLETED|Overall Study||25
147735|NCT00383071|359417|P4|STARTED|Overall Study||25
147736|NCT00383071|359418|P3|STARTED|Overall Study||51
147737|NCT00383071|359419|P2|STARTED|Overall Study||25
147738|NCT00383071|359420|P1|STARTED|Overall Study||25
147739|NCT00383084|359432|P2|NOT COMPLETED|Overall Study||10
147740|NCT00383084|359433|P1|NOT COMPLETED|Overall Study||12
147741|NCT00383084|359432|P2|COMPLETED|Overall Study||28
147742|NCT00383084|359433|P1|COMPLETED|Overall Study||34
147743|NCT00383084|359432|P2|STARTED|Overall Study||38
147744|NCT00383084|359433|P1|STARTED|Overall Study||46
147745|NCT00383110|359447|P2|NOT COMPLETED|Overall Study||0
147746|NCT00383110|359448|P1|NOT COMPLETED|Overall Study||0
147747|NCT00383110|359447|P2|COMPLETED|Overall Study||150
147748|NCT00383110|359448|P1|COMPLETED|Overall Study||150
147749|NCT00383110|359447|P2|STARTED|Overall Study||150
147750|NCT00383110|359448|P1|STARTED|Overall Study||150
147751|NCT00383123|359466|P2|NOT COMPLETED|Overall Study||86
147752|NCT00383123|359467|P1|NOT COMPLETED|Overall Study||111
147753|NCT00383123|359466|P2|COMPLETED|Overall Study||1124
147754|NCT00383123|359467|P1|COMPLETED|Overall Study||2004
147755|NCT00383123|359466|P2|STARTED|Overall Study||1210
147756|NCT00383123|359467|P1|STARTED|Overall Study||2115
147757|NCT00383149|359487|P1|NOT COMPLETED|Overall Study||54
147758|NCT00383149|359487|P1|COMPLETED|Overall Study||0
147759|NCT00383149|359487|P1|STARTED|Overall Study||54
147760|NCT00383162|359504|P2|NOT COMPLETED|Migraine Attack 2 (Period 2)||7
147761|NCT00383162|359505|P1|NOT COMPLETED|Migraine Attack 2 (Period 2)||2
147762|NCT00383162|359504|P2|COMPLETED|Migraine Attack 2 (Period 2)||66
147763|NCT00383162|359505|P1|COMPLETED|Migraine Attack 2 (Period 2)||65
147764|NCT00383162|359504|P2|STARTED|Migraine Attack 2 (Period 2)||73
147765|NCT00383162|359505|P1|STARTED|Migraine Attack 2 (Period 2)||67
147766|NCT00383162|359504|P2|NOT COMPLETED|Migraine Attack 1 (Period 1)||13
147767|NCT00383162|359505|P1|NOT COMPLETED|Migraine Attack 1 (Period 1)||20
147768|NCT00383162|359504|P2|COMPLETED|Migraine Attack 1 (Period 1)|Participants not completing did not take investigational product.|73
147769|NCT00383162|359505|P1|COMPLETED|Migraine Attack 1 (Period 1)|Participants completing a period treated a migraine with investigational product.|67
147770|NCT00383162|359504|P2|STARTED|Migraine Attack 1 (Period 1)||86
147771|NCT00383162|359505|P1|STARTED|Migraine Attack 1 (Period 1)||87
147772|NCT00383240|359551|P4|NOT COMPLETED|Overall Study||77
147773|NCT00383240|359552|P3|NOT COMPLETED|Overall Study||85
147774|NCT00383240|359553|P2|NOT COMPLETED|Overall Study||33
147775|NCT00383240|359554|P1|NOT COMPLETED|Overall Study||35
147776|NCT00383240|359551|P4|COMPLETED|Overall Study||119
147777|NCT00383240|359552|P3|COMPLETED|Overall Study||117
147778|NCT00383240|359553|P2|COMPLETED|Overall Study||159
147779|NCT00383240|359554|P1|COMPLETED|Overall Study||156
147780|NCT00383240|359551|P4|STARTED|Overall Study||196
147781|NCT00383240|359552|P3|STARTED|Overall Study||202
147782|NCT00383240|359553|P2|STARTED|Overall Study||192
147783|NCT00383240|359554|P1|STARTED|Overall Study||191
147784|NCT00383266|359585|P1|NOT COMPLETED|Overall Study||0
147785|NCT00383266|359585|P1|COMPLETED|Overall Study||9
147786|NCT00383266|359585|P1|STARTED|Overall Study||9
147787|NCT00383331|359596|P2|NOT COMPLETED|Overall Study||1
147788|NCT00383331|359597|P1|NOT COMPLETED|Overall Study||0
147789|NCT00383331|359596|P2|COMPLETED|Overall Study||8
147790|NCT00383331|359597|P1|COMPLETED|Overall Study||10
147791|NCT00383331|359596|P2|STARTED|Overall Study||9
147792|NCT00383331|359597|P1|STARTED|Overall Study||10
147793|NCT00383435|359618|P5|NOT COMPLETED|26-Week Treatment Safety Extension||3
147794|NCT00383435|359619|P4|NOT COMPLETED|26-Week Treatment Safety Extension||15
147795|NCT00383435|359620|P3|NOT COMPLETED|26-Week Treatment Safety Extension||16
147796|NCT00383435|359621|P2|NOT COMPLETED|26-Week Treatment Safety Extension||9
147797|NCT00383435|359622|P1|NOT COMPLETED|26-Week Treatment Safety Extension||14
147798|NCT00383435|359618|P5|COMPLETED|26-Week Treatment Safety Extension||10
147799|NCT00383435|359619|P4|COMPLETED|26-Week Treatment Safety Extension||116
147800|NCT00383435|359620|P3|COMPLETED|26-Week Treatment Safety Extension||108
147801|NCT00383435|359621|P2|COMPLETED|26-Week Treatment Safety Extension||121
147802|NCT00383435|359622|P1|COMPLETED|26-Week Treatment Safety Extension||117
147803|NCT00383435|359618|P5|STARTED|26-Week Treatment Safety Extension||13
147804|NCT00383435|359619|P4|STARTED|26-Week Treatment Safety Extension||131
147805|NCT00383435|359620|P3|STARTED|26-Week Treatment Safety Extension||124
147806|NCT00383435|359621|P2|STARTED|26-Week Treatment Safety Extension||130
147807|NCT00383435|359622|P1|STARTED|26-Week Treatment Safety Extension||131
147808|NCT00383435|359618|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||53
147809|NCT00383435|359619|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
147810|NCT00383435|359620|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||46
147811|NCT00383435|359621|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||38
147812|NCT00383435|359622|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||41
147813|NCT00383435|359618|P5|COMPLETED|26-Week Double-Blind Treatment Period||159
147814|NCT00383435|359619|P4|COMPLETED|26-Week Double-Blind Treatment Period||172
147815|NCT00383435|359620|P3|COMPLETED|26-Week Double-Blind Treatment Period||164
147816|NCT00383435|359621|P2|COMPLETED|26-Week Double-Blind Treatment Period||169
147817|NCT00383435|359622|P1|COMPLETED|26-Week Double-Blind Treatment Period||176
147818|NCT00383435|359618|P5|STARTED|26-Week Double-Blind Treatment Period||212
147819|NCT00383435|359619|P4|STARTED|26-Week Double-Blind Treatment Period||209
147820|NCT00383435|359620|P3|STARTED|26-Week Double-Blind Treatment Period||210
147821|NCT00383435|359621|P2|STARTED|26-Week Double-Blind Treatment Period||207
147822|NCT00383435|359622|P1|STARTED|26-Week Double-Blind Treatment Period||217
147823|NCT00383500|359662|P3|NOT COMPLETED|Overall Study||2
147824|NCT00383500|359663|P2|NOT COMPLETED|Overall Study||3
147825|NCT00383500|359664|P1|NOT COMPLETED|Overall Study||8
147826|NCT00383500|359662|P3|COMPLETED|Overall Study||22
147827|NCT00383500|359663|P2|COMPLETED|Overall Study||21
147828|NCT00383500|359664|P1|COMPLETED|Overall Study||19
147829|NCT00383500|359662|P3|STARTED|Overall Study||24
147830|NCT00383500|359663|P2|STARTED|Overall Study||24
147831|NCT00383500|359664|P1|STARTED|Overall Study||27
147832|NCT00383552|359679|P4|NOT COMPLETED|Overall Study||72
147833|NCT00383552|359680|P3|NOT COMPLETED|Overall Study||61
147834|NCT00383552|359681|P2|NOT COMPLETED|Overall Study||41
147835|NCT00383552|359682|P1|NOT COMPLETED|Overall Study||36
147836|NCT00383552|359679|P4|COMPLETED|Overall Study||116
147837|NCT00383552|359680|P3|COMPLETED|Overall Study||127
147838|NCT00383552|359681|P2|COMPLETED|Overall Study||147
147839|NCT00383552|359682|P1|COMPLETED|Overall Study||146
147840|NCT00383552|359679|P4|STARTED|Overall Study||188
147841|NCT00383552|359680|P3|STARTED|Overall Study||188
147842|NCT00383552|359681|P2|STARTED|Overall Study||188
147843|NCT00383552|359682|P1|STARTED|Overall Study||182
147844|NCT00383565|359721|P1|NOT COMPLETED|Overall Study||0
147845|NCT00383565|359721|P1|COMPLETED|Overall Study||9
147846|NCT00383565|359721|P1|STARTED|Overall Study||9
147847|NCT00383643|359730|P3|NOT COMPLETED|Overall Study||1
147848|NCT00383643|359731|P2|NOT COMPLETED|Overall Study||1
147849|NCT00383643|359732|P1|NOT COMPLETED|Overall Study||1
147850|NCT00383643|359730|P3|COMPLETED|Overall Study||13
147851|NCT00383643|359731|P2|COMPLETED|Overall Study||15
147852|NCT00383643|359732|P1|COMPLETED|Overall Study||17
147853|NCT00383643|359730|P3|STARTED|Overall Study||14
147854|NCT00383643|359731|P2|STARTED|Overall Study||16
147855|NCT00383643|359732|P1|STARTED|Overall Study||18
147856|NCT00383721|359757|P5|NOT COMPLETED|26-Week Treatment Safety Extension||0
147857|NCT00383721|359758|P4|NOT COMPLETED|26-Week Treatment Safety Extension||17
147858|NCT00383721|359759|P3|NOT COMPLETED|26-Week Treatment Safety Extension||23
147859|NCT00383721|359760|P2|NOT COMPLETED|26-Week Treatment Safety Extension||17
147860|NCT00383721|359761|P1|NOT COMPLETED|26-Week Treatment Safety Extension||19
147861|NCT00383721|359757|P5|COMPLETED|26-Week Treatment Safety Extension||8
147862|NCT00383721|359758|P4|COMPLETED|26-Week Treatment Safety Extension||131
147863|NCT00383721|359759|P3|COMPLETED|26-Week Treatment Safety Extension||126
147864|NCT00383721|359760|P2|COMPLETED|26-Week Treatment Safety Extension||136
147865|NCT00383721|359761|P1|COMPLETED|26-Week Treatment Safety Extension||126
147866|NCT00383721|359757|P5|STARTED|26-Week Treatment Safety Extension||8
147867|NCT00383721|359758|P4|STARTED|26-Week Treatment Safety Extension||148
147868|NCT00383721|359759|P3|STARTED|26-Week Treatment Safety Extension||149
147869|NCT00383721|359760|P2|STARTED|26-Week Treatment Safety Extension||153
147870|NCT00383721|359761|P1|STARTED|26-Week Treatment Safety Extension||145
147871|NCT00383721|359757|P5|NOT COMPLETED|26-Week Double-Blind Treatment Period||67
147872|NCT00383721|359758|P4|NOT COMPLETED|26-Week Double-Blind Treatment Period||50
147873|NCT00383721|359759|P3|NOT COMPLETED|26-Week Double-Blind Treatment Period||51
147874|NCT00383721|359760|P2|NOT COMPLETED|26-Week Double-Blind Treatment Period||37
147875|NCT00383721|359761|P1|NOT COMPLETED|26-Week Double-Blind Treatment Period||35
147876|NCT00383721|359757|P5|COMPLETED|26-Week Double-Blind Treatment Period||169
147877|NCT00383721|359758|P4|COMPLETED|26-Week Double-Blind Treatment Period||193
147878|NCT00383721|359759|P3|COMPLETED|26-Week Double-Blind Treatment Period||202
147879|NCT00383721|359760|P2|COMPLETED|26-Week Double-Blind Treatment Period||202
147880|NCT00383721|359761|P1|COMPLETED|26-Week Double-Blind Treatment Period|1 participant listed as “ongoing” since the participant status could not be formally confirmed.|190
147881|NCT00383721|359757|P5|STARTED|26-Week Double-Blind Treatment Period||236
147882|NCT00383721|359758|P4|STARTED|26-Week Double-Blind Treatment Period||243
147883|NCT00383721|359759|P3|STARTED|26-Week Double-Blind Treatment Period||253
147884|NCT00383721|359760|P2|STARTED|26-Week Double-Blind Treatment Period||239
147885|NCT00383721|359761|P1|STARTED|26-Week Double-Blind Treatment Period||225
147886|NCT00383747|359800|P4|NOT COMPLETED|Visit 2||0
147887|NCT00383747|359801|P3|NOT COMPLETED|Visit 2||0
147888|NCT00383747|359802|P2|NOT COMPLETED|Visit 2||0
147889|NCT00383747|359803|P1|NOT COMPLETED|Visit 2||0
147890|NCT00383747|359800|P4|COMPLETED|Visit 2||16
147891|NCT00383747|359801|P3|COMPLETED|Visit 2||16
147892|NCT00383747|359802|P2|COMPLETED|Visit 2||14
147893|NCT00383747|359803|P1|COMPLETED|Visit 2||14
147894|NCT00383747|359800|P4|STARTED|Visit 2||16
147895|NCT00383747|359801|P3|STARTED|Visit 2||16
147896|NCT00383747|359802|P2|STARTED|Visit 2||14
147897|NCT00383747|359803|P1|STARTED|Visit 2||14
147898|NCT00383747|359800|P4|NOT COMPLETED|Visit 1||0
147899|NCT00383747|359801|P3|NOT COMPLETED|Visit 1||0
147900|NCT00383747|359802|P2|NOT COMPLETED|Visit 1||0
147901|NCT00383747|359803|P1|NOT COMPLETED|Visit 1||0
147902|NCT00383747|359800|P4|COMPLETED|Visit 1||16
147903|NCT00383747|359801|P3|COMPLETED|Visit 1||16
147904|NCT00383747|359802|P2|COMPLETED|Visit 1||14
147905|NCT00383747|359803|P1|COMPLETED|Visit 1||14
147906|NCT00383747|359800|P4|STARTED|Visit 1||16
147907|NCT00383747|359801|P3|STARTED|Visit 1||16
147908|NCT00383747|359802|P2|STARTED|Visit 1||14
147909|NCT00383747|359803|P1|STARTED|Visit 1||14
147910|NCT00383760|359823|P1|NOT COMPLETED|Overall Study||0
147911|NCT00383760|359823|P1|COMPLETED|Overall Study||15
147912|NCT00383760|359823|P1|STARTED|Overall Study||15
147913|NCT00383786|359839|P2|NOT COMPLETED|Overall Study||12
147914|NCT00383786|359840|P1|NOT COMPLETED|Overall Study||4
147915|NCT00383786|359839|P2|COMPLETED|Overall Study||13
147916|NCT00383786|359840|P1|COMPLETED|Overall Study||18
147917|NCT00383786|359839|P2|STARTED|Overall Study||25
147918|NCT00383786|359840|P1|STARTED|Overall Study||22
147919|NCT00383942|359848|P2|NOT COMPLETED|Overall Study||0
147920|NCT00383942|359849|P1|NOT COMPLETED|Overall Study||0
147921|NCT00383942|359848|P2|COMPLETED|Overall Study||40
147922|NCT00383942|359849|P1|COMPLETED|Overall Study||40
147923|NCT00383942|359848|P2|STARTED|Overall Study||40
147924|NCT00383942|359849|P1|STARTED|Overall Study||40
147925|NCT00384033|359859|P4|NOT COMPLETED|Overall Study||40
147926|NCT00384033|359860|P3|NOT COMPLETED|Overall Study||43
147927|NCT00384033|359861|P2|NOT COMPLETED|Overall Study||35
147928|NCT00384033|359862|P1|NOT COMPLETED|Overall Study||41
147929|NCT00384033|359859|P4|COMPLETED|Overall Study||119
147930|NCT00384033|359860|P3|COMPLETED|Overall Study||117
147931|NCT00384033|359861|P2|COMPLETED|Overall Study||120
147932|NCT00384033|359862|P1|COMPLETED|Overall Study||123
147933|NCT00384033|359859|P4|Treated|Overall Study||157
147934|NCT00384033|359860|P3|Treated|Overall Study||150
147935|NCT00384033|359861|P2|Treated|Overall Study||148
147936|NCT00384033|359862|P1|Treated|Overall Study||161
147937|NCT00384033|359859|P4|STARTED|Overall Study||159
147938|NCT00384033|359860|P3|STARTED|Overall Study||160
147939|NCT00384033|359861|P2|STARTED|Overall Study||155
147940|NCT00384033|359862|P1|STARTED|Overall Study||164
147941|NCT00384059|359906|P2|NOT COMPLETED|Toddler Dose||2
147942|NCT00384059|359907|P1|NOT COMPLETED|Toddler Dose||1
147943|NCT00384059|359906|P2|COMPLETED|Toddler Dose||120
147944|NCT00384059|359907|P1|COMPLETED|Toddler Dose||130
147945|NCT00384059|359906|P2|STARTED|Toddler Dose||122
147946|NCT00384059|359907|P1|STARTED|Toddler Dose||131
147947|NCT00384059|359906|P2|NOT COMPLETED|After Infant Series||10
147948|NCT00384059|359907|P1|NOT COMPLETED|After Infant Series||4
147949|NCT00384059|359906|P2|COMPLETED|After Infant Series||122
147950|NCT00384059|359907|P1|COMPLETED|After Infant Series||131
147951|NCT00384059|359906|P2|STARTED|After Infant Series||132
147952|NCT00384059|359907|P1|STARTED|After Infant Series||135
147953|NCT00384059|359906|P2|NOT COMPLETED|Infant Series||13
147954|NCT00384059|359907|P1|NOT COMPLETED|Infant Series||6
147955|NCT00384059|359906|P2|COMPLETED|Infant Series||132
147956|NCT00384059|359907|P1|COMPLETED|Infant Series||135
147957|NCT00384059|359906|P2|Vaccinated Dose 2|Infant Series||135
147958|NCT00384059|359907|P1|Vaccinated Dose 2|Infant Series||136
147959|NCT00384059|359906|P2|Vaccinated Dose 1|Infant Series||139
147960|NCT00384059|359907|P1|Vaccinated Dose 1|Infant Series||139
147961|NCT00384059|359906|P2|STARTED|Infant Series||145
147962|NCT00384059|359907|P1|STARTED|Infant Series||141
147963|NCT00384085|359956|P3|NOT COMPLETED|Overall Study||56
147964|NCT00384085|359957|P2|NOT COMPLETED|Overall Study||46
147965|NCT00384085|359958|P1|NOT COMPLETED|Overall Study||39
147966|NCT00384085|359956|P3|COMPLETED|Overall Study|Based on the entire ITT population|141
147967|NCT00384085|359957|P2|COMPLETED|Overall Study|Based on the entire ITT population|150
147968|NCT00384085|359958|P1|COMPLETED|Overall Study|Based on the entire ITT population|156
147969|NCT00384085|359956|P3|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||189
147970|NCT00384085|359957|P2|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||186
147971|NCT00384085|359958|P1|Intent-To-Treat (Excluding nonGCP Sites)|Overall Study||187
147972|NCT00384085|359956|P3|Treated (Safety Population)|Overall Study||194
147973|NCT00384085|359957|P2|Treated (Safety Population)|Overall Study||194
147974|NCT00384085|359958|P1|Treated (Safety Population)|Overall Study||194
147975|NCT00384085|359956|P3|Intent-To-Treat (ITT)|Overall Study||197
147976|NCT00384085|359957|P2|Intent-To-Treat (ITT)|Overall Study||196
147977|NCT00384085|359958|P1|Intent-To-Treat (ITT)|Overall Study||195
147978|NCT00384085|359956|P3|STARTED|Overall Study|Randomized|197
147979|NCT00384085|359957|P2|STARTED|Overall Study|Randomized|196
147980|NCT00384085|359958|P1|STARTED|Overall Study|Randomized|195
147981|NCT00384176|359985|P3|NOT COMPLETED|Overall Study||132
147982|NCT00384176|359986|P2|NOT COMPLETED|Overall Study||319
147983|NCT00384176|359987|P1|NOT COMPLETED|Overall Study||312
147984|NCT00384176|359985|P3|COMPLETED|Overall Study||60
147985|NCT00384176|359986|P2|COMPLETED|Overall Study||394
147986|NCT00384176|359987|P1|COMPLETED|Overall Study||397
147987|NCT00384176|359985|P3|STARTED|Overall Study||192
147988|NCT00384176|359986|P2|STARTED|Overall Study||713
147989|NCT00384176|359987|P1|STARTED|Overall Study||709
147990|NCT00384189|360014|P4|NOT COMPLETED|Overall Study||40
147991|NCT00384189|360015|P3|NOT COMPLETED|Overall Study||58
147992|NCT00384189|360016|P2|NOT COMPLETED|Overall Study||57
147993|NCT00384189|360017|P1|NOT COMPLETED|Overall Study||50
147994|NCT00384189|360014|P4|COMPLETED|Overall Study||110
147995|NCT00384189|360015|P3|COMPLETED|Overall Study||255
147996|NCT00384189|360016|P2|COMPLETED|Overall Study||255
147997|NCT00384189|360017|P1|COMPLETED|Overall Study||255
147998|NCT00384189|360014|P4|Actual Treatment Received|Overall Study||146
147999|NCT00384189|360015|P3|Actual Treatment Received|Overall Study|1 participants in the 160 μg arm actually received 40 μg and is moved to that arm.|310
148000|NCT00384189|360016|P2|Actual Treatment Received|Overall Study||312
148001|NCT00384189|360017|P1|Actual Treatment Received|Overall Study|1 participant randomized to 160 μg who actually received 40 μg is included.|305
148002|NCT00384189|360014|P4|Randomized, Not Treated|Overall Study||4
148003|NCT00384189|360015|P3|Randomized, Not Treated|Overall Study||2
148004|NCT00384189|360016|P2|Randomized, Not Treated|Overall Study||0
148005|NCT00384189|360017|P1|Randomized, Not Treated|Overall Study||1
148006|NCT00384189|360014|P4|STARTED|Overall Study||150
148007|NCT00384189|360015|P3|STARTED|Overall Study||313
148008|NCT00384189|360016|P2|STARTED|Overall Study||312
148009|NCT00384189|360017|P1|STARTED|Overall Study||305
148010|NCT00384241|360077|P2|NOT COMPLETED|Overall Study||0
148011|NCT00384241|360078|P1|NOT COMPLETED|Overall Study||0
148012|NCT00384241|360077|P2|COMPLETED|Overall Study||599
148013|NCT00384241|360078|P1|COMPLETED|Overall Study||500
148014|NCT00384241|360077|P2|STARTED|Overall Study||599
148015|NCT00384241|360078|P1|STARTED|Overall Study||500
148016|NCT00384293|360086|P3|NOT COMPLETED|Post-randomization Period||219
148017|NCT00384293|360087|P2|NOT COMPLETED|Post-randomization Period||214
148018|NCT00384293|360088|P1|NOT COMPLETED|Post-randomization Period||0
148019|NCT00384293|360086|P3|COMPLETED|Post-randomization Period||0
148020|NCT00384293|360087|P2|COMPLETED|Post-randomization Period||0
148021|NCT00384293|360088|P1|COMPLETED|Post-randomization Period||0
148022|NCT00384293|360086|P3|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||218
148023|NCT00384293|360087|P2|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period|Received at least one dose of randomized study drug (All Patients as Treated Population)|214
148024|NCT00384293|360088|P1|Received ≥1 Dose of MK0524A Study Drug|Post-randomization Period||0
148025|NCT00384293|360086|P3|STARTED|Post-randomization Period||219
148026|NCT00384293|360087|P2|STARTED|Post-randomization Period||214
148027|NCT00384293|360088|P1|STARTED|Post-randomization Period||0
148028|NCT00384293|360086|P3|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
148029|NCT00384293|360087|P2|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||0
148030|NCT00384293|360088|P1|NOT COMPLETED|MK0524A Active Run-In, Pre-randomization||504
148031|NCT00384293|360086|P3|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
148032|NCT00384293|360087|P2|COMPLETED|MK0524A Active Run-In, Pre-randomization||0
148033|NCT00384293|360088|P1|COMPLETED|MK0524A Active Run-In, Pre-randomization||433
148034|NCT00384293|360086|P3|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
148035|NCT00384293|360087|P2|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization||0
148036|NCT00384293|360088|P1|MK0524A Dose Increased to 2 g|MK0524A Active Run-In, Pre-randomization|MK0524A dose increased to 2 g in active run-in period|813
148037|NCT00384293|360086|P3|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
148038|NCT00384293|360087|P2|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization||0
148039|NCT00384293|360088|P1|Entered Active run-in, MK0524A 1 g|MK0524A Active Run-In, Pre-randomization|Entered active run-in period and received MK0524A 1 g|937
148040|NCT00384293|360086|P3|STARTED|MK0524A Active Run-In, Pre-randomization||0
148041|NCT00384293|360087|P2|STARTED|MK0524A Active Run-In, Pre-randomization||0
148042|NCT00384293|360088|P1|STARTED|MK0524A Active Run-In, Pre-randomization||937
148043|NCT00384332|360101|P2|NOT COMPLETED|Overall Study||0
148044|NCT00384332|360102|P1|NOT COMPLETED|Overall Study||4
148045|NCT00384332|360101|P2|COMPLETED|Overall Study||10
148046|NCT00384332|360102|P1|COMPLETED|Overall Study||9
148047|NCT00384332|360101|P2|STARTED|Overall Study||10
148048|NCT00384332|360102|P1|STARTED|Overall Study||13
148049|NCT00384397|360113|P3|NOT COMPLETED|Overall Study||33
148050|NCT00384397|360114|P2|NOT COMPLETED|Overall Study||46
148051|NCT00384397|360115|P1|NOT COMPLETED|Overall Study||32
148052|NCT00384397|360113|P3|COMPLETED|Overall Study||385
148053|NCT00384397|360114|P2|COMPLETED|Overall Study||247
148054|NCT00384397|360115|P1|COMPLETED|Overall Study||375
148055|NCT00384397|360113|P3|STARTED|Overall Study||418
148056|NCT00384397|360114|P2|STARTED|Overall Study||293
148057|NCT00384397|360115|P1|STARTED|Overall Study||407
148058|NCT00384670|360132|P1|NOT COMPLETED|Overall Study||0
148059|NCT00384670|360132|P1|COMPLETED|Overall Study||7
148060|NCT00384670|360132|P1|STARTED|Overall Study||7
148061|NCT00378508|360144|P2|NOT COMPLETED|Overall Study||3
148062|NCT00378508|360145|P1|NOT COMPLETED|Overall Study||2
148063|NCT00378508|360144|P2|COMPLETED|Overall Study||31
148064|NCT00378508|360145|P1|COMPLETED|Overall Study||27
148065|NCT00378508|360144|P2|Received Intervention/Placebo|Overall Study||31
148066|NCT00378508|360145|P1|Received Intervention/Placebo|Overall Study||28
148067|NCT00378508|360144|P2|Randomized|Overall Study||34
148068|NCT00378508|360145|P1|Randomized|Overall Study||29
148069|NCT00378508|360144|P2|STARTED|Overall Study||34
148070|NCT00378508|360145|P1|STARTED|Overall Study||29
148071|NCT00378534|360161|P1|NOT COMPLETED|Overall Study||60
148072|NCT00378534|360161|P1|COMPLETED|Overall Study|Transplantation Recipients|55
148073|NCT00378534|360161|P1|STARTED|Overall Study||115
148074|NCT00378560|360167|P2|NOT COMPLETED|Overall Study||58
148075|NCT00378560|360168|P1|NOT COMPLETED|Overall Study||56
148076|NCT00378560|360167|P2|COMPLETED|Overall Study||454
148077|NCT00378560|360168|P1|COMPLETED|Overall Study||453
148078|NCT00378560|360167|P2|Vaccinated|Overall Study||512
148079|NCT00378560|360168|P1|Vaccinated|Overall Study||509
148080|NCT00378560|360167|P2|STARTED|Overall Study||512
148081|NCT00378560|360168|P1|STARTED|Overall Study||509
148082|NCT00378573|360182|P1|NOT COMPLETED|Follow-up||14
148083|NCT00378573|360182|P1|COMPLETED|Follow-up||3
148084|NCT00378573|360182|P1|STARTED|Follow-up||17
148085|NCT00378573|360182|P1|NOT COMPLETED|Treatment Period||17
148086|NCT00378573|360182|P1|COMPLETED|Treatment Period|Patients who did not complete treatment moved directly to the follow-up phase of the study.|0
148087|NCT00378573|360182|P1|STARTED|Treatment Period||17
148088|NCT00378599|360188|P1|NOT COMPLETED|Overall Study||52
148089|NCT00378599|360188|P1|COMPLETED|Overall Study||73
148090|NCT00378599|360188|P1|STARTED|Overall Study||125
148091|NCT00384748|360194|P2|NOT COMPLETED|Overall Study||0
148092|NCT00384748|360195|P1|NOT COMPLETED|Overall Study||0
148093|NCT00384748|360194|P2|COMPLETED|Overall Study||23
148094|NCT00384748|360195|P1|COMPLETED|Overall Study||25
148095|NCT00384748|360194|P2|STARTED|Overall Study||23
148096|NCT00384748|360195|P1|STARTED|Overall Study||25
148097|NCT00384813|360203|P2|NOT COMPLETED|Overall Study||0
148098|NCT00384813|360204|P1|NOT COMPLETED|Overall Study||2
148099|NCT00384813|360203|P2|COMPLETED|Overall Study||20
148100|NCT00384813|360204|P1|COMPLETED|Overall Study||21
148101|NCT00384813|360203|P2|STARTED|Overall Study||20
148102|NCT00384813|360204|P1|STARTED|Overall Study||23
148103|NCT00384865|360214|P4|NOT COMPLETED|Overall Study||0
148104|NCT00384865|360215|P3|NOT COMPLETED|Overall Study||0
148105|NCT00384865|360216|P2|NOT COMPLETED|Overall Study||0
148106|NCT00384865|360217|P1|NOT COMPLETED|Overall Study||0
148107|NCT00384865|360214|P4|COMPLETED|Overall Study||16
148108|NCT00384865|360215|P3|COMPLETED|Overall Study||16
148109|NCT00384865|360216|P2|COMPLETED|Overall Study||16
148110|NCT00384865|360217|P1|COMPLETED|Overall Study||16
148111|NCT00384865|360214|P4|Completed Six Month Assessment|Overall Study||11
148112|NCT00384865|360215|P3|Completed Six Month Assessment|Overall Study||15
148113|NCT00384865|360216|P2|Completed Six Month Assessment|Overall Study||12
148114|NCT00384865|360217|P1|Completed Six Month Assessment|Overall Study||11
148115|NCT00384865|360214|P4|STARTED|Overall Study||16
148116|NCT00384865|360215|P3|STARTED|Overall Study||16
148117|NCT00384865|360216|P2|STARTED|Overall Study||16
148118|NCT00384865|360217|P1|STARTED|Overall Study||16
148119|NCT00384930|360240|P5|NOT COMPLETED|Overall Study||47
148120|NCT00384930|360241|P4|NOT COMPLETED|Overall Study||41
148121|NCT00384930|360242|P3|NOT COMPLETED|Overall Study||30
148122|NCT00384930|360243|P2|NOT COMPLETED|Overall Study||27
148123|NCT00384930|360244|P1|NOT COMPLETED|Overall Study||27
148124|NCT00384930|360240|P5|COMPLETED|Overall Study||162
148125|NCT00384930|360241|P4|COMPLETED|Overall Study||175
148126|NCT00384930|360242|P3|COMPLETED|Overall Study||182
148127|NCT00384930|360243|P2|COMPLETED|Overall Study||182
148128|NCT00384930|360244|P1|COMPLETED|Overall Study||185
148129|NCT00384930|360240|P5|Received Double-Blind Study Drug|Overall Study||209
148130|NCT00384930|360241|P4|Received Double-Blind Study Drug|Overall Study||216
148131|NCT00384930|360242|P3|Received Double-Blind Study Drug|Overall Study||212
148132|NCT00384930|360243|P2|Received Double-Blind Study Drug|Overall Study||208
148133|NCT00384930|360244|P1|Received Double-Blind Study Drug|Overall Study||211
148134|NCT00384930|360240|P5|STARTED|Overall Study||209
148135|NCT00384930|360241|P4|STARTED|Overall Study||216
148136|NCT00384930|360242|P3|STARTED|Overall Study||212
148137|NCT00384930|360243|P2|STARTED|Overall Study||209
148138|NCT00384930|360244|P1|STARTED|Overall Study||212
148139|NCT00384956|360298|P1|NOT COMPLETED|Overall Study||3
148140|NCT00384956|360298|P1|COMPLETED|Overall Study||22
148141|NCT00384956|360298|P1|STARTED|Overall Study||25
148142|NCT00385515|360312|P2|NOT COMPLETED|Overall Study||3
148143|NCT00385515|360313|P1|NOT COMPLETED|Overall Study||4
148144|NCT00385515|360312|P2|COMPLETED|Overall Study||21
148145|NCT00385515|360313|P1|COMPLETED|Overall Study||53
148146|NCT00385515|360312|P2|STARTED|Overall Study||24
148147|NCT00385515|360313|P1|STARTED|Overall Study||57
148148|NCT00385541|360321|P2|NOT COMPLETED|Overall Study||1
148149|NCT00385541|360322|P1|NOT COMPLETED|Overall Study||0
148150|NCT00385541|360321|P2|COMPLETED|Overall Study||24
148151|NCT00385541|360322|P1|COMPLETED|Overall Study||25
148152|NCT00385541|360321|P2|STARTED|Overall Study||25
148153|NCT00385541|360322|P1|STARTED|Overall Study||25
148154|NCT00385580|360338|P2|NOT COMPLETED|Overall Study||0
148155|NCT00385580|360339|P1|NOT COMPLETED|Overall Study||0
148156|NCT00385580|360338|P2|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|47
148157|NCT00385580|360339|P1|COMPLETED|Overall Study|Completed=off study. Major reasons for being off study are disease progression, and study toxicity.|48
148158|NCT00385580|360338|P2|STARTED|Overall Study|Number of participants treated.|47
148159|NCT00385580|360339|P1|STARTED|Overall Study|Number of participants treated.|48
148160|NCT00385593|360430|P2|NOT COMPLETED|Overall Study||37
148161|NCT00385593|360431|P1|NOT COMPLETED|Overall Study||58
148162|NCT00385593|360430|P2|COMPLETED|Overall Study||289
148163|NCT00385593|360431|P1|COMPLETED|Overall Study||270
148164|NCT00385593|360430|P2|STARTED|Overall Study||326
148165|NCT00385593|360431|P1|STARTED|Overall Study||328
148166|NCT00385671|360450|P3|NOT COMPLETED|Overall Study||36
148167|NCT00385671|360451|P2|NOT COMPLETED|Overall Study||51
148168|NCT00385671|360452|P1|NOT COMPLETED|Overall Study||38
148169|NCT00385671|360450|P3|COMPLETED|Overall Study||99
148170|NCT00385671|360451|P2|COMPLETED|Overall Study||87
148171|NCT00385671|360452|P1|COMPLETED|Overall Study||96
148172|NCT00385671|360450|P3|STARTED|Overall Study||135
148173|NCT00385671|360451|P2|STARTED|Overall Study||138
148174|NCT00385671|360452|P1|STARTED|Overall Study||134
148175|NCT00385684|360606|P2|NOT COMPLETED|PHASE B||0
148176|NCT00385684|360607|P1|NOT COMPLETED|PHASE B||0
148177|NCT00385684|360606|P2|COMPLETED|PHASE B||3
148178|NCT00385684|360607|P1|COMPLETED|PHASE B||5
148179|NCT00385684|360606|P2|STARTED|PHASE B||3
148180|NCT00385684|360607|P1|STARTED|PHASE B||5
148181|NCT00385684|360606|P2|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||2
148182|NCT00385684|360607|P1|NOT COMPLETED|SECOND INTERVENTION OF PHASE A||0
148183|NCT00385684|360606|P2|COMPLETED|SECOND INTERVENTION OF PHASE A||3
148184|NCT00385684|360607|P1|COMPLETED|SECOND INTERVENTION OF PHASE A||5
148185|NCT00385684|360606|P2|STARTED|SECOND INTERVENTION OF PHASE A||5
148186|NCT00385684|360607|P1|STARTED|SECOND INTERVENTION OF PHASE A||5
148187|NCT00385684|360606|P2|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||0
148188|NCT00385684|360607|P1|NOT COMPLETED|FIRST INTERVENTION OF PHASE A||1
148189|NCT00385684|360606|P2|COMPLETED|FIRST INTERVENTION OF PHASE A||5
148190|NCT00385684|360607|P1|COMPLETED|FIRST INTERVENTION OF PHASE A||5
148191|NCT00385684|360606|P2|STARTED|FIRST INTERVENTION OF PHASE A||5
148192|NCT00385684|360607|P1|STARTED|FIRST INTERVENTION OF PHASE A||6
148193|NCT00385723|360616|P3|NOT COMPLETED|Overall Study||2
148194|NCT00385723|360617|P2|NOT COMPLETED|Overall Study||1
148195|NCT00385723|360618|P1|NOT COMPLETED|Overall Study||2
148196|NCT00385723|360616|P3|COMPLETED|Overall Study||44
148197|NCT00385723|360617|P2|COMPLETED|Overall Study||45
148198|NCT00385723|360618|P1|COMPLETED|Overall Study||44
148199|NCT00385723|360616|P3|STARTED|Overall Study||46
148200|NCT00385723|360617|P2|STARTED|Overall Study||46
148201|NCT00385723|360618|P1|STARTED|Overall Study||46
148202|NCT00385736|360635|P3|NOT COMPLETED|Safety Analysis Set||80
148203|NCT00385736|360636|P2|NOT COMPLETED|Safety Analysis Set||44
148204|NCT00385736|360637|P1|NOT COMPLETED|Safety Analysis Set||70
148205|NCT00385736|360635|P3|COMPLETED|Safety Analysis Set||143
148206|NCT00385736|360636|P2|COMPLETED|Safety Analysis Set||86
148207|NCT00385736|360637|P1|COMPLETED|Safety Analysis Set||153
148208|NCT00385736|360635|P3|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
148209|NCT00385736|360636|P2|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|130
148210|NCT00385736|360637|P1|STARTED|Safety Analysis Set|Includes all subjects enrolled since the start of the study.|223
148211|NCT00385736|360635|P3|NOT COMPLETED|Efficacy Analysis Set - Maintenance||80
148212|NCT00385736|360636|P2|NOT COMPLETED|Efficacy Analysis Set - Maintenance||44
148213|NCT00385736|360637|P1|NOT COMPLETED|Efficacy Analysis Set - Maintenance||69
148214|NCT00385736|360635|P3|COMPLETED|Efficacy Analysis Set - Maintenance||143
148215|NCT00385736|360636|P2|COMPLETED|Efficacy Analysis Set - Maintenance||86
148216|NCT00385736|360637|P1|COMPLETED|Efficacy Analysis Set - Maintenance||153
148217|NCT00385736|360635|P3|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|223
148218|NCT00385736|360636|P2|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|130
148219|NCT00385736|360637|P1|STARTED|Efficacy Analysis Set - Maintenance|Includes all subjects with confirmed UC enrolled since the start of the study|222
148220|NCT00385736|360635|P3|NOT COMPLETED|Efficacy Analysis Set - Induction||9
148221|NCT00385736|360636|P2|NOT COMPLETED|Efficacy Analysis Set - Induction||12
148222|NCT00385736|360637|P1|NOT COMPLETED|Efficacy Analysis Set - Induction||9
148223|NCT00385736|360635|P3|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
148224|NCT00385736|360636|P2|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|118
148225|NCT00385736|360637|P1|COMPLETED|Efficacy Analysis Set - Induction|Completed Week 8 of the study.|121
148226|NCT00385736|360635|P3|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
148227|NCT00385736|360636|P2|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
148228|NCT00385736|360637|P1|STARTED|Efficacy Analysis Set - Induction|Enrolled under Amendment 3 or 4 of the protocol.|130
148229|NCT00385762|360679|P1|NOT COMPLETED|Overall Study||2
148230|NCT00385762|360679|P1|COMPLETED|Overall Study||33
148231|NCT00385762|360679|P1|STARTED|Overall Study||35
148232|NCT00385801|360688|P2|NOT COMPLETED|Overall Study||8
148233|NCT00385801|360689|P1|NOT COMPLETED|Overall Study||9
148234|NCT00385801|360688|P2|COMPLETED|Overall Study||8
148235|NCT00385801|360689|P1|COMPLETED|Overall Study||6
148236|NCT00385801|360688|P2|STARTED|Overall Study||16
148237|NCT00385801|360689|P1|STARTED|Overall Study||15
148238|NCT00385827|360704|P3|NOT COMPLETED|Part 2||48
148239|NCT00385827|360705|P2|NOT COMPLETED|Part 2||33
148240|NCT00385827|360706|P1|NOT COMPLETED|Part 2||0
148241|NCT00385827|360704|P3|COMPLETED|Part 2||0
148242|NCT00385827|360705|P2|COMPLETED|Part 2||16
148243|NCT00385827|360706|P1|COMPLETED|Part 2||0
148244|NCT00385827|360704|P3|Treated|Part 2||46
148245|NCT00385827|360705|P2|Treated|Part 2||47
148246|NCT00385827|360706|P1|Treated|Part 2||0
148247|NCT00385827|360704|P3|STARTED|Part 2||48
148248|NCT00385827|360705|P2|STARTED|Part 2||49
148249|NCT00385827|360706|P1|STARTED|Part 2||0
148250|NCT00385827|360704|P3|NOT COMPLETED|Part 1||0
148251|NCT00385827|360705|P2|NOT COMPLETED|Part 1||0
148252|NCT00385827|360706|P1|NOT COMPLETED|Part 1||9
148253|NCT00385827|360704|P3|COMPLETED|Part 1||0
148254|NCT00385827|360705|P2|COMPLETED|Part 1||0
148255|NCT00385827|360706|P1|COMPLETED|Part 1||0
148256|NCT00385827|360704|P3|Treated|Part 1||0
148257|NCT00385827|360705|P2|Treated|Part 1||0
148258|NCT00385827|360706|P1|Treated|Part 1||9
148259|NCT00385827|360704|P3|STARTED|Part 1||0
148260|NCT00385827|360705|P2|STARTED|Part 1||0
148261|NCT00385827|360706|P1|STARTED|Part 1||9
148262|NCT00385840|360728|P2|NOT COMPLETED|Overall Study||14
148263|NCT00385840|360729|P1|NOT COMPLETED|Overall Study||4
148264|NCT00385840|360728|P2|COMPLETED|Overall Study||531
148265|NCT00385840|360729|P1|COMPLETED|Overall Study||129
148266|NCT00385840|360728|P2|STARTED|Overall Study||545
148267|NCT00385840|360729|P1|STARTED|Overall Study||133
148268|NCT00385918|360751|P3|NOT COMPLETED|Intervention Phase After Randomization||0
148269|NCT00385918|360752|P2|NOT COMPLETED|Intervention Phase After Randomization||0
148270|NCT00385918|360753|P1|NOT COMPLETED|Intervention Phase After Randomization||3
148271|NCT00385918|360751|P3|COMPLETED|Intervention Phase After Randomization||0
148272|NCT00385918|360752|P2|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month home-base intervention|6
148273|NCT00385918|360753|P1|COMPLETED|Intervention Phase After Randomization|Participants completed the 3-month training intervention|12
148274|NCT00385918|360751|P3|STARTED|Intervention Phase After Randomization||0
148275|NCT00385918|360752|P2|STARTED|Intervention Phase After Randomization|Participants successfully completed screening; this is the number in the home stretching arm.|6
148276|NCT00385918|360753|P1|STARTED|Intervention Phase After Randomization|Participant successfully completed screening; this is the number in the Lokomat training arm.|15
148277|NCT00385918|360751|P3|NOT COMPLETED|Feasibility & Baseline Measurement Phase||14
148278|NCT00385918|360752|P2|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
148279|NCT00385918|360753|P1|NOT COMPLETED|Feasibility & Baseline Measurement Phase||0
148280|NCT00385918|360751|P3|COMPLETED|Feasibility & Baseline Measurement Phase||21
148281|NCT00385918|360752|P2|COMPLETED|Feasibility & Baseline Measurement Phase||0
148282|NCT00385918|360753|P1|COMPLETED|Feasibility & Baseline Measurement Phase||0
148283|NCT00385918|360751|P3|Completed Baseline Tests|Feasibility & Baseline Measurement Phase|6 subjects did not complete all baseline tests.|21
148284|NCT00385918|360752|P2|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
148285|NCT00385918|360753|P1|Completed Baseline Tests|Feasibility & Baseline Measurement Phase||0
148286|NCT00385918|360751|P3|Number Eligible|Feasibility & Baseline Measurement Phase|8 subjects failed screening.|27
148287|NCT00385918|360752|P2|Number Eligible|Feasibility & Baseline Measurement Phase||0
148288|NCT00385918|360753|P1|Number Eligible|Feasibility & Baseline Measurement Phase||0
148289|NCT00385918|360751|P3|STARTED|Feasibility & Baseline Measurement Phase|Total # of subjects screened.The screening occurred before randomization.|35
148290|NCT00385918|360752|P2|STARTED|Feasibility & Baseline Measurement Phase||0
148291|NCT00385918|360753|P1|STARTED|Feasibility & Baseline Measurement Phase||0
148292|NCT00385944|360777|P3|NOT COMPLETED|2nd Maintenance Dose Period||0
148293|NCT00385944|360778|P2|NOT COMPLETED|2nd Maintenance Dose Period||3
148294|NCT00385944|360779|P1|NOT COMPLETED|2nd Maintenance Dose Period||2
148295|NCT00385944|360777|P3|COMPLETED|2nd Maintenance Dose Period||0
148296|NCT00385944|360778|P2|COMPLETED|2nd Maintenance Dose Period||19
148297|NCT00385944|360779|P1|COMPLETED|2nd Maintenance Dose Period||22
148298|NCT00385944|360777|P3|STARTED|2nd Maintenance Dose Period||0
148299|NCT00385944|360778|P2|STARTED|2nd Maintenance Dose Period|2 patients discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|22
148300|NCT00385944|360779|P1|STARTED|2nd Maintenance Dose Period|1 patient discontinued prior to the 2nd MD Period (Sponsor decision due to early study termination)|24
148301|NCT00385944|360777|P3|NOT COMPLETED|1st Maintenance Dose Period||0
148302|NCT00385944|360778|P2|NOT COMPLETED|1st Maintenance Dose Period||1
148303|NCT00385944|360779|P1|NOT COMPLETED|1st Maintenance Dose Period||4
148304|NCT00385944|360777|P3|COMPLETED|1st Maintenance Dose Period||0
148305|NCT00385944|360778|P2|COMPLETED|1st Maintenance Dose Period||24
148306|NCT00385944|360779|P1|COMPLETED|1st Maintenance Dose Period||25
148307|NCT00385944|360777|P3|STARTED|1st Maintenance Dose Period||0
148308|NCT00385944|360778|P2|STARTED|1st Maintenance Dose Period|Two patients withdrew from the study after randomization but prior to receiving the 1st MD.|25
148309|NCT00385944|360779|P1|STARTED|1st Maintenance Dose Period||29
148310|NCT00385944|360777|P3|NOT COMPLETED|Loading Dose||0
148311|NCT00385944|360778|P2|NOT COMPLETED|Loading Dose||0
148312|NCT00385944|360779|P1|NOT COMPLETED|Loading Dose||0
148313|NCT00385944|360777|P3|COMPLETED|Loading Dose||56
148314|NCT00385944|360778|P2|COMPLETED|Loading Dose||0
148315|NCT00385944|360779|P1|COMPLETED|Loading Dose||0
148316|NCT00385944|360777|P3|STARTED|Loading Dose||56
148317|NCT00385944|360778|P2|STARTED|Loading Dose||0
148318|NCT00385944|360779|P1|STARTED|Loading Dose||0
148319|NCT00385996|360820|P1|NOT COMPLETED|Overall Study||0
148320|NCT00385996|360820|P1|COMPLETED|Overall Study||22
148321|NCT00385996|360820|P1|STARTED|Overall Study||22
148322|NCT00386009|360827|P2|NOT COMPLETED|Overall Study||10
148323|NCT00386009|360828|P1|NOT COMPLETED|Overall Study||9
148324|NCT00386009|360827|P2|COMPLETED|Overall Study||89
148325|NCT00386009|360828|P1|COMPLETED|Overall Study||92
148326|NCT00386009|360827|P2|STARTED|Overall Study||99
148327|NCT00386009|360828|P1|STARTED|Overall Study||101
148328|NCT00386022|360868|P2|NOT COMPLETED|Plus Estrogen||1
148329|NCT00386022|360869|P1|NOT COMPLETED|Plus Estrogen||2
148330|NCT00386022|360868|P2|COMPLETED|Plus Estrogen||8
148331|NCT00386022|360869|P1|COMPLETED|Plus Estrogen||8
148332|NCT00386022|360868|P2|All Doses GnRH|Plus Estrogen||8
148333|NCT00386022|360869|P1|All Doses GnRH|Plus Estrogen||8
148334|NCT00386022|360868|P2|Estrogen Patch|Plus Estrogen||9
148335|NCT00386022|360869|P1|Estrogen Patch|Plus Estrogen||8
148336|NCT00386022|360868|P2|STARTED|Plus Estrogen||9
148337|NCT00386022|360869|P1|STARTED|Plus Estrogen||10
148338|NCT00386022|360868|P2|NOT COMPLETED|Baseline||0
148339|NCT00386022|360869|P1|NOT COMPLETED|Baseline||0
148340|NCT00386022|360868|P2|COMPLETED|Baseline||9
148341|NCT00386022|360869|P1|COMPLETED|Baseline||10
148342|NCT00386022|360868|P2|All Doses of GnRH|Baseline||9
148343|NCT00386022|360869|P1|All Doses of GnRH|Baseline||10
148344|NCT00386022|360868|P2|STARTED|Baseline||9
148345|NCT00386022|360869|P1|STARTED|Baseline||10
148346|NCT00386100|360879|P2|NOT COMPLETED|Overall Study||131
148347|NCT00386100|360880|P1|NOT COMPLETED|Overall Study||154
148348|NCT00386100|360879|P2|COMPLETED|Overall Study||217
148349|NCT00386100|360880|P1|COMPLETED|Overall Study||186
148350|NCT00386100|360879|P2|STARTED|Overall Study||348
148351|NCT00386100|360880|P1|STARTED|Overall Study||340
148352|NCT00386152|360945|P3|NOT COMPLETED|Overall Study||33
148353|NCT00386152|360946|P2|NOT COMPLETED|Overall Study||40
148354|NCT00386152|360947|P1|NOT COMPLETED|Overall Study||44
148355|NCT00386152|360945|P3|COMPLETED|Overall Study||42
148356|NCT00386152|360946|P2|COMPLETED|Overall Study||37
148357|NCT00386152|360947|P1|COMPLETED|Overall Study||31
148358|NCT00386152|360945|P3|STARTED|Overall Study|number of subjects treated|75
148359|NCT00386152|360946|P2|STARTED|Overall Study|number of subjects treated|77
148360|NCT00386152|360947|P1|STARTED|Overall Study|number of subjects treated|75
148361|NCT00386243|360966|P2|NOT COMPLETED|Overall Study||13
148362|NCT00386243|360967|P1|NOT COMPLETED|Overall Study||7
148363|NCT00386243|360966|P2|COMPLETED|Overall Study||108
148364|NCT00386243|360967|P1|COMPLETED|Overall Study||114
148365|NCT00386243|360966|P2|STARTED|Overall Study||121
148366|NCT00386243|360967|P1|STARTED|Overall Study||121
148367|NCT00386256|360979|P4|NOT COMPLETED|Overall Study||0
148368|NCT00386256|360980|P3|NOT COMPLETED|Overall Study||0
148369|NCT00386256|360981|P2|NOT COMPLETED|Overall Study||0
148370|NCT00386256|360982|P1|NOT COMPLETED|Overall Study||0
148371|NCT00386256|360979|P4|COMPLETED|Overall Study||3
148372|NCT00386256|360980|P3|COMPLETED|Overall Study||4
148373|NCT00386256|360981|P2|COMPLETED|Overall Study||15
148374|NCT00386256|360982|P1|COMPLETED|Overall Study||16
148375|NCT00386256|360979|P4|STARTED|Overall Study||3
148376|NCT00386256|360980|P3|STARTED|Overall Study||4
148377|NCT00386256|360981|P2|STARTED|Overall Study||15
148378|NCT00386256|360982|P1|STARTED|Overall Study||16
148379|NCT00386308|360998|P2|NOT COMPLETED|Overall Study||19
148380|NCT00386308|360999|P1|NOT COMPLETED|Overall Study||29
148381|NCT00386308|360998|P2|COMPLETED|Overall Study||54
148382|NCT00386308|360999|P1|COMPLETED|Overall Study||94
148383|NCT00386308|360998|P2|Modified Intent to Treat Population|Overall Study||72
148384|NCT00386308|360999|P1|Modified Intent to Treat Population|Overall Study||115
148385|NCT00386308|360998|P2|Intent to Treat Population|Overall Study||72
148386|NCT00386308|360999|P1|Intent to Treat Population|Overall Study||117
148387|NCT00386308|360998|P2|STARTED|Overall Study||73
148388|NCT00386308|360999|P1|STARTED|Overall Study||123
148389|NCT00386334|361013|P2|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||1
148390|NCT00386334|361014|P1|NOT COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||3
148391|NCT00386334|361013|P2|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||144
148392|NCT00386334|361014|P1|COMPLETED|Follow up:2 Week Placebo, 2 Week no Drug||143
148393|NCT00386334|361013|P2|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|145
148394|NCT00386334|361014|P1|STARTED|Follow up:2 Week Placebo, 2 Week no Drug|Two subjects withdrew consent prior to starting the follow up period.|146
148395|NCT00386334|361013|P2|NOT COMPLETED|Double Blind Period||47
148396|NCT00386334|361014|P1|NOT COMPLETED|Double Blind Period||46
148397|NCT00386334|361013|P2|COMPLETED|Double Blind Period||147
148398|NCT00386334|361014|P1|COMPLETED|Double Blind Period||148
148399|NCT00386334|361013|P2|STARTED|Double Blind Period||194
148400|NCT00386334|361014|P1|STARTED|Double Blind Period||194
148401|NCT00386360|361158|P2|NOT COMPLETED|Overall Study||17
148402|NCT00386360|361159|P1|NOT COMPLETED|Overall Study||9
148403|NCT00386360|361158|P2|COMPLETED|Overall Study||95
148404|NCT00386360|361159|P1|COMPLETED|Overall Study||40
148405|NCT00386360|361158|P2|Primary Efficacy|Overall Study||77
148406|NCT00386360|361159|P1|Primary Efficacy|Overall Study|Per-protocol patients with evaluable BVTV (trabecular bone volume/tissue volume) at baseline & M12.|36
148407|NCT00386360|361158|P2|Intent to Treat Population (ITT)|Overall Study||110
148408|NCT00386360|361159|P1|Intent to Treat Population (ITT)|Overall Study|Includes all patients randomized and took at least one dose of study drug.|49
148409|NCT00386360|361158|P2|STARTED|Overall Study||112
148410|NCT00386360|361159|P1|STARTED|Overall Study||49
148411|NCT00386425|361194|P3|NOT COMPLETED|Overall Study||0
148412|NCT00386425|361195|P2|NOT COMPLETED|Overall Study||1
148413|NCT00386425|361196|P1|NOT COMPLETED|Overall Study||3
148414|NCT00386425|361194|P3|COMPLETED|Overall Study||53
148415|NCT00386425|361195|P2|COMPLETED|Overall Study|33 severe protein C deficiency; 172 moderate protein C deficiency|205
148416|NCT00386425|361196|P1|COMPLETED|Overall Study|51 severe protein C deficiency; 173 moderate protein C deficiency|224
148417|NCT00386425|361194|P3|Received Study Drug|Overall Study||53
148418|NCT00386425|361195|P2|Received Study Drug|Overall Study||206
148419|NCT00386425|361196|P1|Received Study Drug|Overall Study||227
148420|NCT00386425|361194|P3|STARTED|Overall Study||53
148421|NCT00386425|361195|P2|STARTED|Overall Study|33 severe protein C deficiency; 173 moderate protein C deficiency|206
148422|NCT00386425|361196|P1|STARTED|Overall Study|51 severe protein C deficiency; 176 moderate protein C deficiency|227
148423|NCT00386477|361222|P2|NOT COMPLETED|Overall Study||0
148424|NCT00386477|361223|P1|NOT COMPLETED|Overall Study||0
148425|NCT00386477|361222|P2|COMPLETED|Overall Study||145
148426|NCT00386477|361223|P1|COMPLETED|Overall Study||155
148427|NCT00386477|361222|P2|STARTED|Overall Study||145
148428|NCT00386477|361223|P1|STARTED|Overall Study||155
148429|NCT00386607|361229|P2|NOT COMPLETED|Extension||17
148430|NCT00386607|361230|P1|NOT COMPLETED|Extension||0
148431|NCT00386607|361229|P2|COMPLETED|Extension||145
148432|NCT00386607|361230|P1|COMPLETED|Extension||0
148433|NCT00386607|361229|P2|STARTED|Extension||162
148434|NCT00386607|361230|P1|STARTED|Extension||0
148435|NCT00386607|361229|P2|NOT COMPLETED|Core||0
148436|NCT00386607|361230|P1|NOT COMPLETED|Core||115
148437|NCT00386607|361229|P2|COMPLETED|Core||0
148438|NCT00386607|361230|P1|COMPLETED|Core||486
148439|NCT00386607|361229|P2|STARTED|Core||0
148440|NCT00386607|361230|P1|STARTED|Core||601
148441|NCT00386776|361246|P1|NOT COMPLETED|Overall Study||8
148442|NCT00386776|361246|P1|COMPLETED|Overall Study||32
148443|NCT00386776|361246|P1|STARTED|Overall Study||40
148444|NCT00386880|361256|P2|NOT COMPLETED|Overall Study||0
148445|NCT00386880|361257|P1|NOT COMPLETED|Overall Study||0
148446|NCT00386880|361256|P2|COMPLETED|Overall Study||8
148447|NCT00386880|361257|P1|COMPLETED|Overall Study||30
148448|NCT00386880|361256|P2|STARTED|Overall Study||8
148449|NCT00386880|361257|P1|STARTED|Overall Study||30
148450|NCT00387010|361262|P1|NOT COMPLETED|Treatment Period||11
148451|NCT00387010|361262|P1|COMPLETED|Treatment Period||169
148452|NCT00387010|361262|P1|Full Analysis Set|Treatment Period|FAS: treated patients with at least 1 paired baseline and post baseline efficacy assessment|175
148453|NCT00387010|361262|P1|STARTED|Treatment Period||180
148454|NCT00387010|361262|P1|NOT COMPLETED|Dose Titration Period||38
148455|NCT00387010|361262|P1|COMPLETED|Dose Titration Period||180
148456|NCT00387010|361262|P1|STARTED|Dose Titration Period||218
148457|NCT00387023|361283|P1|NOT COMPLETED|Overall Study||0
148458|NCT00387023|361283|P1|COMPLETED|Overall Study||12
148459|NCT00387023|361283|P1|STARTED|Overall Study||12
148460|NCT00387036|361287|P2|NOT COMPLETED|2-Week Crossover Second Intervention||0
148461|NCT00387036|361288|P1|NOT COMPLETED|2-Week Crossover Second Intervention||0
148462|NCT00387036|361287|P2|COMPLETED|2-Week Crossover Second Intervention||6
148463|NCT00387036|361288|P1|COMPLETED|2-Week Crossover Second Intervention||6
148464|NCT00387036|361287|P2|STARTED|2-Week Crossover Second Intervention||6
148465|NCT00387036|361288|P1|STARTED|2-Week Crossover Second Intervention||6
148466|NCT00387036|361287|P2|NOT COMPLETED|2-Week Placebo Washout||0
148467|NCT00387036|361288|P1|NOT COMPLETED|2-Week Placebo Washout||0
148468|NCT00387036|361287|P2|COMPLETED|2-Week Placebo Washout||6
148469|NCT00387036|361288|P1|COMPLETED|2-Week Placebo Washout||6
148470|NCT00387036|361287|P2|STARTED|2-Week Placebo Washout||6
148471|NCT00387036|361288|P1|STARTED|2-Week Placebo Washout||6
148472|NCT00387036|361287|P2|NOT COMPLETED|2-Week First Intervention||0
148473|NCT00387036|361288|P1|NOT COMPLETED|2-Week First Intervention||0
148474|NCT00387036|361287|P2|COMPLETED|2-Week First Intervention||6
148475|NCT00387036|361288|P1|COMPLETED|2-Week First Intervention||6
148476|NCT00387036|361287|P2|STARTED|2-Week First Intervention||6
148477|NCT00387036|361288|P1|STARTED|2-Week First Intervention||6
148478|NCT00387088|361298|P2|NOT COMPLETED|Overall Study||373
148479|NCT00387088|361299|P1|NOT COMPLETED|Overall Study||318
148480|NCT00387088|361298|P2|COMPLETED|Overall Study||1629
148481|NCT00387088|361299|P1|COMPLETED|Overall Study||1671
148482|NCT00387088|361298|P2|STARTED|Overall Study||2002
148483|NCT00387088|361299|P1|STARTED|Overall Study||1989
148484|NCT00387127|361345|P2|NOT COMPLETED|Overall Study||34
148485|NCT00387127|361346|P1|NOT COMPLETED|Overall Study||33
148486|NCT00387127|361345|P2|COMPLETED|Overall Study||0
148487|NCT00387127|361346|P1|COMPLETED|Overall Study||0
148488|NCT00387127|361345|P2|STARTED|Overall Study||34
148489|NCT00387127|361346|P1|STARTED|Overall Study||33
148490|NCT00387153|361386|P1|NOT COMPLETED|Overall Study||8
148491|NCT00387153|361386|P1|COMPLETED|Overall Study||0
148492|NCT00387153|361386|P1|STARTED|Overall Study||8
148493|NCT00387335|361392|P2|NOT COMPLETED|Overall Study||0
148494|NCT00387335|361393|P1|NOT COMPLETED|Overall Study||0
148495|NCT00387335|361392|P2|COMPLETED|Overall Study||7
148496|NCT00387335|361393|P1|COMPLETED|Overall Study||15
148497|NCT00387335|361392|P2|STARTED|Overall Study||7
148498|NCT00387335|361393|P1|STARTED|Overall Study||15
148499|NCT00387348|361408|P3|NOT COMPLETED|Overall Study||4
148500|NCT00387348|361409|P2|NOT COMPLETED|Overall Study||3
148501|NCT00387348|361410|P1|NOT COMPLETED|Overall Study||3
148502|NCT00387348|361408|P3|COMPLETED|Overall Study||7
148503|NCT00387348|361409|P2|COMPLETED|Overall Study||2
148504|NCT00387348|361410|P1|COMPLETED|Overall Study||5
148505|NCT00387348|361408|P3|STARTED|Overall Study||11
148506|NCT00387348|361409|P2|STARTED|Overall Study||5
148507|NCT00387348|361410|P1|STARTED|Overall Study||8
148508|NCT00387426|361424|P1|NOT COMPLETED|Overall Study||14
148509|NCT00387426|361424|P1|COMPLETED|Overall Study||0
148510|NCT00387426|361424|P1|STARTED|Overall Study||14
148511|NCT00387621|361431|P2|NOT COMPLETED|Second Intervention||0
148512|NCT00387621|361432|P1|NOT COMPLETED|Second Intervention||0
148513|NCT00387621|361431|P2|COMPLETED|Second Intervention||29
148514|NCT00387621|361432|P1|COMPLETED|Second Intervention||29
148515|NCT00387621|361431|P2|STARTED|Second Intervention||29
148516|NCT00387621|361432|P1|STARTED|Second Intervention||29
148517|NCT00387621|361431|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
148518|NCT00387621|361432|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
148519|NCT00387621|361431|P2|COMPLETED|Washout Period of 2 Weeks||29
148520|NCT00387621|361432|P1|COMPLETED|Washout Period of 2 Weeks||29
148521|NCT00387621|361431|P2|STARTED|Washout Period of 2 Weeks||29
148522|NCT00387621|361432|P1|STARTED|Washout Period of 2 Weeks||29
148523|NCT00387621|361431|P2|NOT COMPLETED|First Intervention||0
148524|NCT00387621|361432|P1|NOT COMPLETED|First Intervention||0
148525|NCT00387621|361431|P2|COMPLETED|First Intervention||29
148526|NCT00387621|361432|P1|COMPLETED|First Intervention||29
148527|NCT00387621|361431|P2|STARTED|First Intervention||29
148528|NCT00387621|361432|P1|STARTED|First Intervention||29
148529|NCT00387647|361462|P1|NOT COMPLETED|Overall Study||18
148530|NCT00387647|361462|P1|COMPLETED|Overall Study||6
148531|NCT00387647|361462|P1|STARTED|Overall Study||24
148532|NCT00387660|361470|P2|NOT COMPLETED|Overall Study||0
148533|NCT00387660|361471|P1|NOT COMPLETED|Overall Study||0
148534|NCT00387660|361470|P2|COMPLETED|Overall Study||40
148535|NCT00387660|361471|P1|COMPLETED|Overall Study||40
148536|NCT00387660|361470|P2|STARTED|Overall Study||40
148537|NCT00387660|361471|P1|STARTED|Overall Study||40
148538|NCT00387673|361481|P3|NOT COMPLETED|Overall Study||0
148539|NCT00387673|361482|P2|NOT COMPLETED|Overall Study||0
148540|NCT00387673|361483|P1|NOT COMPLETED|Overall Study||0
148541|NCT00387673|361481|P3|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
148542|NCT00387673|361482|P2|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
148543|NCT00387673|361483|P1|COMPLETED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
148544|NCT00387673|361481|P3|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
148545|NCT00387673|361482|P2|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
148546|NCT00387673|361483|P1|STARTED|Overall Study|Project has officially closed. PI for this project has left VA without forwarding information|0
148547|NCT00387725|361493|P4|NOT COMPLETED|Overall Study||2
148548|NCT00387725|361494|P3|NOT COMPLETED|Overall Study||2
148549|NCT00387725|361495|P2|NOT COMPLETED|Overall Study||1
148550|NCT00387725|361496|P1|NOT COMPLETED|Overall Study||1
148551|NCT00387725|361493|P4|COMPLETED|Overall Study||43
148552|NCT00387725|361494|P3|COMPLETED|Overall Study||43
148553|NCT00387725|361495|P2|COMPLETED|Overall Study||15
148554|NCT00387725|361496|P1|COMPLETED|Overall Study||20
148555|NCT00387725|361493|P4|STARTED|Overall Study||45
148556|NCT00387725|361494|P3|STARTED|Overall Study||45
148557|NCT00387725|361495|P2|STARTED|Overall Study||16
148558|NCT00387725|361496|P1|STARTED|Overall Study||21
148559|NCT00387751|361514|P1|NOT COMPLETED|Overall Study||0
148560|NCT00387751|361514|P1|COMPLETED|Overall Study||14
148561|NCT00387751|361514|P1|STARTED|Overall Study||14
148562|NCT00387764|361518|P1|NOT COMPLETED|Overall Study||31
148563|NCT00387764|361518|P1|COMPLETED|Overall Study|Participants completed treatment (until disease progression), but may not have completed the study.|49
148564|NCT00387764|361518|P1|STARTED|Overall Study||80
148565|NCT00387790|361536|P1|NOT COMPLETED|Overall Study||14
148566|NCT00387790|361536|P1|COMPLETED|Overall Study||50
148567|NCT00387790|361536|P1|STARTED|Overall Study||64
148568|NCT00387829|361542|P2|NOT COMPLETED|Intent-to-treat Population||30
148569|NCT00387829|361543|P1|NOT COMPLETED|Intent-to-treat Population||38
148570|NCT00387829|361542|P2|COMPLETED|Intent-to-treat Population||136
148571|NCT00387829|361543|P1|COMPLETED|Intent-to-treat Population||139
148572|NCT00387829|361542|P2|STARTED|Intent-to-treat Population||166
148573|NCT00387829|361543|P1|STARTED|Intent-to-treat Population||177
148574|NCT00387829|361542|P2|NOT COMPLETED|Safety Population||33
148575|NCT00387829|361543|P1|NOT COMPLETED|Safety Population||39
148576|NCT00387829|361542|P2|COMPLETED|Safety Population||136
148577|NCT00387829|361543|P1|COMPLETED|Safety Population||139
148578|NCT00387829|361542|P2|STARTED|Safety Population||169
148579|NCT00387829|361543|P1|STARTED|Safety Population||178
148580|NCT00387881|361553|P2|NOT COMPLETED|Overall Study||102
148581|NCT00387881|361554|P1|NOT COMPLETED|Overall Study||89
148582|NCT00387881|361553|P2|COMPLETED|Overall Study||243
148583|NCT00387881|361554|P1|COMPLETED|Overall Study||245
148584|NCT00387881|361553|P2|STARTED|Overall Study||345
148585|NCT00387881|361554|P1|STARTED|Overall Study||334
148586|NCT00387894|361576|P1|NOT COMPLETED|Overall Study||1
148587|NCT00387894|361576|P1|COMPLETED|Overall Study||5
148588|NCT00387894|361576|P1|STARTED|Overall Study||6
148589|NCT00387959|361581|P1|NOT COMPLETED|Overall Study||1
148590|NCT00387959|361581|P1|COMPLETED|Overall Study||16
148591|NCT00387959|361581|P1|STARTED|Overall Study||17
148592|NCT00388037|361585|P1|NOT COMPLETED|Overall Study||1
148593|NCT00388037|361585|P1|COMPLETED|Overall Study||30
148594|NCT00388037|361585|P1|STARTED|Overall Study||31
148595|NCT00381485|361592|P4|NOT COMPLETED|Double-Blind Treatment Period||33
148596|NCT00381485|361593|P3|NOT COMPLETED|Double-Blind Treatment Period||25
148597|NCT00381485|361594|P2|NOT COMPLETED|Double-Blind Treatment Period||27
148598|NCT00381485|361595|P1|NOT COMPLETED|Double-Blind Treatment Period||0
148599|NCT00381485|361592|P4|COMPLETED|Double-Blind Treatment Period||207
148600|NCT00381485|361593|P3|COMPLETED|Double-Blind Treatment Period||208
148601|NCT00381485|361594|P2|COMPLETED|Double-Blind Treatment Period||228
148602|NCT00381485|361595|P1|COMPLETED|Double-Blind Treatment Period||0
148603|NCT00381485|361592|P4|STARTED|Double-Blind Treatment Period||240
148604|NCT00381485|361593|P3|STARTED|Double-Blind Treatment Period||233
148605|NCT00381485|361594|P2|STARTED|Double-Blind Treatment Period||255
148606|NCT00381485|361595|P1|STARTED|Double-Blind Treatment Period||0
148607|NCT00381485|361592|P4|NOT COMPLETED|Open-Label Run-In Period||0
148608|NCT00381485|361593|P3|NOT COMPLETED|Open-Label Run-In Period||0
148609|NCT00381485|361594|P2|NOT COMPLETED|Open-Label Run-In Period||0
148610|NCT00381485|361595|P1|NOT COMPLETED|Open-Label Run-In Period||106
148611|NCT00381485|361592|P4|COMPLETED|Open-Label Run-In Period||0
148612|NCT00381485|361593|P3|COMPLETED|Open-Label Run-In Period||0
148613|NCT00381485|361594|P2|COMPLETED|Open-Label Run-In Period||0
148614|NCT00381485|361595|P1|COMPLETED|Open-Label Run-In Period||728
148615|NCT00381485|361592|P4|STARTED|Open-Label Run-In Period||0
148616|NCT00381485|361593|P3|STARTED|Open-Label Run-In Period||0
148617|NCT00381485|361594|P2|STARTED|Open-Label Run-In Period||0
148618|NCT00381485|361595|P1|STARTED|Open-Label Run-In Period||834
148619|NCT00381550|361613|P1|NOT COMPLETED|Overall Study||0
148620|NCT00381550|361613|P1|COMPLETED|Overall Study||35
148621|NCT00381550|361613|P1|STARTED|Overall Study||35
148622|NCT00381563|361620|P2|NOT COMPLETED|Overall Study||6
148623|NCT00381563|361621|P1|NOT COMPLETED|Overall Study||7
148624|NCT00381563|361620|P2|COMPLETED|Overall Study||33
148625|NCT00381563|361621|P1|COMPLETED|Overall Study||34
148626|NCT00381563|361620|P2|STARTED|Overall Study||39
148627|NCT00381563|361621|P1|STARTED|Overall Study||41
148628|NCT00381615|361632|P4|NOT COMPLETED|Overall Study||2
148629|NCT00381615|361633|P3|NOT COMPLETED|Overall Study||1
148630|NCT00381615|361634|P2|NOT COMPLETED|Overall Study||5
148631|NCT00381615|361635|P1|NOT COMPLETED|Overall Study||4
148632|NCT00381615|361632|P4|COMPLETED|Overall Study||22
148633|NCT00381615|361633|P3|COMPLETED|Overall Study||24
148634|NCT00381615|361634|P2|COMPLETED|Overall Study||45
148635|NCT00381615|361635|P1|COMPLETED|Overall Study||44
148636|NCT00381615|361632|P4|STARTED|Overall Study||24
148637|NCT00381615|361633|P3|STARTED|Overall Study||25
148638|NCT00381615|361634|P2|STARTED|Overall Study||50
148639|NCT00381615|361635|P1|STARTED|Overall Study||48
148640|NCT00381628|361689|P4|NOT COMPLETED|Overall Study||0
148641|NCT00381628|361690|P3|NOT COMPLETED|Overall Study||0
148642|NCT00381628|361691|P2|NOT COMPLETED|Overall Study||0
148643|NCT00381628|361692|P1|NOT COMPLETED|Overall Study||0
148644|NCT00381628|361689|P4|COMPLETED|Overall Study||14
148645|NCT00381628|361690|P3|COMPLETED|Overall Study||0
148646|NCT00381628|361691|P2|COMPLETED|Overall Study||27
148647|NCT00381628|361692|P1|COMPLETED|Overall Study||18
148648|NCT00381628|361689|P4|STARTED|Overall Study||14
148649|NCT00381628|361690|P3|STARTED|Overall Study||0
148650|NCT00381628|361691|P2|STARTED|Overall Study||27
148651|NCT00381628|361692|P1|STARTED|Overall Study||18
148652|NCT00381680|361704|P2|NOT COMPLETED|Overall Study||50
148653|NCT00381680|361705|P1|NOT COMPLETED|Overall Study||125
148654|NCT00381680|361704|P2|COMPLETED|Overall Study||19
148655|NCT00381680|361705|P1|COMPLETED|Overall Study||81
148656|NCT00381680|361704|P2|STARTED|Overall Study||69
148657|NCT00381680|361705|P1|STARTED|Overall Study||206
148658|NCT00381693|361720|P1|NOT COMPLETED|Overall Study||8
148659|NCT00381693|361720|P1|COMPLETED|Overall Study||2
148660|NCT00381693|361720|P1|STARTED|Overall Study||10
148661|NCT00381706|361733|P3|NOT COMPLETED|Overall Study||1
148662|NCT00381706|361734|P2|NOT COMPLETED|Overall Study||2
148663|NCT00381706|361735|P1|NOT COMPLETED|Overall Study||7
148664|NCT00381706|361733|P3|COMPLETED|Overall Study||79
148665|NCT00381706|361734|P2|COMPLETED|Overall Study||81
148666|NCT00381706|361735|P1|COMPLETED|Overall Study||75
148667|NCT00381706|361733|P3|STARTED|Overall Study||80
148668|NCT00381706|361734|P2|STARTED|Overall Study||83
148669|NCT00381706|361735|P1|STARTED|Overall Study||82
148670|NCT00381797|361763|P5|NOT COMPLETED|Overall Study||2
148671|NCT00381797|361764|P4|NOT COMPLETED|Overall Study||1
148672|NCT00381797|361765|P3|NOT COMPLETED|Overall Study||0
148673|NCT00381797|361766|P2|NOT COMPLETED|Overall Study||1
148674|NCT00381797|361767|P1|NOT COMPLETED|Overall Study||1
148675|NCT00381797|361763|P5|COMPLETED|Overall Study||35
148676|NCT00381797|361764|P4|COMPLETED|Overall Study||14
148677|NCT00381797|361765|P3|COMPLETED|Overall Study||10
148678|NCT00381797|361766|P2|COMPLETED|Overall Study||16
148679|NCT00381797|361767|P1|COMPLETED|Overall Study||17
148680|NCT00381797|361763|P5|STARTED|Overall Study||37
148681|NCT00381797|361764|P4|STARTED|Overall Study||15
148682|NCT00381797|361765|P3|STARTED|Overall Study||10
148683|NCT00381797|361766|P2|STARTED|Overall Study||17
148684|NCT00381797|361767|P1|STARTED|Overall Study||18
148685|NCT00381810|361817|P1|NOT COMPLETED|B Cell Follow-up||7
148686|NCT00381810|361817|P1|COMPLETED|B Cell Follow-up||0
148776|NCT00388349|361953|P2|STARTED|Phase I Dose Escalation||4
148687|NCT00381810|361817|P1|STARTED|B Cell Follow-up|Participants only entered the B cell follow-up period if their peripheral B cells were depleted.|7
148688|NCT00381810|361817|P1|NOT COMPLETED|Treatment and Safety Follow-up||15
148689|NCT00381810|361817|P1|COMPLETED|Treatment and Safety Follow-up||16
148690|NCT00381810|361817|P1|STARTED|Treatment and Safety Follow-up||31
148691|NCT00381849|361823|P2|NOT COMPLETED|Open-label||0
148692|NCT00381849|361824|P1|NOT COMPLETED|Open-label||0
148693|NCT00381849|361823|P2|COMPLETED|Open-label||9
148694|NCT00381849|361824|P1|COMPLETED|Open-label||10
148695|NCT00381849|361823|P2|STARTED|Open-label||9
148696|NCT00381849|361824|P1|STARTED|Open-label||10
148697|NCT00381849|361823|P2|NOT COMPLETED|Second Intervention||0
148698|NCT00381849|361824|P1|NOT COMPLETED|Second Intervention||0
148699|NCT00381849|361823|P2|COMPLETED|Second Intervention||9
148700|NCT00381849|361824|P1|COMPLETED|Second Intervention||10
148701|NCT00381849|361823|P2|STARTED|Second Intervention||9
148702|NCT00381849|361824|P1|STARTED|Second Intervention||10
148703|NCT00381849|361823|P2|NOT COMPLETED|Wash Out||1
148704|NCT00381849|361824|P1|NOT COMPLETED|Wash Out||0
148705|NCT00381849|361823|P2|COMPLETED|Wash Out||9
148706|NCT00381849|361824|P1|COMPLETED|Wash Out||10
148707|NCT00381849|361823|P2|STARTED|Wash Out||10
148708|NCT00381849|361824|P1|STARTED|Wash Out||10
148709|NCT00381849|361823|P2|NOT COMPLETED|First Intervention||0
148710|NCT00381849|361824|P1|NOT COMPLETED|First Intervention||0
148711|NCT00381849|361823|P2|COMPLETED|First Intervention||10
148712|NCT00381849|361824|P1|COMPLETED|First Intervention||10
148713|NCT00381849|361823|P2|STARTED|First Intervention||10
148714|NCT00381849|361824|P1|STARTED|First Intervention||10
148715|NCT00381862|361842|P1|NOT COMPLETED|Overall Study||10
148716|NCT00381862|361842|P1|COMPLETED|Overall Study||44
148717|NCT00381862|361842|P1|STARTED|Overall Study||54
148718|NCT00381888|361846|P1|NOT COMPLETED|Overall Study||17
148719|NCT00381888|361846|P1|COMPLETED|Overall Study||27
148720|NCT00381888|361846|P1|STARTED|Overall Study||44
148721|NCT00381940|361851|P1|NOT COMPLETED|Overall Study||5
148722|NCT00381940|361851|P1|COMPLETED|Overall Study||21
148723|NCT00381940|361851|P1|STARTED|Overall Study||26
148724|NCT00382018|361859|P4|NOT COMPLETED|Overall Study||59
148725|NCT00382018|361860|P3|NOT COMPLETED|Overall Study||64
148726|NCT00382018|361861|P2|NOT COMPLETED|Overall Study||165
148727|NCT00382018|361862|P1|NOT COMPLETED|Overall Study||0
148728|NCT00382018|361859|P4|COMPLETED|Overall Study||0
148729|NCT00382018|361860|P3|COMPLETED|Overall Study||0
148730|NCT00382018|361861|P2|COMPLETED|Overall Study||0
148731|NCT00382018|361862|P1|COMPLETED|Overall Study|This group of patients did not receive protocol treatment.|276
148732|NCT00382018|361859|P4|STARTED|Overall Study||59
148733|NCT00382018|361860|P3|STARTED|Overall Study||64
148734|NCT00382018|361861|P2|STARTED|Overall Study||165
148735|NCT00382018|361862|P1|STARTED|Overall Study||276
148736|NCT00382031|361882|P2|NOT COMPLETED|Overall Study||0
148737|NCT00382031|361883|P1|NOT COMPLETED|Overall Study||0
148738|NCT00382031|361882|P2|COMPLETED|Overall Study||95
148739|NCT00382031|361883|P1|COMPLETED|Overall Study||191
148740|NCT00382031|361882|P2|STARTED|Overall Study|Of the 95 randomized patients 94 attended Visit2.|95
148741|NCT00382031|361883|P1|STARTED|Overall Study|Of the 191 randomized patients 189 received at least one infusion of zalutumumab|191
148742|NCT00382109|361897|P2|NOT COMPLETED|Overall Study||4
148743|NCT00382109|361898|P1|NOT COMPLETED|Overall Study||12
148744|NCT00382109|361897|P2|COMPLETED|Overall Study||66
148745|NCT00382109|361898|P1|COMPLETED|Overall Study||64
148746|NCT00382109|361897|P2|STARTED|Overall Study||70
148747|NCT00382109|361898|P1|STARTED|Overall Study||76
148748|NCT00382148|361920|P2|NOT COMPLETED|Overall Study||0
148749|NCT00382148|361921|P1|NOT COMPLETED|Overall Study||1
148750|NCT00382148|361920|P2|COMPLETED|Overall Study||7
148751|NCT00382148|361921|P1|COMPLETED|Overall Study||3
148752|NCT00382148|361920|P2|STARTED|Overall Study||7
148753|NCT00382148|361921|P1|STARTED|Overall Study||4
148754|NCT00382174|361935|P3|NOT COMPLETED|Overall Study||21
148755|NCT00382174|361936|P2|NOT COMPLETED|Overall Study||17
148756|NCT00382174|361937|P1|NOT COMPLETED|Overall Study||4
148757|NCT00382174|361935|P3|COMPLETED|Overall Study||51
148758|NCT00382174|361936|P2|COMPLETED|Overall Study||37
148759|NCT00382174|361937|P1|COMPLETED|Overall Study||14
148760|NCT00382174|361935|P3|STARTED|Overall Study||72
148761|NCT00382174|361936|P2|STARTED|Overall Study||54
148762|NCT00382174|361937|P1|STARTED|Overall Study||18
148763|NCT00388154|361948|P1|NOT COMPLETED|Overall Study||1
148764|NCT00388154|361948|P1|COMPLETED|Overall Study||20
148765|NCT00388154|361948|P1|STARTED|Overall Study||21
148766|NCT00388349|361953|P2|NOT COMPLETED|Phase 2 Dose Expansion||0
148767|NCT00388349|361954|P1|NOT COMPLETED|Phase 2 Dose Expansion||0
148768|NCT00388349|361953|P2|COMPLETED|Phase 2 Dose Expansion||0
148769|NCT00388349|361954|P1|COMPLETED|Phase 2 Dose Expansion||139
148770|NCT00388349|361953|P2|STARTED|Phase 2 Dose Expansion|No participants were treated in Phase 2 at 1500 mg/m2 gemcitabine (MTD exceeded)|0
148771|NCT00388349|361954|P1|STARTED|Phase 2 Dose Expansion|Includes the three phase 1 participants who received 1250 mg/m2 gemcitabine (MTD)|139
148772|NCT00388349|361953|P2|NOT COMPLETED|Phase I Dose Escalation||3
148773|NCT00388349|361954|P1|NOT COMPLETED|Phase I Dose Escalation||0
148774|NCT00388349|361953|P2|COMPLETED|Phase I Dose Escalation||1
148775|NCT00388349|361954|P1|COMPLETED|Phase I Dose Escalation||3
148777|NCT00388349|361954|P1|STARTED|Phase I Dose Escalation||3
148778|NCT00388362|361963|P1|NOT COMPLETED|Remained on Study Median of 514 Days||2
148779|NCT00388362|361963|P1|COMPLETED|Remained on Study Median of 514 Days||21
148780|NCT00388362|361963|P1|STARTED|Remained on Study Median of 514 Days||23
148781|NCT00388362|361963|P1|NOT COMPLETED|Enrolled||13
148782|NCT00388362|361963|P1|COMPLETED|Enrolled||23
148783|NCT00388362|361963|P1|STARTED|Enrolled||36
148784|NCT00388505|361970|P2|NOT COMPLETED|Overall Study||38
148785|NCT00388505|361971|P1|NOT COMPLETED|Overall Study||83
148786|NCT00388505|361970|P2|COMPLETED|Overall Study||171
148787|NCT00388505|361971|P1|COMPLETED|Overall Study||225
148788|NCT00388505|361970|P2|STARTED|Overall Study|Randomized patients who received any amount of study medication|209
148789|NCT00388505|361971|P1|STARTED|Overall Study|Randomized patients who received any amount of study medication|308
148790|NCT00388583|361995|P2|NOT COMPLETED|Overall Study||4
148791|NCT00388583|361996|P1|NOT COMPLETED|Overall Study||6
148792|NCT00388583|361995|P2|COMPLETED|Overall Study||406
148793|NCT00388583|361996|P1|COMPLETED|Overall Study||401
148794|NCT00388583|361995|P2|STARTED|Overall Study||410
148795|NCT00388583|361996|P1|STARTED|Overall Study||407
148796|NCT00388726|362010|P2|NOT COMPLETED|Overall Study||244
148797|NCT00388726|362011|P1|NOT COMPLETED|Overall Study||484
148798|NCT00388726|362010|P2|COMPLETED|Overall Study||10
148799|NCT00388726|362011|P1|COMPLETED|Overall Study||24
148800|NCT00388726|362010|P2|STARTED|Overall Study||254
148801|NCT00388726|362011|P1|STARTED|Overall Study||508
148802|NCT00388804|362025|P2|NOT COMPLETED|Overall Study||0
148803|NCT00388804|362026|P1|NOT COMPLETED|Overall Study||0
148804|NCT00388804|362025|P2|COMPLETED|Overall Study||21
148805|NCT00388804|362026|P1|COMPLETED|Overall Study||17
148806|NCT00388804|362025|P2|STARTED|Overall Study||21
148807|NCT00388804|362026|P1|STARTED|Overall Study||17
148808|NCT00388947|362032|P1|NOT COMPLETED|Overall Study||47
148809|NCT00388947|362032|P1|COMPLETED|Overall Study|47 patients excluded because no AMS prolapse device was noted.|1543
148810|NCT00388947|362032|P1|STARTED|Overall Study||1590
148811|NCT00388973|362039|P2|NOT COMPLETED|Overall Study||58
148812|NCT00388973|362040|P1|NOT COMPLETED|Overall Study||56
148813|NCT00388973|362039|P2|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|114
148814|NCT00388973|362040|P1|COMPLETED|Overall Study|Completed 9-week treatment and 2 week follow-up|110
148815|NCT00388973|362039|P2|Completed Study|Overall Study||114
148816|NCT00388973|362040|P1|Completed Study|Overall Study||110
148817|NCT00388973|362039|P2|STARTED|Overall Study|Randomized|172
148818|NCT00388973|362040|P1|STARTED|Overall Study|Randomized|166
148819|NCT00389064|362062|P2|NOT COMPLETED|Overall Study||59
148820|NCT00389064|362063|P1|NOT COMPLETED|Overall Study||45
148821|NCT00389064|362062|P2|COMPLETED|Overall Study||168
148822|NCT00389064|362063|P1|COMPLETED|Overall Study||178
148823|NCT00389064|362062|P2|STARTED|Overall Study||227
148824|NCT00389064|362063|P1|STARTED|Overall Study||223
148825|NCT00389168|362091|P2|NOT COMPLETED|Overall Study||5
148826|NCT00389168|362092|P1|NOT COMPLETED|Overall Study||9
148827|NCT00389168|362091|P2|COMPLETED|Overall Study||53
148828|NCT00389168|362092|P1|COMPLETED|Overall Study||47
148829|NCT00389168|362091|P2|STARTED|Overall Study||58
148830|NCT00389168|362092|P1|STARTED|Overall Study||56
148831|NCT00389207|362111|P3|NOT COMPLETED|Overall Study||41
148832|NCT00389207|362112|P2|NOT COMPLETED|Overall Study||72
148833|NCT00389207|362113|P1|NOT COMPLETED|Overall Study||63
148834|NCT00389207|362111|P3|COMPLETED|Overall Study||152
148835|NCT00389207|362112|P2|COMPLETED|Overall Study||116
148836|NCT00389207|362113|P1|COMPLETED|Overall Study||125
148837|NCT00389207|362111|P3|STARTED|Overall Study||193
148838|NCT00389207|362112|P2|STARTED|Overall Study|4 patients were randomized to NVP BID but not treated and so are not part of the FAS|188
148839|NCT00389207|362113|P1|STARTED|Overall Study|3 patients were randomized to NVP QD but not treated and so not part of the Full Analysis Set (FAS)|188
148840|NCT00389324|362215|P1|NOT COMPLETED|Subcutaneous Phase||7
148841|NCT00389324|362215|P1|COMPLETED|Subcutaneous Phase||25
148842|NCT00389324|362215|P1|STARTED|Subcutaneous Phase||32
148843|NCT00389324|362215|P1|NOT COMPLETED|Intravenous Phase||0
148844|NCT00389324|362215|P1|COMPLETED|Intravenous Phase||32
148845|NCT00389324|362215|P1|STARTED|Intravenous Phase|18 subjects entered from the Run-in Phase and 14 new participants entered directly|32
148846|NCT00389324|362215|P1|NOT COMPLETED|Run-In Phase||3
148847|NCT00389324|362215|P1|COMPLETED|Run-In Phase||18
148848|NCT00389324|362215|P1|STARTED|Run-In Phase||21
148849|NCT00389441|362222|P1|NOT COMPLETED|Overall Study||52
148850|NCT00389441|362222|P1|COMPLETED|Overall Study||0
148851|NCT00389441|362222|P1|STARTED|Overall Study||52
148852|NCT00389467|362235|P4|NOT COMPLETED|Overall Study||0
148853|NCT00389467|362236|P3|NOT COMPLETED|Overall Study||0
148854|NCT00389467|362237|P2|NOT COMPLETED|Overall Study||0
148855|NCT00389467|362238|P1|NOT COMPLETED|Overall Study||0
148856|NCT00389467|362235|P4|COMPLETED|Overall Study||20
148857|NCT00389467|362236|P3|COMPLETED|Overall Study||30
148858|NCT00389467|362237|P2|COMPLETED|Overall Study||34
148859|NCT00389467|362238|P1|COMPLETED|Overall Study||34
148860|NCT00389467|362235|P4|STARTED|Overall Study||20
148861|NCT00389467|362236|P3|STARTED|Overall Study||30
148862|NCT00389467|362237|P2|STARTED|Overall Study||34
148863|NCT00389467|362238|P1|STARTED|Overall Study||34
148864|NCT00389493|362260|P3|NOT COMPLETED|Overall Study||3
148865|NCT00389493|362261|P2|NOT COMPLETED|Overall Study||8
148866|NCT00389493|362262|P1|NOT COMPLETED|Overall Study||3
148867|NCT00389493|362260|P3|COMPLETED|Overall Study||17
148868|NCT00389493|362261|P2|COMPLETED|Overall Study||32
148869|NCT00389493|362262|P1|COMPLETED|Overall Study||37
148870|NCT00389493|362260|P3|STARTED|Overall Study||20
148871|NCT00389493|362261|P2|STARTED|Overall Study||40
148872|NCT00389493|362262|P1|STARTED|Overall Study||40
148873|NCT00389519|362286|P4|NOT COMPLETED|Treated||4
148874|NCT00389519|362287|P3|NOT COMPLETED|Treated||0
148875|NCT00389519|362288|P2|NOT COMPLETED|Treated||1
148876|NCT00389519|362289|P1|NOT COMPLETED|Treated||2
148877|NCT00389519|362286|P4|COMPLETED|Treated||76
148878|NCT00389519|362287|P3|COMPLETED|Treated||40
148879|NCT00389519|362288|P2|COMPLETED|Treated||40
148880|NCT00389519|362289|P1|COMPLETED|Treated||79
148881|NCT00389519|362286|P4|STARTED|Treated||80
148882|NCT00389519|362287|P3|STARTED|Treated||40
148883|NCT00389519|362288|P2|STARTED|Treated||41
148884|NCT00389519|362289|P1|STARTED|Treated||81
148885|NCT00389519|362286|P4|NOT COMPLETED|Randomized||0
148886|NCT00389519|362287|P3|NOT COMPLETED|Randomized||0
148887|NCT00389519|362288|P2|NOT COMPLETED|Randomized||0
148888|NCT00389519|362289|P1|NOT COMPLETED|Randomized||2
148889|NCT00389519|362286|P4|COMPLETED|Randomized||80
148890|NCT00389519|362287|P3|COMPLETED|Randomized||40
148891|NCT00389519|362288|P2|COMPLETED|Randomized||41
148892|NCT00389519|362289|P1|COMPLETED|Randomized||81
148893|NCT00389519|362286|P4|STARTED|Randomized||80
148894|NCT00389519|362287|P3|STARTED|Randomized||40
148895|NCT00389519|362288|P2|STARTED|Randomized||41
148896|NCT00389519|362289|P1|STARTED|Randomized||83
148897|NCT00389519|362286|P4|NOT COMPLETED|Placebo Run-In||0
148898|NCT00389519|362287|P3|NOT COMPLETED|Placebo Run-In||0
148899|NCT00389519|362288|P2|NOT COMPLETED|Placebo Run-In||0
148900|NCT00389519|362289|P1|NOT COMPLETED|Placebo Run-In||178
148901|NCT00389519|362286|P4|COMPLETED|Placebo Run-In||0
148902|NCT00389519|362287|P3|COMPLETED|Placebo Run-In||0
148903|NCT00389519|362288|P2|COMPLETED|Placebo Run-In||0
148904|NCT00389519|362289|P1|COMPLETED|Placebo Run-In||244
148905|NCT00389519|362286|P4|STARTED|Placebo Run-In||0
148906|NCT00389519|362287|P3|STARTED|Placebo Run-In||0
148907|NCT00389519|362288|P2|STARTED|Placebo Run-In||0
148908|NCT00389519|362289|P1|STARTED|Placebo Run-In||422
148909|NCT00389532|362317|P2|NOT COMPLETED|Overall Study||0
148910|NCT00389532|362318|P1|NOT COMPLETED|Overall Study||0
148911|NCT00389532|362317|P2|COMPLETED|Overall Study||56
148912|NCT00389532|362318|P1|COMPLETED|Overall Study|3 of the participants did not have valid post-vaccination serological results|60
148913|NCT00389532|362317|P2|STARTED|Overall Study||56
148914|NCT00389532|362318|P1|STARTED|Overall Study||60
148915|NCT00389597|362330|P4|NOT COMPLETED|Overall Study||6
148916|NCT00389597|362331|P3|NOT COMPLETED|Overall Study||4
148917|NCT00389597|362332|P2|NOT COMPLETED|Overall Study||6
148918|NCT00389597|362333|P1|NOT COMPLETED|Overall Study||8
148919|NCT00389597|362330|P4|COMPLETED|Overall Study||99
148920|NCT00389597|362331|P3|COMPLETED|Overall Study||221
148921|NCT00389597|362332|P2|COMPLETED|Overall Study||75
148922|NCT00389597|362333|P1|COMPLETED|Overall Study||156
148923|NCT00389597|362330|P4|24 mo|Overall Study||99
148924|NCT00389597|362331|P3|24 mo|Overall Study||221
148925|NCT00389597|362332|P2|24 mo|Overall Study||75
148926|NCT00389597|362333|P1|24 mo|Overall Study||156
148927|NCT00389597|362330|P4|STARTED|Overall Study||105
148928|NCT00389597|362331|P3|STARTED|Overall Study||225
148929|NCT00389597|362332|P2|STARTED|Overall Study||81
148930|NCT00389597|362333|P1|STARTED|Overall Study||164
148931|NCT00389805|362345|P2|NOT COMPLETED|Phase II||0
148932|NCT00389805|362346|P1|NOT COMPLETED|Phase II||0
148933|NCT00389805|362345|P2|COMPLETED|Phase II||0
148934|NCT00389805|362346|P1|COMPLETED|Phase II||0
148935|NCT00389805|362345|P2|STARTED|Phase II|The Phase II study was not conducted.|0
148936|NCT00389805|362346|P1|STARTED|Phase II|The Phase II study was not conducted.|0
148937|NCT00389805|362345|P2|NOT COMPLETED|Phase I||0
148938|NCT00389805|362346|P1|NOT COMPLETED|Phase I||0
148939|NCT00389805|362345|P2|COMPLETED|Phase I||12
148940|NCT00389805|362346|P1|COMPLETED|Phase I||15
148941|NCT00389805|362345|P2|STARTED|Phase I||12
148942|NCT00389805|362346|P1|STARTED|Phase I||15
148943|NCT00389818|362372|P1|NOT COMPLETED|Overall Study||3
148944|NCT00389818|362372|P1|COMPLETED|Overall Study||40
148945|NCT00389818|362372|P1|STARTED|Overall Study||43
148946|NCT00389831|362378|P2|NOT COMPLETED|Overall Study||7
148947|NCT00389831|362379|P1|NOT COMPLETED|Overall Study||0
148948|NCT00389831|362378|P2|COMPLETED|Overall Study||27
148949|NCT00389831|362379|P1|COMPLETED|Overall Study||10
148950|NCT00389831|362378|P2|STARTED|Overall Study||34
148951|NCT00389831|362379|P1|STARTED|Overall Study||10
148952|NCT00389857|362407|P2|NOT COMPLETED|Overall Study||0
148953|NCT00389857|362408|P1|NOT COMPLETED|Overall Study||0
148954|NCT00389857|362407|P2|COMPLETED|Overall Study||17
148955|NCT00389857|362408|P1|COMPLETED|Overall Study||14
148956|NCT00389857|362407|P2|STARTED|Overall Study||17
148957|NCT00389857|362408|P1|STARTED|Overall Study||14
148958|NCT00389974|362418|P1|NOT COMPLETED|Overall Study||0
148959|NCT00389974|362418|P1|COMPLETED|Overall Study||19
148960|NCT00389974|362418|P1|STARTED|Overall Study||19
148961|NCT00390013|362425|P4|NOT COMPLETED|Phase 2 Second Treatment||0
148962|NCT00390013|362426|P3|NOT COMPLETED|Phase 2 Second Treatment||0
148963|NCT00390013|362427|P2|NOT COMPLETED|Phase 2 Second Treatment||0
148964|NCT00390013|362428|P1|NOT COMPLETED|Phase 2 Second Treatment||0
148965|NCT00390013|362425|P4|COMPLETED|Phase 2 Second Treatment||0
148966|NCT00390013|362426|P3|COMPLETED|Phase 2 Second Treatment||0
148967|NCT00390013|362427|P2|COMPLETED|Phase 2 Second Treatment||1
148968|NCT00390013|362428|P1|COMPLETED|Phase 2 Second Treatment||2
148969|NCT00390013|362425|P4|STARTED|Phase 2 Second Treatment||0
148970|NCT00390013|362426|P3|STARTED|Phase 2 Second Treatment||0
148971|NCT00390013|362427|P2|STARTED|Phase 2 Second Treatment||1
148972|NCT00390013|362428|P1|STARTED|Phase 2 Second Treatment||2
148973|NCT00390013|362425|P4|NOT COMPLETED|Phase 2 First Treatment||0
148974|NCT00390013|362426|P3|NOT COMPLETED|Phase 2 First Treatment||0
148975|NCT00390013|362427|P2|NOT COMPLETED|Phase 2 First Treatment||1
148976|NCT00390013|362428|P1|NOT COMPLETED|Phase 2 First Treatment||1
148977|NCT00390013|362425|P4|COMPLETED|Phase 2 First Treatment||0
148978|NCT00390013|362426|P3|COMPLETED|Phase 2 First Treatment||0
148979|NCT00390013|362427|P2|COMPLETED|Phase 2 First Treatment||1
148980|NCT00390013|362428|P1|COMPLETED|Phase 2 First Treatment||2
148981|NCT00390013|362425|P4|STARTED|Phase 2 First Treatment||0
148982|NCT00390013|362426|P3|STARTED|Phase 2 First Treatment||0
148983|NCT00390013|362427|P2|STARTED|Phase 2 First Treatment||2
148984|NCT00390013|362428|P1|STARTED|Phase 2 First Treatment||3
148985|NCT00390013|362425|P4|NOT COMPLETED|Phase 1||1
148986|NCT00390013|362426|P3|NOT COMPLETED|Phase 1||0
148987|NCT00390013|362427|P2|NOT COMPLETED|Phase 1||0
148988|NCT00390013|362428|P1|NOT COMPLETED|Phase 1||0
148989|NCT00390013|362425|P4|COMPLETED|Phase 1||1
148990|NCT00390013|362426|P3|COMPLETED|Phase 1||2
148991|NCT00390013|362427|P2|COMPLETED|Phase 1||0
148992|NCT00390013|362428|P1|COMPLETED|Phase 1||0
148993|NCT00390013|362425|P4|STARTED|Phase 1||2
148994|NCT00390013|362426|P3|STARTED|Phase 1||2
148995|NCT00390013|362427|P2|STARTED|Phase 1||0
148996|NCT00390013|362428|P1|STARTED|Phase 1||0
148997|NCT00390182|362434|P1|NOT COMPLETED|Overall Study||5
148998|NCT00390182|362434|P1|COMPLETED|Overall Study||33
148999|NCT00390182|362434|P1|STARTED|Overall Study||38
149000|NCT00390221|362443|P3|NOT COMPLETED|Overall Study||15
149001|NCT00390221|362444|P2|NOT COMPLETED|Overall Study||20
149002|NCT00390221|362445|P1|NOT COMPLETED|Overall Study||18
149003|NCT00390221|362443|P3|COMPLETED|Overall Study||194
149004|NCT00390221|362444|P2|COMPLETED|Overall Study||188
149005|NCT00390221|362445|P1|COMPLETED|Overall Study||186
149006|NCT00390221|362443|P3|STARTED|Overall Study||209
149007|NCT00390221|362444|P2|STARTED|Overall Study||208
149008|NCT00390221|362445|P1|STARTED|Overall Study||204
149009|NCT00390234|362466|P1|NOT COMPLETED|Overall Study||0
149010|NCT00390234|362466|P1|COMPLETED|Overall Study||63
149011|NCT00390234|362466|P1|STARTED|Overall Study||63
149012|NCT00390364|362474|P1|NOT COMPLETED|Overall Study||0
149013|NCT00390364|362474|P1|COMPLETED|Overall Study||1
149014|NCT00390364|362474|P1|STARTED|Overall Study||1
149015|NCT00390416|362478|P1|NOT COMPLETED|Overall Study||4
149016|NCT00390416|362478|P1|COMPLETED|Overall Study||44
149017|NCT00390416|362478|P1|STARTED|Overall Study||48
149018|NCT00390455|362486|P2|NOT COMPLETED|Overall Study||23
149019|NCT00390455|362487|P1|NOT COMPLETED|Overall Study||32
149020|NCT00390455|362486|P2|COMPLETED|Overall Study||124
149021|NCT00390455|362487|P1|COMPLETED|Overall Study||116
149022|NCT00390455|362486|P2|STARTED|Overall Study||147
149023|NCT00390455|362487|P1|STARTED|Overall Study||148
149024|NCT00390468|362505|P1|NOT COMPLETED|Overall Study||3
149025|NCT00390468|362505|P1|COMPLETED|Overall Study||15
149026|NCT00390468|362505|P1|STARTED|Overall Study||18
149027|NCT00390546|362511|P2|NOT COMPLETED|Overall Study||5
149028|NCT00390546|362512|P1|NOT COMPLETED|Overall Study||6
149029|NCT00390546|362511|P2|COMPLETED|Overall Study||34
149030|NCT00390546|362512|P1|COMPLETED|Overall Study||27
149031|NCT00390546|362511|P2|STARTED|Overall Study||39
149032|NCT00390546|362512|P1|STARTED|Overall Study||33
149033|NCT00390559|362522|P1|NOT COMPLETED|Overall Study||44
149034|NCT00390559|362522|P1|COMPLETED|Overall Study||80
149035|NCT00390559|362522|P1|ActiveP/PlaceboC|Overall Study||90
149036|NCT00390559|362522|P1|PlaceboP/PlaceboC|Overall Study||93
149037|NCT00390559|362522|P1|ActiveP/ActiveC|Overall Study||87
149038|NCT00390559|362522|P1|Received PlaceboP/Active C|Overall Study||93
149039|NCT00390559|362522|P1|STARTED|Overall Study||124
149040|NCT00390572|362534|P2|NOT COMPLETED|Overall Study||5
149041|NCT00390572|362535|P1|NOT COMPLETED|Overall Study||8
149042|NCT00390572|362534|P2|COMPLETED|Overall Study||64
149043|NCT00390572|362535|P1|COMPLETED|Overall Study||60
149044|NCT00390572|362534|P2|STARTED|Overall Study||69
149045|NCT00390572|362535|P1|STARTED|Overall Study||68
149046|NCT00390611|362551|P2|NOT COMPLETED|Maintenance Sorafenib to Month 12||0
149047|NCT00390611|362552|P1|NOT COMPLETED|Maintenance Sorafenib to Month 12||10
149048|NCT00390611|362551|P2|COMPLETED|Maintenance Sorafenib to Month 12||0
149049|NCT00390611|362552|P1|COMPLETED|Maintenance Sorafenib to Month 12||13
149050|NCT00390611|362551|P2|STARTED|Maintenance Sorafenib to Month 12|Patients in the Paclitaxel/carboplatin arm did not recieve maintenance sorafenib|0
149051|NCT00390611|362552|P1|STARTED|Maintenance Sorafenib to Month 12|11 patients came off-study between the end of cycle 6 and the start of maintenance|23
149052|NCT00390611|362551|P2|NOT COMPLETED|6 Cycles of Study Treatment||5
149053|NCT00390611|362552|P1|NOT COMPLETED|6 Cycles of Study Treatment||9
149054|NCT00390611|362551|P2|COMPLETED|6 Cycles of Study Treatment||37
149055|NCT00390611|362552|P1|COMPLETED|6 Cycles of Study Treatment||34
149056|NCT00390611|362551|P2|STARTED|6 Cycles of Study Treatment||42
149057|NCT00390611|362552|P1|STARTED|6 Cycles of Study Treatment||43
149058|NCT00390689|362567|P3|NOT COMPLETED|Overall Study||3
149059|NCT00390689|362568|P2|NOT COMPLETED|Overall Study||5
149060|NCT00390689|362569|P1|NOT COMPLETED|Overall Study||5
149061|NCT00390689|362567|P3|COMPLETED|Overall Study||50
149062|NCT00390689|362568|P2|COMPLETED|Overall Study||48
149063|NCT00390689|362569|P1|COMPLETED|Overall Study||43
149064|NCT00390689|362567|P3|STARTED|Overall Study||53
149065|NCT00390689|362568|P2|STARTED|Overall Study||53
149066|NCT00390689|362569|P1|STARTED|Overall Study||48
149067|NCT00390780|362629|P2|NOT COMPLETED|Overall Study||27
149068|NCT00390780|362630|P1|NOT COMPLETED|Overall Study||23
149069|NCT00390780|362629|P2|COMPLETED|Overall Study||260
149070|NCT00390780|362630|P1|COMPLETED|Overall Study||268
149071|NCT00390780|362629|P2|Treatment|Overall Study||287
149072|NCT00390780|362630|P1|Treatment|Overall Study|One patient randomized to miconazole lost study drug, never started treatment, and was discontinued.|290
149073|NCT00390780|362629|P2|STARTED|Overall Study||287
149074|NCT00390780|362630|P1|STARTED|Overall Study||291
149075|NCT00390806|362662|P2|NOT COMPLETED|Overall Study||32
149076|NCT00390806|362663|P1|NOT COMPLETED|Overall Study||30
149077|NCT00390806|362662|P2|COMPLETED|Overall Study||204
149078|NCT00390806|362663|P1|COMPLETED|Overall Study||206
149079|NCT00390806|362662|P2|Ongoing|Overall Study||2
149080|NCT00390806|362663|P1|Ongoing|Overall Study||4
149081|NCT00390806|362662|P2|STARTED|Overall Study||236
149082|NCT00390806|362663|P1|STARTED|Overall Study||236
149083|NCT00390858|362731|P2|NOT COMPLETED|Overall Study||7
149084|NCT00390858|362732|P1|NOT COMPLETED|Overall Study||9
149085|NCT00390858|362731|P2|COMPLETED|Overall Study|13 Participants completed the Extension Study|13
149086|NCT00390858|362732|P1|COMPLETED|Overall Study|11 participants Completed the Extension Study|11
149087|NCT00390858|362731|P2|Completed Core & Entered Extension Study|Overall Study||20
149088|NCT00390858|362732|P1|Completed Core & Entered Extension Study|Overall Study||19
149089|NCT00390858|362731|P2|STARTED|Overall Study|20 Participants started the Core Study|20
149090|NCT00390858|362732|P1|STARTED|Overall Study|20 participants started the Core Study|20
149091|NCT00390884|362746|P2|NOT COMPLETED|Overall Study||2
149092|NCT00390884|362747|P1|NOT COMPLETED|Overall Study||2
149093|NCT00390884|362746|P2|COMPLETED|Overall Study||55
149094|NCT00390884|362747|P1|COMPLETED|Overall Study||114
149095|NCT00390884|362746|P2|STARTED|Overall Study||57
149096|NCT00390884|362747|P1|STARTED|Overall Study||116
149097|NCT00385138|362759|P2|NOT COMPLETED|Overall Study||28
149098|NCT00385138|362760|P1|NOT COMPLETED|Overall Study||30
149099|NCT00385138|362759|P2|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2641
149100|NCT00385138|362760|P1|COMPLETED|Overall Study|"Completed means patient completed scheduled visits or developed a primary endpoint event."|2665
149101|NCT00385138|362759|P2|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2650
149102|NCT00385138|362760|P1|Safety Population|Overall Study|Includes all randomized patients who received at least one dose of study drug.|2662
149103|NCT00385138|362759|P2|Modified Intent-to-treat (mITT)|Overall Study|Excludes 24 patients who either did not received study drug or have PCI.|2645
149104|NCT00385138|362760|P1|Modified Intent-to-treat (mITT)|Overall Study|Excludes 37 patients who either did not receive study drug or have PCI.|2656
149105|NCT00385138|362759|P2|Intent-to-treat (ITT)|Overall Study||2669
149106|NCT00385138|362760|P1|Intent-to-treat (ITT)|Overall Study|All patients randomized excluding two (2) who withdrew consent for using study data.|2693
149107|NCT00385138|362759|P2|STARTED|Overall Study||2669
149108|NCT00385138|362760|P1|STARTED|Overall Study||2695
149109|NCT00385203|362806|P2|NOT COMPLETED|Overall Study||7
149110|NCT00385203|362807|P1|NOT COMPLETED|Overall Study||26
149111|NCT00385203|362806|P2|COMPLETED|Overall Study||3
149112|NCT00385203|362807|P1|COMPLETED|Overall Study||0
149113|NCT00385203|362806|P2|STARTED|Overall Study||10
149114|NCT00385203|362807|P1|STARTED|Overall Study||26
149115|NCT00385216|362825|P2|NOT COMPLETED|Second Intervention||0
149116|NCT00385216|362826|P1|NOT COMPLETED|Second Intervention||0
149117|NCT00385216|362825|P2|COMPLETED|Second Intervention||9
149118|NCT00385216|362826|P1|COMPLETED|Second Intervention||11
149119|NCT00385216|362825|P2|STARTED|Second Intervention||9
149120|NCT00385216|362826|P1|STARTED|Second Intervention||11
149121|NCT00385216|362825|P2|NOT COMPLETED|First Intervention||0
149122|NCT00385216|362826|P1|NOT COMPLETED|First Intervention||0
149123|NCT00385216|362825|P2|COMPLETED|First Intervention||9
149124|NCT00385216|362826|P1|COMPLETED|First Intervention||11
149125|NCT00385216|362825|P2|STARTED|First Intervention||9
149126|NCT00385216|362826|P1|STARTED|First Intervention||11
149127|NCT00385268|362840|P2|NOT COMPLETED|Overall Study||8
149128|NCT00385268|362841|P1|NOT COMPLETED|Overall Study||16
149129|NCT00385268|362840|P2|COMPLETED|Overall Study||18
149130|NCT00385268|362841|P1|COMPLETED|Overall Study||18
149131|NCT00385268|362840|P2|STARTED|Overall Study||26
149132|NCT00385268|362841|P1|STARTED|Overall Study||34
149133|NCT00391027|362849|P2|NOT COMPLETED|Overall Study||12
149134|NCT00391027|362850|P1|NOT COMPLETED|Overall Study||25
149135|NCT00391027|362849|P2|COMPLETED|Overall Study||110
149136|NCT00391027|362850|P1|COMPLETED|Overall Study||110
149137|NCT00391027|362849|P2|STARTED|Overall Study|Full Analysis Set = 121; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|122
149138|NCT00391027|362850|P1|STARTED|Overall Study|Full Analysis Set = 134; 1 subject excluded; missing a baseline or postbaseline HbA1c measurement.|135
149139|NCT00391053|362892|P4|NOT COMPLETED|Overall Study||10
149140|NCT00391053|362893|P3|NOT COMPLETED|Overall Study||2
149141|NCT00391053|362894|P2|NOT COMPLETED|Overall Study||1
149142|NCT00391053|362895|P1|NOT COMPLETED|Overall Study||9
149143|NCT00391053|362892|P4|COMPLETED|Overall Study||1252
149144|NCT00391053|362893|P3|COMPLETED|Overall Study||868
149145|NCT00391053|362894|P2|COMPLETED|Overall Study||847
149146|NCT00391053|362895|P1|COMPLETED|Overall Study||848
149147|NCT00391053|362892|P4|STARTED|Overall Study||1262
149148|NCT00391053|362893|P3|STARTED|Overall Study||870
149149|NCT00391053|362894|P2|STARTED|Overall Study||848
149150|NCT00391053|362895|P1|STARTED|Overall Study||857
149151|NCT00391079|362919|P2|NOT COMPLETED|Overall Study||16
149152|NCT00391079|362920|P1|NOT COMPLETED|Overall Study||26
149153|NCT00391079|362919|P2|COMPLETED|Overall Study||156
149154|NCT00391079|362920|P1|COMPLETED|Overall Study||141
149155|NCT00391079|362919|P2|STARTED|Overall Study||172
149156|NCT00391079|362920|P1|STARTED|Overall Study||167
149157|NCT00391092|362940|P2|NOT COMPLETED|Overall Study||216
149158|NCT00391092|362941|P1|NOT COMPLETED|Overall Study||208
149159|NCT00391092|362940|P2|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
149160|NCT00391092|362941|P1|COMPLETED|Overall Study|This was using a data cutoff of 30 June 2011.|0
149161|NCT00391092|362940|P2|Received Treatment|Overall Study||215
149162|NCT00391092|362941|P1|Received Treatment|Overall Study||206
149163|NCT00391092|362940|P2|STARTED|Overall Study||216
149164|NCT00391092|362941|P1|STARTED|Overall Study||208
149165|NCT00391222|362962|P4|NOT COMPLETED|Period III (Double-Blind Treatment)||0
149166|NCT00391222|362963|P3|NOT COMPLETED|Period III (Double-Blind Treatment)||23
149167|NCT00391222|362964|P2|NOT COMPLETED|Period III (Double-Blind Treatment)||22
149168|NCT00391222|362965|P1|NOT COMPLETED|Period III (Double-Blind Treatment)||28
149169|NCT00391222|362962|P4|COMPLETED|Period III (Double-Blind Treatment)||0
149170|NCT00391222|362963|P3|COMPLETED|Period III (Double-Blind Treatment)||108
149171|NCT00391222|362964|P2|COMPLETED|Period III (Double-Blind Treatment)||113
149172|NCT00391222|362965|P1|COMPLETED|Period III (Double-Blind Treatment)||104
149173|NCT00391222|362962|P4|STARTED|Period III (Double-Blind Treatment)||0
149174|NCT00391222|362963|P3|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|131
149175|NCT00391222|362964|P2|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|135
149176|NCT00391222|362965|P1|STARTED|Period III (Double-Blind Treatment)|Patients were randomized to one of 3 arms in Period III, after completing open-label Period II|132
149177|NCT00391222|362962|P4|NOT COMPLETED|Period II (Open-label Risperidone LAI)||162
149178|NCT00391222|362963|P3|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
149179|NCT00391222|362964|P2|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
149180|NCT00391222|362965|P1|NOT COMPLETED|Period II (Open-label Risperidone LAI)||0
149181|NCT00391222|362962|P4|COMPLETED|Period II (Open-label Risperidone LAI)||398
149182|NCT00391222|362963|P3|COMPLETED|Period II (Open-label Risperidone LAI)||0
149183|NCT00391222|362964|P2|COMPLETED|Period II (Open-label Risperidone LAI)||0
149184|NCT00391222|362965|P1|COMPLETED|Period II (Open-label Risperidone LAI)||0
149185|NCT00391222|362962|P4|STARTED|Period II (Open-label Risperidone LAI)|The 25 patients at the site of Dr. Parikh were excluded from the analysis due to GCP non-compliance|560
149186|NCT00391222|362963|P3|STARTED|Period II (Open-label Risperidone LAI)||0
149187|NCT00391222|362964|P2|STARTED|Period II (Open-label Risperidone LAI)||0
149188|NCT00391222|362965|P1|STARTED|Period II (Open-label Risperidone LAI)||0
149189|NCT00391274|362991|P2|NOT COMPLETED|Overall Study||57
149190|NCT00391274|362992|P1|NOT COMPLETED|Overall Study||61
149191|NCT00391274|362991|P2|COMPLETED|Overall Study||47
149192|NCT00391274|362992|P1|COMPLETED|Overall Study||46
149193|NCT00391274|362991|P2|Received at Least One Dose of Study Drug|Overall Study||102
149194|NCT00391274|362992|P1|Received at Least One Dose of Study Drug|Overall Study||106
149195|NCT00391274|362991|P2|STARTED|Overall Study||104
149196|NCT00391274|362992|P1|STARTED|Overall Study||107
149197|NCT00391625|363008|P1|NOT COMPLETED|Month 84||0
149198|NCT00391625|363008|P1|COMPLETED|Month 84||8
149199|NCT00391625|363008|P1|STARTED|Month 84||8
149200|NCT00391625|363008|P1|NOT COMPLETED|Month 50||1
149201|NCT00391625|363008|P1|COMPLETED|Month 50||8
149202|NCT00391625|363008|P1|STARTED|Month 50||9
149203|NCT00391625|363008|P1|NOT COMPLETED|Month 14||1
149204|NCT00391625|363008|P1|COMPLETED|Month 14||9
149205|NCT00391625|363008|P1|STARTED|Month 14||10
149206|NCT00391625|363008|P1|NOT COMPLETED|Baseline||0
149207|NCT00391625|363008|P1|COMPLETED|Baseline||10
149208|NCT00391625|363008|P1|STARTED|Baseline||10
149209|NCT00391716|363051|P3|NOT COMPLETED|Overall Study||19
149210|NCT00391716|363052|P2|NOT COMPLETED|Overall Study||19
149211|NCT00391716|363053|P1|NOT COMPLETED|Overall Study||27
149212|NCT00391716|363051|P3|COMPLETED|Overall Study||30
149213|NCT00391716|363052|P2|COMPLETED|Overall Study||28
149214|NCT00391716|363053|P1|COMPLETED|Overall Study||27
149215|NCT00391716|363051|P3|STARTED|Overall Study||49
149216|NCT00391716|363052|P2|STARTED|Overall Study||47
149217|NCT00391716|363053|P1|STARTED|Overall Study||54
149218|NCT00391768|363077|P7|NOT COMPLETED|Overall Study||4
149219|NCT00391768|363078|P6|NOT COMPLETED|Overall Study||3
149220|NCT00391768|363079|P5|NOT COMPLETED|Overall Study||2
149221|NCT00391768|363080|P4|NOT COMPLETED|Overall Study||1
149222|NCT00391768|363081|P3|NOT COMPLETED|Overall Study||1
149223|NCT00391768|363082|P2|NOT COMPLETED|Overall Study||0
149224|NCT00391768|363083|P1|NOT COMPLETED|Overall Study||0
149225|NCT00391768|363077|P7|COMPLETED|Overall Study||19
149226|NCT00391768|363078|P6|COMPLETED|Overall Study||7
149227|NCT00391768|363079|P5|COMPLETED|Overall Study||22
149228|NCT00391768|363080|P4|COMPLETED|Overall Study||7
149229|NCT00391768|363081|P3|COMPLETED|Overall Study||6
149230|NCT00391768|363082|P2|COMPLETED|Overall Study||3
149231|NCT00391768|363083|P1|COMPLETED|Overall Study||12
149232|NCT00391768|363077|P7|STARTED|Overall Study||23
149233|NCT00391768|363078|P6|STARTED|Overall Study||10
149234|NCT00391768|363079|P5|STARTED|Overall Study||24
149235|NCT00391768|363080|P4|STARTED|Overall Study||8
149236|NCT00391768|363081|P3|STARTED|Overall Study||7
149237|NCT00391768|363082|P2|STARTED|Overall Study||3
149238|NCT00391768|363083|P1|STARTED|Overall Study||12
149239|NCT00391807|363148|P1|NOT COMPLETED|Overall Study||715
149240|NCT00391807|363148|P1|COMPLETED|Overall Study||968
149241|NCT00391807|363148|P1|STARTED|Overall Study||1683
149242|NCT00391846|363170|P2|NOT COMPLETED|Overall Study||7
149243|NCT00391846|363171|P1|NOT COMPLETED|Overall Study||8
149244|NCT00391846|363170|P2|COMPLETED|Overall Study|118 completed patients includes 5 CV related deaths|118
149245|NCT00391846|363171|P1|COMPLETED|Overall Study|119 completed patients includes 4 CV related deaths|119
149246|NCT00391846|363170|P2|STARTED|Overall Study|Of th 125 randomised patients 7 were discontinued|125
149247|NCT00391846|363171|P1|STARTED|Overall Study|Of the 127 randomised patients 8 were discontinued|127
149248|NCT00391872|363193|P2|NOT COMPLETED|Overall Study||255
149249|NCT00391872|363194|P1|NOT COMPLETED|Overall Study||307
149250|NCT00391872|363193|P2|COMPLETED|Overall Study||9036
149251|NCT00391872|363194|P1|COMPLETED|Overall Study||9026
149252|NCT00391872|363193|P2|STARTED|Overall Study||9291
149253|NCT00391872|363194|P1|STARTED|Overall Study||9333
149254|NCT00391898|363232|P2|NOT COMPLETED|Overall Study||10
149255|NCT00391898|363233|P1|NOT COMPLETED|Overall Study||11
149256|NCT00391898|363232|P2|COMPLETED|Overall Study||39
149257|NCT00391898|363233|P1|COMPLETED|Overall Study||35
149258|NCT00391898|363232|P2|STARTED|Overall Study||49
149259|NCT00391898|363233|P1|STARTED|Overall Study|Safety population for Levodopa/carbidopa/entacapone is 45, for Levodopa/carbidopa, per randomized.|46
149260|NCT00391976|363254|P3|NOT COMPLETED|Overall Study||35
149261|NCT00391976|363255|P2|NOT COMPLETED|Overall Study||25
149262|NCT00391976|363256|P1|NOT COMPLETED|Overall Study||27
149263|NCT00391976|363254|P3|COMPLETED|Overall Study||0
149264|NCT00391976|363255|P2|COMPLETED|Overall Study||18
149265|NCT00391976|363256|P1|COMPLETED|Overall Study||18
149266|NCT00391976|363254|P3|Safety Population|Overall Study||35
149267|NCT00391976|363255|P2|Safety Population|Overall Study||43
149268|NCT00391976|363256|P1|Safety Population|Overall Study|Patients who were enrolled and received at least one dose of study medication.|44
149269|NCT00391976|363254|P3|Randomized|Overall Study||0
149270|NCT00391976|363255|P2|Randomized|Overall Study||43
149271|NCT00391976|363256|P1|Randomized|Overall Study|Randomization occurred after 28 days of treatment & negative antibody test aeruginosa antibody test|45
149272|NCT00391976|363254|P3|STARTED|Overall Study||35
149273|NCT00391976|363255|P2|STARTED|Overall Study||43
149274|NCT00391976|363256|P1|STARTED|Overall Study|Started indicates all patients who were enrolled at Visit 1|45
149275|NCT00391989|363278|P1|NOT COMPLETED|Overall Study||2
149276|NCT00391989|363278|P1|COMPLETED|Overall Study||53
149277|NCT00391989|363278|P1|STARTED|Overall Study||55
149278|NCT00392171|363282|P1|NOT COMPLETED|Overall Study||105
149279|NCT00392171|363282|P1|COMPLETED|Overall Study||15
149280|NCT00392171|363282|P1|STARTED|Overall Study||120
149281|NCT00392197|363288|P2|NOT COMPLETED|Overall Study||30
149282|NCT00392197|363289|P1|NOT COMPLETED|Overall Study||21
149283|NCT00392197|363288|P2|COMPLETED|Overall Study||33
149284|NCT00392197|363289|P1|COMPLETED|Overall Study||27
149285|NCT00392197|363288|P2|STARTED|Overall Study||63
149286|NCT00392197|363289|P1|STARTED|Overall Study||48
149287|NCT00392210|363299|P2|NOT COMPLETED|Second Voiding Trial||0
149288|NCT00392210|363300|P1|NOT COMPLETED|Second Voiding Trial||0
149289|NCT00392210|363299|P2|COMPLETED|Second Voiding Trial||31
149290|NCT00392210|363300|P1|COMPLETED|Second Voiding Trial||34
149291|NCT00392210|363299|P2|STARTED|Second Voiding Trial||31
149292|NCT00392210|363300|P1|STARTED|Second Voiding Trial||34
149293|NCT00392210|363299|P2|NOT COMPLETED|First Voiding Trial||2
149294|NCT00392210|363300|P1|NOT COMPLETED|First Voiding Trial||2
149295|NCT00392210|363299|P2|COMPLETED|First Voiding Trial||31
149296|NCT00392210|363300|P1|COMPLETED|First Voiding Trial||34
149297|NCT00392210|363299|P2|STARTED|First Voiding Trial||33
149298|NCT00392210|363300|P1|STARTED|First Voiding Trial||36
149299|NCT00392223|363308|P2|NOT COMPLETED|Overall Study||13
149300|NCT00392223|363309|P1|NOT COMPLETED|Overall Study||9
149301|NCT00392223|363308|P2|COMPLETED|Overall Study||47
149302|NCT00392223|363309|P1|COMPLETED|Overall Study||49
149303|NCT00392223|363308|P2|STARTED|Overall Study||60
149304|NCT00392223|363309|P1|STARTED|Overall Study||58
149305|NCT00392236|363327|P2|NOT COMPLETED|Overall Study||6
149306|NCT00392236|363328|P1|NOT COMPLETED|Overall Study||12
149307|NCT00392236|363327|P2|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|12
149308|NCT00392236|363328|P1|COMPLETED|Overall Study|Defined as having adherence data for month 6 of the study.|8
149309|NCT00392236|363327|P2|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|18
149310|NCT00392236|363328|P1|STARTED|Overall Study|1 subject post randomization was found to not meet inclusion criteria|20
149311|NCT00392288|363337|P3|NOT COMPLETED|Overall Study||17
149312|NCT00392288|363338|P2|NOT COMPLETED|Overall Study||22
149313|NCT00392288|363339|P1|NOT COMPLETED|Overall Study||32
149314|NCT00392288|363337|P3|COMPLETED|Overall Study|ITT set = 172 patients|159
149315|NCT00392288|363338|P2|COMPLETED|Overall Study|ITT set = 166 patients|155
149316|NCT00392288|363339|P1|COMPLETED|Overall Study|ITT set = 163 patients|143
149317|NCT00392288|363337|P3|Treatment Period|Overall Study||175
149318|NCT00392288|363338|P2|Treatment Period|Overall Study||174
149319|NCT00392288|363339|P1|Treatment Period|Overall Study||172
149320|NCT00392288|363337|P3|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|176
149321|NCT00392288|363338|P2|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|177
149322|NCT00392288|363339|P1|STARTED|Overall Study|Number of randomized subjects is different to number of ITT population in Outcome Measures.|175
149323|NCT00392379|363355|P2|NOT COMPLETED|Overall Study||38
149324|NCT00392379|363356|P1|NOT COMPLETED|Overall Study||22
149325|NCT00392379|363355|P2|COMPLETED|Overall Study|Medication period|96
149326|NCT00392379|363356|P1|COMPLETED|Overall Study|Medication period|114
149327|NCT00392379|363355|P2|STARTED|Overall Study|Medication period|134
149328|NCT00392379|363356|P1|STARTED|Overall Study|Medication period|136
149329|NCT00392392|363366|P1|NOT COMPLETED|Overall Study||20
149330|NCT00392392|363366|P1|COMPLETED|Overall Study||9
149331|NCT00392392|363366|P1|STARTED|Overall Study||29
149332|NCT00392444|363370|P1|NOT COMPLETED|Overall Study||0
149333|NCT00392444|363370|P1|COMPLETED|Overall Study||39
149334|NCT00392444|363370|P1|STARTED|Overall Study||39
149335|NCT00392496|363374|P1|NOT COMPLETED|Overall Study||0
149336|NCT00392496|363374|P1|COMPLETED|Overall Study||19
149337|NCT00392496|363374|P1|STARTED|Overall Study||19
149338|NCT00392665|363380|P2|NOT COMPLETED|Overall Study||15
149339|NCT00392665|363381|P1|NOT COMPLETED|Overall Study||17
149340|NCT00392665|363380|P2|COMPLETED|Overall Study||3
149341|NCT00392665|363381|P1|COMPLETED|Overall Study||1
149342|NCT00392665|363380|P2|STARTED|Overall Study||18
149343|NCT00392665|363381|P1|STARTED|Overall Study||18
149344|NCT00392678|363397|P4|NOT COMPLETED|Overall Study||1
149345|NCT00392678|363398|P3|NOT COMPLETED|Overall Study||2
149346|NCT00392678|363399|P2|NOT COMPLETED|Overall Study||1
149347|NCT00392678|363400|P1|NOT COMPLETED|Overall Study||0
149348|NCT00392678|363397|P4|COMPLETED|Overall Study||26
149349|NCT00392678|363398|P3|COMPLETED|Overall Study||25
149350|NCT00392678|363399|P2|COMPLETED|Overall Study||26
149351|NCT00392678|363400|P1|COMPLETED|Overall Study||27
149352|NCT00392678|363397|P4|STARTED|Overall Study||27
149353|NCT00392678|363398|P3|STARTED|Overall Study||27
149354|NCT00392678|363399|P2|STARTED|Overall Study||27
149355|NCT00392678|363400|P1|STARTED|Overall Study||27
149356|NCT00392704|363434|P1|NOT COMPLETED|Combined Modality Therapy||5
149357|NCT00392704|363434|P1|COMPLETED|Combined Modality Therapy||49
149358|NCT00392704|363434|P1|STARTED|Combined Modality Therapy||54
149359|NCT00392704|363434|P1|NOT COMPLETED|Neoadjuvant Chemotherapy||6
149360|NCT00392704|363434|P1|COMPLETED|Neoadjuvant Chemotherapy||54
149361|NCT00392704|363434|P1|STARTED|Neoadjuvant Chemotherapy||60
149362|NCT00392769|363439|P1|NOT COMPLETED|Overall Study||10
149363|NCT00392769|363439|P1|COMPLETED|Overall Study||23
149364|NCT00392769|363439|P1|STARTED|Overall Study||33
149365|NCT00392782|363443|P1|NOT COMPLETED|Overall Study||0
149366|NCT00392782|363443|P1|COMPLETED|Overall Study||24
149367|NCT00392782|363443|P1|STARTED|Overall Study||24
149368|NCT00392808|363457|P4|NOT COMPLETED|Overall Study||4
149369|NCT00392808|363458|P3|NOT COMPLETED|Overall Study||2
149370|NCT00392808|363459|P2|NOT COMPLETED|Overall Study||3
149371|NCT00392808|363460|P1|NOT COMPLETED|Overall Study||6
149372|NCT00392808|363457|P4|COMPLETED|Overall Study||100
149373|NCT00392808|363458|P3|COMPLETED|Overall Study||107
149374|NCT00392808|363459|P2|COMPLETED|Overall Study||86
149375|NCT00392808|363460|P1|COMPLETED|Overall Study||81
149376|NCT00392808|363457|P4|STARTED|Overall Study||104
149377|NCT00392808|363458|P3|STARTED|Overall Study||109
149378|NCT00392808|363459|P2|STARTED|Overall Study||89
149379|NCT00392808|363460|P1|STARTED|Overall Study||87
149380|NCT00392821|363474|P1|NOT COMPLETED|Overall Study||19
149381|NCT00392821|363474|P1|COMPLETED|Overall Study||59
149382|NCT00392821|363474|P1|STARTED|Overall Study||78
149383|NCT00392834|363481|P2|NOT COMPLETED|Overall Study||0
149384|NCT00392834|363482|P1|NOT COMPLETED|Overall Study||0
149385|NCT00392834|363481|P2|COMPLETED|Overall Study||32
149386|NCT00392834|363482|P1|COMPLETED|Overall Study||2
149387|NCT00392834|363481|P2|STARTED|Overall Study||32
149388|NCT00392834|363482|P1|STARTED|Overall Study||2
149389|NCT00392860|363490|P3|NOT COMPLETED|Overall Study||0
149390|NCT00392860|363491|P2|NOT COMPLETED|Overall Study||0
149391|NCT00392860|363492|P1|NOT COMPLETED|Overall Study||0
149392|NCT00392860|363490|P3|COMPLETED|Overall Study||1
149393|NCT00392860|363491|P2|COMPLETED|Overall Study||0
149394|NCT00392860|363492|P1|COMPLETED|Overall Study||3
149395|NCT00392860|363490|P3|STARTED|Overall Study||1
149396|NCT00392860|363491|P2|STARTED|Overall Study||0
149397|NCT00392860|363492|P1|STARTED|Overall Study||3
149398|NCT00392925|363502|P4|NOT COMPLETED|Randomization to Treatment Group Period||18
149399|NCT00392925|363503|P3|NOT COMPLETED|Randomization to Treatment Group Period||19
149400|NCT00392925|363504|P2|NOT COMPLETED|Randomization to Treatment Group Period||8
149401|NCT00392925|363505|P1|NOT COMPLETED|Randomization to Treatment Group Period||0
149402|NCT00392925|363502|P4|COMPLETED|Randomization to Treatment Group Period|At Week 20|38
149403|NCT00392925|363503|P3|COMPLETED|Randomization to Treatment Group Period|At Week 20|37
149404|NCT00392925|363504|P2|COMPLETED|Randomization to Treatment Group Period|AT Week 20|19
149405|NCT00392925|363505|P1|COMPLETED|Randomization to Treatment Group Period||0
149406|NCT00392925|363502|P4|STARTED|Randomization to Treatment Group Period||56
149407|NCT00392925|363503|P3|STARTED|Randomization to Treatment Group Period||56
149408|NCT00392925|363504|P2|STARTED|Randomization to Treatment Group Period||27
149409|NCT00392925|363505|P1|STARTED|Randomization to Treatment Group Period||0
149410|NCT00392925|363502|P4|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
149411|NCT00392925|363503|P3|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
149412|NCT00392925|363504|P2|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||0
149413|NCT00392925|363505|P1|NOT COMPLETED|4 Week Lead-In Period - Non-Randomized||38
149414|NCT00392925|363502|P4|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
149415|NCT00392925|363503|P3|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
149416|NCT00392925|363504|P2|COMPLETED|4 Week Lead-In Period - Non-Randomized||0
149417|NCT00392925|363505|P1|COMPLETED|4 Week Lead-In Period - Non-Randomized||139
149418|NCT00392925|363502|P4|STARTED|4 Week Lead-In Period - Non-Randomized||0
149419|NCT00392925|363503|P3|STARTED|4 Week Lead-In Period - Non-Randomized||0
149420|NCT00392925|363504|P2|STARTED|4 Week Lead-In Period - Non-Randomized||0
149421|NCT00392925|363505|P1|STARTED|4 Week Lead-In Period - Non-Randomized||177
149422|NCT00393029|363593|P2|NOT COMPLETED|Overall Study||1
149423|NCT00393029|363594|P1|NOT COMPLETED|Overall Study||0
149424|NCT00393029|363593|P2|COMPLETED|Overall Study||9
149425|NCT00393029|363594|P1|COMPLETED|Overall Study||2
149426|NCT00393029|363593|P2|STARTED|Overall Study||10
149427|NCT00393029|363594|P1|STARTED|Overall Study||2
149428|NCT00393042|363603|P2|NOT COMPLETED|Second Intervetion||8
149429|NCT00393042|363604|P1|NOT COMPLETED|Second Intervetion||2
149430|NCT00393042|363603|P2|COMPLETED|Second Intervetion||19
149431|NCT00393042|363604|P1|COMPLETED|Second Intervetion||24
149432|NCT00393042|363603|P2|Completed 25/30 mg Dosage|Second Intervetion||20
149433|NCT00393042|363604|P1|Completed 25/30 mg Dosage|Second Intervetion||24
149434|NCT00393042|363603|P2|Completed the 20mg Dosage|Second Intervetion||21
149435|NCT00393042|363604|P1|Completed the 20mg Dosage|Second Intervetion||24
149436|NCT00393042|363603|P2|Completed 10 mg Dosage|Second Intervetion||24
149437|NCT00393042|363604|P1|Completed 10 mg Dosage|Second Intervetion||26
149438|NCT00393042|363603|P2|Completed Placebo Dosage|Second Intervetion||21
149439|NCT00393042|363604|P1|Completed Placebo Dosage|Second Intervetion||25
149440|NCT00393042|363603|P2|STARTED|Second Intervetion||27
149441|NCT00393042|363604|P1|STARTED|Second Intervetion||26
149442|NCT00393042|363603|P2|NOT COMPLETED|First Intervention||6
149443|NCT00393042|363604|P1|NOT COMPLETED|First Intervention||5
149444|NCT00393042|363603|P2|COMPLETED|First Intervention||27
149445|NCT00393042|363604|P1|COMPLETED|First Intervention||26
149446|NCT00393042|363603|P2|Completed 25/30mg Dosage|First Intervention||27
149447|NCT00393042|363604|P1|Completed 25/30mg Dosage|First Intervention||27
149448|NCT00393042|363603|P2|Completed 20 mg Dosage|First Intervention||28
149449|NCT00393042|363604|P1|Completed 20 mg Dosage|First Intervention||26
149450|NCT00393042|363603|P2|Completed 10mg Dosage|First Intervention||29
149451|NCT00393042|363604|P1|Completed 10mg Dosage|First Intervention||29
149452|NCT00393042|363603|P2|Completed the Placebo Dosage|First Intervention||29
149453|NCT00393042|363604|P1|Completed the Placebo Dosage|First Intervention||27
149454|NCT00393042|363603|P2|STARTED|First Intervention||33
149455|NCT00393042|363604|P1|STARTED|First Intervention||31
149456|NCT00393068|363674|P1|NOT COMPLETED|Overall Study||18
149457|NCT00393068|363674|P1|COMPLETED|Overall Study||44
149458|NCT00393068|363674|P1|STARTED|Overall Study||62
149459|NCT00393094|363678|P1|NOT COMPLETED|Disease Progression After Trtmt: Onstudy||1
149460|NCT00393094|363678|P1|COMPLETED|Disease Progression After Trtmt: Onstudy||29
149461|NCT00393094|363678|P1|STARTED|Disease Progression After Trtmt: Onstudy||30
149462|NCT00393094|363678|P1|NOT COMPLETED|Period1Bevacizumab & Irinotecan Patients||1
149463|NCT00393094|363678|P1|COMPLETED|Period1Bevacizumab & Irinotecan Patients||30
149464|NCT00393094|363678|P1|STARTED|Period1Bevacizumab & Irinotecan Patients||31
149465|NCT00393367|363687|P2|NOT COMPLETED|Overall Study||7
149466|NCT00393367|363688|P1|NOT COMPLETED|Overall Study||2
149467|NCT00393367|363687|P2|COMPLETED|Overall Study||81
149468|NCT00393367|363688|P1|COMPLETED|Overall Study||89
149469|NCT00393367|363687|P2|STARTED|Overall Study||88
149470|NCT00393367|363688|P1|STARTED|Overall Study||91
149471|NCT00393380|363716|P1|NOT COMPLETED|Overall Study||0
149472|NCT00393380|363716|P1|COMPLETED|Overall Study||13
149473|NCT00393380|363716|P1|STARTED|Overall Study||13
149474|NCT00393458|363731|P4|NOT COMPLETED|Overall Study||137
149475|NCT00393458|363732|P3|NOT COMPLETED|Overall Study||112
149476|NCT00393458|363733|P2|NOT COMPLETED|Overall Study||102
149477|NCT00393458|363734|P1|NOT COMPLETED|Overall Study||99
149478|NCT00393458|363731|P4|COMPLETED|Overall Study||295
149479|NCT00393458|363732|P3|COMPLETED|Overall Study||323
149480|NCT00393458|363733|P2|COMPLETED|Overall Study||326
149481|NCT00393458|363734|P1|COMPLETED|Overall Study||338
149482|NCT00393458|363731|P4|Exposed to Study Medication or Placebo|Overall Study||432
149483|NCT00393458|363732|P3|Exposed to Study Medication or Placebo|Overall Study||434
149484|NCT00393458|363733|P2|Exposed to Study Medication or Placebo|Overall Study||425
149485|NCT00393458|363734|P1|Exposed to Study Medication or Placebo|Overall Study||437
149486|NCT00393458|363731|P4|STARTED|Overall Study||432
149487|NCT00393458|363732|P3|STARTED|Overall Study||435
149488|NCT00393458|363733|P2|STARTED|Overall Study||428
149489|NCT00393458|363734|P1|STARTED|Overall Study||437
149490|NCT00393484|363750|P2|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||23
149491|NCT00393484|363751|P1|NOT COMPLETED|Open-label Period (Weeks 96 to 240)||8
149492|NCT00393484|363750|P2|COMPLETED|Open-label Period (Weeks 96 to 240)||21
149493|NCT00393484|363751|P1|COMPLETED|Open-label Period (Weeks 96 to 240)||40
149494|NCT00393484|363750|P2|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|2
149495|NCT00393484|363751|P1|Lack of Efficacy|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|0
149496|NCT00393484|363750|P2|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
149497|NCT00393484|363751|P1|Withdrew Consent|Open-label Period (Weeks 96 to 240)|Did not participate in open-label period|6
149498|NCT00393484|363750|P2|STARTED|Open-label Period (Weeks 96 to 240)||44
149499|NCT00393484|363751|P1|STARTED|Open-label Period (Weeks 96 to 240)||48
149500|NCT00393484|363750|P2|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||12
149501|NCT00393484|363751|P1|NOT COMPLETED|Double-blind Period (Day 1 to Week 96)||2
149502|NCT00393484|363750|P2|COMPLETED|Double-blind Period (Day 1 to Week 96)||52
149503|NCT00393484|363751|P1|COMPLETED|Double-blind Period (Day 1 to Week 96)||54
149504|NCT00393484|363750|P2|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
149505|NCT00393484|363751|P1|Participants Excluded From Analysis|Double-blind Period (Day 1 to Week 96)||1
149506|NCT00393484|363750|P2|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|64
149507|NCT00393484|363751|P1|STARTED|Double-blind Period (Day 1 to Week 96)|Number treated|56
149508|NCT00393510|363785|P2|NOT COMPLETED|Overall Study||9
149509|NCT00393510|363786|P1|NOT COMPLETED|Overall Study||3
149510|NCT00393510|363785|P2|COMPLETED|Overall Study||31
149511|NCT00393510|363786|P1|COMPLETED|Overall Study||37
149512|NCT00393510|363785|P2|STARTED|Overall Study||40
149513|NCT00393510|363786|P1|STARTED|Overall Study||40
149514|NCT00393523|363801|P5|NOT COMPLETED|Overall Study||1
149515|NCT00393523|363802|P4|NOT COMPLETED|Overall Study||6
149516|NCT00393523|363803|P3|NOT COMPLETED|Overall Study||4
149517|NCT00393523|363804|P2|NOT COMPLETED|Overall Study||9
149518|NCT00393523|363805|P1|NOT COMPLETED|Overall Study||12
149519|NCT00393523|363801|P5|COMPLETED|Overall Study||19
149520|NCT00393523|363802|P4|COMPLETED|Overall Study||348
149521|NCT00393523|363803|P3|COMPLETED|Overall Study||349
149522|NCT00393523|363804|P2|COMPLETED|Overall Study||366
149523|NCT00393523|363805|P1|COMPLETED|Overall Study||364
149524|NCT00393523|363801|P5|Vaccination Visit 1|Overall Study||20
149525|NCT00393523|363802|P4|Vaccination Visit 1|Overall Study||352
149526|NCT00393523|363803|P3|Vaccination Visit 1|Overall Study||349
149527|NCT00393523|363804|P2|Vaccination Visit 1|Overall Study||375
149528|NCT00393523|363805|P1|Vaccination Visit 1|Overall Study||374
149529|NCT00393523|363801|P5|STARTED|Overall Study||20
149530|NCT00393523|363802|P4|STARTED|Overall Study||354
149531|NCT00393523|363803|P3|STARTED|Overall Study||353
149532|NCT00393523|363804|P2|STARTED|Overall Study||375
149533|NCT00393523|363805|P1|STARTED|Overall Study||376
149534|NCT00393705|363822|P2|NOT COMPLETED|Overall Study||23
149535|NCT00393705|363823|P1|NOT COMPLETED|Overall Study||23
149536|NCT00393705|363822|P2|COMPLETED|Overall Study||128
149537|NCT00393705|363823|P1|COMPLETED|Overall Study||128
149538|NCT00393705|363822|P2|Received at Least One Dose of Study Drug|Overall Study||139
149539|NCT00393705|363823|P1|Received at Least One Dose of Study Drug|Overall Study||139
149540|NCT00393705|363822|P2|STARTED|Overall Study||151
149541|NCT00393705|363823|P1|STARTED|Overall Study||151
149542|NCT00393718|363849|P2|NOT COMPLETED|Overall Study||22
149543|NCT00393718|363850|P1|NOT COMPLETED|Overall Study||43
149544|NCT00393718|363849|P2|COMPLETED|Overall Study||110
149545|NCT00393718|363850|P1|COMPLETED|Overall Study||225
149546|NCT00393718|363849|P2|STARTED|Overall Study||132
149547|NCT00393718|363850|P1|STARTED|Overall Study||268
149548|NCT00393796|363882|P2|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
149549|NCT00393796|363883|P1|NOT COMPLETED|Open Label Period - Placebo to SUTENT||0
149550|NCT00393796|363882|P2|COMPLETED|Open Label Period - Placebo to SUTENT||16
149551|NCT00393796|363883|P1|COMPLETED|Open Label Period - Placebo to SUTENT||0
149552|NCT00393796|363882|P2|STARTED|Open Label Period - Placebo to SUTENT||16
149553|NCT00393796|363883|P1|STARTED|Open Label Period - Placebo to SUTENT||0
149554|NCT00393796|363882|P2|NOT COMPLETED|Double Blind Period||0
149555|NCT00393796|363883|P1|NOT COMPLETED|Double Blind Period||0
149556|NCT00393796|363882|P2|COMPLETED|Double Blind Period||28
149557|NCT00393796|363883|P1|COMPLETED|Double Blind Period||26
149558|NCT00393796|363882|P2|STARTED|Double Blind Period||28
149559|NCT00393796|363883|P1|STARTED|Double Blind Period||26
149560|NCT00393848|363893|P4|NOT COMPLETED|Overall Study||1
149561|NCT00393848|363894|P3|NOT COMPLETED|Overall Study||2
149562|NCT00393848|363895|P2|NOT COMPLETED|Overall Study||0
149563|NCT00393848|363896|P1|NOT COMPLETED|Overall Study||0
149564|NCT00393848|363893|P4|COMPLETED|Overall Study||8
149565|NCT00393848|363894|P3|COMPLETED|Overall Study||4
149566|NCT00393848|363895|P2|COMPLETED|Overall Study||9
149567|NCT00393848|363896|P1|COMPLETED|Overall Study||16
149568|NCT00393848|363893|P4|STARTED|Overall Study||9
149569|NCT00393848|363894|P3|STARTED|Overall Study||6
149570|NCT00393848|363895|P2|STARTED|Overall Study||9
149571|NCT00393848|363896|P1|STARTED|Overall Study||16
149572|NCT00393861|363908|P1|NOT COMPLETED|Overall Study||26
149573|NCT00393861|363908|P1|COMPLETED|Overall Study||3
149574|NCT00393861|363908|P1|STARTED|Overall Study||29
149575|NCT00393874|363918|P3|NOT COMPLETED|Overall Study||2
149576|NCT00393874|363919|P2|NOT COMPLETED|Overall Study||4
149577|NCT00393874|363920|P1|NOT COMPLETED|Overall Study||3
149578|NCT00393874|363918|P3|COMPLETED|Overall Study||13
149579|NCT00393874|363919|P2|COMPLETED|Overall Study||13
149580|NCT00393874|363920|P1|COMPLETED|Overall Study||15
149581|NCT00393874|363918|P3|STARTED|Overall Study||15
149582|NCT00393874|363919|P2|STARTED|Overall Study||17
149583|NCT00393874|363920|P1|STARTED|Overall Study||18
149584|NCT00393887|363939|P2|NOT COMPLETED|Overall Study||9
149585|NCT00393887|363940|P1|NOT COMPLETED|Overall Study||16
149586|NCT00393887|363939|P2|COMPLETED|Overall Study||41
149587|NCT00393887|363940|P1|COMPLETED|Overall Study||34
149588|NCT00393887|363939|P2|1 Year|Overall Study||50
149589|NCT00393887|363940|P1|1 Year|Overall Study||45
149590|NCT00393887|363939|P2|STARTED|Overall Study||50
149591|NCT00393887|363940|P1|STARTED|Overall Study||50
149592|NCT00393913|363946|P1|NOT COMPLETED|CPAP Withdrawal||0
149593|NCT00393913|363946|P1|COMPLETED|CPAP Withdrawal||42
149594|NCT00393913|363946|P1|CPAP Compliance|CPAP Withdrawal|Only subjects with sufficient CPAP complaince (>4 hrs/night) were included.|42
149595|NCT00393913|363946|P1|STARTED|CPAP Withdrawal|Includes only subjects with good CPAP adherence|42
149596|NCT00393913|363946|P1|NOT COMPLETED|CPAP||7
149597|NCT00393913|363946|P1|COMPLETED|CPAP||93
149598|NCT00393913|363946|P1|STARTED|CPAP|Excludes normal volunteers without OSA|100
149599|NCT00393913|363946|P1|NOT COMPLETED|Initial Assessment||37
149600|NCT00393913|363946|P1|COMPLETED|Initial Assessment||107
149601|NCT00393913|363946|P1|STARTED|Initial Assessment||144
149602|NCT00393939|363954|P2|NOT COMPLETED|Overall Study||297
149603|NCT00393939|363955|P1|NOT COMPLETED|Overall Study||296
149604|NCT00393939|363954|P2|COMPLETED|Overall Study||0
149605|NCT00393939|363955|P1|COMPLETED|Overall Study||0
149606|NCT00393939|363954|P2|Treated|Overall Study||293
149607|NCT00393939|363955|P1|Treated|Overall Study||295
149608|NCT00393939|363954|P2|STARTED|Overall Study||297
149609|NCT00393939|363955|P1|STARTED|Overall Study||296
149610|NCT00393978|363975|P2|NOT COMPLETED|Overall Study||20
149611|NCT00393978|363976|P1|NOT COMPLETED|Overall Study||16
149612|NCT00393978|363975|P2|COMPLETED|Overall Study||18
149613|NCT00393978|363976|P1|COMPLETED|Overall Study||21
149614|NCT00393978|363975|P2|STARTED|Overall Study||38
149615|NCT00393978|363976|P1|STARTED|Overall Study||37
149616|NCT00394082|363984|P1|NOT COMPLETED|Overall Study||26
149617|NCT00394082|363984|P1|COMPLETED|Overall Study|Treatment completed upon disease progression|24
149618|NCT00394082|363984|P1|At Least One Response Assessment|Overall Study||43
149619|NCT00394082|363984|P1|STARTED|Overall Study||50
149620|NCT00394095|363995|P2|NOT COMPLETED|Overall Study||0
149621|NCT00394095|363996|P1|NOT COMPLETED|Overall Study||1
149622|NCT00394095|363995|P2|COMPLETED|Overall Study||14
149623|NCT00394095|363996|P1|COMPLETED|Overall Study||16
149624|NCT00394095|363995|P2|Screened|Overall Study||14
149625|NCT00394095|363996|P1|Screened|Overall Study||17
149626|NCT00394095|363995|P2|STARTED|Overall Study||14
149627|NCT00394095|363996|P1|STARTED|Overall Study||17
149628|NCT00388453|364007|P3|NOT COMPLETED|Overall Study||0
149629|NCT00388453|364008|P2|NOT COMPLETED|Overall Study||0
149630|NCT00388453|364009|P1|NOT COMPLETED|Overall Study||0
149631|NCT00388453|364007|P3|COMPLETED|Overall Study||10
149632|NCT00388453|364008|P2|COMPLETED|Overall Study||17
149633|NCT00388453|364009|P1|COMPLETED|Overall Study||20
149634|NCT00388453|364007|P3|STARTED|Overall Study||10
149635|NCT00388453|364008|P2|STARTED|Overall Study||17
149636|NCT00388453|364009|P1|STARTED|Overall Study||20
149637|NCT00394212|364028|P2|NOT COMPLETED|Overall Study||1
149638|NCT00394212|364029|P1|NOT COMPLETED|Overall Study||7
149639|NCT00394212|364028|P2|COMPLETED|Overall Study||26
149640|NCT00394212|364029|P1|COMPLETED|Overall Study||43
149641|NCT00394212|364028|P2|6 Month Follow-up|Overall Study||26
149642|NCT00394212|364029|P1|6 Month Follow-up|Overall Study||43
149643|NCT00394212|364028|P2|3 Month Follow-up|Overall Study||26
149644|NCT00394212|364029|P1|3 Month Follow-up|Overall Study||45
149645|NCT00394212|364028|P2|6 Week Follow-up|Overall Study||26
149646|NCT00394212|364029|P1|6 Week Follow-up|Overall Study||45
149647|NCT00394212|364028|P2|STARTED|Overall Study||27
149648|NCT00394212|364029|P1|STARTED|Overall Study|2 subjects assigned to suturing underwent sham procedure, results based on Intent-To-Treat (ITT)|50
149649|NCT00394251|364043|P2|NOT COMPLETED|Overall Study||38
149650|NCT00394251|364044|P1|NOT COMPLETED|Overall Study||37
149651|NCT00394251|364043|P2|COMPLETED|Overall Study||61
149652|NCT00394251|364044|P1|COMPLETED|Overall Study||61
149653|NCT00394251|364043|P2|At Least One Dose of Taxane|Overall Study||93
149654|NCT00394251|364044|P1|At Least One Dose of Taxane|Overall Study||93
149655|NCT00394251|364043|P2|STARTED|Overall Study||99
149656|NCT00394251|364044|P1|STARTED|Overall Study||98
149657|NCT00394277|364074|P4|NOT COMPLETED|Overall Study||125
149658|NCT00394277|364075|P3|NOT COMPLETED|Overall Study||120
149659|NCT00394277|364076|P2|NOT COMPLETED|Overall Study||60
149660|NCT00394277|364077|P1|NOT COMPLETED|Overall Study||58
149661|NCT00394277|364074|P4|COMPLETED|Overall Study||266
149662|NCT00394277|364075|P3|COMPLETED|Overall Study||273
149663|NCT00394277|364076|P2|COMPLETED|Overall Study||136
149664|NCT00394277|364077|P1|COMPLETED|Overall Study||137
149665|NCT00394277|364074|P4|STARTED|Overall Study||391
149666|NCT00394277|364075|P3|STARTED|Overall Study||393
149667|NCT00394277|364076|P2|STARTED|Overall Study||196
149668|NCT00394277|364077|P1|STARTED|Overall Study||195
149669|NCT00394329|364103|P4|NOT COMPLETED|Overall Study||24
149670|NCT00394329|364104|P3|NOT COMPLETED|Overall Study||13
149671|NCT00394329|364105|P2|NOT COMPLETED|Overall Study||9
149672|NCT00394329|364106|P1|NOT COMPLETED|Overall Study||8
149673|NCT00394329|364103|P4|COMPLETED|Overall Study||50
149674|NCT00394329|364104|P3|COMPLETED|Overall Study||58
149675|NCT00394329|364105|P2|COMPLETED|Overall Study||63
149676|NCT00394329|364106|P1|COMPLETED|Overall Study||63
149677|NCT00394329|364103|P4|STARTED|Overall Study||74
149678|NCT00394329|364104|P3|STARTED|Overall Study||71
149679|NCT00394329|364105|P2|STARTED|Overall Study||72
149680|NCT00394329|364106|P1|STARTED|Overall Study||71
149681|NCT00394355|364120|P4|NOT COMPLETED|Overall Study||31
149682|NCT00394355|364121|P3|NOT COMPLETED|Overall Study||38
149683|NCT00394355|364122|P2|NOT COMPLETED|Overall Study||34
149684|NCT00394355|364123|P1|NOT COMPLETED|Overall Study||35
149685|NCT00394355|364120|P4|COMPLETED|Overall Study||111
149686|NCT00394355|364121|P3|COMPLETED|Overall Study||109
149687|NCT00394355|364122|P2|COMPLETED|Overall Study||103
149688|NCT00394355|364123|P1|COMPLETED|Overall Study||105
149689|NCT00394355|364120|P4|STARTED|Overall Study||142
149690|NCT00394355|364121|P3|STARTED|Overall Study||147
149691|NCT00394355|364122|P2|STARTED|Overall Study||137
149692|NCT00394355|364123|P1|STARTED|Overall Study||140
149693|NCT00394433|364145|P1|NOT COMPLETED|Overall Study||3
149694|NCT00394433|364145|P1|COMPLETED|Overall Study||35
149695|NCT00394433|364145|P1|Evaluable and Treated|Overall Study||35
149696|NCT00394433|364145|P1|STARTED|Overall Study||38
149697|NCT00394472|364154|P2|NOT COMPLETED|Overall Study||11
149698|NCT00394472|364155|P1|NOT COMPLETED|Overall Study||9
149699|NCT00394472|364154|P2|COMPLETED|Overall Study||111
149700|NCT00394472|364155|P1|COMPLETED|Overall Study||113
149701|NCT00394472|364154|P2|STARTED|Overall Study||122
149702|NCT00394472|364155|P1|STARTED|Overall Study||122
149703|NCT00397462|364166|P3|NOT COMPLETED|Overall Study||0
149704|NCT00397462|364167|P2|NOT COMPLETED|Overall Study||0
149705|NCT00397462|364168|P1|NOT COMPLETED|Overall Study||0
149706|NCT00397462|364166|P3|COMPLETED|Overall Study||15
149707|NCT00397462|364167|P2|COMPLETED|Overall Study||13
149708|NCT00397462|364168|P1|COMPLETED|Overall Study||16
149709|NCT00397462|364166|P3|STARTED|Overall Study||15
149710|NCT00397462|364167|P2|STARTED|Overall Study||13
149711|NCT00397462|364168|P1|STARTED|Overall Study||16
149712|NCT00397488|364179|P1|NOT COMPLETED|Overall Study||7
149713|NCT00397488|364179|P1|COMPLETED|Overall Study||71
149714|NCT00397488|364179|P1|STARTED|Overall Study||78
149715|NCT00397514|364183|P1|NOT COMPLETED|Overall Study||9
149716|NCT00397514|364183|P1|COMPLETED|Overall Study||25
149717|NCT00397514|364183|P1|STARTED|Overall Study||34
149718|NCT00397540|364195|P2|NOT COMPLETED|Overall Study||0
149719|NCT00397540|364196|P1|NOT COMPLETED|Overall Study||1
149720|NCT00397540|364195|P2|COMPLETED|Overall Study||85
149721|NCT00397540|364196|P1|COMPLETED|Overall Study||59
149722|NCT00397540|364195|P2|STARTED|Overall Study||85
149723|NCT00397540|364196|P1|STARTED|Overall Study||60
149724|NCT00397631|364204|P2|NOT COMPLETED|Overall Study||44
149725|NCT00397631|364205|P1|NOT COMPLETED|Overall Study||30
149726|NCT00397631|364204|P2|COMPLETED|Overall Study||215
149727|NCT00397631|364205|P1|COMPLETED|Overall Study||231
149728|NCT00397631|364204|P2|STARTED|Overall Study||259
149729|NCT00397631|364205|P1|STARTED|Overall Study|Randomization ratio was 1:1|261
149730|NCT00397839|364217|P2|NOT COMPLETED|Overall Study||18
149731|NCT00397839|364218|P1|NOT COMPLETED|Overall Study||7
149732|NCT00397839|364217|P2|COMPLETED|Overall Study||69
149733|NCT00397839|364218|P1|COMPLETED|Overall Study||41
149734|NCT00397839|364217|P2|STARTED|Overall Study||87
149735|NCT00397839|364218|P1|STARTED|Overall Study||48
149736|NCT00397878|364232|P1|NOT COMPLETED|Overall Study||0
149737|NCT00397878|364232|P1|COMPLETED|Overall Study||10
149738|NCT00397878|364232|P1|STARTED|Overall Study||10
149739|NCT00397891|364241|P5|NOT COMPLETED|Overall Study||1
149740|NCT00397891|364242|P4|NOT COMPLETED|Overall Study||0
149741|NCT00397891|364243|P3|NOT COMPLETED|Overall Study||0
149742|NCT00397891|364244|P2|NOT COMPLETED|Overall Study||0
149743|NCT00397891|364245|P1|NOT COMPLETED|Overall Study||1
149744|NCT00397891|364241|P5|COMPLETED|Overall Study||7
149745|NCT00397891|364242|P4|COMPLETED|Overall Study||6
149746|NCT00397891|364243|P3|COMPLETED|Overall Study||6
149747|NCT00397891|364244|P2|COMPLETED|Overall Study||6
149748|NCT00397891|364245|P1|COMPLETED|Overall Study||5
149749|NCT00397891|364241|P5|STARTED|Overall Study||8
149750|NCT00397891|364242|P4|STARTED|Overall Study||6
149751|NCT00397891|364243|P3|STARTED|Overall Study||6
149752|NCT00397891|364244|P2|STARTED|Overall Study||6
149753|NCT00397891|364245|P1|STARTED|Overall Study||6
149754|NCT00397904|364343|P1|NOT COMPLETED|Overall Study||0
149755|NCT00397904|364343|P1|COMPLETED|Overall Study||16
149756|NCT00397904|364343|P1|STARTED|Overall Study||16
149757|NCT00397930|364349|P2|NOT COMPLETED|Overall Study||51
149758|NCT00397930|364350|P1|NOT COMPLETED|Overall Study||38
149759|NCT00397930|364349|P2|COMPLETED|Overall Study||153
149760|NCT00397930|364350|P1|COMPLETED|Overall Study||168
149761|NCT00397930|364349|P2|STARTED|Overall Study||204
149762|NCT00397930|364350|P1|STARTED|Overall Study||206
149763|NCT00397982|364356|P1|NOT COMPLETED|Overall Study||4
149764|NCT00397982|364356|P1|COMPLETED|Overall Study||13
149765|NCT00397982|364356|P1|STARTED|Overall Study||17
149766|NCT00398047|364365|P1|NOT COMPLETED|Overall Study||3
149767|NCT00398047|364365|P1|COMPLETED|Overall Study|all three patients progressed before completing|0
149768|NCT00398047|364365|P1|STARTED|Overall Study||3
149769|NCT00398073|364377|P2|NOT COMPLETED|Overall Study||0
149770|NCT00398073|364378|P1|NOT COMPLETED|Overall Study||1
149771|NCT00398073|364377|P2|COMPLETED|Overall Study||17
149772|NCT00398073|364378|P1|COMPLETED|Overall Study||17
149773|NCT00398073|364377|P2|STARTED|Overall Study||17
149774|NCT00398073|364378|P1|STARTED|Overall Study||18
149775|NCT00398086|364391|P3|NOT COMPLETED|Overall Study||2
149776|NCT00398086|364392|P2|NOT COMPLETED|Overall Study||23
149777|NCT00398086|364393|P1|NOT COMPLETED|Overall Study||9
149778|NCT00398086|364391|P3|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|1
149779|NCT00398086|364392|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|21
149780|NCT00398086|364393|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease.|11
149781|NCT00398086|364391|P3|Phase 1, Dose Escalation Population|Overall Study||3
149782|NCT00398086|364392|P2|Phase 1, Dose Escalation Population|Overall Study||7
149783|NCT00398086|364393|P1|Phase 1, Dose Escalation Population|Overall Study||20
149784|NCT00398086|364391|P3|STARTED|Overall Study||3
149785|NCT00398086|364392|P2|STARTED|Overall Study||44
149786|NCT00398086|364393|P1|STARTED|Overall Study||20
149787|NCT00398112|364425|P1|NOT COMPLETED|Overall Study||18
149788|NCT00398112|364425|P1|COMPLETED|Overall Study||0
149789|NCT00398112|364425|P1|STARTED|Overall Study||18
149790|NCT00398138|364433|P1|NOT COMPLETED|Overall Study||2
149791|NCT00398138|364433|P1|COMPLETED|Overall Study||10
149792|NCT00398138|364433|P1|STARTED|Overall Study||12
149793|NCT00398216|364443|P5|NOT COMPLETED|Overall Study||15
149794|NCT00398216|364444|P4|NOT COMPLETED|Overall Study||22
149795|NCT00398216|364445|P3|NOT COMPLETED|Overall Study||21
149796|NCT00398216|364446|P2|NOT COMPLETED|Overall Study||19
149797|NCT00398216|364447|P1|NOT COMPLETED|Overall Study||11
149798|NCT00398216|364443|P5|COMPLETED|Overall Study||157
149799|NCT00398216|364444|P4|COMPLETED|Overall Study||155
149800|NCT00398216|364445|P3|COMPLETED|Overall Study||164
149801|NCT00398216|364446|P2|COMPLETED|Overall Study||151
149802|NCT00398216|364447|P1|COMPLETED|Overall Study||181
149803|NCT00398216|364443|P5|STARTED|Overall Study||172
149804|NCT00398216|364444|P4|STARTED|Overall Study||177
149805|NCT00398216|364445|P3|STARTED|Overall Study||185
149806|NCT00398216|364446|P2|STARTED|Overall Study||170
149807|NCT00398216|364447|P1|STARTED|Overall Study||192
149808|NCT00398320|364474|P1|NOT COMPLETED|Overall Study||6
149809|NCT00398320|364474|P1|COMPLETED|Overall Study||34
149810|NCT00398320|364474|P1|STARTED|Overall Study||40
149811|NCT00398398|364482|P1|NOT COMPLETED|Overall Study||0
149812|NCT00398398|364482|P1|COMPLETED|Overall Study||44
149813|NCT00398398|364482|P1|STARTED|Overall Study||44
149814|NCT00398411|364491|P2|NOT COMPLETED|Overall Study||1
149815|NCT00398411|364492|P1|NOT COMPLETED|Overall Study||0
149816|NCT00398411|364491|P2|COMPLETED|Overall Study||31
149817|NCT00398411|364492|P1|COMPLETED|Overall Study||34
149818|NCT00398411|364491|P2|STARTED|Overall Study||32
149819|NCT00398411|364492|P1|STARTED|Overall Study||34
149820|NCT00398632|364508|P1|NOT COMPLETED|Overall Study||2
149821|NCT00398632|364508|P1|COMPLETED|Overall Study|2/6 subjects withdrew at end of week 6; 1 for lack of efficacy, 1 because of time constraints.|4
149822|NCT00398632|364508|P1|STARTED|Overall Study||6
149823|NCT00398866|364515|P3|NOT COMPLETED|Overall Study||8
149824|NCT00398866|364516|P2|NOT COMPLETED|Overall Study||8
149825|NCT00398866|364517|P1|NOT COMPLETED|Overall Study||14
149826|NCT00398866|364515|P3|COMPLETED|Overall Study||58
149827|NCT00398866|364516|P2|COMPLETED|Overall Study||60
149828|NCT00398866|364517|P1|COMPLETED|Overall Study||52
149829|NCT00398866|364515|P3|STARTED|Overall Study||66
149830|NCT00398866|364516|P2|STARTED|Overall Study||68
149831|NCT00398866|364517|P1|STARTED|Overall Study||66
149832|NCT00398918|364528|P1|NOT COMPLETED|Overall Study||0
149833|NCT00398918|364528|P1|COMPLETED|Overall Study||10
149834|NCT00398918|364528|P1|STARTED|Overall Study||10
149835|NCT00398983|364535|P2|NOT COMPLETED|Overall Study||0
149836|NCT00398983|364536|P1|NOT COMPLETED|Overall Study||0
149837|NCT00398983|364535|P2|COMPLETED|Overall Study||25
149838|NCT00398983|364536|P1|COMPLETED|Overall Study||20
149839|NCT00398983|364535|P2|STARTED|Overall Study||25
149840|NCT00398983|364536|P1|STARTED|Overall Study||20
149841|NCT00399035|364545|P3|NOT COMPLETED|Overall Study||252
149842|NCT00399035|364546|P2|NOT COMPLETED|Overall Study||158
149843|NCT00399035|364547|P1|NOT COMPLETED|Overall Study||313
149844|NCT00399035|364545|P3|COMPLETED|Overall Study||106
149845|NCT00399035|364546|P2|COMPLETED|Overall Study||58
149846|NCT00399035|364547|P1|COMPLETED|Overall Study||189
149847|NCT00399035|364545|P3|STARTED|Overall Study||358
149848|NCT00399035|364546|P2|STARTED|Overall Study||216
149849|NCT00399035|364547|P1|STARTED|Overall Study||502
149850|NCT00399308|364569|P3|NOT COMPLETED|Overall Study||1
149851|NCT00399308|364570|P2|NOT COMPLETED|Overall Study||0
149852|NCT00399308|364571|P1|NOT COMPLETED|Overall Study||0
149853|NCT00399308|364569|P3|COMPLETED|Overall Study|One patient withdrew: did not want to comply with study requirements|11
149854|NCT00399308|364570|P2|COMPLETED|Overall Study||15
149855|NCT00399308|364571|P1|COMPLETED|Overall Study||13
149856|NCT00399308|364569|P3|STARTED|Overall Study||12
149857|NCT00399308|364570|P2|STARTED|Overall Study||15
149858|NCT00399308|364571|P1|STARTED|Overall Study||13
149859|NCT00399360|364592|P4|NOT COMPLETED|Overall Study||6
149860|NCT00399360|364593|P3|NOT COMPLETED|Overall Study||3
149861|NCT00399360|364594|P2|NOT COMPLETED|Overall Study||3
149862|NCT00399360|364595|P1|NOT COMPLETED|Overall Study||2
149863|NCT00399360|364592|P4|COMPLETED|Overall Study||9
149864|NCT00399360|364593|P3|COMPLETED|Overall Study||10
149865|NCT00399360|364594|P2|COMPLETED|Overall Study||8
149866|NCT00399360|364595|P1|COMPLETED|Overall Study||9
149867|NCT00399360|364592|P4|STARTED|Overall Study||15
149868|NCT00399360|364593|P3|STARTED|Overall Study||13
149869|NCT00399360|364594|P2|STARTED|Overall Study||11
149870|NCT00399360|364595|P1|STARTED|Overall Study||11
149871|NCT00399516|364641|P1|NOT COMPLETED|Overall Study||2
149872|NCT00399516|364641|P1|COMPLETED|Overall Study||19
149873|NCT00399516|364641|P1|STARTED|Overall Study||21
149874|NCT00399542|364647|P2|NOT COMPLETED|Overall Study||43
149875|NCT00399542|364648|P1|NOT COMPLETED|Overall Study||84
149876|NCT00399542|364647|P2|COMPLETED|Overall Study||151
149877|NCT00399542|364648|P1|COMPLETED|Overall Study||303
149878|NCT00399542|364647|P2|STARTED|Overall Study||194
149879|NCT00399542|364648|P1|STARTED|Overall Study||387
149880|NCT00399568|364712|P2|NOT COMPLETED|Overall Study||9
149881|NCT00399568|364713|P1|NOT COMPLETED|Overall Study||12
149882|NCT00399568|364712|P2|COMPLETED|Overall Study||156
149883|NCT00399568|364713|P1|COMPLETED|Overall Study||154
149884|NCT00399568|364712|P2|STARTED|Overall Study||165
149885|NCT00399568|364713|P1|STARTED|Overall Study||166
149886|NCT00399763|364727|P2|NOT COMPLETED|Overall Study||3
149887|NCT00399763|364728|P1|NOT COMPLETED|Overall Study||2
149888|NCT00399763|364727|P2|COMPLETED|Overall Study||32
149889|NCT00399763|364728|P1|COMPLETED|Overall Study||33
149890|NCT00399763|364727|P2|STARTED|Overall Study||35
149891|NCT00399763|364728|P1|STARTED|Overall Study||35
149892|NCT00399893|364740|P2|NOT COMPLETED|Overall Study||0
149893|NCT00399893|364741|P1|NOT COMPLETED|Overall Study||1
149894|NCT00399893|364740|P2|COMPLETED|Overall Study||3
149895|NCT00399893|364741|P1|COMPLETED|Overall Study|Participant withdrew after 3 months but was included in results|1
149896|NCT00399893|364740|P2|STARTED|Overall Study||3
149897|NCT00399893|364741|P1|STARTED|Overall Study||2
149898|NCT00391365|364769|P2|NOT COMPLETED|Overall Study||19
149899|NCT00391365|364770|P1|NOT COMPLETED|Overall Study||25
149900|NCT00391365|364769|P2|COMPLETED|Overall Study||151
149901|NCT00391365|364770|P1|COMPLETED|Overall Study||78
149902|NCT00391365|364769|P2|STARTED|Overall Study||170
149903|NCT00391365|364770|P1|STARTED|Overall Study||103
149904|NCT00391391|364784|P4|NOT COMPLETED|Overall Study||19
149905|NCT00391391|364785|P3|NOT COMPLETED|Overall Study||23
149906|NCT00391391|364786|P2|NOT COMPLETED|Overall Study||10
149907|NCT00391391|364787|P1|NOT COMPLETED|Overall Study||9
149908|NCT00391391|364784|P4|COMPLETED|Overall Study||145
149909|NCT00391391|364785|P3|COMPLETED|Overall Study||138
149910|NCT00391391|364786|P2|COMPLETED|Overall Study||87
149911|NCT00391391|364787|P1|COMPLETED|Overall Study||89
149912|NCT00391391|364784|P4|STARTED|Overall Study|1 participant was not vaccinated.|164
149913|NCT00391391|364785|P3|STARTED|Overall Study|1 participant was not vaccinated.|161
149914|NCT00391391|364786|P2|STARTED|Overall Study||97
149915|NCT00391391|364787|P1|STARTED|Overall Study|1 participant was not vaccinated.|98
149916|NCT00391443|364819|P2|NOT COMPLETED|Overall Study||0
149917|NCT00391443|364820|P1|NOT COMPLETED|Overall Study||0
149918|NCT00391443|364819|P2|COMPLETED|Overall Study||407
149919|NCT00391443|364820|P1|COMPLETED|Overall Study||209
149920|NCT00391443|364819|P2|STARTED|Overall Study||407
149921|NCT00391443|364820|P1|STARTED|Overall Study|1 patient in the bosentan arm did not receive treatment & was excluded from the Safety Population.|209
149922|NCT00391469|364832|P2|NOT COMPLETED|Overall Study||0
149923|NCT00391469|364833|P1|NOT COMPLETED|Overall Study||0
149924|NCT00391469|364832|P2|COMPLETED|Overall Study||671
149925|NCT00391469|364833|P1|COMPLETED|Overall Study|5 patients were found to be incarcerated at time of randomization, thus data was not included|688
149926|NCT00391469|364832|P2|STARTED|Overall Study||671
149927|NCT00391469|364833|P1|STARTED|Overall Study||688
149928|NCT00391586|364845|P1|NOT COMPLETED|Overall Study||24
149929|NCT00391586|364845|P1|COMPLETED|Overall Study|These patients received at least 2 cycles of erlotinib|21
149930|NCT00391586|364845|P1|Received Platinum-based Chemotherapy|Overall Study|Total number of patients who received platinum-based chemotherapy after erlotinib treatment|10
149931|NCT00391586|364845|P1|Received First-line Erlotinib|Overall Study|These patients received at least one dose of on-study first-line erlotinib|43
149932|NCT00391586|364845|P1|STARTED|Overall Study||45
149933|NCT00391599|364852|P2|NOT COMPLETED|Overall Study||0
149934|NCT00391599|364853|P1|NOT COMPLETED|Overall Study||0
149935|NCT00391599|364852|P2|COMPLETED|Overall Study||65
149936|NCT00391599|364853|P1|COMPLETED|Overall Study||65
149937|NCT00391599|364852|P2|STARTED|Overall Study||65
149938|NCT00391599|364853|P1|STARTED|Overall Study||65
149939|NCT00400153|364866|P3|NOT COMPLETED|Overall Study||61
149940|NCT00400153|364867|P2|NOT COMPLETED|Overall Study||55
149941|NCT00400153|364868|P1|NOT COMPLETED|Overall Study||48
149942|NCT00400153|364866|P3|COMPLETED|Overall Study||422
149943|NCT00400153|364867|P2|COMPLETED|Overall Study||436
149944|NCT00400153|364868|P1|COMPLETED|Overall Study||438
149945|NCT00400153|364866|P3|STARTED|Overall Study||483
149946|NCT00400153|364867|P2|STARTED|Overall Study||491
149947|NCT00400153|364868|P1|STARTED|Overall Study||486
149948|NCT00400179|365115|P2|NOT COMPLETED|Overall Study||18
149949|NCT00400179|365116|P1|NOT COMPLETED|Overall Study||6
149950|NCT00400179|365115|P2|COMPLETED|Overall Study||508
149951|NCT00400179|365116|P1|COMPLETED|Overall Study|Received Treatment|521
149952|NCT00400179|365115|P2|STARTED|Overall Study||526
149953|NCT00400179|365116|P1|STARTED|Overall Study|Signed informed consent form and randomized|527
149954|NCT00400205|365130|P1|NOT COMPLETED|Overall Study||5
149955|NCT00400205|365130|P1|COMPLETED|Overall Study||9
149956|NCT00400205|365130|P1|STARTED|Overall Study||14
149957|NCT00401973|365137|P3|NOT COMPLETED|Overall Study||23
149958|NCT00401973|365138|P2|NOT COMPLETED|Overall Study||26
149959|NCT00401973|365139|P1|NOT COMPLETED|Overall Study||11
149960|NCT00401973|365137|P3|COMPLETED|Overall Study||50
149961|NCT00401973|365138|P2|COMPLETED|Overall Study||50
149962|NCT00401973|365139|P1|COMPLETED|Overall Study||39
149963|NCT00401973|365137|P3|STARTED|Overall Study||73
149964|NCT00401973|365138|P2|STARTED|Overall Study||76
149965|NCT00401973|365139|P1|STARTED|Overall Study||50
149966|NCT00402025|365179|P3|NOT COMPLETED|Overall Study||10
149967|NCT00402025|365180|P2|NOT COMPLETED|Overall Study||3
149968|NCT00402025|365181|P1|NOT COMPLETED|Overall Study||2
149969|NCT00402025|365179|P3|COMPLETED|Overall Study||0
149970|NCT00402025|365180|P2|COMPLETED|Overall Study||1
149971|NCT00402025|365181|P1|COMPLETED|Overall Study||1
149972|NCT00402025|365179|P3|STARTED|Overall Study||10
149973|NCT00402025|365180|P2|STARTED|Overall Study||4
149974|NCT00402025|365181|P1|STARTED|Overall Study||3
149975|NCT00402051|365206|P2|NOT COMPLETED|Overall Study||35
149976|NCT00402051|365207|P1|NOT COMPLETED|Overall Study||38
149977|NCT00402051|365206|P2|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|32
150068|NCT00402363|365464|P3|NOT COMPLETED|Overall Study||6
149978|NCT00402051|365207|P1|COMPLETED|Overall Study|Completed 6 treatment cycles and 30 days of follow-up after last dose of study drug|28
149979|NCT00402051|365206|P2|Received Treatment|Overall Study||65
149980|NCT00402051|365207|P1|Received Treatment|Overall Study||65
149981|NCT00402051|365206|P2|STARTED|Overall Study||67
149982|NCT00402051|365207|P1|STARTED|Overall Study||66
149983|NCT00402103|365223|P2|NOT COMPLETED|Overall Study||13
149984|NCT00402103|365224|P1|NOT COMPLETED|Overall Study||91
149985|NCT00402103|365223|P2|COMPLETED|Overall Study||73
149986|NCT00402103|365224|P1|COMPLETED|Overall Study||379
149987|NCT00402103|365223|P2|STARTED|Overall Study||86
149988|NCT00402103|365224|P1|STARTED|Overall Study||470
149989|NCT00402168|365240|P2|NOT COMPLETED|Switched From CNI to Belatacept in LT||0
149990|NCT00402168|365241|P1|NOT COMPLETED|Switched From CNI to Belatacept in LT||6
149991|NCT00402168|365240|P2|COMPLETED|Switched From CNI to Belatacept in LT||0
149992|NCT00402168|365241|P1|COMPLETED|Switched From CNI to Belatacept in LT||32
149993|NCT00402168|365240|P2|STARTED|Switched From CNI to Belatacept in LT|Out of 81 starting LT period in CNI group, 38 switched from CNI to Belatacept during the LT period.|0
149994|NCT00402168|365241|P1|STARTED|Switched From CNI to Belatacept in LT|Participants switched from CNI to Belatacept during LT period.|38
149995|NCT00402168|365240|P2|NOT COMPLETED|Long Term (LT)||17
149996|NCT00402168|365241|P1|NOT COMPLETED|Long Term (LT)||11
149997|NCT00402168|365240|P2|COMPLETED|Long Term (LT)||64
149998|NCT00402168|365241|P1|COMPLETED|Long Term (LT)||70
149999|NCT00402168|365240|P2|STARTED|Long Term (LT)|5 completed 12 months, did not enter long term: 1 AE, 1 lack of efficacy, 3 other(non-specified).|81
150000|NCT00402168|365241|P1|STARTED|Long Term (LT)||81
150001|NCT00402168|365240|P2|NOT COMPLETED|Treatment (up to 12 Months)||2
150002|NCT00402168|365241|P1|NOT COMPLETED|Treatment (up to 12 Months)||2
150003|NCT00402168|365240|P2|COMPLETED|Treatment (up to 12 Months)||86
150004|NCT00402168|365241|P1|COMPLETED|Treatment (up to 12 Months)||81
150005|NCT00402168|365240|P2|STARTED|Treatment (up to 12 Months)||88
150006|NCT00402168|365241|P1|STARTED|Treatment (up to 12 Months)||83
150007|NCT00402168|365240|P2|NOT COMPLETED|Randomized||1
150008|NCT00402168|365241|P1|NOT COMPLETED|Randomized||1
150009|NCT00402168|365240|P2|COMPLETED|Randomized||88
150010|NCT00402168|365241|P1|COMPLETED|Randomized||83
150011|NCT00402168|365240|P2|STARTED|Randomized||89
150012|NCT00402168|365241|P1|STARTED|Randomized||84
150013|NCT00402194|365298|P2|NOT COMPLETED|Overall Study||0
150014|NCT00402194|365299|P1|NOT COMPLETED|Overall Study||0
150015|NCT00402194|365298|P2|COMPLETED|Overall Study||8
150016|NCT00402194|365299|P1|COMPLETED|Overall Study||9
150017|NCT00402194|365298|P2|STARTED|Overall Study||8
150018|NCT00402194|365299|P1|STARTED|Overall Study||9
150019|NCT00402233|365311|P4|NOT COMPLETED|Overall Study||11
150020|NCT00402233|365312|P3|NOT COMPLETED|Overall Study||11
150021|NCT00402233|365313|P2|NOT COMPLETED|Overall Study||10
150022|NCT00402233|365314|P1|NOT COMPLETED|Overall Study||5
150023|NCT00402233|365311|P4|COMPLETED|Overall Study||62
150024|NCT00402233|365312|P3|COMPLETED|Overall Study||70
150025|NCT00402233|365313|P2|COMPLETED|Overall Study||70
150026|NCT00402233|365314|P1|COMPLETED|Overall Study||72
150027|NCT00402233|365311|P4|STARTED|Overall Study||73
150028|NCT00402233|365312|P3|STARTED|Overall Study||81
150029|NCT00402233|365313|P2|STARTED|Overall Study||80
150030|NCT00402233|365314|P1|STARTED|Overall Study||77
150031|NCT00402246|365338|P2|NOT COMPLETED|Overall Study||234
150032|NCT00402246|365339|P1|NOT COMPLETED|Overall Study||220
150033|NCT00402246|365338|P2|COMPLETED|Overall Study||749
150034|NCT00402246|365339|P1|COMPLETED|Overall Study||794
150035|NCT00402246|365338|P2|STARTED|Overall Study||983
150036|NCT00402246|365339|P1|STARTED|Overall Study||1014
150037|NCT00402285|365372|P3|NOT COMPLETED|Overall Study||2
150038|NCT00402285|365373|P2|NOT COMPLETED|Overall Study||6
150039|NCT00402285|365374|P1|NOT COMPLETED|Overall Study||7
150040|NCT00402285|365372|P3|COMPLETED|Overall Study||26
150041|NCT00402285|365373|P2|COMPLETED|Overall Study||21
150042|NCT00402285|365374|P1|COMPLETED|Overall Study||22
150043|NCT00402285|365372|P3|STARTED|Overall Study||28
150044|NCT00402285|365373|P2|STARTED|Overall Study||27
150045|NCT00402285|365374|P1|STARTED|Overall Study||29
150046|NCT00402324|365382|P2|NOT COMPLETED|Overall Study||41
150047|NCT00402324|365383|P1|NOT COMPLETED|Overall Study||43
150048|NCT00402324|365382|P2|COMPLETED|Overall Study||60
150049|NCT00402324|365383|P1|COMPLETED|Overall Study||58
150050|NCT00402324|365382|P2|STARTED|Overall Study||101
150051|NCT00402324|365383|P1|STARTED|Overall Study||101
150052|NCT00402337|365418|P5|NOT COMPLETED|Overall Study||8
150053|NCT00402337|365419|P4|NOT COMPLETED|Overall Study||12
150054|NCT00402337|365420|P3|NOT COMPLETED|Overall Study||4
150055|NCT00402337|365421|P2|NOT COMPLETED|Overall Study||6
150056|NCT00402337|365422|P1|NOT COMPLETED|Overall Study||5
150057|NCT00402337|365418|P5|COMPLETED|Overall Study||61
150058|NCT00402337|365419|P4|COMPLETED|Overall Study||51
150059|NCT00402337|365420|P3|COMPLETED|Overall Study||58
150060|NCT00402337|365421|P2|COMPLETED|Overall Study||51
150061|NCT00402337|365422|P1|COMPLETED|Overall Study||54
150062|NCT00402337|365418|P5|STARTED|Overall Study||69
150063|NCT00402337|365419|P4|STARTED|Overall Study||63
150064|NCT00402337|365420|P3|STARTED|Overall Study||62
150065|NCT00402337|365421|P2|STARTED|Overall Study||57
150066|NCT00402337|365422|P1|STARTED|Overall Study||59
150067|NCT00402363|365463|P4|NOT COMPLETED|Overall Study||10
150069|NCT00402363|365465|P2|NOT COMPLETED|Overall Study||30
150070|NCT00402363|365466|P1|NOT COMPLETED|Overall Study||33
150071|NCT00402363|365463|P4|COMPLETED|Overall Study||45
150072|NCT00402363|365464|P3|COMPLETED|Overall Study||60
150073|NCT00402363|365465|P2|COMPLETED|Overall Study||246
150074|NCT00402363|365466|P1|COMPLETED|Overall Study||233
150075|NCT00402363|365463|P4|STARTED|Overall Study||55
150076|NCT00402363|365464|P3|STARTED|Overall Study||66
150077|NCT00402363|365465|P2|STARTED|Overall Study||276
150078|NCT00402363|365466|P1|STARTED|Overall Study||266
150079|NCT00402597|365529|P5|NOT COMPLETED|Overall Study||124
150080|NCT00402597|365530|P4|NOT COMPLETED|Overall Study||74
150081|NCT00402597|365531|P3|NOT COMPLETED|Overall Study||212
150082|NCT00402597|365532|P2|NOT COMPLETED|Overall Study||46
150083|NCT00402597|365533|P1|NOT COMPLETED|Overall Study||191
150084|NCT00402597|365529|P5|COMPLETED|Overall Study||479
150085|NCT00402597|365530|P4|COMPLETED|Overall Study||279
150086|NCT00402597|365531|P3|COMPLETED|Overall Study||834
150087|NCT00402597|365532|P2|COMPLETED|Overall Study||261
150088|NCT00402597|365533|P1|COMPLETED|Overall Study||962
150089|NCT00402597|365529|P5|STARTED|Overall Study||603
150090|NCT00402597|365530|P4|STARTED|Overall Study||353
150091|NCT00402597|365531|P3|STARTED|Overall Study||1046
150092|NCT00402597|365532|P2|STARTED|Overall Study||307
150093|NCT00402597|365533|P1|STARTED|Overall Study||1153
150094|NCT00402649|365570|P1|NOT COMPLETED|Overall Study||2
150095|NCT00402649|365570|P1|COMPLETED|Overall Study||33
150096|NCT00402649|365570|P1|STARTED|Overall Study||35
150097|NCT00402688|365583|P3|NOT COMPLETED|Overall Study||15
150098|NCT00402688|365584|P2|NOT COMPLETED|Overall Study||16
150099|NCT00402688|365585|P1|NOT COMPLETED|Overall Study||21
150100|NCT00402688|365583|P3|COMPLETED|Overall Study||65
150101|NCT00402688|365584|P2|COMPLETED|Overall Study||65
150102|NCT00402688|365585|P1|COMPLETED|Overall Study||60
150103|NCT00402688|365583|P3|STARTED|Overall Study||80
150104|NCT00402688|365584|P2|STARTED|Overall Study||81
150105|NCT00402688|365585|P1|STARTED|Overall Study||81
150106|NCT00402714|365610|P2|NOT COMPLETED|Overall Study||0
150107|NCT00402714|365611|P1|NOT COMPLETED|Overall Study||0
150108|NCT00402714|365610|P2|COMPLETED|Overall Study||11
150109|NCT00402714|365611|P1|COMPLETED|Overall Study||3
150110|NCT00402714|365610|P2|STARTED|Overall Study||11
150111|NCT00402714|365611|P1|STARTED|Overall Study||3
150112|NCT00402727|365621|P2|NOT COMPLETED|Overall Study||34
150113|NCT00402727|365622|P1|NOT COMPLETED|Overall Study||42
150114|NCT00402727|365621|P2|COMPLETED|Overall Study||347
150115|NCT00402727|365622|P1|COMPLETED|Overall Study||390
150116|NCT00402727|365621|P2|Achieving Test Of Cure (TOC)|Overall Study||347
150117|NCT00402727|365622|P1|Achieving Test Of Cure (TOC)|Overall Study||390
150118|NCT00402727|365621|P2|Achieving End Of Treatment (EOT)|Overall Study||355
150119|NCT00402727|365622|P1|Achieving End Of Treatment (EOT)|Overall Study||408
150120|NCT00402727|365621|P2|STARTED|Overall Study||381
150121|NCT00402727|365622|P1|STARTED|Overall Study||432
150122|NCT00402740|365650|P1|NOT COMPLETED|Overall Study||80
150123|NCT00402740|365650|P1|COMPLETED|Overall Study||242
150124|NCT00402740|365650|P1|STARTED|Overall Study||322
150125|NCT00402883|365660|P1|NOT COMPLETED|Maintenance Therapy||0
150126|NCT00402883|365660|P1|COMPLETED|Maintenance Therapy|All 5 patients received limited maintenance therapy due to early trial closure.|5
150127|NCT00402883|365660|P1|STARTED|Maintenance Therapy||5
150128|NCT00402883|365660|P1|NOT COMPLETED|Consolidation Therapy||0
150129|NCT00402883|365660|P1|COMPLETED|Consolidation Therapy||5
150130|NCT00402883|365660|P1|STARTED|Consolidation Therapy||5
150131|NCT00402883|365660|P1|NOT COMPLETED|Induction Therapy||0
150132|NCT00402883|365660|P1|COMPLETED|Induction Therapy||5
150133|NCT00402883|365660|P1|STARTED|Induction Therapy||5
150134|NCT00402896|365664|P1|NOT COMPLETED|Overall Study||0
150135|NCT00402896|365664|P1|COMPLETED|Overall Study||20
150136|NCT00402896|365664|P1|STARTED|Overall Study||20
150137|NCT00402987|365672|P4|NOT COMPLETED|Overall Study||0
150138|NCT00402987|365673|P3|NOT COMPLETED|Overall Study||1
150139|NCT00402987|365674|P2|NOT COMPLETED|Overall Study||0
150140|NCT00402987|365675|P1|NOT COMPLETED|Overall Study||0
150141|NCT00402987|365672|P4|COMPLETED|Overall Study||89
150142|NCT00402987|365673|P3|COMPLETED|Overall Study||44
150143|NCT00402987|365674|P2|COMPLETED|Overall Study||45
150144|NCT00402987|365675|P1|COMPLETED|Overall Study||90
150145|NCT00402987|365672|P4|STARTED|Overall Study||89
150146|NCT00402987|365673|P3|STARTED|Overall Study||45
150147|NCT00402987|365674|P2|STARTED|Overall Study||45
150148|NCT00402987|365675|P1|STARTED|Overall Study||90
150149|NCT00403130|365837|P1|NOT COMPLETED|Overall Study||5
150150|NCT00403130|365837|P1|COMPLETED|Overall Study||26
150151|NCT00403130|365837|P1|STARTED|Overall Study||31
150152|NCT00403234|365848|P4|NOT COMPLETED|Overall Study||0
150153|NCT00403234|365849|P3|NOT COMPLETED|Overall Study||1
150154|NCT00403234|365850|P2|NOT COMPLETED|Overall Study||1
150155|NCT00403234|365851|P1|NOT COMPLETED|Overall Study||1
150156|NCT00403234|365848|P4|COMPLETED|Overall Study||2
150157|NCT00403234|365849|P3|COMPLETED|Overall Study||2
150158|NCT00403234|365850|P2|COMPLETED|Overall Study||2
150159|NCT00403234|365851|P1|COMPLETED|Overall Study||1
150160|NCT00403234|365848|P4|STARTED|Overall Study||2
150161|NCT00403234|365849|P3|STARTED|Overall Study||3
150162|NCT00403234|365850|P2|STARTED|Overall Study||3
150163|NCT00403234|365851|P1|STARTED|Overall Study||2
150164|NCT00403273|365863|P2|NOT COMPLETED|Overall Study||4
150165|NCT00403273|365864|P1|NOT COMPLETED|Overall Study||3
150166|NCT00403273|365863|P2|COMPLETED|Overall Study||25
150167|NCT00403273|365864|P1|COMPLETED|Overall Study||22
150168|NCT00403273|365863|P2|STARTED|Overall Study||29
150169|NCT00403273|365864|P1|STARTED|Overall Study||25
150170|NCT00403403|365892|P2|NOT COMPLETED|Overall Study||0
150171|NCT00403403|365893|P1|NOT COMPLETED|Overall Study||0
150172|NCT00403403|365892|P2|COMPLETED|Overall Study||52
150173|NCT00403403|365893|P1|COMPLETED|Overall Study||50
150174|NCT00403403|365892|P2|Safety-Evaluable Patients|Overall Study||51
150175|NCT00403403|365893|P1|Safety-Evaluable Patients|Overall Study||47
150176|NCT00403403|365892|P2|STARTED|Overall Study||52
150177|NCT00403403|365893|P1|STARTED|Overall Study||50
150178|NCT00403455|365907|P1|NOT COMPLETED|Overall Study||1
150179|NCT00403455|365907|P1|COMPLETED|Overall Study||37
150180|NCT00403455|365907|P1|STARTED|Overall Study||38
150181|NCT00403481|365911|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||2
150182|NCT00403481|365911|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 25 mg||142
150183|NCT00403481|365911|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 25 mg|168 -24 met their blood pressure goal (remained on olmesartan 40 mg/hydrochlorothiazide 12.5mg)= 144|144
150184|NCT00403481|365911|P1|NOT COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||5
150185|NCT00403481|365911|P1|COMPLETED|Olm 40 mg + Hydrochlorothiazide 12.5 mg||168
150186|NCT00403481|365911|P1|STARTED|Olm 40 mg + Hydrochlorothiazide 12.5 mg|177 -4 met their blood pressure goal (remained on olmesartan 40 mg)= 173|173
150187|NCT00403481|365911|P1|NOT COMPLETED|Olm 40 mg||5
150188|NCT00403481|365911|P1|COMPLETED|Olm 40 mg||177
150189|NCT00403481|365911|P1|STARTED|Olm 40 mg|186 -4 met their blood pressure goal (remained on olmesartan 20 mg) = 182|182
150190|NCT00403481|365911|P1|NOT COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||6
150191|NCT00403481|365911|P1|COMPLETED|Olmesartan Medoxomil (Olm) 20 mg||186
150192|NCT00403481|365911|P1|STARTED|Olmesartan Medoxomil (Olm) 20 mg||192
150193|NCT00403546|365928|P3|NOT COMPLETED|Randomized Trial||16
150194|NCT00403546|365929|P2|NOT COMPLETED|Randomized Trial||17
150195|NCT00403546|365930|P1|NOT COMPLETED|Randomized Trial||0
150196|NCT00403546|365928|P3|COMPLETED|Randomized Trial||21
150197|NCT00403546|365929|P2|COMPLETED|Randomized Trial||21
150198|NCT00403546|365930|P1|COMPLETED|Randomized Trial||0
150199|NCT00403546|365928|P3|STARTED|Randomized Trial||37
150200|NCT00403546|365929|P2|STARTED|Randomized Trial||38
150201|NCT00403546|365930|P1|STARTED|Randomized Trial|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|0
150202|NCT00403546|365928|P3|NOT COMPLETED|Screening Phase||0
150203|NCT00403546|365929|P2|NOT COMPLETED|Screening Phase||0
150204|NCT00403546|365930|P1|NOT COMPLETED|Screening Phase||28
150205|NCT00403546|365928|P3|COMPLETED|Screening Phase||0
150206|NCT00403546|365929|P2|COMPLETED|Screening Phase||0
150207|NCT00403546|365930|P1|COMPLETED|Screening Phase|All participants who completed Screening were randomized to the High-Dose and Placebo arms.|75
150208|NCT00403546|365928|P3|STARTED|Screening Phase||0
150209|NCT00403546|365929|P2|STARTED|Screening Phase||0
150210|NCT00403546|365930|P1|STARTED|Screening Phase||103
150211|NCT00403546|365928|P3|NOT COMPLETED|Signed Informed Consent/Open-Label||0
150212|NCT00403546|365929|P2|NOT COMPLETED|Signed Informed Consent/Open-Label||0
150213|NCT00403546|365930|P1|NOT COMPLETED|Signed Informed Consent/Open-Label||28
150214|NCT00403546|365928|P3|COMPLETED|Signed Informed Consent/Open-Label||0
150215|NCT00403546|365929|P2|COMPLETED|Signed Informed Consent/Open-Label||0
150216|NCT00403546|365930|P1|COMPLETED|Signed Informed Consent/Open-Label||103
150217|NCT00403546|365928|P3|STARTED|Signed Informed Consent/Open-Label||0
150218|NCT00403546|365929|P2|STARTED|Signed Informed Consent/Open-Label||0
150219|NCT00403546|365930|P1|STARTED|Signed Informed Consent/Open-Label||131
150220|NCT00403585|365970|P1|NOT COMPLETED|Open-Label Phase; Extension Study||6
150221|NCT00403585|365970|P1|COMPLETED|Open-Label Phase; Extension Study||74
150222|NCT00403585|365970|P1|STARTED|Open-Label Phase; Extension Study|80 of 102 participants completing Study 103814 enrolled in extension (22 didn't continue medication)|80
150223|NCT00403585|365970|P1|NOT COMPLETED|Initial Treatment Phase||2
150224|NCT00403585|365970|P1|COMPLETED|Initial Treatment Phase||102
150225|NCT00403585|365970|P1|STARTED|Initial Treatment Phase||104
150226|NCT00403754|365979|P4|NOT COMPLETED|Open Label: Salmeterol||0
150227|NCT00403754|365980|P3|NOT COMPLETED|Open Label: Salmeterol||0
150228|NCT00403754|365981|P2|NOT COMPLETED|Open Label: Salmeterol||0
150229|NCT00403754|365982|P1|NOT COMPLETED|Open Label: Salmeterol||0
150230|NCT00403754|365979|P4|COMPLETED|Open Label: Salmeterol||11
150231|NCT00403754|365980|P3|COMPLETED|Open Label: Salmeterol||8
150232|NCT00403754|365981|P2|COMPLETED|Open Label: Salmeterol||9
150233|NCT00403754|365982|P1|COMPLETED|Open Label: Salmeterol||11
150234|NCT00403754|365979|P4|STARTED|Open Label: Salmeterol||11
150235|NCT00403754|365980|P3|STARTED|Open Label: Salmeterol||8
150236|NCT00403754|365981|P2|STARTED|Open Label: Salmeterol||9
150237|NCT00403754|365982|P1|STARTED|Open Label: Salmeterol||11
150238|NCT00403754|365979|P4|NOT COMPLETED|Core Treatment Period 4||0
150239|NCT00403754|365980|P3|NOT COMPLETED|Core Treatment Period 4||0
150240|NCT00403754|365981|P2|NOT COMPLETED|Core Treatment Period 4||0
150241|NCT00403754|365982|P1|NOT COMPLETED|Core Treatment Period 4||0
150242|NCT00403754|365979|P4|COMPLETED|Core Treatment Period 4||11
150243|NCT00403754|365980|P3|COMPLETED|Core Treatment Period 4||8
150244|NCT00403754|365981|P2|COMPLETED|Core Treatment Period 4||9
150245|NCT00403754|365982|P1|COMPLETED|Core Treatment Period 4||11
150246|NCT00403754|365979|P4|STARTED|Core Treatment Period 4||11
150247|NCT00403754|365980|P3|STARTED|Core Treatment Period 4||8
150248|NCT00403754|365981|P2|STARTED|Core Treatment Period 4||9
150249|NCT00403754|365982|P1|STARTED|Core Treatment Period 4||11
150250|NCT00403754|365979|P4|NOT COMPLETED|Core Treatment Period 3||0
150251|NCT00403754|365980|P3|NOT COMPLETED|Core Treatment Period 3||0
150252|NCT00403754|365981|P2|NOT COMPLETED|Core Treatment Period 3||0
150253|NCT00403754|365982|P1|NOT COMPLETED|Core Treatment Period 3||0
150254|NCT00403754|365979|P4|COMPLETED|Core Treatment Period 3||11
150255|NCT00403754|365980|P3|COMPLETED|Core Treatment Period 3||8
150256|NCT00403754|365981|P2|COMPLETED|Core Treatment Period 3||9
150257|NCT00403754|365982|P1|COMPLETED|Core Treatment Period 3||11
150258|NCT00403754|365979|P4|STARTED|Core Treatment Period 3||11
150259|NCT00403754|365980|P3|STARTED|Core Treatment Period 3||8
150260|NCT00403754|365981|P2|STARTED|Core Treatment Period 3||9
150261|NCT00403754|365982|P1|STARTED|Core Treatment Period 3||11
150262|NCT00403754|365979|P4|NOT COMPLETED|Core Treatment Period 2||0
150263|NCT00403754|365980|P3|NOT COMPLETED|Core Treatment Period 2||1
150264|NCT00403754|365981|P2|NOT COMPLETED|Core Treatment Period 2||0
150265|NCT00403754|365982|P1|NOT COMPLETED|Core Treatment Period 2||0
150266|NCT00403754|365979|P4|COMPLETED|Core Treatment Period 2||11
150267|NCT00403754|365980|P3|COMPLETED|Core Treatment Period 2||8
150268|NCT00403754|365981|P2|COMPLETED|Core Treatment Period 2||9
150269|NCT00403754|365982|P1|COMPLETED|Core Treatment Period 2||11
150270|NCT00403754|365979|P4|STARTED|Core Treatment Period 2||11
150271|NCT00403754|365980|P3|STARTED|Core Treatment Period 2||9
150272|NCT00403754|365981|P2|STARTED|Core Treatment Period 2||9
150273|NCT00403754|365982|P1|STARTED|Core Treatment Period 2||11
150274|NCT00403754|365979|P4|NOT COMPLETED|Core Treatment Period 1||0
150275|NCT00403754|365980|P3|NOT COMPLETED|Core Treatment Period 1||0
150276|NCT00403754|365981|P2|NOT COMPLETED|Core Treatment Period 1||1
150277|NCT00403754|365982|P1|NOT COMPLETED|Core Treatment Period 1||0
150278|NCT00403754|365979|P4|COMPLETED|Core Treatment Period 1||11
150279|NCT00403754|365980|P3|COMPLETED|Core Treatment Period 1||9
150280|NCT00403754|365981|P2|COMPLETED|Core Treatment Period 1||9
150281|NCT00403754|365982|P1|COMPLETED|Core Treatment Period 1||11
150282|NCT00403754|365979|P4|STARTED|Core Treatment Period 1||11
150283|NCT00403754|365980|P3|STARTED|Core Treatment Period 1||9
150284|NCT00403754|365981|P2|STARTED|Core Treatment Period 1||10
150285|NCT00403754|365982|P1|STARTED|Core Treatment Period 1||11
150286|NCT00403767|366011|P2|NOT COMPLETED|Overall Study||2468
150287|NCT00403767|366012|P1|NOT COMPLETED|Overall Study||2520
150288|NCT00403767|366011|P2|COMPLETED|Overall Study||4657
150289|NCT00403767|366012|P1|COMPLETED|Overall Study||4591
150290|NCT00403767|366011|P2|STARTED|Overall Study||7125
150291|NCT00403767|366012|P1|STARTED|Overall Study||7111
150292|NCT00403845|366036|P4|NOT COMPLETED|Treatment Period 4||0
150293|NCT00403845|366037|P3|NOT COMPLETED|Treatment Period 4||0
150294|NCT00403845|366038|P2|NOT COMPLETED|Treatment Period 4||0
150295|NCT00403845|366039|P1|NOT COMPLETED|Treatment Period 4||0
150296|NCT00403845|366036|P4|COMPLETED|Treatment Period 4||11
150297|NCT00403845|366037|P3|COMPLETED|Treatment Period 4||11
150298|NCT00403845|366038|P2|COMPLETED|Treatment Period 4||13
150299|NCT00403845|366039|P1|COMPLETED|Treatment Period 4||10
150300|NCT00403845|366036|P4|STARTED|Treatment Period 4||11
150301|NCT00403845|366037|P3|STARTED|Treatment Period 4||11
150302|NCT00403845|366038|P2|STARTED|Treatment Period 4||13
150303|NCT00403845|366039|P1|STARTED|Treatment Period 4||10
150304|NCT00403845|366036|P4|NOT COMPLETED|Treatment Period 3||2
150305|NCT00403845|366037|P3|NOT COMPLETED|Treatment Period 3||0
150306|NCT00403845|366038|P2|NOT COMPLETED|Treatment Period 3||0
150307|NCT00403845|366039|P1|NOT COMPLETED|Treatment Period 3||0
150308|NCT00403845|366036|P4|COMPLETED|Treatment Period 3||11
150309|NCT00403845|366037|P3|COMPLETED|Treatment Period 3||11
150310|NCT00403845|366038|P2|COMPLETED|Treatment Period 3||13
150311|NCT00403845|366039|P1|COMPLETED|Treatment Period 3||10
150312|NCT00403845|366036|P4|STARTED|Treatment Period 3||13
150313|NCT00403845|366037|P3|STARTED|Treatment Period 3||11
150314|NCT00403845|366038|P2|STARTED|Treatment Period 3||13
150315|NCT00403845|366039|P1|STARTED|Treatment Period 3||10
150316|NCT00403845|366036|P4|NOT COMPLETED|Treatment Period 2||0
150317|NCT00403845|366037|P3|NOT COMPLETED|Treatment Period 2||0
150318|NCT00403845|366038|P2|NOT COMPLETED|Treatment Period 2||0
150319|NCT00403845|366039|P1|NOT COMPLETED|Treatment Period 2||1
150320|NCT00403845|366036|P4|COMPLETED|Treatment Period 2||13
150321|NCT00403845|366037|P3|COMPLETED|Treatment Period 2||11
150322|NCT00403845|366038|P2|COMPLETED|Treatment Period 2||13
150323|NCT00403845|366039|P1|COMPLETED|Treatment Period 2||10
150324|NCT00403845|366036|P4|STARTED|Treatment Period 2||13
150325|NCT00403845|366037|P3|STARTED|Treatment Period 2||11
150326|NCT00403845|366038|P2|STARTED|Treatment Period 2||13
150327|NCT00403845|366039|P1|STARTED|Treatment Period 2||11
150328|NCT00403845|366036|P4|NOT COMPLETED|Treatment Period 1||1
150329|NCT00403845|366037|P3|NOT COMPLETED|Treatment Period 1||0
150330|NCT00403845|366038|P2|NOT COMPLETED|Treatment Period 1||0
150331|NCT00403845|366039|P1|NOT COMPLETED|Treatment Period 1||1
150332|NCT00403845|366036|P4|COMPLETED|Treatment Period 1||13
150333|NCT00403845|366037|P3|COMPLETED|Treatment Period 1||11
150334|NCT00403845|366038|P2|COMPLETED|Treatment Period 1||13
150335|NCT00403845|366039|P1|COMPLETED|Treatment Period 1||11
150336|NCT00403845|366036|P4|STARTED|Treatment Period 1||14
150337|NCT00403845|366037|P3|STARTED|Treatment Period 1||11
150338|NCT00403845|366038|P2|STARTED|Treatment Period 1||13
150339|NCT00403845|366039|P1|STARTED|Treatment Period 1||12
150340|NCT00404079|366063|P2|NOT COMPLETED|Overall Study||20
150341|NCT00404079|366064|P1|NOT COMPLETED|Overall Study||22
150342|NCT00404079|366063|P2|COMPLETED|Overall Study||105
150343|NCT00404079|366064|P1|COMPLETED|Overall Study||103
150344|NCT00404079|366063|P2|STARTED|Overall Study||125
150345|NCT00404079|366064|P1|STARTED|Overall Study||125
150346|NCT00404092|366074|P4|NOT COMPLETED|Overall Study||0
150347|NCT00404092|366075|P3|NOT COMPLETED|Overall Study||1
150348|NCT00404092|366076|P2|NOT COMPLETED|Overall Study||0
150349|NCT00404092|366077|P1|NOT COMPLETED|Overall Study||1
150350|NCT00404092|366074|P4|COMPLETED|Overall Study||20
150351|NCT00404092|366075|P3|COMPLETED|Overall Study||8
150352|NCT00404092|366076|P2|COMPLETED|Overall Study||8
150353|NCT00404092|366077|P1|COMPLETED|Overall Study||8
150354|NCT00404092|366074|P4|STARTED|Overall Study||20
150355|NCT00404092|366075|P3|STARTED|Overall Study||9
150356|NCT00404092|366076|P2|STARTED|Overall Study||8
150357|NCT00404092|366077|P1|STARTED|Overall Study||9
150358|NCT00404248|366094|P9|NOT COMPLETED|Overall Study||0
150359|NCT00404248|366095|P8|NOT COMPLETED|Overall Study||0
150360|NCT00404248|366096|P7|NOT COMPLETED|Overall Study||0
150361|NCT00404248|366097|P6|NOT COMPLETED|Overall Study||0
150362|NCT00404248|366098|P5|NOT COMPLETED|Overall Study||0
150363|NCT00404248|366099|P4|NOT COMPLETED|Overall Study||0
150364|NCT00404248|366100|P3|NOT COMPLETED|Overall Study||0
150365|NCT00404248|366101|P2|NOT COMPLETED|Overall Study||1
150366|NCT00404248|366102|P1|NOT COMPLETED|Overall Study||0
150367|NCT00404248|366094|P9|COMPLETED|Overall Study||3
150368|NCT00404248|366095|P8|COMPLETED|Overall Study||6
150369|NCT00404248|366096|P7|COMPLETED|Overall Study||6
150370|NCT00404248|366097|P6|COMPLETED|Overall Study||3
150371|NCT00404248|366098|P5|COMPLETED|Overall Study||3
150372|NCT00404248|366099|P4|COMPLETED|Overall Study||2
150373|NCT00404248|366100|P3|COMPLETED|Overall Study||5
150374|NCT00404248|366101|P2|COMPLETED|Overall Study||3
150375|NCT00404248|366102|P1|COMPLETED|Overall Study||3
150376|NCT00404248|366094|P9|STARTED|Overall Study||3
150377|NCT00404248|366095|P8|STARTED|Overall Study||6
150378|NCT00404248|366096|P7|STARTED|Overall Study||6
150379|NCT00404248|366097|P6|STARTED|Overall Study||3
150380|NCT00404248|366098|P5|STARTED|Overall Study||3
150381|NCT00404248|366099|P4|STARTED|Overall Study||2
150382|NCT00404248|366100|P3|STARTED|Overall Study||5
150383|NCT00404248|366101|P2|STARTED|Overall Study||4
150384|NCT00404248|366102|P1|STARTED|Overall Study||3
150385|NCT00404352|366136|P9|NOT COMPLETED|Open Label Extension (up to 36 Months)||2
150386|NCT00404352|366137|P8|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
150387|NCT00404352|366138|P7|NOT COMPLETED|Open Label Extension (up to 36 Months)||1
150388|NCT00404352|366139|P6|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
150389|NCT00404352|366140|P5|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
150390|NCT00404352|366141|P4|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
150391|NCT00404352|366142|P3|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
150392|NCT00404352|366143|P2|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
150393|NCT00404352|366144|P1|NOT COMPLETED|Open Label Extension (up to 36 Months)||0
150394|NCT00404352|366136|P9|COMPLETED|Open Label Extension (up to 36 Months)||9
150395|NCT00404352|366137|P8|COMPLETED|Open Label Extension (up to 36 Months)||4
150396|NCT00404352|366138|P7|COMPLETED|Open Label Extension (up to 36 Months)||3
150397|NCT00404352|366139|P6|COMPLETED|Open Label Extension (up to 36 Months)||0
150398|NCT00404352|366140|P5|COMPLETED|Open Label Extension (up to 36 Months)||0
150399|NCT00404352|366141|P4|COMPLETED|Open Label Extension (up to 36 Months)||0
150400|NCT00404352|366142|P3|COMPLETED|Open Label Extension (up to 36 Months)||0
150401|NCT00404352|366143|P2|COMPLETED|Open Label Extension (up to 36 Months)||0
150402|NCT00404352|366144|P1|COMPLETED|Open Label Extension (up to 36 Months)||0
150403|NCT00404352|366136|P9|STARTED|Open Label Extension (up to 36 Months)|11 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|11
150404|NCT00404352|366137|P8|STARTED|Open Label Extension (up to 36 Months)|5 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|5
150405|NCT00404352|366138|P7|STARTED|Open Label Extension (up to 36 Months)|4 participants who did not convert to CDMS in 24 months and gave consent to enroll in OLE period|4
150406|NCT00404352|366139|P6|STARTED|Open Label Extension (up to 36 Months)||0
150407|NCT00404352|366140|P5|STARTED|Open Label Extension (up to 36 Months)||0
150408|NCT00404352|366141|P4|STARTED|Open Label Extension (up to 36 Months)||0
150409|NCT00404352|366142|P3|STARTED|Open Label Extension (up to 36 Months)||0
150410|NCT00404352|366143|P2|STARTED|Open Label Extension (up to 36 Months)||0
150411|NCT00404352|366144|P1|STARTED|Open Label Extension (up to 36 Months)||0
150412|NCT00404352|366136|P9|NOT COMPLETED|Open Label (up to 24 Month)||0
150413|NCT00404352|366137|P8|NOT COMPLETED|Open Label (up to 24 Month)||0
150414|NCT00404352|366138|P7|NOT COMPLETED|Open Label (up to 24 Month)||0
150415|NCT00404352|366139|P6|NOT COMPLETED|Open Label (up to 24 Month)||7
150416|NCT00404352|366140|P5|NOT COMPLETED|Open Label (up to 24 Month)||2
150417|NCT00404352|366141|P4|NOT COMPLETED|Open Label (up to 24 Month)||3
150418|NCT00404352|366142|P3|NOT COMPLETED|Open Label (up to 24 Month)||0
150419|NCT00404352|366143|P2|NOT COMPLETED|Open Label (up to 24 Month)||0
150420|NCT00404352|366144|P1|NOT COMPLETED|Open Label (up to 24 Month)||0
150421|NCT00404352|366136|P9|COMPLETED|Open Label (up to 24 Month)||0
150422|NCT00404352|366137|P8|COMPLETED|Open Label (up to 24 Month)||0
150423|NCT00404352|366138|P7|COMPLETED|Open Label (up to 24 Month)||0
150424|NCT00404352|366139|P6|COMPLETED|Open Label (up to 24 Month)||52
150425|NCT00404352|366140|P5|COMPLETED|Open Label (up to 24 Month)||28
150426|NCT00404352|366141|P4|COMPLETED|Open Label (up to 24 Month)||28
150427|NCT00404352|366142|P3|COMPLETED|Open Label (up to 24 Month)||0
150428|NCT00404352|366143|P2|COMPLETED|Open Label (up to 24 Month)||0
150429|NCT00404352|366144|P1|COMPLETED|Open Label (up to 24 Month)||0
150430|NCT00404352|366136|P9|STARTED|Open Label (up to 24 Month)||0
150431|NCT00404352|366137|P8|STARTED|Open Label (up to 24 Month)||0
150432|NCT00404352|366138|P7|STARTED|Open Label (up to 24 Month)||0
150433|NCT00404352|366139|P6|STARTED|Open Label (up to 24 Month)|From DB period, 59 participants converted to CDMS and switched to OL period in this study|59
150434|NCT00404352|366140|P5|STARTED|Open Label (up to 24 Month)|From DB period, 30 participants converted to CDMS and switched to OL period in this study|30
150435|NCT00404352|366141|P4|STARTED|Open Label (up to 24 Month)|From DB period, 31 participants converted to CDMS and switched to OL period in this study|31
150436|NCT00404352|366142|P3|STARTED|Open Label (up to 24 Month)||0
150437|NCT00404352|366143|P2|STARTED|Open Label (up to 24 Month)||0
150438|NCT00404352|366144|P1|STARTED|Open Label (up to 24 Month)||0
150439|NCT00404352|366136|P9|NOT COMPLETED|Double Blind (up to 24 Month)||0
150440|NCT00404352|366137|P8|NOT COMPLETED|Double Blind (up to 24 Month)||0
150441|NCT00404352|366138|P7|NOT COMPLETED|Double Blind (up to 24 Month)||0
150442|NCT00404352|366139|P6|NOT COMPLETED|Double Blind (up to 24 Month)||0
150443|NCT00404352|366140|P5|NOT COMPLETED|Double Blind (up to 24 Month)||0
150444|NCT00404352|366141|P4|NOT COMPLETED|Double Blind (up to 24 Month)||0
150445|NCT00404352|366142|P3|NOT COMPLETED|Double Blind (up to 24 Month)||79
150446|NCT00404352|366143|P2|NOT COMPLETED|Double Blind (up to 24 Month)||47
150447|NCT00404352|366144|P1|NOT COMPLETED|Double Blind (up to 24 Month)||52
150448|NCT00404352|366136|P9|COMPLETED|Double Blind (up to 24 Month)||0
150449|NCT00404352|366137|P8|COMPLETED|Double Blind (up to 24 Month)||0
150450|NCT00404352|366138|P7|COMPLETED|Double Blind (up to 24 Month)||0
150451|NCT00404352|366139|P6|COMPLETED|Double Blind (up to 24 Month)||0
150452|NCT00404352|366140|P5|COMPLETED|Double Blind (up to 24 Month)||0
150453|NCT00404352|366141|P4|COMPLETED|Double Blind (up to 24 Month)||0
150454|NCT00404352|366142|P3|COMPLETED|Double Blind (up to 24 Month)||92
150455|NCT00404352|366143|P2|COMPLETED|Double Blind (up to 24 Month)||128
150456|NCT00404352|366144|P1|COMPLETED|Double Blind (up to 24 Month)||119
150457|NCT00404352|366136|P9|Treated|Double Blind (up to 24 Month)||0
150458|NCT00404352|366137|P8|Treated|Double Blind (up to 24 Month)||0
150459|NCT00404352|366138|P7|Treated|Double Blind (up to 24 Month)||0
150460|NCT00404352|366139|P6|Treated|Double Blind (up to 24 Month)||0
150461|NCT00404352|366140|P5|Treated|Double Blind (up to 24 Month)||0
150462|NCT00404352|366141|P4|Treated|Double Blind (up to 24 Month)||0
150463|NCT00404352|366142|P3|Treated|Double Blind (up to 24 Month)||171
150464|NCT00404352|366143|P2|Treated|Double Blind (up to 24 Month)||173
150465|NCT00404352|366144|P1|Treated|Double Blind (up to 24 Month)||171
150466|NCT00404352|366136|P9|STARTED|Double Blind (up to 24 Month)||0
150467|NCT00404352|366137|P8|STARTED|Double Blind (up to 24 Month)||0
150468|NCT00404352|366138|P7|STARTED|Double Blind (up to 24 Month)||0
150469|NCT00404352|366139|P6|STARTED|Double Blind (up to 24 Month)||0
150470|NCT00404352|366140|P5|STARTED|Double Blind (up to 24 Month)||0
150471|NCT00404352|366141|P4|STARTED|Double Blind (up to 24 Month)||0
150472|NCT00404352|366142|P3|STARTED|Double Blind (up to 24 Month)||171
150473|NCT00404352|366143|P2|STARTED|Double Blind (up to 24 Month)||175
150474|NCT00404352|366144|P1|STARTED|Double Blind (up to 24 Month)||171
150475|NCT00394524|366178|P2|NOT COMPLETED|Overall Study||10
150476|NCT00394524|366179|P1|NOT COMPLETED|Overall Study||11
150477|NCT00394524|366178|P2|COMPLETED|Overall Study||68
150478|NCT00394524|366179|P1|COMPLETED|Overall Study||68
150479|NCT00394524|366178|P2|STARTED|Overall Study||78
150480|NCT00394524|366179|P1|STARTED|Overall Study||79
150481|NCT00394914|366191|P3|NOT COMPLETED|Treatment Period||6
150482|NCT00394914|366192|P2|NOT COMPLETED|Treatment Period||10
150483|NCT00394914|366193|P1|NOT COMPLETED|Treatment Period||0
150484|NCT00394914|366191|P3|COMPLETED|Treatment Period||151
150485|NCT00394914|366192|P2|COMPLETED|Treatment Period||144
150486|NCT00394914|366193|P1|COMPLETED|Treatment Period||0
150487|NCT00394914|366191|P3|STARTED|Treatment Period||157
150488|NCT00394914|366192|P2|STARTED|Treatment Period||154
150489|NCT00394914|366193|P1|STARTED|Treatment Period||0
150490|NCT00394914|366191|P3|NOT COMPLETED|Pre-exposure Period||0
150491|NCT00394914|366192|P2|NOT COMPLETED|Pre-exposure Period||0
150492|NCT00394914|366193|P1|NOT COMPLETED|Pre-exposure Period||0
150493|NCT00394914|366191|P3|COMPLETED|Pre-exposure Period||0
150494|NCT00394914|366192|P2|COMPLETED|Pre-exposure Period||0
150495|NCT00394914|366193|P1|COMPLETED|Pre-exposure Period||311
150496|NCT00394914|366191|P3|STARTED|Pre-exposure Period||0
150497|NCT00394914|366192|P2|STARTED|Pre-exposure Period||0
150498|NCT00394914|366193|P1|STARTED|Pre-exposure Period||311
150499|NCT00394914|366191|P3|NOT COMPLETED|Screening Period||0
150500|NCT00394914|366192|P2|NOT COMPLETED|Screening Period||0
150501|NCT00394914|366193|P1|NOT COMPLETED|Screening Period||0
150502|NCT00394914|366191|P3|COMPLETED|Screening Period||0
150503|NCT00394914|366192|P2|COMPLETED|Screening Period||0
150504|NCT00394914|366193|P1|COMPLETED|Screening Period||311
150505|NCT00394914|366191|P3|STARTED|Screening Period||0
150506|NCT00394914|366192|P2|STARTED|Screening Period||0
150507|NCT00394914|366193|P1|STARTED|Screening Period||311
150508|NCT00394953|366219|P2|NOT COMPLETED|Second Treatment Period||74
150509|NCT00394953|366220|P1|NOT COMPLETED|Second Treatment Period||29
150510|NCT00394953|366219|P2|COMPLETED|Second Treatment Period||148
150511|NCT00394953|366220|P1|COMPLETED|Second Treatment Period||187
150512|NCT00394953|366219|P2|STARTED|Second Treatment Period||222
150513|NCT00394953|366220|P1|STARTED|Second Treatment Period||216
150514|NCT00394953|366219|P2|NOT COMPLETED|First Treatment Period||22
150515|NCT00394953|366220|P1|NOT COMPLETED|First Treatment Period||29
150516|NCT00394953|366219|P2|COMPLETED|First Treatment Period||222
150517|NCT00394953|366220|P1|COMPLETED|First Treatment Period||216
150518|NCT00394953|366219|P2|STARTED|First Treatment Period||244
150519|NCT00394953|366220|P1|STARTED|First Treatment Period||245
150520|NCT00395018|366236|P1|NOT COMPLETED|Off-Treatment Follow-up||4
150521|NCT00395018|366236|P1|COMPLETED|Off-Treatment Follow-up|"Completed means completed the study"|1
150522|NCT00395018|366236|P1|STARTED|Off-Treatment Follow-up|Treated participants who discontinued =<72 weeks and did not start other anti-HBV therapy|5
150523|NCT00395018|366236|P1|NOT COMPLETED|On-Treatment||10
150524|NCT00395018|366236|P1|COMPLETED|On-Treatment|"Completed means received treatment through Week 72"|55
150525|NCT00395018|366236|P1|DISCONTINUED AT OR AFTER WEEK 72 VISIT|On-Treatment||0
150526|NCT00395018|366236|P1|DISCONTINUED PRIOR TO WEEK 72 VISIT|On-Treatment||10
150527|NCT00395018|366236|P1|STARTED|On-Treatment|Started = treated (participants who received at least 1 dose of study therapy)|65
150528|NCT00395044|366257|P2|NOT COMPLETED|Overall Study||14
150529|NCT00395044|366258|P1|NOT COMPLETED|Overall Study||18
150530|NCT00395044|366257|P2|COMPLETED|Overall Study||11
150531|NCT00395044|366258|P1|COMPLETED|Overall Study||7
150532|NCT00395044|366257|P2|STARTED|Overall Study||25
150533|NCT00395044|366258|P1|STARTED|Overall Study||25
150534|NCT00395057|366280|P4|NOT COMPLETED|Overall Study||33
150535|NCT00395057|366281|P3|NOT COMPLETED|Overall Study||33
150536|NCT00395057|366282|P2|NOT COMPLETED|Overall Study||34
150537|NCT00395057|366283|P1|NOT COMPLETED|Overall Study||32
150538|NCT00395057|366280|P4|COMPLETED|Overall Study||1
150539|NCT00395057|366281|P3|COMPLETED|Overall Study||2
150540|NCT00395057|366282|P2|COMPLETED|Overall Study||1
150541|NCT00395057|366283|P1|COMPLETED|Overall Study||2
150542|NCT00395057|366280|P4|STARTED|Overall Study||34
150543|NCT00395057|366281|P3|STARTED|Overall Study||35
150544|NCT00395057|366282|P2|STARTED|Overall Study||35
150545|NCT00395057|366283|P1|STARTED|Overall Study||34
150546|NCT00395083|366311|P2|NOT COMPLETED|Overall Study||8
150547|NCT00395083|366312|P1|NOT COMPLETED|Overall Study||10
150548|NCT00395083|366311|P2|COMPLETED|Overall Study||201
150549|NCT00395083|366312|P1|COMPLETED|Overall Study||207
150550|NCT00395083|366311|P2|STARTED|Overall Study||209
150551|NCT00395083|366312|P1|STARTED|Overall Study||217
150552|NCT00395135|366326|P5|NOT COMPLETED|Year 2||190
150553|NCT00395135|366327|P4|NOT COMPLETED|Year 2||88
150554|NCT00395135|366328|P3|NOT COMPLETED|Year 2||147
150555|NCT00395135|366329|P2|NOT COMPLETED|Year 2||0
150556|NCT00395135|366330|P1|NOT COMPLETED|Year 2||0
150557|NCT00395135|366326|P5|COMPLETED|Year 2||507
150558|NCT00395135|366327|P4|COMPLETED|Year 2||195
150559|NCT00395135|366328|P3|COMPLETED|Year 2||426
150560|NCT00395135|366329|P2|COMPLETED|Year 2||0
150561|NCT00395135|366330|P1|COMPLETED|Year 2||0
150562|NCT00395135|366326|P5|STARTED|Year 2||697
150563|NCT00395135|366327|P4|STARTED|Year 2||283
150564|NCT00395135|366328|P3|STARTED|Year 2||573
150565|NCT00395135|366329|P2|STARTED|Year 2||0
150566|NCT00395135|366330|P1|STARTED|Year 2||0
150567|NCT00395135|366326|P5|NOT COMPLETED|Year 1||0
150568|NCT00395135|366327|P4|NOT COMPLETED|Year 1||0
150569|NCT00395135|366328|P3|NOT COMPLETED|Year 1||0
150570|NCT00395135|366329|P2|NOT COMPLETED|Year 1||871
150571|NCT00395135|366330|P1|NOT COMPLETED|Year 1||712
150572|NCT00395135|366326|P5|COMPLETED|Year 1||0
150573|NCT00395135|366327|P4|COMPLETED|Year 1||0
150574|NCT00395135|366328|P3|COMPLETED|Year 1||0
150575|NCT00395135|366329|P2|COMPLETED|Year 1||716
150576|NCT00395135|366330|P1|COMPLETED|Year 1||883
150577|NCT00395135|366326|P5|STARTED|Year 1||0
150578|NCT00395135|366327|P4|STARTED|Year 1||0
150579|NCT00395135|366328|P3|STARTED|Year 1||0
150580|NCT00395135|366329|P2|STARTED|Year 1||1587
150581|NCT00395135|366330|P1|STARTED|Year 1||1595
150582|NCT00395161|366348|P2|NOT COMPLETED|Overall Study||0
150583|NCT00395161|366349|P1|NOT COMPLETED|Overall Study||0
150584|NCT00395161|366348|P2|COMPLETED|Overall Study||144
150585|NCT00395161|366349|P1|COMPLETED|Overall Study||149
150586|NCT00395161|366348|P2|STARTED|Overall Study||144
150587|NCT00395161|366349|P1|STARTED|Overall Study||149
150588|NCT00395226|366365|P2|NOT COMPLETED|Overall Study||5
150589|NCT00395226|366366|P1|NOT COMPLETED|Overall Study||4
150590|NCT00395226|366365|P2|COMPLETED|Overall Study||22
150591|NCT00395226|366366|P1|COMPLETED|Overall Study||22
150592|NCT00395226|366365|P2|STARTED|Overall Study||27
150593|NCT00395226|366366|P1|STARTED|Overall Study||26
150594|NCT00395291|366372|P2|NOT COMPLETED|Second Intervention||0
150595|NCT00395291|366373|P1|NOT COMPLETED|Second Intervention||0
150596|NCT00395291|366372|P2|COMPLETED|Second Intervention||9
150597|NCT00395291|366373|P1|COMPLETED|Second Intervention||13
150598|NCT00395291|366372|P2|STARTED|Second Intervention||9
150599|NCT00395291|366373|P1|STARTED|Second Intervention||13
150600|NCT00395291|366372|P2|NOT COMPLETED|Washout Period for 30 Days||0
150601|NCT00395291|366373|P1|NOT COMPLETED|Washout Period for 30 Days||2
150602|NCT00395291|366372|P2|COMPLETED|Washout Period for 30 Days||9
150603|NCT00395291|366373|P1|COMPLETED|Washout Period for 30 Days||13
150604|NCT00395291|366372|P2|STARTED|Washout Period for 30 Days||9
150605|NCT00395291|366373|P1|STARTED|Washout Period for 30 Days||15
150606|NCT00395291|366372|P2|NOT COMPLETED|First Intervention||0
150607|NCT00395291|366373|P1|NOT COMPLETED|First Intervention||2
150608|NCT00395291|366372|P2|COMPLETED|First Intervention||9
150609|NCT00395291|366373|P1|COMPLETED|First Intervention||15
150610|NCT00395291|366372|P2|STARTED|First Intervention||9
150611|NCT00395291|366373|P1|STARTED|First Intervention||17
150612|NCT00395304|366403|P6|NOT COMPLETED|Treatment Period 3||1
150613|NCT00395304|366404|P5|NOT COMPLETED|Treatment Period 3||0
150614|NCT00395304|366405|P4|NOT COMPLETED|Treatment Period 3||2
150615|NCT00395304|366406|P3|NOT COMPLETED|Treatment Period 3||0
150616|NCT00395304|366407|P2|NOT COMPLETED|Treatment Period 3||2
150617|NCT00395304|366408|P1|NOT COMPLETED|Treatment Period 3||1
150618|NCT00395304|366403|P6|COMPLETED|Treatment Period 3||27
150619|NCT00395304|366404|P5|COMPLETED|Treatment Period 3||27
150620|NCT00395304|366405|P4|COMPLETED|Treatment Period 3||25
150621|NCT00395304|366406|P3|COMPLETED|Treatment Period 3||29
150622|NCT00395304|366407|P2|COMPLETED|Treatment Period 3||20
150623|NCT00395304|366408|P1|COMPLETED|Treatment Period 3||29
150624|NCT00395304|366403|P6|STARTED|Treatment Period 3||28
150625|NCT00395304|366404|P5|STARTED|Treatment Period 3||27
150626|NCT00395304|366405|P4|STARTED|Treatment Period 3||27
150627|NCT00395304|366406|P3|STARTED|Treatment Period 3||29
150628|NCT00395304|366407|P2|STARTED|Treatment Period 3||22
150629|NCT00395304|366408|P1|STARTED|Treatment Period 3||30
150630|NCT00395304|366403|P6|NOT COMPLETED|Treatment Period 2||2
150631|NCT00395304|366404|P5|NOT COMPLETED|Treatment Period 2||0
150632|NCT00395304|366405|P4|NOT COMPLETED|Treatment Period 2||1
150633|NCT00395304|366406|P3|NOT COMPLETED|Treatment Period 2||1
150634|NCT00395304|366407|P2|NOT COMPLETED|Treatment Period 2||4
150635|NCT00395304|366408|P1|NOT COMPLETED|Treatment Period 2||0
150636|NCT00395304|366403|P6|COMPLETED|Treatment Period 2||28
150637|NCT00395304|366404|P5|COMPLETED|Treatment Period 2||27
150638|NCT00395304|366405|P4|COMPLETED|Treatment Period 2||27
150639|NCT00395304|366406|P3|COMPLETED|Treatment Period 2||29
150640|NCT00395304|366407|P2|COMPLETED|Treatment Period 2||22
150641|NCT00395304|366408|P1|COMPLETED|Treatment Period 2||30
150642|NCT00395304|366403|P6|STARTED|Treatment Period 2||30
150643|NCT00395304|366404|P5|STARTED|Treatment Period 2||27
150644|NCT00395304|366405|P4|STARTED|Treatment Period 2||28
150645|NCT00395304|366406|P3|STARTED|Treatment Period 2||30
150646|NCT00395304|366407|P2|STARTED|Treatment Period 2||26
150647|NCT00395304|366408|P1|STARTED|Treatment Period 2||30
150648|NCT00395304|366403|P6|NOT COMPLETED|Treatment Period 1||2
150649|NCT00395304|366404|P5|NOT COMPLETED|Treatment Period 1||1
150650|NCT00395304|366405|P4|NOT COMPLETED|Treatment Period 1||3
150651|NCT00395304|366406|P3|NOT COMPLETED|Treatment Period 1||0
150652|NCT00395304|366407|P2|NOT COMPLETED|Treatment Period 1||4
150653|NCT00395304|366408|P1|NOT COMPLETED|Treatment Period 1||1
150654|NCT00395304|366403|P6|COMPLETED|Treatment Period 1||30
150655|NCT00395304|366404|P5|COMPLETED|Treatment Period 1||27
150656|NCT00395304|366405|P4|COMPLETED|Treatment Period 1||28
150657|NCT00395304|366406|P3|COMPLETED|Treatment Period 1||30
150658|NCT00395304|366407|P2|COMPLETED|Treatment Period 1||26
150659|NCT00395304|366408|P1|COMPLETED|Treatment Period 1||30
150660|NCT00395304|366403|P6|STARTED|Treatment Period 1||32
150661|NCT00395304|366404|P5|STARTED|Treatment Period 1||28
150662|NCT00395304|366405|P4|STARTED|Treatment Period 1||31
150663|NCT00395304|366406|P3|STARTED|Treatment Period 1||30
150664|NCT00395304|366407|P2|STARTED|Treatment Period 1||30
150665|NCT00395304|366408|P1|STARTED|Treatment Period 1||31
150666|NCT00395343|366414|P2|NOT COMPLETED|Overall Study||36
150667|NCT00395343|366415|P1|NOT COMPLETED|Overall Study||41
150668|NCT00395343|366414|P2|COMPLETED|Overall Study||283
150669|NCT00395343|366415|P1|COMPLETED|Overall Study||281
150670|NCT00395343|366414|P2|STARTED|Overall Study||319
150671|NCT00395343|366415|P1|STARTED|Overall Study||322
150672|NCT00395447|366435|P2|NOT COMPLETED|Overall Study||111
150673|NCT00395447|366436|P1|NOT COMPLETED|Overall Study||121
150674|NCT00395447|366435|P2|COMPLETED|Overall Study||602
150675|NCT00395447|366436|P1|COMPLETED|Overall Study||910
150676|NCT00395447|366435|P2|STARTED|Overall Study||713
150677|NCT00395447|366436|P1|STARTED|Overall Study||1031
150678|NCT00395460|366444|P2|NOT COMPLETED|Overall Study||0
150679|NCT00395460|366445|P1|NOT COMPLETED|Overall Study||1
150680|NCT00395460|366444|P2|COMPLETED|Overall Study||75
150681|NCT00395460|366445|P1|COMPLETED|Overall Study||71
150682|NCT00395460|366444|P2|Received Treatment|Overall Study||75
150683|NCT00395460|366445|P1|Received Treatment|Overall Study|1 participant withdrew consent prior to study drug injection and did not receive any study drug.|71
150684|NCT00395460|366444|P2|STARTED|Overall Study||75
150685|NCT00395460|366445|P1|STARTED|Overall Study||72
150686|NCT00395486|366469|P2|NOT COMPLETED|Overall Study||5
150687|NCT00395486|366470|P1|NOT COMPLETED|Overall Study||6
150688|NCT00395486|366469|P2|COMPLETED|Overall Study|Completed subjects|121
150689|NCT00395486|366470|P1|COMPLETED|Overall Study|Completed subjects|126
150690|NCT00395486|366469|P2|STARTED|Overall Study|Randomized subjects|126
150691|NCT00395486|366470|P1|STARTED|Overall Study|Randomized subjects|132
150692|NCT00395512|366502|P4|NOT COMPLETED|Overall Study||38
150693|NCT00395512|366503|P3|NOT COMPLETED|Overall Study||28
150694|NCT00395512|366504|P2|NOT COMPLETED|Overall Study||37
150695|NCT00395512|366505|P1|NOT COMPLETED|Overall Study||38
150696|NCT00395512|366502|P4|COMPLETED|Overall Study||126
150697|NCT00395512|366503|P3|COMPLETED|Overall Study||136
150698|NCT00395512|366504|P2|COMPLETED|Overall Study||126
150699|NCT00395512|366505|P1|COMPLETED|Overall Study||126
150700|NCT00395512|366502|P4|Safety Set|Overall Study|1 participant was lost to follow-up post visit 1. It is unknown if they took any study medication.|163
150701|NCT00395512|366503|P3|Safety Set|Overall Study||164
150702|NCT00395512|366504|P2|Safety Set|Overall Study||163
150703|NCT00395512|366505|P1|Safety Set|Overall Study||164
150704|NCT00395512|366502|P4|STARTED|Overall Study||164
150705|NCT00395512|366503|P3|STARTED|Overall Study||164
150706|NCT00395512|366504|P2|STARTED|Overall Study||163
150707|NCT00395512|366505|P1|STARTED|Overall Study||164
150708|NCT00395629|366678|P3|NOT COMPLETED|Extension Study||3
150709|NCT00395629|366679|P2|NOT COMPLETED|Extension Study||0
150710|NCT00395629|366680|P1|NOT COMPLETED|Extension Study||0
150711|NCT00395629|366678|P3|COMPLETED|Extension Study||8
150712|NCT00395629|366679|P2|COMPLETED|Extension Study||6
150713|NCT00395629|366680|P1|COMPLETED|Extension Study||9
150714|NCT00395629|366678|P3|STARTED|Extension Study||11
150715|NCT00395629|366679|P2|STARTED|Extension Study||6
150716|NCT00395629|366680|P1|STARTED|Extension Study||9
150717|NCT00395629|366678|P3|NOT COMPLETED|Core Study||7
150718|NCT00395629|366679|P2|NOT COMPLETED|Core Study||4
150719|NCT00395629|366680|P1|NOT COMPLETED|Core Study||1
150720|NCT00395629|366678|P3|COMPLETED|Core Study||16
150721|NCT00395629|366679|P2|COMPLETED|Core Study||11
150722|NCT00395629|366680|P1|COMPLETED|Core Study||10
150723|NCT00395629|366678|P3|STARTED|Core Study||23
150724|NCT00395629|366679|P2|STARTED|Core Study||15
150725|NCT00395629|366680|P1|STARTED|Core Study||11
150726|NCT00395642|366694|P1|NOT COMPLETED|Overall Study||13
150727|NCT00395642|366694|P1|COMPLETED|Overall Study||53
150728|NCT00395642|366694|P1|STARTED|Overall Study||66
150729|NCT00395694|366700|P2|NOT COMPLETED|Continuation Phase||13
150730|NCT00395694|366701|P1|NOT COMPLETED|Continuation Phase||15
150731|NCT00395694|366700|P2|COMPLETED|Continuation Phase||35
150732|NCT00395694|366701|P1|COMPLETED|Continuation Phase||34
150733|NCT00395694|366700|P2|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|48
150734|NCT00395694|366701|P1|STARTED|Continuation Phase|One participant completing the Escalation/Maintenance Phase did not start the Continuation Phase.|49
150735|NCT00395694|366700|P2|NOT COMPLETED|Escalation Phase + Maintenance Phase||2
150736|NCT00395694|366701|P1|NOT COMPLETED|Escalation Phase + Maintenance Phase||1
150737|NCT00395694|366700|P2|COMPLETED|Escalation Phase + Maintenance Phase||49
150738|NCT00395694|366701|P1|COMPLETED|Escalation Phase + Maintenance Phase||50
150739|NCT00395694|366700|P2|STARTED|Escalation Phase + Maintenance Phase||51
150740|NCT00395694|366701|P1|STARTED|Escalation Phase + Maintenance Phase||51
150741|NCT00395733|366734|P2|NOT COMPLETED|Period 2||5
150742|NCT00395733|366735|P1|NOT COMPLETED|Period 2||2
150743|NCT00395733|366734|P2|COMPLETED|Period 2||37
150744|NCT00395733|366735|P1|COMPLETED|Period 2||39
150745|NCT00395733|366734|P2|STARTED|Period 2||42
150746|NCT00395733|366735|P1|STARTED|Period 2||41
150747|NCT00395733|366734|P2|NOT COMPLETED|Period 1||0
150748|NCT00395733|366735|P1|NOT COMPLETED|Period 1||0
150749|NCT00395733|366734|P2|COMPLETED|Period 1||42
150750|NCT00395733|366735|P1|COMPLETED|Period 1||41
150751|NCT00395733|366734|P2|STARTED|Period 1||42
150752|NCT00395733|366735|P1|STARTED|Period 1||41
150753|NCT00395746|366760|P3|NOT COMPLETED|Overall Study||22
150754|NCT00395746|366761|P2|NOT COMPLETED|Overall Study||4
150755|NCT00395746|366762|P1|NOT COMPLETED|Overall Study||10
150756|NCT00395746|366760|P3|COMPLETED|Overall Study|Completed 52 weeks treatment|66
150757|NCT00395746|366761|P2|COMPLETED|Overall Study|Completed 52 weeks treatment|84
150758|NCT00395746|366762|P1|COMPLETED|Overall Study|Completed 52 weeks treatment|78
150759|NCT00395746|366760|P3|STARTED|Overall Study|Exposed to study drug|88
150760|NCT00395746|366761|P2|STARTED|Overall Study|Exposed to study drug|88
150761|NCT00395746|366762|P1|STARTED|Overall Study|Exposed to study drug|88
150762|NCT00395850|366810|P4|NOT COMPLETED|Disulfiram/Placebo Treatment||13
150763|NCT00395850|366811|P3|NOT COMPLETED|Disulfiram/Placebo Treatment||19
150764|NCT00395850|366812|P2|NOT COMPLETED|Disulfiram/Placebo Treatment||14
150765|NCT00395850|366813|P1|NOT COMPLETED|Disulfiram/Placebo Treatment||9
150766|NCT00395850|366810|P4|COMPLETED|Disulfiram/Placebo Treatment||8
150767|NCT00395850|366811|P3|COMPLETED|Disulfiram/Placebo Treatment||5
150768|NCT00395850|366812|P2|COMPLETED|Disulfiram/Placebo Treatment||9
150769|NCT00395850|366813|P1|COMPLETED|Disulfiram/Placebo Treatment||11
150770|NCT00395850|366810|P4|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|21
150771|NCT00395850|366811|P3|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|24
150772|NCT00395850|366812|P2|STARTED|Disulfiram/Placebo Treatment|Received at least one dose of disulfiram|23
150773|NCT00395850|366813|P1|STARTED|Disulfiram/Placebo Treatment|Received >= 1 disulfiram dose. Two baseline/randomized subjects dropped out before receiving disulf|20
150774|NCT00395850|366810|P4|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||4
150775|NCT00395850|366811|P3|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||6
150776|NCT00395850|366812|P2|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||2
150777|NCT00395850|366813|P1|NOT COMPLETED|Randomization to Disulfiram/ Pre-admin||5
150778|NCT00395850|366810|P4|COMPLETED|Randomization to Disulfiram/ Pre-admin||21
150779|NCT00395850|366811|P3|COMPLETED|Randomization to Disulfiram/ Pre-admin||24
150780|NCT00395850|366812|P2|COMPLETED|Randomization to Disulfiram/ Pre-admin||23
150781|NCT00395850|366813|P1|COMPLETED|Randomization to Disulfiram/ Pre-admin||22
150782|NCT00395850|366810|P4|STARTED|Randomization to Disulfiram/ Pre-admin||25
150783|NCT00395850|366811|P3|STARTED|Randomization to Disulfiram/ Pre-admin||30
150784|NCT00395850|366812|P2|STARTED|Randomization to Disulfiram/ Pre-admin||25
150785|NCT00395850|366813|P1|STARTED|Randomization to Disulfiram/ Pre-admin||27
150786|NCT00395850|366810|P4|NOT COMPLETED|Pre-randomization Baseline/Induction||0
150787|NCT00395850|366811|P3|NOT COMPLETED|Pre-randomization Baseline/Induction||0
150788|NCT00395850|366812|P2|NOT COMPLETED|Pre-randomization Baseline/Induction||0
150789|NCT00395850|366813|P1|NOT COMPLETED|Pre-randomization Baseline/Induction||11
150790|NCT00395850|366810|P4|COMPLETED|Pre-randomization Baseline/Induction||0
150791|NCT00395850|366811|P3|COMPLETED|Pre-randomization Baseline/Induction||0
150792|NCT00395850|366812|P2|COMPLETED|Pre-randomization Baseline/Induction||0
150793|NCT00395850|366813|P1|COMPLETED|Pre-randomization Baseline/Induction||107
150794|NCT00395850|366810|P4|STARTED|Pre-randomization Baseline/Induction||0
150795|NCT00395850|366811|P3|STARTED|Pre-randomization Baseline/Induction||0
150796|NCT00395850|366812|P2|STARTED|Pre-randomization Baseline/Induction||0
150797|NCT00395850|366813|P1|STARTED|Pre-randomization Baseline/Induction|Pre-randomization and disulfiram (disulf) administration|118
150798|NCT00395863|366829|P2|NOT COMPLETED|Overall Study||3
150799|NCT00395863|366830|P1|NOT COMPLETED|Overall Study||2
150800|NCT00395863|366829|P2|COMPLETED|Overall Study||20
150801|NCT00395863|366830|P1|COMPLETED|Overall Study||21
150802|NCT00395863|366829|P2|STARTED|Overall Study||23
150803|NCT00395863|366830|P1|STARTED|Overall Study||23
150804|NCT00395876|366863|P2|NOT COMPLETED|Overall Study||0
150805|NCT00395876|366864|P1|NOT COMPLETED|Overall Study||3
150806|NCT00395876|366863|P2|COMPLETED|Overall Study||50
150807|NCT00395876|366864|P1|COMPLETED|Overall Study||47
150808|NCT00395876|366863|P2|STARTED|Overall Study||50
150809|NCT00395876|366864|P1|STARTED|Overall Study||50
150810|NCT00395967|366890|P1|NOT COMPLETED|Follow-up Period||2
150811|NCT00395967|366890|P1|COMPLETED|Follow-up Period||3
150812|NCT00395967|366890|P1|STARTED|Follow-up Period|Participants who had transplants.|5
150813|NCT00395967|366890|P1|NOT COMPLETED|Treatment Period||1
150814|NCT00395967|366890|P1|COMPLETED|Treatment Period|Failed mobilization due to <2 fold yield after one day of plerixafor treatment|4
150815|NCT00395967|366890|P1|STARTED|Treatment Period||5
150816|NCT00395993|366901|P2|NOT COMPLETED|Overall Study||19
150817|NCT00395993|366902|P1|NOT COMPLETED|Overall Study||35
150818|NCT00395993|366901|P2|COMPLETED|Overall Study||212
150819|NCT00395993|366902|P1|COMPLETED|Overall Study||211
150820|NCT00395993|366901|P2|STARTED|Overall Study||231
150821|NCT00395993|366902|P1|STARTED|Overall Study||246
150822|NCT00396006|366908|P1|NOT COMPLETED|Overall Study||0
150823|NCT00396006|366908|P1|COMPLETED|Overall Study||13
150824|NCT00396006|366908|P1|STARTED|Overall Study||13
150825|NCT00396032|366925|P2|NOT COMPLETED|Overall Study||5
150826|NCT00396032|366926|P1|NOT COMPLETED|Overall Study||4
150827|NCT00396032|366925|P2|COMPLETED|Overall Study||71
150828|NCT00396032|366926|P1|COMPLETED|Overall Study||70
150829|NCT00396032|366925|P2|STARTED|Overall Study||76
150830|NCT00396032|366926|P1|STARTED|Overall Study||74
150831|NCT00396084|366946|P6|NOT COMPLETED|Overall Study||2
150832|NCT00396084|366947|P5|NOT COMPLETED|Overall Study||1
150833|NCT00396084|366948|P4|NOT COMPLETED|Overall Study||1
150834|NCT00396084|366949|P3|NOT COMPLETED|Overall Study||0
150835|NCT00396084|366950|P2|NOT COMPLETED|Overall Study||0
150836|NCT00396084|366951|P1|NOT COMPLETED|Overall Study||0
150837|NCT00396084|366946|P6|COMPLETED|Overall Study||18
150838|NCT00396084|366947|P5|COMPLETED|Overall Study||9
150839|NCT00396084|366948|P4|COMPLETED|Overall Study||9
150840|NCT00396084|366949|P3|COMPLETED|Overall Study||10
150841|NCT00396084|366950|P2|COMPLETED|Overall Study||10
150842|NCT00396084|366951|P1|COMPLETED|Overall Study||10
150843|NCT00396084|366946|P6|STARTED|Overall Study||20
150844|NCT00396084|366947|P5|STARTED|Overall Study||10
150845|NCT00396084|366948|P4|STARTED|Overall Study||10
150846|NCT00396084|366949|P3|STARTED|Overall Study||10
150847|NCT00396084|366950|P2|STARTED|Overall Study||10
150848|NCT00396084|366951|P1|STARTED|Overall Study||10
150849|NCT00396097|367026|P2|NOT COMPLETED|Overall Study||46
150850|NCT00396097|367027|P1|NOT COMPLETED|Overall Study||26
150851|NCT00396097|367026|P2|COMPLETED|Overall Study||156
150852|NCT00396097|367027|P1|COMPLETED|Overall Study||88
150853|NCT00396097|367026|P2|STARTED|Overall Study||202
150854|NCT00396097|367027|P1|STARTED|Overall Study|4 participants randomized to Individualized Dose, received Standard Dose throughout the study.|114
150855|NCT00396136|367049|P1|NOT COMPLETED|Overall Study||125
150856|NCT00396136|367049|P1|COMPLETED|Overall Study||96
150857|NCT00396136|367049|P1|STARTED|Overall Study||221
150858|NCT00396162|367056|P2|NOT COMPLETED|Overall Study||3
150859|NCT00396162|367057|P1|NOT COMPLETED|Overall Study||2
150860|NCT00396162|367056|P2|COMPLETED|Overall Study||35
150861|NCT00396162|367057|P1|COMPLETED|Overall Study||37
150862|NCT00396162|367056|P2|STARTED|Overall Study||38
150863|NCT00396162|367057|P1|STARTED|Overall Study||39
150864|NCT00396201|367069|P1|NOT COMPLETED|Follow-up Period||0
150865|NCT00396201|367069|P1|COMPLETED|Follow-up Period|Follow-up visit 12 months post-transplant|21
150866|NCT00396201|367069|P1|STARTED|Follow-up Period|Participants who had transplants. One had insufficient collection of cells so no transplant.|21
150867|NCT00396201|367069|P1|NOT COMPLETED|Treatment Period||0
150868|NCT00396201|367069|P1|COMPLETED|Treatment Period|Completed refers to completed all treatment visits.|22
150869|NCT00396201|367069|P1|STARTED|Treatment Period||22
150870|NCT00396253|367086|P1|NOT COMPLETED|Overall Study||13
150871|NCT00396253|367086|P1|COMPLETED|Overall Study||210
150872|NCT00396253|367086|P1|STARTED|Overall Study||223
150873|NCT00396266|367100|P2|NOT COMPLETED|Overall Study||0
150874|NCT00396266|367101|P1|NOT COMPLETED|Overall Study||0
150875|NCT00396266|367100|P2|COMPLETED|Overall Study||14
150876|NCT00396266|367101|P1|COMPLETED|Overall Study||8
150877|NCT00396266|367100|P2|STARTED|Overall Study||14
150878|NCT00396266|367101|P1|STARTED|Overall Study||8
150879|NCT00396279|367122|P1|NOT COMPLETED|Overall Study||30
150880|NCT00396279|367122|P1|COMPLETED|Overall Study|Defined as participants with a complete resection|7
150881|NCT00396279|367122|P1|STARTED|Overall Study||37
150882|NCT00396292|367133|P2|NOT COMPLETED|Overall Study||16
150883|NCT00396292|367134|P1|NOT COMPLETED|Overall Study||9
150884|NCT00396292|367133|P2|COMPLETED|Overall Study||162
150885|NCT00396292|367134|P1|COMPLETED|Overall Study||165
150886|NCT00396292|367133|P2|STARTED|Overall Study||178
150887|NCT00396292|367134|P1|STARTED|Overall Study||174
150888|NCT00396318|367140|P1|NOT COMPLETED|7-Day Post-Treatment Contact||1
150889|NCT00396318|367140|P1|COMPLETED|7-Day Post-Treatment Contact||240
150890|NCT00396318|367140|P1|STARTED|7-Day Post-Treatment Contact||241
150891|NCT00396318|367140|P1|NOT COMPLETED|48- to 96-Hour Follow-Up Period||5
150892|NCT00396318|367140|P1|COMPLETED|48- to 96-Hour Follow-Up Period||241
150893|NCT00396318|367140|P1|STARTED|48- to 96-Hour Follow-Up Period||246
150894|NCT00396318|367140|P1|NOT COMPLETED|At Least One Dose of Tenecteplase (MITT)||5
150895|NCT00396318|367140|P1|COMPLETED|At Least One Dose of Tenecteplase (MITT)||241
150896|NCT00396318|367140|P1|STARTED|At Least One Dose of Tenecteplase (MITT)||246
150897|NCT00396331|367155|P1|NOT COMPLETED|Overall Study||32
150898|NCT00396331|367155|P1|COMPLETED|Overall Study||68
150899|NCT00396331|367155|P1|Number of Participants Transplanted|Overall Study|7 participants had two transplants|87
150900|NCT00396331|367155|P1|Number of Participants Treated|Overall Study||100
150901|NCT00396331|367155|P1|STARTED|Overall Study||100
150902|NCT00396383|367208|P1|NOT COMPLETED|Overall Study||3
150903|NCT00396383|367208|P1|COMPLETED|Overall Study||6
150904|NCT00396383|367208|P1|STARTED|Overall Study||9
150905|NCT00396409|367219|P2|NOT COMPLETED|Period 2 - 2008||2
150906|NCT00396409|367220|P1|NOT COMPLETED|Period 2 - 2008||7
150907|NCT00396409|367219|P2|COMPLETED|Period 2 - 2008||53
150908|NCT00396409|367220|P1|COMPLETED|Period 2 - 2008||52
150909|NCT00396409|367219|P2|STARTED|Period 2 - 2008||55
150910|NCT00396409|367220|P1|STARTED|Period 2 - 2008||59
150911|NCT00396409|367219|P2|NOT COMPLETED|Between Period 1 and Period 2||2
150912|NCT00396409|367220|P1|NOT COMPLETED|Between Period 1 and Period 2||3
150913|NCT00396409|367219|P2|COMPLETED|Between Period 1 and Period 2||55
150914|NCT00396409|367220|P1|COMPLETED|Between Period 1 and Period 2||59
150915|NCT00396409|367219|P2|STARTED|Between Period 1 and Period 2||57
150916|NCT00396409|367220|P1|STARTED|Between Period 1 and Period 2||62
150917|NCT00396409|367219|P2|NOT COMPLETED|Period 1 - 2007||6
150918|NCT00396409|367220|P1|NOT COMPLETED|Period 1 - 2007||3
150919|NCT00396409|367219|P2|COMPLETED|Period 1 - 2007||57
150920|NCT00396409|367220|P1|COMPLETED|Period 1 - 2007||62
150921|NCT00396409|367219|P2|STARTED|Period 1 - 2007||63
150922|NCT00396409|367220|P1|STARTED|Period 1 - 2007||65
150923|NCT00396565|367253|P3|NOT COMPLETED|Overall Study||17
150924|NCT00396565|367254|P2|NOT COMPLETED|Overall Study||91
150925|NCT00396565|367255|P1|NOT COMPLETED|Overall Study||48
150926|NCT00396565|367253|P3|COMPLETED|Overall Study||30
150927|NCT00396565|367254|P2|COMPLETED|Overall Study||47
150928|NCT00396565|367255|P1|COMPLETED|Overall Study||88
150929|NCT00396565|367253|P3|STARTED|Overall Study||47
150930|NCT00396565|367254|P2|STARTED|Overall Study||138
150931|NCT00396565|367255|P1|STARTED|Overall Study||136
150932|NCT00396591|367278|P1|NOT COMPLETED|Overall Study||16
150933|NCT00396591|367278|P1|COMPLETED|Overall Study||0
150934|NCT00396591|367278|P1|STARTED|Overall Study||16
150935|NCT00396630|367290|P2|NOT COMPLETED|Overall Study||5
150936|NCT00396630|367291|P1|NOT COMPLETED|Overall Study||5
150937|NCT00396630|367290|P2|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
150938|NCT00396630|367291|P1|COMPLETED|Overall Study|Completed Visit 4 (Week 17).|95
150939|NCT00396630|367290|P2|STARTED|Overall Study||100
150940|NCT00396630|367291|P1|STARTED|Overall Study||100
150941|NCT00396656|367308|P2|NOT COMPLETED|Second Treatment Period||1
150942|NCT00396656|367309|P1|NOT COMPLETED|Second Treatment Period||0
150943|NCT00396656|367308|P2|COMPLETED|Second Treatment Period||12
150944|NCT00396656|367309|P1|COMPLETED|Second Treatment Period||15
150945|NCT00396656|367308|P2|STARTED|Second Treatment Period||13
150946|NCT00396656|367309|P1|STARTED|Second Treatment Period||15
150947|NCT00396656|367308|P2|NOT COMPLETED|First Treatment Period||2
150948|NCT00396656|367309|P1|NOT COMPLETED|First Treatment Period||0
150949|NCT00396656|367308|P2|COMPLETED|First Treatment Period||13
150950|NCT00396656|367309|P1|COMPLETED|First Treatment Period||15
150951|NCT00396656|367308|P2|STARTED|First Treatment Period||15
150952|NCT00396656|367309|P1|STARTED|First Treatment Period||15
150953|NCT00396812|367325|P1|NOT COMPLETED|Overall Study||1
150954|NCT00396812|367325|P1|COMPLETED|Overall Study|4 subjects completed treatment, but 1 subject terminated early due to disease progression|3
150955|NCT00396812|367325|P1|STARTED|Overall Study||4
150956|NCT00396877|367339|P2|NOT COMPLETED|Overall Study||8
150957|NCT00396877|367340|P1|NOT COMPLETED|Overall Study||6
150958|NCT00396877|367339|P2|COMPLETED|Overall Study|Completed follow-up|459
150959|NCT00396877|367340|P1|COMPLETED|Overall Study|Completed follow-up|433
150960|NCT00396877|367339|P2|Completed Treatment|Overall Study||352
150961|NCT00396877|367340|P1|Completed Treatment|Overall Study||356
150962|NCT00396877|367339|P2|Treated|Overall Study||464
150963|NCT00396877|367340|P1|Treated|Overall Study||436
150964|NCT00396877|367339|P2|STARTED|Overall Study|Randomized|467
150965|NCT00396877|367340|P1|STARTED|Overall Study|Randomized|439
150966|NCT00396981|367352|P2|NOT COMPLETED|Overall Study||9
150967|NCT00396981|367353|P1|NOT COMPLETED|Overall Study||15
150968|NCT00396981|367352|P2|COMPLETED|Overall Study||306
150969|NCT00396981|367353|P1|COMPLETED|Overall Study||296
150970|NCT00396981|367352|P2|STARTED|Overall Study||315
150971|NCT00396981|367353|P1|STARTED|Overall Study||311
150972|NCT00397033|367374|P3|NOT COMPLETED|Overall Study||23
150973|NCT00397033|367375|P2|NOT COMPLETED|Overall Study||37
150974|NCT00397033|367376|P1|NOT COMPLETED|Overall Study||44
150975|NCT00397033|367374|P3|COMPLETED|Overall Study||77
150976|NCT00397033|367375|P2|COMPLETED|Overall Study||72
150977|NCT00397033|367376|P1|COMPLETED|Overall Study||63
150978|NCT00397033|367374|P3|ITT Population|Overall Study||98
150979|NCT00397033|367375|P2|ITT Population|Overall Study||105
150980|NCT00397033|367376|P1|ITT Population|Overall Study||107
150981|NCT00397033|367374|P3|Safety Population: >= 1 Dose of Drug|Overall Study||98
150982|NCT00397033|367375|P2|Safety Population: >= 1 Dose of Drug|Overall Study||108
150983|NCT00397033|367376|P1|Safety Population: >= 1 Dose of Drug|Overall Study||107
150984|NCT00397033|367374|P3|STARTED|Overall Study||100
150985|NCT00397033|367375|P2|STARTED|Overall Study||109
150986|NCT00397033|367376|P1|STARTED|Overall Study||107
150987|NCT00397150|367437|P2|NOT COMPLETED|Overall Study||145
150988|NCT00397150|367438|P1|NOT COMPLETED|Overall Study||135
150989|NCT00397150|367437|P2|COMPLETED|Overall Study||1111
150990|NCT00397150|367438|P1|COMPLETED|Overall Study||1188
150991|NCT00397150|367437|P2|STARTED|Overall Study||1256
150992|NCT00397150|367438|P1|STARTED|Overall Study||1323
150993|NCT00397189|367452|P2|NOT COMPLETED|Extension Period||43
150994|NCT00397189|367453|P1|NOT COMPLETED|Extension Period||113
150995|NCT00397189|367452|P2|COMPLETED|Extension Period||134
150996|NCT00397189|367453|P1|COMPLETED|Extension Period||421
150997|NCT00397189|367452|P2|STARTED|Extension Period|Please note randomization ratio in extension is 3:1|177
150998|NCT00397189|367453|P1|STARTED|Extension Period|Not all completers continued to extension as only patients who wished to proceed were randomized.|534
150999|NCT00397189|367452|P2|NOT COMPLETED|3 Weeks Period||22
151000|NCT00397189|367453|P1|NOT COMPLETED|3 Weeks Period||21
151001|NCT00397189|367452|P2|COMPLETED|3 Weeks Period|out of 373, 362 were included in the ITT population detailed in the Baseline Characteristics|373
151002|NCT00397189|367453|P1|COMPLETED|3 Weeks Period|out of 373, 360 were included in the ITT population detailed in the Baseline Characteristics.|373
151003|NCT00397189|367452|P2|STARTED|3 Weeks Period||395
151004|NCT00397189|367453|P1|STARTED|3 Weeks Period||394
151005|NCT00397215|367463|P4|NOT COMPLETED|Month 24 (Day 720)||0
151006|NCT00397215|367464|P3|NOT COMPLETED|Month 24 (Day 720)||0
151007|NCT00397215|367465|P2|NOT COMPLETED|Month 24 (Day 720)||0
151008|NCT00397215|367466|P1|NOT COMPLETED|Month 24 (Day 720)||0
151009|NCT00397215|367463|P4|COMPLETED|Month 24 (Day 720)||36
151010|NCT00397215|367464|P3|COMPLETED|Month 24 (Day 720)||117
151011|NCT00397215|367465|P2|COMPLETED|Month 24 (Day 720)||45
151012|NCT00397215|367466|P1|COMPLETED|Month 24 (Day 720)||122
151013|NCT00397215|367463|P4|STARTED|Month 24 (Day 720)||36
151014|NCT00397215|367464|P3|STARTED|Month 24 (Day 720)||117
151015|NCT00397215|367465|P2|STARTED|Month 24 (Day 720)||45
151016|NCT00397215|367466|P1|STARTED|Month 24 (Day 720)||122
151017|NCT00397215|367463|P4|NOT COMPLETED|Month 12 (Day 360)||0
151018|NCT00397215|367464|P3|NOT COMPLETED|Month 12 (Day 360)||0
151019|NCT00397215|367465|P2|NOT COMPLETED|Month 12 (Day 360)||0
151020|NCT00397215|367466|P1|NOT COMPLETED|Month 12 (Day 360)||0
151021|NCT00397215|367463|P4|COMPLETED|Month 12 (Day 360)||42
151022|NCT00397215|367464|P3|COMPLETED|Month 12 (Day 360)||125
151023|NCT00397215|367465|P2|COMPLETED|Month 12 (Day 360)||48
151024|NCT00397215|367466|P1|COMPLETED|Month 12 (Day 360)||130
151025|NCT00397215|367463|P4|STARTED|Month 12 (Day 360)||42
151026|NCT00397215|367464|P3|STARTED|Month 12 (Day 360)||125
151027|NCT00397215|367465|P2|STARTED|Month 12 (Day 360)||48
151028|NCT00397215|367466|P1|STARTED|Month 12 (Day 360)||130
151029|NCT00397215|367463|P4|NOT COMPLETED|Month 6 (Day 180)||0
151030|NCT00397215|367464|P3|NOT COMPLETED|Month 6 (Day 180)||5
151031|NCT00397215|367465|P2|NOT COMPLETED|Month 6 (Day 180)||3
151032|NCT00397215|367466|P1|NOT COMPLETED|Month 6 (Day 180)||2
151033|NCT00397215|367463|P4|COMPLETED|Month 6 (Day 180)||51
151034|NCT00397215|367464|P3|COMPLETED|Month 6 (Day 180)||153
151035|NCT00397215|367465|P2|COMPLETED|Month 6 (Day 180)||55
151036|NCT00397215|367466|P1|COMPLETED|Month 6 (Day 180)||162
151037|NCT00397215|367463|P4|STARTED|Month 6 (Day 180)||51
151038|NCT00397215|367464|P3|STARTED|Month 6 (Day 180)||158
151039|NCT00397215|367465|P2|STARTED|Month 6 (Day 180)||58
151040|NCT00397215|367466|P1|STARTED|Month 6 (Day 180)||164
151041|NCT00397215|367463|P4|NOT COMPLETED|Month 0 (Day 0)||4
151042|NCT00397215|367464|P3|NOT COMPLETED|Month 0 (Day 0)||6
151043|NCT00397215|367465|P2|NOT COMPLETED|Month 0 (Day 0)||5
151044|NCT00397215|367466|P1|NOT COMPLETED|Month 0 (Day 0)||7
151045|NCT00397215|367463|P4|COMPLETED|Month 0 (Day 0)||48
151046|NCT00397215|367464|P3|COMPLETED|Month 0 (Day 0)||153
151047|NCT00397215|367465|P2|COMPLETED|Month 0 (Day 0)||56
151048|NCT00397215|367466|P1|COMPLETED|Month 0 (Day 0)||158
151049|NCT00397215|367463|P4|STARTED|Month 0 (Day 0)||52
151050|NCT00397215|367464|P3|STARTED|Month 0 (Day 0)||159
151051|NCT00397215|367465|P2|STARTED|Month 0 (Day 0)||61
151052|NCT00397215|367466|P1|STARTED|Month 0 (Day 0)||165
151053|NCT00397254|367600|P2|NOT COMPLETED|Overall Study||2
151054|NCT00397254|367601|P1|NOT COMPLETED|Overall Study||2
151055|NCT00397254|367600|P2|COMPLETED|Overall Study||74
151056|NCT00397254|367601|P1|COMPLETED|Overall Study||77
151057|NCT00397254|367600|P2|STARTED|Overall Study||76
151058|NCT00397254|367601|P1|STARTED|Overall Study||79
151059|NCT00404495|367621|P2|NOT COMPLETED|Overall Study||11
151060|NCT00404495|367622|P1|NOT COMPLETED|Overall Study||44
151061|NCT00404495|367621|P2|COMPLETED|Overall Study||6
151062|NCT00404495|367622|P1|COMPLETED|Overall Study||22
151063|NCT00404495|367621|P2|STARTED|Overall Study||17
151064|NCT00404495|367622|P1|STARTED|Overall Study||66
151065|NCT00404547|367640|P2|NOT COMPLETED|Overall Study||25
151066|NCT00404547|367641|P1|NOT COMPLETED|Overall Study||90
151067|NCT00404547|367640|P2|COMPLETED|Overall Study||334
151068|NCT00404547|367641|P1|COMPLETED|Overall Study||672
151069|NCT00404547|367640|P2|STARTED|Overall Study||359
151070|NCT00404547|367641|P1|STARTED|Overall Study||762
151071|NCT00404651|367653|P4|NOT COMPLETED|Overall Study||21
151072|NCT00404651|367654|P3|NOT COMPLETED|Overall Study||45
151073|NCT00404651|367655|P2|NOT COMPLETED|Overall Study||28
151074|NCT00404651|367656|P1|NOT COMPLETED|Overall Study||39
151075|NCT00404651|367653|P4|COMPLETED|Overall Study||146
151076|NCT00404651|367654|P3|COMPLETED|Overall Study||294
151077|NCT00404651|367655|P2|COMPLETED|Overall Study||315
151078|NCT00404651|367656|P1|COMPLETED|Overall Study||301
151079|NCT00404651|367653|P4|STARTED|Overall Study||167
151080|NCT00404651|367654|P3|STARTED|Overall Study||339
151081|NCT00404651|367655|P2|STARTED|Overall Study||343
151082|NCT00404651|367656|P1|STARTED|Overall Study||340
151083|NCT00405509|367684|P2|NOT COMPLETED|Overall Study||0
151084|NCT00405509|367685|P1|NOT COMPLETED|Overall Study||0
151085|NCT00405509|367684|P2|COMPLETED|Overall Study||22
151086|NCT00405509|367685|P1|COMPLETED|Overall Study||11
151087|NCT00405509|367684|P2|STARTED|Overall Study||22
151088|NCT00405509|367685|P1|STARTED|Overall Study||11
151089|NCT00405548|367701|P2|NOT COMPLETED|Overall Study||1
151090|NCT00405548|367702|P1|NOT COMPLETED|Overall Study||4
151091|NCT00405548|367701|P2|COMPLETED|Overall Study||12
151092|NCT00405548|367702|P1|COMPLETED|Overall Study||24
151093|NCT00405548|367701|P2|STARTED|Overall Study||13
151094|NCT00405548|367702|P1|STARTED|Overall Study||28
151095|NCT00405587|367718|P4|NOT COMPLETED|Overall Study||20
151096|NCT00405587|367719|P3|NOT COMPLETED|Overall Study||22
151097|NCT00405587|367720|P2|NOT COMPLETED|Overall Study||28
151098|NCT00405587|367721|P1|NOT COMPLETED|Overall Study||26
151099|NCT00405587|367718|P4|COMPLETED|Overall Study||1
151100|NCT00405587|367719|P3|COMPLETED|Overall Study||10
151101|NCT00405587|367720|P2|COMPLETED|Overall Study||2
151102|NCT00405587|367721|P1|COMPLETED|Overall Study||0
151103|NCT00405587|367718|P4|STARTED|Overall Study||21
151104|NCT00405587|367719|P3|STARTED|Overall Study||32
151105|NCT00405587|367720|P2|STARTED|Overall Study||30
151106|NCT00405587|367721|P1|STARTED|Overall Study||26
151107|NCT00405639|367839|P2|NOT COMPLETED|Overall Study||0
151108|NCT00405639|367840|P1|NOT COMPLETED|Overall Study||3
151109|NCT00405639|367839|P2|COMPLETED|Overall Study||12
151110|NCT00405639|367840|P1|COMPLETED|Overall Study||22
151111|NCT00405639|367839|P2|STARTED|Overall Study||12
151112|NCT00405639|367840|P1|STARTED|Overall Study||25
151113|NCT00405652|367852|P1|NOT COMPLETED|Overall Study||4
151114|NCT00405652|367852|P1|COMPLETED|Overall Study||30
151115|NCT00405652|367852|P1|STARTED|Overall Study||34
151116|NCT00405704|367859|P2|NOT COMPLETED|Overall Study||46
151117|NCT00405704|367860|P1|NOT COMPLETED|Overall Study||41
151118|NCT00405704|367859|P2|COMPLETED|Overall Study||259
151119|NCT00405704|367860|P1|COMPLETED|Overall Study||261
151120|NCT00405704|367859|P2|Recurrent UTI With TMP-SMZ Panel|Overall Study||69
151121|NCT00405704|367860|P1|Recurrent UTI With TMP-SMZ Panel|Overall Study||38
151122|NCT00405704|367859|P2|Recurrent UTI With E. Coli|Overall Study||57
151123|NCT00405704|367860|P1|Recurrent UTI With E. Coli|Overall Study||30
151124|NCT00405704|367859|P2|Outcome Stool Assessed|Overall Study||210
151125|NCT00405704|367860|P1|Outcome Stool Assessed|Overall Study||203
151126|NCT00405704|367859|P2|Completed Assessments for New Scarring|Overall Study||227
151127|NCT00405704|367860|P1|Completed Assessments for New Scarring|Overall Study||220
151128|NCT00405704|367859|P2|Completed Outcome Renal Scan|Overall Study||235
151129|NCT00405704|367860|P1|Completed Outcome Renal Scan|Overall Study||227
151130|NCT00405704|367859|P2|STARTED|Overall Study||305
151131|NCT00405704|367860|P1|STARTED|Overall Study||302
151132|NCT00405756|367883|P3|NOT COMPLETED|Follow-up||88
151133|NCT00405756|367884|P2|NOT COMPLETED|Follow-up||90
151134|NCT00405756|367885|P1|NOT COMPLETED|Follow-up||75
151135|NCT00405756|367883|P3|COMPLETED|Follow-up||0
151136|NCT00405756|367884|P2|COMPLETED|Follow-up||0
151137|NCT00405756|367885|P1|COMPLETED|Follow-up||0
151138|NCT00405756|367883|P3|STARTED|Follow-up|52 participants from the Double-blind and 36 from the Open Label Extension|88
151139|NCT00405756|367884|P2|STARTED|Follow-up|65 participants from the Double-blind and 25 from the Open Label Extension|90
151140|NCT00405756|367885|P1|STARTED|Follow-up|66 participants from Double-blind and 9 from the Open Label Extension|75
151141|NCT00405756|367883|P3|NOT COMPLETED|Open-label Extension||72
151142|NCT00405756|367884|P2|NOT COMPLETED|Open-label Extension||47
151143|NCT00405756|367885|P1|NOT COMPLETED|Open-label Extension||19
151144|NCT00405756|367883|P3|COMPLETED|Open-label Extension||0
151145|NCT00405756|367884|P2|COMPLETED|Open-label Extension||0
151146|NCT00405756|367885|P1|COMPLETED|Open-label Extension|Participants continue until disease progression or other reason for discontinuing.|0
151147|NCT00405756|367883|P3|STARTED|Open-label Extension||72
151148|NCT00405756|367884|P2|STARTED|Open-label Extension||47
151149|NCT00405756|367885|P1|STARTED|Open-label Extension||19
151150|NCT00405756|367883|P3|NOT COMPLETED|Double-blind Treatment||154
151151|NCT00405756|367884|P2|NOT COMPLETED|Double-blind Treatment||153
151152|NCT00405756|367885|P1|NOT COMPLETED|Double-blind Treatment||152
151153|NCT00405756|367883|P3|COMPLETED|Double-blind Treatment||0
151154|NCT00405756|367884|P2|COMPLETED|Double-blind Treatment||0
151155|NCT00405756|367885|P1|COMPLETED|Double-blind Treatment|Double-blind Treatment Period had no defined completion.|0
151156|NCT00405756|367883|P3|Safety Population|Double-blind Treatment||153
151157|NCT00405756|367884|P2|Safety Population|Double-blind Treatment||152
151158|NCT00405756|367885|P1|Safety Population|Double-blind Treatment|Participants who took at least one dose of study drug.|150
151159|NCT00405756|367883|P3|STARTED|Double-blind Treatment||154
151160|NCT00405756|367884|P2|STARTED|Double-blind Treatment||153
151161|NCT00405756|367885|P1|STARTED|Double-blind Treatment|Intent to treat population of all randomized participants|152
151162|NCT00405821|367975|P2|NOT COMPLETED|Overall Study||22
151163|NCT00405821|367976|P1|NOT COMPLETED|Overall Study||22
151164|NCT00405821|367975|P2|COMPLETED|Overall Study||198
151165|NCT00405821|367976|P1|COMPLETED|Overall Study||198
151166|NCT00405821|367975|P2|STARTED|Overall Study||220
151167|NCT00405821|367976|P1|STARTED|Overall Study||220
151168|NCT00405912|367989|P3|NOT COMPLETED|Overall Study||16
151169|NCT00405912|367990|P2|NOT COMPLETED|Overall Study||19
151170|NCT00405912|367991|P1|NOT COMPLETED|Overall Study||16
151171|NCT00405912|367989|P3|COMPLETED|Overall Study||23
151172|NCT00405912|367990|P2|COMPLETED|Overall Study||21
151173|NCT00405912|367991|P1|COMPLETED|Overall Study||23
151174|NCT00405912|367989|P3|STARTED|Overall Study||39
151175|NCT00405912|367990|P2|STARTED|Overall Study||40
151176|NCT00405912|367991|P1|STARTED|Overall Study||39
151177|NCT00405938|368004|P2|NOT COMPLETED|Overall Study||0
151178|NCT00405938|368005|P1|NOT COMPLETED|Overall Study||0
151179|NCT00405938|368004|P2|COMPLETED|Overall Study||41
151180|NCT00405938|368005|P1|COMPLETED|Overall Study||38
151181|NCT00405938|368004|P2|STARTED|Overall Study||41
151182|NCT00405938|368005|P1|STARTED|Overall Study||38
151183|NCT00405964|368013|P2|NOT COMPLETED|Overall Study||95
151184|NCT00405964|368014|P1|NOT COMPLETED|Overall Study||59
151185|NCT00405964|368013|P2|COMPLETED|Overall Study||261
151186|NCT00405964|368014|P1|COMPLETED|Overall Study||301
151187|NCT00405964|368013|P2|STARTED|Overall Study||356
151188|NCT00405964|368014|P1|STARTED|Overall Study||360
151189|NCT00406029|368029|P5|NOT COMPLETED|Overall Study||8
151190|NCT00406029|368030|P4|NOT COMPLETED|Overall Study||17
151191|NCT00406029|368031|P3|NOT COMPLETED|Overall Study||10
151192|NCT00406029|368032|P2|NOT COMPLETED|Overall Study||8
151193|NCT00406029|368033|P1|NOT COMPLETED|Overall Study||16
151194|NCT00406029|368029|P5|COMPLETED|Overall Study||41
151195|NCT00406029|368030|P4|COMPLETED|Overall Study||40
151196|NCT00406029|368031|P3|COMPLETED|Overall Study||39
151197|NCT00406029|368032|P2|COMPLETED|Overall Study||41
151198|NCT00406029|368033|P1|COMPLETED|Overall Study||33
151199|NCT00406029|368029|P5|Treated|Overall Study||47
151200|NCT00406029|368030|P4|Treated|Overall Study||54
151201|NCT00406029|368031|P3|Treated|Overall Study||47
151202|NCT00406029|368032|P2|Treated|Overall Study||49
151203|NCT00406029|368033|P1|Treated|Overall Study||49
151204|NCT00406029|368029|P5|STARTED|Overall Study||49
151205|NCT00406029|368030|P4|STARTED|Overall Study||57
151206|NCT00406029|368031|P3|STARTED|Overall Study||49
151207|NCT00406029|368032|P2|STARTED|Overall Study||49
151208|NCT00406029|368033|P1|STARTED|Overall Study||49
151209|NCT00406107|368137|P2|NOT COMPLETED|Overall Study||1
151210|NCT00406107|368138|P1|NOT COMPLETED|Overall Study||1
151211|NCT00406107|368137|P2|COMPLETED|Overall Study||4
151212|NCT00406107|368138|P1|COMPLETED|Overall Study||14
151213|NCT00406107|368137|P2|STARTED|Overall Study||5
151214|NCT00406107|368138|P1|STARTED|Overall Study||15
151215|NCT00406133|368152|P4|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
151216|NCT00406133|368153|P3|NOT COMPLETED|Phase 2 (Second 26 Week Period)||0
151217|NCT00406133|368154|P2|NOT COMPLETED|Phase 2 (Second 26 Week Period)||3
151218|NCT00406133|368155|P1|NOT COMPLETED|Phase 2 (Second 26 Week Period)||2
151219|NCT00406133|368152|P4|COMPLETED|Phase 2 (Second 26 Week Period)||60
151220|NCT00406133|368153|P3|COMPLETED|Phase 2 (Second 26 Week Period)||67
151221|NCT00406133|368154|P2|COMPLETED|Phase 2 (Second 26 Week Period)||152
151222|NCT00406133|368155|P1|COMPLETED|Phase 2 (Second 26 Week Period)||157
151223|NCT00406133|368152|P4|STARTED|Phase 2 (Second 26 Week Period)||60
151224|NCT00406133|368153|P3|STARTED|Phase 2 (Second 26 Week Period)||67
151225|NCT00406133|368154|P2|STARTED|Phase 2 (Second 26 Week Period)||155
151226|NCT00406133|368155|P1|STARTED|Phase 2 (Second 26 Week Period)|3 subjects completed phase 1 but elected not to go into phase 2.|159
151227|NCT00406133|368152|P4|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
151228|NCT00406133|368153|P3|NOT COMPLETED|Phase 1 (First 26 Week Period)||0
151229|NCT00406133|368154|P2|NOT COMPLETED|Phase 1 (First 26 Week Period)||2
151230|NCT00406133|368155|P1|NOT COMPLETED|Phase 1 (First 26 Week Period)||3
151231|NCT00406133|368152|P4|COMPLETED|Phase 1 (First 26 Week Period)||60
151232|NCT00406133|368153|P3|COMPLETED|Phase 1 (First 26 Week Period)||67
151233|NCT00406133|368154|P2|COMPLETED|Phase 1 (First 26 Week Period)||155
151234|NCT00406133|368155|P1|COMPLETED|Phase 1 (First 26 Week Period)||162
151235|NCT00406133|368152|P4|STARTED|Phase 1 (First 26 Week Period)||62
151236|NCT00406133|368153|P3|STARTED|Phase 1 (First 26 Week Period)||67
151237|NCT00406133|368154|P2|STARTED|Phase 1 (First 26 Week Period)||157
151238|NCT00406133|368155|P1|STARTED|Phase 1 (First 26 Week Period)||165
151239|NCT00406276|368217|P1|NOT COMPLETED|Overall Study||4
151240|NCT00406276|368217|P1|COMPLETED|Overall Study||24
151241|NCT00406276|368217|P1|STARTED|Overall Study||28
151242|NCT00406315|368222|P1|NOT COMPLETED|Overall Study||141
151243|NCT00406315|368222|P1|COMPLETED|Overall Study||100
151244|NCT00406315|368222|P1|STARTED|Overall Study|Started = Treated|241
151245|NCT00406354|368243|P3|NOT COMPLETED|All Randomized and Treated Patients||22
151246|NCT00406354|368244|P2|NOT COMPLETED|All Randomized and Treated Patients||13
151247|NCT00406354|368245|P1|NOT COMPLETED|All Randomized and Treated Patients||16
151248|NCT00406354|368243|P3|COMPLETED|All Randomized and Treated Patients||37
151249|NCT00406354|368244|P2|COMPLETED|All Randomized and Treated Patients||48
151250|NCT00406354|368245|P1|COMPLETED|All Randomized and Treated Patients||44
151251|NCT00406354|368243|P3|STARTED|All Randomized and Treated Patients||59
151252|NCT00406354|368244|P2|STARTED|All Randomized and Treated Patients||61
151253|NCT00406354|368245|P1|STARTED|All Randomized and Treated Patients||60
151254|NCT00406354|368243|P3|NOT COMPLETED|All Randomized Patients||1
151255|NCT00406354|368244|P2|NOT COMPLETED|All Randomized Patients||0
151256|NCT00406354|368245|P1|NOT COMPLETED|All Randomized Patients||0
151257|NCT00406354|368243|P3|COMPLETED|All Randomized Patients|One patient was randomized but never received study treatment.|59
151258|NCT00406354|368244|P2|COMPLETED|All Randomized Patients||61
151259|NCT00406354|368245|P1|COMPLETED|All Randomized Patients||60
151260|NCT00406354|368243|P3|STARTED|All Randomized Patients||60
151261|NCT00406354|368244|P2|STARTED|All Randomized Patients||61
151262|NCT00406354|368245|P1|STARTED|All Randomized Patients||60
151263|NCT00406367|368318|P2|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
151264|NCT00406367|368319|P1|NOT COMPLETED|Open-Label Ext. Period - up to 68 Weeks||20
151265|NCT00406367|368318|P2|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||0
151266|NCT00406367|368319|P1|COMPLETED|Open-Label Ext. Period - up to 68 Weeks||82
151267|NCT00406367|368318|P2|STARTED|Open-Label Ext. Period - up to 68 Weeks|In the Open-Label Extension Period no placebo treatment arm was given.|0
151268|NCT00406367|368319|P1|STARTED|Open-Label Ext. Period - up to 68 Weeks||102
151269|NCT00406367|368318|P2|NOT COMPLETED|Main Period - 6 to 20 Weeks||2
151270|NCT00406367|368319|P1|NOT COMPLETED|Main Period - 6 to 20 Weeks||5
151271|NCT00406367|368318|P2|COMPLETED|Main Period - 6 to 20 Weeks||32
151272|NCT00406367|368319|P1|COMPLETED|Main Period - 6 to 20 Weeks||70
151273|NCT00406367|368318|P2|STARTED|Main Period - 6 to 20 Weeks||34
151274|NCT00406367|368319|P1|STARTED|Main Period - 6 to 20 Weeks||75
151275|NCT00406393|368333|P2|NOT COMPLETED|Overall Study||1
151276|NCT00406393|368334|P1|NOT COMPLETED|Overall Study||2
151277|NCT00406393|368333|P2|COMPLETED|Overall Study||152
151278|NCT00406393|368334|P1|COMPLETED|Overall Study||149
151279|NCT00406393|368333|P2|STARTED|Overall Study||153
151280|NCT00406393|368334|P1|STARTED|Overall Study||151
151281|NCT00406640|368364|P2|NOT COMPLETED|OL Extension Phase for Non-Responders||24
151282|NCT00406640|368365|P1|NOT COMPLETED|OL Extension Phase for Non-Responders||22
151283|NCT00406640|368364|P2|COMPLETED|OL Extension Phase for Non-Responders||36
151284|NCT00406640|368365|P1|COMPLETED|OL Extension Phase for Non-Responders||47
151285|NCT00406640|368364|P2|STARTED|OL Extension Phase for Non-Responders||60
151286|NCT00406640|368365|P1|STARTED|OL Extension Phase for Non-Responders||69
151287|NCT00406640|368364|P2|NOT COMPLETED|DB Continuation Phase for Responders||37
151288|NCT00406640|368365|P1|NOT COMPLETED|DB Continuation Phase for Responders||33
151289|NCT00406640|368364|P2|COMPLETED|DB Continuation Phase for Responders||151
151290|NCT00406640|368365|P1|COMPLETED|DB Continuation Phase for Responders||139
151291|NCT00406640|368364|P2|STARTED|DB Continuation Phase for Responders||188
151292|NCT00406640|368365|P1|STARTED|DB Continuation Phase for Responders||172
151293|NCT00406640|368364|P2|NOT COMPLETED|Acute Phase||43
151294|NCT00406640|368365|P1|NOT COMPLETED|Acute Phase||51
151295|NCT00406640|368364|P2|COMPLETED|Acute Phase||256
151296|NCT00406640|368365|P1|COMPLETED|Acute Phase||245
151297|NCT00406640|368364|P2|STARTED|Acute Phase||299
151298|NCT00406640|368365|P1|STARTED|Acute Phase||296
151299|NCT00406653|368399|P7|NOT COMPLETED|Open-Label Period||324
151300|NCT00406653|368400|P6|NOT COMPLETED|Open-Label Period||0
151301|NCT00406653|368401|P5|NOT COMPLETED|Open-Label Period||0
151302|NCT00406653|368402|P4|NOT COMPLETED|Open-Label Period||0
151303|NCT00406653|368403|P3|NOT COMPLETED|Open-Label Period||0
151304|NCT00406653|368404|P2|NOT COMPLETED|Open-Label Period||0
151305|NCT00406653|368405|P1|NOT COMPLETED|Open-Label Period||0
151306|NCT00406653|368399|P7|COMPLETED|Open-Label Period||0
151307|NCT00406653|368400|P6|COMPLETED|Open-Label Period||0
151308|NCT00406653|368401|P5|COMPLETED|Open-Label Period||0
151309|NCT00406653|368402|P4|COMPLETED|Open-Label Period||0
151310|NCT00406653|368403|P3|COMPLETED|Open-Label Period||0
151311|NCT00406653|368404|P2|COMPLETED|Open-Label Period||0
151312|NCT00406653|368405|P1|COMPLETED|Open-Label Period||0
151313|NCT00406653|368399|P7|STARTED|Open-Label Period|All completing IP but failing response criteria and those completing or relapsing on MP entered OL.|324
151314|NCT00406653|368400|P6|STARTED|Open-Label Period||0
151315|NCT00406653|368401|P5|STARTED|Open-Label Period||0
151316|NCT00406653|368402|P4|STARTED|Open-Label Period||0
151317|NCT00406653|368403|P3|STARTED|Open-Label Period||0
151318|NCT00406653|368404|P2|STARTED|Open-Label Period||0
151319|NCT00406653|368405|P1|STARTED|Open-Label Period||0
151320|NCT00406653|368399|P7|NOT COMPLETED|Maintenance Period||0
151321|NCT00406653|368400|P6|NOT COMPLETED|Maintenance Period||36
151322|NCT00406653|368401|P5|NOT COMPLETED|Maintenance Period||30
151323|NCT00406653|368402|P4|NOT COMPLETED|Maintenance Period||0
151324|NCT00406653|368403|P3|NOT COMPLETED|Maintenance Period||0
151325|NCT00406653|368404|P2|NOT COMPLETED|Maintenance Period||0
151326|NCT00406653|368405|P1|NOT COMPLETED|Maintenance Period||0
151327|NCT00406653|368399|P7|COMPLETED|Maintenance Period||0
151328|NCT00406653|368400|P6|COMPLETED|Maintenance Period||10
151329|NCT00406653|368401|P5|COMPLETED|Maintenance Period||14
151330|NCT00406653|368402|P4|COMPLETED|Maintenance Period||0
151331|NCT00406653|368403|P3|COMPLETED|Maintenance Period||0
151332|NCT00406653|368404|P2|COMPLETED|Maintenance Period||0
151333|NCT00406653|368405|P1|COMPLETED|Maintenance Period||0
151334|NCT00406653|368399|P7|STARTED|Maintenance Period||0
151335|NCT00406653|368400|P6|STARTED|Maintenance Period|At end of IP, 46 participants met response criteria and were randomly assigned to placebo in MP.|46
151336|NCT00406653|368401|P5|STARTED|Maintenance Period|At end of IP, 44 participants met response criteria and were randomly assigned to abatacept in MP.|44
151337|NCT00406653|368402|P4|STARTED|Maintenance Period||0
151338|NCT00406653|368403|P3|STARTED|Maintenance Period||0
151339|NCT00406653|368404|P2|STARTED|Maintenance Period||0
151340|NCT00406653|368405|P1|STARTED|Maintenance Period||0
151341|NCT00406653|368399|P7|NOT COMPLETED|Induction Period||0
151342|NCT00406653|368400|P6|NOT COMPLETED|Induction Period||0
151343|NCT00406653|368401|P5|NOT COMPLETED|Induction Period||0
151344|NCT00406653|368402|P4|NOT COMPLETED|Induction Period||26
151345|NCT00406653|368403|P3|NOT COMPLETED|Induction Period||18
151346|NCT00406653|368404|P2|NOT COMPLETED|Induction Period||34
151347|NCT00406653|368405|P1|NOT COMPLETED|Induction Period||15
151348|NCT00406653|368399|P7|COMPLETED|Induction Period||0
151349|NCT00406653|368400|P6|COMPLETED|Induction Period||0
151350|NCT00406653|368401|P5|COMPLETED|Induction Period||0
151351|NCT00406653|368402|P4|COMPLETED|Induction Period||102
151352|NCT00406653|368403|P3|COMPLETED|Induction Period||112
151353|NCT00406653|368404|P2|COMPLETED|Induction Period||94
151354|NCT00406653|368405|P1|COMPLETED|Induction Period||50
151355|NCT00406653|368399|P7|STARTED|Induction Period||0
151356|NCT00406653|368400|P6|STARTED|Induction Period||0
151357|NCT00406653|368401|P5|STARTED|Induction Period||0
151358|NCT00406653|368402|P4|STARTED|Induction Period||128
151359|NCT00406653|368403|P3|STARTED|Induction Period||130
151360|NCT00406653|368404|P2|STARTED|Induction Period||128
151361|NCT00406653|368405|P1|STARTED|Induction Period||65
151362|NCT00406692|368484|P1|NOT COMPLETED|Overall Study||7
151363|NCT00406692|368484|P1|COMPLETED|Overall Study||9
151364|NCT00406692|368484|P1|STARTED|Overall Study||16
151365|NCT00406718|368493|P3|NOT COMPLETED|Overall Study||8
151366|NCT00406718|368494|P2|NOT COMPLETED|Overall Study||14
151367|NCT00406718|368495|P1|NOT COMPLETED|Overall Study||4
151368|NCT00406718|368493|P3|COMPLETED|Overall Study||39
151369|NCT00406718|368494|P2|COMPLETED|Overall Study||34
151370|NCT00406718|368495|P1|COMPLETED|Overall Study||43
151371|NCT00406718|368493|P3|STARTED|Overall Study||47
151372|NCT00406718|368494|P2|STARTED|Overall Study||48
151373|NCT00406718|368495|P1|STARTED|Overall Study||47
151374|NCT00406783|368511|P2|NOT COMPLETED|Overall Study||15
151375|NCT00406783|368512|P1|NOT COMPLETED|Overall Study||14
151376|NCT00406783|368511|P2|COMPLETED|Overall Study||256
151377|NCT00406783|368512|P1|COMPLETED|Overall Study||262
151378|NCT00406783|368511|P2|STARTED|Overall Study||271
151379|NCT00406783|368512|P1|STARTED|Overall Study||276
151380|NCT00406848|368526|P2|NOT COMPLETED|Overall Study||54
151381|NCT00406848|368527|P1|NOT COMPLETED|Overall Study||93
151382|NCT00406848|368526|P2|COMPLETED|Overall Study||67
151383|NCT00406848|368527|P1|COMPLETED|Overall Study||156
151384|NCT00406848|368526|P2|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=95.|121
151385|NCT00406848|368527|P1|STARTED|Overall Study|Represents full safety analysis population. Efficacy analysis population (c,d,e) N=204.|249
151386|NCT00407030|368592|P3|NOT COMPLETED|Extension Period - up to 68 Weeks||0
151387|NCT00407030|368593|P2|NOT COMPLETED|Extension Period - up to 68 Weeks||29
151388|NCT00407030|368594|P1|NOT COMPLETED|Extension Period - up to 68 Weeks||27
151389|NCT00407030|368592|P3|COMPLETED|Extension Period - up to 68 Weeks||0
151390|NCT00407030|368593|P2|COMPLETED|Extension Period - up to 68 Weeks||74
151391|NCT00407030|368594|P1|COMPLETED|Extension Period - up to 68 Weeks||84
151392|NCT00407030|368592|P3|STARTED|Extension Period - up to 68 Weeks|After the Main Period all patients were randomly assigned to the 2 active treatment arms.|0
151393|NCT00407030|368593|P2|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|103
151394|NCT00407030|368594|P1|STARTED|Extension Period - up to 68 Weeks|2 subjects did not enter the Ext. Period, 3 subjects never expressed any need for a new injection|111
151395|NCT00407030|368592|P3|NOT COMPLETED|Main Period - 8 to 20 Weeks||6
151396|NCT00407030|368593|P2|NOT COMPLETED|Main Period - 8 to 20 Weeks||3
151397|NCT00407030|368594|P1|NOT COMPLETED|Main Period - 8 to 20 Weeks||5
151398|NCT00407030|368592|P3|COMPLETED|Main Period - 8 to 20 Weeks||68
151399|NCT00407030|368593|P2|COMPLETED|Main Period - 8 to 20 Weeks||75
151400|NCT00407030|368594|P1|COMPLETED|Main Period - 8 to 20 Weeks||76
151401|NCT00407030|368592|P3|STARTED|Main Period - 8 to 20 Weeks||74
151402|NCT00407030|368593|P2|STARTED|Main Period - 8 to 20 Weeks||78
151403|NCT00407030|368594|P1|STARTED|Main Period - 8 to 20 Weeks||81
151404|NCT00407355|368622|P2|NOT COMPLETED|Overall Study||11
151405|NCT00407355|368623|P1|NOT COMPLETED|Overall Study||10
151406|NCT00407355|368622|P2|COMPLETED|Overall Study||9
151407|NCT00407355|368623|P1|COMPLETED|Overall Study||10
151408|NCT00407355|368622|P2|STARTED|Overall Study||20
151409|NCT00407355|368623|P1|STARTED|Overall Study||20
151410|NCT00407381|368634|P3|NOT COMPLETED|Overall Study||2
151411|NCT00407381|368635|P2|NOT COMPLETED|Overall Study||4
151412|NCT00407381|368636|P1|NOT COMPLETED|Overall Study||3
151413|NCT00407381|368634|P3|COMPLETED|Overall Study||40
151414|NCT00407381|368635|P2|COMPLETED|Overall Study||38
151415|NCT00407381|368636|P1|COMPLETED|Overall Study||39
151416|NCT00407381|368634|P3|STARTED|Overall Study||42
151417|NCT00407381|368635|P2|STARTED|Overall Study||42
151418|NCT00407381|368636|P1|STARTED|Overall Study||42
151419|NCT00407485|368644|P1|NOT COMPLETED|Overall Study||0
151420|NCT00407485|368644|P1|COMPLETED|Overall Study||22
151421|NCT00407485|368644|P1|STARTED|Overall Study||22
151422|NCT00407511|368649|P1|NOT COMPLETED|Overall Study||22
151423|NCT00407511|368649|P1|COMPLETED|Overall Study||99
151424|NCT00407511|368649|P1|STARTED|Overall Study||121
151425|NCT00407537|368665|P2|NOT COMPLETED|Overall Study||44
151426|NCT00407537|368666|P1|NOT COMPLETED|Overall Study||93
151427|NCT00407537|368665|P2|COMPLETED|Overall Study||638
151428|NCT00407537|368666|P1|COMPLETED|Overall Study||686
151429|NCT00407537|368665|P2|Eligible for Efficacy Analysis|Overall Study||657
151430|NCT00407537|368666|P1|Eligible for Efficacy Analysis|Overall Study||760
151431|NCT00407537|368665|P2|STARTED|Overall Study|4 participants assigned to Caduet treatment received usual care only during the study|682
151432|NCT00407537|368666|P1|STARTED|Overall Study||779
151433|NCT00407550|368716|P2|NOT COMPLETED|Overall Study||4
151434|NCT00407550|368717|P1|NOT COMPLETED|Overall Study||3
151435|NCT00407550|368716|P2|COMPLETED|Overall Study||5
151436|NCT00407550|368717|P1|COMPLETED|Overall Study||7
151437|NCT00407550|368716|P2|STARTED|Overall Study||9
151438|NCT00407550|368717|P1|STARTED|Overall Study||10
151439|NCT00407563|368723|P1|NOT COMPLETED|Overall Study||1
151440|NCT00407563|368723|P1|COMPLETED|Overall Study|One patient remains on study treatment.|47
151441|NCT00407563|368723|P1|STARTED|Overall Study||48
151442|NCT00407654|368731|P1|NOT COMPLETED|Overall Study||0
151443|NCT00407654|368731|P1|COMPLETED|Overall Study||75
151444|NCT00407654|368731|P1|STARTED|Overall Study||75
151445|NCT00407745|368745|P2|NOT COMPLETED|Overall Study||17
151446|NCT00407745|368746|P1|NOT COMPLETED|Overall Study||19
151447|NCT00407745|368745|P2|COMPLETED|Overall Study||91
151448|NCT00407745|368746|P1|COMPLETED|Overall Study||93
151449|NCT00407745|368745|P2|Treated|Overall Study||107
151450|NCT00407745|368746|P1|Treated|Overall Study||112
151451|NCT00407745|368745|P2|STARTED|Overall Study||108
151452|NCT00407745|368746|P1|STARTED|Overall Study||112
151453|NCT00394589|368821|P3|NOT COMPLETED|Overall Study||7
151454|NCT00394589|368822|P2|NOT COMPLETED|Overall Study||3
151455|NCT00394589|368823|P1|NOT COMPLETED|Overall Study||8
151456|NCT00394589|368821|P3|COMPLETED|Overall Study||11
151457|NCT00394589|368822|P2|COMPLETED|Overall Study||8
151458|NCT00394589|368823|P1|COMPLETED|Overall Study||6
151459|NCT00394589|368821|P3|STARTED|Overall Study||18
151460|NCT00394589|368822|P2|STARTED|Overall Study||11
151461|NCT00394589|368823|P1|STARTED|Overall Study||14
151462|NCT00394654|368833|P2|NOT COMPLETED|Overall Study||0
151463|NCT00394654|368834|P1|NOT COMPLETED|Overall Study||2
151464|NCT00394654|368833|P2|COMPLETED|Overall Study||15
151465|NCT00394654|368834|P1|COMPLETED|Overall Study||13
151466|NCT00394654|368833|P2|STARTED|Overall Study||15
151467|NCT00394654|368834|P1|STARTED|Overall Study||15
151468|NCT00394706|368904|P8|NOT COMPLETED|Overall Study||0
151469|NCT00394706|368905|P7|NOT COMPLETED|Overall Study||3
151470|NCT00394706|368906|P6|NOT COMPLETED|Overall Study||7
151471|NCT00394706|368907|P5|NOT COMPLETED|Overall Study||2
151472|NCT00394706|368908|P4|NOT COMPLETED|Overall Study||1
151473|NCT00394706|368909|P3|NOT COMPLETED|Overall Study||9
151474|NCT00394706|368910|P2|NOT COMPLETED|Overall Study||2
151475|NCT00394706|368911|P1|NOT COMPLETED|Overall Study||4
151476|NCT00394706|368904|P8|COMPLETED|Overall Study||851
151477|NCT00394706|368905|P7|COMPLETED|Overall Study||926
151478|NCT00394706|368906|P6|COMPLETED|Overall Study||1377
151479|NCT00394706|368907|P5|COMPLETED|Overall Study||1634
151480|NCT00394706|368908|P4|COMPLETED|Overall Study||1632
151481|NCT00394706|368909|P3|COMPLETED|Overall Study||1615
151482|NCT00394706|368910|P2|COMPLETED|Overall Study||1860
151483|NCT00394706|368911|P1|COMPLETED|Overall Study||1815
151484|NCT00394706|368904|P8|STARTED|Overall Study||851
151485|NCT00394706|368905|P7|STARTED|Overall Study||929
151486|NCT00394706|368906|P6|STARTED|Overall Study||1384
151487|NCT00394706|368907|P5|STARTED|Overall Study||1636
151488|NCT00394706|368908|P4|STARTED|Overall Study||1633
151489|NCT00394706|368909|P3|STARTED|Overall Study||1624
151490|NCT00394706|368910|P2|STARTED|Overall Study||1862
151491|NCT00394706|368911|P1|STARTED|Overall Study||1819
151492|NCT00394771|368933|P4|NOT COMPLETED|Overall Study||39
151493|NCT00394771|368934|P3|NOT COMPLETED|Overall Study||47
151494|NCT00394771|368935|P2|NOT COMPLETED|Overall Study||34
151495|NCT00394771|368936|P1|NOT COMPLETED|Overall Study||41
151496|NCT00394771|368933|P4|COMPLETED|Overall Study||109
151497|NCT00394771|368934|P3|COMPLETED|Overall Study||96
151498|NCT00394771|368935|P2|COMPLETED|Overall Study||102
151499|NCT00394771|368936|P1|COMPLETED|Overall Study||99
151500|NCT00394771|368933|P4|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|120
151501|NCT00394771|368934|P3|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|108
151502|NCT00394771|368935|P2|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
151503|NCT00394771|368936|P1|Intent to Treat (ITT) Population|Overall Study|At least one completed 91 day cycle of treatment|110
151504|NCT00394771|368933|P4|STARTED|Overall Study|Safety population of treated participants|148
151505|NCT00394771|368934|P3|STARTED|Overall Study|Safety population of treated participants|143
151506|NCT00394771|368935|P2|STARTED|Overall Study|Safety population of treated participants|136
151507|NCT00394771|368936|P1|STARTED|Overall Study|Safety population of treated participants|140
151508|NCT00394836|369000|P2|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||53
151509|NCT00394836|369001|P1|NOT COMPLETED|Extended Follow-up Phase (2-5 Years)||20
151510|NCT00394836|369000|P2|COMPLETED|Extended Follow-up Phase (2-5 Years)||5
151511|NCT00394836|369001|P1|COMPLETED|Extended Follow-up Phase (2-5 Years)||0
151512|NCT00394836|369000|P2|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|58
151513|NCT00394836|369001|P1|STARTED|Extended Follow-up Phase (2-5 Years)|Not all participants went into extended follow up per protocol.|20
151514|NCT00394836|369000|P2|NOT COMPLETED|Teatment or Follow-up Phase||78
151515|NCT00394836|369001|P1|NOT COMPLETED|Teatment or Follow-up Phase||28
151516|NCT00394836|369000|P2|COMPLETED|Teatment or Follow-up Phase||8
151517|NCT00394836|369001|P1|COMPLETED|Teatment or Follow-up Phase||2
151518|NCT00394836|369000|P2|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|8
151519|NCT00394836|369001|P1|Early Follow-up Entry|Teatment or Follow-up Phase|Did not complete treatment.|4
151520|NCT00394836|369000|P2|STARTED|Teatment or Follow-up Phase||86
151521|NCT00394836|369001|P1|STARTED|Teatment or Follow-up Phase||30
151522|NCT00394888|369046|P3|NOT COMPLETED|Overall Study||0
151523|NCT00394888|369047|P2|NOT COMPLETED|Overall Study||0
151524|NCT00394888|369048|P1|NOT COMPLETED|Overall Study||0
151525|NCT00394888|369046|P3|COMPLETED|Overall Study||201
151526|NCT00394888|369047|P2|COMPLETED|Overall Study||48
151527|NCT00394888|369048|P1|COMPLETED|Overall Study||108
151528|NCT00394888|369046|P3|STARTED|Overall Study||201
151529|NCT00394888|369047|P2|STARTED|Overall Study||48
151530|NCT00394888|369048|P1|STARTED|Overall Study||108
151531|NCT00394901|369063|P4|NOT COMPLETED|Double-blind Phase||27
151532|NCT00394901|369064|P3|NOT COMPLETED|Double-blind Phase||18
151533|NCT00394901|369065|P2|NOT COMPLETED|Double-blind Phase||14
151534|NCT00394901|369066|P1|NOT COMPLETED|Double-blind Phase||15
151535|NCT00394901|369063|P4|COMPLETED|Double-blind Phase||70
151536|NCT00394901|369064|P3|COMPLETED|Double-blind Phase||71
151537|NCT00394901|369065|P2|COMPLETED|Double-blind Phase||73
151538|NCT00394901|369066|P1|COMPLETED|Double-blind Phase||83
151539|NCT00394901|369063|P4|STARTED|Double-blind Phase|Subjects treated with the study drug.|97
151540|NCT00394901|369064|P3|STARTED|Double-blind Phase|Subjects treated with the study drug.|89
151541|NCT00394901|369065|P2|STARTED|Double-blind Phase|Subjects treated with the study drug.|87
151542|NCT00394901|369066|P1|STARTED|Double-blind Phase|Subjects treated with the study drug.|98
151543|NCT00394901|369063|P4|NOT COMPLETED|Baseline Phase||0
151544|NCT00394901|369064|P3|NOT COMPLETED|Baseline Phase||1
151545|NCT00394901|369065|P2|NOT COMPLETED|Baseline Phase||0
151546|NCT00394901|369066|P1|NOT COMPLETED|Baseline Phase||0
151547|NCT00394901|369063|P4|COMPLETED|Baseline Phase||97
151548|NCT00394901|369064|P3|COMPLETED|Baseline Phase||89
151549|NCT00394901|369065|P2|COMPLETED|Baseline Phase||87
151550|NCT00394901|369066|P1|COMPLETED|Baseline Phase||98
151551|NCT00394901|369063|P4|STARTED|Baseline Phase|Subjects randomized|97
151552|NCT00394901|369064|P3|STARTED|Baseline Phase|Subjects randomized|90
151553|NCT00394901|369065|P2|STARTED|Baseline Phase|Subjects randomized|87
151554|NCT00394901|369066|P1|STARTED|Baseline Phase|Subjects randomized|98
151555|NCT00400400|369293|P2|NOT COMPLETED|Overall Study||15
151556|NCT00400400|369294|P1|NOT COMPLETED|Overall Study||14
151557|NCT00400400|369293|P2|COMPLETED|Overall Study||185
151558|NCT00400400|369294|P1|COMPLETED|Overall Study||186
151559|NCT00400400|369293|P2|Intent-to-Treat Population|Overall Study||197
151560|NCT00400400|369294|P1|Intent-to-Treat Population|Overall Study|Participants who received study drug.|199
151561|NCT00400400|369293|P2|STARTED|Overall Study||200
151562|NCT00400400|369294|P1|STARTED|Overall Study||200
151563|NCT00400569|369312|P1|NOT COMPLETED|Overall Study||1
151564|NCT00400569|369312|P1|COMPLETED|Overall Study||47
151565|NCT00400569|369312|P1|STARTED|Overall Study||48
151566|NCT00400634|369325|P2|NOT COMPLETED|Overall Study||1
151567|NCT00400634|369326|P1|NOT COMPLETED|Overall Study||4
151568|NCT00400634|369325|P2|COMPLETED|Overall Study||19
151569|NCT00400634|369326|P1|COMPLETED|Overall Study||34
151570|NCT00400634|369325|P2|STARTED|Overall Study||20
151571|NCT00400634|369326|P1|STARTED|Overall Study||38
151572|NCT00400686|369334|P1|NOT COMPLETED|Overall Study||0
151573|NCT00400686|369334|P1|COMPLETED|Overall Study||31
151574|NCT00400686|369334|P1|STARTED|Overall Study||31
151575|NCT00400712|369342|P2|NOT COMPLETED|Overall Study||16
151576|NCT00400712|369343|P1|NOT COMPLETED|Overall Study||17
151577|NCT00400712|369342|P2|COMPLETED|Overall Study||35
151578|NCT00400712|369343|P1|COMPLETED|Overall Study||35
151579|NCT00400712|369342|P2|STARTED|Overall Study||51
151580|NCT00400712|369343|P1|STARTED|Overall Study||52
151581|NCT00400764|369366|P5|NOT COMPLETED|Phase II||11
151582|NCT00400764|369367|P4|NOT COMPLETED|Phase II||26
151583|NCT00400764|369368|P3|NOT COMPLETED|Phase II||23
151584|NCT00400764|369369|P2|NOT COMPLETED|Phase II||0
151585|NCT00400764|369370|P1|NOT COMPLETED|Phase II||0
151586|NCT00400764|369366|P5|COMPLETED|Phase II||0
151587|NCT00400764|369367|P4|COMPLETED|Phase II||0
151588|NCT00400764|369368|P3|COMPLETED|Phase II||0
151589|NCT00400764|369369|P2|COMPLETED|Phase II||0
151590|NCT00400764|369370|P1|COMPLETED|Phase II||0
151591|NCT00400764|369366|P5|Treated|Phase II||11
151592|NCT00400764|369367|P4|Treated|Phase II||26
151593|NCT00400764|369368|P3|Treated|Phase II|One patient in the Rituximab arm withdrew prior to treatment|22
151594|NCT00400764|369369|P2|Treated|Phase II||0
151595|NCT00400764|369370|P1|Treated|Phase II||0
151596|NCT00400764|369366|P5|STARTED|Phase II||11
151597|NCT00400764|369367|P4|STARTED|Phase II||26
151598|NCT00400764|369368|P3|STARTED|Phase II||23
151599|NCT00400764|369369|P2|STARTED|Phase II||0
151600|NCT00400764|369370|P1|STARTED|Phase II||0
151601|NCT00400764|369366|P5|NOT COMPLETED|Phase Ib||0
151602|NCT00400764|369367|P4|NOT COMPLETED|Phase Ib||0
151603|NCT00400764|369368|P3|NOT COMPLETED|Phase Ib||0
151604|NCT00400764|369369|P2|NOT COMPLETED|Phase Ib||4
151605|NCT00400764|369370|P1|NOT COMPLETED|Phase Ib||6
151606|NCT00400764|369366|P5|COMPLETED|Phase Ib||0
151607|NCT00400764|369367|P4|COMPLETED|Phase Ib||0
151608|NCT00400764|369368|P3|COMPLETED|Phase Ib||0
151609|NCT00400764|369369|P2|COMPLETED|Phase Ib||2
151610|NCT00400764|369370|P1|COMPLETED|Phase Ib|One patient reported as discontinued due to an AE should have been reported as death.|0
151611|NCT00400764|369366|P5|Treated|Phase Ib||0
151612|NCT00400764|369367|P4|Treated|Phase Ib||0
151613|NCT00400764|369368|P3|Treated|Phase Ib||0
151614|NCT00400764|369369|P2|Treated|Phase Ib||6
151615|NCT00400764|369370|P1|Treated|Phase Ib||6
151616|NCT00400764|369366|P5|STARTED|Phase Ib||0
151617|NCT00400764|369367|P4|STARTED|Phase Ib||0
151618|NCT00400764|369368|P3|STARTED|Phase Ib||0
151619|NCT00400764|369369|P2|STARTED|Phase Ib||6
151620|NCT00400764|369370|P1|STARTED|Phase Ib||6
151621|NCT00400803|369421|P1|NOT COMPLETED|Overall Study||0
151622|NCT00400803|369421|P1|COMPLETED|Overall Study||35
151623|NCT00400803|369421|P1|STARTED|Overall Study||35
151624|NCT00400829|369432|P1|NOT COMPLETED|Overall Study||0
151625|NCT00400829|369432|P1|COMPLETED|Overall Study||66
151626|NCT00400829|369432|P1|STARTED|Overall Study||66
151627|NCT00400881|369440|P2|NOT COMPLETED|Overall Study||0
151628|NCT00400881|369441|P1|NOT COMPLETED|Overall Study||0
151629|NCT00400881|369440|P2|COMPLETED|Overall Study||60
151630|NCT00400881|369441|P1|COMPLETED|Overall Study||62
151631|NCT00400881|369440|P2|STARTED|Overall Study||60
151632|NCT00400881|369441|P1|STARTED|Overall Study||62
151633|NCT00400946|369454|P5|NOT COMPLETED|Overall Study||38
151634|NCT00400946|369455|P4|NOT COMPLETED|Overall Study||47
151635|NCT00400946|369456|P3|NOT COMPLETED|Overall Study||2
151636|NCT00400946|369457|P2|NOT COMPLETED|Overall Study||11
151637|NCT00400946|369458|P1|NOT COMPLETED|Overall Study||14
151638|NCT00400946|369454|P5|COMPLETED|Overall Study||206
151639|NCT00400946|369455|P4|COMPLETED|Overall Study||4
151640|NCT00400946|369456|P3|COMPLETED|Overall Study||40
151641|NCT00400946|369457|P2|COMPLETED|Overall Study||221
151642|NCT00400946|369458|P1|COMPLETED|Overall Study||217
151643|NCT00400946|369454|P5|Eligible and Treated|Overall Study||243
151644|NCT00400946|369455|P4|Eligible and Treated|Overall Study||46
151645|NCT00400946|369456|P3|Eligible and Treated|Overall Study||42
151646|NCT00400946|369457|P2|Eligible and Treated|Overall Study||232
151647|NCT00400946|369458|P1|Eligible and Treated|Overall Study||231
151648|NCT00400946|369454|P5|Evaluable for Day 32 MRD|Overall Study||168
151649|NCT00400946|369455|P4|Evaluable for Day 32 MRD|Overall Study||12
151650|NCT00400946|369456|P3|Evaluable for Day 32 MRD|Overall Study||33
151651|NCT00400946|369457|P2|Evaluable for Day 32 MRD|Overall Study||167
151652|NCT00400946|369458|P1|Evaluable for Day 32 MRD|Overall Study||166
151653|NCT00400946|369454|P5|Evaluable for Day 18 Marrow Morphology|Overall Study||152
151654|NCT00400946|369455|P4|Evaluable for Day 18 Marrow Morphology|Overall Study||13
151655|NCT00400946|369456|P3|Evaluable for Day 18 Marrow Morphology|Overall Study||19
151656|NCT00400946|369457|P2|Evaluable for Day 18 Marrow Morphology|Overall Study||161
151657|NCT00400946|369458|P1|Evaluable for Day 18 Marrow Morphology|Overall Study||158
151658|NCT00400946|369454|P5|Evaluable for CNS Directed-Treatment|Overall Study||227
151659|NCT00400946|369455|P4|Evaluable for CNS Directed-Treatment|Overall Study||21
151660|NCT00400946|369456|P3|Evaluable for CNS Directed-Treatment|Overall Study||42
151661|NCT00400946|369457|P2|Evaluable for CNS Directed-Treatment|Overall Study||232
151662|NCT00400946|369458|P1|Evaluable for CNS Directed-Treatment|Overall Study||231
151663|NCT00400946|369454|P5|STARTED|Overall Study||244
151664|NCT00400946|369455|P4|STARTED|Overall Study||51
151665|NCT00400946|369456|P3|STARTED|Overall Study||42
151666|NCT00400946|369457|P2|STARTED|Overall Study||232
151667|NCT00400946|369458|P1|STARTED|Overall Study||231
151668|NCT00401102|369484|P1|NOT COMPLETED|Overall Study||7
151669|NCT00401102|369484|P1|COMPLETED|Overall Study||5
151670|NCT00401102|369484|P1|STARTED|Overall Study||12
151671|NCT00401193|369491|P3|NOT COMPLETED|Overall Study||6
151672|NCT00401193|369492|P2|NOT COMPLETED|Overall Study||11
151673|NCT00401193|369493|P1|NOT COMPLETED|Overall Study||15
151674|NCT00401193|369491|P3|COMPLETED|Overall Study||63
151675|NCT00401193|369492|P2|COMPLETED|Overall Study||106
151676|NCT00401193|369493|P1|COMPLETED|Overall Study||103
151677|NCT00401193|369491|P3|Modified Intent to Treat Population|Overall Study||67
151678|NCT00401193|369492|P2|Modified Intent to Treat Population|Overall Study||115
151679|NCT00401193|369493|P1|Modified Intent to Treat Population|Overall Study||112
151680|NCT00401193|369491|P3|Intent to Treat Population|Overall Study||67
151681|NCT00401193|369492|P2|Intent to Treat Population|Overall Study||115
151682|NCT00401193|369493|P1|Intent to Treat Population|Overall Study||115
151683|NCT00401193|369491|P3|STARTED|Overall Study||69
151684|NCT00401193|369492|P2|STARTED|Overall Study||117
151685|NCT00401193|369493|P1|STARTED|Overall Study||118
151686|NCT00401245|369511|P8|NOT COMPLETED|Double Blind Tapering Phase||7
151687|NCT00401245|369512|P7|NOT COMPLETED|Double Blind Tapering Phase||7
151688|NCT00401245|369513|P6|NOT COMPLETED|Double Blind Tapering Phase||4
151689|NCT00401245|369514|P5|NOT COMPLETED|Double Blind Tapering Phase||4
151690|NCT00401245|369515|P4|NOT COMPLETED|Double Blind Tapering Phase||0
151691|NCT00401245|369516|P3|NOT COMPLETED|Double Blind Tapering Phase||0
151692|NCT00401245|369517|P2|NOT COMPLETED|Double Blind Tapering Phase||0
151693|NCT00401245|369518|P1|NOT COMPLETED|Double Blind Tapering Phase||0
151694|NCT00401245|369511|P8|COMPLETED|Double Blind Tapering Phase||95
151695|NCT00401245|369512|P7|COMPLETED|Double Blind Tapering Phase||80
151696|NCT00401245|369513|P6|COMPLETED|Double Blind Tapering Phase||90
151697|NCT00401245|369514|P5|COMPLETED|Double Blind Tapering Phase||97
151698|NCT00401245|369515|P4|COMPLETED|Double Blind Tapering Phase||0
151699|NCT00401245|369516|P3|COMPLETED|Double Blind Tapering Phase||0
151700|NCT00401245|369517|P2|COMPLETED|Double Blind Tapering Phase||0
151701|NCT00401245|369518|P1|COMPLETED|Double Blind Tapering Phase||0
151702|NCT00401245|369511|P8|STARTED|Double Blind Tapering Phase||102
151703|NCT00401245|369512|P7|STARTED|Double Blind Tapering Phase||87
151704|NCT00401245|369513|P6|STARTED|Double Blind Tapering Phase||94
151705|NCT00401245|369514|P5|STARTED|Double Blind Tapering Phase||101
151706|NCT00401245|369515|P4|STARTED|Double Blind Tapering Phase||0
151707|NCT00401245|369516|P3|STARTED|Double Blind Tapering Phase||0
151708|NCT00401245|369517|P2|STARTED|Double Blind Tapering Phase||0
151709|NCT00401245|369518|P1|STARTED|Double Blind Tapering Phase||0
151710|NCT00401245|369511|P8|NOT COMPLETED|Open Label Phase||0
151711|NCT00401245|369512|P7|NOT COMPLETED|Open Label Phase||0
151712|NCT00401245|369513|P6|NOT COMPLETED|Open Label Phase||0
151713|NCT00401245|369514|P5|NOT COMPLETED|Open Label Phase||0
151714|NCT00401245|369515|P4|NOT COMPLETED|Open Label Phase||21
151715|NCT00401245|369516|P3|NOT COMPLETED|Open Label Phase||23
151716|NCT00401245|369517|P2|NOT COMPLETED|Open Label Phase||35
151717|NCT00401245|369518|P1|NOT COMPLETED|Open Label Phase||21
151718|NCT00401245|369511|P8|COMPLETED|Open Label Phase||0
151719|NCT00401245|369512|P7|COMPLETED|Open Label Phase||0
151720|NCT00401245|369513|P6|COMPLETED|Open Label Phase||0
151721|NCT00401245|369514|P5|COMPLETED|Open Label Phase||0
151722|NCT00401245|369515|P4|COMPLETED|Open Label Phase||84
151723|NCT00401245|369516|P3|COMPLETED|Open Label Phase||95
151724|NCT00401245|369517|P2|COMPLETED|Open Label Phase||81
151725|NCT00401245|369518|P1|COMPLETED|Open Label Phase||101
151726|NCT00401245|369511|P8|STARTED|Open Label Phase||0
151727|NCT00401245|369512|P7|STARTED|Open Label Phase||0
151728|NCT00401245|369513|P6|STARTED|Open Label Phase||0
151729|NCT00401245|369514|P5|STARTED|Open Label Phase||0
151730|NCT00401245|369515|P4|STARTED|Open Label Phase||105
151731|NCT00401245|369516|P3|STARTED|Open Label Phase||118
151732|NCT00401245|369517|P2|STARTED|Open Label Phase||116
151733|NCT00401245|369518|P1|STARTED|Open Label Phase||122
151734|NCT00401245|369511|P8|NOT COMPLETED|Between Titration and Open Label Phase||0
151735|NCT00401245|369512|P7|NOT COMPLETED|Between Titration and Open Label Phase||0
151736|NCT00401245|369513|P6|NOT COMPLETED|Between Titration and Open Label Phase||0
151737|NCT00401245|369514|P5|NOT COMPLETED|Between Titration and Open Label Phase||0
151738|NCT00401245|369515|P4|NOT COMPLETED|Between Titration and Open Label Phase||2
151739|NCT00401245|369516|P3|NOT COMPLETED|Between Titration and Open Label Phase||0
151740|NCT00401245|369517|P2|NOT COMPLETED|Between Titration and Open Label Phase||2
151741|NCT00401245|369518|P1|NOT COMPLETED|Between Titration and Open Label Phase||0
151742|NCT00401245|369511|P8|COMPLETED|Between Titration and Open Label Phase||0
151743|NCT00401245|369512|P7|COMPLETED|Between Titration and Open Label Phase||0
151744|NCT00401245|369513|P6|COMPLETED|Between Titration and Open Label Phase||0
151745|NCT00401245|369514|P5|COMPLETED|Between Titration and Open Label Phase||0
151746|NCT00401245|369515|P4|COMPLETED|Between Titration and Open Label Phase||105
151747|NCT00401245|369516|P3|COMPLETED|Between Titration and Open Label Phase||118
151748|NCT00401245|369517|P2|COMPLETED|Between Titration and Open Label Phase||116
151749|NCT00401245|369518|P1|COMPLETED|Between Titration and Open Label Phase||122
151750|NCT00401245|369511|P8|STARTED|Between Titration and Open Label Phase||0
151751|NCT00401245|369512|P7|STARTED|Between Titration and Open Label Phase||0
151752|NCT00401245|369513|P6|STARTED|Between Titration and Open Label Phase||0
151753|NCT00401245|369514|P5|STARTED|Between Titration and Open Label Phase||0
151754|NCT00401245|369515|P4|STARTED|Between Titration and Open Label Phase||107
151755|NCT00401245|369516|P3|STARTED|Between Titration and Open Label Phase||118
151756|NCT00401245|369517|P2|STARTED|Between Titration and Open Label Phase||118
151757|NCT00401245|369518|P1|STARTED|Between Titration and Open Label Phase||122
151758|NCT00401245|369511|P8|NOT COMPLETED|Double Blind Titration Phase||0
151759|NCT00401245|369512|P7|NOT COMPLETED|Double Blind Titration Phase||0
151760|NCT00401245|369513|P6|NOT COMPLETED|Double Blind Titration Phase||0
151761|NCT00401245|369514|P5|NOT COMPLETED|Double Blind Titration Phase||0
151762|NCT00401245|369515|P4|NOT COMPLETED|Double Blind Titration Phase||15
151763|NCT00401245|369516|P3|NOT COMPLETED|Double Blind Titration Phase||6
151764|NCT00401245|369517|P2|NOT COMPLETED|Double Blind Titration Phase||3
151765|NCT00401245|369518|P1|NOT COMPLETED|Double Blind Titration Phase||4
151766|NCT00401245|369511|P8|COMPLETED|Double Blind Titration Phase||0
151767|NCT00401245|369512|P7|COMPLETED|Double Blind Titration Phase||0
151768|NCT00401245|369513|P6|COMPLETED|Double Blind Titration Phase||0
151769|NCT00401245|369514|P5|COMPLETED|Double Blind Titration Phase||0
151770|NCT00401245|369515|P4|COMPLETED|Double Blind Titration Phase||107
151771|NCT00401245|369516|P3|COMPLETED|Double Blind Titration Phase||118
151772|NCT00401245|369517|P2|COMPLETED|Double Blind Titration Phase||118
151773|NCT00401245|369518|P1|COMPLETED|Double Blind Titration Phase||122
151774|NCT00401245|369511|P8|STARTED|Double Blind Titration Phase||0
151775|NCT00401245|369512|P7|STARTED|Double Blind Titration Phase||0
151776|NCT00401245|369513|P6|STARTED|Double Blind Titration Phase||0
151777|NCT00401245|369514|P5|STARTED|Double Blind Titration Phase||0
151778|NCT00401245|369515|P4|STARTED|Double Blind Titration Phase||122
151779|NCT00401245|369516|P3|STARTED|Double Blind Titration Phase||124
151780|NCT00401245|369517|P2|STARTED|Double Blind Titration Phase||121
151781|NCT00401245|369518|P1|STARTED|Double Blind Titration Phase||126
151782|NCT00401258|369583|P1|NOT COMPLETED|Overall Study||7
151783|NCT00401258|369583|P1|COMPLETED|Overall Study||8
151784|NCT00401258|369583|P1|STARTED|Overall Study||15
151785|NCT00401401|369591|P4|NOT COMPLETED|Overall Study||3
151786|NCT00401401|369592|P3|NOT COMPLETED|Overall Study||1
151787|NCT00401401|369593|P2|NOT COMPLETED|Overall Study||0
151788|NCT00401401|369594|P1|NOT COMPLETED|Overall Study||0
151789|NCT00401401|369591|P4|COMPLETED|Overall Study||9
151790|NCT00401401|369592|P3|COMPLETED|Overall Study||5
151791|NCT00401401|369593|P2|COMPLETED|Overall Study||6
151792|NCT00401401|369594|P1|COMPLETED|Overall Study||6
151793|NCT00401401|369591|P4|STARTED|Overall Study||12
151794|NCT00401401|369592|P3|STARTED|Overall Study||6
151795|NCT00401401|369593|P2|STARTED|Overall Study||6
151796|NCT00401401|369594|P1|STARTED|Overall Study||6
151797|NCT00401414|369619|P3|NOT COMPLETED|Overall Study||0
151798|NCT00401414|369620|P2|NOT COMPLETED|Overall Study||0
151799|NCT00401414|369621|P1|NOT COMPLETED|Overall Study||0
151800|NCT00401414|369619|P3|COMPLETED|Overall Study||79
151801|NCT00401414|369620|P2|COMPLETED|Overall Study||147
151802|NCT00401414|369621|P1|COMPLETED|Overall Study||118
151803|NCT00401414|369619|P3|STARTED|Overall Study||79
151804|NCT00401414|369620|P2|STARTED|Overall Study||147
151805|NCT00401414|369621|P1|STARTED|Overall Study||118
151806|NCT00401531|369643|P2|NOT COMPLETED|Overall Study||10
151807|NCT00401531|369644|P1|NOT COMPLETED|Overall Study||9
151808|NCT00401531|369643|P2|COMPLETED|Overall Study||196
151809|NCT00401531|369644|P1|COMPLETED|Overall Study||197
151810|NCT00401531|369643|P2|STARTED|Overall Study||206
151811|NCT00401531|369644|P1|STARTED|Overall Study||206
151812|NCT00401544|369664|P4|NOT COMPLETED|Overall Study||16
151813|NCT00401544|369665|P3|NOT COMPLETED|Overall Study||12
151814|NCT00401544|369666|P2|NOT COMPLETED|Overall Study||18
151815|NCT00401544|369667|P1|NOT COMPLETED|Overall Study||18
151816|NCT00401544|369664|P4|COMPLETED|Overall Study||44
151817|NCT00401544|369665|P3|COMPLETED|Overall Study||48
151818|NCT00401544|369666|P2|COMPLETED|Overall Study||44
151819|NCT00401544|369667|P1|COMPLETED|Overall Study||38
151820|NCT00401544|369664|P4|STARTED|Overall Study|Randomized and treated|60
151821|NCT00401544|369665|P3|STARTED|Overall Study|Randomized and treated|60
151822|NCT00401544|369666|P2|STARTED|Overall Study|Randomized and treated|62
151823|NCT00401544|369667|P1|STARTED|Overall Study|Randomized and treated|56
151824|NCT00401622|369707|P2|NOT COMPLETED|Overall Study||43
151825|NCT00401622|369708|P1|NOT COMPLETED|Overall Study||34
151826|NCT00401622|369707|P2|COMPLETED|Overall Study||117
151827|NCT00401622|369708|P1|COMPLETED|Overall Study||126
151828|NCT00401622|369707|P2|STARTED|Overall Study||160
151829|NCT00401622|369708|P1|STARTED|Overall Study||160
151830|NCT00401726|369718|P2|NOT COMPLETED|Overall Study||112
151831|NCT00401726|369719|P1|NOT COMPLETED|Overall Study||97
151832|NCT00401726|369718|P2|COMPLETED|Overall Study||156
151833|NCT00401726|369719|P1|COMPLETED|Overall Study||172
151834|NCT00401726|369718|P2|STARTED|Overall Study||268
151835|NCT00401726|369719|P1|STARTED|Overall Study||269
151836|NCT00401752|369741|P2|NOT COMPLETED|Overall Study||18
151837|NCT00401752|369742|P1|NOT COMPLETED|Overall Study||10
151838|NCT00401752|369741|P2|COMPLETED|Overall Study||94
151839|NCT00401752|369742|P1|COMPLETED|Overall Study||97
151840|NCT00401752|369741|P2|Patients Included in Per-Protocol Popula|Overall Study||99
151841|NCT00401752|369742|P1|Patients Included in Per-Protocol Popula|Overall Study||100
151842|NCT00401752|369741|P2|Patients Included in Safety Population|Overall Study||110
151843|NCT00401752|369742|P1|Patients Included in Safety Population|Overall Study||107
151844|NCT00401752|369741|P2|Patients Included in ITT Population|Overall Study||111
151845|NCT00401752|369742|P1|Patients Included in ITT Population|Overall Study||106
151846|NCT00401752|369741|P2|Number of Patients Received Treatment|Overall Study||111
151847|NCT00401752|369742|P1|Number of Patients Received Treatment|Overall Study||107
151848|NCT00401752|369741|P2|STARTED|Overall Study||112
151849|NCT00401752|369742|P1|STARTED|Overall Study||107
151850|NCT00401778|369761|P3|NOT COMPLETED|Overall Study||1
151851|NCT00401778|369762|P2|NOT COMPLETED|Overall Study||1
151852|NCT00401778|369763|P1|NOT COMPLETED|Overall Study||1
151853|NCT00401778|369761|P3|COMPLETED|Overall Study||10
151854|NCT00401778|369762|P2|COMPLETED|Overall Study||11
151855|NCT00401778|369763|P1|COMPLETED|Overall Study||9
151856|NCT00401778|369761|P3|STARTED|Overall Study||11
151857|NCT00401778|369762|P2|STARTED|Overall Study||12
151858|NCT00401778|369763|P1|STARTED|Overall Study||10
151859|NCT00401830|369777|P2|NOT COMPLETED|Overall Study||32
151860|NCT00401830|369778|P1|NOT COMPLETED|Overall Study||31
151861|NCT00401830|369777|P2|COMPLETED|Overall Study||46
151862|NCT00401830|369778|P1|COMPLETED|Overall Study||50
151863|NCT00401830|369777|P2|STARTED|Overall Study||78
151864|NCT00401830|369778|P1|STARTED|Overall Study||81
151865|NCT00401843|369813|P3|NOT COMPLETED|Overall Study||142
151866|NCT00401843|369814|P2|NOT COMPLETED|Overall Study||144
151867|NCT00401843|369815|P1|NOT COMPLETED|Overall Study||21
151868|NCT00401843|369813|P3|COMPLETED|Overall Study||0
151869|NCT00401843|369814|P2|COMPLETED|Overall Study||0
151870|NCT00401843|369815|P1|COMPLETED|Overall Study||0
151871|NCT00401843|369813|P3|Treated|Overall Study||139
151872|NCT00401843|369814|P2|Treated|Overall Study||142
151873|NCT00401843|369815|P1|Treated|Overall Study||21
151874|NCT00401843|369813|P3|STARTED|Overall Study||142
151875|NCT00401843|369814|P2|STARTED|Overall Study||144
151876|NCT00401843|369815|P1|STARTED|Overall Study||21
151877|NCT00401882|369833|P2|NOT COMPLETED|Overall Study||0
151878|NCT00401882|369834|P1|NOT COMPLETED|Overall Study||0
151879|NCT00401882|369833|P2|COMPLETED|Overall Study||5
151880|NCT00401882|369834|P1|COMPLETED|Overall Study||2
151881|NCT00401882|369833|P2|STARTED|Overall Study||5
151882|NCT00401882|369834|P1|STARTED|Overall Study||2
151883|NCT00401960|369852|P2|NOT COMPLETED|Overall Study||0
151884|NCT00401960|369853|P1|NOT COMPLETED|Overall Study||5
151885|NCT00401960|369852|P2|COMPLETED|Overall Study||1
151886|NCT00401960|369853|P1|COMPLETED|Overall Study||0
151887|NCT00401960|369852|P2|STARTED|Overall Study||1
151888|NCT00401960|369853|P1|STARTED|Overall Study||5
151889|NCT00407797|369861|P1|NOT COMPLETED|Overall Study||18
151890|NCT00407797|369861|P1|COMPLETED|Overall Study||118
151891|NCT00407797|369861|P1|Full Analysis Set|Overall Study|At least 1 dose of study medication and had a baseline and at least 1 post-baseline measurement.|135
151892|NCT00407797|369861|P1|STARTED|Overall Study||136
151896|NCT00407966|369884|P1|NOT COMPLETED|Overall Study||0
151897|NCT00407966|369884|P1|COMPLETED|Overall Study||45
151898|NCT00407966|369884|P1|CR|Overall Study||30
151899|NCT00407966|369884|P1|STARTED|Overall Study||45
151900|NCT00408070|369888|P1|NOT COMPLETED|Overall Study||0
151901|NCT00408070|369888|P1|COMPLETED|Overall Study||5
151902|NCT00408070|369888|P1|STARTED|Overall Study||5
151903|NCT00408876|369896|P4|NOT COMPLETED|Overall Study||35
151904|NCT00408876|369897|P3|NOT COMPLETED|Overall Study||50
151905|NCT00408876|369898|P2|NOT COMPLETED|Overall Study||36
151906|NCT00408876|369899|P1|NOT COMPLETED|Overall Study||16
151907|NCT00408876|369896|P4|COMPLETED|Overall Study||82
151908|NCT00408876|369897|P3|COMPLETED|Overall Study||62
151909|NCT00408876|369898|P2|COMPLETED|Overall Study||80
151910|NCT00408876|369899|P1|COMPLETED|Overall Study||43
151911|NCT00408876|369896|P4|STARTED|Overall Study||117
151912|NCT00408876|369897|P3|STARTED|Overall Study||112
151913|NCT00408876|369898|P2|STARTED|Overall Study||116
151914|NCT00408876|369899|P1|STARTED|Overall Study||59
151915|NCT00408902|370149|P1|NOT COMPLETED|Overall Study||10
151916|NCT00408902|370149|P1|COMPLETED|Overall Study||0
151917|NCT00408902|370149|P1|STARTED|Overall Study||10
151918|NCT00408928|370154|P1|NOT COMPLETED|Overall Study||3
151919|NCT00408928|370154|P1|COMPLETED|Overall Study||8
151920|NCT00408928|370154|P1|STARTED|Overall Study||11
151921|NCT00408993|370161|P2|NOT COMPLETED|Overall Study||17
151922|NCT00408993|370162|P1|NOT COMPLETED|Overall Study||19
151923|NCT00408993|370161|P2|COMPLETED|Overall Study||92
151924|NCT00408993|370162|P1|COMPLETED|Overall Study||87
151925|NCT00408993|370161|P2|STARTED|Overall Study||109
151926|NCT00408993|370162|P1|STARTED|Overall Study||106
151927|NCT00409006|370196|P2|NOT COMPLETED|Overall Study||12
151928|NCT00409006|370197|P1|NOT COMPLETED|Overall Study||20
151929|NCT00409006|370196|P2|COMPLETED|Overall Study||19
151930|NCT00409006|370197|P1|COMPLETED|Overall Study||19
151931|NCT00409006|370196|P2|STARTED|Overall Study||31
151932|NCT00409006|370197|P1|STARTED|Overall Study||39
151933|NCT00409175|370213|P2|NOT COMPLETED|Overall Study||19
151934|NCT00409175|370214|P1|NOT COMPLETED|Overall Study||18
151935|NCT00409175|370213|P2|COMPLETED|Overall Study||44
151936|NCT00409175|370214|P1|COMPLETED|Overall Study||47
151937|NCT00409175|370213|P2|STARTED|Overall Study||63
151938|NCT00409175|370214|P1|STARTED|Overall Study||65
151939|NCT00409188|370240|P2|NOT COMPLETED|Overall Study||175
151940|NCT00409188|370241|P1|NOT COMPLETED|Overall Study||383
151941|NCT00409188|370240|P2|COMPLETED|Overall Study||332
151942|NCT00409188|370241|P1|COMPLETED|Overall Study||623
151943|NCT00409188|370240|P2|STARTED|Overall Study||507
151944|NCT00409188|370241|P1|STARTED|Overall Study||1006
151945|NCT00409240|370257|P2|NOT COMPLETED|Overall Study||1
151946|NCT00409240|370258|P1|NOT COMPLETED|Overall Study||3
151947|NCT00409240|370257|P2|COMPLETED|Overall Study||49
151948|NCT00409240|370258|P1|COMPLETED|Overall Study||50
151949|NCT00409240|370257|P2|STARTED|Overall Study||50
151950|NCT00409240|370258|P1|STARTED|Overall Study||53
151951|NCT00409292|370264|P1|NOT COMPLETED|Overall Study||0
151952|NCT00409292|370264|P1|COMPLETED|Overall Study||33
151953|NCT00409292|370264|P1|STARTED|Overall Study||33
151954|NCT00409331|370271|P1|NOT COMPLETED|Overall Study||1
151955|NCT00409331|370271|P1|COMPLETED|Overall Study||0
151956|NCT00409331|370271|P1|STARTED|Overall Study||1
151957|NCT00409344|370277|P2|NOT COMPLETED|Overall Study||0
151958|NCT00409344|370278|P1|NOT COMPLETED|Overall Study||0
151959|NCT00409344|370277|P2|COMPLETED|Overall Study|No participants were enrolled to completion|0
151960|NCT00409344|370278|P1|COMPLETED|Overall Study|No participants were enrolled to completion|0
151961|NCT00409344|370277|P2|STARTED|Overall Study|No participants enrolled|0
151962|NCT00409344|370278|P1|STARTED|Overall Study|No participants enrolled|0
151963|NCT00409409|370298|P2|NOT COMPLETED|Overall Study||4
151964|NCT00409409|370299|P1|NOT COMPLETED|Overall Study||8
151965|NCT00409409|370298|P2|COMPLETED|Overall Study||135
151966|NCT00409409|370299|P1|COMPLETED|Overall Study||131
151967|NCT00409409|370298|P2|STARTED|Overall Study||139
151968|NCT00409409|370299|P1|STARTED|Overall Study||139
151969|NCT00409539|370310|P5|NOT COMPLETED|Overall Study||25
151970|NCT00409539|370311|P4|NOT COMPLETED|Overall Study||12
151971|NCT00409539|370312|P3|NOT COMPLETED|Overall Study||14
151972|NCT00409539|370313|P2|NOT COMPLETED|Overall Study||11
151973|NCT00409539|370314|P1|NOT COMPLETED|Overall Study||11
151974|NCT00409539|370310|P5|COMPLETED|Overall Study||85
151975|NCT00409539|370311|P4|COMPLETED|Overall Study||97
151976|NCT00409539|370312|P3|COMPLETED|Overall Study||95
151977|NCT00409539|370313|P2|COMPLETED|Overall Study||100
151978|NCT00409539|370314|P1|COMPLETED|Overall Study||100
151979|NCT00409539|370310|P5|STARTED|Overall Study||110
151980|NCT00409539|370311|P4|STARTED|Overall Study||109
151981|NCT00409539|370312|P3|STARTED|Overall Study||109
151982|NCT00409539|370313|P2|STARTED|Overall Study||111
151983|NCT00409539|370314|P1|STARTED|Overall Study||111
151984|NCT00409565|370331|P1|NOT COMPLETED|Overall Study||1
151985|NCT00409565|370331|P1|COMPLETED|Overall Study||45
151986|NCT00409565|370331|P1|Overall Response Rate|Overall Study||7
151987|NCT00409565|370331|P1|STARTED|Overall Study||46
151988|NCT00409578|370343|P4|NOT COMPLETED|Overall Study||67
151989|NCT00409578|370344|P3|NOT COMPLETED|Overall Study||54
151990|NCT00409578|370345|P2|NOT COMPLETED|Overall Study||70
151991|NCT00409578|370346|P1|NOT COMPLETED|Overall Study||52
151992|NCT00409578|370343|P4|COMPLETED|Overall Study||214
151993|NCT00409578|370344|P3|COMPLETED|Overall Study||215
151994|NCT00409578|370345|P2|COMPLETED|Overall Study||201
151995|NCT00409578|370346|P1|COMPLETED|Overall Study||228
151996|NCT00409578|370343|P4|STARTED|Overall Study||281
151997|NCT00409578|370344|P3|STARTED|Overall Study||269
151998|NCT00409578|370345|P2|STARTED|Overall Study||271
151999|NCT00409578|370346|P1|STARTED|Overall Study||280
152000|NCT00409617|370368|P1|NOT COMPLETED|Overall Study||160
152001|NCT00409617|370368|P1|COMPLETED|Overall Study||785
152002|NCT00409617|370368|P1|STARTED|Overall Study||945
152003|NCT00409682|370383|P3|NOT COMPLETED|EOW Double-blind Maintenance Period||27
152004|NCT00409682|370384|P2|NOT COMPLETED|EOW Double-blind Maintenance Period||37
152005|NCT00409682|370385|P1|NOT COMPLETED|EOW Double-blind Maintenance Period||0
152006|NCT00409682|370383|P3|COMPLETED|EOW Double-blind Maintenance Period||66
152007|NCT00409682|370384|P2|COMPLETED|EOW Double-blind Maintenance Period||58
152008|NCT00409682|370385|P1|COMPLETED|EOW Double-blind Maintenance Period||0
152009|NCT00409682|370383|P3|STARTED|EOW Double-blind Maintenance Period||93
152010|NCT00409682|370384|P2|STARTED|EOW Double-blind Maintenance Period||95
152011|NCT00409682|370385|P1|STARTED|EOW Double-blind Maintenance Period||0
152012|NCT00409682|370383|P3|NOT COMPLETED|Open-label Induction Period||0
152013|NCT00409682|370384|P2|NOT COMPLETED|Open-label Induction Period||0
152014|NCT00409682|370385|P1|NOT COMPLETED|Open-label Induction Period||4
152015|NCT00409682|370383|P3|COMPLETED|Open-label Induction Period||0
152016|NCT00409682|370384|P2|COMPLETED|Open-label Induction Period||0
152017|NCT00409682|370385|P1|COMPLETED|Open-label Induction Period||188
152018|NCT00409682|370383|P3|STARTED|Open-label Induction Period||0
152019|NCT00409682|370384|P2|STARTED|Open-label Induction Period||0
152020|NCT00409682|370385|P1|STARTED|Open-label Induction Period||192
152021|NCT00409708|370404|P2|NOT COMPLETED|Washout||10
152022|NCT00409708|370405|P1|NOT COMPLETED|Washout||21
152023|NCT00409708|370404|P2|COMPLETED|Washout||29
152024|NCT00409708|370405|P1|COMPLETED|Washout||17
152025|NCT00409708|370404|P2|STARTED|Washout||39
152026|NCT00409708|370405|P1|STARTED|Washout||38
152027|NCT00409708|370404|P2|NOT COMPLETED|Treatment||17
152028|NCT00409708|370405|P1|NOT COMPLETED|Treatment||15
152029|NCT00409708|370404|P2|COMPLETED|Treatment||39
152030|NCT00409708|370405|P1|COMPLETED|Treatment||38
152031|NCT00409708|370404|P2|STARTED|Treatment||56
152032|NCT00409708|370405|P1|STARTED|Treatment|A total of 142 participants were screened for the study but only 109 were randomized to treatment|53
152033|NCT00409747|370423|P1|NOT COMPLETED|Overall Study||1
152034|NCT00409747|370423|P1|COMPLETED|Overall Study||10
152035|NCT00409747|370423|P1|STARTED|Overall Study||11
152036|NCT00409773|370433|P5|NOT COMPLETED|Overall Study||10
152037|NCT00409773|370434|P4|NOT COMPLETED|Overall Study||12
152038|NCT00409773|370435|P3|NOT COMPLETED|Overall Study||9
152039|NCT00409773|370436|P2|NOT COMPLETED|Overall Study||7
152040|NCT00409773|370437|P1|NOT COMPLETED|Overall Study||9
152041|NCT00409773|370433|P5|COMPLETED|Overall Study||218
152042|NCT00409773|370434|P4|COMPLETED|Overall Study||216
152043|NCT00409773|370435|P3|COMPLETED|Overall Study||220
152044|NCT00409773|370436|P2|COMPLETED|Overall Study||222
152045|NCT00409773|370437|P1|COMPLETED|Overall Study||220
152046|NCT00409773|370433|P5|STARTED|Overall Study||228
152047|NCT00409773|370434|P4|STARTED|Overall Study||228
152048|NCT00409773|370435|P3|STARTED|Overall Study||229
152049|NCT00409773|370436|P2|STARTED|Overall Study||229
152050|NCT00409773|370437|P1|STARTED|Overall Study||229
152051|NCT00409786|370519|P1|NOT COMPLETED|Overall Study||3
152052|NCT00409786|370519|P1|COMPLETED|Overall Study||47
152053|NCT00409786|370519|P1|STARTED|Overall Study||50
152054|NCT00409825|370523|P1|NOT COMPLETED|Overall Study||0
152055|NCT00409825|370523|P1|COMPLETED|Overall Study||61
152056|NCT00409825|370523|P1|STARTED|Overall Study||61
152057|NCT00409838|370529|P2|NOT COMPLETED|Long-term Extension Period||0
152058|NCT00409838|370530|P1|NOT COMPLETED|Long-term Extension Period||18
152059|NCT00409838|370529|P2|COMPLETED|Long-term Extension Period||0
152060|NCT00409838|370530|P1|COMPLETED|Long-term Extension Period||87
152061|NCT00409838|370529|P2|STARTED|Long-term Extension Period||0
152062|NCT00409838|370530|P1|STARTED|Long-term Extension Period||105
152063|NCT00409838|370529|P2|NOT COMPLETED|Short-term Period||5
152064|NCT00409838|370530|P1|NOT COMPLETED|Short-term Period||3
152065|NCT00409838|370529|P2|COMPLETED|Short-term Period|Participants who received placebo in this period received abatacept in next period.|52
152066|NCT00409838|370530|P1|COMPLETED|Short-term Period||53
152067|NCT00409838|370529|P2|Treated (Baseline) Population|Short-term Period||57
152068|NCT00409838|370530|P1|Treated (Baseline) Population|Short-term Period||55
152069|NCT00409838|370529|P2|STARTED|Short-term Period|Randomized|57
152070|NCT00409838|370530|P1|STARTED|Short-term Period|Randomized|56
152071|NCT00410046|370591|P1|NOT COMPLETED|Overall Study||5
152072|NCT00410046|370591|P1|COMPLETED|Overall Study||79
152073|NCT00410046|370591|P1|STARTED|Overall Study||84
152074|NCT00410059|370620|P1|NOT COMPLETED|Overall Study||0
152075|NCT00410059|370620|P1|COMPLETED|Overall Study||59
152076|NCT00410059|370620|P1|STARTED|Overall Study||59
152077|NCT00410072|370626|P2|NOT COMPLETED|After Week 48 to Week 96||11
152078|NCT00410072|370627|P1|NOT COMPLETED|After Week 48 to Week 96||6
152079|NCT00410072|370626|P2|COMPLETED|After Week 48 to Week 96||174
152080|NCT00410072|370627|P1|COMPLETED|After Week 48 to Week 96||170
152081|NCT00410072|370626|P2|STARTED|After Week 48 to Week 96||185
152082|NCT00410072|370627|P1|STARTED|After Week 48 to Week 96||176
152083|NCT00410072|370626|P2|NOT COMPLETED|Day 1 to Week 48||12
152084|NCT00410072|370627|P1|NOT COMPLETED|Day 1 to Week 48||6
152085|NCT00410072|370626|P2|COMPLETED|Day 1 to Week 48||185
152086|NCT00410072|370627|P1|COMPLETED|Day 1 to Week 48||176
152087|NCT00410072|370626|P2|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 1 more was randomized but not treated.|197
152088|NCT00410072|370627|P1|STARTED|Day 1 to Week 48|Number of participants randomized and treated; 4 more were randomized but not treated.|182
152089|NCT00410124|370665|P2|NOT COMPLETED|Extension Phase - Open Label (45 Months)||111
152090|NCT00410124|370666|P1|NOT COMPLETED|Extension Phase - Open Label (45 Months)||67
152091|NCT00410124|370665|P2|COMPLETED|Extension Phase - Open Label (45 Months)||0
152092|NCT00410124|370666|P1|COMPLETED|Extension Phase - Open Label (45 Months)||0
152093|NCT00410124|370665|P2|STARTED|Extension Phase - Open Label (45 Months)|Patients on placebo in core received RAD001 in extension phase.|111
152094|NCT00410124|370666|P1|STARTED|Extension Phase - Open Label (45 Months)||67
152095|NCT00410124|370665|P2|NOT COMPLETED|Core Phase Double Blind (15 Months)||133
152096|NCT00410124|370666|P1|NOT COMPLETED|Core Phase Double Blind (15 Months)||202
152097|NCT00410124|370665|P2|COMPLETED|Core Phase Double Blind (15 Months)|All patients ongoing/completed/not completed in core had option to enter extension taking RAD001.|6
152098|NCT00410124|370666|P1|COMPLETED|Core Phase Double Blind (15 Months)|Patients ongoing/completed double blind phase had option entering extension phase continuing RAD001.|75
152099|NCT00410124|370665|P2|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||2
152100|NCT00410124|370666|P1|Completed Double Blind Treatment|Core Phase Double Blind (15 Months)||62
152101|NCT00410124|370665|P2|Ongoing|Core Phase Double Blind (15 Months)||4
152102|NCT00410124|370666|P1|Ongoing|Core Phase Double Blind (15 Months)||13
152103|NCT00410124|370665|P2|STARTED|Core Phase Double Blind (15 Months)||139
152104|NCT00410124|370666|P1|STARTED|Core Phase Double Blind (15 Months)|Started indicates randomized (FAS) and treated|277
152105|NCT00410150|370697|P2|NOT COMPLETED|Overall Study||3
152106|NCT00410150|370698|P1|NOT COMPLETED|Overall Study||2
152107|NCT00410150|370697|P2|COMPLETED|Overall Study|3 study withdrawals (analyzed by intention-to-treat0|17
152108|NCT00410150|370698|P1|COMPLETED|Overall Study|2 study withdrawals (analyzed by intention-to-treat)|20
152109|NCT00410150|370697|P2|STARTED|Overall Study||20
152110|NCT00410150|370698|P1|STARTED|Overall Study||22
152111|NCT00410163|370706|P2|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
152112|NCT00410163|370707|P1|NOT COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
152113|NCT00410163|370706|P2|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||11
152114|NCT00410163|370707|P1|COMPLETED|Extended Follow-up (FU) Phase (2-5 Years||10
152115|NCT00410163|370706|P2|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|21
152116|NCT00410163|370707|P1|STARTED|Extended Follow-up (FU) Phase (2-5 Years|Participants who withdrew from the Treatment Phase were eligible to enter the Extended FU Phase.|20
152117|NCT00410163|370706|P2|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||11
152118|NCT00410163|370707|P1|NOT COMPLETED|Treatment and Follow-up Phase (2 Years)||12
152119|NCT00410163|370706|P2|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
152120|NCT00410163|370707|P1|COMPLETED|Treatment and Follow-up Phase (2 Years)||19
152121|NCT00410163|370706|P2|STARTED|Treatment and Follow-up Phase (2 Years)||30
152122|NCT00410163|370707|P1|STARTED|Treatment and Follow-up Phase (2 Years)||31
152123|NCT00410189|370749|P1|NOT COMPLETED|Overall Study||0
152124|NCT00410189|370749|P1|COMPLETED|Overall Study||54
152125|NCT00410189|370749|P1|STARTED|Overall Study||54
152126|NCT00410202|370757|P3|NOT COMPLETED|Off-treatment Follow up||12
152127|NCT00410202|370758|P2|NOT COMPLETED|Off-treatment Follow up||8
152128|NCT00410202|370759|P1|NOT COMPLETED|Off-treatment Follow up||14
152129|NCT00410202|370757|P3|COMPLETED|Off-treatment Follow up||2
152130|NCT00410202|370758|P2|COMPLETED|Off-treatment Follow up||0
152131|NCT00410202|370759|P1|COMPLETED|Off-treatment Follow up||1
152132|NCT00410202|370757|P3|STARTED|Off-treatment Follow up||14
152133|NCT00410202|370758|P2|STARTED|Off-treatment Follow up||8
152134|NCT00410202|370759|P1|STARTED|Off-treatment Follow up||15
152135|NCT00410202|370757|P3|NOT COMPLETED|On-Treatment||71
152136|NCT00410202|370758|P2|NOT COMPLETED|On-Treatment||79
152137|NCT00410202|370759|P1|NOT COMPLETED|On-Treatment||75
152138|NCT00410202|370757|P3|COMPLETED|On-Treatment|Completed the 100 week dosing|66
152139|NCT00410202|370758|P2|COMPLETED|On-Treatment|Completed the 100 week dosing|61
152140|NCT00410202|370759|P1|COMPLETED|On-Treatment|Completed the 100 week dosing|63
152141|NCT00410202|370757|P3|Discontinued at or After Week 48 Visit|On-Treatment||3
152142|NCT00410202|370758|P2|Discontinued at or After Week 48 Visit|On-Treatment||6
152143|NCT00410202|370759|P1|Discontinued at or After Week 48 Visit|On-Treatment||2
152144|NCT00410202|370757|P3|Discontinued Prior to Week 48 Visit|On-Treatment||2
152145|NCT00410202|370758|P2|Discontinued Prior to Week 48 Visit|On-Treatment||2
152146|NCT00410202|370759|P1|Discontinued Prior to Week 48 Visit|On-Treatment||4
152147|NCT00410202|370757|P3|STARTED|On-Treatment||137
152148|NCT00410202|370758|P2|STARTED|On-Treatment||140
152149|NCT00410202|370759|P1|STARTED|On-Treatment||138
152150|NCT00410280|370841|P2|NOT COMPLETED|Overall Study||0
152151|NCT00410280|370842|P1|NOT COMPLETED|Overall Study||0
152152|NCT00410280|370841|P2|COMPLETED|Overall Study||13
152153|NCT00410280|370842|P1|COMPLETED|Overall Study||14
152154|NCT00410280|370841|P2|STARTED|Overall Study||13
152155|NCT00410280|370842|P1|STARTED|Overall Study||14
152156|NCT00410384|370886|P3|NOT COMPLETED|Overall Study||82
152157|NCT00410384|370887|P2|NOT COMPLETED|Overall Study||72
152158|NCT00410384|370888|P1|NOT COMPLETED|Overall Study||89
152159|NCT00410384|370886|P3|COMPLETED|Overall Study||191
152160|NCT00410384|370887|P2|COMPLETED|Overall Study||199
152161|NCT00410384|370888|P1|COMPLETED|Overall Study||186
152162|NCT00410384|370886|P3|STARTED|Overall Study||273
152163|NCT00410384|370887|P2|STARTED|Overall Study||271
152164|NCT00410384|370888|P1|STARTED|Overall Study||275
152165|NCT00410410|370920|P9|NOT COMPLETED|Open-Label Period (OL)||349
152166|NCT00410410|370921|P8|NOT COMPLETED|Open-Label Period (OL)||0
152167|NCT00410410|370922|P7|NOT COMPLETED|Open-Label Period (OL)||0
152168|NCT00410410|370923|P6|NOT COMPLETED|Open-Label Period (OL)||0
152169|NCT00410410|370924|P5|NOT COMPLETED|Open-Label Period (OL)||0
152170|NCT00410410|370925|P4|NOT COMPLETED|Open-Label Period (OL)||0
152171|NCT00410410|370926|P3|NOT COMPLETED|Open-Label Period (OL)||0
152172|NCT00410410|370927|P2|NOT COMPLETED|Open-Label Period (OL)||0
152173|NCT00410410|370928|P1|NOT COMPLETED|Open-Label Period (OL)||0
152174|NCT00410410|370920|P9|COMPLETED|Open-Label Period (OL)||0
152175|NCT00410410|370921|P8|COMPLETED|Open-Label Period (OL)||0
152176|NCT00410410|370922|P7|COMPLETED|Open-Label Period (OL)||0
152177|NCT00410410|370923|P6|COMPLETED|Open-Label Period (OL)||0
152178|NCT00410410|370924|P5|COMPLETED|Open-Label Period (OL)||0
152179|NCT00410410|370925|P4|COMPLETED|Open-Label Period (OL)||0
152180|NCT00410410|370926|P3|COMPLETED|Open-Label Period (OL)||0
152181|NCT00410410|370927|P2|COMPLETED|Open-Label Period (OL)||0
152182|NCT00410410|370928|P1|COMPLETED|Open-Label Period (OL)||0
152183|NCT00410410|370920|P9|STARTED|Open-Label Period (OL)|349 entered OL (those who completed IP but failed response criteria, or completed/relapsed on MP).|349
152184|NCT00410410|370921|P8|STARTED|Open-Label Period (OL)||0
152185|NCT00410410|370922|P7|STARTED|Open-Label Period (OL)||0
152186|NCT00410410|370923|P6|STARTED|Open-Label Period (OL)||0
152187|NCT00410410|370924|P5|STARTED|Open-Label Period (OL)||0
152188|NCT00410410|370925|P4|STARTED|Open-Label Period (OL)||0
152189|NCT00410410|370926|P3|STARTED|Open-Label Period (OL)||0
152190|NCT00410410|370927|P2|STARTED|Open-Label Period (OL)||0
152191|NCT00410410|370928|P1|STARTED|Open-Label Period (OL)||0
152192|NCT00410410|370920|P9|NOT COMPLETED|Maintenance Period (MP)||0
152193|NCT00410410|370921|P8|NOT COMPLETED|Maintenance Period (MP)||55
152194|NCT00410410|370922|P7|NOT COMPLETED|Maintenance Period (MP)||50
152195|NCT00410410|370923|P6|NOT COMPLETED|Maintenance Period (MP)||0
152196|NCT00410410|370924|P5|NOT COMPLETED|Maintenance Period (MP)||0
152197|NCT00410410|370925|P4|NOT COMPLETED|Maintenance Period (MP)||0
152198|NCT00410410|370926|P3|NOT COMPLETED|Maintenance Period (MP)||0
152199|NCT00410410|370927|P2|NOT COMPLETED|Maintenance Period (MP)||0
152200|NCT00410410|370928|P1|NOT COMPLETED|Maintenance Period (MP)||0
152201|NCT00410410|370920|P9|COMPLETED|Maintenance Period (MP)||0
152202|NCT00410410|370921|P8|COMPLETED|Maintenance Period (MP)||11
152203|NCT00410410|370922|P7|COMPLETED|Maintenance Period (MP)||15
152204|NCT00410410|370923|P6|COMPLETED|Maintenance Period (MP)||0
152205|NCT00410410|370924|P5|COMPLETED|Maintenance Period (MP)||0
152206|NCT00410410|370925|P4|COMPLETED|Maintenance Period (MP)||0
152207|NCT00410410|370926|P3|COMPLETED|Maintenance Period (MP)||0
152208|NCT00410410|370927|P2|COMPLETED|Maintenance Period (MP)||0
152209|NCT00410410|370928|P1|COMPLETED|Maintenance Period (MP)||0
152210|NCT00410410|370920|P9|STARTED|Maintenance Period (MP)||0
152211|NCT00410410|370921|P8|STARTED|Maintenance Period (MP)|At end of IP, 66 participants met response criteria and were randomly assigned to placebo in MP.|66
152212|NCT00410410|370922|P7|STARTED|Maintenance Period (MP)|At end of IP, 65 participants met response criteria and were randomly assigned to abatacept in MP.|65
152213|NCT00410410|370923|P6|STARTED|Maintenance Period (MP)||0
152214|NCT00410410|370924|P5|STARTED|Maintenance Period (MP)||0
152215|NCT00410410|370925|P4|STARTED|Maintenance Period (MP)||0
152216|NCT00410410|370926|P3|STARTED|Maintenance Period (MP)||0
152217|NCT00410410|370927|P2|STARTED|Maintenance Period (MP)||0
152218|NCT00410410|370928|P1|STARTED|Maintenance Period (MP)||0
152219|NCT00410410|370920|P9|NOT COMPLETED|Induction Period (IP)||0
152220|NCT00410410|370921|P8|NOT COMPLETED|Induction Period (IP)||0
152221|NCT00410410|370922|P7|NOT COMPLETED|Induction Period (IP)||0
152222|NCT00410410|370923|P6|NOT COMPLETED|Induction Period (IP)||29
152223|NCT00410410|370924|P5|NOT COMPLETED|Induction Period (IP)||32
152224|NCT00410410|370925|P4|NOT COMPLETED|Induction Period (IP)||20
152225|NCT00410410|370926|P3|NOT COMPLETED|Induction Period (IP)||17
152226|NCT00410410|370927|P2|NOT COMPLETED|Induction Period (IP)||35
152227|NCT00410410|370928|P1|NOT COMPLETED|Induction Period (IP)||35
152228|NCT00410410|370920|P9|COMPLETED|Induction Period (IP)||0
152229|NCT00410410|370921|P8|COMPLETED|Induction Period (IP)||0
152230|NCT00410410|370922|P7|COMPLETED|Induction Period (IP)||0
152231|NCT00410410|370923|P6|COMPLETED|Induction Period (IP)||21
152232|NCT00410410|370924|P5|COMPLETED|Induction Period (IP)||19
152233|NCT00410410|370925|P4|COMPLETED|Induction Period (IP)||120
152234|NCT00410410|370926|P3|COMPLETED|Induction Period (IP)||53
152235|NCT00410410|370927|P2|COMPLETED|Induction Period (IP)||104
152236|NCT00410410|370928|P1|COMPLETED|Induction Period (IP)||106
152237|NCT00410410|370920|P9|STARTED|Induction Period (IP)||0
152238|NCT00410410|370921|P8|STARTED|Induction Period (IP)||0
152239|NCT00410410|370922|P7|STARTED|Induction Period (IP)||0
152240|NCT00410410|370923|P6|STARTED|Induction Period (IP)||50
152241|NCT00410410|370924|P5|STARTED|Induction Period (IP)||51
152242|NCT00410410|370925|P4|STARTED|Induction Period (IP)||140
152243|NCT00410410|370926|P3|STARTED|Induction Period (IP)||70
152244|NCT00410410|370927|P2|STARTED|Induction Period (IP)||139
152245|NCT00410410|370928|P1|STARTED|Induction Period (IP)||141
152246|NCT00410488|371088|P2|NOT COMPLETED|Overall Study||0
152247|NCT00410488|371089|P1|NOT COMPLETED|Overall Study||0
152248|NCT00410488|371088|P2|COMPLETED|Overall Study||34
152249|NCT00410488|371089|P1|COMPLETED|Overall Study||16
152250|NCT00410488|371088|P2|STARTED|Overall Study||34
152251|NCT00410488|371089|P1|STARTED|Overall Study||16
152252|NCT00410514|371097|P3|NOT COMPLETED|Overall Study||7
152253|NCT00410514|371098|P2|NOT COMPLETED|Overall Study||3
152254|NCT00410514|371099|P1|NOT COMPLETED|Overall Study||2
152255|NCT00410514|371097|P3|COMPLETED|Overall Study||58
152256|NCT00410514|371098|P2|COMPLETED|Overall Study||67
152257|NCT00410514|371099|P1|COMPLETED|Overall Study||63
152258|NCT00410514|371097|P3|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|58
152259|NCT00410514|371098|P2|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|64
152260|NCT00410514|371099|P1|Full Analysis Set (FAS)|Overall Study|SAF patients with both Qmax & PdetQmax measurements at baseline and 1 or both measured postbaseline.|63
152261|NCT00410514|371097|P3|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
152262|NCT00410514|371098|P2|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|70
152263|NCT00410514|371099|P1|Safety Analysis Set (SAF)|Overall Study|All patients who received at least 1 dose of double-blind study drug.|65
152264|NCT00410514|371097|P3|STARTED|Overall Study||65
152265|NCT00410514|371098|P2|STARTED|Overall Study||70
152266|NCT00410514|371099|P1|STARTED|Overall Study||65
152267|NCT00410761|371160|P2|NOT COMPLETED|Overall Study||72
152268|NCT00410761|371161|P1|NOT COMPLETED|Overall Study||120
152269|NCT00410761|371160|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|28
152270|NCT00410761|371161|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|111
152271|NCT00410761|371160|P2|STARTED|Overall Study|randomised patients|100
152272|NCT00410761|371161|P1|STARTED|Overall Study|randomised patients|231
152273|NCT00410813|371183|P2|NOT COMPLETED|Overall Study||42
152274|NCT00410813|371184|P1|NOT COMPLETED|Overall Study||43
152275|NCT00410813|371183|P2|COMPLETED|Overall Study||0
152276|NCT00410813|371184|P1|COMPLETED|Overall Study|Patients treated until progression.|0
152277|NCT00410813|371183|P2|Eligible|Overall Study||38
152278|NCT00410813|371184|P1|Eligible|Overall Study||41
152279|NCT00410813|371183|P2|STARTED|Overall Study||42
152280|NCT00410813|371184|P1|STARTED|Overall Study||43
152281|NCT00410826|371221|P2|NOT COMPLETED|Overall Study||4
152282|NCT00410826|371222|P1|NOT COMPLETED|Overall Study||9
152283|NCT00410826|371221|P2|COMPLETED|Overall Study||95
152284|NCT00410826|371222|P1|COMPLETED|Overall Study||96
152285|NCT00410826|371221|P2|STARTED|Overall Study||99
152286|NCT00410826|371222|P1|STARTED|Overall Study||105
152287|NCT00410891|371230|P1|NOT COMPLETED|Overall Study||0
152288|NCT00410891|371230|P1|COMPLETED|Overall Study||129
152289|NCT00410891|371230|P1|STARTED|Overall Study||129
152290|NCT00410904|371236|P2|NOT COMPLETED|Overall Study||0
152291|NCT00410904|371237|P1|NOT COMPLETED|Overall Study||0
152292|NCT00410904|371236|P2|COMPLETED|Overall Study||20
152293|NCT00410904|371237|P1|COMPLETED|Overall Study||40
152294|NCT00410904|371236|P2|STARTED|Overall Study||20
152295|NCT00410904|371237|P1|STARTED|Overall Study||40
152296|NCT00411151|371243|P1|NOT COMPLETED|Overall Study||47
152297|NCT00411151|371243|P1|COMPLETED|Overall Study||5
152298|NCT00411151|371243|P1|STARTED|Overall Study||52
152299|NCT00411216|371255|P2|NOT COMPLETED|Overall Study||2
152300|NCT00411216|371256|P1|NOT COMPLETED|Overall Study||0
152301|NCT00411216|371255|P2|COMPLETED|Overall Study||8
152302|NCT00411216|371256|P1|COMPLETED|Overall Study||13
152303|NCT00411216|371255|P2|STARTED|Overall Study||10
152304|NCT00411216|371256|P1|STARTED|Overall Study||13
152305|NCT00404820|371264|P2|NOT COMPLETED|Overall Study||24
152306|NCT00404820|371265|P1|NOT COMPLETED|Overall Study||19
152307|NCT00404820|371264|P2|COMPLETED|Overall Study||172
152308|NCT00404820|371265|P1|COMPLETED|Overall Study||389
152309|NCT00404820|371264|P2|Started Treatment|Overall Study|The reason why 2 patients did not start treatment is unavailable.|194
152310|NCT00404820|371265|P1|Started Treatment|Overall Study||408
152311|NCT00404820|371264|P2|STARTED|Overall Study||196
152312|NCT00404820|371265|P1|STARTED|Overall Study||408
152313|NCT00404924|371285|P2|NOT COMPLETED|Overall Study||306
152314|NCT00404924|371286|P1|NOT COMPLETED|Overall Study||603
152315|NCT00404924|371285|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|1
152316|NCT00404924|371286|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
152317|NCT00404924|371285|P2|STARTED|Overall Study|randomised patients|307
152318|NCT00404924|371286|P1|STARTED|Overall Study|randomised patients|617
152319|NCT00405067|371305|P3|NOT COMPLETED|Overall Study||5
152320|NCT00405067|371306|P2|NOT COMPLETED|Overall Study||9
152321|NCT00405067|371307|P1|NOT COMPLETED|Overall Study||4
152322|NCT00405067|371305|P3|COMPLETED|Overall Study||24
152323|NCT00405067|371306|P2|COMPLETED|Overall Study||19
152324|NCT00405067|371307|P1|COMPLETED|Overall Study||24
152325|NCT00405067|371305|P3|STARTED|Overall Study||29
152326|NCT00405067|371306|P2|STARTED|Overall Study||28
152327|NCT00405067|371307|P1|STARTED|Overall Study||28
152328|NCT00405275|371344|P2|NOT COMPLETED|Overall Study||19
152329|NCT00405275|371345|P1|NOT COMPLETED|Overall Study||23
152330|NCT00405275|371344|P2|COMPLETED|Overall Study||156
152331|NCT00405275|371345|P1|COMPLETED|Overall Study||155
152332|NCT00405275|371344|P2|24 Week (Switch)|Overall Study||44
152333|NCT00405275|371345|P1|24 Week (Switch)|Overall Study||44
152334|NCT00405275|371344|P2|24 Week (no Switch)|Overall Study||121
152335|NCT00405275|371345|P1|24 Week (no Switch)|Overall Study||119
152336|NCT00405275|371344|P2|24 Weeks (Total)|Overall Study||165
152337|NCT00405275|371345|P1|24 Weeks (Total)|Overall Study||163
152338|NCT00405275|371344|P2|STARTED|Overall Study||175
152339|NCT00405275|371345|P1|STARTED|Overall Study||178
152340|NCT00405288|371353|P2|NOT COMPLETED|Overall Study||0
152341|NCT00405288|371354|P1|NOT COMPLETED|Overall Study||0
152342|NCT00405288|371353|P2|COMPLETED|Overall Study||204
152343|NCT00405288|371354|P1|COMPLETED|Overall Study||204
152344|NCT00405288|371353|P2|STARTED|Overall Study||204
152345|NCT00405288|371354|P1|STARTED|Overall Study||204
152346|NCT00411398|371382|P1|NOT COMPLETED|Overall Study||5
152347|NCT00411398|371382|P1|COMPLETED|Overall Study||10
152348|NCT00411398|371382|P1|STARTED|Overall Study||15
152349|NCT00411411|371388|P2|NOT COMPLETED|Overall Study||0
152350|NCT00411411|371389|P1|NOT COMPLETED|Overall Study||0
152351|NCT00411411|371388|P2|COMPLETED|Overall Study||25
152352|NCT00411411|371389|P1|COMPLETED|Overall Study||24
152353|NCT00411411|371388|P2|STARTED|Overall Study||25
152354|NCT00411411|371389|P1|STARTED|Overall Study||24
152355|NCT00411450|371397|P1|NOT COMPLETED|Overall Study||3
152356|NCT00411450|371397|P1|COMPLETED|Overall Study|Ended second-line treatment|113
152357|NCT00411450|371397|P1|Received Treatment|Overall Study||115
152358|NCT00411450|371397|P1|STARTED|Overall Study||116
152359|NCT00411463|371425|P2|NOT COMPLETED|Overall Study||3
152360|NCT00411463|371426|P1|NOT COMPLETED|Overall Study||3
152361|NCT00411463|371425|P2|COMPLETED|Overall Study||8
152362|NCT00411463|371426|P1|COMPLETED|Overall Study||11
152363|NCT00411463|371425|P2|STARTED|Overall Study||11
152364|NCT00411463|371426|P1|STARTED|Overall Study||14
152365|NCT00411554|371441|P2|NOT COMPLETED|Overall Study||9
152366|NCT00411554|371442|P1|NOT COMPLETED|Overall Study||8
152367|NCT00411554|371441|P2|COMPLETED|Overall Study||147
152368|NCT00411554|371442|P1|COMPLETED|Overall Study||155
152369|NCT00411554|371441|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|156
152370|NCT00411554|371442|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=155|163
152371|NCT00411619|371452|P1|NOT COMPLETED|Overall Study||6
152372|NCT00411619|371452|P1|COMPLETED|Overall Study||22
152373|NCT00411619|371452|P1|STARTED|Overall Study||28
152374|NCT00411645|371459|P2|NOT COMPLETED|Overall Study||164
152375|NCT00411645|371460|P1|NOT COMPLETED|Overall Study||81
152376|NCT00411645|371459|P2|COMPLETED|Overall Study||290
152377|NCT00411645|371460|P1|COMPLETED|Overall Study||146
152378|NCT00411645|371459|P2|STARTED|Overall Study||454
152379|NCT00411645|371460|P1|STARTED|Overall Study||227
152380|NCT00411671|371484|P1|NOT COMPLETED|Overall Study||20
152381|NCT00411671|371484|P1|COMPLETED|Overall Study||85
152382|NCT00411671|371484|P1|STARTED|Overall Study||105
152383|NCT00412737|371492|P2|NOT COMPLETED|Overall Study||6
152384|NCT00412737|371493|P1|NOT COMPLETED|Overall Study||16
152385|NCT00412737|371492|P2|COMPLETED|Overall Study||232
152386|NCT00412737|371493|P1|COMPLETED|Overall Study||221
152387|NCT00412737|371492|P2|STARTED|Overall Study||238
152388|NCT00412737|371493|P1|STARTED|Overall Study||237
152389|NCT00412750|371514|P3|NOT COMPLETED|Overall Study||23
152390|NCT00412750|371515|P2|NOT COMPLETED|Overall Study||21
152391|NCT00412750|371516|P1|NOT COMPLETED|Overall Study||31
152392|NCT00412750|371514|P3|COMPLETED|Overall Study||31
152393|NCT00412750|371515|P2|COMPLETED|Overall Study||34
152394|NCT00412750|371516|P1|COMPLETED|Overall Study||19
152395|NCT00412750|371514|P3|STARTED|Overall Study||54
152396|NCT00412750|371515|P2|STARTED|Overall Study||55
152397|NCT00412750|371516|P1|STARTED|Overall Study||50
152398|NCT00412841|371541|P2|NOT COMPLETED|Overall Study||5
152399|NCT00412841|371542|P1|NOT COMPLETED|Overall Study||10
152400|NCT00412841|371541|P2|COMPLETED|Overall Study||16
152401|NCT00412841|371542|P1|COMPLETED|Overall Study||12
152402|NCT00412841|371541|P2|STARTED|Overall Study||21
152403|NCT00412841|371542|P1|STARTED|Overall Study||22
152404|NCT00412854|371552|P2|NOT COMPLETED|Overall Study||16
152405|NCT00412854|371553|P1|NOT COMPLETED|Overall Study||14
152406|NCT00412854|371552|P2|COMPLETED|Overall Study||314
152407|NCT00412854|371553|P1|COMPLETED|Overall Study||316
152408|NCT00412854|371552|P2|STARTED|Overall Study||330
152409|NCT00412854|371553|P1|STARTED|Overall Study||330
152410|NCT00412867|371579|P1|NOT COMPLETED|Overall Study||0
152411|NCT00412867|371579|P1|COMPLETED|Overall Study||58
152412|NCT00412867|371579|P1|STARTED|Overall Study||58
152413|NCT00412893|371588|P2|NOT COMPLETED|Overall Study||144
152414|NCT00412893|371589|P1|NOT COMPLETED|Overall Study||145
152415|NCT00412893|371588|P2|COMPLETED|Overall Study|Defined as completed treatment|120
152416|NCT00412893|371589|P1|COMPLETED|Overall Study|Defined as completed treatment|118
152417|NCT00412893|371588|P2|Received Treatment|Overall Study||258
152418|NCT00412893|371589|P1|Received Treatment|Overall Study|One participant randomized to this group received voriconazole treatment for the first 7 days|258
152419|NCT00412893|371588|P2|STARTED|Overall Study||264
152420|NCT00412893|371589|P1|STARTED|Overall Study||263
152421|NCT00412932|371615|P1|NOT COMPLETED|Olm+ Hydrochlorothiazide 25 mg||2
152422|NCT00412932|371615|P1|COMPLETED|Olm+ Hydrochlorothiazide 25 mg||123
152423|NCT00412932|371615|P1|STARTED|Olm+ Hydrochlorothiazide 25 mg|153 -28 met their blood pressure goal (stayed on olmesartan 40/hydrochlorothiazide 12.5) = 125|125
152424|NCT00412932|371615|P1|NOT COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||6
152425|NCT00412932|371615|P1|COMPLETED|Olm+Hydrochlorothiazide 12.5 mg||153
152426|NCT00412932|371615|P1|STARTED|Olm+Hydrochlorothiazide 12.5 mg|161 -2 met blood pressure goal (stayed on olmesartan 40) = 159|159
152427|NCT00412932|371615|P1|NOT COMPLETED|Olmesartan 40 mg||8
152428|NCT00412932|371615|P1|COMPLETED|Olmesartan 40 mg||161
152429|NCT00412932|371615|P1|STARTED|Olmesartan 40 mg|171 -1 met blood pressure goal (stayed on olmesartan 20) -1 who erroneously skipped this step = 169.|169
152430|NCT00412932|371615|P1|NOT COMPLETED|Olmesartan (Olm) 20 mg||7
152431|NCT00412932|371615|P1|COMPLETED|Olmesartan (Olm) 20 mg||171
152432|NCT00412932|371615|P1|STARTED|Olmesartan (Olm) 20 mg||178
152433|NCT00412958|371628|P4|NOT COMPLETED|Overall Study||1
152434|NCT00412958|371629|P3|NOT COMPLETED|Overall Study||0
152435|NCT00412958|371630|P2|NOT COMPLETED|Overall Study||4
152436|NCT00412958|371631|P1|NOT COMPLETED|Overall Study||3
152437|NCT00412958|371628|P4|COMPLETED|Overall Study||30
152438|NCT00412958|371629|P3|COMPLETED|Overall Study||32
152439|NCT00412958|371630|P2|COMPLETED|Overall Study||29
152440|NCT00412958|371631|P1|COMPLETED|Overall Study||26
152441|NCT00412958|371628|P4|STARTED|Overall Study||31
152442|NCT00412958|371629|P3|STARTED|Overall Study||32
152443|NCT00412958|371630|P2|STARTED|Overall Study||33
152444|NCT00412958|371631|P1|STARTED|Overall Study||29
152445|NCT00412971|371643|P2|NOT COMPLETED|Overall Study||10
152446|NCT00412971|371644|P1|NOT COMPLETED|Overall Study||30
152447|NCT00412971|371643|P2|COMPLETED|Overall Study||108
152448|NCT00412971|371644|P1|COMPLETED|Overall Study||85
152449|NCT00412971|371643|P2|STARTED|Overall Study||118
152450|NCT00412971|371644|P1|STARTED|Overall Study||115
152451|NCT00412984|371655|P2|NOT COMPLETED|Overall Study||2493
152452|NCT00412984|371656|P1|NOT COMPLETED|Overall Study||2310
152453|NCT00412984|371655|P2|COMPLETED|Overall Study||6588
152454|NCT00412984|371656|P1|COMPLETED|Overall Study||6810
152455|NCT00412984|371655|P2|STARTED|Overall Study|Randomized participants|9081
152456|NCT00412984|371656|P1|STARTED|Overall Study|Randomized participants|9120
152457|NCT00413010|371700|P2|NOT COMPLETED|Overall Study||63
152458|NCT00413010|371701|P1|NOT COMPLETED|Overall Study||72
152459|NCT00413010|371700|P2|COMPLETED|Overall Study||113
152460|NCT00413010|371701|P1|COMPLETED|Overall Study||108
152461|NCT00413010|371700|P2|STARTED|Overall Study||176
152462|NCT00413010|371701|P1|STARTED|Overall Study||180
152463|NCT00413036|371721|P1|NOT COMPLETED|Overall Study||217
152464|NCT00413036|371721|P1|COMPLETED|Overall Study|Participants remain on study drug until progressive disease or unacceptable adverse events develop.|0
152465|NCT00413036|371721|P1|STARTED|Overall Study||217
152466|NCT00413049|371731|P2|NOT COMPLETED|Overall Study||18
152467|NCT00413049|371732|P1|NOT COMPLETED|Overall Study||24
152468|NCT00413049|371731|P2|COMPLETED|Overall Study||331
152469|NCT00413049|371732|P1|COMPLETED|Overall Study||325
152470|NCT00413049|371731|P2|STARTED|Overall Study||349
152471|NCT00413049|371732|P1|STARTED|Overall Study||349
152472|NCT00413062|371750|P2|NOT COMPLETED|Overall Study||210
152473|NCT00413062|371751|P1|NOT COMPLETED|Overall Study||678
152474|NCT00413062|371750|P2|COMPLETED|Overall Study||344
152475|NCT00413062|371751|P1|COMPLETED|Overall Study||988
152476|NCT00413062|371750|P2|STARTED|Overall Study||554
152477|NCT00413062|371751|P1|STARTED|Overall Study||1666
152478|NCT00413153|371777|P2|NOT COMPLETED|Overall Study||1
152479|NCT00413153|371778|P1|NOT COMPLETED|Overall Study||2
152480|NCT00413153|371777|P2|COMPLETED|Overall Study||7
152481|NCT00413153|371778|P1|COMPLETED|Overall Study||5
152482|NCT00413153|371777|P2|STARTED|Overall Study||8
152483|NCT00413153|371778|P1|STARTED|Overall Study||7
152484|NCT00413192|371804|P4|NOT COMPLETED|Overall Study||32
152485|NCT00413192|371805|P3|NOT COMPLETED|Overall Study||19
152486|NCT00413192|371806|P2|NOT COMPLETED|Overall Study||40
152487|NCT00413192|371807|P1|NOT COMPLETED|Overall Study||37
152488|NCT00413192|371804|P4|COMPLETED|Overall Study||0
152489|NCT00413192|371805|P3|COMPLETED|Overall Study||0
152490|NCT00413192|371806|P2|COMPLETED|Overall Study||0
152491|NCT00413192|371807|P1|COMPLETED|Overall Study||0
152492|NCT00413192|371804|P4|STARTED|Overall Study||32
152493|NCT00413192|371805|P3|STARTED|Overall Study||19
152494|NCT00413192|371806|P2|STARTED|Overall Study||40
152495|NCT00413192|371807|P1|STARTED|Overall Study||37
152496|NCT00413218|371847|P2|NOT COMPLETED|Overall Study||96
152497|NCT00413218|371848|P1|NOT COMPLETED|Overall Study||103
152498|NCT00413218|371847|P2|COMPLETED|Overall Study||131
152499|NCT00413218|371848|P1|COMPLETED|Overall Study||120
152500|NCT00413218|371847|P2|Intent to Treat Population (ITT)|Overall Study||219
152501|NCT00413218|371848|P1|Intent to Treat Population (ITT)|Overall Study||221
152502|NCT00413218|371847|P2|STARTED|Overall Study||227
152503|NCT00413218|371848|P1|STARTED|Overall Study||223
152504|NCT00413231|371870|P1|NOT COMPLETED|365-day to 60-month Post Treatment||46
152505|NCT00413231|371870|P1|COMPLETED|365-day to 60-month Post Treatment||93
152506|NCT00413231|371870|P1|STARTED|365-day to 60-month Post Treatment||139
152507|NCT00413231|371870|P1|NOT COMPLETED|30-day to 365-day Post Treatment||13
152508|NCT00413231|371870|P1|COMPLETED|30-day to 365-day Post Treatment||139
152509|NCT00413231|371870|P1|STARTED|30-day to 365-day Post Treatment||152
152510|NCT00413231|371870|P1|NOT COMPLETED|0 to 30-day Post Treatment||8
152511|NCT00413231|371870|P1|COMPLETED|0 to 30-day Post Treatment||152
152512|NCT00413231|371870|P1|STARTED|0 to 30-day Post Treatment||160
152513|NCT00413244|371902|P2|NOT COMPLETED|Overall Study||1
152514|NCT00413244|371903|P1|NOT COMPLETED|Overall Study||10
152515|NCT00413244|371902|P2|COMPLETED|Overall Study||19
152516|NCT00413244|371903|P1|COMPLETED|Overall Study||21
152517|NCT00413244|371902|P2|STARTED|Overall Study||20
152518|NCT00413244|371903|P1|STARTED|Overall Study||31
152519|NCT00413283|371935|P4|NOT COMPLETED|Overall Study||4
152520|NCT00413283|371936|P3|NOT COMPLETED|Overall Study||2
152521|NCT00413283|371937|P2|NOT COMPLETED|Overall Study||3
152522|NCT00413283|371938|P1|NOT COMPLETED|Overall Study||1
152523|NCT00413283|371935|P4|COMPLETED|Overall Study||13
152524|NCT00413283|371936|P3|COMPLETED|Overall Study||16
152525|NCT00413283|371937|P2|COMPLETED|Overall Study||13
152526|NCT00413283|371938|P1|COMPLETED|Overall Study||11
152527|NCT00413283|371935|P4|Received Study Drug|Overall Study||16
152528|NCT00413283|371936|P3|Received Study Drug|Overall Study||18
152529|NCT00413283|371937|P2|Received Study Drug|Overall Study||16
152530|NCT00413283|371938|P1|Received Study Drug|Overall Study||12
152531|NCT00413283|371935|P4|STARTED|Overall Study||17
152532|NCT00413283|371936|P3|STARTED|Overall Study||18
152533|NCT00413283|371937|P2|STARTED|Overall Study||16
152534|NCT00413283|371938|P1|STARTED|Overall Study||12
152535|NCT00413335|371970|P2|NOT COMPLETED|Overall Study||0
152536|NCT00413335|371971|P1|NOT COMPLETED|Overall Study||0
152537|NCT00413335|371970|P2|COMPLETED|Overall Study||9
152538|NCT00413335|371971|P1|COMPLETED|Overall Study||12
152539|NCT00413335|371970|P2|STARTED|Overall Study||9
152540|NCT00413335|371971|P1|STARTED|Overall Study||12
152541|NCT00413374|371985|P1|NOT COMPLETED|Overall Study||6
152542|NCT00413374|371985|P1|COMPLETED|Overall Study||34
152543|NCT00413374|371985|P1|STARTED|Overall Study||40
152544|NCT00413400|371992|P2|NOT COMPLETED|Overall Study||4
152545|NCT00413400|371993|P1|NOT COMPLETED|Overall Study||2
152546|NCT00413400|371992|P2|COMPLETED|Overall Study||12
152547|NCT00413400|371993|P1|COMPLETED|Overall Study||22
152548|NCT00413400|371992|P2|3 Month Visit|Overall Study||12
152549|NCT00413400|371993|P1|3 Month Visit|Overall Study||22
152550|NCT00413400|371992|P2|STARTED|Overall Study||16
152551|NCT00413400|371993|P1|STARTED|Overall Study||24
152552|NCT00413413|372024|P3|NOT COMPLETED|Double-Blind||18
152553|NCT00413413|372025|P2|NOT COMPLETED|Double-Blind||14
152554|NCT00413413|372026|P1|NOT COMPLETED|Double-Blind||15
152555|NCT00413413|372024|P3|COMPLETED|Double-Blind||285
152556|NCT00413413|372025|P2|COMPLETED|Double-Blind||293
152557|NCT00413413|372026|P1|COMPLETED|Double-Blind||293
152558|NCT00413413|372024|P3|STARTED|Double-Blind||303
152559|NCT00413413|372025|P2|STARTED|Double-Blind||307
152560|NCT00413413|372026|P1|STARTED|Double-Blind||308
152561|NCT00413413|372024|P3|NOT COMPLETED|Single-Blind||0
152562|NCT00413413|372025|P2|NOT COMPLETED|Single-Blind||216
152563|NCT00413413|372026|P1|NOT COMPLETED|Single-Blind||0
152564|NCT00413413|372024|P3|COMPLETED|Single-Blind||0
152565|NCT00413413|372025|P2|COMPLETED|Single-Blind||918
152566|NCT00413413|372026|P1|COMPLETED|Single-Blind||0
152567|NCT00413413|372024|P3|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
152568|NCT00413413|372025|P2|STARTED|Single-Blind||1134
152569|NCT00413413|372026|P1|STARTED|Single-Blind|In single-blind period participants were only enrolled to Valsartan 80 mg arm.|0
152570|NCT00413478|372046|P1|NOT COMPLETED|Overall Study||0
152571|NCT00413478|372046|P1|COMPLETED|Overall Study||9
152572|NCT00413478|372046|P1|STARTED|Overall Study||9
152573|NCT00413582|372052|P2|NOT COMPLETED|Overall Study||0
152574|NCT00413582|372053|P1|NOT COMPLETED|Overall Study||0
152575|NCT00413582|372052|P2|COMPLETED|Overall Study|all enrolled completed|55
152576|NCT00413582|372053|P1|COMPLETED|Overall Study|all enrolled completed|55
152577|NCT00413582|372052|P2|Completion of Study|Overall Study|all enrolled completed|55
152578|NCT00413582|372053|P1|Completion of Study|Overall Study|all enrolled completed|55
152579|NCT00413582|372052|P2|STARTED|Overall Study|all enrolled completed|55
152580|NCT00413582|372053|P1|STARTED|Overall Study|all enrolled completed|55
152581|NCT00413634|372063|P2|NOT COMPLETED|Overall Study||0
152582|NCT00413634|372064|P1|NOT COMPLETED|Overall Study||0
152583|NCT00413634|372063|P2|COMPLETED|Overall Study||12
152584|NCT00413634|372064|P1|COMPLETED|Overall Study||12
152585|NCT00413634|372063|P2|STARTED|Overall Study||12
152586|NCT00413634|372064|P1|STARTED|Overall Study||12
152587|NCT00413660|372107|P11|NOT COMPLETED|Post Week 12||1
152588|NCT00413660|372108|P10|NOT COMPLETED|Post Week 12||1
152589|NCT00413660|372109|P9|NOT COMPLETED|Post Week 12||0
152590|NCT00413660|372110|P8|NOT COMPLETED|Post Week 12||0
152591|NCT00413660|372111|P7|NOT COMPLETED|Post Week 12||3
152592|NCT00413660|372112|P6|NOT COMPLETED|Post Week 12||3
152593|NCT00413660|372113|P5|NOT COMPLETED|Post Week 12||6
152594|NCT00413660|372114|P4|NOT COMPLETED|Post Week 12||1
152595|NCT00413660|372115|P3|NOT COMPLETED|Post Week 12||8
152596|NCT00413660|372116|P2|NOT COMPLETED|Post Week 12||4
152597|NCT00413660|372117|P1|NOT COMPLETED|Post Week 12||3
152598|NCT00413660|372107|P11|COMPLETED|Post Week 12||17
152599|NCT00413660|372108|P10|COMPLETED|Post Week 12||12
152600|NCT00413660|372109|P9|COMPLETED|Post Week 12||13
152601|NCT00413660|372110|P8|COMPLETED|Post Week 12||21
152602|NCT00413660|372111|P7|COMPLETED|Post Week 12||37
152603|NCT00413660|372112|P6|COMPLETED|Post Week 12||54
152604|NCT00413660|372113|P5|COMPLETED|Post Week 12||60
152605|NCT00413660|372114|P4|COMPLETED|Post Week 12||66
152606|NCT00413660|372115|P3|COMPLETED|Post Week 12||56
152607|NCT00413660|372116|P2|COMPLETED|Post Week 12||44
152608|NCT00413660|372117|P1|COMPLETED|Post Week 12||40
152609|NCT00413660|372107|P11|STARTED|Post Week 12||18
152610|NCT00413660|372108|P10|STARTED|Post Week 12||13
152611|NCT00413660|372109|P9|STARTED|Post Week 12||13
152612|NCT00413660|372110|P8|STARTED|Post Week 12||21
152613|NCT00413660|372111|P7|STARTED|Post Week 12||40
152614|NCT00413660|372112|P6|STARTED|Post Week 12||57
152615|NCT00413660|372113|P5|STARTED|Post Week 12||66
152616|NCT00413660|372114|P4|STARTED|Post Week 12||67
152617|NCT00413660|372115|P3|STARTED|Post Week 12||64
152618|NCT00413660|372116|P2|STARTED|Post Week 12||48
152619|NCT00413660|372117|P1|STARTED|Post Week 12||43
152620|NCT00413660|372107|P11|NOT COMPLETED|Up To Week 12||0
152621|NCT00413660|372108|P10|NOT COMPLETED|Up To Week 12||0
152622|NCT00413660|372109|P9|NOT COMPLETED|Up To Week 12||0
152623|NCT00413660|372110|P8|NOT COMPLETED|Up To Week 12||0
152624|NCT00413660|372111|P7|NOT COMPLETED|Up To Week 12||11
152625|NCT00413660|372112|P6|NOT COMPLETED|Up To Week 12||10
152626|NCT00413660|372113|P5|NOT COMPLETED|Up To Week 12||9
152627|NCT00413660|372114|P4|NOT COMPLETED|Up To Week 12||8
152628|NCT00413660|372115|P3|NOT COMPLETED|Up To Week 12||7
152629|NCT00413660|372116|P2|NOT COMPLETED|Up To Week 12||7
152630|NCT00413660|372117|P1|NOT COMPLETED|Up To Week 12||7
152631|NCT00413660|372107|P11|COMPLETED|Up To Week 12||0
152632|NCT00413660|372108|P10|COMPLETED|Up To Week 12||0
152633|NCT00413660|372109|P9|COMPLETED|Up To Week 12||0
152634|NCT00413660|372110|P8|COMPLETED|Up To Week 12||0
152635|NCT00413660|372111|P7|COMPLETED|Up To Week 12||58
152636|NCT00413660|372112|P6|COMPLETED|Up To Week 12||70
152637|NCT00413660|372113|P5|COMPLETED|Up To Week 12||66
152638|NCT00413660|372114|P4|COMPLETED|Up To Week 12||67
152639|NCT00413660|372115|P3|COMPLETED|Up To Week 12||64
152640|NCT00413660|372116|P2|COMPLETED|Up To Week 12||61
152641|NCT00413660|372117|P1|COMPLETED|Up To Week 12||64
152642|NCT00413660|372107|P11|Treated|Up To Week 12||0
152643|NCT00413660|372108|P10|Treated|Up To Week 12||0
152644|NCT00413660|372109|P9|Treated|Up To Week 12||0
152645|NCT00413660|372110|P8|Treated|Up To Week 12||0
152646|NCT00413660|372111|P7|Treated|Up To Week 12||69
152647|NCT00413660|372112|P6|Treated|Up To Week 12||80
152648|NCT00413660|372113|P5|Treated|Up To Week 12||75
152649|NCT00413660|372114|P4|Treated|Up To Week 12||74
152650|NCT00413660|372115|P3|Treated|Up To Week 12||71
152651|NCT00413660|372116|P2|Treated|Up To Week 12||68
152652|NCT00413660|372117|P1|Treated|Up To Week 12||70
152653|NCT00413660|372107|P11|STARTED|Up To Week 12||0
152654|NCT00413660|372108|P10|STARTED|Up To Week 12||0
152655|NCT00413660|372109|P9|STARTED|Up To Week 12||0
152656|NCT00413660|372110|P8|STARTED|Up To Week 12||0
152657|NCT00413660|372111|P7|STARTED|Up To Week 12||69
152658|NCT00413660|372112|P6|STARTED|Up To Week 12||80
152659|NCT00413660|372113|P5|STARTED|Up To Week 12||75
152660|NCT00413660|372114|P4|STARTED|Up To Week 12||75
152661|NCT00413660|372115|P3|STARTED|Up To Week 12||71
152662|NCT00413660|372116|P2|STARTED|Up To Week 12||68
152663|NCT00413660|372117|P1|STARTED|Up To Week 12||71
152664|NCT00413777|372465|P2|NOT COMPLETED|Extension Period||0
152665|NCT00413777|372466|P1|NOT COMPLETED|Extension Period||0
152666|NCT00413777|372465|P2|COMPLETED|Extension Period||18
152667|NCT00413777|372466|P1|COMPLETED|Extension Period||17
152668|NCT00413777|372465|P2|STARTED|Extension Period||18
152669|NCT00413777|372466|P1|STARTED|Extension Period||17
152670|NCT00413777|372465|P2|NOT COMPLETED|Fixed-dose Period||3
152671|NCT00413777|372466|P1|NOT COMPLETED|Fixed-dose Period||4
152672|NCT00413777|372465|P2|COMPLETED|Fixed-dose Period||21
152673|NCT00413777|372466|P1|COMPLETED|Fixed-dose Period||18
152674|NCT00413777|372465|P2|STARTED|Fixed-dose Period||24
152675|NCT00413777|372466|P1|STARTED|Fixed-dose Period||22
152676|NCT00413894|372512|P1|NOT COMPLETED|Overall Study||80
152677|NCT00413894|372512|P1|COMPLETED|Overall Study||344
152678|NCT00413894|372512|P1|STARTED|Overall Study||424
152679|NCT00413920|372529|P2|NOT COMPLETED|Overall Study||28
152680|NCT00413920|372530|P1|NOT COMPLETED|Overall Study||28
152681|NCT00413920|372529|P2|COMPLETED|Overall Study||82
152682|NCT00413920|372530|P1|COMPLETED|Overall Study||84
152683|NCT00413920|372529|P2|STARTED|Overall Study||110
152684|NCT00413920|372530|P1|STARTED|Overall Study||112
152685|NCT00413959|372545|P1|NOT COMPLETED|Overall Study||1
152686|NCT00413959|372545|P1|COMPLETED|Overall Study||11
152687|NCT00413959|372545|P1|STARTED|Overall Study||12
152688|NCT00413972|372554|P4|NOT COMPLETED|Overall Study||3
152689|NCT00413972|372555|P3|NOT COMPLETED|Overall Study||10
152690|NCT00413972|372556|P2|NOT COMPLETED|Overall Study||8
152691|NCT00413972|372557|P1|NOT COMPLETED|Overall Study||7
152692|NCT00413972|372554|P4|COMPLETED|Overall Study||95
152693|NCT00413972|372555|P3|COMPLETED|Overall Study||88
152694|NCT00413972|372556|P2|COMPLETED|Overall Study||90
152695|NCT00413972|372557|P1|COMPLETED|Overall Study||91
152696|NCT00413972|372554|P4|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
152697|NCT00413972|372555|P3|STARTED|Overall Study||98
152698|NCT00413972|372556|P2|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
152699|NCT00413972|372557|P1|STARTED|Overall Study|1 of the 98 randomized subjects was not treated and was excluded from the ITT data set.|98
152700|NCT00414011|372567|P1|NOT COMPLETED|Overall Study||5
152701|NCT00414011|372567|P1|COMPLETED|Overall Study||35
152702|NCT00414011|372567|P1|STARTED|Overall Study||40
152703|NCT00414050|372576|P4|NOT COMPLETED|Overall Study||8
152704|NCT00414050|372577|P3|NOT COMPLETED|Overall Study||6
152705|NCT00414050|372578|P2|NOT COMPLETED|Overall Study||8
152706|NCT00414050|372579|P1|NOT COMPLETED|Overall Study||9
152707|NCT00414050|372576|P4|COMPLETED|Overall Study||423
152708|NCT00414050|372577|P3|COMPLETED|Overall Study||423
152709|NCT00414050|372578|P2|COMPLETED|Overall Study||419
152710|NCT00414050|372579|P1|COMPLETED|Overall Study||422
152711|NCT00414050|372576|P4|Received Vaccination 3|Overall Study||424
152712|NCT00414050|372577|P3|Received Vaccination 3|Overall Study||425
152713|NCT00414050|372578|P2|Received Vaccination 3|Overall Study||419
152714|NCT00414050|372579|P1|Received Vaccination 3|Overall Study||424
152715|NCT00414050|372576|P4|Received Vaccination 2|Overall Study||425
152716|NCT00414050|372577|P3|Received Vaccination 2|Overall Study||425
152717|NCT00414050|372578|P2|Received Vaccination 2|Overall Study||421
152718|NCT00414050|372579|P1|Received Vaccination 2|Overall Study||425
152719|NCT00414050|372576|P4|Received Vaccination 1|Overall Study||431
152720|NCT00414050|372577|P3|Received Vaccination 1|Overall Study||429
152721|NCT00414050|372578|P2|Received Vaccination 1|Overall Study||426
152722|NCT00414050|372579|P1|Received Vaccination 1|Overall Study||431
152723|NCT00414050|372576|P4|STARTED|Overall Study||431
152724|NCT00414050|372577|P3|STARTED|Overall Study||429
152725|NCT00414050|372578|P2|STARTED|Overall Study||427
152726|NCT00414050|372579|P1|STARTED|Overall Study||431
152727|NCT00414167|372595|P2|NOT COMPLETED|Overall Study||3
152728|NCT00414167|372596|P1|NOT COMPLETED|Overall Study||4
152729|NCT00414167|372595|P2|COMPLETED|Overall Study||27
152730|NCT00414167|372596|P1|COMPLETED|Overall Study||27
152731|NCT00414167|372595|P2|STARTED|Overall Study||30
152732|NCT00414167|372596|P1|STARTED|Overall Study||31
152733|NCT00414206|372607|P3|NOT COMPLETED|Overall Study||55
152734|NCT00414206|372608|P2|NOT COMPLETED|Overall Study||56
152735|NCT00414206|372609|P1|NOT COMPLETED|Overall Study||58
152736|NCT00414206|372607|P3|COMPLETED|Overall Study||59
152737|NCT00414206|372608|P2|COMPLETED|Overall Study||58
152738|NCT00414206|372609|P1|COMPLETED|Overall Study||57
152739|NCT00414206|372607|P3|STARTED|Overall Study||114
152740|NCT00414206|372608|P2|STARTED|Overall Study||114
152741|NCT00414206|372609|P1|STARTED|Overall Study||115
152742|NCT00414310|372619|P2|NOT COMPLETED|Overall Study||0
152743|NCT00414310|372620|P1|NOT COMPLETED|Overall Study||1
152744|NCT00414310|372619|P2|COMPLETED|Overall Study||79
152745|NCT00414310|372620|P1|COMPLETED|Overall Study||70
152746|NCT00414310|372619|P2|STARTED|Overall Study||79
152747|NCT00414310|372620|P1|STARTED|Overall Study||71
152748|NCT00414388|372626|P1|NOT COMPLETED|Overall Study||1
152749|NCT00414388|372626|P1|COMPLETED|Overall Study||21
152750|NCT00414388|372626|P1|STARTED|Overall Study||22
152751|NCT00414440|372634|P2|NOT COMPLETED|Extension Period||140
152752|NCT00414440|372635|P1|NOT COMPLETED|Extension Period||150
152753|NCT00414440|372634|P2|COMPLETED|Extension Period|Extension|77
152754|NCT00414440|372635|P1|COMPLETED|Extension Period|Extension|64
152755|NCT00414440|372634|P2|STARTED|Extension Period|Extension|217
152756|NCT00414440|372635|P1|STARTED|Extension Period|Extension|214
152757|NCT00414440|372634|P2|NOT COMPLETED|Core Period||32
152758|NCT00414440|372635|P1|NOT COMPLETED|Core Period||70
152759|NCT00414440|372634|P2|COMPLETED|Core Period|Core period|185
152760|NCT00414440|372635|P1|COMPLETED|Core Period|Core period|144
152761|NCT00414440|372634|P2|STARTED|Core Period|Core period|217
152762|NCT00414440|372635|P1|STARTED|Core Period|Core period|214
152763|NCT00414453|372649|P1|NOT COMPLETED|Overall Study||16
152764|NCT00414453|372649|P1|COMPLETED|Overall Study||3
152765|NCT00414453|372649|P1|STARTED|Overall Study||19
152766|NCT00414466|372699|P4|NOT COMPLETED|Overall Study||1
152767|NCT00414466|372700|P3|NOT COMPLETED|Overall Study||1
152768|NCT00414466|372701|P2|NOT COMPLETED|Overall Study||0
152769|NCT00414466|372702|P1|NOT COMPLETED|Overall Study||2
152770|NCT00414466|372699|P4|COMPLETED|Overall Study||42
152771|NCT00414466|372700|P3|COMPLETED|Overall Study||40
152772|NCT00414466|372701|P2|COMPLETED|Overall Study||42
152773|NCT00414466|372702|P1|COMPLETED|Overall Study||42
152774|NCT00414466|372699|P4|STARTED|Overall Study||43
152775|NCT00414466|372700|P3|STARTED|Overall Study||41
152776|NCT00414466|372701|P2|STARTED|Overall Study||42
152777|NCT00414466|372702|P1|STARTED|Overall Study||44
152778|NCT00414518|372722|P2|NOT COMPLETED|Overall Study||0
152779|NCT00414518|372723|P1|NOT COMPLETED|Overall Study||0
152780|NCT00414518|372722|P2|COMPLETED|Overall Study||9
152781|NCT00414518|372723|P1|COMPLETED|Overall Study||7
152782|NCT00414518|372722|P2|STARTED|Overall Study||9
152783|NCT00414518|372723|P1|STARTED|Overall Study||7
152784|NCT00414544|372733|P1|NOT COMPLETED|Overall Study||14
152785|NCT00414544|372733|P1|COMPLETED|Overall Study||131
152786|NCT00414544|372733|P1|STARTED|Overall Study||145
152787|NCT00414596|372739|P1|NOT COMPLETED|Overall Study||2
152788|NCT00414596|372739|P1|COMPLETED|Overall Study|April 2007|18
152789|NCT00414596|372739|P1|STARTED|Overall Study|December 2006|20
152790|NCT00414609|372750|P3|NOT COMPLETED|Extension Study||57
152791|NCT00414609|372751|P2|NOT COMPLETED|Extension Study||0
152792|NCT00414609|372752|P1|NOT COMPLETED|Extension Study||0
152793|NCT00414609|372750|P3|COMPLETED|Extension Study||365
152794|NCT00414609|372751|P2|COMPLETED|Extension Study||0
152795|NCT00414609|372752|P1|COMPLETED|Extension Study||0
152796|NCT00414609|372750|P3|Echocardiogram (ECHO) Analysis Set|Extension Study||400
152797|NCT00414609|372751|P2|Echocardiogram (ECHO) Analysis Set|Extension Study||0
152798|NCT00414609|372752|P1|Echocardiogram (ECHO) Analysis Set|Extension Study||0
152799|NCT00414609|372750|P3|STARTED|Extension Study|Patients of both core arms who completed core study and signed informed consent form for extension.|422
152800|NCT00414609|372751|P2|STARTED|Extension Study||0
152801|NCT00414609|372752|P1|STARTED|Extension Study||0
152802|NCT00414609|372750|P3|NOT COMPLETED|Core Study||0
152803|NCT00414609|372751|P2|NOT COMPLETED|Core Study||45
152804|NCT00414609|372752|P1|NOT COMPLETED|Core Study||34
152805|NCT00414609|372750|P3|COMPLETED|Core Study||0
152806|NCT00414609|372751|P2|COMPLETED|Core Study||378
152807|NCT00414609|372752|P1|COMPLETED|Core Study||363
152808|NCT00414609|372750|P3|Echocardiogram Evaluable Set|Core Study||0
152809|NCT00414609|372751|P2|Echocardiogram Evaluable Set|Core Study||343
152810|NCT00414609|372752|P1|Echocardiogram Evaluable Set|Core Study||330
152811|NCT00414609|372750|P3|Received Study Drug|Core Study||0
152812|NCT00414609|372751|P2|Received Study Drug|Core Study||422
152813|NCT00414609|372752|P1|Received Study Drug|Core Study||397
152814|NCT00414609|372750|P3|STARTED|Core Study||0
152815|NCT00414609|372751|P2|STARTED|Core Study||423
152816|NCT00414609|372752|P1|STARTED|Core Study||397
152817|NCT00414635|372777|P2|NOT COMPLETED|Overall Study||2
152818|NCT00414635|372778|P1|NOT COMPLETED|Overall Study||5
152819|NCT00414635|372777|P2|COMPLETED|Overall Study||28
152820|NCT00414635|372778|P1|COMPLETED|Overall Study||25
152821|NCT00414635|372777|P2|STARTED|Overall Study||30
152822|NCT00414635|372778|P1|STARTED|Overall Study||30
152823|NCT00414661|372800|P4|NOT COMPLETED|Overall Study||3
152824|NCT00414661|372801|P3|NOT COMPLETED|Overall Study||2
152825|NCT00414661|372802|P2|NOT COMPLETED|Overall Study||14
152826|NCT00414661|372803|P1|NOT COMPLETED|Overall Study||14
152827|NCT00414661|372800|P4|COMPLETED|Overall Study||0
152828|NCT00414661|372801|P3|COMPLETED|Overall Study||20
152829|NCT00414661|372802|P2|COMPLETED|Overall Study||75
152830|NCT00414661|372803|P1|COMPLETED|Overall Study||34
152831|NCT00414661|372800|P4|STARTED|Overall Study||3
152832|NCT00414661|372801|P3|STARTED|Overall Study||22
152833|NCT00414661|372802|P2|STARTED|Overall Study||89
152834|NCT00414661|372803|P1|STARTED|Overall Study||48
152835|NCT00414700|372827|P2|NOT COMPLETED|Overall Study||3
152836|NCT00414700|372828|P1|NOT COMPLETED|Overall Study||6
152837|NCT00414700|372827|P2|COMPLETED|Overall Study||58
152838|NCT00414700|372828|P1|COMPLETED|Overall Study||51
152839|NCT00414700|372827|P2|STARTED|Overall Study||61
152840|NCT00414700|372828|P1|STARTED|Overall Study||57
152841|NCT00414726|372850|P2|NOT COMPLETED|Overall Study||1
152842|NCT00414726|372851|P1|NOT COMPLETED|Overall Study||0
152843|NCT00414726|372850|P2|COMPLETED|Overall Study||41
152844|NCT00414726|372851|P1|COMPLETED|Overall Study||43
152845|NCT00414726|372850|P2|STARTED|Overall Study||42
152846|NCT00414726|372851|P1|STARTED|Overall Study||43
152847|NCT00414817|372861|P2|NOT COMPLETED|Overall Study||3016
152848|NCT00414817|372862|P1|NOT COMPLETED|Overall Study||3130
152849|NCT00414817|372861|P2|COMPLETED|Overall Study|Qualified for primary analysis (3260 prior ICS users) or secondary analysis (755 new users) samples.|4015
152850|NCT00414817|372862|P1|COMPLETED|Overall Study|Qualified for primary analysis (3171 prior ICS users) or secondary analysis (732 new users) samples.|3903
152851|NCT00414817|372861|P2|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|184
152852|NCT00414817|372862|P1|<3 Months Follow-up|Overall Study|qualified for analysis sample, but excluded since follow-up too short to assess adherence reliably.|175
152853|NCT00414817|372861|P2|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|123
152854|NCT00414817|372862|P1|Daily Oral Steroid User|Overall Study|qualified for analysis sample, but excluded due to subsequent determination of oral steroid use.|117
152855|NCT00414817|372861|P2|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|900
152856|NCT00414817|372862|P1|Adherent ICS User|Overall Study|Fully adherent ICS users who never qualified for an intervention call.|922
152857|NCT00414817|372861|P2|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|417
152858|NCT00414817|372862|P1|Died or Left Health Plan|Overall Study|These individuals died or terminated Health Plan membership prior to ever qualifying for a call.|451
152859|NCT00414817|372861|P2|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1392
152860|NCT00414817|372862|P1|Never Started on ICS|Overall Study|Not initial users of ICS and not starting during study, hence don't qualify for analysis sample.|1465
152861|NCT00414817|372861|P2|STARTED|Overall Study||7031
152862|NCT00414817|372862|P1|STARTED|Overall Study||7033
152863|NCT00414908|372874|P2|NOT COMPLETED|Overall Study||1
152864|NCT00414908|372875|P1|NOT COMPLETED|Overall Study||1
152865|NCT00414908|372874|P2|COMPLETED|Overall Study||28
152866|NCT00414908|372875|P1|COMPLETED|Overall Study||24
152867|NCT00414908|372874|P2|STARTED|Overall Study||29
152868|NCT00414908|372875|P1|STARTED|Overall Study||25
152869|NCT00414973|372901|P4|NOT COMPLETED|Overall Study||0
152870|NCT00414973|372902|P3|NOT COMPLETED|Overall Study||3
152871|NCT00414973|372903|P2|NOT COMPLETED|Overall Study||10
152872|NCT00414973|372904|P1|NOT COMPLETED|Overall Study||28
152873|NCT00414973|372901|P4|COMPLETED|Overall Study||11
152874|NCT00414973|372902|P3|COMPLETED|Overall Study||21
152875|NCT00414973|372903|P2|COMPLETED|Overall Study||99
152876|NCT00414973|372904|P1|COMPLETED|Overall Study||190
152877|NCT00414973|372901|P4|STARTED|Overall Study||11
152878|NCT00414973|372902|P3|STARTED|Overall Study||24
152879|NCT00414973|372903|P2|STARTED|Overall Study||109
152880|NCT00414973|372904|P1|STARTED|Overall Study||218
152881|NCT00415051|372922|P1|NOT COMPLETED|Overall Study||1
152882|NCT00415051|372922|P1|COMPLETED|Overall Study||19
152883|NCT00415051|372922|P1|STARTED|Overall Study||20
152884|NCT00415168|372929|P1|NOT COMPLETED|Overall Study||52
152885|NCT00415168|372929|P1|COMPLETED|Overall Study||1
152886|NCT00415168|372929|P1|Completed Treatment|Overall Study||15
152887|NCT00415168|372929|P1|STARTED|Overall Study||53
152888|NCT00415194|372941|P2|NOT COMPLETED|Overall Study||342
152889|NCT00415194|372942|P1|NOT COMPLETED|Overall Study||328
152890|NCT00415194|372941|P2|COMPLETED|Overall Study||55
152891|NCT00415194|372942|P1|COMPLETED|Overall Study||70
152892|NCT00415194|372941|P2|Received at Least 1 Dose of Study Drug|Overall Study||385
152893|NCT00415194|372942|P1|Received at Least 1 Dose of Study Drug|Overall Study||392
152894|NCT00415194|372941|P2|STARTED|Overall Study||397
152895|NCT00415194|372942|P1|STARTED|Overall Study||398
152896|NCT00408200|372960|P2|NOT COMPLETED|Overall Study||0
152897|NCT00408200|372961|P1|NOT COMPLETED|Overall Study||0
152898|NCT00408200|372960|P2|COMPLETED|Overall Study||53
152899|NCT00408200|372961|P1|COMPLETED|Overall Study||57
152900|NCT00408200|372960|P2|STARTED|Overall Study||53
152901|NCT00408200|372961|P1|STARTED|Overall Study||57
152902|NCT00408317|372969|P2|NOT COMPLETED|Second Intervention Period||2
152903|NCT00408317|372970|P1|NOT COMPLETED|Second Intervention Period||2
152904|NCT00408317|372969|P2|COMPLETED|Second Intervention Period||14
152905|NCT00408317|372970|P1|COMPLETED|Second Intervention Period||12
152906|NCT00408317|372969|P2|STARTED|Second Intervention Period||16
152907|NCT00408317|372970|P1|STARTED|Second Intervention Period||14
152908|NCT00408317|372969|P2|NOT COMPLETED|First Intervention Period||1
152909|NCT00408317|372970|P1|NOT COMPLETED|First Intervention Period||0
152910|NCT00408317|372969|P2|COMPLETED|First Intervention Period||16
152911|NCT00408317|372970|P1|COMPLETED|First Intervention Period||14
152912|NCT00408317|372969|P2|STARTED|First Intervention Period||17
152913|NCT00408317|372970|P1|STARTED|First Intervention Period||14
152914|NCT00408421|372984|P3|NOT COMPLETED|Treatment Re-Randomization||5
152915|NCT00408421|372985|P2|NOT COMPLETED|Treatment Re-Randomization||7
152916|NCT00408421|372986|P1|NOT COMPLETED|Treatment Re-Randomization||7
152917|NCT00408421|372984|P3|COMPLETED|Treatment Re-Randomization||38
152918|NCT00408421|372985|P2|COMPLETED|Treatment Re-Randomization||39
152919|NCT00408421|372986|P1|COMPLETED|Treatment Re-Randomization||96
152920|NCT00408421|372984|P3|STARTED|Treatment Re-Randomization||43
152921|NCT00408421|372985|P2|STARTED|Treatment Re-Randomization||46
152922|NCT00408421|372986|P1|STARTED|Treatment Re-Randomization||103
152923|NCT00408421|372984|P3|NOT COMPLETED|Treatment Initial Randomization||0
152924|NCT00408421|372985|P2|NOT COMPLETED|Treatment Initial Randomization||22
152925|NCT00408421|372986|P1|NOT COMPLETED|Treatment Initial Randomization||17
152926|NCT00408421|372984|P3|COMPLETED|Treatment Initial Randomization|Patients weren't randomized to Duloxetine 120 mg until Visit 4.|0
152927|NCT00408421|372985|P2|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|89
152928|NCT00408421|372986|P1|COMPLETED|Treatment Initial Randomization|Pre-Re-Randomization (Visit 4)|103
152929|NCT00408421|372984|P3|STARTED|Treatment Initial Randomization||0
152930|NCT00408421|372985|P2|STARTED|Treatment Initial Randomization||111
152931|NCT00408421|372986|P1|STARTED|Treatment Initial Randomization||120
152932|NCT00408460|373060|P1|NOT COMPLETED|Overall Study||0
152933|NCT00408460|373060|P1|COMPLETED|Overall Study||34
152934|NCT00408460|373060|P1|STARTED|Overall Study||34
152935|NCT00408499|373066|P5|NOT COMPLETED|Phase II- MTD Expansion||20
152936|NCT00408499|373067|P4|NOT COMPLETED|Phase II- MTD Expansion||0
152937|NCT00408499|373068|P3|NOT COMPLETED|Phase II- MTD Expansion||0
152938|NCT00408499|373069|P2|NOT COMPLETED|Phase II- MTD Expansion||0
152939|NCT00408499|373070|P1|NOT COMPLETED|Phase II- MTD Expansion||0
152940|NCT00408499|373066|P5|COMPLETED|Phase II- MTD Expansion||24
152941|NCT00408499|373067|P4|COMPLETED|Phase II- MTD Expansion||0
152942|NCT00408499|373068|P3|COMPLETED|Phase II- MTD Expansion||0
152943|NCT00408499|373069|P2|COMPLETED|Phase II- MTD Expansion||0
152944|NCT00408499|373070|P1|COMPLETED|Phase II- MTD Expansion||0
152945|NCT00408499|373066|P5|STARTED|Phase II- MTD Expansion||44
152946|NCT00408499|373067|P4|STARTED|Phase II- MTD Expansion||0
152947|NCT00408499|373068|P3|STARTED|Phase II- MTD Expansion||0
152948|NCT00408499|373069|P2|STARTED|Phase II- MTD Expansion||0
152949|NCT00408499|373070|P1|STARTED|Phase II- MTD Expansion||0
152950|NCT00408499|373066|P5|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
152951|NCT00408499|373067|P4|NOT COMPLETED|Phase 1: Dose Levels 1-4||0
152952|NCT00408499|373068|P3|NOT COMPLETED|Phase 1: Dose Levels 1-4||1
152953|NCT00408499|373069|P2|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
152954|NCT00408499|373070|P1|NOT COMPLETED|Phase 1: Dose Levels 1-4||2
152955|NCT00408499|373066|P5|COMPLETED|Phase 1: Dose Levels 1-4||0
152956|NCT00408499|373067|P4|COMPLETED|Phase 1: Dose Levels 1-4||6
152957|NCT00408499|373068|P3|COMPLETED|Phase 1: Dose Levels 1-4||2
152958|NCT00408499|373069|P2|COMPLETED|Phase 1: Dose Levels 1-4||5
152959|NCT00408499|373070|P1|COMPLETED|Phase 1: Dose Levels 1-4||2
152960|NCT00408499|373066|P5|STARTED|Phase 1: Dose Levels 1-4||0
152961|NCT00408499|373067|P4|STARTED|Phase 1: Dose Levels 1-4||6
152962|NCT00408499|373068|P3|STARTED|Phase 1: Dose Levels 1-4||3
152963|NCT00408499|373069|P2|STARTED|Phase 1: Dose Levels 1-4||7
152964|NCT00408499|373070|P1|STARTED|Phase 1: Dose Levels 1-4||4
152965|NCT00408603|373082|P3|NOT COMPLETED|Overall Study||40
152966|NCT00408603|373083|P2|NOT COMPLETED|Overall Study||2
152967|NCT00408603|373084|P1|NOT COMPLETED|Overall Study||4
152968|NCT00408603|373082|P3|COMPLETED|Overall Study||35
152969|NCT00408603|373083|P2|COMPLETED|Overall Study||37
152970|NCT00408603|373084|P1|COMPLETED|Overall Study||65
152971|NCT00408603|373082|P3|STARTED|Overall Study||75
152972|NCT00408603|373083|P2|STARTED|Overall Study||39
152973|NCT00408603|373084|P1|STARTED|Overall Study||69
152974|NCT00408629|373100|P2|NOT COMPLETED|Overall Study||125
152975|NCT00408629|373101|P1|NOT COMPLETED|Overall Study||97
152976|NCT00408629|373100|P2|COMPLETED|Overall Study||135
152977|NCT00408629|373101|P1|COMPLETED|Overall Study|1 ADA recipient did not receive study drug and discontinued due to other reasons.|161
152978|NCT00408629|373100|P2|STARTED|Overall Study|14 PLB recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (246).|260
152979|NCT00408629|373101|P1|STARTED|Overall Study|10 ADA recipients from 3 noncompliant clinical sites in Safety, but not in Efficacy analyses (248).|258
152980|NCT00408681|373140|P1|NOT COMPLETED|Overall Study||9
152981|NCT00408681|373140|P1|COMPLETED|Overall Study|Completion was defined as administration of the study product for at least 28 days.|11
152982|NCT00408681|373140|P1|STARTED|Overall Study||20
152983|NCT00408694|373157|P1|NOT COMPLETED|Overall Study||2
152984|NCT00408694|373157|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|44
152985|NCT00408694|373157|P1|STARTED|Overall Study||46
152986|NCT00415493|373163|P2|NOT COMPLETED|Overall Study||0
152987|NCT00415493|373164|P1|NOT COMPLETED|Overall Study||0
152988|NCT00415493|373163|P2|COMPLETED|Overall Study||12
152989|NCT00415493|373164|P1|COMPLETED|Overall Study||12
152990|NCT00415493|373163|P2|STARTED|Overall Study||12
152991|NCT00415493|373164|P1|STARTED|Overall Study||12
152992|NCT00415506|373172|P2|NOT COMPLETED|Overall Study||1
152993|NCT00415506|373173|P1|NOT COMPLETED|Overall Study||3
152994|NCT00415506|373172|P2|COMPLETED|Overall Study||9
152995|NCT00415506|373173|P1|COMPLETED|Overall Study||9
152996|NCT00415506|373172|P2|STARTED|Overall Study||10
152997|NCT00415506|373173|P1|STARTED|Overall Study||12
152998|NCT00415532|373183|P2|NOT COMPLETED|Safety Follow Up Period||12
152999|NCT00415532|373184|P1|NOT COMPLETED|Safety Follow Up Period||9
153000|NCT00415532|373183|P2|COMPLETED|Safety Follow Up Period||18
153001|NCT00415532|373184|P1|COMPLETED|Safety Follow Up Period||34
153002|NCT00415532|373183|P2|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|30
153090|NCT00419341|373360|P1|COMPLETED|Efficacy Period||28
153003|NCT00415532|373184|P1|STARTED|Safety Follow Up Period|Participants who completed the treatment period were not required to participate in this follow-up|43
153004|NCT00415532|373183|P2|NOT COMPLETED|Treatment Period||15
153005|NCT00415532|373184|P1|NOT COMPLETED|Treatment Period||17
153006|NCT00415532|373183|P2|COMPLETED|Treatment Period||142
153007|NCT00415532|373184|P1|COMPLETED|Treatment Period||60
153008|NCT00415532|373183|P2|Switched to Romiplostim Group|Treatment Period||0
153009|NCT00415532|373184|P1|Switched to Romiplostim Group|Treatment Period||2
153010|NCT00415532|373183|P2|Received Treatment|Treatment Period||154
153011|NCT00415532|373184|P1|Received Treatment|Treatment Period||75
153012|NCT00415532|373183|P2|STARTED|Treatment Period||157
153013|NCT00415532|373184|P1|STARTED|Treatment Period||77
153014|NCT00418938|373206|P2|NOT COMPLETED|Overall Study||23
153015|NCT00418938|373207|P1|NOT COMPLETED|Overall Study||24
153016|NCT00418938|373206|P2|COMPLETED|Overall Study||108
153017|NCT00418938|373207|P1|COMPLETED|Overall Study||109
153018|NCT00418938|373206|P2|STARTED|Overall Study||131
153019|NCT00418938|373207|P1|STARTED|Overall Study||133
153020|NCT00418951|373228|P3|NOT COMPLETED|Overall Study||0
153021|NCT00418951|373229|P2|NOT COMPLETED|Overall Study||0
153022|NCT00418951|373230|P1|NOT COMPLETED|Overall Study||0
153023|NCT00418951|373228|P3|COMPLETED|Overall Study||40
153024|NCT00418951|373229|P2|COMPLETED|Overall Study||33
153025|NCT00418951|373230|P1|COMPLETED|Overall Study||39
153026|NCT00418951|373228|P3|STARTED|Overall Study||40
153027|NCT00418951|373229|P2|STARTED|Overall Study||33
153028|NCT00418951|373230|P1|STARTED|Overall Study||39
153029|NCT00418964|373241|P3|NOT COMPLETED|Overall Study||6
153030|NCT00418964|373242|P2|NOT COMPLETED|Overall Study||3
153031|NCT00418964|373243|P1|NOT COMPLETED|Overall Study||1
153032|NCT00418964|373241|P3|COMPLETED|Overall Study||14
153033|NCT00418964|373242|P2|COMPLETED|Overall Study||17
153034|NCT00418964|373243|P1|COMPLETED|Overall Study||21
153035|NCT00418964|373241|P3|STARTED|Overall Study||20
153036|NCT00418964|373242|P2|STARTED|Overall Study||20
153037|NCT00418964|373243|P1|STARTED|Overall Study||22
153038|NCT00418977|373253|P2|NOT COMPLETED|Overall Study||3
153039|NCT00418977|373254|P1|NOT COMPLETED|Overall Study||3
153040|NCT00418977|373253|P2|COMPLETED|Overall Study||13
153041|NCT00418977|373254|P1|COMPLETED|Overall Study||40
153042|NCT00418977|373253|P2|STARTED|Overall Study||16
153043|NCT00418977|373254|P1|STARTED|Overall Study||43
153044|NCT00419003|373270|P2|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||0
153045|NCT00419003|373271|P1|NOT COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||1
153046|NCT00419003|373270|P2|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||8
153047|NCT00419003|373271|P1|COMPLETED|Phase 2, Riluzole/Placebo Follow-Up||5
153048|NCT00419003|373270|P2|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|8
153049|NCT00419003|373271|P1|STARTED|Phase 2, Riluzole/Placebo Follow-Up|14 completers of phase I didn’t split up evenly (same way as phase I) in the riluzole/placebo phase.|6
153050|NCT00419003|373270|P2|NOT COMPLETED|Phase I, Ketamine Infusion||6
153051|NCT00419003|373271|P1|NOT COMPLETED|Phase I, Ketamine Infusion||6
153052|NCT00419003|373270|P2|COMPLETED|Phase I, Ketamine Infusion||7
153053|NCT00419003|373271|P1|COMPLETED|Phase I, Ketamine Infusion||7
153054|NCT00419003|373270|P2|STARTED|Phase I, Ketamine Infusion||13
153055|NCT00419003|373271|P1|STARTED|Phase I, Ketamine Infusion||13
153056|NCT00419094|373282|P2|NOT COMPLETED|Overall Study||30
153057|NCT00419094|373283|P1|NOT COMPLETED|Overall Study||7
153058|NCT00419094|373282|P2|COMPLETED|Overall Study||141
153059|NCT00419094|373283|P1|COMPLETED|Overall Study||50
153060|NCT00419094|373282|P2|STARTED|Overall Study||171
153061|NCT00419094|373283|P1|STARTED|Overall Study|Number started refers to number randomized; 303 subjects were screened/enrolled and 228 randomized.|57
153062|NCT00419120|373295|P1|NOT COMPLETED|Long Term Follow up Period||10
153063|NCT00419120|373295|P1|COMPLETED|Long Term Follow up Period||0
153064|NCT00419120|373295|P1|STARTED|Long Term Follow up Period|10 patients are being followed in long term follow up.|10
153065|NCT00419120|373295|P1|NOT COMPLETED|Primary Study Period||0
153066|NCT00419120|373295|P1|COMPLETED|Primary Study Period||10
153067|NCT00419120|373295|P1|STARTED|Primary Study Period||10
153068|NCT00419159|373302|P2|NOT COMPLETED|Overall Study||100
153069|NCT00419159|373303|P1|NOT COMPLETED|Overall Study||99
153070|NCT00419159|373302|P2|COMPLETED|Overall Study||0
153071|NCT00419159|373303|P1|COMPLETED|Overall Study||0
153072|NCT00419159|373302|P2|STARTED|Overall Study||100
153073|NCT00419159|373303|P1|STARTED|Overall Study|Full Analysis Set|99
153074|NCT00419263|373320|P3|NOT COMPLETED|Overall Study||3
153075|NCT00419263|373321|P2|NOT COMPLETED|Overall Study||2
153076|NCT00419263|373322|P1|NOT COMPLETED|Overall Study||3
153077|NCT00419263|373320|P3|COMPLETED|Overall Study||112
153078|NCT00419263|373321|P2|COMPLETED|Overall Study||112
153079|NCT00419263|373322|P1|COMPLETED|Overall Study||112
153080|NCT00419263|373320|P3|STARTED|Overall Study||115
153081|NCT00419263|373321|P2|STARTED|Overall Study||114
153082|NCT00419263|373322|P1|STARTED|Overall Study||115
153083|NCT00419315|373351|P2|NOT COMPLETED|Overall Study||0
153084|NCT00419315|373352|P1|NOT COMPLETED|Overall Study||0
153085|NCT00419315|373351|P2|COMPLETED|Overall Study||78
153086|NCT00419315|373352|P1|COMPLETED|Overall Study||85
153087|NCT00419315|373351|P2|STARTED|Overall Study||78
153088|NCT00419315|373352|P1|STARTED|Overall Study||85
153089|NCT00419341|373360|P1|NOT COMPLETED|Efficacy Period||10
153091|NCT00419341|373360|P1|STARTED|Efficacy Period||38
153092|NCT00419341|373360|P1|NOT COMPLETED|Wash in/Wash Out Period||11
153093|NCT00419341|373360|P1|COMPLETED|Wash in/Wash Out Period||38
153094|NCT00419341|373360|P1|STARTED|Wash in/Wash Out Period||49
153095|NCT00419380|373383|P2|NOT COMPLETED|Overall Study||10
153096|NCT00419380|373384|P1|NOT COMPLETED|Overall Study||1
153097|NCT00419380|373383|P2|COMPLETED|Overall Study||12
153098|NCT00419380|373384|P1|COMPLETED|Overall Study||18
153099|NCT00419380|373383|P2|STARTED|Overall Study||22
153100|NCT00419380|373384|P1|STARTED|Overall Study||19
153101|NCT00419393|373392|P1|NOT COMPLETED|Overall Study||24
153102|NCT00419393|373392|P1|COMPLETED|Overall Study||166
153103|NCT00419393|373392|P1|STARTED|Overall Study|One subject did not receive medication|190
153104|NCT00419445|373403|P3|NOT COMPLETED|Overall Study||1
153105|NCT00419445|373404|P2|NOT COMPLETED|Overall Study||2
153106|NCT00419445|373405|P1|NOT COMPLETED|Overall Study||1
153107|NCT00419445|373403|P3|COMPLETED|Overall Study||7
153108|NCT00419445|373404|P2|COMPLETED|Overall Study||14
153109|NCT00419445|373405|P1|COMPLETED|Overall Study||7
153110|NCT00419445|373403|P3|STARTED|Overall Study||8
153111|NCT00419445|373404|P2|STARTED|Overall Study||16
153112|NCT00419445|373405|P1|STARTED|Overall Study||8
153113|NCT00419744|373416|P3|NOT COMPLETED|Overall Study||133
153114|NCT00419744|373417|P2|NOT COMPLETED|Overall Study||118
153115|NCT00419744|373418|P1|NOT COMPLETED|Overall Study||117
153116|NCT00419744|373416|P3|COMPLETED|Overall Study||271
153117|NCT00419744|373417|P2|COMPLETED|Overall Study||290
153118|NCT00419744|373418|P1|COMPLETED|Overall Study||290
153119|NCT00419744|373416|P3|STARTED|Overall Study||404
153120|NCT00419744|373417|P2|STARTED|Overall Study||408
153121|NCT00419744|373418|P1|STARTED|Overall Study||407
153122|NCT00419757|373449|P2|NOT COMPLETED|Overall Study||21
153123|NCT00419757|373450|P1|NOT COMPLETED|Overall Study||18
153124|NCT00419757|373449|P2|COMPLETED|Overall Study|Randomized patients|102
153125|NCT00419757|373450|P1|COMPLETED|Overall Study|Randomized patients|109
153126|NCT00419757|373449|P2|STARTED|Overall Study|Randomized patients|123
153127|NCT00419757|373450|P1|STARTED|Overall Study|Randomized patients|127
153128|NCT00419770|373488|P2|NOT COMPLETED|Overall Study||1
153129|NCT00419770|373489|P1|NOT COMPLETED|Overall Study||5
153130|NCT00419770|373488|P2|COMPLETED|Overall Study||8
153131|NCT00419770|373489|P1|COMPLETED|Overall Study||6
153132|NCT00419770|373488|P2|STARTED|Overall Study||9
153133|NCT00419770|373489|P1|STARTED|Overall Study||11
153134|NCT00419926|373497|P2|NOT COMPLETED|Overall Study||10
153135|NCT00419926|373498|P1|NOT COMPLETED|Overall Study||14
153136|NCT00419926|373497|P2|COMPLETED|Overall Study||148
153137|NCT00419926|373498|P1|COMPLETED|Overall Study||141
153138|NCT00419926|373497|P2|STARTED|Overall Study|Intention to treat population, 154 is safety population.|158
153139|NCT00419926|373498|P1|STARTED|Overall Study|Intention to treat population, 150 is safety population.|155
153140|NCT00419952|373514|P2|NOT COMPLETED|Overall Study||125
153141|NCT00419952|373515|P1|NOT COMPLETED|Overall Study||149
153142|NCT00419952|373514|P2|COMPLETED|Overall Study||240
153143|NCT00419952|373515|P1|COMPLETED|Overall Study||228
153144|NCT00419952|373514|P2|STARTED|Overall Study||365
153145|NCT00419952|373515|P1|STARTED|Overall Study||377
153146|NCT00420017|373549|P2|NOT COMPLETED|Overall Study||0
153147|NCT00420017|373550|P1|NOT COMPLETED|Overall Study||2
153148|NCT00420017|373549|P2|COMPLETED|Overall Study||40
153149|NCT00420017|373550|P1|COMPLETED|Overall Study|40 completed analysis|38
153150|NCT00420017|373549|P2|STARTED|Overall Study||40
153151|NCT00420017|373550|P1|STARTED|Overall Study||40
153152|NCT00420056|373562|P1|NOT COMPLETED|Overall Study||17
153153|NCT00420056|373562|P1|COMPLETED|Overall Study||0
153154|NCT00420056|373562|P1|STARTED|Overall Study||17
153155|NCT00420095|373586|P2|NOT COMPLETED|Overall Study||1
153156|NCT00420095|373587|P1|NOT COMPLETED|Overall Study||3
153157|NCT00420095|373586|P2|COMPLETED|Overall Study||59
153158|NCT00420095|373587|P1|COMPLETED|Overall Study||54
153159|NCT00420095|373586|P2|STARTED|Overall Study||60
153160|NCT00420095|373587|P1|STARTED|Overall Study||57
153161|NCT00420147|373607|P2|NOT COMPLETED|Overall Study||0
153162|NCT00420147|373608|P1|NOT COMPLETED|Overall Study||0
153163|NCT00420147|373607|P2|COMPLETED|Overall Study||19
153164|NCT00420147|373608|P1|COMPLETED|Overall Study||19
153165|NCT00420147|373607|P2|STARTED|Overall Study||19
153166|NCT00420147|373608|P1|STARTED|Overall Study||19
153167|NCT00420199|373618|P2|NOT COMPLETED|Overall Study||0
153168|NCT00420199|373619|P1|NOT COMPLETED|Overall Study||1
153169|NCT00420199|373618|P2|COMPLETED|Overall Study||23
153170|NCT00420199|373619|P1|COMPLETED|Overall Study||26
153171|NCT00420199|373618|P2|STARTED|Overall Study||23
153172|NCT00420199|373619|P1|STARTED|Overall Study||27
153173|NCT00420212|373675|P3|NOT COMPLETED|Overall Study||96
153174|NCT00420212|373676|P2|NOT COMPLETED|Overall Study||95
153175|NCT00420212|373677|P1|NOT COMPLETED|Overall Study||91
153176|NCT00420212|373675|P3|COMPLETED|Overall Study||320
153177|NCT00420212|373676|P2|COMPLETED|Overall Study||315
153178|NCT00420212|373677|P1|COMPLETED|Overall Study||317
153179|NCT00420212|373675|P3|STARTED|Overall Study|416 participants were dosed; 416 participants were randomized|416
153180|NCT00420212|373676|P2|STARTED|Overall Study|410 participants were dosed; 411 participants were randomized|410
153181|NCT00420212|373677|P1|STARTED|Overall Study|408 participants were dosed; 410 participants were randomized|408
153182|NCT00420238|373703|P2|NOT COMPLETED|12 Week Open-Label Treatment Period 2||1
153183|NCT00420238|373704|P1|NOT COMPLETED|12 Week Open-Label Treatment Period 2||2
153184|NCT00420238|373703|P2|COMPLETED|12 Week Open-Label Treatment Period 2||38
153185|NCT00420238|373704|P1|COMPLETED|12 Week Open-Label Treatment Period 2||36
153186|NCT00420238|373703|P2|STARTED|12 Week Open-Label Treatment Period 2||39
153187|NCT00420238|373704|P1|STARTED|12 Week Open-Label Treatment Period 2||38
153188|NCT00420238|373703|P2|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||4
153189|NCT00420238|373704|P1|NOT COMPLETED|12 Week Double-Blind Treatment Period 1||1
153190|NCT00420238|373703|P2|COMPLETED|12 Week Double-Blind Treatment Period 1||39
153191|NCT00420238|373704|P1|COMPLETED|12 Week Double-Blind Treatment Period 1||38
153192|NCT00420238|373703|P2|STARTED|12 Week Double-Blind Treatment Period 1||43
153193|NCT00420238|373704|P1|STARTED|12 Week Double-Blind Treatment Period 1||39
153194|NCT00420290|373842|P2|NOT COMPLETED|Overall Study||4
153195|NCT00420290|373843|P1|NOT COMPLETED|Overall Study||4
153196|NCT00420290|373842|P2|COMPLETED|Overall Study||7
153197|NCT00420290|373843|P1|COMPLETED|Overall Study||7
153198|NCT00420290|373842|P2|STARTED|Overall Study||11
153199|NCT00420290|373843|P1|STARTED|Overall Study||11
153200|NCT00420303|373859|P2|NOT COMPLETED|Overall Study||4
153201|NCT00420303|373860|P1|NOT COMPLETED|Overall Study||1
153202|NCT00420303|373859|P2|COMPLETED|Overall Study||8
153203|NCT00420303|373860|P1|COMPLETED|Overall Study||11
153204|NCT00420303|373859|P2|STARTED|Overall Study||12
153205|NCT00420303|373860|P1|STARTED|Overall Study||12
153206|NCT00420316|373872|P2|NOT COMPLETED|Overall Study||9
153207|NCT00420316|373873|P1|NOT COMPLETED|Overall Study||12
153208|NCT00420316|373872|P2|COMPLETED|Overall Study||522
153209|NCT00420316|373873|P1|COMPLETED|Overall Study||1070
153210|NCT00420316|373872|P2|STARTED|Overall Study||531
153211|NCT00420316|373873|P1|STARTED|Overall Study||1082
153212|NCT00420342|373898|P3|NOT COMPLETED|Overall Study||1
153213|NCT00420342|373899|P2|NOT COMPLETED|Overall Study||2
153214|NCT00420342|373900|P1|NOT COMPLETED|Overall Study||1
153215|NCT00420342|373898|P3|COMPLETED|Overall Study||28
153216|NCT00420342|373899|P2|COMPLETED|Overall Study||31
153217|NCT00420342|373900|P1|COMPLETED|Overall Study||29
153218|NCT00420342|373898|P3|Received Treatment|Overall Study||29
153219|NCT00420342|373899|P2|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|32
153220|NCT00420342|373900|P1|Received Treatment|Overall Study|1 subject did not confirm if she ever took the study medication.|29
153221|NCT00420342|373898|P3|STARTED|Overall Study||29
153222|NCT00420342|373899|P2|STARTED|Overall Study||33
153223|NCT00420342|373900|P1|STARTED|Overall Study||30
153224|NCT00420407|373943|P2|NOT COMPLETED|Overall Study||6
153225|NCT00420407|373944|P1|NOT COMPLETED|Overall Study||4
153226|NCT00420407|373943|P2|COMPLETED|Overall Study||34
153227|NCT00420407|373944|P1|COMPLETED|Overall Study||37
153228|NCT00420407|373943|P2|STARTED|Overall Study||40
153229|NCT00420407|373944|P1|STARTED|Overall Study||41
153230|NCT00420420|373952|P2|NOT COMPLETED|Overall Study||4
153231|NCT00420420|373953|P1|NOT COMPLETED|Overall Study||8
153232|NCT00420420|373952|P2|COMPLETED|Overall Study||67
153233|NCT00420420|373953|P1|COMPLETED|Overall Study|One patient from the MK-0249 arm discontinued the trial due to an AE prior to receiving study drug.|65
153234|NCT00420420|373952|P2|STARTED|Overall Study|Number of patients randomized.|71
153235|NCT00420420|373953|P1|STARTED|Overall Study|Number of patients randomized.|73
153236|NCT00420459|373969|P1|NOT COMPLETED|Overall Study||0
153237|NCT00420459|373969|P1|COMPLETED|Overall Study||12
153238|NCT00420459|373969|P1|STARTED|Overall Study||12
153239|NCT00420511|373980|P2|NOT COMPLETED|Overall Study||1
153240|NCT00420511|373981|P1|NOT COMPLETED|Overall Study||2
153241|NCT00420511|373980|P2|COMPLETED|Overall Study||10
153242|NCT00420511|373981|P1|COMPLETED|Overall Study||8
153243|NCT00420511|373980|P2|STARTED|Overall Study||11
153244|NCT00420511|373981|P1|STARTED|Overall Study||10
153245|NCT00420628|373993|P2|NOT COMPLETED|Overall Study||4
153246|NCT00420628|373994|P1|NOT COMPLETED|Overall Study||9
153247|NCT00420628|373993|P2|COMPLETED|Overall Study||32
153248|NCT00420628|373994|P1|COMPLETED|Overall Study||63
153249|NCT00420628|373993|P2|STARTED|Overall Study||36
153250|NCT00420628|373994|P1|STARTED|Overall Study||72
153251|NCT00420745|374010|P2|NOT COMPLETED|Overall Study||6
153252|NCT00420745|374011|P1|NOT COMPLETED|Overall Study||15
153253|NCT00420745|374010|P2|COMPLETED|Overall Study||333
153254|NCT00420745|374011|P1|COMPLETED|Overall Study||655
153255|NCT00420745|374010|P2|STARTED|Overall Study||339
153256|NCT00420745|374011|P1|STARTED|Overall Study||670
153257|NCT00420784|374031|P4|NOT COMPLETED|Overall Study||78
153258|NCT00420784|374032|P3|NOT COMPLETED|Overall Study||53
153259|NCT00420784|374033|P2|NOT COMPLETED|Overall Study||58
153260|NCT00420784|374034|P1|NOT COMPLETED|Overall Study||29
153261|NCT00420784|374031|P4|COMPLETED|Overall Study||36
153262|NCT00420784|374032|P3|COMPLETED|Overall Study||58
153263|NCT00420784|374033|P2|COMPLETED|Overall Study||55
153264|NCT00420784|374034|P1|COMPLETED|Overall Study||86
153265|NCT00420784|374031|P4|STARTED|Overall Study||114
153266|NCT00420784|374032|P3|STARTED|Overall Study||111
153267|NCT00420784|374033|P2|STARTED|Overall Study||113
153268|NCT00420784|374034|P1|STARTED|Overall Study||115
153269|NCT00420849|374061|P1|NOT COMPLETED|Overall Study||331
153270|NCT00420849|374061|P1|COMPLETED|Overall Study|Participants completed the study upon commercial availability of lenalidomide|256
153271|NCT00420849|374061|P1|STARTED|Overall Study||587
153272|NCT00420927|374133|P7|NOT COMPLETED|Period 2||53
153273|NCT00420927|374134|P6|NOT COMPLETED|Period 2||15
153274|NCT00420927|374135|P5|NOT COMPLETED|Period 2||43
153275|NCT00420927|374136|P4|NOT COMPLETED|Period 2||10
153276|NCT00420927|374137|P3|NOT COMPLETED|Period 2||13
153277|NCT00420927|374138|P2|NOT COMPLETED|Period 2||0
153278|NCT00420927|374139|P1|NOT COMPLETED|Period 2||0
153279|NCT00420927|374133|P7|COMPLETED|Period 2||295
153280|NCT00420927|374134|P6|COMPLETED|Period 2||97
153281|NCT00420927|374135|P5|COMPLETED|Period 2||216
153282|NCT00420927|374136|P4|COMPLETED|Period 2||95
153283|NCT00420927|374137|P3|COMPLETED|Period 2||89
153284|NCT00420927|374138|P2|COMPLETED|Period 2||0
153285|NCT00420927|374139|P1|COMPLETED|Period 2||0
153286|NCT00420927|374133|P7|STARTED|Period 2||348
153287|NCT00420927|374134|P6|STARTED|Period 2||112
153288|NCT00420927|374135|P5|STARTED|Period 2||259
153289|NCT00420927|374136|P4|STARTED|Period 2||105
153290|NCT00420927|374137|P3|STARTED|Period 2||102
153291|NCT00420927|374138|P2|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
153292|NCT00420927|374139|P1|STARTED|Period 2|This treatment group is not relevant to Period 2.|0
153293|NCT00420927|374133|P7|NOT COMPLETED|Period 1||0
153294|NCT00420927|374134|P6|NOT COMPLETED|Period 1||0
153295|NCT00420927|374135|P5|NOT COMPLETED|Period 1||0
153296|NCT00420927|374136|P4|NOT COMPLETED|Period 1||0
153297|NCT00420927|374137|P3|NOT COMPLETED|Period 1||0
153298|NCT00420927|374138|P2|NOT COMPLETED|Period 1||57
153299|NCT00420927|374139|P1|NOT COMPLETED|Period 1||49
153300|NCT00420927|374133|P7|COMPLETED|Period 1||0
153301|NCT00420927|374134|P6|COMPLETED|Period 1||0
153302|NCT00420927|374135|P5|COMPLETED|Period 1||0
153303|NCT00420927|374136|P4|COMPLETED|Period 1||0
153304|NCT00420927|374137|P3|COMPLETED|Period 1||0
153305|NCT00420927|374138|P2|COMPLETED|Period 1||460
153306|NCT00420927|374139|P1|COMPLETED|Period 1||466
153307|NCT00420927|374133|P7|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
153308|NCT00420927|374134|P6|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
153309|NCT00420927|374135|P5|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
153310|NCT00420927|374136|P4|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
153311|NCT00420927|374137|P3|STARTED|Period 1|This treatment group is not relevant to Period 1.|0
153312|NCT00420927|374138|P2|STARTED|Period 1||517
153313|NCT00420927|374139|P1|STARTED|Period 1||515
153314|NCT00420992|374245|P2|NOT COMPLETED|Maintenance Phase||75
153315|NCT00420992|374246|P1|NOT COMPLETED|Maintenance Phase||61
153316|NCT00420992|374245|P2|COMPLETED|Maintenance Phase||98
153317|NCT00420992|374246|P1|COMPLETED|Maintenance Phase||110
153318|NCT00420992|374245|P2|STARTED|Maintenance Phase||173
153319|NCT00420992|374246|P1|STARTED|Maintenance Phase||171
153320|NCT00420992|374245|P2|NOT COMPLETED|Titration Phase||0
153321|NCT00420992|374246|P1|NOT COMPLETED|Titration Phase||203
153322|NCT00420992|374245|P2|COMPLETED|Titration Phase||0
153323|NCT00420992|374246|P1|COMPLETED|Titration Phase||344
153324|NCT00420992|374245|P2|STARTED|Titration Phase||0
153325|NCT00420992|374246|P1|STARTED|Titration Phase|All patients received ALO-01 during open-label titration phase|547
153326|NCT00421174|374255|P2|NOT COMPLETED|Overall Study||1
153327|NCT00421174|374256|P1|NOT COMPLETED|Overall Study||2
153328|NCT00421174|374255|P2|COMPLETED|Overall Study||18
153329|NCT00421174|374256|P1|COMPLETED|Overall Study||16
153330|NCT00421174|374255|P2|STARTED|Overall Study||19
153331|NCT00421174|374256|P1|STARTED|Overall Study||18
153332|NCT00421343|374284|P1|NOT COMPLETED|Overall Study||6
153333|NCT00421343|374284|P1|COMPLETED|Overall Study||23
153334|NCT00421343|374284|P1|STARTED|Overall Study||29
153335|NCT00421408|374290|P2|NOT COMPLETED|Overall Study||45
153336|NCT00421408|374291|P1|NOT COMPLETED|Overall Study||42
153337|NCT00421408|374290|P2|COMPLETED|Overall Study||61
153338|NCT00421408|374291|P1|COMPLETED|Overall Study||60
153339|NCT00421408|374290|P2|STARTED|Overall Study||106
153340|NCT00421408|374291|P1|STARTED|Overall Study||102
153341|NCT00411749|374311|P2|NOT COMPLETED|Overall Study||0
153342|NCT00411749|374312|P1|NOT COMPLETED|Overall Study||0
153343|NCT00411749|374311|P2|COMPLETED|Overall Study|Completed at 1 month after vaccination series (Month 7). Subjects were followed until Month 7|25
153344|NCT00411749|374312|P1|COMPLETED|Overall Study|Completed at 24 month after vaccination series (Month 30). Subjects were followed until Month 30|82
153345|NCT00411749|374311|P2|Vaccinated|Overall Study||25
153346|NCT00411749|374312|P1|Vaccinated|Overall Study||82
153347|NCT00411749|374311|P2|STARTED|Overall Study||25
153348|NCT00411749|374312|P1|STARTED|Overall Study||82
153349|NCT00411762|374328|P1|NOT COMPLETED|Overall Study||5
153350|NCT00411762|374328|P1|COMPLETED|Overall Study||20
153351|NCT00411762|374328|P1|STARTED|Overall Study||25
153352|NCT00411788|374333|P1|NOT COMPLETED|Overall Study||2
153353|NCT00411788|374333|P1|COMPLETED|Overall Study||9
153354|NCT00411788|374333|P1|STARTED|Overall Study||11
153355|NCT00412061|374344|P2|NOT COMPLETED|Open Label Phase||170
153356|NCT00412061|374345|P1|NOT COMPLETED|Open Label Phase||0
153357|NCT00412061|374344|P2|COMPLETED|Open Label Phase||0
153358|NCT00412061|374345|P1|COMPLETED|Open Label Phase||0
153359|NCT00412061|374344|P2|STARTED|Open Label Phase||170
153360|NCT00412061|374345|P1|STARTED|Open Label Phase||0
153361|NCT00412061|374344|P2|NOT COMPLETED|Double Blind Phase||213
153362|NCT00412061|374345|P1|NOT COMPLETED|Double Blind Phase||216
153363|NCT00412061|374344|P2|COMPLETED|Double Blind Phase||0
153364|NCT00412061|374345|P1|COMPLETED|Double Blind Phase||0
153365|NCT00412061|374344|P2|Safety Set|Double Blind Phase|1 pt randomized never took drug Another randomized did not have valid post BL safety assessment|211
153366|NCT00412061|374345|P1|Safety Set|Double Blind Phase|1 patient did not provide at laest one valid post baseline safety assessment.|215
153367|NCT00412061|374344|P2|STARTED|Double Blind Phase||213
153368|NCT00412061|374345|P1|STARTED|Double Blind Phase||216
153369|NCT00412074|374366|P3|NOT COMPLETED|Overall Study||67
153370|NCT00412074|374367|P2|NOT COMPLETED|Overall Study||22
153371|NCT00412074|374368|P1|NOT COMPLETED|Overall Study||77
153372|NCT00412074|374366|P3|COMPLETED|Overall Study||128
153373|NCT00412074|374367|P2|COMPLETED|Overall Study||44
153374|NCT00412074|374368|P1|COMPLETED|Overall Study||122
153375|NCT00412074|374366|P3|STARTED|Overall Study||195
153376|NCT00412074|374367|P2|STARTED|Overall Study||66
153377|NCT00412074|374368|P1|STARTED|Overall Study||199
153378|NCT00412087|374384|P2|NOT COMPLETED|Overall Study||65
153379|NCT00412087|374385|P1|NOT COMPLETED|Overall Study||62
153380|NCT00412087|374384|P2|COMPLETED|Overall Study||66
153381|NCT00412087|374385|P1|COMPLETED|Overall Study||72
153382|NCT00412087|374384|P2|STARTED|Overall Study||131
153383|NCT00412087|374385|P1|STARTED|Overall Study||134
153384|NCT00412113|374395|P2|NOT COMPLETED|Overall Study||15
153385|NCT00412113|374396|P1|NOT COMPLETED|Overall Study||12
153386|NCT00412113|374395|P2|COMPLETED|Overall Study|15-April-2008|107
153387|NCT00412113|374396|P1|COMPLETED|Overall Study|15-April-2008|111
153388|NCT00412113|374395|P2|Received Treatment|Overall Study||122
153389|NCT00412113|374396|P1|Received Treatment|Overall Study|One subject assigned to Norvasc and TLC did not receive treatment and was excluded from all analyses|122
153390|NCT00412113|374395|P2|STARTED|Overall Study|15-January-2007|122
153391|NCT00412113|374396|P1|STARTED|Overall Study|15-January-2007|123
153392|NCT00412217|374450|P2|NOT COMPLETED|Overall Study||48
153393|NCT00412217|374451|P1|NOT COMPLETED|Overall Study||46
153394|NCT00412217|374450|P2|COMPLETED|Overall Study||0
153395|NCT00412217|374451|P1|COMPLETED|Overall Study||0
153396|NCT00412217|374450|P2|STARTED|Overall Study||48
153397|NCT00412217|374451|P1|STARTED|Overall Study||46
153398|NCT00412243|374463|P1|NOT COMPLETED|Overall Study||0
153399|NCT00412243|374463|P1|COMPLETED|Overall Study||50
153400|NCT00412243|374463|P1|STARTED|Overall Study||50
153401|NCT00412360|374469|P2|NOT COMPLETED|Overall Study||3
153402|NCT00412360|374470|P1|NOT COMPLETED|Overall Study||1
153403|NCT00412360|374469|P2|COMPLETED|Overall Study||108
153404|NCT00412360|374470|P1|COMPLETED|Overall Study||112
153405|NCT00412360|374469|P2|STARTED|Overall Study||111
153406|NCT00412360|374470|P1|STARTED|Overall Study||113
153407|NCT00412373|374496|P2|NOT COMPLETED|Overall Study||77
153408|NCT00412373|374497|P1|NOT COMPLETED|Overall Study||41
153409|NCT00412373|374496|P2|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment..|134
153410|NCT00412373|374497|P1|COMPLETED|Overall Study|Number of Subjects Who Completed Double-Blind Treatment.|52
153411|NCT00412373|374496|P2|STARTED|Overall Study|Number of Subjects Intent-to-Treat Analysis Set.|211
153412|NCT00412373|374497|P1|STARTED|Overall Study|Number of Subjects in Intent-to-Treat Analysis Set.|93
153413|NCT00412425|374539|P2|NOT COMPLETED|Overall Study||0
153414|NCT00412425|374540|P1|NOT COMPLETED|Overall Study||0
153415|NCT00412425|374539|P2|COMPLETED|Overall Study||15
153416|NCT00412425|374540|P1|COMPLETED|Overall Study||15
153417|NCT00412425|374539|P2|STARTED|Overall Study||15
153418|NCT00412425|374540|P1|STARTED|Overall Study||15
153419|NCT00412451|374550|P4|NOT COMPLETED|Overall Study||2
153420|NCT00412451|374551|P3|NOT COMPLETED|Overall Study||1
153421|NCT00412451|374552|P2|NOT COMPLETED|Overall Study||0
153422|NCT00412451|374553|P1|NOT COMPLETED|Overall Study||0
153423|NCT00412451|374550|P4|COMPLETED|Overall Study||11
153424|NCT00412451|374551|P3|COMPLETED|Overall Study||14
153425|NCT00412451|374552|P2|COMPLETED|Overall Study||15
153426|NCT00412451|374553|P1|COMPLETED|Overall Study||8
153427|NCT00412451|374550|P4|STARTED|Overall Study||13
153428|NCT00412451|374551|P3|STARTED|Overall Study||15
153429|NCT00412451|374552|P2|STARTED|Overall Study||15
153430|NCT00412451|374553|P1|STARTED|Overall Study||8
153431|NCT00412464|374563|P1|NOT COMPLETED|Overall Study||0
153432|NCT00412464|374563|P1|COMPLETED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
153433|NCT00412464|374563|P1|STARTED|Overall Study|Age Groups: 1-5 Years (10); 6-12 Years (7); 13-18 years (7)|24
153434|NCT00412516|374574|P3|NOT COMPLETED|Overall Study||0
153435|NCT00412516|374575|P2|NOT COMPLETED|Overall Study||0
153436|NCT00412516|374576|P1|NOT COMPLETED|Overall Study||0
153437|NCT00412516|374574|P3|COMPLETED|Overall Study||214
153438|NCT00412516|374575|P2|COMPLETED|Overall Study||212
153439|NCT00412516|374576|P1|COMPLETED|Overall Study||93
153440|NCT00412516|374574|P3|STARTED|Overall Study||214
153441|NCT00412516|374575|P2|STARTED|Overall Study||212
153442|NCT00412516|374576|P1|STARTED|Overall Study||93
153443|NCT00412529|374595|P2|NOT COMPLETED|Overall Study||0
153444|NCT00412529|374596|P1|NOT COMPLETED|Overall Study||0
153445|NCT00412529|374595|P2|COMPLETED|Overall Study||21
153446|NCT00412529|374596|P1|COMPLETED|Overall Study||23
153447|NCT00412529|374595|P2|STARTED|Overall Study||21
153448|NCT00412529|374596|P1|STARTED|Overall Study||23
153449|NCT00412542|374618|P2|NOT COMPLETED|Overall Study||3
153450|NCT00412542|374619|P1|NOT COMPLETED|Overall Study||0
153451|NCT00412542|374618|P2|COMPLETED|Overall Study||42
153452|NCT00412542|374619|P1|COMPLETED|Overall Study||33
153453|NCT00412542|374618|P2|STARTED|Overall Study||45
153454|NCT00412542|374619|P1|STARTED|Overall Study||33
153455|NCT00412607|374623|P1|NOT COMPLETED|Overall Study||104
153456|NCT00412607|374623|P1|COMPLETED|Overall Study||145
153457|NCT00412607|374623|P1|Started Study Catheter|Overall Study||233
153458|NCT00412607|374623|P1|STARTED|Overall Study||249
153459|NCT00421603|374636|P2|NOT COMPLETED|Overall Study||12
153460|NCT00421603|374637|P1|NOT COMPLETED|Overall Study||11
153461|NCT00421603|374636|P2|COMPLETED|Overall Study|Completed all 14 week sof trial|30
153462|NCT00421603|374637|P1|COMPLETED|Overall Study|Completed all 14 week sof trial|28
153463|NCT00421603|374636|P2|STARTED|Overall Study||42
153464|NCT00421603|374637|P1|STARTED|Overall Study||39
153465|NCT00421733|374646|P3|NOT COMPLETED|Overall Study||20
153466|NCT00421733|374647|P2|NOT COMPLETED|Overall Study||26
153467|NCT00421733|374648|P1|NOT COMPLETED|Overall Study||15
153468|NCT00421733|374646|P3|COMPLETED|Overall Study||73
153469|NCT00421733|374647|P2|COMPLETED|Overall Study||69
153470|NCT00421733|374648|P1|COMPLETED|Overall Study||78
153471|NCT00421733|374646|P3|STARTED|Overall Study||93
153472|NCT00421733|374647|P2|STARTED|Overall Study||95
153473|NCT00421733|374648|P1|STARTED|Overall Study||93
153474|NCT00424255|374668|P2|NOT COMPLETED|Overall Study||346
153475|NCT00424255|374669|P1|NOT COMPLETED|Overall Study||342
153476|NCT00424255|374668|P2|COMPLETED|Overall Study||0
153477|NCT00424255|374669|P1|COMPLETED|Overall Study||0
153478|NCT00424255|374668|P2|STARTED|Overall Study||346
153479|NCT00424255|374669|P1|STARTED|Overall Study||342
153480|NCT00424268|374717|P2|NOT COMPLETED|Overall Study||39
153481|NCT00424268|374718|P1|NOT COMPLETED|Overall Study||62
153482|NCT00424268|374717|P2|COMPLETED|Overall Study||333
153483|NCT00424268|374718|P1|COMPLETED|Overall Study||309
153484|NCT00424268|374717|P2|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|372
153485|NCT00424268|374718|P1|STARTED|Overall Study|Includes all randomized patients who took at least one dose of the investigational drug.|371
153486|NCT00424294|374734|P2|NOT COMPLETED|Overall Study||15
153487|NCT00424294|374735|P1|NOT COMPLETED|Overall Study||8
153488|NCT00424294|374734|P2|COMPLETED|Overall Study||19
153489|NCT00424294|374735|P1|COMPLETED|Overall Study||28
153490|NCT00424294|374734|P2|Treated|Overall Study||34
153491|NCT00424294|374735|P1|Treated|Overall Study||35
153492|NCT00424294|374734|P2|STARTED|Overall Study||34
153493|NCT00424294|374735|P1|STARTED|Overall Study||36
153494|NCT00424346|374787|P4|NOT COMPLETED|Extension Phase||55
153495|NCT00424346|374788|P3|NOT COMPLETED|Extension Phase||55
153496|NCT00424346|374789|P2|NOT COMPLETED|Extension Phase||102
153497|NCT00424346|374790|P1|NOT COMPLETED|Extension Phase||0
153498|NCT00424346|374787|P4|COMPLETED|Extension Phase||3
153499|NCT00424346|374788|P3|COMPLETED|Extension Phase||4
153500|NCT00424346|374789|P2|COMPLETED|Extension Phase||8
153501|NCT00424346|374790|P1|COMPLETED|Extension Phase||0
153502|NCT00424346|374787|P4|STARTED|Extension Phase||58
153503|NCT00424346|374788|P3|STARTED|Extension Phase||59
153504|NCT00424346|374789|P2|STARTED|Extension Phase|Includes participants who completed the Core phase in the Canakinumab 600 mg IV + 300 mg q2wk group.|110
153505|NCT00424346|374790|P1|STARTED|Extension Phase|Participants are represented in the Canakinumab 300 mg q2wk treatment group.|0
153506|NCT00424346|374787|P4|NOT COMPLETED|Core Study||7
153507|NCT00424346|374788|P3|NOT COMPLETED|Core Study||4
153508|NCT00424346|374789|P2|NOT COMPLETED|Core Study||8
153509|NCT00424346|374790|P1|NOT COMPLETED|Core Study||9
153510|NCT00424346|374787|P4|COMPLETED|Core Study||63
153511|NCT00424346|374788|P3|COMPLETED|Core Study||65
153512|NCT00424346|374789|P2|COMPLETED|Core Study||56
153513|NCT00424346|374790|P1|COMPLETED|Core Study||62
153514|NCT00424346|374787|P4|STARTED|Core Study||70
153515|NCT00424346|374788|P3|STARTED|Core Study||69
153516|NCT00424346|374789|P2|STARTED|Core Study||64
153517|NCT00424346|374790|P1|STARTED|Core Study||71
153518|NCT00424372|374903|P1|NOT COMPLETED|Overall Study||31
153519|NCT00424372|374903|P1|COMPLETED|Overall Study||95
153520|NCT00424372|374903|P1|STARTED|Overall Study||126
153521|NCT00424385|374911|P1|NOT COMPLETED|Cohort 1||1
153522|NCT00424385|374911|P1|COMPLETED|Cohort 1||4
153523|NCT00424385|374911|P1|STARTED|Cohort 1||5
153524|NCT00424385|374911|P1|NOT COMPLETED|Cohort 0||6
153525|NCT00424385|374911|P1|COMPLETED|Cohort 0||6
153526|NCT00424385|374911|P1|STARTED|Cohort 0||12
153527|NCT00424398|374921|P3|NOT COMPLETED|Overall Study||0
153528|NCT00424398|374922|P2|NOT COMPLETED|Overall Study||1
153529|NCT00424398|374923|P1|NOT COMPLETED|Overall Study||3
153530|NCT00424398|374921|P3|COMPLETED|Overall Study||36
153531|NCT00424398|374922|P2|COMPLETED|Overall Study||35
153532|NCT00424398|374923|P1|COMPLETED|Overall Study||32
153533|NCT00424398|374921|P3|STARTED|Overall Study||36
153534|NCT00424398|374922|P2|STARTED|Overall Study||36
153535|NCT00424398|374923|P1|STARTED|Overall Study||35
153536|NCT00424476|374970|P3|NOT COMPLETED|Overall Study||49
153537|NCT00424476|374971|P2|NOT COMPLETED|Overall Study||48
153538|NCT00424476|374972|P1|NOT COMPLETED|Overall Study||61
153539|NCT00424476|374970|P3|COMPLETED|Overall Study||241
153540|NCT00424476|374971|P2|COMPLETED|Overall Study||240
153541|NCT00424476|374972|P1|COMPLETED|Overall Study||226
153542|NCT00424476|374970|P3|STARTED|Overall Study||290
153543|NCT00424476|374971|P2|STARTED|Overall Study||288
153544|NCT00424476|374972|P1|STARTED|Overall Study||287
153545|NCT00424502|374995|P1|NOT COMPLETED|Overall Study||0
153546|NCT00424502|374995|P1|COMPLETED|Overall Study||20
153547|NCT00424502|374995|P1|STARTED|Overall Study||20
153548|NCT00424515|375006|P2|NOT COMPLETED|Overall Study||13
153549|NCT00424515|375007|P1|NOT COMPLETED|Overall Study||11
153550|NCT00424515|375006|P2|COMPLETED|Overall Study||0
153551|NCT00424515|375007|P1|COMPLETED|Overall Study||0
153552|NCT00424515|375006|P2|STARTED|Overall Study||13
153553|NCT00424515|375007|P1|STARTED|Overall Study||11
153554|NCT00424528|375020|P3|NOT COMPLETED|Overall Study||4
153555|NCT00424528|375021|P2|NOT COMPLETED|Overall Study||4
153556|NCT00424528|375022|P1|NOT COMPLETED|Overall Study||5
153557|NCT00424528|375020|P3|COMPLETED|Overall Study||74
153558|NCT00424528|375021|P2|COMPLETED|Overall Study||76
153559|NCT00424528|375022|P1|COMPLETED|Overall Study||71
153560|NCT00424528|375020|P3|STARTED|Overall Study||78
153561|NCT00424528|375021|P2|STARTED|Overall Study||80
153562|NCT00424528|375022|P1|STARTED|Overall Study||76
153563|NCT00424554|375077|P2|NOT COMPLETED|Overall Study||0
153564|NCT00424554|375078|P1|NOT COMPLETED|Overall Study||0
153565|NCT00424554|375077|P2|COMPLETED|Overall Study||6
153566|NCT00424554|375078|P1|COMPLETED|Overall Study||34
153567|NCT00424554|375077|P2|STARTED|Overall Study||6
153568|NCT00424554|375078|P1|STARTED|Overall Study||34
153569|NCT00424593|375094|P2|NOT COMPLETED|Dose-Blind Extension Period||0
153570|NCT00424593|375095|P1|NOT COMPLETED|Dose-Blind Extension Period||64
153571|NCT00424593|375094|P2|COMPLETED|Dose-Blind Extension Period||0
153572|NCT00424593|375095|P1|COMPLETED|Dose-Blind Extension Period||117
153573|NCT00424593|375094|P2|STARTED|Dose-Blind Extension Period|98 placebo patients from acute phase entered dose-blind period and received duloxetine.|0
153574|NCT00424593|375095|P1|STARTED|Dose-Blind Extension Period|83 duloxetine patients from the acute phase entered the dose-blind period.|181
153575|NCT00424593|375094|P2|NOT COMPLETED|Acute Double-Blind Period||23
153576|NCT00424593|375095|P1|NOT COMPLETED|Acute Double-Blind Period||31
153577|NCT00424593|375094|P2|COMPLETED|Acute Double-Blind Period||98
153578|NCT00424593|375095|P1|COMPLETED|Acute Double-Blind Period||84
153579|NCT00424593|375094|P2|STARTED|Acute Double-Blind Period||121
153580|NCT00424593|375095|P1|STARTED|Acute Double-Blind Period||115
153581|NCT00424619|375142|P3|NOT COMPLETED|3 Month||0
153582|NCT00424619|375143|P2|NOT COMPLETED|3 Month||0
153583|NCT00424619|375144|P1|NOT COMPLETED|3 Month||0
153584|NCT00424619|375142|P3|COMPLETED|3 Month||17
153585|NCT00424619|375143|P2|COMPLETED|3 Month||18
153586|NCT00424619|375144|P1|COMPLETED|3 Month||12
153587|NCT00424619|375142|P3|STARTED|3 Month||17
153588|NCT00424619|375143|P2|STARTED|3 Month||18
153589|NCT00424619|375144|P1|STARTED|3 Month||12
153590|NCT00424619|375142|P3|NOT COMPLETED|4 Week||0
153591|NCT00424619|375143|P2|NOT COMPLETED|4 Week||0
153592|NCT00424619|375144|P1|NOT COMPLETED|4 Week||0
153593|NCT00424619|375142|P3|COMPLETED|4 Week||17
153594|NCT00424619|375143|P2|COMPLETED|4 Week||17
153595|NCT00424619|375144|P1|COMPLETED|4 Week||18
153596|NCT00424619|375142|P3|STARTED|4 Week||17
153597|NCT00424619|375143|P2|STARTED|4 Week||17
153598|NCT00424619|375144|P1|STARTED|4 Week||18
153599|NCT00424619|375142|P3|NOT COMPLETED|Baseline||1
153600|NCT00424619|375143|P2|NOT COMPLETED|Baseline||0
153601|NCT00424619|375144|P1|NOT COMPLETED|Baseline||0
153602|NCT00424619|375142|P3|COMPLETED|Baseline||20
153603|NCT00424619|375143|P2|COMPLETED|Baseline||22
153604|NCT00424619|375144|P1|COMPLETED|Baseline||22
153605|NCT00424619|375142|P3|STARTED|Baseline|n=21 but one participant was lost as a screen failure|21
153606|NCT00424619|375143|P2|STARTED|Baseline||22
153607|NCT00424619|375144|P1|STARTED|Baseline||22
153608|NCT00424632|375178|P10|NOT COMPLETED|Overall Study||6
153609|NCT00424632|375179|P9|NOT COMPLETED|Overall Study||16
153610|NCT00424632|375180|P8|NOT COMPLETED|Overall Study||3
153611|NCT00424632|375181|P7|NOT COMPLETED|Overall Study||7
153612|NCT00424632|375182|P6|NOT COMPLETED|Overall Study||15
153613|NCT00424632|375183|P5|NOT COMPLETED|Overall Study||3
153614|NCT00424632|375184|P4|NOT COMPLETED|Overall Study||4
153615|NCT00424632|375185|P3|NOT COMPLETED|Overall Study||1
153616|NCT00424632|375186|P2|NOT COMPLETED|Overall Study||1
153617|NCT00424632|375187|P1|NOT COMPLETED|Overall Study||1
153618|NCT00424632|375178|P10|COMPLETED|Overall Study||0
153619|NCT00424632|375179|P9|COMPLETED|Overall Study||0
153620|NCT00424632|375180|P8|COMPLETED|Overall Study||0
153621|NCT00424632|375181|P7|COMPLETED|Overall Study||0
153622|NCT00424632|375182|P6|COMPLETED|Overall Study||0
153623|NCT00424632|375183|P5|COMPLETED|Overall Study||0
153624|NCT00424632|375184|P4|COMPLETED|Overall Study||0
153625|NCT00424632|375185|P3|COMPLETED|Overall Study||0
153626|NCT00424632|375186|P2|COMPLETED|Overall Study||0
153627|NCT00424632|375187|P1|COMPLETED|Overall Study||0
153628|NCT00424632|375178|P10|STARTED|Overall Study||6
153629|NCT00424632|375179|P9|STARTED|Overall Study||16
153630|NCT00424632|375180|P8|STARTED|Overall Study||3
153631|NCT00424632|375181|P7|STARTED|Overall Study||7
153632|NCT00424632|375182|P6|STARTED|Overall Study||15
153633|NCT00424632|375183|P5|STARTED|Overall Study||3
153634|NCT00424632|375184|P4|STARTED|Overall Study||4
153635|NCT00424632|375185|P3|STARTED|Overall Study||1
153636|NCT00424632|375186|P2|STARTED|Overall Study||1
153637|NCT00424632|375187|P1|STARTED|Overall Study||1
153638|NCT00424645|375320|P2|NOT COMPLETED|Overall Study||0
153639|NCT00424645|375321|P1|NOT COMPLETED|Overall Study||1
153640|NCT00424645|375320|P2|COMPLETED|Overall Study||0
153641|NCT00424645|375321|P1|COMPLETED|Overall Study||2
153642|NCT00424645|375320|P2|STARTED|Overall Study||0
153643|NCT00424645|375321|P1|STARTED|Overall Study||3
153644|NCT00424749|375327|P1|NOT COMPLETED|Overall Study||1
153645|NCT00424749|375327|P1|COMPLETED|Overall Study||3
153646|NCT00424749|375327|P1|STARTED|Overall Study||4
153647|NCT00424762|375334|P2|NOT COMPLETED|Overall Study||22
153648|NCT00424762|375335|P1|NOT COMPLETED|Overall Study||20
153649|NCT00424762|375334|P2|COMPLETED|Overall Study||54
153650|NCT00424762|375335|P1|COMPLETED|Overall Study||54
153651|NCT00424762|375334|P2|STARTED|Overall Study||76
153652|NCT00424762|375335|P1|STARTED|Overall Study||74
153653|NCT00424775|375345|P2|NOT COMPLETED|Overall Study||0
153654|NCT00424775|375346|P1|NOT COMPLETED|Overall Study||3
153655|NCT00424775|375345|P2|COMPLETED|Overall Study||0
153656|NCT00424775|375346|P1|COMPLETED|Overall Study||0
153657|NCT00424775|375345|P2|STARTED|Overall Study||0
153658|NCT00424775|375346|P1|STARTED|Overall Study||3
153659|NCT00424827|375354|P1|NOT COMPLETED|Overall Study||1
153660|NCT00424827|375354|P1|COMPLETED|Overall Study||10
153661|NCT00424827|375354|P1|STARTED|Overall Study||11
153662|NCT00425061|375369|P7|NOT COMPLETED|Overall Study||19
153663|NCT00425061|375370|P6|NOT COMPLETED|Overall Study||4
153664|NCT00425061|375371|P5|NOT COMPLETED|Overall Study||26
153665|NCT00425061|375372|P4|NOT COMPLETED|Overall Study||2
153666|NCT00425061|375373|P3|NOT COMPLETED|Overall Study||0
153667|NCT00425061|375374|P2|NOT COMPLETED|Overall Study||2
153668|NCT00425061|375375|P1|NOT COMPLETED|Overall Study||2
153669|NCT00425061|375369|P7|COMPLETED|Overall Study||26
153670|NCT00425061|375370|P6|COMPLETED|Overall Study||0
153671|NCT00425061|375371|P5|COMPLETED|Overall Study||19
153672|NCT00425061|375372|P4|COMPLETED|Overall Study||14
153673|NCT00425061|375373|P3|COMPLETED|Overall Study||16
153674|NCT00425061|375374|P2|COMPLETED|Overall Study||15
153675|NCT00425061|375375|P1|COMPLETED|Overall Study||14
153676|NCT00425061|375369|P7|STARTED|Overall Study||45
153677|NCT00425061|375370|P6|STARTED|Overall Study||4
153678|NCT00425061|375371|P5|STARTED|Overall Study||45
153679|NCT00425061|375372|P4|STARTED|Overall Study||16
153680|NCT00425061|375373|P3|STARTED|Overall Study||16
153681|NCT00425061|375374|P2|STARTED|Overall Study||17
153682|NCT00425061|375375|P1|STARTED|Overall Study||16
153683|NCT00425100|375491|P1|NOT COMPLETED|Overall Study||53
153684|NCT00425100|375491|P1|COMPLETED|Overall Study||463
153685|NCT00425100|375491|P1|STARTED|Overall Study||516
153686|NCT00425113|375530|P2|NOT COMPLETED|Overall Study||2
153687|NCT00425113|375531|P1|NOT COMPLETED|Overall Study||2
153688|NCT00425113|375530|P2|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|16
153689|NCT00425113|375531|P1|COMPLETED|Overall Study|Included in modified intent-to-treat analysis|15
153690|NCT00425113|375530|P2|Exposed to Study Drug|Overall Study||17
153691|NCT00425113|375531|P1|Exposed to Study Drug|Overall Study||16
153692|NCT00425113|375530|P2|STARTED|Overall Study||18
153693|NCT00425113|375531|P1|STARTED|Overall Study||17
153694|NCT00425269|375541|P2|NOT COMPLETED|Overall Study||20
153695|NCT00425269|375542|P1|NOT COMPLETED|Overall Study||19
153696|NCT00425269|375541|P2|COMPLETED|Overall Study||77
153697|NCT00425269|375542|P1|COMPLETED|Overall Study||82
153698|NCT00425269|375541|P2|STARTED|Overall Study||97
153699|NCT00425269|375542|P1|STARTED|Overall Study||101
153700|NCT00425308|375620|P2|NOT COMPLETED|Overall Study||1
153701|NCT00425308|375621|P1|NOT COMPLETED|Overall Study||4
153702|NCT00425308|375620|P2|COMPLETED|Overall Study||14
153703|NCT00425308|375621|P1|COMPLETED|Overall Study||11
153704|NCT00425308|375620|P2|STARTED|Overall Study||15
153705|NCT00425308|375621|P1|STARTED|Overall Study||15
153706|NCT00425373|375658|P9|NOT COMPLETED|Overall Study||18
153707|NCT00425373|375659|P8|NOT COMPLETED|Overall Study||10
153708|NCT00425373|375660|P7|NOT COMPLETED|Overall Study||7
153709|NCT00425373|375661|P6|NOT COMPLETED|Overall Study||9
153710|NCT00425373|375662|P5|NOT COMPLETED|Overall Study||10
153711|NCT00425373|375663|P4|NOT COMPLETED|Overall Study||2
153712|NCT00425373|375664|P3|NOT COMPLETED|Overall Study||3
153713|NCT00425373|375665|P2|NOT COMPLETED|Overall Study||3
153714|NCT00425373|375666|P1|NOT COMPLETED|Overall Study||5
153715|NCT00425373|375658|P9|COMPLETED|Overall Study||148
153716|NCT00425373|375659|P8|COMPLETED|Overall Study||151
153717|NCT00425373|375660|P7|COMPLETED|Overall Study||154
153718|NCT00425373|375661|P6|COMPLETED|Overall Study||154
153719|NCT00425373|375662|P5|COMPLETED|Overall Study||159
153720|NCT00425373|375663|P4|COMPLETED|Overall Study||160
153721|NCT00425373|375664|P3|COMPLETED|Overall Study||157
153722|NCT00425373|375665|P2|COMPLETED|Overall Study||164
153723|NCT00425373|375666|P1|COMPLETED|Overall Study||154
153724|NCT00425373|375658|P9|STARTED|Overall Study||166
153725|NCT00425373|375659|P8|STARTED|Overall Study||161
153726|NCT00425373|375660|P7|STARTED|Overall Study||161
153727|NCT00425373|375661|P6|STARTED|Overall Study||163
153728|NCT00425373|375662|P5|STARTED|Overall Study||169
153729|NCT00425373|375663|P4|STARTED|Overall Study||162
153730|NCT00425373|375664|P3|STARTED|Overall Study||160
153731|NCT00425373|375665|P2|STARTED|Overall Study||167
153732|NCT00425373|375666|P1|STARTED|Overall Study||159
153733|NCT00425386|375722|P1|NOT COMPLETED|Overall Study||3
153734|NCT00425386|375722|P1|COMPLETED|Overall Study||43
153735|NCT00425386|375722|P1|STARTED|Overall Study||46
153736|NCT00425438|375733|P2|NOT COMPLETED|Overall Study||27
153737|NCT00425438|375734|P1|NOT COMPLETED|Overall Study||25
153738|NCT00425438|375733|P2|COMPLETED|Overall Study||0
153739|NCT00425438|375734|P1|COMPLETED|Overall Study||0
153740|NCT00425438|375733|P2|STARTED|Overall Study||27
153741|NCT00425438|375734|P1|STARTED|Overall Study||25
153742|NCT00425503|375750|P1|NOT COMPLETED|Overall Study||3
153743|NCT00425503|375750|P1|COMPLETED|Overall Study||37
153744|NCT00425503|375750|P1|STARTED|Overall Study||40
153745|NCT00425607|375754|P1|NOT COMPLETED|Overall Study||2
153746|NCT00425607|375754|P1|COMPLETED|Overall Study||27
153747|NCT00425607|375754|P1|Received Treatment|Overall Study||28
153748|NCT00425607|375754|P1|STARTED|Overall Study||29
153749|NCT00425672|375758|P1|NOT COMPLETED|Overall Study||1
153750|NCT00425672|375758|P1|COMPLETED|Overall Study||14
153751|NCT00425672|375758|P1|STARTED|Overall Study||15
153752|NCT00425698|375769|P2|NOT COMPLETED|Overall Study||2
153753|NCT00425698|375770|P1|NOT COMPLETED|Overall Study||3
153754|NCT00425698|375769|P2|COMPLETED|Overall Study||42
153755|NCT00425698|375770|P1|COMPLETED|Overall Study||41
153756|NCT00425698|375769|P2|STARTED|Overall Study||44
153757|NCT00425698|375770|P1|STARTED|Overall Study||44
153758|NCT00425750|375776|P1|NOT COMPLETED|Overall Study||25
153759|NCT00425750|375776|P1|COMPLETED|Overall Study||0
153760|NCT00425750|375776|P1|STARTED|Overall Study||25
153761|NCT00425854|375784|P2|NOT COMPLETED|Overall Study||21
153762|NCT00425854|375785|P1|NOT COMPLETED|Overall Study||29
153763|NCT00425854|375784|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
153764|NCT00425854|375785|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (30 Sep 2009)|0
153765|NCT00425854|375784|P2|STARTED|Overall Study|Treated|21
153766|NCT00425854|375785|P1|STARTED|Overall Study|Treated|29
153767|NCT00425945|375808|P2|NOT COMPLETED|Overall Study||5
153768|NCT00425945|375809|P1|NOT COMPLETED|Overall Study||4
153769|NCT00425945|375808|P2|COMPLETED|Overall Study||61
153770|NCT00425945|375809|P1|COMPLETED|Overall Study||60
153771|NCT00425945|375808|P2|STARTED|Overall Study||66
153772|NCT00425945|375809|P1|STARTED|Overall Study||64
153773|NCT00426127|375845|P1|NOT COMPLETED|Overall Study||2
153774|NCT00426127|375845|P1|COMPLETED|Overall Study||0
153775|NCT00426127|375845|P1|STARTED|Overall Study||2
153776|NCT00426153|375853|P2|NOT COMPLETED|Overall Study||0
153777|NCT00426153|375854|P1|NOT COMPLETED|Overall Study||0
153778|NCT00426153|375853|P2|COMPLETED|Overall Study||14
153779|NCT00426153|375854|P1|COMPLETED|Overall Study||28
153780|NCT00426153|375853|P2|STARTED|Overall Study||14
153781|NCT00426153|375854|P1|STARTED|Overall Study|Participants were randomized in a 2:1 ratio, Octreotide LAR depot: Placebo|28
153782|NCT00426231|375868|P2|NOT COMPLETED|Overall Study||12
153783|NCT00426231|375869|P1|NOT COMPLETED|Overall Study||9
153784|NCT00426231|375868|P2|COMPLETED|Overall Study|For the 6-month endpoint|25
153785|NCT00426231|375869|P1|COMPLETED|Overall Study|For the 6 month endpoint|27
153786|NCT00426231|375868|P2|STARTED|Overall Study||37
153787|NCT00426231|375869|P1|STARTED|Overall Study||36
153788|NCT00426270|375877|P1|NOT COMPLETED|Overall Study||6
153789|NCT00426270|375877|P1|COMPLETED|Overall Study||110
153790|NCT00426270|375877|P1|STARTED|Overall Study||116
153791|NCT00426283|375887|P2|NOT COMPLETED|Overall Study||1
153792|NCT00426283|375888|P1|NOT COMPLETED|Overall Study||5
153793|NCT00426283|375887|P2|COMPLETED|Overall Study||13
153794|NCT00426283|375888|P1|COMPLETED|Overall Study||23
153795|NCT00426283|375887|P2|STARTED|Overall Study||14
153796|NCT00426283|375888|P1|STARTED|Overall Study||28
153797|NCT00426361|375897|P3|NOT COMPLETED|Overall Study||5
153798|NCT00426361|375898|P2|NOT COMPLETED|Overall Study||5
153799|NCT00426361|375899|P1|NOT COMPLETED|Overall Study||4
153800|NCT00426361|375897|P3|COMPLETED|Overall Study||243
153801|NCT00426361|375898|P2|COMPLETED|Overall Study||250
153802|NCT00426361|375899|P1|COMPLETED|Overall Study||244
153803|NCT00426361|375897|P3|STARTED|Overall Study||248
153804|NCT00426361|375898|P2|STARTED|Overall Study||255
153805|NCT00426361|375899|P1|STARTED|Overall Study||248
153806|NCT00426556|375953|P4|NOT COMPLETED|Phase II - Extension Phase||23
153807|NCT00426556|375954|P3|NOT COMPLETED|Phase II - Extension Phase||0
153808|NCT00426556|375955|P2|NOT COMPLETED|Phase II - Extension Phase||0
153809|NCT00426556|375956|P1|NOT COMPLETED|Phase II - Extension Phase||0
153810|NCT00426556|375953|P4|COMPLETED|Phase II - Extension Phase|Completed means 'Ongoing'|1
153811|NCT00426556|375954|P3|COMPLETED|Phase II - Extension Phase||0
153812|NCT00426556|375955|P2|COMPLETED|Phase II - Extension Phase||0
153813|NCT00426556|375956|P1|COMPLETED|Phase II - Extension Phase||0
153814|NCT00426556|375953|P4|STARTED|Phase II - Extension Phase|4 patients did not enter the Extension phase.|24
153815|NCT00426556|375954|P3|STARTED|Phase II - Extension Phase||0
153816|NCT00426556|375955|P2|STARTED|Phase II - Extension Phase||0
153817|NCT00426556|375956|P1|STARTED|Phase II - Extension Phase||0
153818|NCT00426556|375953|P4|NOT COMPLETED|Phase II - Core Phase||27
153819|NCT00426556|375954|P3|NOT COMPLETED|Phase II - Core Phase||0
153820|NCT00426556|375955|P2|NOT COMPLETED|Phase II - Core Phase||0
153821|NCT00426556|375956|P1|NOT COMPLETED|Phase II - Core Phase||0
153822|NCT00426556|375953|P4|COMPLETED|Phase II - Core Phase||28
153823|NCT00426556|375954|P3|COMPLETED|Phase II - Core Phase||0
153824|NCT00426556|375955|P2|COMPLETED|Phase II - Core Phase||0
153825|NCT00426556|375956|P1|COMPLETED|Phase II - Core Phase||0
153826|NCT00426556|375953|P4|STARTED|Phase II - Core Phase||55
153827|NCT00426556|375954|P3|STARTED|Phase II - Core Phase||0
153828|NCT00426556|375955|P2|STARTED|Phase II - Core Phase||0
153829|NCT00426556|375956|P1|STARTED|Phase II - Core Phase||0
153830|NCT00426556|375953|P4|NOT COMPLETED|Phase I - Extension Phase||0
153831|NCT00426556|375954|P3|NOT COMPLETED|Phase I - Extension Phase||7
153832|NCT00426556|375955|P2|NOT COMPLETED|Phase I - Extension Phase||6
153833|NCT00426556|375956|P1|NOT COMPLETED|Phase I - Extension Phase||5
153834|NCT00426556|375953|P4|COMPLETED|Phase I - Extension Phase||0
153835|NCT00426556|375954|P3|COMPLETED|Phase I - Extension Phase||0
153836|NCT00426556|375955|P2|COMPLETED|Phase I - Extension Phase||1
153837|NCT00426556|375956|P1|COMPLETED|Phase I - Extension Phase||0
153838|NCT00426556|375953|P4|STARTED|Phase I - Extension Phase||0
153839|NCT00426556|375954|P3|STARTED|Phase I - Extension Phase||7
153840|NCT00426556|375955|P2|STARTED|Phase I - Extension Phase||7
153841|NCT00426556|375956|P1|STARTED|Phase I - Extension Phase||5
153842|NCT00426556|375953|P4|NOT COMPLETED|Phase I - Core Phase||0
153843|NCT00426556|375954|P3|NOT COMPLETED|Phase I - Core Phase||3
153844|NCT00426556|375955|P2|NOT COMPLETED|Phase I - Core Phase||10
153845|NCT00426556|375956|P1|NOT COMPLETED|Phase I - Core Phase||1
153846|NCT00426556|375953|P4|COMPLETED|Phase I - Core Phase||0
153847|NCT00426556|375954|P3|COMPLETED|Phase I - Core Phase||7
153848|NCT00426556|375955|P2|COMPLETED|Phase I - Core Phase||7
153849|NCT00426556|375956|P1|COMPLETED|Phase I - Core Phase||5
153850|NCT00426556|375953|P4|STARTED|Phase I - Core Phase||0
153851|NCT00426556|375954|P3|STARTED|Phase I - Core Phase||10
153852|NCT00426556|375955|P2|STARTED|Phase I - Core Phase||17
153853|NCT00426556|375956|P1|STARTED|Phase I - Core Phase||6
153854|NCT00426660|375978|P1|NOT COMPLETED|Overall Study||131
153855|NCT00426660|375978|P1|COMPLETED|Overall Study||916
153856|NCT00426660|375978|P1|Safety Analysis Set|Overall Study||1032
153857|NCT00426660|375978|P1|Treated|Overall Study||1032
153858|NCT00426660|375978|P1|STARTED|Overall Study||1047
153859|NCT00426751|376007|P2|NOT COMPLETED|Overall Study||20
153860|NCT00426751|376008|P1|NOT COMPLETED|Overall Study||22
153861|NCT00426751|376007|P2|COMPLETED|Overall Study||183
153862|NCT00426751|376008|P1|COMPLETED|Overall Study||204
153863|NCT00426751|376007|P2|STARTED|Overall Study||203
153864|NCT00426751|376008|P1|STARTED|Overall Study||226
153865|NCT00426764|376052|P1|NOT COMPLETED|Overall Study||98
153866|NCT00426764|376052|P1|COMPLETED|Overall Study|Represents patients who completed the study through Cycle 6 (data cutoff of October 31 2010).|33
153867|NCT00426764|376052|P1|Received 6 or More Treatment Cycles|Overall Study||36
153868|NCT00426764|376052|P1|Received 4 or More Treatment Cycles|Overall Study||50
153869|NCT00426764|376052|P1|Histopathologically-Confirmed Population|Overall Study|Central histologic confirmation of peripheral T-cell lymphoma (PTCL).|130
153870|NCT00426764|376052|P1|STARTED|Overall Study|Represents the number of patients who received any amount of study drug.|131
153871|NCT00416455|376068|P2|NOT COMPLETED|Overall Study||8
153872|NCT00416455|376069|P1|NOT COMPLETED|Overall Study||16
153873|NCT00416455|376068|P2|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|207
153874|NCT00416455|376069|P1|COMPLETED|Overall Study|Number of patients with adequate imaging and pathology|153
153875|NCT00416455|376068|P2|STARTED|Overall Study|This is a diagnostic imaging study.|215
153876|NCT00416455|376069|P1|STARTED|Overall Study|This is a diagnostic imaging study.|169
153877|NCT00416494|376083|P2|NOT COMPLETED|Overall Study||0
153878|NCT00416494|376084|P1|NOT COMPLETED|Overall Study||0
153879|NCT00416494|376083|P2|COMPLETED|Overall Study||31
153880|NCT00416494|376084|P1|COMPLETED|Overall Study||19
153881|NCT00416494|376083|P2|STARTED|Overall Study||31
153882|NCT00416494|376084|P1|STARTED|Overall Study||19
153883|NCT00416520|376100|P4|NOT COMPLETED|Placebo-controlled Withdrawal Period||5
153884|NCT00416520|376101|P3|NOT COMPLETED|Placebo-controlled Withdrawal Period||1
153885|NCT00416520|376102|P2|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
153886|NCT00416520|376103|P1|NOT COMPLETED|Placebo-controlled Withdrawal Period||0
153887|NCT00416520|376100|P4|COMPLETED|Placebo-controlled Withdrawal Period||49
153888|NCT00416520|376101|P3|COMPLETED|Placebo-controlled Withdrawal Period||49
153889|NCT00416520|376102|P2|COMPLETED|Placebo-controlled Withdrawal Period||0
153890|NCT00416520|376103|P1|COMPLETED|Placebo-controlled Withdrawal Period||0
153891|NCT00416520|376100|P4|STARTED|Placebo-controlled Withdrawal Period||54
153892|NCT00416520|376101|P3|STARTED|Placebo-controlled Withdrawal Period||50
153893|NCT00416520|376102|P2|STARTED|Placebo-controlled Withdrawal Period||0
153894|NCT00416520|376103|P1|STARTED|Placebo-controlled Withdrawal Period||0
153895|NCT00416520|376100|P4|NOT COMPLETED|Open-label Period||0
153896|NCT00416520|376101|P3|NOT COMPLETED|Open-label Period||0
153897|NCT00416520|376102|P2|NOT COMPLETED|Open-label Period||32
153898|NCT00416520|376103|P1|NOT COMPLETED|Open-label Period||60
153899|NCT00416520|376100|P4|COMPLETED|Open-label Period||0
153900|NCT00416520|376101|P3|COMPLETED|Open-label Period||0
153901|NCT00416520|376102|P2|COMPLETED|Open-label Period||139
153902|NCT00416520|376103|P1|COMPLETED|Open-label Period||105
153903|NCT00416520|376100|P4|STARTED|Open-label Period||0
153904|NCT00416520|376101|P3|STARTED|Open-label Period||0
153905|NCT00416520|376102|P2|STARTED|Open-label Period||171
153906|NCT00416520|376103|P1|STARTED|Open-label Period||165
153907|NCT00416572|376116|P3|NOT COMPLETED|Overall Study||8
153908|NCT00416572|376117|P2|NOT COMPLETED|Overall Study||7
153909|NCT00416572|376118|P1|NOT COMPLETED|Overall Study||13
153910|NCT00416572|376116|P3|COMPLETED|Overall Study||76
153911|NCT00416572|376117|P2|COMPLETED|Overall Study||78
153912|NCT00416572|376118|P1|COMPLETED|Overall Study||70
153913|NCT00416572|376116|P3|STARTED|Overall Study||84
153914|NCT00416572|376117|P2|STARTED|Overall Study||85
153915|NCT00416572|376118|P1|STARTED|Overall Study||83
153916|NCT00416598|376132|P1|NOT COMPLETED|Decitabine Maintenance||72
153917|NCT00416598|376132|P1|COMPLETED|Decitabine Maintenance||62
153918|NCT00416598|376132|P1|STARTED|Decitabine Maintenance||134
153919|NCT00416598|376132|P1|NOT COMPLETED|Induction & Intensification||412
153920|NCT00416598|376132|P1|COMPLETED|Induction & Intensification||134
153921|NCT00416598|376132|P1|STARTED|Induction & Intensification||546
153922|NCT00416624|376141|P4|NOT COMPLETED|Overall Study||17
153923|NCT00416624|376142|P3|NOT COMPLETED|Overall Study||18
153924|NCT00416624|376143|P2|NOT COMPLETED|Overall Study||27
153925|NCT00416624|376144|P1|NOT COMPLETED|Overall Study||22
153926|NCT00416624|376141|P4|COMPLETED|Overall Study||40
153927|NCT00416624|376142|P3|COMPLETED|Overall Study||40
153928|NCT00416624|376143|P2|COMPLETED|Overall Study||33
153929|NCT00416624|376144|P1|COMPLETED|Overall Study||39
153930|NCT00416624|376141|P4|STARTED|Overall Study||57
153931|NCT00416624|376142|P3|STARTED|Overall Study||58
153932|NCT00416624|376143|P2|STARTED|Overall Study||60
153933|NCT00416624|376144|P1|STARTED|Overall Study||61
153934|NCT00416715|376198|P1|NOT COMPLETED|Overall Study||15
153935|NCT00416715|376198|P1|COMPLETED|Overall Study||85
153936|NCT00416715|376198|P1|STARTED|Overall Study||100
153937|NCT00416793|376205|P1|NOT COMPLETED|Overall Study||0
153938|NCT00416793|376205|P1|COMPLETED|Overall Study||9
153939|NCT00416793|376205|P1|STARTED|Overall Study||9
153940|NCT00416884|376209|P1|NOT COMPLETED|Overall Study||1
153941|NCT00416884|376209|P1|COMPLETED|Overall Study||0
153942|NCT00416884|376209|P1|STARTED|Overall Study||1
153943|NCT00417027|376216|P3|NOT COMPLETED|Overall Study||5
153944|NCT00417027|376217|P2|NOT COMPLETED|Overall Study||5
153945|NCT00417027|376218|P1|NOT COMPLETED|Overall Study||0
153946|NCT00417027|376216|P3|COMPLETED|Overall Study||54
153947|NCT00417027|376217|P2|COMPLETED|Overall Study||60
153948|NCT00417027|376218|P1|COMPLETED|Overall Study||66
153949|NCT00417027|376216|P3|STARTED|Overall Study||59
153950|NCT00417027|376217|P2|STARTED|Overall Study||65
153951|NCT00417027|376218|P1|STARTED|Overall Study||66
153952|NCT00417079|376246|P2|NOT COMPLETED|Overall Study||273
153953|NCT00417079|376247|P1|NOT COMPLETED|Overall Study||331
153954|NCT00417079|376246|P2|COMPLETED|Overall Study|Randomized patients|105
153955|NCT00417079|376247|P1|COMPLETED|Overall Study|Randomized patients|46
153956|NCT00417079|376246|P2|STARTED|Overall Study|Randomized patients|378
153957|NCT00417079|376247|P1|STARTED|Overall Study|Randomized patients|377
153958|NCT00417170|376269|P2|NOT COMPLETED|Overall Study||3
153959|NCT00417170|376270|P1|NOT COMPLETED|Overall Study||2
153960|NCT00417170|376269|P2|COMPLETED|Overall Study||22
153961|NCT00417170|376270|P1|COMPLETED|Overall Study||21
153962|NCT00417170|376269|P2|Pharmacodynamics Population|Overall Study||23
153963|NCT00417170|376270|P1|Pharmacodynamics Population|Overall Study||21
153964|NCT00417170|376269|P2|STARTED|Overall Study||25
153965|NCT00417170|376270|P1|STARTED|Overall Study|"Started indicates Safety population."|23
153966|NCT00417248|376284|P1|NOT COMPLETED|Overall Study||8
153967|NCT00417248|376284|P1|COMPLETED|Overall Study||0
153968|NCT00417248|376284|P1|STARTED|Overall Study||8
153969|NCT00417274|376289|P1|NOT COMPLETED|Overall Study||0
153970|NCT00417274|376289|P1|COMPLETED|Overall Study||31
153971|NCT00417274|376289|P1|STARTED|Overall Study||31
153972|NCT00417417|376295|P2|NOT COMPLETED|Overall Study||0
153973|NCT00417417|376296|P1|NOT COMPLETED|Overall Study||0
153974|NCT00417417|376295|P2|COMPLETED|Overall Study||6
153975|NCT00417417|376296|P1|COMPLETED|Overall Study||4
153976|NCT00417417|376295|P2|STARTED|Overall Study||6
153977|NCT00417417|376296|P1|STARTED|Overall Study||4
153978|NCT00417482|376307|P3|NOT COMPLETED|Phase B 2nd 16 Weeks||3
153979|NCT00417482|376308|P2|NOT COMPLETED|Phase B 2nd 16 Weeks||13
153980|NCT00417482|376309|P1|NOT COMPLETED|Phase B 2nd 16 Weeks||3
153981|NCT00417482|376307|P3|COMPLETED|Phase B 2nd 16 Weeks||10
153982|NCT00417482|376308|P2|COMPLETED|Phase B 2nd 16 Weeks||14
153983|NCT00417482|376309|P1|COMPLETED|Phase B 2nd 16 Weeks||10
153984|NCT00417482|376307|P3|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|13
153985|NCT00417482|376308|P2|STARTED|Phase B 2nd 16 Weeks|Placebo for 16 weeks.|27
153986|NCT00417482|376309|P1|STARTED|Phase B 2nd 16 Weeks|Risperidone for 16 weeks.|13
153987|NCT00417482|376307|P3|NOT COMPLETED|Phase B 1st 16 Weeks||27
153988|NCT00417482|376308|P2|NOT COMPLETED|Phase B 1st 16 Weeks||11
153989|NCT00417482|376309|P1|NOT COMPLETED|Phase B 1st 16 Weeks||19
153990|NCT00417482|376307|P3|COMPLETED|Phase B 1st 16 Weeks||13
153991|NCT00417482|376308|P2|COMPLETED|Phase B 1st 16 Weeks||27
153992|NCT00417482|376309|P1|COMPLETED|Phase B 1st 16 Weeks||13
153993|NCT00417482|376307|P3|STARTED|Phase B 1st 16 Weeks|Placebo 16 weeks.|40
153994|NCT00417482|376308|P2|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|38
153995|NCT00417482|376309|P1|STARTED|Phase B 1st 16 Weeks|Risperidone 16 weeks.|32
153996|NCT00417612|376335|P2|NOT COMPLETED|Overall Study||3
153997|NCT00417612|376336|P1|NOT COMPLETED|Overall Study||3
153998|NCT00417612|376335|P2|COMPLETED|Overall Study||8
153999|NCT00417612|376336|P1|COMPLETED|Overall Study||19
154000|NCT00417612|376335|P2|STARTED|Overall Study||11
154001|NCT00417612|376336|P1|STARTED|Overall Study||22
154002|NCT00417885|376359|P1|NOT COMPLETED|Overall Study||6
154003|NCT00417885|376359|P1|COMPLETED|Overall Study||0
154004|NCT00417885|376359|P1|STARTED|Overall Study||6
154005|NCT00417963|376368|P1|NOT COMPLETED|Overall Study||41
154006|NCT00417963|376368|P1|COMPLETED|Overall Study|79 subjects completed in the roll-in cohort and 371 in the pivotal cohort.|445
154007|NCT00417963|376368|P1|STARTED|Overall Study|79 participants were enrolled in the roll-in cohort and 407 in the pivotal cohort.|486
154008|NCT00417976|376385|P1|NOT COMPLETED|Overall Study||3
154009|NCT00417976|376385|P1|COMPLETED|Overall Study||39
154010|NCT00417976|376385|P1|STARTED|Overall Study||42
154011|NCT00417989|376392|P2|NOT COMPLETED|Overall Study||22
154012|NCT00417989|376393|P1|NOT COMPLETED|Overall Study||20
154013|NCT00417989|376392|P2|COMPLETED|Overall Study||219
154014|NCT00417989|376393|P1|COMPLETED|Overall Study||224
154015|NCT00417989|376392|P2|STARTED|Overall Study||241
154016|NCT00417989|376393|P1|STARTED|Overall Study|Intent to Treat include safety population & subjects with baseline & 1 post baseline A1C measurement|244
154017|NCT00418015|376417|P4|NOT COMPLETED|Overall Study||0
154018|NCT00418015|376418|P3|NOT COMPLETED|Overall Study||0
154019|NCT00418015|376419|P2|NOT COMPLETED|Overall Study||0
154020|NCT00418015|376420|P1|NOT COMPLETED|Overall Study||0
154021|NCT00418015|376417|P4|COMPLETED|Overall Study||25
154022|NCT00418015|376418|P3|COMPLETED|Overall Study||78
154023|NCT00418015|376419|P2|COMPLETED|Overall Study||46
154024|NCT00418015|376420|P1|COMPLETED|Overall Study||144
154025|NCT00418015|376417|P4|STARTED|Overall Study||25
154026|NCT00418015|376418|P3|STARTED|Overall Study||78
154027|NCT00418015|376419|P2|STARTED|Overall Study||46
154028|NCT00418015|376420|P1|STARTED|Overall Study||144
154029|NCT00418093|376446|P1|NOT COMPLETED|Overall Study||0
154030|NCT00418093|376446|P1|COMPLETED|Overall Study||19
154031|NCT00418093|376446|P1|Completed Study|Overall Study||19
154032|NCT00418093|376446|P1|STARTED|Overall Study||19
154033|NCT00418145|376453|P1|NOT COMPLETED|Overall Study||6
154034|NCT00418145|376453|P1|COMPLETED|Overall Study||10
154035|NCT00418145|376453|P1|STARTED|Overall Study||16
154036|NCT00418184|376467|P2|NOT COMPLETED|Open-label Phase||5
154037|NCT00418184|376468|P1|NOT COMPLETED|Open-label Phase||5
154038|NCT00418184|376467|P2|COMPLETED|Open-label Phase|5 dropped out|43
154039|NCT00418184|376468|P1|COMPLETED|Open-label Phase|5 dropped out|97
154040|NCT00418184|376467|P2|STARTED|Open-label Phase|1 was not included due to low compliance in the double blind phase, 3 didn't want to participate.|48
154041|NCT00418184|376468|P1|STARTED|Open-label Phase|3 were not included due to low compliance in the double blind phase, 5 didn't want to participate.|102
154042|NCT00418184|376467|P2|NOT COMPLETED|Double-blind Phase||11
154043|NCT00418184|376468|P1|NOT COMPLETED|Double-blind Phase||27
154044|NCT00418184|376467|P2|COMPLETED|Double-blind Phase||52
154045|NCT00418184|376468|P1|COMPLETED|Double-blind Phase||110
154046|NCT00418184|376467|P2|STARTED|Double-blind Phase||63
154047|NCT00418184|376468|P1|STARTED|Double-blind Phase||137
154048|NCT00418262|376476|P1|NOT COMPLETED|Visits 8 Thru 10||5
154049|NCT00418262|376476|P1|COMPLETED|Visits 8 Thru 10||11
154050|NCT00418262|376476|P1|STARTED|Visits 8 Thru 10||16
154051|NCT00418262|376476|P1|NOT COMPLETED|Visits 5 Thru 8||9
154052|NCT00418262|376476|P1|COMPLETED|Visits 5 Thru 8||16
154053|NCT00418262|376476|P1|STARTED|Visits 5 Thru 8||25
154054|NCT00418262|376476|P1|NOT COMPLETED|Visits 1 (Baseline) Thru 5||2
154055|NCT00418262|376476|P1|COMPLETED|Visits 1 (Baseline) Thru 5||25
154056|NCT00418262|376476|P1|STARTED|Visits 1 (Baseline) Thru 5||27
154057|NCT00418314|376496|P2|NOT COMPLETED|Overall Study||2
154058|NCT00418314|376497|P1|NOT COMPLETED|Overall Study||1
154059|NCT00418314|376496|P2|COMPLETED|Overall Study||828
154060|NCT00418314|376497|P1|COMPLETED|Overall Study||816
154061|NCT00418314|376496|P2|STARTED|Overall Study||830
154062|NCT00418314|376497|P1|STARTED|Overall Study||817
154063|NCT00418379|376510|P3|NOT COMPLETED|Year 5||3
154064|NCT00418379|376511|P2|NOT COMPLETED|Year 5||5
154065|NCT00418379|376512|P1|NOT COMPLETED|Year 5||2
154066|NCT00418379|376510|P3|COMPLETED|Year 5||131
154067|NCT00418379|376511|P2|COMPLETED|Year 5||115
154068|NCT00418379|376512|P1|COMPLETED|Year 5||126
154069|NCT00418379|376510|P3|STARTED|Year 5|20 patients withdrew between Year 4 and Year 5 study periods.|134
154070|NCT00418379|376511|P2|STARTED|Year 5|16 patients withdrew between Year 4 and Year 5 study periods.|120
154071|NCT00418379|376512|P1|STARTED|Year 5|14 patients withdrew between Year 4 and Year 5 study periods.|128
154072|NCT00418379|376510|P3|NOT COMPLETED|Year 4||2
154073|NCT00418379|376511|P2|NOT COMPLETED|Year 4||5
154074|NCT00418379|376512|P1|NOT COMPLETED|Year 4||3
154075|NCT00418379|376510|P3|COMPLETED|Year 4||154
154076|NCT00418379|376511|P2|COMPLETED|Year 4||136
154077|NCT00418379|376512|P1|COMPLETED|Year 4||142
154078|NCT00418379|376510|P3|STARTED|Year 4|7 patients withdrew between Year 3 and Year 4 study periods.|156
154079|NCT00418379|376511|P2|STARTED|Year 4|5 patients withdrew between Year 3 and Year 4 study periods.|141
154080|NCT00418379|376512|P1|STARTED|Year 4|3 patients withdrew between Year 3 and Year 4 study periods.|145
154081|NCT00418379|376510|P3|NOT COMPLETED|Year 3||3
154082|NCT00418379|376511|P2|NOT COMPLETED|Year 3||2
154083|NCT00418379|376512|P1|NOT COMPLETED|Year 3||3
154084|NCT00418379|376510|P3|COMPLETED|Year 3||163
154085|NCT00418379|376511|P2|COMPLETED|Year 3||146
154086|NCT00418379|376512|P1|COMPLETED|Year 3||148
154087|NCT00418379|376510|P3|STARTED|Year 3|6 patients withdrew between Year 2 and Year 3 treatment periods.|166
154088|NCT00418379|376511|P2|STARTED|Year 3|7 patients withdrew between Year 2 and Year 3 treatment periods.|148
154089|NCT00418379|376512|P1|STARTED|Year 3|8 patients withdrew between Year 2 and Year 3 treatment periods.|151
154090|NCT00418379|376510|P3|NOT COMPLETED|Year 2||10
154091|NCT00418379|376511|P2|NOT COMPLETED|Year 2||4
154092|NCT00418379|376512|P1|NOT COMPLETED|Year 2||8
154093|NCT00418379|376510|P3|COMPLETED|Year 2||172
154094|NCT00418379|376511|P2|COMPLETED|Year 2||155
154095|NCT00418379|376512|P1|COMPLETED|Year 2||159
154096|NCT00418379|376510|P3|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|182
154097|NCT00418379|376511|P2|STARTED|Year 2|20 patients withdrew between Year 1 and Year 2 treatment periods.|159
154098|NCT00418379|376512|P1|STARTED|Year 2|22 patients withdrew between Year 1 and Year 2 treatment periods.|167
154099|NCT00418379|376510|P3|NOT COMPLETED|Year 1||15
154100|NCT00418379|376511|P2|NOT COMPLETED|Year 1||28
154101|NCT00418379|376512|P1|NOT COMPLETED|Year 1||18
154102|NCT00418379|376510|P3|COMPLETED|Year 1||204
154103|NCT00418379|376511|P2|COMPLETED|Year 1||179
154104|NCT00418379|376512|P1|COMPLETED|Year 1||189
154105|NCT00418379|376510|P3|STARTED|Year 1||219
154106|NCT00418379|376511|P2|STARTED|Year 1||207
154107|NCT00418379|376512|P1|STARTED|Year 1||207
154108|NCT00418522|376522|P2|NOT COMPLETED|Overall Study||42
154109|NCT00418522|376523|P1|NOT COMPLETED|Overall Study||83
154110|NCT00418522|376522|P2|COMPLETED|Overall Study||152
154111|NCT00418522|376523|P1|COMPLETED|Overall Study||136
154112|NCT00418522|376522|P2|Received Treatment|Overall Study||190
154113|NCT00418522|376523|P1|Received Treatment|Overall Study||212
154114|NCT00418522|376522|P2|STARTED|Overall Study||194
154115|NCT00418522|376523|P1|STARTED|Overall Study||219
154116|NCT00418561|376570|P3|NOT COMPLETED|Overall Study||0
154117|NCT00418561|376571|P2|NOT COMPLETED|Overall Study||1
154118|NCT00418561|376572|P1|NOT COMPLETED|Overall Study||0
154119|NCT00418561|376570|P3|COMPLETED|Overall Study||4
154120|NCT00418561|376571|P2|COMPLETED|Overall Study||4
154121|NCT00418561|376572|P1|COMPLETED|Overall Study||4
154122|NCT00418561|376570|P3|STARTED|Overall Study||4
154123|NCT00418561|376571|P2|STARTED|Overall Study||5
154124|NCT00418561|376572|P1|STARTED|Overall Study||4
154125|NCT00418574|376642|P2|NOT COMPLETED|Overall Study||23
154126|NCT00418574|376643|P1|NOT COMPLETED|Overall Study||48
154127|NCT00418574|376642|P2|COMPLETED|Overall Study||272
154128|NCT00418574|376643|P1|COMPLETED|Overall Study||545
154129|NCT00418574|376642|P2|TREATED|Overall Study||294
154130|NCT00418574|376643|P1|TREATED|Overall Study||592
154131|NCT00418574|376642|P2|STARTED|Overall Study||295
154132|NCT00418574|376643|P1|STARTED|Overall Study||593
154133|NCT00418665|376657|P3|NOT COMPLETED|Treatment Extension||2
154134|NCT00418665|376658|P2|NOT COMPLETED|Treatment Extension||4
154135|NCT00418665|376659|P1|NOT COMPLETED|Treatment Extension||6
154136|NCT00418665|376657|P3|COMPLETED|Treatment Extension||7
154137|NCT00418665|376658|P2|COMPLETED|Treatment Extension||4
154138|NCT00418665|376659|P1|COMPLETED|Treatment Extension||1
154139|NCT00418665|376657|P3|STARTED|Treatment Extension||9
154140|NCT00418665|376658|P2|STARTED|Treatment Extension||8
154141|NCT00418665|376659|P1|STARTED|Treatment Extension||7
154142|NCT00418665|376657|P3|NOT COMPLETED|Treatment Period||4
154143|NCT00418665|376658|P2|NOT COMPLETED|Treatment Period||6
154144|NCT00418665|376659|P1|NOT COMPLETED|Treatment Period||5
154145|NCT00418665|376657|P3|COMPLETED|Treatment Period||9
154146|NCT00418665|376658|P2|COMPLETED|Treatment Period||8
154147|NCT00418665|376659|P1|COMPLETED|Treatment Period||7
154148|NCT00418665|376657|P3|Received Study Medication|Treatment Period||13
154149|NCT00418665|376658|P2|Received Study Medication|Treatment Period||13
154150|NCT00418665|376659|P1|Received Study Medication|Treatment Period||11
154151|NCT00418665|376657|P3|STARTED|Treatment Period||13
154152|NCT00418665|376658|P2|STARTED|Treatment Period||14
154153|NCT00418665|376659|P1|STARTED|Treatment Period||12
154154|NCT00418691|376679|P3|NOT COMPLETED|Overall Study||5
154155|NCT00418691|376680|P2|NOT COMPLETED|Overall Study||2
154156|NCT00418691|376681|P1|NOT COMPLETED|Overall Study||2
154157|NCT00418691|376679|P3|COMPLETED|Overall Study||5
154158|NCT00418691|376680|P2|COMPLETED|Overall Study||10
154159|NCT00418691|376681|P1|COMPLETED|Overall Study||9
154160|NCT00418691|376679|P3|STARTED|Overall Study||10
154161|NCT00418691|376680|P2|STARTED|Overall Study||12
154162|NCT00418691|376681|P1|STARTED|Overall Study||11
154163|NCT00418717|376689|P1|NOT COMPLETED|Treatment Period B - Weeks 5-12||2
154164|NCT00418717|376689|P1|COMPLETED|Treatment Period B - Weeks 5-12||39
154165|NCT00418717|376689|P1|STARTED|Treatment Period B - Weeks 5-12||41
154166|NCT00418717|376689|P1|NOT COMPLETED|Treatment Period A - Weeks 1-4||1
154167|NCT00418717|376689|P1|COMPLETED|Treatment Period A - Weeks 1-4||41
154168|NCT00418717|376689|P1|STARTED|Treatment Period A - Weeks 1-4||42
154169|NCT00418834|376696|P2|NOT COMPLETED|Overall Study||20
154170|NCT00418834|376697|P1|NOT COMPLETED|Overall Study||23
154171|NCT00418834|376696|P2|COMPLETED|Overall Study||507
154172|NCT00418834|376697|P1|COMPLETED|Overall Study||503
154173|NCT00418834|376696|P2|STARTED|Overall Study||527
154174|NCT00418834|376697|P1|STARTED|Overall Study||526
154175|NCT00418886|376759|P2|NOT COMPLETED|Overall Study||255
154176|NCT00418886|376760|P1|NOT COMPLETED|Overall Study||226
154177|NCT00418886|376759|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|23
154178|NCT00418886|376760|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|30
154179|NCT00418886|376759|P2|STARTED|Overall Study|randomised patients|278
154180|NCT00418886|376760|P1|STARTED|Overall Study|randomised patients|256
154181|NCT00426842|376784|P1|NOT COMPLETED|Overall Study||1
154182|NCT00426842|376784|P1|COMPLETED|Overall Study||10
154183|NCT00426842|376784|P1|STARTED|Overall Study||11
154184|NCT00426855|376790|P1|NOT COMPLETED|Overall Study||0
154185|NCT00426855|376790|P1|COMPLETED|Overall Study||12
154186|NCT00426855|376790|P1|STARTED|Overall Study||12
154187|NCT00427011|376794|P1|NOT COMPLETED|Overall Study||25
154188|NCT00427011|376794|P1|COMPLETED|Overall Study||0
154189|NCT00427011|376794|P1|STARTED|Overall Study||25
154190|NCT00427037|376807|P2|NOT COMPLETED|Overall Study||7
154191|NCT00427037|376808|P1|NOT COMPLETED|Overall Study||7
154192|NCT00427037|376807|P2|COMPLETED|Overall Study||10
154193|NCT00427037|376808|P1|COMPLETED|Overall Study||10
154194|NCT00427037|376807|P2|STARTED|Overall Study||17
154195|NCT00427037|376808|P1|STARTED|Overall Study||17
154196|NCT00427336|376816|P1|NOT COMPLETED|Overall Study||0
154197|NCT00427336|376816|P1|COMPLETED|Overall Study||9
154198|NCT00427336|376816|P1|STARTED|Overall Study||9
154199|NCT00427349|376820|P1|NOT COMPLETED|Overall Study||46
154200|NCT00427349|376820|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity|0
154201|NCT00427349|376820|P1|Eligible and Treated|Overall Study||44
154202|NCT00427349|376820|P1|Treated|Overall Study||45
154203|NCT00427349|376820|P1|Eligible|Overall Study||45
154204|NCT00427349|376820|P1|STARTED|Overall Study||46
154205|NCT00427557|376826|P1|NOT COMPLETED|Overall Study||0
154206|NCT00427557|376826|P1|COMPLETED|Overall Study||30
154207|NCT00427557|376826|P1|STARTED|Overall Study||30
154208|NCT00427635|376832|P2|NOT COMPLETED|Study Completion to Safety Follow-up||1
154209|NCT00427635|376833|P1|NOT COMPLETED|Study Completion to Safety Follow-up||0
154210|NCT00427635|376832|P2|COMPLETED|Study Completion to Safety Follow-up|One participant lost to follow-up|25
154211|NCT00427635|376833|P1|COMPLETED|Study Completion to Safety Follow-up||25
154212|NCT00427635|376832|P2|STARTED|Study Completion to Safety Follow-up||26
154213|NCT00427635|376833|P1|STARTED|Study Completion to Safety Follow-up||25
154214|NCT00427635|376832|P2|NOT COMPLETED|Treatment Phase||0
154215|NCT00427635|376833|P1|NOT COMPLETED|Treatment Phase||1
154216|NCT00427635|376832|P2|COMPLETED|Treatment Phase|ITT population|26
154217|NCT00427635|376833|P1|COMPLETED|Treatment Phase|ITT population. One voluntary discontinuation by parent/guardian|25
154218|NCT00427635|376832|P2|STARTED|Treatment Phase|Randomised|26
154219|NCT00427635|376833|P1|STARTED|Treatment Phase|Randomised|26
154220|NCT00427661|376861|P1|NOT COMPLETED|Overall Study||0
154221|NCT00427661|376861|P1|COMPLETED|Overall Study||8
154222|NCT00427661|376861|P1|STARTED|Overall Study||8
154223|NCT00427700|376869|P2|NOT COMPLETED|Overall Study||11
154224|NCT00427700|376870|P1|NOT COMPLETED|Overall Study||3
154225|NCT00427700|376869|P2|COMPLETED|Overall Study||31
154226|NCT00427700|376870|P1|COMPLETED|Overall Study||37
154227|NCT00427700|376869|P2|STARTED|Overall Study||42
154228|NCT00427700|376870|P1|STARTED|Overall Study||40
154229|NCT00427765|376878|P1|NOT COMPLETED|Overall Study||0
154230|NCT00427765|376878|P1|COMPLETED|Overall Study||164
154231|NCT00427765|376878|P1|STARTED|Overall Study||164
154232|NCT00427791|376884|P2|NOT COMPLETED|Overall Study||0
154233|NCT00427791|376885|P1|NOT COMPLETED|Overall Study||0
154234|NCT00427791|376884|P2|COMPLETED|Overall Study||13
154235|NCT00427791|376885|P1|COMPLETED|Overall Study||10
154236|NCT00427791|376884|P2|STARTED|Overall Study||13
154237|NCT00427791|376885|P1|STARTED|Overall Study||10
154238|NCT00427804|376895|P2|NOT COMPLETED|Overall Study||0
154239|NCT00427804|376896|P1|NOT COMPLETED|Overall Study||0
154240|NCT00427804|376895|P2|COMPLETED|Overall Study||5
154241|NCT00427804|376896|P1|COMPLETED|Overall Study||4
154242|NCT00427804|376895|P2|STARTED|Overall Study||5
154243|NCT00427804|376896|P1|STARTED|Overall Study||4
154244|NCT00427895|376906|P8|NOT COMPLETED|Vax 2/Year 3 to 4||2
154245|NCT00427895|376907|P7|NOT COMPLETED|Vax 2/Year 3 to 4||0
154246|NCT00427895|376908|P6|NOT COMPLETED|Vax 2/Year 3 to 4||0
154247|NCT00427895|376909|P5|NOT COMPLETED|Vax 2/Year 3 to 4||1
154248|NCT00427895|376910|P4|NOT COMPLETED|Vax 2/Year 3 to 4||0
154249|NCT00427895|376911|P3|NOT COMPLETED|Vax 2/Year 3 to 4||0
154250|NCT00427895|376912|P2|NOT COMPLETED|Vax 2/Year 3 to 4||0
154251|NCT00427895|376913|P1|NOT COMPLETED|Vax 2/Year 3 to 4||0
154252|NCT00427895|376906|P8|COMPLETED|Vax 2/Year 3 to 4||212
154253|NCT00427895|376907|P7|COMPLETED|Vax 2/Year 3 to 4||189
154254|NCT00427895|376908|P6|COMPLETED|Vax 2/Year 3 to 4||108
154255|NCT00427895|376909|P5|COMPLETED|Vax 2/Year 3 to 4||107
154256|NCT00427895|376910|P4|COMPLETED|Vax 2/Year 3 to 4||0
154257|NCT00427895|376911|P3|COMPLETED|Vax 2/Year 3 to 4||0
154258|NCT00427895|376912|P2|COMPLETED|Vax 2/Year 3 to 4||0
154259|NCT00427895|376913|P1|COMPLETED|Vax 2/Year 3 to 4||0
154260|NCT00427895|376906|P8|STARTED|Vax 2/Year 3 to 4||214
154261|NCT00427895|376907|P7|STARTED|Vax 2/Year 3 to 4||189
154262|NCT00427895|376908|P6|STARTED|Vax 2/Year 3 to 4||108
154263|NCT00427895|376909|P5|STARTED|Vax 2/Year 3 to 4||108
154264|NCT00427895|376910|P4|STARTED|Vax 2/Year 3 to 4||0
154265|NCT00427895|376911|P3|STARTED|Vax 2/Year 3 to 4||0
154266|NCT00427895|376912|P2|STARTED|Vax 2/Year 3 to 4||0
154267|NCT00427895|376913|P1|STARTED|Vax 2/Year 3 to 4||0
154268|NCT00427895|376906|P8|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154269|NCT00427895|376907|P7|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154270|NCT00427895|376908|P6|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154271|NCT00427895|376909|P5|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154272|NCT00427895|376910|P4|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||469
154273|NCT00427895|376911|P3|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||159
154274|NCT00427895|376912|P2|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||207
154275|NCT00427895|376913|P1|NOT COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||188
154276|NCT00427895|376906|P8|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154277|NCT00427895|376907|P7|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154278|NCT00427895|376908|P6|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154279|NCT00427895|376909|P5|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154280|NCT00427895|376910|P4|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||0
154281|NCT00427895|376911|P3|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||214
154282|NCT00427895|376912|P2|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||189
154283|NCT00427895|376913|P1|COMPLETED|Between Year 1 - Vax 2/Year 3 to 4||216
154284|NCT00427895|376906|P8|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
154285|NCT00427895|376907|P7|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
154286|NCT00427895|376908|P6|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
154287|NCT00427895|376909|P5|STARTED|Between Year 1 - Vax 2/Year 3 to 4||0
154288|NCT00427895|376910|P4|STARTED|Between Year 1 - Vax 2/Year 3 to 4||469
154289|NCT00427895|376911|P3|STARTED|Between Year 1 - Vax 2/Year 3 to 4||373
154290|NCT00427895|376912|P2|STARTED|Between Year 1 - Vax 2/Year 3 to 4||396
154291|NCT00427895|376913|P1|STARTED|Between Year 1 - Vax 2/Year 3 to 4||404
154292|NCT00427895|376906|P8|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
154293|NCT00427895|376907|P7|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
154294|NCT00427895|376908|P6|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
154295|NCT00427895|376909|P5|NOT COMPLETED|Vax 1/Year 1 Follow-up||0
154296|NCT00427895|376910|P4|NOT COMPLETED|Vax 1/Year 1 Follow-up||33
154297|NCT00427895|376911|P3|NOT COMPLETED|Vax 1/Year 1 Follow-up||19
154298|NCT00427895|376912|P2|NOT COMPLETED|Vax 1/Year 1 Follow-up||15
154299|NCT00427895|376913|P1|NOT COMPLETED|Vax 1/Year 1 Follow-up||7
154300|NCT00427895|376906|P8|COMPLETED|Vax 1/Year 1 Follow-up||0
154301|NCT00427895|376907|P7|COMPLETED|Vax 1/Year 1 Follow-up||0
154302|NCT00427895|376908|P6|COMPLETED|Vax 1/Year 1 Follow-up||0
154303|NCT00427895|376909|P5|COMPLETED|Vax 1/Year 1 Follow-up||0
154304|NCT00427895|376910|P4|COMPLETED|Vax 1/Year 1 Follow-up||469
154305|NCT00427895|376911|P3|COMPLETED|Vax 1/Year 1 Follow-up||373
154306|NCT00427895|376912|P2|COMPLETED|Vax 1/Year 1 Follow-up||396
154307|NCT00427895|376913|P1|COMPLETED|Vax 1/Year 1 Follow-up||404
154308|NCT00427895|376906|P8|STARTED|Vax 1/Year 1 Follow-up||0
154309|NCT00427895|376907|P7|STARTED|Vax 1/Year 1 Follow-up||0
154310|NCT00427895|376908|P6|STARTED|Vax 1/Year 1 Follow-up||0
154311|NCT00427895|376909|P5|STARTED|Vax 1/Year 1 Follow-up||0
154312|NCT00427895|376910|P4|STARTED|Vax 1/Year 1 Follow-up||502
154313|NCT00427895|376911|P3|STARTED|Vax 1/Year 1 Follow-up||392
154314|NCT00427895|376912|P2|STARTED|Vax 1/Year 1 Follow-up||411
154315|NCT00427895|376913|P1|STARTED|Vax 1/Year 1 Follow-up||411
154316|NCT00427895|376906|P8|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
154317|NCT00427895|376907|P7|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
154318|NCT00427895|376908|P6|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
154319|NCT00427895|376909|P5|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
154320|NCT00427895|376910|P4|NOT COMPLETED|Between 6-Month Follow-up - Year 1||352
154321|NCT00427895|376911|P3|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
154322|NCT00427895|376912|P2|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
154323|NCT00427895|376913|P1|NOT COMPLETED|Between 6-Month Follow-up - Year 1||0
154324|NCT00427895|376906|P8|COMPLETED|Between 6-Month Follow-up - Year 1||0
154325|NCT00427895|376907|P7|COMPLETED|Between 6-Month Follow-up - Year 1||0
154326|NCT00427895|376908|P6|COMPLETED|Between 6-Month Follow-up - Year 1||0
154327|NCT00427895|376909|P5|COMPLETED|Between 6-Month Follow-up - Year 1||0
154328|NCT00427895|376910|P4|COMPLETED|Between 6-Month Follow-up - Year 1||502
154329|NCT00427895|376911|P3|COMPLETED|Between 6-Month Follow-up - Year 1||392
154330|NCT00427895|376912|P2|COMPLETED|Between 6-Month Follow-up - Year 1||411
154331|NCT00427895|376913|P1|COMPLETED|Between 6-Month Follow-up - Year 1||411
154332|NCT00427895|376906|P8|STARTED|Between 6-Month Follow-up - Year 1||0
154333|NCT00427895|376907|P7|STARTED|Between 6-Month Follow-up - Year 1||0
154334|NCT00427895|376908|P6|STARTED|Between 6-Month Follow-up - Year 1||0
154335|NCT00427895|376909|P5|STARTED|Between 6-Month Follow-up - Year 1||0
154336|NCT00427895|376910|P4|STARTED|Between 6-Month Follow-up - Year 1||854
154337|NCT00427895|376911|P3|STARTED|Between 6-Month Follow-up - Year 1||392
154338|NCT00427895|376912|P2|STARTED|Between 6-Month Follow-up - Year 1||411
154339|NCT00427895|376913|P1|STARTED|Between 6-Month Follow-up - Year 1||411
154340|NCT00427895|376906|P8|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154341|NCT00427895|376907|P7|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154342|NCT00427895|376908|P6|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154343|NCT00427895|376909|P5|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154344|NCT00427895|376910|P4|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||46
154345|NCT00427895|376911|P3|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||14
154346|NCT00427895|376912|P2|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||6
154347|NCT00427895|376913|P1|NOT COMPLETED|Vax 1 Baseline/6-Month Follow-up||7
154348|NCT00427895|376906|P8|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154349|NCT00427895|376907|P7|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154350|NCT00427895|376908|P6|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154351|NCT00427895|376909|P5|COMPLETED|Vax 1 Baseline/6-Month Follow-up||0
154352|NCT00427895|376910|P4|COMPLETED|Vax 1 Baseline/6-Month Follow-up||854
154353|NCT00427895|376911|P3|COMPLETED|Vax 1 Baseline/6-Month Follow-up||392
154354|NCT00427895|376912|P2|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
154355|NCT00427895|376913|P1|COMPLETED|Vax 1 Baseline/6-Month Follow-up||411
154356|NCT00427895|376906|P8|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
154357|NCT00427895|376907|P7|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
154358|NCT00427895|376908|P6|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
154359|NCT00427895|376909|P5|Vaccinated|Vax 1 Baseline/6-Month Follow-up||0
154360|NCT00427895|376910|P4|Vaccinated|Vax 1 Baseline/6-Month Follow-up||899
154361|NCT00427895|376911|P3|Vaccinated|Vax 1 Baseline/6-Month Follow-up||404
154362|NCT00427895|376912|P2|Vaccinated|Vax 1 Baseline/6-Month Follow-up||414
154363|NCT00427895|376913|P1|Vaccinated|Vax 1 Baseline/6-Month Follow-up||417
154364|NCT00427895|376906|P8|STARTED|Vax 1 Baseline/6-Month Follow-up||0
154365|NCT00427895|376907|P7|STARTED|Vax 1 Baseline/6-Month Follow-up||0
154366|NCT00427895|376908|P6|STARTED|Vax 1 Baseline/6-Month Follow-up||0
154367|NCT00427895|376909|P5|STARTED|Vax 1 Baseline/6-Month Follow-up||0
154368|NCT00427895|376910|P4|STARTED|Vax 1 Baseline/6-Month Follow-up||900
154369|NCT00427895|376911|P3|STARTED|Vax 1 Baseline/6-Month Follow-up||406
154370|NCT00427895|376912|P2|STARTED|Vax 1 Baseline/6-Month Follow-up||417
154371|NCT00427895|376913|P1|STARTED|Vax 1 Baseline/6-Month Follow-up||418
154372|NCT00427921|376968|P1|NOT COMPLETED|Overall Study||50
154373|NCT00427921|376968|P1|COMPLETED|Overall Study||254
154374|NCT00427921|376968|P1|STARTED|Overall Study||304
154375|NCT00427934|376991|P4|NOT COMPLETED|Overall Study||15
154376|NCT00427934|376992|P3|NOT COMPLETED|Overall Study||23
154377|NCT00427934|376993|P2|NOT COMPLETED|Overall Study||0
154378|NCT00427934|376994|P1|NOT COMPLETED|Overall Study||1
154379|NCT00427934|376991|P4|COMPLETED|Overall Study||19
154380|NCT00427934|376992|P3|COMPLETED|Overall Study||55
154381|NCT00427934|376993|P2|COMPLETED|Overall Study||8
154382|NCT00427934|376994|P1|COMPLETED|Overall Study||7
154383|NCT00427934|376991|P4|Treated|Overall Study||33
154384|NCT00427934|376992|P3|Treated|Overall Study||77
154385|NCT00427934|376993|P2|Treated|Overall Study||8
154386|NCT00427934|376994|P1|Treated|Overall Study||8
154387|NCT00427934|376991|P4|STARTED|Overall Study||34
154388|NCT00427934|376992|P3|STARTED|Overall Study||78
154389|NCT00427934|376993|P2|STARTED|Overall Study||8
154390|NCT00427934|376994|P1|STARTED|Overall Study||8
154391|NCT00427960|377064|P2|NOT COMPLETED|Overall Study||4
154392|NCT00427960|377065|P1|NOT COMPLETED|Overall Study||2
154393|NCT00427960|377064|P2|COMPLETED|Overall Study||21
154394|NCT00427960|377065|P1|COMPLETED|Overall Study||28
154395|NCT00427960|377064|P2|STARTED|Overall Study||25
154396|NCT00427960|377065|P1|STARTED|Overall Study||30
154397|NCT00427973|377099|P1|NOT COMPLETED|Overall Study||0
154398|NCT00427973|377099|P1|COMPLETED|Overall Study||17
154399|NCT00427973|377099|P1|STARTED|Overall Study||17
154400|NCT00427999|377106|P1|NOT COMPLETED|Overall Study||32
154401|NCT00427999|377106|P1|COMPLETED|Overall Study||33
154402|NCT00427999|377106|P1|Extension Follow-up|Overall Study||19
154403|NCT00427999|377106|P1|Intent to Treat (ITT)|Overall Study||61
154404|NCT00427999|377106|P1|STARTED|Overall Study||65
154405|NCT00428077|377115|P1|NOT COMPLETED|Overall Study||0
154406|NCT00428077|377115|P1|COMPLETED|Overall Study||4
154407|NCT00428077|377115|P1|STARTED|Overall Study||4
154408|NCT00428090|377123|P4|NOT COMPLETED|Overall Study||28
154409|NCT00428090|377124|P3|NOT COMPLETED|Overall Study||38
154410|NCT00428090|377125|P2|NOT COMPLETED|Overall Study||31
154411|NCT00428090|377126|P1|NOT COMPLETED|Overall Study||34
154412|NCT00428090|377123|P4|COMPLETED|Overall Study||55
154413|NCT00428090|377124|P3|COMPLETED|Overall Study||127
154414|NCT00428090|377125|P2|COMPLETED|Overall Study||135
154415|NCT00428090|377126|P1|COMPLETED|Overall Study||131
154416|NCT00428090|377123|P4|STARTED|Overall Study||83
154417|NCT00428090|377124|P3|STARTED|Overall Study||165
154418|NCT00428090|377125|P2|STARTED|Overall Study||166
154419|NCT00428090|377126|P1|STARTED|Overall Study||165
154420|NCT00428116|377242|P2|NOT COMPLETED|Overall Study||0
154421|NCT00428116|377243|P1|NOT COMPLETED|Overall Study||3
154422|NCT00428116|377242|P2|COMPLETED|Overall Study||21
154423|NCT00428116|377243|P1|COMPLETED|Overall Study||18
154424|NCT00428116|377242|P2|STARTED|Overall Study||21
154425|NCT00428116|377243|P1|STARTED|Overall Study||21
154426|NCT00428207|377251|P2|NOT COMPLETED|Overall Study||0
154427|NCT00428207|377252|P1|NOT COMPLETED|Overall Study||0
154428|NCT00428207|377251|P2|COMPLETED|Overall Study||2
154429|NCT00428207|377252|P1|COMPLETED|Overall Study||2
154430|NCT00428207|377251|P2|STARTED|Overall Study||2
154431|NCT00428207|377252|P1|STARTED|Overall Study||2
154432|NCT00428220|377258|P1|NOT COMPLETED|Overall Study||223
154433|NCT00428220|377258|P1|COMPLETED|Overall Study||0
154434|NCT00428220|377258|P1|STARTED|Overall Study||223
154435|NCT00428246|377277|P3|NOT COMPLETED|Overall Study||1
154436|NCT00428246|377278|P2|NOT COMPLETED|Overall Study||0
154437|NCT00428246|377279|P1|NOT COMPLETED|Overall Study||1
154438|NCT00428246|377277|P3|COMPLETED|Overall Study||7
154439|NCT00428246|377278|P2|COMPLETED|Overall Study||8
154440|NCT00428246|377279|P1|COMPLETED|Overall Study||7
154441|NCT00428246|377277|P3|STARTED|Overall Study||8
154442|NCT00428246|377278|P2|STARTED|Overall Study||8
154443|NCT00428246|377279|P1|STARTED|Overall Study||8
154444|NCT00428298|377289|P2|NOT COMPLETED|Overall Study||11
154445|NCT00428298|377290|P1|NOT COMPLETED|Overall Study||14
154446|NCT00428298|377289|P2|COMPLETED|Overall Study||19
154447|NCT00428298|377290|P1|COMPLETED|Overall Study||16
154448|NCT00428298|377289|P2|Second RBANS at Study Exit|Overall Study||3
154449|NCT00428298|377290|P1|Second RBANS at Study Exit|Overall Study||3
154450|NCT00428298|377289|P2|STARTED|Overall Study||30
154451|NCT00428298|377290|P1|STARTED|Overall Study||30
154452|NCT00428389|377302|P2|NOT COMPLETED|Extension Phase||26
154453|NCT00428389|377303|P1|NOT COMPLETED|Extension Phase||32
154454|NCT00428389|377302|P2|COMPLETED|Extension Phase||91
154455|NCT00428389|377303|P1|COMPLETED|Extension Phase||85
154456|NCT00428389|377302|P2|STARTED|Extension Phase||117
154457|NCT00428389|377303|P1|STARTED|Extension Phase|Participants were required to sign a separate informed consent prior to entering the extension phase|117
154458|NCT00428389|377302|P2|NOT COMPLETED|Core Phase||11
154459|NCT00428389|377303|P1|NOT COMPLETED|Core Phase||11
154460|NCT00428389|377302|P2|COMPLETED|Core Phase||120
154461|NCT00428389|377303|P1|COMPLETED|Core Phase||120
154462|NCT00428389|377302|P2|Intent-to-treat Population|Core Phase|1 patient was discontinued from the study the same day as randomization & excluded from all analyses|130
154463|NCT00428389|377303|P1|Intent-to-treat Population|Core Phase||131
154464|NCT00428389|377302|P2|STARTED|Core Phase||131
154465|NCT00428389|377303|P1|STARTED|Core Phase||131
154466|NCT00428441|377321|P1|NOT COMPLETED|Overall Study||1
154467|NCT00428441|377321|P1|COMPLETED|Overall Study||74
154468|NCT00428441|377321|P1|STARTED|Overall Study||75
154469|NCT00428584|377327|P2|NOT COMPLETED|Extension Phase||29
154470|NCT00428584|377328|P1|NOT COMPLETED|Extension Phase||21
154471|NCT00428584|377327|P2|COMPLETED|Extension Phase||34
154472|NCT00428584|377328|P1|COMPLETED|Extension Phase||35
154473|NCT00428584|377327|P2|STARTED|Extension Phase||63
154474|NCT00428584|377328|P1|STARTED|Extension Phase|Extension Phase - new formulation of rebif to new formulation of rebif|56
154475|NCT00428584|377327|P2|NOT COMPLETED|Comparative Phase||1
154476|NCT00428584|377328|P1|NOT COMPLETED|Comparative Phase||9
154477|NCT00428584|377327|P2|COMPLETED|Comparative Phase||63
154478|NCT00428584|377328|P1|COMPLETED|Comparative Phase|Comparator Phase - new formulation of rebif and Betaseron|56
154479|NCT00428584|377327|P2|STARTED|Comparative Phase||64
154480|NCT00428584|377328|P1|STARTED|Comparative Phase||65
154481|NCT00428597|377354|P2|NOT COMPLETED|Overall Study||85
154482|NCT00428597|377355|P1|NOT COMPLETED|Overall Study||86
154483|NCT00428597|377354|P2|COMPLETED|Overall Study||0
154484|NCT00428597|377355|P1|COMPLETED|Overall Study||0
154485|NCT00428597|377354|P2|Received Treatment|Overall Study||82
154486|NCT00428597|377355|P1|Received Treatment|Overall Study||83
154487|NCT00428597|377354|P2|STARTED|Overall Study||85
154488|NCT00428597|377355|P1|STARTED|Overall Study||86
154489|NCT00428792|377397|P2|NOT COMPLETED|Overall Study||4
154490|NCT00428792|377398|P1|NOT COMPLETED|Overall Study||1
154491|NCT00428792|377397|P2|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|66
154492|NCT00428792|377398|P1|COMPLETED|Overall Study|Information is not available during which cross-over period patients discontinued.|79
154493|NCT00428792|377397|P2|STARTED|Overall Study||70
154494|NCT00428792|377398|P1|STARTED|Overall Study||80
154495|NCT00428844|377425|P3|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
154496|NCT00428844|377426|P2|NOT COMPLETED|Completed Test of Cure (TOC) Visit||2
154497|NCT00428844|377427|P1|NOT COMPLETED|Completed Test of Cure (TOC) Visit||3
154498|NCT00428844|377425|P3|COMPLETED|Completed Test of Cure (TOC) Visit||17
154499|NCT00428844|377426|P2|COMPLETED|Completed Test of Cure (TOC) Visit||16
154500|NCT00428844|377427|P1|COMPLETED|Completed Test of Cure (TOC) Visit||20
154501|NCT00428844|377425|P3|STARTED|Completed Test of Cure (TOC) Visit||19
154502|NCT00428844|377426|P2|STARTED|Completed Test of Cure (TOC) Visit||18
154503|NCT00428844|377427|P1|STARTED|Completed Test of Cure (TOC) Visit||23
154504|NCT00428844|377425|P3|NOT COMPLETED|Completed Study Drug Treatment||7
154505|NCT00428844|377426|P2|NOT COMPLETED|Completed Study Drug Treatment||6
154506|NCT00428844|377427|P1|NOT COMPLETED|Completed Study Drug Treatment||2
154507|NCT00428844|377425|P3|COMPLETED|Completed Study Drug Treatment||19
154508|NCT00428844|377426|P2|COMPLETED|Completed Study Drug Treatment||18
154509|NCT00428844|377427|P1|COMPLETED|Completed Study Drug Treatment||23
154510|NCT00428844|377425|P3|Received First Dose|Completed Study Drug Treatment||25
154511|NCT00428844|377426|P2|Received First Dose|Completed Study Drug Treatment||24
154512|NCT00428844|377427|P1|Received First Dose|Completed Study Drug Treatment||25
154513|NCT00428844|377425|P3|STARTED|Completed Study Drug Treatment||26
154514|NCT00428844|377426|P2|STARTED|Completed Study Drug Treatment||24
154515|NCT00428844|377427|P1|STARTED|Completed Study Drug Treatment||25
154516|NCT00428922|377448|P1|NOT COMPLETED|Overall Study||0
154517|NCT00428922|377448|P1|COMPLETED|Overall Study||26
154518|NCT00428922|377448|P1|STARTED|Overall Study||26
154519|NCT00428948|377457|P2|NOT COMPLETED|Overall Study||67
154520|NCT00428948|377458|P1|NOT COMPLETED|Overall Study||221
154521|NCT00428948|377457|P2|COMPLETED|Overall Study||417
154522|NCT00428948|377458|P1|COMPLETED|Overall Study||740
154523|NCT00428948|377457|P2|Received Treatment|Overall Study||483
154524|NCT00428948|377458|P1|Received Treatment|Overall Study||961
154525|NCT00428948|377457|P2|STARTED|Overall Study||484
154526|NCT00428948|377458|P1|STARTED|Overall Study||961
154527|NCT00428974|377480|P4|NOT COMPLETED|Overall Study||3
154528|NCT00428974|377481|P3|NOT COMPLETED|Overall Study||1
154529|NCT00428974|377482|P2|NOT COMPLETED|Overall Study||0
154530|NCT00428974|377483|P1|NOT COMPLETED|Overall Study||8
154531|NCT00428974|377480|P4|COMPLETED|Overall Study||16
154532|NCT00428974|377481|P3|COMPLETED|Overall Study||14
154533|NCT00428974|377482|P2|COMPLETED|Overall Study||17
154534|NCT00428974|377483|P1|COMPLETED|Overall Study||17
154535|NCT00428974|377480|P4|STARTED|Overall Study||19
154536|NCT00428974|377481|P3|STARTED|Overall Study||15
154537|NCT00428974|377482|P2|STARTED|Overall Study||17
154538|NCT00428974|377483|P1|STARTED|Overall Study|one patient was randomized but never received study treatment|25
154539|NCT00429026|377497|P1|NOT COMPLETED|Overall Study||40
154540|NCT00429026|377497|P1|COMPLETED|Overall Study||0
154541|NCT00429026|377497|P1|STARTED|Overall Study||40
154542|NCT00429104|377501|P1|NOT COMPLETED|Overall Study||1
154543|NCT00429104|377501|P1|COMPLETED|Overall Study||17
154544|NCT00429104|377501|P1|STARTED|Overall Study||18
154545|NCT00429143|377506|P1|NOT COMPLETED|Overall Study||0
154546|NCT00429143|377506|P1|COMPLETED|Overall Study||27
154547|NCT00429143|377506|P1|STARTED|Overall Study||27
154548|NCT00429169|377516|P2|NOT COMPLETED|Overall Study||2
154549|NCT00429169|377517|P1|NOT COMPLETED|Overall Study||2
154550|NCT00429169|377516|P2|COMPLETED|Overall Study|2 subjects excluded: re-diagnosis/ineligibility (1), and did not return after randomization (1).|38
154551|NCT00429169|377517|P1|COMPLETED|Overall Study|2 subjects excluded due to re-diagnosis/ineligibility.|36
154552|NCT00429169|377516|P2|STARTED|Overall Study||40
154553|NCT00429169|377517|P1|STARTED|Overall Study||38
154554|NCT00429182|377527|P1|NOT COMPLETED|Overall Study||7
154555|NCT00429182|377527|P1|COMPLETED|Overall Study||25
154556|NCT00429182|377527|P1|STARTED|Overall Study||32
154557|NCT00429273|377535|P3|NOT COMPLETED|Overall Study||9
154558|NCT00429273|377536|P2|NOT COMPLETED|Overall Study||8
154559|NCT00429273|377537|P1|NOT COMPLETED|Overall Study||8
154560|NCT00429273|377535|P3|COMPLETED|Overall Study||61
154561|NCT00429273|377536|P2|COMPLETED|Overall Study||61
154562|NCT00429273|377537|P1|COMPLETED|Overall Study||60
154563|NCT00429273|377535|P3|STARTED|Overall Study||70
154564|NCT00429273|377536|P2|STARTED|Overall Study||69
154565|NCT00429273|377537|P1|STARTED|Overall Study||68
154566|NCT00429299|377548|P3|NOT COMPLETED|Overall Study||4
154567|NCT00429299|377549|P2|NOT COMPLETED|Overall Study||7
154568|NCT00429299|377550|P1|NOT COMPLETED|Overall Study||4
154569|NCT00429299|377548|P3|COMPLETED|Overall Study||42
154570|NCT00429299|377549|P2|COMPLETED|Overall Study||32
154571|NCT00429299|377550|P1|COMPLETED|Overall Study||32
154572|NCT00429299|377548|P3|STARTED|Overall Study||46
154573|NCT00429299|377549|P2|STARTED|Overall Study||39
154574|NCT00429299|377550|P1|STARTED|Overall Study||36
154575|NCT00429364|377581|P2|NOT COMPLETED|Overall Study||33
154576|NCT00429364|377582|P1|NOT COMPLETED|Overall Study||32
154577|NCT00429364|377581|P2|COMPLETED|Overall Study||272
154578|NCT00429364|377582|P1|COMPLETED|Overall Study||271
154579|NCT00429364|377581|P2|STARTED|Overall Study||305
154580|NCT00429364|377582|P1|STARTED|Overall Study||303
154581|NCT00429403|377640|P2|NOT COMPLETED|Overall Study||0
154582|NCT00429403|377641|P1|NOT COMPLETED|Overall Study||0
154583|NCT00429403|377640|P2|COMPLETED|Overall Study||0
154584|NCT00429403|377641|P1|COMPLETED|Overall Study||1
154585|NCT00429403|377640|P2|STARTED|Overall Study||0
154586|NCT00429403|377641|P1|STARTED|Overall Study||1
154587|NCT00429416|377647|P1|NOT COMPLETED|Overall Study||1
154588|NCT00429416|377647|P1|COMPLETED|Overall Study||13
154589|NCT00429416|377647|P1|STARTED|Overall Study||14
154590|NCT00429494|377655|P1|NOT COMPLETED|Overall Study||15
154591|NCT00429494|377655|P1|COMPLETED|Overall Study||44
154592|NCT00429494|377655|P1|STARTED|Overall Study||59
154593|NCT00429507|377659|P1|NOT COMPLETED|Overall Study||0
154594|NCT00429507|377659|P1|COMPLETED|Overall Study||12
154595|NCT00429507|377659|P1|STARTED|Overall Study||12
154596|NCT00429572|377663|P1|NOT COMPLETED|Overall Study||1
154597|NCT00429572|377663|P1|COMPLETED|Overall Study||18
154598|NCT00429572|377663|P1|STARTED|Overall Study||19
154599|NCT00429663|377673|P2|NOT COMPLETED|Overall Study||39
154600|NCT00429663|377674|P1|NOT COMPLETED|Overall Study||36
154601|NCT00429663|377673|P2|COMPLETED|Overall Study||41
154602|NCT00429663|377674|P1|COMPLETED|Overall Study||40
154603|NCT00429663|377673|P2|STARTED|Overall Study||80
154604|NCT00429663|377674|P1|STARTED|Overall Study||76
154605|NCT00429702|377690|P2|NOT COMPLETED|Overall Study||0
154606|NCT00429702|377691|P1|NOT COMPLETED|Overall Study||0
154607|NCT00429702|377690|P2|COMPLETED|Overall Study||4
154608|NCT00429702|377691|P1|COMPLETED|Overall Study||3
154609|NCT00429702|377690|P2|STARTED|Overall Study||4
154610|NCT00429702|377691|P1|STARTED|Overall Study||3
154611|NCT00429793|377699|P1|NOT COMPLETED|Overall Study||6
154612|NCT00429793|377699|P1|COMPLETED|Overall Study||54
154613|NCT00429793|377699|P1|STARTED|Overall Study||60
154614|NCT00421889|377715|P9|NOT COMPLETED|Overall Study||11
154615|NCT00421889|377716|P8|NOT COMPLETED|Overall Study||2
154616|NCT00421889|377717|P7|NOT COMPLETED|Overall Study||4
154617|NCT00421889|377718|P6|NOT COMPLETED|Overall Study||35
154618|NCT00421889|377719|P5|NOT COMPLETED|Overall Study||6
154619|NCT00421889|377720|P4|NOT COMPLETED|Overall Study||4
154620|NCT00421889|377721|P3|NOT COMPLETED|Overall Study||3
154621|NCT00421889|377722|P2|NOT COMPLETED|Overall Study||5
154622|NCT00421889|377723|P1|NOT COMPLETED|Overall Study||5
154623|NCT00421889|377715|P9|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 4.27|4
154624|NCT00421889|377716|P8|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|1
154625|NCT00421889|377717|P7|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.50|0
154626|NCT00421889|377718|P6|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 7.69|0
154627|NCT00421889|377719|P5|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.00|0
154628|NCT00421889|377720|P4|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 9.25|0
154629|NCT00421889|377721|P3|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 3.33|0
154630|NCT00421889|377722|P2|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 8.20|0
154631|NCT00421889|377723|P1|COMPLETED|Overall Study|Mean number of PXD101 cycles administered: 5.20|0
154632|NCT00421889|377715|P9|STARTED|Overall Study||15
154633|NCT00421889|377716|P8|STARTED|Overall Study||3
154634|NCT00421889|377717|P7|STARTED|Overall Study||4
154635|NCT00421889|377718|P6|STARTED|Overall Study||35
154636|NCT00421889|377719|P5|STARTED|Overall Study||6
154637|NCT00421889|377720|P4|STARTED|Overall Study||4
154638|NCT00421889|377721|P3|STARTED|Overall Study||3
154639|NCT00421889|377722|P2|STARTED|Overall Study||5
154640|NCT00421889|377723|P1|STARTED|Overall Study||5
154641|NCT00421928|377768|P3|NOT COMPLETED|Overall Study||134
154642|NCT00421928|377769|P2|NOT COMPLETED|Overall Study||224
154643|NCT00421928|377770|P1|NOT COMPLETED|Overall Study||163
154644|NCT00421928|377768|P3|COMPLETED|Overall Study||203
154645|NCT00421928|377769|P2|COMPLETED|Overall Study||118
154646|NCT00421928|377770|P1|COMPLETED|Overall Study||181
154647|NCT00421928|377768|P3|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|337
154648|NCT00421928|377769|P2|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug. One subject was enrolled twice.|342
154649|NCT00421928|377770|P1|STARTED|Overall Study|2 randomly assigned to this treatment group did not receive drug|344
154650|NCT00421954|377796|P1|NOT COMPLETED|Overall Study||0
154651|NCT00421954|377796|P1|COMPLETED|Overall Study||0
154652|NCT00421954|377796|P1|STARTED|Overall Study||0
154653|NCT00421993|377804|P4|NOT COMPLETED|Overall Study||57
154654|NCT00421993|377805|P3|NOT COMPLETED|Overall Study||52
154655|NCT00421993|377806|P2|NOT COMPLETED|Overall Study||49
154656|NCT00421993|377807|P1|NOT COMPLETED|Overall Study||53
154657|NCT00421993|377804|P4|COMPLETED|Overall Study||361
154658|NCT00421993|377805|P3|COMPLETED|Overall Study||363
154659|NCT00421993|377806|P2|COMPLETED|Overall Study||369
154660|NCT00421993|377807|P1|COMPLETED|Overall Study||366
154661|NCT00421993|377804|P4|STARTED|Overall Study||418
154662|NCT00421993|377805|P3|STARTED|Overall Study||415
154663|NCT00421993|377806|P2|STARTED|Overall Study||418
154664|NCT00421993|377807|P1|STARTED|Overall Study||419
154665|NCT00422032|377839|P2|NOT COMPLETED|Overall Study||0
154666|NCT00422032|377840|P1|NOT COMPLETED|Overall Study||0
154667|NCT00422032|377839|P2|COMPLETED|Overall Study||21
154668|NCT00422032|377840|P1|COMPLETED|Overall Study||37
154669|NCT00422032|377839|P2|STARTED|Overall Study||21
154670|NCT00422032|377840|P1|STARTED|Overall Study||37
154671|NCT00422058|377852|P6|NOT COMPLETED|Open-Label Extension, Week 20-104||34
154672|NCT00422058|377853|P5|NOT COMPLETED|Open-Label Extension, Week 20-104||35
154673|NCT00422058|377854|P4|NOT COMPLETED|Open-Label Extension, Week 20-104||28
154674|NCT00422058|377855|P3|NOT COMPLETED|Open-Label Extension, Week 20-104||36
154675|NCT00422058|377856|P2|NOT COMPLETED|Open-Label Extension, Week 20-104||39
154676|NCT00422058|377857|P1|NOT COMPLETED|Open-Label Extension, Week 20-104||32
154677|NCT00422058|377852|P6|COMPLETED|Open-Label Extension, Week 20-104||45
154678|NCT00422058|377853|P5|COMPLETED|Open-Label Extension, Week 20-104||47
154679|NCT00422058|377854|P4|COMPLETED|Open-Label Extension, Week 20-104||45
154680|NCT00422058|377855|P3|COMPLETED|Open-Label Extension, Week 20-104||38
154681|NCT00422058|377856|P2|COMPLETED|Open-Label Extension, Week 20-104||46
154682|NCT00422058|377857|P1|COMPLETED|Open-Label Extension, Week 20-104||47
154683|NCT00422058|377852|P6|Enrolled in Extension|Open-Label Extension, Week 20-104||67
154684|NCT00422058|377853|P5|Enrolled in Extension|Open-Label Extension, Week 20-104||72
154685|NCT00422058|377854|P4|Enrolled in Extension|Open-Label Extension, Week 20-104||65
154686|NCT00422058|377855|P3|Enrolled in Extension|Open-Label Extension, Week 20-104||59
154687|NCT00422058|377856|P2|Enrolled in Extension|Open-Label Extension, Week 20-104||68
154688|NCT00422058|377857|P1|Enrolled in Extension|Open-Label Extension, Week 20-104||67
154689|NCT00422058|377852|P6|STARTED|Open-Label Extension, Week 20-104||79
154690|NCT00422058|377853|P5|STARTED|Open-Label Extension, Week 20-104||82
154691|NCT00422058|377854|P4|STARTED|Open-Label Extension, Week 20-104||73
154692|NCT00422058|377855|P3|STARTED|Open-Label Extension, Week 20-104||74
154693|NCT00422058|377856|P2|STARTED|Open-Label Extension, Week 20-104||85
154694|NCT00422058|377857|P1|STARTED|Open-Label Extension, Week 20-104||79
154695|NCT00422058|377852|P6|NOT COMPLETED|Double-Blind, Week 0-20||16
154696|NCT00422058|377853|P5|NOT COMPLETED|Double-Blind, Week 0-20||11
154697|NCT00422058|377854|P4|NOT COMPLETED|Double-Blind, Week 0-20||20
154698|NCT00422058|377855|P3|NOT COMPLETED|Double-Blind, Week 0-20||16
154699|NCT00422058|377856|P2|NOT COMPLETED|Double-Blind, Week 0-20||10
154700|NCT00422058|377857|P1|NOT COMPLETED|Double-Blind, Week 0-20||19
154701|NCT00422058|377852|P6|COMPLETED|Double-Blind, Week 0-20||79
154702|NCT00422058|377853|P5|COMPLETED|Double-Blind, Week 0-20||82
154703|NCT00422058|377854|P4|COMPLETED|Double-Blind, Week 0-20||73
154704|NCT00422058|377855|P3|COMPLETED|Double-Blind, Week 0-20||74
154705|NCT00422058|377856|P2|COMPLETED|Double-Blind, Week 0-20||85
154706|NCT00422058|377857|P1|COMPLETED|Double-Blind, Week 0-20||79
154707|NCT00422058|377852|P6|STARTED|Double-Blind, Week 0-20||95
154708|NCT00422058|377853|P5|STARTED|Double-Blind, Week 0-20||93
154709|NCT00422058|377854|P4|STARTED|Double-Blind, Week 0-20||93
154710|NCT00422058|377855|P3|STARTED|Double-Blind, Week 0-20||90
154711|NCT00422058|377856|P2|STARTED|Double-Blind, Week 0-20||95
154712|NCT00422058|377857|P1|STARTED|Double-Blind, Week 0-20||98
154713|NCT00422097|377991|P8|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154714|NCT00422097|377992|P7|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154715|NCT00422097|377993|P6|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154716|NCT00422097|377994|P5|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154717|NCT00422097|377995|P4|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154718|NCT00422097|377996|P3|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154719|NCT00422097|377997|P2|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154720|NCT00422097|377998|P1|NOT COMPLETED|Ixabepilone With Famotidine or Food||0
154721|NCT00422097|377991|P8|COMPLETED|Ixabepilone With Famotidine or Food||7
154722|NCT00422097|377992|P7|COMPLETED|Ixabepilone With Famotidine or Food||8
154723|NCT00422097|377993|P6|COMPLETED|Ixabepilone With Famotidine or Food||0
154724|NCT00422097|377994|P5|COMPLETED|Ixabepilone With Famotidine or Food||0
154725|NCT00422097|377995|P4|COMPLETED|Ixabepilone With Famotidine or Food||0
154726|NCT00422097|377996|P3|COMPLETED|Ixabepilone With Famotidine or Food||0
154727|NCT00422097|377997|P2|COMPLETED|Ixabepilone With Famotidine or Food||0
154728|NCT00422097|377998|P1|COMPLETED|Ixabepilone With Famotidine or Food||0
154729|NCT00422097|377991|P8|STARTED|Ixabepilone With Famotidine or Food||7
154730|NCT00422097|377992|P7|STARTED|Ixabepilone With Famotidine or Food||8
154731|NCT00422097|377993|P6|STARTED|Ixabepilone With Famotidine or Food||0
154732|NCT00422097|377994|P5|STARTED|Ixabepilone With Famotidine or Food||0
154733|NCT00422097|377995|P4|STARTED|Ixabepilone With Famotidine or Food||0
154734|NCT00422097|377996|P3|STARTED|Ixabepilone With Famotidine or Food||0
154735|NCT00422097|377997|P2|STARTED|Ixabepilone With Famotidine or Food||0
154736|NCT00422097|377998|P1|STARTED|Ixabepilone With Famotidine or Food||0
154737|NCT00422097|377991|P8|NOT COMPLETED|Dose Level 6||0
154738|NCT00422097|377992|P7|NOT COMPLETED|Dose Level 6||0
154739|NCT00422097|377993|P6|NOT COMPLETED|Dose Level 6||0
154740|NCT00422097|377994|P5|NOT COMPLETED|Dose Level 6||0
154741|NCT00422097|377995|P4|NOT COMPLETED|Dose Level 6||0
154742|NCT00422097|377996|P3|NOT COMPLETED|Dose Level 6||0
154743|NCT00422097|377997|P2|NOT COMPLETED|Dose Level 6||0
154744|NCT00422097|377998|P1|NOT COMPLETED|Dose Level 6||0
154745|NCT00422097|377991|P8|COMPLETED|Dose Level 6||0
154746|NCT00422097|377992|P7|COMPLETED|Dose Level 6||0
154747|NCT00422097|377993|P6|COMPLETED|Dose Level 6||6
154748|NCT00422097|377994|P5|COMPLETED|Dose Level 6||0
154749|NCT00422097|377995|P4|COMPLETED|Dose Level 6||0
154750|NCT00422097|377996|P3|COMPLETED|Dose Level 6||0
154751|NCT00422097|377997|P2|COMPLETED|Dose Level 6||0
154752|NCT00422097|377998|P1|COMPLETED|Dose Level 6||0
154753|NCT00422097|377991|P8|STARTED|Dose Level 6||0
154754|NCT00422097|377992|P7|STARTED|Dose Level 6||0
154755|NCT00422097|377993|P6|STARTED|Dose Level 6||6
154756|NCT00422097|377994|P5|STARTED|Dose Level 6||0
154757|NCT00422097|377995|P4|STARTED|Dose Level 6||0
154758|NCT00422097|377996|P3|STARTED|Dose Level 6||0
154759|NCT00422097|377997|P2|STARTED|Dose Level 6||0
154760|NCT00422097|377998|P1|STARTED|Dose Level 6||0
154761|NCT00422097|377991|P8|NOT COMPLETED|Dose Level 5||0
154762|NCT00422097|377992|P7|NOT COMPLETED|Dose Level 5||0
154763|NCT00422097|377993|P6|NOT COMPLETED|Dose Level 5||0
154764|NCT00422097|377994|P5|NOT COMPLETED|Dose Level 5||0
154765|NCT00422097|377995|P4|NOT COMPLETED|Dose Level 5||0
154766|NCT00422097|377996|P3|NOT COMPLETED|Dose Level 5||0
154767|NCT00422097|377997|P2|NOT COMPLETED|Dose Level 5||0
154768|NCT00422097|377998|P1|NOT COMPLETED|Dose Level 5||0
154769|NCT00422097|377991|P8|COMPLETED|Dose Level 5||0
154770|NCT00422097|377992|P7|COMPLETED|Dose Level 5||0
154771|NCT00422097|377993|P6|COMPLETED|Dose Level 5||0
154772|NCT00422097|377994|P5|COMPLETED|Dose Level 5||23
154773|NCT00422097|377995|P4|COMPLETED|Dose Level 5||0
154774|NCT00422097|377996|P3|COMPLETED|Dose Level 5||0
154775|NCT00422097|377997|P2|COMPLETED|Dose Level 5||0
154776|NCT00422097|377998|P1|COMPLETED|Dose Level 5||0
154777|NCT00422097|377991|P8|STARTED|Dose Level 5||0
154778|NCT00422097|377992|P7|STARTED|Dose Level 5||0
154779|NCT00422097|377993|P6|STARTED|Dose Level 5||0
154780|NCT00422097|377994|P5|STARTED|Dose Level 5||23
154781|NCT00422097|377995|P4|STARTED|Dose Level 5||0
154782|NCT00422097|377996|P3|STARTED|Dose Level 5||0
154783|NCT00422097|377997|P2|STARTED|Dose Level 5||0
154784|NCT00422097|377998|P1|STARTED|Dose Level 5||0
154785|NCT00422097|377991|P8|NOT COMPLETED|Dose Level 4||0
154786|NCT00422097|377992|P7|NOT COMPLETED|Dose Level 4||0
154787|NCT00422097|377993|P6|NOT COMPLETED|Dose Level 4||0
154788|NCT00422097|377994|P5|NOT COMPLETED|Dose Level 4||0
154789|NCT00422097|377995|P4|NOT COMPLETED|Dose Level 4||0
154790|NCT00422097|377996|P3|NOT COMPLETED|Dose Level 4||0
154791|NCT00422097|377997|P2|NOT COMPLETED|Dose Level 4||0
154792|NCT00422097|377998|P1|NOT COMPLETED|Dose Level 4||0
154793|NCT00422097|377991|P8|COMPLETED|Dose Level 4||0
154794|NCT00422097|377992|P7|COMPLETED|Dose Level 4||0
154795|NCT00422097|377993|P6|COMPLETED|Dose Level 4||0
154796|NCT00422097|377994|P5|COMPLETED|Dose Level 4||0
154797|NCT00422097|377995|P4|COMPLETED|Dose Level 4||3
154798|NCT00422097|377996|P3|COMPLETED|Dose Level 4||0
154799|NCT00422097|377997|P2|COMPLETED|Dose Level 4||0
154800|NCT00422097|377998|P1|COMPLETED|Dose Level 4||0
154801|NCT00422097|377991|P8|STARTED|Dose Level 4||0
154802|NCT00422097|377992|P7|STARTED|Dose Level 4||0
154803|NCT00422097|377993|P6|STARTED|Dose Level 4||0
154804|NCT00422097|377994|P5|STARTED|Dose Level 4||0
154805|NCT00422097|377995|P4|STARTED|Dose Level 4||3
154806|NCT00422097|377996|P3|STARTED|Dose Level 4||0
154807|NCT00422097|377997|P2|STARTED|Dose Level 4||0
154808|NCT00422097|377998|P1|STARTED|Dose Level 4||0
154809|NCT00422097|377991|P8|NOT COMPLETED|Dose Level 3||0
154810|NCT00422097|377992|P7|NOT COMPLETED|Dose Level 3||0
154811|NCT00422097|377993|P6|NOT COMPLETED|Dose Level 3||0
154812|NCT00422097|377994|P5|NOT COMPLETED|Dose Level 3||0
154813|NCT00422097|377995|P4|NOT COMPLETED|Dose Level 3||0
154814|NCT00422097|377996|P3|NOT COMPLETED|Dose Level 3||0
154815|NCT00422097|377997|P2|NOT COMPLETED|Dose Level 3||0
154816|NCT00422097|377998|P1|NOT COMPLETED|Dose Level 3||0
154817|NCT00422097|377991|P8|COMPLETED|Dose Level 3||0
154818|NCT00422097|377992|P7|COMPLETED|Dose Level 3||0
154819|NCT00422097|377993|P6|COMPLETED|Dose Level 3||0
154820|NCT00422097|377994|P5|COMPLETED|Dose Level 3||0
154821|NCT00422097|377995|P4|COMPLETED|Dose Level 3||0
154822|NCT00422097|377996|P3|COMPLETED|Dose Level 3||3
154823|NCT00422097|377997|P2|COMPLETED|Dose Level 3||0
154824|NCT00422097|377998|P1|COMPLETED|Dose Level 3||0
154825|NCT00422097|377991|P8|STARTED|Dose Level 3||0
154826|NCT00422097|377992|P7|STARTED|Dose Level 3||0
154827|NCT00422097|377993|P6|STARTED|Dose Level 3||0
154828|NCT00422097|377994|P5|STARTED|Dose Level 3||0
154829|NCT00422097|377995|P4|STARTED|Dose Level 3||0
154830|NCT00422097|377996|P3|STARTED|Dose Level 3||3
154831|NCT00422097|377997|P2|STARTED|Dose Level 3||0
154832|NCT00422097|377998|P1|STARTED|Dose Level 3||0
154833|NCT00422097|377991|P8|NOT COMPLETED|Dose Level 2||0
154834|NCT00422097|377992|P7|NOT COMPLETED|Dose Level 2||0
154835|NCT00422097|377993|P6|NOT COMPLETED|Dose Level 2||0
154836|NCT00422097|377994|P5|NOT COMPLETED|Dose Level 2||0
154837|NCT00422097|377995|P4|NOT COMPLETED|Dose Level 2||0
154838|NCT00422097|377996|P3|NOT COMPLETED|Dose Level 2||0
154839|NCT00422097|377997|P2|NOT COMPLETED|Dose Level 2||1
154840|NCT00422097|377998|P1|NOT COMPLETED|Dose Level 2||0
154841|NCT00422097|377991|P8|COMPLETED|Dose Level 2||0
154842|NCT00422097|377992|P7|COMPLETED|Dose Level 2||0
154843|NCT00422097|377993|P6|COMPLETED|Dose Level 2||0
154844|NCT00422097|377994|P5|COMPLETED|Dose Level 2||0
154845|NCT00422097|377995|P4|COMPLETED|Dose Level 2||0
154846|NCT00422097|377996|P3|COMPLETED|Dose Level 2||0
154847|NCT00422097|377997|P2|COMPLETED|Dose Level 2||5
154848|NCT00422097|377998|P1|COMPLETED|Dose Level 2||0
154849|NCT00422097|377991|P8|STARTED|Dose Level 2||0
154850|NCT00422097|377992|P7|STARTED|Dose Level 2||0
154851|NCT00422097|377993|P6|STARTED|Dose Level 2||0
154852|NCT00422097|377994|P5|STARTED|Dose Level 2||0
154853|NCT00422097|377995|P4|STARTED|Dose Level 2||0
154854|NCT00422097|377996|P3|STARTED|Dose Level 2||0
154855|NCT00422097|377997|P2|STARTED|Dose Level 2||6
154856|NCT00422097|377998|P1|STARTED|Dose Level 2||0
154857|NCT00422097|377991|P8|NOT COMPLETED|Dose Level 1||0
154858|NCT00422097|377992|P7|NOT COMPLETED|Dose Level 1||0
154859|NCT00422097|377993|P6|NOT COMPLETED|Dose Level 1||0
154860|NCT00422097|377994|P5|NOT COMPLETED|Dose Level 1||0
154861|NCT00422097|377995|P4|NOT COMPLETED|Dose Level 1||0
154862|NCT00422097|377996|P3|NOT COMPLETED|Dose Level 1||0
154863|NCT00422097|377997|P2|NOT COMPLETED|Dose Level 1||0
154864|NCT00422097|377998|P1|NOT COMPLETED|Dose Level 1||0
154865|NCT00422097|377991|P8|COMPLETED|Dose Level 1||0
154866|NCT00422097|377992|P7|COMPLETED|Dose Level 1||0
154867|NCT00422097|377993|P6|COMPLETED|Dose Level 1||0
154868|NCT00422097|377994|P5|COMPLETED|Dose Level 1||0
154869|NCT00422097|377995|P4|COMPLETED|Dose Level 1||0
154870|NCT00422097|377996|P3|COMPLETED|Dose Level 1||0
154871|NCT00422097|377997|P2|COMPLETED|Dose Level 1||0
154872|NCT00422097|377998|P1|COMPLETED|Dose Level 1||3
154873|NCT00422097|377991|P8|STARTED|Dose Level 1||0
154874|NCT00422097|377992|P7|STARTED|Dose Level 1||0
154875|NCT00422097|377993|P6|STARTED|Dose Level 1||0
154876|NCT00422097|377994|P5|STARTED|Dose Level 1||0
154877|NCT00422097|377995|P4|STARTED|Dose Level 1||0
154878|NCT00422097|377996|P3|STARTED|Dose Level 1||0
154879|NCT00422097|377997|P2|STARTED|Dose Level 1||0
154880|NCT00422097|377998|P1|STARTED|Dose Level 1||3
154881|NCT00422162|378059|P2|NOT COMPLETED|Overall Study||30
154882|NCT00422162|378060|P1|NOT COMPLETED|Overall Study||24
154883|NCT00422162|378059|P2|COMPLETED|Overall Study||142
154884|NCT00422162|378060|P1|COMPLETED|Overall Study||143
154885|NCT00422162|378059|P2|Received Treatment|Overall Study||171
154886|NCT00422162|378060|P1|Received Treatment|Overall Study||167
154887|NCT00422162|378059|P2|STARTED|Overall Study||172
154888|NCT00422162|378060|P1|STARTED|Overall Study||167
154889|NCT00422201|378114|P1|NOT COMPLETED|Overall Study||11
154890|NCT00422201|378114|P1|COMPLETED|Overall Study||7
154891|NCT00422201|378114|P1|STARTED|Overall Study||18
154892|NCT00422227|378120|P2|NOT COMPLETED|Overall Study||15
154893|NCT00422227|378121|P1|NOT COMPLETED|Overall Study||4
154894|NCT00422227|378120|P2|COMPLETED|Overall Study||88
154895|NCT00422227|378121|P1|COMPLETED|Overall Study||193
154896|NCT00422227|378120|P2|STARTED|Overall Study||103
154897|NCT00422227|378121|P1|STARTED|Overall Study||197
154898|NCT00422279|378147|P2|NOT COMPLETED|Overall Study||0
154899|NCT00422279|378148|P1|NOT COMPLETED|Overall Study||0
154900|NCT00422279|378147|P2|COMPLETED|Overall Study||2
154901|NCT00422279|378148|P1|COMPLETED|Overall Study||2
154902|NCT00422279|378147|P2|24 Month After Loading Period|Overall Study||2
154903|NCT00422279|378148|P1|24 Month After Loading Period|Overall Study||2
154904|NCT00422279|378147|P2|STARTED|Overall Study||2
154905|NCT00422279|378148|P1|STARTED|Overall Study||2
154906|NCT00422292|378160|P4|NOT COMPLETED|Overall Study||24
154907|NCT00422292|378161|P3|NOT COMPLETED|Overall Study||22
154908|NCT00422292|378162|P2|NOT COMPLETED|Overall Study||66
154909|NCT00422292|378163|P1|NOT COMPLETED|Overall Study||18
154910|NCT00422292|378160|P4|COMPLETED|Overall Study||452
154911|NCT00422292|378161|P3|COMPLETED|Overall Study||224
154912|NCT00422292|378162|P2|COMPLETED|Overall Study||598
154913|NCT00422292|378163|P1|COMPLETED|Overall Study||239
154914|NCT00422292|378160|P4|STARTED|Overall Study||476
154915|NCT00422292|378161|P3|STARTED|Overall Study||246
154916|NCT00422292|378162|P2|STARTED|Overall Study||664
154917|NCT00422292|378163|P1|STARTED|Overall Study||257
154918|NCT00422383|378194|P5|NOT COMPLETED|Overall Study||3
154919|NCT00422383|378195|P4|NOT COMPLETED|Overall Study||2
154920|NCT00422383|378196|P3|NOT COMPLETED|Overall Study||4
154921|NCT00422383|378197|P2|NOT COMPLETED|Overall Study||14
154922|NCT00422383|378198|P1|NOT COMPLETED|Overall Study||15
154923|NCT00422383|378194|P5|COMPLETED|Overall Study||22
154924|NCT00422383|378195|P4|COMPLETED|Overall Study||4
154925|NCT00422383|378196|P3|COMPLETED|Overall Study||89
154926|NCT00422383|378197|P2|COMPLETED|Overall Study||106
154927|NCT00422383|378198|P1|COMPLETED|Overall Study||119
154928|NCT00422383|378194|P5|STARTED|Overall Study||25
154929|NCT00422383|378195|P4|STARTED|Overall Study||6
154930|NCT00422383|378196|P3|STARTED|Overall Study||93
154931|NCT00422383|378197|P2|STARTED|Overall Study||120
154932|NCT00422383|378198|P1|STARTED|Overall Study||134
154933|NCT00422422|378337|P1|NOT COMPLETED|Overall Study||10
154934|NCT00422422|378337|P1|COMPLETED|Overall Study||90
154935|NCT00422422|378337|P1|STARTED|Overall Study||100
154936|NCT00422448|378349|P1|NOT COMPLETED|Overall Study||0
154937|NCT00422448|378349|P1|COMPLETED|Overall Study||43
154938|NCT00422448|378349|P1|STARTED|Overall Study|22 prospectively enrolled during study period and 21 retrospectively enrolled|43
154939|NCT00422513|378356|P2|NOT COMPLETED|Overall Study||106
154940|NCT00422513|378357|P1|NOT COMPLETED|Overall Study||107
154941|NCT00422513|378356|P2|COMPLETED|Overall Study||24
154942|NCT00422513|378357|P1|COMPLETED|Overall Study||23
154943|NCT00422513|378356|P2|STARTED|Overall Study||130
154944|NCT00422513|378357|P1|STARTED|Overall Study||130
154945|NCT00422656|378369|P1|NOT COMPLETED|Overall Study||0
154946|NCT00422656|378369|P1|COMPLETED|Overall Study||37
154947|NCT00422656|378369|P1|STARTED|Overall Study||37
154948|NCT00422669|378376|P3|NOT COMPLETED|Overall Study||7
154949|NCT00422669|378377|P2|NOT COMPLETED|Overall Study||100
154950|NCT00422669|378378|P1|NOT COMPLETED|Overall Study||98
154951|NCT00422669|378376|P3|COMPLETED|Overall Study||0
154952|NCT00422669|378377|P2|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
154953|NCT00422669|378378|P1|COMPLETED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|0
154954|NCT00422669|378376|P3|STARTED|Overall Study||7
154955|NCT00422669|378377|P2|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|100
154956|NCT00422669|378378|P1|STARTED|Overall Study|Data required for analysis was not collected due to early termination. Analysis will not be done.|98
154957|NCT00422695|378401|P2|NOT COMPLETED|Overall Study||0
154958|NCT00422695|378402|P1|NOT COMPLETED|Overall Study||0
154959|NCT00422695|378401|P2|COMPLETED|Overall Study||38
154960|NCT00422695|378402|P1|COMPLETED|Overall Study||105
154961|NCT00422695|378401|P2|STARTED|Overall Study||38
154962|NCT00422695|378402|P1|STARTED|Overall Study||105
154963|NCT00422734|378412|P2|NOT COMPLETED|Overall Study||21
154964|NCT00422734|378413|P1|NOT COMPLETED|Overall Study||14
154965|NCT00422734|378412|P2|COMPLETED|Overall Study||243
154966|NCT00422734|378413|P1|COMPLETED|Overall Study||64
154967|NCT00422734|378412|P2|STARTED|Overall Study||264
154968|NCT00422734|378413|P1|STARTED|Overall Study||78
154969|NCT00422903|378447|P2|NOT COMPLETED|Overall Study||5
154970|NCT00422903|378448|P1|NOT COMPLETED|Overall Study||4
154971|NCT00422903|378447|P2|COMPLETED|Overall Study||38
154972|NCT00422903|378448|P1|COMPLETED|Overall Study||45
154973|NCT00422903|378447|P2|STARTED|Overall Study||43
154974|NCT00422903|378448|P1|STARTED|Overall Study||49
154975|NCT00422942|378472|P1|NOT COMPLETED|Overall Study||3
154976|NCT00422942|378472|P1|COMPLETED|Overall Study||0
154977|NCT00422942|378472|P1|STARTED|Overall Study||3
154978|NCT00423046|378491|P2|NOT COMPLETED|Overall Study||345
154979|NCT00423046|378492|P1|NOT COMPLETED|Overall Study||340
154980|NCT00423046|378491|P2|COMPLETED|Overall Study|Completed until Month 60|208
154981|NCT00423046|378492|P1|COMPLETED|Overall Study|Completed until Month 60|213
154982|NCT00423046|378491|P2|STARTED|Overall Study||553
154983|NCT00423046|378492|P1|STARTED|Overall Study||553
154984|NCT00423085|378561|P4|NOT COMPLETED|52-Week Open-Label Extension Phase||163
154985|NCT00423085|378562|P3|NOT COMPLETED|52-Week Open-Label Extension Phase||0
154986|NCT00423085|378563|P2|NOT COMPLETED|52-Week Open-Label Extension Phase||0
154987|NCT00423085|378564|P1|NOT COMPLETED|52-Week Open-Label Extension Phase||0
154988|NCT00423085|378561|P4|COMPLETED|52-Week Open-Label Extension Phase||474
154989|NCT00423085|378562|P3|COMPLETED|52-Week Open-Label Extension Phase||0
154990|NCT00423085|378563|P2|COMPLETED|52-Week Open-Label Extension Phase||0
154991|NCT00423085|378564|P1|COMPLETED|52-Week Open-Label Extension Phase||0
154992|NCT00423085|378561|P4|STARTED|52-Week Open-Label Extension Phase|Patients who completed the 24-wk treatment phase were eligible to enroll in the open-label extension|637
154993|NCT00423085|378562|P3|STARTED|52-Week Open-Label Extension Phase||0
154994|NCT00423085|378563|P2|STARTED|52-Week Open-Label Extension Phase||0
154995|NCT00423085|378564|P1|STARTED|52-Week Open-Label Extension Phase||0
154996|NCT00423085|378561|P4|NOT COMPLETED|24-Week Double-Blind Treatment Phase||0
154997|NCT00423085|378562|P3|NOT COMPLETED|24-Week Double-Blind Treatment Phase||59
154998|NCT00423085|378563|P2|NOT COMPLETED|24-Week Double-Blind Treatment Phase||64
154999|NCT00423085|378564|P1|NOT COMPLETED|24-Week Double-Blind Treatment Phase||46
155000|NCT00423085|378561|P4|COMPLETED|24-Week Double-Blind Treatment Phase||0
155001|NCT00423085|378562|P3|COMPLETED|24-Week Double-Blind Treatment Phase||228
155002|NCT00423085|378563|P2|COMPLETED|24-Week Double-Blind Treatment Phase||220
155003|NCT00423085|378564|P1|COMPLETED|24-Week Double-Blind Treatment Phase||242
155004|NCT00423085|378561|P4|STARTED|24-Week Double-Blind Treatment Phase||0
155005|NCT00423085|378562|P3|STARTED|24-Week Double-Blind Treatment Phase||287
155006|NCT00423085|378563|P2|STARTED|24-Week Double-Blind Treatment Phase||284
155007|NCT00423085|378564|P1|STARTED|24-Week Double-Blind Treatment Phase||288
155008|NCT00423098|378593|P2|NOT COMPLETED|Overall Study||4
155009|NCT00423098|378594|P1|NOT COMPLETED|Overall Study||3
155010|NCT00423098|378593|P2|COMPLETED|Overall Study||35
155011|NCT00423098|378594|P1|COMPLETED|Overall Study|Completed 24 weeks of study medication.|39
155012|NCT00423098|378593|P2|STARTED|Overall Study||39
155013|NCT00423098|378594|P1|STARTED|Overall Study|Total number of patients screened was 90, but the total number of randomized patients was 81.|42
155014|NCT00423150|378618|P1|NOT COMPLETED|Overall Study||86
155015|NCT00423150|378618|P1|COMPLETED|Overall Study||0
155016|NCT00423150|378618|P1|STARTED|Overall Study||86
155017|NCT00423176|378624|P2|NOT COMPLETED|Overall Study||29
155018|NCT00423176|378625|P1|NOT COMPLETED|Overall Study||16
155019|NCT00423176|378624|P2|COMPLETED|Overall Study||94
155020|NCT00423176|378625|P1|COMPLETED|Overall Study||98
155021|NCT00423176|378624|P2|STARTED|Overall Study||123
155022|NCT00423176|378625|P1|STARTED|Overall Study||114
155023|NCT00423189|378636|P3|NOT COMPLETED|Overall Study||0
155024|NCT00423189|378637|P2|NOT COMPLETED|Overall Study||1
155025|NCT00423189|378638|P1|NOT COMPLETED|Overall Study||0
155026|NCT00423189|378636|P3|COMPLETED|Overall Study||2
155027|NCT00423189|378637|P2|COMPLETED|Overall Study||2
155028|NCT00423189|378638|P1|COMPLETED|Overall Study||2
155029|NCT00423189|378636|P3|STARTED|Overall Study||2
155030|NCT00423189|378637|P2|STARTED|Overall Study||3
155031|NCT00423189|378638|P1|STARTED|Overall Study||2
155032|NCT00423267|378660|P2|NOT COMPLETED|Period B||0
155033|NCT00423267|378661|P1|NOT COMPLETED|Period B||0
155034|NCT00423267|378660|P2|COMPLETED|Period B||0
155035|NCT00423267|378661|P1|COMPLETED|Period B||12
155036|NCT00423267|378660|P2|STARTED|Period B||0
155037|NCT00423267|378661|P1|STARTED|Period B||12
155038|NCT00423267|378660|P2|NOT COMPLETED|Period A||1
155039|NCT00423267|378661|P1|NOT COMPLETED|Period A||2
155040|NCT00423267|378660|P2|COMPLETED|Period A||6
155041|NCT00423267|378661|P1|COMPLETED|Period A||7
155042|NCT00423267|378660|P2|STARTED|Period A||7
155043|NCT00423267|378661|P1|STARTED|Period A||9
155044|NCT00423293|378678|P1|NOT COMPLETED|Overall Study||11
155045|NCT00423293|378678|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|52
155046|NCT00423293|378678|P1|STARTED|Overall Study||63
155047|NCT00423319|378684|P2|NOT COMPLETED|Overall Study||252
155048|NCT00423319|378685|P1|NOT COMPLETED|Overall Study||224
155049|NCT00423319|378684|P2|COMPLETED|Overall Study||2447
155050|NCT00423319|378685|P1|COMPLETED|Overall Study||2484
155051|NCT00423319|378684|P2|Participants Who Received Treatment|Overall Study||2659
155052|NCT00423319|378685|P1|Participants Who Received Treatment|Overall Study||2673
155053|NCT00423319|378684|P2|STARTED|Overall Study|Randomized|2699
155054|NCT00423319|378685|P1|STARTED|Overall Study|Randomized|2708
155055|NCT00423332|378719|P2|NOT COMPLETED|Overall Study||7
155056|NCT00423332|378720|P1|NOT COMPLETED|Overall Study||9
155057|NCT00423332|378719|P2|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|11
155145|NCT00423670|378847|P4|NOT COMPLETED|Treatment Period||40
155058|NCT00423332|378720|P1|COMPLETED|Overall Study|Number completing 12 weeks blinded randomised treatment|44
155059|NCT00423332|378719|P2|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|4
155060|NCT00423332|378720|P1|Ongoing at Data Cut Off (8th March 2009)|Overall Study|Number ongoing at data cut off (8th March 2009)|22
155061|NCT00423332|378719|P2|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|14
155062|NCT00423332|378720|P1|Continuing After Unblinding|Overall Study|Number starting/ continuing AZD2171 after unblinding|44
155063|NCT00423332|378719|P2|STARTED|Overall Study|Number randomised|18
155064|NCT00423332|378720|P1|STARTED|Overall Study|Randomised|53
155065|NCT00423358|378739|P2|NOT COMPLETED|Overall Study||0
155066|NCT00423358|378740|P1|NOT COMPLETED|Overall Study||0
155067|NCT00423358|378739|P2|COMPLETED|Overall Study||11
155068|NCT00423358|378740|P1|COMPLETED|Overall Study||11
155069|NCT00423358|378739|P2|STARTED|Overall Study||11
155070|NCT00423358|378740|P1|STARTED|Overall Study||11
155071|NCT00423436|378752|P2|NOT COMPLETED|Overall Study||0
155072|NCT00423436|378753|P1|NOT COMPLETED|Overall Study||0
155073|NCT00423436|378752|P2|COMPLETED|Overall Study||33
155074|NCT00423436|378753|P1|COMPLETED|Overall Study||35
155075|NCT00423436|378752|P2|STARTED|Overall Study||33
155076|NCT00423436|378753|P1|STARTED|Overall Study||35
155077|NCT00423449|378759|P5|NOT COMPLETED|Overall Study||7
155078|NCT00423449|378760|P4|NOT COMPLETED|Overall Study||22
155079|NCT00423449|378761|P3|NOT COMPLETED|Overall Study||15
155080|NCT00423449|378762|P2|NOT COMPLETED|Overall Study||4
155081|NCT00423449|378763|P1|NOT COMPLETED|Overall Study||3
155082|NCT00423449|378759|P5|COMPLETED|Overall Study||0
155083|NCT00423449|378760|P4|COMPLETED|Overall Study||5
155084|NCT00423449|378761|P3|COMPLETED|Overall Study||2
155085|NCT00423449|378762|P2|COMPLETED|Overall Study||2
155086|NCT00423449|378763|P1|COMPLETED|Overall Study||1
155087|NCT00423449|378759|P5|STARTED|Overall Study||7
155088|NCT00423449|378760|P4|STARTED|Overall Study||27
155089|NCT00423449|378761|P3|STARTED|Overall Study||17
155090|NCT00423449|378762|P2|STARTED|Overall Study||6
155091|NCT00423449|378763|P1|STARTED|Overall Study||4
155092|NCT00423488|378788|P2|NOT COMPLETED|Overall Study||1
155093|NCT00423488|378789|P1|NOT COMPLETED|Overall Study||5
155094|NCT00423488|378788|P2|COMPLETED|Overall Study||50
155095|NCT00423488|378789|P1|COMPLETED|Overall Study||37
155096|NCT00423488|378788|P2|STARTED|Overall Study||51
155097|NCT00423488|378789|P1|STARTED|Overall Study||42
155098|NCT00423579|378797|P2|NOT COMPLETED|Overall Study||4
155099|NCT00423579|378798|P1|NOT COMPLETED|Overall Study||4
155100|NCT00423579|378797|P2|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
155101|NCT00423579|378798|P1|COMPLETED|Overall Study|These 56 subjects were the Intent-to-Treat population. Analysis based on ITT population.|56
155102|NCT00423579|378797|P2|STARTED|Overall Study||60
155103|NCT00423579|378798|P1|STARTED|Overall Study|61 enrolled, however one subject was ineligible and was removed.|60
155104|NCT00423592|378804|P1|NOT COMPLETED|Overall Study||7
155105|NCT00423592|378804|P1|COMPLETED|Overall Study|Completed study|29
155106|NCT00423592|378804|P1|Completed Preliminary Analysis Cut-off|Overall Study|Preliminary analysis cut-off at Week 12 for primary/secondary endpoint analysis|34
155107|NCT00423592|378804|P1|STARTED|Overall Study|Enrolled|36
155108|NCT00423605|378823|P1|NOT COMPLETED|Overall Study||241
155109|NCT00423605|378823|P1|COMPLETED|Overall Study||319
155110|NCT00423605|378823|P1|STARTED|Overall Study||560
155111|NCT00423657|378829|P2|NOT COMPLETED|Overall Study||25
155112|NCT00423657|378830|P1|NOT COMPLETED|Overall Study||26
155113|NCT00423657|378829|P2|COMPLETED|Overall Study||313
155114|NCT00423657|378830|P1|COMPLETED|Overall Study||316
155115|NCT00423657|378829|P2|STARTED|Overall Study||338
155116|NCT00423657|378830|P1|STARTED|Overall Study||342
155117|NCT00423670|378843|P8|NOT COMPLETED|Follow-up Period||3
155118|NCT00423670|378844|P7|NOT COMPLETED|Follow-up Period||9
155119|NCT00423670|378845|P6|NOT COMPLETED|Follow-up Period||0
155120|NCT00423670|378846|P5|NOT COMPLETED|Follow-up Period||2
155121|NCT00423670|378847|P4|NOT COMPLETED|Follow-up Period||5
155122|NCT00423670|378848|P3|NOT COMPLETED|Follow-up Period||11
155123|NCT00423670|378849|P2|NOT COMPLETED|Follow-up Period||16
155124|NCT00423670|378850|P1|NOT COMPLETED|Follow-up Period||3
155125|NCT00423670|378843|P8|COMPLETED|Follow-up Period||32
155126|NCT00423670|378844|P7|COMPLETED|Follow-up Period||41
155127|NCT00423670|378845|P6|COMPLETED|Follow-up Period||14
155128|NCT00423670|378846|P5|COMPLETED|Follow-up Period||89
155129|NCT00423670|378847|P4|COMPLETED|Follow-up Period||91
155130|NCT00423670|378848|P3|COMPLETED|Follow-up Period||85
155131|NCT00423670|378849|P2|COMPLETED|Follow-up Period||84
155132|NCT00423670|378850|P1|COMPLETED|Follow-up Period||94
155133|NCT00423670|378843|P8|STARTED|Follow-up Period||35
155134|NCT00423670|378844|P7|STARTED|Follow-up Period||50
155135|NCT00423670|378845|P6|STARTED|Follow-up Period||14
155136|NCT00423670|378846|P5|STARTED|Follow-up Period||91
155137|NCT00423670|378847|P4|STARTED|Follow-up Period||96
155138|NCT00423670|378848|P3|STARTED|Follow-up Period||96
155139|NCT00423670|378849|P2|STARTED|Follow-up Period||100
155140|NCT00423670|378850|P1|STARTED|Follow-up Period||97
155141|NCT00423670|378843|P8|NOT COMPLETED|Treatment Period||21
155142|NCT00423670|378844|P7|NOT COMPLETED|Treatment Period||31
155143|NCT00423670|378845|P6|NOT COMPLETED|Treatment Period||8
155144|NCT00423670|378846|P5|NOT COMPLETED|Treatment Period||27
155146|NCT00423670|378848|P3|NOT COMPLETED|Treatment Period||27
155147|NCT00423670|378849|P2|NOT COMPLETED|Treatment Period||30
155148|NCT00423670|378850|P1|NOT COMPLETED|Treatment Period||52
155149|NCT00423670|378843|P8|COMPLETED|Treatment Period||15
155150|NCT00423670|378844|P7|COMPLETED|Treatment Period||28
155151|NCT00423670|378845|P6|COMPLETED|Treatment Period||8
155152|NCT00423670|378846|P5|COMPLETED|Treatment Period||76
155153|NCT00423670|378847|P4|COMPLETED|Treatment Period||63
155154|NCT00423670|378848|P3|COMPLETED|Treatment Period||76
155155|NCT00423670|378849|P2|COMPLETED|Treatment Period||77
155156|NCT00423670|378850|P1|COMPLETED|Treatment Period||52
155157|NCT00423670|378843|P8|STARTED|Treatment Period|Arm 8 were Arm 1 participants that were positive for HCV-RNA at TW 24 and had the option to switch.|36
155158|NCT00423670|378844|P7|STARTED|Treatment Period||59
155159|NCT00423670|378845|P6|STARTED|Treatment Period||16
155160|NCT00423670|378846|P5|STARTED|Treatment Period||103
155161|NCT00423670|378847|P4|STARTED|Treatment Period||103
155162|NCT00423670|378848|P3|STARTED|Treatment Period||103
155163|NCT00423670|378849|P2|STARTED|Treatment Period||107
155164|NCT00423670|378850|P1|STARTED|Treatment Period||104
155165|NCT00423683|378908|P2|NOT COMPLETED|Overall Study||0
155166|NCT00423683|378909|P1|NOT COMPLETED|Overall Study||1
155167|NCT00423683|378908|P2|COMPLETED|Overall Study||33
155168|NCT00423683|378909|P1|COMPLETED|Overall Study||30
155169|NCT00423683|378908|P2|STARTED|Overall Study||33
155170|NCT00423683|378909|P1|STARTED|Overall Study||31
155171|NCT00423722|378923|P2|NOT COMPLETED|Overall Study||13
155172|NCT00423722|378924|P1|NOT COMPLETED|Overall Study||14
155173|NCT00423722|378923|P2|COMPLETED|Overall Study||53
155174|NCT00423722|378924|P1|COMPLETED|Overall Study||49
155175|NCT00423722|378923|P2|STARTED|Overall Study||66
155176|NCT00423722|378924|P1|STARTED|Overall Study||63
155177|NCT00423735|378947|P3|NOT COMPLETED|Overall Study||0
155178|NCT00423735|378948|P2|NOT COMPLETED|Overall Study||6
155179|NCT00423735|378949|P1|NOT COMPLETED|Overall Study||8
155180|NCT00423735|378947|P3|COMPLETED|Overall Study||0
155181|NCT00423735|378948|P2|COMPLETED|Overall Study||29
155182|NCT00423735|378949|P1|COMPLETED|Overall Study||21
155183|NCT00423735|378947|P3|STARTED|Overall Study||0
155184|NCT00423735|378948|P2|STARTED|Overall Study||35
155185|NCT00423735|378949|P1|STARTED|Overall Study||29
155186|NCT00423800|378972|P2|NOT COMPLETED|Overall Study||1
155187|NCT00423800|378973|P1|NOT COMPLETED|Overall Study||0
155188|NCT00423800|378972|P2|COMPLETED|Overall Study||1
155189|NCT00423800|378973|P1|COMPLETED|Overall Study||3
155190|NCT00423800|378972|P2|STARTED|Overall Study||2
155191|NCT00423800|378973|P1|STARTED|Overall Study||3
155192|NCT00423813|378985|P3|NOT COMPLETED|Overall Study||74
155193|NCT00423813|378986|P2|NOT COMPLETED|Overall Study||66
155194|NCT00423813|378987|P1|NOT COMPLETED|Overall Study||57
155195|NCT00423813|378985|P3|COMPLETED|Overall Study||116
155196|NCT00423813|378986|P2|COMPLETED|Overall Study||129
155197|NCT00423813|378987|P1|COMPLETED|Overall Study||131
155198|NCT00423813|378985|P3|Treated|Overall Study||189
155199|NCT00423813|378986|P2|Treated|Overall Study||194
155200|NCT00423813|378987|P1|Treated|Overall Study||188
155201|NCT00423813|378985|P3|STARTED|Overall Study||190
155202|NCT00423813|378986|P2|STARTED|Overall Study||195
155203|NCT00423813|378987|P1|STARTED|Overall Study||188
155204|NCT00423852|378995|P1|NOT COMPLETED|Overall Study||3
155205|NCT00423852|378995|P1|COMPLETED|Overall Study||23
155206|NCT00423852|378995|P1|STARTED|Overall Study||26
155207|NCT00423878|379002|P2|NOT COMPLETED|Overall Study||8
155208|NCT00423878|379003|P1|NOT COMPLETED|Overall Study||20
155209|NCT00423878|379002|P2|COMPLETED|Overall Study||98
155210|NCT00423878|379003|P1|COMPLETED|Overall Study||89
155211|NCT00423878|379002|P2|STARTED|Overall Study||106
155212|NCT00423878|379003|P1|STARTED|Overall Study||109
155213|NCT00423891|379014|P3|NOT COMPLETED|Post-Dosing Follow Up||1
155214|NCT00423891|379015|P2|NOT COMPLETED|Post-Dosing Follow Up||17
155215|NCT00423891|379016|P1|NOT COMPLETED|Post-Dosing Follow Up||2
155216|NCT00423891|379014|P3|COMPLETED|Post-Dosing Follow Up||0
155217|NCT00423891|379015|P2|COMPLETED|Post-Dosing Follow Up||1
155218|NCT00423891|379016|P1|COMPLETED|Post-Dosing Follow Up||20
155219|NCT00423891|379014|P3|STARTED|Post-Dosing Follow Up||1
155220|NCT00423891|379015|P2|STARTED|Post-Dosing Follow Up|1 participant completed treatment but did not enter post dosing follow up period: Withdrew Consent.|18
155221|NCT00423891|379016|P1|STARTED|Post-Dosing Follow Up||22
155222|NCT00423891|379014|P3|NOT COMPLETED|Treatment||4
155223|NCT00423891|379015|P2|NOT COMPLETED|Treatment||0
155224|NCT00423891|379016|P1|NOT COMPLETED|Treatment||2
155225|NCT00423891|379014|P3|COMPLETED|Treatment||1
155226|NCT00423891|379015|P2|COMPLETED|Treatment||19
155227|NCT00423891|379016|P1|COMPLETED|Treatment||22
155228|NCT00423891|379014|P3|STARTED|Treatment||5
155229|NCT00423891|379015|P2|STARTED|Treatment||19
155230|NCT00423891|379016|P1|STARTED|Treatment||24
155231|NCT00423891|379014|P3|NOT COMPLETED|Enrolled||3
155232|NCT00423891|379015|P2|NOT COMPLETED|Enrolled||2
155233|NCT00423891|379016|P1|NOT COMPLETED|Enrolled||11
155234|NCT00423891|379014|P3|COMPLETED|Enrolled||5
155235|NCT00423891|379015|P2|COMPLETED|Enrolled||19
155236|NCT00423891|379016|P1|COMPLETED|Enrolled||24
155237|NCT00423891|379014|P3|STARTED|Enrolled||8
155238|NCT00423891|379015|P2|STARTED|Enrolled||21
155239|NCT00423891|379016|P1|STARTED|Enrolled||35
155240|NCT00423917|379083|P1|NOT COMPLETED|Overall Study||3
155241|NCT00423917|379083|P1|COMPLETED|Overall Study||33
155242|NCT00423917|379083|P1|STARTED|Overall Study||36
155243|NCT00423930|379093|P1|NOT COMPLETED|Overall Study||2
155244|NCT00423930|379093|P1|COMPLETED|Overall Study||42
155245|NCT00423930|379093|P1|STARTED|Overall Study||44
155246|NCT00424008|379100|P2|NOT COMPLETED|Overall Study||335
155247|NCT00424008|379101|P1|NOT COMPLETED|Overall Study||349
155248|NCT00424008|379100|P2|COMPLETED|Overall Study||16
155249|NCT00424008|379101|P1|COMPLETED|Overall Study||22
155250|NCT00424008|379100|P2|STARTED|Overall Study||351
155251|NCT00424008|379101|P1|STARTED|Overall Study||371
155252|NCT00424021|379118|P4|NOT COMPLETED|AMB-220-E Study Period||10
155253|NCT00424021|379119|P3|NOT COMPLETED|AMB-220-E Study Period||5
155254|NCT00424021|379120|P2|NOT COMPLETED|AMB-220-E Study Period||2
155255|NCT00424021|379121|P1|NOT COMPLETED|AMB-220-E Study Period||1
155256|NCT00424021|379118|P4|COMPLETED|AMB-220-E Study Period||16
155257|NCT00424021|379119|P3|COMPLETED|AMB-220-E Study Period||14
155258|NCT00424021|379120|P2|COMPLETED|AMB-220-E Study Period||5
155259|NCT00424021|379121|P1|COMPLETED|AMB-220-E Study Period||1
155260|NCT00424021|379118|P4|STARTED|AMB-220-E Study Period||26
155261|NCT00424021|379119|P3|STARTED|AMB-220-E Study Period||19
155262|NCT00424021|379120|P2|STARTED|AMB-220-E Study Period||7
155263|NCT00424021|379121|P1|STARTED|AMB-220-E Study Period||2
155264|NCT00424021|379118|P4|NOT COMPLETED|NCT00046319 Study Period||1
155265|NCT00424021|379119|P3|NOT COMPLETED|NCT00046319 Study Period||1
155266|NCT00424021|379120|P2|NOT COMPLETED|NCT00046319 Study Period||3
155267|NCT00424021|379121|P1|NOT COMPLETED|NCT00046319 Study Period||1
155268|NCT00424021|379118|P4|COMPLETED|NCT00046319 Study Period||12
155269|NCT00424021|379119|P3|COMPLETED|NCT00046319 Study Period||15
155270|NCT00424021|379120|P2|COMPLETED|NCT00046319 Study Period||16
155271|NCT00424021|379121|P1|COMPLETED|NCT00046319 Study Period||15
155272|NCT00424021|379118|P4|STARTED|NCT00046319 Study Period||13
155273|NCT00424021|379119|P3|STARTED|NCT00046319 Study Period||16
155274|NCT00424021|379120|P2|STARTED|NCT00046319 Study Period||19
155275|NCT00424021|379121|P1|STARTED|NCT00046319 Study Period||16
155276|NCT00424047|379164|P2|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||8
155277|NCT00424047|379165|P1|NOT COMPLETED|Long Term Extension (Up to 25 Jun 2013)||21
155278|NCT00424047|379164|P2|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
155279|NCT00424047|379165|P1|COMPLETED|Long Term Extension (Up to 25 Jun 2013)||0
155280|NCT00424047|379164|P2|STARTED|Long Term Extension (Up to 25 Jun 2013)|2 participants opted to receive dex alone, 3 crossed over to Len/Dex and 3 added Len at a later date|8
155281|NCT00424047|379165|P1|STARTED|Long Term Extension (Up to 25 Jun 2013)||21
155282|NCT00424047|379164|P2|NOT COMPLETED|On Study at Time of Unblinding||167
155283|NCT00424047|379165|P1|NOT COMPLETED|On Study at Time of Unblinding||155
155284|NCT00424047|379164|P2|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term dexamethasone|8
155285|NCT00424047|379165|P1|COMPLETED|On Study at Time of Unblinding|Participants completed = those continuing on long term Lenalidomide and dexamethasone|21
155286|NCT00424047|379164|P2|STARTED|On Study at Time of Unblinding||175
155287|NCT00424047|379165|P1|STARTED|On Study at Time of Unblinding|Refers to original treatment group assignment in the study.|176
155288|NCT00424047|379164|P2|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||156
155289|NCT00424047|379165|P1|NOT COMPLETED|Blinded Treatment (Up to 03 Aug 2005)||122
155290|NCT00424047|379164|P2|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|Ongoing and includes 15 participants who crossed over to lenalidomide/dexamethasone after unblinding|19
155291|NCT00424047|379165|P1|COMPLETED|Blinded Treatment (Up to 03 Aug 2005)|54 participants ongoing and continuing on lenalidomide/dexamethasone treatment|54
155292|NCT00424047|379164|P2|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|4 participants excluded because they had no baseline M-protein assessment|171
155293|NCT00424047|379165|P1|Evaluable Population|Blinded Treatment (Up to 03 Aug 2005)|1 participant excluded because they had no baseline M-protein assessment|175
155294|NCT00424047|379164|P2|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|175
155295|NCT00424047|379165|P1|Safety Population|Blinded Treatment (Up to 03 Aug 2005)|Includes those who took at least one dose of study medication regimen|176
155296|NCT00424047|379164|P2|STARTED|Blinded Treatment (Up to 03 Aug 2005)||175
155297|NCT00424047|379165|P1|STARTED|Blinded Treatment (Up to 03 Aug 2005)||176
155298|NCT00424177|379193|P1|NOT COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||3
155299|NCT00424177|379193|P1|COMPLETED|Cycle 3: Eltrombopag 50 or 75 mg||48
155300|NCT00424177|379193|P1|STARTED|Cycle 3: Eltrombopag 50 or 75 mg||51
155301|NCT00424177|379193|P1|NOT COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||4
155302|NCT00424177|379193|P1|COMPLETED|Cycle 2: Eltrombopag 50 or 75 mg||51
155303|NCT00424177|379193|P1|STARTED|Cycle 2: Eltrombopag 50 or 75 mg||55
155304|NCT00424177|379193|P1|NOT COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||11
155305|NCT00424177|379193|P1|COMPLETED|Cycle 1: Eltrombopag 50 mg Starting Dose||55
155306|NCT00424177|379193|P1|STARTED|Cycle 1: Eltrombopag 50 mg Starting Dose||66
155307|NCT00424190|379222|P2|NOT COMPLETED|Overall Study||30
155308|NCT00424190|379223|P1|NOT COMPLETED|Overall Study||22
155309|NCT00424190|379222|P2|COMPLETED|Overall Study||317
155310|NCT00424190|379223|P1|COMPLETED|Overall Study||329
155311|NCT00424190|379222|P2|STARTED|Overall Study||347
155312|NCT00424190|379223|P1|STARTED|Overall Study||351
155313|NCT00429923|379232|P3|NOT COMPLETED|Overall Study||39
155314|NCT00429923|379233|P2|NOT COMPLETED|Overall Study||4
155315|NCT00429923|379234|P1|NOT COMPLETED|Overall Study||5
155316|NCT00429923|379232|P3|COMPLETED|Overall Study||68
155317|NCT00429923|379233|P2|COMPLETED|Overall Study||51
155318|NCT00429923|379234|P1|COMPLETED|Overall Study||52
155319|NCT00429923|379232|P3|STARTED|Overall Study||107
155320|NCT00429923|379233|P2|STARTED|Overall Study||55
155321|NCT00429923|379234|P1|STARTED|Overall Study||57
155322|NCT00429949|379239|P1|NOT COMPLETED|Overall Study||0
155323|NCT00429949|379239|P1|COMPLETED|Overall Study||21
155324|NCT00429949|379239|P1|STARTED|Overall Study||21
155325|NCT00430027|379249|P1|NOT COMPLETED|Overall Study||8
155326|NCT00430027|379249|P1|COMPLETED|Overall Study||0
155327|NCT00430027|379249|P1|STARTED|Overall Study||8
155328|NCT00430092|379256|P3|NOT COMPLETED|Overall Study||57
155329|NCT00430092|379257|P2|NOT COMPLETED|Overall Study||4
155330|NCT00430092|379258|P1|NOT COMPLETED|Overall Study||6
155331|NCT00430092|379256|P3|COMPLETED|Overall Study||56
155332|NCT00430092|379257|P2|COMPLETED|Overall Study||48
155333|NCT00430092|379258|P1|COMPLETED|Overall Study||48
155334|NCT00430092|379256|P3|STARTED|Overall Study||113
155335|NCT00430092|379257|P2|STARTED|Overall Study||52
155336|NCT00430092|379258|P1|STARTED|Overall Study||54
155337|NCT00431496|379263|P1|NOT COMPLETED|Overall Study||11
155338|NCT00431496|379263|P1|COMPLETED|Overall Study||60
155339|NCT00431496|379263|P1|STARTED|Overall Study||71
155340|NCT00431626|379274|P2|NOT COMPLETED|Overall Study||0
155341|NCT00431626|379275|P1|NOT COMPLETED|Overall Study||0
155342|NCT00431626|379274|P2|COMPLETED|Overall Study||0
155343|NCT00431626|379275|P1|COMPLETED|Overall Study||4
155344|NCT00431626|379274|P2|STARTED|Overall Study||0
155345|NCT00431626|379275|P1|STARTED|Overall Study||4
155346|NCT00431834|379281|P1|NOT COMPLETED|Overall Study||13
155347|NCT00431834|379281|P1|COMPLETED|Overall Study||62
155348|NCT00431834|379281|P1|STARTED|Overall Study||75
155349|NCT00431847|379292|P5|NOT COMPLETED|Overall Study||1
155350|NCT00431847|379293|P4|NOT COMPLETED|Overall Study||14
155351|NCT00431847|379294|P3|NOT COMPLETED|Overall Study||4
155352|NCT00431847|379295|P2|NOT COMPLETED|Overall Study||3
155353|NCT00431847|379296|P1|NOT COMPLETED|Overall Study||6
155354|NCT00431847|379292|P5|COMPLETED|Overall Study||0
155355|NCT00431847|379293|P4|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|170
155356|NCT00431847|379294|P3|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|20
155357|NCT00431847|379295|P2|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|42
155358|NCT00431847|379296|P1|COMPLETED|Overall Study|All participants with at least two study visits were included in analysis.|126
155359|NCT00431847|379292|P5|STARTED|Overall Study||1
155360|NCT00431847|379293|P4|STARTED|Overall Study||184
155361|NCT00431847|379294|P3|STARTED|Overall Study||24
155362|NCT00431847|379295|P2|STARTED|Overall Study||45
155363|NCT00431847|379296|P1|STARTED|Overall Study||132
155364|NCT00431951|379374|P4|NOT COMPLETED|Overall Study||2
155365|NCT00431951|379375|P3|NOT COMPLETED|Overall Study||2
155366|NCT00431951|379376|P2|NOT COMPLETED|Overall Study||2
155367|NCT00431951|379377|P1|NOT COMPLETED|Overall Study||1
155368|NCT00431951|379374|P4|COMPLETED|Overall Study||4
155369|NCT00431951|379375|P3|COMPLETED|Overall Study||6
155370|NCT00431951|379376|P2|COMPLETED|Overall Study||6
155371|NCT00431951|379377|P1|COMPLETED|Overall Study||7
155372|NCT00431951|379374|P4|STARTED|Overall Study||6
155373|NCT00431951|379375|P3|STARTED|Overall Study||8
155374|NCT00431951|379376|P2|STARTED|Overall Study||8
155375|NCT00431951|379377|P1|STARTED|Overall Study||8
155376|NCT00431964|379437|P2|NOT COMPLETED|Overall Study||8
155377|NCT00431964|379438|P1|NOT COMPLETED|Overall Study||6
155378|NCT00431964|379437|P2|COMPLETED|Overall Study||124
155379|NCT00431964|379438|P1|COMPLETED|Overall Study||125
155380|NCT00431964|379437|P2|Withdrew From Study|Overall Study||5
155381|NCT00431964|379438|P1|Withdrew From Study|Overall Study||6
155382|NCT00431964|379437|P2|Did Not Receive Drug|Overall Study||3
155383|NCT00431964|379438|P1|Did Not Receive Drug|Overall Study||0
155384|NCT00431964|379437|P2|Randomized/Received Drug|Overall Study||129
155385|NCT00431964|379438|P1|Randomized/Received Drug|Overall Study||131
155386|NCT00431964|379437|P2|STARTED|Overall Study||132
155387|NCT00431964|379438|P1|STARTED|Overall Study||131
155388|NCT00432159|379449|P5|NOT COMPLETED|Overall Study||10
155389|NCT00432159|379450|P4|NOT COMPLETED|Overall Study||5
155390|NCT00432159|379451|P3|NOT COMPLETED|Overall Study||4
155391|NCT00432159|379452|P2|NOT COMPLETED|Overall Study||30
155392|NCT00432159|379453|P1|NOT COMPLETED|Overall Study||22
155393|NCT00432159|379449|P5|COMPLETED|Overall Study|Actual (Complete efficacy)|79
155394|NCT00432159|379450|P4|COMPLETED|Overall Study|Actual (Complete efficacy)|15
155395|NCT00432159|379451|P3|COMPLETED|Overall Study|Actual (Complete efficacy)|35
155396|NCT00432159|379452|P2|COMPLETED|Overall Study|Actual (Complete efficacy)|137
155397|NCT00432159|379453|P1|COMPLETED|Overall Study|Actual (Complete efficacy)|163
155398|NCT00432159|379449|P5|STARTED|Overall Study||89
155399|NCT00432159|379450|P4|STARTED|Overall Study||20
155400|NCT00432159|379451|P3|STARTED|Overall Study||39
155401|NCT00432159|379452|P2|STARTED|Overall Study||167
155402|NCT00432159|379453|P1|STARTED|Overall Study||185
155403|NCT00432237|379561|P4|NOT COMPLETED|Overall Study||124
155404|NCT00432237|379562|P3|NOT COMPLETED|Overall Study||109
155405|NCT00432237|379563|P2|NOT COMPLETED|Overall Study||101
155406|NCT00432237|379564|P1|NOT COMPLETED|Overall Study||67
155407|NCT00432237|379561|P4|COMPLETED|Overall Study||366
155408|NCT00432237|379562|P3|COMPLETED|Overall Study||375
155409|NCT00432237|379563|P2|COMPLETED|Overall Study||384
155410|NCT00432237|379564|P1|COMPLETED|Overall Study||177
155411|NCT00432237|379561|P4|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
155412|NCT00432237|379562|P3|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|5
155413|NCT00432237|379563|P2|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|3
155414|NCT00432237|379564|P1|Completed--No Data|Overall Study|For patients in this category, diaries were collected but lost prior to data entry.|1
155415|NCT00432237|379561|P4|Completed--With Data|Overall Study||365
155416|NCT00432237|379562|P3|Completed--With Data|Overall Study||370
155417|NCT00432237|379563|P2|Completed--With Data|Overall Study||381
155418|NCT00432237|379564|P1|Completed--With Data|Overall Study||176
155419|NCT00432237|379561|P4|STARTED|Overall Study||490
155420|NCT00432237|379562|P3|STARTED|Overall Study|1 patient in the MK0974 300 mg group was treated but withdrew consent.|484
155421|NCT00432237|379563|P2|STARTED|Overall Study||485
155422|NCT00432237|379564|P1|STARTED|Overall Study|1 patient in the MK0974 50 mg group was treated but withdrew consent.|244
155423|NCT00432276|379604|P2|NOT COMPLETED|Overall Study||156
155424|NCT00432276|379605|P1|NOT COMPLETED|Overall Study||121
155425|NCT00432276|379604|P2|COMPLETED|Overall Study||243
155426|NCT00432276|379605|P1|COMPLETED|Overall Study||283
155427|NCT00432276|379604|P2|Per Protocol Set|Overall Study||306
155428|NCT00432276|379605|P1|Per Protocol Set|Overall Study|Patients who received at least 1 dose of study medication and who had no major protocol violations.|303
155429|NCT00432276|379604|P2|STARTED|Overall Study||399
155430|NCT00432276|379605|P1|STARTED|Overall Study||404
155431|NCT00432341|379693|P2|NOT COMPLETED|Overall Study||0
155432|NCT00432341|379694|P1|NOT COMPLETED|Overall Study||0
155433|NCT00432341|379693|P2|COMPLETED|Overall Study||30
155434|NCT00432341|379694|P1|COMPLETED|Overall Study||24
155435|NCT00432341|379693|P2|STARTED|Overall Study||30
155436|NCT00432341|379694|P1|STARTED|Overall Study||24
155437|NCT00432445|379718|P1|NOT COMPLETED|Overall Study||0
155438|NCT00432445|379718|P1|COMPLETED|Overall Study||2
155439|NCT00432445|379718|P1|STARTED|Overall Study||2
155440|NCT00432458|379724|P2|NOT COMPLETED|Overall Study||1
155441|NCT00432458|379725|P1|NOT COMPLETED|Overall Study||5
155442|NCT00432458|379724|P2|COMPLETED|Overall Study||32
155443|NCT00432458|379725|P1|COMPLETED|Overall Study||30
155444|NCT00432458|379724|P2|STARTED|Overall Study||33
155445|NCT00432458|379725|P1|STARTED|Overall Study||35
155446|NCT00432562|379745|P2|NOT COMPLETED|Overall Study||0
155447|NCT00432562|379746|P1|NOT COMPLETED|Overall Study||3
155448|NCT00432562|379745|P2|COMPLETED|Overall Study||15
155449|NCT00432562|379746|P1|COMPLETED|Overall Study||13
155450|NCT00432562|379745|P2|STARTED|Overall Study||15
155451|NCT00432562|379746|P1|STARTED|Overall Study||16
155452|NCT00432601|379772|P2|NOT COMPLETED|Time 2 to Time 3||22
155453|NCT00432601|379773|P1|NOT COMPLETED|Time 2 to Time 3||19
155454|NCT00432601|379772|P2|COMPLETED|Time 2 to Time 3||122
155455|NCT00432601|379773|P1|COMPLETED|Time 2 to Time 3||122
155456|NCT00432601|379772|P2|STARTED|Time 2 to Time 3||144
155457|NCT00432601|379773|P1|STARTED|Time 2 to Time 3||141
155458|NCT00432601|379772|P2|NOT COMPLETED|Time 1 to Time 2||368
155459|NCT00432601|379773|P1|NOT COMPLETED|Time 1 to Time 2||369
155460|NCT00432601|379772|P2|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|144
155461|NCT00432601|379773|P1|COMPLETED|Time 1 to Time 2|There is large drop-off as only one-third of subjects enrolled were eligible to continue the study|141
155462|NCT00432601|379772|P2|STARTED|Time 1 to Time 2||512
155463|NCT00432601|379773|P1|STARTED|Time 1 to Time 2||510
155464|NCT00432666|379781|P2|NOT COMPLETED|Open-Label Extension Period||0
155465|NCT00432666|379782|P1|NOT COMPLETED|Open-Label Extension Period||25
155466|NCT00432666|379781|P2|COMPLETED|Open-Label Extension Period||0
155467|NCT00432666|379782|P1|COMPLETED|Open-Label Extension Period||120
155468|NCT00432666|379781|P2|STARTED|Open-Label Extension Period|In the Open-Label Extension Period no placebo treatment arm was given.|0
155469|NCT00432666|379782|P1|STARTED|Open-Label Extension Period||145
155470|NCT00432666|379781|P2|NOT COMPLETED|Main Period||1
155471|NCT00432666|379782|P1|NOT COMPLETED|Main Period||2
155472|NCT00432666|379781|P2|COMPLETED|Main Period||74
155473|NCT00432666|379782|P1|COMPLETED|Main Period||71
155474|NCT00432666|379781|P2|STARTED|Main Period||75
155475|NCT00432666|379782|P1|STARTED|Main Period||73
155476|NCT00432744|379946|P2|NOT COMPLETED|Months 7 - 12||1
155477|NCT00432744|379947|P1|NOT COMPLETED|Months 7 - 12||1
155478|NCT00432744|379946|P2|COMPLETED|Months 7 - 12||7
155479|NCT00432744|379947|P1|COMPLETED|Months 7 - 12||6
155480|NCT00432744|379946|P2|STARTED|Months 7 - 12||8
155481|NCT00432744|379947|P1|STARTED|Months 7 - 12||7
155482|NCT00432744|379946|P2|NOT COMPLETED|Months 0-6||4
155483|NCT00432744|379947|P1|NOT COMPLETED|Months 0-6||5
155484|NCT00432744|379946|P2|COMPLETED|Months 0-6|"One patient in period 1 other reason for loss became too disabled to complete the 6 month test."|8
155485|NCT00432744|379947|P1|COMPLETED|Months 0-6||7
155486|NCT00432744|379946|P2|STARTED|Months 0-6||12
155487|NCT00432744|379947|P1|STARTED|Months 0-6||12
155488|NCT00432809|379960|P3|NOT COMPLETED|2 Year Sub-study||1
155489|NCT00432809|379961|P2|NOT COMPLETED|2 Year Sub-study||2
155490|NCT00432809|379962|P1|NOT COMPLETED|2 Year Sub-study||3
155491|NCT00432809|379960|P3|COMPLETED|2 Year Sub-study||19
155492|NCT00432809|379961|P2|COMPLETED|2 Year Sub-study||18
155493|NCT00432809|379962|P1|COMPLETED|2 Year Sub-study||17
155494|NCT00432809|379960|P3|STARTED|2 Year Sub-study||20
155495|NCT00432809|379961|P2|STARTED|2 Year Sub-study||20
155496|NCT00432809|379962|P1|STARTED|2 Year Sub-study||20
155497|NCT00432809|379960|P3|NOT COMPLETED|1 Year Follow-up||1
155498|NCT00432809|379961|P2|NOT COMPLETED|1 Year Follow-up||0
155499|NCT00432809|379962|P1|NOT COMPLETED|1 Year Follow-up||9
155500|NCT00432809|379960|P3|COMPLETED|1 Year Follow-up||49
155501|NCT00432809|379961|P2|COMPLETED|1 Year Follow-up||50
155502|NCT00432809|379962|P1|COMPLETED|1 Year Follow-up||41
155503|NCT00432809|379960|P3|STARTED|1 Year Follow-up||50
155504|NCT00432809|379961|P2|STARTED|1 Year Follow-up||50
155505|NCT00432809|379962|P1|STARTED|1 Year Follow-up||50
155506|NCT00432835|380035|P2|NOT COMPLETED|Overall Study||7
155507|NCT00432835|380036|P1|NOT COMPLETED|Overall Study||6
155508|NCT00432835|380035|P2|COMPLETED|Overall Study|These 23 patients completed the entire 8 day protocol.|23
155509|NCT00432835|380036|P1|COMPLETED|Overall Study|These 22 patients completed the entire 8 day protocol.|22
155510|NCT00432835|380035|P2|Completed 2nd Intervention|Overall Study||23
155511|NCT00432835|380036|P1|Completed 2nd Intervention|Overall Study||22
155512|NCT00432835|380035|P2|Completed 1st Intervention|Overall Study||23
155513|NCT00432835|380036|P1|Completed 1st Intervention|Overall Study||22
155514|NCT00432835|380035|P2|STARTED|Overall Study||30
155515|NCT00432835|380036|P1|STARTED|Overall Study||28
155516|NCT00432991|380048|P2|NOT COMPLETED|Overall Study||12
155517|NCT00432991|380049|P1|NOT COMPLETED|Overall Study||7
155518|NCT00432991|380048|P2|COMPLETED|Overall Study||19
155519|NCT00432991|380049|P1|COMPLETED|Overall Study||15
155520|NCT00432991|380048|P2|STARTED|Overall Study||31
155521|NCT00432991|380049|P1|STARTED|Overall Study||22
155522|NCT00433017|380061|P2|NOT COMPLETED|Overall Study||101
155523|NCT00433017|380062|P1|NOT COMPLETED|Overall Study||96
155524|NCT00433017|380061|P2|COMPLETED|Overall Study||32
155525|NCT00433017|380062|P1|COMPLETED|Overall Study||26
155526|NCT00433017|380061|P2|Completed 12 Month Phase|Overall Study||126
155527|NCT00433017|380062|P1|Completed 12 Month Phase|Overall Study||114
155528|NCT00433017|380061|P2|STARTED|Overall Study||133
155529|NCT00433017|380062|P1|STARTED|Overall Study||122
155530|NCT00433160|380078|P2|NOT COMPLETED|104 Weeks, 28-Week OL Period||3
155531|NCT00433160|380079|P1|NOT COMPLETED|104 Weeks, 28-Week OL Period||10
155532|NCT00433160|380078|P2|COMPLETED|104 Weeks, 28-Week OL Period||47
155533|NCT00433160|380079|P1|COMPLETED|104 Weeks, 28-Week OL Period||92
155534|NCT00433160|380078|P2|Received Treatment|104 Weeks, 28-Week OL Period||50
155535|NCT00433160|380079|P1|Received Treatment|104 Weeks, 28-Week OL Period||102
155536|NCT00433160|380078|P2|STARTED|104 Weeks, 28-Week OL Period|Five participants withdrew at end of first OL period and did not continue on to second OL period.|50
155537|NCT00433160|380079|P1|STARTED|104 Weeks, 28-Week OL Period|Eleven participants withdrew at end of first OL period and did not continue on to second OL period.|102
155538|NCT00433160|380078|P2|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||4
155539|NCT00433160|380079|P1|NOT COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||6
155540|NCT00433160|380078|P2|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||55
155541|NCT00433160|380079|P1|COMPLETED|76 Weeks, 24-Week Open Label (OL) Period||113
155542|NCT00433160|380078|P2|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||59
155543|NCT00433160|380079|P1|Received Treatment|76 Weeks, 24-Week Open Label (OL) Period||119
155544|NCT00433160|380078|P2|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|59
155545|NCT00433160|380079|P1|STARTED|76 Weeks, 24-Week Open Label (OL) Period|One participant did not continue to first OL period due to adverse event after completing DB period.|119
155546|NCT00433160|380078|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||10
155547|NCT00433160|380079|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||17
155548|NCT00433160|380078|P2|COMPLETED|52-Week Double-Blind (DB) Period||60
155549|NCT00433160|380079|P1|COMPLETED|52-Week Double-Blind (DB) Period||120
155550|NCT00433160|380078|P2|Received Treatment|52-Week Double-Blind (DB) Period||68
155551|NCT00433160|380079|P1|Received Treatment|52-Week Double-Blind (DB) Period||136
155552|NCT00433160|380078|P2|STARTED|52-Week Double-Blind (DB) Period||70
155553|NCT00433160|380079|P1|STARTED|52-Week Double-Blind (DB) Period||137
155554|NCT00433199|380129|P2|NOT COMPLETED|Open-Label Period||34
155555|NCT00433199|380130|P1|NOT COMPLETED|Open-Label Period||0
155556|NCT00433199|380129|P2|COMPLETED|Open-Label Period||185
155557|NCT00433199|380130|P1|COMPLETED|Open-Label Period||0
155558|NCT00433199|380129|P2|STARTED|Open-Label Period||219
155559|NCT00433199|380130|P1|STARTED|Open-Label Period||0
155560|NCT00433199|380129|P2|NOT COMPLETED|Double-Blind Period||66
155561|NCT00433199|380130|P1|NOT COMPLETED|Double-Blind Period||12
155562|NCT00433199|380129|P2|COMPLETED|Double-Blind Period||168
155563|NCT00433199|380130|P1|COMPLETED|Double-Blind Period||28
155564|NCT00433199|380129|P2|STARTED|Double-Blind Period||234
155565|NCT00433199|380130|P1|STARTED|Double-Blind Period||40
155566|NCT00433290|380150|P2|NOT COMPLETED|Overall Study||17
155567|NCT00433290|380151|P1|NOT COMPLETED|Overall Study||35
155568|NCT00433290|380150|P2|COMPLETED|Overall Study||111
155569|NCT00433290|380151|P1|COMPLETED|Overall Study||93
155570|NCT00433290|380150|P2|STARTED|Overall Study||128
155571|NCT00433290|380151|P1|STARTED|Overall Study||128
155572|NCT00433329|380218|P1|NOT COMPLETED|Overall Study||21
155573|NCT00433329|380218|P1|COMPLETED|Overall Study||79
155574|NCT00433329|380218|P1|STARTED|Overall Study||100
155575|NCT00433381|380224|P2|NOT COMPLETED|Overall Study||3
155576|NCT00433381|380225|P1|NOT COMPLETED|Overall Study||5
155577|NCT00433381|380224|P2|COMPLETED|Overall Study||57
155578|NCT00433381|380225|P1|COMPLETED|Overall Study|Evaluated for 6-month progression-free survival. (Applies to both arms).|58
155579|NCT00433381|380224|P2|STARTED|Overall Study||60
155580|NCT00433381|380225|P1|STARTED|Overall Study||63
155581|NCT00433446|380231|P1|NOT COMPLETED|Overall Study||61
155582|NCT00433446|380231|P1|COMPLETED|Overall Study||1
155583|NCT00433446|380231|P1|Eligible and Began Protocol Therapy|Overall Study||53
155584|NCT00433446|380231|P1|Eligible|Overall Study||53
155585|NCT00433446|380231|P1|STARTED|Overall Study||62
155586|NCT00433537|380239|P3|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
155587|NCT00433537|380240|P2|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
155588|NCT00433537|380241|P1|NOT COMPLETED|Step 2 - Maintenance Rituximab or ASCT||16
155589|NCT00433537|380239|P3|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||0
155590|NCT00433537|380240|P2|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||22
155591|NCT00433537|380241|P1|COMPLETED|Step 2 - Maintenance Rituximab or ASCT||29
155592|NCT00433537|380239|P3|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||0
155593|NCT00433537|380240|P2|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||22
155594|NCT00433537|380241|P1|Eligible and Treated|Step 2 - Maintenance Rituximab or ASCT||44
155595|NCT00433537|380239|P3|STARTED|Step 2 - Maintenance Rituximab or ASCT|One patient completed VcR-CVAD and then withdrew from the study.|0
155596|NCT00433537|380240|P2|STARTED|Step 2 - Maintenance Rituximab or ASCT||22
155597|NCT00433537|380241|P1|STARTED|Step 2 - Maintenance Rituximab or ASCT|This included all treated patients regardless of eligibility.|45
155598|NCT00433537|380239|P3|NOT COMPLETED|Step 1 - VcR-CVAD Induction||9
155599|NCT00433537|380240|P2|NOT COMPLETED|Step 1 - VcR-CVAD Induction||0
155600|NCT00433537|380241|P1|NOT COMPLETED|Step 1 - VcR-CVAD Induction||1
155601|NCT00433537|380239|P3|COMPLETED|Step 1 - VcR-CVAD Induction||1
155602|NCT00433537|380240|P2|COMPLETED|Step 1 - VcR-CVAD Induction||22
155603|NCT00433537|380241|P1|COMPLETED|Step 1 - VcR-CVAD Induction||44
155604|NCT00433537|380239|P3|Eligible and Treated|Step 1 - VcR-CVAD Induction||9
155605|NCT00433537|380240|P2|Eligible and Treated|Step 1 - VcR-CVAD Induction||22
155606|NCT00433537|380241|P1|Eligible and Treated|Step 1 - VcR-CVAD Induction||44
155607|NCT00433537|380239|P3|STARTED|Step 1 - VcR-CVAD Induction||10
155608|NCT00433537|380240|P2|STARTED|Step 1 - VcR-CVAD Induction||22
155609|NCT00433537|380241|P1|STARTED|Step 1 - VcR-CVAD Induction||45
155610|NCT00433550|380253|P3|NOT COMPLETED|Overall Study||0
155611|NCT00433550|380254|P2|NOT COMPLETED|Overall Study||0
155612|NCT00433550|380255|P1|NOT COMPLETED|Overall Study||0
155613|NCT00433550|380253|P3|COMPLETED|Overall Study||6
155614|NCT00433550|380254|P2|COMPLETED|Overall Study||10
155615|NCT00433550|380255|P1|COMPLETED|Overall Study||17
155616|NCT00433550|380253|P3|STARTED|Overall Study||6
155617|NCT00433550|380254|P2|STARTED|Overall Study||10
155618|NCT00433550|380255|P1|STARTED|Overall Study||17
155619|NCT00433654|380267|P2|NOT COMPLETED|Overall Study||5
155620|NCT00433654|380268|P1|NOT COMPLETED|Overall Study||15
155621|NCT00433654|380267|P2|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|201
155622|NCT00433654|380268|P1|COMPLETED|Overall Study|Subjects completing the 4-month follow-up.|243
155623|NCT00433654|380267|P2|STARTED|Overall Study||206
155624|NCT00433654|380268|P1|STARTED|Overall Study||258
155625|NCT00433745|380299|P1|NOT COMPLETED|Overall Study||0
155626|NCT00433745|380299|P1|COMPLETED|Overall Study||4
155627|NCT00433745|380299|P1|STARTED|Overall Study||4
155628|NCT00433771|380304|P1|NOT COMPLETED|Overall Study||19
155629|NCT00433771|380304|P1|COMPLETED|Overall Study|55 out of 58 patients were evaluable(had a stent placed and had at least 1 week of follow up)|55
155630|NCT00433771|380304|P1|STARTED|Overall Study|74 enrolled patients(signed an Informed Consent Form)were screened.58 were eligible(intent to treat)|74
155631|NCT00433836|380322|P2|NOT COMPLETED|Overall Study||6
155632|NCT00433836|380323|P1|NOT COMPLETED|Overall Study||13
155633|NCT00433836|380322|P2|COMPLETED|Overall Study||143
155634|NCT00433836|380323|P1|COMPLETED|Overall Study||138
155635|NCT00433836|380322|P2|STARTED|Overall Study||149
155636|NCT00433836|380323|P1|STARTED|Overall Study||151
155637|NCT00433914|380337|P2|NOT COMPLETED|Overall Study||3
155638|NCT00433914|380338|P1|NOT COMPLETED|Overall Study||0
155639|NCT00433914|380337|P2|COMPLETED|Overall Study||27
155640|NCT00433914|380338|P1|COMPLETED|Overall Study||30
155641|NCT00433914|380337|P2|STARTED|Overall Study||30
155642|NCT00433914|380338|P1|STARTED|Overall Study||30
155643|NCT00433992|380358|P2|NOT COMPLETED|Overall Study||8
155644|NCT00433992|380359|P1|NOT COMPLETED|Overall Study||9
155645|NCT00433992|380358|P2|COMPLETED|Overall Study||20
155646|NCT00433992|380359|P1|COMPLETED|Overall Study||19
155647|NCT00433992|380358|P2|STARTED|Overall Study||28
155648|NCT00433992|380359|P1|STARTED|Overall Study||28
155649|NCT00415597|380367|P1|NOT COMPLETED|Treatment||305
155650|NCT00415597|380367|P1|COMPLETED|Treatment||160
155651|NCT00415597|380367|P1|STARTED|Treatment||465
155652|NCT00415597|380367|P1|NOT COMPLETED|Enrollment||2
155653|NCT00415597|380367|P1|COMPLETED|Enrollment||465
155654|NCT00415597|380367|P1|STARTED|Enrollment||467
155655|NCT00415610|380376|P3|NOT COMPLETED|Overall Study||5
155656|NCT00415610|380377|P2|NOT COMPLETED|Overall Study||2
155657|NCT00415610|380378|P1|NOT COMPLETED|Overall Study||3
155658|NCT00415610|380376|P3|COMPLETED|Overall Study||17
155659|NCT00415610|380377|P2|COMPLETED|Overall Study||18
155660|NCT00415610|380378|P1|COMPLETED|Overall Study||15
155661|NCT00415610|380376|P3|STARTED|Overall Study||22
155662|NCT00415610|380377|P2|STARTED|Overall Study||20
155663|NCT00415610|380378|P1|STARTED|Overall Study||18
155664|NCT00415623|380394|P2|NOT COMPLETED|Overall Study||5
155665|NCT00415623|380395|P1|NOT COMPLETED|Overall Study||5
155666|NCT00415623|380394|P2|COMPLETED|Overall Study||146
155667|NCT00415623|380395|P1|COMPLETED|Overall Study||149
155668|NCT00415623|380394|P2|STARTED|Overall Study||151
155669|NCT00415623|380395|P1|STARTED|Overall Study||154
155670|NCT00415857|380421|P2|NOT COMPLETED|Overall Study||0
155671|NCT00415857|380422|P1|NOT COMPLETED|Overall Study||0
155672|NCT00415857|380421|P2|COMPLETED|Overall Study||3
155673|NCT00415857|380422|P1|COMPLETED|Overall Study||2
155674|NCT00415857|380421|P2|STARTED|Overall Study||3
155675|NCT00415857|380422|P1|STARTED|Overall Study||2
155676|NCT00415870|380432|P2|NOT COMPLETED|Overall Study||7
155677|NCT00415870|380433|P1|NOT COMPLETED|Overall Study||6
155678|NCT00415870|380432|P2|COMPLETED|Overall Study||26
155679|NCT00415870|380433|P1|COMPLETED|Overall Study||26
155680|NCT00415870|380432|P2|STARTED|Overall Study||33
155681|NCT00415870|380433|P1|STARTED|Overall Study||32
155682|NCT00415909|380439|P1|NOT COMPLETED|Overall Study||3
155683|NCT00415909|380439|P1|COMPLETED|Overall Study||0
155684|NCT00415909|380439|P1|STARTED|Overall Study||3
155685|NCT00416078|380445|P2|NOT COMPLETED|Overall Study||8
155686|NCT00416078|380446|P1|NOT COMPLETED|Overall Study||11
155687|NCT00416078|380445|P2|COMPLETED|Overall Study||16
155688|NCT00416078|380446|P1|COMPLETED|Overall Study||18
155689|NCT00416078|380445|P2|STARTED|Overall Study||24
155690|NCT00416078|380446|P1|STARTED|Overall Study||29
155691|NCT00416182|380464|P2|NOT COMPLETED|Overall Study||2
155692|NCT00416182|380465|P1|NOT COMPLETED|Overall Study||3
155693|NCT00416182|380464|P2|COMPLETED|Overall Study||6
155694|NCT00416182|380465|P1|COMPLETED|Overall Study||5
155695|NCT00416182|380464|P2|STARTED|Overall Study||8
155696|NCT00416182|380465|P1|STARTED|Overall Study||8
155697|NCT00416195|380479|P2|NOT COMPLETED|Overall Study||4
155698|NCT00416195|380480|P1|NOT COMPLETED|Overall Study||2
155699|NCT00416195|380479|P2|COMPLETED|Overall Study||34
155700|NCT00416195|380480|P1|COMPLETED|Overall Study||8
155701|NCT00416195|380479|P2|STARTED|Overall Study||38
155702|NCT00416195|380480|P1|STARTED|Overall Study||10
155703|NCT00434018|380490|P2|NOT COMPLETED|Overall Study||12
155704|NCT00434018|380491|P1|NOT COMPLETED|Overall Study||17
155705|NCT00434018|380490|P2|COMPLETED|Overall Study||57
155706|NCT00434018|380491|P1|COMPLETED|Overall Study||52
155707|NCT00434018|380490|P2|STARTED|Overall Study||69
155708|NCT00434018|380491|P1|STARTED|Overall Study||69
155709|NCT00434057|380507|P1|NOT COMPLETED|Overall Study||1
155710|NCT00434057|380507|P1|COMPLETED|Overall Study|One patient withdrew from the study after signing the Informed Consent Form|1382
155711|NCT00434057|380507|P1|STARTED|Overall Study||1383
155712|NCT00434109|380511|P1|NOT COMPLETED|Overall Study||18
155713|NCT00434109|380511|P1|COMPLETED|Overall Study|Patients completing the maximum eight cycles of sunitinib.|21
155714|NCT00434109|380511|P1|STARTED|Overall Study||39
155715|NCT00434122|380522|P2|NOT COMPLETED|Overall Study||7
155716|NCT00434122|380523|P1|NOT COMPLETED|Overall Study||6
155717|NCT00434122|380522|P2|COMPLETED|Overall Study||36
155718|NCT00434122|380523|P1|COMPLETED|Overall Study||36
155719|NCT00434122|380522|P2|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
155720|NCT00434122|380523|P1|Intention-to-treat (ITT) Population|Overall Study|All randomised and exposed subjects not withdrawn before Stimulation Day 1.|39
155721|NCT00434122|380522|P2|STARTED|Overall Study|Randomised|43
155722|NCT00434122|380523|P1|STARTED|Overall Study|Randomised|42
155723|NCT00434148|380534|P2|NOT COMPLETED|Overall Study||73
155724|NCT00434148|380535|P1|NOT COMPLETED|Overall Study||69
155725|NCT00434148|380534|P2|COMPLETED|Overall Study||7
155726|NCT00434148|380535|P1|COMPLETED|Overall Study||13
155727|NCT00434148|380534|P2|Completed Month 12; Entered Extension|Overall Study||32
155728|NCT00434148|380535|P1|Completed Month 12; Entered Extension|Overall Study||26
155729|NCT00434148|380534|P2|Completed m. 12; Did Not Enter Extension|Overall Study||7
155730|NCT00434148|380535|P1|Completed m. 12; Did Not Enter Extension|Overall Study||13
155731|NCT00434148|380534|P2|Completed Month 12|Overall Study||39
155732|NCT00434148|380535|P1|Completed Month 12|Overall Study||39
155733|NCT00434148|380534|P2|STARTED|Overall Study||80
155734|NCT00434148|380535|P1|STARTED|Overall Study|"Started indicates Full Analysis Set. Patients randomized and treated."|82
155735|NCT00434161|380572|P3|NOT COMPLETED|Overall Study||11
155736|NCT00434161|380573|P2|NOT COMPLETED|Overall Study||3
155737|NCT00434161|380574|P1|NOT COMPLETED|Overall Study||10
155738|NCT00434161|380572|P3|COMPLETED|Overall Study||104
155739|NCT00434161|380573|P2|COMPLETED|Overall Study||54
155740|NCT00434161|380574|P1|COMPLETED|Overall Study||99
155741|NCT00434161|380572|P3|STARTED|Overall Study||115
155742|NCT00434161|380573|P2|STARTED|Overall Study||57
155743|NCT00434161|380574|P1|STARTED|Overall Study||109
155744|NCT00434213|380616|P1|NOT COMPLETED|Overall Study||49
155745|NCT00434213|380616|P1|COMPLETED|Overall Study||260
155746|NCT00434213|380616|P1|STARTED|Overall Study||309
155747|NCT00434226|380623|P2|NOT COMPLETED|Overall Study||26
155748|NCT00434226|380624|P1|NOT COMPLETED|Overall Study||30
155749|NCT00434226|380623|P2|COMPLETED|Overall Study||0
155750|NCT00434226|380624|P1|COMPLETED|Overall Study||0
155751|NCT00434226|380623|P2|STARTED|Overall Study||26
155752|NCT00434226|380624|P1|STARTED|Overall Study||30
155753|NCT00434252|380637|P2|NOT COMPLETED|Overall Study||131
155754|NCT00434252|380638|P1|NOT COMPLETED|Overall Study||64
155755|NCT00434252|380637|P2|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|12
155756|NCT00434252|380638|P1|COMPLETED|Overall Study|Continuing study drug treatment at the time of the data cutoff.|7
155757|NCT00434252|380637|P2|Treated|Overall Study||143
155758|NCT00434252|380638|P1|Treated|Overall Study|One patient died and one patient withdrew prior to receiving study treatment|69
155759|NCT00434252|380637|P2|STARTED|Overall Study||143
155760|NCT00434252|380638|P1|STARTED|Overall Study||71
155761|NCT00434278|380660|P2|NOT COMPLETED|Overall Study||0
155762|NCT00434278|380661|P1|NOT COMPLETED|Overall Study||2
155763|NCT00434278|380660|P2|COMPLETED|Overall Study||13
155764|NCT00434278|380661|P1|COMPLETED|Overall Study||12
155765|NCT00434278|380660|P2|STARTED|Overall Study||13
155766|NCT00434278|380661|P1|STARTED|Overall Study||14
155767|NCT00434304|380669|P1|NOT COMPLETED|Overall Study||20
155768|NCT00434304|380669|P1|COMPLETED|Overall Study||42
155769|NCT00434304|380669|P1|STARTED|Overall Study||62
155770|NCT00434330|380711|P6|NOT COMPLETED|Overall Study||1
155771|NCT00434330|380712|P5|NOT COMPLETED|Overall Study||1
155772|NCT00434330|380713|P4|NOT COMPLETED|Overall Study||2
155773|NCT00434330|380714|P3|NOT COMPLETED|Overall Study||3
155774|NCT00434330|380715|P2|NOT COMPLETED|Overall Study||0
155775|NCT00434330|380716|P1|NOT COMPLETED|Overall Study||1
155776|NCT00434330|380711|P6|COMPLETED|Overall Study||14
155777|NCT00434330|380712|P5|COMPLETED|Overall Study||14
155778|NCT00434330|380713|P4|COMPLETED|Overall Study||13
155779|NCT00434330|380714|P3|COMPLETED|Overall Study||13
155780|NCT00434330|380715|P2|COMPLETED|Overall Study||15
155781|NCT00434330|380716|P1|COMPLETED|Overall Study||14
155782|NCT00434330|380711|P6|STARTED|Overall Study||15
155783|NCT00434330|380712|P5|STARTED|Overall Study||15
155784|NCT00434330|380713|P4|STARTED|Overall Study||15
155785|NCT00434330|380714|P3|STARTED|Overall Study||16
155786|NCT00434330|380715|P2|STARTED|Overall Study||15
155787|NCT00434330|380716|P1|STARTED|Overall Study||15
155788|NCT00434993|380750|P2|NOT COMPLETED|Overall Study||0
155789|NCT00434993|380751|P1|NOT COMPLETED|Overall Study||0
155790|NCT00434993|380750|P2|COMPLETED|Overall Study||130
155791|NCT00434993|380751|P1|COMPLETED|Overall Study||152
155792|NCT00434993|380750|P2|STARTED|Overall Study||130
155793|NCT00434993|380751|P1|STARTED|Overall Study||152
155794|NCT00435019|380777|P2|NOT COMPLETED|Overall Study||10
155795|NCT00435019|380778|P1|NOT COMPLETED|Overall Study||13
155796|NCT00435019|380777|P2|COMPLETED|Overall Study||161
155797|NCT00435019|380778|P1|COMPLETED|Overall Study||164
155798|NCT00435019|380777|P2|Exposed to Study Drug|Overall Study|One subject withdrew before receiving study drug, and thus not included in the full analysis set.|170
155799|NCT00435019|380778|P1|Exposed to Study Drug|Overall Study||177
155800|NCT00435019|380777|P2|STARTED|Overall Study|Randomised|171
155801|NCT00435019|380778|P1|STARTED|Overall Study|Randomised|177
155802|NCT00435045|380790|P2|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||2
155803|NCT00435045|380791|P1|NOT COMPLETED|Weeks 13-16 / 40mg Dose Level||5
155804|NCT00435045|380790|P2|COMPLETED|Weeks 13-16 / 40mg Dose Level||111
155805|NCT00435045|380791|P1|COMPLETED|Weeks 13-16 / 40mg Dose Level||108
155806|NCT00435045|380790|P2|STARTED|Weeks 13-16 / 40mg Dose Level||113
155807|NCT00435045|380791|P1|STARTED|Weeks 13-16 / 40mg Dose Level||113
155808|NCT00435045|380790|P2|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
155809|NCT00435045|380791|P1|NOT COMPLETED|Weeks 9-12 / 20mg Dose Level||5
155810|NCT00435045|380790|P2|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
155811|NCT00435045|380791|P1|COMPLETED|Weeks 9-12 / 20mg Dose Level||113
155812|NCT00435045|380790|P2|STARTED|Weeks 9-12 / 20mg Dose Level||118
155813|NCT00435045|380791|P1|STARTED|Weeks 9-12 / 20mg Dose Level||118
155814|NCT00435045|380790|P2|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||4
155815|NCT00435045|380791|P1|NOT COMPLETED|Weeks 1-8 / 10 mg Dose Level||5
155816|NCT00435045|380790|P2|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
155817|NCT00435045|380791|P1|COMPLETED|Weeks 1-8 / 10 mg Dose Level||118
155818|NCT00435045|380790|P2|STARTED|Weeks 1-8 / 10 mg Dose Level||122
155819|NCT00435045|380791|P1|STARTED|Weeks 1-8 / 10 mg Dose Level||123
155820|NCT00435162|380848|P6|NOT COMPLETED|Period 2 (2 Weeks)||0
155821|NCT00435162|380849|P5|NOT COMPLETED|Period 2 (2 Weeks)||0
155822|NCT00435162|380850|P4|NOT COMPLETED|Period 2 (2 Weeks)||0
155823|NCT00435162|380851|P3|NOT COMPLETED|Period 2 (2 Weeks)||0
155824|NCT00435162|380852|P2|NOT COMPLETED|Period 2 (2 Weeks)||1
155825|NCT00435162|380853|P1|NOT COMPLETED|Period 2 (2 Weeks)||0
155826|NCT00435162|380848|P6|COMPLETED|Period 2 (2 Weeks)||15
155827|NCT00435162|380849|P5|COMPLETED|Period 2 (2 Weeks)||15
155828|NCT00435162|380850|P4|COMPLETED|Period 2 (2 Weeks)||8
155829|NCT00435162|380851|P3|COMPLETED|Period 2 (2 Weeks)||6
155830|NCT00435162|380852|P2|COMPLETED|Period 2 (2 Weeks)||14
155831|NCT00435162|380853|P1|COMPLETED|Period 2 (2 Weeks)||15
155832|NCT00435162|380848|P6|STARTED|Period 2 (2 Weeks)||15
155833|NCT00435162|380849|P5|STARTED|Period 2 (2 Weeks)||15
155834|NCT00435162|380850|P4|STARTED|Period 2 (2 Weeks)||8
155835|NCT00435162|380851|P3|STARTED|Period 2 (2 Weeks)||6
155836|NCT00435162|380852|P2|STARTED|Period 2 (2 Weeks)||15
155837|NCT00435162|380853|P1|STARTED|Period 2 (2 Weeks)||15
155838|NCT00435162|380848|P6|NOT COMPLETED|Period 1 (6 Weeks)||0
155839|NCT00435162|380849|P5|NOT COMPLETED|Period 1 (6 Weeks)||0
155840|NCT00435162|380850|P4|NOT COMPLETED|Period 1 (6 Weeks)||0
155841|NCT00435162|380851|P3|NOT COMPLETED|Period 1 (6 Weeks)||0
155842|NCT00435162|380852|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
155843|NCT00435162|380853|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
155844|NCT00435162|380848|P6|COMPLETED|Period 1 (6 Weeks)||15
155845|NCT00435162|380849|P5|COMPLETED|Period 1 (6 Weeks)||15
155846|NCT00435162|380850|P4|COMPLETED|Period 1 (6 Weeks)||8
155847|NCT00435162|380851|P3|COMPLETED|Period 1 (6 Weeks)||6
155848|NCT00435162|380852|P2|COMPLETED|Period 1 (6 Weeks)||15
155849|NCT00435162|380853|P1|COMPLETED|Period 1 (6 Weeks)||15
155850|NCT00435162|380848|P6|STARTED|Period 1 (6 Weeks)||15
155851|NCT00435162|380849|P5|STARTED|Period 1 (6 Weeks)||15
155852|NCT00435162|380850|P4|STARTED|Period 1 (6 Weeks)||8
155853|NCT00435162|380851|P3|STARTED|Period 1 (6 Weeks)||6
155854|NCT00435162|380852|P2|STARTED|Period 1 (6 Weeks)||15
155855|NCT00435162|380853|P1|STARTED|Period 1 (6 Weeks)||15
155856|NCT00435188|380873|P2|NOT COMPLETED|Overall Study||23
155857|NCT00435188|380874|P1|NOT COMPLETED|Overall Study||22
155858|NCT00435188|380873|P2|COMPLETED|Overall Study||176
155859|NCT00435188|380874|P1|COMPLETED|Overall Study||177
155860|NCT00435188|380873|P2|STARTED|Overall Study||199
155861|NCT00435188|380874|P1|STARTED|Overall Study||199
155862|NCT00435370|380916|P2|NOT COMPLETED|Overall Study||20
155863|NCT00435370|380917|P1|NOT COMPLETED|Overall Study||22
155864|NCT00435370|380916|P2|COMPLETED|Overall Study|The entire recruitment has been completed in December, 2011.|69
155865|NCT00435370|380917|P1|COMPLETED|Overall Study||68
155866|NCT00435370|380916|P2|STARTED|Overall Study|The recruitment restarted in August, 2010.|89
155867|NCT00435370|380917|P1|STARTED|Overall Study||90
155868|NCT00435409|380925|P3|NOT COMPLETED|Overall Study||78
155869|NCT00435409|380926|P2|NOT COMPLETED|Overall Study||143
155870|NCT00435409|380927|P1|NOT COMPLETED|Overall Study||221
155871|NCT00435409|380925|P3|COMPLETED|Overall Study||0
155872|NCT00435409|380926|P2|COMPLETED|Overall Study||0
155873|NCT00435409|380927|P1|COMPLETED|Overall Study||0
155874|NCT00435409|380925|P3|Treated|Overall Study||78
155875|NCT00435409|380926|P2|Treated|Overall Study||139
155876|NCT00435409|380927|P1|Treated|Overall Study||217
155877|NCT00435409|380925|P3|STARTED|Overall Study||78
155878|NCT00435409|380926|P2|STARTED|Overall Study||143
155879|NCT00435409|380927|P1|STARTED|Overall Study||221
155880|NCT00435487|380949|P2|NOT COMPLETED|Overall Study||15
155881|NCT00435487|380950|P1|NOT COMPLETED|Overall Study||12
155882|NCT00435487|380949|P2|COMPLETED|Overall Study||71
155883|NCT00435487|380950|P1|COMPLETED|Overall Study||76
155884|NCT00435487|380949|P2|TREATED|Overall Study|One subject was mistakenly treated with Dalteparin, two subjects withdrew consent before treatment.|83
155885|NCT00435487|380950|P1|TREATED|Overall Study|One additional subject originally randomized to Unfractioned Heparin was treated with Dalteparin.|88
155886|NCT00435487|380949|P2|STARTED|Overall Study||86
155887|NCT00435487|380950|P1|STARTED|Overall Study|87 subjects were randomized however one additional subject originally randomized to UFH was treated.|88
155888|NCT00435539|380971|P5|NOT COMPLETED|Overall Study||0
155889|NCT00435539|380972|P4|NOT COMPLETED|Overall Study||0
155890|NCT00435539|380973|P3|NOT COMPLETED|Overall Study||0
155891|NCT00435539|380974|P2|NOT COMPLETED|Overall Study||0
155892|NCT00435539|380975|P1|NOT COMPLETED|Overall Study||0
155893|NCT00435539|380971|P5|COMPLETED|Overall Study||12
155894|NCT00435539|380972|P4|COMPLETED|Overall Study||12
155895|NCT00435539|380973|P3|COMPLETED|Overall Study||11
155896|NCT00435539|380974|P2|COMPLETED|Overall Study||13
155897|NCT00435539|380975|P1|COMPLETED|Overall Study||12
155898|NCT00435539|380971|P5|STARTED|Overall Study||12
155899|NCT00435539|380972|P4|STARTED|Overall Study||12
155900|NCT00435539|380973|P3|STARTED|Overall Study||11
155901|NCT00435539|380974|P2|STARTED|Overall Study||13
155902|NCT00435539|380975|P1|STARTED|Overall Study||12
155903|NCT00435591|380994|P4|NOT COMPLETED|Overall Study||11
155904|NCT00435591|380995|P3|NOT COMPLETED|Overall Study||5
155905|NCT00435591|380996|P2|NOT COMPLETED|Overall Study||4
155906|NCT00435591|380997|P1|NOT COMPLETED|Overall Study||7
155907|NCT00435591|380994|P4|COMPLETED|Overall Study||19
155908|NCT00435591|380995|P3|COMPLETED|Overall Study||25
155909|NCT00435591|380996|P2|COMPLETED|Overall Study||27
155910|NCT00435591|380997|P1|COMPLETED|Overall Study||23
155911|NCT00435591|380994|P4|End of Treatment|Overall Study||23
155912|NCT00435591|380995|P3|End of Treatment|Overall Study||27
155913|NCT00435591|380996|P2|End of Treatment|Overall Study||27
155914|NCT00435591|380997|P1|End of Treatment|Overall Study||25
155915|NCT00435591|380994|P4|Full Analysis Set|Overall Study||29
155916|NCT00435591|380995|P3|Full Analysis Set|Overall Study||30
155917|NCT00435591|380996|P2|Full Analysis Set|Overall Study||29
155918|NCT00435591|380997|P1|Full Analysis Set|Overall Study||28
155919|NCT00435591|380994|P4|Safety Analysis Set|Overall Study||29
155920|NCT00435591|380995|P3|Safety Analysis Set|Overall Study||30
155921|NCT00435591|380996|P2|Safety Analysis Set|Overall Study||30
155922|NCT00435591|380997|P1|Safety Analysis Set|Overall Study||28
155923|NCT00435591|380994|P4|STARTED|Overall Study||30
155924|NCT00435591|380995|P3|STARTED|Overall Study||30
155925|NCT00435591|380996|P2|STARTED|Overall Study||31
155926|NCT00435591|380997|P1|STARTED|Overall Study||30
155927|NCT00435825|381026|P4|NOT COMPLETED|Overall Study||16
155928|NCT00435825|381027|P3|NOT COMPLETED|Overall Study||11
155929|NCT00435825|381028|P2|NOT COMPLETED|Overall Study||12
155930|NCT00435825|381029|P1|NOT COMPLETED|Overall Study||18
155931|NCT00435825|381026|P4|COMPLETED|Overall Study||120
155932|NCT00435825|381027|P3|COMPLETED|Overall Study||127
155933|NCT00435825|381028|P2|COMPLETED|Overall Study||124
155934|NCT00435825|381029|P1|COMPLETED|Overall Study|Completed is the number of participants who received study treatment and completed follow-up.|123
155935|NCT00435825|381026|P4|Completed 48 Weeks Treatment|Overall Study||117
155936|NCT00435825|381027|P3|Completed 48 Weeks Treatment|Overall Study||124
155937|NCT00435825|381028|P2|Completed 48 Weeks Treatment|Overall Study||0
155938|NCT00435825|381029|P1|Completed 48 Weeks Treatment|Overall Study||0
155939|NCT00435825|381026|P4|Completed 24 Weeks Treatment|Overall Study||131
155940|NCT00435825|381027|P3|Completed 24 Weeks Treatment|Overall Study||134
155941|NCT00435825|381028|P2|Completed 24 Weeks Treatment|Overall Study||126
155942|NCT00435825|381029|P1|Completed 24 Weeks Treatment|Overall Study||128
155943|NCT00435825|381026|P4|Entered Follow-up|Overall Study||133
155944|NCT00435825|381027|P3|Entered Follow-up|Overall Study||135
155945|NCT00435825|381028|P2|Entered Follow-up|Overall Study||132
155946|NCT00435825|381029|P1|Entered Follow-up|Overall Study||140
155947|NCT00435825|381026|P4|Received Study Drug|Overall Study||136
155948|NCT00435825|381027|P3|Received Study Drug|Overall Study||136
155949|NCT00435825|381028|P2|Received Study Drug|Overall Study||136
155950|NCT00435825|381029|P1|Received Study Drug|Overall Study||140
155951|NCT00435825|381026|P4|STARTED|Overall Study||136
155952|NCT00435825|381027|P3|STARTED|Overall Study||138
155953|NCT00435825|381028|P2|STARTED|Overall Study||136
155954|NCT00435825|381029|P1|STARTED|Overall Study||141
155955|NCT00435929|381085|P2|NOT COMPLETED|Overall Study||0
155956|NCT00435929|381086|P1|NOT COMPLETED|Overall Study||0
155957|NCT00435929|381085|P2|COMPLETED|Overall Study||9
155958|NCT00435929|381086|P1|COMPLETED|Overall Study||7
155959|NCT00435929|381085|P2|STARTED|Overall Study||9
155960|NCT00435929|381086|P1|STARTED|Overall Study||7
155961|NCT00435994|381115|P3|NOT COMPLETED|Overall Study||0
155962|NCT00435994|381116|P2|NOT COMPLETED|Overall Study||0
155963|NCT00435994|381117|P1|NOT COMPLETED|Overall Study||7
155964|NCT00435994|381115|P3|COMPLETED|Overall Study||12
155965|NCT00435994|381116|P2|COMPLETED|Overall Study||25
155966|NCT00435994|381117|P1|COMPLETED|Overall Study|7 of the subjects were consented and did not complete the study procedures.|15
155967|NCT00435994|381115|P3|STARTED|Overall Study||12
155968|NCT00435994|381116|P2|STARTED|Overall Study||25
155969|NCT00435994|381117|P1|STARTED|Overall Study||22
155970|NCT00436007|381129|P3|NOT COMPLETED|Overall Study||23
155971|NCT00436007|381130|P2|NOT COMPLETED|Overall Study||14
155972|NCT00436007|381131|P1|NOT COMPLETED|Overall Study||19
155973|NCT00436007|381129|P3|COMPLETED|Overall Study||148
155974|NCT00436007|381130|P2|COMPLETED|Overall Study||156
155975|NCT00436007|381131|P1|COMPLETED|Overall Study||151
155976|NCT00436007|381129|P3|STARTED|Overall Study||171
155977|NCT00436007|381130|P2|STARTED|Overall Study||170
155978|NCT00436007|381131|P1|STARTED|Overall Study||170
155979|NCT00436046|381179|P3|NOT COMPLETED|Overall Study||0
155980|NCT00436046|381180|P2|NOT COMPLETED|Overall Study||0
155981|NCT00436046|381181|P1|NOT COMPLETED|Overall Study||0
155982|NCT00436046|381179|P3|COMPLETED|Overall Study||31
155983|NCT00436046|381180|P2|COMPLETED|Overall Study||32
155984|NCT00436046|381181|P1|COMPLETED|Overall Study||32
155985|NCT00436046|381179|P3|STARTED|Overall Study||31
155986|NCT00436046|381180|P2|STARTED|Overall Study||32
155987|NCT00436046|381181|P1|STARTED|Overall Study||32
155988|NCT00436163|381210|P1|NOT COMPLETED|Overall Study||3
155989|NCT00436163|381210|P1|COMPLETED|Overall Study||36
155990|NCT00436163|381210|P1|STARTED|Overall Study||39
155991|NCT00436215|381221|P1|NOT COMPLETED|Overall Study||4
155992|NCT00436215|381221|P1|COMPLETED|Overall Study||51
155993|NCT00436215|381221|P1|STARTED|Overall Study||55
155994|NCT00436332|381227|P1|NOT COMPLETED|Overall Study||83
155995|NCT00436332|381227|P1|COMPLETED|Overall Study||1
155996|NCT00436332|381227|P1|Eligible and Began Protocol Therapy|Overall Study||79
155997|NCT00436332|381227|P1|Eligible|Overall Study||82
155998|NCT00436332|381227|P1|STARTED|Overall Study||84
155999|NCT00436345|381236|P2|NOT COMPLETED|Overall Study||0
156000|NCT00436345|381237|P1|NOT COMPLETED|Overall Study||3
156001|NCT00436345|381236|P2|COMPLETED|Overall Study||18
156002|NCT00436345|381237|P1|COMPLETED|Overall Study||18
156003|NCT00436345|381236|P2|STARTED|Overall Study||18
156004|NCT00436345|381237|P1|STARTED|Overall Study||21
156005|NCT00436436|381290|P1|NOT COMPLETED|Overall Study||12
156006|NCT00436436|381290|P1|COMPLETED|Overall Study||0
156007|NCT00436436|381290|P1|STARTED|Overall Study||12
156008|NCT00436501|381301|P2|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||3
156009|NCT00436501|381302|P1|NOT COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
156010|NCT00436501|381301|P2|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||46
156011|NCT00436501|381302|P1|COMPLETED|Phase 2: MTD VEGF Trap + Docetaxel||0
156012|NCT00436501|381301|P2|STARTED|Phase 2: MTD VEGF Trap + Docetaxel|After toxicity observations Phase 2 opened June 4, 2008 and closed to entry September 27, 2010.|49
156013|NCT00436501|381302|P1|STARTED|Phase 2: MTD VEGF Trap + Docetaxel||0
156014|NCT00436501|381301|P2|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
156015|NCT00436501|381302|P1|NOT COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
156016|NCT00436501|381301|P2|COMPLETED|Phase 1: VEGF Trap Escalating Dose||0
156017|NCT00436501|381302|P1|COMPLETED|Phase 1: VEGF Trap Escalating Dose||9
156018|NCT00436501|381301|P2|STARTED|Phase 1: VEGF Trap Escalating Dose|Participants registered in next period.|0
156019|NCT00436501|381302|P1|STARTED|Phase 1: VEGF Trap Escalating Dose|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
156020|NCT00436501|381301|P2|NOT COMPLETED|Complete Study Participation||0
156021|NCT00436501|381302|P1|NOT COMPLETED|Complete Study Participation||0
156022|NCT00436501|381301|P2|COMPLETED|Complete Study Participation||49
156023|NCT00436501|381302|P1|COMPLETED|Complete Study Participation||9
156024|NCT00436501|381301|P2|STARTED|Complete Study Participation|After toxicity observations, Phase 2 opened June 4, 2008 and closed September 27, 2010.|49
156025|NCT00436501|381302|P1|STARTED|Complete Study Participation|Phase 1 opened on January 17, 2007 and closed to new patient entry on March 7, 2008.|9
156026|NCT00436553|381316|P3|NOT COMPLETED|Overall Study||10
156027|NCT00436553|381317|P2|NOT COMPLETED|Overall Study||12
156028|NCT00436553|381318|P1|NOT COMPLETED|Overall Study||13
156029|NCT00436553|381316|P3|COMPLETED|Overall Study||102
156030|NCT00436553|381317|P2|COMPLETED|Overall Study||93
156031|NCT00436553|381318|P1|COMPLETED|Overall Study|Completed the 12 month study phase.|91
156032|NCT00436553|381316|P3|STARTED|Overall Study||112
156033|NCT00436553|381317|P2|STARTED|Overall Study||105
156034|NCT00436553|381318|P1|STARTED|Overall Study|"The table shows 12 month data. Started indicates Randomized set of population."|104
156035|NCT00436566|381337|P1|NOT COMPLETED|Overall Study||3
156036|NCT00436566|381337|P1|COMPLETED|Overall Study||109
156037|NCT00436566|381337|P1|STARTED|Overall Study||112
156038|NCT00436605|381341|P1|NOT COMPLETED|Overall Study||3
156039|NCT00436605|381341|P1|COMPLETED|Overall Study||36
156040|NCT00436605|381341|P1|STARTED|Overall Study||39
156041|NCT00436618|381349|P3|NOT COMPLETED|Overall Study||61
156042|NCT00436618|381350|P2|NOT COMPLETED|Overall Study||27
156043|NCT00436618|381351|P1|NOT COMPLETED|Overall Study||30
156044|NCT00436618|381349|P3|COMPLETED|Overall Study||46
156045|NCT00436618|381350|P2|COMPLETED|Overall Study||28
156046|NCT00436618|381351|P1|COMPLETED|Overall Study||84
156047|NCT00436618|381349|P3|STARTED|Overall Study||107
156048|NCT00436618|381350|P2|STARTED|Overall Study||55
156049|NCT00436618|381351|P1|STARTED|Overall Study||114
156050|NCT00436644|381368|P1|NOT COMPLETED|Overall Study||3
156051|NCT00436644|381368|P1|COMPLETED|Overall Study||15
156052|NCT00436644|381368|P1|STARTED|Overall Study||18
156053|NCT00436748|381377|P2|NOT COMPLETED|Overall Study||12
156054|NCT00436748|381378|P1|NOT COMPLETED|Overall Study||11
156055|NCT00436748|381377|P2|COMPLETED|Overall Study||45
156056|NCT00436748|381378|P1|COMPLETED|Overall Study||48
156057|NCT00436748|381377|P2|Received Treatment|Overall Study||56
156058|NCT00436748|381378|P1|Received Treatment|Overall Study||58
156059|NCT00436748|381377|P2|STARTED|Overall Study||57
156060|NCT00436748|381378|P1|STARTED|Overall Study||59
156061|NCT00436826|381414|P6|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||7
156062|NCT00436826|381415|P5|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||51
156063|NCT00436826|381416|P4|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
156064|NCT00436826|381417|P3|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
156065|NCT00436826|381418|P2|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
156066|NCT00436826|381419|P1|NOT COMPLETED|Ext. Period (No Cladribine Treatment)||0
156067|NCT00436826|381414|P6|COMPLETED|Ext. Period (No Cladribine Treatment)||0
156068|NCT00436826|381415|P5|COMPLETED|Ext. Period (No Cladribine Treatment)||1
156069|NCT00436826|381416|P4|COMPLETED|Ext. Period (No Cladribine Treatment)||0
156070|NCT00436826|381417|P3|COMPLETED|Ext. Period (No Cladribine Treatment)||0
156071|NCT00436826|381418|P2|COMPLETED|Ext. Period (No Cladribine Treatment)||0
156072|NCT00436826|381419|P1|COMPLETED|Ext. Period (No Cladribine Treatment)||0
156073|NCT00436826|381414|P6|STARTED|Ext. Period (No Cladribine Treatment)||7
156074|NCT00436826|381415|P5|STARTED|Ext. Period (No Cladribine Treatment)||52
156075|NCT00436826|381416|P4|STARTED|Ext. Period (No Cladribine Treatment)||0
156076|NCT00436826|381417|P3|STARTED|Ext. Period (No Cladribine Treatment)||0
156077|NCT00436826|381418|P2|STARTED|Ext. Period (No Cladribine Treatment)||0
156078|NCT00436826|381419|P1|STARTED|Ext. Period (No Cladribine Treatment)||0
156079|NCT00436826|381414|P6|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
156080|NCT00436826|381415|P5|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
156081|NCT00436826|381416|P4|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||24
156082|NCT00436826|381417|P3|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||44
156083|NCT00436826|381418|P2|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
156084|NCT00436826|381419|P1|NOT COMPLETED|Ext. Period (With Cladribine Treatment)||0
156085|NCT00436826|381414|P6|COMPLETED|Ext. Period (With Cladribine Treatment)||0
156086|NCT00436826|381415|P5|COMPLETED|Ext. Period (With Cladribine Treatment)||0
156087|NCT00436826|381416|P4|COMPLETED|Ext. Period (With Cladribine Treatment)||4
156088|NCT00436826|381417|P3|COMPLETED|Ext. Period (With Cladribine Treatment)||3
156089|NCT00436826|381418|P2|COMPLETED|Ext. Period (With Cladribine Treatment)||0
156090|NCT00436826|381419|P1|COMPLETED|Ext. Period (With Cladribine Treatment)||0
156091|NCT00436826|381414|P6|STARTED|Ext. Period (With Cladribine Treatment)||0
156092|NCT00436826|381415|P5|STARTED|Ext. Period (With Cladribine Treatment)||0
156093|NCT00436826|381416|P4|STARTED|Ext. Period (With Cladribine Treatment)||28
156094|NCT00436826|381417|P3|STARTED|Ext. Period (With Cladribine Treatment)||47
156095|NCT00436826|381418|P2|STARTED|Ext. Period (With Cladribine Treatment)||0
156096|NCT00436826|381419|P1|STARTED|Ext. Period (With Cladribine Treatment)||0
156097|NCT00436826|381414|P6|NOT COMPLETED|Double Blind Period||0
156098|NCT00436826|381415|P5|NOT COMPLETED|Double Blind Period||0
156099|NCT00436826|381416|P4|NOT COMPLETED|Double Blind Period||0
156100|NCT00436826|381417|P3|NOT COMPLETED|Double Blind Period||0
156101|NCT00436826|381418|P2|NOT COMPLETED|Double Blind Period||11
156102|NCT00436826|381419|P1|NOT COMPLETED|Double Blind Period||13
156103|NCT00436826|381414|P6|COMPLETED|Double Blind Period||0
156104|NCT00436826|381415|P5|COMPLETED|Double Blind Period||0
156105|NCT00436826|381416|P4|COMPLETED|Double Blind Period||0
156106|NCT00436826|381417|P3|COMPLETED|Double Blind Period||0
156107|NCT00436826|381418|P2|COMPLETED|Double Blind Period||37
156108|NCT00436826|381419|P1|COMPLETED|Double Blind Period||111
156109|NCT00436826|381414|P6|STARTED|Double Blind Period||0
156110|NCT00436826|381415|P5|STARTED|Double Blind Period||0
156111|NCT00436826|381416|P4|STARTED|Double Blind Period||0
156112|NCT00436826|381417|P3|STARTED|Double Blind Period||0
156113|NCT00436826|381418|P2|STARTED|Double Blind Period||48
156114|NCT00436826|381419|P1|STARTED|Double Blind Period||124
156115|NCT00436852|381441|P2|NOT COMPLETED|Overall Study||45
156116|NCT00436852|381442|P1|NOT COMPLETED|Overall Study||35
156117|NCT00436852|381441|P2|COMPLETED|Overall Study||2
156118|NCT00436852|381442|P1|COMPLETED|Overall Study||10
156119|NCT00436852|381441|P2|STARTED|Overall Study||47
156120|NCT00436852|381442|P1|STARTED|Overall Study||45
156121|NCT00436904|381450|P1|NOT COMPLETED|Overall Study||0
156122|NCT00436904|381450|P1|COMPLETED|Overall Study||30
156123|NCT00436904|381450|P1|STARTED|Overall Study||30
156124|NCT00436917|381459|P1|NOT COMPLETED|Overall Study||54
156125|NCT00436917|381459|P1|COMPLETED|Overall Study||0
156126|NCT00436917|381459|P1|STARTED|Overall Study|6 participants with cancellation, protocol violation and ineligible were excluded from all analysis.|54
156127|NCT00436956|381463|P2|NOT COMPLETED|Overall Study||0
156128|NCT00436956|381464|P1|NOT COMPLETED|Overall Study||1
156129|NCT00436956|381463|P2|COMPLETED|Overall Study||23
156130|NCT00436956|381464|P1|COMPLETED|Overall Study|One pt was not evaluable due to a cord compression on day 2 of therapy; was removed from the trial.|35
156131|NCT00436956|381463|P2|STARTED|Overall Study||23
156132|NCT00436956|381464|P1|STARTED|Overall Study||36
156133|NCT00436969|381475|P2|NOT COMPLETED|Overall Study||52
156134|NCT00436969|381476|P1|NOT COMPLETED|Overall Study||22
156135|NCT00436969|381475|P2|COMPLETED|Overall Study||134
156136|NCT00436969|381476|P1|COMPLETED|Overall Study||66
156137|NCT00436969|381475|P2|Randomized But Not Treated|Overall Study||3
156138|NCT00436969|381476|P1|Randomized But Not Treated|Overall Study||1
156139|NCT00436969|381475|P2|STARTED|Overall Study||186
156140|NCT00436969|381476|P1|STARTED|Overall Study||88
156141|NCT00436982|381526|P2|NOT COMPLETED|Overall Study||5
156142|NCT00436982|381527|P1|NOT COMPLETED|Overall Study||5
156143|NCT00436982|381526|P2|COMPLETED|Overall Study||25
156144|NCT00436982|381527|P1|COMPLETED|Overall Study||25
156145|NCT00436982|381526|P2|STARTED|Overall Study||30
156146|NCT00436982|381527|P1|STARTED|Overall Study||30
156147|NCT00437034|381533|P1|NOT COMPLETED|Overall Study||6
156148|NCT00437034|381533|P1|COMPLETED|Overall Study||0
156149|NCT00437034|381533|P1|STARTED|Overall Study||6
156150|NCT00437073|381539|P2|NOT COMPLETED|Overall Study||1
156151|NCT00437073|381540|P1|NOT COMPLETED|Overall Study||1
156152|NCT00437073|381539|P2|COMPLETED|Overall Study||8
156153|NCT00437073|381540|P1|COMPLETED|Overall Study||12
156154|NCT00437073|381539|P2|STARTED|Overall Study||9
156155|NCT00437073|381540|P1|STARTED|Overall Study||13
156156|NCT00437125|381568|P1|NOT COMPLETED|Overall Study||32
156157|NCT00437125|381568|P1|COMPLETED|Overall Study||119
156158|NCT00437125|381568|P1|STARTED|Overall Study||151
156159|NCT00437203|381597|P10|NOT COMPLETED|Overall Study||4
156160|NCT00437203|381598|P9|NOT COMPLETED|Overall Study||3
156161|NCT00437203|381599|P8|NOT COMPLETED|Overall Study||3
156162|NCT00437203|381600|P7|NOT COMPLETED|Overall Study||7
156163|NCT00437203|381601|P6|NOT COMPLETED|Overall Study||3
156164|NCT00437203|381602|P5|NOT COMPLETED|Overall Study||3
156165|NCT00437203|381603|P4|NOT COMPLETED|Overall Study||3
156166|NCT00437203|381604|P3|NOT COMPLETED|Overall Study||3
156167|NCT00437203|381605|P2|NOT COMPLETED|Overall Study||8
156168|NCT00437203|381606|P1|NOT COMPLETED|Overall Study||6
156169|NCT00437203|381597|P10|COMPLETED|Overall Study||0
156170|NCT00437203|381598|P9|COMPLETED|Overall Study||0
156171|NCT00437203|381599|P8|COMPLETED|Overall Study||0
156172|NCT00437203|381600|P7|COMPLETED|Overall Study||0
156173|NCT00437203|381601|P6|COMPLETED|Overall Study||0
156174|NCT00437203|381602|P5|COMPLETED|Overall Study||0
156175|NCT00437203|381603|P4|COMPLETED|Overall Study||0
156176|NCT00437203|381604|P3|COMPLETED|Overall Study||0
156177|NCT00437203|381605|P2|COMPLETED|Overall Study||0
156178|NCT00437203|381606|P1|COMPLETED|Overall Study||0
156179|NCT00437203|381597|P10|STARTED|Overall Study||4
156180|NCT00437203|381598|P9|STARTED|Overall Study||3
156181|NCT00437203|381599|P8|STARTED|Overall Study||3
156182|NCT00437203|381600|P7|STARTED|Overall Study||7
156183|NCT00437203|381601|P6|STARTED|Overall Study||3
156184|NCT00437203|381602|P5|STARTED|Overall Study||3
156185|NCT00437203|381603|P4|STARTED|Overall Study||3
156186|NCT00437203|381604|P3|STARTED|Overall Study||3
156187|NCT00437203|381605|P2|STARTED|Overall Study||8
156188|NCT00437203|381606|P1|STARTED|Overall Study||6
156189|NCT00437281|381730|P20|NOT COMPLETED|Overall Study||1
156190|NCT00437281|381731|P19|NOT COMPLETED|Overall Study||1
156191|NCT00437281|381732|P18|NOT COMPLETED|Overall Study||0
156192|NCT00437281|381733|P17|NOT COMPLETED|Overall Study||0
156193|NCT00437281|381734|P16|NOT COMPLETED|Overall Study||0
156194|NCT00437281|381735|P15|NOT COMPLETED|Overall Study||1
156195|NCT00437281|381736|P14|NOT COMPLETED|Overall Study||1
156196|NCT00437281|381737|P13|NOT COMPLETED|Overall Study||0
156197|NCT00437281|381738|P12|NOT COMPLETED|Overall Study||0
156198|NCT00437281|381739|P11|NOT COMPLETED|Overall Study||0
156199|NCT00437281|381740|P10|NOT COMPLETED|Overall Study||1
156200|NCT00437281|381741|P9|NOT COMPLETED|Overall Study||0
156201|NCT00437281|381742|P8|NOT COMPLETED|Overall Study||0
156202|NCT00437281|381743|P7|NOT COMPLETED|Overall Study||0
156203|NCT00437281|381744|P6|NOT COMPLETED|Overall Study||1
156204|NCT00437281|381745|P5|NOT COMPLETED|Overall Study||0
156205|NCT00437281|381746|P4|NOT COMPLETED|Overall Study||1
156206|NCT00437281|381747|P3|NOT COMPLETED|Overall Study||0
156207|NCT00437281|381748|P2|NOT COMPLETED|Overall Study||0
156208|NCT00437281|381749|P1|NOT COMPLETED|Overall Study||0
156209|NCT00437281|381730|P20|COMPLETED|Overall Study||2
156210|NCT00437281|381731|P19|COMPLETED|Overall Study||1
156211|NCT00437281|381732|P18|COMPLETED|Overall Study||4
156212|NCT00437281|381733|P17|COMPLETED|Overall Study||3
156213|NCT00437281|381734|P16|COMPLETED|Overall Study||3
156214|NCT00437281|381735|P15|COMPLETED|Overall Study||4
156215|NCT00437281|381736|P14|COMPLETED|Overall Study||2
156216|NCT00437281|381737|P13|COMPLETED|Overall Study||2
156217|NCT00437281|381738|P12|COMPLETED|Overall Study||3
156218|NCT00437281|381739|P11|COMPLETED|Overall Study||3
156219|NCT00437281|381740|P10|COMPLETED|Overall Study||4
156220|NCT00437281|381741|P9|COMPLETED|Overall Study||3
156221|NCT00437281|381742|P8|COMPLETED|Overall Study||3
156222|NCT00437281|381743|P7|COMPLETED|Overall Study||3
156223|NCT00437281|381744|P6|COMPLETED|Overall Study||3
156224|NCT00437281|381745|P5|COMPLETED|Overall Study||4
156225|NCT00437281|381746|P4|COMPLETED|Overall Study||2
156226|NCT00437281|381747|P3|COMPLETED|Overall Study||3
156227|NCT00437281|381748|P2|COMPLETED|Overall Study||3
156228|NCT00437281|381749|P1|COMPLETED|Overall Study||3
156229|NCT00437281|381730|P20|STARTED|Overall Study||3
156230|NCT00437281|381731|P19|STARTED|Overall Study||2
156231|NCT00437281|381732|P18|STARTED|Overall Study||4
156232|NCT00437281|381733|P17|STARTED|Overall Study||3
156233|NCT00437281|381734|P16|STARTED|Overall Study||3
156234|NCT00437281|381735|P15|STARTED|Overall Study||5
156235|NCT00437281|381736|P14|STARTED|Overall Study||3
156236|NCT00437281|381737|P13|STARTED|Overall Study||2
156237|NCT00437281|381738|P12|STARTED|Overall Study||3
156238|NCT00437281|381739|P11|STARTED|Overall Study||3
156239|NCT00437281|381740|P10|STARTED|Overall Study||5
156240|NCT00437281|381741|P9|STARTED|Overall Study||3
156241|NCT00437281|381742|P8|STARTED|Overall Study||3
156242|NCT00437281|381743|P7|STARTED|Overall Study||3
156243|NCT00437281|381744|P6|STARTED|Overall Study||4
156244|NCT00437281|381745|P5|STARTED|Overall Study||4
156245|NCT00437281|381746|P4|STARTED|Overall Study||3
156246|NCT00437281|381747|P3|STARTED|Overall Study||3
156247|NCT00437281|381748|P2|STARTED|Overall Study||3
156248|NCT00437281|381749|P1|STARTED|Overall Study||3
156249|NCT00437398|382043|P1|NOT COMPLETED|Overall Study||0
156250|NCT00437398|382043|P1|COMPLETED|Overall Study||2
156251|NCT00437398|382043|P1|STARTED|Overall Study||2
156252|NCT00437489|382050|P2|NOT COMPLETED|Overall Study||22
156253|NCT00437489|382051|P1|NOT COMPLETED|Overall Study||23
156254|NCT00437489|382050|P2|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
156255|NCT00437489|382051|P1|COMPLETED|Overall Study|2 subjects completed prior to study termination.|2
156256|NCT00437489|382050|P2|STARTED|Overall Study||24
156257|NCT00437489|382051|P1|STARTED|Overall Study||25
156258|NCT00430248|382066|P3|NOT COMPLETED|Overall Study||135
156259|NCT00430248|382067|P2|NOT COMPLETED|Overall Study||158
156260|NCT00430248|382068|P1|NOT COMPLETED|Overall Study||125
156261|NCT00430248|382066|P3|COMPLETED|Overall Study||621
156262|NCT00430248|382067|P2|COMPLETED|Overall Study||598
156263|NCT00430248|382068|P1|COMPLETED|Overall Study||632
156264|NCT00430248|382066|P3|STARTED|Overall Study||756
156265|NCT00430248|382067|P2|STARTED|Overall Study||756
156266|NCT00430248|382068|P1|STARTED|Overall Study||757
156267|NCT00430300|382128|P4|NOT COMPLETED|Overall Study||2
156268|NCT00430300|382129|P3|NOT COMPLETED|Overall Study||6
156269|NCT00430300|382130|P2|NOT COMPLETED|Overall Study||2
156270|NCT00430300|382131|P1|NOT COMPLETED|Overall Study||2
156271|NCT00430300|382128|P4|COMPLETED|Overall Study||15
156272|NCT00430300|382129|P3|COMPLETED|Overall Study||29
156273|NCT00430300|382130|P2|COMPLETED|Overall Study||16
156274|NCT00430300|382131|P1|COMPLETED|Overall Study||15
156275|NCT00430300|382128|P4|STARTED|Overall Study||17
156276|NCT00430300|382129|P3|STARTED|Overall Study||35
156277|NCT00430300|382130|P2|STARTED|Overall Study||18
156278|NCT00430300|382131|P1|STARTED|Overall Study||17
156279|NCT00430352|382233|P1|NOT COMPLETED|Overall Study||138
156280|NCT00430352|382233|P1|COMPLETED|Overall Study||407
156281|NCT00430352|382233|P1|STARTED|Overall Study||545
156282|NCT00430495|382251|P4|NOT COMPLETED|Overall Study||4
156283|NCT00430495|382252|P3|NOT COMPLETED|Overall Study||13
156284|NCT00430495|382253|P2|NOT COMPLETED|Overall Study||7
156285|NCT00430495|382254|P1|NOT COMPLETED|Overall Study||14
156286|NCT00430495|382251|P4|COMPLETED|Overall Study||60
156287|NCT00430495|382252|P3|COMPLETED|Overall Study||49
156288|NCT00430495|382253|P2|COMPLETED|Overall Study||59
156289|NCT00430495|382254|P1|COMPLETED|Overall Study||50
156290|NCT00430495|382251|P4|Treated|Overall Study||64
156291|NCT00430495|382252|P3|Treated|Overall Study||62
156292|NCT00430495|382253|P2|Treated|Overall Study||66
156293|NCT00430495|382254|P1|Treated|Overall Study||62
156294|NCT00430495|382251|P4|STARTED|Overall Study||64
156295|NCT00430495|382252|P3|STARTED|Overall Study||62
156296|NCT00430495|382253|P2|STARTED|Overall Study||66
156297|NCT00430495|382254|P1|STARTED|Overall Study||64
156298|NCT00430508|382296|P4|NOT COMPLETED|Overall Study||5
156299|NCT00430508|382297|P3|NOT COMPLETED|Overall Study||13
156300|NCT00430508|382298|P2|NOT COMPLETED|Overall Study||6
156301|NCT00430508|382299|P1|NOT COMPLETED|Overall Study||3
156302|NCT00430508|382296|P4|COMPLETED|Overall Study||269
156303|NCT00430508|382297|P3|COMPLETED|Overall Study||266
156304|NCT00430508|382298|P2|COMPLETED|Overall Study||272
156305|NCT00430508|382299|P1|COMPLETED|Overall Study||137
156306|NCT00430508|382296|P4|STARTED|Overall Study||274
156307|NCT00430508|382297|P3|STARTED|Overall Study||279
156308|NCT00430508|382298|P2|STARTED|Overall Study||278
156309|NCT00430508|382299|P1|STARTED|Overall Study||140
156310|NCT00430625|382335|P2|NOT COMPLETED|Overall Study||0
156311|NCT00430625|382336|P1|NOT COMPLETED|Overall Study||0
156312|NCT00430625|382335|P2|COMPLETED|Overall Study||12
156313|NCT00430625|382336|P1|COMPLETED|Overall Study||13
156314|NCT00430625|382335|P2|STARTED|Overall Study||12
156315|NCT00430625|382336|P1|STARTED|Overall Study||13
156316|NCT00430638|382354|P2|NOT COMPLETED|Overall Study||48
156317|NCT00430638|382355|P1|NOT COMPLETED|Overall Study||78
156318|NCT00430638|382354|P2|COMPLETED|Overall Study||92
156319|NCT00430638|382355|P1|COMPLETED|Overall Study||60
156320|NCT00430638|382354|P2|STARTED|Overall Study|2 participants were erroneously assigned to olmesartan 40 mg instead of 20 mg|140
156321|NCT00430638|382355|P1|STARTED|Overall Study||138
156322|NCT00430677|382374|P3|NOT COMPLETED|Long-term Extension Period||63
156323|NCT00430677|382375|P2|NOT COMPLETED|Long-term Extension Period||58
156324|NCT00430677|382376|P1|NOT COMPLETED|Long-term Extension Period||60
156325|NCT00430677|382374|P3|COMPLETED|Long-term Extension Period|Completed the long-term extension period|11
156326|NCT00430677|382375|P2|COMPLETED|Long-term Extension Period|Completed the long-term extension period|9
156327|NCT00430677|382376|P1|COMPLETED|Long-term Extension Period|Completed the long-term extension period|10
156328|NCT00430677|382374|P3|STARTED|Long-term Extension Period||74
156329|NCT00430677|382375|P2|STARTED|Long-term Extension Period||67
156330|NCT00430677|382376|P1|STARTED|Long-term Extension Period||70
156331|NCT00430677|382374|P3|NOT COMPLETED|Short-term Period||22
156332|NCT00430677|382375|P2|NOT COMPLETED|Short-term Period||25
156333|NCT00430677|382376|P1|NOT COMPLETED|Short-term Period||23
156334|NCT00430677|382374|P3|COMPLETED|Short-term Period|Completed the short-term period|78
156335|NCT00430677|382375|P2|COMPLETED|Short-term Period|Completed the short-term period|74
156336|NCT00430677|382376|P1|COMPLETED|Short-term Period|Completed the short-term period|76
156337|NCT00430677|382374|P3|STARTED|Short-term Period||100
156338|NCT00430677|382375|P2|STARTED|Short-term Period|1 participant took infliximab on day 1 and was discontinued before receiving study medication.|99
156339|NCT00430677|382376|P1|STARTED|Short-term Period|1 participant died before receiving the first dose of study medication|99
156340|NCT00430716|382500|P3|NOT COMPLETED|Open Label Phase||7
156341|NCT00430716|382501|P2|NOT COMPLETED|Open Label Phase||7
156342|NCT00430716|382502|P1|NOT COMPLETED|Open Label Phase||9
156343|NCT00430716|382500|P3|COMPLETED|Open Label Phase||32
156344|NCT00430716|382501|P2|COMPLETED|Open Label Phase||31
156345|NCT00430716|382502|P1|COMPLETED|Open Label Phase||27
156346|NCT00430716|382500|P3|STARTED|Open Label Phase||39
156347|NCT00430716|382501|P2|STARTED|Open Label Phase||38
156348|NCT00430716|382502|P1|STARTED|Open Label Phase||36
156349|NCT00430716|382500|P3|NOT COMPLETED|Double Blind Phase||6
156350|NCT00430716|382501|P2|NOT COMPLETED|Double Blind Phase||5
156351|NCT00430716|382502|P1|NOT COMPLETED|Double Blind Phase||6
156352|NCT00430716|382500|P3|COMPLETED|Double Blind Phase||39
156353|NCT00430716|382501|P2|COMPLETED|Double Blind Phase||38
156354|NCT00430716|382502|P1|COMPLETED|Double Blind Phase||36
156355|NCT00430716|382500|P3|Treated|Double Blind Phase||45
156356|NCT00430716|382501|P2|Treated|Double Blind Phase||43
156357|NCT00430716|382502|P1|Treated|Double Blind Phase||41
156358|NCT00430716|382500|P3|STARTED|Double Blind Phase||45
156359|NCT00430716|382501|P2|STARTED|Double Blind Phase||43
156360|NCT00430716|382502|P1|STARTED|Double Blind Phase||42
156361|NCT00430755|382531|P1|NOT COMPLETED|Overall Study||53
156362|NCT00430755|382531|P1|COMPLETED|Overall Study||45
156363|NCT00430755|382531|P1|STARTED|Overall Study||98
156364|NCT00430768|382538|P3|NOT COMPLETED|Overall Study||0
156365|NCT00430768|382539|P2|NOT COMPLETED|Overall Study||0
156366|NCT00430768|382540|P1|NOT COMPLETED|Overall Study||0
156367|NCT00430768|382538|P3|COMPLETED|Overall Study||3
156368|NCT00430768|382539|P2|COMPLETED|Overall Study||3
156369|NCT00430768|382540|P1|COMPLETED|Overall Study||3
156370|NCT00430768|382538|P3|STARTED|Overall Study||3
156371|NCT00430768|382539|P2|STARTED|Overall Study||3
156372|NCT00430768|382540|P1|STARTED|Overall Study||3
156373|NCT00430781|382557|P3|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||20
156374|NCT00430781|382558|P2|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||18
156375|NCT00430781|382559|P1|NOT COMPLETED|End-of-Study Analysis; 28 July 2011||24
156376|NCT00430781|382557|P3|COMPLETED|End-of-Study Analysis; 28 July 2011||54
156377|NCT00430781|382558|P2|COMPLETED|End-of-Study Analysis; 28 July 2011||59
156378|NCT00430781|382559|P1|COMPLETED|End-of-Study Analysis; 28 July 2011||53
156379|NCT00430781|382557|P3|STARTED|End-of-Study Analysis; 28 July 2011||74
156380|NCT00430781|382558|P2|STARTED|End-of-Study Analysis; 28 July 2011|1 participant randomized to lapatinib (final analysis table) actually received combination therapy.|77
156381|NCT00430781|382559|P1|STARTED|End-of-Study Analysis; 28 July 2011|Enrollment continued in this arm after data cut for Interim Analysis and before arm closed.|77
156382|NCT00430781|382557|P3|NOT COMPLETED|Final Analysis; 31 July 2008||48
156383|NCT00430781|382558|P2|NOT COMPLETED|Final Analysis; 31 July 2008||39
156384|NCT00430781|382559|P1|NOT COMPLETED|Final Analysis; 31 July 2008||0
156385|NCT00430781|382557|P3|COMPLETED|Final Analysis; 31 July 2008||26
156386|NCT00430781|382558|P2|COMPLETED|Final Analysis; 31 July 2008||39
156387|NCT00430781|382559|P1|COMPLETED|Final Analysis; 31 July 2008||0
156388|NCT00430781|382557|P3|Ongoing|Final Analysis; 31 July 2008||32
156389|NCT00430781|382558|P2|Ongoing|Final Analysis; 31 July 2008||29
156390|NCT00430781|382559|P1|Ongoing|Final Analysis; 31 July 2008||0
156391|NCT00430781|382557|P3|STARTED|Final Analysis; 31 July 2008||74
156392|NCT00430781|382558|P2|STARTED|Final Analysis; 31 July 2008||78
156393|NCT00430781|382559|P1|STARTED|Final Analysis; 31 July 2008||0
156394|NCT00430781|382557|P3|NOT COMPLETED|Interim Analysis; 11 February 2008||60
156395|NCT00430781|382558|P2|NOT COMPLETED|Interim Analysis; 11 February 2008||58
156396|NCT00430781|382559|P1|NOT COMPLETED|Interim Analysis; 11 February 2008||59
156397|NCT00430781|382557|P3|COMPLETED|Interim Analysis; 11 February 2008||0
156398|NCT00430781|382558|P2|COMPLETED|Interim Analysis; 11 February 2008||0
156399|NCT00430781|382559|P1|COMPLETED|Interim Analysis; 11 February 2008||0
156400|NCT00430781|382557|P3|Ongoing|Interim Analysis; 11 February 2008||25
156401|NCT00430781|382558|P2|Ongoing|Interim Analysis; 11 February 2008||20
156402|NCT00430781|382559|P1|Ongoing|Interim Analysis; 11 February 2008||23
156403|NCT00430781|382557|P3|STARTED|Interim Analysis; 11 February 2008||60
156404|NCT00430781|382558|P2|STARTED|Interim Analysis; 11 February 2008||58
156405|NCT00430781|382559|P1|STARTED|Interim Analysis; 11 February 2008||59
156406|NCT00430937|382584|P2|NOT COMPLETED|Overall Study||28
156407|NCT00430937|382585|P1|NOT COMPLETED|Overall Study||27
156408|NCT00430937|382584|P2|COMPLETED|Overall Study||64
156409|NCT00430937|382585|P1|COMPLETED|Overall Study||70
156410|NCT00430937|382584|P2|STARTED|Overall Study||92
156411|NCT00430937|382585|P1|STARTED|Overall Study|Additional 5 participants were randomized; however, they were not exposed to study drug by mistake.|97
156412|NCT00430950|382595|P2|NOT COMPLETED|Overall Study||13
156413|NCT00430950|382596|P1|NOT COMPLETED|Overall Study||13
156414|NCT00430950|382595|P2|COMPLETED|Overall Study||495
156415|NCT00430950|382596|P1|COMPLETED|Overall Study||489
156416|NCT00430950|382595|P2|STARTED|Overall Study||508
156417|NCT00430950|382596|P1|STARTED|Overall Study||502
156418|NCT00431041|382612|P2|NOT COMPLETED|Overall Study||24
156419|NCT00431041|382613|P1|NOT COMPLETED|Overall Study||16
156420|NCT00431041|382612|P2|COMPLETED|Overall Study||40
156421|NCT00431041|382613|P1|COMPLETED|Overall Study||52
156422|NCT00431041|382612|P2|STARTED|Overall Study|Data represents ITT Population: All randomized subjects|64
156423|NCT00431041|382613|P1|STARTED|Overall Study|Data represents Intention To Treat(ITT) Population: All randomized subjects|68
156424|NCT00431067|382625|P1|NOT COMPLETED|Overall Study||41
156425|NCT00431067|382625|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (22-Sep-2009)|0
156426|NCT00431067|382625|P1|STARTED|Overall Study|52 patients screened, 41 treated|41
156427|NCT00431132|382633|P1|NOT COMPLETED|Overall Study||44
156428|NCT00431132|382633|P1|COMPLETED|Overall Study||292
156429|NCT00431132|382633|P1|STARTED|Overall Study||336
156430|NCT00431184|382640|P2|NOT COMPLETED|Second Intervention (Day 2)||0
156431|NCT00431184|382641|P1|NOT COMPLETED|Second Intervention (Day 2)||0
156432|NCT00431184|382640|P2|COMPLETED|Second Intervention (Day 2)||9
156433|NCT00431184|382641|P1|COMPLETED|Second Intervention (Day 2)||10
156434|NCT00431184|382640|P2|STARTED|Second Intervention (Day 2)||9
156435|NCT00431184|382641|P1|STARTED|Second Intervention (Day 2)||10
156436|NCT00431184|382640|P2|NOT COMPLETED|1st Intervention (Day 1)||0
156437|NCT00431184|382641|P1|NOT COMPLETED|1st Intervention (Day 1)||0
156438|NCT00431184|382640|P2|COMPLETED|1st Intervention (Day 1)||9
156439|NCT00431184|382641|P1|COMPLETED|1st Intervention (Day 1)||10
156440|NCT00431184|382640|P2|STARTED|1st Intervention (Day 1)||9
156441|NCT00431184|382641|P1|STARTED|1st Intervention (Day 1)||10
156442|NCT00431444|382651|P2|NOT COMPLETED|Overall Study||7
156443|NCT00431444|382652|P1|NOT COMPLETED|Overall Study||5
156444|NCT00431444|382651|P2|COMPLETED|Overall Study||46
156445|NCT00431444|382652|P1|COMPLETED|Overall Study||51
156446|NCT00431444|382651|P2|STARTED|Overall Study|"Initially 110 randomized, 1 participant of Raloxifene group never took study drug."|53
156447|NCT00431444|382652|P1|STARTED|Overall Study||56
156448|NCT00437645|382678|P2|NOT COMPLETED|Overall Study||115
156449|NCT00437645|382679|P1|NOT COMPLETED|Overall Study||35
156450|NCT00437645|382678|P2|COMPLETED|Overall Study||476
156451|NCT00437645|382679|P1|COMPLETED|Overall Study||557
156452|NCT00437645|382678|P2|STARTED|Overall Study||591
156453|NCT00437645|382679|P1|STARTED|Overall Study||592
156454|NCT00438932|382697|P4|NOT COMPLETED|Overall Study||0
156455|NCT00438932|382698|P3|NOT COMPLETED|Overall Study||0
156456|NCT00438932|382699|P2|NOT COMPLETED|Overall Study||0
156457|NCT00438932|382700|P1|NOT COMPLETED|Overall Study||0
156458|NCT00438932|382697|P4|COMPLETED|Overall Study||4
156459|NCT00438932|382698|P3|COMPLETED|Overall Study||4
156460|NCT00438932|382699|P2|COMPLETED|Overall Study||4
156461|NCT00438932|382700|P1|COMPLETED|Overall Study||4
156462|NCT00438932|382697|P4|STARTED|Overall Study||4
156463|NCT00438932|382698|P3|STARTED|Overall Study||4
156464|NCT00438932|382699|P2|STARTED|Overall Study||4
156465|NCT00438932|382700|P1|STARTED|Overall Study||4
156466|NCT00438971|382714|P1|NOT COMPLETED|Overall Study||2
156467|NCT00438971|382714|P1|COMPLETED|Overall Study||15
156468|NCT00438971|382714|P1|STARTED|Overall Study||17
156469|NCT00439140|382728|P3|NOT COMPLETED|Treatment Cycle 2||0
156470|NCT00439140|382729|P2|NOT COMPLETED|Treatment Cycle 2||1
156471|NCT00439140|382730|P1|NOT COMPLETED|Treatment Cycle 2||2
156472|NCT00439140|382728|P3|COMPLETED|Treatment Cycle 2||0
156473|NCT00439140|382729|P2|COMPLETED|Treatment Cycle 2||6
156474|NCT00439140|382730|P1|COMPLETED|Treatment Cycle 2||11
156475|NCT00439140|382728|P3|STARTED|Treatment Cycle 2|No patients received placebo in Cycle 2.|0
156476|NCT00439140|382729|P2|STARTED|Treatment Cycle 2|6 patients from the 300U arm plus 1 patient from the placebo arm in Cycle 1 entered Cycle 2.|7
156477|NCT00439140|382730|P1|STARTED|Treatment Cycle 2|8 patients from the 200U arm plus 5 patients from the placebo arm in Cycle 1 entered Cycle 2.|13
156478|NCT00439140|382728|P3|NOT COMPLETED|Treatment Cycle 1||1
156479|NCT00439140|382729|P2|NOT COMPLETED|Treatment Cycle 1||4
156480|NCT00439140|382730|P1|NOT COMPLETED|Treatment Cycle 1||1
156481|NCT00439140|382728|P3|COMPLETED|Treatment Cycle 1|5 patients did not enter Cycle 2. 6 patients received botulinum toxin Type A in Cycle 2.|11
156482|NCT00439140|382729|P2|COMPLETED|Treatment Cycle 1||10
156483|NCT00439140|382730|P1|COMPLETED|Treatment Cycle 1||14
156484|NCT00439140|382728|P3|STARTED|Treatment Cycle 1||12
156485|NCT00439140|382729|P2|STARTED|Treatment Cycle 1||14
156486|NCT00439140|382730|P1|STARTED|Treatment Cycle 1||15
156487|NCT00439179|382763|P4|NOT COMPLETED|Overall Study||0
156488|NCT00439179|382764|P3|NOT COMPLETED|Overall Study||0
156489|NCT00439179|382765|P2|NOT COMPLETED|Overall Study||2
156490|NCT00439179|382766|P1|NOT COMPLETED|Overall Study||0
156491|NCT00439179|382763|P4|COMPLETED|Overall Study||5
156492|NCT00439179|382764|P3|COMPLETED|Overall Study||6
156493|NCT00439179|382765|P2|COMPLETED|Overall Study||11
156494|NCT00439179|382766|P1|COMPLETED|Overall Study||3
156495|NCT00439179|382763|P4|STARTED|Overall Study|2 with biliry|5
156496|NCT00439179|382764|P3|STARTED|Overall Study|2 with biliary|6
156497|NCT00439179|382765|P2|STARTED|Overall Study|2 with biliary|13
156498|NCT00439179|382766|P1|STARTED|Overall Study|1 with biliary|3
156499|NCT00439218|382780|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||0
156500|NCT00439218|382780|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
156501|NCT00439218|382780|P1|STARTED|Cohort 2 (500 mg/kg/Day)|One new subject was enrolled into the study after Cohort 1 completed the study.|1
156502|NCT00439218|382780|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||1
156503|NCT00439218|382780|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)|3 subjects completed the study in Cohort 1. Cohort 2 was then opened for new enrollments.|3
156504|NCT00439218|382780|P1|STARTED|Cohort 1 (500 mg/kg/Day)||4
156505|NCT00439231|382791|P1|NOT COMPLETED|Overall Study||28
156506|NCT00439231|382791|P1|COMPLETED|Overall Study|5 subjects had a partial response, 0 complete response, 28 completed off study,|5
156507|NCT00439231|382791|P1|STARTED|Overall Study||33
156508|NCT00439244|382798|P3|NOT COMPLETED|Overall Study||7
156509|NCT00439244|382799|P2|NOT COMPLETED|Overall Study||6
156510|NCT00439244|382800|P1|NOT COMPLETED|Overall Study||11
156511|NCT00439244|382798|P3|COMPLETED|Overall Study||131
156512|NCT00439244|382799|P2|COMPLETED|Overall Study||131
156513|NCT00439244|382800|P1|COMPLETED|Overall Study||126
156514|NCT00439244|382798|P3|Safety Population|Overall Study||137
156515|NCT00439244|382799|P2|Safety Population|Overall Study||137
156516|NCT00439244|382800|P1|Safety Population|Overall Study|Total safety population is 411. One patient was randomized, but never received any study medication.|137
156517|NCT00439244|382798|P3|STARTED|Overall Study||138
156518|NCT00439244|382799|P2|STARTED|Overall Study||137
156519|NCT00439244|382800|P1|STARTED|Overall Study|"Started indicates randomized as well as intent to treat (ITT) population enrolled to study."|137
156520|NCT00439270|382825|P5|NOT COMPLETED|Phase 2 (51.6 Months)||0
156521|NCT00439270|382826|P4|NOT COMPLETED|Phase 2 (51.6 Months)||34
156522|NCT00439270|382827|P3|NOT COMPLETED|Phase 2 (51.6 Months)||0
156523|NCT00439270|382828|P2|NOT COMPLETED|Phase 2 (51.6 Months)||0
156524|NCT00439270|382829|P1|NOT COMPLETED|Phase 2 (51.6 Months)||0
156525|NCT00439270|382825|P5|COMPLETED|Phase 2 (51.6 Months)||0
156526|NCT00439270|382826|P4|COMPLETED|Phase 2 (51.6 Months)||0
156527|NCT00439270|382827|P3|COMPLETED|Phase 2 (51.6 Months)||0
156528|NCT00439270|382828|P2|COMPLETED|Phase 2 (51.6 Months)||0
156529|NCT00439270|382829|P1|COMPLETED|Phase 2 (51.6 Months)||0
156530|NCT00439270|382825|P5|STARTED|Phase 2 (51.6 Months)||0
156531|NCT00439270|382826|P4|STARTED|Phase 2 (51.6 Months)|Includes 4 patients who completed Phase 1|34
156532|NCT00439270|382827|P3|STARTED|Phase 2 (51.6 Months)||0
156533|NCT00439270|382828|P2|STARTED|Phase 2 (51.6 Months)||0
156534|NCT00439270|382829|P1|STARTED|Phase 2 (51.6 Months)||0
156535|NCT00439270|382825|P5|NOT COMPLETED|Phase 1 (18.1 Months)||3
156536|NCT00439270|382826|P4|NOT COMPLETED|Phase 1 (18.1 Months)||0
156537|NCT00439270|382827|P3|NOT COMPLETED|Phase 1 (18.1 Months)||3
156538|NCT00439270|382828|P2|NOT COMPLETED|Phase 1 (18.1 Months)||3
156539|NCT00439270|382829|P1|NOT COMPLETED|Phase 1 (18.1 Months)||3
156540|NCT00439270|382825|P5|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
156541|NCT00439270|382826|P4|COMPLETED|Phase 1 (18.1 Months)|Remained on study|4
156542|NCT00439270|382827|P3|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
156543|NCT00439270|382828|P2|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
156544|NCT00439270|382829|P1|COMPLETED|Phase 1 (18.1 Months)|Remained on study|0
156545|NCT00439270|382825|P5|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
156546|NCT00439270|382826|P4|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|4
156547|NCT00439270|382827|P3|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
156548|NCT00439270|382828|P2|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
156549|NCT00439270|382829|P1|STARTED|Phase 1 (18.1 Months)|Participants who received treatment|3
156550|NCT00439309|382870|P2|NOT COMPLETED|Follow-Up||2
156551|NCT00439309|382871|P1|NOT COMPLETED|Follow-Up||3
156552|NCT00439309|382870|P2|COMPLETED|Follow-Up||13
156553|NCT00439309|382871|P1|COMPLETED|Follow-Up||51
156554|NCT00439309|382870|P2|STARTED|Follow-Up||15
156555|NCT00439309|382871|P1|STARTED|Follow-Up||54
156556|NCT00439309|382870|P2|NOT COMPLETED|Treatment||0
156557|NCT00439309|382871|P1|NOT COMPLETED|Treatment||0
156558|NCT00439309|382870|P2|COMPLETED|Treatment||15
156559|NCT00439309|382871|P1|COMPLETED|Treatment||54
156560|NCT00439309|382870|P2|STARTED|Treatment||15
156561|NCT00439309|382871|P1|STARTED|Treatment||54
156562|NCT00439335|382887|P2|NOT COMPLETED|Overall Study||0
156563|NCT00439335|382888|P1|NOT COMPLETED|Overall Study||2
156564|NCT00439335|382887|P2|COMPLETED|Overall Study||114
156565|NCT00439335|382888|P1|COMPLETED|Overall Study||111
156566|NCT00439335|382887|P2|STARTED|Overall Study||114
156567|NCT00439335|382888|P1|STARTED|Overall Study||113
156568|NCT00439413|382920|P2|NOT COMPLETED|Overall Study||37
156569|NCT00439413|382921|P1|NOT COMPLETED|Overall Study||31
156570|NCT00439413|382920|P2|COMPLETED|Overall Study||88
156571|NCT00439413|382921|P1|COMPLETED|Overall Study||90
156572|NCT00439413|382920|P2|STARTED|Overall Study||125
156573|NCT00439413|382921|P1|STARTED|Overall Study||121
156574|NCT00439517|382931|P2|NOT COMPLETED|Overall Study||0
156575|NCT00439517|382932|P1|NOT COMPLETED|Overall Study||2
156576|NCT00439517|382931|P2|COMPLETED|Overall Study||150
156577|NCT00439517|382932|P1|COMPLETED|Overall Study||150
156578|NCT00439517|382931|P2|STARTED|Overall Study||150
156579|NCT00439517|382932|P1|STARTED|Overall Study||152
156580|NCT00439569|382954|P1|NOT COMPLETED|Cohort 2 (500 mg/kg/Day)||1
156581|NCT00439569|382954|P1|COMPLETED|Cohort 2 (500 mg/kg/Day)||1
156582|NCT00439569|382954|P1|STARTED|Cohort 2 (500 mg/kg/Day)|2 new subjects in Cohort 2 were enrolled into the study after Cohort 1 completed the study.|2
156583|NCT00439569|382954|P1|NOT COMPLETED|Cohort 1 (500 mg/kg/Day)||4
156584|NCT00439569|382954|P1|COMPLETED|Cohort 1 (500 mg/kg/Day)||3
156585|NCT00439569|382954|P1|STARTED|Cohort 1 (500 mg/kg/Day)||7
156586|NCT00439608|382965|P1|NOT COMPLETED|Overall Study||0
156587|NCT00439608|382965|P1|COMPLETED|Overall Study||60
156588|NCT00439608|382965|P1|STARTED|Overall Study||60
156589|NCT00439647|382971|P2|NOT COMPLETED|Overall Study||71
156590|NCT00439647|382972|P1|NOT COMPLETED|Overall Study||58
156591|NCT00439647|382971|P2|COMPLETED|Overall Study||540
156592|NCT00439647|382972|P1|COMPLETED|Overall Study||530
156593|NCT00439647|382971|P2|Modified Intent to Treat (mITT)|Overall Study||574
156594|NCT00439647|382972|P1|Modified Intent to Treat (mITT)|Overall Study||553
156595|NCT00439647|382971|P2|STARTED|Overall Study||611
156596|NCT00439647|382972|P1|STARTED|Overall Study|"Started indicates intent to treat (ITT) and safety set."|588
156597|NCT00439725|383006|P2|NOT COMPLETED|Observational Period||7
156598|NCT00439725|383007|P1|NOT COMPLETED|Observational Period||8
156599|NCT00439725|383006|P2|COMPLETED|Observational Period||553
156600|NCT00439725|383007|P1|COMPLETED|Observational Period||569
156601|NCT00439725|383006|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|560
156602|NCT00439725|383007|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|577
156603|NCT00439725|383006|P2|NOT COMPLETED|Treatment Period||246
156604|NCT00439725|383007|P1|NOT COMPLETED|Treatment Period||236
156605|NCT00439725|383006|P2|COMPLETED|Treatment Period||349
156606|NCT00439725|383007|P1|COMPLETED|Treatment Period||366
156607|NCT00439725|383006|P2|Participants Received Treatment|Treatment Period|Safety population|590
156608|NCT00439725|383007|P1|Participants Received Treatment|Treatment Period|Safety population|598
156609|NCT00439725|383006|P2|STARTED|Treatment Period||595
156610|NCT00439725|383007|P1|STARTED|Treatment Period||602
156611|NCT00439738|383053|P2|NOT COMPLETED|Overall Study||28
156612|NCT00439738|383054|P1|NOT COMPLETED|Overall Study||36
156613|NCT00439738|383053|P2|COMPLETED|Overall Study||178
156614|NCT00439738|383054|P1|COMPLETED|Overall Study||170
156615|NCT00439738|383053|P2|STARTED|Overall Study||206
156616|NCT00439738|383054|P1|STARTED|Overall Study||206
156617|NCT00439777|383072|P2|NOT COMPLETED|Observational Period||41
156618|NCT00439777|383073|P1|NOT COMPLETED|Observational Period||41
156619|NCT00439777|383072|P2|COMPLETED|Observational Period||2156
156620|NCT00439777|383073|P1|COMPLETED|Observational Period||2165
156621|NCT00439777|383072|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2197
156622|NCT00439777|383073|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|2206
156623|NCT00439777|383072|P2|NOT COMPLETED|Treatment Period||459
156624|NCT00439777|383073|P1|NOT COMPLETED|Treatment Period||419
156625|NCT00439777|383072|P2|COMPLETED|Treatment Period||1954
156626|NCT00439777|383073|P1|COMPLETED|Treatment Period||2001
156627|NCT00439777|383072|P2|Participants Received Treatment|Treatment Period||2405
156628|NCT00439777|383073|P1|Participants Received Treatment|Treatment Period||2412
156629|NCT00439777|383072|P2|STARTED|Treatment Period||2413
156630|NCT00439777|383073|P1|STARTED|Treatment Period||2420
156631|NCT00439946|383109|P1|NOT COMPLETED|Overall Study||0
156632|NCT00439946|383109|P1|COMPLETED|Overall Study||8
156633|NCT00439946|383109|P1|STARTED|Overall Study||8
156634|NCT00440011|383128|P2|NOT COMPLETED|Overall Study||3
156635|NCT00440011|383129|P1|NOT COMPLETED|Overall Study||4
156636|NCT00440011|383128|P2|COMPLETED|Overall Study||132
156637|NCT00440011|383129|P1|COMPLETED|Overall Study||127
156638|NCT00440011|383128|P2|STARTED|Overall Study||135
156639|NCT00440011|383129|P1|STARTED|Overall Study||131
156640|NCT00440050|383139|P2|NOT COMPLETED|Overall Study||67
156641|NCT00440050|383140|P1|NOT COMPLETED|Overall Study||40
156642|NCT00440050|383139|P2|COMPLETED|Overall Study||171
156643|NCT00440050|383140|P1|COMPLETED|Overall Study||124
156644|NCT00440050|383139|P2|STARTED|Overall Study||238
156645|NCT00440050|383140|P1|STARTED|Overall Study||164
156646|NCT00440115|383155|P3|NOT COMPLETED|Overall Study||6
156647|NCT00440115|383156|P2|NOT COMPLETED|Overall Study||11
156648|NCT00440115|383157|P1|NOT COMPLETED|Overall Study||7
156649|NCT00440115|383155|P3|COMPLETED|Overall Study||244
156650|NCT00440115|383156|P2|COMPLETED|Overall Study||238
156651|NCT00440115|383157|P1|COMPLETED|Overall Study||244
156652|NCT00440115|383155|P3|STARTED|Overall Study||250
156653|NCT00440115|383156|P2|STARTED|Overall Study||249
156654|NCT00440115|383157|P1|STARTED|Overall Study||251
156655|NCT00440180|383173|P2|NOT COMPLETED|Overall Study||0
156656|NCT00440180|383174|P1|NOT COMPLETED|Overall Study||0
156657|NCT00440180|383173|P2|COMPLETED|Overall Study||10
156658|NCT00440180|383174|P1|COMPLETED|Overall Study||10
156659|NCT00440180|383173|P2|STARTED|Overall Study||10
156660|NCT00440180|383174|P1|STARTED|Overall Study||10
156661|NCT00440193|383182|P2|NOT COMPLETED|Observational Period||38
156662|NCT00440193|383183|P1|NOT COMPLETED|Observational Period||45
156663|NCT00440193|383182|P2|COMPLETED|Observational Period||1369
156664|NCT00440193|383183|P1|COMPLETED|Observational Period||1380
156665|NCT00440193|383182|P2|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1407
156666|NCT00440193|383183|P1|STARTED|Observational Period|All participants who took any study medication and entered the observational period.|1425
156667|NCT00440193|383182|P2|NOT COMPLETED|Treatment Period||351
156668|NCT00440193|383183|P1|NOT COMPLETED|Treatment Period||305
156669|NCT00440193|383182|P2|COMPLETED|Treatment Period||1367
156670|NCT00440193|383183|P1|COMPLETED|Treatment Period||1426
156671|NCT00440193|383182|P2|Participants Received Treatment|Treatment Period||1711
156672|NCT00440193|383183|P1|Participants Received Treatment|Treatment Period||1718
156673|NCT00440193|383182|P2|STARTED|Treatment Period||1718
156674|NCT00440193|383183|P1|STARTED|Treatment Period||1731
156675|NCT00440232|383219|P2|NOT COMPLETED|Overall Study||4
156676|NCT00440232|383220|P1|NOT COMPLETED|Overall Study||3
156677|NCT00440232|383219|P2|COMPLETED|Overall Study||34
156678|NCT00440232|383220|P1|COMPLETED|Overall Study||33
156679|NCT00440232|383219|P2|STARTED|Overall Study||38
156680|NCT00440232|383220|P1|STARTED|Overall Study||36
156681|NCT00440271|383230|P2|NOT COMPLETED|Overall Study||15
156682|NCT00440271|383231|P1|NOT COMPLETED|Overall Study||12
156683|NCT00440271|383230|P2|COMPLETED|Overall Study||3
156684|NCT00440271|383231|P1|COMPLETED|Overall Study||3
156685|NCT00440271|383230|P2|STARTED|Overall Study||18
156686|NCT00440271|383231|P1|STARTED|Overall Study||15
156687|NCT00440297|383265|P2|NOT COMPLETED|Overall Study||18
156688|NCT00440297|383266|P1|NOT COMPLETED|Overall Study||23
156689|NCT00440297|383265|P2|COMPLETED|Overall Study||120
156690|NCT00440297|383266|P1|COMPLETED|Overall Study||116
156691|NCT00440297|383265|P2|Vaccination Visit 4|Overall Study||122
156692|NCT00440297|383266|P1|Vaccination Visit 4|Overall Study||116
156693|NCT00440297|383265|P2|Vaccination Visit 3|Overall Study||125
156694|NCT00440297|383266|P1|Vaccination Visit 3|Overall Study||124
156695|NCT00440297|383265|P2|Vaccination Visit 2|Overall Study||134
156696|NCT00440297|383266|P1|Vaccination Visit 2|Overall Study||136
156697|NCT00440297|383265|P2|Vaccination Visit 1|Overall Study||138
156698|NCT00440297|383266|P1|Vaccination Visit 1|Overall Study||138
156699|NCT00440297|383265|P2|STARTED|Overall Study||138
156700|NCT00440297|383266|P1|STARTED|Overall Study||139
156701|NCT00440310|383282|P2|NOT COMPLETED|Overall Study||30
156702|NCT00440310|383283|P1|NOT COMPLETED|Overall Study||28
156703|NCT00440310|383282|P2|COMPLETED|Overall Study||209
156704|NCT00440310|383283|P1|COMPLETED|Overall Study||216
156705|NCT00440310|383282|P2|Treated|Overall Study||232
156706|NCT00440310|383283|P1|Treated|Overall Study||222
156707|NCT00440310|383282|P2|STARTED|Overall Study||239
156708|NCT00440310|383283|P1|STARTED|Overall Study||244
156709|NCT00440401|383291|P2|NOT COMPLETED|Overall Study||6
156710|NCT00440401|383292|P1|NOT COMPLETED|Overall Study||4
156711|NCT00440401|383291|P2|COMPLETED|Overall Study||54
156712|NCT00440401|383292|P1|COMPLETED|Overall Study||55
156713|NCT00440401|383291|P2|STARTED|Overall Study||60
156714|NCT00440401|383292|P1|STARTED|Overall Study||59
156715|NCT00440466|383303|P3|NOT COMPLETED|Overall Study||41
156716|NCT00440466|383304|P2|NOT COMPLETED|Overall Study||15
156717|NCT00440466|383305|P1|NOT COMPLETED|Overall Study||13
156718|NCT00440466|383303|P3|COMPLETED|Overall Study||174
156719|NCT00440466|383304|P2|COMPLETED|Overall Study||92
156720|NCT00440466|383305|P1|COMPLETED|Overall Study||95
156721|NCT00440466|383303|P3|STARTED|Overall Study||215
156722|NCT00440466|383304|P2|STARTED|Overall Study||107
156723|NCT00440466|383305|P1|STARTED|Overall Study||108
156724|NCT00440505|383337|P6|NOT COMPLETED|Third Intervention||0
156725|NCT00440505|383338|P5|NOT COMPLETED|Third Intervention||0
156726|NCT00440505|383339|P4|NOT COMPLETED|Third Intervention||1
156727|NCT00440505|383340|P3|NOT COMPLETED|Third Intervention||0
156728|NCT00440505|383341|P2|NOT COMPLETED|Third Intervention||0
156729|NCT00440505|383342|P1|NOT COMPLETED|Third Intervention||0
156730|NCT00440505|383337|P6|COMPLETED|Third Intervention||5
156731|NCT00440505|383338|P5|COMPLETED|Third Intervention||5
156732|NCT00440505|383339|P4|COMPLETED|Third Intervention||1
156733|NCT00440505|383340|P3|COMPLETED|Third Intervention||1
156734|NCT00440505|383341|P2|COMPLETED|Third Intervention||2
156735|NCT00440505|383342|P1|COMPLETED|Third Intervention||5
156736|NCT00440505|383337|P6|STARTED|Third Intervention||5
156737|NCT00440505|383338|P5|STARTED|Third Intervention||5
156738|NCT00440505|383339|P4|STARTED|Third Intervention||2
156739|NCT00440505|383340|P3|STARTED|Third Intervention||1
156740|NCT00440505|383341|P2|STARTED|Third Intervention||2
156741|NCT00440505|383342|P1|STARTED|Third Intervention||5
156742|NCT00440505|383337|P6|NOT COMPLETED|Second Intervention||0
156743|NCT00440505|383338|P5|NOT COMPLETED|Second Intervention||0
156744|NCT00440505|383339|P4|NOT COMPLETED|Second Intervention||0
156745|NCT00440505|383340|P3|NOT COMPLETED|Second Intervention||0
156746|NCT00440505|383341|P2|NOT COMPLETED|Second Intervention||0
156747|NCT00440505|383342|P1|NOT COMPLETED|Second Intervention||0
156748|NCT00440505|383337|P6|COMPLETED|Second Intervention||5
156749|NCT00440505|383338|P5|COMPLETED|Second Intervention||5
156750|NCT00440505|383339|P4|COMPLETED|Second Intervention||2
156751|NCT00440505|383340|P3|COMPLETED|Second Intervention||1
156752|NCT00440505|383341|P2|COMPLETED|Second Intervention||2
156753|NCT00440505|383342|P1|COMPLETED|Second Intervention||5
156754|NCT00440505|383337|P6|STARTED|Second Intervention||5
156755|NCT00440505|383338|P5|STARTED|Second Intervention||5
156756|NCT00440505|383339|P4|STARTED|Second Intervention||2
156757|NCT00440505|383340|P3|STARTED|Second Intervention||1
156758|NCT00440505|383341|P2|STARTED|Second Intervention||2
156759|NCT00440505|383342|P1|STARTED|Second Intervention||5
156760|NCT00440505|383337|P6|NOT COMPLETED|First Intervention||0
156761|NCT00440505|383338|P5|NOT COMPLETED|First Intervention||0
156762|NCT00440505|383339|P4|NOT COMPLETED|First Intervention||0
156763|NCT00440505|383340|P3|NOT COMPLETED|First Intervention||0
156764|NCT00440505|383341|P2|NOT COMPLETED|First Intervention||0
156765|NCT00440505|383342|P1|NOT COMPLETED|First Intervention||0
156766|NCT00440505|383337|P6|COMPLETED|First Intervention||5
156767|NCT00440505|383338|P5|COMPLETED|First Intervention||5
156768|NCT00440505|383339|P4|COMPLETED|First Intervention||2
156769|NCT00440505|383340|P3|COMPLETED|First Intervention||1
156770|NCT00440505|383341|P2|COMPLETED|First Intervention||2
156771|NCT00440505|383342|P1|COMPLETED|First Intervention||5
156772|NCT00440505|383337|P6|STARTED|First Intervention||5
156773|NCT00440505|383338|P5|STARTED|First Intervention||5
156774|NCT00440505|383339|P4|STARTED|First Intervention||2
156775|NCT00440505|383340|P3|STARTED|First Intervention||1
156776|NCT00440505|383341|P2|STARTED|First Intervention||2
156777|NCT00440505|383342|P1|STARTED|First Intervention||5
156778|NCT00440518|383362|P3|NOT COMPLETED|Maintenance and Safety Follow-up Periods||15
156779|NCT00440518|383363|P2|NOT COMPLETED|Maintenance and Safety Follow-up Periods||12
156780|NCT00440518|383364|P1|NOT COMPLETED|Maintenance and Safety Follow-up Periods||7
156781|NCT00440518|383362|P3|COMPLETED|Maintenance and Safety Follow-up Periods||55
156782|NCT00440518|383363|P2|COMPLETED|Maintenance and Safety Follow-up Periods||51
156783|NCT00440518|383364|P1|COMPLETED|Maintenance and Safety Follow-up Periods||52
156784|NCT00440518|383362|P3|STARTED|Maintenance and Safety Follow-up Periods||70
156785|NCT00440518|383363|P2|STARTED|Maintenance and Safety Follow-up Periods||63
156786|NCT00440518|383364|P1|STARTED|Maintenance and Safety Follow-up Periods||59
156787|NCT00440518|383362|P3|NOT COMPLETED|Randomized /Titration Period||4
156788|NCT00440518|383363|P2|NOT COMPLETED|Randomized /Titration Period||9
156789|NCT00440518|383364|P1|NOT COMPLETED|Randomized /Titration Period||13
156790|NCT00440518|383362|P3|COMPLETED|Randomized /Titration Period||70
156791|NCT00440518|383363|P2|COMPLETED|Randomized /Titration Period||63
156792|NCT00440518|383364|P1|COMPLETED|Randomized /Titration Period||59
156793|NCT00440518|383362|P3|STARTED|Randomized /Titration Period||74
156794|NCT00440518|383363|P2|STARTED|Randomized /Titration Period||72
156795|NCT00440518|383364|P1|STARTED|Randomized /Titration Period||72
156796|NCT00440531|383387|P3|NOT COMPLETED|Overall Study||7
156797|NCT00440531|383388|P2|NOT COMPLETED|Overall Study||5
156798|NCT00440531|383389|P1|NOT COMPLETED|Overall Study||10
156799|NCT00440531|383387|P3|COMPLETED|Overall Study||165
156800|NCT00440531|383388|P2|COMPLETED|Overall Study||178
156801|NCT00440531|383389|P1|COMPLETED|Overall Study||175
156802|NCT00440531|383387|P3|Vaccination 3|Overall Study||166
156803|NCT00440531|383388|P2|Vaccination 3|Overall Study||178
156804|NCT00440531|383389|P1|Vaccination 3|Overall Study||176
156805|NCT00440531|383387|P3|Vaccination 2|Overall Study||171
156806|NCT00440531|383388|P2|Vaccination 2|Overall Study||182
156807|NCT00440531|383389|P1|Vaccination 2|Overall Study||181
156808|NCT00440531|383387|P3|Vaccination 1|Overall Study||172
156809|NCT00440531|383388|P2|Vaccination 1|Overall Study||183
156810|NCT00440531|383389|P1|Vaccination 1|Overall Study||183
156811|NCT00440531|383387|P3|STARTED|Overall Study||172
156812|NCT00440531|383388|P2|STARTED|Overall Study||183
156813|NCT00440531|383389|P1|STARTED|Overall Study||185
156814|NCT00440557|383406|P3|NOT COMPLETED|Overall Study||35
156815|NCT00440557|383407|P2|NOT COMPLETED|Overall Study||29
156816|NCT00440557|383408|P1|NOT COMPLETED|Overall Study||25
156817|NCT00440557|383406|P3|COMPLETED|Overall Study||90
156818|NCT00440557|383407|P2|COMPLETED|Overall Study||96
156819|NCT00440557|383408|P1|COMPLETED|Overall Study||98
156820|NCT00440557|383406|P3|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
156821|NCT00440557|383407|P2|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|125
156822|NCT00440557|383408|P1|STARTED|Overall Study|Safety population defined as all subjects who received at least 1 injection of study drug.|123
156823|NCT00440700|383440|P3|NOT COMPLETED|Overall Study||4
156824|NCT00440700|383441|P2|NOT COMPLETED|Overall Study||8
156825|NCT00440700|383442|P1|NOT COMPLETED|Overall Study||8
156826|NCT00440700|383440|P3|COMPLETED|Overall Study||120
156827|NCT00440700|383441|P2|COMPLETED|Overall Study||110
156828|NCT00440700|383442|P1|COMPLETED|Overall Study||114
156829|NCT00440700|383440|P3|STARTED|Overall Study||124
156830|NCT00440700|383441|P2|STARTED|Overall Study||118
156831|NCT00440700|383442|P1|STARTED|Overall Study||122
156832|NCT00440830|383466|P4|NOT COMPLETED|Overall Study||0
156833|NCT00440830|383467|P3|NOT COMPLETED|Overall Study||0
156834|NCT00440830|383468|P2|NOT COMPLETED|Overall Study||0
156835|NCT00440830|383469|P1|NOT COMPLETED|Overall Study||0
156836|NCT00440830|383466|P4|COMPLETED|Overall Study||10
156837|NCT00440830|383467|P3|COMPLETED|Overall Study||30
156838|NCT00440830|383468|P2|COMPLETED|Overall Study||8
156839|NCT00440830|383469|P1|COMPLETED|Overall Study||20
156840|NCT00440830|383466|P4|STARTED|Overall Study||10
156841|NCT00440830|383467|P3|STARTED|Overall Study||30
156842|NCT00440830|383468|P2|STARTED|Overall Study||8
156843|NCT00440830|383469|P1|STARTED|Overall Study||20
156844|NCT00440947|383483|P5|NOT COMPLETED|Optional 60-Week Extension Phase||26
156845|NCT00440947|383484|P4|NOT COMPLETED|Optional 60-Week Extension Phase||29
156846|NCT00440947|383485|P3|NOT COMPLETED|Optional 60-Week Extension Phase||0
156847|NCT00440947|383486|P2|NOT COMPLETED|Optional 60-Week Extension Phase||0
156848|NCT00440947|383487|P1|NOT COMPLETED|Optional 60-Week Extension Phase||0
156849|NCT00440947|383483|P5|COMPLETED|Optional 60-Week Extension Phase||154
156850|NCT00440947|383484|P4|COMPLETED|Optional 60-Week Extension Phase||160
156851|NCT00440947|383485|P3|COMPLETED|Optional 60-Week Extension Phase||0
156852|NCT00440947|383486|P2|COMPLETED|Optional 60-Week Extension Phase||0
156853|NCT00440947|383487|P1|COMPLETED|Optional 60-Week Extension Phase||0
156854|NCT00440947|383483|P5|STARTED|Optional 60-Week Extension Phase||180
156855|NCT00440947|383484|P4|STARTED|Optional 60-Week Extension Phase||189
156856|NCT00440947|383485|P3|STARTED|Optional 60-Week Extension Phase||0
156857|NCT00440947|383486|P2|STARTED|Optional 60-Week Extension Phase||0
156858|NCT00440947|383487|P1|STARTED|Optional 60-Week Extension Phase||0
156859|NCT00440947|383483|P5|NOT COMPLETED|48-Week Randomization Phase||0
156860|NCT00440947|383484|P4|NOT COMPLETED|48-Week Randomization Phase||0
156861|NCT00440947|383485|P3|NOT COMPLETED|48-Week Randomization Phase||24
156862|NCT00440947|383486|P2|NOT COMPLETED|48-Week Randomization Phase||16
156863|NCT00440947|383487|P1|NOT COMPLETED|48-Week Randomization Phase||0
156864|NCT00440947|383483|P5|COMPLETED|48-Week Randomization Phase||0
156865|NCT00440947|383484|P4|COMPLETED|48-Week Randomization Phase||0
156866|NCT00440947|383485|P3|COMPLETED|48-Week Randomization Phase||185
156867|NCT00440947|383486|P2|COMPLETED|48-Week Randomization Phase||194
156868|NCT00440947|383487|P1|COMPLETED|48-Week Randomization Phase||0
156869|NCT00440947|383483|P5|STARTED|48-Week Randomization Phase||0
156870|NCT00440947|383484|P4|STARTED|48-Week Randomization Phase||0
156871|NCT00440947|383485|P3|STARTED|48-Week Randomization Phase||209
156872|NCT00440947|383486|P2|STARTED|48-Week Randomization Phase||210
156873|NCT00440947|383487|P1|STARTED|48-Week Randomization Phase||0
156874|NCT00440947|383483|P5|NOT COMPLETED|36-Week Induction Phase||0
156875|NCT00440947|383484|P4|NOT COMPLETED|36-Week Induction Phase||0
156876|NCT00440947|383485|P3|NOT COMPLETED|36-Week Induction Phase||0
156877|NCT00440947|383486|P2|NOT COMPLETED|36-Week Induction Phase||0
156878|NCT00440947|383487|P1|NOT COMPLETED|36-Week Induction Phase||73
156879|NCT00440947|383483|P5|COMPLETED|36-Week Induction Phase||0
156880|NCT00440947|383484|P4|COMPLETED|36-Week Induction Phase||0
156881|NCT00440947|383485|P3|COMPLETED|36-Week Induction Phase||0
156882|NCT00440947|383486|P2|COMPLETED|36-Week Induction Phase||0
156883|NCT00440947|383487|P1|COMPLETED|36-Week Induction Phase|23 PAR without confirmed HIV-RNA<50c/mL prior to Wk 36 couldn’t be randomized but weren’t withdrawn.|442
156884|NCT00440947|383483|P5|STARTED|36-Week Induction Phase||0
156885|NCT00440947|383484|P4|STARTED|36-Week Induction Phase||0
156886|NCT00440947|383485|P3|STARTED|36-Week Induction Phase||0
156887|NCT00440947|383486|P2|STARTED|36-Week Induction Phase||0
156888|NCT00440947|383487|P1|STARTED|36-Week Induction Phase||515
156889|NCT00441012|383540|P2|NOT COMPLETED|Overall Study||13
156890|NCT00441012|383541|P1|NOT COMPLETED|Overall Study||18
156891|NCT00441012|383540|P2|COMPLETED|Overall Study||263
156892|NCT00441012|383541|P1|COMPLETED|Overall Study||252
156893|NCT00441012|383540|P2|Vaccination Visit 3|Overall Study||269
156894|NCT00441012|383541|P1|Vaccination Visit 3|Overall Study||265
156895|NCT00441012|383540|P2|Vaccination Visit 2|Overall Study||272
156896|NCT00441012|383541|P1|Vaccination Visit 2|Overall Study||267
156897|NCT00441012|383540|P2|Vaccination Visit 1|Overall Study|3 participants were vaccinated but were never randomized in the COMVAX™ group|276
156898|NCT00441012|383541|P1|Vaccination Visit 1|Overall Study|1 participant was randomized but not vaccinated in the Modified Process Vaccine group|269
156899|NCT00441012|383540|P2|STARTED|Overall Study||276
156900|NCT00441012|383541|P1|STARTED|Overall Study||270
156901|NCT00441064|383557|P2|NOT COMPLETED|Overall Study||7
156902|NCT00441064|383558|P1|NOT COMPLETED|Overall Study||10
156903|NCT00441064|383557|P2|COMPLETED|Overall Study||56
156904|NCT00441064|383558|P1|COMPLETED|Overall Study||59
156905|NCT00441064|383557|P2|Intent-to-treat (ITT) Population|Overall Study||57
156906|NCT00441064|383558|P1|Intent-to-treat (ITT) Population|Overall Study||61
156907|NCT00441064|383557|P2|Safety Population (SP)|Overall Study||63
156908|NCT00441064|383558|P1|Safety Population (SP)|Overall Study||69
156909|NCT00441064|383557|P2|STARTED|Overall Study||63
156910|NCT00441064|383558|P1|STARTED|Overall Study||69
156911|NCT00441103|383570|P2|NOT COMPLETED|Overall Study||4
156912|NCT00441103|383571|P1|NOT COMPLETED|Overall Study||11
156913|NCT00441103|383570|P2|COMPLETED|Overall Study||56
156914|NCT00441103|383571|P1|COMPLETED|Overall Study||109
156915|NCT00441103|383570|P2|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|60
156916|NCT00441103|383571|P1|STARTED|Overall Study|Intent to treat (ITT) population: all participants who received at least one dose of study drug.|120
156917|NCT00441116|383584|P2|NOT COMPLETED|Overall Study||2
156918|NCT00441116|383585|P1|NOT COMPLETED|Overall Study||3
156919|NCT00441116|383584|P2|COMPLETED|Overall Study||75
156920|NCT00441116|383585|P1|COMPLETED|Overall Study||73
156921|NCT00441116|383584|P2|STARTED|Overall Study||77
156922|NCT00441116|383585|P1|STARTED|Overall Study||76
156923|NCT00441142|383655|P4|NOT COMPLETED|Overall Study||68
156924|NCT00441142|383656|P3|NOT COMPLETED|Overall Study||22
156925|NCT00441142|383657|P2|NOT COMPLETED|Overall Study||7
156926|NCT00441142|383658|P1|NOT COMPLETED|Overall Study||6
156927|NCT00441142|383655|P4|COMPLETED|Overall Study||1
156928|NCT00441142|383656|P3|COMPLETED|Overall Study||7
156929|NCT00441142|383657|P2|COMPLETED|Overall Study||0
156930|NCT00441142|383658|P1|COMPLETED|Overall Study||0
156931|NCT00441142|383655|P4|STARTED|Overall Study||69
156932|NCT00441142|383656|P3|STARTED|Overall Study||29
156933|NCT00441142|383657|P2|STARTED|Overall Study||7
156934|NCT00441142|383658|P1|STARTED|Overall Study||6
156935|NCT00441168|383676|P2|NOT COMPLETED|Follow-up Period||9
156936|NCT00441168|383677|P1|NOT COMPLETED|Follow-up Period||12
156937|NCT00441168|383676|P2|COMPLETED|Follow-up Period||4
156938|NCT00441168|383677|P1|COMPLETED|Follow-up Period||5
156939|NCT00441168|383676|P2|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|13
156940|NCT00441168|383677|P1|STARTED|Follow-up Period|Subjects who did not complete the treatment period could be entered into the follow-up period|17
156941|NCT00441168|383676|P2|NOT COMPLETED|Treatment Period||6
156942|NCT00441168|383677|P1|NOT COMPLETED|Treatment Period||11
156943|NCT00441168|383676|P2|COMPLETED|Treatment Period||7
156944|NCT00441168|383677|P1|COMPLETED|Treatment Period||6
156945|NCT00441168|383676|P2|TREATED|Treatment Period||13
156946|NCT00441168|383677|P1|TREATED|Treatment Period||16
156947|NCT00441168|383676|P2|STARTED|Treatment Period||13
156948|NCT00441168|383677|P1|STARTED|Treatment Period||17
156949|NCT00441259|383689|P2|NOT COMPLETED|Overall Study||0
156950|NCT00441259|383690|P1|NOT COMPLETED|Overall Study||0
156951|NCT00441259|383689|P2|COMPLETED|Overall Study||48
156952|NCT00441259|383690|P1|COMPLETED|Overall Study||48
156953|NCT00441259|383689|P2|STARTED|Overall Study||48
156954|NCT00441259|383690|P1|STARTED|Overall Study||48
156955|NCT00441272|383708|P2|NOT COMPLETED|Overall Study||25
156956|NCT00441272|383709|P1|NOT COMPLETED|Overall Study||25
156957|NCT00441272|383708|P2|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
156958|NCT00441272|383709|P1|COMPLETED|Overall Study|Study terminated prior to enrollment.|0
156959|NCT00441272|383708|P2|STARTED|Overall Study||25
156960|NCT00441272|383709|P1|STARTED|Overall Study||25
156961|NCT00441285|383720|P5|NOT COMPLETED|Overall Study||0
156962|NCT00441285|383721|P4|NOT COMPLETED|Overall Study||0
156963|NCT00441285|383722|P3|NOT COMPLETED|Overall Study||0
156964|NCT00441285|383723|P2|NOT COMPLETED|Overall Study||0
156965|NCT00441285|383724|P1|NOT COMPLETED|Overall Study||0
156966|NCT00441285|383720|P5|COMPLETED|Overall Study||43
156967|NCT00441285|383721|P4|COMPLETED|Overall Study||40
156968|NCT00441285|383722|P3|COMPLETED|Overall Study||41
156969|NCT00441285|383723|P2|COMPLETED|Overall Study||16
156970|NCT00441285|383724|P1|COMPLETED|Overall Study||16
156971|NCT00441285|383720|P5|STARTED|Overall Study||43
156972|NCT00441285|383721|P4|STARTED|Overall Study||40
156973|NCT00441285|383722|P3|STARTED|Overall Study||41
156974|NCT00441285|383723|P2|STARTED|Overall Study||16
156975|NCT00441285|383724|P1|STARTED|Overall Study||16
156976|NCT00441337|383752|P4|NOT COMPLETED|Overall Study||21
156977|NCT00441337|383753|P3|NOT COMPLETED|Overall Study||6
156978|NCT00441337|383754|P2|NOT COMPLETED|Overall Study||6
156979|NCT00441337|383755|P1|NOT COMPLETED|Overall Study||6
156980|NCT00441337|383752|P4|COMPLETED|Overall Study||0
156981|NCT00441337|383753|P3|COMPLETED|Overall Study||0
156982|NCT00441337|383754|P2|COMPLETED|Overall Study||0
156983|NCT00441337|383755|P1|COMPLETED|Overall Study||0
156984|NCT00441337|383752|P4|STARTED|Overall Study||21
156985|NCT00441337|383753|P3|STARTED|Overall Study||6
156986|NCT00441337|383754|P2|STARTED|Overall Study||6
156987|NCT00441337|383755|P1|STARTED|Overall Study||6
156988|NCT00441363|383835|P2|NOT COMPLETED|Overall Study||15
156989|NCT00441363|383836|P1|NOT COMPLETED|Overall Study||17
156990|NCT00441363|383835|P2|COMPLETED|Overall Study||19
156991|NCT00441363|383836|P1|COMPLETED|Overall Study|no subject withdrew early since the trial was terminated|15
156992|NCT00441363|383835|P2|STARTED|Overall Study||34
156993|NCT00441363|383836|P1|STARTED|Overall Study||32
156994|NCT00434356|383846|P2|NOT COMPLETED|Overall Study||23
156995|NCT00434356|383847|P1|NOT COMPLETED|Overall Study||23
156996|NCT00434356|383846|P2|COMPLETED|Overall Study||0
156997|NCT00434356|383847|P1|COMPLETED|Overall Study||0
156998|NCT00434356|383846|P2|STARTED|Overall Study||23
156999|NCT00434356|383847|P1|STARTED|Overall Study||23
157000|NCT00434421|383862|P1|NOT COMPLETED|Overall Study||2
157001|NCT00434421|383862|P1|COMPLETED|Overall Study||26
157002|NCT00434421|383862|P1|STARTED|Overall Study||28
157003|NCT00434434|383869|P3|NOT COMPLETED|Overall Study||1
157004|NCT00434434|383870|P2|NOT COMPLETED|Overall Study||0
157005|NCT00434434|383871|P1|NOT COMPLETED|Overall Study||2
157006|NCT00434434|383869|P3|COMPLETED|Overall Study||13
157007|NCT00434434|383870|P2|COMPLETED|Overall Study||24
157008|NCT00434434|383871|P1|COMPLETED|Overall Study||21
157009|NCT00434434|383869|P3|STARTED|Overall Study||14
157010|NCT00434434|383870|P2|STARTED|Overall Study||24
157011|NCT00434434|383871|P1|STARTED|Overall Study||23
157012|NCT00434590|383884|P2|NOT COMPLETED|Overall Study||5
157013|NCT00434590|383885|P1|NOT COMPLETED|Overall Study||5
157014|NCT00434590|383884|P2|COMPLETED|Overall Study||0
157015|NCT00434590|383885|P1|COMPLETED|Overall Study|All patients randomized had study discontinued because of premature study termination.|0
157016|NCT00434590|383884|P2|STARTED|Overall Study||5
157017|NCT00434590|383885|P1|STARTED|Overall Study||5
157018|NCT00434642|383893|P2|NOT COMPLETED|Open-label Treatment Phase||11
157019|NCT00434642|383894|P1|NOT COMPLETED|Open-label Treatment Phase||0
157020|NCT00434642|383893|P2|COMPLETED|Open-label Treatment Phase||1
157021|NCT00434642|383894|P1|COMPLETED|Open-label Treatment Phase||0
157022|NCT00434642|383893|P2|STARTED|Open-label Treatment Phase|One participant did not continue into the open-label treatment phase.|12
157023|NCT00434642|383894|P1|STARTED|Open-label Treatment Phase||0
157024|NCT00434642|383893|P2|NOT COMPLETED|Blinded Treatment Phase||229
157025|NCT00434642|383894|P1|NOT COMPLETED|Blinded Treatment Phase||242
157026|NCT00434642|383893|P2|COMPLETED|Blinded Treatment Phase||13
157027|NCT00434642|383894|P1|COMPLETED|Blinded Treatment Phase||0
157028|NCT00434642|383893|P2|STARTED|Blinded Treatment Phase||242
157029|NCT00434642|383894|P1|STARTED|Blinded Treatment Phase||242
157030|NCT00434759|383912|P2|NOT COMPLETED|Overall Study||5
157031|NCT00434759|383913|P1|NOT COMPLETED|Overall Study||24
157032|NCT00434759|383912|P2|COMPLETED|Overall Study||38
157033|NCT00434759|383913|P1|COMPLETED|Overall Study||22
157034|NCT00434759|383912|P2|STARTED|Overall Study||43
157035|NCT00434759|383913|P1|STARTED|Overall Study||46
157036|NCT00434876|383929|P2|NOT COMPLETED|Overall Study||1
157037|NCT00434876|383930|P1|NOT COMPLETED|Overall Study||1
157038|NCT00434876|383929|P2|COMPLETED|Overall Study||10
157039|NCT00434876|383930|P1|COMPLETED|Overall Study||10
157040|NCT00434876|383929|P2|STARTED|Overall Study||11
157041|NCT00434876|383930|P1|STARTED|Overall Study||11
157042|NCT00434954|383944|P2|NOT COMPLETED|Overall Study||71
157043|NCT00434954|383945|P1|NOT COMPLETED|Overall Study||82
157044|NCT00434954|383944|P2|COMPLETED|Overall Study||175
157045|NCT00434954|383945|P1|COMPLETED|Overall Study||166
157046|NCT00434954|383944|P2|Completed - Previous Treatment MET + SU|Overall Study||38
157047|NCT00434954|383945|P1|Completed - Previous Treatment MET + SU|Overall Study||31
157048|NCT00434954|383944|P2|Completed - Previous Treatment MET Only|Overall Study||137
157049|NCT00434954|383945|P1|Completed - Previous Treatment MET Only|Overall Study||135
157050|NCT00434954|383944|P2|FAS - Previous Treatment MET + SU|Overall Study||60
157051|NCT00434954|383945|P1|FAS - Previous Treatment MET + SU|Overall Study||66
157052|NCT00434954|383944|P2|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|173
157053|NCT00434954|383945|P1|FAS - Previous Treatment MET Only|Overall Study|"Baseline and efficacy data reported for FAS-Previous Treatment MET Only group."|181
157054|NCT00434954|383944|P2|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|233
157055|NCT00434954|383945|P1|Full Analysis Set (FAS) Overall|Overall Study|FAS=received >=1 dose of study drug. Adverse event data reported for Overall FAS.|247
157056|NCT00434954|383944|P2|Started - Previous Treatment MET + SU|Overall Study||65
157057|NCT00434954|383945|P1|Started - Previous Treatment MET + SU|Overall Study||66
157058|NCT00434954|383944|P2|Started - Previous Treatment MET Only|Overall Study||181
157059|NCT00434954|383945|P1|Started - Previous Treatment MET Only|Overall Study||182
157060|NCT00434954|383944|P2|STARTED|Overall Study||246
157061|NCT00434954|383945|P1|STARTED|Overall Study||248
157062|NCT00434967|383977|P4|NOT COMPLETED|Overall Study||14
157063|NCT00434967|383978|P3|NOT COMPLETED|Overall Study||9
157064|NCT00434967|383979|P2|NOT COMPLETED|Overall Study||8
157065|NCT00434967|383980|P1|NOT COMPLETED|Overall Study||7
157066|NCT00434967|383977|P4|COMPLETED|Overall Study||478
157067|NCT00434967|383978|P3|COMPLETED|Overall Study||461
157068|NCT00434967|383979|P2|COMPLETED|Overall Study||457
157069|NCT00434967|383980|P1|COMPLETED|Overall Study||90
157070|NCT00434967|383977|P4|STARTED|Overall Study||492
157071|NCT00434967|383978|P3|STARTED|Overall Study||470
157072|NCT00434967|383979|P2|STARTED|Overall Study||465
157073|NCT00434967|383980|P1|STARTED|Overall Study||97
157074|NCT00441441|384000|P2|NOT COMPLETED|Overall Study||14
157075|NCT00441441|384001|P1|NOT COMPLETED|Overall Study||11
157076|NCT00441441|384000|P2|COMPLETED|Overall Study||163
157077|NCT00441441|384001|P1|COMPLETED|Overall Study||162
157078|NCT00441441|384000|P2|STARTED|Overall Study||177
157079|NCT00441441|384001|P1|STARTED|Overall Study||173
157080|NCT00441467|384059|P1|NOT COMPLETED|Overall Study||18
157081|NCT00441467|384059|P1|COMPLETED|Overall Study||4
157082|NCT00441467|384059|P1|4 Cycles|Overall Study||7
157083|NCT00441467|384059|P1|2 Cycles|Overall Study||17
157084|NCT00441467|384059|P1|STARTED|Overall Study||22
157085|NCT00441480|384067|P2|NOT COMPLETED|Overall Study||4
157086|NCT00441480|384068|P1|NOT COMPLETED|Overall Study||3
157087|NCT00441480|384067|P2|COMPLETED|Overall Study||41
157088|NCT00441480|384068|P1|COMPLETED|Overall Study||43
157089|NCT00441480|384067|P2|STARTED|Overall Study||45
157090|NCT00441480|384068|P1|STARTED|Overall Study||46
157091|NCT00441545|384100|P2|NOT COMPLETED|Second Intervention||7
157092|NCT00441545|384101|P1|NOT COMPLETED|Second Intervention||12
157093|NCT00441545|384100|P2|COMPLETED|Second Intervention||68
157094|NCT00441545|384101|P1|COMPLETED|Second Intervention||65
157095|NCT00441545|384100|P2|STARTED|Second Intervention||75
157096|NCT00441545|384101|P1|STARTED|Second Intervention||77
157097|NCT00441545|384100|P2|NOT COMPLETED|Washout||0
157098|NCT00441545|384101|P1|NOT COMPLETED|Washout||0
157099|NCT00441545|384100|P2|COMPLETED|Washout||75
157100|NCT00441545|384101|P1|COMPLETED|Washout||77
157101|NCT00441545|384100|P2|STARTED|Washout||75
157102|NCT00441545|384101|P1|STARTED|Washout||77
157103|NCT00441545|384100|P2|NOT COMPLETED|First Intervention||12
157104|NCT00441545|384101|P1|NOT COMPLETED|First Intervention||18
157105|NCT00441545|384100|P2|COMPLETED|First Intervention||75
157106|NCT00441545|384101|P1|COMPLETED|First Intervention||77
157107|NCT00441545|384100|P2|STARTED|First Intervention||87
157108|NCT00441545|384101|P1|STARTED|First Intervention||95
157109|NCT00441558|384113|P1|NOT COMPLETED|Overall Study||1056
157110|NCT00441558|384113|P1|COMPLETED|Overall Study||667
157111|NCT00441558|384113|P1|STARTED|Overall Study||1723
157112|NCT00441584|384117|P1|NOT COMPLETED|Overall Study||105
157113|NCT00441584|384117|P1|COMPLETED|Overall Study||12
157114|NCT00441584|384117|P1|STARTED|Overall Study||117
157115|NCT00441701|384131|P10|NOT COMPLETED|Overall Study||0
157116|NCT00441701|384132|P9|NOT COMPLETED|Overall Study||0
157117|NCT00441701|384133|P8|NOT COMPLETED|Overall Study||0
157118|NCT00441701|384134|P7|NOT COMPLETED|Overall Study||0
157119|NCT00441701|384135|P6|NOT COMPLETED|Overall Study||3
157120|NCT00441701|384136|P5|NOT COMPLETED|Overall Study||2
157121|NCT00441701|384137|P4|NOT COMPLETED|Overall Study||3
157122|NCT00441701|384138|P3|NOT COMPLETED|Overall Study||4
157123|NCT00441701|384139|P2|NOT COMPLETED|Overall Study||4
157124|NCT00441701|384140|P1|NOT COMPLETED|Overall Study||5
157125|NCT00441701|384131|P10|COMPLETED|Overall Study||0
157126|NCT00441701|384132|P9|COMPLETED|Overall Study||0
157127|NCT00441701|384133|P8|COMPLETED|Overall Study||0
157128|NCT00441701|384134|P7|COMPLETED|Overall Study||0
157129|NCT00441701|384135|P6|COMPLETED|Overall Study||8
157130|NCT00441701|384136|P5|COMPLETED|Overall Study||20
157131|NCT00441701|384137|P4|COMPLETED|Overall Study||8
157132|NCT00441701|384138|P3|COMPLETED|Overall Study||18
157133|NCT00441701|384139|P2|COMPLETED|Overall Study||7
157134|NCT00441701|384140|P1|COMPLETED|Overall Study||17
157135|NCT00441701|384131|P10|STARTED|Overall Study||0
157136|NCT00441701|384132|P9|STARTED|Overall Study||0
157137|NCT00441701|384133|P8|STARTED|Overall Study||0
157138|NCT00441701|384134|P7|STARTED|Overall Study||0
157139|NCT00441701|384135|P6|STARTED|Overall Study||11
157140|NCT00441701|384136|P5|STARTED|Overall Study||22
157141|NCT00441701|384137|P4|STARTED|Overall Study||11
157142|NCT00441701|384138|P3|STARTED|Overall Study||22
157143|NCT00441701|384139|P2|STARTED|Overall Study||11
157144|NCT00441701|384140|P1|STARTED|Overall Study||22
157145|NCT00444457|384226|P4|NOT COMPLETED|Toddler Dose||8
157146|NCT00444457|384227|P3|NOT COMPLETED|Toddler Dose||4
157147|NCT00444457|384228|P2|NOT COMPLETED|Toddler Dose||6
157148|NCT00444457|384229|P1|NOT COMPLETED|Toddler Dose||7
157149|NCT00444457|384226|P4|COMPLETED|Toddler Dose||200
157150|NCT00444457|384227|P3|COMPLETED|Toddler Dose||404
157151|NCT00444457|384228|P2|COMPLETED|Toddler Dose||391
157152|NCT00444457|384229|P1|COMPLETED|Toddler Dose||408
157153|NCT00444457|384226|P4|STARTED|Toddler Dose|Vaccinated toddler dose|208
157154|NCT00444457|384227|P3|STARTED|Toddler Dose|Vaccinated toddler dose|408
157155|NCT00444457|384228|P2|STARTED|Toddler Dose|Vaccinated toddler dose|397
157156|NCT00444457|384229|P1|STARTED|Toddler Dose|Vaccinated toddler dose|415
157157|NCT00444457|384226|P4|NOT COMPLETED|After Infant Series||10
157158|NCT00444457|384227|P3|NOT COMPLETED|After Infant Series||19
157159|NCT00444457|384228|P2|NOT COMPLETED|After Infant Series||30
157160|NCT00444457|384229|P1|NOT COMPLETED|After Infant Series||20
157161|NCT00444457|384226|P4|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|208
157162|NCT00444457|384227|P3|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|408
157163|NCT00444457|384228|P2|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|397
157164|NCT00444457|384229|P1|COMPLETED|After Infant Series|Not completed=Withdrawn after infant series|415
157165|NCT00444457|384226|P4|STARTED|After Infant Series||218
157166|NCT00444457|384227|P3|STARTED|After Infant Series||427
157167|NCT00444457|384228|P2|STARTED|After Infant Series||427
157168|NCT00444457|384229|P1|STARTED|After Infant Series||435
157169|NCT00444457|384226|P4|NOT COMPLETED|Infant Series||28
157170|NCT00444457|384227|P3|NOT COMPLETED|Infant Series||61
157171|NCT00444457|384228|P2|NOT COMPLETED|Infant Series||61
157172|NCT00444457|384229|P1|NOT COMPLETED|Infant Series||54
157173|NCT00444457|384226|P4|COMPLETED|Infant Series||218
157174|NCT00444457|384227|P3|COMPLETED|Infant Series||428
157175|NCT00444457|384228|P2|COMPLETED|Infant Series||427
157176|NCT00444457|384229|P1|COMPLETED|Infant Series||435
157177|NCT00444457|384226|P4|Vaccinated Dose 3|Infant Series||225
157178|NCT00444457|384227|P3|Vaccinated Dose 3|Infant Series||438
157179|NCT00444457|384228|P2|Vaccinated Dose 3|Infant Series||435
157180|NCT00444457|384229|P1|Vaccinated Dose 3|Infant Series||442
157181|NCT00444457|384226|P4|Vaccinated Dose 2|Infant Series||228
157182|NCT00444457|384227|P3|Vaccinated Dose 2|Infant Series||455
157183|NCT00444457|384228|P2|Vaccinated Dose 2|Infant Series||447
157184|NCT00444457|384229|P1|Vaccinated Dose 2|Infant Series||455
157185|NCT00444457|384226|P4|Vaccinated Dose 1|Infant Series||244
157186|NCT00444457|384227|P3|Vaccinated Dose 1|Infant Series||485
157187|NCT00444457|384228|P2|Vaccinated Dose 1|Infant Series||484
157188|NCT00444457|384229|P1|Vaccinated Dose 1|Infant Series||486
157189|NCT00444457|384226|P4|STARTED|Infant Series||246
157190|NCT00444457|384227|P3|STARTED|Infant Series||489
157191|NCT00444457|384228|P2|STARTED|Infant Series||488
157192|NCT00444457|384229|P1|STARTED|Infant Series||489
157193|NCT00444535|384291|P1|NOT COMPLETED|Overall Study||24
157194|NCT00444535|384291|P1|COMPLETED|Overall Study||28
157195|NCT00444535|384291|P1|STARTED|Overall Study||52
157196|NCT00444587|384300|P2|NOT COMPLETED|Overall Study||15
157197|NCT00444587|384301|P1|NOT COMPLETED|Overall Study||83
157198|NCT00444587|384300|P2|COMPLETED|Overall Study||1
157199|NCT00444587|384301|P1|COMPLETED|Overall Study||10
157200|NCT00444587|384300|P2|STARTED|Overall Study||16
157201|NCT00444587|384301|P1|STARTED|Overall Study||93
157202|NCT00444600|384326|P4|NOT COMPLETED|Overall Study||10
157203|NCT00444600|384327|P3|NOT COMPLETED|Overall Study||10
157204|NCT00444600|384328|P2|NOT COMPLETED|Overall Study||16
157205|NCT00444600|384329|P1|NOT COMPLETED|Overall Study||19
157206|NCT00444600|384326|P4|COMPLETED|Overall Study|Number of eyes|176
157207|NCT00444600|384327|P3|COMPLETED|Overall Study|Number of eyes|178
157208|NCT00444600|384328|P2|COMPLETED|Overall Study|Number of eyes|171
157209|NCT00444600|384329|P1|COMPLETED|Overall Study|Number of eyes|274
157210|NCT00444600|384326|P4|STARTED|Overall Study|Number of eyes|186
157211|NCT00444600|384327|P3|STARTED|Overall Study|Number of eyes|188
157212|NCT00444600|384328|P2|STARTED|Overall Study|Number of eyes|187
157213|NCT00444600|384329|P1|STARTED|Overall Study|Number of eyes|293
157214|NCT00444626|384419|P1|NOT COMPLETED|Repeat Treatment Period||0
157215|NCT00444626|384419|P1|COMPLETED|Repeat Treatment Period||105
157216|NCT00444626|384419|P1|STARTED|Repeat Treatment Period|23 subjects withdrew after completing the Initial Treatment and did not enter the Repeat Treatment|105
157217|NCT00444626|384419|P1|NOT COMPLETED|Initial Treatment Period||12
157218|NCT00444626|384419|P1|COMPLETED|Initial Treatment Period||128
157219|NCT00444626|384419|P1|STARTED|Initial Treatment Period||140
157220|NCT00444795|384445|P1|NOT COMPLETED|Overall Study||3
157221|NCT00444795|384445|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set.|617
157222|NCT00444795|384445|P1|STARTED|Overall Study||620
157223|NCT00444912|384452|P2|NOT COMPLETED|Overall Study||2
157224|NCT00444912|384453|P1|NOT COMPLETED|Overall Study||3
157225|NCT00444912|384452|P2|COMPLETED|Overall Study||13
157226|NCT00444912|384453|P1|COMPLETED|Overall Study||12
157227|NCT00444912|384452|P2|Received Transplant|Overall Study||14
157228|NCT00444912|384453|P1|Received Transplant|Overall Study||14
157229|NCT00444912|384452|P2|Received Plerixafor|Overall Study||15
157230|NCT00444912|384453|P1|Received Plerixafor|Overall Study||15
157231|NCT00444912|384452|P2|STARTED|Overall Study||15
157232|NCT00444912|384453|P1|STARTED|Overall Study||15
157233|NCT00444925|384484|P3|NOT COMPLETED|Double-blind Treatment Period||81
157234|NCT00444925|384485|P2|NOT COMPLETED|Double-blind Treatment Period||56
157235|NCT00444925|384486|P1|NOT COMPLETED|Double-blind Treatment Period||30
157236|NCT00444925|384484|P3|COMPLETED|Double-blind Treatment Period||598
157237|NCT00444925|384485|P2|COMPLETED|Double-blind Treatment Period||628
157238|NCT00444925|384486|P1|COMPLETED|Double-blind Treatment Period||304
157239|NCT00444925|384484|P3|STARTED|Double-blind Treatment Period||679
157240|NCT00444925|384485|P2|STARTED|Double-blind Treatment Period||684
157241|NCT00444925|384486|P1|STARTED|Double-blind Treatment Period||334
157242|NCT00444925|384484|P3|NOT COMPLETED|Randomized to Double-blind Treatment||6
157243|NCT00444925|384485|P2|NOT COMPLETED|Randomized to Double-blind Treatment||6
157244|NCT00444925|384486|P1|NOT COMPLETED|Randomized to Double-blind Treatment||3
157245|NCT00444925|384484|P3|COMPLETED|Randomized to Double-blind Treatment||679
157246|NCT00444925|384485|P2|COMPLETED|Randomized to Double-blind Treatment||684
157247|NCT00444925|384486|P1|COMPLETED|Randomized to Double-blind Treatment||334
157248|NCT00444925|384484|P3|STARTED|Randomized to Double-blind Treatment||685
157249|NCT00444925|384485|P2|STARTED|Randomized to Double-blind Treatment||690
157250|NCT00444925|384486|P1|STARTED|Randomized to Double-blind Treatment||337
157251|NCT00444925|384484|P3|NOT COMPLETED|Single-blind Placebo Run-In Period||0
157252|NCT00444925|384485|P2|NOT COMPLETED|Single-blind Placebo Run-In Period||0
157253|NCT00444925|384486|P1|NOT COMPLETED|Single-blind Placebo Run-In Period||734
157254|NCT00444925|384484|P3|COMPLETED|Single-blind Placebo Run-In Period||0
157255|NCT00444925|384485|P2|COMPLETED|Single-blind Placebo Run-In Period||0
157256|NCT00444925|384486|P1|COMPLETED|Single-blind Placebo Run-In Period|progressed to randomization in double-blind treatment period|1712
157257|NCT00444925|384484|P3|STARTED|Single-blind Placebo Run-In Period||0
157258|NCT00444925|384485|P2|STARTED|Single-blind Placebo Run-In Period||0
157259|NCT00444925|384486|P1|STARTED|Single-blind Placebo Run-In Period||2446
157260|NCT00444951|384551|P3|NOT COMPLETED|Overall Study||3
157261|NCT00444951|384552|P2|NOT COMPLETED|Overall Study||6
157262|NCT00444951|384553|P1|NOT COMPLETED|Overall Study||5
157263|NCT00444951|384551|P3|COMPLETED|Overall Study||160
157264|NCT00444951|384552|P2|COMPLETED|Overall Study||136
157265|NCT00444951|384553|P1|COMPLETED|Overall Study||140
157266|NCT00444951|384551|P3|STARTED|Overall Study||163
157267|NCT00444951|384552|P2|STARTED|Overall Study||142
157268|NCT00444951|384553|P1|STARTED|Overall Study||145
157269|NCT00445003|384570|P3|NOT COMPLETED|Overall Study||4
157270|NCT00445003|384571|P2|NOT COMPLETED|Overall Study||10
157271|NCT00445003|384572|P1|NOT COMPLETED|Overall Study||5
157272|NCT00445003|384570|P3|COMPLETED|Overall Study||105
157273|NCT00445003|384571|P2|COMPLETED|Overall Study||103
157274|NCT00445003|384572|P1|COMPLETED|Overall Study||118
157275|NCT00445003|384570|P3|STARTED|Overall Study||109
157276|NCT00445003|384571|P2|STARTED|Overall Study||113
157277|NCT00445003|384572|P1|STARTED|Overall Study||123
157278|NCT00445146|384601|P1|NOT COMPLETED|Overall Study||119
157279|NCT00445146|384601|P1|COMPLETED|Overall Study||73
157280|NCT00445146|384601|P1|STARTED|Overall Study||192
157281|NCT00445211|384622|P2|NOT COMPLETED|Overall Study||0
157282|NCT00445211|384623|P1|NOT COMPLETED|Overall Study||0
157283|NCT00445211|384622|P2|COMPLETED|Overall Study||23
157284|NCT00445211|384623|P1|COMPLETED|Overall Study||23
157285|NCT00445211|384622|P2|STARTED|Overall Study||23
157286|NCT00445211|384623|P1|STARTED|Overall Study||23
157287|NCT00445224|384639|P2|NOT COMPLETED|Combined Exercises||0
157288|NCT00445224|384640|P1|NOT COMPLETED|Combined Exercises||0
157289|NCT00445224|384639|P2|COMPLETED|Combined Exercises||13
157290|NCT00445224|384640|P1|COMPLETED|Combined Exercises||13
157291|NCT00445224|384639|P2|STARTED|Combined Exercises||13
157292|NCT00445224|384640|P1|STARTED|Combined Exercises||13
157293|NCT00445224|384639|P2|NOT COMPLETED|Specific Exercises||3
157294|NCT00445224|384640|P1|NOT COMPLETED|Specific Exercises||4
157295|NCT00445224|384639|P2|COMPLETED|Specific Exercises|No adverse event occurred|13
157296|NCT00445224|384640|P1|COMPLETED|Specific Exercises|No adverse event occurred|13
157297|NCT00445224|384639|P2|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|13
157298|NCT00445224|384640|P1|4 Weeks|Specific Exercises|Participants withdrew due to time conflicts|14
157299|NCT00445224|384639|P2|Baseline|Specific Exercises||16
157300|NCT00445224|384640|P1|Baseline|Specific Exercises||17
157301|NCT00445224|384639|P2|STARTED|Specific Exercises||16
157302|NCT00445224|384640|P1|STARTED|Specific Exercises||17
157303|NCT00445263|384652|P2|NOT COMPLETED|Overall Study||1
157304|NCT00445263|384653|P1|NOT COMPLETED|Overall Study||0
157305|NCT00445263|384652|P2|COMPLETED|Overall Study||86
157306|NCT00445263|384653|P1|COMPLETED|Overall Study||83
157307|NCT00445263|384652|P2|STARTED|Overall Study||87
157308|NCT00445263|384653|P1|STARTED|Overall Study||83
157309|NCT00445302|384663|P4|NOT COMPLETED|Overall Study||0
157310|NCT00445302|384664|P3|NOT COMPLETED|Overall Study||0
157311|NCT00445302|384665|P2|NOT COMPLETED|Overall Study||0
157312|NCT00445302|384666|P1|NOT COMPLETED|Overall Study||0
157313|NCT00445302|384663|P4|COMPLETED|Overall Study||6
157314|NCT00445302|384664|P3|COMPLETED|Overall Study||6
157315|NCT00445302|384665|P2|COMPLETED|Overall Study||5
157316|NCT00445302|384666|P1|COMPLETED|Overall Study||6
157317|NCT00445302|384663|P4|STARTED|Overall Study||6
157318|NCT00445302|384664|P3|STARTED|Overall Study||6
157319|NCT00445302|384665|P2|STARTED|Overall Study||5
157320|NCT00445302|384666|P1|STARTED|Overall Study||6
157321|NCT00445315|384697|P5|NOT COMPLETED|Overall Study||0
157322|NCT00445315|384698|P4|NOT COMPLETED|Overall Study||0
157323|NCT00445315|384699|P3|NOT COMPLETED|Overall Study||0
157324|NCT00445315|384700|P2|NOT COMPLETED|Overall Study||0
157325|NCT00445315|384701|P1|NOT COMPLETED|Overall Study||0
157326|NCT00445315|384697|P5|COMPLETED|Overall Study||8
157327|NCT00445315|384698|P4|COMPLETED|Overall Study||6
157328|NCT00445315|384699|P3|COMPLETED|Overall Study||6
157329|NCT00445315|384700|P2|COMPLETED|Overall Study||6
157330|NCT00445315|384701|P1|COMPLETED|Overall Study||6
157331|NCT00445315|384697|P5|STARTED|Overall Study||8
157332|NCT00445315|384698|P4|STARTED|Overall Study||6
157333|NCT00445315|384699|P3|STARTED|Overall Study||6
157334|NCT00445315|384700|P2|STARTED|Overall Study||6
157335|NCT00445315|384701|P1|STARTED|Overall Study||6
157336|NCT00445328|384793|P2|NOT COMPLETED|Overall Study||6
157337|NCT00445328|384794|P1|NOT COMPLETED|Overall Study||3
157338|NCT00445328|384793|P2|COMPLETED|Overall Study||36
157339|NCT00445328|384794|P1|COMPLETED|Overall Study||39
157340|NCT00445328|384793|P2|Received Treatment|Overall Study||42
157341|NCT00445328|384794|P1|Received Treatment|Overall Study|1 subject discontinued after enrollment but prior to study treatment.|41
157342|NCT00445328|384793|P2|STARTED|Overall Study||42
157343|NCT00445328|384794|P1|STARTED|Overall Study||42
157344|NCT00445341|384812|P1|NOT COMPLETED|Overall Study||2
157345|NCT00445341|384812|P1|COMPLETED|Overall Study||26
157346|NCT00445341|384812|P1|STARTED|Overall Study||28
157347|NCT00445432|384820|P4|NOT COMPLETED|148 Weeks of Adalimumab Treatment||44
157348|NCT00445432|384821|P3|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
157349|NCT00445432|384822|P2|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
157350|NCT00445432|384823|P1|NOT COMPLETED|148 Weeks of Adalimumab Treatment||0
157351|NCT00445432|384820|P4|COMPLETED|148 Weeks of Adalimumab Treatment||35
157352|NCT00445432|384821|P3|COMPLETED|148 Weeks of Adalimumab Treatment||0
157353|NCT00445432|384822|P2|COMPLETED|148 Weeks of Adalimumab Treatment||0
157354|NCT00445432|384823|P1|COMPLETED|148 Weeks of Adalimumab Treatment||0
157355|NCT00445432|384820|P4|STARTED|148 Weeks of Adalimumab Treatment|3 participants discontinued while receiving double-blind placebo and never received any adalimumab|79
157356|NCT00445432|384821|P3|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
157357|NCT00445432|384822|P2|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
157358|NCT00445432|384823|P1|STARTED|148 Weeks of Adalimumab Treatment|This group is not applicable for this period.|0
157359|NCT00445432|384820|P4|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
157360|NCT00445432|384821|P3|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||11
157361|NCT00445432|384822|P2|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||23
157362|NCT00445432|384823|P1|NOT COMPLETED|Through Week 52 of NCT00445432 (M06-837)||15
157363|NCT00445432|384820|P4|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||0
157364|NCT00445432|384821|P3|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||21
157365|NCT00445432|384822|P2|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||2
157366|NCT00445432|384823|P1|COMPLETED|Through Week 52 of NCT00445432 (M06-837)||10
157367|NCT00445432|384820|P4|STARTED|Through Week 52 of NCT00445432 (M06-837)|This treatment group is not applicable for this period.|0
157368|NCT00445432|384821|P3|STARTED|Through Week 52 of NCT00445432 (M06-837)||32
157369|NCT00445432|384822|P2|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
157370|NCT00445432|384823|P1|STARTED|Through Week 52 of NCT00445432 (M06-837)||25
157371|NCT00445484|384858|P2|NOT COMPLETED|Overall Study||1
157372|NCT00445484|384859|P1|NOT COMPLETED|Overall Study||4
157373|NCT00445484|384858|P2|COMPLETED|Overall Study||10
157374|NCT00445484|384859|P1|COMPLETED|Overall Study||7
157375|NCT00445484|384858|P2|STARTED|Overall Study||11
157376|NCT00445484|384859|P1|STARTED|Overall Study||11
157377|NCT00445549|384871|P1|NOT COMPLETED|Overall Study||12
157378|NCT00445549|384871|P1|COMPLETED|Overall Study||0
157379|NCT00445549|384871|P1|STARTED|Overall Study||12
157380|NCT00445588|384876|P1|NOT COMPLETED|Overall Study||0
157381|NCT00445588|384876|P1|COMPLETED|Overall Study||56
157382|NCT00445588|384876|P1|STARTED|Overall Study||56
157383|NCT00445679|384885|P4|NOT COMPLETED|Overall Study||47
157384|NCT00445679|384886|P3|NOT COMPLETED|Overall Study||66
157385|NCT00445679|384887|P2|NOT COMPLETED|Overall Study||46
157386|NCT00445679|384888|P1|NOT COMPLETED|Overall Study||48
157387|NCT00445679|384885|P4|COMPLETED|Overall Study||149
157388|NCT00445679|384886|P3|COMPLETED|Overall Study||139
157389|NCT00445679|384887|P2|COMPLETED|Overall Study||157
157390|NCT00445679|384888|P1|COMPLETED|Overall Study||155
157391|NCT00445679|384885|P4|STARTED|Overall Study||196
157392|NCT00445679|384886|P3|STARTED|Overall Study||205
157393|NCT00445679|384887|P2|STARTED|Overall Study||203
157394|NCT00445679|384888|P1|STARTED|Overall Study||203
157395|NCT00445705|384926|P4|NOT COMPLETED|Overall Study||14
157396|NCT00445705|384927|P3|NOT COMPLETED|Overall Study||11
157397|NCT00445705|384928|P2|NOT COMPLETED|Overall Study||11
157398|NCT00445705|384929|P1|NOT COMPLETED|Overall Study||9
157399|NCT00445705|384926|P4|COMPLETED|Overall Study||39
157400|NCT00445705|384927|P3|COMPLETED|Overall Study||41
157401|NCT00445705|384928|P2|COMPLETED|Overall Study||42
157402|NCT00445705|384929|P1|COMPLETED|Overall Study||44
157403|NCT00445705|384926|P4|STARTED|Overall Study||53
157404|NCT00445705|384927|P3|STARTED|Overall Study||52
157405|NCT00445705|384928|P2|STARTED|Overall Study||53
157406|NCT00445705|384929|P1|STARTED|Overall Study||53
157407|NCT00445770|384954|P3|NOT COMPLETED|Overall Study||31
157408|NCT00445770|384955|P2|NOT COMPLETED|Overall Study||35
157409|NCT00445770|384956|P1|NOT COMPLETED|Overall Study||53
157410|NCT00445770|384954|P3|COMPLETED|Overall Study||151
157411|NCT00445770|384955|P2|COMPLETED|Overall Study||157
157412|NCT00445770|384956|P1|COMPLETED|Overall Study||123
157413|NCT00445770|384954|P3|STARTED|Overall Study||182
157414|NCT00445770|384955|P2|STARTED|Overall Study||192
157415|NCT00445770|384956|P1|STARTED|Overall Study||176
157416|NCT00445848|385023|P1|NOT COMPLETED|Overall Study||85
157417|NCT00445848|385023|P1|COMPLETED|Overall Study||0
157418|NCT00445848|385023|P1|STARTED|Overall Study||85
157419|NCT00445939|385033|P4|NOT COMPLETED|Period B - Week 4 - Week 8||1
157420|NCT00445939|385034|P3|NOT COMPLETED|Period B - Week 4 - Week 8||0
157421|NCT00445939|385035|P2|NOT COMPLETED|Period B - Week 4 - Week 8||0
157422|NCT00445939|385036|P1|NOT COMPLETED|Period B - Week 4 - Week 8||2
157423|NCT00445939|385033|P4|COMPLETED|Period B - Week 4 - Week 8||20
157424|NCT00445939|385034|P3|COMPLETED|Period B - Week 4 - Week 8||0
157425|NCT00445939|385035|P2|COMPLETED|Period B - Week 4 - Week 8||0
157426|NCT00445939|385036|P1|COMPLETED|Period B - Week 4 - Week 8||14
157427|NCT00445939|385033|P4|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 160/80 and 80/40 subjects allocated to 40/40 group.|21
157428|NCT00445939|385034|P3|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous placebo subjects allocated to 160/80 mg group.|0
157429|NCT00445939|385035|P2|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 80/40 mg subjects allocated to 40/40 mg group.|0
157430|NCT00445939|385036|P1|STARTED|Period B - Week 4 - Week 8|Non-responders continued after 4 weeks, previous 16 placebo subjects allocated to 160/80 mg group.|16
157431|NCT00445939|385033|P4|NOT COMPLETED|Period A - Week 0 - Week 4||0
157432|NCT00445939|385034|P3|NOT COMPLETED|Period A - Week 0 - Week 4||0
157433|NCT00445939|385035|P2|NOT COMPLETED|Period A - Week 0 - Week 4||2
157434|NCT00445939|385036|P1|NOT COMPLETED|Period A - Week 0 - Week 4||1
157435|NCT00445939|385033|P4|COMPLETED|Period A - Week 0 - Week 4||0
157436|NCT00445939|385034|P3|COMPLETED|Period A - Week 0 - Week 4|7 rated as responders and 16 rated as non-responders in evaluation on Week 4.|23
157437|NCT00445939|385035|P2|COMPLETED|Period A - Week 0 - Week 4|20 rated as responders and 12 rated as non-responders in evaluation on Week 4.|32
157438|NCT00445939|385036|P1|COMPLETED|Period A - Week 0 - Week 4|23 rated as responders and 9 rated as non-responders in evaluation on Week 4.|32
157439|NCT00445939|385033|P4|STARTED|Period A - Week 0 - Week 4||0
157440|NCT00445939|385034|P3|STARTED|Period A - Week 0 - Week 4||23
157441|NCT00445939|385035|P2|STARTED|Period A - Week 0 - Week 4||34
157442|NCT00445939|385036|P1|STARTED|Period A - Week 0 - Week 4||33
157443|NCT00446030|385061|P2|NOT COMPLETED|FOLLOW-UP (up to 2-years)||9
157444|NCT00446030|385062|P1|NOT COMPLETED|FOLLOW-UP (up to 2-years)||30
157445|NCT00446030|385061|P2|COMPLETED|FOLLOW-UP (up to 2-years)||25
157446|NCT00446030|385062|P1|COMPLETED|FOLLOW-UP (up to 2-years)||63
157447|NCT00446030|385061|P2|STARTED|FOLLOW-UP (up to 2-years)||34
157448|NCT00446030|385062|P1|STARTED|FOLLOW-UP (up to 2-years)|All participants, including those who discontinued treatment, continued to the follow-up period.|93
157449|NCT00446030|385061|P2|NOT COMPLETED|TREATMENT (up to 52 Weeks)||9
157450|NCT00446030|385062|P1|NOT COMPLETED|TREATMENT (up to 52 Weeks)||44
157451|NCT00446030|385061|P2|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|25
157452|NCT00446030|385062|P1|COMPLETED|TREATMENT (up to 52 Weeks)|Participants who completed treatment|49
157453|NCT00446030|385061|P2|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||34
157454|NCT00446030|385062|P1|RECEIVED TREATMENT|TREATMENT (up to 52 Weeks)||92
157455|NCT00446030|385061|P2|STARTED|TREATMENT (up to 52 Weeks)||34
157456|NCT00446030|385062|P1|STARTED|TREATMENT (up to 52 Weeks)||93
157457|NCT00446095|385075|P5|NOT COMPLETED|Phase I (28 Days)||3
157458|NCT00446095|385076|P4|NOT COMPLETED|Phase I (28 Days)||1
157459|NCT00446095|385077|P3|NOT COMPLETED|Phase I (28 Days)||0
157460|NCT00446095|385078|P2|NOT COMPLETED|Phase I (28 Days)||0
157461|NCT00446095|385079|P1|NOT COMPLETED|Phase I (28 Days)||0
157462|NCT00446095|385075|P5|COMPLETED|Phase I (28 Days)||4
157463|NCT00446095|385076|P4|COMPLETED|Phase I (28 Days)||5
157464|NCT00446095|385077|P3|COMPLETED|Phase I (28 Days)||0
157465|NCT00446095|385078|P2|COMPLETED|Phase I (28 Days)||0
157466|NCT00446095|385079|P1|COMPLETED|Phase I (28 Days)||0
157467|NCT00446095|385075|P5|STARTED|Phase I (28 Days)||7
157468|NCT00446095|385076|P4|STARTED|Phase I (28 Days)||6
157469|NCT00446095|385077|P3|STARTED|Phase I (28 Days)||0
157470|NCT00446095|385078|P2|STARTED|Phase I (28 Days)||0
157471|NCT00446095|385079|P1|STARTED|Phase I (28 Days)||0
157472|NCT00446095|385075|P5|NOT COMPLETED|Phase II (8 Weeks)||0
157473|NCT00446095|385076|P4|NOT COMPLETED|Phase II (8 Weeks)||0
157474|NCT00446095|385077|P3|NOT COMPLETED|Phase II (8 Weeks)||3
157475|NCT00446095|385078|P2|NOT COMPLETED|Phase II (8 Weeks)||3
157476|NCT00446095|385079|P1|NOT COMPLETED|Phase II (8 Weeks)||12
157477|NCT00446095|385075|P5|COMPLETED|Phase II (8 Weeks)||0
157478|NCT00446095|385076|P4|COMPLETED|Phase II (8 Weeks)||0
157479|NCT00446095|385077|P3|COMPLETED|Phase II (8 Weeks)||21
157480|NCT00446095|385078|P2|COMPLETED|Phase II (8 Weeks)||18
157481|NCT00446095|385079|P1|COMPLETED|Phase II (8 Weeks)||11
157482|NCT00446095|385075|P5|STARTED|Phase II (8 Weeks)||0
157483|NCT00446095|385076|P4|STARTED|Phase II (8 Weeks)||0
157484|NCT00446095|385077|P3|STARTED|Phase II (8 Weeks)||24
157485|NCT00446095|385078|P2|STARTED|Phase II (8 Weeks)||21
157486|NCT00446095|385079|P1|STARTED|Phase II (8 Weeks)||23
157487|NCT00446134|385104|P4|NOT COMPLETED|Overall Study||45
157488|NCT00446134|385105|P3|NOT COMPLETED|Overall Study||43
157489|NCT00446134|385106|P2|NOT COMPLETED|Overall Study||45
157490|NCT00446134|385107|P1|NOT COMPLETED|Overall Study||34
157491|NCT00446134|385104|P4|COMPLETED|Overall Study||25
157492|NCT00446134|385105|P3|COMPLETED|Overall Study||26
157493|NCT00446134|385106|P2|COMPLETED|Overall Study||25
157494|NCT00446134|385107|P1|COMPLETED|Overall Study||35
157495|NCT00446134|385104|P4|STARTED|Overall Study||70
157496|NCT00446134|385105|P3|STARTED|Overall Study|Includes 1 patient who did not receive study drug and was not included in any other analysis|69
157497|NCT00446134|385106|P2|STARTED|Overall Study||70
157498|NCT00446134|385107|P1|STARTED|Overall Study|Includes 2 patients who did not receive study drug and was not included in any other analysis|69
157499|NCT00446147|385131|P2|NOT COMPLETED|Overall Study||14
157500|NCT00446147|385132|P1|NOT COMPLETED|Overall Study||15
157501|NCT00446147|385131|P2|COMPLETED|Overall Study||180
157502|NCT00446147|385132|P1|COMPLETED|Overall Study||180
157503|NCT00446147|385131|P2|STARTED|Overall Study||194
157504|NCT00446147|385132|P1|STARTED|Overall Study||195
157505|NCT00446199|385144|P4|NOT COMPLETED|Overall Study||30
157506|NCT00446199|385145|P3|NOT COMPLETED|Overall Study||27
157507|NCT00446199|385146|P2|NOT COMPLETED|Overall Study||20
157508|NCT00446199|385147|P1|NOT COMPLETED|Overall Study||23
157509|NCT00446199|385144|P4|COMPLETED|Overall Study||153
157510|NCT00446199|385145|P3|COMPLETED|Overall Study||158
157511|NCT00446199|385146|P2|COMPLETED|Overall Study||164
157512|NCT00446199|385147|P1|COMPLETED|Overall Study||160
157513|NCT00446199|385144|P4|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|176
157514|NCT00446199|385145|P3|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|179
157515|NCT00446199|385146|P2|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|177
157516|NCT00446199|385147|P1|Baseline and Postdose VMS Data Available|Overall Study|FAS=all randomized participants with Baseline VMS data and at least 1 day VMS data postdose.|178
157517|NCT00446199|385144|P4|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|180
157518|NCT00446199|385145|P3|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|182
157519|NCT00446199|385146|P2|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|183
157520|NCT00446199|385147|P1|Participants Received Treatment|Overall Study|SAF=all randomized participants who took at least 1 dose of study medication.|181
157521|NCT00446199|385144|P4|STARTED|Overall Study||183
157522|NCT00446199|385145|P3|STARTED|Overall Study||185
157523|NCT00446199|385146|P2|STARTED|Overall Study||184
157524|NCT00446199|385147|P1|STARTED|Overall Study||183
157525|NCT00446251|385225|P1|NOT COMPLETED|Overall Study||5
157526|NCT00446251|385225|P1|COMPLETED|Overall Study||9
157527|NCT00446251|385225|P1|STARTED|Overall Study|14 subjects were enrolled in this Rituximab-mycophenolic mofetil group.|14
157528|NCT00446264|385231|P1|NOT COMPLETED|Overall Study||0
157529|NCT00446264|385231|P1|COMPLETED|Overall Study||14
157530|NCT00446264|385231|P1|STARTED|Overall Study||14
157531|NCT00446290|385240|P1|NOT COMPLETED|Overall Study||0
157532|NCT00446290|385240|P1|COMPLETED|Overall Study||22
157533|NCT00446290|385240|P1|STARTED|Overall Study||22
157534|NCT00446446|385244|P1|NOT COMPLETED|Overall Study||24
157535|NCT00446446|385244|P1|COMPLETED|Overall Study|Participants who completed the 60-day safety visit|28
157536|NCT00446446|385244|P1|STARTED|Overall Study||52
157537|NCT00446459|385255|P1|NOT COMPLETED|12 Months||18
157538|NCT00446459|385255|P1|COMPLETED|12 Months|4 subjects remained at month 12|4
157539|NCT00446459|385255|P1|STARTED|12 Months|22 subjects remained on-study at month 8|22
157540|NCT00446459|385255|P1|NOT COMPLETED|8 Months||12
157541|NCT00446459|385255|P1|COMPLETED|8 Months|22 subjects were on study at month 8.|22
157542|NCT00446459|385255|P1|STARTED|8 Months|34 subjects received any amount of MMF.|34
157543|NCT00446511|385267|P4|NOT COMPLETED|Overall Study||6
157544|NCT00446511|385268|P3|NOT COMPLETED|Overall Study||7
157545|NCT00446511|385269|P2|NOT COMPLETED|Overall Study||2
157546|NCT00446511|385270|P1|NOT COMPLETED|Overall Study||10
157547|NCT00446511|385267|P4|COMPLETED|Overall Study||103
157548|NCT00446511|385268|P3|COMPLETED|Overall Study||96
157549|NCT00446511|385269|P2|COMPLETED|Overall Study||15
157550|NCT00446511|385270|P1|COMPLETED|Overall Study||11
157551|NCT00446511|385267|P4|STARTED|Overall Study||109
157552|NCT00446511|385268|P3|STARTED|Overall Study||103
157553|NCT00446511|385269|P2|STARTED|Overall Study||17
157554|NCT00446511|385270|P1|STARTED|Overall Study||21
157555|NCT00446563|385296|P2|NOT COMPLETED|Overall Study||9
157556|NCT00446563|385297|P1|NOT COMPLETED|Overall Study||7
157557|NCT00446563|385296|P2|COMPLETED|Overall Study||38
157558|NCT00446563|385297|P1|COMPLETED|Overall Study||36
157559|NCT00446563|385296|P2|STARTED|Overall Study||47
157560|NCT00446563|385297|P1|STARTED|Overall Study||43
157561|NCT00446641|385333|P2|NOT COMPLETED|Overall Study||10
157562|NCT00446641|385334|P1|NOT COMPLETED|Overall Study||17
157563|NCT00446641|385333|P2|COMPLETED|Overall Study||109
157564|NCT00446641|385334|P1|COMPLETED|Overall Study||108
157565|NCT00446641|385333|P2|STARTED|Overall Study||119
157566|NCT00446641|385334|P1|STARTED|Overall Study||125
157567|NCT00446654|385354|P2|NOT COMPLETED|Overall Study||0
157568|NCT00446654|385355|P1|NOT COMPLETED|Overall Study||2
157569|NCT00446654|385354|P2|COMPLETED|Overall Study||22
157570|NCT00446654|385355|P1|COMPLETED|Overall Study||19
157571|NCT00446654|385354|P2|STARTED|Overall Study||22
157572|NCT00446654|385355|P1|STARTED|Overall Study||21
157573|NCT00446797|385363|P2|NOT COMPLETED|Overall Study||12
157574|NCT00446797|385364|P1|NOT COMPLETED|Overall Study||8
157575|NCT00446797|385363|P2|COMPLETED|Overall Study||125
157576|NCT00446797|385364|P1|COMPLETED|Overall Study||133
157577|NCT00446797|385363|P2|STARTED|Overall Study||137
157578|NCT00446797|385364|P1|STARTED|Overall Study||141
157579|NCT00437983|385410|P2|NOT COMPLETED|Overall Study||13
157580|NCT00437983|385411|P1|NOT COMPLETED|Overall Study||13
157581|NCT00437983|385410|P2|COMPLETED|Overall Study||65
157582|NCT00437983|385411|P1|COMPLETED|Overall Study||66
157583|NCT00437983|385410|P2|STARTED|Overall Study||78
157584|NCT00437983|385411|P1|STARTED|Overall Study||79
157585|NCT00438100|385423|P2|NOT COMPLETED|Overall Study||4
157586|NCT00438100|385424|P1|NOT COMPLETED|Overall Study||2
157587|NCT00438100|385423|P2|COMPLETED|Overall Study||65
157588|NCT00438100|385424|P1|COMPLETED|Overall Study||71
157589|NCT00438100|385423|P2|STARTED|Overall Study||69
157590|NCT00438100|385424|P1|STARTED|Overall Study||73
157591|NCT00438191|385432|P2|NOT COMPLETED|Overall Study||14
157592|NCT00438191|385433|P1|NOT COMPLETED|Overall Study||11
157593|NCT00438191|385432|P2|COMPLETED|Overall Study||26
157594|NCT00438191|385433|P1|COMPLETED|Overall Study||32
157595|NCT00438191|385432|P2|STARTED|Overall Study||40
157596|NCT00438191|385433|P1|STARTED|Overall Study||43
157597|NCT00438204|385445|P1|NOT COMPLETED|Overall Study||0
157598|NCT00438204|385445|P1|COMPLETED|Overall Study||39
157599|NCT00438204|385445|P1|STARTED|Overall Study||39
157600|NCT00438360|385451|P2|NOT COMPLETED|Overall Study||43
157601|NCT00438360|385452|P1|NOT COMPLETED|Overall Study||72
157602|NCT00438360|385451|P2|COMPLETED|Overall Study||38
157603|NCT00438360|385452|P1|COMPLETED|Overall Study||90
157604|NCT00438360|385451|P2|Intention to Treat (ITT) Population|Overall Study||79
157605|NCT00438360|385452|P1|Intention to Treat (ITT) Population|Overall Study|These numbers are different from those started (randomized) as 2 pts from each arm never took drug.|160
157606|NCT00438360|385451|P2|STARTED|Overall Study||81
157607|NCT00438360|385452|P1|STARTED|Overall Study|"Started indicates randomized patients."|162
157608|NCT00438399|385469|P6|NOT COMPLETED|Overall Study||6
157609|NCT00438399|385470|P5|NOT COMPLETED|Overall Study||3
157610|NCT00438399|385471|P4|NOT COMPLETED|Overall Study||4
157611|NCT00438399|385472|P3|NOT COMPLETED|Overall Study||7
157612|NCT00438399|385473|P2|NOT COMPLETED|Overall Study||8
157613|NCT00438399|385474|P1|NOT COMPLETED|Overall Study||8
157614|NCT00438399|385469|P6|COMPLETED|Overall Study||31
157615|NCT00438399|385470|P5|COMPLETED|Overall Study||30
157616|NCT00438399|385471|P4|COMPLETED|Overall Study||32
157617|NCT00438399|385472|P3|COMPLETED|Overall Study||28
157618|NCT00438399|385473|P2|COMPLETED|Overall Study||32
157619|NCT00438399|385474|P1|COMPLETED|Overall Study||30
157620|NCT00438399|385469|P6|TREATED & ANALYZED|Overall Study||31
157621|NCT00438399|385470|P5|TREATED & ANALYZED|Overall Study||30
157622|NCT00438399|385471|P4|TREATED & ANALYZED|Overall Study||32
157623|NCT00438399|385472|P3|TREATED & ANALYZED|Overall Study||28
157624|NCT00438399|385473|P2|TREATED & ANALYZED|Overall Study||32
157625|NCT00438399|385474|P1|TREATED & ANALYZED|Overall Study||30
157626|NCT00438399|385469|P6|STARTED|Overall Study||37
157627|NCT00438399|385470|P5|STARTED|Overall Study||33
157628|NCT00438399|385471|P4|STARTED|Overall Study||36
157629|NCT00438399|385472|P3|STARTED|Overall Study||35
157630|NCT00438399|385473|P2|STARTED|Overall Study||40
157631|NCT00438399|385474|P1|STARTED|Overall Study||38
157632|NCT00438451|385486|P3|NOT COMPLETED|Overall Study||53
157633|NCT00438451|385487|P2|NOT COMPLETED|Overall Study||66
157634|NCT00438451|385488|P1|NOT COMPLETED|Overall Study||47
157635|NCT00438451|385486|P3|COMPLETED|Overall Study||65
157636|NCT00438451|385487|P2|COMPLETED|Overall Study||55
157637|NCT00438451|385488|P1|COMPLETED|Overall Study||75
157638|NCT00438451|385486|P3|Maintenance Phase (Week 7-58)|Overall Study||93
157639|NCT00438451|385487|P2|Maintenance Phase (Week 7-58)|Overall Study||89
157640|NCT00438451|385488|P1|Maintenance Phase (Week 7-58)|Overall Study||93
157641|NCT00438451|385486|P3|ITT Population|Overall Study||117
157642|NCT00438451|385487|P2|ITT Population|Overall Study||120
157643|NCT00438451|385488|P1|ITT Population|Overall Study||122
157644|NCT00438451|385486|P3|Safety Population|Overall Study||117
157645|NCT00438451|385487|P2|Safety Population|Overall Study||121
157646|NCT00438451|385488|P1|Safety Population|Overall Study||122
157647|NCT00438451|385486|P3|STARTED|Overall Study||118
157648|NCT00438451|385487|P2|STARTED|Overall Study||121
157649|NCT00438451|385488|P1|STARTED|Overall Study||122
157650|NCT00438464|385531|P2|NOT COMPLETED|Overall Study||7
157651|NCT00438464|385532|P1|NOT COMPLETED|Overall Study||14
157652|NCT00438464|385531|P2|COMPLETED|Overall Study||94
157653|NCT00438464|385532|P1|COMPLETED|Overall Study||89
157654|NCT00438464|385531|P2|Received Assigned Intervention|Overall Study||94
157655|NCT00438464|385532|P1|Received Assigned Intervention|Overall Study||89
157656|NCT00438464|385531|P2|STARTED|Overall Study||101
157657|NCT00438464|385532|P1|STARTED|Overall Study||103
157658|NCT00438490|385586|P2|NOT COMPLETED|Overall Study||0
157659|NCT00438490|385587|P1|NOT COMPLETED|Overall Study||0
157660|NCT00438490|385586|P2|COMPLETED|Overall Study||9
157661|NCT00438490|385587|P1|COMPLETED|Overall Study||12
157662|NCT00438490|385586|P2|STARTED|Overall Study||9
157663|NCT00438490|385587|P1|STARTED|Overall Study||12
157664|NCT00438659|385595|P2|NOT COMPLETED|Overall Study||4
157665|NCT00438659|385596|P1|NOT COMPLETED|Overall Study||6
157666|NCT00438659|385595|P2|COMPLETED|Overall Study||82
157667|NCT00438659|385596|P1|COMPLETED|Overall Study||84
157668|NCT00438659|385595|P2|STARTED|Overall Study||86
157669|NCT00438659|385596|P1|STARTED|Overall Study||90
157670|NCT00438672|385620|P2|NOT COMPLETED|Overall Study||9
157671|NCT00438672|385621|P1|NOT COMPLETED|Overall Study||7
157672|NCT00438672|385620|P2|COMPLETED|Overall Study||24
157673|NCT00438672|385621|P1|COMPLETED|Overall Study||24
157674|NCT00438672|385620|P2|STARTED|Overall Study||33
157675|NCT00438672|385621|P1|STARTED|Overall Study||31
157676|NCT00438750|385631|P2|NOT COMPLETED|Overall Study||9
157677|NCT00438750|385632|P1|NOT COMPLETED|Overall Study||9
157678|NCT00438750|385631|P2|COMPLETED|Overall Study||37
157679|NCT00438750|385632|P1|COMPLETED|Overall Study||39
157680|NCT00438750|385631|P2|STARTED|Overall Study||46
157681|NCT00438750|385632|P1|STARTED|Overall Study||48
157682|NCT00438815|385650|P1|NOT COMPLETED|Overall Study||70
157683|NCT00438815|385650|P1|COMPLETED|Overall Study||43
157684|NCT00438815|385650|P1|STARTED|Overall Study||113
157685|NCT00438854|385660|P1|NOT COMPLETED|Overall Study||0
157686|NCT00438854|385660|P1|COMPLETED|Overall Study||15
157687|NCT00438854|385660|P1|STARTED|Overall Study||15
157688|NCT00438880|385666|P2|NOT COMPLETED|Overall Study||0
157689|NCT00438880|385667|P1|NOT COMPLETED|Overall Study||0
157690|NCT00438880|385666|P2|COMPLETED|Overall Study||8
157691|NCT00438880|385667|P1|COMPLETED|Overall Study||30
157692|NCT00438880|385666|P2|STARTED|Overall Study||8
157693|NCT00438880|385667|P1|STARTED|Overall Study||30
157694|NCT00446849|385679|P1|NOT COMPLETED|Maintenance Phase||70
157695|NCT00446849|385679|P1|COMPLETED|Maintenance Phase||138
157696|NCT00446849|385679|P1|STARTED|Maintenance Phase||208
157697|NCT00446849|385679|P1|NOT COMPLETED|Acute Phase||82
157698|NCT00446849|385679|P1|COMPLETED|Acute Phase||56
157699|NCT00446849|385679|P1|STARTED|Acute Phase||138
157700|NCT00446992|385689|P1|NOT COMPLETED|Overall Study||16
157701|NCT00446992|385689|P1|COMPLETED|Overall Study|Intervention Completion|14
157702|NCT00446992|385689|P1|STARTED|Overall Study|Beginning of Intervention|30
157703|NCT00447005|385701|P1|NOT COMPLETED|Overall Study||12
157704|NCT00447005|385701|P1|COMPLETED|Overall Study||0
157705|NCT00447005|385701|P1|STARTED|Overall Study||12
157706|NCT00447057|385719|P4|NOT COMPLETED|Overall Study||26
157707|NCT00447057|385720|P3|NOT COMPLETED|Overall Study||19
157708|NCT00447057|385721|P2|NOT COMPLETED|Overall Study||73
157709|NCT00447057|385722|P1|NOT COMPLETED|Overall Study||83
157710|NCT00447057|385719|P4|COMPLETED|Overall Study||0
157711|NCT00447057|385720|P3|COMPLETED|Overall Study||0
157712|NCT00447057|385721|P2|COMPLETED|Overall Study||3
157713|NCT00447057|385722|P1|COMPLETED|Overall Study||0
157714|NCT00447057|385719|P4|STARTED|Overall Study||26
157715|NCT00447057|385720|P3|STARTED|Overall Study||19
157716|NCT00447057|385721|P2|STARTED|Overall Study||76
157717|NCT00447057|385722|P1|STARTED|Overall Study||83
157718|NCT00447122|385740|P1|NOT COMPLETED|Overall Study||2
157719|NCT00447122|385740|P1|COMPLETED|Overall Study|29 evaluable thus 29 represented in efficacy and safety portion|29
157720|NCT00447122|385740|P1|STARTED|Overall Study||31
157721|NCT00447590|385744|P1|NOT COMPLETED|Overall Study||60
157722|NCT00447590|385744|P1|COMPLETED|Overall Study|Completing the study was defined as the number of participants in the study at month 60 (5 years).|93
157723|NCT00447590|385744|P1|STARTED|Overall Study|153 participants were treated with the LAP-BAND System.|153
157724|NCT00447603|385753|P3|NOT COMPLETED|Filter Period||15
157725|NCT00447603|385754|P2|NOT COMPLETED|Filter Period||4
157726|NCT00447603|385755|P1|NOT COMPLETED|Filter Period||0
157727|NCT00447603|385753|P3|COMPLETED|Filter Period||0
157728|NCT00447603|385754|P2|COMPLETED|Filter Period||0
157729|NCT00447603|385755|P1|COMPLETED|Filter Period||0
157730|NCT00447603|385753|P3|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|15
157731|NCT00447603|385754|P2|STARTED|Filter Period|The study was discontinued early; no participant entered treatment period|4
157732|NCT00447603|385755|P1|STARTED|Filter Period||0
157733|NCT00447603|385753|P3|NOT COMPLETED|Screening||0
157734|NCT00447603|385754|P2|NOT COMPLETED|Screening||0
157735|NCT00447603|385755|P1|NOT COMPLETED|Screening||21
157736|NCT00447603|385753|P3|COMPLETED|Screening||0
157737|NCT00447603|385754|P2|COMPLETED|Screening||0
157738|NCT00447603|385755|P1|COMPLETED|Screening||19
157739|NCT00447603|385753|P3|STARTED|Screening||0
157740|NCT00447603|385754|P2|STARTED|Screening||0
157741|NCT00447603|385755|P1|STARTED|Screening||40
157742|NCT00447876|385777|P2|NOT COMPLETED|Overall Study||4
157743|NCT00447876|385778|P1|NOT COMPLETED|Overall Study||3
157744|NCT00447876|385777|P2|COMPLETED|Overall Study||16
157745|NCT00447876|385778|P1|COMPLETED|Overall Study||17
157746|NCT00447876|385777|P2|STARTED|Overall Study||20
157747|NCT00447876|385778|P1|STARTED|Overall Study||20
157748|NCT00447902|385810|P2|NOT COMPLETED|Overall Study||6
157749|NCT00447902|385811|P1|NOT COMPLETED|Overall Study||4
157750|NCT00447902|385810|P2|COMPLETED|Overall Study||0
157751|NCT00447902|385811|P1|COMPLETED|Overall Study||1
157752|NCT00447902|385810|P2|STARTED|Overall Study||6
157753|NCT00447902|385811|P1|STARTED|Overall Study||5
157754|NCT00448019|385851|P1|NOT COMPLETED|Overall Study||7
157755|NCT00448019|385851|P1|COMPLETED|Overall Study||57
157756|NCT00448019|385851|P1|STARTED|Overall Study||64
157757|NCT00448123|385859|P2|NOT COMPLETED|Overall Study||12
157758|NCT00448123|385860|P1|NOT COMPLETED|Overall Study||15
157759|NCT00448123|385859|P2|COMPLETED|Overall Study||53
157760|NCT00448123|385860|P1|COMPLETED|Overall Study||47
157761|NCT00448123|385859|P2|STARTED|Overall Study||65
157762|NCT00448123|385860|P1|STARTED|Overall Study||62
157763|NCT00448136|385872|P2|NOT COMPLETED|Overall Study||8
157764|NCT00448136|385873|P1|NOT COMPLETED|Overall Study||4
157765|NCT00448136|385872|P2|COMPLETED|Overall Study||41
157766|NCT00448136|385873|P1|COMPLETED|Overall Study||30
157767|NCT00448136|385872|P2|STARTED|Overall Study||49
157768|NCT00448136|385873|P1|STARTED|Overall Study||34
157769|NCT00448175|385911|P2|NOT COMPLETED|Continued PTNS Through 12 Months||0
157770|NCT00448175|385912|P1|NOT COMPLETED|Continued PTNS Through 12 Months||10
157771|NCT00448175|385911|P2|COMPLETED|Continued PTNS Through 12 Months||0
157772|NCT00448175|385912|P1|COMPLETED|Continued PTNS Through 12 Months||25
157773|NCT00448175|385911|P2|STARTED|Continued PTNS Through 12 Months||0
157774|NCT00448175|385912|P1|STARTED|Continued PTNS Through 12 Months||35
157775|NCT00448175|385911|P2|NOT COMPLETED|12 Weeks PTNS vs. Drug||7
157776|NCT00448175|385912|P1|NOT COMPLETED|12 Weeks PTNS vs. Drug||9
157777|NCT00448175|385911|P2|COMPLETED|12 Weeks PTNS vs. Drug||43
157778|NCT00448175|385912|P1|COMPLETED|12 Weeks PTNS vs. Drug||41
157779|NCT00448175|385911|P2|STARTED|12 Weeks PTNS vs. Drug||50
157780|NCT00448175|385912|P1|STARTED|12 Weeks PTNS vs. Drug||50
157781|NCT00448201|385918|P1|NOT COMPLETED|Overall Study||0
157782|NCT00448201|385918|P1|COMPLETED|Overall Study||71
157783|NCT00448201|385918|P1|STARTED|Overall Study||71
157784|NCT00448227|385927|P1|NOT COMPLETED|Overall Study||0
157785|NCT00448227|385927|P1|COMPLETED|Overall Study||18
157786|NCT00448227|385927|P1|STARTED|Overall Study||18
157787|NCT00448279|385956|P2|NOT COMPLETED|Overall Study||29
157788|NCT00448279|385957|P1|NOT COMPLETED|Overall Study||29
157789|NCT00448279|385956|P2|COMPLETED|Overall Study||0
157790|NCT00448279|385957|P1|COMPLETED|Overall Study||0
157791|NCT00448279|385956|P2|STARTED|Overall Study||29
157792|NCT00448279|385957|P1|STARTED|Overall Study||29
157793|NCT00448344|385975|P2|NOT COMPLETED|Overall Study||36
157794|NCT00448344|385976|P1|NOT COMPLETED|Overall Study||30
157795|NCT00448344|385975|P2|COMPLETED|Overall Study||200
157796|NCT00448344|385976|P1|COMPLETED|Overall Study||205
157797|NCT00448344|385975|P2|STARTED|Overall Study||236
157798|NCT00448344|385976|P1|STARTED|Overall Study||235
157799|NCT00448357|385984|P1|NOT COMPLETED|Overall Study||0
157800|NCT00448357|385984|P1|COMPLETED|Overall Study||54
157801|NCT00448357|385984|P1|STARTED|Overall Study||54
157802|NCT00448435|386007|P2|NOT COMPLETED|Extension Period - 20 Weeks||0
157803|NCT00448435|386008|P1|NOT COMPLETED|Extension Period - 20 Weeks||0
157804|NCT00448435|386007|P2|COMPLETED|Extension Period - 20 Weeks||0
157805|NCT00448435|386008|P1|COMPLETED|Extension Period - 20 Weeks||50
157806|NCT00448435|386007|P2|STARTED|Extension Period - 20 Weeks||0
157807|NCT00448435|386008|P1|STARTED|Extension Period - 20 Weeks||50
157808|NCT00448435|386007|P2|NOT COMPLETED|Treatment Period II - 4 Weeks||0
157809|NCT00448435|386008|P1|NOT COMPLETED|Treatment Period II - 4 Weeks||0
157810|NCT00448435|386007|P2|COMPLETED|Treatment Period II - 4 Weeks||25
157811|NCT00448435|386008|P1|COMPLETED|Treatment Period II - 4 Weeks||25
157812|NCT00448435|386007|P2|STARTED|Treatment Period II - 4 Weeks||25
157813|NCT00448435|386008|P1|STARTED|Treatment Period II - 4 Weeks||25
157814|NCT00448435|386007|P2|NOT COMPLETED|Washout Period - 2 Weeks||0
157815|NCT00448435|386008|P1|NOT COMPLETED|Washout Period - 2 Weeks||1
157816|NCT00448435|386007|P2|COMPLETED|Washout Period - 2 Weeks||25
157817|NCT00448435|386008|P1|COMPLETED|Washout Period - 2 Weeks||25
157818|NCT00448435|386007|P2|STARTED|Washout Period - 2 Weeks||25
157819|NCT00448435|386008|P1|STARTED|Washout Period - 2 Weeks||26
157820|NCT00448435|386007|P2|NOT COMPLETED|Treatment Period I - 4 Weeks||0
157821|NCT00448435|386008|P1|NOT COMPLETED|Treatment Period I - 4 Weeks||0
157822|NCT00448435|386007|P2|COMPLETED|Treatment Period I - 4 Weeks||25
157823|NCT00448435|386008|P1|COMPLETED|Treatment Period I - 4 Weeks||26
157824|NCT00448435|386007|P2|STARTED|Treatment Period I - 4 Weeks||25
157825|NCT00448435|386008|P1|STARTED|Treatment Period I - 4 Weeks||26
157826|NCT00448448|386036|P2|NOT COMPLETED|Overall Study||41
157827|NCT00448448|386037|P1|NOT COMPLETED|Overall Study||100
157828|NCT00448448|386036|P2|COMPLETED|Overall Study||96
157829|NCT00448448|386037|P1|COMPLETED|Overall Study||146
157830|NCT00448448|386036|P2|STARTED|Overall Study||137
157831|NCT00448448|386037|P1|STARTED|Overall Study||246
157832|NCT00448539|386045|P2|NOT COMPLETED|Overall Study||152
157833|NCT00448539|386046|P1|NOT COMPLETED|Overall Study||134
157834|NCT00448539|386045|P2|COMPLETED|Overall Study||0
157835|NCT00448539|386046|P1|COMPLETED|Overall Study||0
157836|NCT00448539|386045|P2|STARTED|Overall Study||152
157837|NCT00448539|386046|P1|STARTED|Overall Study||134
157838|NCT00448591|386052|P1|NOT COMPLETED|Overall Study||2296
157839|NCT00448591|386052|P1|COMPLETED|Overall Study||0
157840|NCT00448591|386052|P1|STARTED|Overall Study||2296
157841|NCT00448630|386061|P1|NOT COMPLETED|Overall Study||27
157842|NCT00448630|386061|P1|COMPLETED|Overall Study|Number of patients who remained on same medication to end of study.|301
157843|NCT00448630|386061|P1|STARTED|Overall Study||328
157844|NCT00448682|386106|P1|NOT COMPLETED|Overall Study||0
157845|NCT00448682|386106|P1|COMPLETED|Overall Study||25
157846|NCT00448682|386106|P1|STARTED|Overall Study||25
157847|NCT00448708|386114|P2|NOT COMPLETED|Overall Study||31
157848|NCT00448708|386115|P1|NOT COMPLETED|Overall Study||35
157849|NCT00448708|386114|P2|COMPLETED|Overall Study||79
157850|NCT00448708|386115|P1|COMPLETED|Overall Study||77
157851|NCT00448708|386114|P2|STARTED|Overall Study||110
157852|NCT00448708|386115|P1|STARTED|Overall Study||112
157853|NCT00448760|386123|P1|NOT COMPLETED|Overall Study||3
157854|NCT00448760|386123|P1|COMPLETED|Overall Study||26
157855|NCT00448760|386123|P1|STARTED|Overall Study||29
157856|NCT00448864|386133|P3|NOT COMPLETED|Overall Study||1
157857|NCT00448864|386134|P2|NOT COMPLETED|Overall Study||5
157858|NCT00448864|386135|P1|NOT COMPLETED|Overall Study||5
157859|NCT00448864|386133|P3|COMPLETED|Overall Study||18
157860|NCT00448864|386134|P2|COMPLETED|Overall Study||24
157861|NCT00448864|386135|P1|COMPLETED|Overall Study||22
157862|NCT00448864|386133|P3|Completed Post-operative Period|Overall Study||18
157863|NCT00448864|386134|P2|Completed Post-operative Period|Overall Study||25
157864|NCT00448864|386135|P1|Completed Post-operative Period|Overall Study||26
157865|NCT00448864|386133|P3|Started Post-operative Period|Overall Study||18
157866|NCT00448864|386134|P2|Started Post-operative Period|Overall Study||25
157867|NCT00448864|386135|P1|Started Post-operative Period|Overall Study||26
157868|NCT00448864|386133|P3|Received at Least 1 Dose of Study Drug|Overall Study||18
157869|NCT00448864|386134|P2|Received at Least 1 Dose of Study Drug|Overall Study||25
157870|NCT00448864|386135|P1|Received at Least 1 Dose of Study Drug|Overall Study||26
157871|NCT00448864|386133|P3|STARTED|Overall Study||19
157872|NCT00448864|386134|P2|STARTED|Overall Study||29
157873|NCT00448864|386135|P1|STARTED|Overall Study||27
157874|NCT00448916|386155|P4|NOT COMPLETED|Overall Study||6
157875|NCT00448916|386156|P3|NOT COMPLETED|Overall Study||6
157876|NCT00448916|386157|P2|NOT COMPLETED|Overall Study||6
157877|NCT00448916|386158|P1|NOT COMPLETED|Overall Study||7
157878|NCT00448916|386155|P4|COMPLETED|Overall Study||5
157879|NCT00448916|386156|P3|COMPLETED|Overall Study||6
157880|NCT00448916|386157|P2|COMPLETED|Overall Study||9
157881|NCT00448916|386158|P1|COMPLETED|Overall Study||9
157882|NCT00448916|386155|P4|STARTED|Overall Study||11
157883|NCT00448916|386156|P3|STARTED|Overall Study||12
157884|NCT00448916|386157|P2|STARTED|Overall Study||15
157885|NCT00448916|386158|P1|STARTED|Overall Study||16
157886|NCT00449033|386231|P2|NOT COMPLETED|Follow-up Period||434
157887|NCT00449033|386232|P1|NOT COMPLETED|Follow-up Period||425
157888|NCT00449033|386231|P2|COMPLETED|Follow-up Period||0
157889|NCT00449033|386232|P1|COMPLETED|Follow-up Period||0
157890|NCT00449033|386231|P2|STARTED|Follow-up Period|434 entered, comprising 452 randomized less 12 deaths, 2 lost to follow-up & 4 ongoing on treatment|434
157891|NCT00449033|386232|P1|STARTED|Follow-up Period|425 entered, comprising 452 randomized less 21 deaths & 6 ongoing on treatment|425
157892|NCT00449033|386231|P2|NOT COMPLETED|Treatment Period||452
157893|NCT00449033|386232|P1|NOT COMPLETED|Treatment Period||452
157894|NCT00449033|386231|P2|COMPLETED|Treatment Period||0
157895|NCT00449033|386232|P1|COMPLETED|Treatment Period||0
157896|NCT00449033|386231|P2|Received Treatment|Treatment Period||449
157897|NCT00449033|386232|P1|Received Treatment|Treatment Period||452
157898|NCT00449033|386231|P2|STARTED|Treatment Period|Reasons for not treated: Adverse event (N=1); Consent withdrawn (N=1); Reason missing (N=1)|452
157899|NCT00449033|386232|P1|STARTED|Treatment Period||452
157900|NCT00449046|386266|P1|NOT COMPLETED|Overall Study||0
157901|NCT00449046|386266|P1|COMPLETED|Overall Study||40
157902|NCT00449046|386266|P1|STARTED|Overall Study||40
157903|NCT00449072|386279|P2|NOT COMPLETED|Overall Study||42
157904|NCT00449072|386280|P1|NOT COMPLETED|Overall Study||41
157905|NCT00449072|386279|P2|COMPLETED|Overall Study||109
157906|NCT00449072|386280|P1|COMPLETED|Overall Study||107
157907|NCT00449072|386279|P2|STARTED|Overall Study||151
157908|NCT00449072|386280|P1|STARTED|Overall Study||148
157909|NCT00449150|386307|P3|NOT COMPLETED|Overall Study||47
157910|NCT00449150|386308|P2|NOT COMPLETED|Overall Study||53
157911|NCT00449150|386309|P1|NOT COMPLETED|Overall Study||46
157912|NCT00449150|386307|P3|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|171
157913|NCT00449150|386308|P2|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|177
157914|NCT00449150|386309|P1|COMPLETED|Overall Study|Subjects could have more than one reason for not completing.|173
157915|NCT00449150|386307|P3|STARTED|Overall Study||218
157916|NCT00449150|386308|P2|STARTED|Overall Study||230
157917|NCT00449150|386309|P1|STARTED|Overall Study||219
157918|NCT00449163|386317|P1|NOT COMPLETED|Overall Study||3
157919|NCT00449163|386317|P1|COMPLETED|Overall Study||22
157920|NCT00449163|386317|P1|STARTED|Overall Study||25
157921|NCT00449176|386327|P3|NOT COMPLETED|Overall Study||167
157922|NCT00449176|386328|P2|NOT COMPLETED|Overall Study||195
157923|NCT00449176|386329|P1|NOT COMPLETED|Overall Study||152
157924|NCT00449176|386327|P3|COMPLETED|Overall Study||152
157925|NCT00449176|386328|P2|COMPLETED|Overall Study||133
157926|NCT00449176|386329|P1|COMPLETED|Overall Study||166
157927|NCT00449176|386327|P3|STARTED|Overall Study|5 randomly assigned to this group did not receive drug, 2 enrolled twice(of 326 subjects randomized)|319
157928|NCT00449176|386328|P2|STARTED|Overall Study|6 randomly assigned to this treatment group did not take drug (of 334 subjects initially randomized)|328
157929|NCT00449176|386329|P1|STARTED|Overall Study|3 randomly assigned to this treatment group did not take drug (of 321 subjects initially randomized)|318
157930|NCT00449540|386357|P3|NOT COMPLETED|Treatment Phase||17
157931|NCT00449540|386358|P2|NOT COMPLETED|Treatment Phase||20
157932|NCT00449540|386359|P1|NOT COMPLETED|Treatment Phase||0
157933|NCT00449540|386357|P3|COMPLETED|Treatment Phase||82
157934|NCT00449540|386358|P2|COMPLETED|Treatment Phase||82
157935|NCT00449540|386359|P1|COMPLETED|Treatment Phase||0
157936|NCT00449540|386357|P3|STARTED|Treatment Phase||99
157937|NCT00449540|386358|P2|STARTED|Treatment Phase||102
157938|NCT00449540|386359|P1|STARTED|Treatment Phase||0
157939|NCT00449540|386357|P3|NOT COMPLETED|Pretreatment Phase||0
157940|NCT00449540|386358|P2|NOT COMPLETED|Pretreatment Phase||0
157941|NCT00449540|386359|P1|NOT COMPLETED|Pretreatment Phase||66
157942|NCT00449540|386357|P3|COMPLETED|Pretreatment Phase||0
157943|NCT00449540|386358|P2|COMPLETED|Pretreatment Phase||0
157944|NCT00449540|386359|P1|COMPLETED|Pretreatment Phase||201
157945|NCT00449540|386357|P3|STARTED|Pretreatment Phase||0
157946|NCT00449540|386358|P2|STARTED|Pretreatment Phase||0
157947|NCT00449540|386359|P1|STARTED|Pretreatment Phase||267
157948|NCT00449644|386377|P4|NOT COMPLETED|Overall Study||32
157949|NCT00449644|386378|P3|NOT COMPLETED|Overall Study||29
157950|NCT00449644|386379|P2|NOT COMPLETED|Overall Study||13
157951|NCT00449644|386380|P1|NOT COMPLETED|Overall Study||10
157952|NCT00449644|386377|P4|COMPLETED|Overall Study|After Week 24, 1 patient rolled over to treatment with TMC207 and was not completed or discontinued.|49
157953|NCT00449644|386378|P3|COMPLETED|Overall Study||50
157954|NCT00449644|386379|P2|COMPLETED|Overall Study||11
157955|NCT00449644|386380|P1|COMPLETED|Overall Study||13
157956|NCT00449644|386377|P4|Rollover|Overall Study||1
157957|NCT00449644|386378|P3|Rollover|Overall Study||0
157958|NCT00449644|386379|P2|Rollover|Overall Study||0
157959|NCT00449644|386380|P1|Rollover|Overall Study||0
157960|NCT00449644|386377|P4|STARTED|Overall Study||81
157961|NCT00449644|386378|P3|STARTED|Overall Study||79
157962|NCT00449644|386379|P2|STARTED|Overall Study||24
157963|NCT00449644|386380|P1|STARTED|Overall Study||23
157964|NCT00449696|386400|P2|NOT COMPLETED|Overall Study||9
157965|NCT00449696|386401|P1|NOT COMPLETED|Overall Study||20
157966|NCT00449696|386400|P2|COMPLETED|Overall Study||119
157967|NCT00449696|386401|P1|COMPLETED|Overall Study||231
157968|NCT00449696|386400|P2|Analyzed Participants|Overall Study||128
157969|NCT00449696|386401|P1|Analyzed Participants|Overall Study|2 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|247
157970|NCT00449696|386400|P2|Received Injection|Overall Study||128
157971|NCT00449696|386401|P1|Received Injection|Overall Study||249
157972|NCT00449696|386400|P2|STARTED|Overall Study||128
157973|NCT00449696|386401|P1|STARTED|Overall Study||251
157974|NCT00449748|386423|P1|NOT COMPLETED|Overall Study||0
157975|NCT00449748|386423|P1|COMPLETED|Overall Study||10
157976|NCT00449748|386423|P1|STARTED|Overall Study||10
157977|NCT00449787|386429|P2|NOT COMPLETED|Overall Study||100
157978|NCT00449787|386430|P1|NOT COMPLETED|Overall Study||105
157979|NCT00449787|386429|P2|COMPLETED|Overall Study||98
157980|NCT00449787|386430|P1|COMPLETED|Overall Study||98
157981|NCT00449787|386429|P2|STARTED|Overall Study||198
157982|NCT00449787|386430|P1|STARTED|Overall Study||203
157983|NCT00449865|386442|P2|NOT COMPLETED|Overall Study||534
157984|NCT00449865|386443|P1|NOT COMPLETED|Overall Study||522
157985|NCT00449865|386442|P2|COMPLETED|Overall Study|477 Expected at Year 5|340
157986|NCT00449865|386443|P1|COMPLETED|Overall Study|478 Expected at Year 5|345
157987|NCT00449865|386442|P2|Completed Year 4|Overall Study|686 Expected at Year 4|523
157988|NCT00449865|386443|P1|Completed Year 4|Overall Study|679 Expected at Year 4|521
157989|NCT00449865|386442|P2|Completed Year 3|Overall Study|874 Expected at Year 3|715
157990|NCT00449865|386443|P1|Completed Year 3|Overall Study|867 Expected at Year 3|719
157991|NCT00449865|386442|P2|Completed Year 2|Overall Study|874 Expected at Year 2|766
157992|NCT00449865|386443|P1|Completed Year 2|Overall Study|867 Expected at Year 2|768
157993|NCT00449865|386442|P2|Completed Year 1|Overall Study|874 Expected at Year 1|822
157994|NCT00449865|386443|P1|Completed Year 1|Overall Study|867 Expected at Year 1|802
157995|NCT00449865|386442|P2|STARTED|Overall Study||874
157996|NCT00449865|386443|P1|STARTED|Overall Study||867
157997|NCT00449930|386451|P2|NOT COMPLETED|Overall Study||75
157998|NCT00449930|386452|P1|NOT COMPLETED|Overall Study||61
157999|NCT00449930|386451|P2|COMPLETED|Overall Study||447
158000|NCT00449930|386452|P1|COMPLETED|Overall Study||467
158001|NCT00449930|386451|P2|STARTED|Overall Study||522
158002|NCT00449930|386452|P1|STARTED|Overall Study||528
158003|NCT00449956|386469|P3|NOT COMPLETED|Overall Study||9
158004|NCT00449956|386470|P2|NOT COMPLETED|Overall Study||4
158005|NCT00449956|386471|P1|NOT COMPLETED|Overall Study||10
158006|NCT00449956|386469|P3|COMPLETED|Overall Study||184
158007|NCT00449956|386470|P2|COMPLETED|Overall Study||88
158008|NCT00449956|386471|P1|COMPLETED|Overall Study||179
158009|NCT00449956|386469|P3|STARTED|Overall Study||193
158010|NCT00449956|386470|P2|STARTED|Overall Study||92
158011|NCT00449956|386471|P1|STARTED|Overall Study||189
158012|NCT00441974|386485|P1|NOT COMPLETED|Overall Study||128
158013|NCT00441974|386485|P1|COMPLETED|Overall Study||1342
158014|NCT00441974|386485|P1|STARTED|Overall Study||1470
158015|NCT00442013|386501|P2|NOT COMPLETED|Overall Study||17
158016|NCT00442013|386502|P1|NOT COMPLETED|Overall Study||26
158017|NCT00442013|386501|P2|COMPLETED|Overall Study||132
158018|NCT00442013|386502|P1|COMPLETED|Overall Study||131
158019|NCT00442013|386501|P2|STARTED|Overall Study||149
158020|NCT00442013|386502|P1|STARTED|Overall Study||157
158021|NCT00442117|386520|P2|NOT COMPLETED|Overall Study||38
158022|NCT00442117|386521|P1|NOT COMPLETED|Overall Study||38
158023|NCT00442117|386520|P2|COMPLETED|Overall Study||49
158024|NCT00442117|386521|P1|COMPLETED|Overall Study||47
158025|NCT00442117|386520|P2|STARTED|Overall Study||87
158026|NCT00442117|386521|P1|STARTED|Overall Study||85
158027|NCT00442169|386539|P6|NOT COMPLETED|Part 2||0
158028|NCT00442169|386540|P5|NOT COMPLETED|Part 2||0
158029|NCT00442169|386541|P4|NOT COMPLETED|Part 2||0
158030|NCT00442169|386542|P3|NOT COMPLETED|Part 2||0
158031|NCT00442169|386543|P2|NOT COMPLETED|Part 2||0
158032|NCT00442169|386544|P1|NOT COMPLETED|Part 2||0
158033|NCT00442169|386539|P6|COMPLETED|Part 2||57
158034|NCT00442169|386540|P5|COMPLETED|Part 2||25
158035|NCT00442169|386541|P4|COMPLETED|Part 2||0
158036|NCT00442169|386542|P3|COMPLETED|Part 2||0
158037|NCT00442169|386543|P2|COMPLETED|Part 2||0
158038|NCT00442169|386544|P1|COMPLETED|Part 2||0
158039|NCT00442169|386539|P6|STARTED|Part 2||57
158040|NCT00442169|386540|P5|STARTED|Part 2||25
158041|NCT00442169|386541|P4|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
158042|NCT00442169|386542|P3|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
158043|NCT00442169|386543|P2|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
158044|NCT00442169|386544|P1|STARTED|Part 2|Participants in Part 1 are not the same as those in Part 2|0
158045|NCT00442169|386539|P6|NOT COMPLETED|Part 1||0
158046|NCT00442169|386540|P5|NOT COMPLETED|Part 1||0
158047|NCT00442169|386541|P4|NOT COMPLETED|Part 1||0
158048|NCT00442169|386542|P3|NOT COMPLETED|Part 1||0
158049|NCT00442169|386543|P2|NOT COMPLETED|Part 1||0
158050|NCT00442169|386544|P1|NOT COMPLETED|Part 1||0
158051|NCT00442169|386539|P6|COMPLETED|Part 1||0
158052|NCT00442169|386540|P5|COMPLETED|Part 1||0
158053|NCT00442169|386541|P4|COMPLETED|Part 1||31
158054|NCT00442169|386542|P3|COMPLETED|Part 1||40
158055|NCT00442169|386543|P2|COMPLETED|Part 1||24
158056|NCT00442169|386544|P1|COMPLETED|Part 1||17
158057|NCT00442169|386539|P6|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
158058|NCT00442169|386540|P5|STARTED|Part 1|Participants in Part 2 are not the same as those in Part 1|0
158059|NCT00442169|386541|P4|STARTED|Part 1||31
158060|NCT00442169|386542|P3|STARTED|Part 1||40
158061|NCT00442169|386543|P2|STARTED|Part 1||24
158062|NCT00442169|386544|P1|STARTED|Part 1||17
158063|NCT00442286|386585|P2|NOT COMPLETED|Overall Study||2
158064|NCT00442286|386586|P1|NOT COMPLETED|Overall Study||7
158065|NCT00442286|386585|P2|COMPLETED|Overall Study||82
158066|NCT00442286|386586|P1|COMPLETED|Overall Study||174
158067|NCT00442286|386585|P2|12 Months|Overall Study||82
158068|NCT00442286|386586|P1|12 Months|Overall Study||174
158069|NCT00442286|386585|P2|6 Months|Overall Study||83
158070|NCT00442286|386586|P1|6 Months|Overall Study||177
158071|NCT00442286|386585|P2|STARTED|Overall Study||84
158072|NCT00442286|386586|P1|STARTED|Overall Study||181
158073|NCT00442338|386600|P3|NOT COMPLETED|Overall Study||0
158074|NCT00442338|386601|P2|NOT COMPLETED|Overall Study||0
158075|NCT00442338|386602|P1|NOT COMPLETED|Overall Study||0
158076|NCT00442338|386600|P3|COMPLETED|Overall Study||31
158077|NCT00442338|386601|P2|COMPLETED|Overall Study||30
158078|NCT00442338|386602|P1|COMPLETED|Overall Study||30
158079|NCT00442338|386600|P3|STARTED|Overall Study||31
158080|NCT00442338|386601|P2|STARTED|Overall Study||30
158081|NCT00442338|386602|P1|STARTED|Overall Study||30
158082|NCT00442351|386612|P2|NOT COMPLETED|Overall Study||6
158083|NCT00442351|386613|P1|NOT COMPLETED|Overall Study||7
158084|NCT00442351|386612|P2|COMPLETED|Overall Study||3
158085|NCT00442351|386613|P1|COMPLETED|Overall Study||10
158086|NCT00442351|386612|P2|STARTED|Overall Study||9
158087|NCT00442351|386613|P1|STARTED|Overall Study|Due to poor enrollment and a high screening failure rate, this study was terminated early.|17
158088|NCT00442364|386619|P1|NOT COMPLETED|Overall Study||0
158089|NCT00442364|386619|P1|COMPLETED|Overall Study||60
158090|NCT00442364|386619|P1|STARTED|Overall Study||60
158091|NCT00442416|386625|P2|NOT COMPLETED|Overall Study||39
158092|NCT00442416|386626|P1|NOT COMPLETED|Overall Study||37
158093|NCT00442416|386625|P2|COMPLETED|Overall Study||2
158094|NCT00442416|386626|P1|COMPLETED|Overall Study||2
158095|NCT00442416|386625|P2|STARTED|Overall Study||41
158096|NCT00442416|386626|P1|STARTED|Overall Study||39
158097|NCT00442468|386659|P1|NOT COMPLETED|Overall Study||183
158098|NCT00442468|386659|P1|COMPLETED|Overall Study||1100
158099|NCT00442468|386659|P1|STARTED|Overall Study||1283
158100|NCT00442507|386687|P1|NOT COMPLETED|Overall Study||0
158101|NCT00442507|386687|P1|COMPLETED|Overall Study||6
158102|NCT00442507|386687|P1|STARTED|Overall Study||6
158103|NCT00442546|386697|P3|NOT COMPLETED|Overall Study||33
158104|NCT00442546|386698|P2|NOT COMPLETED|Overall Study||37
158105|NCT00442546|386699|P1|NOT COMPLETED|Overall Study||26
158106|NCT00442546|386697|P3|COMPLETED|Overall Study||71
158107|NCT00442546|386698|P2|COMPLETED|Overall Study||63
158108|NCT00442546|386699|P1|COMPLETED|Overall Study||77
158109|NCT00442546|386697|P3|Received Treatment|Overall Study||98
158110|NCT00442546|386698|P2|Received Treatment|Overall Study||96
158111|NCT00442546|386699|P1|Received Treatment|Overall Study||98
158112|NCT00442546|386697|P3|STARTED|Overall Study||104
158113|NCT00442546|386698|P2|STARTED|Overall Study||100
158114|NCT00442546|386699|P1|STARTED|Overall Study||103
158115|NCT00442559|386823|P2|NOT COMPLETED|Overall Study||35
158116|NCT00442559|386824|P1|NOT COMPLETED|Overall Study||34
158202|NCT00443040|387039|P2|COMPLETED|Overall Study||11
158117|NCT00442559|386823|P2|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|56
158118|NCT00442559|386824|P1|COMPLETED|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|66
158119|NCT00442559|386823|P2|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|60
158120|NCT00442559|386824|P1|12 Weeks After Randomization|Overall Study|12 weeks after randomization was pre-specified as the time point for analysis|68
158121|NCT00442559|386823|P2|STARTED|Overall Study||91
158122|NCT00442559|386824|P1|STARTED|Overall Study||100
158123|NCT00442572|386838|P2|NOT COMPLETED|Overall Study||3
158124|NCT00442572|386839|P1|NOT COMPLETED|Overall Study||8
158125|NCT00442572|386838|P2|COMPLETED|Overall Study||1
158126|NCT00442572|386839|P1|COMPLETED|Overall Study||9
158127|NCT00442572|386838|P2|STARTED|Overall Study||4
158128|NCT00442572|386839|P1|STARTED|Overall Study||17
158129|NCT00442598|386880|P3|NOT COMPLETED|Overall Study||0
158130|NCT00442598|386881|P2|NOT COMPLETED|Overall Study||8
158131|NCT00442598|386882|P1|NOT COMPLETED|Overall Study||6
158132|NCT00442598|386880|P3|COMPLETED|Overall Study||0
158133|NCT00442598|386881|P2|COMPLETED|Overall Study||2
158134|NCT00442598|386882|P1|COMPLETED|Overall Study||1
158135|NCT00442598|386880|P3|Two Cycles|Overall Study||0
158136|NCT00442598|386881|P2|Two Cycles|Overall Study||6
158137|NCT00442598|386882|P1|Two Cycles|Overall Study||5
158138|NCT00442598|386880|P3|STARTED|Overall Study||0
158139|NCT00442598|386881|P2|STARTED|Overall Study||10
158140|NCT00442598|386882|P1|STARTED|Overall Study||7
158141|NCT00442611|386900|P2|NOT COMPLETED|Overall Study||0
158142|NCT00442611|386901|P1|NOT COMPLETED|Overall Study||1
158143|NCT00442611|386900|P2|COMPLETED|Overall Study||3
158144|NCT00442611|386901|P1|COMPLETED|Overall Study||6
158145|NCT00442611|386900|P2|STARTED|Overall Study||3
158146|NCT00442611|386901|P1|STARTED|Overall Study||7
158147|NCT00442689|386914|P3|NOT COMPLETED|Overall Study||9
158148|NCT00442689|386915|P2|NOT COMPLETED|Overall Study||11
158149|NCT00442689|386916|P1|NOT COMPLETED|Overall Study||10
158150|NCT00442689|386914|P3|COMPLETED|Overall Study||13
158151|NCT00442689|386915|P2|COMPLETED|Overall Study||13
158152|NCT00442689|386916|P1|COMPLETED|Overall Study||11
158153|NCT00442689|386914|P3|STARTED|Overall Study||22
158154|NCT00442689|386915|P2|STARTED|Overall Study||24
158155|NCT00442689|386916|P1|STARTED|Overall Study||21
158156|NCT00442702|386944|P2|NOT COMPLETED|Evaluation Period||4
158157|NCT00442702|386945|P1|NOT COMPLETED|Evaluation Period||5
158158|NCT00442702|386944|P2|COMPLETED|Evaluation Period||107
158159|NCT00442702|386945|P1|COMPLETED|Evaluation Period||97
158160|NCT00442702|386944|P2|STARTED|Evaluation Period||111
158161|NCT00442702|386945|P1|STARTED|Evaluation Period||102
158162|NCT00442702|386944|P2|NOT COMPLETED|Titration Period||3
158163|NCT00442702|386945|P1|NOT COMPLETED|Titration Period||12
158164|NCT00442702|386944|P2|COMPLETED|Titration Period||111
158165|NCT00442702|386945|P1|COMPLETED|Titration Period||102
158166|NCT00442702|386944|P2|Safety Population|Titration Period||113
158167|NCT00442702|386945|P1|Safety Population|Titration Period|One patient was randomized to darbepoetin alfa but treated by mistake with Mircera|115
158168|NCT00442702|386944|P2|STARTED|Titration Period||114
158169|NCT00442702|386945|P1|STARTED|Titration Period||114
158170|NCT00442897|386959|P2|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
158171|NCT00442897|386960|P1|NOT COMPLETED|24 Weeks Follow-up (3 Centers)||6
158172|NCT00442897|386959|P2|COMPLETED|24 Weeks Follow-up (3 Centers)||28
158173|NCT00442897|386960|P1|COMPLETED|24 Weeks Follow-up (3 Centers)||29
158174|NCT00442897|386959|P2|STARTED|24 Weeks Follow-up (3 Centers)|65 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|34
158175|NCT00442897|386960|P1|STARTED|24 Weeks Follow-up (3 Centers)|66 Patients did not continue in the additional 12 week extension, for the 24 weeks follow-up period.|35
158176|NCT00442897|386959|P2|NOT COMPLETED|Base Study (12 Week Follow-up)||12
158177|NCT00442897|386960|P1|NOT COMPLETED|Base Study (12 Week Follow-up)||17
158178|NCT00442897|386959|P2|COMPLETED|Base Study (12 Week Follow-up)||99
158179|NCT00442897|386960|P1|COMPLETED|Base Study (12 Week Follow-up)||101
158180|NCT00442897|386959|P2|STARTED|Base Study (12 Week Follow-up)||111
158181|NCT00442897|386960|P1|STARTED|Base Study (12 Week Follow-up)||118
158182|NCT00442936|386972|P4|NOT COMPLETED|Overall Study||1
158183|NCT00442936|386973|P3|NOT COMPLETED|Overall Study||1
158184|NCT00442936|386974|P2|NOT COMPLETED|Overall Study||0
158185|NCT00442936|386975|P1|NOT COMPLETED|Overall Study||1
158186|NCT00442936|386972|P4|COMPLETED|Overall Study||347
158187|NCT00442936|386973|P3|COMPLETED|Overall Study||344
158188|NCT00442936|386974|P2|COMPLETED|Overall Study||354
158189|NCT00442936|386975|P1|COMPLETED|Overall Study||332
158190|NCT00442936|386972|P4|STARTED|Overall Study||348
158191|NCT00442936|386973|P3|STARTED|Overall Study||345
158192|NCT00442936|386974|P2|STARTED|Overall Study||354
158193|NCT00442936|386975|P1|STARTED|Overall Study||333
158194|NCT00442962|387021|P1|NOT COMPLETED|Overall Study||8
158195|NCT00442962|387021|P1|COMPLETED|Overall Study|Completed 48 weeks of follow-up.|46
158196|NCT00442962|387021|P1|Primary Outcome Evaluation|Overall Study|Primary outcome evaluation at week 24.|52
158197|NCT00442962|387021|P1|STARTED|Overall Study||54
158198|NCT00443040|387038|P3|NOT COMPLETED|Overall Study||1
158199|NCT00443040|387039|P2|NOT COMPLETED|Overall Study||0
158200|NCT00443040|387040|P1|NOT COMPLETED|Overall Study||4
158201|NCT00443040|387038|P3|COMPLETED|Overall Study||9
158203|NCT00443040|387040|P1|COMPLETED|Overall Study||10
158204|NCT00443040|387038|P3|STARTED|Overall Study||10
158205|NCT00443040|387039|P2|STARTED|Overall Study||11
158206|NCT00443040|387040|P1|STARTED|Overall Study||14
158207|NCT00443053|387050|P2|NOT COMPLETED|Overall Study||33
158208|NCT00443053|387051|P1|NOT COMPLETED|Overall Study||21
158209|NCT00443053|387050|P2|COMPLETED|Overall Study||1467
158210|NCT00443053|387051|P1|COMPLETED|Overall Study||1481
158211|NCT00443053|387050|P2|STARTED|Overall Study||1500
158212|NCT00443053|387051|P1|STARTED|Overall Study||1502
158213|NCT00443118|387072|P3|NOT COMPLETED|Overall Study||0
158214|NCT00443118|387073|P2|NOT COMPLETED|Overall Study||1
158215|NCT00443118|387074|P1|NOT COMPLETED|Overall Study||4
158216|NCT00443118|387072|P3|COMPLETED|Overall Study||226
158217|NCT00443118|387073|P2|COMPLETED|Overall Study||290
158218|NCT00443118|387074|P1|COMPLETED|Overall Study||511
158219|NCT00443118|387072|P3|STARTED|Overall Study||226
158220|NCT00443118|387073|P2|STARTED|Overall Study||291
158221|NCT00443118|387074|P1|STARTED|Overall Study||515
158222|NCT00443209|387120|P2|NOT COMPLETED|Months 13 to 18 Treatment Period||47
158223|NCT00443209|387121|P1|NOT COMPLETED|Months 13 to 18 Treatment Period||99
158224|NCT00443209|387120|P2|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|39
158225|NCT00443209|387121|P1|COMPLETED|Months 13 to 18 Treatment Period|Trial terminated used for participants not completing 18 months of treatment due to trial completion|87
158226|NCT00443209|387120|P2|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period was optional. 116 participants chose not to continue.|86
158227|NCT00443209|387121|P1|STARTED|Months 13 to 18 Treatment Period|The Months 13 to 18 Treatment Period.was optional. 181 participants chose not to continue.|186
158228|NCT00443209|387120|P2|NOT COMPLETED|Months 1 to 12 Treatment Period||154
158229|NCT00443209|387121|P1|NOT COMPLETED|Months 1 to 12 Treatment Period||345
158230|NCT00443209|387120|P2|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|202
158231|NCT00443209|387121|P1|COMPLETED|Months 1 to 12 Treatment Period|Trial terminated used for participants not completing 12 months of treatment due to trial completion|367
158232|NCT00443209|387120|P2|Treated|Months 1 to 12 Treatment Period||313
158233|NCT00443209|387121|P1|Treated|Months 1 to 12 Treatment Period||641
158234|NCT00443209|387120|P2|STARTED|Months 1 to 12 Treatment Period||356
158235|NCT00443209|387121|P1|STARTED|Months 1 to 12 Treatment Period||712
158236|NCT00443261|387135|P1|NOT COMPLETED|Overall Study||1
158237|NCT00443261|387135|P1|COMPLETED|Overall Study|Study terminated due to poor accrual and only patient enrolled died|0
158238|NCT00443261|387135|P1|Accrual in 10 Months|Overall Study|Patient died due to progressive disease after cycle 1 of treatment|1
158239|NCT00443261|387135|P1|STARTED|Overall Study||1
158240|NCT00443352|387139|P1|NOT COMPLETED|Overall Study||5
158241|NCT00443352|387139|P1|COMPLETED|Overall Study||22
158242|NCT00443352|387139|P1|STARTED|Overall Study||27
158243|NCT00443430|387145|P2|NOT COMPLETED|Overall Study||4
158244|NCT00443430|387146|P1|NOT COMPLETED|Overall Study||4
158245|NCT00443430|387145|P2|COMPLETED|Overall Study||38
158246|NCT00443430|387146|P1|COMPLETED|Overall Study||39
158247|NCT00443430|387145|P2|STARTED|Overall Study||42
158248|NCT00443430|387146|P1|STARTED|Overall Study||43
158249|NCT00443456|387156|P1|NOT COMPLETED|Overall Study||18
158250|NCT00443456|387156|P1|COMPLETED|Overall Study||116
158251|NCT00443456|387156|P1|STARTED|Overall Study||134
158252|NCT00443534|387189|P1|NOT COMPLETED|Overall Study||123
158253|NCT00443534|387189|P1|COMPLETED|Overall Study||0
158254|NCT00443534|387189|P1|Treated|Overall Study||122
158255|NCT00443534|387189|P1|STARTED|Overall Study||123
158256|NCT00443560|387198|P2|NOT COMPLETED|Overall Study||30
158257|NCT00443560|387199|P1|NOT COMPLETED|Overall Study||60
158258|NCT00443560|387198|P2|COMPLETED|Overall Study||1051
158259|NCT00443560|387199|P1|COMPLETED|Overall Study||1021
158260|NCT00443560|387198|P2|STARTED|Overall Study||1081
158261|NCT00443560|387199|P1|STARTED|Overall Study||1081
158262|NCT00443599|387211|P2|NOT COMPLETED|Overall Study||3
158263|NCT00443599|387212|P1|NOT COMPLETED|Overall Study||6
158264|NCT00443599|387211|P2|COMPLETED|Overall Study|Included in per-protocol analysis|490
158265|NCT00443599|387212|P1|COMPLETED|Overall Study|Included in per-protocol analysis|490
158266|NCT00443599|387211|P2|STARTED|Overall Study|Randomly Assigned to Standard Care|493
158267|NCT00443599|387212|P1|STARTED|Overall Study|Randomly Assigned to Tight Glycemic Control|496
158268|NCT00443651|387246|P2|NOT COMPLETED|Overall Study||58
158269|NCT00443651|387247|P1|NOT COMPLETED|Overall Study||95
158270|NCT00443651|387246|P2|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|118
158271|NCT00443651|387247|P1|COMPLETED|Overall Study|Completed the study or the safety follow-up period.|306
158272|NCT00443651|387246|P2|Week 48|Overall Study||134
158273|NCT00443651|387247|P1|Week 48|Overall Study||338
158274|NCT00443651|387246|P2|Week 24|Overall Study||160
158275|NCT00443651|387247|P1|Week 24|Overall Study||376
158276|NCT00443651|387246|P2|STARTED|Overall Study||176
158277|NCT00443651|387247|P1|STARTED|Overall Study||401
158278|NCT00443703|387267|P2|NOT COMPLETED|Overall Study||18
158279|NCT00443703|387268|P1|NOT COMPLETED|Overall Study||28
158280|NCT00443703|387267|P2|COMPLETED|Overall Study||157
158281|NCT00443703|387268|P1|COMPLETED|Overall Study||149
158282|NCT00443703|387267|P2|Treated|Overall Study||174
158283|NCT00443703|387268|P1|Treated|Overall Study||174
158284|NCT00443703|387267|P2|STARTED|Overall Study||175
158285|NCT00443703|387268|P1|STARTED|Overall Study||177
158286|NCT00443729|387320|P2|NOT COMPLETED|Overall Study||7
158287|NCT00443729|387321|P1|NOT COMPLETED|Overall Study||10
158288|NCT00443729|387320|P2|COMPLETED|Overall Study||172
158289|NCT00443729|387321|P1|COMPLETED|Overall Study||166
158290|NCT00443729|387320|P2|Treated|Overall Study||178
158291|NCT00443729|387321|P1|Treated|Overall Study||176
158292|NCT00443729|387320|P2|STARTED|Overall Study||179
158293|NCT00443729|387321|P1|STARTED|Overall Study||176
158294|NCT00443755|387369|P2|NOT COMPLETED|Overall Study||1
158295|NCT00443755|387370|P1|NOT COMPLETED|Overall Study||2
158296|NCT00443755|387369|P2|COMPLETED|Overall Study||13
158297|NCT00443755|387370|P1|COMPLETED|Overall Study||12
158298|NCT00443755|387369|P2|STARTED|Overall Study||14
158299|NCT00443755|387370|P1|STARTED|Overall Study||14
158300|NCT00443781|387402|P1|NOT COMPLETED|Overall Study||25
158301|NCT00443781|387402|P1|COMPLETED|Overall Study||37
158302|NCT00443781|387402|P1|STARTED|Overall Study||62
158303|NCT00443820|387410|P4|NOT COMPLETED|Overall Study||17
158304|NCT00443820|387411|P3|NOT COMPLETED|Overall Study||18
158305|NCT00443820|387412|P2|NOT COMPLETED|Overall Study||19
158306|NCT00443820|387413|P1|NOT COMPLETED|Overall Study||21
158307|NCT00443820|387410|P4|COMPLETED|Overall Study||111
158308|NCT00443820|387411|P3|COMPLETED|Overall Study||117
158309|NCT00443820|387412|P2|COMPLETED|Overall Study|A participant from this gr. discont'ed due to renal failure, was counted as an AE and also as a SAE.|111
158310|NCT00443820|387413|P1|COMPLETED|Overall Study||112
158311|NCT00443820|387410|P4|Safety Population|Overall Study||126
158312|NCT00443820|387411|P3|Safety Population|Overall Study||134
158313|NCT00443820|387412|P2|Safety Population|Overall Study||129
158314|NCT00443820|387413|P1|Safety Population|Overall Study|Participants who received study drug and had at least one post-baseline safety assessment.|131
158315|NCT00443820|387410|P4|STARTED|Overall Study||128
158316|NCT00443820|387411|P3|STARTED|Overall Study||135
158317|NCT00443820|387412|P2|STARTED|Overall Study||130
158318|NCT00443820|387413|P1|STARTED|Overall Study||133
158319|NCT00443872|387435|P1|NOT COMPLETED|Overall Study||17
158320|NCT00443872|387435|P1|COMPLETED|Overall Study||60
158321|NCT00443872|387435|P1|STARTED|Overall Study||77
158322|NCT00443898|387452|P4|NOT COMPLETED|Overall Study||18
158323|NCT00443898|387453|P3|NOT COMPLETED|Overall Study||29
158324|NCT00443898|387454|P2|NOT COMPLETED|Overall Study||25
158325|NCT00443898|387455|P1|NOT COMPLETED|Overall Study||24
158326|NCT00443898|387452|P4|COMPLETED|Overall Study||110
158327|NCT00443898|387453|P3|COMPLETED|Overall Study||107
158328|NCT00443898|387454|P2|COMPLETED|Overall Study||103
158329|NCT00443898|387455|P1|COMPLETED|Overall Study||102
158330|NCT00443898|387452|P4|STARTED|Overall Study||128
158331|NCT00443898|387453|P3|STARTED|Overall Study||136
158332|NCT00443898|387454|P2|STARTED|Overall Study||128
158333|NCT00443898|387455|P1|STARTED|Overall Study||126
158334|NCT00444067|387479|P2|NOT COMPLETED|Overall Study||1
158335|NCT00444067|387480|P1|NOT COMPLETED|Overall Study||0
158336|NCT00444067|387479|P2|COMPLETED|Overall Study||23
158337|NCT00444067|387480|P1|COMPLETED|Overall Study||74
158338|NCT00444067|387479|P2|STARTED|Overall Study||24
158339|NCT00444067|387480|P1|STARTED|Overall Study||74
158340|NCT00444106|387493|P3|NOT COMPLETED|Overall Study||1
158341|NCT00444106|387494|P2|NOT COMPLETED|Overall Study||1
158342|NCT00444106|387495|P1|NOT COMPLETED|Overall Study||2
158343|NCT00444106|387493|P3|COMPLETED|Overall Study||52
158344|NCT00444106|387494|P2|COMPLETED|Overall Study||52
158345|NCT00444106|387495|P1|COMPLETED|Overall Study||157
158346|NCT00444106|387493|P3|Completed Treatment Period|Overall Study||53
158347|NCT00444106|387494|P2|Completed Treatment Period|Overall Study||53
158348|NCT00444106|387495|P1|Completed Treatment Period|Overall Study||159
158349|NCT00444106|387493|P3|STARTED|Overall Study||53
158350|NCT00444106|387494|P2|STARTED|Overall Study||53
158351|NCT00444106|387495|P1|STARTED|Overall Study||159
158352|NCT00444145|387510|P1|NOT COMPLETED|Overall Study||19
158353|NCT00444145|387510|P1|COMPLETED|Overall Study||19
158354|NCT00444145|387510|P1|STARTED|Overall Study||38
158355|NCT00444275|387517|P5|NOT COMPLETED|Maintenance Treatment Phase||179
158356|NCT00444275|387518|P4|NOT COMPLETED|Maintenance Treatment Phase||133
158357|NCT00444275|387519|P3|NOT COMPLETED|Maintenance Treatment Phase||161
158358|NCT00444275|387520|P2|NOT COMPLETED|Maintenance Treatment Phase||0
158359|NCT00444275|387521|P1|NOT COMPLETED|Maintenance Treatment Phase||0
158360|NCT00444275|387517|P5|COMPLETED|Maintenance Treatment Phase||701
158361|NCT00444275|387518|P4|COMPLETED|Maintenance Treatment Phase||764
158362|NCT00444275|387519|P3|COMPLETED|Maintenance Treatment Phase||747
158363|NCT00444275|387520|P2|COMPLETED|Maintenance Treatment Phase||0
158364|NCT00444275|387521|P1|COMPLETED|Maintenance Treatment Phase||0
158365|NCT00444275|387517|P5|STARTED|Maintenance Treatment Phase||880
158366|NCT00444275|387518|P4|STARTED|Maintenance Treatment Phase||897
158367|NCT00444275|387519|P3|STARTED|Maintenance Treatment Phase||908
158368|NCT00444275|387520|P2|STARTED|Maintenance Treatment Phase||0
158369|NCT00444275|387521|P1|STARTED|Maintenance Treatment Phase||0
158370|NCT00444275|387517|P5|NOT COMPLETED|Initial Treatment Phase||0
158371|NCT00444275|387518|P4|NOT COMPLETED|Initial Treatment Phase||0
158372|NCT00444275|387519|P3|NOT COMPLETED|Initial Treatment Phase||0
158373|NCT00444275|387520|P2|NOT COMPLETED|Initial Treatment Phase||96
158374|NCT00444275|387521|P1|NOT COMPLETED|Initial Treatment Phase||248
158375|NCT00444275|387517|P5|COMPLETED|Initial Treatment Phase||0
158376|NCT00444275|387518|P4|COMPLETED|Initial Treatment Phase||0
158377|NCT00444275|387519|P3|COMPLETED|Initial Treatment Phase||0
158378|NCT00444275|387520|P2|COMPLETED|Initial Treatment Phase||777
158379|NCT00444275|387521|P1|COMPLETED|Initial Treatment Phase||1908
158380|NCT00444275|387517|P5|STARTED|Initial Treatment Phase||0
158381|NCT00444275|387518|P4|STARTED|Initial Treatment Phase||0
158382|NCT00444275|387519|P3|STARTED|Initial Treatment Phase||0
158383|NCT00444275|387520|P2|STARTED|Initial Treatment Phase||873
158384|NCT00444275|387521|P1|STARTED|Initial Treatment Phase||2156
158385|NCT00450073|387574|P3|NOT COMPLETED|Overall Study||1
158386|NCT00450073|387575|P2|NOT COMPLETED|Overall Study||0
158387|NCT00450073|387576|P1|NOT COMPLETED|Overall Study||1
158388|NCT00450073|387574|P3|COMPLETED|Overall Study||9
158389|NCT00450073|387575|P2|COMPLETED|Overall Study||10
158390|NCT00450073|387576|P1|COMPLETED|Overall Study||9
158391|NCT00450073|387574|P3|STARTED|Overall Study||10
158392|NCT00450073|387575|P2|STARTED|Overall Study||10
158393|NCT00450073|387576|P1|STARTED|Overall Study||10
158394|NCT00450112|387586|P2|NOT COMPLETED|Overall Study||6
158395|NCT00450112|387587|P1|NOT COMPLETED|Overall Study||13
158396|NCT00450112|387586|P2|COMPLETED|Overall Study||71
158397|NCT00450112|387587|P1|COMPLETED|Overall Study||112
158398|NCT00450112|387586|P2|Analyzed Participants|Overall Study||74
158399|NCT00450112|387587|P1|Analyzed Participants|Overall Study|3 subjects removed from ITT analyses because of no post treatment data (pre-defined criteria).|122
158400|NCT00450112|387586|P2|Received Injection|Overall Study||74
158401|NCT00450112|387587|P1|Received Injection|Overall Study||125
158402|NCT00450112|387586|P2|STARTED|Overall Study||77
158403|NCT00450112|387587|P1|STARTED|Overall Study||125
158404|NCT00450216|387611|P2|NOT COMPLETED|Overall Study||129
158405|NCT00450216|387612|P1|NOT COMPLETED|Overall Study||174
158406|NCT00450216|387611|P2|COMPLETED|Overall Study||170
158407|NCT00450216|387612|P1|COMPLETED|Overall Study||433
158408|NCT00450216|387611|P2|STARTED|Overall Study||299
158409|NCT00450216|387612|P1|STARTED|Overall Study||607
158410|NCT00450242|387626|P2|NOT COMPLETED|Overall Study||1
158411|NCT00450242|387627|P1|NOT COMPLETED|Overall Study||3
158412|NCT00450242|387626|P2|COMPLETED|Overall Study||6
158413|NCT00450242|387627|P1|COMPLETED|Overall Study||4
158414|NCT00450242|387626|P2|STARTED|Overall Study||7
158415|NCT00450242|387627|P1|STARTED|Overall Study||7
158416|NCT00450255|387639|P1|NOT COMPLETED|Overall Study||1
158417|NCT00450255|387639|P1|COMPLETED|Overall Study||40
158418|NCT00450255|387639|P1|STARTED|Overall Study||41
158419|NCT00450294|387645|P1|NOT COMPLETED|Overall Study||0
158420|NCT00450294|387645|P1|COMPLETED|Overall Study||10
158421|NCT00450294|387645|P1|STARTED|Overall Study||10
158422|NCT00450333|387654|P4|NOT COMPLETED|Overall Study||28
158423|NCT00450333|387655|P3|NOT COMPLETED|Overall Study||25
158424|NCT00450333|387656|P2|NOT COMPLETED|Overall Study||63
158425|NCT00450333|387657|P1|NOT COMPLETED|Overall Study||54
158426|NCT00450333|387654|P4|COMPLETED|Overall Study||74
158427|NCT00450333|387655|P3|COMPLETED|Overall Study||75
158428|NCT00450333|387656|P2|COMPLETED|Overall Study||44
158429|NCT00450333|387657|P1|COMPLETED|Overall Study||44
158430|NCT00450333|387654|P4|STARTED|Overall Study||102
158431|NCT00450333|387655|P3|STARTED|Overall Study||100
158432|NCT00450333|387656|P2|STARTED|Overall Study||107
158433|NCT00450333|387657|P1|STARTED|Overall Study||98
158434|NCT00450372|387675|P1|NOT COMPLETED|Overall Study||1
158435|NCT00450372|387675|P1|COMPLETED|Overall Study||37
158436|NCT00450372|387675|P1|STARTED|Overall Study||38
158437|NCT00450385|387684|P1|NOT COMPLETED|Overall Study||13
158438|NCT00450385|387684|P1|COMPLETED|Overall Study||44
158439|NCT00450385|387684|P1|STARTED|Overall Study||57
158440|NCT00452114|387695|P2|NOT COMPLETED|Overall Study||3
158441|NCT00452114|387696|P1|NOT COMPLETED|Overall Study||3
158442|NCT00452114|387695|P2|COMPLETED|Overall Study||10
158443|NCT00452114|387696|P1|COMPLETED|Overall Study||12
158444|NCT00452114|387695|P2|STARTED|Overall Study||13
158445|NCT00452114|387696|P1|STARTED|Overall Study||15
158446|NCT00452335|387705|P3|NOT COMPLETED|Overall Study||9
158447|NCT00452335|387706|P2|NOT COMPLETED|Overall Study||4
158448|NCT00452335|387707|P1|NOT COMPLETED|Overall Study||2
158449|NCT00452335|387705|P3|COMPLETED|Overall Study||23
158450|NCT00452335|387706|P2|COMPLETED|Overall Study||61
158451|NCT00452335|387707|P1|COMPLETED|Overall Study||25
158452|NCT00452335|387705|P3|STARTED|Overall Study||32
158453|NCT00452335|387706|P2|STARTED|Overall Study||65
158454|NCT00452335|387707|P1|STARTED|Overall Study||27
158455|NCT00452348|387744|P2|NOT COMPLETED|Overall Study||84
158456|NCT00452348|387745|P1|NOT COMPLETED|Overall Study||79
158457|NCT00452348|387744|P2|COMPLETED|Overall Study||234
158458|NCT00452348|387745|P1|COMPLETED|Overall Study||231
158459|NCT00452348|387744|P2|STARTED|Overall Study||318
158460|NCT00452348|387745|P1|STARTED|Overall Study||310
158461|NCT00452361|387759|P2|NOT COMPLETED|Overall Study||10
158462|NCT00452361|387760|P1|NOT COMPLETED|Overall Study||21
158463|NCT00452361|387759|P2|COMPLETED|Overall Study||0
158464|NCT00452361|387760|P1|COMPLETED|Overall Study||0
158465|NCT00452361|387759|P2|STARTED|Overall Study||10
158466|NCT00452361|387760|P1|STARTED|Overall Study||21
158467|NCT00452374|387802|P1|NOT COMPLETED|Overall Study||0
158468|NCT00452374|387802|P1|COMPLETED|Overall Study||48
158469|NCT00452374|387802|P1|STARTED|Overall Study||48
158470|NCT00452387|387807|P1|NOT COMPLETED|Overall Study||0
158471|NCT00452387|387807|P1|COMPLETED|Overall Study||22
158472|NCT00452387|387807|P1|STARTED|Overall Study||22
158473|NCT00452400|387820|P5|NOT COMPLETED|Overall Study||3
158474|NCT00452400|387821|P4|NOT COMPLETED|Overall Study||1
158475|NCT00452400|387822|P3|NOT COMPLETED|Overall Study||7
158476|NCT00452400|387823|P2|NOT COMPLETED|Overall Study||1
158477|NCT00452400|387824|P1|NOT COMPLETED|Overall Study||5
158478|NCT00452400|387820|P5|COMPLETED|Overall Study||76
158479|NCT00452400|387821|P4|COMPLETED|Overall Study||85
158480|NCT00452400|387822|P3|COMPLETED|Overall Study||73
158481|NCT00452400|387823|P2|COMPLETED|Overall Study||80
158482|NCT00452400|387824|P1|COMPLETED|Overall Study||74
158483|NCT00452400|387820|P5|STARTED|Overall Study||79
158484|NCT00452400|387821|P4|STARTED|Overall Study||86
158485|NCT00452400|387822|P3|STARTED|Overall Study||80
158486|NCT00452400|387823|P2|STARTED|Overall Study||81
158487|NCT00452400|387824|P1|STARTED|Overall Study||79
158488|NCT00452426|387998|P2|NOT COMPLETED|Overall Study||11
158489|NCT00452426|387999|P1|NOT COMPLETED|Overall Study||7
158490|NCT00452426|387998|P2|COMPLETED|Overall Study||493
158491|NCT00452426|387999|P1|COMPLETED|Overall Study||489
158492|NCT00452426|387998|P2|STARTED|Overall Study||504
158493|NCT00452426|387999|P1|STARTED|Overall Study||496
158494|NCT00452452|388016|P3|NOT COMPLETED|Overall Study||1
158495|NCT00452452|388017|P2|NOT COMPLETED|Overall Study||0
158496|NCT00452452|388018|P1|NOT COMPLETED|Overall Study||2
158497|NCT00452452|388016|P3|COMPLETED|Overall Study||152
158498|NCT00452452|388017|P2|COMPLETED|Overall Study||112
158499|NCT00452452|388018|P1|COMPLETED|Overall Study||88
158500|NCT00452452|388016|P3|Vaccinated Dose 3|Overall Study||0
158501|NCT00452452|388017|P2|Vaccinated Dose 3|Overall Study||0
158502|NCT00452452|388018|P1|Vaccinated Dose 3|Overall Study||89
158503|NCT00452452|388016|P3|Vaccinated Dose 2|Overall Study||0
158504|NCT00452452|388017|P2|Vaccinated Dose 2|Overall Study||112
158505|NCT00452452|388018|P1|Vaccinated Dose 2|Overall Study||90
158506|NCT00452452|388016|P3|Vaccinated Dose 1|Overall Study||152
158507|NCT00452452|388017|P2|Vaccinated Dose 1|Overall Study||112
158508|NCT00452452|388018|P1|Vaccinated Dose 1|Overall Study||90
158509|NCT00452452|388016|P3|STARTED|Overall Study||153
158510|NCT00452452|388017|P2|STARTED|Overall Study||112
158511|NCT00452452|388018|P1|STARTED|Overall Study||90
158512|NCT00452530|388043|P2|NOT COMPLETED|Overall Study||136
158513|NCT00452530|388044|P1|NOT COMPLETED|Overall Study||136
158514|NCT00452530|388043|P2|COMPLETED|Overall Study||1393
158515|NCT00452530|388044|P1|COMPLETED|Overall Study||1392
158516|NCT00452530|388043|P2|Primary Participants|Overall Study||997
158517|NCT00452530|388044|P1|Primary Participants|Overall Study||976
158518|NCT00452530|388043|P2|Evaluable Participants|Overall Study||921
158519|NCT00452530|388044|P1|Evaluable Participants|Overall Study||907
158520|NCT00452530|388043|P2|Received Treatment|Overall Study||1508
158521|NCT00452530|388044|P1|Received Treatment|Overall Study||1501
158522|NCT00452530|388043|P2|STARTED|Overall Study|Randomized|1529
158523|NCT00452530|388044|P1|STARTED|Overall Study|Randomized|1528
158524|NCT00452543|388064|P2|NOT COMPLETED|Overall Study||6
158525|NCT00452543|388065|P1|NOT COMPLETED|Overall Study||5
158526|NCT00452543|388064|P2|COMPLETED|Overall Study||5
158527|NCT00452543|388065|P1|COMPLETED|Overall Study||7
158528|NCT00452543|388064|P2|STARTED|Overall Study||11
158529|NCT00452543|388065|P1|STARTED|Overall Study||12
158530|NCT00452673|388081|P5|NOT COMPLETED|Dose Expansion Period||21
158531|NCT00452673|388082|P4|NOT COMPLETED|Dose Expansion Period||0
158532|NCT00452673|388083|P3|NOT COMPLETED|Dose Expansion Period||0
158533|NCT00452673|388084|P2|NOT COMPLETED|Dose Expansion Period||0
158534|NCT00452673|388085|P1|NOT COMPLETED|Dose Expansion Period||0
158535|NCT00452673|388081|P5|COMPLETED|Dose Expansion Period||0
158536|NCT00452673|388082|P4|COMPLETED|Dose Expansion Period||0
158537|NCT00452673|388083|P3|COMPLETED|Dose Expansion Period||0
158538|NCT00452673|388084|P2|COMPLETED|Dose Expansion Period||0
158539|NCT00452673|388085|P1|COMPLETED|Dose Expansion Period||0
158540|NCT00452673|388081|P5|STARTED|Dose Expansion Period|The last dose level arm in the escalation period was selected for the dose expansion period.|21
158541|NCT00452673|388082|P4|STARTED|Dose Expansion Period||0
158542|NCT00452673|388083|P3|STARTED|Dose Expansion Period||0
158543|NCT00452673|388084|P2|STARTED|Dose Expansion Period||0
158544|NCT00452673|388085|P1|STARTED|Dose Expansion Period||0
158545|NCT00452673|388081|P5|NOT COMPLETED|Dose Escalation Period||0
158546|NCT00452673|388082|P4|NOT COMPLETED|Dose Escalation Period||9
158547|NCT00452673|388083|P3|NOT COMPLETED|Dose Escalation Period||6
158548|NCT00452673|388084|P2|NOT COMPLETED|Dose Escalation Period||9
158549|NCT00452673|388085|P1|NOT COMPLETED|Dose Escalation Period||7
158550|NCT00452673|388081|P5|COMPLETED|Dose Escalation Period||0
158551|NCT00452673|388082|P4|COMPLETED|Dose Escalation Period||0
158552|NCT00452673|388083|P3|COMPLETED|Dose Escalation Period||0
158553|NCT00452673|388084|P2|COMPLETED|Dose Escalation Period||0
158554|NCT00452673|388085|P1|COMPLETED|Dose Escalation Period||0
158555|NCT00452673|388081|P5|STARTED|Dose Escalation Period||0
158556|NCT00452673|388082|P4|STARTED|Dose Escalation Period||9
158557|NCT00452673|388083|P3|STARTED|Dose Escalation Period||6
158558|NCT00452673|388084|P2|STARTED|Dose Escalation Period||9
158559|NCT00452673|388085|P1|STARTED|Dose Escalation Period||7
158560|NCT00452699|388117|P2|NOT COMPLETED|Overall Study||73
158561|NCT00452699|388118|P1|NOT COMPLETED|Overall Study||81
158562|NCT00452699|388117|P2|COMPLETED|Overall Study||242
158563|NCT00452699|388118|P1|COMPLETED|Overall Study||225
158564|NCT00452699|388117|P2|STARTED|Overall Study||315
158565|NCT00452699|388118|P1|STARTED|Overall Study||306
158566|NCT00452790|388132|P2|NOT COMPLETED|Toddler Dose||2
158567|NCT00452790|388133|P1|NOT COMPLETED|Toddler Dose||0
158568|NCT00452790|388132|P2|COMPLETED|Toddler Dose||198
158569|NCT00452790|388133|P1|COMPLETED|Toddler Dose||198
158570|NCT00452790|388132|P2|STARTED|Toddler Dose||200
158571|NCT00452790|388133|P1|STARTED|Toddler Dose||198
158572|NCT00452790|388132|P2|NOT COMPLETED|After Infant Series||14
158573|NCT00452790|388133|P1|NOT COMPLETED|After Infant Series||21
158574|NCT00452790|388132|P2|COMPLETED|After Infant Series||200
158575|NCT00452790|388133|P1|COMPLETED|After Infant Series||198
158576|NCT00452790|388132|P2|STARTED|After Infant Series||214
158577|NCT00452790|388133|P1|STARTED|After Infant Series||219
158578|NCT00452790|388132|P2|NOT COMPLETED|Infant Series||141
158579|NCT00452790|388133|P1|NOT COMPLETED|Infant Series||135
158580|NCT00452790|388132|P2|COMPLETED|Infant Series||214
158581|NCT00452790|388133|P1|COMPLETED|Infant Series||219
158582|NCT00452790|388132|P2|Vaccinated Dose 3|Infant Series||218
158583|NCT00452790|388133|P1|Vaccinated Dose 3|Infant Series||221
158584|NCT00452790|388132|P2|Vaccinated Dose 2|Infant Series||300
158585|NCT00452790|388133|P1|Vaccinated Dose 2|Infant Series||300
158586|NCT00452790|388132|P2|Vaccinated Dose 1|Infant Series||353
158587|NCT00452790|388133|P1|Vaccinated Dose 1|Infant Series||353
158588|NCT00452790|388132|P2|STARTED|Infant Series||355
158589|NCT00452790|388133|P1|STARTED|Infant Series||354
158590|NCT00452868|388167|P1|NOT COMPLETED|Overall Study||2
158591|NCT00452868|388167|P1|COMPLETED|Overall Study||11
158592|NCT00452868|388167|P1|STARTED|Overall Study||13
158593|NCT00453063|388173|P2|NOT COMPLETED|Overall Study||3
158594|NCT00453063|388174|P1|NOT COMPLETED|Overall Study||3
158595|NCT00453063|388173|P2|COMPLETED|Overall Study||212
158596|NCT00453063|388174|P1|COMPLETED|Overall Study||208
158597|NCT00453063|388173|P2|STARTED|Overall Study||215
158598|NCT00453063|388174|P1|STARTED|Overall Study||211
158599|NCT00453102|388188|P1|NOT COMPLETED|Overall Study||2
158600|NCT00453102|388188|P1|COMPLETED|Overall Study||16
158601|NCT00453102|388188|P1|STARTED|Overall Study||18
158602|NCT00453154|388200|P4|NOT COMPLETED|Open Label Sunitinib Crossover||0
158603|NCT00453154|388201|P3|NOT COMPLETED|Open Label Sunitinib Crossover||0
158604|NCT00453154|388202|P2|NOT COMPLETED|Open Label Sunitinib Crossover||0
158605|NCT00453154|388203|P1|NOT COMPLETED|Open Label Sunitinib Crossover||0
158606|NCT00453154|388200|P4|COMPLETED|Open Label Sunitinib Crossover||0
158607|NCT00453154|388201|P3|COMPLETED|Open Label Sunitinib Crossover||18
158608|NCT00453154|388202|P2|COMPLETED|Open Label Sunitinib Crossover||0
158609|NCT00453154|388203|P1|COMPLETED|Open Label Sunitinib Crossover||0
158610|NCT00453154|388200|P4|STARTED|Open Label Sunitinib Crossover||0
158611|NCT00453154|388201|P3|STARTED|Open Label Sunitinib Crossover||18
158612|NCT00453154|388202|P2|STARTED|Open Label Sunitinib Crossover||0
158613|NCT00453154|388203|P1|STARTED|Open Label Sunitinib Crossover||0
158614|NCT00453154|388200|P4|NOT COMPLETED|Double BIind Maintenance||49
158615|NCT00453154|388201|P3|NOT COMPLETED|Double BIind Maintenance||46
158616|NCT00453154|388202|P2|NOT COMPLETED|Double BIind Maintenance||0
158617|NCT00453154|388203|P1|NOT COMPLETED|Double BIind Maintenance||0
158618|NCT00453154|388200|P4|COMPLETED|Double BIind Maintenance||0
158619|NCT00453154|388201|P3|COMPLETED|Double BIind Maintenance||0
158620|NCT00453154|388202|P2|COMPLETED|Double BIind Maintenance||0
158621|NCT00453154|388203|P1|COMPLETED|Double BIind Maintenance||0
158622|NCT00453154|388200|P4|STARTED|Double BIind Maintenance||49
158623|NCT00453154|388201|P3|STARTED|Double BIind Maintenance||46
158624|NCT00453154|388202|P2|STARTED|Double BIind Maintenance||0
158625|NCT00453154|388203|P1|STARTED|Double BIind Maintenance||0
158626|NCT00453154|388200|P4|NOT COMPLETED|Combination Chemotherapy||0
158627|NCT00453154|388201|P3|NOT COMPLETED|Combination Chemotherapy||0
158628|NCT00453154|388202|P2|NOT COMPLETED|Combination Chemotherapy||49
158629|NCT00453154|388203|P1|NOT COMPLETED|Combination Chemotherapy||0
158630|NCT00453154|388200|P4|COMPLETED|Combination Chemotherapy||0
158631|NCT00453154|388201|P3|COMPLETED|Combination Chemotherapy||0
158632|NCT00453154|388202|P2|COMPLETED|Combination Chemotherapy||95
158633|NCT00453154|388203|P1|COMPLETED|Combination Chemotherapy||12
158634|NCT00453154|388200|P4|STARTED|Combination Chemotherapy||0
158635|NCT00453154|388201|P3|STARTED|Combination Chemotherapy||0
158636|NCT00453154|388202|P2|STARTED|Combination Chemotherapy||144
158637|NCT00453154|388203|P1|STARTED|Combination Chemotherapy||12
158638|NCT00453180|388218|P2|NOT COMPLETED|Overall Study||3
158639|NCT00453180|388219|P1|NOT COMPLETED|Overall Study||3
158640|NCT00453180|388218|P2|COMPLETED|Overall Study||12
158641|NCT00453180|388219|P1|COMPLETED|Overall Study||13
158642|NCT00453180|388218|P2|STARTED|Overall Study||15
158643|NCT00453180|388219|P1|STARTED|Overall Study||16
158644|NCT00453193|388235|P1|NOT COMPLETED|Overall Study||0
158645|NCT00453193|388235|P1|COMPLETED|Overall Study||24
158646|NCT00453193|388235|P1|STARTED|Overall Study||24
158647|NCT00453206|388239|P1|NOT COMPLETED|Overall Study||1
158648|NCT00453206|388239|P1|COMPLETED|Overall Study||65
158649|NCT00453206|388239|P1|STARTED|Overall Study||66
158650|NCT00453310|388243|P1|NOT COMPLETED|Overall Study||10
158651|NCT00453310|388243|P1|COMPLETED|Overall Study||0
158652|NCT00453310|388243|P1|STARTED|Overall Study||10
158653|NCT00453336|388247|P1|NOT COMPLETED|Overall Study||0
158654|NCT00453336|388247|P1|COMPLETED|Overall Study||45
158655|NCT00453336|388247|P1|STARTED|Overall Study||45
158656|NCT00453349|388254|P2|NOT COMPLETED|Completed Study||34
158657|NCT00453349|388255|P1|NOT COMPLETED|Completed Study||27
158658|NCT00453349|388254|P2|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|198
158659|NCT00453349|388255|P1|COMPLETED|Completed Study|had follow-up assessment or alternative antibiotic assessment|201
158660|NCT00453349|388254|P2|Completed Study Treatment|Completed Study|23 terminated prematurely|209
158661|NCT00453349|388255|P1|Completed Study Treatment|Completed Study|25 terminated prematurely|203
158662|NCT00453349|388254|P2|STARTED|Completed Study||232
158663|NCT00453349|388255|P1|STARTED|Completed Study||228
158664|NCT00453349|388254|P2|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||11
158665|NCT00453349|388255|P1|NOT COMPLETED|Reaching of Primary Endpoint (TOC)||10
158666|NCT00453349|388254|P2|COMPLETED|Reaching of Primary Endpoint (TOC)||219
158667|NCT00453349|388255|P1|COMPLETED|Reaching of Primary Endpoint (TOC)|All PP patients and ITT patients with a clinical response with no missing information|215
158668|NCT00453349|388254|P2|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||190
158669|NCT00453349|388255|P1|Valid for Primary Efficacy Analysis|Reaching of Primary Endpoint (TOC)||194
158670|NCT00453349|388254|P2|STARTED|Reaching of Primary Endpoint (TOC)|i.e. the ITT population|230
158671|NCT00453349|388255|P1|STARTED|Reaching of Primary Endpoint (TOC)|Subjects who attended the TOC visit or at least had a clinical evaluation at TOC|225
158672|NCT00453349|388254|P2|NOT COMPLETED|Randomized||23
158673|NCT00453349|388255|P1|NOT COMPLETED|Randomized||25
158674|NCT00453349|388254|P2|COMPLETED|Randomized||209
158675|NCT00453349|388255|P1|COMPLETED|Randomized||203
158676|NCT00453349|388254|P2|STARTED|Randomized||232
158677|NCT00453349|388255|P1|STARTED|Randomized||228
158678|NCT00453362|388281|P1|NOT COMPLETED|Overall Study||87
158679|NCT00453362|388281|P1|COMPLETED|Overall Study||1
158680|NCT00453362|388281|P1|FLT-PET Evaluable|Overall Study|Participants who completed all FLT-PET scans through day 56.|50
158681|NCT00453362|388281|P1|FDG-PET Evaluable|Overall Study|Participants who completed all FDG-PET scans through day 56.|51
158682|NCT00453362|388281|P1|Treated With Erlotinib|Overall Study||74
158683|NCT00453362|388281|P1|STARTED|Overall Study|14 participants consented but did not receive drug and are not represented in the baseline data|88
158684|NCT00453388|388309|P4|NOT COMPLETED|Overall Study||0
158685|NCT00453388|388310|P3|NOT COMPLETED|Overall Study||0
158686|NCT00453388|388311|P2|NOT COMPLETED|Overall Study||0
158687|NCT00453388|388312|P1|NOT COMPLETED|Overall Study||0
158688|NCT00453388|388309|P4|COMPLETED|Overall Study||0
158689|NCT00453388|388310|P3|COMPLETED|Overall Study||1
158690|NCT00453388|388311|P2|COMPLETED|Overall Study||5
158691|NCT00453388|388312|P1|COMPLETED|Overall Study||0
158692|NCT00453388|388309|P4|STARTED|Overall Study||0
158693|NCT00453388|388310|P3|STARTED|Overall Study||1
158694|NCT00453388|388311|P2|STARTED|Overall Study||5
158695|NCT00453388|388312|P1|STARTED|Overall Study||0
158696|NCT00453973|388336|P2|NOT COMPLETED|Overall Study||48
158697|NCT00453973|388337|P1|NOT COMPLETED|Overall Study||51
158698|NCT00453973|388336|P2|COMPLETED|Overall Study||15
158699|NCT00453973|388337|P1|COMPLETED|Overall Study||0
158700|NCT00453973|388336|P2|STARTED|Overall Study||63
158701|NCT00453973|388337|P1|STARTED|Overall Study||51
158702|NCT00453986|388348|P5|NOT COMPLETED|Overall Study||0
158703|NCT00453986|388349|P4|NOT COMPLETED|Overall Study||2
158704|NCT00453986|388350|P3|NOT COMPLETED|Overall Study||6
158705|NCT00453986|388351|P2|NOT COMPLETED|Overall Study||5
158706|NCT00453986|388352|P1|NOT COMPLETED|Overall Study||6
158707|NCT00453986|388348|P5|COMPLETED|Overall Study||105
158708|NCT00453986|388349|P4|COMPLETED|Overall Study||310
158709|NCT00453986|388350|P3|COMPLETED|Overall Study||307
158710|NCT00453986|388351|P2|COMPLETED|Overall Study||306
158711|NCT00453986|388352|P1|COMPLETED|Overall Study||305
158712|NCT00453986|388348|P5|STARTED|Overall Study||105
158713|NCT00453986|388349|P4|STARTED|Overall Study||312
158714|NCT00453986|388350|P3|STARTED|Overall Study||313
158715|NCT00453986|388351|P2|STARTED|Overall Study||311
158716|NCT00453986|388352|P1|STARTED|Overall Study||311
158717|NCT00453999|388448|P3|NOT COMPLETED|Overall Study||3
158718|NCT00453999|388449|P2|NOT COMPLETED|Overall Study||5
158719|NCT00453999|388450|P1|NOT COMPLETED|Overall Study||5
158720|NCT00453999|388448|P3|COMPLETED|Overall Study||43
158721|NCT00453999|388449|P2|COMPLETED|Overall Study||41
158722|NCT00453999|388450|P1|COMPLETED|Overall Study||40
158723|NCT00453999|388448|P3|STARTED|Overall Study||46
158724|NCT00453999|388449|P2|STARTED|Overall Study||46
158725|NCT00453999|388450|P1|STARTED|Overall Study||45
158726|NCT00454051|388475|P2|NOT COMPLETED|Overall Study||3
158727|NCT00454051|388476|P1|NOT COMPLETED|Overall Study||3
158728|NCT00454051|388475|P2|COMPLETED|Overall Study||8
158729|NCT00454051|388476|P1|COMPLETED|Overall Study||17
158730|NCT00454051|388475|P2|STARTED|Overall Study||11
158731|NCT00454051|388476|P1|STARTED|Overall Study||20
158732|NCT00454116|388509|P3|NOT COMPLETED|Overall Study||28
158733|NCT00454116|388510|P2|NOT COMPLETED|Overall Study||29
158734|NCT00454116|388511|P1|NOT COMPLETED|Overall Study||27
158735|NCT00454116|388509|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
158736|NCT00454116|388510|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
158737|NCT00454116|388511|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|8
158738|NCT00454116|388509|P3|STARTED|Overall Study|randomised patients|35
158739|NCT00454116|388510|P2|STARTED|Overall Study|randomised patients|36
158740|NCT00454116|388511|P1|STARTED|Overall Study|randomised patients|35
158741|NCT00454142|388519|P1|NOT COMPLETED|Overall Study||1
158742|NCT00454142|388519|P1|COMPLETED|Overall Study||32
158743|NCT00454142|388519|P1|STARTED|Overall Study||33
158744|NCT00454181|388536|P2|NOT COMPLETED|Overall Study||3
158745|NCT00454181|388537|P1|NOT COMPLETED|Overall Study||15
158746|NCT00454181|388536|P2|COMPLETED|Overall Study||11
158747|NCT00454181|388537|P1|COMPLETED|Overall Study||30
158748|NCT00454181|388536|P2|STARTED|Overall Study||14
158749|NCT00454181|388537|P1|STARTED|Overall Study||45
158750|NCT00454194|388555|P2|NOT COMPLETED|Overall Study||14
158751|NCT00454194|388556|P1|NOT COMPLETED|Overall Study||22
158752|NCT00454194|388555|P2|COMPLETED|Overall Study||37
158753|NCT00454194|388556|P1|COMPLETED|Overall Study||25
158754|NCT00454194|388555|P2|STARTED|Overall Study||51
158755|NCT00454194|388556|P1|STARTED|Overall Study||47
158756|NCT00454207|388574|P2|NOT COMPLETED|Overall Study||2
158757|NCT00454207|388575|P1|NOT COMPLETED|Overall Study||4
158758|NCT00454207|388574|P2|COMPLETED|Overall Study||21
158759|NCT00454207|388575|P1|COMPLETED|Overall Study|19 participants completed Part I period. 17 of 19 participants continued from part I into Part II.|17
158760|NCT00454207|388574|P2|STARTED|Overall Study||23
158761|NCT00454207|388575|P1|STARTED|Overall Study||21
158762|NCT00454246|388621|P3|NOT COMPLETED|Overall Study||9
158763|NCT00454246|388622|P2|NOT COMPLETED|Overall Study||29
158764|NCT00454246|388623|P1|NOT COMPLETED|Overall Study||73
158765|NCT00454246|388621|P3|COMPLETED|Overall Study||0
158766|NCT00454246|388622|P2|COMPLETED|Overall Study||0
158767|NCT00454246|388623|P1|COMPLETED|Overall Study||0
158768|NCT00454246|388621|P3|STARTED|Overall Study||9
158769|NCT00454246|388622|P2|STARTED|Overall Study||29
158770|NCT00454246|388623|P1|STARTED|Overall Study||73
158771|NCT00454324|388639|P2|NOT COMPLETED|Overall Study||0
158772|NCT00454324|388640|P1|NOT COMPLETED|Overall Study||0
158773|NCT00454324|388639|P2|COMPLETED|Overall Study||13
158774|NCT00454324|388640|P1|COMPLETED|Overall Study||14
158775|NCT00454324|388639|P2|STARTED|Overall Study||13
158776|NCT00454324|388640|P1|STARTED|Overall Study||14
158777|NCT00454363|388654|P2|NOT COMPLETED|Overall Study||2
158778|NCT00454363|388655|P1|NOT COMPLETED|Overall Study||5
158779|NCT00454363|388654|P2|COMPLETED|Overall Study||29
158780|NCT00454363|388655|P1|COMPLETED|Overall Study||15
158781|NCT00454363|388654|P2|STARTED|Overall Study||31
158782|NCT00454363|388655|P1|STARTED|Overall Study||20
158783|NCT00454532|388666|P4|NOT COMPLETED|Overall Study||0
158784|NCT00454532|388667|P3|NOT COMPLETED|Overall Study||0
158785|NCT00454532|388668|P2|NOT COMPLETED|Overall Study||0
158786|NCT00454532|388669|P1|NOT COMPLETED|Overall Study||0
158787|NCT00454532|388666|P4|COMPLETED|Overall Study||7
158788|NCT00454532|388667|P3|COMPLETED|Overall Study||3
158789|NCT00454532|388668|P2|COMPLETED|Overall Study||6
158790|NCT00454532|388669|P1|COMPLETED|Overall Study||11
158791|NCT00454532|388666|P4|STARTED|Overall Study||7
158792|NCT00454532|388667|P3|STARTED|Overall Study||3
158793|NCT00454532|388668|P2|STARTED|Overall Study||6
158794|NCT00454532|388669|P1|STARTED|Overall Study||11
158795|NCT00454571|388689|P2|NOT COMPLETED|Overall Study||6
158796|NCT00454571|388690|P1|NOT COMPLETED|Overall Study||13
158797|NCT00454571|388689|P2|COMPLETED|Overall Study||13
158798|NCT00454571|388690|P1|COMPLETED|Overall Study||5
158799|NCT00454571|388689|P2|STARTED|Overall Study||19
158800|NCT00454571|388690|P1|STARTED|Overall Study||18
158801|NCT00441727|388701|P3|NOT COMPLETED|Overall Study||168
158802|NCT00441727|388702|P2|NOT COMPLETED|Overall Study||118
158803|NCT00441727|388703|P1|NOT COMPLETED|Overall Study||106
158804|NCT00441727|388701|P3|COMPLETED|Overall Study|ITT/randomised|637
158805|NCT00441727|388702|P2|COMPLETED|Overall Study|ITT/randomised|686
158806|NCT00441727|388703|P1|COMPLETED|Overall Study|ITT/randomised|711
158807|NCT00441727|388701|P3|STARTED|Overall Study|ITT/randomised|805
158808|NCT00441727|388702|P2|STARTED|Overall Study|ITT/randomised|804
158809|NCT00441727|388703|P1|STARTED|Overall Study|ITT/randomised|817
158810|NCT00441766|388730|P4|NOT COMPLETED|Overall Study||6
158811|NCT00441766|388731|P3|NOT COMPLETED|Overall Study||9
158812|NCT00441766|388732|P2|NOT COMPLETED|Overall Study||7
158813|NCT00441766|388733|P1|NOT COMPLETED|Overall Study||14
158814|NCT00441766|388730|P4|COMPLETED|Overall Study||48
158815|NCT00441766|388731|P3|COMPLETED|Overall Study||44
158816|NCT00441766|388732|P2|COMPLETED|Overall Study||46
158817|NCT00441766|388733|P1|COMPLETED|Overall Study||39
158818|NCT00441766|388730|P4|STARTED|Overall Study||54
158819|NCT00441766|388731|P3|STARTED|Overall Study||53
158820|NCT00441766|388732|P2|STARTED|Overall Study||53
158821|NCT00441766|388733|P1|STARTED|Overall Study||53
158822|NCT00441792|388757|P2|NOT COMPLETED|Overall Study||2
158823|NCT00441792|388758|P1|NOT COMPLETED|Overall Study||0
158824|NCT00441792|388757|P2|COMPLETED|Overall Study|2 patients lost to follow up in Etomidate arm due to transfer to outside hospital.|61
158825|NCT00441792|388758|P1|COMPLETED|Overall Study||59
158826|NCT00441792|388757|P2|STARTED|Overall Study||63
158827|NCT00441792|388758|P1|STARTED|Overall Study||59
158828|NCT00447226|388766|P2|NOT COMPLETED|Double-blind Phase||3
158829|NCT00447226|388767|P1|NOT COMPLETED|Double-blind Phase||4
158830|NCT00447226|388766|P2|COMPLETED|Double-blind Phase||0
158831|NCT00447226|388767|P1|COMPLETED|Double-blind Phase||0
158832|NCT00447226|388766|P2|STARTED|Double-blind Phase||3
158833|NCT00447226|388767|P1|STARTED|Double-blind Phase||4
158834|NCT00447226|388766|P2|NOT COMPLETED|12-Week Open-label Phase||25
158835|NCT00447226|388767|P1|NOT COMPLETED|12-Week Open-label Phase||0
158836|NCT00447226|388766|P2|COMPLETED|12-Week Open-label Phase||7
158837|NCT00447226|388767|P1|COMPLETED|12-Week Open-label Phase||0
158838|NCT00447226|388766|P2|STARTED|12-Week Open-label Phase||32
158839|NCT00447226|388767|P1|STARTED|12-Week Open-label Phase||0
158840|NCT00447265|388785|P2|NOT COMPLETED|Overall Study||0
158841|NCT00447265|388786|P1|NOT COMPLETED|Overall Study||1
158842|NCT00447265|388785|P2|COMPLETED|Overall Study||0
158843|NCT00447265|388786|P1|COMPLETED|Overall Study|The participant completed treatment and discontinued follow-up at week 39 after randomization|0
158844|NCT00447265|388785|P2|STARTED|Overall Study||0
158845|NCT00447265|388786|P1|STARTED|Overall Study||1
158846|NCT00447278|388801|P2|NOT COMPLETED|Period III (Optional 6 Month Extension)||15
158847|NCT00447278|388802|P1|NOT COMPLETED|Period III (Optional 6 Month Extension)||30
158848|NCT00447278|388801|P2|COMPLETED|Period III (Optional 6 Month Extension)||140
158849|NCT00447278|388802|P1|COMPLETED|Period III (Optional 6 Month Extension)||109
158850|NCT00447278|388801|P2|STARTED|Period III (Optional 6 Month Extension)|16 choose not to enter this optional period.|155
158851|NCT00447278|388802|P1|STARTED|Period III (Optional 6 Month Extension)|18 choose not to enter this optional period.|139
158852|NCT00447278|388801|P2|NOT COMPLETED|Period II (6 Month Open-Label)||29
158853|NCT00447278|388802|P1|NOT COMPLETED|Period II (6 Month Open-Label)||42
158854|NCT00447278|388801|P2|COMPLETED|Period II (6 Month Open-Label)||171
158855|NCT00447278|388802|P1|COMPLETED|Period II (6 Month Open-Label)||157
158856|NCT00447278|388801|P2|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)|1 patient withdrew due to parent/guardian decision prior to receiving study drug.|199
158857|NCT00447278|388802|P1|Received at Least One Dose of Study Drug|Period II (6 Month Open-Label)||199
158858|NCT00447278|388801|P2|STARTED|Period II (6 Month Open-Label)||200
158859|NCT00447278|388802|P1|STARTED|Period II (6 Month Open-Label)||199
158860|NCT00447330|388823|P1|NOT COMPLETED|Overall Study||2
158861|NCT00447330|388823|P1|COMPLETED|Overall Study||58
158862|NCT00447330|388823|P1|STARTED|Overall Study|2 subjects signed the ICF, but were withdrawn from study prior to receiving any study drug|60
158863|NCT00447382|388832|P2|NOT COMPLETED|Overall Study||6
158864|NCT00447382|388833|P1|NOT COMPLETED|Overall Study||6
158865|NCT00447382|388832|P2|COMPLETED|Overall Study||160
158866|NCT00447382|388833|P1|COMPLETED|Overall Study||158
158867|NCT00447382|388832|P2|STARTED|Overall Study||166
158868|NCT00447382|388833|P1|STARTED|Overall Study||164
158869|NCT00447421|388885|P1|NOT COMPLETED|Overall Study||6
158870|NCT00447421|388885|P1|COMPLETED|Overall Study||3
158871|NCT00447421|388885|P1|STARTED|Overall Study||9
158872|NCT00447499|388895|P1|NOT COMPLETED|Overall Study||7
158873|NCT00447499|388895|P1|COMPLETED|Overall Study||52
158874|NCT00447499|388895|P1|STARTED|Overall Study||59
158875|NCT00454584|388908|P6|NOT COMPLETED|After Controlled Period||32
158876|NCT00454584|388909|P5|NOT COMPLETED|After Controlled Period||12
158877|NCT00454584|388910|P4|NOT COMPLETED|After Controlled Period||26
158878|NCT00454584|388911|P3|NOT COMPLETED|After Controlled Period||0
158879|NCT00454584|388912|P2|NOT COMPLETED|After Controlled Period||0
158880|NCT00454584|388913|P1|NOT COMPLETED|After Controlled Period||0
158881|NCT00454584|388908|P6|COMPLETED|After Controlled Period||310
158882|NCT00454584|388909|P5|COMPLETED|After Controlled Period||189
158883|NCT00454584|388910|P4|COMPLETED|After Controlled Period||310
158884|NCT00454584|388911|P3|COMPLETED|After Controlled Period||0
158885|NCT00454584|388912|P2|COMPLETED|After Controlled Period||0
158886|NCT00454584|388913|P1|COMPLETED|After Controlled Period||0
158887|NCT00454584|388908|P6|STARTED|After Controlled Period||342
158888|NCT00454584|388909|P5|STARTED|After Controlled Period||201
158889|NCT00454584|388910|P4|STARTED|After Controlled Period||336
158890|NCT00454584|388911|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
158891|NCT00454584|388912|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
158892|NCT00454584|388913|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Controlled Period."|0
158893|NCT00454584|388908|P6|NOT COMPLETED|Controlled Period||0
158894|NCT00454584|388909|P5|NOT COMPLETED|Controlled Period||0
158895|NCT00454584|388910|P4|NOT COMPLETED|Controlled Period||0
158896|NCT00454584|388911|P3|NOT COMPLETED|Controlled Period||5
158897|NCT00454584|388912|P2|NOT COMPLETED|Controlled Period||8
158898|NCT00454584|388913|P1|NOT COMPLETED|Controlled Period||11
158899|NCT00454584|388908|P6|COMPLETED|Controlled Period||0
158900|NCT00454584|388909|P5|COMPLETED|Controlled Period||0
158901|NCT00454584|388910|P4|COMPLETED|Controlled Period||0
158902|NCT00454584|388911|P3|COMPLETED|Controlled Period||342
158903|NCT00454584|388912|P2|COMPLETED|Controlled Period||201
158904|NCT00454584|388913|P1|COMPLETED|Controlled Period||336
158905|NCT00454584|388908|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
158906|NCT00454584|388909|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
158907|NCT00454584|388910|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Controlled Period."|0
158908|NCT00454584|388911|P3|STARTED|Controlled Period||347
158909|NCT00454584|388912|P2|STARTED|Controlled Period||209
158910|NCT00454584|388913|P1|STARTED|Controlled Period||347
158911|NCT00454636|388937|P4|NOT COMPLETED|Overall Study||32
158912|NCT00454636|388938|P3|NOT COMPLETED|Overall Study||20
158913|NCT00454636|388939|P2|NOT COMPLETED|Overall Study||23
158914|NCT00454636|388940|P1|NOT COMPLETED|Overall Study||31
158915|NCT00454636|388937|P4|COMPLETED|Overall Study||26
158916|NCT00454636|388938|P3|COMPLETED|Overall Study||7
158917|NCT00454636|388939|P2|COMPLETED|Overall Study||9
158918|NCT00454636|388940|P1|COMPLETED|Overall Study||10
158919|NCT00454636|388937|P4|STARTED|Overall Study||58
158920|NCT00454636|388938|P3|STARTED|Overall Study||27
158921|NCT00454636|388939|P2|STARTED|Overall Study||32
158922|NCT00454636|388940|P1|STARTED|Overall Study||41
158923|NCT00454649|388980|P10|NOT COMPLETED|Overall Study||5
158924|NCT00454649|388981|P9|NOT COMPLETED|Overall Study||20
158925|NCT00454649|388982|P8|NOT COMPLETED|Overall Study||19
158926|NCT00454649|388983|P7|NOT COMPLETED|Overall Study||9
158927|NCT00454649|388984|P6|NOT COMPLETED|Overall Study||7
158928|NCT00454649|388985|P5|NOT COMPLETED|Overall Study||1
158929|NCT00454649|388986|P4|NOT COMPLETED|Overall Study||6
158930|NCT00454649|388987|P3|NOT COMPLETED|Overall Study||19
158931|NCT00454649|388988|P2|NOT COMPLETED|Overall Study||4
158932|NCT00454649|388989|P1|NOT COMPLETED|Overall Study||3
158933|NCT00454649|388980|P10|COMPLETED|Overall Study||1
158934|NCT00454649|388981|P9|COMPLETED|Overall Study||1
158935|NCT00454649|388982|P8|COMPLETED|Overall Study||0
158936|NCT00454649|388983|P7|COMPLETED|Overall Study||0
158937|NCT00454649|388984|P6|COMPLETED|Overall Study||0
158938|NCT00454649|388985|P5|COMPLETED|Overall Study||0
158939|NCT00454649|388986|P4|COMPLETED|Overall Study||1
158940|NCT00454649|388987|P3|COMPLETED|Overall Study||1
158941|NCT00454649|388988|P2|COMPLETED|Overall Study||1
158942|NCT00454649|388989|P1|COMPLETED|Overall Study||0
158943|NCT00454649|388980|P10|STARTED|Overall Study||6
158944|NCT00454649|388981|P9|STARTED|Overall Study||21
158945|NCT00454649|388982|P8|STARTED|Overall Study||19
158946|NCT00454649|388983|P7|STARTED|Overall Study||9
158947|NCT00454649|388984|P6|STARTED|Overall Study||7
158948|NCT00454649|388985|P5|STARTED|Overall Study||1
158949|NCT00454649|388986|P4|STARTED|Overall Study||7
158950|NCT00454649|388987|P3|STARTED|Overall Study||20
158951|NCT00454649|388988|P2|STARTED|Overall Study||5
158952|NCT00454649|388989|P1|STARTED|Overall Study||3
158953|NCT00454779|389116|P2|NOT COMPLETED|Second-line Treatment Phase||3
158954|NCT00454779|389117|P1|NOT COMPLETED|Second-line Treatment Phase||0
158955|NCT00454779|389116|P2|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|27
158956|NCT00454779|389117|P1|COMPLETED|Second-line Treatment Phase|Disease progression (radiographically determined) or death|0
158957|NCT00454779|389116|P2|STARTED|Second-line Treatment Phase|Second-line Panitumumab Monotherapy|30
158958|NCT00454779|389117|P1|STARTED|Second-line Treatment Phase|Subjects in this arm do not have second-line treatment period|0
158959|NCT00454779|389116|P2|NOT COMPLETED|First-line Treatment Phase||8
158960|NCT00454779|389117|P1|NOT COMPLETED|First-line Treatment Phase||5
158961|NCT00454779|389116|P2|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|49
158962|NCT00454779|389117|P1|COMPLETED|First-line Treatment Phase|Disease progression (radiographically determined) or death|51
158963|NCT00454779|389116|P2|Received Study Medication|First-line Treatment Phase||55
158964|NCT00454779|389117|P1|Received Study Medication|First-line Treatment Phase||56
158965|NCT00454779|389116|P2|STARTED|First-line Treatment Phase||57
158966|NCT00454779|389117|P1|STARTED|First-line Treatment Phase||56
158967|NCT00454805|389147|P2|NOT COMPLETED|Overall Study||23
158968|NCT00454805|389148|P1|NOT COMPLETED|Overall Study||26
158969|NCT00454805|389147|P2|COMPLETED|Overall Study|Ongoing at data cut-off|8
158970|NCT00454805|389148|P1|COMPLETED|Overall Study|Ongoing at data cut-off|5
158971|NCT00454805|389147|P2|STARTED|Overall Study|Randomised|31
158972|NCT00454805|389148|P1|STARTED|Overall Study|Randomised|31
158973|NCT00454818|389170|P5|NOT COMPLETED|Phase 2: Randomized Double-blind||4
158974|NCT00454818|389171|P4|NOT COMPLETED|Phase 2: Randomized Double-blind||1
158975|NCT00454818|389172|P3|NOT COMPLETED|Phase 2: Randomized Double-blind||3
158976|NCT00454818|389173|P2|NOT COMPLETED|Phase 2: Randomized Double-blind||2
158977|NCT00454818|389174|P1|NOT COMPLETED|Phase 2: Randomized Double-blind||0
158978|NCT00454818|389170|P5|COMPLETED|Phase 2: Randomized Double-blind||10
158979|NCT00454818|389171|P4|COMPLETED|Phase 2: Randomized Double-blind||8
158980|NCT00454818|389172|P3|COMPLETED|Phase 2: Randomized Double-blind||5
158981|NCT00454818|389173|P2|COMPLETED|Phase 2: Randomized Double-blind||6
158982|NCT00454818|389174|P1|COMPLETED|Phase 2: Randomized Double-blind||0
158983|NCT00454818|389170|P5|STARTED|Phase 2: Randomized Double-blind||14
158984|NCT00454818|389171|P4|STARTED|Phase 2: Randomized Double-blind||9
158985|NCT00454818|389172|P3|STARTED|Phase 2: Randomized Double-blind||8
158986|NCT00454818|389173|P2|STARTED|Phase 2: Randomized Double-blind||8
158987|NCT00454818|389174|P1|STARTED|Phase 2: Randomized Double-blind||0
158988|NCT00454818|389170|P5|NOT COMPLETED|Phase I: Open-label Dose-escalation||0
158989|NCT00454818|389171|P4|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
158990|NCT00454818|389172|P3|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
158991|NCT00454818|389173|P2|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
158992|NCT00454818|389174|P1|NOT COMPLETED|Phase I: Open-label Dose-escalation||1
158993|NCT00454818|389170|P5|COMPLETED|Phase I: Open-label Dose-escalation||0
158994|NCT00454818|389171|P4|COMPLETED|Phase I: Open-label Dose-escalation||2
158995|NCT00454818|389172|P3|COMPLETED|Phase I: Open-label Dose-escalation||2
158996|NCT00454818|389173|P2|COMPLETED|Phase I: Open-label Dose-escalation||2
158997|NCT00454818|389174|P1|COMPLETED|Phase I: Open-label Dose-escalation||2
158998|NCT00454818|389170|P5|STARTED|Phase I: Open-label Dose-escalation||0
158999|NCT00454818|389171|P4|STARTED|Phase I: Open-label Dose-escalation||3
159000|NCT00454818|389172|P3|STARTED|Phase I: Open-label Dose-escalation||3
159001|NCT00454818|389173|P2|STARTED|Phase I: Open-label Dose-escalation||3
159002|NCT00454818|389174|P1|STARTED|Phase I: Open-label Dose-escalation||3
159003|NCT00454857|389251|P1|NOT COMPLETED|Overall Study||54
159004|NCT00454857|389251|P1|COMPLETED|Overall Study||272
159005|NCT00454857|389251|P1|Completed ≥1 Observational Study Visit|Overall Study||319
159006|NCT00454857|389251|P1|Completed Retrospective Chart Review|Overall Study||324
159007|NCT00454857|389251|P1|STARTED|Overall Study||326
159008|NCT00454909|389271|P3|NOT COMPLETED|Overall Study||2
159009|NCT00454909|389272|P2|NOT COMPLETED|Overall Study||3
159010|NCT00454909|389273|P1|NOT COMPLETED|Overall Study||7
159011|NCT00454909|389271|P3|COMPLETED|Overall Study||86
159012|NCT00454909|389272|P2|COMPLETED|Overall Study||194
159013|NCT00454909|389273|P1|COMPLETED|Overall Study||580
159014|NCT00454909|389271|P3|STARTED|Overall Study||88
159015|NCT00454909|389272|P2|STARTED|Overall Study||197
159016|NCT00454909|389273|P1|STARTED|Overall Study||587
159017|NCT00455195|389313|P2|NOT COMPLETED|Extension Study AGLU03206||0
159018|NCT00455195|389314|P1|NOT COMPLETED|Extension Study AGLU03206||0
159019|NCT00455195|389313|P2|COMPLETED|Extension Study AGLU03206||26
159020|NCT00455195|389314|P1|COMPLETED|Extension Study AGLU03206||55
159021|NCT00455195|389313|P2|STARTED|Extension Study AGLU03206|These 26 participants completed placebo double-blind treatment in the AGLU02704 (NCT00158600) study.|26
159022|NCT00455195|389314|P1|STARTED|Extension Study AGLU03206||55
159023|NCT00455195|389313|P2|NOT COMPLETED|Double-blind Study AGLU02704||4
159024|NCT00455195|389314|P1|NOT COMPLETED|Double-blind Study AGLU02704||5
159025|NCT00455195|389313|P2|COMPLETED|Double-blind Study AGLU02704||26
159026|NCT00455195|389314|P1|COMPLETED|Double-blind Study AGLU02704||55
159027|NCT00455195|389313|P2|STARTED|Double-blind Study AGLU02704|See study AGLU02704 (NCT00158600) for results while on placebo.|30
159028|NCT00455195|389314|P1|STARTED|Double-blind Study AGLU02704|Patients randomized to alglucosidase alfa treatment group in AGLU02704 (NCT00158600).|60
159029|NCT00455312|389330|P2|NOT COMPLETED|Overall Study||1
159030|NCT00455312|389331|P1|NOT COMPLETED|Overall Study||0
159031|NCT00455312|389330|P2|COMPLETED|Overall Study||20
159032|NCT00455312|389331|P1|COMPLETED|Overall Study||15
159033|NCT00455312|389330|P2|STARTED|Overall Study||21
159034|NCT00455312|389331|P1|STARTED|Overall Study||15
159035|NCT00455429|389359|P4|NOT COMPLETED|Overall Study||14
159036|NCT00455429|389360|P3|NOT COMPLETED|Overall Study||1
159037|NCT00455429|389361|P2|NOT COMPLETED|Overall Study||5
159038|NCT00455429|389362|P1|NOT COMPLETED|Overall Study||2
159039|NCT00455429|389359|P4|COMPLETED|Overall Study||20
159040|NCT00455429|389360|P3|COMPLETED|Overall Study||16
159041|NCT00455429|389361|P2|COMPLETED|Overall Study||10
159042|NCT00455429|389362|P1|COMPLETED|Overall Study||16
159043|NCT00455429|389359|P4|Treated|Overall Study||32
159044|NCT00455429|389360|P3|Treated|Overall Study||17
159045|NCT00455429|389361|P2|Treated|Overall Study||15
159046|NCT00455429|389362|P1|Treated|Overall Study||18
159047|NCT00455429|389359|P4|STARTED|Overall Study||34
159048|NCT00455429|389360|P3|STARTED|Overall Study||17
159049|NCT00455429|389361|P2|STARTED|Overall Study||15
159050|NCT00455429|389362|P1|STARTED|Overall Study||18
159051|NCT00455455|389419|P2|NOT COMPLETED|Second Intervention||0
159052|NCT00455455|389420|P1|NOT COMPLETED|Second Intervention||0
159053|NCT00455455|389419|P2|COMPLETED|Second Intervention||24
159054|NCT00455455|389420|P1|COMPLETED|Second Intervention||24
159055|NCT00455455|389419|P2|STARTED|Second Intervention||24
159056|NCT00455455|389420|P1|STARTED|Second Intervention||24
159057|NCT00455455|389419|P2|NOT COMPLETED|Washout||0
159058|NCT00455455|389420|P1|NOT COMPLETED|Washout||1
159059|NCT00455455|389419|P2|COMPLETED|Washout||24
159060|NCT00455455|389420|P1|COMPLETED|Washout||24
159061|NCT00455455|389419|P2|STARTED|Washout||24
159062|NCT00455455|389420|P1|STARTED|Washout||25
159063|NCT00455455|389419|P2|NOT COMPLETED|First Intervention||0
159064|NCT00455455|389420|P1|NOT COMPLETED|First Intervention||0
159065|NCT00455455|389419|P2|COMPLETED|First Intervention||24
159066|NCT00455455|389420|P1|COMPLETED|First Intervention||25
159067|NCT00455455|389419|P2|STARTED|First Intervention||24
159068|NCT00455455|389420|P1|STARTED|First Intervention||25
159069|NCT00455455|389419|P2|NOT COMPLETED|Washout||1
159070|NCT00455455|389420|P1|NOT COMPLETED|Washout||0
159071|NCT00455455|389419|P2|COMPLETED|Washout||24
159072|NCT00455455|389420|P1|COMPLETED|Washout||25
159073|NCT00455455|389419|P2|STARTED|Washout||25
159074|NCT00455455|389420|P1|STARTED|Washout||25
159075|NCT00455520|389438|P2|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||62
159076|NCT00455520|389439|P1|NOT COMPLETED|Double Blind Tapentadol ER vs Placebo||63
159077|NCT00455520|389438|P2|COMPLETED|Double Blind Tapentadol ER vs Placebo||131
159078|NCT00455520|389439|P1|COMPLETED|Double Blind Tapentadol ER vs Placebo||133
159079|NCT00455520|389438|P2|STARTED|Double Blind Tapentadol ER vs Placebo|1 subject enrolled two separate times in this study, 2 subjects did not receive study medication|193
159080|NCT00455520|389439|P1|STARTED|Double Blind Tapentadol ER vs Placebo|2 subjects enrolled two separate times in this study, 1 subject did not receive study medication|196
159081|NCT00455520|389438|P2|NOT COMPLETED|Open Label Tapentadol Extended Release||0
159082|NCT00455520|389439|P1|NOT COMPLETED|Open Label Tapentadol Extended Release||196
159083|NCT00455520|389438|P2|COMPLETED|Open Label Tapentadol Extended Release||0
159084|NCT00455520|389439|P1|COMPLETED|Open Label Tapentadol Extended Release||395
159085|NCT00455520|389438|P2|STARTED|Open Label Tapentadol Extended Release||0
159086|NCT00455520|389439|P1|STARTED|Open Label Tapentadol Extended Release||591
159087|NCT00455533|389457|P3|NOT COMPLETED|Period Two: Randomized Period||6
159088|NCT00455533|389458|P2|NOT COMPLETED|Period Two: Randomized Period||6
159089|NCT00455533|389459|P1|NOT COMPLETED|Period Two: Randomized Period||0
159090|NCT00455533|389457|P3|COMPLETED|Period Two: Randomized Period||138
159091|NCT00455533|389458|P2|COMPLETED|Period Two: Randomized Period||139
159092|NCT00455533|389459|P1|COMPLETED|Period Two: Randomized Period||0
159093|NCT00455533|389457|P3|STARTED|Period Two: Randomized Period|147 randomized, 144 randomized and treated with paclitaxel|144
159094|NCT00455533|389458|P2|STARTED|Period Two: Randomized Period|148 randomized, 145 randomized and treated with ixabepilone|145
159095|NCT00455533|389459|P1|STARTED|Period Two: Randomized Period||0
159096|NCT00455533|389457|P3|NOT COMPLETED|Period One: Initial Chemotherapy||0
159097|NCT00455533|389458|P2|NOT COMPLETED|Period One: Initial Chemotherapy||0
159098|NCT00455533|389459|P1|NOT COMPLETED|Period One: Initial Chemotherapy||18
159099|NCT00455533|389457|P3|COMPLETED|Period One: Initial Chemotherapy||0
159100|NCT00455533|389458|P2|COMPLETED|Period One: Initial Chemotherapy||0
159101|NCT00455533|389459|P1|COMPLETED|Period One: Initial Chemotherapy||295
159102|NCT00455533|389457|P3|STARTED|Period One: Initial Chemotherapy||0
159103|NCT00455533|389458|P2|STARTED|Period One: Initial Chemotherapy||0
159104|NCT00455533|389459|P1|STARTED|Period One: Initial Chemotherapy||313
159105|NCT00455650|389508|P6|NOT COMPLETED|Week 3||0
159106|NCT00455650|389509|P5|NOT COMPLETED|Week 3||0
159107|NCT00455650|389510|P4|NOT COMPLETED|Week 3||0
159108|NCT00455650|389511|P3|NOT COMPLETED|Week 3||0
159109|NCT00455650|389512|P2|NOT COMPLETED|Week 3||0
159110|NCT00455650|389513|P1|NOT COMPLETED|Week 3||0
159111|NCT00455650|389508|P6|COMPLETED|Week 3||13
159112|NCT00455650|389509|P5|COMPLETED|Week 3||14
159113|NCT00455650|389510|P4|COMPLETED|Week 3||14
159114|NCT00455650|389511|P3|COMPLETED|Week 3||10
159115|NCT00455650|389512|P2|COMPLETED|Week 3||10
159116|NCT00455650|389513|P1|COMPLETED|Week 3||10
159117|NCT00455650|389508|P6|STARTED|Week 3||13
159118|NCT00455650|389509|P5|STARTED|Week 3||14
159119|NCT00455650|389510|P4|STARTED|Week 3||14
159120|NCT00455650|389511|P3|STARTED|Week 3||10
159121|NCT00455650|389512|P2|STARTED|Week 3||10
159122|NCT00455650|389513|P1|STARTED|Week 3||10
159123|NCT00455650|389508|P6|NOT COMPLETED|Week 2||0
159124|NCT00455650|389509|P5|NOT COMPLETED|Week 2||0
159125|NCT00455650|389510|P4|NOT COMPLETED|Week 2||0
159126|NCT00455650|389511|P3|NOT COMPLETED|Week 2||0
159127|NCT00455650|389512|P2|NOT COMPLETED|Week 2||0
159128|NCT00455650|389513|P1|NOT COMPLETED|Week 2||0
159129|NCT00455650|389508|P6|COMPLETED|Week 2||13
159130|NCT00455650|389509|P5|COMPLETED|Week 2||14
159131|NCT00455650|389510|P4|COMPLETED|Week 2||14
159132|NCT00455650|389511|P3|COMPLETED|Week 2||10
159133|NCT00455650|389512|P2|COMPLETED|Week 2||10
159134|NCT00455650|389513|P1|COMPLETED|Week 2||10
159135|NCT00455650|389508|P6|STARTED|Week 2||13
159136|NCT00455650|389509|P5|STARTED|Week 2||14
159137|NCT00455650|389510|P4|STARTED|Week 2||14
159138|NCT00455650|389511|P3|STARTED|Week 2||10
159139|NCT00455650|389512|P2|STARTED|Week 2||10
159140|NCT00455650|389513|P1|STARTED|Week 2||10
159141|NCT00455650|389508|P6|NOT COMPLETED|Week 1||0
159142|NCT00455650|389509|P5|NOT COMPLETED|Week 1||0
159143|NCT00455650|389510|P4|NOT COMPLETED|Week 1||0
159144|NCT00455650|389511|P3|NOT COMPLETED|Week 1||0
159145|NCT00455650|389512|P2|NOT COMPLETED|Week 1||0
159146|NCT00455650|389513|P1|NOT COMPLETED|Week 1||0
159147|NCT00455650|389508|P6|COMPLETED|Week 1||13
159148|NCT00455650|389509|P5|COMPLETED|Week 1||14
159149|NCT00455650|389510|P4|COMPLETED|Week 1||14
159150|NCT00455650|389511|P3|COMPLETED|Week 1||10
159151|NCT00455650|389512|P2|COMPLETED|Week 1||10
159152|NCT00455650|389513|P1|COMPLETED|Week 1||10
159153|NCT00455650|389508|P6|STARTED|Week 1||13
159154|NCT00455650|389509|P5|STARTED|Week 1||14
159155|NCT00455650|389510|P4|STARTED|Week 1||14
159156|NCT00455650|389511|P3|STARTED|Week 1||10
159157|NCT00455650|389512|P2|STARTED|Week 1||10
159158|NCT00455650|389513|P1|STARTED|Week 1||10
159159|NCT00455663|389544|P3|NOT COMPLETED|Overall Study||3
159160|NCT00455663|389545|P2|NOT COMPLETED|Overall Study||4
159161|NCT00455663|389546|P1|NOT COMPLETED|Overall Study||3
159162|NCT00455663|389544|P3|COMPLETED|Overall Study||29
159163|NCT00455663|389545|P2|COMPLETED|Overall Study||32
159164|NCT00455663|389546|P1|COMPLETED|Overall Study||34
159165|NCT00455663|389544|P3|STARTED|Overall Study||32
159166|NCT00455663|389545|P2|STARTED|Overall Study||36
159167|NCT00455663|389546|P1|STARTED|Overall Study||37
159168|NCT00455702|389565|P2|NOT COMPLETED|Overall Study||3
159169|NCT00455702|389566|P1|NOT COMPLETED|Overall Study||3
159170|NCT00455702|389565|P2|COMPLETED|Overall Study||16
159171|NCT00455702|389566|P1|COMPLETED|Overall Study||16
159172|NCT00455702|389565|P2|STARTED|Overall Study||19
159173|NCT00455702|389566|P1|STARTED|Overall Study||19
159174|NCT00455858|389574|P1|NOT COMPLETED|Overall Study||6
159175|NCT00455858|389574|P1|COMPLETED|Overall Study||81
159176|NCT00455858|389574|P1|STARTED|Overall Study|Enrolled in study and exposed to study drug|87
159177|NCT00455962|389584|P2|NOT COMPLETED|Overall Study||0
159178|NCT00455962|389585|P1|NOT COMPLETED|Overall Study||0
159179|NCT00455962|389584|P2|COMPLETED|Overall Study||13
159180|NCT00455962|389585|P1|COMPLETED|Overall Study||10
159181|NCT00455962|389584|P2|STARTED|Overall Study||13
159182|NCT00455962|389585|P1|STARTED|Overall Study||10
159183|NCT00455975|389593|P2|NOT COMPLETED|Overall Study||21
159184|NCT00455975|389594|P1|NOT COMPLETED|Overall Study||18
159185|NCT00455975|389593|P2|COMPLETED|Overall Study||40
159186|NCT00455975|389594|P1|COMPLETED|Overall Study||40
159187|NCT00455975|389593|P2|STARTED|Overall Study||61
159188|NCT00455975|389594|P1|STARTED|Overall Study||58
159189|NCT00456014|389606|P1|NOT COMPLETED|Tricyclic Phase||3
159190|NCT00456014|389606|P1|COMPLETED|Tricyclic Phase||1
159191|NCT00456014|389606|P1|STARTED|Tricyclic Phase|Only non-remitters from phase 1 were eligible for phase 2, and not all those eligible continued.|4
159192|NCT00456014|389606|P1|NOT COMPLETED|SSRI Phase||9
159193|NCT00456014|389606|P1|COMPLETED|SSRI Phase||28
159194|NCT00456014|389606|P1|STARTED|SSRI Phase||37
159195|NCT00456261|389614|P2|NOT COMPLETED|Maintenance Therapy||0
159196|NCT00456261|389615|P1|NOT COMPLETED|Maintenance Therapy||0
159197|NCT00456261|389614|P2|COMPLETED|Maintenance Therapy||29
159198|NCT00456261|389615|P1|COMPLETED|Maintenance Therapy||3
159199|NCT00456261|389614|P2|STARTED|Maintenance Therapy||29
159200|NCT00456261|389615|P1|STARTED|Maintenance Therapy||3
159201|NCT00456261|389614|P2|NOT COMPLETED|Combination Therapy||26
159202|NCT00456261|389615|P1|NOT COMPLETED|Combination Therapy||52
159203|NCT00456261|389614|P2|COMPLETED|Combination Therapy||29
159204|NCT00456261|389615|P1|COMPLETED|Combination Therapy||3
159205|NCT00456261|389614|P2|STARTED|Combination Therapy||55
159206|NCT00456261|389615|P1|STARTED|Combination Therapy||55
159207|NCT00456495|389625|P1|NOT COMPLETED|Overall Study||2
159208|NCT00456495|389625|P1|COMPLETED|Overall Study||3
159209|NCT00456495|389625|P1|STARTED|Overall Study||5
159210|NCT00456508|389630|P1|NOT COMPLETED|Overall Study||0
159211|NCT00456508|389630|P1|COMPLETED|Overall Study||147
159212|NCT00456508|389630|P1|STARTED|Overall Study||147
159213|NCT00456521|389638|P2|NOT COMPLETED|Overall Study||84
159214|NCT00456521|389639|P1|NOT COMPLETED|Overall Study||249
159215|NCT00456521|389638|P2|COMPLETED|Overall Study||118
159216|NCT00456521|389639|P1|COMPLETED|Overall Study||342
159217|NCT00456521|389638|P2|STARTED|Overall Study||202
159218|NCT00456521|389639|P1|STARTED|Overall Study||591
159219|NCT00456547|389681|P2|NOT COMPLETED|Overall Study||0
159220|NCT00456547|389682|P1|NOT COMPLETED|Overall Study||0
159221|NCT00456547|389681|P2|COMPLETED|Overall Study||12
159222|NCT00456547|389682|P1|COMPLETED|Overall Study||12
159223|NCT00456547|389681|P2|STARTED|Overall Study||12
159224|NCT00456547|389682|P1|STARTED|Overall Study||12
159225|NCT00456599|389694|P1|NOT COMPLETED|Overall Study||3
159226|NCT00456599|389694|P1|COMPLETED|Overall Study||68
159227|NCT00456599|389694|P1|Completed 4th Cycle of Chemotherapy|Overall Study|24 patients (63%) completed a fourth cycle of chemotherapy.|24
159228|NCT00456599|389694|P1|Post-Surgery Adjuvent Therapy|Overall Study|After resection, 26 patients (68%) initiated adjuvant therapy.|26
159229|NCT00456599|389694|P1|Completed Resection|Overall Study|43 patients underwent resection.|43
159230|NCT00456599|389694|P1|Completed Protocol Surgery|Overall Study|Forty-eight patients (71%) underwent laparotomy according to the protocol.|48
159231|NCT00456599|389694|P1|Initiated Cycle 2|Overall Study|5 patients were removed from study prior to initiation of a second cycle.|61
159232|NCT00456599|389694|P1|Completed Cycle 1|Overall Study|Of the 71 patients, 1 was removed for noncompliance; 2 withdrew; 2 did not complete cycle 1.|66
159233|NCT00456599|389694|P1|STARTED|Overall Study||71
159234|NCT00456612|389700|P1|NOT COMPLETED|Overall Study||3
159235|NCT00456612|389700|P1|COMPLETED|Overall Study||1
159236|NCT00456612|389700|P1|STARTED|Overall Study||4
159237|NCT00456625|389705|P1|NOT COMPLETED|Overall Study||0
159238|NCT00456625|389705|P1|COMPLETED|Overall Study||76
159239|NCT00456625|389705|P1|STARTED|Overall Study||76
159240|NCT00456755|389713|P2|NOT COMPLETED|Overall Study||1
159241|NCT00456755|389714|P1|NOT COMPLETED|Overall Study||2
159242|NCT00456755|389713|P2|COMPLETED|Overall Study||62
159243|NCT00456755|389714|P1|COMPLETED|Overall Study||61
159244|NCT00456755|389713|P2|STARTED|Overall Study||63
159245|NCT00456755|389714|P1|STARTED|Overall Study||63
159246|NCT00456807|389724|P2|NOT COMPLETED|Overall Study||0
159247|NCT00456807|389725|P1|NOT COMPLETED|Overall Study||1
159248|NCT00456807|389724|P2|COMPLETED|Overall Study||47
159249|NCT00456807|389725|P1|COMPLETED|Overall Study||52
159250|NCT00456807|389724|P2|STARTED|Overall Study||47
159251|NCT00456807|389725|P1|STARTED|Overall Study||53
159252|NCT00456846|389743|P2|NOT COMPLETED|Overall Study||28
159253|NCT00456846|389744|P1|NOT COMPLETED|Overall Study||16
159254|NCT00456846|389743|P2|COMPLETED|Overall Study|Treatment considered completed upon disease progression|48
159349|NCT00450723|390064|P1|STARTED|Overall Study||39
159255|NCT00456846|389744|P1|COMPLETED|Overall Study|Treatment considered completed upon disease progression|31
159256|NCT00456846|389743|P2|STARTED|Overall Study||76
159257|NCT00456846|389744|P1|STARTED|Overall Study||47
159258|NCT00456989|389764|P1|NOT COMPLETED|Overall Study||0
159259|NCT00456989|389764|P1|COMPLETED|Overall Study||39
159260|NCT00456989|389764|P1|STARTED|Overall Study||39
159261|NCT00457002|389770|P2|NOT COMPLETED|Overall Study||757
159262|NCT00457002|389771|P1|NOT COMPLETED|Overall Study||813
159263|NCT00457002|389770|P2|COMPLETED|Overall Study||2516
159264|NCT00457002|389771|P1|COMPLETED|Overall Study||2442
159265|NCT00457002|389770|P2|STARTED|Overall Study||3273
159266|NCT00457002|389771|P1|STARTED|Overall Study||3255
159267|NCT00457015|389841|P2|NOT COMPLETED|Overall Study||1
159268|NCT00457015|389842|P1|NOT COMPLETED|Overall Study||0
159269|NCT00457015|389841|P2|COMPLETED|Overall Study||47
159270|NCT00457015|389842|P1|COMPLETED|Overall Study||48
159271|NCT00457015|389841|P2|STARTED|Overall Study||48
159272|NCT00457015|389842|P1|STARTED|Overall Study||48
159273|NCT00457197|389858|P2|NOT COMPLETED|Overall Study||1
159274|NCT00457197|389859|P1|NOT COMPLETED|Overall Study||1
159275|NCT00457197|389858|P2|COMPLETED|Overall Study||44
159276|NCT00457197|389859|P1|COMPLETED|Overall Study||44
159277|NCT00457197|389858|P2|STARTED|Overall Study||45
159278|NCT00457197|389859|P1|STARTED|Overall Study||45
159279|NCT00457249|389883|P2|NOT COMPLETED|Overall Study||2
159280|NCT00457249|389884|P1|NOT COMPLETED|Overall Study||12
159281|NCT00457249|389883|P2|COMPLETED|Overall Study||389
159282|NCT00457249|389884|P1|COMPLETED|Overall Study||1158
159283|NCT00457249|389883|P2|STARTED|Overall Study||391
159284|NCT00457249|389884|P1|STARTED|Overall Study||1170
159285|NCT00457301|389898|P2|NOT COMPLETED|Overall Study||24
159286|NCT00457301|389899|P1|NOT COMPLETED|Overall Study||23
159287|NCT00457301|389898|P2|COMPLETED|Overall Study||84
159288|NCT00457301|389899|P1|COMPLETED|Overall Study||82
159289|NCT00457301|389898|P2|STARTED|Overall Study||108
159290|NCT00457301|389899|P1|STARTED|Overall Study||105
159291|NCT00457392|389913|P2|NOT COMPLETED|Overall Study||480
159292|NCT00457392|389914|P1|NOT COMPLETED|Overall Study||480
159293|NCT00457392|389913|P2|COMPLETED|Overall Study||0
159294|NCT00457392|389914|P1|COMPLETED|Overall Study||0
159295|NCT00457392|389913|P2|Treated|Overall Study||477
159296|NCT00457392|389914|P1|Treated|Overall Study||473
159297|NCT00457392|389913|P2|STARTED|Overall Study||480
159298|NCT00457392|389914|P1|STARTED|Overall Study||480
159299|NCT00457418|389930|P1|NOT COMPLETED|Post PK Maintenance||28
159300|NCT00457418|389930|P1|COMPLETED|Post PK Maintenance||3
159301|NCT00457418|389930|P1|STARTED|Post PK Maintenance|4 participants didn't complete the PK sampling phase but continued to post PK maintenance treatment.|31
159302|NCT00457418|389930|P1|NOT COMPLETED|Pharmacokinetic (PK) Sampling Phase||5
159303|NCT00457418|389930|P1|COMPLETED|Pharmacokinetic (PK) Sampling Phase||27
159304|NCT00457418|389930|P1|STARTED|Pharmacokinetic (PK) Sampling Phase||32
159305|NCT00450424|389942|P2|NOT COMPLETED|Overall Study||11
159306|NCT00450424|389943|P1|NOT COMPLETED|Overall Study||20
159307|NCT00450424|389942|P2|COMPLETED|Overall Study||106
159308|NCT00450424|389943|P1|COMPLETED|Overall Study||102
159309|NCT00450424|389942|P2|STARTED|Overall Study||117
159310|NCT00450424|389943|P1|STARTED|Overall Study||122
159311|NCT00450437|389951|P4|NOT COMPLETED|Overall Study||11
159312|NCT00450437|389952|P3|NOT COMPLETED|Overall Study||24
159313|NCT00450437|389953|P2|NOT COMPLETED|Overall Study||16
159314|NCT00450437|389954|P1|NOT COMPLETED|Overall Study||46
159315|NCT00450437|389951|P4|COMPLETED|Overall Study||325
159316|NCT00450437|389952|P3|COMPLETED|Overall Study||999
159317|NCT00450437|389953|P2|COMPLETED|Overall Study||524
159318|NCT00450437|389954|P1|COMPLETED|Overall Study||1594
159319|NCT00450437|389951|P4|STARTED|Overall Study||336
159320|NCT00450437|389952|P3|STARTED|Overall Study||1023
159321|NCT00450437|389953|P2|STARTED|Overall Study||540
159322|NCT00450437|389954|P1|STARTED|Overall Study||1640
159323|NCT00450450|389978|P2|NOT COMPLETED|Overall Study||3
159324|NCT00450450|389979|P1|NOT COMPLETED|Overall Study||5
159325|NCT00450450|389978|P2|COMPLETED|Overall Study||11
159326|NCT00450450|389979|P1|COMPLETED|Overall Study||8
159327|NCT00450450|389978|P2|STARTED|Overall Study||14
159328|NCT00450450|389979|P1|STARTED|Overall Study||13
159329|NCT00450580|390003|P2|NOT COMPLETED|Overall Study||16
159330|NCT00450580|390004|P1|NOT COMPLETED|Overall Study||16
159331|NCT00450580|390003|P2|COMPLETED|Overall Study||90
159332|NCT00450580|390004|P1|COMPLETED|Overall Study||90
159333|NCT00450580|390003|P2|STARTED|Overall Study||106
159334|NCT00450580|390004|P1|STARTED|Overall Study||106
159335|NCT00450619|390024|P2|NOT COMPLETED|Overall Study||1
159336|NCT00450619|390025|P1|NOT COMPLETED|Overall Study||4
159337|NCT00450619|390024|P2|COMPLETED|Overall Study||21
159338|NCT00450619|390025|P1|COMPLETED|Overall Study||18
159339|NCT00450619|390024|P2|STARTED|Overall Study||22
159340|NCT00450619|390025|P1|STARTED|Overall Study||22
159341|NCT00450658|390051|P2|NOT COMPLETED|Overall Study||90
159342|NCT00450658|390052|P1|NOT COMPLETED|Overall Study||143
159343|NCT00450658|390051|P2|COMPLETED|Overall Study||122
159344|NCT00450658|390052|P1|COMPLETED|Overall Study||272
159345|NCT00450658|390051|P2|STARTED|Overall Study||212
159346|NCT00450658|390052|P1|STARTED|Overall Study||415
159347|NCT00450723|390064|P1|NOT COMPLETED|Overall Study||5
159348|NCT00450723|390064|P1|COMPLETED|Overall Study||34
159350|NCT00450749|390073|P3|NOT COMPLETED|Overall Study||2
159351|NCT00450749|390074|P2|NOT COMPLETED|Overall Study||1
159352|NCT00450749|390075|P1|NOT COMPLETED|Overall Study||0
159353|NCT00450749|390073|P3|COMPLETED|Overall Study||2
159354|NCT00450749|390074|P2|COMPLETED|Overall Study||2
159355|NCT00450749|390075|P1|COMPLETED|Overall Study||3
159356|NCT00450749|390073|P3|STARTED|Overall Study||4
159357|NCT00450749|390074|P2|STARTED|Overall Study||3
159358|NCT00450749|390075|P1|STARTED|Overall Study||3
159359|NCT00450801|390083|P1|NOT COMPLETED|Overall Study||1
159360|NCT00450801|390083|P1|COMPLETED|Overall Study||21
159361|NCT00450801|390083|P1|STARTED|Overall Study||22
159362|NCT00450866|390094|P2|NOT COMPLETED|Overall Study||3
159363|NCT00450866|390095|P1|NOT COMPLETED|Overall Study||7
159364|NCT00450866|390094|P2|COMPLETED|Overall Study||7
159365|NCT00450866|390095|P1|COMPLETED|Overall Study||38
159366|NCT00450866|390094|P2|STARTED|Overall Study||10
159367|NCT00450866|390095|P1|STARTED|Overall Study||45
159368|NCT00450983|390105|P1|NOT COMPLETED|Overall Study||0
159369|NCT00450983|390105|P1|COMPLETED|Overall Study||1
159370|NCT00450983|390105|P1|STARTED|Overall Study||1
159371|NCT00451048|390117|P1|NOT COMPLETED|Overall Study||0
159372|NCT00451048|390117|P1|COMPLETED|Overall Study||10
159373|NCT00451048|390117|P1|STARTED|Overall Study||10
159374|NCT00451191|390123|P2|NOT COMPLETED|Overall Study||11
159375|NCT00451191|390124|P1|NOT COMPLETED|Overall Study||15
159376|NCT00451191|390123|P2|COMPLETED|Overall Study||55
159377|NCT00451191|390124|P1|COMPLETED|Overall Study||53
159378|NCT00451191|390123|P2|STARTED|Overall Study||66
159379|NCT00451191|390124|P1|STARTED|Overall Study||68
159380|NCT00451204|390132|P2|NOT COMPLETED|Overall Study||20
159381|NCT00451204|390133|P1|NOT COMPLETED|Overall Study||22
159382|NCT00451204|390132|P2|COMPLETED|Overall Study||56
159383|NCT00451204|390133|P1|COMPLETED|Overall Study|60 completed the study but 3 stopped study drug(s) early|60
159384|NCT00451204|390132|P2|STARTED|Overall Study||76
159385|NCT00451204|390133|P1|STARTED|Overall Study||82
159386|NCT00451282|390151|P2|NOT COMPLETED|Overall Study||5
159387|NCT00451282|390152|P1|NOT COMPLETED|Overall Study||6
159388|NCT00451282|390151|P2|COMPLETED|Overall Study||34
159389|NCT00451282|390152|P1|COMPLETED|Overall Study||40
159390|NCT00451282|390151|P2|STARTED|Overall Study||39
159391|NCT00451282|390152|P1|STARTED|Overall Study||46
159392|NCT00451451|390168|P4|NOT COMPLETED|Overall Study||58
159393|NCT00451451|390169|P3|NOT COMPLETED|Overall Study||72
159394|NCT00451451|390170|P2|NOT COMPLETED|Overall Study||75
159395|NCT00451451|390171|P1|NOT COMPLETED|Overall Study||85
159396|NCT00451451|390168|P4|COMPLETED|Overall Study||292
159397|NCT00451451|390169|P3|COMPLETED|Overall Study||273
159398|NCT00451451|390170|P2|COMPLETED|Overall Study||284
159399|NCT00451451|390171|P1|COMPLETED|Overall Study||278
159400|NCT00451451|390168|P4|STARTED|Overall Study|350 participants were dosed; 360 participants were randomized|350
159401|NCT00451451|390169|P3|STARTED|Overall Study|345 participants were dosed; 345 participants were randomized|345
159402|NCT00451451|390170|P2|STARTED|Overall Study|359 participants were dosed; 362 participants were randomized|359
159403|NCT00451451|390171|P1|STARTED|Overall Study|363 participants were dosed; 363 participants were randomized|363
159404|NCT00451698|390200|P2|NOT COMPLETED|Overall Study||0
159405|NCT00451698|390201|P1|NOT COMPLETED|Overall Study||0
159406|NCT00451698|390200|P2|COMPLETED|Overall Study||6
159407|NCT00451698|390201|P1|COMPLETED|Overall Study||3
159408|NCT00451698|390200|P2|STARTED|Overall Study||6
159409|NCT00451698|390201|P1|STARTED|Overall Study||3
159410|NCT00451906|390209|P1|NOT COMPLETED|Overall Study||2239
159411|NCT00451906|390209|P1|COMPLETED|Overall Study||13
159412|NCT00451906|390209|P1|STARTED|Overall Study||2252
159413|NCT00451958|390221|P5|NOT COMPLETED|CS21A (NCT00451958)||0
159414|NCT00451958|390222|P4|NOT COMPLETED|CS21A (NCT00451958)||39
159415|NCT00451958|390223|P3|NOT COMPLETED|CS21A (NCT00451958)||42
159416|NCT00451958|390224|P2|NOT COMPLETED|CS21A (NCT00451958)||77
159417|NCT00451958|390225|P1|NOT COMPLETED|CS21A (NCT00451958)||65
159418|NCT00451958|390221|P5|COMPLETED|CS21A (NCT00451958)||0
159419|NCT00451958|390222|P4|COMPLETED|CS21A (NCT00451958)||27
159420|NCT00451958|390223|P3|COMPLETED|CS21A (NCT00451958)||27
159421|NCT00451958|390224|P2|COMPLETED|CS21A (NCT00451958)||49
159422|NCT00451958|390225|P1|COMPLETED|CS21A (NCT00451958)||60
159423|NCT00451958|390221|P5|STARTED|CS21A (NCT00451958)|Participants were switched to the degarelix groups when CS21 was completed.|0
159424|NCT00451958|390222|P4|STARTED|CS21A (NCT00451958)|One of the enrolled participants never received any treatment, i.e. the CS21A ITT population=65.|66
159425|NCT00451958|390223|P3|STARTED|CS21A (NCT00451958)|CS21A ITT population.|69
159426|NCT00451958|390224|P2|STARTED|CS21A (NCT00451958)|CS21A ITT population.|126
159427|NCT00451958|390225|P1|STARTED|CS21A (NCT00451958)|CS21A intention-to-treat (ITT) population.|125
159428|NCT00451958|390221|P5|NOT COMPLETED|CS21 (NCT00295750)||32
159429|NCT00451958|390222|P4|NOT COMPLETED|CS21 (NCT00295750)||0
159430|NCT00451958|390223|P3|NOT COMPLETED|CS21 (NCT00295750)||0
159431|NCT00451958|390224|P2|NOT COMPLETED|CS21 (NCT00295750)||43
159432|NCT00451958|390225|P1|NOT COMPLETED|CS21 (NCT00295750)||41
159433|NCT00451958|390221|P5|COMPLETED|CS21 (NCT00295750)||172
159434|NCT00451958|390222|P4|COMPLETED|CS21 (NCT00295750)||0
159435|NCT00451958|390223|P3|COMPLETED|CS21 (NCT00295750)||0
159436|NCT00451958|390224|P2|COMPLETED|CS21 (NCT00295750)||163
159437|NCT00451958|390225|P1|COMPLETED|CS21 (NCT00295750)||169
159438|NCT00451958|390221|P5|STARTED|CS21 (NCT00295750)||204
159439|NCT00451958|390222|P4|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
159440|NCT00451958|390223|P3|STARTED|CS21 (NCT00295750)|Participants were switched from the leuprolide 7.5 mg group when CS21 was completed.|0
159441|NCT00451958|390224|P2|STARTED|CS21 (NCT00295750)|CS21 ITT population.|206
159442|NCT00451958|390225|P1|STARTED|CS21 (NCT00295750)|CS21 intention-to-treat (ITT) population.|210
159443|NCT00457691|390257|P2|NOT COMPLETED|Overall Study||382
159444|NCT00457691|390258|P1|NOT COMPLETED|Overall Study||386
159445|NCT00457691|390257|P2|COMPLETED|Overall Study||0
159446|NCT00457691|390258|P1|COMPLETED|Overall Study||0
159447|NCT00457691|390257|P2|STARTED|Overall Study||382
159448|NCT00457691|390258|P1|STARTED|Overall Study||386
159449|NCT00457730|390280|P2|NOT COMPLETED|Overall Study||1
159450|NCT00457730|390281|P1|NOT COMPLETED|Overall Study||4
159451|NCT00457730|390280|P2|COMPLETED|Overall Study||19
159452|NCT00457730|390281|P1|COMPLETED|Overall Study||14
159453|NCT00457730|390280|P2|STARTED|Overall Study||20
159454|NCT00457730|390281|P1|STARTED|Overall Study||18
159455|NCT00457743|390294|P3|NOT COMPLETED|Overall Study||3
159456|NCT00457743|390295|P2|NOT COMPLETED|Overall Study||27
159457|NCT00457743|390296|P1|NOT COMPLETED|Overall Study||3
159458|NCT00457743|390294|P3|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis(Intent-to treat population).|0
159459|NCT00457743|390295|P2|COMPLETED|Overall Study|However, all 30 subjects enrolled were included in analysis(Intent-to treat population).|3
159460|NCT00457743|390296|P1|COMPLETED|Overall Study|However, all 3 subjects enrolled were included in analysis (Intent-to treat population).|0
159461|NCT00457743|390294|P3|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
159462|NCT00457743|390295|P2|Enrolled in Phase 2|Overall Study|Six subjects who completed Phase 1 entered Phase 2, and 24 subjects were newly enrolled.|30
159463|NCT00457743|390296|P1|Enrolled in Phase 2|Overall Study|Three subjects who completed Phase 1 entered Phase 2.|3
159464|NCT00457743|390294|P3|Completed Phase 1|Overall Study||3
159465|NCT00457743|390295|P2|Completed Phase 1|Overall Study||6
159466|NCT00457743|390296|P1|Completed Phase 1|Overall Study||3
159467|NCT00457743|390294|P3|Enrolled in Phase 1|Overall Study||3
159468|NCT00457743|390295|P2|Enrolled in Phase 1|Overall Study||6
159469|NCT00457743|390296|P1|Enrolled in Phase 1|Overall Study||3
159470|NCT00457743|390294|P3|STARTED|Overall Study|Overall study|3
159471|NCT00457743|390295|P2|STARTED|Overall Study|Overall study|30
159472|NCT00457743|390296|P1|STARTED|Overall Study|Overall study|3
159473|NCT00457795|390338|P1|NOT COMPLETED|Overall Study||0
159474|NCT00457795|390338|P1|COMPLETED|Overall Study||15
159475|NCT00457795|390338|P1|STARTED|Overall Study||15
159476|NCT00457821|390353|P8|NOT COMPLETED|Part 2||1
159477|NCT00457821|390354|P7|NOT COMPLETED|Part 2||0
159478|NCT00457821|390355|P6|NOT COMPLETED|Part 2||0
159479|NCT00457821|390356|P5|NOT COMPLETED|Part 2||0
159480|NCT00457821|390357|P4|NOT COMPLETED|Part 2||0
159481|NCT00457821|390358|P3|NOT COMPLETED|Part 2||0
159482|NCT00457821|390359|P2|NOT COMPLETED|Part 2||0
159483|NCT00457821|390360|P1|NOT COMPLETED|Part 2||0
159484|NCT00457821|390353|P8|COMPLETED|Part 2||4
159485|NCT00457821|390354|P7|COMPLETED|Part 2||7
159486|NCT00457821|390355|P6|COMPLETED|Part 2||8
159487|NCT00457821|390356|P5|COMPLETED|Part 2||0
159488|NCT00457821|390357|P4|COMPLETED|Part 2||0
159489|NCT00457821|390358|P3|COMPLETED|Part 2||0
159490|NCT00457821|390359|P2|COMPLETED|Part 2||0
159491|NCT00457821|390360|P1|COMPLETED|Part 2||0
159492|NCT00457821|390353|P8|Completed Study Drug Treatment|Part 2||4
159493|NCT00457821|390354|P7|Completed Study Drug Treatment|Part 2|1 subject missed a 250-mg dose of ivacaftor on Day 28 of Part 2.|7
159494|NCT00457821|390355|P6|Completed Study Drug Treatment|Part 2||8
159495|NCT00457821|390356|P5|Completed Study Drug Treatment|Part 2||0
159496|NCT00457821|390357|P4|Completed Study Drug Treatment|Part 2||0
159497|NCT00457821|390358|P3|Completed Study Drug Treatment|Part 2||0
159498|NCT00457821|390359|P2|Completed Study Drug Treatment|Part 2||0
159499|NCT00457821|390360|P1|Completed Study Drug Treatment|Part 2||0
159500|NCT00457821|390353|P8|STARTED|Part 2|All subjects who received at least 1 dose of study drug (placebo).|5
159501|NCT00457821|390354|P7|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|7
159502|NCT00457821|390355|P6|STARTED|Part 2|All subjects who received at least 1 dose of study drug (ivacaftor).|8
159503|NCT00457821|390356|P5|STARTED|Part 2|Arm in Part 1 only|0
159504|NCT00457821|390357|P4|STARTED|Part 2|Arm in Part 1 only|0
159505|NCT00457821|390358|P3|STARTED|Part 2|Arm in Part 1 only|0
159506|NCT00457821|390359|P2|STARTED|Part 2|Arm in Part 1 only|0
159507|NCT00457821|390360|P1|STARTED|Part 2|Arm in Part 1 only|0
159508|NCT00457821|390353|P8|NOT COMPLETED|Part 1||0
159509|NCT00457821|390354|P7|NOT COMPLETED|Part 1||0
159510|NCT00457821|390355|P6|NOT COMPLETED|Part 1||0
159511|NCT00457821|390356|P5|NOT COMPLETED|Part 1||0
159512|NCT00457821|390357|P4|NOT COMPLETED|Part 1||0
159513|NCT00457821|390358|P3|NOT COMPLETED|Part 1||1
159514|NCT00457821|390359|P2|NOT COMPLETED|Part 1||0
159515|NCT00457821|390360|P1|NOT COMPLETED|Part 1||0
159516|NCT00457821|390353|P8|COMPLETED|Part 1||0
159517|NCT00457821|390354|P7|COMPLETED|Part 1||0
159518|NCT00457821|390355|P6|COMPLETED|Part 1||0
159519|NCT00457821|390356|P5|COMPLETED|Part 1||4
159520|NCT00457821|390357|P4|COMPLETED|Part 1||4
159521|NCT00457821|390358|P3|COMPLETED|Part 1||4
159522|NCT00457821|390359|P2|COMPLETED|Part 1||4
159523|NCT00457821|390360|P1|COMPLETED|Part 1||4
159524|NCT00457821|390353|P8|STARTED|Part 1|Arm in Part 2 only|0
159525|NCT00457821|390354|P7|STARTED|Part 1|Arm in Part 2 only|0
159526|NCT00457821|390355|P6|STARTED|Part 1|Arm in Part 2 only|0
159527|NCT00457821|390356|P5|STARTED|Part 1|Number of subjects randomized|4
159528|NCT00457821|390357|P4|STARTED|Part 1|Number of subjects randomized|4
159529|NCT00457821|390358|P3|STARTED|Part 1|Number of subjects randomized|5
159530|NCT00457821|390359|P2|STARTED|Part 1|Number of subjects randomized|4
159531|NCT00457821|390360|P1|STARTED|Part 1|Number of subjects randomized|4
159532|NCT00458705|390389|P1|NOT COMPLETED|Overall Study||5
159533|NCT00458705|390389|P1|COMPLETED|Overall Study||40
159534|NCT00458705|390389|P1|STARTED|Overall Study||45
159535|NCT00458822|390393|P1|NOT COMPLETED|Overall Study||0
159536|NCT00458822|390393|P1|COMPLETED|Overall Study||40
159537|NCT00458822|390393|P1|STARTED|Overall Study||40
159538|NCT00458952|390399|P2|NOT COMPLETED|Overall Study||5
159539|NCT00458952|390400|P1|NOT COMPLETED|Overall Study||2
159540|NCT00458952|390399|P2|COMPLETED|Overall Study||9
159541|NCT00458952|390400|P1|COMPLETED|Overall Study||5
159542|NCT00458952|390399|P2|STARTED|Overall Study||14
159543|NCT00458952|390400|P1|STARTED|Overall Study||7
159544|NCT00459043|390406|P2|NOT COMPLETED|Overall Study||0
159545|NCT00459043|390407|P1|NOT COMPLETED|Overall Study||1
159546|NCT00459043|390406|P2|COMPLETED|Overall Study||15
159547|NCT00459043|390407|P1|COMPLETED|Overall Study||14
159548|NCT00459043|390406|P2|STARTED|Overall Study||15
159549|NCT00459043|390407|P1|STARTED|Overall Study||15
159550|NCT00459056|390419|P2|NOT COMPLETED|Second Intervention (Final Three Months)||0
159551|NCT00459056|390420|P1|NOT COMPLETED|Second Intervention (Final Three Months)||0
159552|NCT00459056|390419|P2|COMPLETED|Second Intervention (Final Three Months)||14
159553|NCT00459056|390420|P1|COMPLETED|Second Intervention (Final Three Months)||9
159554|NCT00459056|390419|P2|STARTED|Second Intervention (Final Three Months)||14
159555|NCT00459056|390420|P1|STARTED|Second Intervention (Final Three Months)||9
159556|NCT00459056|390419|P2|NOT COMPLETED|Washout (1 Month)||0
159557|NCT00459056|390420|P1|NOT COMPLETED|Washout (1 Month)||0
159558|NCT00459056|390419|P2|COMPLETED|Washout (1 Month)||14
159559|NCT00459056|390420|P1|COMPLETED|Washout (1 Month)||9
159560|NCT00459056|390419|P2|STARTED|Washout (1 Month)||14
159561|NCT00459056|390420|P1|STARTED|Washout (1 Month)||9
159562|NCT00459056|390419|P2|NOT COMPLETED|First Intervention (First Three Months)||1
159650|NCT00459667|390597|P1|Study Medication Dispensed|Overall Study||586
159563|NCT00459056|390420|P1|NOT COMPLETED|First Intervention (First Three Months)||1
159564|NCT00459056|390419|P2|COMPLETED|First Intervention (First Three Months)||14
159565|NCT00459056|390420|P1|COMPLETED|First Intervention (First Three Months)||9
159566|NCT00459056|390419|P2|STARTED|First Intervention (First Three Months)||15
159567|NCT00459056|390420|P1|STARTED|First Intervention (First Three Months)||10
159568|NCT00459108|390426|P1|NOT COMPLETED|Overall Study||11
159569|NCT00459108|390426|P1|COMPLETED|Overall Study||14
159570|NCT00459108|390426|P1|STARTED|Overall Study||25
159571|NCT00459121|390431|P1|NOT COMPLETED|Overall Study||0
159572|NCT00459121|390431|P1|COMPLETED|Overall Study||2
159573|NCT00459121|390431|P1|STARTED|Overall Study||2
159574|NCT00459134|390437|P2|NOT COMPLETED|Overall Study||25
159575|NCT00459134|390438|P1|NOT COMPLETED|Overall Study||23
159576|NCT00459134|390437|P2|COMPLETED|Overall Study||67
159577|NCT00459134|390438|P1|COMPLETED|Overall Study||71
159578|NCT00459134|390437|P2|STARTED|Overall Study||92
159579|NCT00459134|390438|P1|STARTED|Overall Study||94
159580|NCT00459186|390446|P1|NOT COMPLETED|Combination RAD001 + Docetaxel||0
159581|NCT00459186|390446|P1|COMPLETED|Combination RAD001 + Docetaxel||15
159582|NCT00459186|390446|P1|STARTED|Combination RAD001 + Docetaxel||15
159583|NCT00459186|390446|P1|NOT COMPLETED|PET Imaging and Assessment||3
159584|NCT00459186|390446|P1|COMPLETED|PET Imaging and Assessment||15
159585|NCT00459186|390446|P1|STARTED|PET Imaging and Assessment||18
159586|NCT00459186|390446|P1|NOT COMPLETED|Single Agent RAD001||1
159587|NCT00459186|390446|P1|COMPLETED|Single Agent RAD001||18
159588|NCT00459186|390446|P1|STARTED|Single Agent RAD001||19
159589|NCT00459290|390451|P1|NOT COMPLETED|Overall Study||5
159590|NCT00459290|390451|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|19
159591|NCT00459290|390451|P1|STARTED|Overall Study||24
159592|NCT00459303|390465|P1|NOT COMPLETED|Overall Study||0
159593|NCT00459303|390465|P1|COMPLETED|Overall Study||20
159594|NCT00459303|390465|P1|STARTED|Overall Study||20
159595|NCT00459316|390480|P3|NOT COMPLETED|Step 3||1
159596|NCT00459316|390481|P2|NOT COMPLETED|Step 3||0
159597|NCT00459316|390482|P1|NOT COMPLETED|Step 3||3
159598|NCT00459316|390480|P3|COMPLETED|Step 3||39
159599|NCT00459316|390481|P2|COMPLETED|Step 3||0
159600|NCT00459316|390482|P1|COMPLETED|Step 3||149
159601|NCT00459316|390480|P3|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|40
159602|NCT00459316|390481|P2|STARTED|Step 3|Group 2 participants were not eligible for Step 3|0
159603|NCT00459316|390482|P1|STARTED|Step 3|Not all participants from Steps 1/2 were eligible for Step 3|152
159604|NCT00459316|390480|P3|NOT COMPLETED|Steps 1 & 2||2
159605|NCT00459316|390481|P2|NOT COMPLETED|Steps 1 & 2||7
159606|NCT00459316|390482|P1|NOT COMPLETED|Steps 1 & 2||21
159607|NCT00459316|390480|P3|COMPLETED|Steps 1 & 2||57
159608|NCT00459316|390481|P2|COMPLETED|Steps 1 & 2||32
159609|NCT00459316|390482|P1|COMPLETED|Steps 1 & 2||259
159610|NCT00459316|390480|P3|STARTED|Steps 1 & 2||59
159611|NCT00459316|390481|P2|STARTED|Steps 1 & 2||39
159612|NCT00459316|390482|P1|STARTED|Steps 1 & 2||280
159613|NCT00459342|390536|P1|NOT COMPLETED|Overall Study||1
159614|NCT00459342|390536|P1|COMPLETED|Overall Study||34
159615|NCT00459342|390536|P1|STARTED|Overall Study||35
159616|NCT00459355|390543|P2|NOT COMPLETED|Overall Study||18
159617|NCT00459355|390544|P1|NOT COMPLETED|Overall Study||20
159618|NCT00459355|390543|P2|COMPLETED|Overall Study|Includes 48 dyads, caregiver + care-recipient|96
159619|NCT00459355|390544|P1|COMPLETED|Overall Study|Includes 60 dyads, caregiver + care-recipient|120
159620|NCT00459355|390543|P2|STARTED|Overall Study|Includes 57 dyads, caregiver + care-recipient|114
159621|NCT00459355|390544|P1|STARTED|Overall Study|Includes 70 dyads, caregiver/care-recipient|140
159622|NCT00459368|390558|P2|NOT COMPLETED|Overall Study||329
159623|NCT00459368|390559|P1|NOT COMPLETED|Overall Study||295
159624|NCT00459368|390558|P2|COMPLETED|Overall Study||1034
159625|NCT00459368|390559|P1|COMPLETED|Overall Study||1040
159626|NCT00459368|390558|P2|STARTED|Overall Study||1363
159627|NCT00459368|390559|P1|STARTED|Overall Study||1335
159628|NCT00459381|390565|P1|NOT COMPLETED|Overall Study||0
159629|NCT00459381|390565|P1|COMPLETED|Overall Study||35
159630|NCT00459381|390565|P1|STARTED|Overall Study||35
159631|NCT00459537|390577|P2|NOT COMPLETED|Overall Study||76
159632|NCT00459537|390578|P1|NOT COMPLETED|Overall Study||66
159633|NCT00459537|390577|P2|COMPLETED|Overall Study||446
159634|NCT00459537|390578|P1|COMPLETED|Overall Study||441
159635|NCT00459537|390577|P2|Safety Population|Overall Study||512
159636|NCT00459537|390578|P1|Safety Population|Overall Study|Participants who had at least one dose of study drug and one post-baseline safety assessment.|493
159637|NCT00459537|390577|P2|STARTED|Overall Study||522
159638|NCT00459537|390578|P1|STARTED|Overall Study||507
159639|NCT00459667|390595|P3|NOT COMPLETED|Overall Study||20
159640|NCT00459667|390596|P2|NOT COMPLETED|Overall Study||47
159641|NCT00459667|390597|P1|NOT COMPLETED|Overall Study||38
159642|NCT00459667|390595|P3|COMPLETED|Overall Study||161
159643|NCT00459667|390596|P2|COMPLETED|Overall Study||600
159644|NCT00459667|390597|P1|COMPLETED|Overall Study||554
159645|NCT00459667|390595|P3|Started Treatment|Overall Study||180
159646|NCT00459667|390596|P2|Started Treatment|Overall Study||644
159647|NCT00459667|390597|P1|Started Treatment|Overall Study||586
159648|NCT00459667|390595|P3|Study Medication Dispensed|Overall Study||180
159649|NCT00459667|390596|P2|Study Medication Dispensed|Overall Study||645
159651|NCT00459667|390595|P3|STARTED|Overall Study||181
159652|NCT00459667|390596|P2|STARTED|Overall Study||647
159653|NCT00459667|390597|P1|STARTED|Overall Study||592
159654|NCT00459706|390619|P2|NOT COMPLETED|Overall Study||21
159655|NCT00459706|390620|P1|NOT COMPLETED|Overall Study||26
159656|NCT00459706|390619|P2|COMPLETED|Overall Study||294
159657|NCT00459706|390620|P1|COMPLETED|Overall Study||299
159658|NCT00459706|390619|P2|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|2 participants withdrew consent before the first injection|313
159659|NCT00459706|390620|P1|MODIFIED INTENT-TO-TREAT POPULATION|Overall Study|1 participant had no evaluation after the first injection|324
159660|NCT00459706|390619|P2|STARTED|Overall Study||315
159661|NCT00459706|390620|P1|STARTED|Overall Study||325
159662|NCT00459732|390762|P2|NOT COMPLETED|Overall Study||3
159663|NCT00459732|390763|P1|NOT COMPLETED|Overall Study||4
159664|NCT00459732|390762|P2|COMPLETED|Overall Study|3 on placebo dropped: 1 pregnant after 12 mo, 1 lost to followup, one died after 12 month timepoint|14
159665|NCT00459732|390763|P1|COMPLETED|Overall Study|4 on zn dropped: 1 pregnant and 1 nausea after baseline, 1 lost to followup, 1 exited after 12 month|19
159666|NCT00459732|390762|P2|STARTED|Overall Study||17
159667|NCT00459732|390763|P1|STARTED|Overall Study||23
159668|NCT00459810|390773|P1|NOT COMPLETED|Overall Study||0
159669|NCT00459810|390773|P1|COMPLETED|Overall Study||21
159670|NCT00459810|390773|P1|STARTED|Overall Study||21
159671|NCT00459862|390781|P1|NOT COMPLETED|Overall Study||0
159672|NCT00459862|390781|P1|COMPLETED|Overall Study||34
159673|NCT00459862|390781|P1|STARTED|Overall Study||34
159674|NCT00459875|390790|P1|NOT COMPLETED|Overall Study||3
159675|NCT00459875|390790|P1|COMPLETED|Overall Study||21
159676|NCT00459875|390790|P1|STARTED|Overall Study||24
159677|NCT00459953|390796|P2|NOT COMPLETED|Overall Study||1
159678|NCT00459953|390797|P1|NOT COMPLETED|Overall Study||1
159679|NCT00459953|390796|P2|COMPLETED|Overall Study||70
159680|NCT00459953|390797|P1|COMPLETED|Overall Study||71
159681|NCT00459953|390796|P2|STARTED|Overall Study||71
159682|NCT00459953|390797|P1|STARTED|Overall Study||72
159683|NCT00459979|390803|P1|NOT COMPLETED|Overall Study||2
159684|NCT00459979|390803|P1|COMPLETED|Overall Study||28
159685|NCT00459979|390803|P1|STARTED|Overall Study||30
159686|NCT00460031|390813|P1|NOT COMPLETED|Overall Study||11
159687|NCT00460031|390813|P1|COMPLETED|Overall Study||23
159688|NCT00460031|390813|P1|STARTED|Overall Study||34
159689|NCT00460109|390821|P1|NOT COMPLETED|Overall Study||1
159690|NCT00460109|390821|P1|COMPLETED|Overall Study||23
159691|NCT00460109|390821|P1|STARTED|Overall Study||24
159692|NCT00460239|390829|P9|NOT COMPLETED|Overall Study||0
159693|NCT00460239|390830|P8|NOT COMPLETED|Overall Study||0
159694|NCT00460239|390831|P7|NOT COMPLETED|Overall Study||0
159695|NCT00460239|390832|P6|NOT COMPLETED|Overall Study||3
159696|NCT00460239|390833|P5|NOT COMPLETED|Overall Study||0
159697|NCT00460239|390834|P4|NOT COMPLETED|Overall Study||0
159698|NCT00460239|390835|P3|NOT COMPLETED|Overall Study||0
159699|NCT00460239|390836|P2|NOT COMPLETED|Overall Study||1
159700|NCT00460239|390837|P1|NOT COMPLETED|Overall Study||0
159701|NCT00460239|390829|P9|COMPLETED|Overall Study||1
159702|NCT00460239|390830|P8|COMPLETED|Overall Study||1
159703|NCT00460239|390831|P7|COMPLETED|Overall Study||1
159704|NCT00460239|390832|P6|COMPLETED|Overall Study||1
159705|NCT00460239|390833|P5|COMPLETED|Overall Study||1
159706|NCT00460239|390834|P4|COMPLETED|Overall Study||0
159707|NCT00460239|390835|P3|COMPLETED|Overall Study||1
159708|NCT00460239|390836|P2|COMPLETED|Overall Study||2
159709|NCT00460239|390837|P1|COMPLETED|Overall Study||0
159710|NCT00460239|390829|P9|STARTED|Overall Study||1
159711|NCT00460239|390830|P8|STARTED|Overall Study||1
159712|NCT00460239|390831|P7|STARTED|Overall Study||1
159713|NCT00460239|390832|P6|STARTED|Overall Study||4
159714|NCT00460239|390833|P5|STARTED|Overall Study||1
159715|NCT00460239|390834|P4|STARTED|Overall Study||0
159716|NCT00460239|390835|P3|STARTED|Overall Study||1
159717|NCT00460239|390836|P2|STARTED|Overall Study||3
159718|NCT00460239|390837|P1|STARTED|Overall Study||0
159719|NCT00460265|390908|P2|NOT COMPLETED|Overall Study||89
159720|NCT00460265|390909|P1|NOT COMPLETED|Overall Study||85
159721|NCT00460265|390908|P2|COMPLETED|Overall Study|Completed study=death|241
159722|NCT00460265|390909|P1|COMPLETED|Overall Study|Completed study=death|243
159723|NCT00460265|390908|P2|Received Study Medication|Overall Study||325
159724|NCT00460265|390909|P1|Received Study Medication|Overall Study||325
159725|NCT00460265|390908|P2|Randomized While Alive|Overall Study||330
159726|NCT00460265|390909|P1|Randomized While Alive|Overall Study|1 subject was randomized by error after death|327
159727|NCT00460265|390908|P2|STARTED|Overall Study||330
159728|NCT00460265|390909|P1|STARTED|Overall Study||328
159729|NCT00460408|390929|P4|NOT COMPLETED|Overall Study||0
159730|NCT00460408|390930|P3|NOT COMPLETED|Overall Study||6
159731|NCT00460408|390931|P2|NOT COMPLETED|Overall Study||3
159732|NCT00460408|390932|P1|NOT COMPLETED|Overall Study||67
159733|NCT00460408|390929|P4|COMPLETED|Overall Study||7
159734|NCT00460408|390930|P3|COMPLETED|Overall Study||69
159735|NCT00460408|390931|P2|COMPLETED|Overall Study||13
159736|NCT00460408|390932|P1|COMPLETED|Overall Study||336
159737|NCT00460408|390929|P4|STARTED|Overall Study||7
159738|NCT00460408|390930|P3|STARTED|Overall Study||75
159739|NCT00460408|390931|P2|STARTED|Overall Study||16
159740|NCT00460408|390932|P1|STARTED|Overall Study||403
159741|NCT00460421|390970|P3|NOT COMPLETED|Overall Study||0
159742|NCT00460421|390971|P2|NOT COMPLETED|Overall Study||0
159743|NCT00460421|390972|P1|NOT COMPLETED|Overall Study||0
159744|NCT00460421|390970|P3|COMPLETED|Overall Study||9
159745|NCT00460421|390971|P2|COMPLETED|Overall Study||9
159746|NCT00460421|390972|P1|COMPLETED|Overall Study||9
159747|NCT00460421|390970|P3|STARTED|Overall Study||9
159748|NCT00460421|390971|P2|STARTED|Overall Study||9
159749|NCT00460421|390972|P1|STARTED|Overall Study||9
159750|NCT00460525|391018|P2|NOT COMPLETED|Overall Study||5
159751|NCT00460525|391019|P1|NOT COMPLETED|Overall Study||11
159752|NCT00460525|391018|P2|COMPLETED|Overall Study||194
159753|NCT00460525|391019|P1|COMPLETED|Overall Study||190
159754|NCT00460525|391018|P2|STARTED|Overall Study||199
159755|NCT00460525|391019|P1|STARTED|Overall Study||201
159756|NCT00460551|391059|P1|NOT COMPLETED|Overall Study||0
159757|NCT00460551|391059|P1|COMPLETED|Overall Study|The trial was terminated after Period 1A. Only safety was measured.|13
159758|NCT00460551|391059|P1|STARTED|Overall Study||13
159759|NCT00460564|391068|P8|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
159760|NCT00460564|391069|P7|NOT COMPLETED|Open-Label Phase (36 Weeks)||2
159761|NCT00460564|391070|P6|NOT COMPLETED|Open-Label Phase (36 Weeks)||6
159762|NCT00460564|391071|P5|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
159763|NCT00460564|391072|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
159764|NCT00460564|391073|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
159765|NCT00460564|391074|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
159766|NCT00460564|391075|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
159767|NCT00460564|391068|P8|COMPLETED|Open-Label Phase (36 Weeks)||11
159768|NCT00460564|391069|P7|COMPLETED|Open-Label Phase (36 Weeks)||19
159769|NCT00460564|391070|P6|COMPLETED|Open-Label Phase (36 Weeks)||19
159770|NCT00460564|391071|P5|COMPLETED|Open-Label Phase (36 Weeks)||38
159771|NCT00460564|391072|P4|COMPLETED|Open-Label Phase (36 Weeks)||0
159772|NCT00460564|391073|P3|COMPLETED|Open-Label Phase (36 Weeks)||0
159773|NCT00460564|391074|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
159774|NCT00460564|391075|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
159775|NCT00460564|391068|P8|STARTED|Open-Label Phase (36 Weeks)||11
159776|NCT00460564|391069|P7|STARTED|Open-Label Phase (36 Weeks)||21
159777|NCT00460564|391070|P6|STARTED|Open-Label Phase (36 Weeks)||25
159778|NCT00460564|391071|P5|STARTED|Open-Label Phase (36 Weeks)||47
159779|NCT00460564|391072|P4|STARTED|Open-Label Phase (36 Weeks)||0
159780|NCT00460564|391073|P3|STARTED|Open-Label Phase (36 Weeks)||0
159781|NCT00460564|391074|P2|STARTED|Open-Label Phase (36 Weeks)||0
159782|NCT00460564|391075|P1|STARTED|Open-Label Phase (36 Weeks)||0
159783|NCT00460564|391068|P8|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159784|NCT00460564|391069|P7|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159785|NCT00460564|391070|P6|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159786|NCT00460564|391071|P5|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159787|NCT00460564|391072|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159788|NCT00460564|391073|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159789|NCT00460564|391074|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
159790|NCT00460564|391075|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||4
159791|NCT00460564|391068|P8|COMPLETED|Double-Blind Phase (12 Weeks)||0
159792|NCT00460564|391069|P7|COMPLETED|Double-Blind Phase (12 Weeks)||0
159793|NCT00460564|391070|P6|COMPLETED|Double-Blind Phase (12 Weeks)||0
159794|NCT00460564|391071|P5|COMPLETED|Double-Blind Phase (12 Weeks)||0
159795|NCT00460564|391072|P4|COMPLETED|Double-Blind Phase (12 Weeks)||11
159796|NCT00460564|391073|P3|COMPLETED|Double-Blind Phase (12 Weeks)||21
159797|NCT00460564|391074|P2|COMPLETED|Double-Blind Phase (12 Weeks)||25
159798|NCT00460564|391075|P1|COMPLETED|Double-Blind Phase (12 Weeks)||47
159799|NCT00460564|391068|P8|STARTED|Double-Blind Phase (12 Weeks)||0
159800|NCT00460564|391069|P7|STARTED|Double-Blind Phase (12 Weeks)||0
159801|NCT00460564|391070|P6|STARTED|Double-Blind Phase (12 Weeks)||0
159802|NCT00460564|391071|P5|STARTED|Double-Blind Phase (12 Weeks)||0
159803|NCT00460564|391072|P4|STARTED|Double-Blind Phase (12 Weeks)||11
159804|NCT00460564|391073|P3|STARTED|Double-Blind Phase (12 Weeks)||21
159805|NCT00460564|391074|P2|STARTED|Double-Blind Phase (12 Weeks)||26
159806|NCT00460564|391075|P1|STARTED|Double-Blind Phase (12 Weeks)||51
159807|NCT00460577|391171|P2|NOT COMPLETED|Overall Study||6
159808|NCT00460577|391172|P1|NOT COMPLETED|Overall Study||2
159809|NCT00460577|391171|P2|COMPLETED|Overall Study||24
159810|NCT00460577|391172|P1|COMPLETED|Overall Study||28
159811|NCT00460577|391171|P2|STARTED|Overall Study||30
159812|NCT00460577|391172|P1|STARTED|Overall Study|148 patients were screened; however, 22 did not consent and 66 did not meet inclusion/exclusion.|30
159813|NCT00460603|391198|P12|NOT COMPLETED|Phase 2||41
159814|NCT00460603|391199|P11|NOT COMPLETED|Phase 2||43
159815|NCT00460603|391200|P10|NOT COMPLETED|Phase 2||42
159816|NCT00460603|391201|P9|NOT COMPLETED|Phase 2||0
159817|NCT00460603|391202|P8|NOT COMPLETED|Phase 2||0
159818|NCT00460603|391203|P7|NOT COMPLETED|Phase 2||0
159819|NCT00460603|391204|P6|NOT COMPLETED|Phase 2||0
159820|NCT00460603|391205|P5|NOT COMPLETED|Phase 2||0
159821|NCT00460603|391206|P4|NOT COMPLETED|Phase 2||0
159822|NCT00460603|391207|P3|NOT COMPLETED|Phase 2||0
159823|NCT00460603|391208|P2|NOT COMPLETED|Phase 2||0
159824|NCT00460603|391209|P1|NOT COMPLETED|Phase 2||0
159825|NCT00460603|391198|P12|COMPLETED|Phase 2||0
159826|NCT00460603|391199|P11|COMPLETED|Phase 2||0
159827|NCT00460603|391200|P10|COMPLETED|Phase 2||0
159828|NCT00460603|391201|P9|COMPLETED|Phase 2||0
159829|NCT00460603|391202|P8|COMPLETED|Phase 2||0
159830|NCT00460603|391203|P7|COMPLETED|Phase 2||0
159831|NCT00460603|391204|P6|COMPLETED|Phase 2||0
159832|NCT00460603|391205|P5|COMPLETED|Phase 2||0
159833|NCT00460603|391206|P4|COMPLETED|Phase 2||0
159834|NCT00460603|391207|P3|COMPLETED|Phase 2||0
159835|NCT00460603|391208|P2|COMPLETED|Phase 2||0
159836|NCT00460603|391209|P1|COMPLETED|Phase 2||0
159837|NCT00460603|391198|P12|Treated|Phase 2||41
159838|NCT00460603|391199|P11|Treated|Phase 2||43
159839|NCT00460603|391200|P10|Treated|Phase 2||39
159840|NCT00460603|391201|P9|Treated|Phase 2||0
159841|NCT00460603|391202|P8|Treated|Phase 2||0
159842|NCT00460603|391203|P7|Treated|Phase 2||0
159843|NCT00460603|391204|P6|Treated|Phase 2||0
159844|NCT00460603|391205|P5|Treated|Phase 2||0
159845|NCT00460603|391206|P4|Treated|Phase 2||0
159846|NCT00460603|391207|P3|Treated|Phase 2||0
159847|NCT00460603|391208|P2|Treated|Phase 2||0
159848|NCT00460603|391209|P1|Treated|Phase 2||0
159849|NCT00460603|391198|P12|STARTED|Phase 2||41
159850|NCT00460603|391199|P11|STARTED|Phase 2||43
159851|NCT00460603|391200|P10|STARTED|Phase 2||42
159852|NCT00460603|391201|P9|STARTED|Phase 2||0
159853|NCT00460603|391202|P8|STARTED|Phase 2||0
159854|NCT00460603|391203|P7|STARTED|Phase 2||0
159855|NCT00460603|391204|P6|STARTED|Phase 2||0
159856|NCT00460603|391205|P5|STARTED|Phase 2||0
159857|NCT00460603|391206|P4|STARTED|Phase 2||0
159858|NCT00460603|391207|P3|STARTED|Phase 2||0
159859|NCT00460603|391208|P2|STARTED|Phase 2||0
159860|NCT00460603|391209|P1|STARTED|Phase 2||0
159861|NCT00460603|391198|P12|NOT COMPLETED|Phase 1||0
159862|NCT00460603|391199|P11|NOT COMPLETED|Phase 1||0
159863|NCT00460603|391200|P10|NOT COMPLETED|Phase 1||0
159864|NCT00460603|391201|P9|NOT COMPLETED|Phase 1||18
159865|NCT00460603|391202|P8|NOT COMPLETED|Phase 1||3
159866|NCT00460603|391203|P7|NOT COMPLETED|Phase 1||6
159867|NCT00460603|391204|P6|NOT COMPLETED|Phase 1||4
159868|NCT00460603|391205|P5|NOT COMPLETED|Phase 1||6
159869|NCT00460603|391206|P4|NOT COMPLETED|Phase 1||8
159870|NCT00460603|391207|P3|NOT COMPLETED|Phase 1||4
159871|NCT00460603|391208|P2|NOT COMPLETED|Phase 1||6
159872|NCT00460603|391209|P1|NOT COMPLETED|Phase 1||6
159873|NCT00460603|391198|P12|COMPLETED|Phase 1||0
159874|NCT00460603|391199|P11|COMPLETED|Phase 1||0
159875|NCT00460603|391200|P10|COMPLETED|Phase 1||0
159876|NCT00460603|391201|P9|COMPLETED|Phase 1||0
159877|NCT00460603|391202|P8|COMPLETED|Phase 1||0
159878|NCT00460603|391203|P7|COMPLETED|Phase 1||0
159879|NCT00460603|391204|P6|COMPLETED|Phase 1||0
159880|NCT00460603|391205|P5|COMPLETED|Phase 1||0
159881|NCT00460603|391206|P4|COMPLETED|Phase 1||0
159882|NCT00460603|391207|P3|COMPLETED|Phase 1||0
159883|NCT00460603|391208|P2|COMPLETED|Phase 1||0
159884|NCT00460603|391209|P1|COMPLETED|Phase 1||0
159885|NCT00460603|391198|P12|STARTED|Phase 1||0
159886|NCT00460603|391199|P11|STARTED|Phase 1||0
159887|NCT00460603|391200|P10|STARTED|Phase 1||0
159888|NCT00460603|391201|P9|STARTED|Phase 1||18
159889|NCT00460603|391202|P8|STARTED|Phase 1||3
159890|NCT00460603|391203|P7|STARTED|Phase 1||6
159891|NCT00460603|391204|P6|STARTED|Phase 1||4
159892|NCT00460603|391205|P5|STARTED|Phase 1||6
159893|NCT00460603|391206|P4|STARTED|Phase 1||8
159894|NCT00460603|391207|P3|STARTED|Phase 1||4
159895|NCT00460603|391208|P2|STARTED|Phase 1||6
159896|NCT00460603|391209|P1|STARTED|Phase 1||6
159897|NCT00460655|391303|P4|NOT COMPLETED|Open-Label Phase (36 Weeks)||9
159898|NCT00460655|391304|P3|NOT COMPLETED|Open-Label Phase (36 Weeks)||7
159899|NCT00460655|391305|P2|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
159900|NCT00460655|391306|P1|NOT COMPLETED|Open-Label Phase (36 Weeks)||0
159901|NCT00460655|391303|P4|COMPLETED|Open-Label Phase (36 Weeks)||52
159902|NCT00460655|391304|P3|COMPLETED|Open-Label Phase (36 Weeks)||45
159903|NCT00460655|391305|P2|COMPLETED|Open-Label Phase (36 Weeks)||0
159904|NCT00460655|391306|P1|COMPLETED|Open-Label Phase (36 Weeks)||0
159905|NCT00460655|391303|P4|STARTED|Open-Label Phase (36 Weeks)||61
159906|NCT00460655|391304|P3|STARTED|Open-Label Phase (36 Weeks)||52
159907|NCT00460655|391305|P2|STARTED|Open-Label Phase (36 Weeks)||0
159908|NCT00460655|391306|P1|STARTED|Open-Label Phase (36 Weeks)||0
159909|NCT00460655|391303|P4|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159910|NCT00460655|391304|P3|NOT COMPLETED|Double-Blind Phase (12 Weeks)||0
159911|NCT00460655|391305|P2|NOT COMPLETED|Double-Blind Phase (12 Weeks)||1
159912|NCT00460655|391306|P1|NOT COMPLETED|Double-Blind Phase (12 Weeks)||6
159913|NCT00460655|391303|P4|COMPLETED|Double-Blind Phase (12 Weeks)||0
159914|NCT00460655|391304|P3|COMPLETED|Double-Blind Phase (12 Weeks)||0
159915|NCT00460655|391305|P2|COMPLETED|Double-Blind Phase (12 Weeks)||61
159916|NCT00460655|391306|P1|COMPLETED|Double-Blind Phase (12 Weeks)||52
159917|NCT00460655|391303|P4|STARTED|Double-Blind Phase (12 Weeks)||0
159918|NCT00460655|391304|P3|STARTED|Double-Blind Phase (12 Weeks)||0
159919|NCT00460655|391305|P2|STARTED|Double-Blind Phase (12 Weeks)||62
159920|NCT00460655|391306|P1|STARTED|Double-Blind Phase (12 Weeks)||58
159921|NCT00460746|391338|P1|NOT COMPLETED|Overall Study||2
159922|NCT00460746|391338|P1|COMPLETED|Overall Study||8
159923|NCT00460746|391338|P1|STARTED|Overall Study||10
159924|NCT00460798|391351|P1|NOT COMPLETED|Overall Study||340
159925|NCT00460798|391351|P1|COMPLETED|Overall Study||108
160018|NCT00455013|391550|P2|NOT COMPLETED|Long Term Extension (LTE)||3
159926|NCT00460798|391351|P1|Treated|Overall Study|Subjects with complete dosing information were recorded as 'Treated'|421
159927|NCT00460798|391351|P1|STARTED|Overall Study||448
159928|NCT00460811|391364|P5|NOT COMPLETED|Overall Study||20
159929|NCT00460811|391365|P4|NOT COMPLETED|Overall Study||18
159930|NCT00460811|391366|P3|NOT COMPLETED|Overall Study||14
159931|NCT00460811|391367|P2|NOT COMPLETED|Overall Study||15
159932|NCT00460811|391368|P1|NOT COMPLETED|Overall Study||16
159933|NCT00460811|391364|P5|COMPLETED|Overall Study||65
159934|NCT00460811|391365|P4|COMPLETED|Overall Study||71
159935|NCT00460811|391366|P3|COMPLETED|Overall Study||71
159936|NCT00460811|391367|P2|COMPLETED|Overall Study||67
159937|NCT00460811|391368|P1|COMPLETED|Overall Study||63
159938|NCT00460811|391364|P5|STARTED|Overall Study||85
159939|NCT00460811|391365|P4|STARTED|Overall Study||89
159940|NCT00460811|391366|P3|STARTED|Overall Study||85
159941|NCT00460811|391367|P2|STARTED|Overall Study||82
159942|NCT00460811|391368|P1|STARTED|Overall Study||79
159943|NCT00460993|391412|P2|NOT COMPLETED|Phase 2 (6 Days)||0
159944|NCT00460993|391413|P1|NOT COMPLETED|Phase 2 (6 Days)||0
159945|NCT00460993|391412|P2|COMPLETED|Phase 2 (6 Days)||17
159946|NCT00460993|391413|P1|COMPLETED|Phase 2 (6 Days)||14
159947|NCT00460993|391412|P2|STARTED|Phase 2 (6 Days)||17
159948|NCT00460993|391413|P1|STARTED|Phase 2 (6 Days)||14
159949|NCT00460993|391412|P2|NOT COMPLETED|Phase 1 (6 Days)||0
159950|NCT00460993|391413|P1|NOT COMPLETED|Phase 1 (6 Days)||0
159951|NCT00460993|391412|P2|COMPLETED|Phase 1 (6 Days)||17
159952|NCT00460993|391413|P1|COMPLETED|Phase 1 (6 Days)||14
159953|NCT00460993|391412|P2|STARTED|Phase 1 (6 Days)||17
159954|NCT00460993|391413|P1|STARTED|Phase 1 (6 Days)||14
159955|NCT00461032|391421|P2|NOT COMPLETED|Overall Study||44
159956|NCT00461032|391422|P1|NOT COMPLETED|Overall Study||37
159957|NCT00461032|391421|P2|COMPLETED|Overall Study||536
159958|NCT00461032|391422|P1|COMPLETED|Overall Study||545
159959|NCT00461032|391421|P2|STARTED|Overall Study||580
159960|NCT00461032|391422|P1|STARTED|Overall Study||582
159961|NCT00461097|391436|P2|NOT COMPLETED|Overall Study||0
159962|NCT00461097|391437|P1|NOT COMPLETED|Overall Study||0
159963|NCT00461097|391436|P2|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure.|15
159964|NCT00461097|391437|P1|COMPLETED|Overall Study|Completed: Participants who were assessed for the primary outcome measure and outcome measure #6.|40
159965|NCT00461097|391436|P2|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||0
159966|NCT00461097|391437|P1|Had Year 4 (Mnth 48) Oral Food Challenge|Overall Study||7
159967|NCT00461097|391436|P2|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||0
159968|NCT00461097|391437|P1|Had Year 3 (Mnth 36) Oral Food Challenge|Overall Study||16
159969|NCT00461097|391436|P2|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||1
159970|NCT00461097|391437|P1|Had Month 22 (Wk 96) Oral Food Challenge|Overall Study||34
159971|NCT00461097|391436|P2|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||13
159972|NCT00461097|391437|P1|Had Month 10 (Wk 44) Oral Food Challenge|Overall Study||35
159973|NCT00461097|391436|P2|STARTED|Overall Study||15
159974|NCT00461097|391437|P1|STARTED|Overall Study||40
159975|NCT00461123|391455|P2|NOT COMPLETED|Overall Study||6
159976|NCT00461123|391456|P1|NOT COMPLETED|Overall Study||6
159977|NCT00461123|391455|P2|COMPLETED|Overall Study||19
159978|NCT00461123|391456|P1|COMPLETED|Overall Study||19
159979|NCT00461123|391455|P2|STARTED|Overall Study||25
159980|NCT00461123|391456|P1|STARTED|Overall Study||25
159981|NCT00454987|391473|P3|NOT COMPLETED|Year 4||0
159982|NCT00454987|391474|P2|NOT COMPLETED|Year 4||0
159983|NCT00454987|391475|P1|NOT COMPLETED|Year 4||0
159984|NCT00454987|391473|P3|COMPLETED|Year 4||0
159985|NCT00454987|391474|P2|COMPLETED|Year 4||62
159986|NCT00454987|391475|P1|COMPLETED|Year 4||206
159987|NCT00454987|391473|P3|STARTED|Year 4||0
159988|NCT00454987|391474|P2|STARTED|Year 4||62
159989|NCT00454987|391475|P1|STARTED|Year 4||206
159990|NCT00454987|391473|P3|NOT COMPLETED|Year 2||0
159991|NCT00454987|391474|P2|NOT COMPLETED|Year 2||0
159992|NCT00454987|391475|P1|NOT COMPLETED|Year 2||0
159993|NCT00454987|391473|P3|COMPLETED|Year 2||74
159994|NCT00454987|391474|P2|COMPLETED|Year 2||77
159995|NCT00454987|391475|P1|COMPLETED|Year 2||235
159996|NCT00454987|391473|P3|STARTED|Year 2||74
159997|NCT00454987|391474|P2|STARTED|Year 2||77
159998|NCT00454987|391475|P1|STARTED|Year 2||235
159999|NCT00454987|391473|P3|NOT COMPLETED|Year 1||0
160000|NCT00454987|391474|P2|NOT COMPLETED|Year 1||0
160001|NCT00454987|391475|P1|NOT COMPLETED|Year 1||0
160002|NCT00454987|391473|P3|COMPLETED|Year 1||0
160003|NCT00454987|391474|P2|COMPLETED|Year 1||67
160004|NCT00454987|391475|P1|COMPLETED|Year 1||221
160005|NCT00454987|391473|P3|STARTED|Year 1||0
160006|NCT00454987|391474|P2|STARTED|Year 1||67
160007|NCT00454987|391475|P1|STARTED|Year 1||221
160008|NCT00454987|391473|P3|NOT COMPLETED|Booster Period||0
160009|NCT00454987|391474|P2|NOT COMPLETED|Booster Period||1
160010|NCT00454987|391475|P1|NOT COMPLETED|Booster Period||2
160011|NCT00454987|391473|P3|COMPLETED|Booster Period||0
160012|NCT00454987|391474|P2|COMPLETED|Booster Period||116
160013|NCT00454987|391475|P1|COMPLETED|Booster Period||357
160014|NCT00454987|391473|P3|STARTED|Booster Period||0
160015|NCT00454987|391474|P2|STARTED|Booster Period||117
160016|NCT00454987|391475|P1|STARTED|Booster Period||359
160017|NCT00455013|391549|P3|NOT COMPLETED|Long Term Extension (LTE)||7
160019|NCT00455013|391551|P1|NOT COMPLETED|Long Term Extension (LTE)||2
160020|NCT00455013|391549|P3|COMPLETED|Long Term Extension (LTE)||20
160021|NCT00455013|391550|P2|COMPLETED|Long Term Extension (LTE)||16
160022|NCT00455013|391551|P1|COMPLETED|Long Term Extension (LTE)||25
160023|NCT00455013|391549|P3|STARTED|Long Term Extension (LTE)|1 Participant chose not to enter the LTE.|27
160024|NCT00455013|391550|P2|STARTED|Long Term Extension (LTE)|2 Participants chose not to enter the LTE.|19
160025|NCT00455013|391551|P1|STARTED|Long Term Extension (LTE)||27
160026|NCT00455013|391549|P3|NOT COMPLETED|Short Term Period||2
160027|NCT00455013|391550|P2|NOT COMPLETED|Short Term Period||5
160028|NCT00455013|391551|P1|NOT COMPLETED|Short Term Period||6
160029|NCT00455013|391549|P3|COMPLETED|Short Term Period|1 discontinued tacrolimus by Month 6 and 2 discontinued by Month 12 (1 more by Month 12)|28
160030|NCT00455013|391550|P2|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6; 10 additional switched from sirolimus to MMF.|21
160031|NCT00455013|391551|P1|COMPLETED|Short Term Period|5 discontinued belatacept by Month 6 (1 more by Month 12), 2 switched from MMF to sirolimus.|27
160032|NCT00455013|391549|P3|STARTED|Short Term Period|31 randomized, 30 transplanted and treated|30
160033|NCT00455013|391550|P2|STARTED|Short Term Period|27 randomized, 26 transplanted and treated.|26
160034|NCT00455013|391551|P1|STARTED|Short Term Period|35 randomized, 33 transplanted and treated.|33
160035|NCT00461175|391618|P2|NOT COMPLETED|Overall Study||365
160036|NCT00461175|391619|P1|NOT COMPLETED|Overall Study||522
160037|NCT00461175|391618|P2|COMPLETED|Overall Study||18370
160038|NCT00461175|391619|P1|COMPLETED|Overall Study||43078
160039|NCT00461175|391618|P2|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|18735
160040|NCT00461175|391619|P1|STARTED|Overall Study|859 patients could not be assigned to a cohort and are therefore missing in the participant flow.|43600
160041|NCT00461253|391629|P2|NOT COMPLETED|Overall Study||19798
160042|NCT00461253|391630|P1|NOT COMPLETED|Overall Study||4980
160043|NCT00461253|391629|P2|COMPLETED|Overall Study|Analyzed controls|20452
160044|NCT00461253|391630|P1|COMPLETED|Overall Study|Analyzed cases|5113
160045|NCT00461253|391629|P2|STARTED|Overall Study|Identified controls|40250
160046|NCT00461253|391630|P1|STARTED|Overall Study|Identified cases|10093
160047|NCT00461292|391639|P3|NOT COMPLETED|Treatment Cycle 2||0
160048|NCT00461292|391640|P2|NOT COMPLETED|Treatment Cycle 2||2
160049|NCT00461292|391641|P1|NOT COMPLETED|Treatment Cycle 2||5
160050|NCT00461292|391639|P3|COMPLETED|Treatment Cycle 2||0
160051|NCT00461292|391640|P2|COMPLETED|Treatment Cycle 2||72
160052|NCT00461292|391641|P1|COMPLETED|Treatment Cycle 2||58
160053|NCT00461292|391639|P3|STARTED|Treatment Cycle 2|Cycle 1 Placebo pts were randomized to receive 300U or 200 U in Cycle 2|0
160054|NCT00461292|391640|P2|STARTED|Treatment Cycle 2|42 from the 200U group + 32 from the Placebo group entered Cycle 2|74
160055|NCT00461292|391641|P1|STARTED|Treatment Cycle 2|32 from the 300U group + 31 from the Placebo group entered Cycle 2|63
160056|NCT00461292|391639|P3|NOT COMPLETED|Treatment Cycle 1||11
160057|NCT00461292|391640|P2|NOT COMPLETED|Treatment Cycle 1||12
160058|NCT00461292|391641|P1|NOT COMPLETED|Treatment Cycle 1||15
160059|NCT00461292|391639|P3|COMPLETED|Treatment Cycle 1||81
160060|NCT00461292|391640|P2|COMPLETED|Treatment Cycle 1||80
160061|NCT00461292|391641|P1|COMPLETED|Treatment Cycle 1||76
160062|NCT00461292|391639|P3|STARTED|Treatment Cycle 1||92
160063|NCT00461292|391640|P2|STARTED|Treatment Cycle 1||92
160064|NCT00461292|391641|P1|STARTED|Treatment Cycle 1||91
160065|NCT00461305|391660|P2|NOT COMPLETED|Continued Treatment||0
160066|NCT00461305|391661|P1|NOT COMPLETED|Continued Treatment||95
160067|NCT00461305|391660|P2|COMPLETED|Continued Treatment||0
160068|NCT00461305|391661|P1|COMPLETED|Continued Treatment||254
160069|NCT00461305|391660|P2|STARTED|Continued Treatment|no participants were treated with the DRSP 3 mg/EE 30 μg combination beyond 6 cycles|0
160070|NCT00461305|391661|P1|STARTED|Continued Treatment|FAS, participants from previous treatment who were available to continue treatment|349
160071|NCT00461305|391660|P2|NOT COMPLETED|Treatment||9
160072|NCT00461305|391661|P1|NOT COMPLETED|Treatment||101
160073|NCT00461305|391660|P2|COMPLETED|Treatment||56
160074|NCT00461305|391661|P1|COMPLETED|Treatment||254
160075|NCT00461305|391660|P2|Subjects Received Treatment|Treatment|FAS, safety population|65
160076|NCT00461305|391661|P1|Subjects Received Treatment|Treatment|FAS, safety population|349
160077|NCT00461305|391660|P2|Subjects Dispensed Drugs|Treatment||65
160078|NCT00461305|391661|P1|Subjects Dispensed Drugs|Treatment||350
160079|NCT00461305|391660|P2|STARTED|Treatment|Enrolled|65
160080|NCT00461305|391661|P1|STARTED|Treatment|Enrolled|355
160081|NCT00461331|391721|P2|NOT COMPLETED|Intervention 2||0
160082|NCT00461331|391722|P1|NOT COMPLETED|Intervention 2||0
160083|NCT00461331|391721|P2|COMPLETED|Intervention 2||10
160084|NCT00461331|391722|P1|COMPLETED|Intervention 2||10
160085|NCT00461331|391721|P2|STARTED|Intervention 2||10
160086|NCT00461331|391722|P1|STARTED|Intervention 2||10
160087|NCT00461331|391721|P2|NOT COMPLETED|Washout||0
160088|NCT00461331|391722|P1|NOT COMPLETED|Washout||0
160089|NCT00461331|391721|P2|COMPLETED|Washout||10
160090|NCT00461331|391722|P1|COMPLETED|Washout||10
160091|NCT00461331|391721|P2|STARTED|Washout||10
160092|NCT00461331|391722|P1|STARTED|Washout||10
160093|NCT00461331|391721|P2|NOT COMPLETED|Intervention 1||0
160094|NCT00461331|391722|P1|NOT COMPLETED|Intervention 1||0
160095|NCT00461331|391721|P2|COMPLETED|Intervention 1||10
160096|NCT00461331|391722|P1|COMPLETED|Intervention 1||10
160097|NCT00461331|391721|P2|STARTED|Intervention 1||10
160098|NCT00461331|391722|P1|STARTED|Intervention 1||10
160099|NCT00461500|391734|P2|NOT COMPLETED|Overall Study||6
160100|NCT00461500|391735|P1|NOT COMPLETED|Overall Study||7
160101|NCT00461500|391734|P2|COMPLETED|Overall Study||38
160102|NCT00461500|391735|P1|COMPLETED|Overall Study||30
160103|NCT00461500|391734|P2|STARTED|Overall Study||44
160104|NCT00461500|391735|P1|STARTED|Overall Study||37
160105|NCT00461513|391767|P2|NOT COMPLETED|Overall Study||27
160106|NCT00461513|391768|P1|NOT COMPLETED|Overall Study||28
160107|NCT00461513|391767|P2|COMPLETED|Overall Study||172
160108|NCT00461513|391768|P1|COMPLETED|Overall Study||165
160109|NCT00461513|391767|P2|STARTED|Overall Study||199
160110|NCT00461513|391768|P1|STARTED|Overall Study||193
160111|NCT00461851|391774|P1|NOT COMPLETED|Overall Study||2
160112|NCT00461851|391774|P1|COMPLETED|Overall Study||17
160113|NCT00461851|391774|P1|STARTED|Overall Study||19
160114|NCT00461981|391780|P2|NOT COMPLETED|Overall Study||9
160115|NCT00461981|391781|P1|NOT COMPLETED|Overall Study||11
160116|NCT00461981|391780|P2|COMPLETED|Overall Study||42
160117|NCT00461981|391781|P1|COMPLETED|Overall Study||39
160118|NCT00461981|391780|P2|STARTED|Overall Study||51
160119|NCT00461981|391781|P1|STARTED|Overall Study||50
160120|NCT00462020|391893|P2|NOT COMPLETED|Overall Study||0
160121|NCT00462020|391894|P1|NOT COMPLETED|Overall Study||0
160122|NCT00462020|391893|P2|COMPLETED|Overall Study||50
160123|NCT00462020|391894|P1|COMPLETED|Overall Study||52
160124|NCT00462020|391893|P2|STARTED|Overall Study||50
160125|NCT00462020|391894|P1|STARTED|Overall Study||52
160126|NCT00462072|391903|P3|NOT COMPLETED|Week 10||0
160127|NCT00462072|391904|P2|NOT COMPLETED|Week 10||0
160128|NCT00462072|391905|P1|NOT COMPLETED|Week 10||0
160129|NCT00462072|391903|P3|COMPLETED|Week 10||9
160130|NCT00462072|391904|P2|COMPLETED|Week 10||12
160131|NCT00462072|391905|P1|COMPLETED|Week 10||10
160132|NCT00462072|391903|P3|STARTED|Week 10||9
160133|NCT00462072|391904|P2|STARTED|Week 10||12
160134|NCT00462072|391905|P1|STARTED|Week 10||10
160135|NCT00462072|391903|P3|NOT COMPLETED|Baseline (Week 0)||0
160136|NCT00462072|391904|P2|NOT COMPLETED|Baseline (Week 0)||0
160137|NCT00462072|391905|P1|NOT COMPLETED|Baseline (Week 0)||0
160138|NCT00462072|391903|P3|COMPLETED|Baseline (Week 0)||9
160139|NCT00462072|391904|P2|COMPLETED|Baseline (Week 0)||12
160140|NCT00462072|391905|P1|COMPLETED|Baseline (Week 0)||10
160141|NCT00462072|391903|P3|STARTED|Baseline (Week 0)||9
160142|NCT00462072|391904|P2|STARTED|Baseline (Week 0)||12
160143|NCT00462072|391905|P1|STARTED|Baseline (Week 0)||10
160144|NCT00462228|391919|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
160145|NCT00462228|391919|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
160146|NCT00462228|391919|P1|STARTED|No Treatment (Washout) 4 Weeks||11
160147|NCT00462228|391919|P1|NOT COMPLETED|Placebo or Memantine 12 Weeks||0
160148|NCT00462228|391919|P1|COMPLETED|Placebo or Memantine 12 Weeks||11
160149|NCT00462228|391919|P1|STARTED|Placebo or Memantine 12 Weeks||11
160150|NCT00462228|391919|P1|NOT COMPLETED|No Treatment (Washout) 4 Weeks||0
160151|NCT00462228|391919|P1|COMPLETED|No Treatment (Washout) 4 Weeks||11
160152|NCT00462228|391919|P1|STARTED|No Treatment (Washout) 4 Weeks||11
160153|NCT00462228|391919|P1|NOT COMPLETED|Memantine or Placebo 12 Weeks||0
160154|NCT00462228|391919|P1|COMPLETED|Memantine or Placebo 12 Weeks||11
160155|NCT00462228|391919|P1|STARTED|Memantine or Placebo 12 Weeks||11
160156|NCT00462280|391944|P4|NOT COMPLETED|Overall Study||3
160157|NCT00462280|391945|P3|NOT COMPLETED|Overall Study||0
160158|NCT00462280|391946|P2|NOT COMPLETED|Overall Study||7
160159|NCT00462280|391947|P1|NOT COMPLETED|Overall Study||10
160160|NCT00462280|391944|P4|COMPLETED|Overall Study||4
160161|NCT00462280|391945|P3|COMPLETED|Overall Study||7
160162|NCT00462280|391946|P2|COMPLETED|Overall Study||25
160163|NCT00462280|391947|P1|COMPLETED|Overall Study||24
160164|NCT00462280|391944|P4|STARTED|Overall Study||7
160165|NCT00462280|391945|P3|STARTED|Overall Study||7
160166|NCT00462280|391946|P2|STARTED|Overall Study||32
160167|NCT00462280|391947|P1|STARTED|Overall Study||34
160168|NCT00462306|392009|P2|NOT COMPLETED|Overall Study||13
160169|NCT00462306|392010|P1|NOT COMPLETED|Overall Study||0
160170|NCT00462306|392009|P2|COMPLETED|Overall Study||490
160171|NCT00462306|392010|P1|COMPLETED|Overall Study||4074
160172|NCT00462306|392009|P2|STARTED|Overall Study||503
160173|NCT00462306|392010|P1|STARTED|Overall Study||4074
160174|NCT00462332|392020|P2|NOT COMPLETED|Overall Study||0
160175|NCT00462332|392021|P1|NOT COMPLETED|Overall Study||0
160176|NCT00462332|392020|P2|COMPLETED|Overall Study||41
160177|NCT00462332|392021|P1|COMPLETED|Overall Study||45
160178|NCT00462332|392020|P2|STARTED|Overall Study||41
160179|NCT00462332|392021|P1|STARTED|Overall Study||45
160180|NCT00462345|392029|P1|NOT COMPLETED|Overall Study||3
160181|NCT00462345|392029|P1|COMPLETED|Overall Study||37
160182|NCT00462345|392029|P1|Completed First Course|Overall Study||38
160183|NCT00462345|392029|P1|STARTED|Overall Study||40
160184|NCT00462384|392051|P1|NOT COMPLETED|Overall Study||9
160185|NCT00462384|392051|P1|COMPLETED|Overall Study||30
160186|NCT00462384|392051|P1|STARTED|Overall Study||39
160187|NCT00462423|392059|P1|NOT COMPLETED|Overall Study||0
160188|NCT00462423|392059|P1|COMPLETED|Overall Study||50
160189|NCT00462423|392059|P1|STARTED|Overall Study||50
160190|NCT00462449|392068|P2|NOT COMPLETED|Overall Study||0
160191|NCT00462449|392069|P1|NOT COMPLETED|Overall Study||0
160192|NCT00462449|392068|P2|COMPLETED|Overall Study||10
160193|NCT00462449|392069|P1|COMPLETED|Overall Study||13
160194|NCT00462449|392068|P2|STARTED|Overall Study||10
160195|NCT00462449|392069|P1|STARTED|Overall Study||13
160196|NCT00462462|392081|P2|NOT COMPLETED|Overall Study||1
160197|NCT00462462|392082|P1|NOT COMPLETED|Overall Study||0
160198|NCT00462462|392081|P2|COMPLETED|Overall Study||13
160199|NCT00462462|392082|P1|COMPLETED|Overall Study||17
160200|NCT00462462|392081|P2|STARTED|Overall Study||14
160201|NCT00462462|392082|P1|STARTED|Overall Study||17
160202|NCT00462501|392090|P1|NOT COMPLETED|Overall Study||5
160203|NCT00462501|392090|P1|COMPLETED|Overall Study||30
160204|NCT00462501|392090|P1|STARTED|Overall Study||35
160205|NCT00462605|392094|P1|NOT COMPLETED|Overall Study||14
160206|NCT00462605|392094|P1|COMPLETED|Overall Study||10
160207|NCT00462605|392094|P1|STARTED|Overall Study||24
160208|NCT00462644|392104|P2|NOT COMPLETED|Overall Study||0
160209|NCT00462644|392105|P1|NOT COMPLETED|Overall Study||0
160210|NCT00462644|392104|P2|COMPLETED|Overall Study||12
160211|NCT00462644|392105|P1|COMPLETED|Overall Study||18
160212|NCT00462644|392104|P2|STARTED|Overall Study||12
160213|NCT00462644|392105|P1|STARTED|Overall Study||18
160214|NCT00462670|392125|P2|NOT COMPLETED|Overall Study||7
160215|NCT00462670|392126|P1|NOT COMPLETED|Overall Study||5
160216|NCT00462670|392125|P2|COMPLETED|Overall Study||46
160217|NCT00462670|392126|P1|COMPLETED|Overall Study||52
160218|NCT00462670|392125|P2|STARTED|Overall Study||53
160219|NCT00462670|392126|P1|STARTED|Overall Study||57
160220|NCT00462709|392134|P1|NOT COMPLETED|Overall Study||67
160221|NCT00462709|392134|P1|COMPLETED|Overall Study||79
160222|NCT00462709|392134|P1|STARTED|Overall Study||146
160223|NCT00462722|392144|P3|NOT COMPLETED|Overall Study||12
160224|NCT00462722|392145|P2|NOT COMPLETED|Overall Study||4
160225|NCT00462722|392146|P1|NOT COMPLETED|Overall Study||13
160226|NCT00462722|392144|P3|COMPLETED|Overall Study||42
160227|NCT00462722|392145|P2|COMPLETED|Overall Study||51
160228|NCT00462722|392146|P1|COMPLETED|Overall Study||37
160229|NCT00462722|392144|P3|STARTED|Overall Study||54
160230|NCT00462722|392145|P2|STARTED|Overall Study||55
160231|NCT00462722|392146|P1|STARTED|Overall Study||50
160232|NCT00462748|392181|P3|NOT COMPLETED|Overall Study||11
160233|NCT00462748|392182|P2|NOT COMPLETED|Overall Study||11
160234|NCT00462748|392183|P1|NOT COMPLETED|Overall Study||12
160235|NCT00462748|392181|P3|COMPLETED|Overall Study||251
160236|NCT00462748|392182|P2|COMPLETED|Overall Study||252
160237|NCT00462748|392183|P1|COMPLETED|Overall Study||249
160238|NCT00462748|392181|P3|STARTED|Overall Study||262
160239|NCT00462748|392182|P2|STARTED|Overall Study||263
160240|NCT00462748|392183|P1|STARTED|Overall Study||261
160241|NCT00462826|392191|P1|NOT COMPLETED|Overall Study||5
160242|NCT00462826|392191|P1|COMPLETED|Overall Study||44
160243|NCT00462826|392191|P1|STARTED|Overall Study||49
160244|NCT00462839|392197|P2|NOT COMPLETED|Viewed Second||0
160245|NCT00462839|392198|P1|NOT COMPLETED|Viewed Second||0
160246|NCT00462839|392197|P2|COMPLETED|Viewed Second||53
160247|NCT00462839|392198|P1|COMPLETED|Viewed Second||53
160248|NCT00462839|392197|P2|STARTED|Viewed Second||53
160249|NCT00462839|392198|P1|STARTED|Viewed Second||53
160250|NCT00462839|392197|P2|NOT COMPLETED|Viewed First||0
160251|NCT00462839|392198|P1|NOT COMPLETED|Viewed First||0
160252|NCT00462839|392197|P2|COMPLETED|Viewed First||53
160253|NCT00462839|392198|P1|COMPLETED|Viewed First||53
160254|NCT00462839|392197|P2|STARTED|Viewed First||53
160255|NCT00462839|392198|P1|STARTED|Viewed First||53
160256|NCT00462865|392210|P1|NOT COMPLETED|Overall Study||1
160257|NCT00462865|392210|P1|COMPLETED|Overall Study||17
160258|NCT00462865|392210|P1|STARTED|Overall Study|18 pts enrolled,1 pt experienced a SAE infection normal ANC (gr 3) and did not begin study,see SAE|18
160259|NCT00462917|392218|P4|NOT COMPLETED|Overall Study||11
160260|NCT00462917|392219|P3|NOT COMPLETED|Overall Study||12
160261|NCT00462917|392220|P2|NOT COMPLETED|Overall Study||10
160262|NCT00462917|392221|P1|NOT COMPLETED|Overall Study||10
160263|NCT00462917|392218|P4|COMPLETED|Overall Study||66
160264|NCT00462917|392219|P3|COMPLETED|Overall Study||54
160265|NCT00462917|392220|P2|COMPLETED|Overall Study||65
160266|NCT00462917|392221|P1|COMPLETED|Overall Study||62
160267|NCT00462917|392218|P4|Completed 6 Month Follow-up|Overall Study||66
160268|NCT00462917|392219|P3|Completed 6 Month Follow-up|Overall Study||55
160269|NCT00462917|392220|P2|Completed 6 Month Follow-up|Overall Study||68
160270|NCT00462917|392221|P1|Completed 6 Month Follow-up|Overall Study||63
160271|NCT00462917|392218|P4|Completed 6 Week Follow-up|Overall Study||68
160272|NCT00462917|392219|P3|Completed 6 Week Follow-up|Overall Study||55
160273|NCT00462917|392220|P2|Completed 6 Week Follow-up|Overall Study||70
160274|NCT00462917|392221|P1|Completed 6 Week Follow-up|Overall Study||63
160275|NCT00462917|392218|P4|Received Risk Information|Overall Study||68
160276|NCT00462917|392219|P3|Received Risk Information|Overall Study||55
160277|NCT00462917|392220|P2|Received Risk Information|Overall Study||70
160278|NCT00462917|392221|P1|Received Risk Information|Overall Study||64
160279|NCT00462917|392218|P4|Met With Genetic Counselor|Overall Study||71
160280|NCT00462917|392219|P3|Met With Genetic Counselor|Overall Study||56
160281|NCT00462917|392220|P2|Met With Genetic Counselor|Overall Study||71
160282|NCT00462917|392221|P1|Met With Genetic Counselor|Overall Study||66
160283|NCT00462917|392218|P4|STARTED|Overall Study||77
160284|NCT00462917|392219|P3|STARTED|Overall Study||66
160285|NCT00462917|392220|P2|STARTED|Overall Study||75
160286|NCT00462917|392221|P1|STARTED|Overall Study||72
160287|NCT00462943|392242|P3|NOT COMPLETED|Overall Study||23
160288|NCT00462943|392243|P2|NOT COMPLETED|Overall Study||30
160289|NCT00462943|392244|P1|NOT COMPLETED|Overall Study||45
160290|NCT00462943|392242|P3|COMPLETED|Overall Study||0
160291|NCT00462943|392243|P2|COMPLETED|Overall Study||1
160292|NCT00462943|392244|P1|COMPLETED|Overall Study||1
160293|NCT00462943|392242|P3|STARTED|Overall Study||23
160294|NCT00462943|392243|P2|STARTED|Overall Study||31
160295|NCT00462943|392244|P1|STARTED|Overall Study||46
160296|NCT00462982|392311|P1|NOT COMPLETED|Overall Study||3
160297|NCT00462982|392311|P1|COMPLETED|Overall Study||5
160298|NCT00462982|392311|P1|STARTED|Overall Study||8
160299|NCT00463047|392315|P2|NOT COMPLETED|Double-Blind Treatment Period 2||2
160300|NCT00463047|392316|P1|NOT COMPLETED|Double-Blind Treatment Period 2||1
160301|NCT00463047|392315|P2|COMPLETED|Double-Blind Treatment Period 2||88
160302|NCT00463047|392316|P1|COMPLETED|Double-Blind Treatment Period 2||92
160303|NCT00463047|392315|P2|STARTED|Double-Blind Treatment Period 2||90
160304|NCT00463047|392316|P1|STARTED|Double-Blind Treatment Period 2||93
160305|NCT00463047|392315|P2|NOT COMPLETED|Double-Blind Treatment Period 1||4
160306|NCT00463047|392316|P1|NOT COMPLETED|Double-Blind Treatment Period 1||3
160307|NCT00463047|392315|P2|COMPLETED|Double-Blind Treatment Period 1||90
160308|NCT00463047|392316|P1|COMPLETED|Double-Blind Treatment Period 1||93
160309|NCT00463047|392315|P2|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|94
160310|NCT00463047|392316|P1|STARTED|Double-Blind Treatment Period 1|After completion of titration period subjects were re-randomized to these two treatment arms|96
160311|NCT00463047|392315|P2|NOT COMPLETED|Titration Period 2||23
160312|NCT00463047|392316|P1|NOT COMPLETED|Titration Period 2||30
160313|NCT00463047|392315|P2|COMPLETED|Titration Period 2||98
160314|NCT00463047|392316|P1|COMPLETED|Titration Period 2||93
160315|NCT00463047|392315|P2|STARTED|Titration Period 2||121
160316|NCT00463047|392316|P1|STARTED|Titration Period 2||123
160317|NCT00463047|392315|P2|NOT COMPLETED|Titration Period 1||39
160318|NCT00463047|392316|P1|NOT COMPLETED|Titration Period 1||37
160319|NCT00463047|392315|P2|COMPLETED|Titration Period 1||121
160320|NCT00463047|392316|P1|COMPLETED|Titration Period 1||123
160321|NCT00463047|392315|P2|STARTED|Titration Period 1||160
160322|NCT00463047|392316|P1|STARTED|Titration Period 1|323 subjects entered study period but 3 discontinued before being randomized to treatment|160
160323|NCT00463229|392403|P2|NOT COMPLETED|Overall Study||10
160324|NCT00463229|392404|P1|NOT COMPLETED|Overall Study||9
160325|NCT00463229|392403|P2|COMPLETED|Overall Study||39
160326|NCT00463229|392404|P1|COMPLETED|Overall Study||43
160327|NCT00463229|392403|P2|STARTED|Overall Study||49
160328|NCT00463229|392404|P1|STARTED|Overall Study||52
160329|NCT00463346|392412|P2|NOT COMPLETED|Overall Study||3
160330|NCT00463346|392413|P1|NOT COMPLETED|Overall Study||3
160331|NCT00463346|392412|P2|COMPLETED|Overall Study||8
160332|NCT00463346|392413|P1|COMPLETED|Overall Study||9
160333|NCT00463346|392412|P2|STARTED|Overall Study||11
160334|NCT00463346|392413|P1|STARTED|Overall Study||12
160335|NCT00463385|392425|P4|NOT COMPLETED|Overall Study||22
160336|NCT00463385|392426|P3|NOT COMPLETED|Overall Study||22
160337|NCT00463385|392427|P2|NOT COMPLETED|Overall Study||22
160338|NCT00463385|392428|P1|NOT COMPLETED|Overall Study||22
160339|NCT00463385|392425|P4|COMPLETED|Overall Study||0
160340|NCT00463385|392426|P3|COMPLETED|Overall Study||0
160341|NCT00463385|392427|P2|COMPLETED|Overall Study||0
160342|NCT00463385|392428|P1|COMPLETED|Overall Study||0
160343|NCT00463385|392425|P4|Treated|Overall Study||22
160344|NCT00463385|392426|P3|Treated|Overall Study||19
160345|NCT00463385|392427|P2|Treated|Overall Study||22
160346|NCT00463385|392428|P1|Treated|Overall Study||22
160347|NCT00463385|392425|P4|STARTED|Overall Study||22
160348|NCT00463385|392426|P3|STARTED|Overall Study||22
160349|NCT00463385|392427|P2|STARTED|Overall Study||22
160350|NCT00463385|392428|P1|STARTED|Overall Study||22
160351|NCT00463437|392482|P4|NOT COMPLETED|Overall Study||7
160352|NCT00463437|392483|P3|NOT COMPLETED|Overall Study||6
160353|NCT00463437|392484|P2|NOT COMPLETED|Overall Study||11
160354|NCT00463437|392485|P1|NOT COMPLETED|Overall Study||4
160355|NCT00463437|392482|P4|COMPLETED|Overall Study||350
160356|NCT00463437|392483|P3|COMPLETED|Overall Study||352
160357|NCT00463437|392484|P2|COMPLETED|Overall Study||352
160358|NCT00463437|392485|P1|COMPLETED|Overall Study||355
160359|NCT00463437|392482|P4|STARTED|Overall Study||357
160360|NCT00463437|392483|P3|STARTED|Overall Study||358
160361|NCT00463437|392484|P2|STARTED|Overall Study||363
160362|NCT00463437|392485|P1|STARTED|Overall Study||359
160363|NCT00463567|392554|P7|NOT COMPLETED|Overall Study||11
160364|NCT00463567|392555|P6|NOT COMPLETED|Overall Study||21
160365|NCT00463567|392556|P5|NOT COMPLETED|Overall Study||23
160366|NCT00463567|392557|P4|NOT COMPLETED|Overall Study||131
160367|NCT00463567|392558|P3|NOT COMPLETED|Overall Study||89
160368|NCT00463567|392559|P2|NOT COMPLETED|Overall Study||77
160369|NCT00463567|392560|P1|NOT COMPLETED|Overall Study||95
160370|NCT00463567|392554|P7|COMPLETED|Overall Study||112
160371|NCT00463567|392555|P6|COMPLETED|Overall Study||102
160372|NCT00463567|392556|P5|COMPLETED|Overall Study||107
160373|NCT00463567|392557|P4|COMPLETED|Overall Study||294
160374|NCT00463567|392558|P3|COMPLETED|Overall Study||331
160375|NCT00463567|392559|P2|COMPLETED|Overall Study||341
160376|NCT00463567|392560|P1|COMPLETED|Overall Study||325
160377|NCT00463567|392554|P7|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
160378|NCT00463567|392555|P6|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|122
160379|NCT00463567|392556|P5|Safety Population: Received Study Drug|Overall Study|'Completed' indicates the number of patients in the interim analysis.|127
160380|NCT00463567|392557|P4|Safety Population: Received Study Drug|Overall Study||418
160381|NCT00463567|392558|P3|Safety Population: Received Study Drug|Overall Study||415
160382|NCT00463567|392559|P2|Safety Population: Received Study Drug|Overall Study||416
160383|NCT00463567|392560|P1|Safety Population: Received Study Drug|Overall Study||416
160384|NCT00463567|392554|P7|STARTED|Overall Study||123
160385|NCT00463567|392555|P6|STARTED|Overall Study||123
160386|NCT00463567|392556|P5|STARTED|Overall Study||130
160387|NCT00463567|392557|P4|STARTED|Overall Study||425
160388|NCT00463567|392558|P3|STARTED|Overall Study||420
160389|NCT00463567|392559|P2|STARTED|Overall Study||418
160390|NCT00463567|392560|P1|STARTED|Overall Study|Randomized Participants|420
160391|NCT00463580|392593|P2|NOT COMPLETED|Overall Study||2
160392|NCT00463580|392594|P1|NOT COMPLETED|Overall Study||3
160393|NCT00463580|392593|P2|COMPLETED|Overall Study||28
160394|NCT00463580|392594|P1|COMPLETED|Overall Study||27
160395|NCT00463580|392593|P2|STARTED|Overall Study||30
160396|NCT00463580|392594|P1|STARTED|Overall Study||30
160397|NCT00463606|392605|P3|NOT COMPLETED|Overall Study||20
160398|NCT00463606|392606|P2|NOT COMPLETED|Overall Study||34
160399|NCT00463606|392607|P1|NOT COMPLETED|Overall Study||41
160400|NCT00463606|392605|P3|COMPLETED|Overall Study||231
160401|NCT00463606|392606|P2|COMPLETED|Overall Study||220
160402|NCT00463606|392607|P1|COMPLETED|Overall Study||212
160403|NCT00463606|392605|P3|STARTED|Overall Study||251
160404|NCT00463606|392606|P2|STARTED|Overall Study||254
160405|NCT00463606|392607|P1|STARTED|Overall Study||253
160406|NCT00463788|392632|P2|NOT COMPLETED|Overall Study||54
160407|NCT00463788|392633|P1|NOT COMPLETED|Overall Study||109
160408|NCT00463788|392632|P2|COMPLETED|Overall Study||4
160409|NCT00463788|392633|P1|COMPLETED|Overall Study||6
160410|NCT00463788|392632|P2|Treated|Overall Study||57
160411|NCT00463788|392633|P1|Treated|Overall Study||114
160412|NCT00463788|392632|P2|STARTED|Overall Study||58
160413|NCT00463788|392633|P1|STARTED|Overall Study||115
160414|NCT00463801|392648|P1|NOT COMPLETED|Overall Study||13
160415|NCT00463801|392648|P1|COMPLETED|Overall Study||39
160416|NCT00463801|392648|P1|STARTED|Overall Study||52
160417|NCT00463840|392652|P1|NOT COMPLETED|Overall Study||12
160418|NCT00463840|392652|P1|COMPLETED|Overall Study||12
160419|NCT00463840|392652|P1|STARTED|Overall Study||24
160420|NCT00463866|392658|P2|NOT COMPLETED|Overall Study||340
160421|NCT00463866|392659|P1|NOT COMPLETED|Overall Study||309
160422|NCT00463866|392658|P2|COMPLETED|Overall Study||3705
160423|NCT00463866|392659|P1|COMPLETED|Overall Study||3699
160424|NCT00463866|392658|P2|STARTED|Overall Study|4221 participants randomised. Out of these, 176 had no efficacy data after randomisation.|4045
160425|NCT00463866|392659|P1|STARTED|Overall Study|4203 participants randomised. Out of these, 195 had no efficacy data after randomisation.|4008
160426|NCT00464087|392682|P3|NOT COMPLETED|Overall Study||29
160427|NCT00464087|392683|P2|NOT COMPLETED|Overall Study||0
160428|NCT00464087|392684|P1|NOT COMPLETED|Overall Study||0
160429|NCT00464087|392682|P3|COMPLETED|Overall Study||0
160430|NCT00464087|392683|P2|COMPLETED|Overall Study||51
160431|NCT00464087|392684|P1|COMPLETED|Overall Study||49
160432|NCT00464087|392682|P3|STARTED|Overall Study||29
160433|NCT00464087|392683|P2|STARTED|Overall Study||51
160434|NCT00464087|392684|P1|STARTED|Overall Study||49
160435|NCT00464204|392702|P2|NOT COMPLETED|Overall Study||32
160436|NCT00464204|392703|P1|NOT COMPLETED|Overall Study||49
160437|NCT00464204|392702|P2|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|64
160438|NCT00464204|392703|P1|COMPLETED|Overall Study|Completed=no withdrawal until day 8.|51
160439|NCT00464204|392702|P2|Withdrawal Due to Discharge From ICU|Overall Study||11
160440|NCT00464204|392703|P1|Withdrawal Due to Discharge From ICU|Overall Study||18
160441|NCT00464204|392702|P2|Day 90 Follow-up Performed|Overall Study||74
160442|NCT00464204|392703|P1|Day 90 Follow-up Performed|Overall Study||69
160443|NCT00464204|392702|P2|Day 30 Follow-up Performed|Overall Study||83
160444|NCT00464204|392703|P1|Day 30 Follow-up Performed|Overall Study||89
160445|NCT00464204|392702|P2|Completed Treatment|Overall Study||83
160446|NCT00464204|392703|P1|Completed Treatment|Overall Study||81
160447|NCT00464204|392702|P2|STARTED|Overall Study||96
160448|NCT00464204|392703|P1|STARTED|Overall Study||100
160449|NCT00464269|392741|P4|NOT COMPLETED|Overall Study||9
160450|NCT00464269|392742|P3|NOT COMPLETED|Overall Study||7
160451|NCT00464269|392743|P2|NOT COMPLETED|Overall Study||17
160452|NCT00464269|392744|P1|NOT COMPLETED|Overall Study||6
160453|NCT00464269|392741|P4|COMPLETED|Overall Study||93
160454|NCT00464269|392742|P3|COMPLETED|Overall Study||93
160455|NCT00464269|392743|P2|COMPLETED|Overall Study||82
160456|NCT00464269|392744|P1|COMPLETED|Overall Study||93
160457|NCT00464269|392741|P4|STARTED|Overall Study||102
160458|NCT00464269|392742|P3|STARTED|Overall Study||100
160459|NCT00464269|392743|P2|STARTED|Overall Study||99
160460|NCT00464269|392744|P1|STARTED|Overall Study||99
160461|NCT00464308|392845|P3|NOT COMPLETED|Overall Study||59
160462|NCT00464308|392846|P2|NOT COMPLETED|Overall Study||63
160463|NCT00464308|392847|P1|NOT COMPLETED|Overall Study||69
160464|NCT00464308|392845|P3|COMPLETED|Overall Study||400
160465|NCT00464308|392846|P2|COMPLETED|Overall Study||406
160466|NCT00464308|392847|P1|COMPLETED|Overall Study||395
160467|NCT00464308|392845|P3|STARTED|Overall Study||459
160468|NCT00464308|392846|P2|STARTED|Overall Study||469
160469|NCT00464308|392847|P1|STARTED|Overall Study||464
160470|NCT00464334|392884|P11|NOT COMPLETED|Overall Study||4
160471|NCT00464334|392885|P10|NOT COMPLETED|Overall Study||1
160472|NCT00464334|392886|P9|NOT COMPLETED|Overall Study||6
160473|NCT00464334|392887|P8|NOT COMPLETED|Overall Study||1
160474|NCT00464334|392888|P7|NOT COMPLETED|Overall Study||3
160475|NCT00464334|392889|P6|NOT COMPLETED|Overall Study||4
160476|NCT00464334|392890|P5|NOT COMPLETED|Overall Study||4
160477|NCT00464334|392891|P4|NOT COMPLETED|Overall Study||4
160478|NCT00464334|392892|P3|NOT COMPLETED|Overall Study||5
160479|NCT00464334|392893|P2|NOT COMPLETED|Overall Study||8
160480|NCT00464334|392894|P1|NOT COMPLETED|Overall Study||1
160481|NCT00464334|392884|P11|COMPLETED|Overall Study||4
160482|NCT00464334|392885|P10|COMPLETED|Overall Study||4
160483|NCT00464334|392886|P9|COMPLETED|Overall Study||2
160484|NCT00464334|392887|P8|COMPLETED|Overall Study||7
160485|NCT00464334|392888|P7|COMPLETED|Overall Study||6
160486|NCT00464334|392889|P6|COMPLETED|Overall Study||3
160487|NCT00464334|392890|P5|COMPLETED|Overall Study||3
160488|NCT00464334|392891|P4|COMPLETED|Overall Study||4
160489|NCT00464334|392892|P3|COMPLETED|Overall Study||3
160490|NCT00464334|392893|P2|COMPLETED|Overall Study||5
160491|NCT00464334|392894|P1|COMPLETED|Overall Study||4
160492|NCT00464334|392884|P11|STARTED|Overall Study||8
160493|NCT00464334|392885|P10|STARTED|Overall Study||5
160494|NCT00464334|392886|P9|STARTED|Overall Study||8
160495|NCT00464334|392887|P8|STARTED|Overall Study||8
160496|NCT00464334|392888|P7|STARTED|Overall Study||9
160497|NCT00464334|392889|P6|STARTED|Overall Study||7
160498|NCT00464334|392890|P5|STARTED|Overall Study||7
160499|NCT00464334|392891|P4|STARTED|Overall Study||8
160500|NCT00464334|392892|P3|STARTED|Overall Study||8
160501|NCT00464334|392893|P2|STARTED|Overall Study||13
160502|NCT00464334|392894|P1|STARTED|Overall Study||5
160503|NCT00457951|392954|P3|NOT COMPLETED|Overall Study||12
160504|NCT00457951|392955|P2|NOT COMPLETED|Overall Study||16
160505|NCT00457951|392956|P1|NOT COMPLETED|Overall Study||0
160506|NCT00457951|392954|P3|COMPLETED|Overall Study||60
160507|NCT00457951|392955|P2|COMPLETED|Overall Study||50
160508|NCT00457951|392956|P1|COMPLETED|Overall Study||13
160509|NCT00457951|392954|P3|STARTED|Overall Study||72
160510|NCT00457951|392955|P2|STARTED|Overall Study||66
160511|NCT00457951|392956|P1|STARTED|Overall Study||13
160512|NCT00457977|392965|P2|NOT COMPLETED|Overall Study||25
160513|NCT00457977|392966|P1|NOT COMPLETED|Overall Study||28
160514|NCT00457977|392965|P2|COMPLETED|Overall Study||66
160515|NCT00457977|392966|P1|COMPLETED|Overall Study||62
160516|NCT00457977|392965|P2|2-Year|Overall Study||66
160517|NCT00457977|392966|P1|2-Year|Overall Study||62
160518|NCT00457977|392965|P2|1-Year|Overall Study||76
160519|NCT00457977|392966|P1|1-Year|Overall Study||69
160520|NCT00457977|392965|P2|1-Month|Overall Study||87
160521|NCT00457977|392966|P1|1-Month|Overall Study||88
160522|NCT00457977|392965|P2|STARTED|Overall Study||91
160523|NCT00457977|392966|P1|STARTED|Overall Study||90
160524|NCT00458211|392974|P1|NOT COMPLETED|Overall Study||16
160525|NCT00458211|392974|P1|COMPLETED|Overall Study|12 early termination 2 protocol violation 2 ( from Rochester) withdrawn from further analysis|24
160526|NCT00458211|392974|P1|STARTED|Overall Study||40
160527|NCT00458237|392988|P3|NOT COMPLETED|Overall Study||0
160528|NCT00458237|392989|P2|NOT COMPLETED|Overall Study||0
160529|NCT00458237|392990|P1|NOT COMPLETED|Overall Study||0
160530|NCT00458237|392988|P3|COMPLETED|Overall Study||5
160531|NCT00458237|392989|P2|COMPLETED|Overall Study||3
160532|NCT00458237|392990|P1|COMPLETED|Overall Study||3
160533|NCT00458237|392988|P3|STARTED|Overall Study||5
160534|NCT00458237|392989|P2|STARTED|Overall Study||3
160535|NCT00458237|392990|P1|STARTED|Overall Study||3
160536|NCT00458302|393001|P2|NOT COMPLETED|Overall Study||24
160537|NCT00458302|393002|P1|NOT COMPLETED|Overall Study||20
160538|NCT00458302|393001|P2|COMPLETED|Overall Study||103
160539|NCT00458302|393002|P1|COMPLETED|Overall Study||109
160540|NCT00458302|393001|P2|STARTED|Overall Study||127
160541|NCT00458302|393002|P1|STARTED|Overall Study||129
160542|NCT00458406|393035|P2|NOT COMPLETED|Month 3||0
160543|NCT00458406|393036|P1|NOT COMPLETED|Month 3||0
160544|NCT00458406|393035|P2|COMPLETED|Month 3||13
160545|NCT00458406|393036|P1|COMPLETED|Month 3||43
160546|NCT00458406|393035|P2|STARTED|Month 3||13
160547|NCT00458406|393036|P1|STARTED|Month 3||43
160548|NCT00458406|393035|P2|NOT COMPLETED|Month 1||0
160549|NCT00458406|393036|P1|NOT COMPLETED|Month 1||0
160550|NCT00458406|393035|P2|COMPLETED|Month 1||13
160551|NCT00458406|393036|P1|COMPLETED|Month 1||43
160552|NCT00458406|393035|P2|STARTED|Month 1||13
160553|NCT00458406|393036|P1|STARTED|Month 1||43
160554|NCT00458536|393054|P1|NOT COMPLETED|Overall Study||19
160555|NCT00458536|393054|P1|COMPLETED|Overall Study||19
160556|NCT00458536|393054|P1|STARTED|Overall Study||38
160557|NCT00464438|393060|P2|NOT COMPLETED|Overall Study||6
160558|NCT00464438|393061|P1|NOT COMPLETED|Overall Study||2
160559|NCT00464438|393060|P2|COMPLETED|Overall Study||80
160560|NCT00464438|393061|P1|COMPLETED|Overall Study||83
160561|NCT00464438|393060|P2|STARTED|Overall Study||86
160562|NCT00464438|393061|P1|STARTED|Overall Study||85
160563|NCT00464464|393075|P2|NOT COMPLETED|Overall Study||3
160564|NCT00464464|393076|P1|NOT COMPLETED|Overall Study||5
160565|NCT00464464|393075|P2|COMPLETED|Overall Study||36
160566|NCT00464464|393076|P1|COMPLETED|Overall Study||36
160567|NCT00464464|393075|P2|STARTED|Overall Study||39
160568|NCT00464464|393076|P1|STARTED|Overall Study||41
160569|NCT00464490|393090|P2|NOT COMPLETED|Overall Study||11
160570|NCT00464490|393091|P1|NOT COMPLETED|Overall Study||11
160571|NCT00464490|393090|P2|COMPLETED|Overall Study||10
160572|NCT00464490|393091|P1|COMPLETED|Overall Study||10
160573|NCT00464490|393090|P2|STARTED|Overall Study||21
160574|NCT00464490|393091|P1|STARTED|Overall Study||21
160575|NCT00464542|393097|P1|NOT COMPLETED|Post-treatment||0
160576|NCT00464542|393097|P1|COMPLETED|Post-treatment||10
160577|NCT00464542|393097|P1|STARTED|Post-treatment||10
160578|NCT00464542|393097|P1|NOT COMPLETED|Pre-treatment||2
160579|NCT00464542|393097|P1|COMPLETED|Pre-treatment||10
160580|NCT00464542|393097|P1|STARTED|Pre-treatment||12
160581|NCT00464568|393102|P1|NOT COMPLETED|Overall Study||2
160582|NCT00464568|393102|P1|COMPLETED|Overall Study||30
160583|NCT00464568|393102|P1|STARTED|Overall Study||32
160584|NCT00464646|393177|P2|NOT COMPLETED|Overall Study||0
160585|NCT00464646|393178|P1|NOT COMPLETED|Overall Study||0
160586|NCT00464646|393177|P2|COMPLETED|Overall Study||29
160587|NCT00464646|393178|P1|COMPLETED|Overall Study||76
160588|NCT00464646|393177|P2|STARTED|Overall Study||29
160589|NCT00464646|393178|P1|STARTED|Overall Study||76
160590|NCT00464672|393186|P6|NOT COMPLETED|Overall Study||4
160591|NCT00464672|393187|P5|NOT COMPLETED|Overall Study||10
160592|NCT00464672|393188|P4|NOT COMPLETED|Overall Study||1
160593|NCT00464672|393189|P3|NOT COMPLETED|Overall Study||0
160594|NCT00464672|393190|P2|NOT COMPLETED|Overall Study||10
160595|NCT00464672|393191|P1|NOT COMPLETED|Overall Study||25
160596|NCT00464672|393186|P6|COMPLETED|Overall Study||195
160597|NCT00464672|393187|P5|COMPLETED|Overall Study||392
160598|NCT00464672|393188|P4|COMPLETED|Overall Study||199
160599|NCT00464672|393189|P3|COMPLETED|Overall Study||400
160600|NCT00464672|393190|P2|COMPLETED|Overall Study||222
160601|NCT00464672|393191|P1|COMPLETED|Overall Study||435
160602|NCT00464672|393186|P6|STARTED|Overall Study||199
160603|NCT00464672|393187|P5|STARTED|Overall Study||402
160604|NCT00464672|393188|P4|STARTED|Overall Study||200
160605|NCT00464672|393189|P3|STARTED|Overall Study||400
160606|NCT00464672|393190|P2|STARTED|Overall Study||232
160607|NCT00464672|393191|P1|STARTED|Overall Study||460
160608|NCT00464685|393263|P2|NOT COMPLETED|Overall Study||33
160609|NCT00464685|393264|P1|NOT COMPLETED|Overall Study||23
160610|NCT00464685|393263|P2|COMPLETED|Overall Study||94
160611|NCT00464685|393264|P1|COMPLETED|Overall Study||103
160612|NCT00464685|393263|P2|STARTED|Overall Study||127
160613|NCT00464685|393264|P1|STARTED|Overall Study||126
160614|NCT00464698|393278|P1|NOT COMPLETED|Period 3: 120mg||2
160615|NCT00464698|393278|P1|COMPLETED|Period 3: 120mg||12
160616|NCT00464698|393278|P1|STARTED|Period 3: 120mg||14
160617|NCT00464698|393278|P1|NOT COMPLETED|Period 2: 60 mg||0
160618|NCT00464698|393278|P1|COMPLETED|Period 2: 60 mg||17
160619|NCT00464698|393278|P1|STARTED|Period 2: 60 mg||17
160620|NCT00464698|393278|P1|NOT COMPLETED|Period 1: 30 mg||3
160621|NCT00464698|393278|P1|COMPLETED|Period 1: 30 mg||17
160622|NCT00464698|393278|P1|STARTED|Period 1: 30 mg||20
160623|NCT00468845|393291|P3|NOT COMPLETED|Overall Study||30
160624|NCT00468845|393292|P2|NOT COMPLETED|Overall Study||34
160625|NCT00468845|393293|P1|NOT COMPLETED|Overall Study||21
160626|NCT00468845|393291|P3|COMPLETED|Overall Study||139
160627|NCT00468845|393292|P2|COMPLETED|Overall Study||136
160628|NCT00468845|393293|P1|COMPLETED|Overall Study||141
160629|NCT00468845|393291|P3|Received Treatment|Overall Study||167
160630|NCT00468845|393292|P2|Received Treatment|Overall Study||166
160631|NCT00468845|393293|P1|Received Treatment|Overall Study||161
160632|NCT00468845|393291|P3|STARTED|Overall Study||169
160633|NCT00468845|393292|P2|STARTED|Overall Study||170
160634|NCT00468845|393293|P1|STARTED|Overall Study||162
160635|NCT00468858|393430|P3|NOT COMPLETED|Overall Study||14
160636|NCT00468858|393431|P2|NOT COMPLETED|Overall Study||10
160637|NCT00468858|393432|P1|NOT COMPLETED|Overall Study||9
160638|NCT00468858|393430|P3|COMPLETED|Overall Study||199
160639|NCT00468858|393431|P2|COMPLETED|Overall Study||202
160640|NCT00468858|393432|P1|COMPLETED|Overall Study||202
160641|NCT00468858|393430|P3|STARTED|Overall Study||213
160642|NCT00468858|393431|P2|STARTED|Overall Study||212
160643|NCT00468858|393432|P1|STARTED|Overall Study||211
160644|NCT00468910|393552|P2|NOT COMPLETED|Overall Study||3
160645|NCT00468910|393553|P1|NOT COMPLETED|Overall Study||4
160646|NCT00468910|393552|P2|COMPLETED|Overall Study||36
160647|NCT00468910|393553|P1|COMPLETED|Overall Study||36
160648|NCT00468910|393552|P2|Follow-up|Overall Study||36
160649|NCT00468910|393553|P1|Follow-up|Overall Study||36
160650|NCT00468910|393552|P2|Post-Treatment Biopsy|Overall Study||36
160651|NCT00468910|393553|P1|Post-Treatment Biopsy|Overall Study||36
160652|NCT00468910|393552|P2|Treatment|Overall Study||36
160653|NCT00468910|393553|P1|Treatment|Overall Study||36
160654|NCT00468910|393552|P2|Randomization|Overall Study||39
160655|NCT00468910|393553|P1|Randomization|Overall Study||40
160656|NCT00468910|393552|P2|STARTED|Overall Study||39
160657|NCT00468910|393553|P1|STARTED|Overall Study||40
160658|NCT00469079|393572|P3|NOT COMPLETED|Overall Study||19
160659|NCT00469079|393573|P2|NOT COMPLETED|Overall Study||22
160660|NCT00469079|393574|P1|NOT COMPLETED|Overall Study||9
160661|NCT00469079|393572|P3|COMPLETED|Overall Study||32
160662|NCT00469079|393573|P2|COMPLETED|Overall Study||30
160663|NCT00469079|393574|P1|COMPLETED|Overall Study||18
160664|NCT00469079|393572|P3|STARTED|Overall Study||51
160665|NCT00469079|393573|P2|STARTED|Overall Study||52
160666|NCT00469079|393574|P1|STARTED|Overall Study||27
160667|NCT00469092|393593|P2|NOT COMPLETED|Overall Study||21
160668|NCT00469092|393594|P1|NOT COMPLETED|Overall Study||26
160669|NCT00469092|393593|P2|COMPLETED|Overall Study||220
160670|NCT00469092|393594|P1|COMPLETED|Overall Study||213
160671|NCT00469092|393593|P2|Exposed to Study Drug|Overall Study||238
160672|NCT00469092|393594|P1|Exposed to Study Drug|Overall Study||231
160673|NCT00469092|393593|P2|STARTED|Overall Study||241
160674|NCT00469092|393594|P1|STARTED|Overall Study||239
160675|NCT00469209|393613|P3|NOT COMPLETED|Overall Study||1
160676|NCT00469209|393614|P2|NOT COMPLETED|Overall Study||0
160677|NCT00469209|393615|P1|NOT COMPLETED|Overall Study||1
160678|NCT00469209|393613|P3|COMPLETED|Overall Study||19
160679|NCT00469209|393614|P2|COMPLETED|Overall Study||20
160680|NCT00469209|393615|P1|COMPLETED|Overall Study||19
160681|NCT00469209|393613|P3|STARTED|Overall Study||20
160682|NCT00469209|393614|P2|STARTED|Overall Study||20
160683|NCT00469209|393615|P1|STARTED|Overall Study||20
160684|NCT00469274|393625|P2|NOT COMPLETED|Overall Study||0
160685|NCT00469274|393626|P1|NOT COMPLETED|Overall Study||0
160686|NCT00469274|393625|P2|COMPLETED|Overall Study||42
160687|NCT00469274|393626|P1|COMPLETED|Overall Study||44
160688|NCT00469274|393625|P2|STARTED|Overall Study||42
160689|NCT00469274|393626|P1|STARTED|Overall Study||44
160690|NCT00469391|393634|P2|NOT COMPLETED|Overall Study||5
160691|NCT00469391|393635|P1|NOT COMPLETED|Overall Study||14
160692|NCT00469391|393634|P2|COMPLETED|Overall Study||24
160693|NCT00469391|393635|P1|COMPLETED|Overall Study||13
160694|NCT00469391|393634|P2|Patient Preference|Overall Study||1
160695|NCT00469391|393635|P1|Patient Preference|Overall Study||0
160696|NCT00469391|393634|P2|Lost to Follow up|Overall Study||1
160697|NCT00469391|393635|P1|Lost to Follow up|Overall Study||0
160698|NCT00469391|393634|P2|Adverse Event|Overall Study||0
160699|NCT00469391|393635|P1|Adverse Event|Overall Study||8
160700|NCT00469391|393634|P2|Unsuccessful Implant Procedure|Overall Study||0
160701|NCT00469391|393635|P1|Unsuccessful Implant Procedure|Overall Study||4
160702|NCT00469391|393634|P2|Discontinued Prior to Procedure|Overall Study||3
160703|NCT00469391|393635|P1|Discontinued Prior to Procedure|Overall Study||2
160704|NCT00469391|393634|P2|STARTED|Overall Study||29
160705|NCT00469391|393635|P1|STARTED|Overall Study||27
160706|NCT00469456|393643|P2|NOT COMPLETED|Overall Study||4
160707|NCT00469456|393644|P1|NOT COMPLETED|Overall Study||9
160708|NCT00469456|393643|P2|COMPLETED|Overall Study||131
160709|NCT00469456|393644|P1|COMPLETED|Overall Study||120
160710|NCT00469456|393643|P2|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug.|135
160711|NCT00469456|393644|P1|STARTED|Overall Study|Safety Population defined as all patients who took at least one dose of double-blind study drug|129
160712|NCT00469508|393654|P2|NOT COMPLETED|Overall Study||24
160713|NCT00469508|393655|P1|NOT COMPLETED|Overall Study||20
160714|NCT00469508|393654|P2|COMPLETED|Overall Study||13
160715|NCT00469508|393655|P1|COMPLETED|Overall Study||14
160716|NCT00469508|393654|P2|STARTED|Overall Study||37
160717|NCT00469508|393655|P1|STARTED|Overall Study||34
160718|NCT00469833|393667|P1|NOT COMPLETED|Overall Study||2
160719|NCT00469833|393667|P1|COMPLETED|Overall Study||15
160720|NCT00469833|393667|P1|STARTED|Overall Study|17 subjects met inclusion criteria and consented for the study|17
160721|NCT00469859|393679|P2|NOT COMPLETED|Overall Study||2
160722|NCT00469859|393680|P1|NOT COMPLETED|Overall Study||0
160723|NCT00469859|393679|P2|COMPLETED|Overall Study||6
160724|NCT00469859|393680|P1|COMPLETED|Overall Study||6
160725|NCT00469859|393679|P2|STARTED|Overall Study||8
160726|NCT00469859|393680|P1|STARTED|Overall Study||6
160727|NCT00469898|393688|P1|NOT COMPLETED|Overall Study||25
160728|NCT00469898|393688|P1|COMPLETED|Overall Study||25
160729|NCT00469898|393688|P1|STARTED|Overall Study||50
160730|NCT00470054|393695|P1|NOT COMPLETED|Overall Study||1
160731|NCT00470054|393695|P1|COMPLETED|Overall Study||43
160732|NCT00470054|393695|P1|STARTED|Overall Study||44
160733|NCT00470067|393703|P1|NOT COMPLETED|Overall Study||7
160734|NCT00470067|393703|P1|COMPLETED|Overall Study||2
160735|NCT00470067|393703|P1|STARTED|Overall Study||9
160736|NCT00470106|393711|P4|NOT COMPLETED|Overall Study||2
160737|NCT00470106|393712|P3|NOT COMPLETED|Overall Study||7
160738|NCT00470106|393713|P2|NOT COMPLETED|Overall Study||5
160739|NCT00470106|393714|P1|NOT COMPLETED|Overall Study||3
160740|NCT00470106|393711|P4|COMPLETED|Overall Study||19
160741|NCT00470106|393712|P3|COMPLETED|Overall Study||14
160742|NCT00470106|393713|P2|COMPLETED|Overall Study||19
160743|NCT00470106|393714|P1|COMPLETED|Overall Study||16
160744|NCT00470106|393711|P4|STARTED|Overall Study||21
160745|NCT00470106|393712|P3|STARTED|Overall Study||21
160746|NCT00470106|393713|P2|STARTED|Overall Study||24
160747|NCT00470106|393714|P1|STARTED|Overall Study||19
160748|NCT00470158|393733|P5|NOT COMPLETED|Overall Study||6
160749|NCT00470158|393734|P4|NOT COMPLETED|Overall Study||5
160750|NCT00470158|393735|P3|NOT COMPLETED|Overall Study||8
160751|NCT00470158|393736|P2|NOT COMPLETED|Overall Study||8
160752|NCT00470158|393737|P1|NOT COMPLETED|Overall Study||8
160753|NCT00470158|393733|P5|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|195
160754|NCT00470158|393734|P4|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
160755|NCT00470158|393735|P3|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
160756|NCT00470158|393736|P2|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|191
160757|NCT00470158|393737|P1|COMPLETED|Overall Study|Enrolled for at least 90% of total study time.|193
160758|NCT00470158|393733|P5|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
160759|NCT00470158|393734|P4|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|198
160760|NCT00470158|393735|P3|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
160761|NCT00470158|393736|P2|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|199
160762|NCT00470158|393737|P1|STARTED|Overall Study|9 children received wrong samples at enrollment and were analyzed by the supplement received.|201
160763|NCT00470184|393749|P1|NOT COMPLETED|Overall Study||22
160764|NCT00470184|393749|P1|COMPLETED|Overall Study||19
160765|NCT00470184|393749|P1|Treated With Study Therapy|Overall Study||36
160766|NCT00470184|393749|P1|STARTED|Overall Study||41
160767|NCT00470262|393758|P2|NOT COMPLETED|Overall Study||0
160768|NCT00470262|393759|P1|NOT COMPLETED|Overall Study||2
160769|NCT00470262|393758|P2|COMPLETED|Overall Study||12
160770|NCT00470262|393759|P1|COMPLETED|Overall Study||13
160771|NCT00470262|393758|P2|STARTED|Overall Study||12
160772|NCT00470262|393759|P1|STARTED|Overall Study||15
160773|NCT00470275|393767|P1|NOT COMPLETED|Overall Study||10
160774|NCT00470275|393767|P1|COMPLETED|Overall Study||0
160775|NCT00470275|393767|P1|STARTED|Overall Study||10
160776|NCT00470301|393771|P1|NOT COMPLETED|Overall Study||5
160777|NCT00470301|393771|P1|COMPLETED|Overall Study||55
160778|NCT00470301|393771|P1|STARTED|Overall Study||60
160779|NCT00470392|393777|P2|NOT COMPLETED|Overall Study||0
160780|NCT00470392|393778|P1|NOT COMPLETED|Overall Study||0
160781|NCT00470392|393777|P2|COMPLETED|Overall Study||2
160782|NCT00470392|393778|P1|COMPLETED|Overall Study||7
160783|NCT00470392|393777|P2|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|2
160784|NCT00470392|393778|P1|STARTED|Overall Study|Number of subjects enrolled, passed screening and assigned to this arm.|7
160785|NCT00470418|393790|P2|NOT COMPLETED|Overall Study||0
160786|NCT00470418|393791|P1|NOT COMPLETED|Overall Study||1
160787|NCT00470418|393790|P2|COMPLETED|Overall Study||3
160788|NCT00470418|393791|P1|COMPLETED|Overall Study||6
160789|NCT00470418|393790|P2|STARTED|Overall Study||3
160790|NCT00470418|393791|P1|STARTED|Overall Study||7
160791|NCT00470470|393799|P1|NOT COMPLETED|Overall Study||5
160792|NCT00470470|393799|P1|COMPLETED|Overall Study||25
160793|NCT00470470|393799|P1|STARTED|Overall Study||30
160794|NCT00470535|393804|P1|NOT COMPLETED|Overall Study||18
160795|NCT00470535|393804|P1|COMPLETED|Overall Study||0
160796|NCT00470535|393804|P1|STARTED|Overall Study||18
160797|NCT00470548|393815|P4|NOT COMPLETED|Overall Study||0
160798|NCT00470548|393816|P3|NOT COMPLETED|Overall Study||0
160799|NCT00470548|393817|P2|NOT COMPLETED|Overall Study||0
160800|NCT00470548|393818|P1|NOT COMPLETED|Overall Study||0
160801|NCT00470548|393815|P4|COMPLETED|Overall Study||37
160802|NCT00470548|393816|P3|COMPLETED|Overall Study||6
160803|NCT00470548|393817|P2|COMPLETED|Overall Study||3
160804|NCT00470548|393818|P1|COMPLETED|Overall Study||3
160805|NCT00470548|393815|P4|STARTED|Overall Study||37
160806|NCT00470548|393816|P3|STARTED|Overall Study||6
160807|NCT00470548|393817|P2|STARTED|Overall Study||3
160808|NCT00470548|393818|P1|STARTED|Overall Study||3
160809|NCT00470600|393838|P2|NOT COMPLETED|Overall Study||0
160810|NCT00470600|393839|P1|NOT COMPLETED|Overall Study||0
160811|NCT00470600|393838|P2|COMPLETED|Overall Study|One subject was randomized to incorrect stratification categories (weight).|99
160812|NCT00470600|393839|P1|COMPLETED|Overall Study|Two subjects were randomized to incorrect stratification categories (weight).|86
160813|NCT00470600|393838|P2|STARTED|Overall Study||99
160814|NCT00470600|393839|P1|STARTED|Overall Study||86
160815|NCT00470626|393849|P1|NOT COMPLETED|Overall Study||17
160816|NCT00470626|393849|P1|COMPLETED|Overall Study||112
160817|NCT00470626|393849|P1|STARTED|Overall Study||129
160818|NCT00470834|393857|P2|NOT COMPLETED|Extension Period (24 Months)||23
160819|NCT00470834|393858|P1|NOT COMPLETED|Extension Period (24 Months)||15
160820|NCT00470834|393857|P2|COMPLETED|Extension Period (24 Months)||7
160821|NCT00470834|393858|P1|COMPLETED|Extension Period (24 Months)||11
160822|NCT00470834|393857|P2|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|30
160823|NCT00470834|393858|P1|STARTED|Extension Period (24 Months)|One participant who completed the Treatment Period did not participate in the Extension Period.|26
160824|NCT00470834|393857|P2|NOT COMPLETED|Treatment Period (18 Months)||31
160825|NCT00470834|393858|P1|NOT COMPLETED|Treatment Period (18 Months)||38
160826|NCT00470834|393857|P2|COMPLETED|Treatment Period (18 Months)||31
160827|NCT00470834|393858|P1|COMPLETED|Treatment Period (18 Months)||27
160828|NCT00470834|393857|P2|STARTED|Treatment Period (18 Months)||62
160829|NCT00470834|393858|P1|STARTED|Treatment Period (18 Months)||65
160830|NCT00470847|393872|P1|NOT COMPLETED|Overall Study||1
160831|NCT00470847|393872|P1|COMPLETED|Overall Study||34
160832|NCT00470847|393872|P1|STARTED|Overall Study||35
160833|NCT00471068|393885|P2|NOT COMPLETED|Overall Study||1
160834|NCT00471068|393886|P1|NOT COMPLETED|Overall Study||1
160835|NCT00471068|393885|P2|COMPLETED|Overall Study||24
160836|NCT00471068|393886|P1|COMPLETED|Overall Study||20
160837|NCT00471068|393885|P2|STARTED|Overall Study||25
160838|NCT00471068|393886|P1|STARTED|Overall Study||21
160839|NCT00471107|393895|P3|NOT COMPLETED|Overall Study||3
160840|NCT00471107|393896|P2|NOT COMPLETED|Overall Study||1
160841|NCT00471107|393897|P1|NOT COMPLETED|Overall Study||3
160842|NCT00471107|393895|P3|COMPLETED|Overall Study||12
160843|NCT00471107|393896|P2|COMPLETED|Overall Study||14
160844|NCT00471107|393897|P1|COMPLETED|Overall Study||12
160845|NCT00471107|393895|P3|STARTED|Overall Study||15
160846|NCT00471107|393896|P2|STARTED|Overall Study||15
160847|NCT00471107|393897|P1|STARTED|Overall Study||15
160848|NCT00471146|393907|P2|NOT COMPLETED|Overall Study||174
160849|NCT00471146|393908|P1|NOT COMPLETED|Overall Study||172
160850|NCT00471146|393907|P2|COMPLETED|Overall Study||142
160851|NCT00471146|393908|P1|COMPLETED|Overall Study||142
160852|NCT00471146|393907|P2|Treated|Overall Study||308
160853|NCT00471146|393908|P1|Treated|Overall Study||305
160854|NCT00471146|393907|P2|STARTED|Overall Study||316
160855|NCT00471146|393908|P1|STARTED|Overall Study||314
160856|NCT00471276|393930|P1|NOT COMPLETED|Overall Study||83
160857|NCT00471276|393930|P1|COMPLETED|Overall Study||0
160858|NCT00471276|393930|P1|STARTED|Overall Study||83
160859|NCT00471315|393953|P1|NOT COMPLETED|Overall Study||8
160860|NCT00471315|393953|P1|COMPLETED|Overall Study||10
160861|NCT00471315|393953|P1|STARTED|Overall Study||18
160862|NCT00471328|393960|P2|NOT COMPLETED|Extension Phase||67
160863|NCT00471328|393961|P1|NOT COMPLETED|Extension Phase||41
160864|NCT00471328|393960|P2|COMPLETED|Extension Phase||0
160865|NCT00471328|393961|P1|COMPLETED|Extension Phase||0
160866|NCT00471328|393960|P2|Started:CrossOver During Extension|Extension Phase||10
160867|NCT00471328|393961|P1|Started:CrossOver During Extension|Extension Phase||0
160868|NCT00471328|393960|P2|Started:CrossOver After PrimaryAnalysis|Extension Phase||4
160869|NCT00471328|393961|P1|Started:CrossOver After PrimaryAnalysis|Extension Phase||0
160870|NCT00471328|393960|P2|Started:CrossOver Before PrimaryAnalysis|Extension Phase||53
160871|NCT00471328|393961|P1|Started:CrossOver Before PrimaryAnalysis|Extension Phase||0
160872|NCT00471328|393960|P2|STARTED|Extension Phase||67
160873|NCT00471328|393961|P1|STARTED|Extension Phase|Out of 58 ongoing patients, 17 patients had progression or died before they could enter extension|41
160874|NCT00471328|393960|P2|NOT COMPLETED|Core Phase||67
160875|NCT00471328|393961|P1|NOT COMPLETED|Core Phase||107
160876|NCT00471328|393960|P2|COMPLETED|Core Phase|Ongoing on treatment during completion of core|16
160877|NCT00471328|393961|P1|COMPLETED|Core Phase|Ongoing on treatment during completion of core.|58
160878|NCT00471328|393960|P2|Crossover to Nilotinib:Started Extension|Core Phase||53
160879|NCT00471328|393961|P1|Crossover to Nilotinib:Started Extension|Core Phase||0
160880|NCT00471328|393960|P2|STARTED|Core Phase||83
160881|NCT00471328|393961|P1|STARTED|Core Phase||165
160882|NCT00471354|393980|P1|NOT COMPLETED|Overall Study||52
160883|NCT00471354|393980|P1|COMPLETED|Overall Study||176
160884|NCT00471354|393980|P1|STARTED|Overall Study||228
160885|NCT00461591|393992|P2|NOT COMPLETED|Overall Study||85
160886|NCT00461591|393993|P1|NOT COMPLETED|Overall Study||89
160887|NCT00461591|393992|P2|COMPLETED|Overall Study||311
160888|NCT00461591|393993|P1|COMPLETED|Overall Study||317
160889|NCT00461591|393992|P2|STARTED|Overall Study||396
160890|NCT00461591|393993|P1|STARTED|Overall Study||406
160891|NCT00461630|394003|P2|NOT COMPLETED|Overall Study||827
160892|NCT00461630|394004|P1|NOT COMPLETED|Overall Study||906
160893|NCT00461630|394003|P2|COMPLETED|Overall Study||12008
160894|NCT00461630|394004|P1|COMPLETED|Overall Study||11932
160895|NCT00461630|394003|P2|STARTED|Overall Study||12835
160896|NCT00461630|394004|P1|STARTED|Overall Study||12838
160897|NCT00461682|394018|P1|NOT COMPLETED|Overall Study||1
160898|NCT00461682|394018|P1|COMPLETED|Overall Study||0
160899|NCT00461682|394018|P1|STARTED|Overall Study||1
160900|NCT00461708|394046|P2|NOT COMPLETED|Overall Study||38
160901|NCT00461708|394047|P1|NOT COMPLETED|Overall Study||115
160902|NCT00461708|394046|P2|COMPLETED|Overall Study||0
160903|NCT00461708|394047|P1|COMPLETED|Overall Study||0
160904|NCT00461708|394046|P2|STARTED|Overall Study||38
160905|NCT00461708|394047|P1|STARTED|Overall Study||115
160906|NCT00461734|394075|P2|NOT COMPLETED|Overall Study||60
160907|NCT00461734|394076|P1|NOT COMPLETED|Overall Study||58
160908|NCT00461734|394075|P2|COMPLETED|Overall Study||60
160909|NCT00461734|394076|P1|COMPLETED|Overall Study||62
160910|NCT00461734|394075|P2|STARTED|Overall Study||120
160911|NCT00461734|394076|P1|STARTED|Overall Study||120
160912|NCT00461786|394108|P1|NOT COMPLETED|Overall Study||3
160913|NCT00461786|394108|P1|COMPLETED|Overall Study|Completed means the patient was evaluable for response.|48
160914|NCT00461786|394108|P1|STARTED|Overall Study||51
160915|NCT00471380|394116|P2|NOT COMPLETED|Third Intervention||2
160916|NCT00471380|394117|P1|NOT COMPLETED|Third Intervention||1
160917|NCT00471380|394116|P2|COMPLETED|Third Intervention||14
160918|NCT00471380|394117|P1|COMPLETED|Third Intervention||17
160919|NCT00471380|394116|P2|STARTED|Third Intervention||16
160920|NCT00471380|394117|P1|STARTED|Third Intervention||18
160921|NCT00471380|394116|P2|NOT COMPLETED|Second Intervention||4
160922|NCT00471380|394117|P1|NOT COMPLETED|Second Intervention||0
160923|NCT00471380|394116|P2|COMPLETED|Second Intervention||16
160924|NCT00471380|394117|P1|COMPLETED|Second Intervention||18
160925|NCT00471380|394116|P2|STARTED|Second Intervention||20
160926|NCT00471380|394117|P1|STARTED|Second Intervention||18
160927|NCT00471380|394116|P2|NOT COMPLETED|First Intervention||4
160928|NCT00471380|394117|P1|NOT COMPLETED|First Intervention||4
160929|NCT00471380|394116|P2|COMPLETED|First Intervention||20
160930|NCT00471380|394117|P1|COMPLETED|First Intervention||18
160931|NCT00471380|394116|P2|STARTED|First Intervention||24
160932|NCT00471380|394117|P1|STARTED|First Intervention||22
160933|NCT00471445|394125|P2|NOT COMPLETED|Overall Study||2
160934|NCT00471445|394126|P1|NOT COMPLETED|Overall Study||2
160935|NCT00471445|394125|P2|COMPLETED|Overall Study||231
160936|NCT00471445|394126|P1|COMPLETED|Overall Study||227
160937|NCT00471445|394125|P2|STARTED|Overall Study||233
160938|NCT00471445|394126|P1|STARTED|Overall Study||229
160939|NCT00471497|394135|P3|NOT COMPLETED|Overall Study||40
160940|NCT00471497|394136|P2|NOT COMPLETED|Overall Study||35
160941|NCT00471497|394137|P1|NOT COMPLETED|Overall Study||46
160942|NCT00471497|394135|P3|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|241
160943|NCT00471497|394136|P2|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|247
160944|NCT00471497|394137|P1|COMPLETED|Overall Study|Completed means patient is on treatment in core phase of the study (ongoing) by data cut-off.|237
160945|NCT00471497|394135|P3|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|277
160946|NCT00471497|394136|P2|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|279
160947|NCT00471497|394137|P1|SAFETY ANALYSIS SET|Overall Study|Safety set contained patients who received at least one dose of study medication.|280
160948|NCT00471497|394135|P3|STARTED|Overall Study||281
160949|NCT00471497|394136|P2|STARTED|Overall Study||282
160950|NCT00471497|394137|P1|STARTED|Overall Study||283
160951|NCT00471536|394145|P1|NOT COMPLETED|Overall Study||1
160952|NCT00471536|394145|P1|COMPLETED|Overall Study||18
160953|NCT00471536|394145|P1|STARTED|Overall Study||19
160954|NCT00473512|394159|P5|NOT COMPLETED|Period 2 (Phase 2)||2
160955|NCT00473512|394160|P4|NOT COMPLETED|Period 2 (Phase 2)||23
160956|NCT00473512|394161|P3|NOT COMPLETED|Period 2 (Phase 2)||2
160957|NCT00473512|394162|P2|NOT COMPLETED|Period 2 (Phase 2)||2
160958|NCT00473512|394163|P1|NOT COMPLETED|Period 2 (Phase 2)||1
160959|NCT00473512|394159|P5|COMPLETED|Period 2 (Phase 2)||0
160960|NCT00473512|394160|P4|COMPLETED|Period 2 (Phase 2)||0
160961|NCT00473512|394161|P3|COMPLETED|Period 2 (Phase 2)||0
160962|NCT00473512|394162|P2|COMPLETED|Period 2 (Phase 2)||0
160963|NCT00473512|394163|P1|COMPLETED|Period 2 (Phase 2)||0
160964|NCT00473512|394159|P5|STARTED|Period 2 (Phase 2)||2
160965|NCT00473512|394160|P4|STARTED|Period 2 (Phase 2)|2 participants did not continue to Phase 2 of the study.|23
160966|NCT00473512|394161|P3|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|2
160967|NCT00473512|394162|P2|STARTED|Period 2 (Phase 2)||2
160968|NCT00473512|394163|P1|STARTED|Period 2 (Phase 2)|1 participant did not continue to Phase 2 of the study.|1
160969|NCT00473512|394159|P5|NOT COMPLETED|Period 1 (Phase 1)||1
160970|NCT00473512|394160|P4|NOT COMPLETED|Period 1 (Phase 1)||17
160971|NCT00473512|394161|P3|NOT COMPLETED|Period 1 (Phase 1)||0
160972|NCT00473512|394162|P2|NOT COMPLETED|Period 1 (Phase 1)||1
160973|NCT00473512|394163|P1|NOT COMPLETED|Period 1 (Phase 1)||1
160974|NCT00473512|394159|P5|COMPLETED|Period 1 (Phase 1)||2
160975|NCT00473512|394160|P4|COMPLETED|Period 1 (Phase 1)||25
160976|NCT00473512|394161|P3|COMPLETED|Period 1 (Phase 1)||3
160977|NCT00473512|394162|P2|COMPLETED|Period 1 (Phase 1)||2
160978|NCT00473512|394163|P1|COMPLETED|Period 1 (Phase 1)||2
160979|NCT00473512|394159|P5|STARTED|Period 1 (Phase 1)||3
160980|NCT00473512|394160|P4|STARTED|Period 1 (Phase 1)||42
160981|NCT00473512|394161|P3|STARTED|Period 1 (Phase 1)||3
160982|NCT00473512|394162|P2|STARTED|Period 1 (Phase 1)||3
160983|NCT00473512|394163|P1|STARTED|Period 1 (Phase 1)||3
160984|NCT00473564|394221|P1|NOT COMPLETED|Overall Study||23
160985|NCT00473564|394221|P1|COMPLETED|Overall Study||147
160986|NCT00473564|394221|P1|STARTED|Overall Study||170
160987|NCT00473590|394228|P2|NOT COMPLETED|Overall Study||38
160988|NCT00473590|394229|P1|NOT COMPLETED|Overall Study||45
160989|NCT00473590|394228|P2|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|11
160990|NCT00473590|394229|P1|COMPLETED|Overall Study|Continuing on study as of the data cutoff date of 9 November 2009.|8
160991|NCT00473590|394228|P2|Safety Population|Overall Study||50
160992|NCT00473590|394229|P1|Safety Population|Overall Study|2 patients received at least 1 bevacizumab dose & were analyzed as bevacizumab-treated patients|50
160993|NCT00473590|394228|P2|Treated|Overall Study||48
160994|NCT00473590|394229|P1|Treated|Overall Study||52
160995|NCT00473590|394228|P2|STARTED|Overall Study||49
160996|NCT00473590|394229|P1|STARTED|Overall Study||53
160997|NCT00473642|394248|P3|NOT COMPLETED|Overall Study||2
160998|NCT00473642|394249|P2|NOT COMPLETED|Overall Study||1
160999|NCT00473642|394250|P1|NOT COMPLETED|Overall Study||2
161000|NCT00473642|394248|P3|COMPLETED|Overall Study||8
161001|NCT00473642|394249|P2|COMPLETED|Overall Study||10
161002|NCT00473642|394250|P1|COMPLETED|Overall Study||8
161003|NCT00473642|394248|P3|STARTED|Overall Study||10
161004|NCT00473642|394249|P2|STARTED|Overall Study||11
161005|NCT00473642|394250|P1|STARTED|Overall Study||10
161006|NCT00473655|394261|P3|NOT COMPLETED|Overall Study||8
161007|NCT00473655|394262|P2|NOT COMPLETED|Overall Study||5
161008|NCT00473655|394263|P1|NOT COMPLETED|Overall Study||9
161009|NCT00473655|394261|P3|COMPLETED|Overall Study|8 participants were lost of follow up|103
161010|NCT00473655|394262|P2|COMPLETED|Overall Study|5 participants were lost of follow up|107
161011|NCT00473655|394263|P1|COMPLETED|Overall Study|9 participants were lost of follow up|102
161012|NCT00473655|394261|P3|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
161013|NCT00473655|394262|P2|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|112
161014|NCT00473655|394263|P1|STARTED|Overall Study|Just participants with TG above 200 mg/dl entered this period|111
161015|NCT00473668|394298|P3|NOT COMPLETED|Overall Study||10
161016|NCT00473668|394299|P2|NOT COMPLETED|Overall Study||11
161017|NCT00473668|394300|P1|NOT COMPLETED|Overall Study||5
161018|NCT00473668|394298|P3|COMPLETED|Overall Study||89
161019|NCT00473668|394299|P2|COMPLETED|Overall Study||89
161020|NCT00473668|394300|P1|COMPLETED|Overall Study||95
161021|NCT00473668|394298|P3|STARTED|Overall Study||99
161022|NCT00473668|394299|P2|STARTED|Overall Study||100
161023|NCT00473668|394300|P1|STARTED|Overall Study||100
161024|NCT00473746|394355|P5|NOT COMPLETED|Period 2 (Phase 2)||27
161025|NCT00473746|394356|P4|NOT COMPLETED|Period 2 (Phase 2)||0
161026|NCT00473746|394357|P3|NOT COMPLETED|Period 2 (Phase 2)||0
161027|NCT00473746|394358|P2|NOT COMPLETED|Period 2 (Phase 2)||0
161028|NCT00473746|394359|P1|NOT COMPLETED|Period 2 (Phase 2)||0
161029|NCT00473746|394355|P5|COMPLETED|Period 2 (Phase 2)||6
161030|NCT00473746|394356|P4|COMPLETED|Period 2 (Phase 2)||0
161031|NCT00473746|394357|P3|COMPLETED|Period 2 (Phase 2)||0
161032|NCT00473746|394358|P2|COMPLETED|Period 2 (Phase 2)||0
161033|NCT00473746|394359|P1|COMPLETED|Period 2 (Phase 2)||0
161034|NCT00473746|394355|P5|STARTED|Period 2 (Phase 2)||33
161035|NCT00473746|394356|P4|STARTED|Period 2 (Phase 2)||0
161036|NCT00473746|394357|P3|STARTED|Period 2 (Phase 2)||0
161037|NCT00473746|394358|P2|STARTED|Period 2 (Phase 2)||0
161038|NCT00473746|394359|P1|STARTED|Period 2 (Phase 2)||0
161039|NCT00473746|394355|P5|NOT COMPLETED|Period 1 (Phase 1)||0
161040|NCT00473746|394356|P4|NOT COMPLETED|Period 1 (Phase 1)||10
161041|NCT00473746|394357|P3|NOT COMPLETED|Period 1 (Phase 1)||6
161042|NCT00473746|394358|P2|NOT COMPLETED|Period 1 (Phase 1)||9
161043|NCT00473746|394359|P1|NOT COMPLETED|Period 1 (Phase 1)||6
161044|NCT00473746|394355|P5|COMPLETED|Period 1 (Phase 1)||0
161045|NCT00473746|394356|P4|COMPLETED|Period 1 (Phase 1)|Treatment ongoing|2
161046|NCT00473746|394357|P3|COMPLETED|Period 1 (Phase 1)||0
161047|NCT00473746|394358|P2|COMPLETED|Period 1 (Phase 1)||0
161048|NCT00473746|394359|P1|COMPLETED|Period 1 (Phase 1)||0
161049|NCT00473746|394355|P5|STARTED|Period 1 (Phase 1)||0
161050|NCT00473746|394356|P4|STARTED|Period 1 (Phase 1)||12
161051|NCT00473746|394357|P3|STARTED|Period 1 (Phase 1)||6
161052|NCT00473746|394358|P2|STARTED|Period 1 (Phase 1)||9
161053|NCT00473746|394359|P1|STARTED|Period 1 (Phase 1)||6
161054|NCT00473824|394406|P2|NOT COMPLETED|Overall Study||0
161055|NCT00473824|394407|P1|NOT COMPLETED|Overall Study||5
161056|NCT00473824|394406|P2|COMPLETED|Overall Study|Study Completion/Early Termination Date|2
161057|NCT00473824|394407|P1|COMPLETED|Overall Study|Study Completion/Early Termination Date|0
161058|NCT00473824|394406|P2|STARTED|Overall Study||2
161059|NCT00473824|394407|P1|STARTED|Overall Study||5
161060|NCT00473837|394415|P2|NOT COMPLETED|Overall Study||3
161061|NCT00473837|394416|P1|NOT COMPLETED|Overall Study||1
161062|NCT00473837|394415|P2|COMPLETED|Overall Study||43
161063|NCT00473837|394416|P1|COMPLETED|Overall Study||49
161064|NCT00473837|394415|P2|STARTED|Overall Study||46
161065|NCT00473837|394416|P1|STARTED|Overall Study||50
161066|NCT00473876|394424|P2|NOT COMPLETED|Overall Study||1
161067|NCT00473876|394425|P1|NOT COMPLETED|Overall Study||3
161068|NCT00473876|394424|P2|COMPLETED|Overall Study||22
161069|NCT00473876|394425|P1|COMPLETED|Overall Study||36
161070|NCT00473876|394424|P2|STARTED|Overall Study||23
161071|NCT00473876|394425|P1|STARTED|Overall Study||39
161072|NCT00473889|394435|P2|NOT COMPLETED|Overall Study||64
161073|NCT00473889|394436|P1|NOT COMPLETED|Overall Study||83
161074|NCT00473889|394435|P2|COMPLETED|Overall Study||63
161075|NCT00473889|394436|P1|COMPLETED|Overall Study||43
161076|NCT00473889|394435|P2|STARTED|Overall Study||127
161077|NCT00473889|394436|P1|STARTED|Overall Study||126
161078|NCT00474045|394448|P2|NOT COMPLETED|Overall Study||101
161079|NCT00474045|394449|P1|NOT COMPLETED|Overall Study||106
161080|NCT00474045|394448|P2|COMPLETED|Overall Study||136
161081|NCT00474045|394449|P1|COMPLETED|Overall Study||127
161082|NCT00474045|394448|P2|Pregnancies (for Exposed-pregnant)|Overall Study|2 subjects had spontaneous abortion and became pregnant again|160
161083|NCT00474045|394449|P1|Pregnancies (for Exposed-pregnant)|Overall Study||152
161084|NCT00474045|394448|P2|Exposed-Pregnant Subjects|Overall Study|3 withdrawn before treatment initiation|158
161085|NCT00474045|394449|P1|Exposed-Pregnant Subjects|Overall Study||152
161086|NCT00474045|394448|P2|Exposed-All Subjects|Overall Study|5 withdrawn before treatment initiation|232
161087|NCT00474045|394449|P1|Exposed-All Subjects|Overall Study||233
161088|NCT00474045|394448|P2|STARTED|Overall Study||237
161089|NCT00474045|394449|P1|STARTED|Overall Study||233
161090|NCT00474058|394549|P2|NOT COMPLETED|Overall Study||17
161091|NCT00474058|394550|P1|NOT COMPLETED|Overall Study||24
161092|NCT00474058|394549|P2|COMPLETED|Overall Study||80
161093|NCT00474058|394550|P1|COMPLETED|Overall Study||166
161094|NCT00474058|394549|P2|STARTED|Overall Study||97
161095|NCT00474058|394550|P1|STARTED|Overall Study||190
161096|NCT00474123|394564|P2|NOT COMPLETED|Overall Study||0
161097|NCT00474123|394565|P1|NOT COMPLETED|Overall Study||0
161098|NCT00474123|394564|P2|COMPLETED|Overall Study||40
161099|NCT00474123|394565|P1|COMPLETED|Overall Study||38
161100|NCT00474123|394564|P2|STARTED|Overall Study||40
161101|NCT00474123|394565|P1|STARTED|Overall Study||38
161102|NCT00474175|394592|P3|NOT COMPLETED|Overall Study||4
161103|NCT00474175|394593|P2|NOT COMPLETED|Overall Study||7
161104|NCT00474175|394594|P1|NOT COMPLETED|Overall Study||1
161105|NCT00474175|394592|P3|COMPLETED|Overall Study||225
161106|NCT00474175|394593|P2|COMPLETED|Overall Study||226
161107|NCT00474175|394594|P1|COMPLETED|Overall Study||114
161108|NCT00474175|394592|P3|Treated|Overall Study||228
161109|NCT00474175|394593|P2|Treated|Overall Study||233
161110|NCT00474175|394594|P1|Treated|Overall Study||115
161111|NCT00474175|394592|P3|STARTED|Overall Study||229
161112|NCT00474175|394593|P2|STARTED|Overall Study||233
161113|NCT00474175|394594|P1|STARTED|Overall Study||115
161114|NCT00474188|394629|P1|NOT COMPLETED|Overall Study||6
161115|NCT00474188|394629|P1|COMPLETED|Overall Study|Disease progression=15, adverse event=4, death=1|20
161116|NCT00474188|394629|P1|STARTED|Overall Study||26
161117|NCT00474201|394636|P1|NOT COMPLETED|Overall Study||0
161118|NCT00474201|394636|P1|COMPLETED|Overall Study||15
161119|NCT00474201|394636|P1|STARTED|Overall Study||15
161120|NCT00474240|394647|P6|NOT COMPLETED|Overall Study||18
161121|NCT00474240|394648|P5|NOT COMPLETED|Overall Study||8
161122|NCT00474240|394649|P4|NOT COMPLETED|Overall Study||16
161123|NCT00474240|394650|P3|NOT COMPLETED|Overall Study||9
161124|NCT00474240|394651|P2|NOT COMPLETED|Overall Study||1
161125|NCT00474240|394652|P1|NOT COMPLETED|Overall Study||1
161126|NCT00474240|394647|P6|COMPLETED|Overall Study||8
161127|NCT00474240|394648|P5|COMPLETED|Overall Study||18
161128|NCT00474240|394649|P4|COMPLETED|Overall Study||10
161129|NCT00474240|394650|P3|COMPLETED|Overall Study||17
161130|NCT00474240|394651|P2|COMPLETED|Overall Study||25
161131|NCT00474240|394652|P1|COMPLETED|Overall Study||26
161132|NCT00474240|394647|P6|STARTED|Overall Study||26
161133|NCT00474240|394648|P5|STARTED|Overall Study||26
161134|NCT00474240|394649|P4|STARTED|Overall Study||26
161135|NCT00474240|394650|P3|STARTED|Overall Study||26
161136|NCT00474240|394651|P2|STARTED|Overall Study||26
161137|NCT00474240|394652|P1|STARTED|Overall Study||27
161138|NCT00474383|394672|P2|NOT COMPLETED|Extension||5
161139|NCT00474383|394673|P1|NOT COMPLETED|Extension||0
161140|NCT00474383|394672|P2|COMPLETED|Extension||0
161141|NCT00474383|394673|P1|COMPLETED|Extension||0
161142|NCT00474383|394672|P2|STARTED|Extension||5
161143|NCT00474383|394673|P1|STARTED|Extension||0
161144|NCT00474383|394672|P2|NOT COMPLETED|Between Main Study and Extension||0
161145|NCT00474383|394673|P1|NOT COMPLETED|Between Main Study and Extension||6
161146|NCT00474383|394672|P2|COMPLETED|Between Main Study and Extension||0
161147|NCT00474383|394673|P1|COMPLETED|Between Main Study and Extension||5
161148|NCT00474383|394672|P2|STARTED|Between Main Study and Extension||0
161149|NCT00474383|394673|P1|STARTED|Between Main Study and Extension||11
161150|NCT00474383|394672|P2|NOT COMPLETED|Main Study||0
161151|NCT00474383|394673|P1|NOT COMPLETED|Main Study||36
161152|NCT00474383|394672|P2|COMPLETED|Main Study||0
161153|NCT00474383|394673|P1|COMPLETED|Main Study||11
161154|NCT00474383|394672|P2|STARTED|Main Study||0
161155|NCT00474383|394673|P1|STARTED|Main Study||47
161156|NCT00474487|394688|P4|NOT COMPLETED|Overall Study||0
161157|NCT00474487|394689|P3|NOT COMPLETED|Overall Study||14
161158|NCT00474487|394690|P2|NOT COMPLETED|Overall Study||2
161159|NCT00474487|394691|P1|NOT COMPLETED|Overall Study||30
161160|NCT00474487|394688|P4|COMPLETED|Overall Study||109
161161|NCT00474487|394689|P3|COMPLETED|Overall Study||885
161162|NCT00474487|394690|P2|COMPLETED|Overall Study||215
161163|NCT00474487|394691|P1|COMPLETED|Overall Study||1576
161164|NCT00474487|394688|P4|STARTED|Overall Study||109
161165|NCT00474487|394689|P3|STARTED|Overall Study||899
161166|NCT00474487|394690|P2|STARTED|Overall Study||217
161167|NCT00474487|394691|P1|STARTED|Overall Study||1606
161168|NCT00474526|394728|P17|NOT COMPLETED|Overall Study||9
161169|NCT00474526|394729|P16|NOT COMPLETED|Overall Study||18
161170|NCT00474526|394730|P15|NOT COMPLETED|Overall Study||77
161171|NCT00474526|394731|P14|NOT COMPLETED|Overall Study||156
161172|NCT00474526|394732|P13|NOT COMPLETED|Overall Study||15
161173|NCT00474526|394733|P12|NOT COMPLETED|Overall Study||11
161174|NCT00474526|394734|P11|NOT COMPLETED|Overall Study||10
161175|NCT00474526|394735|P10|NOT COMPLETED|Overall Study||27
161176|NCT00474526|394736|P9|NOT COMPLETED|Overall Study||6
161177|NCT00474526|394737|P8|NOT COMPLETED|Overall Study||6
161178|NCT00474526|394738|P7|NOT COMPLETED|Overall Study||25
161179|NCT00474526|394739|P6|NOT COMPLETED|Overall Study||16
161180|NCT00474526|394740|P5|NOT COMPLETED|Overall Study||68
161181|NCT00474526|394741|P4|NOT COMPLETED|Overall Study||119
161182|NCT00474526|394742|P3|NOT COMPLETED|Overall Study||49
161183|NCT00474526|394743|P2|NOT COMPLETED|Overall Study||46
161184|NCT00474526|394744|P1|NOT COMPLETED|Overall Study||33
161185|NCT00474526|394728|P17|COMPLETED|Overall Study||174
161186|NCT00474526|394729|P16|COMPLETED|Overall Study||152
161187|NCT00474526|394730|P15|COMPLETED|Overall Study||281
161188|NCT00474526|394731|P14|COMPLETED|Overall Study||1270
161189|NCT00474526|394732|P13|COMPLETED|Overall Study||135
161190|NCT00474526|394733|P12|COMPLETED|Overall Study||139
161191|NCT00474526|394734|P11|COMPLETED|Overall Study||141
161192|NCT00474526|394735|P10|COMPLETED|Overall Study||121
161193|NCT00474526|394736|P9|COMPLETED|Overall Study||144
161194|NCT00474526|394737|P8|COMPLETED|Overall Study||145
161195|NCT00474526|394738|P7|COMPLETED|Overall Study||178
161196|NCT00474526|394739|P6|COMPLETED|Overall Study||54
161197|NCT00474526|394740|P5|COMPLETED|Overall Study||8
161198|NCT00474526|394741|P4|COMPLETED|Overall Study||561
161199|NCT00474526|394742|P3|COMPLETED|Overall Study||110
161200|NCT00474526|394743|P2|COMPLETED|Overall Study||120
161201|NCT00474526|394744|P1|COMPLETED|Overall Study||121
161202|NCT00474526|394728|P17|STARTED|Overall Study||183
161203|NCT00474526|394729|P16|STARTED|Overall Study||170
161204|NCT00474526|394730|P15|STARTED|Overall Study||358
161205|NCT00474526|394731|P14|STARTED|Overall Study||1426
161206|NCT00474526|394732|P13|STARTED|Overall Study||150
161207|NCT00474526|394733|P12|STARTED|Overall Study||150
161208|NCT00474526|394734|P11|STARTED|Overall Study||151
161209|NCT00474526|394735|P10|STARTED|Overall Study||148
161210|NCT00474526|394736|P9|STARTED|Overall Study||150
161211|NCT00474526|394737|P8|STARTED|Overall Study||151
161212|NCT00474526|394738|P7|STARTED|Overall Study||203
161213|NCT00474526|394739|P6|STARTED|Overall Study||70
161214|NCT00474526|394740|P5|STARTED|Overall Study||76
161215|NCT00474526|394741|P4|STARTED|Overall Study||680
161216|NCT00474526|394742|P3|STARTED|Overall Study||159
161217|NCT00474526|394743|P2|STARTED|Overall Study||166
161218|NCT00474526|394744|P1|STARTED|Overall Study||154
161219|NCT00474539|394907|P2|NOT COMPLETED|Toddler Dose||0
161220|NCT00474539|394908|P1|NOT COMPLETED|Toddler Dose||1
161221|NCT00474539|394907|P2|COMPLETED|Toddler Dose||220
161222|NCT00474539|394908|P1|COMPLETED|Toddler Dose||208
161223|NCT00474539|394907|P2|STARTED|Toddler Dose||220
161224|NCT00474539|394908|P1|STARTED|Toddler Dose||209
161225|NCT00474539|394907|P2|NOT COMPLETED|After Infant Series||0
161226|NCT00474539|394908|P1|NOT COMPLETED|After Infant Series||4
161227|NCT00474539|394907|P2|COMPLETED|After Infant Series||220
161228|NCT00474539|394908|P1|COMPLETED|After Infant Series||209
161229|NCT00474539|394907|P2|STARTED|After Infant Series||220
161230|NCT00474539|394908|P1|STARTED|After Infant Series||213
161231|NCT00474539|394907|P2|NOT COMPLETED|Infant Series||6
161232|NCT00474539|394908|P1|NOT COMPLETED|Infant Series||10
161233|NCT00474539|394907|P2|COMPLETED|Infant Series||220
161234|NCT00474539|394908|P1|COMPLETED|Infant Series||213
161235|NCT00474539|394907|P2|Vaccinated Dose 3|Infant Series||221
161236|NCT00474539|394908|P1|Vaccinated Dose 3|Infant Series||214
161237|NCT00474539|394907|P2|Vaccinated Dose 2|Infant Series||222
161238|NCT00474539|394908|P1|Vaccinated Dose 2|Infant Series||217
161239|NCT00474539|394907|P2|Vaccinated Dose 1|Infant Series||226
161240|NCT00474539|394908|P1|Vaccinated Dose 1|Infant Series||218
161241|NCT00474539|394907|P2|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|226
161242|NCT00474539|394908|P1|STARTED|Infant Series|One participant was randomized to 7vPnC, but received 13vPnC.|223
161243|NCT00474630|394958|P2|NOT COMPLETED|Overall Study||70
161244|NCT00474630|394959|P1|NOT COMPLETED|Overall Study||160
161245|NCT00474630|394958|P2|COMPLETED|Overall Study||100
161246|NCT00474630|394959|P1|COMPLETED|Overall Study||175
161247|NCT00474630|394958|P2|STARTED|Overall Study||170
161248|NCT00474630|394959|P1|STARTED|Overall Study||335
161249|NCT00474708|395015|P2|NOT COMPLETED|Overall Study||25
161250|NCT00474708|395016|P1|NOT COMPLETED|Overall Study||57
161251|NCT00474708|395015|P2|COMPLETED|Overall Study||342
161252|NCT00474708|395016|P1|COMPLETED|Overall Study||734
161253|NCT00474708|395015|P2|STARTED|Overall Study||367
161254|NCT00474708|395016|P1|STARTED|Overall Study||791
161255|NCT00474760|395031|P7|NOT COMPLETED|Overall Study||10
161256|NCT00474760|395032|P6|NOT COMPLETED|Overall Study||29
161257|NCT00474760|395033|P5|NOT COMPLETED|Overall Study||12
161258|NCT00474760|395034|P4|NOT COMPLETED|Overall Study||3
161259|NCT00474760|395035|P3|NOT COMPLETED|Overall Study||3
161260|NCT00474760|395036|P2|NOT COMPLETED|Overall Study||3
161261|NCT00474760|395037|P1|NOT COMPLETED|Overall Study||3
161262|NCT00474760|395031|P7|COMPLETED|Overall Study||1
161263|NCT00474760|395032|P6|COMPLETED|Overall Study||0
161264|NCT00474760|395033|P5|COMPLETED|Overall Study||1
161265|NCT00474760|395034|P4|COMPLETED|Overall Study||0
161266|NCT00474760|395035|P3|COMPLETED|Overall Study||0
161267|NCT00474760|395036|P2|COMPLETED|Overall Study||0
161268|NCT00474760|395037|P1|COMPLETED|Overall Study||0
161269|NCT00474760|395031|P7|STARTED|Overall Study||11
161270|NCT00474760|395032|P6|STARTED|Overall Study||29
161271|NCT00474760|395033|P5|STARTED|Overall Study||13
161272|NCT00474760|395034|P4|STARTED|Overall Study||3
161273|NCT00474760|395035|P3|STARTED|Overall Study||3
161274|NCT00474760|395036|P2|STARTED|Overall Study||3
161275|NCT00474760|395037|P1|STARTED|Overall Study||3
161276|NCT00474786|395144|P2|NOT COMPLETED|Overall Study||253
161277|NCT00474786|395145|P1|NOT COMPLETED|Overall Study||259
161278|NCT00474786|395144|P2|COMPLETED|Overall Study||0
161279|NCT00474786|395145|P1|COMPLETED|Overall Study||0
161280|NCT00474786|395144|P2|STARTED|Overall Study||253
161281|NCT00474786|395145|P1|STARTED|Overall Study||259
161282|NCT00474812|395163|P1|NOT COMPLETED|Overall Study||7
161283|NCT00474812|395163|P1|COMPLETED|Overall Study||44
161284|NCT00474812|395163|P1|STARTED|Overall Study||51
161285|NCT00474851|395173|P2|NOT COMPLETED|Overall Study||11
161286|NCT00474851|395174|P1|NOT COMPLETED|Overall Study||8
161287|NCT00474851|395173|P2|COMPLETED|Overall Study||16
161288|NCT00474851|395174|P1|COMPLETED|Overall Study||18
161289|NCT00474851|395173|P2|Completed Baseline|Overall Study||26
161290|NCT00474851|395174|P1|Completed Baseline|Overall Study||25
161291|NCT00474851|395173|P2|STARTED|Overall Study||27
161292|NCT00474851|395174|P1|STARTED|Overall Study||26
161293|NCT00474903|395185|P3|NOT COMPLETED|Overall Study||2
161294|NCT00474903|395186|P2|NOT COMPLETED|Overall Study||5
161295|NCT00474903|395187|P1|NOT COMPLETED|Overall Study||1
161296|NCT00474903|395185|P3|COMPLETED|Overall Study||43
161297|NCT00474903|395186|P2|COMPLETED|Overall Study||42
161298|NCT00474903|395187|P1|COMPLETED|Overall Study||29
161299|NCT00474903|395185|P3|STARTED|Overall Study||45
161300|NCT00474903|395186|P2|STARTED|Overall Study||47
161301|NCT00474903|395187|P1|STARTED|Overall Study||30
161302|NCT00474929|395203|P5|NOT COMPLETED|Overall Study||0
161303|NCT00474929|395204|P4|NOT COMPLETED|Overall Study||2
161304|NCT00474929|395205|P3|NOT COMPLETED|Overall Study||2
161305|NCT00474929|395206|P2|NOT COMPLETED|Overall Study||1
161306|NCT00474929|395207|P1|NOT COMPLETED|Overall Study||0
161307|NCT00474929|395203|P5|COMPLETED|Overall Study||77
161308|NCT00474929|395204|P4|COMPLETED|Overall Study||5
161309|NCT00474929|395205|P3|COMPLETED|Overall Study||5
161310|NCT00474929|395206|P2|COMPLETED|Overall Study||5
161311|NCT00474929|395207|P1|COMPLETED|Overall Study||6
161312|NCT00474929|395203|P5|STARTED|Overall Study||77
161313|NCT00474929|395204|P4|STARTED|Overall Study||7
161314|NCT00474929|395205|P3|STARTED|Overall Study||7
161315|NCT00474929|395206|P2|STARTED|Overall Study||6
161316|NCT00474929|395207|P1|STARTED|Overall Study||6
161317|NCT00474955|395221|P1|NOT COMPLETED|Overall Study||8
161318|NCT00474955|395221|P1|COMPLETED|Overall Study||19
161319|NCT00474955|395221|P1|STARTED|Overall Study||27
161320|NCT00474968|395234|P2|NOT COMPLETED|Overall Study||16
161321|NCT00474968|395235|P1|NOT COMPLETED|Overall Study||18
161322|NCT00474968|395234|P2|COMPLETED|Overall Study||355
161323|NCT00474968|395235|P1|COMPLETED|Overall Study||348
161324|NCT00474968|395234|P2|STARTED|Overall Study||371
161325|NCT00474968|395235|P1|STARTED|Overall Study||366
161326|NCT00474994|395245|P1|NOT COMPLETED|Overall Study||5
161327|NCT00474994|395245|P1|COMPLETED|Overall Study||48
161328|NCT00474994|395245|P1|STARTED|Overall Study||53
161329|NCT00475033|395251|P2|NOT COMPLETED|Toddler Dose||0
161330|NCT00475033|395252|P1|NOT COMPLETED|Toddler Dose||4
161331|NCT00475033|395251|P2|COMPLETED|Toddler Dose||282
161332|NCT00475033|395252|P1|COMPLETED|Toddler Dose||283
161333|NCT00475033|395251|P2|STARTED|Toddler Dose|Vaccinated Toddler Dose|282
161334|NCT00475033|395252|P1|STARTED|Toddler Dose|Vaccinated Toddler Dose|287
161335|NCT00475033|395251|P2|NOT COMPLETED|After the Infant Series||8
161336|NCT00475033|395252|P1|NOT COMPLETED|After the Infant Series||6
161337|NCT00475033|395251|P2|COMPLETED|After the Infant Series||282
161338|NCT00475033|395252|P1|COMPLETED|After the Infant Series||287
161339|NCT00475033|395251|P2|Withdrawn After Infant Series|After the Infant Series||8
161340|NCT00475033|395252|P1|Withdrawn After Infant Series|After the Infant Series||6
161341|NCT00475033|395251|P2|STARTED|After the Infant Series||290
161342|NCT00475033|395252|P1|STARTED|After the Infant Series||293
161343|NCT00475033|395251|P2|NOT COMPLETED|Infant Series||13
161344|NCT00475033|395252|P1|NOT COMPLETED|Infant Series||7
161345|NCT00475033|395251|P2|COMPLETED|Infant Series||290
161346|NCT00475033|395252|P1|COMPLETED|Infant Series||293
161347|NCT00475033|395251|P2|Vaccinated Dose 3|Infant Series||294
161348|NCT00475033|395252|P1|Vaccinated Dose 3|Infant Series||293
161349|NCT00475033|395251|P2|Vaccinated Dose 2|Infant Series||296
161350|NCT00475033|395252|P1|Vaccinated Dose 2|Infant Series||297
161351|NCT00475033|395251|P2|Vaccinated Dose 1|Infant Series||303
161352|NCT00475033|395252|P1|Vaccinated Dose 1|Infant Series||300
161353|NCT00475033|395251|P2|STARTED|Infant Series||303
161354|NCT00475033|395252|P1|STARTED|Infant Series||300
161355|NCT00475085|395304|P4|NOT COMPLETED|Overall Study||20
161356|NCT00475085|395305|P3|NOT COMPLETED|Overall Study||19
161357|NCT00475085|395306|P2|NOT COMPLETED|Overall Study||20
161358|NCT00475085|395307|P1|NOT COMPLETED|Overall Study||18
161359|NCT00475085|395304|P4|COMPLETED|Overall Study||234
161360|NCT00475085|395305|P3|COMPLETED|Overall Study||241
161361|NCT00475085|395306|P2|COMPLETED|Overall Study||234
161362|NCT00475085|395307|P1|COMPLETED|Overall Study||235
161363|NCT00475085|395304|P4|STARTED|Overall Study||254
161364|NCT00475085|395305|P3|STARTED|Overall Study||260
161365|NCT00475085|395306|P2|STARTED|Overall Study||254
161366|NCT00475085|395307|P1|STARTED|Overall Study||253
161367|NCT00475150|395319|P2|NOT COMPLETED|Overall Study||0
161368|NCT00475150|395320|P1|NOT COMPLETED|Overall Study||0
161369|NCT00475150|395319|P2|COMPLETED|Overall Study||16
161370|NCT00475150|395320|P1|COMPLETED|Overall Study||23
161371|NCT00475150|395319|P2|STARTED|Overall Study||16
161372|NCT00475150|395320|P1|STARTED|Overall Study||23
161373|NCT00475176|395333|P1|NOT COMPLETED|Overall Study||4
161374|NCT00475176|395333|P1|COMPLETED|Overall Study||20
161375|NCT00475176|395333|P1|STARTED|Overall Study||24
161376|NCT00475228|395340|P2|NOT COMPLETED|Overall Study||17
161377|NCT00475228|395341|P1|NOT COMPLETED|Overall Study||17
161378|NCT00475228|395340|P2|COMPLETED|Overall Study||27
161379|NCT00475228|395341|P1|COMPLETED|Overall Study||27
161380|NCT00475228|395340|P2|STARTED|Overall Study||44
161381|NCT00475228|395341|P1|STARTED|Overall Study||44
161382|NCT00475241|395353|P2|NOT COMPLETED|Overall Study||3
161383|NCT00475241|395354|P1|NOT COMPLETED|Overall Study||7
161384|NCT00475241|395353|P2|COMPLETED|Overall Study||15
161385|NCT00475241|395354|P1|COMPLETED|Overall Study||11
161386|NCT00475241|395353|P2|STARTED|Overall Study||18
161387|NCT00475241|395354|P1|STARTED|Overall Study||18
161388|NCT00475306|395364|P4|NOT COMPLETED|Overall Study||1
161389|NCT00475306|395365|P3|NOT COMPLETED|Overall Study||0
161390|NCT00475306|395366|P2|NOT COMPLETED|Overall Study||1
161391|NCT00475306|395367|P1|NOT COMPLETED|Overall Study||1
161392|NCT00475306|395364|P4|COMPLETED|Overall Study|1 patient's intravenous line infiltrated.|71
161393|NCT00475306|395365|P3|COMPLETED|Overall Study||72
161394|NCT00475306|395366|P2|COMPLETED|Overall Study|For 1 patient, data collection was incomplete and results could not be analyzed|71
161395|NCT00475306|395367|P1|COMPLETED|Overall Study|1 patient had resolution of nausea prior and did not receive the investigational medication|72
161396|NCT00475306|395364|P4|STARTED|Overall Study||72
161397|NCT00475306|395365|P3|STARTED|Overall Study||72
161398|NCT00475306|395366|P2|STARTED|Overall Study||72
161399|NCT00475306|395367|P1|STARTED|Overall Study||73
161400|NCT00475319|395384|P3|NOT COMPLETED|Overall Study||4
161401|NCT00475319|395385|P2|NOT COMPLETED|Overall Study||1
161402|NCT00475319|395386|P1|NOT COMPLETED|Overall Study||2
161403|NCT00475319|395384|P3|COMPLETED|Overall Study||99
161404|NCT00475319|395385|P2|COMPLETED|Overall Study||101
161405|NCT00475319|395386|P1|COMPLETED|Overall Study||101
161406|NCT00475319|395384|P3|STARTED|Overall Study||103
161407|NCT00475319|395385|P2|STARTED|Overall Study||102
161408|NCT00475319|395386|P1|STARTED|Overall Study||103
161409|NCT00475332|395397|P1|NOT COMPLETED|Overall Study||0
161410|NCT00475332|395397|P1|COMPLETED|Overall Study||2
161411|NCT00475332|395397|P1|STARTED|Overall Study||2
161412|NCT00475423|395402|P1|NOT COMPLETED|Overall Study||32
161413|NCT00475423|395402|P1|COMPLETED|Overall Study||90
161414|NCT00475423|395402|P1|STARTED|Overall Study||122
161415|NCT00475501|395427|P4|NOT COMPLETED|Overall Study||4
161416|NCT00475501|395428|P3|NOT COMPLETED|Overall Study||4
161417|NCT00475501|395429|P2|NOT COMPLETED|Overall Study||5
161418|NCT00475501|395430|P1|NOT COMPLETED|Overall Study||7
161419|NCT00475501|395427|P4|COMPLETED|Overall Study||12
161420|NCT00475501|395428|P3|COMPLETED|Overall Study||13
161421|NCT00475501|395429|P2|COMPLETED|Overall Study||8
161422|NCT00475501|395430|P1|COMPLETED|Overall Study||7
161423|NCT00475501|395427|P4|STARTED|Overall Study||16
161424|NCT00475501|395428|P3|STARTED|Overall Study||17
161425|NCT00475501|395429|P2|STARTED|Overall Study||13
161426|NCT00475501|395430|P1|STARTED|Overall Study||14
161427|NCT00475657|395480|P1|NOT COMPLETED|Overall Study||4
161428|NCT00475657|395480|P1|COMPLETED|Overall Study||1
161429|NCT00475657|395480|P1|STARTED|Overall Study||5
161430|NCT00475670|395490|P2|NOT COMPLETED|Overall Study||41
161431|NCT00475670|395491|P1|NOT COMPLETED|Overall Study||3
161432|NCT00475670|395490|P2|COMPLETED|Overall Study||0
161433|NCT00475670|395491|P1|COMPLETED|Overall Study|This cohort was closed prematurely (with only 3 participants) because of enrollment difficulties.|0
161434|NCT00475670|395490|P2|STARTED|Overall Study||41
161435|NCT00475670|395491|P1|STARTED|Overall Study||3
161436|NCT00475709|395515|P1|NOT COMPLETED|Overall Study||76
161437|NCT00475709|395515|P1|COMPLETED|Overall Study||946
161438|NCT00475709|395515|P1|Eligible of Analysis|Overall Study|Excludes eight ineligible subjects|1014
161439|NCT00475709|395515|P1|STARTED|Overall Study||1022
161440|NCT00475722|395523|P2|NOT COMPLETED|Overall Study||12
161441|NCT00475722|395524|P1|NOT COMPLETED|Overall Study||15
161442|NCT00475722|395523|P2|COMPLETED|Overall Study||47
161443|NCT00475722|395524|P1|COMPLETED|Overall Study||46
161444|NCT00475722|395523|P2|STARTED|Overall Study||59
161445|NCT00475722|395524|P1|STARTED|Overall Study||61
161446|NCT00475735|395536|P6|NOT COMPLETED|Treatment Period 2||1
161447|NCT00475735|395537|P5|NOT COMPLETED|Treatment Period 2||1
161448|NCT00475735|395538|P4|NOT COMPLETED|Treatment Period 2||2
161449|NCT00475735|395539|P3|NOT COMPLETED|Treatment Period 2||0
161450|NCT00475735|395540|P2|NOT COMPLETED|Treatment Period 2||1
161451|NCT00475735|395541|P1|NOT COMPLETED|Treatment Period 2||0
161452|NCT00475735|395536|P6|COMPLETED|Treatment Period 2||13
161453|NCT00475735|395537|P5|COMPLETED|Treatment Period 2||15
161454|NCT00475735|395538|P4|COMPLETED|Treatment Period 2||4
161455|NCT00475735|395539|P3|COMPLETED|Treatment Period 2||7
161456|NCT00475735|395540|P2|COMPLETED|Treatment Period 2||9
161457|NCT00475735|395541|P1|COMPLETED|Treatment Period 2||10
161458|NCT00475735|395536|P6|STARTED|Treatment Period 2||14
161459|NCT00475735|395537|P5|STARTED|Treatment Period 2||16
161460|NCT00475735|395538|P4|STARTED|Treatment Period 2||6
161461|NCT00475735|395539|P3|STARTED|Treatment Period 2||7
161462|NCT00475735|395540|P2|STARTED|Treatment Period 2||10
161463|NCT00475735|395541|P1|STARTED|Treatment Period 2||10
161464|NCT00475735|395536|P6|NOT COMPLETED|Treatment Washout||0
161465|NCT00475735|395537|P5|NOT COMPLETED|Treatment Washout||0
161466|NCT00475735|395538|P4|NOT COMPLETED|Treatment Washout||0
161467|NCT00475735|395539|P3|NOT COMPLETED|Treatment Washout||0
161468|NCT00475735|395540|P2|NOT COMPLETED|Treatment Washout||2
161469|NCT00475735|395541|P1|NOT COMPLETED|Treatment Washout||0
161470|NCT00475735|395536|P6|COMPLETED|Treatment Washout||14
161471|NCT00475735|395537|P5|COMPLETED|Treatment Washout||16
161472|NCT00475735|395538|P4|COMPLETED|Treatment Washout||6
161473|NCT00475735|395539|P3|COMPLETED|Treatment Washout||7
161474|NCT00475735|395540|P2|COMPLETED|Treatment Washout||10
161475|NCT00475735|395541|P1|COMPLETED|Treatment Washout||10
161476|NCT00475735|395536|P6|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|14
161477|NCT00475735|395537|P5|STARTED|Treatment Washout|Includes 2 patients that discontinued Treatment Period 1 but continued the Study.|16
161478|NCT00475735|395538|P4|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|6
161479|NCT00475735|395539|P3|STARTED|Treatment Washout||7
161480|NCT00475735|395540|P2|STARTED|Treatment Washout|Includes 1 patient that discontinued Treatment Period 1 but continued the Study.|12
161481|NCT00475735|395541|P1|STARTED|Treatment Washout||10
161482|NCT00475735|395536|P6|NOT COMPLETED|Treatment Period 1||3
161483|NCT00475735|395537|P5|NOT COMPLETED|Treatment Period 1||2
161484|NCT00475735|395538|P4|NOT COMPLETED|Treatment Period 1||2
161485|NCT00475735|395539|P3|NOT COMPLETED|Treatment Period 1||0
161486|NCT00475735|395540|P2|NOT COMPLETED|Treatment Period 1||2
161487|NCT00475735|395541|P1|NOT COMPLETED|Treatment Period 1||4
161488|NCT00475735|395536|P6|COMPLETED|Treatment Period 1||12
161489|NCT00475735|395537|P5|COMPLETED|Treatment Period 1||14
161490|NCT00475735|395538|P4|COMPLETED|Treatment Period 1||5
161491|NCT00475735|395539|P3|COMPLETED|Treatment Period 1||7
161492|NCT00475735|395540|P2|COMPLETED|Treatment Period 1||11
161493|NCT00475735|395541|P1|COMPLETED|Treatment Period 1||10
161494|NCT00475735|395536|P6|STARTED|Treatment Period 1||15
161495|NCT00475735|395537|P5|STARTED|Treatment Period 1||16
161496|NCT00475735|395538|P4|STARTED|Treatment Period 1||7
161497|NCT00475735|395539|P3|STARTED|Treatment Period 1||7
161498|NCT00475735|395540|P2|STARTED|Treatment Period 1||13
161499|NCT00475735|395541|P1|STARTED|Treatment Period 1||14
161500|NCT00475787|395554|P2|NOT COMPLETED|Overall Study||7
161501|NCT00475787|395555|P1|NOT COMPLETED|Overall Study||8
161502|NCT00475787|395554|P2|COMPLETED|Overall Study||60
161503|NCT00475787|395555|P1|COMPLETED|Overall Study||61
161504|NCT00475787|395554|P2|STARTED|Overall Study||67
161505|NCT00475787|395555|P1|STARTED|Overall Study||69
161506|NCT00475852|395571|P2|NOT COMPLETED|Overall Study||548
161507|NCT00475852|395572|P1|NOT COMPLETED|Overall Study||517
161508|NCT00475852|395571|P2|COMPLETED|Overall Study||3029
161509|NCT00475852|395572|P1|COMPLETED|Overall Study||3047
161510|NCT00475852|395571|P2|STARTED|Overall Study||3577
161511|NCT00475852|395572|P1|STARTED|Overall Study||3564
161512|NCT00475865|395603|P3|NOT COMPLETED|Overall Study||6
161513|NCT00475865|395604|P2|NOT COMPLETED|Overall Study||5
161514|NCT00475865|395605|P1|NOT COMPLETED|Overall Study||2
161515|NCT00475865|395603|P3|COMPLETED|Overall Study|completed treatment period|34
161516|NCT00475865|395604|P2|COMPLETED|Overall Study|completed treatment period|37
161517|NCT00475865|395605|P1|COMPLETED|Overall Study||39
161518|NCT00475865|395603|P3|Treated|Overall Study||40
161519|NCT00475865|395604|P2|Treated|Overall Study||42
161520|NCT00475865|395605|P1|Treated|Overall Study|completed treatment period|41
161521|NCT00475865|395603|P3|STARTED|Overall Study|randomized|40
161522|NCT00475865|395604|P2|STARTED|Overall Study|randomized|42
161523|NCT00475865|395605|P1|STARTED|Overall Study|randomized|41
161524|NCT00475878|395635|P2|NOT COMPLETED|Overall Study||0
161525|NCT00475878|395636|P1|NOT COMPLETED|Overall Study||0
161526|NCT00475878|395635|P2|COMPLETED|Overall Study||72
161527|NCT00475878|395636|P1|COMPLETED|Overall Study||75
161528|NCT00475878|395635|P2|STARTED|Overall Study||72
161529|NCT00475878|395636|P1|STARTED|Overall Study||75
161530|NCT00475904|395647|P3|NOT COMPLETED|Overall Study||4
161531|NCT00475904|395648|P2|NOT COMPLETED|Overall Study||13
161532|NCT00475904|395649|P1|NOT COMPLETED|Overall Study||15
161533|NCT00475904|395647|P3|COMPLETED|Overall Study||72
161534|NCT00475904|395648|P2|COMPLETED|Overall Study||131
161535|NCT00475904|395649|P1|COMPLETED|Overall Study||125
161536|NCT00475904|395647|P3|STARTED|Overall Study||76
161537|NCT00475904|395648|P2|STARTED|Overall Study||144
161538|NCT00475904|395649|P1|STARTED|Overall Study||140
161539|NCT00464711|395660|P1|NOT COMPLETED|Overall Study||15
161540|NCT00464711|395660|P1|COMPLETED|Overall Study||25
161541|NCT00464711|395660|P1|STARTED|Overall Study||40
161542|NCT00464737|395667|P3|NOT COMPLETED|Overall Study||55
161543|NCT00464737|395668|P2|NOT COMPLETED|Overall Study||32
161544|NCT00464737|395669|P1|NOT COMPLETED|Overall Study||32
161545|NCT00464737|395667|P3|COMPLETED|Overall Study||19
161546|NCT00464737|395668|P2|COMPLETED|Overall Study||42
161547|NCT00464737|395669|P1|COMPLETED|Overall Study||50
161548|NCT00464737|395667|P3|STARTED|Overall Study||74
161549|NCT00464737|395668|P2|STARTED|Overall Study||74
161550|NCT00464737|395669|P1|STARTED|Overall Study||82
161551|NCT00464945|395718|P2|NOT COMPLETED|Toddler Dose||1
161552|NCT00464945|395719|P1|NOT COMPLETED|Toddler Dose||0
161553|NCT00464945|395718|P2|COMPLETED|Toddler Dose||130
161554|NCT00464945|395719|P1|COMPLETED|Toddler Dose||131
161555|NCT00464945|395718|P2|STARTED|Toddler Dose||131
161556|NCT00464945|395719|P1|STARTED|Toddler Dose||131
161557|NCT00464945|395718|P2|NOT COMPLETED|After Infant Series||2
161558|NCT00464945|395719|P1|NOT COMPLETED|After Infant Series||0
161559|NCT00464945|395718|P2|COMPLETED|After Infant Series||131
161560|NCT00464945|395719|P1|COMPLETED|After Infant Series||131
161561|NCT00464945|395718|P2|STARTED|After Infant Series||133
161562|NCT00464945|395719|P1|STARTED|After Infant Series||131
161563|NCT00464945|395718|P2|NOT COMPLETED|Infant Series||1
161564|NCT00464945|395719|P1|NOT COMPLETED|Infant Series||4
161565|NCT00464945|395718|P2|COMPLETED|Infant Series||133
161566|NCT00464945|395719|P1|COMPLETED|Infant Series||131
161567|NCT00464945|395718|P2|Vaccinated Dose 3|Infant Series||133
161568|NCT00464945|395719|P1|Vaccinated Dose 3|Infant Series||132
161569|NCT00464945|395718|P2|Vaccinated Dose 2|Infant Series||133
161570|NCT00464945|395719|P1|Vaccinated Dose 2|Infant Series||132
161571|NCT00464945|395718|P2|Vaccinated Dose 1|Infant Series||134
161572|NCT00464945|395719|P1|Vaccinated Dose 1|Infant Series||134
161573|NCT00464945|395718|P2|STARTED|Infant Series||134
161574|NCT00464945|395719|P1|STARTED|Infant Series||135
161575|NCT00465088|395749|P2|NOT COMPLETED|Overall Study||9
161576|NCT00465088|395750|P1|NOT COMPLETED|Overall Study||32
161577|NCT00465088|395749|P2|COMPLETED|Overall Study||70
161578|NCT00465088|395750|P1|COMPLETED|Overall Study||82
161579|NCT00465088|395749|P2|STARTED|Overall Study||79
161580|NCT00465088|395750|P1|STARTED|Overall Study|For both arms, started means treated.|114
161581|NCT00465101|395782|P1|NOT COMPLETED|Overall Study||59
161582|NCT00465101|395782|P1|COMPLETED|Overall Study||91
161583|NCT00465101|395782|P1|STARTED|Overall Study||150
161584|NCT00465179|395815|P1|NOT COMPLETED|Overall Study||53
161585|NCT00465179|395815|P1|COMPLETED|Overall Study||4
161586|NCT00465179|395815|P1|STARTED|Overall Study||57
161587|NCT00466505|395821|P1|NOT COMPLETED|Overall Study||17
161588|NCT00466505|395821|P1|COMPLETED|Overall Study||0
161589|NCT00466505|395821|P1|STARTED|Overall Study||17
161590|NCT00466687|395833|P1|NOT COMPLETED|Overall Study||34
161591|NCT00466687|395833|P1|COMPLETED|Overall Study||0
161592|NCT00466687|395833|P1|STARTED|Overall Study||34
161593|NCT00466817|395842|P2|NOT COMPLETED|Overall Study||4
161594|NCT00466817|395843|P1|NOT COMPLETED|Overall Study||5
161595|NCT00466817|395842|P2|COMPLETED|Overall Study||43
161596|NCT00466817|395843|P1|COMPLETED|Overall Study||44
161597|NCT00466817|395842|P2|STARTED|Overall Study||47
161598|NCT00466817|395843|P1|STARTED|Overall Study||49
161599|NCT00466882|395896|P1|NOT COMPLETED|Overall Study||0
161600|NCT00466882|395896|P1|COMPLETED|Overall Study||3
161601|NCT00466882|395896|P1|STARTED|Overall Study||3
161602|NCT00466947|395902|P2|NOT COMPLETED|Study End Analysis Period||2534
161603|NCT00466947|395903|P1|NOT COMPLETED|Study End Analysis Period||2496
161604|NCT00466947|395902|P2|COMPLETED|Study End Analysis Period||9265
161605|NCT00466947|395903|P1|COMPLETED|Study End Analysis Period||9302
161606|NCT00466947|395902|P2|STARTED|Study End Analysis Period||11799
161607|NCT00466947|395903|P1|STARTED|Study End Analysis Period||11798
161608|NCT00466947|395902|P2|NOT COMPLETED|Primary Outcome Analysis Period||11863
161609|NCT00466947|395903|P1|NOT COMPLETED|Primary Outcome Analysis Period||11875
161610|NCT00466947|395902|P2|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
161611|NCT00466947|395903|P1|COMPLETED|Primary Outcome Analysis Period|No data on study completion and withdrawal were available at first analysis as the study was ongoing|0
161612|NCT00466947|395902|P2|Ongoing|Primary Outcome Analysis Period||11863
161613|NCT00466947|395903|P1|Ongoing|Primary Outcome Analysis Period||11875
161614|NCT00466947|395902|P2|STARTED|Primary Outcome Analysis Period||11863
161615|NCT00466947|395903|P1|STARTED|Primary Outcome Analysis Period||11875
161616|NCT00466960|396025|P1|NOT COMPLETED|Overall Study||0
161617|NCT00466960|396025|P1|COMPLETED|Overall Study||21
161618|NCT00466960|396025|P1|STARTED|Overall Study||21
161619|NCT00467038|396036|P2|NOT COMPLETED|Overall Study||0
161620|NCT00467038|396037|P1|NOT COMPLETED|Overall Study||0
161621|NCT00467038|396036|P2|COMPLETED|Overall Study||11
161622|NCT00467038|396037|P1|COMPLETED|Overall Study||11
161623|NCT00467038|396036|P2|STARTED|Overall Study||11
161624|NCT00467038|396037|P1|STARTED|Overall Study||11
161625|NCT00467051|396045|P1|NOT COMPLETED|Overall Study||2
161626|NCT00467051|396045|P1|COMPLETED|Overall Study||18
161627|NCT00467051|396045|P1|STARTED|Overall Study||20
161628|NCT00467077|396049|P1|NOT COMPLETED|Overall Study||0
161629|NCT00467077|396049|P1|COMPLETED|Overall Study||21
161630|NCT00467077|396049|P1|STARTED|Overall Study||21
161631|NCT00467259|396058|P2|NOT COMPLETED|Overall Study||242
161632|NCT00467259|396059|P1|NOT COMPLETED|Overall Study||75
161633|NCT00467259|396058|P2|COMPLETED|Overall Study||778
161634|NCT00467259|396059|P1|COMPLETED|Overall Study||176
161635|NCT00467259|396058|P2|ITT Population|Overall Study|One subject did not take any study medication and was excluded from ITT population.|1019
161636|NCT00467259|396059|P1|ITT Population|Overall Study||251
161637|NCT00467259|396058|P2|STARTED|Overall Study||1020
161638|NCT00467259|396059|P1|STARTED|Overall Study||251
161639|NCT00467285|396071|P2|NOT COMPLETED|Overall Study||4
161640|NCT00467285|396072|P1|NOT COMPLETED|Overall Study||4
161641|NCT00467285|396071|P2|COMPLETED|Overall Study||60
161642|NCT00467285|396072|P1|COMPLETED|Overall Study||28
161643|NCT00467285|396071|P2|STARTED|Overall Study||64
161644|NCT00467285|396072|P1|STARTED|Overall Study||32
161645|NCT00467363|396092|P2|NOT COMPLETED|Overall Study||70
161646|NCT00467363|396093|P1|NOT COMPLETED|Overall Study||80
161647|NCT00467363|396092|P2|COMPLETED|Overall Study||543
161648|NCT00467363|396093|P1|COMPLETED|Overall Study||535
161649|NCT00467363|396092|P2|STARTED|Overall Study||613
161650|NCT00467363|396093|P1|STARTED|Overall Study||615
161651|NCT00467389|396127|P2|NOT COMPLETED|Overall Study||0
161652|NCT00467389|396128|P1|NOT COMPLETED|Overall Study||0
161653|NCT00467389|396127|P2|COMPLETED|Overall Study||6
161654|NCT00467389|396128|P1|COMPLETED|Overall Study||6
161655|NCT00467389|396127|P2|STARTED|Overall Study||6
161656|NCT00467389|396128|P1|STARTED|Overall Study||6
161657|NCT00467519|396140|P2|NOT COMPLETED|Overall Study||23
161658|NCT00467519|396141|P1|NOT COMPLETED|Overall Study||14
161659|NCT00467519|396140|P2|COMPLETED|Overall Study||488
161660|NCT00467519|396141|P1|COMPLETED|Overall Study||517
161661|NCT00467519|396140|P2|STARTED|Overall Study||511
161662|NCT00467519|396141|P1|STARTED|Overall Study||531
161663|NCT00467558|396159|P2|NOT COMPLETED|Overall Study||0
161664|NCT00467558|396160|P1|NOT COMPLETED|Overall Study||2
161665|NCT00467558|396159|P2|COMPLETED|Overall Study||3
161666|NCT00467558|396160|P1|COMPLETED|Overall Study||2
161667|NCT00467558|396159|P2|STARTED|Overall Study||3
161668|NCT00467558|396160|P1|STARTED|Overall Study||4
161669|NCT00467584|396171|P3|NOT COMPLETED|Overall Study||1
161670|NCT00467584|396172|P2|NOT COMPLETED|Overall Study||5
161671|NCT00467584|396173|P1|NOT COMPLETED|Overall Study||4
161672|NCT00467584|396171|P3|COMPLETED|Overall Study||20
161673|NCT00467584|396172|P2|COMPLETED|Overall Study||15
161674|NCT00467584|396173|P1|COMPLETED|Overall Study||17
161675|NCT00467584|396171|P3|STARTED|Overall Study||21
161676|NCT00467584|396172|P2|STARTED|Overall Study||20
161677|NCT00467584|396173|P1|STARTED|Overall Study||21
161678|NCT00467597|396185|P2|NOT COMPLETED|Overall Study||0
161679|NCT00467597|396186|P1|NOT COMPLETED|Overall Study||2
161680|NCT00467597|396185|P2|COMPLETED|Overall Study||6
161681|NCT00467597|396186|P1|COMPLETED|Overall Study||24
161682|NCT00467597|396185|P2|STARTED|Overall Study||6
161683|NCT00467597|396186|P1|STARTED|Overall Study||26
161684|NCT00467610|396196|P1|NOT COMPLETED|Overall Study||1
161685|NCT00467610|396196|P1|COMPLETED|Overall Study||5
161686|NCT00467610|396196|P1|STARTED|Overall Study||6
161687|NCT00467649|396205|P6|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||1
161688|NCT00467649|396206|P5|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
161689|NCT00467649|396207|P4|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||2
161690|NCT00467649|396208|P3|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
161691|NCT00467649|396209|P2|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
161692|NCT00467649|396210|P1|NOT COMPLETED|Phase 2 (Intent-to-Treat Population)||0
161693|NCT00467649|396205|P6|COMPLETED|Phase 2 (Intent-to-Treat Population)||35
161694|NCT00467649|396206|P5|COMPLETED|Phase 2 (Intent-to-Treat Population)||14
161695|NCT00467649|396207|P4|COMPLETED|Phase 2 (Intent-to-Treat Population)||29
161696|NCT00467649|396208|P3|COMPLETED|Phase 2 (Intent-to-Treat Population)||17
161697|NCT00467649|396209|P2|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
161698|NCT00467649|396210|P1|COMPLETED|Phase 2 (Intent-to-Treat Population)||0
161699|NCT00467649|396205|P6|STARTED|Phase 2 (Intent-to-Treat Population)||36
161700|NCT00467649|396206|P5|STARTED|Phase 2 (Intent-to-Treat Population)||14
161701|NCT00467649|396207|P4|STARTED|Phase 2 (Intent-to-Treat Population)||31
161702|NCT00467649|396208|P3|STARTED|Phase 2 (Intent-to-Treat Population)||17
161703|NCT00467649|396209|P2|STARTED|Phase 2 (Intent-to-Treat Population)||0
161704|NCT00467649|396210|P1|STARTED|Phase 2 (Intent-to-Treat Population)||0
161705|NCT00467649|396205|P6|NOT COMPLETED|Phase 1 (Randomized Population)||0
161706|NCT00467649|396206|P5|NOT COMPLETED|Phase 1 (Randomized Population)||0
161707|NCT00467649|396207|P4|NOT COMPLETED|Phase 1 (Randomized Population)||0
161708|NCT00467649|396208|P3|NOT COMPLETED|Phase 1 (Randomized Population)||0
161709|NCT00467649|396209|P2|NOT COMPLETED|Phase 1 (Randomized Population)||6
161710|NCT00467649|396210|P1|NOT COMPLETED|Phase 1 (Randomized Population)||9
161711|NCT00467649|396205|P6|COMPLETED|Phase 1 (Randomized Population)||0
161712|NCT00467649|396206|P5|COMPLETED|Phase 1 (Randomized Population)||0
161713|NCT00467649|396207|P4|COMPLETED|Phase 1 (Randomized Population)||0
161714|NCT00467649|396208|P3|COMPLETED|Phase 1 (Randomized Population)||0
161715|NCT00467649|396209|P2|COMPLETED|Phase 1 (Randomized Population)||50
161716|NCT00467649|396210|P1|COMPLETED|Phase 1 (Randomized Population)||48
161717|NCT00467649|396205|P6|Intent to Treat|Phase 1 (Randomized Population)||0
161718|NCT00467649|396206|P5|Intent to Treat|Phase 1 (Randomized Population)||0
161719|NCT00467649|396207|P4|Intent to Treat|Phase 1 (Randomized Population)||0
161720|NCT00467649|396208|P3|Intent to Treat|Phase 1 (Randomized Population)||0
161721|NCT00467649|396209|P2|Intent to Treat|Phase 1 (Randomized Population)||56
161722|NCT00467649|396210|P1|Intent to Treat|Phase 1 (Randomized Population)||56
161723|NCT00467649|396205|P6|STARTED|Phase 1 (Randomized Population)||0
161724|NCT00467649|396206|P5|STARTED|Phase 1 (Randomized Population)||0
161725|NCT00467649|396207|P4|STARTED|Phase 1 (Randomized Population)||0
161726|NCT00467649|396208|P3|STARTED|Phase 1 (Randomized Population)||0
161727|NCT00467649|396209|P2|STARTED|Phase 1 (Randomized Population)||56
161828|NCT00467779|396473|P12|STARTED|Stage 2A||0
161728|NCT00467649|396210|P1|STARTED|Phase 1 (Randomized Population)|One patient randomized to the SYMLIN group withdrew consent prior to receiving the first dose|57
161729|NCT00467740|396255|P5|NOT COMPLETED|Overall Study||0
161730|NCT00467740|396256|P4|NOT COMPLETED|Overall Study||1
161731|NCT00467740|396257|P3|NOT COMPLETED|Overall Study||2
161732|NCT00467740|396258|P2|NOT COMPLETED|Overall Study||3
161733|NCT00467740|396259|P1|NOT COMPLETED|Overall Study||1
161734|NCT00467740|396255|P5|COMPLETED|Overall Study||61
161735|NCT00467740|396256|P4|COMPLETED|Overall Study||59
161736|NCT00467740|396257|P3|COMPLETED|Overall Study||58
161737|NCT00467740|396258|P2|COMPLETED|Overall Study||58
161738|NCT00467740|396259|P1|COMPLETED|Overall Study||53
161739|NCT00467740|396255|P5|STARTED|Overall Study||61
161740|NCT00467740|396256|P4|STARTED|Overall Study||60
161741|NCT00467740|396257|P3|STARTED|Overall Study||60
161742|NCT00467740|396258|P2|STARTED|Overall Study||61
161743|NCT00467740|396259|P1|STARTED|Overall Study||54
161744|NCT00467753|396448|P2|NOT COMPLETED|Overall Study||2
161745|NCT00467753|396449|P1|NOT COMPLETED|Overall Study||3
161746|NCT00467753|396448|P2|COMPLETED|Overall Study||0
161747|NCT00467753|396449|P1|COMPLETED|Overall Study||0
161748|NCT00467753|396448|P2|STARTED|Overall Study||2
161749|NCT00467753|396449|P1|STARTED|Overall Study||3
161750|NCT00467779|396470|P15|NOT COMPLETED|Stage 3||17
161751|NCT00467779|396471|P14|NOT COMPLETED|Stage 3||0
161752|NCT00467779|396472|P13|NOT COMPLETED|Stage 3||0
161753|NCT00467779|396473|P12|NOT COMPLETED|Stage 3||0
161754|NCT00467779|396474|P11|NOT COMPLETED|Stage 3||0
161755|NCT00467779|396475|P10|NOT COMPLETED|Stage 3||0
161756|NCT00467779|396476|P9|NOT COMPLETED|Stage 3||0
161757|NCT00467779|396477|P8|NOT COMPLETED|Stage 3||0
161758|NCT00467779|396478|P7|NOT COMPLETED|Stage 3||0
161759|NCT00467779|396479|P6|NOT COMPLETED|Stage 3||0
161760|NCT00467779|396480|P5|NOT COMPLETED|Stage 3||0
161761|NCT00467779|396481|P4|NOT COMPLETED|Stage 3||0
161762|NCT00467779|396482|P3|NOT COMPLETED|Stage 3||0
161763|NCT00467779|396483|P2|NOT COMPLETED|Stage 3||0
161764|NCT00467779|396484|P1|NOT COMPLETED|Stage 3||0
161765|NCT00467779|396470|P15|COMPLETED|Stage 3||3
161766|NCT00467779|396471|P14|COMPLETED|Stage 3||0
161767|NCT00467779|396472|P13|COMPLETED|Stage 3||0
161768|NCT00467779|396473|P12|COMPLETED|Stage 3||0
161769|NCT00467779|396474|P11|COMPLETED|Stage 3||0
161770|NCT00467779|396475|P10|COMPLETED|Stage 3||0
161771|NCT00467779|396476|P9|COMPLETED|Stage 3||0
161772|NCT00467779|396477|P8|COMPLETED|Stage 3||0
161773|NCT00467779|396478|P7|COMPLETED|Stage 3||0
161774|NCT00467779|396479|P6|COMPLETED|Stage 3||0
161775|NCT00467779|396480|P5|COMPLETED|Stage 3||0
161776|NCT00467779|396481|P4|COMPLETED|Stage 3||0
161777|NCT00467779|396482|P3|COMPLETED|Stage 3||0
161778|NCT00467779|396483|P2|COMPLETED|Stage 3||0
161779|NCT00467779|396484|P1|COMPLETED|Stage 3||0
161780|NCT00467779|396470|P15|STARTED|Stage 3||20
161781|NCT00467779|396471|P14|STARTED|Stage 3||0
161782|NCT00467779|396472|P13|STARTED|Stage 3||0
161783|NCT00467779|396473|P12|STARTED|Stage 3||0
161784|NCT00467779|396474|P11|STARTED|Stage 3||0
161785|NCT00467779|396475|P10|STARTED|Stage 3||0
161786|NCT00467779|396476|P9|STARTED|Stage 3||0
161787|NCT00467779|396477|P8|STARTED|Stage 3||0
161788|NCT00467779|396478|P7|STARTED|Stage 3||0
161789|NCT00467779|396479|P6|STARTED|Stage 3||0
161790|NCT00467779|396480|P5|STARTED|Stage 3||0
161791|NCT00467779|396481|P4|STARTED|Stage 3||0
161792|NCT00467779|396482|P3|STARTED|Stage 3||0
161793|NCT00467779|396483|P2|STARTED|Stage 3||0
161794|NCT00467779|396484|P1|STARTED|Stage 3||0
161795|NCT00467779|396470|P15|NOT COMPLETED|Stage 2A||0
161796|NCT00467779|396471|P14|NOT COMPLETED|Stage 2A||21
161797|NCT00467779|396472|P13|NOT COMPLETED|Stage 2A||0
161798|NCT00467779|396473|P12|NOT COMPLETED|Stage 2A||0
161799|NCT00467779|396474|P11|NOT COMPLETED|Stage 2A||0
161800|NCT00467779|396475|P10|NOT COMPLETED|Stage 2A||0
161801|NCT00467779|396476|P9|NOT COMPLETED|Stage 2A||0
161802|NCT00467779|396477|P8|NOT COMPLETED|Stage 2A||0
161803|NCT00467779|396478|P7|NOT COMPLETED|Stage 2A||0
161804|NCT00467779|396479|P6|NOT COMPLETED|Stage 2A||0
161805|NCT00467779|396480|P5|NOT COMPLETED|Stage 2A||0
161806|NCT00467779|396481|P4|NOT COMPLETED|Stage 2A||0
161807|NCT00467779|396482|P3|NOT COMPLETED|Stage 2A||0
161808|NCT00467779|396483|P2|NOT COMPLETED|Stage 2A||0
161809|NCT00467779|396484|P1|NOT COMPLETED|Stage 2A||0
161810|NCT00467779|396470|P15|COMPLETED|Stage 2A||0
161811|NCT00467779|396471|P14|COMPLETED|Stage 2A||1
161812|NCT00467779|396472|P13|COMPLETED|Stage 2A||0
161813|NCT00467779|396473|P12|COMPLETED|Stage 2A||0
161814|NCT00467779|396474|P11|COMPLETED|Stage 2A||0
161815|NCT00467779|396475|P10|COMPLETED|Stage 2A||0
161816|NCT00467779|396476|P9|COMPLETED|Stage 2A||0
161817|NCT00467779|396477|P8|COMPLETED|Stage 2A||0
161818|NCT00467779|396478|P7|COMPLETED|Stage 2A||0
161819|NCT00467779|396479|P6|COMPLETED|Stage 2A||0
161820|NCT00467779|396480|P5|COMPLETED|Stage 2A||0
161821|NCT00467779|396481|P4|COMPLETED|Stage 2A||0
161822|NCT00467779|396482|P3|COMPLETED|Stage 2A||0
161823|NCT00467779|396483|P2|COMPLETED|Stage 2A||0
161824|NCT00467779|396484|P1|COMPLETED|Stage 2A||0
161825|NCT00467779|396470|P15|STARTED|Stage 2A||0
161826|NCT00467779|396471|P14|STARTED|Stage 2A||22
161827|NCT00467779|396472|P13|STARTED|Stage 2A||0
161829|NCT00467779|396474|P11|STARTED|Stage 2A||0
161830|NCT00467779|396475|P10|STARTED|Stage 2A||0
161831|NCT00467779|396476|P9|STARTED|Stage 2A||0
161832|NCT00467779|396477|P8|STARTED|Stage 2A||0
161833|NCT00467779|396478|P7|STARTED|Stage 2A||0
161834|NCT00467779|396479|P6|STARTED|Stage 2A||0
161835|NCT00467779|396480|P5|STARTED|Stage 2A||0
161836|NCT00467779|396481|P4|STARTED|Stage 2A||0
161837|NCT00467779|396482|P3|STARTED|Stage 2A||0
161838|NCT00467779|396483|P2|STARTED|Stage 2A||0
161839|NCT00467779|396484|P1|STARTED|Stage 2A||0
161840|NCT00467779|396470|P15|NOT COMPLETED|Stage 2||0
161841|NCT00467779|396471|P14|NOT COMPLETED|Stage 2||0
161842|NCT00467779|396472|P13|NOT COMPLETED|Stage 2||0
161843|NCT00467779|396473|P12|NOT COMPLETED|Stage 2||0
161844|NCT00467779|396474|P11|NOT COMPLETED|Stage 2||0
161845|NCT00467779|396475|P10|NOT COMPLETED|Stage 2||0
161846|NCT00467779|396476|P9|NOT COMPLETED|Stage 2||21
161847|NCT00467779|396477|P8|NOT COMPLETED|Stage 2||0
161848|NCT00467779|396478|P7|NOT COMPLETED|Stage 2||0
161849|NCT00467779|396479|P6|NOT COMPLETED|Stage 2||0
161850|NCT00467779|396480|P5|NOT COMPLETED|Stage 2||0
161851|NCT00467779|396481|P4|NOT COMPLETED|Stage 2||0
161852|NCT00467779|396482|P3|NOT COMPLETED|Stage 2||0
161853|NCT00467779|396483|P2|NOT COMPLETED|Stage 2||0
161854|NCT00467779|396484|P1|NOT COMPLETED|Stage 2||0
161855|NCT00467779|396470|P15|COMPLETED|Stage 2||0
161856|NCT00467779|396471|P14|COMPLETED|Stage 2||0
161857|NCT00467779|396472|P13|COMPLETED|Stage 2||0
161858|NCT00467779|396473|P12|COMPLETED|Stage 2||0
161859|NCT00467779|396474|P11|COMPLETED|Stage 2||0
161860|NCT00467779|396475|P10|COMPLETED|Stage 2||0
161861|NCT00467779|396476|P9|COMPLETED|Stage 2||0
161862|NCT00467779|396477|P8|COMPLETED|Stage 2||0
161863|NCT00467779|396478|P7|COMPLETED|Stage 2||0
161864|NCT00467779|396479|P6|COMPLETED|Stage 2||0
161865|NCT00467779|396480|P5|COMPLETED|Stage 2||0
161866|NCT00467779|396481|P4|COMPLETED|Stage 2||0
161867|NCT00467779|396482|P3|COMPLETED|Stage 2||0
161868|NCT00467779|396483|P2|COMPLETED|Stage 2||0
161869|NCT00467779|396484|P1|COMPLETED|Stage 2||0
161870|NCT00467779|396470|P15|STARTED|Stage 2||0
161871|NCT00467779|396471|P14|STARTED|Stage 2||0
161872|NCT00467779|396472|P13|STARTED|Stage 2||0
161873|NCT00467779|396473|P12|STARTED|Stage 2||0
161874|NCT00467779|396474|P11|STARTED|Stage 2||0
161875|NCT00467779|396475|P10|STARTED|Stage 2||0
161876|NCT00467779|396476|P9|STARTED|Stage 2||21
161877|NCT00467779|396477|P8|STARTED|Stage 2||0
161878|NCT00467779|396478|P7|STARTED|Stage 2||0
161879|NCT00467779|396479|P6|STARTED|Stage 2||0
161880|NCT00467779|396480|P5|STARTED|Stage 2||0
161881|NCT00467779|396481|P4|STARTED|Stage 2||0
161882|NCT00467779|396482|P3|STARTED|Stage 2||0
161883|NCT00467779|396483|P2|STARTED|Stage 2||0
161884|NCT00467779|396484|P1|STARTED|Stage 2||0
161885|NCT00467779|396470|P15|NOT COMPLETED|Stage 1A||0
161886|NCT00467779|396471|P14|NOT COMPLETED|Stage 1A||0
161887|NCT00467779|396472|P13|NOT COMPLETED|Stage 1A||6
161888|NCT00467779|396473|P12|NOT COMPLETED|Stage 1A||8
161889|NCT00467779|396474|P11|NOT COMPLETED|Stage 1A||3
161890|NCT00467779|396475|P10|NOT COMPLETED|Stage 1A||3
161891|NCT00467779|396476|P9|NOT COMPLETED|Stage 1A||0
161892|NCT00467779|396477|P8|NOT COMPLETED|Stage 1A||0
161893|NCT00467779|396478|P7|NOT COMPLETED|Stage 1A||0
161894|NCT00467779|396479|P6|NOT COMPLETED|Stage 1A||0
161895|NCT00467779|396480|P5|NOT COMPLETED|Stage 1A||0
161896|NCT00467779|396481|P4|NOT COMPLETED|Stage 1A||0
161897|NCT00467779|396482|P3|NOT COMPLETED|Stage 1A||0
161898|NCT00467779|396483|P2|NOT COMPLETED|Stage 1A||0
161899|NCT00467779|396484|P1|NOT COMPLETED|Stage 1A||0
161900|NCT00467779|396470|P15|COMPLETED|Stage 1A||0
161901|NCT00467779|396471|P14|COMPLETED|Stage 1A||0
161902|NCT00467779|396472|P13|COMPLETED|Stage 1A||0
161903|NCT00467779|396473|P12|COMPLETED|Stage 1A||0
161904|NCT00467779|396474|P11|COMPLETED|Stage 1A||0
161905|NCT00467779|396475|P10|COMPLETED|Stage 1A||0
161906|NCT00467779|396476|P9|COMPLETED|Stage 1A||0
161907|NCT00467779|396477|P8|COMPLETED|Stage 1A||0
161908|NCT00467779|396478|P7|COMPLETED|Stage 1A||0
161909|NCT00467779|396479|P6|COMPLETED|Stage 1A||0
161910|NCT00467779|396480|P5|COMPLETED|Stage 1A||0
161911|NCT00467779|396481|P4|COMPLETED|Stage 1A||0
161912|NCT00467779|396482|P3|COMPLETED|Stage 1A||0
161913|NCT00467779|396483|P2|COMPLETED|Stage 1A||0
161914|NCT00467779|396484|P1|COMPLETED|Stage 1A||0
161915|NCT00467779|396470|P15|STARTED|Stage 1A||0
161916|NCT00467779|396471|P14|STARTED|Stage 1A||0
161917|NCT00467779|396472|P13|STARTED|Stage 1A||6
161918|NCT00467779|396473|P12|STARTED|Stage 1A||8
161919|NCT00467779|396474|P11|STARTED|Stage 1A||3
161920|NCT00467779|396475|P10|STARTED|Stage 1A||3
161921|NCT00467779|396476|P9|STARTED|Stage 1A||0
161922|NCT00467779|396477|P8|STARTED|Stage 1A||0
161923|NCT00467779|396478|P7|STARTED|Stage 1A||0
161924|NCT00467779|396479|P6|STARTED|Stage 1A||0
161925|NCT00467779|396480|P5|STARTED|Stage 1A||0
161926|NCT00467779|396481|P4|STARTED|Stage 1A||0
161927|NCT00467779|396482|P3|STARTED|Stage 1A||0
161928|NCT00467779|396483|P2|STARTED|Stage 1A||0
161929|NCT00467779|396484|P1|STARTED|Stage 1A||0
161930|NCT00467779|396470|P15|NOT COMPLETED|Stage 1||0
161931|NCT00467779|396471|P14|NOT COMPLETED|Stage 1||0
161932|NCT00467779|396472|P13|NOT COMPLETED|Stage 1||0
161933|NCT00467779|396473|P12|NOT COMPLETED|Stage 1||0
161934|NCT00467779|396474|P11|NOT COMPLETED|Stage 1||0
161935|NCT00467779|396475|P10|NOT COMPLETED|Stage 1||0
161936|NCT00467779|396476|P9|NOT COMPLETED|Stage 1||0
161937|NCT00467779|396477|P8|NOT COMPLETED|Stage 1||7
161938|NCT00467779|396478|P7|NOT COMPLETED|Stage 1||7
161939|NCT00467779|396479|P6|NOT COMPLETED|Stage 1||5
161940|NCT00467779|396480|P5|NOT COMPLETED|Stage 1||3
161941|NCT00467779|396481|P4|NOT COMPLETED|Stage 1||3
161942|NCT00467779|396482|P3|NOT COMPLETED|Stage 1||3
161943|NCT00467779|396483|P2|NOT COMPLETED|Stage 1||3
161944|NCT00467779|396484|P1|NOT COMPLETED|Stage 1||4
161945|NCT00467779|396470|P15|COMPLETED|Stage 1||0
161946|NCT00467779|396471|P14|COMPLETED|Stage 1||0
161947|NCT00467779|396472|P13|COMPLETED|Stage 1||0
161948|NCT00467779|396473|P12|COMPLETED|Stage 1||0
161949|NCT00467779|396474|P11|COMPLETED|Stage 1||0
161950|NCT00467779|396475|P10|COMPLETED|Stage 1||0
161951|NCT00467779|396476|P9|COMPLETED|Stage 1||0
161952|NCT00467779|396477|P8|COMPLETED|Stage 1||0
161953|NCT00467779|396478|P7|COMPLETED|Stage 1||0
161954|NCT00467779|396479|P6|COMPLETED|Stage 1||1
161955|NCT00467779|396480|P5|COMPLETED|Stage 1||0
161956|NCT00467779|396481|P4|COMPLETED|Stage 1||0
161957|NCT00467779|396482|P3|COMPLETED|Stage 1||0
161958|NCT00467779|396483|P2|COMPLETED|Stage 1||0
161959|NCT00467779|396484|P1|COMPLETED|Stage 1||0
161960|NCT00467779|396470|P15|STARTED|Stage 1||0
161961|NCT00467779|396471|P14|STARTED|Stage 1||0
161962|NCT00467779|396472|P13|STARTED|Stage 1||0
161963|NCT00467779|396473|P12|STARTED|Stage 1||0
161964|NCT00467779|396474|P11|STARTED|Stage 1||0
161965|NCT00467779|396475|P10|STARTED|Stage 1||0
161966|NCT00467779|396476|P9|STARTED|Stage 1||0
161967|NCT00467779|396477|P8|STARTED|Stage 1||7
161968|NCT00467779|396478|P7|STARTED|Stage 1||7
161969|NCT00467779|396479|P6|STARTED|Stage 1||6
161970|NCT00467779|396480|P5|STARTED|Stage 1||3
161971|NCT00467779|396481|P4|STARTED|Stage 1||3
161972|NCT00467779|396482|P3|STARTED|Stage 1||3
161973|NCT00467779|396483|P2|STARTED|Stage 1||3
161974|NCT00467779|396484|P1|STARTED|Stage 1||4
161975|NCT00467831|396656|P1|NOT COMPLETED|Overall Study||3
161976|NCT00467831|396656|P1|COMPLETED|Overall Study||0
161977|NCT00467831|396656|P1|STARTED|Overall Study||3
161978|NCT00467844|396663|P3|NOT COMPLETED|Overall Study||14
161979|NCT00467844|396664|P2|NOT COMPLETED|Overall Study||20
161980|NCT00467844|396665|P1|NOT COMPLETED|Overall Study||19
161981|NCT00467844|396663|P3|COMPLETED|Overall Study||38
161982|NCT00467844|396664|P2|COMPLETED|Overall Study||34
161983|NCT00467844|396665|P1|COMPLETED|Overall Study||34
161984|NCT00467844|396663|P3|STARTED|Overall Study||52
161985|NCT00467844|396664|P2|STARTED|Overall Study||54
161986|NCT00467844|396665|P1|STARTED|Overall Study||53
161987|NCT00467857|396678|P2|NOT COMPLETED|Overall Study||8
161988|NCT00467857|396679|P1|NOT COMPLETED|Overall Study||3
161989|NCT00467857|396678|P2|COMPLETED|Overall Study||139
161990|NCT00467857|396679|P1|COMPLETED|Overall Study||143
161991|NCT00467857|396678|P2|STARTED|Overall Study||147
161992|NCT00467857|396679|P1|STARTED|Overall Study||146
161993|NCT00467870|396717|P6|NOT COMPLETED|Overall Study||2
161994|NCT00467870|396718|P5|NOT COMPLETED|Overall Study||37
161995|NCT00467870|396719|P4|NOT COMPLETED|Overall Study||33
161996|NCT00467870|396720|P3|NOT COMPLETED|Overall Study||4
161997|NCT00467870|396721|P2|NOT COMPLETED|Overall Study||43
161998|NCT00467870|396722|P1|NOT COMPLETED|Overall Study||45
161999|NCT00467870|396717|P6|COMPLETED|Overall Study||21
162000|NCT00467870|396718|P5|COMPLETED|Overall Study||93
162001|NCT00467870|396719|P4|COMPLETED|Overall Study||79
162002|NCT00467870|396720|P3|COMPLETED|Overall Study||18
162003|NCT00467870|396721|P2|COMPLETED|Overall Study||74
162004|NCT00467870|396722|P1|COMPLETED|Overall Study||75
162005|NCT00467870|396717|P6|STARTED|Overall Study||23
162006|NCT00467870|396718|P5|STARTED|Overall Study||130
162007|NCT00467870|396719|P4|STARTED|Overall Study||112
162008|NCT00467870|396720|P3|STARTED|Overall Study||22
162009|NCT00467870|396721|P2|STARTED|Overall Study||117
162010|NCT00467870|396722|P1|STARTED|Overall Study||120
162011|NCT00467896|396763|P1|NOT COMPLETED|Overall Study||51
162012|NCT00467896|396763|P1|COMPLETED|Overall Study||11
162013|NCT00467896|396763|P1|STARTED|Overall Study||62
162014|NCT00467961|396783|P1|NOT COMPLETED|Overall Study||7
162015|NCT00467961|396783|P1|COMPLETED|Overall Study||24
162016|NCT00467961|396783|P1|STARTED|Overall Study||31
162017|NCT00468052|396789|P2|NOT COMPLETED|Overall Study||8
162018|NCT00468052|396790|P1|NOT COMPLETED|Overall Study||7
162019|NCT00468052|396789|P2|COMPLETED|Overall Study||61
162020|NCT00468052|396790|P1|COMPLETED|Overall Study||61
162021|NCT00468052|396789|P2|Target Enrollment|Overall Study||70
162022|NCT00468052|396790|P1|Target Enrollment|Overall Study||70
162023|NCT00468052|396789|P2|STARTED|Overall Study|One had an intraoperative complication and was withdrawn. 7 eliminated for a break in protocol.|69
162024|NCT00468052|396790|P1|STARTED|Overall Study|1 subject withdrew consent.Surgery was cancelled for 2. 4 subjects eliminated for break in protocol|68
162025|NCT00468104|396808|P2|NOT COMPLETED|Second Intervention||4
162026|NCT00468104|396809|P1|NOT COMPLETED|Second Intervention||5
162027|NCT00468104|396808|P2|COMPLETED|Second Intervention||37
162028|NCT00468104|396809|P1|COMPLETED|Second Intervention||3
162109|NCT00468585|397067|P3|NOT COMPLETED|Overall Study||5
162029|NCT00468104|396808|P2|STARTED|Second Intervention|4 patients responded to Placebo and did not go to the second intervention|41
162030|NCT00468104|396809|P1|STARTED|Second Intervention|37 responded to Alteplase and did not go to the second intervention|8
162031|NCT00468104|396808|P2|NOT COMPLETED|First Intervention||1
162032|NCT00468104|396809|P1|NOT COMPLETED|First Intervention||9
162033|NCT00468104|396808|P2|COMPLETED|First Intervention||45
162034|NCT00468104|396809|P1|COMPLETED|First Intervention||45
162035|NCT00468104|396808|P2|STARTED|First Intervention||46
162036|NCT00468104|396809|P1|STARTED|First Intervention||54
162037|NCT00468143|396824|P2|NOT COMPLETED|Second Intervention (3 Weeks)||3
162038|NCT00468143|396825|P1|NOT COMPLETED|Second Intervention (3 Weeks)||3
162039|NCT00468143|396824|P2|COMPLETED|Second Intervention (3 Weeks)||24
162040|NCT00468143|396825|P1|COMPLETED|Second Intervention (3 Weeks)||25
162041|NCT00468143|396824|P2|STARTED|Second Intervention (3 Weeks)||27
162042|NCT00468143|396825|P1|STARTED|Second Intervention (3 Weeks)||28
162043|NCT00468143|396824|P2|NOT COMPLETED|First Intervention (3 Weeks)||4
162044|NCT00468143|396825|P1|NOT COMPLETED|First Intervention (3 Weeks)||3
162045|NCT00468143|396824|P2|COMPLETED|First Intervention (3 Weeks)||27
162046|NCT00468143|396825|P1|COMPLETED|First Intervention (3 Weeks)||28
162047|NCT00468143|396824|P2|STARTED|First Intervention (3 Weeks)||31
162048|NCT00468143|396825|P1|STARTED|First Intervention (3 Weeks)||31
162049|NCT00468208|396839|P1|NOT COMPLETED|Overall Study||0
162050|NCT00468208|396839|P1|COMPLETED|Overall Study|All patients reached common closing or early termination|20
162051|NCT00468208|396839|P1|STARTED|Overall Study||20
162052|NCT00468286|396849|P2|NOT COMPLETED|Overall Study||12
162053|NCT00468286|396850|P1|NOT COMPLETED|Overall Study||7
162054|NCT00468286|396849|P2|COMPLETED|Overall Study||54
162055|NCT00468286|396850|P1|COMPLETED|Overall Study||60
162056|NCT00468286|396849|P2|STARTED|Overall Study||66
162057|NCT00468286|396850|P1|STARTED|Overall Study|Started=Intention to treat (ITT) population.|67
162058|NCT00468299|396874|P2|NOT COMPLETED|Overall Study||1
162059|NCT00468299|396875|P1|NOT COMPLETED|Overall Study||0
162060|NCT00468299|396874|P2|COMPLETED|Overall Study||7
162061|NCT00468299|396875|P1|COMPLETED|Overall Study||9
162062|NCT00468299|396874|P2|STARTED|Overall Study||8
162063|NCT00468299|396875|P1|STARTED|Overall Study||9
162064|NCT00468312|396885|P2|NOT COMPLETED|Overall Study||5
162065|NCT00468312|396886|P1|NOT COMPLETED|Overall Study||4
162066|NCT00468312|396885|P2|COMPLETED|Overall Study||204
162067|NCT00468312|396886|P1|COMPLETED|Overall Study||216
162068|NCT00468312|396885|P2|STARTED|Overall Study||209
162069|NCT00468312|396886|P1|STARTED|Overall Study||220
162070|NCT00468481|396902|P2|NOT COMPLETED|Overall Study||24
162071|NCT00468481|396903|P1|NOT COMPLETED|Overall Study||88
162072|NCT00468481|396902|P2|COMPLETED|Overall Study||70
162073|NCT00468481|396903|P1|COMPLETED|Overall Study||203
162074|NCT00468481|396902|P2|Subjects Treated|Overall Study||94
162075|NCT00468481|396903|P1|Subjects Treated|Overall Study||285
162076|NCT00468481|396902|P2|STARTED|Overall Study||94
162077|NCT00468481|396903|P1|STARTED|Overall Study|6 of these randomized subjects did not take any study medication|291
162078|NCT00468546|397003|P2|NOT COMPLETED|Week 24 to Week 104 Analysis||225
162079|NCT00468546|397004|P1|NOT COMPLETED|Week 24 to Week 104 Analysis||105
162080|NCT00468546|397003|P2|COMPLETED|Week 24 to Week 104 Analysis||83
162081|NCT00468546|397004|P1|COMPLETED|Week 24 to Week 104 Analysis||103
162082|NCT00468546|397003|P2|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed W24 analysis were entered in W24 to W104 analysis.|308
162083|NCT00468546|397004|P1|STARTED|Week 24 to Week 104 Analysis|Participants who completed/not completed Week (W) 24 analysis were entered in W24 to W104 analysis.|208
162084|NCT00468546|397003|P2|NOT COMPLETED|Week 24 Analysis||55
162085|NCT00468546|397004|P1|NOT COMPLETED|Week 24 Analysis||97
162086|NCT00468546|397003|P2|COMPLETED|Week 24 Analysis||253
162087|NCT00468546|397004|P1|COMPLETED|Week 24 Analysis||111
162088|NCT00468546|397003|P2|STARTED|Week 24 Analysis||308
162089|NCT00468546|397004|P1|STARTED|Week 24 Analysis||208
162090|NCT00468559|397034|P3|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||17
162091|NCT00468559|397035|P2|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||10
162092|NCT00468559|397036|P1|NOT COMPLETED|Double-blind, Treatment-withdrawal Phase||0
162093|NCT00468559|397034|P3|COMPLETED|Double-blind, Treatment-withdrawal Phase||24
162094|NCT00468559|397035|P2|COMPLETED|Double-blind, Treatment-withdrawal Phase||29
162095|NCT00468559|397036|P1|COMPLETED|Double-blind, Treatment-withdrawal Phase||0
162096|NCT00468559|397034|P3|STARTED|Double-blind, Treatment-withdrawal Phase||41
162097|NCT00468559|397035|P2|STARTED|Double-blind, Treatment-withdrawal Phase||39
162098|NCT00468559|397036|P1|STARTED|Double-blind, Treatment-withdrawal Phase||0
162099|NCT00468559|397034|P3|NOT COMPLETED|Open-label Treatment Phase||0
162100|NCT00468559|397035|P2|NOT COMPLETED|Open-label Treatment Phase||0
162101|NCT00468559|397036|P1|NOT COMPLETED|Open-label Treatment Phase||18
162102|NCT00468559|397034|P3|COMPLETED|Open-label Treatment Phase||0
162103|NCT00468559|397035|P2|COMPLETED|Open-label Treatment Phase||0
162104|NCT00468559|397036|P1|COMPLETED|Open-label Treatment Phase|18 patients discontinued (were not randomized into the double-blind treatment withdrawal phase)|80
162105|NCT00468559|397034|P3|STARTED|Open-label Treatment Phase||0
162106|NCT00468559|397035|P2|STARTED|Open-label Treatment Phase||0
162107|NCT00468559|397036|P1|STARTED|Open-label Treatment Phase|All participants received open-label esomeprazole during this phase of the study|98
162108|NCT00468585|397066|P4|NOT COMPLETED|Overall Study||1
162110|NCT00468585|397068|P2|NOT COMPLETED|Overall Study||0
162111|NCT00468585|397069|P1|NOT COMPLETED|Overall Study||1
162112|NCT00468585|397066|P4|COMPLETED|Overall Study||5
162113|NCT00468585|397067|P3|COMPLETED|Overall Study||45
162114|NCT00468585|397068|P2|COMPLETED|Overall Study||3
162115|NCT00468585|397069|P1|COMPLETED|Overall Study||3
162116|NCT00468585|397066|P4|STARTED|Overall Study||6
162117|NCT00468585|397067|P3|STARTED|Overall Study||50
162118|NCT00468585|397068|P2|STARTED|Overall Study||3
162119|NCT00468585|397069|P1|STARTED|Overall Study||4
162120|NCT00468650|397079|P1|NOT COMPLETED|Overall Study||7
162121|NCT00468650|397079|P1|COMPLETED|Overall Study||110
162122|NCT00468650|397079|P1|STARTED|Overall Study||117
162123|NCT00468676|397125|P2|NOT COMPLETED|Overall Study||12
162124|NCT00468676|397126|P1|NOT COMPLETED|Overall Study||16
162125|NCT00468676|397125|P2|COMPLETED|Overall Study||94
162126|NCT00468676|397126|P1|COMPLETED|Overall Study||92
162127|NCT00468676|397125|P2|STARTED|Overall Study||106
162128|NCT00468676|397126|P1|STARTED|Overall Study||108
162129|NCT00468728|397145|P2|NOT COMPLETED|Follow-up||31
162130|NCT00468728|397146|P1|NOT COMPLETED|Follow-up||34
162131|NCT00468728|397145|P2|COMPLETED|Follow-up||222
162132|NCT00468728|397146|P1|COMPLETED|Follow-up||222
162133|NCT00468728|397145|P2|STARTED|Follow-up||253
162134|NCT00468728|397146|P1|STARTED|Follow-up||256
162135|NCT00468728|397145|P2|NOT COMPLETED|Treatment||11
162136|NCT00468728|397146|P1|NOT COMPLETED|Treatment||4
162137|NCT00468728|397145|P2|COMPLETED|Treatment||253
162138|NCT00468728|397146|P1|COMPLETED|Treatment||256
162139|NCT00468728|397145|P2|STARTED|Treatment||264
162140|NCT00468728|397146|P1|STARTED|Treatment||260
162141|NCT00468728|397145|P2|NOT COMPLETED|Enrollment||7
162142|NCT00468728|397146|P1|NOT COMPLETED|Enrollment||4
162143|NCT00468728|397145|P2|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|264
162144|NCT00468728|397146|P1|COMPLETED|Enrollment|1 fidaxomicin subject received vancomycin, 11 subjects didn't take drug|260
162145|NCT00468728|397145|P2|STARTED|Enrollment||271
162146|NCT00468728|397146|P1|STARTED|Enrollment||264
162147|NCT00468819|397159|P3|NOT COMPLETED|Overall Study||2
162148|NCT00468819|397160|P2|NOT COMPLETED|Overall Study||0
162149|NCT00468819|397161|P1|NOT COMPLETED|Overall Study||6
162150|NCT00468819|397159|P3|COMPLETED|Overall Study||46
162151|NCT00468819|397160|P2|COMPLETED|Overall Study||44
162152|NCT00468819|397161|P1|COMPLETED|Overall Study||42
162153|NCT00468819|397159|P3|Treatment Received/ Safety Follow-up|Overall Study|FAS|48
162154|NCT00468819|397160|P2|Treatment Received/ Safety Follow-up|Overall Study|FAS|44
162155|NCT00468819|397161|P1|Treatment Received/ Safety Follow-up|Overall Study|FAS (Full Analysis Set)|46
162156|NCT00468819|397159|P3|STARTED|Overall Study|Enrolled participants|48
162157|NCT00468819|397160|P2|STARTED|Overall Study|Enrolled participants|44
162158|NCT00468819|397161|P1|STARTED|Overall Study|Enrolled participants|48
162159|NCT00476008|397241|P2|NOT COMPLETED|Overall Study||8
162160|NCT00476008|397242|P1|NOT COMPLETED|Overall Study||9
162161|NCT00476008|397241|P2|COMPLETED|Overall Study||13
162162|NCT00476008|397242|P1|COMPLETED|Overall Study||13
162163|NCT00476008|397241|P2|6 Month Testing|Overall Study||14
162164|NCT00476008|397242|P1|6 Month Testing|Overall Study||15
162165|NCT00476008|397241|P2|STARTED|Overall Study||21
162166|NCT00476008|397242|P1|STARTED|Overall Study||22
162167|NCT00476021|397268|P2|NOT COMPLETED|Overall Study||0
162168|NCT00476021|397269|P1|NOT COMPLETED|Overall Study||0
162169|NCT00476021|397268|P2|COMPLETED|Overall Study||51
162170|NCT00476021|397269|P1|COMPLETED|Overall Study||51
162171|NCT00476021|397268|P2|STARTED|Overall Study||51
162172|NCT00476021|397269|P1|STARTED|Overall Study||51
162173|NCT00476086|397283|P1|NOT COMPLETED|Overall Study||5
162174|NCT00476086|397283|P1|COMPLETED|Overall Study||15
162175|NCT00476086|397283|P1|Received Radiation|Overall Study||15
162176|NCT00476086|397283|P1|Received Chemotherapy|Overall Study||19
162177|NCT00476086|397283|P1|STARTED|Overall Study||20
162178|NCT00476151|397291|P2|NOT COMPLETED|Overall Study||7
162179|NCT00476151|397292|P1|NOT COMPLETED|Overall Study||3
162180|NCT00476151|397291|P2|COMPLETED|Overall Study||107
162181|NCT00476151|397292|P1|COMPLETED|Overall Study||109
162182|NCT00476151|397291|P2|STARTED|Overall Study||114
162183|NCT00476151|397292|P1|STARTED|Overall Study||112
162184|NCT00476229|397298|P1|NOT COMPLETED|Overall Study||1
162185|NCT00476229|397298|P1|COMPLETED|Overall Study||19
162186|NCT00476229|397298|P1|STARTED|Overall Study||20
162187|NCT00476242|397304|P2|NOT COMPLETED|Overall Study||16
162188|NCT00476242|397305|P1|NOT COMPLETED|Overall Study||8
162189|NCT00476242|397304|P2|COMPLETED|Overall Study||12
162190|NCT00476242|397305|P1|COMPLETED|Overall Study||19
162191|NCT00476242|397304|P2|STARTED|Overall Study||28
162192|NCT00476242|397305|P1|STARTED|Overall Study||27
162193|NCT00476827|397319|P6|NOT COMPLETED|Overall Study||0
162194|NCT00476827|397320|P5|NOT COMPLETED|Overall Study||0
162195|NCT00476827|397321|P4|NOT COMPLETED|Overall Study||0
162196|NCT00476827|397322|P3|NOT COMPLETED|Overall Study||0
162197|NCT00476827|397323|P2|NOT COMPLETED|Overall Study||0
162198|NCT00476827|397324|P1|NOT COMPLETED|Overall Study||0
162199|NCT00476827|397319|P6|COMPLETED|Overall Study||2
162200|NCT00476827|397320|P5|COMPLETED|Overall Study||2
162201|NCT00476827|397321|P4|COMPLETED|Overall Study||0
162202|NCT00476827|397322|P3|COMPLETED|Overall Study||1
162203|NCT00476827|397323|P2|COMPLETED|Overall Study||0
162204|NCT00476827|397324|P1|COMPLETED|Overall Study||3
162205|NCT00476827|397319|P6|STARTED|Overall Study||2
162206|NCT00476827|397320|P5|STARTED|Overall Study||2
162207|NCT00476827|397321|P4|STARTED|Overall Study||0
162208|NCT00476827|397322|P3|STARTED|Overall Study||1
162209|NCT00476827|397323|P2|STARTED|Overall Study||0
162210|NCT00476827|397324|P1|STARTED|Overall Study||3
162211|NCT00476957|397356|P2|NOT COMPLETED|Overall Study||193
162212|NCT00476957|397357|P1|NOT COMPLETED|Overall Study||176
162213|NCT00476957|397356|P2|COMPLETED|Overall Study||4159
162214|NCT00476957|397357|P1|COMPLETED|Overall Study||4181
162215|NCT00476957|397356|P2|STARTED|Overall Study||4352
162216|NCT00476957|397357|P1|STARTED|Overall Study||4357
162217|NCT00477152|397365|P1|NOT COMPLETED|Overall Study||3
162218|NCT00477152|397365|P1|COMPLETED|Overall Study|Two patients treated, but assessments incomplete. All available data included in analyses for these.|49
162219|NCT00477152|397365|P1|STARTED|Overall Study|One patient withdrawn prior to treatment, so not included in analyses.|52
162220|NCT00477165|397374|P2|NOT COMPLETED|Overall Study||2
162221|NCT00477165|397375|P1|NOT COMPLETED|Overall Study||7
162222|NCT00477165|397374|P2|COMPLETED|Overall Study||25
162223|NCT00477165|397375|P1|COMPLETED|Overall Study||20
162224|NCT00477165|397374|P2|STARTED|Overall Study||27
162225|NCT00477165|397375|P1|STARTED|Overall Study||27
162226|NCT00477191|397387|P1|NOT COMPLETED|Overall Study||5
162227|NCT00477191|397387|P1|COMPLETED|Overall Study||13
162228|NCT00477191|397387|P1|STARTED|Overall Study||18
162229|NCT00477204|397396|P2|NOT COMPLETED|Overall Study||0
162230|NCT00477204|397397|P1|NOT COMPLETED|Overall Study||0
162231|NCT00477204|397396|P2|COMPLETED|Overall Study||5
162232|NCT00477204|397397|P1|COMPLETED|Overall Study||4
162233|NCT00477204|397396|P2|STARTED|Overall Study||5
162234|NCT00477204|397397|P1|STARTED|Overall Study||4
162235|NCT00477230|397405|P2|NOT COMPLETED|Overall Study||31
162236|NCT00477230|397406|P1|NOT COMPLETED|Overall Study||20
162237|NCT00477230|397405|P2|COMPLETED|Overall Study||1
162238|NCT00477230|397406|P1|COMPLETED|Overall Study||12
162239|NCT00477230|397405|P2|STARTED|Overall Study||32
162240|NCT00477230|397406|P1|STARTED|Overall Study||32
162241|NCT00477269|397414|P3|NOT COMPLETED|Open Label Extension||13
162242|NCT00477269|397415|P2|NOT COMPLETED|Open Label Extension||0
162243|NCT00477269|397416|P1|NOT COMPLETED|Open Label Extension||0
162244|NCT00477269|397414|P3|COMPLETED|Open Label Extension||9
162245|NCT00477269|397415|P2|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
162246|NCT00477269|397416|P1|COMPLETED|Open Label Extension|Arm in the Core study not extension|0
162247|NCT00477269|397414|P3|STARTED|Open Label Extension||22
162248|NCT00477269|397415|P2|STARTED|Open Label Extension|Arm in the Core study not extension|0
162249|NCT00477269|397416|P1|STARTED|Open Label Extension|Arm in the Core study not extension|0
162250|NCT00477269|397414|P3|NOT COMPLETED|Core Study||0
162251|NCT00477269|397415|P2|NOT COMPLETED|Core Study||8
162252|NCT00477269|397416|P1|NOT COMPLETED|Core Study||9
162253|NCT00477269|397414|P3|COMPLETED|Core Study||0
162254|NCT00477269|397415|P2|COMPLETED|Core Study||23
162255|NCT00477269|397416|P1|COMPLETED|Core Study||19
162256|NCT00477269|397414|P3|STARTED|Core Study||0
162257|NCT00477269|397415|P2|STARTED|Core Study||31
162258|NCT00477269|397416|P1|STARTED|Core Study||28
162259|NCT00477295|397470|P2|NOT COMPLETED|Overall Study||109
162260|NCT00477295|397471|P1|NOT COMPLETED|Overall Study||121
162261|NCT00477295|397470|P2|COMPLETED|Overall Study||192
162262|NCT00477295|397471|P1|COMPLETED|Overall Study||161
162263|NCT00477295|397470|P2|STARTED|Overall Study||301
162264|NCT00477295|397471|P1|STARTED|Overall Study||282
162265|NCT00477334|397499|P2|NOT COMPLETED|Overall Study||76
162266|NCT00477334|397500|P1|NOT COMPLETED|Overall Study||170
162267|NCT00477334|397499|P2|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|75
162268|NCT00477334|397500|P1|COMPLETED|Overall Study|Participants completing the first recurrence and follow-up.|142
162269|NCT00477334|397499|P2|Modified Intent to Treat Population|Overall Study||78
162270|NCT00477334|397500|P1|Modified Intent to Treat Population|Overall Study||152
162271|NCT00477334|397499|P2|Participants Completing First Recurrence|Overall Study||92
162272|NCT00477334|397500|P1|Participants Completing First Recurrence|Overall Study||187
162273|NCT00477334|397499|P2|Intent to Treat Population|Overall Study||98
162274|NCT00477334|397500|P1|Intent to Treat Population|Overall Study||201
162275|NCT00477334|397499|P2|Randomized and Took Study Drug|Overall Study||98
162276|NCT00477334|397500|P1|Randomized and Took Study Drug|Overall Study||206
162277|NCT00477334|397499|P2|STARTED|Overall Study||151
162278|NCT00477334|397500|P1|STARTED|Overall Study||312
162279|NCT00477386|397526|P2|NOT COMPLETED|Overall Study||17
162280|NCT00477386|397527|P1|NOT COMPLETED|Overall Study||11
162281|NCT00477386|397526|P2|COMPLETED|Overall Study||0
162282|NCT00477386|397527|P1|COMPLETED|Overall Study||0
162283|NCT00477386|397526|P2|STARTED|Overall Study||17
162284|NCT00477386|397527|P1|STARTED|Overall Study||11
162285|NCT00477451|397539|P4|NOT COMPLETED|Overall Study||0
162286|NCT00477451|397540|P3|NOT COMPLETED|Overall Study||0
162287|NCT00477451|397541|P2|NOT COMPLETED|Overall Study||0
162288|NCT00477451|397542|P1|NOT COMPLETED|Overall Study||0
162289|NCT00477451|397539|P4|COMPLETED|Overall Study||2
162290|NCT00477451|397540|P3|COMPLETED|Overall Study||7
162291|NCT00477451|397541|P2|COMPLETED|Overall Study||20
162292|NCT00477451|397542|P1|COMPLETED|Overall Study||20
162293|NCT00477451|397539|P4|STARTED|Overall Study||2
162294|NCT00477451|397540|P3|STARTED|Overall Study||7
162295|NCT00477451|397541|P2|STARTED|Overall Study||20
162296|NCT00477451|397542|P1|STARTED|Overall Study||20
162297|NCT00477464|397554|P1|NOT COMPLETED|Overall Study||51
162298|NCT00477464|397554|P1|COMPLETED|Overall Study||0
162299|NCT00477464|397554|P1|STARTED|Overall Study||51
162300|NCT00477490|397582|P9|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||8
162301|NCT00477490|397583|P8|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
162302|NCT00477490|397584|P7|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||5
162303|NCT00477490|397585|P6|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||6
162304|NCT00477490|397586|P5|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||20
162305|NCT00477490|397587|P4|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||12
162306|NCT00477490|397588|P3|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||15
162307|NCT00477490|397589|P2|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||28
162308|NCT00477490|397590|P1|NOT COMPLETED|Part II: Extension Week 5 up to Day 169||0
162309|NCT00477490|397582|P9|COMPLETED|Part II: Extension Week 5 up to Day 169||26
162310|NCT00477490|397583|P8|COMPLETED|Part II: Extension Week 5 up to Day 169||29
162311|NCT00477490|397584|P7|COMPLETED|Part II: Extension Week 5 up to Day 169||32
162312|NCT00477490|397585|P6|COMPLETED|Part II: Extension Week 5 up to Day 169||25
162313|NCT00477490|397586|P5|COMPLETED|Part II: Extension Week 5 up to Day 169||107
162314|NCT00477490|397587|P4|COMPLETED|Part II: Extension Week 5 up to Day 169||120
162315|NCT00477490|397588|P3|COMPLETED|Part II: Extension Week 5 up to Day 169||120
162316|NCT00477490|397589|P2|COMPLETED|Part II: Extension Week 5 up to Day 169||107
162317|NCT00477490|397590|P1|COMPLETED|Part II: Extension Week 5 up to Day 169||0
162318|NCT00477490|397582|P9|STARTED|Part II: Extension Week 5 up to Day 169||34
162319|NCT00477490|397583|P8|STARTED|Part II: Extension Week 5 up to Day 169||34
162320|NCT00477490|397584|P7|STARTED|Part II: Extension Week 5 up to Day 169||37
162321|NCT00477490|397585|P6|STARTED|Part II: Extension Week 5 up to Day 169||31
162322|NCT00477490|397586|P5|STARTED|Part II: Extension Week 5 up to Day 169||127
162323|NCT00477490|397587|P4|STARTED|Part II: Extension Week 5 up to Day 169||132
162324|NCT00477490|397588|P3|STARTED|Part II: Extension Week 5 up to Day 169||135
162325|NCT00477490|397589|P2|STARTED|Part II: Extension Week 5 up to Day 169||135
162326|NCT00477490|397590|P1|STARTED|Part II: Extension Week 5 up to Day 169||0
162327|NCT00477490|397582|P9|NOT COMPLETED|Part I: 4 Week Efficacy||0
162328|NCT00477490|397583|P8|NOT COMPLETED|Part I: 4 Week Efficacy||0
162329|NCT00477490|397584|P7|NOT COMPLETED|Part I: 4 Week Efficacy||0
162330|NCT00477490|397585|P6|NOT COMPLETED|Part I: 4 Week Efficacy||0
162331|NCT00477490|397586|P5|NOT COMPLETED|Part I: 4 Week Efficacy||25
162332|NCT00477490|397587|P4|NOT COMPLETED|Part I: 4 Week Efficacy||20
162333|NCT00477490|397588|P3|NOT COMPLETED|Part I: 4 Week Efficacy||10
162334|NCT00477490|397589|P2|NOT COMPLETED|Part I: 4 Week Efficacy||19
162335|NCT00477490|397590|P1|NOT COMPLETED|Part I: 4 Week Efficacy||15
162336|NCT00477490|397582|P9|COMPLETED|Part I: 4 Week Efficacy||0
162337|NCT00477490|397583|P8|COMPLETED|Part I: 4 Week Efficacy||0
162338|NCT00477490|397584|P7|COMPLETED|Part I: 4 Week Efficacy||0
162339|NCT00477490|397585|P6|COMPLETED|Part I: 4 Week Efficacy||0
162340|NCT00477490|397586|P5|COMPLETED|Part I: 4 Week Efficacy||135
162341|NCT00477490|397587|P4|COMPLETED|Part I: 4 Week Efficacy||138
162342|NCT00477490|397588|P3|COMPLETED|Part I: 4 Week Efficacy||148
162343|NCT00477490|397589|P2|COMPLETED|Part I: 4 Week Efficacy||144
162344|NCT00477490|397590|P1|COMPLETED|Part I: 4 Week Efficacy||145
162345|NCT00477490|397582|P9|ITT Population|Part I: 4 Week Efficacy||0
162346|NCT00477490|397583|P8|ITT Population|Part I: 4 Week Efficacy||0
162347|NCT00477490|397584|P7|ITT Population|Part I: 4 Week Efficacy||0
162348|NCT00477490|397585|P6|ITT Population|Part I: 4 Week Efficacy||0
162349|NCT00477490|397586|P5|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|146
162350|NCT00477490|397587|P4|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|148
162351|NCT00477490|397588|P3|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|152
162352|NCT00477490|397589|P2|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|155
162353|NCT00477490|397590|P1|ITT Population|Part I: 4 Week Efficacy|Received at least one dose of study drug and provided at least one primary efficacy measure.|156
162354|NCT00477490|397582|P9|STARTED|Part I: 4 Week Efficacy||0
162355|NCT00477490|397583|P8|STARTED|Part I: 4 Week Efficacy||0
162356|NCT00477490|397584|P7|STARTED|Part I: 4 Week Efficacy||0
162357|NCT00477490|397585|P6|STARTED|Part I: 4 Week Efficacy||0
162358|NCT00477490|397586|P5|STARTED|Part I: 4 Week Efficacy||160
162359|NCT00477490|397587|P4|STARTED|Part I: 4 Week Efficacy||158
162360|NCT00477490|397588|P3|STARTED|Part I: 4 Week Efficacy||158
162361|NCT00477490|397589|P2|STARTED|Part I: 4 Week Efficacy||163
162362|NCT00477490|397590|P1|STARTED|Part I: 4 Week Efficacy||160
162363|NCT00477594|397676|P2|NOT COMPLETED|Follow-up Period||1
162364|NCT00477594|397677|P1|NOT COMPLETED|Follow-up Period||3
162365|NCT00477594|397676|P2|COMPLETED|Follow-up Period||4
162366|NCT00477594|397677|P1|COMPLETED|Follow-up Period||13
162367|NCT00477594|397676|P2|STARTED|Follow-up Period||5
162368|NCT00477594|397677|P1|STARTED|Follow-up Period||16
162369|NCT00477594|397676|P2|NOT COMPLETED|Year 3||0
162370|NCT00477594|397677|P1|NOT COMPLETED|Year 3||2
162371|NCT00477594|397676|P2|COMPLETED|Year 3||0
162372|NCT00477594|397677|P1|COMPLETED|Year 3||2
162373|NCT00477594|397676|P2|STARTED|Year 3||0
162374|NCT00477594|397677|P1|STARTED|Year 3||4
162375|NCT00477594|397676|P2|NOT COMPLETED|Year 1 and Year 2||4
162376|NCT00477594|397677|P1|NOT COMPLETED|Year 1 and Year 2||9
162377|NCT00477594|397676|P2|COMPLETED|Year 1 and Year 2||1
162378|NCT00477594|397677|P1|COMPLETED|Year 1 and Year 2||7
162379|NCT00477594|397676|P2|STARTED|Year 1 and Year 2||5
162380|NCT00477594|397677|P1|STARTED|Year 1 and Year 2||16
162381|NCT00477607|397735|P2|NOT COMPLETED|Overall Study||7
162382|NCT00477607|397736|P1|NOT COMPLETED|Overall Study||7
162383|NCT00477607|397735|P2|COMPLETED|Overall Study||13
162384|NCT00477607|397736|P1|COMPLETED|Overall Study||12
162385|NCT00477607|397735|P2|STARTED|Overall Study||20
162386|NCT00477607|397736|P1|STARTED|Overall Study||19
162387|NCT00477633|397746|P1|NOT COMPLETED|Overall Study||709
162388|NCT00477633|397746|P1|COMPLETED|Overall Study||991
162389|NCT00477633|397746|P1|STARTED|Overall Study||1700
162390|NCT00477672|397755|P3|NOT COMPLETED|Overall Study||16
162391|NCT00477672|397756|P2|NOT COMPLETED|Overall Study||16
162392|NCT00477672|397757|P1|NOT COMPLETED|Overall Study||7
162393|NCT00477672|397755|P3|COMPLETED|Overall Study||83
162394|NCT00477672|397756|P2|COMPLETED|Overall Study||85
162395|NCT00477672|397757|P1|COMPLETED|Overall Study||91
162396|NCT00477672|397755|P3|STARTED|Overall Study||99
162397|NCT00477672|397756|P2|STARTED|Overall Study||101
162398|NCT00477672|397757|P1|STARTED|Overall Study||98
162399|NCT00477685|397768|P1|NOT COMPLETED|Overall Study||0
162400|NCT00477685|397768|P1|COMPLETED|Overall Study||10
162401|NCT00477685|397768|P1|STARTED|Overall Study||10
162402|NCT00477750|397773|P1|NOT COMPLETED|Overall Study||11
162403|NCT00477750|397773|P1|COMPLETED|Overall Study||15
162404|NCT00477750|397773|P1|STARTED|Overall Study||26
162405|NCT00477971|397779|P2|NOT COMPLETED|Overall Study||6
162406|NCT00477971|397780|P1|NOT COMPLETED|Overall Study||17
162407|NCT00477971|397779|P2|COMPLETED|Overall Study||49
162408|NCT00477971|397780|P1|COMPLETED|Overall Study||17
162409|NCT00477971|397779|P2|STARTED|Overall Study||55
162410|NCT00477971|397780|P1|STARTED|Overall Study||34
162411|NCT00478023|397797|P5|NOT COMPLETED|Overall Study||55
162412|NCT00478023|397798|P4|NOT COMPLETED|Overall Study||30
162413|NCT00478023|397799|P3|NOT COMPLETED|Overall Study||20
162414|NCT00478023|397800|P2|NOT COMPLETED|Overall Study||24
162415|NCT00478023|397801|P1|NOT COMPLETED|Overall Study||35
162416|NCT00478023|397797|P5|COMPLETED|Overall Study||114
162417|NCT00478023|397798|P4|COMPLETED|Overall Study||146
162418|NCT00478023|397799|P3|COMPLETED|Overall Study||151
162419|NCT00478023|397800|P2|COMPLETED|Overall Study||144
162420|NCT00478023|397801|P1|COMPLETED|Overall Study||135
162421|NCT00478023|397797|P5|STARTED|Overall Study||169
162422|NCT00478023|397798|P4|STARTED|Overall Study||176
162423|NCT00478023|397799|P3|STARTED|Overall Study||171
162424|NCT00478023|397800|P2|STARTED|Overall Study||168
162425|NCT00478023|397801|P1|STARTED|Overall Study||170
162426|NCT00478036|397821|P3|NOT COMPLETED|Overall Study||0
162427|NCT00478036|397822|P2|NOT COMPLETED|Overall Study||0
162428|NCT00478036|397823|P1|NOT COMPLETED|Overall Study||0
162429|NCT00478036|397821|P3|COMPLETED|Overall Study||14
162430|NCT00478036|397822|P2|COMPLETED|Overall Study||7
162431|NCT00478036|397823|P1|COMPLETED|Overall Study||10
162432|NCT00478036|397821|P3|STARTED|Overall Study||14
162433|NCT00478036|397822|P2|STARTED|Overall Study||7
162434|NCT00478036|397823|P1|STARTED|Overall Study||10
162435|NCT00478140|397831|P1|NOT COMPLETED|Overall Study||3
162436|NCT00478140|397831|P1|COMPLETED|Overall Study||1
162437|NCT00478140|397831|P1|STARTED|Overall Study||4
162438|NCT00478192|397838|P3|NOT COMPLETED|Overall Study||2
162439|NCT00478192|397839|P2|NOT COMPLETED|Overall Study||5
162440|NCT00478192|397840|P1|NOT COMPLETED|Overall Study||4
162441|NCT00478192|397838|P3|COMPLETED|Overall Study||8
162442|NCT00478192|397839|P2|COMPLETED|Overall Study||15
162443|NCT00478192|397840|P1|COMPLETED|Overall Study||16
162444|NCT00478192|397838|P3|End of Treatment|Overall Study||8
162445|NCT00478192|397839|P2|End of Treatment|Overall Study||16
162446|NCT00478192|397840|P1|End of Treatment|Overall Study||18
162447|NCT00478192|397838|P3|Full Analysis Set / Safety Analysis Set|Overall Study||9
162448|NCT00478192|397839|P2|Full Analysis Set / Safety Analysis Set|Overall Study||20
162449|NCT00478192|397840|P1|Full Analysis Set / Safety Analysis Set|Overall Study||20
162450|NCT00478192|397838|P3|STARTED|Overall Study||10
162451|NCT00478192|397839|P2|STARTED|Overall Study||20
162452|NCT00478192|397840|P1|STARTED|Overall Study||20
162453|NCT00478205|397869|P2|NOT COMPLETED|Overall Study||87
162454|NCT00478205|397870|P1|NOT COMPLETED|Overall Study||296
162455|NCT00478205|397869|P2|COMPLETED|Overall Study||399
162456|NCT00478205|397870|P1|COMPLETED|Overall Study||685
162457|NCT00478205|397869|P2|STARTED|Overall Study||486
162458|NCT00478205|397870|P1|STARTED|Overall Study||981
162459|NCT00478218|397884|P2|NOT COMPLETED|Overall Study||0
162460|NCT00478218|397885|P1|NOT COMPLETED|Overall Study||0
162461|NCT00478218|397884|P2|COMPLETED|Overall Study||19
162462|NCT00478218|397885|P1|COMPLETED|Overall Study||34
162463|NCT00478218|397884|P2|STARTED|Overall Study||19
162464|NCT00478218|397885|P1|STARTED|Overall Study||34
162465|NCT00478231|397897|P1|NOT COMPLETED|Overall Study||84
162466|NCT00478231|397897|P1|COMPLETED|Overall Study||125
162467|NCT00478231|397897|P1|Treated|Overall Study||206
162468|NCT00478231|397897|P1|STARTED|Overall Study||209
162469|NCT00478244|397916|P1|NOT COMPLETED|Overall Study||1
162470|NCT00478244|397916|P1|COMPLETED|Overall Study||6
162471|NCT00478244|397916|P1|STARTED|Overall Study||7
162472|NCT00478257|397931|P2|NOT COMPLETED|Overall Study||3
162473|NCT00478257|397932|P1|NOT COMPLETED|Overall Study||8
162474|NCT00478257|397931|P2|COMPLETED|Overall Study||13
162475|NCT00478257|397932|P1|COMPLETED|Overall Study||15
162476|NCT00478257|397931|P2|STARTED|Overall Study||16
162477|NCT00478257|397932|P1|STARTED|Overall Study||23
162478|NCT00478556|397940|P2|NOT COMPLETED|Overall Study||0
162479|NCT00478556|397941|P1|NOT COMPLETED|Overall Study||0
162480|NCT00478556|397940|P2|COMPLETED|Overall Study||149
162481|NCT00478556|397941|P1|COMPLETED|Overall Study||151
162482|NCT00478556|397940|P2|STARTED|Overall Study||149
162483|NCT00478556|397941|P1|STARTED|Overall Study||151
162484|NCT00478569|397949|P1|NOT COMPLETED|Overall Study||409
162485|NCT00478569|397949|P1|COMPLETED|Overall Study||761
162486|NCT00478569|397949|P1|STARTED|Overall Study||1170
162487|NCT00478608|397963|P1|NOT COMPLETED|Overall Study||20
162488|NCT00478608|397963|P1|COMPLETED|Overall Study||59
162489|NCT00478608|397963|P1|STARTED|Overall Study||79
162490|NCT00478647|397971|P1|NOT COMPLETED|Overall Study||2
162491|NCT00478647|397971|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT)=participants who have received at least 1 full or partial dose of study drug.|38
162492|NCT00478647|397971|P1|STARTED|Overall Study||40
162493|NCT00478673|397979|P1|NOT COMPLETED|12-Months Post-Procedure||64
162494|NCT00478673|397979|P1|COMPLETED|12-Months Post-Procedure||231
162495|NCT00478673|397979|P1|STARTED|12-Months Post-Procedure|3 participants who did not complete Period 1 due to death (2) and withdrawal (1) are not included.|295
162496|NCT00478673|397979|P1|NOT COMPLETED|30-Days Post-Procedure||10
162497|NCT00478673|397979|P1|COMPLETED|30-Days Post-Procedure|"7 participants who did not complete this Period due to Missed Visit still continued on to Period 2"|288
162498|NCT00478673|397979|P1|STARTED|30-Days Post-Procedure||298
162499|NCT00478777|397984|P1|NOT COMPLETED|Overall Study||77
162500|NCT00478777|397984|P1|COMPLETED|Overall Study|10 participants had >= 6 months and 63 participants < 6 months treatment prior to study termination.|73
162501|NCT00478777|397984|P1|Safety and Full Analysis Set (FAS)|Overall Study|6 enrolled participants did not receive lenalidomide.|144
162502|NCT00478777|397984|P1|STARTED|Overall Study||150
162503|NCT00478881|397993|P2|NOT COMPLETED|Overall Study||22
162504|NCT00478881|397994|P1|NOT COMPLETED|Overall Study||39
162505|NCT00478881|397993|P2|COMPLETED|Overall Study||176
162506|NCT00478881|397994|P1|COMPLETED|Overall Study||160
162507|NCT00478881|397993|P2|Received Medication|Overall Study||198
162508|NCT00478881|397994|P1|Received Medication|Overall Study||198
162509|NCT00478881|397993|P2|STARTED|Overall Study||198
162510|NCT00478881|397994|P1|STARTED|Overall Study||199
162511|NCT00479037|398020|P2|NOT COMPLETED|Overall Study||6
162512|NCT00479037|398021|P1|NOT COMPLETED|Overall Study||3
162513|NCT00479037|398020|P2|COMPLETED|Overall Study||34
162514|NCT00479037|398021|P1|COMPLETED|Overall Study||38
162515|NCT00479037|398020|P2|STARTED|Overall Study||40
162516|NCT00479037|398021|P1|STARTED|Overall Study||41
162517|NCT00479089|398033|P2|NOT COMPLETED|Overall Study||0
162518|NCT00479089|398034|P1|NOT COMPLETED|Overall Study||0
162519|NCT00479089|398033|P2|COMPLETED|Overall Study||25
162520|NCT00479089|398034|P1|COMPLETED|Overall Study||25
162521|NCT00479089|398033|P2|STARTED|Overall Study||25
162522|NCT00479089|398034|P1|STARTED|Overall Study||25
162523|NCT00479154|398046|P2|NOT COMPLETED|Overall Study||0
162524|NCT00479154|398047|P1|NOT COMPLETED|Overall Study||0
162525|NCT00479154|398046|P2|COMPLETED|Overall Study||3
162526|NCT00479154|398047|P1|COMPLETED|Overall Study||3
162527|NCT00479154|398046|P2|STARTED|Overall Study||3
162528|NCT00479154|398047|P1|STARTED|Overall Study||3
162529|NCT00479232|398055|P6|NOT COMPLETED|Overall Study||30
162530|NCT00479232|398056|P5|NOT COMPLETED|Overall Study||4
162531|NCT00479232|398057|P4|NOT COMPLETED|Overall Study||3
162532|NCT00479232|398058|P3|NOT COMPLETED|Overall Study||28
162533|NCT00479232|398059|P2|NOT COMPLETED|Overall Study||3
162534|NCT00479232|398060|P1|NOT COMPLETED|Overall Study||3
162535|NCT00479232|398055|P6|COMPLETED|Overall Study||0
162536|NCT00479232|398056|P5|COMPLETED|Overall Study||0
162537|NCT00479232|398057|P4|COMPLETED|Overall Study||0
162538|NCT00479232|398058|P3|COMPLETED|Overall Study||0
162539|NCT00479232|398059|P2|COMPLETED|Overall Study||0
162540|NCT00479232|398060|P1|COMPLETED|Overall Study||0
162541|NCT00479232|398055|P6|STARTED|Overall Study||30
162542|NCT00479232|398056|P5|STARTED|Overall Study||4
162543|NCT00479232|398057|P4|STARTED|Overall Study||3
162544|NCT00479232|398058|P3|STARTED|Overall Study||28
162545|NCT00479232|398059|P2|STARTED|Overall Study||3
162546|NCT00479232|398060|P1|STARTED|Overall Study||3
162547|NCT00479258|398080|P2|NOT COMPLETED|Overall Study||0
162548|NCT00479258|398081|P1|NOT COMPLETED|Overall Study||0
162549|NCT00479258|398080|P2|COMPLETED|Overall Study||0
162550|NCT00479258|398081|P1|COMPLETED|Overall Study||0
162551|NCT00479258|398080|P2|STARTED|Overall Study||0
162552|NCT00479258|398081|P1|STARTED|Overall Study||0
162553|NCT00479336|398089|P4|NOT COMPLETED|Overall Study||5
162554|NCT00479336|398090|P3|NOT COMPLETED|Overall Study||1
162555|NCT00479336|398091|P2|NOT COMPLETED|Overall Study||6
162556|NCT00479336|398092|P1|NOT COMPLETED|Overall Study||4
162557|NCT00479336|398089|P4|COMPLETED|Overall Study||21
162558|NCT00479336|398090|P3|COMPLETED|Overall Study||24
162559|NCT00479336|398091|P2|COMPLETED|Overall Study||20
162560|NCT00479336|398092|P1|COMPLETED|Overall Study||23
162561|NCT00479336|398089|P4|STARTED|Overall Study||26
162562|NCT00479336|398090|P3|STARTED|Overall Study||25
162563|NCT00479336|398091|P2|STARTED|Overall Study||26
162564|NCT00479336|398092|P1|STARTED|Overall Study||27
162565|NCT00465569|398108|P2|NOT COMPLETED|Overall Study||0
162566|NCT00465569|398109|P1|NOT COMPLETED|Overall Study||1
162567|NCT00465569|398108|P2|COMPLETED|Overall Study||7
162568|NCT00465569|398109|P1|COMPLETED|Overall Study||12
162569|NCT00465569|398108|P2|STARTED|Overall Study||7
162570|NCT00465569|398109|P1|STARTED|Overall Study||13
162571|NCT00465647|398123|P4|NOT COMPLETED|Overall Study||13
162572|NCT00465647|398124|P3|NOT COMPLETED|Overall Study||11
162573|NCT00465647|398125|P2|NOT COMPLETED|Overall Study||8
162574|NCT00465647|398126|P1|NOT COMPLETED|Overall Study||13
162575|NCT00465647|398123|P4|COMPLETED|Overall Study||12
162576|NCT00465647|398124|P3|COMPLETED|Overall Study||18
162577|NCT00465647|398125|P2|COMPLETED|Overall Study||15
162578|NCT00465647|398126|P1|COMPLETED|Overall Study||26
162579|NCT00465647|398123|P4|STARTED|Overall Study||25
162580|NCT00465647|398124|P3|STARTED|Overall Study||29
162581|NCT00465647|398125|P2|STARTED|Overall Study||23
162582|NCT00465647|398126|P1|STARTED|Overall Study||39
162583|NCT00465738|398151|P2|NOT COMPLETED|Overall Study||6
162584|NCT00465738|398152|P1|NOT COMPLETED|Overall Study||6
162585|NCT00465738|398151|P2|COMPLETED|Overall Study||89
162586|NCT00465738|398152|P1|COMPLETED|Overall Study||91
162587|NCT00465738|398151|P2|STARTED|Overall Study||95
162588|NCT00465738|398152|P1|STARTED|Overall Study||97
162589|NCT00465816|398245|P3|NOT COMPLETED|Overall Study||2
162590|NCT00465816|398246|P2|NOT COMPLETED|Overall Study||0
162591|NCT00465816|398247|P1|NOT COMPLETED|Overall Study||0
162592|NCT00465816|398245|P3|COMPLETED|Overall Study||120
162593|NCT00465816|398246|P2|COMPLETED|Overall Study||122
162594|NCT00465816|398247|P1|COMPLETED|Overall Study||367
162595|NCT00465816|398245|P3|STARTED|Overall Study||122
162596|NCT00465816|398246|P2|STARTED|Overall Study||122
162597|NCT00465816|398247|P1|STARTED|Overall Study||367
162598|NCT00465894|398329|P2|NOT COMPLETED|Overall Study||3
162599|NCT00465894|398330|P1|NOT COMPLETED|Overall Study||5
162600|NCT00465894|398329|P2|COMPLETED|Overall Study||25
162601|NCT00465894|398330|P1|COMPLETED|Overall Study||25
162602|NCT00465894|398329|P2|STARTED|Overall Study||28
162603|NCT00465894|398330|P1|STARTED|Overall Study||30
162604|NCT00465972|398338|P2|NOT COMPLETED|Overall Study||1
162605|NCT00465972|398339|P1|NOT COMPLETED|Overall Study||2
162606|NCT00465972|398338|P2|COMPLETED|Overall Study||23
162607|NCT00465972|398339|P1|COMPLETED|Overall Study||18
162608|NCT00465972|398338|P2|STARTED|Overall Study||24
162609|NCT00465972|398339|P1|STARTED|Overall Study||20
162610|NCT00465985|398347|P2|NOT COMPLETED|Part III - Open-label Treatment Period||0
162611|NCT00465985|398348|P1|NOT COMPLETED|Part III - Open-label Treatment Period||2
162612|NCT00465985|398347|P2|COMPLETED|Part III - Open-label Treatment Period||0
162613|NCT00465985|398348|P1|COMPLETED|Part III - Open-label Treatment Period||29
162614|NCT00465985|398347|P2|STARTED|Part III - Open-label Treatment Period||0
162615|NCT00465985|398348|P1|STARTED|Part III - Open-label Treatment Period|All patients received treatment with ACZ885 in Part III of the study.|31
162616|NCT00465985|398347|P2|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||12
162617|NCT00465985|398348|P1|NOT COMPLETED|Part II - 1:1 ACZ885:Placebo||0
162618|NCT00465985|398347|P2|COMPLETED|Part II - 1:1 ACZ885:Placebo||4
162619|NCT00465985|398348|P1|COMPLETED|Part II - 1:1 ACZ885:Placebo||15
162620|NCT00465985|398347|P2|STARTED|Part II - 1:1 ACZ885:Placebo||16
162621|NCT00465985|398348|P1|STARTED|Part II - 1:1 ACZ885:Placebo|Patients with complete response to treatment entered Part II and were randomized to ACZ885 ,placebo.|15
162622|NCT00465985|398347|P2|NOT COMPLETED|Part I - Open-label Treatment Period||0
162623|NCT00465985|398348|P1|NOT COMPLETED|Part I - Open-label Treatment Period||4
162624|NCT00465985|398347|P2|COMPLETED|Part I - Open-label Treatment Period||0
162625|NCT00465985|398348|P1|COMPLETED|Part I - Open-label Treatment Period|Only patients with a complete response completed Part I and entered Part II of the study.|31
162626|NCT00465985|398347|P2|STARTED|Part I - Open-label Treatment Period||0
162627|NCT00465985|398348|P1|STARTED|Part I - Open-label Treatment Period|All patients received treatment with ACZ885 in Part I of the study.|35
162628|NCT00465998|398369|P1|NOT COMPLETED|Overall Study||0
162629|NCT00465998|398369|P1|COMPLETED|Overall Study||275
162630|NCT00465998|398369|P1|STARTED|Overall Study||275
162631|NCT00466167|398377|P3|NOT COMPLETED|Overall Study||21
162632|NCT00466167|398378|P2|NOT COMPLETED|Overall Study||12
162633|NCT00466167|398379|P1|NOT COMPLETED|Overall Study||20
162634|NCT00466167|398377|P3|COMPLETED|Overall Study||157
162635|NCT00466167|398378|P2|COMPLETED|Overall Study||163
162636|NCT00466167|398379|P1|COMPLETED|Overall Study||145
162637|NCT00466167|398377|P3|STARTED|Overall Study||178
162638|NCT00466167|398378|P2|STARTED|Overall Study||175
162639|NCT00466167|398379|P1|STARTED|Overall Study||165
162640|NCT00466193|398437|P2|NOT COMPLETED|Overall Study||8
162641|NCT00466193|398438|P1|NOT COMPLETED|Overall Study||12
162642|NCT00466193|398437|P2|COMPLETED|Overall Study|One patient did not report at least one Latency Sleep Onset following middle-of-the-night awakening.|137
162643|NCT00466193|398438|P1|COMPLETED|Overall Study||138
162644|NCT00466193|398437|P2|STARTED|Overall Study||145
162645|NCT00466193|398438|P1|STARTED|Overall Study||150
162646|NCT00466206|398462|P1|NOT COMPLETED|Overall Study||0
162647|NCT00466206|398462|P1|COMPLETED|Overall Study|One of 10 patients withdrawn from study but completed treatment under Compassionate Use Designation|10
162648|NCT00466206|398462|P1|STARTED|Overall Study||10
162649|NCT00466310|398473|P3|NOT COMPLETED|Overall Study||0
162650|NCT00466310|398474|P2|NOT COMPLETED|Overall Study||0
162651|NCT00466310|398475|P1|NOT COMPLETED|Overall Study||0
162652|NCT00466310|398473|P3|COMPLETED|Overall Study||31
162653|NCT00466310|398474|P2|COMPLETED|Overall Study||20
162654|NCT00466310|398475|P1|COMPLETED|Overall Study||20
162655|NCT00466310|398473|P3|STARTED|Overall Study||31
162656|NCT00466310|398474|P2|STARTED|Overall Study||20
162657|NCT00466310|398475|P1|STARTED|Overall Study||20
162658|NCT00466323|398485|P2|NOT COMPLETED|Overall Study||23
162659|NCT00466323|398486|P1|NOT COMPLETED|Overall Study||28
162660|NCT00466323|398485|P2|COMPLETED|Overall Study||92
162661|NCT00466323|398486|P1|COMPLETED|Overall Study||89
162662|NCT00466323|398485|P2|STARTED|Overall Study||115
162663|NCT00466323|398486|P1|STARTED|Overall Study||117
162664|NCT00471705|398501|P3|NOT COMPLETED|Overall Study||15
162665|NCT00471705|398502|P2|NOT COMPLETED|Overall Study||22
162666|NCT00471705|398503|P1|NOT COMPLETED|Overall Study||24
162667|NCT00471705|398501|P3|COMPLETED|Overall Study||134
162668|NCT00471705|398502|P2|COMPLETED|Overall Study||121
162669|NCT00471705|398503|P1|COMPLETED|Overall Study||121
162670|NCT00471705|398501|P3|STARTED|Overall Study||149
162671|NCT00471705|398502|P2|STARTED|Overall Study||143
162672|NCT00471705|398503|P1|STARTED|Overall Study||145
162673|NCT00471718|398517|P1|NOT COMPLETED|Overall Study||27
162674|NCT00471718|398517|P1|COMPLETED|Overall Study||0
162675|NCT00471718|398517|P1|STARTED|Overall Study||27
162676|NCT00471822|398526|P1|NOT COMPLETED|Overall Study||2
162677|NCT00471822|398526|P1|COMPLETED|Overall Study||9705
162678|NCT00471822|398526|P1|Treated|Overall Study||9705
162679|NCT00471822|398526|P1|STARTED|Overall Study||9707
162680|NCT00472030|398536|P2|NOT COMPLETED|Overall Study||0
162681|NCT00472030|398537|P1|NOT COMPLETED|Overall Study||1
162682|NCT00472030|398536|P2|COMPLETED|Overall Study||0
162683|NCT00472030|398537|P1|COMPLETED|Overall Study||1
162684|NCT00472030|398536|P2|STARTED|Overall Study||0
162685|NCT00472030|398537|P1|STARTED|Overall Study||2
162686|NCT00472056|398557|P4|NOT COMPLETED|Overall Study||0
162687|NCT00472056|398558|P3|NOT COMPLETED|Overall Study||0
162688|NCT00472056|398559|P2|NOT COMPLETED|Overall Study||0
162689|NCT00472056|398560|P1|NOT COMPLETED|Overall Study||0
162690|NCT00472056|398557|P4|COMPLETED|Overall Study||17
162691|NCT00472056|398558|P3|COMPLETED|Overall Study||32
162692|NCT00472056|398559|P2|COMPLETED|Overall Study||19
162693|NCT00472056|398560|P1|COMPLETED|Overall Study||25
162694|NCT00472056|398557|P4|STARTED|Overall Study||17
162695|NCT00472056|398558|P3|STARTED|Overall Study||32
162696|NCT00472056|398559|P2|STARTED|Overall Study||19
162697|NCT00472056|398560|P1|STARTED|Overall Study||25
162698|NCT00472082|398568|P1|NOT COMPLETED|Overall Study||5
162699|NCT00472082|398568|P1|COMPLETED|Overall Study||0
162700|NCT00472082|398568|P1|STARTED|Overall Study||5
162701|NCT00472199|398575|P2|NOT COMPLETED|Overall Study||60
162702|NCT00472199|398576|P1|NOT COMPLETED|Overall Study||35
162703|NCT00472199|398575|P2|COMPLETED|Overall Study||103
162704|NCT00472199|398576|P1|COMPLETED|Overall Study||131
162705|NCT00472199|398575|P2|STARTED|Overall Study||163
162706|NCT00472199|398576|P1|STARTED|Overall Study||166
162707|NCT00472290|398642|P1|NOT COMPLETED|Overall Study||72
162708|NCT00472290|398642|P1|COMPLETED|Overall Study||0
162709|NCT00472290|398642|P1|STARTED|Overall Study||72
162710|NCT00472303|398654|P3|NOT COMPLETED|Maintenance Phase||17
162711|NCT00472303|398655|P2|NOT COMPLETED|Maintenance Phase||16
162712|NCT00472303|398656|P1|NOT COMPLETED|Maintenance Phase||17
162713|NCT00472303|398654|P3|COMPLETED|Maintenance Phase||95
162714|NCT00472303|398655|P2|COMPLETED|Maintenance Phase||93
162715|NCT00472303|398656|P1|COMPLETED|Maintenance Phase||89
162716|NCT00472303|398654|P3|STARTED|Maintenance Phase|112 of 218 participants in the tapentadol titration arm were re-randomized and treated.|112
162717|NCT00472303|398655|P2|STARTED|Maintenance Phase||109
162718|NCT00472303|398656|P1|STARTED|Maintenance Phase|106 of 218 participants in the tapentadol titration arm were re-randomized and treated.|106
162719|NCT00472303|398654|P3|NOT COMPLETED|Discontinuations After Titration Phase||0
162720|NCT00472303|398655|P2|NOT COMPLETED|Discontinuations After Titration Phase||20
162721|NCT00472303|398656|P1|NOT COMPLETED|Discontinuations After Titration Phase||61
162722|NCT00472303|398654|P3|COMPLETED|Discontinuations After Titration Phase||0
162723|NCT00472303|398655|P2|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|109
162724|NCT00472303|398656|P1|COMPLETED|Discontinuations After Titration Phase|Participants meeting stabilization criteria on days 13-15 in the titration phase were re-randomized.|218
162725|NCT00472303|398654|P3|STARTED|Discontinuations After Titration Phase||0
162726|NCT00472303|398655|P2|STARTED|Discontinuations After Titration Phase||129
162727|NCT00472303|398656|P1|STARTED|Discontinuations After Titration Phase||279
162728|NCT00472303|398654|P3|NOT COMPLETED|Titration Phase||0
162729|NCT00472303|398655|P2|NOT COMPLETED|Titration Phase||29
162730|NCT00472303|398656|P1|NOT COMPLETED|Titration Phase||59
162731|NCT00472303|398654|P3|COMPLETED|Titration Phase||0
162732|NCT00472303|398655|P2|COMPLETED|Titration Phase||129
162733|NCT00472303|398656|P1|COMPLETED|Titration Phase||279
162734|NCT00472303|398654|P3|STARTED|Titration Phase|All participants in the titration phase were in the tapentadol arm during the titration phase.|0
162735|NCT00472303|398655|P2|STARTED|Titration Phase||158
162736|NCT00472303|398656|P1|STARTED|Titration Phase||338
162737|NCT00472420|398719|P1|NOT COMPLETED|Follow-up Period||17
162738|NCT00472420|398719|P1|COMPLETED|Follow-up Period||15
162739|NCT00472420|398719|P1|STARTED|Follow-up Period||32
162740|NCT00472420|398719|P1|NOT COMPLETED|Induction Treatment Period||16
162741|NCT00472420|398719|P1|COMPLETED|Induction Treatment Period||32
162742|NCT00472420|398719|P1|STARTED|Induction Treatment Period||48
162743|NCT00472446|398729|P4|NOT COMPLETED|Overall Study||6
162744|NCT00472446|398730|P3|NOT COMPLETED|Overall Study||7
162745|NCT00472446|398731|P2|NOT COMPLETED|Overall Study||6
162746|NCT00472446|398732|P1|NOT COMPLETED|Overall Study||5
162747|NCT00472446|398729|P4|COMPLETED|Overall Study||39
162748|NCT00472446|398730|P3|COMPLETED|Overall Study||38
162749|NCT00472446|398731|P2|COMPLETED|Overall Study||41
162750|NCT00472446|398732|P1|COMPLETED|Overall Study||41
162751|NCT00472446|398729|P4|STARTED|Overall Study||45
162752|NCT00472446|398730|P3|STARTED|Overall Study||45
162753|NCT00472446|398731|P2|STARTED|Overall Study||47
162754|NCT00472446|398732|P1|STARTED|Overall Study||46
162755|NCT00472576|398764|P2|NOT COMPLETED|Second Intervention||0
162756|NCT00472576|398765|P1|NOT COMPLETED|Second Intervention||0
162757|NCT00472576|398764|P2|COMPLETED|Second Intervention||3
162758|NCT00472576|398765|P1|COMPLETED|Second Intervention||2
162759|NCT00472576|398764|P2|STARTED|Second Intervention||3
162760|NCT00472576|398765|P1|STARTED|Second Intervention||2
162761|NCT00472576|398764|P2|NOT COMPLETED|First Intervention||0
162762|NCT00472576|398765|P1|NOT COMPLETED|First Intervention||0
162763|NCT00472576|398764|P2|COMPLETED|First Intervention||3
162764|NCT00472576|398765|P1|COMPLETED|First Intervention||2
162765|NCT00472576|398764|P2|STARTED|First Intervention||3
162766|NCT00472576|398765|P1|STARTED|First Intervention||2
162767|NCT00472641|398773|P1|NOT COMPLETED|Overall Study||7
162768|NCT00472641|398773|P1|COMPLETED|Overall Study||18
162769|NCT00472641|398773|P1|STARTED|Overall Study||25
162770|NCT00472732|398780|P2|NOT COMPLETED|Overall Study||0
162771|NCT00472732|398781|P1|NOT COMPLETED|Overall Study||0
162772|NCT00472732|398780|P2|COMPLETED|Overall Study||22
162773|NCT00472732|398781|P1|COMPLETED|Overall Study||24
162774|NCT00472732|398780|P2|STARTED|Overall Study||22
162775|NCT00472732|398781|P1|STARTED|Overall Study||24
162776|NCT00472797|398793|P2|NOT COMPLETED|Overall Study||1
162777|NCT00472797|398794|P1|NOT COMPLETED|Overall Study||4
162778|NCT00472797|398793|P2|COMPLETED|Overall Study||112
162779|NCT00472797|398794|P1|COMPLETED|Overall Study||115
162780|NCT00472797|398793|P2|STARTED|Overall Study||113
162781|NCT00472797|398794|P1|STARTED|Overall Study||119
162782|NCT00472849|398820|P2|NOT COMPLETED|Overall Study||0
162783|NCT00472849|398821|P1|NOT COMPLETED|Overall Study||0
162784|NCT00472849|398820|P2|COMPLETED|Overall Study||78
162785|NCT00472849|398821|P1|COMPLETED|Overall Study||12
162786|NCT00472849|398820|P2|STARTED|Overall Study||78
162787|NCT00472849|398821|P1|STARTED|Overall Study||12
162788|NCT00473083|398830|P3|NOT COMPLETED|Overall Study||0
162789|NCT00473083|398831|P2|NOT COMPLETED|Overall Study||0
162790|NCT00473083|398832|P1|NOT COMPLETED|Overall Study||1
162791|NCT00473083|398830|P3|COMPLETED|Overall Study||50
162792|NCT00473083|398831|P2|COMPLETED|Overall Study||50
162793|NCT00473083|398832|P1|COMPLETED|Overall Study|One patient (2%) from treatment arm 1 discontinued the study drug as a result of a TEAE (dizziness)|49
162794|NCT00473083|398830|P3|STARTED|Overall Study||50
162795|NCT00473083|398831|P2|STARTED|Overall Study||50
162796|NCT00473083|398832|P1|STARTED|Overall Study||50
162797|NCT00473265|398858|P1|NOT COMPLETED|Overall Study||20
162798|NCT00473265|398858|P1|COMPLETED|Overall Study||48
162799|NCT00473265|398858|P1|STARTED|Overall Study||68
162800|NCT00473330|398870|P3|NOT COMPLETED|Open-label Extension Through Month 60||77
162801|NCT00473330|398871|P2|NOT COMPLETED|Open-label Extension Through Month 60||78
162802|NCT00473330|398872|P1|NOT COMPLETED|Open-label Extension Through Month 60||88
162803|NCT00473330|398870|P3|COMPLETED|Open-label Extension Through Month 60||0
162804|NCT00473330|398871|P2|COMPLETED|Open-label Extension Through Month 60||1
162805|NCT00473330|398872|P1|COMPLETED|Open-label Extension Through Month 60||1
162806|NCT00473330|398870|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|77
162807|NCT00473330|398871|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|79
162808|NCT00473330|398872|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|89
162809|NCT00473330|398870|P3|NOT COMPLETED|Open-label Extension Through Month 48||27
162810|NCT00473330|398871|P2|NOT COMPLETED|Open-label Extension Through Month 48||20
162811|NCT00473330|398872|P1|NOT COMPLETED|Open-label Extension Through Month 48||26
162812|NCT00473330|398870|P3|COMPLETED|Open-label Extension Through Month 48||50
162813|NCT00473330|398871|P2|COMPLETED|Open-label Extension Through Month 48||59
162814|NCT00473330|398872|P1|COMPLETED|Open-label Extension Through Month 48||63
162815|NCT00473330|398870|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|77
162816|NCT00473330|398871|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|79
162817|NCT00473330|398872|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|89
162818|NCT00473330|398870|P3|NOT COMPLETED|Core Study||41
162819|NCT00473330|398871|P2|NOT COMPLETED|Core Study||25
162820|NCT00473330|398872|P1|NOT COMPLETED|Core Study||27
162821|NCT00473330|398870|P3|COMPLETED|Core Study||86
162822|NCT00473330|398871|P2|COMPLETED|Core Study||100
162823|NCT00473330|398872|P1|COMPLETED|Core Study||98
162824|NCT00473330|398870|P3|STARTED|Core Study||127
162825|NCT00473330|398871|P2|STARTED|Core Study||125
162826|NCT00473330|398872|P1|STARTED|Core Study||125
162827|NCT00473382|398930|P3|NOT COMPLETED|Open-label Extension Through Month 60||82
162828|NCT00473382|398931|P2|NOT COMPLETED|Open-label Extension Through Month 60||82
162829|NCT00473382|398932|P1|NOT COMPLETED|Open-label Extension Through Month 60||86
162830|NCT00473382|398930|P3|COMPLETED|Open-label Extension Through Month 60||2
162831|NCT00473382|398931|P2|COMPLETED|Open-label Extension Through Month 60||1
162832|NCT00473382|398932|P1|COMPLETED|Open-label Extension Through Month 60||2
162833|NCT00473382|398930|P3|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|84
162834|NCT00473382|398931|P2|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|83
162835|NCT00473382|398932|P1|STARTED|Open-label Extension Through Month 60|Not all participants who completed the core study entered the optional open-label extension.|88
162836|NCT00473382|398930|P3|NOT COMPLETED|Open-label Extension Through Month 48||47
162837|NCT00473382|398931|P2|NOT COMPLETED|Open-label Extension Through Month 48||41
162838|NCT00473382|398932|P1|NOT COMPLETED|Open-label Extension Through Month 48||50
162839|NCT00473382|398930|P3|COMPLETED|Open-label Extension Through Month 48||37
162840|NCT00473382|398931|P2|COMPLETED|Open-label Extension Through Month 48||42
162841|NCT00473382|398932|P1|COMPLETED|Open-label Extension Through Month 48||38
162842|NCT00473382|398930|P3|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|84
162843|NCT00473382|398931|P2|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|83
162844|NCT00473382|398932|P1|STARTED|Open-label Extension Through Month 48|Not all participants who completed the core study entered the optional open-label extension.|88
162845|NCT00473382|398930|P3|NOT COMPLETED|Core Study||29
162846|NCT00473382|398931|P2|NOT COMPLETED|Core Study||27
162847|NCT00473382|398932|P1|NOT COMPLETED|Core Study||28
162848|NCT00473382|398930|P3|COMPLETED|Core Study||98
162849|NCT00473382|398931|P2|COMPLETED|Core Study||98
162850|NCT00473382|398932|P1|COMPLETED|Core Study||102
162851|NCT00473382|398930|P3|STARTED|Core Study||127
162852|NCT00473382|398931|P2|STARTED|Core Study||125
162853|NCT00473382|398932|P1|STARTED|Core Study||130
162854|NCT00473434|398987|P1|NOT COMPLETED|Overall Study||32
162855|NCT00473434|398987|P1|COMPLETED|Overall Study||32
162856|NCT00473434|398987|P1|STARTED|Overall Study||64
162857|NCT00479388|399051|P2|NOT COMPLETED|Overall Study||73
162858|NCT00479388|399052|P1|NOT COMPLETED|Overall Study||132
162859|NCT00479388|399051|P2|COMPLETED|Overall Study||537
162860|NCT00479388|399052|P1|COMPLETED|Overall Study||474
162861|NCT00479388|399051|P2|STARTED|Overall Study||610
162862|NCT00479388|399052|P1|STARTED|Overall Study||606
162863|NCT00479401|399065|P3|NOT COMPLETED|Overall Study||12
162864|NCT00479401|399066|P2|NOT COMPLETED|Overall Study||37
162865|NCT00479401|399067|P1|NOT COMPLETED|Overall Study||49
162866|NCT00479401|399065|P3|COMPLETED|Overall Study||91
162867|NCT00479401|399066|P2|COMPLETED|Overall Study||176
162868|NCT00479401|399067|P1|COMPLETED|Overall Study||174
162869|NCT00479401|399065|P3|STARTED|Overall Study||103
162870|NCT00479401|399066|P2|STARTED|Overall Study||213
162871|NCT00479401|399067|P1|STARTED|Overall Study||223
162872|NCT00479466|399126|P6|NOT COMPLETED|Overall Study||4
162873|NCT00479466|399127|P5|NOT COMPLETED|Overall Study||8
162874|NCT00479466|399128|P4|NOT COMPLETED|Overall Study||3
162875|NCT00479466|399129|P3|NOT COMPLETED|Overall Study||3
162876|NCT00479466|399130|P2|NOT COMPLETED|Overall Study||8
162877|NCT00479466|399131|P1|NOT COMPLETED|Overall Study||13
162878|NCT00479466|399126|P6|COMPLETED|Overall Study||53
162879|NCT00479466|399127|P5|COMPLETED|Overall Study||48
162880|NCT00479466|399128|P4|COMPLETED|Overall Study||55
162881|NCT00479466|399129|P3|COMPLETED|Overall Study||54
162882|NCT00479466|399130|P2|COMPLETED|Overall Study||49
162883|NCT00479466|399131|P1|COMPLETED|Overall Study||44
162884|NCT00479466|399126|P6|STARTED|Overall Study||57
162885|NCT00479466|399127|P5|STARTED|Overall Study||56
162886|NCT00479466|399128|P4|STARTED|Overall Study||58
162887|NCT00479466|399129|P3|STARTED|Overall Study||57
162888|NCT00479466|399130|P2|STARTED|Overall Study||57
162889|NCT00479466|399131|P1|STARTED|Overall Study||57
162890|NCT00479557|399164|P7|NOT COMPLETED|Overall Study||2
162891|NCT00479557|399165|P6|NOT COMPLETED|Overall Study||13
162892|NCT00479557|399166|P5|NOT COMPLETED|Overall Study||4
162893|NCT00479557|399167|P4|NOT COMPLETED|Overall Study||5
162894|NCT00479557|399168|P3|NOT COMPLETED|Overall Study||8
162895|NCT00479557|399169|P2|NOT COMPLETED|Overall Study||10
162896|NCT00479557|399170|P1|NOT COMPLETED|Overall Study||10
162897|NCT00479557|399164|P7|COMPLETED|Overall Study||15
162898|NCT00479557|399165|P6|COMPLETED|Overall Study||31
162899|NCT00479557|399166|P5|COMPLETED|Overall Study||8
162900|NCT00479557|399167|P4|COMPLETED|Overall Study||30
162901|NCT00479557|399168|P3|COMPLETED|Overall Study||32
162902|NCT00479557|399169|P2|COMPLETED|Overall Study||51
162903|NCT00479557|399170|P1|COMPLETED|Overall Study||26
162904|NCT00479557|399164|P7|Treated|Overall Study||17
162905|NCT00479557|399165|P6|Treated|Overall Study||44
162906|NCT00479557|399166|P5|Treated|Overall Study||12
162907|NCT00479557|399167|P4|Treated|Overall Study||35
162908|NCT00479557|399168|P3|Treated|Overall Study||40
162909|NCT00479557|399169|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
162910|NCT00479557|399170|P1|Treated|Overall Study||36
162911|NCT00479557|399164|P7|STARTED|Overall Study||17
162912|NCT00479557|399165|P6|STARTED|Overall Study||44
162913|NCT00479557|399166|P5|STARTED|Overall Study||12
162914|NCT00479557|399167|P4|STARTED|Overall Study||35
162915|NCT00479557|399168|P3|STARTED|Overall Study||40
162916|NCT00479557|399169|P2|STARTED|Overall Study||61
162917|NCT00479557|399170|P1|STARTED|Overall Study||36
162918|NCT00479674|399207|P1|NOT COMPLETED|Overall Study||41
162919|NCT00479674|399207|P1|COMPLETED|Overall Study||0
162920|NCT00479674|399207|P1|STARTED|Overall Study||41
162921|NCT00479713|399217|P2|NOT COMPLETED|Overall Study||9
162922|NCT00479713|399218|P1|NOT COMPLETED|Overall Study||13
162923|NCT00479713|399217|P2|COMPLETED|Overall Study||295
162924|NCT00479713|399218|P1|COMPLETED|Overall Study||301
162925|NCT00479713|399217|P2|STARTED|Overall Study||304
162926|NCT00479713|399218|P1|STARTED|Overall Study||314
162927|NCT00483652|399244|P2|NOT COMPLETED|Post-study Follow-up||0
162928|NCT00483652|399245|P1|NOT COMPLETED|Post-study Follow-up||0
162929|NCT00483652|399244|P2|COMPLETED|Post-study Follow-up||114
162930|NCT00483652|399245|P1|COMPLETED|Post-study Follow-up||113
162931|NCT00483652|399244|P2|STARTED|Post-study Follow-up||114
162932|NCT00483652|399245|P1|STARTED|Post-study Follow-up||113
162933|NCT00483652|399244|P2|NOT COMPLETED|Double-blind Treatment Period||5
162934|NCT00483652|399245|P1|NOT COMPLETED|Double-blind Treatment Period||7
162935|NCT00483652|399244|P2|COMPLETED|Double-blind Treatment Period||114
162936|NCT00483652|399245|P1|COMPLETED|Double-blind Treatment Period||113
162937|NCT00483652|399244|P2|STARTED|Double-blind Treatment Period||119
162938|NCT00483652|399245|P1|STARTED|Double-blind Treatment Period||120
162939|NCT00483704|399256|P3|NOT COMPLETED|Treatment||156
162940|NCT00483704|399257|P2|NOT COMPLETED|Treatment||129
162941|NCT00483704|399258|P1|NOT COMPLETED|Treatment||129
162942|NCT00483704|399256|P3|COMPLETED|Treatment||399
162943|NCT00483704|399257|P2|COMPLETED|Treatment||420
162944|NCT00483704|399258|P1|COMPLETED|Treatment||444
162945|NCT00483704|399256|P3|STARTED|Treatment||555
162946|NCT00483704|399257|P2|STARTED|Treatment||549
162947|NCT00483704|399258|P1|STARTED|Treatment||573
162948|NCT00483704|399256|P3|NOT COMPLETED|Randomization||91
162949|NCT00483704|399257|P2|NOT COMPLETED|Randomization||96
162950|NCT00483704|399258|P1|NOT COMPLETED|Randomization||71
162951|NCT00483704|399256|P3|COMPLETED|Randomization||555
162952|NCT00483704|399257|P2|COMPLETED|Randomization||549
162953|NCT00483704|399258|P1|COMPLETED|Randomization||573
162954|NCT00483704|399256|P3|STARTED|Randomization||646
162955|NCT00483704|399257|P2|STARTED|Randomization||645
162956|NCT00483704|399258|P1|STARTED|Randomization||644
162957|NCT00483717|399304|P2|NOT COMPLETED|Overall Study||21
162958|NCT00483717|399305|P1|NOT COMPLETED|Overall Study||24
162959|NCT00483717|399304|P2|COMPLETED|Overall Study||65
162960|NCT00483717|399305|P1|COMPLETED|Overall Study||63
162961|NCT00483717|399304|P2|STARTED|Overall Study||86
162962|NCT00483717|399305|P1|STARTED|Overall Study||87
162963|NCT00483756|399328|P3|NOT COMPLETED|Overall Study||52
162964|NCT00483756|399329|P2|NOT COMPLETED|Overall Study||50
162965|NCT00483756|399330|P1|NOT COMPLETED|Overall Study||33
162966|NCT00483756|399328|P3|COMPLETED|Overall Study||59
162967|NCT00483756|399329|P2|COMPLETED|Overall Study||60
162968|NCT00483756|399330|P1|COMPLETED|Overall Study||77
162969|NCT00483756|399328|P3|Treated|Overall Study||107
162970|NCT00483756|399329|P2|Treated|Overall Study||106
162971|NCT00483756|399330|P1|Treated|Overall Study||109
162972|NCT00483756|399328|P3|STARTED|Overall Study||111
162973|NCT00483756|399329|P2|STARTED|Overall Study||110
162974|NCT00483756|399330|P1|STARTED|Overall Study||110
162975|NCT00483938|399399|P7|NOT COMPLETED|Overall Study||40
162976|NCT00483938|399400|P6|NOT COMPLETED|Overall Study||8
162977|NCT00483938|399401|P5|NOT COMPLETED|Overall Study||2
162978|NCT00483938|399402|P4|NOT COMPLETED|Overall Study||6
162979|NCT00483938|399403|P3|NOT COMPLETED|Overall Study||0
162980|NCT00483938|399404|P2|NOT COMPLETED|Overall Study||19
162981|NCT00483938|399405|P1|NOT COMPLETED|Overall Study||5
162982|NCT00483938|399399|P7|COMPLETED|Overall Study||0
162983|NCT00483938|399400|P6|COMPLETED|Overall Study||18
162984|NCT00483938|399401|P5|COMPLETED|Overall Study||23
162985|NCT00483938|399402|P4|COMPLETED|Overall Study||25
162986|NCT00483938|399403|P3|COMPLETED|Overall Study||30
162987|NCT00483938|399404|P2|COMPLETED|Overall Study||24
162988|NCT00483938|399405|P1|COMPLETED|Overall Study||36
162989|NCT00483938|399399|P7|STARTED|Overall Study||40
162990|NCT00483938|399400|P6|STARTED|Overall Study||26
162991|NCT00483938|399401|P5|STARTED|Overall Study||25
162992|NCT00483938|399402|P4|STARTED|Overall Study||31
162993|NCT00483938|399403|P3|STARTED|Overall Study||30
162994|NCT00483938|399404|P2|STARTED|Overall Study||43
162995|NCT00483938|399405|P1|STARTED|Overall Study||41
162996|NCT00484094|399426|P1|NOT COMPLETED|Overall Study||42
162997|NCT00484094|399426|P1|COMPLETED|Overall Study||167
162998|NCT00484094|399426|P1|STARTED|Overall Study||209
162999|NCT00484159|399438|P3|NOT COMPLETED|Overall Study||0
163000|NCT00484159|399439|P2|NOT COMPLETED|Overall Study||1
163001|NCT00484159|399440|P1|NOT COMPLETED|Overall Study||1
163002|NCT00484159|399438|P3|COMPLETED|Overall Study||51
163003|NCT00484159|399439|P2|COMPLETED|Overall Study||49
163004|NCT00484159|399440|P1|COMPLETED|Overall Study||49
163005|NCT00484159|399438|P3|STARTED|Overall Study||51
163006|NCT00484159|399439|P2|STARTED|Overall Study||50
163007|NCT00484159|399440|P1|STARTED|Overall Study||50
163008|NCT00484185|399451|P1|NOT COMPLETED|Overall Study||71
163009|NCT00484185|399451|P1|COMPLETED|Overall Study||112
163010|NCT00484185|399451|P1|Treated|Overall Study||178
163011|NCT00484185|399451|P1|STARTED|Overall Study||183
163012|NCT00484289|399473|P3|NOT COMPLETED|Post Marketing Phase||0
163013|NCT00484289|399474|P2|NOT COMPLETED|Post Marketing Phase||1
163014|NCT00484289|399475|P1|NOT COMPLETED|Post Marketing Phase||0
163015|NCT00484289|399473|P3|COMPLETED|Post Marketing Phase||10
163016|NCT00484289|399474|P2|COMPLETED|Post Marketing Phase||141
163017|NCT00484289|399475|P1|COMPLETED|Post Marketing Phase||10
163018|NCT00484289|399473|P3|STARTED|Post Marketing Phase||10
163019|NCT00484289|399474|P2|STARTED|Post Marketing Phase||142
163020|NCT00484289|399475|P1|STARTED|Post Marketing Phase||10
163021|NCT00484289|399473|P3|NOT COMPLETED|Long Term Phase||16
163022|NCT00484289|399474|P2|NOT COMPLETED|Long Term Phase||36
163023|NCT00484289|399475|P1|NOT COMPLETED|Long Term Phase||3
163024|NCT00484289|399473|P3|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
163025|NCT00484289|399474|P2|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|142
163026|NCT00484289|399475|P1|COMPLETED|Long Term Phase|Completed participants entered postmarketing phase.|10
163027|NCT00484289|399473|P3|STARTED|Long Term Phase||26
163028|NCT00484289|399474|P2|STARTED|Long Term Phase||178
163029|NCT00484289|399475|P1|STARTED|Long Term Phase||13
163030|NCT00484315|399549|P2|NOT COMPLETED|9-Month Angiographic Follow-up||13
163031|NCT00484315|399550|P1|NOT COMPLETED|9-Month Angiographic Follow-up||28
163032|NCT00484315|399549|P2|COMPLETED|9-Month Angiographic Follow-up||61
163033|NCT00484315|399550|P1|COMPLETED|9-Month Angiographic Follow-up||228
163034|NCT00484315|399549|P2|STARTED|9-Month Angiographic Follow-up||74
163035|NCT00484315|399550|P1|STARTED|9-Month Angiographic Follow-up||256
163036|NCT00484315|399549|P2|NOT COMPLETED|12-Month Clinical Follow-up||9
163037|NCT00484315|399550|P1|NOT COMPLETED|12-Month Clinical Follow-up||28
163038|NCT00484315|399549|P2|COMPLETED|12-Month Clinical Follow-up||311
163039|NCT00484315|399550|P1|COMPLETED|12-Month Clinical Follow-up||914
163040|NCT00484315|399549|P2|STARTED|12-Month Clinical Follow-up||320
163041|NCT00484315|399550|P1|STARTED|12-Month Clinical Follow-up||942
163042|NCT00484393|399560|P2|NOT COMPLETED|Overall Study||0
163043|NCT00484393|399561|P1|NOT COMPLETED|Overall Study||0
163044|NCT00484393|399560|P2|COMPLETED|Overall Study||3
163045|NCT00484393|399561|P1|COMPLETED|Overall Study||4
163046|NCT00484393|399560|P2|STARTED|Overall Study||3
163047|NCT00484393|399561|P1|STARTED|Overall Study||4
163048|NCT00484419|399570|P3|NOT COMPLETED|Overall Study||11
163049|NCT00484419|399571|P2|NOT COMPLETED|Overall Study||5
163050|NCT00484419|399572|P1|NOT COMPLETED|Overall Study||12
163051|NCT00484419|399570|P3|COMPLETED|Overall Study||45
163052|NCT00484419|399571|P2|COMPLETED|Overall Study||51
163053|NCT00484419|399572|P1|COMPLETED|Overall Study||45
163054|NCT00484419|399570|P3|STARTED|Overall Study||56
163055|NCT00484419|399571|P2|STARTED|Overall Study||56
163056|NCT00484419|399572|P1|STARTED|Overall Study||57
163057|NCT00484679|399628|P1|NOT COMPLETED|Overall Study||3
163058|NCT00484679|399628|P1|COMPLETED|Overall Study||15
163059|NCT00484679|399628|P1|STARTED|Overall Study||18
163060|NCT00484939|399634|P2|NOT COMPLETED|Overall Study||140
163061|NCT00484939|399635|P1|NOT COMPLETED|Overall Study||140
163062|NCT00484939|399634|P2|COMPLETED|Overall Study||0
163063|NCT00484939|399635|P1|COMPLETED|Overall Study||0
163064|NCT00484939|399634|P2|STARTED|Overall Study||140
163065|NCT00484939|399635|P1|STARTED|Overall Study||140
163066|NCT00485069|399657|P2|NOT COMPLETED|Overall Study||12
163067|NCT00485069|399658|P1|NOT COMPLETED|Overall Study||18
163068|NCT00485069|399657|P2|COMPLETED|Overall Study||46
163069|NCT00485069|399658|P1|COMPLETED|Overall Study||47
163070|NCT00485069|399657|P2|STARTED|Overall Study||58
163071|NCT00485069|399658|P1|STARTED|Overall Study||65
163072|NCT00485173|399703|P2|NOT COMPLETED|Overall Study||64
163073|NCT00485173|399704|P1|NOT COMPLETED|Overall Study||36
163074|NCT00485173|399703|P2|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|422
163075|NCT00485173|399704|P1|COMPLETED|Overall Study|The number of completed participants is reported the number of subjects who had any 24-month data.|188
163076|NCT00485173|399703|P2|STARTED|Overall Study||486
163077|NCT00485173|399704|P1|STARTED|Overall Study||224
163078|NCT00485264|399750|P6|NOT COMPLETED|Overall Study||0
163079|NCT00485264|399751|P5|NOT COMPLETED|Overall Study||0
163080|NCT00485264|399752|P4|NOT COMPLETED|Overall Study||10
163081|NCT00485264|399753|P3|NOT COMPLETED|Overall Study||0
163082|NCT00485264|399754|P2|NOT COMPLETED|Overall Study||1
163083|NCT00485264|399755|P1|NOT COMPLETED|Overall Study||6
163084|NCT00485264|399750|P6|COMPLETED|Overall Study|Not included in this interim analysis|0
163085|NCT00485264|399751|P5|COMPLETED|Overall Study|Not included in this interim analysis|0
163086|NCT00485264|399752|P4|COMPLETED|Overall Study|Completed week 48|11
163087|NCT00485264|399753|P3|COMPLETED|Overall Study|Completed week 48|18
163088|NCT00485264|399754|P2|COMPLETED|Overall Study|Completed week 48|15
163089|NCT00485264|399755|P1|COMPLETED|Overall Study|Completed week 48|65
163090|NCT00485264|399750|P6|Completed Week 24|Overall Study||0
163091|NCT00485264|399751|P5|Completed Week 24|Overall Study||0
163092|NCT00485264|399752|P4|Completed Week 24|Overall Study||21
163093|NCT00485264|399753|P3|Completed Week 24|Overall Study||18
163094|NCT00485264|399754|P2|Completed Week 24|Overall Study||16
163095|NCT00485264|399755|P1|Completed Week 24|Overall Study||67
163096|NCT00485264|399750|P6|STARTED|Overall Study|Not included in this interim analysis|0
163097|NCT00485264|399751|P5|STARTED|Overall Study|Not included in this interim analysis|0
163098|NCT00485264|399752|P4|STARTED|Overall Study||21
163099|NCT00485264|399753|P3|STARTED|Overall Study||18
163100|NCT00485264|399754|P2|STARTED|Overall Study||16
163101|NCT00485264|399755|P1|STARTED|Overall Study||71
163102|NCT00485303|399839|P1|NOT COMPLETED|Overall Study||56
163103|NCT00485303|399839|P1|COMPLETED|Overall Study||2
163104|NCT00485303|399839|P1|STARTED|Overall Study||58
163105|NCT00485433|399855|P4|NOT COMPLETED|Overall Study||0
163106|NCT00485433|399856|P3|NOT COMPLETED|Overall Study||0
163107|NCT00485433|399857|P2|NOT COMPLETED|Overall Study||0
163108|NCT00485433|399858|P1|NOT COMPLETED|Overall Study||0
163109|NCT00485433|399855|P4|COMPLETED|Overall Study||25
163110|NCT00485433|399856|P3|COMPLETED|Overall Study||24
163111|NCT00485433|399857|P2|COMPLETED|Overall Study||25
163112|NCT00485433|399858|P1|COMPLETED|Overall Study||24
163113|NCT00485433|399855|P4|STARTED|Overall Study||25
163114|NCT00485433|399856|P3|STARTED|Overall Study||24
163115|NCT00485433|399857|P2|STARTED|Overall Study||25
163116|NCT00485433|399858|P1|STARTED|Overall Study||24
163117|NCT00485472|399868|P2|NOT COMPLETED|Overall Study||12
163118|NCT00485472|399869|P1|NOT COMPLETED|Overall Study||16
163119|NCT00485472|399868|P2|COMPLETED|Overall Study||64
163120|NCT00485472|399869|P1|COMPLETED|Overall Study||57
163121|NCT00485472|399868|P2|Entered Maintenance Phase|Overall Study||67
163122|NCT00485472|399869|P1|Entered Maintenance Phase|Overall Study||65
163123|NCT00485472|399868|P2|STARTED|Overall Study||76
163124|NCT00485472|399869|P1|STARTED|Overall Study||73
163125|NCT00485485|399891|P1|NOT COMPLETED|Overall Study||0
163126|NCT00485485|399891|P1|COMPLETED|Overall Study||7
163127|NCT00485485|399891|P1|STARTED|Overall Study||7
163128|NCT00485693|399897|P2|NOT COMPLETED|Overall Study||0
163129|NCT00485693|399898|P1|NOT COMPLETED|Overall Study||0
163130|NCT00485693|399897|P2|COMPLETED|Overall Study||104
163131|NCT00485693|399898|P1|COMPLETED|Overall Study||34
163132|NCT00485693|399897|P2|STARTED|Overall Study||104
163133|NCT00485693|399898|P1|STARTED|Overall Study||34
163134|NCT00485732|399909|P2|NOT COMPLETED|Overall Study||9
163135|NCT00485732|399910|P1|NOT COMPLETED|Overall Study||8
163136|NCT00485732|399909|P2|COMPLETED|Overall Study||67
163137|NCT00485732|399910|P1|COMPLETED|Overall Study||141
163138|NCT00485732|399909|P2|STARTED|Overall Study||76
163139|NCT00485732|399910|P1|STARTED|Overall Study||149
163140|NCT00485758|399932|P2|NOT COMPLETED|Overall Study||65
163141|NCT00485758|399933|P1|NOT COMPLETED|Overall Study||156
163142|NCT00485758|399932|P2|COMPLETED|Overall Study||277
163143|NCT00485758|399933|P1|COMPLETED|Overall Study||298
163144|NCT00485758|399932|P2|STARTED|Overall Study||342
163145|NCT00485758|399933|P1|STARTED|Overall Study||454
163146|NCT00485836|399946|P3|NOT COMPLETED|Overall Study||11
163147|NCT00485836|399947|P2|NOT COMPLETED|Overall Study||3
163148|NCT00485836|399948|P1|NOT COMPLETED|Overall Study||15
163149|NCT00485836|399946|P3|COMPLETED|Overall Study||119
163150|NCT00485836|399947|P2|COMPLETED|Overall Study||129
163151|NCT00485836|399948|P1|COMPLETED|Overall Study||115
163152|NCT00485836|399946|P3|Received Study Drug (Safety Population)|Overall Study||129
163153|NCT00485836|399947|P2|Received Study Drug (Safety Population)|Overall Study||132
163154|NCT00485836|399948|P1|Received Study Drug (Safety Population)|Overall Study||129
163155|NCT00485836|399946|P3|STARTED|Overall Study||130
163156|NCT00485836|399947|P2|STARTED|Overall Study||132
163157|NCT00485836|399948|P1|STARTED|Overall Study||130
163158|NCT00485953|399976|P2|NOT COMPLETED|Overall Study||7
163159|NCT00485953|399977|P1|NOT COMPLETED|Overall Study||7
163160|NCT00485953|399976|P2|COMPLETED|Overall Study||47
163161|NCT00485953|399977|P1|COMPLETED|Overall Study||48
163162|NCT00485953|399976|P2|STARTED|Overall Study||54
163163|NCT00485953|399977|P1|STARTED|Overall Study||55
163164|NCT00486018|399986|P3|NOT COMPLETED|Overall Study||6
163165|NCT00486018|399987|P2|NOT COMPLETED|Overall Study||6
163166|NCT00486018|399988|P1|NOT COMPLETED|Overall Study||9
163167|NCT00486018|399986|P3|COMPLETED|Overall Study||125
163168|NCT00486018|399987|P2|COMPLETED|Overall Study||128
163169|NCT00486018|399988|P1|COMPLETED|Overall Study||123
163170|NCT00486018|399986|P3|Received Drug (Safety Population)|Overall Study||130
163171|NCT00486018|399987|P2|Received Drug (Safety Population)|Overall Study||134
163172|NCT00486018|399988|P1|Received Drug (Safety Population)|Overall Study||131
163173|NCT00486018|399986|P3|STARTED|Overall Study||131
163174|NCT00486018|399987|P2|STARTED|Overall Study||134
163175|NCT00486018|399988|P1|STARTED|Overall Study||132
163176|NCT00486044|400016|P2|NOT COMPLETED|Overall Study||3
163177|NCT00486044|400017|P1|NOT COMPLETED|Overall Study||2
163178|NCT00486044|400016|P2|COMPLETED|Overall Study|21 completed MRI sub-study|46
163179|NCT00486044|400017|P1|COMPLETED|Overall Study|27 completed MRI sub-study|49
163180|NCT00486044|400016|P2|STARTED|Overall Study|23 in MRI sub-study|49
163181|NCT00486044|400017|P1|STARTED|Overall Study|50 received assigned intervention (1 withdrew during baseline) 27 in MRI sub-study|51
163182|NCT00465361|400029|P1|NOT COMPLETED|Post-Intervention Assessment||0
163183|NCT00465361|400029|P1|COMPLETED|Post-Intervention Assessment||3
163184|NCT00465361|400029|P1|STARTED|Post-Intervention Assessment||3
163185|NCT00465361|400029|P1|NOT COMPLETED|Baseline Assessment||4
163186|NCT00465361|400029|P1|COMPLETED|Baseline Assessment||3
163187|NCT00465361|400029|P1|STARTED|Baseline Assessment||7
163188|NCT00465530|400035|P2|NOT COMPLETED|Overall Study||4
163189|NCT00465530|400036|P1|NOT COMPLETED|Overall Study||2
163190|NCT00465530|400035|P2|COMPLETED|Overall Study||15
163191|NCT00465530|400036|P1|COMPLETED|Overall Study||19
163192|NCT00465530|400035|P2|STARTED|Overall Study||19
163193|NCT00465530|400036|P1|STARTED|Overall Study||21
163194|NCT00476476|400048|P2|NOT COMPLETED|Overall Study||24
163195|NCT00476476|400049|P1|NOT COMPLETED|Overall Study||2
163196|NCT00476476|400048|P2|COMPLETED|Overall Study|Treatment was not of fixed duration and thus pts are not considered to have 'Completed' treatment.|0
163197|NCT00476476|400049|P1|COMPLETED|Overall Study||15
163198|NCT00476476|400048|P2|Response Evaluable|Overall Study|One woman was unevaluable due to an allergic reaction that developed after the 2nd dose.|23
163199|NCT00476476|400049|P1|Response Evaluable|Overall Study||17
163200|NCT00476476|400048|P2|STARTED|Overall Study||24
163201|NCT00476476|400049|P1|STARTED|Overall Study||17
163202|NCT00476593|400058|P4|NOT COMPLETED|Overall Study||22
163203|NCT00476593|400059|P3|NOT COMPLETED|Overall Study||8
163204|NCT00476593|400060|P2|NOT COMPLETED|Overall Study||2
163205|NCT00476593|400061|P1|NOT COMPLETED|Overall Study||10
163206|NCT00476593|400058|P4|COMPLETED|Overall Study||107
163207|NCT00476593|400059|P3|COMPLETED|Overall Study||30
163208|NCT00476593|400060|P2|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 17 cases|17
163209|NCT00476593|400061|P1|COMPLETED|Overall Study|all subjects completed treatment in one eye. However, bilateral OCT scans included only in 22 cases|22
163210|NCT00476593|400058|P4|STARTED|Overall Study||129
163211|NCT00476593|400059|P3|STARTED|Overall Study||38
163212|NCT00476593|400060|P2|STARTED|Overall Study||19
163213|NCT00476593|400061|P1|STARTED|Overall Study||32
163214|NCT00476645|400071|P1|NOT COMPLETED|Overall Study||0
163215|NCT00476645|400071|P1|COMPLETED|Overall Study||10
163216|NCT00476645|400071|P1|STARTED|Overall Study||10
163217|NCT00476788|400077|P1|NOT COMPLETED|Overall Study||3
163218|NCT00476788|400077|P1|COMPLETED|Overall Study||11
163219|NCT00476788|400077|P1|STARTED|Overall Study||14
163220|NCT00486226|400082|P1|NOT COMPLETED|Overall Study||13
163221|NCT00486226|400082|P1|COMPLETED|Overall Study||92
163222|NCT00486226|400082|P1|STARTED|Overall Study||105
163223|NCT00486252|400090|P1|NOT COMPLETED|Overall Study||58
163224|NCT00486252|400090|P1|COMPLETED|Overall Study||938
163225|NCT00486252|400090|P1|STARTED|Overall Study||996
163226|NCT00486265|400105|P1|NOT COMPLETED|Overall Study||9
163227|NCT00486265|400105|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met|0
163228|NCT00486265|400105|P1|STARTED|Overall Study|Partipants dosed on day 1.|9
163229|NCT00486278|400109|P1|NOT COMPLETED|Overall Study||9
163230|NCT00486278|400109|P1|COMPLETED|Overall Study||42
163231|NCT00486278|400109|P1|STARTED|Overall Study|96 bleeds by 51 subjects, 77 were treated with vatreptacog alfa and 19 with rFVIIa|51
163232|NCT00486291|400245|P2|NOT COMPLETED|Overall Study||29
163233|NCT00486291|400246|P1|NOT COMPLETED|Overall Study||16
163234|NCT00486291|400245|P2|COMPLETED|Overall Study||76
163235|NCT00486291|400246|P1|COMPLETED|Overall Study||89
163236|NCT00486291|400245|P2|STARTED|Overall Study|1 subject discontinued prior to first dose|105
163237|NCT00486291|400246|P1|STARTED|Overall Study|3 subjects discontinued prior to first dose|105
163238|NCT00486330|400254|P1|NOT COMPLETED|Overall Study||2
163239|NCT00486330|400254|P1|COMPLETED|Overall Study|Of the 12 subjects treated, two developed adverse events leading to study drug discontinuation.|10
163240|NCT00486330|400254|P1|STARTED|Overall Study|Twelve subjects met inclusion/exclusion criteria|12
163241|NCT00486434|400260|P2|NOT COMPLETED|Overall Study||134
163242|NCT00486434|400261|P1|NOT COMPLETED|Overall Study||194
163243|NCT00486434|400260|P2|COMPLETED|Overall Study||454
163244|NCT00486434|400261|P1|COMPLETED|Overall Study||394
163245|NCT00486434|400260|P2|STARTED|Overall Study||588
163246|NCT00486434|400261|P1|STARTED|Overall Study||588
163247|NCT00487084|400274|P3|NOT COMPLETED|Overall Study||5
163248|NCT00487084|400275|P2|NOT COMPLETED|Overall Study||3
163249|NCT00487084|400276|P1|NOT COMPLETED|Overall Study||4
163250|NCT00487084|400274|P3|COMPLETED|Overall Study||28
163251|NCT00487084|400275|P2|COMPLETED|Overall Study||30
163252|NCT00487084|400276|P1|COMPLETED|Overall Study||29
163253|NCT00487084|400274|P3|STARTED|Overall Study||33
163254|NCT00487084|400275|P2|STARTED|Overall Study||33
163255|NCT00487084|400276|P1|STARTED|Overall Study||33
163256|NCT00487162|400295|P2|NOT COMPLETED|Overall Study||5
163257|NCT00487162|400296|P1|NOT COMPLETED|Overall Study||2
163258|NCT00487162|400295|P2|COMPLETED|Overall Study||21
163259|NCT00487162|400296|P1|COMPLETED|Overall Study||28
163260|NCT00487162|400295|P2|STARTED|Overall Study||26
163261|NCT00487162|400296|P1|STARTED|Overall Study||30
163262|NCT00487188|400306|P3|NOT COMPLETED|Maintenance Phase||1
163263|NCT00487188|400307|P2|NOT COMPLETED|Maintenance Phase||0
163264|NCT00487188|400308|P1|NOT COMPLETED|Maintenance Phase||3
163265|NCT00487188|400306|P3|COMPLETED|Maintenance Phase||8
163266|NCT00487188|400307|P2|COMPLETED|Maintenance Phase||8
163267|NCT00487188|400308|P1|COMPLETED|Maintenance Phase||7
163268|NCT00487188|400306|P3|STARTED|Maintenance Phase||9
163269|NCT00487188|400307|P2|STARTED|Maintenance Phase||8
163270|NCT00487188|400308|P1|STARTED|Maintenance Phase||10
163271|NCT00487188|400306|P3|NOT COMPLETED|Induction Phase||0
163272|NCT00487188|400307|P2|NOT COMPLETED|Induction Phase||7
163273|NCT00487188|400308|P1|NOT COMPLETED|Induction Phase||9
163274|NCT00487188|400306|P3|COMPLETED|Induction Phase||0
163275|NCT00487188|400307|P2|COMPLETED|Induction Phase||9
163276|NCT00487188|400308|P1|COMPLETED|Induction Phase||22
163277|NCT00487188|400306|P3|Safety Population|Induction Phase||0
163278|NCT00487188|400307|P2|Safety Population|Induction Phase|2 patients randomized to ENF + HARRT only received treatment with HAART|18
163279|NCT00487188|400308|P1|Safety Population|Induction Phase||29
163280|NCT00487188|400306|P3|STARTED|Induction Phase|Participants were only randomized to this treatment arm in the Maintenance Phase|0
163281|NCT00487188|400307|P2|STARTED|Induction Phase||16
163282|NCT00487188|400308|P1|STARTED|Induction Phase||31
163283|NCT00487240|400347|P2|NOT COMPLETED|Overall Study||26
163284|NCT00487240|400348|P1|NOT COMPLETED|Overall Study||31
163285|NCT00487240|400347|P2|COMPLETED|Overall Study||166
163286|NCT00487240|400348|P1|COMPLETED|Overall Study||164
163287|NCT00487240|400347|P2|Full Analysis Set (ITT Population)|Overall Study||189
163288|NCT00487240|400348|P1|Full Analysis Set (ITT Population)|Overall Study||192
163289|NCT00487240|400347|P2|STARTED|Overall Study||192
163290|NCT00487240|400348|P1|STARTED|Overall Study||195
163291|NCT00487279|400376|P2|NOT COMPLETED|Overall Study||2
163292|NCT00487279|400377|P1|NOT COMPLETED|Overall Study||1
163293|NCT00487279|400376|P2|COMPLETED|Overall Study||35
163294|NCT00487279|400377|P1|COMPLETED|Overall Study||43
163295|NCT00487279|400376|P2|STARTED|Overall Study||37
163296|NCT00487279|400377|P1|STARTED|Overall Study||44
163297|NCT00487396|400385|P1|NOT COMPLETED|Overall Study||3
163298|NCT00487396|400385|P1|COMPLETED|Overall Study||95
163299|NCT00487396|400385|P1|STARTED|Overall Study||98
163300|NCT00487435|400391|P1|NOT COMPLETED|Overall Study||485
163301|NCT00487435|400391|P1|COMPLETED|Overall Study||669
163302|NCT00487435|400391|P1|STARTED|Overall Study|Patients who received at least one dose of Tapentadol (CG5503) Extended Release (ER)|1154
163303|NCT00487461|400399|P3|NOT COMPLETED|Overall Study||4
163304|NCT00487461|400400|P2|NOT COMPLETED|Overall Study||2
163305|NCT00487461|400401|P1|NOT COMPLETED|Overall Study||0
163306|NCT00487461|400399|P3|COMPLETED|Overall Study||7
163307|NCT00487461|400400|P2|COMPLETED|Overall Study||10
163308|NCT00487461|400401|P1|COMPLETED|Overall Study||2
163309|NCT00487461|400399|P3|STARTED|Overall Study||11
163310|NCT00487461|400400|P2|STARTED|Overall Study||12
163311|NCT00487461|400401|P1|STARTED|Overall Study||2
163312|NCT00487539|400416|P4|NOT COMPLETED|Overall Study||4
163313|NCT00487539|400417|P3|NOT COMPLETED|Overall Study||3
163314|NCT00487539|400418|P2|NOT COMPLETED|Overall Study||3
163315|NCT00487539|400419|P1|NOT COMPLETED|Overall Study||7
163316|NCT00487539|400416|P4|COMPLETED|Overall Study||327
163317|NCT00487539|400417|P3|COMPLETED|Overall Study||328
163318|NCT00487539|400418|P2|COMPLETED|Overall Study||69
163319|NCT00487539|400419|P1|COMPLETED|Overall Study||324
163320|NCT00487539|400416|P4|STARTED|Overall Study||331
163321|NCT00487539|400417|P3|STARTED|Overall Study||331
163322|NCT00487539|400418|P2|STARTED|Overall Study||72
163323|NCT00487539|400419|P1|STARTED|Overall Study||331
163324|NCT00487552|400437|P1|NOT COMPLETED|Overall Study||6
163325|NCT00487552|400437|P1|COMPLETED|Overall Study||12
163326|NCT00487552|400437|P1|STARTED|Overall Study||18
163327|NCT00487565|400442|P1|NOT COMPLETED|Overall Study||28
163328|NCT00487565|400442|P1|COMPLETED|Overall Study||182
163329|NCT00487565|400442|P1|STARTED|Overall Study||210
163330|NCT00487578|400448|P2|NOT COMPLETED|Overall Study||4
163331|NCT00487578|400449|P1|NOT COMPLETED|Overall Study||1
163332|NCT00487578|400448|P2|COMPLETED|Overall Study||5
163333|NCT00487578|400449|P1|COMPLETED|Overall Study||2
163334|NCT00487578|400448|P2|STARTED|Overall Study||9
163335|NCT00487578|400449|P1|STARTED|Overall Study||3
163336|NCT00487669|400465|P1|NOT COMPLETED|Overall Study||0
163337|NCT00487669|400465|P1|COMPLETED|Overall Study||12
163338|NCT00487669|400465|P1|STARTED|Overall Study||12
163339|NCT00487695|400475|P2|NOT COMPLETED|Second Procedure||3
163340|NCT00487695|400476|P1|NOT COMPLETED|Second Procedure||1
163341|NCT00487695|400475|P2|COMPLETED|Second Procedure||20
163342|NCT00487695|400476|P1|COMPLETED|Second Procedure||19
163343|NCT00487695|400475|P2|STARTED|Second Procedure||23
163344|NCT00487695|400476|P1|STARTED|Second Procedure||20
163345|NCT00487695|400475|P2|NOT COMPLETED|First Procedure||0
163346|NCT00487695|400476|P1|NOT COMPLETED|First Procedure||3
163347|NCT00487695|400475|P2|COMPLETED|First Procedure||23
163348|NCT00487695|400476|P1|COMPLETED|First Procedure||20
163349|NCT00487695|400475|P2|STARTED|First Procedure||23
163350|NCT00487695|400476|P1|STARTED|First Procedure||23
163351|NCT00487721|400494|P2|NOT COMPLETED|Overall Study||0
163352|NCT00487721|400495|P1|NOT COMPLETED|Overall Study||0
163353|NCT00487721|400494|P2|COMPLETED|Overall Study||6
163354|NCT00487721|400495|P1|COMPLETED|Overall Study||6
163355|NCT00487721|400494|P2|STARTED|Overall Study||6
163356|NCT00487721|400495|P1|STARTED|Overall Study||6
163357|NCT00487747|400500|P1|NOT COMPLETED|Overall Study||11
163358|NCT00487747|400500|P1|COMPLETED|Overall Study||7
163359|NCT00487747|400500|P1|STARTED|Overall Study||18
163360|NCT00487825|400511|P2|NOT COMPLETED|Overall Study||5
163361|NCT00487825|400512|P1|NOT COMPLETED|Overall Study||6
163362|NCT00487825|400511|P2|COMPLETED|Overall Study||21
163363|NCT00487825|400512|P1|COMPLETED|Overall Study||46
163364|NCT00487825|400511|P2|STARTED|Overall Study||26
163365|NCT00487825|400512|P1|STARTED|Overall Study|"Started indicates Intent-to-treat population (ITT)"|52
163366|NCT00487942|400528|P4|NOT COMPLETED|Overall Study||2
163367|NCT00487942|400529|P3|NOT COMPLETED|Overall Study||3
163368|NCT00487942|400530|P2|NOT COMPLETED|Overall Study||3
163369|NCT00487942|400531|P1|NOT COMPLETED|Overall Study||3
163370|NCT00487942|400528|P4|COMPLETED|Overall Study||13
163371|NCT00487942|400529|P3|COMPLETED|Overall Study||12
163372|NCT00487942|400530|P2|COMPLETED|Overall Study||12
163373|NCT00487942|400531|P1|COMPLETED|Overall Study||12
163374|NCT00487942|400528|P4|STARTED|Overall Study|One subject randomized to placebo discontinued prior to receiving any study drug, leaving 14.|15
163375|NCT00487942|400529|P3|STARTED|Overall Study||15
163376|NCT00487942|400530|P2|STARTED|Overall Study||15
163377|NCT00487942|400531|P1|STARTED|Overall Study||15
163378|NCT00487981|400913|P1|NOT COMPLETED|Overall Study||1
163379|NCT00487981|400913|P1|COMPLETED|Overall Study||0
163380|NCT00487981|400913|P1|STARTED|Overall Study||1
163381|NCT00488033|400919|P2|NOT COMPLETED|Overall Study||0
163382|NCT00488033|400920|P1|NOT COMPLETED|Overall Study||1
163383|NCT00488033|400919|P2|COMPLETED|Overall Study||452
163384|NCT00488033|400920|P1|COMPLETED|Overall Study||447
163385|NCT00488033|400919|P2|STARTED|Overall Study||452
163386|NCT00488033|400920|P1|STARTED|Overall Study||448
163387|NCT00488059|400936|P3|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||4
163388|NCT00488059|400937|P2|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
163389|NCT00488059|400938|P1|NOT COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
163390|NCT00488059|400936|P3|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||1
163391|NCT00488059|400937|P2|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
163392|NCT00488059|400938|P1|COMPLETED|Phase II Arm B:Phase I Then ENF 180mg QD||0
163393|NCT00488059|400936|P3|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||5
163394|NCT00488059|400937|P2|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
163395|NCT00488059|400938|P1|STARTED|Phase II Arm B:Phase I Then ENF 180mg QD||0
163396|NCT00488059|400936|P3|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
163397|NCT00488059|400937|P2|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||2
163398|NCT00488059|400938|P1|NOT COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
163399|NCT00488059|400936|P3|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
163400|NCT00488059|400937|P2|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||7
163401|NCT00488059|400938|P1|COMPLETED|Phase II Arm A:Phase I Then ENF 90mg BID||0
163402|NCT00488059|400936|P3|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
163403|NCT00488059|400937|P2|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||9
163404|NCT00488059|400938|P1|STARTED|Phase II Arm A:Phase I Then ENF 90mg BID||0
163405|NCT00488059|400936|P3|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
163406|NCT00488059|400937|P2|NOT COMPLETED|Phase I: ENF 90mg SC BID||0
163407|NCT00488059|400938|P1|NOT COMPLETED|Phase I: ENF 90mg SC BID||15
163408|NCT00488059|400936|P3|COMPLETED|Phase I: ENF 90mg SC BID||0
163409|NCT00488059|400937|P2|COMPLETED|Phase I: ENF 90mg SC BID||0
163410|NCT00488059|400938|P1|COMPLETED|Phase I: ENF 90mg SC BID||14
163411|NCT00488059|400936|P3|STARTED|Phase I: ENF 90mg SC BID||0
163412|NCT00488059|400937|P2|STARTED|Phase I: ENF 90mg SC BID||0
163413|NCT00488059|400938|P1|STARTED|Phase I: ENF 90mg SC BID||29
163414|NCT00488293|400957|P2|NOT COMPLETED|Overall Study||30
163415|NCT00488293|400958|P1|NOT COMPLETED|Overall Study||36
163416|NCT00488293|400957|P2|COMPLETED|Overall Study||166
163417|NCT00488293|400958|P1|COMPLETED|Overall Study||160
163418|NCT00488293|400957|P2|STARTED|Overall Study||196
163419|NCT00488293|400958|P1|STARTED|Overall Study||196
163420|NCT00488319|400985|P3|NOT COMPLETED|Overall Study||122
163421|NCT00488319|400986|P2|NOT COMPLETED|Overall Study||43
163422|NCT00488319|400987|P1|NOT COMPLETED|Overall Study||15
163423|NCT00488319|400985|P3|COMPLETED|Overall Study||121
163424|NCT00488319|400986|P2|COMPLETED|Overall Study||75
163425|NCT00488319|400987|P1|COMPLETED|Overall Study||24
163426|NCT00488319|400985|P3|STARTED|Overall Study||243
163427|NCT00488319|400986|P2|STARTED|Overall Study||118
163428|NCT00488319|400987|P1|STARTED|Overall Study||39
163429|NCT00488345|401075|P3|NOT COMPLETED|Overall Study||3
163430|NCT00488345|401076|P2|NOT COMPLETED|Overall Study||4
163431|NCT00488345|401077|P1|NOT COMPLETED|Overall Study||0
163432|NCT00488345|401075|P3|COMPLETED|Overall Study||17
163433|NCT00488345|401076|P2|COMPLETED|Overall Study||17
163434|NCT00488345|401077|P1|COMPLETED|Overall Study||17
163435|NCT00488345|401075|P3|STARTED|Overall Study||20
163436|NCT00488345|401076|P2|STARTED|Overall Study||21
163437|NCT00488345|401077|P1|STARTED|Overall Study||17
163438|NCT00488475|401100|P1|NOT COMPLETED|Overall Study||1754
163439|NCT00488475|401100|P1|COMPLETED|Overall Study||3191
163440|NCT00488475|401100|P1|STARTED|Overall Study||4945
163441|NCT00488488|401126|P1|NOT COMPLETED|Overall Study||268
163442|NCT00488488|401126|P1|COMPLETED|Overall Study|Excludes 4 participants with missing information.|760
163443|NCT00488488|401126|P1|Analyzed|Overall Study|3 participants were not analyzed due to retrospective documentation.|1025
163444|NCT00488488|401126|P1|STARTED|Overall Study||1028
163445|NCT00488514|401141|P1|NOT COMPLETED|Overall Study||293
163446|NCT00488514|401141|P1|COMPLETED|Overall Study||363
163447|NCT00488514|401141|P1|STARTED|Overall Study||656
163448|NCT00488592|401214|P1|NOT COMPLETED|Overall Study||3
163449|NCT00488592|401214|P1|COMPLETED|Overall Study|7 completed the initial series of 6 vaccinations|7
163450|NCT00488592|401214|P1|STARTED|Overall Study|10 subjects were accrued|10
163451|NCT00488618|401220|P2|NOT COMPLETED|Overall Study||43
163452|NCT00488618|401221|P1|NOT COMPLETED|Overall Study||47
163453|NCT00488618|401220|P2|COMPLETED|Overall Study||75
163454|NCT00488618|401221|P1|COMPLETED|Overall Study||73
163455|NCT00488618|401220|P2|Safety Population: Received Study Drug|Overall Study||118
163456|NCT00488618|401221|P1|Safety Population: Received Study Drug|Overall Study||118
163457|NCT00488618|401220|P2|STARTED|Overall Study||118
163458|NCT00488618|401221|P1|STARTED|Overall Study||120
163459|NCT00488631|401235|P10|NOT COMPLETED|Open Label Study Extension (Week 54-228)||3
163460|NCT00488631|401236|P9|NOT COMPLETED|Open Label Study Extension (Week 54-228)||182
163461|NCT00488631|401237|P8|NOT COMPLETED|Open Label Study Extension (Week 54-228)||27
163462|NCT00488631|401238|P7|NOT COMPLETED|Open Label Study Extension (Week 54-228)||80
163463|NCT00488631|401239|P6|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
163464|NCT00488631|401240|P5|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
163465|NCT00488631|401241|P4|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
163466|NCT00488631|401242|P3|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
163467|NCT00488631|401243|P2|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
163468|NCT00488631|401244|P1|NOT COMPLETED|Open Label Study Extension (Week 54-228)||0
163469|NCT00488631|401235|P10|COMPLETED|Open Label Study Extension (Week 54-228)||4
163470|NCT00488631|401236|P9|COMPLETED|Open Label Study Extension (Week 54-228)||288
163471|NCT00488631|401237|P8|COMPLETED|Open Label Study Extension (Week 54-228)||66
163472|NCT00488631|401238|P7|COMPLETED|Open Label Study Extension (Week 54-228)||16
163473|NCT00488631|401239|P6|COMPLETED|Open Label Study Extension (Week 54-228)||0
163474|NCT00488631|401240|P5|COMPLETED|Open Label Study Extension (Week 54-228)||0
163475|NCT00488631|401241|P4|COMPLETED|Open Label Study Extension (Week 54-228)||0
163476|NCT00488631|401242|P3|COMPLETED|Open Label Study Extension (Week 54-228)||0
163477|NCT00488631|401243|P2|COMPLETED|Open Label Study Extension (Week 54-228)||0
163478|NCT00488631|401244|P1|COMPLETED|Open Label Study Extension (Week 54-228)||0
163479|NCT00488631|401235|P10|STARTED|Open Label Study Extension (Week 54-228)||7
163480|NCT00488631|401236|P9|STARTED|Open Label Study Extension (Week 54-228)||470
163481|NCT00488631|401237|P8|STARTED|Open Label Study Extension (Week 54-228)||93
163482|NCT00488631|401238|P7|STARTED|Open Label Study Extension (Week 54-228)||96
163483|NCT00488631|401239|P6|STARTED|Open Label Study Extension (Week 54-228)||0
163484|NCT00488631|401240|P5|STARTED|Open Label Study Extension (Week 54-228)||0
163485|NCT00488631|401241|P4|STARTED|Open Label Study Extension (Week 54-228)||0
163486|NCT00488631|401242|P3|STARTED|Open Label Study Extension (Week 54-228)||0
163487|NCT00488631|401243|P2|STARTED|Open Label Study Extension (Week 54-228)||0
163488|NCT00488631|401244|P1|STARTED|Open Label Study Extension (Week 54-228)||0
163489|NCT00488631|401235|P10|NOT COMPLETED|Double Blind Period (Week 0-54)||0
163490|NCT00488631|401236|P9|NOT COMPLETED|Double Blind Period (Week 0-54)||0
163491|NCT00488631|401237|P8|NOT COMPLETED|Double Blind Period (Week 0-54)||0
163492|NCT00488631|401238|P7|NOT COMPLETED|Double Blind Period (Week 0-54)||0
163493|NCT00488631|401239|P6|NOT COMPLETED|Double Blind Period (Week 0-54)||216
163494|NCT00488631|401240|P5|NOT COMPLETED|Double Blind Period (Week 0-54)||103
163495|NCT00488631|401241|P4|NOT COMPLETED|Double Blind Period (Week 0-54)||41
163496|NCT00488631|401242|P3|NOT COMPLETED|Double Blind Period (Week 0-54)||45
163497|NCT00488631|401243|P2|NOT COMPLETED|Double Blind Period (Week 0-54)||43
163498|NCT00488631|401244|P1|NOT COMPLETED|Double Blind Period (Week 0-54)||43
163499|NCT00488631|401235|P10|COMPLETED|Double Blind Period (Week 0-54)||0
163500|NCT00488631|401236|P9|COMPLETED|Double Blind Period (Week 0-54)||0
163501|NCT00488631|401237|P8|COMPLETED|Double Blind Period (Week 0-54)||0
163502|NCT00488631|401238|P7|COMPLETED|Double Blind Period (Week 0-54)||0
163503|NCT00488631|401239|P6|COMPLETED|Double Blind Period (Week 0-54)||189
163504|NCT00488631|401240|P5|COMPLETED|Double Blind Period (Week 0-54)||127
163505|NCT00488631|401241|P4|COMPLETED|Double Blind Period (Week 0-54)||88
163506|NCT00488631|401242|P3|COMPLETED|Double Blind Period (Week 0-54)||109
163507|NCT00488631|401243|P2|COMPLETED|Double Blind Period (Week 0-54)||111
163508|NCT00488631|401244|P1|COMPLETED|Double Blind Period (Week 0-54)||113
163509|NCT00488631|401235|P10|STARTED|Double Blind Period (Week 0-54)||0
163510|NCT00488631|401236|P9|STARTED|Double Blind Period (Week 0-54)||0
163511|NCT00488631|401237|P8|STARTED|Double Blind Period (Week 0-54)||0
163512|NCT00488631|401238|P7|STARTED|Double Blind Period (Week 0-54)||0
163513|NCT00488631|401239|P6|STARTED|Double Blind Period (Week 0-54)||405
163514|NCT00488631|401240|P5|STARTED|Double Blind Period (Week 0-54)||230
163515|NCT00488631|401241|P4|STARTED|Double Blind Period (Week 0-54)||129
163516|NCT00488631|401242|P3|STARTED|Double Blind Period (Week 0-54)||154
163517|NCT00488631|401243|P2|STARTED|Double Blind Period (Week 0-54)||154
163518|NCT00488631|401244|P1|STARTED|Double Blind Period (Week 0-54)||156
163519|NCT00488644|401279|P1|NOT COMPLETED|Overall Study||2
163520|NCT00488644|401279|P1|COMPLETED|Overall Study||10
163521|NCT00488644|401279|P1|STARTED|Overall Study||12
163522|NCT00488683|401286|P3|NOT COMPLETED|Overall Study||2
163523|NCT00488683|401287|P2|NOT COMPLETED|Overall Study||6
163524|NCT00488683|401288|P1|NOT COMPLETED|Overall Study||12
163525|NCT00488683|401286|P3|COMPLETED|Overall Study||52
163526|NCT00488683|401287|P2|COMPLETED|Overall Study||48
163527|NCT00488683|401288|P1|COMPLETED|Overall Study||96
163528|NCT00488683|401286|P3|STARTED|Overall Study||54
163529|NCT00488683|401287|P2|STARTED|Overall Study||54
163530|NCT00488683|401288|P1|STARTED|Overall Study||108
163531|NCT00488774|401351|P4|NOT COMPLETED|Overall Study||3
163532|NCT00488774|401352|P3|NOT COMPLETED|Overall Study||5
163533|NCT00488774|401353|P2|NOT COMPLETED|Overall Study||5
163534|NCT00488774|401354|P1|NOT COMPLETED|Overall Study||8
163535|NCT00488774|401351|P4|COMPLETED|Overall Study||74
163536|NCT00488774|401352|P3|COMPLETED|Overall Study||70
163537|NCT00488774|401353|P2|COMPLETED|Overall Study||57
163538|NCT00488774|401354|P1|COMPLETED|Overall Study||69
163539|NCT00488774|401351|P4|STARTED|Overall Study||77
163540|NCT00488774|401352|P3|STARTED|Overall Study||75
163541|NCT00488774|401353|P2|STARTED|Overall Study||62
163542|NCT00488774|401354|P1|STARTED|Overall Study||77
163543|NCT00488826|401371|P3|NOT COMPLETED|Overall Study||26
163544|NCT00488826|401372|P2|NOT COMPLETED|Overall Study||52
163545|NCT00488826|401373|P1|NOT COMPLETED|Overall Study||56
163546|NCT00488826|401371|P3|COMPLETED|Overall Study||178
163547|NCT00488826|401372|P2|COMPLETED|Overall Study||244
163548|NCT00488826|401373|P1|COMPLETED|Overall Study||244
163549|NCT00488826|401371|P3|STARTED|Overall Study||204
163550|NCT00488826|401372|P2|STARTED|Overall Study||296
163551|NCT00488826|401373|P1|STARTED|Overall Study||300
163552|NCT00488865|401384|P1|NOT COMPLETED|Overall Study||0
163553|NCT00488865|401384|P1|COMPLETED|Overall Study||100
163554|NCT00488865|401384|P1|STARTED|Overall Study||100
163555|NCT00489086|401390|P1|NOT COMPLETED|Overall Study||23
163556|NCT00489086|401390|P1|COMPLETED|Overall Study|23 subjects completed 18 months|13
163557|NCT00489086|401390|P1|STARTED|Overall Study||36
163558|NCT00489216|401394|P1|NOT COMPLETED|Overall Study||1
163559|NCT00489216|401394|P1|COMPLETED|Overall Study||1
163560|NCT00489216|401394|P1|STARTED|Overall Study||2
163561|NCT00489255|401405|P2|NOT COMPLETED|Period 3: Days 57 to 84||4
163562|NCT00489255|401406|P1|NOT COMPLETED|Period 3: Days 57 to 84||4
163563|NCT00489255|401405|P2|COMPLETED|Period 3: Days 57 to 84|Re-randomized participants is 27.Sample sizes differed due to withdrawal&re-randomization design.|78
163564|NCT00489255|401406|P1|COMPLETED|Period 3: Days 57 to 84||24
163642|NCT00489476|401570|P3|NOT COMPLETED|Overall Study||0
163643|NCT00489476|401571|P2|NOT COMPLETED|Overall Study||1
163565|NCT00489255|401405|P2|STARTED|Period 3: Days 57 to 84|Re-randomized participants is 30.Sample sizes differed due to withdrawal&re-randomization design.|82
163566|NCT00489255|401406|P1|STARTED|Period 3: Days 57 to 84||28
163567|NCT00489255|401405|P2|NOT COMPLETED|Period 2: Days 29 to 56||4
163568|NCT00489255|401406|P1|NOT COMPLETED|Period 2: Days 29 to 56||3
163569|NCT00489255|401405|P2|COMPLETED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|55
163570|NCT00489255|401406|P1|COMPLETED|Period 2: Days 29 to 56||61
163571|NCT00489255|401405|P2|Completed But Discontinued Study|Period 2: Days 29 to 56|Re-randomized participants is 2.Sample sizes differed due to withdrawal&re-randomization design.|3
163572|NCT00489255|401406|P1|Completed But Discontinued Study|Period 2: Days 29 to 56||3
163573|NCT00489255|401405|P2|Completed and Follow Period 3|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|52
163574|NCT00489255|401406|P1|Completed and Follow Period 3|Period 2: Days 29 to 56||58
163575|NCT00489255|401405|P2|STARTED|Period 2: Days 29 to 56|Re-randomized participants is 26.Sample sizes differed due to withdrawal&re-randomization design.|59
163576|NCT00489255|401406|P1|STARTED|Period 2: Days 29 to 56||64
163577|NCT00489255|401405|P2|NOT COMPLETED|Period 1: Days 1 to 28||12
163578|NCT00489255|401406|P1|NOT COMPLETED|Period 1: Days 1 to 28||29
163579|NCT00489255|401405|P2|COMPLETED|Period 1: Days 1 to 28||34
163580|NCT00489255|401406|P1|COMPLETED|Period 1: Days 1 to 28||107
163581|NCT00489255|401405|P2|Completed But Discontinued Study|Period 1: Days 1 to 28||5
163582|NCT00489255|401406|P1|Completed But Discontinued Study|Period 1: Days 1 to 28||13
163583|NCT00489255|401405|P2|Completed and Follow Period 2|Period 1: Days 1 to 28||29
163584|NCT00489255|401406|P1|Completed and Follow Period 2|Period 1: Days 1 to 28||94
163585|NCT00489255|401405|P2|STARTED|Period 1: Days 1 to 28||46
163586|NCT00489255|401406|P1|STARTED|Period 1: Days 1 to 28||136
163587|NCT00489255|401405|P2|NOT COMPLETED|Screening and Initial Randomization||3
163588|NCT00489255|401406|P1|NOT COMPLETED|Screening and Initial Randomization||9
163589|NCT00489255|401405|P2|COMPLETED|Screening and Initial Randomization||46
163590|NCT00489255|401406|P1|COMPLETED|Screening and Initial Randomization||136
163591|NCT00489255|401405|P2|STARTED|Screening and Initial Randomization|Total randomized subjects to receive placebo|49
163592|NCT00489255|401406|P1|STARTED|Screening and Initial Randomization|Total randomized subjects to receive Tigan|145
163593|NCT00489268|401459|P5|NOT COMPLETED|Overall Study||20
163594|NCT00489268|401460|P4|NOT COMPLETED|Overall Study||0
163595|NCT00489268|401461|P3|NOT COMPLETED|Overall Study||1
163596|NCT00489268|401462|P2|NOT COMPLETED|Overall Study||0
163597|NCT00489268|401463|P1|NOT COMPLETED|Overall Study||0
163598|NCT00489268|401459|P5|COMPLETED|Overall Study||50
163599|NCT00489268|401460|P4|COMPLETED|Overall Study||11
163600|NCT00489268|401461|P3|COMPLETED|Overall Study||9
163601|NCT00489268|401462|P2|COMPLETED|Overall Study||10
163602|NCT00489268|401463|P1|COMPLETED|Overall Study||1
163603|NCT00489268|401459|P5|STARTED|Overall Study||70
163604|NCT00489268|401460|P4|STARTED|Overall Study||11
163605|NCT00489268|401461|P3|STARTED|Overall Study||10
163606|NCT00489268|401462|P2|STARTED|Overall Study||10
163607|NCT00489268|401463|P1|STARTED|Overall Study||1
163608|NCT00489359|401492|P2|NOT COMPLETED|Overall Study||29
163609|NCT00489359|401493|P1|NOT COMPLETED|Overall Study||7
163610|NCT00489359|401492|P2|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|37
163611|NCT00489359|401493|P1|COMPLETED|Overall Study|Received at least 6 cycles of therapy. Not completed implies participant received <6 cycles.|13
163612|NCT00489359|401492|P2|STARTED|Overall Study||66
163613|NCT00489359|401493|P1|STARTED|Overall Study||20
163614|NCT00489411|401518|P2|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||19
163615|NCT00489411|401519|P1|NOT COMPLETED|Crossover Treatment Period (Weeks 8-12)||18
163616|NCT00489411|401518|P2|COMPLETED|Crossover Treatment Period (Weeks 8-12)||74
163617|NCT00489411|401519|P1|COMPLETED|Crossover Treatment Period (Weeks 8-12)||67
163618|NCT00489411|401518|P2|STARTED|Crossover Treatment Period (Weeks 8-12)||93
163619|NCT00489411|401519|P1|STARTED|Crossover Treatment Period (Weeks 8-12)||85
163620|NCT00489411|401518|P2|NOT COMPLETED|Washout Period (Weeks 6-7)||1
163621|NCT00489411|401519|P1|NOT COMPLETED|Washout Period (Weeks 6-7)||2
163622|NCT00489411|401518|P2|COMPLETED|Washout Period (Weeks 6-7)||93
163623|NCT00489411|401519|P1|COMPLETED|Washout Period (Weeks 6-7)||85
163624|NCT00489411|401518|P2|STARTED|Washout Period (Weeks 6-7)||94
163625|NCT00489411|401519|P1|STARTED|Washout Period (Weeks 6-7)||87
163626|NCT00489411|401518|P2|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||22
163627|NCT00489411|401519|P1|NOT COMPLETED|Initial Treatment Period (Weeks 1-5)||28
163628|NCT00489411|401518|P2|COMPLETED|Initial Treatment Period (Weeks 1-5)||94
163629|NCT00489411|401519|P1|COMPLETED|Initial Treatment Period (Weeks 1-5)||87
163630|NCT00489411|401518|P2|STARTED|Initial Treatment Period (Weeks 1-5)||116
163631|NCT00489411|401519|P1|STARTED|Initial Treatment Period (Weeks 1-5)||115
163632|NCT00489424|401534|P3|NOT COMPLETED|Overall Study||5
163633|NCT00489424|401535|P2|NOT COMPLETED|Overall Study||5
163634|NCT00489424|401536|P1|NOT COMPLETED|Overall Study||4
163635|NCT00489424|401534|P3|COMPLETED|Overall Study||257
163636|NCT00489424|401535|P2|COMPLETED|Overall Study||259
163637|NCT00489424|401536|P1|COMPLETED|Overall Study||263
163638|NCT00489424|401534|P3|STARTED|Overall Study||262
163639|NCT00489424|401535|P2|STARTED|Overall Study||264
163640|NCT00489424|401536|P1|STARTED|Overall Study||267
163641|NCT00489476|401569|P4|NOT COMPLETED|Overall Study||0
163644|NCT00489476|401572|P1|NOT COMPLETED|Overall Study||0
163645|NCT00489476|401569|P4|COMPLETED|Overall Study||43
163646|NCT00489476|401570|P3|COMPLETED|Overall Study||43
163647|NCT00489476|401571|P2|COMPLETED|Overall Study||42
163648|NCT00489476|401572|P1|COMPLETED|Overall Study||39
163649|NCT00489476|401569|P4|STARTED|Overall Study||43
163650|NCT00489476|401570|P3|STARTED|Overall Study||43
163651|NCT00489476|401571|P2|STARTED|Overall Study||43
163652|NCT00489476|401572|P1|STARTED|Overall Study||39
163653|NCT00489489|401593|P3|NOT COMPLETED|Overall Study||3
163654|NCT00489489|401594|P2|NOT COMPLETED|Overall Study||5
163655|NCT00489489|401595|P1|NOT COMPLETED|Overall Study||3
163656|NCT00489489|401593|P3|COMPLETED|Overall Study|completed treatment period|37
163657|NCT00489489|401594|P2|COMPLETED|Overall Study|completed treatment period|32
163658|NCT00489489|401595|P1|COMPLETED|Overall Study|completed treatment period|38
163659|NCT00489489|401593|P3|Treated|Overall Study|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|39
163660|NCT00489489|401594|P2|Treated|Overall Study||36
163661|NCT00489489|401595|P1|Treated|Overall Study||41
163662|NCT00489489|401593|P3|STARTED|Overall Study|randomized|40
163663|NCT00489489|401594|P2|STARTED|Overall Study|randomized|37
163664|NCT00489489|401595|P1|STARTED|Overall Study|randomized|41
163665|NCT00489541|401625|P2|NOT COMPLETED|9-Month Angiographic Follow-up||17
163666|NCT00489541|401626|P1|NOT COMPLETED|9-Month Angiographic Follow-up||27
163667|NCT00489541|401625|P2|COMPLETED|9-Month Angiographic Follow-up||108
163668|NCT00489541|401626|P1|COMPLETED|9-Month Angiographic Follow-up||197
163669|NCT00489541|401625|P2|STARTED|9-Month Angiographic Follow-up||125
163670|NCT00489541|401626|P1|STARTED|9-Month Angiographic Follow-up||224
163671|NCT00489541|401625|P2|NOT COMPLETED|12-Month Clinical Follow-up||5
163672|NCT00489541|401626|P1|NOT COMPLETED|12-Month Clinical Follow-up||9
163673|NCT00489541|401625|P2|COMPLETED|12-Month Clinical Follow-up||120
163674|NCT00489541|401626|P1|COMPLETED|12-Month Clinical Follow-up||215
163675|NCT00489541|401625|P2|STARTED|12-Month Clinical Follow-up||125
163676|NCT00489541|401626|P1|STARTED|12-Month Clinical Follow-up||224
163677|NCT00489554|401634|P1|NOT COMPLETED|Overall Study||4
163678|NCT00489554|401634|P1|COMPLETED|Overall Study||226
163679|NCT00489554|401634|P1|STARTED|Overall Study||230
163680|NCT00479765|401652|P1|NOT COMPLETED|Overall Study||4
163681|NCT00479765|401652|P1|COMPLETED|Overall Study||0
163682|NCT00479765|401652|P1|STARTED|Overall Study||4
163683|NCT00479856|401656|P1|NOT COMPLETED|Overall Study||3
163684|NCT00479856|401656|P1|COMPLETED|Overall Study||6
163685|NCT00479856|401656|P1|STARTED|Overall Study||9
163686|NCT00479882|401669|P4|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||18
163687|NCT00479882|401670|P3|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||20
163688|NCT00479882|401671|P2|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||21
163689|NCT00479882|401672|P1|NOT COMPLETED|Crossover: Period III (Weeks 13-20)||25
163690|NCT00479882|401669|P4|COMPLETED|Crossover: Period III (Weeks 13-20)||447
163691|NCT00479882|401670|P3|COMPLETED|Crossover: Period III (Weeks 13-20)||420
163692|NCT00479882|401671|P2|COMPLETED|Crossover: Period III (Weeks 13-20)||419
163693|NCT00479882|401672|P1|COMPLETED|Crossover: Period III (Weeks 13-20)||447
163694|NCT00479882|401669|P4|STARTED|Crossover: Period III (Weeks 13-20)||465
163695|NCT00479882|401670|P3|STARTED|Crossover: Period III (Weeks 13-20)||440
163696|NCT00479882|401671|P2|STARTED|Crossover: Period III (Weeks 13-20)||440
163697|NCT00479882|401672|P1|STARTED|Crossover: Period III (Weeks 13-20)||472
163698|NCT00479882|401669|P4|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||140
163699|NCT00479882|401670|P3|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||157
163700|NCT00479882|401671|P2|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||162
163701|NCT00479882|401672|P1|NOT COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||138
163702|NCT00479882|401669|P4|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||465
163703|NCT00479882|401670|P3|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
163704|NCT00479882|401671|P2|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||440
163705|NCT00479882|401672|P1|COMPLETED|Precrossover: Periods I/II (Weeks 1-12)||472
163706|NCT00479882|401669|P4|STARTED|Precrossover: Periods I/II (Weeks 1-12)||605
163707|NCT00479882|401670|P3|STARTED|Precrossover: Periods I/II (Weeks 1-12)||597
163708|NCT00479882|401671|P2|STARTED|Precrossover: Periods I/II (Weeks 1-12)||602
163709|NCT00479882|401672|P1|STARTED|Precrossover: Periods I/II (Weeks 1-12)||610
163710|NCT00480324|401804|P2|NOT COMPLETED|Overall Study||16
163711|NCT00480324|401805|P1|NOT COMPLETED|Overall Study||32
163712|NCT00480324|401804|P2|COMPLETED|Overall Study||241
163713|NCT00480324|401805|P1|COMPLETED|Overall Study||476
163714|NCT00480324|401804|P2|STARTED|Overall Study||257
163715|NCT00480324|401805|P1|STARTED|Overall Study||508
163716|NCT00480493|401833|P2|NOT COMPLETED|Overall Study||7
163717|NCT00480493|401834|P1|NOT COMPLETED|Overall Study||2
163718|NCT00480493|401833|P2|COMPLETED|Overall Study||21
163719|NCT00480493|401834|P1|COMPLETED|Overall Study||30
163720|NCT00480493|401833|P2|Randomized|Overall Study||28
163721|NCT00480493|401834|P1|Randomized|Overall Study||32
163722|NCT00480493|401833|P2|STARTED|Overall Study||28
163723|NCT00480493|401834|P1|STARTED|Overall Study||32
163724|NCT00480532|401848|P4|NOT COMPLETED|Overall Study||1
163725|NCT00480532|401849|P3|NOT COMPLETED|Overall Study||4
163726|NCT00480532|401850|P2|NOT COMPLETED|Overall Study||4
163727|NCT00480532|401851|P1|NOT COMPLETED|Overall Study||2
163728|NCT00480532|401848|P4|COMPLETED|Overall Study||31
163729|NCT00480532|401849|P3|COMPLETED|Overall Study||29
163730|NCT00480532|401850|P2|COMPLETED|Overall Study||29
163731|NCT00480532|401851|P1|COMPLETED|Overall Study||31
163732|NCT00480532|401848|P4|STARTED|Overall Study||32
163733|NCT00480532|401849|P3|STARTED|Overall Study||33
163734|NCT00480532|401850|P2|STARTED|Overall Study||33
163735|NCT00480532|401851|P1|STARTED|Overall Study||33
163736|NCT00480636|401869|P1|NOT COMPLETED|Overall Study||19
163737|NCT00480636|401869|P1|COMPLETED|Overall Study||83
163738|NCT00480636|401869|P1|STARTED|Overall Study||102
163739|NCT00480740|401880|P3|NOT COMPLETED|Overall Study||0
163740|NCT00480740|401881|P2|NOT COMPLETED|Overall Study||0
163741|NCT00480740|401882|P1|NOT COMPLETED|Overall Study||0
163742|NCT00480740|401880|P3|COMPLETED|Overall Study||6
163743|NCT00480740|401881|P2|COMPLETED|Overall Study||9
163744|NCT00480740|401882|P1|COMPLETED|Overall Study||26
163745|NCT00480740|401880|P3|STARTED|Overall Study||6
163746|NCT00480740|401881|P2|STARTED|Overall Study||9
163747|NCT00480740|401882|P1|STARTED|Overall Study||26
163748|NCT00480779|401892|P2|NOT COMPLETED|Overall Study||3
163749|NCT00480779|401893|P1|NOT COMPLETED|Overall Study||2
163750|NCT00480779|401892|P2|COMPLETED|Overall Study||19
163751|NCT00480779|401893|P1|COMPLETED|Overall Study||24
163752|NCT00480779|401892|P2|STARTED|Overall Study||22
163753|NCT00480779|401893|P1|STARTED|Overall Study||26
163754|NCT00480857|401917|P1|NOT COMPLETED|Overall Study||2
163755|NCT00480857|401917|P1|COMPLETED|Overall Study||17
163756|NCT00480857|401917|P1|STARTED|Overall Study||19
163757|NCT00480987|401922|P1|NOT COMPLETED|Overall Study||0
163758|NCT00480987|401922|P1|COMPLETED|Overall Study||27
163759|NCT00480987|401922|P1|STARTED|Overall Study||27
163760|NCT00481195|401928|P2|NOT COMPLETED|Overall Study||39
163761|NCT00481195|401929|P1|NOT COMPLETED|Overall Study||39
163762|NCT00481195|401928|P2|COMPLETED|Overall Study||90
163763|NCT00481195|401929|P1|COMPLETED|Overall Study||89
163764|NCT00481195|401928|P2|STARTED|Overall Study|Four of these subjects were randomized but never received study medication.|129
163765|NCT00481195|401929|P1|STARTED|Overall Study|Two of these subjects were randomized but never received study medication.|128
163766|NCT00481247|402015|P2|NOT COMPLETED|Overall Study||260
163767|NCT00481247|402016|P1|NOT COMPLETED|Overall Study||259
163768|NCT00481247|402015|P2|COMPLETED|Overall Study||0
163769|NCT00481247|402016|P1|COMPLETED|Overall Study||0
163770|NCT00481247|402015|P2|Received Treatment|Overall Study||258
163771|NCT00481247|402016|P1|Received Treatment|Overall Study||258
163772|NCT00481247|402015|P2|STARTED|Overall Study|Randomized|260
163773|NCT00481247|402016|P1|STARTED|Overall Study|Randomized|259
163774|NCT00481351|402040|P2|NOT COMPLETED|Overall Study||0
163775|NCT00481351|402041|P1|NOT COMPLETED|Overall Study||0
163776|NCT00481351|402040|P2|COMPLETED|Overall Study||12
163777|NCT00481351|402041|P1|COMPLETED|Overall Study||13
163778|NCT00481351|402040|P2|STARTED|Overall Study||12
163779|NCT00481351|402041|P1|STARTED|Overall Study||13
163780|NCT00481507|402057|P2|NOT COMPLETED|Overall Study||0
163781|NCT00481507|402058|P1|NOT COMPLETED|Overall Study||0
163782|NCT00481507|402057|P2|COMPLETED|Overall Study||61
163783|NCT00481507|402058|P1|COMPLETED|Overall Study||64
163784|NCT00481507|402057|P2|STARTED|Overall Study||61
163785|NCT00481507|402058|P1|STARTED|Overall Study||64
163786|NCT00481676|402066|P2|NOT COMPLETED|Overall Study||5
163787|NCT00481676|402067|P1|NOT COMPLETED|Overall Study||2
163788|NCT00481676|402066|P2|COMPLETED|Overall Study||17
163789|NCT00481676|402067|P1|COMPLETED|Overall Study||25
163790|NCT00481676|402066|P2|STARTED|Overall Study||22
163791|NCT00481676|402067|P1|STARTED|Overall Study||27
163792|NCT00481767|402091|P2|NOT COMPLETED|Overall Study||21
163793|NCT00481767|402092|P1|NOT COMPLETED|Overall Study||32
163794|NCT00481767|402091|P2|COMPLETED|Overall Study||205
163795|NCT00481767|402092|P1|COMPLETED|Overall Study||418
163796|NCT00481767|402091|P2|STARTED|Overall Study||226
163797|NCT00481767|402092|P1|STARTED|Overall Study||450
163798|NCT00481845|402124|P2|NOT COMPLETED|Overall Study||0
163799|NCT00481845|402125|P1|NOT COMPLETED|Overall Study||0
163800|NCT00481845|402124|P2|COMPLETED|Overall Study||0
163801|NCT00481845|402125|P1|COMPLETED|Overall Study||1
163802|NCT00481845|402124|P2|STARTED|Overall Study||0
163803|NCT00481845|402125|P1|STARTED|Overall Study||1
163804|NCT00481871|402138|P5|NOT COMPLETED|Overall Study||0
163805|NCT00481871|402139|P4|NOT COMPLETED|Overall Study||0
163806|NCT00481871|402140|P3|NOT COMPLETED|Overall Study||1
163807|NCT00481871|402141|P2|NOT COMPLETED|Overall Study||0
163808|NCT00481871|402142|P1|NOT COMPLETED|Overall Study||0
163809|NCT00481871|402138|P5|COMPLETED|Overall Study||34
163810|NCT00481871|402139|P4|COMPLETED|Overall Study||38
163811|NCT00481871|402140|P3|COMPLETED|Overall Study||17
163812|NCT00481871|402141|P2|COMPLETED|Overall Study||10
163813|NCT00481871|402142|P1|COMPLETED|Overall Study||7
163814|NCT00481871|402138|P5|STARTED|Overall Study||34
163815|NCT00481871|402139|P4|STARTED|Overall Study||38
163816|NCT00481871|402140|P3|STARTED|Overall Study||18
163817|NCT00481871|402141|P2|STARTED|Overall Study||10
163818|NCT00481871|402142|P1|STARTED|Overall Study||7
163819|NCT00481988|402158|P2|NOT COMPLETED|Overall Study||1
163820|NCT00481988|402159|P1|NOT COMPLETED|Overall Study||1
163821|NCT00481988|402158|P2|COMPLETED|Overall Study||8
163822|NCT00481988|402159|P1|COMPLETED|Overall Study||11
163823|NCT00481988|402158|P2|Crossover|Overall Study|patient dropped out of study after 5 sessions to illness unrelated to study|8
163824|NCT00481988|402159|P1|Crossover|Overall Study|patient dropped out of study after 5 sessions to pursue other treatment options|11
163825|NCT00481988|402158|P2|STARTED|Overall Study|one patient was dropped from the study before randomization|9
163826|NCT00481988|402159|P1|STARTED|Overall Study||12
163827|NCT00482014|402171|P4|NOT COMPLETED|Overall Study||23
163828|NCT00482014|402172|P3|NOT COMPLETED|Overall Study||11
163829|NCT00482014|402173|P2|NOT COMPLETED|Overall Study||6
163830|NCT00482014|402174|P1|NOT COMPLETED|Overall Study||7
163831|NCT00482014|402171|P4|COMPLETED|Overall Study||29
163832|NCT00482014|402172|P3|COMPLETED|Overall Study||35
163833|NCT00482014|402173|P2|COMPLETED|Overall Study||7
163834|NCT00482014|402174|P1|COMPLETED|Overall Study||2
163835|NCT00482014|402171|P4|STARTED|Overall Study||52
163836|NCT00482014|402172|P3|STARTED|Overall Study||46
163837|NCT00482014|402173|P2|STARTED|Overall Study||13
163838|NCT00482014|402174|P1|STARTED|Overall Study||9
163839|NCT00482170|402198|P2|NOT COMPLETED|Overall Study||20
163840|NCT00482170|402199|P1|NOT COMPLETED|Overall Study||15
163841|NCT00482170|402198|P2|COMPLETED|Overall Study||194
163842|NCT00482170|402199|P1|COMPLETED|Overall Study||192
163843|NCT00482170|402198|P2|Treated|Overall Study||211
163844|NCT00482170|402199|P1|Treated|Overall Study||207
163845|NCT00482170|402198|P2|STARTED|Overall Study||214
163846|NCT00482170|402199|P1|STARTED|Overall Study||207
163847|NCT00482274|402317|P1|NOT COMPLETED|Overall Study||1
163848|NCT00482274|402317|P1|COMPLETED|Overall Study||2
163849|NCT00482274|402317|P1|STARTED|Overall Study||3
163850|NCT00482391|402325|P1|NOT COMPLETED|Overall Study||3
163851|NCT00482391|402325|P1|COMPLETED|Overall Study||92
163852|NCT00482391|402325|P1|STARTED|Overall Study||95
163853|NCT00482547|402332|P2|NOT COMPLETED|Overall Study||161
163854|NCT00482547|402333|P1|NOT COMPLETED|Overall Study||173
163855|NCT00482547|402332|P2|COMPLETED|Overall Study||428
163856|NCT00482547|402333|P1|COMPLETED|Overall Study||426
163857|NCT00482547|402332|P2|48 Hour Evaluation|Overall Study|428 went on to be included in the Silicone-coated 48 hour efficacy evaluable population.|428
163858|NCT00482547|402333|P1|48 Hour Evaluation|Overall Study|426 went on to be included in the Silver-coated 48 hour efficacy evaluable population.|426
163859|NCT00482547|402332|P2|Successful Catheterization|Overall Study|Out of the 589 SiCS catheter subjects 568 (96.4%) had a successful catheterization.|568
163860|NCT00482547|402333|P1|Successful Catheterization|Overall Study|Out of the 599 AgCS subjects 565 (94.3%) had a successful catheterization.|565
163861|NCT00482547|402332|P2|STARTED|Overall Study|589 subjects were enrolled in the silicone-coated catheter group.|589
163862|NCT00482547|402333|P1|STARTED|Overall Study|599 subjects were enrolled in the silver-coated catheter group.|599
163863|NCT00482612|402357|P4|NOT COMPLETED|Follow-up Period||8
163864|NCT00482612|402358|P3|NOT COMPLETED|Follow-up Period||22
163865|NCT00482612|402359|P2|NOT COMPLETED|Follow-up Period||18
163866|NCT00482612|402360|P1|NOT COMPLETED|Follow-up Period||14
163867|NCT00482612|402357|P4|COMPLETED|Follow-up Period||127
163868|NCT00482612|402358|P3|COMPLETED|Follow-up Period||106
163869|NCT00482612|402359|P2|COMPLETED|Follow-up Period||107
163870|NCT00482612|402360|P1|COMPLETED|Follow-up Period||123
163871|NCT00482612|402357|P4|STARTED|Follow-up Period||135
163872|NCT00482612|402358|P3|STARTED|Follow-up Period||128
163873|NCT00482612|402359|P2|STARTED|Follow-up Period||125
163874|NCT00482612|402360|P1|STARTED|Follow-up Period||137
163875|NCT00482612|402357|P4|NOT COMPLETED|In-treatment Period||0
163876|NCT00482612|402358|P3|NOT COMPLETED|In-treatment Period||1
163877|NCT00482612|402359|P2|NOT COMPLETED|In-treatment Period||0
163878|NCT00482612|402360|P1|NOT COMPLETED|In-treatment Period||0
163879|NCT00482612|402357|P4|COMPLETED|In-treatment Period||135
163880|NCT00482612|402358|P3|COMPLETED|In-treatment Period||128
163881|NCT00482612|402359|P2|COMPLETED|In-treatment Period||125
163882|NCT00482612|402360|P1|COMPLETED|In-treatment Period||137
163883|NCT00482612|402357|P4|Treated|In-treatment Period||135
163884|NCT00482612|402358|P3|Treated|In-treatment Period||128
163885|NCT00482612|402359|P2|Treated|In-treatment Period||125
163886|NCT00482612|402360|P1|Treated|In-treatment Period||137
163887|NCT00482612|402357|P4|STARTED|In-treatment Period||135
163888|NCT00482612|402358|P3|STARTED|In-treatment Period||129
163889|NCT00482612|402359|P2|STARTED|In-treatment Period||125
163890|NCT00482612|402360|P1|STARTED|In-treatment Period||137
163891|NCT00482625|402386|P1|NOT COMPLETED|Overall Study||0
163892|NCT00482625|402386|P1|COMPLETED|Overall Study||6
163893|NCT00482625|402386|P1|STARTED|Overall Study||6
163894|NCT00482703|402397|P2|NOT COMPLETED|Overall Study||0
163895|NCT00482703|402398|P1|NOT COMPLETED|Overall Study||1
163896|NCT00482703|402397|P2|COMPLETED|Overall Study||12
163897|NCT00482703|402398|P1|COMPLETED|Overall Study||10
163898|NCT00482703|402397|P2|STARTED|Overall Study|number enrolled, randomized and treated|12
163899|NCT00482703|402398|P1|STARTED|Overall Study|number enrolled, randomized and treated|11
163900|NCT00482729|402445|P2|NOT COMPLETED|Overall Study||218
163901|NCT00482729|402446|P1|NOT COMPLETED|Overall Study||217
163902|NCT00482729|402445|P2|COMPLETED|Overall Study||406
163903|NCT00482729|402446|P1|COMPLETED|Overall Study||409
163904|NCT00482729|402445|P2|Completed Phase B|Overall Study||406
163905|NCT00482729|402446|P1|Completed Phase B|Overall Study||409
163906|NCT00482729|402445|P2|Completed Phase A|Overall Study||482
163907|NCT00482729|402446|P1|Completed Phase A|Overall Study||484
163908|NCT00482729|402445|P2|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 3 patients were excluded from all analysis|624
163909|NCT00482729|402446|P1|STARTED|Overall Study|Site 079011301 was identified as non-compliant and 1 patient was excluded from all analysis|626
163910|NCT00482911|402462|P2|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
163911|NCT00482911|402463|P1|NOT COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
163912|NCT00482911|402462|P2|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun|5 stopped at Dose D-QOD, 2 stopped at Dose D-QD (1 after first increasing to Dose E-QD)|7
163913|NCT00482911|402463|P1|COMPLETED|Dosing Schedule 2: Len, Cyc, & Sun||0
163914|NCT00482911|402462|P2|STARTED|Dosing Schedule 2: Len, Cyc, & Sun|All received Dose D-QD in cycle 1|7
163915|NCT00482911|402463|P1|STARTED|Dosing Schedule 2: Len, Cyc, & Sun||0
163916|NCT00482911|402462|P2|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
163917|NCT00482911|402463|P1|NOT COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun||0
163918|NCT00482911|402462|P2|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QOD|2
163919|NCT00482911|402463|P1|COMPLETED|Dosing Schedule 1: Len, Cyc, & Sun|1 stopped at Dose B-QD, 1 stopped at Dose C-QD, 1 stopped at Dose C-QOD|3
163920|NCT00482911|402462|P2|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 1|2
163921|NCT00482911|402463|P1|STARTED|Dosing Schedule 1: Len, Cyc, & Sun|All received Dose B-QD in cycle 2|3
163922|NCT00482911|402462|P2|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
163923|NCT00482911|402463|P1|NOT COMPLETED|Dosing Schedule 1: Len & Cyc||0
163924|NCT00482911|402462|P2|COMPLETED|Dosing Schedule 1: Len & Cyc||0
163925|NCT00482911|402463|P1|COMPLETED|Dosing Schedule 1: Len & Cyc||3
163926|NCT00482911|402462|P2|STARTED|Dosing Schedule 1: Len & Cyc||0
163927|NCT00482911|402463|P1|STARTED|Dosing Schedule 1: Len & Cyc|All received Dose A-QD in cycle 1|3
163928|NCT00483002|402477|P1|NOT COMPLETED|Overall Study||2554
163929|NCT00483002|402477|P1|COMPLETED|Overall Study||1165
163930|NCT00483002|402477|P1|STARTED|Overall Study||3719
163931|NCT00483041|402485|P2|NOT COMPLETED|Overall Study||1
163932|NCT00483041|402486|P1|NOT COMPLETED|Overall Study||0
163933|NCT00483041|402485|P2|COMPLETED|Overall Study||5
163934|NCT00483041|402486|P1|COMPLETED|Overall Study||5
163935|NCT00483041|402485|P2|STARTED|Overall Study||6
163936|NCT00483041|402486|P1|STARTED|Overall Study||5
163937|NCT00483119|402518|P2|NOT COMPLETED|Overall Study||1
163938|NCT00483119|402519|P1|NOT COMPLETED|Overall Study||1
163939|NCT00483119|402518|P2|COMPLETED|Overall Study||3
163940|NCT00483119|402519|P1|COMPLETED|Overall Study||4
163941|NCT00483119|402518|P2|STARTED|Overall Study||4
163942|NCT00483119|402519|P1|STARTED|Overall Study||5
163943|NCT00483184|402534|P3|NOT COMPLETED|Overall Study||3
163944|NCT00483184|402535|P2|NOT COMPLETED|Overall Study||4
163945|NCT00483184|402536|P1|NOT COMPLETED|Overall Study||5
163946|NCT00483184|402534|P3|COMPLETED|Overall Study||23
163947|NCT00483184|402535|P2|COMPLETED|Overall Study||27
163948|NCT00483184|402536|P1|COMPLETED|Overall Study||22
163949|NCT00483184|402534|P3|STARTED|Overall Study||26
163950|NCT00483184|402535|P2|STARTED|Overall Study||31
163951|NCT00483184|402536|P1|STARTED|Overall Study||27
163952|NCT00483223|402544|P1|NOT COMPLETED|Overall Study||0
163953|NCT00483223|402544|P1|COMPLETED|Overall Study||86
163954|NCT00483223|402544|P1|STARTED|Overall Study||86
163955|NCT00483262|402553|P2|NOT COMPLETED|Overall Study||0
163956|NCT00483262|402554|P1|NOT COMPLETED|Overall Study||0
163957|NCT00483262|402553|P2|COMPLETED|Overall Study||43
163958|NCT00483262|402554|P1|COMPLETED|Overall Study||20
163959|NCT00483262|402553|P2|STARTED|Overall Study||43
163960|NCT00483262|402554|P1|STARTED|Overall Study||20
163961|NCT00483327|402564|P1|NOT COMPLETED|Overall Study||10
163962|NCT00483327|402564|P1|COMPLETED|Overall Study||20
163963|NCT00483327|402564|P1|STARTED|Overall Study||30
163964|NCT00483379|402573|P2|NOT COMPLETED|Extension Period||0
163965|NCT00483379|402574|P1|NOT COMPLETED|Extension Period||0
163966|NCT00483379|402573|P2|COMPLETED|Extension Period||2
163967|NCT00483379|402574|P1|COMPLETED|Extension Period||1
163968|NCT00483379|402573|P2|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|2
163969|NCT00483379|402574|P1|STARTED|Extension Period|Extension allowed late-onset participants access to treatment until commercially available.|1
163970|NCT00483379|402573|P2|NOT COMPLETED|Treatment Period||0
163971|NCT00483379|402574|P1|NOT COMPLETED|Treatment Period||2
163972|NCT00483379|402573|P2|COMPLETED|Treatment Period||7
163973|NCT00483379|402574|P1|COMPLETED|Treatment Period||4
163974|NCT00483379|402573|P2|STARTED|Treatment Period||7
163975|NCT00483379|402574|P1|STARTED|Treatment Period||6
163976|NCT00483405|402610|P1|NOT COMPLETED|Overall Study||28
163977|NCT00483405|402610|P1|COMPLETED|Overall Study||0
163978|NCT00483405|402610|P1|STARTED|Overall Study||28
163979|NCT00483496|402617|P1|NOT COMPLETED|Overall Study||1
163980|NCT00483496|402617|P1|COMPLETED|Overall Study||15
163981|NCT00483496|402617|P1|STARTED|Overall Study||16
163982|NCT00483548|402630|P2|NOT COMPLETED|Overall Study||46
163983|NCT00483548|402631|P1|NOT COMPLETED|Overall Study||60
163984|NCT00483548|402630|P2|COMPLETED|Overall Study||104
163985|NCT00483548|402631|P1|COMPLETED|Overall Study||88
163986|NCT00483548|402630|P2|Received Study Treatment|Overall Study|3 subjects randomized but not treated.|147
163987|NCT00483548|402631|P1|Received Study Treatment|Overall Study|1 subject randomized but lost to follow up; no treatment data.|147
163988|NCT00483548|402630|P2|STARTED|Overall Study||150
163989|NCT00483548|402631|P1|STARTED|Overall Study||148
163990|NCT00483574|402671|P2|NOT COMPLETED|Overall Study||13
163991|NCT00483574|402672|P1|NOT COMPLETED|Overall Study||102
163992|NCT00483574|402671|P2|COMPLETED|Overall Study||308
163993|NCT00483574|402672|P1|COMPLETED|Overall Study||951
163994|NCT00483574|402671|P2|STARTED|Overall Study||321
163995|NCT00483574|402672|P1|STARTED|Overall Study||1053
163996|NCT00489736|402682|P2|NOT COMPLETED|Overall Study||69
163997|NCT00489736|402683|P1|NOT COMPLETED|Overall Study||96
163998|NCT00489736|402682|P2|COMPLETED|Overall Study|completed study drug period|186
163999|NCT00489736|402683|P1|COMPLETED|Overall Study|completed study drug period|153
164000|NCT00489736|402682|P2|STARTED|Overall Study|Randomized and treated patients|255
164001|NCT00489736|402683|P1|STARTED|Overall Study|Randomized and treated patients|249
164002|NCT00489853|402693|P3|NOT COMPLETED|Follow-up Period||0
164003|NCT00489853|402694|P2|NOT COMPLETED|Follow-up Period||0
164004|NCT00489853|402695|P1|NOT COMPLETED|Follow-up Period||0
164005|NCT00489853|402693|P3|COMPLETED|Follow-up Period||33
164006|NCT00489853|402694|P2|COMPLETED|Follow-up Period||29
164007|NCT00489853|402695|P1|COMPLETED|Follow-up Period||29
164008|NCT00489853|402693|P3|STARTED|Follow-up Period||33
164009|NCT00489853|402694|P2|STARTED|Follow-up Period||29
164010|NCT00489853|402695|P1|STARTED|Follow-up Period||29
164011|NCT00489853|402693|P3|NOT COMPLETED|Treatment Period 3||0
164012|NCT00489853|402694|P2|NOT COMPLETED|Treatment Period 3||1
164013|NCT00489853|402695|P1|NOT COMPLETED|Treatment Period 3||0
164014|NCT00489853|402693|P3|COMPLETED|Treatment Period 3||33
164015|NCT00489853|402694|P2|COMPLETED|Treatment Period 3||29
164016|NCT00489853|402695|P1|COMPLETED|Treatment Period 3||29
164017|NCT00489853|402693|P3|STARTED|Treatment Period 3||33
164018|NCT00489853|402694|P2|STARTED|Treatment Period 3||30
164019|NCT00489853|402695|P1|STARTED|Treatment Period 3||29
164020|NCT00489853|402693|P3|NOT COMPLETED|Wash-out Period 2||2
164021|NCT00489853|402694|P2|NOT COMPLETED|Wash-out Period 2||3
164022|NCT00489853|402695|P1|NOT COMPLETED|Wash-out Period 2||4
164023|NCT00489853|402693|P3|COMPLETED|Wash-out Period 2||31
164024|NCT00489853|402694|P2|COMPLETED|Wash-out Period 2||32
164025|NCT00489853|402695|P1|COMPLETED|Wash-out Period 2||29
164026|NCT00489853|402693|P3|STARTED|Wash-out Period 2||33
164027|NCT00489853|402694|P2|STARTED|Wash-out Period 2||35
164028|NCT00489853|402695|P1|STARTED|Wash-out Period 2||33
164029|NCT00489853|402693|P3|NOT COMPLETED|Treatment Period 2||0
164030|NCT00489853|402694|P2|NOT COMPLETED|Treatment Period 2||0
164031|NCT00489853|402695|P1|NOT COMPLETED|Treatment Period 2||0
164032|NCT00489853|402693|P3|COMPLETED|Treatment Period 2||33
164033|NCT00489853|402694|P2|COMPLETED|Treatment Period 2||35
164034|NCT00489853|402695|P1|COMPLETED|Treatment Period 2||33
164035|NCT00489853|402693|P3|STARTED|Treatment Period 2||33
164036|NCT00489853|402694|P2|STARTED|Treatment Period 2||35
164037|NCT00489853|402695|P1|STARTED|Treatment Period 2||33
164038|NCT00489853|402693|P3|NOT COMPLETED|Wash-out Period 1||6
164039|NCT00489853|402694|P2|NOT COMPLETED|Wash-out Period 1||3
164040|NCT00489853|402695|P1|NOT COMPLETED|Wash-out Period 1||1
164041|NCT00489853|402693|P3|COMPLETED|Wash-out Period 1||32
164042|NCT00489853|402694|P2|COMPLETED|Wash-out Period 1||34
164043|NCT00489853|402695|P1|COMPLETED|Wash-out Period 1||35
164044|NCT00489853|402693|P3|STARTED|Wash-out Period 1||38
164045|NCT00489853|402694|P2|STARTED|Wash-out Period 1||37
164046|NCT00489853|402695|P1|STARTED|Wash-out Period 1||36
164047|NCT00489853|402693|P3|NOT COMPLETED|Treatment Period 1||0
164048|NCT00489853|402694|P2|NOT COMPLETED|Treatment Period 1||0
164049|NCT00489853|402695|P1|NOT COMPLETED|Treatment Period 1||0
164050|NCT00489853|402693|P3|COMPLETED|Treatment Period 1||38
164051|NCT00489853|402694|P2|COMPLETED|Treatment Period 1||37
164052|NCT00489853|402695|P1|COMPLETED|Treatment Period 1||36
164053|NCT00489853|402693|P3|STARTED|Treatment Period 1||38
164054|NCT00489853|402694|P2|STARTED|Treatment Period 1||37
164055|NCT00489853|402695|P1|STARTED|Treatment Period 1||36
164056|NCT00489866|402792|P2|NOT COMPLETED|Overall Study||0
164057|NCT00489866|402793|P1|NOT COMPLETED|Overall Study||2
164058|NCT00489866|402792|P2|COMPLETED|Overall Study||7
164059|NCT00489866|402793|P1|COMPLETED|Overall Study||5
164060|NCT00489866|402792|P2|STARTED|Overall Study||7
164061|NCT00489866|402793|P1|STARTED|Overall Study||7
164062|NCT00490646|402809|P2|NOT COMPLETED|Overall Study||2
164063|NCT00490646|402810|P1|NOT COMPLETED|Overall Study||2
164064|NCT00490646|402809|P2|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=13; study drug toxicity=1)|23
164065|NCT00490646|402810|P1|COMPLETED|Overall Study|Completed=Off-treatment (Major reasons: Disease progression=14; study drug toxicity=4)|23
164066|NCT00490646|402809|P2|Treated|Overall Study||24
164067|NCT00490646|402810|P1|Treated|Overall Study||24
164068|NCT00490646|402809|P2|STARTED|Overall Study||25
164069|NCT00490646|402810|P1|STARTED|Overall Study||25
164070|NCT00490698|402830|P1|NOT COMPLETED|Overall Study||10
164071|NCT00490698|402830|P1|COMPLETED|Overall Study||1
164072|NCT00490698|402830|P1|STARTED|Overall Study||11
164073|NCT00490724|402837|P3|NOT COMPLETED|Period II||3
164074|NCT00490724|402838|P2|NOT COMPLETED|Period II||1
164075|NCT00490724|402839|P1|NOT COMPLETED|Period II||3
164076|NCT00490724|402837|P3|COMPLETED|Period II||16
164077|NCT00490724|402838|P2|COMPLETED|Period II||19
164078|NCT00490724|402839|P1|COMPLETED|Period II||18
164079|NCT00490724|402837|P3|STARTED|Period II||19
164080|NCT00490724|402838|P2|STARTED|Period II||20
164081|NCT00490724|402839|P1|STARTED|Period II||21
164082|NCT00490724|402837|P3|NOT COMPLETED|Period I||1
164083|NCT00490724|402838|P2|NOT COMPLETED|Period I||0
164084|NCT00490724|402839|P1|NOT COMPLETED|Period I||0
164085|NCT00490724|402837|P3|COMPLETED|Period I||19
164086|NCT00490724|402838|P2|COMPLETED|Period I||20
164087|NCT00490724|402839|P1|COMPLETED|Period I||21
164088|NCT00490724|402837|P3|STARTED|Period I||20
164089|NCT00490724|402838|P2|STARTED|Period I||20
164090|NCT00490724|402839|P1|STARTED|Period I||21
164091|NCT00490802|402906|P2|NOT COMPLETED|Overall Study||2
164092|NCT00490802|402907|P1|NOT COMPLETED|Overall Study||1
164093|NCT00490802|402906|P2|COMPLETED|Overall Study||7
164094|NCT00490802|402907|P1|COMPLETED|Overall Study||9
164095|NCT00490802|402906|P2|STARTED|Overall Study||9
164096|NCT00490802|402907|P1|STARTED|Overall Study||10
164097|NCT00490815|402923|P2|NOT COMPLETED|Overall Study||9
164098|NCT00490815|402924|P1|NOT COMPLETED|Overall Study||8
164099|NCT00490815|402923|P2|COMPLETED|Overall Study||8
164100|NCT00490815|402924|P1|COMPLETED|Overall Study||12
164101|NCT00490815|402923|P2|STARTED|Overall Study||17
164102|NCT00490815|402924|P1|STARTED|Overall Study||20
164103|NCT00490841|402932|P1|NOT COMPLETED|Overall Study||13
164104|NCT00490841|402932|P1|COMPLETED|Overall Study||189
164105|NCT00490841|402932|P1|STARTED|Overall Study||202
164106|NCT00490919|402954|P3|NOT COMPLETED|Double-blind Phase||84
164107|NCT00490919|402955|P2|NOT COMPLETED|Double-blind Phase||86
164108|NCT00490919|402956|P1|NOT COMPLETED|Double-blind Phase||0
164109|NCT00490919|402954|P3|COMPLETED|Double-blind Phase||199
164110|NCT00490919|402955|P2|COMPLETED|Double-blind Phase||170
164111|NCT00490919|402956|P1|COMPLETED|Double-blind Phase||0
164112|NCT00490919|402954|P3|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|283
164113|NCT00490919|402955|P2|STARTED|Double-blind Phase|1 subject had no safety data in DB phase; therefore is excluded from randomized safety population.|256
164114|NCT00490919|402956|P1|STARTED|Double-blind Phase||0
164115|NCT00490919|402954|P3|NOT COMPLETED|Open-label Run-in Period||0
164116|NCT00490919|402955|P2|NOT COMPLETED|Open-label Run-in Period||0
164117|NCT00490919|402956|P1|NOT COMPLETED|Open-label Run-in Period||483
164118|NCT00490919|402954|P3|COMPLETED|Open-label Run-in Period||0
164119|NCT00490919|402955|P2|COMPLETED|Open-label Run-in Period||0
164120|NCT00490919|402956|P1|COMPLETED|Open-label Run-in Period|Completed run-in and randomized; however 2 had no safety data after randomization visit (N = 539)|541
164121|NCT00490919|402954|P3|STARTED|Open-label Run-in Period||0
164122|NCT00490919|402955|P2|STARTED|Open-label Run-in Period||0
164123|NCT00490919|402956|P1|STARTED|Open-label Run-in Period||1024
164124|NCT00490945|402972|P5|NOT COMPLETED|Overall Study||0
164125|NCT00490945|402973|P4|NOT COMPLETED|Overall Study||0
164126|NCT00490945|402974|P3|NOT COMPLETED|Overall Study||0
164127|NCT00490945|402975|P2|NOT COMPLETED|Overall Study||1
164128|NCT00490945|402976|P1|NOT COMPLETED|Overall Study||0
164129|NCT00490945|402972|P5|COMPLETED|Overall Study||7
164130|NCT00490945|402973|P4|COMPLETED|Overall Study||7
164131|NCT00490945|402974|P3|COMPLETED|Overall Study||8
164132|NCT00490945|402975|P2|COMPLETED|Overall Study||8
164133|NCT00490945|402976|P1|COMPLETED|Overall Study||8
164134|NCT00490945|402972|P5|STARTED|Overall Study||7
164135|NCT00490945|402973|P4|STARTED|Overall Study||7
164136|NCT00490945|402974|P3|STARTED|Overall Study||8
164137|NCT00490945|402975|P2|STARTED|Overall Study||9
164138|NCT00490945|402976|P1|STARTED|Overall Study||8
164139|NCT00490971|403012|P5|NOT COMPLETED|Maintenance||39
164140|NCT00490971|403013|P4|NOT COMPLETED|Maintenance||53
164141|NCT00490971|403014|P3|NOT COMPLETED|Maintenance||51
164142|NCT00490971|403015|P2|NOT COMPLETED|Maintenance||0
164143|NCT00490971|403016|P1|NOT COMPLETED|Maintenance||0
164144|NCT00490971|403012|P5|COMPLETED|Maintenance||44
164145|NCT00490971|403013|P4|COMPLETED|Maintenance||96
164146|NCT00490971|403014|P3|COMPLETED|Maintenance||96
164147|NCT00490971|403015|P2|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
164148|NCT00490971|403016|P1|COMPLETED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
164149|NCT00490971|403012|P5|STARTED|Maintenance||83
164150|NCT00490971|403013|P4|STARTED|Maintenance|152 participants were assigned to pali/pali, out of which 149 took the study medication.|149
164151|NCT00490971|403014|P3|STARTED|Maintenance|148 participants were assigned to pali/placebo, out of which 147 took the study medication.|147
164152|NCT00490971|403015|P2|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
164153|NCT00490971|403016|P1|STARTED|Maintenance|"0 indicates this group is not relevant to maintenance period."|0
164154|NCT00490971|403012|P5|NOT COMPLETED|Acute/Continuation||0
164155|NCT00490971|403013|P4|NOT COMPLETED|Acute/Continuation||0
164156|NCT00490971|403014|P3|NOT COMPLETED|Acute/Continuation||0
164157|NCT00490971|403015|P2|NOT COMPLETED|Acute/Continuation||62
164158|NCT00490971|403016|P1|NOT COMPLETED|Acute/Continuation||306
164159|NCT00490971|403012|P5|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
164160|NCT00490971|403013|P4|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
164161|NCT00490971|403014|P3|COMPLETED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
164162|NCT00490971|403015|P2|COMPLETED|Acute/Continuation||86
164163|NCT00490971|403016|P1|COMPLETED|Acute/Continuation||308
164164|NCT00490971|403012|P5|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
164165|NCT00490971|403013|P4|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
164166|NCT00490971|403014|P3|STARTED|Acute/Continuation|"0 indicates this group is not relevant to acute and continuation period."|0
164167|NCT00490971|403015|P2|STARTED|Acute/Continuation|149 participants were assigned to paliperidone, out of which 148 took the study medication.|148
164168|NCT00490971|403016|P1|STARTED|Acute/Continuation|617 participants were assigned to paliperidone, out of which 614 took the study medication.|614
164169|NCT00491075|403058|P1|NOT COMPLETED|Overall Study||2
164170|NCT00491075|403058|P1|COMPLETED|Overall Study||14
164171|NCT00491075|403058|P1|STARTED|Overall Study||16
164172|NCT00491179|403064|P2|NOT COMPLETED|Overall Study||2
164173|NCT00491179|403065|P1|NOT COMPLETED|Overall Study||7
164174|NCT00491179|403064|P2|COMPLETED|Overall Study||8
164175|NCT00491179|403065|P1|COMPLETED|Overall Study||18
164176|NCT00491179|403064|P2|STARTED|Overall Study||10
164177|NCT00491179|403065|P1|STARTED|Overall Study||25
164178|NCT00491244|403075|P2|NOT COMPLETED|Overall Study||20
164179|NCT00491244|403076|P1|NOT COMPLETED|Overall Study||27
164180|NCT00491244|403075|P2|COMPLETED|Overall Study||168
164181|NCT00491244|403076|P1|COMPLETED|Overall Study||162
164182|NCT00491244|403075|P2|STARTED|Overall Study||188
164183|NCT00491244|403076|P1|STARTED|Overall Study||189
164184|NCT00491374|403086|P2|NOT COMPLETED|Overall Study||0
164185|NCT00491374|403087|P1|NOT COMPLETED|Overall Study||0
164186|NCT00491374|403086|P2|COMPLETED|Overall Study||0
164187|NCT00491374|403087|P1|COMPLETED|Overall Study||0
164188|NCT00491374|403086|P2|STARTED|Overall Study||0
164189|NCT00491374|403087|P1|STARTED|Overall Study||0
164190|NCT00491387|403093|P1|NOT COMPLETED|Overall Study||0
164191|NCT00491387|403093|P1|COMPLETED|Overall Study||24
164192|NCT00491387|403093|P1|Study Enrollment|Overall Study||24
164193|NCT00491387|403093|P1|STARTED|Overall Study||24
164194|NCT00491400|403099|P2|NOT COMPLETED|Overall Study||4
164195|NCT00491400|403100|P1|NOT COMPLETED|Overall Study||5
164196|NCT00491400|403099|P2|COMPLETED|Overall Study||9
164197|NCT00491400|403100|P1|COMPLETED|Overall Study||10
164198|NCT00491400|403099|P2|Finished Second Treatment|Overall Study|None withdrew during fenofibrate treatment (second treatment)|9
164199|NCT00491400|403100|P1|Finished Second Treatment|Overall Study|2 withdrew during atorvastatin treatment (second treatment)|10
164200|NCT00491400|403099|P2|Started Second Treatment|Overall Study|None withdrew during the washout period|9
164201|NCT00491400|403100|P1|Started Second Treatment|Overall Study|2 withdrew during washout period|12
164202|NCT00491400|403099|P2|Completed First Treatment|Overall Study|4 withdrew during atorvastatin treatment (first treatment)|9
164203|NCT00491400|403100|P1|Completed First Treatment|Overall Study|None withdrew during fenofibrate treatment (first treatment)|14
164204|NCT00491400|403099|P2|Started First Treatment|Overall Study|None withdrew prior to starting atorvastatin|13
164205|NCT00491400|403100|P1|Started First Treatment|Overall Study|1 withdrew prior to starting fenofibrate|14
164206|NCT00491400|403099|P2|STARTED|Overall Study||13
164207|NCT00491400|403100|P1|STARTED|Overall Study||15
164208|NCT00491504|403112|P4|NOT COMPLETED|Overall Study||4
164209|NCT00491504|403113|P3|NOT COMPLETED|Overall Study||4
164210|NCT00491504|403114|P2|NOT COMPLETED|Overall Study||1
164211|NCT00491504|403115|P1|NOT COMPLETED|Overall Study||0
164212|NCT00491504|403112|P4|COMPLETED|Overall Study||73
164213|NCT00491504|403113|P3|COMPLETED|Overall Study||74
164214|NCT00491504|403114|P2|COMPLETED|Overall Study||77
164215|NCT00491504|403115|P1|COMPLETED|Overall Study||77
164216|NCT00491504|403112|P4|STARTED|Overall Study|All subjects who received placebo on Day 1 through Day 7|77
164217|NCT00491504|403113|P3|STARTED|Overall Study|All subjects who received MFNS on Day 1 through Day 7|78
164218|NCT00491504|403114|P2|STARTED|Overall Study|All subjects who received placebo only on Day 1|78
164219|NCT00491504|403115|P1|STARTED|Overall Study|All subjects who received MFNS only on Day 1|77
164220|NCT00491530|403126|P3|NOT COMPLETED|Overall Study||5
164221|NCT00491530|403127|P2|NOT COMPLETED|Overall Study||6
164222|NCT00491530|403128|P1|NOT COMPLETED|Overall Study||12
164223|NCT00491530|403126|P3|COMPLETED|Overall Study||81
164224|NCT00491530|403127|P2|COMPLETED|Overall Study||44
164225|NCT00491530|403128|P1|COMPLETED|Overall Study||162
164226|NCT00491530|403126|P3|STARTED|Overall Study||86
164227|NCT00491530|403127|P2|STARTED|Overall Study||50
164228|NCT00491530|403128|P1|STARTED|Overall Study||174
164229|NCT00491556|403156|P2|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||5
164230|NCT00491556|403157|P1|NOT COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||24
164231|NCT00491556|403156|P2|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||22
164232|NCT00491556|403157|P1|COMPLETED|Wk 48-152: EXP (On De-Int)/Standard Care||25
164233|NCT00491556|403156|P2|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||27
164234|NCT00491556|403157|P1|STARTED|Wk 48-152: EXP (On De-Int)/Standard Care||49
164235|NCT00491556|403156|P2|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||0
164236|NCT00491556|403157|P1|NOT COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||26
164237|NCT00491556|403156|P2|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||27
164238|NCT00491556|403157|P1|COMPLETED|Entry-Week (WK) 48: EXP/Standard Care||49
164239|NCT00491556|403156|P2|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||27
164240|NCT00491556|403157|P1|Wk 24 VL Suppressed (EXP)/WK 24 (STAND)|Entry-Week (WK) 48: EXP/Standard Care||53
164241|NCT00491556|403156|P2|STARTED|Entry-Week (WK) 48: EXP/Standard Care||27
164242|NCT00491556|403157|P1|STARTED|Entry-Week (WK) 48: EXP/Standard Care||75
164243|NCT00491608|403213|P1|NOT COMPLETED|Overall Study||3
164244|NCT00491608|403213|P1|COMPLETED|Overall Study||206
164245|NCT00491608|403213|P1|STARTED|Overall Study|Participants who received treatment|209
164246|NCT00491738|403224|P2|NOT COMPLETED|Overall Study||0
164247|NCT00491738|403225|P1|NOT COMPLETED|Overall Study||0
164248|NCT00491738|403224|P2|COMPLETED|Overall Study||9
164249|NCT00491738|403225|P1|COMPLETED|Overall Study||7
164250|NCT00491738|403224|P2|STARTED|Overall Study||9
164251|NCT00491738|403225|P1|STARTED|Overall Study||7
164252|NCT00491764|403235|P6|NOT COMPLETED|Overall Study||9
164253|NCT00491764|403236|P5|NOT COMPLETED|Overall Study||3
164254|NCT00491764|403237|P4|NOT COMPLETED|Overall Study||8
164255|NCT00491764|403238|P3|NOT COMPLETED|Overall Study||8
164256|NCT00491764|403239|P2|NOT COMPLETED|Overall Study||7
164257|NCT00491764|403240|P1|NOT COMPLETED|Overall Study||5
164258|NCT00491764|403235|P6|COMPLETED|Overall Study||27
164259|NCT00491764|403236|P5|COMPLETED|Overall Study||33
164260|NCT00491764|403237|P4|COMPLETED|Overall Study||28
164261|NCT00491764|403238|P3|COMPLETED|Overall Study||28
164262|NCT00491764|403239|P2|COMPLETED|Overall Study||30
164263|NCT00491764|403240|P1|COMPLETED|Overall Study||32
164264|NCT00491764|403235|P6|STARTED|Overall Study||36
164265|NCT00491764|403236|P5|STARTED|Overall Study||36
164266|NCT00491764|403237|P4|STARTED|Overall Study||36
164267|NCT00491764|403238|P3|STARTED|Overall Study||36
164268|NCT00491764|403239|P2|STARTED|Overall Study||37
164269|NCT00491764|403240|P1|STARTED|Overall Study||37
164270|NCT00491829|403269|P3|NOT COMPLETED|Overall Study||75
164271|NCT00491829|403270|P2|NOT COMPLETED|Overall Study||114
164272|NCT00491829|403271|P1|NOT COMPLETED|Overall Study||95
164273|NCT00491829|403269|P3|COMPLETED|Overall Study||243
164274|NCT00491829|403270|P2|COMPLETED|Overall Study||202
164275|NCT00491829|403271|P1|COMPLETED|Overall Study||216
164276|NCT00491829|403269|P3|STARTED|Overall Study||318
164277|NCT00491829|403270|P2|STARTED|Overall Study||316
164278|NCT00491829|403271|P1|STARTED|Overall Study||311
164279|NCT00491894|403279|P1|NOT COMPLETED|Overall Study||34
164280|NCT00491894|403279|P1|COMPLETED|Overall Study||103
164281|NCT00491894|403279|P1|STARTED|Overall Study||137
164282|NCT00492024|403289|P2|NOT COMPLETED|Follow up||2
164283|NCT00492024|403290|P1|NOT COMPLETED|Follow up||1
164284|NCT00492024|403289|P2|COMPLETED|Follow up||99
164285|NCT00492024|403290|P1|COMPLETED|Follow up||221
164286|NCT00492024|403289|P2|STARTED|Follow up||101
164287|NCT00492024|403290|P1|STARTED|Follow up||222
164288|NCT00492024|403289|P2|NOT COMPLETED|Treatment||22
164289|NCT00492024|403290|P1|NOT COMPLETED|Treatment||29
164290|NCT00492024|403289|P2|COMPLETED|Treatment||101
164291|NCT00492024|403290|P1|COMPLETED|Treatment||222
164292|NCT00492024|403289|P2|STARTED|Treatment||123
164293|NCT00492024|403290|P1|STARTED|Treatment||251
164294|NCT00492063|403310|P4|NOT COMPLETED|Overall Study||10
164295|NCT00492063|403311|P3|NOT COMPLETED|Overall Study||11
164296|NCT00492063|403312|P2|NOT COMPLETED|Overall Study||14
164297|NCT00492063|403313|P1|NOT COMPLETED|Overall Study||10
164298|NCT00492063|403310|P4|COMPLETED|Overall Study||666
164299|NCT00492063|403311|P3|COMPLETED|Overall Study||667
164300|NCT00492063|403312|P2|COMPLETED|Overall Study||634
164301|NCT00492063|403313|P1|COMPLETED|Overall Study||642
164302|NCT00492063|403310|P4|STARTED|Overall Study||676
164303|NCT00492063|403311|P3|STARTED|Overall Study||678
164304|NCT00492063|403312|P2|STARTED|Overall Study||648
164305|NCT00492063|403313|P1|STARTED|Overall Study||652
164306|NCT00492089|403337|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
164307|NCT00492089|403338|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
164308|NCT00492089|403337|P2|COMPLETED|Second Intervention (6 Weeks)||6
164309|NCT00492089|403338|P1|COMPLETED|Second Intervention (6 Weeks)||5
164310|NCT00492089|403337|P2|STARTED|Second Intervention (6 Weeks)||6
164311|NCT00492089|403338|P1|STARTED|Second Intervention (6 Weeks)||5
164312|NCT00492089|403337|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
164313|NCT00492089|403338|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
164314|NCT00492089|403337|P2|COMPLETED|First Intervention (6 Weeks)||6
164315|NCT00492089|403338|P1|COMPLETED|First Intervention (6 Weeks)||5
164316|NCT00492089|403337|P2|STARTED|First Intervention (6 Weeks)||6
164317|NCT00492089|403338|P1|STARTED|First Intervention (6 Weeks)||5
164318|NCT00492206|403344|P1|NOT COMPLETED|Overall Study||0
164319|NCT00492206|403344|P1|COMPLETED|Overall Study||40
164320|NCT00492206|403344|P1|STARTED|Overall Study||40
164321|NCT00492232|403353|P2|NOT COMPLETED|Open-Label Treatment||0
164322|NCT00492232|403354|P1|NOT COMPLETED|Open-Label Treatment||1
164323|NCT00492232|403353|P2|COMPLETED|Open-Label Treatment||0
164324|NCT00492232|403354|P1|COMPLETED|Open-Label Treatment||88
164325|NCT00492232|403353|P2|STARTED|Open-Label Treatment|All subjects received ramelteon in the OLTP.|0
164326|NCT00492232|403354|P1|STARTED|Open-Label Treatment|In the previous DBTP, 45 and 44 subjects were randomized to ramelteon and placebo, respectively.|89
164327|NCT00492232|403353|P2|NOT COMPLETED|Double-Blind Treatment||25
164328|NCT00492232|403354|P1|NOT COMPLETED|Double-Blind Treatment||18
164329|NCT00492232|403353|P2|COMPLETED|Double-Blind Treatment||45
164330|NCT00492232|403354|P1|COMPLETED|Double-Blind Treatment||47
164331|NCT00492232|403353|P2|STARTED|Double-Blind Treatment||70
164332|NCT00492232|403354|P1|STARTED|Double-Blind Treatment||65
164333|NCT00492232|403353|P2|NOT COMPLETED|Placebo Run-in||70
164334|NCT00492232|403354|P1|NOT COMPLETED|Placebo Run-in||0
164335|NCT00492232|403353|P2|COMPLETED|Placebo Run-in|These subjects successfully completed the placebo run-in period and were randomized to the DBTP.|135
164336|NCT00492232|403354|P1|COMPLETED|Placebo Run-in||0
164337|NCT00492232|403353|P2|STARTED|Placebo Run-in|All subjects received placebo in the placebo run-in period.|205
164338|NCT00492232|403354|P1|STARTED|Placebo Run-in||0
164339|NCT00492284|403390|P4|NOT COMPLETED|Overall Study||10
164340|NCT00492284|403391|P3|NOT COMPLETED|Overall Study||6
164341|NCT00492284|403392|P2|NOT COMPLETED|Overall Study||4
164342|NCT00492284|403393|P1|NOT COMPLETED|Overall Study||1
164343|NCT00492284|403390|P4|COMPLETED|Overall Study||31
164344|NCT00492284|403391|P3|COMPLETED|Overall Study||37
164345|NCT00492284|403392|P2|COMPLETED|Overall Study||35
164346|NCT00492284|403393|P1|COMPLETED|Overall Study||38
164347|NCT00492284|403390|P4|STARTED|Overall Study||41
164348|NCT00492284|403391|P3|STARTED|Overall Study||43
164349|NCT00492284|403392|P2|STARTED|Overall Study||39
164350|NCT00492284|403393|P1|STARTED|Overall Study||39
164351|NCT00492297|403435|P1|NOT COMPLETED|Survival Only Follow-up||59
164352|NCT00492297|403435|P1|COMPLETED|Survival Only Follow-up||0
164353|NCT00492297|403435|P1|STARTED|Survival Only Follow-up||59
164354|NCT00492297|403435|P1|NOT COMPLETED|Active Follow-up 30(+4) Days Duration||19
164355|NCT00492297|403435|P1|COMPLETED|Active Follow-up 30(+4) Days Duration||59
164356|NCT00492297|403435|P1|STARTED|Active Follow-up 30(+4) Days Duration|AFU is 30(+4) days duration for subjects withdrawn from sorafenib due to PD.|78
164357|NCT00492297|403435|P1|NOT COMPLETED|Treatment||5
164358|NCT00492297|403435|P1|COMPLETED|Treatment||78
164359|NCT00492297|403435|P1|Second Stage of Simon Optimal Design|Treatment|Recruitment continued into the second stage. 51 of 83 subjects were treated in the second stage.|51
164360|NCT00492297|403435|P1|First Stage of Simon Optimal Design|Treatment|32 subjects of 83 subjects enrolled were treated in first stage.|32
164361|NCT00492297|403435|P1|STARTED|Treatment||83
164362|NCT00492336|403451|P2|NOT COMPLETED|Overall Study||6
164363|NCT00492336|403452|P1|NOT COMPLETED|Overall Study||2
164364|NCT00492336|403451|P2|COMPLETED|Overall Study||23
164365|NCT00492336|403452|P1|COMPLETED|Overall Study||26
164366|NCT00492336|403451|P2|STARTED|Overall Study||29
164367|NCT00492336|403452|P1|STARTED|Overall Study||28
164368|NCT00492401|403458|P1|NOT COMPLETED|Overall Study||0
164369|NCT00492401|403458|P1|COMPLETED|Overall Study||55
164370|NCT00492401|403458|P1|STARTED|Overall Study||55
164371|NCT00492531|403469|P2|NOT COMPLETED|Overall Study||23
164372|NCT00492531|403470|P1|NOT COMPLETED|Overall Study||22
164373|NCT00492531|403469|P2|COMPLETED|Overall Study|Of 14 subjects who completed study, 13 were enrolled in Open label.|14
164453|NCT00492856|403597|P4|STARTED|Post-consolidation||1
164374|NCT00492531|403470|P1|COMPLETED|Overall Study|Of 15 subjects who completed study, 13 were enrolled in Open label.|15
164375|NCT00492531|403469|P2|STARTED|Overall Study||37
164376|NCT00492531|403470|P1|STARTED|Overall Study||37
164377|NCT00492544|403482|P1|NOT COMPLETED|Overall Study||0
164378|NCT00492544|403482|P1|COMPLETED|Overall Study||100
164379|NCT00492544|403482|P1|STARTED|Overall Study||100
164380|NCT00492557|403496|P2|NOT COMPLETED|Overall Study||23
164381|NCT00492557|403497|P1|NOT COMPLETED|Overall Study||24
164382|NCT00492557|403496|P2|COMPLETED|Overall Study||557
164383|NCT00492557|403497|P1|COMPLETED|Overall Study||556
164384|NCT00492557|403496|P2|Vaccinated Dose 2|Overall Study||558
164385|NCT00492557|403497|P1|Vaccinated Dose 2|Overall Study||560
164386|NCT00492557|403496|P2|Vaccinated Dose 1|Overall Study||575
164387|NCT00492557|403497|P1|Vaccinated Dose 1|Overall Study||577
164388|NCT00492557|403496|P2|STARTED|Overall Study||580
164389|NCT00492557|403497|P1|STARTED|Overall Study||580
164390|NCT00492583|403515|P2|NOT COMPLETED|Overall Study||0
164391|NCT00492583|403516|P1|NOT COMPLETED|Overall Study||0
164392|NCT00492583|403515|P2|COMPLETED|Overall Study||87
164393|NCT00492583|403516|P1|COMPLETED|Overall Study||95
164394|NCT00492583|403515|P2|STARTED|Overall Study||87
164395|NCT00492583|403516|P1|STARTED|Overall Study||95
164396|NCT00492622|403522|P1|NOT COMPLETED|Overall Study||0
164397|NCT00492622|403522|P1|COMPLETED|Overall Study||12
164398|NCT00492622|403522|P1|STARTED|Overall Study|all subjects received the immediate release formulation|12
164399|NCT00492726|403534|P2|NOT COMPLETED|Overall Study||36
164400|NCT00492726|403535|P1|NOT COMPLETED|Overall Study||50
164401|NCT00492726|403534|P2|COMPLETED|Overall Study||358
164402|NCT00492726|403535|P1|COMPLETED|Overall Study||360
164403|NCT00492726|403534|P2|End of Study|Overall Study||358
164404|NCT00492726|403535|P1|End of Study|Overall Study||360
164405|NCT00492726|403534|P2|End of Treatment (EOT, Day 5 to 14)|Overall Study||377
164406|NCT00492726|403535|P1|End of Treatment (EOT, Day 5 to 14)|Overall Study||387
164407|NCT00492726|403534|P2|STARTED|Overall Study||394
164408|NCT00492726|403535|P1|STARTED|Overall Study||410
164409|NCT00492752|403561|P4|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||6
164410|NCT00492752|403562|P3|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||47
164411|NCT00492752|403563|P2|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||16
164412|NCT00492752|403564|P1|NOT COMPLETED|Follow-up and/or Open Label Sorafenib||86
164413|NCT00492752|403561|P4|COMPLETED|Follow-up and/or Open Label Sorafenib||0
164414|NCT00492752|403562|P3|COMPLETED|Follow-up and/or Open Label Sorafenib|20 participants were followed up until the end of this trial|20
164415|NCT00492752|403563|P2|COMPLETED|Follow-up and/or Open Label Sorafenib||0
164416|NCT00492752|403564|P1|COMPLETED|Follow-up and/or Open Label Sorafenib|1 participant completed all assessments, 33 were followed up until the end of this trial|34
164417|NCT00492752|403561|P4|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||6
164418|NCT00492752|403562|P3|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
164419|NCT00492752|403563|P2|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||16
164420|NCT00492752|403564|P1|Follow-up First, Then Open Label|Follow-up and/or Open Label Sorafenib||0
164421|NCT00492752|403561|P4|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
164422|NCT00492752|403562|P3|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||67
164423|NCT00492752|403563|P2|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||0
164424|NCT00492752|403564|P1|Follow-up Only (no Open Label Treatment)|Follow-up and/or Open Label Sorafenib||120
164425|NCT00492752|403561|P4|STARTED|Follow-up and/or Open Label Sorafenib||6
164426|NCT00492752|403562|P3|STARTED|Follow-up and/or Open Label Sorafenib||67
164427|NCT00492752|403563|P2|STARTED|Follow-up and/or Open Label Sorafenib||16
164428|NCT00492752|403564|P1|STARTED|Follow-up and/or Open Label Sorafenib||120
164429|NCT00492752|403561|P4|NOT COMPLETED|Double Blind Treatment||0
164430|NCT00492752|403562|P3|NOT COMPLETED|Double Blind Treatment||3
164431|NCT00492752|403563|P2|NOT COMPLETED|Double Blind Treatment||0
164432|NCT00492752|403564|P1|NOT COMPLETED|Double Blind Treatment||14
164433|NCT00492752|403561|P4|COMPLETED|Double Blind Treatment||6
164434|NCT00492752|403562|P3|COMPLETED|Double Blind Treatment||67
164435|NCT00492752|403563|P2|COMPLETED|Double Blind Treatment||16
164436|NCT00492752|403564|P1|COMPLETED|Double Blind Treatment||120
164437|NCT00492752|403561|P4|Received Treatment|Double Blind Treatment|Safety Population|6
164438|NCT00492752|403562|P3|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to protocol violation.|69
164439|NCT00492752|403563|P2|Received Treatment|Double Blind Treatment|Safety Population|16
164440|NCT00492752|403564|P1|Received Treatment|Double Blind Treatment|Safety Population. 1 participant never received treatment due to an Adverse Event.|133
164441|NCT00492752|403561|P4|STARTED|Double Blind Treatment||6
164442|NCT00492752|403562|P3|STARTED|Double Blind Treatment||70
164443|NCT00492752|403563|P2|STARTED|Double Blind Treatment||16
164444|NCT00492752|403564|P1|STARTED|Double Blind Treatment||134
164445|NCT00492856|403597|P4|NOT COMPLETED|Post-consolidation||1
164446|NCT00492856|403598|P3|NOT COMPLETED|Post-consolidation||27
164447|NCT00492856|403599|P2|NOT COMPLETED|Post-consolidation||12
164448|NCT00492856|403600|P1|NOT COMPLETED|Post-consolidation||0
164449|NCT00492856|403597|P4|COMPLETED|Post-consolidation||0
164450|NCT00492856|403598|P3|COMPLETED|Post-consolidation||0
164451|NCT00492856|403599|P2|COMPLETED|Post-consolidation||29
164452|NCT00492856|403600|P1|COMPLETED|Post-consolidation||0
164454|NCT00492856|403598|P3|STARTED|Post-consolidation||27
164455|NCT00492856|403599|P2|STARTED|Post-consolidation||41
164456|NCT00492856|403600|P1|STARTED|Post-consolidation|Patients who achieve CRm, are randomized to the treatment arm, and are eligible.|0
164457|NCT00492856|403597|P4|NOT COMPLETED|Consolidation||0
164458|NCT00492856|403598|P3|NOT COMPLETED|Consolidation||0
164459|NCT00492856|403599|P2|NOT COMPLETED|Consolidation||0
164460|NCT00492856|403600|P1|NOT COMPLETED|Consolidation||9
164461|NCT00492856|403597|P4|COMPLETED|Consolidation||0
164462|NCT00492856|403598|P3|COMPLETED|Consolidation||0
164463|NCT00492856|403599|P2|COMPLETED|Consolidation||0
164464|NCT00492856|403600|P1|COMPLETED|Consolidation||83
164465|NCT00492856|403597|P4|STARTED|Consolidation||0
164466|NCT00492856|403598|P3|STARTED|Consolidation||0
164467|NCT00492856|403599|P2|STARTED|Consolidation||0
164468|NCT00492856|403600|P1|STARTED|Consolidation|Patients in CR (CRm), CRi, or PR after induction, register for consolidation and are eligible.|92
164469|NCT00492856|403597|P4|NOT COMPLETED|Induction||0
164470|NCT00492856|403598|P3|NOT COMPLETED|Induction||0
164471|NCT00492856|403599|P2|NOT COMPLETED|Induction||0
164472|NCT00492856|403600|P1|NOT COMPLETED|Induction||6
164473|NCT00492856|403597|P4|COMPLETED|Induction||0
164474|NCT00492856|403598|P3|COMPLETED|Induction||0
164475|NCT00492856|403599|P2|COMPLETED|Induction||0
164476|NCT00492856|403600|P1|COMPLETED|Induction||99
164477|NCT00492856|403597|P4|STARTED|Induction||0
164478|NCT00492856|403598|P3|STARTED|Induction||0
164479|NCT00492856|403599|P2|STARTED|Induction||0
164480|NCT00492856|403600|P1|STARTED|Induction||105
164481|NCT00492973|403614|P2|NOT COMPLETED|Overall Study||1
164482|NCT00492973|403615|P1|NOT COMPLETED|Overall Study||0
164483|NCT00492973|403614|P2|COMPLETED|Overall Study|One patient died of complications related to deep joint sepsis in the early postoperative period.|38
164484|NCT00492973|403615|P1|COMPLETED|Overall Study||37
164485|NCT00492973|403614|P2|STARTED|Overall Study||39
164486|NCT00492973|403615|P1|STARTED|Overall Study||37
164487|NCT00493012|403631|P2|NOT COMPLETED|Overall Study||17
164488|NCT00493012|403632|P1|NOT COMPLETED|Overall Study||18
164489|NCT00493012|403631|P2|COMPLETED|Overall Study||83
164490|NCT00493012|403632|P1|COMPLETED|Overall Study||82
164491|NCT00493012|403631|P2|STARTED|Overall Study||100
164492|NCT00493012|403632|P1|STARTED|Overall Study||100
164493|NCT00493038|403660|P2|NOT COMPLETED|Follow-up||0
164494|NCT00493038|403661|P1|NOT COMPLETED|Follow-up||1
164495|NCT00493038|403660|P2|COMPLETED|Follow-up||126
164496|NCT00493038|403661|P1|COMPLETED|Follow-up||122
164497|NCT00493038|403660|P2|STARTED|Follow-up||126
164498|NCT00493038|403661|P1|STARTED|Follow-up||123
164499|NCT00493038|403660|P2|NOT COMPLETED|Treatment||20
164500|NCT00493038|403661|P1|NOT COMPLETED|Treatment||24
164501|NCT00493038|403660|P2|COMPLETED|Treatment||126
164502|NCT00493038|403661|P1|COMPLETED|Treatment||123
164503|NCT00493038|403660|P2|Test-of-Cure Visit|Treatment||126
164504|NCT00493038|403661|P1|Test-of-Cure Visit|Treatment||123
164505|NCT00493038|403660|P2|Treated With Study Medication|Treatment||142
164506|NCT00493038|403661|P1|Treated With Study Medication|Treatment||145
164507|NCT00493038|403660|P2|Randomization|Treatment||146
164508|NCT00493038|403661|P1|Randomization|Treatment||147
164509|NCT00493038|403660|P2|STARTED|Treatment||146
164510|NCT00493038|403661|P1|STARTED|Treatment||147
164511|NCT00481065|403683|P8|NOT COMPLETED|Overall Study||19
164512|NCT00481065|403684|P7|NOT COMPLETED|Overall Study||16
164513|NCT00481065|403685|P6|NOT COMPLETED|Overall Study||24
164514|NCT00481065|403686|P5|NOT COMPLETED|Overall Study||23
164515|NCT00481065|403687|P4|NOT COMPLETED|Overall Study||15
164516|NCT00481065|403688|P3|NOT COMPLETED|Overall Study||19
164517|NCT00481065|403689|P2|NOT COMPLETED|Overall Study||17
164518|NCT00481065|403690|P1|NOT COMPLETED|Overall Study||22
164519|NCT00481065|403683|P8|COMPLETED|Overall Study||30
164520|NCT00481065|403684|P7|COMPLETED|Overall Study||34
164521|NCT00481065|403685|P6|COMPLETED|Overall Study||27
164522|NCT00481065|403686|P5|COMPLETED|Overall Study||28
164523|NCT00481065|403687|P4|COMPLETED|Overall Study||37
164524|NCT00481065|403688|P3|COMPLETED|Overall Study||32
164525|NCT00481065|403689|P2|COMPLETED|Overall Study||33
164526|NCT00481065|403690|P1|COMPLETED|Overall Study||29
164527|NCT00481065|403683|P8|STARTED|Overall Study||49
164528|NCT00481065|403684|P7|STARTED|Overall Study||50
164529|NCT00481065|403685|P6|STARTED|Overall Study||51
164530|NCT00481065|403686|P5|STARTED|Overall Study||51
164531|NCT00481065|403687|P4|STARTED|Overall Study||52
164532|NCT00481065|403688|P3|STARTED|Overall Study||51
164533|NCT00481065|403689|P2|STARTED|Overall Study||50
164534|NCT00481065|403690|P1|STARTED|Overall Study||51
164535|NCT00481078|403778|P2|NOT COMPLETED|Overall Study||20
164536|NCT00481078|403779|P1|NOT COMPLETED|Overall Study||42
164537|NCT00481078|403778|P2|COMPLETED|Overall Study||12
164538|NCT00481078|403779|P1|COMPLETED|Overall Study||20
164539|NCT00481078|403778|P2|STARTED|Overall Study||32
164540|NCT00481078|403779|P1|STARTED|Overall Study||62
164541|NCT00486447|403789|P1|NOT COMPLETED|Overall Study||0
164542|NCT00486447|403789|P1|COMPLETED|Overall Study||249
164543|NCT00486447|403789|P1|STARTED|Overall Study||249
164544|NCT00486525|403796|P2|NOT COMPLETED|Overall Study||13
164545|NCT00486525|403797|P1|NOT COMPLETED|Overall Study||6
164546|NCT00486525|403796|P2|COMPLETED|Overall Study||87
164547|NCT00486525|403797|P1|COMPLETED|Overall Study||94
164548|NCT00486525|403796|P2|STARTED|Overall Study||100
164549|NCT00486525|403797|P1|STARTED|Overall Study||100
164550|NCT00486642|403815|P2|NOT COMPLETED|Overall Study||0
164551|NCT00486642|403816|P1|NOT COMPLETED|Overall Study||0
164552|NCT00486642|403815|P2|COMPLETED|Overall Study||13
164553|NCT00486642|403816|P1|COMPLETED|Overall Study||10
164554|NCT00486642|403815|P2|STARTED|Overall Study||13
164555|NCT00486642|403816|P1|STARTED|Overall Study||10
164556|NCT00486720|403840|P2|NOT COMPLETED|Overall Study||12
164557|NCT00486720|403841|P1|NOT COMPLETED|Overall Study||10
164558|NCT00486720|403840|P2|COMPLETED|Overall Study||0
164559|NCT00486720|403841|P1|COMPLETED|Overall Study||0
164560|NCT00486720|403840|P2|STARTED|Overall Study||12
164561|NCT00486720|403841|P1|STARTED|Overall Study|1 randomized patient was discontinued before receiving treatment due to a protocol violation|10
164562|NCT00486759|403851|P2|NOT COMPLETED|Safety Follow-up||118
164563|NCT00486759|403852|P1|NOT COMPLETED|Safety Follow-up||139
164564|NCT00486759|403851|P2|COMPLETED|Safety Follow-up||142
164565|NCT00486759|403852|P1|COMPLETED|Safety Follow-up||64
164566|NCT00486759|403851|P2|STARTED|Safety Follow-up||260
164567|NCT00486759|403852|P1|STARTED|Safety Follow-up||203
164568|NCT00486759|403851|P2|NOT COMPLETED|Treatment||137
164569|NCT00486759|403852|P1|NOT COMPLETED|Treatment||187
164570|NCT00486759|403851|P2|COMPLETED|Treatment||260
164571|NCT00486759|403852|P1|COMPLETED|Treatment||203
164572|NCT00486759|403851|P2|STARTED|Treatment||397
164573|NCT00486759|403852|P1|STARTED|Treatment||390
164574|NCT00486811|403865|P3|NOT COMPLETED|Overall Study||214
164575|NCT00486811|403866|P2|NOT COMPLETED|Overall Study||141
164576|NCT00486811|403867|P1|NOT COMPLETED|Overall Study||122
164577|NCT00486811|403865|P3|COMPLETED|Overall Study||119
164578|NCT00486811|403866|P2|COMPLETED|Overall Study||179
164579|NCT00486811|403867|P1|COMPLETED|Overall Study||215
164580|NCT00486811|403865|P3|STARTED|Overall Study|Two participants were not eligible to be dosed.|333
164581|NCT00486811|403866|P2|STARTED|Overall Study|One participant was not eligible to be dosed.|320
164582|NCT00486811|403867|P1|STARTED|Overall Study||337
164583|NCT00486837|403910|P2|NOT COMPLETED|Overall Study||7
164584|NCT00486837|403911|P1|NOT COMPLETED|Overall Study||9
164585|NCT00486837|403910|P2|COMPLETED|Overall Study||28
164586|NCT00486837|403911|P1|COMPLETED|Overall Study||28
164587|NCT00486837|403910|P2|STARTED|Overall Study||35
164588|NCT00486837|403911|P1|STARTED|Overall Study||37
164589|NCT00486863|403929|P2|NOT COMPLETED|Overall Study||3
164590|NCT00486863|403930|P1|NOT COMPLETED|Overall Study||1
164591|NCT00486863|403929|P2|COMPLETED|Overall Study||183
164592|NCT00486863|403930|P1|COMPLETED|Overall Study||183
164593|NCT00486863|403929|P2|STARTED|Overall Study||186
164594|NCT00486863|403930|P1|STARTED|Overall Study||184
164595|NCT00486902|403974|P2|NOT COMPLETED|Overall Study||5
164596|NCT00486902|403975|P1|NOT COMPLETED|Overall Study||9
164597|NCT00486902|403974|P2|COMPLETED|Overall Study||89
164598|NCT00486902|403975|P1|COMPLETED|Overall Study||85
164599|NCT00486902|403974|P2|STARTED|Overall Study||94
164600|NCT00486902|403975|P1|STARTED|Overall Study||94
164601|NCT00486954|403999|P5|NOT COMPLETED|Randomized Part||14
164602|NCT00486954|404000|P4|NOT COMPLETED|Randomized Part||20
164603|NCT00486954|404001|P3|NOT COMPLETED|Randomized Part||0
164604|NCT00486954|404002|P2|NOT COMPLETED|Randomized Part||0
164605|NCT00486954|404003|P1|NOT COMPLETED|Randomized Part||0
164606|NCT00486954|403999|P5|COMPLETED|Randomized Part||115
164607|NCT00486954|404000|P4|COMPLETED|Randomized Part||112
164608|NCT00486954|404001|P3|COMPLETED|Randomized Part||0
164609|NCT00486954|404002|P2|COMPLETED|Randomized Part||0
164610|NCT00486954|404003|P1|COMPLETED|Randomized Part||0
164611|NCT00486954|403999|P5|STARTED|Randomized Part||129
164612|NCT00486954|404000|P4|STARTED|Randomized Part||132
164613|NCT00486954|404001|P3|STARTED|Randomized Part||0
164614|NCT00486954|404002|P2|STARTED|Randomized Part||0
164615|NCT00486954|404003|P1|STARTED|Randomized Part||0
164616|NCT00486954|403999|P5|NOT COMPLETED|Pilot Part||0
164617|NCT00486954|404000|P4|NOT COMPLETED|Pilot Part||0
164618|NCT00486954|404001|P3|NOT COMPLETED|Pilot Part||6
164619|NCT00486954|404002|P2|NOT COMPLETED|Pilot Part||0
164620|NCT00486954|404003|P1|NOT COMPLETED|Pilot Part||6
164621|NCT00486954|403999|P5|COMPLETED|Pilot Part||0
164622|NCT00486954|404000|P4|COMPLETED|Pilot Part||0
164623|NCT00486954|404001|P3|COMPLETED|Pilot Part||0
164624|NCT00486954|404002|P2|COMPLETED|Pilot Part||0
164625|NCT00486954|404003|P1|COMPLETED|Pilot Part||0
164626|NCT00486954|403999|P5|STARTED|Pilot Part||0
164627|NCT00486954|404000|P4|STARTED|Pilot Part||0
164628|NCT00486954|404001|P3|STARTED|Pilot Part||6
164629|NCT00486954|404002|P2|STARTED|Pilot Part||0
164630|NCT00486954|404003|P1|STARTED|Pilot Part||6
164631|NCT00493181|404099|P1|NOT COMPLETED|Overall Study||0
164632|NCT00493181|404099|P1|COMPLETED|Overall Study||8
164633|NCT00493181|404099|P1|STARTED|Overall Study||8
164634|NCT00493220|404109|P6|NOT COMPLETED|Final 7-Day Safety Follow-up||0
164635|NCT00493220|404110|P5|NOT COMPLETED|Final 7-Day Safety Follow-up||0
164636|NCT00493220|404111|P4|NOT COMPLETED|Final 7-Day Safety Follow-up||0
164637|NCT00493220|404112|P3|NOT COMPLETED|Final 7-Day Safety Follow-up||0
164638|NCT00493220|404113|P2|NOT COMPLETED|Final 7-Day Safety Follow-up||0
164639|NCT00493220|404114|P1|NOT COMPLETED|Final 7-Day Safety Follow-up||0
164640|NCT00493220|404109|P6|COMPLETED|Final 7-Day Safety Follow-up||5
164641|NCT00493220|404110|P5|COMPLETED|Final 7-Day Safety Follow-up||5
164642|NCT00493220|404111|P4|COMPLETED|Final 7-Day Safety Follow-up||5
164643|NCT00493220|404112|P3|COMPLETED|Final 7-Day Safety Follow-up||5
164644|NCT00493220|404113|P2|COMPLETED|Final 7-Day Safety Follow-up||5
164645|NCT00493220|404114|P1|COMPLETED|Final 7-Day Safety Follow-up||4
164646|NCT00493220|404109|P6|STARTED|Final 7-Day Safety Follow-up||5
164647|NCT00493220|404110|P5|STARTED|Final 7-Day Safety Follow-up||5
164648|NCT00493220|404111|P4|STARTED|Final 7-Day Safety Follow-up||5
164649|NCT00493220|404112|P3|STARTED|Final 7-Day Safety Follow-up||5
164650|NCT00493220|404113|P2|STARTED|Final 7-Day Safety Follow-up||5
164651|NCT00493220|404114|P1|STARTED|Final 7-Day Safety Follow-up||4
164652|NCT00493220|404109|P6|NOT COMPLETED|Third Intervention||0
164653|NCT00493220|404110|P5|NOT COMPLETED|Third Intervention||0
164654|NCT00493220|404111|P4|NOT COMPLETED|Third Intervention||0
164655|NCT00493220|404112|P3|NOT COMPLETED|Third Intervention||0
164656|NCT00493220|404113|P2|NOT COMPLETED|Third Intervention||0
164657|NCT00493220|404114|P1|NOT COMPLETED|Third Intervention||1
164658|NCT00493220|404109|P6|COMPLETED|Third Intervention||5
164659|NCT00493220|404110|P5|COMPLETED|Third Intervention||5
164660|NCT00493220|404111|P4|COMPLETED|Third Intervention||5
164661|NCT00493220|404112|P3|COMPLETED|Third Intervention||5
164662|NCT00493220|404113|P2|COMPLETED|Third Intervention||5
164663|NCT00493220|404114|P1|COMPLETED|Third Intervention||4
164664|NCT00493220|404109|P6|STARTED|Third Intervention||5
164665|NCT00493220|404110|P5|STARTED|Third Intervention||5
164666|NCT00493220|404111|P4|STARTED|Third Intervention||5
164667|NCT00493220|404112|P3|STARTED|Third Intervention||5
164668|NCT00493220|404113|P2|STARTED|Third Intervention||5
164669|NCT00493220|404114|P1|STARTED|Third Intervention||5
164670|NCT00493220|404109|P6|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
164671|NCT00493220|404110|P5|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
164672|NCT00493220|404111|P4|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
164673|NCT00493220|404112|P3|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
164674|NCT00493220|404113|P2|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
164675|NCT00493220|404114|P1|NOT COMPLETED|Second 7-Day Washout & Safety Follow-up||0
164676|NCT00493220|404109|P6|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
164677|NCT00493220|404110|P5|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
164678|NCT00493220|404111|P4|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
164679|NCT00493220|404112|P3|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
164680|NCT00493220|404113|P2|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
164681|NCT00493220|404114|P1|COMPLETED|Second 7-Day Washout & Safety Follow-up||5
164682|NCT00493220|404109|P6|STARTED|Second 7-Day Washout & Safety Follow-up||5
164683|NCT00493220|404110|P5|STARTED|Second 7-Day Washout & Safety Follow-up||5
164684|NCT00493220|404111|P4|STARTED|Second 7-Day Washout & Safety Follow-up||5
164685|NCT00493220|404112|P3|STARTED|Second 7-Day Washout & Safety Follow-up||5
164686|NCT00493220|404113|P2|STARTED|Second 7-Day Washout & Safety Follow-up||5
164687|NCT00493220|404114|P1|STARTED|Second 7-Day Washout & Safety Follow-up||5
164688|NCT00493220|404109|P6|NOT COMPLETED|Second Intervention||0
164689|NCT00493220|404110|P5|NOT COMPLETED|Second Intervention||0
164690|NCT00493220|404111|P4|NOT COMPLETED|Second Intervention||0
164691|NCT00493220|404112|P3|NOT COMPLETED|Second Intervention||0
164692|NCT00493220|404113|P2|NOT COMPLETED|Second Intervention||0
164693|NCT00493220|404114|P1|NOT COMPLETED|Second Intervention||0
164694|NCT00493220|404109|P6|COMPLETED|Second Intervention||5
164695|NCT00493220|404110|P5|COMPLETED|Second Intervention||5
164696|NCT00493220|404111|P4|COMPLETED|Second Intervention||5
164697|NCT00493220|404112|P3|COMPLETED|Second Intervention||5
164698|NCT00493220|404113|P2|COMPLETED|Second Intervention||5
164699|NCT00493220|404114|P1|COMPLETED|Second Intervention||5
164700|NCT00493220|404109|P6|STARTED|Second Intervention||5
164701|NCT00493220|404110|P5|STARTED|Second Intervention||5
164702|NCT00493220|404111|P4|STARTED|Second Intervention||5
164703|NCT00493220|404112|P3|STARTED|Second Intervention||5
164704|NCT00493220|404113|P2|STARTED|Second Intervention||5
164705|NCT00493220|404114|P1|STARTED|Second Intervention||5
164706|NCT00493220|404109|P6|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
164707|NCT00493220|404110|P5|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
164708|NCT00493220|404111|P4|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
164709|NCT00493220|404112|P3|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
164710|NCT00493220|404113|P2|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
164711|NCT00493220|404114|P1|NOT COMPLETED|First 7-Day Washout & Safety Follow-up||0
164712|NCT00493220|404109|P6|COMPLETED|First 7-Day Washout & Safety Follow-up||5
164713|NCT00493220|404110|P5|COMPLETED|First 7-Day Washout & Safety Follow-up||5
164714|NCT00493220|404111|P4|COMPLETED|First 7-Day Washout & Safety Follow-up||5
164715|NCT00493220|404112|P3|COMPLETED|First 7-Day Washout & Safety Follow-up||5
164716|NCT00493220|404113|P2|COMPLETED|First 7-Day Washout & Safety Follow-up||5
164717|NCT00493220|404114|P1|COMPLETED|First 7-Day Washout & Safety Follow-up||5
164718|NCT00493220|404109|P6|STARTED|First 7-Day Washout & Safety Follow-up||5
164719|NCT00493220|404110|P5|STARTED|First 7-Day Washout & Safety Follow-up||5
164720|NCT00493220|404111|P4|STARTED|First 7-Day Washout & Safety Follow-up||5
164721|NCT00493220|404112|P3|STARTED|First 7-Day Washout & Safety Follow-up||5
164722|NCT00493220|404113|P2|STARTED|First 7-Day Washout & Safety Follow-up||5
164723|NCT00493220|404114|P1|STARTED|First 7-Day Washout & Safety Follow-up||5
164724|NCT00493220|404109|P6|NOT COMPLETED|First Intervention||0
164725|NCT00493220|404110|P5|NOT COMPLETED|First Intervention||0
164726|NCT00493220|404111|P4|NOT COMPLETED|First Intervention||0
164727|NCT00493220|404112|P3|NOT COMPLETED|First Intervention||0
164728|NCT00493220|404113|P2|NOT COMPLETED|First Intervention||0
164729|NCT00493220|404114|P1|NOT COMPLETED|First Intervention||0
164730|NCT00493220|404109|P6|COMPLETED|First Intervention||5
164731|NCT00493220|404110|P5|COMPLETED|First Intervention||5
164732|NCT00493220|404111|P4|COMPLETED|First Intervention||5
164733|NCT00493220|404112|P3|COMPLETED|First Intervention||5
164734|NCT00493220|404113|P2|COMPLETED|First Intervention||5
164735|NCT00493220|404114|P1|COMPLETED|First Intervention||5
164736|NCT00493220|404109|P6|STARTED|First Intervention||5
164737|NCT00493220|404110|P5|STARTED|First Intervention||5
164738|NCT00493220|404111|P4|STARTED|First Intervention||5
164739|NCT00493220|404112|P3|STARTED|First Intervention||5
164740|NCT00493220|404113|P2|STARTED|First Intervention||5
164741|NCT00493220|404114|P1|STARTED|First Intervention||5
164742|NCT00493246|404139|P8|NOT COMPLETED|Overall Study||0
164743|NCT00493246|404140|P7|NOT COMPLETED|Overall Study||1
164744|NCT00493246|404141|P6|NOT COMPLETED|Overall Study||1
164745|NCT00493246|404142|P5|NOT COMPLETED|Overall Study||1
164746|NCT00493246|404143|P4|NOT COMPLETED|Overall Study||0
164747|NCT00493246|404144|P3|NOT COMPLETED|Overall Study||0
164748|NCT00493246|404145|P2|NOT COMPLETED|Overall Study||0
164749|NCT00493246|404146|P1|NOT COMPLETED|Overall Study||0
164750|NCT00493246|404139|P8|COMPLETED|Overall Study|Completed study 30 days after the last dose|10
164751|NCT00493246|404140|P7|COMPLETED|Overall Study|Completed study 30 days after the last dose|11
164752|NCT00493246|404141|P6|COMPLETED|Overall Study|Completed study 30 days after the last dose|15
164753|NCT00493246|404142|P5|COMPLETED|Overall Study|Completed study 30 days after the last dose|8
164754|NCT00493246|404143|P4|COMPLETED|Overall Study|Completed study 30 days after the last dose|13
164755|NCT00493246|404144|P3|COMPLETED|Overall Study|Completed study 30 days after the last dose|12
164756|NCT00493246|404145|P2|COMPLETED|Overall Study|Completed study 30 days after the last dose|1
164757|NCT00493246|404146|P1|COMPLETED|Overall Study|Completed study 30 days after the last dose|2
164758|NCT00493246|404139|P8|STARTED|Overall Study|All subjects who were randomized.|10
164759|NCT00493246|404140|P7|STARTED|Overall Study|All subjects who were randomized.|12
164760|NCT00493246|404141|P6|STARTED|Overall Study|All subjects who were randomized.|16
164761|NCT00493246|404142|P5|STARTED|Overall Study|All subjects who were randomized.Excludes 1 subject who was randomized in error.|9
164762|NCT00493246|404143|P4|STARTED|Overall Study||13
164763|NCT00493246|404144|P3|STARTED|Overall Study||12
164764|NCT00493246|404145|P2|STARTED|Overall Study||1
164765|NCT00493246|404146|P1|STARTED|Overall Study||2
164766|NCT00493285|404210|P6|NOT COMPLETED|Overall Study||0
164767|NCT00493285|404211|P5|NOT COMPLETED|Overall Study||1
164768|NCT00493285|404212|P4|NOT COMPLETED|Overall Study||0
164769|NCT00493285|404213|P3|NOT COMPLETED|Overall Study||0
164770|NCT00493285|404214|P2|NOT COMPLETED|Overall Study||0
164771|NCT00493285|404215|P1|NOT COMPLETED|Overall Study||0
164772|NCT00493285|404210|P6|COMPLETED|Overall Study||5
164773|NCT00493285|404211|P5|COMPLETED|Overall Study||9
164774|NCT00493285|404212|P4|COMPLETED|Overall Study||6
164775|NCT00493285|404213|P3|COMPLETED|Overall Study||9
164776|NCT00493285|404214|P2|COMPLETED|Overall Study||6
164777|NCT00493285|404215|P1|COMPLETED|Overall Study||13
164778|NCT00493285|404210|P6|STARTED|Overall Study||5
164779|NCT00493285|404211|P5|STARTED|Overall Study||10
164780|NCT00493285|404212|P4|STARTED|Overall Study||6
164781|NCT00493285|404213|P3|STARTED|Overall Study||9
164782|NCT00493285|404214|P2|STARTED|Overall Study||6
164783|NCT00493285|404215|P1|STARTED|Overall Study||13
164784|NCT00493311|404441|P2|NOT COMPLETED|Overall Study||2
164785|NCT00493311|404442|P1|NOT COMPLETED|Overall Study||2
164786|NCT00493311|404441|P2|COMPLETED|Overall Study||29
164787|NCT00493311|404442|P1|COMPLETED|Overall Study||27
164788|NCT00493311|404441|P2|STARTED|Overall Study||31
164789|NCT00493311|404442|P1|STARTED|Overall Study||29
164790|NCT00494585|404456|P1|NOT COMPLETED|Overall Study||0
164791|NCT00494585|404456|P1|COMPLETED|Overall Study||22
164792|NCT00494585|404456|P1|STARTED|Overall Study||22
164793|NCT00494676|404460|P2|NOT COMPLETED|Second Intervention||1
164794|NCT00494676|404461|P1|NOT COMPLETED|Second Intervention||1
164795|NCT00494676|404460|P2|COMPLETED|Second Intervention||28
164796|NCT00494676|404461|P1|COMPLETED|Second Intervention||33
164797|NCT00494676|404460|P2|STARTED|Second Intervention||29
164798|NCT00494676|404461|P1|STARTED|Second Intervention||34
164799|NCT00494676|404460|P2|NOT COMPLETED|First Intervention||3
164800|NCT00494676|404461|P1|NOT COMPLETED|First Intervention||1
164801|NCT00494676|404460|P2|COMPLETED|First Intervention||29
164802|NCT00494676|404461|P1|COMPLETED|First Intervention||34
164803|NCT00494676|404460|P2|STARTED|First Intervention||32
164804|NCT00494676|404461|P1|STARTED|First Intervention||35
164805|NCT00494676|404460|P2|NOT COMPLETED|Allocation||4
164806|NCT00494676|404461|P1|NOT COMPLETED|Allocation||2
164807|NCT00494676|404460|P2|COMPLETED|Allocation||32
164808|NCT00494676|404461|P1|COMPLETED|Allocation||35
164809|NCT00494676|404460|P2|STARTED|Allocation||36
164810|NCT00494676|404461|P1|STARTED|Allocation||37
164811|NCT00494780|404470|P2|NOT COMPLETED|Overall Study||13
164812|NCT00494780|404471|P1|NOT COMPLETED|Overall Study||11
164813|NCT00494780|404470|P2|COMPLETED|Overall Study||17
164814|NCT00494780|404471|P1|COMPLETED|Overall Study||18
164815|NCT00494780|404470|P2|STARTED|Overall Study||30
164816|NCT00494780|404471|P1|STARTED|Overall Study||29
164817|NCT00494806|404511|P2|NOT COMPLETED|Overall Study||0
164818|NCT00494806|404512|P1|NOT COMPLETED|Overall Study||0
164819|NCT00494806|404511|P2|COMPLETED|Overall Study||32
164820|NCT00494806|404512|P1|COMPLETED|Overall Study||34
164821|NCT00494806|404511|P2|STARTED|Overall Study||32
164822|NCT00494806|404512|P1|STARTED|Overall Study||34
164823|NCT00494871|404520|P2|NOT COMPLETED|Follow-up (FU) Period||23
164824|NCT00494871|404521|P1|NOT COMPLETED|Follow-up (FU) Period||29
164825|NCT00494871|404520|P2|COMPLETED|Follow-up (FU) Period||616
164826|NCT00494871|404521|P1|COMPLETED|Follow-up (FU) Period||610
164827|NCT00494871|404520|P2|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|630
164828|NCT00494871|404521|P1|Entered FU and Valid for Safety|Follow-up (FU) Period|Safety population|628
164829|NCT00494871|404520|P2|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
164830|NCT00494871|404521|P1|STARTED|Follow-up (FU) Period|All treated participants were to enter FU period, whether or not they completed the DB period|639
164831|NCT00494871|404520|P2|NOT COMPLETED|Double-blind (DB) Treatment Period||172
164832|NCT00494871|404521|P1|NOT COMPLETED|Double-blind (DB) Treatment Period||160
164833|NCT00494871|404520|P2|COMPLETED|Double-blind (DB) Treatment Period||468
164834|NCT00494871|404521|P1|COMPLETED|Double-blind (DB) Treatment Period||480
164835|NCT00494871|404520|P2|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
164836|NCT00494871|404521|P1|Started Treatment|Double-blind (DB) Treatment Period|Safety population|639
164837|NCT00494871|404520|P2|STARTED|Double-blind (DB) Treatment Period||640
164838|NCT00494871|404521|P1|STARTED|Double-blind (DB) Treatment Period||640
164839|NCT00494975|404553|P2|NOT COMPLETED|Overall Study||1
164840|NCT00494975|404554|P1|NOT COMPLETED|Overall Study||2
164841|NCT00494975|404553|P2|COMPLETED|Overall Study||10
164842|NCT00494975|404554|P1|COMPLETED|Overall Study||8
164843|NCT00494975|404553|P2|STARTED|Overall Study||11
164844|NCT00494975|404554|P1|STARTED|Overall Study||10
164845|NCT00495079|404560|P1|NOT COMPLETED|Overall Study||0
164846|NCT00495079|404560|P1|COMPLETED|Overall Study||65
164847|NCT00495079|404560|P1|STARTED|Overall Study||65
164848|NCT00495131|404569|P2|NOT COMPLETED|Overall Study||6
164849|NCT00495131|404570|P1|NOT COMPLETED|Overall Study||7
164850|NCT00495131|404569|P2|COMPLETED|Overall Study||148
164851|NCT00495131|404570|P1|COMPLETED|Overall Study||147
164852|NCT00495131|404569|P2|STARTED|Overall Study||154
164853|NCT00495131|404570|P1|STARTED|Overall Study||154
164854|NCT00495157|404583|P3|NOT COMPLETED|Overall Study||13
164855|NCT00495157|404584|P2|NOT COMPLETED|Overall Study||23
164856|NCT00495157|404585|P1|NOT COMPLETED|Overall Study||16
164857|NCT00495157|404583|P3|COMPLETED|Overall Study||101
164858|NCT00495157|404584|P2|COMPLETED|Overall Study||92
164859|NCT00495157|404585|P1|COMPLETED|Overall Study||97
164860|NCT00495157|404583|P3|STARTED|Overall Study||114
164861|NCT00495157|404584|P2|STARTED|Overall Study||115
164862|NCT00495157|404585|P1|STARTED|Overall Study||113
164863|NCT00495222|404593|P1|NOT COMPLETED|Overall Study||0
164864|NCT00495222|404593|P1|COMPLETED|Overall Study||9
164865|NCT00495222|404593|P1|STARTED|Overall Study||9
164866|NCT00495391|404598|P2|NOT COMPLETED|Overall Study||21
164867|NCT00495391|404599|P1|NOT COMPLETED|Overall Study||36
164868|NCT00495391|404598|P2|COMPLETED|Overall Study||1
164869|NCT00495391|404599|P1|COMPLETED|Overall Study||6
164870|NCT00495391|404598|P2|From Baseline to End of Follow up|Overall Study||1
164871|NCT00495391|404599|P1|From Baseline to End of Follow up|Overall Study||6
164872|NCT00495391|404598|P2|From Baseline to End of Treatment|Overall Study||1
164873|NCT00495391|404599|P1|From Baseline to End of Treatment|Overall Study||6
164874|NCT00495391|404598|P2|From Baseline to Week 16|Overall Study||11
164875|NCT00495391|404599|P1|From Baseline to Week 16|Overall Study||24
164876|NCT00495391|404598|P2|From Baseline to Week 8|Overall Study||20
164877|NCT00495391|404599|P1|From Baseline to Week 8|Overall Study||31
164878|NCT00495391|404598|P2|STARTED|Overall Study||22
164879|NCT00495391|404599|P1|STARTED|Overall Study||42
164880|NCT00495495|404619|P1|NOT COMPLETED|Overall Study||99
164881|NCT00495495|404619|P1|COMPLETED|Overall Study||295
164882|NCT00495495|404619|P1|STARTED|Overall Study||394
164883|NCT00495586|404634|P2|NOT COMPLETED|Overall Study||4
164884|NCT00495586|404635|P1|NOT COMPLETED|Overall Study||4
164885|NCT00495586|404634|P2|COMPLETED|Overall Study||158
164886|NCT00495586|404635|P1|COMPLETED|Overall Study||152
164887|NCT00495586|404634|P2|STARTED|Overall Study||162
164888|NCT00495586|404635|P1|STARTED|Overall Study||156
164889|NCT00495612|404645|P2|NOT COMPLETED|Overall Study||0
164890|NCT00495612|404646|P1|NOT COMPLETED|Overall Study||4
164891|NCT00495612|404645|P2|COMPLETED|Overall Study||33
164892|NCT00495612|404646|P1|COMPLETED|Overall Study||32
164893|NCT00495612|404645|P2|STARTED|Overall Study||33
164894|NCT00495612|404646|P1|STARTED|Overall Study||36
164895|NCT00495625|404662|P1|NOT COMPLETED|Overall Study||10
164896|NCT00495625|404662|P1|COMPLETED|Overall Study||23
164897|NCT00495625|404662|P1|STARTED|Overall Study||33
164898|NCT00495677|404678|P7|NOT COMPLETED|Stage 2 (25 Days)||0
164899|NCT00495677|404679|P6|NOT COMPLETED|Stage 2 (25 Days)||0
164900|NCT00495677|404680|P5|NOT COMPLETED|Stage 2 (25 Days)||0
164901|NCT00495677|404681|P4|NOT COMPLETED|Stage 2 (25 Days)||0
164902|NCT00495677|404682|P3|NOT COMPLETED|Stage 2 (25 Days)||0
164903|NCT00495677|404683|P2|NOT COMPLETED|Stage 2 (25 Days)||0
164904|NCT00495677|404684|P1|NOT COMPLETED|Stage 2 (25 Days)||0
164905|NCT00495677|404678|P7|COMPLETED|Stage 2 (25 Days)||7
164906|NCT00495677|404679|P6|COMPLETED|Stage 2 (25 Days)||8
164907|NCT00495677|404680|P5|COMPLETED|Stage 2 (25 Days)||8
164908|NCT00495677|404681|P4|COMPLETED|Stage 2 (25 Days)||0
164909|NCT00495677|404682|P3|COMPLETED|Stage 2 (25 Days)||0
164910|NCT00495677|404683|P2|COMPLETED|Stage 2 (25 Days)||0
164911|NCT00495677|404684|P1|COMPLETED|Stage 2 (25 Days)||0
164912|NCT00495677|404678|P7|STARTED|Stage 2 (25 Days)||7
164913|NCT00495677|404679|P6|STARTED|Stage 2 (25 Days)||8
164914|NCT00495677|404680|P5|STARTED|Stage 2 (25 Days)||8
164915|NCT00495677|404681|P4|STARTED|Stage 2 (25 Days)||0
164916|NCT00495677|404682|P3|STARTED|Stage 2 (25 Days)||0
164917|NCT00495677|404683|P2|STARTED|Stage 2 (25 Days)||0
164918|NCT00495677|404684|P1|STARTED|Stage 2 (25 Days)||0
164919|NCT00495677|404678|P7|NOT COMPLETED|Stage 1 (25 Days)||0
164920|NCT00495677|404679|P6|NOT COMPLETED|Stage 1 (25 Days)||0
164921|NCT00495677|404680|P5|NOT COMPLETED|Stage 1 (25 Days)||0
164922|NCT00495677|404681|P4|NOT COMPLETED|Stage 1 (25 Days)||0
164923|NCT00495677|404682|P3|NOT COMPLETED|Stage 1 (25 Days)||1
164924|NCT00495677|404683|P2|NOT COMPLETED|Stage 1 (25 Days)||0
164925|NCT00495677|404684|P1|NOT COMPLETED|Stage 1 (25 Days)||0
164926|NCT00495677|404678|P7|COMPLETED|Stage 1 (25 Days)||0
164927|NCT00495677|404679|P6|COMPLETED|Stage 1 (25 Days)||0
164928|NCT00495677|404680|P5|COMPLETED|Stage 1 (25 Days)||0
164929|NCT00495677|404681|P4|COMPLETED|Stage 1 (25 Days)||6
164930|NCT00495677|404682|P3|COMPLETED|Stage 1 (25 Days)||5
164931|NCT00495677|404683|P2|COMPLETED|Stage 1 (25 Days)||6
164932|NCT00495677|404684|P1|COMPLETED|Stage 1 (25 Days)||2
164933|NCT00495677|404678|P7|STARTED|Stage 1 (25 Days)||0
164934|NCT00495677|404679|P6|STARTED|Stage 1 (25 Days)||0
164935|NCT00495677|404680|P5|STARTED|Stage 1 (25 Days)||0
164936|NCT00495677|404681|P4|STARTED|Stage 1 (25 Days)||6
164937|NCT00495677|404682|P3|STARTED|Stage 1 (25 Days)||6
164938|NCT00495677|404683|P2|STARTED|Stage 1 (25 Days)||6
164939|NCT00495677|404684|P1|STARTED|Stage 1 (25 Days)||2
164940|NCT00495755|404739|P1|NOT COMPLETED|Overall Study||3
164941|NCT00495755|404739|P1|COMPLETED|Overall Study||10
164942|NCT00495755|404739|P1|STARTED|Overall Study||13
164943|NCT00495794|404746|P2|NOT COMPLETED|Overall Study||0
164944|NCT00495794|404747|P1|NOT COMPLETED|Overall Study||522
164945|NCT00495794|404746|P2|COMPLETED|Overall Study||2303
164946|NCT00495794|404747|P1|COMPLETED|Overall Study||1797
164947|NCT00495794|404746|P2|STARTED|Overall Study||2303
164948|NCT00495794|404747|P1|STARTED|Overall Study||2319
164949|NCT00495820|404759|P2|NOT COMPLETED|Overall Study||1
164950|NCT00495820|404760|P1|NOT COMPLETED|Overall Study||1
164951|NCT00495820|404759|P2|COMPLETED|Overall Study||29
164952|NCT00495820|404760|P1|COMPLETED|Overall Study||29
164953|NCT00495820|404759|P2|STARTED|Overall Study||30
164954|NCT00495820|404760|P1|STARTED|Overall Study||30
164955|NCT00496054|404770|P1|NOT COMPLETED|Overall Study||8
164956|NCT00496054|404770|P1|COMPLETED|Overall Study||102
164957|NCT00496054|404770|P1|STARTED|Overall Study||110
164958|NCT00496080|404797|P1|NOT COMPLETED|Overall Study||27
164959|NCT00496080|404797|P1|COMPLETED|Overall Study||60
164960|NCT00496080|404797|P1|STARTED|Overall Study||87
164961|NCT00496197|404807|P1|NOT COMPLETED|Overall Study||122
164962|NCT00496197|404807|P1|COMPLETED|Overall Study||160
164963|NCT00496197|404807|P1|STARTED|Overall Study||282
164964|NCT00496262|404834|P1|NOT COMPLETED|Overall Study||0
164965|NCT00496262|404834|P1|COMPLETED|Overall Study||15
164966|NCT00496262|404834|P1|STARTED|Overall Study||15
164967|NCT00496340|404847|P1|NOT COMPLETED|Overall Study||0
164968|NCT00496340|404847|P1|COMPLETED|Overall Study||42
164969|NCT00496340|404847|P1|STARTED|Overall Study||42
164970|NCT00496366|404860|P1|NOT COMPLETED|Overall Study||1
164971|NCT00496366|404860|P1|COMPLETED|Overall Study||10
164972|NCT00496366|404860|P1|STARTED|Overall Study||11
164973|NCT00496379|404865|P1|NOT COMPLETED|Overall Study||0
164974|NCT00496379|404865|P1|COMPLETED|Overall Study||15
164975|NCT00496379|404865|P1|STARTED|Overall Study||15
164976|NCT00496470|404875|P2|NOT COMPLETED|Overall Study||29
164977|NCT00496470|404876|P1|NOT COMPLETED|Overall Study||26
164978|NCT00496470|404875|P2|COMPLETED|Overall Study||302
164979|NCT00496470|404876|P1|COMPLETED|Overall Study||303
164980|NCT00496470|404875|P2|Received Study Medication|Overall Study||330
164981|NCT00496470|404876|P1|Received Study Medication|Overall Study||329
164982|NCT00496470|404875|P2|STARTED|Overall Study||331
164983|NCT00496470|404876|P1|STARTED|Overall Study||329
164984|NCT00496483|404954|P1|NOT COMPLETED|Overall Study||12
164985|NCT00496483|404954|P1|COMPLETED|Overall Study||48
164986|NCT00496483|404954|P1|Dosed|Overall Study||51
164987|NCT00496483|404954|P1|STARTED|Overall Study||60
164988|NCT00496587|404969|P1|NOT COMPLETED|Overall Study||31
164989|NCT00496587|404969|P1|COMPLETED|Overall Study||3
164990|NCT00496587|404969|P1|STARTED|Overall Study||34
164991|NCT00496626|404977|P2|NOT COMPLETED|Overall Study||6
164992|NCT00496626|404978|P1|NOT COMPLETED|Overall Study||6
164993|NCT00496626|404977|P2|COMPLETED|Overall Study||292
164994|NCT00496626|404978|P1|COMPLETED|Overall Study||296
164995|NCT00496626|404977|P2|STARTED|Overall Study||298
164996|NCT00496626|404978|P1|STARTED|Overall Study||302
164997|NCT00496730|404992|P2|NOT COMPLETED|Overall Study||5
164998|NCT00496730|404993|P1|NOT COMPLETED|Overall Study||6
164999|NCT00496730|404992|P2|COMPLETED|Overall Study||121
165000|NCT00496730|404993|P1|COMPLETED|Overall Study||124
165001|NCT00496730|404992|P2|STARTED|Overall Study||126
165002|NCT00496730|404993|P1|STARTED|Overall Study||130
165003|NCT00496769|405005|P2|NOT COMPLETED|Overall Study||649
165004|NCT00496769|405006|P1|NOT COMPLETED|Overall Study||558
165005|NCT00496769|405005|P2|COMPLETED|Overall Study||2142
165006|NCT00496769|405006|P1|COMPLETED|Overall Study||2249
165007|NCT00496769|405005|P2|Received Treatment|Overall Study||2708
165008|NCT00496769|405006|P1|Received Treatment|Overall Study||2798
165009|NCT00496769|405005|P2|STARTED|Overall Study|Randomized|2791
165010|NCT00496769|405006|P1|STARTED|Overall Study|Randomized|2807
165011|NCT00496782|405030|P2|NOT COMPLETED|Overall Study||2
165012|NCT00496782|405031|P1|NOT COMPLETED|Overall Study||1
165013|NCT00496782|405030|P2|COMPLETED|Overall Study||5
165014|NCT00496782|405031|P1|COMPLETED|Overall Study||8
165015|NCT00496782|405030|P2|STARTED|Overall Study||7
165016|NCT00496782|405031|P1|STARTED|Overall Study||9
165017|NCT00496808|405063|P1|NOT COMPLETED|Overall Study||0
165018|NCT00496808|405063|P1|COMPLETED|Overall Study||69
165019|NCT00496808|405063|P1|STARTED|Overall Study||69
165020|NCT00496834|405070|P2|NOT COMPLETED|Overall Study||13
165021|NCT00496834|405071|P1|NOT COMPLETED|Overall Study||18
165022|NCT00496834|405070|P2|COMPLETED|Overall Study||87
165023|NCT00496834|405071|P1|COMPLETED|Overall Study||83
165024|NCT00496834|405070|P2|STARTED|Overall Study||100
165025|NCT00496834|405071|P1|STARTED|Overall Study||101
165026|NCT00496860|405086|P3|NOT COMPLETED|Overall Study||0
165027|NCT00496860|405087|P2|NOT COMPLETED|Overall Study||1
165028|NCT00496860|405088|P1|NOT COMPLETED|Overall Study||1
165029|NCT00496860|405086|P3|COMPLETED|Overall Study||6
165030|NCT00496860|405087|P2|COMPLETED|Overall Study||15
165031|NCT00496860|405088|P1|COMPLETED|Overall Study||3
165032|NCT00496860|405086|P3|STARTED|Overall Study||6
165033|NCT00496860|405087|P2|STARTED|Overall Study||16
165034|NCT00496860|405088|P1|STARTED|Overall Study||4
165035|NCT00496873|405108|P1|NOT COMPLETED|Overall Study||7
165036|NCT00496873|405108|P1|COMPLETED|Overall Study||78
165037|NCT00496873|405108|P1|STARTED|Overall Study||85
165038|NCT00496964|405116|P2|NOT COMPLETED|Overall Study||1
165039|NCT00496964|405117|P1|NOT COMPLETED|Overall Study||0
165040|NCT00496964|405116|P2|COMPLETED|Overall Study||3
165041|NCT00496964|405117|P1|COMPLETED|Overall Study||1
165042|NCT00496964|405116|P2|STARTED|Overall Study||4
165043|NCT00496964|405117|P1|STARTED|Overall Study||1
165044|NCT00497055|405127|P2|NOT COMPLETED|Overall Study||5
165045|NCT00497055|405128|P1|NOT COMPLETED|Overall Study||10
165046|NCT00497055|405127|P2|COMPLETED|Overall Study||40
165047|NCT00497055|405128|P1|COMPLETED|Overall Study||35
165048|NCT00497055|405127|P2|STARTED|Overall Study||45
165049|NCT00497055|405128|P1|STARTED|Overall Study||45
165050|NCT00497081|405140|P2|NOT COMPLETED|Overall Study||2
165051|NCT00497081|405141|P1|NOT COMPLETED|Overall Study||2
165052|NCT00497081|405140|P2|COMPLETED|Overall Study||28
165053|NCT00497081|405141|P1|COMPLETED|Overall Study||28
165054|NCT00497081|405140|P2|STARTED|Overall Study||30
165055|NCT00497081|405141|P1|STARTED|Overall Study||30
165056|NCT00489970|405153|P2|NOT COMPLETED|Persistence Year 5||0
165057|NCT00489970|405154|P1|NOT COMPLETED|Persistence Year 5||0
165058|NCT00489970|405153|P2|COMPLETED|Persistence Year 5||401
165059|NCT00489970|405154|P1|COMPLETED|Persistence Year 5||856
165060|NCT00489970|405153|P2|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|401
165061|NCT00489970|405154|P1|STARTED|Persistence Year 5|Number of subjects who returned at Year 5|856
165062|NCT00489970|405153|P2|NOT COMPLETED|Persistence Year 3||0
165063|NCT00489970|405154|P1|NOT COMPLETED|Persistence Year 3||0
165064|NCT00489970|405153|P2|COMPLETED|Persistence Year 3||486
165065|NCT00489970|405154|P1|COMPLETED|Persistence Year 3||1019
165066|NCT00489970|405153|P2|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|486
165067|NCT00489970|405154|P1|STARTED|Persistence Year 3|Number of subjects who returned at Year 3|1019
165068|NCT00489970|405153|P2|NOT COMPLETED|Persistence Year 1||0
165069|NCT00489970|405154|P1|NOT COMPLETED|Persistence Year 1||0
165070|NCT00489970|405153|P2|COMPLETED|Persistence Year 1||523
165071|NCT00489970|405154|P1|COMPLETED|Persistence Year 1||1069
165072|NCT00489970|405153|P2|STARTED|Persistence Year 1||523
165073|NCT00489970|405154|P1|STARTED|Persistence Year 1||1069
165074|NCT00490009|405178|P1|NOT COMPLETED|Overall Study||0
165075|NCT00490009|405178|P1|COMPLETED|Overall Study||9
165076|NCT00490009|405178|P1|STARTED|Overall Study||9
165077|NCT00490022|405186|P2|NOT COMPLETED|Overall Study||3
165078|NCT00490022|405187|P1|NOT COMPLETED|Overall Study||1
165079|NCT00490022|405186|P2|COMPLETED|Overall Study||12
165080|NCT00490022|405187|P1|COMPLETED|Overall Study||15
165081|NCT00490022|405186|P2|STARTED|Overall Study||15
165082|NCT00490022|405187|P1|STARTED|Overall Study||16
165083|NCT00490035|405199|P4|NOT COMPLETED|Overall Study||6
165084|NCT00490035|405200|P3|NOT COMPLETED|Overall Study||12
165085|NCT00490035|405201|P2|NOT COMPLETED|Overall Study||6
165086|NCT00490035|405202|P1|NOT COMPLETED|Overall Study||8
165087|NCT00490035|405199|P4|COMPLETED|Overall Study||94
165088|NCT00490035|405200|P3|COMPLETED|Overall Study||88
165089|NCT00490035|405201|P2|COMPLETED|Overall Study||93
165090|NCT00490035|405202|P1|COMPLETED|Overall Study||92
165091|NCT00490035|405199|P4|STARTED|Overall Study||100
165092|NCT00490035|405200|P3|STARTED|Overall Study||100
165093|NCT00490035|405201|P2|STARTED|Overall Study||99
165094|NCT00490035|405202|P1|STARTED|Overall Study||100
165095|NCT00490061|405300|P1|NOT COMPLETED|Overall Study||1
165096|NCT00490061|405300|P1|COMPLETED|Overall Study||16
165097|NCT00490061|405300|P1|STARTED|Overall Study||17
165098|NCT00490100|405305|P1|NOT COMPLETED|Overall Study||3
165099|NCT00490100|405305|P1|COMPLETED|Overall Study||3
165100|NCT00490100|405305|P1|STARTED|Overall Study||6
165101|NCT00490139|405314|P4|NOT COMPLETED|Overall Study||307
165102|NCT00490139|405315|P3|NOT COMPLETED|Overall Study||434
165103|NCT00490139|405316|P2|NOT COMPLETED|Overall Study||275
165104|NCT00490139|405317|P1|NOT COMPLETED|Overall Study||308
165105|NCT00490139|405314|P4|COMPLETED|Overall Study||1790
165106|NCT00490139|405315|P3|COMPLETED|Overall Study||1666
165107|NCT00490139|405316|P2|COMPLETED|Overall Study||1816
165108|NCT00490139|405317|P1|COMPLETED|Overall Study||1785
165109|NCT00490139|405314|P4|STARTED|Overall Study||2097
165110|NCT00490139|405315|P3|STARTED|Overall Study||2100
165111|NCT00490139|405316|P2|STARTED|Overall Study||2091
165112|NCT00490139|405317|P1|STARTED|Overall Study||2093
165113|NCT00490256|405349|P2|NOT COMPLETED|Overall Study||0
165114|NCT00490256|405350|P1|NOT COMPLETED|Overall Study||0
165115|NCT00490256|405349|P2|COMPLETED|Overall Study||7
165116|NCT00490256|405350|P1|COMPLETED|Overall Study||7
165117|NCT00490256|405349|P2|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
165118|NCT00490256|405350|P1|Intraoperative Portion of the Study|Overall Study|Intraoperative management|7
165119|NCT00490256|405349|P2|STARTED|Overall Study||7
165120|NCT00490256|405350|P1|STARTED|Overall Study||7
165121|NCT00490269|405358|P2|NOT COMPLETED|Placebo Then Dronabinol||0
165122|NCT00490269|405359|P1|NOT COMPLETED|Placebo Then Dronabinol||0
165123|NCT00490269|405358|P2|COMPLETED|Placebo Then Dronabinol||6
165124|NCT00490269|405359|P1|COMPLETED|Placebo Then Dronabinol||6
165125|NCT00490269|405358|P2|STARTED|Placebo Then Dronabinol||6
165126|NCT00490269|405359|P1|STARTED|Placebo Then Dronabinol||6
165127|NCT00490269|405358|P2|NOT COMPLETED|Dronabinol Then Placebo||0
165128|NCT00490269|405359|P1|NOT COMPLETED|Dronabinol Then Placebo||0
165129|NCT00490269|405358|P2|COMPLETED|Dronabinol Then Placebo||6
165130|NCT00490269|405359|P1|COMPLETED|Dronabinol Then Placebo||6
165131|NCT00490269|405358|P2|STARTED|Dronabinol Then Placebo||6
165132|NCT00490269|405359|P1|STARTED|Dronabinol Then Placebo||6
165133|NCT00490477|405367|P2|NOT COMPLETED|Overall Study||0
165134|NCT00490477|405368|P1|NOT COMPLETED|Overall Study||0
165135|NCT00490477|405367|P2|COMPLETED|Overall Study||8
165136|NCT00490477|405368|P1|COMPLETED|Overall Study||8
165137|NCT00490477|405367|P2|STARTED|Overall Study||8
165138|NCT00490477|405368|P1|STARTED|Overall Study||8
165139|NCT00490490|405374|P1|NOT COMPLETED|Completed Assessment for TTP||3
165140|NCT00490490|405374|P1|COMPLETED|Completed Assessment for TTP||5
165141|NCT00490490|405374|P1|STARTED|Completed Assessment for TTP||8
165142|NCT00490490|405374|P1|NOT COMPLETED|Completed Assessment for CR||0
165143|NCT00490490|405374|P1|COMPLETED|Completed Assessment for CR||8
165144|NCT00490490|405374|P1|STARTED|Completed Assessment for CR||8
165145|NCT00490542|405382|P2|NOT COMPLETED|Overall Study||4
165146|NCT00490542|405383|P1|NOT COMPLETED|Overall Study||7
165147|NCT00490542|405382|P2|COMPLETED|Overall Study||31
165148|NCT00490542|405383|P1|COMPLETED|Overall Study||31
165149|NCT00490542|405382|P2|STARTED|Overall Study||35
165150|NCT00490542|405383|P1|STARTED|Overall Study||38
165151|NCT00490555|405393|P4|NOT COMPLETED|Overall Study||0
165152|NCT00490555|405394|P3|NOT COMPLETED|Overall Study||2
165153|NCT00490555|405395|P2|NOT COMPLETED|Overall Study||0
165154|NCT00490555|405396|P1|NOT COMPLETED|Overall Study||0
165155|NCT00490555|405393|P4|COMPLETED|Overall Study||7
165156|NCT00490555|405394|P3|COMPLETED|Overall Study||7
165157|NCT00490555|405395|P2|COMPLETED|Overall Study||8
165158|NCT00490555|405396|P1|COMPLETED|Overall Study||8
165159|NCT00490555|405393|P4|STARTED|Overall Study||7
165160|NCT00490555|405394|P3|STARTED|Overall Study||9
165161|NCT00490555|405395|P2|STARTED|Overall Study||8
165162|NCT00490555|405396|P1|STARTED|Overall Study||8
165163|NCT00497146|405424|P2|NOT COMPLETED|Long-term Follow-up Period||6
165164|NCT00497146|405425|P1|NOT COMPLETED|Long-term Follow-up Period||15
165165|NCT00497146|405424|P2|COMPLETED|Long-term Follow-up Period||66
165166|NCT00497146|405425|P1|COMPLETED|Long-term Follow-up Period||50
165167|NCT00497146|405424|P2|STARTED|Long-term Follow-up Period||72
165168|NCT00497146|405425|P1|STARTED|Long-term Follow-up Period||65
165169|NCT00497146|405424|P2|NOT COMPLETED|Treatment Period||21
165170|NCT00497146|405425|P1|NOT COMPLETED|Treatment Period||27
165171|NCT00497146|405424|P2|COMPLETED|Treatment Period||91
165172|NCT00497146|405425|P1|COMPLETED|Treatment Period||88
165173|NCT00497146|405424|P2|STARTED|Treatment Period||112
165174|NCT00497146|405425|P1|STARTED|Treatment Period||115
165175|NCT00497198|405467|P2|NOT COMPLETED|Overall Study||5
165176|NCT00497198|405468|P1|NOT COMPLETED|Overall Study||5
165177|NCT00497198|405467|P2|COMPLETED|Overall Study||86
165178|NCT00497198|405468|P1|COMPLETED|Overall Study||87
165179|NCT00497198|405467|P2|STARTED|Overall Study||91
165180|NCT00497198|405468|P1|STARTED|Overall Study||92
165181|NCT00499863|405484|P2|NOT COMPLETED|Overall Study||43
165182|NCT00499863|405485|P1|NOT COMPLETED|Overall Study||50
165183|NCT00499863|405484|P2|COMPLETED|Overall Study||29
165184|NCT00499863|405485|P1|COMPLETED|Overall Study||95
165185|NCT00499863|405484|P2|STARTED|Overall Study||72
165186|NCT00499863|405485|P1|STARTED|Overall Study||145
165187|NCT00499889|405513|P1|NOT COMPLETED|Overall Study||1
165188|NCT00499889|405513|P1|COMPLETED|Overall Study||41
165189|NCT00499889|405513|P1|STARTED|Overall Study||42
165190|NCT00499915|405521|P2|NOT COMPLETED|Overall Study||6
165191|NCT00499915|405522|P1|NOT COMPLETED|Overall Study||15
165192|NCT00499915|405521|P2|COMPLETED|Overall Study||76
165193|NCT00499915|405522|P1|COMPLETED|Overall Study||68
165194|NCT00499915|405521|P2|STARTED|Overall Study||82
165195|NCT00499915|405522|P1|STARTED|Overall Study||83
165196|NCT00500071|405528|P1|NOT COMPLETED|30-day Safety Follow-up||17
165197|NCT00500071|405528|P1|COMPLETED|30-day Safety Follow-up||278
165198|NCT00500071|405528|P1|STARTED|30-day Safety Follow-up||295
165199|NCT00500071|405528|P1|NOT COMPLETED|Dose-optimization and Maintenance Phase||22
165200|NCT00500071|405528|P1|COMPLETED|Dose-optimization and Maintenance Phase||295
165201|NCT00500071|405528|P1|STARTED|Dose-optimization and Maintenance Phase|Safety population (i.e., received at least one dose of study medication)|317
165202|NCT00500071|405528|P1|NOT COMPLETED|Screening and Washout Phase||1
165203|NCT00500071|405528|P1|COMPLETED|Screening and Washout Phase||317
165204|NCT00500071|405528|P1|STARTED|Screening and Washout Phase||318
165205|NCT00500110|405537|P1|NOT COMPLETED|Overall Study||3
165206|NCT00500110|405537|P1|COMPLETED|Overall Study||36
165207|NCT00500110|405537|P1|STARTED|Overall Study||39
165208|NCT00500149|405541|P2|NOT COMPLETED|Second Intervention (Cross-over Phase)||0
165209|NCT00500149|405542|P1|NOT COMPLETED|Second Intervention (Cross-over Phase)||2
165210|NCT00500149|405541|P2|COMPLETED|Second Intervention (Cross-over Phase)||57
165211|NCT00500149|405542|P1|COMPLETED|Second Intervention (Cross-over Phase)||54
165212|NCT00500149|405541|P2|STARTED|Second Intervention (Cross-over Phase)||57
165213|NCT00500149|405542|P1|STARTED|Second Intervention (Cross-over Phase)||56
165214|NCT00500149|405541|P2|NOT COMPLETED|First Intervention (Cross-over Phase)||2
165215|NCT00500149|405542|P1|NOT COMPLETED|First Intervention (Cross-over Phase)||2
165216|NCT00500149|405541|P2|COMPLETED|First Intervention (Cross-over Phase)||57
165217|NCT00500149|405542|P1|COMPLETED|First Intervention (Cross-over Phase)||56
165218|NCT00500149|405541|P2|STARTED|First Intervention (Cross-over Phase)||59
165219|NCT00500149|405542|P1|STARTED|First Intervention (Cross-over Phase)||58
165220|NCT00500149|405541|P2|NOT COMPLETED|Enrolled (Dose-optimization Phase)||0
165221|NCT00500149|405542|P1|NOT COMPLETED|Enrolled (Dose-optimization Phase)||12
165222|NCT00500149|405541|P2|COMPLETED|Enrolled (Dose-optimization Phase)||0
165223|NCT00500149|405542|P1|COMPLETED|Enrolled (Dose-optimization Phase)||117
165224|NCT00500149|405541|P2|STARTED|Enrolled (Dose-optimization Phase)||0
165225|NCT00500149|405542|P1|STARTED|Enrolled (Dose-optimization Phase)||129
165226|NCT00500240|405552|P2|NOT COMPLETED|Overall Study||0
165227|NCT00500240|405553|P1|NOT COMPLETED|Overall Study||0
165228|NCT00500240|405552|P2|COMPLETED|Overall Study||26
165229|NCT00500240|405553|P1|COMPLETED|Overall Study||25
165230|NCT00500240|405552|P2|STARTED|Overall Study||26
165231|NCT00500240|405553|P1|STARTED|Overall Study||25
165232|NCT00500266|405563|P1|NOT COMPLETED|Overall Study||13
165233|NCT00500266|405563|P1|COMPLETED|Overall Study||1040
165234|NCT00500266|405563|P1|Treated|Overall Study||1049
165235|NCT00500266|405563|P1|STARTED|Overall Study||1053
165236|NCT00500292|405573|P3|NOT COMPLETED|Overall Study||27
165237|NCT00500292|405574|P2|NOT COMPLETED|Overall Study||31
165238|NCT00500292|405575|P1|NOT COMPLETED|Overall Study||25
165239|NCT00500292|405573|P3|COMPLETED|Overall Study|ongoing study treatment at data cut-off|10
165240|NCT00500292|405574|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|4
165241|NCT00500292|405575|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|7
165242|NCT00500292|405573|P3|STARTED|Overall Study|randomised patients|37
165243|NCT00500292|405574|P2|STARTED|Overall Study|randomised patients|35
165244|NCT00500292|405575|P1|STARTED|Overall Study|randomised patients|32
165245|NCT00500318|405585|P2|NOT COMPLETED|Overall Study||17
165246|NCT00500318|405586|P1|NOT COMPLETED|Overall Study||5
165247|NCT00500318|405585|P2|COMPLETED|Overall Study||78
165248|NCT00500318|405586|P1|COMPLETED|Overall Study||81
165249|NCT00500318|405585|P2|STARTED|Overall Study||95
165250|NCT00500318|405586|P1|STARTED|Overall Study||86
165251|NCT00500357|405600|P1|NOT COMPLETED|Overall Study||1
165252|NCT00500357|405600|P1|COMPLETED|Overall Study||104
165253|NCT00500357|405600|P1|Evaluable Immunogenicity Population|Overall Study|Administered Vax 1 and Vax 2 in study 6115A1-500; Vax 3 and at least 1 assay result in 6115A1-3009.|98
165254|NCT00500357|405600|P1|Received 13vPnC (Vax 3)|Overall Study||105
165255|NCT00500357|405600|P1|STARTED|Overall Study||105
165256|NCT00500370|405621|P2|NOT COMPLETED|Overall Study||34
165257|NCT00500370|405622|P1|NOT COMPLETED|Overall Study||33
165258|NCT00500370|405621|P2|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|49
165259|NCT00500370|405622|P1|COMPLETED|Overall Study|COMPLETED = completion of treatment period (Week 24) plus follow-up visit 4 weeks later|47
165260|NCT00500370|405621|P2|Treatment Complete (Week 24)|Overall Study||54
165261|NCT00500370|405622|P1|Treatment Complete (Week 24)|Overall Study||48
165347|NCT00501293|405771|P1|NOT COMPLETED|Optimization Period||1
165262|NCT00500370|405621|P2|Treatment Start-Baseline (Week 0)|Overall Study||79
165263|NCT00500370|405622|P1|Treatment Start-Baseline (Week 0)|Overall Study||73
165264|NCT00500370|405621|P2|STARTED|Overall Study||83
165265|NCT00500370|405622|P1|STARTED|Overall Study||80
165266|NCT00500448|405660|P2|NOT COMPLETED|Overall Study||0
165267|NCT00500448|405661|P1|NOT COMPLETED|Overall Study||0
165268|NCT00500448|405660|P2|COMPLETED|Overall Study||16
165269|NCT00500448|405661|P1|COMPLETED|Overall Study||14
165270|NCT00500448|405660|P2|STARTED|Overall Study||16
165271|NCT00500448|405661|P1|STARTED|Overall Study||14
165272|NCT00500539|405675|P1|NOT COMPLETED|Follow-up Period (16 Weeks)||12
165273|NCT00500539|405675|P1|COMPLETED|Follow-up Period (16 Weeks)||136
165274|NCT00500539|405675|P1|STARTED|Follow-up Period (16 Weeks)|Participants could discontinue study drug and still enter the follow-up period.|148
165275|NCT00500539|405675|P1|NOT COMPLETED|Treatment Period (24 Weeks)||15
165276|NCT00500539|405675|P1|COMPLETED|Treatment Period (24 Weeks)||140
165277|NCT00500539|405675|P1|STARTED|Treatment Period (24 Weeks)||155
165278|NCT00500578|405684|P2|NOT COMPLETED|Overall Study||0
165279|NCT00500578|405685|P1|NOT COMPLETED|Overall Study||0
165280|NCT00500578|405684|P2|COMPLETED|Overall Study|All completed|32
165281|NCT00500578|405685|P1|COMPLETED|Overall Study|All completed|18
165282|NCT00500578|405684|P2|STARTED|Overall Study||32
165283|NCT00500578|405685|P1|STARTED|Overall Study||18
165284|NCT00500656|405695|P4|NOT COMPLETED|Open Label Extension (OLE) Phase||2
165285|NCT00500656|405696|P3|NOT COMPLETED|Open Label Extension (OLE) Phase||1
165286|NCT00500656|405697|P2|NOT COMPLETED|Open Label Extension (OLE) Phase||12
165287|NCT00500656|405698|P1|NOT COMPLETED|Open Label Extension (OLE) Phase||7
165288|NCT00500656|405695|P4|COMPLETED|Open Label Extension (OLE) Phase||6
165289|NCT00500656|405696|P3|COMPLETED|Open Label Extension (OLE) Phase||1
165290|NCT00500656|405697|P2|COMPLETED|Open Label Extension (OLE) Phase||9
165291|NCT00500656|405698|P1|COMPLETED|Open Label Extension (OLE) Phase||16
165292|NCT00500656|405695|P4|STARTED|Open Label Extension (OLE) Phase|Subjects did not experience an angioedema attack during the controlled phase|8
165293|NCT00500656|405696|P3|STARTED|Open Label Extension (OLE) Phase||2
165294|NCT00500656|405697|P2|STARTED|Open Label Extension (OLE) Phase|7 Subjects did not experience an angioedema attack after their first attack in the controlled phase|21
165295|NCT00500656|405698|P1|STARTED|Open Label Extension (OLE) Phase|3 Subjects did not experience an angioedema attack after their first attack in the controlled phase|23
165296|NCT00500656|405695|P4|NOT COMPLETED|Controlled Phase||8
165297|NCT00500656|405696|P3|NOT COMPLETED|Controlled Phase||1
165298|NCT00500656|405697|P2|NOT COMPLETED|Controlled Phase||10
165299|NCT00500656|405698|P1|NOT COMPLETED|Controlled Phase||10
165300|NCT00500656|405695|P4|COMPLETED|Controlled Phase||0
165301|NCT00500656|405696|P3|COMPLETED|Controlled Phase||2
165302|NCT00500656|405697|P2|COMPLETED|Controlled Phase||28
165303|NCT00500656|405698|P1|COMPLETED|Controlled Phase||26
165304|NCT00500656|405695|P4|STARTED|Controlled Phase||8
165305|NCT00500656|405696|P3|STARTED|Controlled Phase||3
165306|NCT00500656|405697|P2|STARTED|Controlled Phase||38
165307|NCT00500656|405698|P1|STARTED|Controlled Phase||36
165308|NCT00500682|405712|P2|NOT COMPLETED|Overall Study||287
165309|NCT00500682|405713|P1|NOT COMPLETED|Overall Study||306
165310|NCT00500682|405712|P2|COMPLETED|Overall Study||223
165311|NCT00500682|405713|P1|COMPLETED|Overall Study||204
165312|NCT00500682|405712|P2|STARTED|Overall Study||510
165313|NCT00500682|405713|P1|STARTED|Overall Study||510
165314|NCT00500760|405721|P2|NOT COMPLETED|Overall Study||24
165315|NCT00500760|405722|P1|NOT COMPLETED|Overall Study||43
165316|NCT00500760|405721|P2|COMPLETED|Overall Study||40
165317|NCT00500760|405722|P1|COMPLETED|Overall Study||46
165318|NCT00500760|405721|P2|Received Treatment|Overall Study||63
165319|NCT00500760|405722|P1|Received Treatment|Overall Study||87
165320|NCT00500760|405721|P2|STARTED|Overall Study||64
165321|NCT00500760|405722|P1|STARTED|Overall Study||89
165322|NCT00501007|405740|P2|NOT COMPLETED|Overall Study||25
165323|NCT00501007|405741|P1|NOT COMPLETED|Overall Study||29
165324|NCT00501007|405740|P2|COMPLETED|Overall Study||78
165325|NCT00501007|405741|P1|COMPLETED|Overall Study||71
165326|NCT00501007|405740|P2|STARTED|Overall Study||103
165327|NCT00501007|405741|P1|STARTED|Overall Study||100
165328|NCT00501046|405749|P2|NOT COMPLETED|Overall Study||294
165329|NCT00501046|405750|P1|NOT COMPLETED|Overall Study||270
165330|NCT00501046|405749|P2|COMPLETED|Overall Study||213
165331|NCT00501046|405750|P1|COMPLETED|Overall Study||238
165332|NCT00501046|405749|P2|STARTED|Overall Study||507
165333|NCT00501046|405750|P1|STARTED|Overall Study||508
165334|NCT00501085|405756|P1|NOT COMPLETED|Overall Study||432
165335|NCT00501085|405756|P1|COMPLETED|Overall Study|Number of participants completing 5 year follow-up visit.|83
165336|NCT00501085|405756|P1|STARTED|Overall Study|Number of participants who were treated with the LAP-BAND System.|515
165337|NCT00501228|405764|P1|NOT COMPLETED|Overall Study||1
165338|NCT00501228|405764|P1|COMPLETED|Overall Study||1
165339|NCT00501228|405764|P1|STARTED|Overall Study||2
165340|NCT00501293|405770|P2|NOT COMPLETED|Maintenance Period||28
165341|NCT00501293|405771|P1|NOT COMPLETED|Maintenance Period||46
165342|NCT00501293|405770|P2|COMPLETED|Maintenance Period||25
165343|NCT00501293|405771|P1|COMPLETED|Maintenance Period||63
165344|NCT00501293|405770|P2|STARTED|Maintenance Period||53
165345|NCT00501293|405771|P1|STARTED|Maintenance Period||109
165346|NCT00501293|405770|P2|NOT COMPLETED|Optimization Period||0
165348|NCT00501293|405770|P2|COMPLETED|Optimization Period||53
165349|NCT00501293|405771|P1|COMPLETED|Optimization Period||109
165350|NCT00501293|405770|P2|STARTED|Optimization Period||53
165351|NCT00501293|405771|P1|STARTED|Optimization Period||110
165352|NCT00501345|405798|P1|NOT COMPLETED|Overall Study||0
165353|NCT00501345|405798|P1|COMPLETED|Overall Study||5
165354|NCT00501345|405798|P1|STARTED|Overall Study||5
165355|NCT00501540|405802|P1|NOT COMPLETED|Overall Study||5
165356|NCT00501540|405802|P1|COMPLETED|Overall Study||10
165357|NCT00501540|405802|P1|STARTED|Overall Study||15
165358|NCT00501592|405811|P3|NOT COMPLETED|Overall Study||3
165359|NCT00501592|405812|P2|NOT COMPLETED|Overall Study||5
165360|NCT00501592|405813|P1|NOT COMPLETED|Overall Study||0
165361|NCT00501592|405811|P3|COMPLETED|Overall Study||20
165362|NCT00501592|405812|P2|COMPLETED|Overall Study||16
165363|NCT00501592|405813|P1|COMPLETED|Overall Study||20
165364|NCT00501592|405811|P3|STARTED|Overall Study||23
165365|NCT00501592|405812|P2|STARTED|Overall Study||21
165366|NCT00501592|405813|P1|STARTED|Overall Study||20
165367|NCT00501631|405826|P2|NOT COMPLETED|Part B (Open-label Period)||51
165368|NCT00501631|405827|P1|NOT COMPLETED|Part B (Open-label Period)||53
165369|NCT00501631|405826|P2|COMPLETED|Part B (Open-label Period)||48
165370|NCT00501631|405827|P1|COMPLETED|Part B (Open-label Period)||37
165371|NCT00501631|405826|P2|STARTED|Part B (Open-label Period)||99
165372|NCT00501631|405827|P1|STARTED|Part B (Open-label Period)||90
165373|NCT00501631|405826|P2|NOT COMPLETED|Part A (Double-blind Period)||49
165374|NCT00501631|405827|P1|NOT COMPLETED|Part A (Double-blind Period)||62
165375|NCT00501631|405826|P2|COMPLETED|Part A (Double-blind Period)||99
165376|NCT00501631|405827|P1|COMPLETED|Part A (Double-blind Period)||90
165377|NCT00501631|405826|P2|STARTED|Part A (Double-blind Period)||148
165378|NCT00501631|405827|P1|STARTED|Part A (Double-blind Period)||152
165379|NCT00501644|405833|P1|NOT COMPLETED|Overall Study||5
165380|NCT00501644|405833|P1|COMPLETED|Overall Study||54
165381|NCT00501644|405833|P1|STARTED|Overall Study||59
165382|NCT00501852|405837|P1|NOT COMPLETED|Overall Study||5
165383|NCT00501852|405837|P1|COMPLETED|Overall Study||78
165384|NCT00501852|405837|P1|Tiotropium|Overall Study||55
165385|NCT00501852|405837|P1|Placebo|Overall Study||55
165386|NCT00501852|405837|P1|NVA237 100µg|Overall Study||54
165387|NCT00501852|405837|P1|NVA237 50µg|Overall Study||53
165388|NCT00501852|405837|P1|NVA237 25µg|Overall Study||51
165389|NCT00501852|405837|P1|NVA237 12.5µg|Overall Study||55
165390|NCT00501852|405837|P1|STARTED|Overall Study||83
165391|NCT00501891|405857|P1|NOT COMPLETED|Overall Study||0
165392|NCT00501891|405857|P1|COMPLETED|Overall Study||32
165393|NCT00501891|405857|P1|STARTED|Overall Study||32
165394|NCT00501943|405866|P2|NOT COMPLETED|Overall Study||3
165395|NCT00501943|405867|P1|NOT COMPLETED|Overall Study||2
165396|NCT00501943|405866|P2|COMPLETED|Overall Study||18
165397|NCT00501943|405867|P1|COMPLETED|Overall Study||20
165398|NCT00501943|405866|P2|STARTED|Overall Study||21
165399|NCT00501943|405867|P1|STARTED|Overall Study||22
165400|NCT00501969|405883|P1|NOT COMPLETED|Overall Study||206
165401|NCT00501969|405883|P1|COMPLETED|Overall Study||189
165402|NCT00501969|405883|P1|STARTED|Overall Study||395
165403|NCT00501995|405889|P1|NOT COMPLETED|Overall Study||1
165404|NCT00501995|405889|P1|COMPLETED|Overall Study||5
165405|NCT00501995|405889|P1|STARTED|Overall Study||6
165406|NCT00502203|405894|P1|NOT COMPLETED|Overall Study||1
165407|NCT00502203|405894|P1|COMPLETED|Overall Study||22
165408|NCT00502203|405894|P1|STARTED|Overall Study||23
165409|NCT00502216|405900|P2|NOT COMPLETED|Overall Study||0
165410|NCT00502216|405901|P1|NOT COMPLETED|Overall Study||0
165411|NCT00502216|405900|P2|COMPLETED|Overall Study||19
165412|NCT00502216|405901|P1|COMPLETED|Overall Study||21
165413|NCT00502216|405900|P2|STARTED|Overall Study||19
165414|NCT00502216|405901|P1|STARTED|Overall Study||21
165415|NCT00502242|405909|P2|NOT COMPLETED|Overall Study||56
165416|NCT00502242|405910|P1|NOT COMPLETED|Overall Study||51
165417|NCT00502242|405909|P2|COMPLETED|Overall Study||84
165418|NCT00502242|405910|P1|COMPLETED|Overall Study||104
165419|NCT00502242|405909|P2|STARTED|Overall Study||140
165420|NCT00502242|405910|P1|STARTED|Overall Study||155
165421|NCT00493454|405961|P1|NOT COMPLETED|Overall Study||1
165422|NCT00493454|405961|P1|COMPLETED|Overall Study||5
165423|NCT00493454|405961|P1|STARTED|Overall Study||6
165424|NCT00493636|405967|P2|NOT COMPLETED|Overall Study||2
165425|NCT00493636|405968|P1|NOT COMPLETED|Overall Study||2
165426|NCT00493636|405967|P2|COMPLETED|Overall Study||77
165427|NCT00493636|405968|P1|COMPLETED|Overall Study||79
165428|NCT00493636|405967|P2|STARTED|Overall Study||79
165429|NCT00493636|405968|P1|STARTED|Overall Study||81
165430|NCT00493649|405982|P1|NOT COMPLETED|Overall Study||82
165431|NCT00493649|405982|P1|COMPLETED|Overall Study||411
165432|NCT00493649|405982|P1|STARTED|Overall Study||493
165433|NCT00493779|405993|P1|NOT COMPLETED|Overall Study||1
165434|NCT00493779|405993|P1|COMPLETED|Overall Study|Completed follow-up phase|97
165435|NCT00493779|405993|P1|STARTED|Overall Study|Number of subjects who had discontinued clopidogrel treatment and entered follow-up phase|98
165436|NCT00493805|406000|P2|NOT COMPLETED|Overall Study||0
165437|NCT00493805|406001|P1|NOT COMPLETED|Overall Study||0
165438|NCT00493805|406000|P2|COMPLETED|Overall Study||42
165439|NCT00493805|406001|P1|COMPLETED|Overall Study||17
165440|NCT00493805|406000|P2|STARTED|Overall Study||42
165441|NCT00493805|406001|P1|STARTED|Overall Study||17
165442|NCT00493974|406011|P2|NOT COMPLETED|Overall Study||14
165443|NCT00493974|406012|P1|NOT COMPLETED|Overall Study||13
165444|NCT00493974|406011|P2|COMPLETED|Overall Study||45
165445|NCT00493974|406012|P1|COMPLETED|Overall Study||47
165446|NCT00493974|406011|P2|STARTED|Overall Study||59
165447|NCT00493974|406012|P1|STARTED|Overall Study||60
165448|NCT00494013|406032|P2|NOT COMPLETED|Overall Study||36
165449|NCT00494013|406033|P1|NOT COMPLETED|Overall Study||30
165450|NCT00494013|406032|P2|COMPLETED|Overall Study||183
165451|NCT00494013|406033|P1|COMPLETED|Overall Study||193
165452|NCT00494013|406032|P2|Full Analysis Set (Intent to Treat)|Overall Study||210
165453|NCT00494013|406033|P1|Full Analysis Set (Intent to Treat)|Overall Study||219
165454|NCT00494013|406032|P2|STARTED|Overall Study||219
165455|NCT00494013|406033|P1|STARTED|Overall Study||223
165456|NCT00494026|406061|P1|NOT COMPLETED|Overall Study||4
165457|NCT00494026|406061|P1|COMPLETED|Overall Study|2 patients did receive the full study treatment prior to the study being terminated.|0
165458|NCT00494026|406061|P1|STARTED|Overall Study||4
165459|NCT00494091|406071|P2|NOT COMPLETED|Overall Study||76
165460|NCT00494091|406072|P1|NOT COMPLETED|Overall Study||6
165461|NCT00494091|406071|P2|COMPLETED|Overall Study||0
165462|NCT00494091|406072|P1|COMPLETED|Overall Study||0
165463|NCT00494091|406071|P2|STARTED|Overall Study||76
165464|NCT00494091|406072|P1|STARTED|Overall Study||6
165465|NCT00494143|406094|P6|NOT COMPLETED|Overall Study||0
165466|NCT00494143|406095|P5|NOT COMPLETED|Overall Study||0
165467|NCT00494143|406096|P4|NOT COMPLETED|Overall Study||0
165468|NCT00494143|406097|P3|NOT COMPLETED|Overall Study||0
165469|NCT00494143|406098|P2|NOT COMPLETED|Overall Study||0
165470|NCT00494143|406099|P1|NOT COMPLETED|Overall Study||0
165471|NCT00494143|406094|P6|COMPLETED|Overall Study||0
165472|NCT00494143|406095|P5|COMPLETED|Overall Study||1
165473|NCT00494143|406096|P4|COMPLETED|Overall Study||0
165474|NCT00494143|406097|P3|COMPLETED|Overall Study||3
165475|NCT00494143|406098|P2|COMPLETED|Overall Study||2
165476|NCT00494143|406099|P1|COMPLETED|Overall Study||1
165477|NCT00494143|406094|P6|STARTED|Overall Study||0
165478|NCT00494143|406095|P5|STARTED|Overall Study||1
165479|NCT00494143|406096|P4|STARTED|Overall Study||0
165480|NCT00494143|406097|P3|STARTED|Overall Study||3
165481|NCT00494143|406098|P2|STARTED|Overall Study||2
165482|NCT00494143|406099|P1|STARTED|Overall Study||1
165483|NCT00494221|406116|P3|NOT COMPLETED|Overall Study||14
165484|NCT00494221|406117|P2|NOT COMPLETED|Overall Study||11
165485|NCT00494221|406118|P1|NOT COMPLETED|Overall Study||16
165486|NCT00494221|406116|P3|COMPLETED|Overall Study||44
165487|NCT00494221|406117|P2|COMPLETED|Overall Study||45
165488|NCT00494221|406118|P1|COMPLETED|Overall Study||42
165489|NCT00494221|406116|P3|STARTED|Overall Study||58
165490|NCT00494221|406117|P2|STARTED|Overall Study||56
165491|NCT00494221|406118|P1|STARTED|Overall Study||58
165492|NCT00494234|406140|P2|NOT COMPLETED|Overall Study||10
165493|NCT00494234|406141|P1|NOT COMPLETED|Overall Study||15
165494|NCT00494234|406140|P2|COMPLETED|Overall Study||17
165495|NCT00494234|406141|P1|COMPLETED|Overall Study||12
165496|NCT00494234|406140|P2|STARTED|Overall Study||27
165497|NCT00494234|406141|P1|STARTED|Overall Study||27
165498|NCT00494299|406159|P2|NOT COMPLETED|Overall Study||229
165499|NCT00494299|406160|P1|NOT COMPLETED|Overall Study||229
165500|NCT00494299|406159|P2|COMPLETED|Overall Study||0
165501|NCT00494299|406160|P1|COMPLETED|Overall Study||0
165502|NCT00494299|406159|P2|Received Treatment|Overall Study||227
165503|NCT00494299|406160|P1|Received Treatment|Overall Study||229
165504|NCT00494299|406159|P2|STARTED|Overall Study||229
165505|NCT00494299|406160|P1|STARTED|Overall Study||229
165506|NCT00494442|406172|P2|NOT COMPLETED|Overall Study||16
165507|NCT00494442|406173|P1|NOT COMPLETED|Overall Study||17
165508|NCT00494442|406172|P2|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|17
165509|NCT00494442|406173|P1|COMPLETED|Overall Study|Patients completed the full study schedule (168 days treatment)|7
165510|NCT00494442|406172|P2|STARTED|Overall Study|Patients received treatment|33
165511|NCT00494442|406173|P1|STARTED|Overall Study|Patients received treatment|24
165512|NCT00494481|406189|P2|NOT COMPLETED|Overall Study||24
165513|NCT00494481|406190|P1|NOT COMPLETED|Overall Study||29
165514|NCT00494481|406189|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
165515|NCT00494481|406190|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|6
165516|NCT00494481|406189|P2|STARTED|Overall Study|randomised patients|29
165517|NCT00494481|406190|P1|STARTED|Overall Study|randomised patients|35
165518|NCT00494494|406198|P2|NOT COMPLETED|Overall Study||0
165519|NCT00494494|406199|P1|NOT COMPLETED|Overall Study||0
165520|NCT00494494|406198|P2|COMPLETED|Overall Study||39
165521|NCT00494494|406199|P1|COMPLETED|Overall Study||40
165522|NCT00494494|406198|P2|STARTED|Overall Study||39
165523|NCT00494494|406199|P1|STARTED|Overall Study||40
165524|NCT00494507|406217|P4|NOT COMPLETED|Open-Label Phase||5
165525|NCT00494507|406218|P3|NOT COMPLETED|Open-Label Phase||5
165526|NCT00494507|406219|P2|NOT COMPLETED|Open-Label Phase||1
165527|NCT00494507|406220|P1|NOT COMPLETED|Open-Label Phase||0
165528|NCT00494507|406217|P4|COMPLETED|Open-Label Phase||14
165529|NCT00494507|406218|P3|COMPLETED|Open-Label Phase||17
165530|NCT00494507|406219|P2|COMPLETED|Open-Label Phase||7
165531|NCT00494507|406220|P1|COMPLETED|Open-Label Phase||9
165532|NCT00494507|406217|P4|STARTED|Open-Label Phase||19
165533|NCT00494507|406218|P3|STARTED|Open-Label Phase||22
165534|NCT00494507|406219|P2|STARTED|Open-Label Phase|1 subject randomized to Acetazolamide in this phase is not included-drug arm was removed from trial.|8
165535|NCT00494507|406220|P1|STARTED|Open-Label Phase||9
165536|NCT00494507|406217|P4|NOT COMPLETED|Double-Blind Phase||1
165537|NCT00494507|406218|P3|NOT COMPLETED|Double-Blind Phase||2
165538|NCT00494507|406219|P2|NOT COMPLETED|Double-Blind Phase||0
165539|NCT00494507|406220|P1|NOT COMPLETED|Double-Blind Phase||3
165540|NCT00494507|406217|P4|COMPLETED|Double-Blind Phase||19
165541|NCT00494507|406218|P3|COMPLETED|Double-Blind Phase||22
165542|NCT00494507|406219|P2|COMPLETED|Double-Blind Phase||9
165543|NCT00494507|406220|P1|COMPLETED|Double-Blind Phase||9
165544|NCT00494507|406217|P4|Reached Endpoint of Acute Worsening|Double-Blind Phase||5
165545|NCT00494507|406218|P3|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
165546|NCT00494507|406219|P2|Reached Endpoint of Acute Worsening|Double-Blind Phase||2
165547|NCT00494507|406220|P1|Reached Endpoint of Acute Worsening|Double-Blind Phase||0
165548|NCT00494507|406217|P4|STARTED|Double-Blind Phase||20
165549|NCT00494507|406218|P3|STARTED|Double-Blind Phase||24
165550|NCT00494507|406219|P2|STARTED|Double-Blind Phase||9
165551|NCT00494507|406220|P1|STARTED|Double-Blind Phase||12
165552|NCT00502320|406270|P2|NOT COMPLETED|Overall Study||7
165553|NCT00502320|406271|P1|NOT COMPLETED|Overall Study||6
165554|NCT00502320|406270|P2|COMPLETED|Overall Study||18
165555|NCT00502320|406271|P1|COMPLETED|Overall Study||19
165556|NCT00502320|406270|P2|Screening Visit|Overall Study|Participant signed informed consent but was a screen failure because she was nursing at the time.|24
165557|NCT00502320|406271|P1|Screening Visit|Overall Study||25
165558|NCT00502320|406270|P2|STARTED|Overall Study||25
165559|NCT00502320|406271|P1|STARTED|Overall Study||25
165560|NCT00502593|406293|P12|NOT COMPLETED|Overall Study||0
165561|NCT00502593|406294|P11|NOT COMPLETED|Overall Study||2
165562|NCT00502593|406295|P10|NOT COMPLETED|Overall Study||0
165563|NCT00502593|406296|P9|NOT COMPLETED|Overall Study||6
165564|NCT00502593|406297|P8|NOT COMPLETED|Overall Study||0
165565|NCT00502593|406298|P7|NOT COMPLETED|Overall Study||5
165566|NCT00502593|406299|P6|NOT COMPLETED|Overall Study||0
165567|NCT00502593|406300|P5|NOT COMPLETED|Overall Study||4
165568|NCT00502593|406301|P4|NOT COMPLETED|Overall Study||4
165569|NCT00502593|406302|P3|NOT COMPLETED|Overall Study||10
165570|NCT00502593|406303|P2|NOT COMPLETED|Overall Study||2
165571|NCT00502593|406304|P1|NOT COMPLETED|Overall Study||3
165572|NCT00502593|406293|P12|COMPLETED|Overall Study||18
165573|NCT00502593|406294|P11|COMPLETED|Overall Study||47
165574|NCT00502593|406295|P10|COMPLETED|Overall Study||17
165575|NCT00502593|406296|P9|COMPLETED|Overall Study||43
165576|NCT00502593|406297|P8|COMPLETED|Overall Study||17
165577|NCT00502593|406298|P7|COMPLETED|Overall Study||44
165578|NCT00502593|406299|P6|COMPLETED|Overall Study||17
165579|NCT00502593|406300|P5|COMPLETED|Overall Study||47
165580|NCT00502593|406301|P4|COMPLETED|Overall Study||14
165581|NCT00502593|406302|P3|COMPLETED|Overall Study||41
165582|NCT00502593|406303|P2|COMPLETED|Overall Study||16
165583|NCT00502593|406304|P1|COMPLETED|Overall Study||48
165584|NCT00502593|406293|P12|STARTED|Overall Study||18
165585|NCT00502593|406294|P11|STARTED|Overall Study||49
165586|NCT00502593|406295|P10|STARTED|Overall Study||17
165587|NCT00502593|406296|P9|STARTED|Overall Study||49
165588|NCT00502593|406297|P8|STARTED|Overall Study||17
165589|NCT00502593|406298|P7|STARTED|Overall Study||49
165590|NCT00502593|406299|P6|STARTED|Overall Study||17
165591|NCT00502593|406300|P5|STARTED|Overall Study||51
165592|NCT00502593|406301|P4|STARTED|Overall Study||18
165593|NCT00502593|406302|P3|STARTED|Overall Study||51
165594|NCT00502593|406303|P2|STARTED|Overall Study||18
165595|NCT00502593|406304|P1|STARTED|Overall Study||51
165596|NCT00503399|406820|P2|NOT COMPLETED|Overall Study||8
165597|NCT00503399|406821|P1|NOT COMPLETED|Overall Study||7
165598|NCT00503399|406820|P2|COMPLETED|Overall Study||39
165599|NCT00503399|406821|P1|COMPLETED|Overall Study||38
165600|NCT00503399|406820|P2|STARTED|Overall Study||47
165601|NCT00503399|406821|P1|STARTED|Overall Study||45
165602|NCT00503425|406843|P1|NOT COMPLETED|Overall Study||54
165603|NCT00503425|406843|P1|COMPLETED|Overall Study||161
165604|NCT00503425|406843|P1|STARTED|Overall Study||215
165605|NCT00503698|406853|P2|NOT COMPLETED|Overall Study||355
165606|NCT00503698|406854|P1|NOT COMPLETED|Overall Study||357
165607|NCT00503698|406853|P2|COMPLETED|Overall Study|Trial prematurely terminated|0
165608|NCT00503698|406854|P1|COMPLETED|Overall Study|Trial prematurely terminated|0
165609|NCT00503698|406853|P2|Exposed to Trial Drug|Overall Study|6 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|349
165610|NCT00503698|406854|P1|Exposed to Trial Drug|Overall Study|11 subjects randomised but not exposed to trial drug. Subjects not included in full analysis set.|346
165611|NCT00503698|406853|P2|STARTED|Overall Study|Randomised|355
165612|NCT00503698|406854|P1|STARTED|Overall Study|Randomised|357
165613|NCT00503750|406868|P1|NOT COMPLETED|Overall Study||0
165614|NCT00503750|406868|P1|COMPLETED|Overall Study||27
165615|NCT00503750|406868|P1|STARTED|Overall Study||27
165616|NCT00503776|406877|P4|NOT COMPLETED|Overall Study||2
165617|NCT00503776|406878|P3|NOT COMPLETED|Overall Study||2
165618|NCT00503776|406879|P2|NOT COMPLETED|Overall Study||0
165619|NCT00503776|406880|P1|NOT COMPLETED|Overall Study||1
165620|NCT00503776|406877|P4|COMPLETED|Overall Study||8
165621|NCT00503776|406878|P3|COMPLETED|Overall Study||10
165622|NCT00503776|406879|P2|COMPLETED|Overall Study||12
165623|NCT00503776|406880|P1|COMPLETED|Overall Study||7
165624|NCT00503776|406877|P4|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|10
165625|NCT00503776|406878|P3|STARTED|Overall Study|one patient withdrew before receiving protocol therapy|12
165626|NCT00503776|406879|P2|STARTED|Overall Study||12
165627|NCT00503776|406880|P1|STARTED|Overall Study||8
165628|NCT00503841|406906|P1|NOT COMPLETED|Overall Study||44
165629|NCT00503841|406906|P1|COMPLETED|Overall Study||0
165630|NCT00503841|406906|P1|STARTED|Overall Study||44
165631|NCT00503906|406910|P1|NOT COMPLETED|Overall Study||1
165632|NCT00503906|406910|P1|COMPLETED|Overall Study||29
165633|NCT00503906|406910|P1|STARTED|Overall Study||30
165634|NCT00503984|406921|P6|NOT COMPLETED|Overall Study||0
165635|NCT00503984|406922|P5|NOT COMPLETED|Overall Study||1
165636|NCT00503984|406923|P4|NOT COMPLETED|Overall Study||0
165637|NCT00503984|406924|P3|NOT COMPLETED|Overall Study||0
165638|NCT00503984|406925|P2|NOT COMPLETED|Overall Study||2
165639|NCT00503984|406926|P1|NOT COMPLETED|Overall Study||0
165640|NCT00503984|406921|P6|COMPLETED|Overall Study||1
165641|NCT00503984|406922|P5|COMPLETED|Overall Study||5
165642|NCT00503984|406923|P4|COMPLETED|Overall Study||6
165643|NCT00503984|406924|P3|COMPLETED|Overall Study||3
165644|NCT00503984|406925|P2|COMPLETED|Overall Study||1
165645|NCT00503984|406926|P1|COMPLETED|Overall Study||3
165646|NCT00503984|406921|P6|STARTED|Overall Study||1
165647|NCT00503984|406922|P5|STARTED|Overall Study||6
165648|NCT00503984|406923|P4|STARTED|Overall Study||6
165649|NCT00503984|406924|P3|STARTED|Overall Study||3
165650|NCT00503984|406925|P2|STARTED|Overall Study||3
165651|NCT00503984|406926|P1|STARTED|Overall Study||3
165652|NCT00503997|406952|P1|NOT COMPLETED|Overall Study||8
165653|NCT00503997|406952|P1|COMPLETED|Overall Study||34
165654|NCT00503997|406952|P1|STARTED|Overall Study||42
165655|NCT00504075|406956|P1|NOT COMPLETED|Overall Study||8
165656|NCT00504075|406956|P1|COMPLETED|Overall Study||27
165657|NCT00504075|406956|P1|STARTED|Overall Study||35
165658|NCT00504153|406962|P1|NOT COMPLETED|Overall Study||6
165659|NCT00504153|406962|P1|COMPLETED|Overall Study||13
165660|NCT00504153|406962|P1|STARTED|Overall Study||19
165661|NCT00504166|406972|P2|NOT COMPLETED|Overall Study||14
165662|NCT00504166|406973|P1|NOT COMPLETED|Overall Study||6
165663|NCT00504166|406972|P2|COMPLETED|Overall Study||13
165664|NCT00504166|406973|P1|COMPLETED|Overall Study||20
165665|NCT00504166|406972|P2|STARTED|Overall Study||27
165666|NCT00504166|406973|P1|STARTED|Overall Study||26
165667|NCT00504231|406983|P4|NOT COMPLETED|Overall Study||0
165668|NCT00504231|406984|P3|NOT COMPLETED|Overall Study||1
165669|NCT00504231|406985|P2|NOT COMPLETED|Overall Study||0
165670|NCT00504231|406986|P1|NOT COMPLETED|Overall Study||0
165671|NCT00504231|406983|P4|COMPLETED|Overall Study||65
165672|NCT00504231|406984|P3|COMPLETED|Overall Study||63
165673|NCT00504231|406985|P2|COMPLETED|Overall Study||64
165674|NCT00504231|406986|P1|COMPLETED|Overall Study||65
165675|NCT00504231|406983|P4|STARTED|Overall Study||65
165676|NCT00504231|406984|P3|STARTED|Overall Study||64
165677|NCT00504231|406985|P2|STARTED|Overall Study||64
165678|NCT00504231|406986|P1|STARTED|Overall Study||65
165679|NCT00504257|407004|P1|NOT COMPLETED|Overall Study||4
165680|NCT00504257|407004|P1|COMPLETED|Overall Study||41
165681|NCT00504257|407004|P1|STARTED|Overall Study||45
165682|NCT00504426|407016|P4|NOT COMPLETED|Overall Study||0
165683|NCT00504426|407017|P3|NOT COMPLETED|Overall Study||4
165684|NCT00504426|407018|P2|NOT COMPLETED|Overall Study||1
165685|NCT00504426|407019|P1|NOT COMPLETED|Overall Study||3
165686|NCT00504426|407016|P4|COMPLETED|Overall Study||24
165687|NCT00504426|407017|P3|COMPLETED|Overall Study||18
165688|NCT00504426|407018|P2|COMPLETED|Overall Study||22
165689|NCT00504426|407019|P1|COMPLETED|Overall Study||29
165690|NCT00504426|407016|P4|STARTED|Overall Study||24
165691|NCT00504426|407017|P3|STARTED|Overall Study||22
165692|NCT00504426|407018|P2|STARTED|Overall Study||23
165693|NCT00504426|407019|P1|STARTED|Overall Study||32
165694|NCT00504504|407033|P1|NOT COMPLETED|Overall Study||0
165695|NCT00504504|407033|P1|COMPLETED|Overall Study||82
165696|NCT00504504|407033|P1|STARTED|Overall Study||82
165697|NCT00504556|407042|P5|NOT COMPLETED|Overall Study||25
165698|NCT00504556|407043|P4|NOT COMPLETED|Overall Study||128
165699|NCT00504556|407044|P3|NOT COMPLETED|Overall Study||31
165700|NCT00504556|407045|P2|NOT COMPLETED|Overall Study||38
165701|NCT00504556|407046|P1|NOT COMPLETED|Overall Study||35
165702|NCT00504556|407042|P5|COMPLETED|Overall Study||226
165703|NCT00504556|407043|P4|COMPLETED|Overall Study||52
165704|NCT00504556|407044|P3|COMPLETED|Overall Study||204
165705|NCT00504556|407045|P2|COMPLETED|Overall Study||207
165706|NCT00504556|407046|P1|COMPLETED|Overall Study||200
165707|NCT00504556|407042|P5|Pharmacodynamic Analysis Set|Overall Study||244
165708|NCT00504556|407043|P4|Pharmacodynamic Analysis Set|Overall Study||170
165709|NCT00504556|407044|P3|Pharmacodynamic Analysis Set|Overall Study||228
165710|NCT00504556|407045|P2|Pharmacodynamic Analysis Set|Overall Study||236
165711|NCT00504556|407046|P1|Pharmacodynamic Analysis Set|Overall Study||230
165712|NCT00504556|407042|P5|Per Protocol Analysis Set|Overall Study||250
165713|NCT00504556|407043|P4|Per Protocol Analysis Set|Overall Study||180
165714|NCT00504556|407044|P3|Per Protocol Analysis Set|Overall Study||234
165715|NCT00504556|407045|P2|Per Protocol Analysis Set|Overall Study||243
165716|NCT00504556|407046|P1|Per Protocol Analysis Set|Overall Study||235
165717|NCT00504556|407042|P5|Safety Analysis Set|Overall Study||250
165718|NCT00504556|407043|P4|Safety Analysis Set|Overall Study||180
165719|NCT00504556|407044|P3|Safety Analysis Set|Overall Study||234
165720|NCT00504556|407045|P2|Safety Analysis Set|Overall Study||244
165721|NCT00504556|407046|P1|Safety Analysis Set|Overall Study||235
165722|NCT00504556|407042|P5|STARTED|Overall Study||251
165723|NCT00504556|407043|P4|STARTED|Overall Study||180
165724|NCT00504556|407044|P3|STARTED|Overall Study||235
165725|NCT00504556|407045|P2|STARTED|Overall Study||245
165726|NCT00504556|407046|P1|STARTED|Overall Study||235
165727|NCT00504595|407110|P4|NOT COMPLETED|Overall Study||0
165728|NCT00504595|407111|P3|NOT COMPLETED|Overall Study||2
165729|NCT00504595|407112|P2|NOT COMPLETED|Overall Study||0
165730|NCT00504595|407113|P1|NOT COMPLETED|Overall Study||1
165731|NCT00504595|407110|P4|COMPLETED|Overall Study||10
165732|NCT00504595|407111|P3|COMPLETED|Overall Study||8
165733|NCT00504595|407112|P2|COMPLETED|Overall Study||10
165734|NCT00504595|407113|P1|COMPLETED|Overall Study||49
165735|NCT00504595|407110|P4|STARTED|Overall Study||10
165736|NCT00504595|407111|P3|STARTED|Overall Study||10
165737|NCT00504595|407112|P2|STARTED|Overall Study||10
165738|NCT00504595|407113|P1|STARTED|Overall Study||50
165739|NCT00504660|407127|P2|NOT COMPLETED|Overall Study||0
165740|NCT00504660|407128|P1|NOT COMPLETED|Overall Study||0
165741|NCT00504660|407127|P2|COMPLETED|Overall Study||43
165742|NCT00504660|407128|P1|COMPLETED|Overall Study||31
165743|NCT00504660|407127|P2|STARTED|Overall Study||43
165744|NCT00504660|407128|P1|STARTED|Overall Study||31
165745|NCT00504725|407136|P2|NOT COMPLETED|Overall Study||0
165746|NCT00504725|407137|P1|NOT COMPLETED|Overall Study||1
165747|NCT00504725|407136|P2|COMPLETED|Overall Study||20
165748|NCT00504725|407137|P1|COMPLETED|Overall Study|Prior to unblinding, one subject was discontinued due to elevated CRP levels at baseline.|20
165749|NCT00504725|407136|P2|STARTED|Overall Study||20
165750|NCT00504725|407137|P1|STARTED|Overall Study||21
165751|NCT00504751|407147|P1|NOT COMPLETED|Overall Study||0
165752|NCT00504751|407147|P1|COMPLETED|Overall Study||15
165753|NCT00504751|407147|P1|STARTED|Overall Study||15
165754|NCT00504777|407151|P1|NOT COMPLETED|Overall Study||1
165755|NCT00504777|407151|P1|COMPLETED|Overall Study||35
165756|NCT00504777|407151|P1|STARTED|Overall Study||36
165757|NCT00504881|407160|P2|NOT COMPLETED|Overall Study||36
165758|NCT00504881|407161|P1|NOT COMPLETED|Overall Study||10
165759|NCT00504881|407160|P2|COMPLETED|Overall Study||323
165760|NCT00504881|407161|P1|COMPLETED|Overall Study||111
165761|NCT00504881|407160|P2|STARTED|Overall Study||359
165762|NCT00504881|407161|P1|STARTED|Overall Study||121
165763|NCT00504894|407213|P2|NOT COMPLETED|Overall Study||0
165764|NCT00504894|407214|P1|NOT COMPLETED|Overall Study||0
165765|NCT00504894|407213|P2|COMPLETED|Overall Study||18
165766|NCT00504894|407214|P1|COMPLETED|Overall Study||17
165767|NCT00504894|407213|P2|STARTED|Overall Study||18
165768|NCT00504894|407214|P1|STARTED|Overall Study||17
165769|NCT00504985|407220|P1|NOT COMPLETED|Overall Study||0
165770|NCT00504985|407220|P1|COMPLETED|Overall Study||14
165771|NCT00504985|407220|P1|STARTED|Overall Study||14
165772|NCT00505076|407227|P3|NOT COMPLETED|Overall Study||5
165773|NCT00505076|407228|P2|NOT COMPLETED|Overall Study||2
165774|NCT00505076|407229|P1|NOT COMPLETED|Overall Study||3
165775|NCT00505076|407227|P3|COMPLETED|Overall Study||17
165776|NCT00505076|407228|P2|COMPLETED|Overall Study||17
165777|NCT00505076|407229|P1|COMPLETED|Overall Study||19
165778|NCT00505076|407227|P3|STARTED|Overall Study||22
165779|NCT00505076|407228|P2|STARTED|Overall Study||19
165780|NCT00505076|407229|P1|STARTED|Overall Study||22
165781|NCT00505284|407248|P5|NOT COMPLETED|Overall Study||33
165782|NCT00505284|407249|P4|NOT COMPLETED|Overall Study||19
165783|NCT00505284|407250|P3|NOT COMPLETED|Overall Study||12
165784|NCT00505284|407251|P2|NOT COMPLETED|Overall Study||16
165785|NCT00505284|407252|P1|NOT COMPLETED|Overall Study||10
165786|NCT00505284|407248|P5|COMPLETED|Overall Study||37
165787|NCT00505284|407249|P4|COMPLETED|Overall Study||49
165788|NCT00505284|407250|P3|COMPLETED|Overall Study||57
165789|NCT00505284|407251|P2|COMPLETED|Overall Study||56
165790|NCT00505284|407252|P1|COMPLETED|Overall Study||63
165791|NCT00505284|407248|P5|STARTED|Overall Study||70
165792|NCT00505284|407249|P4|STARTED|Overall Study||68
165793|NCT00505284|407250|P3|STARTED|Overall Study||69
165794|NCT00505284|407251|P2|STARTED|Overall Study||72
165795|NCT00505284|407252|P1|STARTED|Overall Study||73
165796|NCT00505362|407321|P2|NOT COMPLETED|Overall Study||0
165797|NCT00505362|407322|P1|NOT COMPLETED|Overall Study||0
165798|NCT00505362|407321|P2|COMPLETED|Overall Study||28
165799|NCT00505362|407322|P1|COMPLETED|Overall Study||35
165800|NCT00505362|407321|P2|STARTED|Overall Study||28
165801|NCT00505362|407322|P1|STARTED|Overall Study||35
165802|NCT00505375|407332|P2|NOT COMPLETED|Overall Study||5
165803|NCT00505375|407333|P1|NOT COMPLETED|Overall Study||4
165804|NCT00505375|407332|P2|COMPLETED|Overall Study||30
165805|NCT00505375|407333|P1|COMPLETED|Overall Study||73
165806|NCT00505375|407332|P2|STARTED|Overall Study||35
165807|NCT00505375|407333|P1|STARTED|Overall Study||77
165808|NCT00505414|407341|P5|NOT COMPLETED|Maintenance Phase||0
165809|NCT00505414|407342|P4|NOT COMPLETED|Maintenance Phase||0
165810|NCT00505414|407343|P3|NOT COMPLETED|Maintenance Phase||8
165811|NCT00505414|407344|P2|NOT COMPLETED|Maintenance Phase||5
165812|NCT00505414|407345|P1|NOT COMPLETED|Maintenance Phase||6
165813|NCT00505414|407341|P5|COMPLETED|Maintenance Phase||0
165814|NCT00505414|407342|P4|COMPLETED|Maintenance Phase||0
165815|NCT00505414|407343|P3|COMPLETED|Maintenance Phase||6
165816|NCT00505414|407344|P2|COMPLETED|Maintenance Phase||10
165817|NCT00505414|407345|P1|COMPLETED|Maintenance Phase||12
165818|NCT00505414|407341|P5|Did Not Qualify for Maintenance Phase|Maintenance Phase||1
165819|NCT00505414|407342|P4|Did Not Qualify for Maintenance Phase|Maintenance Phase||3
165820|NCT00505414|407343|P3|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
165821|NCT00505414|407344|P2|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
165822|NCT00505414|407345|P1|Did Not Qualify for Maintenance Phase|Maintenance Phase||0
165823|NCT00505414|407341|P5|STARTED|Maintenance Phase|18 of 19 participants completing the morphine titration phase were continued on morphine.|0
165824|NCT00505414|407342|P4|STARTED|Maintenance Phase|29 of 32 participants were treated in the maintenance phase either with placebo or tapentadol|0
165825|NCT00505414|407343|P3|STARTED|Maintenance Phase|14 of 32 tapentadol titration participants were treated with placebo in the maintenance phase.|14
165826|NCT00505414|407344|P2|STARTED|Maintenance Phase|15 of 32 tapentadol titration participants continued with tapentadol in the maintenance phase|15
165827|NCT00505414|407345|P1|STARTED|Maintenance Phase|18 of the 19 morphine participants continued with morphine in the maintenance phase.|18
165828|NCT00505414|407341|P5|NOT COMPLETED|Titration Phase||12
165829|NCT00505414|407342|P4|NOT COMPLETED|Titration Phase||30
165830|NCT00505414|407343|P3|NOT COMPLETED|Titration Phase||0
165831|NCT00505414|407344|P2|NOT COMPLETED|Titration Phase||0
165832|NCT00505414|407345|P1|NOT COMPLETED|Titration Phase||0
165833|NCT00505414|407341|P5|COMPLETED|Titration Phase||19
165834|NCT00505414|407342|P4|COMPLETED|Titration Phase||32
165835|NCT00505414|407343|P3|COMPLETED|Titration Phase||0
165836|NCT00505414|407344|P2|COMPLETED|Titration Phase||0
165837|NCT00505414|407345|P1|COMPLETED|Titration Phase||0
165838|NCT00505414|407341|P5|STARTED|Titration Phase||31
165839|NCT00505414|407342|P4|STARTED|Titration Phase||62
165840|NCT00505414|407343|P3|STARTED|Titration Phase||0
165841|NCT00505414|407344|P2|STARTED|Titration Phase||0
165842|NCT00505414|407345|P1|STARTED|Titration Phase||0
165843|NCT00505518|407360|P1|NOT COMPLETED|Overall Study||0
165844|NCT00505518|407360|P1|COMPLETED|Overall Study||9
165845|NCT00505518|407360|P1|STARTED|Overall Study||9
165846|NCT00505622|407369|P3|NOT COMPLETED|Overall Study||96
165847|NCT00505622|407370|P2|NOT COMPLETED|Overall Study||108
165848|NCT00505622|407371|P1|NOT COMPLETED|Overall Study||121
165849|NCT00505622|407369|P3|COMPLETED|Overall Study||0
165850|NCT00505622|407370|P2|COMPLETED|Overall Study||0
165851|NCT00505622|407371|P1|COMPLETED|Overall Study||0
165852|NCT00505622|407369|P3|STARTED|Overall Study||96
165853|NCT00505622|407370|P2|STARTED|Overall Study||108
165854|NCT00505622|407371|P1|STARTED|Overall Study||121
165855|NCT00505635|407388|P1|NOT COMPLETED|Overall Study||0
165856|NCT00505635|407388|P1|COMPLETED|Overall Study||5
165857|NCT00505635|407388|P1|STARTED|Overall Study||5
165858|NCT00505661|407392|P1|NOT COMPLETED|Overall Study||4
165859|NCT00505661|407392|P1|COMPLETED|Overall Study||12
165860|NCT00505661|407392|P1|STARTED|Overall Study||16
165861|NCT00505687|407396|P1|NOT COMPLETED|Overall Study||95
165862|NCT00505687|407396|P1|COMPLETED|Overall Study||91
165863|NCT00505687|407396|P1|STARTED|Overall Study||186
165864|NCT00505752|407406|P4|NOT COMPLETED|Overall Study||6
165865|NCT00505752|407407|P3|NOT COMPLETED|Overall Study||8
165866|NCT00505752|407408|P2|NOT COMPLETED|Overall Study||9
165867|NCT00505752|407409|P1|NOT COMPLETED|Overall Study||6
165868|NCT00505752|407406|P4|COMPLETED|Overall Study||126
165869|NCT00505752|407407|P3|COMPLETED|Overall Study||120
165870|NCT00505752|407408|P2|COMPLETED|Overall Study||119
165871|NCT00505752|407409|P1|COMPLETED|Overall Study||126
165872|NCT00505752|407406|P4|STARTED|Overall Study||132
165873|NCT00505752|407407|P3|STARTED|Overall Study||128
165874|NCT00505752|407408|P2|STARTED|Overall Study||128
165875|NCT00505752|407409|P1|STARTED|Overall Study||132
165876|NCT00505765|407426|P3|NOT COMPLETED|Overall Study||3
165877|NCT00505765|407427|P2|NOT COMPLETED|Overall Study||3
165878|NCT00505765|407428|P1|NOT COMPLETED|Overall Study||2
165879|NCT00505765|407426|P3|COMPLETED|Overall Study||19
165880|NCT00505765|407427|P2|COMPLETED|Overall Study||17
165881|NCT00505765|407428|P1|COMPLETED|Overall Study||19
165882|NCT00505765|407426|P3|Mid-Point Assessment|Overall Study||21
165883|NCT00505765|407427|P2|Mid-Point Assessment|Overall Study||19
165884|NCT00505765|407428|P1|Mid-Point Assessment|Overall Study||20
165885|NCT00505765|407426|P3|STARTED|Overall Study||22
165886|NCT00505765|407427|P2|STARTED|Overall Study||20
165887|NCT00505765|407428|P1|STARTED|Overall Study||21
165888|NCT00505778|407453|P2|NOT COMPLETED|Overall Study||135
165889|NCT00505778|407454|P1|NOT COMPLETED|Overall Study||134
165890|NCT00505778|407453|P2|COMPLETED|Overall Study||378
165891|NCT00505778|407454|P1|COMPLETED|Overall Study||380
165892|NCT00505778|407453|P2|Intent to Treat (ITT) Population|Overall Study||511
165893|NCT00505778|407454|P1|Intent to Treat (ITT) Population|Overall Study||512
165894|NCT00505778|407453|P2|STARTED|Overall Study||513
165895|NCT00505778|407454|P1|STARTED|Overall Study||514
165896|NCT00505895|407472|P2|NOT COMPLETED|Overall Study||0
165897|NCT00505895|407473|P1|NOT COMPLETED|Overall Study||0
165898|NCT00505895|407472|P2|COMPLETED|Overall Study||23
165899|NCT00505895|407473|P1|COMPLETED|Overall Study||27
165900|NCT00505895|407472|P2|STARTED|Overall Study||23
165901|NCT00505895|407473|P1|STARTED|Overall Study||27
165902|NCT00505921|407481|P1|NOT COMPLETED|Overall Study||9
165903|NCT00505921|407481|P1|COMPLETED|Overall Study||18
165904|NCT00505921|407481|P1|STARTED|Overall Study||27
165905|NCT00497770|407489|P4|NOT COMPLETED|Overall Study||0
165906|NCT00497770|407490|P3|NOT COMPLETED|Overall Study||0
165907|NCT00497770|407491|P2|NOT COMPLETED|Overall Study||0
165908|NCT00497770|407492|P1|NOT COMPLETED|Overall Study||0
165909|NCT00497770|407489|P4|COMPLETED|Overall Study||28
165910|NCT00497770|407490|P3|COMPLETED|Overall Study||37
165911|NCT00497770|407491|P2|COMPLETED|Overall Study||65
165912|NCT00497770|407492|P1|COMPLETED|Overall Study||304
165913|NCT00497770|407489|P4|STARTED|Overall Study||28
165914|NCT00497770|407490|P3|STARTED|Overall Study||37
165915|NCT00497770|407491|P2|STARTED|Overall Study||65
165916|NCT00497770|407492|P1|STARTED|Overall Study||304
165917|NCT00497796|407544|P2|NOT COMPLETED|Overall Study||59
165918|NCT00497796|407545|P1|NOT COMPLETED|Overall Study||85
165919|NCT00497796|407544|P2|COMPLETED|Overall Study||101
165920|NCT00497796|407545|P1|COMPLETED|Overall Study||62
165921|NCT00497796|407544|P2|STARTED|Overall Study||160
165922|NCT00497796|407545|P1|STARTED|Overall Study||147
165923|NCT00497874|407575|P2|NOT COMPLETED|Overall Study||116
165924|NCT00497874|407576|P1|NOT COMPLETED|Overall Study||147
165925|NCT00497874|407575|P2|COMPLETED|Overall Study||343
165926|NCT00497874|407576|P1|COMPLETED|Overall Study||296
165927|NCT00497874|407575|P2|STARTED|Overall Study||459
165928|NCT00497874|407576|P1|STARTED|Overall Study||443
165929|NCT00498173|407594|P3|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
165930|NCT00498173|407595|P2|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
165931|NCT00498173|407596|P1|NOT COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
165932|NCT00498173|407594|P3|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
165933|NCT00498173|407595|P2|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
165934|NCT00498173|407596|P1|COMPLETED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
165935|NCT00498173|407594|P3|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||26
165936|NCT00498173|407595|P2|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
165937|NCT00498173|407596|P1|STARTED|Phase 2-Atomoxetine Open Label (8 Weeks)||0
165938|NCT00498173|407594|P3|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
165939|NCT00498173|407595|P2|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||1
165940|NCT00498173|407596|P1|NOT COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||2
165941|NCT00498173|407594|P3|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||0
165942|NCT00498173|407595|P2|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||30
165943|NCT00498173|407596|P1|COMPLETED|Phase 1-Blinded Randomization (8 Weeks)||27
165944|NCT00498173|407594|P3|STARTED|Phase 1-Blinded Randomization (8 Weeks)||0
165945|NCT00498173|407595|P2|STARTED|Phase 1-Blinded Randomization (8 Weeks)||31
165946|NCT00498173|407596|P1|STARTED|Phase 1-Blinded Randomization (8 Weeks)||29
165947|NCT00498186|407624|P1|NOT COMPLETED|Overall Study||173
165948|NCT00498186|407624|P1|COMPLETED|Overall Study||122
165949|NCT00498186|407624|P1|STARTED|Overall Study||295
165950|NCT00498355|407629|P1|NOT COMPLETED|Overall Study||1
165951|NCT00498355|407629|P1|COMPLETED|Overall Study||6
165952|NCT00498355|407629|P1|STARTED|Overall Study||7
165953|NCT00498368|407635|P2|NOT COMPLETED|Overall Study||2
165954|NCT00498368|407636|P1|NOT COMPLETED|Overall Study||3
165955|NCT00498368|407635|P2|COMPLETED|Overall Study||15
165956|NCT00498368|407636|P1|COMPLETED|Overall Study||14
165957|NCT00498368|407635|P2|STARTED|Overall Study||17
165958|NCT00498368|407636|P1|STARTED|Overall Study||17
165959|NCT00498433|407651|P3|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
165960|NCT00498433|407652|P2|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
165961|NCT00498433|407653|P1|NOT COMPLETED|Part 2: Double Blind (12 Weeks)||0
165962|NCT00498433|407651|P3|COMPLETED|Part 2: Double Blind (12 Weeks)||8
165963|NCT00498433|407652|P2|COMPLETED|Part 2: Double Blind (12 Weeks)||8
165964|NCT00498433|407653|P1|COMPLETED|Part 2: Double Blind (12 Weeks)||0
165965|NCT00498433|407651|P3|STARTED|Part 2: Double Blind (12 Weeks)||8
165966|NCT00498433|407652|P2|STARTED|Part 2: Double Blind (12 Weeks)||8
165967|NCT00498433|407653|P1|STARTED|Part 2: Double Blind (12 Weeks)||0
165968|NCT00498433|407651|P3|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
165969|NCT00498433|407652|P2|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
165970|NCT00498433|407653|P1|NOT COMPLETED|Part 2: Placebo Run-in (2 Weeks)||20
165971|NCT00498433|407651|P3|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
165972|NCT00498433|407652|P2|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||0
165973|NCT00498433|407653|P1|COMPLETED|Part 2: Placebo Run-in (2 Weeks)||16
165974|NCT00498433|407651|P3|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
165975|NCT00498433|407652|P2|STARTED|Part 2: Placebo Run-in (2 Weeks)|For part 2, this arm belongs to randomized, double blind period.|0
165976|NCT00498433|407653|P1|STARTED|Part 2: Placebo Run-in (2 Weeks)||36
165977|NCT00498433|407651|P3|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
165978|NCT00498433|407652|P2|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
165979|NCT00498433|407653|P1|NOT COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
165980|NCT00498433|407651|P3|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
165981|NCT00498433|407652|P2|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
165982|NCT00498433|407653|P1|COMPLETED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
165983|NCT00498433|407651|P3|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||10
165984|NCT00498433|407652|P2|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
165985|NCT00498433|407653|P1|STARTED|Part 1, Period 3: Amlodipine (4-8 Weeks)||0
165986|NCT00498433|407651|P3|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
165987|NCT00498433|407652|P2|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
165988|NCT00498433|407653|P1|NOT COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
165989|NCT00498433|407651|P3|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
165990|NCT00498433|407652|P2|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||10
165991|NCT00498433|407653|P1|COMPLETED|Part 1, Period 2: Aliskiren (4 Weeks)||0
165992|NCT00498433|407651|P3|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
165993|NCT00498433|407652|P2|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||10
165994|NCT00498433|407653|P1|STARTED|Part 1, Period 2: Aliskiren (4 Weeks)||0
165995|NCT00498433|407651|P3|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
165996|NCT00498433|407652|P2|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
165997|NCT00498433|407653|P1|NOT COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
165998|NCT00498433|407651|P3|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
165999|NCT00498433|407652|P2|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
166000|NCT00498433|407653|P1|COMPLETED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
166001|NCT00498433|407651|P3|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
166002|NCT00498433|407652|P2|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||0
166003|NCT00498433|407653|P1|STARTED|Part 1, Period 1:Placebo Run-in(2 Weeks)||10
166004|NCT00498485|407698|P2|NOT COMPLETED|Overall Study||5
166005|NCT00498485|407699|P1|NOT COMPLETED|Overall Study||1
166006|NCT00498485|407698|P2|COMPLETED|Overall Study||5
166007|NCT00498485|407699|P1|COMPLETED|Overall Study||6
166008|NCT00498485|407698|P2|STARTED|Overall Study||10
166009|NCT00498485|407699|P1|STARTED|Overall Study||7
166010|NCT00498550|407709|P2|NOT COMPLETED|Overall Study||1
166011|NCT00498550|407710|P1|NOT COMPLETED|Overall Study||0
166012|NCT00498550|407709|P2|COMPLETED|Overall Study||15
166013|NCT00498550|407710|P1|COMPLETED|Overall Study|13 of 15 received clozapine all 12 visits, two discontinued clozapine early but remained in study.|15
166014|NCT00498550|407709|P2|STARTED|Overall Study||16
166015|NCT00498550|407710|P1|STARTED|Overall Study||15
166016|NCT00498602|407723|P7|NOT COMPLETED|Overall Study||2
166017|NCT00498602|407724|P6|NOT COMPLETED|Overall Study||13
166018|NCT00498602|407725|P5|NOT COMPLETED|Overall Study||4
166019|NCT00498602|407726|P4|NOT COMPLETED|Overall Study||5
166020|NCT00498602|407727|P3|NOT COMPLETED|Overall Study||8
166021|NCT00498602|407728|P2|NOT COMPLETED|Overall Study||10
166022|NCT00498602|407729|P1|NOT COMPLETED|Overall Study||10
166023|NCT00498602|407723|P7|COMPLETED|Overall Study||15
166024|NCT00498602|407724|P6|COMPLETED|Overall Study||31
166025|NCT00498602|407725|P5|COMPLETED|Overall Study||8
166026|NCT00498602|407726|P4|COMPLETED|Overall Study||30
166027|NCT00498602|407727|P3|COMPLETED|Overall Study||32
166028|NCT00498602|407728|P2|COMPLETED|Overall Study||51
166029|NCT00498602|407729|P1|COMPLETED|Overall Study||26
166030|NCT00498602|407723|P7|Treated|Overall Study||17
166031|NCT00498602|407724|P6|Treated|Overall Study||44
166032|NCT00498602|407725|P5|Treated|Overall Study||12
166033|NCT00498602|407726|P4|Treated|Overall Study||35
166034|NCT00498602|407727|P3|Treated|Overall Study||40
166035|NCT00498602|407728|P2|Treated|Overall Study|One participant discontinued due to an AE, with an outcome of death.|60
166036|NCT00498602|407729|P1|Treated|Overall Study||36
166037|NCT00498602|407723|P7|STARTED|Overall Study||17
166038|NCT00498602|407724|P6|STARTED|Overall Study||44
166039|NCT00498602|407725|P5|STARTED|Overall Study||12
166040|NCT00498602|407726|P4|STARTED|Overall Study||35
166041|NCT00498602|407727|P3|STARTED|Overall Study||40
166042|NCT00498602|407728|P2|STARTED|Overall Study||61
166043|NCT00498602|407729|P1|STARTED|Overall Study||36
166044|NCT00498615|407766|P6|NOT COMPLETED|Placebo||0
166045|NCT00498615|407767|P5|NOT COMPLETED|Placebo||0
166046|NCT00498615|407768|P4|NOT COMPLETED|Placebo||0
166047|NCT00498615|407769|P3|NOT COMPLETED|Placebo||0
166048|NCT00498615|407770|P2|NOT COMPLETED|Placebo||0
166049|NCT00498615|407771|P1|NOT COMPLETED|Placebo||0
166050|NCT00498615|407766|P6|COMPLETED|Placebo||3
166051|NCT00498615|407767|P5|COMPLETED|Placebo||3
166052|NCT00498615|407768|P4|COMPLETED|Placebo||2
166053|NCT00498615|407769|P3|COMPLETED|Placebo||3
166054|NCT00498615|407770|P2|COMPLETED|Placebo||4
166055|NCT00498615|407771|P1|COMPLETED|Placebo||2
166056|NCT00498615|407766|P6|STARTED|Placebo||3
166057|NCT00498615|407767|P5|STARTED|Placebo||3
166058|NCT00498615|407768|P4|STARTED|Placebo||2
166059|NCT00498615|407769|P3|STARTED|Placebo||3
166060|NCT00498615|407770|P2|STARTED|Placebo||4
166061|NCT00498615|407771|P1|STARTED|Placebo||2
166062|NCT00498615|407766|P6|NOT COMPLETED|Fasudil 40mg||0
166063|NCT00498615|407767|P5|NOT COMPLETED|Fasudil 40mg||0
166064|NCT00498615|407768|P4|NOT COMPLETED|Fasudil 40mg||0
166065|NCT00498615|407769|P3|NOT COMPLETED|Fasudil 40mg||0
166066|NCT00498615|407770|P2|NOT COMPLETED|Fasudil 40mg||0
166067|NCT00498615|407771|P1|NOT COMPLETED|Fasudil 40mg||0
166068|NCT00498615|407766|P6|COMPLETED|Fasudil 40mg||3
166069|NCT00498615|407767|P5|COMPLETED|Fasudil 40mg||3
166070|NCT00498615|407768|P4|COMPLETED|Fasudil 40mg||2
166071|NCT00498615|407769|P3|COMPLETED|Fasudil 40mg||3
166072|NCT00498615|407770|P2|COMPLETED|Fasudil 40mg||4
166073|NCT00498615|407771|P1|COMPLETED|Fasudil 40mg||2
166074|NCT00498615|407766|P6|STARTED|Fasudil 40mg||3
166075|NCT00498615|407767|P5|STARTED|Fasudil 40mg||3
166076|NCT00498615|407768|P4|STARTED|Fasudil 40mg||2
166077|NCT00498615|407769|P3|STARTED|Fasudil 40mg||3
166078|NCT00498615|407770|P2|STARTED|Fasudil 40mg||4
166079|NCT00498615|407771|P1|STARTED|Fasudil 40mg||2
166080|NCT00498615|407766|P6|NOT COMPLETED|Fasudil 80mg||0
166081|NCT00498615|407767|P5|NOT COMPLETED|Fasudil 80mg||0
166082|NCT00498615|407768|P4|NOT COMPLETED|Fasudil 80mg||0
166083|NCT00498615|407769|P3|NOT COMPLETED|Fasudil 80mg||0
166084|NCT00498615|407770|P2|NOT COMPLETED|Fasudil 80mg||0
166085|NCT00498615|407771|P1|NOT COMPLETED|Fasudil 80mg||0
166086|NCT00498615|407766|P6|COMPLETED|Fasudil 80mg||3
166087|NCT00498615|407767|P5|COMPLETED|Fasudil 80mg||3
166088|NCT00498615|407768|P4|COMPLETED|Fasudil 80mg||2
166089|NCT00498615|407769|P3|COMPLETED|Fasudil 80mg||3
166090|NCT00498615|407770|P2|COMPLETED|Fasudil 80mg||4
166091|NCT00498615|407771|P1|COMPLETED|Fasudil 80mg||2
166092|NCT00498615|407766|P6|STARTED|Fasudil 80mg||3
166093|NCT00498615|407767|P5|STARTED|Fasudil 80mg||3
166094|NCT00498615|407768|P4|STARTED|Fasudil 80mg||2
166095|NCT00498615|407769|P3|STARTED|Fasudil 80mg||3
166096|NCT00498615|407770|P2|STARTED|Fasudil 80mg||4
166097|NCT00498615|407771|P1|STARTED|Fasudil 80mg||2
166098|NCT00498628|407787|P2|NOT COMPLETED|Overall Study||21
166099|NCT00498628|407788|P1|NOT COMPLETED|Overall Study||15
166100|NCT00498628|407787|P2|COMPLETED|Overall Study||92
166101|NCT00498628|407788|P1|COMPLETED|Overall Study||90
166102|NCT00498628|407787|P2|STARTED|Overall Study||113
166103|NCT00498628|407788|P1|STARTED|Overall Study||105
166104|NCT00498706|407796|P2|NOT COMPLETED|Overall Study||0
166105|NCT00498706|407797|P1|NOT COMPLETED|Overall Study||0
166106|NCT00498706|407796|P2|COMPLETED|Overall Study||162
166107|NCT00498706|407797|P1|COMPLETED|Overall Study||163
166108|NCT00498706|407796|P2|Post Treatment Week 18|Overall Study||162
166109|NCT00498706|407797|P1|Post Treatment Week 18|Overall Study||163
166110|NCT00498706|407796|P2|STARTED|Overall Study||162
166111|NCT00498706|407797|P1|STARTED|Overall Study||163
166112|NCT00498797|407811|P2|NOT COMPLETED|Overall Study||29
166113|NCT00498797|407812|P1|NOT COMPLETED|Overall Study||38
166114|NCT00498797|407811|P2|COMPLETED|Overall Study|ongoing study treatment at data cut-off|14
166115|NCT00498797|407812|P1|COMPLETED|Overall Study|ongoing study treatment at data cut-off|5
166116|NCT00498797|407811|P2|STARTED|Overall Study|randomised patients|43
166117|NCT00498797|407812|P1|STARTED|Overall Study|randomised patients|43
166118|NCT00498927|407820|P1|NOT COMPLETED|Overall Study||0
166119|NCT00498927|407820|P1|COMPLETED|Overall Study||47
166120|NCT00498927|407820|P1|STARTED|Overall Study||47
166121|NCT00498940|407827|P2|NOT COMPLETED|Overall Study||0
166122|NCT00498940|407828|P1|NOT COMPLETED|Overall Study||0
166123|NCT00498940|407827|P2|COMPLETED|Overall Study||31
166124|NCT00498940|407828|P1|COMPLETED|Overall Study||30
166125|NCT00498940|407827|P2|STARTED|Overall Study||31
166126|NCT00498940|407828|P1|STARTED|Overall Study||30
166127|NCT00499031|407834|P1|NOT COMPLETED|Overall Study||3
166128|NCT00499031|407834|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|35
166129|NCT00499031|407834|P1|STARTED|Overall Study|Total number participants enrolled on study|38
166130|NCT00499096|407841|P2|NOT COMPLETED|Overall Study||20
166131|NCT00499096|407842|P1|NOT COMPLETED|Overall Study||23
166132|NCT00499096|407841|P2|COMPLETED|Overall Study||40
166133|NCT00499096|407842|P1|COMPLETED|Overall Study||35
166134|NCT00499096|407841|P2|STARTED|Overall Study||60
166135|NCT00499096|407842|P1|STARTED|Overall Study||58
166136|NCT00499109|407862|P2|NOT COMPLETED|Overall Study||7
166137|NCT00499109|407863|P1|NOT COMPLETED|Overall Study||18
166138|NCT00499109|407862|P2|COMPLETED|Overall Study||85
166139|NCT00499109|407863|P1|COMPLETED|Overall Study||165
166140|NCT00499109|407862|P2|STARTED|Overall Study||92
166141|NCT00499109|407863|P1|STARTED|Overall Study||183
166142|NCT00499122|407876|P1|NOT COMPLETED|Overall Study||2
166143|NCT00499122|407876|P1|COMPLETED|Overall Study||39
166144|NCT00499122|407876|P1|STARTED|Overall Study||41
166145|NCT00499252|407881|P1|NOT COMPLETED|Overall Study||12
166146|NCT00499252|407881|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|39
166147|NCT00499252|407881|P1|STARTED|Overall Study||51
166148|NCT00499343|407889|P2|NOT COMPLETED|Overall Study||0
166149|NCT00499343|407890|P1|NOT COMPLETED|Overall Study||0
166150|NCT00499343|407889|P2|COMPLETED|Overall Study||43
166151|NCT00499343|407890|P1|COMPLETED|Overall Study||41
166152|NCT00499343|407889|P2|STARTED|Overall Study||43
166153|NCT00499343|407890|P1|STARTED|Overall Study||41
166154|NCT00499369|407901|P5|NOT COMPLETED|Overall Study||12
166155|NCT00499369|407902|P4|NOT COMPLETED|Overall Study||9
166156|NCT00499369|407903|P3|NOT COMPLETED|Overall Study||17
166157|NCT00499369|407904|P2|NOT COMPLETED|Overall Study||18
166158|NCT00499369|407905|P1|NOT COMPLETED|Overall Study||16
166159|NCT00499369|407901|P5|COMPLETED|Overall Study||0
166160|NCT00499369|407902|P4|COMPLETED|Overall Study||0
166161|NCT00499369|407903|P3|COMPLETED|Overall Study||0
166162|NCT00499369|407904|P2|COMPLETED|Overall Study||0
166163|NCT00499369|407905|P1|COMPLETED|Overall Study||0
166164|NCT00499369|407901|P5|Eligible|Overall Study||12
166165|NCT00499369|407902|P4|Eligible|Overall Study||8
166166|NCT00499369|407903|P3|Eligible|Overall Study||16
166167|NCT00499369|407904|P2|Eligible|Overall Study||16
166168|NCT00499369|407905|P1|Eligible|Overall Study||14
166169|NCT00499369|407901|P5|STARTED|Overall Study||12
166170|NCT00499369|407902|P4|STARTED|Overall Study||9
166171|NCT00499369|407903|P3|STARTED|Overall Study||17
166172|NCT00499369|407904|P2|STARTED|Overall Study||18
166173|NCT00499369|407905|P1|STARTED|Overall Study||16
166174|NCT00499408|407932|P1|NOT COMPLETED|Overall Study||0
166175|NCT00499408|407932|P1|COMPLETED|Overall Study|Three patients did not have adequate testing to be evaluable for a response.|26
166176|NCT00499408|407932|P1|STARTED|Overall Study||26
166177|NCT00499447|407936|P1|NOT COMPLETED|Overall Study||0
166178|NCT00499447|407936|P1|COMPLETED|Overall Study||13
166179|NCT00499447|407936|P1|STARTED|Overall Study||13
166180|NCT00499460|407942|P2|NOT COMPLETED|Intervention 2 (30 Days)||1
166181|NCT00499460|407943|P1|NOT COMPLETED|Intervention 2 (30 Days)||0
166182|NCT00499460|407942|P2|COMPLETED|Intervention 2 (30 Days)||6
166183|NCT00499460|407943|P1|COMPLETED|Intervention 2 (30 Days)||6
166184|NCT00499460|407942|P2|STARTED|Intervention 2 (30 Days)||7
166185|NCT00499460|407943|P1|STARTED|Intervention 2 (30 Days)||6
166186|NCT00499460|407942|P2|NOT COMPLETED|Intervention 1 (30 Days)||0
166187|NCT00499460|407943|P1|NOT COMPLETED|Intervention 1 (30 Days)||2
166188|NCT00499460|407942|P2|COMPLETED|Intervention 1 (30 Days)||7
166189|NCT00499460|407943|P1|COMPLETED|Intervention 1 (30 Days)||6
166190|NCT00499460|407942|P2|STARTED|Intervention 1 (30 Days)||7
166191|NCT00499460|407943|P1|STARTED|Intervention 1 (30 Days)||8
166192|NCT00499473|407961|P2|NOT COMPLETED|Overall Study||0
166193|NCT00499473|407962|P1|NOT COMPLETED|Overall Study||6
166194|NCT00499473|407961|P2|COMPLETED|Overall Study||4
166195|NCT00499473|407962|P1|COMPLETED|Overall Study|Patients evaluable|21
166196|NCT00499473|407961|P2|STARTED|Overall Study||4
166197|NCT00499473|407962|P1|STARTED|Overall Study||27
166198|NCT00499486|407978|P1|NOT COMPLETED|Overall Study||16
166199|NCT00499486|407978|P1|COMPLETED|Overall Study||31
166200|NCT00499486|407978|P1|STARTED|Overall Study||47
166201|NCT00499590|407987|P3|NOT COMPLETED|Overall Study||113
166202|NCT00499590|407988|P2|NOT COMPLETED|Overall Study||112
166203|NCT00499590|407989|P1|NOT COMPLETED|Overall Study||113
166204|NCT00499590|407987|P3|COMPLETED|Overall Study||0
166205|NCT00499590|407988|P2|COMPLETED|Overall Study||0
166206|NCT00499590|407989|P1|COMPLETED|Overall Study||0
166207|NCT00499590|407987|P3|STARTED|Overall Study||113
166208|NCT00499590|407988|P2|STARTED|Overall Study||112
166209|NCT00499590|407989|P1|STARTED|Overall Study||113
166210|NCT00499603|408002|P2|NOT COMPLETED|Overall Study||1
166211|NCT00499603|408003|P1|NOT COMPLETED|Overall Study||0
166212|NCT00499603|408002|P2|COMPLETED|Overall Study||22
166213|NCT00499603|408003|P1|COMPLETED|Overall Study||27
166214|NCT00499603|408002|P2|STARTED|Overall Study||23
166215|NCT00499603|408003|P1|STARTED|Overall Study||27
166216|NCT00499616|408017|P4|NOT COMPLETED|Overall Study||57
166217|NCT00499616|408018|P3|NOT COMPLETED|Overall Study||36
166218|NCT00499616|408019|P2|NOT COMPLETED|Overall Study||28
166219|NCT00499616|408020|P1|NOT COMPLETED|Overall Study||15
166220|NCT00499616|408017|P4|COMPLETED|Overall Study||0
166221|NCT00499616|408018|P3|COMPLETED|Overall Study||53
166222|NCT00499616|408019|P2|COMPLETED|Overall Study||114
166223|NCT00499616|408020|P1|COMPLETED|Overall Study||161
166224|NCT00499616|408017|P4|STARTED|Overall Study||57
166225|NCT00499616|408018|P3|STARTED|Overall Study||89
166226|NCT00499616|408019|P2|STARTED|Overall Study||142
166227|NCT00499616|408020|P1|STARTED|Overall Study||176
166228|NCT00499655|408057|P2|NOT COMPLETED|Overall Study||0
166229|NCT00499655|408058|P1|NOT COMPLETED|Overall Study||0
166230|NCT00499655|408057|P2|COMPLETED|Overall Study||54
166231|NCT00499655|408058|P1|COMPLETED|Overall Study||53
166232|NCT00499655|408057|P2|STARTED|Overall Study||54
166233|NCT00499655|408058|P1|STARTED|Overall Study||53
166234|NCT00499681|408074|P2|NOT COMPLETED|Overall Study||2
166235|NCT00499681|408075|P1|NOT COMPLETED|Overall Study||0
166236|NCT00499681|408074|P2|COMPLETED|Overall Study||0
166237|NCT00499681|408075|P1|COMPLETED|Overall Study||4
166238|NCT00499681|408074|P2|STARTED|Overall Study||2
166239|NCT00499681|408075|P1|STARTED|Overall Study||4
166240|NCT00499694|408081|P1|NOT COMPLETED|Overall Study||1
166241|NCT00499694|408081|P1|COMPLETED|Overall Study||30
166242|NCT00499694|408081|P1|STARTED|Overall Study||31
166243|NCT00505934|408085|P1|NOT COMPLETED|Overall Study||3
166244|NCT00505934|408085|P1|COMPLETED|Overall Study||16
166245|NCT00505934|408085|P1|STARTED|Overall Study|Of the 23 subjects screened, 19 were enrolled into the study and received levetiracetam IV (LEV IV).|19
166246|NCT00506025|408094|P3|NOT COMPLETED|Overall Study||0
166247|NCT00506025|408095|P2|NOT COMPLETED|Overall Study||0
166248|NCT00506025|408096|P1|NOT COMPLETED|Overall Study||0
166249|NCT00506025|408094|P3|COMPLETED|Overall Study||8
166250|NCT00506025|408095|P2|COMPLETED|Overall Study||9
166251|NCT00506025|408096|P1|COMPLETED|Overall Study||10
166252|NCT00506025|408094|P3|STARTED|Overall Study||8
166253|NCT00506025|408095|P2|STARTED|Overall Study||9
166254|NCT00506025|408096|P1|STARTED|Overall Study||10
166255|NCT00506064|408106|P2|NOT COMPLETED|Overall Study||0
166256|NCT00506064|408107|P1|NOT COMPLETED|Overall Study||0
166257|NCT00506064|408106|P2|COMPLETED|Overall Study||0
166258|NCT00506064|408107|P1|COMPLETED|Overall Study||1
166259|NCT00506064|408106|P2|STARTED|Overall Study||0
166260|NCT00506064|408107|P1|STARTED|Overall Study||1
166261|NCT00506077|408115|P2|NOT COMPLETED|Treatment Period 2||1
166262|NCT00506077|408116|P1|NOT COMPLETED|Treatment Period 2||1
166263|NCT00506077|408115|P2|COMPLETED|Treatment Period 2||23
166264|NCT00506077|408116|P1|COMPLETED|Treatment Period 2||23
166265|NCT00506077|408115|P2|STARTED|Treatment Period 2||24
166266|NCT00506077|408116|P1|STARTED|Treatment Period 2||24
166267|NCT00506077|408115|P2|NOT COMPLETED|Washout||0
166268|NCT00506077|408116|P1|NOT COMPLETED|Washout||0
166269|NCT00506077|408115|P2|COMPLETED|Washout||24
166270|NCT00506077|408116|P1|COMPLETED|Washout||24
166271|NCT00506077|408115|P2|STARTED|Washout||24
166272|NCT00506077|408116|P1|STARTED|Washout||24
166273|NCT00506077|408115|P2|NOT COMPLETED|Treatment Period 1||3
166274|NCT00506077|408116|P1|NOT COMPLETED|Treatment Period 1||4
166275|NCT00506077|408115|P2|COMPLETED|Treatment Period 1||24
166276|NCT00506077|408116|P1|COMPLETED|Treatment Period 1||24
166277|NCT00506077|408115|P2|STARTED|Treatment Period 1||27
166278|NCT00506077|408116|P1|STARTED|Treatment Period 1||28
166279|NCT00506155|408136|P1|NOT COMPLETED|Overall Study||0
166280|NCT00506155|408136|P1|COMPLETED|Overall Study||60
166281|NCT00506155|408136|P1|STARTED|Overall Study||60
166282|NCT00506662|408143|P2|NOT COMPLETED|Overall Study||28
166283|NCT00506662|408144|P1|NOT COMPLETED|Overall Study||17
166284|NCT00506662|408143|P2|COMPLETED|Overall Study||20
166285|NCT00506662|408144|P1|COMPLETED|Overall Study||21
166286|NCT00506662|408143|P2|STARTED|Overall Study||48
166287|NCT00506662|408144|P1|STARTED|Overall Study||38
166288|NCT00506675|408176|P2|NOT COMPLETED|Overall Study||0
166289|NCT00506675|408177|P1|NOT COMPLETED|Overall Study||0
166290|NCT00506675|408176|P2|COMPLETED|Overall Study||28
166291|NCT00506675|408177|P1|COMPLETED|Overall Study||27
166292|NCT00506675|408176|P2|STARTED|Overall Study||28
166293|NCT00506675|408177|P1|STARTED|Overall Study||27
166294|NCT00506714|408191|P2|NOT COMPLETED|Overall Study||0
166295|NCT00506714|408192|P1|NOT COMPLETED|Overall Study||0
166296|NCT00506714|408191|P2|COMPLETED|Overall Study||13
166297|NCT00506714|408192|P1|COMPLETED|Overall Study||13
166298|NCT00506714|408191|P2|STARTED|Overall Study||13
166299|NCT00506714|408192|P1|STARTED|Overall Study||13
166300|NCT00506831|408200|P1|NOT COMPLETED|Overall Study||2
166301|NCT00506831|408200|P1|COMPLETED|Overall Study||7
166302|NCT00506831|408200|P1|STARTED|Overall Study||9
166303|NCT00506857|408204|P1|NOT COMPLETED|Overall Study||0
166304|NCT00506857|408204|P1|COMPLETED|Overall Study||80
166305|NCT00506857|408204|P1|STARTED|Overall Study||80
166306|NCT00506883|408212|P3|NOT COMPLETED|Overall Study||4
166307|NCT00506883|408213|P2|NOT COMPLETED|Overall Study||3
166308|NCT00506883|408214|P1|NOT COMPLETED|Overall Study||7
166309|NCT00506883|408212|P3|COMPLETED|Overall Study||55
166310|NCT00506883|408213|P2|COMPLETED|Overall Study||71
166311|NCT00506883|408214|P1|COMPLETED|Overall Study||45
166312|NCT00506883|408212|P3|STARTED|Overall Study||59
166313|NCT00506883|408213|P2|STARTED|Overall Study||74
166314|NCT00506883|408214|P1|STARTED|Overall Study||52
166315|NCT00506922|408227|P5|NOT COMPLETED|Overall Study||1
166316|NCT00506922|408228|P4|NOT COMPLETED|Overall Study||2
166317|NCT00506922|408229|P3|NOT COMPLETED|Overall Study||0
166318|NCT00506922|408230|P2|NOT COMPLETED|Overall Study||0
166319|NCT00506922|408231|P1|NOT COMPLETED|Overall Study||0
166320|NCT00506922|408227|P5|COMPLETED|Overall Study||10
166321|NCT00506922|408228|P4|COMPLETED|Overall Study||61
166322|NCT00506922|408229|P3|COMPLETED|Overall Study||29
166323|NCT00506922|408230|P2|COMPLETED|Overall Study||10
166324|NCT00506922|408231|P1|COMPLETED|Overall Study||37
166325|NCT00506922|408227|P5|STARTED|Overall Study||11
166326|NCT00506922|408228|P4|STARTED|Overall Study||63
166327|NCT00506922|408229|P3|STARTED|Overall Study||29
166328|NCT00506922|408230|P2|STARTED|Overall Study||10
166329|NCT00506922|408231|P1|STARTED|Overall Study||37
166330|NCT00506948|408239|P1|NOT COMPLETED|Overall Study||10
166331|NCT00506948|408239|P1|COMPLETED|Overall Study||0
166332|NCT00506948|408239|P1|STARTED|Overall Study||10
166333|NCT00507130|408247|P4|NOT COMPLETED|Overall Study||1
166334|NCT00507130|408248|P3|NOT COMPLETED|Overall Study||1
166335|NCT00507130|408249|P2|NOT COMPLETED|Overall Study||0
166336|NCT00507130|408250|P1|NOT COMPLETED|Overall Study||1
166337|NCT00507130|408247|P4|COMPLETED|Overall Study||8
166338|NCT00507130|408248|P3|COMPLETED|Overall Study||8
166339|NCT00507130|408249|P2|COMPLETED|Overall Study||9
166340|NCT00507130|408250|P1|COMPLETED|Overall Study||8
166341|NCT00507130|408247|P4|STARTED|Overall Study||9
166342|NCT00507130|408248|P3|STARTED|Overall Study||9
166343|NCT00507130|408249|P2|STARTED|Overall Study||9
166344|NCT00507130|408250|P1|STARTED|Overall Study||9
166345|NCT00507208|408294|P2|NOT COMPLETED|Overall Study||0
166346|NCT00507208|408295|P1|NOT COMPLETED|Overall Study||0
166347|NCT00507208|408294|P2|COMPLETED|Overall Study||26
166348|NCT00507208|408295|P1|COMPLETED|Overall Study||27
166349|NCT00507208|408294|P2|Received Dynasplint in Crossover|Overall Study||3
166350|NCT00507208|408295|P1|Received Dynasplint in Crossover|Overall Study||0
166351|NCT00507208|408294|P2|STARTED|Overall Study||26
166352|NCT00507208|408295|P1|STARTED|Overall Study||27
166353|NCT00507416|408304|P3|NOT COMPLETED|Overall Study||114
166354|NCT00507416|408305|P2|NOT COMPLETED|Overall Study||125
166355|NCT00507416|408306|P1|NOT COMPLETED|Overall Study||118
166356|NCT00507416|408304|P3|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|53
166357|NCT00507416|408305|P2|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|42
166358|NCT00507416|408306|P1|COMPLETED|Overall Study|Completed is defined as having completed 13 treatment cycles.|50
166359|NCT00507416|408304|P3|Completed 8 Treatment Cycles|Overall Study||69
166360|NCT00507416|408305|P2|Completed 8 Treatment Cycles|Overall Study||60
166361|NCT00507416|408306|P1|Completed 8 Treatment Cycles|Overall Study||82
166362|NCT00507416|408304|P3|Treated (Safety Population)|Overall Study||163
166363|NCT00507416|408305|P2|Treated (Safety Population)|Overall Study||158
166364|NCT00507416|408306|P1|Treated (Safety Population)|Overall Study||165
166365|NCT00507416|408304|P3|STARTED|Overall Study||167
166366|NCT00507416|408305|P2|STARTED|Overall Study||167
166367|NCT00507416|408306|P1|STARTED|Overall Study||168
166368|NCT00507429|408337|P2|NOT COMPLETED|Maintenance Phase||0
166369|NCT00507429|408338|P1|NOT COMPLETED|Maintenance Phase||14
166370|NCT00507429|408337|P2|COMPLETED|Maintenance Phase||0
166371|NCT00507429|408338|P1|COMPLETED|Maintenance Phase|14 subjects were withdrawn due to progressive disease, 2 subjects continued beyond data cut-off|2
166372|NCT00507429|408337|P2|STARTED|Maintenance Phase|Control arm subjects followed for survival only; not enrolled in Maintenance period|0
166373|NCT00507429|408338|P1|STARTED|Maintenance Phase|2 subjects did not enter maintenance: 1/18 progressive disease; 1/18 lost to follow-up.|16
166374|NCT00507429|408337|P2|NOT COMPLETED|Treatment Phase||18
166375|NCT00507429|408338|P1|NOT COMPLETED|Treatment Phase||37
166376|NCT00507429|408337|P2|COMPLETED|Treatment Phase||7
166377|NCT00507429|408338|P1|COMPLETED|Treatment Phase||18
166378|NCT00507429|408337|P2|STARTED|Treatment Phase|Randomized|25
166379|NCT00507429|408338|P1|STARTED|Treatment Phase|Randomized|55
166380|NCT00507442|408350|P4|NOT COMPLETED|Overall Study||5
166381|NCT00507442|408351|P3|NOT COMPLETED|Overall Study||15
166382|NCT00507442|408352|P2|NOT COMPLETED|Overall Study||27
166383|NCT00507442|408353|P1|NOT COMPLETED|Overall Study||16
166384|NCT00507442|408350|P4|COMPLETED|Overall Study||12
166385|NCT00507442|408351|P3|COMPLETED|Overall Study||18
166386|NCT00507442|408352|P2|COMPLETED|Overall Study||39
166387|NCT00507442|408353|P1|COMPLETED|Overall Study||26
166388|NCT00507442|408350|P4|STARTED|Overall Study||17
166389|NCT00507442|408351|P3|STARTED|Overall Study||33
166390|NCT00507442|408352|P2|STARTED|Overall Study||66
166391|NCT00507442|408353|P1|STARTED|Overall Study||42
166392|NCT00507455|408406|P3|NOT COMPLETED|Overall Study||12
166393|NCT00507455|408407|P2|NOT COMPLETED|Overall Study||6
166394|NCT00507455|408408|P1|NOT COMPLETED|Overall Study||12
166395|NCT00507455|408406|P3|COMPLETED|Overall Study||62
166396|NCT00507455|408407|P2|COMPLETED|Overall Study||68
166397|NCT00507455|408408|P1|COMPLETED|Overall Study||62
166398|NCT00507455|408406|P3|STARTED|Overall Study||74
166399|NCT00507455|408407|P2|STARTED|Overall Study||74
166400|NCT00507455|408408|P1|STARTED|Overall Study||74
166401|NCT00507507|408469|P2|NOT COMPLETED|24-week Treatment-free Follow-up Period||17
166402|NCT00507507|408470|P1|NOT COMPLETED|24-week Treatment-free Follow-up Period||10
166403|NCT00507507|408469|P2|COMPLETED|24-week Treatment-free Follow-up Period||12
166404|NCT00507507|408470|P1|COMPLETED|24-week Treatment-free Follow-up Period||16
166405|NCT00507507|408469|P2|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|29
166406|NCT00507507|408470|P1|STARTED|24-week Treatment-free Follow-up Period|Participants who discontinued treatment early may have entered the treatment-free follow-up period.|26
166407|NCT00507507|408469|P2|NOT COMPLETED|Treatment Period||53
166408|NCT00507507|408470|P1|NOT COMPLETED|Treatment Period||52
166409|NCT00507507|408469|P2|COMPLETED|Treatment Period||9
166410|NCT00507507|408470|P1|COMPLETED|Treatment Period||12
166411|NCT00507507|408469|P2|Completed 192 Weeks of Treatment|Treatment Period||52
166412|NCT00507507|408470|P1|Completed 192 Weeks of Treatment|Treatment Period||52
166413|NCT00507507|408469|P2|STARTED|Treatment Period||62
166414|NCT00507507|408470|P1|STARTED|Treatment Period||64
166415|NCT00507546|408504|P2|NOT COMPLETED|Overall Study||1
166416|NCT00507546|408505|P1|NOT COMPLETED|Overall Study||2
166417|NCT00507546|408504|P2|COMPLETED|Overall Study||3
166418|NCT00507546|408505|P1|COMPLETED|Overall Study||2
166419|NCT00507546|408504|P2|STARTED|Overall Study||4
166420|NCT00507546|408505|P1|STARTED|Overall Study||4
166421|NCT00507559|408513|P1|NOT COMPLETED|Overall Study||71
166422|NCT00507559|408513|P1|COMPLETED|Overall Study||84
166423|NCT00507559|408513|P1|STARTED|Overall Study||155
166424|NCT00507689|408529|P2|NOT COMPLETED|Randomized Period||2
166425|NCT00507689|408530|P1|NOT COMPLETED|Randomized Period||1
166426|NCT00507689|408529|P2|COMPLETED|Randomized Period||16
166427|NCT00507689|408530|P1|COMPLETED|Randomized Period||18
166428|NCT00507689|408529|P2|STARTED|Randomized Period|18 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF.|18
166429|NCT00507689|408530|P1|STARTED|Randomized Period|19 of 37 participants who completed the pre-randomization period were randomized to FTC/TDF+HBIg.|19
166430|NCT00507689|408529|P2|NOT COMPLETED|Pre-Randomization Period||0
166431|NCT00507689|408530|P1|NOT COMPLETED|Pre-Randomization Period||3
166432|NCT00507689|408529|P2|COMPLETED|Pre-Randomization Period||0
166433|NCT00507689|408530|P1|COMPLETED|Pre-Randomization Period||37
166434|NCT00507689|408529|P2|STARTED|Pre-Randomization Period||0
166435|NCT00507689|408530|P1|STARTED|Pre-Randomization Period||40
166436|NCT00507767|408547|P1|NOT COMPLETED|Overall Study||0
166437|NCT00507767|408547|P1|COMPLETED|Overall Study||15
166438|NCT00507767|408547|P1|STARTED|Overall Study||15
166439|NCT00507819|408551|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
166440|NCT00507819|408552|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
166441|NCT00507819|408551|P2|COMPLETED|Second Intervention (6 Weeks)||14
166442|NCT00507819|408552|P1|COMPLETED|Second Intervention (6 Weeks)||13
166443|NCT00507819|408551|P2|STARTED|Second Intervention (6 Weeks)||14
166444|NCT00507819|408552|P1|STARTED|Second Intervention (6 Weeks)||13
166445|NCT00507819|408551|P2|NOT COMPLETED|Washout (6 Weeks)||0
166446|NCT00507819|408552|P1|NOT COMPLETED|Washout (6 Weeks)||1
166447|NCT00507819|408551|P2|COMPLETED|Washout (6 Weeks)||14
166448|NCT00507819|408552|P1|COMPLETED|Washout (6 Weeks)||13
166449|NCT00507819|408551|P2|STARTED|Washout (6 Weeks)||14
166450|NCT00507819|408552|P1|STARTED|Washout (6 Weeks)||14
166451|NCT00507819|408551|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
166452|NCT00507819|408552|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
166453|NCT00507819|408551|P2|COMPLETED|First Intervention (6 Weeks)||14
166454|NCT00507819|408552|P1|COMPLETED|First Intervention (6 Weeks)||14
166455|NCT00507819|408551|P2|STARTED|First Intervention (6 Weeks)||14
166456|NCT00507819|408552|P1|STARTED|First Intervention (6 Weeks)||14
166457|NCT00508001|408567|P3|NOT COMPLETED|Overall Study||7
166458|NCT00508001|408568|P2|NOT COMPLETED|Overall Study||12
166459|NCT00508001|408569|P1|NOT COMPLETED|Overall Study||19
166460|NCT00508001|408567|P3|COMPLETED|Overall Study||16
166461|NCT00508001|408568|P2|COMPLETED|Overall Study||13
166462|NCT00508001|408569|P1|COMPLETED|Overall Study||0
166463|NCT00508001|408567|P3|Secondary Treatment Phase|Overall Study||16
166464|NCT00508001|408568|P2|Secondary Treatment Phase|Overall Study||13
166465|NCT00508001|408569|P1|Secondary Treatment Phase|Overall Study||0
166466|NCT00508001|408567|P3|STARTED|Overall Study||23
166467|NCT00508001|408568|P2|STARTED|Overall Study||25
166468|NCT00508001|408569|P1|STARTED|Overall Study||19
166469|NCT00508027|408586|P1|NOT COMPLETED|Dose Level 3||0
166470|NCT00508027|408586|P1|COMPLETED|Dose Level 3||2
166471|NCT00508027|408586|P1|STARTED|Dose Level 3|enrollment discontinued due to FDA recommendations regarding high dose (80mg/day) simvastatin|2
166472|NCT00508027|408586|P1|NOT COMPLETED|Dose Level 2||4
166473|NCT00508027|408586|P1|COMPLETED|Dose Level 2||16
166474|NCT00508027|408586|P1|STARTED|Dose Level 2|The participants starting each dose period is a new cohort of subjects. 20 new subjects in dose 2|20
166475|NCT00508027|408586|P1|NOT COMPLETED|Dose Level 1||8
166476|NCT00508027|408586|P1|COMPLETED|Dose Level 1||12
166477|NCT00508027|408586|P1|STARTED|Dose Level 1|The participants starting each dose period is a new cohort of subjects. 20 subjects started dose 1|20
166478|NCT00508118|408626|P2|NOT COMPLETED|Overall Study||0
166479|NCT00508118|408627|P1|NOT COMPLETED|Overall Study||0
166480|NCT00508118|408626|P2|COMPLETED|Overall Study||4
166481|NCT00508118|408627|P1|COMPLETED|Overall Study||3
166482|NCT00508118|408626|P2|STARTED|Overall Study|Documentation is not available for the 7th subject and treatment arm.|4
166483|NCT00508118|408627|P1|STARTED|Overall Study||3
166484|NCT00508144|408646|P1|NOT COMPLETED|Overall Study||11
166485|NCT00508144|408646|P1|COMPLETED|Overall Study||53
166486|NCT00508144|408646|P1|STARTED|Overall Study||64
166487|NCT00508157|408652|P2|NOT COMPLETED|Overall Study||3
166488|NCT00508157|408653|P1|NOT COMPLETED|Overall Study||2
166489|NCT00508157|408652|P2|COMPLETED|Overall Study||23
166490|NCT00508157|408653|P1|COMPLETED|Overall Study||24
166491|NCT00508157|408652|P2|Safety Sample|Overall Study|1 participant was withdrawn from study prior to receiving study drug & excluded from safety sample.|25
166492|NCT00508157|408653|P1|Safety Sample|Overall Study||26
166493|NCT00508157|408652|P2|Randomized Sample|Overall Study||26
166494|NCT00508157|408653|P1|Randomized Sample|Overall Study||26
166495|NCT00508157|408652|P2|STARTED|Overall Study||26
166496|NCT00508157|408653|P1|STARTED|Overall Study||26
166497|NCT00508274|408675|P1|NOT COMPLETED|Overall Study||2
166498|NCT00508274|408675|P1|COMPLETED|Overall Study||50
166499|NCT00508274|408675|P1|STARTED|Overall Study||52
166500|NCT00508391|408686|P2|NOT COMPLETED|Second Treatment||0
166501|NCT00508391|408687|P1|NOT COMPLETED|Second Treatment||2
166502|NCT00508391|408686|P2|COMPLETED|Second Treatment||59
166503|NCT00508391|408687|P1|COMPLETED|Second Treatment||52
166504|NCT00508391|408686|P2|STARTED|Second Treatment||59
166505|NCT00508391|408687|P1|STARTED|Second Treatment||54
166506|NCT00508391|408686|P2|NOT COMPLETED|First Treatment||3
166507|NCT00508391|408687|P1|NOT COMPLETED|First Treatment||6
166508|NCT00508391|408686|P2|COMPLETED|First Treatment||59
166509|NCT00508391|408687|P1|COMPLETED|First Treatment||54
166510|NCT00508391|408686|P2|STARTED|First Treatment||62
166511|NCT00508391|408687|P1|STARTED|First Treatment||60
166512|NCT00508404|408698|P1|NOT COMPLETED|Overall Study||42
166513|NCT00508404|408698|P1|COMPLETED|Overall Study|Completion of safety follow-up visit conducted 8 weeks after last dose|112
166514|NCT00508404|408698|P1|STARTED|Overall Study||154
166515|NCT00508469|408725|P2|NOT COMPLETED|Overall Study||10
166516|NCT00508469|408726|P1|NOT COMPLETED|Overall Study||17
166517|NCT00508469|408725|P2|COMPLETED|Overall Study||40
166518|NCT00508469|408726|P1|COMPLETED|Overall Study||35
166519|NCT00508469|408725|P2|STARTED|Overall Study||50
166520|NCT00508469|408726|P1|STARTED|Overall Study||52
166521|NCT00508482|408735|P3|NOT COMPLETED|at the 12th Week of Follow-up||0
166522|NCT00508482|408736|P2|NOT COMPLETED|at the 12th Week of Follow-up||0
166523|NCT00508482|408737|P1|NOT COMPLETED|at the 12th Week of Follow-up||0
166524|NCT00508482|408735|P3|COMPLETED|at the 12th Week of Follow-up||98
166525|NCT00508482|408736|P2|COMPLETED|at the 12th Week of Follow-up||96
166526|NCT00508482|408737|P1|COMPLETED|at the 12th Week of Follow-up||196
166527|NCT00508482|408735|P3|STARTED|at the 12th Week of Follow-up||98
166528|NCT00508482|408736|P2|STARTED|at the 12th Week of Follow-up||96
166529|NCT00508482|408737|P1|STARTED|at the 12th Week of Follow-up||196
166530|NCT00508482|408735|P3|NOT COMPLETED|at the 4th Week of Follow-up||1
166531|NCT00508482|408736|P2|NOT COMPLETED|at the 4th Week of Follow-up||6
166532|NCT00508482|408737|P1|NOT COMPLETED|at the 4th Week of Follow-up||20
166533|NCT00508482|408735|P3|COMPLETED|at the 4th Week of Follow-up||98
166534|NCT00508482|408736|P2|COMPLETED|at the 4th Week of Follow-up||96
166535|NCT00508482|408737|P1|COMPLETED|at the 4th Week of Follow-up||196
166536|NCT00508482|408735|P3|STARTED|at the 4th Week of Follow-up||99
166537|NCT00508482|408736|P2|STARTED|at the 4th Week of Follow-up||102
166538|NCT00508482|408737|P1|STARTED|at the 4th Week of Follow-up||216
166539|NCT00508482|408735|P3|NOT COMPLETED|Over 4 Weeks of Treatment||20
166540|NCT00508482|408736|P2|NOT COMPLETED|Over 4 Weeks of Treatment||17
166541|NCT00508482|408737|P1|NOT COMPLETED|Over 4 Weeks of Treatment||21
166542|NCT00508482|408735|P3|COMPLETED|Over 4 Weeks of Treatment||99
166543|NCT00508482|408736|P2|COMPLETED|Over 4 Weeks of Treatment||102
166544|NCT00508482|408737|P1|COMPLETED|Over 4 Weeks of Treatment||216
166545|NCT00508482|408735|P3|STARTED|Over 4 Weeks of Treatment||119
166546|NCT00508482|408736|P2|STARTED|Over 4 Weeks of Treatment||119
166547|NCT00508482|408737|P1|STARTED|Over 4 Weeks of Treatment||237
166548|NCT00508521|408772|P1|NOT COMPLETED|Overall Study||0
166549|NCT00508521|408772|P1|COMPLETED|Overall Study||4
166550|NCT00508521|408772|P1|STARTED|Overall Study||4
166551|NCT00508651|408778|P2|NOT COMPLETED|Overall Study||2
166552|NCT00508651|408779|P1|NOT COMPLETED|Overall Study||4
166553|NCT00508651|408778|P2|COMPLETED|Overall Study||8
166554|NCT00508651|408779|P1|COMPLETED|Overall Study||16
166555|NCT00508651|408778|P2|STARTED|Overall Study||10
166556|NCT00508651|408779|P1|STARTED|Overall Study||20
166557|NCT00508716|408855|P2|NOT COMPLETED|Overall Study||0
166558|NCT00508716|408856|P1|NOT COMPLETED|Overall Study||0
166559|NCT00508716|408855|P2|COMPLETED|Overall Study||63
166560|NCT00508716|408856|P1|COMPLETED|Overall Study||61
166561|NCT00508716|408855|P2|STARTED|Overall Study||63
166562|NCT00508716|408856|P1|STARTED|Overall Study||61
166563|NCT00508742|408864|P2|NOT COMPLETED|Period 3: Toddler Dose||15
166564|NCT00508742|408865|P1|NOT COMPLETED|Period 3: Toddler Dose||25
166565|NCT00508742|408864|P2|COMPLETED|Period 3: Toddler Dose||863
166566|NCT00508742|408865|P1|COMPLETED|Period 3: Toddler Dose||858
166567|NCT00508742|408864|P2|STARTED|Period 3: Toddler Dose||878
166568|NCT00508742|408865|P1|STARTED|Period 3: Toddler Dose||883
166569|NCT00508742|408864|P2|NOT COMPLETED|Period 2: After Infant Series||11
166570|NCT00508742|408865|P1|NOT COMPLETED|Period 2: After Infant Series||7
166571|NCT00508742|408864|P2|COMPLETED|Period 2: After Infant Series||878
166572|NCT00508742|408865|P1|COMPLETED|Period 2: After Infant Series||883
166573|NCT00508742|408864|P2|STARTED|Period 2: After Infant Series||889
166574|NCT00508742|408865|P1|STARTED|Period 2: After Infant Series||890
166575|NCT00508742|408864|P2|NOT COMPLETED|Period 1: Infant Series||45
166576|NCT00508742|408865|P1|NOT COMPLETED|Period 1: Infant Series||42
166577|NCT00508742|408864|P2|COMPLETED|Period 1: Infant Series||889
166578|NCT00508742|408865|P1|COMPLETED|Period 1: Infant Series||890
166579|NCT00508742|408864|P2|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||892
166580|NCT00508742|408865|P1|Vaccinated Dose 3 (at 6 Months of Age)|Period 1: Infant Series||898
166581|NCT00508742|408864|P2|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||902
166582|NCT00508742|408865|P1|Vaccinated Dose 2 (at 4 Months of Age)|Period 1: Infant Series||904
166583|NCT00508742|408864|P2|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||933
166584|NCT00508742|408865|P1|Vaccinated Dose 1 (at 2 Months of Age)|Period 1: Infant Series||930
166585|NCT00508742|408864|P2|STARTED|Period 1: Infant Series||934
166586|NCT00508742|408865|P1|STARTED|Period 1: Infant Series||932
166587|NCT00508755|408879|P1|NOT COMPLETED|Overall Study||1
166588|NCT00508755|408879|P1|COMPLETED|Overall Study||5
166589|NCT00508755|408879|P1|STARTED|Overall Study||6
166590|NCT00508820|408887|P2|NOT COMPLETED|Overall Study||64
166591|NCT00508820|408888|P1|NOT COMPLETED|Overall Study||55
166592|NCT00508820|408887|P2|COMPLETED|Overall Study||175
166593|NCT00508820|408888|P1|COMPLETED|Overall Study||113
166594|NCT00508820|408887|P2|STARTED|Overall Study||239
166595|NCT00508820|408888|P1|STARTED|Overall Study||168
166596|NCT00508872|408898|P1|NOT COMPLETED|Overall Study||2
166597|NCT00508872|408898|P1|COMPLETED|Overall Study||0
166598|NCT00508872|408898|P1|STARTED|Overall Study||2
166599|NCT00508924|408906|P4|NOT COMPLETED|Overall Study||1
166600|NCT00508924|408907|P3|NOT COMPLETED|Overall Study||1
166601|NCT00508924|408908|P2|NOT COMPLETED|Overall Study||0
166602|NCT00508924|408909|P1|NOT COMPLETED|Overall Study||0
166603|NCT00508924|408906|P4|COMPLETED|Overall Study||33
166604|NCT00508924|408907|P3|COMPLETED|Overall Study||31
166605|NCT00508924|408908|P2|COMPLETED|Overall Study||38
166606|NCT00508924|408909|P1|COMPLETED|Overall Study||36
166607|NCT00508924|408906|P4|STARTED|Overall Study||34
166608|NCT00508924|408907|P3|STARTED|Overall Study||32
166609|NCT00508924|408908|P2|STARTED|Overall Study||38
166610|NCT00508924|408909|P1|STARTED|Overall Study||36
166611|NCT00509028|408925|P2|NOT COMPLETED|Overall Study||7
166612|NCT00509028|408926|P1|NOT COMPLETED|Overall Study||12
166613|NCT00509028|408925|P2|COMPLETED|Overall Study||113
166614|NCT00509028|408926|P1|COMPLETED|Overall Study||109
166615|NCT00509028|408925|P2|STARTED|Overall Study||120
166616|NCT00509028|408926|P1|STARTED|Overall Study||121
166617|NCT00509041|408958|P1|NOT COMPLETED|Overall Study||0
166618|NCT00509041|408958|P1|COMPLETED|Overall Study||43
166619|NCT00509041|408958|P1|STARTED|Overall Study||43
166620|NCT00509067|408967|P2|NOT COMPLETED|Overall Study||5
166621|NCT00509067|408968|P1|NOT COMPLETED|Overall Study||4
166622|NCT00509067|408967|P2|COMPLETED|Overall Study||19
166623|NCT00509067|408968|P1|COMPLETED|Overall Study||15
166624|NCT00509067|408967|P2|STARTED|Overall Study||24
166625|NCT00509067|408968|P1|STARTED|Overall Study||19
166626|NCT00502671|408974|P1|NOT COMPLETED|Overall Study||77
166627|NCT00502671|408974|P1|COMPLETED|Overall Study||151
166628|NCT00502671|408974|P1|STARTED|Overall Study||228
166629|NCT00502697|408981|P2|NOT COMPLETED|Overall Study||12
166630|NCT00502697|408982|P1|NOT COMPLETED|Overall Study||13
166631|NCT00502697|408981|P2|COMPLETED|Overall Study||102
166632|NCT00502697|408982|P1|COMPLETED|Overall Study||109
166633|NCT00502697|408981|P2|STARTED|Overall Study||114
166634|NCT00502697|408982|P1|STARTED|Overall Study||122
166635|NCT00502775|408993|P3|NOT COMPLETED|Overall Study||13
166636|NCT00502775|408994|P2|NOT COMPLETED|Overall Study||15
166637|NCT00502775|408995|P1|NOT COMPLETED|Overall Study||10
166638|NCT00502775|408993|P3|COMPLETED|Overall Study||214
166639|NCT00502775|408994|P2|COMPLETED|Overall Study||209
166640|NCT00502775|408995|P1|COMPLETED|Overall Study||219
166641|NCT00502775|408993|P3|STARTED|Overall Study||227
166642|NCT00502775|408994|P2|STARTED|Overall Study||224
166643|NCT00502775|408995|P1|STARTED|Overall Study||229
166644|NCT00502801|409036|P1|NOT COMPLETED|End of Therapy to Test of Cure||8
166645|NCT00502801|409036|P1|COMPLETED|End of Therapy to Test of Cure||121
166646|NCT00502801|409036|P1|STARTED|End of Therapy to Test of Cure||129
166647|NCT00502801|409036|P1|NOT COMPLETED|Treatment Period||54
166648|NCT00502801|409036|P1|COMPLETED|Treatment Period||129
166649|NCT00502801|409036|P1|STARTED|Treatment Period||183
166650|NCT00502840|409041|P1|NOT COMPLETED|Overall Study||100
166651|NCT00502840|409041|P1|COMPLETED|Overall Study||93
166652|NCT00502840|409041|P1|STARTED|Overall Study||193
166653|NCT00502853|409069|P1|NOT COMPLETED|Overall Study||0
166654|NCT00502853|409069|P1|COMPLETED|Overall Study||10
166655|NCT00502853|409069|P1|STARTED|Overall Study||10
166656|NCT00502905|409094|P1|NOT COMPLETED|Overall Study||0
166657|NCT00502905|409094|P1|COMPLETED|Overall Study||196
166658|NCT00502905|409094|P1|STARTED|Overall Study||196
166659|NCT00502944|409100|P2|NOT COMPLETED|Overall Study||1766
166660|NCT00502944|409101|P1|NOT COMPLETED|Overall Study||1064
166661|NCT00502944|409100|P2|COMPLETED|Overall Study||643
166662|NCT00502944|409101|P1|COMPLETED|Overall Study||1382
166663|NCT00502944|409100|P2|STARTED|Overall Study||2409
166664|NCT00502944|409101|P1|STARTED|Overall Study||2446
166665|NCT00502996|409113|P1|NOT COMPLETED|Overall Study||44
166666|NCT00502996|409113|P1|COMPLETED|Overall Study||188
166667|NCT00502996|409113|P1|STARTED|Overall Study||232
166668|NCT00503009|409140|P3|NOT COMPLETED|Overall Study||3
166669|NCT00503009|409141|P2|NOT COMPLETED|Overall Study||2
166670|NCT00503009|409142|P1|NOT COMPLETED|Overall Study||1
166671|NCT00503009|409140|P3|COMPLETED|Overall Study||3
166672|NCT00503009|409141|P2|COMPLETED|Overall Study||3
166673|NCT00503009|409142|P1|COMPLETED|Overall Study||4
166674|NCT00503009|409140|P3|STARTED|Overall Study||6
166675|NCT00503009|409141|P2|STARTED|Overall Study||5
166676|NCT00503009|409142|P1|STARTED|Overall Study||5
166677|NCT00503113|409162|P3|NOT COMPLETED|Overall Study||28
166678|NCT00503113|409163|P2|NOT COMPLETED|Overall Study||28
166679|NCT00503113|409164|P1|NOT COMPLETED|Overall Study||33
166680|NCT00503113|409162|P3|COMPLETED|Overall Study||241
166681|NCT00503113|409163|P2|COMPLETED|Overall Study||236
166682|NCT00503113|409164|P1|COMPLETED|Overall Study||235
166683|NCT00503113|409162|P3|Safety Population|Overall Study||267
166684|NCT00503113|409163|P2|Safety Population|Overall Study||263
166685|NCT00503113|409164|P1|Safety Population|Overall Study||263
166686|NCT00503113|409162|P3|Per Protocol Population (PP)|Overall Study||241
166687|NCT00503113|409163|P2|Per Protocol Population (PP)|Overall Study||243
166688|NCT00503113|409164|P1|Per Protocol Population (PP)|Overall Study||246
166689|NCT00503113|409162|P3|Intent to Treat Population (ITT)|Overall Study||268
166690|NCT00503113|409163|P2|Intent to Treat Population (ITT)|Overall Study||261
166691|NCT00503113|409164|P1|Intent to Treat Population (ITT)|Overall Study||262
166692|NCT00503113|409162|P3|STARTED|Overall Study||269
166693|NCT00503113|409163|P2|STARTED|Overall Study||264
166694|NCT00503113|409164|P1|STARTED|Overall Study||268
166695|NCT00503139|409193|P1|NOT COMPLETED|Overall Study||8
166696|NCT00503139|409193|P1|COMPLETED|Overall Study||676
166697|NCT00503139|409193|P1|STARTED|Overall Study||684
166698|NCT00503308|409206|P2|NOT COMPLETED|Overall Study||1
166699|NCT00503308|409207|P1|NOT COMPLETED|Overall Study||2
166700|NCT00503308|409206|P2|COMPLETED|Overall Study||134
166701|NCT00503308|409207|P1|COMPLETED|Overall Study||144
166702|NCT00503308|409206|P2|STARTED|Overall Study||135
166703|NCT00503308|409207|P1|STARTED|Overall Study||146
166704|NCT00509106|409215|P2|NOT COMPLETED|Overall Study||29
166705|NCT00509106|409216|P1|NOT COMPLETED|Overall Study||31
166706|NCT00509106|409215|P2|COMPLETED|Overall Study||278
166707|NCT00509106|409216|P1|COMPLETED|Overall Study||284
166708|NCT00509106|409215|P2|STARTED|Overall Study||307
166709|NCT00509106|409216|P1|STARTED|Overall Study||315
166710|NCT00509197|409224|P2|NOT COMPLETED|Overall Study||0
166711|NCT00509197|409225|P1|NOT COMPLETED|Overall Study||0
166712|NCT00509197|409224|P2|COMPLETED|Overall Study||6
166713|NCT00509197|409225|P1|COMPLETED|Overall Study||6
166714|NCT00509197|409224|P2|STARTED|Overall Study||6
166715|NCT00509197|409225|P1|STARTED|Overall Study||6
166716|NCT00509223|409239|P2|NOT COMPLETED|Overall Study||72
166717|NCT00509223|409240|P1|NOT COMPLETED|Overall Study||88
166718|NCT00509223|409239|P2|COMPLETED|Overall Study||137
166719|NCT00509223|409240|P1|COMPLETED|Overall Study||119
166720|NCT00509223|409239|P2|STARTED|Overall Study||209
166721|NCT00509223|409240|P1|STARTED|Overall Study||207
166722|NCT00509236|409248|P2|NOT COMPLETED|Overall Study||20
166723|NCT00509236|409249|P1|NOT COMPLETED|Overall Study||17
166724|NCT00509236|409248|P2|COMPLETED|Overall Study||45
166725|NCT00509236|409249|P1|COMPLETED|Overall Study||47
166726|NCT00509236|409248|P2|STARTED|Overall Study||65
166727|NCT00509236|409249|P1|STARTED|Overall Study||64
166728|NCT00509249|409262|P1|NOT COMPLETED|Overall Study||0
166729|NCT00509249|409262|P1|COMPLETED|Overall Study||18
166730|NCT00509249|409262|P1|STARTED|Overall Study||18
166731|NCT00509262|409268|P2|NOT COMPLETED|Overall Study||42
166732|NCT00509262|409269|P1|NOT COMPLETED|Overall Study||47
166733|NCT00509262|409268|P2|COMPLETED|Overall Study||170
166734|NCT00509262|409269|P1|COMPLETED|Overall Study||164
166735|NCT00509262|409268|P2|STARTED|Overall Study||212
166736|NCT00509262|409269|P1|STARTED|Overall Study||211
166737|NCT00509288|409283|P2|NOT COMPLETED|Overall Study||0
166738|NCT00509288|409284|P1|NOT COMPLETED|Overall Study||0
166739|NCT00509288|409283|P2|COMPLETED|Overall Study||3
166740|NCT00509288|409284|P1|COMPLETED|Overall Study||21
166741|NCT00509288|409283|P2|STARTED|Overall Study||3
166742|NCT00509288|409284|P1|STARTED|Overall Study||21
166743|NCT00509366|409297|P5|NOT COMPLETED|Overall Study||0
166744|NCT00509366|409298|P4|NOT COMPLETED|Overall Study||0
166745|NCT00509366|409299|P3|NOT COMPLETED|Overall Study||1
166746|NCT00509366|409300|P2|NOT COMPLETED|Overall Study||1
166747|NCT00509366|409301|P1|NOT COMPLETED|Overall Study||1
166748|NCT00509366|409297|P5|COMPLETED|Overall Study|Patients who were neither assigned nor treated with protocol-based therapy.|51
166749|NCT00509366|409298|P4|COMPLETED|Overall Study|Patients assigned to treatment and treated with docetaxel/gemcitabine treatment combination.|2
166829|NCT00510510|409588|P1|COMPLETED|Overall Study||87
166750|NCT00509366|409299|P3|COMPLETED|Overall Study|Patients assigned to treatment and treated with pemetrexed/gemcitabine treatment combination.|21
166751|NCT00509366|409300|P2|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/pemetrexed treatment combination.|7
166752|NCT00509366|409301|P1|COMPLETED|Overall Study|Patients assigned to treatment and treated with cisplatin/gemcitabine treatment combination.|17
166753|NCT00509366|409297|P5|Assigned Treatment|Overall Study||0
166754|NCT00509366|409298|P4|Assigned Treatment|Overall Study|Patients who were assigned to docetaxel/gemcitabine treatment arm.|2
166755|NCT00509366|409299|P3|Assigned Treatment|Overall Study|Patients who were assigned to pemetrexed/gemcitabine treatment arm.|22
166756|NCT00509366|409300|P2|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/pemetrexed treatment arm.|8
166757|NCT00509366|409301|P1|Assigned Treatment|Overall Study|Patients who were assigned to cisplatin/gemcitabine treatment arm.|18
166758|NCT00509366|409297|P5|STARTED|Overall Study|Registered patients who were neither assigned nor treated with protocol-based therapy.|51
166759|NCT00509366|409298|P4|STARTED|Overall Study|Registered patients who were assigned docetaxel/gemcitabine treatment.|2
166760|NCT00509366|409299|P3|STARTED|Overall Study|Registered patients who were assigned pemetrexed/gemcitabine treatment.|22
166761|NCT00509366|409300|P2|STARTED|Overall Study|Registered patients who were assigned cisplatin/pemetrexed treatment.|8
166762|NCT00509366|409301|P1|STARTED|Overall Study|Registered patients who were assigned cisplatin/gemcitabine treatment.|18
166763|NCT00509392|409314|P3|NOT COMPLETED|Overall Study||0
166764|NCT00509392|409315|P2|NOT COMPLETED|Overall Study||0
166765|NCT00509392|409316|P1|NOT COMPLETED|Overall Study||0
166766|NCT00509392|409314|P3|COMPLETED|Overall Study||4
166767|NCT00509392|409315|P2|COMPLETED|Overall Study||33
166768|NCT00509392|409316|P1|COMPLETED|Overall Study||32
166769|NCT00509392|409314|P3|STARTED|Overall Study||4
166770|NCT00509392|409315|P2|STARTED|Overall Study||33
166771|NCT00509392|409316|P1|STARTED|Overall Study||32
166772|NCT00510146|409364|P2|NOT COMPLETED|Open-Label Treatment||26
166773|NCT00510146|409365|P1|NOT COMPLETED|Open-Label Treatment||71
166774|NCT00510146|409364|P2|COMPLETED|Open-Label Treatment||96
166775|NCT00510146|409365|P1|COMPLETED|Open-Label Treatment||196
166776|NCT00510146|409364|P2|STARTED|Open-Label Treatment||122
166777|NCT00510146|409365|P1|STARTED|Open-Label Treatment||267
166778|NCT00510146|409364|P2|NOT COMPLETED|Double-Blind Treatment||49
166779|NCT00510146|409365|P1|NOT COMPLETED|Double-Blind Treatment||76
166780|NCT00510146|409364|P2|COMPLETED|Double-Blind Treatment||122
166781|NCT00510146|409365|P1|COMPLETED|Double-Blind Treatment||267
166782|NCT00510146|409364|P2|STARTED|Double-Blind Treatment||171
166783|NCT00510146|409365|P1|STARTED|Double-Blind Treatment||343
166784|NCT00510224|409452|P1|NOT COMPLETED|Overall Study||3
166785|NCT00510224|409452|P1|COMPLETED|Overall Study||10
166786|NCT00510224|409452|P1|STARTED|Overall Study||13
166787|NCT00510276|409461|P2|NOT COMPLETED|Extension Open-Label Phase||48
166788|NCT00510276|409462|P1|NOT COMPLETED|Extension Open-Label Phase||33
166789|NCT00510276|409461|P2|COMPLETED|Extension Open-Label Phase||81
166790|NCT00510276|409462|P1|COMPLETED|Extension Open-Label Phase||78
166791|NCT00510276|409461|P2|STARTED|Extension Open-Label Phase|1 patient who completed acute phase did not participate in the optional atometine extension phase|129
166792|NCT00510276|409462|P1|STARTED|Extension Open-Label Phase|4 patients who completed acute phase did not participate in the optional atomoxetine extension phase|111
166793|NCT00510276|409461|P2|NOT COMPLETED|Acute Double-Blind Phase||95
166794|NCT00510276|409462|P1|NOT COMPLETED|Acute Double-Blind Phase||105
166795|NCT00510276|409461|P2|COMPLETED|Acute Double-Blind Phase||130
166796|NCT00510276|409462|P1|COMPLETED|Acute Double-Blind Phase||115
166797|NCT00510276|409461|P2|STARTED|Acute Double-Blind Phase||225
166798|NCT00510276|409462|P1|STARTED|Acute Double-Blind Phase||220
166799|NCT00510289|409547|P1|NOT COMPLETED|Overall Study||12
166800|NCT00510289|409547|P1|COMPLETED|Overall Study|Completed at least one cycle of study drug and had disease assessments|7
166801|NCT00510289|409547|P1|Started Study Drug|Overall Study|3 patients progressed prior to starting study drug|16
166802|NCT00510289|409547|P1|STARTED|Overall Study|All patients who consented|19
166803|NCT00510484|409557|P2|NOT COMPLETED|Period 2||0
166804|NCT00510484|409558|P1|NOT COMPLETED|Period 2||0
166805|NCT00510484|409557|P2|COMPLETED|Period 2||15
166806|NCT00510484|409558|P1|COMPLETED|Period 2||16
166807|NCT00510484|409557|P2|STARTED|Period 2||15
166808|NCT00510484|409558|P1|STARTED|Period 2||16
166809|NCT00510484|409557|P2|NOT COMPLETED|Wash-out Period||1
166810|NCT00510484|409558|P1|NOT COMPLETED|Wash-out Period||0
166811|NCT00510484|409557|P2|COMPLETED|Wash-out Period||15
166812|NCT00510484|409558|P1|COMPLETED|Wash-out Period||16
166813|NCT00510484|409557|P2|STARTED|Wash-out Period||16
166814|NCT00510484|409558|P1|STARTED|Wash-out Period||16
166815|NCT00510484|409557|P2|NOT COMPLETED|Period 1||0
166816|NCT00510484|409558|P1|NOT COMPLETED|Period 1||0
166817|NCT00510484|409557|P2|COMPLETED|Period 1||16
166818|NCT00510484|409558|P1|COMPLETED|Period 1||16
166819|NCT00510484|409557|P2|STARTED|Period 1||16
166820|NCT00510484|409558|P1|STARTED|Period 1||16
166821|NCT00510497|409578|P1|NOT COMPLETED|Overall Study||3
166822|NCT00510497|409578|P1|COMPLETED|Overall Study||8
166823|NCT00510497|409578|P1|STARTED|Overall Study||11
166824|NCT00510510|409586|P3|NOT COMPLETED|Overall Study||17
166825|NCT00510510|409587|P2|NOT COMPLETED|Overall Study||9
166826|NCT00510510|409588|P1|NOT COMPLETED|Overall Study||5
166827|NCT00510510|409586|P3|COMPLETED|Overall Study||74
166828|NCT00510510|409587|P2|COMPLETED|Overall Study||89
166830|NCT00510510|409586|P3|STARTED|Overall Study||91
166831|NCT00510510|409587|P2|STARTED|Overall Study||98
166832|NCT00510510|409588|P1|STARTED|Overall Study||92
166833|NCT00510653|409599|P1|NOT COMPLETED|Overall Study||11
166834|NCT00510653|409599|P1|COMPLETED|Overall Study||13
166835|NCT00510653|409599|P1|STARTED|Overall Study||24
166836|NCT00510692|409605|P2|NOT COMPLETED|Overall Study||3
166837|NCT00510692|409606|P1|NOT COMPLETED|Overall Study||2
166838|NCT00510692|409605|P2|COMPLETED|Overall Study||26
166839|NCT00510692|409606|P1|COMPLETED|Overall Study||27
166840|NCT00510692|409605|P2|STARTED|Overall Study||29
166841|NCT00510692|409606|P1|STARTED|Overall Study||29
166842|NCT00510744|409620|P1|NOT COMPLETED|Overall Study||0
166843|NCT00510744|409620|P1|COMPLETED|Overall Study||5
166844|NCT00510744|409620|P1|STARTED|Overall Study||5
166845|NCT00510783|409626|P2|NOT COMPLETED|Overall Study||29
166846|NCT00510783|409627|P1|NOT COMPLETED|Overall Study||31
166847|NCT00510783|409626|P2|COMPLETED|Overall Study||47
166848|NCT00510783|409627|P1|COMPLETED|Overall Study||51
166849|NCT00510783|409626|P2|STARTED|Overall Study||76
166850|NCT00510783|409627|P1|STARTED|Overall Study||82
166851|NCT00510809|409636|P3|NOT COMPLETED|Overall Study||0
166852|NCT00510809|409637|P2|NOT COMPLETED|Overall Study||0
166853|NCT00510809|409638|P1|NOT COMPLETED|Overall Study||0
166854|NCT00510809|409636|P3|COMPLETED|Overall Study||18
166855|NCT00510809|409637|P2|COMPLETED|Overall Study||18
166856|NCT00510809|409638|P1|COMPLETED|Overall Study||18
166857|NCT00510809|409636|P3|STARTED|Overall Study||18
166858|NCT00510809|409637|P2|STARTED|Overall Study||18
166859|NCT00510809|409638|P1|STARTED|Overall Study||18
166860|NCT00510835|409652|P3|NOT COMPLETED|Overall Study||2
166861|NCT00510835|409653|P2|NOT COMPLETED|Overall Study||2
166862|NCT00510835|409654|P1|NOT COMPLETED|Overall Study||6
166863|NCT00510835|409652|P3|COMPLETED|Overall Study||456
166864|NCT00510835|409653|P2|COMPLETED|Overall Study||446
166865|NCT00510835|409654|P1|COMPLETED|Overall Study||439
166866|NCT00510835|409652|P3|STARTED|Overall Study||458
166867|NCT00510835|409653|P2|STARTED|Overall Study||448
166868|NCT00510835|409654|P1|STARTED|Overall Study||445
166869|NCT00510874|409669|P7|NOT COMPLETED|Overall Study||1
166870|NCT00510874|409670|P6|NOT COMPLETED|Overall Study||0
166871|NCT00510874|409671|P5|NOT COMPLETED|Overall Study||7
166872|NCT00510874|409672|P4|NOT COMPLETED|Overall Study||3
166873|NCT00510874|409673|P3|NOT COMPLETED|Overall Study||1
166874|NCT00510874|409674|P2|NOT COMPLETED|Overall Study||4
166875|NCT00510874|409675|P1|NOT COMPLETED|Overall Study||3
166876|NCT00510874|409669|P7|COMPLETED|Overall Study|Upto Day 182|49
166877|NCT00510874|409670|P6|COMPLETED|Overall Study|Upto Day 182|50
166878|NCT00510874|409671|P5|COMPLETED|Overall Study|Upto Day 182|141
166879|NCT00510874|409672|P4|COMPLETED|Overall Study|Upto Day 182|148
166880|NCT00510874|409673|P3|COMPLETED|Overall Study|Upto Day 182|150
166881|NCT00510874|409674|P2|COMPLETED|Overall Study|Upto Day 182|148
166882|NCT00510874|409675|P1|COMPLETED|Overall Study|Upto Day 182|75
166883|NCT00510874|409669|P7|STARTED|Overall Study||50
166884|NCT00510874|409670|P6|STARTED|Overall Study||50
166885|NCT00510874|409671|P5|STARTED|Overall Study||148
166886|NCT00510874|409672|P4|STARTED|Overall Study||151
166887|NCT00510874|409673|P3|STARTED|Overall Study||151
166888|NCT00510874|409674|P2|STARTED|Overall Study||152
166889|NCT00510874|409675|P1|STARTED|Overall Study||78
166890|NCT00510887|409775|P1|NOT COMPLETED|Overall Study||1
166891|NCT00510887|409775|P1|COMPLETED|Overall Study||11
166892|NCT00510887|409775|P1|STARTED|Overall Study||12
166893|NCT00510952|409786|P2|NOT COMPLETED|Overall Study||16
166894|NCT00510952|409787|P1|NOT COMPLETED|Overall Study||26
166895|NCT00510952|409786|P2|COMPLETED|Overall Study||220
166896|NCT00510952|409787|P1|COMPLETED|Overall Study||209
166897|NCT00510952|409786|P2|Full Analysis Set (Intent to Treat)|Overall Study||229
166898|NCT00510952|409787|P1|Full Analysis Set (Intent to Treat)|Overall Study||229
166899|NCT00510952|409786|P2|STARTED|Overall Study||236
166900|NCT00510952|409787|P1|STARTED|Overall Study||235
166901|NCT00511004|409816|P3|NOT COMPLETED|Overall Study||4
166902|NCT00511004|409817|P2|NOT COMPLETED|Overall Study||0
166903|NCT00511004|409818|P1|NOT COMPLETED|Overall Study||0
166904|NCT00511004|409816|P3|COMPLETED|Overall Study||10
166905|NCT00511004|409817|P2|COMPLETED|Overall Study||13
166906|NCT00511004|409818|P1|COMPLETED|Overall Study||13
166907|NCT00511004|409816|P3|STARTED|Overall Study||14
166908|NCT00511004|409817|P2|STARTED|Overall Study||13
166909|NCT00511004|409818|P1|STARTED|Overall Study||13
166910|NCT00511095|409835|P1|NOT COMPLETED|Overall Study||11
166911|NCT00511095|409835|P1|COMPLETED|Overall Study||196
166912|NCT00511095|409835|P1|STARTED|Overall Study||207
166913|NCT00511108|409845|P4|NOT COMPLETED|Overall Study||5
166914|NCT00511108|409846|P3|NOT COMPLETED|Overall Study||5
166915|NCT00511108|409847|P2|NOT COMPLETED|Overall Study||2
166916|NCT00511108|409848|P1|NOT COMPLETED|Overall Study||6
166917|NCT00511108|409845|P4|COMPLETED|Overall Study||48
166918|NCT00511108|409846|P3|COMPLETED|Overall Study||47
166919|NCT00511108|409847|P2|COMPLETED|Overall Study||52
166920|NCT00511108|409848|P1|COMPLETED|Overall Study||46
166921|NCT00511108|409845|P4|STARTED|Overall Study||53
166922|NCT00511108|409846|P3|STARTED|Overall Study||52
166923|NCT00511108|409847|P2|STARTED|Overall Study||54
166924|NCT00511108|409848|P1|STARTED|Overall Study||52
166925|NCT00511134|409868|P2|NOT COMPLETED|Overall Study||2
166926|NCT00511134|409869|P1|NOT COMPLETED|Overall Study||0
166927|NCT00511134|409868|P2|COMPLETED|Overall Study||1
166928|NCT00511134|409869|P1|COMPLETED|Overall Study||1
166929|NCT00511134|409868|P2|STARTED|Overall Study||3
166930|NCT00511134|409869|P1|STARTED|Overall Study||1
166931|NCT00511147|409877|P1|NOT COMPLETED|Overall Study||7
166932|NCT00511147|409877|P1|COMPLETED|Overall Study||57
166933|NCT00511147|409877|P1|STARTED|Overall Study||64
166934|NCT00511173|409884|P1|NOT COMPLETED|Overall Study||0
166935|NCT00511173|409884|P1|COMPLETED|Overall Study||102
166936|NCT00511173|409884|P1|STARTED|Overall Study||102
166937|NCT00511199|409891|P2|NOT COMPLETED|Overall Study||125
166938|NCT00511199|409892|P1|NOT COMPLETED|Overall Study||449
166939|NCT00511199|409891|P2|COMPLETED|Overall Study||410
166940|NCT00511199|409892|P1|COMPLETED|Overall Study||1142
166941|NCT00511199|409891|P2|STARTED|Overall Study||535
166942|NCT00511199|409892|P1|STARTED|Overall Study||1591
166943|NCT00511238|409918|P2|NOT COMPLETED|Overall Study||226
166944|NCT00511238|409919|P1|NOT COMPLETED|Overall Study||42
166945|NCT00511238|409918|P2|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|40
166946|NCT00511238|409919|P1|COMPLETED|Overall Study|Number of patients who completed 12 cycles of treatment|4
166947|NCT00511238|409918|P2|STARTED|Overall Study||266
166948|NCT00511238|409919|P1|STARTED|Overall Study||46
166949|NCT00511342|409938|P2|NOT COMPLETED|Overall Study||22
166950|NCT00511342|409939|P1|NOT COMPLETED|Overall Study||13
166951|NCT00511342|409938|P2|COMPLETED|Overall Study||32
166952|NCT00511342|409939|P1|COMPLETED|Overall Study||43
166953|NCT00511342|409938|P2|STARTED|Overall Study||54
166954|NCT00511342|409939|P1|STARTED|Overall Study||56
166955|NCT00511355|409965|P2|NOT COMPLETED|Overall Study||9
166956|NCT00511355|409966|P1|NOT COMPLETED|Overall Study||7
166957|NCT00511355|409965|P2|COMPLETED|Overall Study||52
166958|NCT00511355|409966|P1|COMPLETED|Overall Study||53
166959|NCT00511355|409965|P2|STARTED|Overall Study||61
166960|NCT00511355|409966|P1|STARTED|Overall Study||60
166961|NCT00511433|410066|P2|NOT COMPLETED|Overall Study||1
166962|NCT00511433|410067|P1|NOT COMPLETED|Overall Study||6
166963|NCT00511433|410066|P2|COMPLETED|Overall Study||15
166964|NCT00511433|410067|P1|COMPLETED|Overall Study||26
166965|NCT00511433|410066|P2|STARTED|Overall Study||16
166966|NCT00511433|410067|P1|STARTED|Overall Study||32
166967|NCT00511472|410107|P2|NOT COMPLETED|Overall Study||6
166968|NCT00511472|410108|P1|NOT COMPLETED|Overall Study||3
166969|NCT00511472|410107|P2|COMPLETED|Overall Study||17
166970|NCT00511472|410108|P1|COMPLETED|Overall Study||44
166971|NCT00511472|410107|P2|STARTED|Overall Study||23
166972|NCT00511472|410108|P1|STARTED|Overall Study||47
166973|NCT00511667|410127|P2|NOT COMPLETED|Overall Study||3
166974|NCT00511667|410128|P1|NOT COMPLETED|Overall Study||12
166975|NCT00511667|410127|P2|COMPLETED|Overall Study||15
166976|NCT00511667|410128|P1|COMPLETED|Overall Study||40
166977|NCT00511667|410127|P2|STARTED|Overall Study||18
166978|NCT00511667|410128|P1|STARTED|Overall Study||52
166979|NCT00511706|410163|P2|NOT COMPLETED|Overall Study||5
166980|NCT00511706|410164|P1|NOT COMPLETED|Overall Study||8
166981|NCT00511706|410163|P2|COMPLETED|Overall Study||115
166982|NCT00511706|410164|P1|COMPLETED|Overall Study||115
166983|NCT00511706|410163|P2|STARTED|Overall Study||120
166984|NCT00511706|410164|P1|STARTED|Overall Study||123
166985|NCT00511797|410180|P4|NOT COMPLETED|Overall Study||15
166986|NCT00511797|410181|P3|NOT COMPLETED|Overall Study||11
166987|NCT00511797|410182|P2|NOT COMPLETED|Overall Study||8
166988|NCT00511797|410183|P1|NOT COMPLETED|Overall Study||7
166989|NCT00511797|410180|P4|COMPLETED|Overall Study||47
166990|NCT00511797|410181|P3|COMPLETED|Overall Study||51
166991|NCT00511797|410182|P2|COMPLETED|Overall Study||55
166992|NCT00511797|410183|P1|COMPLETED|Overall Study||55
166993|NCT00511797|410180|P4|Subjects Received Treatment|Overall Study|FAS|58
166994|NCT00511797|410181|P3|Subjects Received Treatment|Overall Study|FAS|61
166995|NCT00511797|410182|P2|Subjects Received Treatment|Overall Study|FAS|62
166996|NCT00511797|410183|P1|Subjects Received Treatment|Overall Study|FAS|61
166997|NCT00511797|410180|P4|Subjects Dispensed Drugs|Overall Study||59
166998|NCT00511797|410181|P3|Subjects Dispensed Drugs|Overall Study||61
166999|NCT00511797|410182|P2|Subjects Dispensed Drugs|Overall Study||63
167000|NCT00511797|410183|P1|Subjects Dispensed Drugs|Overall Study||61
167001|NCT00511797|410180|P4|STARTED|Overall Study||62
167002|NCT00511797|410181|P3|STARTED|Overall Study||62
167003|NCT00511797|410182|P2|STARTED|Overall Study||63
167004|NCT00511797|410183|P1|STARTED|Overall Study||62
167005|NCT00511810|410287|P2|NOT COMPLETED|Overall Study||5
167006|NCT00511810|410288|P1|NOT COMPLETED|Overall Study||1
167007|NCT00511810|410287|P2|COMPLETED|Overall Study|2 terminated for worsening symptoms;1 refused a scan;2 lost to follow up (could not be contacted)|7
167008|NCT00511810|410288|P1|COMPLETED|Overall Study||7
167009|NCT00511810|410287|P2|STARTED|Overall Study||12
167010|NCT00511810|410288|P1|STARTED|Overall Study||8
167011|NCT00511836|410296|P2|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||0
167012|NCT00511836|410297|P1|NOT COMPLETED|Optional Open-label VIVITROL (2 Months)||16
167013|NCT00511836|410296|P2|COMPLETED|Optional Open-label VIVITROL (2 Months)||0
167014|NCT00511836|410297|P1|COMPLETED|Optional Open-label VIVITROL (2 Months)||6
167015|NCT00511836|410296|P2|STARTED|Optional Open-label VIVITROL (2 Months)|Not all subjects from the double-blind phase entered the optional open-label extension.|0
167016|NCT00511836|410297|P1|STARTED|Optional Open-label VIVITROL (2 Months)|Subjects who received placebo during Month 1 switched to VIVITROL for the optional extension phase.|22
167017|NCT00511836|410296|P2|NOT COMPLETED|Double-blind Period||0
167018|NCT00511836|410297|P1|NOT COMPLETED|Double-blind Period||1
167019|NCT00511836|410296|P2|COMPLETED|Double-blind Period||15
167020|NCT00511836|410297|P1|COMPLETED|Double-blind Period||15
167021|NCT00511836|410296|P2|STARTED|Double-blind Period||15
167022|NCT00511836|410297|P1|STARTED|Double-blind Period||16
167023|NCT00511862|410315|P3|NOT COMPLETED|Overall Study||0
167024|NCT00511862|410316|P2|NOT COMPLETED|Overall Study||0
167025|NCT00511862|410317|P1|NOT COMPLETED|Overall Study||0
167026|NCT00511862|410315|P3|COMPLETED|Overall Study||47
167027|NCT00511862|410316|P2|COMPLETED|Overall Study||43
167028|NCT00511862|410317|P1|COMPLETED|Overall Study||61
167029|NCT00511862|410315|P3|STARTED|Overall Study||47
167030|NCT00511862|410316|P2|STARTED|Overall Study||43
167031|NCT00511862|410317|P1|STARTED|Overall Study||61
167032|NCT00511901|410330|P2|NOT COMPLETED|Overall Study||3
167033|NCT00511901|410331|P1|NOT COMPLETED|Overall Study||1
167034|NCT00511901|410330|P2|COMPLETED|Overall Study||8
167035|NCT00511901|410331|P1|COMPLETED|Overall Study||10
167036|NCT00511901|410330|P2|STARTED|Overall Study||11
167037|NCT00511901|410331|P1|STARTED|Overall Study||11
167038|NCT00511914|410353|P2|NOT COMPLETED|Overall Study||0
167039|NCT00511914|410354|P1|NOT COMPLETED|Overall Study||0
167040|NCT00511914|410353|P2|COMPLETED|Overall Study||67
167041|NCT00511914|410354|P1|COMPLETED|Overall Study||68
167042|NCT00511914|410353|P2|STARTED|Overall Study||67
167043|NCT00511914|410354|P1|STARTED|Overall Study||68
167044|NCT00511992|410368|P1|NOT COMPLETED|Overall Study||7
167045|NCT00511992|410368|P1|COMPLETED|Overall Study||13
167046|NCT00511992|410368|P1|STARTED|Overall Study||20
167047|NCT00512096|410373|P1|NOT COMPLETED|Overall Study||7
167048|NCT00512096|410373|P1|COMPLETED|Overall Study||23
167049|NCT00512096|410373|P1|STARTED|Overall Study||30
167050|NCT00512148|410377|P1|NOT COMPLETED|Long Term Follow Up Period||6
167051|NCT00512148|410377|P1|COMPLETED|Long Term Follow Up Period|6 patients are being followed in long term follow up|0
167052|NCT00512148|410377|P1|STARTED|Long Term Follow Up Period||6
167053|NCT00512148|410377|P1|NOT COMPLETED|Primay Study Period||1
167054|NCT00512148|410377|P1|COMPLETED|Primay Study Period||6
167055|NCT00512148|410377|P1|STARTED|Primay Study Period||7
167056|NCT00512252|410385|P3|NOT COMPLETED|Overall Study||3
167057|NCT00512252|410386|P2|NOT COMPLETED|Overall Study||0
167058|NCT00512252|410387|P1|NOT COMPLETED|Overall Study||0
167059|NCT00512252|410385|P3|COMPLETED|Overall Study||43
167060|NCT00512252|410386|P2|COMPLETED|Overall Study||3
167061|NCT00512252|410387|P1|COMPLETED|Overall Study||3
167062|NCT00512252|410385|P3|STARTED|Overall Study||46
167063|NCT00512252|410386|P2|STARTED|Overall Study||3
167064|NCT00512252|410387|P1|STARTED|Overall Study||3
167065|NCT00506285|410417|P2|NOT COMPLETED|6-month Open Label Phase||12
167066|NCT00506285|410418|P1|NOT COMPLETED|6-month Open Label Phase||10
167067|NCT00506285|410417|P2|COMPLETED|6-month Open Label Phase||19
167068|NCT00506285|410418|P1|COMPLETED|6-month Open Label Phase||10
167069|NCT00506285|410417|P2|STARTED|6-month Open Label Phase||31
167070|NCT00506285|410418|P1|STARTED|6-month Open Label Phase||20
167071|NCT00506285|410417|P2|NOT COMPLETED|Double Blind Cross-Over Phase||5
167072|NCT00506285|410418|P1|NOT COMPLETED|Double Blind Cross-Over Phase||9
167073|NCT00506285|410417|P2|COMPLETED|Double Blind Cross-Over Phase||31
167074|NCT00506285|410418|P1|COMPLETED|Double Blind Cross-Over Phase||20
167075|NCT00506285|410417|P2|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||31
167076|NCT00506285|410418|P1|Received at Least 1 Dose MTS|Double Blind Cross-Over Phase||29
167077|NCT00506285|410417|P2|STARTED|Double Blind Cross-Over Phase||36
167078|NCT00506285|410418|P1|STARTED|Double Blind Cross-Over Phase||29
167079|NCT00506285|410417|P2|NOT COMPLETED|3 Week Screening Phase||10
167080|NCT00506285|410418|P1|NOT COMPLETED|3 Week Screening Phase||17
167081|NCT00506285|410417|P2|COMPLETED|3 Week Screening Phase||36
167082|NCT00506285|410418|P1|COMPLETED|3 Week Screening Phase||29
167083|NCT00506285|410417|P2|STARTED|3 Week Screening Phase||46
167084|NCT00506285|410418|P1|STARTED|3 Week Screening Phase||46
167085|NCT00506389|410429|P3|NOT COMPLETED|Follow-up Period||0
167086|NCT00506389|410430|P2|NOT COMPLETED|Follow-up Period||0
167087|NCT00506389|410431|P1|NOT COMPLETED|Follow-up Period||0
167088|NCT00506389|410429|P3|COMPLETED|Follow-up Period||136
167089|NCT00506389|410430|P2|COMPLETED|Follow-up Period||138
167090|NCT00506389|410431|P1|COMPLETED|Follow-up Period||139
167091|NCT00506389|410429|P3|STARTED|Follow-up Period|11 participants who discontinued treatment entered the Follow-up Period.|136
167092|NCT00506389|410430|P2|STARTED|Follow-up Period|14 participants who discontinued treatment entered the Follow-up Period.|138
167093|NCT00506389|410431|P1|STARTED|Follow-up Period|22 participants who discontinued treatment entered the Follow-up Period.|139
167094|NCT00506389|410429|P3|NOT COMPLETED|In-treatment Period||12
167095|NCT00506389|410430|P2|NOT COMPLETED|In-treatment Period||15
167096|NCT00506389|410431|P1|NOT COMPLETED|In-treatment Period||26
167097|NCT00506389|410429|P3|COMPLETED|In-treatment Period||125
167098|NCT00506389|410430|P2|COMPLETED|In-treatment Period||124
167099|NCT00506389|410431|P1|COMPLETED|In-treatment Period||117
167100|NCT00506389|410429|P3|All Participants Treated|In-treatment Period||136
167101|NCT00506389|410430|P2|All Participants Treated|In-treatment Period||138
167102|NCT00506389|410431|P1|All Participants Treated|In-treatment Period||139
167103|NCT00506389|410429|P3|STARTED|In-treatment Period||137
167104|NCT00506389|410430|P2|STARTED|In-treatment Period||139
167105|NCT00506389|410431|P1|STARTED|In-treatment Period||143
167106|NCT00506415|410448|P4|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||62
167107|NCT00506415|410449|P3|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
167108|NCT00506415|410450|P2|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
167109|NCT00506415|410451|P1|NOT COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
167110|NCT00506415|410448|P4|COMPLETED|Extended Open Label (Maximum 48 Weeks)||395
167111|NCT00506415|410449|P3|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
167112|NCT00506415|410450|P2|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
167113|NCT00506415|410451|P1|COMPLETED|Extended Open Label (Maximum 48 Weeks)||0
167114|NCT00506415|410448|P4|STARTED|Extended Open Label (Maximum 48 Weeks)|Two participants did not receive study drug, hence excluded from this arm.|457
167115|NCT00506415|410449|P3|STARTED|Extended Open Label (Maximum 48 Weeks)||0
167116|NCT00506415|410450|P2|STARTED|Extended Open Label (Maximum 48 Weeks)||0
167117|NCT00506415|410451|P1|STARTED|Extended Open Label (Maximum 48 Weeks)||0
167118|NCT00506415|410448|P4|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
167119|NCT00506415|410449|P3|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||73
167120|NCT00506415|410450|P2|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||83
167121|NCT00506415|410451|P1|NOT COMPLETED|Double Blind (Maximum 48 Weeks )||0
167122|NCT00506415|410448|P4|COMPLETED|Double Blind (Maximum 48 Weeks )||0
167123|NCT00506415|410449|P3|COMPLETED|Double Blind (Maximum 48 Weeks )||207
167124|NCT00506415|410450|P2|COMPLETED|Double Blind (Maximum 48 Weeks )||203
167125|NCT00506415|410451|P1|COMPLETED|Double Blind (Maximum 48 Weeks )||0
167126|NCT00506415|410448|P4|STARTED|Double Blind (Maximum 48 Weeks )||0
167127|NCT00506415|410449|P3|STARTED|Double Blind (Maximum 48 Weeks )||280
167128|NCT00506415|410450|P2|STARTED|Double Blind (Maximum 48 Weeks )|1 patient was randomized in error and did not receive study drug, hence excluded from this arm.|286
167129|NCT00506415|410451|P1|STARTED|Double Blind (Maximum 48 Weeks )||0
167130|NCT00506415|410448|P4|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
167131|NCT00506415|410449|P3|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
167132|NCT00506415|410450|P2|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
167133|NCT00506415|410451|P1|NOT COMPLETED|Initial Open Label (Maximum 48 Weeks)||499
167134|NCT00506415|410448|P4|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
167135|NCT00506415|410449|P3|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
167136|NCT00506415|410450|P2|COMPLETED|Initial Open Label (Maximum 48 Weeks)||0
167137|NCT00506415|410451|P1|COMPLETED|Initial Open Label (Maximum 48 Weeks)||1085
167138|NCT00506415|410448|P4|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
167139|NCT00506415|410449|P3|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
167140|NCT00506415|410450|P2|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||0
167141|NCT00506415|410451|P1|Exposed to Study Drug|Initial Open Label (Maximum 48 Weeks)||1582
167142|NCT00506415|410448|P4|STARTED|Initial Open Label (Maximum 48 Weeks)||0
167143|NCT00506415|410449|P3|STARTED|Initial Open Label (Maximum 48 Weeks)||0
167144|NCT00506415|410450|P2|STARTED|Initial Open Label (Maximum 48 Weeks)||0
167145|NCT00506415|410451|P1|STARTED|Initial Open Label (Maximum 48 Weeks)|Enrolled patients.|1584
167146|NCT00506441|410473|P2|NOT COMPLETED|Period 2; Double-blind Period||5
167147|NCT00506441|410474|P1|NOT COMPLETED|Period 2; Double-blind Period||3
167148|NCT00506441|410473|P2|COMPLETED|Period 2; Double-blind Period||79
167149|NCT00506441|410474|P1|COMPLETED|Period 2; Double-blind Period||82
167150|NCT00506441|410473|P2|STARTED|Period 2; Double-blind Period||84
167151|NCT00506441|410474|P1|STARTED|Period 2; Double-blind Period||85
167152|NCT00506441|410473|P2|NOT COMPLETED|Period 1; Open-label Period||0
167153|NCT00506441|410474|P1|NOT COMPLETED|Period 1; Open-label Period||76
167154|NCT00506441|410473|P2|COMPLETED|Period 1; Open-label Period||0
167155|NCT00506441|410474|P1|COMPLETED|Period 1; Open-label Period||169
167156|NCT00506441|410473|P2|STARTED|Period 1; Open-label Period||0
167157|NCT00506441|410474|P1|STARTED|Period 1; Open-label Period||245
167158|NCT00506454|410484|P2|NOT COMPLETED|Overall Study||1
167159|NCT00506454|410485|P1|NOT COMPLETED|Overall Study||1
167160|NCT00506454|410484|P2|COMPLETED|Overall Study||10
167161|NCT00506454|410485|P1|COMPLETED|Overall Study||10
167162|NCT00506454|410484|P2|STARTED|Overall Study||11
167163|NCT00506454|410485|P1|STARTED|Overall Study||11
167164|NCT00506493|410491|P1|NOT COMPLETED|Overall Study||11
167165|NCT00506493|410491|P1|COMPLETED|Overall Study||64
167166|NCT00506493|410491|P1|STARTED|Overall Study||75
167167|NCT00506597|410498|P1|NOT COMPLETED|Overall Study||0
167168|NCT00506597|410498|P1|COMPLETED|Overall Study||33
167169|NCT00506597|410498|P1|STARTED|Overall Study||33
167170|NCT00512707|410504|P2|NOT COMPLETED|Overall Study||12
167171|NCT00512707|410505|P1|NOT COMPLETED|Overall Study||10
167172|NCT00512707|410504|P2|COMPLETED|Overall Study||58
167173|NCT00512707|410505|P1|COMPLETED|Overall Study||60
167174|NCT00512707|410504|P2|STARTED|Overall Study||70
167175|NCT00512707|410505|P1|STARTED|Overall Study||70
167176|NCT00512798|410537|P2|NOT COMPLETED|Overall Study||27
167177|NCT00512798|410538|P1|NOT COMPLETED|Overall Study||19
167178|NCT00512798|410537|P2|COMPLETED|Overall Study||1
167179|NCT00512798|410538|P1|COMPLETED|Overall Study||0
167180|NCT00512798|410537|P2|STARTED|Overall Study||28
167181|NCT00512798|410538|P1|STARTED|Overall Study||19
167182|NCT00512876|410547|P1|NOT COMPLETED|Overall Study||4
167183|NCT00512876|410547|P1|COMPLETED|Overall Study||20
167184|NCT00512876|410547|P1|STARTED|Overall Study||24
167185|NCT00512902|410552|P1|NOT COMPLETED|Overall Study||8
167186|NCT00512902|410552|P1|COMPLETED|Overall Study||12
167187|NCT00512902|410552|P1|STARTED|Overall Study||20
167188|NCT00513799|410564|P4|NOT COMPLETED|Four-Month Follow-Up||3
167189|NCT00513799|410565|P3|NOT COMPLETED|Four-Month Follow-Up||7
167190|NCT00513799|410566|P2|NOT COMPLETED|Four-Month Follow-Up||5
167191|NCT00513799|410567|P1|NOT COMPLETED|Four-Month Follow-Up||0
167192|NCT00513799|410564|P4|COMPLETED|Four-Month Follow-Up||51
167193|NCT00513799|410565|P3|COMPLETED|Four-Month Follow-Up||57
167194|NCT00513799|410566|P2|COMPLETED|Four-Month Follow-Up||57
167195|NCT00513799|410567|P1|COMPLETED|Four-Month Follow-Up||64
167196|NCT00513799|410564|P4|STARTED|Four-Month Follow-Up||54
167197|NCT00513799|410565|P3|STARTED|Four-Month Follow-Up||64
167198|NCT00513799|410566|P2|STARTED|Four-Month Follow-Up||62
167199|NCT00513799|410567|P1|STARTED|Four-Month Follow-Up||64
167200|NCT00513799|410564|P4|NOT COMPLETED|One-Month Follow-Up||21
167201|NCT00513799|410565|P3|NOT COMPLETED|One-Month Follow-Up||11
167202|NCT00513799|410566|P2|NOT COMPLETED|One-Month Follow-Up||13
167203|NCT00513799|410567|P1|NOT COMPLETED|One-Month Follow-Up||11
167204|NCT00513799|410564|P4|COMPLETED|One-Month Follow-Up||54
167205|NCT00513799|410565|P3|COMPLETED|One-Month Follow-Up||64
167206|NCT00513799|410566|P2|COMPLETED|One-Month Follow-Up||62
167207|NCT00513799|410567|P1|COMPLETED|One-Month Follow-Up||64
167208|NCT00513799|410564|P4|STARTED|One-Month Follow-Up||75
167209|NCT00513799|410565|P3|STARTED|One-Month Follow-Up||75
167210|NCT00513799|410566|P2|STARTED|One-Month Follow-Up||75
167211|NCT00513799|410567|P1|STARTED|One-Month Follow-Up||75
167212|NCT00514020|410585|P1|NOT COMPLETED|Overall Study||28
167213|NCT00514020|410585|P1|COMPLETED|Overall Study||5
167214|NCT00514020|410585|P1|STARTED|Overall Study|two patients withdrew before treatment; one withdrew after treatment|33
167215|NCT00514137|410589|P1|NOT COMPLETED|Overall Study||0
167216|NCT00514137|410589|P1|COMPLETED|Overall Study||13
167217|NCT00514137|410589|P1|STARTED|Overall Study||13
167218|NCT00514215|410596|P1|NOT COMPLETED|Overall Study||0
167219|NCT00514215|410596|P1|COMPLETED|Overall Study||8
167220|NCT00514215|410596|P1|STARTED|Overall Study||8
167221|NCT00514501|410600|P1|NOT COMPLETED|Overall Study||3
167222|NCT00514501|410600|P1|COMPLETED|Overall Study||507
167223|NCT00514501|410600|P1|STARTED|Overall Study||510
167224|NCT00514514|410609|P3|NOT COMPLETED|Extension - 4 Years||21
167225|NCT00514514|410610|P2|NOT COMPLETED|Extension - 4 Years||22
167226|NCT00514514|410611|P1|NOT COMPLETED|Extension - 4 Years||37
167227|NCT00514514|410609|P3|COMPLETED|Extension - 4 Years||113
167228|NCT00514514|410610|P2|COMPLETED|Extension - 4 Years||117
167229|NCT00514514|410611|P1|COMPLETED|Extension - 4 Years||108
167230|NCT00514514|410609|P3|Non-randomized (Followed)|Extension - 4 Years||0
167231|NCT00514514|410610|P2|Non-randomized (Followed)|Extension - 4 Years||0
167232|NCT00514514|410611|P1|Non-randomized (Followed)|Extension - 4 Years|Patients were not randomized but continued on standard regimen and entered follow up.|95
167233|NCT00514514|410609|P3|STARTED|Extension - 4 Years||134
167234|NCT00514514|410610|P2|STARTED|Extension - 4 Years||139
167235|NCT00514514|410611|P1|STARTED|Extension - 4 Years||145
167236|NCT00514514|410609|P3|NOT COMPLETED|Randomized - 9 Month||38
167237|NCT00514514|410610|P2|NOT COMPLETED|Randomized - 9 Month||61
167238|NCT00514514|410611|P1|NOT COMPLETED|Randomized - 9 Month||39
167239|NCT00514514|410609|P3|COMPLETED|Randomized - 9 Month||124
167240|NCT00514514|410610|P2|COMPLETED|Randomized - 9 Month||110
167241|NCT00514514|410611|P1|COMPLETED|Randomized - 9 Month||127
167242|NCT00514514|410609|P3|Randomized - Received Treatment|Randomized - 9 Month||161
167243|NCT00514514|410610|P2|Randomized - Received Treatment|Randomized - 9 Month||171
167244|NCT00514514|410611|P1|Randomized - Received Treatment|Randomized - 9 Month||165
167245|NCT00514514|410609|P3|STARTED|Randomized - 9 Month||162
167246|NCT00514514|410610|P2|STARTED|Randomized - 9 Month||171
167247|NCT00514514|410611|P1|STARTED|Randomized - 9 Month||166
167248|NCT00514514|410609|P3|NOT COMPLETED|Pre-phase||0
167249|NCT00514514|410610|P2|NOT COMPLETED|Pre-phase||0
167250|NCT00514514|410611|P1|NOT COMPLETED|Pre-phase||303
167251|NCT00514514|410609|P3|COMPLETED|Pre-phase||0
167252|NCT00514514|410610|P2|COMPLETED|Pre-phase||0
167253|NCT00514514|410611|P1|COMPLETED|Pre-phase||499
167254|NCT00514514|410609|P3|STARTED|Pre-phase||0
167255|NCT00514514|410610|P2|STARTED|Pre-phase||0
167256|NCT00514514|410611|P1|STARTED|Pre-phase|All enrolled patients received standard regimen for 3 months|802
167257|NCT00514592|410655|P1|NOT COMPLETED|Overall Study||0
167258|NCT00514592|410655|P1|COMPLETED|Overall Study||230
167259|NCT00514592|410655|P1|STARTED|Overall Study||230
167260|NCT00514683|410665|P5|NOT COMPLETED|Overall Study||33
167261|NCT00514683|410666|P4|NOT COMPLETED|Overall Study||14
167262|NCT00514683|410667|P3|NOT COMPLETED|Overall Study||18
167263|NCT00514683|410668|P2|NOT COMPLETED|Overall Study||25
167264|NCT00514683|410669|P1|NOT COMPLETED|Overall Study||26
167265|NCT00514683|410665|P5|COMPLETED|Overall Study||53
167266|NCT00514683|410666|P4|COMPLETED|Overall Study||72
167267|NCT00514683|410667|P3|COMPLETED|Overall Study||68
167268|NCT00514683|410668|P2|COMPLETED|Overall Study||62
167269|NCT00514683|410669|P1|COMPLETED|Overall Study||61
167270|NCT00514683|410665|P5|STARTED|Overall Study|Randomised|86
167271|NCT00514683|410666|P4|STARTED|Overall Study|Randomised|86
167272|NCT00514683|410667|P3|STARTED|Overall Study|Randomised|86
167273|NCT00514683|410668|P2|STARTED|Overall Study|Randomised|87
167274|NCT00514683|410669|P1|STARTED|Overall Study|Randomised|87
167275|NCT00514709|410862|P2|NOT COMPLETED|Overall Study||0
167276|NCT00514709|410863|P1|NOT COMPLETED|Overall Study||0
167277|NCT00514709|410862|P2|COMPLETED|Overall Study||613
167278|NCT00514709|410863|P1|COMPLETED|Overall Study||1230
167279|NCT00514709|410862|P2|STARTED|Overall Study||613
167280|NCT00514709|410863|P1|STARTED|Overall Study||1230
167281|NCT00514735|410875|P2|NOT COMPLETED|Overall Study||6
167282|NCT00514735|410876|P1|NOT COMPLETED|Overall Study||14
167283|NCT00514735|410875|P2|COMPLETED|Overall Study||66
167284|NCT00514735|410876|P1|COMPLETED|Overall Study||124
167285|NCT00514735|410875|P2|STARTED|Overall Study||72
167286|NCT00514735|410876|P1|STARTED|Overall Study||138
167287|NCT00514813|410898|P4|NOT COMPLETED|Overall Study||4
167288|NCT00514813|410899|P3|NOT COMPLETED|Overall Study||47
167289|NCT00514813|410900|P2|NOT COMPLETED|Overall Study||86
167290|NCT00514813|410901|P1|NOT COMPLETED|Overall Study||15
167291|NCT00514813|410898|P4|COMPLETED|Overall Study||0
167292|NCT00514813|410899|P3|COMPLETED|Overall Study||0
167293|NCT00514813|410900|P2|COMPLETED|Overall Study||0
167294|NCT00514813|410901|P1|COMPLETED|Overall Study||0
167295|NCT00514813|410898|P4|STARTED|Overall Study||4
167296|NCT00514813|410899|P3|STARTED|Overall Study||47
167297|NCT00514813|410900|P2|STARTED|Overall Study||86
167298|NCT00514813|410901|P1|STARTED|Overall Study||15
167299|NCT00514852|410921|P2|NOT COMPLETED|Overall Study||5
167300|NCT00514852|410922|P1|NOT COMPLETED|Overall Study||5
167301|NCT00514852|410921|P2|COMPLETED|Overall Study||154
167302|NCT00514852|410922|P1|COMPLETED|Overall Study||152
167303|NCT00514852|410921|P2|STARTED|Overall Study||159
167304|NCT00514852|410922|P1|STARTED|Overall Study||157
167305|NCT00514917|410948|P2|NOT COMPLETED|Overall Study||115
167306|NCT00514917|410949|P1|NOT COMPLETED|Overall Study||126
167307|NCT00514917|410948|P2|COMPLETED|Overall Study||91
167308|NCT00514917|410949|P1|COMPLETED|Overall Study||81
167309|NCT00514917|410948|P2|Testosterone-Specific Evaluable|Overall Study||124
167310|NCT00514917|410949|P1|Testosterone-Specific Evaluable|Overall Study||122
167311|NCT00514917|410948|P2|Completed Study Treatment|Overall Study||182
167312|NCT00514917|410949|P1|Completed Study Treatment|Overall Study||170
167313|NCT00514917|410948|P2|Treated|Overall Study||204
167314|NCT00514917|410949|P1|Treated|Overall Study||196
167315|NCT00514917|410948|P2|STARTED|Overall Study||206
167316|NCT00514917|410949|P1|STARTED|Overall Study||207
167317|NCT00514943|410977|P2|NOT COMPLETED|Stage 2||36
167318|NCT00514943|410978|P1|NOT COMPLETED|Stage 2||32
167319|NCT00514943|410977|P2|COMPLETED|Stage 2||0
167320|NCT00514943|410978|P1|COMPLETED|Stage 2||0
167321|NCT00514943|410977|P2|STARTED|Stage 2||36
167322|NCT00514943|410978|P1|STARTED|Stage 2||32
167323|NCT00514943|410977|P2|NOT COMPLETED|Stage 1||26
167324|NCT00514943|410978|P1|NOT COMPLETED|Stage 1||30
167325|NCT00514943|410977|P2|COMPLETED|Stage 1||36
167326|NCT00514943|410978|P1|COMPLETED|Stage 1||32
167327|NCT00514943|410977|P2|STARTED|Stage 1|2 randomized patients were not treated|62
167328|NCT00514943|410978|P1|STARTED|Stage 1|1 randomized patient was not treated|62
167329|NCT00515008|411036|P2|NOT COMPLETED|Overall Study||4
167330|NCT00515008|411037|P1|NOT COMPLETED|Overall Study||3
167331|NCT00515008|411036|P2|COMPLETED|Overall Study||29
167332|NCT00515008|411037|P1|COMPLETED|Overall Study||30
167333|NCT00515008|411036|P2|Completed 12 Week Evaluation|Overall Study||29
167334|NCT00515008|411037|P1|Completed 12 Week Evaluation|Overall Study||32
167335|NCT00515008|411036|P2|STARTED|Overall Study||33
167336|NCT00515008|411037|P1|STARTED|Overall Study||33
167337|NCT00515034|411063|P4|NOT COMPLETED|Overall Study||5
167338|NCT00515034|411064|P3|NOT COMPLETED|Overall Study||8
167339|NCT00515034|411065|P2|NOT COMPLETED|Overall Study||2
167340|NCT00515034|411066|P1|NOT COMPLETED|Overall Study||8
167341|NCT00515034|411063|P4|COMPLETED|Overall Study||15
167342|NCT00515034|411064|P3|COMPLETED|Overall Study||54
167343|NCT00515034|411065|P2|COMPLETED|Overall Study||13
167344|NCT00515034|411066|P1|COMPLETED|Overall Study||41
167345|NCT00515034|411063|P4|TREATED|Overall Study||19
167346|NCT00515034|411064|P3|TREATED|Overall Study||61
167347|NCT00515034|411065|P2|TREATED|Overall Study||15
167348|NCT00515034|411066|P1|TREATED|Overall Study||48
167349|NCT00515034|411063|P4|STARTED|Overall Study||20
167350|NCT00515034|411064|P3|STARTED|Overall Study||62
167351|NCT00515034|411065|P2|STARTED|Overall Study||15
167352|NCT00515034|411066|P1|STARTED|Overall Study||49
167353|NCT00515073|411084|P1|NOT COMPLETED|Overall Study||2
167354|NCT00515073|411084|P1|COMPLETED|Overall Study||28
167355|NCT00515073|411084|P1|STARTED|Overall Study||30
167356|NCT00515086|411092|P4|NOT COMPLETED|Overall Study||6
167357|NCT00515086|411093|P3|NOT COMPLETED|Overall Study||5
167358|NCT00515086|411094|P2|NOT COMPLETED|Overall Study||6
167359|NCT00515086|411095|P1|NOT COMPLETED|Overall Study||24
167360|NCT00515086|411092|P4|COMPLETED|Overall Study||0
167361|NCT00515086|411093|P3|COMPLETED|Overall Study||0
167362|NCT00515086|411094|P2|COMPLETED|Overall Study||0
167363|NCT00515086|411095|P1|COMPLETED|Overall Study||0
167364|NCT00515086|411092|P4|STARTED|Overall Study||6
167365|NCT00515086|411093|P3|STARTED|Overall Study||5
167366|NCT00515086|411094|P2|STARTED|Overall Study||6
167367|NCT00515086|411095|P1|STARTED|Overall Study||24
167368|NCT00515099|411124|P2|NOT COMPLETED|Overall Study||4
167369|NCT00515099|411125|P1|NOT COMPLETED|Overall Study||3
167370|NCT00515099|411124|P2|COMPLETED|Overall Study||16
167371|NCT00515099|411125|P1|COMPLETED|Overall Study||35
167372|NCT00515099|411124|P2|STARTED|Overall Study||20
167373|NCT00515099|411125|P1|STARTED|Overall Study||38
167374|NCT00515112|411145|P2|NOT COMPLETED|Overall Study||3
167375|NCT00515112|411146|P1|NOT COMPLETED|Overall Study||3
167376|NCT00515112|411145|P2|COMPLETED|Overall Study||0
167377|NCT00515112|411146|P1|COMPLETED|Overall Study||0
167378|NCT00515112|411145|P2|STARTED|Overall Study||3
167379|NCT00515112|411146|P1|STARTED|Overall Study||3
167380|NCT00515177|411156|P2|NOT COMPLETED|Overall Study||1
167381|NCT00515177|411157|P1|NOT COMPLETED|Overall Study||2
167382|NCT00515177|411156|P2|COMPLETED|Overall Study||9
167383|NCT00515177|411157|P1|COMPLETED|Overall Study||18
167384|NCT00515177|411156|P2|STARTED|Overall Study||10
167385|NCT00515177|411157|P1|STARTED|Overall Study||20
167386|NCT00515203|411175|P2|NOT COMPLETED|Overall Study||0
167387|NCT00515203|411176|P1|NOT COMPLETED|Overall Study||0
167388|NCT00515203|411175|P2|COMPLETED|Overall Study||5
167389|NCT00515203|411176|P1|COMPLETED|Overall Study||17
167390|NCT00515203|411175|P2|STARTED|Overall Study||5
167391|NCT00515203|411176|P1|STARTED|Overall Study||17
167392|NCT00515216|411192|P1|NOT COMPLETED|Overall Study||1
167393|NCT00515216|411192|P1|COMPLETED|Overall Study||25
167394|NCT00515216|411192|P1|STARTED|Overall Study||26
167395|NCT00515294|411218|P4|NOT COMPLETED|Overall Study||4
167396|NCT00515294|411219|P3|NOT COMPLETED|Overall Study||11
167397|NCT00515294|411220|P2|NOT COMPLETED|Overall Study||3
167398|NCT00515294|411221|P1|NOT COMPLETED|Overall Study||9
167399|NCT00515294|411218|P4|COMPLETED|Overall Study||35
167400|NCT00515294|411219|P3|COMPLETED|Overall Study||27
167401|NCT00515294|411220|P2|COMPLETED|Overall Study||36
167402|NCT00515294|411221|P1|COMPLETED|Overall Study||29
167403|NCT00515294|411218|P4|STARTED|Overall Study||39
167404|NCT00515294|411219|P3|STARTED|Overall Study||38
167405|NCT00515294|411220|P2|STARTED|Overall Study||39
167406|NCT00515294|411221|P1|STARTED|Overall Study||38
167407|NCT00515437|411239|P4|NOT COMPLETED|Overall Study||1
167408|NCT00515437|411240|P3|NOT COMPLETED|Overall Study||0
167409|NCT00515437|411241|P2|NOT COMPLETED|Overall Study||0
167410|NCT00515437|411242|P1|NOT COMPLETED|Overall Study||0
167411|NCT00515437|411239|P4|COMPLETED|Overall Study||14
167412|NCT00515437|411240|P3|COMPLETED|Overall Study||13
167413|NCT00515437|411241|P2|COMPLETED|Overall Study||12
167414|NCT00515437|411242|P1|COMPLETED|Overall Study||14
167415|NCT00515437|411239|P4|STARTED|Overall Study||15
167416|NCT00515437|411240|P3|STARTED|Overall Study||13
167417|NCT00515437|411241|P2|STARTED|Overall Study||12
167418|NCT00515437|411242|P1|STARTED|Overall Study||14
167419|NCT00515463|411266|P2|NOT COMPLETED|Overall Study||14
167420|NCT00515463|411267|P1|NOT COMPLETED|Overall Study||14
167421|NCT00515463|411266|P2|COMPLETED|Overall Study||142
167422|NCT00515463|411267|P1|COMPLETED|Overall Study||141
167423|NCT00515463|411266|P2|Received Study Medication|Overall Study||156
167424|NCT00515463|411267|P1|Received Study Medication|Overall Study||154
167425|NCT00515463|411266|P2|STARTED|Overall Study||156
167426|NCT00515463|411267|P1|STARTED|Overall Study||155
167427|NCT00515502|411417|P12|NOT COMPLETED|Treatment Period 4||0
167428|NCT00515502|411418|P11|NOT COMPLETED|Treatment Period 4||0
167429|NCT00515502|411419|P10|NOT COMPLETED|Treatment Period 4||0
167430|NCT00515502|411420|P9|NOT COMPLETED|Treatment Period 4||0
167431|NCT00515502|411421|P8|NOT COMPLETED|Treatment Period 4||0
167432|NCT00515502|411422|P7|NOT COMPLETED|Treatment Period 4||0
167433|NCT00515502|411423|P6|NOT COMPLETED|Treatment Period 4||0
167434|NCT00515502|411424|P5|NOT COMPLETED|Treatment Period 4||0
167435|NCT00515502|411425|P4|NOT COMPLETED|Treatment Period 4||0
167436|NCT00515502|411426|P3|NOT COMPLETED|Treatment Period 4||0
167437|NCT00515502|411427|P2|NOT COMPLETED|Treatment Period 4||0
167438|NCT00515502|411428|P1|NOT COMPLETED|Treatment Period 4||0
167439|NCT00515502|411417|P12|COMPLETED|Treatment Period 4||0
167440|NCT00515502|411418|P11|COMPLETED|Treatment Period 4||1
167441|NCT00515502|411419|P10|COMPLETED|Treatment Period 4||2
167442|NCT00515502|411420|P9|COMPLETED|Treatment Period 4||0
167443|NCT00515502|411421|P8|COMPLETED|Treatment Period 4||1
167444|NCT00515502|411422|P7|COMPLETED|Treatment Period 4||1
167445|NCT00515502|411423|P6|COMPLETED|Treatment Period 4||1
167446|NCT00515502|411424|P5|COMPLETED|Treatment Period 4||3
167447|NCT00515502|411425|P4|COMPLETED|Treatment Period 4||3
167448|NCT00515502|411426|P3|COMPLETED|Treatment Period 4||4
167449|NCT00515502|411427|P2|COMPLETED|Treatment Period 4||3
167450|NCT00515502|411428|P1|COMPLETED|Treatment Period 4||1
167451|NCT00515502|411417|P12|STARTED|Treatment Period 4||0
167452|NCT00515502|411418|P11|STARTED|Treatment Period 4||1
167453|NCT00515502|411419|P10|STARTED|Treatment Period 4||2
167454|NCT00515502|411420|P9|STARTED|Treatment Period 4||0
167455|NCT00515502|411421|P8|STARTED|Treatment Period 4||1
167456|NCT00515502|411422|P7|STARTED|Treatment Period 4||1
167457|NCT00515502|411423|P6|STARTED|Treatment Period 4||1
167458|NCT00515502|411424|P5|STARTED|Treatment Period 4||3
167459|NCT00515502|411425|P4|STARTED|Treatment Period 4||3
167460|NCT00515502|411426|P3|STARTED|Treatment Period 4||4
167461|NCT00515502|411427|P2|STARTED|Treatment Period 4||3
167462|NCT00515502|411428|P1|STARTED|Treatment Period 4||1
167463|NCT00515502|411417|P12|NOT COMPLETED|Washout Period 3||0
167464|NCT00515502|411418|P11|NOT COMPLETED|Washout Period 3||0
167465|NCT00515502|411419|P10|NOT COMPLETED|Washout Period 3||0
167466|NCT00515502|411420|P9|NOT COMPLETED|Washout Period 3||0
167467|NCT00515502|411421|P8|NOT COMPLETED|Washout Period 3||0
167468|NCT00515502|411422|P7|NOT COMPLETED|Washout Period 3||0
167469|NCT00515502|411423|P6|NOT COMPLETED|Washout Period 3||0
167470|NCT00515502|411424|P5|NOT COMPLETED|Washout Period 3||0
167471|NCT00515502|411425|P4|NOT COMPLETED|Washout Period 3||0
167472|NCT00515502|411426|P3|NOT COMPLETED|Washout Period 3||0
167473|NCT00515502|411427|P2|NOT COMPLETED|Washout Period 3||0
167474|NCT00515502|411428|P1|NOT COMPLETED|Washout Period 3||0
167475|NCT00515502|411417|P12|COMPLETED|Washout Period 3||0
167476|NCT00515502|411418|P11|COMPLETED|Washout Period 3||1
167477|NCT00515502|411419|P10|COMPLETED|Washout Period 3||2
167478|NCT00515502|411420|P9|COMPLETED|Washout Period 3||0
167479|NCT00515502|411421|P8|COMPLETED|Washout Period 3||1
167480|NCT00515502|411422|P7|COMPLETED|Washout Period 3||1
167481|NCT00515502|411423|P6|COMPLETED|Washout Period 3||1
167482|NCT00515502|411424|P5|COMPLETED|Washout Period 3||3
167483|NCT00515502|411425|P4|COMPLETED|Washout Period 3||3
167484|NCT00515502|411426|P3|COMPLETED|Washout Period 3||4
167485|NCT00515502|411427|P2|COMPLETED|Washout Period 3||3
167486|NCT00515502|411428|P1|COMPLETED|Washout Period 3||1
167487|NCT00515502|411417|P12|STARTED|Washout Period 3||0
167488|NCT00515502|411418|P11|STARTED|Washout Period 3||1
167489|NCT00515502|411419|P10|STARTED|Washout Period 3||2
167490|NCT00515502|411420|P9|STARTED|Washout Period 3||0
167491|NCT00515502|411421|P8|STARTED|Washout Period 3||1
167492|NCT00515502|411422|P7|STARTED|Washout Period 3||1
167493|NCT00515502|411423|P6|STARTED|Washout Period 3||1
167494|NCT00515502|411424|P5|STARTED|Washout Period 3||3
167495|NCT00515502|411425|P4|STARTED|Washout Period 3||3
167496|NCT00515502|411426|P3|STARTED|Washout Period 3||4
167497|NCT00515502|411427|P2|STARTED|Washout Period 3||3
167498|NCT00515502|411428|P1|STARTED|Washout Period 3||1
167499|NCT00515502|411417|P12|NOT COMPLETED|Treatment Period 3||0
167500|NCT00515502|411418|P11|NOT COMPLETED|Treatment Period 3||0
167501|NCT00515502|411419|P10|NOT COMPLETED|Treatment Period 3||0
167502|NCT00515502|411420|P9|NOT COMPLETED|Treatment Period 3||0
167503|NCT00515502|411421|P8|NOT COMPLETED|Treatment Period 3||0
167504|NCT00515502|411422|P7|NOT COMPLETED|Treatment Period 3||0
167505|NCT00515502|411423|P6|NOT COMPLETED|Treatment Period 3||0
167506|NCT00515502|411424|P5|NOT COMPLETED|Treatment Period 3||0
167507|NCT00515502|411425|P4|NOT COMPLETED|Treatment Period 3||0
167508|NCT00515502|411426|P3|NOT COMPLETED|Treatment Period 3||0
167509|NCT00515502|411427|P2|NOT COMPLETED|Treatment Period 3||0
167510|NCT00515502|411428|P1|NOT COMPLETED|Treatment Period 3||0
167511|NCT00515502|411417|P12|COMPLETED|Treatment Period 3||0
167512|NCT00515502|411418|P11|COMPLETED|Treatment Period 3||1
167513|NCT00515502|411419|P10|COMPLETED|Treatment Period 3||2
167514|NCT00515502|411420|P9|COMPLETED|Treatment Period 3||0
167515|NCT00515502|411421|P8|COMPLETED|Treatment Period 3||1
167516|NCT00515502|411422|P7|COMPLETED|Treatment Period 3||1
167517|NCT00515502|411423|P6|COMPLETED|Treatment Period 3||1
167518|NCT00515502|411424|P5|COMPLETED|Treatment Period 3||3
167519|NCT00515502|411425|P4|COMPLETED|Treatment Period 3||3
167520|NCT00515502|411426|P3|COMPLETED|Treatment Period 3||4
167521|NCT00515502|411427|P2|COMPLETED|Treatment Period 3||3
167522|NCT00515502|411428|P1|COMPLETED|Treatment Period 3||1
167523|NCT00515502|411417|P12|STARTED|Treatment Period 3||0
167524|NCT00515502|411418|P11|STARTED|Treatment Period 3||1
167525|NCT00515502|411419|P10|STARTED|Treatment Period 3||2
167526|NCT00515502|411420|P9|STARTED|Treatment Period 3||0
167527|NCT00515502|411421|P8|STARTED|Treatment Period 3||1
167528|NCT00515502|411422|P7|STARTED|Treatment Period 3||1
167529|NCT00515502|411423|P6|STARTED|Treatment Period 3||1
167530|NCT00515502|411424|P5|STARTED|Treatment Period 3||3
167531|NCT00515502|411425|P4|STARTED|Treatment Period 3||3
167532|NCT00515502|411426|P3|STARTED|Treatment Period 3||4
167533|NCT00515502|411427|P2|STARTED|Treatment Period 3||3
167534|NCT00515502|411428|P1|STARTED|Treatment Period 3||1
167535|NCT00515502|411417|P12|NOT COMPLETED|Washout Period 2||0
167536|NCT00515502|411418|P11|NOT COMPLETED|Washout Period 2||0
167537|NCT00515502|411419|P10|NOT COMPLETED|Washout Period 2||0
167538|NCT00515502|411420|P9|NOT COMPLETED|Washout Period 2||0
167539|NCT00515502|411421|P8|NOT COMPLETED|Washout Period 2||0
167540|NCT00515502|411422|P7|NOT COMPLETED|Washout Period 2||0
167541|NCT00515502|411423|P6|NOT COMPLETED|Washout Period 2||0
167542|NCT00515502|411424|P5|NOT COMPLETED|Washout Period 2||0
167543|NCT00515502|411425|P4|NOT COMPLETED|Washout Period 2||0
167544|NCT00515502|411426|P3|NOT COMPLETED|Washout Period 2||0
167545|NCT00515502|411427|P2|NOT COMPLETED|Washout Period 2||0
167546|NCT00515502|411428|P1|NOT COMPLETED|Washout Period 2||0
167547|NCT00515502|411417|P12|COMPLETED|Washout Period 2||0
167548|NCT00515502|411418|P11|COMPLETED|Washout Period 2||1
167549|NCT00515502|411419|P10|COMPLETED|Washout Period 2||2
167550|NCT00515502|411420|P9|COMPLETED|Washout Period 2||0
167551|NCT00515502|411421|P8|COMPLETED|Washout Period 2||1
167552|NCT00515502|411422|P7|COMPLETED|Washout Period 2||1
167553|NCT00515502|411423|P6|COMPLETED|Washout Period 2||1
167554|NCT00515502|411424|P5|COMPLETED|Washout Period 2||3
167555|NCT00515502|411425|P4|COMPLETED|Washout Period 2||3
167556|NCT00515502|411426|P3|COMPLETED|Washout Period 2||4
167557|NCT00515502|411427|P2|COMPLETED|Washout Period 2||3
167558|NCT00515502|411428|P1|COMPLETED|Washout Period 2||1
167559|NCT00515502|411417|P12|STARTED|Washout Period 2||0
167560|NCT00515502|411418|P11|STARTED|Washout Period 2||1
167561|NCT00515502|411419|P10|STARTED|Washout Period 2||2
167562|NCT00515502|411420|P9|STARTED|Washout Period 2||0
167563|NCT00515502|411421|P8|STARTED|Washout Period 2||1
167564|NCT00515502|411422|P7|STARTED|Washout Period 2||1
167565|NCT00515502|411423|P6|STARTED|Washout Period 2||1
167566|NCT00515502|411424|P5|STARTED|Washout Period 2||3
167567|NCT00515502|411425|P4|STARTED|Washout Period 2||3
167568|NCT00515502|411426|P3|STARTED|Washout Period 2||4
167569|NCT00515502|411427|P2|STARTED|Washout Period 2||3
167570|NCT00515502|411428|P1|STARTED|Washout Period 2||1
167571|NCT00515502|411417|P12|NOT COMPLETED|Treatment Period 2||0
167572|NCT00515502|411418|P11|NOT COMPLETED|Treatment Period 2||0
167573|NCT00515502|411419|P10|NOT COMPLETED|Treatment Period 2||0
167574|NCT00515502|411420|P9|NOT COMPLETED|Treatment Period 2||0
167575|NCT00515502|411421|P8|NOT COMPLETED|Treatment Period 2||0
167576|NCT00515502|411422|P7|NOT COMPLETED|Treatment Period 2||0
167577|NCT00515502|411423|P6|NOT COMPLETED|Treatment Period 2||0
167578|NCT00515502|411424|P5|NOT COMPLETED|Treatment Period 2||0
167579|NCT00515502|411425|P4|NOT COMPLETED|Treatment Period 2||0
167580|NCT00515502|411426|P3|NOT COMPLETED|Treatment Period 2||0
167581|NCT00515502|411427|P2|NOT COMPLETED|Treatment Period 2||1
167582|NCT00515502|411428|P1|NOT COMPLETED|Treatment Period 2||0
167583|NCT00515502|411417|P12|COMPLETED|Treatment Period 2||0
167584|NCT00515502|411418|P11|COMPLETED|Treatment Period 2||1
167585|NCT00515502|411419|P10|COMPLETED|Treatment Period 2||2
167586|NCT00515502|411420|P9|COMPLETED|Treatment Period 2||0
167587|NCT00515502|411421|P8|COMPLETED|Treatment Period 2||1
167588|NCT00515502|411422|P7|COMPLETED|Treatment Period 2||1
167589|NCT00515502|411423|P6|COMPLETED|Treatment Period 2||1
167590|NCT00515502|411424|P5|COMPLETED|Treatment Period 2||3
167591|NCT00515502|411425|P4|COMPLETED|Treatment Period 2||3
167592|NCT00515502|411426|P3|COMPLETED|Treatment Period 2||4
167593|NCT00515502|411427|P2|COMPLETED|Treatment Period 2||3
167594|NCT00515502|411428|P1|COMPLETED|Treatment Period 2||1
167595|NCT00515502|411417|P12|STARTED|Treatment Period 2||0
167596|NCT00515502|411418|P11|STARTED|Treatment Period 2||1
167597|NCT00515502|411419|P10|STARTED|Treatment Period 2||2
167598|NCT00515502|411420|P9|STARTED|Treatment Period 2||0
167599|NCT00515502|411421|P8|STARTED|Treatment Period 2||1
167600|NCT00515502|411422|P7|STARTED|Treatment Period 2||1
167601|NCT00515502|411423|P6|STARTED|Treatment Period 2||1
167602|NCT00515502|411424|P5|STARTED|Treatment Period 2||3
167603|NCT00515502|411425|P4|STARTED|Treatment Period 2||3
167604|NCT00515502|411426|P3|STARTED|Treatment Period 2||4
167605|NCT00515502|411427|P2|STARTED|Treatment Period 2||4
167606|NCT00515502|411428|P1|STARTED|Treatment Period 2||1
167607|NCT00515502|411417|P12|NOT COMPLETED|Washout Period 1||0
167608|NCT00515502|411418|P11|NOT COMPLETED|Washout Period 1||0
167609|NCT00515502|411419|P10|NOT COMPLETED|Washout Period 1||0
167610|NCT00515502|411420|P9|NOT COMPLETED|Washout Period 1||0
167611|NCT00515502|411421|P8|NOT COMPLETED|Washout Period 1||0
167612|NCT00515502|411422|P7|NOT COMPLETED|Washout Period 1||0
167613|NCT00515502|411423|P6|NOT COMPLETED|Washout Period 1||0
167614|NCT00515502|411424|P5|NOT COMPLETED|Washout Period 1||0
167615|NCT00515502|411425|P4|NOT COMPLETED|Washout Period 1||0
167616|NCT00515502|411426|P3|NOT COMPLETED|Washout Period 1||0
167617|NCT00515502|411427|P2|NOT COMPLETED|Washout Period 1||0
167618|NCT00515502|411428|P1|NOT COMPLETED|Washout Period 1||0
167619|NCT00515502|411417|P12|COMPLETED|Washout Period 1||0
167620|NCT00515502|411418|P11|COMPLETED|Washout Period 1||1
167621|NCT00515502|411419|P10|COMPLETED|Washout Period 1||2
167622|NCT00515502|411420|P9|COMPLETED|Washout Period 1||0
167623|NCT00515502|411421|P8|COMPLETED|Washout Period 1||1
167624|NCT00515502|411422|P7|COMPLETED|Washout Period 1||1
167625|NCT00515502|411423|P6|COMPLETED|Washout Period 1||1
167626|NCT00515502|411424|P5|COMPLETED|Washout Period 1||3
167627|NCT00515502|411425|P4|COMPLETED|Washout Period 1||3
167628|NCT00515502|411426|P3|COMPLETED|Washout Period 1||4
167629|NCT00515502|411427|P2|COMPLETED|Washout Period 1||4
167630|NCT00515502|411428|P1|COMPLETED|Washout Period 1||1
167631|NCT00515502|411417|P12|STARTED|Washout Period 1||0
167632|NCT00515502|411418|P11|STARTED|Washout Period 1||1
167633|NCT00515502|411419|P10|STARTED|Washout Period 1||2
167634|NCT00515502|411420|P9|STARTED|Washout Period 1||0
167635|NCT00515502|411421|P8|STARTED|Washout Period 1||1
167636|NCT00515502|411422|P7|STARTED|Washout Period 1||1
167637|NCT00515502|411423|P6|STARTED|Washout Period 1||1
167638|NCT00515502|411424|P5|STARTED|Washout Period 1||3
167639|NCT00515502|411425|P4|STARTED|Washout Period 1||3
167640|NCT00515502|411426|P3|STARTED|Washout Period 1||4
167641|NCT00515502|411427|P2|STARTED|Washout Period 1||4
167642|NCT00515502|411428|P1|STARTED|Washout Period 1||1
167643|NCT00515502|411417|P12|NOT COMPLETED|Treatment Period 1||1
167644|NCT00515502|411418|P11|NOT COMPLETED|Treatment Period 1||0
167645|NCT00515502|411419|P10|NOT COMPLETED|Treatment Period 1||0
167646|NCT00515502|411420|P9|NOT COMPLETED|Treatment Period 1||1
167647|NCT00515502|411421|P8|NOT COMPLETED|Treatment Period 1||0
167648|NCT00515502|411422|P7|NOT COMPLETED|Treatment Period 1||1
167649|NCT00515502|411423|P6|NOT COMPLETED|Treatment Period 1||0
167650|NCT00515502|411424|P5|NOT COMPLETED|Treatment Period 1||0
167651|NCT00515502|411425|P4|NOT COMPLETED|Treatment Period 1||0
167652|NCT00515502|411426|P3|NOT COMPLETED|Treatment Period 1||0
167653|NCT00515502|411427|P2|NOT COMPLETED|Treatment Period 1||0
167654|NCT00515502|411428|P1|NOT COMPLETED|Treatment Period 1||0
167655|NCT00515502|411417|P12|COMPLETED|Treatment Period 1||0
167656|NCT00515502|411418|P11|COMPLETED|Treatment Period 1||1
167657|NCT00515502|411419|P10|COMPLETED|Treatment Period 1||2
167658|NCT00515502|411420|P9|COMPLETED|Treatment Period 1||0
167659|NCT00515502|411421|P8|COMPLETED|Treatment Period 1||1
167660|NCT00515502|411422|P7|COMPLETED|Treatment Period 1||1
167661|NCT00515502|411423|P6|COMPLETED|Treatment Period 1||1
167662|NCT00515502|411424|P5|COMPLETED|Treatment Period 1||3
167663|NCT00515502|411425|P4|COMPLETED|Treatment Period 1||3
167664|NCT00515502|411426|P3|COMPLETED|Treatment Period 1||4
167665|NCT00515502|411427|P2|COMPLETED|Treatment Period 1||4
167666|NCT00515502|411428|P1|COMPLETED|Treatment Period 1||1
167667|NCT00515502|411417|P12|STARTED|Treatment Period 1||1
167668|NCT00515502|411418|P11|STARTED|Treatment Period 1||1
167669|NCT00515502|411419|P10|STARTED|Treatment Period 1||2
167670|NCT00515502|411420|P9|STARTED|Treatment Period 1||1
167671|NCT00515502|411421|P8|STARTED|Treatment Period 1||1
167672|NCT00515502|411422|P7|STARTED|Treatment Period 1||2
167673|NCT00515502|411423|P6|STARTED|Treatment Period 1||1
167674|NCT00515502|411424|P5|STARTED|Treatment Period 1||3
167675|NCT00515502|411425|P4|STARTED|Treatment Period 1||3
167676|NCT00515502|411426|P3|STARTED|Treatment Period 1||4
167677|NCT00515502|411427|P2|STARTED|Treatment Period 1||4
167678|NCT00515502|411428|P1|STARTED|Treatment Period 1||1
167679|NCT00515541|411590|P4|NOT COMPLETED|Overall Study||5
167680|NCT00515541|411591|P3|NOT COMPLETED|Overall Study||0
167681|NCT00515541|411592|P2|NOT COMPLETED|Overall Study||5
167682|NCT00515541|411593|P1|NOT COMPLETED|Overall Study||0
167683|NCT00515541|411590|P4|COMPLETED|Overall Study||6
167684|NCT00515541|411591|P3|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
167685|NCT00515541|411592|P2|COMPLETED|Overall Study||7
167686|NCT00515541|411593|P1|COMPLETED|Overall Study|All subjects completed 24 weeks.|10
167687|NCT00515541|411590|P4|24 Weeks (8 gm Lovaza)|Overall Study|Three subjects withdrew after 18 weeks (1 GI problem, 1 undefined medical problem, 1 no show)|6
167688|NCT00515541|411591|P3|24 Weeks (8 gm Lovaza)|Overall Study||10
167689|NCT00515541|411592|P2|24 Weeks (8 gm Lovaza)|Overall Study|Two subjects withdrew at 20 and 21 weeks due to nausea. Subjects were closed out early.|7
167690|NCT00515541|411593|P1|24 Weeks (8 gm Lovaza)|Overall Study||10
167691|NCT00515541|411590|P4|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 14 weeks with GI problems.|9
167692|NCT00515541|411591|P3|18 Weeks (4 gm Lovaza)|Overall Study||10
167693|NCT00515541|411592|P2|18 Weeks (4 gm Lovaza)|Overall Study|One subject withdrew at 12 weeks due to acquired bleeding disorder present before enrolling.|9
167694|NCT00515541|411593|P1|18 Weeks (4 gm Lovaza)|Overall Study||10
167695|NCT00515541|411590|P4|12 Weeks (2 gm Lovaza)|Overall Study||10
167696|NCT00515541|411591|P3|12 Weeks (2 gm Lovaza)|Overall Study||10
167697|NCT00515541|411592|P2|12 Weeks (2 gm Lovaza)|Overall Study||10
167698|NCT00515541|411593|P1|12 Weeks (2 gm Lovaza)|Overall Study||10
167699|NCT00515541|411590|P4|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled due to no show for appt. after baseline.|10
167700|NCT00515541|411591|P3|6 Weeks (1 gm Lovaza)|Overall Study||10
167701|NCT00515541|411592|P2|6 Weeks (1 gm Lovaza)|Overall Study|One subject pulled after baseline. One subject pulled due to no show for appt.after baseline|10
167702|NCT00515541|411593|P1|6 Weeks (1 gm Lovaza)|Overall Study||10
167703|NCT00515541|411590|P4|STARTED|Overall Study||11
167704|NCT00515541|411591|P3|STARTED|Overall Study||10
167705|NCT00515541|411592|P2|STARTED|Overall Study||12
167706|NCT00515541|411593|P1|STARTED|Overall Study||10
167707|NCT00515619|411615|P1|NOT COMPLETED|Overall Study||216
167708|NCT00515619|411615|P1|COMPLETED|Overall Study||160
167709|NCT00515619|411615|P1|Safety Set|Overall Study||376
167710|NCT00515619|411615|P1|STARTED|Overall Study||376
167711|NCT00515671|411625|P2|NOT COMPLETED|Overall Study||17
167712|NCT00515671|411626|P1|NOT COMPLETED|Overall Study||17
167713|NCT00515671|411625|P2|COMPLETED|Overall Study||41
167714|NCT00515671|411626|P1|COMPLETED|Overall Study||43
167715|NCT00515671|411625|P2|STARTED|Overall Study||58
167716|NCT00515671|411626|P1|STARTED|Overall Study||60
167717|NCT00515697|411634|P1|NOT COMPLETED|Overall Study||0
167718|NCT00515697|411634|P1|COMPLETED|Overall Study||39
167719|NCT00515697|411634|P1|Received at Least 1 Dose of Study Drug|Overall Study||39
167720|NCT00515697|411634|P1|STARTED|Overall Study||39
167721|NCT00515827|411647|P2|NOT COMPLETED|Second Intervention (12 Weeks)||0
167722|NCT00515827|411648|P1|NOT COMPLETED|Second Intervention (12 Weeks)||1
167723|NCT00515827|411647|P2|COMPLETED|Second Intervention (12 Weeks)||25
167724|NCT00515827|411648|P1|COMPLETED|Second Intervention (12 Weeks)||25
167725|NCT00515827|411647|P2|STARTED|Second Intervention (12 Weeks)||25
167726|NCT00515827|411648|P1|STARTED|Second Intervention (12 Weeks)||26
167727|NCT00515827|411647|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
167728|NCT00515827|411648|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
167729|NCT00515827|411647|P2|COMPLETED|First Intervention (12 Weeks)||25
167730|NCT00515827|411648|P1|COMPLETED|First Intervention (12 Weeks)||26
167731|NCT00515827|411647|P2|STARTED|First Intervention (12 Weeks)||26
167732|NCT00515827|411648|P1|STARTED|First Intervention (12 Weeks)||27
167733|NCT00515879|411672|P2|NOT COMPLETED|Overall Study||20
167734|NCT00515879|411673|P1|NOT COMPLETED|Overall Study||25
167735|NCT00515879|411672|P2|COMPLETED|Overall Study||62
167736|NCT00515879|411673|P1|COMPLETED|Overall Study||62
167737|NCT00515879|411672|P2|STARTED|Overall Study||82
167738|NCT00515879|411673|P1|STARTED|Overall Study||87
167739|NCT00516048|411683|P3|NOT COMPLETED|Overall Study||1
167740|NCT00516048|411684|P2|NOT COMPLETED|Overall Study||2
167741|NCT00516048|411685|P1|NOT COMPLETED|Overall Study||0
167742|NCT00516048|411683|P3|COMPLETED|Overall Study||0
167743|NCT00516048|411684|P2|COMPLETED|Overall Study||40
167744|NCT00516048|411685|P1|COMPLETED|Overall Study||15
167745|NCT00516048|411683|P3|STARTED|Overall Study||1
167746|NCT00516048|411684|P2|STARTED|Overall Study||42
167747|NCT00516048|411685|P1|STARTED|Overall Study||15
167748|NCT00516074|411701|P2|NOT COMPLETED|Overall Study||3
167749|NCT00516074|411702|P1|NOT COMPLETED|Overall Study||6
167750|NCT00516074|411701|P2|COMPLETED|Overall Study||23
167751|NCT00516074|411702|P1|COMPLETED|Overall Study||22
167752|NCT00516074|411701|P2|STARTED|Overall Study||26
167753|NCT00516074|411702|P1|STARTED|Overall Study||28
167754|NCT00516139|411718|P1|NOT COMPLETED|Overall Study||38
167755|NCT00516139|411718|P1|COMPLETED|Overall Study|Study completers completed Escalation, AM, and either AO or both Conversion and Monotherapy Phases.|84
167756|NCT00516139|411718|P1|STARTED|Overall Study||122
167757|NCT00516165|411747|P1|NOT COMPLETED|Overall Study||0
167758|NCT00516165|411747|P1|COMPLETED|Overall Study||28
167759|NCT00516165|411747|P1|STARTED|Overall Study||28
167760|NCT00516217|411756|P1|NOT COMPLETED|Overall Study||0
167761|NCT00516217|411756|P1|COMPLETED|Overall Study||29
167762|NCT00516217|411756|P1|STARTED|Overall Study||29
167763|NCT00516269|411764|P2|NOT COMPLETED|Overall Study||3
167764|NCT00516269|411765|P1|NOT COMPLETED|Overall Study||2
167765|NCT00516269|411764|P2|COMPLETED|Overall Study|2 patients did not complete the study and 1 randomized to placebo twice.|16
167766|NCT00516269|411765|P1|COMPLETED|Overall Study|2 patients had an early termination|17
167767|NCT00516269|411764|P2|STARTED|Overall Study||19
167768|NCT00516269|411765|P1|STARTED|Overall Study||19
167769|NCT00509496|411773|P2|NOT COMPLETED|Overall Study||0
167770|NCT00509496|411774|P1|NOT COMPLETED|Overall Study||0
167771|NCT00509496|411773|P2|COMPLETED|Overall Study||2
167772|NCT00509496|411774|P1|COMPLETED|Overall Study||19
167773|NCT00509496|411773|P2|STARTED|Overall Study||2
167774|NCT00509496|411774|P1|STARTED|Overall Study||19
167775|NCT00509587|411782|P1|NOT COMPLETED|Overall Study||0
167776|NCT00509587|411782|P1|COMPLETED|Overall Study||21
167777|NCT00509587|411782|P1|STARTED|Overall Study||21
167778|NCT00509600|411790|P1|NOT COMPLETED|Overall Study||1
167779|NCT00509600|411790|P1|COMPLETED|Overall Study||0
167780|NCT00509600|411790|P1|STARTED|Overall Study||1
167781|NCT00509769|411794|P1|NOT COMPLETED|Overall Study||91
167782|NCT00509769|411794|P1|COMPLETED|Overall Study||21
167783|NCT00509769|411794|P1|STARTED|Overall Study||112
167784|NCT00509795|411807|P4|NOT COMPLETED|Overall Study||27
167785|NCT00509795|411808|P3|NOT COMPLETED|Overall Study||27
167786|NCT00509795|411809|P2|NOT COMPLETED|Overall Study||11
167787|NCT00509795|411810|P1|NOT COMPLETED|Overall Study||22
167788|NCT00509795|411807|P4|COMPLETED|Overall Study||276
167789|NCT00509795|411808|P3|COMPLETED|Overall Study||277
167790|NCT00509795|411809|P2|COMPLETED|Overall Study||293
167791|NCT00509795|411810|P1|COMPLETED|Overall Study||284
167792|NCT00509795|411807|P4|Per Protocol Set (PPS) Population|Overall Study||265
167793|NCT00509795|411808|P3|Per Protocol Set (PPS) Population|Overall Study||270
167794|NCT00509795|411809|P2|Per Protocol Set (PPS) Population|Overall Study||285
167795|NCT00509795|411810|P1|Per Protocol Set (PPS) Population|Overall Study||269
167796|NCT00509795|411807|P4|Full Analysis Set (FAS) Population|Overall Study||301
167797|NCT00509795|411808|P3|Full Analysis Set (FAS) Population|Overall Study||301
167798|NCT00509795|411809|P2|Full Analysis Set (FAS) Population|Overall Study||304
167799|NCT00509795|411810|P1|Full Analysis Set (FAS) Population|Overall Study||304
167800|NCT00509795|411807|P4|Patients Received Treatment (SAF)|Overall Study||303
167801|NCT00509795|411808|P3|Patients Received Treatment (SAF)|Overall Study||304
167802|NCT00509795|411809|P2|Patients Received Treatment (SAF)|Overall Study||304
167803|NCT00509795|411810|P1|Patients Received Treatment (SAF)|Overall Study||304
167804|NCT00509795|411807|P4|STARTED|Overall Study||303
167805|NCT00509795|411808|P3|STARTED|Overall Study||304
167806|NCT00509795|411809|P2|STARTED|Overall Study||304
167807|NCT00509795|411810|P1|STARTED|Overall Study||306
167808|NCT00509873|411843|P2|NOT COMPLETED|Overall Study||15
167809|NCT00509873|411844|P1|NOT COMPLETED|Overall Study||11
167810|NCT00509873|411843|P2|COMPLETED|Overall Study||276
167811|NCT00509873|411844|P1|COMPLETED|Overall Study||276
167812|NCT00509873|411843|P2|STARTED|Overall Study||291
167813|NCT00509873|411844|P1|STARTED|Overall Study||287
167814|NCT00509899|411866|P8|NOT COMPLETED|Overall Study||1
167815|NCT00509899|411867|P7|NOT COMPLETED|Overall Study||1
167816|NCT00509899|411868|P6|NOT COMPLETED|Overall Study||10
167817|NCT00509899|411869|P5|NOT COMPLETED|Overall Study||5
167818|NCT00509899|411870|P4|NOT COMPLETED|Overall Study||4
167819|NCT00509899|411871|P3|NOT COMPLETED|Overall Study||20
167820|NCT00509899|411872|P2|NOT COMPLETED|Overall Study||9
167821|NCT00509899|411873|P1|NOT COMPLETED|Overall Study||16
167822|NCT00509899|411866|P8|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|2
167823|NCT00509899|411867|P7|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|5
167824|NCT00509899|411868|P6|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|12
167825|NCT00509899|411869|P5|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
167826|NCT00509899|411870|P4|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|1
167827|NCT00509899|411871|P3|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|27
167828|NCT00509899|411872|P2|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|26
167829|NCT00509899|411873|P1|COMPLETED|Overall Study|Represents patients still on study at the data cut-off for the interim analysis (31 December 2009).|14
167830|NCT00509899|411866|P8|STARTED|Overall Study||3
167831|NCT00509899|411867|P7|STARTED|Overall Study||6
167832|NCT00509899|411868|P6|STARTED|Overall Study||22
167833|NCT00509899|411869|P5|STARTED|Overall Study||6
167834|NCT00509899|411870|P4|STARTED|Overall Study||5
167835|NCT00509899|411871|P3|STARTED|Overall Study||47
167836|NCT00509899|411872|P2|STARTED|Overall Study||35
167837|NCT00509899|411873|P1|STARTED|Overall Study||30
167838|NCT00509925|411911|P2|NOT COMPLETED|Overall Study||1
167839|NCT00509925|411912|P1|NOT COMPLETED|Overall Study||0
167840|NCT00509925|411911|P2|COMPLETED|Overall Study||10
167841|NCT00509925|411912|P1|COMPLETED|Overall Study||12
167842|NCT00509925|411911|P2|STARTED|Overall Study||11
167843|NCT00509925|411912|P1|STARTED|Overall Study||12
167844|NCT00510068|411954|P2|NOT COMPLETED|Open-label Period||0
167845|NCT00510068|411955|P1|NOT COMPLETED|Open-label Period||225
167846|NCT00510068|411954|P2|COMPLETED|Open-label Period||0
167847|NCT00510068|411955|P1|COMPLETED|Open-label Period||0
167848|NCT00510068|411954|P2|STARTED|Open-label Period||0
167849|NCT00510068|411955|P1|STARTED|Open-label Period|172 patients switched over from placebo & 53 who were initially randomized to Everolimus arm.|225
167850|NCT00510068|411954|P2|NOT COMPLETED|Double-blind Period||203
167851|NCT00510068|411955|P1|NOT COMPLETED|Double-blind Period||207
167852|NCT00510068|411954|P2|COMPLETED|Double-blind Period||0
167853|NCT00510068|411955|P1|COMPLETED|Double-blind Period||0
167854|NCT00510068|411954|P2|Safety Population|Double-blind Period||203
167855|NCT00510068|411955|P1|Safety Population|Double-blind Period||204
167856|NCT00510068|411954|P2|STARTED|Double-blind Period||203
167857|NCT00510068|411955|P1|STARTED|Double-blind Period||207
167858|NCT00516295|411999|P3|NOT COMPLETED|Overall Study||0
167859|NCT00516295|412000|P2|NOT COMPLETED|Overall Study||0
167860|NCT00516295|412001|P1|NOT COMPLETED|Overall Study||3
167861|NCT00516295|411999|P3|COMPLETED|Overall Study||0
167862|NCT00516295|412000|P2|COMPLETED|Overall Study||0
167863|NCT00516295|412001|P1|COMPLETED|Overall Study||4
167864|NCT00516295|411999|P3|STARTED|Overall Study||0
167865|NCT00516295|412000|P2|STARTED|Overall Study||0
167866|NCT00516295|412001|P1|STARTED|Overall Study||7
167867|NCT00516321|412014|P3|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||54
167868|NCT00516321|412015|P2|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||35
167869|NCT00516321|412016|P1|NOT COMPLETED|Double-blind (DB) Antiviral Treatment||0
167870|NCT00516321|412014|P3|COMPLETED|Double-blind (DB) Antiviral Treatment||396
167871|NCT00516321|412015|P2|COMPLETED|Double-blind (DB) Antiviral Treatment||197
167872|NCT00516321|412016|P1|COMPLETED|Double-blind (DB) Antiviral Treatment||0
167873|NCT00516321|412014|P3|STARTED|Double-blind (DB) Antiviral Treatment||450
167874|NCT00516321|412015|P2|STARTED|Double-blind (DB) Antiviral Treatment||232
167875|NCT00516321|412016|P1|STARTED|Double-blind (DB) Antiviral Treatment||0
167876|NCT00516321|412014|P3|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
167877|NCT00516321|412015|P2|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
167878|NCT00516321|412016|P1|NOT COMPLETED|Open-label (OL) Pre-Antiviral Treatment||33
167879|NCT00516321|412014|P3|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
167880|NCT00516321|412015|P2|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||0
167881|NCT00516321|412016|P1|COMPLETED|Open-label (OL) Pre-Antiviral Treatment||682
167882|NCT00516321|412014|P3|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
167883|NCT00516321|412015|P2|STARTED|Open-label (OL) Pre-Antiviral Treatment||0
167884|NCT00516321|412016|P1|STARTED|Open-label (OL) Pre-Antiviral Treatment||715
167885|NCT00516386|412064|P1|NOT COMPLETED|Overall Study||6
167886|NCT00516386|412064|P1|COMPLETED|Overall Study||10
167887|NCT00516386|412064|P1|STARTED|Overall Study||16
167888|NCT00516503|412071|P2|NOT COMPLETED|Overall Study||0
167889|NCT00516503|412072|P1|NOT COMPLETED|Overall Study||0
167890|NCT00516503|412071|P2|COMPLETED|Overall Study||102
167891|NCT00516503|412072|P1|COMPLETED|Overall Study||101
167892|NCT00516503|412071|P2|STARTED|Overall Study||102
167893|NCT00516503|412072|P1|STARTED|Overall Study||101
167894|NCT00517699|412090|P1|NOT COMPLETED|Overall Study||5
167895|NCT00517699|412090|P1|COMPLETED|Overall Study||0
167896|NCT00517699|412090|P1|STARTED|Overall Study||5
167897|NCT00517751|412098|P1|NOT COMPLETED|Overall Study||129
167898|NCT00517751|412098|P1|COMPLETED|Overall Study||33
167899|NCT00517751|412098|P1|STARTED|Overall Study||162
167900|NCT00517829|412123|P2|NOT COMPLETED|Overall Study||75
167901|NCT00517829|412124|P1|NOT COMPLETED|Overall Study||75
167902|NCT00517829|412123|P2|COMPLETED|Overall Study||0
167903|NCT00517829|412124|P1|COMPLETED|Overall Study||0
167904|NCT00517829|412123|P2|STARTED|Overall Study||75
167905|NCT00517829|412124|P1|STARTED|Overall Study||75
167906|NCT00517881|412138|P1|NOT COMPLETED|Overall Study||5
167907|NCT00517881|412138|P1|COMPLETED|Overall Study||24
167908|NCT00517881|412138|P1|STARTED|Overall Study||29
167909|NCT00517933|412150|P2|NOT COMPLETED|Period 2||13
167910|NCT00517933|412151|P1|NOT COMPLETED|Period 2||6
167911|NCT00517933|412150|P2|COMPLETED|Period 2||70
167912|NCT00517933|412151|P1|COMPLETED|Period 2||73
167913|NCT00517933|412150|P2|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|83
167914|NCT00517933|412151|P1|STARTED|Period 2|2 patients terminated after completion of period one, but before starting period 2|79
167915|NCT00517933|412150|P2|NOT COMPLETED|Period 1||6
167916|NCT00517933|412151|P1|NOT COMPLETED|Period 1||8
167917|NCT00517933|412150|P2|COMPLETED|Period 1||85
167918|NCT00517933|412151|P1|COMPLETED|Period 1||81
167919|NCT00517933|412150|P2|STARTED|Period 1|Patients decreased due to death, adverse event and other (see below)|91
167920|NCT00517933|412151|P1|STARTED|Period 1|Patients decreased due to death, adverse event, lost to follow up and other (see below)|89
167921|NCT00518011|412217|P2|NOT COMPLETED|Overall Study||8
167922|NCT00518011|412218|P1|NOT COMPLETED|Overall Study||9
167923|NCT00518011|412217|P2|COMPLETED|Overall Study||0
167924|NCT00518011|412218|P1|COMPLETED|Overall Study||0
167925|NCT00518011|412217|P2|STARTED|Overall Study||8
167926|NCT00518011|412218|P1|STARTED|Overall Study||9
167927|NCT00518089|412240|P2|NOT COMPLETED|Overall Study||31
167928|NCT00518089|412241|P1|NOT COMPLETED|Overall Study||28
167929|NCT00518089|412240|P2|COMPLETED|Overall Study||398
167930|NCT00518089|412241|P1|COMPLETED|Overall Study||402
167931|NCT00518089|412240|P2|STARTED|Overall Study||429
167932|NCT00518089|412241|P1|STARTED|Overall Study||430
167933|NCT00518115|412265|P10|NOT COMPLETED|Overall Study||15
167934|NCT00518115|412266|P9|NOT COMPLETED|Overall Study||5
167935|NCT00518115|412267|P8|NOT COMPLETED|Overall Study||15
167936|NCT00518115|412268|P7|NOT COMPLETED|Overall Study||8
167937|NCT00518115|412269|P6|NOT COMPLETED|Overall Study||15
167938|NCT00518115|412270|P5|NOT COMPLETED|Overall Study||10
167939|NCT00518115|412271|P4|NOT COMPLETED|Overall Study||11
167940|NCT00518115|412272|P3|NOT COMPLETED|Overall Study||17
167941|NCT00518115|412273|P2|NOT COMPLETED|Overall Study||6
167942|NCT00518115|412274|P1|NOT COMPLETED|Overall Study||12
167943|NCT00518115|412265|P10|COMPLETED|Overall Study||20
167944|NCT00518115|412266|P9|COMPLETED|Overall Study||30
167945|NCT00518115|412267|P8|COMPLETED|Overall Study||20
167946|NCT00518115|412268|P7|COMPLETED|Overall Study||25
167947|NCT00518115|412269|P6|COMPLETED|Overall Study||19
167948|NCT00518115|412270|P5|COMPLETED|Overall Study||21
167949|NCT00518115|412271|P4|COMPLETED|Overall Study||24
167950|NCT00518115|412272|P3|COMPLETED|Overall Study||19
167951|NCT00518115|412273|P2|COMPLETED|Overall Study||29
167952|NCT00518115|412274|P1|COMPLETED|Overall Study||40
167953|NCT00518115|412265|P10|Safety Population|Overall Study|These participants received at least one dose of study drug.|34
167954|NCT00518115|412266|P9|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
167955|NCT00518115|412267|P8|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
167956|NCT00518115|412268|P7|Safety Population|Overall Study|These participants received at least one dose of study drug.|32
167957|NCT00518115|412269|P6|Safety Population|Overall Study|These participants received at least one dose of study drug.|33
167958|NCT00518115|412270|P5|Safety Population|Overall Study|These participants received at least one dose of study drug.|31
167959|NCT00518115|412271|P4|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
167960|NCT00518115|412272|P3|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
167961|NCT00518115|412273|P2|Safety Population|Overall Study|These participants received at least one dose of study drug.|35
167962|NCT00518115|412274|P1|Safety Population|Overall Study|These participants received at least one dose of study drug.|51
167963|NCT00518115|412265|P10|STARTED|Overall Study||35
167964|NCT00518115|412266|P9|STARTED|Overall Study||35
167965|NCT00518115|412267|P8|STARTED|Overall Study||35
167966|NCT00518115|412268|P7|STARTED|Overall Study||33
167967|NCT00518115|412269|P6|STARTED|Overall Study||34
167968|NCT00518115|412270|P5|STARTED|Overall Study||31
167969|NCT00518115|412271|P4|STARTED|Overall Study||35
167970|NCT00518115|412272|P3|STARTED|Overall Study||36
167971|NCT00518115|412273|P2|STARTED|Overall Study||35
167972|NCT00518115|412274|P1|STARTED|Overall Study||52
167973|NCT00518180|412433|P3|NOT COMPLETED|Overall Study||82
167974|NCT00518180|412434|P2|NOT COMPLETED|Overall Study||69
167975|NCT00518180|412435|P1|NOT COMPLETED|Overall Study||65
167976|NCT00518180|412433|P3|COMPLETED|Overall Study||457
167977|NCT00518180|412434|P2|COMPLETED|Overall Study||472
167978|NCT00518180|412435|P1|COMPLETED|Overall Study||475
167979|NCT00518180|412433|P3|STARTED|Overall Study||539
167980|NCT00518180|412434|P2|STARTED|Overall Study||541
167981|NCT00518180|412435|P1|STARTED|Overall Study||540
167982|NCT00518206|412479|P2|NOT COMPLETED|Overall Study||6
167983|NCT00518206|412480|P1|NOT COMPLETED|Overall Study||11
167984|NCT00518206|412479|P2|COMPLETED|Overall Study||13
167985|NCT00518206|412480|P1|COMPLETED|Overall Study||16
167986|NCT00518206|412479|P2|STARTED|Overall Study||19
167987|NCT00518206|412480|P1|STARTED|Overall Study||27
167988|NCT00518284|412498|P4|NOT COMPLETED|Overall Study||2
167989|NCT00518284|412499|P3|NOT COMPLETED|Overall Study||1
167990|NCT00518284|412500|P2|NOT COMPLETED|Overall Study||3
167991|NCT00518284|412501|P1|NOT COMPLETED|Overall Study||0
167992|NCT00518284|412498|P4|COMPLETED|Overall Study||0
167993|NCT00518284|412499|P3|COMPLETED|Overall Study||0
167994|NCT00518284|412500|P2|COMPLETED|Overall Study||0
167995|NCT00518284|412501|P1|COMPLETED|Overall Study||0
167996|NCT00518284|412498|P4|STARTED|Overall Study||2
167997|NCT00518284|412499|P3|STARTED|Overall Study||1
167998|NCT00518284|412500|P2|STARTED|Overall Study||3
167999|NCT00518284|412501|P1|STARTED|Overall Study||0
168000|NCT00518323|412559|P4|NOT COMPLETED|Overall Study||25
168001|NCT00518323|412560|P3|NOT COMPLETED|Overall Study||11
168002|NCT00518323|412561|P2|NOT COMPLETED|Overall Study||8
168003|NCT00518323|412562|P1|NOT COMPLETED|Overall Study||19
168004|NCT00518323|412559|P4|COMPLETED|Overall Study||26
168005|NCT00518323|412560|P3|COMPLETED|Overall Study||37
168006|NCT00518323|412561|P2|COMPLETED|Overall Study||40
168007|NCT00518323|412562|P1|COMPLETED|Overall Study||35
168008|NCT00518323|412559|P4|STARTED|Overall Study||51
168009|NCT00518323|412560|P3|STARTED|Overall Study||48
168010|NCT00518323|412561|P2|STARTED|Overall Study||48
168011|NCT00518323|412562|P1|STARTED|Overall Study||54
168012|NCT00518336|412590|P2|NOT COMPLETED|Year 9||1
168013|NCT00518336|412591|P1|NOT COMPLETED|Year 9||5
168014|NCT00518336|412590|P2|COMPLETED|Year 9||212
168015|NCT00518336|412591|P1|COMPLETED|Year 9||219
168016|NCT00518336|412590|P2|STARTED|Year 9||213
168017|NCT00518336|412591|P1|STARTED|Year 9|1 subject did not particpate at the previous timepoint, came back and was added in the Total cohort|224
168018|NCT00518336|412590|P2|NOT COMPLETED|Year 8||2
168019|NCT00518336|412591|P1|NOT COMPLETED|Year 8||1
168020|NCT00518336|412590|P2|COMPLETED|Year 8||211
168021|NCT00518336|412591|P1|COMPLETED|Year 8||222
168022|NCT00518336|412590|P2|STARTED|Year 8|2 subjects withdrawn at Year 7 came back and were therefore no longer considered as withdrawn.|213
168023|NCT00518336|412591|P1|STARTED|Year 8|1 subject withdrawn at Year 7 came back and was therefore no longer considered as withdrawn.|223
168024|NCT00518336|412590|P2|NOT COMPLETED|Year 7||3
168025|NCT00518336|412591|P1|NOT COMPLETED|Year 7||2
168026|NCT00518336|412590|P2|COMPLETED|Year 7||208
168027|NCT00518336|412591|P1|COMPLETED|Year 7||220
168028|NCT00518336|412590|P2|STARTED|Year 7||211
168029|NCT00518336|412591|P1|STARTED|Year 7||222
168030|NCT00518531|412755|P2|NOT COMPLETED|Treatment Period 2||20
168031|NCT00518531|412756|P1|NOT COMPLETED|Treatment Period 2||3
168032|NCT00518531|412755|P2|COMPLETED|Treatment Period 2||95
168033|NCT00518531|412756|P1|COMPLETED|Treatment Period 2||103
168034|NCT00518531|412755|P2|Received Treatment|Treatment Period 2||110
168035|NCT00518531|412756|P1|Received Treatment|Treatment Period 2||106
168036|NCT00518531|412755|P2|STARTED|Treatment Period 2|Participants can start Treatment Period 2 without completing Treatment Period 1.|115
168037|NCT00518531|412756|P1|STARTED|Treatment Period 2||106
168038|NCT00518531|412755|P2|NOT COMPLETED|Treatment Period 1||12
168039|NCT00518531|412756|P1|NOT COMPLETED|Treatment Period 1||18
168040|NCT00518531|412755|P2|COMPLETED|Treatment Period 1|Participants who completed Treatment Period 1 may choose not to start Treatment Period 2|114
168041|NCT00518531|412756|P1|COMPLETED|Treatment Period 1||106
168042|NCT00518531|412755|P2|Received Treatment|Treatment Period 1||124
168043|NCT00518531|412756|P1|Received Treatment|Treatment Period 1||119
168044|NCT00518531|412755|P2|STARTED|Treatment Period 1||126
168045|NCT00518531|412756|P1|STARTED|Treatment Period 1||124
168046|NCT00518622|412798|P8|NOT COMPLETED|Overall Study||0
168047|NCT00518622|412799|P7|NOT COMPLETED|Overall Study||0
168048|NCT00518622|412800|P6|NOT COMPLETED|Overall Study||0
168049|NCT00518622|412801|P5|NOT COMPLETED|Overall Study||0
168050|NCT00518622|412802|P4|NOT COMPLETED|Overall Study||0
168051|NCT00518622|412803|P3|NOT COMPLETED|Overall Study||1
168052|NCT00518622|412804|P2|NOT COMPLETED|Overall Study||1
168053|NCT00518622|412805|P1|NOT COMPLETED|Overall Study||0
168054|NCT00518622|412798|P8|COMPLETED|Overall Study||5
168055|NCT00518622|412799|P7|COMPLETED|Overall Study||4
168056|NCT00518622|412800|P6|COMPLETED|Overall Study||5
168057|NCT00518622|412801|P5|COMPLETED|Overall Study||6
168058|NCT00518622|412802|P4|COMPLETED|Overall Study||5
168059|NCT00518622|412803|P3|COMPLETED|Overall Study||5
168060|NCT00518622|412804|P2|COMPLETED|Overall Study||5
168061|NCT00518622|412805|P1|COMPLETED|Overall Study||3
168062|NCT00518622|412798|P8|Discontinued Therapy|Overall Study||0
168063|NCT00518622|412799|P7|Discontinued Therapy|Overall Study||0
168064|NCT00518622|412800|P6|Discontinued Therapy|Overall Study||0
168065|NCT00518622|412801|P5|Discontinued Therapy|Overall Study||0
168066|NCT00518622|412802|P4|Discontinued Therapy|Overall Study||0
168067|NCT00518622|412803|P3|Discontinued Therapy|Overall Study||0
168068|NCT00518622|412804|P2|Discontinued Therapy|Overall Study||1
168069|NCT00518622|412805|P1|Discontinued Therapy|Overall Study|Discontinued therapy defined if participant has not taken 8 days of medication per the protocol.|0
168070|NCT00518622|412798|P8|Completed Therapy|Overall Study||5
168071|NCT00518622|412799|P7|Completed Therapy|Overall Study||4
168072|NCT00518622|412800|P6|Completed Therapy|Overall Study||5
168073|NCT00518622|412801|P5|Completed Therapy|Overall Study||6
168074|NCT00518622|412802|P4|Completed Therapy|Overall Study||5
168075|NCT00518622|412803|P3|Completed Therapy|Overall Study||6
168076|NCT00518622|412804|P2|Completed Therapy|Overall Study||5
168077|NCT00518622|412805|P1|Completed Therapy|Overall Study|Completed therapy defined if participant has taken 8 days of study medication per the protocol.|3
168078|NCT00518622|412798|P8|STARTED|Overall Study||5
168079|NCT00518622|412799|P7|STARTED|Overall Study||4
168080|NCT00518622|412800|P6|STARTED|Overall Study||5
168081|NCT00518622|412801|P5|STARTED|Overall Study||6
168082|NCT00518622|412802|P4|STARTED|Overall Study||5
168083|NCT00518622|412803|P3|STARTED|Overall Study||6
168084|NCT00518622|412804|P2|STARTED|Overall Study||6
168085|NCT00518622|412805|P1|STARTED|Overall Study||3
168086|NCT00518687|412833|P2|NOT COMPLETED|Overall Study||1420
168087|NCT00518687|412834|P1|NOT COMPLETED|Overall Study||1437
168088|NCT00518687|412833|P2|COMPLETED|Overall Study||2585
168089|NCT00518687|412834|P1|COMPLETED|Overall Study||2568
168090|NCT00518687|412833|P2|Vaccinated|Overall Study||3982
168091|NCT00518687|412834|P1|Vaccinated|Overall Study||3981
168092|NCT00518687|412833|P2|STARTED|Overall Study|An additional 11 participants were not analyzed because of questionable clinical practices at 1 site|4005
168093|NCT00518687|412834|P1|STARTED|Overall Study|An additional 10 participants were not analyzed because of questionable clinical practices at 1 site|4005
168094|NCT00518713|412850|P4|NOT COMPLETED|Overall Study||18
168095|NCT00518713|412851|P3|NOT COMPLETED|Overall Study||18
168096|NCT00518713|412852|P2|NOT COMPLETED|Overall Study||17
168097|NCT00518713|412853|P1|NOT COMPLETED|Overall Study||8
168098|NCT00518713|412850|P4|COMPLETED|Overall Study||41
168099|NCT00518713|412851|P3|COMPLETED|Overall Study||41
168100|NCT00518713|412852|P2|COMPLETED|Overall Study||45
168101|NCT00518713|412853|P1|COMPLETED|Overall Study||50
168102|NCT00518713|412850|P4|Modified Intent-to-Treat Population|Overall Study||57
168103|NCT00518713|412851|P3|Modified Intent-to-Treat Population|Overall Study||49
168104|NCT00518713|412852|P2|Modified Intent-to-Treat Population|Overall Study||58
168105|NCT00518713|412853|P1|Modified Intent-to-Treat Population|Overall Study||53
168106|NCT00518713|412850|P4|STARTED|Overall Study||59
168107|NCT00518713|412851|P3|STARTED|Overall Study||59
168108|NCT00518713|412852|P2|STARTED|Overall Study||62
168109|NCT00518713|412853|P1|STARTED|Overall Study||58
168110|NCT00518882|412913|P2|NOT COMPLETED|Open-Label Extension, Week 26-78||49
168111|NCT00518882|412914|P1|NOT COMPLETED|Open-Label Extension, Week 26-78||41
168112|NCT00518882|412913|P2|COMPLETED|Open-Label Extension, Week 26-78||138
168113|NCT00518882|412914|P1|COMPLETED|Open-Label Extension, Week 26-78||161
168114|NCT00518882|412913|P2|STARTED|Open-Label Extension, Week 26-78||187
168115|NCT00518882|412914|P1|STARTED|Open-Label Extension, Week 26-78||202
168116|NCT00518882|412913|P2|NOT COMPLETED|Double-Blind, Week 0-26||45
168117|NCT00518882|412914|P1|NOT COMPLETED|Double-Blind, Week 0-26||33
168118|NCT00518882|412913|P2|COMPLETED|Double-Blind, Week 0-26||187
168119|NCT00518882|412914|P1|COMPLETED|Double-Blind, Week 0-26||202
168120|NCT00518882|412913|P2|Randomised|Double-Blind, Week 0-26||231
168121|NCT00518882|412914|P1|Randomised|Double-Blind, Week 0-26||233
168122|NCT00518882|412913|P2|STARTED|Double-Blind, Week 0-26|1 subject exposed to study drug before randomisation. Subject only included in safety analysis set|232
168123|NCT00518882|412914|P1|STARTED|Double-Blind, Week 0-26|2 subjects exposed to study drug before randomisation. Subjects only included in safety analysis set|235
168124|NCT00518986|413030|P2|NOT COMPLETED|Overall Study||26
168125|NCT00518986|413031|P1|NOT COMPLETED|Overall Study||26
168126|NCT00518986|413030|P2|COMPLETED|Overall Study||98
168127|NCT00518986|413031|P1|COMPLETED|Overall Study||99
168128|NCT00518986|413030|P2|STARTED|Overall Study||124
168129|NCT00518986|413031|P1|STARTED|Overall Study|One subject discontinued before treatment, only 124 subjects in each treatment group were dosed.|125
168130|NCT00519077|413155|P1|NOT COMPLETED|Overall Study||8
168131|NCT00519077|413155|P1|COMPLETED|Overall Study||36
168132|NCT00519077|413155|P1|STARTED|Overall Study||44
168133|NCT00519090|413162|P2|NOT COMPLETED|Overall Study||0
168134|NCT00519090|413163|P1|NOT COMPLETED|Overall Study||0
168135|NCT00519090|413162|P2|COMPLETED|Overall Study||4
168136|NCT00519090|413163|P1|COMPLETED|Overall Study||2
168137|NCT00519090|413162|P2|STARTED|Overall Study||4
168138|NCT00519090|413163|P1|STARTED|Overall Study||2
168139|NCT00519194|413171|P1|NOT COMPLETED|Overall Study||21
168140|NCT00519194|413171|P1|COMPLETED|Overall Study||91
168141|NCT00519194|413171|P1|STARTED|Overall Study||112
168142|NCT00519285|413177|P2|NOT COMPLETED|Overall Study||612
168143|NCT00519285|413178|P1|NOT COMPLETED|Overall Study||612
168144|NCT00519285|413177|P2|COMPLETED|Overall Study||0
168145|NCT00519285|413178|P1|COMPLETED|Overall Study|Participants were treated until progressive disease, unacceptable toxicity, or refusal of treatment|0
168146|NCT00519285|413177|P2|Still Treated at Cut-off Date|Overall Study||2
168147|NCT00519285|413178|P1|Still Treated at Cut-off Date|Overall Study|The cut-off date for analysis was defined as 07 February 2012, date at which 873 deaths has occurred|1
168148|NCT00519285|413177|P2|TREATED|Overall Study|Received at least part of one dose of aflibercept|605
168149|NCT00519285|413178|P1|TREATED|Overall Study|Received at least part of one dose of placebo|604
168150|NCT00519285|413177|P2|STARTED|Overall Study|Randomized|612
168151|NCT00519285|413178|P1|STARTED|Overall Study|Randomized|612
168152|NCT00519376|413204|P16|NOT COMPLETED|Treatment Period 4||0
168153|NCT00519376|413205|P15|NOT COMPLETED|Treatment Period 4||0
168154|NCT00519376|413206|P14|NOT COMPLETED|Treatment Period 4||0
168155|NCT00519376|413207|P13|NOT COMPLETED|Treatment Period 4||0
168156|NCT00519376|413208|P12|NOT COMPLETED|Treatment Period 4||0
168157|NCT00519376|413209|P11|NOT COMPLETED|Treatment Period 4||0
168158|NCT00519376|413210|P10|NOT COMPLETED|Treatment Period 4||0
168159|NCT00519376|413211|P9|NOT COMPLETED|Treatment Period 4||0
168160|NCT00519376|413212|P8|NOT COMPLETED|Treatment Period 4||0
168161|NCT00519376|413213|P7|NOT COMPLETED|Treatment Period 4||0
168162|NCT00519376|413214|P6|NOT COMPLETED|Treatment Period 4||0
168163|NCT00519376|413215|P5|NOT COMPLETED|Treatment Period 4||0
168164|NCT00519376|413216|P4|NOT COMPLETED|Treatment Period 4||0
168165|NCT00519376|413217|P3|NOT COMPLETED|Treatment Period 4||1
168166|NCT00519376|413218|P2|NOT COMPLETED|Treatment Period 4||0
168167|NCT00519376|413219|P1|NOT COMPLETED|Treatment Period 4||0
168168|NCT00519376|413204|P16|COMPLETED|Treatment Period 4||1
168169|NCT00519376|413205|P15|COMPLETED|Treatment Period 4||1
168170|NCT00519376|413206|P14|COMPLETED|Treatment Period 4||1
168171|NCT00519376|413207|P13|COMPLETED|Treatment Period 4||0
168172|NCT00519376|413208|P12|COMPLETED|Treatment Period 4||1
168173|NCT00519376|413209|P11|COMPLETED|Treatment Period 4||1
168174|NCT00519376|413210|P10|COMPLETED|Treatment Period 4||1
168175|NCT00519376|413211|P9|COMPLETED|Treatment Period 4||1
168176|NCT00519376|413212|P8|COMPLETED|Treatment Period 4||1
168177|NCT00519376|413213|P7|COMPLETED|Treatment Period 4||1
168178|NCT00519376|413214|P6|COMPLETED|Treatment Period 4||1
168179|NCT00519376|413215|P5|COMPLETED|Treatment Period 4||1
168180|NCT00519376|413216|P4|COMPLETED|Treatment Period 4||2
168181|NCT00519376|413217|P3|COMPLETED|Treatment Period 4||1
168182|NCT00519376|413218|P2|COMPLETED|Treatment Period 4||2
168183|NCT00519376|413219|P1|COMPLETED|Treatment Period 4||2
168184|NCT00519376|413204|P16|STARTED|Treatment Period 4||1
168185|NCT00519376|413205|P15|STARTED|Treatment Period 4||1
168186|NCT00519376|413206|P14|STARTED|Treatment Period 4||1
168187|NCT00519376|413207|P13|STARTED|Treatment Period 4||0
168188|NCT00519376|413208|P12|STARTED|Treatment Period 4||1
168189|NCT00519376|413209|P11|STARTED|Treatment Period 4||1
168190|NCT00519376|413210|P10|STARTED|Treatment Period 4||1
168191|NCT00519376|413211|P9|STARTED|Treatment Period 4||1
168192|NCT00519376|413212|P8|STARTED|Treatment Period 4||1
168193|NCT00519376|413213|P7|STARTED|Treatment Period 4||1
168194|NCT00519376|413214|P6|STARTED|Treatment Period 4||1
168195|NCT00519376|413215|P5|STARTED|Treatment Period 4||1
168196|NCT00519376|413216|P4|STARTED|Treatment Period 4||2
168197|NCT00519376|413217|P3|STARTED|Treatment Period 4||2
168198|NCT00519376|413218|P2|STARTED|Treatment Period 4||2
168199|NCT00519376|413219|P1|STARTED|Treatment Period 4||2
168200|NCT00519376|413204|P16|NOT COMPLETED|Washout Period 3||0
168201|NCT00519376|413205|P15|NOT COMPLETED|Washout Period 3||0
168202|NCT00519376|413206|P14|NOT COMPLETED|Washout Period 3||0
168203|NCT00519376|413207|P13|NOT COMPLETED|Washout Period 3||0
168204|NCT00519376|413208|P12|NOT COMPLETED|Washout Period 3||0
168205|NCT00519376|413209|P11|NOT COMPLETED|Washout Period 3||0
168206|NCT00519376|413210|P10|NOT COMPLETED|Washout Period 3||0
168207|NCT00519376|413211|P9|NOT COMPLETED|Washout Period 3||0
168208|NCT00519376|413212|P8|NOT COMPLETED|Washout Period 3||0
168209|NCT00519376|413213|P7|NOT COMPLETED|Washout Period 3||0
168210|NCT00519376|413214|P6|NOT COMPLETED|Washout Period 3||0
168211|NCT00519376|413215|P5|NOT COMPLETED|Washout Period 3||0
168212|NCT00519376|413216|P4|NOT COMPLETED|Washout Period 3||0
168213|NCT00519376|413217|P3|NOT COMPLETED|Washout Period 3||0
168214|NCT00519376|413218|P2|NOT COMPLETED|Washout Period 3||0
168215|NCT00519376|413219|P1|NOT COMPLETED|Washout Period 3||0
168216|NCT00519376|413204|P16|COMPLETED|Washout Period 3||1
168217|NCT00519376|413205|P15|COMPLETED|Washout Period 3||1
168218|NCT00519376|413206|P14|COMPLETED|Washout Period 3||1
168219|NCT00519376|413207|P13|COMPLETED|Washout Period 3||0
168220|NCT00519376|413208|P12|COMPLETED|Washout Period 3||1
168221|NCT00519376|413209|P11|COMPLETED|Washout Period 3||1
168222|NCT00519376|413210|P10|COMPLETED|Washout Period 3||1
168223|NCT00519376|413211|P9|COMPLETED|Washout Period 3||1
168224|NCT00519376|413212|P8|COMPLETED|Washout Period 3||1
168225|NCT00519376|413213|P7|COMPLETED|Washout Period 3||1
168226|NCT00519376|413214|P6|COMPLETED|Washout Period 3||1
168227|NCT00519376|413215|P5|COMPLETED|Washout Period 3||1
168228|NCT00519376|413216|P4|COMPLETED|Washout Period 3||2
168229|NCT00519376|413217|P3|COMPLETED|Washout Period 3||2
168230|NCT00519376|413218|P2|COMPLETED|Washout Period 3||2
168231|NCT00519376|413219|P1|COMPLETED|Washout Period 3||2
168232|NCT00519376|413204|P16|STARTED|Washout Period 3||1
168233|NCT00519376|413205|P15|STARTED|Washout Period 3||1
168234|NCT00519376|413206|P14|STARTED|Washout Period 3||1
168235|NCT00519376|413207|P13|STARTED|Washout Period 3||0
168236|NCT00519376|413208|P12|STARTED|Washout Period 3||1
168237|NCT00519376|413209|P11|STARTED|Washout Period 3||1
168238|NCT00519376|413210|P10|STARTED|Washout Period 3||1
168239|NCT00519376|413211|P9|STARTED|Washout Period 3||1
168240|NCT00519376|413212|P8|STARTED|Washout Period 3||1
168241|NCT00519376|413213|P7|STARTED|Washout Period 3||1
168242|NCT00519376|413214|P6|STARTED|Washout Period 3||1
168243|NCT00519376|413215|P5|STARTED|Washout Period 3||1
168244|NCT00519376|413216|P4|STARTED|Washout Period 3||2
168245|NCT00519376|413217|P3|STARTED|Washout Period 3||2
168246|NCT00519376|413218|P2|STARTED|Washout Period 3||2
168247|NCT00519376|413219|P1|STARTED|Washout Period 3||2
168248|NCT00519376|413204|P16|NOT COMPLETED|Treatment Period 3||0
168249|NCT00519376|413205|P15|NOT COMPLETED|Treatment Period 3||0
168250|NCT00519376|413206|P14|NOT COMPLETED|Treatment Period 3||0
168251|NCT00519376|413207|P13|NOT COMPLETED|Treatment Period 3||0
168252|NCT00519376|413208|P12|NOT COMPLETED|Treatment Period 3||0
168253|NCT00519376|413209|P11|NOT COMPLETED|Treatment Period 3||0
168254|NCT00519376|413210|P10|NOT COMPLETED|Treatment Period 3||0
168255|NCT00519376|413211|P9|NOT COMPLETED|Treatment Period 3||0
168256|NCT00519376|413212|P8|NOT COMPLETED|Treatment Period 3||0
168257|NCT00519376|413213|P7|NOT COMPLETED|Treatment Period 3||0
168258|NCT00519376|413214|P6|NOT COMPLETED|Treatment Period 3||0
168259|NCT00519376|413215|P5|NOT COMPLETED|Treatment Period 3||0
168260|NCT00519376|413216|P4|NOT COMPLETED|Treatment Period 3||0
168261|NCT00519376|413217|P3|NOT COMPLETED|Treatment Period 3||0
168262|NCT00519376|413218|P2|NOT COMPLETED|Treatment Period 3||0
168263|NCT00519376|413219|P1|NOT COMPLETED|Treatment Period 3||0
168264|NCT00519376|413204|P16|COMPLETED|Treatment Period 3||1
168265|NCT00519376|413205|P15|COMPLETED|Treatment Period 3||1
168266|NCT00519376|413206|P14|COMPLETED|Treatment Period 3||1
168267|NCT00519376|413207|P13|COMPLETED|Treatment Period 3||0
168268|NCT00519376|413208|P12|COMPLETED|Treatment Period 3||1
168269|NCT00519376|413209|P11|COMPLETED|Treatment Period 3||1
168270|NCT00519376|413210|P10|COMPLETED|Treatment Period 3||1
168271|NCT00519376|413211|P9|COMPLETED|Treatment Period 3||1
168272|NCT00519376|413212|P8|COMPLETED|Treatment Period 3||1
168273|NCT00519376|413213|P7|COMPLETED|Treatment Period 3||1
168274|NCT00519376|413214|P6|COMPLETED|Treatment Period 3||1
168275|NCT00519376|413215|P5|COMPLETED|Treatment Period 3||1
168276|NCT00519376|413216|P4|COMPLETED|Treatment Period 3||2
168277|NCT00519376|413217|P3|COMPLETED|Treatment Period 3||2
168278|NCT00519376|413218|P2|COMPLETED|Treatment Period 3||2
168279|NCT00519376|413219|P1|COMPLETED|Treatment Period 3||2
168280|NCT00519376|413204|P16|STARTED|Treatment Period 3||1
168281|NCT00519376|413205|P15|STARTED|Treatment Period 3||1
168282|NCT00519376|413206|P14|STARTED|Treatment Period 3||1
168283|NCT00519376|413207|P13|STARTED|Treatment Period 3||0
168284|NCT00519376|413208|P12|STARTED|Treatment Period 3||1
168285|NCT00519376|413209|P11|STARTED|Treatment Period 3||1
168286|NCT00519376|413210|P10|STARTED|Treatment Period 3||1
168287|NCT00519376|413211|P9|STARTED|Treatment Period 3||1
168288|NCT00519376|413212|P8|STARTED|Treatment Period 3||1
168289|NCT00519376|413213|P7|STARTED|Treatment Period 3||1
168290|NCT00519376|413214|P6|STARTED|Treatment Period 3||1
168291|NCT00519376|413215|P5|STARTED|Treatment Period 3||1
168292|NCT00519376|413216|P4|STARTED|Treatment Period 3||2
168293|NCT00519376|413217|P3|STARTED|Treatment Period 3||2
168294|NCT00519376|413218|P2|STARTED|Treatment Period 3||2
168295|NCT00519376|413219|P1|STARTED|Treatment Period 3||2
168296|NCT00519376|413204|P16|NOT COMPLETED|Washout Period 2||0
168297|NCT00519376|413205|P15|NOT COMPLETED|Washout Period 2||0
168298|NCT00519376|413206|P14|NOT COMPLETED|Washout Period 2||0
168299|NCT00519376|413207|P13|NOT COMPLETED|Washout Period 2||0
168300|NCT00519376|413208|P12|NOT COMPLETED|Washout Period 2||0
168301|NCT00519376|413209|P11|NOT COMPLETED|Washout Period 2||0
168302|NCT00519376|413210|P10|NOT COMPLETED|Washout Period 2||0
168303|NCT00519376|413211|P9|NOT COMPLETED|Washout Period 2||0
168304|NCT00519376|413212|P8|NOT COMPLETED|Washout Period 2||0
168305|NCT00519376|413213|P7|NOT COMPLETED|Washout Period 2||0
168306|NCT00519376|413214|P6|NOT COMPLETED|Washout Period 2||0
168307|NCT00519376|413215|P5|NOT COMPLETED|Washout Period 2||0
168308|NCT00519376|413216|P4|NOT COMPLETED|Washout Period 2||0
168309|NCT00519376|413217|P3|NOT COMPLETED|Washout Period 2||0
168310|NCT00519376|413218|P2|NOT COMPLETED|Washout Period 2||0
168311|NCT00519376|413219|P1|NOT COMPLETED|Washout Period 2||0
168312|NCT00519376|413204|P16|COMPLETED|Washout Period 2||1
168313|NCT00519376|413205|P15|COMPLETED|Washout Period 2||1
168314|NCT00519376|413206|P14|COMPLETED|Washout Period 2||1
168315|NCT00519376|413207|P13|COMPLETED|Washout Period 2||0
168316|NCT00519376|413208|P12|COMPLETED|Washout Period 2||1
168317|NCT00519376|413209|P11|COMPLETED|Washout Period 2||1
168318|NCT00519376|413210|P10|COMPLETED|Washout Period 2||1
168319|NCT00519376|413211|P9|COMPLETED|Washout Period 2||1
168320|NCT00519376|413212|P8|COMPLETED|Washout Period 2||1
168321|NCT00519376|413213|P7|COMPLETED|Washout Period 2||1
168322|NCT00519376|413214|P6|COMPLETED|Washout Period 2||1
168323|NCT00519376|413215|P5|COMPLETED|Washout Period 2||1
168324|NCT00519376|413216|P4|COMPLETED|Washout Period 2||2
168325|NCT00519376|413217|P3|COMPLETED|Washout Period 2||2
168326|NCT00519376|413218|P2|COMPLETED|Washout Period 2||2
168327|NCT00519376|413219|P1|COMPLETED|Washout Period 2||2
168328|NCT00519376|413204|P16|STARTED|Washout Period 2||1
168329|NCT00519376|413205|P15|STARTED|Washout Period 2||1
168330|NCT00519376|413206|P14|STARTED|Washout Period 2||1
168331|NCT00519376|413207|P13|STARTED|Washout Period 2||0
168332|NCT00519376|413208|P12|STARTED|Washout Period 2||1
168333|NCT00519376|413209|P11|STARTED|Washout Period 2||1
168334|NCT00519376|413210|P10|STARTED|Washout Period 2||1
168335|NCT00519376|413211|P9|STARTED|Washout Period 2||1
168336|NCT00519376|413212|P8|STARTED|Washout Period 2||1
168337|NCT00519376|413213|P7|STARTED|Washout Period 2||1
168338|NCT00519376|413214|P6|STARTED|Washout Period 2||1
168339|NCT00519376|413215|P5|STARTED|Washout Period 2||1
168340|NCT00519376|413216|P4|STARTED|Washout Period 2||2
168341|NCT00519376|413217|P3|STARTED|Washout Period 2||2
168342|NCT00519376|413218|P2|STARTED|Washout Period 2||2
168343|NCT00519376|413219|P1|STARTED|Washout Period 2||2
168344|NCT00519376|413204|P16|NOT COMPLETED|Treatment Period 2||0
168345|NCT00519376|413205|P15|NOT COMPLETED|Treatment Period 2||0
168346|NCT00519376|413206|P14|NOT COMPLETED|Treatment Period 2||0
168347|NCT00519376|413207|P13|NOT COMPLETED|Treatment Period 2||1
168348|NCT00519376|413208|P12|NOT COMPLETED|Treatment Period 2||0
168349|NCT00519376|413209|P11|NOT COMPLETED|Treatment Period 2||0
168350|NCT00519376|413210|P10|NOT COMPLETED|Treatment Period 2||0
168351|NCT00519376|413211|P9|NOT COMPLETED|Treatment Period 2||0
168352|NCT00519376|413212|P8|NOT COMPLETED|Treatment Period 2||0
168353|NCT00519376|413213|P7|NOT COMPLETED|Treatment Period 2||0
168354|NCT00519376|413214|P6|NOT COMPLETED|Treatment Period 2||0
168355|NCT00519376|413215|P5|NOT COMPLETED|Treatment Period 2||0
168356|NCT00519376|413216|P4|NOT COMPLETED|Treatment Period 2||0
168357|NCT00519376|413217|P3|NOT COMPLETED|Treatment Period 2||0
168358|NCT00519376|413218|P2|NOT COMPLETED|Treatment Period 2||0
168359|NCT00519376|413219|P1|NOT COMPLETED|Treatment Period 2||0
168360|NCT00519376|413204|P16|COMPLETED|Treatment Period 2||1
168361|NCT00519376|413205|P15|COMPLETED|Treatment Period 2||1
168362|NCT00519376|413206|P14|COMPLETED|Treatment Period 2||1
168363|NCT00519376|413207|P13|COMPLETED|Treatment Period 2||0
168364|NCT00519376|413208|P12|COMPLETED|Treatment Period 2||1
168365|NCT00519376|413209|P11|COMPLETED|Treatment Period 2||1
168366|NCT00519376|413210|P10|COMPLETED|Treatment Period 2||1
168367|NCT00519376|413211|P9|COMPLETED|Treatment Period 2||1
168368|NCT00519376|413212|P8|COMPLETED|Treatment Period 2||1
168369|NCT00519376|413213|P7|COMPLETED|Treatment Period 2||1
168370|NCT00519376|413214|P6|COMPLETED|Treatment Period 2||1
168371|NCT00519376|413215|P5|COMPLETED|Treatment Period 2||1
168372|NCT00519376|413216|P4|COMPLETED|Treatment Period 2||2
168373|NCT00519376|413217|P3|COMPLETED|Treatment Period 2||2
168374|NCT00519376|413218|P2|COMPLETED|Treatment Period 2||2
168375|NCT00519376|413219|P1|COMPLETED|Treatment Period 2||2
168376|NCT00519376|413204|P16|STARTED|Treatment Period 2||1
168377|NCT00519376|413205|P15|STARTED|Treatment Period 2||1
168378|NCT00519376|413206|P14|STARTED|Treatment Period 2||1
168379|NCT00519376|413207|P13|STARTED|Treatment Period 2||1
168380|NCT00519376|413208|P12|STARTED|Treatment Period 2||1
168381|NCT00519376|413209|P11|STARTED|Treatment Period 2||1
168382|NCT00519376|413210|P10|STARTED|Treatment Period 2||1
168383|NCT00519376|413211|P9|STARTED|Treatment Period 2||1
168384|NCT00519376|413212|P8|STARTED|Treatment Period 2||1
168385|NCT00519376|413213|P7|STARTED|Treatment Period 2||1
168386|NCT00519376|413214|P6|STARTED|Treatment Period 2||1
168387|NCT00519376|413215|P5|STARTED|Treatment Period 2||1
168388|NCT00519376|413216|P4|STARTED|Treatment Period 2||2
168389|NCT00519376|413217|P3|STARTED|Treatment Period 2||2
168390|NCT00519376|413218|P2|STARTED|Treatment Period 2||2
168391|NCT00519376|413219|P1|STARTED|Treatment Period 2||2
168392|NCT00519376|413204|P16|NOT COMPLETED|Washout Period 1||0
168393|NCT00519376|413205|P15|NOT COMPLETED|Washout Period 1||0
168394|NCT00519376|413206|P14|NOT COMPLETED|Washout Period 1||0
168395|NCT00519376|413207|P13|NOT COMPLETED|Washout Period 1||0
168396|NCT00519376|413208|P12|NOT COMPLETED|Washout Period 1||0
168397|NCT00519376|413209|P11|NOT COMPLETED|Washout Period 1||0
168398|NCT00519376|413210|P10|NOT COMPLETED|Washout Period 1||0
168399|NCT00519376|413211|P9|NOT COMPLETED|Washout Period 1||0
168400|NCT00519376|413212|P8|NOT COMPLETED|Washout Period 1||0
168401|NCT00519376|413213|P7|NOT COMPLETED|Washout Period 1||0
168402|NCT00519376|413214|P6|NOT COMPLETED|Washout Period 1||0
168403|NCT00519376|413215|P5|NOT COMPLETED|Washout Period 1||0
168404|NCT00519376|413216|P4|NOT COMPLETED|Washout Period 1||0
168405|NCT00519376|413217|P3|NOT COMPLETED|Washout Period 1||0
168406|NCT00519376|413218|P2|NOT COMPLETED|Washout Period 1||0
168407|NCT00519376|413219|P1|NOT COMPLETED|Washout Period 1||0
168408|NCT00519376|413204|P16|COMPLETED|Washout Period 1||1
168409|NCT00519376|413205|P15|COMPLETED|Washout Period 1||1
168410|NCT00519376|413206|P14|COMPLETED|Washout Period 1||1
168411|NCT00519376|413207|P13|COMPLETED|Washout Period 1||1
168412|NCT00519376|413208|P12|COMPLETED|Washout Period 1||1
168413|NCT00519376|413209|P11|COMPLETED|Washout Period 1||1
168414|NCT00519376|413210|P10|COMPLETED|Washout Period 1||1
168415|NCT00519376|413211|P9|COMPLETED|Washout Period 1||1
168416|NCT00519376|413212|P8|COMPLETED|Washout Period 1||1
168417|NCT00519376|413213|P7|COMPLETED|Washout Period 1||1
168418|NCT00519376|413214|P6|COMPLETED|Washout Period 1||1
168419|NCT00519376|413215|P5|COMPLETED|Washout Period 1||1
168420|NCT00519376|413216|P4|COMPLETED|Washout Period 1||2
168421|NCT00519376|413217|P3|COMPLETED|Washout Period 1||2
168422|NCT00519376|413218|P2|COMPLETED|Washout Period 1||2
168423|NCT00519376|413219|P1|COMPLETED|Washout Period 1||2
168424|NCT00519376|413204|P16|STARTED|Washout Period 1||1
168425|NCT00519376|413205|P15|STARTED|Washout Period 1||1
168426|NCT00519376|413206|P14|STARTED|Washout Period 1||1
168427|NCT00519376|413207|P13|STARTED|Washout Period 1||1
168428|NCT00519376|413208|P12|STARTED|Washout Period 1||1
168429|NCT00519376|413209|P11|STARTED|Washout Period 1||1
168430|NCT00519376|413210|P10|STARTED|Washout Period 1||1
168431|NCT00519376|413211|P9|STARTED|Washout Period 1||1
168432|NCT00519376|413212|P8|STARTED|Washout Period 1||1
168433|NCT00519376|413213|P7|STARTED|Washout Period 1||1
168434|NCT00519376|413214|P6|STARTED|Washout Period 1||1
168435|NCT00519376|413215|P5|STARTED|Washout Period 1||1
168436|NCT00519376|413216|P4|STARTED|Washout Period 1||2
168437|NCT00519376|413217|P3|STARTED|Washout Period 1||2
168438|NCT00519376|413218|P2|STARTED|Washout Period 1||2
168439|NCT00519376|413219|P1|STARTED|Washout Period 1||2
168440|NCT00519376|413204|P16|NOT COMPLETED|Treatment Period 1||0
168441|NCT00519376|413205|P15|NOT COMPLETED|Treatment Period 1||0
168442|NCT00519376|413206|P14|NOT COMPLETED|Treatment Period 1||0
168443|NCT00519376|413207|P13|NOT COMPLETED|Treatment Period 1||0
168444|NCT00519376|413208|P12|NOT COMPLETED|Treatment Period 1||0
168445|NCT00519376|413209|P11|NOT COMPLETED|Treatment Period 1||0
168446|NCT00519376|413210|P10|NOT COMPLETED|Treatment Period 1||0
168447|NCT00519376|413211|P9|NOT COMPLETED|Treatment Period 1||0
168448|NCT00519376|413212|P8|NOT COMPLETED|Treatment Period 1||0
168449|NCT00519376|413213|P7|NOT COMPLETED|Treatment Period 1||0
168450|NCT00519376|413214|P6|NOT COMPLETED|Treatment Period 1||0
168451|NCT00519376|413215|P5|NOT COMPLETED|Treatment Period 1||0
168452|NCT00519376|413216|P4|NOT COMPLETED|Treatment Period 1||0
168453|NCT00519376|413217|P3|NOT COMPLETED|Treatment Period 1||0
168454|NCT00519376|413218|P2|NOT COMPLETED|Treatment Period 1||0
168455|NCT00519376|413219|P1|NOT COMPLETED|Treatment Period 1||0
168456|NCT00519376|413204|P16|COMPLETED|Treatment Period 1||1
168457|NCT00519376|413205|P15|COMPLETED|Treatment Period 1||1
168458|NCT00519376|413206|P14|COMPLETED|Treatment Period 1||1
168459|NCT00519376|413207|P13|COMPLETED|Treatment Period 1||1
168460|NCT00519376|413208|P12|COMPLETED|Treatment Period 1||1
168461|NCT00519376|413209|P11|COMPLETED|Treatment Period 1||1
168462|NCT00519376|413210|P10|COMPLETED|Treatment Period 1||1
168463|NCT00519376|413211|P9|COMPLETED|Treatment Period 1||1
168464|NCT00519376|413212|P8|COMPLETED|Treatment Period 1||1
168465|NCT00519376|413213|P7|COMPLETED|Treatment Period 1||1
168466|NCT00519376|413214|P6|COMPLETED|Treatment Period 1||1
168467|NCT00519376|413215|P5|COMPLETED|Treatment Period 1||1
168468|NCT00519376|413216|P4|COMPLETED|Treatment Period 1||2
168469|NCT00519376|413217|P3|COMPLETED|Treatment Period 1||2
168470|NCT00519376|413218|P2|COMPLETED|Treatment Period 1||2
168471|NCT00519376|413219|P1|COMPLETED|Treatment Period 1||2
168472|NCT00519376|413204|P16|STARTED|Treatment Period 1||1
168473|NCT00519376|413205|P15|STARTED|Treatment Period 1||1
168474|NCT00519376|413206|P14|STARTED|Treatment Period 1||1
168475|NCT00519376|413207|P13|STARTED|Treatment Period 1||1
168476|NCT00519376|413208|P12|STARTED|Treatment Period 1||1
168477|NCT00519376|413209|P11|STARTED|Treatment Period 1||1
168478|NCT00519376|413210|P10|STARTED|Treatment Period 1||1
168479|NCT00519376|413211|P9|STARTED|Treatment Period 1||1
168480|NCT00519376|413212|P8|STARTED|Treatment Period 1||1
168481|NCT00519376|413213|P7|STARTED|Treatment Period 1||1
168482|NCT00519376|413214|P6|STARTED|Treatment Period 1||1
168483|NCT00519376|413215|P5|STARTED|Treatment Period 1||1
168484|NCT00519376|413216|P4|STARTED|Treatment Period 1||2
168485|NCT00519376|413217|P3|STARTED|Treatment Period 1||2
168486|NCT00519376|413218|P2|STARTED|Treatment Period 1||2
168487|NCT00519376|413219|P1|STARTED|Treatment Period 1||2
168488|NCT00519532|413341|P1|NOT COMPLETED|Overall Study||18
168489|NCT00519532|413341|P1|COMPLETED|Overall Study||66
168490|NCT00519532|413341|P1|STARTED|Overall Study||84
168491|NCT00519584|413352|P4|NOT COMPLETED|Overall Study||0
168492|NCT00519584|413353|P3|NOT COMPLETED|Overall Study||0
168493|NCT00519584|413354|P2|NOT COMPLETED|Overall Study||0
168494|NCT00519584|413355|P1|NOT COMPLETED|Overall Study||0
168495|NCT00519584|413352|P4|COMPLETED|Overall Study||56
168496|NCT00519584|413353|P3|COMPLETED|Overall Study||54
168497|NCT00519584|413354|P2|COMPLETED|Overall Study||54
168498|NCT00519584|413355|P1|COMPLETED|Overall Study||54
168499|NCT00519584|413352|P4|STARTED|Overall Study||56
168500|NCT00519584|413353|P3|STARTED|Overall Study||54
168501|NCT00519584|413354|P2|STARTED|Overall Study||54
168502|NCT00519584|413355|P1|STARTED|Overall Study||54
168503|NCT00519623|413377|P1|NOT COMPLETED|Overall Study||1
168504|NCT00519623|413377|P1|COMPLETED|Overall Study||8
168505|NCT00519623|413377|P1|STARTED|Overall Study||9
168506|NCT00519636|413386|P4|NOT COMPLETED|Post Study Period||1
168507|NCT00519636|413387|P3|NOT COMPLETED|Post Study Period||0
168508|NCT00519636|413388|P2|NOT COMPLETED|Post Study Period||0
168509|NCT00519636|413389|P1|NOT COMPLETED|Post Study Period||0
168510|NCT00519636|413386|P4|COMPLETED|Post Study Period||85
168511|NCT00519636|413387|P3|COMPLETED|Post Study Period||74
168512|NCT00519636|413388|P2|COMPLETED|Post Study Period||71
168513|NCT00519636|413389|P1|COMPLETED|Post Study Period||69
168514|NCT00519636|413386|P4|STARTED|Post Study Period||86
168515|NCT00519636|413387|P3|STARTED|Post Study Period||74
168516|NCT00519636|413388|P2|STARTED|Post Study Period||71
168517|NCT00519636|413389|P1|STARTED|Post Study Period||69
168518|NCT00519636|413386|P4|NOT COMPLETED|Treatment Period 2||2
168519|NCT00519636|413387|P3|NOT COMPLETED|Treatment Period 2||1
168520|NCT00519636|413388|P2|NOT COMPLETED|Treatment Period 2||1
168521|NCT00519636|413389|P1|NOT COMPLETED|Treatment Period 2||0
168522|NCT00519636|413386|P4|COMPLETED|Treatment Period 2||86
168523|NCT00519636|413387|P3|COMPLETED|Treatment Period 2||74
168524|NCT00519636|413388|P2|COMPLETED|Treatment Period 2||71
168525|NCT00519636|413389|P1|COMPLETED|Treatment Period 2||69
168526|NCT00519636|413386|P4|STARTED|Treatment Period 2||88
168527|NCT00519636|413387|P3|STARTED|Treatment Period 2||75
168528|NCT00519636|413388|P2|STARTED|Treatment Period 2||72
168529|NCT00519636|413389|P1|STARTED|Treatment Period 2||69
168530|NCT00519636|413386|P4|NOT COMPLETED|Washout Period||5
168531|NCT00519636|413387|P3|NOT COMPLETED|Washout Period||14
168532|NCT00519636|413388|P2|NOT COMPLETED|Washout Period||14
168533|NCT00519636|413389|P1|NOT COMPLETED|Washout Period||20
168534|NCT00519636|413386|P4|COMPLETED|Washout Period||88
168535|NCT00519636|413387|P3|COMPLETED|Washout Period||75
168536|NCT00519636|413388|P2|COMPLETED|Washout Period||72
168537|NCT00519636|413389|P1|COMPLETED|Washout Period||69
168538|NCT00519636|413386|P4|STARTED|Washout Period||93
168539|NCT00519636|413387|P3|STARTED|Washout Period||89
168540|NCT00519636|413388|P2|STARTED|Washout Period||86
168541|NCT00519636|413389|P1|STARTED|Washout Period||89
168542|NCT00519636|413386|P4|NOT COMPLETED|Treatment Period 1||0
168543|NCT00519636|413387|P3|NOT COMPLETED|Treatment Period 1||1
168544|NCT00519636|413388|P2|NOT COMPLETED|Treatment Period 1||0
168545|NCT00519636|413389|P1|NOT COMPLETED|Treatment Period 1||2
168546|NCT00519636|413386|P4|COMPLETED|Treatment Period 1||93
168547|NCT00519636|413387|P3|COMPLETED|Treatment Period 1||89
168548|NCT00519636|413388|P2|COMPLETED|Treatment Period 1||86
168549|NCT00519636|413389|P1|COMPLETED|Treatment Period 1||89
168550|NCT00519636|413386|P4|STARTED|Treatment Period 1||93
168551|NCT00519636|413387|P3|STARTED|Treatment Period 1||90
168552|NCT00519636|413388|P2|STARTED|Treatment Period 1||86
168553|NCT00519636|413389|P1|STARTED|Treatment Period 1||91
168554|NCT00519649|413419|P1|NOT COMPLETED|Overall Study||1
168555|NCT00519649|413419|P1|COMPLETED|Overall Study||299
168556|NCT00519649|413419|P1|STARTED|Overall Study||300
168557|NCT00519779|413430|P2|NOT COMPLETED|Overall Study||1
168558|NCT00519779|413431|P1|NOT COMPLETED|Overall Study||0
168559|NCT00519779|413430|P2|COMPLETED|Overall Study||33
168560|NCT00519779|413431|P1|COMPLETED|Overall Study||34
168561|NCT00519779|413430|P2|STARTED|Overall Study||34
168562|NCT00519779|413431|P1|STARTED|Overall Study||34
168563|NCT00519818|413447|P1|NOT COMPLETED|Overall Study||0
168564|NCT00519818|413447|P1|COMPLETED|Overall Study||14
168565|NCT00519818|413447|P1|STARTED|Overall Study||14
168566|NCT00519831|413455|P1|NOT COMPLETED|Overall Study||3
168567|NCT00519831|413455|P1|COMPLETED|Overall Study||13
168568|NCT00519831|413455|P1|STARTED|Overall Study||16
168569|NCT00519896|413462|P1|NOT COMPLETED|Overall Study||2
168570|NCT00519896|413462|P1|COMPLETED|Overall Study||33
168571|NCT00519896|413462|P1|STARTED|Overall Study||35
168572|NCT00520013|413471|P3|NOT COMPLETED|Overall Study||11
168573|NCT00520013|413472|P2|NOT COMPLETED|Overall Study||15
168574|NCT00520013|413473|P1|NOT COMPLETED|Overall Study||12
168575|NCT00520013|413471|P3|COMPLETED|Overall Study||0
168576|NCT00520013|413472|P2|COMPLETED|Overall Study||10
168577|NCT00520013|413473|P1|COMPLETED|Overall Study||11
168578|NCT00520013|413471|P3|Treated|Overall Study||11
168579|NCT00520013|413472|P2|Treated|Overall Study||25
168580|NCT00520013|413473|P1|Treated|Overall Study||23
168581|NCT00520013|413471|P3|STARTED|Overall Study|Excludes a pt who went off-study (on reg day) due to consent that may not have been informed (ESL).|11
168582|NCT00520013|413472|P2|STARTED|Overall Study||25
168583|NCT00520013|413473|P1|STARTED|Overall Study||23
168584|NCT00520130|413485|P2|NOT COMPLETED|Overall Study||1
168585|NCT00520130|413486|P1|NOT COMPLETED|Overall Study||5
168586|NCT00520130|413485|P2|COMPLETED|Overall Study||44
168587|NCT00520130|413486|P1|COMPLETED|Overall Study||39
168588|NCT00520130|413485|P2|STARTED|Overall Study||45
168589|NCT00520130|413486|P1|STARTED|Overall Study||44
168590|NCT00513019|413528|P2|NOT COMPLETED|Overall Study||5
168591|NCT00513019|413529|P1|NOT COMPLETED|Overall Study||5
168592|NCT00513019|413528|P2|COMPLETED|Overall Study||13
168593|NCT00513019|413529|P1|COMPLETED|Overall Study||12
168594|NCT00513019|413528|P2|STARTED|Overall Study||18
168595|NCT00513019|413529|P1|STARTED|Overall Study||17
168596|NCT00513071|413535|P1|NOT COMPLETED|Overall Study||5
168597|NCT00513071|413535|P1|COMPLETED|Overall Study||23
168598|NCT00513071|413535|P1|STARTED|Overall Study||28
168599|NCT00513240|413542|P2|NOT COMPLETED|Overall Study||7
168600|NCT00513240|413543|P1|NOT COMPLETED|Overall Study||13
168601|NCT00513240|413542|P2|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|20
168602|NCT00513240|413543|P1|COMPLETED|Overall Study|Competed 12 month neurodevelopmental exam, which are the only results published at this time.|22
168603|NCT00513240|413542|P2|Clinical Data Collection &Pre/Postop MRI|Overall Study||27
168604|NCT00513240|413543|P1|Clinical Data Collection &Pre/Postop MRI|Overall Study|3 not having intended surgery are subtracted from original 35 subjects, leaving 32|32
168605|NCT00513240|413542|P2|STARTED|Overall Study|25 had 3 doses; 1 had 1 dose due to rash; 1 had 2 doses and 1 dose of EPO due to pharmacy error|27
168606|NCT00513240|413543|P1|STARTED|Overall Study|3 did not have intended surgery; 28 had all 3 doses; 4 had 1 dose but no more due to delayed surgery|35
168607|NCT00513292|413552|P2|NOT COMPLETED|Overall Study||0
168608|NCT00513292|413553|P1|NOT COMPLETED|Overall Study||0
168609|NCT00513292|413552|P2|COMPLETED|Overall Study||142
168610|NCT00513292|413553|P1|COMPLETED|Overall Study||138
168611|NCT00513292|413552|P2|STARTED|Overall Study||142
168612|NCT00513292|413553|P1|STARTED|Overall Study||138
168613|NCT00513305|413571|P2|NOT COMPLETED|Overall Study||27
168614|NCT00513305|413572|P1|NOT COMPLETED|Overall Study||28
168615|NCT00513305|413571|P2|COMPLETED|Overall Study||7
168616|NCT00513305|413572|P1|COMPLETED|Overall Study||5
168617|NCT00513305|413571|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication|34
168618|NCT00513305|413572|P1|STARTED|Overall Study||33
168619|NCT00513344|413588|P1|NOT COMPLETED|3rd Intervention 1 Day||0
168620|NCT00513344|413588|P1|COMPLETED|3rd Intervention 1 Day||5
168621|NCT00513344|413588|P1|STARTED|3rd Intervention 1 Day||5
168622|NCT00513344|413588|P1|NOT COMPLETED|Washout Period 3 Days||0
168623|NCT00513344|413588|P1|COMPLETED|Washout Period 3 Days||5
168624|NCT00513344|413588|P1|STARTED|Washout Period 3 Days||5
168625|NCT00513344|413588|P1|NOT COMPLETED|2nd Intervention 1 Day||0
168626|NCT00513344|413588|P1|COMPLETED|2nd Intervention 1 Day||5
168627|NCT00513344|413588|P1|STARTED|2nd Intervention 1 Day||5
168628|NCT00513344|413588|P1|NOT COMPLETED|Washout Period 3 Days||0
168629|NCT00513344|413588|P1|COMPLETED|Washout Period 3 Days||5
168630|NCT00513344|413588|P1|STARTED|Washout Period 3 Days||5
168631|NCT00513344|413588|P1|NOT COMPLETED|1st Intervention 1 Day||0
168632|NCT00513344|413588|P1|COMPLETED|1st Intervention 1 Day||5
168633|NCT00513344|413588|P1|STARTED|1st Intervention 1 Day||5
168634|NCT00513344|413588|P1|NOT COMPLETED|Diet Restriction (3 Days)||0
168635|NCT00513344|413588|P1|COMPLETED|Diet Restriction (3 Days)||5
168636|NCT00513344|413588|P1|STARTED|Diet Restriction (3 Days)||5
168637|NCT00513357|413601|P2|NOT COMPLETED|Overall Study||10
168638|NCT00513357|413602|P1|NOT COMPLETED|Overall Study||15
168639|NCT00513357|413601|P2|COMPLETED|Overall Study||25
168640|NCT00513357|413602|P1|COMPLETED|Overall Study||23
168641|NCT00513357|413601|P2|STARTED|Overall Study||35
168642|NCT00513357|413602|P1|STARTED|Overall Study||38
168643|NCT00513370|413608|P1|NOT COMPLETED|Overall Study||24
168644|NCT00513370|413608|P1|COMPLETED|Overall Study||179
168645|NCT00513370|413608|P1|STARTED|Overall Study||203
168646|NCT00513409|413638|P2|NOT COMPLETED|Overall Study||6
168647|NCT00513409|413639|P1|NOT COMPLETED|Overall Study||2
168648|NCT00513409|413638|P2|COMPLETED|Overall Study||73
168649|NCT00513409|413639|P1|COMPLETED|Overall Study||82
168650|NCT00513409|413638|P2|STARTED|Overall Study||79
168651|NCT00513409|413639|P1|STARTED|Overall Study||84
168652|NCT00513435|413665|P1|NOT COMPLETED|Overall Study||0
168653|NCT00513435|413665|P1|COMPLETED|Overall Study||9
168654|NCT00513435|413665|P1|STARTED|Overall Study||9
168655|NCT00513474|413672|P2|NOT COMPLETED|Overall Study||9
168656|NCT00513474|413673|P1|NOT COMPLETED|Overall Study||7
168657|NCT00513474|413672|P2|COMPLETED|Overall Study||12
168658|NCT00513474|413673|P1|COMPLETED|Overall Study||18
168659|NCT00513474|413672|P2|Received Rasburicase Per Protocol|Overall Study||0
168660|NCT00513474|413673|P1|Received Rasburicase Per Protocol|Overall Study||24
168661|NCT00513474|413672|P2|STARTED|Overall Study||21
168662|NCT00513474|413673|P1|STARTED|Overall Study||25
168663|NCT00513500|413687|P2|NOT COMPLETED|Overall Study||54
168664|NCT00513500|413688|P1|NOT COMPLETED|Overall Study||41
168665|NCT00513500|413687|P2|COMPLETED|Overall Study||2054
168666|NCT00513500|413688|P1|COMPLETED|Overall Study||976
168667|NCT00513500|413687|P2|STARTED|Overall Study||2108
168668|NCT00513500|413688|P1|STARTED|Overall Study||1017
168669|NCT00513526|413698|P1|NOT COMPLETED|Overall Study||17
168670|NCT00513526|413698|P1|COMPLETED|Overall Study||92
168671|NCT00513526|413698|P1|STARTED|Overall Study||109
168672|NCT00513604|413718|P5|NOT COMPLETED|Overall Study||0
168673|NCT00513604|413719|P4|NOT COMPLETED|Overall Study||0
168674|NCT00513604|413720|P3|NOT COMPLETED|Overall Study||3
168675|NCT00513604|413721|P2|NOT COMPLETED|Overall Study||3
168676|NCT00513604|413722|P1|NOT COMPLETED|Overall Study||2
168677|NCT00513604|413718|P5|COMPLETED|Overall Study||35
168678|NCT00513604|413719|P4|COMPLETED|Overall Study||34
168679|NCT00513604|413720|P3|COMPLETED|Overall Study||21
168680|NCT00513604|413721|P2|COMPLETED|Overall Study||36
168681|NCT00513604|413722|P1|COMPLETED|Overall Study||24
168682|NCT00513604|413718|P5|STARTED|Overall Study|Cohort 5 = CD4+ depleted TIL-it is the SAME as cohort 2|35
168683|NCT00513604|413719|P4|STARTED|Overall Study|Cohort 4 = unselected TIL - it is the SAME as cohort 1|34
168684|NCT00513604|413720|P3|STARTED|Overall Study|Cohort 3 = CD4+ depleted (selected) TIL + 600Gy radiation|24
168685|NCT00513604|413721|P2|STARTED|Overall Study|Cohort 2 = CD4+ depleted (selected) TIL|39
168686|NCT00513604|413722|P1|STARTED|Overall Study|Cohort 1 = unselected TIL|26
168687|NCT00513617|413742|P3|NOT COMPLETED|Overall Study||8
168688|NCT00513617|413743|P2|NOT COMPLETED|Overall Study||10
168689|NCT00513617|413744|P1|NOT COMPLETED|Overall Study||11
168690|NCT00513617|413742|P3|COMPLETED|Overall Study||30
168691|NCT00513617|413743|P2|COMPLETED|Overall Study||25
168692|NCT00513617|413744|P1|COMPLETED|Overall Study||25
168693|NCT00513617|413742|P3|STARTED|Overall Study||38
168694|NCT00513617|413743|P2|STARTED|Overall Study||35
168695|NCT00513617|413744|P1|STARTED|Overall Study||36
168696|NCT00513682|413755|P1|NOT COMPLETED|Treatment Phase||0
168697|NCT00513682|413755|P1|COMPLETED|Treatment Phase||7
168698|NCT00513682|413755|P1|STARTED|Treatment Phase||7
168699|NCT00513682|413755|P1|NOT COMPLETED|Washout Phase||2
168700|NCT00513682|413755|P1|COMPLETED|Washout Phase||7
168701|NCT00513682|413755|P1|STARTED|Washout Phase||9
168702|NCT00513682|413755|P1|NOT COMPLETED|Screening Phase||0
168703|NCT00513682|413755|P1|COMPLETED|Screening Phase||9
168704|NCT00513682|413755|P1|STARTED|Screening Phase||9
168705|NCT00513695|413764|P1|NOT COMPLETED|Overall Study||5
168706|NCT00513695|413764|P1|COMPLETED|Overall Study||63
168707|NCT00513695|413764|P1|STARTED|Overall Study||68
168708|NCT00513708|413776|P3|NOT COMPLETED|Overall Study||4
168709|NCT00513708|413777|P2|NOT COMPLETED|Overall Study||4
168710|NCT00513708|413778|P1|NOT COMPLETED|Overall Study||4
168711|NCT00513708|413776|P3|COMPLETED|Overall Study||46
168712|NCT00513708|413777|P2|COMPLETED|Overall Study||46
168713|NCT00513708|413778|P1|COMPLETED|Overall Study||46
168714|NCT00513708|413776|P3|STARTED|Overall Study||50
168715|NCT00513708|413777|P2|STARTED|Overall Study||50
168716|NCT00513708|413778|P1|STARTED|Overall Study||50
168717|NCT00520234|413794|P2|NOT COMPLETED|Overall Study||2
168718|NCT00520234|413795|P1|NOT COMPLETED|Overall Study||1
168719|NCT00520234|413794|P2|COMPLETED|Overall Study||102
168720|NCT00520234|413795|P1|COMPLETED|Overall Study||117
168721|NCT00520234|413794|P2|STARTED|Overall Study||104
168722|NCT00520234|413795|P1|STARTED|Overall Study||118
168723|NCT00520286|413807|P2|NOT COMPLETED|Overall Study||32
168724|NCT00520286|413808|P1|NOT COMPLETED|Overall Study||66
168725|NCT00520286|413807|P2|COMPLETED|Overall Study||36
168726|NCT00520286|413808|P1|COMPLETED|Overall Study||76
168727|NCT00520286|413807|P2|STARTED|Overall Study||68
168728|NCT00520286|413808|P1|STARTED|Overall Study||142
168729|NCT00520299|413819|P3|NOT COMPLETED|Overall Study||6
168730|NCT00520299|413820|P2|NOT COMPLETED|Overall Study||3
168731|NCT00520299|413821|P1|NOT COMPLETED|Overall Study||0
168732|NCT00520299|413819|P3|COMPLETED|Overall Study||13
168733|NCT00520299|413820|P2|COMPLETED|Overall Study||3
168734|NCT00520299|413821|P1|COMPLETED|Overall Study|Defined as completion of 1 treatment cycle|6
168735|NCT00520299|413819|P3|STARTED|Overall Study||19
168736|NCT00520299|413820|P2|STARTED|Overall Study||6
168737|NCT00520299|413821|P1|STARTED|Overall Study||6
168738|NCT00520351|413852|P2|NOT COMPLETED|Second Intervention||0
168739|NCT00520351|413853|P1|NOT COMPLETED|Second Intervention||0
168740|NCT00520351|413852|P2|COMPLETED|Second Intervention||14
168741|NCT00520351|413853|P1|COMPLETED|Second Intervention||14
168742|NCT00520351|413852|P2|STARTED|Second Intervention||14
168743|NCT00520351|413853|P1|STARTED|Second Intervention||14
168744|NCT00520351|413852|P2|NOT COMPLETED|First Intervention||1
168745|NCT00520351|413853|P1|NOT COMPLETED|First Intervention||1
168746|NCT00520351|413852|P2|COMPLETED|First Intervention|End date is Feb.25, 2008|14
168747|NCT00520351|413853|P1|COMPLETED|First Intervention|End date is Feb.25, 2008|14
168748|NCT00520351|413852|P2|STARTED|First Intervention|Start date is Sep.06, 2007|15
168749|NCT00520351|413853|P1|STARTED|First Intervention|Start date is Sep.06, 2007|15
168750|NCT00520403|413865|P1|NOT COMPLETED|Bevacizumab Monotherapy||2
168751|NCT00520403|413865|P1|COMPLETED|Bevacizumab Monotherapy||0
168752|NCT00520403|413865|P1|STARTED|Bevacizumab Monotherapy|2 of 7 participants completing Bevacizumab+IFN/vinblastine cycles initiated bevacizumab monotherapy|2
168753|NCT00520403|413865|P1|NOT COMPLETED|Bevacizumab + IFN/Vinblastine||18
168754|NCT00520403|413865|P1|COMPLETED|Bevacizumab + IFN/Vinblastine||7
168755|NCT00520403|413865|P1|STARTED|Bevacizumab + IFN/Vinblastine||25
168756|NCT00520468|413872|P1|NOT COMPLETED|Overall Study||0
168757|NCT00520468|413872|P1|COMPLETED|Overall Study||14
168758|NCT00520468|413872|P1|STARTED|Overall Study||14
168759|NCT00520494|413876|P1|NOT COMPLETED|Overall Study||1
168760|NCT00520494|413876|P1|COMPLETED|Overall Study||17
168761|NCT00520494|413876|P1|STARTED|Overall Study||18
168762|NCT00522457|413899|P1|NOT COMPLETED|Overall Study||18
168763|NCT00522457|413899|P1|COMPLETED|Overall Study||1
168764|NCT00522457|413899|P1|STARTED|Overall Study||19
168765|NCT00522626|413905|P1|NOT COMPLETED|Overall Study||7
168766|NCT00522626|413905|P1|COMPLETED|Overall Study||12
168767|NCT00522626|413905|P1|STARTED|Overall Study||19
168768|NCT00522795|413909|P1|NOT COMPLETED|Overall Study||0
168769|NCT00522795|413909|P1|COMPLETED|Overall Study||40
168770|NCT00522795|413909|P1|STARTED|Overall Study||40
168771|NCT00522873|413915|P2|NOT COMPLETED|Overall Study||44
168772|NCT00522873|413916|P1|NOT COMPLETED|Overall Study||96
168773|NCT00522873|413915|P2|COMPLETED|Overall Study|128 women completed study medication. 129 women completed the study.|128
168774|NCT00522873|413916|P1|COMPLETED|Overall Study|394 women completed study medication. 398 women completed the study.|394
168775|NCT00522873|413915|P2|Received Treatment|Overall Study||172
168776|NCT00522873|413916|P1|Received Treatment|Overall Study||489
168777|NCT00522873|413915|P2|STARTED|Overall Study||172
168778|NCT00522873|413916|P1|STARTED|Overall Study||490
168779|NCT00522925|413928|P3|NOT COMPLETED|Overall Study||2
168780|NCT00522925|413929|P2|NOT COMPLETED|Overall Study||1
168781|NCT00522925|413930|P1|NOT COMPLETED|Overall Study||8
168782|NCT00522925|413928|P3|COMPLETED|Overall Study||36
168783|NCT00522925|413929|P2|COMPLETED|Overall Study||38
168784|NCT00522925|413930|P1|COMPLETED|Overall Study||28
168785|NCT00522925|413928|P3|STARTED|Overall Study||38
168786|NCT00522925|413929|P2|STARTED|Overall Study||39
168787|NCT00522925|413930|P1|STARTED|Overall Study||36
168788|NCT00522951|413938|P2|NOT COMPLETED|Period 2||1
168789|NCT00522951|413939|P1|NOT COMPLETED|Period 2||2
168790|NCT00522951|413938|P2|COMPLETED|Period 2||75
168791|NCT00522951|413939|P1|COMPLETED|Period 2||84
168792|NCT00522951|413938|P2|Subjects Received Treatment|Period 2||75
168793|NCT00522951|413939|P1|Subjects Received Treatment|Period 2||84
168794|NCT00522951|413938|P2|STARTED|Period 2||76
168795|NCT00522951|413939|P1|STARTED|Period 2||86
168796|NCT00522951|413938|P2|NOT COMPLETED|Washout Period||2
168797|NCT00522951|413939|P1|NOT COMPLETED|Washout Period||0
168798|NCT00522951|413938|P2|COMPLETED|Washout Period||76
168799|NCT00522951|413939|P1|COMPLETED|Washout Period||86
168800|NCT00522951|413938|P2|STARTED|Washout Period||78
168801|NCT00522951|413939|P1|STARTED|Washout Period||86
168802|NCT00522951|413938|P2|NOT COMPLETED|Period 1||1
168803|NCT00522951|413939|P1|NOT COMPLETED|Period 1||0
168804|NCT00522951|413938|P2|COMPLETED|Period 1||78
168805|NCT00522951|413939|P1|COMPLETED|Period 1||86
168806|NCT00522951|413938|P2|Received Treatment|Period 1||78
168807|NCT00522951|413939|P1|Received Treatment|Period 1||86
168808|NCT00522951|413938|P2|STARTED|Period 1||79
168809|NCT00522951|413939|P1|STARTED|Period 1||86
168810|NCT00523237|413979|P1|NOT COMPLETED|Overall Study||0
168811|NCT00523237|413979|P1|COMPLETED|Overall Study||14
168812|NCT00523237|413979|P1|STARTED|Overall Study||14
168813|NCT00523341|413985|P2|NOT COMPLETED|Overall Study||1000
168814|NCT00523341|413986|P1|NOT COMPLETED|Overall Study||924
168815|NCT00523341|413985|P2|COMPLETED|Overall Study||1343
168816|NCT00523341|413986|P1|COMPLETED|Overall Study||1283
168817|NCT00523341|413985|P2|Received Treatment|Overall Study||2343
168818|NCT00523341|413986|P1|Received Treatment|Overall Study||2206
168819|NCT00523341|413985|P2|STARTED|Overall Study||2343
168820|NCT00523341|413986|P1|STARTED|Overall Study||2207
168821|NCT00523367|414086|P1|NOT COMPLETED|Overall Study||23
168822|NCT00523367|414086|P1|COMPLETED|Overall Study||2
168823|NCT00523367|414086|P1|STARTED|Overall Study||25
168824|NCT00523419|414090|P1|NOT COMPLETED|Overall Study||32
168825|NCT00523419|414090|P1|COMPLETED|Overall Study||0
168826|NCT00523419|414090|P1|STARTED|Overall Study||32
168827|NCT00523549|414102|P2|NOT COMPLETED|Overall Study||16
168828|NCT00523549|414103|P1|NOT COMPLETED|Overall Study||19
168829|NCT00523549|414102|P2|COMPLETED|Overall Study||99
168830|NCT00523549|414103|P1|COMPLETED|Overall Study||95
168831|NCT00523549|414102|P2|STARTED|Overall Study||115
168832|NCT00523549|414103|P1|STARTED|Overall Study||114
168833|NCT00523614|414123|P2|NOT COMPLETED|Overall Study||0
168834|NCT00523614|414124|P1|NOT COMPLETED|Overall Study||0
168835|NCT00523614|414123|P2|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
168836|NCT00523614|414124|P1|COMPLETED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
168924|NCT00524303|414592|P1|NOT COMPLETED|Overall Study||12
168837|NCT00523614|414123|P2|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|2720
168838|NCT00523614|414124|P1|STARTED|Overall Study|"As this is a case-control study the categories started and completed are not really applicable."|680
168839|NCT00523640|414130|P1|NOT COMPLETED|Overall Study||1
168840|NCT00523640|414130|P1|COMPLETED|Overall Study|1 patient died before starting treatment|29
168841|NCT00523640|414130|P1|STARTED|Overall Study||30
168842|NCT00523705|414138|P2|NOT COMPLETED|Overall Study||1
168843|NCT00523705|414139|P1|NOT COMPLETED|Overall Study||0
168844|NCT00523705|414138|P2|COMPLETED|Overall Study|1 withdrew due to no time|3
168845|NCT00523705|414139|P1|COMPLETED|Overall Study||7
168846|NCT00523705|414138|P2|STARTED|Overall Study||4
168847|NCT00523705|414139|P1|STARTED|Overall Study||7
168848|NCT00523718|414153|P2|NOT COMPLETED|Overall Study||0
168849|NCT00523718|414154|P1|NOT COMPLETED|Overall Study||3
168850|NCT00523718|414153|P2|COMPLETED|Overall Study||18
168851|NCT00523718|414154|P1|COMPLETED|Overall Study||17
168852|NCT00523718|414153|P2|STARTED|Overall Study||18
168853|NCT00523718|414154|P1|STARTED|Overall Study||20
168854|NCT00523744|414166|P1|NOT COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||0
168855|NCT00523744|414166|P1|COMPLETED|Phase 3 - Amlodipine+Valsartan+HCTZ||91
168856|NCT00523744|414166|P1|STARTED|Phase 3 - Amlodipine+Valsartan+HCTZ|Only patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg at the end of Phase 2.|91
168857|NCT00523744|414166|P1|NOT COMPLETED|Phase 2 - Amlodipine+Valsartan||3
168858|NCT00523744|414166|P1|COMPLETED|Phase 2 - Amlodipine+Valsartan||173
168859|NCT00523744|414166|P1|STARTED|Phase 2 - Amlodipine+Valsartan|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|176
168860|NCT00523744|414166|P1|NOT COMPLETED|Phase 1 - Amlodipine+Olmesartan||6
168861|NCT00523744|414166|P1|COMPLETED|Phase 1 - Amlodipine+Olmesartan||251
168862|NCT00523744|414166|P1|STARTED|Phase 1 - Amlodipine+Olmesartan||257
168863|NCT00523809|414183|P1|NOT COMPLETED|Overall Study||0
168864|NCT00523809|414183|P1|COMPLETED|Overall Study||5
168865|NCT00523809|414183|P1|STARTED|Overall Study||5
168866|NCT00523848|414187|P1|NOT COMPLETED|Overall Study||24
168867|NCT00523848|414187|P1|COMPLETED|Overall Study||22
168868|NCT00523848|414187|P1|Treated With Study Therapy|Overall Study||44
168869|NCT00523848|414187|P1|STARTED|Overall Study||46
168870|NCT00523939|414195|P2|NOT COMPLETED|Overall Study||0
168871|NCT00523939|414196|P1|NOT COMPLETED|Overall Study||0
168872|NCT00523939|414195|P2|COMPLETED|Overall Study||2
168873|NCT00523939|414196|P1|COMPLETED|Overall Study||2
168874|NCT00523939|414195|P2|STARTED|Overall Study||2
168875|NCT00523939|414196|P1|STARTED|Overall Study||2
168876|NCT00523978|414205|P2|NOT COMPLETED|Overall Study||8
168877|NCT00523978|414206|P1|NOT COMPLETED|Overall Study||9
168878|NCT00523978|414205|P2|COMPLETED|Overall Study||79
168879|NCT00523978|414206|P1|COMPLETED|Overall Study||162
168880|NCT00523978|414205|P2|STARTED|Overall Study||87
168881|NCT00523978|414206|P1|STARTED|Overall Study||171
168882|NCT00523991|414220|P2|NOT COMPLETED|Overall Study||27
168883|NCT00523991|414221|P1|NOT COMPLETED|Overall Study||21
168884|NCT00523991|414220|P2|COMPLETED|Overall Study||211
168885|NCT00523991|414221|P1|COMPLETED|Overall Study||198
168886|NCT00523991|414220|P2|STARTED|Overall Study||238
168887|NCT00523991|414221|P1|STARTED|Overall Study||219
168888|NCT00524030|414501|P2|NOT COMPLETED|Overall Study||59
168889|NCT00524030|414502|P1|NOT COMPLETED|Overall Study||17
168890|NCT00524030|414501|P2|COMPLETED|Overall Study||70
168891|NCT00524030|414502|P1|COMPLETED|Overall Study||15
168892|NCT00524030|414501|P2|Completed Taper/Titration Phase|Overall Study||70
168893|NCT00524030|414502|P1|Completed Taper/Titration Phase|Overall Study||15
168894|NCT00524030|414501|P2|Completed Double-Blind Treatment Phase|Overall Study||70
168895|NCT00524030|414502|P1|Completed Double-Blind Treatment Phase|Overall Study||15
168896|NCT00524030|414501|P2|STARTED|Overall Study||129
168897|NCT00524030|414502|P1|STARTED|Overall Study||32
168898|NCT00524043|414521|P3|NOT COMPLETED|Overall Study||31
168899|NCT00524043|414522|P2|NOT COMPLETED|Overall Study||28
168900|NCT00524043|414523|P1|NOT COMPLETED|Overall Study||30
168901|NCT00524043|414521|P3|COMPLETED|Overall Study||35
168902|NCT00524043|414522|P2|COMPLETED|Overall Study||42
168903|NCT00524043|414523|P1|COMPLETED|Overall Study||34
168904|NCT00524043|414521|P3|STARTED|Overall Study||66
168905|NCT00524043|414522|P2|STARTED|Overall Study||70
168906|NCT00524043|414523|P1|STARTED|Overall Study|One patient was randomly assigned to treatment but did not receive placebo.|64
168907|NCT00524121|414543|P1|NOT COMPLETED|Overall Study||19
168908|NCT00524121|414543|P1|COMPLETED|Overall Study||3
168909|NCT00524121|414543|P1|STARTED|Overall Study||22
168910|NCT00524134|414560|P1|NOT COMPLETED|Overall Study||2
168911|NCT00524134|414560|P1|COMPLETED|Overall Study||4
168912|NCT00524134|414560|P1|STARTED|Overall Study||6
168913|NCT00524225|414567|P1|NOT COMPLETED|Overall Study||0
168914|NCT00524225|414567|P1|COMPLETED|Overall Study||3
168915|NCT00524225|414567|P1|STARTED|Overall Study||3
168916|NCT00524264|414574|P2|NOT COMPLETED|Overall Study||27
168917|NCT00524264|414575|P1|NOT COMPLETED|Overall Study||20
168918|NCT00524264|414574|P2|COMPLETED|Overall Study||57
168919|NCT00524264|414575|P1|COMPLETED|Overall Study||144
168920|NCT00524264|414574|P2|STARTED|Overall Study||84
168921|NCT00524264|414575|P1|STARTED|Overall Study||164
168922|NCT00524303|414590|P3|NOT COMPLETED|Overall Study||18
168923|NCT00524303|414591|P2|NOT COMPLETED|Overall Study||10
168925|NCT00524303|414590|P3|COMPLETED|Overall Study||15
168926|NCT00524303|414591|P2|COMPLETED|Overall Study||24
168927|NCT00524303|414592|P1|COMPLETED|Overall Study||21
168928|NCT00524303|414590|P3|STARTED|Overall Study||33
168929|NCT00524303|414591|P2|STARTED|Overall Study||34
168930|NCT00524303|414592|P1|STARTED|Overall Study||33
168931|NCT00524316|414620|P1|NOT COMPLETED|Overall Study||16
168932|NCT00524316|414620|P1|COMPLETED|Overall Study||0
168933|NCT00524316|414620|P1|STARTED|Overall Study||16
168934|NCT00524342|414629|P1|NOT COMPLETED|Overall Study||0
168935|NCT00524342|414629|P1|COMPLETED|Overall Study||7
168936|NCT00524342|414629|P1|STARTED|Overall Study||7
168937|NCT00524368|414636|P2|NOT COMPLETED|Overall Study||48
168938|NCT00524368|414637|P1|NOT COMPLETED|Overall Study||41
168939|NCT00524368|414636|P2|COMPLETED|Overall Study||248
168940|NCT00524368|414637|P1|COMPLETED|Overall Study||253
168941|NCT00524368|414636|P2|STARTED|Overall Study||296
168942|NCT00524368|414637|P1|STARTED|Overall Study||294
168943|NCT00524394|414665|P1|NOT COMPLETED|Overall Study||1
168944|NCT00524394|414665|P1|COMPLETED|Overall Study||1
168945|NCT00524394|414665|P1|STARTED|Overall Study||2
168946|NCT00524420|414671|P2|NOT COMPLETED|Overall Study||0
168947|NCT00524420|414672|P1|NOT COMPLETED|Overall Study||1
168948|NCT00524420|414671|P2|COMPLETED|Overall Study||11
168949|NCT00524420|414672|P1|COMPLETED|Overall Study|1 dropped out after treatment 10 because of poor response and was included in the efficacy analyses.|7
168950|NCT00524420|414671|P2|STARTED|Overall Study||11
168951|NCT00524420|414672|P1|STARTED|Overall Study|One was incorrectly randomized;she did not have a BIRS of >7. Was excluded from efficacy analysis.|8
168952|NCT00524459|414684|P1|NOT COMPLETED|Overall Study||2
168953|NCT00524459|414684|P1|COMPLETED|Overall Study||4
168954|NCT00524459|414684|P1|STARTED|Overall Study||6
168955|NCT00524485|414692|P1|NOT COMPLETED|Overall Study||5
168956|NCT00524485|414692|P1|COMPLETED|Overall Study||7
168957|NCT00524485|414692|P1|STARTED|Overall Study||12
168958|NCT00524511|414704|P2|NOT COMPLETED|Overall Study||7
168959|NCT00524511|414705|P1|NOT COMPLETED|Overall Study||4
168960|NCT00524511|414704|P2|COMPLETED|Overall Study||61
168961|NCT00524511|414705|P1|COMPLETED|Overall Study||64
168962|NCT00524511|414704|P2|STARTED|Overall Study||68
168963|NCT00524511|414705|P1|STARTED|Overall Study||68
168964|NCT00524537|414713|P1|NOT COMPLETED|Overall Study||2574
168965|NCT00524537|414713|P1|COMPLETED|Overall Study|Still enrolled in study at the end of study|2451
168966|NCT00524537|414713|P1|Discontinued After Re-enrollment|Overall Study|Discontinued from study after re-enrollment|102
168967|NCT00524537|414713|P1|Re-enrolled|Overall Study|Discontinued from study and later re-enrolled in study|339
168968|NCT00524537|414713|P1|Discontinued|Overall Study|Discontinued from study|2811
168969|NCT00524537|414713|P1|STARTED|Overall Study|All Treated Population: All participants who received at least 1 injection of Humira in the registry|5025
168970|NCT00524576|414729|P2|NOT COMPLETED|Overall Study||0
168971|NCT00524576|414730|P1|NOT COMPLETED|Overall Study||0
168972|NCT00524576|414729|P2|COMPLETED|Overall Study||47
168973|NCT00524576|414730|P1|COMPLETED|Overall Study||97
168974|NCT00524576|414729|P2|STARTED|Overall Study||47
168975|NCT00524576|414730|P1|STARTED|Overall Study||97
168976|NCT00524589|414748|P1|NOT COMPLETED|Overall Study||18
168977|NCT00524589|414748|P1|COMPLETED|Overall Study||0
168978|NCT00524589|414748|P1|STARTED|Overall Study||18
168979|NCT00524680|414756|P4|NOT COMPLETED|Overall Study||6
168980|NCT00524680|414757|P3|NOT COMPLETED|Overall Study||3
168981|NCT00524680|414758|P2|NOT COMPLETED|Overall Study||1
168982|NCT00524680|414759|P1|NOT COMPLETED|Overall Study||3
168983|NCT00524680|414756|P4|COMPLETED|Overall Study||34
168984|NCT00524680|414757|P3|COMPLETED|Overall Study||33
168985|NCT00524680|414758|P2|COMPLETED|Overall Study||34
168986|NCT00524680|414759|P1|COMPLETED|Overall Study||34
168987|NCT00524680|414756|P4|STARTED|Overall Study||40
168988|NCT00524680|414757|P3|STARTED|Overall Study||36
168989|NCT00524680|414758|P2|STARTED|Overall Study||35
168990|NCT00524680|414759|P1|STARTED|Overall Study||37
168991|NCT00524745|414785|P4|NOT COMPLETED|Overall Study||22
168992|NCT00524745|414786|P3|NOT COMPLETED|Overall Study||29
168993|NCT00524745|414787|P2|NOT COMPLETED|Overall Study||13
168994|NCT00524745|414788|P1|NOT COMPLETED|Overall Study||34
168995|NCT00524745|414785|P4|COMPLETED|Overall Study||205
168996|NCT00524745|414786|P3|COMPLETED|Overall Study||212
168997|NCT00524745|414787|P2|COMPLETED|Overall Study||193
168998|NCT00524745|414788|P1|COMPLETED|Overall Study||195
168999|NCT00524745|414785|P4|STARTED|Overall Study||227
169000|NCT00524745|414786|P3|STARTED|Overall Study||241
169001|NCT00524745|414787|P2|STARTED|Overall Study||206
169002|NCT00524745|414788|P1|STARTED|Overall Study||229
169003|NCT00524771|414812|P2|NOT COMPLETED|Overall Study||585
169004|NCT00524771|414813|P1|NOT COMPLETED|Overall Study||220
169005|NCT00524771|414812|P2|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16431
169006|NCT00524771|414813|P1|COMPLETED|Overall Study|Numbers completed refer to first follow-up. Individual follow-up ranged between 0.5 and 4.0 years.|16864
169007|NCT00524771|414812|P2|STARTED|Overall Study||17016
169008|NCT00524771|414813|P1|STARTED|Overall Study||17084
169009|NCT00524940|414823|P1|NOT COMPLETED|Overall Study||0
169010|NCT00524940|414823|P1|COMPLETED|Overall Study||124
169011|NCT00524940|414823|P1|STARTED|Overall Study||124
169012|NCT00516737|414830|P2|NOT COMPLETED|Overall Study||8
169013|NCT00516737|414831|P1|NOT COMPLETED|Overall Study||11
169014|NCT00516737|414830|P2|COMPLETED|Overall Study||96
169015|NCT00516737|414831|P1|COMPLETED|Overall Study||92
169016|NCT00516737|414830|P2|STARTED|Overall Study||104
169017|NCT00516737|414831|P1|STARTED|Overall Study||103
169018|NCT00516893|414849|P1|NOT COMPLETED|Overall Study||21
169019|NCT00516893|414849|P1|COMPLETED|Overall Study||92
169020|NCT00516893|414849|P1|Received Study Treatment|Overall Study||112
169021|NCT00516893|414849|P1|STARTED|Overall Study||113
169022|NCT00516906|414858|P2|NOT COMPLETED|Overall Study||2
169023|NCT00516906|414859|P1|NOT COMPLETED|Overall Study||6
169024|NCT00516906|414858|P2|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
169025|NCT00516906|414859|P1|COMPLETED|Overall Study|Thirty patients were required to complete. Patients not completing were replaced.|30
169026|NCT00516906|414858|P2|STARTED|Overall Study|33 patients were randomized but one patient was discharged prior to treatment.|32
169027|NCT00516906|414859|P1|STARTED|Overall Study||36
169028|NCT00516919|414869|P2|NOT COMPLETED|Overall Study||7
169029|NCT00516919|414870|P1|NOT COMPLETED|Overall Study||10
169030|NCT00516919|414869|P2|COMPLETED|Overall Study||32
169031|NCT00516919|414870|P1|COMPLETED|Overall Study||30
169032|NCT00516919|414869|P2|STARTED|Overall Study||39
169033|NCT00516919|414870|P1|STARTED|Overall Study||40
169034|NCT00517010|414876|P1|NOT COMPLETED|Overall Study||1
169035|NCT00517010|414876|P1|COMPLETED|Overall Study||5
169036|NCT00517010|414876|P1|STARTED|Overall Study||6
169037|NCT00517075|414885|P4|NOT COMPLETED|Overall Study||0
169038|NCT00517075|414886|P3|NOT COMPLETED|Overall Study||0
169039|NCT00517075|414887|P2|NOT COMPLETED|Overall Study||0
169040|NCT00517075|414888|P1|NOT COMPLETED|Overall Study||0
169041|NCT00517075|414885|P4|COMPLETED|Overall Study||0
169042|NCT00517075|414886|P3|COMPLETED|Overall Study||0
169043|NCT00517075|414887|P2|COMPLETED|Overall Study||0
169044|NCT00517075|414888|P1|COMPLETED|Overall Study||0
169045|NCT00517075|414885|P4|STARTED|Overall Study||0
169046|NCT00517075|414886|P3|STARTED|Overall Study||0
169047|NCT00517075|414887|P2|STARTED|Overall Study||0
169048|NCT00517075|414888|P1|STARTED|Overall Study||0
169049|NCT00517192|414928|P2|NOT COMPLETED|Overall Study||20
169050|NCT00517192|414929|P1|NOT COMPLETED|Overall Study||19
169051|NCT00517192|414928|P2|COMPLETED|Overall Study||0
169052|NCT00517192|414929|P1|COMPLETED|Overall Study||0
169053|NCT00517192|414928|P2|STARTED|Overall Study||20
169054|NCT00517192|414929|P1|STARTED|Overall Study||19
169055|NCT00517296|414979|P2|NOT COMPLETED|Overall Study||0
169056|NCT00517296|414980|P1|NOT COMPLETED|Overall Study||1
169057|NCT00517296|414979|P2|COMPLETED|Overall Study||11
169058|NCT00517296|414980|P1|COMPLETED|Overall Study||9
169059|NCT00517296|414979|P2|STARTED|Overall Study||11
169060|NCT00517296|414980|P1|STARTED|Overall Study||10
169061|NCT00517361|414990|P1|NOT COMPLETED|Overall Study||11
169062|NCT00517361|414990|P1|COMPLETED|Overall Study|This study has been terminated due to poor accrual.|0
169063|NCT00517361|414990|P1|STARTED|Overall Study||11
169064|NCT00517413|414997|P1|NOT COMPLETED|Overall Study||61
169065|NCT00517413|414997|P1|COMPLETED|Overall Study||102
169066|NCT00517413|414997|P1|STARTED|Overall Study||163
169067|NCT00517530|415025|P7|NOT COMPLETED|Overall Study||19
169068|NCT00517530|415026|P6|NOT COMPLETED|Overall Study||19
169069|NCT00517530|415027|P5|NOT COMPLETED|Overall Study||20
169070|NCT00517530|415028|P4|NOT COMPLETED|Overall Study||21
169071|NCT00517530|415029|P3|NOT COMPLETED|Overall Study||18
169072|NCT00517530|415030|P2|NOT COMPLETED|Overall Study||13
169073|NCT00517530|415031|P1|NOT COMPLETED|Overall Study||19
169074|NCT00517530|415025|P7|COMPLETED|Overall Study||1
169075|NCT00517530|415026|P6|COMPLETED|Overall Study||0
169076|NCT00517530|415027|P5|COMPLETED|Overall Study||1
169077|NCT00517530|415028|P4|COMPLETED|Overall Study||1
169078|NCT00517530|415029|P3|COMPLETED|Overall Study||0
169079|NCT00517530|415030|P2|COMPLETED|Overall Study||0
169080|NCT00517530|415031|P1|COMPLETED|Overall Study||2
169081|NCT00517530|415025|P7|Retreated Population|Overall Study||0
169082|NCT00517530|415026|P6|Retreated Population|Overall Study||2
169083|NCT00517530|415027|P5|Retreated Population|Overall Study||2
169084|NCT00517530|415028|P4|Retreated Population|Overall Study||4
169085|NCT00517530|415029|P3|Retreated Population|Overall Study||1
169086|NCT00517530|415030|P2|Retreated Population|Overall Study||2
169087|NCT00517530|415031|P1|Retreated Population|Overall Study||2
169088|NCT00517530|415025|P7|Completed Follow-up|Overall Study||1
169089|NCT00517530|415026|P6|Completed Follow-up|Overall Study||0
169090|NCT00517530|415027|P5|Completed Follow-up|Overall Study||0
169091|NCT00517530|415028|P4|Completed Follow-up|Overall Study||1
169092|NCT00517530|415029|P3|Completed Follow-up|Overall Study||0
169093|NCT00517530|415030|P2|Completed Follow-up|Overall Study||0
169094|NCT00517530|415031|P1|Completed Follow-up|Overall Study||2
169095|NCT00517530|415025|P7|Started Follow-up|Overall Study||19
169096|NCT00517530|415026|P6|Started Follow-up|Overall Study||16
169097|NCT00517530|415027|P5|Started Follow-up|Overall Study||17
169098|NCT00517530|415028|P4|Started Follow-up|Overall Study||21
169099|NCT00517530|415029|P3|Started Follow-up|Overall Study||17
169100|NCT00517530|415030|P2|Started Follow-up|Overall Study||13
169101|NCT00517530|415031|P1|Started Follow-up|Overall Study||20
169102|NCT00517530|415025|P7|Completed Treatment|Overall Study||13
169103|NCT00517530|415026|P6|Completed Treatment|Overall Study||9
169104|NCT00517530|415027|P5|Completed Treatment|Overall Study||9
169105|NCT00517530|415028|P4|Completed Treatment|Overall Study||18
169106|NCT00517530|415029|P3|Completed Treatment|Overall Study||13
169107|NCT00517530|415030|P2|Completed Treatment|Overall Study||13
169108|NCT00517530|415031|P1|Completed Treatment|Overall Study||11
169109|NCT00517530|415025|P7|STARTED|Overall Study||20
169110|NCT00517530|415026|P6|STARTED|Overall Study||19
169111|NCT00517530|415027|P5|STARTED|Overall Study||21
169112|NCT00517530|415028|P4|STARTED|Overall Study||22
169113|NCT00517530|415029|P3|STARTED|Overall Study||18
169114|NCT00517530|415030|P2|STARTED|Overall Study||13
169115|NCT00517530|415031|P1|STARTED|Overall Study||21
169116|NCT00517556|415093|P2|NOT COMPLETED|Overall Study||5
169117|NCT00517556|415094|P1|NOT COMPLETED|Overall Study||4
169118|NCT00517556|415093|P2|COMPLETED|Overall Study||14
169119|NCT00517556|415094|P1|COMPLETED|Overall Study||15
169120|NCT00517556|415093|P2|STARTED|Overall Study||19
169121|NCT00517556|415094|P1|STARTED|Overall Study||19
169122|NCT00517595|415100|P1|NOT COMPLETED|Overall Study||0
169123|NCT00517595|415100|P1|COMPLETED|Overall Study||48
169124|NCT00517595|415100|P1|STARTED|Overall Study||48
169125|NCT00517634|415109|P6|NOT COMPLETED|Third Treatment Period||0
169126|NCT00517634|415110|P5|NOT COMPLETED|Third Treatment Period||0
169127|NCT00517634|415111|P4|NOT COMPLETED|Third Treatment Period||0
169128|NCT00517634|415112|P3|NOT COMPLETED|Third Treatment Period||0
169129|NCT00517634|415113|P2|NOT COMPLETED|Third Treatment Period||0
169130|NCT00517634|415114|P1|NOT COMPLETED|Third Treatment Period||0
169131|NCT00517634|415109|P6|COMPLETED|Third Treatment Period||4
169132|NCT00517634|415110|P5|COMPLETED|Third Treatment Period||3
169133|NCT00517634|415111|P4|COMPLETED|Third Treatment Period||3
169134|NCT00517634|415112|P3|COMPLETED|Third Treatment Period||4
169135|NCT00517634|415113|P2|COMPLETED|Third Treatment Period||4
169136|NCT00517634|415114|P1|COMPLETED|Third Treatment Period||4
169137|NCT00517634|415109|P6|STARTED|Third Treatment Period||4
169138|NCT00517634|415110|P5|STARTED|Third Treatment Period||3
169139|NCT00517634|415111|P4|STARTED|Third Treatment Period||3
169140|NCT00517634|415112|P3|STARTED|Third Treatment Period||4
169141|NCT00517634|415113|P2|STARTED|Third Treatment Period||4
169142|NCT00517634|415114|P1|STARTED|Third Treatment Period||4
169143|NCT00517634|415109|P6|NOT COMPLETED|Second Treatment Period||0
169144|NCT00517634|415110|P5|NOT COMPLETED|Second Treatment Period||1
169145|NCT00517634|415111|P4|NOT COMPLETED|Second Treatment Period||0
169146|NCT00517634|415112|P3|NOT COMPLETED|Second Treatment Period||0
169147|NCT00517634|415113|P2|NOT COMPLETED|Second Treatment Period||0
169148|NCT00517634|415114|P1|NOT COMPLETED|Second Treatment Period||0
169149|NCT00517634|415109|P6|COMPLETED|Second Treatment Period||4
169150|NCT00517634|415110|P5|COMPLETED|Second Treatment Period||3
169151|NCT00517634|415111|P4|COMPLETED|Second Treatment Period||3
169152|NCT00517634|415112|P3|COMPLETED|Second Treatment Period||4
169153|NCT00517634|415113|P2|COMPLETED|Second Treatment Period||4
169154|NCT00517634|415114|P1|COMPLETED|Second Treatment Period||4
169155|NCT00517634|415109|P6|STARTED|Second Treatment Period||4
169156|NCT00517634|415110|P5|STARTED|Second Treatment Period||4
169157|NCT00517634|415111|P4|STARTED|Second Treatment Period||3
169158|NCT00517634|415112|P3|STARTED|Second Treatment Period||4
169159|NCT00517634|415113|P2|STARTED|Second Treatment Period||4
169160|NCT00517634|415114|P1|STARTED|Second Treatment Period||4
169161|NCT00517634|415109|P6|NOT COMPLETED|First Treatment Period||0
169162|NCT00517634|415110|P5|NOT COMPLETED|First Treatment Period||0
169163|NCT00517634|415111|P4|NOT COMPLETED|First Treatment Period||0
169164|NCT00517634|415112|P3|NOT COMPLETED|First Treatment Period||0
169165|NCT00517634|415113|P2|NOT COMPLETED|First Treatment Period||0
169166|NCT00517634|415114|P1|NOT COMPLETED|First Treatment Period||0
169167|NCT00517634|415109|P6|COMPLETED|First Treatment Period||4
169168|NCT00517634|415110|P5|COMPLETED|First Treatment Period||4
169169|NCT00517634|415111|P4|COMPLETED|First Treatment Period||3
169170|NCT00517634|415112|P3|COMPLETED|First Treatment Period||4
169171|NCT00517634|415113|P2|COMPLETED|First Treatment Period||4
169172|NCT00517634|415114|P1|COMPLETED|First Treatment Period||4
169173|NCT00517634|415109|P6|STARTED|First Treatment Period||4
169174|NCT00517634|415110|P5|STARTED|First Treatment Period||4
169175|NCT00517634|415111|P4|STARTED|First Treatment Period||3
169176|NCT00517634|415112|P3|STARTED|First Treatment Period||4
169177|NCT00517634|415113|P2|STARTED|First Treatment Period||4
169178|NCT00517634|415114|P1|STARTED|First Treatment Period||4
169179|NCT00525031|415127|P2|NOT COMPLETED|Overall Study||1
169180|NCT00525031|415128|P1|NOT COMPLETED|Overall Study||1
169181|NCT00525031|415127|P2|COMPLETED|Overall Study||24
169182|NCT00525031|415128|P1|COMPLETED|Overall Study||26
169183|NCT00525031|415127|P2|STARTED|Overall Study||25
169184|NCT00525031|415128|P1|STARTED|Overall Study||27
169185|NCT00525135|415135|P1|NOT COMPLETED|Overall Study||0
169186|NCT00525135|415135|P1|COMPLETED|Overall Study||5
169187|NCT00525135|415135|P1|STARTED|Overall Study||5
169188|NCT00525148|415147|P4|NOT COMPLETED|Overall Study||61
169189|NCT00525148|415148|P3|NOT COMPLETED|Overall Study||7
169190|NCT00525148|415149|P2|NOT COMPLETED|Overall Study||38
169191|NCT00525148|415150|P1|NOT COMPLETED|Overall Study||23
169192|NCT00525148|415147|P4|COMPLETED|Overall Study||0
169193|NCT00525148|415148|P3|COMPLETED|Overall Study||0
169194|NCT00525148|415149|P2|COMPLETED|Overall Study||0
169195|NCT00525148|415150|P1|COMPLETED|Overall Study||0
169196|NCT00525148|415147|P4|STARTED|Overall Study|entered and treated|61
169197|NCT00525148|415148|P3|STARTED|Overall Study|entered and treated|7
169198|NCT00525148|415149|P2|STARTED|Overall Study|entered and treated|38
169199|NCT00525148|415150|P1|STARTED|Overall Study|entered and treated|23
169200|NCT00525161|415168|P1|NOT COMPLETED|Overall Study||1
169201|NCT00525161|415168|P1|COMPLETED|Overall Study||10
169202|NCT00525161|415168|P1|STARTED|Overall Study||11
169203|NCT00525174|415176|P2|NOT COMPLETED|Overall Study||8
169204|NCT00525174|415177|P1|NOT COMPLETED|Overall Study||9
169205|NCT00525174|415176|P2|COMPLETED|Overall Study||81
169206|NCT00525174|415177|P1|COMPLETED|Overall Study||88
169207|NCT00525174|415176|P2|STARTED|Overall Study||89
169208|NCT00525174|415177|P1|STARTED|Overall Study||97
169209|NCT00525265|415227|P2|NOT COMPLETED|Overall Study||0
169210|NCT00525265|415228|P1|NOT COMPLETED|Overall Study||1
169211|NCT00525265|415227|P2|COMPLETED|Overall Study||10
169212|NCT00525265|415228|P1|COMPLETED|Overall Study||9
169213|NCT00525265|415227|P2|STARTED|Overall Study||10
169214|NCT00525265|415228|P1|STARTED|Overall Study||10
169215|NCT00530023|415236|P2|NOT COMPLETED|Overall Study||1
169216|NCT00530023|415237|P1|NOT COMPLETED|Overall Study||0
169217|NCT00530023|415236|P2|COMPLETED|Overall Study||14
169218|NCT00530023|415237|P1|COMPLETED|Overall Study||14
169219|NCT00530023|415236|P2|STARTED|Overall Study||15
169220|NCT00530023|415237|P1|STARTED|Overall Study||14
169221|NCT00530075|415251|P1|NOT COMPLETED|Overall Study||7
169222|NCT00530075|415251|P1|COMPLETED|Overall Study||38
169223|NCT00530075|415251|P1|STARTED|Overall Study||45
169224|NCT00530088|415262|P1|NOT COMPLETED|Overall Study||10
169225|NCT00530088|415262|P1|COMPLETED|Overall Study||20
169226|NCT00530088|415262|P1|STARTED|Overall Study||30
169227|NCT00530257|415267|P1|NOT COMPLETED|Overall Study||1
169228|NCT00530257|415267|P1|COMPLETED|Overall Study||30
169229|NCT00530257|415267|P1|STARTED|Overall Study||31
169230|NCT00530270|415297|P2|NOT COMPLETED|Overall Study||0
169231|NCT00530270|415298|P1|NOT COMPLETED|Overall Study||1
169232|NCT00530270|415297|P2|COMPLETED|Overall Study||6
169233|NCT00530270|415298|P1|COMPLETED|Overall Study||5
169234|NCT00530270|415297|P2|STARTED|Overall Study||6
169235|NCT00530270|415298|P1|STARTED|Overall Study||6
169236|NCT00530335|415312|P1|NOT COMPLETED|Overall Study||6
169237|NCT00530335|415312|P1|COMPLETED|Overall Study||39
169238|NCT00530335|415312|P1|STARTED|Overall Study||45
169239|NCT00530348|415329|P2|NOT COMPLETED|Overall Study||19
169240|NCT00530348|415330|P1|NOT COMPLETED|Overall Study||22
169241|NCT00530348|415329|P2|COMPLETED|Overall Study||367
169242|NCT00530348|415330|P1|COMPLETED|Overall Study||173
169243|NCT00530348|415329|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|376
169244|NCT00530348|415330|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug.|187
169245|NCT00530348|415329|P2|STARTED|Overall Study|Randomized.|386
169246|NCT00530348|415330|P1|STARTED|Overall Study|Randomized.|195
169247|NCT00530439|415348|P2|NOT COMPLETED|Overall Study||26
169248|NCT00530439|415349|P1|NOT COMPLETED|Overall Study||30
169249|NCT00530439|415348|P2|COMPLETED|Overall Study||154
169250|NCT00530439|415349|P1|COMPLETED|Overall Study||150
169251|NCT00530439|415348|P2|STARTED|Overall Study||180
169252|NCT00530439|415349|P1|STARTED|Overall Study||180
169253|NCT00530504|415355|P1|NOT COMPLETED|Overall Study||152
169254|NCT00530504|415355|P1|COMPLETED|Overall Study||1348
169255|NCT00530504|415355|P1|STARTED|Overall Study||1500
169256|NCT00530634|415359|P1|NOT COMPLETED|Overall Study||0
169257|NCT00530634|415359|P1|COMPLETED|Overall Study||3
169258|NCT00530634|415359|P1|STARTED|Overall Study||3
169259|NCT00530712|415363|P1|NOT COMPLETED|12 Month Follow-up Visit||24
169260|NCT00530712|415363|P1|COMPLETED|12 Month Follow-up Visit|Subjects that Completed 12-Month Follow-up Visit|263
169261|NCT00530712|415363|P1|STARTED|12 Month Follow-up Visit|Subjects Expected for 12 Month Visit|287
169262|NCT00530712|415363|P1|NOT COMPLETED|6 Month Follow-up Visit||12
169263|NCT00530712|415363|P1|COMPLETED|6 Month Follow-up Visit|Subjects that Completed 6-Month Follow-up Visit|275
169264|NCT00530712|415363|P1|STARTED|6 Month Follow-up Visit|Subjects Expected for 6-Month Visit|287
169265|NCT00530712|415363|P1|NOT COMPLETED|30 Day Follow-up Visit||7
169266|NCT00530712|415363|P1|COMPLETED|30 Day Follow-up Visit|Subjects that Completed 30-Day Follow-up Visit|280
169267|NCT00530712|415363|P1|STARTED|30 Day Follow-up Visit|Subjects Expected for 30-Day Visit|287
169268|NCT00530712|415363|P1|NOT COMPLETED|Enrollment||0
169269|NCT00530712|415363|P1|COMPLETED|Enrollment|Subjects Available at Discharge|287
169270|NCT00530712|415363|P1|STARTED|Enrollment|Total Enrolled Subjects|287
169271|NCT00530764|415382|P4|NOT COMPLETED|Overall Study||25
169272|NCT00530764|415383|P3|NOT COMPLETED|Overall Study||20
169273|NCT00530764|415384|P2|NOT COMPLETED|Overall Study||21
169274|NCT00530764|415385|P1|NOT COMPLETED|Overall Study||31
169275|NCT00530764|415382|P4|COMPLETED|Overall Study||66
169276|NCT00530764|415383|P3|COMPLETED|Overall Study||71
169277|NCT00530764|415384|P2|COMPLETED|Overall Study||67
169278|NCT00530764|415385|P1|COMPLETED|Overall Study||59
169279|NCT00530764|415382|P4|STARTED|Overall Study||91
169280|NCT00530764|415383|P3|STARTED|Overall Study||91
169281|NCT00530764|415384|P2|STARTED|Overall Study||88
169282|NCT00530764|415385|P1|STARTED|Overall Study||90
169283|NCT00530777|415429|P2|NOT COMPLETED|Overall Study||5
169284|NCT00530777|415430|P1|NOT COMPLETED|Overall Study||7
169285|NCT00530777|415429|P2|COMPLETED|Overall Study||69
169286|NCT00530777|415430|P1|COMPLETED|Overall Study||67
169287|NCT00530777|415429|P2|STARTED|Overall Study||74
169288|NCT00530777|415430|P1|STARTED|Overall Study||74
169289|NCT00530790|415438|P1|NOT COMPLETED|Overall Study||5
169290|NCT00530790|415438|P1|COMPLETED|Overall Study||30
169291|NCT00530790|415438|P1|STARTED|Overall Study||35
169292|NCT00530816|415461|P3|NOT COMPLETED|Overall Study||41
169293|NCT00530816|415462|P2|NOT COMPLETED|Overall Study||42
169294|NCT00530816|415463|P1|NOT COMPLETED|Overall Study||26
169295|NCT00530816|415461|P3|COMPLETED|Overall Study||29
169296|NCT00530816|415462|P2|COMPLETED|Overall Study||17
169297|NCT00530816|415463|P1|COMPLETED|Overall Study||9
169298|NCT00530816|415461|P3|STARTED|Overall Study||70
169299|NCT00530816|415462|P2|STARTED|Overall Study||59
169300|NCT00530816|415463|P1|STARTED|Overall Study||35
169301|NCT00530842|415491|P2|NOT COMPLETED|Period 2||9
169302|NCT00530842|415492|P1|NOT COMPLETED|Period 2||8
169303|NCT00530842|415491|P2|COMPLETED|Period 2||151
169304|NCT00530842|415492|P1|COMPLETED|Period 2||149
169305|NCT00530842|415491|P2|STARTED|Period 2||160
169306|NCT00530842|415492|P1|STARTED|Period 2||157
169307|NCT00530842|415491|P2|NOT COMPLETED|Period 1||11
169308|NCT00530842|415492|P1|NOT COMPLETED|Period 1||14
169309|NCT00530842|415491|P2|COMPLETED|Period 1||161
169310|NCT00530842|415492|P1|COMPLETED|Period 1||158
169311|NCT00530842|415491|P2|STARTED|Period 1||172
169312|NCT00530842|415492|P1|STARTED|Period 1||172
169313|NCT00530842|415491|P2|NOT COMPLETED|Overall Study||21
169314|NCT00530842|415492|P1|NOT COMPLETED|Overall Study||23
169315|NCT00530842|415491|P2|COMPLETED|Overall Study||151
169316|NCT00530842|415492|P1|COMPLETED|Overall Study||149
169317|NCT00530842|415491|P2|STARTED|Overall Study||172
169318|NCT00530842|415492|P1|STARTED|Overall Study||172
169319|NCT00530855|415616|P1|NOT COMPLETED|Overall Study||112
169320|NCT00530855|415616|P1|COMPLETED|Overall Study||210
169321|NCT00530855|415616|P1|STARTED|Overall Study||322
169322|NCT00530894|415627|P4|NOT COMPLETED|Overall Study||94
169323|NCT00530894|415628|P3|NOT COMPLETED|Overall Study||55
169324|NCT00530894|415629|P2|NOT COMPLETED|Overall Study||115
169325|NCT00530894|415630|P1|NOT COMPLETED|Overall Study||88
169326|NCT00530894|415627|P4|COMPLETED|Overall Study||85
169327|NCT00530894|415628|P3|COMPLETED|Overall Study||124
169328|NCT00530894|415629|P2|COMPLETED|Overall Study||236
169329|NCT00530894|415630|P1|COMPLETED|Overall Study||260
169330|NCT00530894|415627|P4|STARTED|Overall Study||179
169331|NCT00530894|415628|P3|STARTED|Overall Study||179
169332|NCT00530894|415629|P2|STARTED|Overall Study||351
169333|NCT00530894|415630|P1|STARTED|Overall Study||348
169334|NCT00530920|415661|P3|NOT COMPLETED|Overall Study||4
169335|NCT00530920|415662|P2|NOT COMPLETED|Overall Study||2
169336|NCT00530920|415663|P1|NOT COMPLETED|Overall Study||0
169337|NCT00530920|415661|P3|COMPLETED|Overall Study||24
169338|NCT00530920|415662|P2|COMPLETED|Overall Study||25
169339|NCT00530920|415663|P1|COMPLETED|Overall Study||30
169340|NCT00530920|415661|P3|STARTED|Overall Study||28
169341|NCT00530920|415662|P2|STARTED|Overall Study||27
169342|NCT00530920|415663|P1|STARTED|Overall Study||30
169343|NCT00530946|415723|P4|NOT COMPLETED|Overall Study||2
169344|NCT00530946|415724|P3|NOT COMPLETED|Overall Study||1
169345|NCT00530946|415725|P2|NOT COMPLETED|Overall Study||2
169346|NCT00530946|415726|P1|NOT COMPLETED|Overall Study||2
169347|NCT00530946|415723|P4|COMPLETED|Overall Study||38
169348|NCT00530946|415724|P3|COMPLETED|Overall Study||40
169349|NCT00530946|415725|P2|COMPLETED|Overall Study||39
169350|NCT00530946|415726|P1|COMPLETED|Overall Study||41
169351|NCT00530946|415723|P4|STARTED|Overall Study||40
169352|NCT00530946|415724|P3|STARTED|Overall Study||41
169353|NCT00530946|415725|P2|STARTED|Overall Study||41
169354|NCT00530946|415726|P1|STARTED|Overall Study||43
169355|NCT00531011|415778|P2|NOT COMPLETED|Overall Study||7
169356|NCT00531011|415779|P1|NOT COMPLETED|Overall Study||4
169357|NCT00531011|415778|P2|COMPLETED|Overall Study||90
169358|NCT00531011|415779|P1|COMPLETED|Overall Study||99
169359|NCT00531011|415778|P2|STARTED|Overall Study||97
169360|NCT00531011|415779|P1|STARTED|Overall Study||103
169361|NCT00531050|415827|P6|NOT COMPLETED|Part 2: Period 3||1
169362|NCT00531050|415828|P5|NOT COMPLETED|Part 2: Period 3||0
169363|NCT00531050|415829|P4|NOT COMPLETED|Part 2: Period 3||0
169364|NCT00531050|415830|P3|NOT COMPLETED|Part 2: Period 3||0
169365|NCT00531050|415831|P2|NOT COMPLETED|Part 2: Period 3||0
169366|NCT00531050|415832|P1|NOT COMPLETED|Part 2: Period 3||1
169367|NCT00531050|415827|P6|COMPLETED|Part 2: Period 3||3
169368|NCT00531050|415828|P5|COMPLETED|Part 2: Period 3||4
169369|NCT00531050|415829|P4|COMPLETED|Part 2: Period 3||4
169370|NCT00531050|415830|P3|COMPLETED|Part 2: Period 3||4
169371|NCT00531050|415831|P2|COMPLETED|Part 2: Period 3||4
169372|NCT00531050|415832|P1|COMPLETED|Part 2: Period 3||2
169373|NCT00531050|415827|P6|STARTED|Part 2: Period 3||4
169374|NCT00531050|415828|P5|STARTED|Part 2: Period 3||4
169375|NCT00531050|415829|P4|STARTED|Part 2: Period 3||4
169376|NCT00531050|415830|P3|STARTED|Part 2: Period 3||4
169377|NCT00531050|415831|P2|STARTED|Part 2: Period 3||4
169378|NCT00531050|415832|P1|STARTED|Part 2: Period 3||3
169379|NCT00531050|415827|P6|NOT COMPLETED|Part 2: Period 2||0
169380|NCT00531050|415828|P5|NOT COMPLETED|Part 2: Period 2||0
169381|NCT00531050|415829|P4|NOT COMPLETED|Part 2: Period 2||0
169382|NCT00531050|415830|P3|NOT COMPLETED|Part 2: Period 2||0
169383|NCT00531050|415831|P2|NOT COMPLETED|Part 2: Period 2||0
169384|NCT00531050|415832|P1|NOT COMPLETED|Part 2: Period 2||0
169385|NCT00531050|415827|P6|COMPLETED|Part 2: Period 2||4
169386|NCT00531050|415828|P5|COMPLETED|Part 2: Period 2||4
169387|NCT00531050|415829|P4|COMPLETED|Part 2: Period 2||4
169388|NCT00531050|415830|P3|COMPLETED|Part 2: Period 2||4
169389|NCT00531050|415831|P2|COMPLETED|Part 2: Period 2||4
169390|NCT00531050|415832|P1|COMPLETED|Part 2: Period 2||3
169391|NCT00531050|415827|P6|STARTED|Part 2: Period 2||4
169392|NCT00531050|415828|P5|STARTED|Part 2: Period 2||4
169393|NCT00531050|415829|P4|STARTED|Part 2: Period 2||4
169394|NCT00531050|415830|P3|STARTED|Part 2: Period 2||4
169395|NCT00531050|415831|P2|STARTED|Part 2: Period 2||4
169396|NCT00531050|415832|P1|STARTED|Part 2: Period 2||3
169397|NCT00531050|415827|P6|NOT COMPLETED|Part 2: Period 1||1
169398|NCT00531050|415828|P5|NOT COMPLETED|Part 2: Period 1||0
169399|NCT00531050|415829|P4|NOT COMPLETED|Part 2: Period 1||0
169400|NCT00531050|415830|P3|NOT COMPLETED|Part 2: Period 1||0
169401|NCT00531050|415831|P2|NOT COMPLETED|Part 2: Period 1||0
169402|NCT00531050|415832|P1|NOT COMPLETED|Part 2: Period 1||0
169403|NCT00531050|415827|P6|COMPLETED|Part 2: Period 1||4
169404|NCT00531050|415828|P5|COMPLETED|Part 2: Period 1||4
169405|NCT00531050|415829|P4|COMPLETED|Part 2: Period 1||4
169406|NCT00531050|415830|P3|COMPLETED|Part 2: Period 1||4
169407|NCT00531050|415831|P2|COMPLETED|Part 2: Period 1||4
169408|NCT00531050|415832|P1|COMPLETED|Part 2: Period 1||3
169409|NCT00531050|415827|P6|STARTED|Part 2: Period 1||5
169410|NCT00531050|415828|P5|STARTED|Part 2: Period 1||4
169411|NCT00531050|415829|P4|STARTED|Part 2: Period 1||4
169412|NCT00531050|415830|P3|STARTED|Part 2: Period 1||4
169413|NCT00531050|415831|P2|STARTED|Part 2: Period 1||4
169414|NCT00531050|415832|P1|STARTED|Part 2: Period 1||3
169415|NCT00531050|415827|P6|NOT COMPLETED|Part 1: Period 3||0
169416|NCT00531050|415828|P5|NOT COMPLETED|Part 1: Period 3||0
169417|NCT00531050|415829|P4|NOT COMPLETED|Part 1: Period 3||0
169418|NCT00531050|415830|P3|NOT COMPLETED|Part 1: Period 3||0
169419|NCT00531050|415831|P2|NOT COMPLETED|Part 1: Period 3||0
169420|NCT00531050|415832|P1|NOT COMPLETED|Part 1: Period 3||1
169421|NCT00531050|415827|P6|COMPLETED|Part 1: Period 3||5
169422|NCT00531050|415828|P5|COMPLETED|Part 1: Period 3||4
169423|NCT00531050|415829|P4|COMPLETED|Part 1: Period 3||4
169424|NCT00531050|415830|P3|COMPLETED|Part 1: Period 3||4
169425|NCT00531050|415831|P2|COMPLETED|Part 1: Period 3||4
169426|NCT00531050|415832|P1|COMPLETED|Part 1: Period 3||3
169427|NCT00531050|415827|P6|STARTED|Part 1: Period 3||5
169428|NCT00531050|415828|P5|STARTED|Part 1: Period 3||4
169429|NCT00531050|415829|P4|STARTED|Part 1: Period 3||4
169430|NCT00531050|415830|P3|STARTED|Part 1: Period 3||4
169431|NCT00531050|415831|P2|STARTED|Part 1: Period 3||4
169432|NCT00531050|415832|P1|STARTED|Part 1: Period 3||4
169433|NCT00531050|415827|P6|NOT COMPLETED|Part 1: Period 2||0
169434|NCT00531050|415828|P5|NOT COMPLETED|Part 1: Period 2||0
169435|NCT00531050|415829|P4|NOT COMPLETED|Part 1: Period 2||0
169436|NCT00531050|415830|P3|NOT COMPLETED|Part 1: Period 2||0
169437|NCT00531050|415831|P2|NOT COMPLETED|Part 1: Period 2||0
169438|NCT00531050|415832|P1|NOT COMPLETED|Part 1: Period 2||0
169439|NCT00531050|415827|P6|COMPLETED|Part 1: Period 2||5
169440|NCT00531050|415828|P5|COMPLETED|Part 1: Period 2||4
169441|NCT00531050|415829|P4|COMPLETED|Part 1: Period 2||4
169442|NCT00531050|415830|P3|COMPLETED|Part 1: Period 2||4
169443|NCT00531050|415831|P2|COMPLETED|Part 1: Period 2||4
169444|NCT00531050|415832|P1|COMPLETED|Part 1: Period 2||4
169445|NCT00531050|415827|P6|STARTED|Part 1: Period 2||5
169446|NCT00531050|415828|P5|STARTED|Part 1: Period 2||4
169447|NCT00531050|415829|P4|STARTED|Part 1: Period 2||4
169448|NCT00531050|415830|P3|STARTED|Part 1: Period 2||4
169449|NCT00531050|415831|P2|STARTED|Part 1: Period 2||4
169450|NCT00531050|415832|P1|STARTED|Part 1: Period 2||4
169451|NCT00531050|415827|P6|NOT COMPLETED|Part 1: Period 1||0
169452|NCT00531050|415828|P5|NOT COMPLETED|Part 1: Period 1||0
169453|NCT00531050|415829|P4|NOT COMPLETED|Part 1: Period 1||1
169454|NCT00531050|415830|P3|NOT COMPLETED|Part 1: Period 1||0
169455|NCT00531050|415831|P2|NOT COMPLETED|Part 1: Period 1||1
169456|NCT00531050|415832|P1|NOT COMPLETED|Part 1: Period 1||0
169457|NCT00531050|415827|P6|COMPLETED|Part 1: Period 1||5
169458|NCT00531050|415828|P5|COMPLETED|Part 1: Period 1||4
169459|NCT00531050|415829|P4|COMPLETED|Part 1: Period 1||4
169460|NCT00531050|415830|P3|COMPLETED|Part 1: Period 1||4
169461|NCT00531050|415831|P2|COMPLETED|Part 1: Period 1||4
169462|NCT00531050|415832|P1|COMPLETED|Part 1: Period 1||4
169463|NCT00531050|415827|P6|STARTED|Part 1: Period 1||5
169464|NCT00531050|415828|P5|STARTED|Part 1: Period 1||4
169465|NCT00531050|415829|P4|STARTED|Part 1: Period 1||5
169466|NCT00531050|415830|P3|STARTED|Part 1: Period 1||4
169467|NCT00531050|415831|P2|STARTED|Part 1: Period 1||5
169468|NCT00531050|415832|P1|STARTED|Part 1: Period 1||4
169469|NCT00531206|415859|P1|NOT COMPLETED|Overall Study||20
169470|NCT00531206|415859|P1|COMPLETED|Overall Study||45
169471|NCT00531206|415859|P1|STARTED|Overall Study||65
169472|NCT00531284|415900|P17|NOT COMPLETED|Overall Study||8
169473|NCT00531284|415901|P16|NOT COMPLETED|Overall Study||12
169474|NCT00531284|415902|P15|NOT COMPLETED|Overall Study||4
169475|NCT00531284|415903|P14|NOT COMPLETED|Overall Study||3
169476|NCT00531284|415904|P13|NOT COMPLETED|Overall Study||2
169477|NCT00531284|415905|P12|NOT COMPLETED|Overall Study||24
169478|NCT00531284|415906|P11|NOT COMPLETED|Overall Study||3
169479|NCT00531284|415907|P10|NOT COMPLETED|Overall Study||4
169480|NCT00531284|415908|P9|NOT COMPLETED|Overall Study||11
169481|NCT00531284|415909|P8|NOT COMPLETED|Overall Study||10
169482|NCT00531284|415910|P7|NOT COMPLETED|Overall Study||6
169483|NCT00531284|415911|P6|NOT COMPLETED|Overall Study||7
169484|NCT00531284|415912|P5|NOT COMPLETED|Overall Study||6
169485|NCT00531284|415913|P4|NOT COMPLETED|Overall Study||63
169486|NCT00531284|415914|P3|NOT COMPLETED|Overall Study||6
169487|NCT00531284|415915|P2|NOT COMPLETED|Overall Study||4
169488|NCT00531284|415916|P1|NOT COMPLETED|Overall Study||3
169489|NCT00531284|415900|P17|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169490|NCT00531284|415901|P16|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|2
169491|NCT00531284|415902|P15|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|3
169492|NCT00531284|415903|P14|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169493|NCT00531284|415904|P13|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169494|NCT00531284|415905|P12|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169495|NCT00531284|415906|P11|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169496|NCT00531284|415907|P10|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169497|NCT00531284|415908|P9|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169498|NCT00531284|415909|P8|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169499|NCT00531284|415910|P7|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169500|NCT00531284|415911|P6|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169501|NCT00531284|415912|P5|COMPLETED|Overall Study|Indicates participants receiving treatment as of the data cut-off date of 07 October 2014|0
169502|NCT00531284|415913|P4|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|2
169503|NCT00531284|415914|P3|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|1
169504|NCT00531284|415915|P2|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
169505|NCT00531284|415916|P1|COMPLETED|Overall Study|Indicates participants who completed 12 cycles of study drug|0
169506|NCT00531284|415900|P17|STARTED|Overall Study||8
169507|NCT00531284|415901|P16|STARTED|Overall Study||14
169508|NCT00531284|415902|P15|STARTED|Overall Study||7
169509|NCT00531284|415903|P14|STARTED|Overall Study||3
169510|NCT00531284|415904|P13|STARTED|Overall Study||2
169511|NCT00531284|415905|P12|STARTED|Overall Study||24
169512|NCT00531284|415906|P11|STARTED|Overall Study||3
169513|NCT00531284|415907|P10|STARTED|Overall Study||4
169514|NCT00531284|415908|P9|STARTED|Overall Study||11
169515|NCT00531284|415909|P8|STARTED|Overall Study||10
169516|NCT00531284|415910|P7|STARTED|Overall Study||6
169517|NCT00531284|415911|P6|STARTED|Overall Study||7
169518|NCT00531284|415912|P5|STARTED|Overall Study||6
169519|NCT00531284|415913|P4|STARTED|Overall Study||65
169520|NCT00531284|415914|P3|STARTED|Overall Study||7
169521|NCT00531284|415915|P2|STARTED|Overall Study||4
169522|NCT00531284|415916|P1|STARTED|Overall Study||3
169523|NCT00531427|416068|P2|NOT COMPLETED|Overall Study||94
169524|NCT00531427|416069|P1|NOT COMPLETED|Overall Study||73
169525|NCT00531427|416068|P2|COMPLETED|Overall Study||191
169526|NCT00531427|416069|P1|COMPLETED|Overall Study||209
169527|NCT00531427|416068|P2|STARTED|Overall Study||285
169528|NCT00531427|416069|P1|STARTED|Overall Study||282
169529|NCT00531453|416082|P2|NOT COMPLETED|Overall Study||0
169530|NCT00531453|416083|P1|NOT COMPLETED|Overall Study||0
169531|NCT00531453|416082|P2|COMPLETED|Overall Study|10 April 2009|49
169532|NCT00531453|416083|P1|COMPLETED|Overall Study|10 April 2009|49
169533|NCT00531453|416082|P2|STARTED|Overall Study|02 October 2007|49
169534|NCT00531453|416083|P1|STARTED|Overall Study|02 October 2007|49
169535|NCT00531479|416093|P2|NOT COMPLETED|Overall Study||83
169536|NCT00531479|416094|P1|NOT COMPLETED|Overall Study||76
169537|NCT00531479|416093|P2|COMPLETED|Overall Study||146
169538|NCT00531479|416094|P1|COMPLETED|Overall Study||154
169539|NCT00531479|416093|P2|Treated|Overall Study||226
169540|NCT00531479|416094|P1|Treated|Overall Study||228
169541|NCT00531479|416093|P2|STARTED|Overall Study||229
169542|NCT00531479|416094|P1|STARTED|Overall Study||230
169543|NCT00531518|416114|P2|NOT COMPLETED|Overall Study||71
169544|NCT00531518|416115|P1|NOT COMPLETED|Overall Study||32
169545|NCT00531518|416114|P2|COMPLETED|Overall Study||134
169546|NCT00531518|416115|P1|COMPLETED|Overall Study||55
169547|NCT00531518|416114|P2|STARTED|Overall Study||205
169548|NCT00531518|416115|P1|STARTED|Overall Study||87
169549|NCT00531661|416123|P2|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||57
169550|NCT00531661|416124|P1|NOT COMPLETED|Study Duration: 15 Months Avg. Follow-up||58
169551|NCT00531661|416123|P2|COMPLETED|Study Duration: 15 Months Avg. Follow-up||197
169552|NCT00531661|416124|P1|COMPLETED|Study Duration: 15 Months Avg. Follow-up||186
169553|NCT00531661|416123|P2|STARTED|Study Duration: 15 Months Avg. Follow-up||254
169554|NCT00531661|416124|P1|STARTED|Study Duration: 15 Months Avg. Follow-up||244
169555|NCT00531661|416123|P2|NOT COMPLETED|6 Months||26
169556|NCT00531661|416124|P1|NOT COMPLETED|6 Months||26
169557|NCT00531661|416123|P2|COMPLETED|6 Months||254
169558|NCT00531661|416124|P1|COMPLETED|6 Months||244
169559|NCT00531661|416123|P2|STARTED|6 Months||280
169560|NCT00531661|416124|P1|STARTED|6 Months||270
169561|NCT00531752|416148|P4|NOT COMPLETED|Second Double-blind Intervention Period||2
169562|NCT00531752|416149|P3|NOT COMPLETED|Second Double-blind Intervention Period||0
169563|NCT00531752|416150|P2|NOT COMPLETED|Second Double-blind Intervention Period||2
169564|NCT00531752|416151|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
169565|NCT00531752|416148|P4|COMPLETED|Second Double-blind Intervention Period||11
169566|NCT00531752|416149|P3|COMPLETED|Second Double-blind Intervention Period||9
169567|NCT00531752|416150|P2|COMPLETED|Second Double-blind Intervention Period||11
169568|NCT00531752|416151|P1|COMPLETED|Second Double-blind Intervention Period||9
169569|NCT00531752|416148|P4|STARTED|Second Double-blind Intervention Period||13
169570|NCT00531752|416149|P3|STARTED|Second Double-blind Intervention Period||9
169571|NCT00531752|416150|P2|STARTED|Second Double-blind Intervention Period||13
169572|NCT00531752|416151|P1|STARTED|Second Double-blind Intervention Period||11
169573|NCT00531752|416148|P4|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
169574|NCT00531752|416149|P3|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
169575|NCT00531752|416150|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
169576|NCT00531752|416151|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
169577|NCT00531752|416148|P4|COMPLETED|Wash-out Period (at Least 7 Days)||13
169578|NCT00531752|416149|P3|COMPLETED|Wash-out Period (at Least 7 Days)||9
169579|NCT00531752|416150|P2|COMPLETED|Wash-out Period (at Least 7 Days)||13
169580|NCT00531752|416151|P1|COMPLETED|Wash-out Period (at Least 7 Days)||11
169581|NCT00531752|416148|P4|STARTED|Wash-out Period (at Least 7 Days)||13
169582|NCT00531752|416149|P3|STARTED|Wash-out Period (at Least 7 Days)||9
169583|NCT00531752|416150|P2|STARTED|Wash-out Period (at Least 7 Days)||13
169584|NCT00531752|416151|P1|STARTED|Wash-out Period (at Least 7 Days)||11
169585|NCT00531752|416148|P4|NOT COMPLETED|First Double-blind Intervention Period||3
169586|NCT00531752|416149|P3|NOT COMPLETED|First Double-blind Intervention Period||7
169587|NCT00531752|416150|P2|NOT COMPLETED|First Double-blind Intervention Period||4
169588|NCT00531752|416151|P1|NOT COMPLETED|First Double-blind Intervention Period||6
169589|NCT00531752|416148|P4|COMPLETED|First Double-blind Intervention Period||13
169590|NCT00531752|416149|P3|COMPLETED|First Double-blind Intervention Period||9
169591|NCT00531752|416150|P2|COMPLETED|First Double-blind Intervention Period||13
169592|NCT00531752|416151|P1|COMPLETED|First Double-blind Intervention Period||11
169593|NCT00531752|416148|P4|Treated|First Double-blind Intervention Period||16
169594|NCT00531752|416149|P3|Treated|First Double-blind Intervention Period||16
169595|NCT00531752|416150|P2|Treated|First Double-blind Intervention Period||17
169596|NCT00531752|416151|P1|Treated|First Double-blind Intervention Period||16
169597|NCT00531752|416148|P4|STARTED|First Double-blind Intervention Period||16
169598|NCT00531752|416149|P3|STARTED|First Double-blind Intervention Period||16
169599|NCT00531752|416150|P2|STARTED|First Double-blind Intervention Period||17
169600|NCT00531752|416151|P1|STARTED|First Double-blind Intervention Period||17
169601|NCT00531817|416230|P2|NOT COMPLETED|Entered Extended Treatment Period||57
169602|NCT00531817|416231|P1|NOT COMPLETED|Entered Extended Treatment Period||137
169603|NCT00531817|416230|P2|COMPLETED|Entered Extended Treatment Period||113
169604|NCT00531817|416231|P1|COMPLETED|Entered Extended Treatment Period||206
169605|NCT00531817|416230|P2|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|170
169606|NCT00531817|416231|P1|STARTED|Entered Extended Treatment Period|Eligible patients completing core study could participate in extension at investigator’s discretion.|343
169607|NCT00531817|416230|P2|NOT COMPLETED|Randomized||34
169608|NCT00531817|416231|P1|NOT COMPLETED|Randomized||59
169609|NCT00531817|416230|P2|COMPLETED|Randomized||173
169610|NCT00531817|416231|P1|COMPLETED|Randomized||353
169611|NCT00531817|416230|P2|Received Study Drug in Core Study|Randomized|2 patients did not receive any study medication. Intent-to-treat population = 205.|205
169612|NCT00531817|416231|P1|Received Study Drug in Core Study|Randomized|3 patients did not receive any study medication. Intent-to-treat population = 409.|409
169613|NCT00531817|416230|P2|STARTED|Randomized||207
169614|NCT00531817|416231|P1|STARTED|Randomized||412
169615|NCT00531843|416260|P2|NOT COMPLETED|Overall Study||0
169616|NCT00531843|416261|P1|NOT COMPLETED|Overall Study||0
169617|NCT00531843|416260|P2|COMPLETED|Overall Study||6
169618|NCT00531843|416261|P1|COMPLETED|Overall Study||81
169619|NCT00531843|416260|P2|STARTED|Overall Study||6
169620|NCT00531843|416261|P1|STARTED|Overall Study||81
169621|NCT00531882|416274|P3|NOT COMPLETED|Overall Study||0
169622|NCT00531882|416275|P2|NOT COMPLETED|Overall Study||0
169623|NCT00531882|416276|P1|NOT COMPLETED|Overall Study||0
169624|NCT00531882|416274|P3|COMPLETED|Overall Study||5
169625|NCT00531882|416275|P2|COMPLETED|Overall Study||10
169626|NCT00531882|416276|P1|COMPLETED|Overall Study||10
169627|NCT00531882|416274|P3|STARTED|Overall Study||5
169628|NCT00531882|416275|P2|STARTED|Overall Study||10
169629|NCT00531882|416276|P1|STARTED|Overall Study||10
169630|NCT00531934|416286|P2|NOT COMPLETED|Overall Study||63
169631|NCT00531934|416287|P1|NOT COMPLETED|Overall Study||66
169632|NCT00531934|416286|P2|COMPLETED|Overall Study||11
169633|NCT00531934|416287|P1|COMPLETED|Overall Study||7
169634|NCT00531934|416286|P2|STARTED|Overall Study||74
169635|NCT00531934|416287|P1|STARTED|Overall Study||73
169636|NCT00531947|416357|P2|NOT COMPLETED|Overall Study||51
169637|NCT00531947|416358|P1|NOT COMPLETED|Overall Study||42
169638|NCT00531947|416357|P2|COMPLETED|Overall Study||101
169639|NCT00531947|416358|P1|COMPLETED|Overall Study||114
169640|NCT00531947|416357|P2|STARTED|Overall Study|all randomized subjects who received at least one dose of EMSAM study medication|152
169641|NCT00531947|416358|P1|STARTED|Overall Study|all randomized subjects who received at least one dose of placebo study medication|156
169642|NCT00531960|416402|P2|NOT COMPLETED|Overall Study||63
169643|NCT00531960|416403|P1|NOT COMPLETED|Overall Study||61
169644|NCT00531960|416402|P2|COMPLETED|Overall Study||0
169645|NCT00531960|416403|P1|COMPLETED|Overall Study||0
169646|NCT00531960|416402|P2|STARTED|Overall Study||63
169647|NCT00531960|416403|P1|STARTED|Overall Study||61
169648|NCT00532129|416419|P1|NOT COMPLETED|Follow-up Period||65
169649|NCT00532129|416419|P1|COMPLETED|Follow-up Period||33
169650|NCT00532129|416419|P1|STARTED|Follow-up Period||98
169651|NCT00532129|416419|P1|NOT COMPLETED|Treatment Period||49
169652|NCT00532129|416419|P1|COMPLETED|Treatment Period||51
169653|NCT00532129|416419|P1|STARTED|Treatment Period||100
169654|NCT00532155|416439|P2|NOT COMPLETED|Overall Study||456
169655|NCT00532155|416440|P1|NOT COMPLETED|Overall Study||457
169656|NCT00532155|416439|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
169657|NCT00532155|416440|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria|0
169658|NCT00532155|416439|P2|SAFETY POPULATION|Overall Study||450
169659|NCT00532155|416440|P1|SAFETY POPULATION|Overall Study||455
169660|NCT00532155|416439|P2|STARTED|Overall Study||456
169661|NCT00532155|416440|P1|STARTED|Overall Study||457
169662|NCT00532259|416454|P1|NOT COMPLETED|Overall Study||32
169663|NCT00532259|416454|P1|COMPLETED|Overall Study||40
169664|NCT00532259|416454|P1|STARTED|Overall Study||72
169665|NCT00532298|416465|P6|NOT COMPLETED|Overall Study||2
169666|NCT00532298|416466|P5|NOT COMPLETED|Overall Study||1
169667|NCT00532298|416467|P4|NOT COMPLETED|Overall Study||0
169668|NCT00532298|416468|P3|NOT COMPLETED|Overall Study||1
169669|NCT00532298|416469|P2|NOT COMPLETED|Overall Study||1
169670|NCT00532298|416470|P1|NOT COMPLETED|Overall Study||2
169671|NCT00532298|416465|P6|COMPLETED|Overall Study||261
169672|NCT00532298|416466|P5|COMPLETED|Overall Study||267
169673|NCT00532298|416467|P4|COMPLETED|Overall Study||264
169674|NCT00532298|416468|P3|COMPLETED|Overall Study||263
169675|NCT00532298|416469|P2|COMPLETED|Overall Study||265
169676|NCT00532298|416470|P1|COMPLETED|Overall Study||267
169677|NCT00532298|416465|P6|STARTED|Overall Study||263
169678|NCT00532298|416466|P5|STARTED|Overall Study||268
169679|NCT00532298|416467|P4|STARTED|Overall Study||264
169680|NCT00532298|416468|P3|STARTED|Overall Study||264
169681|NCT00532298|416469|P2|STARTED|Overall Study||266
169682|NCT00532298|416470|P1|STARTED|Overall Study||269
169683|NCT00532441|416550|P2|NOT COMPLETED|Overall Study||0
169684|NCT00532441|416551|P1|NOT COMPLETED|Overall Study||1
169685|NCT00532441|416550|P2|COMPLETED|Overall Study||11
169686|NCT00532441|416551|P1|COMPLETED|Overall Study||13
169687|NCT00532441|416550|P2|STARTED|Overall Study||11
169688|NCT00532441|416551|P1|STARTED|Overall Study||14
169689|NCT00532480|416560|P1|NOT COMPLETED|Overall Study||3
169690|NCT00532480|416560|P1|COMPLETED|Overall Study||7
169691|NCT00532480|416560|P1|STARTED|Overall Study||10
169692|NCT00532493|416566|P2|NOT COMPLETED|Overall Study||29
169693|NCT00532493|416567|P1|NOT COMPLETED|Overall Study||30
169694|NCT00532493|416566|P2|COMPLETED|Overall Study||123
169695|NCT00532493|416567|P1|COMPLETED|Overall Study||122
169696|NCT00532493|416566|P2|STARTED|Overall Study||152
169697|NCT00532493|416567|P1|STARTED|Overall Study||152
169698|NCT00520546|416597|P1|NOT COMPLETED|Overall Study||6
169699|NCT00520546|416597|P1|COMPLETED|Overall Study||38
169700|NCT00520546|416597|P1|STARTED|Overall Study||44
169701|NCT00520572|416618|P6|NOT COMPLETED|Overall Study||2
169702|NCT00520572|416619|P5|NOT COMPLETED|Overall Study||12
169703|NCT00520572|416620|P4|NOT COMPLETED|Overall Study||14
169704|NCT00520572|416621|P3|NOT COMPLETED|Overall Study||15
169705|NCT00520572|416622|P2|NOT COMPLETED|Overall Study||14
169706|NCT00520572|416623|P1|NOT COMPLETED|Overall Study||12
169707|NCT00520572|416618|P6|COMPLETED|Overall Study|Participants completed the study.|62
169708|NCT00520572|416619|P5|COMPLETED|Overall Study|Participants completed the study.|53
169709|NCT00520572|416620|P4|COMPLETED|Overall Study|Participants completed the study.|50
169710|NCT00520572|416621|P3|COMPLETED|Overall Study|Participants completed the study.|49
169711|NCT00520572|416622|P2|COMPLETED|Overall Study|Participants completed the study.|50
169712|NCT00520572|416623|P1|COMPLETED|Overall Study|Participants completed the study.|52
169713|NCT00520572|416618|P6|STARTED|Overall Study|Participants randomised.|64
169714|NCT00520572|416619|P5|STARTED|Overall Study|Participants randomised.|65
169715|NCT00520572|416620|P4|STARTED|Overall Study|Participants randomised.|64
169716|NCT00520572|416621|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
169717|NCT00520572|416622|P2|STARTED|Overall Study|Participants randomised.|64
169718|NCT00520572|416623|P1|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|64
169719|NCT00520676|416663|P2|NOT COMPLETED|Overall Study||103
169720|NCT00520676|416664|P1|NOT COMPLETED|Overall Study||101
169721|NCT00520676|416663|P2|COMPLETED|Overall Study||29
169722|NCT00520676|416664|P1|COMPLETED|Overall Study||27
169723|NCT00520676|416663|P2|Qualified Intent-to-treat (Q-ITT)|Overall Study||105
169724|NCT00520676|416664|P1|Qualified Intent-to-treat (Q-ITT)|Overall Study||106
169725|NCT00520676|416663|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
169726|NCT00520676|416664|P1|Received at Least 1 Dose of Study Drug|Overall Study||118
169727|NCT00520676|416663|P2|STARTED|Overall Study||132
169728|NCT00520676|416664|P1|STARTED|Overall Study||128
169729|NCT00520741|416686|P2|NOT COMPLETED|Overall Study||125
169730|NCT00520741|416687|P1|NOT COMPLETED|Overall Study||37
169731|NCT00520741|416686|P2|COMPLETED|Overall Study||194
169732|NCT00520741|416687|P1|COMPLETED|Overall Study||69
169733|NCT00520741|416686|P2|STARTED|Overall Study|One subject was randomized at 2 sites and excluded from the Safety Set.|319
169734|NCT00520741|416687|P1|STARTED|Overall Study||106
169735|NCT00520767|416703|P1|NOT COMPLETED|Overall Study||2
169736|NCT00520767|416703|P1|COMPLETED|Overall Study||33
169737|NCT00520767|416703|P1|STARTED|Overall Study||35
169738|NCT00520845|416707|P1|NOT COMPLETED|Overall Study||22
169739|NCT00520845|416707|P1|COMPLETED|Overall Study||1
169740|NCT00520845|416707|P1|STARTED|Overall Study||23
169741|NCT00520936|416723|P8|NOT COMPLETED|Overall Study||1
169742|NCT00520936|416724|P7|NOT COMPLETED|Overall Study||4
169743|NCT00520936|416725|P6|NOT COMPLETED|Overall Study||0
169744|NCT00520936|416726|P5|NOT COMPLETED|Overall Study||1
169745|NCT00520936|416727|P4|NOT COMPLETED|Overall Study||0
169746|NCT00520936|416728|P3|NOT COMPLETED|Overall Study||2
169747|NCT00520936|416729|P2|NOT COMPLETED|Overall Study||4
169748|NCT00520936|416730|P1|NOT COMPLETED|Overall Study||0
169749|NCT00520936|416723|P8|COMPLETED|Overall Study||9
169750|NCT00520936|416724|P7|COMPLETED|Overall Study||7
169751|NCT00520936|416725|P6|COMPLETED|Overall Study||10
169752|NCT00520936|416726|P5|COMPLETED|Overall Study||5
169753|NCT00520936|416727|P4|COMPLETED|Overall Study||5
169754|NCT00520936|416728|P3|COMPLETED|Overall Study||7
169755|NCT00520936|416729|P2|COMPLETED|Overall Study||7
169756|NCT00520936|416730|P1|COMPLETED|Overall Study|Study completion defined as treated until disease progression. Completed=progressive disease.|10
169757|NCT00520936|416723|P8|STARTED|Overall Study||10
169758|NCT00520936|416724|P7|STARTED|Overall Study||11
169759|NCT00520936|416725|P6|STARTED|Overall Study||10
169760|NCT00520936|416726|P5|STARTED|Overall Study||6
169761|NCT00520936|416727|P4|STARTED|Overall Study||5
169762|NCT00520936|416728|P3|STARTED|Overall Study||9
169763|NCT00520936|416729|P2|STARTED|Overall Study||11
169764|NCT00520936|416730|P1|STARTED|Overall Study|75 participants entered the study and 72 were enrolled and received study drug.|10
169765|NCT00520975|416759|P2|NOT COMPLETED|Overall Study||48
169766|NCT00520975|416760|P1|NOT COMPLETED|Overall Study||48
169767|NCT00520975|416759|P2|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
169768|NCT00520975|416760|P1|COMPLETED|Overall Study|Treatment continued until progression or intolerable toxicity.|0
169769|NCT00520975|416759|P2|Treated and Reported Adverse Events Data|Overall Study||45
169770|NCT00520975|416760|P1|Treated and Reported Adverse Events Data|Overall Study||47
169771|NCT00520975|416759|P2|STARTED|Overall Study||48
169772|NCT00520975|416760|P1|STARTED|Overall Study||48
169773|NCT00521001|416784|P1|NOT COMPLETED|Overall Study||1
169774|NCT00521001|416784|P1|COMPLETED|Overall Study||48
169775|NCT00521001|416784|P1|STARTED|Overall Study||49
169776|NCT00521014|416791|P1|NOT COMPLETED|Overall Study||1
169777|NCT00521014|416791|P1|COMPLETED|Overall Study||13
169778|NCT00521014|416791|P1|STARTED|Overall Study||14
169779|NCT00521053|416795|P1|NOT COMPLETED|Observation Phase||68
169780|NCT00521053|416795|P1|COMPLETED|Observation Phase||12
169781|NCT00521053|416795|P1|STARTED|Observation Phase||80
169782|NCT00521053|416795|P1|NOT COMPLETED|Treatment Phase||0
169783|NCT00521053|416795|P1|COMPLETED|Treatment Phase||80
169784|NCT00521053|416795|P1|Received 4 Cycles of PV-10|Treatment Phase||3
169785|NCT00521053|416795|P1|Received 3 Cycles of PV-10|Treatment Phase||16
169786|NCT00521053|416795|P1|Received 2 Cycles of PV-10|Treatment Phase||26
169787|NCT00521053|416795|P1|Received 1 Cycle of PV-10|Treatment Phase||35
169788|NCT00521053|416795|P1|STARTED|Treatment Phase||80
169789|NCT00521079|416807|P2|NOT COMPLETED|Overall Study||5
169790|NCT00521079|416808|P1|NOT COMPLETED|Overall Study||14
169791|NCT00521079|416807|P2|COMPLETED|Overall Study||97
169792|NCT00521079|416808|P1|COMPLETED|Overall Study||178
169793|NCT00521079|416807|P2|Surgical Roll-In|Overall Study||5
169794|NCT00521079|416808|P1|Surgical Roll-In|Overall Study||9
169795|NCT00521079|416807|P2|STARTED|Overall Study||102
169796|NCT00521079|416808|P1|STARTED|Overall Study||192
169797|NCT00521144|416823|P5|NOT COMPLETED|Overall Study||7
169798|NCT00521144|416824|P4|NOT COMPLETED|Overall Study||1
169799|NCT00521144|416825|P3|NOT COMPLETED|Overall Study||2
169800|NCT00521144|416826|P2|NOT COMPLETED|Overall Study||3
169801|NCT00521144|416827|P1|NOT COMPLETED|Overall Study||4
169802|NCT00521144|416823|P5|COMPLETED|Overall Study||0
169803|NCT00521144|416824|P4|COMPLETED|Overall Study||0
169804|NCT00521144|416825|P3|COMPLETED|Overall Study||1
169805|NCT00521144|416826|P2|COMPLETED|Overall Study||2
169806|NCT00521144|416827|P1|COMPLETED|Overall Study||2
169807|NCT00521144|416823|P5|STARTED|Overall Study||7
169808|NCT00521144|416824|P4|STARTED|Overall Study||1
169809|NCT00521144|416825|P3|STARTED|Overall Study||3
169810|NCT00521144|416826|P2|STARTED|Overall Study||5
169811|NCT00521144|416827|P1|STARTED|Overall Study||6
169812|NCT00521339|416839|P3|NOT COMPLETED|Observational Follow Up Phase||0
169813|NCT00521339|416840|P2|NOT COMPLETED|Observational Follow Up Phase||0
169814|NCT00521339|416841|P1|NOT COMPLETED|Observational Follow Up Phase||0
169815|NCT00521339|416839|P3|COMPLETED|Observational Follow Up Phase||4
169816|NCT00521339|416840|P2|COMPLETED|Observational Follow Up Phase||4
169817|NCT00521339|416841|P1|COMPLETED|Observational Follow Up Phase||14
169818|NCT00521339|416839|P3|STARTED|Observational Follow Up Phase||4
169819|NCT00521339|416840|P2|STARTED|Observational Follow Up Phase||4
169820|NCT00521339|416841|P1|STARTED|Observational Follow Up Phase||14
169821|NCT00521339|416839|P3|NOT COMPLETED|Treatment Extension Phase||3
169822|NCT00521339|416840|P2|NOT COMPLETED|Treatment Extension Phase||0
169823|NCT00521339|416841|P1|NOT COMPLETED|Treatment Extension Phase||0
169824|NCT00521339|416839|P3|COMPLETED|Treatment Extension Phase||4
169825|NCT00521339|416840|P2|COMPLETED|Treatment Extension Phase||4
169826|NCT00521339|416841|P1|COMPLETED|Treatment Extension Phase||0
169827|NCT00521339|416839|P3|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|7
169828|NCT00521339|416840|P2|STARTED|Treatment Extension Phase|Some participants had completed the treatment phase prior to inception of extension phase|4
169829|NCT00521339|416841|P1|STARTED|Treatment Extension Phase||0
169830|NCT00521339|416839|P3|NOT COMPLETED|Treatment Phase||0
169831|NCT00521339|416840|P2|NOT COMPLETED|Treatment Phase||0
169832|NCT00521339|416841|P1|NOT COMPLETED|Treatment Phase||12
169833|NCT00521339|416839|P3|COMPLETED|Treatment Phase||0
169834|NCT00521339|416840|P2|COMPLETED|Treatment Phase||0
169835|NCT00521339|416841|P1|COMPLETED|Treatment Phase||19
169836|NCT00521339|416839|P3|Received Apremilast|Treatment Phase||0
169837|NCT00521339|416840|P2|Received Apremilast|Treatment Phase||0
169838|NCT00521339|416841|P1|Received Apremilast|Treatment Phase|1 participant withdrew consent prior to first visit and was excluded from safety population|30
169839|NCT00521339|416839|P3|STARTED|Treatment Phase||0
169840|NCT00521339|416840|P2|STARTED|Treatment Phase||0
169841|NCT00521339|416841|P1|STARTED|Treatment Phase||31
169842|NCT00521352|416906|P2|NOT COMPLETED|Overall Study||3
169843|NCT00521352|416907|P1|NOT COMPLETED|Overall Study||1
169844|NCT00521352|416906|P2|COMPLETED|Overall Study||10
169845|NCT00521352|416907|P1|COMPLETED|Overall Study||11
169846|NCT00521352|416906|P2|STARTED|Overall Study||13
169847|NCT00521352|416907|P1|STARTED|Overall Study||12
169848|NCT00521365|416917|P1|NOT COMPLETED|Overall Study||20
169849|NCT00521365|416917|P1|COMPLETED|Overall Study|68 participants completed the study and 68 completed without protocol deviations|68
169926|NCT00522041|417062|P1|COMPLETED|Overall Study||106
169850|NCT00521365|416917|P1|Safety Analysis Set|Overall Study|All participants who received study treatment|88
169851|NCT00521365|416917|P1|Per Protocol (PP) Population|Overall Study|All participants without protocol deviations|68
169852|NCT00521365|416917|P1|Modified Intention to Treat (mITT)|Overall Study|Participants who have an YMRS assessment at inclusion, and at least one assessment after inclusion|88
169853|NCT00521365|416917|P1|STARTED|Overall Study|98 participants were screened and obtain 88 patients who receive study treatment|88
169854|NCT00521456|416936|P2|NOT COMPLETED|Overall Study||28
169855|NCT00521456|416937|P1|NOT COMPLETED|Overall Study||13
169856|NCT00521456|416936|P2|COMPLETED|Overall Study||59
169857|NCT00521456|416937|P1|COMPLETED|Overall Study||163
169858|NCT00521456|416936|P2|STARTED|Overall Study||87
169859|NCT00521456|416937|P1|STARTED|Overall Study||176
169860|NCT00521586|416951|P2|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||12
169861|NCT00521586|416952|P1|NOT COMPLETED|Revaccination With 13vPnC (Year 5)||3
169862|NCT00521586|416951|P2|COMPLETED|Revaccination With 13vPnC (Year 5)||351
169863|NCT00521586|416952|P1|COMPLETED|Revaccination With 13vPnC (Year 5)||361
169864|NCT00521586|416951|P2|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||351
169865|NCT00521586|416952|P1|Completed 6 Month Follow-up|Revaccination With 13vPnC (Year 5)||361
169866|NCT00521586|416951|P2|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||359
169867|NCT00521586|416952|P1|Completed 1 Month Follow-up|Revaccination With 13vPnC (Year 5)||363
169868|NCT00521586|416951|P2|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||363
169869|NCT00521586|416952|P1|Vaccinated 13vPnC (Year 5)|Revaccination With 13vPnC (Year 5)||364
169870|NCT00521586|416951|P2|STARTED|Revaccination With 13vPnC (Year 5)||363
169871|NCT00521586|416952|P1|STARTED|Revaccination With 13vPnC (Year 5)||364
169872|NCT00521586|416951|P2|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||170
169873|NCT00521586|416952|P1|NOT COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||169
169874|NCT00521586|416951|P2|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||363
169875|NCT00521586|416952|P1|COMPLETED|Follow-up (From 6-month[Year 0]-Year 5)||364
169876|NCT00521586|416951|P2|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
169877|NCT00521586|416952|P1|STARTED|Follow-up (From 6-month[Year 0]-Year 5)||533
169878|NCT00521586|416951|P2|NOT COMPLETED|Initial Vaccination (Year 0)||29
169879|NCT00521586|416952|P1|NOT COMPLETED|Initial Vaccination (Year 0)||21
169880|NCT00521586|416951|P2|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
169881|NCT00521586|416952|P1|COMPLETED|Initial Vaccination (Year 0)|6 additional participants initially reported to have withdrawn, actually completed follow-up(Year 0)|533
169882|NCT00521586|416951|P2|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|529
169883|NCT00521586|416952|P1|Initially Reported to Complete Year 0|Initial Vaccination (Year 0)|Initially 1060 participants were reported to complete follow-up(Year 0),but 1066 actually completed.|531
169884|NCT00521586|416951|P2|Vaccinated Dose 2|Initial Vaccination (Year 0)||543
169885|NCT00521586|416952|P1|Vaccinated Dose 2|Initial Vaccination (Year 0)||538
169886|NCT00521586|416951|P2|Vaccinated Dose 1|Initial Vaccination (Year 0)||560
169887|NCT00521586|416952|P1|Vaccinated Dose 1|Initial Vaccination (Year 0)||551
169888|NCT00521586|416951|P2|STARTED|Initial Vaccination (Year 0)||562
169889|NCT00521586|416952|P1|STARTED|Initial Vaccination (Year 0)||554
169890|NCT00521599|417013|P3|NOT COMPLETED|Overall Study||36
169891|NCT00521599|417014|P2|NOT COMPLETED|Overall Study||29
169892|NCT00521599|417015|P1|NOT COMPLETED|Overall Study||25
169893|NCT00521599|417013|P3|COMPLETED|Overall Study||100
169894|NCT00521599|417014|P2|COMPLETED|Overall Study||239
169895|NCT00521599|417015|P1|COMPLETED|Overall Study||243
169896|NCT00521599|417013|P3|STARTED|Overall Study||136
169897|NCT00521599|417014|P2|STARTED|Overall Study||268
169898|NCT00521599|417015|P1|STARTED|Overall Study||268
169899|NCT00521924|417026|P2|NOT COMPLETED|Overall Study||4
169900|NCT00521924|417027|P1|NOT COMPLETED|Overall Study||4
169901|NCT00521924|417026|P2|COMPLETED|Overall Study|At Early Termination, 3 patients completed Week 6 and 1 completed Week 22.|0
169902|NCT00521924|417027|P1|COMPLETED|Overall Study|At Early Termination, 1 patient completed Week 2 and 2 patients completed Week 6.|0
169903|NCT00521924|417026|P2|STARTED|Overall Study|Subjects randomized|4
169904|NCT00521924|417027|P1|STARTED|Overall Study|Subjects randomized|4
169905|NCT00521976|417033|P1|NOT COMPLETED|Overall Study||0
169906|NCT00521976|417033|P1|COMPLETED|Overall Study||871
169907|NCT00521976|417033|P1|STARTED|Overall Study||871
169908|NCT00521989|417043|P5|NOT COMPLETED|Overall Study||23
169909|NCT00521989|417044|P4|NOT COMPLETED|Overall Study||12
169910|NCT00521989|417045|P3|NOT COMPLETED|Overall Study||16
169911|NCT00521989|417046|P2|NOT COMPLETED|Overall Study||17
169912|NCT00521989|417047|P1|NOT COMPLETED|Overall Study||20
169913|NCT00521989|417043|P5|COMPLETED|Overall Study||35
169914|NCT00521989|417044|P4|COMPLETED|Overall Study||42
169915|NCT00521989|417045|P3|COMPLETED|Overall Study||41
169916|NCT00521989|417046|P2|COMPLETED|Overall Study||37
169917|NCT00521989|417047|P1|COMPLETED|Overall Study||36
169918|NCT00521989|417043|P5|STARTED|Overall Study||58
169919|NCT00521989|417044|P4|STARTED|Overall Study||54
169920|NCT00521989|417045|P3|STARTED|Overall Study||57
169921|NCT00521989|417046|P2|STARTED|Overall Study||54
169922|NCT00521989|417047|P1|STARTED|Overall Study||56
169923|NCT00522041|417061|P2|NOT COMPLETED|Overall Study||12
169924|NCT00522041|417062|P1|NOT COMPLETED|Overall Study||17
169925|NCT00522041|417061|P2|COMPLETED|Overall Study||113
169927|NCT00522041|417061|P2|Received Treatment|Overall Study||124
169928|NCT00522041|417062|P1|Received Treatment|Overall Study||123
169929|NCT00522041|417061|P2|STARTED|Overall Study||125
169930|NCT00522041|417062|P1|STARTED|Overall Study||123
169931|NCT00522171|417074|P2|NOT COMPLETED|Overall Study||0
169932|NCT00522171|417075|P1|NOT COMPLETED|Overall Study||0
169933|NCT00522171|417074|P2|COMPLETED|Overall Study||15
169934|NCT00522171|417075|P1|COMPLETED|Overall Study||15
169935|NCT00522171|417074|P2|STARTED|Overall Study||15
169936|NCT00522171|417075|P1|STARTED|Overall Study||15
169937|NCT00522275|417083|P1|NOT COMPLETED|Overall Study||170
169938|NCT00522275|417083|P1|COMPLETED|Overall Study||138
169939|NCT00522275|417083|P1|STARTED|Overall Study||308
169940|NCT00522301|417091|P1|NOT COMPLETED|Overall Study||6
169941|NCT00522301|417091|P1|COMPLETED|Overall Study||0
169942|NCT00522301|417091|P1|STARTED|Overall Study||6
169943|NCT00522379|417100|P5|NOT COMPLETED|Overall Study||27
169944|NCT00522379|417101|P4|NOT COMPLETED|Overall Study||14
169945|NCT00522379|417102|P3|NOT COMPLETED|Overall Study||22
169946|NCT00522379|417103|P2|NOT COMPLETED|Overall Study||23
169947|NCT00522379|417104|P1|NOT COMPLETED|Overall Study||22
169948|NCT00522379|417100|P5|COMPLETED|Overall Study||81
169949|NCT00522379|417101|P4|COMPLETED|Overall Study||80
169950|NCT00522379|417102|P3|COMPLETED|Overall Study||82
169951|NCT00522379|417103|P2|COMPLETED|Overall Study||84
169952|NCT00522379|417104|P1|COMPLETED|Overall Study||79
169953|NCT00522379|417100|P5|STARTED|Overall Study||108
169954|NCT00522379|417101|P4|STARTED|Overall Study||94
169955|NCT00522379|417102|P3|STARTED|Overall Study||104
169956|NCT00522379|417103|P2|STARTED|Overall Study||107
169957|NCT00522379|417104|P1|STARTED|Overall Study||101
169958|NCT00522392|417208|P2|NOT COMPLETED|Overall Study||13
169959|NCT00522392|417209|P1|NOT COMPLETED|Overall Study||8
169960|NCT00522392|417208|P2|COMPLETED|Overall Study||12
169961|NCT00522392|417209|P1|COMPLETED|Overall Study||15
169962|NCT00522392|417208|P2|Pts w/ QOL Assessments Complete|Overall Study||8
169963|NCT00522392|417209|P1|Pts w/ QOL Assessments Complete|Overall Study||12
169964|NCT00522392|417208|P2|Pts w/ Measurable Disease at Baseline|Overall Study||16
169965|NCT00522392|417209|P1|Pts w/ Measurable Disease at Baseline|Overall Study||16
169966|NCT00522392|417208|P2|STARTED|Overall Study||25
169967|NCT00522392|417209|P1|STARTED|Overall Study||23
169968|NCT00522418|417223|P2|NOT COMPLETED|Overall Study||58
169969|NCT00522418|417224|P1|NOT COMPLETED|Overall Study||57
169970|NCT00522418|417223|P2|COMPLETED|Overall Study|Completed 2-year follow-up|5
169971|NCT00522418|417224|P1|COMPLETED|Overall Study|Completed 2-year follow-up|2
169972|NCT00522418|417223|P2|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|29
169973|NCT00522418|417224|P1|Baseline and Month 12|Overall Study|Completed Baseline and Month 12|31
169974|NCT00522418|417223|P2|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|35
169975|NCT00522418|417224|P1|Baseline and Month 9|Overall Study|Completed Baseline and Month 9|33
169976|NCT00522418|417223|P2|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|45
169977|NCT00522418|417224|P1|Baseline and Month 6|Overall Study|Completed Baseline and Month 6|38
169978|NCT00522418|417223|P2|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
169979|NCT00522418|417224|P1|Baseline and Month 3|Overall Study|Completed Baseline and Month 3|47
169980|NCT00522418|417223|P2|Efficacy Set|Overall Study|10 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
169981|NCT00522418|417224|P1|Efficacy Set|Overall Study|6 pts. data excluded: exited prior to collection of baseline data & one postbaseline followup QOLIE|48
169982|NCT00522418|417223|P2|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|58
169983|NCT00522418|417224|P1|Safety Set|Overall Study|Data of 5 randomized patients removed due to lack of ICF approval by site’s local ethics committee.|54
169984|NCT00522418|417223|P2|STARTED|Overall Study||63
169985|NCT00522418|417224|P1|STARTED|Overall Study||59
169986|NCT00522431|417270|P1|NOT COMPLETED|Overall Study||11
169987|NCT00522431|417270|P1|COMPLETED|Overall Study||138
169988|NCT00522431|417270|P1|STARTED|Overall Study||149
169989|NCT00532779|417278|P3|NOT COMPLETED|Overall Study||291
169990|NCT00532779|417279|P2|NOT COMPLETED|Overall Study||287
169991|NCT00532779|417280|P1|NOT COMPLETED|Overall Study||294
169992|NCT00532779|417278|P3|COMPLETED|Overall Study||290
169993|NCT00532779|417279|P2|COMPLETED|Overall Study||296
169994|NCT00532779|417280|P1|COMPLETED|Overall Study||284
169995|NCT00532779|417278|P3|STARTED|Overall Study||581
169996|NCT00532779|417279|P2|STARTED|Overall Study||583
169997|NCT00532779|417280|P1|STARTED|Overall Study||578
169998|NCT00536198|417341|P2|NOT COMPLETED|Overall Study||39
169999|NCT00536198|417342|P1|NOT COMPLETED|Overall Study||37
170000|NCT00536198|417341|P2|COMPLETED|Overall Study||88
170001|NCT00536198|417342|P1|COMPLETED|Overall Study||88
170002|NCT00536198|417341|P2|Cycle 6|Overall Study||88
170003|NCT00536198|417342|P1|Cycle 6|Overall Study||88
170004|NCT00536198|417341|P2|Cycle 5|Overall Study||85
170005|NCT00536198|417342|P1|Cycle 5|Overall Study||88
170006|NCT00536198|417341|P2|Cycle 4|Overall Study||98
170007|NCT00536198|417342|P1|Cycle 4|Overall Study||95
170008|NCT00536198|417341|P2|Cycle 3|Overall Study||101
170009|NCT00536198|417342|P1|Cycle 3|Overall Study||100
170010|NCT00536198|417341|P2|Cycle 2|Overall Study||112
170011|NCT00536198|417342|P1|Cycle 2|Overall Study||104
170012|NCT00536198|417341|P2|Cycle 1|Overall Study||123
170013|NCT00536198|417342|P1|Cycle 1|Overall Study||110
170014|NCT00536198|417341|P2|STARTED|Overall Study||127
170015|NCT00536198|417342|P1|STARTED|Overall Study||125
170016|NCT00536263|417373|P3|NOT COMPLETED|Overall Study||21
170017|NCT00536263|417374|P2|NOT COMPLETED|Overall Study||14
170018|NCT00536263|417375|P1|NOT COMPLETED|Overall Study||11
170019|NCT00536263|417373|P3|COMPLETED|Overall Study||204
170020|NCT00536263|417374|P2|COMPLETED|Overall Study||207
170021|NCT00536263|417375|P1|COMPLETED|Overall Study||214
170022|NCT00536263|417373|P3|STARTED|Overall Study|One (1) participant withdrawn from study for non-compliance.|225
170023|NCT00536263|417374|P2|STARTED|Overall Study||221
170024|NCT00536263|417375|P1|STARTED|Overall Study||225
170025|NCT00536341|417415|P2|NOT COMPLETED|Overall Study||11
170026|NCT00536341|417416|P1|NOT COMPLETED|Overall Study||5
170027|NCT00536341|417415|P2|COMPLETED|Overall Study||43
170028|NCT00536341|417416|P1|COMPLETED|Overall Study||5
170029|NCT00536341|417415|P2|STARTED|Overall Study||54
170030|NCT00536341|417416|P1|STARTED|Overall Study||10
170031|NCT00536380|417429|P3|NOT COMPLETED|Overall Study||10
170032|NCT00536380|417430|P2|NOT COMPLETED|Overall Study||9
170033|NCT00536380|417431|P1|NOT COMPLETED|Overall Study||12
170034|NCT00536380|417429|P3|COMPLETED|Overall Study||94
170035|NCT00536380|417430|P2|COMPLETED|Overall Study||95
170036|NCT00536380|417431|P1|COMPLETED|Overall Study||94
170037|NCT00536380|417429|P3|STARTED|Overall Study||104
170038|NCT00536380|417430|P2|STARTED|Overall Study||104
170039|NCT00536380|417431|P1|STARTED|Overall Study||106
170040|NCT00536471|417443|P4|NOT COMPLETED|Overall Study||74
170041|NCT00536471|417444|P3|NOT COMPLETED|Overall Study||139
170042|NCT00536471|417445|P2|NOT COMPLETED|Overall Study||84
170043|NCT00536471|417446|P1|NOT COMPLETED|Overall Study||156
170044|NCT00536471|417443|P4|COMPLETED|Overall Study||57
170045|NCT00536471|417444|P3|COMPLETED|Overall Study||122
170046|NCT00536471|417445|P2|COMPLETED|Overall Study||43
170047|NCT00536471|417446|P1|COMPLETED|Overall Study||101
170048|NCT00536471|417443|P4|STARTED|Overall Study||131
170049|NCT00536471|417444|P3|STARTED|Overall Study||261
170050|NCT00536471|417445|P2|STARTED|Overall Study||127
170051|NCT00536471|417446|P1|STARTED|Overall Study||257
170052|NCT00536484|417690|P2|NOT COMPLETED|Overall Study||56
170053|NCT00536484|417691|P1|NOT COMPLETED|Overall Study||60
170054|NCT00536484|417690|P2|COMPLETED|Overall Study|134 completed on 4mg dose and 248 on 8mg dose|382
170055|NCT00536484|417691|P1|COMPLETED|Overall Study|88 completed on matched 4mg dose and 297 on matched 8mg dose|385
170056|NCT00536484|417690|P2|STARTED|Overall Study|448 participants randomised; 10 not treated|438
170057|NCT00536484|417691|P1|STARTED|Overall Study|448 participants randomised; 3 not treated|445
170058|NCT00536510|417723|P2|NOT COMPLETED|Overall Study||29
170059|NCT00536510|417724|P1|NOT COMPLETED|Overall Study||82
170060|NCT00536510|417723|P2|COMPLETED|Overall Study||295
170061|NCT00536510|417724|P1|COMPLETED|Overall Study||240
170062|NCT00536510|417723|P2|STARTED|Overall Study||324
170063|NCT00536510|417724|P1|STARTED|Overall Study||322
170064|NCT00536575|417732|P1|NOT COMPLETED|Overall Study||2
170065|NCT00536575|417732|P1|COMPLETED|Overall Study||11
170066|NCT00536575|417732|P1|STARTED|Overall Study||13
170067|NCT00536731|417739|P3|NOT COMPLETED|Overall Study||5
170068|NCT00536731|417740|P2|NOT COMPLETED|Overall Study||5
170069|NCT00536731|417741|P1|NOT COMPLETED|Overall Study||4
170070|NCT00536731|417739|P3|COMPLETED|Overall Study||238
170071|NCT00536731|417740|P2|COMPLETED|Overall Study||241
170072|NCT00536731|417741|P1|COMPLETED|Overall Study||249
170073|NCT00536731|417739|P3|STARTED|Overall Study||243
170074|NCT00536731|417740|P2|STARTED|Overall Study||246
170075|NCT00536731|417741|P1|STARTED|Overall Study||253
170076|NCT00536744|417787|P2|NOT COMPLETED|Overall Study||28
170077|NCT00536744|417788|P1|NOT COMPLETED|Overall Study||29
170078|NCT00536744|417787|P2|COMPLETED|Overall Study||71
170079|NCT00536744|417788|P1|COMPLETED|Overall Study||78
170080|NCT00536744|417787|P2|STARTED|Overall Study||99
170081|NCT00536744|417788|P1|STARTED|Overall Study||107
170082|NCT00536809|417794|P1|NOT COMPLETED|Phase II||2
170083|NCT00536809|417794|P1|COMPLETED|Phase II||0
170084|NCT00536809|417794|P1|STARTED|Phase II||2
170085|NCT00536809|417794|P1|NOT COMPLETED|Phase I (Dose-finding Phase)||0
170086|NCT00536809|417794|P1|COMPLETED|Phase I (Dose-finding Phase)||10
170087|NCT00536809|417794|P1|STARTED|Phase I (Dose-finding Phase)||10
170088|NCT00536874|417815|P1|NOT COMPLETED|Overall Study||4
170089|NCT00536874|417815|P1|COMPLETED|Overall Study||35
170090|NCT00536874|417815|P1|STARTED|Overall Study||39
170091|NCT00536913|417827|P2|NOT COMPLETED|Overall Study||0
170092|NCT00536913|417828|P1|NOT COMPLETED|Overall Study||0
170093|NCT00536913|417827|P2|COMPLETED|Overall Study||52
170094|NCT00536913|417828|P1|COMPLETED|Overall Study||55
170095|NCT00536913|417827|P2|STARTED|Overall Study||52
170096|NCT00536913|417828|P1|STARTED|Overall Study||55
170097|NCT00536978|417850|P1|NOT COMPLETED|Overall Study||22
170098|NCT00536978|417850|P1|COMPLETED|Overall Study||0
170099|NCT00536978|417850|P1|STARTED|Overall Study||22
170100|NCT00536991|417854|P1|NOT COMPLETED|Overall Study||13
170101|NCT00536991|417854|P1|COMPLETED|Overall Study||38
170102|NCT00536991|417854|P1|STARTED|Overall Study||51
170103|NCT00537017|417861|P1|NOT COMPLETED|Follow-up Phase||9
170104|NCT00537017|417861|P1|COMPLETED|Follow-up Phase||126
170192|NCT00537316|417989|P4|COMPLETED|Part 1||0
170193|NCT00537316|417990|P3|COMPLETED|Part 1||63
170105|NCT00537017|417861|P1|STARTED|Follow-up Phase|All TP participants were eligible for FUP entry. 5 participants completing TP did not enter FUP.|135
170106|NCT00537017|417861|P1|NOT COMPLETED|Treatment Phase||34
170107|NCT00537017|417861|P1|COMPLETED|Treatment Phase||106
170108|NCT00537017|417861|P1|STARTED|Treatment Phase||140
170109|NCT00537030|417872|P1|NOT COMPLETED|Overall Study||16
170110|NCT00537030|417872|P1|COMPLETED|Overall Study||43
170111|NCT00537030|417872|P1|STARTED|Overall Study||59
170112|NCT00537056|417876|P1|NOT COMPLETED|12-month Follow-up||0
170113|NCT00537056|417876|P1|COMPLETED|12-month Follow-up||17
170114|NCT00537056|417876|P1|STARTED|12-month Follow-up||17
170115|NCT00537056|417876|P1|NOT COMPLETED|Interim PET/CT||5
170116|NCT00537056|417876|P1|COMPLETED|Interim PET/CT||12
170117|NCT00537056|417876|P1|STARTED|Interim PET/CT||17
170118|NCT00537056|417876|P1|NOT COMPLETED|Baseline PET/CT||0
170119|NCT00537056|417876|P1|COMPLETED|Baseline PET/CT||17
170120|NCT00537056|417876|P1|STARTED|Baseline PET/CT||17
170121|NCT00537082|417891|P3|NOT COMPLETED|Overall Study||6
170122|NCT00537082|417892|P2|NOT COMPLETED|Overall Study||9
170123|NCT00537082|417893|P1|NOT COMPLETED|Overall Study||9
170124|NCT00537082|417891|P3|COMPLETED|Overall Study||51
170125|NCT00537082|417892|P2|COMPLETED|Overall Study||48
170126|NCT00537082|417893|P1|COMPLETED|Overall Study||48
170127|NCT00537082|417891|P3|STARTED|Overall Study||57
170128|NCT00537082|417892|P2|STARTED|Overall Study||57
170129|NCT00537082|417893|P1|STARTED|Overall Study||57
170130|NCT00537095|417912|P2|NOT COMPLETED|Overall Study||57
170131|NCT00537095|417913|P1|NOT COMPLETED|Overall Study||51
170132|NCT00537095|417912|P2|COMPLETED|Overall Study||16
170133|NCT00537095|417913|P1|COMPLETED|Overall Study||21
170134|NCT00537095|417912|P2|STARTED|Overall Study||73
170135|NCT00537095|417913|P1|STARTED|Overall Study||72
170136|NCT00537199|417925|P1|NOT COMPLETED|Overall Study||1
170137|NCT00537199|417925|P1|COMPLETED|Overall Study||0
170138|NCT00537199|417925|P1|STARTED|Overall Study||1
170139|NCT00537238|417931|P2|NOT COMPLETED|Overall Study||173
170140|NCT00537238|417932|P1|NOT COMPLETED|Overall Study||174
170141|NCT00537238|417931|P2|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|82
170142|NCT00537238|417932|P1|COMPLETED|Overall Study|Completed designates participants who completed the opt blinded continuation phase.|80
170143|NCT00537238|417931|P2|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|195
170144|NCT00537238|417932|P1|Entered Opt Blinded Continuation Phase|Overall Study|Participants who had clinical benefit were eligible to progress into opt blinded continuation phase.|185
170235|NCT00537407|418098|P5|COMPLETED|Part 2 Weeks 5-48 or 72||3
170145|NCT00537238|417931|P2|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|210
170146|NCT00537238|417932|P1|Completed Maintenance Phase|Overall Study|Primary analysis drawn from the population in the maintenance phase.|208
170147|NCT00537238|417931|P2|Completed Titration Phase|Overall Study||236
170148|NCT00537238|417932|P1|Completed Titration Phase|Overall Study||226
170149|NCT00537238|417931|P2|STARTED|Overall Study||255
170150|NCT00537238|417932|P1|STARTED|Overall Study||254
170151|NCT00537277|417952|P1|NOT COMPLETED|Overall Study||49
170152|NCT00537277|417952|P1|COMPLETED|Overall Study||112
170153|NCT00537277|417952|P1|Exposed to Trial Drug|Overall Study|One subject not exposed to trial drug, and thus not included in full analysis set (FAS)|160
170154|NCT00537277|417952|P1|STARTED|Overall Study||161
170155|NCT00537303|417963|P2|NOT COMPLETED|Overall Study||25
170156|NCT00537303|417964|P1|NOT COMPLETED|Overall Study||26
170157|NCT00537303|417963|P2|COMPLETED|Overall Study||125
170158|NCT00537303|417964|P1|COMPLETED|Overall Study||120
170159|NCT00537303|417963|P2|STARTED|Overall Study||150
170160|NCT00537303|417964|P1|STARTED|Overall Study||146
170161|NCT00537316|417986|P7|NOT COMPLETED|Part 2||2
170162|NCT00537316|417987|P6|NOT COMPLETED|Part 2||4
170163|NCT00537316|417988|P5|NOT COMPLETED|Part 2||1
170164|NCT00537316|417989|P4|NOT COMPLETED|Part 2||3
170165|NCT00537316|417990|P3|NOT COMPLETED|Part 2||32
170166|NCT00537316|417991|P2|NOT COMPLETED|Part 2||9
170167|NCT00537316|417992|P1|NOT COMPLETED|Part 2||26
170168|NCT00537316|417986|P7|COMPLETED|Part 2||0
170169|NCT00537316|417987|P6|COMPLETED|Part 2||0
170170|NCT00537316|417988|P5|COMPLETED|Part 2||1
170171|NCT00537316|417989|P4|COMPLETED|Part 2||2
170172|NCT00537316|417990|P3|COMPLETED|Part 2||16
170173|NCT00537316|417991|P2|COMPLETED|Part 2||1
170174|NCT00537316|417992|P1|COMPLETED|Part 2||11
170175|NCT00537316|417986|P7|STARTED|Part 2||2
170176|NCT00537316|417987|P6|STARTED|Part 2||4
170177|NCT00537316|417988|P5|STARTED|Part 2||2
170178|NCT00537316|417989|P4|STARTED|Part 2||5
170179|NCT00537316|417990|P3|STARTED|Part 2||48
170180|NCT00537316|417991|P2|STARTED|Part 2||10
170181|NCT00537316|417992|P1|STARTED|Part 2||37
170182|NCT00537316|417986|P7|NOT COMPLETED|Part 1||0
170183|NCT00537316|417987|P6|NOT COMPLETED|Part 1||0
170184|NCT00537316|417988|P5|NOT COMPLETED|Part 1||0
170185|NCT00537316|417989|P4|NOT COMPLETED|Part 1||0
170186|NCT00537316|417990|P3|NOT COMPLETED|Part 1||17
170187|NCT00537316|417991|P2|NOT COMPLETED|Part 1||27
170188|NCT00537316|417992|P1|NOT COMPLETED|Part 1||14
170189|NCT00537316|417986|P7|COMPLETED|Part 1||0
170190|NCT00537316|417987|P6|COMPLETED|Part 1||0
170191|NCT00537316|417988|P5|COMPLETED|Part 1||0
170194|NCT00537316|417991|P2|COMPLETED|Part 1||53
170195|NCT00537316|417992|P1|COMPLETED|Part 1||65
170196|NCT00537316|417986|P7|STARTED|Part 1||0
170197|NCT00537316|417987|P6|STARTED|Part 1||0
170198|NCT00537316|417988|P5|STARTED|Part 1||0
170199|NCT00537316|417989|P4|STARTED|Part 1||0
170200|NCT00537316|417990|P3|STARTED|Part 1||80
170201|NCT00537316|417991|P2|STARTED|Part 1||80
170202|NCT00537316|417992|P1|STARTED|Part 1||79
170203|NCT00537329|418017|P1|NOT COMPLETED|Overall Study||26
170204|NCT00537329|418017|P1|COMPLETED|Overall Study||17
170205|NCT00537329|418017|P1|STARTED|Overall Study||43
170206|NCT00537381|418033|P2|NOT COMPLETED|Overall Study||62
170207|NCT00537381|418034|P1|NOT COMPLETED|Overall Study||56
170208|NCT00537381|418033|P2|COMPLETED|Overall Study||4
170209|NCT00537381|418034|P1|COMPLETED|Overall Study||9
170210|NCT00537381|418033|P2|STARTED|Overall Study||66
170211|NCT00537381|418034|P1|STARTED|Overall Study|11 Participants after disease progression switched to intetumumab alone (2) or D+P+ Intetumumab (9).|65
170212|NCT00537394|418057|P3|NOT COMPLETED|2nd Year of Follow-up||6
170213|NCT00537394|418058|P2|NOT COMPLETED|2nd Year of Follow-up||9
170214|NCT00537394|418059|P1|NOT COMPLETED|2nd Year of Follow-up||11
170215|NCT00537394|418057|P3|COMPLETED|2nd Year of Follow-up||44
170216|NCT00537394|418058|P2|COMPLETED|2nd Year of Follow-up||159
170217|NCT00537394|418059|P1|COMPLETED|2nd Year of Follow-up||158
170218|NCT00537394|418057|P3|STARTED|2nd Year of Follow-up||50
170219|NCT00537394|418058|P2|STARTED|2nd Year of Follow-up||168
170220|NCT00537394|418059|P1|STARTED|2nd Year of Follow-up||169
170221|NCT00537394|418057|P3|NOT COMPLETED|First Year of Follow-up||3
170222|NCT00537394|418058|P2|NOT COMPLETED|First Year of Follow-up||11
170223|NCT00537394|418059|P1|NOT COMPLETED|First Year of Follow-up||12
170224|NCT00537394|418057|P3|COMPLETED|First Year of Follow-up||50
170225|NCT00537394|418058|P2|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|168
170226|NCT00537394|418059|P1|COMPLETED|First Year of Follow-up|Completed refers to completing first 48 weeks of follow-up.|169
170227|NCT00537394|418057|P3|STARTED|First Year of Follow-up||53
170228|NCT00537394|418058|P2|STARTED|First Year of Follow-up||179
170229|NCT00537394|418059|P1|STARTED|First Year of Follow-up||181
170230|NCT00537407|418098|P5|NOT COMPLETED|Part 2 Weeks 5-48 or 72||7
170231|NCT00537407|418099|P4|NOT COMPLETED|Part 2 Weeks 5-48 or 72||6
170232|NCT00537407|418100|P3|NOT COMPLETED|Part 2 Weeks 5-48 or 72||9
170233|NCT00537407|418101|P2|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
170234|NCT00537407|418102|P1|NOT COMPLETED|Part 2 Weeks 5-48 or 72||8
170236|NCT00537407|418099|P4|COMPLETED|Part 2 Weeks 5-48 or 72||4
170237|NCT00537407|418100|P3|COMPLETED|Part 2 Weeks 5-48 or 72||2
170238|NCT00537407|418101|P2|COMPLETED|Part 2 Weeks 5-48 or 72||1
170239|NCT00537407|418102|P1|COMPLETED|Part 2 Weeks 5-48 or 72||2
170240|NCT00537407|418098|P5|STARTED|Part 2 Weeks 5-48 or 72||10
170241|NCT00537407|418099|P4|STARTED|Part 2 Weeks 5-48 or 72||10
170242|NCT00537407|418100|P3|STARTED|Part 2 Weeks 5-48 or 72||11
170243|NCT00537407|418101|P2|STARTED|Part 2 Weeks 5-48 or 72||9
170244|NCT00537407|418102|P1|STARTED|Part 2 Weeks 5-48 or 72||10
170245|NCT00537407|418098|P5|NOT COMPLETED|Part 1 Weeks 1-4||0
170246|NCT00537407|418099|P4|NOT COMPLETED|Part 1 Weeks 1-4||0
170247|NCT00537407|418100|P3|NOT COMPLETED|Part 1 Weeks 1-4||0
170248|NCT00537407|418101|P2|NOT COMPLETED|Part 1 Weeks 1-4||0
170249|NCT00537407|418102|P1|NOT COMPLETED|Part 1 Weeks 1-4||0
170250|NCT00537407|418098|P5|COMPLETED|Part 1 Weeks 1-4||10
170251|NCT00537407|418099|P4|COMPLETED|Part 1 Weeks 1-4||10
170252|NCT00537407|418100|P3|COMPLETED|Part 1 Weeks 1-4||11
170253|NCT00537407|418101|P2|COMPLETED|Part 1 Weeks 1-4||9
170254|NCT00537407|418102|P1|COMPLETED|Part 1 Weeks 1-4||10
170255|NCT00537407|418098|P5|STARTED|Part 1 Weeks 1-4||10
170256|NCT00537407|418099|P4|STARTED|Part 1 Weeks 1-4||10
170257|NCT00537407|418100|P3|STARTED|Part 1 Weeks 1-4||11
170258|NCT00537407|418101|P2|STARTED|Part 1 Weeks 1-4||9
170259|NCT00537407|418102|P1|STARTED|Part 1 Weeks 1-4||10
170260|NCT00537485|418141|P2|NOT COMPLETED|Overall Study||10
170261|NCT00537485|418142|P1|NOT COMPLETED|Overall Study||15
170262|NCT00537485|418141|P2|COMPLETED|Overall Study||80
170263|NCT00537485|418142|P1|COMPLETED|Overall Study||75
170264|NCT00537485|418141|P2|STARTED|Overall Study||90
170265|NCT00537485|418142|P1|STARTED|Overall Study||90
170266|NCT00537511|418166|P1|NOT COMPLETED|Maintenance Phase (Monotherapy)||8
170267|NCT00537511|418166|P1|COMPLETED|Maintenance Phase (Monotherapy)||0
170268|NCT00537511|418166|P1|STARTED|Maintenance Phase (Monotherapy)||8
170269|NCT00537511|418166|P1|NOT COMPLETED|Recovery Period (Monotherapy)||8
170270|NCT00537511|418166|P1|COMPLETED|Recovery Period (Monotherapy)||3
170271|NCT00537511|418166|P1|STARTED|Recovery Period (Monotherapy)||11
170272|NCT00537511|418166|P1|NOT COMPLETED|Extension Period (Combination)||6
170273|NCT00537511|418166|P1|COMPLETED|Extension Period (Combination)||11
170274|NCT00537511|418166|P1|STARTED|Extension Period (Combination)||17
170275|NCT00537511|418166|P1|NOT COMPLETED|Treatment Period (Combination)||5
170276|NCT00537511|418166|P1|COMPLETED|Treatment Period (Combination)||17
170277|NCT00537511|418166|P1|Safety Population|Treatment Period (Combination)|Safety = All participants who took ≥1 dose of study treatment.|22
170278|NCT00537511|418166|P1|Intent-to-Treat (ITT) Populaton|Treatment Period (Combination)|ITT = all participants enrolled in the study.|22
170279|NCT00537511|418166|P1|STARTED|Treatment Period (Combination)||22
170280|NCT00537680|418194|P3|NOT COMPLETED|Overall Study||0
170281|NCT00537680|418195|P2|NOT COMPLETED|Overall Study||2
170282|NCT00537680|418196|P1|NOT COMPLETED|Overall Study||0
170283|NCT00537680|418194|P3|COMPLETED|Overall Study||24
170284|NCT00537680|418195|P2|COMPLETED|Overall Study||22
170285|NCT00537680|418196|P1|COMPLETED|Overall Study||22
170286|NCT00537680|418194|P3|STARTED|Overall Study||24
170287|NCT00537680|418195|P2|STARTED|Overall Study||24
170288|NCT00537680|418196|P1|STARTED|Overall Study||22
170289|NCT00537745|418204|P1|NOT COMPLETED|Overall Study||5
170290|NCT00537745|418204|P1|COMPLETED|Overall Study||9
170291|NCT00537745|418204|P1|Began Intervention|Overall Study||11
170292|NCT00537745|418204|P1|STARTED|Overall Study|There were three screen fails and two early terminations.|14
170293|NCT00537771|418211|P2|NOT COMPLETED|Overall Study||61
170294|NCT00537771|418212|P1|NOT COMPLETED|Overall Study||29
170295|NCT00537771|418211|P2|COMPLETED|Overall Study||114
170296|NCT00537771|418212|P1|COMPLETED|Overall Study||149
170297|NCT00537771|418211|P2|STARTED|Overall Study||175
170298|NCT00537771|418212|P1|STARTED|Overall Study||178
170299|NCT00537810|418226|P4|NOT COMPLETED|Overall Study||4
170300|NCT00537810|418227|P3|NOT COMPLETED|Overall Study||4
170301|NCT00537810|418228|P2|NOT COMPLETED|Overall Study||13
170302|NCT00537810|418229|P1|NOT COMPLETED|Overall Study||6
170303|NCT00537810|418226|P4|COMPLETED|Overall Study||22
170304|NCT00537810|418227|P3|COMPLETED|Overall Study||21
170305|NCT00537810|418228|P2|COMPLETED|Overall Study||14
170306|NCT00537810|418229|P1|COMPLETED|Overall Study||20
170307|NCT00537810|418226|P4|STARTED|Overall Study||26
170308|NCT00537810|418227|P3|STARTED|Overall Study||25
170309|NCT00537810|418228|P2|STARTED|Overall Study||27
170310|NCT00537810|418229|P1|STARTED|Overall Study||26
170311|NCT00537823|418245|P2|NOT COMPLETED|Overall Study||0
170312|NCT00537823|418246|P1|NOT COMPLETED|Overall Study||2
170313|NCT00537823|418245|P2|COMPLETED|Overall Study||2
170314|NCT00537823|418246|P1|COMPLETED|Overall Study||5
170315|NCT00537823|418245|P2|STARTED|Overall Study||2
170316|NCT00537823|418246|P1|STARTED|Overall Study||7
170317|NCT00537940|418270|P2|NOT COMPLETED|Overall Study||179
170318|NCT00537940|418271|P1|NOT COMPLETED|Overall Study||183
170319|NCT00537940|418270|P2|COMPLETED|Overall Study||62
170320|NCT00537940|418271|P1|COMPLETED|Overall Study|2 participants had both treatment related and non-treatment related AE leading to discontinuation.|58
170321|NCT00537940|418270|P2|Entered Opt Blinded Continuation Phase|Overall Study||139
170322|NCT00537940|418271|P1|Entered Opt Blinded Continuation Phase|Overall Study||140
170323|NCT00537940|418270|P2|Completed Maintenance Phase|Overall Study||172
170324|NCT00537940|418271|P1|Completed Maintenance Phase|Overall Study||187
170325|NCT00537940|418270|P2|Completed Titration Phase|Overall Study||210
170326|NCT00537940|418271|P1|Completed Titration Phase|Overall Study||213
170327|NCT00537940|418270|P2|STARTED|Overall Study||241
170328|NCT00537940|418271|P1|STARTED|Overall Study||241
170329|NCT00537979|418295|P2|NOT COMPLETED|Overall Study||20
170330|NCT00537979|418296|P1|NOT COMPLETED|Overall Study||6
170331|NCT00537979|418295|P2|COMPLETED|Overall Study||89
170332|NCT00537979|418296|P1|COMPLETED|Overall Study||32
170333|NCT00537979|418295|P2|STARTED|Overall Study||109
170334|NCT00537979|418296|P1|STARTED|Overall Study||38
170335|NCT00538213|418313|P3|NOT COMPLETED|Overall Study||0
170336|NCT00538213|418314|P2|NOT COMPLETED|Overall Study||0
170337|NCT00538213|418315|P1|NOT COMPLETED|Overall Study||0
170338|NCT00538213|418313|P3|COMPLETED|Overall Study||38
170339|NCT00538213|418314|P2|COMPLETED|Overall Study||40
170340|NCT00538213|418315|P1|COMPLETED|Overall Study||55
170341|NCT00538213|418313|P3|STARTED|Overall Study||38
170342|NCT00538213|418314|P2|STARTED|Overall Study||40
170343|NCT00538213|418315|P1|STARTED|Overall Study||55
170344|NCT00538291|418362|P1|NOT COMPLETED|Overall Study||3
170345|NCT00538291|418362|P1|COMPLETED|Overall Study||10
170346|NCT00538291|418362|P1|STARTED|Overall Study||13
170347|NCT00538304|418368|P2|NOT COMPLETED|Overall Study||5
170348|NCT00538304|418369|P1|NOT COMPLETED|Overall Study||7
170349|NCT00538304|418368|P2|COMPLETED|Overall Study||66
170350|NCT00538304|418369|P1|COMPLETED|Overall Study||144
170351|NCT00538304|418368|P2|STARTED|Overall Study||71
170352|NCT00538304|418369|P1|STARTED|Overall Study||151
170353|NCT00538434|418389|P4|NOT COMPLETED|Overall Study||6
170354|NCT00538434|418390|P3|NOT COMPLETED|Overall Study||7
170355|NCT00538434|418391|P2|NOT COMPLETED|Overall Study||11
170356|NCT00538434|418392|P1|NOT COMPLETED|Overall Study||9
170357|NCT00538434|418389|P4|COMPLETED|Overall Study|Completed all scheduled study visits|51
170358|NCT00538434|418390|P3|COMPLETED|Overall Study|Completed all scheduled study visits|50
170359|NCT00538434|418391|P2|COMPLETED|Overall Study|Completed all scheduled study visits|46
170360|NCT00538434|418392|P1|COMPLETED|Overall Study|Completed all scheduled study visits|47
170361|NCT00538434|418389|P4|Intent-to-treat (ITT) Population|Overall Study||57
170362|NCT00538434|418390|P3|Intent-to-treat (ITT) Population|Overall Study||57
170363|NCT00538434|418391|P2|Intent-to-treat (ITT) Population|Overall Study||57
170364|NCT00538434|418392|P1|Intent-to-treat (ITT) Population|Overall Study|1 participant was randomized but not treated|55
170365|NCT00538434|418389|P4|STARTED|Overall Study||57
170366|NCT00538434|418390|P3|STARTED|Overall Study||57
170367|NCT00538434|418391|P2|STARTED|Overall Study||57
170368|NCT00538434|418392|P1|STARTED|Overall Study||56
170369|NCT00538473|418416|P2|NOT COMPLETED|Overall Study||0
170370|NCT00538473|418417|P1|NOT COMPLETED|Overall Study||1
170371|NCT00538473|418416|P2|COMPLETED|Overall Study||35
170372|NCT00538473|418417|P1|COMPLETED|Overall Study||32
170373|NCT00538473|418416|P2|STARTED|Overall Study||35
170374|NCT00538473|418417|P1|STARTED|Overall Study||33
170375|NCT00538512|418452|P3|NOT COMPLETED|Overall Study||13
170376|NCT00538512|418453|P2|NOT COMPLETED|Overall Study||30
170377|NCT00538512|418454|P1|NOT COMPLETED|Overall Study||27
170378|NCT00538512|418452|P3|COMPLETED|Overall Study||312
170379|NCT00538512|418453|P2|COMPLETED|Overall Study||783
170380|NCT00538512|418454|P1|COMPLETED|Overall Study||787
170381|NCT00538512|418452|P3|STARTED|Overall Study||325
170382|NCT00538512|418453|P2|STARTED|Overall Study||813
170383|NCT00538512|418454|P1|STARTED|Overall Study||814
170384|NCT00538590|418464|P2|NOT COMPLETED|Overall Study||0
170385|NCT00538590|418465|P1|NOT COMPLETED|Overall Study||1
170386|NCT00538590|418464|P2|COMPLETED|Overall Study||10
170387|NCT00538590|418465|P1|COMPLETED|Overall Study|Deceased 8 months after surgery due to known cardiovascular co-morbidity.|9
170388|NCT00538590|418464|P2|STARTED|Overall Study||10
170389|NCT00538590|418465|P1|STARTED|Overall Study||10
170390|NCT00538616|418481|P2|NOT COMPLETED|Overall Study||0
170391|NCT00538616|418482|P1|NOT COMPLETED|Overall Study||0
170392|NCT00538616|418481|P2|COMPLETED|Overall Study||3
170393|NCT00538616|418482|P1|COMPLETED|Overall Study||5
170394|NCT00538616|418481|P2|STARTED|Overall Study||3
170395|NCT00538616|418482|P1|STARTED|Overall Study||5
170396|NCT00538629|418488|P1|NOT COMPLETED|Overall Study||22
170397|NCT00538629|418488|P1|COMPLETED|Overall Study||449
170398|NCT00538629|418488|P1|STARTED|Overall Study||471
170399|NCT00538642|418535|P2|NOT COMPLETED|Overall Study||5
170400|NCT00538642|418536|P1|NOT COMPLETED|Overall Study||1
170401|NCT00538642|418535|P2|COMPLETED|Overall Study||9
170402|NCT00538642|418536|P1|COMPLETED|Overall Study||9
170403|NCT00538642|418535|P2|STARTED|Overall Study||14
170404|NCT00538642|418536|P1|STARTED|Overall Study||10
170405|NCT00525421|418578|P2|NOT COMPLETED|Overall Study||0
170406|NCT00525421|418579|P1|NOT COMPLETED|Overall Study||0
170407|NCT00525421|418578|P2|COMPLETED|Overall Study||10
170408|NCT00525421|418579|P1|COMPLETED|Overall Study||10
170409|NCT00525421|418578|P2|STARTED|Overall Study||10
170410|NCT00525421|418579|P1|STARTED|Overall Study|Enrollment started october 2007|10
170411|NCT00525499|418591|P4|NOT COMPLETED|Overall Study||7
170412|NCT00525499|418592|P3|NOT COMPLETED|Overall Study||7
170413|NCT00525499|418593|P2|NOT COMPLETED|Overall Study||7
170414|NCT00525499|418594|P1|NOT COMPLETED|Overall Study||7
170415|NCT00525499|418591|P4|COMPLETED|Overall Study||39
170416|NCT00525499|418592|P3|COMPLETED|Overall Study||40
170417|NCT00525499|418593|P2|COMPLETED|Overall Study||39
170418|NCT00525499|418594|P1|COMPLETED|Overall Study||40
170419|NCT00525499|418591|P4|STARTED|Overall Study||46
170420|NCT00525499|418592|P3|STARTED|Overall Study||47
170421|NCT00525499|418593|P2|STARTED|Overall Study||46
170422|NCT00525499|418594|P1|STARTED|Overall Study||47
170423|NCT00525512|418610|P4|NOT COMPLETED|Open-Label Phase||5
170424|NCT00525512|418611|P3|NOT COMPLETED|Open-Label Phase||6
170425|NCT00525512|418612|P2|NOT COMPLETED|Open-Label Phase||0
170426|NCT00525512|418613|P1|NOT COMPLETED|Open-Label Phase||0
170427|NCT00525512|418610|P4|COMPLETED|Open-Label Phase||189
170428|NCT00525512|418611|P3|COMPLETED|Open-Label Phase||158
170429|NCT00525512|418612|P2|COMPLETED|Open-Label Phase||0
170430|NCT00525512|418613|P1|COMPLETED|Open-Label Phase||0
170431|NCT00525512|418610|P4|STARTED|Open-Label Phase||194
170432|NCT00525512|418611|P3|STARTED|Open-Label Phase||164
170433|NCT00525512|418612|P2|STARTED|Open-Label Phase||0
170434|NCT00525512|418613|P1|STARTED|Open-Label Phase||0
170435|NCT00525512|418610|P4|NOT COMPLETED|Double-Blind Phase||0
170436|NCT00525512|418611|P3|NOT COMPLETED|Double-Blind Phase||0
170437|NCT00525512|418612|P2|NOT COMPLETED|Double-Blind Phase||66
170438|NCT00525512|418613|P1|NOT COMPLETED|Double-Blind Phase||96
170439|NCT00525512|418610|P4|COMPLETED|Double-Blind Phase||0
170440|NCT00525512|418611|P3|COMPLETED|Double-Blind Phase||0
170441|NCT00525512|418612|P2|COMPLETED|Double-Blind Phase||194
170442|NCT00525512|418613|P1|COMPLETED|Double-Blind Phase||163
170443|NCT00525512|418610|P4|STARTED|Double-Blind Phase||0
170444|NCT00525512|418611|P3|STARTED|Double-Blind Phase||0
170445|NCT00525512|418612|P2|STARTED|Double-Blind Phase||260
170446|NCT00525512|418613|P1|STARTED|Double-Blind Phase||259
170447|NCT00525525|418753|P2|NOT COMPLETED|Overall Study||0
170448|NCT00525525|418754|P1|NOT COMPLETED|Overall Study||0
170449|NCT00525525|418753|P2|COMPLETED|Overall Study||15
170450|NCT00525525|418754|P1|COMPLETED|Overall Study||59
170451|NCT00525525|418753|P2|STARTED|Overall Study||15
170452|NCT00525525|418754|P1|STARTED|Overall Study||59
170453|NCT00525603|418761|P1|NOT COMPLETED|Overall Study||0
170454|NCT00525603|418761|P1|COMPLETED|Overall Study||60
170455|NCT00525603|418761|P1|STARTED|Overall Study||60
170456|NCT00525629|418767|P2|NOT COMPLETED|Overall Study||5
170457|NCT00525629|418768|P1|NOT COMPLETED|Overall Study||5
170458|NCT00525629|418767|P2|COMPLETED|Overall Study||15
170459|NCT00525629|418768|P1|COMPLETED|Overall Study||15
170460|NCT00525629|418767|P2|STARTED|Overall Study||20
170461|NCT00525629|418768|P1|STARTED|Overall Study||20
170462|NCT00525733|418776|P2|NOT COMPLETED|Overall Study||3
170463|NCT00525733|418777|P1|NOT COMPLETED|Overall Study||3
170464|NCT00525733|418776|P2|COMPLETED|Overall Study||23
170465|NCT00525733|418777|P1|COMPLETED|Overall Study||11
170466|NCT00525733|418776|P2|STARTED|Overall Study||26
170467|NCT00525733|418777|P1|STARTED|Overall Study||14
170468|NCT00525798|418785|P2|NOT COMPLETED|Overall Study||599
170469|NCT00525798|418786|P1|NOT COMPLETED|Overall Study||756
170470|NCT00525798|418785|P2|COMPLETED|Overall Study||1732
170471|NCT00525798|418786|P1|COMPLETED|Overall Study||1578
170472|NCT00525798|418785|P2|STARTED|Overall Study||2331
170473|NCT00525798|418786|P1|STARTED|Overall Study||2334
170474|NCT00525824|418798|P4|NOT COMPLETED|Overall Study||15
170475|NCT00525824|418799|P3|NOT COMPLETED|Overall Study||19
170476|NCT00525824|418800|P2|NOT COMPLETED|Overall Study||28
170477|NCT00525824|418801|P1|NOT COMPLETED|Overall Study||19
170478|NCT00525824|418798|P4|COMPLETED|Overall Study||188
170479|NCT00525824|418799|P3|COMPLETED|Overall Study||183
170480|NCT00525824|418800|P2|COMPLETED|Overall Study||186
170481|NCT00525824|418801|P1|COMPLETED|Overall Study||195
170482|NCT00525824|418798|P4|STARTED|Overall Study|Randomized population|203
170483|NCT00525824|418799|P3|STARTED|Overall Study|Randomized population|202
170484|NCT00525824|418800|P2|STARTED|Overall Study|Randomized population|214
170485|NCT00525824|418801|P1|STARTED|Overall Study|Randomized population|214
170486|NCT00525837|418863|P1|NOT COMPLETED|Overall Study||4
170487|NCT00525837|418863|P1|COMPLETED|Overall Study||14
170488|NCT00525837|418863|P1|STARTED|Overall Study||18
170489|NCT00525876|418869|P2|NOT COMPLETED|Overall Study||0
170490|NCT00525876|418870|P1|NOT COMPLETED|Overall Study||0
170491|NCT00525876|418869|P2|COMPLETED|Overall Study||20
170492|NCT00525876|418870|P1|COMPLETED|Overall Study||16
170493|NCT00525876|418869|P2|STARTED|Overall Study||20
170494|NCT00525876|418870|P1|STARTED|Overall Study||16
170495|NCT00525902|418876|P1|NOT COMPLETED|Overall Study||1
170496|NCT00525902|418876|P1|COMPLETED|Overall Study||30
170497|NCT00525902|418876|P1|50 Weeks|Overall Study||12
170498|NCT00525902|418876|P1|10 Weeks|Overall Study||30
170499|NCT00525902|418876|P1|STARTED|Overall Study||31
170500|NCT00525915|418883|P2|NOT COMPLETED|Overall Study||9
170501|NCT00525915|418884|P1|NOT COMPLETED|Overall Study||8
170502|NCT00525915|418883|P2|COMPLETED|Overall Study||54
170503|NCT00525915|418884|P1|COMPLETED|Overall Study|Participants who underwent surgery.|55
170504|NCT00525915|418883|P2|STARTED|Overall Study||63
170505|NCT00525915|418884|P1|STARTED|Overall Study||63
170506|NCT00526058|418892|P2|NOT COMPLETED|Period: Second Intervention||0
170507|NCT00526058|418893|P1|NOT COMPLETED|Period: Second Intervention||0
170508|NCT00526058|418892|P2|COMPLETED|Period: Second Intervention||9
170509|NCT00526058|418893|P1|COMPLETED|Period: Second Intervention||9
170510|NCT00526058|418892|P2|STARTED|Period: Second Intervention||9
170511|NCT00526058|418893|P1|STARTED|Period: Second Intervention||9
170512|NCT00526058|418892|P2|NOT COMPLETED|Period: First Intervention||0
170513|NCT00526058|418893|P1|NOT COMPLETED|Period: First Intervention||0
170514|NCT00526058|418892|P2|COMPLETED|Period: First Intervention||9
170515|NCT00526058|418893|P1|COMPLETED|Period: First Intervention||9
170516|NCT00526058|418892|P2|STARTED|Period: First Intervention||9
170517|NCT00526058|418893|P1|STARTED|Period: First Intervention||9
170518|NCT00526097|418901|P2|NOT COMPLETED|Overall Study||56
170519|NCT00526097|418902|P1|NOT COMPLETED|Overall Study||15
170520|NCT00526097|418901|P2|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|191
170521|NCT00526097|418902|P1|COMPLETED|Overall Study|Completed: Participant without premature discontinuation in the randomised treatment period|106
170522|NCT00526097|418901|P2|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|247
170523|NCT00526097|418902|P1|STARTED|Overall Study|Started: Participant was randomised and took at least one dose of randomised study medication|121
170524|NCT00526110|419080|P2|NOT COMPLETED|Overall Study||41
170525|NCT00526110|419081|P1|NOT COMPLETED|Overall Study||2
170526|NCT00526110|419080|P2|COMPLETED|Overall Study||4
170527|NCT00526110|419081|P1|COMPLETED|Overall Study||51
170528|NCT00526110|419080|P2|STARTED|Overall Study||45
170529|NCT00526110|419081|P1|STARTED|Overall Study||53
170530|NCT00526123|419090|P2|NOT COMPLETED|Overall Study||246
170531|NCT00526123|419091|P1|NOT COMPLETED|Overall Study||264
170532|NCT00526123|419090|P2|COMPLETED|Overall Study||50
170533|NCT00526123|419091|P1|COMPLETED|Overall Study||39
170534|NCT00526123|419090|P2|STARTED|Overall Study|Intent-to-Treat population|296
170535|NCT00526123|419091|P1|STARTED|Overall Study|Intent-to-Treat population|303
170536|NCT00526162|419111|P1|NOT COMPLETED|Overall Study||3
170537|NCT00526162|419111|P1|COMPLETED|Overall Study||80
170538|NCT00526162|419111|P1|STARTED|Overall Study||83
170539|NCT00526188|419116|P1|NOT COMPLETED|Overall Study||0
170540|NCT00526188|419116|P1|COMPLETED|Overall Study||234
170541|NCT00526188|419116|P1|STARTED|Overall Study||234
170542|NCT00526227|419122|P1|NOT COMPLETED|Overall Study||2
170543|NCT00526227|419122|P1|COMPLETED|Overall Study||79
170544|NCT00526227|419122|P1|STARTED|Overall Study||81
170545|NCT00526292|419127|P1|NOT COMPLETED|Overall Study||0
170546|NCT00526292|419127|P1|COMPLETED|Overall Study||6
170547|NCT00526292|419127|P1|STARTED|Overall Study||6
170548|NCT00526331|419131|P1|NOT COMPLETED|Overall Study||55
170549|NCT00526331|419131|P1|COMPLETED|Overall Study||0
170550|NCT00526331|419131|P1|STARTED|Overall Study||55
170551|NCT00526474|419137|P2|NOT COMPLETED|Overall Study||272
170552|NCT00526474|419138|P1|NOT COMPLETED|Overall Study||292
170553|NCT00526474|419137|P2|COMPLETED|Overall Study||12953
170554|NCT00526474|419138|P1|COMPLETED|Overall Study||12932
170555|NCT00526474|419137|P2|Received Study Drug|Overall Study||13186
170556|NCT00526474|419138|P1|Received Study Drug|Overall Study||13166
170557|NCT00526474|419137|P2|STARTED|Overall Study||13225
170558|NCT00526474|419138|P1|STARTED|Overall Study||13224
170559|NCT00526630|419206|P2|NOT COMPLETED|Second Intervention Period - 12 Weeks||1
170560|NCT00526630|419207|P1|NOT COMPLETED|Second Intervention Period - 12 Weeks||2
170561|NCT00526630|419206|P2|COMPLETED|Second Intervention Period - 12 Weeks||7
170562|NCT00526630|419207|P1|COMPLETED|Second Intervention Period - 12 Weeks||10
170563|NCT00526630|419206|P2|STARTED|Second Intervention Period - 12 Weeks||8
170564|NCT00526630|419207|P1|STARTED|Second Intervention Period - 12 Weeks||12
170565|NCT00526630|419206|P2|NOT COMPLETED|First Intervention Period - 12 Weeks||3
170566|NCT00526630|419207|P1|NOT COMPLETED|First Intervention Period - 12 Weeks||0
170567|NCT00526630|419206|P2|COMPLETED|First Intervention Period - 12 Weeks||8
170568|NCT00526630|419207|P1|COMPLETED|First Intervention Period - 12 Weeks||12
170569|NCT00526630|419206|P2|STARTED|First Intervention Period - 12 Weeks||11
170570|NCT00526630|419207|P1|STARTED|First Intervention Period - 12 Weeks||12
170571|NCT00526669|419235|P2|NOT COMPLETED|Combined Treatment Phase||8
170572|NCT00526669|419236|P1|NOT COMPLETED|Combined Treatment Phase||0
170573|NCT00526669|419235|P2|COMPLETED|Combined Treatment Phase||59
170574|NCT00526669|419236|P1|COMPLETED|Combined Treatment Phase||0
170575|NCT00526669|419235|P2|STARTED|Combined Treatment Phase||67
170576|NCT00526669|419236|P1|STARTED|Combined Treatment Phase||0
170577|NCT00526669|419235|P2|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
170578|NCT00526669|419236|P1|NOT COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
170579|NCT00526669|419235|P2|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||0
170580|NCT00526669|419236|P1|COMPLETED|7-Day Run-in Monotherapy Treatment Phase||67
170581|NCT00526669|419235|P2|STARTED|7-Day Run-in Monotherapy Treatment Phase||0
170582|NCT00526669|419236|P1|STARTED|7-Day Run-in Monotherapy Treatment Phase||67
170583|NCT00527514|419265|P1|NOT COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||2
170584|NCT00527514|419265|P1|COMPLETED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg||132
170585|NCT00527514|419265|P1|STARTED|Weeks 10-12:Aml 10 mg +Olmesartan 40 mg|158 -24 who met blood pressure goal = 134|134
170586|NCT00527514|419265|P1|NOT COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||3
170587|NCT00527514|419265|P1|COMPLETED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg||158
170588|NCT00527514|419265|P1|STARTED|Weeks 7-9: Aml 5 mg + Olmesartan 40 mg|178 -19 who met blood pressure goal + 2 who were mis-titrated = 161|161
170589|NCT00527514|419265|P1|NOT COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||2
170590|NCT00527514|419265|P1|COMPLETED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg||178
170591|NCT00527514|419265|P1|STARTED|Weeks 4-6: Aml 5mg+Olmesartan 20 mg|184 -2 who were mis-titrated -2 who met blood pressure goal = 180|180
170592|NCT00527514|419265|P1|NOT COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg||1
170593|NCT00527514|419265|P1|COMPLETED|Weeks 1-3: Amlodipine (Aml) 5mg|1 participant dropped out. 2 participants were subsequently mis-titrated to the third regimen.|184
170594|NCT00527514|419265|P1|STARTED|Weeks 1-3: Amlodipine (Aml) 5mg||185
170595|NCT00527566|419277|P1|NOT COMPLETED|Overall Study||0
170596|NCT00527566|419277|P1|COMPLETED|Overall Study||10
170597|NCT00527566|419277|P1|STARTED|Overall Study||10
170598|NCT00527592|419286|P1|NOT COMPLETED|Overall Study||0
170599|NCT00527592|419286|P1|COMPLETED|Overall Study||54
170600|NCT00527592|419286|P1|STARTED|Overall Study||54
170601|NCT00527605|419294|P2|NOT COMPLETED|Overall Study||11
170602|NCT00527605|419295|P1|NOT COMPLETED|Overall Study||13
170603|NCT00527605|419294|P2|COMPLETED|Overall Study||116
170604|NCT00527605|419295|P1|COMPLETED|Overall Study||113
170605|NCT00527605|419294|P2|STARTED|Overall Study||127
170606|NCT00527605|419295|P1|STARTED|Overall Study||126
170607|NCT00527618|419331|P2|NOT COMPLETED|Week 15-18 (Second Intervention)||3
170608|NCT00527618|419332|P1|NOT COMPLETED|Week 15-18 (Second Intervention)||0
170609|NCT00527618|419331|P2|COMPLETED|Week 15-18 (Second Intervention)|Acyclovir|13
170610|NCT00527618|419332|P1|COMPLETED|Week 15-18 (Second Intervention)|Valacyclovir|12
170611|NCT00527618|419331|P2|STARTED|Week 15-18 (Second Intervention)|Acyclovir|16
170612|NCT00527618|419332|P1|STARTED|Week 15-18 (Second Intervention)|Valacyclovir|12
170613|NCT00527618|419331|P2|NOT COMPLETED|Week 13-14 (Washout)||0
170614|NCT00527618|419332|P1|NOT COMPLETED|Week 13-14 (Washout)||1
170615|NCT00527618|419331|P2|COMPLETED|Week 13-14 (Washout)||16
170616|NCT00527618|419332|P1|COMPLETED|Week 13-14 (Washout)||12
170617|NCT00527618|419331|P2|STARTED|Week 13-14 (Washout)||16
170618|NCT00527618|419332|P1|STARTED|Week 13-14 (Washout)||13
170619|NCT00527618|419331|P2|NOT COMPLETED|Week 1-12 (First Intervention)||2
170620|NCT00527618|419332|P1|NOT COMPLETED|Week 1-12 (First Intervention)||3
170621|NCT00527618|419331|P2|COMPLETED|Week 1-12 (First Intervention)|Valacyclovir|16
170622|NCT00527618|419332|P1|COMPLETED|Week 1-12 (First Intervention)|Acyclovir|13
170623|NCT00527618|419331|P2|STARTED|Week 1-12 (First Intervention)|Valacyclovir; one participant was removed from the study due to urticaria after 2.5 weeks|18
170624|NCT00527618|419332|P1|STARTED|Week 1-12 (First Intervention)|Acyclovir|16
170625|NCT00527722|419347|P2|NOT COMPLETED|Overall Study||0
170626|NCT00527722|419348|P1|NOT COMPLETED|Overall Study||0
170627|NCT00527722|419347|P2|COMPLETED|Overall Study||25
170628|NCT00527722|419348|P1|COMPLETED|Overall Study||22
170629|NCT00527722|419347|P2|STARTED|Overall Study||25
170630|NCT00527722|419348|P1|STARTED|Overall Study||22
170631|NCT00527735|419357|P3|NOT COMPLETED|Overall Study||107
170632|NCT00527735|419358|P2|NOT COMPLETED|Overall Study||107
170633|NCT00527735|419359|P1|NOT COMPLETED|Overall Study||108
170634|NCT00527735|419357|P3|COMPLETED|Overall Study|Still on treatment|2
170635|NCT00527735|419358|P2|COMPLETED|Overall Study|Still on treatment|2
170636|NCT00527735|419359|P1|COMPLETED|Overall Study|Still on treatment|5
170637|NCT00527735|419357|P3|STARTED|Overall Study|Treated|109
170638|NCT00527735|419358|P2|STARTED|Overall Study|Treated|109
170639|NCT00527735|419359|P1|STARTED|Overall Study|Treated|113
170640|NCT00527748|419431|P1|NOT COMPLETED|Overall Study||3
170641|NCT00527748|419431|P1|COMPLETED|Overall Study||23
170642|NCT00527748|419431|P1|STARTED|Overall Study||26
170643|NCT00527787|419437|P2|NOT COMPLETED|Overall Study||63
170644|NCT00527787|419438|P1|NOT COMPLETED|Overall Study||38
170645|NCT00527787|419437|P2|COMPLETED|Overall Study||153
170646|NCT00527787|419438|P1|COMPLETED|Overall Study||180
170647|NCT00527787|419437|P2|STARTED|Overall Study|Safety and Intent-to-treat population (>=1 dose drug + no baseline ulcer) N=216|216
170648|NCT00527787|419438|P1|STARTED|Overall Study||218
170649|NCT00527826|419462|P2|NOT COMPLETED|Overall Study||26
170650|NCT00527826|419463|P1|NOT COMPLETED|Overall Study||21
170651|NCT00527826|419462|P2|COMPLETED|Overall Study||80
170652|NCT00527826|419463|P1|COMPLETED|Overall Study||87
170653|NCT00527826|419462|P2|STARTED|Overall Study||106
170654|NCT00527826|419463|P1|STARTED|Overall Study|All Patients Population was used for Participant Flow section.|108
170655|NCT00527878|419510|P2|NOT COMPLETED|Intervention 2||0
170656|NCT00527878|419511|P1|NOT COMPLETED|Intervention 2||0
170657|NCT00527878|419510|P2|COMPLETED|Intervention 2||4
170658|NCT00527878|419511|P1|COMPLETED|Intervention 2||5
170659|NCT00527878|419510|P2|STARTED|Intervention 2||4
170660|NCT00527878|419511|P1|STARTED|Intervention 2||5
170661|NCT00527878|419510|P2|NOT COMPLETED|Intervention 1||3
170662|NCT00527878|419511|P1|NOT COMPLETED|Intervention 1||2
170663|NCT00527878|419510|P2|COMPLETED|Intervention 1||4
170664|NCT00527878|419511|P1|COMPLETED|Intervention 1||5
170665|NCT00527878|419510|P2|STARTED|Intervention 1||7
170666|NCT00527878|419511|P1|STARTED|Intervention 1||7
170667|NCT00527904|419523|P1|NOT COMPLETED|Overall Study||96
170668|NCT00527904|419523|P1|COMPLETED|Overall Study||143
170669|NCT00527904|419523|P1|STARTED|Overall Study||239
170670|NCT00527943|419529|P2|NOT COMPLETED|Overall Study||146
170671|NCT00527943|419530|P1|NOT COMPLETED|Overall Study||160
170672|NCT00527943|419529|P2|COMPLETED|Overall Study||6327
170673|NCT00527943|419530|P1|COMPLETED|Overall Study||6311
170674|NCT00527943|419529|P2|Received Treatment|Overall Study||6446
170675|NCT00527943|419530|P1|Received Treatment|Overall Study||6441
170676|NCT00527943|419529|P2|STARTED|Overall Study||6473
170677|NCT00527943|419530|P1|STARTED|Overall Study||6471
170678|NCT00527982|419564|P2|NOT COMPLETED|Overall Study||0
170679|NCT00527982|419565|P1|NOT COMPLETED|Overall Study||1
170680|NCT00527982|419564|P2|COMPLETED|Overall Study||0
170681|NCT00527982|419565|P1|COMPLETED|Overall Study||0
170682|NCT00527982|419564|P2|STARTED|Overall Study||0
170683|NCT00527982|419565|P1|STARTED|Overall Study||1
170684|NCT00528021|419575|P4|NOT COMPLETED|Overall Study||9
170685|NCT00528021|419576|P3|NOT COMPLETED|Overall Study||7
170686|NCT00528021|419577|P2|NOT COMPLETED|Overall Study||13
170687|NCT00528021|419578|P1|NOT COMPLETED|Overall Study||17
170688|NCT00528021|419575|P4|COMPLETED|Overall Study||47
170689|NCT00528021|419576|P3|COMPLETED|Overall Study||49
170690|NCT00528021|419577|P2|COMPLETED|Overall Study||46
170691|NCT00528021|419578|P1|COMPLETED|Overall Study||42
170692|NCT00528021|419575|P4|STARTED|Overall Study||56
170693|NCT00528021|419576|P3|STARTED|Overall Study||56
170694|NCT00528021|419577|P2|STARTED|Overall Study||59
170695|NCT00528021|419578|P1|STARTED|Overall Study||59
170696|NCT00528112|419590|P2|NOT COMPLETED|Extension Phase||157
170697|NCT00528112|419591|P1|NOT COMPLETED|Extension Phase||0
170698|NCT00528112|419590|P2|COMPLETED|Extension Phase||550
170699|NCT00528112|419591|P1|COMPLETED|Extension Phase||0
170700|NCT00528112|419590|P2|STARTED|Extension Phase||707
170701|NCT00528112|419591|P1|STARTED|Extension Phase|Only subjects in the LCS16 groups could participate in the extension phase|0
170702|NCT00528112|419590|P2|NOT COMPLETED|Treatment up to 3 Years||583
170703|NCT00528112|419591|P1|NOT COMPLETED|Treatment up to 3 Years||613
170704|NCT00528112|419590|P2|COMPLETED|Treatment up to 3 Years||870
170705|NCT00528112|419591|P1|COMPLETED|Treatment up to 3 Years||819
170706|NCT00528112|419590|P2|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1452
170707|NCT00528112|419591|P1|Participants Received Treatment|Treatment up to 3 Years|Full analysis set/Safety population|1432
170708|NCT00528112|419590|P2|STARTED|Treatment up to 3 Years||1453
170709|NCT00528112|419591|P1|STARTED|Treatment up to 3 Years||1432
170710|NCT00528190|419647|P2|NOT COMPLETED|Overall Study||1
170711|NCT00528190|419648|P1|NOT COMPLETED|Overall Study||0
170712|NCT00528190|419647|P2|COMPLETED|Overall Study||16
170713|NCT00528190|419648|P1|COMPLETED|Overall Study||18
170714|NCT00528190|419647|P2|STARTED|Overall Study||17
170715|NCT00528190|419648|P1|STARTED|Overall Study||18
170716|NCT00528268|419656|P2|NOT COMPLETED|Overall Study||1
170717|NCT00528268|419657|P1|NOT COMPLETED|Overall Study||1
170718|NCT00528268|419656|P2|COMPLETED|Overall Study||7
170719|NCT00528268|419657|P1|COMPLETED|Overall Study||5
170720|NCT00528268|419656|P2|STARTED|Overall Study||8
170721|NCT00528268|419657|P1|STARTED|Overall Study||6
170722|NCT00528372|419672|P9|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
170723|NCT00528372|419673|P8|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||6
170724|NCT00528372|419674|P7|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||17
170725|NCT00528372|419675|P6|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||15
170726|NCT00528372|419676|P5|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||21
170727|NCT00528372|419677|P4|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||14
170728|NCT00528372|419678|P3|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||8
170729|NCT00528372|419679|P2|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||19
170730|NCT00528372|419680|P1|NOT COMPLETED|Long-term (LT) Period (Weeks 24-102)||20
170731|NCT00528372|419672|P9|COMPLETED|Long-term (LT) Period (Weeks 24-102)||27
170732|NCT00528372|419673|P8|COMPLETED|Long-term (LT) Period (Weeks 24-102)||22
170733|NCT00528372|419674|P7|COMPLETED|Long-term (LT) Period (Weeks 24-102)||48
170734|NCT00528372|419675|P6|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
170735|NCT00528372|419676|P5|COMPLETED|Long-term (LT) Period (Weeks 24-102)||37
170736|NCT00528372|419677|P4|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
170737|NCT00528372|419678|P3|COMPLETED|Long-term (LT) Period (Weeks 24-102)||43
170738|NCT00528372|419679|P2|COMPLETED|Long-term (LT) Period (Weeks 24-102)||40
170739|NCT00528372|419680|P1|COMPLETED|Long-term (LT) Period (Weeks 24-102)||42
170740|NCT00528372|419672|P9|STARTED|Long-term (LT) Period (Weeks 24-102)|1 patient completed ST phase but withdrew for sponsor administrative reason before start of LT phase|33
170741|NCT00528372|419673|P8|STARTED|Long-term (LT) Period (Weeks 24-102)||28
170742|NCT00528372|419674|P7|STARTED|Long-term (LT) Period (Weeks 24-102)||65
170743|NCT00528372|419675|P6|STARTED|Long-term (LT) Period (Weeks 24-102)||57
170744|NCT00528372|419676|P5|STARTED|Long-term (LT) Period (Weeks 24-102)||58
170745|NCT00528372|419677|P4|STARTED|Long-term (LT) Period (Weeks 24-102)||56
170746|NCT00528372|419678|P3|STARTED|Long-term (LT) Period (Weeks 24-102)||51
170747|NCT00528372|419679|P2|STARTED|Long-term (LT) Period (Weeks 24-102)||59
170748|NCT00528372|419680|P1|STARTED|Long-term (LT) Period (Weeks 24-102)||62
170749|NCT00528372|419672|P9|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
170750|NCT00528372|419673|P8|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||6
170751|NCT00528372|419674|P7|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
170752|NCT00528372|419675|P6|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||11
170753|NCT00528372|419676|P5|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||9
170754|NCT00528372|419677|P4|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||13
170755|NCT00528372|419678|P3|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
170756|NCT00528372|419679|P2|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||5
170757|NCT00528372|419680|P1|NOT COMPLETED|Short-term (ST) Period (Day 1-Week 24)||12
170758|NCT00528372|419672|P9|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||34
170759|NCT00528372|419673|P8|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||28
170760|NCT00528372|419674|P7|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||65
170761|NCT00528372|419675|P6|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
170762|NCT00528372|419676|P5|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||58
170763|NCT00528372|419677|P4|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||57
170764|NCT00528372|419678|P3|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||52
170765|NCT00528372|419679|P2|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||60
170766|NCT00528372|419680|P1|COMPLETED|Short-term (ST) Period (Day 1-Week 24)||63
170767|NCT00528372|419672|P9|STARTED|Short-term (ST) Period (Day 1-Week 24)||39
170768|NCT00528372|419673|P8|STARTED|Short-term (ST) Period (Day 1-Week 24)||34
170769|NCT00528372|419674|P7|STARTED|Short-term (ST) Period (Day 1-Week 24)||76
170770|NCT00528372|419675|P6|STARTED|Short-term (ST) Period (Day 1-Week 24)||68
170771|NCT00528372|419676|P5|STARTED|Short-term (ST) Period (Day 1-Week 24)||67
170772|NCT00528372|419677|P4|STARTED|Short-term (ST) Period (Day 1-Week 24)||70
170773|NCT00528372|419678|P3|STARTED|Short-term (ST) Period (Day 1-Week 24)||64
170774|NCT00528372|419679|P2|STARTED|Short-term (ST) Period (Day 1-Week 24)||65
170775|NCT00528372|419680|P1|STARTED|Short-term (ST) Period (Day 1-Week 24)||75
170776|NCT00528398|419792|P1|NOT COMPLETED|Overall Study||0
170777|NCT00528398|419792|P1|COMPLETED|Overall Study||111
170778|NCT00528398|419792|P1|STARTED|Overall Study||111
170779|NCT00528411|419800|P3|NOT COMPLETED|Overall Study||1
170780|NCT00528411|419801|P2|NOT COMPLETED|Overall Study||3
170781|NCT00528411|419802|P1|NOT COMPLETED|Overall Study||5
170782|NCT00528411|419800|P3|COMPLETED|Overall Study||11
170783|NCT00528411|419801|P2|COMPLETED|Overall Study||51
170784|NCT00528411|419802|P1|COMPLETED|Overall Study||52
170785|NCT00528411|419800|P3|STARTED|Overall Study||12
170786|NCT00528411|419801|P2|STARTED|Overall Study||54
170787|NCT00528411|419802|P1|STARTED|Overall Study||57
170788|NCT00528424|419925|P1|NOT COMPLETED|Overall Study||29
170789|NCT00528424|419925|P1|COMPLETED|Overall Study||257
170790|NCT00528424|419925|P1|STARTED|Overall Study||286
170791|NCT00528450|419929|P1|NOT COMPLETED|Overall Study||0
170792|NCT00528450|419929|P1|COMPLETED|Overall Study||1
170793|NCT00528450|419929|P1|STARTED|Overall Study||1
170794|NCT00528528|419937|P4|NOT COMPLETED|Overall Study||3
170795|NCT00528528|419938|P3|NOT COMPLETED|Overall Study||3
170796|NCT00528528|419939|P2|NOT COMPLETED|Overall Study||3
170797|NCT00528528|419940|P1|NOT COMPLETED|Overall Study||3
170798|NCT00528528|419937|P4|COMPLETED|Overall Study||36
170799|NCT00528528|419938|P3|COMPLETED|Overall Study||37
170800|NCT00528528|419939|P2|COMPLETED|Overall Study||39
170801|NCT00528528|419940|P1|COMPLETED|Overall Study||37
170802|NCT00528528|419937|P4|Ongoing at Time of Cut-off|Overall Study||0
170803|NCT00528528|419938|P3|Ongoing at Time of Cut-off|Overall Study||1
170804|NCT00528528|419939|P2|Ongoing at Time of Cut-off|Overall Study||0
170805|NCT00528528|419940|P1|Ongoing at Time of Cut-off|Overall Study||0
170806|NCT00528528|419937|P4|STARTED|Overall Study||39
170807|NCT00528528|419938|P3|STARTED|Overall Study||40
170808|NCT00528528|419939|P2|STARTED|Overall Study||42
170809|NCT00528528|419940|P1|STARTED|Overall Study||40
170810|NCT00528541|419976|P2|NOT COMPLETED|Overall Study||1
170811|NCT00528541|419977|P1|NOT COMPLETED|Overall Study||2
170812|NCT00528541|419976|P2|COMPLETED|Overall Study||69
170813|NCT00528541|419977|P1|COMPLETED|Overall Study||73
170814|NCT00528541|419976|P2|STARTED|Overall Study||70
170815|NCT00528541|419977|P1|STARTED|Overall Study||75
170816|NCT00528567|420001|P2|NOT COMPLETED|Overall Study||308
170817|NCT00528567|420002|P1|NOT COMPLETED|Overall Study||431
170818|NCT00528567|420001|P2|COMPLETED|Overall Study||982
170819|NCT00528567|420002|P1|COMPLETED|Overall Study||870
170820|NCT00528567|420001|P2|Safety Population|Overall Study||1271
170821|NCT00528567|420002|P1|Safety Population|Overall Study||1288
170822|NCT00528567|420001|P2|Intention to Treat|Overall Study||1290
170823|NCT00528567|420002|P1|Intention to Treat|Overall Study||1301
170824|NCT00528567|420001|P2|STARTED|Overall Study||1290
170825|NCT00528567|420002|P1|STARTED|Overall Study||1301
170826|NCT00528606|420042|P2|NOT COMPLETED|Overall Study||4
170827|NCT00528606|420043|P1|NOT COMPLETED|Overall Study||13
170828|NCT00528606|420042|P2|COMPLETED|Overall Study||100
170829|NCT00528606|420043|P1|COMPLETED|Overall Study||191
170830|NCT00528606|420042|P2|STARTED|Overall Study||104
170831|NCT00528606|420043|P1|STARTED|Overall Study||204
170832|NCT00528645|420049|P1|NOT COMPLETED|Overall Study||3
170833|NCT00528645|420049|P1|COMPLETED|Overall Study||20
170834|NCT00528645|420049|P1|STARTED|Overall Study||23
170835|NCT00528775|420053|P1|NOT COMPLETED|Overall Study||1
170836|NCT00528775|420053|P1|COMPLETED|Overall Study||5
170837|NCT00528775|420053|P1|STARTED|Overall Study||6
170838|NCT00528788|420061|P1|NOT COMPLETED|Overall Study||4
170839|NCT00528788|420061|P1|COMPLETED|Overall Study||20
170840|NCT00528788|420061|P1|STARTED|Overall Study||24
170841|NCT00528801|420067|P2|NOT COMPLETED|Overall Study||11
170842|NCT00528801|420068|P1|NOT COMPLETED|Overall Study||27
170843|NCT00528801|420067|P2|COMPLETED|Overall Study||41
170844|NCT00528801|420068|P1|COMPLETED|Overall Study||133
170845|NCT00528801|420067|P2|STARTED|Overall Study||52
170846|NCT00528801|420068|P1|STARTED|Overall Study||160
170847|NCT00528840|420078|P1|NOT COMPLETED|Overall Study||33
170848|NCT00528840|420078|P1|COMPLETED|Overall Study||168
170849|NCT00528840|420078|P1|STARTED|Overall Study||201
170850|NCT00528866|420082|P1|NOT COMPLETED|Overall Study||6
170851|NCT00528866|420082|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|74
170852|NCT00528866|420082|P1|STARTED|Overall Study||80
170853|NCT00528879|420098|P4|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||24
170854|NCT00528879|420099|P3|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||33
170855|NCT00528879|420100|P2|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||38
170856|NCT00528879|420101|P1|NOT COMPLETED|Long-term Period (Weeks 24 to 102)||42
170857|NCT00528879|420098|P4|COMPLETED|Long-term Period (Weeks 24 to 102)||95
170858|NCT00528879|420099|P3|COMPLETED|Long-term Period (Weeks 24 to 102)||89
170859|NCT00528879|420100|P2|COMPLETED|Long-term Period (Weeks 24 to 102)||82
170860|NCT00528879|420101|P1|COMPLETED|Long-term Period (Weeks 24 to 102)||73
170861|NCT00528879|420098|P4|STARTED|Long-term Period (Weeks 24 to 102)||119
170862|NCT00528879|420099|P3|STARTED|Long-term Period (Weeks 24 to 102)||122
170863|NCT00528879|420100|P2|STARTED|Long-term Period (Weeks 24 to 102)||120
170864|NCT00528879|420101|P1|STARTED|Long-term Period (Weeks 24 to 102)||115
170865|NCT00528879|420098|P4|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||16
170866|NCT00528879|420099|P3|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||15
170867|NCT00528879|420100|P2|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||17
170868|NCT00528879|420101|P1|NOT COMPLETED|Short-term Period (Day 1 to Week 24)||22
170869|NCT00528879|420098|P4|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|119
170870|NCT00528879|420099|P3|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|122
170871|NCT00528879|420100|P2|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|120
170872|NCT00528879|420101|P1|COMPLETED|Short-term Period (Day 1 to Week 24)|Completed=entered Long-term Period|115
170873|NCT00528879|420098|P4|Completed the Period|Short-term Period (Day 1 to Week 24)||121
170874|NCT00528879|420099|P3|Completed the Period|Short-term Period (Day 1 to Week 24)||122
170875|NCT00528879|420100|P2|Completed the Period|Short-term Period (Day 1 to Week 24)||121
170876|NCT00528879|420101|P1|Completed the Period|Short-term Period (Day 1 to Week 24)||119
170877|NCT00528879|420098|P4|STARTED|Short-term Period (Day 1 to Week 24)||135
170878|NCT00528879|420099|P3|STARTED|Short-term Period (Day 1 to Week 24)||137
170879|NCT00528879|420100|P2|STARTED|Short-term Period (Day 1 to Week 24)||137
170880|NCT00528879|420101|P1|STARTED|Short-term Period (Day 1 to Week 24)||137
170881|NCT00528931|420167|P1|NOT COMPLETED|Overall Study||1
170882|NCT00528931|420167|P1|COMPLETED|Overall Study||15
170883|NCT00528931|420167|P1|STARTED|Overall Study||16
170884|NCT00528957|420177|P2|NOT COMPLETED|Second Extension (Week 144 to Week 240)||40
170885|NCT00528957|420178|P1|NOT COMPLETED|Second Extension (Week 144 to Week 240)||34
170886|NCT00528957|420177|P2|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
170887|NCT00528957|420178|P1|COMPLETED|Second Extension (Week 144 to Week 240)|Study is ongoing, therefore no participants have completed the study.|0
170888|NCT00528957|420177|P2|STARTED|Second Extension (Week 144 to Week 240)||40
170889|NCT00528957|420178|P1|STARTED|Second Extension (Week 144 to Week 240)|One participant completed the first extension and did not enroll in the second extension.|34
170890|NCT00528957|420177|P2|NOT COMPLETED|First Extension (Week 48 to Week 144)||1
170891|NCT00528957|420178|P1|NOT COMPLETED|First Extension (Week 48 to Week 144)||3
170892|NCT00528957|420177|P2|COMPLETED|First Extension (Week 48 to Week 144)||40
170893|NCT00528957|420178|P1|COMPLETED|First Extension (Week 48 to Week 144)||35
170894|NCT00528957|420177|P2|STARTED|First Extension (Week 48 to Week 144)|Seven participants completed the 48-week randomized phase and did not enroll in the first extension.|41
170895|NCT00528957|420178|P1|STARTED|First Extension (Week 48 to Week 144)|Six participants completed the 48-week randomized phase and did not enroll in the first extension.|38
170896|NCT00528957|420177|P2|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||1
170897|NCT00528957|420178|P1|NOT COMPLETED|Randomized Phase (Baseline to Week 48)||4
170898|NCT00528957|420177|P2|COMPLETED|Randomized Phase (Baseline to Week 48)||48
170899|NCT00528957|420178|P1|COMPLETED|Randomized Phase (Baseline to Week 48)||44
170900|NCT00528957|420177|P2|STARTED|Randomized Phase (Baseline to Week 48)||49
170901|NCT00528957|420178|P1|STARTED|Randomized Phase (Baseline to Week 48)||48
170902|NCT00529035|420221|P1|NOT COMPLETED|Overall Study||1
170903|NCT00529035|420221|P1|COMPLETED|Overall Study|28 evaluable, 1 patient withdrew participation and was not evaluable|28
170904|NCT00529035|420221|P1|STARTED|Overall Study|29 enrolled|29
170905|NCT00529087|420235|P3|NOT COMPLETED|Overall Study||16
170906|NCT00529087|420236|P2|NOT COMPLETED|Overall Study||28
170907|NCT00529087|420237|P1|NOT COMPLETED|Overall Study||28
170908|NCT00529087|420235|P3|COMPLETED|Overall Study||146
170909|NCT00529087|420236|P2|COMPLETED|Overall Study||120
170910|NCT00529087|420237|P1|COMPLETED|Overall Study||122
170911|NCT00529087|420235|P3|STARTED|Overall Study||162
170912|NCT00529087|420236|P2|STARTED|Overall Study||148
170913|NCT00529087|420237|P1|STARTED|Overall Study||150
170914|NCT00529100|420304|P2|NOT COMPLETED|Overall Study||9
170915|NCT00529100|420305|P1|NOT COMPLETED|Overall Study||0
170916|NCT00529100|420304|P2|COMPLETED|Overall Study||24
170917|NCT00529100|420305|P1|COMPLETED|Overall Study||16
170918|NCT00529100|420304|P2|Received at Least 1 Dose of Study Drug|Overall Study||33
170919|NCT00529100|420305|P1|Received at Least 1 Dose of Study Drug|Overall Study||16
170920|NCT00529100|420304|P2|STARTED|Overall Study||33
170921|NCT00529100|420305|P1|STARTED|Overall Study||16
170922|NCT00529126|420323|P4|NOT COMPLETED|Overall Study||0
170923|NCT00529126|420324|P3|NOT COMPLETED|Overall Study||0
170924|NCT00529126|420325|P2|NOT COMPLETED|Overall Study||0
170925|NCT00529126|420326|P1|NOT COMPLETED|Overall Study||0
170926|NCT00529126|420323|P4|COMPLETED|Overall Study||26
170927|NCT00529126|420324|P3|COMPLETED|Overall Study||24
170928|NCT00529126|420325|P2|COMPLETED|Overall Study||25
170929|NCT00529126|420326|P1|COMPLETED|Overall Study||25
170930|NCT00529126|420323|P4|STARTED|Overall Study||26
170931|NCT00529126|420324|P3|STARTED|Overall Study||24
170932|NCT00529126|420325|P2|STARTED|Overall Study||25
170933|NCT00529126|420326|P1|STARTED|Overall Study||25
170934|NCT00529152|420336|P1|NOT COMPLETED|Overall Study||5
170935|NCT00529152|420336|P1|COMPLETED|Overall Study||95
170936|NCT00529152|420336|P1|STARTED|Overall Study||100
170937|NCT00529191|420342|P2|NOT COMPLETED|Overall Study||0
170938|NCT00529191|420343|P1|NOT COMPLETED|Overall Study||3
170939|NCT00529191|420342|P2|COMPLETED|Overall Study||13
170940|NCT00529191|420343|P1|COMPLETED|Overall Study||24
170941|NCT00529191|420342|P2|STARTED|Overall Study||13
170942|NCT00529191|420343|P1|STARTED|Overall Study||27
170943|NCT00529204|420365|P1|NOT COMPLETED|Overall Study||0
170944|NCT00529204|420365|P1|COMPLETED|Overall Study||1
170945|NCT00529204|420365|P1|STARTED|Overall Study||1
170946|NCT00529217|420371|P1|NOT COMPLETED|Overall Study||4
170947|NCT00529217|420371|P1|COMPLETED|Overall Study||8
170948|NCT00529217|420371|P1|STARTED|Overall Study||12
170949|NCT00529243|420376|P1|NOT COMPLETED|Overall Study||3
170950|NCT00529243|420376|P1|COMPLETED|Overall Study||49
170951|NCT00529243|420376|P1|STARTED|Overall Study||52
170952|NCT00529282|420383|P2|NOT COMPLETED|Overall Study||0
170953|NCT00529282|420384|P1|NOT COMPLETED|Overall Study||0
170954|NCT00529282|420383|P2|COMPLETED|Overall Study||2
170955|NCT00529282|420384|P1|COMPLETED|Overall Study||0
170956|NCT00529282|420383|P2|STARTED|Overall Study||2
170957|NCT00529282|420384|P1|STARTED|Overall Study||0
170958|NCT00529308|420398|P2|NOT COMPLETED|Overall Study||1
170959|NCT00529308|420399|P1|NOT COMPLETED|Overall Study||1
170960|NCT00529308|420398|P2|COMPLETED|Overall Study||10
170961|NCT00529308|420399|P1|COMPLETED|Overall Study||8
170962|NCT00529308|420398|P2|STARTED|Overall Study||11
170963|NCT00529308|420399|P1|STARTED|Overall Study||9
170964|NCT00529399|420416|P3|NOT COMPLETED|Overall Study||2
170965|NCT00529399|420417|P2|NOT COMPLETED|Overall Study||1
170966|NCT00529399|420418|P1|NOT COMPLETED|Overall Study||2
170967|NCT00529399|420416|P3|COMPLETED|Overall Study||46
170968|NCT00529399|420417|P2|COMPLETED|Overall Study||48
170969|NCT00529399|420418|P1|COMPLETED|Overall Study||46
170970|NCT00529399|420416|P3|STARTED|Overall Study||48
170971|NCT00529399|420417|P2|STARTED|Overall Study||49
170972|NCT00529399|420418|P1|STARTED|Overall Study||48
170973|NCT00529451|420430|P4|NOT COMPLETED|Overall Study||31
170974|NCT00529451|420431|P3|NOT COMPLETED|Overall Study||40
170975|NCT00529451|420432|P2|NOT COMPLETED|Overall Study||48
170976|NCT00529451|420433|P1|NOT COMPLETED|Overall Study||37
170977|NCT00529451|420430|P4|COMPLETED|Overall Study||299
170978|NCT00529451|420431|P3|COMPLETED|Overall Study||292
170979|NCT00529451|420432|P2|COMPLETED|Overall Study||275
170980|NCT00529451|420433|P1|COMPLETED|Overall Study||294
170981|NCT00529451|420430|P4|STARTED|Overall Study||330
170982|NCT00529451|420431|P3|STARTED|Overall Study||332
170983|NCT00529451|420432|P2|STARTED|Overall Study||323
170984|NCT00529451|420433|P1|STARTED|Overall Study||331
170985|NCT00529464|420460|P3|NOT COMPLETED|Overall Study||0
170986|NCT00529464|420461|P2|NOT COMPLETED|Overall Study||0
170987|NCT00529464|420462|P1|NOT COMPLETED|Overall Study||0
170988|NCT00529464|420460|P3|COMPLETED|Overall Study||0
170989|NCT00529464|420461|P2|COMPLETED|Overall Study||0
170990|NCT00529464|420462|P1|COMPLETED|Overall Study||0
170991|NCT00529464|420460|P3|STARTED|Overall Study||0
170992|NCT00529464|420461|P2|STARTED|Overall Study||0
170993|NCT00529464|420462|P1|STARTED|Overall Study||0
170994|NCT00529516|420473|P3|NOT COMPLETED|Overall Study||1
170995|NCT00529516|420474|P2|NOT COMPLETED|Overall Study||2
170996|NCT00529516|420475|P1|NOT COMPLETED|Overall Study||3
170997|NCT00529516|420473|P3|COMPLETED|Overall Study||288
170998|NCT00529516|420474|P2|COMPLETED|Overall Study||486
170999|NCT00529516|420475|P1|COMPLETED|Overall Study||472
171000|NCT00529516|420473|P3|STARTED|Overall Study||289
171001|NCT00529516|420474|P2|STARTED|Overall Study||488
171002|NCT00529516|420475|P1|STARTED|Overall Study||475
171003|NCT00529529|420546|P3|NOT COMPLETED|Overall Study||31
171004|NCT00529529|420547|P2|NOT COMPLETED|Overall Study||43
171005|NCT00529529|420548|P1|NOT COMPLETED|Overall Study||43
171006|NCT00529529|420546|P3|COMPLETED|Overall Study||238
171007|NCT00529529|420547|P2|COMPLETED|Overall Study||225
171008|NCT00529529|420548|P1|COMPLETED|Overall Study||225
171009|NCT00529529|420546|P3|STARTED|Overall Study||269
171010|NCT00529529|420547|P2|STARTED|Overall Study||268
171011|NCT00529529|420548|P1|STARTED|Overall Study||268
171012|NCT00529542|420606|P2|NOT COMPLETED|Overall Study||1
171013|NCT00529542|420607|P1|NOT COMPLETED|Overall Study||1
171014|NCT00529542|420606|P2|COMPLETED|Overall Study||10
171015|NCT00529542|420607|P1|COMPLETED|Overall Study||8
171016|NCT00529542|420606|P2|STARTED|Overall Study||11
171017|NCT00529542|420607|P1|STARTED|Overall Study||9
171018|NCT00529555|420650|P3|NOT COMPLETED|Overall Study||26
171019|NCT00529555|420651|P2|NOT COMPLETED|Overall Study||30
171020|NCT00529555|420652|P1|NOT COMPLETED|Overall Study||29
171021|NCT00529555|420650|P3|COMPLETED|Overall Study||174
171022|NCT00529555|420651|P2|COMPLETED|Overall Study||172
171023|NCT00529555|420652|P1|COMPLETED|Overall Study||171
171024|NCT00529555|420650|P3|STARTED|Overall Study||200
171025|NCT00529555|420651|P2|STARTED|Overall Study||202
171026|NCT00529555|420652|P1|STARTED|Overall Study||200
171027|NCT00529568|420662|P3|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||102
171028|NCT00529568|420663|P2|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||48
171029|NCT00529568|420664|P1|NOT COMPLETED|Double-bilnd Antiviral Treatment Phase||0
171030|NCT00529568|420662|P3|COMPLETED|Double-bilnd Antiviral Treatment Phase||404
171031|NCT00529568|420663|P2|COMPLETED|Double-bilnd Antiviral Treatment Phase||205
171032|NCT00529568|420664|P1|COMPLETED|Double-bilnd Antiviral Treatment Phase||0
171033|NCT00529568|420662|P3|STARTED|Double-bilnd Antiviral Treatment Phase||506
171034|NCT00529568|420663|P2|STARTED|Double-bilnd Antiviral Treatment Phase||253
171035|NCT00529568|420664|P1|STARTED|Double-bilnd Antiviral Treatment Phase||0
171036|NCT00529568|420662|P3|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
171037|NCT00529568|420663|P2|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
171038|NCT00529568|420664|P1|NOT COMPLETED|Open-label Pre-Antiviral Treatment Phase||46
171039|NCT00529568|420662|P3|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
171040|NCT00529568|420663|P2|COMPLETED|Open-label Pre-Antiviral Treatment Phase||0
171041|NCT00529568|420664|P1|COMPLETED|Open-label Pre-Antiviral Treatment Phase||759
171042|NCT00529568|420662|P3|STARTED|Open-label Pre-Antiviral Treatment Phase||0
171043|NCT00529568|420663|P2|STARTED|Open-label Pre-Antiviral Treatment Phase||0
171044|NCT00529568|420664|P1|STARTED|Open-label Pre-Antiviral Treatment Phase||805
171045|NCT00529633|420714|P2|NOT COMPLETED|Overall Study||1
171046|NCT00529633|420715|P1|NOT COMPLETED|Overall Study||1
171047|NCT00529633|420714|P2|COMPLETED|Overall Study||1
171048|NCT00529633|420715|P1|COMPLETED|Overall Study||1
171049|NCT00529633|420714|P2|STARTED|Overall Study||2
171050|NCT00529633|420715|P1|STARTED|Overall Study||2
171051|NCT00529659|420727|P2|NOT COMPLETED|Overall Study||23
171052|NCT00529659|420728|P1|NOT COMPLETED|Overall Study||11
171053|NCT00529659|420727|P2|COMPLETED|Overall Study||66
171054|NCT00529659|420728|P1|COMPLETED|Overall Study||70
171055|NCT00529659|420727|P2|STARTED|Overall Study||89
171056|NCT00529659|420728|P1|STARTED|Overall Study||81
171057|NCT00529763|420747|P3|NOT COMPLETED|Overall Study||7
171058|NCT00529763|420748|P2|NOT COMPLETED|Overall Study||33
171059|NCT00529763|420749|P1|NOT COMPLETED|Overall Study||10
171060|NCT00529763|420747|P3|COMPLETED|Overall Study|52 participants still on treatment; not completed = off treatment (n=7)|52
171061|NCT00529763|420748|P2|COMPLETED|Overall Study|4 participants still on treatment; not completed = off treatment (n=33)|4
171062|NCT00529763|420749|P1|COMPLETED|Overall Study|15 participants still on treatment; not completed = off treatment (n=10)|15
171063|NCT00529763|420747|P3|STARTED|Overall Study||59
171064|NCT00529763|420748|P2|STARTED|Overall Study|38 participants were enrolled; 37 were treated in this cohort|37
171065|NCT00529763|420749|P1|STARTED|Overall Study||25
171066|NCT00529789|420785|P1|NOT COMPLETED|Study Period IV||6
171067|NCT00529789|420785|P1|COMPLETED|Study Period IV|Includes 1 patient who withdrew at last visit; didn't enter Taper; however received 30 weeks of drug|42
171068|NCT00529789|420785|P1|STARTED|Study Period IV||48
171069|NCT00529789|420785|P1|NOT COMPLETED|Study Period II/III||24
171070|NCT00529789|420785|P1|COMPLETED|Study Period II/III||48
171071|NCT00529789|420785|P1|STARTED|Study Period II/III||72
171072|NCT00538733|420807|P1|NOT COMPLETED|Overall Study||12
171073|NCT00538733|420807|P1|COMPLETED|Overall Study||14
171074|NCT00538733|420807|P1|Removed to Pursue Alternative Theray|Overall Study||2
171075|NCT00538733|420807|P1|Removed to Pursue a Stem Cell Transplant|Overall Study||11
171076|NCT00538733|420807|P1|Removed Due to Progression of Disease|Overall Study||1
171077|NCT00538733|420807|P1|STARTED|Overall Study||26
171078|NCT00538785|420816|P2|NOT COMPLETED|Overall Study||17
171079|NCT00538785|420817|P1|NOT COMPLETED|Overall Study||19
171080|NCT00538785|420816|P2|COMPLETED|Overall Study||595
171081|NCT00538785|420817|P1|COMPLETED|Overall Study||604
171082|NCT00538785|420816|P2|STARTED|Overall Study||612
171083|NCT00538785|420817|P1|STARTED|Overall Study|A subject was randomized without appropriate consent in France and is not included in the results.|623
171084|NCT00538824|420838|P1|NOT COMPLETED|Overall Study||0
171085|NCT00538824|420838|P1|COMPLETED|Overall Study||5
171086|NCT00538824|420838|P1|Progression of Disease|Overall Study||2
171087|NCT00538824|420838|P1|STARTED|Overall Study||5
171088|NCT00538850|420842|P3|NOT COMPLETED|Placebo - Double-blind||3
171089|NCT00538850|420843|P2|NOT COMPLETED|Placebo - Double-blind||0
171090|NCT00538850|420844|P1|NOT COMPLETED|Placebo - Double-blind||0
171091|NCT00538850|420842|P3|COMPLETED|Placebo - Double-blind||95
171092|NCT00538850|420843|P2|COMPLETED|Placebo - Double-blind||0
171093|NCT00538850|420844|P1|COMPLETED|Placebo - Double-blind||0
171094|NCT00538850|420842|P3|STARTED|Placebo - Double-blind||98
171095|NCT00538850|420843|P2|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
171096|NCT00538850|420844|P1|STARTED|Placebo - Double-blind|There were no participants in this reporting group in the double-blind period.|0
171097|NCT00538850|420842|P3|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
171098|NCT00538850|420843|P2|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||3
171099|NCT00538850|420844|P1|NOT COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
171100|NCT00538850|420842|P3|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
171101|NCT00538850|420843|P2|COMPLETED|Fentanyl Sublingual Spray - Double-blind||95
171102|NCT00538850|420844|P1|COMPLETED|Fentanyl Sublingual Spray - Double-blind||0
171103|NCT00538850|420842|P3|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
171104|NCT00538850|420843|P2|STARTED|Fentanyl Sublingual Spray - Double-blind||98
171105|NCT00538850|420844|P1|STARTED|Fentanyl Sublingual Spray - Double-blind|There were no participants in this reporting group in the double-blind period.|0
171106|NCT00538850|420842|P3|NOT COMPLETED|Titration Period||0
171107|NCT00538850|420843|P2|NOT COMPLETED|Titration Period||0
171108|NCT00538850|420844|P1|NOT COMPLETED|Titration Period||32
171109|NCT00538850|420842|P3|COMPLETED|Titration Period||0
171110|NCT00538850|420843|P2|COMPLETED|Titration Period||0
171111|NCT00538850|420844|P1|COMPLETED|Titration Period||98
171112|NCT00538850|420842|P3|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
171113|NCT00538850|420843|P2|STARTED|Titration Period|There were no participants in this reporting group in the titration period.|0
171114|NCT00538850|420844|P1|STARTED|Titration Period||130
171115|NCT00538863|420856|P1|NOT COMPLETED|Open-label Maintenance||106
171116|NCT00538863|420856|P1|COMPLETED|Open-label Maintenance||163
171117|NCT00538863|420856|P1|STARTED|Open-label Maintenance|Five participants who completed the titration period did not start the maintenance period.|269
171118|NCT00538863|420856|P1|NOT COMPLETED|Open-label Titration||45
171119|NCT00538863|420856|P1|COMPLETED|Open-label Titration||184
171120|NCT00538863|420856|P1|STARTED|Open-label Titration||229
171121|NCT00538902|420865|P3|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
171122|NCT00538902|420866|P2|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||64
171123|NCT00538902|420867|P1|NOT COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||36
171124|NCT00538902|420865|P3|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||52
171125|NCT00538902|420866|P2|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||55
171126|NCT00538902|420867|P1|COMPLETED|OL Wk 24 to End (Primary D/C Reasons)||23
171127|NCT00538902|420865|P3|STARTED|OL Wk 24 to End (Primary D/C Reasons)||116
171128|NCT00538902|420866|P2|STARTED|OL Wk 24 to End (Primary D/C Reasons)||119
171129|NCT00538902|420867|P1|STARTED|OL Wk 24 to End (Primary D/C Reasons)||59
171130|NCT00538902|420865|P3|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||5
171131|NCT00538902|420866|P2|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||2
171132|NCT00538902|420867|P1|NOT COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||1
171133|NCT00538902|420865|P3|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||116
171134|NCT00538902|420866|P2|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||119
171230|NCT00539591|421013|P1|NOT COMPLETED|Overall Study||5
171135|NCT00538902|420867|P1|COMPLETED|DB Wk 0 Through 12 (Primary D/C Reasons)||59
171136|NCT00538902|420865|P3|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
171137|NCT00538902|420866|P2|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||121
171138|NCT00538902|420867|P1|STARTED|DB Wk 0 Through 12 (Primary D/C Reasons)||60
171139|NCT00538915|420902|P1|NOT COMPLETED|Overall Study||11
171140|NCT00538915|420902|P1|COMPLETED|Overall Study||52
171141|NCT00538915|420902|P1|STARTED|Overall Study||63
171142|NCT00538980|420906|P1|NOT COMPLETED|Overall Study||10
171143|NCT00538980|420906|P1|COMPLETED|Overall Study||0
171144|NCT00538980|420906|P1|STARTED|Overall Study||10
171145|NCT00539006|420918|P4|NOT COMPLETED|Post-Study||0
171146|NCT00539006|420919|P3|NOT COMPLETED|Post-Study||0
171147|NCT00539006|420920|P2|NOT COMPLETED|Post-Study||0
171148|NCT00539006|420921|P1|NOT COMPLETED|Post-Study||0
171149|NCT00539006|420918|P4|COMPLETED|Post-Study||81
171150|NCT00539006|420919|P3|COMPLETED|Post-Study||77
171151|NCT00539006|420920|P2|COMPLETED|Post-Study||83
171152|NCT00539006|420921|P1|COMPLETED|Post-Study||75
171153|NCT00539006|420918|P4|STARTED|Post-Study||81
171154|NCT00539006|420919|P3|STARTED|Post-Study||77
171155|NCT00539006|420920|P2|STARTED|Post-Study||83
171156|NCT00539006|420921|P1|STARTED|Post-Study||75
171157|NCT00539006|420918|P4|NOT COMPLETED|Treatment Period 2||0
171158|NCT00539006|420919|P3|NOT COMPLETED|Treatment Period 2||0
171159|NCT00539006|420920|P2|NOT COMPLETED|Treatment Period 2||1
171160|NCT00539006|420921|P1|NOT COMPLETED|Treatment Period 2||1
171161|NCT00539006|420918|P4|COMPLETED|Treatment Period 2||81
171162|NCT00539006|420919|P3|COMPLETED|Treatment Period 2||77
171163|NCT00539006|420920|P2|COMPLETED|Treatment Period 2||83
171164|NCT00539006|420921|P1|COMPLETED|Treatment Period 2||75
171165|NCT00539006|420918|P4|STARTED|Treatment Period 2||81
171166|NCT00539006|420919|P3|STARTED|Treatment Period 2||77
171167|NCT00539006|420920|P2|STARTED|Treatment Period 2||84
171168|NCT00539006|420921|P1|STARTED|Treatment Period 2||76
171169|NCT00539006|420918|P4|NOT COMPLETED|Washout||9
171170|NCT00539006|420919|P3|NOT COMPLETED|Washout||16
171171|NCT00539006|420920|P2|NOT COMPLETED|Washout||10
171172|NCT00539006|420921|P1|NOT COMPLETED|Washout||20
171173|NCT00539006|420918|P4|COMPLETED|Washout||81
171174|NCT00539006|420919|P3|COMPLETED|Washout||77
171175|NCT00539006|420920|P2|COMPLETED|Washout||84
171176|NCT00539006|420921|P1|COMPLETED|Washout||76
171177|NCT00539006|420918|P4|STARTED|Washout||90
171178|NCT00539006|420919|P3|STARTED|Washout||93
171179|NCT00539006|420920|P2|STARTED|Washout||94
171180|NCT00539006|420921|P1|STARTED|Washout||96
171181|NCT00539006|420918|P4|NOT COMPLETED|Treatment Period 1||1
171182|NCT00539006|420919|P3|NOT COMPLETED|Treatment Period 1||2
171183|NCT00539006|420920|P2|NOT COMPLETED|Treatment Period 1||0
171184|NCT00539006|420921|P1|NOT COMPLETED|Treatment Period 1||0
171185|NCT00539006|420918|P4|COMPLETED|Treatment Period 1||90
171186|NCT00539006|420919|P3|COMPLETED|Treatment Period 1||93
171187|NCT00539006|420920|P2|COMPLETED|Treatment Period 1||94
171188|NCT00539006|420921|P1|COMPLETED|Treatment Period 1||96
171189|NCT00539006|420918|P4|STARTED|Treatment Period 1||91
171190|NCT00539006|420919|P3|STARTED|Treatment Period 1||95
171191|NCT00539006|420920|P2|STARTED|Treatment Period 1||94
171192|NCT00539006|420921|P1|STARTED|Treatment Period 1||96
171193|NCT00539006|420918|P4|NOT COMPLETED|Pre-treatment||0
171194|NCT00539006|420919|P3|NOT COMPLETED|Pre-treatment||0
171195|NCT00539006|420920|P2|NOT COMPLETED|Pre-treatment||1
171196|NCT00539006|420921|P1|NOT COMPLETED|Pre-treatment||0
171197|NCT00539006|420918|P4|COMPLETED|Pre-treatment||91
171198|NCT00539006|420919|P3|COMPLETED|Pre-treatment||95
171199|NCT00539006|420920|P2|COMPLETED|Pre-treatment||94
171200|NCT00539006|420921|P1|COMPLETED|Pre-treatment||96
171201|NCT00539006|420918|P4|STARTED|Pre-treatment||91
171202|NCT00539006|420919|P3|STARTED|Pre-treatment||95
171203|NCT00539006|420920|P2|STARTED|Pre-treatment||95
171204|NCT00539006|420921|P1|STARTED|Pre-treatment||96
171205|NCT00539513|420953|P2|NOT COMPLETED|Overall Study||2
171206|NCT00539513|420954|P1|NOT COMPLETED|Overall Study||2
171207|NCT00539513|420953|P2|COMPLETED|Overall Study||3
171208|NCT00539513|420954|P1|COMPLETED|Overall Study||3
171209|NCT00539513|420953|P2|Received Allocated Intervention|Overall Study||4
171210|NCT00539513|420954|P1|Received Allocated Intervention|Overall Study||3
171211|NCT00539513|420953|P2|STARTED|Overall Study||5
171212|NCT00539513|420954|P1|STARTED|Overall Study||5
171213|NCT00539526|420969|P3|NOT COMPLETED|Overall Study||2
171214|NCT00539526|420970|P2|NOT COMPLETED|Overall Study||2
171215|NCT00539526|420971|P1|NOT COMPLETED|Overall Study||3
171216|NCT00539526|420969|P3|COMPLETED|Overall Study||36
171217|NCT00539526|420970|P2|COMPLETED|Overall Study||31
171218|NCT00539526|420971|P1|COMPLETED|Overall Study||32
171219|NCT00539526|420969|P3|STARTED|Overall Study||38
171220|NCT00539526|420970|P2|STARTED|Overall Study||33
171221|NCT00539526|420971|P1|STARTED|Overall Study||35
171222|NCT00539539|420987|P2|NOT COMPLETED|Overall Study||0
171223|NCT00539539|420988|P1|NOT COMPLETED|Overall Study||0
171224|NCT00539539|420987|P2|COMPLETED|Overall Study||771
171225|NCT00539539|420988|P1|COMPLETED|Overall Study||815
171226|NCT00539539|420987|P2|STARTED|Overall Study||771
171227|NCT00539539|420988|P1|STARTED|Overall Study||815
171228|NCT00539591|421011|P3|NOT COMPLETED|Overall Study||3
171229|NCT00539591|421012|P2|NOT COMPLETED|Overall Study||2
171231|NCT00539591|421011|P3|COMPLETED|Overall Study||1
171232|NCT00539591|421012|P2|COMPLETED|Overall Study||0
171233|NCT00539591|421013|P1|COMPLETED|Overall Study||18
171234|NCT00539591|421011|P3|STARTED|Overall Study||4
171235|NCT00539591|421012|P2|STARTED|Overall Study||2
171236|NCT00539591|421013|P1|STARTED|Overall Study||23
171237|NCT00539617|421121|P1|NOT COMPLETED|Treatment Period||0
171238|NCT00539617|421121|P1|COMPLETED|Treatment Period||3
171239|NCT00539617|421121|P1|STARTED|Treatment Period||3
171240|NCT00539617|421121|P1|NOT COMPLETED|Run-In Period||1
171241|NCT00539617|421121|P1|COMPLETED|Run-In Period||3
171242|NCT00539617|421121|P1|STARTED|Run-In Period||4
171243|NCT00539617|421121|P1|NOT COMPLETED|Pre-screening Period||3
171244|NCT00539617|421121|P1|COMPLETED|Pre-screening Period||4
171245|NCT00539617|421121|P1|STARTED|Pre-screening Period||7
171246|NCT00539695|421126|P1|NOT COMPLETED|Overall Study||13
171247|NCT00539695|421126|P1|COMPLETED|Overall Study||12
171248|NCT00539695|421126|P1|Evaluable Patients|Overall Study|Patients who received IL-2.|22
171249|NCT00539695|421126|P1|STARTED|Overall Study||25
171250|NCT00539734|421130|P1|NOT COMPLETED|Overall Study||1
171251|NCT00539734|421130|P1|COMPLETED|Overall Study||25
171252|NCT00539734|421130|P1|STARTED|Overall Study||26
171253|NCT00539864|421137|P2|NOT COMPLETED|Overall Study||2
171254|NCT00539864|421138|P1|NOT COMPLETED|Overall Study||1
171255|NCT00539864|421137|P2|COMPLETED|Overall Study||300
171256|NCT00539864|421138|P1|COMPLETED|Overall Study||299
171257|NCT00539864|421137|P2|STARTED|Overall Study||302
171258|NCT00539864|421138|P1|STARTED|Overall Study||300
171259|NCT00539942|421152|P2|NOT COMPLETED|Overall Study||0
171260|NCT00539942|421153|P1|NOT COMPLETED|Overall Study||0
171261|NCT00539942|421152|P2|COMPLETED|Overall Study||3
171262|NCT00539942|421153|P1|COMPLETED|Overall Study||4
171263|NCT00539942|421152|P2|STARTED|Overall Study||3
171264|NCT00539942|421153|P1|STARTED|Overall Study||4
171265|NCT00539994|421164|P3|NOT COMPLETED|Overall Study||2
171266|NCT00539994|421165|P2|NOT COMPLETED|Overall Study||1
171267|NCT00539994|421166|P1|NOT COMPLETED|Overall Study||3
171268|NCT00539994|421164|P3|COMPLETED|Overall Study||13
171269|NCT00539994|421165|P2|COMPLETED|Overall Study||18
171270|NCT00539994|421166|P1|COMPLETED|Overall Study||20
171271|NCT00539994|421164|P3|STARTED|Overall Study||15
171272|NCT00539994|421165|P2|STARTED|Overall Study||19
171273|NCT00539994|421166|P1|STARTED|Overall Study||23
171274|NCT00540046|421205|P2|NOT COMPLETED|Overall Study||23
171275|NCT00540046|421206|P1|NOT COMPLETED|Overall Study||33
171276|NCT00540046|421205|P2|COMPLETED|Overall Study||88
171277|NCT00540046|421206|P1|COMPLETED|Overall Study||71
171278|NCT00540046|421205|P2|STARTED|Overall Study||111
171279|NCT00540046|421206|P1|STARTED|Overall Study||104
171280|NCT00540124|421217|P3|NOT COMPLETED|Overall Study||1
171281|NCT00540124|421218|P2|NOT COMPLETED|Overall Study||3
171282|NCT00540124|421219|P1|NOT COMPLETED|Overall Study||4
171283|NCT00540124|421217|P3|COMPLETED|Overall Study||48
171284|NCT00540124|421218|P2|COMPLETED|Overall Study||48
171285|NCT00540124|421219|P1|COMPLETED|Overall Study||47
171286|NCT00540124|421217|P3|STARTED|Overall Study||49
171287|NCT00540124|421218|P2|STARTED|Overall Study||51
171288|NCT00540124|421219|P1|STARTED|Overall Study||51
171289|NCT00540228|421268|P5|NOT COMPLETED|Overall Study||0
171290|NCT00540228|421269|P4|NOT COMPLETED|Overall Study||0
171291|NCT00540228|421270|P3|NOT COMPLETED|Overall Study||0
171292|NCT00540228|421271|P2|NOT COMPLETED|Overall Study||1
171293|NCT00540228|421272|P1|NOT COMPLETED|Overall Study||3
171294|NCT00540228|421268|P5|COMPLETED|Overall Study||202
171295|NCT00540228|421269|P4|COMPLETED|Overall Study||202
171296|NCT00540228|421270|P3|COMPLETED|Overall Study||204
171297|NCT00540228|421271|P2|COMPLETED|Overall Study||197
171298|NCT00540228|421272|P1|COMPLETED|Overall Study||197
171299|NCT00540228|421268|P5|STARTED|Overall Study||202
171300|NCT00540228|421269|P4|STARTED|Overall Study||202
171301|NCT00540228|421270|P3|STARTED|Overall Study||204
171302|NCT00540228|421271|P2|STARTED|Overall Study||198
171303|NCT00540228|421272|P1|STARTED|Overall Study||200
171304|NCT00540293|421339|P1|NOT COMPLETED|Overall Study||35
171305|NCT00540293|421339|P1|COMPLETED|Overall Study||390
171306|NCT00540293|421339|P1|STARTED|Overall Study||425
171307|NCT00540423|421384|P3|NOT COMPLETED|Open-Label Treatment Period||2
171308|NCT00540423|421385|P2|NOT COMPLETED|Open-Label Treatment Period||0
171309|NCT00540423|421386|P1|NOT COMPLETED|Open-Label Treatment Period||0
171310|NCT00540423|421384|P3|COMPLETED|Open-Label Treatment Period||20
171311|NCT00540423|421385|P2|COMPLETED|Open-Label Treatment Period||0
171312|NCT00540423|421386|P1|COMPLETED|Open-Label Treatment Period||0
171313|NCT00540423|421384|P3|STARTED|Open-Label Treatment Period||22
171314|NCT00540423|421385|P2|STARTED|Open-Label Treatment Period||0
171315|NCT00540423|421386|P1|STARTED|Open-Label Treatment Period||0
171316|NCT00540423|421384|P3|NOT COMPLETED|Double-Blind Treatment Period||0
171317|NCT00540423|421385|P2|NOT COMPLETED|Double-Blind Treatment Period||1
171318|NCT00540423|421386|P1|NOT COMPLETED|Double-Blind Treatment Period||0
171319|NCT00540423|421384|P3|COMPLETED|Double-Blind Treatment Period||0
171320|NCT00540423|421385|P2|COMPLETED|Double-Blind Treatment Period||14
171321|NCT00540423|421386|P1|COMPLETED|Double-Blind Treatment Period||8
171322|NCT00540423|421384|P3|STARTED|Double-Blind Treatment Period||0
171323|NCT00540423|421385|P2|STARTED|Double-Blind Treatment Period||15
171324|NCT00540423|421386|P1|STARTED|Double-Blind Treatment Period||8
171325|NCT00540436|421436|P1|NOT COMPLETED|Second 12-Week Treatment Period||1
171326|NCT00540436|421436|P1|COMPLETED|Second 12-Week Treatment Period||21
171327|NCT00540436|421436|P1|STARTED|Second 12-Week Treatment Period||22
171328|NCT00540436|421436|P1|NOT COMPLETED|First 12-Week Treatment Period||3
171329|NCT00540436|421436|P1|COMPLETED|First 12-Week Treatment Period||22
171330|NCT00540436|421436|P1|STARTED|First 12-Week Treatment Period||25
171331|NCT00540449|421451|P2|NOT COMPLETED|Overall Study||78
171332|NCT00540449|421452|P1|NOT COMPLETED|Overall Study||84
171333|NCT00540449|421451|P2|COMPLETED|Overall Study||266
171334|NCT00540449|421452|P1|COMPLETED|Overall Study||262
171335|NCT00540449|421451|P2|STARTED|Overall Study||344
171336|NCT00540449|421452|P1|STARTED|Overall Study||346
171337|NCT00540514|421476|P2|NOT COMPLETED|Overall Study||266
171338|NCT00540514|421477|P1|NOT COMPLETED|Overall Study||246
171339|NCT00540514|421476|P2|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|265
171340|NCT00540514|421477|P1|COMPLETED|Overall Study|Completed defined as discontinuation due to progressive disease|275
171341|NCT00540514|421476|P2|Biomarker Population|Overall Study||36
171342|NCT00540514|421477|P1|Biomarker Population|Overall Study||35
171343|NCT00540514|421476|P2|Treated|Overall Study||524
171344|NCT00540514|421477|P1|Treated|Overall Study||514
171345|NCT00540514|421476|P2|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|531
171346|NCT00540514|421477|P1|STARTED|Overall Study|Intent-to-treat Population: all randomized patients regardless of treatment received.|521
171347|NCT00540579|421507|P1|NOT COMPLETED|Overall Study||0
171348|NCT00540579|421507|P1|COMPLETED|Overall Study||23
171349|NCT00540579|421507|P1|STARTED|Overall Study||23
171350|NCT00540592|421522|P10|NOT COMPLETED|Overall Study||2
171351|NCT00540592|421523|P9|NOT COMPLETED|Overall Study||1
171352|NCT00540592|421524|P8|NOT COMPLETED|Overall Study||1
171353|NCT00540592|421525|P7|NOT COMPLETED|Overall Study||0
171354|NCT00540592|421526|P6|NOT COMPLETED|Overall Study||0
171355|NCT00540592|421527|P5|NOT COMPLETED|Overall Study||1
171356|NCT00540592|421528|P4|NOT COMPLETED|Overall Study||1
171357|NCT00540592|421529|P3|NOT COMPLETED|Overall Study||1
171358|NCT00540592|421530|P2|NOT COMPLETED|Overall Study||1
171359|NCT00540592|421531|P1|NOT COMPLETED|Overall Study||2
171360|NCT00540592|421522|P10|COMPLETED|Overall Study||201
171361|NCT00540592|421523|P9|COMPLETED|Overall Study||199
171362|NCT00540592|421524|P8|COMPLETED|Overall Study||198
171363|NCT00540592|421525|P7|COMPLETED|Overall Study||198
171364|NCT00540592|421526|P6|COMPLETED|Overall Study||198
171365|NCT00540592|421527|P5|COMPLETED|Overall Study||198
171366|NCT00540592|421528|P4|COMPLETED|Overall Study||201
171367|NCT00540592|421529|P3|COMPLETED|Overall Study||201
171368|NCT00540592|421530|P2|COMPLETED|Overall Study||201
171369|NCT00540592|421531|P1|COMPLETED|Overall Study||202
171370|NCT00540592|421522|P10|Completed at Day 180|Overall Study||189
171371|NCT00540592|421523|P9|Completed at Day 180|Overall Study||198
171372|NCT00540592|421524|P8|Completed at Day 180|Overall Study||193
171373|NCT00540592|421525|P7|Completed at Day 180|Overall Study||196
171374|NCT00540592|421526|P6|Completed at Day 180|Overall Study||198
171375|NCT00540592|421527|P5|Completed at Day 180|Overall Study||195
171376|NCT00540592|421528|P4|Completed at Day 180|Overall Study||197
171377|NCT00540592|421529|P3|Completed at Day 180|Overall Study||197
171378|NCT00540592|421530|P2|Completed at Day 180|Overall Study||201
171379|NCT00540592|421531|P1|Completed at Day 180|Overall Study||200
171380|NCT00540592|421522|P10|STARTED|Overall Study||203
171381|NCT00540592|421523|P9|STARTED|Overall Study||200
171382|NCT00540592|421524|P8|STARTED|Overall Study||199
171383|NCT00540592|421525|P7|STARTED|Overall Study||198
171384|NCT00540592|421526|P6|STARTED|Overall Study||198
171385|NCT00540592|421527|P5|STARTED|Overall Study||199
171386|NCT00540592|421528|P4|STARTED|Overall Study||202
171387|NCT00540592|421529|P3|STARTED|Overall Study||202
171388|NCT00540592|421530|P2|STARTED|Overall Study||202
171389|NCT00540592|421531|P1|STARTED|Overall Study||204
171390|NCT00540644|421765|P2|NOT COMPLETED|Overall Study||9
171391|NCT00540644|421766|P1|NOT COMPLETED|Overall Study||9
171392|NCT00540644|421765|P2|COMPLETED|Overall Study||13
171393|NCT00540644|421766|P1|COMPLETED|Overall Study||39
171394|NCT00540644|421765|P2|STARTED|Overall Study||22
171395|NCT00540644|421766|P1|STARTED|Overall Study||48
171396|NCT00540722|421776|P1|NOT COMPLETED|Overall Study||0
171397|NCT00540722|421776|P1|COMPLETED|Overall Study||56
171398|NCT00540722|421776|P1|STARTED|Overall Study||56
171399|NCT00540969|421786|P2|NOT COMPLETED|Overall Study||0
171400|NCT00540969|421787|P1|NOT COMPLETED|Overall Study||0
171401|NCT00540969|421786|P2|COMPLETED|Overall Study||1
171402|NCT00540969|421787|P1|COMPLETED|Overall Study||2
171403|NCT00540969|421786|P2|STARTED|Overall Study||1
171404|NCT00540969|421787|P1|STARTED|Overall Study||2
171405|NCT00541034|421797|P1|NOT COMPLETED|Overall Study||3
171406|NCT00541034|421797|P1|COMPLETED|Overall Study||46
171407|NCT00541034|421797|P1|STARTED|Overall Study||49
171408|NCT00541099|421801|P1|NOT COMPLETED|Overall Study||3
171409|NCT00541099|421801|P1|COMPLETED|Overall Study||8
171410|NCT00541099|421801|P1|STARTED|Overall Study||11
171411|NCT00541190|421807|P2|NOT COMPLETED|Overall Study||0
171412|NCT00541190|421808|P1|NOT COMPLETED|Overall Study||0
171413|NCT00541190|421807|P2|COMPLETED|Overall Study||11
171414|NCT00541190|421808|P1|COMPLETED|Overall Study||10
171415|NCT00541190|421807|P2|STARTED|Overall Study||11
171416|NCT00541190|421808|P1|STARTED|Overall Study||10
171417|NCT00541229|421822|P6|NOT COMPLETED|Treatment Period III (Week 11)||1
171418|NCT00541229|421823|P5|NOT COMPLETED|Treatment Period III (Week 11)||1
171419|NCT00541229|421824|P4|NOT COMPLETED|Treatment Period III (Week 11)||0
171420|NCT00541229|421825|P3|NOT COMPLETED|Treatment Period III (Week 11)||1
171421|NCT00541229|421826|P2|NOT COMPLETED|Treatment Period III (Week 11)||0
171422|NCT00541229|421827|P1|NOT COMPLETED|Treatment Period III (Week 11)||0
171423|NCT00541229|421822|P6|COMPLETED|Treatment Period III (Week 11)||4
171424|NCT00541229|421823|P5|COMPLETED|Treatment Period III (Week 11)||6
171425|NCT00541229|421824|P4|COMPLETED|Treatment Period III (Week 11)||8
171426|NCT00541229|421825|P3|COMPLETED|Treatment Period III (Week 11)||9
171427|NCT00541229|421826|P2|COMPLETED|Treatment Period III (Week 11)||8
171428|NCT00541229|421827|P1|COMPLETED|Treatment Period III (Week 11)||7
171429|NCT00541229|421822|P6|STARTED|Treatment Period III (Week 11)||5
171430|NCT00541229|421823|P5|STARTED|Treatment Period III (Week 11)||7
171431|NCT00541229|421824|P4|STARTED|Treatment Period III (Week 11)||8
171432|NCT00541229|421825|P3|STARTED|Treatment Period III (Week 11)||10
171433|NCT00541229|421826|P2|STARTED|Treatment Period III (Week 11)||8
171434|NCT00541229|421827|P1|STARTED|Treatment Period III (Week 11)||7
171435|NCT00541229|421822|P6|NOT COMPLETED|Washout Period II (Week 7-10)||3
171436|NCT00541229|421823|P5|NOT COMPLETED|Washout Period II (Week 7-10)||4
171437|NCT00541229|421824|P4|NOT COMPLETED|Washout Period II (Week 7-10)||4
171438|NCT00541229|421825|P3|NOT COMPLETED|Washout Period II (Week 7-10)||2
171439|NCT00541229|421826|P2|NOT COMPLETED|Washout Period II (Week 7-10)||4
171440|NCT00541229|421827|P1|NOT COMPLETED|Washout Period II (Week 7-10)||4
171441|NCT00541229|421822|P6|COMPLETED|Washout Period II (Week 7-10)||5
171442|NCT00541229|421823|P5|COMPLETED|Washout Period II (Week 7-10)||7
171443|NCT00541229|421824|P4|COMPLETED|Washout Period II (Week 7-10)||8
171444|NCT00541229|421825|P3|COMPLETED|Washout Period II (Week 7-10)||10
171445|NCT00541229|421826|P2|COMPLETED|Washout Period II (Week 7-10)||8
171446|NCT00541229|421827|P1|COMPLETED|Washout Period II (Week 7-10)||7
171447|NCT00541229|421822|P6|STARTED|Washout Period II (Week 7-10)||8
171448|NCT00541229|421823|P5|STARTED|Washout Period II (Week 7-10)||11
171449|NCT00541229|421824|P4|STARTED|Washout Period II (Week 7-10)||12
171450|NCT00541229|421825|P3|STARTED|Washout Period II (Week 7-10)||12
171451|NCT00541229|421826|P2|STARTED|Washout Period II (Week 7-10)||12
171452|NCT00541229|421827|P1|STARTED|Washout Period II (Week 7-10)||11
171453|NCT00541229|421822|P6|NOT COMPLETED|Treatment Period II (Week 6)||3
171454|NCT00541229|421823|P5|NOT COMPLETED|Treatment Period II (Week 6)||2
171455|NCT00541229|421824|P4|NOT COMPLETED|Treatment Period II (Week 6)||1
171456|NCT00541229|421825|P3|NOT COMPLETED|Treatment Period II (Week 6)||1
171457|NCT00541229|421826|P2|NOT COMPLETED|Treatment Period II (Week 6)||1
171458|NCT00541229|421827|P1|NOT COMPLETED|Treatment Period II (Week 6)||2
171459|NCT00541229|421822|P6|COMPLETED|Treatment Period II (Week 6)||8
171460|NCT00541229|421823|P5|COMPLETED|Treatment Period II (Week 6)||11
171461|NCT00541229|421824|P4|COMPLETED|Treatment Period II (Week 6)||12
171462|NCT00541229|421825|P3|COMPLETED|Treatment Period II (Week 6)||12
171463|NCT00541229|421826|P2|COMPLETED|Treatment Period II (Week 6)||12
171464|NCT00541229|421827|P1|COMPLETED|Treatment Period II (Week 6)||11
171465|NCT00541229|421822|P6|STARTED|Treatment Period II (Week 6)||11
171466|NCT00541229|421823|P5|STARTED|Treatment Period II (Week 6)||13
171467|NCT00541229|421824|P4|STARTED|Treatment Period II (Week 6)||13
171468|NCT00541229|421825|P3|STARTED|Treatment Period II (Week 6)||13
171469|NCT00541229|421826|P2|STARTED|Treatment Period II (Week 6)||13
171470|NCT00541229|421827|P1|STARTED|Treatment Period II (Week 6)||13
171471|NCT00541229|421822|P6|NOT COMPLETED|Washout Period I (Week 2-5)||5
171472|NCT00541229|421823|P5|NOT COMPLETED|Washout Period I (Week 2-5)||1
171473|NCT00541229|421824|P4|NOT COMPLETED|Washout Period I (Week 2-5)||4
171474|NCT00541229|421825|P3|NOT COMPLETED|Washout Period I (Week 2-5)||4
171475|NCT00541229|421826|P2|NOT COMPLETED|Washout Period I (Week 2-5)||2
171476|NCT00541229|421827|P1|NOT COMPLETED|Washout Period I (Week 2-5)||4
171477|NCT00541229|421822|P6|COMPLETED|Washout Period I (Week 2-5)||11
171478|NCT00541229|421823|P5|COMPLETED|Washout Period I (Week 2-5)||13
171479|NCT00541229|421824|P4|COMPLETED|Washout Period I (Week 2-5)||13
171480|NCT00541229|421825|P3|COMPLETED|Washout Period I (Week 2-5)||13
171481|NCT00541229|421826|P2|COMPLETED|Washout Period I (Week 2-5)||13
171482|NCT00541229|421827|P1|COMPLETED|Washout Period I (Week 2-5)||13
171483|NCT00541229|421822|P6|STARTED|Washout Period I (Week 2-5)||16
171484|NCT00541229|421823|P5|STARTED|Washout Period I (Week 2-5)||14
171485|NCT00541229|421824|P4|STARTED|Washout Period I (Week 2-5)||17
171486|NCT00541229|421825|P3|STARTED|Washout Period I (Week 2-5)||17
171487|NCT00541229|421826|P2|STARTED|Washout Period I (Week 2-5)||15
171488|NCT00541229|421827|P1|STARTED|Washout Period I (Week 2-5)||17
171489|NCT00541229|421822|P6|NOT COMPLETED|Treatment Period I (Week 1)||2
171490|NCT00541229|421823|P5|NOT COMPLETED|Treatment Period I (Week 1)||0
171491|NCT00541229|421824|P4|NOT COMPLETED|Treatment Period I (Week 1)||1
171492|NCT00541229|421825|P3|NOT COMPLETED|Treatment Period I (Week 1)||3
171493|NCT00541229|421826|P2|NOT COMPLETED|Treatment Period I (Week 1)||1
171494|NCT00541229|421827|P1|NOT COMPLETED|Treatment Period I (Week 1)||0
171495|NCT00541229|421822|P6|COMPLETED|Treatment Period I (Week 1)||16
171496|NCT00541229|421823|P5|COMPLETED|Treatment Period I (Week 1)||14
171497|NCT00541229|421824|P4|COMPLETED|Treatment Period I (Week 1)||17
171498|NCT00541229|421825|P3|COMPLETED|Treatment Period I (Week 1)||17
171499|NCT00541229|421826|P2|COMPLETED|Treatment Period I (Week 1)||15
171500|NCT00541229|421827|P1|COMPLETED|Treatment Period I (Week 1)||17
171501|NCT00541229|421822|P6|STARTED|Treatment Period I (Week 1)||18
171502|NCT00541229|421823|P5|STARTED|Treatment Period I (Week 1)||14
171503|NCT00541229|421824|P4|STARTED|Treatment Period I (Week 1)||18
171504|NCT00541229|421825|P3|STARTED|Treatment Period I (Week 1)||20
171505|NCT00541229|421826|P2|STARTED|Treatment Period I (Week 1)||16
171506|NCT00541229|421827|P1|STARTED|Treatment Period I (Week 1)||17
171507|NCT00541242|421837|P2|NOT COMPLETED|Treatment Period 2||7
171508|NCT00541242|421838|P1|NOT COMPLETED|Treatment Period 2||9
171509|NCT00541242|421837|P2|COMPLETED|Treatment Period 2||266
171510|NCT00541242|421838|P1|COMPLETED|Treatment Period 2||261
171511|NCT00541242|421837|P2|STARTED|Treatment Period 2||273
171512|NCT00541242|421838|P1|STARTED|Treatment Period 2||270
171513|NCT00541242|421837|P2|NOT COMPLETED|Treatment Period 1||0
171514|NCT00541242|421838|P1|NOT COMPLETED|Treatment Period 1||0
171515|NCT00541242|421837|P2|COMPLETED|Treatment Period 1|43 of the 586 patients did not enter Treatment Period 2 (Randomized at Week 6)|586
171516|NCT00541242|421838|P1|COMPLETED|Treatment Period 1||0
171517|NCT00541242|421837|P2|STARTED|Treatment Period 1|586 patients were enrolled and received open-label latanoprost for 6 weeks|586
171518|NCT00541242|421838|P1|STARTED|Treatment Period 1||0
171519|NCT00541307|421846|P1|NOT COMPLETED|Overall Study||24
171520|NCT00541307|421846|P1|COMPLETED|Overall Study||95
171521|NCT00541307|421846|P1|STARTED|Overall Study||119
171522|NCT00541346|421854|P1|NOT COMPLETED|Follow-up||1
171523|NCT00541346|421854|P1|COMPLETED|Follow-up||15
171524|NCT00541346|421854|P1|STARTED|Follow-up||16
171525|NCT00541346|421854|P1|NOT COMPLETED|Baseline||0
171526|NCT00541346|421854|P1|COMPLETED|Baseline||16
171527|NCT00541346|421854|P1|STARTED|Baseline||16
171528|NCT00541450|421870|P2|NOT COMPLETED|Phase B||31
171529|NCT00541450|421871|P1|NOT COMPLETED|Phase B||37
171530|NCT00541450|421870|P2|COMPLETED|Phase B||200
171531|NCT00541450|421871|P1|COMPLETED|Phase B||187
171532|NCT00541450|421870|P2|STARTED|Phase B||231
171533|NCT00541450|421871|P1|STARTED|Phase B||224
171534|NCT00541450|421870|P2|NOT COMPLETED|Phase A||17
171535|NCT00541450|421871|P1|NOT COMPLETED|Phase A||20
171536|NCT00541450|421870|P2|COMPLETED|Phase A||231
171537|NCT00541450|421871|P1|COMPLETED|Phase A||224
171538|NCT00541450|421870|P2|STARTED|Phase A||248
171539|NCT00541450|421871|P1|STARTED|Phase A||244
171540|NCT00541593|421889|P1|NOT COMPLETED|Overall Study||0
171541|NCT00541593|421889|P1|COMPLETED|Overall Study||5
171542|NCT00541593|421889|P1|STARTED|Overall Study||5
171543|NCT00541658|421896|P3|NOT COMPLETED|Overall Study||68
171544|NCT00541658|421897|P2|NOT COMPLETED|Overall Study||73
171545|NCT00541658|421898|P1|NOT COMPLETED|Overall Study||60
171546|NCT00541658|421896|P3|COMPLETED|Overall Study||240
171547|NCT00541658|421897|P2|COMPLETED|Overall Study||234
171548|NCT00541658|421898|P1|COMPLETED|Overall Study||248
171549|NCT00541658|421896|P3|ITT Population|Overall Study||308
171550|NCT00541658|421897|P2|ITT Population|Overall Study||307
171551|NCT00541658|421898|P1|ITT Population|Overall Study||307
171552|NCT00541658|421896|P3|STARTED|Overall Study||308
171553|NCT00541658|421897|P2|STARTED|Overall Study||307
171554|NCT00541658|421898|P1|STARTED|Overall Study||308
171555|NCT00541671|422057|P2|NOT COMPLETED|Overall Study||0
171556|NCT00541671|422058|P1|NOT COMPLETED|Overall Study||0
171557|NCT00541671|422057|P2|COMPLETED|Overall Study||12
171558|NCT00541671|422058|P1|COMPLETED|Overall Study||13
171559|NCT00541671|422057|P2|STARTED|Overall Study||12
171560|NCT00541671|422058|P1|STARTED|Overall Study||13
171561|NCT00541775|422067|P3|NOT COMPLETED|Overall Study||8
171562|NCT00541775|422068|P2|NOT COMPLETED|Overall Study||2
171563|NCT00541775|422069|P1|NOT COMPLETED|Overall Study||9
171564|NCT00541775|422067|P3|COMPLETED|Overall Study||84
171565|NCT00541775|422068|P2|COMPLETED|Overall Study||85
171566|NCT00541775|422069|P1|COMPLETED|Overall Study||85
171567|NCT00541775|422067|P3|STARTED|Overall Study||92
171568|NCT00541775|422068|P2|STARTED|Overall Study||87
171569|NCT00541775|422069|P1|STARTED|Overall Study||94
171570|NCT00526799|422085|P2|NOT COMPLETED|Overall Study||1
171571|NCT00526799|422086|P1|NOT COMPLETED|Overall Study||1
171572|NCT00526799|422085|P2|COMPLETED|Overall Study||13
171573|NCT00526799|422086|P1|COMPLETED|Overall Study||15
171574|NCT00526799|422085|P2|STARTED|Overall Study||14
171575|NCT00526799|422086|P1|STARTED|Overall Study||16
171576|NCT00526890|422094|P1|NOT COMPLETED|Overall Study||7
171577|NCT00526890|422094|P1|COMPLETED|Overall Study||14
171578|NCT00526890|422094|P1|STARTED|Overall Study||21
171579|NCT00526994|422106|P3|NOT COMPLETED|Overall Study||107
171580|NCT00526994|422107|P2|NOT COMPLETED|Overall Study||121
171581|NCT00526994|422108|P1|NOT COMPLETED|Overall Study||108
171582|NCT00526994|422106|P3|COMPLETED|Overall Study||791
171583|NCT00526994|422107|P2|COMPLETED|Overall Study||772
171584|NCT00526994|422108|P1|COMPLETED|Overall Study||801
171585|NCT00526994|422106|P3|STARTED|Overall Study||898
171586|NCT00526994|422107|P2|STARTED|Overall Study||893
171587|NCT00526994|422108|P1|STARTED|Overall Study||909
171588|NCT00527072|422125|P1|NOT COMPLETED|Overall Study||36
171589|NCT00527072|422125|P1|COMPLETED|Overall Study||179
171590|NCT00527072|422125|P1|STARTED|Overall Study||215
171591|NCT00527098|422133|P2|NOT COMPLETED|Overall Study||0
171592|NCT00527098|422134|P1|NOT COMPLETED|Overall Study||0
171593|NCT00527098|422133|P2|COMPLETED|Overall Study||83
171594|NCT00527098|422134|P1|COMPLETED|Overall Study||36
171595|NCT00527098|422133|P2|STARTED|Overall Study||83
171596|NCT00527098|422134|P1|STARTED|Overall Study||36
171597|NCT00527111|422141|P2|NOT COMPLETED|Overall Study||22
171598|NCT00527111|422142|P1|NOT COMPLETED|Overall Study||20
171599|NCT00527111|422141|P2|COMPLETED|Overall Study||47
171600|NCT00527111|422142|P1|COMPLETED|Overall Study||50
171601|NCT00527111|422141|P2|STARTED|Overall Study||69
171602|NCT00527111|422142|P1|STARTED|Overall Study||70
171603|NCT00527124|422158|P2|NOT COMPLETED|Overall Study||0
171604|NCT00527124|422159|P1|NOT COMPLETED|Overall Study||0
171605|NCT00527124|422158|P2|COMPLETED|Overall Study||28
171606|NCT00527124|422159|P1|COMPLETED|Overall Study||29
171607|NCT00527124|422158|P2|STARTED|Overall Study||28
171608|NCT00527124|422159|P1|STARTED|Overall Study||29
171609|NCT00527319|422168|P3|NOT COMPLETED|Overall Study||6
171610|NCT00527319|422169|P2|NOT COMPLETED|Overall Study||4
171611|NCT00527319|422170|P1|NOT COMPLETED|Overall Study||6
171612|NCT00527319|422168|P3|COMPLETED|Overall Study||7
171613|NCT00527319|422169|P2|COMPLETED|Overall Study||8
171614|NCT00527319|422170|P1|COMPLETED|Overall Study||6
171615|NCT00527319|422168|P3|STARTED|Overall Study||13
171616|NCT00527319|422169|P2|STARTED|Overall Study||12
171617|NCT00527319|422170|P1|STARTED|Overall Study||12
171618|NCT00527332|422183|P2|NOT COMPLETED|Overall Study||9
171619|NCT00527332|422184|P1|NOT COMPLETED|Overall Study||9
171620|NCT00527332|422183|P2|COMPLETED|Overall Study||80
171621|NCT00527332|422184|P1|COMPLETED|Overall Study||82
171622|NCT00527332|422183|P2|STARTED|Overall Study||89
171623|NCT00527332|422184|P1|STARTED|Overall Study||91
171624|NCT00527397|422190|P1|NOT COMPLETED|Overall Study||24
171625|NCT00527397|422190|P1|COMPLETED|Overall Study||0
171626|NCT00527397|422190|P1|STARTED|Overall Study||24
171627|NCT00527423|422214|P1|NOT COMPLETED|Overall Study||37
171628|NCT00527423|422214|P1|COMPLETED|Overall Study||120
171629|NCT00527423|422214|P1|STARTED|Overall Study||157
171630|NCT00527475|422222|P2|NOT COMPLETED|Overall Study||1
171631|NCT00527475|422223|P1|NOT COMPLETED|Overall Study||3
171632|NCT00527475|422222|P2|COMPLETED|Overall Study||29
171633|NCT00527475|422223|P1|COMPLETED|Overall Study||27
171634|NCT00527475|422222|P2|STARTED|Overall Study||30
171635|NCT00527475|422223|P1|STARTED|Overall Study||30
171636|NCT00527488|422233|P4|NOT COMPLETED|Overall Study||0
171637|NCT00527488|422234|P3|NOT COMPLETED|Overall Study||1
171638|NCT00527488|422235|P2|NOT COMPLETED|Overall Study||1
171639|NCT00527488|422236|P1|NOT COMPLETED|Overall Study||0
171640|NCT00527488|422233|P4|COMPLETED|Overall Study||13
171641|NCT00527488|422234|P3|COMPLETED|Overall Study||12
171642|NCT00527488|422235|P2|COMPLETED|Overall Study||12
171643|NCT00527488|422236|P1|COMPLETED|Overall Study||13
171644|NCT00527488|422233|P4|STARTED|Overall Study||13
171645|NCT00527488|422234|P3|STARTED|Overall Study||13
171646|NCT00527488|422235|P2|STARTED|Overall Study||13
171647|NCT00527488|422236|P1|STARTED|Overall Study||13
171648|NCT00532883|422314|P4|NOT COMPLETED|Overall Study||5
171649|NCT00532883|422315|P3|NOT COMPLETED|Overall Study||4
171650|NCT00532883|422316|P2|NOT COMPLETED|Overall Study||7
171651|NCT00532883|422317|P1|NOT COMPLETED|Overall Study||6
171652|NCT00532883|422314|P4|COMPLETED|Overall Study|Study terminated early.|6
171653|NCT00532883|422315|P3|COMPLETED|Overall Study|Study terminated early.|6
171654|NCT00532883|422316|P2|COMPLETED|Overall Study|Study terminated early.|5
171655|NCT00532883|422317|P1|COMPLETED|Overall Study|Study terminated early.|5
171656|NCT00532883|422314|P4|STARTED|Overall Study||11
171657|NCT00532883|422315|P3|STARTED|Overall Study||10
171658|NCT00532883|422316|P2|STARTED|Overall Study||12
171659|NCT00532883|422317|P1|STARTED|Overall Study||11
171660|NCT00532935|422329|P2|NOT COMPLETED|Overall Study||52
171661|NCT00532935|422330|P1|NOT COMPLETED|Overall Study||51
171662|NCT00532935|422329|P2|COMPLETED|Overall Study||204
171663|NCT00532935|422330|P1|COMPLETED|Overall Study||210
171664|NCT00532935|422329|P2|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|256
171665|NCT00532935|422330|P1|STARTED|Overall Study|Excludes 1 patient who was randomized twice at different sites.|261
171666|NCT00532948|422347|P3|NOT COMPLETED|Overall Study||4
171667|NCT00532948|422348|P2|NOT COMPLETED|Overall Study||5
171668|NCT00532948|422349|P1|NOT COMPLETED|Overall Study||4
171669|NCT00532948|422347|P3|COMPLETED|Overall Study||2
171670|NCT00532948|422348|P2|COMPLETED|Overall Study||9
171671|NCT00532948|422349|P1|COMPLETED|Overall Study||0
171672|NCT00532948|422347|P3|STARTED|Overall Study||6
171673|NCT00532948|422348|P2|STARTED|Overall Study||14
171674|NCT00532948|422349|P1|STARTED|Overall Study||4
171675|NCT00533702|422381|P2|NOT COMPLETED|Overall Study||2
171676|NCT00533702|422382|P1|NOT COMPLETED|Overall Study||5
171677|NCT00533702|422381|P2|COMPLETED|Overall Study||50
171678|NCT00533702|422382|P1|COMPLETED|Overall Study||49
171679|NCT00533702|422381|P2|Received Any Quantity of Study Drug|Overall Study||50
171680|NCT00533702|422382|P1|Received Any Quantity of Study Drug|Overall Study||52
171681|NCT00533702|422381|P2|STARTED|Overall Study||52
171682|NCT00533702|422382|P1|STARTED|Overall Study||54
171683|NCT00533897|422409|P8|NOT COMPLETED|Long Term Extension (LTE)||25
171684|NCT00533897|422410|P7|NOT COMPLETED|Long Term Extension (LTE)||13
171685|NCT00533897|422411|P6|NOT COMPLETED|Long Term Extension (LTE)||0
171686|NCT00533897|422412|P5|NOT COMPLETED|Long Term Extension (LTE)||0
171687|NCT00533897|422413|P4|NOT COMPLETED|Long Term Extension (LTE)||0
171688|NCT00533897|422414|P3|NOT COMPLETED|Long Term Extension (LTE)||0
171689|NCT00533897|422415|P2|NOT COMPLETED|Long Term Extension (LTE)||0
171690|NCT00533897|422416|P1|NOT COMPLETED|Long Term Extension (LTE)||0
171691|NCT00533897|422409|P8|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|88
171692|NCT00533897|422410|P7|COMPLETED|Long Term Extension (LTE)|Participant continued until SC ABA was available in respective country or Sponsor ended study.|24
171693|NCT00533897|422411|P6|COMPLETED|Long Term Extension (LTE)||0
171694|NCT00533897|422412|P5|COMPLETED|Long Term Extension (LTE)||0
171695|NCT00533897|422413|P4|COMPLETED|Long Term Extension (LTE)||0
171696|NCT00533897|422414|P3|COMPLETED|Long Term Extension (LTE)||0
171697|NCT00533897|422415|P2|COMPLETED|Long Term Extension (LTE)||0
171698|NCT00533897|422416|P1|COMPLETED|Long Term Extension (LTE)||0
171699|NCT00533897|422409|P8|STARTED|Long Term Extension (LTE)|117 completed RI but 4 did not enter LTE: 1 lack of efficacy and 3 had their site closed.|113
171700|NCT00533897|422410|P7|STARTED|Long Term Extension (LTE)|37 non-responders in Lead-In entered the LTE directly and didn't participate in DBW or RI Periods.|37
171701|NCT00533897|422411|P6|STARTED|Long Term Extension (LTE)||0
171702|NCT00533897|422412|P5|STARTED|Long Term Extension (LTE)||0
171703|NCT00533897|422413|P4|STARTED|Long Term Extension (LTE)||0
171704|NCT00533897|422414|P3|STARTED|Long Term Extension (LTE)||0
171705|NCT00533897|422415|P2|STARTED|Long Term Extension (LTE)||0
171706|NCT00533897|422416|P1|STARTED|Long Term Extension (LTE)||0
171707|NCT00533897|422409|P8|NOT COMPLETED|Re-introduction (RI) Period 3||0
171708|NCT00533897|422410|P7|NOT COMPLETED|Re-introduction (RI) Period 3||0
171709|NCT00533897|422411|P6|NOT COMPLETED|Re-introduction (RI) Period 3||2
171710|NCT00533897|422412|P5|NOT COMPLETED|Re-introduction (RI) Period 3||0
171711|NCT00533897|422413|P4|NOT COMPLETED|Re-introduction (RI) Period 3||0
171712|NCT00533897|422414|P3|NOT COMPLETED|Re-introduction (RI) Period 3||0
171713|NCT00533897|422415|P2|NOT COMPLETED|Re-introduction (RI) Period 3||0
171714|NCT00533897|422416|P1|NOT COMPLETED|Re-introduction (RI) Period 3||0
171715|NCT00533897|422409|P8|COMPLETED|Re-introduction (RI) Period 3||0
171716|NCT00533897|422410|P7|COMPLETED|Re-introduction (RI) Period 3||0
171717|NCT00533897|422411|P6|COMPLETED|Re-introduction (RI) Period 3||42
171718|NCT00533897|422412|P5|COMPLETED|Re-introduction (RI) Period 3||35
171719|NCT00533897|422413|P4|COMPLETED|Re-introduction (RI) Period 3||40
171720|NCT00533897|422414|P3|COMPLETED|Re-introduction (RI) Period 3||0
171721|NCT00533897|422415|P2|COMPLETED|Re-introduction (RI) Period 3||0
171722|NCT00533897|422416|P1|COMPLETED|Re-introduction (RI) Period 3||0
171723|NCT00533897|422409|P8|STARTED|Re-introduction (RI) Period 3||0
171724|NCT00533897|422410|P7|STARTED|Re-introduction (RI) Period 3||0
171725|NCT00533897|422411|P6|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|44
171726|NCT00533897|422412|P5|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|35
171727|NCT00533897|422413|P4|STARTED|Re-introduction (RI) Period 3|1 participant discontinued the DBW Period due to Lack of Efficacy to enter RI Period early|40
171728|NCT00533897|422414|P3|STARTED|Re-introduction (RI) Period 3||0
171729|NCT00533897|422415|P2|STARTED|Re-introduction (RI) Period 3||0
171730|NCT00533897|422416|P1|STARTED|Re-introduction (RI) Period 3||0
171731|NCT00533897|422409|P8|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171732|NCT00533897|422410|P7|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171733|NCT00533897|422411|P6|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171734|NCT00533897|422412|P5|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171735|NCT00533897|422413|P4|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171736|NCT00533897|422414|P3|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||3
171737|NCT00533897|422415|P2|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||1
171738|NCT00533897|422416|P1|NOT COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171739|NCT00533897|422409|P8|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171740|NCT00533897|422410|P7|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171741|NCT00533897|422411|P6|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171742|NCT00533897|422412|P5|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171743|NCT00533897|422413|P4|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171744|NCT00533897|422414|P3|COMPLETED|Double-blind Withdrawal (DBW) Period 2|Two participants discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|77
171745|NCT00533897|422415|P2|COMPLETED|Double-blind Withdrawal (DBW) Period 2|One participant discontinued the DBW Period due to Lack of Efficacy to enter the RI Period early|39
171746|NCT00533897|422416|P1|COMPLETED|Double-blind Withdrawal (DBW) Period 2||0
171747|NCT00533897|422409|P8|STARTED|Double-blind Withdrawal (DBW) Period 2||0
171748|NCT00533897|422410|P7|STARTED|Double-blind Withdrawal (DBW) Period 2||0
171749|NCT00533897|422411|P6|STARTED|Double-blind Withdrawal (DBW) Period 2||0
171750|NCT00533897|422412|P5|STARTED|Double-blind Withdrawal (DBW) Period 2||0
171751|NCT00533897|422413|P4|STARTED|Double-blind Withdrawal (DBW) Period 2||0
171752|NCT00533897|422414|P3|STARTED|Double-blind Withdrawal (DBW) Period 2||80
171753|NCT00533897|422415|P2|STARTED|Double-blind Withdrawal (DBW) Period 2||40
171754|NCT00533897|422416|P1|STARTED|Double-blind Withdrawal (DBW) Period 2||0
171755|NCT00533897|422409|P8|NOT COMPLETED|Lead-in (LI) Period 1||0
171756|NCT00533897|422410|P7|NOT COMPLETED|Lead-in (LI) Period 1||0
171757|NCT00533897|422411|P6|NOT COMPLETED|Lead-in (LI) Period 1||0
171758|NCT00533897|422412|P5|NOT COMPLETED|Lead-in (LI) Period 1||0
171759|NCT00533897|422413|P4|NOT COMPLETED|Lead-in (LI) Period 1||0
171760|NCT00533897|422414|P3|NOT COMPLETED|Lead-in (LI) Period 1||0
171761|NCT00533897|422415|P2|NOT COMPLETED|Lead-in (LI) Period 1||0
171762|NCT00533897|422416|P1|NOT COMPLETED|Lead-in (LI) Period 1||10
171763|NCT00533897|422409|P8|COMPLETED|Lead-in (LI) Period 1||0
171764|NCT00533897|422410|P7|COMPLETED|Lead-in (LI) Period 1||0
171765|NCT00533897|422411|P6|COMPLETED|Lead-in (LI) Period 1||0
171766|NCT00533897|422412|P5|COMPLETED|Lead-in (LI) Period 1||0
171767|NCT00533897|422413|P4|COMPLETED|Lead-in (LI) Period 1||0
171768|NCT00533897|422414|P3|COMPLETED|Lead-in (LI) Period 1||0
171769|NCT00533897|422415|P2|COMPLETED|Lead-in (LI) Period 1||0
171770|NCT00533897|422416|P1|COMPLETED|Lead-in (LI) Period 1|37 participants entered the LTE directly and did not enter the DBW Period nor receive DBW treatment.|157
171771|NCT00533897|422409|P8|STARTED|Lead-in (LI) Period 1||0
171772|NCT00533897|422410|P7|STARTED|Lead-in (LI) Period 1||0
171773|NCT00533897|422411|P6|STARTED|Lead-in (LI) Period 1||0
171774|NCT00533897|422412|P5|STARTED|Lead-in (LI) Period 1||0
171775|NCT00533897|422413|P4|STARTED|Lead-in (LI) Period 1||0
171776|NCT00533897|422414|P3|STARTED|Lead-in (LI) Period 1||0
171777|NCT00533897|422415|P2|STARTED|Lead-in (LI) Period 1||0
171778|NCT00533897|422416|P1|STARTED|Lead-in (LI) Period 1||167
171779|NCT00533949|422558|P4|NOT COMPLETED|Overall Study||10
171780|NCT00533949|422559|P3|NOT COMPLETED|Overall Study||10
171781|NCT00533949|422560|P2|NOT COMPLETED|Overall Study||14
171782|NCT00533949|422561|P1|NOT COMPLETED|Overall Study||15
171783|NCT00533949|422558|P4|COMPLETED|Overall Study||100
171784|NCT00533949|422559|P3|COMPLETED|Overall Study||137
171785|NCT00533949|422560|P2|COMPLETED|Overall Study||107
171786|NCT00533949|422561|P1|COMPLETED|Overall Study||151
171787|NCT00533949|422558|P4|STARTED|Overall Study||110
171788|NCT00533949|422559|P3|STARTED|Overall Study||147
171789|NCT00533949|422560|P2|STARTED|Overall Study||121
171790|NCT00533949|422561|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|166
171791|NCT00534001|422591|P2|NOT COMPLETED|Overall Study||4
171792|NCT00534001|422592|P1|NOT COMPLETED|Overall Study||5
171793|NCT00534001|422591|P2|COMPLETED|Overall Study||43
171794|NCT00534001|422592|P1|COMPLETED|Overall Study||43
171795|NCT00534001|422591|P2|STARTED|Overall Study||47
171796|NCT00534001|422592|P1|STARTED|Overall Study||48
171797|NCT00534092|422602|P2|NOT COMPLETED|Overall Study||0
171798|NCT00534092|422603|P1|NOT COMPLETED|Overall Study||2
171799|NCT00534092|422602|P2|COMPLETED|Overall Study||14
171800|NCT00534092|422603|P1|COMPLETED|Overall Study||53
171801|NCT00534092|422602|P2|STARTED|Overall Study||14
171802|NCT00534092|422603|P1|STARTED|Overall Study||55
171803|NCT00534105|422628|P2|NOT COMPLETED|Overall Study||39
171804|NCT00534105|422629|P1|NOT COMPLETED|Overall Study||23
171805|NCT00534105|422628|P2|COMPLETED|Overall Study||20
171806|NCT00534105|422629|P1|COMPLETED|Overall Study||24
171807|NCT00534105|422628|P2|STARTED|Overall Study||59
171808|NCT00534105|422629|P1|STARTED|Overall Study||47
171809|NCT00534209|422641|P1|NOT COMPLETED|Overall Study||0
171810|NCT00534209|422641|P1|COMPLETED|Overall Study||1
171811|NCT00534209|422641|P1|STARTED|Overall Study||1
171812|NCT00534248|422647|P2|NOT COMPLETED|Overall Study||673
171813|NCT00534248|422648|P1|NOT COMPLETED|Overall Study||661
171814|NCT00534248|422647|P2|COMPLETED|Overall Study||10555
171815|NCT00534248|422648|P1|COMPLETED|Overall Study||10550
171816|NCT00534248|422647|P2|VACCINATED|Overall Study||11210
171817|NCT00534248|422648|P1|VACCINATED|Overall Study||11186
171818|NCT00534248|422647|P2|STARTED|Overall Study||11228
171819|NCT00534248|422648|P1|STARTED|Overall Study||11211
171820|NCT00534313|422662|P4|NOT COMPLETED|Long-term Period||33
171821|NCT00534313|422663|P3|NOT COMPLETED|Long-term Period||43
171822|NCT00534313|422664|P2|NOT COMPLETED|Long-term Period||34
171823|NCT00534313|422665|P1|NOT COMPLETED|Long-term Period||37
171824|NCT00534313|422662|P4|COMPLETED|Long-term Period||0
171825|NCT00534313|422663|P3|COMPLETED|Long-term Period||0
171826|NCT00534313|422664|P2|COMPLETED|Long-term Period||0
171827|NCT00534313|422665|P1|COMPLETED|Long-term Period||0
171828|NCT00534313|422662|P4|STARTED|Long-term Period||33
171829|NCT00534313|422663|P3|STARTED|Long-term Period||43
171830|NCT00534313|422664|P2|STARTED|Long-term Period||34
171831|NCT00534313|422665|P1|STARTED|Long-term Period||37
171832|NCT00534313|422662|P4|NOT COMPLETED|Short-term Period||9
171833|NCT00534313|422663|P3|NOT COMPLETED|Short-term Period||2
171834|NCT00534313|422664|P2|NOT COMPLETED|Short-term Period||6
171835|NCT00534313|422665|P1|NOT COMPLETED|Short-term Period||6
171836|NCT00534313|422662|P4|COMPLETED|Short-term Period|Completed the short-term study|33
171837|NCT00534313|422663|P3|COMPLETED|Short-term Period|Completed the short-term study|43
171838|NCT00534313|422664|P2|COMPLETED|Short-term Period|Completed the short-term study|34
171839|NCT00534313|422665|P1|COMPLETED|Short-term Period|Completed the short-term study|37
171840|NCT00534313|422662|P4|STARTED|Short-term Period||42
171841|NCT00534313|422663|P3|STARTED|Short-term Period||45
171842|NCT00534313|422664|P2|STARTED|Short-term Period||40
171843|NCT00534313|422665|P1|STARTED|Short-term Period||43
171844|NCT00534352|422758|P1|NOT COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||4
172009|NCT00535132|423039|P2|STARTED|Safety Analysis Set||101
171845|NCT00534352|422758|P1|COMPLETED|Optional Extension: DRV/Rtv + TDF/FTC||14
171846|NCT00534352|422758|P1|STARTED|Optional Extension: DRV/Rtv + TDF/FTC||18
171847|NCT00534352|422758|P1|NOT COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||1
171848|NCT00534352|422758|P1|COMPLETED|Treatment C: DRV/Rtv + TDF/FTC||20
171849|NCT00534352|422758|P1|STARTED|Treatment C: DRV/Rtv + TDF/FTC||21
171850|NCT00534352|422758|P1|NOT COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||0
171851|NCT00534352|422758|P1|COMPLETED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
171852|NCT00534352|422758|P1|STARTED|Treatment B: TMC125 + TDF/FTC + DRV/Rtv||21
171853|NCT00534352|422758|P1|NOT COMPLETED|Treatment A: TMC125 + TDF/FTC||2
171854|NCT00534352|422758|P1|COMPLETED|Treatment A: TMC125 + TDF/FTC||21
171855|NCT00534352|422758|P1|STARTED|Treatment A: TMC125 + TDF/FTC||23
171856|NCT00534365|422800|P2|NOT COMPLETED|Overall Study||7
171857|NCT00534365|422801|P1|NOT COMPLETED|Overall Study||0
171858|NCT00534365|422800|P2|COMPLETED|Overall Study||129
171859|NCT00534365|422801|P1|COMPLETED|Overall Study||127
171860|NCT00534365|422800|P2|Included in Intent to Treat Analysis|Overall Study||136
171861|NCT00534365|422801|P1|Included in Intent to Treat Analysis|Overall Study||127
171862|NCT00534365|422800|P2|Follow up at 12 Months or More|Overall Study||128
171863|NCT00534365|422801|P1|Follow up at 12 Months or More|Overall Study||119
171864|NCT00534365|422800|P2|Any Follow up|Overall Study||135
171865|NCT00534365|422801|P1|Any Follow up|Overall Study||126
171866|NCT00534365|422800|P2|Received Procedure|Overall Study|7 patients excluded due to receipt of sling other than mini-sling|129
171867|NCT00534365|422801|P1|Received Procedure|Overall Study||127
171868|NCT00534365|422800|P2|STARTED|Overall Study||136
171869|NCT00534365|422801|P1|STARTED|Overall Study||127
171870|NCT00534404|422818|P3|NOT COMPLETED|Overall Study||242
171871|NCT00534404|422819|P2|NOT COMPLETED|Overall Study||143
171872|NCT00534404|422820|P1|NOT COMPLETED|Overall Study||180
171873|NCT00534404|422818|P3|COMPLETED|Overall Study||586
171874|NCT00534404|422819|P2|COMPLETED|Overall Study||687
171875|NCT00534404|422820|P1|COMPLETED|Overall Study||647
171876|NCT00534404|422818|P3|3-month Follow up Completed|Overall Study||593
171877|NCT00534404|422819|P2|3-month Follow up Completed|Overall Study||731
171878|NCT00534404|422820|P1|3-month Follow up Completed|Overall Study||682
171879|NCT00534404|422818|P3|1-month Follow up Completed|Overall Study||626
171880|NCT00534404|422819|P2|1-month Follow up Completed|Overall Study||781
171881|NCT00534404|422820|P1|1-month Follow up Completed|Overall Study||742
171882|NCT00534404|422818|P3|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
171883|NCT00534404|422819|P2|Completed at Least 1 Counseling Call|Overall Study|There was no counseling offered in this arm|0
171884|NCT00534404|422820|P1|Completed at Least 1 Counseling Call|Overall Study||813
171885|NCT00534404|422818|P3|Completed Second NRT Order|Overall Study|NRT not available for this arm.|0
171886|NCT00534404|422819|P2|Completed Second NRT Order|Overall Study||789
171887|NCT00534404|422820|P1|Completed Second NRT Order|Overall Study||640
171888|NCT00534404|422818|P3|Completed First NRT Order|Overall Study|NRT was not available for this arm|0
171889|NCT00534404|422819|P2|Completed First NRT Order|Overall Study|Participants could order NRT without completing a web session|821
171890|NCT00534404|422820|P1|Completed First NRT Order|Overall Study||765
171891|NCT00534404|422818|P3|Completed at Least 1 Online Session|Overall Study||658
171892|NCT00534404|422819|P2|Completed at Least 1 Online Session|Overall Study||813
171893|NCT00534404|422820|P1|Completed at Least 1 Online Session|Overall Study||781
171894|NCT00534404|422818|P3|STARTED|Overall Study||828
171895|NCT00534404|422819|P2|STARTED|Overall Study||830
171896|NCT00534404|422820|P1|STARTED|Overall Study||827
171897|NCT00534417|422834|P1|NOT COMPLETED|Overall Study||0
171898|NCT00534417|422834|P1|COMPLETED|Overall Study||41
171899|NCT00534417|422834|P1|STARTED|Overall Study||41
171900|NCT00534495|422848|P3|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||11
171901|NCT00534495|422849|P2|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
171902|NCT00534495|422850|P1|NOT COMPLETED|Long Term Ext. Phase Week 24-month 21||0
171903|NCT00534495|422848|P3|COMPLETED|Long Term Ext. Phase Week 24-month 21||29
171904|NCT00534495|422849|P2|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
171905|NCT00534495|422850|P1|COMPLETED|Long Term Ext. Phase Week 24-month 21||0
171906|NCT00534495|422848|P3|STARTED|Long Term Ext. Phase Week 24-month 21||40
171907|NCT00534495|422849|P2|STARTED|Long Term Ext. Phase Week 24-month 21||0
171908|NCT00534495|422850|P1|STARTED|Long Term Ext. Phase Week 24-month 21||0
171909|NCT00534495|422848|P3|NOT COMPLETED|All Active Treatment Phase Week 4-24||0
171910|NCT00534495|422849|P2|NOT COMPLETED|All Active Treatment Phase Week 4-24||9
171911|NCT00534495|422850|P1|NOT COMPLETED|All Active Treatment Phase Week 4-24||4
171912|NCT00534495|422848|P3|COMPLETED|All Active Treatment Phase Week 4-24||0
171913|NCT00534495|422849|P2|COMPLETED|All Active Treatment Phase Week 4-24||25
171914|NCT00534495|422850|P1|COMPLETED|All Active Treatment Phase Week 4-24||32
171915|NCT00534495|422848|P3|STARTED|All Active Treatment Phase Week 4-24||0
171916|NCT00534495|422849|P2|STARTED|All Active Treatment Phase Week 4-24||34
171917|NCT00534495|422850|P1|STARTED|All Active Treatment Phase Week 4-24||36
171918|NCT00534495|422848|P3|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
171919|NCT00534495|422849|P2|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||1
171920|NCT00534495|422850|P1|NOT COMPLETED|Double Blind Placebo Phase Week 0-4||0
171921|NCT00534495|422848|P3|COMPLETED|Double Blind Placebo Phase Week 0-4||0
171922|NCT00534495|422849|P2|COMPLETED|Double Blind Placebo Phase Week 0-4||34
172835|NCT00546273|424888|P2|STARTED|IV||0
171923|NCT00534495|422850|P1|COMPLETED|Double Blind Placebo Phase Week 0-4||36
171924|NCT00534495|422848|P3|STARTED|Double Blind Placebo Phase Week 0-4||0
171925|NCT00534495|422849|P2|STARTED|Double Blind Placebo Phase Week 0-4||35
171926|NCT00534495|422850|P1|STARTED|Double Blind Placebo Phase Week 0-4||36
171927|NCT00534599|422875|P2|NOT COMPLETED|Overall Study||32
171928|NCT00534599|422876|P1|NOT COMPLETED|Overall Study||57
171929|NCT00534599|422875|P2|COMPLETED|Overall Study||168
171930|NCT00534599|422876|P1|COMPLETED|Overall Study||152
171931|NCT00534599|422875|P2|STARTED|Overall Study|Randomized|200
171932|NCT00534599|422876|P1|STARTED|Overall Study|Randomized|209
171933|NCT00534638|422912|P2|NOT COMPLETED|Overall Study||11791
171934|NCT00534638|422913|P1|NOT COMPLETED|Overall Study||6491
171935|NCT00534638|422912|P2|COMPLETED|Overall Study||5547
171936|NCT00534638|422913|P1|COMPLETED|Overall Study||8346
171937|NCT00534638|422912|P2|STARTED|Overall Study||17338
171938|NCT00534638|422913|P1|STARTED|Overall Study||14837
171939|NCT00534794|422948|P2|NOT COMPLETED|Overall Study||0
171940|NCT00534794|422949|P1|NOT COMPLETED|Overall Study||0
171941|NCT00534794|422948|P2|COMPLETED|Overall Study||39
171942|NCT00534794|422949|P1|COMPLETED|Overall Study||40
171943|NCT00534794|422948|P2|STARTED|Overall Study||39
171944|NCT00534794|422949|P1|STARTED|Overall Study||40
171945|NCT00534833|422959|P2|NOT COMPLETED|Overall Study||0
171946|NCT00534833|422960|P1|NOT COMPLETED|Overall Study||0
171947|NCT00534833|422959|P2|COMPLETED|Overall Study||180
171948|NCT00534833|422960|P1|COMPLETED|Overall Study||182
171949|NCT00534833|422959|P2|STARTED|Overall Study||180
171950|NCT00534833|422960|P1|STARTED|Overall Study||182
171951|NCT00534937|422972|P2|NOT COMPLETED|Overall Study||12
171952|NCT00534937|422973|P1|NOT COMPLETED|Overall Study||8
171953|NCT00534937|422972|P2|COMPLETED|Overall Study||35
171954|NCT00534937|422973|P1|COMPLETED|Overall Study||34
171955|NCT00534937|422972|P2|STARTED|Overall Study||47
171956|NCT00534937|422973|P1|STARTED|Overall Study||42
171957|NCT00534976|422987|P2|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||0
171958|NCT00534976|422988|P1|NOT COMPLETED|Period 3: Crossover Placebo/ Montelukast||2
171959|NCT00534976|422987|P2|COMPLETED|Period 3: Crossover Placebo/ Montelukast||32
171960|NCT00534976|422988|P1|COMPLETED|Period 3: Crossover Placebo/ Montelukast||31
171961|NCT00534976|422987|P2|STARTED|Period 3: Crossover Placebo/ Montelukast||32
171962|NCT00534976|422988|P1|STARTED|Period 3: Crossover Placebo/ Montelukast||33
171963|NCT00534976|422987|P2|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||1
171964|NCT00534976|422988|P1|NOT COMPLETED|Period 2: Treatment Montelukast/ Placebo||0
171965|NCT00534976|422987|P2|COMPLETED|Period 2: Treatment Montelukast/ Placebo||32
171966|NCT00534976|422988|P1|COMPLETED|Period 2: Treatment Montelukast/ Placebo||33
171967|NCT00534976|422987|P2|STARTED|Period 2: Treatment Montelukast/ Placebo||33
171968|NCT00534976|422988|P1|STARTED|Period 2: Treatment Montelukast/ Placebo||33
171969|NCT00534976|422987|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
171970|NCT00534976|422988|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
171971|NCT00534976|422987|P2|COMPLETED|Period 1: Placebo Run-in||33
171972|NCT00534976|422988|P1|COMPLETED|Period 1: Placebo Run-in||33
171973|NCT00534976|422987|P2|STARTED|Period 1: Placebo Run-in||33
171974|NCT00534976|422988|P1|STARTED|Period 1: Placebo Run-in||33
171975|NCT00535002|423016|P8|NOT COMPLETED|Overall Study||0
171976|NCT00535002|423017|P7|NOT COMPLETED|Overall Study||0
171977|NCT00535002|423018|P6|NOT COMPLETED|Overall Study||0
171978|NCT00535002|423019|P5|NOT COMPLETED|Overall Study||0
171979|NCT00535002|423020|P4|NOT COMPLETED|Overall Study||0
171980|NCT00535002|423021|P3|NOT COMPLETED|Overall Study||0
171981|NCT00535002|423022|P2|NOT COMPLETED|Overall Study||0
171982|NCT00535002|423023|P1|NOT COMPLETED|Overall Study||0
171983|NCT00535002|423016|P8|COMPLETED|Overall Study||16
171984|NCT00535002|423017|P7|COMPLETED|Overall Study||12
171985|NCT00535002|423018|P6|COMPLETED|Overall Study||17
171986|NCT00535002|423019|P5|COMPLETED|Overall Study||9
171987|NCT00535002|423020|P4|COMPLETED|Overall Study||14
171988|NCT00535002|423021|P3|COMPLETED|Overall Study||13
171989|NCT00535002|423022|P2|COMPLETED|Overall Study||12
171990|NCT00535002|423023|P1|COMPLETED|Overall Study||19
171991|NCT00535002|423016|P8|STARTED|Overall Study||16
171992|NCT00535002|423017|P7|STARTED|Overall Study||12
171993|NCT00535002|423018|P6|STARTED|Overall Study||17
171994|NCT00535002|423019|P5|STARTED|Overall Study||9
171995|NCT00535002|423020|P4|STARTED|Overall Study||14
171996|NCT00535002|423021|P3|STARTED|Overall Study||13
171997|NCT00535002|423022|P2|STARTED|Overall Study||12
171998|NCT00535002|423023|P1|STARTED|Overall Study||19
171999|NCT00535132|423039|P2|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
172000|NCT00535132|423040|P1|NOT COMPLETED|Intent-to-Treat (ITT) Analysis Set||3
172001|NCT00535132|423039|P2|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|96
172002|NCT00535132|423040|P1|COMPLETED|Intent-to-Treat (ITT) Analysis Set|Patients who received at least one dose of study drug and have some follow-up efficacy data.|95
172003|NCT00535132|423039|P2|STARTED|Intent-to-Treat (ITT) Analysis Set||99
172004|NCT00535132|423040|P1|STARTED|Intent-to-Treat (ITT) Analysis Set||98
172005|NCT00535132|423039|P2|NOT COMPLETED|Safety Analysis Set||2
172006|NCT00535132|423040|P1|NOT COMPLETED|Safety Analysis Set||2
172007|NCT00535132|423039|P2|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|99
172008|NCT00535132|423040|P1|COMPLETED|Safety Analysis Set|Two patients were randomized but not treated.|98
172010|NCT00535132|423040|P1|STARTED|Safety Analysis Set||100
172011|NCT00535132|423039|P2|NOT COMPLETED|Randomized Population||0
172012|NCT00535132|423040|P1|NOT COMPLETED|Randomized Population||0
172013|NCT00535132|423039|P2|COMPLETED|Randomized Population||101
172014|NCT00535132|423040|P1|COMPLETED|Randomized Population||100
172015|NCT00535132|423039|P2|STARTED|Randomized Population|Number of Subjects Randomized|101
172016|NCT00535132|423040|P1|STARTED|Randomized Population|Number of Subjects Randomized|100
172017|NCT00535145|423090|P1|NOT COMPLETED|Phase II||15
172018|NCT00535145|423090|P1|COMPLETED|Phase II||69
172019|NCT00535145|423090|P1|STARTED|Phase II|Of the 85 participants who completed Phase 1, 84 met the criteria to enroll into Phase 2|84
172020|NCT00535145|423090|P1|NOT COMPLETED|Phase I||29
172021|NCT00535145|423090|P1|COMPLETED|Phase I||85
172022|NCT00535145|423090|P1|STARTED|Phase I||114
172023|NCT00535223|423102|P2|NOT COMPLETED|Overall Study||1
172024|NCT00535223|423103|P1|NOT COMPLETED|Overall Study||4
172025|NCT00535223|423102|P2|COMPLETED|Overall Study||39
172026|NCT00535223|423103|P1|COMPLETED|Overall Study||37
172027|NCT00535223|423102|P2|STARTED|Overall Study|Patients were randomized in cohorts of ten.|40
172028|NCT00535223|423103|P1|STARTED|Overall Study|Patients were randomized in cohorts of ten.|41
172029|NCT00535262|423111|P1|NOT COMPLETED|Overall Study||3
172030|NCT00535262|423111|P1|COMPLETED|Overall Study|Pharmaceutical company withdrew supply of EmSam prematurely before protocol was complete.|0
172031|NCT00535262|423111|P1|STARTED|Overall Study|3 patients were enrolled in the study. Data was collected for only two weeks before funding expired.|3
172032|NCT00535288|423120|P5|NOT COMPLETED|Overall Study||42
172033|NCT00535288|423121|P4|NOT COMPLETED|Overall Study||29
172034|NCT00535288|423122|P3|NOT COMPLETED|Overall Study||33
172035|NCT00535288|423123|P2|NOT COMPLETED|Overall Study||32
172036|NCT00535288|423124|P1|NOT COMPLETED|Overall Study||54
172037|NCT00535288|423120|P5|COMPLETED|Overall Study||116
172038|NCT00535288|423121|P4|COMPLETED|Overall Study||122
172039|NCT00535288|423122|P3|COMPLETED|Overall Study||127
172040|NCT00535288|423123|P2|COMPLETED|Overall Study||130
172041|NCT00535288|423124|P1|COMPLETED|Overall Study||260
172042|NCT00535288|423120|P5|STARTED|Overall Study|One participant randomized to receive placebo received esmirtazapine 18 mg.|158
172043|NCT00535288|423121|P4|STARTED|Overall Study||151
172044|NCT00535288|423122|P3|STARTED|Overall Study||160
172045|NCT00535288|423123|P2|STARTED|Overall Study||162
172046|NCT00535288|423124|P1|STARTED|Overall Study|2 participants randomized to receive placebo did not receive placebo|314
172047|NCT00535301|423203|P2|NOT COMPLETED|Overall Study||5
172048|NCT00535301|423204|P1|NOT COMPLETED|Overall Study||5
172049|NCT00535301|423203|P2|COMPLETED|Overall Study||33
172050|NCT00535301|423204|P1|COMPLETED|Overall Study||33
172051|NCT00535301|423203|P2|STARTED|Overall Study||38
172052|NCT00535301|423204|P1|STARTED|Overall Study||38
172053|NCT00535392|423214|P1|NOT COMPLETED|Overall Study||0
172054|NCT00535392|423214|P1|COMPLETED|Overall Study||33
172055|NCT00535392|423214|P1|STARTED|Overall Study||33
172056|NCT00535405|423225|P5|NOT COMPLETED|Overall Study||16
172057|NCT00535405|423226|P4|NOT COMPLETED|Overall Study||22
172058|NCT00535405|423227|P3|NOT COMPLETED|Overall Study||18
172059|NCT00535405|423228|P2|NOT COMPLETED|Overall Study||26
172060|NCT00535405|423229|P1|NOT COMPLETED|Overall Study||17
172061|NCT00535405|423225|P5|COMPLETED|Overall Study||241
172062|NCT00535405|423226|P4|COMPLETED|Overall Study||235
172063|NCT00535405|423227|P3|COMPLETED|Overall Study||241
172064|NCT00535405|423228|P2|COMPLETED|Overall Study||233
172065|NCT00535405|423229|P1|COMPLETED|Overall Study||240
172066|NCT00535405|423225|P5|STARTED|Overall Study||257
172067|NCT00535405|423226|P4|STARTED|Overall Study||257
172068|NCT00535405|423227|P3|STARTED|Overall Study||259
172069|NCT00535405|423228|P2|STARTED|Overall Study||259
172070|NCT00535405|423229|P1|STARTED|Overall Study||257
172071|NCT00535496|423268|P4|NOT COMPLETED|Overall Study||0
172072|NCT00535496|423269|P3|NOT COMPLETED|Overall Study||0
172073|NCT00535496|423270|P2|NOT COMPLETED|Overall Study||2
172074|NCT00535496|423271|P1|NOT COMPLETED|Overall Study||0
172075|NCT00535496|423268|P4|COMPLETED|Overall Study||31
172076|NCT00535496|423269|P3|COMPLETED|Overall Study||30
172077|NCT00535496|423270|P2|COMPLETED|Overall Study||13
172078|NCT00535496|423271|P1|COMPLETED|Overall Study||15
172079|NCT00535496|423268|P4|All-Subjects-Treated (AST) Group|Overall Study||31
172080|NCT00535496|423269|P3|All-Subjects-Treated (AST) Group|Overall Study||30
172081|NCT00535496|423270|P2|All-Subjects-Treated (AST) Group|Overall Study||14
172082|NCT00535496|423271|P1|All-Subjects-Treated (AST) Group|Overall Study||15
172083|NCT00535496|423268|P4|STARTED|Overall Study||31
172084|NCT00535496|423269|P3|STARTED|Overall Study||30
172085|NCT00535496|423270|P2|STARTED|Overall Study||15
172086|NCT00535496|423271|P1|STARTED|Overall Study||15
172087|NCT00535587|423290|P4|NOT COMPLETED|Overall Study||13
172088|NCT00535587|423291|P3|NOT COMPLETED|Overall Study||8
172089|NCT00535587|423292|P2|NOT COMPLETED|Overall Study||11
172090|NCT00535587|423293|P1|NOT COMPLETED|Overall Study||10
172091|NCT00535587|423290|P4|COMPLETED|Overall Study||41
172092|NCT00535587|423291|P3|COMPLETED|Overall Study||39
172093|NCT00535587|423292|P2|COMPLETED|Overall Study||42
172094|NCT00535587|423293|P1|COMPLETED|Overall Study||43
172095|NCT00535587|423290|P4|STARTED|Overall Study||54
172096|NCT00535587|423291|P3|STARTED|Overall Study||47
172097|NCT00535587|423292|P2|STARTED|Overall Study||53
172098|NCT00535587|423293|P1|STARTED|Overall Study||53
172099|NCT00535652|423301|P1|NOT COMPLETED|Overall Study||3
172100|NCT00535652|423301|P1|COMPLETED|Overall Study||20
172101|NCT00535652|423301|P1|STARTED|Overall Study||23
172102|NCT00535730|423307|P2|NOT COMPLETED|Overall Study||7
172103|NCT00535730|423308|P1|NOT COMPLETED|Overall Study||2
172104|NCT00535730|423307|P2|COMPLETED|Overall Study||230
172105|NCT00535730|423308|P1|COMPLETED|Overall Study||234
172106|NCT00535730|423307|P2|STARTED|Overall Study|Two subjects were allocated but not vaccinated making the number of subjects vaccinated 235|237
172107|NCT00535730|423308|P1|STARTED|Overall Study||236
172108|NCT00535769|423327|P2|NOT COMPLETED|Overall Study||0
172109|NCT00535769|423328|P1|NOT COMPLETED|Overall Study||0
172110|NCT00535769|423327|P2|COMPLETED|Overall Study||35
172111|NCT00535769|423328|P1|COMPLETED|Overall Study||35
172112|NCT00535769|423327|P2|STARTED|Overall Study||35
172113|NCT00535769|423328|P1|STARTED|Overall Study||35
172114|NCT00535782|423339|P3|NOT COMPLETED|Part 2: 80-Week Open-label Period||26
172115|NCT00535782|423340|P2|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
172116|NCT00535782|423341|P1|NOT COMPLETED|Part 2: 80-Week Open-label Period||0
172117|NCT00535782|423339|P3|COMPLETED|Part 2: 80-Week Open-label Period||98
172118|NCT00535782|423340|P2|COMPLETED|Part 2: 80-Week Open-label Period||0
172119|NCT00535782|423341|P1|COMPLETED|Part 2: 80-Week Open-label Period||0
172120|NCT00535782|423339|P3|STARTED|Part 2: 80-Week Open-label Period||124
172121|NCT00535782|423340|P2|STARTED|Part 2: 80-Week Open-label Period||0
172122|NCT00535782|423341|P1|STARTED|Part 2: 80-Week Open-label Period||0
172123|NCT00535782|423339|P3|NOT COMPLETED|Part 1: 24-Week Double-blind Period||0
172124|NCT00535782|423340|P2|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
172125|NCT00535782|423341|P1|NOT COMPLETED|Part 1: 24-Week Double-blind Period||4
172126|NCT00535782|423339|P3|COMPLETED|Part 1: 24-Week Double-blind Period||0
172127|NCT00535782|423340|P2|COMPLETED|Part 1: 24-Week Double-blind Period||59
172128|NCT00535782|423341|P1|COMPLETED|Part 1: 24-Week Double-blind Period||65
172129|NCT00535782|423339|P3|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
172130|NCT00535782|423340|P2|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||62
172131|NCT00535782|423341|P1|Treated With Placebo + MTX|Part 1: 24-Week Double-blind Period||0
172132|NCT00535782|423339|P3|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||0
172133|NCT00535782|423340|P2|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period|1 misrandomized patient received the TCZ in error, and 1 patient received TCZ as rescue therapy.|2
172134|NCT00535782|423341|P1|Treated With TCZ + MTX|Part 1: 24-Week Double-blind Period||69
172135|NCT00535782|423339|P3|STARTED|Part 1: 24-Week Double-blind Period||0
172136|NCT00535782|423340|P2|STARTED|Part 1: 24-Week Double-blind Period||63
172137|NCT00535782|423341|P1|STARTED|Part 1: 24-Week Double-blind Period||69
172138|NCT00535821|423358|P2|NOT COMPLETED|Overall Study||0
172139|NCT00535821|423359|P1|NOT COMPLETED|Overall Study||0
172140|NCT00535821|423358|P2|COMPLETED|Overall Study||3
172141|NCT00535821|423359|P1|COMPLETED|Overall Study||2
172142|NCT00535821|423358|P2|STARTED|Overall Study||3
172143|NCT00535821|423359|P1|STARTED|Overall Study||2
172144|NCT00535847|423368|P3|NOT COMPLETED|Overall Study||2
172145|NCT00535847|423369|P2|NOT COMPLETED|Overall Study||14
172146|NCT00535847|423370|P1|NOT COMPLETED|Overall Study||22
172147|NCT00535847|423368|P3|COMPLETED|Overall Study||0
172148|NCT00535847|423369|P2|COMPLETED|Overall Study||20
172149|NCT00535847|423370|P1|COMPLETED|Overall Study||59
172150|NCT00535847|423368|P3|STARTED|Overall Study||2
172151|NCT00535847|423369|P2|STARTED|Overall Study||34
172152|NCT00535847|423370|P1|STARTED|Overall Study||81
172153|NCT00535873|423394|P1|NOT COMPLETED|Overall Study||0
172154|NCT00535873|423394|P1|COMPLETED|Overall Study||60
172155|NCT00535873|423394|P1|STARTED|Overall Study||60
172156|NCT00535938|423400|P2|NOT COMPLETED|Overall Study||462
172157|NCT00535938|423401|P1|NOT COMPLETED|Overall Study||391
172158|NCT00535938|423400|P2|COMPLETED|Overall Study||404
172159|NCT00535938|423401|P1|COMPLETED|Overall Study||115
172160|NCT00535938|423400|P2|STARTED|Overall Study||866
172161|NCT00535938|423401|P1|STARTED|Overall Study||506
172162|NCT00536107|423439|P2|NOT COMPLETED|Overall Study||6
172163|NCT00536107|423440|P1|NOT COMPLETED|Overall Study||8
172164|NCT00536107|423439|P2|COMPLETED|Overall Study||0
172165|NCT00536107|423440|P1|COMPLETED|Overall Study||0
172166|NCT00536107|423439|P2|STARTED|Overall Study||6
172167|NCT00536107|423440|P1|STARTED|Overall Study||8
172168|NCT00536120|423450|P2|NOT COMPLETED|Overall Study||3
172169|NCT00536120|423451|P1|NOT COMPLETED|Overall Study||6
172170|NCT00536120|423450|P2|COMPLETED|Overall Study||27
172171|NCT00536120|423451|P1|COMPLETED|Overall Study||24
172172|NCT00536120|423450|P2|STARTED|Overall Study||30
172173|NCT00536120|423451|P1|STARTED|Overall Study||30
172174|NCT00536172|423465|P2|NOT COMPLETED|Overall Study||9
172175|NCT00536172|423466|P1|NOT COMPLETED|Overall Study||14
172176|NCT00536172|423465|P2|COMPLETED|Overall Study||65
172177|NCT00536172|423466|P1|COMPLETED|Overall Study||60
172178|NCT00536172|423465|P2|STARTED|Overall Study||74
172179|NCT00536172|423466|P1|STARTED|Overall Study||74
172180|NCT00541970|423476|P4|NOT COMPLETED|Month 60||72
172181|NCT00541970|423477|P3|NOT COMPLETED|Month 60||82
172182|NCT00541970|423478|P2|NOT COMPLETED|Month 60||77
172183|NCT00541970|423479|P1|NOT COMPLETED|Month 60||78
172184|NCT00541970|423476|P4|COMPLETED|Month 60||167
172185|NCT00541970|423477|P3|COMPLETED|Month 60||158
172186|NCT00541970|423478|P2|COMPLETED|Month 60||164
172187|NCT00541970|423479|P1|COMPLETED|Month 60||162
172188|NCT00541970|423476|P4|STARTED|Month 60||239
172189|NCT00541970|423477|P3|STARTED|Month 60||240
172190|NCT00541970|423478|P2|STARTED|Month 60||241
172191|NCT00541970|423479|P1|STARTED|Month 60||240
172192|NCT00541970|423476|P4|NOT COMPLETED|Month 48||75
172193|NCT00541970|423477|P3|NOT COMPLETED|Month 48||73
172194|NCT00541970|423478|P2|NOT COMPLETED|Month 48||73
172195|NCT00541970|423479|P1|NOT COMPLETED|Month 48||71
172196|NCT00541970|423476|P4|COMPLETED|Month 48||164
172197|NCT00541970|423477|P3|COMPLETED|Month 48||167
172198|NCT00541970|423478|P2|COMPLETED|Month 48||168
172199|NCT00541970|423479|P1|COMPLETED|Month 48||169
172200|NCT00541970|423476|P4|STARTED|Month 48||239
172201|NCT00541970|423477|P3|STARTED|Month 48||240
172202|NCT00541970|423478|P2|STARTED|Month 48||241
172203|NCT00541970|423479|P1|STARTED|Month 48||240
172204|NCT00541970|423476|P4|NOT COMPLETED|Month 36||60
172205|NCT00541970|423477|P3|NOT COMPLETED|Month 36||66
172206|NCT00541970|423478|P2|NOT COMPLETED|Month 36||66
172207|NCT00541970|423479|P1|NOT COMPLETED|Month 36||61
172208|NCT00541970|423476|P4|COMPLETED|Month 36||179
172209|NCT00541970|423477|P3|COMPLETED|Month 36||174
172210|NCT00541970|423478|P2|COMPLETED|Month 36||175
172211|NCT00541970|423479|P1|COMPLETED|Month 36||179
172212|NCT00541970|423476|P4|STARTED|Month 36||239
172213|NCT00541970|423477|P3|STARTED|Month 36||240
172214|NCT00541970|423478|P2|STARTED|Month 36||241
172215|NCT00541970|423479|P1|STARTED|Month 36||240
172216|NCT00541970|423476|P4|NOT COMPLETED|Month 24||22
172217|NCT00541970|423477|P3|NOT COMPLETED|Month 24||32
172218|NCT00541970|423478|P2|NOT COMPLETED|Month 24||32
172219|NCT00541970|423479|P1|NOT COMPLETED|Month 24||29
172220|NCT00541970|423476|P4|COMPLETED|Month 24||217
172221|NCT00541970|423477|P3|COMPLETED|Month 24||208
172222|NCT00541970|423478|P2|COMPLETED|Month 24||209
172223|NCT00541970|423479|P1|COMPLETED|Month 24||211
172224|NCT00541970|423476|P4|STARTED|Month 24||239
172225|NCT00541970|423477|P3|STARTED|Month 24||240
172226|NCT00541970|423478|P2|STARTED|Month 24||241
172227|NCT00541970|423479|P1|STARTED|Month 24||240
172228|NCT00541970|423476|P4|NOT COMPLETED|Month 18||17
172229|NCT00541970|423477|P3|NOT COMPLETED|Month 18||25
172230|NCT00541970|423478|P2|NOT COMPLETED|Month 18||24
172231|NCT00541970|423479|P1|NOT COMPLETED|Month 18||14
172232|NCT00541970|423476|P4|COMPLETED|Month 18||222
172233|NCT00541970|423477|P3|COMPLETED|Month 18||215
172234|NCT00541970|423478|P2|COMPLETED|Month 18||217
172235|NCT00541970|423479|P1|COMPLETED|Month 18||226
172236|NCT00541970|423476|P4|STARTED|Month 18||239
172237|NCT00541970|423477|P3|STARTED|Month 18||240
172238|NCT00541970|423478|P2|STARTED|Month 18||241
172239|NCT00541970|423479|P1|STARTED|Month 18||240
172240|NCT00541970|423476|P4|NOT COMPLETED|Month 12||16
172241|NCT00541970|423477|P3|NOT COMPLETED|Month 12||21
172242|NCT00541970|423478|P2|NOT COMPLETED|Month 12||22
172243|NCT00541970|423479|P1|NOT COMPLETED|Month 12||12
172244|NCT00541970|423476|P4|COMPLETED|Month 12||223
172245|NCT00541970|423477|P3|COMPLETED|Month 12||219
172246|NCT00541970|423478|P2|COMPLETED|Month 12||219
172247|NCT00541970|423479|P1|COMPLETED|Month 12||228
172248|NCT00541970|423476|P4|STARTED|Month 12||239
172249|NCT00541970|423477|P3|STARTED|Month 12||240
172250|NCT00541970|423478|P2|STARTED|Month 12||241
172251|NCT00541970|423479|P1|STARTED|Month 12||240
172252|NCT00541970|423476|P4|NOT COMPLETED|Month 7||5
172253|NCT00541970|423477|P3|NOT COMPLETED|Month 7||11
172254|NCT00541970|423478|P2|NOT COMPLETED|Month 7||13
172255|NCT00541970|423479|P1|NOT COMPLETED|Month 7||9
172256|NCT00541970|423476|P4|COMPLETED|Month 7||234
172257|NCT00541970|423477|P3|COMPLETED|Month 7||229
172258|NCT00541970|423478|P2|COMPLETED|Month 7||228
172259|NCT00541970|423479|P1|COMPLETED|Month 7||231
172260|NCT00541970|423476|P4|STARTED|Month 7||239
172261|NCT00541970|423477|P3|STARTED|Month 7||240
172262|NCT00541970|423478|P2|STARTED|Month 7||241
172263|NCT00541970|423479|P1|STARTED|Month 7||240
172264|NCT00542178|423634|P8|NOT COMPLETED|Overall Study||85
172265|NCT00542178|423635|P7|NOT COMPLETED|Overall Study||87
172266|NCT00542178|423636|P6|NOT COMPLETED|Overall Study||89
172267|NCT00542178|423637|P5|NOT COMPLETED|Overall Study||64
172268|NCT00542178|423638|P4|NOT COMPLETED|Overall Study||62
172269|NCT00542178|423639|P3|NOT COMPLETED|Overall Study||74
172270|NCT00542178|423640|P2|NOT COMPLETED|Overall Study||80
172271|NCT00542178|423641|P1|NOT COMPLETED|Overall Study||75
172272|NCT00542178|423634|P8|COMPLETED|Overall Study||381
172273|NCT00542178|423635|P7|COMPLETED|Overall Study||406
172274|NCT00542178|423636|P6|COMPLETED|Overall Study||406
172275|NCT00542178|423637|P5|COMPLETED|Overall Study||400
172276|NCT00542178|423638|P4|COMPLETED|Overall Study||308
172277|NCT00542178|423639|P3|COMPLETED|Overall Study||308
172278|NCT00542178|423640|P2|COMPLETED|Overall Study||332
172279|NCT00542178|423641|P1|COMPLETED|Overall Study||315
172280|NCT00542178|423634|P8|STARTED|Overall Study||466
172281|NCT00542178|423635|P7|STARTED|Overall Study||493
172282|NCT00542178|423636|P6|STARTED|Overall Study||495
172283|NCT00542178|423637|P5|STARTED|Overall Study||464
172284|NCT00542178|423638|P4|STARTED|Overall Study||370
172285|NCT00542178|423639|P3|STARTED|Overall Study||382
172286|NCT00542178|423640|P2|STARTED|Overall Study||412
172287|NCT00542178|423641|P1|STARTED|Overall Study||390
172288|NCT00543140|423655|P1|NOT COMPLETED|Overall Study||72
172289|NCT00543140|423655|P1|COMPLETED|Overall Study||231
172290|NCT00543140|423655|P1|STARTED|Overall Study||303
172291|NCT00543296|423663|P1|NOT COMPLETED|Overall Study||7
172292|NCT00543296|423663|P1|COMPLETED|Overall Study||14
172293|NCT00543296|423663|P1|STARTED|Overall Study||21
172294|NCT00543543|423674|P4|NOT COMPLETED|Extension Study||226
172295|NCT00543543|423675|P3|NOT COMPLETED|Extension Study||0
172296|NCT00543543|423676|P2|NOT COMPLETED|Extension Study||0
172297|NCT00543543|423677|P1|NOT COMPLETED|Extension Study||0
172298|NCT00543543|423674|P4|COMPLETED|Extension Study||2824
172299|NCT00543543|423675|P3|COMPLETED|Extension Study||0
172300|NCT00543543|423676|P2|COMPLETED|Extension Study||150
172301|NCT00543543|423677|P1|COMPLETED|Extension Study||0
172302|NCT00543543|423674|P4|STARTED|Extension Study|Cohort 2|3050
172303|NCT00543543|423675|P3|STARTED|Extension Study|This group did not participate in the Extension Study|0
172304|NCT00543543|423676|P2|STARTED|Extension Study|Cohort 1|150
172305|NCT00543543|423677|P1|STARTED|Extension Study|This group did not participate in the Extension Study|0
172306|NCT00543543|423674|P4|NOT COMPLETED|Base Study||1222
172307|NCT00543543|423675|P3|NOT COMPLETED|Base Study||14
172308|NCT00543543|423676|P2|NOT COMPLETED|Base Study||1252
172309|NCT00543543|423677|P1|NOT COMPLETED|Base Study||20
172310|NCT00543543|423674|P4|COMPLETED|Base Study|Follow-up was up to 54 months|5887
172311|NCT00543543|423675|P3|COMPLETED|Base Study|Follow-up was up to 7 months|296
172312|NCT00543543|423676|P2|COMPLETED|Base Study|Follow-up was up to 54 months|5854
172313|NCT00543543|423677|P1|COMPLETED|Base Study|Follow-up was up to 7 months|295
172314|NCT00543543|423674|P4|Completed 3 Vaccinations|Base Study||6934
172315|NCT00543543|423675|P3|Completed 3 Vaccinations|Base Study||297
172316|NCT00543543|423676|P2|Completed 3 Vaccinations|Base Study||6928
172317|NCT00543543|423677|P1|Completed 3 Vaccinations|Base Study||300
172318|NCT00543543|423674|P4|STARTED|Base Study||7109
172319|NCT00543543|423675|P3|STARTED|Base Study||310
172320|NCT00543543|423676|P2|STARTED|Base Study||7106
172321|NCT00543543|423677|P1|STARTED|Base Study||315
172322|NCT00543569|423722|P4|NOT COMPLETED|Overall Study||9
172323|NCT00543569|423723|P3|NOT COMPLETED|Overall Study||20
172324|NCT00543569|423724|P2|NOT COMPLETED|Overall Study||8
172325|NCT00543569|423725|P1|NOT COMPLETED|Overall Study||12
172326|NCT00543569|423722|P4|COMPLETED|Overall Study||72
172327|NCT00543569|423723|P3|COMPLETED|Overall Study||60
172328|NCT00543569|423724|P2|COMPLETED|Overall Study||72
172329|NCT00543569|423725|P1|COMPLETED|Overall Study||70
172330|NCT00543569|423722|P4|Received Treatment|Overall Study||78
172331|NCT00543569|423723|P3|Received Treatment|Overall Study||75
172332|NCT00543569|423724|P2|Received Treatment|Overall Study||77
172333|NCT00543569|423725|P1|Received Treatment|Overall Study||79
172334|NCT00543569|423722|P4|STARTED|Overall Study||81
172335|NCT00543569|423723|P3|STARTED|Overall Study||80
172336|NCT00543569|423724|P2|STARTED|Overall Study||80
172337|NCT00543569|423725|P1|STARTED|Overall Study||82
172338|NCT00543725|423829|P2|NOT COMPLETED|Overall Study||74
172339|NCT00543725|423830|P1|NOT COMPLETED|Overall Study||68
172340|NCT00543725|423829|P2|COMPLETED|Overall Study||264
172341|NCT00543725|423830|P1|COMPLETED|Overall Study||272
172342|NCT00543725|423829|P2|STARTED|Overall Study||338
172343|NCT00543725|423830|P1|STARTED|Overall Study||340
172344|NCT00543764|423854|P2|NOT COMPLETED|Overall Study||0
172345|NCT00543764|423855|P1|NOT COMPLETED|Overall Study||0
172346|NCT00543764|423854|P2|COMPLETED|Overall Study||50
172347|NCT00543764|423855|P1|COMPLETED|Overall Study||100
172348|NCT00543764|423854|P2|STARTED|Overall Study||50
172349|NCT00543764|423855|P1|STARTED|Overall Study||100
172350|NCT00543803|423861|P1|NOT COMPLETED|Overall Study||142
172351|NCT00543803|423861|P1|COMPLETED|Overall Study||192
172352|NCT00543803|423861|P1|STARTED|Overall Study||334
172353|NCT00543855|423882|P4|NOT COMPLETED|Overall Study||4
172354|NCT00543855|423883|P3|NOT COMPLETED|Overall Study||6
172355|NCT00543855|423884|P2|NOT COMPLETED|Overall Study||2
172356|NCT00543855|423885|P1|NOT COMPLETED|Overall Study||4
172357|NCT00543855|423882|P4|COMPLETED|Overall Study||30
172358|NCT00543855|423883|P3|COMPLETED|Overall Study||31
172359|NCT00543855|423884|P2|COMPLETED|Overall Study||31
172360|NCT00543855|423885|P1|COMPLETED|Overall Study||31
172361|NCT00543855|423882|P4|STARTED|Overall Study||34
172362|NCT00543855|423883|P3|STARTED|Overall Study||37
172363|NCT00543855|423884|P2|STARTED|Overall Study||33
172364|NCT00543855|423885|P1|STARTED|Overall Study||35
172365|NCT00543985|423907|P1|NOT COMPLETED|Overall Study||4
172366|NCT00543985|423907|P1|COMPLETED|Overall Study||32
172367|NCT00543985|423907|P1|STARTED|Overall Study||36
172368|NCT00544167|423914|P1|NOT COMPLETED|Overall Study||29
172369|NCT00544167|423914|P1|COMPLETED|Overall Study||16
172370|NCT00544167|423914|P1|STARTED|Overall Study||45
172371|NCT00544440|423918|P1|NOT COMPLETED|Overall Study||57
172372|NCT00544440|423918|P1|COMPLETED|Overall Study||0
172373|NCT00544440|423918|P1|STARTED|Overall Study||57
172374|NCT00544544|423925|P1|NOT COMPLETED|Overall Study||3
172375|NCT00544544|423925|P1|COMPLETED|Overall Study||11
172376|NCT00544544|423925|P1|STARTED|Overall Study||14
172377|NCT00544557|423929|P1|NOT COMPLETED|Overall Study||434
172378|NCT00544557|423929|P1|COMPLETED|Overall Study||1251
172379|NCT00544557|423929|P1|STARTED|Overall Study||1685
172380|NCT00544648|423962|P2|NOT COMPLETED|Overall Study||1
172381|NCT00544648|423963|P1|NOT COMPLETED|Overall Study||3
172836|NCT00546273|424889|P1|STARTED|IV||0
172382|NCT00544648|423962|P2|COMPLETED|Overall Study||1
172383|NCT00544648|423963|P1|COMPLETED|Overall Study||8
172384|NCT00544648|423962|P2|STARTED|Overall Study||2
172385|NCT00544648|423963|P1|STARTED|Overall Study||11
172386|NCT00544674|423977|P1|NOT COMPLETED|Overall Study||1
172387|NCT00544674|423977|P1|COMPLETED|Overall Study||4
172388|NCT00544674|423977|P1|STARTED|Overall Study|1 subject registered and expired prior to dosing|5
172389|NCT00544713|423983|P2|NOT COMPLETED|Overall Study||5
172390|NCT00544713|423984|P1|NOT COMPLETED|Overall Study||3
172391|NCT00544713|423983|P2|COMPLETED|Overall Study||109
172392|NCT00544713|423984|P1|COMPLETED|Overall Study||111
172393|NCT00544713|423983|P2|STARTED|Overall Study||114
172394|NCT00544713|423984|P1|STARTED|Overall Study||114
172395|NCT00544778|424014|P1|NOT COMPLETED|Overall Study||0
172396|NCT00544778|424014|P1|COMPLETED|Overall Study||7
172397|NCT00544778|424014|P1|STARTED|Overall Study||7
172398|NCT00544817|424018|P1|NOT COMPLETED|Follow-up Systemic Therapy||19
172399|NCT00544817|424018|P1|COMPLETED|Follow-up Systemic Therapy||9
172400|NCT00544817|424018|P1|STARTED|Follow-up Systemic Therapy||28
172401|NCT00544817|424018|P1|NOT COMPLETED|No Treatment Interval||12
172402|NCT00544817|424018|P1|COMPLETED|No Treatment Interval||28
172403|NCT00544817|424018|P1|STARTED|No Treatment Interval||40
172404|NCT00544817|424018|P1|NOT COMPLETED|Combined Modality||7
172405|NCT00544817|424018|P1|COMPLETED|Combined Modality||40
172406|NCT00544817|424018|P1|STARTED|Combined Modality||47
172407|NCT00544869|424027|P3|NOT COMPLETED|Overall Study||0
172408|NCT00544869|424028|P2|NOT COMPLETED|Overall Study||2
172409|NCT00544869|424029|P1|NOT COMPLETED|Overall Study||12
172410|NCT00544869|424027|P3|COMPLETED|Overall Study||2
172411|NCT00544869|424028|P2|COMPLETED|Overall Study||12
172412|NCT00544869|424029|P1|COMPLETED|Overall Study||24
172413|NCT00544869|424027|P3|STARTED|Overall Study||2
172414|NCT00544869|424028|P2|STARTED|Overall Study||14
172415|NCT00544869|424029|P1|STARTED|Overall Study||36
172416|NCT00544882|424039|P3|NOT COMPLETED|Cycle 3: Follow-up||0
172417|NCT00544882|424040|P2|NOT COMPLETED|Cycle 3: Follow-up||2
172418|NCT00544882|424041|P1|NOT COMPLETED|Cycle 3: Follow-up||0
172419|NCT00544882|424039|P3|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|28
172420|NCT00544882|424040|P2|COMPLETED|Cycle 3: Follow-up|Completed 21 days of Cycle 3|26
172421|NCT00544882|424041|P1|COMPLETED|Cycle 3: Follow-up||0
172422|NCT00544882|424039|P3|STARTED|Cycle 3: Follow-up||28
172423|NCT00544882|424040|P2|STARTED|Cycle 3: Follow-up||28
172424|NCT00544882|424041|P1|STARTED|Cycle 3: Follow-up||0
172425|NCT00544882|424039|P3|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
172426|NCT00544882|424040|P2|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||1
172427|NCT00544882|424041|P1|NOT COMPLETED|Cycle 2: Randomized Treatment Cycle||0
172428|NCT00544882|424039|P3|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
172429|NCT00544882|424040|P2|COMPLETED|Cycle 2: Randomized Treatment Cycle||28
172430|NCT00544882|424041|P1|COMPLETED|Cycle 2: Randomized Treatment Cycle||0
172431|NCT00544882|424039|P3|Treated|Cycle 2: Randomized Treatment Cycle|One participant was dropped from the study due to noncompliance prior to treatment.|28
172432|NCT00544882|424040|P2|Treated|Cycle 2: Randomized Treatment Cycle|One participant withdrew prior to treatment|28
172433|NCT00544882|424041|P1|Treated|Cycle 2: Randomized Treatment Cycle||0
172434|NCT00544882|424039|P3|STARTED|Cycle 2: Randomized Treatment Cycle||29
172435|NCT00544882|424040|P2|STARTED|Cycle 2: Randomized Treatment Cycle||29
172436|NCT00544882|424041|P1|STARTED|Cycle 2: Randomized Treatment Cycle||0
172437|NCT00544882|424039|P3|NOT COMPLETED|Cycle 1: Run-in Cycle||0
172438|NCT00544882|424040|P2|NOT COMPLETED|Cycle 1: Run-in Cycle||0
172439|NCT00544882|424041|P1|NOT COMPLETED|Cycle 1: Run-in Cycle||3
172440|NCT00544882|424039|P3|COMPLETED|Cycle 1: Run-in Cycle||0
172441|NCT00544882|424040|P2|COMPLETED|Cycle 1: Run-in Cycle||0
172442|NCT00544882|424041|P1|COMPLETED|Cycle 1: Run-in Cycle||58
172443|NCT00544882|424039|P3|STARTED|Cycle 1: Run-in Cycle||0
172444|NCT00544882|424040|P2|STARTED|Cycle 1: Run-in Cycle||0
172445|NCT00544882|424041|P1|STARTED|Cycle 1: Run-in Cycle||61
172446|NCT00544908|424063|P1|NOT COMPLETED|Overall Study||0
172447|NCT00544908|424063|P1|COMPLETED|Overall Study||7
172448|NCT00544908|424063|P1|STARTED|Overall Study||7
172449|NCT00545025|424070|P2|NOT COMPLETED|Overall Study||0
172450|NCT00545025|424071|P1|NOT COMPLETED|Overall Study||0
172451|NCT00545025|424070|P2|COMPLETED|Overall Study||83
172452|NCT00545025|424071|P1|COMPLETED|Overall Study||160
172453|NCT00545025|424070|P2|STARTED|Overall Study||83
172454|NCT00545025|424071|P1|STARTED|Overall Study||160
172455|NCT00545051|424093|P2|NOT COMPLETED|Overall Study||7
172456|NCT00545051|424094|P1|NOT COMPLETED|Overall Study||9
172457|NCT00545051|424093|P2|COMPLETED|Overall Study||65
172458|NCT00545051|424094|P1|COMPLETED|Overall Study||59
172459|NCT00545051|424093|P2|STARTED|Overall Study||72
172460|NCT00545051|424094|P1|STARTED|Overall Study||68
172461|NCT00545064|424108|P1|NOT COMPLETED|Overall Study||8
172462|NCT00545064|424108|P1|COMPLETED|Overall Study||170
172463|NCT00545064|424108|P1|Visit 3 (Week 8)|Overall Study|8 patients didn’t complete the 8-week period. 6 were retrieved and considered as Visit 3 (Week 8)|176
172464|NCT00545064|424108|P1|Visit 2 (Week 4)|Overall Study||169
172465|NCT00545064|424108|P1|Visit 1 (Baseline)|Overall Study||178
172466|NCT00545064|424108|P1|STARTED|Overall Study||178
172467|NCT00545103|424121|P4|NOT COMPLETED|Overall Study||70
172468|NCT00545103|424122|P3|NOT COMPLETED|Overall Study||76
172469|NCT00545103|424123|P2|NOT COMPLETED|Overall Study||78
172470|NCT00545103|424124|P1|NOT COMPLETED|Overall Study||75
172471|NCT00545103|424121|P4|COMPLETED|Overall Study||76
172472|NCT00545103|424122|P3|COMPLETED|Overall Study||74
172473|NCT00545103|424123|P2|COMPLETED|Overall Study||70
172474|NCT00545103|424124|P1|COMPLETED|Overall Study||73
172475|NCT00545103|424121|P4|STARTED|Overall Study||146
172476|NCT00545103|424122|P3|STARTED|Overall Study||150
172477|NCT00545103|424123|P2|STARTED|Overall Study||148
172478|NCT00545103|424124|P1|STARTED|Overall Study||148
172479|NCT00545155|424158|P1|NOT COMPLETED|Overall Study||0
172480|NCT00545155|424158|P1|COMPLETED|Overall Study||187
172481|NCT00545155|424158|P1|STARTED|Overall Study||187
172482|NCT00545168|424174|P3|NOT COMPLETED|Overall Study||21
172483|NCT00545168|424175|P2|NOT COMPLETED|Overall Study||5
172484|NCT00545168|424176|P1|NOT COMPLETED|Overall Study||16
172485|NCT00545168|424174|P3|COMPLETED|Overall Study||193
172486|NCT00545168|424175|P2|COMPLETED|Overall Study||58
172487|NCT00545168|424176|P1|COMPLETED|Overall Study||187
172488|NCT00545168|424174|P3|STARTED|Overall Study||214
172489|NCT00545168|424175|P2|STARTED|Overall Study||63
172490|NCT00545168|424176|P1|STARTED|Overall Study||203
172491|NCT00545181|424187|P2|NOT COMPLETED|Overall Study||0
172492|NCT00545181|424188|P1|NOT COMPLETED|Overall Study||0
172493|NCT00545181|424187|P2|COMPLETED|Overall Study||25
172494|NCT00545181|424188|P1|COMPLETED|Overall Study||29
172495|NCT00545181|424187|P2|STARTED|Overall Study||25
172496|NCT00545181|424188|P1|STARTED|Overall Study||29
172497|NCT00545233|424196|P2|NOT COMPLETED|Overall Study||35
172498|NCT00545233|424197|P1|NOT COMPLETED|Overall Study||46
172499|NCT00545233|424196|P2|COMPLETED|Overall Study||41
172500|NCT00545233|424197|P1|COMPLETED|Overall Study||33
172501|NCT00545233|424196|P2|Intent-to-Treat (ITT)|Overall Study||73
172502|NCT00545233|424197|P1|Intent-to-Treat (ITT)|Overall Study||77
172503|NCT00545233|424196|P2|Safety Set|Overall Study||75
172504|NCT00545233|424197|P1|Safety Set|Overall Study||77
172505|NCT00545233|424196|P2|STARTED|Overall Study||76
172506|NCT00545233|424197|P1|STARTED|Overall Study||79
172507|NCT00545272|424250|P6|NOT COMPLETED|Overall Study||3
172508|NCT00545272|424251|P5|NOT COMPLETED|Overall Study||2
172509|NCT00545272|424252|P4|NOT COMPLETED|Overall Study||1
172510|NCT00545272|424253|P3|NOT COMPLETED|Overall Study||1
172511|NCT00545272|424254|P2|NOT COMPLETED|Overall Study||1
172512|NCT00545272|424255|P1|NOT COMPLETED|Overall Study||0
172513|NCT00545272|424250|P6|COMPLETED|Overall Study||59
172514|NCT00545272|424251|P5|COMPLETED|Overall Study||62
172515|NCT00545272|424252|P4|COMPLETED|Overall Study||71
172516|NCT00545272|424253|P3|COMPLETED|Overall Study||64
172517|NCT00545272|424254|P2|COMPLETED|Overall Study||67
172518|NCT00545272|424255|P1|COMPLETED|Overall Study||61
172519|NCT00545272|424250|P6|STARTED|Overall Study||62
172520|NCT00545272|424251|P5|STARTED|Overall Study||64
172521|NCT00545272|424252|P4|STARTED|Overall Study||72
172522|NCT00545272|424253|P3|STARTED|Overall Study||65
172523|NCT00545272|424254|P2|STARTED|Overall Study||68
172524|NCT00545272|424255|P1|STARTED|Overall Study||61
172525|NCT00545298|424308|P3|NOT COMPLETED|Overall Study||1
172526|NCT00545298|424309|P2|NOT COMPLETED|Overall Study||0
172527|NCT00545298|424310|P1|NOT COMPLETED|Overall Study||2
172528|NCT00545298|424308|P3|COMPLETED|Overall Study||0
172529|NCT00545298|424309|P2|COMPLETED|Overall Study||1
172530|NCT00545298|424310|P1|COMPLETED|Overall Study||0
172531|NCT00545298|424308|P3|STARTED|Overall Study||1
172532|NCT00545298|424309|P2|STARTED|Overall Study||1
172533|NCT00545298|424310|P1|STARTED|Overall Study||2
172534|NCT00545363|424323|P2|NOT COMPLETED|Overall Study||15
172535|NCT00545363|424324|P1|NOT COMPLETED|Overall Study||19
172536|NCT00545363|424323|P2|COMPLETED|Overall Study||343
172537|NCT00545363|424324|P1|COMPLETED|Overall Study||339
172538|NCT00545363|424323|P2|Treated|Overall Study||357
172539|NCT00545363|424324|P1|Treated|Overall Study||354
172540|NCT00545363|424323|P2|STARTED|Overall Study||358
172541|NCT00545363|424324|P1|STARTED|Overall Study||358
172542|NCT00545402|424338|P2|NOT COMPLETED|Overall Study||29
172543|NCT00545402|424339|P1|NOT COMPLETED|Overall Study||34
172544|NCT00545402|424338|P2|COMPLETED|Overall Study||61
172545|NCT00545402|424339|P1|COMPLETED|Overall Study||56
172546|NCT00545402|424338|P2|STARTED|Overall Study||90
172547|NCT00545402|424339|P1|STARTED|Overall Study||90
172548|NCT00545441|424357|P2|NOT COMPLETED|Overall Study||16
172549|NCT00545441|424358|P1|NOT COMPLETED|Overall Study||18
172550|NCT00545441|424357|P2|COMPLETED|Overall Study||26
172551|NCT00545441|424358|P1|COMPLETED|Overall Study||26
172552|NCT00545441|424357|P2|STARTED|Overall Study||42
172553|NCT00545441|424358|P1|STARTED|Overall Study||44
172554|NCT00545506|424366|P2|NOT COMPLETED|Overall Study||0
172555|NCT00545506|424367|P1|NOT COMPLETED|Overall Study||0
172556|NCT00545506|424366|P2|COMPLETED|Overall Study||3
172557|NCT00545506|424367|P1|COMPLETED|Overall Study||3
172558|NCT00545506|424366|P2|STARTED|Overall Study||3
172559|NCT00545506|424367|P1|STARTED|Overall Study||3
172560|NCT00545571|424373|P1|NOT COMPLETED|Overall Study||67
172561|NCT00545571|424373|P1|COMPLETED|Overall Study||53
172562|NCT00545571|424373|P1|STARTED|Overall Study||120
172563|NCT00545584|424389|P3|NOT COMPLETED|Overall Study||56
172564|NCT00545584|424390|P2|NOT COMPLETED|Overall Study||80
172565|NCT00545584|424391|P1|NOT COMPLETED|Overall Study||79
172566|NCT00545584|424389|P3|COMPLETED|Overall Study||250
172567|NCT00545584|424390|P2|COMPLETED|Overall Study||334
172568|NCT00545584|424391|P1|COMPLETED|Overall Study||333
172569|NCT00545584|424389|P3|STARTED|Overall Study|306 subjects were randomized but only 305 were treated.|306
172570|NCT00545584|424390|P2|STARTED|Overall Study||414
172571|NCT00545584|424391|P1|STARTED|Overall Study||412
172572|NCT00545623|424406|P4|NOT COMPLETED|Overall Study||11
172573|NCT00545623|424407|P3|NOT COMPLETED|Overall Study||13
172574|NCT00545623|424408|P2|NOT COMPLETED|Overall Study||10
172575|NCT00545623|424409|P1|NOT COMPLETED|Overall Study||7
172576|NCT00545623|424406|P4|COMPLETED|Overall Study||23
172577|NCT00545623|424407|P3|COMPLETED|Overall Study||20
172578|NCT00545623|424408|P2|COMPLETED|Overall Study||21
172579|NCT00545623|424409|P1|COMPLETED|Overall Study||25
172580|NCT00545623|424406|P4|STARTED|Overall Study||34
172581|NCT00545623|424407|P3|STARTED|Overall Study||33
172582|NCT00545623|424408|P2|STARTED|Overall Study||31
172583|NCT00545623|424409|P1|STARTED|Overall Study||32
172584|NCT00545662|424421|P2|NOT COMPLETED|Overall Study||79
172585|NCT00545662|424422|P1|NOT COMPLETED|Overall Study||85
172586|NCT00545662|424421|P2|COMPLETED|Overall Study||528
172587|NCT00545662|424422|P1|COMPLETED|Overall Study||521
172588|NCT00545662|424421|P2|STARTED|Overall Study||607
172589|NCT00545662|424422|P1|STARTED|Overall Study||606
172590|NCT00533117|424432|P4|NOT COMPLETED|Overall Study||5
172591|NCT00533117|424433|P3|NOT COMPLETED|Overall Study||6
172592|NCT00533117|424434|P2|NOT COMPLETED|Overall Study||5
172593|NCT00533117|424435|P1|NOT COMPLETED|Overall Study||4
172594|NCT00533117|424432|P4|COMPLETED|Overall Study||13
172595|NCT00533117|424433|P3|COMPLETED|Overall Study||14
172596|NCT00533117|424434|P2|COMPLETED|Overall Study||14
172597|NCT00533117|424435|P1|COMPLETED|Overall Study||14
172598|NCT00533117|424432|P4|STARTED|Overall Study||18
172599|NCT00533117|424433|P3|STARTED|Overall Study||20
172600|NCT00533117|424434|P2|STARTED|Overall Study||19
172601|NCT00533117|424435|P1|STARTED|Overall Study||18
172602|NCT00533273|424445|P2|NOT COMPLETED|Open-label||0
172603|NCT00533273|424446|P1|NOT COMPLETED|Open-label||6
172604|NCT00533273|424445|P2|COMPLETED|Open-label||0
172605|NCT00533273|424446|P1|COMPLETED|Open-label||58
172606|NCT00533273|424445|P2|STARTED|Open-label|no placebo - this phase was open label|0
172607|NCT00533273|424446|P1|STARTED|Open-label|open-label was extension of double-blind; 64 of 66 patients continued into open-label|64
172608|NCT00533273|424445|P2|NOT COMPLETED|Double-blind||2
172609|NCT00533273|424446|P1|NOT COMPLETED|Double-blind||0
172610|NCT00533273|424445|P2|COMPLETED|Double-blind||19
172611|NCT00533273|424446|P1|COMPLETED|Double-blind||45
172612|NCT00533273|424445|P2|STARTED|Double-blind||21
172613|NCT00533273|424446|P1|STARTED|Double-blind||45
172614|NCT00533351|424454|P2|NOT COMPLETED|Period 3||0
172615|NCT00533351|424455|P1|NOT COMPLETED|Period 3||0
172616|NCT00533351|424454|P2|COMPLETED|Period 3||0
172617|NCT00533351|424455|P1|COMPLETED|Period 3||3
172618|NCT00533351|424454|P2|STARTED|Period 3|No patients continued to Period 3|0
172619|NCT00533351|424455|P1|STARTED|Period 3|Three out of the five patients who completed Period 2 continued to Period 3|3
172620|NCT00533351|424454|P2|NOT COMPLETED|Period 2||0
172621|NCT00533351|424455|P1|NOT COMPLETED|Period 2||0
172622|NCT00533351|424454|P2|COMPLETED|Period 2||1
172623|NCT00533351|424455|P1|COMPLETED|Period 2||5
172624|NCT00533351|424454|P2|STARTED|Period 2||1
172625|NCT00533351|424455|P1|STARTED|Period 2||5
172626|NCT00533351|424454|P2|NOT COMPLETED|Period 1||1
172627|NCT00533351|424455|P1|NOT COMPLETED|Period 1||2
172628|NCT00533351|424454|P2|COMPLETED|Period 1||1
172629|NCT00533351|424455|P1|COMPLETED|Period 1||5
172630|NCT00533351|424454|P2|STARTED|Period 1||2
172631|NCT00533351|424455|P1|STARTED|Period 1||7
172632|NCT00533442|424465|P2|NOT COMPLETED|Follow-up||10
172633|NCT00533442|424466|P1|NOT COMPLETED|Follow-up||9
172634|NCT00533442|424465|P2|COMPLETED|Follow-up||74
172635|NCT00533442|424466|P1|COMPLETED|Follow-up||77
172636|NCT00533442|424465|P2|STARTED|Follow-up|Ongoing Follow-up at 17-124 months (N=74); Lost to Follow-up (N=10, at 5-67 months).|84
172637|NCT00533442|424466|P1|STARTED|Follow-up|Ongoing Follow-up at 13-123 months (N=77); Lost to Follow-up (N=9, at 5-100 months).|86
172638|NCT00533442|424465|P2|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
172639|NCT00533442|424466|P1|NOT COMPLETED|Allocation and Intent to Treat Analysis||0
172640|NCT00533442|424465|P2|COMPLETED|Allocation and Intent to Treat Analysis||84
172641|NCT00533442|424466|P1|COMPLETED|Allocation and Intent to Treat Analysis||86
172642|NCT00533442|424465|P2|STARTED|Allocation and Intent to Treat Analysis||84
172643|NCT00533442|424466|P1|STARTED|Allocation and Intent to Treat Analysis||86
172644|NCT00533507|424476|P1|NOT COMPLETED|Overall Study||1
172645|NCT00533507|424476|P1|COMPLETED|Overall Study||229
172646|NCT00533507|424476|P1|STARTED|Overall Study||230
172647|NCT00533546|424495|P1|NOT COMPLETED|Overall Study||0
172648|NCT00533546|424495|P1|COMPLETED|Overall Study||12
172649|NCT00533546|424495|P1|STARTED|Overall Study||12
172650|NCT00539032|424504|P2|NOT COMPLETED|Overall Study||1
172651|NCT00539032|424505|P1|NOT COMPLETED|Overall Study||2
172652|NCT00539032|424504|P2|COMPLETED|Overall Study||84
172653|NCT00539032|424505|P1|COMPLETED|Overall Study||151
172654|NCT00539032|424504|P2|STARTED|Overall Study||85
172655|NCT00539032|424505|P1|STARTED|Overall Study||153
172656|NCT00539110|424517|P2|NOT COMPLETED|Overall Study||0
172657|NCT00539110|424518|P1|NOT COMPLETED|Overall Study||0
172658|NCT00539110|424517|P2|COMPLETED|Overall Study||5
172659|NCT00539110|424518|P1|COMPLETED|Overall Study||5
172660|NCT00539110|424517|P2|STARTED|Overall Study||5
172661|NCT00539110|424518|P1|STARTED|Overall Study||5
172662|NCT00539188|424526|P2|NOT COMPLETED|Overall Study||1
172663|NCT00539188|424527|P1|NOT COMPLETED|Overall Study||3
172664|NCT00539188|424526|P2|COMPLETED|Overall Study||1
172665|NCT00539188|424527|P1|COMPLETED|Overall Study||1
172666|NCT00539188|424526|P2|Received Allocated Intervention|Overall Study||2
172667|NCT00539188|424527|P1|Received Allocated Intervention|Overall Study||3
172668|NCT00539188|424526|P2|STARTED|Overall Study||2
172669|NCT00539188|424527|P1|STARTED|Overall Study||4
172670|NCT00539240|424542|P3|NOT COMPLETED|Overall Study||15
172671|NCT00539240|424543|P2|NOT COMPLETED|Overall Study||7
172672|NCT00539240|424544|P1|NOT COMPLETED|Overall Study||6
172673|NCT00539240|424542|P3|COMPLETED|Overall Study||39
172674|NCT00539240|424543|P2|COMPLETED|Overall Study||48
172675|NCT00539240|424544|P1|COMPLETED|Overall Study||53
172676|NCT00539240|424542|P3|STARTED|Overall Study||54
172677|NCT00539240|424543|P2|STARTED|Overall Study||55
172678|NCT00539240|424544|P1|STARTED|Overall Study||59
172679|NCT00539279|424563|P2|NOT COMPLETED|6-Month Follow-Up Assessment||7
172680|NCT00539279|424564|P1|NOT COMPLETED|6-Month Follow-Up Assessment||1
172681|NCT00539279|424563|P2|COMPLETED|6-Month Follow-Up Assessment||22
172682|NCT00539279|424564|P1|COMPLETED|6-Month Follow-Up Assessment||17
172683|NCT00539279|424563|P2|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to RT)|29
172684|NCT00539279|424564|P1|STARTED|6-Month Follow-Up Assessment|Individuals eligible for 6-month assessment (includes all individuals randomized to PE)|18
172685|NCT00539279|424563|P2|NOT COMPLETED|Post-Treatment Assessment||9
172686|NCT00539279|424564|P1|NOT COMPLETED|Post-Treatment Assessment||12
172687|NCT00539279|424563|P2|COMPLETED|Post-Treatment Assessment||29
172688|NCT00539279|424564|P1|COMPLETED|Post-Treatment Assessment||18
172689|NCT00539279|424563|P2|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to RT)|38
172690|NCT00539279|424564|P1|STARTED|Post-Treatment Assessment|Individuals eligible for post-treatment assessment (includes all individuals randomized to PE)|30
172691|NCT00539279|424563|P2|NOT COMPLETED|Treatment||8
172692|NCT00539279|424564|P1|NOT COMPLETED|Treatment||11
172693|NCT00539279|424563|P2|COMPLETED|Treatment||38
172694|NCT00539279|424564|P1|COMPLETED|Treatment||30
172695|NCT00539279|424563|P2|STARTED|Treatment||46
172696|NCT00539279|424564|P1|STARTED|Treatment||41
172697|NCT00539305|424584|P2|NOT COMPLETED|Overall Study||2
172698|NCT00539305|424585|P1|NOT COMPLETED|Overall Study||1
172699|NCT00539305|424584|P2|COMPLETED|Overall Study||10
172700|NCT00539305|424585|P1|COMPLETED|Overall Study||9
172701|NCT00539305|424584|P2|STARTED|Overall Study||12
172702|NCT00539305|424585|P1|STARTED|Overall Study||10
172703|NCT00545688|424601|P4|NOT COMPLETED|Follow-Up Period||27
172704|NCT00545688|424602|P3|NOT COMPLETED|Follow-Up Period||20
172705|NCT00545688|424603|P2|NOT COMPLETED|Follow-Up Period||19
172706|NCT00545688|424604|P1|NOT COMPLETED|Follow-Up Period||21
172707|NCT00545688|424601|P4|COMPLETED|Follow-Up Period||60
172708|NCT00545688|424602|P3|COMPLETED|Follow-Up Period||78
172709|NCT00545688|424603|P2|COMPLETED|Follow-Up Period||83
172710|NCT00545688|424604|P1|COMPLETED|Follow-Up Period||77
172711|NCT00545688|424601|P4|STARTED|Follow-Up Period||87
172712|NCT00545688|424602|P3|STARTED|Follow-Up Period||98
172713|NCT00545688|424603|P2|STARTED|Follow-Up Period||102
172714|NCT00545688|424604|P1|STARTED|Follow-Up Period||98
172715|NCT00545688|424601|P4|NOT COMPLETED|Adjuvant Treatment Period||14
172716|NCT00545688|424602|P3|NOT COMPLETED|Adjuvant Treatment Period||4
172717|NCT00545688|424603|P2|NOT COMPLETED|Adjuvant Treatment Period||8
172718|NCT00545688|424604|P1|NOT COMPLETED|Adjuvant Treatment Period||5
172719|NCT00545688|424601|P4|COMPLETED|Adjuvant Treatment Period||74
172720|NCT00545688|424602|P3|COMPLETED|Adjuvant Treatment Period||90
172721|NCT00545688|424603|P2|COMPLETED|Adjuvant Treatment Period||94
172722|NCT00545688|424604|P1|COMPLETED|Adjuvant Treatment Period||98
172723|NCT00545688|424601|P4|STARTED|Adjuvant Treatment Period||88
172724|NCT00545688|424602|P3|STARTED|Adjuvant Treatment Period||94
172725|NCT00545688|424603|P2|STARTED|Adjuvant Treatment Period||102
172726|NCT00545688|424604|P1|STARTED|Adjuvant Treatment Period||103
172727|NCT00545688|424601|P4|NOT COMPLETED|Neo-Adjuvant Treatment Period||6
172728|NCT00545688|424602|P3|NOT COMPLETED|Neo-Adjuvant Treatment Period||14
172729|NCT00545688|424603|P2|NOT COMPLETED|Neo-Adjuvant Treatment Period||5
172730|NCT00545688|424604|P1|NOT COMPLETED|Neo-Adjuvant Treatment Period||4
172731|NCT00545688|424601|P4|COMPLETED|Neo-Adjuvant Treatment Period||88
172732|NCT00545688|424602|P3|COMPLETED|Neo-Adjuvant Treatment Period||94
172733|NCT00545688|424603|P2|COMPLETED|Neo-Adjuvant Treatment Period||102
172734|NCT00545688|424604|P1|COMPLETED|Neo-Adjuvant Treatment Period||103
172735|NCT00545688|424601|P4|STARTED|Neo-Adjuvant Treatment Period||94
172736|NCT00545688|424602|P3|STARTED|Neo-Adjuvant Treatment Period||108
172737|NCT00545688|424603|P2|STARTED|Neo-Adjuvant Treatment Period||107
172738|NCT00545688|424604|P1|STARTED|Neo-Adjuvant Treatment Period||107
172739|NCT00545740|424678|P4|NOT COMPLETED|Overall Study||71
172740|NCT00545740|424679|P3|NOT COMPLETED|Overall Study||96
172741|NCT00545740|424680|P2|NOT COMPLETED|Overall Study||83
172742|NCT00545740|424681|P1|NOT COMPLETED|Overall Study||75
172743|NCT00545740|424678|P4|COMPLETED|Overall Study||78
172744|NCT00545740|424679|P3|COMPLETED|Overall Study||55
172745|NCT00545740|424680|P2|COMPLETED|Overall Study||62
172746|NCT00545740|424681|P1|COMPLETED|Overall Study||70
172747|NCT00545740|424678|P4|STARTED|Overall Study||149
172748|NCT00545740|424679|P3|STARTED|Overall Study||151
172749|NCT00545740|424680|P2|STARTED|Overall Study||145
172750|NCT00545740|424681|P1|STARTED|Overall Study||145
172751|NCT00545753|424718|P3|NOT COMPLETED|Overall Study||26
172752|NCT00545753|424719|P2|NOT COMPLETED|Overall Study||5
172753|NCT00545753|424720|P1|NOT COMPLETED|Overall Study||16
172754|NCT00545753|424718|P3|COMPLETED|Overall Study||230
172755|NCT00545753|424719|P2|COMPLETED|Overall Study||54
172756|NCT00545753|424720|P1|COMPLETED|Overall Study||227
172757|NCT00545753|424718|P3|STARTED|Overall Study||256
172758|NCT00545753|424719|P2|STARTED|Overall Study||59
172759|NCT00545753|424720|P1|STARTED|Overall Study||243
172760|NCT00545766|424729|P1|NOT COMPLETED|Overall Study||5
172761|NCT00545766|424729|P1|COMPLETED|Overall Study||36
172762|NCT00545766|424729|P1|STARTED|Overall Study||41
172763|NCT00545779|424733|P1|NOT COMPLETED|Overall Study||44
172764|NCT00545779|424733|P1|COMPLETED|Overall Study||633
172765|NCT00545779|424733|P1|STARTED|Overall Study||677
172766|NCT00545792|424746|P1|NOT COMPLETED|Overall Study||1
172767|NCT00545792|424746|P1|COMPLETED|Overall Study||20
172768|NCT00545792|424746|P1|STARTED|Overall Study||21
172769|NCT00545844|424751|P1|NOT COMPLETED|Overall Study||12
172770|NCT00545844|424751|P1|COMPLETED|Overall Study||301
172771|NCT00545844|424751|P1|STARTED|Overall Study||313
172772|NCT00545948|424768|P3|NOT COMPLETED|Overall Study||7
172773|NCT00545948|424769|P2|NOT COMPLETED|Overall Study||1
172774|NCT00545948|424770|P1|NOT COMPLETED|Overall Study||1
172775|NCT00545948|424768|P3|COMPLETED|Overall Study||0
172776|NCT00545948|424769|P2|COMPLETED|Overall Study|Patients who received pemetrexed + cisplatin protocol therapy.|14
172777|NCT00545948|424770|P1|COMPLETED|Overall Study|Patients who received vinorelbine + cisplatin protocol therapy.|8
172778|NCT00545948|424768|P3|Assigned Treatment|Overall Study||0
172779|NCT00545948|424769|P2|Assigned Treatment|Overall Study||15
172780|NCT00545948|424770|P1|Assigned Treatment|Overall Study||9
172781|NCT00545948|424768|P3|STARTED|Overall Study|Registered patients who were not assigned to receive protocol therapy.|7
172782|NCT00545948|424769|P2|STARTED|Overall Study|Registered patients assigned to receive pemetrexed + cisplatin protocol therapy.|15
172783|NCT00545948|424770|P1|STARTED|Overall Study|Registered patients assigned to receive vinorelbine + cisplatin protocol therapy.|9
172784|NCT00545974|424782|P2|NOT COMPLETED|Overall Study||3
172785|NCT00545974|424783|P1|NOT COMPLETED|Overall Study||2
172786|NCT00545974|424782|P2|COMPLETED|Overall Study|subjects completed 26 weeks treatment in placebo cohort|39
172787|NCT00545974|424783|P1|COMPLETED|Overall Study|subjects completed 26 weeks treatment in memantine cohort|37
172788|NCT00545974|424782|P2|STARTED|Overall Study|subjects randomized to placebo cohort|42
172789|NCT00545974|424783|P1|STARTED|Overall Study|subjects randomized to memantine cohort|39
172790|NCT00546000|424791|P1|NOT COMPLETED|Overall Study||4
172791|NCT00546000|424791|P1|COMPLETED|Overall Study||52
172792|NCT00546000|424791|P1|STARTED|Overall Study||56
172793|NCT00546078|424798|P2|NOT COMPLETED|Overall Study||7
172794|NCT00546078|424799|P1|NOT COMPLETED|Overall Study||4
172795|NCT00546078|424798|P2|COMPLETED|Overall Study||43
172796|NCT00546078|424799|P1|COMPLETED|Overall Study||61
172797|NCT00546078|424798|P2|Month 18|Overall Study||45
172798|NCT00546078|424799|P1|Month 18|Overall Study||61
172799|NCT00546078|424798|P2|STARTED|Overall Study||50
172800|NCT00546078|424799|P1|STARTED|Overall Study||65
172801|NCT00546104|424837|P1|NOT COMPLETED|Overall Study||0
172802|NCT00546104|424837|P1|COMPLETED|Overall Study||31
172803|NCT00546104|424837|P1|STARTED|Overall Study||31
172804|NCT00546117|424848|P2|NOT COMPLETED|Overall Study||0
172805|NCT00546117|424849|P1|NOT COMPLETED|Overall Study||4
172806|NCT00546117|424848|P2|COMPLETED|Overall Study||7
172807|NCT00546117|424849|P1|COMPLETED|Overall Study||5
172808|NCT00546117|424848|P2|STARTED|Overall Study||7
172809|NCT00546117|424849|P1|STARTED|Overall Study||9
172810|NCT00546156|424859|P2|NOT COMPLETED|Overall Study||1
172811|NCT00546156|424860|P1|NOT COMPLETED|Overall Study||14
172812|NCT00546156|424859|P2|COMPLETED|Overall Study||19
172813|NCT00546156|424860|P1|COMPLETED|Overall Study||70
172814|NCT00546156|424859|P2|STARTED|Overall Study||20
172815|NCT00546156|424860|P1|STARTED|Overall Study||84
172816|NCT00546260|424869|P2|NOT COMPLETED|Overall Study||2
172817|NCT00546260|424870|P1|NOT COMPLETED|Overall Study||8
172818|NCT00546260|424869|P2|COMPLETED|Overall Study||32
172819|NCT00546260|424870|P1|COMPLETED|Overall Study||28
172820|NCT00546260|424869|P2|STARTED|Overall Study||34
172821|NCT00546260|424870|P1|STARTED|Overall Study||36
172822|NCT00546273|424885|P5|NOT COMPLETED|IV||0
172823|NCT00546273|424886|P4|NOT COMPLETED|IV||0
172824|NCT00546273|424887|P3|NOT COMPLETED|IV||0
172825|NCT00546273|424888|P2|NOT COMPLETED|IV||0
172826|NCT00546273|424889|P1|NOT COMPLETED|IV||0
172827|NCT00546273|424885|P5|COMPLETED|IV||2
172828|NCT00546273|424886|P4|COMPLETED|IV||4
172829|NCT00546273|424887|P3|COMPLETED|IV||0
172830|NCT00546273|424888|P2|COMPLETED|IV||0
172831|NCT00546273|424889|P1|COMPLETED|IV||0
172832|NCT00546273|424885|P5|STARTED|IV||2
172833|NCT00546273|424886|P4|STARTED|IV||4
172834|NCT00546273|424887|P3|STARTED|IV||0
172837|NCT00546273|424885|P5|NOT COMPLETED|III||0
172838|NCT00546273|424886|P4|NOT COMPLETED|III||0
172839|NCT00546273|424887|P3|NOT COMPLETED|III||0
172840|NCT00546273|424888|P2|NOT COMPLETED|III||0
172841|NCT00546273|424889|P1|NOT COMPLETED|III||0
172842|NCT00546273|424885|P5|COMPLETED|III||2
172843|NCT00546273|424886|P4|COMPLETED|III||0
172844|NCT00546273|424887|P3|COMPLETED|III||4
172845|NCT00546273|424888|P2|COMPLETED|III||0
172846|NCT00546273|424889|P1|COMPLETED|III||0
172847|NCT00546273|424885|P5|STARTED|III||2
172848|NCT00546273|424886|P4|STARTED|III||0
172849|NCT00546273|424887|P3|STARTED|III||4
172850|NCT00546273|424888|P2|STARTED|III||0
172851|NCT00546273|424889|P1|STARTED|III||0
172852|NCT00546273|424885|P5|NOT COMPLETED|II||0
172853|NCT00546273|424886|P4|NOT COMPLETED|II||0
172854|NCT00546273|424887|P3|NOT COMPLETED|II||0
172855|NCT00546273|424888|P2|NOT COMPLETED|II||0
172856|NCT00546273|424889|P1|NOT COMPLETED|II||0
172857|NCT00546273|424885|P5|COMPLETED|II||2
172858|NCT00546273|424886|P4|COMPLETED|II||0
172859|NCT00546273|424887|P3|COMPLETED|II||0
172860|NCT00546273|424888|P2|COMPLETED|II||4
172861|NCT00546273|424889|P1|COMPLETED|II||0
172862|NCT00546273|424885|P5|STARTED|II||2
172863|NCT00546273|424886|P4|STARTED|II||0
172864|NCT00546273|424887|P3|STARTED|II||0
172865|NCT00546273|424888|P2|STARTED|II||4
172866|NCT00546273|424889|P1|STARTED|II||0
172867|NCT00546273|424885|P5|NOT COMPLETED|I||0
172868|NCT00546273|424886|P4|NOT COMPLETED|I||0
172869|NCT00546273|424887|P3|NOT COMPLETED|I||0
172870|NCT00546273|424888|P2|NOT COMPLETED|I||0
172871|NCT00546273|424889|P1|NOT COMPLETED|I||0
172872|NCT00546273|424885|P5|COMPLETED|I||2
172873|NCT00546273|424886|P4|COMPLETED|I||0
172874|NCT00546273|424887|P3|COMPLETED|I||0
172875|NCT00546273|424888|P2|COMPLETED|I||0
172876|NCT00546273|424889|P1|COMPLETED|I||4
172877|NCT00546273|424885|P5|STARTED|I||2
172878|NCT00546273|424886|P4|STARTED|I||0
172879|NCT00546273|424887|P3|STARTED|I||0
172880|NCT00546273|424888|P2|STARTED|I||0
172881|NCT00546273|424889|P1|STARTED|I||4
172882|NCT00546351|424896|P1|NOT COMPLETED|Overall Study||236
172883|NCT00546351|424896|P1|COMPLETED|Overall Study||385
172884|NCT00546351|424896|P1|STARTED|Overall Study||621
172885|NCT00546364|424927|P3|NOT COMPLETED|Overall Study||17
172886|NCT00546364|424928|P2|NOT COMPLETED|Overall Study||18
172887|NCT00546364|424929|P1|NOT COMPLETED|Overall Study||17
172888|NCT00546364|424927|P3|COMPLETED|Overall Study|Still on treatment|3
172889|NCT00546364|424928|P2|COMPLETED|Overall Study|Still on treatment|4
172890|NCT00546364|424929|P1|COMPLETED|Overall Study|Still on treatment|3
172891|NCT00546364|424927|P3|Never Treated|Overall Study||0
172892|NCT00546364|424928|P2|Never Treated|Overall Study||0
172893|NCT00546364|424929|P1|Never Treated|Overall Study||0
172894|NCT00546364|424927|P3|STARTED|Overall Study||20
172895|NCT00546364|424928|P2|STARTED|Overall Study||22
172896|NCT00546364|424929|P1|STARTED|Overall Study||20
172897|NCT00546377|424964|P1|NOT COMPLETED|Overall Study||7
172898|NCT00546377|424964|P1|COMPLETED|Overall Study||43
172899|NCT00546377|424964|P1|STARTED|Overall Study||50
172900|NCT00546429|424969|P1|NOT COMPLETED|Overall Study||30
172901|NCT00546429|424969|P1|COMPLETED|Overall Study||32
172902|NCT00546429|424969|P1|STARTED|Overall Study|2 subjects did not have a preoperative Merle D'Aubigne score.|62
172903|NCT00546481|424975|P3|NOT COMPLETED|Maintenance Phase (CERA)||4
172904|NCT00546481|424976|P2|NOT COMPLETED|Maintenance Phase (CERA)||0
172905|NCT00546481|424977|P1|NOT COMPLETED|Maintenance Phase (CERA)||0
172906|NCT00546481|424975|P3|COMPLETED|Maintenance Phase (CERA)||50
172907|NCT00546481|424976|P2|COMPLETED|Maintenance Phase (CERA)||0
172908|NCT00546481|424977|P1|COMPLETED|Maintenance Phase (CERA)||0
172909|NCT00546481|424975|P3|STARTED|Maintenance Phase (CERA)||54
172910|NCT00546481|424976|P2|STARTED|Maintenance Phase (CERA)||0
172911|NCT00546481|424977|P1|STARTED|Maintenance Phase (CERA)||0
172912|NCT00546481|424975|P3|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
172913|NCT00546481|424976|P2|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||5
172914|NCT00546481|424977|P1|NOT COMPLETED|Correction Phase (CERA or Epoetin Beta)||6
172915|NCT00546481|424975|P3|COMPLETED|Correction Phase (CERA or Epoetin Beta)||0
172916|NCT00546481|424976|P2|COMPLETED|Correction Phase (CERA or Epoetin Beta)||36
172917|NCT00546481|424977|P1|COMPLETED|Correction Phase (CERA or Epoetin Beta)||33
172918|NCT00546481|424975|P3|STARTED|Correction Phase (CERA or Epoetin Beta)||0
172919|NCT00546481|424976|P2|STARTED|Correction Phase (CERA or Epoetin Beta)||41
172920|NCT00546481|424977|P1|STARTED|Correction Phase (CERA or Epoetin Beta)||39
172921|NCT00546572|425002|P2|NOT COMPLETED|Vax 2 / Year 1||2
172922|NCT00546572|425003|P1|NOT COMPLETED|Vax 2 / Year 1||4
172923|NCT00546572|425002|P2|COMPLETED|Vax 2 / Year 1||402
172924|NCT00546572|425003|P1|COMPLETED|Vax 2 / Year 1||387
172925|NCT00546572|425002|P2|Received Vax 2|Vax 2 / Year 1||404
172926|NCT00546572|425003|P1|Received Vax 2|Vax 2 / Year 1||391
172927|NCT00546572|425002|P2|STARTED|Vax 2 / Year 1||404
172928|NCT00546572|425003|P1|STARTED|Vax 2 / Year 1||391
172929|NCT00546572|425002|P2|NOT COMPLETED|Vax 1 / Year 0||70
172930|NCT00546572|425003|P1|NOT COMPLETED|Vax 1 / Year 0||73
172931|NCT00546572|425002|P2|COMPLETED|Vax 1 / Year 0||404
172932|NCT00546572|425003|P1|COMPLETED|Vax 1 / Year 0||391
172933|NCT00546572|425002|P2|Received Vax 1|Vax 1 / Year 0||473
172934|NCT00546572|425003|P1|Received Vax 1|Vax 1 / Year 0||463
172935|NCT00546572|425002|P2|STARTED|Vax 1 / Year 0||474
172936|NCT00546572|425003|P1|STARTED|Vax 1 / Year 0||464
172937|NCT00546637|425047|P2|NOT COMPLETED|Overall Study||49
172938|NCT00546637|425048|P1|NOT COMPLETED|Overall Study||73
172939|NCT00546637|425047|P2|COMPLETED|Overall Study||424
172940|NCT00546637|425048|P1|COMPLETED|Overall Study||401
172941|NCT00546637|425047|P2|Received Treatment|Overall Study||472
172942|NCT00546637|425048|P1|Received Treatment|Overall Study||471
172943|NCT00546637|425047|P2|STARTED|Overall Study||473
172944|NCT00546637|425048|P1|STARTED|Overall Study||474
172945|NCT00546715|425124|P4|NOT COMPLETED|Overall Study||0
172946|NCT00546715|425125|P3|NOT COMPLETED|Overall Study||0
172947|NCT00546715|425126|P2|NOT COMPLETED|Overall Study||1
172948|NCT00546715|425127|P1|NOT COMPLETED|Overall Study||0
172949|NCT00546715|425124|P4|COMPLETED|Overall Study||2
172950|NCT00546715|425125|P3|COMPLETED|Overall Study||5
172951|NCT00546715|425126|P2|COMPLETED|Overall Study||4
172952|NCT00546715|425127|P1|COMPLETED|Overall Study||6
172953|NCT00546715|425124|P4|STARTED|Overall Study||2
172954|NCT00546715|425125|P3|STARTED|Overall Study||5
172955|NCT00546715|425126|P2|STARTED|Overall Study||5
172956|NCT00546715|425127|P1|STARTED|Overall Study||6
172957|NCT00546728|425182|P2|NOT COMPLETED|Overall Study||0
172958|NCT00546728|425183|P1|NOT COMPLETED|Overall Study||0
172959|NCT00546728|425182|P2|COMPLETED|Overall Study||25
172960|NCT00546728|425183|P1|COMPLETED|Overall Study||25
172961|NCT00546728|425182|P2|STARTED|Overall Study||25
172962|NCT00546728|425183|P1|STARTED|Overall Study||25
172963|NCT00546754|425191|P2|NOT COMPLETED|Overall Study||49
172964|NCT00546754|425192|P1|NOT COMPLETED|Overall Study||50
172965|NCT00546754|425191|P2|COMPLETED|Overall Study||334
172966|NCT00546754|425192|P1|COMPLETED|Overall Study||375
172967|NCT00546754|425191|P2|Week 12|Overall Study||334
172968|NCT00546754|425192|P1|Week 12|Overall Study||375
172969|NCT00546754|425191|P2|Week 6|Overall Study||347
172970|NCT00546754|425192|P1|Week 6|Overall Study||396
172971|NCT00546754|425191|P2|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|373
172972|NCT00546754|425192|P1|Treated|Overall Study|Patients that received at least one dose of study medication and had 1 follow-up visit|416
172973|NCT00546754|425191|P2|STARTED|Overall Study|Number of patients enrolled and randomized|383
172974|NCT00546754|425192|P1|STARTED|Overall Study|Number of patients enrolled and randomized|425
172975|NCT00546819|425224|P2|NOT COMPLETED|Overall Study||6
172976|NCT00546819|425225|P1|NOT COMPLETED|Overall Study||8
172977|NCT00546819|425224|P2|COMPLETED|Overall Study||96
172978|NCT00546819|425225|P1|COMPLETED|Overall Study||199
172979|NCT00546819|425224|P2|VACCINATED|Overall Study||100
172980|NCT00546819|425225|P1|VACCINATED|Overall Study||206
172981|NCT00546819|425224|P2|STARTED|Overall Study||102
172982|NCT00546819|425225|P1|STARTED|Overall Study||207
172983|NCT00546871|425235|P2|NOT COMPLETED|Study Extension Period||1
172984|NCT00546871|425236|P1|NOT COMPLETED|Study Extension Period||1
172985|NCT00546871|425235|P2|COMPLETED|Study Extension Period||25
172986|NCT00546871|425236|P1|COMPLETED|Study Extension Period||9
172987|NCT00546871|425235|P2|STARTED|Study Extension Period|6 withdrawn after Part 3b|26
172988|NCT00546871|425236|P1|STARTED|Study Extension Period|2 withdrawn after Part 3b|10
172989|NCT00546871|425235|P2|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
172990|NCT00546871|425236|P1|NOT COMPLETED|Part 3b - SC IGIV 12 Weeks||0
172991|NCT00546871|425235|P2|COMPLETED|Part 3b - SC IGIV 12 Weeks||32
172992|NCT00546871|425236|P1|COMPLETED|Part 3b - SC IGIV 12 Weeks||12
172993|NCT00546871|425235|P2|STARTED|Part 3b - SC IGIV 12 Weeks||32
172994|NCT00546871|425236|P1|STARTED|Part 3b - SC IGIV 12 Weeks||12
172995|NCT00546871|425235|P2|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
172996|NCT00546871|425236|P1|NOT COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||0
172997|NCT00546871|425235|P2|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
172998|NCT00546871|425236|P1|COMPLETED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
172999|NCT00546871|425235|P2|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||32
173000|NCT00546871|425236|P1|STARTED|Part 3a- SC IGIV Adjusted Dose, PK Based||12
173001|NCT00546871|425235|P2|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||3
173002|NCT00546871|425236|P1|NOT COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||1
173003|NCT00546871|425235|P2|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||32
173004|NCT00546871|425236|P1|COMPLETED|Part 2 - Subcutaneous (SC) IGIV, PK||12
173005|NCT00546871|425235|P2|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||35
173006|NCT00546871|425236|P1|STARTED|Part 2 - Subcutaneous (SC) IGIV, PK||13
173007|NCT00546871|425235|P2|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||0
173008|NCT00546871|425236|P1|NOT COMPLETED|Part 1 - IV Infusions of IGIV, PK||1
173009|NCT00546871|425235|P2|COMPLETED|Part 1 - IV Infusions of IGIV, PK||35
173010|NCT00546871|425236|P1|COMPLETED|Part 1 - IV Infusions of IGIV, PK||13
173011|NCT00546871|425235|P2|STARTED|Part 1 - IV Infusions of IGIV, PK||35
173012|NCT00546871|425236|P1|STARTED|Part 1 - IV Infusions of IGIV, PK||14
173013|NCT00546884|425341|P2|NOT COMPLETED|Overall Study||0
173014|NCT00546884|425342|P1|NOT COMPLETED|Overall Study||0
173015|NCT00546884|425341|P2|COMPLETED|Overall Study||117
173016|NCT00546884|425342|P1|COMPLETED|Overall Study||145
173017|NCT00546884|425341|P2|STARTED|Overall Study||117
173018|NCT00546884|425342|P1|STARTED|Overall Study||145
173019|NCT00546897|425350|P2|NOT COMPLETED|Overall Study||0
173020|NCT00546897|425351|P1|NOT COMPLETED|Overall Study||0
173021|NCT00546897|425350|P2|COMPLETED|Overall Study||33
173022|NCT00546897|425351|P1|COMPLETED|Overall Study||15
173023|NCT00546897|425350|P2|STARTED|Overall Study||33
173024|NCT00546897|425351|P1|STARTED|Overall Study||15
173025|NCT00546910|425389|P2|NOT COMPLETED|Overall Study||11
173026|NCT00546910|425390|P1|NOT COMPLETED|Overall Study||9
173027|NCT00546910|425389|P2|COMPLETED|Overall Study||51
173028|NCT00546910|425390|P1|COMPLETED|Overall Study||54
173029|NCT00546910|425389|P2|STARTED|Overall Study||62
173030|NCT00546910|425390|P1|STARTED|Overall Study||63
173031|NCT00547118|425410|P2|NOT COMPLETED|Overall Study||2
173032|NCT00547118|425411|P1|NOT COMPLETED|Overall Study||1
173033|NCT00547118|425410|P2|COMPLETED|Overall Study||7
173034|NCT00547118|425411|P1|COMPLETED|Overall Study||7
173035|NCT00547118|425410|P2|STARTED|Overall Study||9
173036|NCT00547118|425411|P1|STARTED|Overall Study||8
173037|NCT00547157|425419|P2|NOT COMPLETED|Overall Study||23
173038|NCT00547157|425420|P1|NOT COMPLETED|Overall Study||49
173039|NCT00547157|425419|P2|COMPLETED|Overall Study||39
173040|NCT00547157|425420|P1|COMPLETED|Overall Study||41
173041|NCT00547157|425419|P2|STARTED|Overall Study||62
173042|NCT00547157|425420|P1|STARTED|Overall Study||90
173043|NCT00547365|425436|P1|NOT COMPLETED|Overall Study||8
173044|NCT00547365|425436|P1|COMPLETED|Overall Study||2
173045|NCT00547365|425436|P1|STARTED|Overall Study||10
173046|NCT00547456|425441|P1|NOT COMPLETED|Overall Study||0
173047|NCT00547456|425441|P1|COMPLETED|Overall Study||20
173048|NCT00547456|425441|P1|STARTED|Overall Study||20
173049|NCT00547521|425447|P2|NOT COMPLETED|Long Term Extension (LTE) Study||31
173050|NCT00547521|425448|P1|NOT COMPLETED|Long Term Extension (LTE) Study||0
173051|NCT00547521|425447|P2|COMPLETED|Long Term Extension (LTE) Study||59
173052|NCT00547521|425448|P1|COMPLETED|Long Term Extension (LTE) Study||0
173053|NCT00547521|425447|P2|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|90
173054|NCT00547521|425448|P1|STARTED|Long Term Extension (LTE) Study|ST Study had 2 arms, LTE Study pooled all participants who had abatacept injection.|0
173055|NCT00547521|425447|P2|NOT COMPLETED|Short Term Study (4 Months)||4
173056|NCT00547521|425448|P1|NOT COMPLETED|Short Term Study (4 Months)||1
173057|NCT00547521|425447|P2|COMPLETED|Short Term Study (4 Months)||45
173058|NCT00547521|425448|P1|COMPLETED|Short Term Study (4 Months)||50
173059|NCT00547521|425447|P2|STARTED|Short Term Study (4 Months)|Number of participants treated.|49
173060|NCT00547521|425448|P1|STARTED|Short Term Study (4 Months)|Number of participants treated.|51
173061|NCT00547534|425518|P1|NOT COMPLETED|Overall Study||11
173062|NCT00547534|425518|P1|COMPLETED|Overall Study|25 patients received at least 4 cycles. 29 patients were evaluable for response.|19
173063|NCT00547534|425518|P1|STARTED|Overall Study|31 patients enrolled; one patient was determined to be ineligible, and did not receive any therapy.|30
173064|NCT00547638|425526|P2|NOT COMPLETED|Overall Study||14
173065|NCT00547638|425527|P1|NOT COMPLETED|Overall Study||24
173066|NCT00547638|425526|P2|COMPLETED|Overall Study||59
173067|NCT00547638|425527|P1|COMPLETED|Overall Study||119
173068|NCT00547638|425526|P2|STARTED|Overall Study||73
173069|NCT00547638|425527|P1|STARTED|Overall Study||143
173070|NCT00547703|425545|P2|NOT COMPLETED|Overall Study||0
173071|NCT00547703|425546|P1|NOT COMPLETED|Overall Study||1
173072|NCT00547703|425545|P2|COMPLETED|Overall Study||1
173073|NCT00547703|425546|P1|COMPLETED|Overall Study||3
173074|NCT00547703|425545|P2|STARTED|Overall Study||1
173075|NCT00547703|425546|P1|STARTED|Overall Study||4
173076|NCT00547911|425556|P6|NOT COMPLETED|Overall Study||0
173077|NCT00547911|425557|P5|NOT COMPLETED|Overall Study||0
173078|NCT00547911|425558|P4|NOT COMPLETED|Overall Study||1
173079|NCT00547911|425559|P3|NOT COMPLETED|Overall Study||0
173080|NCT00547911|425560|P2|NOT COMPLETED|Overall Study||0
173081|NCT00547911|425561|P1|NOT COMPLETED|Overall Study||0
173082|NCT00547911|425556|P6|COMPLETED|Overall Study||3
173083|NCT00547911|425557|P5|COMPLETED|Overall Study||3
173084|NCT00547911|425558|P4|COMPLETED|Overall Study||1
173085|NCT00547911|425559|P3|COMPLETED|Overall Study||2
173086|NCT00547911|425560|P2|COMPLETED|Overall Study||2
173087|NCT00547911|425561|P1|COMPLETED|Overall Study||2
173088|NCT00547911|425556|P6|STARTED|Overall Study||3
173089|NCT00547911|425557|P5|STARTED|Overall Study||3
173090|NCT00547911|425558|P4|STARTED|Overall Study||2
173091|NCT00547911|425559|P3|STARTED|Overall Study||2
173092|NCT00547911|425560|P2|STARTED|Overall Study||2
173093|NCT00547911|425561|P1|STARTED|Overall Study||2
173094|NCT00548041|425590|P1|NOT COMPLETED|Overall Study||0
173095|NCT00548041|425590|P1|COMPLETED|Overall Study||100
173096|NCT00548041|425590|P1|STARTED|Overall Study||100
173097|NCT00548132|425596|P2|NOT COMPLETED|Overall Study||0
173098|NCT00548132|425597|P1|NOT COMPLETED|Overall Study||0
173099|NCT00548132|425596|P2|COMPLETED|Overall Study||554
173100|NCT00548132|425597|P1|COMPLETED|Overall Study||534
173101|NCT00548132|425596|P2|Consented to Study|Overall Study||554
173102|NCT00548132|425597|P1|Consented to Study|Overall Study||534
173103|NCT00548132|425596|P2|STARTED|Overall Study||554
173104|NCT00548132|425597|P1|STARTED|Overall Study||534
173105|NCT00548145|425607|P2|NOT COMPLETED|Overall Study||4
173106|NCT00548145|425608|P1|NOT COMPLETED|Overall Study||1
173107|NCT00548145|425607|P2|COMPLETED|Overall Study||16
173108|NCT00548145|425608|P1|COMPLETED|Overall Study||17
173109|NCT00548145|425607|P2|STARTED|Overall Study||20
173110|NCT00548145|425608|P1|STARTED|Overall Study||18
173111|NCT00548184|425614|P1|NOT COMPLETED|Overall Study||5
173112|NCT00548184|425614|P1|COMPLETED|Overall Study|65 patients were on treatment. 5 did not complete due to adverse events or other reasons.|60
173113|NCT00548184|425614|P1|STARTED|Overall Study||65
173114|NCT00548249|425623|P5|NOT COMPLETED|Overall Study||21
173115|NCT00548249|425624|P4|NOT COMPLETED|Overall Study||13
173116|NCT00548249|425625|P3|NOT COMPLETED|Overall Study||20
173117|NCT00548249|425626|P2|NOT COMPLETED|Overall Study||13
173118|NCT00548249|425627|P1|NOT COMPLETED|Overall Study||16
173119|NCT00548249|425623|P5|COMPLETED|Overall Study||7
173120|NCT00548249|425624|P4|COMPLETED|Overall Study||9
173121|NCT00548249|425625|P3|COMPLETED|Overall Study||9
173122|NCT00548249|425626|P2|COMPLETED|Overall Study||13
173123|NCT00548249|425627|P1|COMPLETED|Overall Study||10
173124|NCT00548249|425623|P5|STARTED|Overall Study||28
173125|NCT00548249|425624|P4|STARTED|Overall Study||22
173126|NCT00548249|425625|P3|STARTED|Overall Study||29
173127|NCT00548249|425626|P2|STARTED|Overall Study||26
173128|NCT00548249|425627|P1|STARTED|Overall Study||26
173129|NCT00548262|425664|P1|NOT COMPLETED|Overall Study||32
173130|NCT00548262|425664|P1|COMPLETED|Overall Study|1 N had D/C recorded as died and as lack of efficacy; reported as lack of efficacy in reason for D/C|22
173131|NCT00548262|425664|P1|STARTED|Overall Study|1 participant (N) had death recorded twice; reported as 1 death in reason for discontinuation (D/C)|54
173132|NCT00548327|425691|P2|NOT COMPLETED|Overall Study||1
173133|NCT00548327|425692|P1|NOT COMPLETED|Overall Study||0
173134|NCT00548327|425691|P2|COMPLETED|Overall Study|Patient randomized to receive placebo first. While on placebo, Adverse Event lead to discontinuation|4
173135|NCT00548327|425692|P1|COMPLETED|Overall Study||6
173136|NCT00548327|425691|P2|STARTED|Overall Study||5
173137|NCT00548327|425692|P1|STARTED|Overall Study||6
173138|NCT00548340|425713|P3|NOT COMPLETED|Overall Study||9
173139|NCT00548340|425714|P2|NOT COMPLETED|Overall Study||11
173140|NCT00548340|425715|P1|NOT COMPLETED|Overall Study||8
173141|NCT00548340|425713|P3|COMPLETED|Overall Study||95
173142|NCT00548340|425714|P2|COMPLETED|Overall Study||98
173143|NCT00548340|425715|P1|COMPLETED|Overall Study||101
173144|NCT00548340|425713|P3|STARTED|Overall Study||104
173145|NCT00548340|425714|P2|STARTED|Overall Study||109
173146|NCT00548340|425715|P1|STARTED|Overall Study||109
173147|NCT00548405|425735|P3|NOT COMPLETED|Overall Study||9
173148|NCT00548405|425736|P2|NOT COMPLETED|Overall Study||20
173149|NCT00548405|425737|P1|NOT COMPLETED|Overall Study||56
173150|NCT00548405|425735|P3|COMPLETED|Overall Study||164
173151|NCT00548405|425736|P2|COMPLETED|Overall Study||416
173152|NCT00548405|425737|P1|COMPLETED|Overall Study||175
173153|NCT00548405|425735|P3|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|170
173154|NCT00548405|425736|P2|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|426
173155|NCT00548405|425737|P1|Treated|Overall Study|All randomized participants who received at least 1 dose of study drug as per initial randomization.|202
173156|NCT00548405|425735|P3|STARTED|Overall Study|Randomized.|173
173157|NCT00548405|425736|P2|STARTED|Overall Study|Randomized.|436
173158|NCT00548405|425737|P1|STARTED|Overall Study|Randomized.|231
173159|NCT00548418|425755|P1|NOT COMPLETED|Overall Study||0
173160|NCT00548418|425755|P1|COMPLETED|Overall Study||27
173161|NCT00548418|425755|P1|STARTED|Overall Study||27
173162|NCT00548431|425763|P1|NOT COMPLETED|Overall Study||0
173163|NCT00548431|425763|P1|COMPLETED|Overall Study||38
173164|NCT00548431|425763|P1|STARTED|Overall Study||38
173165|NCT00548548|425769|P2|NOT COMPLETED|Overall Study||366
173166|NCT00548548|425770|P1|NOT COMPLETED|Overall Study||362
173167|NCT00548548|425769|P2|COMPLETED|Overall Study||21
173168|NCT00548548|425770|P1|COMPLETED|Overall Study|Completed treatment discontinuation form was not completed; patient was counted alive on treatment.|25
173169|NCT00548548|425769|P2|Safety Population|Overall Study||381
173170|NCT00548548|425770|P1|Safety Population|Overall Study|Four patients randomized to placebo received single doses of bevacizumab in error.|386
173171|NCT00548548|425769|P2|Treated|Overall Study||384
173172|NCT00548548|425770|P1|Treated|Overall Study||383
173173|NCT00548548|425769|P2|STARTED|Overall Study||387
173174|NCT00548548|425770|P1|STARTED|Overall Study||387
173175|NCT00542269|425793|P3|NOT COMPLETED|Overall Study||6
173176|NCT00542269|425794|P2|NOT COMPLETED|Overall Study||6
173177|NCT00542269|425795|P1|NOT COMPLETED|Overall Study||13
173178|NCT00542269|425793|P3|COMPLETED|Overall Study||51
173179|NCT00542269|425794|P2|COMPLETED|Overall Study||54
173180|NCT00542269|425795|P1|COMPLETED|Overall Study||48
173181|NCT00542269|425793|P3|STARTED|Overall Study||57
173182|NCT00542269|425794|P2|STARTED|Overall Study||60
173183|NCT00542269|425795|P1|STARTED|Overall Study||61
173184|NCT00542308|425824|P1|NOT COMPLETED|Overall Study||0
173185|NCT00542308|425824|P1|COMPLETED|Overall Study||90
173186|NCT00542308|425824|P1|STARTED|Overall Study||90
173187|NCT00542321|425831|P2|NOT COMPLETED|Overall Study||1
173188|NCT00542321|425832|P1|NOT COMPLETED|Overall Study||0
173189|NCT00542321|425831|P2|COMPLETED|Overall Study||7
173190|NCT00542321|425832|P1|COMPLETED|Overall Study||8
173191|NCT00542321|425831|P2|STARTED|Overall Study||8
173192|NCT00542321|425832|P1|STARTED|Overall Study||8
173193|NCT00542386|425852|P6|NOT COMPLETED|Overall Study||50
173194|NCT00542386|425853|P5|NOT COMPLETED|Overall Study||40
173195|NCT00542386|425854|P4|NOT COMPLETED|Overall Study||38
173196|NCT00542386|425855|P3|NOT COMPLETED|Overall Study||33
173197|NCT00542386|425856|P2|NOT COMPLETED|Overall Study||28
173198|NCT00542386|425857|P1|NOT COMPLETED|Overall Study||43
173199|NCT00542386|425852|P6|COMPLETED|Overall Study||82
173200|NCT00542386|425853|P5|COMPLETED|Overall Study||62
173201|NCT00542386|425854|P4|COMPLETED|Overall Study||65
173202|NCT00542386|425855|P3|COMPLETED|Overall Study||66
173203|NCT00542386|425856|P2|COMPLETED|Overall Study||74
173204|NCT00542386|425857|P1|COMPLETED|Overall Study||61
173205|NCT00542386|425852|P6|STARTED|Overall Study||132
173206|NCT00542386|425853|P5|STARTED|Overall Study||102
173207|NCT00542386|425854|P4|STARTED|Overall Study||103
173208|NCT00542386|425855|P3|STARTED|Overall Study||99
173209|NCT00542386|425856|P2|STARTED|Overall Study||102
173210|NCT00542386|425857|P1|STARTED|Overall Study||104
173211|NCT00542425|425882|P5|NOT COMPLETED|Extended 24 Weeks of Treatment||1
173212|NCT00542425|425883|P4|NOT COMPLETED|Extended 24 Weeks of Treatment||1
173213|NCT00542425|425884|P3|NOT COMPLETED|Extended 24 Weeks of Treatment||2
173214|NCT00542425|425885|P2|NOT COMPLETED|Extended 24 Weeks of Treatment||2
173215|NCT00542425|425886|P1|NOT COMPLETED|Extended 24 Weeks of Treatment||1
173216|NCT00542425|425882|P5|COMPLETED|Extended 24 Weeks of Treatment||13
173217|NCT00542425|425883|P4|COMPLETED|Extended 24 Weeks of Treatment||6
173218|NCT00542425|425884|P3|COMPLETED|Extended 24 Weeks of Treatment||8
173219|NCT00542425|425885|P2|COMPLETED|Extended 24 Weeks of Treatment||11
173220|NCT00542425|425886|P1|COMPLETED|Extended 24 Weeks of Treatment||10
173221|NCT00542425|425882|P5|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|14
173222|NCT00542425|425883|P4|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|7
173223|NCT00542425|425884|P3|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|10
173224|NCT00542425|425885|P2|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|13
173225|NCT00542425|425886|P1|STARTED|Extended 24 Weeks of Treatment|Not all patients were eligible for extension study, often due to the regulatory approval timeline.|11
173226|NCT00542425|425882|P5|NOT COMPLETED|Initial 24 Weeks||6
173227|NCT00542425|425883|P4|NOT COMPLETED|Initial 24 Weeks||11
173228|NCT00542425|425884|P3|NOT COMPLETED|Initial 24 Weeks||7
173229|NCT00542425|425885|P2|NOT COMPLETED|Initial 24 Weeks||10
173230|NCT00542425|425886|P1|NOT COMPLETED|Initial 24 Weeks||4
173231|NCT00542425|425882|P5|COMPLETED|Initial 24 Weeks||39
173232|NCT00542425|425883|P4|COMPLETED|Initial 24 Weeks||34
173233|NCT00542425|425884|P3|COMPLETED|Initial 24 Weeks||36
173234|NCT00542425|425885|P2|COMPLETED|Initial 24 Weeks||33
173235|NCT00542425|425886|P1|COMPLETED|Initial 24 Weeks||42
173236|NCT00542425|425882|P5|STARTED|Initial 24 Weeks||45
173237|NCT00542425|425883|P4|STARTED|Initial 24 Weeks||45
173238|NCT00542425|425884|P3|STARTED|Initial 24 Weeks||43
173239|NCT00542425|425885|P2|STARTED|Initial 24 Weeks||43
173240|NCT00542425|425886|P1|STARTED|Initial 24 Weeks||46
173241|NCT00542542|425920|P2|NOT COMPLETED|Overall Study||0
173242|NCT00542542|425921|P1|NOT COMPLETED|Overall Study||0
173243|NCT00542542|425920|P2|COMPLETED|Overall Study||44
173244|NCT00542542|425921|P1|COMPLETED|Overall Study||44
173245|NCT00542542|425920|P2|STARTED|Overall Study||44
173246|NCT00542542|425921|P1|STARTED|Overall Study||44
173247|NCT00542620|425929|P2|NOT COMPLETED|Overall Study||0
173248|NCT00542620|425930|P1|NOT COMPLETED|Overall Study||0
173249|NCT00542620|425929|P2|COMPLETED|Overall Study||12
173250|NCT00542620|425930|P1|COMPLETED|Overall Study||13
173251|NCT00542620|425929|P2|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|13
173252|NCT00542620|425930|P1|Exposed to Drug|Overall Study|One subject randomly assigned to receive mixed injections, but received a separate injection mode|12
173253|NCT00542620|425929|P2|STARTED|Overall Study||12
173254|NCT00542620|425930|P1|STARTED|Overall Study||13
173255|NCT00542789|425996|P2|NOT COMPLETED|Overall Study||78
173256|NCT00542789|425997|P1|NOT COMPLETED|Overall Study||41
173257|NCT00542789|425996|P2|COMPLETED|Overall Study||90
173258|NCT00542789|425997|P1|COMPLETED|Overall Study||134
173259|NCT00542789|425996|P2|STARTED|Overall Study|Randomised|168
173260|NCT00542789|425997|P1|STARTED|Overall Study|Randomised|175
173261|NCT00542815|426010|P3|NOT COMPLETED|Overall Study||32
173262|NCT00542815|426011|P2|NOT COMPLETED|Overall Study||32
173263|NCT00542815|426012|P1|NOT COMPLETED|Overall Study||106
173264|NCT00542815|426010|P3|COMPLETED|Overall Study||92
173265|NCT00542815|426011|P2|COMPLETED|Overall Study||44
173266|NCT00542815|426012|P1|COMPLETED|Overall Study||326
173267|NCT00542815|426010|P3|STARTED|Overall Study||124
173268|NCT00542815|426011|P2|STARTED|Overall Study||76
173269|NCT00542815|426012|P1|STARTED|Overall Study||432
173270|NCT00542828|426023|P1|NOT COMPLETED|Overall Study||13
173271|NCT00542828|426023|P1|COMPLETED|Overall Study|Number of participants who completed the 12-month study period.|3
173272|NCT00542828|426023|P1|STARTED|Overall Study|Number of participants enrolled in the study; of the 16 enrolled, 14 received study treatment.|16
173273|NCT00542880|426040|P2|NOT COMPLETED|Period 3||2
173274|NCT00542880|426041|P1|NOT COMPLETED|Period 3||0
173275|NCT00542880|426040|P2|COMPLETED|Period 3||201
173276|NCT00542880|426041|P1|COMPLETED|Period 3||204
173277|NCT00542880|426040|P2|STARTED|Period 3||203
173278|NCT00542880|426041|P1|STARTED|Period 3||204
173279|NCT00542880|426040|P2|NOT COMPLETED|Period 2||10
173280|NCT00542880|426041|P1|NOT COMPLETED|Period 2||7
173281|NCT00542880|426040|P2|COMPLETED|Period 2||203
173282|NCT00542880|426041|P1|COMPLETED|Period 2||204
173283|NCT00542880|426040|P2|STARTED|Period 2||213
173284|NCT00542880|426041|P1|STARTED|Period 2||211
173285|NCT00542880|426040|P2|NOT COMPLETED|Period 1||12
173286|NCT00542880|426041|P1|NOT COMPLETED|Period 1||6
173287|NCT00542880|426040|P2|COMPLETED|Period 1||213
173288|NCT00542880|426041|P1|COMPLETED|Period 1||211
173289|NCT00542880|426040|P2|STARTED|Period 1||225
173290|NCT00542880|426041|P1|STARTED|Period 1|This was a cross-over study|217
173291|NCT00542971|426077|P1|NOT COMPLETED|Overall Study||0
173292|NCT00542971|426077|P1|COMPLETED|Overall Study||75
173293|NCT00542971|426077|P1|STARTED|Overall Study||75
173294|NCT00542997|426082|P1|NOT COMPLETED|Efficacy Period||3
173295|NCT00542997|426082|P1|COMPLETED|Efficacy Period||43
173296|NCT00542997|426082|P1|STARTED|Efficacy Period||46
173297|NCT00542997|426082|P1|NOT COMPLETED|Wash in / Wash Out Period||5
173298|NCT00542997|426082|P1|COMPLETED|Wash in / Wash Out Period||46
173299|NCT00542997|426082|P1|STARTED|Wash in / Wash Out Period||51
173300|NCT00543101|426099|P2|NOT COMPLETED|Overall Study||0
173301|NCT00543101|426100|P1|NOT COMPLETED|Overall Study||0
173302|NCT00543101|426099|P2|COMPLETED|Overall Study||12
173303|NCT00543101|426100|P1|COMPLETED|Overall Study||12
173304|NCT00543101|426099|P2|STARTED|Overall Study||12
173305|NCT00543101|426100|P1|STARTED|Overall Study||12
173306|NCT00548691|426114|P2|NOT COMPLETED|Overall Study||9
173307|NCT00548691|426115|P1|NOT COMPLETED|Overall Study||7
173308|NCT00548691|426114|P2|COMPLETED|Overall Study||250
173309|NCT00548691|426115|P1|COMPLETED|Overall Study||251
173310|NCT00548691|426114|P2|STARTED|Overall Study||259
173311|NCT00548691|426115|P1|STARTED|Overall Study||258
173312|NCT00548717|426123|P2|NOT COMPLETED|Overall Study||2
173313|NCT00548717|426124|P1|NOT COMPLETED|Overall Study||9
173314|NCT00548717|426123|P2|COMPLETED|Overall Study||0
173315|NCT00548717|426124|P1|COMPLETED|Overall Study||4
173316|NCT00548717|426123|P2|STARTED|Overall Study||2
173317|NCT00548717|426124|P1|STARTED|Overall Study||13
173318|NCT00548808|426143|P2|NOT COMPLETED|Overall Study||26
173319|NCT00548808|426144|P1|NOT COMPLETED|Overall Study||42
173320|NCT00548808|426143|P2|COMPLETED|Overall Study||186
173321|NCT00548808|426144|P1|COMPLETED|Overall Study||172
173322|NCT00548808|426143|P2|Per-Protocol Set|Overall Study||184
173323|NCT00548808|426144|P1|Per-Protocol Set|Overall Study||177
173324|NCT00548808|426143|P2|Full Analysis Set|Overall Study||212
173325|NCT00548808|426144|P1|Full Analysis Set|Overall Study||211
173326|NCT00548808|426143|P2|STARTED|Overall Study||212
173327|NCT00548808|426144|P1|STARTED|Overall Study||214
173328|NCT00548847|426166|P1|NOT COMPLETED|Overall Study||7
173329|NCT00548847|426166|P1|COMPLETED|Overall Study||8
173330|NCT00548847|426166|P1|STARTED|Overall Study||15
173331|NCT00548860|426173|P2|NOT COMPLETED|Overall Study||175
173332|NCT00548860|426174|P1|NOT COMPLETED|Overall Study||136
173333|NCT00548860|426173|P2|COMPLETED|Overall Study||847
173334|NCT00548860|426174|P1|COMPLETED|Overall Study||860
173335|NCT00548860|426173|P2|STARTED|Overall Study||1022
173336|NCT00548860|426174|P1|STARTED|Overall Study||996
173337|NCT00548886|426180|P1|NOT COMPLETED|Overall Study||0
173338|NCT00548886|426180|P1|COMPLETED|Overall Study||7
173339|NCT00548886|426180|P1|STARTED|Overall Study||7
173340|NCT00549172|426186|P2|NOT COMPLETED|Overall Study||0
173341|NCT00549172|426187|P1|NOT COMPLETED|Overall Study||0
173342|NCT00549172|426186|P2|COMPLETED|Overall Study||76
173343|NCT00549172|426187|P1|COMPLETED|Overall Study||70
173344|NCT00549172|426186|P2|STARTED|Overall Study||76
173345|NCT00549172|426187|P1|STARTED|Overall Study||70
173346|NCT00549198|426203|P2|NOT COMPLETED|Overall Study||63
173347|NCT00549198|426204|P1|NOT COMPLETED|Overall Study||80
173348|NCT00549198|426203|P2|COMPLETED|Overall Study||134
173349|NCT00549198|426204|P1|COMPLETED|Overall Study||115
173350|NCT00549198|426203|P2|STARTED|Overall Study|Four participants were randomized but were not exposed to study drug (TDF/FTC).|197
173351|NCT00549198|426204|P1|STARTED|Overall Study|Three participants were randomized but were not exposed to study drug (ABC/3TC).|195
173352|NCT00549302|426326|P3|NOT COMPLETED|Open-Label||69
173353|NCT00549302|426327|P2|NOT COMPLETED|Open-Label||0
173354|NCT00549302|426328|P1|NOT COMPLETED|Open-Label||0
173355|NCT00549302|426326|P3|COMPLETED|Open-Label|Another death occurred during the 30-day follow-up period after study drug discontinuation|217
173356|NCT00549302|426327|P2|COMPLETED|Open-Label||0
173357|NCT00549302|426328|P1|COMPLETED|Open-Label||0
173358|NCT00549302|426326|P3|STARTED|Open-Label|7 participants who completed the Double-Blind Period did not enter the Open-Label Period.|286
173359|NCT00549302|426327|P2|STARTED|Open-Label||0
173360|NCT00549302|426328|P1|STARTED|Open-Label||0
173361|NCT00549302|426326|P3|NOT COMPLETED|Double-Blind||0
173362|NCT00549302|426327|P2|NOT COMPLETED|Double-Blind||53
173363|NCT00549302|426328|P1|NOT COMPLETED|Double-Blind||11
173364|NCT00549302|426326|P3|COMPLETED|Double-Blind||0
173365|NCT00549302|426327|P2|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|241
173366|NCT00549302|426328|P1|COMPLETED|Double-Blind|Participants who completed the Double-Blind Period were eligible to enter the Open-Label Period.|52
173367|NCT00549302|426326|P3|Received at Least One Dose of Study Drug|Double-Blind||0
173368|NCT00549302|426327|P2|Received at Least One Dose of Study Drug|Double-Blind||294
173369|NCT00549302|426328|P1|Received at Least One Dose of Study Drug|Double-Blind||63
173370|NCT00549302|426326|P3|STARTED|Double-Blind||0
173371|NCT00549302|426327|P2|STARTED|Double-Blind||294
173372|NCT00549302|426328|P1|STARTED|Double-Blind||63
173373|NCT00549328|426338|P1|NOT COMPLETED|Overall Study||14
173374|NCT00549328|426338|P1|COMPLETED|Overall Study||0
173375|NCT00549328|426338|P1|STARTED|Overall Study||14
173376|NCT00549393|426349|P2|NOT COMPLETED|Period 3 (6 Months)||0
173377|NCT00549393|426350|P1|NOT COMPLETED|Period 3 (6 Months)||0
173378|NCT00549393|426349|P2|COMPLETED|Period 3 (6 Months)||1326
173379|NCT00549393|426350|P1|COMPLETED|Period 3 (6 Months)||1103
173380|NCT00549393|426349|P2|Per Protocol|Period 3 (6 Months)||1326
173381|NCT00549393|426350|P1|Per Protocol|Period 3 (6 Months)||667
173382|NCT00549393|426349|P2|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1326
173383|NCT00549393|426350|P1|STARTED|Period 3 (6 Months)|number not equal to period 1 due to unit cross over design|1103
173384|NCT00549393|426349|P2|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
173385|NCT00549393|426350|P1|NOT COMPLETED|Period 2 Washout (2 Weeks)||0
173386|NCT00549393|426349|P2|COMPLETED|Period 2 Washout (2 Weeks)||0
173387|NCT00549393|426350|P1|COMPLETED|Period 2 Washout (2 Weeks)||0
173388|NCT00549393|426349|P2|STARTED|Period 2 Washout (2 Weeks)||0
173389|NCT00549393|426350|P1|STARTED|Period 2 Washout (2 Weeks)||0
173390|NCT00549393|426349|P2|NOT COMPLETED|Period 1 (6 Months)||0
173391|NCT00549393|426350|P1|NOT COMPLETED|Period 1 (6 Months)||0
173392|NCT00549393|426349|P2|COMPLETED|Period 1 (6 Months)||1199
173393|NCT00549393|426350|P1|COMPLETED|Period 1 (6 Months)||1319
173394|NCT00549393|426349|P2|Per Protocol|Period 1 (6 Months)||1199
173395|NCT00549393|426350|P1|Per Protocol|Period 1 (6 Months)||880
173396|NCT00549393|426349|P2|STARTED|Period 1 (6 Months)|ITT|1199
173397|NCT00549393|426350|P1|STARTED|Period 1 (6 Months)|intention to treat (ITT)|1319
173398|NCT00549445|426362|P2|NOT COMPLETED|Overall Study||17
173399|NCT00549445|426363|P1|NOT COMPLETED|Overall Study||15
173400|NCT00549445|426362|P2|COMPLETED|Overall Study||13
173401|NCT00549445|426363|P1|COMPLETED|Overall Study||8
173402|NCT00549445|426362|P2|STARTED|Overall Study||30
173403|NCT00549445|426363|P1|STARTED|Overall Study||23
173404|NCT00549549|426373|P4|NOT COMPLETED|Overall Study||25
173405|NCT00549549|426374|P3|NOT COMPLETED|Overall Study||17
173406|NCT00549549|426375|P2|NOT COMPLETED|Overall Study||22
173407|NCT00549549|426376|P1|NOT COMPLETED|Overall Study||24
173408|NCT00549549|426373|P4|COMPLETED|Overall Study||78
173409|NCT00549549|426374|P3|COMPLETED|Overall Study||82
173410|NCT00549549|426375|P2|COMPLETED|Overall Study||77
173411|NCT00549549|426376|P1|COMPLETED|Overall Study||77
173412|NCT00549549|426373|P4|Treated|Overall Study||102
173413|NCT00549549|426374|P3|Treated|Overall Study||98
173414|NCT00549549|426375|P2|Treated|Overall Study||99
173415|NCT00549549|426376|P1|Treated|Overall Study||101
173416|NCT00549549|426373|P4|STARTED|Overall Study||103
173417|NCT00549549|426374|P3|STARTED|Overall Study||99
173418|NCT00549549|426375|P2|STARTED|Overall Study||99
173419|NCT00549549|426376|P1|STARTED|Overall Study||101
173420|NCT00549562|426442|P1|NOT COMPLETED|Overall Study||2
173421|NCT00549562|426442|P1|COMPLETED|Overall Study||23
173422|NCT00549562|426442|P1|STARTED|Overall Study||25
173423|NCT00549601|426453|P3|NOT COMPLETED|Received Study Drug||4
173424|NCT00549601|426454|P2|NOT COMPLETED|Received Study Drug||11
173425|NCT00549601|426455|P1|NOT COMPLETED|Received Study Drug||7
173426|NCT00549601|426453|P3|COMPLETED|Received Study Drug||45
173427|NCT00549601|426454|P2|COMPLETED|Received Study Drug||36
173428|NCT00549601|426455|P1|COMPLETED|Received Study Drug||36
173429|NCT00549601|426453|P3|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|49
173430|NCT00549601|426454|P2|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|47
173431|NCT00549601|426455|P1|STARTED|Received Study Drug|Subjects who started this period (safety population) received at least 1 dose of study drug.|43
173432|NCT00549601|426453|P3|NOT COMPLETED|Randomized||2
173433|NCT00549601|426454|P2|NOT COMPLETED|Randomized||1
173434|NCT00549601|426455|P1|NOT COMPLETED|Randomized||0
173435|NCT00549601|426453|P3|COMPLETED|Randomized||49
173436|NCT00549601|426454|P2|COMPLETED|Randomized||47
173437|NCT00549601|426455|P1|COMPLETED|Randomized||43
173438|NCT00549601|426453|P3|STARTED|Randomized||51
173439|NCT00549601|426454|P2|STARTED|Randomized||48
173440|NCT00549601|426455|P1|STARTED|Randomized||43
173441|NCT00549640|426479|P2|NOT COMPLETED|Overall Study||16
173442|NCT00549640|426480|P1|NOT COMPLETED|Overall Study||18
173443|NCT00549640|426479|P2|COMPLETED|Overall Study||24
173444|NCT00549640|426480|P1|COMPLETED|Overall Study|For the primary endpoint, subjects who discontinued participation were assumed to be smoking.|22
173445|NCT00549640|426479|P2|STARTED|Overall Study||40
173446|NCT00549640|426480|P1|STARTED|Overall Study||40
173447|NCT00549718|426494|P4|NOT COMPLETED|Overall Study||55
173448|NCT00549718|426495|P3|NOT COMPLETED|Overall Study||39
173449|NCT00549718|426496|P2|NOT COMPLETED|Overall Study||37
173450|NCT00549718|426497|P1|NOT COMPLETED|Overall Study||41
173451|NCT00549718|426494|P4|COMPLETED|Overall Study||73
173452|NCT00549718|426495|P3|COMPLETED|Overall Study||85
173453|NCT00549718|426496|P2|COMPLETED|Overall Study||86
173454|NCT00549718|426497|P1|COMPLETED|Overall Study||84
173455|NCT00549718|426494|P4|STARTED|Overall Study||128
173456|NCT00549718|426495|P3|STARTED|Overall Study||124
173457|NCT00549718|426496|P2|STARTED|Overall Study||123
173458|NCT00549718|426497|P1|STARTED|Overall Study||125
173459|NCT00549757|426513|P2|NOT COMPLETED|Extension Period (in Average 9 Months)||635
173460|NCT00549757|426514|P1|NOT COMPLETED|Extension Period (in Average 9 Months)||625
173461|NCT00549757|426513|P2|COMPLETED|Extension Period (in Average 9 Months)||3182
173462|NCT00549757|426514|P1|COMPLETED|Extension Period (in Average 9 Months)||3148
173463|NCT00549757|426513|P2|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3817
173464|NCT00549757|426514|P1|STARTED|Extension Period (in Average 9 Months)|"As explained in pre-assignment detail, follow up was made after drug discontinuation"|3773
173465|NCT00549757|426513|P2|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4310
173466|NCT00549757|426514|P1|NOT COMPLETED|Active Treatment Phase: Max. 50 Months||4296
173467|NCT00549757|426513|P2|COMPLETED|Active Treatment Phase: Max. 50 Months||0
173468|NCT00549757|426514|P1|COMPLETED|Active Treatment Phase: Max. 50 Months||0
173469|NCT00549757|426513|P2|Safety Set|Active Treatment Phase: Max. 50 Months||4285
173470|NCT00549757|426514|P1|Safety Set|Active Treatment Phase: Max. 50 Months||4272
173471|NCT00549757|426513|P2|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4287
173472|NCT00549757|426514|P1|Full Analysis Set|Active Treatment Phase: Max. 50 Months||4274
173473|NCT00549757|426513|P2|STARTED|Active Treatment Phase: Max. 50 Months||4310
173474|NCT00549757|426514|P1|STARTED|Active Treatment Phase: Max. 50 Months|"Started indicates randomized patients."|4296
173475|NCT00549770|426580|P8|NOT COMPLETED|Overall Study||25
173476|NCT00549770|426581|P7|NOT COMPLETED|Overall Study||14
173477|NCT00549770|426582|P6|NOT COMPLETED|Overall Study||13
173478|NCT00549770|426583|P5|NOT COMPLETED|Overall Study||17
173479|NCT00549770|426584|P4|NOT COMPLETED|Overall Study||16
173480|NCT00549770|426585|P3|NOT COMPLETED|Overall Study||10
173481|NCT00549770|426586|P2|NOT COMPLETED|Overall Study||11
173482|NCT00549770|426587|P1|NOT COMPLETED|Overall Study||7
173483|NCT00549770|426580|P8|COMPLETED|Overall Study||148
173484|NCT00549770|426581|P7|COMPLETED|Overall Study||151
173485|NCT00549770|426582|P6|COMPLETED|Overall Study||151
173486|NCT00549770|426583|P5|COMPLETED|Overall Study||149
173487|NCT00549770|426584|P4|COMPLETED|Overall Study||147
173488|NCT00549770|426585|P3|COMPLETED|Overall Study||162
173489|NCT00549770|426586|P2|COMPLETED|Overall Study||158
173490|NCT00549770|426587|P1|COMPLETED|Overall Study||149
173491|NCT00549770|426580|P8|Ambulatory Blood Pressure Monitoring|Overall Study||57
173492|NCT00549770|426581|P7|Ambulatory Blood Pressure Monitoring|Overall Study||50
173493|NCT00549770|426582|P6|Ambulatory Blood Pressure Monitoring|Overall Study||54
173494|NCT00549770|426583|P5|Ambulatory Blood Pressure Monitoring|Overall Study||49
173495|NCT00549770|426584|P4|Ambulatory Blood Pressure Monitoring|Overall Study||55
173496|NCT00549770|426585|P3|Ambulatory Blood Pressure Monitoring|Overall Study||53
173497|NCT00549770|426586|P2|Ambulatory Blood Pressure Monitoring|Overall Study||61
173498|NCT00549770|426587|P1|Ambulatory Blood Pressure Monitoring|Overall Study||48
173499|NCT00549770|426580|P8|Intent-to-treat Population|Overall Study||172
173500|NCT00549770|426581|P7|Intent-to-treat Population|Overall Study||164
173501|NCT00549770|426582|P6|Intent-to-treat Population|Overall Study||163
173502|NCT00549770|426583|P5|Intent-to-treat Population|Overall Study||163
173503|NCT00549770|426584|P4|Intent-to-treat Population|Overall Study||163
173504|NCT00549770|426585|P3|Intent-to-treat Population|Overall Study||170
173505|NCT00549770|426586|P2|Intent-to-treat Population|Overall Study||168
173506|NCT00549770|426587|P1|Intent-to-treat Population|Overall Study||154
173507|NCT00549770|426580|P8|STARTED|Overall Study||173
173508|NCT00549770|426581|P7|STARTED|Overall Study||165
173509|NCT00549770|426582|P6|STARTED|Overall Study||164
173510|NCT00549770|426583|P5|STARTED|Overall Study||166
173511|NCT00549770|426584|P4|STARTED|Overall Study||163
173512|NCT00549770|426585|P3|STARTED|Overall Study||172
173513|NCT00549770|426586|P2|STARTED|Overall Study||169
173514|NCT00549770|426587|P1|STARTED|Overall Study||156
173515|NCT00549783|426671|P2|NOT COMPLETED|Overall Study||13
173516|NCT00549783|426672|P1|NOT COMPLETED|Overall Study||8
173517|NCT00549783|426671|P2|COMPLETED|Overall Study||122
173518|NCT00549783|426672|P1|COMPLETED|Overall Study||131
173519|NCT00549783|426671|P2|STARTED|Overall Study||135
173520|NCT00549783|426672|P1|STARTED|Overall Study||139
173521|NCT00549822|426702|P1|NOT COMPLETED|Overall Study||0
173522|NCT00549822|426702|P1|COMPLETED|Overall Study||3
173523|NCT00549822|426702|P1|STARTED|Overall Study||3
173524|NCT00549900|426708|P1|NOT COMPLETED|Overall Study||1
173525|NCT00549900|426708|P1|COMPLETED|Overall Study||29
173526|NCT00549900|426708|P1|STARTED|Overall Study||30
173527|NCT00549939|426720|P3|NOT COMPLETED|40-week Open Label Treatment Period||5
173528|NCT00549939|426721|P2|NOT COMPLETED|40-week Open Label Treatment Period||5
173529|NCT00549939|426722|P1|NOT COMPLETED|40-week Open Label Treatment Period||0
173530|NCT00549939|426720|P3|COMPLETED|40-week Open Label Treatment Period||78
173531|NCT00549939|426721|P2|COMPLETED|40-week Open Label Treatment Period||75
173532|NCT00549939|426722|P1|COMPLETED|40-week Open Label Treatment Period||0
173533|NCT00549939|426720|P3|STARTED|40-week Open Label Treatment Period|55 patients continued Alfuzosin 0.2 mg/kg/day and 28 patients started Alfuzosin 0.2 mg/kg/day.|83
173534|NCT00549939|426721|P2|STARTED|40-week Open Label Treatment Period|54 patients continued Alfuzosin 0.1 mg/kg/day and 26 patients started Alfuzosin 0.1 mg/kg/day.|80
173535|NCT00549939|426722|P1|STARTED|40-week Open Label Treatment Period|54 patients continued and switched to Alfuzosin: 26 to 0.1 mg/kg/day and 28 to 0.2 mg/kg/day.|0
173536|NCT00549939|426720|P3|NOT COMPLETED|12-week Double Blind Treatment Period||2
173537|NCT00549939|426721|P2|NOT COMPLETED|12-week Double Blind Treatment Period||2
173538|NCT00549939|426722|P1|NOT COMPLETED|12-week Double Blind Treatment Period||1
173539|NCT00549939|426720|P3|COMPLETED|12-week Double Blind Treatment Period||56
173540|NCT00549939|426721|P2|COMPLETED|12-week Double Blind Treatment Period||55
173541|NCT00549939|426722|P1|COMPLETED|12-week Double Blind Treatment Period||56
173542|NCT00549939|426720|P3|STARTED|12-week Double Blind Treatment Period||58
173543|NCT00549939|426721|P2|STARTED|12-week Double Blind Treatment Period||57
173544|NCT00549939|426722|P1|STARTED|12-week Double Blind Treatment Period|29 (Alfuzosin 0.1 mg/kg/day matching placebo) + 28 (Alfuzosin 0.2 mg/kg/day matching placebo)|57
173545|NCT00550043|426754|P5|NOT COMPLETED|Overall Study||1
173546|NCT00550043|426755|P4|NOT COMPLETED|Overall Study||2
173547|NCT00550043|426756|P3|NOT COMPLETED|Overall Study||1
173548|NCT00550043|426757|P2|NOT COMPLETED|Overall Study||3
173549|NCT00550043|426758|P1|NOT COMPLETED|Overall Study||0
173550|NCT00550043|426754|P5|COMPLETED|Overall Study||9
173551|NCT00550043|426755|P4|COMPLETED|Overall Study||8
173552|NCT00550043|426756|P3|COMPLETED|Overall Study||8
173553|NCT00550043|426757|P2|COMPLETED|Overall Study||9
173554|NCT00550043|426758|P1|COMPLETED|Overall Study||9
173555|NCT00550043|426754|P5|STARTED|Overall Study||10
173556|NCT00550043|426755|P4|STARTED|Overall Study||10
173557|NCT00550043|426756|P3|STARTED|Overall Study||9
173558|NCT00550043|426757|P2|STARTED|Overall Study||12
173559|NCT00550043|426758|P1|STARTED|Overall Study||9
173560|NCT00550147|426810|P1|NOT COMPLETED|Quetiapine Addition Treatment Period||6
173561|NCT00550147|426810|P1|COMPLETED|Quetiapine Addition Treatment Period||18
173562|NCT00550147|426810|P1|STARTED|Quetiapine Addition Treatment Period||24
173563|NCT00550147|426810|P1|NOT COMPLETED|OROS Methylphenidate Monotherapy||6
173564|NCT00550147|426810|P1|COMPLETED|OROS Methylphenidate Monotherapy||24
173565|NCT00550147|426810|P1|STARTED|OROS Methylphenidate Monotherapy||30
173566|NCT00550173|426831|P3|NOT COMPLETED|Overall Study||73
173567|NCT00550173|426832|P2|NOT COMPLETED|Overall Study||63
173568|NCT00550173|426833|P1|NOT COMPLETED|Overall Study||72
173569|NCT00550173|426831|P3|COMPLETED|Overall Study||11
173570|NCT00550173|426832|P2|COMPLETED|Overall Study||19
173571|NCT00550173|426833|P1|COMPLETED|Overall Study||9
173572|NCT00550173|426831|P3|Not Discontinued at 18 Months|Overall Study||11
173573|NCT00550173|426832|P2|Not Discontinued at 18 Months|Overall Study||19
173574|NCT00550173|426833|P1|Not Discontinued at 18 Months|Overall Study||9
173575|NCT00550173|426831|P3|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|80
173576|NCT00550173|426832|P2|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|82
173577|NCT00550173|426833|P1|Qualified Participants|Overall Study|Participants with tumors of nonsquamous histology|78
173578|NCT00550173|426831|P3|STARTED|Overall Study||84
173579|NCT00550173|426832|P2|STARTED|Overall Study||82
173580|NCT00550173|426833|P1|STARTED|Overall Study||81
173581|NCT00550277|426862|P1|NOT COMPLETED|Overall Study||9
173582|NCT00550277|426862|P1|COMPLETED|Overall Study||11
173583|NCT00550277|426862|P1|STARTED|Overall Study||20
173584|NCT00550368|426868|P2|NOT COMPLETED|Overall Study||0
173585|NCT00550368|426869|P1|NOT COMPLETED|Overall Study||0
173586|NCT00550368|426868|P2|COMPLETED|Overall Study||19
173587|NCT00550368|426869|P1|COMPLETED|Overall Study||26
173588|NCT00550368|426868|P2|STARTED|Overall Study||19
173589|NCT00550368|426869|P1|STARTED|Overall Study||26
173590|NCT00550394|426879|P2|NOT COMPLETED|Overall Study||13
173591|NCT00550394|426880|P1|NOT COMPLETED|Overall Study||12
173592|NCT00550394|426879|P2|COMPLETED|Overall Study||5
173593|NCT00550394|426880|P1|COMPLETED|Overall Study||9
173594|NCT00550394|426879|P2|STARTED|Overall Study||18
173595|NCT00550394|426880|P1|STARTED|Overall Study||21
173596|NCT00550407|426894|P3|NOT COMPLETED|26-Week Randomized Phase||24
173597|NCT00550407|426895|P2|NOT COMPLETED|26-Week Randomized Phase||43
173598|NCT00550407|426896|P1|NOT COMPLETED|26-Week Randomized Phase||0
173599|NCT00550407|426894|P3|COMPLETED|26-Week Randomized Phase||21
173600|NCT00550407|426895|P2|COMPLETED|26-Week Randomized Phase||15
173601|NCT00550407|426896|P1|COMPLETED|26-Week Randomized Phase||0
173602|NCT00550407|426894|P3|STARTED|26-Week Randomized Phase||45
173603|NCT00550407|426895|P2|STARTED|26-Week Randomized Phase||58
173604|NCT00550407|426896|P1|STARTED|26-Week Randomized Phase||0
173605|NCT00550407|426894|P3|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
173606|NCT00550407|426895|P2|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
173607|NCT00550407|426896|P1|NOT COMPLETED|8-16 Week Preliminary (Open-Label) Phase||112
173608|NCT00550407|426894|P3|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
173609|NCT00550407|426895|P2|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||0
173610|NCT00550407|426896|P1|COMPLETED|8-16 Week Preliminary (Open-Label) Phase||103
173611|NCT00550407|426894|P3|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
173612|NCT00550407|426895|P2|STARTED|8-16 Week Preliminary (Open-Label) Phase||0
173613|NCT00550407|426896|P1|STARTED|8-16 Week Preliminary (Open-Label) Phase||215
173614|NCT00550446|426936|P11|NOT COMPLETED|Post Week 12||1
173615|NCT00550446|426937|P10|NOT COMPLETED|Post Week 12||7
173616|NCT00550446|426938|P9|NOT COMPLETED|Post Week 12||2
173617|NCT00550446|426939|P8|NOT COMPLETED|Post Week 12||1
173618|NCT00550446|426940|P7|NOT COMPLETED|Post Week 12||2
173619|NCT00550446|426941|P6|NOT COMPLETED|Post Week 12||1
173620|NCT00550446|426942|P5|NOT COMPLETED|Post Week 12||2
173621|NCT00550446|426943|P4|NOT COMPLETED|Post Week 12||3
173622|NCT00550446|426944|P3|NOT COMPLETED|Post Week 12||3
173623|NCT00550446|426945|P2|NOT COMPLETED|Post Week 12||2
173624|NCT00550446|426946|P1|NOT COMPLETED|Post Week 12||3
173625|NCT00550446|426936|P11|COMPLETED|Post Week 12||24
173626|NCT00550446|426937|P10|COMPLETED|Post Week 12||37
173627|NCT00550446|426938|P9|COMPLETED|Post Week 12||15
173628|NCT00550446|426939|P8|COMPLETED|Post Week 12||16
173629|NCT00550446|426940|P7|COMPLETED|Post Week 12||19
173630|NCT00550446|426941|P6|COMPLETED|Post Week 12||0
173631|NCT00550446|426942|P5|COMPLETED|Post Week 12||52
173632|NCT00550446|426943|P4|COMPLETED|Post Week 12||55
173633|NCT00550446|426944|P3|COMPLETED|Post Week 12||43
173634|NCT00550446|426945|P2|COMPLETED|Post Week 12||28
173635|NCT00550446|426946|P1|COMPLETED|Post Week 12||24
173636|NCT00550446|426936|P11|STARTED|Post Week 12||25
173637|NCT00550446|426937|P10|STARTED|Post Week 12||44
173638|NCT00550446|426938|P9|STARTED|Post Week 12||17
173639|NCT00550446|426939|P8|STARTED|Post Week 12||17
173640|NCT00550446|426940|P7|STARTED|Post Week 12||21
173641|NCT00550446|426941|P6|STARTED|Post Week 12||1
173642|NCT00550446|426942|P5|STARTED|Post Week 12||54
173643|NCT00550446|426943|P4|STARTED|Post Week 12||58
173644|NCT00550446|426944|P3|STARTED|Post Week 12||46
173645|NCT00550446|426945|P2|STARTED|Post Week 12||30
173646|NCT00550446|426946|P1|STARTED|Post Week 12||27
173647|NCT00550446|426936|P11|NOT COMPLETED|Up To Week 12||0
173648|NCT00550446|426937|P10|NOT COMPLETED|Up To Week 12||0
173649|NCT00550446|426938|P9|NOT COMPLETED|Up To Week 12||0
173650|NCT00550446|426939|P8|NOT COMPLETED|Up To Week 12||0
173651|NCT00550446|426940|P7|NOT COMPLETED|Up To Week 12||13
173652|NCT00550446|426941|P6|NOT COMPLETED|Up To Week 12||8
173653|NCT00550446|426942|P5|NOT COMPLETED|Up To Week 12||3
173654|NCT00550446|426943|P4|NOT COMPLETED|Up To Week 12||3
173655|NCT00550446|426944|P3|NOT COMPLETED|Up To Week 12||4
173656|NCT00550446|426945|P2|NOT COMPLETED|Up To Week 12||5
173657|NCT00550446|426946|P1|NOT COMPLETED|Up To Week 12||10
173658|NCT00550446|426936|P11|COMPLETED|Up To Week 12||0
173659|NCT00550446|426937|P10|COMPLETED|Up To Week 12||0
173660|NCT00550446|426938|P9|COMPLETED|Up To Week 12||0
173661|NCT00550446|426939|P8|COMPLETED|Up To Week 12||0
173662|NCT00550446|426940|P7|COMPLETED|Up To Week 12||46
173663|NCT00550446|426941|P6|COMPLETED|Up To Week 12||45
173664|NCT00550446|426942|P5|COMPLETED|Up To Week 12||54
173665|NCT00550446|426943|P4|COMPLETED|Up To Week 12||58
173666|NCT00550446|426944|P3|COMPLETED|Up To Week 12||46
173667|NCT00550446|426945|P2|COMPLETED|Up To Week 12||47
173668|NCT00550446|426946|P1|COMPLETED|Up To Week 12||44
173669|NCT00550446|426936|P11|Treated|Up To Week 12||0
173670|NCT00550446|426937|P10|Treated|Up To Week 12||0
173671|NCT00550446|426938|P9|Treated|Up To Week 12||0
173672|NCT00550446|426939|P8|Treated|Up To Week 12||0
173673|NCT00550446|426940|P7|Treated|Up To Week 12||59
173674|NCT00550446|426941|P6|Treated|Up To Week 12||53
173675|NCT00550446|426942|P5|Treated|Up To Week 12||57
173676|NCT00550446|426943|P4|Treated|Up To Week 12||61
173677|NCT00550446|426944|P3|Treated|Up To Week 12||49
173678|NCT00550446|426945|P2|Treated|Up To Week 12||51
173679|NCT00550446|426946|P1|Treated|Up To Week 12||54
173680|NCT00550446|426936|P11|STARTED|Up To Week 12||0
173681|NCT00550446|426937|P10|STARTED|Up To Week 12||0
173682|NCT00550446|426938|P9|STARTED|Up To Week 12||0
173683|NCT00550446|426939|P8|STARTED|Up To Week 12||0
173684|NCT00550446|426940|P7|STARTED|Up To Week 12||59
173685|NCT00550446|426941|P6|STARTED|Up To Week 12||53
173686|NCT00550446|426942|P5|STARTED|Up To Week 12||57
173687|NCT00550446|426943|P4|STARTED|Up To Week 12||61
173688|NCT00550446|426944|P3|STARTED|Up To Week 12||50
173689|NCT00550446|426945|P2|STARTED|Up To Week 12||52
173690|NCT00550446|426946|P1|STARTED|Up To Week 12||54
173691|NCT00550459|427380|P2|NOT COMPLETED|Overall Study||3
173692|NCT00550459|427381|P1|NOT COMPLETED|Overall Study||1
173693|NCT00550459|427380|P2|COMPLETED|Overall Study||26
173694|NCT00550459|427381|P1|COMPLETED|Overall Study||27
173695|NCT00550459|427380|P2|STARTED|Overall Study||29
173696|NCT00550459|427381|P1|STARTED|Overall Study||28
173697|NCT00550537|427443|P1|NOT COMPLETED|Overall Study||104
173698|NCT00550537|427443|P1|COMPLETED|Overall Study||12
173699|NCT00550537|427443|P1|STARTED|Overall Study||116
173700|NCT00550550|427460|P2|NOT COMPLETED|Overall Study||29
173701|NCT00550550|427461|P1|NOT COMPLETED|Overall Study||34
173702|NCT00550550|427460|P2|COMPLETED|Overall Study||140
173703|NCT00550550|427461|P1|COMPLETED|Overall Study||142
173704|NCT00550550|427460|P2|Number Treated|Overall Study||169
173705|NCT00550550|427461|P1|Number Treated|Overall Study||175
173706|NCT00550550|427460|P2|STARTED|Overall Study||169
173707|NCT00550550|427461|P1|STARTED|Overall Study||176
173708|NCT00550589|427473|P1|NOT COMPLETED|Overall Study||0
173709|NCT00550589|427473|P1|COMPLETED|Overall Study||33
173710|NCT00550589|427473|P1|STARTED|Overall Study||33
173711|NCT00550654|427484|P1|NOT COMPLETED|Overall Study||0
173712|NCT00550654|427484|P1|COMPLETED|Overall Study||1
173713|NCT00550654|427484|P1|STARTED|Overall Study||1
173714|NCT00550680|427494|P1|NOT COMPLETED|Overall Study||56
173715|NCT00550680|427494|P1|COMPLETED|Overall Study||152
173716|NCT00550680|427494|P1|STARTED|Overall Study||208
173717|NCT00550732|427503|P1|NOT COMPLETED|Overall Study||11
173718|NCT00550732|427503|P1|COMPLETED|Overall Study||29
173719|NCT00550732|427503|P1|STARTED|Overall Study||40
173720|NCT00550745|427516|P2|NOT COMPLETED|Overall Study||60
173721|NCT00550745|427517|P1|NOT COMPLETED|Overall Study||87
173722|NCT00550745|427516|P2|COMPLETED|Overall Study||5939
173723|NCT00550745|427517|P1|COMPLETED|Overall Study||5913
173724|NCT00550745|427516|P2|STARTED|Overall Study||5999
173725|NCT00550745|427517|P1|STARTED|Overall Study||6000
173726|NCT00550771|427527|P2|NOT COMPLETED|Overall Study||10
173727|NCT00550771|427528|P1|NOT COMPLETED|Overall Study||17
173728|NCT00550771|427527|P2|COMPLETED|Overall Study||50
173729|NCT00550771|427528|P1|COMPLETED|Overall Study||104
173730|NCT00550771|427527|P2|STARTED|Overall Study||60
173731|NCT00550771|427528|P1|STARTED|Overall Study||121
173732|NCT00550836|427542|P2|NOT COMPLETED|Overall Study||9
173733|NCT00550836|427543|P1|NOT COMPLETED|Overall Study||3
173734|NCT00550836|427542|P2|COMPLETED|Overall Study||46
173735|NCT00550836|427543|P1|COMPLETED|Overall Study||46
173736|NCT00550836|427542|P2|STARTED|Overall Study||55
173737|NCT00550836|427543|P1|STARTED|Overall Study||49
173738|NCT00550862|427561|P4|NOT COMPLETED|Overall Study||1
173739|NCT00550862|427562|P3|NOT COMPLETED|Overall Study||16
173740|NCT00550862|427563|P2|NOT COMPLETED|Overall Study||6
173741|NCT00550862|427564|P1|NOT COMPLETED|Overall Study||6
173742|NCT00550862|427561|P4|COMPLETED|Overall Study||37
173743|NCT00550862|427562|P3|COMPLETED|Overall Study||25
173744|NCT00550862|427563|P2|COMPLETED|Overall Study||42
173745|NCT00550862|427564|P1|COMPLETED|Overall Study||32
173746|NCT00550862|427561|P4|STARTED|Overall Study||38
173747|NCT00550862|427562|P3|STARTED|Overall Study||41
173748|NCT00550862|427563|P2|STARTED|Overall Study||48
173749|NCT00550862|427564|P1|STARTED|Overall Study||38
173750|NCT00550953|427584|P2|NOT COMPLETED|Overall Study||6
173751|NCT00550953|427585|P1|NOT COMPLETED|Overall Study||6
173752|NCT00550953|427584|P2|COMPLETED|Overall Study||152
173753|NCT00550953|427585|P1|COMPLETED|Overall Study||150
173754|NCT00550953|427584|P2|STARTED|Overall Study||158
173755|NCT00550953|427585|P1|STARTED|Overall Study||156
173756|NCT00551031|427610|P5|NOT COMPLETED|Overall Study||1
173757|NCT00551031|427611|P4|NOT COMPLETED|Overall Study||3
173758|NCT00551031|427612|P3|NOT COMPLETED|Overall Study||2
173759|NCT00551031|427613|P2|NOT COMPLETED|Overall Study||11
173760|NCT00551031|427614|P1|NOT COMPLETED|Overall Study||2
173761|NCT00551031|427610|P5|COMPLETED|Overall Study||185
173762|NCT00551031|427611|P4|COMPLETED|Overall Study||317
173763|NCT00551031|427612|P3|COMPLETED|Overall Study||317
173764|NCT00551031|427613|P2|COMPLETED|Overall Study||625
173765|NCT00551031|427614|P1|COMPLETED|Overall Study||635
173766|NCT00551031|427610|P5|STARTED|Overall Study||186
173767|NCT00551031|427611|P4|STARTED|Overall Study||320
173768|NCT00551031|427612|P3|STARTED|Overall Study||319
173769|NCT00551031|427613|P2|STARTED|Overall Study||636
173770|NCT00551031|427614|P1|STARTED|Overall Study||637
173771|NCT00551070|427641|P1|NOT COMPLETED|Overall Study||0
173772|NCT00551070|427641|P1|COMPLETED|Overall Study||52
173773|NCT00551070|427641|P1|STARTED|Overall Study||52
173774|NCT00551135|427655|P4|NOT COMPLETED|Overall Study||5
173775|NCT00551135|427656|P3|NOT COMPLETED|Overall Study||5
173776|NCT00551135|427657|P2|NOT COMPLETED|Overall Study||2
173777|NCT00551135|427658|P1|NOT COMPLETED|Overall Study||5
173778|NCT00551135|427655|P4|COMPLETED|Overall Study||103
173779|NCT00551135|427656|P3|COMPLETED|Overall Study||98
173780|NCT00551135|427657|P2|COMPLETED|Overall Study||104
173781|NCT00551135|427658|P1|COMPLETED|Overall Study||103
173782|NCT00551135|427655|P4|STARTED|Overall Study||108
173783|NCT00551135|427656|P3|STARTED|Overall Study||103
173784|NCT00551135|427657|P2|STARTED|Overall Study||106
173785|NCT00551135|427658|P1|STARTED|Overall Study||108
173786|NCT00551161|427772|P1|NOT COMPLETED|Overall Study||1
173787|NCT00551161|427772|P1|COMPLETED|Overall Study||11
173788|NCT00551161|427772|P1|STARTED|Overall Study||12
173789|NCT00551174|427778|P2|NOT COMPLETED|Overall Study||6
173790|NCT00551174|427779|P1|NOT COMPLETED|Overall Study||19
173791|NCT00551174|427778|P2|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|394
173792|NCT00551174|427779|P1|COMPLETED|Overall Study|Intent-to-Treat (ITT) Population|362
173793|NCT00551174|427778|P2|STARTED|Overall Study||400
173794|NCT00551174|427779|P1|STARTED|Overall Study||381
173795|NCT00551200|427791|P1|NOT COMPLETED|Overall Study||4
173796|NCT00551200|427791|P1|COMPLETED|Overall Study||10
173797|NCT00551200|427791|P1|STARTED|Overall Study||14
173798|NCT00551213|427806|P2|NOT COMPLETED|Overall Study||17
173799|NCT00551213|427807|P1|NOT COMPLETED|Overall Study||50
173800|NCT00551213|427806|P2|COMPLETED|Overall Study||0
173801|NCT00551213|427807|P1|COMPLETED|Overall Study||0
173802|NCT00551213|427806|P2|Treated|Overall Study||15
173803|NCT00551213|427807|P1|Treated|Overall Study||49
173804|NCT00551213|427806|P2|STARTED|Overall Study||17
173805|NCT00551213|427807|P1|STARTED|Overall Study||50
173806|NCT00551291|427823|P1|NOT COMPLETED|Overall Study||1
173807|NCT00551291|427823|P1|COMPLETED|Overall Study||9
173808|NCT00551291|427823|P1|STARTED|Overall Study||10
173809|NCT00551369|427829|P1|NOT COMPLETED|Overall Study||7
173810|NCT00551369|427829|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|26
173811|NCT00551369|427829|P1|STARTED|Overall Study||33
173812|NCT00551421|427836|P1|NOT COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||1
173813|NCT00551421|427836|P1|COMPLETED|Amended Protocol (Cetuximab-refr. mCRC)||13
173814|NCT00551421|427836|P1|STARTED|Amended Protocol (Cetuximab-refr. mCRC)||14
173815|NCT00551421|427836|P1|NOT COMPLETED|Original Protocol, Dose Level 1||0
173816|NCT00551421|427836|P1|COMPLETED|Original Protocol, Dose Level 1|1 subject developed Grade 3 diarrhea, all 3 subjects experienced significant skin toxicity.|3
173817|NCT00551421|427836|P1|STARTED|Original Protocol, Dose Level 1||3
173818|NCT00551525|427843|P1|NOT COMPLETED|Overall Study||5
173819|NCT00551525|427843|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study|62
173820|NCT00551525|427843|P1|STARTED|Overall Study||67
173821|NCT00546052|427852|P1|NOT COMPLETED|Overall Study||227
173822|NCT00546052|427852|P1|COMPLETED|Overall Study||1511
173823|NCT00546052|427852|P1|Week 52|Overall Study||1511
173824|NCT00546052|427852|P1|Week 32|Overall Study||1583
173825|NCT00546052|427852|P1|Week 12|Overall Study||1650
173826|NCT00546052|427852|P1|Week 8|Overall Study||1680
173827|NCT00546052|427852|P1|Week 4|Overall Study||1714
173828|NCT00546052|427852|P1|STARTED|Overall Study||1738
173829|NCT00551642|427872|P2|NOT COMPLETED|Overall Study||63
173830|NCT00551642|427873|P1|NOT COMPLETED|Overall Study||61
173831|NCT00551642|427872|P2|COMPLETED|Overall Study||338
173832|NCT00551642|427873|P1|COMPLETED|Overall Study||338
173833|NCT00551642|427872|P2|STARTED|Overall Study||401
173834|NCT00551642|427873|P1|STARTED|Overall Study||399
173835|NCT00551707|427884|P5|NOT COMPLETED|Overall Study||1
173836|NCT00551707|427885|P4|NOT COMPLETED|Overall Study||4
173837|NCT00551707|427886|P3|NOT COMPLETED|Overall Study||3
173838|NCT00551707|427887|P2|NOT COMPLETED|Overall Study||6
173839|NCT00551707|427888|P1|NOT COMPLETED|Overall Study||0
173840|NCT00551707|427884|P5|COMPLETED|Overall Study||3
173841|NCT00551707|427885|P4|COMPLETED|Overall Study||4
173842|NCT00551707|427886|P3|COMPLETED|Overall Study||10
173843|NCT00551707|427887|P2|COMPLETED|Overall Study||16
173844|NCT00551707|427888|P1|COMPLETED|Overall Study||4
173845|NCT00551707|427884|P5|STARTED|Overall Study||4
173846|NCT00551707|427885|P4|STARTED|Overall Study||8
173847|NCT00551707|427886|P3|STARTED|Overall Study||13
173848|NCT00551707|427887|P2|STARTED|Overall Study||22
173849|NCT00551707|427888|P1|STARTED|Overall Study||4
173850|NCT00551746|427907|P2|NOT COMPLETED|Overall Study||8
173851|NCT00551746|427908|P1|NOT COMPLETED|Overall Study||11
173852|NCT00551746|427907|P2|COMPLETED|Overall Study||26
173853|NCT00551746|427908|P1|COMPLETED|Overall Study||25
173854|NCT00551746|427907|P2|STARTED|Overall Study||34
173855|NCT00551746|427908|P1|STARTED|Overall Study||36
173856|NCT00551759|427914|P1|NOT COMPLETED|Overall Study||13
173857|NCT00551759|427914|P1|COMPLETED|Overall Study||9
173858|NCT00551759|427914|P1|Received Adjuvant Therapy|Overall Study||12
173859|NCT00551759|427914|P1|Underwent Surgery|Overall Study||17
173860|NCT00551759|427914|P1|Eligible and Began Treatment|Overall Study||21
173861|NCT00551759|427914|P1|STARTED|Overall Study||22
173862|NCT00553631|427920|P2|NOT COMPLETED|Overall Study||1
173863|NCT00553631|427921|P1|NOT COMPLETED|Overall Study||1
173864|NCT00553631|427920|P2|COMPLETED|Overall Study||16
173865|NCT00553631|427921|P1|COMPLETED|Overall Study||16
173866|NCT00553631|427920|P2|STARTED|Overall Study|Intent-to-treat (ITT) population|17
173867|NCT00553631|427921|P1|STARTED|Overall Study|Intent-to-treat (ITT) population|17
173868|NCT00553644|427941|P1|NOT COMPLETED|Overall Study||28
173869|NCT00553644|427941|P1|COMPLETED|Overall Study||25
173870|NCT00553644|427941|P1|STARTED|Overall Study||53
173871|NCT00553696|427952|P4|NOT COMPLETED|Overall Study||1
173872|NCT00553696|427953|P3|NOT COMPLETED|Overall Study||6
173873|NCT00553696|427954|P2|NOT COMPLETED|Overall Study||16
173874|NCT00553696|427955|P1|NOT COMPLETED|Overall Study||4
173875|NCT00553696|427952|P4|COMPLETED|Overall Study||0
173876|NCT00553696|427953|P3|COMPLETED|Overall Study||0
173877|NCT00553696|427954|P2|COMPLETED|Overall Study||0
173878|NCT00553696|427955|P1|COMPLETED|Overall Study||0
173879|NCT00553696|427952|P4|STARTED|Overall Study||1
173880|NCT00553696|427953|P3|STARTED|Overall Study||6
173881|NCT00553696|427954|P2|STARTED|Overall Study||16
173882|NCT00553696|427955|P1|STARTED|Overall Study||4
173883|NCT00553735|427993|P1|NOT COMPLETED|Overall Study||7
173884|NCT00553735|427993|P1|COMPLETED|Overall Study||1
173885|NCT00553735|427993|P1|STARTED|Overall Study||8
173886|NCT00553787|428013|P3|NOT COMPLETED|Overall Study||262
173887|NCT00553787|428014|P2|NOT COMPLETED|Overall Study||124
173888|NCT00553787|428015|P1|NOT COMPLETED|Overall Study||378
173889|NCT00553787|428013|P3|COMPLETED|Overall Study||733
173890|NCT00553787|428014|P2|COMPLETED|Overall Study||374
173891|NCT00553787|428015|P1|COMPLETED|Overall Study||616
173892|NCT00553787|428013|P3|STARTED|Overall Study||995
173893|NCT00553787|428014|P2|STARTED|Overall Study||498
173894|NCT00553787|428015|P1|STARTED|Overall Study||994
173895|NCT00553839|428026|P1|NOT COMPLETED|Overall Study||0
173896|NCT00553839|428026|P1|COMPLETED|Overall Study||21
173897|NCT00553839|428026|P1|STARTED|Overall Study||21
173898|NCT00553969|428036|P4|NOT COMPLETED|Overall Study||1
173899|NCT00553969|428037|P3|NOT COMPLETED|Overall Study||1
173900|NCT00553969|428038|P2|NOT COMPLETED|Overall Study||0
173901|NCT00553969|428039|P1|NOT COMPLETED|Overall Study||8
173902|NCT00553969|428036|P4|COMPLETED|Overall Study||23
173903|NCT00553969|428037|P3|COMPLETED|Overall Study||21
173904|NCT00553969|428038|P2|COMPLETED|Overall Study||24
173905|NCT00553969|428039|P1|COMPLETED|Overall Study||23
173906|NCT00553969|428036|P4|STARTED|Overall Study||24
173907|NCT00553969|428037|P3|STARTED|Overall Study||22
173908|NCT00553969|428038|P2|STARTED|Overall Study||24
173909|NCT00553969|428039|P1|STARTED|Overall Study||31
173910|NCT00554099|428052|P3|NOT COMPLETED|Non-Treatment Phase (9 Months)||3
173911|NCT00554099|428053|P2|NOT COMPLETED|Non-Treatment Phase (9 Months)||5
173912|NCT00554099|428054|P1|NOT COMPLETED|Non-Treatment Phase (9 Months)||7
173913|NCT00554099|428052|P3|COMPLETED|Non-Treatment Phase (9 Months)||24
173914|NCT00554099|428053|P2|COMPLETED|Non-Treatment Phase (9 Months)||27
173915|NCT00554099|428054|P1|COMPLETED|Non-Treatment Phase (9 Months)||22
173916|NCT00554099|428052|P3|STARTED|Non-Treatment Phase (9 Months)||27
173917|NCT00554099|428053|P2|STARTED|Non-Treatment Phase (9 Months)||32
173918|NCT00554099|428054|P1|STARTED|Non-Treatment Phase (9 Months)||29
173919|NCT00554099|428052|P3|NOT COMPLETED|Treatment Period (12 Weeks)||9
173920|NCT00554099|428053|P2|NOT COMPLETED|Treatment Period (12 Weeks)||8
173921|NCT00554099|428054|P1|NOT COMPLETED|Treatment Period (12 Weeks)||12
173922|NCT00554099|428052|P3|COMPLETED|Treatment Period (12 Weeks)||27
173923|NCT00554099|428053|P2|COMPLETED|Treatment Period (12 Weeks)||32
173924|NCT00554099|428054|P1|COMPLETED|Treatment Period (12 Weeks)||29
173925|NCT00554099|428052|P3|STARTED|Treatment Period (12 Weeks)||36
173926|NCT00554099|428053|P2|STARTED|Treatment Period (12 Weeks)||40
173927|NCT00554099|428054|P1|STARTED|Treatment Period (12 Weeks)||41
173928|NCT00554190|428083|P1|NOT COMPLETED|Overall Study||10
173929|NCT00554190|428083|P1|COMPLETED|Overall Study|10 subjects did not complete the Termination Study Forms|19
173930|NCT00554190|428083|P1|STARTED|Overall Study|29 subjects treated.|29
173931|NCT00554216|428092|P3|NOT COMPLETED|Overall Study||172
173932|NCT00554216|428093|P2|NOT COMPLETED|Overall Study||94
173933|NCT00554216|428094|P1|NOT COMPLETED|Overall Study||242
173934|NCT00554216|428092|P3|COMPLETED|Overall Study||340
173935|NCT00554216|428093|P2|COMPLETED|Overall Study||147
173936|NCT00554216|428094|P1|COMPLETED|Overall Study||272
173937|NCT00554216|428092|P3|STARTED|Overall Study||512
173938|NCT00554216|428093|P2|STARTED|Overall Study||241
173939|NCT00554216|428094|P1|STARTED|Overall Study||514
173940|NCT00554229|428107|P2|NOT COMPLETED|Overall Study||225
173941|NCT00554229|428108|P1|NOT COMPLETED|Overall Study||226
173942|NCT00554229|428107|P2|COMPLETED|Overall Study||70
173943|NCT00554229|428108|P1|COMPLETED|Overall Study||73
173944|NCT00554229|428107|P2|Patients Who Received Treatment|Overall Study||295
173945|NCT00554229|428108|P1|Patients Who Received Treatment|Overall Study||298
173946|NCT00554229|428107|P2|STARTED|Overall Study||295
173947|NCT00554229|428108|P1|STARTED|Overall Study||299
173948|NCT00554294|428132|P2|NOT COMPLETED|Overall Study||80
173949|NCT00554294|428133|P1|NOT COMPLETED|Overall Study||160
173950|NCT00554294|428132|P2|COMPLETED|Overall Study||1641
173951|NCT00554294|428133|P1|COMPLETED|Overall Study||1309
173952|NCT00554294|428132|P2|STARTED|Overall Study||1721
173953|NCT00554294|428133|P1|STARTED|Overall Study||1469
173954|NCT00554372|428139|P2|NOT COMPLETED|Overall Study||0
173955|NCT00554372|428140|P1|NOT COMPLETED|Overall Study||0
173956|NCT00554372|428139|P2|COMPLETED|Overall Study||16
173957|NCT00554372|428140|P1|COMPLETED|Overall Study||14
173958|NCT00554372|428139|P2|STARTED|Overall Study||16
173959|NCT00554372|428140|P1|STARTED|Overall Study||14
173960|NCT00554463|428152|P1|NOT COMPLETED|Overall Study||0
173961|NCT00554463|428152|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|5
173962|NCT00554463|428152|P1|STARTED|Overall Study||5
173963|NCT00554515|428156|P1|NOT COMPLETED|Overall Study||118
173964|NCT00554515|428156|P1|COMPLETED|Overall Study||5
173965|NCT00554515|428156|P1|Treated|Overall Study||120
173966|NCT00554515|428156|P1|STARTED|Overall Study||123
173967|NCT00554619|428185|P1|NOT COMPLETED|Overall Study||3
173968|NCT00554619|428185|P1|COMPLETED|Overall Study||18
173969|NCT00554619|428185|P1|STARTED|Overall Study||21
173970|NCT00554671|428199|P2|NOT COMPLETED|Overall Study||16
173971|NCT00554671|428200|P1|NOT COMPLETED|Overall Study||20
173972|NCT00554671|428199|P2|COMPLETED|Overall Study||117
173973|NCT00554671|428200|P1|COMPLETED|Overall Study||97
173974|NCT00554671|428199|P2|STARTED|Overall Study||133
173975|NCT00554671|428200|P1|STARTED|Overall Study||117
173976|NCT00554749|428208|P1|NOT COMPLETED|Overall Study||0
173977|NCT00554749|428208|P1|COMPLETED|Overall Study||7
173978|NCT00554749|428208|P1|STARTED|Overall Study||7
173979|NCT00554801|428215|P2|NOT COMPLETED|Overall Study||0
173980|NCT00554801|428216|P1|NOT COMPLETED|Overall Study||19
173981|NCT00554801|428215|P2|COMPLETED|Overall Study||29
173982|NCT00554801|428216|P1|COMPLETED|Overall Study||36
173983|NCT00554801|428215|P2|STARTED|Overall Study||29
173984|NCT00554801|428216|P1|STARTED|Overall Study||55
173985|NCT00554840|428224|P2|NOT COMPLETED|Overall Study||1
173986|NCT00554840|428225|P1|NOT COMPLETED|Overall Study||0
173987|NCT00554840|428224|P2|COMPLETED|Overall Study||4
173988|NCT00554840|428225|P1|COMPLETED|Overall Study||4
173989|NCT00554840|428224|P2|STARTED|Overall Study||5
173990|NCT00554840|428225|P1|STARTED|Overall Study||4
173991|NCT00554853|428243|P2|NOT COMPLETED|Crossover Arm (3 Months)||2
173992|NCT00554853|428244|P1|NOT COMPLETED|Crossover Arm (3 Months)||3
173993|NCT00554853|428243|P2|COMPLETED|Crossover Arm (3 Months)||55
173994|NCT00554853|428244|P1|COMPLETED|Crossover Arm (3 Months)||53
173995|NCT00554853|428243|P2|STARTED|Crossover Arm (3 Months)||57
173996|NCT00554853|428244|P1|STARTED|Crossover Arm (3 Months)||56
173997|NCT00554853|428243|P2|NOT COMPLETED|Washout Period (2 Weeks)||7
173998|NCT00554853|428244|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
173999|NCT00554853|428243|P2|COMPLETED|Washout Period (2 Weeks)||57
174000|NCT00554853|428244|P1|COMPLETED|Washout Period (2 Weeks)||56
174001|NCT00554853|428243|P2|STARTED|Washout Period (2 Weeks)||64
174002|NCT00554853|428244|P1|STARTED|Washout Period (2 Weeks)||56
174003|NCT00554853|428243|P2|NOT COMPLETED|First Arm of Study||7
174004|NCT00554853|428244|P1|NOT COMPLETED|First Arm of Study||16
174005|NCT00554853|428243|P2|COMPLETED|First Arm of Study||64
174006|NCT00554853|428244|P1|COMPLETED|First Arm of Study||56
174007|NCT00554853|428243|P2|STARTED|First Arm of Study||71
174008|NCT00554853|428244|P1|STARTED|First Arm of Study||72
174009|NCT00554970|428260|P4|NOT COMPLETED|Period 2||0
174010|NCT00554970|428261|P3|NOT COMPLETED|Period 2||1
174011|NCT00554970|428262|P2|NOT COMPLETED|Period 2||0
174012|NCT00554970|428263|P1|NOT COMPLETED|Period 2||0
174013|NCT00554970|428260|P4|COMPLETED|Period 2||8
174014|NCT00554970|428261|P3|COMPLETED|Period 2||7
174015|NCT00554970|428262|P2|COMPLETED|Period 2||8
174016|NCT00554970|428263|P1|COMPLETED|Period 2||7
174017|NCT00554970|428260|P4|STARTED|Period 2||8
174018|NCT00554970|428261|P3|STARTED|Period 2||8
174019|NCT00554970|428262|P2|STARTED|Period 2||8
174020|NCT00554970|428263|P1|STARTED|Period 2||7
174021|NCT00554970|428260|P4|NOT COMPLETED|Period 1||0
174022|NCT00554970|428261|P3|NOT COMPLETED|Period 1||0
174023|NCT00554970|428262|P2|NOT COMPLETED|Period 1||0
174024|NCT00554970|428263|P1|NOT COMPLETED|Period 1||1
174025|NCT00554970|428260|P4|COMPLETED|Period 1||8
174026|NCT00554970|428261|P3|COMPLETED|Period 1||8
174027|NCT00554970|428262|P2|COMPLETED|Period 1||8
174028|NCT00554970|428263|P1|COMPLETED|Period 1||7
174029|NCT00554970|428260|P4|STARTED|Period 1||8
174030|NCT00554970|428261|P3|STARTED|Period 1||8
174031|NCT00554970|428262|P2|STARTED|Period 1||8
174032|NCT00554970|428263|P1|STARTED|Period 1||8
174033|NCT00554996|428293|P1|NOT COMPLETED|Overall Study||0
174034|NCT00554996|428293|P1|COMPLETED|Overall Study||10
174035|NCT00554996|428293|P1|STARTED|Overall Study||10
174036|NCT00555009|428299|P2|NOT COMPLETED|Overall Study||6
174037|NCT00555009|428300|P1|NOT COMPLETED|Overall Study||2
174038|NCT00555009|428299|P2|COMPLETED|Overall Study||0
174039|NCT00555009|428300|P1|COMPLETED|Overall Study||2
174040|NCT00555009|428299|P2|STARTED|Overall Study||6
174041|NCT00555009|428300|P1|STARTED|Overall Study||4
174042|NCT00555048|428322|P1|NOT COMPLETED|Overall Study||0
174043|NCT00555048|428322|P1|COMPLETED|Overall Study||1
174044|NCT00555048|428322|P1|STARTED|Overall Study||1
174045|NCT00555061|428332|P1|NOT COMPLETED|Overall Study||9
174046|NCT00555061|428332|P1|COMPLETED|Overall Study||78
174047|NCT00555061|428332|P1|STARTED|Overall Study|One participant did not receive study medication and was not included in the analysis population.|87
174048|NCT00555152|428343|P4|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
174049|NCT00555152|428344|P3|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
174050|NCT00555152|428345|P2|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
174051|NCT00555152|428346|P1|NOT COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
174052|NCT00555152|428343|P4|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||9
174053|NCT00555152|428344|P3|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
174054|NCT00555152|428345|P2|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||10
174055|NCT00555152|428346|P1|COMPLETED|Transfer to MD Anderson: 9/19/11-8/28/14||0
174056|NCT00555152|428343|P4|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||9
174057|NCT00555152|428344|P3|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||0
174058|NCT00555152|428345|P2|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14||10
174059|NCT00555152|428346|P1|STARTED|Transfer to MD Anderson: 9/19/11-8/28/14|Participants in initial and second study registration periods reported separately.|0
174060|NCT00555152|428343|P4|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
174061|NCT00555152|428344|P3|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
174062|NCT00555152|428345|P2|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
174063|NCT00555152|428346|P1|NOT COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
174064|NCT00555152|428343|P4|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||1
174065|NCT00555152|428344|P3|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
174066|NCT00555152|428345|P2|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||0
174067|NCT00555152|428346|P1|COMPLETED|Period Open at BCM: 1/17/08-3/8/10||2
174068|NCT00555152|428343|P4|STARTED|Period Open at BCM: 1/17/08-3/8/10||1
174069|NCT00555152|428344|P3|STARTED|Period Open at BCM: 1/17/08-3/8/10||0
174070|NCT00555152|428345|P2|STARTED|Period Open at BCM: 1/17/08-3/8/10|Participants in initial and second study registration periods reported separately.|0
174071|NCT00555152|428346|P1|STARTED|Period Open at BCM: 1/17/08-3/8/10||2
174072|NCT00555217|428370|P2|NOT COMPLETED|Overall Study||68
174073|NCT00555217|428371|P1|NOT COMPLETED|Overall Study||75
174074|NCT00555217|428370|P2|COMPLETED|Overall Study||656
174075|NCT00555217|428371|P1|COMPLETED|Overall Study||649
174076|NCT00555217|428370|P2|STARTED|Overall Study||724
174077|NCT00555217|428371|P1|STARTED|Overall Study||724
174078|NCT00555321|428384|P5|NOT COMPLETED|Long-term Extension Phase||26
174079|NCT00555321|428385|P4|NOT COMPLETED|Long-term Extension Phase||38
174080|NCT00555321|428386|P3|NOT COMPLETED|Long-term Extension Phase||24
174081|NCT00555321|428387|P2|NOT COMPLETED|Long-term Extension Phase||27
174082|NCT00555321|428388|P1|NOT COMPLETED|Long-term Extension Phase||30
174083|NCT00555321|428384|P5|COMPLETED|Long-term Extension Phase||0
174084|NCT00555321|428385|P4|COMPLETED|Long-term Extension Phase||0
174085|NCT00555321|428386|P3|COMPLETED|Long-term Extension Phase||0
174086|NCT00555321|428387|P2|COMPLETED|Long-term Extension Phase||0
174087|NCT00555321|428388|P1|COMPLETED|Long-term Extension Phase||0
174088|NCT00555321|428384|P5|STARTED|Long-term Extension Phase|6 participants did not enter LTE|26
174089|NCT00555321|428385|P4|STARTED|Long-term Extension Phase|8 participants did not enter LTE|38
174090|NCT00555321|428386|P3|STARTED|Long-term Extension Phase|2 participants did not enter LTE|24
174091|NCT00555321|428387|P2|STARTED|Long-term Extension Phase|2 participants did not enter LTE|27
174092|NCT00555321|428388|P1|STARTED|Long-term Extension Phase|1 participant did not enter LTE|30
174093|NCT00555321|428384|P5|NOT COMPLETED|Treatment Phase up to 12-months||22
174094|NCT00555321|428385|P4|NOT COMPLETED|Treatment Phase up to 12-months||7
174095|NCT00555321|428386|P3|NOT COMPLETED|Treatment Phase up to 12-months||24
174096|NCT00555321|428387|P2|NOT COMPLETED|Treatment Phase up to 12-months||22
174097|NCT00555321|428388|P1|NOT COMPLETED|Treatment Phase up to 12-months||21
174098|NCT00555321|428384|P5|COMPLETED|Treatment Phase up to 12-months||32
174099|NCT00555321|428385|P4|COMPLETED|Treatment Phase up to 12-months||46
174100|NCT00555321|428386|P3|COMPLETED|Treatment Phase up to 12-months||26
174101|NCT00555321|428387|P2|COMPLETED|Treatment Phase up to 12-months||29
174102|NCT00555321|428388|P1|COMPLETED|Treatment Phase up to 12-months||31
174103|NCT00555321|428384|P5|Received Transplant and Treated|Treatment Phase up to 12-months||50
174104|NCT00555321|428385|P4|Received Transplant and Treated|Treatment Phase up to 12-months||53
174105|NCT00555321|428386|P3|Received Transplant and Treated|Treatment Phase up to 12-months||49
174106|NCT00555321|428387|P2|Received Transplant and Treated|Treatment Phase up to 12-months||48
174107|NCT00555321|428388|P1|Received Transplant and Treated|Treatment Phase up to 12-months||50
174108|NCT00555321|428384|P5|STARTED|Treatment Phase up to 12-months||54
174109|NCT00555321|428385|P4|STARTED|Treatment Phase up to 12-months||53
174110|NCT00555321|428386|P3|STARTED|Treatment Phase up to 12-months||50
174111|NCT00555321|428387|P2|STARTED|Treatment Phase up to 12-months||51
174112|NCT00555321|428388|P1|STARTED|Treatment Phase up to 12-months||52
174113|NCT00555360|428692|P2|NOT COMPLETED|Overall Study||36
174114|NCT00555360|428693|P1|NOT COMPLETED|Overall Study||27
174115|NCT00555360|428692|P2|COMPLETED|Overall Study||153
174116|NCT00555360|428693|P1|COMPLETED|Overall Study||156
174117|NCT00555360|428692|P2|STARTED|Overall Study||189
174118|NCT00555360|428693|P1|STARTED|Overall Study||183
174119|NCT00555425|428705|P2|NOT COMPLETED|Overall Study||19
174120|NCT00555425|428706|P1|NOT COMPLETED|Overall Study||51
174121|NCT00555425|428705|P2|COMPLETED|Overall Study||37
174122|NCT00555425|428706|P1|COMPLETED|Overall Study||6
174123|NCT00555425|428705|P2|STARTED|Overall Study||56
174124|NCT00555425|428706|P1|STARTED|Overall Study||57
174125|NCT00555438|428724|P1|NOT COMPLETED|Between 10 Days and 30 Days Postoperativ||5
174126|NCT00555438|428724|P1|COMPLETED|Between 10 Days and 30 Days Postoperativ||433
174127|NCT00555438|428724|P1|STARTED|Between 10 Days and 30 Days Postoperativ||438
174128|NCT00555438|428724|P1|NOT COMPLETED|10 Days Post-operative||4
174129|NCT00555438|428724|P1|COMPLETED|10 Days Post-operative|438 patients attended the day 10 visit (four patients died during hospitalization)|438
174130|NCT00555438|428724|P1|STARTED|10 Days Post-operative||442
174131|NCT00555464|428734|P2|NOT COMPLETED|Overall Study||3
174132|NCT00555464|428735|P1|NOT COMPLETED|Overall Study||0
174133|NCT00555464|428734|P2|COMPLETED|Overall Study||1
174134|NCT00555464|428735|P1|COMPLETED|Overall Study||4
174135|NCT00555464|428734|P2|STARTED|Overall Study||4
174136|NCT00555464|428735|P1|STARTED|Overall Study||4
174137|NCT00555477|428745|P2|NOT COMPLETED|Overall Study||13
174138|NCT00555477|428746|P1|NOT COMPLETED|Overall Study||2
174139|NCT00555477|428745|P2|COMPLETED|Overall Study||32
174140|NCT00555477|428746|P1|COMPLETED|Overall Study||12
174141|NCT00555477|428745|P2|STARTED|Overall Study||45
174142|NCT00555477|428746|P1|STARTED|Overall Study||14
174143|NCT00555568|428754|P3|NOT COMPLETED|Overall Study||16
174144|NCT00555568|428755|P2|NOT COMPLETED|Overall Study||16
174145|NCT00555568|428756|P1|NOT COMPLETED|Overall Study||26
174146|NCT00555568|428754|P3|COMPLETED|Overall Study||84
174147|NCT00555568|428755|P2|COMPLETED|Overall Study||82
174148|NCT00555568|428756|P1|COMPLETED|Overall Study||74
174149|NCT00555568|428754|P3|STARTED|Overall Study||100
174150|NCT00555568|428755|P2|STARTED|Overall Study||98
174151|NCT00555568|428756|P1|STARTED|Overall Study||100
174152|NCT00555620|428782|P6|NOT COMPLETED|Overall Study||22
174153|NCT00555620|428783|P5|NOT COMPLETED|Overall Study||3
174154|NCT00555620|428784|P4|NOT COMPLETED|Overall Study||23
174155|NCT00555620|428785|P3|NOT COMPLETED|Overall Study||15
174156|NCT00555620|428786|P2|NOT COMPLETED|Overall Study||7
174157|NCT00555620|428787|P1|NOT COMPLETED|Overall Study||6
174158|NCT00555620|428782|P6|COMPLETED|Overall Study||0
174159|NCT00555620|428783|P5|COMPLETED|Overall Study||0
174160|NCT00555620|428784|P4|COMPLETED|Overall Study||0
174161|NCT00555620|428785|P3|COMPLETED|Overall Study||0
174162|NCT00555620|428786|P2|COMPLETED|Overall Study||0
174163|NCT00555620|428787|P1|COMPLETED|Overall Study||0
174164|NCT00555620|428782|P6|STARTED|Overall Study||22
174165|NCT00555620|428783|P5|STARTED|Overall Study||3
174166|NCT00555620|428784|P4|STARTED|Overall Study||23
174167|NCT00555620|428785|P3|STARTED|Overall Study||15
174168|NCT00555620|428786|P2|STARTED|Overall Study||7
174169|NCT00555620|428787|P1|STARTED|Overall Study||6
174170|NCT00555672|428901|P2|NOT COMPLETED|Overall Study||10
174171|NCT00555672|428902|P1|NOT COMPLETED|Overall Study||24
174172|NCT00555672|428901|P2|COMPLETED|Overall Study||0
174173|NCT00555672|428902|P1|COMPLETED|Overall Study||0
174174|NCT00555672|428901|P2|STARTED|Overall Study||10
174175|NCT00555672|428902|P1|STARTED|Overall Study||24
174176|NCT00555750|428923|P2|NOT COMPLETED|Overall Study||0
174177|NCT00555750|428924|P1|NOT COMPLETED|Overall Study||0
174178|NCT00555750|428923|P2|COMPLETED|Overall Study||10
174179|NCT00555750|428924|P1|COMPLETED|Overall Study||10
174180|NCT00555750|428923|P2|STARTED|Overall Study||10
174181|NCT00555750|428924|P1|STARTED|Overall Study||10
174182|NCT00555880|428956|P2|NOT COMPLETED|Treatment Period 2 (1 Day)||0
174183|NCT00555880|428957|P1|NOT COMPLETED|Treatment Period 2 (1 Day)||0
174184|NCT00555880|428956|P2|COMPLETED|Treatment Period 2 (1 Day)||11
174185|NCT00555880|428957|P1|COMPLETED|Treatment Period 2 (1 Day)||13
174186|NCT00555880|428956|P2|STARTED|Treatment Period 2 (1 Day)||11
174187|NCT00555880|428957|P1|STARTED|Treatment Period 2 (1 Day)||13
174188|NCT00555880|428956|P2|NOT COMPLETED|Washout (1 Day)||0
174189|NCT00555880|428957|P1|NOT COMPLETED|Washout (1 Day)||0
174190|NCT00555880|428956|P2|COMPLETED|Washout (1 Day)||11
174191|NCT00555880|428957|P1|COMPLETED|Washout (1 Day)||13
174192|NCT00555880|428956|P2|STARTED|Washout (1 Day)||11
174193|NCT00555880|428957|P1|STARTED|Washout (1 Day)||13
174194|NCT00555880|428956|P2|NOT COMPLETED|Treatment Period 1 (1 Day)||0
174195|NCT00555880|428957|P1|NOT COMPLETED|Treatment Period 1 (1 Day)||0
174196|NCT00555880|428956|P2|COMPLETED|Treatment Period 1 (1 Day)||11
174197|NCT00555880|428957|P1|COMPLETED|Treatment Period 1 (1 Day)||13
174198|NCT00555880|428956|P2|STARTED|Treatment Period 1 (1 Day)||11
174199|NCT00555880|428957|P1|STARTED|Treatment Period 1 (1 Day)||13
174200|NCT00555893|428996|P2|NOT COMPLETED|Overall Study||0
174201|NCT00555893|428997|P1|NOT COMPLETED|Overall Study||0
174202|NCT00555893|428996|P2|COMPLETED|Overall Study||63
174203|NCT00555893|428997|P1|COMPLETED|Overall Study||130
174204|NCT00555893|428996|P2|Final Analysis|Overall Study|n=12 excluded from number started because >119 hrs|51
174205|NCT00555893|428997|P1|Final Analysis|Overall Study|n=16 excluded from number started because >119 hrs|114
174206|NCT00555893|428996|P2|STARTED|Overall Study||63
174207|NCT00555893|428997|P1|STARTED|Overall Study||130
174208|NCT00555906|429008|P5|NOT COMPLETED|Phase 2||32
174209|NCT00555906|429009|P4|NOT COMPLETED|Phase 2||0
174210|NCT00555906|429010|P3|NOT COMPLETED|Phase 2||0
174211|NCT00555906|429011|P2|NOT COMPLETED|Phase 2||0
174212|NCT00555906|429012|P1|NOT COMPLETED|Phase 2||0
174213|NCT00555906|429008|P5|COMPLETED|Phase 2||0
174214|NCT00555906|429009|P4|COMPLETED|Phase 2||0
174215|NCT00555906|429010|P3|COMPLETED|Phase 2||0
174216|NCT00555906|429011|P2|COMPLETED|Phase 2||0
174217|NCT00555906|429012|P1|COMPLETED|Phase 2||0
174218|NCT00555906|429008|P5|Treated|Phase 2||30
174219|NCT00555906|429009|P4|Treated|Phase 2||0
174220|NCT00555906|429010|P3|Treated|Phase 2||0
174221|NCT00555906|429011|P2|Treated|Phase 2||0
174222|NCT00555906|429012|P1|Treated|Phase 2||0
174223|NCT00555906|429008|P5|STARTED|Phase 2||32
174224|NCT00555906|429009|P4|STARTED|Phase 2||0
174225|NCT00555906|429010|P3|STARTED|Phase 2||0
174226|NCT00555906|429011|P2|STARTED|Phase 2||0
174227|NCT00555906|429012|P1|STARTED|Phase 2||0
174228|NCT00555906|429008|P5|NOT COMPLETED|Phase 1||0
174229|NCT00555906|429009|P4|NOT COMPLETED|Phase 1||5
174230|NCT00555906|429010|P3|NOT COMPLETED|Phase 1||7
174231|NCT00555906|429011|P2|NOT COMPLETED|Phase 1||6
174232|NCT00555906|429012|P1|NOT COMPLETED|Phase 1||3
174233|NCT00555906|429008|P5|COMPLETED|Phase 1||0
174234|NCT00555906|429009|P4|COMPLETED|Phase 1||0
174235|NCT00555906|429010|P3|COMPLETED|Phase 1||0
174236|NCT00555906|429011|P2|COMPLETED|Phase 1||0
174237|NCT00555906|429012|P1|COMPLETED|Phase 1||0
174238|NCT00555906|429008|P5|STARTED|Phase 1||0
174239|NCT00555906|429009|P4|STARTED|Phase 1||5
174240|NCT00555906|429010|P3|STARTED|Phase 1||7
174241|NCT00555906|429011|P2|STARTED|Phase 1||6
174242|NCT00555906|429012|P1|STARTED|Phase 1||3
174243|NCT00555997|429045|P4|NOT COMPLETED|Phase 2 SPCD||3
174244|NCT00555997|429046|P3|NOT COMPLETED|Phase 2 SPCD||7
174245|NCT00555997|429047|P2|NOT COMPLETED|Phase 2 SPCD||0
174246|NCT00555997|429048|P1|NOT COMPLETED|Phase 2 SPCD||0
174247|NCT00555997|429045|P4|COMPLETED|Phase 2 SPCD||22
174248|NCT00555997|429046|P3|COMPLETED|Phase 2 SPCD||31
174249|NCT00555997|429047|P2|COMPLETED|Phase 2 SPCD||0
174250|NCT00555997|429048|P1|COMPLETED|Phase 2 SPCD||0
174251|NCT00555997|429045|P4|STARTED|Phase 2 SPCD||25
174252|NCT00555997|429046|P3|STARTED|Phase 2 SPCD||38
174253|NCT00555997|429047|P2|STARTED|Phase 2 SPCD||0
174254|NCT00555997|429048|P1|STARTED|Phase 2 SPCD||0
174255|NCT00555997|429045|P4|NOT COMPLETED|Phase 1 SPCD||0
174256|NCT00555997|429046|P3|NOT COMPLETED|Phase 1 SPCD||0
174257|NCT00555997|429047|P2|NOT COMPLETED|Phase 1 SPCD||15
174258|NCT00555997|429048|P1|NOT COMPLETED|Phase 1 SPCD||12
174259|NCT00555997|429045|P4|COMPLETED|Phase 1 SPCD||0
174260|NCT00555997|429046|P3|COMPLETED|Phase 1 SPCD||0
174261|NCT00555997|429047|P2|COMPLETED|Phase 1 SPCD||76
174262|NCT00555997|429048|P1|COMPLETED|Phase 1 SPCD||17
174263|NCT00555997|429045|P4|STARTED|Phase 1 SPCD||0
174264|NCT00555997|429046|P3|STARTED|Phase 1 SPCD||0
174265|NCT00555997|429047|P2|STARTED|Phase 1 SPCD||91
174266|NCT00555997|429048|P1|STARTED|Phase 1 SPCD||29
174267|NCT00556049|429064|P1|NOT COMPLETED|Overall Study||0
174268|NCT00556049|429064|P1|COMPLETED|Overall Study||72
174269|NCT00556049|429064|P1|STARTED|Overall Study||72
174270|NCT00556075|429071|P3|NOT COMPLETED|Overall Study||8
174271|NCT00556075|429072|P2|NOT COMPLETED|Overall Study||9
174272|NCT00556075|429073|P1|NOT COMPLETED|Overall Study||13
174273|NCT00556075|429071|P3|COMPLETED|Overall Study||15
174274|NCT00556075|429072|P2|COMPLETED|Overall Study||13
174275|NCT00556075|429073|P1|COMPLETED|Overall Study||9
174276|NCT00556075|429071|P3|STARTED|Overall Study||23
174277|NCT00556075|429072|P2|STARTED|Overall Study||22
174278|NCT00556075|429073|P1|STARTED|Overall Study||22
174279|NCT00556140|429096|P1|NOT COMPLETED|Overall Study||3
174280|NCT00556140|429096|P1|COMPLETED|Overall Study||13
174281|NCT00556140|429096|P1|STARTED|Overall Study||16
174282|NCT00549055|429101|P1|NOT COMPLETED|Overall Study||35
174283|NCT00549055|429101|P1|COMPLETED|Overall Study||3
174284|NCT00549055|429101|P1|STARTED|Overall Study||38
174285|NCT00556166|429111|P1|NOT COMPLETED|Overall Study||1
174286|NCT00556166|429111|P1|COMPLETED|Overall Study||3
174287|NCT00556166|429111|P1|STARTED|Overall Study||4
174288|NCT00556322|429118|P2|NOT COMPLETED|Overall Study||203
174289|NCT00556322|429119|P1|NOT COMPLETED|Overall Study||221
174290|NCT00556322|429118|P2|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
174291|NCT00556322|429119|P1|COMPLETED|Overall Study|Data cutoff was 01 August 2010|0
174292|NCT00556322|429118|P2|STARTED|Overall Study||203
174293|NCT00556322|429119|P1|STARTED|Overall Study||221
174294|NCT00556374|429169|P2|NOT COMPLETED|Overall Study||220
174295|NCT00556374|429170|P1|NOT COMPLETED|Overall Study||247
174296|NCT00556374|429169|P2|COMPLETED|Overall Study|Indicates participants continuing study|1491
174297|NCT00556374|429170|P1|COMPLETED|Overall Study|Indicates participants continuing study|1462
174298|NCT00556374|429169|P2|Received Study Drug|Overall Study||1700
174299|NCT00556374|429170|P1|Received Study Drug|Overall Study||1699
174300|NCT00556374|429169|P2|STARTED|Overall Study||1711
174301|NCT00556374|429170|P1|STARTED|Overall Study||1709
174302|NCT00556400|429188|P2|NOT COMPLETED|Overall Study||0
174303|NCT00556400|429189|P1|NOT COMPLETED|Overall Study||0
174304|NCT00556400|429188|P2|COMPLETED|Overall Study||0
174305|NCT00556400|429189|P1|COMPLETED|Overall Study||1
174306|NCT00556400|429188|P2|STARTED|Overall Study||0
174307|NCT00556400|429189|P1|STARTED|Overall Study||1
174308|NCT00556426|429198|P1|NOT COMPLETED|Overall Study||9
174309|NCT00556426|429198|P1|COMPLETED|Overall Study||91
174310|NCT00556426|429198|P1|STARTED|Overall Study||100
174311|NCT00556452|429209|P3|NOT COMPLETED|Overall Study||0
174312|NCT00556452|429210|P2|NOT COMPLETED|Overall Study||0
174313|NCT00556452|429211|P1|NOT COMPLETED|Overall Study||0
174314|NCT00556452|429209|P3|COMPLETED|Overall Study||19
174315|NCT00556452|429210|P2|COMPLETED|Overall Study||21
174316|NCT00556452|429211|P1|COMPLETED|Overall Study||6
174317|NCT00556452|429209|P3|STARTED|Overall Study||19
174318|NCT00556452|429210|P2|STARTED|Overall Study||21
174319|NCT00556452|429211|P1|STARTED|Overall Study||6
174320|NCT00556478|429219|P2|NOT COMPLETED|Open-Label Phase||10
174321|NCT00556478|429220|P1|NOT COMPLETED|Open-Label Phase||14
174322|NCT00556478|429219|P2|COMPLETED|Open-Label Phase||67
174323|NCT00556478|429220|P1|COMPLETED|Open-Label Phase||132
174324|NCT00556478|429219|P2|Treated in Open-label|Open-Label Phase||71
174325|NCT00556478|429220|P1|Treated in Open-label|Open-Label Phase||142
174326|NCT00556478|429219|P2|STARTED|Open-Label Phase||77
174327|NCT00556478|429220|P1|STARTED|Open-Label Phase||146
174328|NCT00556478|429219|P2|NOT COMPLETED|Double-blind Phase||8
174329|NCT00556478|429220|P1|NOT COMPLETED|Double-blind Phase||21
174330|NCT00556478|429219|P2|COMPLETED|Double-blind Phase||77
174331|NCT00556478|429220|P1|COMPLETED|Double-blind Phase||150
174332|NCT00556478|429219|P2|ITT|Double-blind Phase||82
174333|NCT00556478|429220|P1|ITT|Double-blind Phase||167
174334|NCT00556478|429219|P2|STARTED|Double-blind Phase||85
174335|NCT00556478|429220|P1|STARTED|Double-blind Phase||171
174336|NCT00559507|429245|P1|NOT COMPLETED|Overall Study||3
174337|NCT00559507|429245|P1|COMPLETED|Overall Study||9
174338|NCT00559507|429245|P1|STARTED|Overall Study||12
174339|NCT00559585|429253|P2|NOT COMPLETED|Open Label LT Period Main + Sub-Study||0
174340|NCT00559585|429254|P1|NOT COMPLETED|Open Label LT Period Main + Sub-Study||428
174341|NCT00559585|429253|P2|COMPLETED|Open Label LT Period Main + Sub-Study||0
174342|NCT00559585|429254|P1|COMPLETED|Open Label LT Period Main + Sub-Study||945
174343|NCT00559585|429253|P2|STARTED|Open Label LT Period Main + Sub-Study|IV administration was discontinued and abatacept was only administered SC during LT Period.|0
174344|NCT00559585|429254|P1|STARTED|Open Label LT Period Main + Sub-Study|1373 includes 15 participants from ST Period Sub-Study who rolled over into LT Period (6 SC + 9 IV).|1373
174345|NCT00559585|429253|P2|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
174346|NCT00559585|429254|P1|NOT COMPLETED|Anti-TNF Sub-Study in ST Period||1
174347|NCT00559585|429253|P2|COMPLETED|Anti-TNF Sub-Study in ST Period||9
174348|NCT00559585|429254|P1|COMPLETED|Anti-TNF Sub-Study in ST Period||7
174443|NCT00560313|429491|P1|STARTED|Overall Study||54
174349|NCT00559585|429253|P2|STARTED|Anti-TNF Sub-Study in ST Period|9 completed Sub-Study ST Period and 9 chose to over into the LT Period.|10
174350|NCT00559585|429254|P1|STARTED|Anti-TNF Sub-Study in ST Period|7 completed Sub-Study ST period and 6 chose to roll over into LT Period.|8
174351|NCT00559585|429253|P2|NOT COMPLETED|Double Blind ST Period Main Study||45
174352|NCT00559585|429254|P1|NOT COMPLETED|Double Blind ST Period Main Study||43
174353|NCT00559585|429253|P2|COMPLETED|Double Blind ST Period Main Study||676
174354|NCT00559585|429254|P1|COMPLETED|Double Blind ST Period Main Study||693
174355|NCT00559585|429253|P2|STARTED|Double Blind ST Period Main Study|Randomized and treated|721
174356|NCT00559585|429254|P1|STARTED|Double Blind ST Period Main Study|Randomized and treated|736
174357|NCT00559637|429314|P1|NOT COMPLETED|Overall Study||54
174358|NCT00559637|429314|P1|COMPLETED|Overall Study||130
174359|NCT00559637|429314|P1|STARTED|Overall Study||184
174360|NCT00559754|429325|P1|NOT COMPLETED|Overall Study||11
174361|NCT00559754|429325|P1|COMPLETED|Overall Study||61
174362|NCT00559754|429325|P1|STARTED|Overall Study||72
174363|NCT00559897|429349|P1|NOT COMPLETED|Overall Study||0
174364|NCT00559897|429349|P1|COMPLETED|Overall Study||6
174365|NCT00559897|429349|P1|STARTED|Overall Study||6
174366|NCT00559936|429353|P1|NOT COMPLETED|Overall Study||4
174367|NCT00559936|429353|P1|COMPLETED|Overall Study||20
174368|NCT00559936|429353|P1|STARTED|Overall Study||24
174369|NCT00559949|429358|P1|NOT COMPLETED|Overall Study||7
174370|NCT00559949|429358|P1|COMPLETED|Overall Study||32
174371|NCT00559949|429358|P1|STARTED|Overall Study||39
174372|NCT00559962|429373|P8|NOT COMPLETED|Overall Study||4
174373|NCT00559962|429374|P7|NOT COMPLETED|Overall Study||5
174374|NCT00559962|429375|P6|NOT COMPLETED|Overall Study||5
174375|NCT00559962|429376|P5|NOT COMPLETED|Overall Study||14
174376|NCT00559962|429377|P4|NOT COMPLETED|Overall Study||5
174377|NCT00559962|429378|P3|NOT COMPLETED|Overall Study||10
174378|NCT00559962|429379|P2|NOT COMPLETED|Overall Study||9
174379|NCT00559962|429380|P1|NOT COMPLETED|Overall Study||2
174380|NCT00559962|429373|P8|COMPLETED|Overall Study||25
174381|NCT00559962|429374|P7|COMPLETED|Overall Study||28
174382|NCT00559962|429375|P6|COMPLETED|Overall Study||23
174383|NCT00559962|429376|P5|COMPLETED|Overall Study||21
174384|NCT00559962|429377|P4|COMPLETED|Overall Study||29
174385|NCT00559962|429378|P3|COMPLETED|Overall Study||24
174386|NCT00559962|429379|P2|COMPLETED|Overall Study||25
174387|NCT00559962|429380|P1|COMPLETED|Overall Study||31
174388|NCT00559962|429373|P8|STARTED|Overall Study||29
174389|NCT00559962|429374|P7|STARTED|Overall Study||33
174390|NCT00559962|429375|P6|STARTED|Overall Study||28
174391|NCT00559962|429376|P5|STARTED|Overall Study||35
174392|NCT00559962|429377|P4|STARTED|Overall Study||34
174393|NCT00559962|429378|P3|STARTED|Overall Study||34
174394|NCT00559962|429379|P2|STARTED|Overall Study||34
174395|NCT00559962|429380|P1|STARTED|Overall Study||33
174396|NCT00559988|429402|P2|NOT COMPLETED|Overall Study||352
174397|NCT00559988|429403|P1|NOT COMPLETED|Overall Study||351
174398|NCT00559988|429402|P2|COMPLETED|Overall Study||1009
174399|NCT00559988|429403|P1|COMPLETED|Overall Study||1006
174400|NCT00559988|429402|P2|STARTED|Overall Study||1361
174401|NCT00559988|429403|P1|STARTED|Overall Study||1357
174402|NCT00560066|429411|P2|NOT COMPLETED|Overall Study||22
174403|NCT00560066|429412|P1|NOT COMPLETED|Overall Study||6
174404|NCT00560066|429411|P2|COMPLETED|Overall Study||980
174405|NCT00560066|429412|P1|COMPLETED|Overall Study||390
174406|NCT00560066|429411|P2|STARTED|Overall Study||1002
174407|NCT00560066|429412|P1|STARTED|Overall Study||396
174408|NCT00560105|429444|P2|NOT COMPLETED|Overall Study||2
174409|NCT00560105|429445|P1|NOT COMPLETED|Overall Study||1
174410|NCT00560105|429444|P2|COMPLETED|Overall Study||18
174411|NCT00560105|429445|P1|COMPLETED|Overall Study||19
174412|NCT00560105|429444|P2|STARTED|Overall Study||20
174413|NCT00560105|429445|P1|STARTED|Overall Study||20
174414|NCT00560235|429460|P3|NOT COMPLETED|Phase 2||97
174415|NCT00560235|429461|P2|NOT COMPLETED|Phase 2||0
174416|NCT00560235|429462|P1|NOT COMPLETED|Phase 2||0
174417|NCT00560235|429460|P3|COMPLETED|Phase 2||10
174418|NCT00560235|429461|P2|COMPLETED|Phase 2||0
174419|NCT00560235|429462|P1|COMPLETED|Phase 2||0
174420|NCT00560235|429460|P3|STARTED|Phase 2||107
174421|NCT00560235|429461|P2|STARTED|Phase 2||0
174422|NCT00560235|429462|P1|STARTED|Phase 2||0
174423|NCT00560235|429460|P3|NOT COMPLETED|Phase 1B||0
174424|NCT00560235|429461|P2|NOT COMPLETED|Phase 1B||19
174425|NCT00560235|429462|P1|NOT COMPLETED|Phase 1B||0
174426|NCT00560235|429460|P3|COMPLETED|Phase 1B||0
174427|NCT00560235|429461|P2|COMPLETED|Phase 1B||2
174428|NCT00560235|429462|P1|COMPLETED|Phase 1B||0
174429|NCT00560235|429460|P3|STARTED|Phase 1B||0
174430|NCT00560235|429461|P2|STARTED|Phase 1B||21
174431|NCT00560235|429462|P1|STARTED|Phase 1B||0
174432|NCT00560235|429460|P3|NOT COMPLETED|Phase 1||0
174433|NCT00560235|429461|P2|NOT COMPLETED|Phase 1||0
174434|NCT00560235|429462|P1|NOT COMPLETED|Phase 1||8
174435|NCT00560235|429460|P3|COMPLETED|Phase 1||0
174436|NCT00560235|429461|P2|COMPLETED|Phase 1||0
174437|NCT00560235|429462|P1|COMPLETED|Phase 1||2
174438|NCT00560235|429460|P3|STARTED|Phase 1||0
174439|NCT00560235|429461|P2|STARTED|Phase 1||0
174440|NCT00560235|429462|P1|STARTED|Phase 1||10
174441|NCT00560313|429491|P1|NOT COMPLETED|Overall Study||6
174442|NCT00560313|429491|P1|COMPLETED|Overall Study||48
174444|NCT00560352|429518|P3|NOT COMPLETED|Overall Study||4
174445|NCT00560352|429519|P2|NOT COMPLETED|Overall Study||3
174446|NCT00560352|429520|P1|NOT COMPLETED|Overall Study||7
174447|NCT00560352|429518|P3|COMPLETED|Overall Study||0
174448|NCT00560352|429519|P2|COMPLETED|Overall Study||0
174449|NCT00560352|429520|P1|COMPLETED|Overall Study||0
174450|NCT00560352|429518|P3|STARTED|Overall Study||4
174451|NCT00560352|429519|P2|STARTED|Overall Study||3
174452|NCT00560352|429520|P1|STARTED|Overall Study||7
174453|NCT00560391|429542|P5|NOT COMPLETED|Overall Study||2
174454|NCT00560391|429543|P4|NOT COMPLETED|Overall Study||1
174455|NCT00560391|429544|P3|NOT COMPLETED|Overall Study||0
174456|NCT00560391|429545|P2|NOT COMPLETED|Overall Study||0
174457|NCT00560391|429546|P1|NOT COMPLETED|Overall Study||0
174458|NCT00560391|429542|P5|COMPLETED|Overall Study|Completed=offtreatment;Disease progression-6;Study drug toxicity-7; Unrelated AE-1,Subject request-1|15
174459|NCT00560391|429543|P4|COMPLETED|Overall Study|Completed=off treatment; Disease progression-2; Unrelated AE 1 and Subject request 2|5
174460|NCT00560391|429544|P3|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Maximum clinical benefit-1; Unrelated AE-1|3
174461|NCT00560391|429545|P2|COMPLETED|Overall Study|Completed=off treatment; Disease progression-1;Death-1; Unrelated AE-1|3
174462|NCT00560391|429546|P1|COMPLETED|Overall Study|Completed=off treatment;Disease progression-1;Death-1;Max. clinical benefit-2;Study drug toxicity-2|6
174463|NCT00560391|429542|P5|STARTED|Overall Study|Participants who received treatment|17
174464|NCT00560391|429543|P4|STARTED|Overall Study|Participants who received treatment|6
174465|NCT00560391|429544|P3|STARTED|Overall Study|Participants who received treatment|3
174466|NCT00560391|429545|P2|STARTED|Overall Study|Participants who received treatment|3
174467|NCT00560391|429546|P1|STARTED|Overall Study|Participants who received treatment|6
174468|NCT00560404|429601|P2|NOT COMPLETED|Overall Study||21
174469|NCT00560404|429602|P1|NOT COMPLETED|Overall Study||36
174470|NCT00560404|429601|P2|COMPLETED|Overall Study||100
174471|NCT00560404|429602|P1|COMPLETED|Overall Study||76
174472|NCT00560404|429601|P2|STARTED|Overall Study||121
174473|NCT00560404|429602|P1|STARTED|Overall Study||112
174474|NCT00560417|429646|P2|NOT COMPLETED|Overall Study||17
174475|NCT00560417|429647|P1|NOT COMPLETED|Overall Study||17
174476|NCT00560417|429646|P2|COMPLETED|Overall Study||151
174477|NCT00560417|429647|P1|COMPLETED|Overall Study||154
174478|NCT00560417|429646|P2|Intention to Treat (ITT) Population|Overall Study||167
174479|NCT00560417|429647|P1|Intention to Treat (ITT) Population|Overall Study||170
174480|NCT00560417|429646|P2|STARTED|Overall Study||168
174481|NCT00560417|429647|P1|STARTED|Overall Study||171
174482|NCT00560508|429675|P2|NOT COMPLETED|52-week Open-label Period Pramipexole ER||11
174483|NCT00560508|429676|P1|NOT COMPLETED|52-week Open-label Period Pramipexole ER||8
174484|NCT00560508|429675|P2|COMPLETED|52-week Open-label Period Pramipexole ER||42
174485|NCT00560508|429676|P1|COMPLETED|52-week Open-label Period Pramipexole ER||43
174486|NCT00560508|429675|P2|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|53
174487|NCT00560508|429676|P1|STARTED|52-week Open-label Period Pramipexole ER|all patients received Pramipexole ER for the 52-week open-label period|51
174488|NCT00560508|429675|P2|NOT COMPLETED|12 Week Double-blind Period||3
174489|NCT00560508|429676|P1|NOT COMPLETED|12 Week Double-blind Period||5
174490|NCT00560508|429675|P2|COMPLETED|12 Week Double-blind Period||53
174491|NCT00560508|429676|P1|COMPLETED|12 Week Double-blind Period||51
174492|NCT00560508|429675|P2|STARTED|12 Week Double-blind Period||56
174493|NCT00560508|429676|P1|STARTED|12 Week Double-blind Period||56
174494|NCT00560560|429735|P2|NOT COMPLETED|Overall Study||83
174495|NCT00560560|429736|P1|NOT COMPLETED|Overall Study||85
174496|NCT00560560|429735|P2|COMPLETED|Overall Study||0
174497|NCT00560560|429736|P1|COMPLETED|Overall Study||0
174498|NCT00560560|429735|P2|STARTED|Overall Study||83
174499|NCT00560560|429736|P1|STARTED|Overall Study||85
174500|NCT00560573|429756|P6|NOT COMPLETED|Overall Study||13
174501|NCT00560573|429757|P5|NOT COMPLETED|Overall Study||7
174502|NCT00560573|429758|P4|NOT COMPLETED|Overall Study||10
174503|NCT00560573|429759|P3|NOT COMPLETED|Overall Study||6
174504|NCT00560573|429760|P2|NOT COMPLETED|Overall Study||3
174505|NCT00560573|429761|P1|NOT COMPLETED|Overall Study||6
174506|NCT00560573|429756|P6|COMPLETED|Overall Study||0
174507|NCT00560573|429757|P5|COMPLETED|Overall Study||1
174508|NCT00560573|429758|P4|COMPLETED|Overall Study||0
174509|NCT00560573|429759|P3|COMPLETED|Overall Study||0
174510|NCT00560573|429760|P2|COMPLETED|Overall Study||0
174511|NCT00560573|429761|P1|COMPLETED|Overall Study||0
174512|NCT00560573|429756|P6|Treated|Overall Study||13
174513|NCT00560573|429757|P5|Treated|Overall Study||7
174514|NCT00560573|429758|P4|Treated|Overall Study||10
174515|NCT00560573|429759|P3|Treated|Overall Study||6
174516|NCT00560573|429760|P2|Treated|Overall Study||3
174517|NCT00560573|429761|P1|Treated|Overall Study||6
174518|NCT00560573|429756|P6|STARTED|Overall Study||13
174519|NCT00560573|429757|P5|STARTED|Overall Study||8
174520|NCT00560573|429758|P4|STARTED|Overall Study||10
174521|NCT00560573|429759|P3|STARTED|Overall Study||6
174522|NCT00560573|429760|P2|STARTED|Overall Study||3
174523|NCT00560573|429761|P1|STARTED|Overall Study||6
174524|NCT00560612|429815|P2|NOT COMPLETED|Overall Study||0
174525|NCT00560612|429816|P1|NOT COMPLETED|Overall Study||0
174526|NCT00560612|429815|P2|COMPLETED|Overall Study||7
174527|NCT00560612|429816|P1|COMPLETED|Overall Study||5
174528|NCT00560612|429815|P2|STARTED|Overall Study||7
174529|NCT00560612|429816|P1|STARTED|Overall Study||5
174530|NCT00560703|429824|P2|NOT COMPLETED|Overall Study||6
174531|NCT00560703|429825|P1|NOT COMPLETED|Overall Study||0
174532|NCT00560703|429824|P2|COMPLETED|Overall Study||18
174533|NCT00560703|429825|P1|COMPLETED|Overall Study||46
174534|NCT00560703|429824|P2|STARTED|Overall Study||24
174535|NCT00560703|429825|P1|STARTED|Overall Study||46
174536|NCT00560794|429833|P1|NOT COMPLETED|Overall Study||11
174537|NCT00560794|429833|P1|COMPLETED|Overall Study||10
174538|NCT00560794|429833|P1|Completed 1 Treatment Cycle|Overall Study||20
174539|NCT00560794|429833|P1|STARTED|Overall Study||21
174540|NCT00560833|429855|P5|NOT COMPLETED|Overall Study||42
174541|NCT00560833|429856|P4|NOT COMPLETED|Overall Study||31
174542|NCT00560833|429857|P3|NOT COMPLETED|Overall Study||39
174543|NCT00560833|429858|P2|NOT COMPLETED|Overall Study||26
174544|NCT00560833|429859|P1|NOT COMPLETED|Overall Study||44
174545|NCT00560833|429855|P5|COMPLETED|Overall Study||114
174546|NCT00560833|429856|P4|COMPLETED|Overall Study||124
174547|NCT00560833|429857|P3|COMPLETED|Overall Study||121
174548|NCT00560833|429858|P2|COMPLETED|Overall Study||129
174549|NCT00560833|429859|P1|COMPLETED|Overall Study||273
174550|NCT00560833|429855|P5|Treated|Overall Study|One participant was randomized but not treated|155
174551|NCT00560833|429856|P4|Treated|Overall Study||155
174552|NCT00560833|429857|P3|Treated|Overall Study||160
174553|NCT00560833|429858|P2|Treated|Overall Study|One participant was randomized but not treated|154
174554|NCT00560833|429859|P1|Treated|Overall Study|One participant was not randomized but was treated with placebo|317
174555|NCT00560833|429855|P5|STARTED|Overall Study||156
174556|NCT00560833|429856|P4|STARTED|Overall Study||155
174557|NCT00560833|429857|P3|STARTED|Overall Study||160
174558|NCT00560833|429858|P2|STARTED|Overall Study||155
174559|NCT00560833|429859|P1|STARTED|Overall Study||317
174560|NCT00560859|429893|P2|NOT COMPLETED|Overall Study||24
174561|NCT00560859|429894|P1|NOT COMPLETED|Overall Study||32
174562|NCT00560859|429893|P2|COMPLETED|Overall Study||203
174563|NCT00560859|429894|P1|COMPLETED|Overall Study||194
174564|NCT00560859|429893|P2|STARTED|Overall Study||227
174565|NCT00560859|429894|P1|STARTED|Overall Study||226
174566|NCT00560885|429904|P1|NOT COMPLETED|Overall Study||8
174567|NCT00560885|429904|P1|COMPLETED|Overall Study||47
174568|NCT00560885|429904|P1|2 Year Follow-up|Overall Study||47
174569|NCT00560885|429904|P1|12 Month Follow-up|Overall Study|48 pts available for 12 month follow-up, 46 pts assessed|48
174570|NCT00560885|429904|P1|6 Month Follow-up|Overall Study|50 pts available for 6 month follow-up, 50 pts assessed|50
174571|NCT00560885|429904|P1|3 Month Follow-up|Overall Study|51 pts available for 3 month follow-up, 48 pts assessed.|51
174572|NCT00560885|429904|P1|30 Day Follow-up|Overall Study|53 pts available for 30 day follow-up, 52 pts assessed|53
174573|NCT00560885|429904|P1|STARTED|Overall Study||55
174574|NCT00560937|429913|P2|NOT COMPLETED|Overall Study||2
174575|NCT00560937|429914|P1|NOT COMPLETED|Overall Study||1
174576|NCT00560937|429913|P2|COMPLETED|Overall Study||9
174577|NCT00560937|429914|P1|COMPLETED|Overall Study|One participant was withdrawn after 6 weeks and data were carried forward|9
174578|NCT00560937|429913|P2|STARTED|Overall Study||11
174579|NCT00560937|429914|P1|STARTED|Overall Study||10
174580|NCT00560950|429932|P2|NOT COMPLETED|Overall Study||0
174581|NCT00560950|429933|P1|NOT COMPLETED|Overall Study||1
174582|NCT00560950|429932|P2|COMPLETED|Overall Study||71
174583|NCT00560950|429933|P1|COMPLETED|Overall Study||71
174584|NCT00560950|429932|P2|STARTED|Overall Study||71
174585|NCT00560950|429933|P1|STARTED|Overall Study||72
174586|NCT00561002|429971|P2|NOT COMPLETED|Overall Study||0
174587|NCT00561002|429972|P1|NOT COMPLETED|Overall Study||0
174588|NCT00561002|429971|P2|COMPLETED|Overall Study||9
174589|NCT00561002|429972|P1|COMPLETED|Overall Study||23
174590|NCT00561002|429971|P2|STARTED|Overall Study||9
174591|NCT00561002|429972|P1|STARTED|Overall Study||23
174592|NCT00561015|429990|P6|NOT COMPLETED|Overall Study||3
174593|NCT00561015|429991|P5|NOT COMPLETED|Overall Study||1
174594|NCT00561015|429992|P4|NOT COMPLETED|Overall Study||1
174595|NCT00561015|429993|P3|NOT COMPLETED|Overall Study||0
174596|NCT00561015|429994|P2|NOT COMPLETED|Overall Study||0
174597|NCT00561015|429995|P1|NOT COMPLETED|Overall Study||4
174598|NCT00561015|429990|P6|COMPLETED|Overall Study||6
174599|NCT00561015|429991|P5|COMPLETED|Overall Study||8
174600|NCT00561015|429992|P4|COMPLETED|Overall Study||7
174601|NCT00561015|429993|P3|COMPLETED|Overall Study||9
174602|NCT00561015|429994|P2|COMPLETED|Overall Study||5
174603|NCT00561015|429995|P1|COMPLETED|Overall Study||5
174604|NCT00561015|429990|P6|STARTED|Overall Study||9
174605|NCT00561015|429991|P5|STARTED|Overall Study||9
174606|NCT00561015|429992|P4|STARTED|Overall Study||8
174607|NCT00561015|429993|P3|STARTED|Overall Study||9
174608|NCT00561015|429994|P2|STARTED|Overall Study||5
174609|NCT00561015|429995|P1|STARTED|Overall Study||9
174610|NCT00561145|430071|P2|NOT COMPLETED|Overall Study||0
174611|NCT00561145|430072|P1|NOT COMPLETED|Overall Study||0
174612|NCT00561145|430071|P2|COMPLETED|Overall Study||17
174613|NCT00561145|430072|P1|COMPLETED|Overall Study||15
174614|NCT00561145|430071|P2|STARTED|Overall Study||17
174615|NCT00561145|430072|P1|STARTED|Overall Study||15
174616|NCT00561340|430080|P2|NOT COMPLETED|Overall Study||0
174617|NCT00561340|430081|P1|NOT COMPLETED|Overall Study||6
174618|NCT00561340|430080|P2|COMPLETED|Overall Study||16
174619|NCT00561340|430081|P1|COMPLETED|Overall Study||7
174620|NCT00561340|430080|P2|STARTED|Overall Study||16
174621|NCT00561340|430081|P1|STARTED|Overall Study||13
174622|NCT00561353|430099|P10|NOT COMPLETED|Overall Study||2
174623|NCT00561353|430100|P9|NOT COMPLETED|Overall Study||7
174624|NCT00561353|430101|P8|NOT COMPLETED|Overall Study||4
174625|NCT00561353|430102|P7|NOT COMPLETED|Overall Study||6
174626|NCT00561353|430103|P6|NOT COMPLETED|Overall Study||6
174627|NCT00561353|430104|P5|NOT COMPLETED|Overall Study||1
174628|NCT00561353|430105|P4|NOT COMPLETED|Overall Study||6
174629|NCT00561353|430106|P3|NOT COMPLETED|Overall Study||3
174630|NCT00561353|430107|P2|NOT COMPLETED|Overall Study||3
174631|NCT00561353|430108|P1|NOT COMPLETED|Overall Study||5
174632|NCT00561353|430099|P10|COMPLETED|Overall Study||3
174633|NCT00561353|430100|P9|COMPLETED|Overall Study||2
174634|NCT00561353|430101|P8|COMPLETED|Overall Study||6
174635|NCT00561353|430102|P7|COMPLETED|Overall Study||3
174636|NCT00561353|430103|P6|COMPLETED|Overall Study||3
174637|NCT00561353|430104|P5|COMPLETED|Overall Study||5
174638|NCT00561353|430105|P4|COMPLETED|Overall Study||12
174639|NCT00561353|430106|P3|COMPLETED|Overall Study||10
174640|NCT00561353|430107|P2|COMPLETED|Overall Study||16
174641|NCT00561353|430108|P1|COMPLETED|Overall Study||13
174642|NCT00561353|430099|P10|STARTED|Overall Study||5
174643|NCT00561353|430100|P9|STARTED|Overall Study||9
174644|NCT00561353|430101|P8|STARTED|Overall Study||10
174645|NCT00561353|430102|P7|STARTED|Overall Study||9
174646|NCT00561353|430103|P6|STARTED|Overall Study||9
174647|NCT00561353|430104|P5|STARTED|Overall Study||6
174648|NCT00561353|430105|P4|STARTED|Overall Study||18
174649|NCT00561353|430106|P3|STARTED|Overall Study||13
174650|NCT00561353|430107|P2|STARTED|Overall Study||19
174651|NCT00561353|430108|P1|STARTED|Overall Study||18
174652|NCT00561392|430261|P1|NOT COMPLETED|Overall Study||53
174653|NCT00561392|430261|P1|COMPLETED|Overall Study||155
174654|NCT00561392|430261|P1|STARTED|Overall Study||208
174655|NCT00561418|430273|P1|NOT COMPLETED|Overall Study||0
174656|NCT00561418|430273|P1|COMPLETED|Overall Study||23
174657|NCT00561418|430273|P1|STARTED|Overall Study||23
174658|NCT00561431|430282|P2|NOT COMPLETED|Overall Study||0
174659|NCT00561431|430283|P1|NOT COMPLETED|Overall Study||0
174660|NCT00561431|430282|P2|COMPLETED|Overall Study||100
174661|NCT00561431|430283|P1|COMPLETED|Overall Study||100
174662|NCT00561431|430282|P2|STARTED|Overall Study||100
174663|NCT00561431|430283|P1|STARTED|Overall Study||100
174664|NCT00561457|430291|P1|NOT COMPLETED|Overall Study||24
174665|NCT00561457|430291|P1|COMPLETED|Overall Study||110
174666|NCT00561457|430291|P1|STARTED|Overall Study||134
174667|NCT00561470|430297|P2|NOT COMPLETED|Overall Study||612
174668|NCT00561470|430298|P1|NOT COMPLETED|Overall Study||614
174669|NCT00561470|430297|P2|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
174670|NCT00561470|430298|P1|COMPLETED|Overall Study|Participants met treatment discontinuation criteria or were ongoing treatment on the cutoff date|0
174671|NCT00561470|430297|P2|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|14
174672|NCT00561470|430298|P1|ONGOING TREATMENT|Overall Study|Participants continuing treatment on the cutoff date of the final analysis|11
174673|NCT00561470|430297|P2|SAFETY POPULATION|Overall Study|Treated participants including 4 from Placebo/FOLFIRI who received at least 1 dose of Aflibercept|611
174674|NCT00561470|430298|P1|SAFETY POPULATION|Overall Study|Treated participants excluding 4 who received at least 1 dose of Aflibercept|605
174675|NCT00561470|430297|P2|TREATED|Overall Study||607
174676|NCT00561470|430298|P1|TREATED|Overall Study||609
174677|NCT00561470|430297|P2|STARTED|Overall Study||612
174678|NCT00561470|430298|P1|STARTED|Overall Study||614
174679|NCT00561574|430314|P2|NOT COMPLETED|Overall Study||58
174680|NCT00561574|430315|P1|NOT COMPLETED|Overall Study||48
174681|NCT00561574|430314|P2|COMPLETED|Overall Study||73
174682|NCT00561574|430315|P1|COMPLETED|Overall Study||80
174683|NCT00561574|430314|P2|STARTED|Overall Study||131
174684|NCT00561574|430315|P1|STARTED|Overall Study||128
174685|NCT00561600|430341|P2|NOT COMPLETED|Overall Study||16
174686|NCT00561600|430342|P1|NOT COMPLETED|Overall Study||18
174687|NCT00561600|430341|P2|COMPLETED|Overall Study||119
174688|NCT00561600|430342|P1|COMPLETED|Overall Study||112
174689|NCT00561600|430341|P2|STARTED|Overall Study||135
174690|NCT00561600|430342|P1|STARTED|Overall Study||130
174691|NCT00561652|430404|P2|NOT COMPLETED|Overall Study||1
174692|NCT00561652|430405|P1|NOT COMPLETED|Overall Study||0
174693|NCT00561652|430404|P2|COMPLETED|Overall Study||19
174694|NCT00561652|430405|P1|COMPLETED|Overall Study||10
174695|NCT00561652|430404|P2|STARTED|Overall Study||20
174696|NCT00561652|430405|P1|STARTED|Overall Study||10
174697|NCT00561678|430425|P2|NOT COMPLETED|Overall Study||6
174698|NCT00561678|430426|P1|NOT COMPLETED|Overall Study||8
174699|NCT00561678|430425|P2|COMPLETED|Overall Study||201
174700|NCT00561678|430426|P1|COMPLETED|Overall Study||189
174701|NCT00561678|430425|P2|STARTED|Overall Study||207
174702|NCT00561678|430426|P1|STARTED|Overall Study||197
174703|NCT00561730|430442|P1|NOT COMPLETED|Overall Study||9
174704|NCT00561730|430442|P1|COMPLETED|Overall Study||1986
174705|NCT00561730|430442|P1|STARTED|Overall Study||1995
174706|NCT00561795|430458|P4|NOT COMPLETED|Overall Study||0
174707|NCT00561795|430459|P3|NOT COMPLETED|Overall Study||0
174708|NCT00561795|430460|P2|NOT COMPLETED|Overall Study||6
174709|NCT00561795|430461|P1|NOT COMPLETED|Overall Study||4
174710|NCT00561795|430458|P4|COMPLETED|Overall Study||0
174711|NCT00561795|430459|P3|COMPLETED|Overall Study||0
174712|NCT00561795|430460|P2|COMPLETED|Overall Study||0
174713|NCT00561795|430461|P1|COMPLETED|Overall Study||2
174714|NCT00561795|430458|P4|STARTED|Overall Study||0
174715|NCT00561795|430459|P3|STARTED|Overall Study||0
174716|NCT00561795|430460|P2|STARTED|Overall Study||6
174717|NCT00561795|430461|P1|STARTED|Overall Study||6
174718|NCT00561821|430485|P4|NOT COMPLETED|Overall Study||3
174719|NCT00561821|430486|P3|NOT COMPLETED|Overall Study||2
174720|NCT00561821|430487|P2|NOT COMPLETED|Overall Study||6
174721|NCT00561821|430488|P1|NOT COMPLETED|Overall Study||5
174722|NCT00561821|430485|P4|COMPLETED|Overall Study||133
174723|NCT00561821|430486|P3|COMPLETED|Overall Study||132
174724|NCT00561821|430487|P2|COMPLETED|Overall Study||130
174725|NCT00561821|430488|P1|COMPLETED|Overall Study||127
174726|NCT00561821|430485|P4|Treated|Overall Study||136
174727|NCT00561821|430486|P3|Treated|Overall Study||133
174728|NCT00561821|430487|P2|Treated|Overall Study||136
174729|NCT00561821|430488|P1|Treated|Overall Study||132
174730|NCT00561821|430485|P4|STARTED|Overall Study||136
174731|NCT00561821|430486|P3|STARTED|Overall Study||134
174732|NCT00561821|430487|P2|STARTED|Overall Study||136
174733|NCT00561821|430488|P1|STARTED|Overall Study||132
174734|NCT00561834|430562|P1|NOT COMPLETED|Overall Study||0
174735|NCT00561834|430562|P1|COMPLETED|Overall Study||2
174736|NCT00561834|430562|P1|STARTED|Overall Study||2
174737|NCT00561912|430566|P1|NOT COMPLETED|Overall Study||1
174738|NCT00561912|430566|P1|COMPLETED|Overall Study||1
174739|NCT00561912|430566|P1|STARTED|Overall Study||2
174740|NCT00561925|430573|P5|NOT COMPLETED|Open-Label Extension Period||50
174741|NCT00561925|430574|P4|NOT COMPLETED|Open-Label Extension Period||43
174742|NCT00561925|430575|P3|NOT COMPLETED|Open-Label Extension Period||0
174743|NCT00561925|430576|P2|NOT COMPLETED|Open-Label Extension Period||0
174744|NCT00561925|430577|P1|NOT COMPLETED|Open-Label Extension Period||0
174745|NCT00561925|430573|P5|COMPLETED|Open-Label Extension Period||328
174746|NCT00561925|430574|P4|COMPLETED|Open-Label Extension Period||315
174747|NCT00561925|430575|P3|COMPLETED|Open-Label Extension Period||0
174748|NCT00561925|430576|P2|COMPLETED|Open-Label Extension Period||1
174749|NCT00561925|430577|P1|COMPLETED|Open-Label Extension Period||0
174750|NCT00561925|430573|P5|STARTED|Open-Label Extension Period||378
174751|NCT00561925|430574|P4|STARTED|Open-Label Extension Period||358
174752|NCT00561925|430575|P3|STARTED|Open-Label Extension Period||0
174753|NCT00561925|430576|P2|STARTED|Open-Label Extension Period||1
174754|NCT00561925|430577|P1|STARTED|Open-Label Extension Period||0
174755|NCT00561925|430573|P5|NOT COMPLETED|144-week Double-blind, Double-dummy||0
174756|NCT00561925|430574|P4|NOT COMPLETED|144-week Double-blind, Double-dummy||0
174757|NCT00561925|430575|P3|NOT COMPLETED|144-week Double-blind, Double-dummy||127
174758|NCT00561925|430576|P2|NOT COMPLETED|144-week Double-blind, Double-dummy||150
174759|NCT00561925|430577|P1|NOT COMPLETED|144-week Double-blind, Double-dummy||0
174760|NCT00561925|430573|P5|COMPLETED|144-week Double-blind, Double-dummy||0
174761|NCT00561925|430574|P4|COMPLETED|144-week Double-blind, Double-dummy||0
174762|NCT00561925|430575|P3|COMPLETED|144-week Double-blind, Double-dummy||378
174763|NCT00561925|430576|P2|COMPLETED|144-week Double-blind, Double-dummy||358
174764|NCT00561925|430577|P1|COMPLETED|144-week Double-blind, Double-dummy||0
174765|NCT00561925|430573|P5|STARTED|144-week Double-blind, Double-dummy||0
174766|NCT00561925|430574|P4|STARTED|144-week Double-blind, Double-dummy||0
174767|NCT00561925|430575|P3|STARTED|144-week Double-blind, Double-dummy||505
174768|NCT00561925|430576|P2|STARTED|144-week Double-blind, Double-dummy||508
174769|NCT00561925|430577|P1|STARTED|144-week Double-blind, Double-dummy||0
174770|NCT00561925|430573|P5|NOT COMPLETED|14 Day Lead-In Period||0
174771|NCT00561925|430574|P4|NOT COMPLETED|14 Day Lead-In Period||0
174772|NCT00561925|430575|P3|NOT COMPLETED|14 Day Lead-In Period||0
174773|NCT00561925|430576|P2|NOT COMPLETED|14 Day Lead-In Period||0
174774|NCT00561925|430577|P1|NOT COMPLETED|14 Day Lead-In Period||55
174775|NCT00561925|430573|P5|COMPLETED|14 Day Lead-In Period||0
174776|NCT00561925|430574|P4|COMPLETED|14 Day Lead-In Period||0
174777|NCT00561925|430575|P3|COMPLETED|14 Day Lead-In Period||0
174778|NCT00561925|430576|P2|COMPLETED|14 Day Lead-In Period||0
174779|NCT00561925|430577|P1|COMPLETED|14 Day Lead-In Period||1013
174780|NCT00561925|430573|P5|STARTED|14 Day Lead-In Period||0
174781|NCT00561925|430574|P4|STARTED|14 Day Lead-In Period||0
174782|NCT00561925|430575|P3|STARTED|14 Day Lead-In Period||0
174783|NCT00561925|430576|P2|STARTED|14 Day Lead-In Period||0
174784|NCT00561925|430577|P1|STARTED|14 Day Lead-In Period||1068
174785|NCT00561951|430629|P3|NOT COMPLETED|Overall Study||32
174786|NCT00561951|430630|P2|NOT COMPLETED|Overall Study||34
174787|NCT00561951|430631|P1|NOT COMPLETED|Overall Study||33
174788|NCT00561951|430629|P3|COMPLETED|Overall Study||281
174789|NCT00561951|430630|P2|COMPLETED|Overall Study||286
174790|NCT00561951|430631|P1|COMPLETED|Overall Study||285
174791|NCT00561951|430629|P3|STARTED|Overall Study||313
174792|NCT00561951|430630|P2|STARTED|Overall Study||320
174793|NCT00561951|430631|P1|STARTED|Overall Study||318
174794|NCT00552032|430686|P2|NOT COMPLETED|Overall Study||19
174795|NCT00552032|430687|P1|NOT COMPLETED|Overall Study||17
174796|NCT00552032|430686|P2|COMPLETED|Overall Study||47
174797|NCT00552032|430687|P1|COMPLETED|Overall Study||49
174798|NCT00552032|430686|P2|STARTED|Overall Study||66
174799|NCT00552032|430687|P1|STARTED|Overall Study||66
174800|NCT00552058|430733|P2|NOT COMPLETED|Overall Study||24
174801|NCT00552058|430734|P1|NOT COMPLETED|Overall Study||16
174802|NCT00552058|430733|P2|COMPLETED|Overall Study||192
174803|NCT00552058|430734|P1|COMPLETED|Overall Study||207
174804|NCT00552058|430733|P2|STARTED|Overall Study||216
174805|NCT00552058|430734|P1|STARTED|Overall Study||223
174806|NCT00552084|430774|P2|NOT COMPLETED|Overall Study||9
174807|NCT00552084|430775|P1|NOT COMPLETED|Overall Study||8
174808|NCT00552084|430774|P2|COMPLETED|Overall Study||55
174809|NCT00552084|430775|P1|COMPLETED|Overall Study||118
174810|NCT00552084|430774|P2|STARTED|Overall Study||64
174811|NCT00552084|430775|P1|STARTED|Overall Study||126
174812|NCT00552110|430786|P5|NOT COMPLETED|Overall Study||9
174813|NCT00552110|430787|P4|NOT COMPLETED|Overall Study||8
174814|NCT00552110|430788|P3|NOT COMPLETED|Overall Study||2
174815|NCT00552110|430789|P2|NOT COMPLETED|Overall Study||5
174816|NCT00552110|430790|P1|NOT COMPLETED|Overall Study||4
174817|NCT00552110|430786|P5|COMPLETED|Overall Study||133
174818|NCT00552110|430787|P4|COMPLETED|Overall Study||133
174819|NCT00552110|430788|P3|COMPLETED|Overall Study||137
174820|NCT00552110|430789|P2|COMPLETED|Overall Study||134
174821|NCT00552110|430790|P1|COMPLETED|Overall Study||142
174822|NCT00552110|430786|P5|STARTED|Overall Study||142
174823|NCT00552110|430787|P4|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|141
174824|NCT00552110|430788|P3|STARTED|Overall Study||139
174825|NCT00552110|430789|P2|STARTED|Overall Study||139
174826|NCT00552110|430790|P1|STARTED|Overall Study|One subject was excluded from the intent to treat population because there was no record of dosing.|146
174827|NCT00552175|430810|P3|NOT COMPLETED|Overall Study||14
174828|NCT00552175|430811|P2|NOT COMPLETED|Overall Study||13
174829|NCT00552175|430812|P1|NOT COMPLETED|Overall Study||17
174830|NCT00552175|430810|P3|COMPLETED|Overall Study||72
174831|NCT00552175|430811|P2|COMPLETED|Overall Study||73
174832|NCT00552175|430812|P1|COMPLETED|Overall Study||150
174833|NCT00552175|430810|P3|Full Analysis Set Population|Overall Study||86
174834|NCT00552175|430811|P2|Full Analysis Set Population|Overall Study||85
174835|NCT00552175|430812|P1|Full Analysis Set Population|Overall Study||167
174836|NCT00552175|430810|P3|STARTED|Overall Study||86
174837|NCT00552175|430811|P2|STARTED|Overall Study||86
174838|NCT00552175|430812|P1|STARTED|Overall Study||167
174839|NCT00552188|430849|P2|NOT COMPLETED|Overall Study||5
174840|NCT00552188|430850|P1|NOT COMPLETED|Overall Study||2
174841|NCT00552188|430849|P2|COMPLETED|Overall Study||21
174842|NCT00552188|430850|P1|COMPLETED|Overall Study||24
174843|NCT00552188|430849|P2|STARTED|Overall Study||26
174844|NCT00552188|430850|P1|STARTED|Overall Study||26
174845|NCT00552240|430860|P2|NOT COMPLETED|Overall Study||18
174846|NCT00552240|430861|P1|NOT COMPLETED|Overall Study||24
174847|NCT00552240|430860|P2|COMPLETED|Overall Study||59
174848|NCT00552240|430861|P1|COMPLETED|Overall Study||51
174849|NCT00552240|430860|P2|STARTED|Overall Study|Number in Full Analysis Set (FAS)|77
174850|NCT00552240|430861|P1|STARTED|Overall Study|Number in Full Analysis Set (FAS)|75
174851|NCT00552279|430963|P2|NOT COMPLETED|Overall Study||3
174852|NCT00552279|430964|P1|NOT COMPLETED|Overall Study||14
174853|NCT00552279|430963|P2|COMPLETED|Overall Study||398
174854|NCT00552279|430964|P1|COMPLETED|Overall Study||389
174855|NCT00552279|430963|P2|STARTED|Overall Study||401
174856|NCT00552279|430964|P1|STARTED|Overall Study||403
174857|NCT00552305|430988|P1|NOT COMPLETED|Overall Study||250
174858|NCT00552305|430988|P1|COMPLETED|Overall Study||120
174859|NCT00552305|430988|P1|STARTED|Overall Study||370
174860|NCT00552344|430996|P1|NOT COMPLETED|Overall Study||315
174861|NCT00552344|430996|P1|COMPLETED|Overall Study||87
174862|NCT00552344|430996|P1|STARTED|Overall Study||402
174863|NCT00552396|431012|P7|NOT COMPLETED|Overall Study||9
174864|NCT00552396|431013|P6|NOT COMPLETED|Overall Study||3
174865|NCT00552396|431014|P5|NOT COMPLETED|Overall Study||3
174866|NCT00552396|431015|P4|NOT COMPLETED|Overall Study||6
174867|NCT00552396|431016|P3|NOT COMPLETED|Overall Study||3
174868|NCT00552396|431017|P2|NOT COMPLETED|Overall Study||3
174869|NCT00552396|431018|P1|NOT COMPLETED|Overall Study||3
174870|NCT00552396|431012|P7|COMPLETED|Overall Study||1
174871|NCT00552396|431013|P6|COMPLETED|Overall Study||0
174872|NCT00552396|431014|P5|COMPLETED|Overall Study||0
174873|NCT00552396|431015|P4|COMPLETED|Overall Study||0
174874|NCT00552396|431016|P3|COMPLETED|Overall Study||0
174875|NCT00552396|431017|P2|COMPLETED|Overall Study||0
174876|NCT00552396|431018|P1|COMPLETED|Overall Study||1
174877|NCT00552396|431012|P7|STARTED|Overall Study||10
174878|NCT00552396|431013|P6|STARTED|Overall Study||3
174879|NCT00552396|431014|P5|STARTED|Overall Study||3
174880|NCT00552396|431015|P4|STARTED|Overall Study||6
174881|NCT00552396|431016|P3|STARTED|Overall Study||3
174882|NCT00552396|431017|P2|STARTED|Overall Study||3
174883|NCT00552396|431018|P1|STARTED|Overall Study||4
174884|NCT00552409|431057|P2|NOT COMPLETED|Overall Study||2
174885|NCT00552409|431058|P1|NOT COMPLETED|Overall Study||1
174886|NCT00552409|431057|P2|COMPLETED|Overall Study||9
174887|NCT00552409|431058|P1|COMPLETED|Overall Study||10
174888|NCT00552409|431057|P2|STARTED|Overall Study||11
174889|NCT00552409|431058|P1|STARTED|Overall Study||11
174890|NCT00552422|431064|P1|NOT COMPLETED|Overall Study||0
174891|NCT00552422|431064|P1|COMPLETED|Overall Study||6
174892|NCT00552422|431064|P1|STARTED|Overall Study||6
174893|NCT00552448|431070|P2|NOT COMPLETED|Overall Study||0
174894|NCT00552448|431071|P1|NOT COMPLETED|Overall Study||1
174895|NCT00552448|431070|P2|COMPLETED|Overall Study||16
174896|NCT00552448|431071|P1|COMPLETED|Overall Study||19
174897|NCT00552448|431070|P2|STARTED|Overall Study||16
174898|NCT00552448|431071|P1|STARTED|Overall Study||20
174899|NCT00552513|431085|P2|NOT COMPLETED|Overall Study||1
174900|NCT00552513|431086|P1|NOT COMPLETED|Overall Study||5
174901|NCT00552513|431085|P2|COMPLETED|Overall Study||1437
174902|NCT00552513|431086|P1|COMPLETED|Overall Study||1588
174903|NCT00552513|431085|P2|STARTED|Overall Study||1438
174904|NCT00552513|431086|P1|STARTED|Overall Study||1593
174905|NCT00552578|431098|P2|NOT COMPLETED|Overall Study||1
174906|NCT00552578|431099|P1|NOT COMPLETED|Overall Study||1
174907|NCT00552578|431098|P2|COMPLETED|Overall Study||5
174908|NCT00552578|431099|P1|COMPLETED|Overall Study||5
174909|NCT00552578|431098|P2|STARTED|Overall Study||6
174910|NCT00552578|431099|P1|STARTED|Overall Study||6
174911|NCT00552669|431111|P2|NOT COMPLETED|Overall Study||7
174912|NCT00552669|431112|P1|NOT COMPLETED|Overall Study||3
174913|NCT00552669|431111|P2|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|93
174914|NCT00552669|431112|P1|COMPLETED|Overall Study|All patients were followed for 18.3 +/- 7 months.|97
174915|NCT00552669|431111|P2|STARTED|Overall Study|patients|100
174916|NCT00552669|431112|P1|STARTED|Overall Study|patients|100
174917|NCT00552695|431124|P2|NOT COMPLETED|Overall Study||0
174918|NCT00552695|431125|P1|NOT COMPLETED|Overall Study||0
174919|NCT00552695|431124|P2|COMPLETED|Overall Study|September 2007|23
174920|NCT00552695|431125|P1|COMPLETED|Overall Study|September 2007|22
174921|NCT00552695|431124|P2|STARTED|Overall Study|August 2007|23
174922|NCT00552695|431125|P1|STARTED|Overall Study|August 2007|22
174923|NCT00552760|431135|P2|NOT COMPLETED|Overall Study||33
174924|NCT00552760|431136|P1|NOT COMPLETED|Overall Study||26
174925|NCT00552760|431135|P2|COMPLETED|Overall Study||8
174926|NCT00552760|431136|P1|COMPLETED|Overall Study||16
174927|NCT00552760|431135|P2|STARTED|Overall Study||41
174928|NCT00552760|431136|P1|STARTED|Overall Study||42
174929|NCT00552786|431152|P2|NOT COMPLETED|Second Intervention||0
174930|NCT00552786|431153|P1|NOT COMPLETED|Second Intervention||0
174931|NCT00552786|431152|P2|COMPLETED|Second Intervention||28
174932|NCT00552786|431153|P1|COMPLETED|Second Intervention||25
174933|NCT00552786|431152|P2|STARTED|Second Intervention||28
174934|NCT00552786|431153|P1|STARTED|Second Intervention||25
174935|NCT00552786|431152|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
174936|NCT00552786|431153|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
174937|NCT00552786|431152|P2|COMPLETED|Washout Period of 2 Weeks||28
174938|NCT00552786|431153|P1|COMPLETED|Washout Period of 2 Weeks||25
174939|NCT00552786|431152|P2|STARTED|Washout Period of 2 Weeks||28
174940|NCT00552786|431153|P1|STARTED|Washout Period of 2 Weeks||25
174941|NCT00552786|431152|P2|NOT COMPLETED|First Intervention||0
174942|NCT00552786|431153|P1|NOT COMPLETED|First Intervention||0
174943|NCT00552786|431152|P2|COMPLETED|First Intervention||28
174944|NCT00552786|431153|P1|COMPLETED|First Intervention||25
174945|NCT00552786|431152|P2|Medication and Hearing Evaluation|First Intervention||28
174946|NCT00552786|431153|P1|Medication and Hearing Evaluation|First Intervention||25
174947|NCT00552786|431152|P2|STARTED|First Intervention||28
174948|NCT00552786|431153|P1|STARTED|First Intervention||25
174949|NCT00552812|431161|P1|NOT COMPLETED|Overall Study||20
174950|NCT00552812|431161|P1|COMPLETED|Overall Study|Some still remain inside the 2 year follow up window. 2 year follow up data is not yet complete.|85
174951|NCT00552812|431161|P1|STARTED|Overall Study|168 consents, 57 failed cath criteria, 5 met criteria but received covered stent, 1 withdrew consent|105
174952|NCT00553098|431167|P1|NOT COMPLETED|Overall Study||1
174953|NCT00553098|431167|P1|COMPLETED|Overall Study||28
174954|NCT00553098|431167|P1|STARTED|Overall Study||29
174955|NCT00553150|431183|P4|NOT COMPLETED|Overall Study||4
174956|NCT00553150|431184|P3|NOT COMPLETED|Overall Study||0
174957|NCT00553150|431185|P2|NOT COMPLETED|Overall Study||0
174958|NCT00553150|431186|P1|NOT COMPLETED|Overall Study||0
174959|NCT00553150|431183|P4|COMPLETED|Overall Study||100
174960|NCT00553150|431184|P3|COMPLETED|Overall Study||6
174961|NCT00553150|431185|P2|COMPLETED|Overall Study||6
174962|NCT00553150|431186|P1|COMPLETED|Overall Study||6
174963|NCT00553150|431183|P4|STARTED|Overall Study||104
174964|NCT00553150|431184|P3|STARTED|Overall Study||6
174965|NCT00553150|431185|P2|STARTED|Overall Study||6
174966|NCT00553150|431186|P1|STARTED|Overall Study||6
174967|NCT00553202|431198|P1|NOT COMPLETED|Overall Study||68
174968|NCT00553202|431198|P1|COMPLETED|Overall Study||90
174969|NCT00553202|431198|P1|STARTED|Overall Study||158
174970|NCT00553267|431209|P3|NOT COMPLETED|Overall Study||10
174971|NCT00553267|431210|P2|NOT COMPLETED|Overall Study||18
174972|NCT00553267|431211|P1|NOT COMPLETED|Overall Study||14
174973|NCT00553267|431209|P3|COMPLETED|Overall Study||307
174974|NCT00553267|431210|P2|COMPLETED|Overall Study||297
174975|NCT00553267|431211|P1|COMPLETED|Overall Study||301
174976|NCT00553267|431209|P3|STARTED|Overall Study||317
174977|NCT00553267|431210|P2|STARTED|Overall Study||315
174978|NCT00553267|431211|P1|STARTED|Overall Study||315
174979|NCT00553280|431246|P1|NOT COMPLETED|Overall Study||26
174980|NCT00553280|431246|P1|COMPLETED|Overall Study||97
174981|NCT00553280|431246|P1|STARTED|Overall Study||123
174982|NCT00553319|431258|P3|NOT COMPLETED|Overall Study||9
174983|NCT00553319|431259|P2|NOT COMPLETED|Overall Study||10
174984|NCT00553319|431260|P1|NOT COMPLETED|Overall Study||14
174985|NCT00553319|431258|P3|COMPLETED|Overall Study||34
174986|NCT00553319|431259|P2|COMPLETED|Overall Study||30
174987|NCT00553319|431260|P1|COMPLETED|Overall Study||29
174988|NCT00553319|431258|P3|STARTED|Overall Study||43
174989|NCT00553319|431259|P2|STARTED|Overall Study||40
174990|NCT00553319|431260|P1|STARTED|Overall Study||43
174991|NCT00553332|431271|P1|NOT COMPLETED|Overall Study||1
174992|NCT00553332|431271|P1|COMPLETED|Overall Study|evaluable for response|28
174993|NCT00553332|431271|P1|STARTED|Overall Study||29
174994|NCT00553358|431283|P3|NOT COMPLETED|Overall Study||60
174995|NCT00553358|431284|P2|NOT COMPLETED|Overall Study||12
174996|NCT00553358|431285|P1|NOT COMPLETED|Overall Study||53
174997|NCT00553358|431283|P3|COMPLETED|Overall Study||92
174998|NCT00553358|431284|P2|COMPLETED|Overall Study||137
174999|NCT00553358|431285|P1|COMPLETED|Overall Study||101
175000|NCT00553358|431283|P3|STARTED|Overall Study||152
175001|NCT00553358|431284|P2|STARTED|Overall Study||149
175002|NCT00553358|431285|P1|STARTED|Overall Study||154
175003|NCT00553436|431311|P1|NOT COMPLETED|Overall Study||1
175004|NCT00553436|431311|P1|COMPLETED|Overall Study|09 April 2009|6
175005|NCT00553436|431311|P1|STARTED|Overall Study|20 August 2007|7
175006|NCT00553462|431317|P1|NOT COMPLETED|Overall Study||14
175007|NCT00553462|431317|P1|COMPLETED|Overall Study||61
175008|NCT00553462|431317|P1|STARTED|Overall Study||75
175009|NCT00553475|431326|P3|NOT COMPLETED|Overall Study||13
175010|NCT00553475|431327|P2|NOT COMPLETED|Overall Study||20
175011|NCT00553475|431328|P1|NOT COMPLETED|Overall Study||16
175012|NCT00553475|431326|P3|COMPLETED|Overall Study||32
175013|NCT00553475|431327|P2|COMPLETED|Overall Study||114
175014|NCT00553475|431328|P1|COMPLETED|Overall Study||119
175015|NCT00553475|431326|P3|STARTED|Overall Study||45
175016|NCT00553475|431327|P2|STARTED|Overall Study||134
175017|NCT00553475|431328|P1|STARTED|Overall Study||135
175018|NCT00553501|431450|P1|NOT COMPLETED|Overall Study||4
175019|NCT00553501|431450|P1|COMPLETED|Overall Study||55
175020|NCT00553501|431450|P1|STARTED|Overall Study||59
175021|NCT00553514|431461|P5|NOT COMPLETED|Overall Study||7
175022|NCT00553514|431462|P4|NOT COMPLETED|Overall Study||7
175023|NCT00553514|431463|P3|NOT COMPLETED|Overall Study||6
175024|NCT00553514|431464|P2|NOT COMPLETED|Overall Study||8
175025|NCT00553514|431465|P1|NOT COMPLETED|Overall Study||8
175026|NCT00553514|431461|P5|COMPLETED|Overall Study||8
175027|NCT00553514|431462|P4|COMPLETED|Overall Study||6
175028|NCT00553514|431463|P3|COMPLETED|Overall Study||9
175029|NCT00553514|431464|P2|COMPLETED|Overall Study||6
175030|NCT00553514|431465|P1|COMPLETED|Overall Study||6
175031|NCT00553514|431461|P5|STARTED|Overall Study||15
175032|NCT00553514|431462|P4|STARTED|Overall Study||13
175033|NCT00553514|431463|P3|STARTED|Overall Study||15
175034|NCT00553514|431464|P2|STARTED|Overall Study||14
175035|NCT00553514|431465|P1|STARTED|Overall Study||14
175036|NCT00553605|431504|P2|NOT COMPLETED|Overall Study||3
175037|NCT00553605|431505|P1|NOT COMPLETED|Overall Study||4
175038|NCT00553605|431504|P2|COMPLETED|Overall Study||161
175039|NCT00553605|431505|P1|COMPLETED|Overall Study||172
175040|NCT00553605|431504|P2|Treated|Overall Study||164
175041|NCT00553605|431505|P1|Treated|Overall Study||174
175042|NCT00553605|431504|P2|STARTED|Overall Study||164
175043|NCT00553605|431505|P1|STARTED|Overall Study||176
175044|NCT00561977|431532|P3|NOT COMPLETED|Overall Study||2
175045|NCT00561977|431533|P2|NOT COMPLETED|Overall Study||3
175046|NCT00561977|431534|P1|NOT COMPLETED|Overall Study||0
175047|NCT00561977|431532|P3|COMPLETED|Overall Study||10
175048|NCT00561977|431533|P2|COMPLETED|Overall Study||9
175049|NCT00561977|431534|P1|COMPLETED|Overall Study||12
175050|NCT00561977|431532|P3|STARTED|Overall Study||12
175051|NCT00561977|431533|P2|STARTED|Overall Study||12
175052|NCT00561977|431534|P1|STARTED|Overall Study||12
175053|NCT00562094|431557|P1|NOT COMPLETED|Overall Study||62
175054|NCT00562094|431557|P1|COMPLETED|Overall Study||8554
175055|NCT00562094|431557|P1|STARTED|Overall Study||8616
175056|NCT00562120|431569|P4|NOT COMPLETED|Fourth Intervention Period||0
175057|NCT00562120|431570|P3|NOT COMPLETED|Fourth Intervention Period||0
175058|NCT00562120|431571|P2|NOT COMPLETED|Fourth Intervention Period||0
175059|NCT00562120|431572|P1|NOT COMPLETED|Fourth Intervention Period||0
175060|NCT00562120|431569|P4|COMPLETED|Fourth Intervention Period||5
175061|NCT00562120|431570|P3|COMPLETED|Fourth Intervention Period||5
175062|NCT00562120|431571|P2|COMPLETED|Fourth Intervention Period||5
175063|NCT00562120|431572|P1|COMPLETED|Fourth Intervention Period||4
175064|NCT00562120|431569|P4|STARTED|Fourth Intervention Period||5
175065|NCT00562120|431570|P3|STARTED|Fourth Intervention Period||5
175066|NCT00562120|431571|P2|STARTED|Fourth Intervention Period||5
175067|NCT00562120|431572|P1|STARTED|Fourth Intervention Period||4
175068|NCT00562120|431569|P4|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
175069|NCT00562120|431570|P3|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
175070|NCT00562120|431571|P2|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
175071|NCT00562120|431572|P1|NOT COMPLETED|Washout Period 3 (At Least 14 Days)||0
175072|NCT00562120|431569|P4|COMPLETED|Washout Period 3 (At Least 14 Days)||5
175073|NCT00562120|431570|P3|COMPLETED|Washout Period 3 (At Least 14 Days)||5
175074|NCT00562120|431571|P2|COMPLETED|Washout Period 3 (At Least 14 Days)||5
175075|NCT00562120|431572|P1|COMPLETED|Washout Period 3 (At Least 14 Days)||4
175076|NCT00562120|431569|P4|STARTED|Washout Period 3 (At Least 14 Days)||5
175077|NCT00562120|431570|P3|STARTED|Washout Period 3 (At Least 14 Days)||5
175078|NCT00562120|431571|P2|STARTED|Washout Period 3 (At Least 14 Days)||5
175079|NCT00562120|431572|P1|STARTED|Washout Period 3 (At Least 14 Days)||4
175080|NCT00562120|431569|P4|NOT COMPLETED|Third Intervention Period||0
175081|NCT00562120|431570|P3|NOT COMPLETED|Third Intervention Period||0
175082|NCT00562120|431571|P2|NOT COMPLETED|Third Intervention Period||0
175083|NCT00562120|431572|P1|NOT COMPLETED|Third Intervention Period||0
175084|NCT00562120|431569|P4|COMPLETED|Third Intervention Period||5
175085|NCT00562120|431570|P3|COMPLETED|Third Intervention Period||5
175086|NCT00562120|431571|P2|COMPLETED|Third Intervention Period||5
175087|NCT00562120|431572|P1|COMPLETED|Third Intervention Period||4
175088|NCT00562120|431569|P4|STARTED|Third Intervention Period||5
175089|NCT00562120|431570|P3|STARTED|Third Intervention Period||5
175090|NCT00562120|431571|P2|STARTED|Third Intervention Period||5
175091|NCT00562120|431572|P1|STARTED|Third Intervention Period||4
175092|NCT00562120|431569|P4|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
175093|NCT00562120|431570|P3|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
175094|NCT00562120|431571|P2|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
175095|NCT00562120|431572|P1|NOT COMPLETED|Washout Period 2 (At Least 14 Days)||0
175096|NCT00562120|431569|P4|COMPLETED|Washout Period 2 (At Least 14 Days)||5
175097|NCT00562120|431570|P3|COMPLETED|Washout Period 2 (At Least 14 Days)||5
175098|NCT00562120|431571|P2|COMPLETED|Washout Period 2 (At Least 14 Days)||5
175099|NCT00562120|431572|P1|COMPLETED|Washout Period 2 (At Least 14 Days)||4
175100|NCT00562120|431569|P4|STARTED|Washout Period 2 (At Least 14 Days)||5
175101|NCT00562120|431570|P3|STARTED|Washout Period 2 (At Least 14 Days)||5
175102|NCT00562120|431571|P2|STARTED|Washout Period 2 (At Least 14 Days)||5
175103|NCT00562120|431572|P1|STARTED|Washout Period 2 (At Least 14 Days)||4
175104|NCT00562120|431569|P4|NOT COMPLETED|Second Intervention Period||0
175105|NCT00562120|431570|P3|NOT COMPLETED|Second Intervention Period||0
175106|NCT00562120|431571|P2|NOT COMPLETED|Second Intervention Period||0
175107|NCT00562120|431572|P1|NOT COMPLETED|Second Intervention Period||0
175108|NCT00562120|431569|P4|COMPLETED|Second Intervention Period||5
175109|NCT00562120|431570|P3|COMPLETED|Second Intervention Period||5
175110|NCT00562120|431571|P2|COMPLETED|Second Intervention Period||5
175111|NCT00562120|431572|P1|COMPLETED|Second Intervention Period||4
175112|NCT00562120|431569|P4|STARTED|Second Intervention Period||5
175113|NCT00562120|431570|P3|STARTED|Second Intervention Period||5
175114|NCT00562120|431571|P2|STARTED|Second Intervention Period||5
175115|NCT00562120|431572|P1|STARTED|Second Intervention Period||4
175116|NCT00562120|431569|P4|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
175117|NCT00562120|431570|P3|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
175118|NCT00562120|431571|P2|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
175119|NCT00562120|431572|P1|NOT COMPLETED|Washout Period 1 (At Least 14 Days)||0
175120|NCT00562120|431569|P4|COMPLETED|Washout Period 1 (At Least 14 Days)||5
175121|NCT00562120|431570|P3|COMPLETED|Washout Period 1 (At Least 14 Days)||5
175122|NCT00562120|431571|P2|COMPLETED|Washout Period 1 (At Least 14 Days)||5
175123|NCT00562120|431572|P1|COMPLETED|Washout Period 1 (At Least 14 Days)||4
175124|NCT00562120|431569|P4|STARTED|Washout Period 1 (At Least 14 Days)||5
175125|NCT00562120|431570|P3|STARTED|Washout Period 1 (At Least 14 Days)||5
175126|NCT00562120|431571|P2|STARTED|Washout Period 1 (At Least 14 Days)||5
175127|NCT00562120|431572|P1|STARTED|Washout Period 1 (At Least 14 Days)||4
175128|NCT00562120|431569|P4|NOT COMPLETED|First Intervention Period||0
175129|NCT00562120|431570|P3|NOT COMPLETED|First Intervention Period||0
175130|NCT00562120|431571|P2|NOT COMPLETED|First Intervention Period||0
175131|NCT00562120|431572|P1|NOT COMPLETED|First Intervention Period||2
175132|NCT00562120|431569|P4|COMPLETED|First Intervention Period||5
175133|NCT00562120|431570|P3|COMPLETED|First Intervention Period||5
175134|NCT00562120|431571|P2|COMPLETED|First Intervention Period||5
175135|NCT00562120|431572|P1|COMPLETED|First Intervention Period||4
175136|NCT00562120|431569|P4|Treated|First Intervention Period||5
175137|NCT00562120|431570|P3|Treated|First Intervention Period||5
175138|NCT00562120|431571|P2|Treated|First Intervention Period||5
175139|NCT00562120|431572|P1|Treated|First Intervention Period||5
175140|NCT00562120|431569|P4|STARTED|First Intervention Period||5
175141|NCT00562120|431570|P3|STARTED|First Intervention Period||5
175142|NCT00562120|431571|P2|STARTED|First Intervention Period||5
175143|NCT00562120|431572|P1|STARTED|First Intervention Period||6
175144|NCT00562159|431606|P2|NOT COMPLETED|Overall Study||33
175145|NCT00562159|431607|P1|NOT COMPLETED|Overall Study||38
175146|NCT00562159|431606|P2|COMPLETED|Overall Study||192
175147|NCT00562159|431607|P1|COMPLETED|Overall Study||175
175148|NCT00562159|431606|P2|STARTED|Overall Study||225
175149|NCT00562159|431607|P1|STARTED|Overall Study||213
175150|NCT00562302|431621|P2|NOT COMPLETED|Overall Study||32
175151|NCT00562302|431622|P1|NOT COMPLETED|Overall Study||20
175152|NCT00562302|431621|P2|COMPLETED|Overall Study||137
175153|NCT00562302|431622|P1|COMPLETED|Overall Study||150
175154|NCT00562302|431621|P2|STARTED|Overall Study||169
175155|NCT00562302|431622|P1|STARTED|Overall Study||170
175156|NCT00562861|431644|P2|NOT COMPLETED|Overall Study||11
175157|NCT00562861|431645|P1|NOT COMPLETED|Overall Study||20
175158|NCT00562861|431644|P2|COMPLETED|Overall Study||48
175159|NCT00562861|431645|P1|COMPLETED|Overall Study||40
175160|NCT00562861|431644|P2|STARTED|Overall Study||59
175161|NCT00562861|431645|P1|STARTED|Overall Study||60
175162|NCT00563290|431653|P2|NOT COMPLETED|Overall Study||0
175163|NCT00563290|431654|P1|NOT COMPLETED|Overall Study||0
175164|NCT00563290|431653|P2|COMPLETED|Overall Study||4
175165|NCT00563290|431654|P1|COMPLETED|Overall Study||3
175166|NCT00563290|431653|P2|STARTED|Overall Study||4
175167|NCT00563290|431654|P1|STARTED|Overall Study||3
175168|NCT00563316|431663|P1|NOT COMPLETED|Overall Study||12
175169|NCT00563316|431663|P1|COMPLETED|Overall Study||16
175170|NCT00563316|431663|P1|Received Investigational Product|Overall Study||27
175171|NCT00563316|431663|P1|STARTED|Overall Study||28
175172|NCT00563368|431681|P7|NOT COMPLETED|Overall Study||33
175173|NCT00563368|431682|P6|NOT COMPLETED|Overall Study||30
175174|NCT00563368|431683|P5|NOT COMPLETED|Overall Study||28
175175|NCT00563368|431684|P4|NOT COMPLETED|Overall Study||29
175176|NCT00563368|431685|P3|NOT COMPLETED|Overall Study||30
175177|NCT00563368|431686|P2|NOT COMPLETED|Overall Study||30
175178|NCT00563368|431687|P1|NOT COMPLETED|Overall Study||35
175179|NCT00563368|431681|P7|COMPLETED|Overall Study||75
175180|NCT00563368|431682|P6|COMPLETED|Overall Study||77
175181|NCT00563368|431683|P5|COMPLETED|Overall Study||80
175182|NCT00563368|431684|P4|COMPLETED|Overall Study||78
175183|NCT00563368|431685|P3|COMPLETED|Overall Study||78
175184|NCT00563368|431686|P2|COMPLETED|Overall Study||79
175185|NCT00563368|431687|P1|COMPLETED|Overall Study||74
175186|NCT00563368|431681|P7|STARTED|Overall Study||108
175187|NCT00563368|431682|P6|STARTED|Overall Study||107
175188|NCT00563368|431683|P5|STARTED|Overall Study||108
175189|NCT00563368|431684|P4|STARTED|Overall Study||107
175190|NCT00563368|431685|P3|STARTED|Overall Study||108
175191|NCT00563368|431686|P2|STARTED|Overall Study||109
175192|NCT00563368|431687|P1|STARTED|Overall Study||109
175193|NCT00563381|431712|P2|NOT COMPLETED|Overall Study||648
175194|NCT00563381|431713|P1|NOT COMPLETED|Overall Study||585
175195|NCT00563381|431712|P2|COMPLETED|Overall Study|Completed treatment|3021
175196|NCT00563381|431713|P1|COMPLETED|Overall Study|Completed treatment|3122
175197|NCT00563381|431712|P2|STARTED|Overall Study|Started treatment|3669
175198|NCT00563381|431713|P1|STARTED|Overall Study|Started treatment|3707
175199|NCT00563576|431781|P2|NOT COMPLETED|Overall Study||14
175200|NCT00563576|431782|P1|NOT COMPLETED|Overall Study||14
175201|NCT00563576|431781|P2|COMPLETED|Overall Study||22
175202|NCT00563576|431782|P1|COMPLETED|Overall Study||21
175203|NCT00563576|431781|P2|STARTED|Overall Study||36
175204|NCT00563576|431782|P1|STARTED|Overall Study||35
175205|NCT00563706|431801|P9|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175206|NCT00563706|431802|P8|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175207|NCT00563706|431803|P7|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175208|NCT00563706|431804|P6|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175209|NCT00563706|431805|P5|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175210|NCT00563706|431806|P4|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175211|NCT00563706|431807|P3|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175212|NCT00563706|431808|P2|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175213|NCT00563706|431809|P1|NOT COMPLETED|Taper Phase (Day 29 up to Day 35)||0
175214|NCT00563706|431801|P9|COMPLETED|Taper Phase (Day 29 up to Day 35)||32
175215|NCT00563706|431802|P8|COMPLETED|Taper Phase (Day 29 up to Day 35)||16
175216|NCT00563706|431803|P7|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
175217|NCT00563706|431804|P6|COMPLETED|Taper Phase (Day 29 up to Day 35)||14
175218|NCT00563706|431805|P5|COMPLETED|Taper Phase (Day 29 up to Day 35)||11
175219|NCT00563706|431806|P4|COMPLETED|Taper Phase (Day 29 up to Day 35)||9
175220|NCT00563706|431807|P3|COMPLETED|Taper Phase (Day 29 up to Day 35)||3
175221|NCT00563706|431808|P2|COMPLETED|Taper Phase (Day 29 up to Day 35)||13
175222|NCT00563706|431809|P1|COMPLETED|Taper Phase (Day 29 up to Day 35)||20
175223|NCT00563706|431801|P9|STARTED|Taper Phase (Day 29 up to Day 35)||32
175224|NCT00563706|431802|P8|STARTED|Taper Phase (Day 29 up to Day 35)||16
175225|NCT00563706|431803|P7|STARTED|Taper Phase (Day 29 up to Day 35)||9
175226|NCT00563706|431804|P6|STARTED|Taper Phase (Day 29 up to Day 35)||14
175227|NCT00563706|431805|P5|STARTED|Taper Phase (Day 29 up to Day 35)||11
175228|NCT00563706|431806|P4|STARTED|Taper Phase (Day 29 up to Day 35)||9
175229|NCT00563706|431807|P3|STARTED|Taper Phase (Day 29 up to Day 35)||3
175230|NCT00563706|431808|P2|STARTED|Taper Phase (Day 29 up to Day 35)||13
175231|NCT00563706|431809|P1|STARTED|Taper Phase (Day 29 up to Day 35)||20
175232|NCT00563706|431801|P9|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
175233|NCT00563706|431802|P8|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
175234|NCT00563706|431803|P7|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
175235|NCT00563706|431804|P6|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
175236|NCT00563706|431805|P5|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
175237|NCT00563706|431806|P4|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||10
175238|NCT00563706|431807|P3|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
175239|NCT00563706|431808|P2|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||5
175240|NCT00563706|431809|P1|NOT COMPLETED|DB Treatment Period (Day 1 up to Day 28)||17
175241|NCT00563706|431801|P9|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||32
175242|NCT00563706|431802|P8|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||16
175330|NCT00564681|432034|P2|STARTED|Overall Study||61
175243|NCT00563706|431803|P7|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
175244|NCT00563706|431804|P6|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||14
175245|NCT00563706|431805|P5|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||11
175246|NCT00563706|431806|P4|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||9
175247|NCT00563706|431807|P3|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||3
175248|NCT00563706|431808|P2|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||13
175249|NCT00563706|431809|P1|COMPLETED|DB Treatment Period (Day 1 up to Day 28)||20
175250|NCT00563706|431801|P9|STARTED|DB Treatment Period (Day 1 up to Day 28)||43
175251|NCT00563706|431802|P8|STARTED|DB Treatment Period (Day 1 up to Day 28)||30
175252|NCT00563706|431803|P7|STARTED|DB Treatment Period (Day 1 up to Day 28)||12
175253|NCT00563706|431804|P6|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
175254|NCT00563706|431805|P5|STARTED|DB Treatment Period (Day 1 up to Day 28)||16
175255|NCT00563706|431806|P4|STARTED|DB Treatment Period (Day 1 up to Day 28)||19
175256|NCT00563706|431807|P3|STARTED|DB Treatment Period (Day 1 up to Day 28)||8
175257|NCT00563706|431808|P2|STARTED|DB Treatment Period (Day 1 up to Day 28)||18
175258|NCT00563706|431809|P1|STARTED|DB Treatment Period (Day 1 up to Day 28)||37
175259|NCT00563797|431912|P2|NOT COMPLETED|Overall Study||2
175260|NCT00563797|431913|P1|NOT COMPLETED|Overall Study||7
175261|NCT00563797|431912|P2|COMPLETED|Overall Study||8
175262|NCT00563797|431913|P1|COMPLETED|Overall Study||4
175263|NCT00563797|431912|P2|Follow-Up|Overall Study||10
175264|NCT00563797|431913|P1|Follow-Up|Overall Study||11
175265|NCT00563797|431912|P2|Received Allocated Intervention|Overall Study||10
175266|NCT00563797|431913|P1|Received Allocated Intervention|Overall Study||11
175267|NCT00563797|431912|P2|STARTED|Overall Study||10
175268|NCT00563797|431913|P1|STARTED|Overall Study||11
175269|NCT00564265|431925|P1|NOT COMPLETED|Overall Study||0
175270|NCT00564265|431925|P1|COMPLETED|Overall Study||24
175271|NCT00564265|431925|P1|STARTED|Overall Study||24
175272|NCT00564278|431931|P2|NOT COMPLETED|Overall Study||42
175273|NCT00564278|431932|P1|NOT COMPLETED|Overall Study||47
175274|NCT00564278|431931|P2|COMPLETED|Overall Study||56
175275|NCT00564278|431932|P1|COMPLETED|Overall Study||50
175276|NCT00564278|431931|P2|STARTED|Overall Study||98
175277|NCT00564278|431932|P1|STARTED|Overall Study||97
175278|NCT00564447|431956|P8|NOT COMPLETED|Overall Study||0
175279|NCT00564447|431957|P7|NOT COMPLETED|Overall Study||0
175280|NCT00564447|431958|P6|NOT COMPLETED|Overall Study||0
175281|NCT00564447|431959|P5|NOT COMPLETED|Overall Study||0
175282|NCT00564447|431960|P4|NOT COMPLETED|Overall Study||0
175283|NCT00564447|431961|P3|NOT COMPLETED|Overall Study||0
175284|NCT00564447|431962|P2|NOT COMPLETED|Overall Study||0
175285|NCT00564447|431963|P1|NOT COMPLETED|Overall Study||0
175286|NCT00564447|431956|P8|COMPLETED|Overall Study||6
175287|NCT00564447|431957|P7|COMPLETED|Overall Study||6
175288|NCT00564447|431958|P6|COMPLETED|Overall Study||6
175289|NCT00564447|431959|P5|COMPLETED|Overall Study||6
175290|NCT00564447|431960|P4|COMPLETED|Overall Study||6
175291|NCT00564447|431961|P3|COMPLETED|Overall Study||6
175292|NCT00564447|431962|P2|COMPLETED|Overall Study||6
175293|NCT00564447|431963|P1|COMPLETED|Overall Study||6
175294|NCT00564447|431956|P8|STARTED|Overall Study||6
175295|NCT00564447|431957|P7|STARTED|Overall Study||6
175296|NCT00564447|431958|P6|STARTED|Overall Study||6
175297|NCT00564447|431959|P5|STARTED|Overall Study||6
175298|NCT00564447|431960|P4|STARTED|Overall Study||6
175299|NCT00564447|431961|P3|STARTED|Overall Study||6
175300|NCT00564447|431962|P2|STARTED|Overall Study||6
175301|NCT00564447|431963|P1|STARTED|Overall Study||6
175302|NCT00564486|431984|P4|NOT COMPLETED|Overall Study||7
175303|NCT00564486|431985|P3|NOT COMPLETED|Overall Study||3
175304|NCT00564486|431986|P2|NOT COMPLETED|Overall Study||1
175305|NCT00564486|431987|P1|NOT COMPLETED|Overall Study||7
175306|NCT00564486|431984|P4|COMPLETED|Overall Study||60
175307|NCT00564486|431985|P3|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|39
175308|NCT00564486|431986|P2|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|91
175309|NCT00564486|431987|P1|COMPLETED|Overall Study|Includes all subjects who returned to clinic for Day 7 visit.|36
175310|NCT00564486|431984|P4|STARTED|Overall Study||67
175311|NCT00564486|431985|P3|STARTED|Overall Study|One subject randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|42
175312|NCT00564486|431986|P2|STARTED|Overall Study|One subject was randomized to receive 1 g IVAPAP but was administered 650 mg IV in error|92
175313|NCT00564486|431987|P1|STARTED|Overall Study||43
175314|NCT00564629|432005|P2|NOT COMPLETED|Overall Study||9
175315|NCT00564629|432006|P1|NOT COMPLETED|Overall Study||15
175316|NCT00564629|432005|P2|COMPLETED|Overall Study||45
175317|NCT00564629|432006|P1|COMPLETED|Overall Study||36
175318|NCT00564629|432005|P2|STARTED|Overall Study||54
175319|NCT00564629|432006|P1|STARTED|Overall Study||51
175320|NCT00564681|432032|P4|NOT COMPLETED|Overall Study||2
175321|NCT00564681|432033|P3|NOT COMPLETED|Overall Study||3
175322|NCT00564681|432034|P2|NOT COMPLETED|Overall Study||3
175323|NCT00564681|432035|P1|NOT COMPLETED|Overall Study||11
175324|NCT00564681|432032|P4|COMPLETED|Overall Study||19
175325|NCT00564681|432033|P3|COMPLETED|Overall Study||40
175326|NCT00564681|432034|P2|COMPLETED|Overall Study||58
175327|NCT00564681|432035|P1|COMPLETED|Overall Study||106
175328|NCT00564681|432032|P4|STARTED|Overall Study||21
175329|NCT00564681|432033|P3|STARTED|Overall Study||43
175331|NCT00564681|432035|P1|STARTED|Overall Study||117
175332|NCT00564733|432056|P1|NOT COMPLETED|Overall Study||9
175333|NCT00564733|432056|P1|COMPLETED|Overall Study||46
175334|NCT00564733|432056|P1|STARTED|Overall Study||55
175335|NCT00564850|432060|P1|NOT COMPLETED|Overall Study||2
175336|NCT00564850|432060|P1|COMPLETED|Overall Study||35
175337|NCT00564850|432060|P1|STARTED|Overall Study||37
175338|NCT00564876|432078|P1|NOT COMPLETED|Overall Study||0
175339|NCT00564876|432078|P1|COMPLETED|Overall Study||2
175340|NCT00564876|432078|P1|STARTED|Overall Study||2
175341|NCT00564889|432085|P1|NOT COMPLETED|Overall Study||29
175342|NCT00564889|432085|P1|COMPLETED|Overall Study||6
175343|NCT00564889|432085|P1|STARTED|Overall Study||35
175344|NCT00564902|432096|P3|NOT COMPLETED|Overall Study||4
175345|NCT00564902|432097|P2|NOT COMPLETED|Overall Study||4
175346|NCT00564902|432098|P1|NOT COMPLETED|Overall Study||1
175347|NCT00564902|432096|P3|COMPLETED|Overall Study||21
175348|NCT00564902|432097|P2|COMPLETED|Overall Study||21
175349|NCT00564902|432098|P1|COMPLETED|Overall Study||9
175350|NCT00564902|432096|P3|12 Months|Overall Study||21
175351|NCT00564902|432097|P2|12 Months|Overall Study||21
175352|NCT00564902|432098|P1|12 Months|Overall Study||9
175353|NCT00564902|432096|P3|8 Months|Overall Study||21
175354|NCT00564902|432097|P2|8 Months|Overall Study||22
175355|NCT00564902|432098|P1|8 Months|Overall Study||9
175356|NCT00564902|432096|P3|4 Months|Overall Study||23
175357|NCT00564902|432097|P2|4 Months|Overall Study||24
175358|NCT00564902|432098|P1|4 Months|Overall Study||9
175359|NCT00564902|432096|P3|STARTED|Overall Study||25
175360|NCT00564902|432097|P2|STARTED|Overall Study||25
175361|NCT00564902|432098|P1|STARTED|Overall Study||10
175362|NCT00564954|432132|P2|NOT COMPLETED|Period 2- 1 Week||0
175363|NCT00564954|432133|P1|NOT COMPLETED|Period 2- 1 Week||0
175364|NCT00564954|432132|P2|COMPLETED|Period 2- 1 Week||42
175365|NCT00564954|432133|P1|COMPLETED|Period 2- 1 Week||44
175366|NCT00564954|432132|P2|STARTED|Period 2- 1 Week||42
175367|NCT00564954|432133|P1|STARTED|Period 2- 1 Week||44
175368|NCT00564954|432132|P2|NOT COMPLETED|Period 1- 1 Week||0
175369|NCT00564954|432133|P1|NOT COMPLETED|Period 1- 1 Week||0
175370|NCT00564954|432132|P2|COMPLETED|Period 1- 1 Week||42
175371|NCT00564954|432133|P1|COMPLETED|Period 1- 1 Week||44
175372|NCT00564954|432132|P2|STARTED|Period 1- 1 Week||42
175373|NCT00564954|432133|P1|STARTED|Period 1- 1 Week||44
175374|NCT00565045|432151|P2|NOT COMPLETED|Overall Study||3
175375|NCT00565045|432152|P1|NOT COMPLETED|Overall Study||1
175376|NCT00565045|432151|P2|COMPLETED|Overall Study||8
175377|NCT00565045|432152|P1|COMPLETED|Overall Study||9
175378|NCT00565045|432151|P2|STARTED|Overall Study||11
175379|NCT00565045|432152|P1|STARTED|Overall Study||10
175380|NCT00565058|432168|P2|NOT COMPLETED|Overall Study||0
175381|NCT00565058|432169|P1|NOT COMPLETED|Overall Study||1
175382|NCT00565058|432168|P2|COMPLETED|Overall Study||15
175383|NCT00565058|432169|P1|COMPLETED|Overall Study||9
175384|NCT00565058|432168|P2|STARTED|Overall Study||15
175385|NCT00565058|432169|P1|STARTED|Overall Study||10
175386|NCT00565084|432177|P3|NOT COMPLETED|Third Treatment Period||0
175387|NCT00565084|432178|P2|NOT COMPLETED|Third Treatment Period||0
175388|NCT00565084|432179|P1|NOT COMPLETED|Third Treatment Period||0
175389|NCT00565084|432177|P3|COMPLETED|Third Treatment Period||11
175390|NCT00565084|432178|P2|COMPLETED|Third Treatment Period||11
175391|NCT00565084|432179|P1|COMPLETED|Third Treatment Period||11
175392|NCT00565084|432177|P3|STARTED|Third Treatment Period||11
175393|NCT00565084|432178|P2|STARTED|Third Treatment Period||11
175394|NCT00565084|432179|P1|STARTED|Third Treatment Period||11
175395|NCT00565084|432177|P3|NOT COMPLETED|Second Treatment Period||0
175396|NCT00565084|432178|P2|NOT COMPLETED|Second Treatment Period||0
175397|NCT00565084|432179|P1|NOT COMPLETED|Second Treatment Period||0
175398|NCT00565084|432177|P3|COMPLETED|Second Treatment Period||11
175399|NCT00565084|432178|P2|COMPLETED|Second Treatment Period||11
175400|NCT00565084|432179|P1|COMPLETED|Second Treatment Period||11
175401|NCT00565084|432177|P3|STARTED|Second Treatment Period||11
175402|NCT00565084|432178|P2|STARTED|Second Treatment Period||11
175403|NCT00565084|432179|P1|STARTED|Second Treatment Period||11
175404|NCT00565084|432177|P3|NOT COMPLETED|First Treatment Period||0
175405|NCT00565084|432178|P2|NOT COMPLETED|First Treatment Period||0
175406|NCT00565084|432179|P1|NOT COMPLETED|First Treatment Period||0
175407|NCT00565084|432177|P3|COMPLETED|First Treatment Period||11
175408|NCT00565084|432178|P2|COMPLETED|First Treatment Period||11
175409|NCT00565084|432179|P1|COMPLETED|First Treatment Period||11
175410|NCT00565084|432177|P3|STARTED|First Treatment Period||11
175411|NCT00565084|432178|P2|STARTED|First Treatment Period||11
175412|NCT00565084|432179|P1|STARTED|First Treatment Period||11
175413|NCT00565110|432189|P2|NOT COMPLETED|Overall Study||131
175414|NCT00565110|432190|P1|NOT COMPLETED|Overall Study||131
175415|NCT00565110|432189|P2|COMPLETED|Overall Study||111
175416|NCT00565110|432190|P1|COMPLETED|Overall Study||99
175417|NCT00565110|432189|P2|12-Month|Overall Study||144
175418|NCT00565110|432190|P1|12-Month|Overall Study||114
175419|NCT00565110|432189|P2|STARTED|Overall Study||242
175420|NCT00565110|432190|P1|STARTED|Overall Study||230
175421|NCT00565136|432198|P1|NOT COMPLETED|Overall Study||3
175422|NCT00565136|432198|P1|COMPLETED|Overall Study||26
175423|NCT00565136|432198|P1|STARTED|Overall Study||29
175424|NCT00565266|432216|P1|NOT COMPLETED|Overall Study||36
175425|NCT00565266|432216|P1|COMPLETED|Overall Study||174
175426|NCT00565266|432216|P1|STARTED|Overall Study||210
175427|NCT00556894|432227|P3|NOT COMPLETED|Overall Study||19
175428|NCT00556894|432228|P2|NOT COMPLETED|Overall Study||19
175429|NCT00556894|432229|P1|NOT COMPLETED|Overall Study||16
175430|NCT00556894|432227|P3|COMPLETED|Overall Study||65
175431|NCT00556894|432228|P2|COMPLETED|Overall Study||68
175432|NCT00556894|432229|P1|COMPLETED|Overall Study||66
175433|NCT00556894|432227|P3|STARTED|Overall Study||84
175434|NCT00556894|432228|P2|STARTED|Overall Study||87
175435|NCT00556894|432229|P1|STARTED|Overall Study||82
175436|NCT00556933|432241|P4|NOT COMPLETED|CNI Withdrawal vs. Minimization||2
175437|NCT00556933|432242|P3|NOT COMPLETED|CNI Withdrawal vs. Minimization||3
175438|NCT00556933|432243|P2|NOT COMPLETED|CNI Withdrawal vs. Minimization||4
175439|NCT00556933|432244|P1|NOT COMPLETED|CNI Withdrawal vs. Minimization||1
175440|NCT00556933|432241|P4|COMPLETED|CNI Withdrawal vs. Minimization||41
175441|NCT00556933|432242|P3|COMPLETED|CNI Withdrawal vs. Minimization||36
175442|NCT00556933|432243|P2|COMPLETED|CNI Withdrawal vs. Minimization||33
175443|NCT00556933|432244|P1|COMPLETED|CNI Withdrawal vs. Minimization||42
175444|NCT00556933|432241|P4|STARTED|CNI Withdrawal vs. Minimization||43
175445|NCT00556933|432242|P3|STARTED|CNI Withdrawal vs. Minimization||39
175446|NCT00556933|432243|P2|STARTED|CNI Withdrawal vs. Minimization||37
175447|NCT00556933|432244|P1|STARTED|CNI Withdrawal vs. Minimization||43
175448|NCT00556933|432241|P4|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
175449|NCT00556933|432242|P3|NOT COMPLETED|Single vs. Divided-dose rATG Induction||6
175450|NCT00556933|432243|P2|NOT COMPLETED|Single vs. Divided-dose rATG Induction||8
175451|NCT00556933|432244|P1|NOT COMPLETED|Single vs. Divided-dose rATG Induction||2
175452|NCT00556933|432241|P4|COMPLETED|Single vs. Divided-dose rATG Induction||43
175453|NCT00556933|432242|P3|COMPLETED|Single vs. Divided-dose rATG Induction||39
175454|NCT00556933|432243|P2|COMPLETED|Single vs. Divided-dose rATG Induction||37
175455|NCT00556933|432244|P1|COMPLETED|Single vs. Divided-dose rATG Induction||43
175456|NCT00556933|432241|P4|STARTED|Single vs. Divided-dose rATG Induction||45
175457|NCT00556933|432242|P3|STARTED|Single vs. Divided-dose rATG Induction||45
175458|NCT00556933|432243|P2|STARTED|Single vs. Divided-dose rATG Induction||45
175459|NCT00556933|432244|P1|STARTED|Single vs. Divided-dose rATG Induction||45
175460|NCT00556946|432298|P1|NOT COMPLETED|Overall Study||1
175461|NCT00556946|432298|P1|COMPLETED|Overall Study||16
175462|NCT00556946|432298|P1|STARTED|Overall Study||17
175463|NCT00556972|432302|P1|NOT COMPLETED|Overall Study||0
175464|NCT00556972|432302|P1|COMPLETED|Overall Study||4
175465|NCT00556972|432302|P1|STARTED|Overall Study||4
175466|NCT00556998|432309|P1|NOT COMPLETED|Voriconazole Oral||2
175467|NCT00556998|432309|P1|COMPLETED|Voriconazole Oral||20
175468|NCT00556998|432309|P1|STARTED|Voriconazole Oral|One participant received voriconazole 150 mg every 12 hours during oral phase.|22
175469|NCT00556998|432309|P1|NOT COMPLETED|Voriconazole Intravenous (IV)||5
175470|NCT00556998|432309|P1|COMPLETED|Voriconazole Intravenous (IV)|One participant received 2 days of oral; then received IV again before discontinuing from study.|21
175471|NCT00556998|432309|P1|Treated|Voriconazole Intravenous (IV)||26
175472|NCT00556998|432309|P1|STARTED|Voriconazole Intravenous (IV)||26
175473|NCT00557076|432331|P2|NOT COMPLETED|Overall Study||1
175474|NCT00557076|432332|P1|NOT COMPLETED|Overall Study||0
175475|NCT00557076|432331|P2|COMPLETED|Overall Study|One participant was withdrawn due to unblinding|7
175476|NCT00557076|432332|P1|COMPLETED|Overall Study||8
175477|NCT00557076|432331|P2|STARTED|Overall Study||8
175478|NCT00557076|432332|P1|STARTED|Overall Study||8
175479|NCT00557245|432343|P3|NOT COMPLETED|Overall Study||12
175480|NCT00557245|432344|P2|NOT COMPLETED|Overall Study||12
175481|NCT00557245|432345|P1|NOT COMPLETED|Overall Study||12
175482|NCT00557245|432343|P3|COMPLETED|Overall Study||1574
175483|NCT00557245|432344|P2|COMPLETED|Overall Study||1571
175484|NCT00557245|432345|P1|COMPLETED|Overall Study||1577
175485|NCT00557245|432343|P3|STARTED|Overall Study||1586
175486|NCT00557245|432344|P2|STARTED|Overall Study||1583
175487|NCT00557245|432345|P1|STARTED|Overall Study||1589
175488|NCT00557284|432385|P2|NOT COMPLETED|Overall Study||0
175489|NCT00557284|432386|P1|NOT COMPLETED|Overall Study||0
175490|NCT00557284|432385|P2|COMPLETED|Overall Study||11
175491|NCT00557284|432386|P1|COMPLETED|Overall Study||9
175492|NCT00557284|432385|P2|STARTED|Overall Study||11
175493|NCT00557284|432386|P1|STARTED|Overall Study||9
175494|NCT00557310|432406|P1|NOT COMPLETED|Extension Phase (18 - 24 Months)||5
175495|NCT00557310|432406|P1|COMPLETED|Extension Phase (18 - 24 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|25
175496|NCT00557310|432406|P1|STARTED|Extension Phase (18 - 24 Months)||30
175497|NCT00557310|432406|P1|NOT COMPLETED|Main Study (0 - 18 Months)||5
175498|NCT00557310|432406|P1|COMPLETED|Main Study (0 - 18 Months)|One had a metal hip implant, a protocol violation, and was excluded from efficacy analyses.|30
175499|NCT00557310|432406|P1|STARTED|Main Study (0 - 18 Months)||35
175500|NCT00557323|432426|P1|NOT COMPLETED|Overall Study||7
175501|NCT00557323|432426|P1|COMPLETED|Overall Study||27
175502|NCT00557323|432426|P1|STARTED|Overall Study||34
175503|NCT00557349|432433|P2|NOT COMPLETED|Overall Study||5
175504|NCT00557349|432434|P1|NOT COMPLETED|Overall Study||5
175505|NCT00557349|432433|P2|COMPLETED|Overall Study||13
175506|NCT00557349|432434|P1|COMPLETED|Overall Study||17
175507|NCT00557349|432433|P2|STARTED|Overall Study||18
175508|NCT00557349|432434|P1|STARTED|Overall Study|omeprazole/bicarb|22
175509|NCT00557362|432446|P4|NOT COMPLETED|Overall Study||3
175510|NCT00557362|432447|P3|NOT COMPLETED|Overall Study||4
175511|NCT00557362|432448|P2|NOT COMPLETED|Overall Study||2
175512|NCT00557362|432449|P1|NOT COMPLETED|Overall Study||2
175513|NCT00557362|432446|P4|COMPLETED|Overall Study||27
175514|NCT00557362|432447|P3|COMPLETED|Overall Study||26
175515|NCT00557362|432448|P2|COMPLETED|Overall Study||28
175516|NCT00557362|432449|P1|COMPLETED|Overall Study||28
175517|NCT00557362|432446|P4|STARTED|Overall Study||30
175518|NCT00557362|432447|P3|STARTED|Overall Study||30
175519|NCT00557362|432448|P2|STARTED|Overall Study||30
175520|NCT00557362|432449|P1|STARTED|Overall Study||30
175521|NCT00557440|432468|P3|NOT COMPLETED|Treatment Period 3||0
175522|NCT00557440|432469|P2|NOT COMPLETED|Treatment Period 3||0
175523|NCT00557440|432470|P1|NOT COMPLETED|Treatment Period 3||0
175524|NCT00557440|432468|P3|COMPLETED|Treatment Period 3||12
175525|NCT00557440|432469|P2|COMPLETED|Treatment Period 3||12
175526|NCT00557440|432470|P1|COMPLETED|Treatment Period 3||12
175527|NCT00557440|432468|P3|STARTED|Treatment Period 3||12
175528|NCT00557440|432469|P2|STARTED|Treatment Period 3||12
175529|NCT00557440|432470|P1|STARTED|Treatment Period 3||12
175530|NCT00557440|432468|P3|NOT COMPLETED|Treatment Period 2||0
175531|NCT00557440|432469|P2|NOT COMPLETED|Treatment Period 2||0
175532|NCT00557440|432470|P1|NOT COMPLETED|Treatment Period 2||0
175533|NCT00557440|432468|P3|COMPLETED|Treatment Period 2||12
175534|NCT00557440|432469|P2|COMPLETED|Treatment Period 2||12
175535|NCT00557440|432470|P1|COMPLETED|Treatment Period 2||12
175536|NCT00557440|432468|P3|STARTED|Treatment Period 2||12
175537|NCT00557440|432469|P2|STARTED|Treatment Period 2||12
175538|NCT00557440|432470|P1|STARTED|Treatment Period 2||12
175539|NCT00557440|432468|P3|NOT COMPLETED|Treatment Period 1||1
175540|NCT00557440|432469|P2|NOT COMPLETED|Treatment Period 1||0
175541|NCT00557440|432470|P1|NOT COMPLETED|Treatment Period 1||0
175542|NCT00557440|432468|P3|COMPLETED|Treatment Period 1||12
175543|NCT00557440|432469|P2|COMPLETED|Treatment Period 1||12
175544|NCT00557440|432470|P1|COMPLETED|Treatment Period 1||12
175545|NCT00557440|432468|P3|STARTED|Treatment Period 1||13
175546|NCT00557440|432469|P2|STARTED|Treatment Period 1||12
175547|NCT00557440|432470|P1|STARTED|Treatment Period 1||12
175548|NCT00557466|432496|P6|NOT COMPLETED|Overall Study||6
175549|NCT00557466|432497|P5|NOT COMPLETED|Overall Study||3
175550|NCT00557466|432498|P4|NOT COMPLETED|Overall Study||4
175551|NCT00557466|432499|P3|NOT COMPLETED|Overall Study||6
175552|NCT00557466|432500|P2|NOT COMPLETED|Overall Study||5
175553|NCT00557466|432501|P1|NOT COMPLETED|Overall Study||4
175554|NCT00557466|432496|P6|COMPLETED|Overall Study||85
175555|NCT00557466|432497|P5|COMPLETED|Overall Study||87
175556|NCT00557466|432498|P4|COMPLETED|Overall Study||92
175557|NCT00557466|432499|P3|COMPLETED|Overall Study||95
175558|NCT00557466|432500|P2|COMPLETED|Overall Study||87
175559|NCT00557466|432501|P1|COMPLETED|Overall Study||94
175560|NCT00557466|432496|P6|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|89
175561|NCT00557466|432497|P5|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|87
175562|NCT00557466|432498|P4|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|93
175563|NCT00557466|432499|P3|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
175564|NCT00557466|432500|P2|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|91
175565|NCT00557466|432501|P1|Intent to Treat Population|Overall Study|All randomized patients who had a baseline and at least one post-dose FEV1 measurement|98
175566|NCT00557466|432496|P6|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|91
175567|NCT00557466|432497|P5|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|90
175568|NCT00557466|432498|P4|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|96
175569|NCT00557466|432499|P3|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|101
175570|NCT00557466|432500|P2|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|92
175571|NCT00557466|432501|P1|Safety Population|Overall Study|All randomized patients who received at least one dose of the study drug|98
175572|NCT00557466|432496|P6|STARTED|Overall Study||91
175573|NCT00557466|432497|P5|STARTED|Overall Study||90
175574|NCT00557466|432498|P4|STARTED|Overall Study||96
175575|NCT00557466|432499|P3|STARTED|Overall Study||101
175576|NCT00557466|432500|P2|STARTED|Overall Study||92
175577|NCT00557466|432501|P1|STARTED|Overall Study||98
175578|NCT00557492|432551|P1|NOT COMPLETED|Overall Study||1
175579|NCT00557492|432551|P1|COMPLETED|Overall Study|Evaluable for outcomes|58
175580|NCT00557492|432551|P1|STARTED|Overall Study||59
175581|NCT00557505|432572|P9|NOT COMPLETED|Overall Study||17
175582|NCT00557505|432573|P8|NOT COMPLETED|Overall Study||5
175583|NCT00557505|432574|P7|NOT COMPLETED|Overall Study||3
175584|NCT00557505|432575|P6|NOT COMPLETED|Overall Study||3
175585|NCT00557505|432576|P5|NOT COMPLETED|Overall Study||2
175586|NCT00557505|432577|P4|NOT COMPLETED|Overall Study||3
175587|NCT00557505|432578|P3|NOT COMPLETED|Overall Study||4
175588|NCT00557505|432579|P2|NOT COMPLETED|Overall Study||3
175589|NCT00557505|432580|P1|NOT COMPLETED|Overall Study||3
175590|NCT00557505|432572|P9|COMPLETED|Overall Study||0
175591|NCT00557505|432573|P8|COMPLETED|Overall Study||0
175592|NCT00557505|432574|P7|COMPLETED|Overall Study||0
175593|NCT00557505|432575|P6|COMPLETED|Overall Study||0
175594|NCT00557505|432576|P5|COMPLETED|Overall Study||0
175595|NCT00557505|432577|P4|COMPLETED|Overall Study||0
175596|NCT00557505|432578|P3|COMPLETED|Overall Study||0
175597|NCT00557505|432579|P2|COMPLETED|Overall Study||0
175598|NCT00557505|432580|P1|COMPLETED|Overall Study||0
175599|NCT00557505|432572|P9|STARTED|Overall Study||17
175600|NCT00557505|432573|P8|STARTED|Overall Study||5
175601|NCT00557505|432574|P7|STARTED|Overall Study||3
175602|NCT00557505|432575|P6|STARTED|Overall Study||3
175603|NCT00557505|432576|P5|STARTED|Overall Study||2
175604|NCT00557505|432577|P4|STARTED|Overall Study||3
175605|NCT00557505|432578|P3|STARTED|Overall Study||4
175606|NCT00557505|432579|P2|STARTED|Overall Study||3
175607|NCT00557505|432580|P1|STARTED|Overall Study||3
175608|NCT00557622|432746|P2|NOT COMPLETED|12-Week Treatment Phase||1
175609|NCT00557622|432747|P1|NOT COMPLETED|12-Week Treatment Phase||0
175610|NCT00557622|432746|P2|COMPLETED|12-Week Treatment Phase||1
175611|NCT00557622|432747|P1|COMPLETED|12-Week Treatment Phase||1
175612|NCT00557622|432746|P2|STARTED|12-Week Treatment Phase||2
175613|NCT00557622|432747|P1|STARTED|12-Week Treatment Phase||1
175614|NCT00557622|432746|P2|NOT COMPLETED|4-Week Run-in Phase||0
175615|NCT00557622|432747|P1|NOT COMPLETED|4-Week Run-in Phase||2
175616|NCT00557622|432746|P2|COMPLETED|4-Week Run-in Phase||0
175617|NCT00557622|432747|P1|COMPLETED|4-Week Run-in Phase||3
175618|NCT00557622|432746|P2|STARTED|4-Week Run-in Phase||0
175619|NCT00557622|432747|P1|STARTED|4-Week Run-in Phase||5
175620|NCT00557830|432770|P3|NOT COMPLETED|Treatment Phase||0
175621|NCT00557830|432771|P2|NOT COMPLETED|Treatment Phase||0
175622|NCT00557830|432772|P1|NOT COMPLETED|Treatment Phase||0
175623|NCT00557830|432770|P3|COMPLETED|Treatment Phase||2
175624|NCT00557830|432771|P2|COMPLETED|Treatment Phase||4
175625|NCT00557830|432772|P1|COMPLETED|Treatment Phase||0
175626|NCT00557830|432770|P3|STARTED|Treatment Phase||2
175627|NCT00557830|432771|P2|STARTED|Treatment Phase||4
175628|NCT00557830|432772|P1|STARTED|Treatment Phase||0
175629|NCT00557830|432770|P3|NOT COMPLETED|Screening Treatment Phase||0
175630|NCT00557830|432771|P2|NOT COMPLETED|Screening Treatment Phase||0
175631|NCT00557830|432772|P1|NOT COMPLETED|Screening Treatment Phase||6
175632|NCT00557830|432770|P3|COMPLETED|Screening Treatment Phase||0
175633|NCT00557830|432771|P2|COMPLETED|Screening Treatment Phase||0
175634|NCT00557830|432772|P1|COMPLETED|Screening Treatment Phase||6
175635|NCT00557830|432770|P3|STARTED|Screening Treatment Phase||0
175636|NCT00557830|432771|P2|STARTED|Screening Treatment Phase||0
175637|NCT00557830|432772|P1|STARTED|Screening Treatment Phase||12
175638|NCT00557856|432792|P9|NOT COMPLETED|Part 2: Exploratory Phase||24
175639|NCT00557856|432793|P8|NOT COMPLETED|Part 2: Exploratory Phase||0
175640|NCT00557856|432794|P7|NOT COMPLETED|Part 2: Exploratory Phase||0
175641|NCT00557856|432795|P6|NOT COMPLETED|Part 2: Exploratory Phase||0
175642|NCT00557856|432796|P5|NOT COMPLETED|Part 2: Exploratory Phase||0
175643|NCT00557856|432797|P4|NOT COMPLETED|Part 2: Exploratory Phase||0
175644|NCT00557856|432798|P3|NOT COMPLETED|Part 2: Exploratory Phase||0
175645|NCT00557856|432799|P2|NOT COMPLETED|Part 2: Exploratory Phase||0
175646|NCT00557856|432800|P1|NOT COMPLETED|Part 2: Exploratory Phase||0
175647|NCT00557856|432792|P9|COMPLETED|Part 2: Exploratory Phase||0
175648|NCT00557856|432793|P8|COMPLETED|Part 2: Exploratory Phase||0
175649|NCT00557856|432794|P7|COMPLETED|Part 2: Exploratory Phase||0
175650|NCT00557856|432795|P6|COMPLETED|Part 2: Exploratory Phase||0
175651|NCT00557856|432796|P5|COMPLETED|Part 2: Exploratory Phase||0
175652|NCT00557856|432797|P4|COMPLETED|Part 2: Exploratory Phase||0
175653|NCT00557856|432798|P3|COMPLETED|Part 2: Exploratory Phase||0
175654|NCT00557856|432799|P2|COMPLETED|Part 2: Exploratory Phase||0
175655|NCT00557856|432800|P1|COMPLETED|Part 2: Exploratory Phase||0
175656|NCT00557856|432792|P9|STARTED|Part 2: Exploratory Phase||24
175657|NCT00557856|432793|P8|STARTED|Part 2: Exploratory Phase||0
175658|NCT00557856|432794|P7|STARTED|Part 2: Exploratory Phase||0
175659|NCT00557856|432795|P6|STARTED|Part 2: Exploratory Phase||0
175660|NCT00557856|432796|P5|STARTED|Part 2: Exploratory Phase||0
175661|NCT00557856|432797|P4|STARTED|Part 2: Exploratory Phase||0
175662|NCT00557856|432798|P3|STARTED|Part 2: Exploratory Phase||0
175663|NCT00557856|432799|P2|STARTED|Part 2: Exploratory Phase||0
175664|NCT00557856|432800|P1|STARTED|Part 2: Exploratory Phase||0
175665|NCT00557856|432792|P9|NOT COMPLETED|Part 1: Dose Escalation Phase||0
175666|NCT00557856|432793|P8|NOT COMPLETED|Part 1: Dose Escalation Phase||6
175667|NCT00557856|432794|P7|NOT COMPLETED|Part 1: Dose Escalation Phase||7
175668|NCT00557856|432795|P6|NOT COMPLETED|Part 1: Dose Escalation Phase||8
175669|NCT00557856|432796|P5|NOT COMPLETED|Part 1: Dose Escalation Phase||4
175670|NCT00557856|432797|P4|NOT COMPLETED|Part 1: Dose Escalation Phase||3
175671|NCT00557856|432798|P3|NOT COMPLETED|Part 1: Dose Escalation Phase||6
175672|NCT00557856|432799|P2|NOT COMPLETED|Part 1: Dose Escalation Phase||5
175673|NCT00557856|432800|P1|NOT COMPLETED|Part 1: Dose Escalation Phase||7
175674|NCT00557856|432792|P9|COMPLETED|Part 1: Dose Escalation Phase||0
175675|NCT00557856|432793|P8|COMPLETED|Part 1: Dose Escalation Phase||0
175676|NCT00557856|432794|P7|COMPLETED|Part 1: Dose Escalation Phase||0
175677|NCT00557856|432795|P6|COMPLETED|Part 1: Dose Escalation Phase||0
175678|NCT00557856|432796|P5|COMPLETED|Part 1: Dose Escalation Phase||0
175679|NCT00557856|432797|P4|COMPLETED|Part 1: Dose Escalation Phase||0
175680|NCT00557856|432798|P3|COMPLETED|Part 1: Dose Escalation Phase||0
175681|NCT00557856|432799|P2|COMPLETED|Part 1: Dose Escalation Phase||0
175682|NCT00557856|432800|P1|COMPLETED|Part 1: Dose Escalation Phase||0
175683|NCT00557856|432792|P9|Treated|Part 1: Dose Escalation Phase||0
175684|NCT00557856|432793|P8|Treated|Part 1: Dose Escalation Phase||6
175685|NCT00557856|432794|P7|Treated|Part 1: Dose Escalation Phase||7
175686|NCT00557856|432795|P6|Treated|Part 1: Dose Escalation Phase||8
175687|NCT00557856|432796|P5|Treated|Part 1: Dose Escalation Phase||4
175688|NCT00557856|432797|P4|Treated|Part 1: Dose Escalation Phase||3
175689|NCT00557856|432798|P3|Treated|Part 1: Dose Escalation Phase||6
175690|NCT00557856|432799|P2|Treated|Part 1: Dose Escalation Phase||5
175691|NCT00557856|432800|P1|Treated|Part 1: Dose Escalation Phase||5
175692|NCT00557856|432792|P9|STARTED|Part 1: Dose Escalation Phase||0
175693|NCT00557856|432793|P8|STARTED|Part 1: Dose Escalation Phase||6
175694|NCT00557856|432794|P7|STARTED|Part 1: Dose Escalation Phase||7
175695|NCT00557856|432795|P6|STARTED|Part 1: Dose Escalation Phase||8
175696|NCT00557856|432796|P5|STARTED|Part 1: Dose Escalation Phase||4
175697|NCT00557856|432797|P4|STARTED|Part 1: Dose Escalation Phase||3
175698|NCT00557856|432798|P3|STARTED|Part 1: Dose Escalation Phase||6
175699|NCT00557856|432799|P2|STARTED|Part 1: Dose Escalation Phase||5
175700|NCT00557856|432800|P1|STARTED|Part 1: Dose Escalation Phase||7
175701|NCT00557947|432996|P1|NOT COMPLETED|Overall Study||0
175702|NCT00557947|432996|P1|COMPLETED|Overall Study||83
175703|NCT00557947|432996|P1|STARTED|Overall Study||83
175704|NCT00558012|433014|P2|NOT COMPLETED|Overall Study||18
175705|NCT00558012|433015|P1|NOT COMPLETED|Overall Study||25
175706|NCT00558012|433014|P2|COMPLETED|Overall Study||74
175707|NCT00558012|433015|P1|COMPLETED|Overall Study||64
175708|NCT00558012|433014|P2|STARTED|Overall Study||92
175709|NCT00558012|433015|P1|STARTED|Overall Study||89
175710|NCT00558025|433023|P2|NOT COMPLETED|Overall Study||3
175711|NCT00558025|433024|P1|NOT COMPLETED|Overall Study||4
175712|NCT00558025|433023|P2|COMPLETED|Overall Study||49
175713|NCT00558025|433024|P1|COMPLETED|Overall Study||100
175714|NCT00558025|433023|P2|STARTED|Overall Study||52
175715|NCT00558025|433024|P1|STARTED|Overall Study||104
175716|NCT00558064|433048|P2|NOT COMPLETED|Overall Study||5
175717|NCT00558064|433049|P1|NOT COMPLETED|Overall Study||5
175718|NCT00558064|433048|P2|COMPLETED|Overall Study||257
175719|NCT00558064|433049|P1|COMPLETED|Overall Study||264
175720|NCT00558064|433048|P2|STARTED|Overall Study||262
175721|NCT00558064|433049|P1|STARTED|Overall Study||269
175722|NCT00558103|433074|P6|NOT COMPLETED|Monotherapy Extension Phase||9
175723|NCT00558103|433075|P5|NOT COMPLETED|Monotherapy Extension Phase||0
175724|NCT00558103|433076|P4|NOT COMPLETED|Monotherapy Extension Phase||0
175725|NCT00558103|433077|P3|NOT COMPLETED|Monotherapy Extension Phase||0
175726|NCT00558103|433078|P2|NOT COMPLETED|Monotherapy Extension Phase||0
175727|NCT00558103|433079|P1|NOT COMPLETED|Monotherapy Extension Phase||0
175728|NCT00558103|433074|P6|COMPLETED|Monotherapy Extension Phase||0
175729|NCT00558103|433075|P5|COMPLETED|Monotherapy Extension Phase||0
175730|NCT00558103|433076|P4|COMPLETED|Monotherapy Extension Phase||0
175731|NCT00558103|433077|P3|COMPLETED|Monotherapy Extension Phase||0
175732|NCT00558103|433078|P2|COMPLETED|Monotherapy Extension Phase||0
175733|NCT00558103|433079|P1|COMPLETED|Monotherapy Extension Phase||0
175734|NCT00558103|433074|P6|STARTED|Monotherapy Extension Phase|9/11 participants completing pazopanib monotherapy elected to receive lapatinib monotherapy.|9
175735|NCT00558103|433075|P5|STARTED|Monotherapy Extension Phase||0
175736|NCT00558103|433076|P4|STARTED|Monotherapy Extension Phase||0
175737|NCT00558103|433077|P3|STARTED|Monotherapy Extension Phase||0
175738|NCT00558103|433078|P2|STARTED|Monotherapy Extension Phase||0
175739|NCT00558103|433079|P1|STARTED|Monotherapy Extension Phase||0
175740|NCT00558103|433074|P6|NOT COMPLETED|Randomized Treatment Phase||0
175741|NCT00558103|433075|P5|NOT COMPLETED|Randomized Treatment Phase||5
175742|NCT00558103|433076|P4|NOT COMPLETED|Randomized Treatment Phase||2
175743|NCT00558103|433077|P3|NOT COMPLETED|Randomized Treatment Phase||3
175744|NCT00558103|433078|P2|NOT COMPLETED|Randomized Treatment Phase||4
175745|NCT00558103|433079|P1|NOT COMPLETED|Randomized Treatment Phase||5
175746|NCT00558103|433074|P6|COMPLETED|Randomized Treatment Phase||0
175747|NCT00558103|433075|P5|COMPLETED|Randomized Treatment Phase||33
175748|NCT00558103|433076|P4|COMPLETED|Randomized Treatment Phase||11
175749|NCT00558103|433077|P3|COMPLETED|Randomized Treatment Phase||33
175750|NCT00558103|433078|P2|COMPLETED|Randomized Treatment Phase||34
175751|NCT00558103|433079|P1|COMPLETED|Randomized Treatment Phase||33
175752|NCT00558103|433074|P6|STARTED|Randomized Treatment Phase||0
175753|NCT00558103|433075|P5|STARTED|Randomized Treatment Phase||38
175754|NCT00558103|433076|P4|STARTED|Randomized Treatment Phase||13
175755|NCT00558103|433077|P3|STARTED|Randomized Treatment Phase||36
175756|NCT00558103|433078|P2|STARTED|Randomized Treatment Phase||38
175757|NCT00558103|433079|P1|STARTED|Randomized Treatment Phase||38
175758|NCT00558246|433107|P1|NOT COMPLETED|Overall Study||0
175759|NCT00558246|433107|P1|COMPLETED|Overall Study||79
175760|NCT00558246|433107|P1|STARTED|Overall Study||79
175761|NCT00558259|433124|P2|NOT COMPLETED|Overall Study||99
175762|NCT00558259|433125|P1|NOT COMPLETED|Overall Study||71
175763|NCT00558259|433124|P2|COMPLETED|Overall Study|Completed treatment.|563
175764|NCT00558259|433125|P1|COMPLETED|Overall Study|Completed treatment.|610
175765|NCT00558259|433124|P2|STARTED|Overall Study|Number who started treatment. There were 6 patients randomised to placebo and not treated.|662
175766|NCT00558259|433125|P1|STARTED|Overall Study|Number who started treatment. There were 4 patients randomised to Dabigatran and not treated.|681
175767|NCT00558272|433147|P2|NOT COMPLETED|Overall Study||2
175768|NCT00558272|433148|P1|NOT COMPLETED|Overall Study||13
175769|NCT00558272|433147|P2|COMPLETED|Overall Study|4-week treatment period|68
175770|NCT00558272|433148|P1|COMPLETED|Overall Study|4-week treatment period|56
175771|NCT00558272|433147|P2|30 Days Follow-up|Overall Study|30 days after last dose|67
175772|NCT00558272|433148|P1|30 Days Follow-up|Overall Study|30 days after last dose|41
175773|NCT00558272|433147|P2|STARTED|Overall Study|Randomised|70
175774|NCT00558272|433148|P1|STARTED|Overall Study|Randomised|69
175775|NCT00558285|433191|P5|NOT COMPLETED|Overall Study||4
175776|NCT00558285|433192|P4|NOT COMPLETED|Overall Study||4
175777|NCT00558285|433193|P3|NOT COMPLETED|Overall Study||5
175778|NCT00558285|433194|P2|NOT COMPLETED|Overall Study||3
175779|NCT00558285|433195|P1|NOT COMPLETED|Overall Study||6
175780|NCT00558285|433191|P5|COMPLETED|Overall Study||49
175781|NCT00558285|433192|P4|COMPLETED|Overall Study||48
175782|NCT00558285|433193|P3|COMPLETED|Overall Study||46
175783|NCT00558285|433194|P2|COMPLETED|Overall Study||48
175784|NCT00558285|433195|P1|COMPLETED|Overall Study||44
175785|NCT00558285|433191|P5|Safety: Received Study Drug|Overall Study||53
175786|NCT00558285|433192|P4|Safety: Received Study Drug|Overall Study||51
175787|NCT00558285|433193|P3|Safety: Received Study Drug|Overall Study||51
175788|NCT00558285|433194|P2|Safety: Received Study Drug|Overall Study||51
175789|NCT00558285|433195|P1|Safety: Received Study Drug|Overall Study||49
175790|NCT00558285|433191|P5|STARTED|Overall Study||53
175791|NCT00558285|433192|P4|STARTED|Overall Study||52
175792|NCT00558285|433193|P3|STARTED|Overall Study||51
175793|NCT00558285|433194|P2|STARTED|Overall Study||51
175794|NCT00558285|433195|P1|STARTED|Overall Study||50
175795|NCT00558363|433239|P2|NOT COMPLETED|Overall Study||36
175796|NCT00558363|433240|P1|NOT COMPLETED|Overall Study||71
175797|NCT00558363|433239|P2|COMPLETED|Overall Study||111
175798|NCT00558363|433240|P1|COMPLETED|Overall Study||76
175799|NCT00558363|433239|P2|STARTED|Overall Study||147
175800|NCT00558363|433240|P1|STARTED|Overall Study||147
175801|NCT00558428|433294|P4|NOT COMPLETED|Overall Study||11
175802|NCT00558428|433295|P3|NOT COMPLETED|Overall Study||4
175803|NCT00558428|433296|P2|NOT COMPLETED|Overall Study||24
175804|NCT00558428|433297|P1|NOT COMPLETED|Overall Study||12
175805|NCT00558428|433294|P4|COMPLETED|Overall Study||266
175806|NCT00558428|433295|P3|COMPLETED|Overall Study||273
175807|NCT00558428|433296|P2|COMPLETED|Overall Study||252
175808|NCT00558428|433297|P1|COMPLETED|Overall Study||255
175809|NCT00558428|433294|P4|STARTED|Overall Study||277
175810|NCT00558428|433295|P3|STARTED|Overall Study||277
175811|NCT00558428|433296|P2|STARTED|Overall Study||276
175812|NCT00558428|433297|P1|STARTED|Overall Study||267
175813|NCT00558467|433337|P2|NOT COMPLETED|Overall Study||4
175814|NCT00558467|433338|P1|NOT COMPLETED|Overall Study||1
175815|NCT00558467|433337|P2|COMPLETED|Overall Study||39
175816|NCT00558467|433338|P1|COMPLETED|Overall Study||19
175817|NCT00558467|433337|P2|STARTED|Overall Study||43
175818|NCT00558467|433338|P1|STARTED|Overall Study||20
175819|NCT00558558|433394|P1|NOT COMPLETED|Overall Study||6
175820|NCT00558558|433394|P1|COMPLETED|Overall Study||0
175821|NCT00558558|433394|P1|STARTED|Overall Study||6
175822|NCT00558571|433402|P4|NOT COMPLETED|Overall Study||0
175823|NCT00558571|433403|P3|NOT COMPLETED|Overall Study||0
175824|NCT00558571|433404|P2|NOT COMPLETED|Overall Study||0
175825|NCT00558571|433405|P1|NOT COMPLETED|Overall Study||0
175826|NCT00558571|433402|P4|COMPLETED|Overall Study||30
175827|NCT00558571|433403|P3|COMPLETED|Overall Study||16
175828|NCT00558571|433404|P2|COMPLETED|Overall Study||16
175829|NCT00558571|433405|P1|COMPLETED|Overall Study||16
175830|NCT00558571|433402|P4|STARTED|Overall Study||30
175831|NCT00558571|433403|P3|STARTED|Overall Study||16
175832|NCT00558571|433404|P2|STARTED|Overall Study||16
175833|NCT00558571|433405|P1|STARTED|Overall Study||16
175834|NCT00558636|433482|P2|NOT COMPLETED|Follow-up||7
175835|NCT00558636|433483|P1|NOT COMPLETED|Follow-up||12
175836|NCT00558636|433482|P2|COMPLETED|Follow-up|Study was prematurely terminated|0
175837|NCT00558636|433483|P1|COMPLETED|Follow-up|Study was prematurely terminated|0
175838|NCT00558636|433482|P2|STARTED|Follow-up|7 subjects entered Follow-up phase before they completed the treatment phase|7
175839|NCT00558636|433483|P1|STARTED|Follow-up|12 subjects entered Follow-up phase before they completed the treatment phase|12
175840|NCT00558636|433482|P2|NOT COMPLETED|Treatment||44
175841|NCT00558636|433483|P1|NOT COMPLETED|Treatment||47
175842|NCT00558636|433482|P2|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
175843|NCT00558636|433483|P1|COMPLETED|Treatment|Patients still on treatment did not enter follow-up because the study was prematurely terminated|0
175844|NCT00558636|433482|P2|Start of Maintenance Monotherapy|Treatment|Placebo taken as the single agent in the Maintenance Phase|2
175845|NCT00558636|433483|P1|Start of Maintenance Monotherapy|Treatment|Sorafenib taken as the single agent in the Maintenance Phase|2
175846|NCT00558636|433482|P2|STARTED|Treatment||44
175847|NCT00558636|433483|P1|STARTED|Treatment|up to 6 cycles of combination therapy|47
175848|NCT00558701|433503|P2|NOT COMPLETED|Overall Study||4
175849|NCT00558701|433504|P1|NOT COMPLETED|Overall Study||1
175850|NCT00558701|433503|P2|COMPLETED|Overall Study||11
175851|NCT00558701|433504|P1|COMPLETED|Overall Study||14
175852|NCT00558701|433503|P2|STARTED|Overall Study||15
175853|NCT00558701|433504|P1|STARTED|Overall Study||15
175854|NCT00558753|433512|P2|NOT COMPLETED|Overall Study||7
175855|NCT00558753|433513|P1|NOT COMPLETED|Overall Study||5
175856|NCT00558753|433512|P2|COMPLETED|Overall Study||113
175857|NCT00558753|433513|P1|COMPLETED|Overall Study||115
175858|NCT00558753|433512|P2|STARTED|Overall Study||120
175859|NCT00558753|433513|P1|STARTED|Overall Study||120
175860|NCT00558792|433526|P3|NOT COMPLETED|Overall Study||0
175861|NCT00558792|433527|P2|NOT COMPLETED|Overall Study||0
175862|NCT00558792|433528|P1|NOT COMPLETED|Overall Study||0
175863|NCT00558792|433526|P3|COMPLETED|Overall Study||60
175864|NCT00558792|433527|P2|COMPLETED|Overall Study||63
175865|NCT00558792|433528|P1|COMPLETED|Overall Study||68
175866|NCT00558792|433526|P3|STARTED|Overall Study||60
175867|NCT00558792|433527|P2|STARTED|Overall Study||63
175868|NCT00558792|433528|P1|STARTED|Overall Study||68
175869|NCT00558831|433572|P1|NOT COMPLETED|Overall Study||1
175870|NCT00558831|433572|P1|COMPLETED|Overall Study||10
175871|NCT00558831|433572|P1|STARTED|Overall Study||11
175872|NCT00558870|433580|P2|NOT COMPLETED|Overall Study||0
175873|NCT00558870|433581|P1|NOT COMPLETED|Overall Study||0
175874|NCT00558870|433580|P2|COMPLETED|Overall Study||2
175875|NCT00558870|433581|P1|COMPLETED|Overall Study||2
175876|NCT00558870|433580|P2|STARTED|Overall Study||2
175877|NCT00558870|433581|P1|STARTED|Overall Study||2
175878|NCT00558896|433596|P7|NOT COMPLETED|Overall Study||24
175879|NCT00558896|433597|P6|NOT COMPLETED|Overall Study||52
175880|NCT00558896|433598|P5|NOT COMPLETED|Overall Study||23
175881|NCT00558896|433599|P4|NOT COMPLETED|Overall Study||12
175882|NCT00558896|433600|P3|NOT COMPLETED|Overall Study||5
175883|NCT00558896|433601|P2|NOT COMPLETED|Overall Study||7
175884|NCT00558896|433602|P1|NOT COMPLETED|Overall Study||21
175885|NCT00558896|433596|P7|COMPLETED|Overall Study||9
175886|NCT00558896|433597|P6|COMPLETED|Overall Study||68
175887|NCT00558896|433598|P5|COMPLETED|Overall Study||37
175888|NCT00558896|433599|P4|COMPLETED|Overall Study||23
175889|NCT00558896|433600|P3|COMPLETED|Overall Study||30
175890|NCT00558896|433601|P2|COMPLETED|Overall Study||27
175891|NCT00558896|433602|P1|COMPLETED|Overall Study||39
175892|NCT00558896|433596|P7|STARTED|Overall Study||33
175893|NCT00558896|433597|P6|STARTED|Overall Study||120
175894|NCT00558896|433598|P5|STARTED|Overall Study||60
175895|NCT00558896|433599|P4|STARTED|Overall Study||35
175896|NCT00558896|433600|P3|STARTED|Overall Study||35
175897|NCT00558896|433601|P2|STARTED|Overall Study||34
175898|NCT00558896|433602|P1|STARTED|Overall Study||60
175899|NCT00559013|433632|P1|NOT COMPLETED|Overall Study||0
175900|NCT00559013|433632|P1|COMPLETED|Overall Study||38
175901|NCT00559013|433632|P1|STARTED|Overall Study||38
175902|NCT00559104|433638|P2|NOT COMPLETED|Overall Study||0
175903|NCT00559104|433639|P1|NOT COMPLETED|Overall Study||9
175904|NCT00559104|433638|P2|COMPLETED|Overall Study||5
175905|NCT00559104|433639|P1|COMPLETED|Overall Study|Progression was the reason for off-treatment for 9 of 9 patients who went off of treatment.|46
175906|NCT00559104|433638|P2|STARTED|Overall Study||5
175907|NCT00559104|433639|P1|STARTED|Overall Study||55
175908|NCT00559273|433651|P2|NOT COMPLETED|Evaluation Period (8 Weeks)||5
175909|NCT00559273|433652|P1|NOT COMPLETED|Evaluation Period (8 Weeks)||3
175910|NCT00559273|433651|P2|COMPLETED|Evaluation Period (8 Weeks)||137
175911|NCT00559273|433652|P1|COMPLETED|Evaluation Period (8 Weeks)||141
175912|NCT00559273|433651|P2|STARTED|Evaluation Period (8 Weeks)||142
175913|NCT00559273|433652|P1|STARTED|Evaluation Period (8 Weeks)||144
175914|NCT00559273|433651|P2|NOT COMPLETED|Correction Period (20 Weeks)||12
175915|NCT00559273|433652|P1|NOT COMPLETED|Correction Period (20 Weeks)||9
175916|NCT00559273|433651|P2|COMPLETED|Correction Period (20 Weeks)||142
175917|NCT00559273|433652|P1|COMPLETED|Correction Period (20 Weeks)||144
175918|NCT00559273|433651|P2|Treated|Correction Period (20 Weeks)||154
175919|NCT00559273|433652|P1|Treated|Correction Period (20 Weeks)||151
175920|NCT00559273|433651|P2|STARTED|Correction Period (20 Weeks)||154
175921|NCT00559273|433652|P1|STARTED|Correction Period (20 Weeks)||153
175922|NCT00559364|433674|P2|NOT COMPLETED|Overall Study||0
175923|NCT00559364|433675|P1|NOT COMPLETED|Overall Study||1
175924|NCT00559364|433674|P2|COMPLETED|Overall Study||20
175925|NCT00559364|433675|P1|COMPLETED|Overall Study||29
175926|NCT00559364|433674|P2|STARTED|Overall Study||20
175927|NCT00559364|433675|P1|STARTED|Overall Study||30
175928|NCT00559377|433685|P1|NOT COMPLETED|Overall Study||9
175929|NCT00559377|433685|P1|COMPLETED|Overall Study||7
175930|NCT00559377|433685|P1|STARTED|Overall Study||16
175931|NCT00565370|433693|P1|NOT COMPLETED|Overall Study||0
175932|NCT00565370|433693|P1|COMPLETED|Overall Study||21
175933|NCT00565370|433693|P1|STARTED|Overall Study||21
175934|NCT00565409|433701|P4|NOT COMPLETED|Period 2 Double-Blind||59
175935|NCT00565409|433702|P3|NOT COMPLETED|Period 2 Double-Blind||27
175936|NCT00565409|433703|P2|NOT COMPLETED|Period 2 Double-Blind||21
175937|NCT00565409|433704|P1|NOT COMPLETED|Period 2 Double-Blind||0
175938|NCT00565409|433701|P4|COMPLETED|Period 2 Double-Blind||141
175939|NCT00565409|433702|P3|COMPLETED|Period 2 Double-Blind||175
175940|NCT00565409|433703|P2|COMPLETED|Period 2 Double-Blind||181
175941|NCT00565409|433704|P1|COMPLETED|Period 2 Double-Blind||0
175942|NCT00565409|433701|P4|STARTED|Period 2 Double-Blind||200
175943|NCT00565409|433702|P3|STARTED|Period 2 Double-Blind||202
175944|NCT00565409|433703|P2|STARTED|Period 2 Double-Blind||202
175945|NCT00565409|433704|P1|STARTED|Period 2 Double-Blind||0
175946|NCT00565409|433701|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
175947|NCT00565409|433702|P3|NOT COMPLETED|After Period 1, Prior to Period 2||0
175948|NCT00565409|433703|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
175949|NCT00565409|433704|P1|NOT COMPLETED|After Period 1, Prior to Period 2||152
175950|NCT00565409|433701|P4|COMPLETED|After Period 1, Prior to Period 2||0
175951|NCT00565409|433702|P3|COMPLETED|After Period 1, Prior to Period 2||0
175952|NCT00565409|433703|P2|COMPLETED|After Period 1, Prior to Period 2||0
175953|NCT00565409|433704|P1|COMPLETED|After Period 1, Prior to Period 2||604
175954|NCT00565409|433701|P4|STARTED|After Period 1, Prior to Period 2||0
175955|NCT00565409|433702|P3|STARTED|After Period 1, Prior to Period 2||0
175956|NCT00565409|433703|P2|STARTED|After Period 1, Prior to Period 2||0
175957|NCT00565409|433704|P1|STARTED|After Period 1, Prior to Period 2||756
175958|NCT00565409|433701|P4|NOT COMPLETED|Period 1 Open Label||0
175959|NCT00565409|433702|P3|NOT COMPLETED|Period 1 Open Label||0
175960|NCT00565409|433703|P2|NOT COMPLETED|Period 1 Open Label||0
175961|NCT00565409|433704|P1|NOT COMPLETED|Period 1 Open Label||78
175962|NCT00565409|433701|P4|COMPLETED|Period 1 Open Label||0
175963|NCT00565409|433702|P3|COMPLETED|Period 1 Open Label||0
175964|NCT00565409|433703|P2|COMPLETED|Period 1 Open Label||0
175965|NCT00565409|433704|P1|COMPLETED|Period 1 Open Label||756
175966|NCT00565409|433701|P4|STARTED|Period 1 Open Label||0
175967|NCT00565409|433702|P3|STARTED|Period 1 Open Label||0
175968|NCT00565409|433703|P2|STARTED|Period 1 Open Label||0
175969|NCT00565409|433704|P1|STARTED|Period 1 Open Label||834
175970|NCT00565448|433808|P2|NOT COMPLETED|Overall Study||2
175971|NCT00565448|433809|P1|NOT COMPLETED|Overall Study||3
175972|NCT00565448|433808|P2|COMPLETED|Overall Study|Completed induction period as per protocol.|23
175973|NCT00565448|433809|P1|COMPLETED|Overall Study|Completed induction period as per protocol.|47
175974|NCT00565448|433808|P2|STARTED|Overall Study|ITT population: all randomized participants. All were treated.|25
175975|NCT00565448|433809|P1|STARTED|Overall Study|Intent to treat (ITT) population: all randomized participants. All were treated.|50
175976|NCT00565461|433824|P4|NOT COMPLETED|Overall Study||3
175977|NCT00565461|433825|P3|NOT COMPLETED|Overall Study||1
175978|NCT00565461|433826|P2|NOT COMPLETED|Overall Study||1
175979|NCT00565461|433827|P1|NOT COMPLETED|Overall Study||0
175980|NCT00565461|433824|P4|COMPLETED|Overall Study||37
175981|NCT00565461|433825|P3|COMPLETED|Overall Study||39
175982|NCT00565461|433826|P2|COMPLETED|Overall Study||39
175983|NCT00565461|433827|P1|COMPLETED|Overall Study||40
175984|NCT00565461|433824|P4|STARTED|Overall Study||40
175985|NCT00565461|433825|P3|STARTED|Overall Study||40
175986|NCT00565461|433826|P2|STARTED|Overall Study||40
175987|NCT00565461|433827|P1|STARTED|Overall Study||40
175988|NCT00565604|433839|P1|NOT COMPLETED|Overall Study||4
175989|NCT00565604|433839|P1|COMPLETED|Overall Study||39
175990|NCT00565604|433839|P1|6 Month|Overall Study||39
175991|NCT00565604|433839|P1|6 Week|Overall Study||39
175992|NCT00565604|433839|P1|2 Week|Overall Study||41
175993|NCT00565604|433839|P1|7 Day|Overall Study||41
175994|NCT00565604|433839|P1|STARTED|Overall Study||43
175995|NCT00565643|433848|P2|NOT COMPLETED|Overall Study||0
175996|NCT00565643|433849|P1|NOT COMPLETED|Overall Study||0
175997|NCT00565643|433848|P2|COMPLETED|Overall Study||373
175998|NCT00565643|433849|P1|COMPLETED|Overall Study||380
175999|NCT00565643|433848|P2|Primary Outcome (Subsequent Cesarean)|Overall Study||92
176000|NCT00565643|433849|P1|Primary Outcome (Subsequent Cesarean)|Overall Study||80
176001|NCT00565643|433848|P2|Safety Data|Overall Study||373
176002|NCT00565643|433849|P1|Safety Data|Overall Study||380
176003|NCT00565643|433848|P2|STARTED|Overall Study||373
176004|NCT00565643|433849|P1|STARTED|Overall Study||380
176005|NCT00566020|433867|P2|NOT COMPLETED|46-week Long-term Administration Phase||17
176006|NCT00566020|433868|P1|NOT COMPLETED|46-week Long-term Administration Phase||0
176007|NCT00566020|433867|P2|COMPLETED|46-week Long-term Administration Phase||68
176008|NCT00566020|433868|P1|COMPLETED|46-week Long-term Administration Phase||0
176009|NCT00566020|433867|P2|STARTED|46-week Long-term Administration Phase||85
176010|NCT00566020|433868|P1|STARTED|46-week Long-term Administration Phase||0
176011|NCT00566020|433867|P2|NOT COMPLETED|6-week Dosage Adjustment Phase||0
176012|NCT00566020|433868|P1|NOT COMPLETED|6-week Dosage Adjustment Phase||7
176013|NCT00566020|433867|P2|COMPLETED|6-week Dosage Adjustment Phase||0
176014|NCT00566020|433868|P1|COMPLETED|6-week Dosage Adjustment Phase||85
176015|NCT00566020|433867|P2|STARTED|6-week Dosage Adjustment Phase||0
176016|NCT00566020|433868|P1|STARTED|6-week Dosage Adjustment Phase||92
176017|NCT00566111|433895|P2|NOT COMPLETED|Overall Study||2
176018|NCT00566111|433896|P1|NOT COMPLETED|Overall Study||0
176019|NCT00566111|433895|P2|COMPLETED|Overall Study||1
176020|NCT00566111|433896|P1|COMPLETED|Overall Study||2
176021|NCT00566111|433895|P2|STARTED|Overall Study||3
176022|NCT00566111|433896|P1|STARTED|Overall Study||2
176023|NCT00566150|433912|P2|NOT COMPLETED|Overall Study||5
176024|NCT00566150|433913|P1|NOT COMPLETED|Overall Study||9
176025|NCT00566150|433912|P2|COMPLETED|Overall Study||11
176026|NCT00566150|433913|P1|COMPLETED|Overall Study||10
176027|NCT00566150|433912|P2|STARTED|Overall Study||16
176028|NCT00566150|433913|P1|STARTED|Overall Study||19
176029|NCT00566254|433927|P2|NOT COMPLETED|Overall Study||14
176030|NCT00566254|433928|P1|NOT COMPLETED|Overall Study||10
176031|NCT00566254|433927|P2|COMPLETED|Overall Study||93
176032|NCT00566254|433928|P1|COMPLETED|Overall Study||90
176033|NCT00566254|433927|P2|STARTED|Overall Study||107
176034|NCT00566254|433928|P1|STARTED|Overall Study||100
176035|NCT00566462|433942|P2|NOT COMPLETED|Overall Study||0
176036|NCT00566462|433943|P1|NOT COMPLETED|Overall Study||0
176037|NCT00566462|433942|P2|COMPLETED|Overall Study||0
176038|NCT00566462|433943|P1|COMPLETED|Overall Study||1
176039|NCT00566462|433942|P2|STARTED|Overall Study||0
176040|NCT00566462|433943|P1|STARTED|Overall Study||1
176041|NCT00566501|433953|P2|NOT COMPLETED|Overall Study||126
176042|NCT00566501|433954|P1|NOT COMPLETED|Overall Study||156
176043|NCT00566501|433953|P2|COMPLETED|Overall Study||210
176044|NCT00566501|433954|P1|COMPLETED|Overall Study||423
176045|NCT00566501|433953|P2|Not Determined|Overall Study||0
176046|NCT00566501|433954|P1|Not Determined|Overall Study||1
176047|NCT00566501|433953|P2|Other ( Not Specified)|Overall Study||21
176048|NCT00566501|433954|P1|Other ( Not Specified)|Overall Study||24
176049|NCT00566501|433953|P2|Medication Non-compliance|Overall Study||0
176050|NCT00566501|433954|P1|Medication Non-compliance|Overall Study||5
176051|NCT00566501|433953|P2|Protocol Violation|Overall Study||2
176052|NCT00566501|433954|P1|Protocol Violation|Overall Study||2
176053|NCT00566501|433953|P2|Request of Investigator or Sponsor|Overall Study||7
176054|NCT00566501|433954|P1|Request of Investigator or Sponsor|Overall Study||6
176055|NCT00566501|433953|P2|Withdraw of Consent by Subject|Overall Study||30
176056|NCT00566501|433954|P1|Withdraw of Consent by Subject|Overall Study||33
176057|NCT00566501|433953|P2|Lack of Efficacy|Overall Study||3
176058|NCT00566501|433954|P1|Lack of Efficacy|Overall Study||8
176059|NCT00566501|433953|P2|Adverse Event|Overall Study||59
176060|NCT00566501|433954|P1|Adverse Event|Overall Study||68
176061|NCT00566501|433953|P2|Discontinued|Overall Study||122
176062|NCT00566501|433954|P1|Discontinued|Overall Study||146
176063|NCT00566501|433953|P2|Safety Population|Overall Study||332
176064|NCT00566501|433954|P1|Safety Population|Overall Study||570
176065|NCT00566501|433953|P2|STARTED|Overall Study||336
176066|NCT00566501|433954|P1|STARTED|Overall Study||579
176067|NCT00566579|433962|P2|NOT COMPLETED|Overall Study||0
176068|NCT00566579|433963|P1|NOT COMPLETED|Overall Study||0
176069|NCT00566579|433962|P2|COMPLETED|Overall Study||31
176070|NCT00566579|433963|P1|COMPLETED|Overall Study||29
176071|NCT00566579|433962|P2|STARTED|Overall Study||31
176072|NCT00566579|433963|P1|STARTED|Overall Study||29
176073|NCT00566631|433969|P1|NOT COMPLETED|Part 2: Extension Phase||82
176074|NCT00566631|433969|P1|COMPLETED|Part 2: Extension Phase||57
176075|NCT00566631|433969|P1|STARTED|Part 2: Extension Phase||139
176076|NCT00566631|433969|P1|NOT COMPLETED|Between Treatment and Extension Phase||95
176077|NCT00566631|433969|P1|COMPLETED|Between Treatment and Extension Phase||139
176078|NCT00566631|433969|P1|STARTED|Between Treatment and Extension Phase||234
176079|NCT00566631|433969|P1|NOT COMPLETED|Part 1: Core Treatment Phase||60
176080|NCT00566631|433969|P1|COMPLETED|Part 1: Core Treatment Phase||234
176081|NCT00566631|433969|P1|STARTED|Part 1: Core Treatment Phase||294
176082|NCT00566696|433984|P1|NOT COMPLETED|Overall Study||42
176083|NCT00566696|433984|P1|COMPLETED|Overall Study||31
176084|NCT00566696|433984|P1|STARTED|Overall Study||73
176085|NCT00566709|433994|P2|NOT COMPLETED|Overall Study||0
176086|NCT00566709|433995|P1|NOT COMPLETED|Overall Study||5
176087|NCT00566709|433994|P2|COMPLETED|Overall Study||51
176088|NCT00566709|433995|P1|COMPLETED|Overall Study||46
176089|NCT00566709|433994|P2|STARTED|Overall Study||51
176090|NCT00566709|433995|P1|STARTED|Overall Study||51
176091|NCT00566722|434014|P3|NOT COMPLETED|Overall Study||9
176092|NCT00566722|434015|P2|NOT COMPLETED|Overall Study||5
176093|NCT00566722|434016|P1|NOT COMPLETED|Overall Study||2
176094|NCT00566722|434014|P3|COMPLETED|Overall Study||73
176095|NCT00566722|434015|P2|COMPLETED|Overall Study||24
176096|NCT00566722|434016|P1|COMPLETED|Overall Study||39
176097|NCT00566722|434014|P3|STARTED|Overall Study||82
176098|NCT00566722|434015|P2|STARTED|Overall Study||29
176099|NCT00566722|434016|P1|STARTED|Overall Study||41
176100|NCT00566735|434062|P2|NOT COMPLETED|Overall Study||7
176101|NCT00566735|434063|P1|NOT COMPLETED|Overall Study||2
176102|NCT00566735|434062|P2|COMPLETED|Overall Study|7 participants withdrew before baselines. Therefore, 12 participants will be included in baselines.|12
176103|NCT00566735|434063|P1|COMPLETED|Overall Study|2 participants withdrew before baselines. Therefore, 18 participants will be included in baselines.|18
176104|NCT00566735|434062|P2|Withdrew Before Baseline Measures|Overall Study||7
176105|NCT00566735|434063|P1|Withdrew Before Baseline Measures|Overall Study||2
176106|NCT00566735|434062|P2|STARTED|Overall Study||19
176107|NCT00566735|434063|P1|STARTED|Overall Study||20
176108|NCT00566852|434075|P2|NOT COMPLETED|Overall Study||198
176109|NCT00566852|434076|P1|NOT COMPLETED|Overall Study||207
176110|NCT00566852|434075|P2|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|78
176111|NCT00566852|434076|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|71
176112|NCT00566852|434075|P2|STARTED|Overall Study||276
176113|NCT00566852|434076|P1|STARTED|Overall Study||278
176114|NCT00566930|434095|P3|NOT COMPLETED|Overall Study||1
176115|NCT00566930|434096|P2|NOT COMPLETED|Overall Study||4
176116|NCT00566930|434097|P1|NOT COMPLETED|Overall Study||2
176117|NCT00566930|434095|P3|COMPLETED|Overall Study||32
176118|NCT00566930|434096|P2|COMPLETED|Overall Study||32
176119|NCT00566930|434097|P1|COMPLETED|Overall Study||27
176120|NCT00566930|434095|P3|STARTED|Overall Study||33
176121|NCT00566930|434096|P2|STARTED|Overall Study||36
176122|NCT00566930|434097|P1|STARTED|Overall Study||29
176123|NCT00566943|434107|P2|NOT COMPLETED|Overall Study||0
176124|NCT00566943|434108|P1|NOT COMPLETED|Overall Study||0
176125|NCT00566943|434107|P2|COMPLETED|Overall Study||49
176126|NCT00566943|434108|P1|COMPLETED|Overall Study||52
176127|NCT00566943|434107|P2|STARTED|Overall Study||49
176128|NCT00566943|434108|P1|STARTED|Overall Study||52
176129|NCT00566969|434123|P3|NOT COMPLETED|Overall Study||12
176130|NCT00566969|434124|P2|NOT COMPLETED|Overall Study||9
176131|NCT00566969|434125|P1|NOT COMPLETED|Overall Study||15
176132|NCT00566969|434123|P3|COMPLETED|Overall Study||23
176133|NCT00566969|434124|P2|COMPLETED|Overall Study||28
176134|NCT00566969|434125|P1|COMPLETED|Overall Study||19
176135|NCT00566969|434123|P3|STARTED|Overall Study||35
176136|NCT00566969|434124|P2|STARTED|Overall Study||37
176137|NCT00566969|434125|P1|STARTED|Overall Study||34
176138|NCT00566982|434135|P2|NOT COMPLETED|Overall Study||69
176139|NCT00566982|434136|P1|NOT COMPLETED|Overall Study||8
176140|NCT00566982|434135|P2|COMPLETED|Overall Study||294
176141|NCT00566982|434136|P1|COMPLETED|Overall Study||55
176142|NCT00566982|434135|P2|STARTED|Overall Study||363
176143|NCT00566982|434136|P1|STARTED|Overall Study||63
176144|NCT00566995|434158|P1|NOT COMPLETED|Overall Study||8
176145|NCT00566995|434158|P1|COMPLETED|Overall Study||29
176146|NCT00566995|434158|P1|STARTED|Overall Study||37
176147|NCT00567008|434165|P2|NOT COMPLETED|Overall Study||1
176148|NCT00567008|434166|P1|NOT COMPLETED|Overall Study||1
176149|NCT00567008|434165|P2|COMPLETED|Overall Study||18
176150|NCT00567008|434166|P1|COMPLETED|Overall Study||17
176151|NCT00567008|434165|P2|STARTED|Overall Study||19
176152|NCT00567008|434166|P1|STARTED|Overall Study||18
176153|NCT00567112|434172|P3|NOT COMPLETED|Treatment Period 4 (3 Days)||0
176154|NCT00567112|434173|P2|NOT COMPLETED|Treatment Period 4 (3 Days)||0
176155|NCT00567112|434174|P1|NOT COMPLETED|Treatment Period 4 (3 Days)||0
176156|NCT00567112|434172|P3|COMPLETED|Treatment Period 4 (3 Days)||3
176157|NCT00567112|434173|P2|COMPLETED|Treatment Period 4 (3 Days)||7
176158|NCT00567112|434174|P1|COMPLETED|Treatment Period 4 (3 Days)||4
176159|NCT00567112|434172|P3|STARTED|Treatment Period 4 (3 Days)||3
176160|NCT00567112|434173|P2|STARTED|Treatment Period 4 (3 Days)||7
176161|NCT00567112|434174|P1|STARTED|Treatment Period 4 (3 Days)||4
176162|NCT00567112|434172|P3|NOT COMPLETED|Washout Period 3 (3 Days)||0
176163|NCT00567112|434173|P2|NOT COMPLETED|Washout Period 3 (3 Days)||0
176164|NCT00567112|434174|P1|NOT COMPLETED|Washout Period 3 (3 Days)||3
176165|NCT00567112|434172|P3|COMPLETED|Washout Period 3 (3 Days)||3
176166|NCT00567112|434173|P2|COMPLETED|Washout Period 3 (3 Days)||7
176167|NCT00567112|434174|P1|COMPLETED|Washout Period 3 (3 Days)||4
176168|NCT00567112|434172|P3|STARTED|Washout Period 3 (3 Days)||3
176169|NCT00567112|434173|P2|STARTED|Washout Period 3 (3 Days)||7
176170|NCT00567112|434174|P1|STARTED|Washout Period 3 (3 Days)||7
176171|NCT00567112|434172|P3|NOT COMPLETED|Treatment Period 3 (3 Days)||0
176172|NCT00567112|434173|P2|NOT COMPLETED|Treatment Period 3 (3 Days)||0
176173|NCT00567112|434174|P1|NOT COMPLETED|Treatment Period 3 (3 Days)||0
176174|NCT00567112|434172|P3|COMPLETED|Treatment Period 3 (3 Days)||3
176175|NCT00567112|434173|P2|COMPLETED|Treatment Period 3 (3 Days)||7
176176|NCT00567112|434174|P1|COMPLETED|Treatment Period 3 (3 Days)||7
176177|NCT00567112|434172|P3|STARTED|Treatment Period 3 (3 Days)||3
176178|NCT00567112|434173|P2|STARTED|Treatment Period 3 (3 Days)||7
176179|NCT00567112|434174|P1|STARTED|Treatment Period 3 (3 Days)||7
176180|NCT00567112|434172|P3|NOT COMPLETED|Washout Period 2 (3 Days)||0
176181|NCT00567112|434173|P2|NOT COMPLETED|Washout Period 2 (3 Days)||0
176182|NCT00567112|434174|P1|NOT COMPLETED|Washout Period 2 (3 Days)||0
176183|NCT00567112|434172|P3|COMPLETED|Washout Period 2 (3 Days)||3
176184|NCT00567112|434173|P2|COMPLETED|Washout Period 2 (3 Days)||7
176185|NCT00567112|434174|P1|COMPLETED|Washout Period 2 (3 Days)||7
176186|NCT00567112|434172|P3|STARTED|Washout Period 2 (3 Days)||3
176187|NCT00567112|434173|P2|STARTED|Washout Period 2 (3 Days)||7
176188|NCT00567112|434174|P1|STARTED|Washout Period 2 (3 Days)||7
176189|NCT00567112|434172|P3|NOT COMPLETED|Treatment Period 2 (3 Days)||0
176190|NCT00567112|434173|P2|NOT COMPLETED|Treatment Period 2 (3 Days)||1
176191|NCT00567112|434174|P1|NOT COMPLETED|Treatment Period 2 (3 Days)||0
176192|NCT00567112|434172|P3|COMPLETED|Treatment Period 2 (3 Days)||3
176193|NCT00567112|434173|P2|COMPLETED|Treatment Period 2 (3 Days)||7
176194|NCT00567112|434174|P1|COMPLETED|Treatment Period 2 (3 Days)||7
176195|NCT00567112|434172|P3|STARTED|Treatment Period 2 (3 Days)|3 new participants added to Treatment Group ABCD & received treatment sequence BCD for Periods 2-4|3
176196|NCT00567112|434173|P2|STARTED|Treatment Period 2 (3 Days)||8
176197|NCT00567112|434174|P1|STARTED|Treatment Period 2 (3 Days)||7
176198|NCT00567112|434172|P3|NOT COMPLETED|Washout Period 1 (3 Days)||0
176199|NCT00567112|434173|P2|NOT COMPLETED|Washout Period 1 (3 Days)||0
176200|NCT00567112|434174|P1|NOT COMPLETED|Washout Period 1 (3 Days)||0
176201|NCT00567112|434172|P3|COMPLETED|Washout Period 1 (3 Days)||0
176202|NCT00567112|434173|P2|COMPLETED|Washout Period 1 (3 Days)||8
176203|NCT00567112|434174|P1|COMPLETED|Washout Period 1 (3 Days)||7
176204|NCT00567112|434172|P3|STARTED|Washout Period 1 (3 Days)||0
176205|NCT00567112|434173|P2|STARTED|Washout Period 1 (3 Days)||8
176206|NCT00567112|434174|P1|STARTED|Washout Period 1 (3 Days)||7
176207|NCT00567112|434172|P3|NOT COMPLETED|Treatment Period 1 (3 Days)||0
176208|NCT00567112|434173|P2|NOT COMPLETED|Treatment Period 1 (3 Days)||0
176209|NCT00567112|434174|P1|NOT COMPLETED|Treatment Period 1 (3 Days)||0
176210|NCT00567112|434172|P3|COMPLETED|Treatment Period 1 (3 Days)||0
176211|NCT00567112|434173|P2|COMPLETED|Treatment Period 1 (3 Days)||8
176212|NCT00567112|434174|P1|COMPLETED|Treatment Period 1 (3 Days)||7
176213|NCT00567112|434172|P3|STARTED|Treatment Period 1 (3 Days)||0
176214|NCT00567112|434173|P2|STARTED|Treatment Period 1 (3 Days)||8
176215|NCT00567112|434174|P1|STARTED|Treatment Period 1 (3 Days)||7
176216|NCT00567164|434199|P3|NOT COMPLETED|Overall Study||72
176217|NCT00567164|434200|P2|NOT COMPLETED|Overall Study||73
176218|NCT00567164|434201|P1|NOT COMPLETED|Overall Study||546
176219|NCT00567164|434199|P3|COMPLETED|Overall Study||160
176220|NCT00567164|434200|P2|COMPLETED|Overall Study||161
176221|NCT00567164|434201|P1|COMPLETED|Overall Study||875
176222|NCT00567164|434199|P3|Subjects Received Treatment|Overall Study|Full Analysis Set|226
176223|NCT00567164|434200|P2|Subjects Received Treatment|Overall Study|Full Analysis Set|232
176224|NCT00567164|434201|P1|Subjects Received Treatment|Overall Study|Full Analysis Set|1406
176225|NCT00567164|434199|P3|STARTED|Overall Study||232
176226|NCT00567164|434200|P2|STARTED|Overall Study||234
176227|NCT00567164|434201|P1|STARTED|Overall Study||1421
176228|NCT00567190|434275|P2|NOT COMPLETED|Overall Study||264
176229|NCT00567190|434276|P1|NOT COMPLETED|Overall Study||210
176230|NCT00567190|434275|P2|COMPLETED|Overall Study|On 11 February 2014, 37 were alive and on study treatment; 105 were alive and in survival follow-up|142
176231|NCT00567190|434276|P1|COMPLETED|Overall Study|On 11 February 2014, 67 were alive and on study treatment; 125 were alive and in survival follow-up|192
176232|NCT00567190|434275|P2|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|406
176233|NCT00567190|434276|P1|STARTED|Overall Study|All randomized patients (Intent-to-Treat [ITT]) population|402
176234|NCT00567229|434293|P1|NOT COMPLETED|Overall Study||0
176235|NCT00567229|434293|P1|COMPLETED|Overall Study||3
176236|NCT00567229|434293|P1|STARTED|Overall Study||3
176237|NCT00567242|434299|P2|NOT COMPLETED|Overall Study||0
176238|NCT00567242|434300|P1|NOT COMPLETED|Overall Study||0
176239|NCT00567242|434299|P2|COMPLETED|Overall Study||7
176240|NCT00567242|434300|P1|COMPLETED|Overall Study||7
176241|NCT00567242|434299|P2|STARTED|Overall Study||7
176242|NCT00567242|434300|P1|STARTED|Overall Study||7
176243|NCT00567255|434312|P2|NOT COMPLETED|Overall Study||228
176244|NCT00567255|434313|P1|NOT COMPLETED|Overall Study||463
176245|NCT00567255|434312|P2|COMPLETED|Overall Study||267
176246|NCT00567255|434313|P1|COMPLETED|Overall Study||538
176247|NCT00567255|434312|P2|STARTED|Overall Study||495
176248|NCT00567255|434313|P1|STARTED|Overall Study||1001
176249|NCT00567268|434357|P1|NOT COMPLETED|Overall Study||50
176250|NCT00567268|434357|P1|COMPLETED|Overall Study||1144
176251|NCT00567268|434357|P1|STARTED|Overall Study||1194
176252|NCT00567307|434408|P2|NOT COMPLETED|Overall Study||1
176253|NCT00567307|434409|P1|NOT COMPLETED|Overall Study||12
176254|NCT00567307|434408|P2|COMPLETED|Overall Study||104
176255|NCT00567307|434409|P1|COMPLETED|Overall Study||99
176256|NCT00567307|434408|P2|STARTED|Overall Study||105
176257|NCT00567307|434409|P1|STARTED|Overall Study||111
176258|NCT00567320|434417|P2|NOT COMPLETED|Overall Study||0
176259|NCT00567320|434418|P1|NOT COMPLETED|Overall Study||0
176260|NCT00567320|434417|P2|COMPLETED|Overall Study||18
176261|NCT00567320|434418|P1|COMPLETED|Overall Study||13
176262|NCT00567320|434417|P2|STARTED|Overall Study||18
176263|NCT00567320|434418|P1|STARTED|Overall Study||13
176264|NCT00567476|434426|P2|NOT COMPLETED|Overall Study||4
176265|NCT00567476|434427|P1|NOT COMPLETED|Overall Study||8
176266|NCT00567476|434426|P2|COMPLETED|Overall Study||34
176267|NCT00567476|434427|P1|COMPLETED|Overall Study||70
176268|NCT00567476|434426|P2|STARTED|Overall Study||38
176269|NCT00567476|434427|P1|STARTED|Overall Study||78
176270|NCT00567502|434455|P4|NOT COMPLETED|Overall Study||87
176271|NCT00567502|434456|P3|NOT COMPLETED|Overall Study||908
176272|NCT00567502|434457|P2|NOT COMPLETED|Overall Study||33
176273|NCT00567502|434458|P1|NOT COMPLETED|Overall Study||241
176274|NCT00567502|434455|P4|COMPLETED|Overall Study||23
176275|NCT00567502|434456|P3|COMPLETED|Overall Study||1758
176276|NCT00567502|434457|P2|COMPLETED|Overall Study||108
176277|NCT00567502|434458|P1|COMPLETED|Overall Study||563
176278|NCT00567502|434455|P4|Initiated Treatment|Overall Study||38
176279|NCT00567502|434456|P3|Initiated Treatment|Overall Study||2666
176280|NCT00567502|434457|P2|Initiated Treatment|Overall Study||141
176281|NCT00567502|434458|P1|Initiated Treatment|Overall Study||804
176282|NCT00567502|434455|P4|STARTED|Overall Study||110
176283|NCT00567502|434456|P3|STARTED|Overall Study||2666
176284|NCT00567502|434457|P2|STARTED|Overall Study||141
176285|NCT00567502|434458|P1|STARTED|Overall Study||804
176286|NCT00567541|434495|P2|NOT COMPLETED|Overall Study||1
176287|NCT00567541|434496|P1|NOT COMPLETED|Overall Study||0
176288|NCT00567541|434495|P2|COMPLETED|Overall Study||8
176289|NCT00567541|434496|P1|COMPLETED|Overall Study||7
176290|NCT00567541|434495|P2|STARTED|Overall Study||9
176291|NCT00567541|434496|P1|STARTED|Overall Study||7
176292|NCT00567567|434505|P3|NOT COMPLETED|Overall Study||278
176293|NCT00567567|434506|P2|NOT COMPLETED|Overall Study||134
176294|NCT00567567|434507|P1|NOT COMPLETED|Overall Study||152
176295|NCT00567567|434505|P3|COMPLETED|Overall Study||1
176296|NCT00567567|434506|P2|COMPLETED|Overall Study||42
176297|NCT00567567|434507|P1|COMPLETED|Overall Study||58
176298|NCT00567567|434505|P3|STARTED|Overall Study||279
176299|NCT00567567|434506|P2|STARTED|Overall Study||176
176300|NCT00567567|434507|P1|STARTED|Overall Study||210
176301|NCT00567593|434531|P1|NOT COMPLETED|Overall Study||2
176302|NCT00567593|434531|P1|COMPLETED|Overall Study||10
176303|NCT00567593|434531|P1|STARTED|Overall Study||12
176304|NCT00567840|434540|P5|NOT COMPLETED|Overall Study||0
176305|NCT00567840|434541|P4|NOT COMPLETED|Overall Study||1
176306|NCT00567840|434542|P3|NOT COMPLETED|Overall Study||1
176307|NCT00567840|434543|P2|NOT COMPLETED|Overall Study||0
176308|NCT00567840|434544|P1|NOT COMPLETED|Overall Study||2
176309|NCT00567840|434540|P5|COMPLETED|Overall Study||8
176310|NCT00567840|434541|P4|COMPLETED|Overall Study||14
176311|NCT00567840|434542|P3|COMPLETED|Overall Study||15
176312|NCT00567840|434543|P2|COMPLETED|Overall Study||15
176313|NCT00567840|434544|P1|COMPLETED|Overall Study||13
176314|NCT00567840|434540|P5|STARTED|Overall Study||8
176315|NCT00567840|434541|P4|STARTED|Overall Study||15
176316|NCT00567840|434542|P3|STARTED|Overall Study||16
176317|NCT00567840|434543|P2|STARTED|Overall Study||15
176318|NCT00567840|434544|P1|STARTED|Overall Study||15
176319|NCT00567879|434587|P6|NOT COMPLETED|Overall Study||3
176320|NCT00567879|434588|P5|NOT COMPLETED|Overall Study||12
176321|NCT00567879|434589|P4|NOT COMPLETED|Overall Study||6
176322|NCT00567879|434590|P3|NOT COMPLETED|Overall Study||21
176323|NCT00567879|434591|P2|NOT COMPLETED|Overall Study||7
176324|NCT00567879|434592|P1|NOT COMPLETED|Overall Study||7
176325|NCT00567879|434587|P6|COMPLETED|Overall Study||0
176326|NCT00567879|434588|P5|COMPLETED|Overall Study||0
176327|NCT00567879|434589|P4|COMPLETED|Overall Study||0
176328|NCT00567879|434590|P3|COMPLETED|Overall Study||0
176329|NCT00567879|434591|P2|COMPLETED|Overall Study||0
176330|NCT00567879|434592|P1|COMPLETED|Overall Study||0
176331|NCT00567879|434587|P6|Maximum Tolerated Dose Determining Set|Overall Study||3
176332|NCT00567879|434588|P5|Maximum Tolerated Dose Determining Set|Overall Study||12
176333|NCT00567879|434589|P4|Maximum Tolerated Dose Determining Set|Overall Study||6
176334|NCT00567879|434590|P3|Maximum Tolerated Dose Determining Set|Overall Study|6 participants belonged to the dose expansion group at 20mg/m2 i.v.|18
176335|NCT00567879|434591|P2|Maximum Tolerated Dose Determining Set|Overall Study||7
176336|NCT00567879|434592|P1|Maximum Tolerated Dose Determining Set|Overall Study||5
176337|NCT00567879|434587|P6|STARTED|Overall Study||3
176338|NCT00567879|434588|P5|STARTED|Overall Study||12
176339|NCT00567879|434589|P4|STARTED|Overall Study||6
176340|NCT00567879|434590|P3|STARTED|Overall Study|7 participants belonged to the dose expansion group at 20mg/m2 i.v.|21
176341|NCT00567879|434591|P2|STARTED|Overall Study||7
176342|NCT00567879|434592|P1|STARTED|Overall Study||7
176343|NCT00567892|434615|P4|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||1
176344|NCT00567892|434616|P3|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
176345|NCT00567892|434617|P2|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
176346|NCT00567892|434618|P1|NOT COMPLETED|Second Treatment (2 or 4 Weeks)||0
176347|NCT00567892|434615|P4|COMPLETED|Second Treatment (2 or 4 Weeks)||5
176348|NCT00567892|434616|P3|COMPLETED|Second Treatment (2 or 4 Weeks)||9
176349|NCT00567892|434617|P2|COMPLETED|Second Treatment (2 or 4 Weeks)||7
176350|NCT00567892|434618|P1|COMPLETED|Second Treatment (2 or 4 Weeks)||7
176351|NCT00567892|434615|P4|STARTED|Second Treatment (2 or 4 Weeks)||6
176352|NCT00567892|434616|P3|STARTED|Second Treatment (2 or 4 Weeks)||9
176353|NCT00567892|434617|P2|STARTED|Second Treatment (2 or 4 Weeks)||7
176354|NCT00567892|434618|P1|STARTED|Second Treatment (2 or 4 Weeks)||7
176355|NCT00567892|434615|P4|NOT COMPLETED|Washout (2 Weeks)||0
176356|NCT00567892|434616|P3|NOT COMPLETED|Washout (2 Weeks)||0
176357|NCT00567892|434617|P2|NOT COMPLETED|Washout (2 Weeks)||0
176358|NCT00567892|434618|P1|NOT COMPLETED|Washout (2 Weeks)||0
176359|NCT00567892|434615|P4|COMPLETED|Washout (2 Weeks)||6
176360|NCT00567892|434616|P3|COMPLETED|Washout (2 Weeks)||9
176361|NCT00567892|434617|P2|COMPLETED|Washout (2 Weeks)||7
176362|NCT00567892|434618|P1|COMPLETED|Washout (2 Weeks)||7
176363|NCT00567892|434615|P4|STARTED|Washout (2 Weeks)||6
176364|NCT00567892|434616|P3|STARTED|Washout (2 Weeks)||9
176365|NCT00567892|434617|P2|STARTED|Washout (2 Weeks)||7
176366|NCT00567892|434618|P1|STARTED|Washout (2 Weeks)||7
176367|NCT00567892|434615|P4|NOT COMPLETED|First Treatment (2 or 4 Weeks)||4
176368|NCT00567892|434616|P3|NOT COMPLETED|First Treatment (2 or 4 Weeks)||1
176369|NCT00567892|434617|P2|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
176370|NCT00567892|434618|P1|NOT COMPLETED|First Treatment (2 or 4 Weeks)||0
176371|NCT00567892|434615|P4|COMPLETED|First Treatment (2 or 4 Weeks)||6
176372|NCT00567892|434616|P3|COMPLETED|First Treatment (2 or 4 Weeks)||9
176373|NCT00567892|434617|P2|COMPLETED|First Treatment (2 or 4 Weeks)||7
176374|NCT00567892|434618|P1|COMPLETED|First Treatment (2 or 4 Weeks)||7
176375|NCT00567892|434615|P4|STARTED|First Treatment (2 or 4 Weeks)||10
176376|NCT00567892|434616|P3|STARTED|First Treatment (2 or 4 Weeks)||10
176377|NCT00567892|434617|P2|STARTED|First Treatment (2 or 4 Weeks)||7
176378|NCT00567892|434618|P1|STARTED|First Treatment (2 or 4 Weeks)||7
176379|NCT00567996|434633|P3|NOT COMPLETED|Overall Study||70
176380|NCT00567996|434634|P2|NOT COMPLETED|Overall Study||50
176381|NCT00567996|434635|P1|NOT COMPLETED|Overall Study||44
176382|NCT00567996|434633|P3|COMPLETED|Overall Study||265
176383|NCT00567996|434634|P2|COMPLETED|Overall Study||284
176384|NCT00567996|434635|P1|COMPLETED|Overall Study||289
176385|NCT00567996|434633|P3|Intent-to-treat: Received Study Drug|Overall Study||335
176386|NCT00567996|434634|P2|Intent-to-treat: Received Study Drug|Overall Study||333
176387|NCT00567996|434635|P1|Intent-to-treat: Received Study Drug|Overall Study||330
176388|NCT00567996|434633|P3|STARTED|Overall Study||335
176389|NCT00567996|434634|P2|STARTED|Overall Study||334
176390|NCT00567996|434635|P1|STARTED|Overall Study|Randomized participants|333
176391|NCT00568022|434652|P3|NOT COMPLETED|Overall Study||0
176392|NCT00568022|434653|P2|NOT COMPLETED|Overall Study||0
176393|NCT00568022|434654|P1|NOT COMPLETED|Overall Study||0
176394|NCT00568022|434652|P3|COMPLETED|Overall Study||3
176395|NCT00568022|434653|P2|COMPLETED|Overall Study||3
176396|NCT00568022|434654|P1|COMPLETED|Overall Study||3
176397|NCT00568022|434652|P3|STARTED|Overall Study||3
176398|NCT00568022|434653|P2|STARTED|Overall Study||3
176399|NCT00568022|434654|P1|STARTED|Overall Study||3
176400|NCT00568061|434686|P2|NOT COMPLETED|Overall Study||2
176401|NCT00568061|434687|P1|NOT COMPLETED|Overall Study||5
176402|NCT00568061|434686|P2|COMPLETED|Overall Study||14
176403|NCT00568061|434687|P1|COMPLETED|Overall Study||8
176404|NCT00568061|434686|P2|STARTED|Overall Study||16
176405|NCT00568061|434687|P1|STARTED|Overall Study||13
176406|NCT00568087|434695|P2|NOT COMPLETED|Overall Study||7
176407|NCT00568087|434696|P1|NOT COMPLETED|Overall Study||7
176408|NCT00568087|434695|P2|COMPLETED|Overall Study||17
176409|NCT00568087|434696|P1|COMPLETED|Overall Study||15
176410|NCT00568087|434695|P2|Received Intervention|Overall Study||23
176411|NCT00568087|434696|P1|Received Intervention|Overall Study||21
176412|NCT00568087|434695|P2|STARTED|Overall Study||24
176413|NCT00568087|434696|P1|STARTED|Overall Study||22
176414|NCT00568178|434708|P6|NOT COMPLETED|Open Label Extension||80
176415|NCT00568178|434709|P5|NOT COMPLETED|Open Label Extension||79
176416|NCT00568178|434710|P4|NOT COMPLETED|Open Label Extension||0
176417|NCT00568178|434711|P3|NOT COMPLETED|Open Label Extension||0
176418|NCT00568178|434712|P2|NOT COMPLETED|Open Label Extension||0
176419|NCT00568178|434713|P1|NOT COMPLETED|Open Label Extension||0
176420|NCT00568178|434708|P6|COMPLETED|Open Label Extension||54
176421|NCT00568178|434709|P5|COMPLETED|Open Label Extension||55
176422|NCT00568178|434710|P4|COMPLETED|Open Label Extension||0
176423|NCT00568178|434711|P3|COMPLETED|Open Label Extension||0
176424|NCT00568178|434712|P2|COMPLETED|Open Label Extension||0
176425|NCT00568178|434713|P1|COMPLETED|Open Label Extension||0
176426|NCT00568178|434708|P6|STARTED|Open Label Extension||134
176427|NCT00568178|434709|P5|STARTED|Open Label Extension||134
176428|NCT00568178|434710|P4|STARTED|Open Label Extension||0
176429|NCT00568178|434711|P3|STARTED|Open Label Extension||0
176430|NCT00568178|434712|P2|STARTED|Open Label Extension||0
176431|NCT00568178|434713|P1|STARTED|Open Label Extension||0
176432|NCT00568178|434708|P6|NOT COMPLETED|Double Blind Base Study||0
176433|NCT00568178|434709|P5|NOT COMPLETED|Double Blind Base Study||0
176434|NCT00568178|434710|P4|NOT COMPLETED|Double Blind Base Study||5
176435|NCT00568178|434711|P3|NOT COMPLETED|Double Blind Base Study||1
176436|NCT00568178|434712|P2|NOT COMPLETED|Double Blind Base Study||6
176437|NCT00568178|434713|P1|NOT COMPLETED|Double Blind Base Study||6
176438|NCT00568178|434708|P6|COMPLETED|Double Blind Base Study||0
176439|NCT00568178|434709|P5|COMPLETED|Double Blind Base Study||0
176440|NCT00568178|434710|P4|COMPLETED|Double Blind Base Study||25
176441|NCT00568178|434711|P3|COMPLETED|Double Blind Base Study||29
176442|NCT00568178|434712|P2|COMPLETED|Double Blind Base Study||118
176443|NCT00568178|434713|P1|COMPLETED|Double Blind Base Study||116
176444|NCT00568178|434708|P6|STARTED|Double Blind Base Study||0
176445|NCT00568178|434709|P5|STARTED|Double Blind Base Study||0
176446|NCT00568178|434710|P4|STARTED|Double Blind Base Study||30
176447|NCT00568178|434711|P3|STARTED|Double Blind Base Study||30
176448|NCT00568178|434712|P2|STARTED|Double Blind Base Study||124
176449|NCT00568178|434713|P1|STARTED|Double Blind Base Study||122
176450|NCT00568334|434731|P2|NOT COMPLETED|Overall Study||1
176451|NCT00568334|434732|P1|NOT COMPLETED|Overall Study||1
176452|NCT00568334|434731|P2|COMPLETED|Overall Study||121
176453|NCT00568334|434732|P1|COMPLETED|Overall Study||121
176454|NCT00568334|434731|P2|STARTED|Overall Study||122
176455|NCT00568334|434732|P1|STARTED|Overall Study||122
176456|NCT00568386|434758|P2|NOT COMPLETED|Overall Study||0
176457|NCT00568386|434759|P1|NOT COMPLETED|Overall Study||0
176458|NCT00568386|434758|P2|COMPLETED|Overall Study||20
176459|NCT00568386|434759|P1|COMPLETED|Overall Study||20
176460|NCT00568386|434758|P2|STARTED|Overall Study||20
176461|NCT00568386|434759|P1|STARTED|Overall Study||20
176462|NCT00568399|434765|P1|NOT COMPLETED|Overall Study||15
176463|NCT00568399|434765|P1|COMPLETED|Overall Study|Of 48 subject enrolled, 37 initiated sodium thiosulfate treatment. 22 completed the entire protocol|22
176464|NCT00568399|434765|P1|STARTED|Overall Study||37
176465|NCT00568451|434773|P4|NOT COMPLETED|Overall Study||7
176466|NCT00568451|434774|P3|NOT COMPLETED|Overall Study||2
176467|NCT00568451|434775|P2|NOT COMPLETED|Overall Study||0
176468|NCT00568451|434776|P1|NOT COMPLETED|Overall Study||0
176469|NCT00568451|434773|P4|COMPLETED|Overall Study||2
176470|NCT00568451|434774|P3|COMPLETED|Overall Study||0
176471|NCT00568451|434775|P2|COMPLETED|Overall Study||0
176472|NCT00568451|434776|P1|COMPLETED|Overall Study||0
176473|NCT00568451|434773|P4|STARTED|Overall Study||9
176474|NCT00568451|434774|P3|STARTED|Overall Study||2
176475|NCT00568451|434775|P2|STARTED|Overall Study||0
176476|NCT00568451|434776|P1|STARTED|Overall Study||0
176477|NCT00556491|434794|P2|NOT COMPLETED|Overall Study||1
176478|NCT00556491|434795|P1|NOT COMPLETED|Overall Study||1
176479|NCT00556491|434794|P2|COMPLETED|Overall Study||19
176480|NCT00556491|434795|P1|COMPLETED|Overall Study||19
176481|NCT00556491|434794|P2|STARTED|Overall Study||20
176482|NCT00556491|434795|P1|STARTED|Overall Study|January 2008|20
176483|NCT00556504|434803|P2|NOT COMPLETED|Overall Study||9
176484|NCT00556504|434804|P1|NOT COMPLETED|Overall Study||8
176485|NCT00556504|434803|P2|COMPLETED|Overall Study||33
176486|NCT00556504|434804|P1|COMPLETED|Overall Study||34
176487|NCT00556504|434803|P2|Safety Population|Overall Study||42
176488|NCT00556504|434804|P1|Safety Population|Overall Study||41
176489|NCT00556504|434803|P2|Intend-to Treat Population|Overall Study||42
176490|NCT00556504|434804|P1|Intend-to Treat Population|Overall Study||42
176491|NCT00556504|434803|P2|STARTED|Overall Study||42
176492|NCT00556504|434804|P1|STARTED|Overall Study||42
176493|NCT00556543|434822|P1|NOT COMPLETED|Overall Study||0
176494|NCT00556543|434822|P1|COMPLETED|Overall Study|Subjects completed 180 days of study enrollment|10
176495|NCT00556543|434822|P1|STARTED|Overall Study||10
176496|NCT00556673|434840|P2|NOT COMPLETED|Overall Study||2
176497|NCT00556673|434841|P1|NOT COMPLETED|Overall Study||3
176498|NCT00556673|434840|P2|COMPLETED|Overall Study||13
176499|NCT00556673|434841|P1|COMPLETED|Overall Study||13
176500|NCT00556673|434840|P2|Pharmacodynamic (PD) Population|Overall Study|3 patients inadvertently unblinded were not included in PD analysis population.|12
176501|NCT00556673|434841|P1|Pharmacodynamic (PD) Population|Overall Study|4 patients inadvertently unblinded were not included in PD analysis population.|12
176502|NCT00556673|434840|P2|STARTED|Overall Study||15
176503|NCT00556673|434841|P1|STARTED|Overall Study||16
176504|NCT00556712|434879|P2|NOT COMPLETED|Overall Study||438
176505|NCT00556712|434880|P1|NOT COMPLETED|Overall Study||451
176506|NCT00556712|434879|P2|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
176507|NCT00556712|434880|P1|COMPLETED|Overall Study|Data cutoff date: 17 May 2008|0
176508|NCT00556712|434879|P2|STARTED|Overall Study||438
176509|NCT00556712|434880|P1|STARTED|Overall Study||451
176510|NCT00562315|434956|P1|NOT COMPLETED|Overall Study||0
176511|NCT00562315|434956|P1|COMPLETED|Overall Study||93
176512|NCT00562315|434956|P1|STARTED|Overall Study||93
176513|NCT00562328|434971|P1|NOT COMPLETED|Overall Study||0
176514|NCT00562328|434971|P1|COMPLETED|Overall Study||33
176515|NCT00562328|434971|P1|STARTED|Overall Study||33
176516|NCT00562354|434977|P2|NOT COMPLETED|Overall Study||2
176517|NCT00562354|434978|P1|NOT COMPLETED|Overall Study||0
176518|NCT00562354|434977|P2|COMPLETED|Overall Study||135
176519|NCT00562354|434978|P1|COMPLETED|Overall Study||134
176520|NCT00562354|434977|P2|Evaluable Immunogenicity Population|Overall Study||134
176521|NCT00562354|434978|P1|Evaluable Immunogenicity Population|Overall Study||134
176522|NCT00562354|434977|P2|Received Study Treatment|Overall Study||136
176523|NCT00562354|434978|P1|Received Study Treatment|Overall Study||134
176524|NCT00562354|434977|P2|STARTED|Overall Study||137
176525|NCT00562354|434978|P1|STARTED|Overall Study||134
176526|NCT00562484|435021|P2|NOT COMPLETED|Overall Study||104
176527|NCT00562484|435022|P1|NOT COMPLETED|Overall Study||206
176528|NCT00562484|435021|P2|COMPLETED|Overall Study||4907
176529|NCT00562484|435022|P1|COMPLETED|Overall Study||9827
176530|NCT00562484|435021|P2|STARTED|Overall Study||5011
176531|NCT00562484|435022|P1|STARTED|Overall Study||10033
176532|NCT00562588|435054|P2|NOT COMPLETED|Overall Study||99
176533|NCT00562588|435055|P1|NOT COMPLETED|Overall Study||92
176534|NCT00562588|435054|P2|COMPLETED|Overall Study||184
176535|NCT00562588|435055|P1|COMPLETED|Overall Study||168
176536|NCT00562588|435054|P2|STARTED|Overall Study||283
176537|NCT00562588|435055|P1|STARTED|Overall Study||260
176538|NCT00562627|435086|P3|NOT COMPLETED|Overall Study||1
176539|NCT00562627|435087|P2|NOT COMPLETED|Overall Study||1
176540|NCT00562627|435088|P1|NOT COMPLETED|Overall Study||1
176541|NCT00562627|435086|P3|COMPLETED|Overall Study||33
176542|NCT00562627|435087|P2|COMPLETED|Overall Study||33
176543|NCT00562627|435088|P1|COMPLETED|Overall Study||33
176544|NCT00562627|435086|P3|STARTED|Overall Study||34
176545|NCT00562627|435087|P2|STARTED|Overall Study||34
176546|NCT00562627|435088|P1|STARTED|Overall Study||34
176547|NCT00568555|435104|P2|NOT COMPLETED|Overall Study||1
176548|NCT00568555|435105|P1|NOT COMPLETED|Overall Study||1
176549|NCT00568555|435104|P2|COMPLETED|Overall Study||14
176550|NCT00568555|435105|P1|COMPLETED|Overall Study||15
176551|NCT00568555|435104|P2|STARTED|Overall Study||15
176552|NCT00568555|435105|P1|STARTED|Overall Study||16
176553|NCT00568685|435122|P3|NOT COMPLETED|Overall Study||5
176554|NCT00568685|435123|P2|NOT COMPLETED|Overall Study||5
176555|NCT00568685|435124|P1|NOT COMPLETED|Overall Study||10
176556|NCT00568685|435122|P3|COMPLETED|Overall Study||46
176557|NCT00568685|435123|P2|COMPLETED|Overall Study||46
176558|NCT00568685|435124|P1|COMPLETED|Overall Study||41
176559|NCT00568685|435122|P3|STARTED|Overall Study||51
176560|NCT00568685|435123|P2|STARTED|Overall Study||51
176561|NCT00568685|435124|P1|STARTED|Overall Study||51
176562|NCT00568776|435160|P4|NOT COMPLETED|Overall Study||72
176563|NCT00568776|435161|P3|NOT COMPLETED|Overall Study||74
176564|NCT00568776|435162|P2|NOT COMPLETED|Overall Study||36
176565|NCT00568776|435163|P1|NOT COMPLETED|Overall Study||30
176566|NCT00568776|435160|P4|COMPLETED|Overall Study||19
176567|NCT00568776|435161|P3|COMPLETED|Overall Study||15
176568|NCT00568776|435162|P2|COMPLETED|Overall Study||52
176569|NCT00568776|435163|P1|COMPLETED|Overall Study||53
176570|NCT00568776|435160|P4|STARTED|Overall Study|42 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|91
176571|NCT00568776|435161|P3|STARTED|Overall Study|41 patients withdrawn per interim safety review (sponsors decision); excluded in efficacy analysis.|89
176572|NCT00568776|435162|P2|STARTED|Overall Study|One randomized patient withdrew consent and did not receive ELND005 250 mg BID|88
176573|NCT00568776|435163|P1|STARTED|Overall Study|One randomized patient withdrew consent and did not receive placebo|83
176574|NCT00568854|435199|P2|NOT COMPLETED|Overall Study||0
176575|NCT00568854|435200|P1|NOT COMPLETED|Overall Study||0
176576|NCT00568854|435199|P2|COMPLETED|Overall Study||4
176577|NCT00568854|435200|P1|COMPLETED|Overall Study||6
176578|NCT00568854|435199|P2|STARTED|Overall Study||4
176579|NCT00568854|435200|P1|STARTED|Overall Study||6
176580|NCT00568958|435210|P2|NOT COMPLETED|Follow-Up||4
176581|NCT00568958|435211|P1|NOT COMPLETED|Follow-Up||8
176582|NCT00568958|435210|P2|COMPLETED|Follow-Up||63
176583|NCT00568958|435211|P1|COMPLETED|Follow-Up||53
176584|NCT00568958|435210|P2|STARTED|Follow-Up||67
176585|NCT00568958|435211|P1|STARTED|Follow-Up||61
176586|NCT00568958|435210|P2|NOT COMPLETED|Allocation||3
176587|NCT00568958|435211|P1|NOT COMPLETED|Allocation||9
176588|NCT00568958|435210|P2|COMPLETED|Allocation||67
176589|NCT00568958|435211|P1|COMPLETED|Allocation||61
176590|NCT00568958|435210|P2|STARTED|Allocation||70
176591|NCT00568958|435211|P1|STARTED|Allocation||70
176592|NCT00569010|435233|P4|NOT COMPLETED|Overall Study||0
176593|NCT00569010|435234|P3|NOT COMPLETED|Overall Study||0
176594|NCT00569010|435235|P2|NOT COMPLETED|Overall Study||0
176595|NCT00569010|435236|P1|NOT COMPLETED|Overall Study||0
176596|NCT00569010|435233|P4|COMPLETED|Overall Study||11
176597|NCT00569010|435234|P3|COMPLETED|Overall Study||11
176598|NCT00569010|435235|P2|COMPLETED|Overall Study||6
176599|NCT00569010|435236|P1|COMPLETED|Overall Study||6
176600|NCT00569010|435233|P4|STARTED|Overall Study||11
176601|NCT00569010|435234|P3|STARTED|Overall Study||11
176602|NCT00569010|435235|P2|STARTED|Overall Study||6
176603|NCT00569010|435236|P1|STARTED|Overall Study||6
176604|NCT00569127|435248|P2|NOT COMPLETED|Overall Study||213
176605|NCT00569127|435249|P1|NOT COMPLETED|Overall Study||214
176606|NCT00569127|435248|P2|COMPLETED|Overall Study||0
176607|NCT00569127|435249|P1|COMPLETED|Overall Study||0
176608|NCT00569127|435248|P2|Eligible|Overall Study||202
176609|NCT00569127|435249|P1|Eligible|Overall Study||200
176610|NCT00569127|435248|P2|STARTED|Overall Study||213
176611|NCT00569127|435249|P1|STARTED|Overall Study||214
176612|NCT00569166|435268|P3|NOT COMPLETED|Overall Study||4
176613|NCT00569166|435269|P2|NOT COMPLETED|Overall Study||6
176614|NCT00569166|435270|P1|NOT COMPLETED|Overall Study||9
176615|NCT00569166|435268|P3|COMPLETED|Overall Study||27
176616|NCT00569166|435269|P2|COMPLETED|Overall Study||25
176617|NCT00569166|435270|P1|COMPLETED|Overall Study||21
176618|NCT00569166|435268|P3|STARTED|Overall Study||31
176619|NCT00569166|435269|P2|STARTED|Overall Study||31
176620|NCT00569166|435270|P1|STARTED|Overall Study||30
176621|NCT00569192|435305|P3|NOT COMPLETED|Overall Study||25
176622|NCT00569192|435306|P2|NOT COMPLETED|Overall Study||20
176623|NCT00569192|435307|P1|NOT COMPLETED|Overall Study||23
176624|NCT00569192|435305|P3|COMPLETED|Overall Study||99
176625|NCT00569192|435306|P2|COMPLETED|Overall Study||105
176626|NCT00569192|435307|P1|COMPLETED|Overall Study||88
176627|NCT00569192|435305|P3|STARTED|Overall Study||124
176628|NCT00569192|435306|P2|STARTED|Overall Study||125
176629|NCT00569192|435307|P1|STARTED|Overall Study||111
176630|NCT00569231|435330|P1|NOT COMPLETED|Overall Study||7
176631|NCT00569231|435330|P1|COMPLETED|Overall Study||11
176632|NCT00569231|435330|P1|STARTED|Overall Study||18
176633|NCT00569270|435337|P2|NOT COMPLETED|Period: Second Intervention||0
176634|NCT00569270|435338|P1|NOT COMPLETED|Period: Second Intervention||0
176635|NCT00569270|435337|P2|COMPLETED|Period: Second Intervention||14
176636|NCT00569270|435338|P1|COMPLETED|Period: Second Intervention||15
176637|NCT00569270|435337|P2|29 Days|Period: Second Intervention||14
176638|NCT00569270|435338|P1|29 Days|Period: Second Intervention||15
176639|NCT00569270|435337|P2|STARTED|Period: Second Intervention||14
176640|NCT00569270|435338|P1|STARTED|Period: Second Intervention||15
176641|NCT00569270|435337|P2|NOT COMPLETED|Period: First Intervention||1
176642|NCT00569270|435338|P1|NOT COMPLETED|Period: First Intervention||0
176643|NCT00569270|435337|P2|COMPLETED|Period: First Intervention||14
176644|NCT00569270|435338|P1|COMPLETED|Period: First Intervention||15
176645|NCT00569270|435337|P2|STARTED|Period: First Intervention||15
176646|NCT00569270|435338|P1|STARTED|Period: First Intervention|randomized cross over study|15
176647|NCT00569374|435373|P1|NOT COMPLETED|Overall Study||4
176648|NCT00569374|435373|P1|COMPLETED|Overall Study||4
176649|NCT00569374|435373|P1|STARTED|Overall Study||8
176650|NCT00569530|435385|P2|NOT COMPLETED|Overall Study||0
176651|NCT00569530|435386|P1|NOT COMPLETED|Overall Study||0
176652|NCT00569530|435385|P2|COMPLETED|Overall Study||42
176653|NCT00569530|435386|P1|COMPLETED|Overall Study||43
176654|NCT00569530|435385|P2|STARTED|Overall Study||42
176655|NCT00569530|435386|P1|STARTED|Overall Study||43
176656|NCT00569582|435394|P1|NOT COMPLETED|Overall Study||16
176657|NCT00569582|435394|P1|COMPLETED|Overall Study||34
176658|NCT00569582|435394|P1|STARTED|Overall Study||50
176659|NCT00569660|435399|P1|NOT COMPLETED|Overall Study||0
176660|NCT00569660|435399|P1|COMPLETED|Overall Study||34
176661|NCT00569660|435399|P1|STARTED|Overall Study||34
176662|NCT00569673|435403|P1|NOT COMPLETED|Overall Study||0
176663|NCT00569673|435403|P1|COMPLETED|Overall Study|Total number participants that are eligible and evaluable.|71
176664|NCT00569673|435403|P1|STARTED|Overall Study|Total number participants enrolled on study|71
176665|NCT00569777|435409|P2|NOT COMPLETED|Overall Study||3
176666|NCT00569777|435410|P1|NOT COMPLETED|Overall Study||10
176667|NCT00569777|435409|P2|COMPLETED|Overall Study||101
176668|NCT00569777|435410|P1|COMPLETED|Overall Study||196
176669|NCT00569777|435409|P2|STARTED|Overall Study||104
176670|NCT00569777|435410|P1|STARTED|Overall Study||206
176671|NCT00569803|435460|P8|NOT COMPLETED|Overall Study||1
176672|NCT00569803|435461|P7|NOT COMPLETED|Overall Study||0
176673|NCT00569803|435462|P6|NOT COMPLETED|Overall Study||0
176674|NCT00569803|435463|P5|NOT COMPLETED|Overall Study||0
176675|NCT00569803|435464|P4|NOT COMPLETED|Overall Study||1
176676|NCT00569803|435465|P3|NOT COMPLETED|Overall Study||0
176677|NCT00569803|435466|P2|NOT COMPLETED|Overall Study||0
176678|NCT00569803|435467|P1|NOT COMPLETED|Overall Study||1
176679|NCT00569803|435460|P8|COMPLETED|Overall Study||5
176680|NCT00569803|435461|P7|COMPLETED|Overall Study||10
176681|NCT00569803|435462|P6|COMPLETED|Overall Study||5
176682|NCT00569803|435463|P5|COMPLETED|Overall Study||5
176683|NCT00569803|435464|P4|COMPLETED|Overall Study||5
176684|NCT00569803|435465|P3|COMPLETED|Overall Study||5
176685|NCT00569803|435466|P2|COMPLETED|Overall Study||5
176686|NCT00569803|435467|P1|COMPLETED|Overall Study||4
176687|NCT00569803|435460|P8|STARTED|Overall Study||6
176688|NCT00569803|435461|P7|STARTED|Overall Study||10
176689|NCT00569803|435462|P6|STARTED|Overall Study||5
176690|NCT00569803|435463|P5|STARTED|Overall Study||5
176691|NCT00569803|435464|P4|STARTED|Overall Study||6
176692|NCT00569803|435465|P3|STARTED|Overall Study||5
176693|NCT00569803|435466|P2|STARTED|Overall Study||5
176694|NCT00569803|435467|P1|STARTED|Overall Study||5
176695|NCT00569855|435592|P1|NOT COMPLETED|Overall Study||0
176696|NCT00569855|435592|P1|COMPLETED|Overall Study|785 subjects treated with study drug|785
176697|NCT00569855|435592|P1|STARTED|Overall Study|832 subjects enrolled; however, study records only available for analysis from 2004 =446 subjects|785
176698|NCT00569868|435596|P1|NOT COMPLETED|Overall Study||0
176699|NCT00569868|435596|P1|COMPLETED|Overall Study||11
176700|NCT00569868|435596|P1|STARTED|Overall Study||11
176701|NCT00569946|435600|P1|NOT COMPLETED|Overall Study||59
176702|NCT00569946|435600|P1|COMPLETED|Overall Study||5
176703|NCT00569946|435600|P1|STARTED|Overall Study||64
176704|NCT00570037|435618|P2|NOT COMPLETED|Overall Study||69
176705|NCT00570037|435619|P1|NOT COMPLETED|Overall Study||44
176706|NCT00570037|435618|P2|COMPLETED|Overall Study||237
176707|NCT00570037|435619|P1|COMPLETED|Overall Study||194
176708|NCT00570037|435618|P2|STARTED|Overall Study||306
176709|NCT00570037|435619|P1|STARTED|Overall Study||238
176710|NCT00570089|435629|P2|NOT COMPLETED|Perod 2||0
176711|NCT00570089|435630|P1|NOT COMPLETED|Perod 2||0
176712|NCT00570089|435629|P2|COMPLETED|Perod 2||10
176713|NCT00570089|435630|P1|COMPLETED|Perod 2||10
176714|NCT00570089|435629|P2|STARTED|Perod 2||10
176715|NCT00570089|435630|P1|STARTED|Perod 2||10
176716|NCT00570089|435629|P2|NOT COMPLETED|Period 1||0
176717|NCT00570089|435630|P1|NOT COMPLETED|Period 1||0
176718|NCT00570089|435629|P2|COMPLETED|Period 1||10
176719|NCT00570089|435630|P1|COMPLETED|Period 1||10
176720|NCT00570089|435629|P2|STARTED|Period 1||10
176721|NCT00570089|435630|P1|STARTED|Period 1||10
176722|NCT00570141|435638|P1|NOT COMPLETED|Overall Study||3
176723|NCT00570141|435638|P1|COMPLETED|Overall Study||10
176724|NCT00570141|435638|P1|STARTED|Overall Study||13
176725|NCT00570232|435643|P1|NOT COMPLETED|Overall Study||23
176726|NCT00570232|435643|P1|COMPLETED|Overall Study||8
176727|NCT00570232|435643|P1|STARTED|Overall Study||31
176728|NCT00570310|435651|P2|NOT COMPLETED|Overall Study||6
176729|NCT00570310|435652|P1|NOT COMPLETED|Overall Study||2
176730|NCT00570310|435651|P2|COMPLETED|Overall Study||45
176731|NCT00570310|435652|P1|COMPLETED|Overall Study||51
176732|NCT00570310|435651|P2|STARTED|Overall Study||51
176733|NCT00570310|435652|P1|STARTED|Overall Study||53
176734|NCT00570349|435663|P3|NOT COMPLETED|Overall Study||0
176735|NCT00570349|435664|P2|NOT COMPLETED|Overall Study||0
176736|NCT00570349|435665|P1|NOT COMPLETED|Overall Study||0
176737|NCT00570349|435663|P3|COMPLETED|Overall Study||6
176738|NCT00570349|435664|P2|COMPLETED|Overall Study||6
176739|NCT00570349|435665|P1|COMPLETED|Overall Study||6
176740|NCT00570349|435663|P3|STARTED|Overall Study||6
176741|NCT00570349|435664|P2|STARTED|Overall Study||6
176742|NCT00570349|435665|P1|STARTED|Overall Study||6
176743|NCT00570362|435681|P2|NOT COMPLETED|Overall Study||0
176744|NCT00570362|435682|P1|NOT COMPLETED|Overall Study||0
176745|NCT00570362|435681|P2|COMPLETED|Overall Study||30
176746|NCT00570362|435682|P1|COMPLETED|Overall Study||19
176747|NCT00570362|435681|P2|STARTED|Overall Study||30
176748|NCT00570362|435682|P1|STARTED|Overall Study||19
176749|NCT00570401|435688|P1|NOT COMPLETED|Overall Study||2
176750|NCT00570401|435688|P1|COMPLETED|Overall Study||19
176751|NCT00570401|435688|P1|STARTED|Overall Study||21
176752|NCT00570492|435694|P3|NOT COMPLETED|52-week Double-blind Treatment Period||51
176753|NCT00570492|435695|P2|NOT COMPLETED|52-week Double-blind Treatment Period||50
176754|NCT00570492|435696|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
176755|NCT00570492|435694|P3|COMPLETED|52-week Double-blind Treatment Period||186
176756|NCT00570492|435695|P2|COMPLETED|52-week Double-blind Treatment Period||187
176757|NCT00570492|435696|P1|COMPLETED|52-week Double-blind Treatment Period||0
176758|NCT00570492|435694|P3|STARTED|52-week Double-blind Treatment Period||237
176759|NCT00570492|435695|P2|STARTED|52-week Double-blind Treatment Period||237
176760|NCT00570492|435696|P1|STARTED|52-week Double-blind Treatment Period||0
176761|NCT00570492|435694|P3|NOT COMPLETED|16-week Single-blind Baseline Period||0
176762|NCT00570492|435695|P2|NOT COMPLETED|16-week Single-blind Baseline Period||0
176763|NCT00570492|435696|P1|NOT COMPLETED|16-week Single-blind Baseline Period||436
176764|NCT00570492|435694|P3|COMPLETED|16-week Single-blind Baseline Period||0
176765|NCT00570492|435695|P2|COMPLETED|16-week Single-blind Baseline Period||0
176766|NCT00570492|435696|P1|COMPLETED|16-week Single-blind Baseline Period||474
176767|NCT00570492|435694|P3|STARTED|16-week Single-blind Baseline Period||0
176768|NCT00570492|435695|P2|STARTED|16-week Single-blind Baseline Period||0
176769|NCT00570492|435696|P1|STARTED|16-week Single-blind Baseline Period||910
176770|NCT00570505|435734|P1|NOT COMPLETED|Overall Study||41
176771|NCT00570505|435734|P1|COMPLETED|Overall Study|The number of subjects completing the 60-month study|108
176772|NCT00570505|435734|P1|STARTED|Overall Study||149
176773|NCT00570531|435745|P1|NOT COMPLETED|Overall Study||0
176774|NCT00570531|435745|P1|COMPLETED|Overall Study||6
176775|NCT00570531|435745|P1|STARTED|Overall Study||6
176776|NCT00570674|435751|P7|NOT COMPLETED|Overall Study||0
176777|NCT00570674|435752|P6|NOT COMPLETED|Overall Study||0
176778|NCT00570674|435753|P5|NOT COMPLETED|Overall Study||0
176779|NCT00570674|435754|P4|NOT COMPLETED|Overall Study||0
176780|NCT00570674|435755|P3|NOT COMPLETED|Overall Study||1
176781|NCT00570674|435756|P2|NOT COMPLETED|Overall Study||0
176782|NCT00570674|435757|P1|NOT COMPLETED|Overall Study||0
176783|NCT00570674|435751|P7|COMPLETED|Overall Study||0
176784|NCT00570674|435752|P6|COMPLETED|Overall Study||10
176785|NCT00570674|435753|P5|COMPLETED|Overall Study||3
176786|NCT00570674|435754|P4|COMPLETED|Overall Study||3
176787|NCT00570674|435755|P3|COMPLETED|Overall Study||3
176788|NCT00570674|435756|P2|COMPLETED|Overall Study||3
176789|NCT00570674|435757|P1|COMPLETED|Overall Study||6
176790|NCT00570674|435751|P7|PEG Evaluable|Overall Study||0
176791|NCT00570674|435752|P6|PEG Evaluable|Overall Study||10
176792|NCT00570674|435753|P5|PEG Evaluable|Overall Study||2
176793|NCT00570674|435754|P4|PEG Evaluable|Overall Study||3
176794|NCT00570674|435755|P3|PEG Evaluable|Overall Study||3
176795|NCT00570674|435756|P2|PEG Evaluable|Overall Study||3
176796|NCT00570674|435757|P1|PEG Evaluable|Overall Study||6
176797|NCT00570674|435751|P7|Treated|Overall Study||0
176798|NCT00570674|435752|P6|Treated|Overall Study||10
176799|NCT00570674|435753|P5|Treated|Overall Study||3
176800|NCT00570674|435754|P4|Treated|Overall Study||3
176801|NCT00570674|435755|P3|Treated|Overall Study||3
176802|NCT00570674|435756|P2|Treated|Overall Study||3
176803|NCT00570674|435757|P1|Treated|Overall Study||6
176804|NCT00570674|435751|P7|STARTED|Overall Study|The study did not continue beyond phase I.|0
176805|NCT00570674|435752|P6|STARTED|Overall Study||10
176806|NCT00570674|435753|P5|STARTED|Overall Study||3
176807|NCT00570674|435754|P4|STARTED|Overall Study||3
176808|NCT00570674|435755|P3|STARTED|Overall Study||4
176809|NCT00570674|435756|P2|STARTED|Overall Study||3
176810|NCT00570674|435757|P1|STARTED|Overall Study||6
176811|NCT00570687|435772|P10|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176812|NCT00570687|435773|P9|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176813|NCT00570687|435774|P8|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176814|NCT00570687|435775|P7|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176815|NCT00570687|435776|P6|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176816|NCT00570687|435777|P5|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176817|NCT00570687|435778|P4|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176818|NCT00570687|435779|P3|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176819|NCT00570687|435780|P2|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176820|NCT00570687|435781|P1|NOT COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176821|NCT00570687|435772|P10|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176822|NCT00570687|435773|P9|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176823|NCT00570687|435774|P8|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176824|NCT00570687|435775|P7|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176825|NCT00570687|435776|P6|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176826|NCT00570687|435777|P5|COMPLETED|Clamp 2 (1 Day) - Amendment 1||0
176827|NCT00570687|435778|P4|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
176828|NCT00570687|435779|P3|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
176829|NCT00570687|435780|P2|COMPLETED|Clamp 2 (1 Day) - Amendment 1||2
176830|NCT00570687|435781|P1|COMPLETED|Clamp 2 (1 Day) - Amendment 1||4
176831|NCT00570687|435772|P10|STARTED|Clamp 2 (1 Day) - Amendment 1||0
176832|NCT00570687|435773|P9|STARTED|Clamp 2 (1 Day) - Amendment 1||0
176833|NCT00570687|435774|P8|STARTED|Clamp 2 (1 Day) - Amendment 1||0
176834|NCT00570687|435775|P7|STARTED|Clamp 2 (1 Day) - Amendment 1||0
176835|NCT00570687|435776|P6|STARTED|Clamp 2 (1 Day) - Amendment 1||0
176836|NCT00570687|435777|P5|STARTED|Clamp 2 (1 Day) - Amendment 1||0
176837|NCT00570687|435778|P4|STARTED|Clamp 2 (1 Day) - Amendment 1||4
176838|NCT00570687|435779|P3|STARTED|Clamp 2 (1 Day) - Amendment 1||2
176839|NCT00570687|435780|P2|STARTED|Clamp 2 (1 Day) - Amendment 1||2
176840|NCT00570687|435781|P1|STARTED|Clamp 2 (1 Day) - Amendment 1||4
176841|NCT00570687|435772|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176842|NCT00570687|435773|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176843|NCT00570687|435774|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176844|NCT00570687|435775|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176845|NCT00570687|435776|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176846|NCT00570687|435777|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176847|NCT00570687|435778|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176848|NCT00570687|435779|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176849|NCT00570687|435780|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176850|NCT00570687|435781|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176851|NCT00570687|435772|P10|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176852|NCT00570687|435773|P9|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176853|NCT00570687|435774|P8|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176854|NCT00570687|435775|P7|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176855|NCT00570687|435776|P6|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176856|NCT00570687|435777|P5|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||0
176857|NCT00570687|435778|P4|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
176858|NCT00570687|435779|P3|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
176859|NCT00570687|435780|P2|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||2
176860|NCT00570687|435781|P1|COMPLETED|Washout 3 (7-21 Days) - Amendment 1||4
176861|NCT00570687|435772|P10|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
176862|NCT00570687|435773|P9|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
176863|NCT00570687|435774|P8|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
176864|NCT00570687|435775|P7|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
176865|NCT00570687|435776|P6|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
176866|NCT00570687|435777|P5|STARTED|Washout 3 (7-21 Days) - Amendment 1||0
176867|NCT00570687|435778|P4|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
176868|NCT00570687|435779|P3|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
176869|NCT00570687|435780|P2|STARTED|Washout 3 (7-21 Days) - Amendment 1||2
176870|NCT00570687|435781|P1|STARTED|Washout 3 (7-21 Days) - Amendment 1||4
176871|NCT00570687|435772|P10|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176872|NCT00570687|435773|P9|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176873|NCT00570687|435774|P8|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176874|NCT00570687|435775|P7|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176875|NCT00570687|435776|P6|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176876|NCT00570687|435777|P5|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176877|NCT00570687|435778|P4|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176878|NCT00570687|435779|P3|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176879|NCT00570687|435780|P2|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176880|NCT00570687|435781|P1|NOT COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176881|NCT00570687|435772|P10|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176882|NCT00570687|435773|P9|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176883|NCT00570687|435774|P8|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176884|NCT00570687|435775|P7|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176885|NCT00570687|435776|P6|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176886|NCT00570687|435777|P5|COMPLETED|Clamp 1 (1 Day) - Amendment 1||0
176887|NCT00570687|435778|P4|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
176888|NCT00570687|435779|P3|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
176889|NCT00570687|435780|P2|COMPLETED|Clamp 1 (1 Day) - Amendment 1||2
176890|NCT00570687|435781|P1|COMPLETED|Clamp 1 (1 Day) - Amendment 1||4
176891|NCT00570687|435772|P10|STARTED|Clamp 1 (1 Day) - Amendment 1||0
176892|NCT00570687|435773|P9|STARTED|Clamp 1 (1 Day) - Amendment 1||0
176893|NCT00570687|435774|P8|STARTED|Clamp 1 (1 Day) - Amendment 1||0
176894|NCT00570687|435775|P7|STARTED|Clamp 1 (1 Day) - Amendment 1||0
176895|NCT00570687|435776|P6|STARTED|Clamp 1 (1 Day) - Amendment 1||0
176896|NCT00570687|435777|P5|STARTED|Clamp 1 (1 Day) - Amendment 1||0
176897|NCT00570687|435778|P4|STARTED|Clamp 1 (1 Day) - Amendment 1||4
176898|NCT00570687|435779|P3|STARTED|Clamp 1 (1 Day) - Amendment 1||2
176899|NCT00570687|435780|P2|STARTED|Clamp 1 (1 Day) - Amendment 1||2
176900|NCT00570687|435781|P1|STARTED|Clamp 1 (1 Day) - Amendment 1||4
176901|NCT00570687|435772|P10|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176902|NCT00570687|435773|P9|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176903|NCT00570687|435774|P8|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176904|NCT00570687|435775|P7|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176905|NCT00570687|435776|P6|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176906|NCT00570687|435777|P5|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176907|NCT00570687|435778|P4|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176908|NCT00570687|435779|P3|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176909|NCT00570687|435780|P2|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176910|NCT00570687|435781|P1|NOT COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176911|NCT00570687|435772|P10|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176912|NCT00570687|435773|P9|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176913|NCT00570687|435774|P8|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176914|NCT00570687|435775|P7|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176915|NCT00570687|435776|P6|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176916|NCT00570687|435777|P5|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||0
176917|NCT00570687|435778|P4|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
176918|NCT00570687|435779|P3|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
176919|NCT00570687|435780|P2|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||2
176920|NCT00570687|435781|P1|COMPLETED|Washout 2 (8 Weeks) - Amendment 1||4
176921|NCT00570687|435772|P10|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
176922|NCT00570687|435773|P9|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
176923|NCT00570687|435774|P8|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
176924|NCT00570687|435775|P7|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
176925|NCT00570687|435776|P6|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
176926|NCT00570687|435777|P5|STARTED|Washout 2 (8 Weeks) - Amendment 1||0
176927|NCT00570687|435778|P4|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
176928|NCT00570687|435779|P3|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
176929|NCT00570687|435780|P2|STARTED|Washout 2 (8 Weeks) - Amendment 1||2
176930|NCT00570687|435781|P1|STARTED|Washout 2 (8 Weeks) - Amendment 1||4
176931|NCT00570687|435772|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176932|NCT00570687|435773|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176933|NCT00570687|435774|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176934|NCT00570687|435775|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176935|NCT00570687|435776|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176936|NCT00570687|435777|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176937|NCT00570687|435778|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176938|NCT00570687|435779|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176939|NCT00570687|435780|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176940|NCT00570687|435781|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176941|NCT00570687|435772|P10|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176942|NCT00570687|435773|P9|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176943|NCT00570687|435774|P8|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176944|NCT00570687|435775|P7|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176945|NCT00570687|435776|P6|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176946|NCT00570687|435777|P5|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||0
176947|NCT00570687|435778|P4|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
176948|NCT00570687|435779|P3|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
176949|NCT00570687|435780|P2|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||2
176950|NCT00570687|435781|P1|COMPLETED|Meal Challenge 2 (1 Day) - Amendment 1||4
176951|NCT00570687|435772|P10|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
176952|NCT00570687|435773|P9|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
176953|NCT00570687|435774|P8|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
176954|NCT00570687|435775|P7|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
176955|NCT00570687|435776|P6|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
176956|NCT00570687|435777|P5|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||0
176957|NCT00570687|435778|P4|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
176958|NCT00570687|435779|P3|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
176959|NCT00570687|435780|P2|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||2
176960|NCT00570687|435781|P1|STARTED|Meal Challenge 2 (1 Day) - Amendment 1||4
176961|NCT00570687|435772|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176962|NCT00570687|435773|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176963|NCT00570687|435774|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176964|NCT00570687|435775|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176965|NCT00570687|435776|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176966|NCT00570687|435777|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176967|NCT00570687|435778|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176968|NCT00570687|435779|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176969|NCT00570687|435780|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176970|NCT00570687|435781|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176971|NCT00570687|435772|P10|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176972|NCT00570687|435773|P9|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176973|NCT00570687|435774|P8|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176974|NCT00570687|435775|P7|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176975|NCT00570687|435776|P6|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176976|NCT00570687|435777|P5|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||0
176977|NCT00570687|435778|P4|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
176978|NCT00570687|435779|P3|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
176979|NCT00570687|435780|P2|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||2
176980|NCT00570687|435781|P1|COMPLETED|Washout 1 (7-21 Days) - Amendment 1||4
176981|NCT00570687|435772|P10|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
176982|NCT00570687|435773|P9|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
176983|NCT00570687|435774|P8|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
176984|NCT00570687|435775|P7|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
176985|NCT00570687|435776|P6|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
176986|NCT00570687|435777|P5|STARTED|Washout 1 (7-21 Days) - Amendment 1||0
176987|NCT00570687|435778|P4|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
176988|NCT00570687|435779|P3|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
176989|NCT00570687|435780|P2|STARTED|Washout 1 (7-21 Days) - Amendment 1||2
176990|NCT00570687|435781|P1|STARTED|Washout 1 (7-21 Days) - Amendment 1||4
176991|NCT00570687|435772|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176992|NCT00570687|435773|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176993|NCT00570687|435774|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176994|NCT00570687|435775|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176995|NCT00570687|435776|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176996|NCT00570687|435777|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176997|NCT00570687|435778|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176998|NCT00570687|435779|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
176999|NCT00570687|435780|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177000|NCT00570687|435781|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177001|NCT00570687|435772|P10|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177002|NCT00570687|435773|P9|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177003|NCT00570687|435774|P8|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177004|NCT00570687|435775|P7|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177005|NCT00570687|435776|P6|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177006|NCT00570687|435777|P5|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||0
177007|NCT00570687|435778|P4|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
177008|NCT00570687|435779|P3|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
177009|NCT00570687|435780|P2|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||2
177010|NCT00570687|435781|P1|COMPLETED|Meal Challenge 1 (1 Day) - Amendment 1||4
177011|NCT00570687|435772|P10|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
177012|NCT00570687|435773|P9|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
177013|NCT00570687|435774|P8|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
177014|NCT00570687|435775|P7|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
177015|NCT00570687|435776|P6|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
177016|NCT00570687|435777|P5|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||0
177017|NCT00570687|435778|P4|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
177018|NCT00570687|435779|P3|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
177019|NCT00570687|435780|P2|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||2
177020|NCT00570687|435781|P1|STARTED|Meal Challenge 1 (1 Day) - Amendment 1||4
177021|NCT00570687|435772|P10|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177022|NCT00570687|435773|P9|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177023|NCT00570687|435774|P8|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177024|NCT00570687|435775|P7|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||1
177025|NCT00570687|435776|P6|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177026|NCT00570687|435777|P5|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177027|NCT00570687|435778|P4|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177028|NCT00570687|435779|P3|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177029|NCT00570687|435780|P2|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177030|NCT00570687|435781|P1|NOT COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177031|NCT00570687|435772|P10|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177032|NCT00570687|435773|P9|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177033|NCT00570687|435774|P8|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177034|NCT00570687|435775|P7|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177035|NCT00570687|435776|P6|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177036|NCT00570687|435777|P5|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177037|NCT00570687|435778|P4|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177038|NCT00570687|435779|P3|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177039|NCT00570687|435780|P2|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177040|NCT00570687|435781|P1|COMPLETED|Washout 5 (7-21 Days) - Orig Protocol||0
177041|NCT00570687|435772|P10|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177042|NCT00570687|435773|P9|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177043|NCT00570687|435774|P8|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177044|NCT00570687|435775|P7|STARTED|Washout 5 (7-21 Days) - Orig Protocol||1
177045|NCT00570687|435776|P6|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177046|NCT00570687|435777|P5|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177047|NCT00570687|435778|P4|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177048|NCT00570687|435779|P3|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177049|NCT00570687|435780|P2|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177050|NCT00570687|435781|P1|STARTED|Washout 5 (7-21 Days) - Orig Protocol||0
177051|NCT00570687|435772|P10|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177052|NCT00570687|435773|P9|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177053|NCT00570687|435774|P8|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177054|NCT00570687|435775|P7|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177055|NCT00570687|435776|P6|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177056|NCT00570687|435777|P5|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177057|NCT00570687|435778|P4|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177058|NCT00570687|435779|P3|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177059|NCT00570687|435780|P2|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177060|NCT00570687|435781|P1|NOT COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177061|NCT00570687|435772|P10|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177062|NCT00570687|435773|P9|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177063|NCT00570687|435774|P8|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177064|NCT00570687|435775|P7|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||1
177065|NCT00570687|435776|P6|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177066|NCT00570687|435777|P5|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177067|NCT00570687|435778|P4|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177068|NCT00570687|435779|P3|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177069|NCT00570687|435780|P2|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177070|NCT00570687|435781|P1|COMPLETED|Clamp 2 (1 Day) - Orig Protocol||0
177071|NCT00570687|435772|P10|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177072|NCT00570687|435773|P9|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177073|NCT00570687|435774|P8|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177074|NCT00570687|435775|P7|STARTED|Clamp 2 (1 Day) - Orig Protocol||1
177075|NCT00570687|435776|P6|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177076|NCT00570687|435777|P5|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177077|NCT00570687|435778|P4|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177078|NCT00570687|435779|P3|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177079|NCT00570687|435780|P2|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177080|NCT00570687|435781|P1|STARTED|Clamp 2 (1 Day) - Orig Protocol||0
177081|NCT00570687|435772|P10|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177082|NCT00570687|435773|P9|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
177083|NCT00570687|435774|P8|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177084|NCT00570687|435775|P7|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177085|NCT00570687|435776|P6|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177086|NCT00570687|435777|P5|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177087|NCT00570687|435778|P4|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177088|NCT00570687|435779|P3|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177089|NCT00570687|435780|P2|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177090|NCT00570687|435781|P1|NOT COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177091|NCT00570687|435772|P10|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177092|NCT00570687|435773|P9|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177093|NCT00570687|435774|P8|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177094|NCT00570687|435775|P7|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||1
177095|NCT00570687|435776|P6|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177096|NCT00570687|435777|P5|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177097|NCT00570687|435778|P4|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177098|NCT00570687|435779|P3|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177099|NCT00570687|435780|P2|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177100|NCT00570687|435781|P1|COMPLETED|Washout 4 (7-21 Days) - Orig Protocol||0
177101|NCT00570687|435772|P10|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177102|NCT00570687|435773|P9|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
177103|NCT00570687|435774|P8|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177104|NCT00570687|435775|P7|STARTED|Washout 4 (7-21 Days) - Orig Protocol||1
177105|NCT00570687|435776|P6|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177106|NCT00570687|435777|P5|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177107|NCT00570687|435778|P4|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177108|NCT00570687|435779|P3|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177109|NCT00570687|435780|P2|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177110|NCT00570687|435781|P1|STARTED|Washout 4 (7-21 Days) - Orig Protocol||0
177111|NCT00570687|435772|P10|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177112|NCT00570687|435773|P9|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177113|NCT00570687|435774|P8|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177114|NCT00570687|435775|P7|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177115|NCT00570687|435776|P6|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177116|NCT00570687|435777|P5|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177117|NCT00570687|435778|P4|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177118|NCT00570687|435779|P3|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177119|NCT00570687|435780|P2|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177120|NCT00570687|435781|P1|NOT COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177121|NCT00570687|435772|P10|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177122|NCT00570687|435773|P9|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
177123|NCT00570687|435774|P8|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177124|NCT00570687|435775|P7|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||1
177125|NCT00570687|435776|P6|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177126|NCT00570687|435777|P5|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177127|NCT00570687|435778|P4|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177128|NCT00570687|435779|P3|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177129|NCT00570687|435780|P2|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177130|NCT00570687|435781|P1|COMPLETED|Clamp 1 (1 Day) - Orig Protocol||0
177131|NCT00570687|435772|P10|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177132|NCT00570687|435773|P9|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
177133|NCT00570687|435774|P8|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177134|NCT00570687|435775|P7|STARTED|Clamp 1 (1 Day) - Orig Protocol||1
177135|NCT00570687|435776|P6|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177136|NCT00570687|435777|P5|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177137|NCT00570687|435778|P4|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177138|NCT00570687|435779|P3|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177139|NCT00570687|435780|P2|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177140|NCT00570687|435781|P1|STARTED|Clamp 1 (1 Day) - Orig Protocol||0
177141|NCT00570687|435772|P10|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
177142|NCT00570687|435773|P9|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
177143|NCT00570687|435774|P8|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
177144|NCT00570687|435775|P7|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||2
177145|NCT00570687|435776|P6|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
177146|NCT00570687|435777|P5|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||3
177147|NCT00570687|435778|P4|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177148|NCT00570687|435779|P3|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177149|NCT00570687|435780|P2|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177150|NCT00570687|435781|P1|NOT COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177151|NCT00570687|435772|P10|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177152|NCT00570687|435773|P9|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
177153|NCT00570687|435774|P8|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177154|NCT00570687|435775|P7|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||1
177155|NCT00570687|435776|P6|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177156|NCT00570687|435777|P5|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177157|NCT00570687|435778|P4|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177158|NCT00570687|435779|P3|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177159|NCT00570687|435780|P2|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177160|NCT00570687|435781|P1|COMPLETED|Washout 3 (7-21 Days) - Orig Protocol||0
177161|NCT00570687|435772|P10|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
177162|NCT00570687|435773|P9|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
177163|NCT00570687|435774|P8|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
177164|NCT00570687|435775|P7|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
177165|NCT00570687|435776|P6|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
177166|NCT00570687|435777|P5|STARTED|Washout 3 (7-21 Days) - Orig Protocol||3
177167|NCT00570687|435778|P4|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
177168|NCT00570687|435779|P3|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
177169|NCT00570687|435780|P2|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
177170|NCT00570687|435781|P1|STARTED|Washout 3 (7-21 Days) - Orig Protocol||0
177171|NCT00570687|435772|P10|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177172|NCT00570687|435773|P9|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177173|NCT00570687|435774|P8|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177174|NCT00570687|435775|P7|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177175|NCT00570687|435776|P6|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177176|NCT00570687|435777|P5|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177177|NCT00570687|435778|P4|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177178|NCT00570687|435779|P3|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177179|NCT00570687|435780|P2|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177180|NCT00570687|435781|P1|NOT COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177181|NCT00570687|435772|P10|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177182|NCT00570687|435773|P9|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177183|NCT00570687|435774|P8|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177184|NCT00570687|435775|P7|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177185|NCT00570687|435776|P6|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177186|NCT00570687|435777|P5|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177187|NCT00570687|435778|P4|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177188|NCT00570687|435779|P3|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177189|NCT00570687|435780|P2|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177190|NCT00570687|435781|P1|COMPLETED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177191|NCT00570687|435772|P10|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177192|NCT00570687|435773|P9|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177193|NCT00570687|435774|P8|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177194|NCT00570687|435775|P7|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177195|NCT00570687|435776|P6|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177196|NCT00570687|435777|P5|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||3
177197|NCT00570687|435778|P4|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177198|NCT00570687|435779|P3|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177199|NCT00570687|435780|P2|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177200|NCT00570687|435781|P1|STARTED|Meal Challenge 3 (1 Day) - Orig Protocol||0
177201|NCT00570687|435772|P10|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177202|NCT00570687|435773|P9|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177203|NCT00570687|435774|P8|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177204|NCT00570687|435775|P7|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177205|NCT00570687|435776|P6|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177206|NCT00570687|435777|P5|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177207|NCT00570687|435778|P4|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177208|NCT00570687|435779|P3|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177209|NCT00570687|435780|P2|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177210|NCT00570687|435781|P1|NOT COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177211|NCT00570687|435772|P10|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
177212|NCT00570687|435773|P9|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
177213|NCT00570687|435774|P8|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
177214|NCT00570687|435775|P7|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
177215|NCT00570687|435776|P6|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
177216|NCT00570687|435777|P5|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||3
177217|NCT00570687|435778|P4|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177218|NCT00570687|435779|P3|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177219|NCT00570687|435780|P2|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177220|NCT00570687|435781|P1|COMPLETED|Washout 2 (7-21 Days) - Orig Protocol||0
177221|NCT00570687|435772|P10|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
177222|NCT00570687|435773|P9|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
177223|NCT00570687|435774|P8|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
177224|NCT00570687|435775|P7|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
177225|NCT00570687|435776|P6|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
177226|NCT00570687|435777|P5|STARTED|Washout 2 (7-21 Days) - Orig Protocol||3
177227|NCT00570687|435778|P4|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
177228|NCT00570687|435779|P3|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
177229|NCT00570687|435780|P2|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
177230|NCT00570687|435781|P1|STARTED|Washout 2 (7-21 Days) - Orig Protocol||0
177231|NCT00570687|435772|P10|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177232|NCT00570687|435773|P9|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177233|NCT00570687|435774|P8|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177234|NCT00570687|435775|P7|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177235|NCT00570687|435776|P6|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177236|NCT00570687|435777|P5|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177237|NCT00570687|435778|P4|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177238|NCT00570687|435779|P3|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177239|NCT00570687|435780|P2|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177240|NCT00570687|435781|P1|NOT COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177241|NCT00570687|435772|P10|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177242|NCT00570687|435773|P9|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177243|NCT00570687|435774|P8|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177244|NCT00570687|435775|P7|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177245|NCT00570687|435776|P6|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177246|NCT00570687|435777|P5|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177247|NCT00570687|435778|P4|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177248|NCT00570687|435779|P3|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177249|NCT00570687|435780|P2|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177250|NCT00570687|435781|P1|COMPLETED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177251|NCT00570687|435772|P10|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177252|NCT00570687|435773|P9|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177253|NCT00570687|435774|P8|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177254|NCT00570687|435775|P7|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177255|NCT00570687|435776|P6|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177256|NCT00570687|435777|P5|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||3
177257|NCT00570687|435778|P4|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177258|NCT00570687|435779|P3|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177259|NCT00570687|435780|P2|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177260|NCT00570687|435781|P1|STARTED|Meal Challenge 2 (1 Day) - Orig Protocol||0
177261|NCT00570687|435772|P10|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177262|NCT00570687|435773|P9|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177263|NCT00570687|435774|P8|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177264|NCT00570687|435775|P7|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177265|NCT00570687|435776|P6|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177266|NCT00570687|435777|P5|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177267|NCT00570687|435778|P4|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177268|NCT00570687|435779|P3|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177269|NCT00570687|435780|P2|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177270|NCT00570687|435781|P1|NOT COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177271|NCT00570687|435772|P10|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
177272|NCT00570687|435773|P9|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
177273|NCT00570687|435774|P8|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
177274|NCT00570687|435775|P7|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
177275|NCT00570687|435776|P6|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
177276|NCT00570687|435777|P5|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||3
177277|NCT00570687|435778|P4|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177278|NCT00570687|435779|P3|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177279|NCT00570687|435780|P2|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177280|NCT00570687|435781|P1|COMPLETED|Washout 1 (7-21 Days) - Orig Protocol||0
177281|NCT00570687|435772|P10|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
177282|NCT00570687|435773|P9|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
177283|NCT00570687|435774|P8|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
177284|NCT00570687|435775|P7|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
177285|NCT00570687|435776|P6|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
177286|NCT00570687|435777|P5|STARTED|Washout 1 (7-21 Days) - Orig Protocol||3
177287|NCT00570687|435778|P4|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
177288|NCT00570687|435779|P3|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
177289|NCT00570687|435780|P2|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
177290|NCT00570687|435781|P1|STARTED|Washout 1 (7-21 Days) - Orig Protocol||0
177291|NCT00570687|435772|P10|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177292|NCT00570687|435773|P9|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177293|NCT00570687|435774|P8|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177294|NCT00570687|435775|P7|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177295|NCT00570687|435776|P6|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177296|NCT00570687|435777|P5|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177297|NCT00570687|435778|P4|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177298|NCT00570687|435779|P3|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177299|NCT00570687|435780|P2|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177300|NCT00570687|435781|P1|NOT COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177301|NCT00570687|435772|P10|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177302|NCT00570687|435773|P9|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177303|NCT00570687|435774|P8|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177304|NCT00570687|435775|P7|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177305|NCT00570687|435776|P6|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177306|NCT00570687|435777|P5|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177307|NCT00570687|435778|P4|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177308|NCT00570687|435779|P3|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177309|NCT00570687|435780|P2|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177310|NCT00570687|435781|P1|COMPLETED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177311|NCT00570687|435772|P10|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177312|NCT00570687|435773|P9|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177313|NCT00570687|435774|P8|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177314|NCT00570687|435775|P7|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177315|NCT00570687|435776|P6|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177316|NCT00570687|435777|P5|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||3
177317|NCT00570687|435778|P4|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177318|NCT00570687|435779|P3|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177319|NCT00570687|435780|P2|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177320|NCT00570687|435781|P1|STARTED|Meal Challenge 1 (1 Day) - Orig Protocol||0
177321|NCT00570713|435809|P2|NOT COMPLETED|Overall Study||77
177322|NCT00570713|435810|P1|NOT COMPLETED|Overall Study||78
177323|NCT00570713|435809|P2|COMPLETED|Overall Study||0
177324|NCT00570713|435810|P1|COMPLETED|Overall Study||0
177325|NCT00570713|435809|P2|STARTED|Overall Study||77
177326|NCT00570713|435810|P1|STARTED|Overall Study||78
177327|NCT00570739|435824|P4|NOT COMPLETED|Overall Study||12
177328|NCT00570739|435825|P3|NOT COMPLETED|Overall Study||16
177329|NCT00570739|435826|P2|NOT COMPLETED|Overall Study||21
177330|NCT00570739|435827|P1|NOT COMPLETED|Overall Study||21
177331|NCT00570739|435824|P4|COMPLETED|Overall Study||96
177332|NCT00570739|435825|P3|COMPLETED|Overall Study||92
177333|NCT00570739|435826|P2|COMPLETED|Overall Study||124
177334|NCT00570739|435827|P1|COMPLETED|Overall Study||120
177335|NCT00570739|435824|P4|STARTED|Overall Study||108
177336|NCT00570739|435825|P3|STARTED|Overall Study||108
177337|NCT00570739|435826|P2|STARTED|Overall Study||145
177338|NCT00570739|435827|P1|STARTED|Overall Study||141
177339|NCT00570765|435980|P3|NOT COMPLETED|Overall Study||0
177340|NCT00570765|435981|P2|NOT COMPLETED|Overall Study||7
177341|NCT00570765|435982|P1|NOT COMPLETED|Overall Study||4
177342|NCT00570765|435980|P3|COMPLETED|Overall Study||23
177343|NCT00570765|435981|P2|COMPLETED|Overall Study||9
177344|NCT00570765|435982|P1|COMPLETED|Overall Study||16
177345|NCT00570765|435980|P3|STARTED|Overall Study||23
177346|NCT00570765|435981|P2|STARTED|Overall Study||16
177347|NCT00570765|435982|P1|STARTED|Overall Study||20
177348|NCT00570778|435996|P4|NOT COMPLETED|Overall Study||4
177349|NCT00570778|435997|P3|NOT COMPLETED|Overall Study||7
177350|NCT00570778|435998|P2|NOT COMPLETED|Overall Study||4
177351|NCT00570778|435999|P1|NOT COMPLETED|Overall Study||4
177352|NCT00570778|435996|P4|COMPLETED|Overall Study||34
177353|NCT00570778|435997|P3|COMPLETED|Overall Study||30
177354|NCT00570778|435998|P2|COMPLETED|Overall Study||34
177355|NCT00570778|435999|P1|COMPLETED|Overall Study||37
177356|NCT00570778|435996|P4|Modified Intent-to-treat Population|Overall Study||37
177357|NCT00570778|435997|P3|Modified Intent-to-treat Population|Overall Study||35
177358|NCT00570778|435998|P2|Modified Intent-to-treat Population|Overall Study||37
177359|NCT00570778|435999|P1|Modified Intent-to-treat Population|Overall Study||40
177360|NCT00570778|435996|P4|Safety Population: Received Study Drug|Overall Study||38
177361|NCT00570778|435997|P3|Safety Population: Received Study Drug|Overall Study||36
177362|NCT00570778|435998|P2|Safety Population: Received Study Drug|Overall Study||38
177363|NCT00570778|435999|P1|Safety Population: Received Study Drug|Overall Study|Safety Population included all participants who received at least 1 dose of any study drug.|41
177364|NCT00570778|435996|P4|STARTED|Overall Study||38
177365|NCT00570778|435997|P3|STARTED|Overall Study||37
177366|NCT00570778|435998|P2|STARTED|Overall Study||38
177367|NCT00570778|435999|P1|STARTED|Overall Study||41
177368|NCT00570908|436017|P1|NOT COMPLETED|Overall Study||7
177369|NCT00570908|436017|P1|COMPLETED|Overall Study|5 patients progressed during the study treatment|5
177370|NCT00570908|436017|P1|STARTED|Overall Study||12
177371|NCT00570921|436021|P1|NOT COMPLETED|Overall Study||2
177372|NCT00570921|436021|P1|COMPLETED|Overall Study||31
177373|NCT00570921|436021|P1|STARTED|Overall Study||33
177374|NCT00570960|436029|P2|NOT COMPLETED|Overall Study||0
177375|NCT00570960|436030|P1|NOT COMPLETED|Overall Study||0
177376|NCT00570960|436029|P2|COMPLETED|Overall Study||4
177377|NCT00570960|436030|P1|COMPLETED|Overall Study||4
177378|NCT00570960|436029|P2|STARTED|Overall Study||4
177379|NCT00570960|436030|P1|STARTED|Overall Study||4
177380|NCT00571038|436038|P2|NOT COMPLETED|Overall Study||14
177381|NCT00571038|436039|P1|NOT COMPLETED|Overall Study||11
177382|NCT00571038|436038|P2|COMPLETED|Overall Study|5 died 2 moved 3 asked to be withdrawn 4 unable to reach|171
177383|NCT00571038|436039|P1|COMPLETED|Overall Study|"7 died 2 moved
1 asked to be withdrawn
1 unable to reach"|208
177384|NCT00571038|436038|P2|18 Month Survey Only|Overall Study||163
177385|NCT00571038|436039|P1|18 Month Survey Only|Overall Study||199
177386|NCT00571038|436038|P2|6 Month Follow up|Overall Study||176
177387|NCT00571038|436039|P1|6 Month Follow up|Overall Study||208
177388|NCT00571038|436038|P2|STARTED|Overall Study||185
177389|NCT00571038|436039|P1|STARTED|Overall Study||219
177390|NCT00571103|436085|P1|NOT COMPLETED|Overall Study||2
177391|NCT00571103|436085|P1|COMPLETED|Overall Study|Of the 28 participants, 1 subject withdrew and 1 was lost to follow-up after their baseline visit.|26
177392|NCT00571103|436085|P1|STARTED|Overall Study||28
177393|NCT00571194|436090|P1|NOT COMPLETED|Overall Study||0
177394|NCT00571194|436090|P1|COMPLETED|Overall Study||7
177395|NCT00571194|436090|P1|STARTED|Overall Study||7
177396|NCT00571324|436094|P2|NOT COMPLETED|Intervention 2 (7 Hours)||0
177397|NCT00571324|436095|P1|NOT COMPLETED|Intervention 2 (7 Hours)||0
177398|NCT00571324|436094|P2|COMPLETED|Intervention 2 (7 Hours)||4
177399|NCT00571324|436095|P1|COMPLETED|Intervention 2 (7 Hours)||5
177400|NCT00571324|436094|P2|STARTED|Intervention 2 (7 Hours)||4
177401|NCT00571324|436095|P1|STARTED|Intervention 2 (7 Hours)||5
177402|NCT00571324|436094|P2|NOT COMPLETED|Intervention 1 (7 Hours)||0
177403|NCT00571324|436095|P1|NOT COMPLETED|Intervention 1 (7 Hours)||0
177404|NCT00571324|436094|P2|COMPLETED|Intervention 1 (7 Hours)||4
177405|NCT00571324|436095|P1|COMPLETED|Intervention 1 (7 Hours)||5
177406|NCT00571324|436094|P2|STARTED|Intervention 1 (7 Hours)||4
177407|NCT00571324|436095|P1|STARTED|Intervention 1 (7 Hours)||5
177408|NCT00571428|436109|P2|NOT COMPLETED|Overall Study||0
177409|NCT00571428|436110|P1|NOT COMPLETED|Overall Study||0
177410|NCT00571428|436109|P2|COMPLETED|Overall Study||18
177411|NCT00571428|436110|P1|COMPLETED|Overall Study||15
177412|NCT00571428|436109|P2|STARTED|Overall Study||18
177413|NCT00571428|436110|P1|STARTED|Overall Study||15
177414|NCT00565721|436142|P1|NOT COMPLETED|Overall Study||17
177415|NCT00565721|436142|P1|COMPLETED|Overall Study||16
177416|NCT00565721|436142|P1|STARTED|Overall Study||33
177417|NCT00565747|436163|P2|NOT COMPLETED|Overall Study||73
177418|NCT00565747|436164|P1|NOT COMPLETED|Overall Study||67
177419|NCT00565747|436163|P2|COMPLETED|Overall Study|Completed with an embryo transfer|605
177420|NCT00565747|436164|P1|COMPLETED|Overall Study|Completed with an embryo transfer|587
177421|NCT00565747|436163|P2|STARTED|Overall Study||678
177422|NCT00565747|436164|P1|STARTED|Overall Study||654
177423|NCT00565812|436177|P3|NOT COMPLETED|Overall Study||130
177424|NCT00565812|436178|P2|NOT COMPLETED|Overall Study||135
177425|NCT00565812|436179|P1|NOT COMPLETED|Overall Study||144
177426|NCT00565812|436177|P3|COMPLETED|Overall Study||356
177427|NCT00565812|436178|P2|COMPLETED|Overall Study||351
177428|NCT00565812|436179|P1|COMPLETED|Overall Study||341
177429|NCT00565812|436177|P3|STARTED|Overall Study||486
177430|NCT00565812|436178|P2|STARTED|Overall Study||486
177431|NCT00565812|436179|P1|STARTED|Overall Study||485
177432|NCT00571649|436318|P2|NOT COMPLETED|Follow-up Period||528
177433|NCT00571649|436319|P1|NOT COMPLETED|Follow-up Period||545
177434|NCT00571649|436318|P2|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3107
177435|NCT00571649|436319|P1|COMPLETED|Follow-up Period|Began day after last dose study drug; ended on Day 90 (+/- 7 days) .|3038
177436|NCT00571649|436318|P2|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3635
177437|NCT00571649|436319|P1|STARTED|Follow-up Period|Participants were required to enter follow-up even if treatment period not completed.|3583
177438|NCT00571649|436318|P2|NOT COMPLETED|Treatment Period||1004
177439|NCT00571649|436319|P1|NOT COMPLETED|Treatment Period||1092
177440|NCT00571649|436318|P2|COMPLETED|Treatment Period||3047
177441|NCT00571649|436319|P1|COMPLETED|Treatment Period||2958
177442|NCT00571649|436318|P2|Day 35|Treatment Period||3115
177443|NCT00571649|436319|P1|Day 35|Treatment Period||3033
177444|NCT00571649|436318|P2|Day 10|Treatment Period||3499
177445|NCT00571649|436319|P1|Day 10|Treatment Period||3454
177446|NCT00571649|436318|P2|Participants Received Treatment|Treatment Period||4001
177447|NCT00571649|436319|P1|Participants Received Treatment|Treatment Period||3997
177448|NCT00571649|436318|P2|STARTED|Treatment Period||4051
177449|NCT00571649|436319|P1|STARTED|Treatment Period||4050
177450|NCT00571662|436351|P1|NOT COMPLETED|Overall Study||8
177451|NCT00571662|436351|P1|COMPLETED|Overall Study||68
177452|NCT00571662|436351|P1|STARTED|Overall Study||76
177453|NCT00571688|436359|P2|NOT COMPLETED|Overall Study||6
177454|NCT00571688|436360|P1|NOT COMPLETED|Overall Study||5
177455|NCT00571688|436359|P2|COMPLETED|Overall Study||19
177456|NCT00571688|436360|P1|COMPLETED|Overall Study||20
177457|NCT00571688|436359|P2|STARTED|Overall Study||25
177458|NCT00571688|436360|P1|STARTED|Overall Study||25
177459|NCT00571701|436368|P2|NOT COMPLETED|Second Intervention 12 Months||1
177460|NCT00571701|436369|P1|NOT COMPLETED|Second Intervention 12 Months||3
177461|NCT00571701|436368|P2|COMPLETED|Second Intervention 12 Months||20
177462|NCT00571701|436369|P1|COMPLETED|Second Intervention 12 Months||13
177463|NCT00571701|436368|P2|STARTED|Second Intervention 12 Months||21
177464|NCT00571701|436369|P1|STARTED|Second Intervention 12 Months||16
177465|NCT00571701|436368|P2|NOT COMPLETED|First Intervention 12 Months||1
177466|NCT00571701|436369|P1|NOT COMPLETED|First Intervention 12 Months||3
177467|NCT00571701|436368|P2|COMPLETED|First Intervention 12 Months||21
177468|NCT00571701|436369|P1|COMPLETED|First Intervention 12 Months||16
177469|NCT00571701|436368|P2|STARTED|First Intervention 12 Months||22
177470|NCT00571701|436369|P1|STARTED|First Intervention 12 Months||19
177471|NCT00573131|436395|P2|NOT COMPLETED|Overall Study||8
177472|NCT00573131|436396|P1|NOT COMPLETED|Overall Study||10
177473|NCT00573131|436395|P2|COMPLETED|Overall Study||57
177474|NCT00573131|436396|P1|COMPLETED|Overall Study||62
177475|NCT00573131|436395|P2|STARTED|Overall Study||65
177476|NCT00573131|436396|P1|STARTED|Overall Study||72
177477|NCT00573144|436404|P2|NOT COMPLETED|Overall Study||3
177478|NCT00573144|436405|P1|NOT COMPLETED|Overall Study||2
177479|NCT00573144|436404|P2|COMPLETED|Overall Study||25
177480|NCT00573144|436405|P1|COMPLETED|Overall Study||28
177481|NCT00573144|436404|P2|STARTED|Overall Study||28
177482|NCT00573144|436405|P1|STARTED|Overall Study||30
177483|NCT00573157|436417|P2|NOT COMPLETED|Overall Study||2
177484|NCT00573157|436418|P1|NOT COMPLETED|Overall Study||4
177485|NCT00573157|436417|P2|COMPLETED|Overall Study||0
177486|NCT00573157|436418|P1|COMPLETED|Overall Study||0
177487|NCT00573157|436417|P2|STARTED|Overall Study||2
177488|NCT00573157|436418|P1|STARTED|Overall Study||4
177489|NCT00573170|436428|P6|NOT COMPLETED|Third Treatment Period||2
177490|NCT00573170|436429|P5|NOT COMPLETED|Third Treatment Period||0
177491|NCT00573170|436430|P4|NOT COMPLETED|Third Treatment Period||0
177492|NCT00573170|436431|P3|NOT COMPLETED|Third Treatment Period||0
177493|NCT00573170|436432|P2|NOT COMPLETED|Third Treatment Period||0
177494|NCT00573170|436433|P1|NOT COMPLETED|Third Treatment Period||1
177495|NCT00573170|436428|P6|COMPLETED|Third Treatment Period||51
177496|NCT00573170|436429|P5|COMPLETED|Third Treatment Period||51
177497|NCT00573170|436430|P4|COMPLETED|Third Treatment Period||56
177498|NCT00573170|436431|P3|COMPLETED|Third Treatment Period||55
177499|NCT00573170|436432|P2|COMPLETED|Third Treatment Period||54
177500|NCT00573170|436433|P1|COMPLETED|Third Treatment Period||50
177501|NCT00573170|436428|P6|STARTED|Third Treatment Period||53
177502|NCT00573170|436429|P5|STARTED|Third Treatment Period||51
177503|NCT00573170|436430|P4|STARTED|Third Treatment Period||56
177504|NCT00573170|436431|P3|STARTED|Third Treatment Period||55
177505|NCT00573170|436432|P2|STARTED|Third Treatment Period||54
177506|NCT00573170|436433|P1|STARTED|Third Treatment Period||51
177507|NCT00573170|436428|P6|NOT COMPLETED|Second Washout Period||2
177508|NCT00573170|436429|P5|NOT COMPLETED|Second Washout Period||8
177509|NCT00573170|436430|P4|NOT COMPLETED|Second Washout Period||5
177510|NCT00573170|436431|P3|NOT COMPLETED|Second Washout Period||4
177511|NCT00573170|436432|P2|NOT COMPLETED|Second Washout Period||4
177512|NCT00573170|436433|P1|NOT COMPLETED|Second Washout Period||5
177513|NCT00573170|436428|P6|COMPLETED|Second Washout Period||53
177514|NCT00573170|436429|P5|COMPLETED|Second Washout Period||51
177515|NCT00573170|436430|P4|COMPLETED|Second Washout Period||56
177516|NCT00573170|436431|P3|COMPLETED|Second Washout Period||55
177517|NCT00573170|436432|P2|COMPLETED|Second Washout Period||54
177518|NCT00573170|436433|P1|COMPLETED|Second Washout Period||51
177519|NCT00573170|436428|P6|STARTED|Second Washout Period||55
177520|NCT00573170|436429|P5|STARTED|Second Washout Period||59
177521|NCT00573170|436430|P4|STARTED|Second Washout Period||61
177522|NCT00573170|436431|P3|STARTED|Second Washout Period||59
177523|NCT00573170|436432|P2|STARTED|Second Washout Period||58
177524|NCT00573170|436433|P1|STARTED|Second Washout Period||56
177525|NCT00573170|436428|P6|NOT COMPLETED|Second Treatment Period||0
177526|NCT00573170|436429|P5|NOT COMPLETED|Second Treatment Period||0
177527|NCT00573170|436430|P4|NOT COMPLETED|Second Treatment Period||0
177528|NCT00573170|436431|P3|NOT COMPLETED|Second Treatment Period||0
177529|NCT00573170|436432|P2|NOT COMPLETED|Second Treatment Period||0
177530|NCT00573170|436433|P1|NOT COMPLETED|Second Treatment Period||0
177531|NCT00573170|436428|P6|COMPLETED|Second Treatment Period||55
177532|NCT00573170|436429|P5|COMPLETED|Second Treatment Period||59
177533|NCT00573170|436430|P4|COMPLETED|Second Treatment Period||61
177534|NCT00573170|436431|P3|COMPLETED|Second Treatment Period||59
177535|NCT00573170|436432|P2|COMPLETED|Second Treatment Period||58
177536|NCT00573170|436433|P1|COMPLETED|Second Treatment Period||56
177537|NCT00573170|436428|P6|STARTED|Second Treatment Period||55
177538|NCT00573170|436429|P5|STARTED|Second Treatment Period||59
177539|NCT00573170|436430|P4|STARTED|Second Treatment Period||61
177540|NCT00573170|436431|P3|STARTED|Second Treatment Period||59
177541|NCT00573170|436432|P2|STARTED|Second Treatment Period||58
177542|NCT00573170|436433|P1|STARTED|Second Treatment Period||56
177543|NCT00573170|436428|P6|NOT COMPLETED|First Washout Period||7
177544|NCT00573170|436429|P5|NOT COMPLETED|First Washout Period||3
177545|NCT00573170|436430|P4|NOT COMPLETED|First Washout Period||5
177546|NCT00573170|436431|P3|NOT COMPLETED|First Washout Period||1
177547|NCT00573170|436432|P2|NOT COMPLETED|First Washout Period||2
177548|NCT00573170|436433|P1|NOT COMPLETED|First Washout Period||8
177549|NCT00573170|436428|P6|COMPLETED|First Washout Period||55
177550|NCT00573170|436429|P5|COMPLETED|First Washout Period|Source data list 4 noncompleters; per number starting next period, there were only 3 noncompleters.|59
177551|NCT00573170|436430|P4|COMPLETED|First Washout Period||61
177552|NCT00573170|436431|P3|COMPLETED|First Washout Period||59
177553|NCT00573170|436432|P2|COMPLETED|First Washout Period||58
177554|NCT00573170|436433|P1|COMPLETED|First Washout Period||56
177555|NCT00573170|436428|P6|STARTED|First Washout Period||62
177556|NCT00573170|436429|P5|STARTED|First Washout Period||62
177557|NCT00573170|436430|P4|STARTED|First Washout Period||66
177558|NCT00573170|436431|P3|STARTED|First Washout Period||60
177559|NCT00573170|436432|P2|STARTED|First Washout Period||60
177560|NCT00573170|436433|P1|STARTED|First Washout Period||64
177561|NCT00573170|436428|P6|NOT COMPLETED|First Treatment Period||0
177562|NCT00573170|436429|P5|NOT COMPLETED|First Treatment Period||1
177563|NCT00573170|436430|P4|NOT COMPLETED|First Treatment Period||0
177564|NCT00573170|436431|P3|NOT COMPLETED|First Treatment Period||0
177565|NCT00573170|436432|P2|NOT COMPLETED|First Treatment Period||0
177566|NCT00573170|436433|P1|NOT COMPLETED|First Treatment Period||0
177567|NCT00573170|436428|P6|COMPLETED|First Treatment Period||62
177568|NCT00573170|436429|P5|COMPLETED|First Treatment Period||62
177569|NCT00573170|436430|P4|COMPLETED|First Treatment Period||66
177570|NCT00573170|436431|P3|COMPLETED|First Treatment Period||60
177571|NCT00573170|436432|P2|COMPLETED|First Treatment Period||60
177572|NCT00573170|436433|P1|COMPLETED|First Treatment Period||64
177573|NCT00573170|436428|P6|STARTED|First Treatment Period||62
177574|NCT00573170|436429|P5|STARTED|First Treatment Period||63
177575|NCT00573170|436430|P4|STARTED|First Treatment Period||66
177576|NCT00573170|436431|P3|STARTED|First Treatment Period||60
177577|NCT00573170|436432|P2|STARTED|First Treatment Period||60
177578|NCT00573170|436433|P1|STARTED|First Treatment Period||64
177579|NCT00573183|436509|P2|NOT COMPLETED|Overall Study||63
177580|NCT00573183|436510|P1|NOT COMPLETED|Overall Study||72
177581|NCT00573183|436509|P2|COMPLETED|Overall Study||174
177582|NCT00573183|436510|P1|COMPLETED|Overall Study||162
177583|NCT00573183|436509|P2|STARTED|Overall Study||237
177584|NCT00573183|436510|P1|STARTED|Overall Study||234
177585|NCT00573248|436520|P2|NOT COMPLETED|Overall Study||11
177586|NCT00573248|436521|P1|NOT COMPLETED|Overall Study||15
177587|NCT00573248|436520|P2|COMPLETED|Overall Study||27
177588|NCT00573248|436521|P1|COMPLETED|Overall Study||25
177589|NCT00573248|436520|P2|Nicotine Patches and Placebo Patches|Overall Study||27
177590|NCT00573248|436521|P1|Nicotine Patches and Placebo Patches|Overall Study||25
177591|NCT00573248|436520|P2|STARTED|Overall Study||38
177592|NCT00573248|436521|P1|STARTED|Overall Study||40
177593|NCT00573261|436535|P2|NOT COMPLETED|Overall Study||5
177594|NCT00573261|436536|P1|NOT COMPLETED|Overall Study||6
177595|NCT00573261|436535|P2|COMPLETED|Overall Study||15
177596|NCT00573261|436536|P1|COMPLETED|Overall Study||14
177597|NCT00573261|436535|P2|STARTED|Overall Study||20
177598|NCT00573261|436536|P1|STARTED|Overall Study||20
177599|NCT00573287|436564|P2|NOT COMPLETED|Overall Study||3
177600|NCT00573287|436565|P1|NOT COMPLETED|Overall Study||4
177601|NCT00573287|436564|P2|COMPLETED|Overall Study||4
177602|NCT00573287|436565|P1|COMPLETED|Overall Study||3
177603|NCT00573287|436564|P2|STARTED|Overall Study||7
177604|NCT00573287|436565|P1|STARTED|Overall Study||7
177605|NCT00573313|436575|P4|NOT COMPLETED|Overall Study||0
177606|NCT00573313|436576|P3|NOT COMPLETED|Overall Study||6
177607|NCT00573313|436577|P2|NOT COMPLETED|Overall Study||0
177608|NCT00573313|436578|P1|NOT COMPLETED|Overall Study||5
177609|NCT00573313|436575|P4|COMPLETED|Overall Study||26
177610|NCT00573313|436576|P3|COMPLETED|Overall Study||13
177611|NCT00573313|436577|P2|COMPLETED|Overall Study||28
177612|NCT00573313|436578|P1|COMPLETED|Overall Study||13
177613|NCT00573313|436575|P4|STARTED|Overall Study||26
177614|NCT00573313|436576|P3|STARTED|Overall Study|Nineteen recruited to start.|19
177615|NCT00573313|436577|P2|STARTED|Overall Study||28
177616|NCT00573313|436578|P1|STARTED|Overall Study|Eighteen participants recruited to start.|18
177617|NCT00573391|436588|P2|NOT COMPLETED|Overall Study||2
177618|NCT00573391|436589|P1|NOT COMPLETED|Overall Study||3
177619|NCT00573391|436588|P2|COMPLETED|Overall Study||0
177620|NCT00573391|436589|P1|COMPLETED|Overall Study||0
177621|NCT00573391|436588|P2|STARTED|Overall Study||2
177622|NCT00573391|436589|P1|STARTED|Overall Study||3
177623|NCT00573430|436598|P3|NOT COMPLETED|Overall Study||10
177624|NCT00573430|436599|P2|NOT COMPLETED|Overall Study||5
177625|NCT00573430|436600|P1|NOT COMPLETED|Overall Study||1
177626|NCT00573430|436598|P3|COMPLETED|Overall Study||33
177627|NCT00573430|436599|P2|COMPLETED|Overall Study||40
177628|NCT00573430|436600|P1|COMPLETED|Overall Study||39
177629|NCT00573430|436598|P3|STARTED|Overall Study|randomized|43
177630|NCT00573430|436599|P2|STARTED|Overall Study|randomized|45
177631|NCT00573430|436600|P1|STARTED|Overall Study|randomized|40
177632|NCT00573443|436623|P3|NOT COMPLETED|Open-Label Extension Phase||0
177633|NCT00573443|436624|P2|NOT COMPLETED|Open-Label Extension Phase||0
177634|NCT00573443|436625|P1|NOT COMPLETED|Open-Label Extension Phase||18
177635|NCT00573443|436623|P3|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177636|NCT00573443|436624|P2|COMPLETED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177637|NCT00573443|436625|P1|COMPLETED|Open-Label Extension Phase||235
177638|NCT00573443|436623|P3|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177639|NCT00573443|436624|P2|Subjects With PBA Secondary to MS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177640|NCT00573443|436625|P1|Subjects With PBA Secondary to MS|Open-Label Extension Phase||107
177641|NCT00573443|436623|P3|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177642|NCT00573443|436624|P2|Subjects With PBA Secondary to ALS|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177643|NCT00573443|436625|P1|Subjects With PBA Secondary to ALS|Open-Label Extension Phase||146
177644|NCT00573443|436623|P3|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177645|NCT00573443|436624|P2|STARTED|Open-Label Extension Phase|DB period of this arm could begin an optional 12 week OLE period taking AVP-923-30.|0
177646|NCT00573443|436625|P1|STARTED|Open-Label Extension Phase|Subjects who completed any of the arms in the DB phase had the option to enroll in this OLE phase|253
177647|NCT00573443|436623|P3|NOT COMPLETED|Double-Blind Phase||15
177648|NCT00573443|436624|P2|NOT COMPLETED|Double-Blind Phase||19
177649|NCT00573443|436625|P1|NOT COMPLETED|Double-Blind Phase||9
177650|NCT00573443|436623|P3|COMPLETED|Double-Blind Phase||94
177651|NCT00573443|436624|P2|COMPLETED|Double-Blind Phase||88
177652|NCT00573443|436625|P1|COMPLETED|Double-Blind Phase||101
177653|NCT00573443|436623|P3|Subjects With PBA Secondary to MS|Double-Blind Phase||45
177654|NCT00573443|436624|P2|Subjects With PBA Secondary to MS|Double-Blind Phase||39
177655|NCT00573443|436625|P1|Subjects With PBA Secondary to MS|Double-Blind Phase||45
177656|NCT00573443|436623|P3|Subjects With PBA Secondary to ALS|Double-Blind Phase||64
177657|NCT00573443|436624|P2|Subjects With PBA Secondary to ALS|Double-Blind Phase||68
177658|NCT00573443|436625|P1|Subjects With PBA Secondary to ALS|Double-Blind Phase||65
177659|NCT00573443|436623|P3|STARTED|Double-Blind Phase||109
177660|NCT00573443|436624|P2|STARTED|Double-Blind Phase||107
177661|NCT00573443|436625|P1|STARTED|Double-Blind Phase||110
177662|NCT00573469|436655|P3|NOT COMPLETED|Overall Study||4
177663|NCT00573469|436656|P2|NOT COMPLETED|Overall Study||4
177664|NCT00573469|436657|P1|NOT COMPLETED|Overall Study||6
177665|NCT00573469|436655|P3|COMPLETED|Overall Study||22
177666|NCT00573469|436656|P2|COMPLETED|Overall Study||21
177667|NCT00573469|436657|P1|COMPLETED|Overall Study||20
177668|NCT00573469|436655|P3|STARTED|Overall Study||26
177669|NCT00573469|436656|P2|STARTED|Overall Study||25
177670|NCT00573469|436657|P1|STARTED|Overall Study||26
177671|NCT00573508|436679|P2|NOT COMPLETED|Overall Study||41
177672|NCT00573508|436680|P1|NOT COMPLETED|Overall Study||64
177673|NCT00573508|436679|P2|COMPLETED|Overall Study||345
177674|NCT00573508|436680|P1|COMPLETED|Overall Study||318
177675|NCT00573508|436679|P2|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|377
177676|NCT00573508|436680|P1|Full Analysis Set (FAS)|Overall Study|Patients who took >= 1 dose of double-blind study drug, had a baseline OAB-q & >= 1 subsequent visit|374
177677|NCT00573508|436679|P2|STARTED|Overall Study||386
177678|NCT00573508|436680|P1|STARTED|Overall Study||382
177679|NCT00573534|436710|P1|NOT COMPLETED|Overall Study||3
177680|NCT00573534|436710|P1|COMPLETED|Overall Study||5
177681|NCT00573534|436710|P1|STARTED|Overall Study||8
177682|NCT00573755|436717|P2|NOT COMPLETED|Overall Study||0
177683|NCT00573755|436718|P1|NOT COMPLETED|Overall Study||1
177684|NCT00573755|436717|P2|COMPLETED|Overall Study||2
177685|NCT00573755|436718|P1|COMPLETED|Overall Study||1
177686|NCT00573755|436717|P2|STARTED|Overall Study||2
177687|NCT00573755|436718|P1|STARTED|Overall Study||2
177688|NCT00573768|436737|P3|NOT COMPLETED|Overall Study||4
177689|NCT00573768|436738|P2|NOT COMPLETED|Overall Study||2
177690|NCT00573768|436739|P1|NOT COMPLETED|Overall Study||2
177691|NCT00573768|436737|P3|COMPLETED|Overall Study||87
177692|NCT00573768|436738|P2|COMPLETED|Overall Study||89
177693|NCT00573768|436739|P1|COMPLETED|Overall Study||87
177694|NCT00573768|436737|P3|STARTED|Overall Study||91
177695|NCT00573768|436738|P2|STARTED|Overall Study||91
177696|NCT00573768|436739|P1|STARTED|Overall Study||89
177697|NCT00573859|436747|P1|NOT COMPLETED|Smoking Versus Abstinence||12
177698|NCT00573859|436747|P1|COMPLETED|Smoking Versus Abstinence||15
177699|NCT00573859|436747|P1|STARTED|Smoking Versus Abstinence||27
177700|NCT00573859|436747|P1|NOT COMPLETED|Medication Versus Placebo||12
177701|NCT00573859|436747|P1|COMPLETED|Medication Versus Placebo||15
177702|NCT00573859|436747|P1|STARTED|Medication Versus Placebo||27
177703|NCT00573937|436755|P2|NOT COMPLETED|Overall Study||1
177704|NCT00573937|436756|P1|NOT COMPLETED|Overall Study||0
177705|NCT00573937|436755|P2|COMPLETED|Overall Study||0
177706|NCT00573937|436756|P1|COMPLETED|Overall Study||0
177707|NCT00573937|436755|P2|STARTED|Overall Study||1
177708|NCT00573937|436756|P1|STARTED|Overall Study||0
177709|NCT00574067|436768|P4|NOT COMPLETED|Overall Study||0
177710|NCT00574067|436769|P3|NOT COMPLETED|Overall Study||0
177711|NCT00574067|436770|P2|NOT COMPLETED|Overall Study||1
177712|NCT00574067|436771|P1|NOT COMPLETED|Overall Study||1
177713|NCT00574067|436768|P4|COMPLETED|Overall Study||53
177714|NCT00574067|436769|P3|COMPLETED|Overall Study||54
177715|NCT00574067|436770|P2|COMPLETED|Overall Study||52
177716|NCT00574067|436771|P1|COMPLETED|Overall Study||52
177717|NCT00574067|436768|P4|STARTED|Overall Study||53
177718|NCT00574067|436769|P3|STARTED|Overall Study||54
177719|NCT00574067|436770|P2|STARTED|Overall Study||53
177720|NCT00574067|436771|P1|STARTED|Overall Study||53
177721|NCT00574080|436807|P2|NOT COMPLETED|Overall Study||10
177722|NCT00574080|436808|P1|NOT COMPLETED|Overall Study||10
177723|NCT00574080|436807|P2|COMPLETED|Overall Study||0
177724|NCT00574080|436808|P1|COMPLETED|Overall Study||0
177725|NCT00574080|436807|P2|STARTED|Overall Study||10
177726|NCT00574080|436808|P1|STARTED|Overall Study||10
177727|NCT00574145|436815|P2|NOT COMPLETED|Overall Study||1
177728|NCT00574145|436816|P1|NOT COMPLETED|Overall Study||2
177729|NCT00574145|436815|P2|COMPLETED|Overall Study||21
177730|NCT00574145|436816|P1|COMPLETED|Overall Study||20
177731|NCT00574145|436815|P2|STARTED|Overall Study||22
177732|NCT00574145|436816|P1|STARTED|Overall Study||22
177733|NCT00574171|436826|P1|NOT COMPLETED|Overall Study||0
177734|NCT00574171|436826|P1|COMPLETED|Overall Study||29
177735|NCT00574171|436826|P1|STARTED|Overall Study||29
177736|NCT00574249|436832|P2|NOT COMPLETED|Overall Study||28
177737|NCT00574249|436833|P1|NOT COMPLETED|Overall Study||26
177738|NCT00574249|436832|P2|COMPLETED|Overall Study||338
177739|NCT00574249|436833|P1|COMPLETED|Overall Study||338
177740|NCT00574249|436832|P2|STARTED|Overall Study||366
177741|NCT00574249|436833|P1|STARTED|Overall Study||364
177742|NCT00574275|436875|P2|NOT COMPLETED|Overall Study||271
177743|NCT00574275|436876|P1|NOT COMPLETED|Overall Study||275
177744|NCT00574275|436875|P2|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
177745|NCT00574275|436876|P1|COMPLETED|Overall Study|All participants stopped when they met treatment discontinuation criteria or by DMC recommendation|0
177746|NCT00574275|436875|P2|SAFETY POPULATION|Overall Study|Includes 2 participants from the Placebo and Gemcitabine arm who received 1 dose of Aflibercept|270
177747|NCT00574275|436876|P1|SAFETY POPULATION|Overall Study|Excludes 2 participants who received 1 dose of Aflibercept|271
177748|NCT00574275|436875|P2|TREATED|Overall Study||268
177749|NCT00574275|436876|P1|TREATED|Overall Study||273
177750|NCT00574275|436875|P2|STARTED|Overall Study||271
177751|NCT00574275|436876|P1|STARTED|Overall Study||275
177752|NCT00574288|436899|P7|NOT COMPLETED|Overall Study||42
177753|NCT00574288|436900|P6|NOT COMPLETED|Overall Study||30
177754|NCT00574288|436901|P5|NOT COMPLETED|Overall Study||1
177755|NCT00574288|436902|P4|NOT COMPLETED|Overall Study||2
177756|NCT00574288|436903|P3|NOT COMPLETED|Overall Study||0
177757|NCT00574288|436904|P2|NOT COMPLETED|Overall Study||1
177758|NCT00574288|436905|P1|NOT COMPLETED|Overall Study||13
177759|NCT00574288|436899|P7|COMPLETED|Overall Study||0
177760|NCT00574288|436900|P6|COMPLETED|Overall Study||0
177761|NCT00574288|436901|P5|COMPLETED|Overall Study||2
177762|NCT00574288|436902|P4|COMPLETED|Overall Study||1
177763|NCT00574288|436903|P3|COMPLETED|Overall Study||3
177764|NCT00574288|436904|P2|COMPLETED|Overall Study||2
177765|NCT00574288|436905|P1|COMPLETED|Overall Study||7
177766|NCT00574288|436899|P7|STARTED|Overall Study||42
177767|NCT00574288|436900|P6|STARTED|Overall Study||30
177768|NCT00574288|436901|P5|STARTED|Overall Study||3
177769|NCT00574288|436902|P4|STARTED|Overall Study||3
177770|NCT00574288|436903|P3|STARTED|Overall Study||3
177771|NCT00574288|436904|P2|STARTED|Overall Study||3
177772|NCT00574288|436905|P1|STARTED|Overall Study||20
177773|NCT00574340|436941|P2|NOT COMPLETED|Study 2 (2 Days)||0
177774|NCT00574340|436942|P1|NOT COMPLETED|Study 2 (2 Days)||0
177775|NCT00574340|436941|P2|COMPLETED|Study 2 (2 Days)||6
177776|NCT00574340|436942|P1|COMPLETED|Study 2 (2 Days)||6
177777|NCT00574340|436941|P2|STARTED|Study 2 (2 Days)||6
177778|NCT00574340|436942|P1|STARTED|Study 2 (2 Days)||6
177779|NCT00574340|436941|P2|NOT COMPLETED|Study 1 (2 Days)||0
177780|NCT00574340|436942|P1|NOT COMPLETED|Study 1 (2 Days)||0
177781|NCT00574340|436941|P2|COMPLETED|Study 1 (2 Days)||10
177782|NCT00574340|436942|P1|COMPLETED|Study 1 (2 Days)||10
177783|NCT00574340|436941|P2|STARTED|Study 1 (2 Days)||10
177784|NCT00574340|436942|P1|STARTED|Study 1 (2 Days)||10
177785|NCT00574405|436950|P2|NOT COMPLETED|Overall Study||2
177786|NCT00574405|436951|P1|NOT COMPLETED|Overall Study||3
177787|NCT00574405|436950|P2|COMPLETED|Overall Study||10
177788|NCT00574405|436951|P1|COMPLETED|Overall Study||9
177789|NCT00574405|436950|P2|STARTED|Overall Study||12
177790|NCT00574405|436951|P1|STARTED|Overall Study||12
177791|NCT00574548|436959|P2|NOT COMPLETED|Overall Study||16
177792|NCT00574548|436960|P1|NOT COMPLETED|Overall Study||61
177793|NCT00574548|436959|P2|COMPLETED|Overall Study||222
177794|NCT00574548|436960|P1|COMPLETED|Overall Study||421
177795|NCT00574548|436959|P2|Completed Vax 2 (6 Month Contact)|Overall Study||222
177796|NCT00574548|436960|P1|Completed Vax 2 (6 Month Contact)|Overall Study||421
177797|NCT00574548|436959|P2|Received Vax 2|Overall Study||223
177798|NCT00574548|436960|P1|Received Vax 2|Overall Study||427
177799|NCT00574548|436959|P2|Withdrawn Before Vax 2|Overall Study||11
177800|NCT00574548|436960|P1|Withdrawn Before Vax 2|Overall Study||41
177801|NCT00574548|436959|P2|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||3
177802|NCT00574548|436960|P1|Withdrawn After Vax 1 (6 Month Contact)|Overall Study||7
177803|NCT00574548|436959|P2|Completed Vax 1 (6 Month Contact)|Overall Study||234
177804|NCT00574548|436960|P1|Completed Vax 1 (6 Month Contact)|Overall Study||468
177805|NCT00574548|436959|P2|Received Vaccination 1 (Vax 1)|Overall Study||237
177806|NCT00574548|436960|P1|Received Vaccination 1 (Vax 1)|Overall Study||478
177807|NCT00574548|436959|P2|STARTED|Overall Study||238
177808|NCT00574548|436960|P1|STARTED|Overall Study||482
177809|NCT00574704|437008|P4|NOT COMPLETED|Overall Study||0
177810|NCT00574704|437009|P3|NOT COMPLETED|Overall Study||1
177811|NCT00574704|437010|P2|NOT COMPLETED|Overall Study||0
177812|NCT00574704|437011|P1|NOT COMPLETED|Overall Study||0
177813|NCT00574704|437008|P4|COMPLETED|Overall Study||10
177814|NCT00574704|437009|P3|COMPLETED|Overall Study||9
177815|NCT00574704|437010|P2|COMPLETED|Overall Study||10
177816|NCT00574704|437011|P1|COMPLETED|Overall Study||10
177817|NCT00574704|437008|P4|STARTED|Overall Study||10
177818|NCT00574704|437009|P3|STARTED|Overall Study||10
177819|NCT00574704|437010|P2|STARTED|Overall Study||10
177820|NCT00574704|437011|P1|STARTED|Overall Study||10
177821|NCT00574795|437021|P1|NOT COMPLETED|Toddler Dose||1
177822|NCT00574795|437021|P1|COMPLETED|Toddler Dose||184
177823|NCT00574795|437021|P1|STARTED|Toddler Dose||185
177824|NCT00574795|437021|P1|NOT COMPLETED|After Infant Series||3
177825|NCT00574795|437021|P1|COMPLETED|After Infant Series||185
177826|NCT00574795|437021|P1|STARTED|After Infant Series||188
177827|NCT00574795|437021|P1|NOT COMPLETED|Infant Series||5
177828|NCT00574795|437021|P1|COMPLETED|Infant Series||188
177829|NCT00574795|437021|P1|Vaccinated Dose 3|Infant Series||190
177830|NCT00574795|437021|P1|Vaccinated Dose 2|Infant Series||190
177831|NCT00574795|437021|P1|Vaccinated Dose 1|Infant Series||193
177832|NCT00574795|437021|P1|STARTED|Infant Series||193
177833|NCT00574834|437041|P3|NOT COMPLETED|Overall Study||0
177834|NCT00574834|437042|P2|NOT COMPLETED|Overall Study||0
177835|NCT00574834|437043|P1|NOT COMPLETED|Overall Study||0
177836|NCT00574834|437041|P3|COMPLETED|Overall Study||4
177837|NCT00574834|437042|P2|COMPLETED|Overall Study||4
177838|NCT00574834|437043|P1|COMPLETED|Overall Study||9
177839|NCT00574834|437041|P3|STARTED|Overall Study||4
177840|NCT00574834|437042|P2|STARTED|Overall Study||4
177841|NCT00574834|437043|P1|STARTED|Overall Study||9
177842|NCT00574847|437053|P2|NOT COMPLETED|Overall Study||7
177843|NCT00574847|437054|P1|NOT COMPLETED|Overall Study||8
177844|NCT00574847|437053|P2|COMPLETED|Overall Study||56
177845|NCT00574847|437054|P1|COMPLETED|Overall Study||56
177846|NCT00574847|437053|P2|STARTED|Overall Study||63
177847|NCT00574847|437054|P1|STARTED|Overall Study||64
177848|NCT00574873|437088|P2|NOT COMPLETED|Overall Study||251
177849|NCT00574873|437089|P1|NOT COMPLETED|Overall Study||238
177850|NCT00574873|437088|P2|COMPLETED|Overall Study||1
177851|NCT00574873|437089|P1|COMPLETED|Overall Study||12
177852|NCT00574873|437088|P2|Treated|Overall Study||251
177853|NCT00574873|437089|P1|Treated|Overall Study||248
177854|NCT00574873|437088|P2|STARTED|Overall Study||252
177855|NCT00574873|437089|P1|STARTED|Overall Study||250
177856|NCT00574912|437105|P1|NOT COMPLETED|Overall Study||8
177857|NCT00574912|437105|P1|COMPLETED|Overall Study||12
177858|NCT00574912|437105|P1|Completed 2.0|Overall Study||12
177859|NCT00574912|437105|P1|Completed 1.5|Overall Study||12
177860|NCT00574912|437105|P1|Completed 1.0|Overall Study||12
177861|NCT00574912|437105|P1|Completed 0.5|Overall Study||12
177862|NCT00574912|437105|P1|Completed Placebo|Overall Study|12 original participants started the trial.|12
177863|NCT00574912|437105|P1|STARTED|Overall Study||20
177864|NCT00574990|437120|P3|NOT COMPLETED|Overall Study||0
177865|NCT00574990|437121|P2|NOT COMPLETED|Overall Study||0
177866|NCT00574990|437122|P1|NOT COMPLETED|Overall Study||0
177867|NCT00574990|437120|P3|COMPLETED|Overall Study||8
177868|NCT00574990|437121|P2|COMPLETED|Overall Study||19
177869|NCT00574990|437122|P1|COMPLETED|Overall Study||12
177870|NCT00574990|437120|P3|STARTED|Overall Study||8
177871|NCT00574990|437121|P2|STARTED|Overall Study||19
177872|NCT00574990|437122|P1|STARTED|Overall Study||12
177873|NCT00575016|437137|P4|NOT COMPLETED|Treatment Cycle 2||0
177874|NCT00575016|437138|P3|NOT COMPLETED|Treatment Cycle 2||0
177875|NCT00575016|437139|P2|NOT COMPLETED|Treatment Cycle 2||0
177876|NCT00575016|437140|P1|NOT COMPLETED|Treatment Cycle 2||1
177877|NCT00575016|437137|P4|COMPLETED|Treatment Cycle 2||0
177878|NCT00575016|437138|P3|COMPLETED|Treatment Cycle 2||0
177879|NCT00575016|437139|P2|COMPLETED|Treatment Cycle 2||0
177880|NCT00575016|437140|P1|COMPLETED|Treatment Cycle 2||30
177881|NCT00575016|437137|P4|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
177882|NCT00575016|437138|P3|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
177883|NCT00575016|437139|P2|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|0
177884|NCT00575016|437140|P1|STARTED|Treatment Cycle 2|All patients received 200U in Treatment Cycle 2.|31
177885|NCT00575016|437137|P4|NOT COMPLETED|Treatment Cycle 1||5
177886|NCT00575016|437138|P3|NOT COMPLETED|Treatment Cycle 1||4
177887|NCT00575016|437139|P2|NOT COMPLETED|Treatment Cycle 1||5
177888|NCT00575016|437140|P1|NOT COMPLETED|Treatment Cycle 1||9
177889|NCT00575016|437137|P4|COMPLETED|Treatment Cycle 1|9 pts from Placebo group entered Cycle 2|12
177890|NCT00575016|437138|P3|COMPLETED|Treatment Cycle 1|8 pts from 50U group entered Cycle 2|15
177891|NCT00575016|437139|P2|COMPLETED|Treatment Cycle 1|11 pts from 100U group entered Cycle 2|16
177892|NCT00575016|437140|P1|COMPLETED|Treatment Cycle 1|3 pts from 200U group entered Cycle 2|8
177893|NCT00575016|437137|P4|STARTED|Treatment Cycle 1|1 pt randomized to Placebo never received treatment|17
177894|NCT00575016|437138|P3|STARTED|Treatment Cycle 1||19
177895|NCT00575016|437139|P2|STARTED|Treatment Cycle 1||21
177896|NCT00575016|437140|P1|STARTED|Treatment Cycle 1||17
177897|NCT00575029|437158|P1|NOT COMPLETED|Overall Study||0
177898|NCT00575029|437158|P1|COMPLETED|Overall Study||7
177899|NCT00575029|437158|P1|STARTED|Overall Study||7
177900|NCT00575042|437163|P1|NOT COMPLETED|Overall Study||3
177901|NCT00575042|437163|P1|COMPLETED|Overall Study|2 with side effects and 1 lost to follow-up|17
177902|NCT00575042|437163|P1|STARTED|Overall Study||20
177903|NCT00575094|437168|P1|NOT COMPLETED|Overall Study||3
177904|NCT00575094|437168|P1|COMPLETED|Overall Study||6
177905|NCT00575094|437168|P1|STARTED|Overall Study||9
177906|NCT00575146|437172|P1|NOT COMPLETED|Overall Study||3
177907|NCT00575146|437172|P1|COMPLETED|Overall Study||17
177908|NCT00575146|437172|P1|STARTED|Overall Study||20
177909|NCT00575185|437180|P2|NOT COMPLETED|Overall Study||0
177910|NCT00575185|437181|P1|NOT COMPLETED|Overall Study||0
177911|NCT00575185|437180|P2|COMPLETED|Overall Study||11
177912|NCT00575185|437181|P1|COMPLETED|Overall Study||12
177913|NCT00575185|437180|P2|STARTED|Overall Study||11
177914|NCT00575185|437181|P1|STARTED|Overall Study||12
177915|NCT00575367|437191|P2|NOT COMPLETED|Overall Study||0
177916|NCT00575367|437192|P1|NOT COMPLETED|Overall Study||0
177917|NCT00575367|437191|P2|COMPLETED|Overall Study||18
177918|NCT00575367|437192|P1|COMPLETED|Overall Study||19
177919|NCT00575367|437191|P2|STARTED|Overall Study||18
177920|NCT00575367|437192|P1|STARTED|Overall Study||19
177921|NCT00575380|437200|P2|NOT COMPLETED|Overall Study||3
177922|NCT00575380|437201|P1|NOT COMPLETED|Overall Study||1
177923|NCT00575380|437200|P2|COMPLETED|Overall Study||55
177924|NCT00575380|437201|P1|COMPLETED|Overall Study||57
177925|NCT00575380|437200|P2|STARTED|Overall Study||58
177926|NCT00575380|437201|P1|STARTED|Overall Study||58
177927|NCT00575510|437212|P3|NOT COMPLETED|Overall Study||17
177928|NCT00575510|437213|P2|NOT COMPLETED|Overall Study||13
177929|NCT00575510|437214|P1|NOT COMPLETED|Overall Study||12
177930|NCT00575510|437212|P3|COMPLETED|Overall Study||96
177931|NCT00575510|437213|P2|COMPLETED|Overall Study||101
177932|NCT00575510|437214|P1|COMPLETED|Overall Study||102
177933|NCT00575510|437212|P3|STARTED|Overall Study||113
177934|NCT00575510|437213|P2|STARTED|Overall Study||114
177935|NCT00575510|437214|P1|STARTED|Overall Study||114
177936|NCT00575588|437227|P2|NOT COMPLETED|Overall Study||283
177937|NCT00575588|437228|P1|NOT COMPLETED|Overall Study||263
177938|NCT00575588|437227|P2|COMPLETED|Overall Study|Completed 104 weeks of treatment|147
178194|NCT00580957|438025|P2|COMPLETED|Overall Study||21
177939|NCT00575588|437228|P1|COMPLETED|Overall Study|Completed 104 weeks of treatment|165
177940|NCT00575588|437227|P2|STARTED|Overall Study|Randomized and treated|430
177941|NCT00575588|437228|P1|STARTED|Overall Study|Randomized and treated|428
177942|NCT00575666|437250|P2|NOT COMPLETED|Overall Study||3
177943|NCT00575666|437251|P1|NOT COMPLETED|Overall Study||4
177944|NCT00575666|437250|P2|COMPLETED|Overall Study||21
177945|NCT00575666|437251|P1|COMPLETED|Overall Study||17
177946|NCT00575666|437250|P2|STARTED|Overall Study||24
177947|NCT00575666|437251|P1|STARTED|Overall Study||21
177948|NCT00575887|437289|P1|NOT COMPLETED|Overall Study||0
177949|NCT00575887|437289|P1|COMPLETED|Overall Study||25
177950|NCT00575887|437289|P1|STARTED|Overall Study||25
177951|NCT00575965|437293|P1|NOT COMPLETED|Overall Study||0
177952|NCT00575965|437293|P1|COMPLETED|Overall Study||18
177953|NCT00575965|437293|P1|STARTED|Overall Study||18
177954|NCT00579059|437300|P2|NOT COMPLETED|Overall Study||10
177955|NCT00579059|437301|P1|NOT COMPLETED|Overall Study||21
177956|NCT00579059|437300|P2|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
177957|NCT00579059|437301|P1|COMPLETED|Overall Study|No Patients completed through 5 years due to study closure at 1-year of follow-up.|0
177958|NCT00579059|437300|P2|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
177959|NCT00579059|437301|P1|5 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
177960|NCT00579059|437300|P2|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
177961|NCT00579059|437301|P1|3 Years|Overall Study|Incomplete due to study closure at 1-year of follow-up.|0
177962|NCT00579059|437300|P2|1 Year|Overall Study|7 patients didn't return for follow-up.|3
177963|NCT00579059|437301|P1|1 Year|Overall Study|13 patients didn't return for follow-up.|8
177964|NCT00579059|437300|P2|6 Months|Overall Study|6 patients didn't return for follow-up.|4
177965|NCT00579059|437301|P1|6 Months|Overall Study|10 Patients didn't return for follow-up.|11
177966|NCT00579059|437300|P2|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|9
177967|NCT00579059|437301|P1|Immediate Post-Op|Overall Study|1 Patient didn't return for follow-up.|20
177968|NCT00579059|437300|P2|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|10
177969|NCT00579059|437301|P1|STARTED|Overall Study|Enrollment was incomplete due to study cancellation.|21
177970|NCT00579098|437311|P2|NOT COMPLETED|Overall Study||8
177971|NCT00579098|437312|P1|NOT COMPLETED|Overall Study||9
177972|NCT00579098|437311|P2|COMPLETED|Overall Study||55
177973|NCT00579098|437312|P1|COMPLETED|Overall Study||53
177974|NCT00579098|437311|P2|STARTED|Overall Study||63
177975|NCT00579098|437312|P1|STARTED|Overall Study||62
177976|NCT00579111|437328|P2|NOT COMPLETED|Overall Study||1
177977|NCT00579111|437329|P1|NOT COMPLETED|Overall Study||2
177978|NCT00579111|437328|P2|COMPLETED|Overall Study||0
177979|NCT00579111|437329|P1|COMPLETED|Overall Study||1
177980|NCT00579111|437328|P2|STARTED|Overall Study||1
177981|NCT00579111|437329|P1|STARTED|Overall Study||3
177982|NCT00579137|437337|P1|NOT COMPLETED|Overall Study||0
177983|NCT00579137|437337|P1|COMPLETED|Overall Study||3
177984|NCT00579137|437337|P1|STARTED|Overall Study||3
177985|NCT00579254|437344|P1|NOT COMPLETED|Overall Study||112
177986|NCT00579254|437344|P1|COMPLETED|Overall Study||0
177987|NCT00579254|437344|P1|STARTED|Overall Study||112
177988|NCT00579345|437356|P8|NOT COMPLETED|Overall Study||2
177989|NCT00579345|437357|P7|NOT COMPLETED|Overall Study||0
177990|NCT00579345|437358|P6|NOT COMPLETED|Overall Study||0
177991|NCT00579345|437359|P5|NOT COMPLETED|Overall Study||0
177992|NCT00579345|437360|P4|NOT COMPLETED|Overall Study||1
177993|NCT00579345|437361|P3|NOT COMPLETED|Overall Study||2
177994|NCT00579345|437362|P2|NOT COMPLETED|Overall Study||1
177995|NCT00579345|437363|P1|NOT COMPLETED|Overall Study||5
177996|NCT00579345|437356|P8|COMPLETED|Overall Study||42
177997|NCT00579345|437357|P7|COMPLETED|Overall Study||57
177998|NCT00579345|437358|P6|COMPLETED|Overall Study||78
177999|NCT00579345|437359|P5|COMPLETED|Overall Study||90
178000|NCT00579345|437360|P4|COMPLETED|Overall Study||143
178001|NCT00579345|437361|P3|COMPLETED|Overall Study||389
178002|NCT00579345|437362|P2|COMPLETED|Overall Study||168
178003|NCT00579345|437363|P1|COMPLETED|Overall Study||544
178004|NCT00579345|437356|P8|STARTED|Overall Study||44
178005|NCT00579345|437357|P7|STARTED|Overall Study||57
178006|NCT00579345|437358|P6|STARTED|Overall Study||78
178007|NCT00579345|437359|P5|STARTED|Overall Study||90
178008|NCT00579345|437360|P4|STARTED|Overall Study||144
178009|NCT00579345|437361|P3|STARTED|Overall Study||391
178010|NCT00579345|437362|P2|STARTED|Overall Study||169
178011|NCT00579345|437363|P1|STARTED|Overall Study||549
178012|NCT00579501|437395|P1|NOT COMPLETED|Overall Study||29
178013|NCT00579501|437395|P1|COMPLETED|Overall Study||0
178014|NCT00579501|437395|P1|STARTED|Overall Study||29
178015|NCT00579670|437405|P5|NOT COMPLETED|Overall Study||0
178016|NCT00579670|437406|P4|NOT COMPLETED|Overall Study||22
178017|NCT00579670|437407|P3|NOT COMPLETED|Overall Study||4
178018|NCT00579670|437408|P2|NOT COMPLETED|Overall Study||1
178019|NCT00579670|437409|P1|NOT COMPLETED|Overall Study||2
178020|NCT00579670|437405|P5|COMPLETED|Overall Study||5
178021|NCT00579670|437406|P4|COMPLETED|Overall Study||263
178022|NCT00579670|437407|P3|COMPLETED|Overall Study||84
178023|NCT00579670|437408|P2|COMPLETED|Overall Study||56
178024|NCT00579670|437409|P1|COMPLETED|Overall Study||13
178025|NCT00579670|437405|P5|Population: Within SmPC (Completed)|Overall Study||0
178026|NCT00579670|437406|P4|Population: Within SmPC (Completed)|Overall Study|DC: AE N=2; Lack of efficacy N=5; LTFU N=3; Other unspecified N=2|147
178027|NCT00579670|437407|P3|Population: Within SmPC (Completed)|Overall Study|DC: AE N=1; Lack of efficacy N=1; Other unspecified N=1; Withdrawal by subject N=1|79
178028|NCT00579670|437408|P2|Population: Within SmPC (Completed)|Overall Study|DC: Lost to follow-up (LTFU) N=1|55
178029|NCT00579670|437409|P1|Population: Within SmPC (Completed)|Overall Study|Not Completed (DC): Subject died N=1; Adverse Event (AE) N=1|13
178030|NCT00579670|437405|P5|Population: Within SmPC (Started)|Overall Study|"Ziprasidone Unknown reporting group is not applicable to the Within SmPC population"|0
178031|NCT00579670|437406|P4|Population: Within SmPC (Started)|Overall Study||159
178032|NCT00579670|437407|P3|Population: Within SmPC (Started)|Overall Study||83
178033|NCT00579670|437408|P2|Population: Within SmPC (Started)|Overall Study||56
178034|NCT00579670|437409|P1|Population: Within SmPC (Started)|Overall Study|"Within summary of product characteristics (SmPC): FAS subjects who received all doses Within SmPC"|15
178035|NCT00579670|437405|P5|STARTED|Overall Study||5
178036|NCT00579670|437406|P4|STARTED|Overall Study||285
178037|NCT00579670|437407|P3|STARTED|Overall Study||88
178038|NCT00579670|437408|P2|STARTED|Overall Study||57
178039|NCT00579670|437409|P1|STARTED|Overall Study|Full Analysis Set (FAS): at least 1 dose study medication and at least 1 efficacy measurement|15
178040|NCT00579813|437623|P2|NOT COMPLETED|Overall Study||0
178041|NCT00579813|437624|P1|NOT COMPLETED|Overall Study||0
178042|NCT00579813|437623|P2|COMPLETED|Overall Study||10
178043|NCT00579813|437624|P1|COMPLETED|Overall Study||60
178044|NCT00579813|437623|P2|STARTED|Overall Study||10
178045|NCT00579813|437624|P1|STARTED|Overall Study||60
178046|NCT00579826|437642|P2|NOT COMPLETED|Overall Study||3
178047|NCT00579826|437643|P1|NOT COMPLETED|Overall Study||5
178048|NCT00579826|437642|P2|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|23
178049|NCT00579826|437643|P1|COMPLETED|Overall Study|Optional open label letrozole months 6-12; followed by RPFNA,|24
178050|NCT00579826|437642|P2|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|25
178051|NCT00579826|437643|P1|6 Months|Overall Study|RPFNA for assessment for primary endpoint.|28
178052|NCT00579826|437642|P2|STARTED|Overall Study||26
178053|NCT00579826|437643|P1|STARTED|Overall Study||29
178054|NCT00579982|437653|P1|NOT COMPLETED|Overall Study||8
178055|NCT00579982|437653|P1|COMPLETED|Overall Study||89
178056|NCT00579982|437653|P1|STARTED|Overall Study||97
178057|NCT00580034|437672|P2|NOT COMPLETED|Overall Study||0
178058|NCT00580034|437673|P1|NOT COMPLETED|Overall Study||10
178059|NCT00580034|437672|P2|COMPLETED|Overall Study||88
178060|NCT00580034|437673|P1|COMPLETED|Overall Study||78
178061|NCT00580034|437672|P2|STARTED|Overall Study||88
178062|NCT00580034|437673|P1|STARTED|Overall Study||88
178063|NCT00580073|437679|P1|NOT COMPLETED|Overall Study||0
178064|NCT00580073|437679|P1|COMPLETED|Overall Study||6
178065|NCT00580073|437679|P1|STARTED|Overall Study||6
178066|NCT00580138|437685|P1|NOT COMPLETED|Overall Study||0
178067|NCT00580138|437685|P1|COMPLETED|Overall Study||30
178068|NCT00580138|437685|P1|STARTED|Overall Study||30
178069|NCT00580151|437691|P2|NOT COMPLETED|Overall Study||0
178070|NCT00580151|437692|P1|NOT COMPLETED|Overall Study||0
178071|NCT00580151|437691|P2|COMPLETED|Overall Study||0
178072|NCT00580151|437692|P1|COMPLETED|Overall Study||9
178073|NCT00580151|437691|P2|STARTED|Overall Study||0
178074|NCT00580151|437692|P1|STARTED|Overall Study||9
178075|NCT00580229|437700|P1|NOT COMPLETED|Overall Study||0
178076|NCT00580229|437700|P1|COMPLETED|Overall Study||50
178077|NCT00580229|437700|P1|STARTED|Overall Study||50
178078|NCT00580294|437704|P1|NOT COMPLETED|Overall Study||0
178079|NCT00580294|437704|P1|COMPLETED|Overall Study||12
178080|NCT00580294|437704|P1|STARTED|Overall Study||12
178081|NCT00580333|437708|P1|NOT COMPLETED|Overall Study||0
178082|NCT00580333|437708|P1|COMPLETED|Overall Study||51
178083|NCT00580333|437708|P1|STARTED|Overall Study||51
178084|NCT00580372|437715|P1|NOT COMPLETED|Overall Study||0
178085|NCT00580372|437715|P1|COMPLETED|Overall Study||231
178086|NCT00580372|437715|P1|STARTED|Overall Study||231
178087|NCT00580398|437721|P2|NOT COMPLETED|Overall Study||0
178088|NCT00580398|437722|P1|NOT COMPLETED|Overall Study||0
178089|NCT00580398|437721|P2|COMPLETED|Overall Study||32
178090|NCT00580398|437722|P1|COMPLETED|Overall Study||17
178091|NCT00580398|437721|P2|STARTED|Overall Study||32
178092|NCT00580398|437722|P1|STARTED|Overall Study||17
178093|NCT00580502|437730|P1|NOT COMPLETED|Overall Study||0
178094|NCT00580502|437730|P1|COMPLETED|Overall Study||50
178095|NCT00580502|437730|P1|STARTED|Overall Study||50
178096|NCT00580606|437739|P2|NOT COMPLETED|Open Label (OL)||12
178097|NCT00580606|437740|P1|NOT COMPLETED|Open Label (OL)||9
178098|NCT00580606|437739|P2|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|5
178099|NCT00580606|437740|P1|COMPLETED|Open Label (OL)|Completed dosing & final Wk 164 desensitization OFC & Wk 172 tolerance OFC (if passed Wk 164 OFC).|9
178100|NCT00580606|437739|P2|Had Week 172 Oral Food Challenge|Open Label (OL)||2
178101|NCT00580606|437740|P1|Had Week 172 Oral Food Challenge|Open Label (OL)||2
178102|NCT00580606|437739|P2|Had Week 164 Oral Food Challenge|Open Label (OL)||5
178103|NCT00580606|437740|P1|Had Week 164 Oral Food Challenge|Open Label (OL)||9
178104|NCT00580606|437739|P2|Had Week 116 Oral Food Challenge|Open Label (OL)||6
178105|NCT00580606|437740|P1|Had Week 116 Oral Food Challenge|Open Label (OL)||13
178106|NCT00580606|437739|P2|Had Week 68 Oral Food Challenge|Open Label (OL)||12
178107|NCT00580606|437740|P1|Had Week 68 Oral Food Challenge|Open Label (OL)||15
178108|NCT00580606|437739|P2|Had Week 44 Oral Food Challenge|Open Label (OL)|After 44 weeks of OL high dose SLIT; 1 additional participant declined Week 44 OFC in OL period.|12
178109|NCT00580606|437740|P1|Had Week 44 Oral Food Challenge|Open Label (OL)|The Week 44 OFC for Low Dose Peanut SLIT was done at the end of the DB Period, not the OL period.|0
178110|NCT00580606|437739|P2|STARTED|Open Label (OL)|1 participant discontinued dosing before OL period; 2 passed Week 44 OFC & ineligible to crossover.|17
178111|NCT00580606|437740|P1|STARTED|Open Label (OL)|2 participants discontinued dosing before Open Label (OL) period.|18
178112|NCT00580606|437739|P2|NOT COMPLETED|Double Blind (DB)||0
178113|NCT00580606|437740|P1|NOT COMPLETED|Double Blind (DB)||0
178114|NCT00580606|437739|P2|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
178115|NCT00580606|437740|P1|COMPLETED|Double Blind (DB)|Completed: Participants who were assessed for the primary outcome measure.|20
178116|NCT00580606|437739|P2|Had Week 44 Oral Food Challenge|Double Blind (DB)||19
178117|NCT00580606|437740|P1|Had Week 44 Oral Food Challenge|Double Blind (DB)||18
178118|NCT00580606|437739|P2|STARTED|Double Blind (DB)||20
178119|NCT00580606|437740|P1|STARTED|Double Blind (DB)||20
178120|NCT00580671|437761|P3|NOT COMPLETED|Overall Study||17
178121|NCT00580671|437762|P2|NOT COMPLETED|Overall Study||16
178122|NCT00580671|437763|P1|NOT COMPLETED|Overall Study||16
178123|NCT00580671|437761|P3|COMPLETED|Overall Study||34
178124|NCT00580671|437762|P2|COMPLETED|Overall Study||35
178125|NCT00580671|437763|P1|COMPLETED|Overall Study||35
178126|NCT00580671|437761|P3|STARTED|Overall Study||51
178127|NCT00580671|437762|P2|STARTED|Overall Study||51
178128|NCT00580671|437763|P1|STARTED|Overall Study||51
178129|NCT00580723|437777|P1|NOT COMPLETED|Overall Study||8
178130|NCT00580723|437777|P1|COMPLETED|Overall Study||16
178131|NCT00580723|437777|P1|STARTED|Overall Study||24
178132|NCT00580788|437787|P4|NOT COMPLETED|Overall Study||1
178133|NCT00580788|437788|P3|NOT COMPLETED|Overall Study||0
178134|NCT00580788|437789|P2|NOT COMPLETED|Overall Study||0
178135|NCT00580788|437790|P1|NOT COMPLETED|Overall Study||0
178136|NCT00580788|437787|P4|COMPLETED|Overall Study|One subject was stopped early for hypertension. One subject completed but was not analyzed.|1
178137|NCT00580788|437788|P3|COMPLETED|Overall Study||3
178138|NCT00580788|437789|P2|COMPLETED|Overall Study||6
178139|NCT00580788|437790|P1|COMPLETED|Overall Study||3
178140|NCT00580788|437787|P4|STARTED|Overall Study||2
178141|NCT00580788|437788|P3|STARTED|Overall Study||3
178142|NCT00580788|437789|P2|STARTED|Overall Study||6
178143|NCT00580788|437790|P1|STARTED|Overall Study||3
178144|NCT00580801|437851|P3|NOT COMPLETED|Overall Study||3
178145|NCT00580801|437852|P2|NOT COMPLETED|Overall Study||1
178146|NCT00580801|437853|P1|NOT COMPLETED|Overall Study||6
178147|NCT00580801|437851|P3|COMPLETED|Overall Study||5
178148|NCT00580801|437852|P2|COMPLETED|Overall Study||7
178149|NCT00580801|437853|P1|COMPLETED|Overall Study||2
178150|NCT00580801|437851|P3|STARTED|Overall Study||8
178151|NCT00580801|437852|P2|STARTED|Overall Study||8
178152|NCT00580801|437853|P1|STARTED|Overall Study||8
178153|NCT00580840|437888|P4|NOT COMPLETED|Double-Blind||15
178154|NCT00580840|437889|P3|NOT COMPLETED|Double-Blind||9
178155|NCT00580840|437890|P2|NOT COMPLETED|Double-Blind||7
178156|NCT00580840|437891|P1|NOT COMPLETED|Double-Blind||0
178157|NCT00580840|437888|P4|COMPLETED|Double-Blind||54
178158|NCT00580840|437889|P3|COMPLETED|Double-Blind||61
178159|NCT00580840|437890|P2|COMPLETED|Double-Blind||63
178160|NCT00580840|437891|P1|COMPLETED|Double-Blind||0
178161|NCT00580840|437888|P4|STARTED|Double-Blind||69
178162|NCT00580840|437889|P3|STARTED|Double-Blind||70
178163|NCT00580840|437890|P2|STARTED|Double-Blind||70
178164|NCT00580840|437891|P1|STARTED|Double-Blind||0
178165|NCT00580840|437888|P4|NOT COMPLETED|Run-in||0
178166|NCT00580840|437889|P3|NOT COMPLETED|Run-in||0
178167|NCT00580840|437890|P2|NOT COMPLETED|Run-in||0
178168|NCT00580840|437891|P1|NOT COMPLETED|Run-in||124
178169|NCT00580840|437888|P4|COMPLETED|Run-in||0
178170|NCT00580840|437889|P3|COMPLETED|Run-in||0
178171|NCT00580840|437890|P2|COMPLETED|Run-in||0
178172|NCT00580840|437891|P1|COMPLETED|Run-in|Of the 209 randomized participants, 208 are in the Full Analysis Set (FAS).|209
178173|NCT00580840|437888|P4|STARTED|Run-in||0
178174|NCT00580840|437889|P3|STARTED|Run-in||0
178175|NCT00580840|437890|P2|STARTED|Run-in||0
178176|NCT00580840|437891|P1|STARTED|Run-in|620 subjects were screened for the study with 333 being enrolled.|333
178177|NCT00580853|437999|P3|NOT COMPLETED|Overall Study||0
178178|NCT00580853|438000|P2|NOT COMPLETED|Overall Study||0
178179|NCT00580853|438001|P1|NOT COMPLETED|Overall Study||0
178180|NCT00580853|437999|P3|COMPLETED|Overall Study||21
178181|NCT00580853|438000|P2|COMPLETED|Overall Study||21
178182|NCT00580853|438001|P1|COMPLETED|Overall Study||20
178183|NCT00580853|437999|P3|STARTED|Overall Study||21
178184|NCT00580853|438000|P2|STARTED|Overall Study||21
178185|NCT00580853|438001|P1|STARTED|Overall Study||20
178186|NCT00580866|438014|P2|NOT COMPLETED|Overall Study||2
178187|NCT00580866|438015|P1|NOT COMPLETED|Overall Study||2
178188|NCT00580866|438014|P2|COMPLETED|Overall Study||5
178189|NCT00580866|438015|P1|COMPLETED|Overall Study||8
178190|NCT00580866|438014|P2|STARTED|Overall Study||7
178191|NCT00580866|438015|P1|STARTED|Overall Study||10
178192|NCT00580957|438025|P2|NOT COMPLETED|Overall Study||7
178193|NCT00580957|438026|P1|NOT COMPLETED|Overall Study||7
178195|NCT00580957|438026|P1|COMPLETED|Overall Study||21
178196|NCT00580957|438025|P2|STARTED|Overall Study||28
178197|NCT00580957|438026|P1|STARTED|Overall Study||28
178198|NCT00580970|438034|P1|NOT COMPLETED|Treatment (Lovastatin)||19
178199|NCT00580970|438034|P1|COMPLETED|Treatment (Lovastatin)||53
178200|NCT00580970|438034|P1|6 Months of Treatment|Treatment (Lovastatin)|Subjects evaluable for analysis|53
178201|NCT00580970|438034|P1|STARTED|Treatment (Lovastatin)||72
178202|NCT00580970|438034|P1|NOT COMPLETED|Pre-treatment||1
178203|NCT00580970|438034|P1|COMPLETED|Pre-treatment||72
178204|NCT00580970|438034|P1|STARTED|Pre-treatment||73
178205|NCT00580983|438038|P1|NOT COMPLETED|Overall Study||7
178206|NCT00580983|438038|P1|COMPLETED|Overall Study||73
178207|NCT00580983|438038|P1|STARTED|Overall Study||80
178208|NCT00581061|438043|P1|NOT COMPLETED|Overall Study||0
178209|NCT00581061|438043|P1|COMPLETED|Overall Study||13
178210|NCT00581061|438043|P1|STARTED|Overall Study||13
178211|NCT00581100|438051|P2|NOT COMPLETED|Overall Study||5
178212|NCT00581100|438052|P1|NOT COMPLETED|Overall Study||7
178213|NCT00581100|438051|P2|COMPLETED|Overall Study||29
178214|NCT00581100|438052|P1|COMPLETED|Overall Study||31
178215|NCT00581100|438051|P2|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|33
178216|NCT00581100|438052|P1|Modified Intent-To-Treat Population|Overall Study|At least one dose of study medication, and had baseline and post-baseline data.|36
178217|NCT00581100|438051|P2|STARTED|Overall Study||34
178218|NCT00581100|438052|P1|STARTED|Overall Study||38
178219|NCT00581113|438090|P2|NOT COMPLETED|Overall Study||1
178220|NCT00581113|438091|P1|NOT COMPLETED|Overall Study||0
178221|NCT00581113|438090|P2|COMPLETED|Overall Study||3
178222|NCT00581113|438091|P1|COMPLETED|Overall Study||4
178223|NCT00581113|438090|P2|STARTED|Overall Study||4
178224|NCT00581113|438091|P1|STARTED|Overall Study||4
178225|NCT00581230|438099|P1|NOT COMPLETED|Overall Study||0
178226|NCT00581230|438099|P1|COMPLETED|Overall Study||51
178227|NCT00581230|438099|P1|Laryngoscopy With RAMP|Overall Study||51
178228|NCT00581230|438099|P1|Laryngoscopy Without RAMP|Overall Study||51
178229|NCT00581230|438099|P1|STARTED|Overall Study||51
178230|NCT00581256|438108|P2|NOT COMPLETED|Overall Study||0
178231|NCT00581256|438109|P1|NOT COMPLETED|Overall Study||0
178232|NCT00581256|438108|P2|COMPLETED|Overall Study||26
178233|NCT00581256|438109|P1|COMPLETED|Overall Study||28
178234|NCT00581256|438108|P2|STARTED|Overall Study||26
178235|NCT00581256|438109|P1|STARTED|Overall Study||28
178236|NCT00581308|438121|P1|NOT COMPLETED|Month 12||21
178237|NCT00581308|438121|P1|COMPLETED|Month 12||177
178238|NCT00581308|438121|P1|STARTED|Month 12||198
178239|NCT00581308|438121|P1|NOT COMPLETED|Month 6||5
178240|NCT00581308|438121|P1|COMPLETED|Month 6||198
178241|NCT00581308|438121|P1|STARTED|Month 6||203
178242|NCT00581308|438121|P1|NOT COMPLETED|Month 1||9
178243|NCT00581308|438121|P1|COMPLETED|Month 1||203
178244|NCT00581308|438121|P1|STARTED|Month 1||212
178245|NCT00581308|438121|P1|NOT COMPLETED|Pre Discharge||3
178246|NCT00581308|438121|P1|COMPLETED|Pre Discharge||212
178247|NCT00581308|438121|P1|STARTED|Pre Discharge||215
178248|NCT00581347|438131|P2|NOT COMPLETED|Overall Study||0
178249|NCT00581347|438132|P1|NOT COMPLETED|Overall Study||0
178250|NCT00581347|438131|P2|COMPLETED|Overall Study||3707
178251|NCT00581347|438132|P1|COMPLETED|Overall Study||3839
178252|NCT00581347|438131|P2|STARTED|Overall Study||3707
178253|NCT00581347|438132|P1|STARTED|Overall Study||3839
178254|NCT00581360|438140|P1|NOT COMPLETED|Overall Study||1
178255|NCT00581360|438140|P1|COMPLETED|Overall Study||9
178256|NCT00581360|438140|P1|STARTED|Overall Study||10
178257|NCT00581386|438151|P3|NOT COMPLETED|Overall Study||0
178258|NCT00581386|438152|P2|NOT COMPLETED|Overall Study||0
178259|NCT00581386|438153|P1|NOT COMPLETED|Overall Study||0
178260|NCT00581386|438151|P3|COMPLETED|Overall Study|04/15/2009|72
178261|NCT00581386|438152|P2|COMPLETED|Overall Study|04/15/2009|73
178262|NCT00581386|438153|P1|COMPLETED|Overall Study|04/15/2009|73
178263|NCT00581386|438151|P3|STARTED|Overall Study|05/30/2007|72
178264|NCT00581386|438152|P2|STARTED|Overall Study|05/30/2007|73
178265|NCT00581386|438153|P1|STARTED|Overall Study|05/30/2007|73
178266|NCT00581399|438178|P2|NOT COMPLETED|Overall Study||0
178267|NCT00581399|438179|P1|NOT COMPLETED|Overall Study||0
178268|NCT00581399|438178|P2|COMPLETED|Overall Study||48
178269|NCT00581399|438179|P1|COMPLETED|Overall Study||46
178270|NCT00581399|438178|P2|STARTED|Overall Study||48
178271|NCT00581399|438179|P1|STARTED|Overall Study||46
178272|NCT00571922|438189|P2|NOT COMPLETED|Overall Study||36
178273|NCT00571922|438190|P1|NOT COMPLETED|Overall Study||36
178274|NCT00571922|438189|P2|COMPLETED|Overall Study||0
178275|NCT00571922|438190|P1|COMPLETED|Overall Study||0
178276|NCT00571922|438189|P2|STARTED|Overall Study||36
178277|NCT00571922|438190|P1|STARTED|Overall Study||36
178278|NCT00571948|438200|P2|NOT COMPLETED|Overall Study||14
178279|NCT00571948|438201|P1|NOT COMPLETED|Overall Study||11
178280|NCT00571948|438200|P2|COMPLETED|Overall Study|Excluded n = 3) Reasons: diet record < 75 % of days (n = 2); blood analysis failed (n= 1)|52
178281|NCT00571948|438201|P1|COMPLETED|Overall Study|Excluded from analysis (n = 2) Reason: diet record for less than 75 % of days (n = 2)|55
178282|NCT00571948|438200|P2|STARTED|Overall Study||66
178283|NCT00571948|438201|P1|STARTED|Overall Study||66
178284|NCT00571961|438207|P1|NOT COMPLETED|Overall Study||0
178285|NCT00571961|438207|P1|COMPLETED|Overall Study||12
178286|NCT00571961|438207|P1|STARTED|Overall Study||12
178287|NCT00571974|438213|P2|NOT COMPLETED|Phase II||4
178288|NCT00571974|438214|P1|NOT COMPLETED|Phase II||0
178289|NCT00571974|438213|P2|COMPLETED|Phase II||17
178290|NCT00571974|438214|P1|COMPLETED|Phase II||0
178291|NCT00571974|438213|P2|STARTED|Phase II|3 participants are from phase I|21
178292|NCT00571974|438214|P1|STARTED|Phase II||0
178293|NCT00571974|438213|P2|NOT COMPLETED|Phase I||0
178294|NCT00571974|438214|P1|NOT COMPLETED|Phase I||0
178295|NCT00571974|438213|P2|COMPLETED|Phase I||0
178296|NCT00571974|438214|P1|COMPLETED|Phase I||9
178297|NCT00571974|438213|P2|STARTED|Phase I||0
178298|NCT00571974|438214|P1|STARTED|Phase I||9
178299|NCT00571987|438220|P1|NOT COMPLETED|Overall Study||7
178300|NCT00571987|438220|P1|COMPLETED|Overall Study||100
178301|NCT00571987|438220|P1|STARTED|Overall Study||107
178302|NCT00572039|438227|P2|NOT COMPLETED|Overall Study||10
178303|NCT00572039|438228|P1|NOT COMPLETED|Overall Study||16
178304|NCT00572039|438227|P2|COMPLETED|Overall Study||110
178305|NCT00572039|438228|P1|COMPLETED|Overall Study||105
178306|NCT00572039|438227|P2|STARTED|Overall Study||120
178307|NCT00572039|438228|P1|STARTED|Overall Study||121
178308|NCT00572117|438242|P2|NOT COMPLETED|Overall Study||2
178309|NCT00572117|438243|P1|NOT COMPLETED|Overall Study||2
178310|NCT00572117|438242|P2|COMPLETED|Overall Study||5
178311|NCT00572117|438243|P1|COMPLETED|Overall Study||3
178312|NCT00572117|438242|P2|STARTED|Overall Study||7
178313|NCT00572117|438243|P1|STARTED|Overall Study||5
178314|NCT00572156|438255|P4|NOT COMPLETED|Overall Study||25
178315|NCT00572156|438256|P3|NOT COMPLETED|Overall Study||27
178316|NCT00572156|438257|P2|NOT COMPLETED|Overall Study||26
178317|NCT00572156|438258|P1|NOT COMPLETED|Overall Study||26
178318|NCT00572156|438255|P4|COMPLETED|Overall Study||1
178319|NCT00572156|438256|P3|COMPLETED|Overall Study||0
178320|NCT00572156|438257|P2|COMPLETED|Overall Study||1
178321|NCT00572156|438258|P1|COMPLETED|Overall Study||0
178322|NCT00572156|438255|P4|STARTED|Overall Study||26
178323|NCT00572156|438256|P3|STARTED|Overall Study||27
178324|NCT00572156|438257|P2|STARTED|Overall Study||27
178325|NCT00572156|438258|P1|STARTED|Overall Study||26
178326|NCT00572260|438316|P1|NOT COMPLETED|Overall Study||0
178327|NCT00572260|438316|P1|COMPLETED|Overall Study||11
178328|NCT00572260|438316|P1|STARTED|Overall Study||11
178329|NCT00572468|438322|P2|NOT COMPLETED|Overall Study||4
178330|NCT00572468|438323|P1|NOT COMPLETED|Overall Study||2
178331|NCT00572468|438322|P2|COMPLETED|Overall Study||16
178332|NCT00572468|438323|P1|COMPLETED|Overall Study||20
178333|NCT00572468|438322|P2|STARTED|Overall Study||20
178334|NCT00572468|438323|P1|STARTED|Overall Study||22
178335|NCT00572533|438333|P2|NOT COMPLETED|Overall Study||3
178336|NCT00572533|438334|P1|NOT COMPLETED|Overall Study||7
178337|NCT00572533|438333|P2|COMPLETED|Overall Study||28
178338|NCT00572533|438334|P1|COMPLETED|Overall Study||24
178339|NCT00572533|438333|P2|STARTED|Overall Study||31
178340|NCT00572533|438334|P1|STARTED|Overall Study||31
178341|NCT00572572|438356|P2|NOT COMPLETED|Overall Study||6
178342|NCT00572572|438357|P1|NOT COMPLETED|Overall Study||3
178343|NCT00572572|438356|P2|COMPLETED|Overall Study||28
178344|NCT00572572|438357|P1|COMPLETED|Overall Study||32
178345|NCT00572572|438356|P2|STARTED|Overall Study||34
178346|NCT00572572|438357|P1|STARTED|Overall Study||35
178347|NCT00572624|438375|P2|NOT COMPLETED|Overall Study||4
178348|NCT00572624|438376|P1|NOT COMPLETED|Overall Study||17
178349|NCT00572624|438375|P2|COMPLETED|Overall Study||10
178350|NCT00572624|438376|P1|COMPLETED|Overall Study||20
178351|NCT00572624|438375|P2|STARTED|Overall Study||14
178352|NCT00572624|438376|P1|STARTED|Overall Study||37
178353|NCT00572728|438402|P1|NOT COMPLETED|Overall Study||39
178354|NCT00572728|438402|P1|COMPLETED|Overall Study|51 patients eligible for primary objective analysis|51
178355|NCT00572728|438402|P1|RCB Evaluation|Overall Study|Secondary: histopathology was available in 35 patients for RCB evaluation|35
178356|NCT00572728|438402|P1|LN Evaluation After NAC|Overall Study|Secondary:38 patients were available for histopathological LN evaluation after NAC|38
178357|NCT00572728|438402|P1|Completed FLT3 Scan|Overall Study|Secondary analysis milestone: 43 pts had FLT-3 performed.|43
178358|NCT00572728|438402|P1|Pathology Complete|Overall Study||51
178359|NCT00572728|438402|P1|Second Chemotherapy Initiated After FLT2|Overall Study||52
178360|NCT00572728|438402|P1|Second Chemotherapy Initiated|Overall Study||59
178361|NCT00572728|438402|P1|Completed FLT2 Scan|Overall Study||60
178362|NCT00572728|438402|P1|First Therapy Initiated|Overall Study||65
178363|NCT00572728|438402|P1|Completed FLT1 Scan|Overall Study||67
178364|NCT00572728|438402|P1|On Study|Overall Study||71
178365|NCT00572728|438402|P1|Did Not Withdraw|Overall Study||72
178366|NCT00572728|438402|P1|Enrolled Under Amendment 5 or Later|Overall Study||82
178367|NCT00572728|438402|P1|Eligible|Overall Study||87
178368|NCT00572728|438402|P1|STARTED|Overall Study|Registered|90
178369|NCT00572832|438416|P2|NOT COMPLETED|Overall Study||12
178370|NCT00572832|438417|P1|NOT COMPLETED|Overall Study||0
178371|NCT00572832|438416|P2|COMPLETED|Overall Study||88
178372|NCT00572832|438417|P1|COMPLETED|Overall Study||100
178373|NCT00572832|438416|P2|STARTED|Overall Study||100
178374|NCT00572832|438417|P1|STARTED|Overall Study||100
178375|NCT00572897|438425|P2|NOT COMPLETED|Overall Study||0
178376|NCT00572897|438426|P1|NOT COMPLETED|Overall Study||0
178377|NCT00572897|438425|P2|COMPLETED|Overall Study||34
178378|NCT00572897|438426|P1|COMPLETED|Overall Study||32
178379|NCT00572897|438425|P2|STARTED|Overall Study||34
178380|NCT00572897|438426|P1|STARTED|Overall Study||32
178381|NCT00572910|438448|P11|NOT COMPLETED|Overall Study||3
178382|NCT00572910|438449|P10|NOT COMPLETED|Overall Study||6
178383|NCT00572910|438450|P9|NOT COMPLETED|Overall Study||3
178384|NCT00572910|438451|P8|NOT COMPLETED|Overall Study||4
178385|NCT00572910|438452|P7|NOT COMPLETED|Overall Study||4
178386|NCT00572910|438453|P6|NOT COMPLETED|Overall Study||3
178387|NCT00572910|438454|P5|NOT COMPLETED|Overall Study||2
178388|NCT00572910|438455|P4|NOT COMPLETED|Overall Study||4
178389|NCT00572910|438456|P3|NOT COMPLETED|Overall Study||2
178390|NCT00572910|438457|P2|NOT COMPLETED|Overall Study||3
178391|NCT00572910|438458|P1|NOT COMPLETED|Overall Study||4
178392|NCT00572910|438448|P11|COMPLETED|Overall Study||15
178393|NCT00572910|438449|P10|COMPLETED|Overall Study||13
178394|NCT00572910|438450|P9|COMPLETED|Overall Study||16
178395|NCT00572910|438451|P8|COMPLETED|Overall Study||15
178396|NCT00572910|438452|P7|COMPLETED|Overall Study||15
178397|NCT00572910|438453|P6|COMPLETED|Overall Study||16
178398|NCT00572910|438454|P5|COMPLETED|Overall Study||17
178399|NCT00572910|438455|P4|COMPLETED|Overall Study||14
178400|NCT00572910|438456|P3|COMPLETED|Overall Study||17
178401|NCT00572910|438457|P2|COMPLETED|Overall Study||15
178402|NCT00572910|438458|P1|COMPLETED|Overall Study||15
178403|NCT00572910|438448|P11|STARTED|Overall Study||18
178404|NCT00572910|438449|P10|STARTED|Overall Study||19
178405|NCT00572910|438450|P9|STARTED|Overall Study||19
178406|NCT00572910|438451|P8|STARTED|Overall Study||19
178407|NCT00572910|438452|P7|STARTED|Overall Study||19
178408|NCT00572910|438453|P6|STARTED|Overall Study||19
178409|NCT00572910|438454|P5|STARTED|Overall Study||19
178410|NCT00572910|438455|P4|STARTED|Overall Study||18
178411|NCT00572910|438456|P3|STARTED|Overall Study||19
178412|NCT00572910|438457|P2|STARTED|Overall Study||18
178413|NCT00572910|438458|P1|STARTED|Overall Study||19
178414|NCT00573066|438504|P1|NOT COMPLETED|Overall Study||20
178415|NCT00573066|438504|P1|COMPLETED|Overall Study||36
178416|NCT00573066|438504|P1|STARTED|Overall Study||56
178417|NCT00581529|438508|P1|NOT COMPLETED|Overall Study||0
178418|NCT00581529|438508|P1|COMPLETED|Overall Study||34
178419|NCT00581529|438508|P1|STARTED|Overall Study||34
178420|NCT00581542|438515|P2|NOT COMPLETED|Overall Study||23
178421|NCT00581542|438516|P1|NOT COMPLETED|Overall Study||11
178422|NCT00581542|438515|P2|COMPLETED|Overall Study||39
178423|NCT00581542|438516|P1|COMPLETED|Overall Study||51
178424|NCT00581542|438515|P2|STARTED|Overall Study||62
178425|NCT00581542|438516|P1|STARTED|Overall Study||62
178426|NCT00581555|438526|P2|NOT COMPLETED|Overall Study||20
178427|NCT00581555|438527|P1|NOT COMPLETED|Overall Study||43
178428|NCT00581555|438526|P2|COMPLETED|Overall Study||38
178429|NCT00581555|438527|P1|COMPLETED|Overall Study||19
178430|NCT00581555|438526|P2|STARTED|Overall Study||58
178431|NCT00581555|438527|P1|STARTED|Overall Study||62
178432|NCT00581581|438551|P2|NOT COMPLETED|Overall Study||0
178433|NCT00581581|438552|P1|NOT COMPLETED|Overall Study||0
178434|NCT00581581|438551|P2|COMPLETED|Overall Study||30
178435|NCT00581581|438552|P1|COMPLETED|Overall Study||32
178436|NCT00581581|438551|P2|STARTED|Overall Study||30
178437|NCT00581581|438552|P1|STARTED|Overall Study||32
178438|NCT00581776|438558|P1|NOT COMPLETED|Overall Study||3
178439|NCT00581776|438558|P1|COMPLETED|Overall Study|3 subjects did not complete the planned induction chemotherapy.|27
178440|NCT00581776|438558|P1|STARTED|Overall Study||30
178441|NCT00581828|438565|P1|NOT COMPLETED|Overall Study||1
178442|NCT00581828|438565|P1|COMPLETED|Overall Study||18
178443|NCT00581828|438565|P1|STARTED|Overall Study||19
178444|NCT00581854|438569|P1|NOT COMPLETED|Overall Study||0
178445|NCT00581854|438569|P1|COMPLETED|Overall Study||22
178446|NCT00581854|438569|P1|STARTED|Overall Study||22
178447|NCT00582491|438575|P2|NOT COMPLETED|Overall Study||0
178448|NCT00582491|438576|P1|NOT COMPLETED|Overall Study||1
178449|NCT00582491|438575|P2|COMPLETED|Overall Study||10
178450|NCT00582491|438576|P1|COMPLETED|Overall Study||10
178451|NCT00582491|438575|P2|STARTED|Overall Study||10
178452|NCT00582491|438576|P1|STARTED|Overall Study||11
178453|NCT00582517|438600|P2|NOT COMPLETED|Overall Study||0
178454|NCT00582517|438601|P1|NOT COMPLETED|Overall Study||0
178455|NCT00582517|438600|P2|COMPLETED|Overall Study||55
178456|NCT00582517|438601|P1|COMPLETED|Overall Study||45
178457|NCT00582517|438600|P2|STARTED|Overall Study||55
178458|NCT00582517|438601|P1|STARTED|Overall Study||45
178459|NCT00582556|438610|P3|NOT COMPLETED|Overall Study||2
178460|NCT00582556|438611|P2|NOT COMPLETED|Overall Study||1
178461|NCT00582556|438612|P1|NOT COMPLETED|Overall Study||0
178462|NCT00582556|438610|P3|COMPLETED|Overall Study||12
178463|NCT00582556|438611|P2|COMPLETED|Overall Study||14
178464|NCT00582556|438612|P1|COMPLETED|Overall Study||14
178465|NCT00582556|438610|P3|STARTED|Overall Study||14
178466|NCT00582556|438611|P2|STARTED|Overall Study||15
178467|NCT00582556|438612|P1|STARTED|Overall Study||14
178468|NCT00582608|438629|P1|NOT COMPLETED|Overall Study||12
178469|NCT00582608|438629|P1|COMPLETED|Overall Study||0
178470|NCT00582608|438629|P1|STARTED|Overall Study||12
178471|NCT00582660|438635|P2|NOT COMPLETED|Overall Study||0
178472|NCT00582660|438636|P1|NOT COMPLETED|Overall Study||0
178473|NCT00582660|438635|P2|COMPLETED|Overall Study||20
178474|NCT00582660|438636|P1|COMPLETED|Overall Study||20
178475|NCT00582660|438635|P2|STARTED|Overall Study||20
178476|NCT00582660|438636|P1|STARTED|Overall Study||20
178477|NCT00582712|438644|P1|NOT COMPLETED|Overall Study||4
178478|NCT00582712|438644|P1|COMPLETED|Overall Study||1
178479|NCT00582712|438644|P1|STARTED|Overall Study||5
178480|NCT00582738|438650|P2|NOT COMPLETED|Overall Study||18
178481|NCT00582738|438651|P1|NOT COMPLETED|Overall Study||9
178482|NCT00582738|438650|P2|COMPLETED|Overall Study||4
178483|NCT00582738|438651|P1|COMPLETED|Overall Study||12
178484|NCT00582738|438650|P2|STARTED|Overall Study||22
178485|NCT00582738|438651|P1|STARTED|Overall Study||21
178486|NCT00582790|438675|P1|NOT COMPLETED|Overall Study||1
178487|NCT00582790|438675|P1|COMPLETED|Overall Study||11
178488|NCT00582790|438675|P1|STARTED|Overall Study|only 11 of the 12 patients received study treatment.|12
178489|NCT00582816|438682|P1|NOT COMPLETED|Overall Study||3
178490|NCT00582816|438682|P1|COMPLETED|Overall Study|"Completed here means patients stably engrafted with donor cells."|6
178491|NCT00582816|438682|P1|STARTED|Overall Study||9
178492|NCT00582894|438692|P1|NOT COMPLETED|Overall Study||0
178493|NCT00582894|438692|P1|COMPLETED|Overall Study||17
178494|NCT00582894|438692|P1|Day 100 Post Transplant|Overall Study||17
178495|NCT00582894|438692|P1|STARTED|Overall Study||17
178496|NCT00582907|438699|P4|NOT COMPLETED|4th Course||0
178497|NCT00582907|438700|P3|NOT COMPLETED|4th Course||0
178498|NCT00582907|438701|P2|NOT COMPLETED|4th Course||0
178499|NCT00582907|438702|P1|NOT COMPLETED|4th Course||0
178500|NCT00582907|438699|P4|COMPLETED|4th Course||3
178501|NCT00582907|438700|P3|COMPLETED|4th Course||3
178502|NCT00582907|438701|P2|COMPLETED|4th Course||3
178503|NCT00582907|438702|P1|COMPLETED|4th Course||2
178504|NCT00582907|438699|P4|STARTED|4th Course||3
178505|NCT00582907|438700|P3|STARTED|4th Course||3
178506|NCT00582907|438701|P2|STARTED|4th Course||3
178507|NCT00582907|438702|P1|STARTED|4th Course||2
178508|NCT00582907|438699|P4|NOT COMPLETED|3rd Course||0
178509|NCT00582907|438700|P3|NOT COMPLETED|3rd Course||0
178510|NCT00582907|438701|P2|NOT COMPLETED|3rd Course||0
178511|NCT00582907|438702|P1|NOT COMPLETED|3rd Course||0
178512|NCT00582907|438699|P4|COMPLETED|3rd Course||3
178513|NCT00582907|438700|P3|COMPLETED|3rd Course||3
178514|NCT00582907|438701|P2|COMPLETED|3rd Course||3
178515|NCT00582907|438702|P1|COMPLETED|3rd Course||2
178516|NCT00582907|438699|P4|STARTED|3rd Course||3
178517|NCT00582907|438700|P3|STARTED|3rd Course||3
178518|NCT00582907|438701|P2|STARTED|3rd Course||3
178519|NCT00582907|438702|P1|STARTED|3rd Course||2
178520|NCT00582907|438699|P4|NOT COMPLETED|2nd Course||0
178521|NCT00582907|438700|P3|NOT COMPLETED|2nd Course||0
178522|NCT00582907|438701|P2|NOT COMPLETED|2nd Course||0
178523|NCT00582907|438702|P1|NOT COMPLETED|2nd Course||1
178524|NCT00582907|438699|P4|COMPLETED|2nd Course||3
178525|NCT00582907|438700|P3|COMPLETED|2nd Course||3
178526|NCT00582907|438701|P2|COMPLETED|2nd Course||3
178527|NCT00582907|438702|P1|COMPLETED|2nd Course||2
178528|NCT00582907|438699|P4|STARTED|2nd Course||3
178529|NCT00582907|438700|P3|STARTED|2nd Course||3
178530|NCT00582907|438701|P2|STARTED|2nd Course||3
178531|NCT00582907|438702|P1|STARTED|2nd Course||3
178532|NCT00582907|438699|P4|NOT COMPLETED|1st Course||1
178533|NCT00582907|438700|P3|NOT COMPLETED|1st Course||0
178534|NCT00582907|438701|P2|NOT COMPLETED|1st Course||0
178535|NCT00582907|438702|P1|NOT COMPLETED|1st Course||1
178536|NCT00582907|438699|P4|COMPLETED|1st Course|Patient lost to follow-up towards end of 1st course|3
178537|NCT00582907|438700|P3|COMPLETED|1st Course||3
178538|NCT00582907|438701|P2|COMPLETED|1st Course||3
178539|NCT00582907|438702|P1|COMPLETED|1st Course|1 left after 1st course (transportation issues)|3
178540|NCT00582907|438699|P4|STARTED|1st Course||4
178541|NCT00582907|438700|P3|STARTED|1st Course||3
178542|NCT00582907|438701|P2|STARTED|1st Course||3
178543|NCT00582907|438702|P1|STARTED|1st Course||4
178544|NCT00582933|438734|P1|NOT COMPLETED|Overall Study||3
178545|NCT00582933|438734|P1|COMPLETED|Overall Study||92
178546|NCT00582933|438734|P1|STARTED|Overall Study||95
178547|NCT00582946|438738|P1|NOT COMPLETED|Overall Study||0
178548|NCT00582946|438738|P1|COMPLETED|Overall Study||16
178549|NCT00582946|438738|P1|STARTED|Overall Study||16
178550|NCT00582972|438742|P1|NOT COMPLETED|Overall Study||2
178551|NCT00582972|438742|P1|COMPLETED|Overall Study||21
178552|NCT00582972|438742|P1|STARTED|Overall Study||23
178553|NCT00583115|438747|P1|NOT COMPLETED|Overall Study||1
178554|NCT00583115|438747|P1|COMPLETED|Overall Study||0
178555|NCT00583115|438747|P1|STARTED|Overall Study||1
178556|NCT00583219|438752|P1|NOT COMPLETED|Phase 2||1
178557|NCT00583219|438752|P1|COMPLETED|Phase 2||21
178558|NCT00583219|438752|P1|STARTED|Phase 2|6 subjects from P1 continued in P2; plus 16 new subjects. All subjects in P2 got 300 units Botox.|22
178559|NCT00583219|438752|P1|NOT COMPLETED|Phase 1||0
178560|NCT00583219|438752|P1|COMPLETED|Phase 1||9
178561|NCT00583219|438752|P1|STARTED|Phase 1|First 3 subjects in Phase 1 received 200 units Botox. The remaining subjects got 300 units Botox.|9
178562|NCT00583362|438769|P1|NOT COMPLETED|Overall Study||202
178563|NCT00583362|438769|P1|COMPLETED|Overall Study||96
178564|NCT00583362|438769|P1|STARTED|Overall Study||298
178565|NCT00583453|438795|P2|NOT COMPLETED|Overall Study||2
178566|NCT00583453|438796|P1|NOT COMPLETED|Overall Study||0
178567|NCT00583453|438795|P2|COMPLETED|Overall Study||6
178568|NCT00583453|438796|P1|COMPLETED|Overall Study||9
178569|NCT00583453|438795|P2|STARTED|Overall Study||8
178570|NCT00583453|438796|P1|STARTED|Overall Study||9
178571|NCT00583492|438812|P2|NOT COMPLETED|Overall Study||0
178572|NCT00583492|438813|P1|NOT COMPLETED|Overall Study||0
178573|NCT00583492|438812|P2|COMPLETED|Overall Study||23
178574|NCT00583492|438813|P1|COMPLETED|Overall Study||21
178575|NCT00583492|438812|P2|STARTED|Overall Study||23
178576|NCT00583492|438813|P1|STARTED|Overall Study||21
178577|NCT00583557|438829|P1|NOT COMPLETED|Overall Study||70
178578|NCT00583557|438829|P1|COMPLETED|Overall Study|Completer defined as subjects whose reason for discontinuation was sponsor discontinuation of study|85
178579|NCT00583557|438829|P1|Received at Least 1 Dose Belimumab|Overall Study||153
178580|NCT00583557|438829|P1|STARTED|Overall Study||155
178581|NCT00583596|438833|P1|NOT COMPLETED|Overall Study||284
178582|NCT00583596|438833|P1|COMPLETED|Overall Study||152
178583|NCT00583596|438833|P1|STARTED|Overall Study|Subjects in Phase 2 clinical trial who received the AMPLATZER Duct Occluder.|436
178584|NCT00583622|438838|P1|NOT COMPLETED|Overall Study||0
178585|NCT00583622|438838|P1|COMPLETED|Overall Study||12
178586|NCT00583622|438838|P1|STARTED|Overall Study||12
178587|NCT00583661|438843|P1|NOT COMPLETED|Overall Study||0
178588|NCT00583661|438843|P1|COMPLETED|Overall Study||48
178589|NCT00583661|438843|P1|STARTED|Overall Study||48
178590|NCT00583700|438852|P2|NOT COMPLETED|Overall Study||4
178591|NCT00583700|438853|P1|NOT COMPLETED|Overall Study||3
178592|NCT00583700|438852|P2|COMPLETED|Overall Study||23
178593|NCT00583700|438853|P1|COMPLETED|Overall Study||24
178594|NCT00583700|438852|P2|STARTED|Overall Study||27
178595|NCT00583700|438853|P1|STARTED|Overall Study||27
178596|NCT00583713|438864|P3|NOT COMPLETED|Overall Study||0
178597|NCT00583713|438865|P2|NOT COMPLETED|Overall Study||0
178598|NCT00583713|438866|P1|NOT COMPLETED|Overall Study||0
178599|NCT00583713|438864|P3|COMPLETED|Overall Study||6
178600|NCT00583713|438865|P2|COMPLETED|Overall Study||6
178601|NCT00583713|438866|P1|COMPLETED|Overall Study||6
178602|NCT00583713|438864|P3|STARTED|Overall Study||6
178603|NCT00583713|438865|P2|STARTED|Overall Study||6
178604|NCT00583713|438866|P1|STARTED|Overall Study||6
178605|NCT00583908|438889|P12|NOT COMPLETED|Period 4 - Fourth Intervention||0
178606|NCT00583908|438890|P11|NOT COMPLETED|Period 4 - Fourth Intervention||0
178607|NCT00583908|438891|P10|NOT COMPLETED|Period 4 - Fourth Intervention||0
178608|NCT00583908|438892|P9|NOT COMPLETED|Period 4 - Fourth Intervention||0
178609|NCT00583908|438893|P8|NOT COMPLETED|Period 4 - Fourth Intervention||0
178610|NCT00583908|438894|P7|NOT COMPLETED|Period 4 - Fourth Intervention||0
178611|NCT00583908|438895|P6|NOT COMPLETED|Period 4 - Fourth Intervention||0
178612|NCT00583908|438896|P5|NOT COMPLETED|Period 4 - Fourth Intervention||0
178613|NCT00583908|438897|P4|NOT COMPLETED|Period 4 - Fourth Intervention||0
178614|NCT00583908|438898|P3|NOT COMPLETED|Period 4 - Fourth Intervention||0
178615|NCT00583908|438899|P2|NOT COMPLETED|Period 4 - Fourth Intervention||0
178616|NCT00583908|438900|P1|NOT COMPLETED|Period 4 - Fourth Intervention||0
178617|NCT00583908|438889|P12|COMPLETED|Period 4 - Fourth Intervention||1
178618|NCT00583908|438890|P11|COMPLETED|Period 4 - Fourth Intervention||1
178619|NCT00583908|438891|P10|COMPLETED|Period 4 - Fourth Intervention||1
178620|NCT00583908|438892|P9|COMPLETED|Period 4 - Fourth Intervention||1
178621|NCT00583908|438893|P8|COMPLETED|Period 4 - Fourth Intervention||1
178622|NCT00583908|438894|P7|COMPLETED|Period 4 - Fourth Intervention||1
178623|NCT00583908|438895|P6|COMPLETED|Period 4 - Fourth Intervention||1
178624|NCT00583908|438896|P5|COMPLETED|Period 4 - Fourth Intervention||2
178625|NCT00583908|438897|P4|COMPLETED|Period 4 - Fourth Intervention||1
178626|NCT00583908|438898|P3|COMPLETED|Period 4 - Fourth Intervention||1
178627|NCT00583908|438899|P2|COMPLETED|Period 4 - Fourth Intervention||2
178628|NCT00583908|438900|P1|COMPLETED|Period 4 - Fourth Intervention||1
178629|NCT00583908|438889|P12|STARTED|Period 4 - Fourth Intervention||1
178630|NCT00583908|438890|P11|STARTED|Period 4 - Fourth Intervention||1
178631|NCT00583908|438891|P10|STARTED|Period 4 - Fourth Intervention||1
178632|NCT00583908|438892|P9|STARTED|Period 4 - Fourth Intervention||1
178633|NCT00583908|438893|P8|STARTED|Period 4 - Fourth Intervention||1
178634|NCT00583908|438894|P7|STARTED|Period 4 - Fourth Intervention||1
178635|NCT00583908|438895|P6|STARTED|Period 4 - Fourth Intervention||1
178636|NCT00583908|438896|P5|STARTED|Period 4 - Fourth Intervention||2
178637|NCT00583908|438897|P4|STARTED|Period 4 - Fourth Intervention||1
178638|NCT00583908|438898|P3|STARTED|Period 4 - Fourth Intervention||1
178639|NCT00583908|438899|P2|STARTED|Period 4 - Fourth Intervention||2
178640|NCT00583908|438900|P1|STARTED|Period 4 - Fourth Intervention||1
178641|NCT00583908|438889|P12|NOT COMPLETED|Period 3 - Third Intervention||0
178642|NCT00583908|438890|P11|NOT COMPLETED|Period 3 - Third Intervention||0
178643|NCT00583908|438891|P10|NOT COMPLETED|Period 3 - Third Intervention||0
178644|NCT00583908|438892|P9|NOT COMPLETED|Period 3 - Third Intervention||0
178645|NCT00583908|438893|P8|NOT COMPLETED|Period 3 - Third Intervention||0
178646|NCT00583908|438894|P7|NOT COMPLETED|Period 3 - Third Intervention||0
178647|NCT00583908|438895|P6|NOT COMPLETED|Period 3 - Third Intervention||0
178648|NCT00583908|438896|P5|NOT COMPLETED|Period 3 - Third Intervention||0
178649|NCT00583908|438897|P4|NOT COMPLETED|Period 3 - Third Intervention||0
178650|NCT00583908|438898|P3|NOT COMPLETED|Period 3 - Third Intervention||0
178651|NCT00583908|438899|P2|NOT COMPLETED|Period 3 - Third Intervention||0
178652|NCT00583908|438900|P1|NOT COMPLETED|Period 3 - Third Intervention||0
178653|NCT00583908|438889|P12|COMPLETED|Period 3 - Third Intervention||1
178654|NCT00583908|438890|P11|COMPLETED|Period 3 - Third Intervention||1
178655|NCT00583908|438891|P10|COMPLETED|Period 3 - Third Intervention||1
178656|NCT00583908|438892|P9|COMPLETED|Period 3 - Third Intervention||1
178657|NCT00583908|438893|P8|COMPLETED|Period 3 - Third Intervention||1
178658|NCT00583908|438894|P7|COMPLETED|Period 3 - Third Intervention||1
178659|NCT00583908|438895|P6|COMPLETED|Period 3 - Third Intervention||1
178660|NCT00583908|438896|P5|COMPLETED|Period 3 - Third Intervention||2
178661|NCT00583908|438897|P4|COMPLETED|Period 3 - Third Intervention||1
178662|NCT00583908|438898|P3|COMPLETED|Period 3 - Third Intervention||1
178663|NCT00583908|438899|P2|COMPLETED|Period 3 - Third Intervention||2
178664|NCT00583908|438900|P1|COMPLETED|Period 3 - Third Intervention||1
178665|NCT00583908|438889|P12|STARTED|Period 3 - Third Intervention||1
178666|NCT00583908|438890|P11|STARTED|Period 3 - Third Intervention||1
178667|NCT00583908|438891|P10|STARTED|Period 3 - Third Intervention||1
178668|NCT00583908|438892|P9|STARTED|Period 3 - Third Intervention||1
178669|NCT00583908|438893|P8|STARTED|Period 3 - Third Intervention||1
178670|NCT00583908|438894|P7|STARTED|Period 3 - Third Intervention||1
178671|NCT00583908|438895|P6|STARTED|Period 3 - Third Intervention||1
178672|NCT00583908|438896|P5|STARTED|Period 3 - Third Intervention||2
178673|NCT00583908|438897|P4|STARTED|Period 3 - Third Intervention||1
178674|NCT00583908|438898|P3|STARTED|Period 3 - Third Intervention||1
178675|NCT00583908|438899|P2|STARTED|Period 3 - Third Intervention||2
178676|NCT00583908|438900|P1|STARTED|Period 3 - Third Intervention||1
178677|NCT00583908|438889|P12|NOT COMPLETED|Period 2 - Second Intervention||0
178678|NCT00583908|438890|P11|NOT COMPLETED|Period 2 - Second Intervention||0
178679|NCT00583908|438891|P10|NOT COMPLETED|Period 2 - Second Intervention||0
178680|NCT00583908|438892|P9|NOT COMPLETED|Period 2 - Second Intervention||0
178681|NCT00583908|438893|P8|NOT COMPLETED|Period 2 - Second Intervention||0
178682|NCT00583908|438894|P7|NOT COMPLETED|Period 2 - Second Intervention||0
178683|NCT00583908|438895|P6|NOT COMPLETED|Period 2 - Second Intervention||0
178684|NCT00583908|438896|P5|NOT COMPLETED|Period 2 - Second Intervention||0
178685|NCT00583908|438897|P4|NOT COMPLETED|Period 2 - Second Intervention||0
178686|NCT00583908|438898|P3|NOT COMPLETED|Period 2 - Second Intervention||0
178687|NCT00583908|438899|P2|NOT COMPLETED|Period 2 - Second Intervention||0
178688|NCT00583908|438900|P1|NOT COMPLETED|Period 2 - Second Intervention||0
178689|NCT00583908|438889|P12|COMPLETED|Period 2 - Second Intervention||1
178690|NCT00583908|438890|P11|COMPLETED|Period 2 - Second Intervention||1
178691|NCT00583908|438891|P10|COMPLETED|Period 2 - Second Intervention||1
178692|NCT00583908|438892|P9|COMPLETED|Period 2 - Second Intervention||1
178693|NCT00583908|438893|P8|COMPLETED|Period 2 - Second Intervention||1
178694|NCT00583908|438894|P7|COMPLETED|Period 2 - Second Intervention||1
178695|NCT00583908|438895|P6|COMPLETED|Period 2 - Second Intervention||1
178696|NCT00583908|438896|P5|COMPLETED|Period 2 - Second Intervention||2
178697|NCT00583908|438897|P4|COMPLETED|Period 2 - Second Intervention||1
178698|NCT00583908|438898|P3|COMPLETED|Period 2 - Second Intervention||1
178699|NCT00583908|438899|P2|COMPLETED|Period 2 - Second Intervention||2
178700|NCT00583908|438900|P1|COMPLETED|Period 2 - Second Intervention||1
178701|NCT00583908|438889|P12|STARTED|Period 2 - Second Intervention||1
178702|NCT00583908|438890|P11|STARTED|Period 2 - Second Intervention||1
178703|NCT00583908|438891|P10|STARTED|Period 2 - Second Intervention||1
178704|NCT00583908|438892|P9|STARTED|Period 2 - Second Intervention||1
178705|NCT00583908|438893|P8|STARTED|Period 2 - Second Intervention||1
178706|NCT00583908|438894|P7|STARTED|Period 2 - Second Intervention||1
178707|NCT00583908|438895|P6|STARTED|Period 2 - Second Intervention||1
178708|NCT00583908|438896|P5|STARTED|Period 2 - Second Intervention||2
178709|NCT00583908|438897|P4|STARTED|Period 2 - Second Intervention||1
178710|NCT00583908|438898|P3|STARTED|Period 2 - Second Intervention||1
178711|NCT00583908|438899|P2|STARTED|Period 2 - Second Intervention||2
178712|NCT00583908|438900|P1|STARTED|Period 2 - Second Intervention||1
178713|NCT00583908|438889|P12|NOT COMPLETED|Period 1 - First Intervention||0
178714|NCT00583908|438890|P11|NOT COMPLETED|Period 1 - First Intervention||0
178715|NCT00583908|438891|P10|NOT COMPLETED|Period 1 - First Intervention||0
178716|NCT00583908|438892|P9|NOT COMPLETED|Period 1 - First Intervention||0
178717|NCT00583908|438893|P8|NOT COMPLETED|Period 1 - First Intervention||0
178718|NCT00583908|438894|P7|NOT COMPLETED|Period 1 - First Intervention||0
178719|NCT00583908|438895|P6|NOT COMPLETED|Period 1 - First Intervention||0
178720|NCT00583908|438896|P5|NOT COMPLETED|Period 1 - First Intervention||0
178721|NCT00583908|438897|P4|NOT COMPLETED|Period 1 - First Intervention||0
178722|NCT00583908|438898|P3|NOT COMPLETED|Period 1 - First Intervention||0
178723|NCT00583908|438899|P2|NOT COMPLETED|Period 1 - First Intervention||0
178724|NCT00583908|438900|P1|NOT COMPLETED|Period 1 - First Intervention||0
178725|NCT00583908|438889|P12|COMPLETED|Period 1 - First Intervention||1
178726|NCT00583908|438890|P11|COMPLETED|Period 1 - First Intervention||1
178727|NCT00583908|438891|P10|COMPLETED|Period 1 - First Intervention||1
178728|NCT00583908|438892|P9|COMPLETED|Period 1 - First Intervention||1
178729|NCT00583908|438893|P8|COMPLETED|Period 1 - First Intervention||1
178730|NCT00583908|438894|P7|COMPLETED|Period 1 - First Intervention||1
178731|NCT00583908|438895|P6|COMPLETED|Period 1 - First Intervention||1
178732|NCT00583908|438896|P5|COMPLETED|Period 1 - First Intervention||2
178733|NCT00583908|438897|P4|COMPLETED|Period 1 - First Intervention||1
178734|NCT00583908|438898|P3|COMPLETED|Period 1 - First Intervention||1
178735|NCT00583908|438899|P2|COMPLETED|Period 1 - First Intervention||2
178736|NCT00583908|438900|P1|COMPLETED|Period 1 - First Intervention||1
178737|NCT00583908|438889|P12|STARTED|Period 1 - First Intervention||1
178738|NCT00583908|438890|P11|STARTED|Period 1 - First Intervention||1
178739|NCT00583908|438891|P10|STARTED|Period 1 - First Intervention||1
178740|NCT00583908|438892|P9|STARTED|Period 1 - First Intervention||1
178741|NCT00583908|438893|P8|STARTED|Period 1 - First Intervention||1
178742|NCT00583908|438894|P7|STARTED|Period 1 - First Intervention||1
178743|NCT00583908|438895|P6|STARTED|Period 1 - First Intervention||1
178744|NCT00583908|438896|P5|STARTED|Period 1 - First Intervention||2
178745|NCT00583908|438897|P4|STARTED|Period 1 - First Intervention||1
178746|NCT00583908|438898|P3|STARTED|Period 1 - First Intervention||1
178747|NCT00583908|438899|P2|STARTED|Period 1 - First Intervention||2
178748|NCT00583908|438900|P1|STARTED|Period 1 - First Intervention||1
178749|NCT00583947|438956|P2|NOT COMPLETED|Open Label Period||0
178750|NCT00583947|438957|P1|NOT COMPLETED|Open Label Period||0
178751|NCT00583947|438956|P2|COMPLETED|Open Label Period||24
178752|NCT00583947|438957|P1|COMPLETED|Open Label Period||22
178753|NCT00583947|438956|P2|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|24
178754|NCT00583947|438957|P1|STARTED|Open Label Period|3 subjects were dosed with arformoterol 7.5 microgram in error|22
178755|NCT00583947|438956|P2|NOT COMPLETED|Washout||0
178756|NCT00583947|438957|P1|NOT COMPLETED|Washout||0
178757|NCT00583947|438956|P2|COMPLETED|Washout||24
178758|NCT00583947|438957|P1|COMPLETED|Washout||22
178759|NCT00583947|438956|P2|STARTED|Washout||24
178760|NCT00583947|438957|P1|STARTED|Washout||22
178761|NCT00583947|438956|P2|NOT COMPLETED|Cross-over Period||2
178762|NCT00583947|438957|P1|NOT COMPLETED|Cross-over Period||5
178763|NCT00583947|438956|P2|COMPLETED|Cross-over Period||24
178764|NCT00583947|438957|P1|COMPLETED|Cross-over Period||22
178765|NCT00583947|438956|P2|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|26
178766|NCT00583947|438957|P1|STARTED|Cross-over Period|Participants were stratified by age group at randomization: ages 2-5 yrs and 6-11 years|27
178767|NCT00584077|439007|P1|NOT COMPLETED|Overall Study||0
178768|NCT00584077|439007|P1|COMPLETED|Overall Study||15
178769|NCT00584077|439007|P1|STARTED|Overall Study||15
178770|NCT00584194|439011|P1|NOT COMPLETED|Overall Study||135
178771|NCT00584194|439011|P1|COMPLETED|Overall Study||143
178772|NCT00584194|439011|P1|STARTED|Overall Study||278
178773|NCT00584220|439019|P2|NOT COMPLETED|Second Period||0
178774|NCT00584220|439020|P1|NOT COMPLETED|Second Period||0
178775|NCT00584220|439019|P2|COMPLETED|Second Period||39
178776|NCT00584220|439020|P1|COMPLETED|Second Period||48
178777|NCT00584220|439019|P2|STARTED|Second Period||39
178778|NCT00584220|439020|P1|STARTED|Second Period||48
178779|NCT00584220|439019|P2|NOT COMPLETED|First Period||0
178780|NCT00584220|439020|P1|NOT COMPLETED|First Period||0
178781|NCT00584220|439019|P2|COMPLETED|First Period||39
178782|NCT00584220|439020|P1|COMPLETED|First Period||48
178783|NCT00584220|439019|P2|STARTED|First Period||39
178784|NCT00584220|439020|P1|STARTED|First Period||48
178785|NCT00584402|439028|P1|NOT COMPLETED|Overall Study||0
178786|NCT00584402|439028|P1|COMPLETED|Overall Study||8
178787|NCT00584402|439028|P1|STARTED|Overall Study||8
178788|NCT00584415|439033|P1|NOT COMPLETED|Overall Study||7
178789|NCT00584415|439033|P1|COMPLETED|Overall Study||112
178790|NCT00584415|439033|P1|STARTED|Overall Study|A total of 119 enrolled and 112 underwent the ablation procedure;|119
178791|NCT00584454|439038|P1|NOT COMPLETED|Overall Study||4
178792|NCT00584454|439038|P1|COMPLETED|Overall Study||6
178793|NCT00584454|439038|P1|STARTED|Overall Study||10
178794|NCT00584480|439042|P1|NOT COMPLETED|Second 8 Weeks (40 Treatments)||0
178795|NCT00584480|439042|P1|COMPLETED|Second 8 Weeks (40 Treatments)||10
178796|NCT00584480|439042|P1|STARTED|Second 8 Weeks (40 Treatments)||10
178797|NCT00584480|439042|P1|NOT COMPLETED|4-Week Break From Treatment||0
178798|NCT00584480|439042|P1|COMPLETED|4-Week Break From Treatment||10
178799|NCT00584480|439042|P1|STARTED|4-Week Break From Treatment||10
178800|NCT00584480|439042|P1|NOT COMPLETED|First 8 Weeks (40 Treatments)||0
178801|NCT00584480|439042|P1|COMPLETED|First 8 Weeks (40 Treatments)||10
178802|NCT00584480|439042|P1|STARTED|First 8 Weeks (40 Treatments)||10
178803|NCT00584701|439046|P1|NOT COMPLETED|Follow-up||12
178804|NCT00584701|439046|P1|COMPLETED|Follow-up||34
178805|NCT00584701|439046|P1|STARTED|Follow-up||46
178806|NCT00584701|439046|P1|NOT COMPLETED|Active Risperidone||3
178807|NCT00584701|439046|P1|COMPLETED|Active Risperidone||46
178808|NCT00584701|439046|P1|STARTED|Active Risperidone||49
178809|NCT00584727|439051|P6|NOT COMPLETED|Third Intervention||2
178810|NCT00584727|439052|P5|NOT COMPLETED|Third Intervention||4
178811|NCT00584727|439053|P4|NOT COMPLETED|Third Intervention||0
178812|NCT00584727|439054|P3|NOT COMPLETED|Third Intervention||1
178813|NCT00584727|439055|P2|NOT COMPLETED|Third Intervention||0
178814|NCT00584727|439056|P1|NOT COMPLETED|Third Intervention||0
178815|NCT00584727|439051|P6|COMPLETED|Third Intervention||14
178816|NCT00584727|439052|P5|COMPLETED|Third Intervention||12
178817|NCT00584727|439053|P4|COMPLETED|Third Intervention||14
178818|NCT00584727|439054|P3|COMPLETED|Third Intervention||14
178819|NCT00584727|439055|P2|COMPLETED|Third Intervention||17
178820|NCT00584727|439056|P1|COMPLETED|Third Intervention||17
178821|NCT00584727|439051|P6|STARTED|Third Intervention||16
178822|NCT00584727|439052|P5|STARTED|Third Intervention||16
178823|NCT00584727|439053|P4|STARTED|Third Intervention||14
178824|NCT00584727|439054|P3|STARTED|Third Intervention||15
178825|NCT00584727|439055|P2|STARTED|Third Intervention||17
178826|NCT00584727|439056|P1|STARTED|Third Intervention||17
178827|NCT00584727|439051|P6|NOT COMPLETED|Second Intervention||0
178828|NCT00584727|439052|P5|NOT COMPLETED|Second Intervention||0
178829|NCT00584727|439053|P4|NOT COMPLETED|Second Intervention||0
178830|NCT00584727|439054|P3|NOT COMPLETED|Second Intervention||0
178831|NCT00584727|439055|P2|NOT COMPLETED|Second Intervention||0
178832|NCT00584727|439056|P1|NOT COMPLETED|Second Intervention||0
178833|NCT00584727|439051|P6|COMPLETED|Second Intervention||16
178834|NCT00584727|439052|P5|COMPLETED|Second Intervention||16
178835|NCT00584727|439053|P4|COMPLETED|Second Intervention||14
178836|NCT00584727|439054|P3|COMPLETED|Second Intervention||15
178837|NCT00584727|439055|P2|COMPLETED|Second Intervention||17
178838|NCT00584727|439056|P1|COMPLETED|Second Intervention||17
178839|NCT00584727|439051|P6|STARTED|Second Intervention||16
178840|NCT00584727|439052|P5|STARTED|Second Intervention||16
178841|NCT00584727|439053|P4|STARTED|Second Intervention||14
178842|NCT00584727|439054|P3|STARTED|Second Intervention||15
178843|NCT00584727|439055|P2|STARTED|Second Intervention||17
178844|NCT00584727|439056|P1|STARTED|Second Intervention||17
178845|NCT00584727|439051|P6|NOT COMPLETED|First Intervention||0
178846|NCT00584727|439052|P5|NOT COMPLETED|First Intervention||0
178847|NCT00584727|439053|P4|NOT COMPLETED|First Intervention||0
178848|NCT00584727|439054|P3|NOT COMPLETED|First Intervention||1
178849|NCT00584727|439055|P2|NOT COMPLETED|First Intervention||0
178850|NCT00584727|439056|P1|NOT COMPLETED|First Intervention||0
178851|NCT00584727|439051|P6|COMPLETED|First Intervention||16
178852|NCT00584727|439052|P5|COMPLETED|First Intervention||16
178853|NCT00584727|439053|P4|COMPLETED|First Intervention||14
178854|NCT00584727|439054|P3|COMPLETED|First Intervention||15
178855|NCT00584727|439055|P2|COMPLETED|First Intervention||17
178856|NCT00584727|439056|P1|COMPLETED|First Intervention||17
178857|NCT00584727|439051|P6|STARTED|First Intervention||16
178858|NCT00584727|439052|P5|STARTED|First Intervention||16
178859|NCT00584727|439053|P4|STARTED|First Intervention||14
178860|NCT00584727|439054|P3|STARTED|First Intervention||16
178861|NCT00584727|439055|P2|STARTED|First Intervention||17
178862|NCT00584727|439056|P1|STARTED|First Intervention||17
178863|NCT00584740|439082|P2|NOT COMPLETED|Overall Study||6
178864|NCT00584740|439083|P1|NOT COMPLETED|Overall Study||12
178865|NCT00584740|439082|P2|COMPLETED|Overall Study||14
178866|NCT00584740|439083|P1|COMPLETED|Overall Study||27
178867|NCT00584740|439082|P2|STARTED|Overall Study||20
178868|NCT00584740|439083|P1|STARTED|Overall Study||39
178869|NCT00584831|439101|P19|NOT COMPLETED|Intervention 4||0
178870|NCT00584831|439102|P18|NOT COMPLETED|Intervention 4||0
178871|NCT00584831|439103|P17|NOT COMPLETED|Intervention 4||0
178872|NCT00584831|439104|P16|NOT COMPLETED|Intervention 4||0
178873|NCT00584831|439105|P15|NOT COMPLETED|Intervention 4||0
178874|NCT00584831|439106|P14|NOT COMPLETED|Intervention 4||0
178875|NCT00584831|439107|P13|NOT COMPLETED|Intervention 4||0
178876|NCT00584831|439108|P12|NOT COMPLETED|Intervention 4||0
178877|NCT00584831|439109|P11|NOT COMPLETED|Intervention 4||0
178878|NCT00584831|439110|P10|NOT COMPLETED|Intervention 4||0
178879|NCT00584831|439111|P9|NOT COMPLETED|Intervention 4||0
178880|NCT00584831|439112|P8|NOT COMPLETED|Intervention 4||0
178881|NCT00584831|439113|P7|NOT COMPLETED|Intervention 4||0
178882|NCT00584831|439114|P6|NOT COMPLETED|Intervention 4||0
178883|NCT00584831|439115|P5|NOT COMPLETED|Intervention 4||0
178884|NCT00584831|439116|P4|NOT COMPLETED|Intervention 4||0
178885|NCT00584831|439117|P3|NOT COMPLETED|Intervention 4||0
178886|NCT00584831|439118|P2|NOT COMPLETED|Intervention 4||0
178887|NCT00584831|439119|P1|NOT COMPLETED|Intervention 4||0
178888|NCT00584831|439101|P19|COMPLETED|Intervention 4||1
178889|NCT00584831|439102|P18|COMPLETED|Intervention 4||1
178890|NCT00584831|439103|P17|COMPLETED|Intervention 4||4
178891|NCT00584831|439104|P16|COMPLETED|Intervention 4||1
178892|NCT00584831|439105|P15|COMPLETED|Intervention 4||2
178893|NCT00584831|439106|P14|COMPLETED|Intervention 4||1
178894|NCT00584831|439107|P13|COMPLETED|Intervention 4||2
178895|NCT00584831|439108|P12|COMPLETED|Intervention 4||1
178896|NCT00584831|439109|P11|COMPLETED|Intervention 4||2
178897|NCT00584831|439110|P10|COMPLETED|Intervention 4||2
178898|NCT00584831|439111|P9|COMPLETED|Intervention 4||3
178899|NCT00584831|439112|P8|COMPLETED|Intervention 4||2
178900|NCT00584831|439113|P7|COMPLETED|Intervention 4||6
178901|NCT00584831|439114|P6|COMPLETED|Intervention 4||1
178902|NCT00584831|439115|P5|COMPLETED|Intervention 4||2
178903|NCT00584831|439116|P4|COMPLETED|Intervention 4||1
178904|NCT00584831|439117|P3|COMPLETED|Intervention 4||2
178905|NCT00584831|439118|P2|COMPLETED|Intervention 4||3
178906|NCT00584831|439119|P1|COMPLETED|Intervention 4||1
178907|NCT00584831|439101|P19|STARTED|Intervention 4||1
178908|NCT00584831|439102|P18|STARTED|Intervention 4||1
178909|NCT00584831|439103|P17|STARTED|Intervention 4||4
178910|NCT00584831|439104|P16|STARTED|Intervention 4||1
178911|NCT00584831|439105|P15|STARTED|Intervention 4||2
178912|NCT00584831|439106|P14|STARTED|Intervention 4||1
178913|NCT00584831|439107|P13|STARTED|Intervention 4||2
178914|NCT00584831|439108|P12|STARTED|Intervention 4||1
178915|NCT00584831|439109|P11|STARTED|Intervention 4||2
178916|NCT00584831|439110|P10|STARTED|Intervention 4||2
178917|NCT00584831|439111|P9|STARTED|Intervention 4||3
178918|NCT00584831|439112|P8|STARTED|Intervention 4||2
178919|NCT00584831|439113|P7|STARTED|Intervention 4||6
178920|NCT00584831|439114|P6|STARTED|Intervention 4||1
178921|NCT00584831|439115|P5|STARTED|Intervention 4||2
178922|NCT00584831|439116|P4|STARTED|Intervention 4||1
178923|NCT00584831|439117|P3|STARTED|Intervention 4||2
178924|NCT00584831|439118|P2|STARTED|Intervention 4||3
178925|NCT00584831|439119|P1|STARTED|Intervention 4||1
178926|NCT00584831|439101|P19|NOT COMPLETED|Intervention 3||0
178927|NCT00584831|439102|P18|NOT COMPLETED|Intervention 3||0
178928|NCT00584831|439103|P17|NOT COMPLETED|Intervention 3||0
178929|NCT00584831|439104|P16|NOT COMPLETED|Intervention 3||0
178930|NCT00584831|439105|P15|NOT COMPLETED|Intervention 3||0
178931|NCT00584831|439106|P14|NOT COMPLETED|Intervention 3||0
178932|NCT00584831|439107|P13|NOT COMPLETED|Intervention 3||0
178933|NCT00584831|439108|P12|NOT COMPLETED|Intervention 3||0
178934|NCT00584831|439109|P11|NOT COMPLETED|Intervention 3||0
178935|NCT00584831|439110|P10|NOT COMPLETED|Intervention 3||0
178936|NCT00584831|439111|P9|NOT COMPLETED|Intervention 3||0
178937|NCT00584831|439112|P8|NOT COMPLETED|Intervention 3||0
178938|NCT00584831|439113|P7|NOT COMPLETED|Intervention 3||0
178939|NCT00584831|439114|P6|NOT COMPLETED|Intervention 3||0
178940|NCT00584831|439115|P5|NOT COMPLETED|Intervention 3||0
178941|NCT00584831|439116|P4|NOT COMPLETED|Intervention 3||0
178942|NCT00584831|439117|P3|NOT COMPLETED|Intervention 3||0
178943|NCT00584831|439118|P2|NOT COMPLETED|Intervention 3||0
178944|NCT00584831|439119|P1|NOT COMPLETED|Intervention 3||0
178945|NCT00584831|439101|P19|COMPLETED|Intervention 3||1
178946|NCT00584831|439102|P18|COMPLETED|Intervention 3||1
178947|NCT00584831|439103|P17|COMPLETED|Intervention 3||4
178948|NCT00584831|439104|P16|COMPLETED|Intervention 3||1
178949|NCT00584831|439105|P15|COMPLETED|Intervention 3||3
178950|NCT00584831|439106|P14|COMPLETED|Intervention 3||1
178951|NCT00584831|439107|P13|COMPLETED|Intervention 3||2
178952|NCT00584831|439108|P12|COMPLETED|Intervention 3||1
178953|NCT00584831|439109|P11|COMPLETED|Intervention 3||2
178954|NCT00584831|439110|P10|COMPLETED|Intervention 3||2
178955|NCT00584831|439111|P9|COMPLETED|Intervention 3||4
178956|NCT00584831|439112|P8|COMPLETED|Intervention 3||2
178957|NCT00584831|439113|P7|COMPLETED|Intervention 3||6
178958|NCT00584831|439114|P6|COMPLETED|Intervention 3||1
178959|NCT00584831|439115|P5|COMPLETED|Intervention 3||2
178960|NCT00584831|439116|P4|COMPLETED|Intervention 3||1
178961|NCT00584831|439117|P3|COMPLETED|Intervention 3||2
178962|NCT00584831|439118|P2|COMPLETED|Intervention 3||3
178963|NCT00584831|439119|P1|COMPLETED|Intervention 3||1
178964|NCT00584831|439101|P19|STARTED|Intervention 3||1
178965|NCT00584831|439102|P18|STARTED|Intervention 3||1
178966|NCT00584831|439103|P17|STARTED|Intervention 3||4
178967|NCT00584831|439104|P16|STARTED|Intervention 3||1
178968|NCT00584831|439105|P15|STARTED|Intervention 3||3
178969|NCT00584831|439106|P14|STARTED|Intervention 3||1
178970|NCT00584831|439107|P13|STARTED|Intervention 3||2
178971|NCT00584831|439108|P12|STARTED|Intervention 3||1
178972|NCT00584831|439109|P11|STARTED|Intervention 3||2
178973|NCT00584831|439110|P10|STARTED|Intervention 3||2
178974|NCT00584831|439111|P9|STARTED|Intervention 3||4
178975|NCT00584831|439112|P8|STARTED|Intervention 3||2
178976|NCT00584831|439113|P7|STARTED|Intervention 3||6
178977|NCT00584831|439114|P6|STARTED|Intervention 3||1
178978|NCT00584831|439115|P5|STARTED|Intervention 3||2
178979|NCT00584831|439116|P4|STARTED|Intervention 3||1
178980|NCT00584831|439117|P3|STARTED|Intervention 3||2
178981|NCT00584831|439118|P2|STARTED|Intervention 3||3
178982|NCT00584831|439119|P1|STARTED|Intervention 3||1
178983|NCT00584831|439101|P19|NOT COMPLETED|Intervention 2||0
178984|NCT00584831|439102|P18|NOT COMPLETED|Intervention 2||0
178985|NCT00584831|439103|P17|NOT COMPLETED|Intervention 2||0
178986|NCT00584831|439104|P16|NOT COMPLETED|Intervention 2||0
178987|NCT00584831|439105|P15|NOT COMPLETED|Intervention 2||0
178988|NCT00584831|439106|P14|NOT COMPLETED|Intervention 2||0
178989|NCT00584831|439107|P13|NOT COMPLETED|Intervention 2||0
178990|NCT00584831|439108|P12|NOT COMPLETED|Intervention 2||0
178991|NCT00584831|439109|P11|NOT COMPLETED|Intervention 2||0
178992|NCT00584831|439110|P10|NOT COMPLETED|Intervention 2||0
178993|NCT00584831|439111|P9|NOT COMPLETED|Intervention 2||0
178994|NCT00584831|439112|P8|NOT COMPLETED|Intervention 2||0
178995|NCT00584831|439113|P7|NOT COMPLETED|Intervention 2||0
178996|NCT00584831|439114|P6|NOT COMPLETED|Intervention 2||0
178997|NCT00584831|439115|P5|NOT COMPLETED|Intervention 2||0
178998|NCT00584831|439116|P4|NOT COMPLETED|Intervention 2||0
178999|NCT00584831|439117|P3|NOT COMPLETED|Intervention 2||0
179000|NCT00584831|439118|P2|NOT COMPLETED|Intervention 2||0
179001|NCT00584831|439119|P1|NOT COMPLETED|Intervention 2||0
179002|NCT00584831|439101|P19|COMPLETED|Intervention 2||1
179003|NCT00584831|439102|P18|COMPLETED|Intervention 2||1
179004|NCT00584831|439103|P17|COMPLETED|Intervention 2||4
179005|NCT00584831|439104|P16|COMPLETED|Intervention 2||1
179006|NCT00584831|439105|P15|COMPLETED|Intervention 2||3
179007|NCT00584831|439106|P14|COMPLETED|Intervention 2||1
179008|NCT00584831|439107|P13|COMPLETED|Intervention 2||2
179009|NCT00584831|439108|P12|COMPLETED|Intervention 2||1
179010|NCT00584831|439109|P11|COMPLETED|Intervention 2||2
179011|NCT00584831|439110|P10|COMPLETED|Intervention 2||2
179012|NCT00584831|439111|P9|COMPLETED|Intervention 2||4
179013|NCT00584831|439112|P8|COMPLETED|Intervention 2||2
179014|NCT00584831|439113|P7|COMPLETED|Intervention 2||6
179015|NCT00584831|439114|P6|COMPLETED|Intervention 2||1
179016|NCT00584831|439115|P5|COMPLETED|Intervention 2||2
179017|NCT00584831|439116|P4|COMPLETED|Intervention 2||1
179018|NCT00584831|439117|P3|COMPLETED|Intervention 2||2
179019|NCT00584831|439118|P2|COMPLETED|Intervention 2||3
179020|NCT00584831|439119|P1|COMPLETED|Intervention 2||1
179021|NCT00584831|439101|P19|STARTED|Intervention 2||1
179022|NCT00584831|439102|P18|STARTED|Intervention 2||1
179023|NCT00584831|439103|P17|STARTED|Intervention 2||4
179024|NCT00584831|439104|P16|STARTED|Intervention 2||1
179025|NCT00584831|439105|P15|STARTED|Intervention 2||3
179026|NCT00584831|439106|P14|STARTED|Intervention 2||1
179027|NCT00584831|439107|P13|STARTED|Intervention 2||2
179028|NCT00584831|439108|P12|STARTED|Intervention 2||1
179029|NCT00584831|439109|P11|STARTED|Intervention 2||2
179030|NCT00584831|439110|P10|STARTED|Intervention 2||2
179031|NCT00584831|439111|P9|STARTED|Intervention 2||4
179032|NCT00584831|439112|P8|STARTED|Intervention 2||2
179033|NCT00584831|439113|P7|STARTED|Intervention 2||6
179034|NCT00584831|439114|P6|STARTED|Intervention 2||1
179035|NCT00584831|439115|P5|STARTED|Intervention 2||2
179036|NCT00584831|439116|P4|STARTED|Intervention 2||1
179037|NCT00584831|439117|P3|STARTED|Intervention 2||2
179038|NCT00584831|439118|P2|STARTED|Intervention 2||3
179039|NCT00584831|439119|P1|STARTED|Intervention 2||1
179040|NCT00584831|439101|P19|NOT COMPLETED|Intervention 1||0
179041|NCT00584831|439102|P18|NOT COMPLETED|Intervention 1||0
179042|NCT00584831|439103|P17|NOT COMPLETED|Intervention 1||0
179043|NCT00584831|439104|P16|NOT COMPLETED|Intervention 1||0
179044|NCT00584831|439105|P15|NOT COMPLETED|Intervention 1||0
179045|NCT00584831|439106|P14|NOT COMPLETED|Intervention 1||0
179046|NCT00584831|439107|P13|NOT COMPLETED|Intervention 1||0
179047|NCT00584831|439108|P12|NOT COMPLETED|Intervention 1||0
179048|NCT00584831|439109|P11|NOT COMPLETED|Intervention 1||0
179049|NCT00584831|439110|P10|NOT COMPLETED|Intervention 1||0
179050|NCT00584831|439111|P9|NOT COMPLETED|Intervention 1||0
179051|NCT00584831|439112|P8|NOT COMPLETED|Intervention 1||0
179052|NCT00584831|439113|P7|NOT COMPLETED|Intervention 1||0
179053|NCT00584831|439114|P6|NOT COMPLETED|Intervention 1||0
179054|NCT00584831|439115|P5|NOT COMPLETED|Intervention 1||0
179055|NCT00584831|439116|P4|NOT COMPLETED|Intervention 1||0
179056|NCT00584831|439117|P3|NOT COMPLETED|Intervention 1||0
179057|NCT00584831|439118|P2|NOT COMPLETED|Intervention 1||0
179058|NCT00584831|439119|P1|NOT COMPLETED|Intervention 1||0
179059|NCT00584831|439101|P19|COMPLETED|Intervention 1||1
179060|NCT00584831|439102|P18|COMPLETED|Intervention 1||1
179061|NCT00584831|439103|P17|COMPLETED|Intervention 1||4
179062|NCT00584831|439104|P16|COMPLETED|Intervention 1||1
179063|NCT00584831|439105|P15|COMPLETED|Intervention 1||3
179064|NCT00584831|439106|P14|COMPLETED|Intervention 1||1
179065|NCT00584831|439107|P13|COMPLETED|Intervention 1||2
179066|NCT00584831|439108|P12|COMPLETED|Intervention 1||1
179067|NCT00584831|439109|P11|COMPLETED|Intervention 1||2
179068|NCT00584831|439110|P10|COMPLETED|Intervention 1||2
179069|NCT00584831|439111|P9|COMPLETED|Intervention 1||4
179070|NCT00584831|439112|P8|COMPLETED|Intervention 1||2
179071|NCT00584831|439113|P7|COMPLETED|Intervention 1||6
179072|NCT00584831|439114|P6|COMPLETED|Intervention 1||1
179073|NCT00584831|439115|P5|COMPLETED|Intervention 1||2
179074|NCT00584831|439116|P4|COMPLETED|Intervention 1||1
179075|NCT00584831|439117|P3|COMPLETED|Intervention 1||2
179076|NCT00584831|439118|P2|COMPLETED|Intervention 1||3
179077|NCT00584831|439119|P1|COMPLETED|Intervention 1||1
179078|NCT00584831|439101|P19|STARTED|Intervention 1||1
179079|NCT00584831|439102|P18|STARTED|Intervention 1||1
179080|NCT00584831|439103|P17|STARTED|Intervention 1||4
179081|NCT00584831|439104|P16|STARTED|Intervention 1||1
179082|NCT00584831|439105|P15|STARTED|Intervention 1||3
179083|NCT00584831|439106|P14|STARTED|Intervention 1||1
179084|NCT00584831|439107|P13|STARTED|Intervention 1||2
179085|NCT00584831|439108|P12|STARTED|Intervention 1||1
179086|NCT00584831|439109|P11|STARTED|Intervention 1||2
179087|NCT00584831|439110|P10|STARTED|Intervention 1||2
179088|NCT00584831|439111|P9|STARTED|Intervention 1||4
179089|NCT00584831|439112|P8|STARTED|Intervention 1||2
179090|NCT00584831|439113|P7|STARTED|Intervention 1||6
179091|NCT00584831|439114|P6|STARTED|Intervention 1||1
179092|NCT00584831|439115|P5|STARTED|Intervention 1||2
179093|NCT00584831|439116|P4|STARTED|Intervention 1||1
179094|NCT00584831|439117|P3|STARTED|Intervention 1||2
179095|NCT00584831|439118|P2|STARTED|Intervention 1||3
179096|NCT00584831|439119|P1|STARTED|Intervention 1||1
179097|NCT00584844|439141|P1|NOT COMPLETED|Overall Study||79
179098|NCT00584844|439141|P1|COMPLETED|Overall Study||405
179099|NCT00584844|439141|P1|STARTED|Overall Study||484
179100|NCT00584857|439151|P1|NOT COMPLETED|Overall Study||0
179101|NCT00584857|439151|P1|COMPLETED|Overall Study||30
179102|NCT00584857|439151|P1|STARTED|Overall Study||30
179103|NCT00584909|439156|P1|NOT COMPLETED|Overall Study||4
179104|NCT00584909|439156|P1|COMPLETED|Overall Study||9
179105|NCT00584909|439156|P1|STARTED|Overall Study||13
179106|NCT00584935|439161|P1|NOT COMPLETED|Overall Study||0
179107|NCT00584935|439161|P1|COMPLETED|Overall Study||3
179108|NCT00584935|439161|P1|STARTED|Overall Study||3
179109|NCT00584948|439167|P2|NOT COMPLETED|Overall Study||11
179110|NCT00584948|439168|P1|NOT COMPLETED|Overall Study||13
179111|NCT00584948|439167|P2|COMPLETED|Overall Study||36
179112|NCT00584948|439168|P1|COMPLETED|Overall Study||34
179113|NCT00584948|439167|P2|STARTED|Overall Study||47
179114|NCT00584948|439168|P1|STARTED|Overall Study||47
179115|NCT00576472|439191|P15|NOT COMPLETED|MPH Home Maintenance Phase||23
179116|NCT00576472|439192|P14|NOT COMPLETED|MPH Home Maintenance Phase||27
179117|NCT00576472|439193|P13|NOT COMPLETED|MPH Home Maintenance Phase||0
179118|NCT00576472|439194|P12|NOT COMPLETED|MPH Home Maintenance Phase||0
179119|NCT00576472|439195|P11|NOT COMPLETED|MPH Home Maintenance Phase||0
179120|NCT00576472|439196|P10|NOT COMPLETED|MPH Home Maintenance Phase||0
179121|NCT00576472|439197|P9|NOT COMPLETED|MPH Home Maintenance Phase||0
179122|NCT00576472|439198|P8|NOT COMPLETED|MPH Home Maintenance Phase||0
179123|NCT00576472|439199|P7|NOT COMPLETED|MPH Home Maintenance Phase||0
179124|NCT00576472|439200|P6|NOT COMPLETED|MPH Home Maintenance Phase||0
179125|NCT00576472|439201|P5|NOT COMPLETED|MPH Home Maintenance Phase||0
179126|NCT00576472|439202|P4|NOT COMPLETED|MPH Home Maintenance Phase||0
179127|NCT00576472|439203|P3|NOT COMPLETED|MPH Home Maintenance Phase||0
179128|NCT00576472|439204|P2|NOT COMPLETED|MPH Home Maintenance Phase||0
179129|NCT00576472|439205|P1|NOT COMPLETED|MPH Home Maintenance Phase||0
179130|NCT00576472|439191|P15|COMPLETED|MPH Home Maintenance Phase||68
179131|NCT00576472|439192|P14|COMPLETED|MPH Home Maintenance Phase||0
179132|NCT00576472|439193|P13|COMPLETED|MPH Home Maintenance Phase||0
179133|NCT00576472|439194|P12|COMPLETED|MPH Home Maintenance Phase||0
179134|NCT00576472|439195|P11|COMPLETED|MPH Home Maintenance Phase||0
179135|NCT00576472|439196|P10|COMPLETED|MPH Home Maintenance Phase||0
179136|NCT00576472|439197|P9|COMPLETED|MPH Home Maintenance Phase||0
179137|NCT00576472|439198|P8|COMPLETED|MPH Home Maintenance Phase||0
179138|NCT00576472|439199|P7|COMPLETED|MPH Home Maintenance Phase||0
179139|NCT00576472|439200|P6|COMPLETED|MPH Home Maintenance Phase||0
179140|NCT00576472|439201|P5|COMPLETED|MPH Home Maintenance Phase||0
179141|NCT00576472|439202|P4|COMPLETED|MPH Home Maintenance Phase||0
179142|NCT00576472|439203|P3|COMPLETED|MPH Home Maintenance Phase||0
179143|NCT00576472|439204|P2|COMPLETED|MPH Home Maintenance Phase||0
179144|NCT00576472|439205|P1|COMPLETED|MPH Home Maintenance Phase||0
179145|NCT00576472|439191|P15|STARTED|MPH Home Maintenance Phase||91
179146|NCT00576472|439192|P14|STARTED|MPH Home Maintenance Phase||27
179147|NCT00576472|439193|P13|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179148|NCT00576472|439194|P12|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179149|NCT00576472|439195|P11|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179150|NCT00576472|439196|P10|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179151|NCT00576472|439197|P9|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179152|NCT00576472|439198|P8|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179153|NCT00576472|439199|P7|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179154|NCT00576472|439200|P6|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179155|NCT00576472|439201|P5|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179156|NCT00576472|439202|P4|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179157|NCT00576472|439203|P3|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179158|NCT00576472|439204|P2|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179159|NCT00576472|439205|P1|STARTED|MPH Home Maintenance Phase|Group not associated with Home Maintenance Phase.|0
179160|NCT00576472|439191|P15|NOT COMPLETED|MPH Cross Over Phase||0
179161|NCT00576472|439192|P14|NOT COMPLETED|MPH Cross Over Phase||0
179162|NCT00576472|439193|P13|NOT COMPLETED|MPH Cross Over Phase||0
179163|NCT00576472|439194|P12|NOT COMPLETED|MPH Cross Over Phase||1
179164|NCT00576472|439195|P11|NOT COMPLETED|MPH Cross Over Phase||1
179165|NCT00576472|439196|P10|NOT COMPLETED|MPH Cross Over Phase||0
179166|NCT00576472|439197|P9|NOT COMPLETED|MPH Cross Over Phase||2
179167|NCT00576472|439198|P8|NOT COMPLETED|MPH Cross Over Phase||0
179168|NCT00576472|439199|P7|NOT COMPLETED|MPH Cross Over Phase||12
179169|NCT00576472|439200|P6|NOT COMPLETED|MPH Cross Over Phase||0
179170|NCT00576472|439201|P5|NOT COMPLETED|MPH Cross Over Phase||0
179171|NCT00576472|439202|P4|NOT COMPLETED|MPH Cross Over Phase||0
179172|NCT00576472|439203|P3|NOT COMPLETED|MPH Cross Over Phase||0
179173|NCT00576472|439204|P2|NOT COMPLETED|MPH Cross Over Phase||0
179174|NCT00576472|439205|P1|NOT COMPLETED|MPH Cross Over Phase||0
179175|NCT00576472|439191|P15|COMPLETED|MPH Cross Over Phase||0
179176|NCT00576472|439192|P14|COMPLETED|MPH Cross Over Phase||0
179177|NCT00576472|439193|P13|COMPLETED|MPH Cross Over Phase||21
179178|NCT00576472|439194|P12|COMPLETED|MPH Cross Over Phase||17
179179|NCT00576472|439195|P11|COMPLETED|MPH Cross Over Phase||22
179180|NCT00576472|439196|P10|COMPLETED|MPH Cross Over Phase||22
179181|NCT00576472|439197|P9|COMPLETED|MPH Cross Over Phase||16
179182|NCT00576472|439198|P8|COMPLETED|MPH Cross Over Phase||20
179183|NCT00576472|439199|P7|COMPLETED|MPH Cross Over Phase||0
179184|NCT00576472|439200|P6|COMPLETED|MPH Cross Over Phase||0
179185|NCT00576472|439201|P5|COMPLETED|MPH Cross Over Phase||0
179186|NCT00576472|439202|P4|COMPLETED|MPH Cross Over Phase||0
179187|NCT00576472|439203|P3|COMPLETED|MPH Cross Over Phase||0
179188|NCT00576472|439204|P2|COMPLETED|MPH Cross Over Phase||0
179189|NCT00576472|439205|P1|COMPLETED|MPH Cross Over Phase||0
179190|NCT00576472|439191|P15|STARTED|MPH Cross Over Phase||0
179191|NCT00576472|439192|P14|STARTED|MPH Cross Over Phase||0
179192|NCT00576472|439193|P13|STARTED|MPH Cross Over Phase||21
179193|NCT00576472|439194|P12|STARTED|MPH Cross Over Phase||18
179194|NCT00576472|439195|P11|STARTED|MPH Cross Over Phase||23
179195|NCT00576472|439196|P10|STARTED|MPH Cross Over Phase||22
179196|NCT00576472|439197|P9|STARTED|MPH Cross Over Phase||18
179197|NCT00576472|439198|P8|STARTED|MPH Cross Over Phase||20
179198|NCT00576472|439199|P7|STARTED|MPH Cross Over Phase||12
179199|NCT00576472|439200|P6|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179200|NCT00576472|439201|P5|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179201|NCT00576472|439202|P4|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179202|NCT00576472|439203|P3|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179203|NCT00576472|439204|P2|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179204|NCT00576472|439205|P1|STARTED|MPH Cross Over Phase|Group not associated with MPH Cross-over phase.|0
179205|NCT00576472|439191|P15|NOT COMPLETED|MPH In-Lab Phase||0
179206|NCT00576472|439192|P14|NOT COMPLETED|MPH In-Lab Phase||0
179207|NCT00576472|439193|P13|NOT COMPLETED|MPH In-Lab Phase||0
179208|NCT00576472|439194|P12|NOT COMPLETED|MPH In-Lab Phase||0
179209|NCT00576472|439195|P11|NOT COMPLETED|MPH In-Lab Phase||0
179210|NCT00576472|439196|P10|NOT COMPLETED|MPH In-Lab Phase||0
179211|NCT00576472|439197|P9|NOT COMPLETED|MPH In-Lab Phase||0
179212|NCT00576472|439198|P8|NOT COMPLETED|MPH In-Lab Phase||0
179213|NCT00576472|439199|P7|NOT COMPLETED|MPH In-Lab Phase||0
179214|NCT00576472|439200|P6|NOT COMPLETED|MPH In-Lab Phase||0
179215|NCT00576472|439201|P5|NOT COMPLETED|MPH In-Lab Phase||0
179216|NCT00576472|439202|P4|NOT COMPLETED|MPH In-Lab Phase||335
179217|NCT00576472|439203|P3|NOT COMPLETED|MPH In-Lab Phase||0
179218|NCT00576472|439204|P2|NOT COMPLETED|MPH In-Lab Phase||0
179219|NCT00576472|439205|P1|NOT COMPLETED|MPH In-Lab Phase||0
179220|NCT00576472|439191|P15|COMPLETED|MPH In-Lab Phase||0
179221|NCT00576472|439192|P14|COMPLETED|MPH In-Lab Phase||0
179222|NCT00576472|439193|P13|COMPLETED|MPH In-Lab Phase||0
179223|NCT00576472|439194|P12|COMPLETED|MPH In-Lab Phase||0
179224|NCT00576472|439195|P11|COMPLETED|MPH In-Lab Phase||0
179225|NCT00576472|439196|P10|COMPLETED|MPH In-Lab Phase||0
179226|NCT00576472|439197|P9|COMPLETED|MPH In-Lab Phase||0
179227|NCT00576472|439198|P8|COMPLETED|MPH In-Lab Phase||0
179228|NCT00576472|439199|P7|COMPLETED|MPH In-Lab Phase||0
179229|NCT00576472|439200|P6|COMPLETED|MPH In-Lab Phase||67
179230|NCT00576472|439201|P5|COMPLETED|MPH In-Lab Phase||67
179231|NCT00576472|439202|P4|COMPLETED|MPH In-Lab Phase||0
179232|NCT00576472|439203|P3|COMPLETED|MPH In-Lab Phase||0
179233|NCT00576472|439204|P2|COMPLETED|MPH In-Lab Phase||0
179234|NCT00576472|439205|P1|COMPLETED|MPH In-Lab Phase||0
179235|NCT00576472|439191|P15|STARTED|MPH In-Lab Phase||0
179236|NCT00576472|439192|P14|STARTED|MPH In-Lab Phase||0
179237|NCT00576472|439193|P13|STARTED|MPH In-Lab Phase||0
179238|NCT00576472|439194|P12|STARTED|MPH In-Lab Phase||0
179239|NCT00576472|439195|P11|STARTED|MPH In-Lab Phase||0
179240|NCT00576472|439196|P10|STARTED|MPH In-Lab Phase||0
179241|NCT00576472|439197|P9|STARTED|MPH In-Lab Phase||0
179242|NCT00576472|439198|P8|STARTED|MPH In-Lab Phase||0
179243|NCT00576472|439199|P7|STARTED|MPH In-Lab Phase||0
179244|NCT00576472|439200|P6|STARTED|MPH In-Lab Phase||67
179245|NCT00576472|439201|P5|STARTED|MPH In-Lab Phase||67
179246|NCT00576472|439202|P4|STARTED|MPH In-Lab Phase||335
179247|NCT00576472|439203|P3|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
179248|NCT00576472|439204|P2|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
179249|NCT00576472|439205|P1|STARTED|MPH In-Lab Phase|Group only associated with Screening phase.|0
179250|NCT00576472|439191|P15|NOT COMPLETED|Initial Screening||0
179251|NCT00576472|439192|P14|NOT COMPLETED|Initial Screening||0
179252|NCT00576472|439193|P13|NOT COMPLETED|Initial Screening||0
179253|NCT00576472|439194|P12|NOT COMPLETED|Initial Screening||0
179254|NCT00576472|439195|P11|NOT COMPLETED|Initial Screening||0
179255|NCT00576472|439196|P10|NOT COMPLETED|Initial Screening||0
179256|NCT00576472|439197|P9|NOT COMPLETED|Initial Screening||0
179257|NCT00576472|439198|P8|NOT COMPLETED|Initial Screening||0
179258|NCT00576472|439199|P7|NOT COMPLETED|Initial Screening||0
179259|NCT00576472|439200|P6|NOT COMPLETED|Initial Screening||0
179260|NCT00576472|439201|P5|NOT COMPLETED|Initial Screening||0
179261|NCT00576472|439202|P4|NOT COMPLETED|Initial Screening||0
179262|NCT00576472|439203|P3|NOT COMPLETED|Initial Screening||0
179263|NCT00576472|439204|P2|NOT COMPLETED|Initial Screening||0
179264|NCT00576472|439205|P1|NOT COMPLETED|Initial Screening||0
179265|NCT00576472|439191|P15|COMPLETED|Initial Screening||0
179266|NCT00576472|439192|P14|COMPLETED|Initial Screening||0
179267|NCT00576472|439193|P13|COMPLETED|Initial Screening||0
179268|NCT00576472|439194|P12|COMPLETED|Initial Screening||0
179269|NCT00576472|439195|P11|COMPLETED|Initial Screening||0
179270|NCT00576472|439196|P10|COMPLETED|Initial Screening||0
179271|NCT00576472|439197|P9|COMPLETED|Initial Screening||0
179272|NCT00576472|439198|P8|COMPLETED|Initial Screening||0
179273|NCT00576472|439199|P7|COMPLETED|Initial Screening||0
179274|NCT00576472|439200|P6|COMPLETED|Initial Screening||0
179275|NCT00576472|439201|P5|COMPLETED|Initial Screening||0
179276|NCT00576472|439202|P4|COMPLETED|Initial Screening||0
179277|NCT00576472|439203|P3|COMPLETED|Initial Screening||199
179278|NCT00576472|439204|P2|COMPLETED|Initial Screening||40
179279|NCT00576472|439205|P1|COMPLETED|Initial Screening||230
179280|NCT00576472|439191|P15|STARTED|Initial Screening||0
179281|NCT00576472|439192|P14|STARTED|Initial Screening||0
179282|NCT00576472|439193|P13|STARTED|Initial Screening||0
179283|NCT00576472|439194|P12|STARTED|Initial Screening||0
179284|NCT00576472|439195|P11|STARTED|Initial Screening||0
179285|NCT00576472|439196|P10|STARTED|Initial Screening||0
179286|NCT00576472|439197|P9|STARTED|Initial Screening||0
179287|NCT00576472|439198|P8|STARTED|Initial Screening||0
179288|NCT00576472|439199|P7|STARTED|Initial Screening||0
179289|NCT00576472|439200|P6|STARTED|Initial Screening||0
179290|NCT00576472|439201|P5|STARTED|Initial Screening||0
179291|NCT00576472|439202|P4|STARTED|Initial Screening||0
179292|NCT00576472|439203|P3|STARTED|Initial Screening||199
179293|NCT00576472|439204|P2|STARTED|Initial Screening||40
179294|NCT00576472|439205|P1|STARTED|Initial Screening||230
179295|NCT00576524|439297|P2|NOT COMPLETED|Overall Study||0
179296|NCT00576524|439298|P1|NOT COMPLETED|Overall Study||0
179297|NCT00576524|439297|P2|COMPLETED|Overall Study||0
179298|NCT00576524|439298|P1|COMPLETED|Overall Study||2
179299|NCT00576524|439297|P2|STARTED|Overall Study||0
179300|NCT00576524|439298|P1|STARTED|Overall Study||2
179301|NCT00576576|439308|P1|NOT COMPLETED|Overall Study||7
179302|NCT00576576|439308|P1|COMPLETED|Overall Study||20
179303|NCT00576576|439308|P1|STARTED|Overall Study||27
179304|NCT00576628|439314|P1|NOT COMPLETED|Overall Study||43
179305|NCT00576628|439314|P1|COMPLETED|Overall Study||82
179306|NCT00576628|439314|P1|STARTED|Overall Study||125
179307|NCT00576693|439336|P2|NOT COMPLETED|Overall Study||24
179308|NCT00576693|439337|P1|NOT COMPLETED|Overall Study||10
179309|NCT00576693|439336|P2|COMPLETED|Overall Study||203
179310|NCT00576693|439337|P1|COMPLETED|Overall Study||214
179311|NCT00576693|439336|P2|STARTED|Overall Study||227
179312|NCT00576693|439337|P1|STARTED|Overall Study||224
179313|NCT00576732|439346|P6|NOT COMPLETED|OPEN LABEL||8
179314|NCT00576732|439347|P5|NOT COMPLETED|OPEN LABEL||4
179315|NCT00576732|439348|P4|NOT COMPLETED|OPEN LABEL||11
179316|NCT00576732|439349|P3|NOT COMPLETED|OPEN LABEL||0
179317|NCT00576732|439350|P2|NOT COMPLETED|OPEN LABEL||0
179318|NCT00576732|439351|P1|NOT COMPLETED|OPEN LABEL||0
179319|NCT00576732|439346|P6|COMPLETED|OPEN LABEL||17
179320|NCT00576732|439347|P5|COMPLETED|OPEN LABEL||20
179321|NCT00576732|439348|P4|COMPLETED|OPEN LABEL||19
179322|NCT00576732|439349|P3|COMPLETED|OPEN LABEL||0
179323|NCT00576732|439350|P2|COMPLETED|OPEN LABEL||0
179324|NCT00576732|439351|P1|COMPLETED|OPEN LABEL||0
179325|NCT00576732|439346|P6|STARTED|OPEN LABEL|All 25 double-blind RIS high dose completers and 0 RIS high dose non-completers entered open-label.|25
179326|NCT00576732|439347|P5|STARTED|OPEN LABEL|24 of 25 double-blind RIS low dose completers and 0 RIS low dose non-completers entered open-label.|24
179327|NCT00576732|439348|P4|STARTED|OPEN LABEL|26 of 27 double-blind placebo completers and 4 of 8 placebo non-completers entered open-label.|30
179328|NCT00576732|439349|P3|STARTED|OPEN LABEL||0
179329|NCT00576732|439350|P2|STARTED|OPEN LABEL||0
179330|NCT00576732|439351|P1|STARTED|OPEN LABEL||0
179331|NCT00576732|439346|P6|NOT COMPLETED|DOUBLE BLIND||0
179332|NCT00576732|439347|P5|NOT COMPLETED|DOUBLE BLIND||0
179333|NCT00576732|439348|P4|NOT COMPLETED|DOUBLE BLIND||0
179334|NCT00576732|439349|P3|NOT COMPLETED|DOUBLE BLIND||6
179335|NCT00576732|439350|P2|NOT COMPLETED|DOUBLE BLIND||5
179336|NCT00576732|439351|P1|NOT COMPLETED|DOUBLE BLIND||8
179337|NCT00576732|439346|P6|COMPLETED|DOUBLE BLIND||0
179338|NCT00576732|439347|P5|COMPLETED|DOUBLE BLIND||0
179339|NCT00576732|439348|P4|COMPLETED|DOUBLE BLIND||0
179340|NCT00576732|439349|P3|COMPLETED|DOUBLE BLIND||25
179341|NCT00576732|439350|P2|COMPLETED|DOUBLE BLIND||25
179342|NCT00576732|439351|P1|COMPLETED|DOUBLE BLIND||27
179343|NCT00576732|439346|P6|STARTED|DOUBLE BLIND||0
179344|NCT00576732|439347|P5|STARTED|DOUBLE BLIND||0
179345|NCT00576732|439348|P4|STARTED|DOUBLE BLIND||0
179346|NCT00576732|439349|P3|STARTED|DOUBLE BLIND||31
179347|NCT00576732|439350|P2|STARTED|DOUBLE BLIND||30
179348|NCT00576732|439351|P1|STARTED|DOUBLE BLIND||35
179349|NCT00576758|439383|P2|NOT COMPLETED|Follow-up Period||17
179350|NCT00576758|439384|P1|NOT COMPLETED|Follow-up Period||27
179351|NCT00576758|439383|P2|COMPLETED|Follow-up Period||34
179352|NCT00576758|439384|P1|COMPLETED|Follow-up Period||28
179353|NCT00576758|439383|P2|STARTED|Follow-up Period|Includes 21 pts who entered follow-up after induction and didn't enter the extended treatment phase.|51
179354|NCT00576758|439384|P1|STARTED|Follow-up Period|Includes 23 pts who entered follow-up after induction and didn't enter the extended treatment phase.|55
179355|NCT00576758|439383|P2|NOT COMPLETED|Extension Treatment Period||43
179356|NCT00576758|439384|P1|NOT COMPLETED|Extension Treatment Period||42
179357|NCT00576758|439383|P2|COMPLETED|Extension Treatment Period||30
179358|NCT00576758|439384|P1|COMPLETED|Extension Treatment Period|+ 2 patients (pts) who withdrew prior to receiving study drug.|30
179359|NCT00576758|439383|P2|STARTED|Extension Treatment Period|8 patients did not enter extended treatment phase/follow-up phase + 2 patients entered follow-up.|73
179360|NCT00576758|439384|P1|STARTED|Extension Treatment Period|6 patients did not enter extended treatment phase/follow-up + 1 patient entered follow-up.|72
179361|NCT00576758|439383|P2|NOT COMPLETED|Induction Treatment Period||5
179362|NCT00576758|439384|P1|NOT COMPLETED|Induction Treatment Period||8
179363|NCT00576758|439383|P2|COMPLETED|Induction Treatment Period||83
179364|NCT00576758|439384|P1|COMPLETED|Induction Treatment Period||79
179365|NCT00576758|439383|P2|Received Treatment|Induction Treatment Period||87
179366|NCT00576758|439384|P1|Received Treatment|Induction Treatment Period||86
179367|NCT00576758|439383|P2|STARTED|Induction Treatment Period||88
179368|NCT00576758|439384|P1|STARTED|Induction Treatment Period||87
179369|NCT00576823|439430|P3|NOT COMPLETED|40-week Safety Extension Phase||0
179370|NCT00576823|439431|P2|NOT COMPLETED|40-week Safety Extension Phase||0
179371|NCT00576823|439432|P1|NOT COMPLETED|40-week Safety Extension Phase||1
179372|NCT00576823|439430|P3|COMPLETED|40-week Safety Extension Phase||6
179373|NCT00576823|439431|P2|COMPLETED|40-week Safety Extension Phase||6
179374|NCT00576823|439432|P1|COMPLETED|40-week Safety Extension Phase||10
179375|NCT00576823|439430|P3|STARTED|40-week Safety Extension Phase|One patient refused to continue in the extension phase.|6
179376|NCT00576823|439431|P2|STARTED|40-week Safety Extension Phase||6
179377|NCT00576823|439432|P1|STARTED|40-week Safety Extension Phase||11
179378|NCT00576823|439430|P3|NOT COMPLETED|12-week Efficacy Phase||0
179379|NCT00576823|439431|P2|NOT COMPLETED|12-week Efficacy Phase||0
179380|NCT00576823|439432|P1|NOT COMPLETED|12-week Efficacy Phase||1
179381|NCT00576823|439430|P3|COMPLETED|12-week Efficacy Phase||7
179382|NCT00576823|439431|P2|COMPLETED|12-week Efficacy Phase||6
179383|NCT00576823|439432|P1|COMPLETED|12-week Efficacy Phase||11
179384|NCT00576823|439430|P3|STARTED|12-week Efficacy Phase||7
179385|NCT00576823|439431|P2|STARTED|12-week Efficacy Phase||6
179386|NCT00576823|439432|P1|STARTED|12-week Efficacy Phase||12
179387|NCT00576901|439446|P1|NOT COMPLETED|Overall Study||3
179388|NCT00576901|439446|P1|COMPLETED|Overall Study||20
179389|NCT00576901|439446|P1|STARTED|Overall Study||23
179390|NCT00576927|439456|P1|NOT COMPLETED|Randomization 1:1 Placebo or Active Drug||0
179391|NCT00576927|439456|P1|COMPLETED|Randomization 1:1 Placebo or Active Drug||22
179392|NCT00576927|439456|P1|STARTED|Randomization 1:1 Placebo or Active Drug||22
179393|NCT00576927|439456|P1|NOT COMPLETED|Sleep Hygiene With Study Drug||0
179394|NCT00576927|439456|P1|COMPLETED|Sleep Hygiene With Study Drug||22
179395|NCT00576927|439456|P1|STARTED|Sleep Hygiene With Study Drug||22
179396|NCT00576927|439456|P1|NOT COMPLETED|Sleep Hygiene With the Placebo||1
179397|NCT00576927|439456|P1|COMPLETED|Sleep Hygiene With the Placebo||22
179398|NCT00576927|439456|P1|STARTED|Sleep Hygiene With the Placebo||23
179399|NCT00576927|439456|P1|NOT COMPLETED|Sleep Hygiene Behavioral Intervention||7
179400|NCT00576927|439456|P1|COMPLETED|Sleep Hygiene Behavioral Intervention||23
179401|NCT00576927|439456|P1|STARTED|Sleep Hygiene Behavioral Intervention||30
179402|NCT00576927|439456|P1|NOT COMPLETED|Baseline||13
179403|NCT00576927|439456|P1|COMPLETED|Baseline||30
179404|NCT00576927|439456|P1|STARTED|Baseline||43
179405|NCT00576927|439456|P1|NOT COMPLETED|Clinical Assessment||36
179406|NCT00576927|439456|P1|COMPLETED|Clinical Assessment||43
179407|NCT00576927|439456|P1|STARTED|Clinical Assessment||79
179408|NCT00577005|439470|P2|NOT COMPLETED|Overall Study||3
179409|NCT00577005|439471|P1|NOT COMPLETED|Overall Study||5
179410|NCT00577005|439470|P2|COMPLETED|Overall Study||9
179411|NCT00577005|439471|P1|COMPLETED|Overall Study||11
179412|NCT00577005|439470|P2|STARTED|Overall Study||12
179413|NCT00577005|439471|P1|STARTED|Overall Study||16
179414|NCT00577031|439483|P1|NOT COMPLETED|Overall Study||205
179415|NCT00577031|439483|P1|COMPLETED|Overall Study||0
179416|NCT00577031|439483|P1|STARTED|Overall Study||205
179417|NCT00577083|439504|P2|NOT COMPLETED|Second Intervention (14days)||0
179418|NCT00577083|439505|P1|NOT COMPLETED|Second Intervention (14days)||0
179419|NCT00577083|439504|P2|COMPLETED|Second Intervention (14days)||52
179420|NCT00577083|439505|P1|COMPLETED|Second Intervention (14days)||48
179421|NCT00577083|439504|P2|STARTED|Second Intervention (14days)||52
179422|NCT00577083|439505|P1|STARTED|Second Intervention (14days)||48
179423|NCT00577083|439504|P2|NOT COMPLETED|Washout (14 Days)||0
179424|NCT00577083|439505|P1|NOT COMPLETED|Washout (14 Days)||0
179425|NCT00577083|439504|P2|COMPLETED|Washout (14 Days)||52
179426|NCT00577083|439505|P1|COMPLETED|Washout (14 Days)||48
179427|NCT00577083|439504|P2|STARTED|Washout (14 Days)||52
179428|NCT00577083|439505|P1|STARTED|Washout (14 Days)||48
179429|NCT00577083|439504|P2|NOT COMPLETED|First Intervention (14 Days)||0
179430|NCT00577083|439505|P1|NOT COMPLETED|First Intervention (14 Days)||0
179431|NCT00577083|439504|P2|COMPLETED|First Intervention (14 Days)||52
179432|NCT00577083|439505|P1|COMPLETED|First Intervention (14 Days)||48
179433|NCT00577083|439504|P2|STARTED|First Intervention (14 Days)||52
179434|NCT00577083|439505|P1|STARTED|First Intervention (14 Days)||48
179435|NCT00577096|439513|P2|NOT COMPLETED|Long Term Participation||0
179436|NCT00577096|439514|P1|NOT COMPLETED|Long Term Participation||0
179437|NCT00577096|439513|P2|COMPLETED|Long Term Participation|Sub-set of patients (n=69) who completed short term (n=120) continued in long term participation.|35
179438|NCT00577096|439514|P1|COMPLETED|Long Term Participation||34
179439|NCT00577096|439513|P2|STARTED|Long Term Participation|Only 35 patients who met long-term eligibility (response to EPO) were enrolled.|35
179440|NCT00577096|439514|P1|STARTED|Long Term Participation|Only the first 34 patients who met long-term eligibility (response to EPO) were enrolled.|34
179441|NCT00577096|439513|P2|NOT COMPLETED|Short Term Participation||8
179442|NCT00577096|439514|P1|NOT COMPLETED|Short Term Participation||7
179443|NCT00577096|439513|P2|COMPLETED|Short Term Participation||58
179444|NCT00577096|439514|P1|COMPLETED|Short Term Participation||62
179445|NCT00577096|439513|P2|STARTED|Short Term Participation||66
179446|NCT00577096|439514|P1|STARTED|Short Term Participation||69
179447|NCT00577122|439540|P2|NOT COMPLETED|Overall Study||16
179448|NCT00577122|439541|P1|NOT COMPLETED|Overall Study||14
179449|NCT00577122|439540|P2|COMPLETED|Overall Study||0
179450|NCT00577122|439541|P1|COMPLETED|Overall Study||0
179451|NCT00577122|439540|P2|STARTED|Overall Study||16
179452|NCT00577122|439541|P1|STARTED|Overall Study||14
179453|NCT00577135|439557|P4|NOT COMPLETED|Overall Study||0
179454|NCT00577135|439558|P3|NOT COMPLETED|Overall Study||0
179455|NCT00577135|439559|P2|NOT COMPLETED|Overall Study||0
179456|NCT00577135|439560|P1|NOT COMPLETED|Overall Study||0
179457|NCT00577135|439557|P4|COMPLETED|Overall Study||75
179458|NCT00577135|439558|P3|COMPLETED|Overall Study||77
179459|NCT00577135|439559|P2|COMPLETED|Overall Study||82
179460|NCT00577135|439560|P1|COMPLETED|Overall Study||74
179461|NCT00577135|439557|P4|STARTED|Overall Study||75
179462|NCT00577135|439558|P3|STARTED|Overall Study||77
179463|NCT00577135|439559|P2|STARTED|Overall Study||82
179464|NCT00577135|439560|P1|STARTED|Overall Study||74
179465|NCT00577356|439678|P1|NOT COMPLETED|Overall Study||0
179466|NCT00577356|439678|P1|COMPLETED|Overall Study||6
179467|NCT00577356|439678|P1|STARTED|Overall Study||6
179468|NCT00577382|439684|P2|NOT COMPLETED|Overall Study||31
179469|NCT00577382|439685|P1|NOT COMPLETED|Overall Study||21
179470|NCT00577382|439684|P2|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
179471|NCT00577382|439685|P1|COMPLETED|Overall Study|Since treatment duration was not fixed, patients were not considered to have completed treatment.|0
179472|NCT00577382|439684|P2|STARTED|Overall Study||31
179473|NCT00577382|439685|P1|STARTED|Overall Study||21
179474|NCT00577395|439699|P2|NOT COMPLETED|Overall Study||6
179475|NCT00577395|439700|P1|NOT COMPLETED|Overall Study||7
179476|NCT00577395|439699|P2|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
179477|NCT00577395|439700|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for lack of enrollment|0
179478|NCT00577395|439699|P2|STARTED|Overall Study|67 were planned for Treatment 1, but due to enrollment difficulties this was not met.|6
179479|NCT00577395|439700|P1|STARTED|Overall Study|67 planned for Treatment 2, but due to enrollment difficulties this was not met.|7
179480|NCT00577408|439710|P2|NOT COMPLETED|Overall Study||23
179481|NCT00577408|439711|P1|NOT COMPLETED|Overall Study||12
179482|NCT00577408|439710|P2|COMPLETED|Overall Study||9
179483|NCT00577408|439711|P1|COMPLETED|Overall Study||16
179484|NCT00577408|439710|P2|STARTED|Overall Study||32
179485|NCT00577408|439711|P1|STARTED|Overall Study||28
179486|NCT00577460|439720|P3|NOT COMPLETED|Overall Study||27
179487|NCT00577460|439721|P2|NOT COMPLETED|Overall Study||19
179488|NCT00577460|439722|P1|NOT COMPLETED|Overall Study||16
179489|NCT00577460|439720|P3|COMPLETED|Overall Study||112
179490|NCT00577460|439721|P2|COMPLETED|Overall Study||104
179491|NCT00577460|439722|P1|COMPLETED|Overall Study||113
179492|NCT00577460|439720|P3|STARTED|Overall Study||139
179493|NCT00577460|439721|P2|STARTED|Overall Study||123
179494|NCT00577460|439722|P1|STARTED|Overall Study||129
179495|NCT00577473|439831|P2|NOT COMPLETED|Overall Study||24
179496|NCT00577473|439832|P1|NOT COMPLETED|Overall Study||21
179497|NCT00577473|439831|P2|COMPLETED|Overall Study||123
179498|NCT00577473|439832|P1|COMPLETED|Overall Study||133
179499|NCT00577473|439831|P2|ITT Population|Overall Study||136
179500|NCT00577473|439832|P1|ITT Population|Overall Study||150
179501|NCT00577473|439831|P2|STARTED|Overall Study||147
179502|NCT00577473|439832|P1|STARTED|Overall Study||154
179503|NCT00577512|439860|P1|NOT COMPLETED|Overall Study||4
179504|NCT00577512|439860|P1|COMPLETED|Overall Study||0
179505|NCT00577512|439860|P1|STARTED|Overall Study||4
179506|NCT00577629|439864|P1|NOT COMPLETED|Long Term Follow-Up||25
179507|NCT00577629|439864|P1|COMPLETED|Long Term Follow-Up||13
179508|NCT00577629|439864|P1|STARTED|Long Term Follow-Up||38
179509|NCT00577629|439864|P1|NOT COMPLETED|Treatment Period||1
179510|NCT00577629|439864|P1|COMPLETED|Treatment Period||38
179511|NCT00577629|439864|P1|STARTED|Treatment Period||39
179512|NCT00577642|439872|P1|NOT COMPLETED|Overall Study||1
179513|NCT00577642|439872|P1|COMPLETED|Overall Study||28
179514|NCT00577642|439872|P1|STARTED|Overall Study||29
179515|NCT00577655|439878|P2|NOT COMPLETED|Overall Study||4
179516|NCT00577655|439879|P1|NOT COMPLETED|Overall Study||1
179517|NCT00577655|439878|P2|COMPLETED|Overall Study||47
179518|NCT00577655|439879|P1|COMPLETED|Overall Study||51
179519|NCT00577655|439878|P2|STARTED|Overall Study|This number represents the number of participants randomized.|51
179520|NCT00577655|439879|P1|STARTED|Overall Study|This number represents the number of participants randomized.|52
179521|NCT00577707|439917|P1|NOT COMPLETED|Overall Study||3
179522|NCT00577707|439917|P1|COMPLETED|Overall Study||6
179523|NCT00577707|439917|P1|STARTED|Overall Study||9
179524|NCT00577720|439925|P4|NOT COMPLETED|Overall Study||7
179525|NCT00577720|439926|P3|NOT COMPLETED|Overall Study||1
179526|NCT00577720|439927|P2|NOT COMPLETED|Overall Study||1
179527|NCT00577720|439928|P1|NOT COMPLETED|Overall Study||4
179528|NCT00577720|439925|P4|COMPLETED|Overall Study||65
179529|NCT00577720|439926|P3|COMPLETED|Overall Study||35
179530|NCT00577720|439927|P2|COMPLETED|Overall Study||35
179531|NCT00577720|439928|P1|COMPLETED|Overall Study||33
179532|NCT00577720|439925|P4|ITT (Intent to Treat) Population|Overall Study||65
179533|NCT00577720|439926|P3|ITT (Intent to Treat) Population|Overall Study||35
179534|NCT00577720|439927|P2|ITT (Intent to Treat) Population|Overall Study||35
179535|NCT00577720|439928|P1|ITT (Intent to Treat) Population|Overall Study||34
179536|NCT00577720|439925|P4|STARTED|Overall Study||72
179537|NCT00577720|439926|P3|STARTED|Overall Study||36
179538|NCT00577720|439927|P2|STARTED|Overall Study||36
179539|NCT00577720|439928|P1|STARTED|Overall Study||37
179540|NCT00577772|439948|P2|NOT COMPLETED|Overall Study||1
179541|NCT00577772|439949|P1|NOT COMPLETED|Overall Study||0
179542|NCT00577772|439948|P2|COMPLETED|Overall Study||6
179543|NCT00577772|439949|P1|COMPLETED|Overall Study||10
179544|NCT00577772|439948|P2|STARTED|Overall Study||7
179545|NCT00577772|439949|P1|STARTED|Overall Study||10
179546|NCT00577824|439958|P3|NOT COMPLETED|Overall Study||2
179547|NCT00577824|439959|P2|NOT COMPLETED|Overall Study||20
179548|NCT00577824|439960|P1|NOT COMPLETED|Overall Study||7
179549|NCT00577824|439958|P3|COMPLETED|Overall Study||34
179550|NCT00577824|439959|P2|COMPLETED|Overall Study||53
179551|NCT00577824|439960|P1|COMPLETED|Overall Study||65
179552|NCT00577824|439958|P3|Full Analysis Set|Overall Study||35
179553|NCT00577824|439959|P2|Full Analysis Set|Overall Study||72
179554|NCT00577824|439960|P1|Full Analysis Set|Overall Study|Full Analysis Set=subject received at least one dose of study medication (active or placebo)|72
179555|NCT00577824|439958|P3|STARTED|Overall Study||36
179556|NCT00577824|439959|P2|STARTED|Overall Study||73
179557|NCT00577824|439960|P1|STARTED|Overall Study|Started=Randomized|72
179558|NCT00577863|440018|P2|NOT COMPLETED|Overall Study||14
179559|NCT00577863|440019|P1|NOT COMPLETED|Overall Study||10
179560|NCT00577863|440018|P2|COMPLETED|Overall Study||94
179561|NCT00577863|440019|P1|COMPLETED|Overall Study||82
179562|NCT00577863|440018|P2|Received at Least One Injection|Overall Study||107
179563|NCT00577863|440019|P1|Received at Least One Injection|Overall Study||92
179564|NCT00577863|440018|P2|STARTED|Overall Study||108
179565|NCT00577863|440019|P1|STARTED|Overall Study||92
179566|NCT00577889|440061|P3|NOT COMPLETED|Overall Study||0
179567|NCT00577889|440062|P2|NOT COMPLETED|Overall Study||0
179568|NCT00577889|440063|P1|NOT COMPLETED|Overall Study||1
179569|NCT00577889|440061|P3|COMPLETED|Overall Study||6
179570|NCT00577889|440062|P2|COMPLETED|Overall Study||6
179571|NCT00577889|440063|P1|COMPLETED|Overall Study||8
179572|NCT00577889|440061|P3|STARTED|Overall Study||6
179573|NCT00577889|440062|P2|STARTED|Overall Study||6
179574|NCT00577889|440063|P1|STARTED|Overall Study||9
179575|NCT00578071|440080|P1|NOT COMPLETED|Overall Study||0
179576|NCT00578071|440080|P1|COMPLETED|Overall Study||29
179577|NCT00578071|440080|P1|STARTED|Overall Study||29
179578|NCT00578136|440089|P2|NOT COMPLETED|Overall Study||1
179579|NCT00578136|440090|P1|NOT COMPLETED|Overall Study||1
179580|NCT00578136|440089|P2|COMPLETED|Overall Study||26
179581|NCT00578136|440090|P1|COMPLETED|Overall Study||26
179582|NCT00578136|440089|P2|STARTED|Overall Study||27
179583|NCT00578136|440090|P1|STARTED|Overall Study||27
179584|NCT00578175|440101|P3|NOT COMPLETED|Overall Study||24
179585|NCT00578175|440102|P2|NOT COMPLETED|Overall Study||43
179586|NCT00578175|440103|P1|NOT COMPLETED|Overall Study||70
179587|NCT00578175|440101|P3|COMPLETED|Overall Study||365
179588|NCT00578175|440102|P2|COMPLETED|Overall Study||646
179589|NCT00578175|440103|P1|COMPLETED|Overall Study||635
179590|NCT00578175|440101|P3|STARTED|Overall Study||389
179591|NCT00578175|440102|P2|STARTED|Overall Study||689
179592|NCT00578175|440103|P1|STARTED|Overall Study||705
179593|NCT00578214|440183|P3|NOT COMPLETED|Overall Study||0
179594|NCT00578214|440184|P2|NOT COMPLETED|Overall Study||0
179595|NCT00578214|440185|P1|NOT COMPLETED|Overall Study||0
179596|NCT00578214|440183|P3|COMPLETED|Overall Study||31
179597|NCT00578214|440184|P2|COMPLETED|Overall Study||22
179598|NCT00578214|440185|P1|COMPLETED|Overall Study||22
179599|NCT00578214|440183|P3|STARTED|Overall Study||31
179600|NCT00578214|440184|P2|STARTED|Overall Study||22
179601|NCT00578214|440185|P1|STARTED|Overall Study||22
179602|NCT00578227|440235|P3|NOT COMPLETED|Overall Study||4
179603|NCT00578227|440236|P2|NOT COMPLETED|Overall Study||2
179604|NCT00578227|440237|P1|NOT COMPLETED|Overall Study||5
179605|NCT00578227|440235|P3|COMPLETED|Overall Study||267
179606|NCT00578227|440236|P2|COMPLETED|Overall Study||268
179607|NCT00578227|440237|P1|COMPLETED|Overall Study||267
179608|NCT00578227|440235|P3|STARTED|Overall Study||271
179609|NCT00578227|440236|P2|STARTED|Overall Study||270
179610|NCT00578227|440237|P1|STARTED|Overall Study||272
179611|NCT00578279|440309|P2|NOT COMPLETED|Overall Study||0
179612|NCT00578279|440310|P1|NOT COMPLETED|Overall Study||0
179613|NCT00578279|440309|P2|COMPLETED|Overall Study||10
179614|NCT00578279|440310|P1|COMPLETED|Overall Study||10
179615|NCT00578279|440309|P2|STARTED|Overall Study||10
179616|NCT00578279|440310|P1|STARTED|Overall Study||10
179617|NCT00578305|440319|P3|NOT COMPLETED|Safety Follow-up Phase||46
179618|NCT00578305|440320|P2|NOT COMPLETED|Safety Follow-up Phase||45
179619|NCT00578305|440321|P1|NOT COMPLETED|Safety Follow-up Phase||46
179620|NCT00578305|440319|P3|COMPLETED|Safety Follow-up Phase||8
179621|NCT00578305|440320|P2|COMPLETED|Safety Follow-up Phase||9
179622|NCT00578305|440321|P1|COMPLETED|Safety Follow-up Phase||11
179623|NCT00578305|440319|P3|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
179624|NCT00578305|440320|P2|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|54
179625|NCT00578305|440321|P1|STARTED|Safety Follow-up Phase|Some participants entered safety follow-up directly from the double-blind treatment period.|57
179626|NCT00578305|440319|P3|NOT COMPLETED|Extension Phase||3
179627|NCT00578305|440320|P2|NOT COMPLETED|Extension Phase||1
179628|NCT00578305|440321|P1|NOT COMPLETED|Extension Phase||4
179629|NCT00578305|440319|P3|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|40
179630|NCT00578305|440320|P2|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
179631|NCT00578305|440321|P1|COMPLETED|Extension Phase|Some participants completed the study in this period and did not enter the safety follow-up period.|49
179632|NCT00578305|440319|P3|STARTED|Extension Phase||43
179633|NCT00578305|440320|P2|STARTED|Extension Phase||50
179634|NCT00578305|440321|P1|STARTED|Extension Phase||53
179635|NCT00578305|440319|P3|NOT COMPLETED|Double-blind Treatment Phase||14
179636|NCT00578305|440320|P2|NOT COMPLETED|Double-blind Treatment Phase||4
179637|NCT00578305|440321|P1|NOT COMPLETED|Double-blind Treatment Phase||3
179638|NCT00578305|440319|P3|COMPLETED|Double-blind Treatment Phase||49
179639|NCT00578305|440320|P2|COMPLETED|Double-blind Treatment Phase||56
179640|NCT00578305|440321|P1|COMPLETED|Double-blind Treatment Phase||59
179641|NCT00578305|440319|P3|Treated|Double-blind Treatment Phase||63
179642|NCT00578305|440320|P2|Treated|Double-blind Treatment Phase||60
179643|NCT00578305|440321|P1|Treated|Double-blind Treatment Phase||62
179644|NCT00578305|440319|P3|STARTED|Double-blind Treatment Phase||63
179645|NCT00578305|440320|P2|STARTED|Double-blind Treatment Phase||60
179646|NCT00578305|440321|P1|STARTED|Double-blind Treatment Phase||62
179647|NCT00578318|440382|P2|NOT COMPLETED|Overall Study||0
179648|NCT00578318|440383|P1|NOT COMPLETED|Overall Study||3
179649|NCT00578318|440382|P2|COMPLETED|Overall Study||8
179650|NCT00578318|440383|P1|COMPLETED|Overall Study||5
179651|NCT00578318|440382|P2|STARTED|Overall Study||8
179652|NCT00578318|440383|P1|STARTED|Overall Study||8
179653|NCT00578331|440391|P2|NOT COMPLETED|Overall Study||125
179654|NCT00578331|440392|P1|NOT COMPLETED|Overall Study||116
179655|NCT00578331|440391|P2|COMPLETED|Overall Study||320
179656|NCT00578331|440392|P1|COMPLETED|Overall Study||329
179657|NCT00578331|440391|P2|STARTED|Overall Study||445
179658|NCT00578331|440392|P1|STARTED|Overall Study||445
179659|NCT00578383|440404|P4|NOT COMPLETED|Overall Study||6
179660|NCT00578383|440405|P3|NOT COMPLETED|Overall Study||6
179661|NCT00578383|440406|P2|NOT COMPLETED|Overall Study||16
179662|NCT00578383|440407|P1|NOT COMPLETED|Overall Study||16
179663|NCT00578383|440404|P4|COMPLETED|Overall Study||9
179664|NCT00578383|440405|P3|COMPLETED|Overall Study||13
179665|NCT00578383|440406|P2|COMPLETED|Overall Study||20
179666|NCT00578383|440407|P1|COMPLETED|Overall Study||21
179667|NCT00578383|440404|P4|STARTED|Overall Study||15
179668|NCT00578383|440405|P3|STARTED|Overall Study||19
179669|NCT00578383|440406|P2|STARTED|Overall Study||36
179670|NCT00578383|440407|P1|STARTED|Overall Study||37
179671|NCT00578448|440437|P1|NOT COMPLETED|1 Year Long Term Extension (LTE)||1
179672|NCT00578448|440437|P1|COMPLETED|1 Year Long Term Extension (LTE)||8
179673|NCT00578448|440437|P1|STARTED|1 Year Long Term Extension (LTE)||9
179674|NCT00578448|440437|P1|NOT COMPLETED|Day 1 up to 3 Years of Planned Study||3
179675|NCT00578448|440437|P1|COMPLETED|Day 1 up to 3 Years of Planned Study||9
179676|NCT00578448|440437|P1|STARTED|Day 1 up to 3 Years of Planned Study||12
179677|NCT00578461|440451|P1|NOT COMPLETED|Overall Study||0
179678|NCT00578461|440451|P1|COMPLETED|Overall Study||26
179679|NCT00578461|440451|P1|STARTED|Overall Study||26
179680|NCT00578539|440455|P1|NOT COMPLETED|Overall Study||0
179681|NCT00578539|440455|P1|COMPLETED|Overall Study||24
179682|NCT00578539|440455|P1|STARTED|Overall Study||24
179683|NCT00578552|440462|P3|NOT COMPLETED|Overall Study||15
179684|NCT00578552|440463|P2|NOT COMPLETED|Overall Study||14
179685|NCT00578552|440464|P1|NOT COMPLETED|Overall Study||15
179686|NCT00578552|440462|P3|COMPLETED|Overall Study||11
179687|NCT00578552|440463|P2|COMPLETED|Overall Study||13
179688|NCT00578552|440464|P1|COMPLETED|Overall Study||12
179689|NCT00578552|440462|P3|STARTED|Overall Study||26
179690|NCT00578552|440463|P2|STARTED|Overall Study||27
179691|NCT00578552|440464|P1|STARTED|Overall Study||27
179692|NCT00578565|440472|P1|NOT COMPLETED|Overall Study||3
179693|NCT00578565|440472|P1|COMPLETED|Overall Study||7
179694|NCT00578565|440472|P1|STARTED|Overall Study||10
179695|NCT00578617|440483|P2|NOT COMPLETED|Overall Study||0
179696|NCT00578617|440484|P1|NOT COMPLETED|Overall Study||0
179697|NCT00578617|440483|P2|COMPLETED|Overall Study||29
179698|NCT00578617|440484|P1|COMPLETED|Overall Study||31
179699|NCT00578617|440483|P2|STARTED|Overall Study||29
179700|NCT00578617|440484|P1|STARTED|Overall Study||31
179701|NCT00578734|440492|P2|NOT COMPLETED|Overall Study||0
179702|NCT00578734|440493|P1|NOT COMPLETED|Overall Study||0
179703|NCT00578734|440492|P2|COMPLETED|Overall Study||81
179704|NCT00578734|440493|P1|COMPLETED|Overall Study||84
179705|NCT00578734|440492|P2|STARTED|Overall Study||81
179706|NCT00578734|440493|P1|STARTED|Overall Study||84
179707|NCT00578786|440504|P3|NOT COMPLETED|Overall Study||30
179708|NCT00578786|440505|P2|NOT COMPLETED|Overall Study||66
179709|NCT00578786|440506|P1|NOT COMPLETED|Overall Study||39
179710|NCT00578786|440504|P3|COMPLETED|Overall Study||67
179711|NCT00578786|440505|P2|COMPLETED|Overall Study||124
179712|NCT00578786|440506|P1|COMPLETED|Overall Study||57
179713|NCT00578786|440504|P3|STARTED|Overall Study||97
179714|NCT00578786|440505|P2|STARTED|Overall Study||190
179715|NCT00578786|440506|P1|STARTED|Overall Study||96
179716|NCT00578812|440587|P2|NOT COMPLETED|Overall Study||7
179717|NCT00578812|440588|P1|NOT COMPLETED|Overall Study||6
179718|NCT00578812|440587|P2|COMPLETED|Overall Study||185
179719|NCT00578812|440588|P1|COMPLETED|Overall Study|Modified Intent-to-Treat (treated patients; analyzed as randomized).|218
179720|NCT00578812|440587|P2|STARTED|Overall Study||192
179721|NCT00578812|440588|P1|STARTED|Overall Study|Does not include investigational training patients (78 STARTED, 76 COMPLETED, 2 Not Treated).|224
179722|NCT00578864|440626|P2|NOT COMPLETED|Overall Study||0
179723|NCT00578864|440627|P1|NOT COMPLETED|Overall Study||1
179724|NCT00578864|440626|P2|COMPLETED|Overall Study||6
179725|NCT00578864|440627|P1|COMPLETED|Overall Study|died of complications of surgery after 2 cycles|6
179726|NCT00578864|440626|P2|STARTED|Overall Study||6
179727|NCT00578864|440627|P1|STARTED|Overall Study||7
179728|NCT00578877|440643|P2|NOT COMPLETED|Overall Study||128
179729|NCT00578877|440644|P1|NOT COMPLETED|Overall Study||81
179730|NCT00578877|440643|P2|COMPLETED|Overall Study||172
179731|NCT00578877|440644|P1|COMPLETED|Overall Study||69
179732|NCT00578877|440643|P2|STARTED|Overall Study||300
179733|NCT00578877|440644|P1|STARTED|Overall Study||150
179734|NCT00578903|440650|P1|NOT COMPLETED|Overall Study||0
179735|NCT00578903|440650|P1|COMPLETED|Overall Study||22
179736|NCT00578903|440650|P1|STARTED|Overall Study||22
179737|NCT00578929|440663|P4|NOT COMPLETED|Randomized Period||14
179738|NCT00578929|440664|P3|NOT COMPLETED|Randomized Period||8
179739|NCT00578929|440665|P2|NOT COMPLETED|Randomized Period||14
179740|NCT00578929|440666|P1|NOT COMPLETED|Randomized Period||17
179741|NCT00578929|440663|P4|COMPLETED|Randomized Period||283
179742|NCT00578929|440664|P3|COMPLETED|Randomized Period||288
179743|NCT00578929|440665|P2|COMPLETED|Randomized Period||283
179744|NCT00578929|440666|P1|COMPLETED|Randomized Period||281
179745|NCT00578929|440663|P4|STARTED|Randomized Period||297
179746|NCT00578929|440664|P3|STARTED|Randomized Period||296
179747|NCT00578929|440665|P2|STARTED|Randomized Period||297
179748|NCT00578929|440666|P1|STARTED|Randomized Period||298
179749|NCT00578929|440663|P4|NOT COMPLETED|Vehicle Run-In Period||0
179750|NCT00578929|440664|P3|NOT COMPLETED|Vehicle Run-In Period||0
179751|NCT00578929|440665|P2|NOT COMPLETED|Vehicle Run-In Period||0
179752|NCT00578929|440666|P1|NOT COMPLETED|Vehicle Run-In Period||0
179753|NCT00578929|440663|P4|COMPLETED|Vehicle Run-In Period||0
179754|NCT00578929|440664|P3|COMPLETED|Vehicle Run-In Period||0
179755|NCT00578929|440665|P2|COMPLETED|Vehicle Run-In Period||2388
179756|NCT00578929|440666|P1|COMPLETED|Vehicle Run-In Period||0
179757|NCT00578929|440663|P4|STARTED|Vehicle Run-In Period||0
179758|NCT00578929|440664|P3|STARTED|Vehicle Run-In Period||0
179759|NCT00578929|440665|P2|STARTED|Vehicle Run-In Period||2388
179760|NCT00578929|440666|P1|STARTED|Vehicle Run-In Period||0
179761|NCT00578942|440681|P1|NOT COMPLETED|Overall Study||1
179762|NCT00578942|440681|P1|COMPLETED|Overall Study||47
179763|NCT00578942|440681|P1|STARTED|Overall Study||48
179764|NCT00578968|440690|P3|NOT COMPLETED|Intervention||0
179765|NCT00578968|440691|P2|NOT COMPLETED|Intervention||0
179766|NCT00578968|440692|P1|NOT COMPLETED|Intervention||0
179767|NCT00578968|440690|P3|COMPLETED|Intervention||0
179768|NCT00578968|440691|P2|COMPLETED|Intervention||12
179769|NCT00578968|440692|P1|COMPLETED|Intervention||12
179770|NCT00578968|440690|P3|STARTED|Intervention||0
179771|NCT00578968|440691|P2|STARTED|Intervention||12
179772|NCT00578968|440692|P1|STARTED|Intervention||12
179773|NCT00578968|440690|P3|NOT COMPLETED|Baseline (Prior to Intervention)||0
179774|NCT00578968|440691|P2|NOT COMPLETED|Baseline (Prior to Intervention)||0
179775|NCT00578968|440692|P1|NOT COMPLETED|Baseline (Prior to Intervention)||0
179776|NCT00578968|440690|P3|COMPLETED|Baseline (Prior to Intervention)||12
179777|NCT00578968|440691|P2|COMPLETED|Baseline (Prior to Intervention)||12
179778|NCT00578968|440692|P1|COMPLETED|Baseline (Prior to Intervention)||12
179779|NCT00578968|440690|P3|STARTED|Baseline (Prior to Intervention)||12
179780|NCT00578968|440691|P2|STARTED|Baseline (Prior to Intervention)||12
179781|NCT00578968|440692|P1|STARTED|Baseline (Prior to Intervention)||12
179782|NCT00584987|440757|P4|NOT COMPLETED|Overall Study||1
179783|NCT00584987|440758|P3|NOT COMPLETED|Overall Study||1
179784|NCT00584987|440759|P2|NOT COMPLETED|Overall Study||1
179785|NCT00584987|440760|P1|NOT COMPLETED|Overall Study||1
179786|NCT00584987|440757|P4|COMPLETED|Overall Study||15
179787|NCT00584987|440758|P3|COMPLETED|Overall Study||16
179788|NCT00584987|440759|P2|COMPLETED|Overall Study||15
179789|NCT00584987|440760|P1|COMPLETED|Overall Study||14
179790|NCT00584987|440757|P4|STARTED|Overall Study||16
179791|NCT00584987|440758|P3|STARTED|Overall Study||17
179792|NCT00584987|440759|P2|STARTED|Overall Study||16
179793|NCT00584987|440760|P1|STARTED|Overall Study||15
179794|NCT00585013|440792|P2|NOT COMPLETED|Overall Study||0
179795|NCT00585013|440793|P1|NOT COMPLETED|Overall Study||0
179796|NCT00585013|440792|P2|COMPLETED|Overall Study||8
179797|NCT00585013|440793|P1|COMPLETED|Overall Study||8
179798|NCT00585013|440792|P2|STARTED|Overall Study||8
179799|NCT00585013|440793|P1|STARTED|Overall Study||8
179800|NCT00585039|440809|P2|NOT COMPLETED|Overall Study||0
179801|NCT00585039|440810|P1|NOT COMPLETED|Overall Study||2
179802|NCT00585039|440809|P2|COMPLETED|Overall Study||44
179803|NCT00585039|440810|P1|COMPLETED|Overall Study||55
179804|NCT00585039|440809|P2|STARTED|Overall Study||44
179805|NCT00585039|440810|P1|STARTED|Overall Study||57
179806|NCT00585078|440818|P1|NOT COMPLETED|Overall Study||40
179807|NCT00585078|440818|P1|COMPLETED|Overall Study||0
179808|NCT00585078|440818|P1|Response Evaluable|Overall Study||24
179809|NCT00585078|440818|P1|Toxicity Evaluable|Overall Study||36
179810|NCT00585078|440818|P1|Treated|Overall Study||37
179811|NCT00585078|440818|P1|STARTED|Overall Study||40
179812|NCT00585104|440825|P1|NOT COMPLETED|Overall Study||4
179813|NCT00585104|440825|P1|COMPLETED|Overall Study||6
179814|NCT00585104|440825|P1|STARTED|Overall Study||10
179815|NCT00585169|440829|P1|NOT COMPLETED|Overall Study||1
179816|NCT00585169|440829|P1|COMPLETED|Overall Study||28
179817|NCT00585169|440829|P1|STARTED|Overall Study||29
179818|NCT00585182|440835|P1|NOT COMPLETED|Overall Study||0
179819|NCT00585182|440835|P1|COMPLETED|Overall Study||28
179820|NCT00585182|440835|P1|STARTED|Overall Study||28
179821|NCT00585221|440840|P1|NOT COMPLETED|Overall Study||8
179822|NCT00585221|440840|P1|COMPLETED|Overall Study||0
179823|NCT00585221|440840|P1|STARTED|Overall Study||8
179824|NCT00585286|440845|P1|NOT COMPLETED|Overall Study||1
179825|NCT00585286|440845|P1|COMPLETED|Overall Study||14
179826|NCT00585286|440845|P1|STARTED|Overall Study||15
179827|NCT00585312|440854|P2|NOT COMPLETED|Overall Study||44
179828|NCT00585312|440855|P1|NOT COMPLETED|Overall Study||51
179829|NCT00585312|440854|P2|COMPLETED|Overall Study||7
179830|NCT00585312|440855|P1|COMPLETED|Overall Study||4
179831|NCT00585312|440854|P2|Treated|Overall Study||48
179832|NCT00585312|440855|P1|Treated|Overall Study||53
179833|NCT00585312|440854|P2|STARTED|Overall Study|STARTED=Randomized|51
179834|NCT00585312|440855|P1|STARTED|Overall Study|STARTED=Randomized|55
179835|NCT00586898|440867|P1|NOT COMPLETED|Overall Study||7
179836|NCT00586898|440867|P1|COMPLETED|Overall Study||29
179837|NCT00586898|440867|P1|STARTED|Overall Study||36
179838|NCT00587041|440874|P3|NOT COMPLETED|Overall Study||0
179839|NCT00587041|440875|P2|NOT COMPLETED|Overall Study||0
179840|NCT00587041|440876|P1|NOT COMPLETED|Overall Study||0
179841|NCT00587041|440874|P3|COMPLETED|Overall Study||14
179842|NCT00587041|440875|P2|COMPLETED|Overall Study||14
179843|NCT00587041|440876|P1|COMPLETED|Overall Study||12
179844|NCT00587041|440874|P3|STARTED|Overall Study||14
179845|NCT00587041|440875|P2|STARTED|Overall Study||14
179846|NCT00587041|440876|P1|STARTED|Overall Study||12
179847|NCT00587054|440887|P1|NOT COMPLETED|Overall Study||9
179848|NCT00587054|440887|P1|COMPLETED|Overall Study||120
179849|NCT00587054|440887|P1|STARTED|Overall Study||129
179850|NCT00587067|440891|P1|NOT COMPLETED|Overall Study||0
179851|NCT00587067|440891|P1|COMPLETED|Overall Study||34
179852|NCT00587067|440891|P1|STARTED|Overall Study||34
179853|NCT00587132|440901|P4|NOT COMPLETED|Overall Study||0
179854|NCT00587132|440902|P3|NOT COMPLETED|Overall Study||0
179855|NCT00587132|440903|P2|NOT COMPLETED|Overall Study||0
179856|NCT00587132|440904|P1|NOT COMPLETED|Overall Study||0
179857|NCT00587132|440901|P4|COMPLETED|Overall Study||0
179858|NCT00587132|440902|P3|COMPLETED|Overall Study||0
179859|NCT00587132|440903|P2|COMPLETED|Overall Study||0
179860|NCT00587132|440904|P1|COMPLETED|Overall Study||4
179861|NCT00587132|440901|P4|STARTED|Overall Study||0
179862|NCT00587132|440902|P3|STARTED|Overall Study||0
179863|NCT00587132|440903|P2|STARTED|Overall Study||0
179864|NCT00587132|440904|P1|STARTED|Overall Study||4
179865|NCT00587158|440916|P2|NOT COMPLETED|Overall Study||8
179866|NCT00587158|440917|P1|NOT COMPLETED|Overall Study||5
179867|NCT00587158|440916|P2|COMPLETED|Overall Study||43
179868|NCT00587158|440917|P1|COMPLETED|Overall Study||44
179869|NCT00587158|440916|P2|Continued in Study|Overall Study||46
179870|NCT00587158|440917|P1|Continued in Study|Overall Study||45
179871|NCT00587158|440916|P2|STARTED|Overall Study||51
179872|NCT00587158|440917|P1|STARTED|Overall Study||49
179873|NCT00587171|440949|P2|NOT COMPLETED|Overall Study||1
179874|NCT00587171|440950|P1|NOT COMPLETED|Overall Study||1
179875|NCT00587171|440949|P2|COMPLETED|Overall Study||9
179876|NCT00587171|440950|P1|COMPLETED|Overall Study||8
179877|NCT00587171|440949|P2|STARTED|Overall Study||10
179878|NCT00587171|440950|P1|STARTED|Overall Study||9
179879|NCT00587223|440978|P1|NOT COMPLETED|Overall Study||1
179880|NCT00587223|440978|P1|COMPLETED|Overall Study|Subject withdrawn from study at Day 7.|0
179881|NCT00587223|440978|P1|STARTED|Overall Study|Study design was within-subject control. Only 1 subject was enrolled in the study.|1
179882|NCT00587288|440995|P2|NOT COMPLETED|Overall Study||9
179883|NCT00587288|440996|P1|NOT COMPLETED|Overall Study||3
179884|NCT00587288|440995|P2|COMPLETED|Overall Study||44
179885|NCT00587288|440996|P1|COMPLETED|Overall Study||50
179886|NCT00587288|440995|P2|STARTED|Overall Study||53
179887|NCT00587288|440996|P1|STARTED|Overall Study||53
179888|NCT00587431|441016|P2|NOT COMPLETED|Overall Study||1
179889|NCT00587431|441017|P1|NOT COMPLETED|Overall Study||1
179890|NCT00587431|441016|P2|COMPLETED|Overall Study||38
179891|NCT00587431|441017|P1|COMPLETED|Overall Study||62
179892|NCT00587431|441016|P2|STARTED|Overall Study||39
179893|NCT00587431|441017|P1|STARTED|Overall Study||63
179894|NCT00587457|441029|P3|NOT COMPLETED|Overall Study||5
179895|NCT00587457|441030|P2|NOT COMPLETED|Overall Study||3
179896|NCT00587457|441031|P1|NOT COMPLETED|Overall Study||3
179897|NCT00587457|441029|P3|COMPLETED|Overall Study||0
179898|NCT00587457|441030|P2|COMPLETED|Overall Study||0
179899|NCT00587457|441031|P1|COMPLETED|Overall Study||0
179900|NCT00587457|441029|P3|STARTED|Overall Study||5
179901|NCT00587457|441030|P2|STARTED|Overall Study||3
179902|NCT00587457|441031|P1|STARTED|Overall Study||3
179903|NCT00587483|441069|P3|NOT COMPLETED|Overall Study||0
179904|NCT00587483|441070|P2|NOT COMPLETED|Overall Study||0
179905|NCT00587483|441071|P1|NOT COMPLETED|Overall Study||0
179906|NCT00587483|441069|P3|COMPLETED|Overall Study||112
179907|NCT00587483|441070|P2|COMPLETED|Overall Study||115
179908|NCT00587483|441071|P1|COMPLETED|Overall Study||115
179909|NCT00587483|441069|P3|STARTED|Overall Study||112
179910|NCT00587483|441070|P2|STARTED|Overall Study||115
179911|NCT00587483|441071|P1|STARTED|Overall Study||115
179912|NCT00587587|441099|P2|NOT COMPLETED|Overall Study||1
179913|NCT00587587|441100|P1|NOT COMPLETED|Overall Study||6
179914|NCT00587587|441099|P2|COMPLETED|Overall Study||12
179915|NCT00587587|441100|P1|COMPLETED|Overall Study||11
179916|NCT00587587|441099|P2|STARTED|Overall Study||13
179917|NCT00587587|441100|P1|STARTED|Overall Study||17
179918|NCT00587639|441120|P1|NOT COMPLETED|Overall Study||1
179919|NCT00587639|441120|P1|COMPLETED|Overall Study||7
179920|NCT00587639|441120|P1|STARTED|Overall Study||8
179921|NCT00587678|441128|P3|NOT COMPLETED|Overall Study||8
179922|NCT00587678|441129|P2|NOT COMPLETED|Overall Study||4
179923|NCT00587678|441130|P1|NOT COMPLETED|Overall Study||6
179924|NCT00587678|441128|P3|COMPLETED|Overall Study||33
179925|NCT00587678|441129|P2|COMPLETED|Overall Study||18
179926|NCT00587678|441130|P1|COMPLETED|Overall Study||16
179927|NCT00587678|441128|P3|STARTED|Overall Study||41
179928|NCT00587678|441129|P2|STARTED|Overall Study||22
179929|NCT00587678|441130|P1|STARTED|Overall Study||22
179930|NCT00587769|441168|P1|NOT COMPLETED|Overall Study||0
179931|NCT00587769|441168|P1|COMPLETED|Overall Study||38
179932|NCT00587769|441168|P1|STARTED|Overall Study||38
179933|NCT00587795|441175|P2|NOT COMPLETED|Overall Study||0
179934|NCT00587795|441176|P1|NOT COMPLETED|Overall Study||1
179935|NCT00587795|441175|P2|COMPLETED|Overall Study||0
179936|NCT00587795|441176|P1|COMPLETED|Overall Study||0
179937|NCT00587795|441175|P2|STARTED|Overall Study||0
179938|NCT00587795|441176|P1|STARTED|Overall Study||1
179939|NCT00587834|441182|P1|NOT COMPLETED|Overall Study||0
179940|NCT00587834|441182|P1|COMPLETED|Overall Study||96
179941|NCT00587834|441182|P1|STARTED|Overall Study||96
179942|NCT00587847|441198|P1|NOT COMPLETED|Overall Study||7
179943|NCT00587847|441198|P1|COMPLETED|Overall Study||5
179944|NCT00587847|441198|P1|STARTED|Overall Study||12
179945|NCT00587860|441205|P2|NOT COMPLETED|Overall Study||5
179946|NCT00587860|441206|P1|NOT COMPLETED|Overall Study||5
179947|NCT00587860|441205|P2|COMPLETED|Overall Study||30
179948|NCT00587860|441206|P1|COMPLETED|Overall Study||30
179949|NCT00587860|441205|P2|STARTED|Overall Study||35
179950|NCT00587860|441206|P1|STARTED|Overall Study||35
179951|NCT00587964|441226|P1|NOT COMPLETED|Overall Study||12
179952|NCT00587964|441226|P1|COMPLETED|Overall Study||39
179953|NCT00587964|441226|P1|STARTED|Overall Study||51
179954|NCT00587990|441233|P3|NOT COMPLETED|Overall Study||0
179955|NCT00587990|441234|P2|NOT COMPLETED|Overall Study||0
179956|NCT00587990|441235|P1|NOT COMPLETED|Overall Study||0
179957|NCT00587990|441233|P3|COMPLETED|Overall Study||3
179958|NCT00587990|441234|P2|COMPLETED|Overall Study||4
179959|NCT00587990|441235|P1|COMPLETED|Overall Study||2
179960|NCT00587990|441233|P3|STARTED|Overall Study||3
179961|NCT00587990|441234|P2|STARTED|Overall Study||4
179962|NCT00587990|441235|P1|STARTED|Overall Study||2
179963|NCT00588094|441243|P1|NOT COMPLETED|Overall Study||5
179964|NCT00588094|441243|P1|COMPLETED|Overall Study||15
179965|NCT00588094|441243|P1|STARTED|Overall Study||20
179966|NCT00588146|441247|P2|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
179967|NCT00588146|441248|P1|NOT COMPLETED|Second Intervention (6 Months to 1 Year)||0
179968|NCT00588146|441247|P2|COMPLETED|Second Intervention (6 Months to 1 Year)||2
179969|NCT00588146|441248|P1|COMPLETED|Second Intervention (6 Months to 1 Year)||1
179970|NCT00588146|441247|P2|STARTED|Second Intervention (6 Months to 1 Year)||2
179971|NCT00588146|441248|P1|STARTED|Second Intervention (6 Months to 1 Year)||1
179972|NCT00588146|441247|P2|NOT COMPLETED|First Intervention (Baseline to 6 mo)||3
179973|NCT00588146|441248|P1|NOT COMPLETED|First Intervention (Baseline to 6 mo)||4
179974|NCT00588146|441247|P2|COMPLETED|First Intervention (Baseline to 6 mo)||2
179975|NCT00588146|441248|P1|COMPLETED|First Intervention (Baseline to 6 mo)||1
179976|NCT00588146|441247|P2|STARTED|First Intervention (Baseline to 6 mo)||5
179977|NCT00588146|441248|P1|STARTED|First Intervention (Baseline to 6 mo)||5
179978|NCT00588159|441256|P2|NOT COMPLETED|Overall Study||11
179979|NCT00588159|441257|P1|NOT COMPLETED|Overall Study||15
179980|NCT00588159|441256|P2|COMPLETED|Overall Study||63
179981|NCT00588159|441257|P1|COMPLETED|Overall Study||57
179982|NCT00588159|441256|P2|STARTED|Overall Study||74
179983|NCT00588159|441257|P1|STARTED|Overall Study||72
179984|NCT00588237|441273|P1|NOT COMPLETED|Overall Study||4
179985|NCT00588237|441273|P1|COMPLETED|Overall Study||38
179986|NCT00588237|441273|P1|STARTED|Overall Study||42
179987|NCT00588341|441277|P1|NOT COMPLETED|Overall Study||5
179988|NCT00588341|441277|P1|COMPLETED|Overall Study||19
179989|NCT00588341|441277|P1|STARTED|Overall Study||24
179990|NCT00588354|441283|P2|NOT COMPLETED|Baseline to 4 Weeks||1
179991|NCT00588354|441284|P1|NOT COMPLETED|Baseline to 4 Weeks||0
179992|NCT00588354|441283|P2|COMPLETED|Baseline to 4 Weeks||14
179993|NCT00588354|441284|P1|COMPLETED|Baseline to 4 Weeks||9
179994|NCT00588354|441283|P2|STARTED|Baseline to 4 Weeks||15
179995|NCT00588354|441284|P1|STARTED|Baseline to 4 Weeks||9
179996|NCT00588354|441283|P2|NOT COMPLETED|Baseline to 2 Weeks||0
179997|NCT00588354|441284|P1|NOT COMPLETED|Baseline to 2 Weeks||2
179998|NCT00588354|441283|P2|COMPLETED|Baseline to 2 Weeks||15
179999|NCT00588354|441284|P1|COMPLETED|Baseline to 2 Weeks||9
180000|NCT00588354|441283|P2|STARTED|Baseline to 2 Weeks||15
180001|NCT00588354|441284|P1|STARTED|Baseline to 2 Weeks||11
180002|NCT00588380|441304|P1|NOT COMPLETED|Overall Study||0
180003|NCT00588380|441304|P1|COMPLETED|Overall Study||88
180004|NCT00588380|441304|P1|STARTED|Overall Study||88
180005|NCT00588406|441311|P2|NOT COMPLETED|Overall Study||0
180006|NCT00588406|441312|P1|NOT COMPLETED|Overall Study||0
180007|NCT00588406|441311|P2|COMPLETED|Overall Study||49
180008|NCT00588406|441312|P1|COMPLETED|Overall Study||46
180009|NCT00588406|441311|P2|STARTED|Overall Study||49
180010|NCT00588406|441312|P1|STARTED|Overall Study||46
180011|NCT00588445|441320|P1|NOT COMPLETED|Overall Study||15
180012|NCT00588445|441320|P1|COMPLETED|Overall Study||50
180013|NCT00588445|441320|P1|STARTED|Overall Study||65
180014|NCT00588471|441328|P2|NOT COMPLETED|Overall Study||0
180015|NCT00588471|441329|P1|NOT COMPLETED|Overall Study||0
180016|NCT00588471|441328|P2|COMPLETED|Overall Study||29
180017|NCT00588471|441329|P1|COMPLETED|Overall Study||28
180018|NCT00588471|441328|P2|STARTED|Overall Study||29
180019|NCT00588471|441329|P1|STARTED|Overall Study||28
180020|NCT00588536|441337|P1|NOT COMPLETED|Overall Study||0
180021|NCT00588536|441337|P1|COMPLETED|Overall Study||5
180022|NCT00588536|441337|P1|STARTED|Overall Study||5
180023|NCT00588640|441341|P1|NOT COMPLETED|Overall Study||2
180024|NCT00588640|441341|P1|COMPLETED|Overall Study||8
180025|NCT00588640|441341|P1|STARTED|Overall Study||10
180026|NCT00588666|441345|P1|NOT COMPLETED|Overall Study||4
180027|NCT00588666|441345|P1|COMPLETED|Overall Study||47
180028|NCT00588666|441345|P1|STARTED|Overall Study||51
180029|NCT00588692|441352|P2|NOT COMPLETED|Overall Study||3
180030|NCT00588692|441353|P1|NOT COMPLETED|Overall Study||7
180031|NCT00588692|441352|P2|COMPLETED|Overall Study||27
180032|NCT00588692|441353|P1|COMPLETED|Overall Study||23
180033|NCT00588692|441352|P2|STARTED|Overall Study||30
180034|NCT00588692|441353|P1|STARTED|Overall Study||30
180035|NCT00588731|441391|P2|NOT COMPLETED|Overall Study||2
180036|NCT00588731|441392|P1|NOT COMPLETED|Overall Study||3
180037|NCT00588731|441391|P2|COMPLETED|Overall Study||18
180038|NCT00588731|441392|P1|COMPLETED|Overall Study||18
180039|NCT00588731|441391|P2|STARTED|Overall Study||20
180040|NCT00588731|441392|P1|STARTED|Overall Study||21
180041|NCT00588809|441400|P1|NOT COMPLETED|Overall Study||0
180042|NCT00588809|441400|P1|COMPLETED|Overall Study||47
180043|NCT00588809|441400|P1|STARTED|Overall Study||47
180044|NCT00588822|441409|P1|NOT COMPLETED|Overall Study||8
180045|NCT00588822|441409|P1|COMPLETED|Overall Study||13
180046|NCT00588822|441409|P1|STARTED|Overall Study||21
180047|NCT00588848|441420|P2|NOT COMPLETED|Overall Study||0
180048|NCT00588848|441421|P1|NOT COMPLETED|Overall Study||0
180049|NCT00588848|441420|P2|COMPLETED|Overall Study||8
180050|NCT00588848|441421|P1|COMPLETED|Overall Study||3
180051|NCT00588848|441420|P2|STARTED|Overall Study||8
180052|NCT00588848|441421|P1|STARTED|Overall Study||3
180053|NCT00588861|441431|P2|NOT COMPLETED|10 Years||114
180054|NCT00588861|441432|P1|NOT COMPLETED|10 Years||107
180055|NCT00588861|441431|P2|COMPLETED|10 Years||0
180056|NCT00588861|441432|P1|COMPLETED|10 Years||0
180057|NCT00588861|441431|P2|STARTED|10 Years|114 cases were due at 10 Years, however no patients returned for follow-up.|114
180058|NCT00588861|441432|P1|STARTED|10 Years|107 cases were due at 10 Years, however no patients returned for follow-up.|107
180059|NCT00588861|441431|P2|NOT COMPLETED|8 Years||114
180060|NCT00588861|441432|P1|NOT COMPLETED|8 Years||105
180061|NCT00588861|441431|P2|COMPLETED|8 Years||0
180062|NCT00588861|441432|P1|COMPLETED|8 Years||2
180063|NCT00588861|441431|P2|STARTED|8 Years|114 cases were due at 8 Years, however no patients returned for follow-up.|114
180064|NCT00588861|441432|P1|STARTED|8 Years|107 cases were due at 8 Years, however only 2 returned for follow-up.|107
180065|NCT00588861|441431|P2|NOT COMPLETED|6 Years||109
180066|NCT00588861|441432|P1|NOT COMPLETED|6 Years||104
180067|NCT00588861|441431|P2|COMPLETED|6 Years||5
180068|NCT00588861|441432|P1|COMPLETED|6 Years||3
180069|NCT00588861|441431|P2|STARTED|6 Years|114 cases were due at 6 Years, however only 5 returned for follow-up.|114
180070|NCT00588861|441432|P1|STARTED|6 Years|107 cases were due at 6 Years, however only 3 returned for follow-up.|107
180071|NCT00588861|441431|P2|NOT COMPLETED|4 Years||103
180072|NCT00588861|441432|P1|NOT COMPLETED|4 Years||91
180073|NCT00588861|441431|P2|COMPLETED|4 Years||11
180074|NCT00588861|441432|P1|COMPLETED|4 Years||16
180075|NCT00588861|441431|P2|STARTED|4 Years|114 cases were due at 4 Years, however only 11 returned for follow-up.|114
180076|NCT00588861|441432|P1|STARTED|4 Years|107 cases were due at 4 Years, however only 16 returned for follow-up.|107
180077|NCT00588861|441431|P2|NOT COMPLETED|2 Years||87
180078|NCT00588861|441432|P1|NOT COMPLETED|2 Years||92
180079|NCT00588861|441431|P2|COMPLETED|2 Years||27
180080|NCT00588861|441432|P1|COMPLETED|2 Years||15
180081|NCT00588861|441431|P2|STARTED|2 Years|114 cases were due at 2 Years, however only 27 returned for follow-up.|114
180082|NCT00588861|441432|P1|STARTED|2 Years|107 cases were due at 2 Years, however only 15 returned for follow-up.|107
180083|NCT00588861|441431|P2|NOT COMPLETED|1 Year||82
180084|NCT00588861|441432|P1|NOT COMPLETED|1 Year||89
180085|NCT00588861|441431|P2|COMPLETED|1 Year||32
180086|NCT00588861|441432|P1|COMPLETED|1 Year||18
180087|NCT00588861|441431|P2|STARTED|1 Year|114 cases were due at 1 Year, however only 32 returned for follow-up.|114
180088|NCT00588861|441432|P1|STARTED|1 Year|107 cases were due at 1 Year, however only 18 returned for follow-up.|107
180089|NCT00588861|441431|P2|NOT COMPLETED|6 Months||73
180090|NCT00588861|441432|P1|NOT COMPLETED|6 Months||98
180091|NCT00588861|441431|P2|COMPLETED|6 Months||41
180092|NCT00588861|441432|P1|COMPLETED|6 Months||9
180093|NCT00588861|441431|P2|STARTED|6 Months|114 cases were due at 6 Months, however only 41 returned for follow-up.|114
180094|NCT00588861|441432|P1|STARTED|6 Months|107 cases were due at 6 Months, however only 9 returned for follow-up.|107
180095|NCT00588861|441431|P2|NOT COMPLETED|Pre-Operative||86
180096|NCT00588861|441432|P1|NOT COMPLETED|Pre-Operative||95
180097|NCT00588861|441431|P2|COMPLETED|Pre-Operative||114
180098|NCT00588861|441432|P1|COMPLETED|Pre-Operative||107
180099|NCT00588861|441431|P2|STARTED|Pre-Operative|200 patients were enrolled, however only 114 contributed preop data.|200
180100|NCT00588861|441432|P1|STARTED|Pre-Operative|202 Patients were enrolled, however only 107 contributed preop data.|202
180101|NCT00588900|441440|P1|NOT COMPLETED|Overall Study||0
180102|NCT00588900|441440|P1|COMPLETED|Overall Study||5
180103|NCT00588900|441440|P1|STARTED|Overall Study||5
180104|NCT00588952|441448|P2|NOT COMPLETED|Overall Study||7
180105|NCT00588952|441449|P1|NOT COMPLETED|Overall Study||3
180106|NCT00588952|441448|P2|COMPLETED|Overall Study||63
180107|NCT00588952|441449|P1|COMPLETED|Overall Study||26
180108|NCT00588952|441448|P2|STARTED|Overall Study||70
180109|NCT00588952|441449|P1|STARTED|Overall Study||29
180110|NCT00588965|441469|P1|NOT COMPLETED|Overall Study||0
180111|NCT00588965|441469|P1|COMPLETED|Overall Study||35
180112|NCT00588965|441469|P1|STARTED|Overall Study||35
180113|NCT00589108|441480|P3|NOT COMPLETED|Overall Study||5
180114|NCT00589108|441481|P2|NOT COMPLETED|Overall Study||4
180115|NCT00589108|441482|P1|NOT COMPLETED|Overall Study||4
180116|NCT00589108|441480|P3|COMPLETED|Overall Study||75
180117|NCT00589108|441481|P2|COMPLETED|Overall Study||76
180118|NCT00589108|441482|P1|COMPLETED|Overall Study||76
180119|NCT00589108|441480|P3|STARTED|Overall Study||80
180120|NCT00589108|441481|P2|STARTED|Overall Study||80
180121|NCT00589108|441482|P1|STARTED|Overall Study||80
180122|NCT00589121|441504|P2|NOT COMPLETED|Overall Study||7
180123|NCT00589121|441505|P1|NOT COMPLETED|Overall Study||2
180124|NCT00589121|441504|P2|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|79
180125|NCT00589121|441505|P1|COMPLETED|Overall Study|Subjects with data available for the analysis are considered to have completed the study.|10
180126|NCT00589121|441504|P2|STARTED|Overall Study||86
180127|NCT00589121|441505|P1|STARTED|Overall Study||12
180128|NCT00589277|441524|P2|NOT COMPLETED|Overall Study||286
180129|NCT00589277|441525|P1|NOT COMPLETED|Overall Study||460
180130|NCT00589277|441524|P2|COMPLETED|Overall Study||524
180131|NCT00589277|441525|P1|COMPLETED|Overall Study||762
180132|NCT00589277|441524|P2|Completed 3 Month Follow Up|Overall Study||524
180133|NCT00589277|441525|P1|Completed 3 Month Follow Up|Overall Study||762
180134|NCT00589277|441524|P2|Completed 2 Week Follow Up|Overall Study||424
180135|NCT00589277|441525|P1|Completed 2 Week Follow Up|Overall Study||603
180136|NCT00589277|441524|P2|STARTED|Overall Study||810
180137|NCT00589277|441525|P1|STARTED|Overall Study||1222
180138|NCT00589290|441535|P1|NOT COMPLETED|Overall Study||1
180139|NCT00589290|441535|P1|COMPLETED|Overall Study||40
180140|NCT00589290|441535|P1|STARTED|Overall Study||41
180141|NCT00589303|441545|P2|NOT COMPLETED|Overall Study||1
180142|NCT00589303|441546|P1|NOT COMPLETED|Overall Study||2
180143|NCT00589303|441545|P2|COMPLETED|Overall Study||12
180144|NCT00589303|441546|P1|COMPLETED|Overall Study||12
180145|NCT00589303|441545|P2|STARTED|Overall Study||13
180146|NCT00589303|441546|P1|STARTED|Overall Study||14
180147|NCT00576056|441552|P1|NOT COMPLETED|Overall Study||14
180148|NCT00576056|441552|P1|COMPLETED|Overall Study||5
180149|NCT00576056|441552|P1|STARTED|Overall Study||19
180150|NCT00576147|441557|P1|NOT COMPLETED|Overall Study||0
180151|NCT00576147|441557|P1|COMPLETED|Overall Study||431
180152|NCT00576147|441557|P1|STARTED|Overall Study||431
180153|NCT00576199|441561|P1|NOT COMPLETED|Overall Study||30
180154|NCT00576199|441561|P1|COMPLETED|Overall Study||0
180155|NCT00576199|441561|P1|STARTED|Overall Study||30
180156|NCT00576251|441572|P2|NOT COMPLETED|Overall Study||1
180157|NCT00576251|441573|P1|NOT COMPLETED|Overall Study||1
180158|NCT00576251|441572|P2|COMPLETED|Overall Study||111
180159|NCT00576251|441573|P1|COMPLETED|Overall Study||108
180160|NCT00576251|441572|P2|STARTED|Overall Study||112
180161|NCT00576251|441573|P1|STARTED|Overall Study||109
180162|NCT00576303|441579|P1|NOT COMPLETED|Long Term Safety Period||16
180163|NCT00576303|441579|P1|COMPLETED|Long Term Safety Period||162
180164|NCT00576303|441579|P1|STARTED|Long Term Safety Period||178
180165|NCT00576303|441579|P1|NOT COMPLETED|Efficacy Evaluation Period||5
180166|NCT00576303|441579|P1|COMPLETED|Efficacy Evaluation Period||178
180167|NCT00576303|441579|P1|STARTED|Efficacy Evaluation Period||183
180168|NCT00576303|441579|P1|NOT COMPLETED|Dose Titration Period||17
180169|NCT00576303|441579|P1|COMPLETED|Dose Titration Period||183
180170|NCT00576303|441579|P1|STARTED|Dose Titration Period||200
180171|NCT00576316|441588|P1|NOT COMPLETED|Overall Study||20
180172|NCT00576316|441588|P1|COMPLETED|Overall Study|Number of patients who completed study|181
180173|NCT00576316|441588|P1|STARTED|Overall Study|Number of patients recruited|201
180174|NCT00576381|441593|P1|NOT COMPLETED|Overall Study||7
180175|NCT00576381|441593|P1|COMPLETED|Overall Study||23
180176|NCT00576381|441593|P1|STARTED|Overall Study||30
180177|NCT00576420|441600|P3|NOT COMPLETED|Overall Study||1
180178|NCT00576420|441601|P2|NOT COMPLETED|Overall Study||0
180179|NCT00576420|441602|P1|NOT COMPLETED|Overall Study||0
180180|NCT00576420|441600|P3|COMPLETED|Overall Study||22
180181|NCT00576420|441601|P2|COMPLETED|Overall Study||24
180182|NCT00576420|441602|P1|COMPLETED|Overall Study||26
180183|NCT00576420|441600|P3|STARTED|Overall Study||23
180184|NCT00576420|441601|P2|STARTED|Overall Study||24
180185|NCT00576420|441602|P1|STARTED|Overall Study||26
180186|NCT00581867|441767|P2|NOT COMPLETED|Second Intervention||0
180187|NCT00581867|441768|P1|NOT COMPLETED|Second Intervention||0
180188|NCT00581867|441767|P2|COMPLETED|Second Intervention||14
180189|NCT00581867|441768|P1|COMPLETED|Second Intervention||15
180190|NCT00581867|441767|P2|STARTED|Second Intervention|1 individual completed period 1 (Intranasal Insulin) but did not complete period 2 (Placebo).|14
180191|NCT00581867|441768|P1|STARTED|Second Intervention|n=1 completed period 1 (placebo) but not period 2 (insulin). This individuals died between periods.|15
180192|NCT00581867|441767|P2|NOT COMPLETED|First Intervention||0
180193|NCT00581867|441768|P1|NOT COMPLETED|First Intervention||0
180194|NCT00581867|441767|P2|COMPLETED|First Intervention||15
180195|NCT00581867|441768|P1|COMPLETED|First Intervention||16
180196|NCT00581867|441767|P2|STARTED|First Intervention||15
180197|NCT00581867|441768|P1|STARTED|First Intervention||16
180198|NCT00581919|441776|P1|NOT COMPLETED|Overall Study||24
180199|NCT00581919|441776|P1|COMPLETED|Overall Study||8
180200|NCT00581919|441776|P1|STARTED|Overall Study||32
180201|NCT00581945|441784|P2|NOT COMPLETED|Overall Study||10
180202|NCT00581945|441785|P1|NOT COMPLETED|Overall Study||9
180203|NCT00581945|441784|P2|COMPLETED|Overall Study||63
180204|NCT00581945|441785|P1|COMPLETED|Overall Study||65
180205|NCT00581945|441784|P2|STARTED|Overall Study||73
180206|NCT00581945|441785|P1|STARTED|Overall Study||74
180207|NCT00581971|441801|P1|NOT COMPLETED|Overall Study||0
180208|NCT00581971|441801|P1|COMPLETED|Overall Study||30
180209|NCT00581971|441801|P1|STARTED|Overall Study||30
180210|NCT00582010|441808|P2|NOT COMPLETED|Overall Study||1
180211|NCT00582010|441809|P1|NOT COMPLETED|Overall Study||0
180212|NCT00582010|441808|P2|COMPLETED|Overall Study||39
180213|NCT00582010|441809|P1|COMPLETED|Overall Study||40
180214|NCT00582010|441808|P2|STARTED|Overall Study||40
180215|NCT00582010|441809|P1|STARTED|Overall Study||40
180216|NCT00582036|441833|P2|NOT COMPLETED|Overall Study||1
180217|NCT00582036|441834|P1|NOT COMPLETED|Overall Study||0
180218|NCT00582036|441833|P2|COMPLETED|Overall Study|One patient withdrew consent|5
180219|NCT00582036|441834|P1|COMPLETED|Overall Study||5
180220|NCT00582036|441833|P2|STARTED|Overall Study||6
180221|NCT00582036|441834|P1|STARTED|Overall Study||5
180222|NCT00582075|441840|P1|NOT COMPLETED|Overall Study||0
180223|NCT00582075|441840|P1|COMPLETED|Overall Study||25
180224|NCT00582075|441840|P1|STARTED|Overall Study||25
180225|NCT00582114|441847|P2|NOT COMPLETED|Overall Study||54
180226|NCT00582114|441848|P1|NOT COMPLETED|Overall Study||42
180227|NCT00582114|441847|P2|COMPLETED|Overall Study||46
180228|NCT00582114|441848|P1|COMPLETED|Overall Study||58
180229|NCT00582114|441847|P2|STARTED|Overall Study||100
180230|NCT00582114|441848|P1|STARTED|Overall Study||100
180231|NCT00582205|441856|P1|NOT COMPLETED|Overall Study||10
180232|NCT00582205|441856|P1|COMPLETED|Overall Study||11
180233|NCT00582205|441856|P1|STARTED|Overall Study||21
180234|NCT00582309|441864|P3|NOT COMPLETED|Overall Study||2
180235|NCT00582309|441865|P2|NOT COMPLETED|Overall Study||0
180236|NCT00582309|441866|P1|NOT COMPLETED|Overall Study||0
180237|NCT00582309|441864|P3|COMPLETED|Overall Study|2 did not have enough data collected to be used|44
180238|NCT00582309|441865|P2|COMPLETED|Overall Study||49
180239|NCT00582309|441866|P1|COMPLETED|Overall Study||56
180240|NCT00582309|441864|P3|STARTED|Overall Study||46
180241|NCT00582309|441865|P2|STARTED|Overall Study||49
180242|NCT00582309|441866|P1|STARTED|Overall Study||56
180243|NCT00582361|441876|P2|NOT COMPLETED|Overall Study||0
180244|NCT00582361|441877|P1|NOT COMPLETED|Overall Study||0
180245|NCT00582361|441876|P2|COMPLETED|Overall Study||38
180246|NCT00582361|441877|P1|COMPLETED|Overall Study||25
180247|NCT00582361|441876|P2|STARTED|Overall Study||38
180248|NCT00582361|441877|P1|STARTED|Overall Study||25
180249|NCT00582400|441885|P1|NOT COMPLETED|Overall Study||3
180250|NCT00582400|441885|P1|COMPLETED|Overall Study||6
180251|NCT00582400|441885|P1|STARTED|Overall Study||9
180252|NCT00582426|441894|P2|NOT COMPLETED|Overall Study||13
180253|NCT00582426|441895|P1|NOT COMPLETED|Overall Study||20
180254|NCT00582426|441894|P2|COMPLETED|Overall Study||58
180255|NCT00582426|441895|P1|COMPLETED|Overall Study||48
180256|NCT00582426|441894|P2|STARTED|Overall Study||71
180257|NCT00582426|441895|P1|STARTED|Overall Study|"Patient in both arms belongs to started indicates safety and intent to treat (ITT) populations."|68
180258|NCT00589550|441921|P1|NOT COMPLETED|Overall Study||1
180259|NCT00589550|441921|P1|COMPLETED|Overall Study||0
180260|NCT00589550|441921|P1|Withdrew From Study|Overall Study||1
180261|NCT00589550|441921|P1|STARTED|Overall Study||1
180262|NCT00589563|441931|P1|NOT COMPLETED|Overall Study||0
180263|NCT00589563|441931|P1|COMPLETED|Overall Study||32
180264|NCT00589563|441931|P1|STARTED|Overall Study||32
180265|NCT00589602|441948|P1|NOT COMPLETED|Overall Study||1
180266|NCT00589602|441948|P1|COMPLETED|Overall Study||12
180267|NCT00589602|441948|P1|STARTED|Overall Study||13
180268|NCT00589628|441958|P2|NOT COMPLETED|Overall Study||1
180269|NCT00589628|441959|P1|NOT COMPLETED|Overall Study||0
180270|NCT00589628|441958|P2|COMPLETED|Overall Study||5
180271|NCT00589628|441959|P1|COMPLETED|Overall Study||7
180272|NCT00589628|441958|P2|STARTED|Overall Study||6
180273|NCT00589628|441959|P1|STARTED|Overall Study||7
180274|NCT00589667|441965|P1|NOT COMPLETED|Overall Study||3
180275|NCT00589667|441965|P1|COMPLETED|Overall Study||23
180276|NCT00589667|441965|P1|STARTED|Overall Study||26
180277|NCT00589693|441972|P2|NOT COMPLETED|Overall Study||29
180278|NCT00589693|441973|P1|NOT COMPLETED|Overall Study||44
180279|NCT00589693|441972|P2|COMPLETED|Overall Study||83
180280|NCT00589693|441973|P1|COMPLETED|Overall Study||71
180281|NCT00589693|441972|P2|STARTED|Overall Study||112
180282|NCT00589693|441973|P1|STARTED|Overall Study||115
180283|NCT00589784|441989|P2|NOT COMPLETED|Overall Study||10
180284|NCT00589784|441990|P1|NOT COMPLETED|Overall Study||1
180285|NCT00589784|441989|P2|COMPLETED|Overall Study||4
180286|NCT00589784|441990|P1|COMPLETED|Overall Study||35
180287|NCT00589784|441989|P2|STARTED|Overall Study||14
180288|NCT00589784|441990|P1|STARTED|Overall Study||36
180289|NCT00593320|441997|P2|NOT COMPLETED|Overall Study||0
180290|NCT00593320|441998|P1|NOT COMPLETED|Overall Study||0
180291|NCT00593320|441997|P2|COMPLETED|Overall Study||1
180292|NCT00593320|441998|P1|COMPLETED|Overall Study||1
180293|NCT00593320|441997|P2|STARTED|Overall Study||1
180294|NCT00593320|441998|P1|STARTED|Overall Study||1
180295|NCT00593333|442012|P2|NOT COMPLETED|Overall Study||11
180296|NCT00593333|442013|P1|NOT COMPLETED|Overall Study||10
180297|NCT00593333|442012|P2|COMPLETED|Overall Study||45
180298|NCT00593333|442013|P1|COMPLETED|Overall Study||44
180299|NCT00593333|442012|P2|STARTED|Overall Study||56
180300|NCT00593333|442013|P1|STARTED|Overall Study||54
180301|NCT00593346|442019|P1|NOT COMPLETED|Overall Study||0
180302|NCT00593346|442019|P1|COMPLETED|Overall Study||151
180303|NCT00593346|442019|P1|STARTED|Overall Study||151
180304|NCT00593372|442036|P2|NOT COMPLETED|Overall Study||0
180305|NCT00593372|442037|P1|NOT COMPLETED|Overall Study||0
180306|NCT00593372|442036|P2|COMPLETED|Overall Study|Three evaluated and completed protocol.|3
180307|NCT00593372|442037|P1|COMPLETED|Overall Study|Eight completed behavioral treatment.|8
180308|NCT00593372|442036|P2|STARTED|Overall Study|Three evaluated but only maintained medical treatment.|3
180309|NCT00593372|442037|P1|STARTED|Overall Study|Eight enrolled in behavioral treatment.|8
180310|NCT00593450|442047|P4|NOT COMPLETED|Overall Study||29
180311|NCT00593450|442048|P3|NOT COMPLETED|Overall Study||13
180312|NCT00593450|442049|P2|NOT COMPLETED|Overall Study||21
180313|NCT00593450|442050|P1|NOT COMPLETED|Overall Study||17
180314|NCT00593450|442047|P4|COMPLETED|Overall Study||271
180315|NCT00593450|442048|P3|COMPLETED|Overall Study||285
180316|NCT00593450|442049|P2|COMPLETED|Overall Study||265
180317|NCT00593450|442050|P1|COMPLETED|Overall Study||284
180318|NCT00593450|442047|P4|STARTED|Overall Study||300
180319|NCT00593450|442048|P3|STARTED|Overall Study||298
180320|NCT00593450|442049|P2|STARTED|Overall Study||286
180321|NCT00593450|442050|P1|STARTED|Overall Study||301
180322|NCT00593606|442120|P1|NOT COMPLETED|Overall Study||27
180323|NCT00593606|442120|P1|COMPLETED|Overall Study||97
180324|NCT00593606|442120|P1|Treatment Period Completed|Overall Study||99
180325|NCT00593606|442120|P1|Full Analysis Set|Overall Study||114
180326|NCT00593606|442120|P1|Start of Treatment - Safety Set|Overall Study||116
180327|NCT00593606|442120|P1|STARTED|Overall Study||124
180328|NCT00593645|442216|P1|NOT COMPLETED|Overall Study||0
180329|NCT00593645|442216|P1|COMPLETED|Overall Study||7
180330|NCT00593645|442216|P1|STARTED|Overall Study||7
180331|NCT00593684|442232|P2|NOT COMPLETED|Overall Study||1
180332|NCT00593684|442233|P1|NOT COMPLETED|Overall Study||2
180333|NCT00593684|442232|P2|COMPLETED|Overall Study||24
180334|NCT00593684|442233|P1|COMPLETED|Overall Study||23
180335|NCT00593684|442232|P2|STARTED|Overall Study||25
180336|NCT00593684|442233|P1|STARTED|Overall Study||25
180337|NCT00593736|442249|P4|NOT COMPLETED|Treatment Period and Placebo Run-out||4
180338|NCT00593736|442250|P3|NOT COMPLETED|Treatment Period and Placebo Run-out||5
180339|NCT00593736|442251|P2|NOT COMPLETED|Treatment Period and Placebo Run-out||2
180340|NCT00593736|442252|P1|NOT COMPLETED|Treatment Period and Placebo Run-out||3
180341|NCT00593736|442249|P4|COMPLETED|Treatment Period and Placebo Run-out||28
180342|NCT00593736|442250|P3|COMPLETED|Treatment Period and Placebo Run-out||30
180343|NCT00593736|442251|P2|COMPLETED|Treatment Period and Placebo Run-out||31
180344|NCT00593736|442252|P1|COMPLETED|Treatment Period and Placebo Run-out||29
180345|NCT00593736|442249|P4|STARTED|Treatment Period and Placebo Run-out||32
180346|NCT00593736|442250|P3|STARTED|Treatment Period and Placebo Run-out||35
180347|NCT00593736|442251|P2|STARTED|Treatment Period and Placebo Run-out||33
180348|NCT00593736|442252|P1|STARTED|Treatment Period and Placebo Run-out||32
180349|NCT00593736|442249|P4|NOT COMPLETED|Screening Period and Placebo Run-in||417
180350|NCT00593736|442250|P3|NOT COMPLETED|Screening Period and Placebo Run-in||0
180351|NCT00593736|442251|P2|NOT COMPLETED|Screening Period and Placebo Run-in||0
180352|NCT00593736|442252|P1|NOT COMPLETED|Screening Period and Placebo Run-in||0
180353|NCT00593736|442249|P4|COMPLETED|Screening Period and Placebo Run-in||132
180354|NCT00593736|442250|P3|COMPLETED|Screening Period and Placebo Run-in||0
180355|NCT00593736|442251|P2|COMPLETED|Screening Period and Placebo Run-in||0
180356|NCT00593736|442252|P1|COMPLETED|Screening Period and Placebo Run-in||0
180357|NCT00593736|442249|P4|STARTED|Screening Period and Placebo Run-in||549
180358|NCT00593736|442250|P3|STARTED|Screening Period and Placebo Run-in||0
180359|NCT00593736|442251|P2|STARTED|Screening Period and Placebo Run-in||0
180360|NCT00593736|442252|P1|STARTED|Screening Period and Placebo Run-in||0
180361|NCT00593814|442500|P2|NOT COMPLETED|Overall Study||0
180362|NCT00593814|442501|P1|NOT COMPLETED|Overall Study||24
180363|NCT00593814|442500|P2|COMPLETED|Overall Study||120
180364|NCT00593814|442501|P1|COMPLETED|Overall Study||115
180365|NCT00593814|442500|P2|STARTED|Overall Study||120
180366|NCT00593814|442501|P1|STARTED|Overall Study||139
180367|NCT00593827|442509|P2|NOT COMPLETED|Overall Study||2
180368|NCT00593827|442510|P1|NOT COMPLETED|Overall Study||0
180369|NCT00593827|442509|P2|COMPLETED|Overall Study|Completed=off-study (Major reasons: AEs=30; disease progression=55; not treated=2).|89
180370|NCT00593827|442510|P1|COMPLETED|Overall Study|Completed=off-study (Major reasons: Adverse events (AE)=15; disease progression=76; not treated=3).|85
180371|NCT00593827|442509|P2|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|89
180372|NCT00593827|442510|P1|Evaluable Population|Overall Study|Treated participants with CR, PR, SD, PD, or NE response. Refer outcome measure 3 and 4 for details.|79
180373|NCT00593827|442509|P2|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|89
180374|NCT00593827|442510|P1|Safety Population|Overall Study|Participants (eligible and ineligible) who received at least 1 dose of study drug.|82
180375|NCT00593827|442509|P2|STARTED|Overall Study|ITT Population: Participants who were randomized (eligible and ineligible).|91
180376|NCT00593827|442510|P1|STARTED|Overall Study|Intent-to-Treat (ITT) Population: Participants who were randomized (eligible and ineligible).|85
180377|NCT00593840|442532|P1|NOT COMPLETED|Overall Study||1
180378|NCT00593840|442532|P1|COMPLETED|Overall Study||72
180379|NCT00593840|442532|P1|STARTED|Overall Study||73
180380|NCT00593866|442542|P1|NOT COMPLETED|Overall Study||0
180381|NCT00593866|442542|P1|COMPLETED|Overall Study||50
180382|NCT00593866|442542|P1|STARTED|Overall Study||50
180383|NCT00593918|442549|P2|NOT COMPLETED|Overall Study||24
180384|NCT00593918|442550|P1|NOT COMPLETED|Overall Study||5
180385|NCT00593918|442549|P2|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|50
180386|NCT00593918|442550|P1|COMPLETED|Overall Study|Some children did not come in for the blood draw at visit 2|12
180387|NCT00593918|442549|P2|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/AG and AA genotypes|74
180388|NCT00593918|442550|P1|STARTED|Overall Study|Number of children with Toll-like Receptor 4 (TLR4) -2026/GG Genotype|17
180389|NCT00593957|442561|P3|NOT COMPLETED|Overall Study||2
180390|NCT00593957|442562|P2|NOT COMPLETED|Overall Study||1
180391|NCT00593957|442563|P1|NOT COMPLETED|Overall Study||0
180392|NCT00593957|442561|P3|COMPLETED|Overall Study||10
180393|NCT00593957|442562|P2|COMPLETED|Overall Study||12
180394|NCT00593957|442563|P1|COMPLETED|Overall Study||13
180395|NCT00593957|442561|P3|STARTED|Overall Study||12
180396|NCT00593957|442562|P2|STARTED|Overall Study||13
180397|NCT00593957|442563|P1|STARTED|Overall Study||13
180398|NCT00594022|442587|P2|NOT COMPLETED|Overall Study||0
180399|NCT00594022|442588|P1|NOT COMPLETED|Overall Study||0
180400|NCT00594022|442587|P2|COMPLETED|Overall Study||173
180401|NCT00594022|442588|P1|COMPLETED|Overall Study||176
180402|NCT00594022|442587|P2|STARTED|Overall Study||173
180403|NCT00594022|442588|P1|STARTED|Overall Study||176
180404|NCT00594035|442604|P2|NOT COMPLETED|Overall Study||3
180405|NCT00594035|442605|P1|NOT COMPLETED|Overall Study||2
180406|NCT00594035|442604|P2|COMPLETED|Overall Study|53 control group subjects were evaluable at the 90-day visit|53
180407|NCT00594035|442605|P1|COMPLETED|Overall Study|100 Spinal Sealant subjects were evaluable at the 90-day visit|100
180408|NCT00594035|442604|P2|STARTED|Overall Study|56 subjects were randomized to the control group (standard of care)|56
180409|NCT00594035|442605|P1|STARTED|Overall Study|102 subjects were randomized to Spinal Sealant|102
180410|NCT00594100|442611|P1|NOT COMPLETED|Follow-up Through 30 Days Post Procedure||12
180411|NCT00594100|442611|P1|COMPLETED|Follow-up Through 30 Days Post Procedure||224
180412|NCT00594100|442611|P1|STARTED|Follow-up Through 30 Days Post Procedure||236
180413|NCT00594100|442611|P1|NOT COMPLETED|Procedure||9
180414|NCT00594100|442611|P1|COMPLETED|Procedure||236
180415|NCT00594100|442611|P1|STARTED|Procedure||245
180416|NCT00594165|442620|P1|NOT COMPLETED|Overall Study||217
180499|NCT00594568|442841|P3|COMPLETED|Safety Follow Up (SFU)-Optional||172
180417|NCT00594165|442620|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
180418|NCT00594165|442620|P1|STARTED|Overall Study||217
180419|NCT00594178|442626|P1|NOT COMPLETED|Overall Study||5
180420|NCT00594178|442626|P1|COMPLETED|Overall Study||12
180421|NCT00594178|442626|P1|STARTED|Overall Study||17
180422|NCT00594204|442633|P2|NOT COMPLETED|Overall Study||45
180423|NCT00594204|442634|P1|NOT COMPLETED|Overall Study||58
180424|NCT00594204|442633|P2|COMPLETED|Overall Study||154
180425|NCT00594204|442634|P1|COMPLETED|Overall Study||336
180426|NCT00594204|442633|P2|Received Treatment|Overall Study||198
180427|NCT00594204|442634|P1|Received Treatment|Overall Study||390
180428|NCT00594204|442633|P2|STARTED|Overall Study||199
180429|NCT00594204|442634|P1|STARTED|Overall Study||394
180430|NCT00594230|442646|P2|NOT COMPLETED|Overall Study||9
180431|NCT00594230|442647|P1|NOT COMPLETED|Overall Study||15
180432|NCT00594230|442646|P2|COMPLETED|Overall Study||1
180433|NCT00594230|442647|P1|COMPLETED|Overall Study||1
180434|NCT00594230|442646|P2|STARTED|Overall Study||10
180435|NCT00594230|442647|P1|STARTED|Overall Study||16
180436|NCT00594256|442653|P1|NOT COMPLETED|Overall Study||0
180437|NCT00594256|442653|P1|COMPLETED|Overall Study||8
180438|NCT00594256|442653|P1|STARTED|Overall Study||8
180439|NCT00594308|442661|P1|NOT COMPLETED|Overall Study||0
180440|NCT00594308|442661|P1|COMPLETED|Overall Study||10
180441|NCT00594308|442661|P1|STARTED|Overall Study||10
180442|NCT00594386|442669|P1|NOT COMPLETED|Overall Study||258
180443|NCT00594386|442669|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
180444|NCT00594386|442669|P1|STARTED|Overall Study||258
180445|NCT00594399|442677|P3|NOT COMPLETED|Rerandomization Arm 1 Only||0
180446|NCT00594399|442678|P2|NOT COMPLETED|Rerandomization Arm 1 Only||4
180447|NCT00594399|442679|P1|NOT COMPLETED|Rerandomization Arm 1 Only||2
180448|NCT00594399|442677|P3|COMPLETED|Rerandomization Arm 1 Only||82
180449|NCT00594399|442678|P2|COMPLETED|Rerandomization Arm 1 Only||114
180450|NCT00594399|442679|P1|COMPLETED|Rerandomization Arm 1 Only||79
180451|NCT00594399|442677|P3|Rerandomization|Rerandomization Arm 1 Only||82
180452|NCT00594399|442678|P2|Rerandomization|Rerandomization Arm 1 Only||114
180453|NCT00594399|442679|P1|Rerandomization|Rerandomization Arm 1 Only|Rerandomized to continue to receive telephone calls every 2 weeks or at a reduced dose of 1/ month|81
180534|NCT00594659|442941|P1|COMPLETED|Overall Study||16
180454|NCT00594399|442677|P3|STARTED|Rerandomization Arm 1 Only|This sample reflects newly randomized study Arm|82
180455|NCT00594399|442678|P2|STARTED|Rerandomization Arm 1 Only||118
180456|NCT00594399|442679|P1|STARTED|Rerandomization Arm 1 Only|Total sample in Arm 1 was rerandomized and allocated to remain in Arm 1 or assigned to Arm 3|81
180457|NCT00594399|442677|P3|NOT COMPLETED|Initial 3 Month Counseling||0
180458|NCT00594399|442678|P2|NOT COMPLETED|Initial 3 Month Counseling||4
180459|NCT00594399|442679|P1|NOT COMPLETED|Initial 3 Month Counseling||17
180460|NCT00594399|442677|P3|COMPLETED|Initial 3 Month Counseling||0
180461|NCT00594399|442678|P2|COMPLETED|Initial 3 Month Counseling||118
180462|NCT00594399|442679|P1|COMPLETED|Initial 3 Month Counseling||163
180463|NCT00594399|442677|P3|STARTED|Initial 3 Month Counseling||0
180464|NCT00594399|442678|P2|STARTED|Initial 3 Month Counseling||122
180465|NCT00594399|442679|P1|STARTED|Initial 3 Month Counseling||180
180466|NCT00594425|442704|P3|NOT COMPLETED|Overall Study||10
180467|NCT00594425|442705|P2|NOT COMPLETED|Overall Study||14
180468|NCT00594425|442706|P1|NOT COMPLETED|Overall Study||7
180469|NCT00594425|442704|P3|COMPLETED|Overall Study||42
180470|NCT00594425|442705|P2|COMPLETED|Overall Study||34
180471|NCT00594425|442706|P1|COMPLETED|Overall Study||43
180472|NCT00594425|442704|P3|STARTED|Overall Study||52
180473|NCT00594425|442705|P2|STARTED|Overall Study||48
180474|NCT00594425|442706|P1|STARTED|Overall Study||50
180475|NCT00594464|442816|P1|NOT COMPLETED|Overall Study||3
180476|NCT00594464|442816|P1|COMPLETED|Overall Study||11
180477|NCT00594464|442816|P1|STARTED|Overall Study||14
180478|NCT00594516|442828|P3|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||8
180479|NCT00594516|442829|P2|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||7
180480|NCT00594516|442830|P1|NOT COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
180481|NCT00594516|442828|P3|COMPLETED|DB: Tapentadol IR to ER & ER to IR||35
180482|NCT00594516|442829|P2|COMPLETED|DB: Tapentadol IR to ER & ER to IR||37
180483|NCT00594516|442830|P1|COMPLETED|DB: Tapentadol IR to ER & ER to IR||0
180484|NCT00594516|442828|P3|STARTED|DB: Tapentadol IR to ER & ER to IR||43
180485|NCT00594516|442829|P2|STARTED|DB: Tapentadol IR to ER & ER to IR||44
180486|NCT00594516|442830|P1|STARTED|DB: Tapentadol IR to ER & ER to IR||0
180487|NCT00594516|442828|P3|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
180488|NCT00594516|442829|P2|NOT COMPLETED|Open Label (OL): Tapentadol IR||0
180489|NCT00594516|442830|P1|NOT COMPLETED|Open Label (OL): Tapentadol IR||29
180490|NCT00594516|442828|P3|COMPLETED|Open Label (OL): Tapentadol IR||0
180491|NCT00594516|442829|P2|COMPLETED|Open Label (OL): Tapentadol IR||0
180492|NCT00594516|442830|P1|COMPLETED|Open Label (OL): Tapentadol IR||87
180493|NCT00594516|442828|P3|STARTED|Open Label (OL): Tapentadol IR||0
180494|NCT00594516|442829|P2|STARTED|Open Label (OL): Tapentadol IR||0
180495|NCT00594516|442830|P1|STARTED|Open Label (OL): Tapentadol IR|one patient was enrolled but lost to follow up at the start of open label therefore was not included|116
180496|NCT00594568|442841|P3|NOT COMPLETED|Safety Follow Up (SFU)-Optional||42
180497|NCT00594568|442842|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||55
180498|NCT00594568|442843|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||61
180500|NCT00594568|442842|P2|COMPLETED|Safety Follow Up (SFU)-Optional||168
180501|NCT00594568|442843|P1|COMPLETED|Safety Follow Up (SFU)-Optional||229
180502|NCT00594568|442841|P3|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional, pts entered from initial treatment and delayed start or did not enter SFU.|214
180503|NCT00594568|442842|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|223
180504|NCT00594568|442843|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|290
180505|NCT00594568|442841|P3|NOT COMPLETED|Delayed Start||66
180506|NCT00594568|442842|P2|NOT COMPLETED|Delayed Start||77
180507|NCT00594568|442843|P1|NOT COMPLETED|Delayed Start||98
180508|NCT00594568|442841|P3|COMPLETED|Delayed Start||55
180509|NCT00594568|442842|P2|COMPLETED|Delayed Start||76
180510|NCT00594568|442843|P1|COMPLETED|Delayed Start||91
180511|NCT00594568|442841|P3|STARTED|Delayed Start||121
180512|NCT00594568|442842|P2|STARTED|Delayed Start||153
180513|NCT00594568|442843|P1|STARTED|Delayed Start||189
180514|NCT00594568|442841|P3|NOT COMPLETED|Initial Treatment||408
180515|NCT00594568|442842|P2|NOT COMPLETED|Initial Treatment||354
180516|NCT00594568|442843|P1|NOT COMPLETED|Initial Treatment||312
180517|NCT00594568|442841|P3|COMPLETED|Initial Treatment||121
180518|NCT00594568|442842|P2|COMPLETED|Initial Treatment||153
180519|NCT00594568|442843|P1|COMPLETED|Initial Treatment||189
180520|NCT00594568|442841|P3|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|527
180521|NCT00594568|442842|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who had at least 1 dose of study drug.|506
180522|NCT00594568|442843|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants (pts) who had at least 1 dose of study drug.|501
180523|NCT00594568|442841|P3|STARTED|Initial Treatment||529
180524|NCT00594568|442842|P2|STARTED|Initial Treatment||507
180525|NCT00594568|442843|P1|STARTED|Initial Treatment||501
180526|NCT00594646|442931|P1|NOT COMPLETED|Overall Study||16
180527|NCT00594646|442931|P1|COMPLETED|Overall Study||84
180528|NCT00594646|442931|P1|STARTED|Overall Study||100
180529|NCT00594659|442939|P3|NOT COMPLETED|Overall Study||7
180530|NCT00594659|442940|P2|NOT COMPLETED|Overall Study||9
180531|NCT00594659|442941|P1|NOT COMPLETED|Overall Study||13
180532|NCT00594659|442939|P3|COMPLETED|Overall Study||9
180533|NCT00594659|442940|P2|COMPLETED|Overall Study||21
180535|NCT00594659|442939|P3|STARTED|Overall Study||16
180536|NCT00594659|442940|P2|STARTED|Overall Study||30
180537|NCT00594659|442941|P1|STARTED|Overall Study||29
180538|NCT00594685|442952|P1|NOT COMPLETED|Overall Study||0
180539|NCT00594685|442952|P1|COMPLETED|Overall Study||10
180540|NCT00594685|442952|P1|STARTED|Overall Study||10
180541|NCT00594815|442969|P1|NOT COMPLETED|Overall Study||9
180542|NCT00594815|442969|P1|COMPLETED|Overall Study||43
180543|NCT00594815|442969|P1|STARTED|Overall Study||52
180544|NCT00594854|442976|P2|NOT COMPLETED|Overall Study||10
180545|NCT00594854|442977|P1|NOT COMPLETED|Overall Study||7
180546|NCT00594854|442976|P2|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|1
180547|NCT00594854|442977|P1|COMPLETED|Overall Study|POZEN reached an agreement with the FDA to terminate the study due to low and inadequate enrollment.|2
180548|NCT00594854|442976|P2|STARTED|Overall Study||11
180549|NCT00594854|442977|P1|STARTED|Overall Study||9
180550|NCT00594880|442989|P2|NOT COMPLETED|Overall Study||1
180551|NCT00594880|442990|P1|NOT COMPLETED|Overall Study||2
180552|NCT00594880|442989|P2|COMPLETED|Overall Study||10
180553|NCT00594880|442990|P1|COMPLETED|Overall Study||10
180554|NCT00594880|442989|P2|STARTED|Overall Study||11
180555|NCT00594880|442990|P1|STARTED|Overall Study||12
180556|NCT00594906|443002|P2|NOT COMPLETED|Overall Study||2
180557|NCT00594906|443003|P1|NOT COMPLETED|Overall Study||1
180558|NCT00594906|443002|P2|COMPLETED|Overall Study||1
180559|NCT00594906|443003|P1|COMPLETED|Overall Study||6
180560|NCT00594906|443002|P2|STARTED|Overall Study||3
180561|NCT00594906|443003|P1|STARTED|Overall Study||7
180562|NCT00594945|443012|P3|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
180563|NCT00594945|443013|P2|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
180564|NCT00594945|443014|P1|NOT COMPLETED|Cohort 2 / Treatment Period 2||0
180565|NCT00594945|443012|P3|COMPLETED|Cohort 2 / Treatment Period 2||2
180566|NCT00594945|443013|P2|COMPLETED|Cohort 2 / Treatment Period 2||3
180567|NCT00594945|443014|P1|COMPLETED|Cohort 2 / Treatment Period 2||0
180568|NCT00594945|443012|P3|STARTED|Cohort 2 / Treatment Period 2||2
180569|NCT00594945|443013|P2|STARTED|Cohort 2 / Treatment Period 2||3
180570|NCT00594945|443014|P1|STARTED|Cohort 2 / Treatment Period 2||0
180571|NCT00594945|443012|P3|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
180572|NCT00594945|443013|P2|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
180573|NCT00594945|443014|P1|NOT COMPLETED|Cohort 1 / Treatment Period 1||0
180574|NCT00594945|443012|P3|COMPLETED|Cohort 1 / Treatment Period 1||2
180575|NCT00594945|443013|P2|COMPLETED|Cohort 1 / Treatment Period 1||0
180576|NCT00594945|443014|P1|COMPLETED|Cohort 1 / Treatment Period 1||4
180577|NCT00594945|443012|P3|STARTED|Cohort 1 / Treatment Period 1||2
180578|NCT00594945|443013|P2|STARTED|Cohort 1 / Treatment Period 1||0
180579|NCT00594945|443014|P1|STARTED|Cohort 1 / Treatment Period 1||4
180580|NCT00594958|443023|P3|NOT COMPLETED|Overall Study||10
180581|NCT00594958|443024|P2|NOT COMPLETED|Overall Study||3
180582|NCT00594958|443025|P1|NOT COMPLETED|Overall Study||14
180583|NCT00594958|443023|P3|COMPLETED|Overall Study||202
180584|NCT00594958|443024|P2|COMPLETED|Overall Study||210
180585|NCT00594958|443025|P1|COMPLETED|Overall Study||200
180586|NCT00594958|443023|P3|Randomized and at Least 1 Vaccination|Overall Study||211
180587|NCT00594958|443024|P2|Randomized and at Least 1 Vaccination|Overall Study||213
180588|NCT00594958|443025|P1|Randomized and at Least 1 Vaccination|Overall Study||212
180589|NCT00594958|443023|P3|STARTED|Overall Study||212
180590|NCT00594958|443024|P2|STARTED|Overall Study||213
180591|NCT00594958|443025|P1|STARTED|Overall Study||214
180592|NCT00595075|443035|P2|NOT COMPLETED|Overall Study||0
180593|NCT00595075|443036|P1|NOT COMPLETED|Overall Study||1
180594|NCT00595075|443035|P2|COMPLETED|Overall Study||5
180595|NCT00595075|443036|P1|COMPLETED|Overall Study||5
180596|NCT00595075|443035|P2|STARTED|Overall Study||5
180597|NCT00595075|443036|P1|STARTED|Overall Study||6
180598|NCT00595088|443054|P1|NOT COMPLETED|Overall Study||40
180599|NCT00595088|443054|P1|COMPLETED|Overall Study|5 patients ongoing, 7 completed the study (week 46)and 35 withdrew prematurely|7
180600|NCT00595088|443054|P1|STARTED|Overall Study||47
180601|NCT00595114|443063|P2|NOT COMPLETED|Overall Study||0
180602|NCT00595114|443064|P1|NOT COMPLETED|Overall Study||0
180603|NCT00595114|443063|P2|COMPLETED|Overall Study||19
180604|NCT00595114|443064|P1|COMPLETED|Overall Study||24
180605|NCT00595114|443063|P2|STARTED|Overall Study||19
180606|NCT00595114|443064|P1|STARTED|Overall Study||24
180607|NCT00595127|443070|P1|NOT COMPLETED|Overall Study||10
180608|NCT00595127|443070|P1|COMPLETED|Overall Study||11
180609|NCT00595127|443070|P1|STARTED|Overall Study||21
180610|NCT00595153|443077|P3|NOT COMPLETED|Overall Study||25
180611|NCT00595153|443078|P2|NOT COMPLETED|Overall Study||16
180612|NCT00595153|443079|P1|NOT COMPLETED|Overall Study||4
180613|NCT00595153|443077|P3|COMPLETED|Overall Study||36
180614|NCT00595153|443078|P2|COMPLETED|Overall Study||26
180615|NCT00595153|443079|P1|COMPLETED|Overall Study||20
180616|NCT00595153|443077|P3|STARTED|Overall Study||61
180617|NCT00595153|443078|P2|STARTED|Overall Study||42
180618|NCT00595153|443079|P1|STARTED|Overall Study||24
180619|NCT00595270|443090|P3|NOT COMPLETED|Overall Study||8
180620|NCT00595270|443091|P2|NOT COMPLETED|Overall Study||10
180621|NCT00595270|443092|P1|NOT COMPLETED|Overall Study||6
180622|NCT00595270|443090|P3|COMPLETED|Overall Study||108
180623|NCT00595270|443091|P2|COMPLETED|Overall Study||107
180624|NCT00595270|443092|P1|COMPLETED|Overall Study||110
180625|NCT00595270|443090|P3|STARTED|Overall Study||116
180626|NCT00595270|443091|P2|STARTED|Overall Study||117
180627|NCT00595270|443092|P1|STARTED|Overall Study||116
180628|NCT00595309|443100|P1|NOT COMPLETED|Overall Study||4
180629|NCT00595309|443100|P1|COMPLETED|Overall Study||194
180630|NCT00595309|443100|P1|STARTED|Overall Study||198
180631|NCT00595335|443106|P2|NOT COMPLETED|Six Months to Twelve Months||1
180632|NCT00595335|443107|P1|NOT COMPLETED|Six Months to Twelve Months||1
180633|NCT00595335|443106|P2|COMPLETED|Six Months to Twelve Months||9
180634|NCT00595335|443107|P1|COMPLETED|Six Months to Twelve Months||10
180635|NCT00595335|443106|P2|STARTED|Six Months to Twelve Months||10
180636|NCT00595335|443107|P1|STARTED|Six Months to Twelve Months||11
180637|NCT00595335|443106|P2|NOT COMPLETED|Baseline to Six Months||2
180638|NCT00595335|443107|P1|NOT COMPLETED|Baseline to Six Months||2
180639|NCT00595335|443106|P2|COMPLETED|Baseline to Six Months||10
180640|NCT00595335|443107|P1|COMPLETED|Baseline to Six Months||11
180641|NCT00595335|443106|P2|STARTED|Baseline to Six Months||12
180642|NCT00595335|443107|P1|STARTED|Baseline to Six Months||13
180643|NCT00595361|443129|P2|NOT COMPLETED|Overall Study||0
180644|NCT00595361|443130|P1|NOT COMPLETED|Overall Study||0
180645|NCT00595361|443129|P2|COMPLETED|Overall Study||18
180646|NCT00595361|443130|P1|COMPLETED|Overall Study||12
180647|NCT00595361|443129|P2|STARTED|Overall Study||18
180648|NCT00595361|443130|P1|STARTED|Overall Study||12
180649|NCT00595413|443144|P4|NOT COMPLETED|Overall Study||4
180650|NCT00595413|443145|P3|NOT COMPLETED|Overall Study||8
180651|NCT00595413|443146|P2|NOT COMPLETED|Overall Study||5
180652|NCT00595413|443147|P1|NOT COMPLETED|Overall Study||7
180653|NCT00595413|443144|P4|COMPLETED|Overall Study||75
180654|NCT00595413|443145|P3|COMPLETED|Overall Study||70
180655|NCT00595413|443146|P2|COMPLETED|Overall Study||73
180656|NCT00595413|443147|P1|COMPLETED|Overall Study||69
180657|NCT00595413|443144|P4|STARTED|Overall Study||79
180658|NCT00595413|443145|P3|STARTED|Overall Study||78
180659|NCT00595413|443146|P2|STARTED|Overall Study||78
180660|NCT00595413|443147|P1|STARTED|Overall Study||76
180661|NCT00595465|443176|P3|NOT COMPLETED|Overall Study||7
180662|NCT00595465|443177|P2|NOT COMPLETED|Overall Study||4
180663|NCT00595465|443178|P1|NOT COMPLETED|Overall Study||6
180664|NCT00595465|443176|P3|COMPLETED|Overall Study||121
180665|NCT00595465|443177|P2|COMPLETED|Overall Study||125
180666|NCT00595465|443178|P1|COMPLETED|Overall Study||124
180667|NCT00595465|443176|P3|STARTED|Overall Study||128
180668|NCT00595465|443177|P2|STARTED|Overall Study||129
180669|NCT00595465|443178|P1|STARTED|Overall Study||130
180670|NCT00595504|443188|P2|NOT COMPLETED|Overall Study||3
180671|NCT00595504|443189|P1|NOT COMPLETED|Overall Study||2
180672|NCT00595504|443188|P2|COMPLETED|Overall Study||6
180673|NCT00595504|443189|P1|COMPLETED|Overall Study||14
180674|NCT00595504|443188|P2|STARTED|Overall Study||9
180675|NCT00595504|443189|P1|STARTED|Overall Study||16
180676|NCT00595517|443199|P1|NOT COMPLETED|Overall Study||19
180677|NCT00595517|443199|P1|COMPLETED|Overall Study||111
180678|NCT00595517|443199|P1|STARTED|Overall Study||130
180679|NCT00595530|443206|P1|NOT COMPLETED|Overall Study||0
180680|NCT00595530|443206|P1|COMPLETED|Overall Study||3
180681|NCT00595530|443206|P1|STARTED|Overall Study||3
180682|NCT00595556|443212|P2|NOT COMPLETED|Overall Study||1
180683|NCT00595556|443213|P1|NOT COMPLETED|Overall Study||3
180684|NCT00595556|443212|P2|COMPLETED|Overall Study||19
180685|NCT00595556|443213|P1|COMPLETED|Overall Study||17
180686|NCT00595556|443212|P2|STARTED|Overall Study||20
180687|NCT00595556|443213|P1|STARTED|Overall Study||20
180688|NCT00595582|443227|P1|NOT COMPLETED|Overall Study||10
180689|NCT00595582|443227|P1|COMPLETED|Overall Study||0
180690|NCT00595582|443227|P1|STARTED|Overall Study||10
180691|NCT00585351|443237|P8|NOT COMPLETED|Enrollment Period (Intervention)||1
180692|NCT00585351|443238|P7|NOT COMPLETED|Enrollment Period (Intervention)||2
180693|NCT00585351|443239|P6|NOT COMPLETED|Enrollment Period (Intervention)||2
180694|NCT00585351|443240|P5|NOT COMPLETED|Enrollment Period (Intervention)||2
180695|NCT00585351|443241|P4|NOT COMPLETED|Enrollment Period (Intervention)||0
180696|NCT00585351|443242|P3|NOT COMPLETED|Enrollment Period (Intervention)||0
180697|NCT00585351|443243|P2|NOT COMPLETED|Enrollment Period (Intervention)||0
180698|NCT00585351|443244|P1|NOT COMPLETED|Enrollment Period (Intervention)||0
180699|NCT00585351|443237|P8|COMPLETED|Enrollment Period (Intervention)||2
180700|NCT00585351|443238|P7|COMPLETED|Enrollment Period (Intervention)||5
180701|NCT00585351|443239|P6|COMPLETED|Enrollment Period (Intervention)||5
180702|NCT00585351|443240|P5|COMPLETED|Enrollment Period (Intervention)||3
180703|NCT00585351|443241|P4|COMPLETED|Enrollment Period (Intervention)||15
180704|NCT00585351|443242|P3|COMPLETED|Enrollment Period (Intervention)||15
180705|NCT00585351|443243|P2|COMPLETED|Enrollment Period (Intervention)||0
180706|NCT00585351|443244|P1|COMPLETED|Enrollment Period (Intervention)||0
180707|NCT00585351|443237|P8|STARTED|Enrollment Period (Intervention)||3
180708|NCT00585351|443238|P7|STARTED|Enrollment Period (Intervention)||7
180709|NCT00585351|443239|P6|STARTED|Enrollment Period (Intervention)||7
180710|NCT00585351|443240|P5|STARTED|Enrollment Period (Intervention)||5
180711|NCT00585351|443241|P4|STARTED|Enrollment Period (Intervention)||15
180712|NCT00585351|443242|P3|STARTED|Enrollment Period (Intervention)||15
180797|NCT00585637|443303|P3|STARTED|Baseline||83
180713|NCT00585351|443243|P2|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in No Advanced Notification group for this period."|0
180714|NCT00585351|443244|P1|STARTED|Enrollment Period (Intervention)|"Please refer to additional columns for subjects in Advanced Notification group for this period."|0
180715|NCT00585351|443237|P8|NOT COMPLETED|Notification Period (Informed Consent)||0
180716|NCT00585351|443238|P7|NOT COMPLETED|Notification Period (Informed Consent)||0
180717|NCT00585351|443239|P6|NOT COMPLETED|Notification Period (Informed Consent)||0
180718|NCT00585351|443240|P5|NOT COMPLETED|Notification Period (Informed Consent)||0
180719|NCT00585351|443241|P4|NOT COMPLETED|Notification Period (Informed Consent)||0
180720|NCT00585351|443242|P3|NOT COMPLETED|Notification Period (Informed Consent)||0
180721|NCT00585351|443243|P2|NOT COMPLETED|Notification Period (Informed Consent)||25
180722|NCT00585351|443244|P1|NOT COMPLETED|Notification Period (Informed Consent)||23
180723|NCT00585351|443237|P8|COMPLETED|Notification Period (Informed Consent)||0
180724|NCT00585351|443238|P7|COMPLETED|Notification Period (Informed Consent)||0
180725|NCT00585351|443239|P6|COMPLETED|Notification Period (Informed Consent)||0
180726|NCT00585351|443240|P5|COMPLETED|Notification Period (Informed Consent)||0
180727|NCT00585351|443241|P4|COMPLETED|Notification Period (Informed Consent)||0
180728|NCT00585351|443242|P3|COMPLETED|Notification Period (Informed Consent)||0
180729|NCT00585351|443243|P2|COMPLETED|Notification Period (Informed Consent)||25
180730|NCT00585351|443244|P1|COMPLETED|Notification Period (Informed Consent)||27
180731|NCT00585351|443237|P8|STARTED|Notification Period (Informed Consent)||0
180732|NCT00585351|443238|P7|STARTED|Notification Period (Informed Consent)||0
180733|NCT00585351|443239|P6|STARTED|Notification Period (Informed Consent)||0
180734|NCT00585351|443240|P5|STARTED|Notification Period (Informed Consent)||0
180735|NCT00585351|443241|P4|STARTED|Notification Period (Informed Consent)||0
180736|NCT00585351|443242|P3|STARTED|Notification Period (Informed Consent)||0
180737|NCT00585351|443243|P2|STARTED|Notification Period (Informed Consent)||50
180738|NCT00585351|443244|P1|STARTED|Notification Period (Informed Consent)||50
180739|NCT00585377|443258|P1|NOT COMPLETED|Overall Study||0
180740|NCT00585377|443258|P1|COMPLETED|Overall Study||50
180741|NCT00585377|443258|P1|STARTED|Overall Study||50
180742|NCT00585468|443264|P2|NOT COMPLETED|Second Intervention||0
180743|NCT00585468|443265|P1|NOT COMPLETED|Second Intervention||0
180744|NCT00585468|443264|P2|COMPLETED|Second Intervention||10
180745|NCT00585468|443265|P1|COMPLETED|Second Intervention||9
180746|NCT00585468|443264|P2|STARTED|Second Intervention||10
180747|NCT00585468|443265|P1|STARTED|Second Intervention||9
180748|NCT00585468|443264|P2|NOT COMPLETED|First Intervention||1
180749|NCT00585468|443265|P1|NOT COMPLETED|First Intervention||1
180750|NCT00585468|443264|P2|COMPLETED|First Intervention||10
180751|NCT00585468|443265|P1|COMPLETED|First Intervention||9
180752|NCT00585468|443264|P2|STARTED|First Intervention||11
180753|NCT00585468|443265|P1|STARTED|First Intervention||10
180754|NCT00585494|443285|P1|NOT COMPLETED|Overall Study||56
180755|NCT00585494|443285|P1|COMPLETED|Overall Study||244
180756|NCT00585494|443285|P1|STARTED|Overall Study||300
180757|NCT00585533|443289|P1|NOT COMPLETED|Overall Study||9
180758|NCT00585533|443289|P1|COMPLETED|Overall Study||31
180759|NCT00585533|443289|P1|STARTED|Overall Study||40
180760|NCT00585585|443294|P1|NOT COMPLETED|Overall Study||1
180761|NCT00585585|443294|P1|COMPLETED|Overall Study||0
180762|NCT00585585|443294|P1|Patients Receiving Drug|Overall Study||1
180763|NCT00585585|443294|P1|STARTED|Overall Study||1
180764|NCT00585637|443302|P4|NOT COMPLETED|6-month Time Point||6
180765|NCT00585637|443303|P3|NOT COMPLETED|6-month Time Point||11
180766|NCT00585637|443304|P2|NOT COMPLETED|6-month Time Point||13
180767|NCT00585637|443305|P1|NOT COMPLETED|6-month Time Point||6
180768|NCT00585637|443302|P4|COMPLETED|6-month Time Point||77
180769|NCT00585637|443303|P3|COMPLETED|6-month Time Point||72
180770|NCT00585637|443304|P2|COMPLETED|6-month Time Point||68
180771|NCT00585637|443305|P1|COMPLETED|6-month Time Point||75
180772|NCT00585637|443302|P4|STARTED|6-month Time Point||83
180773|NCT00585637|443303|P3|STARTED|6-month Time Point||83
180774|NCT00585637|443304|P2|STARTED|6-month Time Point||81
180775|NCT00585637|443305|P1|STARTED|6-month Time Point||81
180776|NCT00585637|443302|P4|NOT COMPLETED|3-month Time Point||5
180777|NCT00585637|443303|P3|NOT COMPLETED|3-month Time Point||7
180778|NCT00585637|443304|P2|NOT COMPLETED|3-month Time Point||14
180779|NCT00585637|443305|P1|NOT COMPLETED|3-month Time Point||10
180780|NCT00585637|443302|P4|COMPLETED|3-month Time Point||78
180781|NCT00585637|443303|P3|COMPLETED|3-month Time Point||76
180782|NCT00585637|443304|P2|COMPLETED|3-month Time Point||67
180783|NCT00585637|443305|P1|COMPLETED|3-month Time Point||71
180784|NCT00585637|443302|P4|STARTED|3-month Time Point||83
180785|NCT00585637|443303|P3|STARTED|3-month Time Point||83
180786|NCT00585637|443304|P2|STARTED|3-month Time Point||81
180787|NCT00585637|443305|P1|STARTED|3-month Time Point||81
180788|NCT00585637|443302|P4|NOT COMPLETED|Baseline||0
180789|NCT00585637|443303|P3|NOT COMPLETED|Baseline||0
180790|NCT00585637|443304|P2|NOT COMPLETED|Baseline||0
180791|NCT00585637|443305|P1|NOT COMPLETED|Baseline||0
180792|NCT00585637|443302|P4|COMPLETED|Baseline||83
180793|NCT00585637|443303|P3|COMPLETED|Baseline||83
180794|NCT00585637|443304|P2|COMPLETED|Baseline||81
180795|NCT00585637|443305|P1|COMPLETED|Baseline||81
180796|NCT00585637|443302|P4|STARTED|Baseline||83
180798|NCT00585637|443304|P2|STARTED|Baseline||81
180799|NCT00585637|443305|P1|STARTED|Baseline||81
180800|NCT00585650|443333|P2|NOT COMPLETED|Overall Study||0
180801|NCT00585650|443334|P1|NOT COMPLETED|Overall Study||0
180802|NCT00585650|443333|P2|COMPLETED|Overall Study||12
180803|NCT00585650|443334|P1|COMPLETED|Overall Study||8
180804|NCT00585650|443333|P2|STARTED|Overall Study||12
180805|NCT00585650|443334|P1|STARTED|Overall Study||8
180806|NCT00585689|443340|P1|NOT COMPLETED|Overall Study||7
180807|NCT00585689|443340|P1|COMPLETED|Overall Study||22
180808|NCT00585689|443340|P1|STARTED|Overall Study||29
180809|NCT00585715|443346|P2|NOT COMPLETED|Overall Study||0
180810|NCT00585715|443347|P1|NOT COMPLETED|Overall Study||3
180811|NCT00585715|443346|P2|COMPLETED|Overall Study||11
180812|NCT00585715|443347|P1|COMPLETED|Overall Study||8
180813|NCT00585715|443346|P2|STARTED|Overall Study||11
180814|NCT00585715|443347|P1|STARTED|Overall Study||11
180815|NCT00585910|443355|P1|NOT COMPLETED|ATMX + Osmotic-Release Methylphenidate||9
180816|NCT00585910|443355|P1|COMPLETED|ATMX + Osmotic-Release Methylphenidate||41
180817|NCT00585910|443355|P1|STARTED|ATMX + Osmotic-Release Methylphenidate|Number of participants to add OROS MPH to their ATMX regimen|50
180818|NCT00585910|443355|P1|NOT COMPLETED|Atomoxetine (ATMX) Alone||17
180819|NCT00585910|443355|P1|COMPLETED|Atomoxetine (ATMX) Alone|Number of subjects who completed Phase I. 15 completed only Phase I. 40 proceeded onto Phase II.|55
180820|NCT00585910|443355|P1|STARTED|Atomoxetine (ATMX) Alone|This is the number of subjects who were exposed to ATMX in Phase I of the study.|72
180821|NCT00585923|443363|P2|NOT COMPLETED|Overall Study||33
180822|NCT00585923|443364|P1|NOT COMPLETED|Overall Study||31
180823|NCT00585923|443363|P2|COMPLETED|Overall Study||26
180824|NCT00585923|443364|P1|COMPLETED|Overall Study||25
180825|NCT00585923|443363|P2|STARTED|Overall Study||59
180826|NCT00585923|443364|P1|STARTED|Overall Study||56
180827|NCT00585975|443380|P2|NOT COMPLETED|Overall Study||13
180828|NCT00585975|443381|P1|NOT COMPLETED|Overall Study||15
180829|NCT00585975|443380|P2|COMPLETED|Overall Study||278
180830|NCT00585975|443381|P1|COMPLETED|Overall Study||262
180831|NCT00585975|443380|P2|STARTED|Overall Study||291
180832|NCT00585975|443381|P1|STARTED|Overall Study||277
180833|NCT00586066|443391|P2|NOT COMPLETED|Overall Study||10
180834|NCT00586066|443392|P1|NOT COMPLETED|Overall Study||18
180835|NCT00586066|443391|P2|COMPLETED|Overall Study||14
180836|NCT00586066|443392|P1|COMPLETED|Overall Study||30
180837|NCT00586066|443391|P2|STARTED|Overall Study||24
180838|NCT00586066|443392|P1|STARTED|Overall Study||48
180839|NCT00586105|443402|P1|NOT COMPLETED|Overall Study||39
180840|NCT00586105|443402|P1|COMPLETED|Overall Study||0
180841|NCT00586105|443402|P1|STARTED|Overall Study||39
180842|NCT00586157|443415|P2|NOT COMPLETED|Second Intervention||1
180843|NCT00586157|443416|P1|NOT COMPLETED|Second Intervention||2
180844|NCT00586157|443415|P2|COMPLETED|Second Intervention||14
180845|NCT00586157|443416|P1|COMPLETED|Second Intervention||12
180846|NCT00586157|443415|P2|STARTED|Second Intervention||15
180847|NCT00586157|443416|P1|STARTED|Second Intervention||14
180848|NCT00586157|443415|P2|NOT COMPLETED|First Intervention||0
180849|NCT00586157|443416|P1|NOT COMPLETED|First Intervention||1
180850|NCT00586157|443415|P2|COMPLETED|First Intervention||15
180851|NCT00586157|443416|P1|COMPLETED|First Intervention||14
180852|NCT00586157|443415|P2|STARTED|First Intervention||15
180853|NCT00586157|443416|P1|STARTED|First Intervention||15
180854|NCT00586170|443428|P2|NOT COMPLETED|Overall Study||0
180855|NCT00586170|443429|P1|NOT COMPLETED|Overall Study||0
180856|NCT00586170|443428|P2|COMPLETED|Overall Study||3
180857|NCT00586170|443429|P1|COMPLETED|Overall Study||5
180858|NCT00586170|443428|P2|STARTED|Overall Study|Initially enrollment was listed as 9. 1 placebo patient withdrew prior to surgery, so enrollment=8.|3
180859|NCT00586170|443429|P1|STARTED|Overall Study||5
180860|NCT00586196|443439|P2|NOT COMPLETED|Overall Study||0
180861|NCT00586196|443440|P1|NOT COMPLETED|Overall Study||0
180862|NCT00586196|443439|P2|COMPLETED|Overall Study||9
180863|NCT00586196|443440|P1|COMPLETED|Overall Study||7
180864|NCT00586196|443439|P2|STARTED|Overall Study||9
180865|NCT00586196|443440|P1|STARTED|Overall Study||7
180866|NCT00586261|443450|P2|NOT COMPLETED|Overall Study||0
180867|NCT00586261|443451|P1|NOT COMPLETED|Overall Study||0
180868|NCT00586261|443450|P2|COMPLETED|Overall Study||19
180869|NCT00586261|443451|P1|COMPLETED|Overall Study||17
180870|NCT00586261|443450|P2|STARTED|Overall Study||19
180871|NCT00586261|443451|P1|STARTED|Overall Study||17
180872|NCT00586313|443457|P1|NOT COMPLETED|Overall Study||2
180873|NCT00586313|443457|P1|COMPLETED|Overall Study||19
180874|NCT00586313|443457|P1|STARTED|Overall Study||21
180875|NCT00586326|443462|P1|NOT COMPLETED|Treated Through 5-yr Follow Up-Treated||26
180876|NCT00586326|443462|P1|COMPLETED|Treated Through 5-yr Follow Up-Treated||74
180877|NCT00586326|443462|P1|STARTED|Treated Through 5-yr Follow Up-Treated||100
180878|NCT00586326|443462|P1|NOT COMPLETED|Device Placed toTreatment-ITT||18
180879|NCT00586326|443462|P1|COMPLETED|Device Placed toTreatment-ITT||100
180880|NCT00586326|443462|P1|STARTED|Device Placed toTreatment-ITT||118
180881|NCT00586326|443462|P1|NOT COMPLETED|Enrollment to Device Placement-Enrolled||15
180882|NCT00586326|443462|P1|COMPLETED|Enrollment to Device Placement-Enrolled||118
180883|NCT00586326|443462|P1|STARTED|Enrollment to Device Placement-Enrolled||133
180884|NCT00586339|443476|P3|NOT COMPLETED|Overall Study||6
180885|NCT00586339|443477|P2|NOT COMPLETED|Overall Study||7
180886|NCT00586339|443478|P1|NOT COMPLETED|Overall Study||7
180887|NCT00586339|443476|P3|COMPLETED|Overall Study||24
180888|NCT00586339|443477|P2|COMPLETED|Overall Study||52
180889|NCT00586339|443478|P1|COMPLETED|Overall Study||54
180890|NCT00586339|443476|P3|STARTED|Overall Study||30
180891|NCT00586339|443477|P2|STARTED|Overall Study||59
180892|NCT00586339|443478|P1|STARTED|Overall Study||61
180893|NCT00586469|443572|P2|NOT COMPLETED|Overall Study||1
180894|NCT00586469|443573|P1|NOT COMPLETED|Overall Study||0
180895|NCT00586469|443572|P2|COMPLETED|Overall Study||499
180896|NCT00586469|443573|P1|COMPLETED|Overall Study||500
180897|NCT00586469|443572|P2|STARTED|Overall Study||500
180898|NCT00586469|443573|P1|STARTED|Overall Study||500
180899|NCT00586482|443599|P2|NOT COMPLETED|Overall Study||0
180900|NCT00586482|443600|P1|NOT COMPLETED|Overall Study||0
180901|NCT00586482|443599|P2|COMPLETED|Overall Study||24
180902|NCT00586482|443600|P1|COMPLETED|Overall Study||22
180903|NCT00586482|443599|P2|STARTED|Overall Study||24
180904|NCT00586482|443600|P1|STARTED|Overall Study||22
180905|NCT00586495|443614|P1|NOT COMPLETED|Follow-up||92
180906|NCT00586495|443614|P1|COMPLETED|Follow-up||0
180907|NCT00586495|443614|P1|STARTED|Follow-up||92
180908|NCT00586495|443614|P1|NOT COMPLETED|Treatment Period||95
180909|NCT00586495|443614|P1|COMPLETED|Treatment Period||0
180910|NCT00586495|443614|P1|STARTED|Treatment Period||95
180911|NCT00586521|443624|P1|NOT COMPLETED|Prophylactic Treatment (Months 8-13)||0
180912|NCT00586521|443624|P1|COMPLETED|Prophylactic Treatment (Months 8-13)||19
180913|NCT00586521|443624|P1|STARTED|Prophylactic Treatment (Months 8-13)||19
180914|NCT00586521|443624|P1|NOT COMPLETED|On Demand Treatment (Months 1-6)||1
180915|NCT00586521|443624|P1|COMPLETED|On Demand Treatment (Months 1-6)||19
180916|NCT00586521|443624|P1|STARTED|On Demand Treatment (Months 1-6)||20
180917|NCT00586573|443631|P1|NOT COMPLETED|Overall Study||6
180918|NCT00586573|443631|P1|COMPLETED|Overall Study||28
180919|NCT00586573|443631|P1|STARTED|Overall Study||34
180920|NCT00586612|443637|P2|NOT COMPLETED|Booster Phase||1
180921|NCT00586612|443638|P1|NOT COMPLETED|Booster Phase||3
180922|NCT00586612|443637|P2|COMPLETED|Booster Phase||143
180923|NCT00586612|443638|P1|COMPLETED|Booster Phase||151
180924|NCT00586612|443637|P2|STARTED|Booster Phase||144
180925|NCT00586612|443638|P1|STARTED|Booster Phase||154
180926|NCT00586612|443637|P2|NOT COMPLETED|Primary Phase||3
180927|NCT00586612|443638|P1|NOT COMPLETED|Primary Phase||1
180928|NCT00586612|443637|P2|COMPLETED|Primary Phase||147
180929|NCT00586612|443638|P1|COMPLETED|Primary Phase||162
180930|NCT00586612|443637|P2|STARTED|Primary Phase||150
180931|NCT00586612|443638|P1|STARTED|Primary Phase||163
180932|NCT00586625|443706|P2|NOT COMPLETED|Overall Study||17
180933|NCT00586625|443707|P1|NOT COMPLETED|Overall Study||43
180934|NCT00586625|443706|P2|COMPLETED|Overall Study||269
180935|NCT00586625|443707|P1|COMPLETED|Overall Study||532
180936|NCT00586625|443706|P2|STARTED|Overall Study||286
180937|NCT00586625|443707|P1|STARTED|Overall Study||575
180938|NCT00586664|443716|P3|NOT COMPLETED|Overall Study||1
180939|NCT00586664|443717|P2|NOT COMPLETED|Overall Study||7
180940|NCT00586664|443718|P1|NOT COMPLETED|Overall Study||5
180941|NCT00586664|443716|P3|COMPLETED|Overall Study||43
180942|NCT00586664|443717|P2|COMPLETED|Overall Study||36
180943|NCT00586664|443718|P1|COMPLETED|Overall Study||38
180944|NCT00586664|443716|P3|STARTED|Overall Study||44
180945|NCT00586664|443717|P2|STARTED|Overall Study||43
180946|NCT00586664|443718|P1|STARTED|Overall Study||43
180947|NCT00586690|443764|P2|NOT COMPLETED|Overall Study||0
180948|NCT00586690|443765|P1|NOT COMPLETED|Overall Study||16
180949|NCT00586690|443764|P2|COMPLETED|Overall Study||22
180950|NCT00586690|443765|P1|COMPLETED|Overall Study||5
180951|NCT00586690|443764|P2|STARTED|Overall Study||22
180952|NCT00586690|443765|P1|STARTED|Overall Study|Four consented subjects were screen failures.|21
180953|NCT00586703|443772|P1|NOT COMPLETED|Overall Study||12
180954|NCT00586703|443772|P1|COMPLETED|Overall Study||4
180955|NCT00586703|443772|P1|STARTED|Overall Study||16
180956|NCT00586716|443779|P2|NOT COMPLETED|Overall Study||0
180957|NCT00586716|443780|P1|NOT COMPLETED|Overall Study||0
180958|NCT00586716|443779|P2|COMPLETED|Overall Study||8
180959|NCT00586716|443780|P1|COMPLETED|Overall Study||14
180960|NCT00586716|443779|P2|STARTED|Overall Study||8
180961|NCT00586716|443780|P1|STARTED|Overall Study||14
180962|NCT00586729|443789|P2|NOT COMPLETED|Overall Study||1
180963|NCT00586729|443790|P1|NOT COMPLETED|Overall Study||3
180964|NCT00586729|443789|P2|COMPLETED|Overall Study||8
180965|NCT00586729|443790|P1|COMPLETED|Overall Study||11
180966|NCT00586729|443789|P2|STARTED|Overall Study||9
180967|NCT00586729|443790|P1|STARTED|Overall Study||14
180968|NCT00586820|443802|P2|NOT COMPLETED|Overall Study||0
180969|NCT00586820|443803|P1|NOT COMPLETED|Overall Study||1
180970|NCT00586820|443802|P2|COMPLETED|Overall Study||11
180971|NCT00586820|443803|P1|COMPLETED|Overall Study||11
180972|NCT00586820|443802|P2|STARTED|Overall Study||11
180973|NCT00586820|443803|P1|STARTED|Overall Study||12
180974|NCT00586846|443811|P1|NOT COMPLETED|Overall Study||6
180975|NCT00586846|443811|P1|COMPLETED|Overall Study||34
180976|NCT00586846|443811|P1|STARTED|Overall Study||40
180977|NCT00595764|443817|P2|NOT COMPLETED|Overall Study||43
180978|NCT00595764|443818|P1|NOT COMPLETED|Overall Study||39
180979|NCT00595764|443817|P2|COMPLETED|Overall Study||27
180980|NCT00595764|443818|P1|COMPLETED|Overall Study||32
180981|NCT00595764|443817|P2|STARTED|Overall Study||70
180982|NCT00595764|443818|P1|STARTED|Overall Study||71
180983|NCT00595790|443835|P3|NOT COMPLETED|Overall Study||3
180984|NCT00595790|443836|P2|NOT COMPLETED|Overall Study||1
180985|NCT00595790|443837|P1|NOT COMPLETED|Overall Study||2
180986|NCT00595790|443835|P3|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|122
180987|NCT00595790|443836|P2|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
180988|NCT00595790|443837|P1|COMPLETED|Overall Study|The Participant Flow shows all study participants randomized.Prim. Outcome is based on PP Population|123
180989|NCT00595790|443835|P3|STARTED|Overall Study|125 subjects randomized to this group, 124 subjects received 1x6 mcg.(Safety Population: N=124)|125
180990|NCT00595790|443836|P2|STARTED|Overall Study|124 subjects randomized to this group, 125 subjects received 1x12 mcg.(Safety Population: N=125)|124
180991|NCT00595790|443837|P1|STARTED|Overall Study||125
180992|NCT00595868|443847|P2|NOT COMPLETED|Overall Study||50
180993|NCT00595868|443848|P1|NOT COMPLETED|Overall Study||45
180994|NCT00595868|443847|P2|COMPLETED|Overall Study||61
180995|NCT00595868|443848|P1|COMPLETED|Overall Study||62
180996|NCT00595868|443847|P2|STARTED|Overall Study||111
180997|NCT00595868|443848|P1|STARTED|Overall Study||107
180998|NCT00595881|443856|P1|NOT COMPLETED|Overall Study||0
180999|NCT00595881|443856|P1|COMPLETED|Overall Study||420
181000|NCT00595881|443856|P1|STARTED|Overall Study||420
181001|NCT00595920|443861|P1|NOT COMPLETED|Overall Study||116
181002|NCT00595920|443861|P1|COMPLETED|Overall Study||0
181003|NCT00595920|443861|P1|Patients Dosed|Overall Study|116 patients enrolled; however, only 38 received at least 1 dose.|38
181004|NCT00595920|443861|P1|STARTED|Overall Study||116
181005|NCT00595946|443867|P2|NOT COMPLETED|Overall Study||69
181006|NCT00595946|443868|P1|NOT COMPLETED|Overall Study||64
181007|NCT00595946|443867|P2|COMPLETED|Overall Study||152
181008|NCT00595946|443868|P1|COMPLETED|Overall Study||154
181009|NCT00595946|443867|P2|STARTED|Overall Study||221
181010|NCT00595946|443868|P1|STARTED|Overall Study||218
181011|NCT00595959|443884|P1|NOT COMPLETED|Overall Study||2
181012|NCT00595959|443884|P1|COMPLETED|Overall Study||63
181013|NCT00595959|443884|P1|STARTED|Overall Study||65
181014|NCT00596011|443901|P2|NOT COMPLETED|Overall Study||10
181015|NCT00596011|443902|P1|NOT COMPLETED|Overall Study||13
181016|NCT00596011|443901|P2|COMPLETED|Overall Study||38
181017|NCT00596011|443902|P1|COMPLETED|Overall Study||36
181018|NCT00596011|443901|P2|STARTED|Overall Study||48
181019|NCT00596011|443902|P1|STARTED|Overall Study||49
181020|NCT00596102|443921|P3|NOT COMPLETED|Up to Month 60||637
181021|NCT00596102|443922|P2|NOT COMPLETED|Up to Month 60||338
181022|NCT00596102|443923|P1|NOT COMPLETED|Up to Month 60||2181
181023|NCT00596102|443921|P3|COMPLETED|Up to Month 60||0
181024|NCT00596102|443922|P2|COMPLETED|Up to Month 60||0
181025|NCT00596102|443923|P1|COMPLETED|Up to Month 60|"long-term safety follow-up beyond Month 6 for a sub-set of subjects in IC51 group only"|102
181026|NCT00596102|443921|P3|STARTED|Up to Month 60||637
181027|NCT00596102|443922|P2|STARTED|Up to Month 60||338
181028|NCT00596102|443923|P1|STARTED|Up to Month 60||2283
181029|NCT00596102|443921|P3|NOT COMPLETED|Up to Month 6||0
181030|NCT00596102|443922|P2|NOT COMPLETED|Up to Month 6||0
181031|NCT00596102|443923|P1|NOT COMPLETED|Up to Month 6||0
181032|NCT00596102|443921|P3|COMPLETED|Up to Month 6||637
181033|NCT00596102|443922|P2|COMPLETED|Up to Month 6||338
181034|NCT00596102|443923|P1|COMPLETED|Up to Month 6||2283
181035|NCT00596102|443921|P3|STARTED|Up to Month 6||637
181036|NCT00596102|443922|P2|STARTED|Up to Month 6||338
181037|NCT00596102|443923|P1|STARTED|Up to Month 6||2283
181038|NCT00597116|443932|P2|NOT COMPLETED|Overall Study||11
181039|NCT00597116|443933|P1|NOT COMPLETED|Overall Study||14
181040|NCT00597116|443932|P2|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
181041|NCT00597116|443933|P1|COMPLETED|Overall Study|Randomised patients ongoing study treatment at data cut-off|0
181042|NCT00597116|443932|P2|STARTED|Overall Study||11
181043|NCT00597116|443933|P1|STARTED|Overall Study||14
181044|NCT00597207|443947|P2|NOT COMPLETED|Overall Study||7
181045|NCT00597207|443948|P1|NOT COMPLETED|Overall Study||5
181046|NCT00597207|443947|P2|COMPLETED|Overall Study||2125
181047|NCT00597207|443948|P1|COMPLETED|Overall Study||2094
181048|NCT00597207|443947|P2|STARTED|Overall Study||2132
181049|NCT00597207|443948|P1|STARTED|Overall Study||2099
181050|NCT00597272|443961|P7|NOT COMPLETED|Overall Study||0
181051|NCT00597272|443962|P6|NOT COMPLETED|Overall Study||0
181052|NCT00597272|443963|P5|NOT COMPLETED|Overall Study||0
181053|NCT00597272|443964|P4|NOT COMPLETED|Overall Study||0
181054|NCT00597272|443965|P3|NOT COMPLETED|Overall Study||0
181055|NCT00597272|443966|P2|NOT COMPLETED|Overall Study||0
181056|NCT00597272|443967|P1|NOT COMPLETED|Overall Study||0
181057|NCT00597272|443961|P7|COMPLETED|Overall Study||10
181058|NCT00597272|443962|P6|COMPLETED|Overall Study||10
181059|NCT00597272|443963|P5|COMPLETED|Overall Study||1
181060|NCT00597272|443964|P4|COMPLETED|Overall Study||1
181061|NCT00597272|443965|P3|COMPLETED|Overall Study||10
181062|NCT00597272|443966|P2|COMPLETED|Overall Study||1
181063|NCT00597272|443967|P1|COMPLETED|Overall Study||1
181064|NCT00597272|443961|P7|STARTED|Overall Study||10
181065|NCT00597272|443962|P6|STARTED|Overall Study||10
181066|NCT00597272|443963|P5|STARTED|Overall Study||1
181067|NCT00597272|443964|P4|STARTED|Overall Study||1
181068|NCT00597272|443965|P3|STARTED|Overall Study||10
181069|NCT00597272|443966|P2|STARTED|Overall Study||1
181070|NCT00597272|443967|P1|STARTED|Overall Study||1
181071|NCT00597376|443985|P2|NOT COMPLETED|Overall Study||4
181072|NCT00597376|443986|P1|NOT COMPLETED|Overall Study||8
181073|NCT00597376|443985|P2|COMPLETED|Overall Study|All participants started (53) were included in primary analyses.|49
181074|NCT00597376|443986|P1|COMPLETED|Overall Study|All participants started (51) were included in primary analyses.|43
181075|NCT00597376|443985|P2|STARTED|Overall Study||53
181076|NCT00597376|443986|P1|STARTED|Overall Study||51
181077|NCT00597402|443996|P1|NOT COMPLETED|Overall Study||0
181078|NCT00597402|443996|P1|COMPLETED|Overall Study||125
181079|NCT00597402|443996|P1|STARTED|Overall Study||125
181080|NCT00597428|444005|P2|NOT COMPLETED|Overall Study||71
181081|NCT00597428|444006|P1|NOT COMPLETED|Overall Study||61
181082|NCT00597428|444005|P2|COMPLETED|Overall Study||152
181083|NCT00597428|444006|P1|COMPLETED|Overall Study||153
181084|NCT00597428|444005|P2|STARTED|Overall Study||223
181085|NCT00597428|444006|P1|STARTED|Overall Study||214
181086|NCT00597493|444022|P1|NOT COMPLETED|Overall Study||0
181087|NCT00597493|444022|P1|COMPLETED|Overall Study||32
181088|NCT00597493|444022|P1|STARTED|Overall Study||32
181089|NCT00597506|444039|P1|NOT COMPLETED|Overall Study||1
181090|NCT00597506|444039|P1|COMPLETED|Overall Study||49
181091|NCT00597506|444039|P1|STARTED|Overall Study||50
181092|NCT00597519|444044|P1|NOT COMPLETED|Overall Study||1
181093|NCT00597519|444044|P1|COMPLETED|Overall Study||27
181094|NCT00597519|444044|P1|STARTED|Overall Study||28
181095|NCT00597545|444050|P2|NOT COMPLETED|Overall Study||0
181096|NCT00597545|444051|P1|NOT COMPLETED|Overall Study||0
181097|NCT00597545|444050|P2|COMPLETED|Overall Study||6
181098|NCT00597545|444051|P1|COMPLETED|Overall Study||4
181099|NCT00597545|444050|P2|STARTED|Overall Study||6
181100|NCT00597545|444051|P1|STARTED|Overall Study||4
181101|NCT00597558|444057|P1|NOT COMPLETED|Overall Study||4
181102|NCT00597558|444057|P1|COMPLETED|Overall Study||9
181103|NCT00597558|444057|P1|STARTED|Overall Study||13
181104|NCT00597584|444065|P2|NOT COMPLETED|Overall Study||63
181105|NCT00597584|444066|P1|NOT COMPLETED|Overall Study||128
181106|NCT00597584|444065|P2|COMPLETED|Overall Study||211
181107|NCT00597584|444066|P1|COMPLETED|Overall Study||421
181108|NCT00597584|444065|P2|STARTED|Overall Study||274
181109|NCT00597584|444066|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin|549
181110|NCT00597675|444078|P2|NOT COMPLETED|Open Label Phase||0
181111|NCT00597675|444079|P1|NOT COMPLETED|Open Label Phase||0
181112|NCT00597675|444078|P2|COMPLETED|Open Label Phase||5
181113|NCT00597675|444079|P1|COMPLETED|Open Label Phase||2
181114|NCT00597675|444078|P2|STARTED|Open Label Phase||5
181115|NCT00597675|444079|P1|STARTED|Open Label Phase|Patients previously on placebo were crossed over onto open label peanut OIT|2
181116|NCT00597675|444078|P2|NOT COMPLETED|Blinded Phase||1
181117|NCT00597675|444079|P1|NOT COMPLETED|Blinded Phase||2
181118|NCT00597675|444078|P2|COMPLETED|Blinded Phase||5
181119|NCT00597675|444079|P1|COMPLETED|Blinded Phase||2
181120|NCT00597675|444078|P2|STARTED|Blinded Phase||6
181121|NCT00597675|444079|P1|STARTED|Blinded Phase||4
181122|NCT00597701|444092|P2|NOT COMPLETED|Overall Study||8
181123|NCT00597701|444093|P1|NOT COMPLETED|Overall Study||7
181124|NCT00597701|444092|P2|COMPLETED|Overall Study||13
181125|NCT00597701|444093|P1|COMPLETED|Overall Study||18
181126|NCT00597701|444092|P2|STARTED|Overall Study||21
181127|NCT00597701|444093|P1|STARTED|Overall Study||25
181128|NCT00597714|444101|P3|NOT COMPLETED|Overall Study||10
181129|NCT00597714|444102|P2|NOT COMPLETED|Overall Study||46
181130|NCT00597714|444103|P1|NOT COMPLETED|Overall Study||56
181131|NCT00597714|444101|P3|COMPLETED|Overall Study||84
181132|NCT00597714|444102|P2|COMPLETED|Overall Study||11
181133|NCT00597714|444103|P1|COMPLETED|Overall Study||24
181134|NCT00597714|444101|P3|STARTED|Overall Study||94
181135|NCT00597714|444102|P2|STARTED|Overall Study||57
181136|NCT00597714|444103|P1|STARTED|Overall Study||80
181137|NCT00597727|444117|P5|NOT COMPLETED|Open-label Extended Maintenance Phase||2
181138|NCT00597727|444118|P4|NOT COMPLETED|Open-label Extended Maintenance Phase||3
181139|NCT00597727|444119|P3|NOT COMPLETED|Open-label Extended Maintenance Phase||6
181140|NCT00597727|444120|P2|NOT COMPLETED|Open-label Extended Maintenance Phase||0
181141|NCT00597727|444121|P1|NOT COMPLETED|Open-label Extended Maintenance Phase||0
181142|NCT00597727|444117|P5|COMPLETED|Open-label Extended Maintenance Phase||1
181143|NCT00597727|444118|P4|COMPLETED|Open-label Extended Maintenance Phase||14
181144|NCT00597727|444119|P3|COMPLETED|Open-label Extended Maintenance Phase||23
181145|NCT00597727|444120|P2|COMPLETED|Open-label Extended Maintenance Phase||0
181146|NCT00597727|444121|P1|COMPLETED|Open-label Extended Maintenance Phase||0
181147|NCT00597727|444117|P5|STARTED|Open-label Extended Maintenance Phase||3
181148|NCT00597727|444118|P4|STARTED|Open-label Extended Maintenance Phase||17
181149|NCT00597727|444119|P3|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding.|29
181150|NCT00597727|444120|P2|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
181151|NCT00597727|444121|P1|STARTED|Open-label Extended Maintenance Phase|Blinded peanut SLIT + blinded placebo SLIT continued in Ext Open Label Peanut SLIT after unblinding|0
181152|NCT00597727|444117|P5|NOT COMPLETED|12 Month Blinded Phase||1
181153|NCT00597727|444118|P4|NOT COMPLETED|12 Month Blinded Phase||10
181154|NCT00597727|444119|P3|NOT COMPLETED|12 Month Blinded Phase||0
181155|NCT00597727|444120|P2|NOT COMPLETED|12 Month Blinded Phase||0
181156|NCT00597727|444121|P1|NOT COMPLETED|12 Month Blinded Phase||0
181157|NCT00597727|444117|P5|COMPLETED|12 Month Blinded Phase||3
181158|NCT00597727|444118|P4|COMPLETED|12 Month Blinded Phase||17
181159|NCT00597727|444119|P3|COMPLETED|12 Month Blinded Phase||0
181160|NCT00597727|444120|P2|COMPLETED|12 Month Blinded Phase||15
181161|NCT00597727|444121|P1|COMPLETED|12 Month Blinded Phase||14
181162|NCT00597727|444117|P5|STARTED|12 Month Blinded Phase||4
181163|NCT00597727|444118|P4|STARTED|12 Month Blinded Phase||27
181164|NCT00597727|444119|P3|STARTED|12 Month Blinded Phase||0
181165|NCT00597727|444120|P2|STARTED|12 Month Blinded Phase||15
181166|NCT00597727|444121|P1|STARTED|12 Month Blinded Phase||14
181167|NCT00597753|444137|P2|NOT COMPLETED|Overall Study||69
181168|NCT00597753|444138|P1|NOT COMPLETED|Overall Study||166
181169|NCT00597753|444137|P2|COMPLETED|Overall Study||202
181170|NCT00597753|444138|P1|COMPLETED|Overall Study||366
181171|NCT00597753|444137|P2|STARTED|Overall Study||271
181172|NCT00597753|444138|P1|STARTED|Overall Study|Randomization was 2:1 peginesatide to epoetin alfa|532
181173|NCT00597896|444150|P2|NOT COMPLETED|Overall Study||2
181174|NCT00597896|444151|P1|NOT COMPLETED|Overall Study||3
181175|NCT00597896|444150|P2|COMPLETED|Overall Study||24
181176|NCT00597896|444151|P1|COMPLETED|Overall Study||21
181177|NCT00597896|444150|P2|STARTED|Overall Study||26
181178|NCT00597896|444151|P1|STARTED|Overall Study||24
181179|NCT00597909|444180|P3|NOT COMPLETED|Overall Study||0
181180|NCT00597909|444181|P2|NOT COMPLETED|Overall Study||0
181181|NCT00597909|444182|P1|NOT COMPLETED|Overall Study||0
181182|NCT00597909|444180|P3|COMPLETED|Overall Study||0
181183|NCT00597909|444181|P2|COMPLETED|Overall Study||0
181184|NCT00597909|444182|P1|COMPLETED|Overall Study||0
181185|NCT00597909|444180|P3|STARTED|Overall Study||0
181186|NCT00597909|444181|P2|STARTED|Overall Study||0
181187|NCT00597909|444182|P1|STARTED|Overall Study||0
181188|NCT00598078|444190|P2|NOT COMPLETED|Period 3 (Day 3)||0
181189|NCT00598078|444191|P1|NOT COMPLETED|Period 3 (Day 3)||0
181190|NCT00598078|444190|P2|COMPLETED|Period 3 (Day 3)||10
181191|NCT00598078|444191|P1|COMPLETED|Period 3 (Day 3)||9
181192|NCT00598078|444190|P2|STARTED|Period 3 (Day 3)||10
181193|NCT00598078|444191|P1|STARTED|Period 3 (Day 3)||9
181194|NCT00598078|444190|P2|NOT COMPLETED|Period 2 (Day 2)||0
181195|NCT00598078|444191|P1|NOT COMPLETED|Period 2 (Day 2)||1
181196|NCT00598078|444190|P2|COMPLETED|Period 2 (Day 2)||10
181197|NCT00598078|444191|P1|COMPLETED|Period 2 (Day 2)||9
181198|NCT00598078|444190|P2|STARTED|Period 2 (Day 2)||10
181199|NCT00598078|444191|P1|STARTED|Period 2 (Day 2)||10
181200|NCT00598078|444190|P2|NOT COMPLETED|Period 1 (Day 1)||0
181201|NCT00598078|444191|P1|NOT COMPLETED|Period 1 (Day 1)||0
181202|NCT00598078|444190|P2|COMPLETED|Period 1 (Day 1)||10
181203|NCT00598078|444191|P1|COMPLETED|Period 1 (Day 1)||10
181204|NCT00598078|444190|P2|STARTED|Period 1 (Day 1)||10
181205|NCT00598078|444191|P1|STARTED|Period 1 (Day 1)||10
181206|NCT00598273|444202|P3|NOT COMPLETED|Overall Study||39
181207|NCT00598273|444203|P2|NOT COMPLETED|Overall Study||38
181208|NCT00598273|444204|P1|NOT COMPLETED|Overall Study||41
181209|NCT00598273|444202|P3|COMPLETED|Overall Study||125
181210|NCT00598273|444203|P2|COMPLETED|Overall Study||127
181211|NCT00598273|444204|P1|COMPLETED|Overall Study||120
181212|NCT00598273|444202|P3|STARTED|Overall Study||164
181213|NCT00598273|444203|P2|STARTED|Overall Study||165
181214|NCT00598273|444204|P1|STARTED|Overall Study||161
181215|NCT00598442|444221|P3|NOT COMPLETED|Overall Study||24
181216|NCT00598442|444222|P2|NOT COMPLETED|Overall Study||39
181217|NCT00598442|444223|P1|NOT COMPLETED|Overall Study||43
181218|NCT00598442|444221|P3|COMPLETED|Overall Study||139
181219|NCT00598442|444222|P2|COMPLETED|Overall Study||124
181220|NCT00598442|444223|P1|COMPLETED|Overall Study||124
181221|NCT00598442|444221|P3|STARTED|Overall Study||163
181222|NCT00598442|444222|P2|STARTED|Overall Study||163
181223|NCT00598442|444223|P1|STARTED|Overall Study||167
181224|NCT00598507|444237|P1|NOT COMPLETED|Overall Study||0
181225|NCT00598507|444237|P1|COMPLETED|Overall Study||35
181226|NCT00598507|444237|P1|STARTED|Overall Study||35
181227|NCT00598559|444247|P3|NOT COMPLETED|Overall Study||3
181228|NCT00598559|444248|P2|NOT COMPLETED|Overall Study||28
181229|NCT00598559|444249|P1|NOT COMPLETED|Overall Study||27
181230|NCT00598559|444247|P3|COMPLETED|Overall Study|Subjects completed 5 days of treatment|27
181231|NCT00598559|444248|P2|COMPLETED|Overall Study|Subjects completed 5 days of treatment|63
181232|NCT00598559|444249|P1|COMPLETED|Overall Study|Subjects completed 5 days of treatment|65
181233|NCT00598559|444247|P3|STARTED|Overall Study||30
181234|NCT00598559|444248|P2|STARTED|Overall Study||91
181235|NCT00598559|444249|P1|STARTED|Overall Study||92
181236|NCT00598585|444268|P2|NOT COMPLETED|Overall Study||0
181237|NCT00598585|444269|P1|NOT COMPLETED|Overall Study||1
181238|NCT00598585|444268|P2|COMPLETED|Overall Study||6
181239|NCT00598585|444269|P1|COMPLETED|Overall Study||5
181240|NCT00598585|444268|P2|STARTED|Overall Study||6
181241|NCT00598585|444269|P1|STARTED|Overall Study||6
181242|NCT00598650|444275|P1|NOT COMPLETED|Overall Study||27
181243|NCT00598650|444275|P1|COMPLETED|Overall Study|5 subjects withdrew for multiple reasons|81
181244|NCT00598650|444275|P1|STARTED|Overall Study||108
181245|NCT00598689|444284|P2|NOT COMPLETED|Overall Study||0
181246|NCT00598689|444285|P1|NOT COMPLETED|Overall Study||0
181247|NCT00598689|444284|P2|COMPLETED|Overall Study||40
181248|NCT00598689|444285|P1|COMPLETED|Overall Study||40
181249|NCT00598689|444284|P2|STARTED|Overall Study||40
181250|NCT00598689|444285|P1|STARTED|Overall Study||40
181251|NCT00598702|444303|P8|NOT COMPLETED|Overall Study||0
181252|NCT00598702|444304|P7|NOT COMPLETED|Overall Study||1
181253|NCT00598702|444305|P6|NOT COMPLETED|Overall Study||12
181254|NCT00598702|444306|P5|NOT COMPLETED|Overall Study||3
181255|NCT00598702|444307|P4|NOT COMPLETED|Overall Study||8
181256|NCT00598702|444308|P3|NOT COMPLETED|Overall Study||2
181257|NCT00598702|444309|P2|NOT COMPLETED|Overall Study||2
181258|NCT00598702|444310|P1|NOT COMPLETED|Overall Study||0
181259|NCT00598702|444303|P8|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|4
181260|NCT00598702|444304|P7|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|0
181261|NCT00598702|444305|P6|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|30
181262|NCT00598702|444306|P5|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|6
181263|NCT00598702|444307|P4|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|25
181264|NCT00598702|444308|P3|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|5
181265|NCT00598702|444309|P2|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
181266|NCT00598702|444310|P1|COMPLETED|Overall Study|Completed treatment period per requirements of protocol version under which the subject enrolled.|1
181267|NCT00598702|444303|P8|STARTED|Overall Study||4
181268|NCT00598702|444304|P7|STARTED|Overall Study||1
181269|NCT00598702|444305|P6|STARTED|Overall Study||42
181270|NCT00598702|444306|P5|STARTED|Overall Study||9
181271|NCT00598702|444307|P4|STARTED|Overall Study||33
181272|NCT00598702|444308|P3|STARTED|Overall Study||7
181273|NCT00598702|444309|P2|STARTED|Overall Study||3
181274|NCT00598702|444310|P1|STARTED|Overall Study||1
181275|NCT00598806|444354|P2|NOT COMPLETED|Overall Study||64
181276|NCT00598806|444355|P1|NOT COMPLETED|Overall Study||73
181277|NCT00598806|444354|P2|COMPLETED|Overall Study||346
181278|NCT00598806|444355|P1|COMPLETED|Overall Study||329
181279|NCT00598806|444354|P2|STARTED|Overall Study||410
181280|NCT00598806|444355|P1|STARTED|Overall Study||402
181281|NCT00598819|444363|P1|NOT COMPLETED|Overall Study||0
181282|NCT00598819|444363|P1|COMPLETED|Overall Study||14
181283|NCT00598819|444363|P1|STARTED|Overall Study||14
181284|NCT00598832|444373|P2|NOT COMPLETED|Overall Study||82
181285|NCT00598832|444374|P1|NOT COMPLETED|Overall Study||62
181286|NCT00598832|444373|P2|COMPLETED|Overall Study||460
181287|NCT00598832|444374|P1|COMPLETED|Overall Study||471
181288|NCT00598832|444373|P2|STARTED|Overall Study||542
181289|NCT00598832|444374|P1|STARTED|Overall Study||533
181290|NCT00598871|444390|P2|NOT COMPLETED|Overall Study||1
181291|NCT00598871|444391|P1|NOT COMPLETED|Overall Study||0
181292|NCT00598871|444390|P2|COMPLETED|Overall Study||8
181293|NCT00598871|444391|P1|COMPLETED|Overall Study||3
181294|NCT00598871|444390|P2|STARTED|Overall Study||9
181295|NCT00598871|444391|P1|STARTED|Overall Study||3
181296|NCT00599014|444399|P1|NOT COMPLETED|Overall Study||0
181297|NCT00599014|444399|P1|COMPLETED|Overall Study||335
181298|NCT00599014|444399|P1|STARTED|Overall Study||335
181299|NCT00599027|444406|P2|NOT COMPLETED|Overall Study||3
181300|NCT00599027|444407|P1|NOT COMPLETED|Overall Study||1
181301|NCT00599027|444406|P2|COMPLETED|Overall Study||22
181302|NCT00599027|444407|P1|COMPLETED|Overall Study||25
181303|NCT00599027|444406|P2|STARTED|Overall Study||25
181304|NCT00599027|444407|P1|STARTED|Overall Study||26
181305|NCT00599053|444415|P2|NOT COMPLETED|Overall Study||0
181306|NCT00599053|444416|P1|NOT COMPLETED|Overall Study||0
181307|NCT00599053|444415|P2|COMPLETED|Overall Study||2
181308|NCT00599053|444416|P1|COMPLETED|Overall Study||5
181309|NCT00599053|444415|P2|STARTED|Overall Study||2
181310|NCT00599053|444416|P1|STARTED|Overall Study||5
181311|NCT00599131|444428|P1|NOT COMPLETED|Overall Study||0
181312|NCT00599131|444428|P1|COMPLETED|Overall Study||4
181313|NCT00599131|444428|P1|STARTED|Overall Study||4
181314|NCT00599196|444436|P1|NOT COMPLETED|Overall Study||381
181315|NCT00599196|444436|P1|COMPLETED|Overall Study|Study fully recruited. Completed upon market authorization and commercial availability of Neupro.|0
181316|NCT00599196|444436|P1|STARTED|Overall Study||381
181317|NCT00599248|444444|P4|NOT COMPLETED|Overall Study||0
181318|NCT00599248|444445|P3|NOT COMPLETED|Overall Study||0
181319|NCT00599248|444446|P2|NOT COMPLETED|Overall Study||0
181320|NCT00599248|444447|P1|NOT COMPLETED|Overall Study||0
181321|NCT00599248|444444|P4|COMPLETED|Overall Study||3
181322|NCT00599248|444445|P3|COMPLETED|Overall Study||3
181323|NCT00599248|444446|P2|COMPLETED|Overall Study||3
181324|NCT00599248|444447|P1|COMPLETED|Overall Study||3
181325|NCT00599248|444444|P4|STARTED|Overall Study||3
181326|NCT00599248|444445|P3|STARTED|Overall Study||3
181327|NCT00599248|444446|P2|STARTED|Overall Study||3
181328|NCT00599248|444447|P1|STARTED|Overall Study||3
181329|NCT00599313|444475|P1|NOT COMPLETED|Overall Study||36
181330|NCT00599313|444475|P1|COMPLETED|Overall Study||0
181331|NCT00599313|444475|P1|STARTED|Overall Study||36
181332|NCT00599326|444484|P1|NOT COMPLETED|Overall Study||2
181333|NCT00599326|444484|P1|COMPLETED|Overall Study||8
181334|NCT00599326|444484|P1|STARTED|Overall Study||10
181335|NCT00599339|444489|P1|NOT COMPLETED|Overall Study||664
181336|NCT00599339|444489|P1|COMPLETED|Overall Study||1531
181337|NCT00599339|444489|P1|Safety Set|Overall Study||2179
181338|NCT00599339|444489|P1|STARTED|Overall Study||2195
181339|NCT00599521|444593|P2|NOT COMPLETED|Overall Study||69
181340|NCT00599521|444594|P1|NOT COMPLETED|Overall Study||60
181341|NCT00599521|444593|P2|COMPLETED|Overall Study||462
181342|NCT00599521|444594|P1|COMPLETED|Overall Study||475
181343|NCT00599521|444593|P2|STARTED|Overall Study||531
181344|NCT00599521|444594|P1|STARTED|Overall Study||535
181345|NCT00590720|444610|P2|NOT COMPLETED|Overall Study||1
181346|NCT00590720|444611|P1|NOT COMPLETED|Overall Study||1
181347|NCT00590720|444610|P2|COMPLETED|Overall Study||6
181348|NCT00590720|444611|P1|COMPLETED|Overall Study||3
181349|NCT00590720|444610|P2|STARTED|Overall Study||7
181350|NCT00590720|444611|P1|STARTED|Overall Study||4
181351|NCT00590759|444653|P1|NOT COMPLETED|Overall Study||80
181352|NCT00590759|444653|P1|COMPLETED|Overall Study||70
181353|NCT00590759|444653|P1|STARTED|Overall Study||150
181354|NCT00590772|444658|P1|NOT COMPLETED|Overall Study||0
181355|NCT00590772|444658|P1|COMPLETED|Overall Study||31
181356|NCT00590772|444658|P1|STARTED|Overall Study||31
181357|NCT00590863|444667|P3|NOT COMPLETED|Overall Study||78
181358|NCT00590863|444668|P2|NOT COMPLETED|Overall Study||82
181359|NCT00590863|444669|P1|NOT COMPLETED|Overall Study||84
181360|NCT00590863|444667|P3|COMPLETED|Overall Study||146
181361|NCT00590863|444668|P2|COMPLETED|Overall Study||138
181362|NCT00590863|444669|P1|COMPLETED|Overall Study||137
181363|NCT00590863|444667|P3|STARTED|Overall Study||224
181364|NCT00590863|444668|P2|STARTED|Overall Study||220
181365|NCT00590863|444669|P1|STARTED|Overall Study||221
181366|NCT00590889|444682|P2|NOT COMPLETED|Overall Study||299
181367|NCT00590889|444683|P1|NOT COMPLETED|Overall Study||286
181368|NCT00590889|444682|P2|COMPLETED|Overall Study||104
181369|NCT00590889|444683|P1|COMPLETED|Overall Study||118
181370|NCT00590889|444682|P2|STARTED|Overall Study||403
181371|NCT00590889|444683|P1|STARTED|Overall Study||404
181372|NCT00590902|444689|P1|NOT COMPLETED|Overall Study||1
181373|NCT00590902|444689|P1|COMPLETED|Overall Study||80
181374|NCT00590902|444689|P1|STARTED|Overall Study||81
181375|NCT00590967|444695|P2|NOT COMPLETED|Overall Study||5
181376|NCT00590967|444696|P1|NOT COMPLETED|Overall Study||3
181377|NCT00590967|444695|P2|COMPLETED|Overall Study||20
181378|NCT00590967|444696|P1|COMPLETED|Overall Study||41
181379|NCT00590967|444695|P2|STARTED|Overall Study||25
181380|NCT00590967|444696|P1|STARTED|Overall Study||44
181381|NCT00591006|444708|P24|NOT COMPLETED|Overall Study||1
181382|NCT00591006|444709|P23|NOT COMPLETED|Overall Study||1
181383|NCT00591006|444710|P22|NOT COMPLETED|Overall Study||0
181384|NCT00591006|444711|P21|NOT COMPLETED|Overall Study||0
181385|NCT00591006|444712|P20|NOT COMPLETED|Overall Study||0
181386|NCT00591006|444713|P19|NOT COMPLETED|Overall Study||0
181387|NCT00591006|444714|P18|NOT COMPLETED|Overall Study||0
181388|NCT00591006|444715|P17|NOT COMPLETED|Overall Study||0
181389|NCT00591006|444716|P16|NOT COMPLETED|Overall Study||1
181390|NCT00591006|444717|P15|NOT COMPLETED|Overall Study||0
181391|NCT00591006|444718|P14|NOT COMPLETED|Overall Study||0
181392|NCT00591006|444719|P13|NOT COMPLETED|Overall Study||0
181393|NCT00591006|444720|P12|NOT COMPLETED|Overall Study||0
181394|NCT00591006|444721|P11|NOT COMPLETED|Overall Study||0
181395|NCT00591006|444722|P10|NOT COMPLETED|Overall Study||0
181396|NCT00591006|444723|P9|NOT COMPLETED|Overall Study||0
181397|NCT00591006|444724|P8|NOT COMPLETED|Overall Study||0
181398|NCT00591006|444725|P7|NOT COMPLETED|Overall Study||0
181399|NCT00591006|444726|P6|NOT COMPLETED|Overall Study||0
181400|NCT00591006|444727|P5|NOT COMPLETED|Overall Study||0
181401|NCT00591006|444728|P4|NOT COMPLETED|Overall Study||0
181402|NCT00591006|444729|P3|NOT COMPLETED|Overall Study||0
181403|NCT00591006|444730|P2|NOT COMPLETED|Overall Study||0
181404|NCT00591006|444731|P1|NOT COMPLETED|Overall Study||0
181405|NCT00591006|444708|P24|COMPLETED|Overall Study||0
181406|NCT00591006|444709|P23|COMPLETED|Overall Study||0
181407|NCT00591006|444710|P22|COMPLETED|Overall Study||1
181408|NCT00591006|444711|P21|COMPLETED|Overall Study||0
181409|NCT00591006|444712|P20|COMPLETED|Overall Study||1
181410|NCT00591006|444713|P19|COMPLETED|Overall Study||0
181411|NCT00591006|444714|P18|COMPLETED|Overall Study||1
181412|NCT00591006|444715|P17|COMPLETED|Overall Study||0
181413|NCT00591006|444716|P16|COMPLETED|Overall Study||0
181414|NCT00591006|444717|P15|COMPLETED|Overall Study||0
181415|NCT00591006|444718|P14|COMPLETED|Overall Study||2
181416|NCT00591006|444719|P13|COMPLETED|Overall Study||1
181417|NCT00591006|444720|P12|COMPLETED|Overall Study||1
181418|NCT00591006|444721|P11|COMPLETED|Overall Study||0
181419|NCT00591006|444722|P10|COMPLETED|Overall Study||1
181420|NCT00591006|444723|P9|COMPLETED|Overall Study||1
181421|NCT00591006|444724|P8|COMPLETED|Overall Study||0
181422|NCT00591006|444725|P7|COMPLETED|Overall Study||1
181423|NCT00591006|444726|P6|COMPLETED|Overall Study||0
181424|NCT00591006|444727|P5|COMPLETED|Overall Study||1
181425|NCT00591006|444728|P4|COMPLETED|Overall Study||1
181426|NCT00591006|444729|P3|COMPLETED|Overall Study||1
181427|NCT00591006|444730|P2|COMPLETED|Overall Study||0
181428|NCT00591006|444731|P1|COMPLETED|Overall Study||1
181429|NCT00591006|444708|P24|Treatment #4|Overall Study||0
181430|NCT00591006|444709|P23|Treatment #4|Overall Study||0
181431|NCT00591006|444710|P22|Treatment #4|Overall Study||1
181432|NCT00591006|444711|P21|Treatment #4|Overall Study||0
181433|NCT00591006|444712|P20|Treatment #4|Overall Study||1
181434|NCT00591006|444713|P19|Treatment #4|Overall Study||0
181435|NCT00591006|444714|P18|Treatment #4|Overall Study||1
181436|NCT00591006|444715|P17|Treatment #4|Overall Study||0
181437|NCT00591006|444716|P16|Treatment #4|Overall Study||0
181438|NCT00591006|444717|P15|Treatment #4|Overall Study||0
181439|NCT00591006|444718|P14|Treatment #4|Overall Study||2
181440|NCT00591006|444719|P13|Treatment #4|Overall Study||1
181441|NCT00591006|444720|P12|Treatment #4|Overall Study||1
181442|NCT00591006|444721|P11|Treatment #4|Overall Study||0
181443|NCT00591006|444722|P10|Treatment #4|Overall Study||1
181444|NCT00591006|444723|P9|Treatment #4|Overall Study||1
181445|NCT00591006|444724|P8|Treatment #4|Overall Study||0
181446|NCT00591006|444725|P7|Treatment #4|Overall Study||1
181447|NCT00591006|444726|P6|Treatment #4|Overall Study||0
181448|NCT00591006|444727|P5|Treatment #4|Overall Study||1
181449|NCT00591006|444728|P4|Treatment #4|Overall Study||1
181450|NCT00591006|444729|P3|Treatment #4|Overall Study||1
181451|NCT00591006|444730|P2|Treatment #4|Overall Study||0
181452|NCT00591006|444731|P1|Treatment #4|Overall Study||1
181453|NCT00591006|444708|P24|Treatment #3|Overall Study||1
181454|NCT00591006|444709|P23|Treatment #3|Overall Study||1
181455|NCT00591006|444710|P22|Treatment #3|Overall Study||1
181456|NCT00591006|444711|P21|Treatment #3|Overall Study||0
181457|NCT00591006|444712|P20|Treatment #3|Overall Study||1
181458|NCT00591006|444713|P19|Treatment #3|Overall Study||0
181459|NCT00591006|444714|P18|Treatment #3|Overall Study||1
181460|NCT00591006|444715|P17|Treatment #3|Overall Study||0
181461|NCT00591006|444716|P16|Treatment #3|Overall Study||0
181462|NCT00591006|444717|P15|Treatment #3|Overall Study||0
181463|NCT00591006|444718|P14|Treatment #3|Overall Study||2
181464|NCT00591006|444719|P13|Treatment #3|Overall Study||1
181465|NCT00591006|444720|P12|Treatment #3|Overall Study||1
181466|NCT00591006|444721|P11|Treatment #3|Overall Study||0
181467|NCT00591006|444722|P10|Treatment #3|Overall Study||1
181468|NCT00591006|444723|P9|Treatment #3|Overall Study||1
181469|NCT00591006|444724|P8|Treatment #3|Overall Study||0
181470|NCT00591006|444725|P7|Treatment #3|Overall Study||1
181471|NCT00591006|444726|P6|Treatment #3|Overall Study||0
181472|NCT00591006|444727|P5|Treatment #3|Overall Study||1
181473|NCT00591006|444728|P4|Treatment #3|Overall Study||1
181474|NCT00591006|444729|P3|Treatment #3|Overall Study||1
181475|NCT00591006|444730|P2|Treatment #3|Overall Study||0
181476|NCT00591006|444731|P1|Treatment #3|Overall Study||1
181477|NCT00591006|444708|P24|Treatment #2|Overall Study||1
181478|NCT00591006|444709|P23|Treatment #2|Overall Study||1
181479|NCT00591006|444710|P22|Treatment #2|Overall Study||1
181480|NCT00591006|444711|P21|Treatment #2|Overall Study||0
181481|NCT00591006|444712|P20|Treatment #2|Overall Study||1
181482|NCT00591006|444713|P19|Treatment #2|Overall Study||0
181483|NCT00591006|444714|P18|Treatment #2|Overall Study||1
181484|NCT00591006|444715|P17|Treatment #2|Overall Study||0
181485|NCT00591006|444716|P16|Treatment #2|Overall Study||0
181486|NCT00591006|444717|P15|Treatment #2|Overall Study||0
181487|NCT00591006|444718|P14|Treatment #2|Overall Study||2
181488|NCT00591006|444719|P13|Treatment #2|Overall Study||1
181489|NCT00591006|444720|P12|Treatment #2|Overall Study||1
181490|NCT00591006|444721|P11|Treatment #2|Overall Study||0
181491|NCT00591006|444722|P10|Treatment #2|Overall Study||1
181492|NCT00591006|444723|P9|Treatment #2|Overall Study||1
181493|NCT00591006|444724|P8|Treatment #2|Overall Study||0
181494|NCT00591006|444725|P7|Treatment #2|Overall Study||1
181495|NCT00591006|444726|P6|Treatment #2|Overall Study||0
181496|NCT00591006|444727|P5|Treatment #2|Overall Study||1
181497|NCT00591006|444728|P4|Treatment #2|Overall Study||1
181498|NCT00591006|444729|P3|Treatment #2|Overall Study||1
181499|NCT00591006|444730|P2|Treatment #2|Overall Study||0
181500|NCT00591006|444731|P1|Treatment #2|Overall Study||1
181501|NCT00591006|444708|P24|STARTED|Overall Study||1
181502|NCT00591006|444709|P23|STARTED|Overall Study||1
181503|NCT00591006|444710|P22|STARTED|Overall Study||1
181504|NCT00591006|444711|P21|STARTED|Overall Study||0
181505|NCT00591006|444712|P20|STARTED|Overall Study||1
181506|NCT00591006|444713|P19|STARTED|Overall Study||0
181507|NCT00591006|444714|P18|STARTED|Overall Study||1
181508|NCT00591006|444715|P17|STARTED|Overall Study||0
181509|NCT00591006|444716|P16|STARTED|Overall Study||1
181510|NCT00591006|444717|P15|STARTED|Overall Study||0
181511|NCT00591006|444718|P14|STARTED|Overall Study||2
181512|NCT00591006|444719|P13|STARTED|Overall Study||1
181513|NCT00591006|444720|P12|STARTED|Overall Study||1
181514|NCT00591006|444721|P11|STARTED|Overall Study||0
181515|NCT00591006|444722|P10|STARTED|Overall Study||1
181516|NCT00591006|444723|P9|STARTED|Overall Study||1
181517|NCT00591006|444724|P8|STARTED|Overall Study||0
181518|NCT00591006|444725|P7|STARTED|Overall Study||1
181519|NCT00591006|444726|P6|STARTED|Overall Study||0
181520|NCT00591006|444727|P5|STARTED|Overall Study||1
181521|NCT00591006|444728|P4|STARTED|Overall Study||1
181522|NCT00591006|444729|P3|STARTED|Overall Study||1
181523|NCT00591006|444730|P2|STARTED|Overall Study||0
181524|NCT00591006|444731|P1|STARTED|Overall Study||1
181525|NCT00591019|444749|P2|NOT COMPLETED|Intevention 2 (14 Days)||0
181526|NCT00591019|444750|P1|NOT COMPLETED|Intevention 2 (14 Days)||0
181527|NCT00591019|444749|P2|COMPLETED|Intevention 2 (14 Days)||3
181528|NCT00591019|444750|P1|COMPLETED|Intevention 2 (14 Days)||2
181529|NCT00591019|444749|P2|STARTED|Intevention 2 (14 Days)||3
181530|NCT00591019|444750|P1|STARTED|Intevention 2 (14 Days)||2
181531|NCT00591019|444749|P2|NOT COMPLETED|Intervention 1 (14 Days)||0
181532|NCT00591019|444750|P1|NOT COMPLETED|Intervention 1 (14 Days)||0
181533|NCT00591019|444749|P2|COMPLETED|Intervention 1 (14 Days)||3
181534|NCT00591019|444750|P1|COMPLETED|Intervention 1 (14 Days)||2
181535|NCT00591019|444749|P2|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|3
181536|NCT00591019|444750|P1|STARTED|Intervention 1 (14 Days)|One subject dropped out after baseline|2
181537|NCT00591019|444749|P2|NOT COMPLETED|Baseline (1 Day)||0
181538|NCT00591019|444750|P1|NOT COMPLETED|Baseline (1 Day)||0
181539|NCT00591019|444749|P2|COMPLETED|Baseline (1 Day)||4
181540|NCT00591019|444750|P1|COMPLETED|Baseline (1 Day)||3
181541|NCT00591019|444749|P2|STARTED|Baseline (1 Day)||4
181542|NCT00591019|444750|P1|STARTED|Baseline (1 Day)||3
181543|NCT00591149|444761|P1|NOT COMPLETED|Overall Study||5
181544|NCT00591149|444761|P1|COMPLETED|Overall Study||11
181545|NCT00591149|444761|P1|STARTED|Overall Study||16
181546|NCT00591214|444765|P1|NOT COMPLETED|Overall Study||8
181547|NCT00591214|444765|P1|COMPLETED|Overall Study||2
181548|NCT00591214|444765|P1|STARTED|Overall Study||10
181549|NCT00591227|444776|P2|NOT COMPLETED|Overall Study||0
181550|NCT00591227|444777|P1|NOT COMPLETED|Overall Study||0
181551|NCT00591227|444776|P2|COMPLETED|Overall Study||87
181552|NCT00591227|444777|P1|COMPLETED|Overall Study||89
181553|NCT00591227|444776|P2|STARTED|Overall Study||87
181554|NCT00591227|444777|P1|STARTED|Overall Study||89
181555|NCT00591240|444785|P2|NOT COMPLETED|Overall Study||0
181556|NCT00591240|444786|P1|NOT COMPLETED|Overall Study||0
181557|NCT00591240|444785|P2|COMPLETED|Overall Study||222
181558|NCT00591240|444786|P1|COMPLETED|Overall Study||116
181559|NCT00591240|444785|P2|STARTED|Overall Study||222
181560|NCT00591240|444786|P1|STARTED|Overall Study||116
181561|NCT00591253|444795|P3|NOT COMPLETED|Overall Study||15
181562|NCT00591253|444796|P2|NOT COMPLETED|Overall Study||21
181563|NCT00591253|444797|P1|NOT COMPLETED|Overall Study||14
181564|NCT00591253|444795|P3|COMPLETED|Overall Study||123
181565|NCT00591253|444796|P2|COMPLETED|Overall Study||116
181566|NCT00591253|444797|P1|COMPLETED|Overall Study||126
181567|NCT00591253|444795|P3|STARTED|Overall Study|Randomized or Treated|138
181568|NCT00591253|444796|P2|STARTED|Overall Study|Randomized or Treated|137
181569|NCT00591253|444797|P1|STARTED|Overall Study|Randomized or Treated|140
181570|NCT00591266|444850|P3|NOT COMPLETED|Overall Study||14
181571|NCT00591266|444851|P2|NOT COMPLETED|Overall Study||11
181572|NCT00591266|444852|P1|NOT COMPLETED|Overall Study||9
181573|NCT00591266|444850|P3|COMPLETED|Overall Study||175
181574|NCT00591266|444851|P2|COMPLETED|Overall Study||177
181575|NCT00591266|444852|P1|COMPLETED|Overall Study||180
181576|NCT00591266|444850|P3|STARTED|Overall Study|Randomized only|189
181577|NCT00591266|444851|P2|STARTED|Overall Study|Randomized only|188
181578|NCT00591266|444852|P1|STARTED|Overall Study|Randomized only|189
181579|NCT00591305|444904|P2|NOT COMPLETED|Overall Study||0
181580|NCT00591305|444905|P1|NOT COMPLETED|Overall Study||0
181581|NCT00591305|444904|P2|COMPLETED|Overall Study||0
181582|NCT00591305|444905|P1|COMPLETED|Overall Study||1
181583|NCT00591305|444904|P2|1st Follow-up in 2 Wks After Surgery|Overall Study||0
181584|NCT00591305|444905|P1|1st Follow-up in 2 Wks After Surgery|Overall Study||1
181585|NCT00591305|444904|P2|STARTED|Overall Study||0
181586|NCT00591305|444905|P1|STARTED|Overall Study||1
181587|NCT00591344|444917|P2|NOT COMPLETED|Overall Study||8
181588|NCT00591344|444918|P1|NOT COMPLETED|Overall Study||5
181589|NCT00591344|444917|P2|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|18
181590|NCT00591344|444918|P1|COMPLETED|Overall Study|Number of subjects who completed the final 24 month test|20
181591|NCT00591344|444917|P2|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
181592|NCT00591344|444918|P1|Completed the 6 Month Test|Overall Study|Number of subjects who completed the 6 month test|24
181593|NCT00591344|444917|P2|STARTED|Overall Study|26 randomized, 2 withdrew before the 6 month test and were replaced, 24 completed 6 month test|26
181594|NCT00591344|444918|P1|STARTED|Overall Study|25 randomized, 1 withdrew before the 6 month test and was replaced; 24 completed the 6 month test|25
181595|NCT00591370|444928|P1|NOT COMPLETED|Overall Study||2
181596|NCT00591370|444928|P1|COMPLETED|Overall Study||49
181597|NCT00591370|444928|P1|STARTED|Overall Study||51
181598|NCT00591565|444934|P1|NOT COMPLETED|Overall Study||5
181599|NCT00591565|444934|P1|COMPLETED|Overall Study||8
181600|NCT00591565|444934|P1|STARTED|Overall Study||13
181601|NCT00591578|444941|P3|NOT COMPLETED|Open-Label Extension Phase||0
181602|NCT00591578|444942|P2|NOT COMPLETED|Open-Label Extension Phase||10
181603|NCT00591578|444943|P1|NOT COMPLETED|Open-Label Extension Phase||6
181604|NCT00591578|444941|P3|COMPLETED|Open-Label Extension Phase||0
181605|NCT00591578|444942|P2|COMPLETED|Open-Label Extension Phase||105
181606|NCT00591578|444943|P1|COMPLETED|Open-Label Extension Phase||49
181607|NCT00591578|444941|P3|STARTED|Open-Label Extension Phase||0
181608|NCT00591578|444942|P2|STARTED|Open-Label Extension Phase||115
181609|NCT00591578|444943|P1|STARTED|Open-Label Extension Phase||55
181610|NCT00591578|444941|P3|NOT COMPLETED|Double-Blind Treatment Phase||84
181611|NCT00591578|444942|P2|NOT COMPLETED|Double-Blind Treatment Phase||80
181612|NCT00591578|444943|P1|NOT COMPLETED|Double-Blind Treatment Phase||78
181613|NCT00591578|444941|P3|COMPLETED|Double-Blind Treatment Phase||244
181614|NCT00591578|444942|P2|COMPLETED|Double-Blind Treatment Phase||249
181615|NCT00591578|444943|P1|COMPLETED|Double-Blind Treatment Phase||249
181616|NCT00591578|444941|P3|STARTED|Double-Blind Treatment Phase|Two participants randomized but not treated.|328
181617|NCT00591578|444942|P2|STARTED|Double-Blind Treatment Phase||329
181618|NCT00591578|444943|P1|STARTED|Double-Blind Treatment Phase||327
181619|NCT00591591|444996|P2|NOT COMPLETED|Overall Study||39
181620|NCT00591591|444997|P1|NOT COMPLETED|Overall Study||11
181621|NCT00591591|444996|P2|COMPLETED|Overall Study||94
181622|NCT00591591|444997|P1|COMPLETED|Overall Study||165
181623|NCT00591591|444996|P2|STARTED|Overall Study||133
181624|NCT00591591|444997|P1|STARTED|Overall Study||176
181625|NCT00591721|445013|P2|NOT COMPLETED|Overall Study||22
181626|NCT00591721|445014|P1|NOT COMPLETED|Overall Study||21
181627|NCT00591721|445013|P2|COMPLETED|Overall Study||70
181628|NCT00591721|445014|P1|COMPLETED|Overall Study||68
181629|NCT00591721|445013|P2|STARTED|Overall Study||92
181630|NCT00591721|445014|P1|STARTED|Overall Study||89
181631|NCT00591734|445020|P1|NOT COMPLETED|Overall Study||53
181632|NCT00591734|445020|P1|COMPLETED|Overall Study||4
181633|NCT00591734|445020|P1|STARTED|Overall Study||57
181634|NCT00591760|445026|P2|NOT COMPLETED|Overall Study||0
181635|NCT00591760|445027|P1|NOT COMPLETED|Overall Study||0
181636|NCT00591760|445026|P2|COMPLETED|Overall Study||28
181637|NCT00591760|445027|P1|COMPLETED|Overall Study||28
181638|NCT00591760|445026|P2|STARTED|Overall Study||28
181639|NCT00591760|445027|P1|STARTED|Overall Study||28
181640|NCT00591773|445036|P3|NOT COMPLETED|Overall Study||16
181641|NCT00591773|445037|P2|NOT COMPLETED|Overall Study||24
181642|NCT00591773|445038|P1|NOT COMPLETED|Overall Study||16
181643|NCT00591773|445036|P3|COMPLETED|Overall Study||168
181644|NCT00591773|445037|P2|COMPLETED|Overall Study||158
181645|NCT00591773|445038|P1|COMPLETED|Overall Study||169
181646|NCT00591773|445036|P3|STARTED|Overall Study||184
181647|NCT00591773|445037|P2|STARTED|Overall Study||182
181648|NCT00591773|445038|P1|STARTED|Overall Study||185
181649|NCT00591825|445092|P4|NOT COMPLETED|Overall Study||0
181650|NCT00591825|445093|P3|NOT COMPLETED|Overall Study||0
181651|NCT00591825|445094|P2|NOT COMPLETED|Overall Study||0
181652|NCT00591825|445095|P1|NOT COMPLETED|Overall Study||0
181653|NCT00591825|445092|P4|COMPLETED|Overall Study||14
181654|NCT00591825|445093|P3|COMPLETED|Overall Study||13
181655|NCT00591825|445094|P2|COMPLETED|Overall Study||13
181656|NCT00591825|445095|P1|COMPLETED|Overall Study||14
181657|NCT00591825|445092|P4|STARTED|Overall Study||14
181658|NCT00591825|445093|P3|STARTED|Overall Study||13
181659|NCT00591825|445094|P2|STARTED|Overall Study||13
181660|NCT00591825|445095|P1|STARTED|Overall Study||14
181661|NCT00591851|445121|P1|NOT COMPLETED|Overall Study||6
181662|NCT00591851|445121|P1|COMPLETED|Overall Study||64
181663|NCT00591851|445121|P1|STARTED|Overall Study||70
181664|NCT00591864|445125|P1|NOT COMPLETED|Overall Study||5
181665|NCT00591864|445125|P1|COMPLETED|Overall Study||84
181666|NCT00591864|445125|P1|STARTED|Overall Study||89
181667|NCT00592007|445131|P1|NOT COMPLETED|Overall Study||2
181668|NCT00592007|445131|P1|COMPLETED|Overall Study||5
181669|NCT00592007|445131|P1|STARTED|Overall Study||7
181670|NCT00592072|445136|P2|NOT COMPLETED|Second Sequence||0
181671|NCT00592072|445137|P1|NOT COMPLETED|Second Sequence||0
181672|NCT00592072|445136|P2|COMPLETED|Second Sequence||5
181673|NCT00592072|445137|P1|COMPLETED|Second Sequence||5
181674|NCT00592072|445136|P2|STARTED|Second Sequence||5
181675|NCT00592072|445137|P1|STARTED|Second Sequence||5
181676|NCT00592072|445136|P2|NOT COMPLETED|Wash Out Period||1
181677|NCT00592072|445137|P1|NOT COMPLETED|Wash Out Period||1
181678|NCT00592072|445136|P2|COMPLETED|Wash Out Period||5
181679|NCT00592072|445137|P1|COMPLETED|Wash Out Period||5
181680|NCT00592072|445136|P2|STARTED|Wash Out Period||6
181681|NCT00592072|445137|P1|STARTED|Wash Out Period||6
181682|NCT00592072|445136|P2|NOT COMPLETED|First Sequence||0
181683|NCT00592072|445137|P1|NOT COMPLETED|First Sequence||0
181684|NCT00592072|445136|P2|COMPLETED|First Sequence||6
181685|NCT00592072|445137|P1|COMPLETED|First Sequence||6
181686|NCT00592072|445136|P2|STARTED|First Sequence||6
181687|NCT00592072|445137|P1|STARTED|First Sequence||6
181688|NCT00592124|445165|P6|NOT COMPLETED|Overall Study||3
181689|NCT00592124|445166|P5|NOT COMPLETED|Overall Study||3
181690|NCT00592124|445167|P4|NOT COMPLETED|Overall Study||3
181691|NCT00592124|445168|P3|NOT COMPLETED|Overall Study||6
181692|NCT00592124|445169|P2|NOT COMPLETED|Overall Study||5
181693|NCT00592124|445170|P1|NOT COMPLETED|Overall Study||4
181694|NCT00592124|445165|P6|COMPLETED|Overall Study||24
181695|NCT00592124|445166|P5|COMPLETED|Overall Study||24
181696|NCT00592124|445167|P4|COMPLETED|Overall Study||24
181697|NCT00592124|445168|P3|COMPLETED|Overall Study||24
181698|NCT00592124|445169|P2|COMPLETED|Overall Study||24
181699|NCT00592124|445170|P1|COMPLETED|Overall Study||24
181700|NCT00592124|445165|P6|STARTED|Overall Study||27
181701|NCT00592124|445166|P5|STARTED|Overall Study||27
181702|NCT00592124|445167|P4|STARTED|Overall Study||27
181703|NCT00592124|445168|P3|STARTED|Overall Study||30
181704|NCT00592124|445169|P2|STARTED|Overall Study||29
181705|NCT00592124|445170|P1|STARTED|Overall Study||28
181706|NCT00592176|445221|P1|NOT COMPLETED|Overall Study||0
181707|NCT00592176|445221|P1|COMPLETED|Overall Study||5
181708|NCT00592176|445221|P1|STARTED|Overall Study||5
181709|NCT00592319|445228|P2|NOT COMPLETED|Overall Study||3
181710|NCT00592319|445229|P1|NOT COMPLETED|Overall Study||0
181711|NCT00592319|445228|P2|COMPLETED|Overall Study||5
181712|NCT00592319|445229|P1|COMPLETED|Overall Study||2
181713|NCT00592319|445228|P2|STARTED|Overall Study||8
181714|NCT00592319|445229|P1|STARTED|Overall Study||2
181715|NCT00592358|445237|P1|NOT COMPLETED|Overall Study||6
181716|NCT00592358|445237|P1|COMPLETED|Overall Study||11
181717|NCT00592358|445237|P1|STARTED|Overall Study||17
181718|NCT00592384|445244|P2|NOT COMPLETED|Overall Study||6
181719|NCT00592384|445245|P1|NOT COMPLETED|Overall Study||5
181720|NCT00592384|445244|P2|COMPLETED|Overall Study||63
181721|NCT00592384|445245|P1|COMPLETED|Overall Study||59
181722|NCT00592384|445244|P2|STARTED|Overall Study||69
181723|NCT00592384|445245|P1|STARTED|Overall Study||64
181724|NCT00592475|445256|P3|NOT COMPLETED|Overall Study||0
181725|NCT00592475|445257|P2|NOT COMPLETED|Overall Study||0
181726|NCT00592475|445258|P1|NOT COMPLETED|Overall Study||0
181727|NCT00592475|445256|P3|COMPLETED|Overall Study||5
181728|NCT00592475|445257|P2|COMPLETED|Overall Study||9
181729|NCT00592475|445258|P1|COMPLETED|Overall Study||6
181730|NCT00592475|445256|P3|STARTED|Overall Study||5
181731|NCT00592475|445257|P2|STARTED|Overall Study||9
181732|NCT00592475|445258|P1|STARTED|Overall Study||6
181733|NCT00592488|445283|P2|NOT COMPLETED|Overall Study||0
181734|NCT00592488|445284|P1|NOT COMPLETED|Overall Study||0
181735|NCT00592488|445283|P2|COMPLETED|Overall Study||7
181736|NCT00592488|445284|P1|COMPLETED|Overall Study||6
181737|NCT00592488|445283|P2|STARTED|Overall Study||7
181738|NCT00592488|445284|P1|STARTED|Overall Study||6
181739|NCT00592631|445292|P2|NOT COMPLETED|Overall Study||2
181740|NCT00592631|445293|P1|NOT COMPLETED|Overall Study||0
181741|NCT00592631|445292|P2|COMPLETED|Overall Study||9
181742|NCT00592631|445293|P1|COMPLETED|Overall Study||16
181743|NCT00592631|445292|P2|STARTED|Overall Study||11
181744|NCT00592631|445293|P1|STARTED|Overall Study||16
181745|NCT00592683|445301|P2|NOT COMPLETED|Overall Study||4
181746|NCT00592683|445302|P1|NOT COMPLETED|Overall Study||4
181747|NCT00592683|445301|P2|COMPLETED|Overall Study||6
181748|NCT00592683|445302|P1|COMPLETED|Overall Study||6
181749|NCT00592683|445301|P2|STARTED|Overall Study||10
181750|NCT00592683|445302|P1|STARTED|Overall Study||10
181751|NCT00592761|445310|P2|NOT COMPLETED|Second Intervention (2 Weeks)||0
181752|NCT00592761|445311|P1|NOT COMPLETED|Second Intervention (2 Weeks)||0
181753|NCT00592761|445310|P2|COMPLETED|Second Intervention (2 Weeks)||9
181754|NCT00592761|445311|P1|COMPLETED|Second Intervention (2 Weeks)||9
181755|NCT00592761|445310|P2|STARTED|Second Intervention (2 Weeks)||9
181756|NCT00592761|445311|P1|STARTED|Second Intervention (2 Weeks)||9
181757|NCT00592761|445310|P2|NOT COMPLETED|First Intervention (2 Weeks)||0
181758|NCT00592761|445311|P1|NOT COMPLETED|First Intervention (2 Weeks)||0
181759|NCT00592761|445310|P2|COMPLETED|First Intervention (2 Weeks)||9
181760|NCT00592761|445311|P1|COMPLETED|First Intervention (2 Weeks)||9
181761|NCT00592761|445310|P2|STARTED|First Intervention (2 Weeks)||9
181762|NCT00592761|445311|P1|STARTED|First Intervention (2 Weeks)||9
181763|NCT00592774|445328|P5|NOT COMPLETED|Overall Study||14
181764|NCT00592774|445329|P4|NOT COMPLETED|Overall Study||14
181765|NCT00592774|445330|P3|NOT COMPLETED|Overall Study||4
181766|NCT00592774|445331|P2|NOT COMPLETED|Overall Study||32
181767|NCT00592774|445332|P1|NOT COMPLETED|Overall Study||11
181768|NCT00592774|445328|P5|COMPLETED|Overall Study||9
181769|NCT00592774|445329|P4|COMPLETED|Overall Study||8
181770|NCT00592774|445330|P3|COMPLETED|Overall Study||18
181771|NCT00592774|445331|P2|COMPLETED|Overall Study||21
181772|NCT00592774|445332|P1|COMPLETED|Overall Study||15
181773|NCT00592774|445328|P5|STARTED|Overall Study||23
181774|NCT00592774|445329|P4|STARTED|Overall Study||22
181775|NCT00592774|445330|P3|STARTED|Overall Study||22
181776|NCT00592774|445331|P2|STARTED|Overall Study||53
181777|NCT00592774|445332|P1|STARTED|Overall Study||26
181778|NCT00592839|445392|P3|NOT COMPLETED|Overall Study||6
181779|NCT00592839|445393|P2|NOT COMPLETED|Overall Study||4
181780|NCT00592839|445394|P1|NOT COMPLETED|Overall Study||2
181781|NCT00592839|445392|P3|COMPLETED|Overall Study||46
181782|NCT00592839|445393|P2|COMPLETED|Overall Study||48
181783|NCT00592839|445394|P1|COMPLETED|Overall Study||51
181784|NCT00592839|445392|P3|STARTED|Overall Study||52
181785|NCT00592839|445393|P2|STARTED|Overall Study||52
181786|NCT00592839|445394|P1|STARTED|Overall Study||53
181787|NCT00592852|445417|P1|NOT COMPLETED|Overall Study||6
181788|NCT00592852|445417|P1|COMPLETED|Overall Study||7
181789|NCT00592852|445417|P1|STARTED|Overall Study||13
181790|NCT00592904|445426|P4|NOT COMPLETED|Overall Study||11
181791|NCT00592904|445427|P3|NOT COMPLETED|Overall Study||17
181792|NCT00592904|445428|P2|NOT COMPLETED|Overall Study||55
181793|NCT00592904|445429|P1|NOT COMPLETED|Overall Study||25
181794|NCT00592904|445426|P4|COMPLETED|Overall Study||19
181795|NCT00592904|445427|P3|COMPLETED|Overall Study||10
181796|NCT00592904|445428|P2|COMPLETED|Overall Study||93
181797|NCT00592904|445429|P1|COMPLETED|Overall Study||32
181798|NCT00592904|445426|P4|STARTED|Overall Study||30
181799|NCT00592904|445427|P3|STARTED|Overall Study||27
181800|NCT00592904|445428|P2|STARTED|Overall Study||148
181801|NCT00592904|445429|P1|STARTED|Overall Study||57
181802|NCT00592943|445457|P2|NOT COMPLETED|Overall Study||0
181803|NCT00592943|445458|P1|NOT COMPLETED|Overall Study||0
181804|NCT00592943|445457|P2|COMPLETED|Overall Study||6
181805|NCT00592943|445458|P1|COMPLETED|Overall Study||6
181806|NCT00592943|445457|P2|STARTED|Overall Study||6
181807|NCT00592943|445458|P1|STARTED|Overall Study||6
181808|NCT00593112|445470|P2|NOT COMPLETED|Overall Study||0
181809|NCT00593112|445471|P1|NOT COMPLETED|Overall Study||10
181810|NCT00593112|445470|P2|COMPLETED|Overall Study||12
181811|NCT00593112|445471|P1|COMPLETED|Overall Study||17
181812|NCT00593112|445470|P2|STARTED|Overall Study||12
181813|NCT00593112|445471|P1|STARTED|Overall Study||27
181814|NCT00599755|445481|P1|NOT COMPLETED|Overall Study||19
181815|NCT00599755|445481|P1|COMPLETED|Overall Study||49
181816|NCT00599755|445481|P1|STARTED|Overall Study||68
181817|NCT00599872|445492|P2|NOT COMPLETED|Overall Study||33
181818|NCT00599872|445493|P1|NOT COMPLETED|Overall Study||49
181819|NCT00599872|445492|P2|COMPLETED|Overall Study||181
181820|NCT00599872|445493|P1|COMPLETED|Overall Study||167
181821|NCT00599872|445492|P2|STARTED|Overall Study||214
181822|NCT00599872|445493|P1|STARTED|Overall Study||216
181823|NCT00599924|445516|P7|NOT COMPLETED|Overall Study||5
181824|NCT00599924|445517|P6|NOT COMPLETED|Overall Study||4
181825|NCT00599924|445518|P5|NOT COMPLETED|Overall Study||6
181826|NCT00599924|445519|P4|NOT COMPLETED|Overall Study||8
181827|NCT00599924|445520|P3|NOT COMPLETED|Overall Study||2
181828|NCT00599924|445521|P2|NOT COMPLETED|Overall Study||5
181829|NCT00599924|445522|P1|NOT COMPLETED|Overall Study||3
181830|NCT00599924|445516|P7|COMPLETED|Overall Study||3
181831|NCT00599924|445517|P6|COMPLETED|Overall Study||2
181832|NCT00599924|445518|P5|COMPLETED|Overall Study||3
181833|NCT00599924|445519|P4|COMPLETED|Overall Study||4
181834|NCT00599924|445520|P3|COMPLETED|Overall Study||3
181835|NCT00599924|445521|P2|COMPLETED|Overall Study||4
181836|NCT00599924|445522|P1|COMPLETED|Overall Study||1
181837|NCT00599924|445516|P7|STARTED|Overall Study||8
181838|NCT00599924|445517|P6|STARTED|Overall Study||6
181839|NCT00599924|445518|P5|STARTED|Overall Study||9
181840|NCT00599924|445519|P4|STARTED|Overall Study||12
181841|NCT00599924|445520|P3|STARTED|Overall Study||5
181842|NCT00599924|445521|P2|STARTED|Overall Study||9
181843|NCT00599924|445522|P1|STARTED|Overall Study||4
181844|NCT00601250|445609|P2|NOT COMPLETED|Overall Study||39
181845|NCT00601250|445610|P1|NOT COMPLETED|Overall Study||14
181846|NCT00601250|445609|P2|COMPLETED|Overall Study|number who completed treatment|484
181847|NCT00601250|445610|P1|COMPLETED|Overall Study|number who completed treatment|163
181848|NCT00601250|445609|P2|STARTED|Overall Study|number who started treatment. One additional patient was randomised but not treated.|523
181849|NCT00601250|445610|P1|STARTED|Overall Study|number who started treatment|177
181850|NCT00601354|445646|P2|NOT COMPLETED|Overall Study||5
181851|NCT00601354|445647|P1|NOT COMPLETED|Overall Study||4
181852|NCT00601354|445646|P2|COMPLETED|Overall Study||4
181853|NCT00601354|445647|P1|COMPLETED|Overall Study||4
181854|NCT00601354|445646|P2|STARTED|Overall Study||9
181855|NCT00601354|445647|P1|STARTED|Overall Study||8
181856|NCT00601367|445657|P1|NOT COMPLETED|Overall Study||187
181857|NCT00601367|445657|P1|COMPLETED|Overall Study||293
181858|NCT00601367|445657|P1|STARTED|Overall Study||480
181859|NCT00601419|445661|P1|NOT COMPLETED|Overall Study||4
181860|NCT00601419|445661|P1|COMPLETED|Overall Study||226
181861|NCT00601419|445661|P1|STARTED|Overall Study||230
181862|NCT00601458|445688|P3|NOT COMPLETED|Overall Study||2
181863|NCT00601458|445689|P2|NOT COMPLETED|Overall Study||5
181864|NCT00601458|445690|P1|NOT COMPLETED|Overall Study||4
181865|NCT00601458|445688|P3|COMPLETED|Overall Study||28
181866|NCT00601458|445689|P2|COMPLETED|Overall Study||29
181867|NCT00601458|445690|P1|COMPLETED|Overall Study||32
181868|NCT00601458|445688|P3|STARTED|Overall Study||30
181869|NCT00601458|445689|P2|STARTED|Overall Study||34
181870|NCT00601458|445690|P1|STARTED|Overall Study||36
181871|NCT00601523|445703|P2|NOT COMPLETED|Overall Study||26
181872|NCT00601523|445704|P1|NOT COMPLETED|Overall Study||77
181873|NCT00601523|445703|P2|COMPLETED|Overall Study||117
181874|NCT00601523|445704|P1|COMPLETED|Overall Study||291
181875|NCT00601523|445703|P2|STARTED|Overall Study||143
181876|NCT00601523|445704|P1|STARTED|Overall Study||368
181877|NCT00601627|445736|P1|NOT COMPLETED|Overall Study||0
181878|NCT00601627|445736|P1|COMPLETED|Overall Study||51
181879|NCT00601627|445736|P1|STARTED|Overall Study||51
181880|NCT00601640|445748|P3|NOT COMPLETED|Overall Study||10
181881|NCT00601640|445749|P2|NOT COMPLETED|Overall Study||5
181882|NCT00601640|445750|P1|NOT COMPLETED|Overall Study||5
181883|NCT00601640|445748|P3|COMPLETED|Overall Study||42
181884|NCT00601640|445749|P2|COMPLETED|Overall Study||47
181885|NCT00601640|445750|P1|COMPLETED|Overall Study||47
181886|NCT00601640|445748|P3|STARTED|Overall Study||52
181887|NCT00601640|445749|P2|STARTED|Overall Study||52
181888|NCT00601640|445750|P1|STARTED|Overall Study||52
181889|NCT00601718|445764|P1|NOT COMPLETED|Overall Study||0
181890|NCT00601718|445764|P1|COMPLETED|Overall Study||29
181891|NCT00601718|445764|P1|STARTED|Overall Study||29
181892|NCT00601731|445783|P4|NOT COMPLETED|Overall Study||1
181893|NCT00601731|445784|P3|NOT COMPLETED|Overall Study||15
181894|NCT00601731|445785|P2|NOT COMPLETED|Overall Study||0
181895|NCT00601731|445786|P1|NOT COMPLETED|Overall Study||23
181896|NCT00601731|445783|P4|COMPLETED|Overall Study||29
181897|NCT00601731|445784|P3|COMPLETED|Overall Study||151
181898|NCT00601731|445785|P2|COMPLETED|Overall Study||43
181899|NCT00601731|445786|P1|COMPLETED|Overall Study||120
181900|NCT00601731|445783|P4|STARTED|Overall Study||30
181901|NCT00601731|445784|P3|STARTED|Overall Study||166
181902|NCT00601731|445785|P2|STARTED|Overall Study||43
181903|NCT00601731|445786|P1|STARTED|Overall Study||143
181904|NCT00601796|445836|P1|NOT COMPLETED|Overall Study||0
181905|NCT00601796|445836|P1|COMPLETED|Overall Study||24
181906|NCT00601796|445836|P1|STARTED|Overall Study||24
181907|NCT00601835|445845|P2|NOT COMPLETED|Overall Study||14
181908|NCT00601835|445846|P1|NOT COMPLETED|Overall Study||60
181909|NCT00601835|445845|P2|COMPLETED|Overall Study||686
181910|NCT00601835|445846|P1|COMPLETED|Overall Study||2890
181911|NCT00601835|445845|P2|STARTED|Overall Study||700
181912|NCT00601835|445846|P1|STARTED|Overall Study||2950
181913|NCT00601900|445858|P2|NOT COMPLETED|Overall Study||3
181914|NCT00601900|445859|P1|NOT COMPLETED|Overall Study||0
181915|NCT00601900|445858|P2|COMPLETED|Overall Study||196
181916|NCT00601900|445859|P1|COMPLETED|Overall Study||195
181917|NCT00601900|445858|P2|STARTED|Overall Study||199
181918|NCT00601900|445859|P1|STARTED|Overall Study||195
181919|NCT00601926|445873|P1|NOT COMPLETED|Overall Study||0
181920|NCT00601926|445873|P1|COMPLETED|Overall Study||5
181921|NCT00601926|445873|P1|STARTED|Overall Study||5
181922|NCT00601952|445881|P2|NOT COMPLETED|Overall Study||0
181923|NCT00601952|445882|P1|NOT COMPLETED|Overall Study||2
181924|NCT00601952|445881|P2|COMPLETED|Overall Study||17
181925|NCT00601952|445882|P1|COMPLETED|Overall Study||12
181926|NCT00601952|445881|P2|STARTED|Overall Study||17
181927|NCT00601952|445882|P1|STARTED|Overall Study||14
181928|NCT00601965|445892|P4|NOT COMPLETED|Overall Study||1
181929|NCT00601965|445893|P3|NOT COMPLETED|Overall Study||0
181930|NCT00601965|445894|P2|NOT COMPLETED|Overall Study||2
181931|NCT00601965|445895|P1|NOT COMPLETED|Overall Study||0
181932|NCT00601965|445892|P4|COMPLETED|Overall Study||17
181933|NCT00601965|445893|P3|COMPLETED|Overall Study||19
181934|NCT00601965|445894|P2|COMPLETED|Overall Study||16
181935|NCT00601965|445895|P1|COMPLETED|Overall Study||18
181936|NCT00601965|445892|P4|STARTED|Overall Study||18
181937|NCT00601965|445893|P3|STARTED|Overall Study||19
181938|NCT00601965|445894|P2|STARTED|Overall Study||18
181939|NCT00601965|445895|P1|STARTED|Overall Study||18
181940|NCT00602043|445909|P1|NOT COMPLETED|Overall Study||5
181941|NCT00602043|445909|P1|COMPLETED|Overall Study||15
181942|NCT00602043|445909|P1|STARTED|Overall Study||20
181943|NCT00602290|445917|P3|NOT COMPLETED|Overall Study||1
181944|NCT00602290|445918|P2|NOT COMPLETED|Overall Study||2
181945|NCT00602290|445919|P1|NOT COMPLETED|Overall Study||2
181946|NCT00602290|445917|P3|COMPLETED|Overall Study||46
181947|NCT00602290|445918|P2|COMPLETED|Overall Study||46
181948|NCT00602290|445919|P1|COMPLETED|Overall Study||46
181949|NCT00602290|445917|P3|STARTED|Overall Study||47
181950|NCT00602290|445918|P2|STARTED|Overall Study||48
181951|NCT00602290|445919|P1|STARTED|Overall Study||48
181952|NCT00602355|445930|P3|NOT COMPLETED|Overall Study||10
181953|NCT00602355|445931|P2|NOT COMPLETED|Overall Study||18
181954|NCT00602355|445932|P1|NOT COMPLETED|Overall Study||9
181955|NCT00602355|445930|P3|COMPLETED|Overall Study||43
181956|NCT00602355|445931|P2|COMPLETED|Overall Study||38
181957|NCT00602355|445932|P1|COMPLETED|Overall Study||44
181958|NCT00602355|445930|P3|STARTED|Overall Study||53
181959|NCT00602355|445931|P2|STARTED|Overall Study||56
181960|NCT00602355|445932|P1|STARTED|Overall Study||53
181961|NCT00602420|445954|P2|NOT COMPLETED|Overall Study||24
181962|NCT00602420|445955|P1|NOT COMPLETED|Overall Study||25
181963|NCT00602420|445954|P2|COMPLETED|Overall Study||229
181964|NCT00602420|445955|P1|COMPLETED|Overall Study||232
181965|NCT00602420|445954|P2|STARTED|Overall Study||253
181966|NCT00602420|445955|P1|STARTED|Overall Study||257
181967|NCT00602446|445961|P1|NOT COMPLETED|Overall Study||0
181968|NCT00602446|445961|P1|COMPLETED|Overall Study||3
181969|NCT00602446|445961|P1|STARTED|Overall Study||3
181970|NCT00602459|445970|P4|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
181971|NCT00602459|445971|P3|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
181972|NCT00602459|445972|P2|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
181973|NCT00602459|445973|P1|NOT COMPLETED|Re-assignment After Del(11q22.3) Testing||0
181974|NCT00602459|445970|P4|COMPLETED|Re-assignment After Del(11q22.3) Testing||31
181975|NCT00602459|445971|P3|COMPLETED|Re-assignment After Del(11q22.3) Testing||137
181976|NCT00602459|445972|P2|COMPLETED|Re-assignment After Del(11q22.3) Testing||109
181977|NCT00602459|445973|P1|COMPLETED|Re-assignment After Del(11q22.3) Testing||123
181978|NCT00602459|445970|P4|STARTED|Re-assignment After Del(11q22.3) Testing||31
181979|NCT00602459|445971|P3|STARTED|Re-assignment After Del(11q22.3) Testing||137
181980|NCT00602459|445972|P2|STARTED|Re-assignment After Del(11q22.3) Testing||109
181981|NCT00602459|445973|P1|STARTED|Re-assignment After Del(11q22.3) Testing||123
181982|NCT00602459|445970|P4|NOT COMPLETED|Initial Registration/Randomization||0
181983|NCT00602459|445971|P3|NOT COMPLETED|Initial Registration/Randomization||3
181984|NCT00602459|445972|P2|NOT COMPLETED|Initial Registration/Randomization||10
181985|NCT00602459|445973|P1|NOT COMPLETED|Initial Registration/Randomization||5
181986|NCT00602459|445970|P4|COMPLETED|Initial Registration/Randomization||0
181987|NCT00602459|445971|P3|COMPLETED|Initial Registration/Randomization||137
181988|NCT00602459|445972|P2|COMPLETED|Initial Registration/Randomization||130
181989|NCT00602459|445973|P1|COMPLETED|Initial Registration/Randomization||133
181990|NCT00602459|445970|P4|STARTED|Initial Registration/Randomization||0
181991|NCT00602459|445971|P3|STARTED|Initial Registration/Randomization||140
181992|NCT00602459|445972|P2|STARTED|Initial Registration/Randomization||140
181993|NCT00602459|445973|P1|STARTED|Initial Registration/Randomization||138
181994|NCT00602472|445991|P2|NOT COMPLETED|Overall Study||58
181995|NCT00602472|445992|P1|NOT COMPLETED|Overall Study||21
181996|NCT00602472|445991|P2|COMPLETED|Overall Study|number who completed treatment|734
181997|NCT00602472|445992|P1|COMPLETED|Overall Study|number who completed treatment|242
181998|NCT00602472|445991|P2|STARTED|Overall Study|3 randomised patients never took medication.|792
181999|NCT00602472|445992|P1|STARTED|Overall Study|3 randomised patients never took medication.|263
182000|NCT00602537|446024|P2|NOT COMPLETED|Follow Up Study Comparison||3
182001|NCT00602537|446025|P1|NOT COMPLETED|Follow Up Study Comparison||11
182002|NCT00602537|446024|P2|COMPLETED|Follow Up Study Comparison||14
182003|NCT00602537|446025|P1|COMPLETED|Follow Up Study Comparison||31
182004|NCT00602537|446024|P2|STARTED|Follow Up Study Comparison||17
182005|NCT00602537|446025|P1|STARTED|Follow Up Study Comparison||42
182006|NCT00602537|446024|P2|NOT COMPLETED|12 Week Double Blind Comparison||47
182007|NCT00602537|446025|P1|NOT COMPLETED|12 Week Double Blind Comparison||23
182008|NCT00602537|446024|P2|COMPLETED|12 Week Double Blind Comparison||17
182009|NCT00602537|446025|P1|COMPLETED|12 Week Double Blind Comparison||42
182010|NCT00602537|446024|P2|Responded|12 Week Double Blind Comparison||22
182011|NCT00602537|446025|P1|Responded|12 Week Double Blind Comparison||44
182012|NCT00602537|446024|P2|STARTED|12 Week Double Blind Comparison||64
182013|NCT00602537|446025|P1|STARTED|12 Week Double Blind Comparison||65
182014|NCT00602641|446035|P2|NOT COMPLETED|Overall Study||152
182015|NCT00602641|446036|P1|NOT COMPLETED|Overall Study||154
182016|NCT00602641|446035|P2|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
182017|NCT00602641|446036|P1|COMPLETED|Overall Study|Treatment continued until progression of disease, unacceptable toxicity or patient withdrawal.|0
182018|NCT00602641|446035|P2|Started Protocol Therapy|Overall Study||150
182019|NCT00602641|446036|P1|Started Protocol Therapy|Overall Study||148
182020|NCT00602641|446035|P2|STARTED|Overall Study||152
182021|NCT00602641|446036|P1|STARTED|Overall Study||154
182022|NCT00602771|446050|P2|NOT COMPLETED|Overall Study||0
182023|NCT00602771|446051|P1|NOT COMPLETED|Overall Study||1
182024|NCT00602771|446050|P2|COMPLETED|Overall Study||21
182025|NCT00602771|446051|P1|COMPLETED|Overall Study||62
182026|NCT00602771|446050|P2|STARTED|Overall Study||21
182027|NCT00602771|446051|P1|STARTED|Overall Study||63
182028|NCT00602836|446057|P1|NOT COMPLETED|Overall Study||5
182029|NCT00602836|446057|P1|COMPLETED|Overall Study||39
182030|NCT00602836|446057|P1|STARTED|Overall Study||44
182031|NCT00602927|446063|P2|NOT COMPLETED|Period 3: 13 Days||3
182032|NCT00602927|446064|P1|NOT COMPLETED|Period 3: 13 Days||2
182033|NCT00602927|446063|P2|COMPLETED|Period 3: 13 Days||9
182034|NCT00602927|446064|P1|COMPLETED|Period 3: 13 Days||13
182035|NCT00602927|446063|P2|STARTED|Period 3: 13 Days||12
182036|NCT00602927|446064|P1|STARTED|Period 3: 13 Days||15
182037|NCT00602927|446063|P2|NOT COMPLETED|Period 2: 14 Days||2
182038|NCT00602927|446064|P1|NOT COMPLETED|Period 2: 14 Days||0
182039|NCT00602927|446063|P2|COMPLETED|Period 2: 14 Days||12
182040|NCT00602927|446064|P1|COMPLETED|Period 2: 14 Days||15
182041|NCT00602927|446063|P2|STARTED|Period 2: 14 Days||14
182042|NCT00602927|446064|P1|STARTED|Period 2: 14 Days||15
182043|NCT00602927|446063|P2|NOT COMPLETED|Period 1: 13 Days||5
182044|NCT00602927|446064|P1|NOT COMPLETED|Period 1: 13 Days||4
182045|NCT00602927|446063|P2|COMPLETED|Period 1: 13 Days||14
182046|NCT00602927|446064|P1|COMPLETED|Period 1: 13 Days||15
182047|NCT00602927|446063|P2|STARTED|Period 1: 13 Days||19
182048|NCT00602927|446064|P1|STARTED|Period 1: 13 Days||19
182049|NCT00602979|446077|P5|NOT COMPLETED|Overall Study||3
182050|NCT00602979|446078|P4|NOT COMPLETED|Overall Study||3
182051|NCT00602979|446079|P3|NOT COMPLETED|Overall Study||3
182052|NCT00602979|446080|P2|NOT COMPLETED|Overall Study||3
182053|NCT00602979|446081|P1|NOT COMPLETED|Overall Study||3
182054|NCT00602979|446077|P5|COMPLETED|Overall Study||45
182055|NCT00602979|446078|P4|COMPLETED|Overall Study||45
182056|NCT00602979|446079|P3|COMPLETED|Overall Study||45
182057|NCT00602979|446080|P2|COMPLETED|Overall Study||45
182058|NCT00602979|446081|P1|COMPLETED|Overall Study||45
182059|NCT00602979|446077|P5|STARTED|Overall Study||48
182060|NCT00602979|446078|P4|STARTED|Overall Study||48
182061|NCT00602979|446079|P3|STARTED|Overall Study||48
182062|NCT00602979|446080|P2|STARTED|Overall Study||48
182063|NCT00602979|446081|P1|STARTED|Overall Study||48
182064|NCT00603018|446093|P1|NOT COMPLETED|Overall Study||0
182065|NCT00603018|446093|P1|COMPLETED|Overall Study||23
182066|NCT00603018|446093|P1|STARTED|Overall Study||23
182067|NCT00603044|446100|P2|NOT COMPLETED|Overall Study||0
182068|NCT00603044|446101|P1|NOT COMPLETED|Overall Study||0
182069|NCT00603044|446100|P2|COMPLETED|Overall Study||13
182070|NCT00603044|446101|P1|COMPLETED|Overall Study||11
182071|NCT00603044|446100|P2|STARTED|Overall Study||13
182072|NCT00603044|446101|P1|STARTED|Overall Study||11
182073|NCT00603187|446117|P1|NOT COMPLETED|Overall Study||0
182074|NCT00603187|446117|P1|COMPLETED|Overall Study||4
182075|NCT00603187|446117|P1|STARTED|Overall Study||4
182076|NCT00603239|446125|P2|NOT COMPLETED|Overall Study||4
182077|NCT00603239|446126|P1|NOT COMPLETED|Overall Study||15
182078|NCT00603239|446125|P2|COMPLETED|Overall Study||50
182079|NCT00603239|446126|P1|COMPLETED|Overall Study||96
182080|NCT00603239|446125|P2|STARTED|Overall Study||54
182081|NCT00603239|446126|P1|STARTED|Overall Study||111
182082|NCT00603265|446155|P3|NOT COMPLETED|Overall Study||5
182083|NCT00603265|446156|P2|NOT COMPLETED|Overall Study||16
182084|NCT00603265|446157|P1|NOT COMPLETED|Overall Study||7
182085|NCT00603265|446155|P3|COMPLETED|Overall Study||67
182086|NCT00603265|446156|P2|COMPLETED|Overall Study||62
182087|NCT00603265|446157|P1|COMPLETED|Overall Study||69
182088|NCT00603265|446155|P3|Received at Least 1 Dose of Study Drug|Overall Study||72
182089|NCT00603265|446156|P2|Received at Least 1 Dose of Study Drug|Overall Study||78
182090|NCT00603265|446157|P1|Received at Least 1 Dose of Study Drug|Overall Study||75
182091|NCT00603265|446155|P3|STARTED|Overall Study||72
182092|NCT00603265|446156|P2|STARTED|Overall Study||78
182093|NCT00603265|446157|P1|STARTED|Overall Study|1 participant was randomized in error and did not receive study medication|76
182094|NCT00603278|446189|P6|NOT COMPLETED|Overall Study||19
182095|NCT00603278|446190|P5|NOT COMPLETED|Overall Study||13
182096|NCT00603278|446191|P4|NOT COMPLETED|Overall Study||11
182097|NCT00603278|446192|P3|NOT COMPLETED|Overall Study||14
182098|NCT00603278|446193|P2|NOT COMPLETED|Overall Study||17
182099|NCT00603278|446194|P1|NOT COMPLETED|Overall Study||41
182100|NCT00603278|446189|P6|COMPLETED|Overall Study||81
182101|NCT00603278|446190|P5|COMPLETED|Overall Study||86
182102|NCT00603278|446191|P4|COMPLETED|Overall Study||92
182103|NCT00603278|446192|P3|COMPLETED|Overall Study||87
182104|NCT00603278|446193|P2|COMPLETED|Overall Study||88
182105|NCT00603278|446194|P1|COMPLETED|Overall Study||66
182106|NCT00603278|446189|P6|STARTED|Overall Study||100
182107|NCT00603278|446190|P5|STARTED|Overall Study||99
182108|NCT00603278|446191|P4|STARTED|Overall Study||103
182109|NCT00603278|446192|P3|STARTED|Overall Study||101
182110|NCT00603278|446193|P2|STARTED|Overall Study||105
182111|NCT00603278|446194|P1|STARTED|Overall Study||107
182112|NCT00603291|446343|P3|NOT COMPLETED|Overall Study||96
182113|NCT00603291|446344|P2|NOT COMPLETED|Overall Study||87
182114|NCT00603291|446345|P1|NOT COMPLETED|Overall Study||20
182115|NCT00603291|446343|P3|COMPLETED|Overall Study||157
182116|NCT00603291|446344|P2|COMPLETED|Overall Study||169
182117|NCT00603291|446345|P1|COMPLETED|Overall Study||75
182118|NCT00603291|446343|P3|STARTED|Overall Study||253
182119|NCT00603291|446344|P2|STARTED|Overall Study||256
182120|NCT00603291|446345|P1|STARTED|Overall Study||95
182121|NCT00603304|446358|P2|NOT COMPLETED|Overall Study||31
182122|NCT00603304|446359|P1|NOT COMPLETED|Overall Study||32
182123|NCT00603304|446358|P2|COMPLETED|Overall Study||155
182124|NCT00603304|446359|P1|COMPLETED|Overall Study||151
182125|NCT00603304|446358|P2|STARTED|Overall Study||186
182126|NCT00603304|446359|P1|STARTED|Overall Study||183
182127|NCT00603382|446399|P6|NOT COMPLETED|Overall Study||18
182128|NCT00603382|446400|P5|NOT COMPLETED|Overall Study||9
182129|NCT00603382|446401|P4|NOT COMPLETED|Overall Study||12
182130|NCT00603382|446402|P3|NOT COMPLETED|Overall Study||9
182131|NCT00603382|446403|P2|NOT COMPLETED|Overall Study||14
182132|NCT00603382|446404|P1|NOT COMPLETED|Overall Study||18
182133|NCT00603382|446399|P6|COMPLETED|Overall Study||84
182134|NCT00603382|446400|P5|COMPLETED|Overall Study||86
182135|NCT00603382|446401|P4|COMPLETED|Overall Study||98
182136|NCT00603382|446402|P3|COMPLETED|Overall Study||91
182137|NCT00603382|446403|P2|COMPLETED|Overall Study||83
182138|NCT00603382|446404|P1|COMPLETED|Overall Study||76
182139|NCT00603382|446399|P6|STARTED|Overall Study||102
182140|NCT00603382|446400|P5|STARTED|Overall Study||95
182141|NCT00603382|446401|P4|STARTED|Overall Study||110
182142|NCT00603382|446402|P3|STARTED|Overall Study||100
182143|NCT00603382|446403|P2|STARTED|Overall Study||97
182144|NCT00603382|446404|P1|STARTED|Overall Study||94
182145|NCT00603408|446550|P1|NOT COMPLETED|Overall Study||0
182146|NCT00603408|446550|P1|COMPLETED|Overall Study||5
182147|NCT00603408|446550|P1|STARTED|Overall Study||5
182148|NCT00603447|446568|P7|NOT COMPLETED|Overall Study||24
182149|NCT00603447|446569|P6|NOT COMPLETED|Overall Study||2
182150|NCT00603447|446570|P5|NOT COMPLETED|Overall Study||5
182151|NCT00603447|446571|P4|NOT COMPLETED|Overall Study||2
182152|NCT00603447|446572|P3|NOT COMPLETED|Overall Study||2
182153|NCT00603447|446573|P2|NOT COMPLETED|Overall Study||3
182154|NCT00603447|446574|P1|NOT COMPLETED|Overall Study||0
182155|NCT00603447|446568|P7|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|20
182156|NCT00603447|446569|P6|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
182157|NCT00603447|446570|P5|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|1
182158|NCT00603447|446571|P4|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|4
182159|NCT00603447|446572|P3|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
182241|NCT00603590|446940|P2|Eight Months|Overall Study||194
182160|NCT00603447|446573|P2|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|3
182161|NCT00603447|446574|P1|COMPLETED|Overall Study|Participants on-going as of 08 May 2013, discontinued due to PD or completed treatment per protocol.|6
182162|NCT00603447|446568|P7|STARTED|Overall Study||44
182163|NCT00603447|446569|P6|STARTED|Overall Study||8
182164|NCT00603447|446570|P5|STARTED|Overall Study||6
182165|NCT00603447|446571|P4|STARTED|Overall Study||6
182166|NCT00603447|446572|P3|STARTED|Overall Study||8
182167|NCT00603447|446573|P2|STARTED|Overall Study||6
182168|NCT00603447|446574|P1|STARTED|Overall Study||6
182169|NCT00603473|446596|P1|NOT COMPLETED|Overall Study||9
182170|NCT00603473|446596|P1|COMPLETED|Overall Study||80
182171|NCT00603473|446596|P1|STARTED|Overall Study||89
182172|NCT00603512|446607|P5|NOT COMPLETED|Overall Study||5
182173|NCT00603512|446608|P4|NOT COMPLETED|Overall Study||7
182174|NCT00603512|446609|P3|NOT COMPLETED|Overall Study||5
182175|NCT00603512|446610|P2|NOT COMPLETED|Overall Study||5
182176|NCT00603512|446611|P1|NOT COMPLETED|Overall Study||2
182177|NCT00603512|446607|P5|COMPLETED|Overall Study||23
182178|NCT00603512|446608|P4|COMPLETED|Overall Study||21
182179|NCT00603512|446609|P3|COMPLETED|Overall Study||23
182180|NCT00603512|446610|P2|COMPLETED|Overall Study||23
182181|NCT00603512|446611|P1|COMPLETED|Overall Study||26
182182|NCT00603512|446607|P5|Treated|Overall Study||28
182183|NCT00603512|446608|P4|Treated|Overall Study||26
182184|NCT00603512|446609|P3|Treated|Overall Study||27
182185|NCT00603512|446610|P2|Treated|Overall Study||27
182186|NCT00603512|446611|P1|Treated|Overall Study||28
182187|NCT00603512|446607|P5|STARTED|Overall Study||28
182188|NCT00603512|446608|P4|STARTED|Overall Study||28
182189|NCT00603512|446609|P3|STARTED|Overall Study||28
182190|NCT00603512|446610|P2|STARTED|Overall Study||28
182191|NCT00603512|446611|P1|STARTED|Overall Study||28
182192|NCT00603525|446755|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||111
182193|NCT00603525|446756|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
182194|NCT00603525|446757|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
182195|NCT00603525|446755|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||13
182196|NCT00603525|446756|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
182197|NCT00603525|446757|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
182198|NCT00603525|446755|P3|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)|As par. were not on active drug during the Follow-up Period, withdrawal reasons were not collected.|111
182199|NCT00603525|446756|P2|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
182200|NCT00603525|446757|P1|Unknown Reason for Withdrawal|Follow-up Period (Approximately 2 Years)||0
182201|NCT00603525|446755|P3|STARTED|Follow-up Period (Approximately 2 Years)|124 participants (par) completing/withdrawing from the DB or OL Periods attended >=1 follow-up visit|124
182202|NCT00603525|446756|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
182203|NCT00603525|446757|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
182204|NCT00603525|446755|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
182205|NCT00603525|446756|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||112
182206|NCT00603525|446757|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
182207|NCT00603525|446755|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
182208|NCT00603525|446756|P2|COMPLETED|OL Treatment Period (120 Weeks)||13
182209|NCT00603525|446757|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
182210|NCT00603525|446755|P3|STARTED|OL Treatment Period (120 Weeks)||0
182211|NCT00603525|446756|P2|STARTED|OL Treatment Period (120 Weeks)|61 participants received OFA during the DB Period; 64 received placebo during the DB Period.|125
182212|NCT00603525|446757|P1|STARTED|OL Treatment Period (120 Weeks)||0
182213|NCT00603525|446755|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
182214|NCT00603525|446756|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||22
182215|NCT00603525|446757|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||17
182216|NCT00603525|446755|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
182217|NCT00603525|446756|P2|COMPLETED|DB Treatment Period (24 Weeks)||63
182218|NCT00603525|446757|P1|COMPLETED|DB Treatment Period (24 Weeks)||67
182219|NCT00603525|446755|P3|STARTED|DB Treatment Period (24 Weeks)||0
182220|NCT00603525|446756|P2|STARTED|DB Treatment Period (24 Weeks)||85
182221|NCT00603525|446757|P1|STARTED|DB Treatment Period (24 Weeks)||84
182222|NCT00603538|446887|P3|NOT COMPLETED|Overall Study||2
182223|NCT00603538|446888|P2|NOT COMPLETED|Overall Study||4
182224|NCT00603538|446889|P1|NOT COMPLETED|Overall Study||3
182225|NCT00603538|446887|P3|COMPLETED|Overall Study||4
182226|NCT00603538|446888|P2|COMPLETED|Overall Study||3
182227|NCT00603538|446889|P1|COMPLETED|Overall Study||3
182228|NCT00603538|446887|P3|STARTED|Overall Study||6
182229|NCT00603538|446888|P2|STARTED|Overall Study|Including one participant who discontinued from the study prior to CP-751,871 administration.|7
182230|NCT00603538|446889|P1|STARTED|Overall Study||6
182231|NCT00603564|446929|P2|NOT COMPLETED|Overall Study||0
182232|NCT00603564|446930|P1|NOT COMPLETED|Overall Study||0
182233|NCT00603564|446929|P2|COMPLETED|Overall Study|February 2008|27
182234|NCT00603564|446930|P1|COMPLETED|Overall Study|February 2008|20
182235|NCT00603564|446929|P2|STARTED|Overall Study|January 2006|27
182236|NCT00603564|446930|P1|STARTED|Overall Study|January 2006|20
182237|NCT00603590|446940|P2|NOT COMPLETED|Overall Study||51
182238|NCT00603590|446941|P1|NOT COMPLETED|Overall Study||76
182239|NCT00603590|446940|P2|COMPLETED|Overall Study||183
182240|NCT00603590|446941|P1|COMPLETED|Overall Study||165
182242|NCT00603590|446941|P1|Eight Months|Overall Study||178
182243|NCT00603590|446940|P2|Four Months|Overall Study||200
182244|NCT00603590|446941|P1|Four Months|Overall Study||187
182245|NCT00603590|446940|P2|One Month|Overall Study||212
182246|NCT00603590|446941|P1|One Month|Overall Study||204
182247|NCT00603590|446940|P2|STARTED|Overall Study||234
182248|NCT00603590|446941|P1|STARTED|Overall Study||241
182249|NCT00603642|446953|P2|NOT COMPLETED|Overall Study||0
182250|NCT00603642|446954|P1|NOT COMPLETED|Overall Study||0
182251|NCT00603642|446953|P2|COMPLETED|Overall Study||22
182252|NCT00603642|446954|P1|COMPLETED|Overall Study||12
182253|NCT00603642|446953|P2|STARTED|Overall Study||22
182254|NCT00603642|446954|P1|STARTED|Overall Study||12
182255|NCT00603733|446970|P2|NOT COMPLETED|Maintenance Phase ITT||16
182256|NCT00603733|446971|P1|NOT COMPLETED|Maintenance Phase ITT||10
182257|NCT00603733|446970|P2|COMPLETED|Maintenance Phase ITT||66
182258|NCT00603733|446971|P1|COMPLETED|Maintenance Phase ITT||61
182259|NCT00603733|446970|P2|STARTED|Maintenance Phase ITT||82
182260|NCT00603733|446971|P1|STARTED|Maintenance Phase ITT|Note:82 subjects randomized at Active phase & 71 at Run-In phase progressed to the maintenance phase|71
182261|NCT00603733|446970|P2|NOT COMPLETED|Run-In Phase - 4 Weeks||13
182262|NCT00603733|446971|P1|NOT COMPLETED|Run-In Phase - 4 Weeks||14
182263|NCT00603733|446970|P2|COMPLETED|Run-In Phase - 4 Weeks||36
182264|NCT00603733|446971|P1|COMPLETED|Run-In Phase - 4 Weeks||35
182265|NCT00603733|446970|P2|STARTED|Run-In Phase - 4 Weeks||49
182266|NCT00603733|446971|P1|STARTED|Run-In Phase - 4 Weeks|Note: Of the 98 subjects randomized at Run-In, 71 progressed into the maintenance phase.|49
182267|NCT00603733|446970|P2|NOT COMPLETED|Active Phase ITT||17
182268|NCT00603733|446971|P1|NOT COMPLETED|Active Phase ITT||11
182269|NCT00603733|446970|P2|COMPLETED|Active Phase ITT||78
182270|NCT00603733|446971|P1|COMPLETED|Active Phase ITT||84
182271|NCT00603733|446970|P2|STARTED|Active Phase ITT||95
182272|NCT00603733|446971|P1|STARTED|Active Phase ITT|Note: a total of 190 new participants were enrolled and randomized in the Active Phase|95
182273|NCT00603746|446987|P6|NOT COMPLETED|Overall Study||13
182274|NCT00603746|446988|P5|NOT COMPLETED|Overall Study||17
182275|NCT00603746|446989|P4|NOT COMPLETED|Overall Study||13
182276|NCT00603746|446990|P3|NOT COMPLETED|Overall Study||8
182277|NCT00603746|446991|P2|NOT COMPLETED|Overall Study||18
182278|NCT00603746|446992|P1|NOT COMPLETED|Overall Study||38
182279|NCT00603746|446987|P6|COMPLETED|Overall Study||97
182280|NCT00603746|446988|P5|COMPLETED|Overall Study||85
182281|NCT00603746|446989|P4|COMPLETED|Overall Study||94
182282|NCT00603746|446990|P3|COMPLETED|Overall Study||93
182283|NCT00603746|446991|P2|COMPLETED|Overall Study||81
182284|NCT00603746|446992|P1|COMPLETED|Overall Study||65
182285|NCT00603746|446987|P6|STARTED|Overall Study||110
182286|NCT00603746|446988|P5|STARTED|Overall Study||102
182287|NCT00603746|446989|P4|STARTED|Overall Study||107
182288|NCT00603746|446990|P3|STARTED|Overall Study||101
182289|NCT00603746|446991|P2|STARTED|Overall Study||99
182290|NCT00603746|446992|P1|STARTED|Overall Study||103
182291|NCT00589849|447138|P1|NOT COMPLETED|Overall Study||0
182292|NCT00589849|447138|P1|COMPLETED|Overall Study||32
182293|NCT00589849|447138|P1|STARTED|Overall Study||32
182294|NCT00589888|447142|P5|NOT COMPLETED|64-gram Oral Fat Load||0
182295|NCT00589888|447143|P4|NOT COMPLETED|64-gram Oral Fat Load||0
182296|NCT00589888|447144|P3|NOT COMPLETED|64-gram Oral Fat Load||0
182297|NCT00589888|447145|P2|NOT COMPLETED|64-gram Oral Fat Load||0
182298|NCT00589888|447146|P1|NOT COMPLETED|64-gram Oral Fat Load||0
182299|NCT00589888|447142|P5|COMPLETED|64-gram Oral Fat Load||13
182300|NCT00589888|447143|P4|COMPLETED|64-gram Oral Fat Load||0
182301|NCT00589888|447144|P3|COMPLETED|64-gram Oral Fat Load||0
182302|NCT00589888|447145|P2|COMPLETED|64-gram Oral Fat Load||0
182303|NCT00589888|447146|P1|COMPLETED|64-gram Oral Fat Load||0
182304|NCT00589888|447142|P5|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
182305|NCT00589888|447143|P4|STARTED|64-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
182306|NCT00589888|447144|P3|STARTED|64-gram Oral Fat Load||0
182307|NCT00589888|447145|P2|STARTED|64-gram Oral Fat Load||0
182308|NCT00589888|447146|P1|STARTED|64-gram Oral Fat Load||0
182309|NCT00589888|447142|P5|NOT COMPLETED|32-gram Oral Fat Load||0
182310|NCT00589888|447143|P4|NOT COMPLETED|32-gram Oral Fat Load||0
182311|NCT00589888|447144|P3|NOT COMPLETED|32-gram Oral Fat Load||0
182312|NCT00589888|447145|P2|NOT COMPLETED|32-gram Oral Fat Load||0
182313|NCT00589888|447146|P1|NOT COMPLETED|32-gram Oral Fat Load||0
182314|NCT00589888|447142|P5|COMPLETED|32-gram Oral Fat Load||0
182315|NCT00589888|447143|P4|COMPLETED|32-gram Oral Fat Load||13
182316|NCT00589888|447144|P3|COMPLETED|32-gram Oral Fat Load||0
182317|NCT00589888|447145|P2|COMPLETED|32-gram Oral Fat Load||0
182318|NCT00589888|447146|P1|COMPLETED|32-gram Oral Fat Load||0
182319|NCT00589888|447142|P5|STARTED|32-gram Oral Fat Load||0
182320|NCT00589888|447143|P4|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|13
182321|NCT00589888|447144|P3|STARTED|32-gram Oral Fat Load|the same 13 patients did each of the 5 arms at 5 different visits|0
182322|NCT00589888|447145|P2|STARTED|32-gram Oral Fat Load||0
182323|NCT00589888|447146|P1|STARTED|32-gram Oral Fat Load||0
182324|NCT00589888|447142|P5|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
182325|NCT00589888|447143|P4|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
182326|NCT00589888|447144|P3|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
182327|NCT00589888|447145|P2|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
182328|NCT00589888|447146|P1|NOT COMPLETED|Intralipid 20% @ 40cc/Hour||0
182329|NCT00589888|447142|P5|COMPLETED|Intralipid 20% @ 40cc/Hour||0
182330|NCT00589888|447143|P4|COMPLETED|Intralipid 20% @ 40cc/Hour||0
182331|NCT00589888|447144|P3|COMPLETED|Intralipid 20% @ 40cc/Hour||13
182332|NCT00589888|447145|P2|COMPLETED|Intralipid 20% @ 40cc/Hour||0
182333|NCT00589888|447146|P1|COMPLETED|Intralipid 20% @ 40cc/Hour||0
182334|NCT00589888|447142|P5|STARTED|Intralipid 20% @ 40cc/Hour||0
182335|NCT00589888|447143|P4|STARTED|Intralipid 20% @ 40cc/Hour||0
182336|NCT00589888|447144|P3|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
182337|NCT00589888|447145|P2|STARTED|Intralipid 20% @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|0
182338|NCT00589888|447146|P1|STARTED|Intralipid 20% @ 40cc/Hour||0
182339|NCT00589888|447142|P5|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
182340|NCT00589888|447143|P4|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
182341|NCT00589888|447144|P3|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
182342|NCT00589888|447145|P2|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
182343|NCT00589888|447146|P1|NOT COMPLETED|Intralipid 20% @ 20cc/hr||0
182344|NCT00589888|447142|P5|COMPLETED|Intralipid 20% @ 20cc/hr||0
182345|NCT00589888|447143|P4|COMPLETED|Intralipid 20% @ 20cc/hr||0
182346|NCT00589888|447144|P3|COMPLETED|Intralipid 20% @ 20cc/hr||0
182347|NCT00589888|447145|P2|COMPLETED|Intralipid 20% @ 20cc/hr||13
182348|NCT00589888|447146|P1|COMPLETED|Intralipid 20% @ 20cc/hr||0
182349|NCT00589888|447142|P5|STARTED|Intralipid 20% @ 20cc/hr||0
182350|NCT00589888|447143|P4|STARTED|Intralipid 20% @ 20cc/hr||0
182351|NCT00589888|447144|P3|STARTED|Intralipid 20% @ 20cc/hr||0
182352|NCT00589888|447145|P2|STARTED|Intralipid 20% @ 20cc/hr||13
182353|NCT00589888|447146|P1|STARTED|Intralipid 20% @ 20cc/hr|the same 13 patients did each of the 5 arms at 5 different visits|0
182354|NCT00589888|447142|P5|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
182355|NCT00589888|447143|P4|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
182356|NCT00589888|447144|P3|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
182357|NCT00589888|447145|P2|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
182358|NCT00589888|447146|P1|NOT COMPLETED|Normal Saline @ 40cc/Hour||0
182359|NCT00589888|447142|P5|COMPLETED|Normal Saline @ 40cc/Hour||0
182360|NCT00589888|447143|P4|COMPLETED|Normal Saline @ 40cc/Hour||0
182361|NCT00589888|447144|P3|COMPLETED|Normal Saline @ 40cc/Hour||0
182362|NCT00589888|447145|P2|COMPLETED|Normal Saline @ 40cc/Hour||0
182363|NCT00589888|447146|P1|COMPLETED|Normal Saline @ 40cc/Hour||13
182364|NCT00589888|447142|P5|STARTED|Normal Saline @ 40cc/Hour||0
182365|NCT00589888|447143|P4|STARTED|Normal Saline @ 40cc/Hour||0
182366|NCT00589888|447144|P3|STARTED|Normal Saline @ 40cc/Hour||0
182367|NCT00589888|447145|P2|STARTED|Normal Saline @ 40cc/Hour||0
182368|NCT00589888|447146|P1|STARTED|Normal Saline @ 40cc/Hour|the same 13 patients did each of the 5 arms at 5 different visits|13
182369|NCT00589914|447160|P2|NOT COMPLETED|Overall Study||137
182370|NCT00589914|447161|P1|NOT COMPLETED|Overall Study||150
182371|NCT00589914|447160|P2|COMPLETED|Overall Study||471
182372|NCT00589914|447161|P1|COMPLETED|Overall Study||456
182373|NCT00589914|447160|P2|STARTED|Overall Study||608
182374|NCT00589914|447161|P1|STARTED|Overall Study||606
182375|NCT00589979|447173|P3|NOT COMPLETED|Double-Blind Treatment Period 3||1
182376|NCT00589979|447174|P2|NOT COMPLETED|Double-Blind Treatment Period 3||1
182377|NCT00589979|447175|P1|NOT COMPLETED|Double-Blind Treatment Period 3||0
182378|NCT00589979|447173|P3|COMPLETED|Double-Blind Treatment Period 3||38
182379|NCT00589979|447174|P2|COMPLETED|Double-Blind Treatment Period 3||46
182380|NCT00589979|447175|P1|COMPLETED|Double-Blind Treatment Period 3||0
182381|NCT00589979|447173|P3|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|39
182382|NCT00589979|447174|P2|STARTED|Double-Blind Treatment Period 3|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|47
182383|NCT00589979|447175|P1|STARTED|Double-Blind Treatment Period 3||0
182384|NCT00589979|447173|P3|NOT COMPLETED|Double-Blind Treatment Period 2||2
182385|NCT00589979|447174|P2|NOT COMPLETED|Double-Blind Treatment Period 2||1
182386|NCT00589979|447175|P1|NOT COMPLETED|Double-Blind Treatment Period 2||0
182387|NCT00589979|447173|P3|COMPLETED|Double-Blind Treatment Period 2||39
182388|NCT00589979|447174|P2|COMPLETED|Double-Blind Treatment Period 2||47
182389|NCT00589979|447175|P1|COMPLETED|Double-Blind Treatment Period 2||0
182390|NCT00589979|447173|P3|STARTED|Double-Blind Treatment Period 2|N=20 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|41
182391|NCT00589979|447174|P2|STARTED|Double-Blind Treatment Period 2|N=19 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|48
182392|NCT00589979|447175|P1|STARTED|Double-Blind Treatment Period 2||0
182393|NCT00589979|447173|P3|NOT COMPLETED|Double-Blind Treatment Period 1||2
182394|NCT00589979|447174|P2|NOT COMPLETED|Double-Blind Treatment Period 1||2
182395|NCT00589979|447175|P1|NOT COMPLETED|Double-Blind Treatment Period 1||0
182396|NCT00589979|447173|P3|COMPLETED|Double-Blind Treatment Period 1||41
182397|NCT00589979|447174|P2|COMPLETED|Double-Blind Treatment Period 1||48
182398|NCT00589979|447175|P1|COMPLETED|Double-Blind Treatment Period 1||0
182399|NCT00589979|447173|P3|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|43
182400|NCT00589979|447174|P2|STARTED|Double-Blind Treatment Period 1|N=21 randomized on or after 22JAN2008; included in mod. intent-to-treat (MITT) analysis population.|50
182494|NCT00596271|447392|P1|NOT COMPLETED|Overall Study||5
182401|NCT00589979|447175|P1|STARTED|Double-Blind Treatment Period 1|Participants completing the Run-in Period were then randomized to two different treatment sequences.|0
182402|NCT00589979|447173|P3|NOT COMPLETED|Run-In Period||0
182403|NCT00589979|447174|P2|NOT COMPLETED|Run-In Period||0
182404|NCT00589979|447175|P1|NOT COMPLETED|Run-In Period||76
182405|NCT00589979|447173|P3|COMPLETED|Run-In Period||0
182406|NCT00589979|447174|P2|COMPLETED|Run-In Period||0
182407|NCT00589979|447175|P1|COMPLETED|Run-In Period||93
182408|NCT00589979|447173|P3|STARTED|Run-In Period||0
182409|NCT00589979|447174|P2|STARTED|Run-In Period||0
182410|NCT00589979|447175|P1|STARTED|Run-In Period||169
182411|NCT00590005|447212|P2|NOT COMPLETED|Overall Study||0
182412|NCT00590005|447213|P1|NOT COMPLETED|Overall Study||0
182413|NCT00590005|447212|P2|COMPLETED|Overall Study||119
182414|NCT00590005|447213|P1|COMPLETED|Overall Study||106
182415|NCT00590005|447212|P2|STARTED|Overall Study||119
182416|NCT00590005|447213|P1|STARTED|Overall Study||106
182417|NCT00590018|447223|P2|NOT COMPLETED|Overall Study||0
182418|NCT00590018|447224|P1|NOT COMPLETED|Overall Study||0
182419|NCT00590018|447223|P2|COMPLETED|Overall Study||9
182420|NCT00590018|447224|P1|COMPLETED|Overall Study||9
182421|NCT00590018|447223|P2|STARTED|Overall Study||9
182422|NCT00590018|447224|P1|STARTED|Overall Study||9
182423|NCT00590031|447232|P1|NOT COMPLETED|Overall Study||6
182424|NCT00590031|447232|P1|COMPLETED|Overall Study||55
182425|NCT00590031|447232|P1|STARTED|Overall Study||61
182426|NCT00590044|447239|P2|NOT COMPLETED|Overall Study||2
182427|NCT00590044|447240|P1|NOT COMPLETED|Overall Study||4
182428|NCT00590044|447239|P2|COMPLETED|Overall Study||34
182429|NCT00590044|447240|P1|COMPLETED|Overall Study||34
182430|NCT00590044|447239|P2|STARTED|Overall Study||36
182431|NCT00590044|447240|P1|STARTED|Overall Study||38
182432|NCT00590135|447246|P1|NOT COMPLETED|Overall Study||59
182433|NCT00590135|447246|P1|COMPLETED|Overall Study||0
182434|NCT00590135|447246|P1|STARTED|Overall Study||59
182435|NCT00590161|447256|P2|NOT COMPLETED|Overall Study||3
182436|NCT00590161|447257|P1|NOT COMPLETED|Overall Study||3
182437|NCT00590161|447256|P2|COMPLETED|Overall Study||26
182438|NCT00590161|447257|P1|COMPLETED|Overall Study||23
182439|NCT00590161|447256|P2|STARTED|Overall Study||29
182440|NCT00590161|447257|P1|STARTED|Overall Study||26
182441|NCT00590226|447265|P2|NOT COMPLETED|Overall Study||0
182442|NCT00590226|447266|P1|NOT COMPLETED|Overall Study||0
182443|NCT00590226|447265|P2|COMPLETED|Overall Study||63
182444|NCT00590226|447266|P1|COMPLETED|Overall Study||67
182445|NCT00590226|447265|P2|STARTED|Overall Study||63
182446|NCT00590226|447266|P1|STARTED|Overall Study||67
182447|NCT00590317|447276|P2|NOT COMPLETED|Overall Study||5
182448|NCT00590317|447277|P1|NOT COMPLETED|Overall Study||1
182449|NCT00590317|447276|P2|COMPLETED|Overall Study||27
182450|NCT00590317|447277|P1|COMPLETED|Overall Study||31
182451|NCT00590317|447276|P2|STARTED|Overall Study||32
182452|NCT00590317|447277|P1|STARTED|Overall Study||32
182453|NCT00590369|447289|P2|NOT COMPLETED|Overall Study||0
182454|NCT00590369|447290|P1|NOT COMPLETED|Overall Study||0
182455|NCT00590369|447289|P2|COMPLETED|Overall Study||5
182456|NCT00590369|447290|P1|COMPLETED|Overall Study|Study stopped early due to difficulty recruiting subjects|6
182457|NCT00590369|447289|P2|STARTED|Overall Study||5
182458|NCT00590369|447290|P1|STARTED|Overall Study||6
182459|NCT00590460|447306|P1|NOT COMPLETED|Overall Study||0
182460|NCT00590460|447306|P1|COMPLETED|Overall Study||5
182461|NCT00590460|447306|P1|STARTED|Overall Study||5
182462|NCT00590538|447318|P1|NOT COMPLETED|Overall Study||2
182463|NCT00590538|447318|P1|COMPLETED|Overall Study||7
182464|NCT00590538|447318|P1|STARTED|Overall Study|STUDY NOT UNBLINDED AT TIME OF TERMINATION; THEREFORE NUMBER ASSIGNED TO EACH GROUP IS NOT KNOWN.|9
182465|NCT00590564|447326|P1|NOT COMPLETED|Overall Study||18
182466|NCT00590564|447326|P1|COMPLETED|Overall Study||24
182467|NCT00590564|447326|P1|STARTED|Overall Study||42
182468|NCT00590577|447334|P4|NOT COMPLETED|Overall Study||93
182469|NCT00590577|447335|P3|NOT COMPLETED|Overall Study||73
182470|NCT00590577|447336|P2|NOT COMPLETED|Overall Study||76
182471|NCT00590577|447337|P1|NOT COMPLETED|Overall Study||77
182472|NCT00590577|447334|P4|COMPLETED|Overall Study||71
182473|NCT00590577|447335|P3|COMPLETED|Overall Study||90
182474|NCT00590577|447336|P2|COMPLETED|Overall Study||89
182475|NCT00590577|447337|P1|COMPLETED|Overall Study||83
182476|NCT00590577|447334|P4|STARTED|Overall Study||164
182477|NCT00590577|447335|P3|STARTED|Overall Study||163
182478|NCT00590577|447336|P2|STARTED|Overall Study||165
182479|NCT00590577|447337|P1|STARTED|Overall Study||160
182480|NCT00590590|447358|P3|NOT COMPLETED|Overall Study||6
182481|NCT00590590|447359|P2|NOT COMPLETED|Overall Study||6
182482|NCT00590590|447360|P1|NOT COMPLETED|Overall Study||7
182483|NCT00590590|447358|P3|COMPLETED|Overall Study||21
182484|NCT00590590|447359|P2|COMPLETED|Overall Study||33
182485|NCT00590590|447360|P1|COMPLETED|Overall Study||32
182486|NCT00590590|447358|P3|STARTED|Overall Study||27
182487|NCT00590590|447359|P2|STARTED|Overall Study||39
182488|NCT00590590|447360|P1|STARTED|Overall Study||39
182489|NCT00596167|447383|P1|NOT COMPLETED|Overall Study||0
182490|NCT00596167|447383|P1|COMPLETED|Overall Study||6
182491|NCT00596167|447383|P1|STARTED|Overall Study|All recruited subjects completed the study.|6
182492|NCT00596271|447390|P3|NOT COMPLETED|Overall Study||1
182493|NCT00596271|447391|P2|NOT COMPLETED|Overall Study||6
182495|NCT00596271|447390|P3|COMPLETED|Overall Study||61
182496|NCT00596271|447391|P2|COMPLETED|Overall Study||59
182497|NCT00596271|447392|P1|COMPLETED|Overall Study||60
182498|NCT00596271|447390|P3|STARTED|Overall Study||62
182499|NCT00596271|447391|P2|STARTED|Overall Study||65
182500|NCT00596271|447392|P1|STARTED|Overall Study||65
182501|NCT00596362|447401|P1|NOT COMPLETED|Overall Study||1
182502|NCT00596362|447401|P1|COMPLETED|Overall Study||0
182503|NCT00596362|447401|P1|STARTED|Overall Study||1
182504|NCT00596427|447407|P2|NOT COMPLETED|Overall Study||2
182505|NCT00596427|447408|P1|NOT COMPLETED|Overall Study||4
182506|NCT00596427|447407|P2|COMPLETED|Overall Study||28
182507|NCT00596427|447408|P1|COMPLETED|Overall Study||26
182508|NCT00596427|447407|P2|STARTED|Overall Study||30
182509|NCT00596427|447408|P1|STARTED|Overall Study||30
182510|NCT00596440|447438|P2|NOT COMPLETED|Overall Study||80
182511|NCT00596440|447439|P1|NOT COMPLETED|Overall Study||65
182512|NCT00596440|447438|P2|COMPLETED|Overall Study||41
182513|NCT00596440|447439|P1|COMPLETED|Overall Study||48
182514|NCT00596440|447438|P2|Showed to First Treatment Session|Overall Study||52
182515|NCT00596440|447439|P1|Showed to First Treatment Session|Overall Study||61
182516|NCT00596440|447438|P2|Showed to Eligibility Visit|Overall Study||72
182517|NCT00596440|447439|P1|Showed to Eligibility Visit|Overall Study||85
182518|NCT00596440|447438|P2|STARTED|Overall Study||121
182519|NCT00596440|447439|P1|STARTED|Overall Study||113
182520|NCT00596453|447451|P2|NOT COMPLETED|Overall Study||3
182521|NCT00596453|447452|P1|NOT COMPLETED|Overall Study||1
182522|NCT00596453|447451|P2|COMPLETED|Overall Study||12
182523|NCT00596453|447452|P1|COMPLETED|Overall Study||12
182524|NCT00596453|447451|P2|STARTED|Overall Study||15
182525|NCT00596453|447452|P1|STARTED|Overall Study||13
182526|NCT00596466|447458|P1|NOT COMPLETED|Overall Study||17
182527|NCT00596466|447458|P1|COMPLETED|Overall Study||58
182528|NCT00596466|447458|P1|Enrolled, Treated|Overall Study||73
182529|NCT00596466|447458|P1|STARTED|Overall Study||75
182530|NCT00596622|447467|P1|NOT COMPLETED|Overall Study||13
182531|NCT00596622|447467|P1|COMPLETED|Overall Study||33
182532|NCT00596622|447467|P1|STARTED|Overall Study||46
182533|NCT00596635|447479|P3|NOT COMPLETED|Overall Study||8
182534|NCT00596635|447480|P2|NOT COMPLETED|Overall Study||13
182535|NCT00596635|447481|P1|NOT COMPLETED|Overall Study||7
182536|NCT00596635|447479|P3|COMPLETED|Overall Study||11
182537|NCT00596635|447480|P2|COMPLETED|Overall Study||7
182538|NCT00596635|447481|P1|COMPLETED|Overall Study||10
182539|NCT00596635|447479|P3|STARTED|Overall Study||19
182540|NCT00596635|447480|P2|STARTED|Overall Study||20
182541|NCT00596635|447481|P1|STARTED|Overall Study||17
182542|NCT00596687|447497|P2|NOT COMPLETED|Overall Study||9
182543|NCT00596687|447498|P1|NOT COMPLETED|Overall Study||14
182544|NCT00596687|447497|P2|COMPLETED|Overall Study||107
182545|NCT00596687|447498|P1|COMPLETED|Overall Study||104
182546|NCT00596687|447497|P2|STARTED|Overall Study||116
182547|NCT00596687|447498|P1|STARTED|Overall Study||118
182548|NCT00596752|447508|P2|NOT COMPLETED|Overall Study||143
182549|NCT00596752|447509|P1|NOT COMPLETED|Overall Study||126
182550|NCT00596752|447508|P2|COMPLETED|Overall Study||282
182551|NCT00596752|447509|P1|COMPLETED|Overall Study||289
182552|NCT00596752|447508|P2|Randomized and Treated|Overall Study||424
182553|NCT00596752|447509|P1|Randomized and Treated|Overall Study||415
182554|NCT00596752|447508|P2|STARTED|Overall Study||425
182555|NCT00596752|447509|P1|STARTED|Overall Study||415
182556|NCT00596817|447540|P2|NOT COMPLETED|Double-blind Period||79
182557|NCT00596817|447541|P1|NOT COMPLETED|Double-blind Period||88
182558|NCT00596817|447540|P2|COMPLETED|Double-blind Period||125
182559|NCT00596817|447541|P1|COMPLETED|Double-blind Period||104
182560|NCT00596817|447540|P2|STARTED|Double-blind Period|206 patients were randomised. 2 did not receive study medication. 204 is FAS.|204
182561|NCT00596817|447541|P1|STARTED|Double-blind Period|194 patients were randomised. 2 did not receive study medication. 192 is full-analysis set (FAS).|192
182562|NCT00596817|447540|P2|NOT COMPLETED|Open-label Period to Double-blind Period||92
182563|NCT00596817|447541|P1|NOT COMPLETED|Open-label Period to Double-blind Period||0
182564|NCT00596817|447540|P2|COMPLETED|Open-label Period to Double-blind Period||400
182565|NCT00596817|447541|P1|COMPLETED|Open-label Period to Double-blind Period||0
182566|NCT00596817|447540|P2|STARTED|Open-label Period to Double-blind Period||492
182567|NCT00596817|447541|P1|STARTED|Open-label Period to Double-blind Period||0
182568|NCT00596817|447540|P2|NOT COMPLETED|Open-label Period||147
182569|NCT00596817|447541|P1|NOT COMPLETED|Open-label Period||0
182570|NCT00596817|447540|P2|COMPLETED|Open-label Period||492
182571|NCT00596817|447541|P1|COMPLETED|Open-label Period||0
182572|NCT00596817|447540|P2|STARTED|Open-label Period||639
182573|NCT00596817|447541|P1|STARTED|Open-label Period||0
182574|NCT00596830|447566|P2|NOT COMPLETED|Overall Study||339
182575|NCT00596830|447567|P1|NOT COMPLETED|Overall Study||342
182576|NCT00596830|447566|P2|COMPLETED|Overall Study||0
182577|NCT00596830|447567|P1|COMPLETED|Overall Study||0
182578|NCT00596830|447566|P2|Treated|Overall Study||332
182579|NCT00596830|447567|P1|Treated|Overall Study|1 participant in this group only received chemo and did not complete due to death.|339
182580|NCT00596830|447566|P2|STARTED|Overall Study||339
182581|NCT00596830|447567|P1|STARTED|Overall Study|1 participant in this group only received paclitaxel and carboplatin (chemo).|342
182582|NCT00596934|447590|P1|NOT COMPLETED|Overall Study||2
182583|NCT00596934|447590|P1|COMPLETED|Overall Study||7
182584|NCT00596934|447590|P1|STARTED|Overall Study||9
182585|NCT00596947|447603|P2|NOT COMPLETED|Overall Study||3
182586|NCT00596947|447604|P1|NOT COMPLETED|Overall Study||6
182587|NCT00596947|447603|P2|COMPLETED|Overall Study||6
182588|NCT00596947|447604|P1|COMPLETED|Overall Study||3
182589|NCT00596947|447603|P2|STARTED|Overall Study||9
182590|NCT00596947|447604|P1|STARTED|Overall Study||9
182591|NCT00596960|447646|P2|NOT COMPLETED|Overall Study||9
182592|NCT00596960|447647|P1|NOT COMPLETED|Overall Study||11
182593|NCT00596960|447646|P2|COMPLETED|Overall Study||60
182594|NCT00596960|447647|P1|COMPLETED|Overall Study||59
182595|NCT00596960|447646|P2|STARTED|Overall Study|One subject did not have any alcohol use data and thus was excluded from the statistical analysis|69
182596|NCT00596960|447647|P1|STARTED|Overall Study||70
182597|NCT00597012|447659|P2|NOT COMPLETED|Overall Study||8
182598|NCT00597012|447660|P1|NOT COMPLETED|Overall Study||13
182599|NCT00597012|447659|P2|COMPLETED|Overall Study||169
182600|NCT00597012|447660|P1|COMPLETED|Overall Study||161
182601|NCT00597012|447659|P2|STARTED|Overall Study||177
182602|NCT00597012|447660|P1|STARTED|Overall Study||174
182603|NCT00597038|447672|P2|NOT COMPLETED|Overall Study||4
182604|NCT00597038|447673|P1|NOT COMPLETED|Overall Study||2
182605|NCT00597038|447672|P2|COMPLETED|Overall Study|Two patients withdrew, one did not complete due to progressive disease, one patient died.|30
182606|NCT00597038|447673|P1|COMPLETED|Overall Study|One did not complete due to PI decision, one did not complete due to progressive disease.|14
182607|NCT00597038|447672|P2|STARTED|Overall Study||34
182608|NCT00597038|447673|P1|STARTED|Overall Study||16
182609|NCT00603798|447685|P3|NOT COMPLETED|Overall Study||10
182610|NCT00603798|447686|P2|NOT COMPLETED|Overall Study||7
182611|NCT00603798|447687|P1|NOT COMPLETED|Overall Study||10
182612|NCT00603798|447685|P3|COMPLETED|Overall Study||154
182613|NCT00603798|447686|P2|COMPLETED|Overall Study||157
182614|NCT00603798|447687|P1|COMPLETED|Overall Study||152
182615|NCT00603798|447685|P3|STARTED|Overall Study||164
182616|NCT00603798|447686|P2|STARTED|Overall Study||164
182617|NCT00603798|447687|P1|STARTED|Overall Study||162
182618|NCT00603837|447706|P2|NOT COMPLETED|Overall Study||0
182619|NCT00603837|447707|P1|NOT COMPLETED|Overall Study||3
182620|NCT00603837|447706|P2|COMPLETED|Overall Study||19
182621|NCT00603837|447707|P1|COMPLETED|Overall Study||17
182622|NCT00603837|447706|P2|STARTED|Overall Study||19
182623|NCT00603837|447707|P1|STARTED|Overall Study||20
182624|NCT00603889|447713|P1|NOT COMPLETED|Overall Study||0
182625|NCT00603889|447713|P1|COMPLETED|Overall Study||12
182626|NCT00603889|447713|P1|STARTED|Overall Study||12
182627|NCT00603902|447723|P3|NOT COMPLETED|Overall Study||769
182628|NCT00603902|447724|P2|NOT COMPLETED|Overall Study||686
182629|NCT00603902|447725|P1|NOT COMPLETED|Overall Study||329
182630|NCT00603902|447723|P3|COMPLETED|Overall Study||834
182631|NCT00603902|447724|P2|COMPLETED|Overall Study||917
182632|NCT00603902|447725|P1|COMPLETED|Overall Study||473
182633|NCT00603902|447723|P3|STARTED|Overall Study||1603
182634|NCT00603902|447724|P2|STARTED|Overall Study||1603
182635|NCT00603902|447725|P1|STARTED|Overall Study||802
182636|NCT00603915|447736|P1|NOT COMPLETED|Overall Study||1
182637|NCT00603915|447736|P1|COMPLETED|Overall Study||19
182638|NCT00603915|447736|P1|STARTED|Overall Study||20
182639|NCT00603993|447741|P1|NOT COMPLETED|Overall Study||20
182640|NCT00603993|447741|P1|COMPLETED|Overall Study||68
182641|NCT00603993|447741|P1|STARTED|Overall Study||88
182642|NCT00604019|447756|P2|NOT COMPLETED|Overall Study||0
182643|NCT00604019|447757|P1|NOT COMPLETED|Overall Study||0
182644|NCT00604019|447756|P2|COMPLETED|Overall Study||118
182645|NCT00604019|447757|P1|COMPLETED|Overall Study||134
182646|NCT00604019|447756|P2|STARTED|Overall Study||118
182647|NCT00604019|447757|P1|STARTED|Overall Study||134
182648|NCT00604045|447765|P2|NOT COMPLETED|Overall Study||1
182649|NCT00604045|447766|P1|NOT COMPLETED|Overall Study||1
182650|NCT00604045|447765|P2|COMPLETED|Overall Study||9
182651|NCT00604045|447766|P1|COMPLETED|Overall Study||14
182652|NCT00604045|447765|P2|STARTED|Overall Study||10
182653|NCT00604045|447766|P1|STARTED|Overall Study||15
182654|NCT00604383|447774|P2|NOT COMPLETED|Overall Study||84
182655|NCT00604383|447775|P1|NOT COMPLETED|Overall Study||87
182656|NCT00604383|447774|P2|COMPLETED|Overall Study||256
182657|NCT00604383|447775|P1|COMPLETED|Overall Study||258
182658|NCT00604383|447774|P2|Received Extended Treatment|Overall Study||141
182659|NCT00604383|447775|P1|Received Extended Treatment|Overall Study||136
182660|NCT00604383|447774|P2|Received at Least 1 Dose of Study Drug|Overall Study||340
182661|NCT00604383|447775|P1|Received at Least 1 Dose of Study Drug|Overall Study||345
182662|NCT00604383|447774|P2|STARTED|Overall Study||340
182663|NCT00604383|447775|P1|STARTED|Overall Study||345
182664|NCT00604461|447789|P1|NOT COMPLETED|Overall Study||1
182665|NCT00604461|447789|P1|COMPLETED|Overall Study|Death within 30 days of treatment occurred in 1 patient.|12
182666|NCT00604461|447789|P1|STARTED|Overall Study||13
182667|NCT00604500|447794|P1|NOT COMPLETED|Overall Study||11
182668|NCT00604500|447794|P1|COMPLETED|Overall Study|There were 233 participants who took at least 90% of the labeled actuations (Completer Population).|261
182669|NCT00604500|447794|P1|STARTED|Overall Study||272
182670|NCT00604552|447803|P2|NOT COMPLETED|Overall Study||0
182671|NCT00604552|447804|P1|NOT COMPLETED|Overall Study||0
182672|NCT00604552|447803|P2|COMPLETED|Overall Study||160
182673|NCT00604552|447804|P1|COMPLETED|Overall Study||189
182674|NCT00604552|447803|P2|STARTED|Overall Study||160
182675|NCT00604552|447804|P1|STARTED|Overall Study||189
182676|NCT00604565|447812|P2|NOT COMPLETED|Overall Study||3
182677|NCT00604565|447813|P1|NOT COMPLETED|Overall Study||0
182678|NCT00604565|447812|P2|COMPLETED|Overall Study||4
182679|NCT00604565|447813|P1|COMPLETED|Overall Study||4
182680|NCT00604565|447812|P2|STARTED|Overall Study||7
182681|NCT00604565|447813|P1|STARTED|Overall Study||4
182682|NCT00604669|447821|P1|NOT COMPLETED|Overall Study||7
182683|NCT00604669|447821|P1|COMPLETED|Overall Study||163
182684|NCT00604669|447821|P1|STARTED|Overall Study||170
182685|NCT00604695|447827|P2|NOT COMPLETED|Overall Study||4
182686|NCT00604695|447828|P1|NOT COMPLETED|Overall Study||0
182687|NCT00604695|447827|P2|COMPLETED|Overall Study||16
182688|NCT00604695|447828|P1|COMPLETED|Overall Study||20
182689|NCT00604695|447827|P2|STARTED|Overall Study||20
182690|NCT00604695|447828|P1|STARTED|Overall Study||20
182691|NCT00604708|447852|P2|NOT COMPLETED|Overall Study||40
182692|NCT00604708|447853|P1|NOT COMPLETED|Overall Study||31
182693|NCT00604708|447852|P2|COMPLETED|Overall Study||397
182694|NCT00604708|447853|P1|COMPLETED|Overall Study||399
182695|NCT00604708|447852|P2|STARTED|Overall Study||437
182696|NCT00604708|447853|P1|STARTED|Overall Study||430
182697|NCT00604721|447861|P1|NOT COMPLETED|Overall Study||2
182698|NCT00604721|447861|P1|COMPLETED|Overall Study|2 patients failed to complete a full cycle of therapy.|17
182699|NCT00604721|447861|P1|STARTED|Overall Study||19
182700|NCT00604786|447869|P2|NOT COMPLETED|Overall Study||0
182701|NCT00604786|447870|P1|NOT COMPLETED|Overall Study||2
182702|NCT00604786|447869|P2|COMPLETED|Overall Study||4
182703|NCT00604786|447870|P1|COMPLETED|Overall Study||12
182704|NCT00604786|447869|P2|STARTED|Overall Study||4
182705|NCT00604786|447870|P1|STARTED|Overall Study||14
182706|NCT00604812|447879|P6|NOT COMPLETED|Overall Study||0
182707|NCT00604812|447880|P5|NOT COMPLETED|Overall Study||0
182708|NCT00604812|447881|P4|NOT COMPLETED|Overall Study||0
182709|NCT00604812|447882|P3|NOT COMPLETED|Overall Study||0
182710|NCT00604812|447883|P2|NOT COMPLETED|Overall Study||0
182711|NCT00604812|447884|P1|NOT COMPLETED|Overall Study||0
182712|NCT00604812|447879|P6|COMPLETED|Overall Study||1
182713|NCT00604812|447880|P5|COMPLETED|Overall Study||5
182714|NCT00604812|447881|P4|COMPLETED|Overall Study||3
182715|NCT00604812|447882|P3|COMPLETED|Overall Study||10
182716|NCT00604812|447883|P2|COMPLETED|Overall Study||3
182717|NCT00604812|447884|P1|COMPLETED|Overall Study||9
182718|NCT00604812|447879|P6|STARTED|Overall Study||1
182719|NCT00604812|447880|P5|STARTED|Overall Study||5
182720|NCT00604812|447881|P4|STARTED|Overall Study||3
182721|NCT00604812|447882|P3|STARTED|Overall Study||10
182722|NCT00604812|447883|P2|STARTED|Overall Study||3
182723|NCT00604812|447884|P1|STARTED|Overall Study||9
182724|NCT00604851|447906|P2|NOT COMPLETED|Overall Study||26
182725|NCT00604851|447907|P1|NOT COMPLETED|Overall Study||17
182726|NCT00604851|447906|P2|COMPLETED|Overall Study||131
182727|NCT00604851|447907|P1|COMPLETED|Overall Study||132
182728|NCT00604851|447906|P2|STARTED|Overall Study||157
182729|NCT00604851|447907|P1|STARTED|Overall Study||149
182730|NCT00604968|447913|P1|NOT COMPLETED|Overall Study||0
182731|NCT00604968|447913|P1|COMPLETED|Overall Study|Due to the nature of study, all subjects receiving drug were considered to have completed.|25
182732|NCT00604968|447913|P1|STARTED|Overall Study||25
182733|NCT00605033|447928|P2|NOT COMPLETED|Overall Study||8
182734|NCT00605033|447929|P1|NOT COMPLETED|Overall Study||7
182735|NCT00605033|447928|P2|COMPLETED|Overall Study||90
182736|NCT00605033|447929|P1|COMPLETED|Overall Study||136
182737|NCT00605033|447928|P2|STARTED|Overall Study|One participant was randomized but withdrew before taking any study medication (treated n=97).|98
182738|NCT00605033|447929|P1|STARTED|Overall Study||143
182739|NCT00605072|447938|P3|NOT COMPLETED|Overall Study||4
182740|NCT00605072|447939|P2|NOT COMPLETED|Overall Study||11
182741|NCT00605072|447940|P1|NOT COMPLETED|Overall Study||7
182742|NCT00605072|447938|P3|COMPLETED|Overall Study||11
182743|NCT00605072|447939|P2|COMPLETED|Overall Study||9
182744|NCT00605072|447940|P1|COMPLETED|Overall Study||11
182745|NCT00605072|447938|P3|STARTED|Overall Study||15
182746|NCT00605072|447939|P2|STARTED|Overall Study||20
182747|NCT00605072|447940|P1|STARTED|Overall Study||18
182748|NCT00605085|447962|P2|NOT COMPLETED|Overall Study||25
182749|NCT00605085|447963|P1|NOT COMPLETED|Overall Study||50
182750|NCT00605085|447962|P2|COMPLETED|Overall Study||638
182751|NCT00605085|447963|P1|COMPLETED|Overall Study||1962
182752|NCT00605085|447962|P2|STARTED|Overall Study||663
182753|NCT00605085|447963|P1|STARTED|Overall Study||2012
182754|NCT00605150|447969|P1|NOT COMPLETED|Overall Study||1
182755|NCT00605150|447969|P1|COMPLETED|Overall Study||10
182756|NCT00605150|447969|P1|STARTED|Overall Study|11 started|11
182757|NCT00605176|447976|P3|NOT COMPLETED|Overall Study||9
182758|NCT00605176|447977|P2|NOT COMPLETED|Overall Study||6
182759|NCT00605176|447978|P1|NOT COMPLETED|Overall Study||11
182760|NCT00605176|447976|P3|COMPLETED|Overall Study||150
182761|NCT00605176|447977|P2|COMPLETED|Overall Study||154
182762|NCT00605176|447978|P1|COMPLETED|Overall Study||149
182763|NCT00605176|447976|P3|STARTED|Overall Study||159
182764|NCT00605176|447977|P2|STARTED|Overall Study||160
182765|NCT00605176|447978|P1|STARTED|Overall Study||160
182766|NCT00605202|447995|P2|NOT COMPLETED|Second Intervention||0
182767|NCT00605202|447996|P1|NOT COMPLETED|Second Intervention||0
182768|NCT00605202|447995|P2|COMPLETED|Second Intervention||5
182769|NCT00605202|447996|P1|COMPLETED|Second Intervention||5
182770|NCT00605202|447995|P2|STARTED|Second Intervention||5
182771|NCT00605202|447996|P1|STARTED|Second Intervention||5
182772|NCT00605202|447995|P2|NOT COMPLETED|Washout Period of 3 Weeks||0
182773|NCT00605202|447996|P1|NOT COMPLETED|Washout Period of 3 Weeks||0
182774|NCT00605202|447995|P2|COMPLETED|Washout Period of 3 Weeks||5
182775|NCT00605202|447996|P1|COMPLETED|Washout Period of 3 Weeks||5
182776|NCT00605202|447995|P2|STARTED|Washout Period of 3 Weeks||5
182777|NCT00605202|447996|P1|STARTED|Washout Period of 3 Weeks||5
182778|NCT00605202|447995|P2|NOT COMPLETED|First Intervention||0
182779|NCT00605202|447996|P1|NOT COMPLETED|First Intervention||0
182780|NCT00605202|447995|P2|COMPLETED|First Intervention||5
182781|NCT00605202|447996|P1|COMPLETED|First Intervention||5
182782|NCT00605202|447995|P2|STARTED|First Intervention||5
182783|NCT00605202|447996|P1|STARTED|First Intervention||5
182784|NCT00605267|448004|P2|NOT COMPLETED|Overall Study||9
182785|NCT00605267|448005|P1|NOT COMPLETED|Overall Study||3
182786|NCT00605267|448004|P2|COMPLETED|Overall Study|Breast surgery performed|90
182787|NCT00605267|448005|P1|COMPLETED|Overall Study|Breast surgery performed|95
182788|NCT00605267|448004|P2|STARTED|Overall Study||99
182789|NCT00605267|448005|P1|STARTED|Overall Study||98
182790|NCT00605280|448047|P4|NOT COMPLETED|Year 3 Extension||9
182791|NCT00605280|448048|P3|NOT COMPLETED|Year 3 Extension||0
182792|NCT00605280|448049|P2|NOT COMPLETED|Year 3 Extension||0
182793|NCT00605280|448050|P1|NOT COMPLETED|Year 3 Extension||8
182794|NCT00605280|448047|P4|COMPLETED|Year 3 Extension||45
182795|NCT00605280|448048|P3|COMPLETED|Year 3 Extension||0
182796|NCT00605280|448049|P2|COMPLETED|Year 3 Extension||0
182797|NCT00605280|448050|P1|COMPLETED|Year 3 Extension||38
182798|NCT00605280|448047|P4|Received 0.3 mg Treatment|Year 3 Extension||54
182799|NCT00605280|448048|P3|Received 0.3 mg Treatment|Year 3 Extension||0
182800|NCT00605280|448049|P2|Received 0.3 mg Treatment|Year 3 Extension||0
182801|NCT00605280|448050|P1|Received 0.3 mg Treatment|Year 3 Extension||46
182802|NCT00605280|448047|P4|STARTED|Year 3 Extension||54
182803|NCT00605280|448048|P3|STARTED|Year 3 Extension||0
182804|NCT00605280|448049|P2|STARTED|Year 3 Extension||0
182805|NCT00605280|448050|P1|STARTED|Year 3 Extension||46
182806|NCT00605280|448047|P4|NOT COMPLETED|Year 2||22
182807|NCT00605280|448048|P3|NOT COMPLETED|Year 2||6
182808|NCT00605280|448049|P2|NOT COMPLETED|Year 2||6
182809|NCT00605280|448050|P1|NOT COMPLETED|Year 2||24
182810|NCT00605280|448047|P4|COMPLETED|Year 2||102
182811|NCT00605280|448048|P3|COMPLETED|Year 2||0
182812|NCT00605280|448049|P2|COMPLETED|Year 2||5
182813|NCT00605280|448050|P1|COMPLETED|Year 2||102
182814|NCT00605280|448047|P4|Received 0.3 mg Treatment|Year 2||0
182815|NCT00605280|448048|P3|Received 0.3 mg Treatment|Year 2||2
182816|NCT00605280|448049|P2|Received 0.3 mg Treatment|Year 2||3
182817|NCT00605280|448050|P1|Received 0.3 mg Treatment|Year 2||126
182818|NCT00605280|448047|P4|STARTED|Year 2||124
182819|NCT00605280|448048|P3|STARTED|Year 2||6
182820|NCT00605280|448049|P2|STARTED|Year 2||11
182821|NCT00605280|448050|P1|STARTED|Year 2||126
182822|NCT00605280|448047|P4|NOT COMPLETED|Year 1||19
182823|NCT00605280|448048|P3|NOT COMPLETED|Year 1||1
182824|NCT00605280|448049|P2|NOT COMPLETED|Year 1||11
182825|NCT00605280|448050|P1|NOT COMPLETED|Year 1||19
182826|NCT00605280|448047|P4|COMPLETED|Year 1||124
182827|NCT00605280|448048|P3|COMPLETED|Year 1||6
182828|NCT00605280|448049|P2|COMPLETED|Year 1||11
182829|NCT00605280|448050|P1|COMPLETED|Year 1||126
182830|NCT00605280|448047|P4|Received 0.3 mg Treatment|Year 1||0
182831|NCT00605280|448048|P3|Received 0.3 mg Treatment|Year 1||3
182832|NCT00605280|448049|P2|Received 0.3 mg Treatment|Year 1||13
182833|NCT00605280|448050|P1|Received 0.3 mg Treatment|Year 1||144
182834|NCT00605280|448047|P4|STARTED|Year 1||143
182835|NCT00605280|448048|P3|STARTED|Year 1||7
182836|NCT00605280|448049|P2|STARTED|Year 1||22
182837|NCT00605280|448050|P1|STARTED|Year 1||145
182838|NCT00605293|448084|P2|NOT COMPLETED|Overall Study||5
182839|NCT00605293|448085|P1|NOT COMPLETED|Overall Study||17
182840|NCT00605293|448084|P2|COMPLETED|Overall Study||31
182841|NCT00605293|448085|P1|COMPLETED|Overall Study||48
182842|NCT00605293|448084|P2|STARTED|Overall Study||36
182843|NCT00605293|448085|P1|STARTED|Overall Study||65
182844|NCT00605306|448103|P2|NOT COMPLETED|Overall Study||1
182845|NCT00605306|448104|P1|NOT COMPLETED|Overall Study||0
182846|NCT00605306|448103|P2|COMPLETED|Overall Study||13
182847|NCT00605306|448104|P1|COMPLETED|Overall Study||14
182848|NCT00605306|448103|P2|STARTED|Overall Study||14
182849|NCT00605306|448104|P1|STARTED|Overall Study||14
182850|NCT00605345|448118|P2|NOT COMPLETED|Overall Study||3
182851|NCT00605345|448119|P1|NOT COMPLETED|Overall Study||1
182852|NCT00605345|448118|P2|COMPLETED|Overall Study||22
182853|NCT00605345|448119|P1|COMPLETED|Overall Study||45
182854|NCT00605345|448118|P2|STARTED|Overall Study||25
182855|NCT00605345|448119|P1|STARTED|Overall Study||46
182856|NCT00605358|448137|P2|NOT COMPLETED|Overall Study||0
182857|NCT00605358|448138|P1|NOT COMPLETED|Overall Study||0
182858|NCT00605358|448137|P2|COMPLETED|Overall Study||80
182859|NCT00605358|448138|P1|COMPLETED|Overall Study||81
182860|NCT00605358|448137|P2|STARTED|Overall Study||80
182861|NCT00605358|448138|P1|STARTED|Overall Study||81
182862|NCT00605384|448146|P2|NOT COMPLETED|Overall Study||1
182863|NCT00605384|448147|P1|NOT COMPLETED|Overall Study||1
182864|NCT00605384|448146|P2|COMPLETED|Overall Study|study terminated early|0
182865|NCT00605384|448147|P1|COMPLETED|Overall Study|study terminated early|0
182866|NCT00605384|448146|P2|STARTED|Overall Study||1
182867|NCT00605384|448147|P1|STARTED|Overall Study||1
182868|NCT00605423|448177|P2|NOT COMPLETED|Overall Study||0
182869|NCT00605423|448178|P1|NOT COMPLETED|Overall Study||0
182870|NCT00605423|448177|P2|COMPLETED|Overall Study||2
182871|NCT00605423|448178|P1|COMPLETED|Overall Study||4
182872|NCT00605423|448177|P2|STARTED|Overall Study||2
182873|NCT00605423|448178|P1|STARTED|Overall Study||4
182874|NCT00605475|448198|P10|NOT COMPLETED|Overall Study||2
182875|NCT00605475|448199|P9|NOT COMPLETED|Overall Study||2
182876|NCT00605475|448200|P8|NOT COMPLETED|Overall Study||0
182877|NCT00605475|448201|P7|NOT COMPLETED|Overall Study||1
182878|NCT00605475|448202|P6|NOT COMPLETED|Overall Study||2
182879|NCT00605475|448203|P5|NOT COMPLETED|Overall Study||1
182880|NCT00605475|448204|P4|NOT COMPLETED|Overall Study||0
182881|NCT00605475|448205|P3|NOT COMPLETED|Overall Study||0
182882|NCT00605475|448206|P2|NOT COMPLETED|Overall Study||0
182883|NCT00605475|448207|P1|NOT COMPLETED|Overall Study||0
182884|NCT00605475|448198|P10|COMPLETED|Overall Study||8
182885|NCT00605475|448199|P9|COMPLETED|Overall Study||18
182886|NCT00605475|448200|P8|COMPLETED|Overall Study||24
182887|NCT00605475|448201|P7|COMPLETED|Overall Study||22
182888|NCT00605475|448202|P6|COMPLETED|Overall Study||22
182889|NCT00605475|448203|P5|COMPLETED|Overall Study||24
182890|NCT00605475|448204|P4|COMPLETED|Overall Study||45
182891|NCT00605475|448205|P3|COMPLETED|Overall Study||45
182892|NCT00605475|448206|P2|COMPLETED|Overall Study||5
182893|NCT00605475|448207|P1|COMPLETED|Overall Study||10
182894|NCT00605475|448198|P10|STARTED|Overall Study||10
182895|NCT00605475|448199|P9|STARTED|Overall Study||20
182896|NCT00605475|448200|P8|STARTED|Overall Study||24
182897|NCT00605475|448201|P7|STARTED|Overall Study||23
182898|NCT00605475|448202|P6|STARTED|Overall Study||24
182899|NCT00605475|448203|P5|STARTED|Overall Study||25
182900|NCT00605475|448204|P4|STARTED|Overall Study||45
182901|NCT00605475|448205|P3|STARTED|Overall Study||45
182902|NCT00605475|448206|P2|STARTED|Overall Study||5
182903|NCT00605475|448207|P1|STARTED|Overall Study||10
182904|NCT00605540|448329|P1|NOT COMPLETED|Overall Study||38
182905|NCT00605540|448329|P1|COMPLETED|Overall Study||95
182906|NCT00605540|448329|P1|STARTED|Overall Study||133
182907|NCT00605657|448337|P1|NOT COMPLETED|Overall Study||2
182908|NCT00605657|448337|P1|COMPLETED|Overall Study||3
182909|NCT00605657|448337|P1|STARTED|Overall Study||5
182910|NCT00605696|448344|P2|NOT COMPLETED|Overall Study||0
182911|NCT00605696|448345|P1|NOT COMPLETED|Overall Study||0
182912|NCT00605696|448344|P2|COMPLETED|Overall Study||11
182913|NCT00605696|448345|P1|COMPLETED|Overall Study||7
182914|NCT00605696|448344|P2|STARTED|Overall Study||11
182915|NCT00605696|448345|P1|STARTED|Overall Study||7
182916|NCT00605722|448353|P1|NOT COMPLETED|Overall Study||51
182917|NCT00605722|448353|P1|COMPLETED|Overall Study|Completed=Completed Treatment.|0
182918|NCT00605722|448353|P1|STARTED|Overall Study||51
182919|NCT00605813|448363|P1|NOT COMPLETED|Overall Study||25
182920|NCT00605813|448363|P1|COMPLETED|Overall Study||517
182921|NCT00605813|448363|P1|STARTED|Overall Study||542
182922|NCT00605839|448379|P3|NOT COMPLETED|Overall Study||0
182923|NCT00605839|448380|P2|NOT COMPLETED|Overall Study||0
182924|NCT00605839|448381|P1|NOT COMPLETED|Overall Study||1
182925|NCT00605839|448379|P3|COMPLETED|Overall Study||28
182926|NCT00605839|448380|P2|COMPLETED|Overall Study||37
182927|NCT00605839|448381|P1|COMPLETED|Overall Study|One patient would not keep to the text messaging constraints and had to be removed.|39
182928|NCT00605839|448379|P3|STARTED|Overall Study||28
182929|NCT00605839|448380|P2|STARTED|Overall Study||37
182930|NCT00605839|448381|P1|STARTED|Overall Study||40
182931|NCT00605865|448389|P1|NOT COMPLETED|Overall Study||115
182932|NCT00605865|448389|P1|COMPLETED|Overall Study||2157
182933|NCT00605865|448389|P1|STARTED|Overall Study||2272
182934|NCT00605904|448430|P2|NOT COMPLETED|Infusion Sessions||3
182935|NCT00605904|448431|P1|NOT COMPLETED|Infusion Sessions||1
182936|NCT00605904|448430|P2|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|13
182937|NCT00605904|448431|P1|COMPLETED|Infusion Sessions|Subjects who completed all three types of infusion (given in a different order for each subject)|12
182938|NCT00605904|448430|P2|Yohimbine Infusion|Infusion Sessions|Milestones (infusions) were not received in the same order for each subjects so are not consecutive.|15
182939|NCT00605904|448431|P1|Yohimbine Infusion|Infusion Sessions||12
182940|NCT00605904|448430|P2|mCPP Infusion|Infusion Sessions||13
182941|NCT00605904|448431|P1|mCPP Infusion|Infusion Sessions||12
182942|NCT00605904|448430|P2|Saline Infusion|Infusion Sessions||14
182943|NCT00605904|448431|P1|Saline Infusion|Infusion Sessions||13
182944|NCT00605904|448430|P2|STARTED|Infusion Sessions||16
182945|NCT00605904|448431|P1|STARTED|Infusion Sessions||13
182946|NCT00605904|448430|P2|NOT COMPLETED|Baseline Data Collection and Dosing||5
182947|NCT00605904|448431|P1|NOT COMPLETED|Baseline Data Collection and Dosing||0
182948|NCT00605904|448430|P2|COMPLETED|Baseline Data Collection and Dosing||16
182949|NCT00605904|448431|P1|COMPLETED|Baseline Data Collection and Dosing||13
182950|NCT00605904|448430|P2|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|21
183046|NCT00606593|448667|P6|NOT COMPLETED|Overall Study||0
182951|NCT00605904|448431|P1|STARTED|Baseline Data Collection and Dosing|While 37 subjects were enrolled in the protocol, only 34 were randomized to a study arm|13
182952|NCT00605917|448441|P1|NOT COMPLETED|Overall Study||79
182953|NCT00605917|448441|P1|COMPLETED|Overall Study||908
182954|NCT00605917|448441|P1|STARTED|Overall Study||987
182955|NCT00606008|448480|P1|NOT COMPLETED|Overall Study||5
182956|NCT00606008|448480|P1|COMPLETED|Overall Study||25
182957|NCT00606008|448480|P1|STARTED|Overall Study||30
182958|NCT00606021|448496|P3|NOT COMPLETED|Maintenance Phase||17
182959|NCT00606021|448497|P2|NOT COMPLETED|Maintenance Phase||23
182960|NCT00606021|448498|P1|NOT COMPLETED|Maintenance Phase||0
182961|NCT00606021|448496|P3|COMPLETED|Maintenance Phase||10
182962|NCT00606021|448497|P2|COMPLETED|Maintenance Phase||5
182963|NCT00606021|448498|P1|COMPLETED|Maintenance Phase||0
182964|NCT00606021|448496|P3|STARTED|Maintenance Phase||27
182965|NCT00606021|448497|P2|STARTED|Maintenance Phase||28
182966|NCT00606021|448498|P1|STARTED|Maintenance Phase||0
182967|NCT00606021|448496|P3|NOT COMPLETED|Induction Phase||0
182968|NCT00606021|448497|P2|NOT COMPLETED|Induction Phase||0
182969|NCT00606021|448498|P1|NOT COMPLETED|Induction Phase||87
182970|NCT00606021|448496|P3|COMPLETED|Induction Phase||0
182971|NCT00606021|448497|P2|COMPLETED|Induction Phase||0
182972|NCT00606021|448498|P1|COMPLETED|Induction Phase||19
182973|NCT00606021|448496|P3|STARTED|Induction Phase||0
182974|NCT00606021|448497|P2|STARTED|Induction Phase||0
182975|NCT00606021|448498|P1|STARTED|Induction Phase||106
182976|NCT00606034|448516|P1|NOT COMPLETED|Overall Study||1
182977|NCT00606034|448516|P1|COMPLETED|Overall Study||20
182978|NCT00606034|448516|P1|STARTED|Overall Study||21
182979|NCT00606086|448524|P2|NOT COMPLETED|Overall Study||15
182980|NCT00606086|448525|P1|NOT COMPLETED|Overall Study||12
182981|NCT00606086|448524|P2|COMPLETED|Overall Study||53
182982|NCT00606086|448525|P1|COMPLETED|Overall Study||60
182983|NCT00606086|448524|P2|STARTED|Overall Study||68
182984|NCT00606086|448525|P1|STARTED|Overall Study||72
182985|NCT00606138|448533|P2|NOT COMPLETED|Overall Study||0
182986|NCT00606138|448534|P1|NOT COMPLETED|Overall Study||0
182987|NCT00606138|448533|P2|COMPLETED|Overall Study||2
182988|NCT00606138|448534|P1|COMPLETED|Overall Study||6
182989|NCT00606138|448533|P2|STARTED|Overall Study||2
182990|NCT00606138|448534|P1|STARTED|Overall Study||6
182991|NCT00606177|448550|P2|NOT COMPLETED|Overall Study||25
182992|NCT00606177|448551|P1|NOT COMPLETED|Overall Study||27
182993|NCT00606177|448550|P2|COMPLETED|Overall Study||19
182994|NCT00606177|448551|P1|COMPLETED|Overall Study||28
182995|NCT00606177|448550|P2|STARTED|Overall Study||44
182996|NCT00606177|448551|P1|STARTED|Overall Study||55
182997|NCT00606229|448559|P1|NOT COMPLETED|Overall Study||22
182998|NCT00606229|448559|P1|COMPLETED|Overall Study||19
182999|NCT00606229|448559|P1|STARTED|Overall Study||41
183000|NCT00606281|448566|P2|NOT COMPLETED|Overall Study||66
183001|NCT00606281|448567|P1|NOT COMPLETED|Overall Study||56
183002|NCT00606281|448566|P2|COMPLETED|Overall Study||64
183003|NCT00606281|448567|P1|COMPLETED|Overall Study||72
183004|NCT00606281|448566|P2|STARTED|Overall Study||130
183005|NCT00606281|448567|P1|STARTED|Overall Study||128
183006|NCT00606320|448575|P1|NOT COMPLETED|Overall Study||37
183007|NCT00606320|448575|P1|COMPLETED|Overall Study||22
183008|NCT00606320|448575|P1|STARTED|Overall Study||59
183009|NCT00606489|448582|P2|NOT COMPLETED|Overall Study||0
183010|NCT00606489|448583|P1|NOT COMPLETED|Overall Study||0
183011|NCT00606489|448582|P2|COMPLETED|Overall Study||40
183012|NCT00606489|448583|P1|COMPLETED|Overall Study||21
183013|NCT00606489|448582|P2|STARTED|Overall Study||40
183014|NCT00606489|448583|P1|STARTED|Overall Study||21
183015|NCT00606502|448591|P2|NOT COMPLETED|Treatment||3
183016|NCT00606502|448592|P1|NOT COMPLETED|Treatment||0
183017|NCT00606502|448591|P2|COMPLETED|Treatment||98
183018|NCT00606502|448592|P1|COMPLETED|Treatment||97
183019|NCT00606502|448591|P2|STARTED|Treatment||101
183020|NCT00606502|448592|P1|STARTED|Treatment||97
183021|NCT00606502|448591|P2|NOT COMPLETED|Randomization||0
183022|NCT00606502|448592|P1|NOT COMPLETED|Randomization||3
183023|NCT00606502|448591|P2|COMPLETED|Randomization||101
183024|NCT00606502|448592|P1|COMPLETED|Randomization||97
183025|NCT00606502|448591|P2|STARTED|Randomization||101
183026|NCT00606502|448592|P1|STARTED|Randomization||100
183027|NCT00606554|448606|P2|NOT COMPLETED|Overall Study||0
183028|NCT00606554|448607|P1|NOT COMPLETED|Overall Study||0
183029|NCT00606554|448606|P2|COMPLETED|Overall Study||18
183030|NCT00606554|448607|P1|COMPLETED|Overall Study||15
183031|NCT00606554|448606|P2|STARTED|Overall Study||18
183032|NCT00606554|448607|P1|STARTED|Overall Study||15
183033|NCT00606580|448620|P3|NOT COMPLETED|Overall Study||22
183034|NCT00606580|448621|P2|NOT COMPLETED|Overall Study||3
183035|NCT00606580|448622|P1|NOT COMPLETED|Overall Study||2
183036|NCT00606580|448620|P3|COMPLETED|Overall Study||103
183037|NCT00606580|448621|P2|COMPLETED|Overall Study||122
183038|NCT00606580|448622|P1|COMPLETED|Overall Study||123
183039|NCT00606580|448620|P3|STARTED|Overall Study||125
183040|NCT00606580|448621|P2|STARTED|Overall Study||125
183041|NCT00606580|448622|P1|STARTED|Overall Study||125
183042|NCT00606593|448663|P10|NOT COMPLETED|Overall Study||0
183043|NCT00606593|448664|P9|NOT COMPLETED|Overall Study||1
183044|NCT00606593|448665|P8|NOT COMPLETED|Overall Study||2
183045|NCT00606593|448666|P7|NOT COMPLETED|Overall Study||1
183047|NCT00606593|448668|P5|NOT COMPLETED|Overall Study||1
183048|NCT00606593|448669|P4|NOT COMPLETED|Overall Study||1
183049|NCT00606593|448670|P3|NOT COMPLETED|Overall Study||2
183050|NCT00606593|448671|P2|NOT COMPLETED|Overall Study||0
183051|NCT00606593|448672|P1|NOT COMPLETED|Overall Study||1
183052|NCT00606593|448663|P10|COMPLETED|Overall Study||11
183053|NCT00606593|448664|P9|COMPLETED|Overall Study||11
183054|NCT00606593|448665|P8|COMPLETED|Overall Study||9
183055|NCT00606593|448666|P7|COMPLETED|Overall Study||10
183056|NCT00606593|448667|P6|COMPLETED|Overall Study||11
183057|NCT00606593|448668|P5|COMPLETED|Overall Study||11
183058|NCT00606593|448669|P4|COMPLETED|Overall Study||10
183059|NCT00606593|448670|P3|COMPLETED|Overall Study||9
183060|NCT00606593|448671|P2|COMPLETED|Overall Study||11
183061|NCT00606593|448672|P1|COMPLETED|Overall Study||10
183062|NCT00606593|448663|P10|5th Double-blind Treatment|Overall Study||11
183063|NCT00606593|448664|P9|5th Double-blind Treatment|Overall Study||11
183064|NCT00606593|448665|P8|5th Double-blind Treatment|Overall Study||9
183065|NCT00606593|448666|P7|5th Double-blind Treatment|Overall Study||10
183066|NCT00606593|448667|P6|5th Double-blind Treatment|Overall Study||11
183067|NCT00606593|448668|P5|5th Double-blind Treatment|Overall Study||11
183068|NCT00606593|448669|P4|5th Double-blind Treatment|Overall Study||10
183069|NCT00606593|448670|P3|5th Double-blind Treatment|Overall Study||9
183070|NCT00606593|448671|P2|5th Double-blind Treatment|Overall Study||11
183071|NCT00606593|448672|P1|5th Double-blind Treatment|Overall Study||10
183072|NCT00606593|448663|P10|4th Double-blind Treatment|Overall Study||11
183073|NCT00606593|448664|P9|4th Double-blind Treatment|Overall Study||11
183074|NCT00606593|448665|P8|4th Double-blind Treatment|Overall Study||9
183075|NCT00606593|448666|P7|4th Double-blind Treatment|Overall Study||10
183076|NCT00606593|448667|P6|4th Double-blind Treatment|Overall Study||11
183077|NCT00606593|448668|P5|4th Double-blind Treatment|Overall Study||11
183078|NCT00606593|448669|P4|4th Double-blind Treatment|Overall Study||10
183079|NCT00606593|448670|P3|4th Double-blind Treatment|Overall Study||10
183080|NCT00606593|448671|P2|4th Double-blind Treatment|Overall Study||11
183081|NCT00606593|448672|P1|4th Double-blind Treatment|Overall Study||10
183082|NCT00606593|448663|P10|3rd Double-blind Treatment|Overall Study||11
183083|NCT00606593|448664|P9|3rd Double-blind Treatment|Overall Study||12
183084|NCT00606593|448665|P8|3rd Double-blind Treatment|Overall Study||9
183085|NCT00606593|448666|P7|3rd Double-blind Treatment|Overall Study||10
183086|NCT00606593|448667|P6|3rd Double-blind Treatment|Overall Study||11
183087|NCT00606593|448668|P5|3rd Double-blind Treatment|Overall Study||11
183088|NCT00606593|448669|P4|3rd Double-blind Treatment|Overall Study||10
183089|NCT00606593|448670|P3|3rd Double-blind Treatment|Overall Study||10
183090|NCT00606593|448671|P2|3rd Double-blind Treatment|Overall Study||11
183091|NCT00606593|448672|P1|3rd Double-blind Treatment|Overall Study||11
183092|NCT00606593|448663|P10|2nd Double-blind Treatment|Overall Study||11
183093|NCT00606593|448664|P9|2nd Double-blind Treatment|Overall Study||12
183094|NCT00606593|448665|P8|2nd Double-blind Treatment|Overall Study||9
183095|NCT00606593|448666|P7|2nd Double-blind Treatment|Overall Study||10
183096|NCT00606593|448667|P6|2nd Double-blind Treatment|Overall Study||11
183097|NCT00606593|448668|P5|2nd Double-blind Treatment|Overall Study||12
183098|NCT00606593|448669|P4|2nd Double-blind Treatment|Overall Study||10
183099|NCT00606593|448670|P3|2nd Double-blind Treatment|Overall Study||11
183100|NCT00606593|448671|P2|2nd Double-blind Treatment|Overall Study||11
183101|NCT00606593|448672|P1|2nd Double-blind Treatment|Overall Study||11
183102|NCT00606593|448663|P10|1st Double-blind Treatment|Overall Study||11
183103|NCT00606593|448664|P9|1st Double-blind Treatment|Overall Study||12
183104|NCT00606593|448665|P8|1st Double-blind Treatment|Overall Study||11
183105|NCT00606593|448666|P7|1st Double-blind Treatment|Overall Study||11
183106|NCT00606593|448667|P6|1st Double-blind Treatment|Overall Study||11
183107|NCT00606593|448668|P5|1st Double-blind Treatment|Overall Study||12
183108|NCT00606593|448669|P4|1st Double-blind Treatment|Overall Study||11
183109|NCT00606593|448670|P3|1st Double-blind Treatment|Overall Study||11
183110|NCT00606593|448671|P2|1st Double-blind Treatment|Overall Study||11
183111|NCT00606593|448672|P1|1st Double-blind Treatment|Overall Study||11
183112|NCT00606593|448663|P10|STARTED|Overall Study|Randomized participants|11
183113|NCT00606593|448664|P9|STARTED|Overall Study|Randomized participants|12
183114|NCT00606593|448665|P8|STARTED|Overall Study|Randomized participants. One participant actually received the treatment sequence 200/P/100/ 50/25|11
183115|NCT00606593|448666|P7|STARTED|Overall Study|Randomized participants|11
183116|NCT00606593|448667|P6|STARTED|Overall Study|Randomized participants|11
183117|NCT00606593|448668|P5|STARTED|Overall Study|Randomized participants|12
183118|NCT00606593|448669|P4|STARTED|Overall Study|Randomized participants|11
183119|NCT00606593|448670|P3|STARTED|Overall Study|Randomized participants|11
183120|NCT00606593|448671|P2|STARTED|Overall Study|Randomized participants|11
183121|NCT00606593|448672|P1|STARTED|Overall Study|Randomized participants|11
183122|NCT00606632|448690|P1|NOT COMPLETED|Overall Study||22
183123|NCT00606632|448690|P1|COMPLETED|Overall Study||204
183124|NCT00606632|448690|P1|STARTED|Overall Study||226
183125|NCT00606684|448703|P7|NOT COMPLETED|Double-Blind Treatment Period||8
183126|NCT00606684|448704|P6|NOT COMPLETED|Double-Blind Treatment Period||9
183127|NCT00606684|448705|P5|NOT COMPLETED|Double-Blind Treatment Period||9
183128|NCT00606684|448706|P4|NOT COMPLETED|Double-Blind Treatment Period||10
183129|NCT00606684|448707|P3|NOT COMPLETED|Double-Blind Treatment Period||11
183130|NCT00606684|448708|P2|NOT COMPLETED|Double-Blind Treatment Period||16
183131|NCT00606684|448709|P1|NOT COMPLETED|Double-Blind Treatment Period||0
183132|NCT00606684|448703|P7|COMPLETED|Double-Blind Treatment Period||91
183133|NCT00606684|448704|P6|COMPLETED|Double-Blind Treatment Period||92
183134|NCT00606684|448705|P5|COMPLETED|Double-Blind Treatment Period||92
183135|NCT00606684|448706|P4|COMPLETED|Double-Blind Treatment Period||91
183136|NCT00606684|448707|P3|COMPLETED|Double-Blind Treatment Period||88
183137|NCT00606684|448708|P2|COMPLETED|Double-Blind Treatment Period||85
183138|NCT00606684|448709|P1|COMPLETED|Double-Blind Treatment Period||0
183139|NCT00606684|448703|P7|STARTED|Double-Blind Treatment Period||99
183140|NCT00606684|448704|P6|STARTED|Double-Blind Treatment Period||101
183141|NCT00606684|448705|P5|STARTED|Double-Blind Treatment Period||101
183142|NCT00606684|448706|P4|STARTED|Double-Blind Treatment Period||101
183143|NCT00606684|448707|P3|STARTED|Double-Blind Treatment Period||99
183144|NCT00606684|448708|P2|STARTED|Double-Blind Treatment Period||101
183145|NCT00606684|448709|P1|STARTED|Double-Blind Treatment Period||0
183146|NCT00606684|448703|P7|NOT COMPLETED|2-week Single-Blind Run-in Period||0
183147|NCT00606684|448704|P6|NOT COMPLETED|2-week Single-Blind Run-in Period||0
183148|NCT00606684|448705|P5|NOT COMPLETED|2-week Single-Blind Run-in Period||0
183149|NCT00606684|448706|P4|NOT COMPLETED|2-week Single-Blind Run-in Period||0
183150|NCT00606684|448707|P3|NOT COMPLETED|2-week Single-Blind Run-in Period||0
183151|NCT00606684|448708|P2|NOT COMPLETED|2-week Single-Blind Run-in Period||0
183152|NCT00606684|448709|P1|NOT COMPLETED|2-week Single-Blind Run-in Period||246
183153|NCT00606684|448703|P7|COMPLETED|2-week Single-Blind Run-in Period||0
183154|NCT00606684|448704|P6|COMPLETED|2-week Single-Blind Run-in Period||0
183155|NCT00606684|448705|P5|COMPLETED|2-week Single-Blind Run-in Period||0
183156|NCT00606684|448706|P4|COMPLETED|2-week Single-Blind Run-in Period||0
183157|NCT00606684|448707|P3|COMPLETED|2-week Single-Blind Run-in Period||0
183158|NCT00606684|448708|P2|COMPLETED|2-week Single-Blind Run-in Period||0
183159|NCT00606684|448709|P1|COMPLETED|2-week Single-Blind Run-in Period||605
183160|NCT00606684|448703|P7|STARTED|2-week Single-Blind Run-in Period||0
183161|NCT00606684|448704|P6|STARTED|2-week Single-Blind Run-in Period||0
183162|NCT00606684|448705|P5|STARTED|2-week Single-Blind Run-in Period||0
183163|NCT00606684|448706|P4|STARTED|2-week Single-Blind Run-in Period||0
183164|NCT00606684|448707|P3|STARTED|2-week Single-Blind Run-in Period||0
183165|NCT00606684|448708|P2|STARTED|2-week Single-Blind Run-in Period||0
183166|NCT00606684|448709|P1|STARTED|2-week Single-Blind Run-in Period||851
183167|NCT00606801|448743|P2|NOT COMPLETED|Intervention||3
183168|NCT00606801|448744|P1|NOT COMPLETED|Intervention||3
183169|NCT00606801|448743|P2|COMPLETED|Intervention||14
183170|NCT00606801|448744|P1|COMPLETED|Intervention||14
183171|NCT00606801|448743|P2|STARTED|Intervention||17
183172|NCT00606801|448744|P1|STARTED|Intervention||17
183173|NCT00606801|448743|P2|NOT COMPLETED|Adaptation||0
183174|NCT00606801|448744|P1|NOT COMPLETED|Adaptation||0
183175|NCT00606801|448743|P2|COMPLETED|Adaptation||17
183176|NCT00606801|448744|P1|COMPLETED|Adaptation||17
183177|NCT00606801|448743|P2|STARTED|Adaptation||17
183178|NCT00606801|448744|P1|STARTED|Adaptation||17
183179|NCT00600015|448768|P2|NOT COMPLETED|Overall Study||35
183180|NCT00600015|448769|P1|NOT COMPLETED|Overall Study||60
183181|NCT00600015|448768|P2|COMPLETED|Overall Study|Completed >=2 cycles|20
183182|NCT00600015|448769|P1|COMPLETED|Overall Study|Completed >=2 cycles|51
183183|NCT00600015|448768|P2|STARTED|Overall Study||55
183184|NCT00600015|448769|P1|STARTED|Overall Study||111
183185|NCT00600028|448779|P2|NOT COMPLETED|Second Intervention (12 Weeks)||2
183186|NCT00600028|448780|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
183187|NCT00600028|448779|P2|COMPLETED|Second Intervention (12 Weeks)||8
183188|NCT00600028|448780|P1|COMPLETED|Second Intervention (12 Weeks)||12
183189|NCT00600028|448779|P2|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|10
183190|NCT00600028|448780|P1|STARTED|Second Intervention (12 Weeks)|Number of participants starting the second intervention (after a 2-week washout)|12
183191|NCT00600028|448779|P2|NOT COMPLETED|First Intervention (12 Weeks)||1
183192|NCT00600028|448780|P1|NOT COMPLETED|First Intervention (12 Weeks)||1
183193|NCT00600028|448779|P2|COMPLETED|First Intervention (12 Weeks)||10
183194|NCT00600028|448780|P1|COMPLETED|First Intervention (12 Weeks)||12
183195|NCT00600028|448779|P2|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|11
183196|NCT00600028|448780|P1|STARTED|First Intervention (12 Weeks)|Number of participants starting the first intervention (prior to washout)|13
183197|NCT00600067|448794|P2|NOT COMPLETED|Overall Study||7
183198|NCT00600067|448795|P1|NOT COMPLETED|Overall Study||3
183199|NCT00600067|448794|P2|COMPLETED|Overall Study||68
183200|NCT00600067|448795|P1|COMPLETED|Overall Study||52
183201|NCT00600067|448794|P2|STARTED|Overall Study||75
183202|NCT00600067|448795|P1|STARTED|Overall Study||55
183203|NCT00600080|448803|P2|NOT COMPLETED|Period 2: One-week to Two-weeks||0
183204|NCT00600080|448804|P1|NOT COMPLETED|Period 2: One-week to Two-weeks||0
183205|NCT00600080|448803|P2|COMPLETED|Period 2: One-week to Two-weeks||32
183206|NCT00600080|448804|P1|COMPLETED|Period 2: One-week to Two-weeks||28
183207|NCT00600080|448803|P2|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|32
183208|NCT00600080|448804|P1|STARTED|Period 2: One-week to Two-weeks|This is a crossover study, arms are switched at period change.|28
183209|NCT00600080|448803|P2|NOT COMPLETED|Period 1: Baseline to One-week||0
183210|NCT00600080|448804|P1|NOT COMPLETED|Period 1: Baseline to One-week||0
183211|NCT00600080|448803|P2|COMPLETED|Period 1: Baseline to One-week||32
183212|NCT00600080|448804|P1|COMPLETED|Period 1: Baseline to One-week||28
183213|NCT00600080|448803|P2|STARTED|Period 1: Baseline to One-week||32
183214|NCT00600080|448804|P1|STARTED|Period 1: Baseline to One-week||28
183215|NCT00600119|448822|P6|NOT COMPLETED|Follow-up Period||1
183216|NCT00600119|448823|P5|NOT COMPLETED|Follow-up Period||0
183217|NCT00600119|448824|P4|NOT COMPLETED|Follow-up Period||0
183218|NCT00600119|448825|P3|NOT COMPLETED|Follow-up Period||0
183219|NCT00600119|448826|P2|NOT COMPLETED|Follow-up Period||0
183220|NCT00600119|448827|P1|NOT COMPLETED|Follow-up Period||1
183221|NCT00600119|448822|P6|COMPLETED|Follow-up Period||20
183222|NCT00600119|448823|P5|COMPLETED|Follow-up Period||31
183223|NCT00600119|448824|P4|COMPLETED|Follow-up Period||28
183224|NCT00600119|448825|P3|COMPLETED|Follow-up Period||27
183225|NCT00600119|448826|P2|COMPLETED|Follow-up Period||28
183226|NCT00600119|448827|P1|COMPLETED|Follow-up Period||26
183227|NCT00600119|448822|P6|STARTED|Follow-up Period||21
183228|NCT00600119|448823|P5|STARTED|Follow-up Period||31
183229|NCT00600119|448824|P4|STARTED|Follow-up Period||28
183230|NCT00600119|448825|P3|STARTED|Follow-up Period||27
183231|NCT00600119|448826|P2|STARTED|Follow-up Period||28
183232|NCT00600119|448827|P1|STARTED|Follow-up Period||27
183233|NCT00600119|448822|P6|NOT COMPLETED|Double-blind Treatment Period||14
183234|NCT00600119|448823|P5|NOT COMPLETED|Double-blind Treatment Period||6
183235|NCT00600119|448824|P4|NOT COMPLETED|Double-blind Treatment Period||2
183236|NCT00600119|448825|P3|NOT COMPLETED|Double-blind Treatment Period||0
183237|NCT00600119|448826|P2|NOT COMPLETED|Double-blind Treatment Period||5
183238|NCT00600119|448827|P1|NOT COMPLETED|Double-blind Treatment Period||5
183239|NCT00600119|448822|P6|COMPLETED|Double-blind Treatment Period||21
183240|NCT00600119|448823|P5|COMPLETED|Double-blind Treatment Period||31
183241|NCT00600119|448824|P4|COMPLETED|Double-blind Treatment Period||28
183242|NCT00600119|448825|P3|COMPLETED|Double-blind Treatment Period||27
183243|NCT00600119|448826|P2|COMPLETED|Double-blind Treatment Period||28
183244|NCT00600119|448827|P1|COMPLETED|Double-blind Treatment Period||27
183245|NCT00600119|448822|P6|STARTED|Double-blind Treatment Period||35
183246|NCT00600119|448823|P5|STARTED|Double-blind Treatment Period||37
183247|NCT00600119|448824|P4|STARTED|Double-blind Treatment Period||30
183248|NCT00600119|448825|P3|STARTED|Double-blind Treatment Period||27
183249|NCT00600119|448826|P2|STARTED|Double-blind Treatment Period||33
183250|NCT00600119|448827|P1|STARTED|Double-blind Treatment Period||32
183251|NCT00600119|448822|P6|NOT COMPLETED|Single-blind Placebo run-in Period||2
183252|NCT00600119|448823|P5|NOT COMPLETED|Single-blind Placebo run-in Period||2
183253|NCT00600119|448824|P4|NOT COMPLETED|Single-blind Placebo run-in Period||1
183254|NCT00600119|448825|P3|NOT COMPLETED|Single-blind Placebo run-in Period||2
183255|NCT00600119|448826|P2|NOT COMPLETED|Single-blind Placebo run-in Period||2
183256|NCT00600119|448827|P1|NOT COMPLETED|Single-blind Placebo run-in Period||4
183257|NCT00600119|448822|P6|COMPLETED|Single-blind Placebo run-in Period||35
183258|NCT00600119|448823|P5|COMPLETED|Single-blind Placebo run-in Period||37
183259|NCT00600119|448824|P4|COMPLETED|Single-blind Placebo run-in Period||30
183260|NCT00600119|448825|P3|COMPLETED|Single-blind Placebo run-in Period||27
183261|NCT00600119|448826|P2|COMPLETED|Single-blind Placebo run-in Period||33
183262|NCT00600119|448827|P1|COMPLETED|Single-blind Placebo run-in Period||32
183263|NCT00600119|448822|P6|STARTED|Single-blind Placebo run-in Period||37
183264|NCT00600119|448823|P5|STARTED|Single-blind Placebo run-in Period||39
183265|NCT00600119|448824|P4|STARTED|Single-blind Placebo run-in Period||31
183266|NCT00600119|448825|P3|STARTED|Single-blind Placebo run-in Period||29
183267|NCT00600119|448826|P2|STARTED|Single-blind Placebo run-in Period||35
183268|NCT00600119|448827|P1|STARTED|Single-blind Placebo run-in Period||36
183269|NCT00600171|448865|P6|NOT COMPLETED|Overall Study||5
183270|NCT00600171|448866|P5|NOT COMPLETED|Overall Study||8
183271|NCT00600171|448867|P4|NOT COMPLETED|Overall Study||12
183272|NCT00600171|448868|P3|NOT COMPLETED|Overall Study||10
183273|NCT00600171|448869|P2|NOT COMPLETED|Overall Study||17
183274|NCT00600171|448870|P1|NOT COMPLETED|Overall Study||16
183275|NCT00600171|448865|P6|COMPLETED|Overall Study||97
183276|NCT00600171|448866|P5|COMPLETED|Overall Study||93
183277|NCT00600171|448867|P4|COMPLETED|Overall Study||88
183278|NCT00600171|448868|P3|COMPLETED|Overall Study||91
183279|NCT00600171|448869|P2|COMPLETED|Overall Study||84
183280|NCT00600171|448870|P1|COMPLETED|Overall Study||86
183281|NCT00600171|448865|P6|STARTED|Overall Study||102
183282|NCT00600171|448866|P5|STARTED|Overall Study||101
183283|NCT00600171|448867|P4|STARTED|Overall Study||100
183284|NCT00600171|448868|P3|STARTED|Overall Study||101
183285|NCT00600171|448869|P2|STARTED|Overall Study||101
183286|NCT00600171|448870|P1|STARTED|Overall Study||102
183287|NCT00600353|448940|P2|NOT COMPLETED|Overall Study||1
183288|NCT00600353|448941|P1|NOT COMPLETED|Overall Study||1
183289|NCT00600353|448940|P2|COMPLETED|Overall Study||9
183290|NCT00600353|448941|P1|COMPLETED|Overall Study||9
183291|NCT00600353|448940|P2|STARTED|Overall Study||10
183292|NCT00600353|448941|P1|STARTED|Overall Study||10
183293|NCT00600613|448953|P1|NOT COMPLETED|Overall Study||1
183294|NCT00600613|448953|P1|COMPLETED|Overall Study||5
183295|NCT00600613|448953|P1|STARTED|Overall Study||6
183296|NCT00600704|448959|P2|NOT COMPLETED|Overall Study||0
183297|NCT00600704|448960|P1|NOT COMPLETED|Overall Study||0
183298|NCT00600704|448959|P2|COMPLETED|Overall Study||92
183299|NCT00600704|448960|P1|COMPLETED|Overall Study||100
183300|NCT00600704|448959|P2|STARTED|Overall Study||92
183301|NCT00600704|448960|P1|STARTED|Overall Study||100
183302|NCT00600743|448970|P4|NOT COMPLETED|Overall Study||0
183303|NCT00600743|448971|P3|NOT COMPLETED|Overall Study||0
183304|NCT00600743|448972|P2|NOT COMPLETED|Overall Study||0
183305|NCT00600743|448973|P1|NOT COMPLETED|Overall Study||0
183306|NCT00600743|448970|P4|COMPLETED|Overall Study||7
183307|NCT00600743|448971|P3|COMPLETED|Overall Study||8
183308|NCT00600743|448972|P2|COMPLETED|Overall Study||4
183309|NCT00600743|448973|P1|COMPLETED|Overall Study||4
183310|NCT00600743|448970|P4|STARTED|Overall Study||7
183311|NCT00600743|448971|P3|STARTED|Overall Study||8
183312|NCT00600743|448972|P2|STARTED|Overall Study||4
183313|NCT00600743|448973|P1|STARTED|Overall Study||4
183314|NCT00600756|449002|P2|NOT COMPLETED|Overall Study Analysis After 12 Months||176
183315|NCT00600756|449003|P1|NOT COMPLETED|Overall Study Analysis After 12 Months||183
183316|NCT00600756|449002|P2|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|227
183317|NCT00600756|449003|P1|COMPLETED|Overall Study Analysis After 12 Months|Completed study to Visit 7 (includes premature withdrawals with final visit in the Visit 7 window)|212
183318|NCT00600756|449002|P2|ITT Analysis|Overall Study Analysis After 12 Months||392
183319|NCT00600756|449003|P1|ITT Analysis|Overall Study Analysis After 12 Months||379
183320|NCT00600756|449002|P2|Safety Analysis|Overall Study Analysis After 12 Months||402
183321|NCT00600756|449003|P1|Safety Analysis|Overall Study Analysis After 12 Months||391
183322|NCT00600756|449002|P2|Randomized Analysis|Overall Study Analysis After 12 Months||403
183323|NCT00600756|449003|P1|Randomized Analysis|Overall Study Analysis After 12 Months||395
183324|NCT00600756|449002|P2|STARTED|Overall Study Analysis After 12 Months||403
183325|NCT00600756|449003|P1|STARTED|Overall Study Analysis After 12 Months||395
183326|NCT00600756|449002|P2|NOT COMPLETED|Analysis After 6 Months||120
183327|NCT00600756|449003|P1|NOT COMPLETED|Analysis After 6 Months||131
183328|NCT00600756|449002|P2|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|283
183329|NCT00600756|449003|P1|COMPLETED|Analysis After 6 Months|Completers are all patients who completed the study up to Visit 5 (including premature withdraw)|264
183330|NCT00600756|449002|P2|STARTED|Analysis After 6 Months||403
183331|NCT00600756|449003|P1|STARTED|Analysis After 6 Months||395
183332|NCT00600821|449071|P2|NOT COMPLETED|Overall Study||60
183333|NCT00600821|449072|P1|NOT COMPLETED|Overall Study||58
183334|NCT00600821|449071|P2|COMPLETED|Overall Study||0
183335|NCT00600821|449072|P1|COMPLETED|Overall Study||0
183336|NCT00600821|449071|P2|Treated|Overall Study||59
183337|NCT00600821|449072|P1|Treated|Overall Study||58
183338|NCT00600821|449071|P2|STARTED|Overall Study||60
183339|NCT00600821|449072|P1|STARTED|Overall Study||58
183340|NCT00600886|449100|P2|NOT COMPLETED|Extension - After Crossover (CAS)||13
183341|NCT00600886|449101|P1|NOT COMPLETED|Extension - After Crossover (CAS)||62
183342|NCT00600886|449100|P2|COMPLETED|Extension - After Crossover (CAS)|Completed the study|25
183343|NCT00600886|449101|P1|COMPLETED|Extension - After Crossover (CAS)|Completed after month 26: transferred to a roll-over protocol or commercial supply of Pas.LAR|19
183344|NCT00600886|449100|P2|Discontinued After M26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|0
183345|NCT00600886|449101|P1|Discontinued After M26|Extension - After Crossover (CAS)||31
183346|NCT00600886|449100|P2|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||13
183347|NCT00600886|449101|P1|Discontinued Between M12 and M26|Extension - After Crossover (CAS)||31
183348|NCT00600886|449100|P2|Completed After Month 26|Extension - After Crossover (CAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in study after M26|0
183349|NCT00600886|449101|P1|Completed After Month 26|Extension - After Crossover (CAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|19
183350|NCT00600886|449100|P2|Completed Study at Month 26|Extension - After Crossover (CAS)|Per protocol, Pts who received Octreotide LAR in Ext. phase were not followed in study after M26|25
183351|NCT00600886|449101|P1|Completed Study at Month 26|Extension - After Crossover (CAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
183352|NCT00600886|449100|P2|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Octreotide LAR|38
183353|NCT00600886|449101|P1|STARTED|Extension - After Crossover (CAS)|Started = anyone who entered the extension and crossed over to Pasireotide LAR|81
183354|NCT00600886|449100|P2|NOT COMPLETED|Extension - Same Treatment (FAS)||11
183355|NCT00600886|449101|P1|NOT COMPLETED|Extension - Same Treatment (FAS)||46
183356|NCT00600886|449100|P2|COMPLETED|Extension - Same Treatment (FAS)|Completed = completed the study|35
183357|NCT00600886|449101|P1|COMPLETED|Extension - Same Treatment (FAS)|Completed= completed after M26, switched to commercial pasireotide LAR or entered roll-over protocol|28
183358|NCT00600886|449100|P2|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||10
183359|NCT00600886|449101|P1|Discontinued Between M12 and M26|Extension - Same Treatment (FAS)||23
183360|NCT00600886|449100|P2|Discontinued After Month 26|Extension - Same Treatment (FAS)|Received treatment and discontinued after M26: Recorded as protocol deviation|1
183361|NCT00600886|449101|P1|Discontinued After Month 26|Extension - Same Treatment (FAS)||23
183362|NCT00600886|449100|P2|Completed Study After Month 26|Extension - Same Treatment (FAS)|Received treatment and completed after M26: Recorded as protocol deviation|4
183439|NCT00606892|449259|P2|STARTED|Second Intervention||4
183363|NCT00600886|449101|P1|Completed Study After Month 26|Extension - Same Treatment (FAS)|Completed = Pts who transferred to a roll-over protocol or commercial supply of Pasireotide LAR|28
183364|NCT00600886|449100|P2|Completed Study at Month 26|Extension - Same Treatment (FAS)|Per protocol, pts who received Octreotide LAR in ext. phase were not followed in the study after M26|31
183365|NCT00600886|449101|P1|Completed Study at Month 26|Extension - Same Treatment (FAS)|Pas. LAR pts in Ext. were not considered completers at M26 as treatment could continue after M26.|0
183366|NCT00600886|449100|P2|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Octreotide LAR|46
183367|NCT00600886|449101|P1|STARTED|Extension - Same Treatment (FAS)|Started = anyone who entered the extension and continued the same treatment of Pasireotide LAR|74
183368|NCT00600886|449100|P2|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||26
183369|NCT00600886|449101|P1|NOT COMPLETED|Core Phase - Full Analysis Set (FAS)||35
183370|NCT00600886|449100|P2|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|156
183371|NCT00600886|449101|P1|COMPLETED|Core Phase - Full Analysis Set (FAS)|Completed = anyone who did not discontinue prior to month 12.|141
183372|NCT00600886|449100|P2|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||46
183373|NCT00600886|449101|P1|Entered Ext Continued Same Treatment|Core Phase - Full Analysis Set (FAS)||74
183374|NCT00600886|449100|P2|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||81
183375|NCT00600886|449101|P1|Entered Extension, Crossed Over|Core Phase - Full Analysis Set (FAS)||38
183376|NCT00600886|449100|P2|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
183377|NCT00600886|449101|P1|Did Not Enter Extension|Core Phase - Full Analysis Set (FAS)||29
183378|NCT00600886|449100|P2|STARTED|Core Phase - Full Analysis Set (FAS)||182
183379|NCT00600886|449101|P1|STARTED|Core Phase - Full Analysis Set (FAS)||176
183380|NCT00600938|449165|P4|NOT COMPLETED|Extension Study||1
183381|NCT00600938|449166|P3|NOT COMPLETED|Extension Study||9
183382|NCT00600938|449167|P2|NOT COMPLETED|Extension Study||5
183383|NCT00600938|449168|P1|NOT COMPLETED|Extension Study||9
183384|NCT00600938|449165|P4|COMPLETED|Extension Study||0
183385|NCT00600938|449166|P3|COMPLETED|Extension Study||33
183386|NCT00600938|449167|P2|COMPLETED|Extension Study||24
183387|NCT00600938|449168|P1|COMPLETED|Extension Study||65
183388|NCT00600938|449165|P4|Extension Safety Set|Extension Study||1
183389|NCT00600938|449166|P3|Extension Safety Set|Extension Study||42
183390|NCT00600938|449167|P2|Extension Safety Set|Extension Study||29
183391|NCT00600938|449168|P1|Extension Safety Set|Extension Study|1 patient did not receive drug in the ext. phase but received drug in the core phase|73
183392|NCT00600938|449165|P4|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|1
183393|NCT00600938|449166|P3|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|42
183394|NCT00600938|449167|P2|STARTED|Extension Study|Of the 78 patients who completed the DFO core, 29 went on DFO ext. phase; 42 went to the DFO-ICL|29
183395|NCT00600938|449168|P1|STARTED|Extension Study|Of the 82 patients who completed the ICL core, 74 continued on the ICL ext. phase; 1 went to ICL-DFO|74
183396|NCT00600938|449165|P4|NOT COMPLETED|Core Study||0
183397|NCT00600938|449166|P3|NOT COMPLETED|Core Study||0
183398|NCT00600938|449167|P2|NOT COMPLETED|Core Study||21
183399|NCT00600938|449168|P1|NOT COMPLETED|Core Study||16
183400|NCT00600938|449165|P4|COMPLETED|Core Study||0
183401|NCT00600938|449166|P3|COMPLETED|Core Study||0
183402|NCT00600938|449167|P2|COMPLETED|Core Study||78
183403|NCT00600938|449168|P1|COMPLETED|Core Study||82
183404|NCT00600938|449165|P4|Per Protocol Set (PPS)|Core Study||0
183405|NCT00600938|449166|P3|Per Protocol Set (PPS)|Core Study||0
183406|NCT00600938|449167|P2|Per Protocol Set (PPS)|Core Study||81
183407|NCT00600938|449168|P1|Per Protocol Set (PPS)|Core Study||91
183408|NCT00600938|449165|P4|Core Safety Set|Core Study||0
183409|NCT00600938|449166|P3|Core Safety Set|Core Study||0
183410|NCT00600938|449167|P2|Core Safety Set|Core Study||91
183411|NCT00600938|449168|P1|Core Safety Set|Core Study||96
183412|NCT00600938|449165|P4|STARTED|Core Study||0
183413|NCT00600938|449166|P3|STARTED|Core Study||0
183414|NCT00600938|449167|P2|STARTED|Core Study||99
183415|NCT00600938|449168|P1|STARTED|Core Study||98
183416|NCT00601107|449234|P4|NOT COMPLETED|Overall Study||12
183417|NCT00601107|449235|P3|NOT COMPLETED|Overall Study||12
183418|NCT00601107|449236|P2|NOT COMPLETED|Overall Study||9
183419|NCT00601107|449237|P1|NOT COMPLETED|Overall Study||13
183420|NCT00601107|449234|P4|COMPLETED|Overall Study||13
183421|NCT00601107|449235|P3|COMPLETED|Overall Study||16
183422|NCT00601107|449236|P2|COMPLETED|Overall Study||22
183423|NCT00601107|449237|P1|COMPLETED|Overall Study||14
183424|NCT00601107|449234|P4|Treated|Overall Study||25
183425|NCT00601107|449235|P3|Treated|Overall Study||28
183426|NCT00601107|449236|P2|Treated|Overall Study||31
183427|NCT00601107|449237|P1|Treated|Overall Study||27
183428|NCT00601107|449234|P4|STARTED|Overall Study||25
183429|NCT00601107|449235|P3|STARTED|Overall Study||28
183430|NCT00601107|449236|P2|STARTED|Overall Study||31
183431|NCT00601107|449237|P1|STARTED|Overall Study|Randomized.|27
183432|NCT00601146|449255|P1|NOT COMPLETED|Overall Study||161
183433|NCT00601146|449255|P1|COMPLETED|Overall Study||39
183434|NCT00601146|449255|P1|STARTED|Overall Study||200
183435|NCT00606892|449259|P2|NOT COMPLETED|Second Intervention||0
183436|NCT00606892|449260|P1|NOT COMPLETED|Second Intervention||0
183437|NCT00606892|449259|P2|COMPLETED|Second Intervention||4
183438|NCT00606892|449260|P1|COMPLETED|Second Intervention||8
183440|NCT00606892|449260|P1|STARTED|Second Intervention||8
183441|NCT00606892|449259|P2|NOT COMPLETED|Washout Period||0
183442|NCT00606892|449260|P1|NOT COMPLETED|Washout Period||0
183443|NCT00606892|449259|P2|COMPLETED|Washout Period||4
183444|NCT00606892|449260|P1|COMPLETED|Washout Period||8
183445|NCT00606892|449259|P2|STARTED|Washout Period||4
183446|NCT00606892|449260|P1|STARTED|Washout Period||8
183447|NCT00606892|449259|P2|NOT COMPLETED|First Intervention||4
183448|NCT00606892|449260|P1|NOT COMPLETED|First Intervention||1
183449|NCT00606892|449259|P2|COMPLETED|First Intervention||4
183450|NCT00606892|449260|P1|COMPLETED|First Intervention||8
183451|NCT00606892|449259|P2|STARTED|First Intervention||8
183452|NCT00606892|449260|P1|STARTED|First Intervention||9
183453|NCT00606892|449259|P2|NOT COMPLETED|Adaptation||0
183454|NCT00606892|449260|P1|NOT COMPLETED|Adaptation||0
183455|NCT00606892|449259|P2|COMPLETED|Adaptation||8
183456|NCT00606892|449260|P1|COMPLETED|Adaptation||9
183457|NCT00606892|449259|P2|STARTED|Adaptation||8
183458|NCT00606892|449260|P1|STARTED|Adaptation||9
183459|NCT00606905|449294|P2|NOT COMPLETED|Overall Study||15
183460|NCT00606905|449295|P1|NOT COMPLETED|Overall Study||15
183461|NCT00606905|449294|P2|COMPLETED|Overall Study||24
183462|NCT00606905|449295|P1|COMPLETED|Overall Study||23
183463|NCT00606905|449294|P2|Pregnancy|Overall Study||33
183464|NCT00606905|449295|P1|Pregnancy|Overall Study||29
183465|NCT00606905|449294|P2|STARTED|Overall Study||39
183466|NCT00606905|449295|P1|STARTED|Overall Study||38
183467|NCT00606931|449301|P1|NOT COMPLETED|Overall Study||3
183468|NCT00606931|449301|P1|COMPLETED|Overall Study||19
183469|NCT00606931|449301|P1|STARTED|Overall Study||22
183470|NCT00606944|449309|P2|NOT COMPLETED|Overall Study||0
183471|NCT00606944|449310|P1|NOT COMPLETED|Overall Study||0
183472|NCT00606944|449309|P2|COMPLETED|Overall Study||100
183473|NCT00606944|449310|P1|COMPLETED|Overall Study||98
183474|NCT00606944|449309|P2|STARTED|Overall Study||100
183475|NCT00606944|449310|P1|STARTED|Overall Study||98
183476|NCT00607048|449318|P6|NOT COMPLETED|Overall Study||5
183477|NCT00607048|449319|P5|NOT COMPLETED|Overall Study||6
183478|NCT00607048|449320|P4|NOT COMPLETED|Overall Study||3
183479|NCT00607048|449321|P3|NOT COMPLETED|Overall Study||4
183480|NCT00607048|449322|P2|NOT COMPLETED|Overall Study||4
183481|NCT00607048|449323|P1|NOT COMPLETED|Overall Study||3
183482|NCT00607048|449318|P6|COMPLETED|Overall Study||2
183483|NCT00607048|449319|P5|COMPLETED|Overall Study||0
183484|NCT00607048|449320|P4|COMPLETED|Overall Study||0
183485|NCT00607048|449321|P3|COMPLETED|Overall Study||3
183486|NCT00607048|449322|P2|COMPLETED|Overall Study||2
183487|NCT00607048|449323|P1|COMPLETED|Overall Study||0
183488|NCT00607048|449318|P6|STARTED|Overall Study||7
183489|NCT00607048|449319|P5|STARTED|Overall Study||6
183490|NCT00607048|449320|P4|STARTED|Overall Study||3
183491|NCT00607048|449321|P3|STARTED|Overall Study||7
183492|NCT00607048|449322|P2|STARTED|Overall Study||6
183493|NCT00607048|449323|P1|STARTED|Overall Study||3
183494|NCT00607087|449408|P3|NOT COMPLETED|Period 3||0
183495|NCT00607087|449409|P2|NOT COMPLETED|Period 3||2
183496|NCT00607087|449410|P1|NOT COMPLETED|Period 3||2
183497|NCT00607087|449408|P3|COMPLETED|Period 3||84
183498|NCT00607087|449409|P2|COMPLETED|Period 3||84
183499|NCT00607087|449410|P1|COMPLETED|Period 3||84
183500|NCT00607087|449408|P3|STARTED|Period 3||84
183501|NCT00607087|449409|P2|STARTED|Period 3||86
183502|NCT00607087|449410|P1|STARTED|Period 3||86
183503|NCT00607087|449408|P3|NOT COMPLETED|Period 2||5
183504|NCT00607087|449409|P2|NOT COMPLETED|Period 2||3
183505|NCT00607087|449410|P1|NOT COMPLETED|Period 2||1
183506|NCT00607087|449408|P3|COMPLETED|Period 2||84
183507|NCT00607087|449409|P2|COMPLETED|Period 2||86
183508|NCT00607087|449410|P1|COMPLETED|Period 2||86
183509|NCT00607087|449408|P3|STARTED|Period 2||89
183510|NCT00607087|449409|P2|STARTED|Period 2||89
183511|NCT00607087|449410|P1|STARTED|Period 2||87
183512|NCT00607087|449408|P3|NOT COMPLETED|Period 1||5
183513|NCT00607087|449409|P2|NOT COMPLETED|Period 1||6
183514|NCT00607087|449410|P1|NOT COMPLETED|Period 1||12
183515|NCT00607087|449408|P3|COMPLETED|Period 1||89
183516|NCT00607087|449409|P2|COMPLETED|Period 1||89
183517|NCT00607087|449410|P1|COMPLETED|Period 1||87
183518|NCT00607087|449408|P3|STARTED|Period 1||94
183519|NCT00607087|449409|P2|STARTED|Period 1||95
183520|NCT00607087|449410|P1|STARTED|Period 1||99
183521|NCT00607087|449408|P3|NOT COMPLETED|Overall Study||10
183522|NCT00607087|449409|P2|NOT COMPLETED|Overall Study||11
183523|NCT00607087|449410|P1|NOT COMPLETED|Overall Study||15
183524|NCT00607087|449408|P3|COMPLETED|Overall Study||84
183525|NCT00607087|449409|P2|COMPLETED|Overall Study||84
183526|NCT00607087|449410|P1|COMPLETED|Overall Study||84
183527|NCT00607087|449408|P3|STARTED|Overall Study||94
183528|NCT00607087|449409|P2|STARTED|Overall Study||95
183529|NCT00607087|449410|P1|STARTED|Overall Study||99
183530|NCT00607113|449468|P2|NOT COMPLETED|Overall Study||0
183531|NCT00607113|449469|P1|NOT COMPLETED|Overall Study||0
183532|NCT00607113|449468|P2|COMPLETED|Overall Study||20
183533|NCT00607113|449469|P1|COMPLETED|Overall Study||19
183534|NCT00607113|449468|P2|STARTED|Overall Study||20
183535|NCT00607113|449469|P1|STARTED|Overall Study||19
183536|NCT00607126|449476|P2|NOT COMPLETED|Overall Study||0
183537|NCT00607126|449477|P1|NOT COMPLETED|Overall Study||0
183538|NCT00607126|449476|P2|COMPLETED|Overall Study||19
183539|NCT00607126|449477|P1|COMPLETED|Overall Study||17
183540|NCT00607126|449476|P2|STARTED|Overall Study||19
183541|NCT00607126|449477|P1|STARTED|Overall Study||17
183542|NCT00611325|449491|P2|NOT COMPLETED|Overall Study||0
183543|NCT00611325|449492|P1|NOT COMPLETED|Overall Study||0
183544|NCT00611325|449491|P2|COMPLETED|Overall Study||28
183545|NCT00611325|449492|P1|COMPLETED|Overall Study||28
183546|NCT00611325|449491|P2|STARTED|Overall Study||28
183547|NCT00611325|449492|P1|STARTED|Overall Study||28
183548|NCT00611403|449508|P2|NOT COMPLETED|Post Treatment Extension Phase||1
183549|NCT00611403|449509|P1|NOT COMPLETED|Post Treatment Extension Phase||4
183550|NCT00611403|449508|P2|COMPLETED|Post Treatment Extension Phase||24
183551|NCT00611403|449509|P1|COMPLETED|Post Treatment Extension Phase||22
183552|NCT00611403|449508|P2|STARTED|Post Treatment Extension Phase|25 of 69 pts who received ENDURA® in the Treatment Phase entered the Post Treatment Extension Phase|25
183553|NCT00611403|449509|P1|STARTED|Post Treatment Extension Phase|26 of 68 pts who received RESTASIS® in the Treatment Phase entered the Post Treatment Ext. Phase|26
183554|NCT00611403|449508|P2|NOT COMPLETED|Treatment Phase||11
183555|NCT00611403|449509|P1|NOT COMPLETED|Treatment Phase||6
183556|NCT00611403|449508|P2|COMPLETED|Treatment Phase||58
183557|NCT00611403|449509|P1|COMPLETED|Treatment Phase||62
183558|NCT00611403|449508|P2|STARTED|Treatment Phase||69
183559|NCT00611403|449509|P1|STARTED|Treatment Phase||68
183560|NCT00611442|449521|P2|NOT COMPLETED|Overall Study||2
183561|NCT00611442|449522|P1|NOT COMPLETED|Overall Study||1
183562|NCT00611442|449521|P2|COMPLETED|Overall Study||94
183563|NCT00611442|449522|P1|COMPLETED|Overall Study||94
183564|NCT00611442|449521|P2|STARTED|Overall Study||96
183565|NCT00611442|449522|P1|STARTED|Overall Study||95
183566|NCT00611455|449536|P3|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||211
183567|NCT00611455|449537|P2|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
183568|NCT00611455|449538|P1|NOT COMPLETED|Follow-up Period (Approximately 2 Years)||0
183569|NCT00611455|449536|P3|COMPLETED|Follow-up Period (Approximately 2 Years)||49
183570|NCT00611455|449537|P2|COMPLETED|Follow-up Period (Approximately 2 Years)||0
183571|NCT00611455|449538|P1|COMPLETED|Follow-up Period (Approximately 2 Years)||0
183572|NCT00611455|449536|P3|STARTED|Follow-up Period (Approximately 2 Years)|These participants received at least one infusion of placebo or ofatumumab.|260
183573|NCT00611455|449537|P2|STARTED|Follow-up Period (Approximately 2 Years)||0
183574|NCT00611455|449538|P1|STARTED|Follow-up Period (Approximately 2 Years)||0
183575|NCT00611455|449536|P3|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
183576|NCT00611455|449537|P2|NOT COMPLETED|OL Treatment Period (120 Weeks)||179
183577|NCT00611455|449538|P1|NOT COMPLETED|OL Treatment Period (120 Weeks)||0
183578|NCT00611455|449536|P3|COMPLETED|OL Treatment Period (120 Weeks)||0
183579|NCT00611455|449537|P2|COMPLETED|OL Treatment Period (120 Weeks)||52
183580|NCT00611455|449538|P1|COMPLETED|OL Treatment Period (120 Weeks)||0
183581|NCT00611455|449536|P3|STARTED|OL Treatment Period (120 Weeks)||0
183582|NCT00611455|449537|P2|STARTED|OL Treatment Period (120 Weeks)|118 participants received OFA during the DB Period; 113 received placebo during the DB Period.|231
183583|NCT00611455|449538|P1|STARTED|OL Treatment Period (120 Weeks)||0
183584|NCT00611455|449536|P3|NOT COMPLETED|DB Treatment Period (24 Weeks)||0
183585|NCT00611455|449537|P2|NOT COMPLETED|DB Treatment Period (24 Weeks)||14
183586|NCT00611455|449538|P1|NOT COMPLETED|DB Treatment Period (24 Weeks)||13
183587|NCT00611455|449536|P3|COMPLETED|DB Treatment Period (24 Weeks)||0
183588|NCT00611455|449537|P2|COMPLETED|DB Treatment Period (24 Weeks)||117
183589|NCT00611455|449538|P1|COMPLETED|DB Treatment Period (24 Weeks)||121
183590|NCT00611455|449536|P3|STARTED|DB Treatment Period (24 Weeks)||0
183591|NCT00611455|449537|P2|STARTED|DB Treatment Period (24 Weeks)||131
183592|NCT00611455|449538|P1|STARTED|DB Treatment Period (24 Weeks)||134
183593|NCT00611468|449664|P4|NOT COMPLETED|Overall Study||0
183594|NCT00611468|449665|P3|NOT COMPLETED|Overall Study||0
183595|NCT00611468|449666|P2|NOT COMPLETED|Overall Study||1
183596|NCT00611468|449667|P1|NOT COMPLETED|Overall Study||0
183597|NCT00611468|449664|P4|COMPLETED|Overall Study||13
183598|NCT00611468|449665|P3|COMPLETED|Overall Study||6
183599|NCT00611468|449666|P2|COMPLETED|Overall Study|One subject did not complete Cycle 1 of treatment and was replaced.|6
183600|NCT00611468|449667|P1|COMPLETED|Overall Study||3
183601|NCT00611468|449664|P4|STARTED|Overall Study||13
183602|NCT00611468|449665|P3|STARTED|Overall Study||6
183603|NCT00611468|449666|P2|STARTED|Overall Study||7
183604|NCT00611468|449667|P1|STARTED|Overall Study||3
183605|NCT00611533|449677|P2|NOT COMPLETED|Second Intervention (6 Weeks)||2
183606|NCT00611533|449678|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
183607|NCT00611533|449677|P2|COMPLETED|Second Intervention (6 Weeks)||4
183608|NCT00611533|449678|P1|COMPLETED|Second Intervention (6 Weeks)||8
183609|NCT00611533|449677|P2|STARTED|Second Intervention (6 Weeks)||6
183610|NCT00611533|449678|P1|STARTED|Second Intervention (6 Weeks)||8
183611|NCT00611533|449677|P2|NOT COMPLETED|First Intervention (6 Weeks)||2
183612|NCT00611533|449678|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
183613|NCT00611533|449677|P2|COMPLETED|First Intervention (6 Weeks)||6
183614|NCT00611533|449678|P1|COMPLETED|First Intervention (6 Weeks)||8
183615|NCT00611533|449677|P2|STARTED|First Intervention (6 Weeks)||8
183616|NCT00611533|449678|P1|STARTED|First Intervention (6 Weeks)||8
183617|NCT00611559|449700|P3|NOT COMPLETED|Overall Study||1
183618|NCT00611559|449701|P2|NOT COMPLETED|Overall Study||1
183619|NCT00611559|449702|P1|NOT COMPLETED|Overall Study||1
183620|NCT00611559|449700|P3|COMPLETED|Overall Study||56
183621|NCT00611559|449701|P2|COMPLETED|Overall Study||114
183622|NCT00611559|449702|P1|COMPLETED|Overall Study||110
183623|NCT00611559|449700|P3|STARTED|Overall Study||57
183624|NCT00611559|449701|P2|STARTED|Overall Study||115
183625|NCT00611559|449702|P1|STARTED|Overall Study||111
183626|NCT00611624|449761|P1|NOT COMPLETED|Overall Study||0
183627|NCT00611624|449761|P1|COMPLETED|Overall Study||28
183628|NCT00611624|449761|P1|STARTED|Overall Study||28
183629|NCT00611715|449768|P2|NOT COMPLETED|Overall Study||6
183630|NCT00611715|449769|P1|NOT COMPLETED|Overall Study||41
183631|NCT00611715|449768|P2|COMPLETED|Overall Study||0
183632|NCT00611715|449769|P1|COMPLETED|Overall Study|"2 pts in Arm 1 remain on-tx. They are not accounted for in off-tx reasonor completed data fields"|1
183633|NCT00611715|449768|P2|STARTED|Overall Study||6
183634|NCT00611715|449769|P1|STARTED|Overall Study||42
183635|NCT00611767|449783|P2|NOT COMPLETED|Overall Study||2
183636|NCT00611767|449784|P1|NOT COMPLETED|Overall Study||9
183637|NCT00611767|449783|P2|COMPLETED|Overall Study||22
183638|NCT00611767|449784|P1|COMPLETED|Overall Study||40
183639|NCT00611767|449783|P2|Placebo Test Day|Overall Study||1
183640|NCT00611767|449784|P1|Placebo Test Day|Overall Study||6
183641|NCT00611767|449783|P2|Thiopental Test Day|Overall Study||1
183642|NCT00611767|449784|P1|Thiopental Test Day|Overall Study||3
183643|NCT00611767|449783|P2|STARTED|Overall Study||24
183644|NCT00611767|449784|P1|STARTED|Overall Study||49
183645|NCT00611806|449946|P2|NOT COMPLETED|Overall Study||3
183646|NCT00611806|449947|P1|NOT COMPLETED|Overall Study||16
183647|NCT00611806|449946|P2|COMPLETED|Overall Study||43
183648|NCT00611806|449947|P1|COMPLETED|Overall Study||78
183649|NCT00611806|449946|P2|STARTED|Overall Study||46
183650|NCT00611806|449947|P1|STARTED|Overall Study||94
183651|NCT00611884|449963|P4|NOT COMPLETED|Overall Study||6
183652|NCT00611884|449964|P3|NOT COMPLETED|Overall Study||4
183653|NCT00611884|449965|P2|NOT COMPLETED|Overall Study||9
183654|NCT00611884|449966|P1|NOT COMPLETED|Overall Study||9
183655|NCT00611884|449963|P4|COMPLETED|Overall Study||56
183656|NCT00611884|449964|P3|COMPLETED|Overall Study||58
183657|NCT00611884|449965|P2|COMPLETED|Overall Study||51
183658|NCT00611884|449966|P1|COMPLETED|Overall Study||52
183659|NCT00611884|449963|P4|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
183660|NCT00611884|449964|P3|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|61
183661|NCT00611884|449965|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|59
183662|NCT00611884|449966|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|58
183663|NCT00611884|449963|P4|STARTED|Overall Study||62
183664|NCT00611884|449964|P3|STARTED|Overall Study||62
183665|NCT00611884|449965|P2|STARTED|Overall Study||60
183666|NCT00611884|449966|P1|STARTED|Overall Study||61
183667|NCT00611897|450020|P2|NOT COMPLETED|Day 2: Crossover Treatment||0
183668|NCT00611897|450021|P1|NOT COMPLETED|Day 2: Crossover Treatment||0
183669|NCT00611897|450020|P2|COMPLETED|Day 2: Crossover Treatment||8
183670|NCT00611897|450021|P1|COMPLETED|Day 2: Crossover Treatment||8
183671|NCT00611897|450020|P2|STARTED|Day 2: Crossover Treatment||8
183672|NCT00611897|450021|P1|STARTED|Day 2: Crossover Treatment||8
183673|NCT00611897|450020|P2|NOT COMPLETED|Day 1: Initial Treatment||0
183674|NCT00611897|450021|P1|NOT COMPLETED|Day 1: Initial Treatment||0
183675|NCT00611897|450020|P2|COMPLETED|Day 1: Initial Treatment||8
183676|NCT00611897|450021|P1|COMPLETED|Day 1: Initial Treatment||8
183677|NCT00611897|450020|P2|STARTED|Day 1: Initial Treatment||8
183678|NCT00611897|450021|P1|STARTED|Day 1: Initial Treatment||8
183679|NCT00612040|450048|P3|NOT COMPLETED|Overall Study||7
183680|NCT00612040|450049|P2|NOT COMPLETED|Overall Study||7
183681|NCT00612040|450050|P1|NOT COMPLETED|Overall Study||5
183682|NCT00612040|450048|P3|COMPLETED|Overall Study||52
183683|NCT00612040|450049|P2|COMPLETED|Overall Study||52
183684|NCT00612040|450050|P1|COMPLETED|Overall Study||55
183685|NCT00612040|450048|P3|Exposed|Overall Study||59
183686|NCT00612040|450049|P2|Exposed|Overall Study||59
183687|NCT00612040|450050|P1|Exposed|Overall Study||60
183688|NCT00612040|450048|P3|STARTED|Overall Study||59
183689|NCT00612040|450049|P2|STARTED|Overall Study||59
183690|NCT00612040|450050|P1|STARTED|Overall Study||60
183691|NCT00612066|450094|P1|NOT COMPLETED|Overall Study||1
183692|NCT00612066|450094|P1|COMPLETED|Overall Study||1
183693|NCT00612066|450094|P1|STARTED|Overall Study||2
183694|NCT00612105|450100|P2|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||0
183695|NCT00612105|450101|P1|NOT COMPLETED|Period Title 3: 3-Week Taper Phase||1
183696|NCT00612105|450100|P2|COMPLETED|Period Title 3: 3-Week Taper Phase||58
183697|NCT00612105|450101|P1|COMPLETED|Period Title 3: 3-Week Taper Phase||85
183698|NCT00612105|450100|P2|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|58
183699|NCT00612105|450101|P1|STARTED|Period Title 3: 3-Week Taper Phase|Includes participants who discontinued during the titration phase and entered taper phase.|86
183700|NCT00612105|450100|P2|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||2
183701|NCT00612105|450101|P1|NOT COMPLETED|Period Title 2: 4-Week Maintenance Phase||11
183702|NCT00612105|450100|P2|COMPLETED|Period Title 2: 4-Week Maintenance Phase||55
183703|NCT00612105|450101|P1|COMPLETED|Period Title 2: 4-Week Maintenance Phase||78
183704|NCT00612105|450100|P2|STARTED|Period Title 2: 4-Week Maintenance Phase||57
183705|NCT00612105|450101|P1|STARTED|Period Title 2: 4-Week Maintenance Phase||89
183706|NCT00612105|450100|P2|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||5
183707|NCT00612105|450101|P1|NOT COMPLETED|Period Title 1: 6-Week Titration Phase||36
183708|NCT00612105|450100|P2|COMPLETED|Period Title 1: 6-Week Titration Phase||57
183709|NCT00612105|450101|P1|COMPLETED|Period Title 1: 6-Week Titration Phase||89
183710|NCT00612105|450100|P2|STARTED|Period Title 1: 6-Week Titration Phase||62
183711|NCT00612105|450101|P1|STARTED|Period Title 1: 6-Week Titration Phase||125
183712|NCT00612222|450151|P1|NOT COMPLETED|Overall Study||0
183713|NCT00612222|450151|P1|COMPLETED|Overall Study||4
183714|NCT00612222|450151|P1|STARTED|Overall Study||4
183715|NCT00612313|450159|P2|NOT COMPLETED|Overall Study||13
183716|NCT00612313|450160|P1|NOT COMPLETED|Overall Study||17
183717|NCT00612313|450159|P2|COMPLETED|Overall Study||62
183718|NCT00612313|450160|P1|COMPLETED|Overall Study||52
183719|NCT00612313|450159|P2|STARTED|Overall Study||75
183720|NCT00612313|450160|P1|STARTED|Overall Study||69
183721|NCT00612339|450176|P1|NOT COMPLETED|Overall Study||0
183722|NCT00612339|450176|P1|COMPLETED|Overall Study||41
183723|NCT00612339|450176|P1|STARTED|Overall Study||41
183724|NCT00612352|450182|P2|NOT COMPLETED|Overall Study||6
183725|NCT00612352|450183|P1|NOT COMPLETED|Overall Study||9
183726|NCT00612352|450182|P2|COMPLETED|Overall Study||109
183727|NCT00612352|450183|P1|COMPLETED|Overall Study||56
183728|NCT00612352|450182|P2|Placebo|Overall Study||4
183729|NCT00612352|450183|P1|Placebo|Overall Study||4
183730|NCT00612352|450182|P2|40%mg|Overall Study||0
183731|NCT00612352|450183|P1|40%mg|Overall Study||1
183732|NCT00612352|450182|P2|100%mg|Overall Study||1
183733|NCT00612352|450183|P1|100%mg|Overall Study||2
183734|NCT00612352|450182|P2|Placebo & 100%mg|Overall Study||0
183735|NCT00612352|450183|P1|Placebo & 100%mg|Overall Study||1
183736|NCT00612352|450182|P2|40%mg & 100%mg|Overall Study||1
183737|NCT00612352|450183|P1|40%mg & 100%mg|Overall Study||1
183738|NCT00612352|450182|P2|STARTED|Overall Study||115
183739|NCT00612352|450183|P1|STARTED|Overall Study||65
183740|NCT00612430|450299|P2|NOT COMPLETED|Overall Study||0
183741|NCT00612430|450300|P1|NOT COMPLETED|Overall Study||0
183742|NCT00612430|450299|P2|COMPLETED|Overall Study||27
183743|NCT00612430|450300|P1|COMPLETED|Overall Study||32
183744|NCT00612430|450299|P2|STARTED|Overall Study||27
183745|NCT00612430|450300|P1|STARTED|Overall Study||32
183746|NCT00612508|450316|P2|NOT COMPLETED|Overall Study||4
183747|NCT00612508|450317|P1|NOT COMPLETED|Overall Study||3
183748|NCT00612508|450316|P2|COMPLETED|Overall Study|6 nuvaring users returned for the 84 day biopsy|3
183749|NCT00612508|450317|P1|COMPLETED|Overall Study|5 desogen users returned for the 84 day biopsy|4
183750|NCT00612508|450316|P2|STARTED|Overall Study||7
183751|NCT00612508|450317|P1|STARTED|Overall Study||7
183752|NCT00612534|450329|P4|NOT COMPLETED|Overall Study||17
183753|NCT00612534|450330|P3|NOT COMPLETED|Overall Study||7
183754|NCT00612534|450331|P2|NOT COMPLETED|Overall Study||17
183755|NCT00612534|450332|P1|NOT COMPLETED|Overall Study||13
183756|NCT00612534|450329|P4|COMPLETED|Overall Study||7
183757|NCT00612534|450330|P3|COMPLETED|Overall Study||13
183758|NCT00612534|450331|P2|COMPLETED|Overall Study||9
183759|NCT00612534|450332|P1|COMPLETED|Overall Study||11
183760|NCT00612534|450329|P4|STARTED|Overall Study||24
183761|NCT00612534|450330|P3|STARTED|Overall Study||20
183762|NCT00612534|450331|P2|STARTED|Overall Study||26
183763|NCT00612534|450332|P1|STARTED|Overall Study||24
183764|NCT00612560|450346|P4|NOT COMPLETED|Overall Study||0
183765|NCT00612560|450347|P3|NOT COMPLETED|Overall Study||0
183766|NCT00612560|450348|P2|NOT COMPLETED|Overall Study||0
183767|NCT00612560|450349|P1|NOT COMPLETED|Overall Study||0
183768|NCT00612560|450346|P4|COMPLETED|Overall Study||6
183769|NCT00612560|450347|P3|COMPLETED|Overall Study||8
183770|NCT00612560|450348|P2|COMPLETED|Overall Study||7
183771|NCT00612560|450349|P1|COMPLETED|Overall Study||7
183772|NCT00612560|450346|P4|STARTED|Overall Study||6
183773|NCT00612560|450347|P3|STARTED|Overall Study||8
183774|NCT00612560|450348|P2|STARTED|Overall Study||7
183775|NCT00612560|450349|P1|STARTED|Overall Study||7
183776|NCT00612573|450375|P4|NOT COMPLETED|Overall Study||13
183777|NCT00612573|450376|P3|NOT COMPLETED|Overall Study||9
183778|NCT00612573|450377|P2|NOT COMPLETED|Overall Study||14
183779|NCT00612573|450378|P1|NOT COMPLETED|Overall Study||12
183780|NCT00612573|450375|P4|COMPLETED|Overall Study||54
183781|NCT00612573|450376|P3|COMPLETED|Overall Study||52
183782|NCT00612573|450377|P2|COMPLETED|Overall Study||51
183783|NCT00612573|450378|P1|COMPLETED|Overall Study||52
183784|NCT00612573|450375|P4|STARTED|Overall Study||67
183785|NCT00612573|450376|P3|STARTED|Overall Study||61
183786|NCT00612573|450377|P2|STARTED|Overall Study||65
183787|NCT00612573|450378|P1|STARTED|Overall Study||64
183788|NCT00612677|450400|P1|NOT COMPLETED|Overall Study||1
183789|NCT00612677|450400|P1|COMPLETED|Overall Study||0
183790|NCT00612677|450400|P1|STARTED|Overall Study||1
183791|NCT00612690|450408|P2|NOT COMPLETED|Overall Study||118
183792|NCT00612690|450409|P1|NOT COMPLETED|Overall Study||115
183793|NCT00612690|450408|P2|COMPLETED|Overall Study||89
183794|NCT00612690|450409|P1|COMPLETED|Overall Study||160
183795|NCT00612690|450408|P2|STARTED|Overall Study||207
183796|NCT00612690|450409|P1|STARTED|Overall Study||275
183797|NCT00612807|450419|P2|NOT COMPLETED|Overall Study||0
183798|NCT00612807|450420|P1|NOT COMPLETED|Overall Study||2
183799|NCT00612807|450419|P2|COMPLETED|Overall Study||28
183800|NCT00612807|450420|P1|COMPLETED|Overall Study||12
183801|NCT00612807|450419|P2|STARTED|Overall Study||28
183802|NCT00612807|450420|P1|STARTED|Overall Study||14
183803|NCT00612924|450430|P2|NOT COMPLETED|Overall Study||9
183804|NCT00612924|450431|P1|NOT COMPLETED|Overall Study||7
183805|NCT00612924|450430|P2|COMPLETED|Overall Study||85
183806|NCT00612924|450431|P1|COMPLETED|Overall Study||94
183807|NCT00612924|450430|P2|STARTED|Overall Study||94
183808|NCT00612924|450431|P1|STARTED|Overall Study||101
183809|NCT00613015|450448|P6|NOT COMPLETED|Overall Study||3
183810|NCT00613015|450449|P5|NOT COMPLETED|Overall Study||2
183811|NCT00613015|450450|P4|NOT COMPLETED|Overall Study||3
183812|NCT00613015|450451|P3|NOT COMPLETED|Overall Study||3
183813|NCT00613015|450452|P2|NOT COMPLETED|Overall Study||1
183814|NCT00613015|450453|P1|NOT COMPLETED|Overall Study||0
183815|NCT00613015|450448|P6|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|16
183816|NCT00613015|450449|P5|COMPLETED|Overall Study|Two participants did not complete one-week follow-up visit.|13
183817|NCT00613015|450450|P4|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|21
183818|NCT00613015|450451|P3|COMPLETED|Overall Study|Three participants did not complete one-week follow-up visit.|23
183819|NCT00613015|450452|P2|COMPLETED|Overall Study|One participant did not complete the one-week follow-up visit.|11
183820|NCT00613015|450453|P1|COMPLETED|Overall Study||13
183821|NCT00613015|450448|P6|STARTED|Overall Study||19
183822|NCT00613015|450449|P5|STARTED|Overall Study||15
183823|NCT00613015|450450|P4|STARTED|Overall Study||24
183824|NCT00613015|450451|P3|STARTED|Overall Study||26
183825|NCT00613015|450452|P2|STARTED|Overall Study||12
183826|NCT00613015|450453|P1|STARTED|Overall Study||13
183827|NCT00613028|450475|P2|NOT COMPLETED|Overall Study||1
183828|NCT00613028|450476|P1|NOT COMPLETED|Overall Study||0
183829|NCT00613028|450475|P2|COMPLETED|Overall Study||12
183830|NCT00613028|450476|P1|COMPLETED|Overall Study||10
183831|NCT00613028|450475|P2|STARTED|Overall Study||13
183832|NCT00613028|450476|P1|STARTED|Overall Study||10
183833|NCT00613080|450490|P1|NOT COMPLETED|Overall Study||11
183834|NCT00613080|450490|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|68
183835|NCT00613080|450490|P1|STARTED|Overall Study||79
183836|NCT00613106|450496|P2|NOT COMPLETED|Overall Study||9
183837|NCT00613106|450497|P1|NOT COMPLETED|Overall Study||20
183838|NCT00613106|450496|P2|COMPLETED|Overall Study||38
183839|NCT00613106|450497|P1|COMPLETED|Overall Study||112
183840|NCT00613106|450496|P2|STARTED|Overall Study||47
183841|NCT00613106|450497|P1|STARTED|Overall Study||132
183842|NCT00613301|450503|P1|NOT COMPLETED|Overall Study||228
183843|NCT00613301|450503|P1|COMPLETED|Overall Study||188
183844|NCT00613301|450503|P1|STARTED|Overall Study||416
183845|NCT00613314|450510|P1|NOT COMPLETED|Overall Study||155
183846|NCT00613314|450510|P1|COMPLETED|Overall Study||15113
183847|NCT00613314|450510|P1|STARTED|Overall Study||15268
183848|NCT00613327|450518|P1|NOT COMPLETED|Overall Study||101
183849|NCT00613327|450518|P1|COMPLETED|Overall Study||244
183850|NCT00613327|450518|P1|STARTED|Overall Study||345
183851|NCT00613366|450539|P2|NOT COMPLETED|Overall Study||2
183852|NCT00613366|450540|P1|NOT COMPLETED|Overall Study||3
183853|NCT00613366|450539|P2|COMPLETED|Overall Study||18
183854|NCT00613366|450540|P1|COMPLETED|Overall Study||17
183855|NCT00613366|450539|P2|STARTED|Overall Study||20
183856|NCT00613366|450540|P1|STARTED|Overall Study||20
183857|NCT00613379|450551|P3|NOT COMPLETED|Overall Study||0
183858|NCT00613379|450552|P2|NOT COMPLETED|Overall Study||0
183859|NCT00613379|450553|P1|NOT COMPLETED|Overall Study||0
183860|NCT00613379|450551|P3|COMPLETED|Overall Study||11
183861|NCT00613379|450552|P2|COMPLETED|Overall Study||10
183862|NCT00613379|450553|P1|COMPLETED|Overall Study||10
183863|NCT00613379|450551|P3|STARTED|Overall Study||11
183864|NCT00613379|450552|P2|STARTED|Overall Study||10
183865|NCT00613379|450553|P1|STARTED|Overall Study||10
183866|NCT00613405|450563|P2|NOT COMPLETED|Overall Study||0
183867|NCT00613405|450564|P1|NOT COMPLETED|Overall Study||0
183868|NCT00613405|450563|P2|COMPLETED|Overall Study||42
183869|NCT00613405|450564|P1|COMPLETED|Overall Study||45
183870|NCT00613405|450563|P2|STARTED|Overall Study||42
183871|NCT00613405|450564|P1|STARTED|Overall Study||45
183872|NCT00613509|450572|P2|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
183873|NCT00613509|450573|P1|NOT COMPLETED|Cycle 2 (Group 2 = Crossover)||0
183874|NCT00613509|450572|P2|COMPLETED|Cycle 2 (Group 2 = Crossover)||4
183875|NCT00613509|450573|P1|COMPLETED|Cycle 2 (Group 2 = Crossover)||11
183876|NCT00613509|450572|P2|STARTED|Cycle 2 (Group 2 = Crossover)||4
183877|NCT00613509|450573|P1|STARTED|Cycle 2 (Group 2 = Crossover)||11
183878|NCT00613509|450572|P2|NOT COMPLETED|Cycle 1||8
183879|NCT00613509|450573|P1|NOT COMPLETED|Cycle 1||5
183880|NCT00613509|450572|P2|COMPLETED|Cycle 1|Completion of Cycle 1. 12 participants were deemed evaluable|4
183881|NCT00613509|450573|P1|COMPLETED|Cycle 1|Completion of Cycle 1. 9 participants were deemed evaluable|6
183882|NCT00613509|450572|P2|STARTED|Cycle 1||12
183883|NCT00613509|450573|P1|STARTED|Cycle 1||11
183884|NCT00613574|450595|P1|NOT COMPLETED|Overall Study||6
183885|NCT00613574|450595|P1|COMPLETED|Overall Study||401
183886|NCT00613574|450595|P1|STARTED|Overall Study||407
183887|NCT00613626|450608|P3|NOT COMPLETED|Overall Study||0
183888|NCT00613626|450609|P2|NOT COMPLETED|Overall Study||1
183889|NCT00613626|450610|P1|NOT COMPLETED|Overall Study||0
183890|NCT00613626|450608|P3|COMPLETED|Overall Study||7
183891|NCT00613626|450609|P2|COMPLETED|Overall Study||33
183892|NCT00613626|450610|P1|COMPLETED|Overall Study||33
183893|NCT00613626|450608|P3|1st Dose ZD6474|Overall Study||7
183894|NCT00613626|450609|P2|1st Dose ZD6474|Overall Study||34
183895|NCT00613626|450610|P1|1st Dose ZD6474|Overall Study||33
183896|NCT00613626|450608|P3|STARTED|Overall Study|These participants provided the toxicity data to determine if ZD6474+Etopiside+Cisplatin was safe.|7
183897|NCT00613626|450609|P2|STARTED|Overall Study||34
183898|NCT00613626|450610|P1|STARTED|Overall Study||33
183899|NCT00613730|450626|P1|NOT COMPLETED|Overall Study||3
183900|NCT00613730|450626|P1|COMPLETED|Overall Study||0
183901|NCT00613730|450626|P1|STARTED|Overall Study||3
183902|NCT00604162|450632|P1|NOT COMPLETED|Overall Study||4
183903|NCT00604162|450632|P1|COMPLETED|Overall Study||328
183904|NCT00604162|450632|P1|STARTED|Overall Study||332
183905|NCT00604175|450646|P3|NOT COMPLETED|Week 29 Through Week 72||4
183906|NCT00604175|450647|P2|NOT COMPLETED|Week 29 Through Week 72||7
183907|NCT00604175|450648|P1|NOT COMPLETED|Week 29 Through Week 72||12
183908|NCT00604175|450646|P3|COMPLETED|Week 29 Through Week 72||89
183909|NCT00604175|450647|P2|COMPLETED|Week 29 Through Week 72||85
183910|NCT00604175|450648|P1|COMPLETED|Week 29 Through Week 72||108
183911|NCT00604175|450646|P3|STARTED|Week 29 Through Week 72||93
183912|NCT00604175|450647|P2|STARTED|Week 29 Through Week 72||92
183913|NCT00604175|450648|P1|STARTED|Week 29 Through Week 72||120
183914|NCT00604175|450646|P3|NOT COMPLETED|Entry Through Week 28||1
183915|NCT00604175|450647|P2|NOT COMPLETED|Entry Through Week 28||3
183916|NCT00604175|450648|P1|NOT COMPLETED|Entry Through Week 28||10
183917|NCT00604175|450646|P3|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|93
183918|NCT00604175|450647|P2|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|92
183919|NCT00604175|450648|P1|COMPLETED|Entry Through Week 28|Completed 28 weeks of the study (the primary endpoint time point).|120
183920|NCT00604175|450646|P3|STARTED|Entry Through Week 28||94
183921|NCT00604175|450647|P2|STARTED|Entry Through Week 28||95
183922|NCT00604175|450648|P1|STARTED|Entry Through Week 28||130
183923|NCT00604188|450703|P2|NOT COMPLETED|Overall Study||25
183924|NCT00604188|450704|P1|NOT COMPLETED|Overall Study||27
183925|NCT00604188|450703|P2|COMPLETED|Overall Study||70
183926|NCT00604188|450704|P1|COMPLETED|Overall Study||66
183927|NCT00604188|450703|P2|STARTED|Overall Study|The ITT population for Subutex-to-Suboxone Induction is 94 participants|95
183928|NCT00604188|450704|P1|STARTED|Overall Study||93
183929|NCT00604214|450726|P2|NOT COMPLETED|Day 91 to Day 180||32
183930|NCT00604214|450727|P1|NOT COMPLETED|Day 91 to Day 180||26
183931|NCT00604214|450726|P2|COMPLETED|Day 91 to Day 180||521
183932|NCT00604214|450727|P1|COMPLETED|Day 91 to Day 180||529
183933|NCT00604214|450726|P2|STARTED|Day 91 to Day 180||553
183934|NCT00604214|450727|P1|STARTED|Day 91 to Day 180||555
183935|NCT00604214|450726|P2|NOT COMPLETED|Day 29 to Day 90||79
183936|NCT00604214|450727|P1|NOT COMPLETED|Day 29 to Day 90||68
183937|NCT00604214|450726|P2|COMPLETED|Day 29 to Day 90||553
183938|NCT00604214|450727|P1|COMPLETED|Day 29 to Day 90||555
183939|NCT00604214|450726|P2|STARTED|Day 29 to Day 90||632
183940|NCT00604214|450727|P1|STARTED|Day 29 to Day 90||623
183941|NCT00604214|450726|P2|NOT COMPLETED|Baseline to Day 28||213
183942|NCT00604214|450727|P1|NOT COMPLETED|Baseline to Day 28||228
183943|NCT00604214|450726|P2|COMPLETED|Baseline to Day 28||632
183944|NCT00604214|450727|P1|COMPLETED|Baseline to Day 28||623
183945|NCT00604214|450726|P2|Received Study Drug|Baseline to Day 28||833
183946|NCT00604214|450727|P1|Received Study Drug|Baseline to Day 28||833
183947|NCT00604214|450726|P2|STARTED|Baseline to Day 28||845
183948|NCT00604214|450727|P1|STARTED|Baseline to Day 28||851
183949|NCT00604279|450759|P2|NOT COMPLETED|Overall Study||38
183950|NCT00604279|450760|P1|NOT COMPLETED|Overall Study||64
183951|NCT00604279|450759|P2|COMPLETED|Overall Study||185
183952|NCT00604279|450760|P1|COMPLETED|Overall Study||165
183953|NCT00604279|450759|P2|STARTED|Overall Study||223
183954|NCT00604279|450760|P1|STARTED|Overall Study||229
183955|NCT00613821|450776|P2|NOT COMPLETED|Overall Study||1
183956|NCT00613821|450777|P1|NOT COMPLETED|Overall Study||2
183957|NCT00613821|450776|P2|COMPLETED|Overall Study||39
183958|NCT00613821|450777|P1|COMPLETED|Overall Study||38
183959|NCT00613821|450776|P2|STARTED|Overall Study||40
183960|NCT00613821|450777|P1|STARTED|Overall Study||40
183961|NCT00613925|450785|P2|NOT COMPLETED|Overall Study||1
183962|NCT00613925|450786|P1|NOT COMPLETED|Overall Study||0
183963|NCT00613925|450785|P2|COMPLETED|Overall Study||32
183964|NCT00613925|450786|P1|COMPLETED|Overall Study||37
183965|NCT00613925|450785|P2|STARTED|Overall Study||33
183966|NCT00613925|450786|P1|STARTED|Overall Study||37
183967|NCT00613938|450798|P4|NOT COMPLETED|Overall Study||26
183968|NCT00613938|450799|P3|NOT COMPLETED|Overall Study||23
183969|NCT00613938|450800|P2|NOT COMPLETED|Overall Study||28
183970|NCT00613938|450801|P1|NOT COMPLETED|Overall Study||20
183971|NCT00613938|450798|P4|COMPLETED|Overall Study||253
183972|NCT00613938|450799|P3|COMPLETED|Overall Study||255
183973|NCT00613938|450800|P2|COMPLETED|Overall Study||247
183974|NCT00613938|450801|P1|COMPLETED|Overall Study||49
183975|NCT00613938|450798|P4|STARTED|Overall Study|one patient did not have a valid baseline score therefore excluded from above|279
183976|NCT00613938|450799|P3|STARTED|Overall Study||278
183977|NCT00613938|450800|P2|STARTED|Overall Study||275
183978|NCT00613938|450801|P1|STARTED|Overall Study||69
183979|NCT00613951|450834|P3|NOT COMPLETED|Overall Study||5
183980|NCT00613951|450835|P2|NOT COMPLETED|Overall Study||5
183981|NCT00613951|450836|P1|NOT COMPLETED|Overall Study||7
183982|NCT00613951|450834|P3|COMPLETED|Overall Study||57
183983|NCT00613951|450835|P2|COMPLETED|Overall Study||54
183984|NCT00613951|450836|P1|COMPLETED|Overall Study||54
183985|NCT00613951|450834|P3|Exposed|Overall Study||62
183986|NCT00613951|450835|P2|Exposed|Overall Study||59
183987|NCT00613951|450836|P1|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|60
183988|NCT00613951|450834|P3|STARTED|Overall Study||62
183989|NCT00613951|450835|P2|STARTED|Overall Study||59
183990|NCT00613951|450836|P1|STARTED|Overall Study||61
183991|NCT00614055|450880|P3|NOT COMPLETED|Overall Study||5
183992|NCT00614055|450881|P2|NOT COMPLETED|Overall Study||6
183993|NCT00614055|450882|P1|NOT COMPLETED|Overall Study||4
183994|NCT00614055|450880|P3|COMPLETED|Overall Study||55
183995|NCT00614055|450881|P2|COMPLETED|Overall Study||53
183996|NCT00614055|450882|P1|COMPLETED|Overall Study||55
183997|NCT00614055|450880|P3|Exposed|Overall Study||60
183998|NCT00614055|450881|P2|Exposed|Overall Study||59
183999|NCT00614055|450882|P1|Exposed|Overall Study||59
184000|NCT00614055|450880|P3|STARTED|Overall Study||60
184001|NCT00614055|450881|P2|STARTED|Overall Study||59
184002|NCT00614055|450882|P1|STARTED|Overall Study||59
184003|NCT00614120|450930|P4|NOT COMPLETED|Overall Study||16
184004|NCT00614120|450931|P3|NOT COMPLETED|Overall Study||59
184005|NCT00614120|450932|P2|NOT COMPLETED|Overall Study||46
184006|NCT00614120|450933|P1|NOT COMPLETED|Overall Study||29
184007|NCT00614120|450930|P4|COMPLETED|Overall Study||215
184008|NCT00614120|450931|P3|COMPLETED|Overall Study||175
184009|NCT00614120|450932|P2|COMPLETED|Overall Study||187
184010|NCT00614120|450933|P1|COMPLETED|Overall Study||202
184011|NCT00614120|450930|P4|Exposed to Study Drug|Overall Study||231
184012|NCT00614120|450931|P3|Exposed to Study Drug|Overall Study|Subject withdrew before exposure to study products, and thus not included in full analysis set.|233
184013|NCT00614120|450932|P2|Exposed to Study Drug|Overall Study||233
184014|NCT00614120|450933|P1|Exposed to Study Drug|Overall Study||231
184015|NCT00614120|450930|P4|STARTED|Overall Study|Randomised|231
184016|NCT00614120|450931|P3|STARTED|Overall Study|Randomised|234
184017|NCT00614120|450932|P2|STARTED|Overall Study|Randomised|233
184018|NCT00614120|450933|P1|STARTED|Overall Study|Randomised|231
184019|NCT00616421|450974|P3|NOT COMPLETED|Overall Study||41
184020|NCT00616421|450975|P2|NOT COMPLETED|Overall Study||38
184021|NCT00616421|450976|P1|NOT COMPLETED|Overall Study||26
184022|NCT00616421|450974|P3|COMPLETED|Overall Study||1229
184023|NCT00616421|450975|P2|COMPLETED|Overall Study||1240
184024|NCT00616421|450976|P1|COMPLETED|Overall Study||333
184025|NCT00616421|450974|P3|STARTED|Overall Study||1270
184026|NCT00616421|450975|P2|STARTED|Overall Study||1278
184027|NCT00616421|450976|P1|STARTED|Overall Study||359
184028|NCT00616434|451015|P2|NOT COMPLETED|Overall Study||8
184029|NCT00616434|451016|P1|NOT COMPLETED|Overall Study||6
184030|NCT00616434|451015|P2|COMPLETED|Overall Study||53
184031|NCT00616434|451016|P1|COMPLETED|Overall Study||56
184032|NCT00616434|451015|P2|STARTED|Overall Study||61
184033|NCT00616434|451016|P1|STARTED|Overall Study||62
184034|NCT00616577|451029|P3|NOT COMPLETED|Overall Study||0
184035|NCT00616577|451030|P2|NOT COMPLETED|Overall Study||0
184036|NCT00616577|451031|P1|NOT COMPLETED|Overall Study||0
184037|NCT00616577|451029|P3|COMPLETED|Overall Study||7
184038|NCT00616577|451030|P2|COMPLETED|Overall Study||9
184039|NCT00616577|451031|P1|COMPLETED|Overall Study||6
184040|NCT00616577|451029|P3|STARTED|Overall Study||7
184041|NCT00616577|451030|P2|STARTED|Overall Study||9
184042|NCT00616577|451031|P1|STARTED|Overall Study||6
184043|NCT00616603|451042|P3|NOT COMPLETED|Overall Study||2
184044|NCT00616603|451043|P2|NOT COMPLETED|Overall Study||0
184045|NCT00616603|451044|P1|NOT COMPLETED|Overall Study||2
184046|NCT00616603|451042|P3|COMPLETED|Overall Study||13
184047|NCT00616603|451043|P2|COMPLETED|Overall Study||14
184048|NCT00616603|451044|P1|COMPLETED|Overall Study||12
184049|NCT00616603|451042|P3|STARTED|Overall Study||15
184050|NCT00616603|451043|P2|STARTED|Overall Study||14
184051|NCT00616603|451044|P1|STARTED|Overall Study||14
184052|NCT00616629|451057|P5|NOT COMPLETED|Overall Study||0
184053|NCT00616629|451058|P4|NOT COMPLETED|Overall Study||0
184054|NCT00616629|451059|P3|NOT COMPLETED|Overall Study||1
184055|NCT00616629|451060|P2|NOT COMPLETED|Overall Study||2
184056|NCT00616629|451061|P1|NOT COMPLETED|Overall Study||2
184057|NCT00616629|451057|P5|COMPLETED|Overall Study||12
184058|NCT00616629|451058|P4|COMPLETED|Overall Study||2
184059|NCT00616629|451059|P3|COMPLETED|Overall Study||13
184060|NCT00616629|451060|P2|COMPLETED|Overall Study||12
184061|NCT00616629|451061|P1|COMPLETED|Overall Study||11
184062|NCT00616629|451057|P5|STARTED|Overall Study||12
184063|NCT00616629|451058|P4|STARTED|Overall Study||2
184064|NCT00616629|451059|P3|STARTED|Overall Study|One patient never received study drug|14
184065|NCT00616629|451060|P2|STARTED|Overall Study|Two patients never received study drug|14
184066|NCT00616629|451061|P1|STARTED|Overall Study|Two patients never received study drug|13
184067|NCT00616642|451105|P2|NOT COMPLETED|Overall Study||1
184068|NCT00616642|451106|P1|NOT COMPLETED|Overall Study||0
184069|NCT00616642|451105|P2|COMPLETED|Overall Study||0
184070|NCT00616642|451106|P1|COMPLETED|Overall Study||0
184071|NCT00616642|451105|P2|STARTED|Overall Study||1
184072|NCT00616642|451106|P1|STARTED|Overall Study||0
184073|NCT00616655|451115|P3|NOT COMPLETED|Overall Study||48
184074|NCT00616655|451116|P2|NOT COMPLETED|Overall Study||41
184075|NCT00616655|451117|P1|NOT COMPLETED|Overall Study||35
184076|NCT00616655|451115|P3|COMPLETED|Overall Study||103
184077|NCT00616655|451116|P2|COMPLETED|Overall Study||112
184078|NCT00616655|451117|P1|COMPLETED|Overall Study||117
184079|NCT00616655|451115|P3|STARTED|Overall Study||151
184080|NCT00616655|451116|P2|STARTED|Overall Study||153
184081|NCT00616655|451117|P1|STARTED|Overall Study||152
184082|NCT00616759|451157|P2|NOT COMPLETED|Overall Study||2
184083|NCT00616759|451158|P1|NOT COMPLETED|Overall Study||3
184084|NCT00616759|451157|P2|COMPLETED|Overall Study||8
184085|NCT00616759|451158|P1|COMPLETED|Overall Study||7
184086|NCT00616759|451157|P2|STARTED|Overall Study||10
184087|NCT00616759|451158|P1|STARTED|Overall Study||10
184088|NCT00616772|451166|P2|NOT COMPLETED|Overall Study||102
184089|NCT00616772|451167|P1|NOT COMPLETED|Overall Study||115
184090|NCT00616772|451166|P2|COMPLETED|Overall Study||240
184091|NCT00616772|451167|P1|COMPLETED|Overall Study||225
184092|NCT00616772|451166|P2|Treated|Overall Study||339
184093|NCT00616772|451167|P1|Treated|Overall Study||337
184094|NCT00616772|451166|P2|STARTED|Overall Study||342
184095|NCT00616772|451167|P1|STARTED|Overall Study||340
184096|NCT00616902|451183|P2|NOT COMPLETED|Overall Study||6
184097|NCT00616902|451184|P1|NOT COMPLETED|Overall Study||6
184098|NCT00616902|451183|P2|COMPLETED|Overall Study||0
184099|NCT00616902|451184|P1|COMPLETED|Overall Study||0
184100|NCT00616902|451183|P2|STARTED|Overall Study||6
184101|NCT00616902|451184|P1|STARTED|Overall Study||6
184102|NCT00616928|451212|P4|NOT COMPLETED|Overall Study||7
184103|NCT00616928|451213|P3|NOT COMPLETED|Overall Study||17
184104|NCT00616928|451214|P2|NOT COMPLETED|Overall Study||18
184105|NCT00616928|451215|P1|NOT COMPLETED|Overall Study||62
184106|NCT00616928|451212|P4|COMPLETED|Overall Study||364
184107|NCT00616928|451213|P3|COMPLETED|Overall Study||1101
184108|NCT00616928|451214|P2|COMPLETED|Overall Study||750
184109|NCT00616928|451215|P1|COMPLETED|Overall Study||2242
184110|NCT00616928|451212|P4|STARTED|Overall Study||371
184111|NCT00616928|451213|P3|STARTED|Overall Study||1118
184112|NCT00616928|451214|P2|STARTED|Overall Study||768
184113|NCT00616928|451215|P1|STARTED|Overall Study||2304
184114|NCT00616967|451279|P3|NOT COMPLETED|Overall Study||1
184115|NCT00616967|451280|P2|NOT COMPLETED|Overall Study||0
184116|NCT00616967|451281|P1|NOT COMPLETED|Overall Study||0
184117|NCT00616967|451279|P3|COMPLETED|Overall Study||30
184118|NCT00616967|451280|P2|COMPLETED|Overall Study||31
184119|NCT00616967|451281|P1|COMPLETED|Overall Study||6
184120|NCT00616967|451279|P3|STARTED|Overall Study||31
184121|NCT00616967|451280|P2|STARTED|Overall Study||31
184122|NCT00616967|451281|P1|STARTED|Overall Study||6
184123|NCT00617058|451293|P3|NOT COMPLETED|Overall Study||0
184124|NCT00617058|451294|P2|NOT COMPLETED|Overall Study||0
184125|NCT00617058|451295|P1|NOT COMPLETED|Overall Study||0
184126|NCT00617058|451293|P3|COMPLETED|Overall Study||0
184127|NCT00617058|451294|P2|COMPLETED|Overall Study||0
184128|NCT00617058|451295|P1|COMPLETED|Overall Study||1
184129|NCT00617058|451293|P3|STARTED|Overall Study||0
184130|NCT00617058|451294|P2|STARTED|Overall Study||0
184131|NCT00617058|451295|P1|STARTED|Overall Study||1
184132|NCT00617084|451335|P2|NOT COMPLETED|Overall Study||26
184133|NCT00617084|451336|P1|NOT COMPLETED|Overall Study||21
184134|NCT00617084|451335|P2|COMPLETED|Overall Study||1126
184135|NCT00617084|451336|P1|COMPLETED|Overall Study||1119
184136|NCT00617084|451335|P2|STARTED|Overall Study||1152
184137|NCT00617084|451336|P1|STARTED|Overall Study||1140
184138|NCT00617097|451346|P2|NOT COMPLETED|Overall Study||0
184139|NCT00617097|451347|P1|NOT COMPLETED|Overall Study||0
184140|NCT00617097|451346|P2|COMPLETED|Overall Study||25
184141|NCT00617097|451347|P1|COMPLETED|Overall Study||25
184142|NCT00617097|451346|P2|STARTED|Overall Study||25
184143|NCT00617097|451347|P1|STARTED|Overall Study||25
184144|NCT00617123|451361|P2|NOT COMPLETED|Study Treatment Period||16
184145|NCT00617123|451362|P1|NOT COMPLETED|Study Treatment Period||17
184146|NCT00617123|451361|P2|COMPLETED|Study Treatment Period||79
184147|NCT00617123|451362|P1|COMPLETED|Study Treatment Period||81
184148|NCT00617123|451361|P2|Treated|Study Treatment Period||95
184149|NCT00617123|451362|P1|Treated|Study Treatment Period|1 participant was not treated|97
184150|NCT00617123|451361|P2|STARTED|Study Treatment Period||95
184151|NCT00617123|451362|P1|STARTED|Study Treatment Period||98
184152|NCT00617123|451361|P2|NOT COMPLETED|Referral Screening Period||26
184153|NCT00617123|451362|P1|NOT COMPLETED|Referral Screening Period||39
184154|NCT00617123|451361|P2|COMPLETED|Referral Screening Period||95
184155|NCT00617123|451362|P1|COMPLETED|Referral Screening Period||98
184156|NCT00617123|451361|P2|STARTED|Referral Screening Period||121
184157|NCT00617123|451362|P1|STARTED|Referral Screening Period||137
184158|NCT00617175|451378|P2|NOT COMPLETED|Overall Study||0
184159|NCT00617175|451379|P1|NOT COMPLETED|Overall Study||0
184160|NCT00617175|451378|P2|COMPLETED|Overall Study||948
184161|NCT00617175|451379|P1|COMPLETED|Overall Study||954
184162|NCT00617175|451378|P2|STARTED|Overall Study||948
184163|NCT00617175|451379|P1|STARTED|Overall Study||954
184164|NCT00617188|451385|P1|NOT COMPLETED|Overall Study||0
184165|NCT00617188|451385|P1|COMPLETED|Overall Study||26
184166|NCT00617188|451385|P1|STARTED|Overall Study||26
184167|NCT00617201|451396|P2|NOT COMPLETED|Overall Study||13
184168|NCT00617201|451397|P1|NOT COMPLETED|Overall Study||9
184169|NCT00617201|451396|P2|COMPLETED|Overall Study||12
184170|NCT00617201|451397|P1|COMPLETED|Overall Study||16
184171|NCT00617201|451396|P2|STARTED|Overall Study||25
184172|NCT00617201|451397|P1|STARTED|Overall Study||25
184173|NCT00617240|451407|P2|NOT COMPLETED|Overall Study||0
184174|NCT00617240|451408|P1|NOT COMPLETED|Overall Study||1
184175|NCT00617240|451407|P2|COMPLETED|Overall Study||4
184176|NCT00617240|451408|P1|COMPLETED|Overall Study||4
184177|NCT00617240|451407|P2|STARTED|Overall Study||4
184178|NCT00617240|451408|P1|STARTED|Overall Study||5
184179|NCT00617279|451428|P2|NOT COMPLETED|Overall Study||17
184180|NCT00617279|451429|P1|NOT COMPLETED|Overall Study||14
184181|NCT00617279|451428|P2|COMPLETED|Overall Study||0
184182|NCT00617279|451429|P1|COMPLETED|Overall Study||0
184183|NCT00617279|451428|P2|STARTED|Overall Study||17
184184|NCT00617279|451429|P1|STARTED|Overall Study||14
184185|NCT00617305|451486|P3|NOT COMPLETED|Overall Study||1
184186|NCT00617305|451487|P2|NOT COMPLETED|Overall Study||0
184187|NCT00617305|451488|P1|NOT COMPLETED|Overall Study||8
184188|NCT00617305|451486|P3|COMPLETED|Overall Study||0
184189|NCT00617305|451487|P2|COMPLETED|Overall Study||4
184190|NCT00617305|451488|P1|COMPLETED|Overall Study||25
184191|NCT00617305|451486|P3|Completed 24-week Primary Analysis|Overall Study||0
184192|NCT00617305|451487|P2|Completed 24-week Primary Analysis|Overall Study||4
184193|NCT00617305|451488|P1|Completed 24-week Primary Analysis|Overall Study||31
184194|NCT00617305|451486|P3|STARTED|Overall Study||1
184195|NCT00617305|451487|P2|STARTED|Overall Study||4
184196|NCT00617305|451488|P1|STARTED|Overall Study||33
184197|NCT00617357|451542|P1|NOT COMPLETED|Overall Study||16
184198|NCT00617357|451542|P1|COMPLETED|Overall Study|67 subjects completed study; 7 completed early, 60 completed 24 month visit|67
184199|NCT00617357|451542|P1|STARTED|Overall Study|83 subjects enrolled, 80 subjects received Strattice reinforcement of hernia repair|83
184200|NCT00617396|451552|P1|NOT COMPLETED|Overall Study||0
184201|NCT00617396|451552|P1|COMPLETED|Overall Study||25
184202|NCT00617396|451552|P1|STARTED|Overall Study||25
184203|NCT00617409|451559|P3|NOT COMPLETED|Overall Study||27
184204|NCT00617409|451560|P2|NOT COMPLETED|Overall Study||18
184205|NCT00617409|451561|P1|NOT COMPLETED|Overall Study||16
184206|NCT00617409|451559|P3|COMPLETED|Overall Study||4
184207|NCT00617409|451560|P2|COMPLETED|Overall Study||2
184208|NCT00617409|451561|P1|COMPLETED|Overall Study||2
184209|NCT00617409|451559|P3|STARTED|Overall Study||31
184210|NCT00617409|451560|P2|STARTED|Overall Study||20
184211|NCT00617409|451561|P1|STARTED|Overall Study||18
184212|NCT00617461|451572|P2|NOT COMPLETED|6-Day Down-Titration Period||2
184213|NCT00617461|451573|P1|NOT COMPLETED|6-Day Down-Titration Period||2
184214|NCT00617461|451572|P2|COMPLETED|6-Day Down-Titration Period||35
184215|NCT00617461|451573|P1|COMPLETED|6-Day Down-Titration Period||39
184216|NCT00617461|451572|P2|STARTED|6-Day Down-Titration Period||37
184217|NCT00617461|451573|P1|STARTED|6-Day Down-Titration Period||41
184218|NCT00617461|451572|P2|NOT COMPLETED|Second Treatment Intervention Period||4
184219|NCT00617461|451573|P1|NOT COMPLETED|Second Treatment Intervention Period||0
184220|NCT00617461|451572|P2|COMPLETED|Second Treatment Intervention Period||37
184221|NCT00617461|451573|P1|COMPLETED|Second Treatment Intervention Period||41
184222|NCT00617461|451572|P2|STARTED|Second Treatment Intervention Period||41
184223|NCT00617461|451573|P1|STARTED|Second Treatment Intervention Period||41
184224|NCT00617461|451572|P2|NOT COMPLETED|4-Day Crossover Period||0
184225|NCT00617461|451573|P1|NOT COMPLETED|4-Day Crossover Period||1
184226|NCT00617461|451572|P2|COMPLETED|4-Day Crossover Period||40
184227|NCT00617461|451573|P1|COMPLETED|4-Day Crossover Period||41
184228|NCT00617461|451572|P2|STARTED|4-Day Crossover Period|One 3600:1200 participant skipped the Crossover period, going directly to second Treatment Period.|40
184229|NCT00617461|451573|P1|STARTED|4-Day Crossover Period||42
184230|NCT00617461|451572|P2|NOT COMPLETED|First Treatment Intervention Period||3
184231|NCT00617461|451573|P1|NOT COMPLETED|First Treatment Intervention Period||10
184232|NCT00617461|451572|P2|COMPLETED|First Treatment Intervention Period||41
184233|NCT00617461|451573|P1|COMPLETED|First Treatment Intervention Period||42
184234|NCT00617461|451572|P2|STARTED|First Treatment Intervention Period||44
184235|NCT00617461|451573|P1|STARTED|First Treatment Intervention Period|2 par. (1 withdrawal due to inv. discretion, 1 withdrawal by subject) did not take study drug.|52
184236|NCT00617591|451626|P1|NOT COMPLETED|Overall Study||10
184237|NCT00617591|451626|P1|COMPLETED|Overall Study||47
184238|NCT00617591|451626|P1|STARTED|Overall Study||57
184239|NCT00617604|451636|P2|NOT COMPLETED|Overall Study||20
184240|NCT00617604|451637|P1|NOT COMPLETED|Overall Study||18
184241|NCT00617604|451636|P2|COMPLETED|Overall Study|Completed Month 6 assessment|88
184242|NCT00617604|451637|P1|COMPLETED|Overall Study|Completed Month 6 assessment|92
184243|NCT00617604|451636|P2|Completed 12 Weeks of Treatment|Overall Study||83
184244|NCT00617604|451637|P1|Completed 12 Weeks of Treatment|Overall Study||89
184245|NCT00617604|451636|P2|Received Treatment|Overall Study||105
184246|NCT00617604|451637|P1|Received Treatment|Overall Study||107
184247|NCT00617604|451636|P2|STARTED|Overall Study||108
184248|NCT00617604|451637|P1|STARTED|Overall Study||110
184249|NCT00617669|451683|P2|NOT COMPLETED|Overall Study||451
184250|NCT00617669|451684|P1|NOT COMPLETED|Overall Study||430
184251|NCT00617669|451683|P2|COMPLETED|Overall Study|Patients receiving placebo at data cut-off|77
184252|NCT00617669|451684|P1|COMPLETED|Overall Study|Patients receiving ZD4054 10 mg at data cut-off|94
184253|NCT00617669|451683|P2|Patients Who Received IP|Overall Study||525
184254|NCT00617669|451684|P1|Patients Who Received IP|Overall Study||522
184255|NCT00617669|451683|P2|STARTED|Overall Study||528
184256|NCT00617669|451684|P1|STARTED|Overall Study||524
184257|NCT00617708|451707|P3|NOT COMPLETED|Overall Study||64
184258|NCT00617708|451708|P2|NOT COMPLETED|Overall Study||60
184259|NCT00617708|451709|P1|NOT COMPLETED|Overall Study||10
184260|NCT00617708|451707|P3|COMPLETED|Overall Study||0
184261|NCT00617708|451708|P2|COMPLETED|Overall Study||0
184262|NCT00617708|451709|P1|COMPLETED|Overall Study||0
184263|NCT00617708|451707|P3|Eligible and Began Protocol Therapy|Overall Study||59
184264|NCT00617708|451708|P2|Eligible and Began Protocol Therapy|Overall Study||57
184265|NCT00617708|451709|P1|Eligible and Began Protocol Therapy|Overall Study||9
184266|NCT00617708|451707|P3|STARTED|Overall Study||64
184267|NCT00617708|451708|P2|STARTED|Overall Study||60
184268|NCT00617708|451709|P1|STARTED|Overall Study||10
184269|NCT00617773|451724|P1|NOT COMPLETED|Overall Study||24
184270|NCT00617773|451724|P1|COMPLETED|Overall Study|Patients COMPLETED were evaluated as having no disease progression at the end of cycle 3.|7
184271|NCT00617773|451724|P1|STARTED|Overall Study||31
184272|NCT00617851|451743|P4|NOT COMPLETED|Overall Study||25
184273|NCT00617851|451744|P3|NOT COMPLETED|Overall Study||45
184274|NCT00617851|451745|P2|NOT COMPLETED|Overall Study||40
184275|NCT00617851|451746|P1|NOT COMPLETED|Overall Study||47
184276|NCT00617851|451743|P4|COMPLETED|Overall Study||192
184277|NCT00617851|451744|P3|COMPLETED|Overall Study||384
184278|NCT00617851|451745|P2|COMPLETED|Overall Study||391
184279|NCT00617851|451746|P1|COMPLETED|Overall Study||383
184280|NCT00617851|451743|P4|STARTED|Overall Study||217
184281|NCT00617851|451744|P3|STARTED|Overall Study||429
184282|NCT00617851|451745|P2|STARTED|Overall Study||431
184283|NCT00617851|451746|P1|STARTED|Overall Study||430
184284|NCT00617890|451788|P4|NOT COMPLETED|Overall Study||115
184285|NCT00617890|451789|P3|NOT COMPLETED|Overall Study||35
184286|NCT00617890|451790|P2|NOT COMPLETED|Overall Study||28
184287|NCT00617890|451791|P1|NOT COMPLETED|Overall Study||31
184288|NCT00617890|451788|P4|COMPLETED|Overall Study||1
184289|NCT00617890|451789|P3|COMPLETED|Overall Study||0
184290|NCT00617890|451790|P2|COMPLETED|Overall Study||5
184291|NCT00617890|451791|P1|COMPLETED|Overall Study||4
184292|NCT00617890|451788|P4|Received Treatment|Overall Study||115
184293|NCT00617890|451789|P3|Received Treatment|Overall Study||34
184294|NCT00617890|451790|P2|Received Treatment|Overall Study||33
184295|NCT00617890|451791|P1|Received Treatment|Overall Study||34
184296|NCT00617890|451788|P4|STARTED|Overall Study||116
184297|NCT00617890|451789|P3|STARTED|Overall Study||35
184298|NCT00617890|451790|P2|STARTED|Overall Study||33
184299|NCT00617890|451791|P1|STARTED|Overall Study||35
184300|NCT00617903|451825|P2|NOT COMPLETED|Overall Study||7
184301|NCT00617903|451826|P1|NOT COMPLETED|Overall Study||3
184302|NCT00617903|451825|P2|COMPLETED|Overall Study||35
184303|NCT00617903|451826|P1|COMPLETED|Overall Study||38
184304|NCT00617903|451825|P2|STARTED|Overall Study||42
184305|NCT00617903|451826|P1|STARTED|Overall Study||41
184306|NCT00617929|451868|P1|NOT COMPLETED|Overall Study||1
184307|NCT00617929|451868|P1|COMPLETED|Overall Study||11
184308|NCT00617929|451868|P1|STARTED|Overall Study||12
184309|NCT00617942|451880|P2|NOT COMPLETED|Overall Study||4
184310|NCT00617942|451881|P1|NOT COMPLETED|Overall Study||8
184311|NCT00617942|451880|P2|COMPLETED|Overall Study||19
184312|NCT00617942|451881|P1|COMPLETED|Overall Study||29
184313|NCT00617942|451880|P2|STARTED|Overall Study||23
184314|NCT00617942|451881|P1|STARTED|Overall Study||37
184315|NCT00617981|451895|P2|NOT COMPLETED|Overall Study||102
184316|NCT00617981|451896|P1|NOT COMPLETED|Overall Study||110
184317|NCT00617981|451895|P2|COMPLETED|Overall Study||245
184318|NCT00617981|451896|P1|COMPLETED|Overall Study||244
184319|NCT00617981|451895|P2|STARTED|Overall Study||347
184320|NCT00617981|451896|P1|STARTED|Overall Study||354
184321|NCT00618072|451905|P3|NOT COMPLETED|Overall Study||4
184322|NCT00618072|451906|P2|NOT COMPLETED|Overall Study||1
184323|NCT00618072|451907|P1|NOT COMPLETED|Overall Study||2
184324|NCT00618072|451905|P3|COMPLETED|Overall Study||11
184325|NCT00618072|451906|P2|COMPLETED|Overall Study||14
184326|NCT00618072|451907|P1|COMPLETED|Overall Study||14
184327|NCT00618072|451905|P3|STARTED|Overall Study||15
184328|NCT00618072|451906|P2|STARTED|Overall Study||15
184329|NCT00618072|451907|P1|STARTED|Overall Study||16
184330|NCT00618332|451941|P2|NOT COMPLETED|Overall Study||0
184331|NCT00618332|451942|P1|NOT COMPLETED|Overall Study||0
184332|NCT00618332|451941|P2|COMPLETED|Overall Study||20
184333|NCT00618332|451942|P1|COMPLETED|Overall Study||20
184334|NCT00618332|451941|P2|STARTED|Overall Study||20
184335|NCT00618332|451942|P1|STARTED|Overall Study||20
184336|NCT00618371|451964|P1|NOT COMPLETED|Overall Study||2
184337|NCT00618371|451964|P1|COMPLETED|Overall Study||10
184338|NCT00618371|451964|P1|STARTED|Overall Study||12
184339|NCT00618410|451969|P2|NOT COMPLETED|Second Intervention||0
184340|NCT00618410|451970|P1|NOT COMPLETED|Second Intervention||0
184341|NCT00618410|451969|P2|COMPLETED|Second Intervention||5
184342|NCT00618410|451970|P1|COMPLETED|Second Intervention||7
184343|NCT00618410|451969|P2|STARTED|Second Intervention||5
184344|NCT00618410|451970|P1|STARTED|Second Intervention||7
184345|NCT00618410|451969|P2|NOT COMPLETED|Washout Period (2 Weeks)||1
184346|NCT00618410|451970|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
184347|NCT00618410|451969|P2|COMPLETED|Washout Period (2 Weeks)||5
184348|NCT00618410|451970|P1|COMPLETED|Washout Period (2 Weeks)||7
184349|NCT00618410|451969|P2|STARTED|Washout Period (2 Weeks)||6
184350|NCT00618410|451970|P1|STARTED|Washout Period (2 Weeks)||7
184351|NCT00618410|451969|P2|NOT COMPLETED|First Intervention||0
184352|NCT00618410|451970|P1|NOT COMPLETED|First Intervention||0
184353|NCT00618410|451969|P2|COMPLETED|First Intervention||6
184354|NCT00618410|451970|P1|COMPLETED|First Intervention||7
184355|NCT00618410|451969|P2|STARTED|First Intervention||6
184356|NCT00618410|451970|P1|STARTED|First Intervention||7
184357|NCT00618436|451988|P2|NOT COMPLETED|Overall Study||0
184358|NCT00618436|451989|P1|NOT COMPLETED|Overall Study||0
184359|NCT00618436|451988|P2|COMPLETED|Overall Study||18
184360|NCT00618436|451989|P1|COMPLETED|Overall Study||34
184361|NCT00618436|451988|P2|STARTED|Overall Study||18
184362|NCT00618436|451989|P1|STARTED|Overall Study||34
184363|NCT00618449|452001|P2|NOT COMPLETED|Overall Study||110
184364|NCT00618449|452002|P1|NOT COMPLETED|Overall Study||98
184365|NCT00618449|452001|P2|COMPLETED|Overall Study||558
184366|NCT00618449|452002|P1|COMPLETED|Overall Study||581
184367|NCT00618449|452001|P2|1-year, Post-treatment|Overall Study||558
184368|NCT00618449|452002|P1|1-year, Post-treatment|Overall Study||581
184369|NCT00618449|452001|P2|1-month, Post-treatment|Overall Study||656
184370|NCT00618449|452002|P1|1-month, Post-treatment|Overall Study||666
184371|NCT00618449|452001|P2|STARTED|Overall Study||668
184372|NCT00618449|452002|P1|STARTED|Overall Study||679
184373|NCT00618514|452010|P3|NOT COMPLETED|Overall Study||4
184374|NCT00618514|452011|P2|NOT COMPLETED|Overall Study||12
184375|NCT00618514|452012|P1|NOT COMPLETED|Overall Study||11
184376|NCT00618514|452010|P3|COMPLETED|Overall Study||12
184377|NCT00618514|452011|P2|COMPLETED|Overall Study||26
184378|NCT00618514|452012|P1|COMPLETED|Overall Study||25
184379|NCT00618514|452010|P3|STARTED|Overall Study||16
184380|NCT00618514|452011|P2|STARTED|Overall Study||38
184381|NCT00618514|452012|P1|STARTED|Overall Study||36
184382|NCT00618540|452030|P1|NOT COMPLETED|Overall Study||0
184383|NCT00618540|452030|P1|COMPLETED|Overall Study||1
184384|NCT00618540|452030|P1|STARTED|Overall Study||1
184385|NCT00618618|452045|P4|NOT COMPLETED|Overall Study||1
184386|NCT00618618|452046|P3|NOT COMPLETED|Overall Study||3
184387|NCT00618618|452047|P2|NOT COMPLETED|Overall Study||3
184388|NCT00618618|452048|P1|NOT COMPLETED|Overall Study||4
184389|NCT00618618|452045|P4|COMPLETED|Overall Study||13
184390|NCT00618618|452046|P3|COMPLETED|Overall Study||18
184391|NCT00618618|452047|P2|COMPLETED|Overall Study||11
184392|NCT00618618|452048|P1|COMPLETED|Overall Study||20
184393|NCT00618618|452045|P4|Received Treatment|Overall Study||14
184394|NCT00618618|452046|P3|Received Treatment|Overall Study||20
184395|NCT00618618|452047|P2|Received Treatment|Overall Study||13
184396|NCT00618618|452048|P1|Received Treatment|Overall Study||24
184397|NCT00618618|452045|P4|STARTED|Overall Study||14
184398|NCT00618618|452046|P3|STARTED|Overall Study||21
184399|NCT00618618|452047|P2|STARTED|Overall Study||14
184400|NCT00618618|452048|P1|STARTED|Overall Study||24
184401|NCT00618722|452098|P4|NOT COMPLETED|Overall Study||4
184402|NCT00618722|452099|P3|NOT COMPLETED|Overall Study||3
184403|NCT00618722|452100|P2|NOT COMPLETED|Overall Study||2
184404|NCT00618722|452101|P1|NOT COMPLETED|Overall Study||3
184405|NCT00618722|452098|P4|COMPLETED|Overall Study||18
184406|NCT00618722|452099|P3|COMPLETED|Overall Study||19
184407|NCT00618722|452100|P2|COMPLETED|Overall Study||18
184408|NCT00618722|452101|P1|COMPLETED|Overall Study||18
184409|NCT00618722|452098|P4|Received Treatment|Overall Study||22
184410|NCT00618722|452099|P3|Received Treatment|Overall Study||22
184411|NCT00618722|452100|P2|Received Treatment|Overall Study||20
184412|NCT00618722|452101|P1|Received Treatment|Overall Study||20
184413|NCT00618722|452098|P4|STARTED|Overall Study||22
184414|NCT00618722|452099|P3|STARTED|Overall Study||22
184415|NCT00618722|452100|P2|STARTED|Overall Study||20
184416|NCT00618722|452101|P1|STARTED|Overall Study||21
184417|NCT00618748|452138|P3|NOT COMPLETED|Overall Study||14
184418|NCT00618748|452139|P2|NOT COMPLETED|Overall Study||5
184419|NCT00618748|452140|P1|NOT COMPLETED|Overall Study||11
184420|NCT00618748|452138|P3|COMPLETED|Overall Study||6
184421|NCT00618748|452139|P2|COMPLETED|Overall Study||20
184422|NCT00618748|452140|P1|COMPLETED|Overall Study||45
184423|NCT00618748|452138|P3|STARTED|Overall Study||20
184424|NCT00618748|452139|P2|STARTED|Overall Study||25
184425|NCT00618748|452140|P1|STARTED|Overall Study||56
184426|NCT00618774|452183|P2|NOT COMPLETED|Overall Study||3
184427|NCT00618774|452184|P1|NOT COMPLETED|Overall Study||6
184428|NCT00618774|452183|P2|COMPLETED|Overall Study||45
184429|NCT00618774|452184|P1|COMPLETED|Overall Study||205
184430|NCT00618774|452183|P2|STARTED|Overall Study||48
184431|NCT00618774|452184|P1|STARTED|Overall Study||211
184432|NCT00618787|452216|P2|NOT COMPLETED|Overall Study||2
184433|NCT00618787|452217|P1|NOT COMPLETED|Overall Study||3
184434|NCT00618787|452216|P2|COMPLETED|Overall Study||21
184435|NCT00618787|452217|P1|COMPLETED|Overall Study||19
184436|NCT00618787|452216|P2|STARTED|Overall Study||23
184437|NCT00618787|452217|P1|STARTED|Overall Study||22
184438|NCT00618813|452223|P1|NOT COMPLETED|Overall Study||4
184439|NCT00618813|452223|P1|COMPLETED|Overall Study||31
184440|NCT00618813|452223|P1|Completed Week 29 to Week 37 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|33
184441|NCT00618813|452223|P1|Completed Week 23 to Week 28 Therapy|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
184442|NCT00618813|452223|P1|Completed Week 13 to Week 22 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|34
184443|NCT00618813|452223|P1|Completed Enrollment - Week 12 Treatment|Overall Study|Patients that complete this segment of protocol therapy are evaluated for outcome measure.|35
184444|NCT00618813|452223|P1|STARTED|Overall Study||35
184445|NCT00618826|452231|P1|NOT COMPLETED|Overall Study||1
184446|NCT00618826|452231|P1|COMPLETED|Overall Study||13
184447|NCT00618826|452231|P1|STARTED|Overall Study||14
184448|NCT00618839|452236|P1|NOT COMPLETED|Overall Study||0
184449|NCT00618839|452236|P1|COMPLETED|Overall Study||15
184450|NCT00618839|452236|P1|STARTED|Overall Study||15
184451|NCT00607243|452247|P2|NOT COMPLETED|Telephone Safety Assessment Period||2
184452|NCT00607243|452248|P1|NOT COMPLETED|Telephone Safety Assessment Period||5
184453|NCT00607243|452247|P2|COMPLETED|Telephone Safety Assessment Period|40 Available for 3 months 39 Available for 6 months|39
184454|NCT00607243|452248|P1|COMPLETED|Telephone Safety Assessment Period|80 Available for 3 months 77 Available for 6 months|77
184455|NCT00607243|452247|P2|STARTED|Telephone Safety Assessment Period||41
184456|NCT00607243|452248|P1|STARTED|Telephone Safety Assessment Period||82
184457|NCT00607243|452247|P2|NOT COMPLETED|Initial Post-vaccination Period||0
184458|NCT00607243|452248|P1|NOT COMPLETED|Initial Post-vaccination Period||0
184459|NCT00607243|452247|P2|COMPLETED|Initial Post-vaccination Period||41
184460|NCT00607243|452248|P1|COMPLETED|Initial Post-vaccination Period||82
184461|NCT00607243|452247|P2|STARTED|Initial Post-vaccination Period||41
184462|NCT00607243|452248|P1|STARTED|Initial Post-vaccination Period||82
184463|NCT00607269|452256|P2|NOT COMPLETED|Overall Study||0
184464|NCT00607269|452257|P1|NOT COMPLETED|Overall Study||0
184465|NCT00607269|452256|P2|COMPLETED|Overall Study||64
184466|NCT00607269|452257|P1|COMPLETED|Overall Study||67
184467|NCT00607269|452256|P2|STARTED|Overall Study||64
184468|NCT00607269|452257|P1|STARTED|Overall Study||67
184469|NCT00607321|452269|P1|NOT COMPLETED|Overall Study||0
184470|NCT00607321|452269|P1|COMPLETED|Overall Study||60
184471|NCT00607321|452269|P1|STARTED|Overall Study||60
184472|NCT00607373|452279|P2|NOT COMPLETED|Follow-up Period||5
184473|NCT00607373|452280|P1|NOT COMPLETED|Follow-up Period||1
184474|NCT00607373|452279|P2|COMPLETED|Follow-up Period||6
184475|NCT00607373|452280|P1|COMPLETED|Follow-up Period||0
184476|NCT00607373|452279|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|11
184561|NCT00608842|452503|P4|STARTED|Overall Study||17
184477|NCT00607373|452280|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|1
184478|NCT00607373|452279|P2|NOT COMPLETED|Treatment Period||6
184479|NCT00607373|452280|P1|NOT COMPLETED|Treatment Period||0
184480|NCT00607373|452279|P2|COMPLETED|Treatment Period|23 enrolled in open-label extension study NCT00694109|28
184481|NCT00607373|452280|P1|COMPLETED|Treatment Period|16 enrolled in open-label extension study NCT00694109|17
184482|NCT00607373|452279|P2|STARTED|Treatment Period||34
184483|NCT00607373|452280|P1|STARTED|Treatment Period||17
184484|NCT00607386|452324|P1|NOT COMPLETED|Overall Study||1
184485|NCT00607386|452324|P1|COMPLETED|Overall Study||27
184486|NCT00607386|452324|P1|STARTED|Overall Study||28
184487|NCT00607477|452339|P2|NOT COMPLETED|Overall Study||0
184488|NCT00607477|452340|P1|NOT COMPLETED|Overall Study||0
184489|NCT00607477|452339|P2|COMPLETED|Overall Study||2
184490|NCT00607477|452340|P1|COMPLETED|Overall Study||0
184491|NCT00607477|452339|P2|STARTED|Overall Study||2
184492|NCT00607477|452340|P1|STARTED|Overall Study||0
184493|NCT00607594|452346|P1|NOT COMPLETED|Overall Study||0
184494|NCT00607594|452346|P1|COMPLETED|Overall Study||21
184495|NCT00607594|452346|P1|STARTED|Overall Study||21
184496|NCT00607672|452356|P3|NOT COMPLETED|Overall Study||5
184497|NCT00607672|452357|P2|NOT COMPLETED|Overall Study||3
184498|NCT00607672|452358|P1|NOT COMPLETED|Overall Study||4
184499|NCT00607672|452356|P3|COMPLETED|Overall Study||22
184500|NCT00607672|452357|P2|COMPLETED|Overall Study||24
184501|NCT00607672|452358|P1|COMPLETED|Overall Study||28
184502|NCT00607672|452356|P3|STARTED|Overall Study||27
184503|NCT00607672|452357|P2|STARTED|Overall Study||27
184504|NCT00607672|452358|P1|STARTED|Overall Study||32
184505|NCT00607724|452409|P7|NOT COMPLETED|Stage 2: Expanded Cohort||11
184506|NCT00607724|452410|P6|NOT COMPLETED|Stage 2: Expanded Cohort||12
184507|NCT00607724|452411|P5|NOT COMPLETED|Stage 2: Expanded Cohort||9
184508|NCT00607724|452412|P4|NOT COMPLETED|Stage 2: Expanded Cohort||5
184509|NCT00607724|452413|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
184510|NCT00607724|452414|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
184511|NCT00607724|452415|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
184512|NCT00607724|452409|P7|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
184513|NCT00607724|452410|P6|COMPLETED|Stage 2: Expanded Cohort||0
184514|NCT00607724|452411|P5|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|5
184515|NCT00607724|452412|P4|COMPLETED|Stage 2: Expanded Cohort|Participants still on treatment at time of study closure were considered ‘completers’.|1
184516|NCT00607724|452413|P3|COMPLETED|Stage 2: Expanded Cohort||0
184517|NCT00607724|452414|P2|COMPLETED|Stage 2: Expanded Cohort||0
184518|NCT00607724|452415|P1|COMPLETED|Stage 2: Expanded Cohort||0
184519|NCT00607724|452409|P7|STARTED|Stage 2: Expanded Cohort||16
184520|NCT00607724|452410|P6|STARTED|Stage 2: Expanded Cohort||12
184521|NCT00607724|452411|P5|STARTED|Stage 2: Expanded Cohort||14
184522|NCT00607724|452412|P4|STARTED|Stage 2: Expanded Cohort||6
184523|NCT00607724|452413|P3|STARTED|Stage 2: Expanded Cohort||0
184524|NCT00607724|452414|P2|STARTED|Stage 2: Expanded Cohort||0
184525|NCT00607724|452415|P1|STARTED|Stage 2: Expanded Cohort||0
184526|NCT00607724|452409|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
184527|NCT00607724|452410|P6|NOT COMPLETED|Stage 1: Dose Escalation||0
184528|NCT00607724|452411|P5|NOT COMPLETED|Stage 1: Dose Escalation||0
184529|NCT00607724|452412|P4|NOT COMPLETED|Stage 1: Dose Escalation||0
184530|NCT00607724|452413|P3|NOT COMPLETED|Stage 1: Dose Escalation||4
184531|NCT00607724|452414|P2|NOT COMPLETED|Stage 1: Dose Escalation||8
184532|NCT00607724|452415|P1|NOT COMPLETED|Stage 1: Dose Escalation||7
184533|NCT00607724|452409|P7|COMPLETED|Stage 1: Dose Escalation||0
184534|NCT00607724|452410|P6|COMPLETED|Stage 1: Dose Escalation||0
184535|NCT00607724|452411|P5|COMPLETED|Stage 1: Dose Escalation||0
184536|NCT00607724|452412|P4|COMPLETED|Stage 1: Dose Escalation||0
184537|NCT00607724|452413|P3|COMPLETED|Stage 1: Dose Escalation||0
184538|NCT00607724|452414|P2|COMPLETED|Stage 1: Dose Escalation|Participants still on treatment at time of study closure were considered ‘completers’.|1
184539|NCT00607724|452415|P1|COMPLETED|Stage 1: Dose Escalation||0
184540|NCT00607724|452409|P7|STARTED|Stage 1: Dose Escalation||0
184541|NCT00607724|452410|P6|STARTED|Stage 1: Dose Escalation||0
184542|NCT00607724|452411|P5|STARTED|Stage 1: Dose Escalation||0
184543|NCT00607724|452412|P4|STARTED|Stage 1: Dose Escalation||0
184544|NCT00607724|452413|P3|STARTED|Stage 1: Dose Escalation||4
184545|NCT00607724|452414|P2|STARTED|Stage 1: Dose Escalation||9
184546|NCT00607724|452415|P1|STARTED|Stage 1: Dose Escalation||7
184547|NCT00608777|452491|P1|NOT COMPLETED|Overall Study||0
184548|NCT00608777|452491|P1|COMPLETED|Overall Study||6
184549|NCT00608777|452491|P1|STARTED|Overall Study||6
184550|NCT00608829|452495|P1|NOT COMPLETED|Overall Study||15
184551|NCT00608829|452495|P1|COMPLETED|Overall Study||8
184552|NCT00608829|452495|P1|STARTED|Overall Study||23
184553|NCT00608842|452503|P4|NOT COMPLETED|Overall Study||1
184554|NCT00608842|452504|P3|NOT COMPLETED|Overall Study||2
184555|NCT00608842|452505|P2|NOT COMPLETED|Overall Study||1
184556|NCT00608842|452506|P1|NOT COMPLETED|Overall Study||1
184557|NCT00608842|452503|P4|COMPLETED|Overall Study||16
184558|NCT00608842|452504|P3|COMPLETED|Overall Study||13
184559|NCT00608842|452505|P2|COMPLETED|Overall Study||14
184560|NCT00608842|452506|P1|COMPLETED|Overall Study||14
184562|NCT00608842|452504|P3|STARTED|Overall Study||15
184563|NCT00608842|452505|P2|STARTED|Overall Study||15
184564|NCT00608842|452506|P1|STARTED|Overall Study||15
184565|NCT00608868|452540|P1|NOT COMPLETED|Overall Study||15
184566|NCT00608868|452540|P1|COMPLETED|Overall Study||141
184567|NCT00608868|452540|P1|Per Protocol (PP) Population|Overall Study||121
184568|NCT00608868|452540|P1|Intention to Treat (ITT) Population|Overall Study|8 patients who had no target lesion and 8 who had no tumor assessment after baseline were excluded|138
184569|NCT00608868|452540|P1|Treatment Completed|Overall Study||141
184570|NCT00608868|452540|P1|Safety Population|Overall Study|2 patients who received no study treatment were excluded|154
184571|NCT00608868|452540|P1|Enrolled|Overall Study||156
184572|NCT00608868|452540|P1|STARTED|Overall Study||156
184573|NCT00608881|452549|P2|NOT COMPLETED|Overall Study||66
184574|NCT00608881|452550|P1|NOT COMPLETED|Overall Study||79
184575|NCT00608881|452549|P2|COMPLETED|Overall Study||240
184576|NCT00608881|452550|P1|COMPLETED|Overall Study||224
184577|NCT00608881|452549|P2|STARTED|Overall Study||306
184578|NCT00608881|452550|P1|STARTED|Overall Study||303
184579|NCT00608907|452587|P3|NOT COMPLETED|Overall Study||1
184580|NCT00608907|452588|P2|NOT COMPLETED|Overall Study||0
184581|NCT00608907|452589|P1|NOT COMPLETED|Overall Study||12
184582|NCT00608907|452587|P3|COMPLETED|Overall Study||17
184583|NCT00608907|452588|P2|COMPLETED|Overall Study||13
184584|NCT00608907|452589|P1|COMPLETED|Overall Study||18
184585|NCT00608907|452587|P3|STARTED|Overall Study||18
184586|NCT00608907|452588|P2|STARTED|Overall Study||13
184587|NCT00608907|452589|P1|STARTED|Overall Study||30
184588|NCT00608959|452599|P1|NOT COMPLETED|Part 2||0
184589|NCT00608959|452599|P1|COMPLETED|Part 2||25
184590|NCT00608959|452599|P1|STARTED|Part 2|20 Part 1 subjects also participated in Part 2.Five more subjects were enrolled for a total of 25.|25
184591|NCT00608959|452599|P1|NOT COMPLETED|Part 1||1
184592|NCT00608959|452599|P1|COMPLETED|Part 1||24
184593|NCT00608959|452599|P1|STARTED|Part 1|25 subjects each participated in Parts 1 and 2 .A total of 20 subjects participated in both parts.|25
184594|NCT00608985|452613|P4|NOT COMPLETED|Overall Study||9
184595|NCT00608985|452614|P3|NOT COMPLETED|Overall Study||6
184596|NCT00608985|452615|P2|NOT COMPLETED|Overall Study||13
184597|NCT00608985|452616|P1|NOT COMPLETED|Overall Study||16
184598|NCT00608985|452613|P4|COMPLETED|Overall Study|Completed follow-up|159
184599|NCT00608985|452614|P3|COMPLETED|Overall Study|Completed follow-up|170
184600|NCT00608985|452615|P2|COMPLETED|Overall Study|Completed follow-up|173
184601|NCT00608985|452616|P1|COMPLETED|Overall Study|Completed follow-up|161
184602|NCT00608985|452613|P4|Completed Double-blind Treatment|Overall Study||161
184603|NCT00608985|452614|P3|Completed Double-blind Treatment|Overall Study||171
184604|NCT00608985|452615|P2|Completed Double-blind Treatment|Overall Study||174
184605|NCT00608985|452616|P1|Completed Double-blind Treatment|Overall Study||163
184606|NCT00608985|452613|P4|STARTED|Overall Study|Randomized and started double-blind treatment|168
184607|NCT00608985|452614|P3|STARTED|Overall Study|Randomized and started double-blind treatment|176
184608|NCT00608985|452615|P2|STARTED|Overall Study|Randomized and started double-blind treatment|186
184609|NCT00608985|452616|P1|STARTED|Overall Study|Randomized and started double-blind treatment|177
184610|NCT00609167|452648|P2|NOT COMPLETED|Overall Study||7
184611|NCT00609167|452649|P1|NOT COMPLETED|Overall Study||8
184612|NCT00609167|452648|P2|COMPLETED|Overall Study||23
184613|NCT00609167|452649|P1|COMPLETED|Overall Study||25
184614|NCT00609167|452648|P2|STARTED|Overall Study||30
184615|NCT00609167|452649|P1|STARTED|Overall Study||33
184616|NCT00609245|452671|P1|NOT COMPLETED|Overall Study||1
184617|NCT00609245|452671|P1|COMPLETED|Overall Study||12
184618|NCT00609245|452671|P1|STARTED|Overall Study||13
184619|NCT00609336|452677|P1|NOT COMPLETED|Overall Study||13
184620|NCT00609336|452677|P1|COMPLETED|Overall Study||22
184621|NCT00609336|452677|P1|Surgery|Overall Study||22
184622|NCT00609336|452677|P1|STARTED|Overall Study||35
184623|NCT00609362|452691|P2|NOT COMPLETED|Overall Study||1
184624|NCT00609362|452692|P1|NOT COMPLETED|Overall Study||3
184625|NCT00609362|452691|P2|COMPLETED|Overall Study||27
184626|NCT00609362|452692|P1|COMPLETED|Overall Study||26
184627|NCT00609362|452691|P2|STARTED|Overall Study||28
184628|NCT00609362|452692|P1|STARTED|Overall Study||29
184629|NCT00609466|452705|P3|NOT COMPLETED|Overall Study||4
184630|NCT00609466|452706|P2|NOT COMPLETED|Overall Study||6
184631|NCT00609466|452707|P1|NOT COMPLETED|Overall Study||2
184632|NCT00609466|452705|P3|COMPLETED|Overall Study||95
184633|NCT00609466|452706|P2|COMPLETED|Overall Study||90
184634|NCT00609466|452707|P1|COMPLETED|Overall Study||94
184635|NCT00609466|452705|P3|STARTED|Overall Study||99
184636|NCT00609466|452706|P2|STARTED|Overall Study||96
184637|NCT00609466|452707|P1|STARTED|Overall Study||96
184638|NCT00609492|452736|P3|NOT COMPLETED|Overall Study||7
184639|NCT00609492|452737|P2|NOT COMPLETED|Overall Study||3
184640|NCT00609492|452738|P1|NOT COMPLETED|Overall Study||1
184641|NCT00609492|452736|P3|COMPLETED|Overall Study||122
184642|NCT00609492|452737|P2|COMPLETED|Overall Study||69
184643|NCT00609492|452738|P1|COMPLETED|Overall Study||43
184644|NCT00609492|452736|P3|STARTED|Overall Study||129
184645|NCT00609492|452737|P2|STARTED|Overall Study||72
184646|NCT00609492|452738|P1|STARTED|Overall Study||44
184647|NCT00609518|452822|P2|NOT COMPLETED|Overall Study||40
184648|NCT00609518|452823|P1|NOT COMPLETED|Overall Study||43
184649|NCT00609518|452822|P2|COMPLETED|Overall Study||17
184650|NCT00609518|452823|P1|COMPLETED|Overall Study||11
184651|NCT00609518|452822|P2|Completed 6 Treatment Cycles|Overall Study||22
184652|NCT00609518|452823|P1|Completed 6 Treatment Cycles|Overall Study||19
184653|NCT00609518|452822|P2|STARTED|Overall Study||57
184654|NCT00609518|452823|P1|STARTED|Overall Study||54
184655|NCT00609622|452837|P2|NOT COMPLETED|Overall Study||95
184656|NCT00609622|452838|P1|NOT COMPLETED|Overall Study||96
184657|NCT00609622|452837|P2|COMPLETED|Overall Study||0
184658|NCT00609622|452838|P1|COMPLETED|Overall Study||0
184659|NCT00609622|452837|P2|STARTED|Overall Study||95
184660|NCT00609622|452838|P1|STARTED|Overall Study||96
184661|NCT00609674|452860|P2|NOT COMPLETED|Overall Study||7
184662|NCT00609674|452861|P1|NOT COMPLETED|Overall Study||7
184663|NCT00609674|452860|P2|COMPLETED|Overall Study||153
184664|NCT00609674|452861|P1|COMPLETED|Overall Study||148
184665|NCT00609674|452860|P2|STARTED|Overall Study||160
184666|NCT00609674|452861|P1|STARTED|Overall Study||155
184667|NCT00609739|452895|P1|NOT COMPLETED|Overall Study||0
184668|NCT00609739|452895|P1|COMPLETED|Overall Study||1
184669|NCT00609739|452895|P1|STARTED|Overall Study||1
184670|NCT00609765|452902|P1|NOT COMPLETED|Overall Study||1
184671|NCT00609765|452902|P1|COMPLETED|Overall Study||0
184672|NCT00609765|452902|P1|STARTED|Overall Study||1
184673|NCT00609804|452909|P2|NOT COMPLETED|Overall Study||28
184674|NCT00609804|452910|P1|NOT COMPLETED|Overall Study||25
184675|NCT00609804|452909|P2|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
184676|NCT00609804|452910|P1|COMPLETED|Overall Study|Pts remained on study until required to end treatment due to progression/toxicity/MD decision/etc|0
184677|NCT00609804|452909|P2|STARTED|Overall Study||28
184678|NCT00609804|452910|P1|STARTED|Overall Study||25
184679|NCT00609869|452920|P1|NOT COMPLETED|Overall Study||11
184680|NCT00609869|452920|P1|COMPLETED|Overall Study||18
184681|NCT00609869|452920|P1|STARTED|Overall Study||29
184682|NCT00609947|452926|P1|NOT COMPLETED|Overall Study||1
184683|NCT00609947|452926|P1|COMPLETED|Overall Study|One death due to automobile accident.|240
184684|NCT00609947|452926|P1|STARTED|Overall Study||241
184685|NCT00609973|452933|P2|NOT COMPLETED|Overall Study||6
184686|NCT00609973|452934|P1|NOT COMPLETED|Overall Study||8
184687|NCT00609973|452933|P2|COMPLETED|Overall Study||10
184688|NCT00609973|452934|P1|COMPLETED|Overall Study||9
184689|NCT00609973|452933|P2|STARTED|Overall Study||16
184690|NCT00609973|452934|P1|STARTED|Overall Study||17
184691|NCT00609986|452944|P2|NOT COMPLETED|Overall Study||3
184692|NCT00609986|452945|P1|NOT COMPLETED|Overall Study||8
184693|NCT00609986|452944|P2|COMPLETED|Overall Study||49
184694|NCT00609986|452945|P1|COMPLETED|Overall Study||44
184695|NCT00609986|452944|P2|Received Transplant|Overall Study||49
184696|NCT00609986|452945|P1|Received Transplant|Overall Study||44
184697|NCT00609986|452944|P2|STARTED|Overall Study||52
184698|NCT00609986|452945|P1|STARTED|Overall Study||52
184699|NCT00610129|452957|P1|NOT COMPLETED|Overall Study||3
184700|NCT00610129|452957|P1|COMPLETED|Overall Study||25
184701|NCT00610129|452957|P1|STARTED|Overall Study||28
184702|NCT00610155|452961|P6|NOT COMPLETED|Period 3||0
184703|NCT00610155|452962|P5|NOT COMPLETED|Period 3||0
184704|NCT00610155|452963|P4|NOT COMPLETED|Period 3||0
184705|NCT00610155|452964|P3|NOT COMPLETED|Period 3||0
184706|NCT00610155|452965|P2|NOT COMPLETED|Period 3||0
184707|NCT00610155|452966|P1|NOT COMPLETED|Period 3||1
184708|NCT00610155|452961|P6|COMPLETED|Period 3||1
184709|NCT00610155|452962|P5|COMPLETED|Period 3||3
184710|NCT00610155|452963|P4|COMPLETED|Period 3||3
184711|NCT00610155|452964|P3|COMPLETED|Period 3||3
184712|NCT00610155|452965|P2|COMPLETED|Period 3||3
184713|NCT00610155|452966|P1|COMPLETED|Period 3||3
184714|NCT00610155|452961|P6|STARTED|Period 3||1
184715|NCT00610155|452962|P5|STARTED|Period 3||3
184716|NCT00610155|452963|P4|STARTED|Period 3||3
184717|NCT00610155|452964|P3|STARTED|Period 3||3
184718|NCT00610155|452965|P2|STARTED|Period 3||3
184719|NCT00610155|452966|P1|STARTED|Period 3||4
184720|NCT00610155|452961|P6|NOT COMPLETED|Washout Period 2 (7 Days)||0
184721|NCT00610155|452962|P5|NOT COMPLETED|Washout Period 2 (7 Days)||0
184722|NCT00610155|452963|P4|NOT COMPLETED|Washout Period 2 (7 Days)||0
184723|NCT00610155|452964|P3|NOT COMPLETED|Washout Period 2 (7 Days)||0
184724|NCT00610155|452965|P2|NOT COMPLETED|Washout Period 2 (7 Days)||0
184725|NCT00610155|452966|P1|NOT COMPLETED|Washout Period 2 (7 Days)||0
184726|NCT00610155|452961|P6|COMPLETED|Washout Period 2 (7 Days)||1
184727|NCT00610155|452962|P5|COMPLETED|Washout Period 2 (7 Days)||3
184728|NCT00610155|452963|P4|COMPLETED|Washout Period 2 (7 Days)||3
184729|NCT00610155|452964|P3|COMPLETED|Washout Period 2 (7 Days)||3
184730|NCT00610155|452965|P2|COMPLETED|Washout Period 2 (7 Days)||3
184731|NCT00610155|452966|P1|COMPLETED|Washout Period 2 (7 Days)||4
184732|NCT00610155|452961|P6|STARTED|Washout Period 2 (7 Days)||1
184733|NCT00610155|452962|P5|STARTED|Washout Period 2 (7 Days)||3
184734|NCT00610155|452963|P4|STARTED|Washout Period 2 (7 Days)||3
184735|NCT00610155|452964|P3|STARTED|Washout Period 2 (7 Days)||3
184736|NCT00610155|452965|P2|STARTED|Washout Period 2 (7 Days)||3
184737|NCT00610155|452966|P1|STARTED|Washout Period 2 (7 Days)||4
184738|NCT00610155|452961|P6|NOT COMPLETED|Period 2||0
184739|NCT00610155|452962|P5|NOT COMPLETED|Period 2||0
184740|NCT00610155|452963|P4|NOT COMPLETED|Period 2||0
184741|NCT00610155|452964|P3|NOT COMPLETED|Period 2||0
184742|NCT00610155|452965|P2|NOT COMPLETED|Period 2||0
184743|NCT00610155|452966|P1|NOT COMPLETED|Period 2||0
184744|NCT00610155|452961|P6|COMPLETED|Period 2||1
184745|NCT00610155|452962|P5|COMPLETED|Period 2||3
184746|NCT00610155|452963|P4|COMPLETED|Period 2||3
184747|NCT00610155|452964|P3|COMPLETED|Period 2||3
184748|NCT00610155|452965|P2|COMPLETED|Period 2||3
184749|NCT00610155|452966|P1|COMPLETED|Period 2||4
184750|NCT00610155|452961|P6|STARTED|Period 2||1
184751|NCT00610155|452962|P5|STARTED|Period 2||3
184752|NCT00610155|452963|P4|STARTED|Period 2||3
184753|NCT00610155|452964|P3|STARTED|Period 2||3
184754|NCT00610155|452965|P2|STARTED|Period 2||3
184755|NCT00610155|452966|P1|STARTED|Period 2||4
184756|NCT00610155|452961|P6|NOT COMPLETED|Washout Period 1 (7 Days)||0
184757|NCT00610155|452962|P5|NOT COMPLETED|Washout Period 1 (7 Days)||0
184758|NCT00610155|452963|P4|NOT COMPLETED|Washout Period 1 (7 Days)||0
184759|NCT00610155|452964|P3|NOT COMPLETED|Washout Period 1 (7 Days)||0
184760|NCT00610155|452965|P2|NOT COMPLETED|Washout Period 1 (7 Days)||0
184761|NCT00610155|452966|P1|NOT COMPLETED|Washout Period 1 (7 Days)||0
184762|NCT00610155|452961|P6|COMPLETED|Washout Period 1 (7 Days)||1
184763|NCT00610155|452962|P5|COMPLETED|Washout Period 1 (7 Days)||3
184764|NCT00610155|452963|P4|COMPLETED|Washout Period 1 (7 Days)||3
184765|NCT00610155|452964|P3|COMPLETED|Washout Period 1 (7 Days)||3
184766|NCT00610155|452965|P2|COMPLETED|Washout Period 1 (7 Days)||3
184767|NCT00610155|452966|P1|COMPLETED|Washout Period 1 (7 Days)||4
184768|NCT00610155|452961|P6|STARTED|Washout Period 1 (7 Days)||1
184769|NCT00610155|452962|P5|STARTED|Washout Period 1 (7 Days)||3
184770|NCT00610155|452963|P4|STARTED|Washout Period 1 (7 Days)||3
184771|NCT00610155|452964|P3|STARTED|Washout Period 1 (7 Days)||3
184772|NCT00610155|452965|P2|STARTED|Washout Period 1 (7 Days)||3
184773|NCT00610155|452966|P1|STARTED|Washout Period 1 (7 Days)||4
184774|NCT00610155|452961|P6|NOT COMPLETED|Period 1||0
184775|NCT00610155|452962|P5|NOT COMPLETED|Period 1||0
184776|NCT00610155|452963|P4|NOT COMPLETED|Period 1||0
184777|NCT00610155|452964|P3|NOT COMPLETED|Period 1||1
184778|NCT00610155|452965|P2|NOT COMPLETED|Period 1||0
184779|NCT00610155|452966|P1|NOT COMPLETED|Period 1||0
184780|NCT00610155|452961|P6|COMPLETED|Period 1||1
184781|NCT00610155|452962|P5|COMPLETED|Period 1||3
184782|NCT00610155|452963|P4|COMPLETED|Period 1||3
184783|NCT00610155|452964|P3|COMPLETED|Period 1||3
184784|NCT00610155|452965|P2|COMPLETED|Period 1||3
184785|NCT00610155|452966|P1|COMPLETED|Period 1||4
184786|NCT00610155|452961|P6|STARTED|Period 1||1
184787|NCT00610155|452962|P5|STARTED|Period 1||3
184788|NCT00610155|452963|P4|STARTED|Period 1||3
184789|NCT00610155|452964|P3|STARTED|Period 1||4
184790|NCT00610155|452965|P2|STARTED|Period 1||3
184791|NCT00610155|452966|P1|STARTED|Period 1||4
184792|NCT00610168|453015|P2|NOT COMPLETED|Overall Study||0
184793|NCT00610168|453016|P1|NOT COMPLETED|Overall Study||2
184794|NCT00610168|453015|P2|COMPLETED|Overall Study||7
184795|NCT00610168|453016|P1|COMPLETED|Overall Study||73
184796|NCT00610168|453015|P2|STARTED|Overall Study||7
184797|NCT00610168|453016|P1|STARTED|Overall Study||75
184798|NCT00610207|453035|P1|NOT COMPLETED|Overall Study||3
184799|NCT00610207|453035|P1|COMPLETED|Overall Study||18
184800|NCT00610207|453035|P1|STARTED|Overall Study||21
184801|NCT00610311|453040|P1|NOT COMPLETED|Overall Study||0
184802|NCT00610311|453040|P1|COMPLETED|Overall Study||3
184803|NCT00610311|453040|P1|STARTED|Overall Study||3
184804|NCT00610363|453049|P2|NOT COMPLETED|Overall Study||3
184805|NCT00610363|453050|P1|NOT COMPLETED|Overall Study||11
184806|NCT00610363|453049|P2|COMPLETED|Overall Study||38
184807|NCT00610363|453050|P1|COMPLETED|Overall Study||31
184808|NCT00610363|453049|P2|STARTED|Overall Study||41
184809|NCT00610363|453050|P1|STARTED|Overall Study||42
184810|NCT00610441|453072|P4|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
184811|NCT00610441|453073|P3|NOT COMPLETED|Treatment Period 2 - 3 Weeks||0
184812|NCT00610441|453074|P2|NOT COMPLETED|Treatment Period 2 - 3 Weeks||1
184813|NCT00610441|453075|P1|NOT COMPLETED|Treatment Period 2 - 3 Weeks||2
184814|NCT00610441|453072|P4|COMPLETED|Treatment Period 2 - 3 Weeks||14
184815|NCT00610441|453073|P3|COMPLETED|Treatment Period 2 - 3 Weeks||9
184816|NCT00610441|453074|P2|COMPLETED|Treatment Period 2 - 3 Weeks||12
184817|NCT00610441|453075|P1|COMPLETED|Treatment Period 2 - 3 Weeks||10
184818|NCT00610441|453072|P4|STARTED|Treatment Period 2 - 3 Weeks||16
184819|NCT00610441|453073|P3|STARTED|Treatment Period 2 - 3 Weeks||9
184820|NCT00610441|453074|P2|STARTED|Treatment Period 2 - 3 Weeks||13
184821|NCT00610441|453075|P1|STARTED|Treatment Period 2 - 3 Weeks||12
184822|NCT00610441|453072|P4|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
184823|NCT00610441|453073|P3|NOT COMPLETED|Placebo Washout Period - 2 Weeks||2
184824|NCT00610441|453074|P2|NOT COMPLETED|Placebo Washout Period - 2 Weeks||1
184825|NCT00610441|453075|P1|NOT COMPLETED|Placebo Washout Period - 2 Weeks||0
184826|NCT00610441|453072|P4|COMPLETED|Placebo Washout Period - 2 Weeks||16
184827|NCT00610441|453073|P3|COMPLETED|Placebo Washout Period - 2 Weeks||9
184828|NCT00610441|453074|P2|COMPLETED|Placebo Washout Period - 2 Weeks||13
184829|NCT00610441|453075|P1|COMPLETED|Placebo Washout Period - 2 Weeks||12
184830|NCT00610441|453072|P4|STARTED|Placebo Washout Period - 2 Weeks||16
184831|NCT00610441|453073|P3|STARTED|Placebo Washout Period - 2 Weeks||11
184832|NCT00610441|453074|P2|STARTED|Placebo Washout Period - 2 Weeks||14
184833|NCT00610441|453075|P1|STARTED|Placebo Washout Period - 2 Weeks||12
184834|NCT00610441|453072|P4|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
184835|NCT00610441|453073|P3|NOT COMPLETED|Treatment Period 1 - 3 Weeks||7
184836|NCT00610441|453074|P2|NOT COMPLETED|Treatment Period 1 - 3 Weeks||2
184837|NCT00610441|453075|P1|NOT COMPLETED|Treatment Period 1 - 3 Weeks||3
184838|NCT00610441|453072|P4|COMPLETED|Treatment Period 1 - 3 Weeks||16
184839|NCT00610441|453073|P3|COMPLETED|Treatment Period 1 - 3 Weeks||11
184840|NCT00610441|453074|P2|COMPLETED|Treatment Period 1 - 3 Weeks||14
184841|NCT00610441|453075|P1|COMPLETED|Treatment Period 1 - 3 Weeks||12
184842|NCT00610441|453072|P4|STARTED|Treatment Period 1 - 3 Weeks||18
184843|NCT00610441|453073|P3|STARTED|Treatment Period 1 - 3 Weeks||18
184844|NCT00610441|453074|P2|STARTED|Treatment Period 1 - 3 Weeks||16
184845|NCT00610441|453075|P1|STARTED|Treatment Period 1 - 3 Weeks||15
184846|NCT00610532|453166|P1|NOT COMPLETED|Intravenous Phenytoin Plus Probenecid||0
184847|NCT00610532|453166|P1|COMPLETED|Intravenous Phenytoin Plus Probenecid||7
184848|NCT00610532|453166|P1|STARTED|Intravenous Phenytoin Plus Probenecid|one participant dropped out between periods|7
184849|NCT00610532|453166|P1|NOT COMPLETED|Intravenous Phenytoin Alone||0
184850|NCT00610532|453166|P1|COMPLETED|Intravenous Phenytoin Alone||8
184851|NCT00610532|453166|P1|STARTED|Intravenous Phenytoin Alone||8
184852|NCT00610649|453183|P11|NOT COMPLETED|Overall Study||1
184853|NCT00610649|453184|P10|NOT COMPLETED|Overall Study||1
184854|NCT00610649|453185|P9|NOT COMPLETED|Overall Study||0
184855|NCT00610649|453186|P8|NOT COMPLETED|Overall Study||0
184856|NCT00610649|453187|P7|NOT COMPLETED|Overall Study||0
184857|NCT00610649|453188|P6|NOT COMPLETED|Overall Study||0
184858|NCT00610649|453189|P5|NOT COMPLETED|Overall Study||0
184859|NCT00610649|453190|P4|NOT COMPLETED|Overall Study||0
184860|NCT00610649|453191|P3|NOT COMPLETED|Overall Study||0
184861|NCT00610649|453192|P2|NOT COMPLETED|Overall Study||1
184862|NCT00610649|453193|P1|NOT COMPLETED|Overall Study||1
184863|NCT00610649|453183|P11|COMPLETED|Overall Study||9
184864|NCT00610649|453184|P10|COMPLETED|Overall Study||9
184865|NCT00610649|453185|P9|COMPLETED|Overall Study||10
184866|NCT00610649|453186|P8|COMPLETED|Overall Study||2
184867|NCT00610649|453187|P7|COMPLETED|Overall Study||4
184868|NCT00610649|453188|P6|COMPLETED|Overall Study||2
184869|NCT00610649|453189|P5|COMPLETED|Overall Study||4
184870|NCT00610649|453190|P4|COMPLETED|Overall Study||2
184871|NCT00610649|453191|P3|COMPLETED|Overall Study||4
184872|NCT00610649|453192|P2|COMPLETED|Overall Study||1
184873|NCT00610649|453193|P1|COMPLETED|Overall Study||3
184874|NCT00610649|453183|P11|STARTED|Overall Study||10
184875|NCT00610649|453184|P10|STARTED|Overall Study||10
184876|NCT00610649|453185|P9|STARTED|Overall Study||10
184877|NCT00610649|453186|P8|STARTED|Overall Study||2
184878|NCT00610649|453187|P7|STARTED|Overall Study||4
184879|NCT00610649|453188|P6|STARTED|Overall Study||2
184880|NCT00610649|453189|P5|STARTED|Overall Study||4
184881|NCT00610649|453190|P4|STARTED|Overall Study||2
184882|NCT00610649|453191|P3|STARTED|Overall Study||4
184883|NCT00610649|453192|P2|STARTED|Overall Study||2
184884|NCT00610649|453193|P1|STARTED|Overall Study||4
184885|NCT00610675|453247|P1|NOT COMPLETED|Overall Study||220
184886|NCT00610675|453247|P1|COMPLETED|Overall Study||126
184887|NCT00610675|453247|P1|Treated|Overall Study||342
184888|NCT00610675|453247|P1|STARTED|Overall Study||346
184889|NCT00610688|453261|P3|NOT COMPLETED|Overall Study||8
184890|NCT00610688|453262|P2|NOT COMPLETED|Overall Study||13
184891|NCT00610688|453263|P1|NOT COMPLETED|Overall Study||9
184892|NCT00610688|453261|P3|COMPLETED|Overall Study||55
184893|NCT00610688|453262|P2|COMPLETED|Overall Study||52
184894|NCT00610688|453263|P1|COMPLETED|Overall Study||55
184895|NCT00610688|453261|P3|STARTED|Overall Study||63
184896|NCT00610688|453262|P2|STARTED|Overall Study||65
184897|NCT00610688|453263|P1|STARTED|Overall Study||64
184898|NCT00610701|453279|P2|NOT COMPLETED|Overall Study||11
184899|NCT00610701|453280|P1|NOT COMPLETED|Overall Study||10
184900|NCT00610701|453279|P2|COMPLETED|Overall Study||9
184901|NCT00610701|453280|P1|COMPLETED|Overall Study||5
184902|NCT00610701|453279|P2|STARTED|Overall Study||20
184903|NCT00610701|453280|P1|STARTED|Overall Study||15
184904|NCT00610714|453288|P2|NOT COMPLETED|Overall Study||24
184905|NCT00610714|453289|P1|NOT COMPLETED|Overall Study||26
184906|NCT00610714|453288|P2|COMPLETED|Overall Study||82
184907|NCT00610714|453289|P1|COMPLETED|Overall Study||79
184908|NCT00610714|453288|P2|STARTED|Overall Study||106
184909|NCT00610714|453289|P1|STARTED|Overall Study||105
184910|NCT00610740|453299|P1|NOT COMPLETED|Overall Study||0
184911|NCT00610740|453299|P1|COMPLETED|Overall Study||18
184912|NCT00610740|453299|P1|STARTED|Overall Study||18
184913|NCT00610857|453305|P1|NOT COMPLETED|Overall Study||2
184914|NCT00610857|453305|P1|COMPLETED|Overall Study||35
184915|NCT00610857|453305|P1|STARTED|Overall Study||37
184916|NCT00610883|453312|P1|NOT COMPLETED|Overall Study||0
184917|NCT00610883|453312|P1|COMPLETED|Overall Study||17
184918|NCT00610883|453312|P1|STARTED|Overall Study||17
184919|NCT00610987|453318|P2|NOT COMPLETED|Overall Study||0
184920|NCT00610987|453319|P1|NOT COMPLETED|Overall Study||0
184921|NCT00610987|453318|P2|COMPLETED|Overall Study||71
184922|NCT00610987|453319|P1|COMPLETED|Overall Study||75
184923|NCT00610987|453318|P2|STARTED|Overall Study||71
184924|NCT00610987|453319|P1|STARTED|Overall Study||75
184925|NCT00611026|453328|P3|NOT COMPLETED|Double-blind Treatment Period||98
184926|NCT00611026|453329|P2|NOT COMPLETED|Double-blind Treatment Period||88
184927|NCT00611026|453330|P1|NOT COMPLETED|Double-blind Treatment Period||47
184928|NCT00611026|453328|P3|COMPLETED|Double-blind Treatment Period||862
184929|NCT00611026|453329|P2|COMPLETED|Double-blind Treatment Period||885
184930|NCT00611026|453330|P1|COMPLETED|Double-blind Treatment Period||431
184931|NCT00611026|453328|P3|STARTED|Double-blind Treatment Period||960
184932|NCT00611026|453329|P2|STARTED|Double-blind Treatment Period||973
184933|NCT00611026|453330|P1|STARTED|Double-blind Treatment Period||478
184934|NCT00611026|453328|P3|NOT COMPLETED|Randomized to Double-blind Treatment||3
184935|NCT00611026|453329|P2|NOT COMPLETED|Randomized to Double-blind Treatment||1
184936|NCT00611026|453330|P1|NOT COMPLETED|Randomized to Double-blind Treatment||2
184937|NCT00611026|453328|P3|COMPLETED|Randomized to Double-blind Treatment||960
184938|NCT00611026|453329|P2|COMPLETED|Randomized to Double-blind Treatment||973
184939|NCT00611026|453330|P1|COMPLETED|Randomized to Double-blind Treatment||478
184940|NCT00611026|453328|P3|STARTED|Randomized to Double-blind Treatment||963
184941|NCT00611026|453329|P2|STARTED|Randomized to Double-blind Treatment||974
184942|NCT00611026|453330|P1|STARTED|Randomized to Double-blind Treatment||480
184943|NCT00611130|453396|P2|NOT COMPLETED|Overall Study||47
184944|NCT00611130|453397|P1|NOT COMPLETED|Overall Study||49
184945|NCT00611130|453396|P2|COMPLETED|Overall Study||47
184946|NCT00611130|453397|P1|COMPLETED|Overall Study||43
184947|NCT00611130|453396|P2|Completed 12 Week Treatment Phase|Overall Study||64
184948|NCT00611130|453397|P1|Completed 12 Week Treatment Phase|Overall Study||61
184949|NCT00611130|453396|P2|STARTED|Overall Study||94
184950|NCT00611130|453397|P1|STARTED|Overall Study||92
184951|NCT00611247|453406|P2|NOT COMPLETED|Overall Study||21
184952|NCT00611247|453407|P1|NOT COMPLETED|Overall Study||2
184953|NCT00611247|453406|P2|COMPLETED|Overall Study||10
184954|NCT00611247|453407|P1|COMPLETED|Overall Study||3
184955|NCT00611247|453406|P2|STARTED|Overall Study||31
184956|NCT00611247|453407|P1|STARTED|Overall Study||5
184957|NCT00618956|453419|P2|NOT COMPLETED|Overall Study||50
184958|NCT00618956|453420|P1|NOT COMPLETED|Overall Study||25
184959|NCT00618956|453419|P2|COMPLETED|Overall Study||160
184960|NCT00618956|453420|P1|COMPLETED|Overall Study||86
184961|NCT00618956|453419|P2|STARTED|Overall Study||210
184962|NCT00618956|453420|P1|STARTED|Overall Study||111
184963|NCT00618982|453436|P1|NOT COMPLETED|Overall Study||50
184964|NCT00618982|453436|P1|COMPLETED|Overall Study||33
184965|NCT00618982|453436|P1|STARTED|Overall Study||83
184966|NCT00618995|453457|P4|NOT COMPLETED|Period 4||0
184967|NCT00618995|453458|P3|NOT COMPLETED|Period 4||0
184968|NCT00618995|453459|P2|NOT COMPLETED|Period 4||0
184969|NCT00618995|453460|P1|NOT COMPLETED|Period 4||1
184970|NCT00618995|453457|P4|COMPLETED|Period 4||6
184971|NCT00618995|453458|P3|COMPLETED|Period 4||4
184972|NCT00618995|453459|P2|COMPLETED|Period 4||6
184973|NCT00618995|453460|P1|COMPLETED|Period 4||5
184974|NCT00618995|453457|P4|STARTED|Period 4||6
184975|NCT00618995|453458|P3|STARTED|Period 4||4
184976|NCT00618995|453459|P2|STARTED|Period 4||6
184977|NCT00618995|453460|P1|STARTED|Period 4||6
184978|NCT00618995|453457|P4|NOT COMPLETED|Period 3||0
184979|NCT00618995|453458|P3|NOT COMPLETED|Period 3||0
184980|NCT00618995|453459|P2|NOT COMPLETED|Period 3||0
184981|NCT00618995|453460|P1|NOT COMPLETED|Period 3||0
184982|NCT00618995|453457|P4|COMPLETED|Period 3||6
184983|NCT00618995|453458|P3|COMPLETED|Period 3||4
184984|NCT00618995|453459|P2|COMPLETED|Period 3||6
184985|NCT00618995|453460|P1|COMPLETED|Period 3||6
184986|NCT00618995|453457|P4|STARTED|Period 3||6
184987|NCT00618995|453458|P3|STARTED|Period 3||4
184988|NCT00618995|453459|P2|STARTED|Period 3||6
184989|NCT00618995|453460|P1|STARTED|Period 3||6
184990|NCT00618995|453457|P4|NOT COMPLETED|Period 2||0
184991|NCT00618995|453458|P3|NOT COMPLETED|Period 2||1
184992|NCT00618995|453459|P2|NOT COMPLETED|Period 2||0
184993|NCT00618995|453460|P1|NOT COMPLETED|Period 2||0
184994|NCT00618995|453457|P4|COMPLETED|Period 2||6
184995|NCT00618995|453458|P3|COMPLETED|Period 2||4
184996|NCT00618995|453459|P2|COMPLETED|Period 2||6
184997|NCT00618995|453460|P1|COMPLETED|Period 2||6
184998|NCT00618995|453457|P4|STARTED|Period 2||6
184999|NCT00618995|453458|P3|STARTED|Period 2||5
185000|NCT00618995|453459|P2|STARTED|Period 2||6
185001|NCT00618995|453460|P1|STARTED|Period 2||6
185002|NCT00618995|453457|P4|NOT COMPLETED|Period 1||0
185003|NCT00618995|453458|P3|NOT COMPLETED|Period 1||2
185004|NCT00618995|453459|P2|NOT COMPLETED|Period 1||1
185005|NCT00618995|453460|P1|NOT COMPLETED|Period 1||0
185006|NCT00618995|453457|P4|COMPLETED|Period 1||6
185007|NCT00618995|453458|P3|COMPLETED|Period 1||5
185008|NCT00618995|453459|P2|COMPLETED|Period 1||6
185009|NCT00618995|453460|P1|COMPLETED|Period 1||6
185010|NCT00618995|453457|P4|STARTED|Period 1||6
185011|NCT00618995|453458|P3|STARTED|Period 1||7
185012|NCT00618995|453459|P2|STARTED|Period 1||7
185013|NCT00618995|453460|P1|STARTED|Period 1||6
185014|NCT00619060|453474|P2|NOT COMPLETED|Overall Study||0
185015|NCT00619060|453475|P1|NOT COMPLETED|Overall Study||0
185016|NCT00619060|453474|P2|COMPLETED|Overall Study||12
185017|NCT00619060|453475|P1|COMPLETED|Overall Study||10
185018|NCT00619060|453474|P2|STARTED|Overall Study||12
185019|NCT00619060|453475|P1|STARTED|Overall Study||10
185020|NCT00619073|453483|P2|NOT COMPLETED|Second Intervention - 60 Days||0
185021|NCT00619073|453484|P1|NOT COMPLETED|Second Intervention - 60 Days||0
185022|NCT00619073|453483|P2|COMPLETED|Second Intervention - 60 Days||8
185023|NCT00619073|453484|P1|COMPLETED|Second Intervention - 60 Days||8
185024|NCT00619073|453483|P2|STARTED|Second Intervention - 60 Days||8
185025|NCT00619073|453484|P1|STARTED|Second Intervention - 60 Days||8
185026|NCT00619073|453483|P2|NOT COMPLETED|Washout Period (30 Days)||0
185027|NCT00619073|453484|P1|NOT COMPLETED|Washout Period (30 Days)||0
185028|NCT00619073|453483|P2|COMPLETED|Washout Period (30 Days)||8
185029|NCT00619073|453484|P1|COMPLETED|Washout Period (30 Days)||8
185030|NCT00619073|453483|P2|STARTED|Washout Period (30 Days)||8
185031|NCT00619073|453484|P1|STARTED|Washout Period (30 Days)||8
185032|NCT00619073|453483|P2|NOT COMPLETED|First Intervention - 60 Days||0
185033|NCT00619073|453484|P1|NOT COMPLETED|First Intervention - 60 Days||0
185034|NCT00619073|453483|P2|COMPLETED|First Intervention - 60 Days||8
185035|NCT00619073|453484|P1|COMPLETED|First Intervention - 60 Days||8
185036|NCT00619073|453483|P2|STARTED|First Intervention - 60 Days||8
185037|NCT00619073|453484|P1|STARTED|First Intervention - 60 Days||8
185038|NCT00619099|453492|P2|NOT COMPLETED|Overall Study||19
185039|NCT00619099|453493|P1|NOT COMPLETED|Overall Study||33
185040|NCT00619099|453492|P2|COMPLETED|Overall Study||4
185041|NCT00619099|453493|P1|COMPLETED|Overall Study||11
185042|NCT00619099|453492|P2|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|22
185043|NCT00619099|453493|P1|Received at Least 2 Cycles of Treatment|Overall Study|Subjects included in the Modified Intent to Treat Population|43
185044|NCT00619099|453492|P2|STARTED|Overall Study|All randomized subjects|23
185045|NCT00619099|453493|P1|STARTED|Overall Study|All randomized subjects|44
185046|NCT00619112|453499|P1|NOT COMPLETED|Overall Study||0
185047|NCT00619112|453499|P1|COMPLETED|Overall Study|enrolled all patients from Nov 2007 to Jan 2012|60
185048|NCT00619112|453499|P1|STARTED|Overall Study||60
185049|NCT00619151|453505|P2|NOT COMPLETED|Overall Study||0
185050|NCT00619151|453506|P1|NOT COMPLETED|Overall Study||1
185051|NCT00619151|453505|P2|COMPLETED|Overall Study||0
185052|NCT00619151|453506|P1|COMPLETED|Overall Study||1
185053|NCT00619151|453505|P2|STARTED|Overall Study||0
185054|NCT00619151|453506|P1|STARTED|Overall Study||2
185055|NCT00619177|453514|P1|NOT COMPLETED|Overall Study||508
185056|NCT00619177|453514|P1|COMPLETED|Overall Study|"Due to some missing termination information, the number of completed may be larger than 3061."|3061
185057|NCT00619177|453514|P1|STARTED|Overall Study|treated set = 3569 (treated with Movalis)|3569
185058|NCT00619190|453524|P2|NOT COMPLETED|Overall Study||0
185059|NCT00619190|453525|P1|NOT COMPLETED|Overall Study||1
185060|NCT00619190|453524|P2|COMPLETED|Overall Study||9
185061|NCT00619190|453525|P1|COMPLETED|Overall Study||20
185062|NCT00619190|453524|P2|STARTED|Overall Study||9
185063|NCT00619190|453525|P1|STARTED|Overall Study||21
185064|NCT00619229|453537|P2|NOT COMPLETED|Overall Study||2
185065|NCT00619229|453538|P1|NOT COMPLETED|Overall Study||4
185066|NCT00619229|453537|P2|COMPLETED|Overall Study||16
185067|NCT00619229|453538|P1|COMPLETED|Overall Study||14
185068|NCT00619229|453537|P2|Full Analysis Set (FAS)|Overall Study||17
185069|NCT00619229|453538|P1|Full Analysis Set (FAS)|Overall Study||16
185070|NCT00619229|453537|P2|STARTED|Overall Study||18
185071|NCT00619229|453538|P1|STARTED|Overall Study||18
185072|NCT00619242|453564|P1|NOT COMPLETED|Overall Study||0
185073|NCT00619242|453564|P1|COMPLETED|Overall Study||3
185074|NCT00619242|453564|P1|STARTED|Overall Study||3
185075|NCT00619762|453568|P1|NOT COMPLETED|Overall Study||3
185076|NCT00619762|453568|P1|COMPLETED|Overall Study|(25 breasts) last patient visit 11/09/2009|14
185077|NCT00619762|453568|P1|STARTED|Overall Study|(29 breasts) First patient implanted 10/23/2007|17
185078|NCT00619801|453575|P2|NOT COMPLETED|Overall Study||3
185079|NCT00619801|453576|P1|NOT COMPLETED|Overall Study||1
185080|NCT00619801|453575|P2|COMPLETED|Overall Study||111
185081|NCT00619801|453576|P1|COMPLETED|Overall Study||58
185082|NCT00619801|453575|P2|Safety Population|Overall Study||114
185083|NCT00619801|453576|P1|Safety Population|Overall Study||59
185084|NCT00619801|453575|P2|STARTED|Overall Study||114
185085|NCT00619801|453576|P1|STARTED|Overall Study||59
185086|NCT00619827|453608|P2|NOT COMPLETED|Overall Study||4
185087|NCT00619827|453609|P1|NOT COMPLETED|Overall Study||3
185088|NCT00619827|453608|P2|COMPLETED|Overall Study||40
185089|NCT00619827|453609|P1|COMPLETED|Overall Study||42
185090|NCT00619827|453608|P2|STARTED|Overall Study||44
185091|NCT00619827|453609|P1|STARTED|Overall Study||45
185092|NCT00619892|453617|P2|NOT COMPLETED|Overall Study||2
185093|NCT00619892|453618|P1|NOT COMPLETED|Overall Study||3
185094|NCT00619892|453617|P2|COMPLETED|Overall Study||11
185095|NCT00619892|453618|P1|COMPLETED|Overall Study||10
185096|NCT00619892|453617|P2|STARTED|Overall Study||13
185097|NCT00619892|453618|P1|STARTED|Overall Study||13
185098|NCT00619918|453628|P2|NOT COMPLETED|Overall Study||22
185099|NCT00619918|453629|P1|NOT COMPLETED|Overall Study||20
185100|NCT00619918|453628|P2|COMPLETED|Overall Study||195
185101|NCT00619918|453629|P1|COMPLETED|Overall Study||210
185102|NCT00619918|453628|P2|STARTED|Overall Study||217
185103|NCT00619918|453629|P1|STARTED|Overall Study||230
185104|NCT00619957|453639|P2|NOT COMPLETED|Month 48 Open-Label||17
185105|NCT00619957|453640|P1|NOT COMPLETED|Month 48 Open-Label||12
185106|NCT00619957|453639|P2|COMPLETED|Month 48 Open-Label||134
185107|NCT00619957|453640|P1|COMPLETED|Month 48 Open-Label||55
185108|NCT00619957|453639|P2|STARTED|Month 48 Open-Label||151
185109|NCT00619957|453640|P1|STARTED|Month 48 Open-Label||67
185110|NCT00619957|453639|P2|NOT COMPLETED|Month 24 Double-Blind||17
185111|NCT00619957|453640|P1|NOT COMPLETED|Month 24 Double-Blind||18
185112|NCT00619957|453639|P2|COMPLETED|Month 24 Double-Blind||175
185113|NCT00619957|453640|P1|COMPLETED|Month 24 Double-Blind||75
185114|NCT00619957|453639|P2|Intent to Treat (ITT Population)|Month 24 Double-Blind|One subject did not take any study medication.|191
185115|NCT00619957|453640|P1|Intent to Treat (ITT Population)|Month 24 Double-Blind||93
185116|NCT00619957|453639|P2|STARTED|Month 24 Double-Blind||192
185117|NCT00619957|453640|P1|STARTED|Month 24 Double-Blind||93
185118|NCT00619970|453723|P3|NOT COMPLETED|Overall Study||2
185119|NCT00619970|453724|P2|NOT COMPLETED|Overall Study||3
185120|NCT00619970|453725|P1|NOT COMPLETED|Overall Study||0
185121|NCT00619970|453723|P3|COMPLETED|Overall Study||24
185122|NCT00619970|453724|P2|COMPLETED|Overall Study||46
185123|NCT00619970|453725|P1|COMPLETED|Overall Study||40
185124|NCT00619970|453723|P3|STARTED|Overall Study||26
185125|NCT00619970|453724|P2|STARTED|Overall Study||49
185126|NCT00619970|453725|P1|STARTED|Overall Study||40
185127|NCT00619983|453739|P4|NOT COMPLETED|Gabapentin Alone||0
185128|NCT00619983|453740|P3|NOT COMPLETED|Gabapentin Alone||0
185129|NCT00619983|453741|P2|NOT COMPLETED|Gabapentin Alone||0
185130|NCT00619983|453742|P1|NOT COMPLETED|Gabapentin Alone||0
185131|NCT00619983|453739|P4|COMPLETED|Gabapentin Alone||3
185132|NCT00619983|453740|P3|COMPLETED|Gabapentin Alone||4
185133|NCT00619983|453741|P2|COMPLETED|Gabapentin Alone||4
185134|NCT00619983|453742|P1|COMPLETED|Gabapentin Alone||3
185135|NCT00619983|453739|P4|STARTED|Gabapentin Alone||3
185136|NCT00619983|453740|P3|STARTED|Gabapentin Alone||4
185137|NCT00619983|453741|P2|STARTED|Gabapentin Alone||4
185138|NCT00619983|453742|P1|STARTED|Gabapentin Alone||3
185139|NCT00619983|453739|P4|NOT COMPLETED|Test Drug Plus Gabapentin||0
185140|NCT00619983|453740|P3|NOT COMPLETED|Test Drug Plus Gabapentin||0
185141|NCT00619983|453741|P2|NOT COMPLETED|Test Drug Plus Gabapentin||0
185142|NCT00619983|453742|P1|NOT COMPLETED|Test Drug Plus Gabapentin||0
185143|NCT00619983|453739|P4|COMPLETED|Test Drug Plus Gabapentin||3
185144|NCT00619983|453740|P3|COMPLETED|Test Drug Plus Gabapentin||4
185145|NCT00619983|453741|P2|COMPLETED|Test Drug Plus Gabapentin||4
185146|NCT00619983|453742|P1|COMPLETED|Test Drug Plus Gabapentin||3
185147|NCT00619983|453739|P4|STARTED|Test Drug Plus Gabapentin||3
185148|NCT00619983|453740|P3|STARTED|Test Drug Plus Gabapentin||4
185149|NCT00619983|453741|P2|STARTED|Test Drug Plus Gabapentin||4
185150|NCT00619983|453742|P1|STARTED|Test Drug Plus Gabapentin||3
185151|NCT00619983|453739|P4|NOT COMPLETED|Test Drug Alone||3
185152|NCT00619983|453740|P3|NOT COMPLETED|Test Drug Alone||2
185153|NCT00619983|453741|P2|NOT COMPLETED|Test Drug Alone||1
185154|NCT00619983|453742|P1|NOT COMPLETED|Test Drug Alone||2
185155|NCT00619983|453739|P4|COMPLETED|Test Drug Alone||3
185156|NCT00619983|453740|P3|COMPLETED|Test Drug Alone||4
185157|NCT00619983|453741|P2|COMPLETED|Test Drug Alone||4
185158|NCT00619983|453742|P1|COMPLETED|Test Drug Alone||3
185159|NCT00619983|453739|P4|STARTED|Test Drug Alone||6
185160|NCT00619983|453740|P3|STARTED|Test Drug Alone||6
185161|NCT00619983|453741|P2|STARTED|Test Drug Alone||5
185162|NCT00619983|453742|P1|STARTED|Test Drug Alone||5
185163|NCT00620022|453752|P2|NOT COMPLETED|Treatment Period 2||2
185164|NCT00620022|453753|P1|NOT COMPLETED|Treatment Period 2||2
185165|NCT00620022|453752|P2|COMPLETED|Treatment Period 2||35
185166|NCT00620022|453753|P1|COMPLETED|Treatment Period 2||39
185167|NCT00620022|453752|P2|STARTED|Treatment Period 2||37
185168|NCT00620022|453753|P1|STARTED|Treatment Period 2||41
185169|NCT00620022|453752|P2|NOT COMPLETED|Treatment Period 1||6
185170|NCT00620022|453753|P1|NOT COMPLETED|Treatment Period 1||5
185171|NCT00620022|453752|P2|COMPLETED|Treatment Period 1||37
185172|NCT00620022|453753|P1|COMPLETED|Treatment Period 1||41
185173|NCT00620022|453752|P2|STARTED|Treatment Period 1|Of 44 randomized patients, 1 patient discontinued before receiving any study treatment.|43
185174|NCT00620022|453753|P1|STARTED|Treatment Period 1||46
185175|NCT00620035|453761|P1|NOT COMPLETED|Overall Study||145
185176|NCT00620035|453761|P1|COMPLETED|Overall Study||156
185177|NCT00620035|453761|P1|STARTED|Overall Study||301
185178|NCT00620074|453771|P1|NOT COMPLETED|Overall Study||1
185179|NCT00620074|453771|P1|COMPLETED|Overall Study||5
185180|NCT00620074|453771|P1|STARTED|Overall Study||6
185181|NCT00620113|453783|P4|NOT COMPLETED|Overall Study||10
185182|NCT00620113|453784|P3|NOT COMPLETED|Overall Study||5
185183|NCT00620113|453785|P2|NOT COMPLETED|Overall Study||7
185184|NCT00620113|453786|P1|NOT COMPLETED|Overall Study||13
185185|NCT00620113|453783|P4|COMPLETED|Overall Study||59
185186|NCT00620113|453784|P3|COMPLETED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|66
185187|NCT00620113|453785|P2|COMPLETED|Overall Study||67
185188|NCT00620113|453786|P1|COMPLETED|Overall Study||60
185189|NCT00620113|453783|P4|Efficacy/Safety Population|Overall Study||69
185190|NCT00620113|453784|P3|Efficacy/Safety Population|Overall Study||70
185191|NCT00620113|453785|P2|Efficacy/Safety Population|Overall Study||74
185192|NCT00620113|453786|P1|Efficacy/Safety Population|Overall Study||73
185193|NCT00620113|453783|P4|STARTED|Overall Study||69
185194|NCT00620113|453784|P3|STARTED|Overall Study|Includes 1 participant who also received 50 mg dose by accident during study.|71
185195|NCT00620113|453785|P2|STARTED|Overall Study||74
185196|NCT00620113|453786|P1|STARTED|Overall Study||73
185197|NCT00620126|453838|P2|NOT COMPLETED|Overall Study||5
185198|NCT00620126|453839|P1|NOT COMPLETED|Overall Study||11
185199|NCT00620126|453838|P2|COMPLETED|Overall Study||17
185200|NCT00620126|453839|P1|COMPLETED|Overall Study||14
185201|NCT00620126|453838|P2|STARTED|Overall Study||22
185202|NCT00620126|453839|P1|STARTED|Overall Study||25
185203|NCT00620282|453852|P3|NOT COMPLETED|Overall Study||1
185204|NCT00620282|453853|P2|NOT COMPLETED|Overall Study||2
185205|NCT00620282|453854|P1|NOT COMPLETED|Overall Study||0
185206|NCT00620282|453852|P3|COMPLETED|Overall Study||16
185207|NCT00620282|453853|P2|COMPLETED|Overall Study||14
185208|NCT00620282|453854|P1|COMPLETED|Overall Study||16
185209|NCT00620282|453852|P3|STARTED|Overall Study||17
185210|NCT00620282|453853|P2|STARTED|Overall Study||16
185211|NCT00620282|453854|P1|STARTED|Overall Study||16
185212|NCT00620373|453901|P1|NOT COMPLETED|Overall Study||33
185213|NCT00620373|453901|P1|COMPLETED|Overall Study||936
185214|NCT00620373|453901|P1|STARTED|Overall Study||969
185215|NCT00620425|453917|P1|NOT COMPLETED|Overall Study||0
185216|NCT00620425|453917|P1|COMPLETED|Overall Study||18
185217|NCT00620425|453917|P1|STARTED|Overall Study||18
185218|NCT00620464|453930|P2|NOT COMPLETED|Overall Study||24
185219|NCT00620464|453931|P1|NOT COMPLETED|Overall Study||20
185220|NCT00620464|453930|P2|COMPLETED|Overall Study||32
185221|NCT00620464|453931|P1|COMPLETED|Overall Study||32
185222|NCT00620464|453930|P2|STARTED|Overall Study||56
185223|NCT00620464|453931|P1|STARTED|Overall Study||52
185224|NCT00620542|453941|P4|NOT COMPLETED|Part B (2 Year Core Study)||144
185225|NCT00620542|453942|P3|NOT COMPLETED|Part B (2 Year Core Study)||148
185226|NCT00620542|453943|P2|NOT COMPLETED|Part B (2 Year Core Study)||0
185227|NCT00620542|453944|P1|NOT COMPLETED|Part B (2 Year Core Study)||0
185228|NCT00620542|453941|P4|COMPLETED|Part B (2 Year Core Study)||547
185229|NCT00620542|453942|P3|COMPLETED|Part B (2 Year Core Study)||546
185230|NCT00620542|453943|P2|COMPLETED|Part B (2 Year Core Study)||0
185231|NCT00620542|453944|P1|COMPLETED|Part B (2 Year Core Study)||0
185232|NCT00620542|453941|P4|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|519
185233|NCT00620542|453942|P3|Intent-to-treat Population|Part B (2 Year Core Study)|Patients who received treatment and had a baseline and end of study (Week 104) IVUS|520
185234|NCT00620542|453943|P2|Intent-to-treat Population|Part B (2 Year Core Study)||0
185235|NCT00620542|453944|P1|Intent-to-treat Population|Part B (2 Year Core Study)||0
185236|NCT00620542|453941|P4|Received Treatment|Part B (2 Year Core Study)||689
185322|NCT00620659|453994|P1|NOT COMPLETED|Placebo Washout Period 1||0
185237|NCT00620542|453942|P3|Received Treatment|Part B (2 Year Core Study)||691
185238|NCT00620542|453943|P2|Received Treatment|Part B (2 Year Core Study)||0
185239|NCT00620542|453944|P1|Received Treatment|Part B (2 Year Core Study)||0
185240|NCT00620542|453941|P4|STARTED|Part B (2 Year Core Study)|Of 691 patients randomized, N=689 received treatment.|691
185241|NCT00620542|453942|P3|STARTED|Part B (2 Year Core Study)|Of 694 patients randomized, N=691 received treatment.|694
185242|NCT00620542|453943|P2|STARTED|Part B (2 Year Core Study)||0
185243|NCT00620542|453944|P1|STARTED|Part B (2 Year Core Study)||0
185244|NCT00620542|453941|P4|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
185245|NCT00620542|453942|P3|NOT COMPLETED|Part A (Run-in - 2 Weeks)||0
185246|NCT00620542|453943|P2|NOT COMPLETED|Part A (Run-in - 2 Weeks)||476
185247|NCT00620542|453944|P1|NOT COMPLETED|Part A (Run-in - 2 Weeks)||472
185248|NCT00620542|453941|P4|COMPLETED|Part A (Run-in - 2 Weeks)||0
185249|NCT00620542|453942|P3|COMPLETED|Part A (Run-in - 2 Weeks)||0
185250|NCT00620542|453943|P2|COMPLETED|Part A (Run-in - 2 Weeks)||690
185251|NCT00620542|453944|P1|COMPLETED|Part A (Run-in - 2 Weeks)||695
185252|NCT00620542|453941|P4|Received Treatment|Part A (Run-in - 2 Weeks)||0
185253|NCT00620542|453942|P3|Received Treatment|Part A (Run-in - 2 Weeks)||0
185254|NCT00620542|453943|P2|Received Treatment|Part A (Run-in - 2 Weeks)||795
185255|NCT00620542|453944|P1|Received Treatment|Part A (Run-in - 2 Weeks)||783
185256|NCT00620542|453941|P4|STARTED|Part A (Run-in - 2 Weeks)||0
185257|NCT00620542|453942|P3|STARTED|Part A (Run-in - 2 Weeks)||0
185258|NCT00620542|453943|P2|STARTED|Part A (Run-in - 2 Weeks)|Of 1166 randomized, N=795 received treatment.|1166
185259|NCT00620542|453944|P1|STARTED|Part A (Run-in - 2 Weeks)|Of 1167 randomized, N=783 received treatment.|1167
185260|NCT00620555|453982|P1|NOT COMPLETED|Overall Study||21
185261|NCT00620555|453982|P1|COMPLETED|Overall Study||44
185262|NCT00620555|453982|P1|STARTED|Overall Study||65
185263|NCT00620659|453989|P6|NOT COMPLETED|Treatment Period 3||0
185264|NCT00620659|453990|P5|NOT COMPLETED|Treatment Period 3||0
185265|NCT00620659|453991|P4|NOT COMPLETED|Treatment Period 3||1
185266|NCT00620659|453992|P3|NOT COMPLETED|Treatment Period 3||0
185267|NCT00620659|453993|P2|NOT COMPLETED|Treatment Period 3||2
185268|NCT00620659|453994|P1|NOT COMPLETED|Treatment Period 3||0
185269|NCT00620659|453989|P6|COMPLETED|Treatment Period 3||20
185270|NCT00620659|453990|P5|COMPLETED|Treatment Period 3||15
185271|NCT00620659|453991|P4|COMPLETED|Treatment Period 3||17
185272|NCT00620659|453992|P3|COMPLETED|Treatment Period 3||19
185273|NCT00620659|453993|P2|COMPLETED|Treatment Period 3||16
185274|NCT00620659|453994|P1|COMPLETED|Treatment Period 3||16
185275|NCT00620659|453989|P6|STARTED|Treatment Period 3||20
185276|NCT00620659|453990|P5|STARTED|Treatment Period 3||15
185277|NCT00620659|453991|P4|STARTED|Treatment Period 3||18
185278|NCT00620659|453992|P3|STARTED|Treatment Period 3||19
185279|NCT00620659|453993|P2|STARTED|Treatment Period 3||18
185280|NCT00620659|453994|P1|STARTED|Treatment Period 3||16
185281|NCT00620659|453989|P6|NOT COMPLETED|Placebo Washout Period 2||0
185282|NCT00620659|453990|P5|NOT COMPLETED|Placebo Washout Period 2||0
185283|NCT00620659|453991|P4|NOT COMPLETED|Placebo Washout Period 2||0
185284|NCT00620659|453992|P3|NOT COMPLETED|Placebo Washout Period 2||0
185285|NCT00620659|453993|P2|NOT COMPLETED|Placebo Washout Period 2||0
185286|NCT00620659|453994|P1|NOT COMPLETED|Placebo Washout Period 2||2
185287|NCT00620659|453989|P6|COMPLETED|Placebo Washout Period 2||20
185288|NCT00620659|453990|P5|COMPLETED|Placebo Washout Period 2||15
185289|NCT00620659|453991|P4|COMPLETED|Placebo Washout Period 2||18
185290|NCT00620659|453992|P3|COMPLETED|Placebo Washout Period 2||19
185291|NCT00620659|453993|P2|COMPLETED|Placebo Washout Period 2||18
185292|NCT00620659|453994|P1|COMPLETED|Placebo Washout Period 2||16
185293|NCT00620659|453989|P6|STARTED|Placebo Washout Period 2||20
185294|NCT00620659|453990|P5|STARTED|Placebo Washout Period 2||15
185295|NCT00620659|453991|P4|STARTED|Placebo Washout Period 2||18
185296|NCT00620659|453992|P3|STARTED|Placebo Washout Period 2||19
185297|NCT00620659|453993|P2|STARTED|Placebo Washout Period 2||18
185298|NCT00620659|453994|P1|STARTED|Placebo Washout Period 2||18
185299|NCT00620659|453989|P6|NOT COMPLETED|Treatment Period 2||0
185300|NCT00620659|453990|P5|NOT COMPLETED|Treatment Period 2||5
185301|NCT00620659|453991|P4|NOT COMPLETED|Treatment Period 2||0
185302|NCT00620659|453992|P3|NOT COMPLETED|Treatment Period 2||1
185303|NCT00620659|453993|P2|NOT COMPLETED|Treatment Period 2||3
185304|NCT00620659|453994|P1|NOT COMPLETED|Treatment Period 2||0
185305|NCT00620659|453989|P6|COMPLETED|Treatment Period 2||20
185306|NCT00620659|453990|P5|COMPLETED|Treatment Period 2||15
185307|NCT00620659|453991|P4|COMPLETED|Treatment Period 2||18
185308|NCT00620659|453992|P3|COMPLETED|Treatment Period 2||19
185309|NCT00620659|453993|P2|COMPLETED|Treatment Period 2||18
185310|NCT00620659|453994|P1|COMPLETED|Treatment Period 2||18
185311|NCT00620659|453989|P6|STARTED|Treatment Period 2||20
185312|NCT00620659|453990|P5|STARTED|Treatment Period 2||20
185313|NCT00620659|453991|P4|STARTED|Treatment Period 2||18
185314|NCT00620659|453992|P3|STARTED|Treatment Period 2||20
185315|NCT00620659|453993|P2|STARTED|Treatment Period 2||21
185316|NCT00620659|453994|P1|STARTED|Treatment Period 2||18
185317|NCT00620659|453989|P6|NOT COMPLETED|Placebo Washout Period 1||0
185318|NCT00620659|453990|P5|NOT COMPLETED|Placebo Washout Period 1||0
185319|NCT00620659|453991|P4|NOT COMPLETED|Placebo Washout Period 1||1
185320|NCT00620659|453992|P3|NOT COMPLETED|Placebo Washout Period 1||0
185321|NCT00620659|453993|P2|NOT COMPLETED|Placebo Washout Period 1||0
185323|NCT00620659|453989|P6|COMPLETED|Placebo Washout Period 1||20
185324|NCT00620659|453990|P5|COMPLETED|Placebo Washout Period 1||20
185325|NCT00620659|453991|P4|COMPLETED|Placebo Washout Period 1||18
185326|NCT00620659|453992|P3|COMPLETED|Placebo Washout Period 1||20
185327|NCT00620659|453993|P2|COMPLETED|Placebo Washout Period 1||21
185328|NCT00620659|453994|P1|COMPLETED|Placebo Washout Period 1||18
185329|NCT00620659|453989|P6|STARTED|Placebo Washout Period 1||20
185330|NCT00620659|453990|P5|STARTED|Placebo Washout Period 1||20
185331|NCT00620659|453991|P4|STARTED|Placebo Washout Period 1||19
185332|NCT00620659|453992|P3|STARTED|Placebo Washout Period 1||20
185333|NCT00620659|453993|P2|STARTED|Placebo Washout Period 1||21
185334|NCT00620659|453994|P1|STARTED|Placebo Washout Period 1||18
185335|NCT00620659|453989|P6|NOT COMPLETED|Treatment Period 1||0
185336|NCT00620659|453990|P5|NOT COMPLETED|Treatment Period 1||1
185337|NCT00620659|453991|P4|NOT COMPLETED|Treatment Period 1||3
185338|NCT00620659|453992|P3|NOT COMPLETED|Treatment Period 1||1
185339|NCT00620659|453993|P2|NOT COMPLETED|Treatment Period 1||0
185340|NCT00620659|453994|P1|NOT COMPLETED|Treatment Period 1||3
185341|NCT00620659|453989|P6|COMPLETED|Treatment Period 1||20
185342|NCT00620659|453990|P5|COMPLETED|Treatment Period 1||20
185343|NCT00620659|453991|P4|COMPLETED|Treatment Period 1|1 patient discontinued from MK0249, but continued in following periods, & completed the study|18
185344|NCT00620659|453992|P3|COMPLETED|Treatment Period 1||20
185345|NCT00620659|453993|P2|COMPLETED|Treatment Period 1||21
185346|NCT00620659|453994|P1|COMPLETED|Treatment Period 1||18
185347|NCT00620659|453989|P6|STARTED|Treatment Period 1||20
185348|NCT00620659|453990|P5|STARTED|Treatment Period 1||21
185349|NCT00620659|453991|P4|STARTED|Treatment Period 1||21
185350|NCT00620659|453992|P3|STARTED|Treatment Period 1||21
185351|NCT00620659|453993|P2|STARTED|Treatment Period 1||21
185352|NCT00620659|453994|P1|STARTED|Treatment Period 1||21
185353|NCT00620698|454012|P1|NOT COMPLETED|Overall Study||29
185354|NCT00620698|454012|P1|COMPLETED|Overall Study||60
185355|NCT00620698|454012|P1|STARTED|Overall Study||89
185356|NCT00620711|454018|P1|NOT COMPLETED|Overall Study||0
185357|NCT00620711|454018|P1|COMPLETED|Overall Study||4
185358|NCT00620711|454018|P1|STARTED|Overall Study||4
185359|NCT00620750|454023|P1|NOT COMPLETED|Overall Study||25
185360|NCT00620750|454023|P1|COMPLETED|Overall Study||40
185361|NCT00620750|454023|P1|STARTED|Overall Study||65
185362|NCT00620763|454027|P2|NOT COMPLETED|Period: Second Intervention||0
185363|NCT00620763|454028|P1|NOT COMPLETED|Period: Second Intervention||1
185364|NCT00620763|454027|P2|COMPLETED|Period: Second Intervention||7
185365|NCT00620763|454028|P1|COMPLETED|Period: Second Intervention||9
185366|NCT00620763|454027|P2|STARTED|Period: Second Intervention||7
185367|NCT00620763|454028|P1|STARTED|Period: Second Intervention||10
185368|NCT00620763|454027|P2|NOT COMPLETED|Period: Washout Period of 1 Week||0
185369|NCT00620763|454028|P1|NOT COMPLETED|Period: Washout Period of 1 Week||0
185370|NCT00620763|454027|P2|COMPLETED|Period: Washout Period of 1 Week||7
185371|NCT00620763|454028|P1|COMPLETED|Period: Washout Period of 1 Week||10
185372|NCT00620763|454027|P2|STARTED|Period: Washout Period of 1 Week||7
185373|NCT00620763|454028|P1|STARTED|Period: Washout Period of 1 Week||10
185374|NCT00620763|454027|P2|NOT COMPLETED|Period: First Intervention||5
185375|NCT00620763|454028|P1|NOT COMPLETED|Period: First Intervention||0
185376|NCT00620763|454027|P2|COMPLETED|Period: First Intervention||7
185377|NCT00620763|454028|P1|COMPLETED|Period: First Intervention||10
185378|NCT00620763|454027|P2|STARTED|Period: First Intervention||12
185379|NCT00620763|454028|P1|STARTED|Period: First Intervention||10
185380|NCT00620776|454036|P2|NOT COMPLETED|Overall Study||16
185381|NCT00620776|454037|P1|NOT COMPLETED|Overall Study||12
185382|NCT00620776|454036|P2|COMPLETED|Overall Study|24 out of 35 attended the week 24 (last) assessment.|24
185383|NCT00620776|454037|P1|COMPLETED|Overall Study|17 out of 26 attended the week 24 (last) assessment.|17
185384|NCT00620776|454036|P2|Received at Least One Session/Dose|Overall Study|35 out of 40 that consented to receive medication alone received at least one dose of medication.|35
185385|NCT00620776|454037|P1|Received at Least One Session/Dose|Overall Study|26 out of 29 that consented to the combined treatment option received at least one session of CBT.|26
185386|NCT00620776|454036|P2|STARTED|Overall Study|All 40 patients that were randomly assigned to not be offered CBT consented to this option.|40
185387|NCT00620776|454037|P1|STARTED|Overall Study|29 patients (of the 77 that were randomly assigned to add on CBT) consented to this option.|29
185388|NCT00620815|454068|P3|NOT COMPLETED|Overall Study||7
185389|NCT00620815|454069|P2|NOT COMPLETED|Overall Study||11
185390|NCT00620815|454070|P1|NOT COMPLETED|Overall Study||4
185391|NCT00620815|454068|P3|COMPLETED|Overall Study||192
185392|NCT00620815|454069|P2|COMPLETED|Overall Study||192
185393|NCT00620815|454070|P1|COMPLETED|Overall Study||195
185394|NCT00620815|454068|P3|STARTED|Overall Study||199
185395|NCT00620815|454069|P2|STARTED|Overall Study||203
185396|NCT00620815|454070|P1|STARTED|Overall Study||199
185397|NCT00620828|454110|P2|NOT COMPLETED|Overall Study||0
185398|NCT00620828|454111|P1|NOT COMPLETED|Overall Study||0
185399|NCT00620828|454110|P2|COMPLETED|Overall Study||35
185400|NCT00620828|454111|P1|COMPLETED|Overall Study||32
185401|NCT00620828|454110|P2|Number of Subjects Enrolled = 67|Overall Study||35
185402|NCT00620828|454111|P1|Number of Subjects Enrolled = 67|Overall Study||32
185403|NCT00620828|454110|P2|STARTED|Overall Study||35
185404|NCT00620828|454111|P1|STARTED|Overall Study||32
185405|NCT00620854|454131|P6|NOT COMPLETED|Period 3||0
185406|NCT00620854|454132|P5|NOT COMPLETED|Period 3||0
185407|NCT00620854|454133|P4|NOT COMPLETED|Period 3||0
185408|NCT00620854|454134|P3|NOT COMPLETED|Period 3||0
185409|NCT00620854|454135|P2|NOT COMPLETED|Period 3||0
185410|NCT00620854|454136|P1|NOT COMPLETED|Period 3||0
185411|NCT00620854|454131|P6|COMPLETED|Period 3||4
185412|NCT00620854|454132|P5|COMPLETED|Period 3||4
185413|NCT00620854|454133|P4|COMPLETED|Period 3||3
185414|NCT00620854|454134|P3|COMPLETED|Period 3||3
185415|NCT00620854|454135|P2|COMPLETED|Period 3||4
185416|NCT00620854|454136|P1|COMPLETED|Period 3||4
185417|NCT00620854|454131|P6|STARTED|Period 3||4
185418|NCT00620854|454132|P5|STARTED|Period 3||4
185419|NCT00620854|454133|P4|STARTED|Period 3||3
185420|NCT00620854|454134|P3|STARTED|Period 3||3
185421|NCT00620854|454135|P2|STARTED|Period 3||4
185422|NCT00620854|454136|P1|STARTED|Period 3||4
185423|NCT00620854|454131|P6|NOT COMPLETED|Washout 2||0
185424|NCT00620854|454132|P5|NOT COMPLETED|Washout 2||0
185425|NCT00620854|454133|P4|NOT COMPLETED|Washout 2||0
185426|NCT00620854|454134|P3|NOT COMPLETED|Washout 2||0
185427|NCT00620854|454135|P2|NOT COMPLETED|Washout 2||0
185428|NCT00620854|454136|P1|NOT COMPLETED|Washout 2||0
185429|NCT00620854|454131|P6|COMPLETED|Washout 2||4
185430|NCT00620854|454132|P5|COMPLETED|Washout 2||4
185431|NCT00620854|454133|P4|COMPLETED|Washout 2||3
185432|NCT00620854|454134|P3|COMPLETED|Washout 2||3
185433|NCT00620854|454135|P2|COMPLETED|Washout 2||4
185434|NCT00620854|454136|P1|COMPLETED|Washout 2||4
185435|NCT00620854|454131|P6|STARTED|Washout 2||4
185436|NCT00620854|454132|P5|STARTED|Washout 2||4
185437|NCT00620854|454133|P4|STARTED|Washout 2||3
185438|NCT00620854|454134|P3|STARTED|Washout 2||3
185439|NCT00620854|454135|P2|STARTED|Washout 2||4
185440|NCT00620854|454136|P1|STARTED|Washout 2||4
185441|NCT00620854|454131|P6|NOT COMPLETED|Period 2||0
185442|NCT00620854|454132|P5|NOT COMPLETED|Period 2||0
185443|NCT00620854|454133|P4|NOT COMPLETED|Period 2||0
185444|NCT00620854|454134|P3|NOT COMPLETED|Period 2||0
185445|NCT00620854|454135|P2|NOT COMPLETED|Period 2||0
185446|NCT00620854|454136|P1|NOT COMPLETED|Period 2||0
185447|NCT00620854|454131|P6|COMPLETED|Period 2||4
185448|NCT00620854|454132|P5|COMPLETED|Period 2||4
185449|NCT00620854|454133|P4|COMPLETED|Period 2||3
185450|NCT00620854|454134|P3|COMPLETED|Period 2||3
185451|NCT00620854|454135|P2|COMPLETED|Period 2||4
185452|NCT00620854|454136|P1|COMPLETED|Period 2||4
185453|NCT00620854|454131|P6|STARTED|Period 2||4
185454|NCT00620854|454132|P5|STARTED|Period 2||4
185455|NCT00620854|454133|P4|STARTED|Period 2||3
185456|NCT00620854|454134|P3|STARTED|Period 2||3
185457|NCT00620854|454135|P2|STARTED|Period 2||4
185458|NCT00620854|454136|P1|STARTED|Period 2||4
185459|NCT00620854|454131|P6|NOT COMPLETED|Washout 1||0
185460|NCT00620854|454132|P5|NOT COMPLETED|Washout 1||0
185461|NCT00620854|454133|P4|NOT COMPLETED|Washout 1||1
185462|NCT00620854|454134|P3|NOT COMPLETED|Washout 1||1
185463|NCT00620854|454135|P2|NOT COMPLETED|Washout 1||0
185464|NCT00620854|454136|P1|NOT COMPLETED|Washout 1||0
185465|NCT00620854|454131|P6|COMPLETED|Washout 1||4
185466|NCT00620854|454132|P5|COMPLETED|Washout 1||4
185467|NCT00620854|454133|P4|COMPLETED|Washout 1||3
185468|NCT00620854|454134|P3|COMPLETED|Washout 1||3
185469|NCT00620854|454135|P2|COMPLETED|Washout 1||4
185470|NCT00620854|454136|P1|COMPLETED|Washout 1||4
185471|NCT00620854|454131|P6|STARTED|Washout 1||4
185472|NCT00620854|454132|P5|STARTED|Washout 1||4
185473|NCT00620854|454133|P4|STARTED|Washout 1||4
185474|NCT00620854|454134|P3|STARTED|Washout 1||4
185475|NCT00620854|454135|P2|STARTED|Washout 1||4
185476|NCT00620854|454136|P1|STARTED|Washout 1||4
185477|NCT00620854|454131|P6|NOT COMPLETED|Period 1||0
185478|NCT00620854|454132|P5|NOT COMPLETED|Period 1||0
185479|NCT00620854|454133|P4|NOT COMPLETED|Period 1||0
185480|NCT00620854|454134|P3|NOT COMPLETED|Period 1||0
185481|NCT00620854|454135|P2|NOT COMPLETED|Period 1||0
185482|NCT00620854|454136|P1|NOT COMPLETED|Period 1||0
185483|NCT00620854|454131|P6|COMPLETED|Period 1||4
185484|NCT00620854|454132|P5|COMPLETED|Period 1||4
185485|NCT00620854|454133|P4|COMPLETED|Period 1||4
185486|NCT00620854|454134|P3|COMPLETED|Period 1||4
185487|NCT00620854|454135|P2|COMPLETED|Period 1||4
185488|NCT00620854|454136|P1|COMPLETED|Period 1||4
185489|NCT00620854|454131|P6|STARTED|Period 1||4
185490|NCT00620854|454132|P5|STARTED|Period 1||4
185491|NCT00620854|454133|P4|STARTED|Period 1||4
185492|NCT00620854|454134|P3|STARTED|Period 1||4
185493|NCT00620854|454135|P2|STARTED|Period 1||4
185494|NCT00620854|454136|P1|STARTED|Period 1||4
185495|NCT00621023|454147|P1|NOT COMPLETED|Overall Study||6
185496|NCT00621023|454147|P1|COMPLETED|Overall Study|Completed is defined as 5 years of follow up.|0
185497|NCT00621023|454147|P1|STARTED|Overall Study||6
185498|NCT00621049|454155|P2|NOT COMPLETED|Maintenance Treatment||0
185499|NCT00621049|454156|P1|NOT COMPLETED|Maintenance Treatment||15
185500|NCT00621049|454155|P2|COMPLETED|Maintenance Treatment||0
185501|NCT00621049|454156|P1|COMPLETED|Maintenance Treatment||34
185502|NCT00621049|454155|P2|STARTED|Maintenance Treatment|Per protocol, only the Docetaxel/Carboplatin/Bevacizumab/Erlotinib arm enters maintenance therapy|0
185503|NCT00621049|454156|P1|STARTED|Maintenance Treatment|3 patients came off study between the end of adjuvant therapy and the start of maintenance|49
185504|NCT00621049|454155|P2|NOT COMPLETED|Adjuvant Treatment||10
185505|NCT00621049|454156|P1|NOT COMPLETED|Adjuvant Treatment||3
185506|NCT00621049|454155|P2|COMPLETED|Adjuvant Treatment||47
185507|NCT00621049|454156|P1|COMPLETED|Adjuvant Treatment||52
185508|NCT00621049|454155|P2|STARTED|Adjuvant Treatment||57
185509|NCT00621049|454156|P1|STARTED|Adjuvant Treatment||55
185510|NCT00621140|454170|P2|NOT COMPLETED|Overall Study||18
185511|NCT00621140|454171|P1|NOT COMPLETED|Overall Study||15
185512|NCT00621140|454170|P2|COMPLETED|Overall Study|number who completed treatment|318
185513|NCT00621140|454171|P1|COMPLETED|Overall Study|number who completed treatment|152
185514|NCT00621140|454170|P2|STARTED|Overall Study|number who started treatment|336
185515|NCT00621140|454171|P1|STARTED|Overall Study|number who started treatment|167
185516|NCT00621153|454205|P2|NOT COMPLETED|Overall Study||15
185517|NCT00621153|454206|P1|NOT COMPLETED|Overall Study||20
185518|NCT00621153|454205|P2|COMPLETED|Overall Study|completed|101
185519|NCT00621153|454206|P1|COMPLETED|Overall Study|completed|97
185520|NCT00621153|454205|P2|Discontinued|Overall Study||15
185521|NCT00621153|454206|P1|Discontinued|Overall Study||20
185522|NCT00621153|454205|P2|STARTED|Overall Study|randomised|116
185523|NCT00621153|454206|P1|STARTED|Overall Study|randomised|117
185524|NCT00621192|454216|P4|NOT COMPLETED|Overall Study||3
185525|NCT00621192|454217|P3|NOT COMPLETED|Overall Study||5
185526|NCT00621192|454218|P2|NOT COMPLETED|Overall Study||9
185527|NCT00621192|454219|P1|NOT COMPLETED|Overall Study||4
185528|NCT00621192|454216|P4|COMPLETED|Overall Study||24
185529|NCT00621192|454217|P3|COMPLETED|Overall Study||26
185530|NCT00621192|454218|P2|COMPLETED|Overall Study||94
185531|NCT00621192|454219|P1|COMPLETED|Overall Study||35
185532|NCT00621192|454216|P4|Efficacy Population|Overall Study||27
185533|NCT00621192|454217|P3|Efficacy Population|Overall Study||28
185534|NCT00621192|454218|P2|Efficacy Population|Overall Study||101
185535|NCT00621192|454219|P1|Efficacy Population|Overall Study||39
185536|NCT00621192|454216|P4|Safety Population|Overall Study||27
185537|NCT00621192|454217|P3|Safety Population|Overall Study||31
185538|NCT00621192|454218|P2|Safety Population|Overall Study||103
185539|NCT00621192|454219|P1|Safety Population|Overall Study||39
185540|NCT00621192|454216|P4|STARTED|Overall Study||27
185541|NCT00621192|454217|P3|STARTED|Overall Study||31
185542|NCT00621192|454218|P2|STARTED|Overall Study||103
185543|NCT00621192|454219|P1|STARTED|Overall Study||39
185544|NCT00621244|454245|P4|NOT COMPLETED|Overall Study||23
185545|NCT00621244|454246|P3|NOT COMPLETED|Overall Study||33
185546|NCT00621244|454247|P2|NOT COMPLETED|Overall Study||34
185547|NCT00621244|454248|P1|NOT COMPLETED|Overall Study||86
185548|NCT00621244|454245|P4|COMPLETED|Overall Study||0
185549|NCT00621244|454246|P3|COMPLETED|Overall Study||0
185550|NCT00621244|454247|P2|COMPLETED|Overall Study||0
185551|NCT00621244|454248|P1|COMPLETED|Overall Study||0
185552|NCT00621244|454245|P4|STARTED|Overall Study||23
185553|NCT00621244|454246|P3|STARTED|Overall Study||33
185554|NCT00621244|454247|P2|STARTED|Overall Study||34
185555|NCT00621244|454248|P1|STARTED|Overall Study||86
185556|NCT00621257|454353|P5|NOT COMPLETED|Overall Study||9
185557|NCT00621257|454354|P4|NOT COMPLETED|Overall Study||6
185558|NCT00621257|454355|P3|NOT COMPLETED|Overall Study||3
185559|NCT00621257|454356|P2|NOT COMPLETED|Overall Study||3
185560|NCT00621257|454357|P1|NOT COMPLETED|Overall Study||4
185561|NCT00621257|454353|P5|COMPLETED|Overall Study||22
185562|NCT00621257|454354|P4|COMPLETED|Overall Study||26
185563|NCT00621257|454355|P3|COMPLETED|Overall Study||20
185564|NCT00621257|454356|P2|COMPLETED|Overall Study||21
185565|NCT00621257|454357|P1|COMPLETED|Overall Study||20
185566|NCT00621257|454353|P5|STARTED|Overall Study||31
185567|NCT00621257|454354|P4|STARTED|Overall Study||32
185568|NCT00621257|454355|P3|STARTED|Overall Study||23
185569|NCT00621257|454356|P2|STARTED|Overall Study||24
185570|NCT00621257|454357|P1|STARTED|Overall Study||24
185571|NCT00621296|454369|P1|NOT COMPLETED|Overall Study||14
185572|NCT00621296|454369|P1|COMPLETED|Overall Study||1
185573|NCT00621296|454369|P1|STARTED|Overall Study||15
185574|NCT00621322|454379|P6|NOT COMPLETED|Overall Study||4
185575|NCT00621322|454380|P5|NOT COMPLETED|Overall Study||1
185576|NCT00621322|454381|P4|NOT COMPLETED|Overall Study||3
185577|NCT00621322|454382|P3|NOT COMPLETED|Overall Study||2
185578|NCT00621322|454383|P2|NOT COMPLETED|Overall Study||0
185579|NCT00621322|454384|P1|NOT COMPLETED|Overall Study||1
185580|NCT00621322|454379|P6|COMPLETED|Overall Study||36
185581|NCT00621322|454380|P5|COMPLETED|Overall Study||39
185582|NCT00621322|454381|P4|COMPLETED|Overall Study||37
185583|NCT00621322|454382|P3|COMPLETED|Overall Study||38
185584|NCT00621322|454383|P2|COMPLETED|Overall Study||10
185585|NCT00621322|454384|P1|COMPLETED|Overall Study||9
185586|NCT00621322|454379|P6|STARTED|Overall Study||40
185587|NCT00621322|454380|P5|STARTED|Overall Study||40
185588|NCT00621322|454381|P4|STARTED|Overall Study||40
185589|NCT00621322|454382|P3|STARTED|Overall Study||40
185590|NCT00621322|454383|P2|STARTED|Overall Study||10
185591|NCT00621322|454384|P1|STARTED|Overall Study||10
185592|NCT00621348|454467|P3|NOT COMPLETED|Overall Study||0
185593|NCT00621348|454468|P2|NOT COMPLETED|Overall Study||0
185594|NCT00621348|454469|P1|NOT COMPLETED|Overall Study||0
185595|NCT00621348|454467|P3|COMPLETED|Overall Study||56
185596|NCT00621348|454468|P2|COMPLETED|Overall Study||53
185597|NCT00621348|454469|P1|COMPLETED|Overall Study||58
185598|NCT00621348|454467|P3|STARTED|Overall Study||56
185599|NCT00621348|454468|P2|STARTED|Overall Study||53
185600|NCT00621348|454469|P1|STARTED|Overall Study||58
185601|NCT00621504|454488|P2|NOT COMPLETED|Overall Study||25
185602|NCT00621504|454489|P1|NOT COMPLETED|Overall Study||26
185603|NCT00621504|454488|P2|COMPLETED|Overall Study||282
185604|NCT00621504|454489|P1|COMPLETED|Overall Study||273
185605|NCT00621504|454488|P2|STARTED|Overall Study||307
185606|NCT00621504|454489|P1|STARTED|Overall Study||299
185607|NCT00621517|454497|P2|NOT COMPLETED|Overall Study||7
185608|NCT00621517|454498|P1|NOT COMPLETED|Overall Study||7
185609|NCT00621517|454497|P2|COMPLETED|Overall Study||24
185610|NCT00621517|454498|P1|COMPLETED|Overall Study||22
185611|NCT00621517|454497|P2|STARTED|Overall Study||31
185612|NCT00621517|454498|P1|STARTED|Overall Study||29
185613|NCT00621530|454506|P2|NOT COMPLETED|Overall Study||3
185614|NCT00621530|454507|P1|NOT COMPLETED|Overall Study||2
185615|NCT00621530|454506|P2|COMPLETED|Overall Study||29
185616|NCT00621530|454507|P1|COMPLETED|Overall Study||28
185617|NCT00621530|454506|P2|STARTED|Overall Study||32
185618|NCT00621530|454507|P1|STARTED|Overall Study||30
185619|NCT00621543|454521|P1|NOT COMPLETED|Overall Study||23
185620|NCT00621543|454521|P1|COMPLETED|Overall Study||97
185621|NCT00621543|454521|P1|STARTED|Overall Study||120
185622|NCT00621582|454526|P1|NOT COMPLETED|Overall Study||106
185623|NCT00621582|454526|P1|COMPLETED|Overall Study||4812
185624|NCT00621582|454526|P1|STARTED|Overall Study||4918
185625|NCT00621621|454536|P2|NOT COMPLETED|Overall Study||0
185626|NCT00621621|454537|P1|NOT COMPLETED|Overall Study||30
185627|NCT00621621|454536|P2|COMPLETED|Overall Study||705
185628|NCT00621621|454537|P1|COMPLETED|Overall Study|Treated with the experimental catheter|75
185629|NCT00621621|454536|P2|STARTED|Overall Study||705
185630|NCT00621621|454537|P1|STARTED|Overall Study|Date of Post- Approval Study protocol approval|105
185631|NCT00621686|454547|P2|NOT COMPLETED|Overall Study||0
185632|NCT00621686|454548|P1|NOT COMPLETED|Overall Study||0
185633|NCT00621686|454547|P2|COMPLETED|Overall Study||35
185634|NCT00621686|454548|P1|COMPLETED|Overall Study||19
185635|NCT00621686|454547|P2|STARTED|Overall Study||35
185636|NCT00621686|454548|P1|STARTED|Overall Study||19
185637|NCT00621764|454562|P4|NOT COMPLETED|Overall Study||1
185638|NCT00621764|454563|P3|NOT COMPLETED|Overall Study||0
185639|NCT00621764|454564|P2|NOT COMPLETED|Overall Study||0
185640|NCT00621764|454565|P1|NOT COMPLETED|Overall Study||0
185641|NCT00621764|454562|P4|COMPLETED|Overall Study||98
185642|NCT00621764|454563|P3|COMPLETED|Overall Study||101
185643|NCT00621764|454564|P2|COMPLETED|Overall Study||50
185644|NCT00621764|454565|P1|COMPLETED|Overall Study||50
185645|NCT00621764|454562|P4|STARTED|Overall Study||99
185646|NCT00621764|454563|P3|STARTED|Overall Study||101
185647|NCT00621764|454564|P2|STARTED|Overall Study||50
185648|NCT00621764|454565|P1|STARTED|Overall Study||50
185649|NCT00621777|454597|P2|NOT COMPLETED|Randomized Phase||19
185650|NCT00621777|454598|P1|NOT COMPLETED|Randomized Phase||7
185651|NCT00621777|454597|P2|COMPLETED|Randomized Phase||28
185652|NCT00621777|454598|P1|COMPLETED|Randomized Phase||33
185653|NCT00621777|454597|P2|STARTED|Randomized Phase||47
185654|NCT00621777|454598|P1|STARTED|Randomized Phase|87 open phase participants were continuously abstinent for at least 14 days and were randomized|40
185655|NCT00621777|454597|P2|NOT COMPLETED|Open Phase||0
185656|NCT00621777|454598|P1|NOT COMPLETED|Open Phase||116
185657|NCT00621777|454597|P2|COMPLETED|Open Phase||0
185658|NCT00621777|454598|P1|COMPLETED|Open Phase||87
185659|NCT00621777|454597|P2|STARTED|Open Phase|During this open label phase, all study participants received varenicline|0
185660|NCT00621777|454598|P1|STARTED|Open Phase||203
185661|NCT00621842|454605|P1|NOT COMPLETED|Overall Study||19
185662|NCT00621842|454605|P1|COMPLETED|Overall Study||38
185663|NCT00621842|454605|P1|STARTED|Overall Study||57
185664|NCT00621855|454625|P5|NOT COMPLETED|Overall Study||55
185665|NCT00621855|454626|P4|NOT COMPLETED|Overall Study||67
185666|NCT00621855|454627|P3|NOT COMPLETED|Overall Study||81
185667|NCT00621855|454628|P2|NOT COMPLETED|Overall Study||61
185668|NCT00621855|454629|P1|NOT COMPLETED|Overall Study||76
185669|NCT00621855|454625|P5|COMPLETED|Overall Study|Completed means completed treatment|318
185670|NCT00621855|454626|P4|COMPLETED|Overall Study|Completed means completed treatment|284
185671|NCT00621855|454627|P3|COMPLETED|Overall Study|Completed means completed treatment|330
185672|NCT00621855|454628|P2|COMPLETED|Overall Study|Completed means completed treatment|310
185673|NCT00621855|454629|P1|COMPLETED|Overall Study|Completed means completed treatment|296
185674|NCT00621855|454625|P5|STARTED|Overall Study|Started means randomised to treatment|373
185675|NCT00621855|454626|P4|STARTED|Overall Study|Started means randomised to treatment|351
185676|NCT00621855|454627|P3|STARTED|Overall Study|Started means randomised to treatment|411
185677|NCT00621855|454628|P2|STARTED|Overall Study|Started means randomised to treatment|371
185678|NCT00621855|454629|P1|STARTED|Overall Study|Started means randomised to treatment|372
185679|NCT00621933|454671|P1|NOT COMPLETED|Overall Study||0
185680|NCT00621933|454671|P1|COMPLETED|Overall Study||399
185681|NCT00621933|454671|P1|STARTED|Overall Study||399
185682|NCT00621946|454680|P2|NOT COMPLETED|Overall Study||1
185683|NCT00621946|454681|P1|NOT COMPLETED|Overall Study||0
185684|NCT00621946|454680|P2|COMPLETED|Overall Study||12
185685|NCT00621946|454681|P1|COMPLETED|Overall Study||13
185686|NCT00621946|454680|P2|STARTED|Overall Study||13
185687|NCT00621946|454681|P1|STARTED|Overall Study||13
185688|NCT00621959|454699|P2|NOT COMPLETED|Overall Study||9
185689|NCT00621959|454700|P1|NOT COMPLETED|Overall Study||7
185690|NCT00621959|454699|P2|COMPLETED|Overall Study||292
185691|NCT00621959|454700|P1|COMPLETED|Overall Study||288
185692|NCT00621959|454699|P2|STARTED|Overall Study||301
185693|NCT00621959|454700|P1|STARTED|Overall Study|In all 791 subjects have been screened and 596 have been randomized|295
185694|NCT00621985|454708|P1|NOT COMPLETED|Dexamethasone Admission||1
185695|NCT00621985|454708|P1|COMPLETED|Dexamethasone Admission||4
185696|NCT00621985|454708|P1|STARTED|Dexamethasone Admission||5
185697|NCT00621985|454708|P1|NOT COMPLETED|Hydrocortisone Admission||0
185698|NCT00621985|454708|P1|COMPLETED|Hydrocortisone Admission||5
185699|NCT00621985|454708|P1|STARTED|Hydrocortisone Admission||5
185700|NCT00622167|454714|P1|NOT COMPLETED|Overall Study||20
185701|NCT00622167|454714|P1|COMPLETED|Overall Study||4
185702|NCT00622167|454714|P1|STARTED|Overall Study||24
185703|NCT00607789|454720|P2|NOT COMPLETED|Overall Study||6
185704|NCT00607789|454721|P1|NOT COMPLETED|Overall Study||7
185705|NCT00607789|454720|P2|COMPLETED|Overall Study||14
185706|NCT00607789|454721|P1|COMPLETED|Overall Study||13
185707|NCT00607789|454720|P2|STARTED|Overall Study||20
185708|NCT00607789|454721|P1|STARTED|Overall Study|20 participants were randomized in each group|20
185709|NCT00607815|454731|P2|NOT COMPLETED|Overall Study||11
185710|NCT00607815|454732|P1|NOT COMPLETED|Overall Study||23
185711|NCT00607815|454731|P2|COMPLETED|Overall Study||25
185712|NCT00607815|454732|P1|COMPLETED|Overall Study||20
185713|NCT00607815|454731|P2|STARTED|Overall Study||36
185714|NCT00607815|454732|P1|STARTED|Overall Study||43
185715|NCT00607867|454748|P2|NOT COMPLETED|Overall Study||0
185716|NCT00607867|454749|P1|NOT COMPLETED|Overall Study||0
185717|NCT00607867|454748|P2|COMPLETED|Overall Study||7
185718|NCT00607867|454749|P1|COMPLETED|Overall Study||7
185719|NCT00607867|454748|P2|STARTED|Overall Study||7
185720|NCT00607867|454749|P1|STARTED|Overall Study||7
185721|NCT00607880|454767|P2|NOT COMPLETED|Overall Study||0
185722|NCT00607880|454768|P1|NOT COMPLETED|Overall Study||1
185723|NCT00607880|454767|P2|COMPLETED|Overall Study||50
185724|NCT00607880|454768|P1|COMPLETED|Overall Study||49
185725|NCT00607880|454767|P2|STARTED|Overall Study||50
185726|NCT00607880|454768|P1|STARTED|Overall Study||50
185727|NCT00608426|454782|P2|NOT COMPLETED|Overall Study||905
185728|NCT00608426|454783|P1|NOT COMPLETED|Overall Study||836
185729|NCT00608426|454782|P2|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1614
185730|NCT00608426|454783|P1|COMPLETED|Overall Study|This is total # of completed surveys. Not completed primary outcome.|1768
185731|NCT00608426|454782|P2|STARTED|Overall Study||2519
185732|NCT00608426|454783|P1|STARTED|Overall Study||2604
185733|NCT00608465|454793|P1|NOT COMPLETED|Overall Study||0
185734|NCT00608465|454793|P1|COMPLETED|Overall Study||4
185735|NCT00608465|454793|P1|STARTED|Overall Study||4
185736|NCT00608491|454800|P2|NOT COMPLETED|Overall Study||22
185737|NCT00608491|454801|P1|NOT COMPLETED|Overall Study||21
185738|NCT00608491|454800|P2|COMPLETED|Overall Study||72
185739|NCT00608491|454801|P1|COMPLETED|Overall Study||73
185740|NCT00608491|454800|P2|STARTED|Overall Study||94
185741|NCT00608491|454801|P1|STARTED|Overall Study||94
185742|NCT00608517|454948|P3|NOT COMPLETED|Overall Study||0
185743|NCT00608517|454949|P2|NOT COMPLETED|Overall Study||0
185744|NCT00608517|454950|P1|NOT COMPLETED|Overall Study||1
185745|NCT00608517|454948|P3|COMPLETED|Overall Study||1
185746|NCT00608517|454949|P2|COMPLETED|Overall Study||3
185747|NCT00608517|454950|P1|COMPLETED|Overall Study||1
185748|NCT00608517|454948|P3|STARTED|Overall Study||1
185749|NCT00608517|454949|P2|STARTED|Overall Study||3
185750|NCT00608517|454950|P1|STARTED|Overall Study||2
185751|NCT00608530|454978|P2|NOT COMPLETED|Overall Study||5
185752|NCT00608530|454979|P1|NOT COMPLETED|Overall Study||11
185753|NCT00608530|454978|P2|COMPLETED|Overall Study||28
185754|NCT00608530|454979|P1|COMPLETED|Overall Study||22
185755|NCT00608530|454978|P2|Attended > 0 Treatment Sessions|Overall Study||31
185756|NCT00608530|454979|P1|Attended > 0 Treatment Sessions|Overall Study||28
185757|NCT00608530|454978|P2|STARTED|Overall Study|Randomized|33
185758|NCT00608530|454979|P1|STARTED|Overall Study|Randomized|33
185759|NCT00608543|454989|P1|NOT COMPLETED|Overall Study||4
185760|NCT00608543|454989|P1|COMPLETED|Overall Study||13
185761|NCT00608543|454989|P1|STARTED|Overall Study||17
185762|NCT00608569|455000|P2|NOT COMPLETED|Overall Study||9
185763|NCT00608569|455001|P1|NOT COMPLETED|Overall Study||10
185764|NCT00608569|455000|P2|COMPLETED|Overall Study||119
185765|NCT00608569|455001|P1|COMPLETED|Overall Study||119
185766|NCT00608569|455000|P2|STARTED|Overall Study||128
185767|NCT00608569|455001|P1|STARTED|Overall Study||129
185768|NCT00608582|455023|P2|NOT COMPLETED|Overall Study||4
185769|NCT00608582|455024|P1|NOT COMPLETED|Overall Study||4
185770|NCT00608582|455023|P2|COMPLETED|Overall Study||7
185771|NCT00608582|455024|P1|COMPLETED|Overall Study||10
185772|NCT00608582|455023|P2|STARTED|Overall Study||11
185773|NCT00608582|455024|P1|STARTED|Overall Study||14
185774|NCT00608634|455035|P3|NOT COMPLETED|Overall Study||1
185775|NCT00608634|455036|P2|NOT COMPLETED|Overall Study||1
185776|NCT00608634|455037|P1|NOT COMPLETED|Overall Study||2
185777|NCT00608634|455035|P3|COMPLETED|Overall Study||27
185778|NCT00608634|455036|P2|COMPLETED|Overall Study||26
185779|NCT00608634|455037|P1|COMPLETED|Overall Study||26
185780|NCT00608634|455035|P3|STARTED|Overall Study||28
185781|NCT00608634|455036|P2|STARTED|Overall Study||27
185782|NCT00608634|455037|P1|STARTED|Overall Study||28
185783|NCT00614198|455050|P2|NOT COMPLETED|Stage 2||12
185784|NCT00614198|455051|P1|NOT COMPLETED|Stage 2||8
185785|NCT00614198|455050|P2|COMPLETED|Stage 2||17
185786|NCT00614198|455051|P1|COMPLETED|Stage 2||18
185787|NCT00614198|455050|P2|STARTED|Stage 2|Reallocated to gluten- and casein-free dietary intervention|29
185788|NCT00614198|455051|P1|STARTED|Stage 2||26
185789|NCT00614198|455050|P2|NOT COMPLETED|Stage 1||5
185790|NCT00614198|455051|P1|NOT COMPLETED|Stage 1||12
185791|NCT00614198|455050|P2|COMPLETED|Stage 1||29
185792|NCT00614198|455051|P1|COMPLETED|Stage 1||26
185793|NCT00614198|455050|P2|STARTED|Stage 1||34
185794|NCT00614198|455051|P1|STARTED|Stage 1||38
185795|NCT00614315|455057|P1|NOT COMPLETED|Overall Study||0
185796|NCT00614315|455057|P1|COMPLETED|Overall Study||30
185797|NCT00614315|455057|P1|STARTED|Overall Study||30
185798|NCT00614380|455066|P4|NOT COMPLETED|Overall Study||2
185799|NCT00614380|455067|P3|NOT COMPLETED|Overall Study||1
185800|NCT00614380|455068|P2|NOT COMPLETED|Overall Study||8
185801|NCT00614380|455069|P1|NOT COMPLETED|Overall Study||35
185802|NCT00614380|455066|P4|COMPLETED|Overall Study||179
185803|NCT00614380|455067|P3|COMPLETED|Overall Study||24
185804|NCT00614380|455068|P2|COMPLETED|Overall Study||198
185805|NCT00614380|455069|P1|COMPLETED|Overall Study||529
185806|NCT00614380|455066|P4|STARTED|Overall Study||181
185807|NCT00614380|455067|P3|STARTED|Overall Study||25
185808|NCT00614380|455068|P2|STARTED|Overall Study||206
185809|NCT00614380|455069|P1|STARTED|Overall Study||564
185810|NCT00614393|455123|P5|NOT COMPLETED|Overall Study||180
185811|NCT00614393|455124|P4|NOT COMPLETED|Overall Study||180
185812|NCT00614393|455125|P3|NOT COMPLETED|Overall Study||10
185813|NCT00614393|455126|P2|NOT COMPLETED|Overall Study||8
185814|NCT00614393|455127|P1|NOT COMPLETED|Overall Study||180
185815|NCT00614393|455123|P5|COMPLETED|Overall Study||0
185816|NCT00614393|455124|P4|COMPLETED|Overall Study||0
185817|NCT00614393|455125|P3|COMPLETED|Overall Study||0
185818|NCT00614393|455126|P2|COMPLETED|Overall Study||0
185819|NCT00614393|455127|P1|COMPLETED|Overall Study||0
185820|NCT00614393|455123|P5|Treated|Overall Study||178
185821|NCT00614393|455124|P4|Treated|Overall Study||180
185822|NCT00614393|455125|P3|Treated|Overall Study||10
185823|NCT00614393|455126|P2|Treated|Overall Study||8
185824|NCT00614393|455127|P1|Treated|Overall Study||180
185825|NCT00614393|455123|P5|STARTED|Overall Study||180
185826|NCT00614393|455124|P4|STARTED|Overall Study||180
185827|NCT00614393|455125|P3|STARTED|Overall Study||10
185828|NCT00614393|455126|P2|STARTED|Overall Study||8
185829|NCT00614393|455127|P1|STARTED|Overall Study||180
185830|NCT00614406|455171|P2|NOT COMPLETED|Overall Study||0
185831|NCT00614406|455172|P1|NOT COMPLETED|Overall Study||0
185832|NCT00614406|455171|P2|COMPLETED|Overall Study||4
185833|NCT00614406|455172|P1|COMPLETED|Overall Study||7
185834|NCT00614406|455171|P2|STARTED|Overall Study||4
185835|NCT00614406|455172|P1|STARTED|Overall Study||7
185836|NCT00614445|455180|P2|NOT COMPLETED|Overall Study||49
185837|NCT00614445|455181|P1|NOT COMPLETED|Overall Study||28
185838|NCT00614445|455180|P2|COMPLETED|Overall Study||91
185839|NCT00614445|455181|P1|COMPLETED|Overall Study||112
185840|NCT00614445|455180|P2|STARTED|Overall Study||140
185841|NCT00614445|455181|P1|STARTED|Overall Study||140
185842|NCT00614458|455187|P1|NOT COMPLETED|Overall Study||0
185843|NCT00614458|455187|P1|COMPLETED|Overall Study||6
185844|NCT00614458|455187|P1|STARTED|Overall Study||6
185845|NCT00614484|455191|P1|NOT COMPLETED|Overall Study||0
185846|NCT00614484|455191|P1|COMPLETED|Overall Study||28
185847|NCT00614484|455191|P1|STARTED|Overall Study||28
185848|NCT00614523|455198|P2|NOT COMPLETED|Overall Study||131
185849|NCT00614523|455199|P1|NOT COMPLETED|Overall Study||63
185850|NCT00614523|455198|P2|COMPLETED|Overall Study||36
185851|NCT00614523|455199|P1|COMPLETED|Overall Study||20
185852|NCT00614523|455198|P2|STARTED|Overall Study||167
185853|NCT00614523|455199|P1|STARTED|Overall Study||83
185854|NCT00614575|455223|P1|NOT COMPLETED|Overall Study||228
185855|NCT00614575|455223|P1|COMPLETED|Overall Study||861
185856|NCT00614575|455223|P1|STARTED|Overall Study|The number of patients enrolled.|1089
185857|NCT00614614|455234|P5|NOT COMPLETED|Booster Vaccination Phase||13
185858|NCT00614614|455235|P4|NOT COMPLETED|Booster Vaccination Phase||19
185859|NCT00614614|455236|P3|NOT COMPLETED|Booster Vaccination Phase||27
185860|NCT00614614|455237|P2|NOT COMPLETED|Booster Vaccination Phase||6
185861|NCT00614614|455238|P1|NOT COMPLETED|Booster Vaccination Phase||0
185862|NCT00614614|455234|P5|COMPLETED|Booster Vaccination Phase||396
185863|NCT00614614|455235|P4|COMPLETED|Booster Vaccination Phase||210
185864|NCT00614614|455236|P3|COMPLETED|Booster Vaccination Phase||405
185865|NCT00614614|455237|P2|COMPLETED|Booster Vaccination Phase||227
185866|NCT00614614|455238|P1|COMPLETED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
185867|NCT00614614|455234|P5|STARTED|Booster Vaccination Phase||409
185868|NCT00614614|455235|P4|STARTED|Booster Vaccination Phase||229
185869|NCT00614614|455236|P3|STARTED|Booster Vaccination Phase||432
185870|NCT00614614|455237|P2|STARTED|Booster Vaccination Phase||233
185871|NCT00614614|455238|P1|STARTED|Booster Vaccination Phase|Menhibrix 1 Group was re-randomized to Nimenrix 1,Menhibrix 2 and Nimenrix 2 Groups in booster phase|0
185872|NCT00614614|455234|P5|NOT COMPLETED|Primary Vaccination Phase||0
185873|NCT00614614|455235|P4|NOT COMPLETED|Primary Vaccination Phase||0
185874|NCT00614614|455236|P3|NOT COMPLETED|Primary Vaccination Phase||0
185875|NCT00614614|455237|P2|NOT COMPLETED|Primary Vaccination Phase||17
185876|NCT00614614|455238|P1|NOT COMPLETED|Primary Vaccination Phase||90
185877|NCT00614614|455234|P5|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
185878|NCT00614614|455235|P4|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
185879|NCT00614614|455236|P3|COMPLETED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
185880|NCT00614614|455237|P2|COMPLETED|Primary Vaccination Phase||265
185881|NCT00614614|455238|P1|COMPLETED|Primary Vaccination Phase||1182
185882|NCT00614614|455234|P5|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
185883|NCT00614614|455235|P4|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
185884|NCT00614614|455236|P3|STARTED|Primary Vaccination Phase|Primary vaccination phase involved subjects from MenHibrix 1 Group and ActHIB- Infanrix Group only.|0
185885|NCT00614614|455237|P2|STARTED|Primary Vaccination Phase||282
185886|NCT00614614|455238|P1|STARTED|Primary Vaccination Phase||1272
185887|NCT00614744|455363|P2|NOT COMPLETED|Overall Study||6
185888|NCT00614744|455364|P1|NOT COMPLETED|Overall Study||5
185889|NCT00614744|455363|P2|COMPLETED|Overall Study||79
185890|NCT00614744|455364|P1|COMPLETED|Overall Study||78
185891|NCT00614744|455363|P2|STARTED|Overall Study||85
185892|NCT00614744|455364|P1|STARTED|Overall Study||83
185893|NCT00614874|455388|P1|NOT COMPLETED|Overall Study||2
185894|NCT00614874|455388|P1|COMPLETED|Overall Study||14
185895|NCT00614874|455388|P1|STARTED|Overall Study||16
185896|NCT00614913|455395|P1|NOT COMPLETED|Overall Study||0
185897|NCT00614913|455395|P1|COMPLETED|Overall Study||76
185898|NCT00614913|455395|P1|STARTED|Overall Study||76
185899|NCT00614926|455402|P2|NOT COMPLETED|Overall Study||0
185900|NCT00614926|455403|P1|NOT COMPLETED|Overall Study||4
185901|NCT00614926|455402|P2|COMPLETED|Overall Study||7
185902|NCT00614926|455403|P1|COMPLETED|Overall Study||21
185903|NCT00614926|455402|P2|STARTED|Overall Study||7
185904|NCT00614926|455403|P1|STARTED|Overall Study||25
185905|NCT00614939|455413|P2|NOT COMPLETED|Overall Study||43
185906|NCT00614939|455414|P1|NOT COMPLETED|Overall Study||35
185907|NCT00614939|455413|P2|COMPLETED|Overall Study|Completed 52 weeks of treatment|42
185908|NCT00614939|455414|P1|COMPLETED|Overall Study|Completed 52 weeks of treatment|50
185909|NCT00614939|455413|P2|STARTED|Overall Study|Randomized and treated|85
185910|NCT00614939|455414|P1|STARTED|Overall Study|Randomized and treated|85
185911|NCT00614991|455452|P6|NOT COMPLETED|Overall Study||0
185912|NCT00614991|455453|P5|NOT COMPLETED|Overall Study||1
185913|NCT00614991|455454|P4|NOT COMPLETED|Overall Study||0
185914|NCT00614991|455455|P3|NOT COMPLETED|Overall Study||0
185915|NCT00614991|455456|P2|NOT COMPLETED|Overall Study||3
185916|NCT00614991|455457|P1|NOT COMPLETED|Overall Study||3
185917|NCT00614991|455452|P6|COMPLETED|Overall Study||6
185918|NCT00614991|455453|P5|COMPLETED|Overall Study||6
185919|NCT00614991|455454|P4|COMPLETED|Overall Study||7
185920|NCT00614991|455455|P3|COMPLETED|Overall Study||7
185921|NCT00614991|455456|P2|COMPLETED|Overall Study||6
185922|NCT00614991|455457|P1|COMPLETED|Overall Study||5
185923|NCT00614991|455452|P6|STARTED|Overall Study||6
185924|NCT00614991|455453|P5|STARTED|Overall Study||7
185925|NCT00614991|455454|P4|STARTED|Overall Study||7
185926|NCT00614991|455455|P3|STARTED|Overall Study||7
185927|NCT00614991|455456|P2|STARTED|Overall Study||9
185928|NCT00614991|455457|P1|STARTED|Overall Study||8
185929|NCT00615017|455495|P6|NOT COMPLETED|Overall Study||3
185930|NCT00615017|455496|P5|NOT COMPLETED|Overall Study||1
185931|NCT00615017|455497|P4|NOT COMPLETED|Overall Study||1
185932|NCT00615017|455498|P3|NOT COMPLETED|Overall Study||5
185933|NCT00615017|455499|P2|NOT COMPLETED|Overall Study||1
185934|NCT00615017|455500|P1|NOT COMPLETED|Overall Study||0
185935|NCT00615017|455495|P6|COMPLETED|Overall Study|Patient completed the study drug|20
185936|NCT00615017|455496|P5|COMPLETED|Overall Study|Patient completed the study drug|7
185937|NCT00615017|455497|P4|COMPLETED|Overall Study|Patient completed the study drug|9
185938|NCT00615017|455498|P3|COMPLETED|Overall Study|Patient completed the study drug|7
185939|NCT00615017|455499|P2|COMPLETED|Overall Study|Patient completed the study drug|8
185940|NCT00615017|455500|P1|COMPLETED|Overall Study|Patient completed the study drug|8
185941|NCT00615017|455495|P6|STARTED|Overall Study|Patients received treatment|23
185942|NCT00615017|455496|P5|STARTED|Overall Study|Patients received treatment|8
185943|NCT00615017|455497|P4|STARTED|Overall Study|Patients received treatment|10
185944|NCT00615017|455498|P3|STARTED|Overall Study|Patients received treatment|12
185945|NCT00615017|455499|P2|STARTED|Overall Study|Patients received treatment|9
185946|NCT00615017|455500|P1|STARTED|Overall Study|Patients received treatment|8
185947|NCT00615030|455652|P12|NOT COMPLETED|Period III||0
185948|NCT00615030|455653|P11|NOT COMPLETED|Period III||0
185949|NCT00615030|455654|P10|NOT COMPLETED|Period III||0
185950|NCT00615030|455655|P9|NOT COMPLETED|Period III||0
185951|NCT00615030|455656|P8|NOT COMPLETED|Period III||0
185952|NCT00615030|455657|P7|NOT COMPLETED|Period III||0
185953|NCT00615030|455658|P6|NOT COMPLETED|Period III||0
185954|NCT00615030|455659|P5|NOT COMPLETED|Period III||0
185955|NCT00615030|455660|P4|NOT COMPLETED|Period III||1
185956|NCT00615030|455661|P3|NOT COMPLETED|Period III||0
185957|NCT00615030|455662|P2|NOT COMPLETED|Period III||0
185958|NCT00615030|455663|P1|NOT COMPLETED|Period III||1
185959|NCT00615030|455652|P12|COMPLETED|Period III||6
185960|NCT00615030|455653|P11|COMPLETED|Period III||7
185961|NCT00615030|455654|P10|COMPLETED|Period III||8
185962|NCT00615030|455655|P9|COMPLETED|Period III||7
185963|NCT00615030|455656|P8|COMPLETED|Period III||7
185964|NCT00615030|455657|P7|COMPLETED|Period III||6
185965|NCT00615030|455658|P6|COMPLETED|Period III||5
185966|NCT00615030|455659|P5|COMPLETED|Period III||8
185967|NCT00615030|455660|P4|COMPLETED|Period III||6
185968|NCT00615030|455661|P3|COMPLETED|Period III||8
185969|NCT00615030|455662|P2|COMPLETED|Period III||8
185970|NCT00615030|455663|P1|COMPLETED|Period III||7
185971|NCT00615030|455652|P12|STARTED|Period III||6
185972|NCT00615030|455653|P11|STARTED|Period III||7
185973|NCT00615030|455654|P10|STARTED|Period III||8
185974|NCT00615030|455655|P9|STARTED|Period III||7
185975|NCT00615030|455656|P8|STARTED|Period III||7
185976|NCT00615030|455657|P7|STARTED|Period III||6
185977|NCT00615030|455658|P6|STARTED|Period III||5
185978|NCT00615030|455659|P5|STARTED|Period III||8
185979|NCT00615030|455660|P4|STARTED|Period III||7
185980|NCT00615030|455661|P3|STARTED|Period III||8
185981|NCT00615030|455662|P2|STARTED|Period III||8
185982|NCT00615030|455663|P1|STARTED|Period III||8
185983|NCT00615030|455652|P12|NOT COMPLETED|Period II||0
185984|NCT00615030|455653|P11|NOT COMPLETED|Period II||0
185985|NCT00615030|455654|P10|NOT COMPLETED|Period II||0
185986|NCT00615030|455655|P9|NOT COMPLETED|Period II||1
185987|NCT00615030|455656|P8|NOT COMPLETED|Period II||0
185988|NCT00615030|455657|P7|NOT COMPLETED|Period II||1
185989|NCT00615030|455658|P6|NOT COMPLETED|Period II||0
185990|NCT00615030|455659|P5|NOT COMPLETED|Period II||0
185991|NCT00615030|455660|P4|NOT COMPLETED|Period II||1
185992|NCT00615030|455661|P3|NOT COMPLETED|Period II||1
185993|NCT00615030|455662|P2|NOT COMPLETED|Period II||0
185994|NCT00615030|455663|P1|NOT COMPLETED|Period II||0
185995|NCT00615030|455652|P12|COMPLETED|Period II||6
185996|NCT00615030|455653|P11|COMPLETED|Period II||7
185997|NCT00615030|455654|P10|COMPLETED|Period II||8
185998|NCT00615030|455655|P9|COMPLETED|Period II||7
185999|NCT00615030|455656|P8|COMPLETED|Period II||7
186000|NCT00615030|455657|P7|COMPLETED|Period II||6
186001|NCT00615030|455658|P6|COMPLETED|Period II||5
186002|NCT00615030|455659|P5|COMPLETED|Period II||8
186003|NCT00615030|455660|P4|COMPLETED|Period II||7
186004|NCT00615030|455661|P3|COMPLETED|Period II||8
186005|NCT00615030|455662|P2|COMPLETED|Period II||8
186006|NCT00615030|455663|P1|COMPLETED|Period II||8
186007|NCT00615030|455652|P12|STARTED|Period II||6
186008|NCT00615030|455653|P11|STARTED|Period II||7
186009|NCT00615030|455654|P10|STARTED|Period II||8
186010|NCT00615030|455655|P9|STARTED|Period II||8
186011|NCT00615030|455656|P8|STARTED|Period II||7
186012|NCT00615030|455657|P7|STARTED|Period II||7
186013|NCT00615030|455658|P6|STARTED|Period II||5
186014|NCT00615030|455659|P5|STARTED|Period II||8
186015|NCT00615030|455660|P4|STARTED|Period II||8
186016|NCT00615030|455661|P3|STARTED|Period II||9
186017|NCT00615030|455662|P2|STARTED|Period II||8
186018|NCT00615030|455663|P1|STARTED|Period II||8
186019|NCT00615030|455652|P12|NOT COMPLETED|Period I||1
186020|NCT00615030|455653|P11|NOT COMPLETED|Period I||1
186021|NCT00615030|455654|P10|NOT COMPLETED|Period I||0
186022|NCT00615030|455655|P9|NOT COMPLETED|Period I||1
186023|NCT00615030|455656|P8|NOT COMPLETED|Period I||0
186024|NCT00615030|455657|P7|NOT COMPLETED|Period I||0
186025|NCT00615030|455658|P6|NOT COMPLETED|Period I||1
186026|NCT00615030|455659|P5|NOT COMPLETED|Period I||1
186027|NCT00615030|455660|P4|NOT COMPLETED|Period I||0
186028|NCT00615030|455661|P3|NOT COMPLETED|Period I||0
186029|NCT00615030|455662|P2|NOT COMPLETED|Period I||0
186030|NCT00615030|455663|P1|NOT COMPLETED|Period I||1
186031|NCT00615030|455652|P12|COMPLETED|Period I||6
186032|NCT00615030|455653|P11|COMPLETED|Period I||7
186033|NCT00615030|455654|P10|COMPLETED|Period I||8
186034|NCT00615030|455655|P9|COMPLETED|Period I||8
186035|NCT00615030|455656|P8|COMPLETED|Period I||7
186036|NCT00615030|455657|P7|COMPLETED|Period I||7
186037|NCT00615030|455658|P6|COMPLETED|Period I||5
186038|NCT00615030|455659|P5|COMPLETED|Period I||8
186039|NCT00615030|455660|P4|COMPLETED|Period I||8
186040|NCT00615030|455661|P3|COMPLETED|Period I||9
186041|NCT00615030|455662|P2|COMPLETED|Period I||8
186042|NCT00615030|455663|P1|COMPLETED|Period I||8
186043|NCT00615030|455652|P12|STARTED|Period I||7
186044|NCT00615030|455653|P11|STARTED|Period I||8
186045|NCT00615030|455654|P10|STARTED|Period I||8
186046|NCT00615030|455655|P9|STARTED|Period I||9
186047|NCT00615030|455656|P8|STARTED|Period I||7
186048|NCT00615030|455657|P7|STARTED|Period I||7
186049|NCT00615030|455658|P6|STARTED|Period I|1 randomized patient in this sequence dropped out before exposure to study drug in Period I.|6
186050|NCT00615030|455659|P5|STARTED|Period I||9
186051|NCT00615030|455660|P4|STARTED|Period I||8
186052|NCT00615030|455661|P3|STARTED|Period I||9
186053|NCT00615030|455662|P2|STARTED|Period I||8
186054|NCT00615030|455663|P1|STARTED|Period I||9
186055|NCT00615056|455681|P4|NOT COMPLETED|Overall Study||35
186056|NCT00615056|455682|P3|NOT COMPLETED|Overall Study||36
186057|NCT00615056|455683|P2|NOT COMPLETED|Overall Study||51
186058|NCT00615056|455684|P1|NOT COMPLETED|Overall Study||49
186059|NCT00615056|455681|P4|COMPLETED|Overall Study||0
186060|NCT00615056|455682|P3|COMPLETED|Overall Study||0
186061|NCT00615056|455683|P2|COMPLETED|Overall Study||0
186062|NCT00615056|455684|P1|COMPLETED|Overall Study||0
186063|NCT00615056|455681|P4|Treated|Overall Study||35
186064|NCT00615056|455682|P3|Treated|Overall Study||36
186065|NCT00615056|455683|P2|Treated|Overall Study||51
186066|NCT00615056|455684|P1|Treated|Overall Study||46
186067|NCT00615056|455681|P4|STARTED|Overall Study||35
186068|NCT00615056|455682|P3|STARTED|Overall Study||36
186069|NCT00615056|455683|P2|STARTED|Overall Study||51
186070|NCT00615056|455684|P1|STARTED|Overall Study||49
186071|NCT00615069|455714|P1|NOT COMPLETED|Overall Study||16
186072|NCT00615069|455714|P1|COMPLETED|Overall Study||19
186073|NCT00615069|455714|P1|STARTED|Overall Study||35
186074|NCT00615108|455719|P1|NOT COMPLETED|Overall Study||507
186075|NCT00615108|455719|P1|COMPLETED|Overall Study||2641
186076|NCT00615108|455719|P1|STARTED|Overall Study||3148
186077|NCT00615199|455738|P4|NOT COMPLETED|Overall Study||2
186078|NCT00615199|455739|P3|NOT COMPLETED|Overall Study||1
186079|NCT00615199|455740|P2|NOT COMPLETED|Overall Study||2
186080|NCT00615199|455741|P1|NOT COMPLETED|Overall Study||8
186081|NCT00615199|455738|P4|COMPLETED|Overall Study||33
186082|NCT00615199|455739|P3|COMPLETED|Overall Study||33
186083|NCT00615199|455740|P2|COMPLETED|Overall Study||34
186084|NCT00615199|455741|P1|COMPLETED|Overall Study||26
186085|NCT00615199|455738|P4|STARTED|Overall Study||35
186086|NCT00615199|455739|P3|STARTED|Overall Study||34
186087|NCT00615199|455740|P2|STARTED|Overall Study||36
186088|NCT00615199|455741|P1|STARTED|Overall Study||34
186089|NCT00615264|455777|P2|NOT COMPLETED|Overall Study||52
186090|NCT00615264|455778|P1|NOT COMPLETED|Overall Study||50
186091|NCT00615264|455777|P2|COMPLETED|Overall Study||180
186092|NCT00615264|455778|P1|COMPLETED|Overall Study||175
186093|NCT00615264|455777|P2|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||213
186094|NCT00615264|455778|P1|ITT Patients Who Met Inc/Excl (MITT)|Overall Study||209
186095|NCT00615264|455777|P2|Received at Least One Dose (ITT)|Overall Study||231
186096|NCT00615264|455778|P1|Received at Least One Dose (ITT)|Overall Study||225
186097|NCT00615264|455777|P2|STARTED|Overall Study||232
186098|NCT00615264|455778|P1|STARTED|Overall Study||225
186099|NCT00615290|455786|P1|NOT COMPLETED|Overall Study||8
186100|NCT00615290|455786|P1|COMPLETED|Overall Study||34
186101|NCT00615290|455786|P1|STARTED|Overall Study||42
186102|NCT00615433|455802|P4|NOT COMPLETED|Overall Study||45
186103|NCT00615433|455803|P3|NOT COMPLETED|Overall Study||39
186104|NCT00615433|455804|P2|NOT COMPLETED|Overall Study||53
186105|NCT00615433|455805|P1|NOT COMPLETED|Overall Study||43
186106|NCT00615433|455802|P4|COMPLETED|Overall Study||71
186107|NCT00615433|455803|P3|COMPLETED|Overall Study||84
186108|NCT00615433|455804|P2|COMPLETED|Overall Study||66
186109|NCT00615433|455805|P1|COMPLETED|Overall Study||77
186110|NCT00615433|455802|P4|STARTED|Overall Study||116
186111|NCT00615433|455803|P3|STARTED|Overall Study||123
186112|NCT00615433|455804|P2|STARTED|Overall Study||119
186113|NCT00615433|455805|P1|STARTED|Overall Study||120
186114|NCT00615459|455819|P4|NOT COMPLETED|Period III||0
186115|NCT00615459|455820|P3|NOT COMPLETED|Period III||1
186116|NCT00615459|455821|P2|NOT COMPLETED|Period III||3
186117|NCT00615459|455822|P1|NOT COMPLETED|Period III||0
186118|NCT00615459|455819|P4|COMPLETED|Period III||41
186119|NCT00615459|455820|P3|COMPLETED|Period III||39
186120|NCT00615459|455821|P2|COMPLETED|Period III||37
186121|NCT00615459|455822|P1|COMPLETED|Period III||36
186122|NCT00615459|455819|P4|STARTED|Period III||41
186123|NCT00615459|455820|P3|STARTED|Period III||40
186124|NCT00615459|455821|P2|STARTED|Period III||40
186125|NCT00615459|455822|P1|STARTED|Period III||36
186126|NCT00615459|455819|P4|NOT COMPLETED|Period II||1
186127|NCT00615459|455820|P3|NOT COMPLETED|Period II||0
186128|NCT00615459|455821|P2|NOT COMPLETED|Period II||0
186129|NCT00615459|455822|P1|NOT COMPLETED|Period II||1
186130|NCT00615459|455819|P4|COMPLETED|Period II||41
186131|NCT00615459|455820|P3|COMPLETED|Period II||40
186132|NCT00615459|455821|P2|COMPLETED|Period II||40
186133|NCT00615459|455822|P1|COMPLETED|Period II||36
186134|NCT00615459|455819|P4|STARTED|Period II||42
186135|NCT00615459|455820|P3|STARTED|Period II||40
186136|NCT00615459|455821|P2|STARTED|Period II||40
186137|NCT00615459|455822|P1|STARTED|Period II||37
186138|NCT00615459|455819|P4|NOT COMPLETED|Period I||1
186139|NCT00615459|455820|P3|NOT COMPLETED|Period I||2
186140|NCT00615459|455821|P2|NOT COMPLETED|Period I||1
186141|NCT00615459|455822|P1|NOT COMPLETED|Period I||4
186142|NCT00615459|455819|P4|COMPLETED|Period I||42
186143|NCT00615459|455820|P3|COMPLETED|Period I||40
186144|NCT00615459|455821|P2|COMPLETED|Period I||40
186145|NCT00615459|455822|P1|COMPLETED|Period I||37
186146|NCT00615459|455819|P4|STARTED|Period I||43
186147|NCT00615459|455820|P3|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|42
186148|NCT00615459|455821|P2|STARTED|Period I|1 randomized patient of this sequence was never exposed to drug. Hence, dropped out before Period I.|41
186149|NCT00615459|455822|P1|STARTED|Period I||41
186150|NCT00615472|455838|P2|NOT COMPLETED|Overall Study||0
186151|NCT00615472|455839|P1|NOT COMPLETED|Overall Study||0
186152|NCT00615472|455838|P2|COMPLETED|Overall Study||28
186153|NCT00615472|455839|P1|COMPLETED|Overall Study||30
186154|NCT00615472|455838|P2|STARTED|Overall Study||28
186155|NCT00615472|455839|P1|STARTED|Overall Study||30
186156|NCT00615550|455847|P2|NOT COMPLETED|Overall Study||1
186157|NCT00615550|455848|P1|NOT COMPLETED|Overall Study||6
186158|NCT00615550|455847|P2|COMPLETED|Overall Study||235
186159|NCT00615550|455848|P1|COMPLETED|Overall Study||223
186160|NCT00615550|455847|P2|STARTED|Overall Study||236
186161|NCT00615550|455848|P1|STARTED|Overall Study||229
186162|NCT00615589|455862|P1|NOT COMPLETED|Overall Study||0
186163|NCT00615589|455862|P1|COMPLETED|Overall Study||22
186164|NCT00615589|455862|P1|STARTED|Overall Study||22
186165|NCT00615719|455870|P1|NOT COMPLETED|Overall Study||5
186166|NCT00615719|455870|P1|COMPLETED|Overall Study||30
186167|NCT00615719|455870|P1|STARTED|Overall Study||35
186168|NCT00615836|455878|P5|NOT COMPLETED|Extension Study (FE992026 CS31)||0
186169|NCT00615836|455879|P4|NOT COMPLETED|Extension Study (FE992026 CS31)||84
186170|NCT00615836|455880|P3|NOT COMPLETED|Extension Study (FE992026 CS31)||73
186171|NCT00615836|455881|P2|NOT COMPLETED|Extension Study (FE992026 CS31)||86
186172|NCT00615836|455882|P1|NOT COMPLETED|Extension Study (FE992026 CS31)||141
186173|NCT00615836|455878|P5|COMPLETED|Extension Study (FE992026 CS31)||0
186174|NCT00615836|455879|P4|COMPLETED|Extension Study (FE992026 CS31)||53
186175|NCT00615836|455880|P3|COMPLETED|Extension Study (FE992026 CS31)||59
186176|NCT00615836|455881|P2|COMPLETED|Extension Study (FE992026 CS31)||58
186177|NCT00615836|455882|P1|COMPLETED|Extension Study (FE992026 CS31)||0
186178|NCT00615836|455878|P5|STARTED|Extension Study (FE992026 CS31)||0
186179|NCT00615836|455879|P4|STARTED|Extension Study (FE992026 CS31)||137
186180|NCT00615836|455880|P3|STARTED|Extension Study (FE992026 CS31)||132
186181|NCT00615836|455881|P2|STARTED|Extension Study (FE992026 CS31)||144
186182|NCT00615836|455882|P1|STARTED|Extension Study (FE992026 CS31)||141
186183|NCT00615836|455878|P5|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||15
186184|NCT00615836|455879|P4|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||25
186185|NCT00615836|455880|P3|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||20
186186|NCT00615836|455881|P2|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||10
186187|NCT00615836|455882|P1|NOT COMPLETED|Part I of Core Study (FE992026 CS29)||19
186188|NCT00615836|455878|P5|COMPLETED|Part I of Core Study (FE992026 CS29)||145
186189|NCT00615836|455879|P4|COMPLETED|Part I of Core Study (FE992026 CS29)||135
186190|NCT00615836|455880|P3|COMPLETED|Part I of Core Study (FE992026 CS29)||138
186191|NCT00615836|455881|P2|COMPLETED|Part I of Core Study (FE992026 CS29)||148
186192|NCT00615836|455882|P1|COMPLETED|Part I of Core Study (FE992026 CS29)||144
186193|NCT00615836|455878|P5|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|156
186194|NCT00615836|455879|P4|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|146
186276|NCT00622440|456126|P2|NOT COMPLETED|Week 12 - Week 48 (Treatment)||6
186195|NCT00615836|455880|P3|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|148
186196|NCT00615836|455881|P2|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|152
186197|NCT00615836|455882|P1|Intent-to-treat Population|Part I of Core Study (FE992026 CS29)|Received at least 1 dose of study drug and provided at least 1 primary efficacy measure.|155
186198|NCT00615836|455878|P5|STARTED|Part I of Core Study (FE992026 CS29)||160
186199|NCT00615836|455879|P4|STARTED|Part I of Core Study (FE992026 CS29)||160
186200|NCT00615836|455880|P3|STARTED|Part I of Core Study (FE992026 CS29)||158
186201|NCT00615836|455881|P2|STARTED|Part I of Core Study (FE992026 CS29)||158
186202|NCT00615836|455882|P1|STARTED|Part I of Core Study (FE992026 CS29)||163
186203|NCT00615901|455942|P1|NOT COMPLETED|Overall Study||9
186204|NCT00615901|455942|P1|COMPLETED|Overall Study||29
186205|NCT00615901|455942|P1|STARTED|Overall Study||38
186206|NCT00615914|455946|P1|NOT COMPLETED|Overall Study||637
186207|NCT00615914|455946|P1|COMPLETED|Overall Study||1008
186208|NCT00615914|455946|P1|STARTED|Overall Study|The number of patients enrolled|1645
186209|NCT00615927|455955|P2|NOT COMPLETED|Overall Study||0
186210|NCT00615927|455956|P1|NOT COMPLETED|Overall Study||0
186211|NCT00615927|455955|P2|COMPLETED|Overall Study||32
186212|NCT00615927|455956|P1|COMPLETED|Overall Study||32
186213|NCT00615927|455955|P2|STARTED|Overall Study||32
186214|NCT00615927|455956|P1|STARTED|Overall Study||32
186215|NCT00615992|455970|P1|NOT COMPLETED|Overall Study||67
186216|NCT00615992|455970|P1|COMPLETED|Overall Study||687
186217|NCT00615992|455970|P1|STARTED|Overall Study||754
186218|NCT00616018|455979|P1|NOT COMPLETED|Overall Study||3
186219|NCT00616018|455979|P1|COMPLETED|Overall Study||24
186220|NCT00616018|455979|P1|STARTED|Overall Study||27
186221|NCT00616109|455984|P1|NOT COMPLETED|Overall Study||0
186222|NCT00616109|455984|P1|COMPLETED|Overall Study||16
186223|NCT00616109|455984|P1|STARTED|Overall Study||16
186224|NCT00616122|455991|P1|NOT COMPLETED|Overall Study||7
186225|NCT00616122|455991|P1|COMPLETED|Overall Study||25
186226|NCT00616122|455991|P1|STARTED|Overall Study||32
186227|NCT00616200|455998|P1|NOT COMPLETED|Four Week Very Low Carbohydrate Diet||3
186228|NCT00616200|455998|P1|COMPLETED|Four Week Very Low Carbohydrate Diet||13
186229|NCT00616200|455998|P1|STARTED|Four Week Very Low Carbohydrate Diet||16
186230|NCT00616200|455998|P1|NOT COMPLETED|Two Week Standard Diet||1
186231|NCT00616200|455998|P1|COMPLETED|Two Week Standard Diet||16
186232|NCT00616200|455998|P1|STARTED|Two Week Standard Diet||17
186233|NCT00616239|456004|P1|NOT COMPLETED|Overall Study||2
186234|NCT00616239|456004|P1|COMPLETED|Overall Study||18
186235|NCT00616239|456004|P1|STARTED|Overall Study||20
186236|NCT00616343|456008|P1|NOT COMPLETED|Overall Study||0
186237|NCT00616343|456008|P1|COMPLETED|Overall Study||9
186238|NCT00616343|456008|P1|STARTED|Overall Study||9
186239|NCT00622284|456014|P2|NOT COMPLETED|Overall Study||171
186240|NCT00622284|456015|P1|NOT COMPLETED|Overall Study||189
186241|NCT00622284|456014|P2|COMPLETED|Overall Study|Number who completed treatment.|604
186242|NCT00622284|456015|P1|COMPLETED|Overall Study|Number who completed treatment.|587
186243|NCT00622284|456014|P2|STARTED|Overall Study|Number who started treatment.|775
186244|NCT00622284|456015|P1|STARTED|Overall Study|Number who started treatment. One patient in the Linagliptin group was randomized but not treated.|776
186245|NCT00622336|456077|P1|NOT COMPLETED|Extension Phase||21
186246|NCT00622336|456077|P1|COMPLETED|Extension Phase||0
186247|NCT00622336|456077|P1|STARTED|Extension Phase||21
186248|NCT00622336|456077|P1|NOT COMPLETED|Treatment Phase||309
186249|NCT00622336|456077|P1|COMPLETED|Treatment Phase|Completed = those who completed the treatment phase and were ongoing in the extension study|21
186250|NCT00622336|456077|P1|Safety Population|Treatment Phase||330
186251|NCT00622336|456077|P1|STARTED|Treatment Phase||330
186252|NCT00622388|456086|P1|NOT COMPLETED|Overall Study||72
186253|NCT00622388|456086|P1|COMPLETED|Overall Study||9
186254|NCT00622388|456086|P1|STARTED|Overall Study||81
186255|NCT00622401|456107|P3|NOT COMPLETED|Overall Study||0
186256|NCT00622401|456108|P2|NOT COMPLETED|Overall Study||2
186257|NCT00622401|456109|P1|NOT COMPLETED|Overall Study||3
186258|NCT00622401|456107|P3|COMPLETED|Overall Study||0
186259|NCT00622401|456108|P2|COMPLETED|Overall Study||0
186260|NCT00622401|456109|P1|COMPLETED|Overall Study||3
186261|NCT00622401|456107|P3|STARTED|Overall Study|Never Opened|0
186262|NCT00622401|456108|P2|STARTED|Overall Study||2
186263|NCT00622401|456109|P1|STARTED|Overall Study||6
186264|NCT00622427|456115|P2|NOT COMPLETED|Overall Study||0
186265|NCT00622427|456116|P1|NOT COMPLETED|Overall Study||0
186266|NCT00622427|456115|P2|COMPLETED|Overall Study|each subject received 2 weeks of placebo, then 2 weeks of Ramelteon after a two week wash out period|16
186267|NCT00622427|456116|P1|COMPLETED|Overall Study|each subject received 2 weeks of Ramelteon, then 2 weeks of placebo after a two week wash out period|16
186268|NCT00622427|456115|P2|STARTED|Overall Study||16
186269|NCT00622427|456116|P1|STARTED|Overall Study||16
186270|NCT00622440|456126|P2|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||1
186271|NCT00622440|456127|P1|NOT COMPLETED|Week 60 (Post-treatment Follow-up Visit)||0
186272|NCT00622440|456126|P2|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||27
186273|NCT00622440|456127|P1|COMPLETED|Week 60 (Post-treatment Follow-up Visit)||28
186274|NCT00622440|456126|P2|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
186275|NCT00622440|456127|P1|STARTED|Week 60 (Post-treatment Follow-up Visit)||28
186277|NCT00622440|456127|P1|NOT COMPLETED|Week 12 - Week 48 (Treatment)||3
186278|NCT00622440|456126|P2|COMPLETED|Week 12 - Week 48 (Treatment)||28
186279|NCT00622440|456127|P1|COMPLETED|Week 12 - Week 48 (Treatment)||28
186280|NCT00622440|456126|P2|STARTED|Week 12 - Week 48 (Treatment)||34
186281|NCT00622440|456127|P1|STARTED|Week 12 - Week 48 (Treatment)||31
186282|NCT00622440|456126|P2|NOT COMPLETED|Baseline - Week 12 (Treatment)||1
186283|NCT00622440|456127|P1|NOT COMPLETED|Baseline - Week 12 (Treatment)||4
186284|NCT00622440|456126|P2|COMPLETED|Baseline - Week 12 (Treatment)||34
186285|NCT00622440|456127|P1|COMPLETED|Baseline - Week 12 (Treatment)||31
186286|NCT00622440|456126|P2|STARTED|Baseline - Week 12 (Treatment)||35
186287|NCT00622440|456127|P1|STARTED|Baseline - Week 12 (Treatment)||35
186288|NCT00622518|456141|P2|NOT COMPLETED|Overall Study||0
186289|NCT00622518|456142|P1|NOT COMPLETED|Overall Study||0
186290|NCT00622518|456141|P2|COMPLETED|Overall Study||60
186291|NCT00622518|456142|P1|COMPLETED|Overall Study||59
186292|NCT00622518|456141|P2|STARTED|Overall Study||60
186293|NCT00622518|456142|P1|STARTED|Overall Study||59
186294|NCT00623428|456152|P2|NOT COMPLETED|Follow-up Period||15
186295|NCT00623428|456153|P1|NOT COMPLETED|Follow-up Period||29
186296|NCT00623428|456152|P2|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 24 weeks of follow-up|78
186297|NCT00623428|456153|P1|COMPLETED|Follow-up Period|Patients who had an HCV RNA sample at 48 weeks of follow-up|66
186298|NCT00623428|456152|P2|STARTED|Follow-up Period||93
186299|NCT00623428|456153|P1|STARTED|Follow-up Period||95
186300|NCT00623428|456152|P2|NOT COMPLETED|Treatment Period||27
186301|NCT00623428|456153|P1|NOT COMPLETED|Treatment Period||0
186302|NCT00623428|456152|P2|COMPLETED|Treatment Period|Patients who completed 48 weeks of treatment|66
186303|NCT00623428|456153|P1|COMPLETED|Treatment Period|Patients who completed 24 weeks of treatment|95
186304|NCT00623428|456152|P2|STARTED|Treatment Period||93
186305|NCT00623428|456153|P1|STARTED|Treatment Period||95
186306|NCT00623441|456171|P1|NOT COMPLETED|Overall Study||0
186307|NCT00623441|456171|P1|COMPLETED|Overall Study|12 months follow-up compliance was 94.2%|8314
186308|NCT00623441|456171|P1|STARTED|Overall Study||8314
186309|NCT00623467|456175|P1|NOT COMPLETED|Overall Study||7
186310|NCT00623467|456175|P1|COMPLETED|Overall Study||336
186311|NCT00623467|456175|P1|STARTED|Overall Study||343
186312|NCT00623480|456241|P2|NOT COMPLETED|Overall Study||7
186313|NCT00623480|456242|P1|NOT COMPLETED|Overall Study||7
186314|NCT00623480|456241|P2|COMPLETED|Overall Study||35
186315|NCT00623480|456242|P1|COMPLETED|Overall Study||35
186316|NCT00623480|456241|P2|STARTED|Overall Study||42
186317|NCT00623480|456242|P1|STARTED|Overall Study||42
186318|NCT00623506|456256|P2|NOT COMPLETED|Overall Study||4
186319|NCT00623506|456257|P1|NOT COMPLETED|Overall Study||4
186320|NCT00623506|456256|P2|COMPLETED|Overall Study||11
186321|NCT00623506|456257|P1|COMPLETED|Overall Study||11
186322|NCT00623506|456256|P2|Week 4|Overall Study||11
186323|NCT00623506|456257|P1|Week 4|Overall Study||11
186324|NCT00623506|456256|P2|STARTED|Overall Study||15
186325|NCT00623506|456257|P1|STARTED|Overall Study||15
186326|NCT00623545|456267|P1|NOT COMPLETED|Overall Study||10
186327|NCT00623545|456267|P1|COMPLETED|Overall Study||18
186328|NCT00623545|456267|P1|STARTED|Overall Study||28
186329|NCT00623597|456274|P2|NOT COMPLETED|Overall Study||0
186330|NCT00623597|456275|P1|NOT COMPLETED|Overall Study||1
186331|NCT00623597|456274|P2|COMPLETED|Overall Study||13
186332|NCT00623597|456275|P1|COMPLETED|Overall Study||4
186333|NCT00623597|456274|P2|STARTED|Overall Study||13
186334|NCT00623597|456275|P1|STARTED|Overall Study||5
186335|NCT00623636|456340|P2|NOT COMPLETED|Open Label||412
186336|NCT00623636|456341|P1|NOT COMPLETED|Open Label||0
186337|NCT00623636|456340|P2|COMPLETED|Open Label||263
186338|NCT00623636|456341|P1|COMPLETED|Open Label||0
186339|NCT00623636|456340|P2|STARTED|Open Label|Includes eligible Placebo and MAP0004 patients from the double-blind period.|675
186340|NCT00623636|456341|P1|STARTED|Open Label|Eligible double-blind placebo patients received MAP0004 in the open-label period.|0
186341|NCT00623636|456340|P2|NOT COMPLETED|Double Blind||28
186342|NCT00623636|456341|P1|NOT COMPLETED|Double Blind||33
186343|NCT00623636|456340|P2|COMPLETED|Double Blind||422
186344|NCT00623636|456341|P1|COMPLETED|Double Blind||419
186345|NCT00623636|456340|P2|STARTED|Double Blind||450
186346|NCT00623636|456341|P1|STARTED|Double Blind||452
186347|NCT00623714|456362|P2|NOT COMPLETED|Period 2||0
186348|NCT00623714|456363|P1|NOT COMPLETED|Period 2||0
186349|NCT00623714|456362|P2|COMPLETED|Period 2||7
186350|NCT00623714|456363|P1|COMPLETED|Period 2||6
186351|NCT00623714|456362|P2|STARTED|Period 2||7
186352|NCT00623714|456363|P1|STARTED|Period 2||6
186353|NCT00623714|456362|P2|NOT COMPLETED|Period 1||0
186354|NCT00623714|456363|P1|NOT COMPLETED|Period 1||0
186355|NCT00623714|456362|P2|COMPLETED|Period 1||7
186356|NCT00623714|456363|P1|COMPLETED|Period 1||6
186357|NCT00623714|456362|P2|STARTED|Period 1||7
186358|NCT00623714|456363|P1|STARTED|Period 1||6
186359|NCT00623727|456373|P2|NOT COMPLETED|Open Label Extension Period||0
186360|NCT00623727|456374|P1|NOT COMPLETED|Open Label Extension Period||0
186361|NCT00623727|456373|P2|COMPLETED|Open Label Extension Period||0
186362|NCT00623727|456374|P1|COMPLETED|Open Label Extension Period||20
186363|NCT00623727|456373|P2|STARTED|Open Label Extension Period||0
186364|NCT00623727|456374|P1|STARTED|Open Label Extension Period|10 participants of each group entered open-label extension period after completion of DB study|20
186365|NCT00623727|456373|P2|NOT COMPLETED|Open Label Follow-up||8
186366|NCT00623727|456374|P1|NOT COMPLETED|Open Label Follow-up||0
186367|NCT00623727|456373|P2|COMPLETED|Open Label Follow-up||18
186368|NCT00623727|456374|P1|COMPLETED|Open Label Follow-up||0
186369|NCT00623727|456373|P2|STARTED|Open Label Follow-up|13 Participants from each group after DB period terminated entered open label follow up.|26
186370|NCT00623727|456374|P1|STARTED|Open Label Follow-up||0
186371|NCT00623727|456373|P2|NOT COMPLETED|Double Blind (DB)||32
186372|NCT00623727|456374|P1|NOT COMPLETED|Double Blind (DB)||36
186373|NCT00623727|456373|P2|COMPLETED|Double Blind (DB)||41
186374|NCT00623727|456374|P1|COMPLETED|Double Blind (DB)||34
186375|NCT00623727|456373|P2|Participants Received Treatment|Double Blind (DB)||72
186376|NCT00623727|456374|P1|Participants Received Treatment|Double Blind (DB)||67
186377|NCT00623727|456373|P2|STARTED|Double Blind (DB)|only 72 participants are applicable for baseline characteristic evaluation|73
186378|NCT00623727|456374|P1|STARTED|Double Blind (DB)|only 67 participants are applicable for baseline characteristic evaluation|70
186379|NCT00623766|456396|P2|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||2
186380|NCT00623766|456397|P1|NOT COMPLETED|Maintenance Phase (Week 24 to Year 2)||10
186381|NCT00623766|456396|P2|COMPLETED|Maintenance Phase (Week 24 to Year 2)||0
186382|NCT00623766|456397|P1|COMPLETED|Maintenance Phase (Week 24 to Year 2)|Inadvertently not noted as discontinued (disease progression); data collection error at site closure|1
186383|NCT00623766|456396|P2|STARTED|Maintenance Phase (Week 24 to Year 2)||2
186384|NCT00623766|456397|P1|STARTED|Maintenance Phase (Week 24 to Year 2)||11
186385|NCT00623766|456396|P2|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||16
186386|NCT00623766|456397|P1|NOT COMPLETED|Induction Phase (Day 1 to Week 24)||36
186387|NCT00623766|456396|P2|COMPLETED|Induction Phase (Day 1 to Week 24)|3 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|5
186388|NCT00623766|456397|P1|COMPLETED|Induction Phase (Day 1 to Week 24)|4 patients completed Induction but did not enter Maintenance; they were only followed up with scans.|15
186389|NCT00623766|456396|P2|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|21
186390|NCT00623766|456397|P1|STARTED|Induction Phase (Day 1 to Week 24)|Participants who received treatment|51
186391|NCT00623779|456422|P3|NOT COMPLETED|Overall Study||1
186392|NCT00623779|456423|P2|NOT COMPLETED|Overall Study||3
186393|NCT00623779|456424|P1|NOT COMPLETED|Overall Study||3
186394|NCT00623779|456422|P3|COMPLETED|Overall Study||44
186395|NCT00623779|456423|P2|COMPLETED|Overall Study||39
186396|NCT00623779|456424|P1|COMPLETED|Overall Study||38
186397|NCT00623779|456422|P3|STARTED|Overall Study||45
186398|NCT00623779|456423|P2|STARTED|Overall Study||42
186399|NCT00623779|456424|P1|STARTED|Overall Study||41
186400|NCT00623805|456473|P2|NOT COMPLETED|Overall Study||22
186401|NCT00623805|456474|P1|NOT COMPLETED|Overall Study||20
186402|NCT00623805|456473|P2|COMPLETED|Overall Study||39
186403|NCT00623805|456474|P1|COMPLETED|Overall Study||42
186404|NCT00623805|456473|P2|STARTED|Overall Study||61
186405|NCT00623805|456474|P1|STARTED|Overall Study||62
186406|NCT00623831|456490|P2|NOT COMPLETED|Overall Study||1
186407|NCT00623831|456491|P1|NOT COMPLETED|Overall Study||1
186408|NCT00623831|456490|P2|COMPLETED|Overall Study||3
186409|NCT00623831|456491|P1|COMPLETED|Overall Study||12
186410|NCT00623831|456490|P2|STARTED|Overall Study||4
186411|NCT00623831|456491|P1|STARTED|Overall Study||13
186412|NCT00623935|456501|P1|NOT COMPLETED|Overall Study||2
186413|NCT00623935|456501|P1|COMPLETED|Overall Study||54
186414|NCT00623935|456501|P1|STARTED|Overall Study||56
186415|NCT00623974|456510|P4|NOT COMPLETED|Overall Study||0
186416|NCT00623974|456511|P3|NOT COMPLETED|Overall Study||0
186417|NCT00623974|456512|P2|NOT COMPLETED|Overall Study||0
186418|NCT00623974|456513|P1|NOT COMPLETED|Overall Study||0
186419|NCT00623974|456510|P4|COMPLETED|Overall Study||0
186420|NCT00623974|456511|P3|COMPLETED|Overall Study||0
186421|NCT00623974|456512|P2|COMPLETED|Overall Study||0
186422|NCT00623974|456513|P1|COMPLETED|Overall Study||0
186423|NCT00623974|456510|P4|STARTED|Overall Study||0
186424|NCT00623974|456511|P3|STARTED|Overall Study||0
186425|NCT00623974|456512|P2|STARTED|Overall Study||0
186426|NCT00623974|456513|P1|STARTED|Overall Study||0
186427|NCT00624052|456527|P4|NOT COMPLETED|Overall Study||4
186428|NCT00624052|456528|P3|NOT COMPLETED|Overall Study||3
186429|NCT00624052|456529|P2|NOT COMPLETED|Overall Study||14
186430|NCT00624052|456530|P1|NOT COMPLETED|Overall Study||15
186431|NCT00624052|456527|P4|COMPLETED|Overall Study||88
186432|NCT00624052|456528|P3|COMPLETED|Overall Study||88
186433|NCT00624052|456529|P2|COMPLETED|Overall Study||422
186434|NCT00624052|456530|P1|COMPLETED|Overall Study||204
186435|NCT00624052|456527|P4|STARTED|Overall Study||92
186436|NCT00624052|456528|P3|STARTED|Overall Study||91
186437|NCT00624052|456529|P2|STARTED|Overall Study||436
186438|NCT00624052|456530|P1|STARTED|Overall Study||219
186439|NCT00624065|456581|P2|NOT COMPLETED|Overall Study||24
186440|NCT00624065|456582|P1|NOT COMPLETED|Overall Study||19
186441|NCT00624065|456581|P2|COMPLETED|Overall Study||192
186442|NCT00624065|456582|P1|COMPLETED|Overall Study||197
186443|NCT00624065|456581|P2|STARTED|Overall Study||216
186444|NCT00624065|456582|P1|STARTED|Overall Study||216
186445|NCT00624195|456592|P2|NOT COMPLETED|Overall Study||7
186446|NCT00624195|456593|P1|NOT COMPLETED|Overall Study||3
186447|NCT00624195|456592|P2|COMPLETED|Overall Study||23
186448|NCT00624195|456593|P1|COMPLETED|Overall Study||26
186449|NCT00624195|456592|P2|STARTED|Overall Study||30
186450|NCT00624195|456593|P1|STARTED|Overall Study||29
186451|NCT00624221|456601|P2|NOT COMPLETED|Overall Study||0
186452|NCT00624221|456602|P1|NOT COMPLETED|Overall Study||0
186453|NCT00624221|456601|P2|COMPLETED|Overall Study||20
186454|NCT00624221|456602|P1|COMPLETED|Overall Study||20
186455|NCT00624221|456601|P2|STARTED|Overall Study||20
186456|NCT00624221|456602|P1|STARTED|Overall Study||20
186457|NCT00624234|456614|P6|NOT COMPLETED|Overall Study||0
186458|NCT00624234|456615|P5|NOT COMPLETED|Overall Study||0
186459|NCT00624234|456616|P4|NOT COMPLETED|Overall Study||0
186460|NCT00624234|456617|P3|NOT COMPLETED|Overall Study||0
186461|NCT00624234|456618|P2|NOT COMPLETED|Overall Study||0
186462|NCT00624234|456619|P1|NOT COMPLETED|Overall Study||0
186463|NCT00624234|456614|P6|COMPLETED|Overall Study||14
186464|NCT00624234|456615|P5|COMPLETED|Overall Study||18
186465|NCT00624234|456616|P4|COMPLETED|Overall Study||14
186466|NCT00624234|456617|P3|COMPLETED|Overall Study||26
186467|NCT00624234|456618|P2|COMPLETED|Overall Study||9
186468|NCT00624234|456619|P1|COMPLETED|Overall Study||8
186469|NCT00624234|456614|P6|STARTED|Overall Study||14
186470|NCT00624234|456615|P5|STARTED|Overall Study||18
186471|NCT00624234|456616|P4|STARTED|Overall Study||14
186472|NCT00624234|456617|P3|STARTED|Overall Study||26
186473|NCT00624234|456618|P2|STARTED|Overall Study||9
186474|NCT00624234|456619|P1|STARTED|Overall Study||8
186475|NCT00624286|456635|P2|NOT COMPLETED|Overall Study||27
186476|NCT00624286|456636|P1|NOT COMPLETED|Overall Study||25
186477|NCT00624286|456635|P2|COMPLETED|Overall Study||178
186478|NCT00624286|456636|P1|COMPLETED|Overall Study||186
186479|NCT00624286|456635|P2|STARTED|Overall Study||205
186480|NCT00624286|456636|P1|STARTED|Overall Study||211
186481|NCT00624338|456647|P3|NOT COMPLETED|Overall Study||46
186482|NCT00624338|456648|P2|NOT COMPLETED|Overall Study||83
186483|NCT00624338|456649|P1|NOT COMPLETED|Overall Study||47
186484|NCT00624338|456647|P3|COMPLETED|Overall Study||111
186485|NCT00624338|456648|P2|COMPLETED|Overall Study||62
186486|NCT00624338|456649|P1|COMPLETED|Overall Study||112
186487|NCT00624338|456647|P3|Treated|Overall Study||154
186488|NCT00624338|456648|P2|Treated|Overall Study||144
186489|NCT00624338|456649|P1|Treated|Overall Study||157
186490|NCT00624338|456647|P3|STARTED|Overall Study||157
186491|NCT00624338|456648|P2|STARTED|Overall Study||145
186492|NCT00624338|456649|P1|STARTED|Overall Study||159
186493|NCT00624377|456669|P1|NOT COMPLETED|Overall Study||644
186494|NCT00624377|456669|P1|COMPLETED|Overall Study||1387
186495|NCT00624377|456669|P1|STARTED|Overall Study||2031
186496|NCT00624416|456680|P1|NOT COMPLETED|Overall Study||0
186497|NCT00624416|456680|P1|COMPLETED|Overall Study||10
186498|NCT00624416|456680|P1|STARTED|Overall Study||10
186499|NCT00624442|456691|P5|NOT COMPLETED|Overall Study||2
186500|NCT00624442|456692|P4|NOT COMPLETED|Overall Study||0
186501|NCT00624442|456693|P3|NOT COMPLETED|Overall Study||2
186502|NCT00624442|456694|P2|NOT COMPLETED|Overall Study||1
186503|NCT00624442|456695|P1|NOT COMPLETED|Overall Study||0
186504|NCT00624442|456691|P5|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
186505|NCT00624442|456692|P4|COMPLETED|Overall Study||8
186506|NCT00624442|456693|P3|COMPLETED|Overall Study|Two patients discontinued after meeting termination criteria during dosing.|8
186507|NCT00624442|456694|P2|COMPLETED|Overall Study|One patient was discontinued after inadvertant overdose.|8
186508|NCT00624442|456695|P1|COMPLETED|Overall Study||8
186509|NCT00624442|456691|P5|STARTED|Overall Study||10
186510|NCT00624442|456692|P4|STARTED|Overall Study||8
186511|NCT00624442|456693|P3|STARTED|Overall Study||10
186512|NCT00624442|456694|P2|STARTED|Overall Study||9
186513|NCT00624442|456695|P1|STARTED|Overall Study||8
186514|NCT00624468|456723|P4|NOT COMPLETED|Safety Follow-up (SFU) Period||3
186515|NCT00624468|456724|P3|NOT COMPLETED|Safety Follow-up (SFU) Period||2
186516|NCT00624468|456725|P2|NOT COMPLETED|Safety Follow-up (SFU) Period||0
186517|NCT00624468|456726|P1|NOT COMPLETED|Safety Follow-up (SFU) Period||0
186518|NCT00624468|456723|P4|COMPLETED|Safety Follow-up (SFU) Period||11
186519|NCT00624468|456724|P3|COMPLETED|Safety Follow-up (SFU) Period||11
186520|NCT00624468|456725|P2|COMPLETED|Safety Follow-up (SFU) Period||0
186521|NCT00624468|456726|P1|COMPLETED|Safety Follow-up (SFU) Period||0
186522|NCT00624468|456723|P4|STARTED|Safety Follow-up (SFU) Period||14
186523|NCT00624468|456724|P3|STARTED|Safety Follow-up (SFU) Period||13
186524|NCT00624468|456725|P2|STARTED|Safety Follow-up (SFU) Period||0
186525|NCT00624468|456726|P1|STARTED|Safety Follow-up (SFU) Period||0
186526|NCT00624468|456723|P4|NOT COMPLETED|Double-blind Period||0
186527|NCT00624468|456724|P3|NOT COMPLETED|Double-blind Period||0
186528|NCT00624468|456725|P2|NOT COMPLETED|Double-blind Period||13
186529|NCT00624468|456726|P1|NOT COMPLETED|Double-blind Period||14
186530|NCT00624468|456723|P4|COMPLETED|Double-blind Period||0
186531|NCT00624468|456724|P3|COMPLETED|Double-blind Period||0
186532|NCT00624468|456725|P2|COMPLETED|Double-blind Period||4
186533|NCT00624468|456726|P1|COMPLETED|Double-blind Period||3
186534|NCT00624468|456723|P4|STARTED|Double-blind Period||0
186535|NCT00624468|456724|P3|STARTED|Double-blind Period||0
186536|NCT00624468|456725|P2|STARTED|Double-blind Period||17
186537|NCT00624468|456726|P1|STARTED|Double-blind Period||17
186538|NCT00624520|456754|P2|NOT COMPLETED|Overall Study||8
186539|NCT00624520|456755|P1|NOT COMPLETED|Overall Study||12
186540|NCT00624520|456754|P2|COMPLETED|Overall Study||39
186541|NCT00624520|456755|P1|COMPLETED|Overall Study||44
186542|NCT00624520|456754|P2|STARTED|Overall Study||47
186543|NCT00624520|456755|P1|STARTED|Overall Study||56
186544|NCT00624559|456784|P4|NOT COMPLETED|Overall Study||0
186545|NCT00624559|456785|P3|NOT COMPLETED|Overall Study||0
186546|NCT00624559|456786|P2|NOT COMPLETED|Overall Study||0
186547|NCT00624559|456787|P1|NOT COMPLETED|Overall Study||0
186548|NCT00624559|456784|P4|COMPLETED|Overall Study||3
186549|NCT00624559|456785|P3|COMPLETED|Overall Study||3
186550|NCT00624559|456786|P2|COMPLETED|Overall Study||3
186551|NCT00624559|456787|P1|COMPLETED|Overall Study||3
186552|NCT00624559|456784|P4|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
186553|NCT00624559|456785|P3|STARTED|Overall Study|Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
186554|NCT00624559|456786|P2|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day|3
186555|NCT00624559|456787|P1|STARTED|Overall Study|Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day|3
186556|NCT00624585|456801|P1|NOT COMPLETED|Overall Study||12
186557|NCT00624585|456801|P1|COMPLETED|Overall Study||6
186558|NCT00624585|456801|P1|STARTED|Overall Study||18
186559|NCT00624780|456814|P6|NOT COMPLETED|Follow-up (Week 26)||0
186560|NCT00624780|456815|P5|NOT COMPLETED|Follow-up (Week 26)||2
186561|NCT00624780|456816|P4|NOT COMPLETED|Follow-up (Week 26)||0
186562|NCT00624780|456817|P3|NOT COMPLETED|Follow-up (Week 26)||2
186563|NCT00624780|456818|P2|NOT COMPLETED|Follow-up (Week 26)||1
186564|NCT00624780|456819|P1|NOT COMPLETED|Follow-up (Week 26)||2
186565|NCT00624780|456814|P6|COMPLETED|Follow-up (Week 26)||29
186566|NCT00624780|456815|P5|COMPLETED|Follow-up (Week 26)||93
186567|NCT00624780|456816|P4|COMPLETED|Follow-up (Week 26)||26
186568|NCT00624780|456817|P3|COMPLETED|Follow-up (Week 26)||89
186569|NCT00624780|456818|P2|COMPLETED|Follow-up (Week 26)||27
186570|NCT00624780|456819|P1|COMPLETED|Follow-up (Week 26)||102
186571|NCT00624780|456814|P6|STARTED|Follow-up (Week 26)||29
186572|NCT00624780|456815|P5|STARTED|Follow-up (Week 26)||95
186573|NCT00624780|456816|P4|STARTED|Follow-up (Week 26)||26
186574|NCT00624780|456817|P3|STARTED|Follow-up (Week 26)||91
186575|NCT00624780|456818|P2|STARTED|Follow-up (Week 26)||28
186576|NCT00624780|456819|P1|STARTED|Follow-up (Week 26)||104
186577|NCT00624780|456814|P6|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
186578|NCT00624780|456815|P5|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
186579|NCT00624780|456816|P4|NOT COMPLETED|Treatment Discontinuation (Week 25)||1
186580|NCT00624780|456817|P3|NOT COMPLETED|Treatment Discontinuation (Week 25)||3
186581|NCT00624780|456818|P2|NOT COMPLETED|Treatment Discontinuation (Week 25)||0
186582|NCT00624780|456819|P1|NOT COMPLETED|Treatment Discontinuation (Week 25)||2
186583|NCT00624780|456814|P6|COMPLETED|Treatment Discontinuation (Week 25)||29
186584|NCT00624780|456815|P5|COMPLETED|Treatment Discontinuation (Week 25)||95
186585|NCT00624780|456816|P4|COMPLETED|Treatment Discontinuation (Week 25)||26
186586|NCT00624780|456817|P3|COMPLETED|Treatment Discontinuation (Week 25)||91
186587|NCT00624780|456818|P2|COMPLETED|Treatment Discontinuation (Week 25)||28
186588|NCT00624780|456819|P1|COMPLETED|Treatment Discontinuation (Week 25)||104
186589|NCT00624780|456814|P6|STARTED|Treatment Discontinuation (Week 25)||30
186590|NCT00624780|456815|P5|STARTED|Treatment Discontinuation (Week 25)||95
186591|NCT00624780|456816|P4|STARTED|Treatment Discontinuation (Week 25)||27
186592|NCT00624780|456817|P3|STARTED|Treatment Discontinuation (Week 25)||94
186593|NCT00624780|456818|P2|STARTED|Treatment Discontinuation (Week 25)||28
186594|NCT00624780|456819|P1|STARTED|Treatment Discontinuation (Week 25)||106
186595|NCT00624780|456814|P6|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||9
186596|NCT00624780|456815|P5|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||19
186597|NCT00624780|456816|P4|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
186598|NCT00624780|456817|P3|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||18
186599|NCT00624780|456818|P2|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||11
186600|NCT00624780|456819|P1|NOT COMPLETED|Fixed Dosing (Week 13 to Week 24)||15
186601|NCT00624780|456814|P6|COMPLETED|Fixed Dosing (Week 13 to Week 24)||30
186602|NCT00624780|456815|P5|COMPLETED|Fixed Dosing (Week 13 to Week 24)||95
186603|NCT00624780|456816|P4|COMPLETED|Fixed Dosing (Week 13 to Week 24)||27
186604|NCT00624780|456817|P3|COMPLETED|Fixed Dosing (Week 13 to Week 24)||94
186605|NCT00624780|456818|P2|COMPLETED|Fixed Dosing (Week 13 to Week 24)||28
186606|NCT00624780|456819|P1|COMPLETED|Fixed Dosing (Week 13 to Week 24)||106
186607|NCT00624780|456814|P6|STARTED|Fixed Dosing (Week 13 to Week 24)||39
186608|NCT00624780|456815|P5|STARTED|Fixed Dosing (Week 13 to Week 24)||114
186609|NCT00624780|456816|P4|STARTED|Fixed Dosing (Week 13 to Week 24)||38
186610|NCT00624780|456817|P3|STARTED|Fixed Dosing (Week 13 to Week 24)||112
186611|NCT00624780|456818|P2|STARTED|Fixed Dosing (Week 13 to Week 24)||39
186612|NCT00624780|456819|P1|STARTED|Fixed Dosing (Week 13 to Week 24)||121
186613|NCT00624780|456814|P6|NOT COMPLETED|Treatment Optimization (Up to Week 12)||11
186614|NCT00624780|456815|P5|NOT COMPLETED|Treatment Optimization (Up to Week 12)||39
186615|NCT00624780|456816|P4|NOT COMPLETED|Treatment Optimization (Up to Week 12)||14
186616|NCT00624780|456817|P3|NOT COMPLETED|Treatment Optimization (Up to Week 12)||42
186617|NCT00624780|456818|P2|NOT COMPLETED|Treatment Optimization (Up to Week 12)||13
186618|NCT00624780|456819|P1|NOT COMPLETED|Treatment Optimization (Up to Week 12)||33
186619|NCT00624780|456814|P6|COMPLETED|Treatment Optimization (Up to Week 12)||39
186620|NCT00624780|456815|P5|COMPLETED|Treatment Optimization (Up to Week 12)||114
186621|NCT00624780|456816|P4|COMPLETED|Treatment Optimization (Up to Week 12)||38
186622|NCT00624780|456817|P3|COMPLETED|Treatment Optimization (Up to Week 12)||112
186623|NCT00624780|456818|P2|COMPLETED|Treatment Optimization (Up to Week 12)||39
186624|NCT00624780|456819|P1|COMPLETED|Treatment Optimization (Up to Week 12)||121
186625|NCT00624780|456814|P6|STARTED|Treatment Optimization (Up to Week 12)||50
186626|NCT00624780|456815|P5|STARTED|Treatment Optimization (Up to Week 12)||153
186627|NCT00624780|456816|P4|STARTED|Treatment Optimization (Up to Week 12)||52
186628|NCT00624780|456817|P3|STARTED|Treatment Optimization (Up to Week 12)||154
186629|NCT00624780|456818|P2|STARTED|Treatment Optimization (Up to Week 12)||52
186630|NCT00624780|456819|P1|STARTED|Treatment Optimization (Up to Week 12)||154
186631|NCT00624806|457003|P2|NOT COMPLETED|Overall Study||0
186632|NCT00624806|457004|P1|NOT COMPLETED|Overall Study||0
186633|NCT00624806|457003|P2|COMPLETED|Overall Study||8
186634|NCT00624806|457004|P1|COMPLETED|Overall Study||10
186635|NCT00624806|457003|P2|STARTED|Overall Study||8
186636|NCT00624806|457004|P1|STARTED|Overall Study||10
186637|NCT00624832|457018|P4|NOT COMPLETED|Overall Study||1
186638|NCT00624832|457019|P3|NOT COMPLETED|Overall Study||0
186639|NCT00624832|457020|P2|NOT COMPLETED|Overall Study||1
186640|NCT00624832|457021|P1|NOT COMPLETED|Overall Study||2
186641|NCT00624832|457018|P4|COMPLETED|Overall Study||15
186642|NCT00624832|457019|P3|COMPLETED|Overall Study||10
186643|NCT00624832|457020|P2|COMPLETED|Overall Study||15
186644|NCT00624832|457021|P1|COMPLETED|Overall Study||16
186645|NCT00624832|457018|P4|STARTED|Overall Study||16
186646|NCT00624832|457019|P3|STARTED|Overall Study||10
186647|NCT00624832|457020|P2|STARTED|Overall Study||16
186648|NCT00624832|457021|P1|STARTED|Overall Study||18
186649|NCT00625131|457035|P3|NOT COMPLETED|Overall Study||5
186650|NCT00625131|457036|P2|NOT COMPLETED|Overall Study||2
186651|NCT00625131|457037|P1|NOT COMPLETED|Overall Study||4
186652|NCT00625131|457035|P3|COMPLETED|Overall Study||0
186653|NCT00625131|457036|P2|COMPLETED|Overall Study||42
186654|NCT00625131|457037|P1|COMPLETED|Overall Study||34
186655|NCT00625131|457035|P3|STARTED|Overall Study|These participants were not included in any analyses.|5
186656|NCT00625131|457036|P2|STARTED|Overall Study||44
186657|NCT00625131|457037|P1|STARTED|Overall Study||38
186658|NCT00625183|457047|P1|NOT COMPLETED|Overall Study||1
186659|NCT00625183|457047|P1|COMPLETED|Overall Study||4
186660|NCT00625183|457047|P1|STARTED|Overall Study||5
186661|NCT00625365|457054|P1|NOT COMPLETED|Overall Study||7
186756|NCT00619359|457426|P2|COMPLETED|Overall Study||1094
186662|NCT00625365|457054|P1|COMPLETED|Overall Study|Participants who were analyzed for safety|1053
186663|NCT00625365|457054|P1|STARTED|Overall Study||1060
186664|NCT00625391|457064|P4|NOT COMPLETED|Overall Study||1
186665|NCT00625391|457065|P3|NOT COMPLETED|Overall Study||5
186666|NCT00625391|457066|P2|NOT COMPLETED|Overall Study||8
186667|NCT00625391|457067|P1|NOT COMPLETED|Overall Study||7
186668|NCT00625391|457064|P4|COMPLETED|Overall Study||37
186669|NCT00625391|457065|P3|COMPLETED|Overall Study||37
186670|NCT00625391|457066|P2|COMPLETED|Overall Study||39
186671|NCT00625391|457067|P1|COMPLETED|Overall Study||37
186672|NCT00625391|457064|P4|STARTED|Overall Study||38
186673|NCT00625391|457065|P3|STARTED|Overall Study||42
186674|NCT00625391|457066|P2|STARTED|Overall Study||47
186675|NCT00625391|457067|P1|STARTED|Overall Study||44
186676|NCT00625404|457083|P2|NOT COMPLETED|Overall Study||173
186677|NCT00625404|457084|P1|NOT COMPLETED|Overall Study||207
186678|NCT00625404|457083|P2|COMPLETED|Overall Study||885
186679|NCT00625404|457084|P1|COMPLETED|Overall Study||855
186680|NCT00625404|457083|P2|STARTED|Overall Study||1058
186681|NCT00625404|457084|P1|STARTED|Overall Study||1062
186682|NCT00625586|457110|P1|NOT COMPLETED|Overall Study||1
186683|NCT00625586|457110|P1|COMPLETED|Overall Study||1
186684|NCT00625586|457110|P1|STARTED|Overall Study||2
186685|NCT00625729|457120|P1|NOT COMPLETED|Overall Study||0
186686|NCT00625729|457120|P1|COMPLETED|Overall Study||6
186687|NCT00625729|457120|P1|STARTED|Overall Study||6
186688|NCT00625742|457129|P1|NOT COMPLETED|Overall Study||12
186689|NCT00625742|457129|P1|COMPLETED|Overall Study||3
186690|NCT00625742|457129|P1|STARTED|Overall Study||15
186691|NCT00625820|457134|P1|NOT COMPLETED|Overall Study||1
186692|NCT00625820|457134|P1|COMPLETED|Overall Study||16
186693|NCT00625820|457134|P1|STARTED|Overall Study||17
186694|NCT00607919|457142|P2|NOT COMPLETED|Open-Label Phase||12
186695|NCT00607919|457143|P1|NOT COMPLETED|Open-Label Phase||10
186696|NCT00607919|457142|P2|COMPLETED|Open-Label Phase||59
186697|NCT00607919|457143|P1|COMPLETED|Open-Label Phase||74
186698|NCT00607919|457142|P2|STARTED|Open-Label Phase||71
186699|NCT00607919|457143|P1|STARTED|Open-Label Phase||84
186700|NCT00607919|457142|P2|NOT COMPLETED|Acute Phase||16
186701|NCT00607919|457143|P1|NOT COMPLETED|Acute Phase||34
186702|NCT00607919|457142|P2|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|73
186703|NCT00607919|457143|P1|COMPLETED|Acute Phase|2 participants completed acute phase but did not continue into open-label.|86
186704|NCT00607919|457142|P2|STARTED|Acute Phase||89
186705|NCT00607919|457143|P1|STARTED|Acute Phase||120
186706|NCT00607997|457203|P4|NOT COMPLETED|Overall Study||16
186707|NCT00607997|457204|P3|NOT COMPLETED|Overall Study||24
186708|NCT00607997|457205|P2|NOT COMPLETED|Overall Study||27
186709|NCT00607997|457206|P1|NOT COMPLETED|Overall Study||27
186710|NCT00607997|457203|P4|COMPLETED|Overall Study||4
186711|NCT00607997|457204|P3|COMPLETED|Overall Study||5
186712|NCT00607997|457205|P2|COMPLETED|Overall Study||8
186713|NCT00607997|457206|P1|COMPLETED|Overall Study||2
186714|NCT00607997|457203|P4|STARTED|Overall Study||20
186715|NCT00607997|457204|P3|STARTED|Overall Study||29
186716|NCT00607997|457205|P2|STARTED|Overall Study||35
186717|NCT00607997|457206|P1|STARTED|Overall Study||29
186718|NCT00608023|457265|P3|NOT COMPLETED|Overall Study||14
186719|NCT00608023|457266|P2|NOT COMPLETED|Overall Study||22
186720|NCT00608023|457267|P1|NOT COMPLETED|Overall Study||12
186721|NCT00608023|457265|P3|COMPLETED|Overall Study||72
186722|NCT00608023|457266|P2|COMPLETED|Overall Study||63
186723|NCT00608023|457267|P1|COMPLETED|Overall Study||80
186724|NCT00608023|457265|P3|STARTED|Overall Study||86
186725|NCT00608023|457266|P2|STARTED|Overall Study||85
186726|NCT00608023|457267|P1|STARTED|Overall Study||92
186727|NCT00608140|457289|P2|NOT COMPLETED|Overall Study||1
186728|NCT00608140|457290|P1|NOT COMPLETED|Overall Study||1
186729|NCT00608140|457289|P2|COMPLETED|Overall Study|Study ended early due to low enrollment|0
186730|NCT00608140|457290|P1|COMPLETED|Overall Study|Study ended early due to low enrollment|0
186731|NCT00608140|457289|P2|STARTED|Overall Study||1
186732|NCT00608140|457290|P1|STARTED|Overall Study||1
186733|NCT00608205|457300|P2|NOT COMPLETED|Overall Study||3
186734|NCT00608205|457301|P1|NOT COMPLETED|Overall Study||3
186735|NCT00608205|457300|P2|COMPLETED|Overall Study||31
186736|NCT00608205|457301|P1|COMPLETED|Overall Study||32
186737|NCT00608205|457300|P2|STARTED|Overall Study||34
186738|NCT00608205|457301|P1|STARTED|Overall Study||35
186739|NCT00608244|457389|P1|NOT COMPLETED|Overall Study||2
186740|NCT00608244|457389|P1|COMPLETED|Overall Study||57
186741|NCT00608244|457389|P1|STARTED|Overall Study||59
186742|NCT00608322|457400|P2|NOT COMPLETED|Overall Study||1
186743|NCT00608322|457401|P1|NOT COMPLETED|Overall Study||2
186744|NCT00608322|457400|P2|COMPLETED|Overall Study||22
186745|NCT00608322|457401|P1|COMPLETED|Overall Study||24
186746|NCT00608322|457400|P2|STARTED|Overall Study||23
186747|NCT00608322|457401|P1|STARTED|Overall Study||26
186748|NCT00619307|457409|P2|NOT COMPLETED|Overall Study||4
186749|NCT00619307|457410|P1|NOT COMPLETED|Overall Study||4
186750|NCT00619307|457409|P2|COMPLETED|Overall Study||53
186751|NCT00619307|457410|P1|COMPLETED|Overall Study||56
186752|NCT00619307|457409|P2|STARTED|Overall Study||57
186753|NCT00619307|457410|P1|STARTED|Overall Study||60
186754|NCT00619359|457426|P2|NOT COMPLETED|Overall Study||81
186755|NCT00619359|457427|P1|NOT COMPLETED|Overall Study||67
186757|NCT00619359|457427|P1|COMPLETED|Overall Study||1080
186758|NCT00619359|457426|P2|STARTED|Overall Study||1175
186759|NCT00619359|457427|P1|STARTED|Overall Study||1147
186760|NCT00619385|457440|P3|NOT COMPLETED|Overall Study||4
186761|NCT00619385|457441|P2|NOT COMPLETED|Overall Study||2
186762|NCT00619385|457442|P1|NOT COMPLETED|Overall Study||1
186763|NCT00619385|457440|P3|COMPLETED|Overall Study||6
186764|NCT00619385|457441|P2|COMPLETED|Overall Study||6
186765|NCT00619385|457442|P1|COMPLETED|Overall Study||6
186766|NCT00619385|457440|P3|STARTED|Overall Study||10
186767|NCT00619385|457441|P2|STARTED|Overall Study||8
186768|NCT00619385|457442|P1|STARTED|Overall Study||7
186769|NCT00619476|457459|P4|NOT COMPLETED|Overall Study||34
186770|NCT00619476|457460|P3|NOT COMPLETED|Overall Study||24
186771|NCT00619476|457461|P2|NOT COMPLETED|Overall Study||22
186772|NCT00619476|457462|P1|NOT COMPLETED|Overall Study||31
186773|NCT00619476|457459|P4|COMPLETED|Overall Study||56
186774|NCT00619476|457460|P3|COMPLETED|Overall Study||60
186775|NCT00619476|457461|P2|COMPLETED|Overall Study||85
186776|NCT00619476|457462|P1|COMPLETED|Overall Study||64
186777|NCT00619476|457459|P4|Safety Population|Overall Study||87
186778|NCT00619476|457460|P3|Safety Population|Overall Study||82
186779|NCT00619476|457461|P2|Safety Population|Overall Study||107
186780|NCT00619476|457462|P1|Safety Population|Overall Study||95
186781|NCT00619476|457459|P4|Intent-to-Treat Population|Overall Study||87
186782|NCT00619476|457460|P3|Intent-to-Treat Population|Overall Study||82
186783|NCT00619476|457461|P2|Intent-to-Treat Population|Overall Study||107
186784|NCT00619476|457462|P1|Intent-to-Treat Population|Overall Study||95
186785|NCT00619476|457459|P4|STARTED|Overall Study||90
186786|NCT00619476|457460|P3|STARTED|Overall Study||84
186787|NCT00619476|457461|P2|STARTED|Overall Study||107
186788|NCT00619476|457462|P1|STARTED|Overall Study||95
186789|NCT00619489|457546|P2|NOT COMPLETED|Overall Study||34
186790|NCT00619489|457547|P1|NOT COMPLETED|Overall Study||23
186791|NCT00619489|457546|P2|COMPLETED|Overall Study||1
186792|NCT00619489|457547|P1|COMPLETED|Overall Study||14
186793|NCT00619489|457546|P2|STARTED|Overall Study||35
186794|NCT00619489|457547|P1|STARTED|Overall Study||37
186795|NCT00619502|457567|P2|NOT COMPLETED|Overall Study||10
186796|NCT00619502|457568|P1|NOT COMPLETED|Overall Study||8
186797|NCT00619502|457567|P2|COMPLETED|Overall Study||114
186798|NCT00619502|457568|P1|COMPLETED|Overall Study||122
186799|NCT00619502|457567|P2|STARTED|Overall Study||124
186800|NCT00619502|457568|P1|STARTED|Overall Study||130
186801|NCT00619619|457586|P8|NOT COMPLETED|Overall Study||3
186802|NCT00619619|457587|P7|NOT COMPLETED|Overall Study||1
186803|NCT00619619|457588|P6|NOT COMPLETED|Overall Study||0
186804|NCT00619619|457589|P5|NOT COMPLETED|Overall Study||2
186805|NCT00619619|457590|P4|NOT COMPLETED|Overall Study||1
186806|NCT00619619|457591|P3|NOT COMPLETED|Overall Study||1
186807|NCT00619619|457592|P2|NOT COMPLETED|Overall Study||0
186808|NCT00619619|457593|P1|NOT COMPLETED|Overall Study||0
186809|NCT00619619|457586|P8|COMPLETED|Overall Study||5
186810|NCT00619619|457587|P7|COMPLETED|Overall Study||7
186811|NCT00619619|457588|P6|COMPLETED|Overall Study||7
186812|NCT00619619|457589|P5|COMPLETED|Overall Study||5
186813|NCT00619619|457590|P4|COMPLETED|Overall Study||6
186814|NCT00619619|457591|P3|COMPLETED|Overall Study||8
186815|NCT00619619|457592|P2|COMPLETED|Overall Study||7
186816|NCT00619619|457593|P1|COMPLETED|Overall Study|Completed=conclusion of Test Article (treatment) phase for all treatment groups in 3151A6-2000.|6
186817|NCT00619619|457586|P8|Entered the Extension Study|Overall Study||7
186818|NCT00619619|457587|P7|Entered the Extension Study|Overall Study||6
186819|NCT00619619|457588|P6|Entered the Extension Study|Overall Study||6
186820|NCT00619619|457589|P5|Entered the Extension Study|Overall Study||7
186821|NCT00619619|457590|P4|Entered the Extension Study|Overall Study||3
186822|NCT00619619|457591|P3|Entered the Extension Study|Overall Study||8
186823|NCT00619619|457592|P2|Entered the Extension Study|Overall Study||5
186824|NCT00619619|457593|P1|Entered the Extension Study|Overall Study|Extension study: 3151A6-2001 (NCT00669110)|6
186825|NCT00619619|457586|P8|STARTED|Overall Study||8
186826|NCT00619619|457587|P7|STARTED|Overall Study||8
186827|NCT00619619|457588|P6|STARTED|Overall Study||7
186828|NCT00619619|457589|P5|STARTED|Overall Study||7
186829|NCT00619619|457590|P4|STARTED|Overall Study||7
186830|NCT00619619|457591|P3|STARTED|Overall Study||9
186831|NCT00619619|457592|P2|STARTED|Overall Study||7
186832|NCT00619619|457593|P1|STARTED|Overall Study||6
186833|NCT00619645|457678|P1|NOT COMPLETED|Overall Study||1
186834|NCT00619645|457678|P1|COMPLETED|Overall Study||7
186835|NCT00619645|457678|P1|STARTED|Overall Study||8
186836|NCT00619684|457684|P1|NOT COMPLETED|Overall Study||0
186837|NCT00619684|457684|P1|COMPLETED|Overall Study||18
186838|NCT00619684|457684|P1|STARTED|Overall Study||18
186839|NCT00625872|457695|P2|NOT COMPLETED|Overall Study||6
186840|NCT00625872|457696|P1|NOT COMPLETED|Overall Study||4
186841|NCT00625872|457695|P2|COMPLETED|Overall Study||5
186842|NCT00625872|457696|P1|COMPLETED|Overall Study||8
186843|NCT00625872|457695|P2|Treated|Overall Study||10
186844|NCT00625872|457696|P1|Treated|Overall Study||12
186845|NCT00625872|457695|P2|STARTED|Overall Study||11
186846|NCT00625872|457696|P1|STARTED|Overall Study||12
186847|NCT00625989|457806|P2|NOT COMPLETED|Overall Study||0
186848|NCT00625989|457807|P1|NOT COMPLETED|Overall Study||0
186849|NCT00625989|457806|P2|COMPLETED|Overall Study||6
186850|NCT00625989|457807|P1|COMPLETED|Overall Study||6
186851|NCT00625989|457806|P2|STARTED|Overall Study||6
186852|NCT00625989|457807|P1|STARTED|Overall Study||6
186853|NCT00626028|457816|P2|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
186854|NCT00626028|457817|P1|NOT COMPLETED|Treatment 3 10 Minute Dose NO or O2||0
186855|NCT00626028|457816|P2|COMPLETED|Treatment 3 10 Minute Dose NO or O2||59
186856|NCT00626028|457817|P1|COMPLETED|Treatment 3 10 Minute Dose NO or O2||62
186857|NCT00626028|457816|P2|STARTED|Treatment 3 10 Minute Dose NO or O2||59
186858|NCT00626028|457817|P1|STARTED|Treatment 3 10 Minute Dose NO or O2||62
186859|NCT00626028|457816|P2|NOT COMPLETED|Washout Period of 10 Minutes||0
186860|NCT00626028|457817|P1|NOT COMPLETED|Washout Period of 10 Minutes||0
186861|NCT00626028|457816|P2|COMPLETED|Washout Period of 10 Minutes||59
186862|NCT00626028|457817|P1|COMPLETED|Washout Period of 10 Minutes||62
186863|NCT00626028|457816|P2|STARTED|Washout Period of 10 Minutes||59
186864|NCT00626028|457817|P1|STARTED|Washout Period of 10 Minutes||62
186865|NCT00626028|457816|P2|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
186866|NCT00626028|457817|P1|NOT COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||0
186867|NCT00626028|457816|P2|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||59
186868|NCT00626028|457817|P1|COMPLETED|Treatment 2 10 Minute Dose NO Plus O2||62
186869|NCT00626028|457816|P2|STARTED|Treatment 2 10 Minute Dose NO Plus O2||59
186870|NCT00626028|457817|P1|STARTED|Treatment 2 10 Minute Dose NO Plus O2||62
186871|NCT00626028|457816|P2|NOT COMPLETED|Treatment 1 NO First, O2 Last||9
186872|NCT00626028|457817|P1|NOT COMPLETED|Treatment 1 NO First, O2 Last||6
186873|NCT00626028|457816|P2|COMPLETED|Treatment 1 NO First, O2 Last||59
186874|NCT00626028|457817|P1|COMPLETED|Treatment 1 NO First, O2 Last||62
186875|NCT00626028|457816|P2|STARTED|Treatment 1 NO First, O2 Last||68
186876|NCT00626028|457817|P1|STARTED|Treatment 1 NO First, O2 Last||68
186877|NCT00626093|457827|P1|NOT COMPLETED|Overall Study||23
186878|NCT00626093|457827|P1|COMPLETED|Overall Study||54
186879|NCT00626093|457827|P1|STARTED|Overall Study||77
186880|NCT00629525|457832|P1|NOT COMPLETED|Overall Study||3
186881|NCT00629525|457832|P1|COMPLETED|Overall Study||32
186882|NCT00629525|457832|P1|STARTED|Overall Study||35
186883|NCT00629707|457842|P2|NOT COMPLETED|Overall Study||2
186884|NCT00629707|457843|P1|NOT COMPLETED|Overall Study||0
186885|NCT00629707|457842|P2|COMPLETED|Overall Study||8
186886|NCT00629707|457843|P1|COMPLETED|Overall Study||10
186887|NCT00629707|457842|P2|STARTED|Overall Study||10
186888|NCT00629707|457843|P1|STARTED|Overall Study||10
186889|NCT00629772|457851|P2|NOT COMPLETED|Second Intervention Week 14 - Week 26||2
186890|NCT00629772|457852|P1|NOT COMPLETED|Second Intervention Week 14 - Week 26||1
186891|NCT00629772|457851|P2|COMPLETED|Second Intervention Week 14 - Week 26||10
186892|NCT00629772|457852|P1|COMPLETED|Second Intervention Week 14 - Week 26||11
186893|NCT00629772|457851|P2|STARTED|Second Intervention Week 14 - Week 26||12
186894|NCT00629772|457852|P1|STARTED|Second Intervention Week 14 - Week 26|Patient withdrew at Week 14 and therefore never received infliximab.|12
186895|NCT00629772|457851|P2|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
186896|NCT00629772|457852|P1|NOT COMPLETED|First Intervention - Day 0 - Week 14||0
186897|NCT00629772|457851|P2|COMPLETED|First Intervention - Day 0 - Week 14||12
186898|NCT00629772|457852|P1|COMPLETED|First Intervention - Day 0 - Week 14||12
186899|NCT00629772|457851|P2|STARTED|First Intervention - Day 0 - Week 14||12
186900|NCT00629772|457852|P1|STARTED|First Intervention - Day 0 - Week 14||12
186901|NCT00629850|457872|P2|NOT COMPLETED|Overall Study||0
186902|NCT00629850|457873|P1|NOT COMPLETED|Overall Study||0
186903|NCT00629850|457872|P2|COMPLETED|Overall Study||0
186904|NCT00629850|457873|P1|COMPLETED|Overall Study||1
186905|NCT00629850|457872|P2|STARTED|Overall Study||0
186906|NCT00629850|457873|P1|STARTED|Overall Study||1
186907|NCT00630058|457885|P2|NOT COMPLETED|Overall Study||4
186908|NCT00630058|457886|P1|NOT COMPLETED|Overall Study||4
186909|NCT00630058|457885|P2|COMPLETED|Overall Study||6
186910|NCT00630058|457886|P1|COMPLETED|Overall Study||6
186911|NCT00630058|457885|P2|STARTED|Overall Study||10
186912|NCT00630058|457886|P1|STARTED|Overall Study||10
186913|NCT00630292|457902|P1|NOT COMPLETED|Overall Study||1
186914|NCT00630292|457902|P1|COMPLETED|Overall Study||5
186915|NCT00630292|457902|P1|STARTED|Overall Study||6
186916|NCT00630305|457906|P1|NOT COMPLETED|Overall Study||2
186917|NCT00630305|457906|P1|COMPLETED|Overall Study||35
186918|NCT00630305|457906|P1|STARTED|Overall Study||37
186919|NCT00630331|457931|P3|NOT COMPLETED|Overall Study||188
186920|NCT00630331|457932|P2|NOT COMPLETED|Overall Study||166
186921|NCT00630331|457933|P1|NOT COMPLETED|Overall Study||206
186922|NCT00630331|457931|P3|COMPLETED|Overall Study||3712
186923|NCT00630331|457932|P2|COMPLETED|Overall Study||3510
186924|NCT00630331|457933|P1|COMPLETED|Overall Study||3622
186925|NCT00630331|457931|P3|STARTED|Overall Study||3900
186926|NCT00630331|457932|P2|STARTED|Overall Study||3676
186927|NCT00630331|457933|P1|STARTED|Overall Study||3828
186928|NCT00630344|457974|P1|NOT COMPLETED|Overall Study||0
186929|NCT00630344|457974|P1|COMPLETED|Overall Study||36
186930|NCT00630344|457974|P1|STARTED|Overall Study||36
186931|NCT00630396|457978|P1|NOT COMPLETED|Overall Study||7
186932|NCT00630396|457978|P1|COMPLETED|Overall Study||53
186933|NCT00630396|457978|P1|STARTED|Overall Study||60
186934|NCT00630409|457984|P1|NOT COMPLETED|Overall Study||1
186935|NCT00630409|457984|P1|COMPLETED|Overall Study||4
186936|NCT00630409|457984|P1|STARTED|Overall Study||5
186937|NCT00630487|457991|P2|NOT COMPLETED|Overall Study||0
186938|NCT00630487|457992|P1|NOT COMPLETED|Overall Study||0
186939|NCT00630487|457991|P2|COMPLETED|Overall Study||0
186940|NCT00630487|457992|P1|COMPLETED|Overall Study||0
186941|NCT00630487|457991|P2|STARTED|Overall Study||0
186942|NCT00630487|457992|P1|STARTED|Overall Study||0
186943|NCT00630539|458030|P4|NOT COMPLETED|Overall Study||3
186944|NCT00630539|458031|P3|NOT COMPLETED|Overall Study||1
186945|NCT00630539|458032|P2|NOT COMPLETED|Overall Study||4
186946|NCT00630539|458033|P1|NOT COMPLETED|Overall Study||1
186947|NCT00630539|458030|P4|COMPLETED|Overall Study||27
186948|NCT00630539|458031|P3|COMPLETED|Overall Study||28
186949|NCT00630539|458032|P2|COMPLETED|Overall Study||29
186950|NCT00630539|458033|P1|COMPLETED|Overall Study||33
186951|NCT00630539|458030|P4|STARTED|Overall Study||30
186952|NCT00630539|458031|P3|STARTED|Overall Study||29
186953|NCT00630539|458032|P2|STARTED|Overall Study||33
186954|NCT00630539|458033|P1|STARTED|Overall Study||34
186955|NCT00630734|458090|P3|NOT COMPLETED|Overall Study||1
186956|NCT00630734|458091|P2|NOT COMPLETED|Overall Study||1
186957|NCT00630734|458092|P1|NOT COMPLETED|Overall Study||2
186958|NCT00630734|458090|P3|COMPLETED|Overall Study||7
186959|NCT00630734|458091|P2|COMPLETED|Overall Study||12
186960|NCT00630734|458092|P1|COMPLETED|Overall Study||9
186961|NCT00630734|458090|P3|STARTED|Overall Study||8
186962|NCT00630734|458091|P2|STARTED|Overall Study||13
186963|NCT00630734|458092|P1|STARTED|Overall Study||11
186964|NCT00630747|458127|P1|NOT COMPLETED|Overall Study||9
186965|NCT00630747|458127|P1|COMPLETED|Overall Study||85
186966|NCT00630747|458127|P1|Participants Treated in Phase I of Study|Overall Study||94
186967|NCT00630747|458127|P1|STARTED|Overall Study||94
186968|NCT00630786|458139|P3|NOT COMPLETED|Overall Study||2
186969|NCT00630786|458140|P2|NOT COMPLETED|Overall Study||2
186970|NCT00630786|458141|P1|NOT COMPLETED|Overall Study||1
186971|NCT00630786|458139|P3|COMPLETED|Overall Study|Completed study defined as participant death|7
186972|NCT00630786|458140|P2|COMPLETED|Overall Study|Completed study defined as participant death|23
186973|NCT00630786|458141|P1|COMPLETED|Overall Study|Completed study defined as participant death|18
186974|NCT00630786|458139|P3|Received Study Medication|Overall Study||8
186975|NCT00630786|458140|P2|Received Study Medication|Overall Study||25
186976|NCT00630786|458141|P1|Received Study Medication|Overall Study||19
186977|NCT00630786|458139|P3|STARTED|Overall Study|All patients were enrolled in Part 2.|9
186978|NCT00630786|458140|P2|STARTED|Overall Study|Includes 3 patients enrolled in Part 1 and 22 patients enrolled in Part 2.|25
186979|NCT00630786|458141|P1|STARTED|Overall Study|Includes 2 patients enrolled in Part 1 and 17 patients enrolled in Part 2.|19
186980|NCT00630825|458164|P4|NOT COMPLETED|Overall Study||6
186981|NCT00630825|458165|P3|NOT COMPLETED|Overall Study||8
186982|NCT00630825|458166|P2|NOT COMPLETED|Overall Study||7
186983|NCT00630825|458167|P1|NOT COMPLETED|Overall Study||9
186984|NCT00630825|458164|P4|COMPLETED|Overall Study||60
186985|NCT00630825|458165|P3|COMPLETED|Overall Study||58
186986|NCT00630825|458166|P2|COMPLETED|Overall Study||58
186987|NCT00630825|458167|P1|COMPLETED|Overall Study||56
186988|NCT00630825|458164|P4|Received at Least One Dose of Study Drug|Overall Study||66
186989|NCT00630825|458165|P3|Received at Least One Dose of Study Drug|Overall Study||66
186990|NCT00630825|458166|P2|Received at Least One Dose of Study Drug|Overall Study||65
186991|NCT00630825|458167|P1|Received at Least One Dose of Study Drug|Overall Study||65
186992|NCT00630825|458164|P4|STARTED|Overall Study||66
186993|NCT00630825|458165|P3|STARTED|Overall Study||66
186994|NCT00630825|458166|P2|STARTED|Overall Study||65
186995|NCT00630825|458167|P1|STARTED|Overall Study||65
186996|NCT00630838|458238|P2|NOT COMPLETED|Overall Study||2
186997|NCT00630838|458239|P1|NOT COMPLETED|Overall Study||0
186998|NCT00630838|458238|P2|COMPLETED|Overall Study||28
186999|NCT00630838|458239|P1|COMPLETED|Overall Study||32
187000|NCT00630838|458238|P2|STARTED|Overall Study||30
187001|NCT00630838|458239|P1|STARTED|Overall Study||32
187002|NCT00630864|458247|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||2
187003|NCT00630864|458247|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||18
187004|NCT00630864|458247|P1|STARTED|Part 2 (After Week 6 up to Month 12)||20
187005|NCT00630864|458247|P1|NOT COMPLETED|Part 1 (up to Week 6)||1
187006|NCT00630864|458247|P1|COMPLETED|Part 1 (up to Week 6)||20
187007|NCT00630864|458247|P1|STARTED|Part 1 (up to Week 6)||21
187008|NCT00630877|458287|P3|NOT COMPLETED|Overall Study||10
187009|NCT00630877|458288|P2|NOT COMPLETED|Overall Study||15
187010|NCT00630877|458289|P1|NOT COMPLETED|Overall Study||19
187011|NCT00630877|458287|P3|COMPLETED|Overall Study||80
187012|NCT00630877|458288|P2|COMPLETED|Overall Study||75
187013|NCT00630877|458289|P1|COMPLETED|Overall Study||72
187014|NCT00630877|458287|P3|STARTED|Overall Study||90
187015|NCT00630877|458288|P2|STARTED|Overall Study||90
187016|NCT00630877|458289|P1|STARTED|Overall Study|For all arms, started means treated.|91
187017|NCT00630916|458307|P1|NOT COMPLETED|Overall Study||210
187018|NCT00630916|458307|P1|COMPLETED|Overall Study|The number of patients that were active (i.e. not drop out) at the end of the study.|546
187019|NCT00630916|458307|P1|Study Cohort|Overall Study|Enrolled but did not receive device via physician decision, protocol violation, or lack of efficacy.|699
187020|NCT00630916|458307|P1|STARTED|Overall Study|Total patients enrolled (i.e. consented) to participate in the study.|756
187021|NCT00630955|458317|P3|NOT COMPLETED|Overall Study||12
187022|NCT00630955|458318|P2|NOT COMPLETED|Overall Study||6
187023|NCT00630955|458319|P1|NOT COMPLETED|Overall Study||3
187024|NCT00630955|458317|P3|COMPLETED|Overall Study||28
187025|NCT00630955|458318|P2|COMPLETED|Overall Study||31
187026|NCT00630955|458319|P1|COMPLETED|Overall Study||31
187027|NCT00630955|458317|P3|STARTED|Overall Study||40
187028|NCT00630955|458318|P2|STARTED|Overall Study||37
187029|NCT00630955|458319|P1|STARTED|Overall Study||34
187030|NCT00630994|458330|P1|NOT COMPLETED|Overall Study||4
187031|NCT00630994|458330|P1|COMPLETED|Overall Study||0
187032|NCT00630994|458330|P1|STARTED|Overall Study||4
187033|NCT00631007|458344|P6|NOT COMPLETED|Overall Study||15
187034|NCT00631007|458345|P5|NOT COMPLETED|Overall Study||12
187035|NCT00631007|458346|P4|NOT COMPLETED|Overall Study||9
187036|NCT00631007|458347|P3|NOT COMPLETED|Overall Study||10
187037|NCT00631007|458348|P2|NOT COMPLETED|Overall Study||11
187038|NCT00631007|458349|P1|NOT COMPLETED|Overall Study||11
187039|NCT00631007|458344|P6|COMPLETED|Overall Study||46
187040|NCT00631007|458345|P5|COMPLETED|Overall Study||48
187041|NCT00631007|458346|P4|COMPLETED|Overall Study||53
187042|NCT00631007|458347|P3|COMPLETED|Overall Study||53
187043|NCT00631007|458348|P2|COMPLETED|Overall Study||50
187044|NCT00631007|458349|P1|COMPLETED|Overall Study||49
187045|NCT00631007|458344|P6|STARTED|Overall Study||61
187046|NCT00631007|458345|P5|STARTED|Overall Study||60
187047|NCT00631007|458346|P4|STARTED|Overall Study||62
187048|NCT00631007|458347|P3|STARTED|Overall Study||63
187049|NCT00631007|458348|P2|STARTED|Overall Study||61
187050|NCT00631007|458349|P1|STARTED|Overall Study||60
187051|NCT00631020|458369|P1|NOT COMPLETED|Overall Study||8
187052|NCT00631020|458369|P1|COMPLETED|Overall Study||26
187053|NCT00631020|458369|P1|STARTED|Overall Study||34
187054|NCT00631189|458382|P4|NOT COMPLETED|Treatment Phase||7
187055|NCT00631189|458383|P3|NOT COMPLETED|Treatment Phase||11
187056|NCT00631189|458384|P2|NOT COMPLETED|Treatment Phase||7
187057|NCT00631189|458385|P1|NOT COMPLETED|Treatment Phase||0
187058|NCT00631189|458382|P4|COMPLETED|Treatment Phase||103
187059|NCT00631189|458383|P3|COMPLETED|Treatment Phase||92
187060|NCT00631189|458384|P2|COMPLETED|Treatment Phase||97
187061|NCT00631189|458385|P1|COMPLETED|Treatment Phase||0
187062|NCT00631189|458382|P4|STARTED|Treatment Phase||110
187063|NCT00631189|458383|P3|STARTED|Treatment Phase||103
187064|NCT00631189|458384|P2|STARTED|Treatment Phase||104
187065|NCT00631189|458385|P1|STARTED|Treatment Phase||0
187066|NCT00631189|458382|P4|NOT COMPLETED|Initial Phase||0
187067|NCT00631189|458383|P3|NOT COMPLETED|Initial Phase||0
187068|NCT00631189|458384|P2|NOT COMPLETED|Initial Phase||0
187069|NCT00631189|458385|P1|NOT COMPLETED|Initial Phase||351
187070|NCT00631189|458382|P4|COMPLETED|Initial Phase||0
187071|NCT00631189|458383|P3|COMPLETED|Initial Phase||0
187072|NCT00631189|458384|P2|COMPLETED|Initial Phase||0
187073|NCT00631189|458385|P1|COMPLETED|Initial Phase||317
187074|NCT00631189|458382|P4|STARTED|Initial Phase||0
187075|NCT00631189|458383|P3|STARTED|Initial Phase||0
187076|NCT00631189|458384|P2|STARTED|Initial Phase||0
187077|NCT00631189|458385|P1|STARTED|Initial Phase||668
187078|NCT00631358|458429|P2|NOT COMPLETED|Overall Study||2
187079|NCT00631358|458430|P1|NOT COMPLETED|Overall Study||6
187080|NCT00631358|458429|P2|COMPLETED|Overall Study||45
187081|NCT00631358|458430|P1|COMPLETED|Overall Study||44
187082|NCT00631358|458429|P2|STARTED|Overall Study||47
187083|NCT00631358|458430|P1|STARTED|Overall Study||50
187084|NCT00631371|458446|P2|NOT COMPLETED|Overall Study||391
187085|NCT00631371|458447|P1|NOT COMPLETED|Overall Study||400
187086|NCT00631371|458446|P2|COMPLETED|Overall Study||0
187087|NCT00631371|458447|P1|COMPLETED|Overall Study||0
187088|NCT00631371|458446|P2|Treated|Overall Study||391
187089|NCT00631371|458447|P1|Treated|Overall Study||393
187090|NCT00631371|458446|P2|STARTED|Overall Study||391
187091|NCT00631371|458447|P1|STARTED|Overall Study||400
187092|NCT00631410|458461|P2|NOT COMPLETED|Overall Study||6
187093|NCT00631410|458462|P1|NOT COMPLETED|Overall Study||6
187094|NCT00631410|458461|P2|COMPLETED|Overall Study||0
187095|NCT00631410|458462|P1|COMPLETED|Overall Study||0
187096|NCT00631410|458461|P2|STARTED|Overall Study||6
187097|NCT00631410|458462|P1|STARTED|Overall Study||6
187098|NCT00631449|458481|P2|NOT COMPLETED|Overall Study||0
187099|NCT00631449|458482|P1|NOT COMPLETED|Overall Study||0
187100|NCT00631449|458481|P2|COMPLETED|Overall Study||15
187101|NCT00631449|458482|P1|COMPLETED|Overall Study||15
187102|NCT00631449|458481|P2|STARTED|Overall Study||15
187103|NCT00631449|458482|P1|STARTED|Overall Study||15
187104|NCT00631475|458488|P1|NOT COMPLETED|Overall Study||45
187105|NCT00631475|458488|P1|COMPLETED|Overall Study||83
187106|NCT00631475|458488|P1|STARTED|Overall Study||128
187107|NCT00631488|458499|P3|NOT COMPLETED|Overall Study||2
187108|NCT00631488|458500|P2|NOT COMPLETED|Overall Study||2
187109|NCT00631488|458501|P1|NOT COMPLETED|Overall Study||4
187110|NCT00631488|458499|P3|COMPLETED|Overall Study||47
187111|NCT00631488|458500|P2|COMPLETED|Overall Study||47
187112|NCT00631488|458501|P1|COMPLETED|Overall Study||44
187113|NCT00631488|458499|P3|Completed Post-Treatment Period|Overall Study||47
187114|NCT00631488|458500|P2|Completed Post-Treatment Period|Overall Study||47
187115|NCT00631488|458501|P1|Completed Post-Treatment Period|Overall Study||44
187116|NCT00631488|458499|P3|STARTED|Overall Study||49
187117|NCT00631488|458500|P2|STARTED|Overall Study||49
187118|NCT00631488|458501|P1|STARTED|Overall Study||48
187119|NCT00631540|458521|P1|NOT COMPLETED|Overall Study||14
187120|NCT00631540|458521|P1|COMPLETED|Overall Study||86
187121|NCT00631540|458521|P1|STARTED|Overall Study||100
187122|NCT00631657|458532|P3|NOT COMPLETED|7-Day Discontinuation Period||1
187123|NCT00631657|458533|P2|NOT COMPLETED|7-Day Discontinuation Period||1
187124|NCT00631657|458534|P1|NOT COMPLETED|7-Day Discontinuation Period||2
187125|NCT00631657|458532|P3|COMPLETED|7-Day Discontinuation Period||65
187126|NCT00631657|458533|P2|COMPLETED|7-Day Discontinuation Period||136
187127|NCT00631657|458534|P1|COMPLETED|7-Day Discontinuation Period||65
187128|NCT00631657|458532|P3|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|65
187129|NCT00631657|458533|P2|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|136
187130|NCT00631657|458534|P1|Treated|7-Day Discontinuation Period|One participant was not treated during the Discontinuation Period.|66
187131|NCT00631657|458532|P3|STARTED|7-Day Discontinuation Period||66
187132|NCT00631657|458533|P2|STARTED|7-Day Discontinuation Period||137
187133|NCT00631657|458534|P1|STARTED|7-Day Discontinuation Period|One participant was radomized in the Discont. Period, without completing the Treatment Period.|67
187134|NCT00631657|458532|P3|NOT COMPLETED|6-Month Treatment Period||50
187135|NCT00631657|458533|P2|NOT COMPLETED|6-Month Treatment Period||0
187136|NCT00631657|458534|P1|NOT COMPLETED|6-Month Treatment Period||141
187137|NCT00631657|458532|P3|COMPLETED|6-Month Treatment Period||66
187138|NCT00631657|458533|P2|COMPLETED|6-Month Treatment Period||0
187139|NCT00631657|458534|P1|COMPLETED|6-Month Treatment Period||203
187140|NCT00631657|458532|P3|Treated|6-Month Treatment Period|One randomized participant was not treated during the 6-month Treatment Period.|115
187141|NCT00631657|458533|P2|Treated|6-Month Treatment Period||0
187142|NCT00631657|458534|P1|Treated|6-Month Treatment Period|Two randomized participants were not treated during the 6-month Treatment Period.|342
187143|NCT00631657|458532|P3|STARTED|6-Month Treatment Period||116
187144|NCT00631657|458533|P2|STARTED|6-Month Treatment Period||0
187145|NCT00631657|458534|P1|STARTED|6-Month Treatment Period||344
187146|NCT00631670|458563|P2|NOT COMPLETED|Overall Study||0
187147|NCT00631670|458564|P1|NOT COMPLETED|Overall Study||0
187148|NCT00631670|458563|P2|COMPLETED|Overall Study||0
187149|NCT00631670|458564|P1|COMPLETED|Overall Study||21
187150|NCT00631670|458563|P2|STARTED|Overall Study||0
187151|NCT00631670|458564|P1|STARTED|Overall Study||21
187152|NCT00631696|458580|P2|NOT COMPLETED|Overall Study||40
187153|NCT00631696|458581|P1|NOT COMPLETED|Overall Study||37
187154|NCT00631696|458580|P2|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|70
187155|NCT00631696|458581|P1|COMPLETED|Overall Study|Completed study at time of database release 18Oct2011.|75
187156|NCT00631696|458580|P2|Ongoing at Database Release 18Oct2011|Overall Study||0
187157|NCT00631696|458581|P1|Ongoing at Database Release 18Oct2011|Overall Study|Completed Tx at time of database release 18Oct2011; included in all analyses.|2
187158|NCT00631696|458580|P2|Received Study Treatment (Tx)|Overall Study||109
187159|NCT00631696|458581|P1|Received Study Treatment (Tx)|Overall Study||111
187160|NCT00631696|458580|P2|STARTED|Overall Study||110
187161|NCT00631696|458581|P1|STARTED|Overall Study||112
187162|NCT00631748|458607|P2|NOT COMPLETED|Overall Study||22
187163|NCT00631748|458608|P1|NOT COMPLETED|Overall Study||18
187164|NCT00631748|458607|P2|COMPLETED|Overall Study|9 participants completed the double-blind portion of the study; 5 participants completed follow-up.|9
187165|NCT00631748|458608|P1|COMPLETED|Overall Study|11 participants completed the double-blind portion of the study; 8 participants completed follow-up.|11
187166|NCT00631748|458607|P2|STARTED|Overall Study||31
187167|NCT00631748|458608|P1|STARTED|Overall Study||29
187168|NCT00631917|458618|P2|NOT COMPLETED|Overall Study||108
187169|NCT00631917|458619|P1|NOT COMPLETED|Overall Study||88
187170|NCT00631917|458618|P2|COMPLETED|Overall Study||291
187171|NCT00631917|458619|P1|COMPLETED|Overall Study||287
187172|NCT00631917|458618|P2|STARTED|Overall Study||399
187173|NCT00631917|458619|P1|STARTED|Overall Study||375
187174|NCT00631969|458635|P2|NOT COMPLETED|Overall Study||21
187175|NCT00631969|458636|P1|NOT COMPLETED|Overall Study||15
187176|NCT00631969|458635|P2|COMPLETED|Overall Study||155
187177|NCT00631969|458636|P1|COMPLETED|Overall Study||171
187178|NCT00631969|458635|P2|Received Treatment|Overall Study|safety population|174
187179|NCT00631969|458636|P1|Received Treatment|Overall Study|safety population|184
187180|NCT00631969|458635|P2|STARTED|Overall Study||176
187181|NCT00631969|458636|P1|STARTED|Overall Study||186
187182|NCT00622635|458680|P6|NOT COMPLETED|Treatment Period 3||0
187183|NCT00622635|458681|P5|NOT COMPLETED|Treatment Period 3||0
187184|NCT00622635|458682|P4|NOT COMPLETED|Treatment Period 3||3
187185|NCT00622635|458683|P3|NOT COMPLETED|Treatment Period 3||0
187186|NCT00622635|458684|P2|NOT COMPLETED|Treatment Period 3||0
187187|NCT00622635|458685|P1|NOT COMPLETED|Treatment Period 3||0
187188|NCT00622635|458680|P6|COMPLETED|Treatment Period 3||10
187189|NCT00622635|458681|P5|COMPLETED|Treatment Period 3||9
187190|NCT00622635|458682|P4|COMPLETED|Treatment Period 3||10
187191|NCT00622635|458683|P3|COMPLETED|Treatment Period 3||10
187192|NCT00622635|458684|P2|COMPLETED|Treatment Period 3||10
187193|NCT00622635|458685|P1|COMPLETED|Treatment Period 3||12
187194|NCT00622635|458680|P6|STARTED|Treatment Period 3||10
187195|NCT00622635|458681|P5|STARTED|Treatment Period 3||9
187196|NCT00622635|458682|P4|STARTED|Treatment Period 3||13
187197|NCT00622635|458683|P3|STARTED|Treatment Period 3||10
187198|NCT00622635|458684|P2|STARTED|Treatment Period 3||10
187199|NCT00622635|458685|P1|STARTED|Treatment Period 3||12
187200|NCT00622635|458680|P6|NOT COMPLETED|Treatment Period 2||0
187201|NCT00622635|458681|P5|NOT COMPLETED|Treatment Period 2||0
187202|NCT00622635|458682|P4|NOT COMPLETED|Treatment Period 2||0
187203|NCT00622635|458683|P3|NOT COMPLETED|Treatment Period 2||0
187204|NCT00622635|458684|P2|NOT COMPLETED|Treatment Period 2||0
187205|NCT00622635|458685|P1|NOT COMPLETED|Treatment Period 2||1
187206|NCT00622635|458680|P6|COMPLETED|Treatment Period 2||10
187207|NCT00622635|458681|P5|COMPLETED|Treatment Period 2||9
187208|NCT00622635|458682|P4|COMPLETED|Treatment Period 2||13
187209|NCT00622635|458683|P3|COMPLETED|Treatment Period 2||10
187210|NCT00622635|458684|P2|COMPLETED|Treatment Period 2||10
187211|NCT00622635|458685|P1|COMPLETED|Treatment Period 2||12
187212|NCT00622635|458680|P6|STARTED|Treatment Period 2||10
187213|NCT00622635|458681|P5|STARTED|Treatment Period 2||9
187214|NCT00622635|458682|P4|STARTED|Treatment Period 2||13
187215|NCT00622635|458683|P3|STARTED|Treatment Period 2||10
187216|NCT00622635|458684|P2|STARTED|Treatment Period 2||10
187217|NCT00622635|458685|P1|STARTED|Treatment Period 2||13
187218|NCT00622635|458680|P6|NOT COMPLETED|Treatment Period 1||0
187219|NCT00622635|458681|P5|NOT COMPLETED|Treatment Period 1||1
187220|NCT00622635|458682|P4|NOT COMPLETED|Treatment Period 1||0
187221|NCT00622635|458683|P3|NOT COMPLETED|Treatment Period 1||1
187222|NCT00622635|458684|P2|NOT COMPLETED|Treatment Period 1||1
187223|NCT00622635|458685|P1|NOT COMPLETED|Treatment Period 1||0
187224|NCT00622635|458680|P6|COMPLETED|Treatment Period 1||10
187225|NCT00622635|458681|P5|COMPLETED|Treatment Period 1||9
187226|NCT00622635|458682|P4|COMPLETED|Treatment Period 1||13
187227|NCT00622635|458683|P3|COMPLETED|Treatment Period 1||10
187228|NCT00622635|458684|P2|COMPLETED|Treatment Period 1||10
187229|NCT00622635|458685|P1|COMPLETED|Treatment Period 1||13
187230|NCT00622635|458680|P6|STARTED|Treatment Period 1||10
187231|NCT00622635|458681|P5|STARTED|Treatment Period 1||10
187232|NCT00622635|458682|P4|STARTED|Treatment Period 1||13
187233|NCT00622635|458683|P3|STARTED|Treatment Period 1||11
187234|NCT00622635|458684|P2|STARTED|Treatment Period 1||11
187235|NCT00622635|458685|P1|STARTED|Treatment Period 1||13
187236|NCT00622700|458753|P7|NOT COMPLETED|Extension Treatment Period||30
187237|NCT00622700|458754|P6|NOT COMPLETED|Extension Treatment Period||17
187238|NCT00622700|458755|P5|NOT COMPLETED|Extension Treatment Period||39
187239|NCT00622700|458756|P4|NOT COMPLETED|Extension Treatment Period||21
187240|NCT00622700|458757|P3|NOT COMPLETED|Extension Treatment Period||0
187241|NCT00622700|458758|P2|NOT COMPLETED|Extension Treatment Period||0
187242|NCT00622700|458759|P1|NOT COMPLETED|Extension Treatment Period||0
187243|NCT00622700|458753|P7|COMPLETED|Extension Treatment Period||120
187244|NCT00622700|458754|P6|COMPLETED|Extension Treatment Period||50
187245|NCT00622700|458755|P5|COMPLETED|Extension Treatment Period||103
187246|NCT00622700|458756|P4|COMPLETED|Extension Treatment Period||43
187247|NCT00622700|458757|P3|COMPLETED|Extension Treatment Period||0
187248|NCT00622700|458758|P2|COMPLETED|Extension Treatment Period||0
187249|NCT00622700|458759|P1|COMPLETED|Extension Treatment Period||0
187250|NCT00622700|458753|P7|STARTED|Extension Treatment Period|13 participants completed core treatment period but did not enter in extension treatment period.|150
187251|NCT00622700|458754|P6|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|67
187252|NCT00622700|458755|P5|STARTED|Extension Treatment Period|8 participants completed core treatment period but did not enter in extension treatment period.|142
187253|NCT00622700|458756|P4|STARTED|Extension Treatment Period|10 participants completed core treatment period but did not enter in extension treatment period.|64
187254|NCT00622700|458757|P3|STARTED|Extension Treatment Period||0
187255|NCT00622700|458758|P2|STARTED|Extension Treatment Period||0
187256|NCT00622700|458759|P1|STARTED|Extension Treatment Period|Participants were re-randomized in a 1:1 ratio to either teriflunomide 7 mg or 14 mg treatment arm.|0
187257|NCT00622700|458753|P7|NOT COMPLETED|Core Treatment Period||0
187258|NCT00622700|458754|P6|NOT COMPLETED|Core Treatment Period||0
187259|NCT00622700|458755|P5|NOT COMPLETED|Core Treatment Period||0
187260|NCT00622700|458756|P4|NOT COMPLETED|Core Treatment Period||0
187261|NCT00622700|458757|P3|NOT COMPLETED|Core Treatment Period||53
187262|NCT00622700|458758|P2|NOT COMPLETED|Core Treatment Period||55
187263|NCT00622700|458759|P1|NOT COMPLETED|Core Treatment Period||56
187264|NCT00622700|458753|P7|COMPLETED|Core Treatment Period||0
187265|NCT00622700|458754|P6|COMPLETED|Core Treatment Period||0
187266|NCT00622700|458755|P5|COMPLETED|Core Treatment Period||0
187267|NCT00622700|458756|P4|COMPLETED|Core Treatment Period||0
187268|NCT00622700|458757|P3|COMPLETED|Core Treatment Period||163
187269|NCT00622700|458758|P2|COMPLETED|Core Treatment Period||150
187270|NCT00622700|458759|P1|COMPLETED|Core Treatment Period||141
187271|NCT00622700|458753|P7|Treated|Core Treatment Period||0
187272|NCT00622700|458754|P6|Treated|Core Treatment Period||0
187273|NCT00622700|458755|P5|Treated|Core Treatment Period||0
187274|NCT00622700|458756|P4|Treated|Core Treatment Period||0
187275|NCT00622700|458757|P3|Treated|Core Treatment Period||214
187276|NCT00622700|458758|P2|Treated|Core Treatment Period||203
187277|NCT00622700|458759|P1|Treated|Core Treatment Period||197
187278|NCT00622700|458753|P7|STARTED|Core Treatment Period||0
187279|NCT00622700|458754|P6|STARTED|Core Treatment Period||0
187280|NCT00622700|458755|P5|STARTED|Core Treatment Period||0
187281|NCT00622700|458756|P4|STARTED|Core Treatment Period||0
187282|NCT00622700|458757|P3|STARTED|Core Treatment Period||216
187283|NCT00622700|458758|P2|STARTED|Core Treatment Period||205
187284|NCT00622700|458759|P1|STARTED|Core Treatment Period||197
187285|NCT00622713|458818|P1|NOT COMPLETED|Overall Study||59
187286|NCT00622713|458818|P1|COMPLETED|Overall Study||169
187287|NCT00622713|458818|P1|Intent to Treat (ITT) Population|Overall Study||218
187288|NCT00622713|458818|P1|Exposed to Study Drug|Overall Study||226
187289|NCT00622713|458818|P1|STARTED|Overall Study||228
187290|NCT00622726|458828|P2|NOT COMPLETED|August, 2010 to April, 2013||5
187291|NCT00622726|458829|P1|NOT COMPLETED|August, 2010 to April, 2013||1
187292|NCT00622726|458828|P2|COMPLETED|August, 2010 to April, 2013||68
187293|NCT00622726|458829|P1|COMPLETED|August, 2010 to April, 2013||69
187294|NCT00622726|458828|P2|STARTED|August, 2010 to April, 2013||73
187295|NCT00622726|458829|P1|STARTED|August, 2010 to April, 2013||70
187296|NCT00622726|458828|P2|NOT COMPLETED|March, 2008 to August, 2010||2
187297|NCT00622726|458829|P1|NOT COMPLETED|March, 2008 to August, 2010||5
187298|NCT00622726|458828|P2|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|73
187299|NCT00622726|458829|P1|COMPLETED|March, 2008 to August, 2010|All infants were extremely immature with multiple neonatal intensive care unit complications.|70
187300|NCT00622726|458828|P2|STARTED|March, 2008 to August, 2010||75
187301|NCT00622726|458829|P1|STARTED|March, 2008 to August, 2010||75
187302|NCT00622739|458841|P2|NOT COMPLETED|Overall Study||6
187303|NCT00622739|458842|P1|NOT COMPLETED|Overall Study||2
187304|NCT00622739|458841|P2|COMPLETED|Overall Study||9
187305|NCT00622739|458842|P1|COMPLETED|Overall Study||11
187306|NCT00622739|458841|P2|STARTED|Overall Study||15
187307|NCT00622739|458842|P1|STARTED|Overall Study||13
187308|NCT00622869|458851|P3|NOT COMPLETED|Overall Study||39
187309|NCT00622869|458852|P2|NOT COMPLETED|Overall Study||57
187310|NCT00622869|458853|P1|NOT COMPLETED|Overall Study||43
187311|NCT00622869|458851|P3|COMPLETED|Overall Study||204
187312|NCT00622869|458852|P2|COMPLETED|Overall Study||174
187313|NCT00622869|458853|P1|COMPLETED|Overall Study||202
187314|NCT00622869|458851|P3|STARTED|Overall Study||243
187315|NCT00622869|458852|P2|STARTED|Overall Study||231
187316|NCT00622869|458853|P1|STARTED|Overall Study||245
187317|NCT00622908|458872|P2|NOT COMPLETED|Overall Study||10
187318|NCT00622908|458873|P1|NOT COMPLETED|Overall Study||3
187319|NCT00622908|458872|P2|COMPLETED|Overall Study||122
187320|NCT00622908|458873|P1|COMPLETED|Overall Study||134
187321|NCT00622908|458872|P2|STARTED|Overall Study|Intent to treat population|132
187322|NCT00622908|458873|P1|STARTED|Overall Study|Intent to treat population|137
187323|NCT00623012|458885|P1|NOT COMPLETED|Overall Study||0
187324|NCT00623012|458885|P1|COMPLETED|Overall Study||2
187325|NCT00623012|458885|P1|STARTED|Overall Study||2
187326|NCT00623103|458893|P2|NOT COMPLETED|Overall Study||113
187327|NCT00623103|458894|P1|NOT COMPLETED|Overall Study||111
187328|NCT00623103|458893|P2|COMPLETED|Overall Study||175
187329|NCT00623103|458894|P1|COMPLETED|Overall Study||184
187330|NCT00623103|458893|P2|Safety Set: Received Study Drug|Overall Study||288
187331|NCT00623103|458894|P1|Safety Set: Received Study Drug|Overall Study|One randomized participant did not receive study drug and was not included in the Safety set.|294
187332|NCT00623103|458893|P2|STARTED|Overall Study||288
187333|NCT00623103|458894|P1|STARTED|Overall Study||295
187334|NCT00623181|458916|P2|NOT COMPLETED|Overall Study||0
187335|NCT00623181|458917|P1|NOT COMPLETED|Overall Study||0
187336|NCT00623181|458916|P2|COMPLETED|Overall Study||54
187337|NCT00623181|458917|P1|COMPLETED|Overall Study||56
187338|NCT00623181|458916|P2|STARTED|Overall Study||54
187339|NCT00623181|458917|P1|STARTED|Overall Study||56
187340|NCT00623194|458929|P1|NOT COMPLETED|Overall Study||5
187341|NCT00623194|458929|P1|COMPLETED|Overall Study||141
187342|NCT00623194|458929|P1|STARTED|Overall Study||146
187343|NCT00623233|458949|P1|NOT COMPLETED|Overall Study||24
187344|NCT00623233|458949|P1|COMPLETED|Overall Study|Included those who discontinued due to PD or death and those who achieved complete response (CR).|28
187345|NCT00623233|458949|P1|STARTED|Overall Study||52
187346|NCT00632021|458958|P2|NOT COMPLETED|Overall Study||4
187347|NCT00632021|458959|P1|NOT COMPLETED|Overall Study||7
187348|NCT00632021|458958|P2|COMPLETED|Overall Study||428
187349|NCT00632021|458959|P1|COMPLETED|Overall Study||423
187350|NCT00632021|458958|P2|STARTED|Overall Study||432
187351|NCT00632021|458959|P1|STARTED|Overall Study||430
187352|NCT00632099|458969|P2|NOT COMPLETED|Overall Study||3
187353|NCT00632099|458970|P1|NOT COMPLETED|Overall Study||3
187354|NCT00632099|458969|P2|COMPLETED|Overall Study||8
187355|NCT00632099|458970|P1|COMPLETED|Overall Study||7
187356|NCT00632099|458969|P2|STARTED|Overall Study||11
187357|NCT00632099|458970|P1|STARTED|Overall Study||10
187358|NCT00632125|458976|P1|NOT COMPLETED|Overall Study||302
187359|NCT00632125|458976|P1|COMPLETED|Overall Study||1393
187360|NCT00632125|458976|P1|STARTED|Overall Study|1,698 patients were enrolled but 3 patients did not receive any study medication.|1695
187361|NCT00632203|458982|P2|NOT COMPLETED|Overall Study||0
187362|NCT00632203|458983|P1|NOT COMPLETED|Overall Study||1
187363|NCT00632203|458982|P2|COMPLETED|Overall Study||27
187364|NCT00632203|458983|P1|COMPLETED|Overall Study||25
187365|NCT00632203|458982|P2|STARTED|Overall Study||27
187366|NCT00632203|458983|P1|STARTED|Overall Study||26
187367|NCT00632229|459003|P2|NOT COMPLETED|Overall Study||6
187368|NCT00632229|459004|P1|NOT COMPLETED|Overall Study||6
187369|NCT00632229|459003|P2|COMPLETED|Overall Study||11
187370|NCT00632229|459004|P1|COMPLETED|Overall Study||11
187371|NCT00632229|459003|P2|STARTED|Overall Study||17
187372|NCT00632229|459004|P1|STARTED|Overall Study||17
187373|NCT00632281|459012|P1|NOT COMPLETED|Overall Study||0
187374|NCT00632281|459012|P1|COMPLETED|Overall Study||38
187375|NCT00632281|459012|P1|STARTED|Overall Study||38
187376|NCT00632463|459020|P3|NOT COMPLETED|Overall Study||0
187377|NCT00632463|459021|P2|NOT COMPLETED|Overall Study||1
187378|NCT00632463|459022|P1|NOT COMPLETED|Overall Study||0
187379|NCT00632463|459020|P3|COMPLETED|Overall Study||7
187380|NCT00632463|459021|P2|COMPLETED|Overall Study||6
187381|NCT00632463|459022|P1|COMPLETED|Overall Study||7
187382|NCT00632463|459020|P3|STARTED|Overall Study||7
187383|NCT00632463|459021|P2|STARTED|Overall Study||7
187384|NCT00632463|459022|P1|STARTED|Overall Study||7
187385|NCT00632489|459039|P3|NOT COMPLETED|Overall Study||0
187386|NCT00632489|459040|P2|NOT COMPLETED|Overall Study||5
187387|NCT00632489|459041|P1|NOT COMPLETED|Overall Study||15
187388|NCT00632489|459039|P3|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
187389|NCT00632489|459040|P2|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
187390|NCT00632489|459041|P1|COMPLETED|Overall Study|Pts remained on study until disease progression, intolerable toxicity or other reason to discontinue|0
187391|NCT00632489|459039|P3|STARTED|Overall Study||0
187392|NCT00632489|459040|P2|STARTED|Overall Study||5
187393|NCT00632489|459041|P1|STARTED|Overall Study||15
187394|NCT00632502|459054|P2|NOT COMPLETED|Overall Study||1
187395|NCT00632502|459055|P1|NOT COMPLETED|Overall Study||3
187396|NCT00632502|459054|P2|COMPLETED|Overall Study||11
187397|NCT00632502|459055|P1|COMPLETED|Overall Study||22
187398|NCT00632502|459054|P2|Completed Treatment|Overall Study||9
187399|NCT00632502|459055|P1|Completed Treatment|Overall Study||19
187400|NCT00632502|459054|P2|Treated|Overall Study||12
187401|NCT00632502|459055|P1|Treated|Overall Study||22
187402|NCT00632502|459054|P2|STARTED|Overall Study||12
187403|NCT00632502|459055|P1|STARTED|Overall Study||25
187404|NCT00632541|459080|P1|NOT COMPLETED|Overall Study||7
187405|NCT00632541|459080|P1|COMPLETED|Overall Study||11
187406|NCT00632541|459080|P1|STARTED|Overall Study|18 subjects were accrued to the study|18
187407|NCT00632619|459086|P2|NOT COMPLETED|Overall Study||4
187408|NCT00632619|459087|P1|NOT COMPLETED|Overall Study||8
187409|NCT00632619|459086|P2|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
nd cohort completed follow up 7/18/11"|31
187410|NCT00632619|459087|P1|COMPLETED|Overall Study|"st cohort completed follow up by 5/24/10
nd cohort completed follow up 7/18/11"|25
187411|NCT00632619|459086|P2|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|35
187412|NCT00632619|459087|P1|STARTED|Overall Study|first cohort started 9/11/09 second cohort started 12/7/11|33
187413|NCT00632632|459103|P2|NOT COMPLETED|Overall Study||3
187414|NCT00632632|459104|P1|NOT COMPLETED|Overall Study||0
187415|NCT00632632|459103|P2|COMPLETED|Overall Study||9
187416|NCT00632632|459104|P1|COMPLETED|Overall Study||13
187417|NCT00632632|459103|P2|STARTED|Overall Study||12
187418|NCT00632632|459104|P1|STARTED|Overall Study||13
187419|NCT00632736|459114|P1|NOT COMPLETED|Overall Study||268
187420|NCT00632736|459114|P1|COMPLETED|Overall Study||151
187421|NCT00632736|459114|P1|STARTED|Overall Study||419
187422|NCT00632749|459133|P14|NOT COMPLETED|Overall Study||6
187423|NCT00632749|459134|P13|NOT COMPLETED|Overall Study||3
187424|NCT00632749|459135|P12|NOT COMPLETED|Overall Study||4
187425|NCT00632749|459136|P11|NOT COMPLETED|Overall Study||7
187426|NCT00632749|459137|P10|NOT COMPLETED|Overall Study||3
187427|NCT00632749|459138|P9|NOT COMPLETED|Overall Study||5
187428|NCT00632749|459139|P8|NOT COMPLETED|Overall Study||4
187429|NCT00632749|459140|P7|NOT COMPLETED|Overall Study||5
187430|NCT00632749|459141|P6|NOT COMPLETED|Overall Study||8
187431|NCT00632749|459142|P5|NOT COMPLETED|Overall Study||7
187432|NCT00632749|459143|P4|NOT COMPLETED|Overall Study||4
187433|NCT00632749|459144|P3|NOT COMPLETED|Overall Study||3
187434|NCT00632749|459145|P2|NOT COMPLETED|Overall Study||5
187435|NCT00632749|459146|P1|NOT COMPLETED|Overall Study||4
187436|NCT00632749|459133|P14|COMPLETED|Overall Study||0
187437|NCT00632749|459134|P13|COMPLETED|Overall Study||0
187438|NCT00632749|459135|P12|COMPLETED|Overall Study||0
187439|NCT00632749|459136|P11|COMPLETED|Overall Study||0
187440|NCT00632749|459137|P10|COMPLETED|Overall Study||0
187441|NCT00632749|459138|P9|COMPLETED|Overall Study||0
187442|NCT00632749|459139|P8|COMPLETED|Overall Study||0
187443|NCT00632749|459140|P7|COMPLETED|Overall Study||0
187444|NCT00632749|459141|P6|COMPLETED|Overall Study||0
187445|NCT00632749|459142|P5|COMPLETED|Overall Study||0
187446|NCT00632749|459143|P4|COMPLETED|Overall Study||0
187447|NCT00632749|459144|P3|COMPLETED|Overall Study||0
187448|NCT00632749|459145|P2|COMPLETED|Overall Study||0
187449|NCT00632749|459146|P1|COMPLETED|Overall Study||0
187450|NCT00632749|459133|P14|Not Treated|Overall Study||0
187451|NCT00632749|459134|P13|Not Treated|Overall Study||0
187452|NCT00632749|459135|P12|Not Treated|Overall Study||0
187453|NCT00632749|459136|P11|Not Treated|Overall Study||0
187454|NCT00632749|459137|P10|Not Treated|Overall Study||0
187455|NCT00632749|459138|P9|Not Treated|Overall Study||0
187456|NCT00632749|459139|P8|Not Treated|Overall Study||0
187457|NCT00632749|459140|P7|Not Treated|Overall Study||1
187458|NCT00632749|459141|P6|Not Treated|Overall Study||1
187459|NCT00632749|459142|P5|Not Treated|Overall Study||0
187460|NCT00632749|459143|P4|Not Treated|Overall Study||0
187461|NCT00632749|459144|P3|Not Treated|Overall Study||0
187462|NCT00632749|459145|P2|Not Treated|Overall Study||2
187463|NCT00632749|459146|P1|Not Treated|Overall Study||0
187464|NCT00632749|459133|P14|Treated|Overall Study||6
187465|NCT00632749|459134|P13|Treated|Overall Study||3
187466|NCT00632749|459135|P12|Treated|Overall Study||4
187467|NCT00632749|459136|P11|Treated|Overall Study||7
187468|NCT00632749|459137|P10|Treated|Overall Study||3
187469|NCT00632749|459138|P9|Treated|Overall Study||5
187470|NCT00632749|459139|P8|Treated|Overall Study||4
187471|NCT00632749|459140|P7|Treated|Overall Study||4
187472|NCT00632749|459141|P6|Treated|Overall Study||7
187473|NCT00632749|459142|P5|Treated|Overall Study||7
187474|NCT00632749|459143|P4|Treated|Overall Study||4
187475|NCT00632749|459144|P3|Treated|Overall Study||3
187476|NCT00632749|459145|P2|Treated|Overall Study||3
187477|NCT00632749|459146|P1|Treated|Overall Study||4
187478|NCT00632749|459133|P14|STARTED|Overall Study||6
187479|NCT00632749|459134|P13|STARTED|Overall Study||3
187480|NCT00632749|459135|P12|STARTED|Overall Study||4
187481|NCT00632749|459136|P11|STARTED|Overall Study||7
187482|NCT00632749|459137|P10|STARTED|Overall Study||3
187483|NCT00632749|459138|P9|STARTED|Overall Study||5
187484|NCT00632749|459139|P8|STARTED|Overall Study||4
187485|NCT00632749|459140|P7|STARTED|Overall Study||5
187486|NCT00632749|459141|P6|STARTED|Overall Study||8
187487|NCT00632749|459142|P5|STARTED|Overall Study||7
187488|NCT00632749|459143|P4|STARTED|Overall Study||4
187489|NCT00632749|459144|P3|STARTED|Overall Study||3
187490|NCT00632749|459145|P2|STARTED|Overall Study||5
187491|NCT00632749|459146|P1|STARTED|Overall Study||4
187492|NCT00632814|459443|P3|NOT COMPLETED|Overall Study||0
187493|NCT00632814|459444|P2|NOT COMPLETED|Overall Study||0
187494|NCT00632814|459445|P1|NOT COMPLETED|Overall Study||0
187495|NCT00632814|459443|P3|COMPLETED|Overall Study||8
187496|NCT00632814|459444|P2|COMPLETED|Overall Study||13
187497|NCT00632814|459445|P1|COMPLETED|Overall Study||11
187498|NCT00632814|459443|P3|STARTED|Overall Study||8
187499|NCT00632814|459444|P2|STARTED|Overall Study||13
187500|NCT00632814|459445|P1|STARTED|Overall Study||11
187501|NCT00632931|459477|P3|NOT COMPLETED|Part 2||24
187502|NCT00632931|459478|P2|NOT COMPLETED|Part 2||0
187503|NCT00632931|459479|P1|NOT COMPLETED|Part 2||0
187504|NCT00632931|459477|P3|COMPLETED|Part 2||0
187505|NCT00632931|459478|P2|COMPLETED|Part 2||0
187506|NCT00632931|459479|P1|COMPLETED|Part 2||0
187507|NCT00632931|459477|P3|STARTED|Part 2||24
187508|NCT00632931|459478|P2|STARTED|Part 2||0
187509|NCT00632931|459479|P1|STARTED|Part 2||0
187510|NCT00632931|459477|P3|NOT COMPLETED|Post-Part 1 Washout||0
187511|NCT00632931|459478|P2|NOT COMPLETED|Post-Part 1 Washout||0
187512|NCT00632931|459479|P1|NOT COMPLETED|Post-Part 1 Washout||0
187513|NCT00632931|459477|P3|COMPLETED|Post-Part 1 Washout||0
187514|NCT00632931|459478|P2|COMPLETED|Post-Part 1 Washout||12
187515|NCT00632931|459479|P1|COMPLETED|Post-Part 1 Washout||12
187516|NCT00632931|459477|P3|STARTED|Post-Part 1 Washout||0
187517|NCT00632931|459478|P2|STARTED|Post-Part 1 Washout||12
187518|NCT00632931|459479|P1|STARTED|Post-Part 1 Washout|1 patient who did not complete Period 1 was subsequently enrolled into Post Part 1|12
187519|NCT00632931|459477|P3|NOT COMPLETED|Part 1, Period 2||0
187520|NCT00632931|459478|P2|NOT COMPLETED|Part 1, Period 2||0
187521|NCT00632931|459479|P1|NOT COMPLETED|Part 1, Period 2||0
187522|NCT00632931|459477|P3|COMPLETED|Part 1, Period 2||0
187523|NCT00632931|459478|P2|COMPLETED|Part 1, Period 2||12
187524|NCT00632931|459479|P1|COMPLETED|Part 1, Period 2||11
187525|NCT00632931|459477|P3|STARTED|Part 1, Period 2||0
187526|NCT00632931|459478|P2|STARTED|Part 1, Period 2||12
187527|NCT00632931|459479|P1|STARTED|Part 1, Period 2||11
187528|NCT00632931|459477|P3|NOT COMPLETED|Part 1, Washout||0
187529|NCT00632931|459478|P2|NOT COMPLETED|Part 1, Washout||0
187530|NCT00632931|459479|P1|NOT COMPLETED|Part 1, Washout||0
187531|NCT00632931|459477|P3|COMPLETED|Part 1, Washout||0
187532|NCT00632931|459478|P2|COMPLETED|Part 1, Washout||12
187533|NCT00632931|459479|P1|COMPLETED|Part 1, Washout||11
187534|NCT00632931|459477|P3|STARTED|Part 1, Washout||0
187535|NCT00632931|459478|P2|STARTED|Part 1, Washout||12
187536|NCT00632931|459479|P1|STARTED|Part 1, Washout||11
187537|NCT00632931|459477|P3|NOT COMPLETED|Part 1, Period 1||0
187538|NCT00632931|459478|P2|NOT COMPLETED|Part 1, Period 1||0
187539|NCT00632931|459479|P1|NOT COMPLETED|Part 1, Period 1||2
187540|NCT00632931|459477|P3|COMPLETED|Part 1, Period 1||0
187541|NCT00632931|459478|P2|COMPLETED|Part 1, Period 1||12
187542|NCT00632931|459479|P1|COMPLETED|Part 1, Period 1||11
187543|NCT00632931|459477|P3|STARTED|Part 1, Period 1||0
187544|NCT00632931|459478|P2|STARTED|Part 1, Period 1||12
187545|NCT00632931|459479|P1|STARTED|Part 1, Period 1||13
187546|NCT00632970|459500|P2|NOT COMPLETED|Overall Study||0
187547|NCT00632970|459501|P1|NOT COMPLETED|Overall Study||0
187548|NCT00632970|459500|P2|COMPLETED|Overall Study||3
187549|NCT00632970|459501|P1|COMPLETED|Overall Study||3
187550|NCT00632970|459500|P2|STARTED|Overall Study||3
187551|NCT00632970|459501|P1|STARTED|Overall Study||3
187552|NCT00633009|459510|P3|NOT COMPLETED|Overall Study||1
187553|NCT00633009|459511|P2|NOT COMPLETED|Overall Study||4
187554|NCT00633009|459512|P1|NOT COMPLETED|Overall Study||4
187555|NCT00633009|459510|P3|COMPLETED|Overall Study||10
187556|NCT00633009|459511|P2|COMPLETED|Overall Study||23
187557|NCT00633009|459512|P1|COMPLETED|Overall Study||8
187558|NCT00633009|459510|P3|STARTED|Overall Study||11
187559|NCT00633009|459511|P2|STARTED|Overall Study||27
187560|NCT00633009|459512|P1|STARTED|Overall Study||12
187561|NCT00633074|459525|P2|NOT COMPLETED|Overall Study||0
187562|NCT00633074|459526|P1|NOT COMPLETED|Overall Study||1
187563|NCT00633074|459525|P2|COMPLETED|Overall Study||360
187564|NCT00633074|459526|P1|COMPLETED|Overall Study||359
187565|NCT00633074|459525|P2|STARTED|Overall Study||360
187566|NCT00633074|459526|P1|STARTED|Overall Study||360
187567|NCT00633087|459554|P1|NOT COMPLETED|Overall Study||0
187568|NCT00633087|459554|P1|COMPLETED|Overall Study||12
187569|NCT00633087|459554|P1|STARTED|Overall Study||12
187570|NCT00633126|459561|P1|NOT COMPLETED|Overall Study||1
187571|NCT00633126|459561|P1|COMPLETED|Overall Study||8
187572|NCT00633126|459561|P1|STARTED|Overall Study||9
187573|NCT00633139|459569|P3|NOT COMPLETED|Overall Study||1
187574|NCT00633139|459570|P2|NOT COMPLETED|Overall Study||1
187575|NCT00633139|459571|P1|NOT COMPLETED|Overall Study||0
187576|NCT00633139|459569|P3|COMPLETED|Overall Study||3
187577|NCT00633139|459570|P2|COMPLETED|Overall Study||4
187578|NCT00633139|459571|P1|COMPLETED|Overall Study||4
187579|NCT00633139|459569|P3|STARTED|Overall Study||4
187580|NCT00633139|459570|P2|STARTED|Overall Study||5
187581|NCT00633139|459571|P1|STARTED|Overall Study||4
187582|NCT00633152|459587|P2|NOT COMPLETED|Overall Study||6
187583|NCT00633152|459588|P1|NOT COMPLETED|Overall Study||14
187584|NCT00633152|459587|P2|COMPLETED|Overall Study||41
187585|NCT00633152|459588|P1|COMPLETED|Overall Study||89
187586|NCT00633152|459587|P2|Clinically Evaluable Population|Overall Study||39
187587|NCT00633152|459588|P1|Clinically Evaluable Population|Overall Study||86
187588|NCT00633152|459587|P2|MITT and Safety Population|Overall Study||45
187589|NCT00633152|459588|P1|MITT and Safety Population|Overall Study||98
187590|NCT00633152|459587|P2|STARTED|Overall Study||47
187591|NCT00633152|459588|P1|STARTED|Overall Study||103
187592|NCT00633217|459598|P2|NOT COMPLETED|Overall Study||23
187593|NCT00633217|459599|P1|NOT COMPLETED|Overall Study||15
187594|NCT00633217|459598|P2|COMPLETED|Overall Study||103
187595|NCT00633217|459599|P1|COMPLETED|Overall Study||106
187596|NCT00633217|459598|P2|STARTED|Overall Study||126
187597|NCT00633217|459599|P1|STARTED|Overall Study||121
187598|NCT00633243|459611|P2|NOT COMPLETED|Overall Study||7
187599|NCT00633243|459612|P1|NOT COMPLETED|Overall Study||1
187600|NCT00633243|459611|P2|COMPLETED|Overall Study||2
187601|NCT00633243|459612|P1|COMPLETED|Overall Study||11
187602|NCT00633243|459611|P2|STARTED|Overall Study||9
187603|NCT00633243|459612|P1|STARTED|Overall Study||12
187604|NCT00633256|459620|P2|NOT COMPLETED|Overall Study||3
187605|NCT00633256|459621|P1|NOT COMPLETED|Overall Study||4
187606|NCT00633256|459620|P2|COMPLETED|Overall Study||10
187607|NCT00633256|459621|P1|COMPLETED|Overall Study||8
187608|NCT00633256|459620|P2|STARTED|Overall Study||13
187609|NCT00633256|459621|P1|STARTED|Overall Study||12
187610|NCT00633360|459633|P2|NOT COMPLETED|Overall Study||3
187611|NCT00633360|459634|P1|NOT COMPLETED|Overall Study||4
187612|NCT00633360|459633|P2|COMPLETED|Overall Study||13
187613|NCT00633360|459634|P1|COMPLETED|Overall Study||12
187614|NCT00633360|459633|P2|STARTED|Overall Study||16
187615|NCT00633360|459634|P1|STARTED|Overall Study||16
187616|NCT00633399|459644|P2|NOT COMPLETED|Overall Study||15
187617|NCT00633399|459645|P1|NOT COMPLETED|Overall Study||22
187618|NCT00633399|459644|P2|COMPLETED|Overall Study||53
187619|NCT00633399|459645|P1|COMPLETED|Overall Study||49
187620|NCT00633399|459644|P2|STARTED|Overall Study||68
187621|NCT00633399|459645|P1|STARTED|Overall Study||71
187622|NCT00633464|459657|P2|NOT COMPLETED|Overall Study||2
187623|NCT00633464|459658|P1|NOT COMPLETED|Overall Study||0
187624|NCT00633464|459657|P2|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-25,study drug toxicity-4,subject request-3|37
187625|NCT00633464|459658|P1|COMPLETED|Overall Study|Completed=Offstudy;major reasons:Disease progression-27,study drug toxicity-7,max clinical benefit-3|40
187626|NCT00633464|459657|P2|Treated|Overall Study||37
187627|NCT00633464|459658|P1|Treated|Overall Study||40
187628|NCT00633464|459657|P2|STARTED|Overall Study||39
187629|NCT00633464|459658|P1|STARTED|Overall Study||40
187630|NCT00633477|459680|P2|NOT COMPLETED|Overall Study||0
187631|NCT00633477|459681|P1|NOT COMPLETED|Overall Study||2
187632|NCT00633477|459680|P2|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|11
187633|NCT00633477|459681|P1|COMPLETED|Overall Study|Include all subjects who could be evaluated for 28-d survival.|5
187634|NCT00633477|459680|P2|Completed Study Through Day 28|Overall Study||8
187635|NCT00633477|459681|P1|Completed Study Through Day 28|Overall Study||4
187636|NCT00633477|459680|P2|Prematurely Discontinued Study Drug|Overall Study||0
187637|NCT00633477|459681|P1|Prematurely Discontinued Study Drug|Overall Study||1
187638|NCT00633477|459680|P2|Randomized But Not Treated|Overall Study||0
187639|NCT00633477|459681|P1|Randomized But Not Treated|Overall Study||1
187640|NCT00633477|459680|P2|STARTED|Overall Study||11
187641|NCT00633477|459681|P1|STARTED|Overall Study|Seven subjects were randomized, however, one was not treated.|7
187642|NCT00633594|459698|P3|NOT COMPLETED|Overall Study||10
187643|NCT00633594|459699|P2|NOT COMPLETED|Overall Study||5
187644|NCT00633594|459700|P1|NOT COMPLETED|Overall Study||0
187645|NCT00633594|459698|P3|COMPLETED|Overall Study||16
187646|NCT00633594|459699|P2|COMPLETED|Overall Study||3
187647|NCT00633594|459700|P1|COMPLETED|Overall Study||5
187648|NCT00633594|459698|P3|STARTED|Overall Study||26
187649|NCT00633594|459699|P2|STARTED|Overall Study||8
187650|NCT00633594|459700|P1|STARTED|Overall Study||5
187651|NCT00633750|459727|P1|NOT COMPLETED|Overall Study||5
187652|NCT00633750|459727|P1|COMPLETED|Overall Study||42
187653|NCT00633750|459727|P1|STARTED|Overall Study||47
187654|NCT00633867|459735|P2|NOT COMPLETED|Overall Study||0
187655|NCT00633867|459736|P1|NOT COMPLETED|Overall Study||0
187656|NCT00633867|459735|P2|COMPLETED|Overall Study||60
187657|NCT00633867|459736|P1|COMPLETED|Overall Study||60
187658|NCT00633867|459735|P2|STARTED|Overall Study||60
187659|NCT00633867|459736|P1|STARTED|Overall Study||60
187660|NCT00633880|459745|P3|NOT COMPLETED|Randomized Double Blind||0
187661|NCT00633880|459746|P2|NOT COMPLETED|Randomized Double Blind||0
187662|NCT00633880|459747|P1|NOT COMPLETED|Randomized Double Blind||0
187663|NCT00633880|459745|P3|COMPLETED|Randomized Double Blind||51
187664|NCT00633880|459746|P2|COMPLETED|Randomized Double Blind||50
187665|NCT00633880|459747|P1|COMPLETED|Randomized Double Blind||0
187666|NCT00633880|459745|P3|STARTED|Randomized Double Blind||51
187667|NCT00633880|459746|P2|STARTED|Randomized Double Blind||50
187668|NCT00633880|459747|P1|STARTED|Randomized Double Blind||0
187669|NCT00633880|459745|P3|NOT COMPLETED|Open Label Titration||0
187670|NCT00633880|459746|P2|NOT COMPLETED|Open Label Titration||0
187671|NCT00633880|459747|P1|NOT COMPLETED|Open Label Titration||80
187672|NCT00633880|459745|P3|COMPLETED|Open Label Titration||0
187673|NCT00633880|459746|P2|COMPLETED|Open Label Titration||0
187674|NCT00633880|459747|P1|COMPLETED|Open Label Titration||101
187675|NCT00633880|459745|P3|STARTED|Open Label Titration||0
187676|NCT00633880|459746|P2|STARTED|Open Label Titration||0
187677|NCT00633880|459747|P1|STARTED|Open Label Titration||181
187678|NCT00633893|459777|P3|NOT COMPLETED|Overall Study||188
187679|NCT00633893|459778|P2|NOT COMPLETED|Overall Study||129
187680|NCT00633893|459779|P1|NOT COMPLETED|Overall Study||114
187681|NCT00633893|459777|P3|COMPLETED|Overall Study||641
187682|NCT00633893|459778|P2|COMPLETED|Overall Study||684
187683|NCT00633893|459779|P1|COMPLETED|Overall Study||726
187684|NCT00633893|459777|P3|STARTED|Overall Study|3 participants were randomized to placebo but not treated.|829
187685|NCT00633893|459778|P2|STARTED|Overall Study|2 participants were randomized to 5 mg study drug but not treated.|813
187686|NCT00633893|459779|P1|STARTED|Overall Study||840
187687|NCT00633919|459852|P2|NOT COMPLETED|Overall Study||22
187688|NCT00633919|459853|P1|NOT COMPLETED|Overall Study||27
187689|NCT00633919|459852|P2|COMPLETED|Overall Study||39
187690|NCT00633919|459853|P1|COMPLETED|Overall Study||36
187691|NCT00633919|459852|P2|STARTED|Overall Study||61
187692|NCT00633919|459853|P1|STARTED|Overall Study||63
187693|NCT00633932|459870|P3|NOT COMPLETED|Overall Study||11
187694|NCT00633932|459871|P2|NOT COMPLETED|Overall Study||14
187695|NCT00633932|459872|P1|NOT COMPLETED|Overall Study||12
187696|NCT00633932|459870|P3|COMPLETED|Overall Study||180
187697|NCT00633932|459871|P2|COMPLETED|Overall Study||176
187698|NCT00633932|459872|P1|COMPLETED|Overall Study||179
187699|NCT00633932|459870|P3|STARTED|Overall Study|Randomised|191
187700|NCT00633932|459871|P2|STARTED|Overall Study|Randomised|190
187701|NCT00633932|459872|P1|STARTED|Overall Study|Randomised|191
187702|NCT00633984|459885|P2|NOT COMPLETED|Overall Study||13
187703|NCT00633984|459886|P1|NOT COMPLETED|Overall Study||9
187704|NCT00633984|459885|P2|COMPLETED|Overall Study||69
187705|NCT00633984|459886|P1|COMPLETED|Overall Study||78
187706|NCT00633984|459885|P2|STARTED|Overall Study||82
187707|NCT00633984|459886|P1|STARTED|Overall Study||87
187708|NCT00634010|459896|P2|NOT COMPLETED|Overall Study||14
187709|NCT00634010|459897|P1|NOT COMPLETED|Overall Study||10
187710|NCT00634010|459896|P2|COMPLETED|Overall Study||4
187711|NCT00634010|459897|P1|COMPLETED|Overall Study||8
187712|NCT00634010|459896|P2|STARTED|Overall Study||18
187713|NCT00634010|459897|P1|STARTED|Overall Study||18
187714|NCT00634036|459905|P2|NOT COMPLETED|Overall Study||2
187715|NCT00634036|459906|P1|NOT COMPLETED|Overall Study||2
187716|NCT00634036|459905|P2|COMPLETED|Overall Study||9
187717|NCT00634036|459906|P1|COMPLETED|Overall Study||10
187718|NCT00634036|459905|P2|STARTED|Overall Study||11
187719|NCT00634036|459906|P1|STARTED|Overall Study||12
187720|NCT00634049|459918|P1|NOT COMPLETED|Overall Study||3
187721|NCT00634049|459918|P1|COMPLETED|Overall Study||146
187722|NCT00634049|459918|P1|STARTED|Overall Study||149
187723|NCT00634088|459999|P4|NOT COMPLETED|Time Period 4: Triplet Combination||0
187724|NCT00634088|460000|P3|NOT COMPLETED|Time Period 4: Triplet Combination||0
187725|NCT00634088|460001|P2|NOT COMPLETED|Time Period 4: Triplet Combination||0
187726|NCT00634088|460002|P1|NOT COMPLETED|Time Period 4: Triplet Combination||0
187727|NCT00634088|459999|P4|COMPLETED|Time Period 4: Triplet Combination||0
187728|NCT00634088|460000|P3|COMPLETED|Time Period 4: Triplet Combination||0
187729|NCT00634088|460001|P2|COMPLETED|Time Period 4: Triplet Combination||0
187730|NCT00634088|460002|P1|COMPLETED|Time Period 4: Triplet Combination||0
187731|NCT00634088|459999|P4|STARTED|Time Period 4: Triplet Combination||0
187732|NCT00634088|460000|P3|STARTED|Time Period 4: Triplet Combination||0
187733|NCT00634088|460001|P2|STARTED|Time Period 4: Triplet Combination||0
187734|NCT00634088|460002|P1|STARTED|Time Period 4: Triplet Combination||0
187735|NCT00634088|459999|P4|NOT COMPLETED|Time Period 3: Dose Level 3||0
187736|NCT00634088|460000|P3|NOT COMPLETED|Time Period 3: Dose Level 3||1
187737|NCT00634088|460001|P2|NOT COMPLETED|Time Period 3: Dose Level 3||0
187738|NCT00634088|460002|P1|NOT COMPLETED|Time Period 3: Dose Level 3||0
187739|NCT00634088|459999|P4|COMPLETED|Time Period 3: Dose Level 3||0
187740|NCT00634088|460000|P3|COMPLETED|Time Period 3: Dose Level 3||0
187741|NCT00634088|460001|P2|COMPLETED|Time Period 3: Dose Level 3||0
187742|NCT00634088|460002|P1|COMPLETED|Time Period 3: Dose Level 3||0
187743|NCT00634088|459999|P4|STARTED|Time Period 3: Dose Level 3||0
187744|NCT00634088|460000|P3|STARTED|Time Period 3: Dose Level 3||1
187745|NCT00634088|460001|P2|STARTED|Time Period 3: Dose Level 3||0
187746|NCT00634088|460002|P1|STARTED|Time Period 3: Dose Level 3||0
187747|NCT00634088|459999|P4|NOT COMPLETED|Time Period 2: Dose Level 2||0
187748|NCT00634088|460000|P3|NOT COMPLETED|Time Period 2: Dose Level 2||0
187749|NCT00634088|460001|P2|NOT COMPLETED|Time Period 2: Dose Level 2||3
187750|NCT00634088|460002|P1|NOT COMPLETED|Time Period 2: Dose Level 2||0
187751|NCT00634088|459999|P4|COMPLETED|Time Period 2: Dose Level 2||0
187752|NCT00634088|460000|P3|COMPLETED|Time Period 2: Dose Level 2||0
187753|NCT00634088|460001|P2|COMPLETED|Time Period 2: Dose Level 2||0
187754|NCT00634088|460002|P1|COMPLETED|Time Period 2: Dose Level 2||0
187755|NCT00634088|459999|P4|STARTED|Time Period 2: Dose Level 2||0
187756|NCT00634088|460000|P3|STARTED|Time Period 2: Dose Level 2||0
187757|NCT00634088|460001|P2|STARTED|Time Period 2: Dose Level 2||3
187758|NCT00634088|460002|P1|STARTED|Time Period 2: Dose Level 2||0
187759|NCT00634088|459999|P4|NOT COMPLETED|Time Period 1: Dose Level 1||0
187760|NCT00634088|460000|P3|NOT COMPLETED|Time Period 1: Dose Level 1||0
187761|NCT00634088|460001|P2|NOT COMPLETED|Time Period 1: Dose Level 1||0
187762|NCT00634088|460002|P1|NOT COMPLETED|Time Period 1: Dose Level 1||6
187763|NCT00634088|459999|P4|COMPLETED|Time Period 1: Dose Level 1||0
187764|NCT00634088|460000|P3|COMPLETED|Time Period 1: Dose Level 1||0
187765|NCT00634088|460001|P2|COMPLETED|Time Period 1: Dose Level 1||0
187766|NCT00634088|460002|P1|COMPLETED|Time Period 1: Dose Level 1||0
187767|NCT00634088|459999|P4|STARTED|Time Period 1: Dose Level 1||0
187768|NCT00634088|460000|P3|STARTED|Time Period 1: Dose Level 1||0
187769|NCT00634088|460001|P2|STARTED|Time Period 1: Dose Level 1||0
187770|NCT00634088|460002|P1|STARTED|Time Period 1: Dose Level 1||6
187771|NCT00634114|460056|P3|NOT COMPLETED|Overall Study||39
187772|NCT00634114|460057|P2|NOT COMPLETED|Overall Study||35
187773|NCT00634114|460058|P1|NOT COMPLETED|Overall Study||28
187774|NCT00634114|460056|P3|COMPLETED|Overall Study|Completed|148
187775|NCT00634114|460057|P2|COMPLETED|Overall Study|Completed|154
187776|NCT00634114|460058|P1|COMPLETED|Overall Study|Completed|160
187777|NCT00634114|460056|P3|STARTED|Overall Study|Randomised|187
187778|NCT00634114|460057|P2|STARTED|Overall Study|Randomised|189
187779|NCT00634114|460058|P1|STARTED|Overall Study|Randomised|188
187780|NCT00634166|460074|P2|NOT COMPLETED|Overall Study||60
187781|NCT00634166|460075|P1|NOT COMPLETED|Overall Study||60
187782|NCT00634166|460074|P2|COMPLETED|Overall Study||78
187783|NCT00634166|460075|P1|COMPLETED|Overall Study||22
187784|NCT00634166|460074|P2|STARTED|Overall Study||138
187785|NCT00634166|460075|P1|STARTED|Overall Study||82
187786|NCT00634179|460081|P1|NOT COMPLETED|Phase II: Maintenance||1
187787|NCT00634179|460081|P1|COMPLETED|Phase II: Maintenance||29
187788|NCT00634179|460081|P1|STARTED|Phase II: Maintenance||30
187789|NCT00634179|460081|P1|NOT COMPLETED|Phase I: Induction||0
187790|NCT00634179|460081|P1|COMPLETED|Phase I: Induction||19
187791|NCT00634179|460081|P1|STARTED|Phase I: Induction||19
187792|NCT00634244|460091|P3|NOT COMPLETED|Overall Study||0
187793|NCT00634244|460092|P2|NOT COMPLETED|Overall Study||13
187794|NCT00634244|460093|P1|NOT COMPLETED|Overall Study||1
187795|NCT00634244|460091|P3|COMPLETED|Overall Study||20
187796|NCT00634244|460092|P2|COMPLETED|Overall Study||24
187797|NCT00634244|460093|P1|COMPLETED|Overall Study||34
187798|NCT00634244|460091|P3|Eligible and Treated|Overall Study||20
187799|NCT00634244|460092|P2|Eligible and Treated|Overall Study||36
187800|NCT00634244|460093|P1|Eligible and Treated|Overall Study||35
187801|NCT00634244|460091|P3|STARTED|Overall Study||20
187802|NCT00634244|460092|P2|STARTED|Overall Study||37
187803|NCT00634244|460093|P1|STARTED|Overall Study||35
187804|NCT00634270|460106|P2|NOT COMPLETED|Overall Study||1
187805|NCT00634270|460107|P1|NOT COMPLETED|Overall Study||3
187806|NCT00634270|460106|P2|COMPLETED|Overall Study||12
187807|NCT00634270|460107|P1|COMPLETED|Overall Study||46
187808|NCT00634270|460106|P2|STARTED|Overall Study||13
187809|NCT00634270|460107|P1|STARTED|Overall Study|February 12, 2008|49
187810|NCT00634322|460134|P3|NOT COMPLETED|Overall Study||0
187811|NCT00634322|460135|P2|NOT COMPLETED|Overall Study||0
187812|NCT00634322|460136|P1|NOT COMPLETED|Overall Study||0
187813|NCT00634322|460134|P3|COMPLETED|Overall Study||5
187814|NCT00634322|460135|P2|COMPLETED|Overall Study||1
187815|NCT00634322|460136|P1|COMPLETED|Overall Study||1
187816|NCT00634322|460134|P3|STARTED|Overall Study||5
187817|NCT00634322|460135|P2|STARTED|Overall Study||1
187818|NCT00634322|460136|P1|STARTED|Overall Study||1
187819|NCT00634504|460146|P2|NOT COMPLETED|Overall Study||0
187820|NCT00634504|460147|P1|NOT COMPLETED|Overall Study||1
187821|NCT00634504|460146|P2|COMPLETED|Overall Study||9
187822|NCT00634504|460147|P1|COMPLETED|Overall Study||10
187823|NCT00634504|460146|P2|STARTED|Overall Study||9
187824|NCT00634504|460147|P1|STARTED|Overall Study||11
187825|NCT00634543|460155|P2|NOT COMPLETED|Overall Study||21
187826|NCT00634543|460156|P1|NOT COMPLETED|Overall Study||19
187827|NCT00634543|460155|P2|COMPLETED|Overall Study||63
187828|NCT00634543|460156|P1|COMPLETED|Overall Study||59
187829|NCT00634543|460155|P2|Treated|Overall Study||80
187830|NCT00634543|460156|P1|Treated|Overall Study||76
187831|NCT00634543|460155|P2|STARTED|Overall Study||84
187832|NCT00634543|460156|P1|STARTED|Overall Study||78
187833|NCT00634569|460174|P2|NOT COMPLETED|Overall Study||5
187834|NCT00634569|460175|P1|NOT COMPLETED|Overall Study||0
187835|NCT00634569|460174|P2|COMPLETED|Overall Study||5
187836|NCT00634569|460175|P1|COMPLETED|Overall Study||14
187837|NCT00634569|460174|P2|STARTED|Overall Study||10
187838|NCT00634569|460175|P1|STARTED|Overall Study||14
187839|NCT00634582|460187|P1|NOT COMPLETED|Overall Study||0
187840|NCT00634582|460187|P1|COMPLETED|Overall Study||2
187841|NCT00634582|460187|P1|STARTED|Overall Study||2
187842|NCT00634621|460191|P1|NOT COMPLETED|Overall Study||0
187843|NCT00634621|460191|P1|COMPLETED|Overall Study||283
187844|NCT00634621|460191|P1|STARTED|Overall Study||283
187845|NCT00634647|460199|P1|NOT COMPLETED|Overall Study||9
187846|NCT00634647|460199|P1|COMPLETED|Overall Study||15
187847|NCT00634647|460199|P1|STARTED|Overall Study||24
187848|NCT00634751|460208|P4|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
187849|NCT00634751|460209|P3|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||1
187850|NCT00634751|460210|P2|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
187851|NCT00634751|460211|P1|NOT COMPLETED|Pancreatic and Bilial Tract Cancer||0
187852|NCT00634751|460208|P4|COMPLETED|Pancreatic and Bilial Tract Cancer||7
187853|NCT00634751|460209|P3|COMPLETED|Pancreatic and Bilial Tract Cancer||23
187854|NCT00634751|460210|P2|COMPLETED|Pancreatic and Bilial Tract Cancer||0
187855|NCT00634751|460211|P1|COMPLETED|Pancreatic and Bilial Tract Cancer||0
187856|NCT00634751|460208|P4|STARTED|Pancreatic and Bilial Tract Cancer||8
187857|NCT00634751|460209|P3|STARTED|Pancreatic and Bilial Tract Cancer||24
187858|NCT00634751|460210|P2|STARTED|Pancreatic and Bilial Tract Cancer||0
187859|NCT00634751|460211|P1|STARTED|Pancreatic and Bilial Tract Cancer||0
187860|NCT00634751|460208|P4|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
187861|NCT00634751|460209|P3|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
187862|NCT00634751|460210|P2|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||1
187863|NCT00634751|460211|P1|NOT COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
187864|NCT00634751|460208|P4|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
187865|NCT00634751|460209|P3|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
187866|NCT00634751|460210|P2|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||6
187867|NCT00634751|460211|P1|COMPLETED|Phase I: 400mg Sorafenib BID+2DOC||0
187868|NCT00634751|460208|P4|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
187869|NCT00634751|460209|P3|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
187870|NCT00634751|460210|P2|STARTED|Phase I: 400mg Sorafenib BID+2DOC||7
187871|NCT00634751|460211|P1|STARTED|Phase I: 400mg Sorafenib BID+2DOC||0
187872|NCT00634751|460208|P4|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
187873|NCT00634751|460209|P3|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
187874|NCT00634751|460210|P2|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
187875|NCT00634751|460211|P1|NOT COMPLETED|Phase I: 200mg Sorafenib+2DOC||1
187876|NCT00634751|460208|P4|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
187877|NCT00634751|460209|P3|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
187878|NCT00634751|460210|P2|COMPLETED|Phase I: 200mg Sorafenib+2DOC||0
187879|NCT00634751|460211|P1|COMPLETED|Phase I: 200mg Sorafenib+2DOC||8
187880|NCT00634751|460208|P4|STARTED|Phase I: 200mg Sorafenib+2DOC||0
187881|NCT00634751|460209|P3|STARTED|Phase I: 200mg Sorafenib+2DOC||0
187882|NCT00634751|460210|P2|STARTED|Phase I: 200mg Sorafenib+2DOC||0
187883|NCT00634751|460211|P1|STARTED|Phase I: 200mg Sorafenib+2DOC||9
187884|NCT00634842|460231|P2|NOT COMPLETED|Overall Study||18
187885|NCT00634842|460232|P1|NOT COMPLETED|Overall Study||15
187886|NCT00634842|460231|P2|COMPLETED|Overall Study||104
187887|NCT00634842|460232|P1|COMPLETED|Overall Study||107
187888|NCT00634842|460231|P2|STARTED|Overall Study||122
187889|NCT00634842|460232|P1|STARTED|Overall Study||122
187890|NCT00634907|460246|P2|NOT COMPLETED|Overall Study||17
187891|NCT00634907|460247|P1|NOT COMPLETED|Overall Study||17
187892|NCT00634907|460246|P2|COMPLETED|Overall Study||115
187893|NCT00634907|460247|P1|COMPLETED|Overall Study||114
187894|NCT00634907|460246|P2|STARTED|Overall Study||132
187895|NCT00634907|460247|P1|STARTED|Overall Study||131
187896|NCT00634920|460272|P3|NOT COMPLETED|Period 2 - Post-Randomization||0
187897|NCT00634920|460273|P2|NOT COMPLETED|Period 2 - Post-Randomization||32
187898|NCT00634920|460274|P1|NOT COMPLETED|Period 2 - Post-Randomization||61
187899|NCT00634920|460272|P3|COMPLETED|Period 2 - Post-Randomization||0
187900|NCT00634920|460273|P2|COMPLETED|Period 2 - Post-Randomization||68
187901|NCT00634920|460274|P1|COMPLETED|Period 2 - Post-Randomization||43
187902|NCT00634920|460272|P3|Full Analysis Set (FAS)|Period 2 - Post-Randomization||0
187903|NCT00634920|460273|P2|Full Analysis Set (FAS)|Period 2 - Post-Randomization||90
187904|NCT00634920|460274|P1|Full Analysis Set (FAS)|Period 2 - Post-Randomization||92
187905|NCT00634920|460272|P3|STARTED|Period 2 - Post-Randomization|This group included patients who had renal TX but did not qualify for randomization at Visit 2.|0
187906|NCT00634920|460273|P2|STARTED|Period 2 - Post-Randomization||100
188073|NCT00626275|460397|P4|NOT COMPLETED|Part A - Treatment Period 2||0
187907|NCT00634920|460274|P1|STARTED|Period 2 - Post-Randomization|2 patients randomized in this group did not receive at least one dose of study drug.|104
187908|NCT00634920|460272|P3|NOT COMPLETED|Period 1 - Pre-Randomization||137
187909|NCT00634920|460273|P2|NOT COMPLETED|Period 1 - Pre-Randomization||0
187910|NCT00634920|460274|P1|NOT COMPLETED|Period 1 - Pre-Randomization||0
187911|NCT00634920|460272|P3|COMPLETED|Period 1 - Pre-Randomization|Total number of patients who became randomized|204
187912|NCT00634920|460273|P2|COMPLETED|Period 1 - Pre-Randomization||0
187913|NCT00634920|460274|P1|COMPLETED|Period 1 - Pre-Randomization||0
187914|NCT00634920|460272|P3|STARTED|Period 1 - Pre-Randomization|Total number of Enrolled patients|341
187915|NCT00634920|460273|P2|STARTED|Period 1 - Pre-Randomization||0
187916|NCT00634920|460274|P1|STARTED|Period 1 - Pre-Randomization||0
187917|NCT00634933|460319|P5|NOT COMPLETED|Part B: Week 24 to Week 52||10
187918|NCT00634933|460320|P4|NOT COMPLETED|Part B: Week 24 to Week 52||6
187919|NCT00634933|460321|P3|NOT COMPLETED|Part B: Week 24 to Week 52||22
187920|NCT00634933|460322|P2|NOT COMPLETED|Part B: Week 24 to Week 52||14
187921|NCT00634933|460323|P1|NOT COMPLETED|Part B: Week 24 to Week 52||0
187922|NCT00634933|460319|P5|COMPLETED|Part B: Week 24 to Week 52||22
187923|NCT00634933|460320|P4|COMPLETED|Part B: Week 24 to Week 52||25
187924|NCT00634933|460321|P3|COMPLETED|Part B: Week 24 to Week 52||33
187925|NCT00634933|460322|P2|COMPLETED|Part B: Week 24 to Week 52||42
187926|NCT00634933|460323|P1|COMPLETED|Part B: Week 24 to Week 52||0
187927|NCT00634933|460319|P5|STARTED|Part B: Week 24 to Week 52||32
187928|NCT00634933|460320|P4|STARTED|Part B: Week 24 to Week 52||31
187929|NCT00634933|460321|P3|STARTED|Part B: Week 24 to Week 52||55
187930|NCT00634933|460322|P2|STARTED|Part B: Week 24 to Week 52||56
187931|NCT00634933|460323|P1|STARTED|Part B: Week 24 to Week 52||0
187932|NCT00634933|460319|P5|NOT COMPLETED|Between Part A and Part B||0
187933|NCT00634933|460320|P4|NOT COMPLETED|Between Part A and Part B||0
187934|NCT00634933|460321|P3|NOT COMPLETED|Between Part A and Part B||0
187935|NCT00634933|460322|P2|NOT COMPLETED|Between Part A and Part B||1
187936|NCT00634933|460323|P1|NOT COMPLETED|Between Part A and Part B||0
187937|NCT00634933|460319|P5|COMPLETED|Between Part A and Part B||32
187938|NCT00634933|460320|P4|COMPLETED|Between Part A and Part B||31
187939|NCT00634933|460321|P3|COMPLETED|Between Part A and Part B||55
187940|NCT00634933|460322|P2|COMPLETED|Between Part A and Part B||56
187941|NCT00634933|460323|P1|COMPLETED|Between Part A and Part B||0
187942|NCT00634933|460319|P5|STARTED|Between Part A and Part B||32
187943|NCT00634933|460320|P4|STARTED|Between Part A and Part B||31
187944|NCT00634933|460321|P3|STARTED|Between Part A and Part B||55
187945|NCT00634933|460322|P2|STARTED|Between Part A and Part B||57
187946|NCT00634933|460323|P1|STARTED|Between Part A and Part B||0
187947|NCT00634933|460319|P5|NOT COMPLETED|Part A: Baseline to Week 24||0
187948|NCT00634933|460320|P4|NOT COMPLETED|Part A: Baseline to Week 24||0
187949|NCT00634933|460321|P3|NOT COMPLETED|Part A: Baseline to Week 24||18
187950|NCT00634933|460322|P2|NOT COMPLETED|Part A: Baseline to Week 24||18
187951|NCT00634933|460323|P1|NOT COMPLETED|Part A: Baseline to Week 24||11
187952|NCT00634933|460319|P5|COMPLETED|Part A: Baseline to Week 24||0
187953|NCT00634933|460320|P4|COMPLETED|Part A: Baseline to Week 24||0
187954|NCT00634933|460321|P3|COMPLETED|Part A: Baseline to Week 24||55
187955|NCT00634933|460322|P2|COMPLETED|Part A: Baseline to Week 24||57
187956|NCT00634933|460323|P1|COMPLETED|Part A: Baseline to Week 24||63
187957|NCT00634933|460319|P5|STARTED|Part A: Baseline to Week 24||0
187958|NCT00634933|460320|P4|STARTED|Part A: Baseline to Week 24||0
187959|NCT00634933|460321|P3|STARTED|Part A: Baseline to Week 24||73
187960|NCT00634933|460322|P2|STARTED|Part A: Baseline to Week 24||75
187961|NCT00634933|460323|P1|STARTED|Part A: Baseline to Week 24||74
187962|NCT00626210|460389|P1|NOT COMPLETED|Overall Study||0
187963|NCT00626210|460389|P1|COMPLETED|Overall Study||2
187964|NCT00626210|460389|P1|STARTED|Overall Study||2
187965|NCT00626275|460393|P8|NOT COMPLETED|Part B||1
187966|NCT00626275|460394|P7|NOT COMPLETED|Part B||1
187967|NCT00626275|460395|P6|NOT COMPLETED|Part B||0
187968|NCT00626275|460396|P5|NOT COMPLETED|Part B||0
187969|NCT00626275|460397|P4|NOT COMPLETED|Part B||0
187970|NCT00626275|460398|P3|NOT COMPLETED|Part B||0
187971|NCT00626275|460399|P2|NOT COMPLETED|Part B||0
187972|NCT00626275|460400|P1|NOT COMPLETED|Part B||0
187973|NCT00626275|460393|P8|COMPLETED|Part B||23
187974|NCT00626275|460394|P7|COMPLETED|Part B||19
187975|NCT00626275|460395|P6|COMPLETED|Part B||0
187976|NCT00626275|460396|P5|COMPLETED|Part B||0
187977|NCT00626275|460397|P4|COMPLETED|Part B||0
187978|NCT00626275|460398|P3|COMPLETED|Part B||0
187979|NCT00626275|460399|P2|COMPLETED|Part B||0
187980|NCT00626275|460400|P1|COMPLETED|Part B||0
187981|NCT00626275|460393|P8|STARTED|Part B||24
187982|NCT00626275|460394|P7|STARTED|Part B||20
187983|NCT00626275|460395|P6|STARTED|Part B||0
187984|NCT00626275|460396|P5|STARTED|Part B||0
187985|NCT00626275|460397|P4|STARTED|Part B||0
187986|NCT00626275|460398|P3|STARTED|Part B||0
187987|NCT00626275|460399|P2|STARTED|Part B||0
187988|NCT00626275|460400|P1|STARTED|Part B||0
187989|NCT00626275|460393|P8|NOT COMPLETED|Re-randomization Period for Part B||0
187990|NCT00626275|460394|P7|NOT COMPLETED|Re-randomization Period for Part B||0
187991|NCT00626275|460395|P6|NOT COMPLETED|Re-randomization Period for Part B||0
187992|NCT00626275|460396|P5|NOT COMPLETED|Re-randomization Period for Part B||0
187993|NCT00626275|460397|P4|NOT COMPLETED|Re-randomization Period for Part B||0
187994|NCT00626275|460398|P3|NOT COMPLETED|Re-randomization Period for Part B||0
187995|NCT00626275|460399|P2|NOT COMPLETED|Re-randomization Period for Part B||0
187996|NCT00626275|460400|P1|NOT COMPLETED|Re-randomization Period for Part B||0
187997|NCT00626275|460393|P8|COMPLETED|Re-randomization Period for Part B||24
187998|NCT00626275|460394|P7|COMPLETED|Re-randomization Period for Part B||20
187999|NCT00626275|460395|P6|COMPLETED|Re-randomization Period for Part B||0
188000|NCT00626275|460396|P5|COMPLETED|Re-randomization Period for Part B||0
188001|NCT00626275|460397|P4|COMPLETED|Re-randomization Period for Part B||0
188002|NCT00626275|460398|P3|COMPLETED|Re-randomization Period for Part B||0
188003|NCT00626275|460399|P2|COMPLETED|Re-randomization Period for Part B||0
188004|NCT00626275|460400|P1|COMPLETED|Re-randomization Period for Part B||0
188005|NCT00626275|460393|P8|STARTED|Re-randomization Period for Part B||24
188006|NCT00626275|460394|P7|STARTED|Re-randomization Period for Part B||20
188007|NCT00626275|460395|P6|STARTED|Re-randomization Period for Part B||0
188008|NCT00626275|460396|P5|STARTED|Re-randomization Period for Part B||0
188009|NCT00626275|460397|P4|STARTED|Re-randomization Period for Part B||0
188010|NCT00626275|460398|P3|STARTED|Re-randomization Period for Part B||0
188011|NCT00626275|460399|P2|STARTED|Re-randomization Period for Part B||0
188012|NCT00626275|460400|P1|STARTED|Re-randomization Period for Part B||0
188013|NCT00626275|460393|P8|NOT COMPLETED|Part A - Treatment Period 3||0
188014|NCT00626275|460394|P7|NOT COMPLETED|Part A - Treatment Period 3||0
188015|NCT00626275|460395|P6|NOT COMPLETED|Part A - Treatment Period 3||0
188016|NCT00626275|460396|P5|NOT COMPLETED|Part A - Treatment Period 3||0
188017|NCT00626275|460397|P4|NOT COMPLETED|Part A - Treatment Period 3||0
188018|NCT00626275|460398|P3|NOT COMPLETED|Part A - Treatment Period 3||0
188019|NCT00626275|460399|P2|NOT COMPLETED|Part A - Treatment Period 3||0
188020|NCT00626275|460400|P1|NOT COMPLETED|Part A - Treatment Period 3||0
188021|NCT00626275|460393|P8|COMPLETED|Part A - Treatment Period 3||0
188022|NCT00626275|460394|P7|COMPLETED|Part A - Treatment Period 3||0
188023|NCT00626275|460395|P6|COMPLETED|Part A - Treatment Period 3||8
188024|NCT00626275|460396|P5|COMPLETED|Part A - Treatment Period 3||9
188025|NCT00626275|460397|P4|COMPLETED|Part A - Treatment Period 3||8
188026|NCT00626275|460398|P3|COMPLETED|Part A - Treatment Period 3||6
188027|NCT00626275|460399|P2|COMPLETED|Part A - Treatment Period 3||7
188028|NCT00626275|460400|P1|COMPLETED|Part A - Treatment Period 3||6
188029|NCT00626275|460393|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
188030|NCT00626275|460394|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||0
188031|NCT00626275|460395|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
188032|NCT00626275|460396|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||9
188033|NCT00626275|460397|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||8
188034|NCT00626275|460398|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
188035|NCT00626275|460399|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||7
188036|NCT00626275|460400|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 3||6
188037|NCT00626275|460393|P8|STARTED|Part A - Treatment Period 3||0
188038|NCT00626275|460394|P7|STARTED|Part A - Treatment Period 3||0
188039|NCT00626275|460395|P6|STARTED|Part A - Treatment Period 3||8
188040|NCT00626275|460396|P5|STARTED|Part A - Treatment Period 3||9
188041|NCT00626275|460397|P4|STARTED|Part A - Treatment Period 3||8
188042|NCT00626275|460398|P3|STARTED|Part A - Treatment Period 3||6
188043|NCT00626275|460399|P2|STARTED|Part A - Treatment Period 3||7
188044|NCT00626275|460400|P1|STARTED|Part A - Treatment Period 3||6
188045|NCT00626275|460393|P8|NOT COMPLETED|Part A - Washout Period 2||0
188046|NCT00626275|460394|P7|NOT COMPLETED|Part A - Washout Period 2||0
188047|NCT00626275|460395|P6|NOT COMPLETED|Part A - Washout Period 2||0
188048|NCT00626275|460396|P5|NOT COMPLETED|Part A - Washout Period 2||0
188049|NCT00626275|460397|P4|NOT COMPLETED|Part A - Washout Period 2||0
188050|NCT00626275|460398|P3|NOT COMPLETED|Part A - Washout Period 2||0
188051|NCT00626275|460399|P2|NOT COMPLETED|Part A - Washout Period 2||0
188052|NCT00626275|460400|P1|NOT COMPLETED|Part A - Washout Period 2||0
188053|NCT00626275|460393|P8|COMPLETED|Part A - Washout Period 2||0
188054|NCT00626275|460394|P7|COMPLETED|Part A - Washout Period 2||0
188055|NCT00626275|460395|P6|COMPLETED|Part A - Washout Period 2||8
188056|NCT00626275|460396|P5|COMPLETED|Part A - Washout Period 2||9
188057|NCT00626275|460397|P4|COMPLETED|Part A - Washout Period 2||8
188058|NCT00626275|460398|P3|COMPLETED|Part A - Washout Period 2||6
188059|NCT00626275|460399|P2|COMPLETED|Part A - Washout Period 2||7
188060|NCT00626275|460400|P1|COMPLETED|Part A - Washout Period 2||6
188061|NCT00626275|460393|P8|STARTED|Part A - Washout Period 2||0
188062|NCT00626275|460394|P7|STARTED|Part A - Washout Period 2||0
188063|NCT00626275|460395|P6|STARTED|Part A - Washout Period 2||8
188064|NCT00626275|460396|P5|STARTED|Part A - Washout Period 2||9
188065|NCT00626275|460397|P4|STARTED|Part A - Washout Period 2||8
188066|NCT00626275|460398|P3|STARTED|Part A - Washout Period 2||6
188067|NCT00626275|460399|P2|STARTED|Part A - Washout Period 2||7
188068|NCT00626275|460400|P1|STARTED|Part A - Washout Period 2||6
188069|NCT00626275|460393|P8|NOT COMPLETED|Part A - Treatment Period 2||0
188070|NCT00626275|460394|P7|NOT COMPLETED|Part A - Treatment Period 2||0
188071|NCT00626275|460395|P6|NOT COMPLETED|Part A - Treatment Period 2||0
188072|NCT00626275|460396|P5|NOT COMPLETED|Part A - Treatment Period 2||0
188074|NCT00626275|460398|P3|NOT COMPLETED|Part A - Treatment Period 2||0
188075|NCT00626275|460399|P2|NOT COMPLETED|Part A - Treatment Period 2||0
188076|NCT00626275|460400|P1|NOT COMPLETED|Part A - Treatment Period 2||0
188077|NCT00626275|460393|P8|COMPLETED|Part A - Treatment Period 2||0
188078|NCT00626275|460394|P7|COMPLETED|Part A - Treatment Period 2||0
188079|NCT00626275|460395|P6|COMPLETED|Part A - Treatment Period 2||8
188080|NCT00626275|460396|P5|COMPLETED|Part A - Treatment Period 2||9
188081|NCT00626275|460397|P4|COMPLETED|Part A - Treatment Period 2||8
188082|NCT00626275|460398|P3|COMPLETED|Part A - Treatment Period 2||6
188083|NCT00626275|460399|P2|COMPLETED|Part A - Treatment Period 2||7
188084|NCT00626275|460400|P1|COMPLETED|Part A - Treatment Period 2||6
188085|NCT00626275|460393|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
188086|NCT00626275|460394|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||0
188087|NCT00626275|460395|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
188088|NCT00626275|460396|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||9
188089|NCT00626275|460397|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||8
188090|NCT00626275|460398|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
188091|NCT00626275|460399|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||7
188092|NCT00626275|460400|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 2||6
188093|NCT00626275|460393|P8|STARTED|Part A - Treatment Period 2||0
188094|NCT00626275|460394|P7|STARTED|Part A - Treatment Period 2||0
188095|NCT00626275|460395|P6|STARTED|Part A - Treatment Period 2||8
188096|NCT00626275|460396|P5|STARTED|Part A - Treatment Period 2||9
188097|NCT00626275|460397|P4|STARTED|Part A - Treatment Period 2||8
188098|NCT00626275|460398|P3|STARTED|Part A - Treatment Period 2||6
188099|NCT00626275|460399|P2|STARTED|Part A - Treatment Period 2||7
188100|NCT00626275|460400|P1|STARTED|Part A - Treatment Period 2||6
188101|NCT00626275|460393|P8|NOT COMPLETED|Part A - Washout Period 1||0
188102|NCT00626275|460394|P7|NOT COMPLETED|Part A - Washout Period 1||0
188103|NCT00626275|460395|P6|NOT COMPLETED|Part A - Washout Period 1||0
188104|NCT00626275|460396|P5|NOT COMPLETED|Part A - Washout Period 1||0
188105|NCT00626275|460397|P4|NOT COMPLETED|Part A - Washout Period 1||0
188106|NCT00626275|460398|P3|NOT COMPLETED|Part A - Washout Period 1||0
188107|NCT00626275|460399|P2|NOT COMPLETED|Part A - Washout Period 1||0
188108|NCT00626275|460400|P1|NOT COMPLETED|Part A - Washout Period 1||0
188109|NCT00626275|460393|P8|COMPLETED|Part A - Washout Period 1||0
188110|NCT00626275|460394|P7|COMPLETED|Part A - Washout Period 1||0
188111|NCT00626275|460395|P6|COMPLETED|Part A - Washout Period 1||8
188112|NCT00626275|460396|P5|COMPLETED|Part A - Washout Period 1||9
188113|NCT00626275|460397|P4|COMPLETED|Part A - Washout Period 1||8
188114|NCT00626275|460398|P3|COMPLETED|Part A - Washout Period 1||6
188115|NCT00626275|460399|P2|COMPLETED|Part A - Washout Period 1||7
188116|NCT00626275|460400|P1|COMPLETED|Part A - Washout Period 1||6
188117|NCT00626275|460393|P8|STARTED|Part A - Washout Period 1||0
188118|NCT00626275|460394|P7|STARTED|Part A - Washout Period 1||0
188119|NCT00626275|460395|P6|STARTED|Part A - Washout Period 1||8
188120|NCT00626275|460396|P5|STARTED|Part A - Washout Period 1||9
188121|NCT00626275|460397|P4|STARTED|Part A - Washout Period 1||8
188122|NCT00626275|460398|P3|STARTED|Part A - Washout Period 1||6
188123|NCT00626275|460399|P2|STARTED|Part A - Washout Period 1||7
188124|NCT00626275|460400|P1|STARTED|Part A - Washout Period 1||6
188125|NCT00626275|460393|P8|NOT COMPLETED|Part A - Treatment Period 1||0
188126|NCT00626275|460394|P7|NOT COMPLETED|Part A - Treatment Period 1||0
188127|NCT00626275|460395|P6|NOT COMPLETED|Part A - Treatment Period 1||0
188128|NCT00626275|460396|P5|NOT COMPLETED|Part A - Treatment Period 1||0
188129|NCT00626275|460397|P4|NOT COMPLETED|Part A - Treatment Period 1||0
188130|NCT00626275|460398|P3|NOT COMPLETED|Part A - Treatment Period 1||1
188131|NCT00626275|460399|P2|NOT COMPLETED|Part A - Treatment Period 1||0
188132|NCT00626275|460400|P1|NOT COMPLETED|Part A - Treatment Period 1||1
188133|NCT00626275|460393|P8|COMPLETED|Part A - Treatment Period 1||0
188134|NCT00626275|460394|P7|COMPLETED|Part A - Treatment Period 1||0
188135|NCT00626275|460395|P6|COMPLETED|Part A - Treatment Period 1||8
188136|NCT00626275|460396|P5|COMPLETED|Part A - Treatment Period 1||9
188137|NCT00626275|460397|P4|COMPLETED|Part A - Treatment Period 1||8
188138|NCT00626275|460398|P3|COMPLETED|Part A - Treatment Period 1||6
188139|NCT00626275|460399|P2|COMPLETED|Part A - Treatment Period 1||7
188140|NCT00626275|460400|P1|COMPLETED|Part A - Treatment Period 1||6
188141|NCT00626275|460393|P8|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
188142|NCT00626275|460394|P7|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||0
188143|NCT00626275|460395|P6|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
188144|NCT00626275|460396|P5|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||9
188145|NCT00626275|460397|P4|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||8
188146|NCT00626275|460398|P3|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
188147|NCT00626275|460399|P2|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
188148|NCT00626275|460400|P1|Received at Least 1 Dose of Study Drug|Part A - Treatment Period 1||7
188149|NCT00626275|460393|P8|STARTED|Part A - Treatment Period 1||0
188150|NCT00626275|460394|P7|STARTED|Part A - Treatment Period 1||0
188151|NCT00626275|460395|P6|STARTED|Part A - Treatment Period 1||8
188152|NCT00626275|460396|P5|STARTED|Part A - Treatment Period 1||9
188153|NCT00626275|460397|P4|STARTED|Part A - Treatment Period 1||8
188154|NCT00626275|460398|P3|STARTED|Part A - Treatment Period 1||7
188155|NCT00626275|460399|P2|STARTED|Part A - Treatment Period 1||7
188156|NCT00626275|460400|P1|STARTED|Part A - Treatment Period 1||7
188157|NCT00626327|460443|P3|NOT COMPLETED|Overall Study||88
188158|NCT00626327|460444|P2|NOT COMPLETED|Overall Study||59
188159|NCT00626327|460445|P1|NOT COMPLETED|Overall Study||78
188160|NCT00626327|460443|P3|COMPLETED|Overall Study||422
188161|NCT00626327|460444|P2|COMPLETED|Overall Study||557
188162|NCT00626327|460445|P1|COMPLETED|Overall Study||426
188163|NCT00626327|460443|P3|STARTED|Overall Study||510
188164|NCT00626327|460444|P2|STARTED|Overall Study||616
188165|NCT00626327|460445|P1|STARTED|Overall Study||504
188166|NCT00626340|460471|P1|NOT COMPLETED|Overall Study||0
188167|NCT00626340|460471|P1|COMPLETED|Overall Study||18
188168|NCT00626340|460471|P1|STARTED|Overall Study||18
188169|NCT00626392|460481|P6|NOT COMPLETED|Coadministration Period||6
188170|NCT00626392|460482|P5|NOT COMPLETED|Coadministration Period||5
188171|NCT00626392|460483|P4|NOT COMPLETED|Coadministration Period||7
188172|NCT00626392|460484|P3|NOT COMPLETED|Coadministration Period||10
188173|NCT00626392|460485|P2|NOT COMPLETED|Coadministration Period||5
188174|NCT00626392|460486|P1|NOT COMPLETED|Coadministration Period||4
188175|NCT00626392|460481|P6|COMPLETED|Coadministration Period||38
188176|NCT00626392|460482|P5|COMPLETED|Coadministration Period||36
188177|NCT00626392|460483|P4|COMPLETED|Coadministration Period||36
188178|NCT00626392|460484|P3|COMPLETED|Coadministration Period||31
188179|NCT00626392|460485|P2|COMPLETED|Coadministration Period||38
188180|NCT00626392|460486|P1|COMPLETED|Coadministration Period||40
188181|NCT00626392|460481|P6|STARTED|Coadministration Period||44
188182|NCT00626392|460482|P5|STARTED|Coadministration Period||41
188183|NCT00626392|460483|P4|STARTED|Coadministration Period||43
188184|NCT00626392|460484|P3|STARTED|Coadministration Period||41
188185|NCT00626392|460485|P2|STARTED|Coadministration Period||43
188186|NCT00626392|460486|P1|STARTED|Coadministration Period||44
188187|NCT00626392|460481|P6|NOT COMPLETED|Run-in Period||1
188188|NCT00626392|460482|P5|NOT COMPLETED|Run-in Period||4
188189|NCT00626392|460483|P4|NOT COMPLETED|Run-in Period||1
188190|NCT00626392|460484|P3|NOT COMPLETED|Run-in Period||3
188191|NCT00626392|460485|P2|NOT COMPLETED|Run-in Period||1
188192|NCT00626392|460486|P1|NOT COMPLETED|Run-in Period||1
188193|NCT00626392|460481|P6|COMPLETED|Run-in Period||44
188194|NCT00626392|460482|P5|COMPLETED|Run-in Period||41
188195|NCT00626392|460483|P4|COMPLETED|Run-in Period||43
188196|NCT00626392|460484|P3|COMPLETED|Run-in Period||41
188197|NCT00626392|460485|P2|COMPLETED|Run-in Period||43
188198|NCT00626392|460486|P1|COMPLETED|Run-in Period||44
188199|NCT00626392|460481|P6|STARTED|Run-in Period||45
188200|NCT00626392|460482|P5|STARTED|Run-in Period||45
188201|NCT00626392|460483|P4|STARTED|Run-in Period||44
188202|NCT00626392|460484|P3|STARTED|Run-in Period||44
188203|NCT00626392|460485|P2|STARTED|Run-in Period||44
188204|NCT00626392|460486|P1|STARTED|Run-in Period||45
188205|NCT00626431|460500|P2|NOT COMPLETED|Overall Study||45
188206|NCT00626431|460501|P1|NOT COMPLETED|Overall Study||17
188207|NCT00626431|460500|P2|COMPLETED|Overall Study||114
188208|NCT00626431|460501|P1|COMPLETED|Overall Study||134
188209|NCT00626431|460500|P2|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|159
188210|NCT00626431|460501|P1|STARTED|Overall Study|Separate groups of subjects received Formulation A and B and data were not compared between groups.|151
188211|NCT00626444|460516|P1|NOT COMPLETED|Overall Study||0
188212|NCT00626444|460516|P1|COMPLETED|Overall Study||2
188213|NCT00626444|460516|P1|STARTED|Overall Study||2
188214|NCT00626522|460527|P6|NOT COMPLETED|Overall Study||2
188215|NCT00626522|460528|P5|NOT COMPLETED|Overall Study||7
188216|NCT00626522|460529|P4|NOT COMPLETED|Overall Study||2
188217|NCT00626522|460530|P3|NOT COMPLETED|Overall Study||8
188218|NCT00626522|460531|P2|NOT COMPLETED|Overall Study||7
188219|NCT00626522|460532|P1|NOT COMPLETED|Overall Study||6
188220|NCT00626522|460527|P6|COMPLETED|Overall Study||57
188221|NCT00626522|460528|P5|COMPLETED|Overall Study||58
188222|NCT00626522|460529|P4|COMPLETED|Overall Study||74
188223|NCT00626522|460530|P3|COMPLETED|Overall Study||117
188224|NCT00626522|460531|P2|COMPLETED|Overall Study||113
188225|NCT00626522|460532|P1|COMPLETED|Overall Study||115
188226|NCT00626522|460527|P6|STARTED|Overall Study||59
188227|NCT00626522|460528|P5|STARTED|Overall Study||65
188228|NCT00626522|460529|P4|STARTED|Overall Study||76
188229|NCT00626522|460530|P3|STARTED|Overall Study||125
188230|NCT00626522|460531|P2|STARTED|Overall Study||120
188231|NCT00626522|460532|P1|STARTED|Overall Study||121
188232|NCT00626548|460572|P2|NOT COMPLETED|Overall Study||716
188233|NCT00626548|460573|P1|NOT COMPLETED|Overall Study||705
188234|NCT00626548|460572|P2|COMPLETED|Overall Study||0
188235|NCT00626548|460573|P1|COMPLETED|Overall Study||0
188236|NCT00626548|460572|P2|Patients Received Treatment|Overall Study||712
188237|NCT00626548|460573|P1|Patients Received Treatment|Overall Study||703
188238|NCT00626548|460572|P2|STARTED|Overall Study||716
188239|NCT00626548|460573|P1|STARTED|Overall Study||705
188240|NCT00626561|460581|P1|NOT COMPLETED|Overall Study||4
188241|NCT00626561|460581|P1|COMPLETED|Overall Study||0
188242|NCT00626561|460581|P1|STARTED|Overall Study||4
188243|NCT00626574|460587|P2|NOT COMPLETED|Overall Study||0
188244|NCT00626574|460588|P1|NOT COMPLETED|Overall Study||0
188245|NCT00626574|460587|P2|COMPLETED|Overall Study||1
188246|NCT00626574|460588|P1|COMPLETED|Overall Study||2
188247|NCT00626574|460587|P2|STARTED|Overall Study||1
188248|NCT00626574|460588|P1|STARTED|Overall Study||2
188249|NCT00626639|460596|P2|NOT COMPLETED|Overall Study||2
188250|NCT00626639|460597|P1|NOT COMPLETED|Overall Study||2
188251|NCT00626639|460596|P2|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|1
188252|NCT00626639|460597|P1|COMPLETED|Overall Study|Participants who received all 8 doses of investigational product.|0
188253|NCT00626639|460596|P2|STARTED|Overall Study||3
188254|NCT00626639|460597|P1|STARTED|Overall Study||2
188255|NCT00627016|460617|P2|NOT COMPLETED|Overall Study||6
188256|NCT00627016|460618|P1|NOT COMPLETED|Overall Study||6
188257|NCT00627016|460617|P2|COMPLETED|Overall Study||146
188258|NCT00627016|460618|P1|COMPLETED|Overall Study||147
188259|NCT00627016|460617|P2|STARTED|Overall Study||152
188260|NCT00627016|460618|P1|STARTED|Overall Study||153
188261|NCT00627042|460628|P1|NOT COMPLETED|Overall Study||2
188262|NCT00627042|460628|P1|COMPLETED|Overall Study||40
188263|NCT00627042|460628|P1|Received at Least 1 Dose of Study Drug|Overall Study||42
188264|NCT00627042|460628|P1|STARTED|Overall Study||42
188265|NCT00627094|460640|P2|NOT COMPLETED|Overall Study||15
188266|NCT00627094|460641|P1|NOT COMPLETED|Overall Study||12
188267|NCT00627094|460640|P2|COMPLETED|Overall Study||45
188268|NCT00627094|460641|P1|COMPLETED|Overall Study||48
188269|NCT00627094|460640|P2|STARTED|Overall Study||60
188270|NCT00627094|460641|P1|STARTED|Overall Study||60
188271|NCT00627393|460655|P2|NOT COMPLETED|Per-Protocol Analysis||13
188272|NCT00627393|460656|P1|NOT COMPLETED|Per-Protocol Analysis||10
188273|NCT00627393|460655|P2|COMPLETED|Per-Protocol Analysis||35
188274|NCT00627393|460656|P1|COMPLETED|Per-Protocol Analysis||39
188275|NCT00627393|460655|P2|STARTED|Per-Protocol Analysis||48
188276|NCT00627393|460656|P1|STARTED|Per-Protocol Analysis||49
188277|NCT00627393|460655|P2|NOT COMPLETED|Intention-To-Treat Analysis||8
188278|NCT00627393|460656|P1|NOT COMPLETED|Intention-To-Treat Analysis||9
188279|NCT00627393|460655|P2|COMPLETED|Intention-To-Treat Analysis||48
188280|NCT00627393|460656|P1|COMPLETED|Intention-To-Treat Analysis||49
188281|NCT00627393|460655|P2|STARTED|Intention-To-Treat Analysis||56
188282|NCT00627393|460656|P1|STARTED|Intention-To-Treat Analysis||58
188283|NCT00627406|460679|P4|NOT COMPLETED|Overall Study||0
188284|NCT00627406|460680|P3|NOT COMPLETED|Overall Study||0
188285|NCT00627406|460681|P2|NOT COMPLETED|Overall Study||0
188286|NCT00627406|460682|P1|NOT COMPLETED|Overall Study||0
188287|NCT00627406|460679|P4|COMPLETED|Overall Study||141
188288|NCT00627406|460680|P3|COMPLETED|Overall Study||125
188289|NCT00627406|460681|P2|COMPLETED|Overall Study||58
188290|NCT00627406|460682|P1|COMPLETED|Overall Study||60
188291|NCT00627406|460679|P4|STARTED|Overall Study||141
188292|NCT00627406|460680|P3|STARTED|Overall Study||125
188293|NCT00627406|460681|P2|STARTED|Overall Study||58
188294|NCT00627406|460682|P1|STARTED|Overall Study||60
188295|NCT00627445|460698|P2|NOT COMPLETED|Overall Study||12
188296|NCT00627445|460699|P1|NOT COMPLETED|Overall Study||9
188297|NCT00627445|460698|P2|COMPLETED|Overall Study||210
188298|NCT00627445|460699|P1|COMPLETED|Overall Study||210
188299|NCT00627445|460698|P2|Exposed to Study Drug|Overall Study||222
188300|NCT00627445|460699|P1|Exposed to Study Drug|Overall Study||219
188301|NCT00627445|460698|P2|STARTED|Overall Study||222
188302|NCT00627445|460699|P1|STARTED|Overall Study||219
188303|NCT00627458|460722|P3|NOT COMPLETED|Overall Study||6
188304|NCT00627458|460723|P2|NOT COMPLETED|Overall Study||7
188305|NCT00627458|460724|P1|NOT COMPLETED|Overall Study||4
188306|NCT00627458|460722|P3|COMPLETED|Overall Study||133
188307|NCT00627458|460723|P2|COMPLETED|Overall Study||130
188308|NCT00627458|460724|P1|COMPLETED|Overall Study||123
188309|NCT00627458|460722|P3|STARTED|Overall Study||139
188310|NCT00627458|460723|P2|STARTED|Overall Study||137
188311|NCT00627458|460724|P1|STARTED|Overall Study||127
188312|NCT00627497|460801|P4|NOT COMPLETED|Overall Study||0
188313|NCT00627497|460802|P3|NOT COMPLETED|Overall Study||0
188314|NCT00627497|460803|P2|NOT COMPLETED|Overall Study||1
188315|NCT00627497|460804|P1|NOT COMPLETED|Overall Study||1
188316|NCT00627497|460801|P4|COMPLETED|Overall Study||2
188317|NCT00627497|460802|P3|COMPLETED|Overall Study||4
188318|NCT00627497|460803|P2|COMPLETED|Overall Study||11
188319|NCT00627497|460804|P1|COMPLETED|Overall Study||13
188320|NCT00627497|460801|P4|STARTED|Overall Study||2
188321|NCT00627497|460802|P3|STARTED|Overall Study||4
188322|NCT00627497|460803|P2|STARTED|Overall Study||12
188323|NCT00627497|460804|P1|STARTED|Overall Study||14
188324|NCT00627523|460864|P2|NOT COMPLETED|Overall Study||2
188325|NCT00627523|460865|P1|NOT COMPLETED|Overall Study||2
188326|NCT00627523|460864|P2|COMPLETED|Overall Study||20
188327|NCT00627523|460865|P1|COMPLETED|Overall Study||19
188328|NCT00627523|460864|P2|STARTED|Overall Study||22
188329|NCT00627523|460865|P1|STARTED|Overall Study|22 assigned to Genotropin and 21 in Control; 1 did not take Genotropin, so considered as Control.|21
188330|NCT00627679|460889|P4|NOT COMPLETED|Overall Study||0
188331|NCT00627679|460890|P3|NOT COMPLETED|Overall Study||0
188332|NCT00627679|460891|P2|NOT COMPLETED|Overall Study||0
188333|NCT00627679|460892|P1|NOT COMPLETED|Overall Study||0
188334|NCT00627679|460889|P4|COMPLETED|Overall Study||4
188335|NCT00627679|460890|P3|COMPLETED|Overall Study||4
188336|NCT00627679|460891|P2|COMPLETED|Overall Study||4
188337|NCT00627679|460892|P1|COMPLETED|Overall Study||4
188338|NCT00627679|460889|P4|STARTED|Overall Study||4
188339|NCT00627679|460890|P3|STARTED|Overall Study||4
188340|NCT00627679|460891|P2|STARTED|Overall Study||4
188341|NCT00627679|460892|P1|STARTED|Overall Study||4
188342|NCT00627705|460920|P2|NOT COMPLETED|Overall Study||6
188343|NCT00627705|460921|P1|NOT COMPLETED|Overall Study||2
188344|NCT00627705|460920|P2|COMPLETED|Overall Study||12
188345|NCT00627705|460921|P1|COMPLETED|Overall Study||13
188346|NCT00627705|460920|P2|STARTED|Overall Study||18
188347|NCT00627705|460921|P1|STARTED|Overall Study||15
188348|NCT00627861|460941|P1|NOT COMPLETED|Overall Study||0
188349|NCT00627861|460941|P1|COMPLETED|Overall Study||1
188350|NCT00627861|460941|P1|STARTED|Overall Study||1
188351|NCT00627926|460950|P3|NOT COMPLETED|Overall Study||95
188352|NCT00627926|460951|P2|NOT COMPLETED|Overall Study||104
188353|NCT00627926|460952|P1|NOT COMPLETED|Overall Study||159
188354|NCT00627926|460950|P3|COMPLETED|Overall Study||268
188355|NCT00627926|460951|P2|COMPLETED|Overall Study||260
188356|NCT00627926|460952|P1|COMPLETED|Overall Study||202
188357|NCT00627926|460950|P3|STARTED|Overall Study||363
188358|NCT00627926|460951|P2|STARTED|Overall Study||364
188359|NCT00627926|460952|P1|STARTED|Overall Study||361
188360|NCT00627978|460998|P2|NOT COMPLETED|Overall Study||0
188361|NCT00627978|460999|P1|NOT COMPLETED|Overall Study||0
188362|NCT00627978|460998|P2|COMPLETED|Overall Study||5
188363|NCT00627978|460999|P1|COMPLETED|Overall Study||10
188364|NCT00627978|460998|P2|STARTED|Overall Study||5
188365|NCT00627978|460999|P1|STARTED|Overall Study||10
188366|NCT00628030|461007|P2|NOT COMPLETED|Post to 6 Month Follow-up||30
188367|NCT00628030|461008|P1|NOT COMPLETED|Post to 6 Month Follow-up||32
188368|NCT00628030|461007|P2|COMPLETED|Post to 6 Month Follow-up||33
188369|NCT00628030|461008|P1|COMPLETED|Post to 6 Month Follow-up||27
188370|NCT00628030|461007|P2|STARTED|Post to 6 Month Follow-up||63
188371|NCT00628030|461008|P1|STARTED|Post to 6 Month Follow-up||59
188372|NCT00628030|461007|P2|NOT COMPLETED|Baseline to Post-Assessment||29
188373|NCT00628030|461008|P1|NOT COMPLETED|Baseline to Post-Assessment||33
188374|NCT00628030|461007|P2|COMPLETED|Baseline to Post-Assessment||63
188375|NCT00628030|461008|P1|COMPLETED|Baseline to Post-Assessment||59
188376|NCT00628030|461007|P2|STARTED|Baseline to Post-Assessment||92
188377|NCT00628030|461008|P1|STARTED|Baseline to Post-Assessment||92
188378|NCT00628108|461024|P2|NOT COMPLETED|Overall Study||3
188379|NCT00628108|461025|P1|NOT COMPLETED|Overall Study||1
188380|NCT00628108|461024|P2|COMPLETED|Overall Study||43
188381|NCT00628108|461025|P1|COMPLETED|Overall Study||22
188382|NCT00628108|461024|P2|Safety Population|Overall Study|Subjects in the Safety Population were analyzed as treated.|45
188383|NCT00628108|461025|P1|Safety Population|Overall Study||24
188384|NCT00628108|461024|P2|STARTED|Overall Study|One subject was randomized to levocetirizine but received placebo.|46
188385|NCT00628108|461025|P1|STARTED|Overall Study||23
188386|NCT00628134|461055|P2|NOT COMPLETED|Overall Study||0
188387|NCT00628134|461056|P1|NOT COMPLETED|Overall Study||0
188388|NCT00628134|461055|P2|COMPLETED|Overall Study||4
188389|NCT00628134|461056|P1|COMPLETED|Overall Study||4
188390|NCT00628134|461055|P2|STARTED|Overall Study||4
188391|NCT00628134|461056|P1|STARTED|Overall Study||4
188392|NCT00628147|461066|P2|NOT COMPLETED|Overall Study||1
188393|NCT00628147|461067|P1|NOT COMPLETED|Overall Study||7
188394|NCT00628147|461066|P2|COMPLETED|Overall Study||141
188395|NCT00628147|461067|P1|COMPLETED|Overall Study||135
188396|NCT00628147|461066|P2|STARTED|Overall Study||142
188397|NCT00628147|461067|P1|STARTED|Overall Study||142
188398|NCT00628212|461083|P4|NOT COMPLETED|Overall Study||5
188399|NCT00628212|461084|P3|NOT COMPLETED|Overall Study||3
188400|NCT00628212|461085|P2|NOT COMPLETED|Overall Study||1
188401|NCT00628212|461086|P1|NOT COMPLETED|Overall Study||3
188402|NCT00628212|461083|P4|COMPLETED|Overall Study||76
188403|NCT00628212|461084|P3|COMPLETED|Overall Study||76
188404|NCT00628212|461085|P2|COMPLETED|Overall Study||83
188405|NCT00628212|461086|P1|COMPLETED|Overall Study||77
188406|NCT00628212|461083|P4|STARTED|Overall Study||81
188407|NCT00628212|461084|P3|STARTED|Overall Study||79
188408|NCT00628212|461085|P2|STARTED|Overall Study||84
188409|NCT00628212|461086|P1|STARTED|Overall Study||80
188410|NCT00628251|461111|P3|NOT COMPLETED|Cross-over/ Continuation of Olaparib||17
188411|NCT00628251|461112|P2|NOT COMPLETED|Cross-over/ Continuation of Olaparib||26
188412|NCT00628251|461113|P1|NOT COMPLETED|Cross-over/ Continuation of Olaparib||27
188413|NCT00628251|461111|P3|COMPLETED|Cross-over/ Continuation of Olaparib|Patients ongoing crossover treatment|8
188414|NCT00628251|461112|P2|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|6
188415|NCT00628251|461113|P1|COMPLETED|Cross-over/ Continuation of Olaparib|Ongoing initial study treatment at primary data cut-off|5
188416|NCT00628251|461111|P3|STARTED|Cross-over/ Continuation of Olaparib|Patients who crossed over from Liposomal doxorubicin to Olaparib 400 mg bd|25
188417|NCT00628251|461112|P2|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
188418|NCT00628251|461113|P1|STARTED|Cross-over/ Continuation of Olaparib|Patients who received treatment|32
188419|NCT00628251|461111|P3|NOT COMPLETED|Randomised Part||8
188420|NCT00628251|461112|P2|NOT COMPLETED|Randomised Part||0
188421|NCT00628251|461113|P1|NOT COMPLETED|Randomised Part||0
188422|NCT00628251|461111|P3|COMPLETED|Randomised Part|Patients who received olaparib (crossed over). 1 of 33 did not receive Liposomal Doxorubicin.|25
188423|NCT00628251|461112|P2|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
188424|NCT00628251|461113|P1|COMPLETED|Randomised Part|Patients who received olaparib treatment|32
188425|NCT00628251|461111|P3|STARTED|Randomised Part|Patients randomised|33
188426|NCT00628251|461112|P2|STARTED|Randomised Part|Patients randomised|32
188427|NCT00628251|461113|P1|STARTED|Randomised Part|Patients randomised|32
188428|NCT00628355|461154|P2|NOT COMPLETED|Overall Study||1
188429|NCT00628355|461155|P1|NOT COMPLETED|Overall Study||1
188430|NCT00628355|461154|P2|COMPLETED|Overall Study||14
188431|NCT00628355|461155|P1|COMPLETED|Overall Study||14
188432|NCT00628355|461154|P2|STARTED|Overall Study||15
188433|NCT00628355|461155|P1|STARTED|Overall Study||15
188434|NCT00628407|461163|P1|NOT COMPLETED|Overall Study||0
188435|NCT00628407|461163|P1|COMPLETED|Overall Study||13
188436|NCT00628407|461163|P1|STARTED|Overall Study||13
188437|NCT00628446|461167|P1|NOT COMPLETED|Overall Study||7
188438|NCT00628446|461167|P1|COMPLETED|Overall Study||38
188439|NCT00628446|461167|P1|STARTED|Overall Study||45
188440|NCT00628589|461175|P3|NOT COMPLETED|Overall Study||3
188441|NCT00628589|461176|P2|NOT COMPLETED|Overall Study||2
188442|NCT00628589|461177|P1|NOT COMPLETED|Overall Study||1
188443|NCT00628589|461175|P3|COMPLETED|Overall Study||110
188444|NCT00628589|461176|P2|COMPLETED|Overall Study||114
188445|NCT00628589|461177|P1|COMPLETED|Overall Study||114
188446|NCT00628589|461175|P3|STARTED|Overall Study||113
188447|NCT00628589|461176|P2|STARTED|Overall Study||116
188448|NCT00628589|461177|P1|STARTED|Overall Study||115
188449|NCT00628628|461193|P2|NOT COMPLETED|Overall Study||0
188450|NCT00628628|461194|P1|NOT COMPLETED|Overall Study||0
188451|NCT00628628|461193|P2|COMPLETED|Overall Study||40
188452|NCT00628628|461194|P1|COMPLETED|Overall Study||40
188453|NCT00628628|461193|P2|STARTED|Overall Study||40
188454|NCT00628628|461194|P1|STARTED|Overall Study||40
188455|NCT00628758|461202|P2|NOT COMPLETED|Overall Study||42
188456|NCT00628758|461203|P1|NOT COMPLETED|Overall Study||44
188457|NCT00628758|461202|P2|COMPLETED|Overall Study||179
188458|NCT00628758|461203|P1|COMPLETED|Overall Study||165
188459|NCT00628758|461202|P2|STARTED|Overall Study||221
188460|NCT00628758|461203|P1|STARTED|Overall Study||209
188461|NCT00628862|461218|P3|NOT COMPLETED|Overall Study||22
188462|NCT00628862|461219|P2|NOT COMPLETED|Overall Study||17
188463|NCT00628862|461220|P1|NOT COMPLETED|Overall Study||11
188464|NCT00628862|461218|P3|COMPLETED|Overall Study|randomised patients|186
188465|NCT00628862|461219|P2|COMPLETED|Overall Study|randomised patients|182
188466|NCT00628862|461220|P1|COMPLETED|Overall Study|randomised patients|195
188467|NCT00628862|461218|P3|STARTED|Overall Study|randomised patients|208
188468|NCT00628862|461219|P2|STARTED|Overall Study|randomised patients|199
188469|NCT00628862|461220|P1|STARTED|Overall Study|randomised patients|206
188470|NCT00628901|461266|P2|NOT COMPLETED|Overall Study||1
188471|NCT00628901|461267|P1|NOT COMPLETED|Overall Study||3
188472|NCT00628901|461266|P2|COMPLETED|Overall Study||29
188473|NCT00628901|461267|P1|COMPLETED|Overall Study||27
188474|NCT00628901|461266|P2|STARTED|Overall Study||30
188475|NCT00628901|461267|P1|STARTED|Overall Study||30
188476|NCT00628927|461297|P2|NOT COMPLETED|Overall Study||0
188477|NCT00628927|461298|P1|NOT COMPLETED|Overall Study||8
188478|NCT00628927|461297|P2|COMPLETED|Overall Study||30
188479|NCT00628927|461298|P1|COMPLETED|Overall Study||175
188480|NCT00628927|461297|P2|STARTED|Overall Study||30
188481|NCT00628927|461298|P1|STARTED|Overall Study||183
188482|NCT00629018|461311|P2|NOT COMPLETED|Overall Study||0
188483|NCT00629018|461312|P1|NOT COMPLETED|Overall Study||0
188484|NCT00629018|461311|P2|COMPLETED|Overall Study||55
188485|NCT00629018|461312|P1|COMPLETED|Overall Study||55
188486|NCT00629018|461311|P2|STARTED|Overall Study||55
188487|NCT00629018|461312|P1|STARTED|Overall Study||55
188488|NCT00629239|461322|P2|NOT COMPLETED|Overall Study||4
188489|NCT00629239|461323|P1|NOT COMPLETED|Overall Study||8
188490|NCT00629239|461322|P2|COMPLETED|Overall Study||28
188491|NCT00629239|461323|P1|COMPLETED|Overall Study||26
188492|NCT00629239|461322|P2|STARTED|Overall Study||32
188493|NCT00629239|461323|P1|STARTED|Overall Study||34
188494|NCT00629265|461357|P2|NOT COMPLETED|Overall Study||20
188495|NCT00629265|461358|P1|NOT COMPLETED|Overall Study||32
188496|NCT00629265|461357|P2|COMPLETED|Overall Study||34
188497|NCT00629265|461358|P1|COMPLETED|Overall Study||84
188498|NCT00629265|461357|P2|STARTED|Overall Study||54
188499|NCT00629265|461358|P1|STARTED|Overall Study||116
188500|NCT00629499|461366|P1|NOT COMPLETED|Overall Study||0
188501|NCT00629499|461366|P1|COMPLETED|Overall Study||63
188502|NCT00629499|461366|P1|STARTED|Overall Study||63
188503|NCT00635024|461370|P1|NOT COMPLETED|Overall Study||1
188504|NCT00635024|461370|P1|COMPLETED|Overall Study||0
188505|NCT00635024|461370|P1|STARTED|Overall Study||1
188506|NCT00635050|461378|P1|NOT COMPLETED|Overall Study||1
188507|NCT00635050|461378|P1|COMPLETED|Overall Study|Followup through 10 years planned.|31
188508|NCT00635050|461378|P1|STARTED|Overall Study|No patient received regimen B due to grade 3 toxicity in the third patient treated on regimen A.|32
188509|NCT00635089|461385|P1|NOT COMPLETED|Overall Study||78
188510|NCT00635089|461385|P1|COMPLETED|Overall Study|Participants who had not withdrawn at the time of study termination.|112
188511|NCT00635089|461385|P1|Completed >/= 16 Weeks of Study|Overall Study||181
188512|NCT00635089|461385|P1|STARTED|Overall Study||190
188513|NCT00635102|461414|P2|NOT COMPLETED|Overall Study||8
188514|NCT00635102|461415|P1|NOT COMPLETED|Overall Study||7
188515|NCT00635102|461414|P2|COMPLETED|Overall Study||22
188516|NCT00635102|461415|P1|COMPLETED|Overall Study||20
188517|NCT00635102|461414|P2|STARTED|Overall Study||30
188518|NCT00635102|461415|P1|STARTED|Overall Study||27
188519|NCT00635128|461511|P2|NOT COMPLETED|Overall Study||0
188520|NCT00635128|461512|P1|NOT COMPLETED|Overall Study||0
188521|NCT00635128|461511|P2|COMPLETED|Overall Study||64
188522|NCT00635128|461512|P1|COMPLETED|Overall Study||351
188523|NCT00635128|461511|P2|STARTED|Overall Study||64
188524|NCT00635128|461512|P1|STARTED|Overall Study||351
188525|NCT00635154|461540|P1|NOT COMPLETED|Overall Study||33
188526|NCT00635154|461540|P1|COMPLETED|Overall Study||21
188527|NCT00635154|461540|P1|STARTED|Overall Study||54
188528|NCT00635219|461555|P5|NOT COMPLETED|Overall Study||42
188529|NCT00635219|461556|P4|NOT COMPLETED|Overall Study||34
188530|NCT00635219|461557|P3|NOT COMPLETED|Overall Study||35
188531|NCT00635219|461558|P2|NOT COMPLETED|Overall Study||25
188532|NCT00635219|461559|P1|NOT COMPLETED|Overall Study||25
188533|NCT00635219|461555|P5|COMPLETED|Overall Study||113
188534|NCT00635219|461556|P4|COMPLETED|Overall Study||117
188535|NCT00635219|461557|P3|COMPLETED|Overall Study||122
188536|NCT00635219|461558|P2|COMPLETED|Overall Study||130
188537|NCT00635219|461559|P1|COMPLETED|Overall Study||123
188538|NCT00635219|461555|P5|STARTED|Overall Study||155
188539|NCT00635219|461556|P4|STARTED|Overall Study||151
188540|NCT00635219|461557|P3|STARTED|Overall Study||157
188541|NCT00635219|461558|P2|STARTED|Overall Study||155
188542|NCT00635219|461559|P1|STARTED|Overall Study||148
188543|NCT00635232|461621|P5|NOT COMPLETED|Overall Study||8
188544|NCT00635232|461622|P4|NOT COMPLETED|Overall Study||10
188545|NCT00635232|461623|P3|NOT COMPLETED|Overall Study||3
188546|NCT00635232|461624|P2|NOT COMPLETED|Overall Study||20
188547|NCT00635232|461625|P1|NOT COMPLETED|Overall Study||14
188548|NCT00635232|461621|P5|COMPLETED|Overall Study||20
188549|NCT00635232|461622|P4|COMPLETED|Overall Study||48
188550|NCT00635232|461623|P3|COMPLETED|Overall Study||55
188551|NCT00635232|461624|P2|COMPLETED|Overall Study||39
188552|NCT00635232|461625|P1|COMPLETED|Overall Study||44
188553|NCT00635232|461621|P5|STARTED|Overall Study||28
188554|NCT00635232|461622|P4|STARTED|Overall Study||58
188555|NCT00635232|461623|P3|STARTED|Overall Study||58
188556|NCT00635232|461624|P2|STARTED|Overall Study||59
188557|NCT00635232|461625|P1|STARTED|Overall Study||58
188558|NCT00635661|461647|P1|NOT COMPLETED|Overall Study||4
188559|NCT00635661|461647|P1|COMPLETED|Overall Study||30
188560|NCT00635661|461647|P1|STARTED|Overall Study||34
188561|NCT00635700|461653|P2|NOT COMPLETED|Overall Study||14
188562|NCT00635700|461654|P1|NOT COMPLETED|Overall Study||15
188563|NCT00635700|461653|P2|COMPLETED|Overall Study||13
188564|NCT00635700|461654|P1|COMPLETED|Overall Study||9
188565|NCT00635700|461653|P2|STARTED|Overall Study||27
188566|NCT00635700|461654|P1|STARTED|Overall Study||24
188567|NCT00635804|461668|P8|NOT COMPLETED|Overall Study||0
188568|NCT00635804|461669|P7|NOT COMPLETED|Overall Study||0
188569|NCT00635804|461670|P6|NOT COMPLETED|Overall Study||1
188570|NCT00635804|461671|P5|NOT COMPLETED|Overall Study||0
188571|NCT00635804|461672|P4|NOT COMPLETED|Overall Study||0
188572|NCT00635804|461673|P3|NOT COMPLETED|Overall Study||0
188573|NCT00635804|461674|P2|NOT COMPLETED|Overall Study||0
188574|NCT00635804|461675|P1|NOT COMPLETED|Overall Study||1
188575|NCT00635804|461668|P8|COMPLETED|Overall Study||14
188576|NCT00635804|461669|P7|COMPLETED|Overall Study||3
188577|NCT00635804|461670|P6|COMPLETED|Overall Study||11
188578|NCT00635804|461671|P5|COMPLETED|Overall Study||6
188579|NCT00635804|461672|P4|COMPLETED|Overall Study||6
188580|NCT00635804|461673|P3|COMPLETED|Overall Study||6
188581|NCT00635804|461674|P2|COMPLETED|Overall Study||6
188582|NCT00635804|461675|P1|COMPLETED|Overall Study||6
188583|NCT00635804|461668|P8|STARTED|Overall Study||14
188584|NCT00635804|461669|P7|STARTED|Overall Study||3
188585|NCT00635804|461670|P6|STARTED|Overall Study||12
188586|NCT00635804|461671|P5|STARTED|Overall Study||6
188587|NCT00635804|461672|P4|STARTED|Overall Study||6
188588|NCT00635804|461673|P3|STARTED|Overall Study||6
188589|NCT00635804|461674|P2|STARTED|Overall Study||6
188590|NCT00635804|461675|P1|STARTED|Overall Study||7
188591|NCT00635817|461776|P4|NOT COMPLETED|Overall Study||0
188592|NCT00635817|461777|P3|NOT COMPLETED|Overall Study||2
188593|NCT00635817|461778|P2|NOT COMPLETED|Overall Study||2
188594|NCT00635817|461779|P1|NOT COMPLETED|Overall Study||6
188595|NCT00635817|461776|P4|COMPLETED|Overall Study||21
188596|NCT00635817|461777|P3|COMPLETED|Overall Study||19
188597|NCT00635817|461778|P2|COMPLETED|Overall Study||19
188598|NCT00635817|461779|P1|COMPLETED|Overall Study||15
188599|NCT00635817|461776|P4|STARTED|Overall Study||21
188600|NCT00635817|461777|P3|STARTED|Overall Study||21
188601|NCT00635817|461778|P2|STARTED|Overall Study||21
188602|NCT00635817|461779|P1|STARTED|Overall Study||21
188603|NCT00635830|461825|P2|NOT COMPLETED|Overall Study||0
188604|NCT00635830|461826|P1|NOT COMPLETED|Overall Study||0
188605|NCT00635830|461825|P2|COMPLETED|Overall Study||20
188606|NCT00635830|461826|P1|COMPLETED|Overall Study||20
188607|NCT00635830|461825|P2|STARTED|Overall Study||20
188608|NCT00635830|461826|P1|STARTED|Overall Study||20
188609|NCT00635882|461838|P6|NOT COMPLETED|Overall Study||0
188610|NCT00635882|461839|P5|NOT COMPLETED|Overall Study||0
188611|NCT00635882|461840|P4|NOT COMPLETED|Overall Study||0
188612|NCT00635882|461841|P3|NOT COMPLETED|Overall Study||0
188613|NCT00635882|461842|P2|NOT COMPLETED|Overall Study||0
188614|NCT00635882|461843|P1|NOT COMPLETED|Overall Study||1
188615|NCT00635882|461838|P6|COMPLETED|Overall Study||13
188616|NCT00635882|461839|P5|COMPLETED|Overall Study||16
188617|NCT00635882|461840|P4|COMPLETED|Overall Study||15
188618|NCT00635882|461841|P3|COMPLETED|Overall Study||12
188619|NCT00635882|461842|P2|COMPLETED|Overall Study||17
188620|NCT00635882|461843|P1|COMPLETED|Overall Study||19
188621|NCT00635882|461838|P6|STARTED|Overall Study||13
188622|NCT00635882|461839|P5|STARTED|Overall Study||16
188623|NCT00635882|461840|P4|STARTED|Overall Study||15
188624|NCT00635882|461841|P3|STARTED|Overall Study||12
188625|NCT00635882|461842|P2|STARTED|Overall Study||17
188626|NCT00635882|461843|P1|STARTED|Overall Study||20
188627|NCT00636077|461905|P4|NOT COMPLETED|Week 4||0
188628|NCT00636077|461906|P3|NOT COMPLETED|Week 4||0
188629|NCT00636077|461907|P2|NOT COMPLETED|Week 4||0
188630|NCT00636077|461908|P1|NOT COMPLETED|Week 4||0
188631|NCT00636077|461905|P4|COMPLETED|Week 4||3
188632|NCT00636077|461906|P3|COMPLETED|Week 4||3
188633|NCT00636077|461907|P2|COMPLETED|Week 4||3
188634|NCT00636077|461908|P1|COMPLETED|Week 4||3
188635|NCT00636077|461905|P4|STARTED|Week 4||3
188636|NCT00636077|461906|P3|STARTED|Week 4||3
188637|NCT00636077|461907|P2|STARTED|Week 4||3
188638|NCT00636077|461908|P1|STARTED|Week 4||3
188639|NCT00636077|461905|P4|NOT COMPLETED|Week 3||0
188640|NCT00636077|461906|P3|NOT COMPLETED|Week 3||0
188641|NCT00636077|461907|P2|NOT COMPLETED|Week 3||0
188642|NCT00636077|461908|P1|NOT COMPLETED|Week 3||0
188643|NCT00636077|461905|P4|COMPLETED|Week 3||3
188644|NCT00636077|461906|P3|COMPLETED|Week 3||3
188645|NCT00636077|461907|P2|COMPLETED|Week 3||3
188646|NCT00636077|461908|P1|COMPLETED|Week 3||3
188647|NCT00636077|461905|P4|STARTED|Week 3||3
188648|NCT00636077|461906|P3|STARTED|Week 3||3
188649|NCT00636077|461907|P2|STARTED|Week 3||3
188650|NCT00636077|461908|P1|STARTED|Week 3||3
188651|NCT00636077|461905|P4|NOT COMPLETED|Week 2||0
188652|NCT00636077|461906|P3|NOT COMPLETED|Week 2||0
188653|NCT00636077|461907|P2|NOT COMPLETED|Week 2||0
188654|NCT00636077|461908|P1|NOT COMPLETED|Week 2||0
188655|NCT00636077|461905|P4|COMPLETED|Week 2||3
188656|NCT00636077|461906|P3|COMPLETED|Week 2||3
188657|NCT00636077|461907|P2|COMPLETED|Week 2||3
188658|NCT00636077|461908|P1|COMPLETED|Week 2||3
188659|NCT00636077|461905|P4|STARTED|Week 2||3
188660|NCT00636077|461906|P3|STARTED|Week 2||3
188661|NCT00636077|461907|P2|STARTED|Week 2||3
188662|NCT00636077|461908|P1|STARTED|Week 2||3
188663|NCT00636077|461905|P4|NOT COMPLETED|Week 1||0
188664|NCT00636077|461906|P3|NOT COMPLETED|Week 1||0
188665|NCT00636077|461907|P2|NOT COMPLETED|Week 1||0
188666|NCT00636077|461908|P1|NOT COMPLETED|Week 1||0
188667|NCT00636077|461905|P4|COMPLETED|Week 1||3
188668|NCT00636077|461906|P3|COMPLETED|Week 1||3
188669|NCT00636077|461907|P2|COMPLETED|Week 1||3
188670|NCT00636077|461908|P1|COMPLETED|Week 1||3
188671|NCT00636077|461905|P4|STARTED|Week 1||3
188672|NCT00636077|461906|P3|STARTED|Week 1||3
188673|NCT00636077|461907|P2|STARTED|Week 1||3
188674|NCT00636077|461908|P1|STARTED|Week 1||3
188675|NCT00636155|461938|P1|NOT COMPLETED|Overall Study||18
188676|NCT00636155|461938|P1|COMPLETED|Overall Study|Completed maximum 6 cycles of treatment|2
188677|NCT00636155|461938|P1|STARTED|Overall Study||20
188678|NCT00636168|461946|P2|NOT COMPLETED|Treated With Study Drug||411
188679|NCT00636168|461947|P1|NOT COMPLETED|Treated With Study Drug||447
188680|NCT00636168|461946|P2|COMPLETED|Treated With Study Drug||63
188681|NCT00636168|461947|P1|COMPLETED|Treated With Study Drug||24
188682|NCT00636168|461946|P2|STARTED|Treated With Study Drug||474
188683|NCT00636168|461947|P1|STARTED|Treated With Study Drug||471
188684|NCT00636168|461946|P2|NOT COMPLETED|Randomized to Study Drug||2
188685|NCT00636168|461947|P1|NOT COMPLETED|Randomized to Study Drug||4
188686|NCT00636168|461946|P2|COMPLETED|Randomized to Study Drug||474
188687|NCT00636168|461947|P1|COMPLETED|Randomized to Study Drug||471
188688|NCT00636168|461946|P2|STARTED|Randomized to Study Drug||476
188689|NCT00636168|461947|P1|STARTED|Randomized to Study Drug||475
188690|NCT00636194|461969|P2|NOT COMPLETED|Overall Study||0
188691|NCT00636194|461970|P1|NOT COMPLETED|Overall Study||3
188692|NCT00636194|461969|P2|COMPLETED|Overall Study||175
188693|NCT00636194|461970|P1|COMPLETED|Overall Study||172
188694|NCT00636194|461969|P2|STARTED|Overall Study||175
188695|NCT00636194|461970|P1|STARTED|Overall Study||175
188696|NCT00636207|461983|P7|NOT COMPLETED|Overall Study||0
188697|NCT00636207|461984|P6|NOT COMPLETED|Overall Study||0
188698|NCT00636207|461985|P5|NOT COMPLETED|Overall Study||1
188699|NCT00636207|461986|P4|NOT COMPLETED|Overall Study||0
188700|NCT00636207|461987|P3|NOT COMPLETED|Overall Study||0
188701|NCT00636207|461988|P2|NOT COMPLETED|Overall Study||1
188702|NCT00636207|461989|P1|NOT COMPLETED|Overall Study||1
188703|NCT00636207|461983|P7|COMPLETED|Overall Study||3
188704|NCT00636207|461984|P6|COMPLETED|Overall Study||1
188705|NCT00636207|461985|P5|COMPLETED|Overall Study||8
188706|NCT00636207|461986|P4|COMPLETED|Overall Study||6
188707|NCT00636207|461987|P3|COMPLETED|Overall Study||18
188708|NCT00636207|461988|P2|COMPLETED|Overall Study||7
188709|NCT00636207|461989|P1|COMPLETED|Overall Study||0
188710|NCT00636207|461983|P7|STARTED|Overall Study||3
188711|NCT00636207|461984|P6|STARTED|Overall Study||1
188712|NCT00636207|461985|P5|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|9
188713|NCT00636207|461986|P4|STARTED|Overall Study||6
188714|NCT00636207|461987|P3|STARTED|Overall Study||18
188715|NCT00636207|461988|P2|STARTED|Overall Study|One participant withdrew consent after completing all study doses.|8
188716|NCT00636207|461989|P1|STARTED|Overall Study|One participant discontinued after completing Period 2. Doses in Periods 1 and 2 were Montelukast.|1
188717|NCT00636220|462051|P1|NOT COMPLETED|Overall Study||0
188718|NCT00636220|462051|P1|COMPLETED|Overall Study||101
188719|NCT00636220|462051|P1|STARTED|Overall Study||101
188720|NCT00636363|462058|P3|NOT COMPLETED|Overall Study||18
188721|NCT00636363|462059|P2|NOT COMPLETED|Overall Study||20
188722|NCT00636363|462060|P1|NOT COMPLETED|Overall Study||13
188723|NCT00636363|462058|P3|COMPLETED|Overall Study||163
188724|NCT00636363|462059|P2|COMPLETED|Overall Study||156
188725|NCT00636363|462060|P1|COMPLETED|Overall Study||165
188726|NCT00636363|462058|P3|STARTED|Overall Study||181
188727|NCT00636363|462059|P2|STARTED|Overall Study||176
188728|NCT00636363|462060|P1|STARTED|Overall Study||178
188729|NCT00636389|462074|P2|NOT COMPLETED|Period 2 - 1 Week||0
188730|NCT00636389|462075|P1|NOT COMPLETED|Period 2 - 1 Week||0
188731|NCT00636389|462074|P2|COMPLETED|Period 2 - 1 Week||5
188732|NCT00636389|462075|P1|COMPLETED|Period 2 - 1 Week||7
188733|NCT00636389|462074|P2|STARTED|Period 2 - 1 Week||5
188734|NCT00636389|462075|P1|STARTED|Period 2 - 1 Week||7
188735|NCT00636389|462074|P2|NOT COMPLETED|Period 1 - 1 Week||0
188736|NCT00636389|462075|P1|NOT COMPLETED|Period 1 - 1 Week||0
188737|NCT00636389|462074|P2|COMPLETED|Period 1 - 1 Week||5
188738|NCT00636389|462075|P1|COMPLETED|Period 1 - 1 Week||7
188739|NCT00636389|462074|P2|STARTED|Period 1 - 1 Week||5
188740|NCT00636389|462075|P1|STARTED|Period 1 - 1 Week||7
188741|NCT00636441|462092|P7|NOT COMPLETED|Overall Study||18
188742|NCT00636441|462093|P6|NOT COMPLETED|Overall Study||1
188743|NCT00636441|462094|P5|NOT COMPLETED|Overall Study||0
188744|NCT00636441|462095|P4|NOT COMPLETED|Overall Study||0
188745|NCT00636441|462096|P3|NOT COMPLETED|Overall Study||1
188746|NCT00636441|462097|P2|NOT COMPLETED|Overall Study||1
188747|NCT00636441|462098|P1|NOT COMPLETED|Overall Study||0
188748|NCT00636441|462092|P7|COMPLETED|Overall Study||0
188749|NCT00636441|462093|P6|COMPLETED|Overall Study||6
188750|NCT00636441|462094|P5|COMPLETED|Overall Study||6
188751|NCT00636441|462095|P4|COMPLETED|Overall Study||6
188752|NCT00636441|462096|P3|COMPLETED|Overall Study||5
188753|NCT00636441|462097|P2|COMPLETED|Overall Study||6
188754|NCT00636441|462098|P1|COMPLETED|Overall Study||6
188755|NCT00636441|462092|P7|Assigned Treatment|Overall Study|This is a late determined ineligibility.|1
188756|NCT00636441|462093|P6|Assigned Treatment|Overall Study||7
188757|NCT00636441|462094|P5|Assigned Treatment|Overall Study||6
188758|NCT00636441|462095|P4|Assigned Treatment|Overall Study||6
188759|NCT00636441|462096|P3|Assigned Treatment|Overall Study||6
188760|NCT00636441|462097|P2|Assigned Treatment|Overall Study||7
188761|NCT00636441|462098|P1|Assigned Treatment|Overall Study||6
188762|NCT00636441|462092|P7|STARTED|Overall Study||18
188763|NCT00636441|462093|P6|STARTED|Overall Study||7
188764|NCT00636441|462094|P5|STARTED|Overall Study||6
188765|NCT00636441|462095|P4|STARTED|Overall Study||6
188766|NCT00636441|462096|P3|STARTED|Overall Study||6
188767|NCT00636441|462097|P2|STARTED|Overall Study||7
188768|NCT00636441|462098|P1|STARTED|Overall Study||6
188769|NCT00636610|462129|P2|NOT COMPLETED|Overall Study||83
188770|NCT00636610|462130|P1|NOT COMPLETED|Overall Study||92
188771|NCT00636610|462129|P2|COMPLETED|Overall Study||18
188772|NCT00636610|462130|P1|COMPLETED|Overall Study||6
188773|NCT00636610|462129|P2|STARTED|Overall Study||101
188774|NCT00636610|462130|P1|STARTED|Overall Study||98
188775|NCT00636636|462142|P2|NOT COMPLETED|Overall Study||39
188776|NCT00636636|462143|P1|NOT COMPLETED|Overall Study||36
188777|NCT00636636|462142|P2|COMPLETED|Overall Study||192
188778|NCT00636636|462143|P1|COMPLETED|Overall Study||185
188779|NCT00636636|462142|P2|379|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
188780|NCT00636636|462143|P1|379|Overall Study||186
188781|NCT00636636|462142|P2|Safety & Efficacy of Gabapentin ER|Overall Study|1 patient randomized twice, not included in ITT, but completed medication and counted as completer|194
188782|NCT00636636|462143|P1|Safety & Efficacy of Gabapentin ER|Overall Study||186
188783|NCT00636636|462142|P2|STARTED|Overall Study||231
188784|NCT00636636|462143|P1|STARTED|Overall Study||221
188785|NCT00636649|462159|P2|NOT COMPLETED|Overall Study||0
188786|NCT00636649|462160|P1|NOT COMPLETED|Overall Study||0
188787|NCT00636649|462159|P2|COMPLETED|Overall Study||20
188788|NCT00636649|462160|P1|COMPLETED|Overall Study||20
188789|NCT00636649|462159|P2|STARTED|Overall Study||20
188790|NCT00636649|462160|P1|STARTED|Overall Study||20
188791|NCT00636701|462190|P2|NOT COMPLETED|Overall Study||0
188792|NCT00636701|462191|P1|NOT COMPLETED|Overall Study||0
188793|NCT00636701|462190|P2|COMPLETED|Overall Study||2
188794|NCT00636701|462191|P1|COMPLETED|Overall Study||2
188795|NCT00636701|462190|P2|STARTED|Overall Study||2
188796|NCT00636701|462191|P1|STARTED|Overall Study||2
188797|NCT00636792|462197|P1|NOT COMPLETED|Overall Study||33
188798|NCT00636792|462197|P1|COMPLETED|Overall Study||40
188799|NCT00636792|462197|P1|STARTED|Overall Study||73
188800|NCT00636805|462202|P1|NOT COMPLETED|Overall Study||0
188801|NCT00636805|462202|P1|COMPLETED|Overall Study||63
188802|NCT00636805|462202|P1|STARTED|Overall Study||63
188803|NCT00636818|462212|P1|NOT COMPLETED|Overall Study||11
188804|NCT00636818|462212|P1|COMPLETED|Overall Study||34
188805|NCT00636818|462212|P1|Received at Least One Dose of Study Drug|Overall Study|One patient was lost to follow up and did not receive any study drug.|44
188806|NCT00636818|462212|P1|STARTED|Overall Study||45
188807|NCT00636961|462229|P2|NOT COMPLETED|Period 2||0
188808|NCT00636961|462230|P1|NOT COMPLETED|Period 2||1
188809|NCT00636961|462229|P2|COMPLETED|Period 2||12
188810|NCT00636961|462230|P1|COMPLETED|Period 2||12
188811|NCT00636961|462229|P2|STARTED|Period 2||12
188812|NCT00636961|462230|P1|STARTED|Period 2||13
188813|NCT00636961|462229|P2|NOT COMPLETED|Period 1||1
188814|NCT00636961|462230|P1|NOT COMPLETED|Period 1||1
188815|NCT00636961|462229|P2|COMPLETED|Period 1||12
188816|NCT00636961|462230|P1|COMPLETED|Period 1||13
188817|NCT00636961|462229|P2|STARTED|Period 1||13
188818|NCT00636961|462230|P1|STARTED|Period 1||14
188819|NCT00636987|462244|P1|NOT COMPLETED|Overall Study||189
188820|NCT00636987|462244|P1|COMPLETED|Overall Study||108
188821|NCT00636987|462244|P1|STARTED|Overall Study||297
188822|NCT00637000|462254|P2|NOT COMPLETED|Overall Study||3
188823|NCT00637000|462255|P1|NOT COMPLETED|Overall Study||4
188824|NCT00637000|462254|P2|COMPLETED|Overall Study||15
188825|NCT00637000|462255|P1|COMPLETED|Overall Study||16
188826|NCT00637000|462254|P2|Evaluable|Overall Study||16
188827|NCT00637000|462255|P1|Evaluable|Overall Study||18
188828|NCT00637000|462254|P2|STARTED|Overall Study|Randomized and treated|18
188829|NCT00637000|462255|P1|STARTED|Overall Study|Randomized and treated|20
188830|NCT00637156|462297|P2|NOT COMPLETED|Overall Study||24
188831|NCT00637156|462298|P1|NOT COMPLETED|Overall Study||10
188832|NCT00637156|462297|P2|COMPLETED|Overall Study||164
188833|NCT00637156|462298|P1|COMPLETED|Overall Study||199
188834|NCT00637156|462297|P2|STARTED|Overall Study||188
188835|NCT00637156|462298|P1|STARTED|Overall Study||209
188836|NCT00637195|462340|P2|NOT COMPLETED|Overall Study||1
188837|NCT00637195|462341|P1|NOT COMPLETED|Overall Study||3
188838|NCT00637195|462340|P2|COMPLETED|Overall Study||75
188839|NCT00637195|462341|P1|COMPLETED|Overall Study||73
188840|NCT00637195|462340|P2|STARTED|Overall Study||76
188841|NCT00637195|462341|P1|STARTED|Overall Study||76
188842|NCT00637247|462377|P2|NOT COMPLETED|Overall Study||0
188843|NCT00637247|462378|P1|NOT COMPLETED|Overall Study||0
188844|NCT00637247|462377|P2|COMPLETED|Overall Study||70
188845|NCT00637247|462378|P1|COMPLETED|Overall Study||72
188846|NCT00637247|462377|P2|STARTED|Overall Study||70
188847|NCT00637247|462378|P1|STARTED|Overall Study||72
188848|NCT00637273|462391|P3|NOT COMPLETED|Overall Study||41
188849|NCT00637273|462392|P2|NOT COMPLETED|Overall Study||28
188850|NCT00637273|462393|P1|NOT COMPLETED|Overall Study||43
188851|NCT00637273|462391|P3|COMPLETED|Overall Study||131
188852|NCT00637273|462392|P2|COMPLETED|Overall Study||144
188853|NCT00637273|462393|P1|COMPLETED|Overall Study||127
188854|NCT00637273|462391|P3|Intent to Treat (ITT)|Overall Study||165
188855|NCT00637273|462392|P2|Intent to Treat (ITT)|Overall Study||166
188856|NCT00637273|462393|P1|Intent to Treat (ITT)|Overall Study||160
188857|NCT00637273|462391|P3|STARTED|Overall Study||172
188858|NCT00637273|462392|P2|STARTED|Overall Study||172
188859|NCT00637273|462393|P1|STARTED|Overall Study||170
188860|NCT00637299|462436|P2|NOT COMPLETED|Overall Study||0
188861|NCT00637299|462437|P1|NOT COMPLETED|Overall Study||0
188862|NCT00637299|462436|P2|COMPLETED|Overall Study||10
188863|NCT00637299|462437|P1|COMPLETED|Overall Study||10
188864|NCT00637299|462436|P2|STARTED|Overall Study||10
188865|NCT00637299|462437|P1|STARTED|Overall Study||10
188866|NCT00637312|462447|P2|NOT COMPLETED|Overall Study||17
188867|NCT00637312|462448|P1|NOT COMPLETED|Overall Study||42
188868|NCT00637312|462447|P2|COMPLETED|Overall Study||19
188869|NCT00637312|462448|P1|COMPLETED|Overall Study||30
188870|NCT00637312|462447|P2|STARTED|Overall Study||36
188871|NCT00637312|462448|P1|STARTED|Overall Study||72
188872|NCT00637377|462458|P4|NOT COMPLETED|Overall Study||29
188873|NCT00637377|462459|P3|NOT COMPLETED|Overall Study||37
188874|NCT00637377|462460|P2|NOT COMPLETED|Overall Study||32
188875|NCT00637377|462461|P1|NOT COMPLETED|Overall Study||27
188876|NCT00637377|462458|P4|COMPLETED|Overall Study||284
188877|NCT00637377|462459|P3|COMPLETED|Overall Study||274
188878|NCT00637377|462460|P2|COMPLETED|Overall Study||281
188879|NCT00637377|462461|P1|COMPLETED|Overall Study||276
188880|NCT00637377|462458|P4|Participants Treated (FAS)|Overall Study||306
188881|NCT00637377|462459|P3|Participants Treated (FAS)|Overall Study||296
188882|NCT00637377|462460|P2|Participants Treated (FAS)|Overall Study||309
188883|NCT00637377|462461|P1|Participants Treated (FAS)|Overall Study||291
188884|NCT00637377|462458|P4|Participants Received Treatment|Overall Study|safety population|307
188885|NCT00637377|462459|P3|Participants Received Treatment|Overall Study|safety population|297
188886|NCT00637377|462460|P2|Participants Received Treatment|Overall Study|safety population|309
188887|NCT00637377|462461|P1|Participants Received Treatment|Overall Study|safety population|291
188888|NCT00637377|462458|P4|STARTED|Overall Study||313
188889|NCT00637377|462459|P3|STARTED|Overall Study||311
188890|NCT00637377|462460|P2|STARTED|Overall Study||313
188891|NCT00637377|462461|P1|STARTED|Overall Study||303
188892|NCT00637416|462489|P2|NOT COMPLETED|Overall Study||2
188893|NCT00637416|462490|P1|NOT COMPLETED|Overall Study||1
188894|NCT00637416|462489|P2|COMPLETED|Overall Study||3
188895|NCT00637416|462490|P1|COMPLETED|Overall Study||3
188896|NCT00637416|462489|P2|STARTED|Overall Study||5
188897|NCT00637416|462490|P1|STARTED|Overall Study||4
188898|NCT00637494|462498|P2|NOT COMPLETED|Overall Study||43
188899|NCT00637494|462499|P1|NOT COMPLETED|Overall Study||32
188900|NCT00637494|462498|P2|COMPLETED|Overall Study||108
188901|NCT00637494|462499|P1|COMPLETED|Overall Study||109
188902|NCT00637494|462498|P2|STARTED|Overall Study||151
188903|NCT00637494|462499|P1|STARTED|Overall Study||141
188904|NCT00637572|462509|P2|NOT COMPLETED|Overall Study||7
188905|NCT00637572|462510|P1|NOT COMPLETED|Overall Study||3
188906|NCT00637572|462509|P2|COMPLETED|Overall Study||24
188907|NCT00637572|462510|P1|COMPLETED|Overall Study||29
188908|NCT00637572|462509|P2|STARTED|Overall Study||31
188909|NCT00637572|462510|P1|STARTED|Overall Study||32
188910|NCT00637728|462538|P3|NOT COMPLETED|Extension Phase||0
188911|NCT00637728|462539|P2|NOT COMPLETED|Extension Phase||0
188912|NCT00637728|462540|P1|NOT COMPLETED|Extension Phase||0
188913|NCT00637728|462538|P3|COMPLETED|Extension Phase||0
188914|NCT00637728|462539|P2|COMPLETED|Extension Phase||0
188915|NCT00637728|462540|P1|COMPLETED|Extension Phase||0
188916|NCT00637728|462538|P3|STARTED|Extension Phase||0
188917|NCT00637728|462539|P2|STARTED|Extension Phase||0
188918|NCT00637728|462540|P1|STARTED|Extension Phase||0
188919|NCT00637728|462538|P3|NOT COMPLETED|Double-blind Phase||0
188920|NCT00637728|462539|P2|NOT COMPLETED|Double-blind Phase||1
188921|NCT00637728|462540|P1|NOT COMPLETED|Double-blind Phase||4
188922|NCT00637728|462538|P3|COMPLETED|Double-blind Phase||0
188923|NCT00637728|462539|P2|COMPLETED|Double-blind Phase||0
188924|NCT00637728|462540|P1|COMPLETED|Double-blind Phase||0
188925|NCT00637728|462538|P3|STARTED|Double-blind Phase||0
188926|NCT00637728|462539|P2|STARTED|Double-blind Phase||1
188927|NCT00637728|462540|P1|STARTED|Double-blind Phase||4
188928|NCT00637780|462553|P1|NOT COMPLETED|Overall Study||0
188929|NCT00637780|462553|P1|COMPLETED|Overall Study||2
188930|NCT00637780|462553|P1|STARTED|Overall Study||2
188931|NCT00637806|462571|P4|NOT COMPLETED|Extension Phase||1
188932|NCT00637806|462572|P3|NOT COMPLETED|Extension Phase||0
188933|NCT00637806|462573|P2|NOT COMPLETED|Extension Phase||0
188934|NCT00637806|462574|P1|NOT COMPLETED|Extension Phase||0
188935|NCT00637806|462571|P4|COMPLETED|Extension Phase||0
188936|NCT00637806|462572|P3|COMPLETED|Extension Phase||0
188937|NCT00637806|462573|P2|COMPLETED|Extension Phase||0
188938|NCT00637806|462574|P1|COMPLETED|Extension Phase||0
188939|NCT00637806|462571|P4|STARTED|Extension Phase||1
188940|NCT00637806|462572|P3|STARTED|Extension Phase||0
188941|NCT00637806|462573|P2|STARTED|Extension Phase||0
188942|NCT00637806|462574|P1|STARTED|Extension Phase||0
188943|NCT00637806|462571|P4|NOT COMPLETED|Double-blind Phase||0
188944|NCT00637806|462572|P3|NOT COMPLETED|Double-blind Phase||1
188945|NCT00637806|462573|P2|NOT COMPLETED|Double-blind Phase||0
188946|NCT00637806|462574|P1|NOT COMPLETED|Double-blind Phase||2
188947|NCT00637806|462571|P4|COMPLETED|Double-blind Phase||0
188948|NCT00637806|462572|P3|COMPLETED|Double-blind Phase||1
188949|NCT00637806|462573|P2|COMPLETED|Double-blind Phase||0
188950|NCT00637806|462574|P1|COMPLETED|Double-blind Phase||0
188951|NCT00637806|462571|P4|STARTED|Double-blind Phase||0
188952|NCT00637806|462572|P3|STARTED|Double-blind Phase||2
188953|NCT00637806|462573|P2|STARTED|Double-blind Phase||0
188954|NCT00637806|462574|P1|STARTED|Double-blind Phase||2
188955|NCT00637923|462594|P2|NOT COMPLETED|Overall Study||19
188956|NCT00637923|462595|P1|NOT COMPLETED|Overall Study||30
188957|NCT00637923|462594|P2|COMPLETED|Overall Study||18
188958|NCT00637923|462595|P1|COMPLETED|Overall Study||45
188959|NCT00637923|462594|P2|STARTED|Overall Study||37
188960|NCT00637923|462595|P1|STARTED|Overall Study||75
188961|NCT00638014|462617|P2|NOT COMPLETED|Overall Study||0
188962|NCT00638014|462618|P1|NOT COMPLETED|Overall Study||0
188963|NCT00638014|462617|P2|COMPLETED|Overall Study||28
188964|NCT00638014|462618|P1|COMPLETED|Overall Study||23
188965|NCT00638014|462617|P2|STARTED|Overall Study||28
188966|NCT00638014|462618|P1|STARTED|Overall Study||23
188967|NCT00638027|462628|P2|NOT COMPLETED|Overall Study||2
188968|NCT00638027|462629|P1|NOT COMPLETED|Overall Study||0
188969|NCT00638027|462628|P2|COMPLETED|Overall Study|all 10 included in analyses|8
188970|NCT00638027|462629|P1|COMPLETED|Overall Study||11
188971|NCT00638027|462628|P2|STARTED|Overall Study||10
188972|NCT00638027|462629|P1|STARTED|Overall Study||11
188973|NCT00638157|462641|P2|NOT COMPLETED|Overall Study||4
188974|NCT00638157|462642|P1|NOT COMPLETED|Overall Study||7
188975|NCT00638157|462641|P2|COMPLETED|Overall Study|4 subjects completed study drug in this arm|8
188976|NCT00638157|462642|P1|COMPLETED|Overall Study|4 subjects completed study drug in this arm|5
188977|NCT00638157|462641|P2|Treated|Overall Study||12
188978|NCT00638157|462642|P1|Treated|Overall Study||10
188979|NCT00638157|462641|P2|STARTED|Overall Study||12
188980|NCT00638157|462642|P1|STARTED|Overall Study||12
188981|NCT00626743|462652|P2|NOT COMPLETED|Treatment Period 2||0
188982|NCT00626743|462653|P1|NOT COMPLETED|Treatment Period 2||0
188983|NCT00626743|462652|P2|COMPLETED|Treatment Period 2||6
188984|NCT00626743|462653|P1|COMPLETED|Treatment Period 2||6
188985|NCT00626743|462652|P2|STARTED|Treatment Period 2||6
188986|NCT00626743|462653|P1|STARTED|Treatment Period 2||6
188987|NCT00626743|462652|P2|NOT COMPLETED|Wash-out Period of 6 Days||0
188988|NCT00626743|462653|P1|NOT COMPLETED|Wash-out Period of 6 Days||0
188989|NCT00626743|462652|P2|COMPLETED|Wash-out Period of 6 Days||6
188990|NCT00626743|462653|P1|COMPLETED|Wash-out Period of 6 Days||6
188991|NCT00626743|462652|P2|STARTED|Wash-out Period of 6 Days||6
188992|NCT00626743|462653|P1|STARTED|Wash-out Period of 6 Days||6
188993|NCT00626743|462652|P2|NOT COMPLETED|Treatment Period 1||1
188994|NCT00626743|462653|P1|NOT COMPLETED|Treatment Period 1||0
188995|NCT00626743|462652|P2|COMPLETED|Treatment Period 1||6
188996|NCT00626743|462653|P1|COMPLETED|Treatment Period 1||6
188997|NCT00626743|462652|P2|STARTED|Treatment Period 1||7
188998|NCT00626743|462653|P1|STARTED|Treatment Period 1||6
188999|NCT00626782|462663|P2|NOT COMPLETED|Overall Study||0
189000|NCT00626782|462664|P1|NOT COMPLETED|Overall Study||0
189001|NCT00626782|462663|P2|COMPLETED|Overall Study||12
189002|NCT00626782|462664|P1|COMPLETED|Overall Study||12
189003|NCT00626782|462663|P2|STARTED|Overall Study||12
189004|NCT00626782|462664|P1|STARTED|Overall Study||12
189005|NCT00626808|462674|P4|NOT COMPLETED|Overall Study||0
189006|NCT00626808|462675|P3|NOT COMPLETED|Overall Study||0
189007|NCT00626808|462676|P2|NOT COMPLETED|Overall Study||0
189008|NCT00626808|462677|P1|NOT COMPLETED|Overall Study||0
189009|NCT00626808|462674|P4|COMPLETED|Overall Study||2906
189010|NCT00626808|462675|P3|COMPLETED|Overall Study||30011
189011|NCT00626808|462676|P2|COMPLETED|Overall Study||34316
189012|NCT00626808|462677|P1|COMPLETED|Overall Study||254464
189013|NCT00626808|462674|P4|STARTED|Overall Study||2906
189014|NCT00626808|462675|P3|STARTED|Overall Study||30011
189015|NCT00626808|462676|P2|STARTED|Overall Study||34316
189016|NCT00626808|462677|P1|STARTED|Overall Study||254464
189017|NCT00626821|462743|P1|NOT COMPLETED|Overall Study||221
189018|NCT00626821|462743|P1|COMPLETED|Overall Study||2796
189019|NCT00626821|462743|P1|Quality of Life|Overall Study|Attended both visit 1 and visit 2|2672
189020|NCT00626821|462743|P1|STARTED|Overall Study||3017
189021|NCT00626925|462749|P2|NOT COMPLETED|Overall Study||9
189022|NCT00626925|462750|P1|NOT COMPLETED|Overall Study||12
189023|NCT00626925|462749|P2|COMPLETED|Overall Study||62
189024|NCT00626925|462750|P1|COMPLETED|Overall Study||55
189025|NCT00626925|462749|P2|STARTED|Overall Study||71
189026|NCT00626925|462750|P1|STARTED|Overall Study||67
189027|NCT00632411|462778|P2|NOT COMPLETED|Overall Study||176
189028|NCT00632411|462779|P1|NOT COMPLETED|Overall Study||160
189029|NCT00632411|462778|P2|COMPLETED|Overall Study||473
189030|NCT00632411|462779|P1|COMPLETED|Overall Study||489
189031|NCT00632411|462778|P2|STARTED|Overall Study||649
189032|NCT00632411|462779|P1|STARTED|Overall Study||649
189033|NCT00632424|462788|P1|NOT COMPLETED|Overall Study||18
189034|NCT00632424|462788|P1|COMPLETED|Overall Study||0
189035|NCT00632424|462788|P1|STARTED|Overall Study||18
189036|NCT00638183|462810|P1|NOT COMPLETED|Overall Study||119
189037|NCT00638183|462810|P1|COMPLETED|Overall Study||266
189038|NCT00638183|462810|P1|STARTED|Overall Study||385
189039|NCT00638222|462820|P3|NOT COMPLETED|Overall Study||0
189040|NCT00638222|462821|P2|NOT COMPLETED|Overall Study||0
189041|NCT00638222|462822|P1|NOT COMPLETED|Overall Study||0
189042|NCT00638222|462820|P3|COMPLETED|Overall Study||6
189043|NCT00638222|462821|P2|COMPLETED|Overall Study||0
189044|NCT00638222|462822|P1|COMPLETED|Overall Study||0
189045|NCT00638222|462820|P3|STARTED|Overall Study||6
189046|NCT00638222|462821|P2|STARTED|Overall Study||0
189047|NCT00638222|462822|P1|STARTED|Overall Study||0
189048|NCT00638235|462838|P9|NOT COMPLETED|Overall Study||18
189049|NCT00638235|462839|P8|NOT COMPLETED|Overall Study||1
189050|NCT00638235|462840|P7|NOT COMPLETED|Overall Study||0
189051|NCT00638235|462841|P6|NOT COMPLETED|Overall Study||26
189052|NCT00638235|462842|P5|NOT COMPLETED|Overall Study||13
189053|NCT00638235|462843|P4|NOT COMPLETED|Overall Study||10
189054|NCT00638235|462844|P3|NOT COMPLETED|Overall Study||18
189055|NCT00638235|462845|P2|NOT COMPLETED|Overall Study||3
189056|NCT00638235|462846|P1|NOT COMPLETED|Overall Study||31
189057|NCT00638235|462838|P9|COMPLETED|Overall Study||124
189058|NCT00638235|462839|P8|COMPLETED|Overall Study|Ph-VI ended after 12M b/c next generation of Elevate Anterior was already under trial in Phase VII|34
189059|NCT00638235|462840|P7|COMPLETED|Overall Study||23
189060|NCT00638235|462841|P6|COMPLETED|Overall Study||113
189061|NCT00638235|462842|P5|COMPLETED|Overall Study||42
189062|NCT00638235|462843|P4|COMPLETED|Overall Study||46
189063|NCT00638235|462844|P3|COMPLETED|Overall Study|Ph-II ended before all subjects had 24M b/c Perigee next generation was already under trial P-III/IV|63
189064|NCT00638235|462845|P2|COMPLETED|Overall Study||23
189065|NCT00638235|462846|P1|COMPLETED|Overall Study||110
189066|NCT00638235|462838|P9|STARTED|Overall Study||142
189067|NCT00638235|462839|P8|STARTED|Overall Study||35
189068|NCT00638235|462840|P7|STARTED|Overall Study||23
189069|NCT00638235|462841|P6|STARTED|Overall Study||139
189070|NCT00638235|462842|P5|STARTED|Overall Study||55
189071|NCT00638235|462843|P4|STARTED|Overall Study||56
189072|NCT00638235|462844|P3|STARTED|Overall Study||81
189073|NCT00638235|462845|P2|STARTED|Overall Study||26
189074|NCT00638235|462846|P1|STARTED|Overall Study||141
189075|NCT00638365|463247|P3|NOT COMPLETED|Overall Study||0
189076|NCT00638365|463248|P2|NOT COMPLETED|Overall Study||0
189077|NCT00638365|463249|P1|NOT COMPLETED|Overall Study||0
189078|NCT00638365|463247|P3|COMPLETED|Overall Study||8
189079|NCT00638365|463248|P2|COMPLETED|Overall Study||10
189080|NCT00638365|463249|P1|COMPLETED|Overall Study||9
189081|NCT00638365|463247|P3|STARTED|Overall Study||8
189082|NCT00638365|463248|P2|STARTED|Overall Study||10
189083|NCT00638365|463249|P1|STARTED|Overall Study||9
189084|NCT00638378|463257|P1|NOT COMPLETED|Overall Study||22
189085|NCT00638378|463257|P1|COMPLETED|Overall Study||0
189086|NCT00638378|463257|P1|STARTED|Overall Study||22
189087|NCT00638443|463264|P2|NOT COMPLETED|Second Intervention||0
189088|NCT00638443|463265|P1|NOT COMPLETED|Second Intervention||0
189089|NCT00638443|463264|P2|COMPLETED|Second Intervention||14
189090|NCT00638443|463265|P1|COMPLETED|Second Intervention||12
189091|NCT00638443|463264|P2|STARTED|Second Intervention||14
189092|NCT00638443|463265|P1|STARTED|Second Intervention||12
189093|NCT00638443|463264|P2|NOT COMPLETED|Washout||0
189094|NCT00638443|463265|P1|NOT COMPLETED|Washout||0
189095|NCT00638443|463264|P2|COMPLETED|Washout||14
189096|NCT00638443|463265|P1|COMPLETED|Washout||12
189097|NCT00638443|463264|P2|STARTED|Washout||14
189098|NCT00638443|463265|P1|STARTED|Washout||12
189099|NCT00638443|463264|P2|NOT COMPLETED|First Intervention||1
189100|NCT00638443|463265|P1|NOT COMPLETED|First Intervention||2
189101|NCT00638443|463264|P2|COMPLETED|First Intervention||14
189102|NCT00638443|463265|P1|COMPLETED|First Intervention||12
189103|NCT00638443|463264|P2|STARTED|First Intervention||15
189104|NCT00638443|463265|P1|STARTED|First Intervention||14
189105|NCT00640393|463293|P3|NOT COMPLETED|Part 2||3
189106|NCT00640393|463294|P2|NOT COMPLETED|Part 2||10
189107|NCT00640393|463295|P1|NOT COMPLETED|Part 2||0
189108|NCT00640393|463293|P3|COMPLETED|Part 2|Per protocol analysis of 27 to 29 participants that were compliant depending on evaluation or visit|35
189109|NCT00640393|463294|P2|COMPLETED|Part 2|Per Protocol analysis is of 7 participants that were compliant to protocol|27
189110|NCT00640393|463295|P1|COMPLETED|Part 2||0
189111|NCT00640393|463293|P3|STARTED|Part 2||38
189112|NCT00640393|463294|P2|STARTED|Part 2||37
189113|NCT00640393|463295|P1|STARTED|Part 2||0
189114|NCT00640393|463293|P3|NOT COMPLETED|Randomization||0
189115|NCT00640393|463294|P2|NOT COMPLETED|Randomization||0
189116|NCT00640393|463295|P1|NOT COMPLETED|Randomization||19
189117|NCT00640393|463293|P3|COMPLETED|Randomization||0
189118|NCT00640393|463294|P2|COMPLETED|Randomization||0
189119|NCT00640393|463295|P1|COMPLETED|Randomization||75
189120|NCT00640393|463293|P3|STARTED|Randomization||0
189121|NCT00640393|463294|P2|STARTED|Randomization||0
189122|NCT00640393|463295|P1|STARTED|Randomization||94
189123|NCT00640393|463293|P3|NOT COMPLETED|Part 1||0
189124|NCT00640393|463294|P2|NOT COMPLETED|Part 1||0
189125|NCT00640393|463295|P1|NOT COMPLETED|Part 1||5
189126|NCT00640393|463293|P3|COMPLETED|Part 1||0
189127|NCT00640393|463294|P2|COMPLETED|Part 1||0
189128|NCT00640393|463295|P1|COMPLETED|Part 1||94
189129|NCT00640393|463293|P3|STARTED|Part 1||0
189130|NCT00640393|463294|P2|STARTED|Part 1||0
189131|NCT00640393|463295|P1|STARTED|Part 1||99
189132|NCT00640510|463359|P2|NOT COMPLETED|Overall Study||2
189133|NCT00640510|463360|P1|NOT COMPLETED|Overall Study||1
189134|NCT00640510|463359|P2|COMPLETED|Overall Study||15
189135|NCT00640510|463360|P1|COMPLETED|Overall Study||16
189136|NCT00640510|463359|P2|STARTED|Overall Study|One patient randomized to placebo discontinued prior to receiving study drug.|17
189137|NCT00640510|463360|P1|STARTED|Overall Study||17
189138|NCT00640562|463374|P2|NOT COMPLETED|Overall Study||26
189139|NCT00640562|463375|P1|NOT COMPLETED|Overall Study||18
189140|NCT00640562|463374|P2|COMPLETED|Overall Study||81
189141|NCT00640562|463375|P1|COMPLETED|Overall Study||91
189142|NCT00640562|463374|P2|STARTED|Overall Study||107
189143|NCT00640562|463375|P1|STARTED|Overall Study||109
189144|NCT00640601|463401|P1|NOT COMPLETED|Overall Study||112
189145|NCT00640601|463401|P1|COMPLETED|Overall Study||183
189146|NCT00640601|463401|P1|STARTED|Overall Study|331 patients enrolled and 295 patients started investigational product (IP)|295
189147|NCT00640614|463417|P2|NOT COMPLETED|Overall Study||0
189148|NCT00640614|463418|P1|NOT COMPLETED|Overall Study||1
189149|NCT00640614|463417|P2|COMPLETED|Overall Study||110
189150|NCT00640614|463418|P1|COMPLETED|Overall Study||124
189151|NCT00640614|463417|P2|STARTED|Overall Study||110
189152|NCT00640614|463418|P1|STARTED|Overall Study||125
189153|NCT00640822|463463|P3|NOT COMPLETED|Overall Study||25
189154|NCT00640822|463464|P2|NOT COMPLETED|Overall Study||59
189155|NCT00640822|463465|P1|NOT COMPLETED|Overall Study||43
189156|NCT00640822|463463|P3|COMPLETED|Overall Study||77
189157|NCT00640822|463464|P2|COMPLETED|Overall Study||258
189158|NCT00640822|463465|P1|COMPLETED|Overall Study||279
189159|NCT00640822|463463|P3|STARTED|Overall Study||102
189160|NCT00640822|463464|P2|STARTED|Overall Study||317
189161|NCT00640822|463465|P1|STARTED|Overall Study||322
189162|NCT00640835|463475|P2|NOT COMPLETED|Overall Study||57
189163|NCT00640835|463476|P1|NOT COMPLETED|Overall Study||76
189164|NCT00640835|463475|P2|COMPLETED|Overall Study||131
189165|NCT00640835|463476|P1|COMPLETED|Overall Study||118
189166|NCT00640835|463475|P2|STARTED|Overall Study||188
189167|NCT00640835|463476|P1|STARTED|Overall Study||194
189168|NCT00640926|463487|P3|NOT COMPLETED|Overall Study||8
189169|NCT00640926|463488|P2|NOT COMPLETED|Overall Study||6
189170|NCT00640926|463489|P1|NOT COMPLETED|Overall Study||8
189171|NCT00640926|463487|P3|COMPLETED|Overall Study||45
189172|NCT00640926|463488|P2|COMPLETED|Overall Study||46
189173|NCT00640926|463489|P1|COMPLETED|Overall Study||45
189174|NCT00640926|463487|P3|STARTED|Overall Study||53
189175|NCT00640926|463488|P2|STARTED|Overall Study||52
189176|NCT00640926|463489|P1|STARTED|Overall Study||53
189177|NCT00640978|463500|P1|NOT COMPLETED|Overall Study||0
189178|NCT00640978|463500|P1|COMPLETED|Overall Study||15
189179|NCT00640978|463500|P1|STARTED|Overall Study||15
189180|NCT00641043|463506|P2|NOT COMPLETED|Overall Study||15
189181|NCT00641043|463507|P1|NOT COMPLETED|Overall Study||19
189182|NCT00641043|463506|P2|COMPLETED|Overall Study|number who completed treatment|244
189183|NCT00641043|463507|P1|COMPLETED|Overall Study|number who completed treatment|111
189184|NCT00641043|463506|P2|STARTED|Overall Study|number who started treatment|259
189185|NCT00641043|463507|P1|STARTED|Overall Study|number who started treatment|130
189186|NCT00641056|463539|P2|NOT COMPLETED|Overall Study||25
189187|NCT00641056|463540|P1|NOT COMPLETED|Overall Study||29
189188|NCT00641056|463539|P2|COMPLETED|Overall Study||209
189189|NCT00641056|463540|P1|COMPLETED|Overall Study||204
189190|NCT00641056|463539|P2|Intent to Treat (ITT)|Overall Study||223
189191|NCT00641056|463540|P1|Intent to Treat (ITT)|Overall Study||233
189192|NCT00641056|463539|P2|STARTED|Overall Study||234
189193|NCT00641056|463540|P1|STARTED|Overall Study||233
189194|NCT00641537|463571|P8|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
189195|NCT00641537|463572|P7|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
189196|NCT00641537|463573|P6|NOT COMPLETED|24-Week Supplemental Follow-up Period||1
189197|NCT00641537|463574|P5|NOT COMPLETED|24-Week Supplemental Follow-up Period||5
189198|NCT00641537|463575|P4|NOT COMPLETED|24-Week Supplemental Follow-up Period||4
189199|NCT00641537|463576|P3|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
189200|NCT00641537|463577|P2|NOT COMPLETED|24-Week Supplemental Follow-up Period||3
189201|NCT00641537|463578|P1|NOT COMPLETED|24-Week Supplemental Follow-up Period||0
189202|NCT00641537|463571|P8|COMPLETED|24-Week Supplemental Follow-up Period||10
189203|NCT00641537|463572|P7|COMPLETED|24-Week Supplemental Follow-up Period||8
189204|NCT00641537|463573|P6|COMPLETED|24-Week Supplemental Follow-up Period||14
189205|NCT00641537|463574|P5|COMPLETED|24-Week Supplemental Follow-up Period||193
189206|NCT00641537|463575|P4|COMPLETED|24-Week Supplemental Follow-up Period||147
189207|NCT00641537|463576|P3|COMPLETED|24-Week Supplemental Follow-up Period||140
189208|NCT00641537|463577|P2|COMPLETED|24-Week Supplemental Follow-up Period||66
189209|NCT00641537|463578|P1|COMPLETED|24-Week Supplemental Follow-up Period||75
189210|NCT00641537|463571|P8|STARTED|24-Week Supplemental Follow-up Period||11
189211|NCT00641537|463572|P7|STARTED|24-Week Supplemental Follow-up Period||9
189212|NCT00641537|463573|P6|STARTED|24-Week Supplemental Follow-up Period||15
189213|NCT00641537|463574|P5|STARTED|24-Week Supplemental Follow-up Period||198
189214|NCT00641537|463575|P4|STARTED|24-Week Supplemental Follow-up Period||151
189215|NCT00641537|463576|P3|STARTED|24-Week Supplemental Follow-up Period||143
189216|NCT00641537|463577|P2|STARTED|24-Week Supplemental Follow-up Period||69
189217|NCT00641537|463578|P1|STARTED|24-Week Supplemental Follow-up Period||75
189218|NCT00641537|463571|P8|NOT COMPLETED|96-week Period||6
189219|NCT00641537|463572|P7|NOT COMPLETED|96-week Period||5
189220|NCT00641537|463573|P6|NOT COMPLETED|96-week Period||7
189221|NCT00641537|463574|P5|NOT COMPLETED|96-week Period||18
189222|NCT00641537|463575|P4|NOT COMPLETED|96-week Period||12
189223|NCT00641537|463576|P3|NOT COMPLETED|96-week Period||20
189224|NCT00641537|463577|P2|NOT COMPLETED|96-week Period||10
189225|NCT00641537|463578|P1|NOT COMPLETED|96-week Period||9
189226|NCT00641537|463571|P8|COMPLETED|96-week Period||16
189227|NCT00641537|463572|P7|COMPLETED|96-week Period||12
189228|NCT00641537|463573|P6|COMPLETED|96-week Period||15
189229|NCT00641537|463574|P5|COMPLETED|96-week Period||226
189230|NCT00641537|463575|P4|COMPLETED|96-week Period||174
189231|NCT00641537|463576|P3|COMPLETED|96-week Period||166
189232|NCT00641537|463577|P2|COMPLETED|96-week Period||82
189233|NCT00641537|463578|P1|COMPLETED|96-week Period||89
189234|NCT00641537|463571|P8|STARTED|96-week Period||22
189235|NCT00641537|463572|P7|STARTED|96-week Period||17
189236|NCT00641537|463573|P6|STARTED|96-week Period||22
189237|NCT00641537|463574|P5|STARTED|96-week Period||244
189238|NCT00641537|463575|P4|STARTED|96-week Period||186
189239|NCT00641537|463576|P3|STARTED|96-week Period||186
189240|NCT00641537|463577|P2|STARTED|96-week Period||92
189241|NCT00641537|463578|P1|STARTED|96-week Period||98
189242|NCT00641563|463631|P2|NOT COMPLETED|Infusion 2||0
189243|NCT00641563|463632|P1|NOT COMPLETED|Infusion 2||0
189244|NCT00641563|463631|P2|COMPLETED|Infusion 2||5
189245|NCT00641563|463632|P1|COMPLETED|Infusion 2||5
189246|NCT00641563|463631|P2|STARTED|Infusion 2||5
189247|NCT00641563|463632|P1|STARTED|Infusion 2||5
189248|NCT00641563|463631|P2|NOT COMPLETED|Infusion 1||0
189249|NCT00641563|463632|P1|NOT COMPLETED|Infusion 1||0
189250|NCT00641563|463631|P2|COMPLETED|Infusion 1||5
189251|NCT00641563|463632|P1|COMPLETED|Infusion 1||5
189252|NCT00641563|463631|P2|STARTED|Infusion 1||5
189253|NCT00641563|463632|P1|STARTED|Infusion 1||5
189257|NCT00641667|463644|P1|NOT COMPLETED|Overall Study||6
189258|NCT00641667|463644|P1|COMPLETED|Overall Study||60
189259|NCT00641667|463644|P1|STARTED|Overall Study||66
189260|NCT00641706|463656|P2|NOT COMPLETED|Overall Study||3
189261|NCT00641706|463657|P1|NOT COMPLETED|Overall Study||9
189262|NCT00641706|463656|P2|COMPLETED|Overall Study||4
189263|NCT00641706|463657|P1|COMPLETED|Overall Study||28
189264|NCT00641706|463656|P2|STARTED|Overall Study||7
189265|NCT00641706|463657|P1|STARTED|Overall Study||37
189266|NCT00641719|463671|P2|NOT COMPLETED|Overall Study||37
189267|NCT00641719|463672|P1|NOT COMPLETED|Overall Study||30
189268|NCT00641719|463671|P2|COMPLETED|Overall Study|1 participant discontinued during taper phase, not during treatment phase.|92
189269|NCT00641719|463672|P1|COMPLETED|Overall Study||99
189270|NCT00641719|463671|P2|STARTED|Overall Study||129
189271|NCT00641719|463672|P1|STARTED|Overall Study||129
189272|NCT00641745|463696|P2|NOT COMPLETED|Overall Study||113
189273|NCT00641745|463697|P1|NOT COMPLETED|Overall Study||280
189274|NCT00641745|463696|P2|COMPLETED|Overall Study||89
189275|NCT00641745|463697|P1|COMPLETED|Overall Study||147
189276|NCT00641745|463696|P2|STARTED|Overall Study||202
189277|NCT00641745|463697|P1|STARTED|Overall Study||427
189278|NCT00641862|463705|P2|NOT COMPLETED|Overall Study||38
189279|NCT00641862|463706|P1|NOT COMPLETED|Overall Study||44
189280|NCT00641862|463705|P2|COMPLETED|Overall Study||145
189281|NCT00641862|463706|P1|COMPLETED|Overall Study||139
189282|NCT00641862|463705|P2|STARTED|Overall Study||183
189283|NCT00641862|463706|P1|STARTED|Overall Study||183
189284|NCT00642174|463714|P2|NOT COMPLETED|Period 2 - Crossover Drug||0
189285|NCT00642174|463715|P1|NOT COMPLETED|Period 2 - Crossover Drug||0
189286|NCT00642174|463714|P2|COMPLETED|Period 2 - Crossover Drug||16
189287|NCT00642174|463715|P1|COMPLETED|Period 2 - Crossover Drug||18
189288|NCT00642174|463714|P2|STARTED|Period 2 - Crossover Drug||16
189289|NCT00642174|463715|P1|STARTED|Period 2 - Crossover Drug||18
189290|NCT00642174|463714|P2|NOT COMPLETED|Period 1 - Initial Drug||1
189291|NCT00642174|463715|P1|NOT COMPLETED|Period 1 - Initial Drug||0
189292|NCT00642174|463714|P2|COMPLETED|Period 1 - Initial Drug||16
189293|NCT00642174|463715|P1|COMPLETED|Period 1 - Initial Drug||18
189294|NCT00642174|463714|P2|STARTED|Period 1 - Initial Drug||17
189295|NCT00642174|463715|P1|STARTED|Period 1 - Initial Drug||18
189296|NCT00642278|463736|P7|NOT COMPLETED|Overall Study||5
189297|NCT00642278|463737|P6|NOT COMPLETED|Overall Study||7
189298|NCT00642278|463738|P5|NOT COMPLETED|Overall Study||8
189299|NCT00642278|463739|P4|NOT COMPLETED|Overall Study||9
189300|NCT00642278|463740|P3|NOT COMPLETED|Overall Study||5
189301|NCT00642278|463741|P2|NOT COMPLETED|Overall Study||5
189302|NCT00642278|463742|P1|NOT COMPLETED|Overall Study||10
189303|NCT00642278|463736|P7|COMPLETED|Overall Study||60
189304|NCT00642278|463737|P6|COMPLETED|Overall Study||57
189305|NCT00642278|463738|P5|COMPLETED|Overall Study||56
189306|NCT00642278|463739|P4|COMPLETED|Overall Study||56
189307|NCT00642278|463740|P3|COMPLETED|Overall Study||59
189308|NCT00642278|463741|P2|COMPLETED|Overall Study||59
189309|NCT00642278|463742|P1|COMPLETED|Overall Study||55
189310|NCT00642278|463736|P7|STARTED|Overall Study||65
189311|NCT00642278|463737|P6|STARTED|Overall Study||64
189312|NCT00642278|463738|P5|STARTED|Overall Study||64
189313|NCT00642278|463739|P4|STARTED|Overall Study||65
189314|NCT00642278|463740|P3|STARTED|Overall Study||64
189315|NCT00642278|463741|P2|STARTED|Overall Study||64
189316|NCT00642278|463742|P1|STARTED|Overall Study||65
189317|NCT00642304|463793|P1|NOT COMPLETED|Overall Study||6
189318|NCT00642304|463793|P1|COMPLETED|Overall Study||14
189319|NCT00642304|463793|P1|STARTED|Overall Study||20
189320|NCT00642356|463804|P2|NOT COMPLETED|Overall Study||3
189321|NCT00642356|463805|P1|NOT COMPLETED|Overall Study||2
189322|NCT00642356|463804|P2|COMPLETED|Overall Study||4
189323|NCT00642356|463805|P1|COMPLETED|Overall Study||5
189324|NCT00642356|463804|P2|STARTED|Overall Study||7
189325|NCT00642356|463805|P1|STARTED|Overall Study||7
189326|NCT00642369|463815|P2|NOT COMPLETED|Overall Study||6
189327|NCT00642369|463816|P1|NOT COMPLETED|Overall Study||5
189328|NCT00642369|463815|P2|COMPLETED|Overall Study||24
189329|NCT00642369|463816|P1|COMPLETED|Overall Study||25
189330|NCT00642369|463815|P2|STARTED|Overall Study||30
189331|NCT00642369|463816|P1|STARTED|Overall Study||30
189332|NCT00642382|463826|P2|NOT COMPLETED|Overall Study||0
189333|NCT00642382|463827|P1|NOT COMPLETED|Overall Study||0
189334|NCT00642382|463826|P2|COMPLETED|Overall Study||0
189335|NCT00642382|463827|P1|COMPLETED|Overall Study||0
189336|NCT00642382|463826|P2|STARTED|Overall Study||0
189337|NCT00642382|463827|P1|STARTED|Overall Study||0
189338|NCT00642460|463835|P6|NOT COMPLETED|Part III: Open-Label Up to Week 260||21
189339|NCT00642460|463836|P5|NOT COMPLETED|Part III: Open-Label Up to Week 260||25
189340|NCT00642460|463837|P4|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
189341|NCT00642460|463838|P3|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
189342|NCT00642460|463839|P2|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
189343|NCT00642460|463840|P1|NOT COMPLETED|Part III: Open-Label Up to Week 260||0
189344|NCT00642460|463835|P6|COMPLETED|Part III: Open-Label Up to Week 260||38
189345|NCT00642460|463836|P5|COMPLETED|Part III: Open-Label Up to Week 260||28
189346|NCT00642460|463837|P4|COMPLETED|Part III: Open-Label Up to Week 260||0
189347|NCT00642460|463838|P3|COMPLETED|Part III: Open-Label Up to Week 260||0
189348|NCT00642460|463839|P2|COMPLETED|Part III: Open-Label Up to Week 260||0
189349|NCT00642460|463840|P1|COMPLETED|Part III: Open-Label Up to Week 260||0
189350|NCT00642460|463835|P6|STARTED|Part III: Open-Label Up to Week 260||59
189351|NCT00642460|463836|P5|STARTED|Part III: Open-Label Up to Week 260||53
189352|NCT00642460|463837|P4|STARTED|Part III: Open-Label Up to Week 260||0
189353|NCT00642460|463838|P3|STARTED|Part III: Open-Label Up to Week 260||0
189354|NCT00642460|463839|P2|STARTED|Part III: Open-Label Up to Week 260||0
189355|NCT00642460|463840|P1|STARTED|Part III: Open-Label Up to Week 260||0
189356|NCT00642460|463835|P6|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
189357|NCT00642460|463836|P5|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
189358|NCT00642460|463837|P4|NOT COMPLETED|Part II: Open-Label Up to Week 92||3
189359|NCT00642460|463838|P3|NOT COMPLETED|Part II: Open-Label Up to Week 92||0
189360|NCT00642460|463839|P2|NOT COMPLETED|Part II: Open-Label Up to Week 92||8
189361|NCT00642460|463840|P1|NOT COMPLETED|Part II: Open-Label Up to Week 92||9
189362|NCT00642460|463835|P6|COMPLETED|Part II: Open-Label Up to Week 92||0
189363|NCT00642460|463836|P5|COMPLETED|Part II: Open-Label Up to Week 92||0
189364|NCT00642460|463837|P4|COMPLETED|Part II: Open-Label Up to Week 92||17
189365|NCT00642460|463838|P3|COMPLETED|Part II: Open-Label Up to Week 92||0
189366|NCT00642460|463839|P2|COMPLETED|Part II: Open-Label Up to Week 92||32
189367|NCT00642460|463840|P1|COMPLETED|Part II: Open-Label Up to Week 92||43
189368|NCT00642460|463835|P6|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
189369|NCT00642460|463836|P5|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
189370|NCT00642460|463837|P4|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||20
189371|NCT00642460|463838|P3|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||0
189372|NCT00642460|463839|P2|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||40
189373|NCT00642460|463840|P1|Part II: Intent-to-treat|Part II: Open-Label Up to Week 92||52
189374|NCT00642460|463835|P6|STARTED|Part II: Open-Label Up to Week 92||0
189375|NCT00642460|463836|P5|STARTED|Part II: Open-Label Up to Week 92||0
189376|NCT00642460|463837|P4|STARTED|Part II: Open-Label Up to Week 92|19 Participants switched from 12 mg/kg to 8 mg/kg and 1 Participant switched from 8mg/kg to 12 mg/kg|20
189377|NCT00642460|463838|P3|STARTED|Part II: Open-Label Up to Week 92|Placebo group received open-label Tocilizumab 8 mg/kg or 12 mg/kg based on body weight in Part II.|0
189378|NCT00642460|463839|P2|STARTED|Part II: Open-Label Up to Week 92||40
189379|NCT00642460|463840|P1|STARTED|Part II: Open-Label Up to Week 92|Includes Participants who received Open-Label in Part II or Open-Label escape therapy in Part I.|52
189380|NCT00642460|463835|P6|NOT COMPLETED|Part I: 12 Week Double-Blind||0
189381|NCT00642460|463836|P5|NOT COMPLETED|Part I: 12 Week Double-Blind||0
189382|NCT00642460|463837|P4|NOT COMPLETED|Part I: 12 Week Double-Blind||0
189383|NCT00642460|463838|P3|NOT COMPLETED|Part I: 12 Week Double-Blind||1
189384|NCT00642460|463839|P2|NOT COMPLETED|Part I: 12 Week Double-Blind||1
189385|NCT00642460|463840|P1|NOT COMPLETED|Part I: 12 Week Double-Blind||1
189386|NCT00642460|463835|P6|COMPLETED|Part I: 12 Week Double-Blind||0
189387|NCT00642460|463836|P5|COMPLETED|Part I: 12 Week Double-Blind||0
189388|NCT00642460|463837|P4|COMPLETED|Part I: 12 Week Double-Blind||0
189389|NCT00642460|463838|P3|COMPLETED|Part I: 12 Week Double-Blind||36
189390|NCT00642460|463839|P2|COMPLETED|Part I: 12 Week Double-Blind||37
189391|NCT00642460|463840|P1|COMPLETED|Part I: 12 Week Double-Blind||36
189392|NCT00642460|463835|P6|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
189393|NCT00642460|463836|P5|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
189394|NCT00642460|463837|P4|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||0
189395|NCT00642460|463838|P3|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
189396|NCT00642460|463839|P2|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||38
189397|NCT00642460|463840|P1|Part I : Intent-to-treat|Part I: 12 Week Double-Blind||37
189398|NCT00642460|463835|P6|STARTED|Part I: 12 Week Double-Blind||0
189399|NCT00642460|463836|P5|STARTED|Part I: 12 Week Double-Blind||0
189400|NCT00642460|463837|P4|STARTED|Part I: 12 Week Double-Blind||0
189401|NCT00642460|463838|P3|STARTED|Part I: 12 Week Double-Blind||37
189402|NCT00642460|463839|P2|STARTED|Part I: 12 Week Double-Blind||38
189403|NCT00642460|463840|P1|STARTED|Part I: 12 Week Double-Blind||37
189404|NCT00642473|463906|P2|NOT COMPLETED|Overall Study||11
189405|NCT00642473|463907|P1|NOT COMPLETED|Overall Study||4
189406|NCT00642473|463906|P2|COMPLETED|Overall Study||5
189407|NCT00642473|463907|P1|COMPLETED|Overall Study||14
189408|NCT00642473|463906|P2|STARTED|Overall Study||16
189409|NCT00642473|463907|P1|STARTED|Overall Study||18
189410|NCT00642603|463921|P2|NOT COMPLETED|Overall Study||18
189411|NCT00642603|463922|P1|NOT COMPLETED|Overall Study||21
189412|NCT00642603|463921|P2|COMPLETED|Overall Study||2
189413|NCT00642603|463922|P1|COMPLETED|Overall Study||0
189414|NCT00642603|463921|P2|Safety Population|Overall Study||20
189415|NCT00642603|463922|P1|Safety Population|Overall Study||19
189416|NCT00642603|463921|P2|STARTED|Overall Study||20
189417|NCT00642603|463922|P1|STARTED|Overall Study||21
189418|NCT00642616|463932|P4|NOT COMPLETED|Overall Study||7
189419|NCT00642616|463933|P3|NOT COMPLETED|Overall Study||9
189420|NCT00642616|463934|P2|NOT COMPLETED|Overall Study||7
189421|NCT00642616|463935|P1|NOT COMPLETED|Overall Study||9
189422|NCT00642616|463932|P4|COMPLETED|Overall Study||1
189423|NCT00642616|463933|P3|COMPLETED|Overall Study||0
189424|NCT00642616|463934|P2|COMPLETED|Overall Study||1
189425|NCT00642616|463935|P1|COMPLETED|Overall Study||0
189426|NCT00642616|463932|P4|STARTED|Overall Study||8
189427|NCT00642616|463933|P3|STARTED|Overall Study||9
189428|NCT00642616|463934|P2|STARTED|Overall Study||8
189429|NCT00642616|463935|P1|STARTED|Overall Study||9
189430|NCT00642642|463957|P1|NOT COMPLETED|Treatment & Follow Up||17
189431|NCT00642642|463957|P1|COMPLETED|Treatment & Follow Up||92
189432|NCT00642642|463957|P1|STARTED|Treatment & Follow Up||109
189433|NCT00642642|463957|P1|NOT COMPLETED|Biopsy & Product Manufacture||13
189525|NCT00635492|464142|P1|STARTED|Overall Study|This population consists of the analysis population.|1114
189434|NCT00642642|463957|P1|COMPLETED|Biopsy & Product Manufacture|Patients biopsied and for whom study product could be produced are considered completed|109
189435|NCT00642642|463957|P1|STARTED|Biopsy & Product Manufacture||122
189436|NCT00642668|463970|P1|NOT COMPLETED|Overall Study||14
189437|NCT00642668|463970|P1|COMPLETED|Overall Study||21
189438|NCT00642668|463970|P1|STARTED|Overall Study||35
189439|NCT00642694|463980|P2|NOT COMPLETED|Overall Study||4
189440|NCT00642694|463981|P1|NOT COMPLETED|Overall Study||6
189441|NCT00642694|463980|P2|COMPLETED|Overall Study||11
189442|NCT00642694|463981|P1|COMPLETED|Overall Study||8
189443|NCT00642694|463980|P2|STARTED|Overall Study||15
189444|NCT00642694|463981|P1|STARTED|Overall Study||14
189445|NCT00642707|463993|P4|NOT COMPLETED|Overall Study||2
189446|NCT00642707|463994|P3|NOT COMPLETED|Overall Study||0
189447|NCT00642707|463995|P2|NOT COMPLETED|Overall Study||0
189448|NCT00642707|463996|P1|NOT COMPLETED|Overall Study||1
189449|NCT00642707|463993|P4|COMPLETED|Overall Study||8
189450|NCT00642707|463994|P3|COMPLETED|Overall Study||12
189451|NCT00642707|463995|P2|COMPLETED|Overall Study||11
189452|NCT00642707|463996|P1|COMPLETED|Overall Study||10
189453|NCT00642707|463993|P4|STARTED|Overall Study||10
189454|NCT00642707|463994|P3|STARTED|Overall Study||12
189455|NCT00642707|463995|P2|STARTED|Overall Study||11
189456|NCT00642707|463996|P1|STARTED|Overall Study||11
189457|NCT00642746|464008|P2|NOT COMPLETED|Overall Study||0
189458|NCT00642746|464009|P1|NOT COMPLETED|Overall Study||1
189459|NCT00642746|464008|P2|COMPLETED|Overall Study||1
189460|NCT00642746|464009|P1|COMPLETED|Overall Study||9
189461|NCT00642746|464008|P2|STARTED|Overall Study||1
189462|NCT00642746|464009|P1|STARTED|Overall Study||10
189463|NCT00642759|464019|P1|NOT COMPLETED|Overall Study||1
189464|NCT00642759|464019|P1|COMPLETED|Overall Study||35
189465|NCT00642759|464019|P1|STARTED|Overall Study||36
189466|NCT00642772|464026|P1|NOT COMPLETED|Overall Study||10
189467|NCT00642772|464026|P1|COMPLETED|Overall Study||14
189468|NCT00642772|464026|P1|STARTED|Overall Study||24
189469|NCT00642811|464036|P6|NOT COMPLETED|Overall Study||1
189470|NCT00642811|464037|P5|NOT COMPLETED|Overall Study||1
189471|NCT00642811|464038|P4|NOT COMPLETED|Overall Study||1
189472|NCT00642811|464039|P3|NOT COMPLETED|Overall Study||0
189473|NCT00642811|464040|P2|NOT COMPLETED|Overall Study||4
189474|NCT00642811|464041|P1|NOT COMPLETED|Overall Study||3
189475|NCT00642811|464036|P6|COMPLETED|Overall Study||13
189476|NCT00642811|464037|P5|COMPLETED|Overall Study||13
189477|NCT00642811|464038|P4|COMPLETED|Overall Study||15
189478|NCT00642811|464039|P3|COMPLETED|Overall Study||13
189479|NCT00642811|464040|P2|COMPLETED|Overall Study||17
189480|NCT00642811|464041|P1|COMPLETED|Overall Study||17
189481|NCT00642811|464036|P6|STARTED|Overall Study||14
189482|NCT00642811|464037|P5|STARTED|Overall Study||14
189483|NCT00642811|464038|P4|STARTED|Overall Study||16
189484|NCT00642811|464039|P3|STARTED|Overall Study||13
189485|NCT00642811|464040|P2|STARTED|Overall Study||21
189486|NCT00642811|464041|P1|STARTED|Overall Study||20
189487|NCT00635349|464065|P2|NOT COMPLETED|Overall Study||48
189488|NCT00635349|464066|P1|NOT COMPLETED|Overall Study||44
189489|NCT00635349|464065|P2|COMPLETED|Overall Study||19
189490|NCT00635349|464066|P1|COMPLETED|Overall Study||29
189491|NCT00635349|464065|P2|STARTED|Overall Study||67
189492|NCT00635349|464066|P1|STARTED|Overall Study||73
189493|NCT00635362|464086|P2|NOT COMPLETED|Overall Study||8
189494|NCT00635362|464087|P1|NOT COMPLETED|Overall Study||13
189495|NCT00635362|464086|P2|COMPLETED|Overall Study||12
189496|NCT00635362|464087|P1|COMPLETED|Overall Study||9
189497|NCT00635362|464086|P2|STARTED|Overall Study||20
189498|NCT00635362|464087|P1|STARTED|Overall Study||22
189499|NCT00635427|464106|P5|NOT COMPLETED|Overall Study||8
189500|NCT00635427|464107|P4|NOT COMPLETED|Overall Study||9
189501|NCT00635427|464108|P3|NOT COMPLETED|Overall Study||11
189502|NCT00635427|464109|P2|NOT COMPLETED|Overall Study||6
189503|NCT00635427|464110|P1|NOT COMPLETED|Overall Study||12
189504|NCT00635427|464106|P5|COMPLETED|Overall Study||30
189505|NCT00635427|464107|P4|COMPLETED|Overall Study||7
189506|NCT00635427|464108|P3|COMPLETED|Overall Study||5
189507|NCT00635427|464109|P2|COMPLETED|Overall Study||6
189508|NCT00635427|464110|P1|COMPLETED|Overall Study||1
189509|NCT00635427|464106|P5|STARTED|Overall Study||38
189510|NCT00635427|464107|P4|STARTED|Overall Study||16
189511|NCT00635427|464108|P3|STARTED|Overall Study||16
189512|NCT00635427|464109|P2|STARTED|Overall Study|11 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|12
189513|NCT00635427|464110|P1|STARTED|Overall Study|12 participants were considered ITT population as 1 participant did not have type 1 Gaucher disease|13
189514|NCT00635479|464132|P2|NOT COMPLETED|Overall Study||18
189515|NCT00635479|464133|P1|NOT COMPLETED|Overall Study||6
189516|NCT00635479|464132|P2|COMPLETED|Overall Study||42
189517|NCT00635479|464133|P1|COMPLETED|Overall Study||49
189518|NCT00635479|464132|P2|STARTED|Overall Study||60
189519|NCT00635479|464133|P1|STARTED|Overall Study||55
189520|NCT00635492|464141|P2|NOT COMPLETED|Overall Study||282
189521|NCT00635492|464142|P1|NOT COMPLETED|Overall Study||279
189522|NCT00635492|464141|P2|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|992
189523|NCT00635492|464142|P1|COMPLETED|Overall Study|This population consists of patients that completed the 24 month study.|835
189524|NCT00635492|464141|P2|STARTED|Overall Study|This population consists of the analysis population.|1274
189526|NCT00635570|464188|P2|NOT COMPLETED|Overall Study||11
189527|NCT00635570|464189|P1|NOT COMPLETED|Overall Study||15
189528|NCT00635570|464188|P2|COMPLETED|Overall Study||126
189529|NCT00635570|464189|P1|COMPLETED|Overall Study||121
189530|NCT00635570|464188|P2|STARTED|Overall Study||137
189531|NCT00635570|464189|P1|STARTED|Overall Study||136
189532|NCT00635609|464203|P2|NOT COMPLETED|Overall Study||3
189533|NCT00635609|464204|P1|NOT COMPLETED|Overall Study||7
189534|NCT00635609|464203|P2|COMPLETED|Overall Study||42
189535|NCT00635609|464204|P1|COMPLETED|Overall Study||41
189536|NCT00635609|464203|P2|STARTED|Overall Study||45
189537|NCT00635609|464204|P1|STARTED|Overall Study||48
189538|NCT00635648|464214|P1|NOT COMPLETED|Overall Study||37
189539|NCT00635648|464214|P1|COMPLETED|Overall Study||26
189540|NCT00635648|464214|P1|STARTED|Overall Study||63
189541|NCT00642850|464221|P1|NOT COMPLETED|Overall Study||33
189542|NCT00642850|464221|P1|COMPLETED|Overall Study||155
189543|NCT00642850|464221|P1|STARTED|Overall Study||188
189544|NCT00642902|464235|P4|NOT COMPLETED|Overall Study||40
189545|NCT00642902|464236|P3|NOT COMPLETED|Overall Study||43
189546|NCT00642902|464237|P2|NOT COMPLETED|Overall Study||42
189547|NCT00642902|464238|P1|NOT COMPLETED|Overall Study||40
189548|NCT00642902|464235|P4|COMPLETED|Overall Study||25
189549|NCT00642902|464236|P3|COMPLETED|Overall Study||21
189550|NCT00642902|464237|P2|COMPLETED|Overall Study||21
189551|NCT00642902|464238|P1|COMPLETED|Overall Study||23
189552|NCT00642902|464235|P4|Treated|Overall Study||65
189553|NCT00642902|464236|P3|Treated|Overall Study||63
189554|NCT00642902|464237|P2|Treated|Overall Study||63
189555|NCT00642902|464238|P1|Treated|Overall Study||63
189556|NCT00642902|464235|P4|STARTED|Overall Study||65
189557|NCT00642902|464236|P3|STARTED|Overall Study||64
189558|NCT00642902|464237|P2|STARTED|Overall Study||63
189559|NCT00642902|464238|P1|STARTED|Overall Study||63
189560|NCT00642993|464262|P2|NOT COMPLETED|Overall Study||16
189561|NCT00642993|464263|P1|NOT COMPLETED|Overall Study||106
189562|NCT00642993|464262|P2|COMPLETED|Overall Study||118
189563|NCT00642993|464263|P1|COMPLETED|Overall Study||161
189564|NCT00642993|464262|P2|STARTED|Overall Study||134
189565|NCT00642993|464263|P1|STARTED|Overall Study||267
189566|NCT00643006|464279|P2|NOT COMPLETED|Overall Study||4
189567|NCT00643006|464280|P1|NOT COMPLETED|Overall Study||5
189568|NCT00643006|464279|P2|COMPLETED|Overall Study||29
189569|NCT00643006|464280|P1|COMPLETED|Overall Study||29
189570|NCT00643006|464279|P2|STARTED|Overall Study||33
189571|NCT00643006|464280|P1|STARTED|Overall Study||34
189572|NCT00643097|464291|P3|NOT COMPLETED|Overall Study||0
189573|NCT00643097|464292|P2|NOT COMPLETED|Overall Study||0
189574|NCT00643097|464293|P1|NOT COMPLETED|Overall Study||0
189575|NCT00643097|464291|P3|COMPLETED|Overall Study||10
189576|NCT00643097|464292|P2|COMPLETED|Overall Study||12
189577|NCT00643097|464293|P1|COMPLETED|Overall Study||18
189578|NCT00643097|464291|P3|STARTED|Overall Study||10
189579|NCT00643097|464292|P2|STARTED|Overall Study||12
189580|NCT00643097|464293|P1|STARTED|Overall Study||18
189581|NCT00645528|464310|P1|NOT COMPLETED|Overall Study||7
189582|NCT00645528|464310|P1|COMPLETED|Overall Study||32
189583|NCT00645528|464310|P1|STARTED|Overall Study||39
189584|NCT00645567|464319|P1|NOT COMPLETED|Overall Study||1
189585|NCT00645567|464319|P1|COMPLETED|Overall Study|One individual provided consent & was dropped due to an unrelated injury to his hand at his home.|4
189586|NCT00645567|464319|P1|STARTED|Overall Study||5
189587|NCT00645593|464329|P2|NOT COMPLETED|Overall Study||0
189588|NCT00645593|464330|P1|NOT COMPLETED|Overall Study||1
189589|NCT00645593|464329|P2|COMPLETED|Overall Study||60
189590|NCT00645593|464330|P1|COMPLETED|Overall Study||28
189591|NCT00645593|464329|P2|STARTED|Overall Study||60
189592|NCT00645593|464330|P1|STARTED|Overall Study||29
189593|NCT00645671|464344|P2|NOT COMPLETED|Overall Study||6
189594|NCT00645671|464345|P1|NOT COMPLETED|Overall Study||1
189595|NCT00645671|464344|P2|COMPLETED|Overall Study||193
189596|NCT00645671|464345|P1|COMPLETED|Overall Study||200
189597|NCT00645671|464344|P2|STARTED|Overall Study||199
189598|NCT00645671|464345|P1|STARTED|Overall Study||201
189599|NCT00645762|464357|P1|NOT COMPLETED|Overall Study||4
189600|NCT00645762|464357|P1|COMPLETED|Overall Study||67
189601|NCT00645762|464357|P1|STARTED|Overall Study||71
189602|NCT00645788|464367|P4|NOT COMPLETED|Overall Study||14
189603|NCT00645788|464368|P3|NOT COMPLETED|Overall Study||18
189604|NCT00645788|464369|P2|NOT COMPLETED|Overall Study||27
189605|NCT00645788|464370|P1|NOT COMPLETED|Overall Study||20
189606|NCT00645788|464367|P4|COMPLETED|Overall Study||21
189607|NCT00645788|464368|P3|COMPLETED|Overall Study||47
189608|NCT00645788|464369|P2|COMPLETED|Overall Study||67
189609|NCT00645788|464370|P1|COMPLETED|Overall Study||74
189610|NCT00645788|464367|P4|Participants Receive Treatment|Overall Study||35
189611|NCT00645788|464368|P3|Participants Receive Treatment|Overall Study||65
189612|NCT00645788|464369|P2|Participants Receive Treatment|Overall Study||93
189613|NCT00645788|464370|P1|Participants Receive Treatment|Overall Study||93
189614|NCT00645788|464367|P4|STARTED|Overall Study||35
189615|NCT00645788|464368|P3|STARTED|Overall Study||65
189616|NCT00645788|464369|P2|STARTED|Overall Study||94
189617|NCT00645788|464370|P1|STARTED|Overall Study||94
189618|NCT00645827|464422|P2|NOT COMPLETED|Overall Study||0
189619|NCT00645827|464423|P1|NOT COMPLETED|Overall Study||0
189620|NCT00645827|464422|P2|COMPLETED|Overall Study||17
189621|NCT00645827|464423|P1|COMPLETED|Overall Study||14
189622|NCT00645827|464422|P2|STARTED|Overall Study||17
189623|NCT00645827|464423|P1|STARTED|Overall Study||14
189624|NCT00645853|464431|P2|NOT COMPLETED|Overall Study||57
189625|NCT00645853|464432|P1|NOT COMPLETED|Overall Study||92
189626|NCT00645853|464431|P2|COMPLETED|Overall Study||178
189627|NCT00645853|464432|P1|COMPLETED|Overall Study||196
189628|NCT00645853|464431|P2|AZ Study Closure in Hungary|Overall Study||40
189629|NCT00645853|464432|P1|AZ Study Closure in Hungary|Overall Study||60
189630|NCT00645853|464431|P2|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|178
189631|NCT00645853|464432|P1|Discontinued Patient No Due to Closure|Overall Study|No of patients discontinued due the study termination caused tablet formulation stability problems|196
189632|NCT00645853|464431|P2|No of Patients After Dose Switch|Overall Study|No changes for VKA patients|188
189633|NCT00645853|464432|P1|No of Patients After Dose Switch|Overall Study|All patients in the AZD0837 arm switched from their initial doses, to a general dose of 300 mg od|209
189634|NCT00645853|464431|P2|STARTED|Overall Study||235
189635|NCT00645853|464432|P1|STARTED|Overall Study||288
189636|NCT00645944|464452|P2|NOT COMPLETED|Received Medication||3
189637|NCT00645944|464453|P1|NOT COMPLETED|Received Medication||6
189638|NCT00645944|464452|P2|COMPLETED|Received Medication||14
189639|NCT00645944|464453|P1|COMPLETED|Received Medication||13
189640|NCT00645944|464452|P2|STARTED|Received Medication||17
189641|NCT00645944|464453|P1|STARTED|Received Medication||19
189642|NCT00645944|464452|P2|NOT COMPLETED|Randomized||2
189643|NCT00645944|464453|P1|NOT COMPLETED|Randomized||1
189644|NCT00645944|464452|P2|COMPLETED|Randomized||17
189645|NCT00645944|464453|P1|COMPLETED|Randomized||19
189646|NCT00645944|464452|P2|STARTED|Randomized||19
189647|NCT00645944|464453|P1|STARTED|Randomized||20
189648|NCT00645970|464461|P2|NOT COMPLETED|Overall Study||186
189649|NCT00645970|464462|P1|NOT COMPLETED|Overall Study||109
189650|NCT00645970|464461|P2|COMPLETED|Overall Study||32
189651|NCT00645970|464462|P1|COMPLETED|Overall Study||32
189652|NCT00645970|464461|P2|1 Year|Overall Study||42
189653|NCT00645970|464462|P1|1 Year|Overall Study||37
189654|NCT00645970|464461|P2|6 Months|Overall Study||97
189655|NCT00645970|464462|P1|6 Months|Overall Study||58
189656|NCT00645970|464461|P2|STARTED|Overall Study||218
189657|NCT00645970|464462|P1|STARTED|Overall Study||141
189658|NCT00646048|464468|P1|NOT COMPLETED|Overall Study||16
189659|NCT00646048|464468|P1|COMPLETED|Overall Study||27
189660|NCT00646048|464468|P1|STARTED|Overall Study||43
189661|NCT00646282|464476|P2|NOT COMPLETED|Overall Study||4
189662|NCT00646282|464477|P1|NOT COMPLETED|Overall Study||4
189663|NCT00646282|464476|P2|COMPLETED|Overall Study||0
189664|NCT00646282|464477|P1|COMPLETED|Overall Study||0
189665|NCT00646282|464476|P2|STARTED|Overall Study||4
189666|NCT00646282|464477|P1|STARTED|Overall Study||4
189667|NCT00646399|464485|P2|NOT COMPLETED|Overall Study||74
189668|NCT00646399|464486|P1|NOT COMPLETED|Overall Study||83
189669|NCT00646399|464485|P2|COMPLETED|Overall Study||713
189670|NCT00646399|464486|P1|COMPLETED|Overall Study||709
189671|NCT00646399|464485|P2|STARTED|Overall Study||787
189672|NCT00646399|464486|P1|STARTED|Overall Study||792
189673|NCT00646581|464494|P2|NOT COMPLETED|Overall Study||0
189674|NCT00646581|464495|P1|NOT COMPLETED|Overall Study||0
189675|NCT00646581|464494|P2|COMPLETED|Overall Study||15
189676|NCT00646581|464495|P1|COMPLETED|Overall Study||15
189677|NCT00646581|464494|P2|STARTED|Overall Study||15
189678|NCT00646581|464495|P1|STARTED|Overall Study||15
189679|NCT00646646|464515|P4|NOT COMPLETED|Overall Study||0
189680|NCT00646646|464516|P3|NOT COMPLETED|Overall Study||0
189681|NCT00646646|464517|P2|NOT COMPLETED|Overall Study||0
189682|NCT00646646|464518|P1|NOT COMPLETED|Overall Study||0
189683|NCT00646646|464515|P4|COMPLETED|Overall Study||20
189684|NCT00646646|464516|P3|COMPLETED|Overall Study||15
189685|NCT00646646|464517|P2|COMPLETED|Overall Study||15
189686|NCT00646646|464518|P1|COMPLETED|Overall Study||15
189687|NCT00646646|464515|P4|STARTED|Overall Study||20
189688|NCT00646646|464516|P3|STARTED|Overall Study||15
189689|NCT00646646|464517|P2|STARTED|Overall Study||15
189690|NCT00646646|464518|P1|STARTED|Overall Study||15
189691|NCT00646763|464530|P2|NOT COMPLETED|Overall Study||0
189692|NCT00646763|464531|P1|NOT COMPLETED|Overall Study||0
189693|NCT00646763|464530|P2|COMPLETED|Overall Study||17
189694|NCT00646763|464531|P1|COMPLETED|Overall Study||18
189695|NCT00646763|464530|P2|STARTED|Overall Study||17
189696|NCT00646763|464531|P1|STARTED|Overall Study||18
189697|NCT00646776|464543|P2|NOT COMPLETED|Overall Study||13
189698|NCT00646776|464544|P1|NOT COMPLETED|Overall Study||1
189699|NCT00646776|464543|P2|COMPLETED|Overall Study||5
189700|NCT00646776|464544|P1|COMPLETED|Overall Study||14
189701|NCT00646776|464543|P2|STARTED|Overall Study|Treated on Day 1|18
189702|NCT00646776|464544|P1|STARTED|Overall Study|Treated on Day 1|15
189703|NCT00646958|464594|P3|NOT COMPLETED|Overall Study||9
189704|NCT00646958|464595|P2|NOT COMPLETED|Overall Study||9
189705|NCT00646958|464596|P1|NOT COMPLETED|Overall Study||11
189706|NCT00646958|464594|P3|COMPLETED|Overall Study||40
189707|NCT00646958|464595|P2|COMPLETED|Overall Study||41
189708|NCT00646958|464596|P1|COMPLETED|Overall Study||40
189709|NCT00646958|464594|P3|STARTED|Overall Study|No. Participants Randomized|49
189710|NCT00646958|464595|P2|STARTED|Overall Study|No. Participants Randomized|50
189711|NCT00646958|464596|P1|STARTED|Overall Study|Number (No.) Participants Randomized|51
189712|NCT00647270|464610|P3|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||7
189713|NCT00647270|464611|P2|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||9
189714|NCT00647270|464612|P1|NOT COMPLETED|Period 2, Placebo Switched to Adalimumab||3
189715|NCT00647270|464610|P3|COMPLETED|Period 2, Placebo Switched to Adalimumab||175
189716|NCT00647270|464611|P2|COMPLETED|Period 2, Placebo Switched to Adalimumab||137
189717|NCT00647270|464612|P1|COMPLETED|Period 2, Placebo Switched to Adalimumab||45
189718|NCT00647270|464610|P3|STARTED|Period 2, Placebo Switched to Adalimumab||182
189719|NCT00647270|464611|P2|STARTED|Period 2, Placebo Switched to Adalimumab||146
189720|NCT00647270|464612|P1|STARTED|Period 2, Placebo Switched to Adalimumab|Placebo subjects in Period 1 received adalimumab 40 mg eow in Period 2|48
189721|NCT00647270|464610|P3|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||23
189722|NCT00647270|464611|P2|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||13
189723|NCT00647270|464612|P1|NOT COMPLETED|Period 1, Placebo-control (12 Weeks)||8
189724|NCT00647270|464610|P3|COMPLETED|Period 1, Placebo-control (12 Weeks)||182
189725|NCT00647270|464611|P2|COMPLETED|Period 1, Placebo-control (12 Weeks)||146
189726|NCT00647270|464612|P1|COMPLETED|Period 1, Placebo-control (12 Weeks)||48
189727|NCT00647270|464610|P3|STARTED|Period 1, Placebo-control (12 Weeks)||205
189728|NCT00647270|464611|P2|STARTED|Period 1, Placebo-control (12 Weeks)||159
189729|NCT00647270|464612|P1|STARTED|Period 1, Placebo-control (12 Weeks)|Placebo subjects in Period 1 received adalimumab 40 mg every other week in Period 2.|56
189730|NCT00647400|464637|P2|NOT COMPLETED|Overall Study||13
189731|NCT00647400|464638|P1|NOT COMPLETED|Overall Study||22
189732|NCT00647400|464637|P2|COMPLETED|Overall Study||45
189733|NCT00647400|464638|P1|COMPLETED|Overall Study||67
189734|NCT00647400|464637|P2|STARTED|Overall Study||58
189735|NCT00647400|464638|P1|STARTED|Overall Study||89
189736|NCT00647556|464650|P2|NOT COMPLETED|Overall Study||2
189737|NCT00647556|464651|P1|NOT COMPLETED|Overall Study||3
189738|NCT00647556|464650|P2|COMPLETED|Overall Study||13
189739|NCT00647556|464651|P1|COMPLETED|Overall Study||12
189740|NCT00647556|464650|P2|STARTED|Overall Study||15
189741|NCT00647556|464651|P1|STARTED|Overall Study||15
189742|NCT00647699|464667|P2|NOT COMPLETED|Overall Study||12
189743|NCT00647699|464668|P1|NOT COMPLETED|Overall Study||8
189744|NCT00647699|464667|P2|COMPLETED|Overall Study||62
189745|NCT00647699|464668|P1|COMPLETED|Overall Study||65
189746|NCT00647699|464667|P2|STARTED|Overall Study||74
189747|NCT00647699|464668|P1|STARTED|Overall Study||73
189748|NCT00638651|464674|P1|NOT COMPLETED|Overall Study||0
189749|NCT00638651|464674|P1|COMPLETED|Overall Study||3
189750|NCT00638651|464674|P1|STARTED|Overall Study||3
189751|NCT00638690|464681|P2|NOT COMPLETED|Overall Study||342
189752|NCT00638690|464682|P1|NOT COMPLETED|Overall Study||681
189753|NCT00638690|464681|P2|COMPLETED|Overall Study||56
189754|NCT00638690|464682|P1|COMPLETED|Overall Study||116
189755|NCT00638690|464681|P2|STARTED|Overall Study||398
189756|NCT00638690|464682|P1|STARTED|Overall Study||797
189757|NCT00638716|464698|P3|NOT COMPLETED|Overall Study||12
189758|NCT00638716|464699|P2|NOT COMPLETED|Overall Study||15
189759|NCT00638716|464700|P1|NOT COMPLETED|Overall Study||7
189760|NCT00638716|464698|P3|COMPLETED|Overall Study||46
189761|NCT00638716|464699|P2|COMPLETED|Overall Study||37
189762|NCT00638716|464700|P1|COMPLETED|Overall Study||43
189763|NCT00638716|464698|P3|STARTED|Overall Study||58
189764|NCT00638716|464699|P2|STARTED|Overall Study||52
189765|NCT00638716|464700|P1|STARTED|Overall Study||50
189766|NCT00638820|464714|P1|NOT COMPLETED|Overall Study||0
189767|NCT00638820|464714|P1|COMPLETED|Overall Study||3
189768|NCT00638820|464714|P1|STARTED|Overall Study||3
189769|NCT00638846|464723|P2|NOT COMPLETED|Overall Study||6
189770|NCT00638846|464724|P1|NOT COMPLETED|Overall Study||4
189771|NCT00638846|464723|P2|COMPLETED|Overall Study||133
189772|NCT00638846|464724|P1|COMPLETED|Overall Study||133
189773|NCT00638846|464723|P2|STARTED|Overall Study||139
189774|NCT00638846|464724|P1|STARTED|Overall Study||137
189775|NCT00638885|464740|P1|NOT COMPLETED|Overall Study||0
189776|NCT00638885|464740|P1|COMPLETED|Overall Study||142
189777|NCT00638885|464740|P1|STARTED|Overall Study||142
189778|NCT00638924|464744|P1|NOT COMPLETED|Overall Study||0
189779|NCT00638924|464744|P1|COMPLETED|Overall Study||40
189780|NCT00638924|464744|P1|2 Months|Overall Study||40
189781|NCT00638924|464744|P1|STARTED|Overall Study||40
189782|NCT00638937|464749|P1|NOT COMPLETED|Overall Study||0
189783|NCT00638937|464749|P1|COMPLETED|Overall Study||37
189784|NCT00638937|464749|P1|STARTED|Overall Study||37
189785|NCT00638963|464761|P2|NOT COMPLETED|Overall Study||0
189786|NCT00638963|464762|P1|NOT COMPLETED|Overall Study||1
189787|NCT00638963|464761|P2|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|3
189788|NCT00638963|464762|P1|COMPLETED|Overall Study|including follow-up at Week 38 & Week 52|2
189789|NCT00638963|464761|P2|STARTED|Overall Study|Received randomized treatment assignment|3
189790|NCT00638963|464762|P1|STARTED|Overall Study|Received randomized treatment assignment|3
189791|NCT00638989|464784|P3|NOT COMPLETED|Overall Study||1
189792|NCT00638989|464785|P2|NOT COMPLETED|Overall Study||0
189793|NCT00638989|464786|P1|NOT COMPLETED|Overall Study||0
189794|NCT00638989|464784|P3|COMPLETED|Overall Study||9
189795|NCT00638989|464785|P2|COMPLETED|Overall Study||10
189796|NCT00638989|464786|P1|COMPLETED|Overall Study||10
189797|NCT00638989|464784|P3|STARTED|Overall Study||10
189798|NCT00638989|464785|P2|STARTED|Overall Study||10
189799|NCT00638989|464786|P1|STARTED|Overall Study||10
189800|NCT00639002|464824|P1|NOT COMPLETED|Overall Study||13
189801|NCT00639002|464824|P1|COMPLETED|Overall Study||0
189802|NCT00639002|464824|P1|Received Ruxolitinib + Dexamethasone|Overall Study||7
189803|NCT00639002|464824|P1|Received Ruxolitinib|Overall Study||13
189804|NCT00639002|464824|P1|STARTED|Overall Study||13
189805|NCT00639093|464832|P2|NOT COMPLETED|Overall Study||0
189806|NCT00639093|464833|P1|NOT COMPLETED|Overall Study||0
189807|NCT00639093|464832|P2|COMPLETED|Overall Study|46|46
189808|NCT00639093|464833|P1|COMPLETED|Overall Study|45|45
189809|NCT00639093|464832|P2|STARTED|Overall Study|46|46
189810|NCT00639093|464833|P1|STARTED|Overall Study|45|45
189811|NCT00639158|464841|P2|NOT COMPLETED|Overall Study||30
189812|NCT00639158|464842|P1|NOT COMPLETED|Overall Study||26
189813|NCT00639158|464841|P2|COMPLETED|Overall Study|30 subjects prematurely discontinued treatment|240
189814|NCT00639158|464842|P1|COMPLETED|Overall Study|26 subjects prematurely discontinued treatment.|246
189815|NCT00639158|464841|P2|STARTED|Overall Study|1 subject was randomized but not treated because of an abnormal ECG that precluded treatment.|270
189816|NCT00639158|464842|P1|STARTED|Overall Study|All randomized subjects were treated.|272
189817|NCT00639223|464864|P2|NOT COMPLETED|Overall Study||2
189818|NCT00639223|464865|P1|NOT COMPLETED|Overall Study||0
189819|NCT00639223|464864|P2|COMPLETED|Overall Study||19
189820|NCT00639223|464865|P1|COMPLETED|Overall Study||22
189821|NCT00639223|464864|P2|STARTED|Overall Study||21
189822|NCT00639223|464865|P1|STARTED|Overall Study||22
189823|NCT00639379|464873|P2|NOT COMPLETED|Period 2 - 2 Weeks||0
189824|NCT00639379|464874|P1|NOT COMPLETED|Period 2 - 2 Weeks||0
189825|NCT00639379|464873|P2|COMPLETED|Period 2 - 2 Weeks||45
189826|NCT00639379|464874|P1|COMPLETED|Period 2 - 2 Weeks||39
189827|NCT00639379|464873|P2|STARTED|Period 2 - 2 Weeks||45
189828|NCT00639379|464874|P1|STARTED|Period 2 - 2 Weeks||39
189829|NCT00639379|464873|P2|NOT COMPLETED|Period 1 - 2 Weeks||0
189830|NCT00639379|464874|P1|NOT COMPLETED|Period 1 - 2 Weeks||5
189831|NCT00639379|464873|P2|COMPLETED|Period 1 - 2 Weeks||45
189832|NCT00639379|464874|P1|COMPLETED|Period 1 - 2 Weeks||39
189833|NCT00639379|464873|P2|STARTED|Period 1 - 2 Weeks||45
189834|NCT00639379|464874|P1|STARTED|Period 1 - 2 Weeks||44
189835|NCT00639418|464892|P4|NOT COMPLETED|Overall Study||0
189836|NCT00639418|464893|P3|NOT COMPLETED|Overall Study||0
189837|NCT00639418|464894|P2|NOT COMPLETED|Overall Study||0
189838|NCT00639418|464895|P1|NOT COMPLETED|Overall Study||0
189839|NCT00639418|464892|P4|COMPLETED|Overall Study||46930
189840|NCT00639418|464893|P3|COMPLETED|Overall Study||36496
189841|NCT00639418|464894|P2|COMPLETED|Overall Study||35967
189842|NCT00639418|464895|P1|COMPLETED|Overall Study||28101
189843|NCT00639418|464892|P4|STARTED|Overall Study||46930
189844|NCT00639418|464893|P3|STARTED|Overall Study||36496
189845|NCT00639418|464894|P2|STARTED|Overall Study||35967
189846|NCT00639418|464895|P1|STARTED|Overall Study||28101
189847|NCT00639457|464915|P2|NOT COMPLETED|Overall Study||3
189848|NCT00639457|464916|P1|NOT COMPLETED|Overall Study||2
189849|NCT00639457|464915|P2|COMPLETED|Overall Study||19
189850|NCT00639457|464916|P1|COMPLETED|Overall Study||20
189851|NCT00639457|464915|P2|STARTED|Overall Study||22
189852|NCT00639457|464916|P1|STARTED|Overall Study||22
189853|NCT00639509|464950|P1|NOT COMPLETED|Overall Study||1
189854|NCT00639509|464950|P1|COMPLETED|Overall Study||23
189855|NCT00639509|464950|P1|STARTED|Overall Study||24
189856|NCT00639678|464960|P4|NOT COMPLETED|Overall Study||0
189857|NCT00639678|464961|P3|NOT COMPLETED|Overall Study||11
189858|NCT00639678|464962|P2|NOT COMPLETED|Overall Study||1
189859|NCT00639678|464963|P1|NOT COMPLETED|Overall Study||4
189860|NCT00639678|464960|P4|COMPLETED|Overall Study||23
189861|NCT00639678|464961|P3|COMPLETED|Overall Study||206
189862|NCT00639678|464962|P2|COMPLETED|Overall Study||5
189863|NCT00639678|464963|P1|COMPLETED|Overall Study||70
189864|NCT00639678|464960|P4|STARTED|Overall Study||23
189865|NCT00639678|464961|P3|STARTED|Overall Study||217
189866|NCT00639678|464962|P2|STARTED|Overall Study||6
189867|NCT00639678|464963|P1|STARTED|Overall Study||74
189868|NCT00639717|465023|P1|NOT COMPLETED|Overall Study||0
189869|NCT00639717|465023|P1|COMPLETED|Overall Study||48
189870|NCT00639717|465023|P1|STARTED|Overall Study||48
189871|NCT00639769|465031|P1|NOT COMPLETED|Overall Study||40
189872|NCT00639769|465031|P1|COMPLETED|Overall Study||0
189873|NCT00639769|465031|P1|STARTED|Overall Study||40
189874|NCT00639860|465036|P1|NOT COMPLETED|Overall Study||0
189875|NCT00639860|465036|P1|COMPLETED|Overall Study||10
189876|NCT00639860|465036|P1|STARTED|Overall Study||10
189877|NCT00640016|465048|P4|NOT COMPLETED|Overall Study||3
189878|NCT00640016|465049|P3|NOT COMPLETED|Overall Study||3
189879|NCT00640016|465050|P2|NOT COMPLETED|Overall Study||2
189880|NCT00640016|465051|P1|NOT COMPLETED|Overall Study||2
189881|NCT00640016|465048|P4|COMPLETED|Overall Study||1
189882|NCT00640016|465049|P3|COMPLETED|Overall Study||1
189883|NCT00640016|465050|P2|COMPLETED|Overall Study||1
189884|NCT00640016|465051|P1|COMPLETED|Overall Study||1
189885|NCT00640016|465048|P4|Treated|Overall Study||4
189886|NCT00640016|465049|P3|Treated|Overall Study||4
189887|NCT00640016|465050|P2|Treated|Overall Study||2
189888|NCT00640016|465051|P1|Treated|Overall Study||3
189889|NCT00640016|465048|P4|STARTED|Overall Study||4
189890|NCT00640016|465049|P3|STARTED|Overall Study||4
189891|NCT00640016|465050|P2|STARTED|Overall Study||3
189892|NCT00640016|465051|P1|STARTED|Overall Study||3
189893|NCT00640042|465095|P1|NOT COMPLETED|Treatment||926
189894|NCT00640042|465095|P1|COMPLETED|Treatment||561
189895|NCT00640042|465095|P1|STARTED|Treatment||1487
189896|NCT00640042|465095|P1|NOT COMPLETED|Enrollment||83
189897|NCT00640042|465095|P1|COMPLETED|Enrollment|Number of patients with evidence of study drug receipt|1487
189898|NCT00640042|465095|P1|STARTED|Enrollment|Number of patients with evidence of prescription card receipt|1570
189899|NCT00640315|465109|P2|NOT COMPLETED|Overall Study||1
189900|NCT00640315|465110|P1|NOT COMPLETED|Overall Study||0
189901|NCT00640315|465109|P2|COMPLETED|Overall Study||12
189902|NCT00640315|465110|P1|COMPLETED|Overall Study||10
189903|NCT00640315|465109|P2|Participants Received Treatment|Overall Study||13
189904|NCT00640315|465110|P1|Participants Received Treatment|Overall Study||10
189905|NCT00640315|465109|P2|STARTED|Overall Study||13
189906|NCT00640315|465110|P1|STARTED|Overall Study||10
189907|NCT00640328|465242|P6|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
189908|NCT00640328|465243|P5|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
189909|NCT00640328|465244|P4|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
189910|NCT00640328|465245|P3|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
189911|NCT00640328|465246|P2|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||1
189912|NCT00640328|465247|P1|NOT COMPLETED|IFUP (Week 48 to Individual Termination)||0
189913|NCT00640328|465242|P6|COMPLETED|IFUP (Week 48 to Individual Termination)||4
189914|NCT00640328|465243|P5|COMPLETED|IFUP (Week 48 to Individual Termination)||4
189915|NCT00640328|465244|P4|COMPLETED|IFUP (Week 48 to Individual Termination)||3
189916|NCT00640328|465245|P3|COMPLETED|IFUP (Week 48 to Individual Termination)||6
189917|NCT00640328|465246|P2|COMPLETED|IFUP (Week 48 to Individual Termination)||10
189918|NCT00640328|465247|P1|COMPLETED|IFUP (Week 48 to Individual Termination)||8
189919|NCT00640328|465242|P6|STARTED|IFUP (Week 48 to Individual Termination)||4
189920|NCT00640328|465243|P5|STARTED|IFUP (Week 48 to Individual Termination)||4
189921|NCT00640328|465244|P4|STARTED|IFUP (Week 48 to Individual Termination)||4
189922|NCT00640328|465245|P3|STARTED|IFUP (Week 48 to Individual Termination)||7
189923|NCT00640328|465246|P2|STARTED|IFUP (Week 48 to Individual Termination)||11
189924|NCT00640328|465247|P1|STARTED|IFUP (Week 48 to Individual Termination)||8
189925|NCT00640328|465242|P6|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
189926|NCT00640328|465243|P5|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||1
189927|NCT00640328|465244|P4|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
189928|NCT00640328|465245|P3|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
189929|NCT00640328|465246|P2|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
189930|NCT00640328|465247|P1|NOT COMPLETED|Second Treatment Period (Weeks 24-48)||0
189931|NCT00640328|465242|P6|COMPLETED|Second Treatment Period (Weeks 24-48)||4
189932|NCT00640328|465243|P5|COMPLETED|Second Treatment Period (Weeks 24-48)||3
189933|NCT00640328|465244|P4|COMPLETED|Second Treatment Period (Weeks 24-48)||4
189934|NCT00640328|465245|P3|COMPLETED|Second Treatment Period (Weeks 24-48)||7
189935|NCT00640328|465246|P2|COMPLETED|Second Treatment Period (Weeks 24-48)||10
189936|NCT00640328|465247|P1|COMPLETED|Second Treatment Period (Weeks 24-48)||8
189937|NCT00640328|465242|P6|STARTED|Second Treatment Period (Weeks 24-48)||4
189938|NCT00640328|465243|P5|STARTED|Second Treatment Period (Weeks 24-48)||4
189939|NCT00640328|465244|P4|STARTED|Second Treatment Period (Weeks 24-48)||4
189940|NCT00640328|465245|P3|STARTED|Second Treatment Period (Weeks 24-48)||7
189941|NCT00640328|465246|P2|STARTED|Second Treatment Period (Weeks 24-48)||10
189942|NCT00640328|465247|P1|STARTED|Second Treatment Period (Weeks 24-48)||8
189943|NCT00640328|465242|P6|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
189944|NCT00640328|465243|P5|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
189945|NCT00640328|465244|P4|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
189946|NCT00640328|465245|P3|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
189947|NCT00640328|465246|P2|NOT COMPLETED|First Treatment Period (Weeks 0-24)||1
189948|NCT00640328|465247|P1|NOT COMPLETED|First Treatment Period (Weeks 0-24)||0
189949|NCT00640328|465242|P6|COMPLETED|First Treatment Period (Weeks 0-24)||4
189950|NCT00640328|465243|P5|COMPLETED|First Treatment Period (Weeks 0-24)||4
189951|NCT00640328|465244|P4|COMPLETED|First Treatment Period (Weeks 0-24)||4
189952|NCT00640328|465245|P3|COMPLETED|First Treatment Period (Weeks 0-24)||7
189953|NCT00640328|465246|P2|COMPLETED|First Treatment Period (Weeks 0-24)||10
189954|NCT00640328|465247|P1|COMPLETED|First Treatment Period (Weeks 0-24)||8
189955|NCT00640328|465242|P6|STARTED|First Treatment Period (Weeks 0-24)||4
189956|NCT00640328|465243|P5|STARTED|First Treatment Period (Weeks 0-24)||4
189957|NCT00640328|465244|P4|STARTED|First Treatment Period (Weeks 0-24)||4
189958|NCT00640328|465245|P3|STARTED|First Treatment Period (Weeks 0-24)||7
189959|NCT00640328|465246|P2|STARTED|First Treatment Period (Weeks 0-24)||11
189960|NCT00640328|465247|P1|STARTED|First Treatment Period (Weeks 0-24)||8
189961|NCT00640341|465414|P3|NOT COMPLETED|Overall Study||7
189962|NCT00640341|465415|P2|NOT COMPLETED|Overall Study||5
189963|NCT00640341|465416|P1|NOT COMPLETED|Overall Study||21
189964|NCT00640341|465414|P3|COMPLETED|Overall Study||163
189965|NCT00640341|465415|P2|COMPLETED|Overall Study||165
189966|NCT00640341|465416|P1|COMPLETED|Overall Study||149
189967|NCT00640341|465414|P3|Eligible Participants at Baseline|Overall Study||168
189968|NCT00640341|465415|P2|Eligible Participants at Baseline|Overall Study||167
189969|NCT00640341|465416|P1|Eligible Participants at Baseline|Overall Study||165
189970|NCT00640341|465414|P3|STARTED|Overall Study||170
189971|NCT00640341|465415|P2|STARTED|Overall Study||170
189972|NCT00640341|465416|P1|STARTED|Overall Study|All Starting participants were dispensed lenses|170
189973|NCT00647998|465432|P2|NOT COMPLETED|Overall Study||0
189974|NCT00647998|465433|P1|NOT COMPLETED|Overall Study||0
189975|NCT00647998|465432|P2|COMPLETED|Overall Study||9
189976|NCT00647998|465433|P1|COMPLETED|Overall Study||9
189977|NCT00647998|465432|P2|STARTED|Overall Study||9
189978|NCT00647998|465433|P1|STARTED|Overall Study||9
189979|NCT00648037|465443|P1|NOT COMPLETED|Overall Study||16
189980|NCT00648037|465443|P1|COMPLETED|Overall Study||10
189981|NCT00648037|465443|P1|STARTED|Overall Study||26
189982|NCT00648115|465450|P3|NOT COMPLETED|Overall Study||0
189983|NCT00648115|465451|P2|NOT COMPLETED|Overall Study||0
189984|NCT00648115|465452|P1|NOT COMPLETED|Overall Study||0
189985|NCT00648115|465450|P3|COMPLETED|Overall Study||27
189986|NCT00648115|465451|P2|COMPLETED|Overall Study||42
189987|NCT00648115|465452|P1|COMPLETED|Overall Study||42
189988|NCT00648115|465450|P3|STARTED|Overall Study||27
189989|NCT00648115|465451|P2|STARTED|Overall Study||42
189990|NCT00648115|465452|P1|STARTED|Overall Study||42
189991|NCT00648167|465463|P1|NOT COMPLETED|Overall Study||7
189992|NCT00648167|465463|P1|COMPLETED|Overall Study||48
189993|NCT00648167|465463|P1|Start Dose 6 g/Day|Overall Study||21
189994|NCT00648167|465463|P1|Start Dose 4.5 g/Day|Overall Study||34
189995|NCT00648167|465463|P1|STARTED|Overall Study||55
189996|NCT00650546|465467|P1|NOT COMPLETED|Overall Study||0
189997|NCT00650546|465467|P1|COMPLETED|Overall Study||8
189998|NCT00650546|465467|P1|STARTED|Overall Study||8
189999|NCT00650585|465474|P2|NOT COMPLETED|Overall Study||1477
190000|NCT00650585|465475|P1|NOT COMPLETED|Overall Study||1797
190001|NCT00650585|465474|P2|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2513
190002|NCT00650585|465475|P1|COMPLETED|Overall Study|Completed posttest--a self-report survey administered 30 approximately 30 days after treatment|2551
190003|NCT00650585|465474|P2|STARTED|Overall Study||3990
190004|NCT00650585|465475|P1|STARTED|Overall Study||4348
190005|NCT00650767|465499|P4|NOT COMPLETED|Overall Study||11
190006|NCT00650767|465500|P3|NOT COMPLETED|Overall Study||14
190007|NCT00650767|465501|P2|NOT COMPLETED|Overall Study||9
190008|NCT00650767|465502|P1|NOT COMPLETED|Overall Study||5
190009|NCT00650767|465499|P4|COMPLETED|Overall Study||39
190010|NCT00650767|465500|P3|COMPLETED|Overall Study||36
190011|NCT00650767|465501|P2|COMPLETED|Overall Study||41
190012|NCT00650767|465502|P1|COMPLETED|Overall Study||46
190013|NCT00650767|465499|P4|STARTED|Overall Study||50
190014|NCT00650767|465500|P3|STARTED|Overall Study||50
190015|NCT00650767|465501|P2|STARTED|Overall Study||50
190016|NCT00650767|465502|P1|STARTED|Overall Study||51
190017|NCT00650806|466008|P4|NOT COMPLETED|Overall Study||26
190018|NCT00650806|466009|P3|NOT COMPLETED|Overall Study||29
190019|NCT00650806|466010|P2|NOT COMPLETED|Overall Study||21
190020|NCT00650806|466011|P1|NOT COMPLETED|Overall Study||18
190021|NCT00650806|466008|P4|COMPLETED|Overall Study||70
190022|NCT00650806|466009|P3|COMPLETED|Overall Study||64
190023|NCT00650806|466010|P2|COMPLETED|Overall Study||77
190024|NCT00650806|466011|P1|COMPLETED|Overall Study||71
190025|NCT00650806|466008|P4|STARTED|Overall Study||96
190026|NCT00650806|466009|P3|STARTED|Overall Study||93
190027|NCT00650806|466010|P2|STARTED|Overall Study||98
190028|NCT00650806|466011|P1|STARTED|Overall Study||89
190029|NCT00650845|466051|P2|NOT COMPLETED|Overall Study||13
190030|NCT00650845|466052|P1|NOT COMPLETED|Overall Study||5
190031|NCT00650845|466051|P2|COMPLETED|Overall Study||44
190032|NCT00650845|466052|P1|COMPLETED|Overall Study||70
190033|NCT00650845|466051|P2|STARTED|Overall Study||57
190034|NCT00650845|466052|P1|STARTED|Overall Study||75
190035|NCT00650858|466071|P3|NOT COMPLETED|Overall Study||0
190036|NCT00650858|466072|P2|NOT COMPLETED|Overall Study||0
190037|NCT00650858|466073|P1|NOT COMPLETED|Overall Study||0
190038|NCT00650858|466071|P3|COMPLETED|Overall Study||36
190039|NCT00650858|466072|P2|COMPLETED|Overall Study||8
190040|NCT00650858|466073|P1|COMPLETED|Overall Study||8
190041|NCT00650858|466071|P3|STARTED|Overall Study||36
190042|NCT00650858|466072|P2|STARTED|Overall Study||8
190043|NCT00650858|466073|P1|STARTED|Overall Study||8
190044|NCT00651040|466089|P2|NOT COMPLETED|Overall Study||1
190045|NCT00651040|466090|P1|NOT COMPLETED|Overall Study||3
190046|NCT00651040|466089|P2|COMPLETED|Overall Study||14
190047|NCT00651040|466090|P1|COMPLETED|Overall Study||13
190048|NCT00651040|466089|P2|STARTED|Overall Study||15
190049|NCT00651040|466090|P1|STARTED|Overall Study||16
190050|NCT00651118|466100|P4|NOT COMPLETED|Overall Study||7
190051|NCT00651118|466101|P3|NOT COMPLETED|Overall Study||11
190052|NCT00651118|466102|P2|NOT COMPLETED|Overall Study||7
190053|NCT00651118|466103|P1|NOT COMPLETED|Overall Study||9
190054|NCT00651118|466100|P4|COMPLETED|Overall Study||203
190055|NCT00651118|466101|P3|COMPLETED|Overall Study||197
190056|NCT00651118|466102|P2|COMPLETED|Overall Study||200
190057|NCT00651118|466103|P1|COMPLETED|Overall Study||198
190058|NCT00651118|466100|P4|STARTED|Overall Study||210
190059|NCT00651118|466101|P3|STARTED|Overall Study||208
190060|NCT00651118|466102|P2|STARTED|Overall Study||207
190061|NCT00651118|466103|P1|STARTED|Overall Study||207
190062|NCT00651157|466121|P1|NOT COMPLETED|Overall Study||2
190063|NCT00651157|466121|P1|COMPLETED|Overall Study||21
190064|NCT00651157|466121|P1|STARTED|Overall Study||23
190065|NCT00651183|466129|P2|NOT COMPLETED|Overall Study||10
190066|NCT00651183|466130|P1|NOT COMPLETED|Overall Study||20
190067|NCT00651183|466129|P2|COMPLETED|Overall Study|"other reasons. No explanation was required to be given by the physicians"|87
190068|NCT00651183|466130|P1|COMPLETED|Overall Study|Case Report Form (CRF) listed reasons for early termination, of which one was|169
190069|NCT00651183|466129|P2|STARTED|Overall Study||97
190070|NCT00651183|466130|P1|STARTED|Overall Study|"For one patient the information was not given, therefore, the patient was listed missing"|189
190071|NCT00651261|466144|P2|NOT COMPLETED|Overall Study||306
190072|NCT00651261|466145|P1|NOT COMPLETED|Overall Study||291
190073|NCT00651261|466144|P2|COMPLETED|Overall Study||51
190074|NCT00651261|466145|P1|COMPLETED|Overall Study||69
190075|NCT00651261|466144|P2|STARTED|Overall Study||357
190076|NCT00651261|466145|P1|STARTED|Overall Study||360
190077|NCT00651313|466161|P2|NOT COMPLETED|Overall Study||6
190078|NCT00651313|466162|P1|NOT COMPLETED|Overall Study||6
190079|NCT00651313|466161|P2|COMPLETED|Overall Study||37
190080|NCT00651313|466162|P1|COMPLETED|Overall Study||35
190081|NCT00651313|466161|P2|STARTED|Overall Study||43
190082|NCT00651313|466162|P1|STARTED|Overall Study||41
190083|NCT00651482|466168|P1|NOT COMPLETED|Overall Study||0
190084|NCT00651482|466168|P1|COMPLETED|Overall Study||10
190085|NCT00651482|466168|P1|STARTED|Overall Study||10
190086|NCT00651625|466182|P2|NOT COMPLETED|Overall Study||0
190087|NCT00651625|466183|P1|NOT COMPLETED|Overall Study||0
190088|NCT00651625|466182|P2|COMPLETED|Overall Study||218
190089|NCT00651625|466183|P1|COMPLETED|Overall Study||219
190090|NCT00651625|466182|P2|STARTED|Overall Study||218
190091|NCT00651625|466183|P1|STARTED|Overall Study||219
190092|NCT00651755|466195|P2|NOT COMPLETED|Cycle 2 (Second 21 Days)||1
190093|NCT00651755|466196|P1|NOT COMPLETED|Cycle 2 (Second 21 Days)||0
190094|NCT00651755|466195|P2|COMPLETED|Cycle 2 (Second 21 Days)||8
190095|NCT00651755|466196|P1|COMPLETED|Cycle 2 (Second 21 Days)||10
190096|NCT00651755|466195|P2|STARTED|Cycle 2 (Second 21 Days)||9
190097|NCT00651755|466196|P1|STARTED|Cycle 2 (Second 21 Days)||10
190098|NCT00651755|466195|P2|NOT COMPLETED|Cycle 1 (First 21 Days)||0
190099|NCT00651755|466196|P1|NOT COMPLETED|Cycle 1 (First 21 Days)||1
190100|NCT00651755|466195|P2|COMPLETED|Cycle 1 (First 21 Days)||9
190101|NCT00651755|466196|P1|COMPLETED|Cycle 1 (First 21 Days)||10
190102|NCT00651755|466195|P2|STARTED|Cycle 1 (First 21 Days)||9
190103|NCT00651755|466196|P1|STARTED|Cycle 1 (First 21 Days)||11
190104|NCT00651820|466212|P1|NOT COMPLETED|Overall Study||2
190105|NCT00651820|466212|P1|COMPLETED|Overall Study||26
190106|NCT00651820|466212|P1|STARTED|Overall Study||28
190107|NCT00651924|466221|P2|NOT COMPLETED|Overall Study||7
190108|NCT00651924|466222|P1|NOT COMPLETED|Overall Study||0
190109|NCT00651924|466221|P2|COMPLETED|Overall Study||2
190110|NCT00651924|466222|P1|COMPLETED|Overall Study||18
190111|NCT00651924|466221|P2|STARTED|Overall Study||9
190112|NCT00651924|466222|P1|STARTED|Overall Study||18
190113|NCT00652028|466232|P4|NOT COMPLETED|Overall Study||0
190114|NCT00652028|466233|P3|NOT COMPLETED|Overall Study||1
190115|NCT00652028|466234|P2|NOT COMPLETED|Overall Study||1
190116|NCT00652028|466235|P1|NOT COMPLETED|Overall Study||1
190117|NCT00652028|466232|P4|COMPLETED|Overall Study||14
190118|NCT00652028|466233|P3|COMPLETED|Overall Study||14
190119|NCT00652028|466234|P2|COMPLETED|Overall Study||13
190120|NCT00652028|466235|P1|COMPLETED|Overall Study||15
190121|NCT00652028|466232|P4|STARTED|Overall Study||14
190122|NCT00652028|466233|P3|STARTED|Overall Study||15
190123|NCT00652028|466234|P2|STARTED|Overall Study||14
190124|NCT00652028|466235|P1|STARTED|Overall Study||16
190125|NCT00652093|466283|P6|NOT COMPLETED|Overall Study||0
190126|NCT00652093|466284|P5|NOT COMPLETED|Overall Study||2
190127|NCT00652093|466285|P4|NOT COMPLETED|Overall Study||0
190128|NCT00652093|466286|P3|NOT COMPLETED|Overall Study||1
190129|NCT00652093|466287|P2|NOT COMPLETED|Overall Study||0
190130|NCT00652093|466288|P1|NOT COMPLETED|Overall Study||0
190131|NCT00652093|466283|P6|COMPLETED|Overall Study||4
190132|NCT00652093|466284|P5|COMPLETED|Overall Study||2
190133|NCT00652093|466285|P4|COMPLETED|Overall Study||4
190134|NCT00652093|466286|P3|COMPLETED|Overall Study||3
190135|NCT00652093|466287|P2|COMPLETED|Overall Study||4
190136|NCT00652093|466288|P1|COMPLETED|Overall Study||4
190137|NCT00652093|466283|P6|STARTED|Overall Study||4
190138|NCT00652093|466284|P5|STARTED|Overall Study||4
190139|NCT00652093|466285|P4|STARTED|Overall Study||4
190140|NCT00652093|466286|P3|STARTED|Overall Study||4
190141|NCT00652093|466287|P2|STARTED|Overall Study||4
190142|NCT00652093|466288|P1|STARTED|Overall Study||4
190143|NCT00652145|466370|P2|NOT COMPLETED|Overall Study||0
190144|NCT00652145|466371|P1|NOT COMPLETED|Overall Study||0
190145|NCT00652145|466370|P2|COMPLETED|Overall Study||26
190146|NCT00652145|466371|P1|COMPLETED|Overall Study||26
190147|NCT00652145|466370|P2|STARTED|Overall Study||26
190148|NCT00652145|466371|P1|STARTED|Overall Study||26
190149|NCT00652314|466383|P2|NOT COMPLETED|Overall Study||9
190150|NCT00652314|466384|P1|NOT COMPLETED|Overall Study||9
190151|NCT00652314|466383|P2|COMPLETED|Overall Study||26
190152|NCT00652314|466384|P1|COMPLETED|Overall Study||53
190153|NCT00652314|466383|P2|STARTED|Overall Study||35
190154|NCT00652314|466384|P1|STARTED|Overall Study||62
190155|NCT00652327|466400|P2|NOT COMPLETED|Overall Study||5
190156|NCT00652327|466401|P1|NOT COMPLETED|Overall Study||0
190157|NCT00652327|466400|P2|COMPLETED|Overall Study||36
190158|NCT00652327|466401|P1|COMPLETED|Overall Study||42
190159|NCT00652327|466400|P2|STARTED|Overall Study|Participants who recieved randomized treatment assignment to double the dose of ongoing statin|41
190160|NCT00652327|466401|P1|STARTED|Overall Study|Participants who recieved randomized treatment assignment to ezetimibe and ongoing statin|42
190161|NCT00652340|466409|P2|NOT COMPLETED|Overall Study||3
190162|NCT00652340|466410|P1|NOT COMPLETED|Overall Study||4
190163|NCT00652340|466409|P2|COMPLETED|Overall Study|3 patients remained on study at database lock.|39
190164|NCT00652340|466410|P1|COMPLETED|Overall Study|4 patients remained on study at database lock.|74
190165|NCT00652340|466409|P2|STARTED|Overall Study||42
190166|NCT00652340|466410|P1|STARTED|Overall Study||78
190167|NCT00652366|466423|P5|NOT COMPLETED|Overall Study||36
190168|NCT00652366|466424|P4|NOT COMPLETED|Overall Study||179
190169|NCT00652366|466425|P3|NOT COMPLETED|Overall Study||71
190170|NCT00652366|466426|P2|NOT COMPLETED|Overall Study||75
190171|NCT00652366|466427|P1|NOT COMPLETED|Overall Study||106
190172|NCT00652366|466423|P5|COMPLETED|Overall Study||0
190173|NCT00652366|466424|P4|COMPLETED|Overall Study||0
190174|NCT00652366|466425|P3|COMPLETED|Overall Study||0
190175|NCT00652366|466426|P2|COMPLETED|Overall Study||0
190176|NCT00652366|466427|P1|COMPLETED|Overall Study||0
190177|NCT00652366|466423|P5|STARTED|Overall Study||36
190178|NCT00652366|466424|P4|STARTED|Overall Study||179
190179|NCT00652366|466425|P3|STARTED|Overall Study||71
190180|NCT00652366|466426|P2|STARTED|Overall Study||75
190181|NCT00652366|466427|P1|STARTED|Overall Study||106
190182|NCT00652626|466467|P7|NOT COMPLETED|Extension Phase||3
190183|NCT00652626|466468|P6|NOT COMPLETED|Extension Phase||12
190184|NCT00652626|466469|P5|NOT COMPLETED|Extension Phase||0
190185|NCT00652626|466470|P4|NOT COMPLETED|Extension Phase||0
190186|NCT00652626|466471|P3|NOT COMPLETED|Extension Phase||0
190187|NCT00652626|466472|P2|NOT COMPLETED|Extension Phase||0
190188|NCT00652626|466473|P1|NOT COMPLETED|Extension Phase||0
190189|NCT00652626|466467|P7|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|1
190190|NCT00652626|466468|P6|COMPLETED|Extension Phase|A participant was considered completed if they had completed 6 cycles of therapy.|2
190191|NCT00652626|466469|P5|COMPLETED|Extension Phase||0
190192|NCT00652626|466470|P4|COMPLETED|Extension Phase||0
190193|NCT00652626|466471|P3|COMPLETED|Extension Phase||0
190194|NCT00652626|466472|P2|COMPLETED|Extension Phase||0
190195|NCT00652626|466473|P1|COMPLETED|Extension Phase||0
190196|NCT00652626|466467|P7|STARTED|Extension Phase||4
190197|NCT00652626|466468|P6|STARTED|Extension Phase||14
190198|NCT00652626|466469|P5|STARTED|Extension Phase||0
190199|NCT00652626|466470|P4|STARTED|Extension Phase||0
190200|NCT00652626|466471|P3|STARTED|Extension Phase||0
190201|NCT00652626|466472|P2|STARTED|Extension Phase||0
190202|NCT00652626|466473|P1|STARTED|Extension Phase||0
190203|NCT00652626|466467|P7|NOT COMPLETED|Initial Treatment Phase||0
190204|NCT00652626|466468|P6|NOT COMPLETED|Initial Treatment Phase||0
190205|NCT00652626|466469|P5|NOT COMPLETED|Initial Treatment Phase||3
190206|NCT00652626|466470|P4|NOT COMPLETED|Initial Treatment Phase||1
190207|NCT00652626|466471|P3|NOT COMPLETED|Initial Treatment Phase||1
190208|NCT00652626|466472|P2|NOT COMPLETED|Initial Treatment Phase||0
190209|NCT00652626|466473|P1|NOT COMPLETED|Initial Treatment Phase||0
190210|NCT00652626|466467|P7|COMPLETED|Initial Treatment Phase||0
190211|NCT00652626|466468|P6|COMPLETED|Initial Treatment Phase||0
190212|NCT00652626|466469|P5|COMPLETED|Initial Treatment Phase||5
190213|NCT00652626|466470|P4|COMPLETED|Initial Treatment Phase||5
190214|NCT00652626|466471|P3|COMPLETED|Initial Treatment Phase||6
190215|NCT00652626|466472|P2|COMPLETED|Initial Treatment Phase||5
190216|NCT00652626|466473|P1|COMPLETED|Initial Treatment Phase||5
190217|NCT00652626|466467|P7|Received Study Drug|Initial Treatment Phase||0
190218|NCT00652626|466468|P6|Received Study Drug|Initial Treatment Phase||0
190219|NCT00652626|466469|P5|Received Study Drug|Initial Treatment Phase||6
190220|NCT00652626|466470|P4|Received Study Drug|Initial Treatment Phase||5
190221|NCT00652626|466471|P3|Received Study Drug|Initial Treatment Phase||6
190222|NCT00652626|466472|P2|Received Study Drug|Initial Treatment Phase||5
190223|NCT00652626|466473|P1|Received Study Drug|Initial Treatment Phase||5
190224|NCT00652626|466467|P7|STARTED|Initial Treatment Phase||0
190225|NCT00652626|466468|P6|STARTED|Initial Treatment Phase||0
190226|NCT00652626|466469|P5|STARTED|Initial Treatment Phase||8
190227|NCT00652626|466470|P4|STARTED|Initial Treatment Phase||6
190228|NCT00652626|466471|P3|STARTED|Initial Treatment Phase||7
190229|NCT00652626|466472|P2|STARTED|Initial Treatment Phase||5
190230|NCT00652626|466473|P1|STARTED|Initial Treatment Phase||5
190231|NCT00643201|466539|P2|NOT COMPLETED|Completed Study Follow Up||79
190232|NCT00643201|466540|P1|NOT COMPLETED|Completed Study Follow Up||70
190233|NCT00643201|466539|P2|COMPLETED|Completed Study Follow Up|Of 79 who did not complete follow up: 3 completed treatment, 76 discontinued treatment|2560
190234|NCT00643201|466540|P1|COMPLETED|Completed Study Follow Up|Of 70 who did not complete follow up: 7 completed treatment; 63 discontinued treatment|2547
190235|NCT00643201|466539|P2|STARTED|Completed Study Follow Up||2639
190236|NCT00643201|466540|P1|STARTED|Completed Study Follow Up||2617
190237|NCT00643201|466539|P2|NOT COMPLETED|Randomized, Completed 6 Months of Study||413
190238|NCT00643201|466540|P1|NOT COMPLETED|Randomized, Completed 6 Months of Study||377
190239|NCT00643201|466539|P2|COMPLETED|Randomized, Completed 6 Months of Study||2291
190240|NCT00643201|466540|P1|COMPLETED|Randomized, Completed 6 Months of Study||2314
190241|NCT00643201|466539|P2|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2704
190242|NCT00643201|466540|P1|STARTED|Randomized, Completed 6 Months of Study|15 participants were randomized to treatment but not treated.|2691
190243|NCT00643448|466589|P3|NOT COMPLETED|Overall Study||6
190244|NCT00643448|466590|P2|NOT COMPLETED|Overall Study||5
190245|NCT00643448|466591|P1|NOT COMPLETED|Overall Study||4
190246|NCT00643448|466589|P3|COMPLETED|Overall Study||16
190247|NCT00643448|466590|P2|COMPLETED|Overall Study||17
190248|NCT00643448|466591|P1|COMPLETED|Overall Study||17
190249|NCT00643448|466589|P3|STARTED|Overall Study||22
190250|NCT00643448|466590|P2|STARTED|Overall Study||22
190251|NCT00643448|466591|P1|STARTED|Overall Study||21
190252|NCT00643487|466606|P1|NOT COMPLETED|Overall Study||3
190253|NCT00643487|466606|P1|COMPLETED|Overall Study||5
190254|NCT00643487|466606|P1|STARTED|Overall Study||8
190255|NCT00643565|466612|P2|NOT COMPLETED|Overall Study||74
190256|NCT00643565|466613|P1|NOT COMPLETED|Overall Study||80
190257|NCT00643565|466612|P2|COMPLETED|Overall Study||0
190258|NCT00643565|466613|P1|COMPLETED|Overall Study||0
190259|NCT00643565|466612|P2|STARTED|Overall Study||74
190260|NCT00643565|466613|P1|STARTED|Overall Study||80
190261|NCT00643578|466635|P2|NOT COMPLETED|Overall Study||0
190262|NCT00643578|466636|P1|NOT COMPLETED|Overall Study||2
190263|NCT00643578|466635|P2|COMPLETED|Overall Study||6
190264|NCT00643578|466636|P1|COMPLETED|Overall Study||4
190265|NCT00643578|466635|P2|STARTED|Overall Study||6
190266|NCT00643578|466636|P1|STARTED|Overall Study||6
190267|NCT00643604|466644|P1|NOT COMPLETED|Overall Study||1
190268|NCT00643604|466644|P1|COMPLETED|Overall Study||6
190269|NCT00643604|466644|P1|STARTED|Overall Study||7
190270|NCT00643682|466663|P2|NOT COMPLETED|Overall Study||509
190271|NCT00643682|466664|P1|NOT COMPLETED|Overall Study||522
190272|NCT00643682|466663|P2|COMPLETED|Overall Study||492
190273|NCT00643682|466664|P1|COMPLETED|Overall Study||477
190274|NCT00643682|466663|P2|STARTED|Overall Study||1001
190275|NCT00643682|466664|P1|STARTED|Overall Study||999
190276|NCT00643760|466681|P5|NOT COMPLETED|Overall Study||19
190277|NCT00643760|466682|P4|NOT COMPLETED|Overall Study||38
190278|NCT00643760|466683|P3|NOT COMPLETED|Overall Study||19
190279|NCT00643760|466684|P2|NOT COMPLETED|Overall Study||15
190280|NCT00643760|466685|P1|NOT COMPLETED|Overall Study||30
190281|NCT00643760|466681|P5|COMPLETED|Overall Study||47
190282|NCT00643760|466682|P4|COMPLETED|Overall Study||79
190283|NCT00643760|466683|P3|COMPLETED|Overall Study||37
190284|NCT00643760|466684|P2|COMPLETED|Overall Study||47
190285|NCT00643760|466685|P1|COMPLETED|Overall Study||90
190286|NCT00643760|466681|P5|ITT Population|Overall Study||66
190287|NCT00643760|466682|P4|ITT Population|Overall Study||116
190288|NCT00643760|466683|P3|ITT Population|Overall Study||56
190289|NCT00643760|466684|P2|ITT Population|Overall Study||62
190290|NCT00643760|466685|P1|ITT Population|Overall Study||120
190291|NCT00643760|466681|P5|Safety Population/Treated With Drug|Overall Study||66
190292|NCT00643760|466682|P4|Safety Population/Treated With Drug|Overall Study||116
190293|NCT00643760|466683|P3|Safety Population/Treated With Drug|Overall Study||56
190294|NCT00643760|466684|P2|Safety Population/Treated With Drug|Overall Study||62
190295|NCT00643760|466685|P1|Safety Population/Treated With Drug|Overall Study||120
190296|NCT00643760|466681|P5|STARTED|Overall Study||66
190297|NCT00643760|466682|P4|STARTED|Overall Study||117
190298|NCT00643760|466683|P3|STARTED|Overall Study||56
190299|NCT00643760|466684|P2|STARTED|Overall Study||62
190300|NCT00643760|466685|P1|STARTED|Overall Study||120
190301|NCT00643851|466790|P3|NOT COMPLETED|Overall Study||30
190302|NCT00643851|466791|P2|NOT COMPLETED|Overall Study||33
190303|NCT00643851|466792|P1|NOT COMPLETED|Overall Study||17
190304|NCT00643851|466790|P3|COMPLETED|Overall Study||171
190305|NCT00643851|466791|P2|COMPLETED|Overall Study||170
190306|NCT00643851|466792|P1|COMPLETED|Overall Study||177
190307|NCT00643851|466790|P3|STARTED|Overall Study||201
190308|NCT00643851|466791|P2|STARTED|Overall Study||203
190309|NCT00643851|466792|P1|STARTED|Overall Study||194
190310|NCT00643916|466821|P6|NOT COMPLETED|Overall Study||1
190311|NCT00643916|466822|P5|NOT COMPLETED|Overall Study||2
190312|NCT00643916|466823|P4|NOT COMPLETED|Overall Study||2
190313|NCT00643916|466824|P3|NOT COMPLETED|Overall Study||6
190314|NCT00643916|466825|P2|NOT COMPLETED|Overall Study||6
190315|NCT00643916|466826|P1|NOT COMPLETED|Overall Study||4
190316|NCT00643916|466821|P6|COMPLETED|Overall Study||66
190317|NCT00643916|466822|P5|COMPLETED|Overall Study||57
190318|NCT00643916|466823|P4|COMPLETED|Overall Study||60
190319|NCT00643916|466824|P3|COMPLETED|Overall Study||62
190320|NCT00643916|466825|P2|COMPLETED|Overall Study||61
190321|NCT00643916|466826|P1|COMPLETED|Overall Study||51
190322|NCT00643916|466821|P6|STARTED|Overall Study||67
190323|NCT00643916|466822|P5|STARTED|Overall Study||59
190324|NCT00643916|466823|P4|STARTED|Overall Study||62
190325|NCT00643916|466824|P3|STARTED|Overall Study||68
190326|NCT00643916|466825|P2|STARTED|Overall Study||67
190327|NCT00643916|466826|P1|STARTED|Overall Study||55
190328|NCT00644059|466849|P3|NOT COMPLETED|Overall Study||65
190329|NCT00644059|466850|P2|NOT COMPLETED|Overall Study||123
190330|NCT00644059|466851|P1|NOT COMPLETED|Overall Study||124
190331|NCT00644059|466849|P3|COMPLETED|Overall Study||969
190332|NCT00644059|466850|P2|COMPLETED|Overall Study||1726
190333|NCT00644059|466851|P1|COMPLETED|Overall Study||1895
190334|NCT00644059|466849|P3|STARTED|Overall Study||1034
190335|NCT00644059|466850|P2|STARTED|Overall Study||1849
190336|NCT00644059|466851|P1|STARTED|Overall Study||2019
190337|NCT00644189|466935|P4|NOT COMPLETED|Phase II||0
190338|NCT00644189|466936|P3|NOT COMPLETED|Phase II||0
190339|NCT00644189|466937|P2|NOT COMPLETED|Phase II||0
190340|NCT00644189|466938|P1|NOT COMPLETED|Phase II||0
190341|NCT00644189|466935|P4|COMPLETED|Phase II||50
190342|NCT00644189|466936|P3|COMPLETED|Phase II||0
190343|NCT00644189|466937|P2|COMPLETED|Phase II||0
190344|NCT00644189|466938|P1|COMPLETED|Phase II||0
190345|NCT00644189|466935|P4|Completed All 6 Cycles of Treatment|Phase II||19
190346|NCT00644189|466936|P3|Completed All 6 Cycles of Treatment|Phase II||0
190347|NCT00644189|466937|P2|Completed All 6 Cycles of Treatment|Phase II||0
190348|NCT00644189|466938|P1|Completed All 6 Cycles of Treatment|Phase II||0
190349|NCT00644189|466935|P4|STARTED|Phase II|Additional participants were added to the phase I sample at the phase II 3mg dose level|50
190350|NCT00644189|466936|P3|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
190351|NCT00644189|466937|P2|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
190352|NCT00644189|466938|P1|STARTED|Phase II|All phase I participants were included in the 3mg Phase II dose group|0
190353|NCT00644189|466935|P4|NOT COMPLETED|Phase I||0
190354|NCT00644189|466936|P3|NOT COMPLETED|Phase I||0
190355|NCT00644189|466937|P2|NOT COMPLETED|Phase I||0
190356|NCT00644189|466938|P1|NOT COMPLETED|Phase I||0
190357|NCT00644189|466935|P4|COMPLETED|Phase I||18
190358|NCT00644189|466936|P3|COMPLETED|Phase I||6
190359|NCT00644189|466937|P2|COMPLETED|Phase I||3
190360|NCT00644189|466938|P1|COMPLETED|Phase I||3
190361|NCT00644189|466935|P4|STARTED|Phase I||18
190362|NCT00644189|466936|P3|STARTED|Phase I||6
190363|NCT00644189|466937|P2|STARTED|Phase I||3
190364|NCT00644189|466938|P1|STARTED|Phase I||3
190365|NCT00644228|466953|P2|NOT COMPLETED|Maintenance||135
190366|NCT00644228|466954|P1|NOT COMPLETED|Maintenance||143
190367|NCT00644228|466953|P2|COMPLETED|Maintenance||0
190368|NCT00644228|466954|P1|COMPLETED|Maintenance||0
190369|NCT00644228|466953|P2|STARTED|Maintenance|2 patients who completed induction did not continue on to maintenance due to other (2).|135
190370|NCT00644228|466954|P1|STARTED|Maintenance|3 patients who completed induction did not continue on to maintenance due to refusal (1), other (2).|143
190371|NCT00644228|466953|P2|NOT COMPLETED|Induction Therapy||105
190372|NCT00644228|466954|P1|NOT COMPLETED|Induction Therapy||83
190373|NCT00644228|466953|P2|COMPLETED|Induction Therapy||137
190374|NCT00644228|466954|P1|COMPLETED|Induction Therapy||146
190375|NCT00644228|466953|P2|STARTED|Induction Therapy||242
190376|NCT00644228|466954|P1|STARTED|Induction Therapy||229
190377|NCT00644228|466953|P2|NOT COMPLETED|Randomization & Eligibility||22
190378|NCT00644228|466954|P1|NOT COMPLETED|Randomization & Eligibility||32
190379|NCT00644228|466953|P2|COMPLETED|Randomization & Eligibility||242
190380|NCT00644228|466954|P1|COMPLETED|Randomization & Eligibility||229
190381|NCT00644228|466953|P2|Eligible and Analyzable|Randomization & Eligibility||242
190382|NCT00644228|466954|P1|Eligible and Analyzable|Randomization & Eligibility||229
190383|NCT00644228|466953|P2|STARTED|Randomization & Eligibility||264
190384|NCT00644228|466954|P1|STARTED|Randomization & Eligibility||261
190385|NCT00644280|466966|P2|NOT COMPLETED|Overall Study||0
190386|NCT00644280|466967|P1|NOT COMPLETED|Overall Study||0
190387|NCT00644280|466966|P2|COMPLETED|Overall Study||5
190388|NCT00644280|466967|P1|COMPLETED|Overall Study||6
190389|NCT00644280|466966|P2|STARTED|Overall Study||5
190390|NCT00644280|466967|P1|STARTED|Overall Study||6
190391|NCT00644332|466975|P1|NOT COMPLETED|Overall Study||21
190392|NCT00644332|466975|P1|COMPLETED|Overall Study||150
190393|NCT00644332|466975|P1|STARTED|Overall Study|172 patients were enrolled; one withdrew consent prior to starting treatment|171
190394|NCT00644592|466990|P2|NOT COMPLETED|Overall Study||0
190395|NCT00644592|466991|P1|NOT COMPLETED|Overall Study||0
190396|NCT00644592|466990|P2|COMPLETED|Overall Study||6
190397|NCT00644592|466991|P1|COMPLETED|Overall Study||5
190398|NCT00644592|466990|P2|STARTED|Overall Study||6
190399|NCT00644592|466991|P1|STARTED|Overall Study||5
190400|NCT00644657|466997|P1|NOT COMPLETED|Overall Study||0
190401|NCT00644657|466997|P1|COMPLETED|Overall Study||27
190402|NCT00644657|466997|P1|STARTED|Overall Study||27
190403|NCT00644787|467002|P3|NOT COMPLETED|Period 2: Double Blind Phase||7
190404|NCT00644787|467003|P2|NOT COMPLETED|Period 2: Double Blind Phase||9
190405|NCT00644787|467004|P1|NOT COMPLETED|Period 2: Double Blind Phase||0
190406|NCT00644787|467002|P3|COMPLETED|Period 2: Double Blind Phase||55
190407|NCT00644787|467003|P2|COMPLETED|Period 2: Double Blind Phase||49
190408|NCT00644787|467004|P1|COMPLETED|Period 2: Double Blind Phase||0
190409|NCT00644787|467002|P3|STARTED|Period 2: Double Blind Phase||62
190410|NCT00644787|467003|P2|STARTED|Period 2: Double Blind Phase||58
190411|NCT00644787|467004|P1|STARTED|Period 2: Double Blind Phase||0
190412|NCT00644787|467002|P3|NOT COMPLETED|Period 1: Titration Phase||0
190413|NCT00644787|467003|P2|NOT COMPLETED|Period 1: Titration Phase||0
190414|NCT00644787|467004|P1|NOT COMPLETED|Period 1: Titration Phase||27
190415|NCT00644787|467002|P3|COMPLETED|Period 1: Titration Phase||0
190416|NCT00644787|467003|P2|COMPLETED|Period 1: Titration Phase||0
190417|NCT00644787|467004|P1|COMPLETED|Period 1: Titration Phase||129
190418|NCT00644787|467002|P3|STARTED|Period 1: Titration Phase||0
190419|NCT00644787|467003|P2|STARTED|Period 1: Titration Phase||0
190420|NCT00644787|467004|P1|STARTED|Period 1: Titration Phase||156
190421|NCT00644917|467032|P1|NOT COMPLETED|Overall Study||2
190422|NCT00644917|467032|P1|COMPLETED|Overall Study||36
190423|NCT00644917|467032|P1|STARTED|Overall Study||38
190424|NCT00644969|467042|P2|NOT COMPLETED|Post Treatment Phase||3
190425|NCT00644969|467043|P1|NOT COMPLETED|Post Treatment Phase||10
190426|NCT00644969|467042|P2|COMPLETED|Post Treatment Phase||37
190427|NCT00644969|467043|P1|COMPLETED|Post Treatment Phase||61
190428|NCT00644969|467042|P2|STARTED|Post Treatment Phase||40
190429|NCT00644969|467043|P1|STARTED|Post Treatment Phase||71
190430|NCT00644969|467042|P2|NOT COMPLETED|Treatment Phase||3
190431|NCT00644969|467043|P1|NOT COMPLETED|Treatment Phase||14
190432|NCT00644969|467042|P2|COMPLETED|Treatment Phase||40
190433|NCT00644969|467043|P1|COMPLETED|Treatment Phase||71
190434|NCT00644969|467042|P2|STARTED|Treatment Phase||43
190435|NCT00644969|467043|P1|STARTED|Treatment Phase||85
190436|NCT00644995|467091|P2|NOT COMPLETED|Overall Study||4
190437|NCT00644995|467092|P1|NOT COMPLETED|Overall Study||2
190438|NCT00644995|467091|P2|COMPLETED|Overall Study||23
190439|NCT00644995|467092|P1|COMPLETED|Overall Study|Completed 6 month assessment|23
190440|NCT00644995|467091|P2|Completed 4 Month Assessment|Overall Study||24
190441|NCT00644995|467092|P1|Completed 4 Month Assessment|Overall Study||23
190442|NCT00644995|467091|P2|STARTED|Overall Study||27
190443|NCT00644995|467092|P1|STARTED|Overall Study||25
190444|NCT00645047|467112|P2|NOT COMPLETED|Overall Study||39
190445|NCT00645047|467113|P1|NOT COMPLETED|Overall Study||43
190446|NCT00645047|467112|P2|COMPLETED|Overall Study||65
190447|NCT00645047|467113|P1|COMPLETED|Overall Study|6 month follow up|60
190448|NCT00645047|467112|P2|Post|Overall Study||80
190449|NCT00645047|467113|P1|Post|Overall Study||74
190450|NCT00645047|467112|P2|STARTED|Overall Study||104
190451|NCT00645047|467113|P1|STARTED|Overall Study||103
190452|NCT00645099|467137|P2|NOT COMPLETED|Overall Study||42
190453|NCT00645099|467138|P1|NOT COMPLETED|Overall Study||71
190454|NCT00645099|467137|P2|COMPLETED|Overall Study||178
190455|NCT00645099|467138|P1|COMPLETED|Overall Study||168
190456|NCT00645099|467137|P2|STARTED|Overall Study||220
190457|NCT00645099|467138|P1|STARTED|Overall Study||239
190458|NCT00645164|467180|P1|NOT COMPLETED|Overall Study||7
190459|NCT00645164|467180|P1|COMPLETED|Overall Study||52
190460|NCT00645164|467180|P1|STARTED|Overall Study||59
190461|NCT00645333|467184|P1|NOT COMPLETED|Overall Study||0
190462|NCT00645333|467184|P1|COMPLETED|Overall Study||30
190463|NCT00645333|467184|P1|STARTED|Overall Study||30
190464|NCT00645359|467189|P1|NOT COMPLETED|Overall Study||0
190465|NCT00645359|467189|P1|COMPLETED|Overall Study||9
190466|NCT00645359|467189|P1|STARTED|Overall Study||9
190467|NCT00645411|467198|P4|NOT COMPLETED|Overall Study||103
190468|NCT00645411|467199|P3|NOT COMPLETED|Overall Study||151
190469|NCT00645411|467200|P2|NOT COMPLETED|Overall Study||6
190470|NCT00645411|467201|P1|NOT COMPLETED|Overall Study||13
190471|NCT00645411|467198|P4|COMPLETED|Overall Study||919
190472|NCT00645411|467199|P3|COMPLETED|Overall Study||1457
190473|NCT00645411|467200|P2|COMPLETED|Overall Study||312
190474|NCT00645411|467201|P1|COMPLETED|Overall Study||643
190475|NCT00645411|467198|P4|STARTED|Overall Study||1022
190476|NCT00645411|467199|P3|STARTED|Overall Study||1608
190477|NCT00645411|467200|P2|STARTED|Overall Study||318
190478|NCT00645411|467201|P1|STARTED|Overall Study||656
190479|NCT00652834|467233|P1|NOT COMPLETED|Overall Study||5
190480|NCT00652834|467233|P1|COMPLETED|Overall Study|3 subjects withdrew after completing baseline questionnaire. 2 did not complete 30-day visit.|18
190481|NCT00652834|467233|P1|STARTED|Overall Study||23
190482|NCT00652899|467237|P1|NOT COMPLETED|Overall Study||2
190483|NCT00652899|467237|P1|COMPLETED|Overall Study||12
190484|NCT00652899|467237|P1|STARTED|Overall Study||14
190485|NCT00652938|467250|P3|NOT COMPLETED|Overall Study||5
190486|NCT00652938|467251|P2|NOT COMPLETED|Overall Study||7
190487|NCT00652938|467252|P1|NOT COMPLETED|Overall Study||1
190488|NCT00652938|467250|P3|COMPLETED|Overall Study||242
190489|NCT00652938|467251|P2|COMPLETED|Overall Study||240
190490|NCT00652938|467252|P1|COMPLETED|Overall Study||246
190491|NCT00652938|467250|P3|STARTED|Overall Study||247
190492|NCT00652938|467251|P2|STARTED|Overall Study||247
190493|NCT00652938|467252|P1|STARTED|Overall Study||247
190494|NCT00653068|467321|P1|NOT COMPLETED|Overall Study||50
190495|NCT00653068|467321|P1|COMPLETED|Overall Study||20
190496|NCT00653068|467321|P1|STARTED|Overall Study||70
190497|NCT00653133|467334|P2|NOT COMPLETED|Overall Study||0
190498|NCT00653133|467335|P1|NOT COMPLETED|Overall Study||0
190499|NCT00653133|467334|P2|COMPLETED|Overall Study||497
190500|NCT00653133|467335|P1|COMPLETED|Overall Study||1324
190501|NCT00653133|467334|P2|STARTED|Overall Study||497
190502|NCT00653133|467335|P1|STARTED|Overall Study||1324
190503|NCT00653159|467343|P2|NOT COMPLETED|Overall Study||3
190504|NCT00653159|467344|P1|NOT COMPLETED|Overall Study||5
190505|NCT00653159|467343|P2|COMPLETED|Overall Study||9
190506|NCT00653159|467344|P1|COMPLETED|Overall Study||6
190507|NCT00653159|467343|P2|STARTED|Overall Study||12
190508|NCT00653159|467344|P1|STARTED|Overall Study||11
190509|NCT00654420|467362|P4|NOT COMPLETED|Phase II||38
190510|NCT00654420|467363|P3|NOT COMPLETED|Phase II||37
190511|NCT00654420|467364|P2|NOT COMPLETED|Phase II||0
190512|NCT00654420|467365|P1|NOT COMPLETED|Phase II||0
190513|NCT00654420|467362|P4|COMPLETED|Phase II||0
190514|NCT00654420|467363|P3|COMPLETED|Phase II||0
190515|NCT00654420|467364|P2|COMPLETED|Phase II||0
190516|NCT00654420|467365|P1|COMPLETED|Phase II||0
190517|NCT00654420|467362|P4|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|38
190518|NCT00654420|467363|P3|STARTED|Phase II|New participants were enrolled in the Phase II part of the study that did not participate in Phase 1|37
190519|NCT00654420|467364|P2|STARTED|Phase II||0
190520|NCT00654420|467365|P1|STARTED|Phase II||0
190521|NCT00654420|467362|P4|NOT COMPLETED|Phase I (Dose Escalation)||0
190522|NCT00654420|467363|P3|NOT COMPLETED|Phase I (Dose Escalation)||0
190523|NCT00654420|467364|P2|NOT COMPLETED|Phase I (Dose Escalation)||16
190524|NCT00654420|467365|P1|NOT COMPLETED|Phase I (Dose Escalation)||4
190525|NCT00654420|467362|P4|COMPLETED|Phase I (Dose Escalation)||0
190526|NCT00654420|467363|P3|COMPLETED|Phase I (Dose Escalation)||0
190527|NCT00654420|467364|P2|COMPLETED|Phase I (Dose Escalation)||0
190528|NCT00654420|467365|P1|COMPLETED|Phase I (Dose Escalation)||0
190529|NCT00654420|467362|P4|STARTED|Phase I (Dose Escalation)||0
190530|NCT00654420|467363|P3|STARTED|Phase I (Dose Escalation)||0
190531|NCT00654420|467364|P2|STARTED|Phase I (Dose Escalation)||16
190532|NCT00654420|467365|P1|STARTED|Phase I (Dose Escalation)||4
190533|NCT00654498|467389|P2|NOT COMPLETED|Overall Study||12
190534|NCT00654498|467390|P1|NOT COMPLETED|Overall Study||14
190535|NCT00654498|467389|P2|COMPLETED|Overall Study||91
190536|NCT00654498|467390|P1|COMPLETED|Overall Study||189
190537|NCT00654498|467389|P2|STARTED|Overall Study||103
190538|NCT00654498|467390|P1|STARTED|Overall Study||203
190539|NCT00654511|467422|P4|NOT COMPLETED|Overall Study||0
190540|NCT00654511|467423|P3|NOT COMPLETED|Overall Study||0
190541|NCT00654511|467424|P2|NOT COMPLETED|Overall Study||0
190542|NCT00654511|467425|P1|NOT COMPLETED|Overall Study||0
190543|NCT00654511|467422|P4|COMPLETED|Overall Study||25
190544|NCT00654511|467423|P3|COMPLETED|Overall Study||25
190545|NCT00654511|467424|P2|COMPLETED|Overall Study||25
190546|NCT00654511|467425|P1|COMPLETED|Overall Study||26
190547|NCT00654511|467422|P4|STARTED|Overall Study||25
190548|NCT00654511|467423|P3|STARTED|Overall Study||25
190549|NCT00654511|467424|P2|STARTED|Overall Study||25
190550|NCT00654511|467425|P1|STARTED|Overall Study||26
190551|NCT00654628|467439|P1|NOT COMPLETED|6 –Week Extension Period (Single Site)||5
190552|NCT00654628|467439|P1|COMPLETED|6 –Week Extension Period (Single Site)||55
190553|NCT00654628|467439|P1|STARTED|6 –Week Extension Period (Single Site)|Subjects who completed the first 6-week period and participated in the second 6-week study period.|60
190554|NCT00654628|467439|P1|NOT COMPLETED|6-week Active Treatment Period||21
190555|NCT00654628|467439|P1|COMPLETED|6-week Active Treatment Period||152
190556|NCT00654628|467439|P1|STARTED|6-week Active Treatment Period||173
190557|NCT00654641|467456|P2|NOT COMPLETED|Overall Study||3
190558|NCT00654641|467457|P1|NOT COMPLETED|Overall Study||2
190559|NCT00654641|467456|P2|COMPLETED|Overall Study||23
190560|NCT00654641|467457|P1|COMPLETED|Overall Study||26
190561|NCT00654641|467456|P2|STARTED|Overall Study||26
190562|NCT00654641|467457|P1|STARTED|Overall Study||28
190563|NCT00654654|467463|P1|NOT COMPLETED|Overall Study||7
190564|NCT00654654|467463|P1|COMPLETED|Overall Study||43
190565|NCT00654654|467463|P1|STARTED|Overall Study||50
190566|NCT00654745|467468|P1|NOT COMPLETED|Overall Study||43
190567|NCT00654745|467468|P1|COMPLETED|Overall Study||164
190568|NCT00654745|467468|P1|STARTED|Overall Study|This is single group study in which subjects were titrated to the next of 7 arms if BP goal not met.|207
190569|NCT00654784|467508|P2|NOT COMPLETED|Overall Study||0
190570|NCT00654784|467509|P1|NOT COMPLETED|Overall Study||0
190571|NCT00654784|467508|P2|COMPLETED|Overall Study||8
190572|NCT00654784|467509|P1|COMPLETED|Overall Study||13
190573|NCT00654784|467508|P2|STARTED|Overall Study||8
190574|NCT00654784|467509|P1|STARTED|Overall Study||13
190575|NCT00654875|467517|P2|NOT COMPLETED|Overall Study||17
190576|NCT00654875|467518|P1|NOT COMPLETED|Overall Study||17
190577|NCT00654875|467517|P2|COMPLETED|Overall Study||147
190578|NCT00654875|467518|P1|COMPLETED|Overall Study||147
190579|NCT00654875|467517|P2|STARTED|Overall Study||164
190580|NCT00654875|467518|P1|STARTED|Overall Study||164
190581|NCT00654901|467540|P4|NOT COMPLETED|Overall Study||0
190582|NCT00654901|467541|P3|NOT COMPLETED|Overall Study||2
190583|NCT00654901|467542|P2|NOT COMPLETED|Overall Study||0
190584|NCT00654901|467543|P1|NOT COMPLETED|Overall Study||4
190585|NCT00654901|467540|P4|COMPLETED|Overall Study||113
190586|NCT00654901|467541|P3|COMPLETED|Overall Study||250
190587|NCT00654901|467542|P2|COMPLETED|Overall Study||262
190588|NCT00654901|467543|P1|COMPLETED|Overall Study||250
190589|NCT00654901|467540|P4|STARTED|Overall Study||113
190590|NCT00654901|467541|P3|STARTED|Overall Study||252
190591|NCT00654901|467542|P2|STARTED|Overall Study||262
190592|NCT00654901|467543|P1|STARTED|Overall Study||254
190593|NCT00654927|467561|P1|NOT COMPLETED|Overall Study||107
190594|NCT00654927|467561|P1|COMPLETED|Overall Study||70
190595|NCT00654927|467561|P1|STARTED|Overall Study||177
190596|NCT00654940|467571|P2|NOT COMPLETED|Period 2||0
190597|NCT00654940|467572|P1|NOT COMPLETED|Period 2||0
190598|NCT00654940|467571|P2|COMPLETED|Period 2||11
190599|NCT00654940|467572|P1|COMPLETED|Period 2||12
190600|NCT00654940|467571|P2|STARTED|Period 2||11
190601|NCT00654940|467572|P1|STARTED|Period 2||12
190602|NCT00654940|467571|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
190603|NCT00654940|467572|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
190604|NCT00654940|467571|P2|COMPLETED|Washout Period of 2 Weeks||11
190605|NCT00654940|467572|P1|COMPLETED|Washout Period of 2 Weeks||12
190606|NCT00654940|467571|P2|STARTED|Washout Period of 2 Weeks||11
190607|NCT00654940|467572|P1|STARTED|Washout Period of 2 Weeks||12
190608|NCT00654940|467571|P2|NOT COMPLETED|Period 1||1
190609|NCT00654940|467572|P1|NOT COMPLETED|Period 1||1
190610|NCT00654940|467571|P2|COMPLETED|Period 1||11
190611|NCT00654940|467572|P1|COMPLETED|Period 1||12
190612|NCT00654940|467571|P2|Received Study Treatment|Period 1||12
190613|NCT00654940|467572|P1|Received Study Treatment|Period 1||12
190614|NCT00654940|467571|P2|STARTED|Period 1|Assigned to study treatment.|12
190615|NCT00654940|467572|P1|STARTED|Period 1|Assigned to study treatment.|13
190616|NCT00654953|467587|P3|NOT COMPLETED|Overall Study||22
190617|NCT00654953|467588|P2|NOT COMPLETED|Overall Study||28
190618|NCT00654953|467589|P1|NOT COMPLETED|Overall Study||30
190619|NCT00654953|467587|P3|COMPLETED|Overall Study||8
190620|NCT00654953|467588|P2|COMPLETED|Overall Study||8
190621|NCT00654953|467589|P1|COMPLETED|Overall Study||6
190622|NCT00654953|467587|P3|STARTED|Overall Study||30
190623|NCT00654953|467588|P2|STARTED|Overall Study||36
190624|NCT00654953|467589|P1|STARTED|Overall Study||36
190625|NCT00654992|467599|P2|NOT COMPLETED|Overall Study||0
190626|NCT00654992|467600|P1|NOT COMPLETED|Overall Study||0
190627|NCT00654992|467599|P2|COMPLETED|Overall Study||35
190628|NCT00654992|467600|P1|COMPLETED|Overall Study||36
190629|NCT00654992|467599|P2|STARTED|Overall Study||35
190630|NCT00654992|467600|P1|STARTED|Overall Study||36
190631|NCT00655083|467608|P2|NOT COMPLETED|Overall Study||0
190632|NCT00655083|467609|P1|NOT COMPLETED|Overall Study||0
190633|NCT00655083|467608|P2|COMPLETED|Overall Study||8
190634|NCT00655083|467609|P1|COMPLETED|Overall Study||12
190635|NCT00655083|467608|P2|STARTED|Overall Study||8
190636|NCT00655083|467609|P1|STARTED|Overall Study||12
190637|NCT00655356|467623|P2|NOT COMPLETED|Overall Study||10
190638|NCT00655356|467624|P1|NOT COMPLETED|Overall Study||17
190639|NCT00655356|467623|P2|COMPLETED|Overall Study||98
190640|NCT00655356|467624|P1|COMPLETED|Overall Study||93
190641|NCT00655356|467623|P2|STARTED|Overall Study||108
190642|NCT00655356|467624|P1|STARTED|Overall Study||110
190643|NCT00655486|467636|P1|NOT COMPLETED|Overall Study||28
190644|NCT00655486|467636|P1|COMPLETED|Overall Study||69
190645|NCT00655486|467636|P1|STARTED|Overall Study||97
190646|NCT00655551|467644|P3|NOT COMPLETED|Period 4 (up to 7 Days)||0
190647|NCT00655551|467645|P2|NOT COMPLETED|Period 4 (up to 7 Days)||2
190648|NCT00655551|467646|P1|NOT COMPLETED|Period 4 (up to 7 Days)||0
190649|NCT00655551|467644|P3|COMPLETED|Period 4 (up to 7 Days)||0
190650|NCT00655551|467645|P2|COMPLETED|Period 4 (up to 7 Days)||23
190651|NCT00655551|467646|P1|COMPLETED|Period 4 (up to 7 Days)||0
190652|NCT00655551|467644|P3|STARTED|Period 4 (up to 7 Days)||0
190653|NCT00655551|467645|P2|STARTED|Period 4 (up to 7 Days)||25
190654|NCT00655551|467646|P1|STARTED|Period 4 (up to 7 Days)||0
190655|NCT00655551|467644|P3|NOT COMPLETED|Period 3 (up to 7 Days)||4
190656|NCT00655551|467645|P2|NOT COMPLETED|Period 3 (up to 7 Days)||0
190657|NCT00655551|467646|P1|NOT COMPLETED|Period 3 (up to 7 Days)||0
190658|NCT00655551|467644|P3|COMPLETED|Period 3 (up to 7 Days)||21
190659|NCT00655551|467645|P2|COMPLETED|Period 3 (up to 7 Days)||0
190660|NCT00655551|467646|P1|COMPLETED|Period 3 (up to 7 Days)||0
190661|NCT00655551|467644|P3|STARTED|Period 3 (up to 7 Days)||25
190662|NCT00655551|467645|P2|STARTED|Period 3 (up to 7 Days)||0
190663|NCT00655551|467646|P1|STARTED|Period 3 (up to 7 Days)||0
190664|NCT00655551|467644|P3|NOT COMPLETED|Period 2 (up to 7 Days)||0
190665|NCT00655551|467645|P2|NOT COMPLETED|Period 2 (up to 7 Days)||1
190666|NCT00655551|467646|P1|NOT COMPLETED|Period 2 (up to 7 Days)||0
190667|NCT00655551|467644|P3|COMPLETED|Period 2 (up to 7 Days)||0
190668|NCT00655551|467645|P2|COMPLETED|Period 2 (up to 7 Days)||24
190669|NCT00655551|467646|P1|COMPLETED|Period 2 (up to 7 Days)||0
190670|NCT00655551|467644|P3|STARTED|Period 2 (up to 7 Days)||0
190671|NCT00655551|467645|P2|STARTED|Period 2 (up to 7 Days)||25
190672|NCT00655551|467646|P1|STARTED|Period 2 (up to 7 Days)||0
190673|NCT00655551|467644|P3|NOT COMPLETED|Period 1 (up to 7 Days)||0
190674|NCT00655551|467645|P2|NOT COMPLETED|Period 1 (up to 7 Days)||0
190675|NCT00655551|467646|P1|NOT COMPLETED|Period 1 (up to 7 Days)||0
190676|NCT00655551|467644|P3|COMPLETED|Period 1 (up to 7 Days)||0
190677|NCT00655551|467645|P2|COMPLETED|Period 1 (up to 7 Days)||0
190678|NCT00655551|467646|P1|COMPLETED|Period 1 (up to 7 Days)||25
190679|NCT00655551|467644|P3|STARTED|Period 1 (up to 7 Days)||0
190680|NCT00655551|467645|P2|STARTED|Period 1 (up to 7 Days)||0
190681|NCT00655551|467646|P1|STARTED|Period 1 (up to 7 Days)||25
190682|NCT00655551|467644|P3|NOT COMPLETED|All Periods Combined||4
190683|NCT00655551|467645|P2|NOT COMPLETED|All Periods Combined||3
190684|NCT00655551|467646|P1|NOT COMPLETED|All Periods Combined||0
190685|NCT00655551|467644|P3|COMPLETED|All Periods Combined||21
190686|NCT00655551|467645|P2|COMPLETED|All Periods Combined||47
190687|NCT00655551|467646|P1|COMPLETED|All Periods Combined||25
190688|NCT00655551|467644|P3|STARTED|All Periods Combined||25
190689|NCT00655551|467645|P2|STARTED|All Periods Combined||50
190690|NCT00655551|467646|P1|STARTED|All Periods Combined||25
190691|NCT00655564|467660|P1|NOT COMPLETED|Overall Study||3
190692|NCT00655564|467660|P1|COMPLETED|Overall Study||12
190693|NCT00655564|467660|P1|STARTED|Overall Study||15
190694|NCT00655629|467667|P2|NOT COMPLETED|Overall Study||23
190695|NCT00655629|467668|P1|NOT COMPLETED|Overall Study||21
190696|NCT00655629|467667|P2|COMPLETED|Overall Study||144
190697|NCT00655629|467668|P1|COMPLETED|Overall Study||151
190698|NCT00655629|467667|P2|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion.(safety population)|166
190699|NCT00655629|467668|P1|Participants Received Treatment|Overall Study|1 patient could not verify drug ingestion. (safety population)|171
190700|NCT00655629|467667|P2|STARTED|Overall Study||167
190701|NCT00655629|467668|P1|STARTED|Overall Study||172
190702|NCT00655642|467708|P4|NOT COMPLETED|Overall Study||2
190703|NCT00655642|467709|P3|NOT COMPLETED|Overall Study||2
190704|NCT00655642|467710|P2|NOT COMPLETED|Overall Study||3
190705|NCT00655642|467711|P1|NOT COMPLETED|Overall Study||1
190706|NCT00655642|467708|P4|COMPLETED|Overall Study|1 patient's initial Visual analog scale (VAS)<40; 1 patient was withdrawn by treating physician|39
190707|NCT00655642|467709|P3|COMPLETED|Overall Study|1 patient left the ED prior to receiving drug; 1 patient's nausea resolved prior to receiving drug|43
190708|NCT00655642|467710|P2|COMPLETED|Overall Study|1 patient given drug orally rather than intravenous(iv);1 patient refused iv; 1 pt lost to follow-up|40
190709|NCT00655642|467711|P1|COMPLETED|Overall Study|1 patient withdrawn by treating physician after consent|41
190710|NCT00655642|467708|P4|STARTED|Overall Study||41
190711|NCT00655642|467709|P3|STARTED|Overall Study||45
190712|NCT00655642|467710|P2|STARTED|Overall Study||43
190713|NCT00655642|467711|P1|STARTED|Overall Study||42
190714|NCT00655668|467721|P1|NOT COMPLETED|Overall Study||54
190715|NCT00655668|467721|P1|COMPLETED|Overall Study|Participants dosed up to 24 months, disease progression or unacceptable adverse events developed.|0
190716|NCT00655668|467721|P1|STARTED|Overall Study|Planned enrollment: 80 participants|54
190717|NCT00655733|467731|P2|NOT COMPLETED|Overall Study||8
190718|NCT00655733|467732|P1|NOT COMPLETED|Overall Study||7
190719|NCT00655733|467731|P2|COMPLETED|Overall Study||42
190720|NCT00655733|467732|P1|COMPLETED|Overall Study||44
190721|NCT00655733|467731|P2|STARTED|Overall Study||50
190722|NCT00655733|467732|P1|STARTED|Overall Study||51
190723|NCT00655746|467738|P1|NOT COMPLETED|Overall Study||1
190724|NCT00655746|467738|P1|COMPLETED|Overall Study||13
190725|NCT00655746|467738|P1|STARTED|Overall Study||14
190726|NCT00655811|467755|P1|NOT COMPLETED|Overall Study||0
190727|NCT00655811|467755|P1|COMPLETED|Overall Study||40
190728|NCT00655811|467755|P1|STARTED|Overall Study||40
190729|NCT00655824|467769|P1|NOT COMPLETED|Follow-up (FU) Period||66
190730|NCT00655824|467769|P1|COMPLETED|Follow-up (FU) Period||13
190731|NCT00655824|467769|P1|STARTED|Follow-up (FU) Period|A participant who withdrew from the Treatment Phase could still enter the Follow-up Phase.|79
190732|NCT00655824|467769|P1|NOT COMPLETED|Treatment Period||84
190733|NCT00655824|467769|P1|COMPLETED|Treatment Period||8
190734|NCT00655824|467769|P1|STARTED|Treatment Period||92
190735|NCT00655850|467813|P1|NOT COMPLETED|Overall Study||3
190736|NCT00655850|467813|P1|COMPLETED|Overall Study||36
190737|NCT00655850|467813|P1|STARTED|Overall Study||39
190738|NCT00655863|467823|P3|NOT COMPLETED|Overall Study||1
190739|NCT00655863|467824|P2|NOT COMPLETED|Overall Study||0
190740|NCT00655863|467825|P1|NOT COMPLETED|Overall Study||0
190741|NCT00655863|467823|P3|COMPLETED|Overall Study||21
190742|NCT00655863|467824|P2|COMPLETED|Overall Study||25
190743|NCT00655863|467825|P1|COMPLETED|Overall Study||24
190744|NCT00655863|467823|P3|STARTED|Overall Study||22
190745|NCT00655863|467824|P2|STARTED|Overall Study||25
190746|NCT00655863|467825|P1|STARTED|Overall Study||24
190747|NCT00655889|467884|P1|NOT COMPLETED|Overall Study||2
190748|NCT00655889|467884|P1|COMPLETED|Overall Study||11
190749|NCT00655889|467884|P1|STARTED|Overall Study||13
190750|NCT00656058|467889|P1|NOT COMPLETED|Overall Study||6
190751|NCT00656058|467889|P1|COMPLETED|Overall Study||19
190752|NCT00656058|467889|P1|STARTED|Overall Study||25
190753|NCT00656084|467898|P1|NOT COMPLETED|Overall Study||7
190754|NCT00656084|467898|P1|COMPLETED|Overall Study||9
190755|NCT00656084|467898|P1|STARTED|Overall Study||16
190756|NCT00656136|467907|P2|NOT COMPLETED|Overall Study||390
190757|NCT00656136|467908|P1|NOT COMPLETED|Overall Study||195
190758|NCT00656136|467907|P2|COMPLETED|Overall Study||0
190759|NCT00656136|467908|P1|COMPLETED|Overall Study||0
190760|NCT00656136|467907|P2|STARTED|Overall Study|Randomised patients.|390
190761|NCT00656136|467908|P1|STARTED|Overall Study|Randomised patients.|195
190762|NCT00656175|467920|P2|NOT COMPLETED|Overall Study||1
190763|NCT00656175|467921|P1|NOT COMPLETED|Overall Study||1
190764|NCT00656175|467920|P2|COMPLETED|Overall Study||20
190765|NCT00656175|467921|P1|COMPLETED|Overall Study||17
190766|NCT00656175|467920|P2|STARTED|Overall Study||21
190767|NCT00656175|467921|P1|STARTED|Overall Study||18
190768|NCT00656201|467929|P2|NOT COMPLETED|Overall Study||32
190769|NCT00656201|467930|P1|NOT COMPLETED|Overall Study||29
190770|NCT00656201|467929|P2|COMPLETED|Overall Study||201
190771|NCT00656201|467930|P1|COMPLETED|Overall Study||206
190772|NCT00656201|467929|P2|STARTED|Overall Study||233
190773|NCT00656201|467930|P1|STARTED|Overall Study||235
190774|NCT00656292|467938|P2|NOT COMPLETED|Overall Study||5
190775|NCT00656292|467939|P1|NOT COMPLETED|Overall Study||3
190776|NCT00656292|467938|P2|COMPLETED|Overall Study||24
190777|NCT00656292|467939|P1|COMPLETED|Overall Study||29
190778|NCT00656292|467938|P2|STARTED|Overall Study||29
190779|NCT00656292|467939|P1|STARTED|Overall Study||32
190780|NCT00656370|467955|P1|NOT COMPLETED|Overall Study||10
190781|NCT00656370|467955|P1|COMPLETED|Overall Study|15 subjects were randomized and completed stage 1.|15
190782|NCT00656370|467955|P1|STARTED|Overall Study|25 subjects were assessed for eligibility and signed an Informed Consent Form.|25
190783|NCT00656448|467963|P2|NOT COMPLETED|Overall Study||0
190784|NCT00656448|467964|P1|NOT COMPLETED|Overall Study||0
190785|NCT00656448|467963|P2|COMPLETED|Overall Study||25
190786|NCT00656448|467964|P1|COMPLETED|Overall Study||25
190787|NCT00656448|467963|P2|STARTED|Overall Study||25
190788|NCT00656448|467964|P1|STARTED|Overall Study||25
190789|NCT00656474|467972|P1|NOT COMPLETED|Overall Study||1
190790|NCT00656474|467972|P1|COMPLETED|Overall Study||11
190791|NCT00656474|467972|P1|STARTED|Overall Study||12
190792|NCT00656487|467982|P3|NOT COMPLETED|Overall Study||0
190793|NCT00656487|467983|P2|NOT COMPLETED|Overall Study||4
190794|NCT00656487|467984|P1|NOT COMPLETED|Overall Study||2
190795|NCT00656487|467982|P3|COMPLETED|Overall Study||20
190796|NCT00656487|467983|P2|COMPLETED|Overall Study||19
190797|NCT00656487|467984|P1|COMPLETED|Overall Study||21
190798|NCT00656487|467982|P3|STARTED|Overall Study||20
190799|NCT00656487|467983|P2|STARTED|Overall Study||23
190800|NCT00656487|467984|P1|STARTED|Overall Study||23
190801|NCT00656513|468010|P3|NOT COMPLETED|Overall Study||22
190802|NCT00656513|468011|P2|NOT COMPLETED|Overall Study||30
190803|NCT00656513|468012|P1|NOT COMPLETED|Overall Study||4
190804|NCT00656513|468010|P3|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|53
190805|NCT00656513|468011|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|43
190806|NCT00656513|468012|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
190807|NCT00656513|468010|P3|STARTED|Overall Study||75
190808|NCT00656513|468011|P2|STARTED|Overall Study||73
190809|NCT00656513|468012|P1|STARTED|Overall Study||48
190810|NCT00656617|468031|P1|NOT COMPLETED|Overall Study||7
190811|NCT00656617|468031|P1|COMPLETED|Overall Study||99
190812|NCT00656617|468031|P1|Induction Phase|Overall Study|Induction phase following determination of safe combination Vorinostat with Idarubicin.|103
190813|NCT00656617|468031|P1|Run-in Induction Phase|Overall Study|Initial run-in: Vorinostat induction dose 500 mg orally three times daily for 3 days.|3
190814|NCT00656617|468031|P1|STARTED|Overall Study||106
190815|NCT00656630|468040|P3|NOT COMPLETED|Overall Study||2
190816|NCT00656630|468041|P2|NOT COMPLETED|Overall Study||2
190817|NCT00656630|468042|P1|NOT COMPLETED|Overall Study||2
190818|NCT00656630|468040|P3|COMPLETED|Overall Study||17
190819|NCT00656630|468041|P2|COMPLETED|Overall Study||25
190820|NCT00656630|468042|P1|COMPLETED|Overall Study||20
190821|NCT00656630|468040|P3|STARTED|Overall Study||19
190822|NCT00656630|468041|P2|STARTED|Overall Study||27
190823|NCT00656630|468042|P1|STARTED|Overall Study||22
190824|NCT00656656|468062|P1|NOT COMPLETED|Overall Study||0
190825|NCT00656656|468062|P1|COMPLETED|Overall Study||23
190826|NCT00656656|468062|P1|STARTED|Overall Study||23
190827|NCT00656669|468067|P1|NOT COMPLETED|AC (Cycles 6-9)||2
190828|NCT00656669|468067|P1|COMPLETED|AC (Cycles 6-9)||15
190829|NCT00656669|468067|P1|STARTED|AC (Cycles 6-9)||17
190830|NCT00656669|468067|P1|NOT COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||6
190831|NCT00656669|468067|P1|COMPLETED|Paclitaxel/Sunitinib (Cycles 2-5)||17
190832|NCT00656669|468067|P1|STARTED|Paclitaxel/Sunitinib (Cycles 2-5)||23
190833|NCT00656669|468067|P1|NOT COMPLETED|Single Agent Sunitinib (Cycle 1)||0
190834|NCT00656669|468067|P1|COMPLETED|Single Agent Sunitinib (Cycle 1)||23
190835|NCT00656669|468067|P1|STARTED|Single Agent Sunitinib (Cycle 1)||23
190836|NCT00656799|468076|P1|NOT COMPLETED|Overall Study||2
190837|NCT00656799|468076|P1|COMPLETED|Overall Study||4
190838|NCT00656799|468076|P1|STARTED|Overall Study||6
190839|NCT00656851|468100|P2|NOT COMPLETED|Overall Study||4
190840|NCT00656851|468101|P1|NOT COMPLETED|Overall Study||0
190841|NCT00656851|468100|P2|COMPLETED|Overall Study||8
190842|NCT00656851|468101|P1|COMPLETED|Overall Study||12
190843|NCT00656851|468100|P2|STARTED|Overall Study||12
190844|NCT00656851|468101|P1|STARTED|Overall Study||12
190845|NCT00648895|468125|P2|NOT COMPLETED|Overall Study||1
190846|NCT00648895|468126|P1|NOT COMPLETED|Overall Study||0
190847|NCT00648895|468125|P2|COMPLETED|Overall Study||5
190848|NCT00648895|468126|P1|COMPLETED|Overall Study||6
190849|NCT00648895|468125|P2|STARTED|Overall Study||6
190850|NCT00648895|468126|P1|STARTED|Overall Study||6
190851|NCT00648908|468132|P1|NOT COMPLETED|Overall Study||115
190852|NCT00648908|468132|P1|COMPLETED|Overall Study||154
190853|NCT00648908|468132|P1|STARTED|Overall Study||269
190854|NCT00649220|468140|P1|NOT COMPLETED|Overall Study||3
190855|NCT00649220|468140|P1|COMPLETED|Overall Study||16
190856|NCT00649220|468140|P1|STARTED|Overall Study||19
190857|NCT00649389|468155|P4|NOT COMPLETED|Overall Study||111
190858|NCT00649389|468156|P3|NOT COMPLETED|Overall Study||88
190859|NCT00649389|468157|P2|NOT COMPLETED|Overall Study||106
190860|NCT00649389|468158|P1|NOT COMPLETED|Overall Study||71
190861|NCT00649389|468155|P4|COMPLETED|Overall Study||516
190862|NCT00649389|468156|P3|COMPLETED|Overall Study||512
190863|NCT00649389|468157|P2|COMPLETED|Overall Study||531
190864|NCT00649389|468158|P1|COMPLETED|Overall Study||557
190865|NCT00649389|468155|P4|STARTED|Overall Study||627
190866|NCT00649389|468156|P3|STARTED|Overall Study||600
190867|NCT00649389|468157|P2|STARTED|Overall Study||637
190868|NCT00649389|468158|P1|STARTED|Overall Study||628
190869|NCT00649428|468182|P2|NOT COMPLETED|Overall Study||15
190870|NCT00649428|468183|P1|NOT COMPLETED|Overall Study||20
190871|NCT00649428|468182|P2|COMPLETED|Overall Study||88
190872|NCT00649428|468183|P1|COMPLETED|Overall Study||80
190873|NCT00649428|468182|P2|STARTED|Overall Study||103
190874|NCT00649428|468183|P1|STARTED|Overall Study||100
190875|NCT00649792|468195|P1|NOT COMPLETED|Overall Study||68
190876|NCT00649792|468195|P1|COMPLETED|Overall Study||146
190877|NCT00649792|468195|P1|STARTED|Overall Study||214
190878|NCT00649961|468203|P1|NOT COMPLETED|Overall Study||0
190879|NCT00649961|468203|P1|COMPLETED|Overall Study||18
190880|NCT00649961|468203|P1|STARTED|Overall Study||18
190881|NCT00650078|468209|P2|NOT COMPLETED|Overall Study||13
190882|NCT00650078|468210|P1|NOT COMPLETED|Overall Study||14
190883|NCT00650078|468209|P2|COMPLETED|Overall Study||106
190884|NCT00650078|468210|P1|COMPLETED|Overall Study||217
190885|NCT00650078|468209|P2|STARTED|Overall Study||119
190886|NCT00650078|468210|P1|STARTED|Overall Study||231
190887|NCT00650091|468220|P3|NOT COMPLETED|Amended Study Design||0
190888|NCT00650091|468221|P2|NOT COMPLETED|Amended Study Design||20
190889|NCT00650091|468222|P1|NOT COMPLETED|Amended Study Design||23
190890|NCT00650091|468220|P3|COMPLETED|Amended Study Design||0
190891|NCT00650091|468221|P2|COMPLETED|Amended Study Design||111
190892|NCT00650091|468222|P1|COMPLETED|Amended Study Design||110
190893|NCT00650091|468220|P3|STARTED|Amended Study Design|Study Drug was discontinued for all subjects due to safety concerns.|0
190894|NCT00650091|468221|P2|STARTED|Amended Study Design||131
190895|NCT00650091|468222|P1|STARTED|Amended Study Design||133
190896|NCT00650091|468220|P3|NOT COMPLETED|Initial Study Design - Interim Analysis||0
190897|NCT00650091|468221|P2|NOT COMPLETED|Initial Study Design - Interim Analysis||0
190898|NCT00650091|468222|P1|NOT COMPLETED|Initial Study Design - Interim Analysis||0
190899|NCT00650091|468220|P3|COMPLETED|Initial Study Design - Interim Analysis||77
190900|NCT00650091|468221|P2|COMPLETED|Initial Study Design - Interim Analysis||78
190901|NCT00650091|468222|P1|COMPLETED|Initial Study Design - Interim Analysis||81
190902|NCT00650091|468220|P3|STARTED|Initial Study Design - Interim Analysis||77
190903|NCT00650091|468221|P2|STARTED|Initial Study Design - Interim Analysis||78
190904|NCT00650091|468222|P1|STARTED|Initial Study Design - Interim Analysis||81
190905|NCT00650104|468240|P1|NOT COMPLETED|Overall Study||41
190906|NCT00650104|468240|P1|COMPLETED|Overall Study||42
190907|NCT00650104|468240|P1|STARTED|Overall Study||83
190908|NCT00650260|468255|P2|NOT COMPLETED|Overall Study||0
190909|NCT00650260|468256|P1|NOT COMPLETED|Overall Study||0
190910|NCT00650260|468255|P2|COMPLETED|Overall Study||21
190911|NCT00650260|468256|P1|COMPLETED|Overall Study||21
190912|NCT00650260|468255|P2|STARTED|Overall Study||21
190913|NCT00650260|468256|P1|STARTED|Overall Study||21
190914|NCT00656916|468274|P2|NOT COMPLETED|Overall Study||0
190915|NCT00656916|468275|P1|NOT COMPLETED|Overall Study||0
190916|NCT00656916|468274|P2|COMPLETED|Overall Study||0
190917|NCT00656916|468275|P1|COMPLETED|Overall Study||1
190918|NCT00656916|468274|P2|STARTED|Overall Study||0
190919|NCT00656916|468275|P1|STARTED|Overall Study||1
190920|NCT00656968|468283|P2|NOT COMPLETED|Overall Study||0
190921|NCT00656968|468284|P1|NOT COMPLETED|Overall Study||0
190922|NCT00656968|468283|P2|COMPLETED|Overall Study||117
190923|NCT00656968|468284|P1|COMPLETED|Overall Study||115
190924|NCT00656968|468283|P2|STARTED|Overall Study||117
190925|NCT00656968|468284|P1|STARTED|Overall Study||115
190926|NCT00657020|468292|P2|NOT COMPLETED|PERIOD 2||0
190927|NCT00657020|468293|P1|NOT COMPLETED|PERIOD 2||0
190928|NCT00657020|468292|P2|COMPLETED|PERIOD 2||11
190929|NCT00657020|468293|P1|COMPLETED|PERIOD 2||11
190930|NCT00657020|468292|P2|STARTED|PERIOD 2||11
190931|NCT00657020|468293|P1|STARTED|PERIOD 2||11
190932|NCT00657020|468292|P2|NOT COMPLETED|PERIOD 1||1
190933|NCT00657020|468293|P1|NOT COMPLETED|PERIOD 1||0
190934|NCT00657020|468292|P2|COMPLETED|PERIOD 1||11
190935|NCT00657020|468293|P1|COMPLETED|PERIOD 1||11
190936|NCT00657020|468292|P2|STARTED|PERIOD 1||12
190937|NCT00657020|468293|P1|STARTED|PERIOD 1||11
190938|NCT00657046|468324|P3|NOT COMPLETED|Overall Study||2
190939|NCT00657046|468325|P2|NOT COMPLETED|Overall Study||3
190940|NCT00657046|468326|P1|NOT COMPLETED|Overall Study||4
190941|NCT00657046|468324|P3|COMPLETED|Overall Study||21
190942|NCT00657046|468325|P2|COMPLETED|Overall Study||29
190943|NCT00657046|468326|P1|COMPLETED|Overall Study||26
190944|NCT00657046|468324|P3|Had Visits up to Visit 18|Overall Study||23
190945|NCT00657046|468325|P2|Had Visits up to Visit 18|Overall Study||30
190946|NCT00657046|468326|P1|Had Visits up to Visit 18|Overall Study||28
190947|NCT00657046|468324|P3|Had at Least 1 Post Baseline Visit|Overall Study||23
190948|NCT00657046|468325|P2|Had at Least 1 Post Baseline Visit|Overall Study||31
190949|NCT00657046|468326|P1|Had at Least 1 Post Baseline Visit|Overall Study||30
190950|NCT00657046|468324|P3|STARTED|Overall Study||23
190951|NCT00657046|468325|P2|STARTED|Overall Study||32
190952|NCT00657046|468326|P1|STARTED|Overall Study||30
190953|NCT00657150|468360|P2|NOT COMPLETED|Treatment||97
190954|NCT00657150|468361|P1|NOT COMPLETED|Treatment||107
190955|NCT00657150|468360|P2|COMPLETED|Treatment||906
190956|NCT00657150|468361|P1|COMPLETED|Treatment||903
190957|NCT00657150|468360|P2|STARTED|Treatment||1003
190958|NCT00657150|468361|P1|STARTED|Treatment||1010
190959|NCT00657150|468360|P2|NOT COMPLETED|Overall Study||93
190960|NCT00657150|468361|P1|NOT COMPLETED|Overall Study||115
190961|NCT00657150|468360|P2|COMPLETED|Overall Study||910
190962|NCT00657150|468361|P1|COMPLETED|Overall Study||895
190963|NCT00657150|468360|P2|STARTED|Overall Study||1003
190964|NCT00657150|468361|P1|STARTED|Overall Study||1010
190965|NCT00658112|468389|P1|NOT COMPLETED|Overall Study||9
190966|NCT00658112|468389|P1|COMPLETED|Overall Study||11
190967|NCT00658112|468389|P1|STARTED|Overall Study||20
190968|NCT00658138|468393|P1|NOT COMPLETED|Overall Study||21
190969|NCT00658138|468393|P1|COMPLETED|Overall Study||40
190970|NCT00658138|468393|P1|STARTED|Overall Study||61
190971|NCT00658320|468400|P2|NOT COMPLETED|Extension Study: After Month 24||0
190972|NCT00658320|468401|P1|NOT COMPLETED|Extension Study: After Month 24||2
190973|NCT00658320|468400|P2|COMPLETED|Extension Study: After Month 24||0
190974|NCT00658320|468401|P1|COMPLETED|Extension Study: After Month 24||42
190975|NCT00658320|468400|P2|STARTED|Extension Study: After Month 24||0
190976|NCT00658320|468401|P1|STARTED|Extension Study: After Month 24||44
190977|NCT00658320|468400|P2|NOT COMPLETED|Extension Study: Month 12 to Month 24||7
190978|NCT00658320|468401|P1|NOT COMPLETED|Extension Study: Month 12 to Month 24||6
190979|NCT00658320|468400|P2|COMPLETED|Extension Study: Month 12 to Month 24||50
190980|NCT00658320|468401|P1|COMPLETED|Extension Study: Month 12 to Month 24||47
190981|NCT00658320|468400|P2|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
190982|NCT00658320|468401|P1|Extension ITT: Received Study Drug|Extension Study: Month 12 to Month 24||50
190983|NCT00658320|468400|P2|STARTED|Extension Study: Month 12 to Month 24||57
190984|NCT00658320|468401|P1|STARTED|Extension Study: Month 12 to Month 24||53
190985|NCT00658320|468400|P2|NOT COMPLETED|Core Study: 12 Months||3
190986|NCT00658320|468401|P1|NOT COMPLETED|Core Study: 12 Months||5
190987|NCT00658320|468400|P2|COMPLETED|Core Study: 12 Months||58
190988|NCT00658320|468401|P1|COMPLETED|Core Study: 12 Months||56
190989|NCT00658320|468400|P2|STARTED|Core Study: 12 Months||61
190990|NCT00658320|468401|P1|STARTED|Core Study: 12 Months||61
190991|NCT00658333|468426|P2|NOT COMPLETED|Overall Study||1
190992|NCT00658333|468427|P1|NOT COMPLETED|Overall Study||2
190993|NCT00658333|468426|P2|COMPLETED|Overall Study||14
190994|NCT00658333|468427|P1|COMPLETED|Overall Study||13
190995|NCT00658333|468426|P2|STARTED|Overall Study||15
190996|NCT00658333|468427|P1|STARTED|Overall Study||15
190997|NCT00658385|468435|P1|NOT COMPLETED|Overall Study||0
190998|NCT00658385|468435|P1|COMPLETED|Overall Study||5
190999|NCT00658385|468435|P1|STARTED|Overall Study||5
191000|NCT00658411|468439|P1|NOT COMPLETED|Overall Study||0
191001|NCT00658411|468439|P1|COMPLETED|Overall Study||5
191002|NCT00658411|468439|P1|STARTED|Overall Study||5
191003|NCT00658528|468449|P2|NOT COMPLETED|Overall Study||45
191004|NCT00658528|468450|P1|NOT COMPLETED|Overall Study||40
191005|NCT00658528|468449|P2|COMPLETED|Overall Study||479
191006|NCT00658528|468450|P1|COMPLETED|Overall Study||491
191007|NCT00658528|468449|P2|STARTED|Overall Study|Treated|524
191008|NCT00658528|468450|P1|STARTED|Overall Study|Treated|531
191009|NCT00658541|468460|P2|NOT COMPLETED|Second Intervention||0
191010|NCT00658541|468461|P1|NOT COMPLETED|Second Intervention||0
191011|NCT00658541|468460|P2|COMPLETED|Second Intervention||17
191012|NCT00658541|468461|P1|COMPLETED|Second Intervention||18
191013|NCT00658541|468460|P2|STARTED|Second Intervention||17
191014|NCT00658541|468461|P1|STARTED|Second Intervention||18
191015|NCT00658541|468460|P2|NOT COMPLETED|Washout Period of 7 Days||2
191016|NCT00658541|468461|P1|NOT COMPLETED|Washout Period of 7 Days||1
191017|NCT00658541|468460|P2|COMPLETED|Washout Period of 7 Days||17
191018|NCT00658541|468461|P1|COMPLETED|Washout Period of 7 Days||18
191019|NCT00658541|468460|P2|STARTED|Washout Period of 7 Days||19
191020|NCT00658541|468461|P1|STARTED|Washout Period of 7 Days||19
191021|NCT00658541|468460|P2|NOT COMPLETED|First Intervention||0
191022|NCT00658541|468461|P1|NOT COMPLETED|First Intervention||0
191023|NCT00658541|468460|P2|COMPLETED|First Intervention||19
191024|NCT00658541|468461|P1|COMPLETED|First Intervention||19
191025|NCT00658541|468460|P2|STARTED|First Intervention||19
191026|NCT00658541|468461|P1|STARTED|First Intervention||19
191027|NCT00658567|468474|P3|NOT COMPLETED|Overall Study||6
191028|NCT00658567|468475|P2|NOT COMPLETED|Overall Study||4
191029|NCT00658567|468476|P1|NOT COMPLETED|Overall Study||8
191030|NCT00658567|468474|P3|COMPLETED|Overall Study||35
191031|NCT00658567|468475|P2|COMPLETED|Overall Study||38
191032|NCT00658567|468476|P1|COMPLETED|Overall Study||32
191033|NCT00658567|468474|P3|STARTED|Overall Study||41
191034|NCT00658567|468475|P2|STARTED|Overall Study||42
191035|NCT00658567|468476|P1|STARTED|Overall Study||40
191036|NCT00658606|468489|P2|NOT COMPLETED|Overall Study||23
191037|NCT00658606|468490|P1|NOT COMPLETED|Overall Study||16
191038|NCT00658606|468489|P2|COMPLETED|Overall Study|Represents patients who completed follow-up|26
191039|NCT00658606|468490|P1|COMPLETED|Overall Study|Represents patients who completed follow-up|33
191040|NCT00658606|468489|P2|Completed Treatment|Overall Study||44
191041|NCT00658606|468490|P1|Completed Treatment|Overall Study||42
191042|NCT00658606|468489|P2|STARTED|Overall Study||49
191043|NCT00658606|468490|P1|STARTED|Overall Study||49
191044|NCT00658619|468521|P5|NOT COMPLETED|Overall Study||2
191045|NCT00658619|468522|P4|NOT COMPLETED|Overall Study||12
191046|NCT00658619|468523|P3|NOT COMPLETED|Overall Study||10
191047|NCT00658619|468524|P2|NOT COMPLETED|Overall Study||1
191048|NCT00658619|468525|P1|NOT COMPLETED|Overall Study||0
191049|NCT00658619|468521|P5|COMPLETED|Overall Study||21
191050|NCT00658619|468522|P4|COMPLETED|Overall Study||37
191051|NCT00658619|468523|P3|COMPLETED|Overall Study||31
191052|NCT00658619|468524|P2|COMPLETED|Overall Study||2
191053|NCT00658619|468525|P1|COMPLETED|Overall Study||3
191054|NCT00658619|468521|P5|STARTED|Overall Study||23
191055|NCT00658619|468522|P4|STARTED|Overall Study||49
191056|NCT00658619|468523|P3|STARTED|Overall Study||41
191057|NCT00658619|468524|P2|STARTED|Overall Study||3
191058|NCT00658619|468525|P1|STARTED|Overall Study||3
191059|NCT00658632|468547|P2|NOT COMPLETED|Overall Study||65
191060|NCT00658632|468548|P1|NOT COMPLETED|Overall Study||64
191061|NCT00658632|468547|P2|COMPLETED|Overall Study||633
191062|NCT00658632|468548|P1|COMPLETED|Overall Study||618
191063|NCT00658632|468547|P2|STARTED|Overall Study|Treated|698
191064|NCT00658632|468548|P1|STARTED|Overall Study|Treated|682
191065|NCT00658658|468563|P5|NOT COMPLETED|Overall Study||5
191066|NCT00658658|468564|P4|NOT COMPLETED|Overall Study||2
191067|NCT00658658|468565|P3|NOT COMPLETED|Overall Study||0
191068|NCT00658658|468566|P2|NOT COMPLETED|Overall Study||2
191069|NCT00658658|468567|P1|NOT COMPLETED|Overall Study||5
191070|NCT00658658|468563|P5|COMPLETED|Overall Study||3
191071|NCT00658658|468564|P4|COMPLETED|Overall Study||4
191072|NCT00658658|468565|P3|COMPLETED|Overall Study||4
191073|NCT00658658|468566|P2|COMPLETED|Overall Study||5
191074|NCT00658658|468567|P1|COMPLETED|Overall Study||1
191075|NCT00658658|468563|P5|STARTED|Overall Study||8
191076|NCT00658658|468564|P4|STARTED|Overall Study||6
191077|NCT00658658|468565|P3|STARTED|Overall Study||4
191078|NCT00658658|468566|P2|STARTED|Overall Study||7
191079|NCT00658658|468567|P1|STARTED|Overall Study||6
191080|NCT00658684|468627|P4|NOT COMPLETED|Overall Study||1
191081|NCT00658684|468628|P3|NOT COMPLETED|Overall Study||3
191082|NCT00658684|468629|P2|NOT COMPLETED|Overall Study||15
191083|NCT00658684|468630|P1|NOT COMPLETED|Overall Study||19
191084|NCT00658684|468627|P4|COMPLETED|Overall Study||27
191085|NCT00658684|468628|P3|COMPLETED|Overall Study||22
191086|NCT00658684|468629|P2|COMPLETED|Overall Study||84
191087|NCT00658684|468630|P1|COMPLETED|Overall Study||133
191088|NCT00658684|468627|P4|STARTED|Overall Study||28
191089|NCT00658684|468628|P3|STARTED|Overall Study||25
191090|NCT00658684|468629|P2|STARTED|Overall Study||99
191091|NCT00658684|468630|P1|STARTED|Overall Study||152
191092|NCT00658697|468680|P1|NOT COMPLETED|Overall Study||0
191093|NCT00658697|468680|P1|COMPLETED|Overall Study||41
191094|NCT00658697|468680|P1|STARTED|Overall Study||41
191095|NCT00658723|468690|P3|NOT COMPLETED|Overall Study||7
191096|NCT00658723|468691|P2|NOT COMPLETED|Overall Study||4
191097|NCT00658723|468692|P1|NOT COMPLETED|Overall Study||4
191098|NCT00658723|468690|P3|COMPLETED|Overall Study||44
191099|NCT00658723|468691|P2|COMPLETED|Overall Study||26
191100|NCT00658723|468692|P1|COMPLETED|Overall Study||56
191101|NCT00658723|468690|P3|STARTED|Overall Study||51
191102|NCT00658723|468691|P2|STARTED|Overall Study||30
191103|NCT00658723|468692|P1|STARTED|Overall Study||60
191104|NCT00658736|468721|P2|NOT COMPLETED|Overall Study||2
191105|NCT00658736|468722|P1|NOT COMPLETED|Overall Study||6
191106|NCT00658736|468721|P2|COMPLETED|Overall Study||19
191107|NCT00658736|468722|P1|COMPLETED|Overall Study||13
191108|NCT00658736|468721|P2|STARTED|Overall Study||21
191109|NCT00658736|468722|P1|STARTED|Overall Study||19
191110|NCT00658775|468732|P2|NOT COMPLETED|Overall Study||43
191111|NCT00658775|468733|P1|NOT COMPLETED|Overall Study||42
191112|NCT00658775|468732|P2|COMPLETED|Overall Study||485
191113|NCT00658775|468733|P1|COMPLETED|Overall Study||495
191114|NCT00658775|468732|P2|STARTED|Overall Study|Treated|528
191115|NCT00658775|468733|P1|STARTED|Overall Study|Treated|537
191116|NCT00658788|468743|P1|NOT COMPLETED|Overall Study||74
191117|NCT00658788|468743|P1|COMPLETED|Overall Study||231
191118|NCT00658788|468743|P1|STARTED|Overall Study||305
191119|NCT00658814|468798|P2|NOT COMPLETED|Maintenance Therapy||1
191120|NCT00658814|468799|P1|NOT COMPLETED|Maintenance Therapy||3
191121|NCT00658814|468798|P2|COMPLETED|Maintenance Therapy||7
191122|NCT00658814|468799|P1|COMPLETED|Maintenance Therapy||17
191123|NCT00658814|468798|P2|Eligible|Maintenance Therapy||8
191124|NCT00658814|468799|P1|Eligible|Maintenance Therapy||19
191125|NCT00658814|468798|P2|STARTED|Maintenance Therapy||8
191126|NCT00658814|468799|P1|STARTED|Maintenance Therapy||20
191127|NCT00658814|468798|P2|NOT COMPLETED|Consolidation Therapy||3
191128|NCT00658814|468799|P1|NOT COMPLETED|Consolidation Therapy||2
191129|NCT00658814|468798|P2|COMPLETED|Consolidation Therapy||10
191130|NCT00658814|468799|P1|COMPLETED|Consolidation Therapy||22
191131|NCT00658814|468798|P2|Eligible|Consolidation Therapy||11
191132|NCT00658814|468799|P1|Eligible|Consolidation Therapy||22
191133|NCT00658814|468798|P2|STARTED|Consolidation Therapy||13
191134|NCT00658814|468799|P1|STARTED|Consolidation Therapy||24
191135|NCT00658814|468798|P2|NOT COMPLETED|Remission Induction Chemotherapy||18
191136|NCT00658814|468799|P1|NOT COMPLETED|Remission Induction Chemotherapy||8
191137|NCT00658814|468798|P2|COMPLETED|Remission Induction Chemotherapy||41
191138|NCT00658814|468799|P1|COMPLETED|Remission Induction Chemotherapy||75
191139|NCT00658814|468798|P2|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||54
191140|NCT00658814|468799|P1|Eligible and Began Protocol Therapy|Remission Induction Chemotherapy||79
191141|NCT00658814|468798|P2|Eligible|Remission Induction Chemotherapy||57
191142|NCT00658814|468799|P1|Eligible|Remission Induction Chemotherapy||82
191143|NCT00658814|468798|P2|STARTED|Remission Induction Chemotherapy||59
191144|NCT00658814|468799|P1|STARTED|Remission Induction Chemotherapy||83
191145|NCT00658996|468813|P2|NOT COMPLETED|Second Intervention||1
191146|NCT00658996|468814|P1|NOT COMPLETED|Second Intervention||1
191147|NCT00658996|468813|P2|COMPLETED|Second Intervention||104
191148|NCT00658996|468814|P1|COMPLETED|Second Intervention||105
191149|NCT00658996|468813|P2|STARTED|Second Intervention||105
191150|NCT00658996|468814|P1|STARTED|Second Intervention||106
191151|NCT00658996|468813|P2|NOT COMPLETED|Crossover Period||1
191152|NCT00658996|468814|P1|NOT COMPLETED|Crossover Period||2
191153|NCT00658996|468813|P2|COMPLETED|Crossover Period||105
191154|NCT00658996|468814|P1|COMPLETED|Crossover Period||106
191155|NCT00658996|468813|P2|STARTED|Crossover Period||106
191156|NCT00658996|468814|P1|STARTED|Crossover Period||108
191157|NCT00658996|468813|P2|NOT COMPLETED|First Intervention||1
191158|NCT00658996|468814|P1|NOT COMPLETED|First Intervention||1
191159|NCT00658996|468813|P2|COMPLETED|First Intervention||106
191160|NCT00658996|468814|P1|COMPLETED|First Intervention||108
191161|NCT00658996|468813|P2|STARTED|First Intervention||107
191162|NCT00658996|468814|P1|STARTED|First Intervention||109
191163|NCT00659061|468826|P2|NOT COMPLETED|Overall Study||15
191164|NCT00659061|468827|P1|NOT COMPLETED|Overall Study||21
191165|NCT00659061|468826|P2|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
191166|NCT00659061|468827|P1|COMPLETED|Overall Study|Those with either complete or partial biochemical and anthropometric data|287
191167|NCT00659061|468826|P2|STARTED|Overall Study||302
191168|NCT00659061|468827|P1|STARTED|Overall Study||308
191169|NCT00659165|468847|P2|NOT COMPLETED|Overall Study||0
191170|NCT00659165|468848|P1|NOT COMPLETED|Overall Study||0
191171|NCT00659165|468847|P2|COMPLETED|Overall Study||5
191172|NCT00659165|468848|P1|COMPLETED|Overall Study||5
191173|NCT00659165|468847|P2|STARTED|Overall Study||5
191174|NCT00659165|468848|P1|STARTED|Overall Study||5
191175|NCT00659230|468856|P2|NOT COMPLETED|Overall Study||12
191176|NCT00659230|468857|P1|NOT COMPLETED|Overall Study||9
191177|NCT00659230|468856|P2|COMPLETED|Overall Study||37
191178|NCT00659230|468857|P1|COMPLETED|Overall Study||42
191179|NCT00659230|468856|P2|STARTED|Overall Study|3 did not return post-randomization, 4 lost source documents, thus 7 excluded from results analysis|49
191180|NCT00659230|468857|P1|STARTED|Overall Study|2 did not return post-randomization, 5 lost source documents, thus 7 excluded from results analysis|51
191181|NCT00659269|468871|P2|NOT COMPLETED|Overall Study||1
191182|NCT00659269|468872|P1|NOT COMPLETED|Overall Study||1
191183|NCT00659269|468871|P2|COMPLETED|Overall Study||161
191184|NCT00659269|468872|P1|COMPLETED|Overall Study||156
191185|NCT00659269|468871|P2|Group 3 (Taxanes)|Overall Study||97
191186|NCT00659269|468872|P1|Group 3 (Taxanes)|Overall Study||92
191187|NCT00659269|468871|P2|Group 2 (Vinca Alkaloids)|Overall Study||12
191188|NCT00659269|468872|P1|Group 2 (Vinca Alkaloids)|Overall Study||12
191189|NCT00659269|468871|P2|Group 1 (Heavy Metals)|Overall Study||52
191190|NCT00659269|468872|P1|Group 1 (Heavy Metals)|Overall Study||52
191191|NCT00659269|468871|P2|STARTED|Overall Study||162
191192|NCT00659269|468872|P1|STARTED|Overall Study||157
191193|NCT00659295|468902|P2|NOT COMPLETED|Overall Study||5603
191194|NCT00659295|468903|P1|NOT COMPLETED|Overall Study||2708
191195|NCT00659295|468902|P2|COMPLETED|Overall Study||32038
191196|NCT00659295|468903|P1|COMPLETED|Overall Study||10821
191197|NCT00659295|468902|P2|STARTED|Overall Study||37641
191198|NCT00659295|468903|P1|STARTED|Overall Study||13529
191199|NCT00659334|468916|P7|NOT COMPLETED|Overall Study||1
191200|NCT00659334|468917|P6|NOT COMPLETED|Overall Study||0
191201|NCT00659334|468918|P5|NOT COMPLETED|Overall Study||0
191202|NCT00659334|468919|P4|NOT COMPLETED|Overall Study||0
191203|NCT00659334|468920|P3|NOT COMPLETED|Overall Study||0
191204|NCT00659334|468921|P2|NOT COMPLETED|Overall Study||5
191205|NCT00659334|468922|P1|NOT COMPLETED|Overall Study||8
191206|NCT00659334|468916|P7|COMPLETED|Overall Study|1 screen failure|20
191207|NCT00659334|468917|P6|COMPLETED|Overall Study||0
191208|NCT00659334|468918|P5|COMPLETED|Overall Study||1
191209|NCT00659334|468919|P4|COMPLETED|Overall Study||2
191210|NCT00659334|468920|P3|COMPLETED|Overall Study||5
191211|NCT00659334|468921|P2|COMPLETED|Overall Study|5 Screen failures|36
191212|NCT00659334|468922|P1|COMPLETED|Overall Study|8 Screen failures|38
191213|NCT00659334|468916|P7|STARTED|Overall Study||21
191214|NCT00659334|468917|P6|STARTED|Overall Study||0
191215|NCT00659334|468918|P5|STARTED|Overall Study||1
191216|NCT00659334|468919|P4|STARTED|Overall Study||2
191217|NCT00659334|468920|P3|STARTED|Overall Study||5
191218|NCT00659334|468921|P2|STARTED|Overall Study||41
191219|NCT00659334|468922|P1|STARTED|Overall Study||46
191220|NCT00659360|468938|P1|NOT COMPLETED|Overall Study||0
191221|NCT00659360|468938|P1|COMPLETED|Overall Study||17
191222|NCT00659360|468938|P1|STARTED|Overall Study||17
191223|NCT00659373|468948|P2|NOT COMPLETED|Overall Study||7
191224|NCT00659373|468949|P1|NOT COMPLETED|Overall Study||5
191225|NCT00659373|468948|P2|COMPLETED|Overall Study||54
191226|NCT00659373|468949|P1|COMPLETED|Overall Study||20
191227|NCT00659373|468948|P2|STARTED|Overall Study||61
191228|NCT00659373|468949|P1|STARTED|Overall Study||25
191229|NCT00659438|468957|P2|NOT COMPLETED|Overall Study||8
191230|NCT00659438|468958|P1|NOT COMPLETED|Overall Study||14
191231|NCT00659438|468957|P2|COMPLETED|Overall Study||40
191232|NCT00659438|468958|P1|COMPLETED|Overall Study||33
191233|NCT00659438|468957|P2|Safety Analysis Set|Overall Study||47
191234|NCT00659438|468958|P1|Safety Analysis Set|Overall Study|One patient randomized to placebo was accounted in vandetanib group as he mistakenly received drug|48
191235|NCT00659438|468957|P2|Secondary Analysis Set|Overall Study||48
191236|NCT00659438|468958|P1|Secondary Analysis Set|Overall Study||47
191237|NCT00659438|468957|P2|Assessable Set : Primary Analysis|Overall Study||45
191238|NCT00659438|468958|P1|Assessable Set : Primary Analysis|Overall Study||44
191239|NCT00659438|468957|P2|STARTED|Overall Study||48
191240|NCT00659438|468958|P1|STARTED|Overall Study||47
191241|NCT00659490|468983|P3|NOT COMPLETED|Overall Study||1
191242|NCT00659490|468984|P2|NOT COMPLETED|Overall Study||0
191243|NCT00659490|468985|P1|NOT COMPLETED|Overall Study||2
191244|NCT00659490|468983|P3|COMPLETED|Overall Study||30
191245|NCT00659490|468984|P2|COMPLETED|Overall Study||59
191246|NCT00659490|468985|P1|COMPLETED|Overall Study||59
191247|NCT00659490|468983|P3|STARTED|Overall Study||31
191248|NCT00659490|468984|P2|STARTED|Overall Study||59
191249|NCT00659490|468985|P1|STARTED|Overall Study||61
191250|NCT00659529|469056|P1|NOT COMPLETED|Overall Study||16
191251|NCT00659529|469056|P1|COMPLETED|Overall Study|4 patients withdrew as a result of side effects. 3 subjects were withdrawn by the investigator.|20
191252|NCT00659529|469056|P1|Received at Least One Dose of Study Drug|Overall Study|Received at least one dose of study drug|27
191253|NCT00659529|469056|P1|STARTED|Overall Study|There were 9 screen failures (subjects who did not meet inclusion/exclusion criteria)|36
191254|NCT00659581|469060|P1|NOT COMPLETED|Overall Study||8582
191255|NCT00659581|469060|P1|COMPLETED|Overall Study||12412
191256|NCT00659581|469060|P1|STARTED|Overall Study||20994
191257|NCT00659607|469072|P1|NOT COMPLETED|Overall Study||316
191258|NCT00659607|469072|P1|COMPLETED|Overall Study||3616
191259|NCT00659607|469072|P1|STARTED|Overall Study||3932
191260|NCT00659633|469090|P1|NOT COMPLETED|Overall Study||0
191261|NCT00659633|469090|P1|COMPLETED|Overall Study||10
191262|NCT00659633|469090|P1|STARTED|Overall Study||10
191263|NCT00659724|469094|P1|NOT COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||0
191264|NCT00659724|469094|P1|COMPLETED|Weeks 3-4: Assessment of HD-C4 Big||33
191265|NCT00659724|469094|P1|STARTED|Weeks 3-4: Assessment of HD-C4 Big||33
191266|NCT00659724|469094|P1|NOT COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||0
191267|NCT00659724|469094|P1|COMPLETED|Weeks 1-2: Assessment of 180NR or 200NR||33
191268|NCT00659724|469094|P1|STARTED|Weeks 1-2: Assessment of 180NR or 200NR||33
191269|NCT00659737|469114|P2|NOT COMPLETED|Overall Study||0
191270|NCT00659737|469115|P1|NOT COMPLETED|Overall Study||0
191271|NCT00659737|469114|P2|COMPLETED|Overall Study||58
191272|NCT00659737|469115|P1|COMPLETED|Overall Study||57
191273|NCT00659737|469114|P2|STARTED|Overall Study||58
191274|NCT00659737|469115|P1|STARTED|Overall Study||57
191275|NCT00659789|469123|P2|NOT COMPLETED|Overall Study||7
191276|NCT00659789|469124|P1|NOT COMPLETED|Overall Study||7
191277|NCT00659789|469123|P2|COMPLETED|Overall Study||36
191278|NCT00659789|469124|P1|COMPLETED|Overall Study||86
191279|NCT00659789|469123|P2|STARTED|Overall Study||43
191280|NCT00659789|469124|P1|STARTED|Overall Study||93
191281|NCT00659815|469142|P2|NOT COMPLETED|Overall Study||4
191282|NCT00659815|469143|P1|NOT COMPLETED|Overall Study||4
191283|NCT00659815|469142|P2|COMPLETED|Overall Study||147
191284|NCT00659815|469143|P1|COMPLETED|Overall Study||153
191285|NCT00659815|469142|P2|STARTED|Overall Study||151
191286|NCT00659815|469143|P1|STARTED|Overall Study||157
191287|NCT00659880|469153|P1|NOT COMPLETED|Overall Study||5
191288|NCT00659880|469153|P1|COMPLETED|Overall Study|60 months|4
191289|NCT00659880|469153|P1|24 Months|Overall Study||6
191290|NCT00659880|469153|P1|12 Months|Overall Study||7
191291|NCT00659880|469153|P1|6 Months|Overall Study||9
191292|NCT00659880|469153|P1|6 Weeks|Overall Study||9
191293|NCT00659880|469153|P1|STARTED|Overall Study||9
191294|NCT00659945|469160|P2|NOT COMPLETED|Overall Study||0
191295|NCT00659945|469161|P1|NOT COMPLETED|Overall Study||0
191296|NCT00659945|469160|P2|COMPLETED|Overall Study||75
191297|NCT00659945|469161|P1|COMPLETED|Overall Study||75
191298|NCT00659945|469160|P2|STARTED|Overall Study||75
191299|NCT00659945|469161|P1|STARTED|Overall Study||75
191300|NCT00659984|469167|P1|NOT COMPLETED|Overall Study||1
191301|NCT00659984|469167|P1|COMPLETED|Overall Study||14
191302|NCT00659984|469167|P1|STARTED|Overall Study||15
191303|NCT00660010|469178|P1|NOT COMPLETED|Overall Study||9
191304|NCT00660010|469178|P1|COMPLETED|Overall Study||46
191305|NCT00660010|469178|P1|STARTED|Overall Study||55
191306|NCT00660023|469192|P1|NOT COMPLETED|Overall Study||29
191307|NCT00660023|469192|P1|COMPLETED|Overall Study||95
191308|NCT00660023|469192|P1|Treated|Overall Study||114
191309|NCT00660023|469192|P1|STARTED|Overall Study||124
191310|NCT00660049|469203|P1|NOT COMPLETED|Overall Study||6
191311|NCT00660049|469203|P1|COMPLETED|Overall Study||6
191312|NCT00660049|469203|P1|STARTED|Overall Study||12
191313|NCT00660075|469209|P2|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
191314|NCT00660075|469210|P1|NOT COMPLETED|Second Intervention (Week 11 to Week 16||0
191315|NCT00660075|469209|P2|COMPLETED|Second Intervention (Week 11 to Week 16||18
191316|NCT00660075|469210|P1|COMPLETED|Second Intervention (Week 11 to Week 16||18
191317|NCT00660075|469209|P2|STARTED|Second Intervention (Week 11 to Week 16||18
191318|NCT00660075|469210|P1|STARTED|Second Intervention (Week 11 to Week 16||18
191319|NCT00660075|469209|P2|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
191320|NCT00660075|469210|P1|NOT COMPLETED|Washout Period (Week 7 to Week 10)||0
191321|NCT00660075|469209|P2|COMPLETED|Washout Period (Week 7 to Week 10)||18
191322|NCT00660075|469210|P1|COMPLETED|Washout Period (Week 7 to Week 10)||18
191323|NCT00660075|469209|P2|STARTED|Washout Period (Week 7 to Week 10)||18
191324|NCT00660075|469210|P1|STARTED|Washout Period (Week 7 to Week 10)||18
191325|NCT00660075|469209|P2|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
191326|NCT00660075|469210|P1|NOT COMPLETED|First Intervention (Week 1 to Week 6)||0
191327|NCT00660075|469209|P2|COMPLETED|First Intervention (Week 1 to Week 6)||18
191328|NCT00660075|469210|P1|COMPLETED|First Intervention (Week 1 to Week 6)||18
191329|NCT00660075|469209|P2|STARTED|First Intervention (Week 1 to Week 6)||18
191330|NCT00660075|469210|P1|STARTED|First Intervention (Week 1 to Week 6)||18
191331|NCT00660179|469219|P3|NOT COMPLETED|Overall Study||41
191332|NCT00660179|469220|P2|NOT COMPLETED|Overall Study||58
191333|NCT00660179|469221|P1|NOT COMPLETED|Overall Study||56
191334|NCT00660179|469219|P3|COMPLETED|Overall Study||201
191335|NCT00660179|469220|P2|COMPLETED|Overall Study||192
191336|NCT00660179|469221|P1|COMPLETED|Overall Study||194
191337|NCT00660179|469219|P3|STARTED|Overall Study||242
191338|NCT00660179|469220|P2|STARTED|Overall Study||250
191339|NCT00660179|469221|P1|STARTED|Overall Study||250
191340|NCT00660192|469255|P2|NOT COMPLETED|Overall Study||3
191341|NCT00660192|469256|P1|NOT COMPLETED|Overall Study||2
191342|NCT00660192|469255|P2|COMPLETED|Overall Study||10
191343|NCT00660192|469256|P1|COMPLETED|Overall Study||10
191344|NCT00660192|469255|P2|STARTED|Overall Study||13
191345|NCT00660192|469256|P1|STARTED|Overall Study||12
191346|NCT00653224|469266|P2|NOT COMPLETED|Overall Study||7
191347|NCT00653224|469267|P1|NOT COMPLETED|Overall Study||7
191348|NCT00653224|469266|P2|COMPLETED|Overall Study||280
191349|NCT00653224|469267|P1|COMPLETED|Overall Study||286
191350|NCT00653224|469266|P2|STARTED|Overall Study||287
191351|NCT00653224|469267|P1|STARTED|Overall Study||293
191352|NCT00653263|469451|P1|NOT COMPLETED|Overall Study||2
191353|NCT00653263|469451|P1|COMPLETED|Overall Study||6
191354|NCT00653263|469451|P1|STARTED|Overall Study|1 dropped out of treatment and the other had untreated hypertension|8
191355|NCT00653328|469457|P1|NOT COMPLETED|Overall Study||15
191356|NCT00653328|469457|P1|COMPLETED|Overall Study||0
191357|NCT00653328|469457|P1|STARTED|Overall Study||15
191358|NCT00653523|469464|P1|NOT COMPLETED|Overall Study||19
191359|NCT00653523|469464|P1|COMPLETED|Overall Study||132
191360|NCT00653523|469464|P1|STARTED|Overall Study||151
191361|NCT00653861|469468|P1|NOT COMPLETED|Overall Study||0
191362|NCT00653861|469468|P1|COMPLETED|Overall Study||72
191363|NCT00653861|469468|P1|STARTED|Overall Study||72
191364|NCT00653939|469479|P2|NOT COMPLETED|Overall Study||15
191365|NCT00653939|469480|P1|NOT COMPLETED|Overall Study||12
191366|NCT00653939|469479|P2|COMPLETED|Overall Study||17
191367|NCT00653939|469480|P1|COMPLETED|Overall Study||19
191368|NCT00653939|469479|P2|STARTED|Overall Study|1 patient randomized did not receive treatment due to acute renal failure.|32
191369|NCT00653939|469480|P1|STARTED|Overall Study|2 patients randomized did not receive treatment due to brain metastasis or consent withdrawal.|31
191370|NCT00654004|469498|P2|NOT COMPLETED|Overall Study||0
191371|NCT00654004|469499|P1|NOT COMPLETED|Overall Study||1
191372|NCT00654004|469498|P2|COMPLETED|Overall Study||12
191373|NCT00654004|469499|P1|COMPLETED|Overall Study||13
191374|NCT00654004|469498|P2|STARTED|Overall Study||12
191375|NCT00654004|469499|P1|STARTED|Overall Study||14
191376|NCT00654030|469513|P1|NOT COMPLETED|Overall Study||2
191377|NCT00654030|469513|P1|COMPLETED|Overall Study||10
191378|NCT00654030|469513|P1|STARTED|Overall Study||12
191379|NCT00654095|469517|P1|NOT COMPLETED|Overall Study||32
191380|NCT00654095|469517|P1|COMPLETED|Overall Study||114
191381|NCT00654095|469517|P1|STARTED|Overall Study||146
191382|NCT00654147|469523|P2|NOT COMPLETED|Overall Study||4
191383|NCT00654147|469524|P1|NOT COMPLETED|Overall Study||2
191384|NCT00654147|469523|P2|COMPLETED|Overall Study||19
191385|NCT00654147|469524|P1|COMPLETED|Overall Study||19
191386|NCT00654147|469523|P2|STARTED|Overall Study||23
191387|NCT00654147|469524|P1|STARTED|Overall Study||21
191388|NCT00654186|469540|P1|NOT COMPLETED|Overall Study||5
191389|NCT00654186|469540|P1|COMPLETED|Overall Study||27
191390|NCT00654186|469540|P1|STARTED|Overall Study||32
191391|NCT00654329|469550|P4|NOT COMPLETED|Overall Study||0
191392|NCT00654329|469551|P3|NOT COMPLETED|Overall Study||0
191393|NCT00654329|469552|P2|NOT COMPLETED|Overall Study||0
191394|NCT00654329|469553|P1|NOT COMPLETED|Overall Study||0
191395|NCT00654329|469550|P4|COMPLETED|Overall Study||27
191396|NCT00654329|469551|P3|COMPLETED|Overall Study||23
191397|NCT00654329|469552|P2|COMPLETED|Overall Study||28
191398|NCT00654329|469553|P1|COMPLETED|Overall Study||23
191399|NCT00654329|469550|P4|STARTED|Overall Study||27
191400|NCT00654329|469551|P3|STARTED|Overall Study||23
191401|NCT00654329|469552|P2|STARTED|Overall Study||28
191402|NCT00654329|469553|P1|STARTED|Overall Study||23
191403|NCT00654355|469569|P2|NOT COMPLETED|Overall Study||2
191404|NCT00654355|469570|P1|NOT COMPLETED|Overall Study||2
191405|NCT00654355|469569|P2|COMPLETED|Overall Study||13
191406|NCT00654355|469570|P1|COMPLETED|Overall Study||13
191407|NCT00654355|469569|P2|STARTED|Overall Study||15
191408|NCT00654355|469570|P1|STARTED|Overall Study||15
191409|NCT00654368|469583|P3|NOT COMPLETED|Overall Study||32
191410|NCT00654368|469584|P2|NOT COMPLETED|Overall Study||48
191411|NCT00654368|469585|P1|NOT COMPLETED|Overall Study||53
191412|NCT00654368|469583|P3|COMPLETED|Overall Study||75
191413|NCT00654368|469584|P2|COMPLETED|Overall Study||50
191414|NCT00654368|469585|P1|COMPLETED|Overall Study||0
191415|NCT00654368|469583|P3|STARTED|Overall Study||107
191416|NCT00654368|469584|P2|STARTED|Overall Study||98
191417|NCT00654368|469585|P1|STARTED|Overall Study||53
191418|NCT00654381|469620|P6|NOT COMPLETED|Extension Stage||3
191419|NCT00654381|469621|P5|NOT COMPLETED|Extension Stage||3
191420|NCT00654381|469622|P4|NOT COMPLETED|Extension Stage||9
191421|NCT00654381|469623|P3|NOT COMPLETED|Extension Stage||11
191422|NCT00654381|469624|P2|NOT COMPLETED|Extension Stage||2
191423|NCT00654381|469625|P1|NOT COMPLETED|Extension Stage||1
191424|NCT00654381|469620|P6|COMPLETED|Extension Stage||73
191425|NCT00654381|469621|P5|COMPLETED|Extension Stage||68
191426|NCT00654381|469622|P4|COMPLETED|Extension Stage||142
191427|NCT00654381|469623|P3|COMPLETED|Extension Stage||142
191428|NCT00654381|469624|P2|COMPLETED|Extension Stage||36
191429|NCT00654381|469625|P1|COMPLETED|Extension Stage||33
191430|NCT00654381|469620|P6|STARTED|Extension Stage||76
191431|NCT00654381|469621|P5|STARTED|Extension Stage||71
191432|NCT00654381|469622|P4|STARTED|Extension Stage||151
191433|NCT00654381|469623|P3|STARTED|Extension Stage||153
191434|NCT00654381|469624|P2|STARTED|Extension Stage||38
191435|NCT00654381|469625|P1|STARTED|Extension Stage||34
191436|NCT00654381|469620|P6|NOT COMPLETED|2nd Stage||3
191437|NCT00654381|469621|P5|NOT COMPLETED|2nd Stage||8
191438|NCT00654381|469622|P4|NOT COMPLETED|2nd Stage||4
191439|NCT00654381|469623|P3|NOT COMPLETED|2nd Stage||3
191440|NCT00654381|469624|P2|NOT COMPLETED|2nd Stage||0
191441|NCT00654381|469625|P1|NOT COMPLETED|2nd Stage||2
191442|NCT00654381|469620|P6|COMPLETED|2nd Stage||76
191443|NCT00654381|469621|P5|COMPLETED|2nd Stage||71
191444|NCT00654381|469622|P4|COMPLETED|2nd Stage||151
191445|NCT00654381|469623|P3|COMPLETED|2nd Stage||153
191446|NCT00654381|469624|P2|COMPLETED|2nd Stage||38
191447|NCT00654381|469625|P1|COMPLETED|2nd Stage||34
191448|NCT00654381|469620|P6|STARTED|2nd Stage||79
191449|NCT00654381|469621|P5|STARTED|2nd Stage||79
191450|NCT00654381|469622|P4|STARTED|2nd Stage||155
191451|NCT00654381|469623|P3|STARTED|2nd Stage||156
191452|NCT00654381|469624|P2|STARTED|2nd Stage||38
191453|NCT00654381|469625|P1|STARTED|2nd Stage||36
191454|NCT00654381|469620|P6|NOT COMPLETED|1st Stage||2
191455|NCT00654381|469621|P5|NOT COMPLETED|1st Stage||2
191456|NCT00654381|469622|P4|NOT COMPLETED|1st Stage||5
191457|NCT00654381|469623|P3|NOT COMPLETED|1st Stage||3
191458|NCT00654381|469624|P2|NOT COMPLETED|1st Stage||3
191459|NCT00654381|469625|P1|NOT COMPLETED|1st Stage||3
191460|NCT00654381|469620|P6|COMPLETED|1st Stage||79
191461|NCT00654381|469621|P5|COMPLETED|1st Stage||79
191462|NCT00654381|469622|P4|COMPLETED|1st Stage||155
191463|NCT00654381|469623|P3|COMPLETED|1st Stage||156
191464|NCT00654381|469624|P2|COMPLETED|1st Stage||38
191465|NCT00654381|469625|P1|COMPLETED|1st Stage||36
191466|NCT00654381|469620|P6|STARTED|1st Stage||81
191467|NCT00654381|469621|P5|STARTED|1st Stage||81
191468|NCT00654381|469622|P4|STARTED|1st Stage||160
191469|NCT00654381|469623|P3|STARTED|1st Stage||159
191470|NCT00654381|469624|P2|STARTED|1st Stage||41
191471|NCT00654381|469625|P1|STARTED|1st Stage||39
191472|NCT00660309|469661|P2|NOT COMPLETED|Overall Study||3
191473|NCT00660309|469662|P1|NOT COMPLETED|Overall Study||2
191474|NCT00660309|469661|P2|COMPLETED|Overall Study||19
191475|NCT00660309|469662|P1|COMPLETED|Overall Study||21
191476|NCT00660309|469661|P2|Pharmacodynamic Analysis Set|Overall Study||20
191477|NCT00660309|469662|P1|Pharmacodynamic Analysis Set|Overall Study||22
191478|NCT00660309|469661|P2|Treated With Aliskiren or Irbesartan|Overall Study||21
191479|NCT00660309|469662|P1|Treated With Aliskiren or Irbesartan|Overall Study||22
191480|NCT00660309|469661|P2|STARTED|Overall Study|Represents participants who received one dose of Captopril.|22
191481|NCT00660309|469662|P1|STARTED|Overall Study|Represents participants who received one dose of Captopril.|23
191482|NCT00660348|469703|P2|NOT COMPLETED|Overall Study||0
191483|NCT00660348|469704|P1|NOT COMPLETED|Overall Study||1
191484|NCT00660348|469703|P2|COMPLETED|Overall Study||0
191485|NCT00660348|469704|P1|COMPLETED|Overall Study||0
191486|NCT00660348|469703|P2|STARTED|Overall Study||0
191487|NCT00660348|469704|P1|STARTED|Overall Study||1
191488|NCT00660387|469712|P2|NOT COMPLETED|Overall Study||3
191489|NCT00660387|469713|P1|NOT COMPLETED|Overall Study||2
191490|NCT00660387|469712|P2|COMPLETED|Overall Study||31
191491|NCT00660387|469713|P1|COMPLETED|Overall Study||35
191492|NCT00660387|469712|P2|STARTED|Overall Study||34
191493|NCT00660387|469713|P1|STARTED|Overall Study||37
191494|NCT00660400|469765|P1|NOT COMPLETED|Overall Study||4
191495|NCT00660400|469765|P1|COMPLETED|Overall Study||21
191496|NCT00660400|469765|P1|STARTED|Overall Study||25
191497|NCT00660504|469774|P2|NOT COMPLETED|Overall Study||1
191498|NCT00660504|469775|P1|NOT COMPLETED|Overall Study||0
191499|NCT00660504|469774|P2|COMPLETED|Overall Study||150
191500|NCT00660504|469775|P1|COMPLETED|Overall Study||149
191501|NCT00660504|469774|P2|STARTED|Overall Study||151
191502|NCT00660504|469775|P1|STARTED|Overall Study||149
191503|NCT00660517|469791|P4|NOT COMPLETED|Overall Study||7
191504|NCT00660517|469792|P3|NOT COMPLETED|Overall Study||7
191505|NCT00660517|469793|P2|NOT COMPLETED|Overall Study||8
191506|NCT00660517|469794|P1|NOT COMPLETED|Overall Study||8
191507|NCT00660517|469791|P4|COMPLETED|Overall Study||144
191508|NCT00660517|469792|P3|COMPLETED|Overall Study||144
191509|NCT00660517|469793|P2|COMPLETED|Overall Study||144
191510|NCT00660517|469794|P1|COMPLETED|Overall Study||145
191511|NCT00660517|469791|P4|STARTED|Overall Study||151
191512|NCT00660517|469792|P3|STARTED|Overall Study||151
191513|NCT00660517|469793|P2|STARTED|Overall Study||152
191514|NCT00660517|469794|P1|STARTED|Overall Study||153
191515|NCT00660543|469812|P1|NOT COMPLETED|Overall Study||0
191516|NCT00660543|469812|P1|COMPLETED|Overall Study||14
191517|NCT00660543|469812|P1|STARTED|Overall Study||14
191518|NCT00660595|469823|P2|NOT COMPLETED|Overall Study||9
191519|NCT00660595|469824|P1|NOT COMPLETED|Overall Study||18
191520|NCT00660595|469823|P2|COMPLETED|Overall Study|One of the two was lost to follow-up|1
191521|NCT00660595|469824|P1|COMPLETED|Overall Study||1
191522|NCT00660595|469823|P2|STARTED|Overall Study||10
191523|NCT00660595|469824|P1|STARTED|Overall Study||19
191524|NCT00660816|469838|P2|NOT COMPLETED|Overall Study||19
191525|NCT00660816|469839|P1|NOT COMPLETED|Overall Study||20
191526|NCT00660816|469838|P2|COMPLETED|Overall Study||3
191527|NCT00660816|469839|P1|COMPLETED|Overall Study||4
191528|NCT00660816|469838|P2|STARTED|Overall Study||22
191529|NCT00660816|469839|P1|STARTED|Overall Study||24
191530|NCT00660829|469853|P2|NOT COMPLETED|Overall Study||19
191531|NCT00660829|469854|P1|NOT COMPLETED|Overall Study||18
191532|NCT00660829|469853|P2|COMPLETED|Overall Study||249
191533|NCT00660829|469854|P1|COMPLETED|Overall Study||250
191534|NCT00660829|469853|P2|STARTED|Overall Study|2 subjects were randomized in error|268
191535|NCT00660829|469854|P1|STARTED|Overall Study|2 subjects were randomized in error|268
191536|NCT00660907|469872|P2|NOT COMPLETED|Overall Study||94
191537|NCT00660907|469873|P1|NOT COMPLETED|Overall Study||84
191538|NCT00660907|469872|P2|COMPLETED|Overall Study||314
191539|NCT00660907|469873|P1|COMPLETED|Overall Study||322
191540|NCT00660907|469872|P2|STARTED|Overall Study|Of the 408 randomized participants only 401 were included in the full analysis set.|408
191541|NCT00660907|469873|P1|STARTED|Overall Study|Of the 406 randomized participants only 400 were included in the full analysis set.|406
191542|NCT00660985|469887|P2|NOT COMPLETED|Overall Study||0
191543|NCT00660985|469888|P1|NOT COMPLETED|Overall Study||1
191544|NCT00660985|469887|P2|COMPLETED|Overall Study||25
191545|NCT00660985|469888|P1|COMPLETED|Overall Study||25
191546|NCT00660985|469887|P2|STARTED|Overall Study||25
191547|NCT00660985|469888|P1|STARTED|Overall Study||26
191548|NCT00661037|469912|P2|NOT COMPLETED|Overall Study||257
191549|NCT00661037|469913|P1|NOT COMPLETED|Overall Study||154
191550|NCT00661037|469912|P2|COMPLETED|Overall Study||1027
191551|NCT00661037|469913|P1|COMPLETED|Overall Study||682
191552|NCT00661037|469912|P2|Deaths|Overall Study||188
191553|NCT00661037|469913|P1|Deaths|Overall Study||108
191554|NCT00661037|469912|P2|Witdrawn|Overall Study||68
191555|NCT00661037|469913|P1|Witdrawn|Overall Study||47
191556|NCT00661037|469912|P2|STARTED|Overall Study||1284
191557|NCT00661037|469913|P1|STARTED|Overall Study||836
191558|NCT00661089|469925|P2|NOT COMPLETED|Overall Study||2
191559|NCT00661089|469926|P1|NOT COMPLETED|Overall Study||0
191560|NCT00661089|469925|P2|COMPLETED|Overall Study||9
191561|NCT00661089|469926|P1|COMPLETED|Overall Study||10
191562|NCT00661089|469925|P2|STARTED|Overall Study||11
191563|NCT00661089|469926|P1|STARTED|Overall Study||10
191564|NCT00661193|469936|P2|NOT COMPLETED|Overall Study||26
191565|NCT00661193|469937|P1|NOT COMPLETED|Overall Study||33
191566|NCT00661193|469936|P2|COMPLETED|Overall Study||0
191567|NCT00661193|469937|P1|COMPLETED|Overall Study||0
191568|NCT00661193|469936|P2|STARTED|Overall Study||26
191569|NCT00661193|469937|P1|STARTED|Overall Study||33
191570|NCT00661258|469947|P2|NOT COMPLETED|Overall Study||1
191571|NCT00661258|469948|P1|NOT COMPLETED|Overall Study||3
191572|NCT00661258|469947|P2|COMPLETED|Overall Study||33
191573|NCT00661258|469948|P1|COMPLETED|Overall Study||31
191574|NCT00661258|469947|P2|STARTED|Overall Study||34
191575|NCT00661258|469948|P1|STARTED|Overall Study||34
191576|NCT00661362|469958|P2|NOT COMPLETED|Overall Study||40
191577|NCT00661362|469959|P1|NOT COMPLETED|Overall Study||29
191578|NCT00661362|469958|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|247
191579|NCT00661362|469959|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|254
191580|NCT00661362|469958|P2|STARTED|Overall Study|Randomized and treated|287
191581|NCT00661362|469959|P1|STARTED|Overall Study|Randomized and treated|283
191582|NCT00661388|469975|P1|NOT COMPLETED|Overall Study||24
191583|NCT00661388|469975|P1|COMPLETED|Overall Study||51
191584|NCT00661388|469975|P1|STARTED|Overall Study||75
191585|NCT00661427|469998|P2|NOT COMPLETED|Overall Study||7
191586|NCT00661427|469999|P1|NOT COMPLETED|Overall Study||5
191587|NCT00661427|469998|P2|COMPLETED|Overall Study||19
191588|NCT00661427|469999|P1|COMPLETED|Overall Study||30
191589|NCT00661427|469998|P2|STARTED|Overall Study||26
191590|NCT00661427|469999|P1|STARTED|Overall Study||35
191591|NCT00661453|470005|P1|NOT COMPLETED|Overall Study||13
191592|NCT00661453|470005|P1|COMPLETED|Overall Study||25
191593|NCT00661453|470005|P1|STARTED|Overall Study||38
191594|NCT00661479|470013|P4|NOT COMPLETED|Overall Study||0
191595|NCT00661479|470014|P3|NOT COMPLETED|Overall Study||0
191596|NCT00661479|470015|P2|NOT COMPLETED|Overall Study||0
191597|NCT00661479|470016|P1|NOT COMPLETED|Overall Study||0
191598|NCT00661479|470013|P4|COMPLETED|Overall Study||3
191599|NCT00661479|470014|P3|COMPLETED|Overall Study||3
191600|NCT00661479|470015|P2|COMPLETED|Overall Study||3
191601|NCT00661479|470016|P1|COMPLETED|Overall Study||12
191602|NCT00661479|470013|P4|STARTED|Overall Study||3
191603|NCT00661479|470014|P3|STARTED|Overall Study||3
191604|NCT00661479|470015|P2|STARTED|Overall Study||3
191605|NCT00661479|470016|P1|STARTED|Overall Study||12
191606|NCT00661492|470031|P2|NOT COMPLETED|Overall Study||29
191607|NCT00661492|470032|P1|NOT COMPLETED|Overall Study||68
191608|NCT00661492|470031|P2|COMPLETED|Overall Study||11
191609|NCT00661492|470032|P1|COMPLETED|Overall Study||7
191610|NCT00661492|470031|P2|STARTED|Overall Study||40
191611|NCT00661492|470032|P1|STARTED|Overall Study||75
191612|NCT00661505|470052|P1|NOT COMPLETED|Overall Study||30
191613|NCT00661505|470052|P1|COMPLETED|Overall Study||102
191614|NCT00661505|470052|P1|STARTED|Overall Study||132
191615|NCT00661531|470078|P1|NOT COMPLETED|Overall Study||3
191616|NCT00661531|470078|P1|COMPLETED|Overall Study||8
191617|NCT00661531|470078|P1|STARTED|Overall Study||11
191618|NCT00661544|470083|P1|NOT COMPLETED|Overall Study||0
191619|NCT00661544|470083|P1|COMPLETED|Overall Study||48
191620|NCT00661544|470083|P1|STARTED|Overall Study||48
191621|NCT00661570|470087|P1|NOT COMPLETED|Overall Study||0
191622|NCT00661570|470087|P1|COMPLETED|Overall Study||26
191623|NCT00661570|470087|P1|STARTED|Overall Study||26
191624|NCT00661583|470097|P3|NOT COMPLETED|Overall Study||0
191625|NCT00661583|470098|P2|NOT COMPLETED|Overall Study||0
191626|NCT00661583|470099|P1|NOT COMPLETED|Overall Study||0
191627|NCT00661583|470097|P3|COMPLETED|Overall Study||10
191628|NCT00661583|470098|P2|COMPLETED|Overall Study||10
191629|NCT00661583|470099|P1|COMPLETED|Overall Study||10
191630|NCT00661583|470097|P3|STARTED|Overall Study||10
191631|NCT00661583|470098|P2|STARTED|Overall Study||10
191632|NCT00661583|470099|P1|STARTED|Overall Study||10
191633|NCT00661609|470116|P1|NOT COMPLETED|Overall Study||41
191634|NCT00661609|470116|P1|COMPLETED|Overall Study|Treatment is not for a fixed period and continues until a discontinuation criterion is met.|0
191635|NCT00661609|470116|P1|STARTED|Overall Study|All dosed patients|41
191636|NCT00661622|470125|P2|NOT COMPLETED|Overall Study||0
191637|NCT00661622|470126|P1|NOT COMPLETED|Overall Study||1
191638|NCT00661622|470125|P2|COMPLETED|Overall Study||27
191639|NCT00661622|470126|P1|COMPLETED|Overall Study||25
191640|NCT00661622|470125|P2|STARTED|Overall Study||27
191641|NCT00661622|470126|P1|STARTED|Overall Study||26
191642|NCT00661661|470142|P2|NOT COMPLETED|Overall Study||39
191643|NCT00661661|470143|P1|NOT COMPLETED|Overall Study||140
191644|NCT00661661|470142|P2|COMPLETED|Overall Study||66
191645|NCT00661661|470143|P1|COMPLETED|Overall Study||242
191646|NCT00661661|470142|P2|STARTED|Overall Study||105
191647|NCT00661661|470143|P1|STARTED|Overall Study||382
191648|NCT00661674|470217|P6|NOT COMPLETED|Overall Study||0
191649|NCT00661674|470218|P5|NOT COMPLETED|Overall Study||0
191650|NCT00661674|470219|P4|NOT COMPLETED|Overall Study||0
191651|NCT00661674|470220|P3|NOT COMPLETED|Overall Study||0
191652|NCT00661674|470221|P2|NOT COMPLETED|Overall Study||0
191653|NCT00661674|470222|P1|NOT COMPLETED|Overall Study||0
191654|NCT00661674|470217|P6|COMPLETED|Overall Study|Participant 9 completed sequence 6|1
191655|NCT00661674|470218|P5|COMPLETED|Overall Study|Participants 6 & 8 completed sequence 5|2
191656|NCT00661674|470219|P4|COMPLETED|Overall Study|Participant 5 completed sequence 4|1
191657|NCT00661674|470220|P3|COMPLETED|Overall Study|Participants 4 & 7 completed sequence 3|2
191658|NCT00661674|470221|P2|COMPLETED|Overall Study|Participants 2 & 3 completed sequence 2|2
191659|NCT00661674|470222|P1|COMPLETED|Overall Study|Participants 1 & 10 completed sequence 1|2
191660|NCT00661674|470217|P6|STARTED|Overall Study|Participant 9 was assigned to sequence 6|1
191661|NCT00661674|470218|P5|STARTED|Overall Study|Participants 6 & 8 were assigned to sequence 5|2
191662|NCT00661674|470219|P4|STARTED|Overall Study|Participant 5 was assigned to sequence 4|1
191663|NCT00661674|470220|P3|STARTED|Overall Study|Participants 4 & 7 were assigned to sequence 3|2
191664|NCT00661674|470221|P2|STARTED|Overall Study|Participants 2 & 3 were assigned to sequence 2|2
191665|NCT00661674|470222|P1|STARTED|Overall Study|Participants 1 & 10 were assigned to sequence 1|2
191666|NCT00661687|470233|P1|NOT COMPLETED|Overall Study||15
191667|NCT00661687|470233|P1|COMPLETED|Overall Study|Number indicates number of subjects successfully completing study.|189
191668|NCT00661687|470233|P1|STARTED|Overall Study|Contralateral study design, numbers indicate number of subjects.|204
191669|NCT00661713|470251|P8|NOT COMPLETED|Overall Study||11
191670|NCT00661713|470252|P7|NOT COMPLETED|Overall Study||64
191671|NCT00661713|470253|P6|NOT COMPLETED|Overall Study||37
191672|NCT00661713|470254|P5|NOT COMPLETED|Overall Study||20
191673|NCT00661713|470255|P4|NOT COMPLETED|Overall Study||28
191674|NCT00661713|470256|P3|NOT COMPLETED|Overall Study||17
191675|NCT00661713|470257|P2|NOT COMPLETED|Overall Study||39
191676|NCT00661713|470258|P1|NOT COMPLETED|Overall Study||16
191677|NCT00661713|470251|P8|COMPLETED|Overall Study||117
191678|NCT00661713|470252|P7|COMPLETED|Overall Study||309
191679|NCT00661713|470253|P6|COMPLETED|Overall Study||216
191680|NCT00661713|470254|P5|COMPLETED|Overall Study||107
191681|NCT00661713|470255|P4|COMPLETED|Overall Study||219
191682|NCT00661713|470256|P3|COMPLETED|Overall Study||111
191683|NCT00661713|470257|P2|COMPLETED|Overall Study||208
191684|NCT00661713|470258|P1|COMPLETED|Overall Study||112
191685|NCT00661713|470251|P8|STARTED|Overall Study||128
191686|NCT00661713|470252|P7|STARTED|Overall Study||373
191687|NCT00661713|470253|P6|STARTED|Overall Study||253
191688|NCT00661713|470254|P5|STARTED|Overall Study||127
191689|NCT00661713|470255|P4|STARTED|Overall Study||247
191690|NCT00661713|470256|P3|STARTED|Overall Study||128
191691|NCT00661713|470257|P2|STARTED|Overall Study||247
191692|NCT00661713|470258|P1|STARTED|Overall Study||128
191693|NCT00661726|470348|P1|NOT COMPLETED|Overall Study||1
191694|NCT00661726|470348|P1|COMPLETED|Overall Study||5
191695|NCT00661726|470348|P1|STARTED|Overall Study||6
191696|NCT00661778|470363|P1|NOT COMPLETED|Overall Study||50
191697|NCT00661778|470363|P1|COMPLETED|Overall Study||0
191698|NCT00661778|470363|P1|STARTED|Overall Study||50
191699|NCT00661830|470372|P2|NOT COMPLETED|Overall Study||42
191700|NCT00661830|470373|P1|NOT COMPLETED|Overall Study||40
191701|NCT00661830|470372|P2|COMPLETED|Overall Study||6
191702|NCT00661830|470373|P1|COMPLETED|Overall Study||9
191703|NCT00661830|470372|P2|STARTED|Overall Study||48
191704|NCT00661830|470373|P1|STARTED|Overall Study||49
191705|NCT00661895|470387|P2|NOT COMPLETED|Overall Study||0
191706|NCT00661895|470388|P1|NOT COMPLETED|Overall Study||0
191707|NCT00661895|470387|P2|COMPLETED|Overall Study||50
191708|NCT00661895|470388|P1|COMPLETED|Overall Study||49
191709|NCT00661895|470387|P2|STARTED|Overall Study||50
191710|NCT00661895|470388|P1|STARTED|Overall Study||49
191711|NCT00661960|470397|P3|NOT COMPLETED|Overall Study||1
191712|NCT00661960|470398|P2|NOT COMPLETED|Overall Study||3
191713|NCT00661960|470399|P1|NOT COMPLETED|Overall Study||0
191714|NCT00661960|470397|P3|COMPLETED|Overall Study||9
191715|NCT00661960|470398|P2|COMPLETED|Overall Study||7
191716|NCT00661960|470399|P1|COMPLETED|Overall Study||5
191717|NCT00661960|470397|P3|STARTED|Overall Study||10
191718|NCT00661960|470398|P2|STARTED|Overall Study||10
191719|NCT00661960|470399|P1|STARTED|Overall Study||5
191720|NCT00661999|470410|P3|NOT COMPLETED|Overall Study||57
191721|NCT00661999|470411|P2|NOT COMPLETED|Overall Study||50
191722|NCT00661999|470412|P1|NOT COMPLETED|Overall Study||59
191723|NCT00661999|470410|P3|COMPLETED|Overall Study||106
191724|NCT00661999|470411|P2|COMPLETED|Overall Study||113
191725|NCT00661999|470412|P1|COMPLETED|Overall Study||105
191726|NCT00661999|470410|P3|STARTED|Overall Study||163
191727|NCT00661999|470411|P2|STARTED|Overall Study||163
191728|NCT00661999|470412|P1|STARTED|Overall Study||164
191729|NCT00662012|470465|P1|NOT COMPLETED|Overall Study||87
191730|NCT00662012|470465|P1|COMPLETED|Overall Study||327
191731|NCT00662012|470465|P1|STARTED|Overall Study||414
191732|NCT00662025|470470|P1|NOT COMPLETED|Overall Study||63
191733|NCT00662025|470470|P1|COMPLETED|Overall Study||0
191734|NCT00662025|470470|P1|STARTED|Overall Study|All 63 participants were included in Full Analysis Set population.|63
191735|NCT00662038|470490|P1|NOT COMPLETED|Overall Study||631
191736|NCT00662038|470490|P1|COMPLETED|Overall Study||427
191737|NCT00662038|470490|P1|STARTED|Overall Study||1058
191738|NCT00662129|470494|P1|NOT COMPLETED|Overall Study||3
191739|NCT00662129|470494|P1|COMPLETED|Overall Study||47
191740|NCT00662129|470494|P1|STARTED|Overall Study||50
191741|NCT00662155|470508|P4|NOT COMPLETED|Overall Study||4
191742|NCT00662155|470509|P3|NOT COMPLETED|Overall Study||7
191743|NCT00662155|470510|P2|NOT COMPLETED|Overall Study||5
191744|NCT00662155|470511|P1|NOT COMPLETED|Overall Study||3
191745|NCT00662155|470508|P4|COMPLETED|Overall Study||14
191746|NCT00662155|470509|P3|COMPLETED|Overall Study||13
191747|NCT00662155|470510|P2|COMPLETED|Overall Study||15
191748|NCT00662155|470511|P1|COMPLETED|Overall Study||13
191749|NCT00662155|470508|P4|STARTED|Overall Study||18
191750|NCT00662155|470509|P3|STARTED|Overall Study||20
191751|NCT00662155|470510|P2|STARTED|Overall Study||20
191752|NCT00662155|470511|P1|STARTED|Overall Study||16
191753|NCT00662207|470525|P1|NOT COMPLETED|Overall Study||0
191754|NCT00662207|470525|P1|COMPLETED|Overall Study||3
191755|NCT00662207|470525|P1|STARTED|Overall Study||3
191756|NCT00662311|470535|P3|NOT COMPLETED|Overall Study||0
191757|NCT00662311|470536|P2|NOT COMPLETED|Overall Study||0
191758|NCT00662311|470537|P1|NOT COMPLETED|Overall Study||1
191759|NCT00662311|470535|P3|COMPLETED|Overall Study||0
191760|NCT00662311|470536|P2|COMPLETED|Overall Study||0
191761|NCT00662311|470537|P1|COMPLETED|Overall Study||4
191762|NCT00662311|470535|P3|STARTED|Overall Study||0
191763|NCT00662311|470536|P2|STARTED|Overall Study||0
191764|NCT00662311|470537|P1|STARTED|Overall Study||5
191765|NCT00662363|470562|P2|NOT COMPLETED|Overall Study||10
191766|NCT00662363|470563|P1|NOT COMPLETED|Overall Study||11
191767|NCT00662363|470562|P2|COMPLETED|Overall Study|one subject died before receiving any study med 2 subjects withdrew before taking any study med|22
191768|NCT00662363|470563|P1|COMPLETED|Overall Study|1 subject withdrew before taking any study medication|21
191769|NCT00662363|470562|P2|STARTED|Overall Study||32
191770|NCT00662363|470563|P1|STARTED|Overall Study||32
191771|NCT00662389|470571|P1|NOT COMPLETED|Overall Study||0
191772|NCT00662389|470571|P1|COMPLETED|Overall Study||4
191773|NCT00662389|470571|P1|STARTED|Overall Study||4
191774|NCT00662532|470576|P2|NOT COMPLETED|Overall Study||2
191775|NCT00662532|470577|P1|NOT COMPLETED|Overall Study||0
191776|NCT00662532|470576|P2|COMPLETED|Overall Study||20
191777|NCT00662532|470577|P1|COMPLETED|Overall Study||22
191778|NCT00662532|470576|P2|STARTED|Overall Study||22
191779|NCT00662532|470577|P1|STARTED|Overall Study||22
191780|NCT00662545|470589|P2|NOT COMPLETED|Overall Study||0
191781|NCT00662545|470590|P1|NOT COMPLETED|Overall Study||0
191782|NCT00662545|470589|P2|COMPLETED|Overall Study||5
191783|NCT00662545|470590|P1|COMPLETED|Overall Study||5
191784|NCT00662545|470589|P2|STARTED|Overall Study||5
191785|NCT00662545|470590|P1|STARTED|Overall Study||5
191786|NCT00662558|470606|P2|NOT COMPLETED|Overall Study||110
191787|NCT00662558|470607|P1|NOT COMPLETED|Overall Study||56
191788|NCT00662558|470606|P2|COMPLETED|Overall Study||294
191789|NCT00662558|470607|P1|COMPLETED|Overall Study||342
191790|NCT00662558|470606|P2|Received Treatment|Overall Study||396
191791|NCT00662558|470607|P1|Received Treatment|Overall Study||396
191792|NCT00662558|470606|P2|STARTED|Overall Study||404
191793|NCT00662558|470607|P1|STARTED|Overall Study||398
191794|NCT00662649|470643|P5|NOT COMPLETED|Extension Study (Month 24 to 60)||29
191795|NCT00662649|470644|P4|NOT COMPLETED|Extension Study (Month 24 to 60)||33
191796|NCT00662649|470645|P3|NOT COMPLETED|Extension Study (Month 24 to 60)||0
191797|NCT00662649|470646|P2|NOT COMPLETED|Extension Study (Month 24 to 60)||41
191798|NCT00662649|470647|P1|NOT COMPLETED|Extension Study (Month 24 to 60)||44
191799|NCT00662649|470643|P5|COMPLETED|Extension Study (Month 24 to 60)||126
191800|NCT00662649|470644|P4|COMPLETED|Extension Study (Month 24 to 60)||112
191801|NCT00662649|470645|P3|COMPLETED|Extension Study (Month 24 to 60)||0
191802|NCT00662649|470646|P2|COMPLETED|Extension Study (Month 24 to 60)||290
191803|NCT00662649|470647|P1|COMPLETED|Extension Study (Month 24 to 60)|"completed refers to patients that completed extension study in different time points."|245
191804|NCT00662649|470643|P5|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||13
191805|NCT00662649|470644|P4|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||11
191806|NCT00662649|470645|P3|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||0
191807|NCT00662649|470646|P2|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||32
191808|NCT00662649|470647|P1|From Beginning of Core at Month 54|Extension Study (Month 24 to 60)||31
191809|NCT00662649|470643|P5|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||67
191810|NCT00662649|470644|P4|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||58
191811|NCT00662649|470645|P3|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||0
191812|NCT00662649|470646|P2|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||152
191813|NCT00662649|470647|P1|From Beginning of Core at Month 48|Extension Study (Month 24 to 60)||125
191814|NCT00662649|470643|P5|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||136
191815|NCT00662649|470644|P4|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||120
191816|NCT00662649|470645|P3|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||0
191817|NCT00662649|470646|P2|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||301
191818|NCT00662649|470647|P1|From Beginning of Core at Month 42|Extension Study (Month 24 to 60)||254
191819|NCT00662649|470643|P5|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||145
191820|NCT00662649|470644|P4|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||130
191821|NCT00662649|470645|P3|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||0
191822|NCT00662649|470646|P2|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||311
191823|NCT00662649|470647|P1|From Beginning of Core at Month 36|Extension Study (Month 24 to 60)||270
191824|NCT00662649|470643|P5|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||152
191825|NCT00662649|470644|P4|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||136
191826|NCT00662649|470645|P3|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||0
191827|NCT00662649|470646|P2|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||324
191828|NCT00662649|470647|P1|From Beginning of Core at Month 30|Extension Study (Month 24 to 60)||276
191829|NCT00662649|470643|P5|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||155
191830|NCT00662649|470644|P4|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||145
191831|NCT00662649|470645|P3|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||0
191832|NCT00662649|470646|P2|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||331
191833|NCT00662649|470647|P1|From Beginning of Core at Month 24|Extension Study (Month 24 to 60)||289
191834|NCT00662649|470643|P5|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||154
191835|NCT00662649|470644|P4|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||145
191836|NCT00662649|470645|P3|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||0
191837|NCT00662649|470646|P2|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||330
191838|NCT00662649|470647|P1|Extension Intent to Treat Population|Extension Study (Month 24 to 60)||287
191839|NCT00662649|470643|P5|STARTED|Extension Study (Month 24 to 60)||155
191840|NCT00662649|470644|P4|STARTED|Extension Study (Month 24 to 60)||145
191841|NCT00662649|470645|P3|STARTED|Extension Study (Month 24 to 60)|This reporting group is used only for core study|0
191842|NCT00662649|470646|P2|STARTED|Extension Study (Month 24 to 60)||331
191843|NCT00662649|470647|P1|STARTED|Extension Study (Month 24 to 60)||289
191844|NCT00662649|470643|P5|NOT COMPLETED|Core Study (24 Months)||0
191845|NCT00662649|470644|P4|NOT COMPLETED|Core Study (24 Months)||0
191846|NCT00662649|470645|P3|NOT COMPLETED|Core Study (24 Months)||86
191847|NCT00662649|470646|P2|NOT COMPLETED|Core Study (24 Months)||56
191848|NCT00662649|470647|P1|NOT COMPLETED|Core Study (24 Months)||97
191849|NCT00662649|470643|P5|COMPLETED|Core Study (24 Months)||0
191850|NCT00662649|470644|P4|COMPLETED|Core Study (24 Months)||0
191851|NCT00662649|470645|P3|COMPLETED|Core Study (24 Months)||332
191852|NCT00662649|470646|P2|COMPLETED|Core Study (24 Months)||369
191853|NCT00662649|470647|P1|COMPLETED|Core Study (24 Months)||332
191854|NCT00662649|470643|P5|Intent to Treat (ITT)|Core Study (24 Months)||0
191855|NCT00662649|470644|P4|Intent to Treat (ITT)|Core Study (24 Months)||0
191856|NCT00662649|470645|P3|Intent to Treat (ITT)|Core Study (24 Months)||418
191857|NCT00662649|470646|P2|Intent to Treat (ITT)|Core Study (24 Months)||425
191858|NCT00662649|470647|P1|Intent to Treat (ITT)|Core Study (24 Months)||429
191859|NCT00662649|470643|P5|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
191860|NCT00662649|470644|P4|STARTED|Core Study (24 Months)|This reporting group is used only in extension study.|0
191861|NCT00662649|470645|P3|STARTED|Core Study (24 Months)||418
191862|NCT00662649|470646|P2|STARTED|Core Study (24 Months)||425
191863|NCT00662649|470647|P1|STARTED|Core Study (24 Months)||429
191864|NCT00662675|470687|P2|NOT COMPLETED|Overall Study||0
191865|NCT00662675|470688|P1|NOT COMPLETED|Overall Study||0
191866|NCT00662675|470687|P2|COMPLETED|Overall Study||20
191867|NCT00662675|470688|P1|COMPLETED|Overall Study||20
191868|NCT00662675|470687|P2|STARTED|Overall Study||20
191869|NCT00662675|470688|P1|STARTED|Overall Study||20
191870|NCT00662818|470700|P2|NOT COMPLETED|Period 2 (6 Weeks)||12
191871|NCT00662818|470701|P1|NOT COMPLETED|Period 2 (6 Weeks)||13
191872|NCT00662818|470700|P2|COMPLETED|Period 2 (6 Weeks)||41
191873|NCT00662818|470701|P1|COMPLETED|Period 2 (6 Weeks)||38
191874|NCT00662818|470700|P2|STARTED|Period 2 (6 Weeks)||53
191875|NCT00662818|470701|P1|STARTED|Period 2 (6 Weeks)||51
191876|NCT00662818|470700|P2|NOT COMPLETED|Wash-Out (14 Days)||5
191877|NCT00662818|470701|P1|NOT COMPLETED|Wash-Out (14 Days)||5
191878|NCT00662818|470700|P2|COMPLETED|Wash-Out (14 Days)||53
191879|NCT00662818|470701|P1|COMPLETED|Wash-Out (14 Days)||51
191880|NCT00662818|470700|P2|STARTED|Wash-Out (14 Days)||58
191881|NCT00662818|470701|P1|STARTED|Wash-Out (14 Days)||56
191882|NCT00662818|470700|P2|NOT COMPLETED|Period 1 (6 Weeks)||23
191883|NCT00662818|470701|P1|NOT COMPLETED|Period 1 (6 Weeks)||28
191884|NCT00662818|470700|P2|COMPLETED|Period 1 (6 Weeks)||58
191885|NCT00662818|470701|P1|COMPLETED|Period 1 (6 Weeks)||56
191886|NCT00662818|470700|P2|Treated|Period 1 (6 Weeks)||58
191887|NCT00662818|470701|P1|Treated|Period 1 (6 Weeks)||56
191888|NCT00662818|470700|P2|STARTED|Period 1 (6 Weeks)||81
191889|NCT00662818|470701|P1|STARTED|Period 1 (6 Weeks)||84
191890|NCT00662831|470725|P2|NOT COMPLETED|Overall Study||59
191891|NCT00662831|470726|P1|NOT COMPLETED|Overall Study||106
191892|NCT00662831|470725|P2|COMPLETED|Overall Study||33
191893|NCT00662831|470726|P1|COMPLETED|Overall Study||78
191894|NCT00662831|470725|P2|STARTED|Overall Study||92
191895|NCT00662831|470726|P1|STARTED|Overall Study||184
191896|NCT00662857|470764|P2|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
191897|NCT00662857|470765|P1|NOT COMPLETED|Lispro Dosing Period (1 Day)||0
191898|NCT00662857|470764|P2|COMPLETED|Lispro Dosing Period (1 Day)||14
191899|NCT00662857|470765|P1|COMPLETED|Lispro Dosing Period (1 Day)||12
191900|NCT00662857|470764|P2|STARTED|Lispro Dosing Period (1 Day)||14
191901|NCT00662857|470765|P1|STARTED|Lispro Dosing Period (1 Day)||12
191902|NCT00662857|470764|P2|NOT COMPLETED|Washout 2 (3 - 14 Days)||0
191903|NCT00662857|470765|P1|NOT COMPLETED|Washout 2 (3 - 14 Days)||1
191904|NCT00662857|470764|P2|COMPLETED|Washout 2 (3 - 14 Days)||14
191905|NCT00662857|470765|P1|COMPLETED|Washout 2 (3 - 14 Days)||12
191906|NCT00662857|470764|P2|STARTED|Washout 2 (3 - 14 Days)||14
191907|NCT00662857|470765|P1|STARTED|Washout 2 (3 - 14 Days)||13
191908|NCT00662857|470764|P2|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
191909|NCT00662857|470765|P1|NOT COMPLETED|TI Dosing Period 2 (1 Day)||0
191910|NCT00662857|470764|P2|COMPLETED|TI Dosing Period 2 (1 Day)||14
191911|NCT00662857|470765|P1|COMPLETED|TI Dosing Period 2 (1 Day)||13
191912|NCT00662857|470764|P2|STARTED|TI Dosing Period 2 (1 Day)||14
191913|NCT00662857|470765|P1|STARTED|TI Dosing Period 2 (1 Day)||13
191914|NCT00662857|470764|P2|NOT COMPLETED|Washout 1 (3 - 14 Days)||2
191915|NCT00662857|470765|P1|NOT COMPLETED|Washout 1 (3 - 14 Days)||0
191916|NCT00662857|470764|P2|COMPLETED|Washout 1 (3 - 14 Days)||14
191917|NCT00662857|470765|P1|COMPLETED|Washout 1 (3 - 14 Days)||13
191918|NCT00662857|470764|P2|STARTED|Washout 1 (3 - 14 Days)||16
191919|NCT00662857|470765|P1|STARTED|Washout 1 (3 - 14 Days)||13
191920|NCT00662857|470764|P2|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
191921|NCT00662857|470765|P1|NOT COMPLETED|TI Dosing Period 1 (1 Day)||0
191922|NCT00662857|470764|P2|COMPLETED|TI Dosing Period 1 (1 Day)||16
191923|NCT00662857|470765|P1|COMPLETED|TI Dosing Period 1 (1 Day)||13
191924|NCT00662857|470764|P2|STARTED|TI Dosing Period 1 (1 Day)||16
191925|NCT00662857|470765|P1|STARTED|TI Dosing Period 1 (1 Day)||13
191926|NCT00662909|470781|P3|NOT COMPLETED|Overall Study||53
191927|NCT00662909|470782|P2|NOT COMPLETED|Overall Study||59
191928|NCT00662909|470783|P1|NOT COMPLETED|Overall Study||69
191929|NCT00662909|470781|P3|COMPLETED|Overall Study||380
191930|NCT00662909|470782|P2|COMPLETED|Overall Study||383
191931|NCT00662909|470783|P1|COMPLETED|Overall Study||385
191932|NCT00662909|470781|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|296
191933|NCT00662909|470782|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|312
191934|NCT00662909|470783|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|325
191935|NCT00662909|470781|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|412
191936|NCT00662909|470782|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|425
191937|NCT00662909|470783|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|433
191938|NCT00662909|470781|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
191939|NCT00662909|470782|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|442
191940|NCT00662909|470783|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|453
191941|NCT00662909|470781|P3|STARTED|Overall Study||433
191942|NCT00662909|470782|P2|STARTED|Overall Study||442
191943|NCT00662909|470783|P1|STARTED|Overall Study||454
191944|NCT00663026|470884|P3|NOT COMPLETED|Overall Study||4
191945|NCT00663026|470885|P2|NOT COMPLETED|Overall Study||6
191946|NCT00663026|470886|P1|NOT COMPLETED|Overall Study||2
191947|NCT00663026|470884|P3|COMPLETED|Overall Study||27
191948|NCT00663026|470885|P2|COMPLETED|Overall Study||23
191949|NCT00663026|470886|P1|COMPLETED|Overall Study||17
191950|NCT00663026|470884|P3|STARTED|Overall Study||31
191951|NCT00663026|470885|P2|STARTED|Overall Study||29
191952|NCT00663026|470886|P1|STARTED|Overall Study||19
191953|NCT00663052|470908|P2|NOT COMPLETED|Overall Study||10
191954|NCT00663052|470909|P1|NOT COMPLETED|Overall Study||12
191955|NCT00663052|470908|P2|COMPLETED|Overall Study||127
191956|NCT00663052|470909|P1|COMPLETED|Overall Study||124
191957|NCT00663052|470908|P2|STARTED|Overall Study||137
191958|NCT00663052|470909|P1|STARTED|Overall Study||136
191959|NCT00663117|470991|P2|NOT COMPLETED|Overall Study||0
191960|NCT00663117|470992|P1|NOT COMPLETED|Overall Study||1
191961|NCT00663117|470991|P2|COMPLETED|Overall Study||20
191962|NCT00663117|470992|P1|COMPLETED|Overall Study|One patient in placebo flared and was unblinded and crossed over to active drug|19
191963|NCT00663117|470991|P2|STARTED|Overall Study||20
191964|NCT00663117|470992|P1|STARTED|Overall Study||20
191965|NCT00663169|471006|P2|NOT COMPLETED|Overall Study||0
191966|NCT00663169|471007|P1|NOT COMPLETED|Overall Study||0
191967|NCT00663169|471006|P2|COMPLETED|Overall Study||3
191968|NCT00663169|471007|P1|COMPLETED|Overall Study||3
191969|NCT00663169|471006|P2|STARTED|Overall Study||3
191970|NCT00663169|471007|P1|STARTED|Overall Study||3
191971|NCT00663208|471037|P7|NOT COMPLETED|Follow-up Period||1
191972|NCT00663208|471038|P6|NOT COMPLETED|Follow-up Period||0
191973|NCT00663208|471039|P5|NOT COMPLETED|Follow-up Period||0
191974|NCT00663208|471040|P4|NOT COMPLETED|Follow-up Period||2
191975|NCT00663208|471041|P3|NOT COMPLETED|Follow-up Period||3
191976|NCT00663208|471042|P2|NOT COMPLETED|Follow-up Period||0
191977|NCT00663208|471043|P1|NOT COMPLETED|Follow-up Period||3
191978|NCT00663208|471037|P7|COMPLETED|Follow-up Period||5
191979|NCT00663208|471038|P6|COMPLETED|Follow-up Period||4
191980|NCT00663208|471039|P5|COMPLETED|Follow-up Period||4
191981|NCT00663208|471040|P4|COMPLETED|Follow-up Period||2
191982|NCT00663208|471041|P3|COMPLETED|Follow-up Period||1
191983|NCT00663208|471042|P2|COMPLETED|Follow-up Period||3
191984|NCT00663208|471043|P1|COMPLETED|Follow-up Period||1
191985|NCT00663208|471037|P7|STARTED|Follow-up Period||6
191986|NCT00663208|471038|P6|STARTED|Follow-up Period||4
191987|NCT00663208|471039|P5|STARTED|Follow-up Period||4
191988|NCT00663208|471040|P4|STARTED|Follow-up Period||4
191989|NCT00663208|471041|P3|STARTED|Follow-up Period||4
191990|NCT00663208|471042|P2|STARTED|Follow-up Period||3
191991|NCT00663208|471043|P1|STARTED|Follow-up Period||4
191992|NCT00663208|471037|P7|NOT COMPLETED|Treatment Period||0
191993|NCT00663208|471038|P6|NOT COMPLETED|Treatment Period||0
191994|NCT00663208|471039|P5|NOT COMPLETED|Treatment Period||0
191995|NCT00663208|471040|P4|NOT COMPLETED|Treatment Period||0
191996|NCT00663208|471041|P3|NOT COMPLETED|Treatment Period||0
191997|NCT00663208|471042|P2|NOT COMPLETED|Treatment Period||1
191998|NCT00663208|471043|P1|NOT COMPLETED|Treatment Period||0
191999|NCT00663208|471037|P7|COMPLETED|Treatment Period||6
192000|NCT00663208|471038|P6|COMPLETED|Treatment Period||4
192001|NCT00663208|471039|P5|COMPLETED|Treatment Period||4
192002|NCT00663208|471040|P4|COMPLETED|Treatment Period||4
192003|NCT00663208|471041|P3|COMPLETED|Treatment Period||4
192004|NCT00663208|471042|P2|COMPLETED|Treatment Period||3
192005|NCT00663208|471043|P1|COMPLETED|Treatment Period||4
192006|NCT00663208|471037|P7|STARTED|Treatment Period||6
192007|NCT00663208|471038|P6|STARTED|Treatment Period||4
192008|NCT00663208|471039|P5|STARTED|Treatment Period||4
192009|NCT00663208|471040|P4|STARTED|Treatment Period||4
192010|NCT00663208|471041|P3|STARTED|Treatment Period||4
192011|NCT00663208|471042|P2|STARTED|Treatment Period||4
192012|NCT00663208|471043|P1|STARTED|Treatment Period||4
192013|NCT00663234|471193|P1|NOT COMPLETED|Overall Study||1
192014|NCT00663234|471193|P1|COMPLETED|Overall Study||27
192015|NCT00663234|471193|P1|Dose Increased to 20 mg at Week 8|Overall Study||10
192016|NCT00663234|471193|P1|STARTED|Overall Study||28
192017|NCT00663260|471222|P3|NOT COMPLETED|Overall Study||16
192018|NCT00663260|471223|P2|NOT COMPLETED|Overall Study||11
192019|NCT00663260|471224|P1|NOT COMPLETED|Overall Study||21
192020|NCT00663260|471222|P3|COMPLETED|Overall Study||69
192021|NCT00663260|471223|P2|COMPLETED|Overall Study||72
192022|NCT00663260|471224|P1|COMPLETED|Overall Study||63
192023|NCT00663260|471222|P3|STARTED|Overall Study||85
192024|NCT00663260|471223|P2|STARTED|Overall Study||83
192025|NCT00663260|471224|P1|STARTED|Overall Study||84
192026|NCT00657267|471238|P1|NOT COMPLETED|Overall Study||54
192027|NCT00657267|471238|P1|COMPLETED|Overall Study||4
192028|NCT00657267|471238|P1|STARTED|Overall Study||58
192029|NCT00657280|471246|P1|NOT COMPLETED|Overall Study||0
192030|NCT00657280|471246|P1|COMPLETED|Overall Study||16
192031|NCT00657280|471246|P1|STARTED|Overall Study||16
192032|NCT00657358|471250|P1|NOT COMPLETED|Overall Study||6
192033|NCT00657358|471250|P1|COMPLETED|Overall Study||16
192034|NCT00657358|471250|P1|STARTED|Overall Study||22
192035|NCT00657371|471258|P1|NOT COMPLETED|Overall Study||39
192036|NCT00657371|471258|P1|COMPLETED|Overall Study||249
192037|NCT00657371|471258|P1|STARTED|Overall Study||288
192038|NCT00657553|471265|P2|NOT COMPLETED|Overall Study||5
192039|NCT00657553|471266|P1|NOT COMPLETED|Overall Study||5
192040|NCT00657553|471265|P2|COMPLETED|Overall Study||0
192041|NCT00657553|471266|P1|COMPLETED|Overall Study||0
192042|NCT00657553|471265|P2|STARTED|Overall Study||5
192043|NCT00657553|471266|P1|STARTED|Overall Study||5
192044|NCT00657657|471272|P1|NOT COMPLETED|Overall Study||0
192045|NCT00657657|471272|P1|COMPLETED|Overall Study||29
192046|NCT00657657|471272|P1|STARTED|Overall Study||29
192047|NCT00657709|471285|P5|NOT COMPLETED|Overall Study||33
192048|NCT00657709|471286|P4|NOT COMPLETED|Overall Study||14
192049|NCT00657709|471287|P3|NOT COMPLETED|Overall Study||28
192050|NCT00657709|471288|P2|NOT COMPLETED|Overall Study||33
192051|NCT00657709|471289|P1|NOT COMPLETED|Overall Study||23
192052|NCT00657709|471285|P5|COMPLETED|Overall Study||457
192053|NCT00657709|471286|P4|COMPLETED|Overall Study||645
192054|NCT00657709|471287|P3|COMPLETED|Overall Study||792
192055|NCT00657709|471288|P2|COMPLETED|Overall Study||795
192056|NCT00657709|471289|P1|COMPLETED|Overall Study||810
192057|NCT00657709|471285|P5|STARTED|Overall Study||490
192058|NCT00657709|471286|P4|STARTED|Overall Study||659
192059|NCT00657709|471287|P3|STARTED|Overall Study||820
192060|NCT00657709|471288|P2|STARTED|Overall Study||828
192061|NCT00657709|471289|P1|STARTED|Overall Study||833
192062|NCT00663403|471330|P1|NOT COMPLETED|Overall Study||0
192063|NCT00663403|471330|P1|COMPLETED|Overall Study||8
192064|NCT00663403|471330|P1|STARTED|Overall Study||8
192065|NCT00664742|471340|P1|NOT COMPLETED|Overall Study||126
192066|NCT00664742|471340|P1|COMPLETED|Overall Study||481
192067|NCT00664742|471340|P1|STARTED|Overall Study||607
192068|NCT00665002|471345|P1|NOT COMPLETED|Overall Study||12
192069|NCT00665002|471345|P1|COMPLETED|Overall Study||4
192070|NCT00665002|471345|P1|STARTED|Overall Study||16
192071|NCT00665132|471350|P1|NOT COMPLETED|Overall Study||0
192072|NCT00665132|471350|P1|COMPLETED|Overall Study||10
192073|NCT00665132|471350|P1|STARTED|Overall Study||10
192074|NCT00665353|471357|P1|NOT COMPLETED|Study Step 2||14
192075|NCT00665353|471357|P1|COMPLETED|Study Step 2||2
192076|NCT00665353|471357|P1|STARTED|Study Step 2||16
192077|NCT00665353|471357|P1|NOT COMPLETED|Study Step 1||3
192078|NCT00665353|471357|P1|COMPLETED|Study Step 1||16
192079|NCT00665353|471357|P1|STARTED|Study Step 1||19
192080|NCT00665366|471369|P2|NOT COMPLETED|Overall Study||59
192081|NCT00665366|471370|P1|NOT COMPLETED|Overall Study||58
192082|NCT00665366|471369|P2|COMPLETED|Overall Study||122
192083|NCT00665366|471370|P1|COMPLETED|Overall Study||131
192084|NCT00665366|471369|P2|STARTED|Overall Study|Participants randomized|181
192085|NCT00665366|471370|P1|STARTED|Overall Study|Participants randomized|189
192086|NCT00665431|471401|P3|NOT COMPLETED|Overall Study||24
192087|NCT00665431|471402|P2|NOT COMPLETED|Overall Study||57
192088|NCT00665431|471403|P1|NOT COMPLETED|Overall Study||40
192089|NCT00665431|471401|P3|COMPLETED|Overall Study||98
192090|NCT00665431|471402|P2|COMPLETED|Overall Study||188
192091|NCT00665431|471403|P1|COMPLETED|Overall Study||203
192092|NCT00665431|471401|P3|STARTED|Overall Study|Safety population|122
192093|NCT00665431|471402|P2|STARTED|Overall Study|Safety population|245
192094|NCT00665431|471403|P1|STARTED|Overall Study|Safety population|243
192095|NCT00665444|471444|P1|NOT COMPLETED|Overall Study||2
192096|NCT00665444|471444|P1|COMPLETED|Overall Study||1
192097|NCT00665444|471444|P1|STARTED|Overall Study||3
192098|NCT00665470|471451|P2|NOT COMPLETED|Overall Study||0
192099|NCT00665470|471452|P1|NOT COMPLETED|Overall Study||0
192100|NCT00665470|471451|P2|COMPLETED|Overall Study||0
192101|NCT00665470|471452|P1|COMPLETED|Overall Study||10
192102|NCT00665470|471451|P2|STARTED|Overall Study||0
192103|NCT00665470|471452|P1|STARTED|Overall Study||10
192104|NCT00665626|471462|P2|NOT COMPLETED|Overall Study||22
192105|NCT00665626|471463|P1|NOT COMPLETED|Overall Study||10
192106|NCT00665626|471462|P2|COMPLETED|Overall Study|Participants completed the study|124
192107|NCT00665626|471463|P1|COMPLETED|Overall Study|Participants completed the study|63
192108|NCT00665626|471462|P2|STARTED|Overall Study|Participants randomized|146
192109|NCT00665626|471463|P1|STARTED|Overall Study|Participants randomized|73
192110|NCT00665704|471529|P1|NOT COMPLETED|Overall Study||0
192111|NCT00665704|471529|P1|COMPLETED|Overall Study||9
192112|NCT00665704|471529|P1|STARTED|Overall Study||9
192113|NCT00665847|471534|P1|NOT COMPLETED|Overall Study||25
192114|NCT00665847|471534|P1|COMPLETED|Overall Study||76
192115|NCT00665847|471534|P1|STARTED|Overall Study||101
192116|NCT00665925|471550|P4|NOT COMPLETED|Overall Study||21
192117|NCT00665925|471551|P3|NOT COMPLETED|Overall Study||26
192118|NCT00665925|471552|P2|NOT COMPLETED|Overall Study||17
192119|NCT00665925|471553|P1|NOT COMPLETED|Overall Study||15
192120|NCT00665925|471550|P4|COMPLETED|Overall Study|Participants completed the study|131
192121|NCT00665925|471551|P3|COMPLETED|Overall Study|Participants completed the study|126
192122|NCT00665925|471552|P2|COMPLETED|Overall Study|Participants completed the study|59
192123|NCT00665925|471553|P1|COMPLETED|Overall Study|Participants completed the study|62
192124|NCT00665925|471550|P4|STARTED|Overall Study|Participants randomized|152
192125|NCT00665925|471551|P3|STARTED|Overall Study|Participants randomized|152
192126|NCT00665925|471552|P2|STARTED|Overall Study|Participants randomized|76
192127|NCT00665925|471553|P1|STARTED|Overall Study|Participants randomized|77
192128|NCT00666029|471966|P2|NOT COMPLETED|Overall Study||0
192129|NCT00666029|471967|P1|NOT COMPLETED|Overall Study||1
192130|NCT00666029|471966|P2|COMPLETED|Overall Study||20
192131|NCT00666029|471967|P1|COMPLETED|Overall Study||19
192132|NCT00666029|471966|P2|STARTED|Overall Study||20
192133|NCT00666029|471967|P1|STARTED|Overall Study||20
192134|NCT00666198|471975|P1|NOT COMPLETED|Overall Study||33
192135|NCT00666198|471975|P1|COMPLETED|Overall Study||3304
192136|NCT00666198|471975|P1|STARTED|Overall Study||3337
192137|NCT00666211|471990|P2|NOT COMPLETED|Overall Study||38
192138|NCT00666211|471991|P1|NOT COMPLETED|Overall Study||20
192139|NCT00666211|471990|P2|COMPLETED|Overall Study||18
192140|NCT00666211|471991|P1|COMPLETED|Overall Study||22
192141|NCT00666211|471990|P2|STARTED|Overall Study||56
192142|NCT00666211|471991|P1|STARTED|Overall Study||42
192143|NCT00666224|472011|P2|NOT COMPLETED|Open-Label||85
192144|NCT00666224|472012|P1|NOT COMPLETED|Open-Label||35
192145|NCT00666224|472011|P2|COMPLETED|Open-Label||126
192146|NCT00666224|472012|P1|COMPLETED|Open-Label||163
192147|NCT00666224|472011|P2|STARTED|Open-Label||211
192148|NCT00666224|472012|P1|STARTED|Open-Label|454 participants took at least one dose of GA including 45 who didn't continue into the OL.|198
192149|NCT00666224|472011|P2|NOT COMPLETED|Double-Blind||27
192150|NCT00666224|472012|P1|NOT COMPLETED|Double-Blind||45
192151|NCT00666224|472011|P2|COMPLETED|Double-Blind|55 completed 3 years treatment, 109 converted to CDMS, 47 switched to OL as per DMC|211
192152|NCT00666224|472012|P1|COMPLETED|Double-Blind|78 completed 3 years treatment, 66 converted to CDMS, 54 switched to OL as per DMC|198
192153|NCT00666224|472011|P2|STARTED|Double-Blind||238
192154|NCT00666224|472012|P1|STARTED|Double-Blind||243
192155|NCT00666263|472029|P2|NOT COMPLETED|End of Study Visit||0
192156|NCT00666263|472030|P1|NOT COMPLETED|End of Study Visit||0
192157|NCT00666263|472029|P2|COMPLETED|End of Study Visit||22
192158|NCT00666263|472030|P1|COMPLETED|End of Study Visit||22
192240|NCT00666588|472374|P3|STARTED|Overall Study||6
192159|NCT00666263|472029|P2|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
192160|NCT00666263|472030|P1|STARTED|End of Study Visit|End of Study Visit done on all 22 randomized regardless of participation in Study Parts|22
192161|NCT00666263|472029|P2|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||1
192162|NCT00666263|472030|P1|NOT COMPLETED|Study Part 5 (Stabilization Phase 3)||0
192163|NCT00666263|472029|P2|COMPLETED|Study Part 5 (Stabilization Phase 3)||20
192164|NCT00666263|472030|P1|COMPLETED|Study Part 5 (Stabilization Phase 3)||21
192165|NCT00666263|472029|P2|STARTED|Study Part 5 (Stabilization Phase 3)||21
192166|NCT00666263|472030|P1|STARTED|Study Part 5 (Stabilization Phase 3)||21
192167|NCT00666263|472029|P2|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||0
192168|NCT00666263|472030|P1|NOT COMPLETED|Study Part 4 (Cross-over Period 2)||1
192169|NCT00666263|472029|P2|COMPLETED|Study Part 4 (Cross-over Period 2)||21
192170|NCT00666263|472030|P1|COMPLETED|Study Part 4 (Cross-over Period 2)||21
192171|NCT00666263|472029|P2|STARTED|Study Part 4 (Cross-over Period 2)||21
192172|NCT00666263|472030|P1|STARTED|Study Part 4 (Cross-over Period 2)||22
192173|NCT00666263|472029|P2|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
192174|NCT00666263|472030|P1|NOT COMPLETED|Study Part 3 (Stabilization Phase 2)||0
192175|NCT00666263|472029|P2|COMPLETED|Study Part 3 (Stabilization Phase 2)||21
192176|NCT00666263|472030|P1|COMPLETED|Study Part 3 (Stabilization Phase 2)||22
192177|NCT00666263|472029|P2|STARTED|Study Part 3 (Stabilization Phase 2)||21
192178|NCT00666263|472030|P1|STARTED|Study Part 3 (Stabilization Phase 2)||22
192179|NCT00666263|472029|P2|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
192180|NCT00666263|472030|P1|NOT COMPLETED|Study Part 2 (Cross-over Period 1)||0
192181|NCT00666263|472029|P2|COMPLETED|Study Part 2 (Cross-over Period 1)||21
192182|NCT00666263|472030|P1|COMPLETED|Study Part 2 (Cross-over Period 1)||22
192183|NCT00666263|472029|P2|STARTED|Study Part 2 (Cross-over Period 1)||21
192184|NCT00666263|472030|P1|STARTED|Study Part 2 (Cross-over Period 1)||22
192185|NCT00666263|472029|P2|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||1
192186|NCT00666263|472030|P1|NOT COMPLETED|Study Part 1 (Stabilization Phase 1)||0
192187|NCT00666263|472029|P2|COMPLETED|Study Part 1 (Stabilization Phase 1)||21
192188|NCT00666263|472030|P1|COMPLETED|Study Part 1 (Stabilization Phase 1)||22
192189|NCT00666263|472029|P2|STARTED|Study Part 1 (Stabilization Phase 1)||22
192190|NCT00666263|472030|P1|STARTED|Study Part 1 (Stabilization Phase 1)||22
192191|NCT00666276|472172|P1|NOT COMPLETED|Overall Study||34
192192|NCT00666276|472172|P1|COMPLETED|Overall Study||970
192193|NCT00666276|472172|P1|STARTED|Overall Study||1004
192194|NCT00666328|472196|P1|NOT COMPLETED|Overall Study||5
192283|NCT00666835|472527|P2|NOT COMPLETED|Overall Study||22
192284|NCT00666835|472528|P1|NOT COMPLETED|Overall Study||53
192195|NCT00666328|472196|P1|COMPLETED|Overall Study|30/35 completed the study within the Safety population; 28/33 completed within the mITT population.|30
192196|NCT00666328|472196|P1|Modified Intent To Treat (mITT)|Overall Study|mITT population: participants dosed and in whom all inclusion and no exclusion criteria were met|33
192197|NCT00666328|472196|P1|STARTED|Overall Study|Safety population: participants dosed with study drug (primary population for Safety analyses)|35
192198|NCT00666406|472209|P2|NOT COMPLETED|Second PK Infusion||0
192199|NCT00666406|472210|P1|NOT COMPLETED|Second PK Infusion||0
192200|NCT00666406|472209|P2|COMPLETED|Second PK Infusion||3
192201|NCT00666406|472210|P1|COMPLETED|Second PK Infusion||6
192202|NCT00666406|472209|P2|STARTED|Second PK Infusion||3
192203|NCT00666406|472210|P1|STARTED|Second PK Infusion||6
192204|NCT00666406|472209|P2|NOT COMPLETED|First PK Infusion||0
192205|NCT00666406|472210|P1|NOT COMPLETED|First PK Infusion||0
192206|NCT00666406|472209|P2|COMPLETED|First PK Infusion||3
192207|NCT00666406|472210|P1|COMPLETED|First PK Infusion||6
192208|NCT00666406|472209|P2|STARTED|First PK Infusion||3
192209|NCT00666406|472210|P1|STARTED|First PK Infusion||6
192210|NCT00666458|472287|P2|NOT COMPLETED|Overall Study||24
192211|NCT00666458|472288|P1|NOT COMPLETED|Overall Study||38
192212|NCT00666458|472287|P2|COMPLETED|Overall Study|Completed 18 weeks of treatment|374
192213|NCT00666458|472288|P1|COMPLETED|Overall Study|Completed 18 weeks of treatment|365
192214|NCT00666458|472287|P2|STARTED|Overall Study|Randomized and treated|398
192215|NCT00666458|472288|P1|STARTED|Overall Study|Randomized and treated|403
192216|NCT00666536|472302|P2|NOT COMPLETED|Overall Study||37
192217|NCT00666536|472303|P1|NOT COMPLETED|Overall Study||33
192218|NCT00666536|472302|P2|COMPLETED|Overall Study||322
192219|NCT00666536|472303|P1|COMPLETED|Overall Study||336
192220|NCT00666536|472302|P2|STARTED|Overall Study||359
192221|NCT00666536|472303|P1|STARTED|Overall Study||369
192222|NCT00666562|472322|P3|NOT COMPLETED|Overall Study||0
192223|NCT00666562|472323|P2|NOT COMPLETED|Overall Study||2
192224|NCT00666562|472324|P1|NOT COMPLETED|Overall Study||0
192225|NCT00666562|472322|P3|COMPLETED|Overall Study||10
192226|NCT00666562|472323|P2|COMPLETED|Overall Study||8
192227|NCT00666562|472324|P1|COMPLETED|Overall Study||11
192228|NCT00666562|472322|P3|STARTED|Overall Study||10
192229|NCT00666562|472323|P2|STARTED|Overall Study||10
192230|NCT00666562|472324|P1|STARTED|Overall Study||11
192231|NCT00666588|472373|P4|NOT COMPLETED|Overall Study||2
192232|NCT00666588|472374|P3|NOT COMPLETED|Overall Study||0
192233|NCT00666588|472375|P2|NOT COMPLETED|Overall Study||0
192234|NCT00666588|472376|P1|NOT COMPLETED|Overall Study||4
192235|NCT00666588|472373|P4|COMPLETED|Overall Study||20
192236|NCT00666588|472374|P3|COMPLETED|Overall Study||6
192237|NCT00666588|472375|P2|COMPLETED|Overall Study||6
192238|NCT00666588|472376|P1|COMPLETED|Overall Study||14
192239|NCT00666588|472373|P4|STARTED|Overall Study||22
192241|NCT00666588|472375|P2|STARTED|Overall Study||6
192242|NCT00666588|472376|P1|STARTED|Overall Study||18
192243|NCT00666666|472390|P1|NOT COMPLETED|Overall Study||0
192244|NCT00666666|472390|P1|COMPLETED|Overall Study||55
192245|NCT00666666|472390|P1|STARTED|Overall Study||55
192246|NCT00666679|472398|P2|NOT COMPLETED|Second Intervention||1
192247|NCT00666679|472399|P1|NOT COMPLETED|Second Intervention||1
192248|NCT00666679|472398|P2|COMPLETED|Second Intervention||64
192249|NCT00666679|472399|P1|COMPLETED|Second Intervention||61
192250|NCT00666679|472398|P2|STARTED|Second Intervention||65
192251|NCT00666679|472399|P1|STARTED|Second Intervention||62
192252|NCT00666679|472398|P2|NOT COMPLETED|Washout Period of 1 Week||2
192253|NCT00666679|472399|P1|NOT COMPLETED|Washout Period of 1 Week||0
192254|NCT00666679|472398|P2|COMPLETED|Washout Period of 1 Week||65
192255|NCT00666679|472399|P1|COMPLETED|Washout Period of 1 Week||62
192256|NCT00666679|472398|P2|STARTED|Washout Period of 1 Week||67
192257|NCT00666679|472399|P1|STARTED|Washout Period of 1 Week||62
192258|NCT00666679|472398|P2|NOT COMPLETED|First Intervention||1
192259|NCT00666679|472399|P1|NOT COMPLETED|First Intervention||4
192260|NCT00666679|472398|P2|COMPLETED|First Intervention||67
192261|NCT00666679|472399|P1|COMPLETED|First Intervention||62
192262|NCT00666679|472398|P2|STARTED|First Intervention||68
192263|NCT00666679|472399|P1|STARTED|First Intervention||66
192264|NCT00666705|472419|P1|NOT COMPLETED|Overall Study||1
192265|NCT00666705|472419|P1|COMPLETED|Overall Study||17
192266|NCT00666705|472419|P1|Raltegravir + Maraviroc (Days 12 - 14)|Overall Study|400 mg Raltegravir every 12 hours plus 300 mg Maraviroc every 12 hours (AM doses only on Day 14)|17
192267|NCT00666705|472419|P1|Maraviroc Alone (Days 6 - 11)|Overall Study|300 mg Maraviroc every 12 hours|18
192268|NCT00666705|472419|P1|Washout (Days 4 - 5)|Overall Study||18
192269|NCT00666705|472419|P1|Raltegravir Alone (Days 1 - 3)|Overall Study|400 mg Raltegravir every 12 hours (AM dose on Day 3)|18
192270|NCT00666705|472419|P1|STARTED|Overall Study||18
192271|NCT00666718|472438|P2|NOT COMPLETED|Overall Study||18
192272|NCT00666718|472439|P1|NOT COMPLETED|Overall Study||12
192273|NCT00666718|472438|P2|COMPLETED|Overall Study||169
192274|NCT00666718|472439|P1|COMPLETED|Overall Study||175
192275|NCT00666718|472438|P2|STARTED|Overall Study||187
192276|NCT00666718|472439|P1|STARTED|Overall Study||187
192277|NCT00666757|472467|P2|NOT COMPLETED|Overall Study||97
192278|NCT00666757|472468|P1|NOT COMPLETED|Overall Study||100
192279|NCT00666757|472467|P2|COMPLETED|Overall Study||281
192280|NCT00666757|472468|P1|COMPLETED|Overall Study||272
192281|NCT00666757|472467|P2|STARTED|Overall Study||378
192282|NCT00666757|472468|P1|STARTED|Overall Study||372
192285|NCT00666835|472527|P2|COMPLETED|Overall Study||142
192286|NCT00666835|472528|P1|COMPLETED|Overall Study||261
192287|NCT00666835|472527|P2|STARTED|Overall Study||164
192288|NCT00666835|472528|P1|STARTED|Overall Study||314
192289|NCT00666848|472539|P3|NOT COMPLETED|Overall Study||0
192290|NCT00666848|472540|P2|NOT COMPLETED|Overall Study||0
192291|NCT00666848|472541|P1|NOT COMPLETED|Overall Study||0
192292|NCT00666848|472539|P3|COMPLETED|Overall Study|finished Aim 3|7
192293|NCT00666848|472540|P2|COMPLETED|Overall Study|finished Aim 1|9
192294|NCT00666848|472541|P1|COMPLETED|Overall Study|finished Aim 2|8
192295|NCT00666848|472539|P3|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|7
192296|NCT00666848|472540|P2|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|9
192297|NCT00666848|472541|P1|STARTED|Overall Study|15 didn't meet inclusion criteria. 3 withdrew before randomized. 1 withdrawn before randomized.|8
192298|NCT00666926|472552|P16|NOT COMPLETED|Overall Study||8
192299|NCT00666926|472553|P15|NOT COMPLETED|Overall Study||7
192300|NCT00666926|472554|P14|NOT COMPLETED|Overall Study||4
192301|NCT00666926|472555|P13|NOT COMPLETED|Overall Study||3
192302|NCT00666926|472556|P12|NOT COMPLETED|Overall Study||33
192303|NCT00666926|472557|P11|NOT COMPLETED|Overall Study||6
192304|NCT00666926|472558|P10|NOT COMPLETED|Overall Study||10
192305|NCT00666926|472559|P9|NOT COMPLETED|Overall Study||3
192306|NCT00666926|472560|P8|NOT COMPLETED|Overall Study||1
192307|NCT00666926|472561|P7|NOT COMPLETED|Overall Study||4
192308|NCT00666926|472562|P6|NOT COMPLETED|Overall Study||4
192309|NCT00666926|472563|P5|NOT COMPLETED|Overall Study||3
192310|NCT00666926|472564|P4|NOT COMPLETED|Overall Study||4
192311|NCT00666926|472565|P3|NOT COMPLETED|Overall Study||3
192312|NCT00666926|472566|P2|NOT COMPLETED|Overall Study||4
192313|NCT00666926|472567|P1|NOT COMPLETED|Overall Study||2
192314|NCT00666926|472552|P16|COMPLETED|Overall Study||0
192315|NCT00666926|472553|P15|COMPLETED|Overall Study||0
192316|NCT00666926|472554|P14|COMPLETED|Overall Study||0
192317|NCT00666926|472555|P13|COMPLETED|Overall Study||0
192318|NCT00666926|472556|P12|COMPLETED|Overall Study||0
192319|NCT00666926|472557|P11|COMPLETED|Overall Study||0
192320|NCT00666926|472558|P10|COMPLETED|Overall Study||0
192321|NCT00666926|472559|P9|COMPLETED|Overall Study||0
192322|NCT00666926|472560|P8|COMPLETED|Overall Study||0
192323|NCT00666926|472561|P7|COMPLETED|Overall Study||0
192324|NCT00666926|472562|P6|COMPLETED|Overall Study||0
192325|NCT00666926|472563|P5|COMPLETED|Overall Study||0
192326|NCT00666926|472564|P4|COMPLETED|Overall Study||0
192327|NCT00666926|472565|P3|COMPLETED|Overall Study||0
192328|NCT00666926|472566|P2|COMPLETED|Overall Study||0
192329|NCT00666926|472567|P1|COMPLETED|Overall Study||0
192330|NCT00666926|472552|P16|STARTED|Overall Study||8
192331|NCT00666926|472553|P15|STARTED|Overall Study||7
192332|NCT00666926|472554|P14|STARTED|Overall Study||4
192333|NCT00666926|472555|P13|STARTED|Overall Study||3
192334|NCT00666926|472556|P12|STARTED|Overall Study||33
192335|NCT00666926|472557|P11|STARTED|Overall Study||6
192336|NCT00666926|472558|P10|STARTED|Overall Study||10
192337|NCT00666926|472559|P9|STARTED|Overall Study||3
192338|NCT00666926|472560|P8|STARTED|Overall Study||1
192339|NCT00666926|472561|P7|STARTED|Overall Study||4
192340|NCT00666926|472562|P6|STARTED|Overall Study||4
192341|NCT00666926|472563|P5|STARTED|Overall Study||3
192342|NCT00666926|472564|P4|STARTED|Overall Study||4
192343|NCT00666926|472565|P3|STARTED|Overall Study||3
192344|NCT00666926|472566|P2|STARTED|Overall Study||4
192345|NCT00666926|472567|P1|STARTED|Overall Study||2
192346|NCT00666965|472862|P4|NOT COMPLETED|Overall Study||15
192347|NCT00666965|472863|P3|NOT COMPLETED|Overall Study||2
192348|NCT00666965|472864|P2|NOT COMPLETED|Overall Study||4
192349|NCT00666965|472865|P1|NOT COMPLETED|Overall Study||3
192350|NCT00666965|472862|P4|COMPLETED|Overall Study||42
192351|NCT00666965|472863|P3|COMPLETED|Overall Study||56
192352|NCT00666965|472864|P2|COMPLETED|Overall Study||53
192353|NCT00666965|472865|P1|COMPLETED|Overall Study||55
192354|NCT00666965|472862|P4|STARTED|Overall Study||57
192355|NCT00666965|472863|P3|STARTED|Overall Study||58
192356|NCT00666965|472864|P2|STARTED|Overall Study||57
192357|NCT00666965|472865|P1|STARTED|Overall Study||58
192358|NCT00666978|472897|P2|NOT COMPLETED|Overall Study||83
192359|NCT00666978|472898|P1|NOT COMPLETED|Overall Study||78
192360|NCT00666978|472897|P2|COMPLETED|Overall Study||187
192361|NCT00666978|472898|P1|COMPLETED|Overall Study||192
192362|NCT00666978|472897|P2|STARTED|Overall Study||270
192363|NCT00666978|472898|P1|STARTED|Overall Study||270
192364|NCT00667095|472909|P2|NOT COMPLETED|Overall Study||1
192365|NCT00667095|472910|P1|NOT COMPLETED|Overall Study||0
192366|NCT00667095|472909|P2|COMPLETED|Overall Study||9
192367|NCT00667095|472910|P1|COMPLETED|Overall Study||11
192368|NCT00667095|472909|P2|STARTED|Overall Study||10
192369|NCT00667095|472910|P1|STARTED|Overall Study||11
192370|NCT00660660|472928|P2|NOT COMPLETED|Overall Study||9
192371|NCT00660660|472929|P1|NOT COMPLETED|Overall Study||5
192372|NCT00660660|472928|P2|COMPLETED|Overall Study|Number of completed patients is based on randomized population (133) minus withdrawals (9).|124
192373|NCT00660660|472929|P1|COMPLETED|Overall Study|Number of completed patients is based on randomized population (143) minus withdrawals (5).|138
192374|NCT00660660|472928|P2|Met Criteria for MITT Population|Overall Study||125
192375|NCT00660660|472929|P1|Met Criteria for MITT Population|Overall Study||137
192376|NCT00660660|472928|P2|STARTED|Overall Study|Randomized|133
192377|NCT00660660|472929|P1|STARTED|Overall Study|Randomized|143
192378|NCT00660699|473027|P1|NOT COMPLETED|Overall Study||2
192379|NCT00660699|473027|P1|COMPLETED|Overall Study||48
192380|NCT00660699|473027|P1|STARTED|Overall Study||50
192381|NCT00667186|473043|P2|NOT COMPLETED|Overall Study||0
192382|NCT00667186|473044|P1|NOT COMPLETED|Overall Study||0
192383|NCT00667186|473043|P2|COMPLETED|Overall Study||4880
192384|NCT00667186|473044|P1|COMPLETED|Overall Study||4692
192385|NCT00667186|473043|P2|STARTED|Overall Study||4880
192386|NCT00667186|473044|P1|STARTED|Overall Study||4692
192387|NCT00667225|473054|P2|NOT COMPLETED|Overall Study||1
192388|NCT00667225|473055|P1|NOT COMPLETED|Overall Study||1
192389|NCT00667225|473054|P2|COMPLETED|Overall Study||12
192390|NCT00667225|473055|P1|COMPLETED|Overall Study||15
192391|NCT00667225|473054|P2|STARTED|Overall Study||13
192392|NCT00667225|473055|P1|STARTED|Overall Study||16
192393|NCT00667251|473065|P2|NOT COMPLETED|Overall Study||95
192394|NCT00667251|473066|P1|NOT COMPLETED|Overall Study||70
192395|NCT00667251|473065|P2|COMPLETED|Overall Study||231
192396|NCT00667251|473066|P1|COMPLETED|Overall Study||256
192397|NCT00667251|473065|P2|Not Started|Overall Study||1
192398|NCT00667251|473066|P1|Not Started|Overall Study||4
192399|NCT00667251|473065|P2|Monotherapy|Overall Study||232
192400|NCT00667251|473066|P1|Monotherapy|Overall Study||225
192401|NCT00667251|473065|P2|Combination Rx|Overall Study||325
192402|NCT00667251|473066|P1|Combination Rx|Overall Study||322
192403|NCT00667251|473065|P2|STARTED|Overall Study||326
192404|NCT00667251|473066|P1|STARTED|Overall Study||326
192405|NCT00667277|473090|P1|NOT COMPLETED|Overall Study||2
192406|NCT00667277|473090|P1|COMPLETED|Overall Study||11
192407|NCT00667277|473090|P1|STARTED|Overall Study||13
192408|NCT00667342|473098|P3|NOT COMPLETED|Overall Study||9
192409|NCT00667342|473099|P2|NOT COMPLETED|Overall Study||0
192410|NCT00667342|473100|P1|NOT COMPLETED|Overall Study||14
192411|NCT00667342|473098|P3|COMPLETED|Overall Study||3
192412|NCT00667342|473099|P2|COMPLETED|Overall Study||0
192413|NCT00667342|473100|P1|COMPLETED|Overall Study||17
192414|NCT00667342|473098|P3|STARTED|Overall Study||12
192415|NCT00667342|473099|P2|STARTED|Overall Study||0
192416|NCT00667342|473100|P1|STARTED|Overall Study||31
192417|NCT00667355|473138|P1|NOT COMPLETED|Overall Study||11
192418|NCT00667355|473138|P1|COMPLETED|Overall Study||30
192419|NCT00667355|473138|P1|STARTED|Overall Study||41
192420|NCT00667368|473162|P2|NOT COMPLETED|Overall Study||172
192421|NCT00667368|473163|P1|NOT COMPLETED|Overall Study||200
192422|NCT00667368|473162|P2|COMPLETED|Overall Study||511
192423|NCT00667368|473163|P1|COMPLETED|Overall Study||482
192424|NCT00667368|473162|P2|STARTED|Overall Study||683
192425|NCT00667368|473163|P1|STARTED|Overall Study||682
192426|NCT00667381|473173|P2|NOT COMPLETED|Overall Study||0
192427|NCT00667381|473174|P1|NOT COMPLETED|Overall Study||0
192428|NCT00667381|473173|P2|COMPLETED|Overall Study||503
192429|NCT00667381|473174|P1|COMPLETED|Overall Study||501
192430|NCT00667381|473173|P2|STARTED|Overall Study||503
192431|NCT00667381|473174|P1|STARTED|Overall Study||501
192432|NCT00667394|473190|P2|NOT COMPLETED|Overall Study||0
192433|NCT00667394|473191|P1|NOT COMPLETED|Overall Study||4
192434|NCT00667394|473190|P2|COMPLETED|Overall Study||1
192435|NCT00667394|473191|P1|COMPLETED|Overall Study||37
192436|NCT00667394|473190|P2|STARTED|Overall Study||1
192437|NCT00667394|473191|P1|STARTED|Overall Study||41
192438|NCT00667420|473199|P1|NOT COMPLETED|Overall Study||10
192439|NCT00667420|473199|P1|COMPLETED|Overall Study||7
192440|NCT00667420|473199|P1|Completion of Surgery/Re-staging|Overall Study||11
192441|NCT00667420|473199|P1|Completion of Pre-operative EOX-P|Overall Study||15
192442|NCT00667420|473199|P1|STARTED|Overall Study||17
192443|NCT00667446|473209|P2|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||1
192444|NCT00667446|473210|P1|NOT COMPLETED|Safety Follow-up Period (12 Weeks)||0
192445|NCT00667446|473209|P2|COMPLETED|Safety Follow-up Period (12 Weeks)||25
192446|NCT00667446|473210|P1|COMPLETED|Safety Follow-up Period (12 Weeks)||28
192447|NCT00667446|473209|P2|STARTED|Safety Follow-up Period (12 Weeks)||26
192448|NCT00667446|473210|P1|STARTED|Safety Follow-up Period (12 Weeks)||28
192449|NCT00667446|473209|P2|NOT COMPLETED|Treatment Period (36 Months)||25
192450|NCT00667446|473210|P1|NOT COMPLETED|Treatment Period (36 Months)||23
192451|NCT00667446|473209|P2|COMPLETED|Treatment Period (36 Months)||13
192452|NCT00667446|473210|P1|COMPLETED|Treatment Period (36 Months)||11
192453|NCT00667446|473209|P2|STARTED|Treatment Period (36 Months)||38
192454|NCT00667446|473210|P1|STARTED|Treatment Period (36 Months)||34
192455|NCT00667459|473234|P2|NOT COMPLETED|Overall Study||45
192456|NCT00667459|473235|P1|NOT COMPLETED|Overall Study||8
192457|NCT00667459|473234|P2|COMPLETED|Overall Study||220
192458|NCT00667459|473235|P1|COMPLETED|Overall Study||272
192459|NCT00667459|473234|P2|STARTED|Overall Study||265
192460|NCT00667459|473235|P1|STARTED|Overall Study||280
192461|NCT00667563|473275|P1|NOT COMPLETED|Overall Study||24
192462|NCT00667563|473275|P1|COMPLETED|Overall Study||126
192463|NCT00667563|473275|P1|STARTED|Overall Study||150
192464|NCT00667576|473290|P5|NOT COMPLETED|Overall Study||1
192465|NCT00667576|473291|P4|NOT COMPLETED|Overall Study||4
192466|NCT00667576|473292|P3|NOT COMPLETED|Overall Study||2
192467|NCT00667576|473293|P2|NOT COMPLETED|Overall Study||1
192468|NCT00667576|473294|P1|NOT COMPLETED|Overall Study||2
192469|NCT00667576|473290|P5|COMPLETED|Overall Study||29
192470|NCT00667576|473291|P4|COMPLETED|Overall Study||27
192471|NCT00667576|473292|P3|COMPLETED|Overall Study||29
192472|NCT00667576|473293|P2|COMPLETED|Overall Study||30
192473|NCT00667576|473294|P1|COMPLETED|Overall Study||28
192474|NCT00667576|473290|P5|STARTED|Overall Study||30
192475|NCT00667576|473291|P4|STARTED|Overall Study||31
192476|NCT00667576|473292|P3|STARTED|Overall Study||31
192477|NCT00667576|473293|P2|STARTED|Overall Study||31
192478|NCT00667576|473294|P1|STARTED|Overall Study||30
192479|NCT00667589|473345|P4|NOT COMPLETED|Overall Study||1
192480|NCT00667589|473346|P3|NOT COMPLETED|Overall Study||3
192481|NCT00667589|473347|P2|NOT COMPLETED|Overall Study||0
192482|NCT00667589|473348|P1|NOT COMPLETED|Overall Study||1
192483|NCT00667589|473345|P4|COMPLETED|Overall Study||1
192484|NCT00667589|473346|P3|COMPLETED|Overall Study||0
192485|NCT00667589|473347|P2|COMPLETED|Overall Study||0
192486|NCT00667589|473348|P1|COMPLETED|Overall Study||0
192487|NCT00667589|473345|P4|STARTED|Overall Study||2
192488|NCT00667589|473346|P3|STARTED|Overall Study||3
192489|NCT00667589|473347|P2|STARTED|Overall Study||0
192490|NCT00667589|473348|P1|STARTED|Overall Study||1
192491|NCT00667602|473361|P3|NOT COMPLETED|Overall Study||18
192492|NCT00667602|473362|P2|NOT COMPLETED|Overall Study||15
192493|NCT00667602|473363|P1|NOT COMPLETED|Overall Study||8
192494|NCT00667602|473361|P3|COMPLETED|Overall Study||197
192495|NCT00667602|473362|P2|COMPLETED|Overall Study||213
192496|NCT00667602|473363|P1|COMPLETED|Overall Study||211
192497|NCT00667602|473361|P3|STARTED|Overall Study||215
192498|NCT00667602|473362|P2|STARTED|Overall Study||228
192499|NCT00667602|473363|P1|STARTED|Overall Study||219
192500|NCT00667693|473411|P2|NOT COMPLETED|Overall Study||2
192501|NCT00667693|473412|P1|NOT COMPLETED|Overall Study||0
192502|NCT00667693|473411|P2|COMPLETED|Overall Study||50
192503|NCT00667693|473412|P1|COMPLETED|Overall Study||49
192504|NCT00667693|473411|P2|STARTED|Overall Study||52
192505|NCT00667693|473412|P1|STARTED|Overall Study||49
192506|NCT00667732|473420|P3|NOT COMPLETED|Extension (26 Weeks)||0
192507|NCT00667732|473421|P2|NOT COMPLETED|Extension (26 Weeks)||0
192508|NCT00667732|473422|P1|NOT COMPLETED|Extension (26 Weeks)||0
192509|NCT00667732|473420|P3|COMPLETED|Extension (26 Weeks)||17
192510|NCT00667732|473421|P2|COMPLETED|Extension (26 Weeks)||14
192511|NCT00667732|473422|P1|COMPLETED|Extension (26 Weeks)||0
192512|NCT00667732|473420|P3|STARTED|Extension (26 Weeks)||17
192513|NCT00667732|473421|P2|STARTED|Extension (26 Weeks)||14
192514|NCT00667732|473422|P1|STARTED|Extension (26 Weeks)||0
192515|NCT00667732|473420|P3|NOT COMPLETED|Randomization (24 Weeks)||0
192516|NCT00667732|473421|P2|NOT COMPLETED|Randomization (24 Weeks)||1
192517|NCT00667732|473422|P1|NOT COMPLETED|Randomization (24 Weeks)||0
192518|NCT00667732|473420|P3|COMPLETED|Randomization (24 Weeks)||17
192519|NCT00667732|473421|P2|COMPLETED|Randomization (24 Weeks)||16
192520|NCT00667732|473422|P1|COMPLETED|Randomization (24 Weeks)||0
192521|NCT00667732|473420|P3|Participants Enrolled in Substudy|Randomization (24 Weeks)||9
192522|NCT00667732|473421|P2|Participants Enrolled in Substudy|Randomization (24 Weeks)||11
192523|NCT00667732|473422|P1|Participants Enrolled in Substudy|Randomization (24 Weeks)||0
192524|NCT00667732|473420|P3|STARTED|Randomization (24 Weeks)||17
192525|NCT00667732|473421|P2|STARTED|Randomization (24 Weeks)||17
192526|NCT00667732|473422|P1|STARTED|Randomization (24 Weeks)||0
192527|NCT00667732|473420|P3|NOT COMPLETED|Run -In (8 Weeks)||0
192528|NCT00667732|473421|P2|NOT COMPLETED|Run -In (8 Weeks)||0
192529|NCT00667732|473422|P1|NOT COMPLETED|Run -In (8 Weeks)||7
192530|NCT00667732|473420|P3|COMPLETED|Run -In (8 Weeks)||0
192531|NCT00667732|473421|P2|COMPLETED|Run -In (8 Weeks)||0
192532|NCT00667732|473422|P1|COMPLETED|Run -In (8 Weeks)||34
192533|NCT00667732|473420|P3|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
192534|NCT00667732|473421|P2|Participants Enrolled in Substudy|Run -In (8 Weeks)||0
192535|NCT00667732|473422|P1|Participants Enrolled in Substudy|Run -In (8 Weeks)||20
192536|NCT00667732|473420|P3|STARTED|Run -In (8 Weeks)||0
192537|NCT00667732|473421|P2|STARTED|Run -In (8 Weeks)||0
192538|NCT00667732|473422|P1|STARTED|Run -In (8 Weeks)||41
192539|NCT00667745|473435|P2|NOT COMPLETED|Overall Study||21
192540|NCT00667745|473436|P1|NOT COMPLETED|Overall Study||25
192541|NCT00667745|473435|P2|COMPLETED|Overall Study||121
192542|NCT00667745|473436|P1|COMPLETED|Overall Study||116
192543|NCT00667745|473435|P2|STARTED|Overall Study||142
192544|NCT00667745|473436|P1|STARTED|Overall Study||141
192545|NCT00667810|473448|P4|NOT COMPLETED|Overall Study||2
192546|NCT00667810|473449|P3|NOT COMPLETED|Overall Study||222
192547|NCT00667810|473450|P2|NOT COMPLETED|Overall Study||170
192548|NCT00667810|473451|P1|NOT COMPLETED|Overall Study||167
192549|NCT00667810|473448|P4|COMPLETED|Overall Study||9
192550|NCT00667810|473449|P3|COMPLETED|Overall Study||124
192551|NCT00667810|473450|P2|COMPLETED|Overall Study||94
192552|NCT00667810|473451|P1|COMPLETED|Overall Study||102
192553|NCT00667810|473448|P4|Treated|Overall Study||11
192554|NCT00667810|473449|P3|Treated|Overall Study||344
192555|NCT00667810|473450|P2|Treated|Overall Study||263
192556|NCT00667810|473451|P1|Treated|Overall Study||267
192557|NCT00667810|473448|P4|STARTED|Overall Study||11
192558|NCT00667810|473449|P3|STARTED|Overall Study||346
192559|NCT00667810|473450|P2|STARTED|Overall Study||264
192560|NCT00667810|473451|P1|STARTED|Overall Study||269
192561|NCT00667849|473510|P2|NOT COMPLETED|Overall Study||121
192562|NCT00667849|473511|P1|NOT COMPLETED|Overall Study||108
192563|NCT00667849|473510|P2|COMPLETED|Overall Study||130
192564|NCT00667849|473511|P1|COMPLETED|Overall Study||142
192565|NCT00667849|473510|P2|STARTED|Overall Study||251
192566|NCT00667849|473511|P1|STARTED|Overall Study||250
192567|NCT00667875|473524|P3|NOT COMPLETED|Overall Study||13
192568|NCT00667875|473525|P2|NOT COMPLETED|Overall Study||11
192569|NCT00667875|473526|P1|NOT COMPLETED|Overall Study||10
192570|NCT00667875|473524|P3|COMPLETED|Overall Study||8
192571|NCT00667875|473525|P2|COMPLETED|Overall Study||10
192572|NCT00667875|473526|P1|COMPLETED|Overall Study|Subjects who dropped out during treatment are considered completed if they provide end of study data|13
192573|NCT00667875|473524|P3|STARTED|Overall Study|2 subjects had no data following randomization and were excluded from the analysis.|21
192574|NCT00667875|473525|P2|STARTED|Overall Study||21
192575|NCT00667875|473526|P1|STARTED|Overall Study|3 subjects had no data after randomization and were excluded from analysis|23
192576|NCT00667992|473536|P2|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
192577|NCT00667992|473537|P1|NOT COMPLETED|Forth Intervention 400 Mcg Twice Daily||0
192578|NCT00667992|473536|P2|COMPLETED|Forth Intervention 400 Mcg Twice Daily||35
192579|NCT00667992|473537|P1|COMPLETED|Forth Intervention 400 Mcg Twice Daily||33
192580|NCT00667992|473536|P2|STARTED|Forth Intervention 400 Mcg Twice Daily||35
192581|NCT00667992|473537|P1|STARTED|Forth Intervention 400 Mcg Twice Daily||33
192582|NCT00667992|473536|P2|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
192583|NCT00667992|473537|P1|NOT COMPLETED|Third Intervention 100 Mcg Twice Daily||1
192584|NCT00667992|473536|P2|COMPLETED|Third Intervention 100 Mcg Twice Daily||35
192585|NCT00667992|473537|P1|COMPLETED|Third Intervention 100 Mcg Twice Daily||33
192586|NCT00667992|473536|P2|STARTED|Third Intervention 100 Mcg Twice Daily||36
192587|NCT00667992|473537|P1|STARTED|Third Intervention 100 Mcg Twice Daily||34
192588|NCT00667992|473536|P2|NOT COMPLETED|Wash-out||5
192589|NCT00667992|473537|P1|NOT COMPLETED|Wash-out||7
192590|NCT00667992|473536|P2|COMPLETED|Wash-out||36
192591|NCT00667992|473537|P1|COMPLETED|Wash-out||34
192592|NCT00667992|473536|P2|STARTED|Wash-out||41
192593|NCT00667992|473537|P1|STARTED|Wash-out||41
192594|NCT00667992|473536|P2|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||4
192595|NCT00667992|473537|P1|NOT COMPLETED|Second Intervention 400 Mcg Twice Daily||3
192596|NCT00667992|473536|P2|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
192597|NCT00667992|473537|P1|COMPLETED|Second Intervention 400 Mcg Twice Daily||41
192598|NCT00667992|473536|P2|STARTED|Second Intervention 400 Mcg Twice Daily||45
192599|NCT00667992|473537|P1|STARTED|Second Intervention 400 Mcg Twice Daily||44
192600|NCT00667992|473536|P2|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
192601|NCT00667992|473537|P1|NOT COMPLETED|First Intervention 100 Mcg Twice Daily||5
192602|NCT00667992|473536|P2|COMPLETED|First Intervention 100 Mcg Twice Daily||45
192603|NCT00667992|473537|P1|COMPLETED|First Intervention 100 Mcg Twice Daily||44
192604|NCT00667992|473536|P2|STARTED|First Intervention 100 Mcg Twice Daily||50
192605|NCT00667992|473537|P1|STARTED|First Intervention 100 Mcg Twice Daily||49
192606|NCT00668200|473591|P1|NOT COMPLETED|Overall Study||3
192607|NCT00668200|473591|P1|COMPLETED|Overall Study||77
192608|NCT00668200|473591|P1|Intent to Treat (ITT)|Overall Study||80
192609|NCT00668200|473591|P1|Safety Population|Overall Study|1 patient was not included in the ITT patient was enrolled in error|81
192610|NCT00668200|473591|P1|STARTED|Overall Study||80
192611|NCT00668265|473599|P2|NOT COMPLETED|Overall Study||5
192612|NCT00668265|473600|P1|NOT COMPLETED|Overall Study||9
192613|NCT00668265|473599|P2|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
192614|NCT00668265|473600|P1|COMPLETED|Overall Study|The PI left, no records avaialable; the number of subjects who completed the study is not known|0
192615|NCT00668265|473599|P2|STARTED|Overall Study||5
192616|NCT00668265|473600|P1|STARTED|Overall Study||9
192617|NCT00668317|473608|P1|NOT COMPLETED|Overall Study||2
192618|NCT00668317|473608|P1|COMPLETED|Overall Study||3
192619|NCT00668317|473608|P1|STARTED|Overall Study||5
192620|NCT00668382|473612|P1|NOT COMPLETED|Overall Study||0
192621|NCT00668382|473612|P1|COMPLETED|Overall Study||11
192622|NCT00668382|473612|P1|STARTED|Overall Study|beginning of trial|11
192623|NCT00668395|473619|P3|NOT COMPLETED|Overall Study||1
192624|NCT00668395|473620|P2|NOT COMPLETED|Overall Study||6
192625|NCT00668395|473621|P1|NOT COMPLETED|Overall Study||6
192626|NCT00668395|473619|P3|COMPLETED|Overall Study||5
192627|NCT00668395|473620|P2|COMPLETED|Overall Study||16
192628|NCT00668395|473621|P1|COMPLETED|Overall Study||39
192629|NCT00668395|473619|P3|STARTED|Overall Study||6
192630|NCT00668395|473620|P2|STARTED|Overall Study||22
192631|NCT00668395|473621|P1|STARTED|Overall Study||45
192632|NCT00668434|473631|P2|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||11
192633|NCT00668434|473632|P1|NOT COMPLETED|Secondary Outcome Time Point (52 Weeks)||22
192634|NCT00668434|473631|P2|COMPLETED|Secondary Outcome Time Point (52 Weeks)||77
192635|NCT00668434|473632|P1|COMPLETED|Secondary Outcome Time Point (52 Weeks)||157
192636|NCT00668434|473631|P2|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|88
192637|NCT00668434|473632|P1|STARTED|Secondary Outcome Time Point (52 Weeks)|Baseline|179
192638|NCT00668434|473631|P2|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||0
192639|NCT00668434|473632|P1|NOT COMPLETED|Primary Outcome Time Point (3 Weeks)||2
192640|NCT00668434|473631|P2|COMPLETED|Primary Outcome Time Point (3 Weeks)||88
192641|NCT00668434|473632|P1|COMPLETED|Primary Outcome Time Point (3 Weeks)||179
192642|NCT00668434|473631|P2|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|88
192643|NCT00668434|473632|P1|STARTED|Primary Outcome Time Point (3 Weeks)|Baseline|181
192644|NCT00668525|473647|P3|NOT COMPLETED|Overall Study||53
192645|NCT00668525|473648|P2|NOT COMPLETED|Overall Study||93
192646|NCT00668525|473649|P1|NOT COMPLETED|Overall Study||77
192647|NCT00668525|473647|P3|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|167
192648|NCT00668525|473648|P2|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|239
192649|NCT00668525|473649|P1|COMPLETED|Overall Study|The number of patients completed are based on the Randomized Population.|248
192650|NCT00668525|473647|P3|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|220
192651|NCT00668525|473648|P2|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|332
192652|NCT00668525|473649|P1|STARTED|Overall Study|The number of patients started are based on the Randomized Population.|325
192653|NCT00668564|473660|P1|NOT COMPLETED|Overall Study||0
192654|NCT00668564|473660|P1|COMPLETED|Overall Study||18
192655|NCT00668564|473660|P1|STARTED|Overall Study||18
192656|NCT00668733|473667|P2|NOT COMPLETED|Overall Study||7
192657|NCT00668733|473668|P1|NOT COMPLETED|Overall Study||2
192658|NCT00668733|473667|P2|COMPLETED|Overall Study||83
192659|NCT00668733|473668|P1|COMPLETED|Overall Study||87
192660|NCT00668733|473667|P2|STARTED|Overall Study||90
192661|NCT00668733|473668|P1|STARTED|Overall Study||89
192662|NCT00668746|473676|P2|NOT COMPLETED|Overall Study||1
192663|NCT00668746|473677|P1|NOT COMPLETED|Overall Study||2
192664|NCT00668746|473676|P2|COMPLETED|Overall Study||11
192665|NCT00668746|473677|P1|COMPLETED|Overall Study||21
192666|NCT00668746|473676|P2|STARTED|Overall Study||12
192667|NCT00668746|473677|P1|STARTED|Overall Study||23
192668|NCT00668785|473695|P1|NOT COMPLETED|Overall Study||0
192669|NCT00668785|473695|P1|COMPLETED|Overall Study||6
192670|NCT00668785|473695|P1|STARTED|Overall Study||6
192671|NCT00668863|473699|P1|NOT COMPLETED|Overall Study||71
192672|NCT00668863|473699|P1|COMPLETED|Overall Study||0
192673|NCT00668863|473699|P1|STARTED|Overall Study||71
192674|NCT00668902|473721|P3|NOT COMPLETED|Overall Study||0
192675|NCT00668902|473722|P2|NOT COMPLETED|Overall Study||0
192676|NCT00668902|473723|P1|NOT COMPLETED|Overall Study||0
192677|NCT00668902|473721|P3|COMPLETED|Overall Study||5
192678|NCT00668902|473722|P2|COMPLETED|Overall Study||10
192679|NCT00668902|473723|P1|COMPLETED|Overall Study||10
192680|NCT00668902|473721|P3|STARTED|Overall Study||5
192681|NCT00668902|473722|P2|STARTED|Overall Study||10
192682|NCT00668902|473723|P1|STARTED|Overall Study||10
192683|NCT00669019|473731|P1|NOT COMPLETED|Overall Study||0
192684|NCT00669019|473731|P1|COMPLETED|Overall Study||23
192685|NCT00669019|473731|P1|STARTED|Overall Study||23
192686|NCT00669032|473738|P2|NOT COMPLETED|Overall Study||59
192687|NCT00669032|473739|P1|NOT COMPLETED|Overall Study||44
192688|NCT00669032|473738|P2|COMPLETED|Overall Study||94
192689|NCT00669032|473739|P1|COMPLETED|Overall Study||109
192690|NCT00669032|473738|P2|STARTED|Overall Study||153
192691|NCT00669032|473739|P1|STARTED|Overall Study||153
192692|NCT00669071|473767|P1|NOT COMPLETED|Overall Study||4
192693|NCT00669071|473767|P1|COMPLETED|Overall Study||52
192694|NCT00669071|473767|P1|STARTED|Overall Study||56
192695|NCT00669110|473788|P2|NOT COMPLETED|Overall Study||13
192696|NCT00669110|473789|P1|NOT COMPLETED|Overall Study||8
192697|NCT00669110|473788|P2|COMPLETED|Overall Study||7
192698|NCT00669110|473789|P1|COMPLETED|Overall Study||12
192699|NCT00669110|473788|P2|STARTED|Overall Study||20
192700|NCT00669110|473789|P1|STARTED|Overall Study||20
192701|NCT00669214|473827|P2|NOT COMPLETED|Open-Label Treatment Period (Week 24)||9
192702|NCT00669214|473828|P1|NOT COMPLETED|Open-Label Treatment Period (Week 24)||4
192703|NCT00669214|473827|P2|COMPLETED|Open-Label Treatment Period (Week 24)||46
192704|NCT00669214|473828|P1|COMPLETED|Open-Label Treatment Period (Week 24)||18
192705|NCT00669214|473827|P2|STARTED|Open-Label Treatment Period (Week 24)||55
192706|NCT00669214|473828|P1|STARTED|Open-Label Treatment Period (Week 24)||22
192707|NCT00669214|473827|P2|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||7
192708|NCT00669214|473828|P1|NOT COMPLETED|Double-Blind Treatment Period (Week 12)||5
192709|NCT00669214|473827|P2|COMPLETED|Double-Blind Treatment Period (Week 12)||55
192710|NCT00669214|473828|P1|COMPLETED|Double-Blind Treatment Period (Week 12)||22
192711|NCT00669214|473827|P2|STARTED|Double-Blind Treatment Period (Week 12)||62
192712|NCT00669214|473828|P1|STARTED|Double-Blind Treatment Period (Week 12)||27
192713|NCT00669240|473860|P1|NOT COMPLETED|Overall Study||165
192714|NCT00669240|473860|P1|COMPLETED|Overall Study||402
192715|NCT00669240|473860|P1|Received Treatment|Overall Study||551
192716|NCT00669240|473860|P1|Assigned to Treatment|Overall Study||566
192717|NCT00669240|473860|P1|STARTED|Overall Study||567
192718|NCT00669279|473876|P2|NOT COMPLETED|Overall Study||0
192719|NCT00669279|473877|P1|NOT COMPLETED|Overall Study||0
192720|NCT00669279|473876|P2|COMPLETED|Overall Study||19
192721|NCT00669279|473877|P1|COMPLETED|Overall Study||22
192722|NCT00669279|473876|P2|STARTED|Overall Study||19
192723|NCT00669279|473877|P1|STARTED|Overall Study||22
192724|NCT00669318|473883|P1|NOT COMPLETED|Overall Study||2
192725|NCT00669318|473883|P1|COMPLETED|Overall Study||39
192726|NCT00669318|473883|P1|STARTED|Overall Study||41
192727|NCT00669331|473893|P2|NOT COMPLETED|Blinded Treatment Period||39
192728|NCT00669331|473894|P1|NOT COMPLETED|Blinded Treatment Period||42
192729|NCT00669331|473893|P2|COMPLETED|Blinded Treatment Period||189
192730|NCT00669331|473894|P1|COMPLETED|Blinded Treatment Period||191
192731|NCT00669331|473893|P2|STARTED|Blinded Treatment Period||228
192732|NCT00669331|473894|P1|STARTED|Blinded Treatment Period||233
192733|NCT00669331|473893|P2|NOT COMPLETED|Randomisation to First Dose||13
192734|NCT00669331|473894|P1|NOT COMPLETED|Randomisation to First Dose||11
192735|NCT00669331|473893|P2|COMPLETED|Randomisation to First Dose||228
192736|NCT00669331|473894|P1|COMPLETED|Randomisation to First Dose||233
192737|NCT00669331|473893|P2|STARTED|Randomisation to First Dose||241
192738|NCT00669331|473894|P1|STARTED|Randomisation to First Dose||244
192739|NCT00669396|473938|P2|NOT COMPLETED|Overall Study||12
192740|NCT00669396|473939|P1|NOT COMPLETED|Overall Study||10
192741|NCT00669396|473938|P2|COMPLETED|Overall Study||22
192742|NCT00669396|473939|P1|COMPLETED|Overall Study||13
192743|NCT00669396|473938|P2|STARTED|Overall Study||34
192744|NCT00669396|473939|P1|STARTED|Overall Study||23
192745|NCT00669461|473951|P1|NOT COMPLETED|Overall Study||0
192746|NCT00669461|473951|P1|COMPLETED|Overall Study||1
192747|NCT00669461|473951|P1|STARTED|Overall Study||1
192748|NCT00669539|473958|P2|NOT COMPLETED|Overall Study||9
192749|NCT00669539|473959|P1|NOT COMPLETED|Overall Study||8
192750|NCT00669539|473958|P2|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|43
192751|NCT00669539|473959|P1|COMPLETED|Overall Study|Completed defined as completing 18 week primary outcome exam|86
192752|NCT00669539|473958|P2|STARTED|Overall Study||52
192753|NCT00669539|473959|P1|STARTED|Overall Study||94
192754|NCT00669552|473965|P1|NOT COMPLETED|Overall Study||0
192755|NCT00669552|473965|P1|COMPLETED|Overall Study||11
192756|NCT00669552|473965|P1|STARTED|Overall Study||11
192757|NCT00669578|473971|P2|NOT COMPLETED|Overall Study||0
192758|NCT00669578|473972|P1|NOT COMPLETED|Overall Study||0
192759|NCT00669578|473971|P2|COMPLETED|Overall Study||65
192760|NCT00669578|473972|P1|COMPLETED|Overall Study||12
192761|NCT00669578|473971|P2|STARTED|Overall Study||65
192762|NCT00669578|473972|P1|STARTED|Overall Study||12
192763|NCT00669617|473985|P5|NOT COMPLETED|Period 5||0
192764|NCT00669617|473986|P4|NOT COMPLETED|Period 5||0
192765|NCT00669617|473987|P3|NOT COMPLETED|Period 5||0
192766|NCT00669617|473988|P2|NOT COMPLETED|Period 5||0
192767|NCT00669617|473989|P1|NOT COMPLETED|Period 5||0
192768|NCT00669617|473985|P5|COMPLETED|Period 5||17
192769|NCT00669617|473986|P4|COMPLETED|Period 5||18
192770|NCT00669617|473987|P3|COMPLETED|Period 5||17
192771|NCT00669617|473988|P2|COMPLETED|Period 5||17
192772|NCT00669617|473989|P1|COMPLETED|Period 5||17
192773|NCT00669617|473985|P5|STARTED|Period 5||17
192774|NCT00669617|473986|P4|STARTED|Period 5||18
192775|NCT00669617|473987|P3|STARTED|Period 5||17
192776|NCT00669617|473988|P2|STARTED|Period 5||17
192777|NCT00669617|473989|P1|STARTED|Period 5||17
192778|NCT00669617|473985|P5|NOT COMPLETED|Period 4||0
192779|NCT00669617|473986|P4|NOT COMPLETED|Period 4||0
192780|NCT00669617|473987|P3|NOT COMPLETED|Period 4||0
192781|NCT00669617|473988|P2|NOT COMPLETED|Period 4||0
192782|NCT00669617|473989|P1|NOT COMPLETED|Period 4||0
192783|NCT00669617|473985|P5|COMPLETED|Period 4||17
192784|NCT00669617|473986|P4|COMPLETED|Period 4||18
192785|NCT00669617|473987|P3|COMPLETED|Period 4||17
192786|NCT00669617|473988|P2|COMPLETED|Period 4||17
192787|NCT00669617|473989|P1|COMPLETED|Period 4||17
192788|NCT00669617|473985|P5|STARTED|Period 4||17
192789|NCT00669617|473986|P4|STARTED|Period 4||18
192790|NCT00669617|473987|P3|STARTED|Period 4||17
192791|NCT00669617|473988|P2|STARTED|Period 4||17
192792|NCT00669617|473989|P1|STARTED|Period 4||17
192793|NCT00669617|473985|P5|NOT COMPLETED|Period 3||0
192794|NCT00669617|473986|P4|NOT COMPLETED|Period 3||0
192795|NCT00669617|473987|P3|NOT COMPLETED|Period 3||0
192796|NCT00669617|473988|P2|NOT COMPLETED|Period 3||0
192797|NCT00669617|473989|P1|NOT COMPLETED|Period 3||1
192798|NCT00669617|473985|P5|COMPLETED|Period 3||17
192799|NCT00669617|473986|P4|COMPLETED|Period 3||18
192800|NCT00669617|473987|P3|COMPLETED|Period 3||17
192801|NCT00669617|473988|P2|COMPLETED|Period 3||17
192802|NCT00669617|473989|P1|COMPLETED|Period 3||17
192803|NCT00669617|473985|P5|STARTED|Period 3||17
192804|NCT00669617|473986|P4|STARTED|Period 3||18
192805|NCT00669617|473987|P3|STARTED|Period 3||17
192806|NCT00669617|473988|P2|STARTED|Period 3||17
192807|NCT00669617|473989|P1|STARTED|Period 3||18
192808|NCT00669617|473985|P5|NOT COMPLETED|Period 2||0
192809|NCT00669617|473986|P4|NOT COMPLETED|Period 2||0
192810|NCT00669617|473987|P3|NOT COMPLETED|Period 2||0
192811|NCT00669617|473988|P2|NOT COMPLETED|Period 2||0
192812|NCT00669617|473989|P1|NOT COMPLETED|Period 2||0
192813|NCT00669617|473985|P5|COMPLETED|Period 2||17
192814|NCT00669617|473986|P4|COMPLETED|Period 2||18
192815|NCT00669617|473987|P3|COMPLETED|Period 2||17
192816|NCT00669617|473988|P2|COMPLETED|Period 2||17
192817|NCT00669617|473989|P1|COMPLETED|Period 2||18
192818|NCT00669617|473985|P5|STARTED|Period 2||17
192819|NCT00669617|473986|P4|STARTED|Period 2||18
192820|NCT00669617|473987|P3|STARTED|Period 2||17
192821|NCT00669617|473988|P2|STARTED|Period 2||17
192822|NCT00669617|473989|P1|STARTED|Period 2||18
192823|NCT00669617|473985|P5|NOT COMPLETED|Period 1||1
192824|NCT00669617|473986|P4|NOT COMPLETED|Period 1||0
192825|NCT00669617|473987|P3|NOT COMPLETED|Period 1||1
192826|NCT00669617|473988|P2|NOT COMPLETED|Period 1||0
192827|NCT00669617|473989|P1|NOT COMPLETED|Period 1||0
192828|NCT00669617|473985|P5|COMPLETED|Period 1||17
192829|NCT00669617|473986|P4|COMPLETED|Period 1||18
192830|NCT00669617|473987|P3|COMPLETED|Period 1||17
192831|NCT00669617|473988|P2|COMPLETED|Period 1||17
192832|NCT00669617|473989|P1|COMPLETED|Period 1||18
192833|NCT00669617|473985|P5|STARTED|Period 1||18
192834|NCT00669617|473986|P4|STARTED|Period 1||18
192835|NCT00669617|473987|P3|STARTED|Period 1||18
192836|NCT00669617|473988|P2|STARTED|Period 1||17
192837|NCT00669617|473989|P1|STARTED|Period 1||18
192838|NCT00669682|474001|P1|NOT COMPLETED|Overall Study||0
192839|NCT00669682|474001|P1|COMPLETED|Overall Study||9
192840|NCT00669682|474001|P1|STARTED|Overall Study||9
192841|NCT00669864|474006|P1|NOT COMPLETED|Overall Study||9
192842|NCT00669864|474006|P1|COMPLETED|Overall Study||284
192843|NCT00669864|474006|P1|STARTED|Overall Study||293
192844|NCT00669903|474019|P4|NOT COMPLETED|Overall Study||4
192845|NCT00669903|474020|P3|NOT COMPLETED|Overall Study||5
192846|NCT00669903|474021|P2|NOT COMPLETED|Overall Study||5
192847|NCT00669903|474022|P1|NOT COMPLETED|Overall Study||1
192848|NCT00669903|474019|P4|COMPLETED|Overall Study||18
192849|NCT00669903|474020|P3|COMPLETED|Overall Study||13
192850|NCT00669903|474021|P2|COMPLETED|Overall Study||32
192851|NCT00669903|474022|P1|COMPLETED|Overall Study||22
192852|NCT00669903|474019|P4|Completed Treatment Period|Overall Study||19
192853|NCT00669903|474020|P3|Completed Treatment Period|Overall Study||13
192854|NCT00669903|474021|P2|Completed Treatment Period|Overall Study||33
192855|NCT00669903|474022|P1|Completed Treatment Period|Overall Study||23
192856|NCT00669903|474019|P4|STARTED|Overall Study||22
192857|NCT00669903|474020|P3|STARTED|Overall Study||18
192858|NCT00669903|474021|P2|STARTED|Overall Study||37
192859|NCT00669903|474022|P1|STARTED|Overall Study||23
192860|NCT00669916|474054|P2|NOT COMPLETED|Overall Study||0
192861|NCT00669916|474055|P1|NOT COMPLETED|Overall Study||0
192862|NCT00669916|474054|P2|COMPLETED|Overall Study||18
192863|NCT00669916|474055|P1|COMPLETED|Overall Study||18
192864|NCT00669916|474054|P2|STARTED|Overall Study||18
192865|NCT00669916|474055|P1|STARTED|Overall Study||18
192866|NCT00669942|474081|P12|NOT COMPLETED|Healthy Volunteers||0
192867|NCT00669942|474082|P11|NOT COMPLETED|Healthy Volunteers||1
192868|NCT00669942|474083|P10|NOT COMPLETED|Healthy Volunteers||0
192869|NCT00669942|474084|P9|NOT COMPLETED|Healthy Volunteers||0
192870|NCT00669942|474085|P8|NOT COMPLETED|Healthy Volunteers||0
192871|NCT00669942|474086|P7|NOT COMPLETED|Healthy Volunteers||0
192872|NCT00669942|474087|P6|NOT COMPLETED|Healthy Volunteers||0
192873|NCT00669942|474088|P5|NOT COMPLETED|Healthy Volunteers||0
192874|NCT00669942|474089|P4|NOT COMPLETED|Healthy Volunteers||0
192875|NCT00669942|474090|P3|NOT COMPLETED|Healthy Volunteers||0
192876|NCT00669942|474091|P2|NOT COMPLETED|Healthy Volunteers||0
192877|NCT00669942|474092|P1|NOT COMPLETED|Healthy Volunteers||0
192878|NCT00669942|474081|P12|COMPLETED|Healthy Volunteers||2
192879|NCT00669942|474082|P11|COMPLETED|Healthy Volunteers||2
192880|NCT00669942|474083|P10|COMPLETED|Healthy Volunteers||3
192881|NCT00669942|474084|P9|COMPLETED|Healthy Volunteers||0
192882|NCT00669942|474085|P8|COMPLETED|Healthy Volunteers||0
192883|NCT00669942|474086|P7|COMPLETED|Healthy Volunteers||0
192884|NCT00669942|474087|P6|COMPLETED|Healthy Volunteers||0
192885|NCT00669942|474088|P5|COMPLETED|Healthy Volunteers||0
192886|NCT00669942|474089|P4|COMPLETED|Healthy Volunteers||0
192887|NCT00669942|474090|P3|COMPLETED|Healthy Volunteers||0
192888|NCT00669942|474091|P2|COMPLETED|Healthy Volunteers||0
192889|NCT00669942|474092|P1|COMPLETED|Healthy Volunteers||0
192890|NCT00669942|474081|P12|STARTED|Healthy Volunteers||2
192891|NCT00669942|474082|P11|STARTED|Healthy Volunteers||3
192892|NCT00669942|474083|P10|STARTED|Healthy Volunteers||3
192893|NCT00669942|474084|P9|STARTED|Healthy Volunteers||0
192894|NCT00669942|474085|P8|STARTED|Healthy Volunteers||0
192895|NCT00669942|474086|P7|STARTED|Healthy Volunteers||0
192896|NCT00669942|474087|P6|STARTED|Healthy Volunteers||0
192897|NCT00669942|474088|P5|STARTED|Healthy Volunteers||0
192898|NCT00669942|474089|P4|STARTED|Healthy Volunteers||0
192899|NCT00669942|474090|P3|STARTED|Healthy Volunteers||0
192900|NCT00669942|474091|P2|STARTED|Healthy Volunteers||0
192901|NCT00669942|474092|P1|STARTED|Healthy Volunteers||0
192902|NCT00669942|474081|P12|NOT COMPLETED|Parts 2 and 3||0
192903|NCT00669942|474082|P11|NOT COMPLETED|Parts 2 and 3||0
192904|NCT00669942|474083|P10|NOT COMPLETED|Parts 2 and 3||0
192905|NCT00669942|474084|P9|NOT COMPLETED|Parts 2 and 3||3
192906|NCT00669942|474085|P8|NOT COMPLETED|Parts 2 and 3||2
192907|NCT00669942|474086|P7|NOT COMPLETED|Parts 2 and 3||0
192908|NCT00669942|474087|P6|NOT COMPLETED|Parts 2 and 3||2
192909|NCT00669942|474088|P5|NOT COMPLETED|Parts 2 and 3||0
192910|NCT00669942|474089|P4|NOT COMPLETED|Parts 2 and 3||0
192911|NCT00669942|474090|P3|NOT COMPLETED|Parts 2 and 3||0
192912|NCT00669942|474091|P2|NOT COMPLETED|Parts 2 and 3||0
192913|NCT00669942|474092|P1|NOT COMPLETED|Parts 2 and 3||0
192914|NCT00669942|474081|P12|COMPLETED|Parts 2 and 3||0
192915|NCT00669942|474082|P11|COMPLETED|Parts 2 and 3||0
192916|NCT00669942|474083|P10|COMPLETED|Parts 2 and 3||0
192917|NCT00669942|474084|P9|COMPLETED|Parts 2 and 3||23
192918|NCT00669942|474085|P8|COMPLETED|Parts 2 and 3||24
192919|NCT00669942|474086|P7|COMPLETED|Parts 2 and 3||6
192920|NCT00669942|474087|P6|COMPLETED|Parts 2 and 3||4
192921|NCT00669942|474088|P5|COMPLETED|Parts 2 and 3||0
192922|NCT00669942|474089|P4|COMPLETED|Parts 2 and 3||0
192923|NCT00669942|474090|P3|COMPLETED|Parts 2 and 3||0
192924|NCT00669942|474091|P2|COMPLETED|Parts 2 and 3||0
192925|NCT00669942|474092|P1|COMPLETED|Parts 2 and 3||0
192926|NCT00669942|474081|P12|STARTED|Parts 2 and 3||0
192927|NCT00669942|474082|P11|STARTED|Parts 2 and 3||0
192928|NCT00669942|474083|P10|STARTED|Parts 2 and 3||0
192929|NCT00669942|474084|P9|STARTED|Parts 2 and 3||26
192930|NCT00669942|474085|P8|STARTED|Parts 2 and 3||26
192931|NCT00669942|474086|P7|STARTED|Parts 2 and 3||6
192932|NCT00669942|474087|P6|STARTED|Parts 2 and 3||6
192933|NCT00669942|474088|P5|STARTED|Parts 2 and 3||0
192934|NCT00669942|474089|P4|STARTED|Parts 2 and 3||0
192935|NCT00669942|474090|P3|STARTED|Parts 2 and 3||0
192936|NCT00669942|474091|P2|STARTED|Parts 2 and 3||0
192937|NCT00669942|474092|P1|STARTED|Parts 2 and 3||0
192938|NCT00669942|474081|P12|NOT COMPLETED|Part 1||0
192939|NCT00669942|474082|P11|NOT COMPLETED|Part 1||0
192940|NCT00669942|474083|P10|NOT COMPLETED|Part 1||0
192941|NCT00669942|474084|P9|NOT COMPLETED|Part 1||0
192942|NCT00669942|474085|P8|NOT COMPLETED|Part 1||0
192943|NCT00669942|474086|P7|NOT COMPLETED|Part 1||0
192944|NCT00669942|474087|P6|NOT COMPLETED|Part 1||0
192945|NCT00669942|474088|P5|NOT COMPLETED|Part 1||0
192946|NCT00669942|474089|P4|NOT COMPLETED|Part 1||0
192947|NCT00669942|474090|P3|NOT COMPLETED|Part 1||0
192948|NCT00669942|474091|P2|NOT COMPLETED|Part 1||0
192949|NCT00669942|474092|P1|NOT COMPLETED|Part 1||0
192950|NCT00669942|474081|P12|COMPLETED|Part 1||0
192951|NCT00669942|474082|P11|COMPLETED|Part 1||0
192952|NCT00669942|474083|P10|COMPLETED|Part 1||0
192953|NCT00669942|474084|P9|COMPLETED|Part 1||0
192954|NCT00669942|474085|P8|COMPLETED|Part 1||0
192955|NCT00669942|474086|P7|COMPLETED|Part 1||0
192956|NCT00669942|474087|P6|COMPLETED|Part 1||0
192957|NCT00669942|474088|P5|COMPLETED|Part 1||8
192958|NCT00669942|474089|P4|COMPLETED|Part 1||6
192959|NCT00669942|474090|P3|COMPLETED|Part 1||6
192960|NCT00669942|474091|P2|COMPLETED|Part 1||6
192961|NCT00669942|474092|P1|COMPLETED|Part 1||6
192962|NCT00669942|474081|P12|STARTED|Part 1||0
192963|NCT00669942|474082|P11|STARTED|Part 1||0
192964|NCT00669942|474083|P10|STARTED|Part 1||0
192965|NCT00669942|474084|P9|STARTED|Part 1||0
192966|NCT00669942|474085|P8|STARTED|Part 1||0
192967|NCT00669942|474086|P7|STARTED|Part 1||0
192968|NCT00669942|474087|P6|STARTED|Part 1||0
192969|NCT00669942|474088|P5|STARTED|Part 1||8
192970|NCT00669942|474089|P4|STARTED|Part 1||6
192971|NCT00669942|474090|P3|STARTED|Part 1||6
192972|NCT00669942|474091|P2|STARTED|Part 1||6
192973|NCT00669942|474092|P1|STARTED|Part 1||6
192974|NCT00669955|474156|P2|NOT COMPLETED|Overall Study||27
192975|NCT00669955|474157|P1|NOT COMPLETED|Overall Study||14
192976|NCT00669955|474156|P2|COMPLETED|Overall Study||195
192977|NCT00669955|474157|P1|COMPLETED|Overall Study||204
192978|NCT00669955|474156|P2|STARTED|Overall Study||222
192979|NCT00669955|474157|P1|STARTED|Overall Study|216 patients received study drug. 2 patients were dispensed study drug but did not take it|218
192980|NCT00663702|474177|P2|NOT COMPLETED|Overall Study||10
192981|NCT00663702|474178|P1|NOT COMPLETED|Overall Study||18
192982|NCT00663702|474177|P2|COMPLETED|Overall Study||61
192983|NCT00663702|474178|P1|COMPLETED|Overall Study||34
192984|NCT00663702|474177|P2|STARTED|Overall Study||71
192985|NCT00663702|474178|P1|STARTED|Overall Study||52
192986|NCT00663793|474203|P2|NOT COMPLETED|Overall Study||0
192987|NCT00663793|474204|P1|NOT COMPLETED|Overall Study||0
192988|NCT00663793|474203|P2|COMPLETED|Overall Study||8
192989|NCT00663793|474204|P1|COMPLETED|Overall Study||8
192990|NCT00663793|474203|P2|STARTED|Overall Study||8
192991|NCT00663793|474204|P1|STARTED|Overall Study||8
192992|NCT00663819|474216|P2|NOT COMPLETED|Overall Study||0
192993|NCT00663819|474217|P1|NOT COMPLETED|Overall Study||0
192994|NCT00663819|474216|P2|COMPLETED|Overall Study||135
192995|NCT00663819|474217|P1|COMPLETED|Overall Study||123
192996|NCT00663819|474216|P2|STARTED|Overall Study||135
192997|NCT00663819|474217|P1|STARTED|Overall Study||123
192998|NCT00663858|474226|P3|NOT COMPLETED|Overall Study||20
192999|NCT00663858|474227|P2|NOT COMPLETED|Overall Study||10
193000|NCT00663858|474228|P1|NOT COMPLETED|Overall Study||34
193001|NCT00663858|474226|P3|COMPLETED|Overall Study||82
193002|NCT00663858|474227|P2|COMPLETED|Overall Study||96
193003|NCT00663858|474228|P1|COMPLETED|Overall Study||178
193004|NCT00663858|474226|P3|STARTED|Overall Study||102
193005|NCT00663858|474227|P2|STARTED|Overall Study||106
193006|NCT00663858|474228|P1|STARTED|Overall Study||212
193007|NCT00663923|474236|P1|NOT COMPLETED|Overall Study||2
193008|NCT00663923|474236|P1|COMPLETED|Overall Study||48
193009|NCT00663923|474236|P1|STARTED|Overall Study||50
193010|NCT00663962|474252|P2|NOT COMPLETED|Overall Study||0
193011|NCT00663962|474253|P1|NOT COMPLETED|Overall Study||1
193012|NCT00663962|474252|P2|COMPLETED|Overall Study||8
193013|NCT00663962|474253|P1|COMPLETED|Overall Study|1 patient excluded for somnolence and unblinded--in 300mg group|6
193014|NCT00663962|474252|P2|STARTED|Overall Study||8
193015|NCT00663962|474253|P1|STARTED|Overall Study||7
193016|NCT00664066|474259|P1|NOT COMPLETED|Overall Study||3
193017|NCT00664066|474259|P1|COMPLETED|Overall Study||0
193018|NCT00664066|474259|P1|STARTED|Overall Study||3
193019|NCT00664105|474263|P1|NOT COMPLETED|Overall Study||24
193020|NCT00664105|474263|P1|COMPLETED|Overall Study||39
193021|NCT00664105|474263|P1|STARTED|Overall Study||63
193022|NCT00664326|474270|P1|NOT COMPLETED|Overall Study||24
193023|NCT00664326|474270|P1|COMPLETED|Overall Study||25
193024|NCT00664326|474270|P1|STARTED|Overall Study||49
193025|NCT00664430|474289|P1|NOT COMPLETED|Overall Study||13
193026|NCT00664430|474289|P1|COMPLETED|Overall Study|Study terminated early due to low enrollment rate.|0
193027|NCT00664430|474289|P1|STARTED|Overall Study||13
193028|NCT00664521|474297|P2|NOT COMPLETED|Overall Study||1
193029|NCT00664521|474298|P1|NOT COMPLETED|Overall Study||6
193030|NCT00664521|474297|P2|COMPLETED|Overall Study||8
193031|NCT00664521|474298|P1|COMPLETED|Overall Study||12
193032|NCT00664521|474297|P2|STARTED|Overall Study||9
193033|NCT00664521|474298|P1|STARTED|Overall Study||18
193034|NCT00664534|474320|P2|NOT COMPLETED|Overall Study||33
193035|NCT00664534|474321|P1|NOT COMPLETED|Overall Study||41
193036|NCT00664534|474320|P2|COMPLETED|Overall Study||138
193037|NCT00664534|474321|P1|COMPLETED|Overall Study||132
193038|NCT00664534|474320|P2|STARTED|Overall Study||171
193039|NCT00664534|474321|P1|STARTED|Overall Study||173
193040|NCT00664560|474350|P3|NOT COMPLETED|Overall Study||19
193041|NCT00664560|474351|P2|NOT COMPLETED|Overall Study||35
193042|NCT00664560|474352|P1|NOT COMPLETED|Overall Study||39
193043|NCT00664560|474350|P3|COMPLETED|Overall Study||105
193044|NCT00664560|474351|P2|COMPLETED|Overall Study||208
193045|NCT00664560|474352|P1|COMPLETED|Overall Study||208
193046|NCT00664560|474350|P3|STARTED|Overall Study|Safety Population|124
193047|NCT00664560|474351|P2|STARTED|Overall Study|Safety Population|243
193048|NCT00664560|474352|P1|STARTED|Overall Study|Safety Population|247
193049|NCT00670007|474393|P1|NOT COMPLETED|Overall Study||9
193050|NCT00670007|474393|P1|COMPLETED|Overall Study||131
193051|NCT00670007|474393|P1|STARTED|Overall Study||140
193052|NCT00670111|474421|P3|NOT COMPLETED|Six Months to Twelve Months||0
193053|NCT00670111|474422|P2|NOT COMPLETED|Six Months to Twelve Months||0
193054|NCT00670111|474423|P1|NOT COMPLETED|Six Months to Twelve Months||0
193055|NCT00670111|474421|P3|COMPLETED|Six Months to Twelve Months||0
193056|NCT00670111|474422|P2|COMPLETED|Six Months to Twelve Months||8
193057|NCT00670111|474423|P1|COMPLETED|Six Months to Twelve Months||4
193058|NCT00670111|474421|P3|STARTED|Six Months to Twelve Months||0
193059|NCT00670111|474422|P2|STARTED|Six Months to Twelve Months||8
193060|NCT00670111|474423|P1|STARTED|Six Months to Twelve Months||4
193061|NCT00670111|474421|P3|NOT COMPLETED|One Month to Six Months||0
193062|NCT00670111|474422|P2|NOT COMPLETED|One Month to Six Months||0
193063|NCT00670111|474423|P1|NOT COMPLETED|One Month to Six Months||0
193064|NCT00670111|474421|P3|COMPLETED|One Month to Six Months||0
193065|NCT00670111|474422|P2|COMPLETED|One Month to Six Months|8 patients in this group completed the 1 month visit; 4 had data eligible for endpoint analysis.|8
193066|NCT00670111|474423|P1|COMPLETED|One Month to Six Months|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
193067|NCT00670111|474421|P3|STARTED|One Month to Six Months||0
193068|NCT00670111|474422|P2|STARTED|One Month to Six Months||8
193069|NCT00670111|474423|P1|STARTED|One Month to Six Months||4
193070|NCT00670111|474421|P3|NOT COMPLETED|One Month Period B||0
193071|NCT00670111|474422|P2|NOT COMPLETED|One Month Period B||0
193072|NCT00670111|474423|P1|NOT COMPLETED|One Month Period B||0
193073|NCT00670111|474421|P3|COMPLETED|One Month Period B||0
193074|NCT00670111|474422|P2|COMPLETED|One Month Period B|8 patients in this group completed the 1 month visit; 6 had data eligible for endpoint analysis.|8
193075|NCT00670111|474423|P1|COMPLETED|One Month Period B|4 patients in this group completed the 1 month visit; 0 had data eligible for endpoint analysis.|4
193076|NCT00670111|474421|P3|STARTED|One Month Period B||0
193077|NCT00670111|474422|P2|STARTED|One Month Period B||8
193078|NCT00670111|474423|P1|STARTED|One Month Period B||4
193079|NCT00670111|474421|P3|NOT COMPLETED|One Month Period A||0
193080|NCT00670111|474422|P2|NOT COMPLETED|One Month Period A||0
193081|NCT00670111|474423|P1|NOT COMPLETED|One Month Period A||0
193082|NCT00670111|474421|P3|COMPLETED|One Month Period A||0
193083|NCT00670111|474422|P2|COMPLETED|One Month Period A||8
193084|NCT00670111|474423|P1|COMPLETED|One Month Period A||4
193085|NCT00670111|474421|P3|STARTED|One Month Period A||0
193086|NCT00670111|474422|P2|STARTED|One Month Period A||8
193087|NCT00670111|474423|P1|STARTED|One Month Period A||4
193088|NCT00670111|474421|P3|NOT COMPLETED|Enrollment to One Month||19
193089|NCT00670111|474422|P2|NOT COMPLETED|Enrollment to One Month||0
193090|NCT00670111|474423|P1|NOT COMPLETED|Enrollment to One Month||1
193091|NCT00670111|474421|P3|COMPLETED|Enrollment to One Month||0
193092|NCT00670111|474422|P2|COMPLETED|Enrollment to One Month||8
193093|NCT00670111|474423|P1|COMPLETED|Enrollment to One Month||4
193094|NCT00670111|474421|P3|STARTED|Enrollment to One Month||19
193095|NCT00670111|474422|P2|STARTED|Enrollment to One Month||8
193096|NCT00670111|474423|P1|STARTED|Enrollment to One Month||5
193097|NCT00670202|474433|P2|NOT COMPLETED|Overall Study||0
193098|NCT00670202|474434|P1|NOT COMPLETED|Overall Study||0
193099|NCT00670202|474433|P2|COMPLETED|Overall Study||0
193100|NCT00670202|474434|P1|COMPLETED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
193101|NCT00670202|474433|P2|STARTED|Overall Study||0
193102|NCT00670202|474434|P1|STARTED|Overall Study|Investigators blinded to study drug assignment due to early termination of study|2
193103|NCT00670228|474442|P2|NOT COMPLETED|Overall Study||3
193104|NCT00670228|474443|P1|NOT COMPLETED|Overall Study||5
193105|NCT00670228|474442|P2|COMPLETED|Overall Study||12
193106|NCT00670228|474443|P1|COMPLETED|Overall Study||13
193107|NCT00670228|474442|P2|STARTED|Overall Study||15
193108|NCT00670228|474443|P1|STARTED|Overall Study||18
193109|NCT00670241|474458|P3|NOT COMPLETED|Overall Study||27
193110|NCT00670241|474459|P2|NOT COMPLETED|Overall Study||21
193111|NCT00670241|474460|P1|NOT COMPLETED|Overall Study||12
193112|NCT00670241|474458|P3|COMPLETED|Overall Study||64
193113|NCT00670241|474459|P2|COMPLETED|Overall Study||163
193114|NCT00670241|474460|P1|COMPLETED|Overall Study||171
193115|NCT00670241|474458|P3|STARTED|Overall Study||91
193116|NCT00670241|474459|P2|STARTED|Overall Study||184
193117|NCT00670241|474460|P1|STARTED|Overall Study||183
193118|NCT00670267|474480|P1|NOT COMPLETED|Overall Study||1
193119|NCT00670267|474480|P1|COMPLETED|Overall Study||9
193120|NCT00670267|474480|P1|STARTED|Overall Study||10
193121|NCT00670306|474488|P1|NOT COMPLETED|Overall Study||55
193122|NCT00670306|474488|P1|COMPLETED|Overall Study||473
193123|NCT00670306|474488|P1|STARTED|Overall Study||528
193124|NCT00670930|474494|P2|NOT COMPLETED|Overall Study||1
193125|NCT00670930|474495|P1|NOT COMPLETED|Overall Study||1
193126|NCT00670930|474494|P2|COMPLETED|Overall Study||12
193127|NCT00670930|474495|P1|COMPLETED|Overall Study||22
193128|NCT00670930|474494|P2|Intent to Treat (ITT) Population|Overall Study||12
193129|NCT00670930|474495|P1|Intent to Treat (ITT) Population|Overall Study||23
193130|NCT00670930|474494|P2|STARTED|Overall Study||13
193131|NCT00670930|474495|P1|STARTED|Overall Study|"Started indicates Randomized and Safety populaiton"|23
193132|NCT00670956|474509|P1|NOT COMPLETED|Overall Study||0
193133|NCT00670956|474509|P1|COMPLETED|Overall Study||1
193134|NCT00670956|474509|P1|STARTED|Overall Study||1
193135|NCT00670982|474517|P2|NOT COMPLETED|Overall Study||0
193136|NCT00670982|474518|P1|NOT COMPLETED|Overall Study||0
193137|NCT00670982|474517|P2|COMPLETED|Overall Study||7
193138|NCT00670982|474518|P1|COMPLETED|Overall Study||22
193139|NCT00670982|474517|P2|STARTED|Overall Study||7
193140|NCT00670982|474518|P1|STARTED|Overall Study||22
193141|NCT00671060|474529|P2|NOT COMPLETED|Overall Study||1
193142|NCT00671060|474530|P1|NOT COMPLETED|Overall Study||1
193143|NCT00671060|474529|P2|COMPLETED|Overall Study|1 woman was withdrawn from the study due to preeclampsia.|75
193144|NCT00671060|474530|P1|COMPLETED|Overall Study|1 woman completed study but was excluded from analysis because gestational age <14 weeks.|76
193145|NCT00671060|474529|P2|STARTED|Overall Study||76
193146|NCT00671060|474530|P1|STARTED|Overall Study||77
193147|NCT00671177|474538|P2|NOT COMPLETED|Overall Study||1
193148|NCT00671177|474539|P1|NOT COMPLETED|Overall Study||2
193149|NCT00671177|474538|P2|COMPLETED|Overall Study||114
193150|NCT00671177|474539|P1|COMPLETED|Overall Study||112
193151|NCT00671177|474538|P2|STARTED|Overall Study||115
193152|NCT00671177|474539|P1|STARTED|Overall Study||114
193153|NCT00671437|474549|P1|NOT COMPLETED|Overall Study||15
193154|NCT00671437|474549|P1|COMPLETED|Overall Study||27
193155|NCT00671437|474549|P1|STARTED|Overall Study||42
193156|NCT00671502|474571|P3|NOT COMPLETED|Overall Study||27
193157|NCT00671502|474572|P2|NOT COMPLETED|Overall Study||39
193158|NCT00671502|474573|P1|NOT COMPLETED|Overall Study||39
193159|NCT00671502|474571|P3|COMPLETED|Overall Study||252
193160|NCT00671502|474572|P2|COMPLETED|Overall Study||241
193161|NCT00671502|474573|P1|COMPLETED|Overall Study||242
193162|NCT00671502|474571|P3|STARTED|Overall Study||279
193163|NCT00671502|474572|P2|STARTED|Overall Study||280
193164|NCT00671502|474573|P1|STARTED|Overall Study||281
193165|NCT00671515|474581|P1|NOT COMPLETED|Phase 2||4
193166|NCT00671515|474581|P1|COMPLETED|Phase 2||9
193167|NCT00671515|474581|P1|STARTED|Phase 2||13
193168|NCT00671515|474581|P1|NOT COMPLETED|Phase 1||3
193169|NCT00671515|474581|P1|COMPLETED|Phase 1||20
193170|NCT00671515|474581|P1|STARTED|Phase 1||23
193171|NCT00671528|474589|P3|NOT COMPLETED|Overall Study||0
193172|NCT00671528|474590|P2|NOT COMPLETED|Overall Study||0
193173|NCT00671528|474591|P1|NOT COMPLETED|Overall Study||0
193174|NCT00671528|474589|P3|COMPLETED|Overall Study||1
193175|NCT00671528|474590|P2|COMPLETED|Overall Study||1
193176|NCT00671528|474591|P1|COMPLETED|Overall Study||1
193177|NCT00671528|474589|P3|STARTED|Overall Study||1
193178|NCT00671528|474590|P2|STARTED|Overall Study||1
193179|NCT00671528|474591|P1|STARTED|Overall Study||1
193180|NCT00671554|474602|P1|NOT COMPLETED|Overall Study||3
193181|NCT00671554|474602|P1|COMPLETED|Overall Study||0
193182|NCT00671554|474602|P1|STARTED|Overall Study||3
193183|NCT00671606|474607|P1|NOT COMPLETED|Overall Study||0
193184|NCT00671606|474607|P1|COMPLETED|Overall Study||5
193185|NCT00671606|474607|P1|STARTED|Overall Study||5
193186|NCT00671671|474613|P2|NOT COMPLETED|Overall Study||0
193187|NCT00671671|474614|P1|NOT COMPLETED|Overall Study||0
193188|NCT00671671|474613|P2|COMPLETED|Overall Study||10
193189|NCT00671671|474614|P1|COMPLETED|Overall Study||10
193190|NCT00671671|474613|P2|STARTED|Overall Study||10
193191|NCT00671671|474614|P1|STARTED|Overall Study||10
193192|NCT00671723|474643|P3|NOT COMPLETED|Overall Study||0
193193|NCT00671723|474644|P2|NOT COMPLETED|Overall Study||0
193194|NCT00671723|474645|P1|NOT COMPLETED|Overall Study||0
193195|NCT00671723|474643|P3|COMPLETED|Overall Study||11
193196|NCT00671723|474644|P2|COMPLETED|Overall Study||11
193197|NCT00671723|474645|P1|COMPLETED|Overall Study||11
193198|NCT00671723|474643|P3|STARTED|Overall Study||11
193199|NCT00671723|474644|P2|STARTED|Overall Study||11
193200|NCT00671723|474645|P1|STARTED|Overall Study||11
193201|NCT00671749|474656|P1|NOT COMPLETED|Overall Study||8
193202|NCT00671749|474656|P1|COMPLETED|Overall Study||92
193203|NCT00671749|474656|P1|STARTED|Overall Study||100
193204|NCT00671788|474666|P1|NOT COMPLETED|Overall Study||14
193205|NCT00671788|474666|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|21
193206|NCT00671788|474666|P1|STARTED|Overall Study||35
193207|NCT00671853|474675|P2|NOT COMPLETED|Overall Study||27
193208|NCT00671853|474676|P1|NOT COMPLETED|Overall Study||20
193209|NCT00671853|474675|P2|COMPLETED|Overall Study||18
193210|NCT00671853|474676|P1|COMPLETED|Overall Study||26
193211|NCT00671853|474675|P2|STARTED|Overall Study||45
193212|NCT00671853|474676|P1|STARTED|Overall Study||46
193213|NCT00671879|474695|P3|NOT COMPLETED|Overall Study||6
193214|NCT00671879|474696|P2|NOT COMPLETED|Overall Study||4
193215|NCT00671879|474697|P1|NOT COMPLETED|Overall Study||0
193216|NCT00671879|474695|P3|COMPLETED|Overall Study||274
193217|NCT00671879|474696|P2|COMPLETED|Overall Study||275
193218|NCT00671879|474697|P1|COMPLETED|Overall Study||281
193219|NCT00671879|474695|P3|STARTED|Overall Study||280
193220|NCT00671879|474696|P2|STARTED|Overall Study||279
193221|NCT00671879|474697|P1|STARTED|Overall Study||281
193222|NCT00671918|474708|P1|NOT COMPLETED|Overall Study||17
193223|NCT00671918|474708|P1|COMPLETED|Overall Study||169
193224|NCT00671918|474708|P1|STARTED|Overall Study||186
193225|NCT00671931|474718|P5|NOT COMPLETED|Overall Study||1
193226|NCT00671931|474719|P4|NOT COMPLETED|Overall Study||2
193227|NCT00671931|474720|P3|NOT COMPLETED|Overall Study||0
193228|NCT00671931|474721|P2|NOT COMPLETED|Overall Study||0
193229|NCT00671931|474722|P1|NOT COMPLETED|Overall Study||1
193230|NCT00671931|474718|P5|COMPLETED|Overall Study|Low heart rate requiring treatment|7
193231|NCT00671931|474719|P4|COMPLETED|Overall Study|Prepositioning - Neuromonitoring required|8
193232|NCT00671931|474720|P3|COMPLETED|Overall Study|all completed|9
193233|NCT00671931|474721|P2|COMPLETED|Overall Study|All completed|8
193234|NCT00671931|474722|P1|COMPLETED|Overall Study|Nueromonitoring equipment falure|8
193235|NCT00671931|474718|P5|STARTED|Overall Study||8
193236|NCT00671931|474719|P4|STARTED|Overall Study||10
193237|NCT00671931|474720|P3|STARTED|Overall Study||9
193238|NCT00671931|474721|P2|STARTED|Overall Study||8
193239|NCT00671931|474722|P1|STARTED|Overall Study||9
193240|NCT00671970|474736|P2|NOT COMPLETED|Overall Study||0
193241|NCT00671970|474737|P1|NOT COMPLETED|Overall Study||0
193242|NCT00671970|474736|P2|COMPLETED|Overall Study||25
193243|NCT00671970|474737|P1|COMPLETED|Overall Study||32
193244|NCT00671970|474736|P2|STARTED|Overall Study||25
193245|NCT00671970|474737|P1|STARTED|Overall Study||32
193246|NCT00672100|474763|P3|NOT COMPLETED|Overall Study||0
193247|NCT00672100|474764|P2|NOT COMPLETED|Overall Study||0
193248|NCT00672100|474765|P1|NOT COMPLETED|Overall Study||0
193249|NCT00672100|474763|P3|COMPLETED|Overall Study||12
193250|NCT00672100|474764|P2|COMPLETED|Overall Study||12
193251|NCT00672100|474765|P1|COMPLETED|Overall Study||12
193252|NCT00672100|474763|P3|PACU (Within 8 Hours)|Overall Study||12
193253|NCT00672100|474764|P2|PACU (Within 8 Hours)|Overall Study||12
193254|NCT00672100|474765|P1|PACU (Within 8 Hours)|Overall Study||12
193255|NCT00672100|474763|P3|STARTED|Overall Study||12
193256|NCT00672100|474764|P2|STARTED|Overall Study||12
193257|NCT00672100|474765|P1|STARTED|Overall Study||12
193258|NCT00672178|474780|P1|NOT COMPLETED|Overall Study||0
193259|NCT00672178|474780|P1|COMPLETED|Overall Study||1
193260|NCT00672178|474780|P1|STARTED|Overall Study||1
193261|NCT00672204|474784|P1|NOT COMPLETED|Overall Study||20
193262|NCT00672204|474784|P1|COMPLETED|Overall Study||3
193263|NCT00672204|474784|P1|STARTED|Overall Study||23
193264|NCT00672243|474788|P1|NOT COMPLETED|Overall Study||0
193265|NCT00672243|474788|P1|COMPLETED|Overall Study||32
193266|NCT00672243|474788|P1|STARTED|Overall Study||32
193267|NCT00672256|474796|P1|NOT COMPLETED|Overall Study||44
193268|NCT00672256|474796|P1|COMPLETED|Overall Study||18
193269|NCT00672256|474796|P1|STARTED|Overall Study|January 2007|62
193270|NCT00672438|474805|P2|NOT COMPLETED|Infusion 2||0
193271|NCT00672438|474806|P1|NOT COMPLETED|Infusion 2||0
193272|NCT00672438|474805|P2|COMPLETED|Infusion 2||118
193273|NCT00672438|474806|P1|COMPLETED|Infusion 2||119
193274|NCT00672438|474805|P2|STARTED|Infusion 2||118
193275|NCT00672438|474806|P1|STARTED|Infusion 2||119
193276|NCT00672438|474805|P2|NOT COMPLETED|Washout||0
193277|NCT00672438|474806|P1|NOT COMPLETED|Washout||0
193278|NCT00672438|474805|P2|COMPLETED|Washout||118
193279|NCT00672438|474806|P1|COMPLETED|Washout||119
193280|NCT00672438|474805|P2|STARTED|Washout||118
193281|NCT00672438|474806|P1|STARTED|Washout||119
193282|NCT00672438|474805|P2|NOT COMPLETED|Infusion 1||0
193283|NCT00672438|474806|P1|NOT COMPLETED|Infusion 1||0
193284|NCT00672438|474805|P2|COMPLETED|Infusion 1||118
193285|NCT00672438|474806|P1|COMPLETED|Infusion 1||119
193286|NCT00672438|474805|P2|STARTED|Infusion 1||118
193287|NCT00672438|474806|P1|STARTED|Infusion 1||119
193288|NCT00672490|474839|P2|NOT COMPLETED|Overall Study||32
193289|NCT00672490|474840|P1|NOT COMPLETED|Overall Study||24
193290|NCT00672490|474839|P2|COMPLETED|Overall Study||157
193291|NCT00672490|474840|P1|COMPLETED|Overall Study||163
193292|NCT00672490|474839|P2|STARTED|Overall Study||189
193293|NCT00672490|474840|P1|STARTED|Overall Study||187
193294|NCT00672555|474862|P1|NOT COMPLETED|Overall Study||6
193295|NCT00672555|474862|P1|COMPLETED|Overall Study|All patients were seen at 3 weeks in the outpatient clinic.|64
193296|NCT00672555|474862|P1|STARTED|Overall Study||70
193297|NCT00672594|474871|P1|NOT COMPLETED|Overall Study||3
193298|NCT00672594|474871|P1|COMPLETED|Overall Study||27
193299|NCT00672594|474871|P1|STARTED|Overall Study||30
193300|NCT00672620|474886|P4|NOT COMPLETED|Overall Study||42
193301|NCT00672620|474887|P3|NOT COMPLETED|Overall Study||31
193302|NCT00672620|474888|P2|NOT COMPLETED|Overall Study||54
193303|NCT00672620|474889|P1|NOT COMPLETED|Overall Study||33
193304|NCT00672620|474886|P4|COMPLETED|Overall Study||110
193305|NCT00672620|474887|P3|COMPLETED|Overall Study||122
193306|NCT00672620|474888|P2|COMPLETED|Overall Study||99
193307|NCT00672620|474889|P1|COMPLETED|Overall Study||120
193308|NCT00672620|474886|P4|Treated|Overall Study||150
193309|NCT00672620|474887|P3|Treated|Overall Study||153
193310|NCT00672620|474888|P2|Treated|Overall Study||149
193311|NCT00672620|474889|P1|Treated|Overall Study||151
193312|NCT00672620|474886|P4|STARTED|Overall Study||152
193313|NCT00672620|474887|P3|STARTED|Overall Study||153
193314|NCT00672620|474888|P2|STARTED|Overall Study||153
193315|NCT00672620|474889|P1|STARTED|Overall Study||153
193316|NCT00672633|474945|P2|NOT COMPLETED|Overall Study||1
193317|NCT00672633|474946|P1|NOT COMPLETED|Overall Study||0
193318|NCT00672633|474945|P2|COMPLETED|Overall Study||12
193319|NCT00672633|474946|P1|COMPLETED|Overall Study||12
193320|NCT00672633|474945|P2|STARTED|Overall Study||13
193321|NCT00672633|474946|P1|STARTED|Overall Study||12
193322|NCT00672646|474959|P3|NOT COMPLETED|Overall Study||3
193323|NCT00672646|474960|P2|NOT COMPLETED|Overall Study||1
193324|NCT00672646|474961|P1|NOT COMPLETED|Overall Study||0
193325|NCT00672646|474959|P3|COMPLETED|Overall Study||37
193326|NCT00672646|474960|P2|COMPLETED|Overall Study||22
193327|NCT00672646|474961|P1|COMPLETED|Overall Study||40
193328|NCT00672646|474959|P3|STARTED|Overall Study||40
193329|NCT00672646|474960|P2|STARTED|Overall Study||23
193330|NCT00672646|474961|P1|STARTED|Overall Study||40
193331|NCT00672737|474984|P1|NOT COMPLETED|Overall Study||8
193332|NCT00672737|474984|P1|COMPLETED|Overall Study||48
193333|NCT00672737|474984|P1|STARTED|Overall Study||56
193334|NCT00672841|474993|P2|NOT COMPLETED|Overall Study||15
193335|NCT00672841|474994|P1|NOT COMPLETED|Overall Study||1
193336|NCT00672841|474993|P2|COMPLETED|Overall Study||32
193337|NCT00672841|474994|P1|COMPLETED|Overall Study||16
193338|NCT00672841|474993|P2|STARTED|Overall Study||47
193339|NCT00672841|474994|P1|STARTED|Overall Study||17
193340|NCT00672854|475008|P2|NOT COMPLETED|Overall Study||0
193341|NCT00672854|475009|P1|NOT COMPLETED|Overall Study||0
193342|NCT00672854|475008|P2|COMPLETED|Overall Study||51
193343|NCT00672854|475009|P1|COMPLETED|Overall Study||49
193344|NCT00672854|475008|P2|STARTED|Overall Study||51
193345|NCT00672854|475009|P1|STARTED|Overall Study||49
193346|NCT00672932|475017|P2|NOT COMPLETED|Overall Study||0
193347|NCT00672932|475018|P1|NOT COMPLETED|Overall Study||0
193348|NCT00672932|475017|P2|COMPLETED|Overall Study||9
193349|NCT00672932|475018|P1|COMPLETED|Overall Study||9
193350|NCT00672932|475017|P2|Rolled Over to Raltegravir|Overall Study|6 subjects randomized to no drug later rolled over to receive raltegravir|6
193351|NCT00672932|475018|P1|Rolled Over to Raltegravir|Overall Study||0
193352|NCT00672932|475017|P2|Provided Analyzable Blood and CSF Sample|Overall Study||9
193353|NCT00672932|475018|P1|Provided Analyzable Blood and CSF Sample|Overall Study|one subject was censored when pharmacological study showed no drug in plasma or CSF|8
193354|NCT00672932|475017|P2|Completed Initial 12-week Assignment|Overall Study||9
193355|NCT00672932|475018|P1|Completed Initial 12-week Assignment|Overall Study||9
193356|NCT00672932|475017|P2|STARTED|Overall Study||9
193357|NCT00672932|475018|P1|STARTED|Overall Study||9
193358|NCT00672958|475028|P2|NOT COMPLETED|Overall Study||56
193359|NCT00672958|475029|P1|NOT COMPLETED|Overall Study||64
193360|NCT00672958|475028|P2|COMPLETED|Overall Study||244
193361|NCT00672958|475029|P1|COMPLETED|Overall Study||236
193362|NCT00672958|475028|P2|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|292
193363|NCT00672958|475029|P1|Full Analysis Set|Overall Study|All safety set patients who had at least 1 valid postbaseline primary efficacy assessment.|286
193364|NCT00672958|475028|P2|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|299
193365|NCT00672958|475029|P1|Safety Set|Overall Study|All randomized patients who received at least 1 dose of double-blind study drug.|298
193366|NCT00672958|475028|P2|STARTED|Overall Study||300
193367|NCT00672958|475029|P1|STARTED|Overall Study||300
193368|NCT00672984|475062|P3|NOT COMPLETED|Third Intervention||1
193369|NCT00672984|475063|P2|NOT COMPLETED|Third Intervention||0
193370|NCT00672984|475064|P1|NOT COMPLETED|Third Intervention||1
193371|NCT00672984|475062|P3|COMPLETED|Third Intervention||23
193372|NCT00672984|475063|P2|COMPLETED|Third Intervention||17
193373|NCT00672984|475064|P1|COMPLETED|Third Intervention||21
193374|NCT00672984|475062|P3|STARTED|Third Intervention||24
193375|NCT00672984|475063|P2|STARTED|Third Intervention||17
193376|NCT00672984|475064|P1|STARTED|Third Intervention||22
193377|NCT00672984|475062|P3|NOT COMPLETED|Second Intervention||1
193378|NCT00672984|475063|P2|NOT COMPLETED|Second Intervention||6
193379|NCT00672984|475064|P1|NOT COMPLETED|Second Intervention||0
193380|NCT00672984|475062|P3|COMPLETED|Second Intervention||24
193381|NCT00672984|475063|P2|COMPLETED|Second Intervention||17
193382|NCT00672984|475064|P1|COMPLETED|Second Intervention||22
193383|NCT00672984|475062|P3|STARTED|Second Intervention||25
193384|NCT00672984|475063|P2|STARTED|Second Intervention||23
193385|NCT00672984|475064|P1|STARTED|Second Intervention||22
193386|NCT00672984|475062|P3|NOT COMPLETED|First Intervention||2
193387|NCT00672984|475063|P2|NOT COMPLETED|First Intervention||2
193388|NCT00672984|475064|P1|NOT COMPLETED|First Intervention||9
193389|NCT00672984|475062|P3|COMPLETED|First Intervention||25
193390|NCT00672984|475063|P2|COMPLETED|First Intervention||23
193391|NCT00672984|475064|P1|COMPLETED|First Intervention||22
193392|NCT00672984|475062|P3|STARTED|First Intervention||27
193393|NCT00672984|475063|P2|STARTED|First Intervention||25
193394|NCT00672984|475064|P1|STARTED|First Intervention||31
193395|NCT00673049|475115|P4|NOT COMPLETED|After Progression on Erlotinib||83
193396|NCT00673049|475116|P3|NOT COMPLETED|After Progression on Erlotinib||0
193397|NCT00673049|475117|P2|NOT COMPLETED|After Progression on Erlotinib||0
193398|NCT00673049|475118|P1|NOT COMPLETED|After Progression on Erlotinib||0
193399|NCT00673049|475115|P4|COMPLETED|After Progression on Erlotinib||0
193400|NCT00673049|475116|P3|COMPLETED|After Progression on Erlotinib||0
193401|NCT00673049|475117|P2|COMPLETED|After Progression on Erlotinib||0
193402|NCT00673049|475118|P1|COMPLETED|After Progression on Erlotinib||0
193403|NCT00673049|475115|P4|STARTED|After Progression on Erlotinib||83
193404|NCT00673049|475116|P3|STARTED|After Progression on Erlotinib||0
193405|NCT00673049|475117|P2|STARTED|After Progression on Erlotinib||0
193406|NCT00673049|475118|P1|STARTED|After Progression on Erlotinib||0
193407|NCT00673049|475115|P4|NOT COMPLETED|Before Progression on Erlotinib||0
193408|NCT00673049|475116|P3|NOT COMPLETED|Before Progression on Erlotinib||1
193409|NCT00673049|475117|P2|NOT COMPLETED|Before Progression on Erlotinib||290
193410|NCT00673049|475118|P1|NOT COMPLETED|Before Progression on Erlotinib||292
193411|NCT00673049|475115|P4|COMPLETED|Before Progression on Erlotinib||0
193412|NCT00673049|475116|P3|COMPLETED|Before Progression on Erlotinib||0
193413|NCT00673049|475117|P2|COMPLETED|Before Progression on Erlotinib||0
193414|NCT00673049|475118|P1|COMPLETED|Before Progression on Erlotinib||0
193415|NCT00673049|475115|P4|Treated|Before Progression on Erlotinib||0
193416|NCT00673049|475116|P3|Treated|Before Progression on Erlotinib||1
193417|NCT00673049|475117|P2|Treated|Before Progression on Erlotinib||289
193418|NCT00673049|475118|P1|Treated|Before Progression on Erlotinib||289
193419|NCT00673049|475115|P4|STARTED|Before Progression on Erlotinib|Participants treated with erlo alone who subsequently received figi upon disease progression.|0
193420|NCT00673049|475116|P3|STARTED|Before Progression on Erlotinib||1
193421|NCT00673049|475117|P2|STARTED|Before Progression on Erlotinib||290
193422|NCT00673049|475118|P1|STARTED|Before Progression on Erlotinib||292
193423|NCT00673075|475141|P2|NOT COMPLETED|Overall Study||7
193424|NCT00673075|475142|P1|NOT COMPLETED|Overall Study||9
193425|NCT00673075|475141|P2|COMPLETED|Overall Study||11
193426|NCT00673075|475142|P1|COMPLETED|Overall Study||12
193427|NCT00673075|475141|P2|STARTED|Overall Study||18
193428|NCT00673075|475142|P1|STARTED|Overall Study||21
193429|NCT00673114|475156|P1|NOT COMPLETED|Overall Study||0
193430|NCT00673114|475156|P1|COMPLETED|Overall Study||3
193431|NCT00673114|475156|P1|STARTED|Overall Study||3
193432|NCT00673127|475167|P1|NOT COMPLETED|Overall Study||0
193433|NCT00673127|475167|P1|COMPLETED|Overall Study||57
193434|NCT00673127|475167|P1|STARTED|Overall Study||57
193435|NCT00673153|475172|P1|NOT COMPLETED|Overall Study||1
193436|NCT00673153|475172|P1|COMPLETED|Overall Study||30
193437|NCT00673153|475172|P1|STARTED|Overall Study||31
193438|NCT00673179|475182|P2|NOT COMPLETED|Overall Study||0
193439|NCT00673179|475183|P1|NOT COMPLETED|Overall Study||3
193440|NCT00673179|475182|P2|COMPLETED|Overall Study||0
193441|NCT00673179|475183|P1|COMPLETED|Overall Study||4
193442|NCT00673179|475182|P2|STARTED|Overall Study||0
193443|NCT00673179|475183|P1|STARTED|Overall Study||7
193444|NCT00673231|475193|P4|NOT COMPLETED|Overall Study||18
193445|NCT00673231|475194|P3|NOT COMPLETED|Overall Study||26
193446|NCT00673231|475195|P2|NOT COMPLETED|Overall Study||22
193447|NCT00673231|475196|P1|NOT COMPLETED|Overall Study||29
193448|NCT00673231|475193|P4|COMPLETED|Overall Study||178
193449|NCT00673231|475194|P3|COMPLETED|Overall Study||186
193450|NCT00673231|475195|P2|COMPLETED|Overall Study||180
193451|NCT00673231|475196|P1|COMPLETED|Overall Study||168
193452|NCT00673231|475193|P4|STARTED|Overall Study|Of the 196 randomized participants only 194 were included in the full analysis set|196
193453|NCT00673231|475194|P3|STARTED|Overall Study|Of the 212 randomized participants only 211 were included in the full analysis set|212
193454|NCT00673231|475195|P2|STARTED|Overall Study|All 202 were included in the full analysis set|202
193455|NCT00673231|475196|P1|STARTED|Overall Study|Of the 197 randomized participants only 193 were included in the full analysis set|197
193456|NCT00673257|475226|P1|NOT COMPLETED|Overall Study||5
193457|NCT00673257|475226|P1|COMPLETED|Overall Study||102
193458|NCT00673257|475226|P1|STARTED|Overall Study||107
193459|NCT00673361|475231|P1|NOT COMPLETED|Overall Study||2
193460|NCT00673361|475231|P1|COMPLETED|Overall Study||7
193461|NCT00673361|475231|P1|STARTED|Overall Study||9
193462|NCT00667511|475235|P1|NOT COMPLETED|Intervention 2: Home NHD||4
193463|NCT00667511|475235|P1|COMPLETED|Intervention 2: Home NHD||39
193464|NCT00667511|475235|P1|STARTED|Intervention 2: Home NHD||43
193465|NCT00667511|475235|P1|NOT COMPLETED|Training/Transition Period||8
193466|NCT00667511|475235|P1|COMPLETED|Training/Transition Period||43
193467|NCT00667511|475235|P1|STARTED|Training/Transition Period||51
193468|NCT00667511|475235|P1|NOT COMPLETED|Intervention 1: Home DHD||7
193469|NCT00667511|475235|P1|COMPLETED|Intervention 1: Home DHD||51
193470|NCT00667511|475235|P1|STARTED|Intervention 1: Home DHD||58
193471|NCT00673387|475251|P8|NOT COMPLETED|Overall Study||35
193472|NCT00673387|475252|P7|NOT COMPLETED|Overall Study||30
193473|NCT00673387|475253|P6|NOT COMPLETED|Overall Study||34
193474|NCT00673387|475254|P5|NOT COMPLETED|Overall Study||30
193475|NCT00673387|475255|P4|NOT COMPLETED|Overall Study||26
193476|NCT00673387|475256|P3|NOT COMPLETED|Overall Study||31
193477|NCT00673387|475257|P2|NOT COMPLETED|Overall Study||23
193478|NCT00673387|475258|P1|NOT COMPLETED|Overall Study||29
193479|NCT00673387|475251|P8|COMPLETED|Overall Study||40
193480|NCT00673387|475252|P7|COMPLETED|Overall Study||48
193481|NCT00673387|475253|P6|COMPLETED|Overall Study||44
193482|NCT00673387|475254|P5|COMPLETED|Overall Study||48
193483|NCT00673387|475255|P4|COMPLETED|Overall Study||49
193484|NCT00673387|475256|P3|COMPLETED|Overall Study||41
193485|NCT00673387|475257|P2|COMPLETED|Overall Study||54
193486|NCT00673387|475258|P1|COMPLETED|Overall Study||46
193487|NCT00673387|475251|P8|STARTED|Overall Study||75
193488|NCT00673387|475252|P7|STARTED|Overall Study||78
193489|NCT00673387|475253|P6|STARTED|Overall Study||78
193490|NCT00673387|475254|P5|STARTED|Overall Study||78
193491|NCT00673387|475255|P4|STARTED|Overall Study||75
193492|NCT00673387|475256|P3|STARTED|Overall Study||72
193493|NCT00673387|475257|P2|STARTED|Overall Study||77
193494|NCT00673387|475258|P1|STARTED|Overall Study||75
193495|NCT00673400|475474|P1|NOT COMPLETED|Overall Study||0
193496|NCT00673400|475474|P1|COMPLETED|Overall Study||52
193497|NCT00673400|475474|P1|STARTED|Overall Study||52
193498|NCT00673439|475491|P1|NOT COMPLETED|Overall Study||0
193499|NCT00673439|475491|P1|COMPLETED|Overall Study||3
193500|NCT00673439|475491|P1|STARTED|Overall Study||3
193501|NCT00673452|475497|P2|NOT COMPLETED|Continuation Double-Blind Phase||34
193502|NCT00673452|475498|P1|NOT COMPLETED|Continuation Double-Blind Phase||25
193503|NCT00673452|475497|P2|COMPLETED|Continuation Double-Blind Phase||153
193504|NCT00673452|475498|P1|COMPLETED|Continuation Double-Blind Phase||151
193505|NCT00673452|475497|P2|STARTED|Continuation Double-Blind Phase|Patients on placebo in acute phase received 60 mg duloxetine during the continuation phase.|187
193506|NCT00673452|475498|P1|STARTED|Continuation Double-Blind Phase||176
193507|NCT00673452|475497|P2|NOT COMPLETED|Acute Double-Blind Phase||80
193508|NCT00673452|475498|P1|NOT COMPLETED|Acute Double-Blind Phase||87
193509|NCT00673452|475497|P2|COMPLETED|Acute Double-Blind Phase||187
193510|NCT00673452|475498|P1|COMPLETED|Acute Double-Blind Phase||176
193511|NCT00673452|475497|P2|STARTED|Acute Double-Blind Phase||267
193512|NCT00673452|475498|P1|STARTED|Acute Double-Blind Phase||263
193513|NCT00673465|475532|P12|NOT COMPLETED|Part 2 (India)||0
193514|NCT00673465|475533|P11|NOT COMPLETED|Part 2 (India)||0
193515|NCT00673465|475534|P10|NOT COMPLETED|Part 2 (India)||0
193516|NCT00673465|475535|P9|NOT COMPLETED|Part 2 (India)||0
193517|NCT00673465|475536|P8|NOT COMPLETED|Part 2 (India)||0
193518|NCT00673465|475537|P7|NOT COMPLETED|Part 2 (India)||0
193519|NCT00673465|475538|P6|NOT COMPLETED|Part 2 (India)||0
193520|NCT00673465|475539|P5|NOT COMPLETED|Part 2 (India)||0
193521|NCT00673465|475540|P4|NOT COMPLETED|Part 2 (India)||0
193522|NCT00673465|475541|P3|NOT COMPLETED|Part 2 (India)||0
193523|NCT00673465|475542|P2|NOT COMPLETED|Part 2 (India)||0
193524|NCT00673465|475543|P1|NOT COMPLETED|Part 2 (India)||0
193525|NCT00673465|475532|P12|COMPLETED|Part 2 (India)||0
193526|NCT00673465|475533|P11|COMPLETED|Part 2 (India)||0
193527|NCT00673465|475534|P10|COMPLETED|Part 2 (India)||0
193528|NCT00673465|475535|P9|COMPLETED|Part 2 (India)||0
193529|NCT00673465|475536|P8|COMPLETED|Part 2 (India)||0
193530|NCT00673465|475537|P7|COMPLETED|Part 2 (India)||0
193531|NCT00673465|475538|P6|COMPLETED|Part 2 (India)||0
193532|NCT00673465|475539|P5|COMPLETED|Part 2 (India)||0
193533|NCT00673465|475540|P4|COMPLETED|Part 2 (India)||0
193534|NCT00673465|475541|P3|COMPLETED|Part 2 (India)||0
193535|NCT00673465|475542|P2|COMPLETED|Part 2 (India)||0
193536|NCT00673465|475543|P1|COMPLETED|Part 2 (India)||0
193537|NCT00673465|475532|P12|STARTED|Part 2 (India)||0
193538|NCT00673465|475533|P11|STARTED|Part 2 (India)||0
193539|NCT00673465|475534|P10|STARTED|Part 2 (India)||0
193540|NCT00673465|475535|P9|STARTED|Part 2 (India)||0
193541|NCT00673465|475536|P8|STARTED|Part 2 (India)||0
193542|NCT00673465|475537|P7|STARTED|Part 2 (India)||0
193543|NCT00673465|475538|P6|STARTED|Part 2 (India)||0
193544|NCT00673465|475539|P5|STARTED|Part 2 (India)||0
193545|NCT00673465|475540|P4|STARTED|Part 2 (India)||0
193546|NCT00673465|475541|P3|STARTED|Part 2 (India)||0
193547|NCT00673465|475542|P2|STARTED|Part 2 (India)||0
193548|NCT00673465|475543|P1|STARTED|Part 2 (India)||0
193549|NCT00673465|475532|P12|NOT COMPLETED|Part 1/Period 3 (United States)||0
193550|NCT00673465|475533|P11|NOT COMPLETED|Part 1/Period 3 (United States)||0
193551|NCT00673465|475534|P10|NOT COMPLETED|Part 1/Period 3 (United States)||0
193552|NCT00673465|475535|P9|NOT COMPLETED|Part 1/Period 3 (United States)||0
193553|NCT00673465|475536|P8|NOT COMPLETED|Part 1/Period 3 (United States)||0
193554|NCT00673465|475537|P7|NOT COMPLETED|Part 1/Period 3 (United States)||0
193555|NCT00673465|475538|P6|NOT COMPLETED|Part 1/Period 3 (United States)||0
193556|NCT00673465|475539|P5|NOT COMPLETED|Part 1/Period 3 (United States)||0
193557|NCT00673465|475540|P4|NOT COMPLETED|Part 1/Period 3 (United States)||0
193558|NCT00673465|475541|P3|NOT COMPLETED|Part 1/Period 3 (United States)||0
193559|NCT00673465|475542|P2|NOT COMPLETED|Part 1/Period 3 (United States)||0
193560|NCT00673465|475543|P1|NOT COMPLETED|Part 1/Period 3 (United States)||0
193561|NCT00673465|475532|P12|COMPLETED|Part 1/Period 3 (United States)||0
193562|NCT00673465|475533|P11|COMPLETED|Part 1/Period 3 (United States)||0
193563|NCT00673465|475534|P10|COMPLETED|Part 1/Period 3 (United States)||0
193564|NCT00673465|475535|P9|COMPLETED|Part 1/Period 3 (United States)||0
193565|NCT00673465|475536|P8|COMPLETED|Part 1/Period 3 (United States)||0
193566|NCT00673465|475537|P7|COMPLETED|Part 1/Period 3 (United States)||0
193567|NCT00673465|475538|P6|COMPLETED|Part 1/Period 3 (United States)||1
193568|NCT00673465|475539|P5|COMPLETED|Part 1/Period 3 (United States)||1
193569|NCT00673465|475540|P4|COMPLETED|Part 1/Period 3 (United States)||3
193570|NCT00673465|475541|P3|COMPLETED|Part 1/Period 3 (United States)||3
193571|NCT00673465|475542|P2|COMPLETED|Part 1/Period 3 (United States)||3
193572|NCT00673465|475543|P1|COMPLETED|Part 1/Period 3 (United States)||3
193573|NCT00673465|475532|P12|STARTED|Part 1/Period 3 (United States)||0
193574|NCT00673465|475533|P11|STARTED|Part 1/Period 3 (United States)||0
193575|NCT00673465|475534|P10|STARTED|Part 1/Period 3 (United States)||0
193576|NCT00673465|475535|P9|STARTED|Part 1/Period 3 (United States)||0
193577|NCT00673465|475536|P8|STARTED|Part 1/Period 3 (United States)||0
193578|NCT00673465|475537|P7|STARTED|Part 1/Period 3 (United States)||0
193579|NCT00673465|475538|P6|STARTED|Part 1/Period 3 (United States)||1
193580|NCT00673465|475539|P5|STARTED|Part 1/Period 3 (United States)||1
193581|NCT00673465|475540|P4|STARTED|Part 1/Period 3 (United States)||3
193582|NCT00673465|475541|P3|STARTED|Part 1/Period 3 (United States)||3
193583|NCT00673465|475542|P2|STARTED|Part 1/Period 3 (United States)||3
193584|NCT00673465|475543|P1|STARTED|Part 1/Period 3 (United States)||3
193585|NCT00673465|475532|P12|NOT COMPLETED|Part 1/Period 2 (United States)||0
193586|NCT00673465|475533|P11|NOT COMPLETED|Part 1/Period 2 (United States)||0
193587|NCT00673465|475534|P10|NOT COMPLETED|Part 1/Period 2 (United States)||0
193588|NCT00673465|475535|P9|NOT COMPLETED|Part 1/Period 2 (United States)||0
193589|NCT00673465|475536|P8|NOT COMPLETED|Part 1/Period 2 (United States)||0
193590|NCT00673465|475537|P7|NOT COMPLETED|Part 1/Period 2 (United States)||0
193591|NCT00673465|475538|P6|NOT COMPLETED|Part 1/Period 2 (United States)||0
193592|NCT00673465|475539|P5|NOT COMPLETED|Part 1/Period 2 (United States)||1
193593|NCT00673465|475540|P4|NOT COMPLETED|Part 1/Period 2 (United States)||0
193594|NCT00673465|475541|P3|NOT COMPLETED|Part 1/Period 2 (United States)||0
193595|NCT00673465|475542|P2|NOT COMPLETED|Part 1/Period 2 (United States)||0
193596|NCT00673465|475543|P1|NOT COMPLETED|Part 1/Period 2 (United States)||0
193597|NCT00673465|475532|P12|COMPLETED|Part 1/Period 2 (United States)||0
193598|NCT00673465|475533|P11|COMPLETED|Part 1/Period 2 (United States)||0
193599|NCT00673465|475534|P10|COMPLETED|Part 1/Period 2 (United States)||0
193600|NCT00673465|475535|P9|COMPLETED|Part 1/Period 2 (United States)||0
193601|NCT00673465|475536|P8|COMPLETED|Part 1/Period 2 (United States)||0
193602|NCT00673465|475537|P7|COMPLETED|Part 1/Period 2 (United States)||0
193603|NCT00673465|475538|P6|COMPLETED|Part 1/Period 2 (United States)||1
193604|NCT00673465|475539|P5|COMPLETED|Part 1/Period 2 (United States)||1
193605|NCT00673465|475540|P4|COMPLETED|Part 1/Period 2 (United States)||3
193606|NCT00673465|475541|P3|COMPLETED|Part 1/Period 2 (United States)||3
193607|NCT00673465|475542|P2|COMPLETED|Part 1/Period 2 (United States)||3
193608|NCT00673465|475543|P1|COMPLETED|Part 1/Period 2 (United States)||3
193609|NCT00673465|475532|P12|STARTED|Part 1/Period 2 (United States)||0
193610|NCT00673465|475533|P11|STARTED|Part 1/Period 2 (United States)||0
193611|NCT00673465|475534|P10|STARTED|Part 1/Period 2 (United States)||0
193612|NCT00673465|475535|P9|STARTED|Part 1/Period 2 (United States)||0
193613|NCT00673465|475536|P8|STARTED|Part 1/Period 2 (United States)||0
193614|NCT00673465|475537|P7|STARTED|Part 1/Period 2 (United States)||0
193615|NCT00673465|475538|P6|STARTED|Part 1/Period 2 (United States)||1
193616|NCT00673465|475539|P5|STARTED|Part 1/Period 2 (United States)||2
193617|NCT00673465|475540|P4|STARTED|Part 1/Period 2 (United States)||3
193618|NCT00673465|475541|P3|STARTED|Part 1/Period 2 (United States)||3
193619|NCT00673465|475542|P2|STARTED|Part 1/Period 2 (United States)||3
193620|NCT00673465|475543|P1|STARTED|Part 1/Period 2 (United States)||3
193621|NCT00673465|475532|P12|NOT COMPLETED|Part 1/Period 1 (United States)||0
193622|NCT00673465|475533|P11|NOT COMPLETED|Part 1/Period 1 (United States)||0
193623|NCT00673465|475534|P10|NOT COMPLETED|Part 1/Period 1 (United States)||0
193624|NCT00673465|475535|P9|NOT COMPLETED|Part 1/Period 1 (United States)||0
193625|NCT00673465|475536|P8|NOT COMPLETED|Part 1/Period 1 (United States)||0
193626|NCT00673465|475537|P7|NOT COMPLETED|Part 1/Period 1 (United States)||0
193627|NCT00673465|475538|P6|NOT COMPLETED|Part 1/Period 1 (United States)||1
193628|NCT00673465|475539|P5|NOT COMPLETED|Part 1/Period 1 (United States)||1
193629|NCT00673465|475540|P4|NOT COMPLETED|Part 1/Period 1 (United States)||0
193630|NCT00673465|475541|P3|NOT COMPLETED|Part 1/Period 1 (United States)||0
193631|NCT00673465|475542|P2|NOT COMPLETED|Part 1/Period 1 (United States)||0
193632|NCT00673465|475543|P1|NOT COMPLETED|Part 1/Period 1 (United States)||0
193633|NCT00673465|475532|P12|COMPLETED|Part 1/Period 1 (United States)||0
193634|NCT00673465|475533|P11|COMPLETED|Part 1/Period 1 (United States)||0
193635|NCT00673465|475534|P10|COMPLETED|Part 1/Period 1 (United States)||0
193636|NCT00673465|475535|P9|COMPLETED|Part 1/Period 1 (United States)||0
193637|NCT00673465|475536|P8|COMPLETED|Part 1/Period 1 (United States)||0
193638|NCT00673465|475537|P7|COMPLETED|Part 1/Period 1 (United States)||0
193639|NCT00673465|475538|P6|COMPLETED|Part 1/Period 1 (United States)||1
193640|NCT00673465|475539|P5|COMPLETED|Part 1/Period 1 (United States)||2
193641|NCT00673465|475540|P4|COMPLETED|Part 1/Period 1 (United States)||3
193642|NCT00673465|475541|P3|COMPLETED|Part 1/Period 1 (United States)||3
193643|NCT00673465|475542|P2|COMPLETED|Part 1/Period 1 (United States)||3
193644|NCT00673465|475543|P1|COMPLETED|Part 1/Period 1 (United States)||3
193645|NCT00673465|475532|P12|STARTED|Part 1/Period 1 (United States)||0
193646|NCT00673465|475533|P11|STARTED|Part 1/Period 1 (United States)||0
193647|NCT00673465|475534|P10|STARTED|Part 1/Period 1 (United States)||0
193648|NCT00673465|475535|P9|STARTED|Part 1/Period 1 (United States)||0
193649|NCT00673465|475536|P8|STARTED|Part 1/Period 1 (United States)||0
193650|NCT00673465|475537|P7|STARTED|Part 1/Period 1 (United States)||0
193651|NCT00673465|475538|P6|STARTED|Part 1/Period 1 (United States)||2
193652|NCT00673465|475539|P5|STARTED|Part 1/Period 1 (United States)||3
193653|NCT00673465|475540|P4|STARTED|Part 1/Period 1 (United States)||3
193654|NCT00673465|475541|P3|STARTED|Part 1/Period 1 (United States)||3
193655|NCT00673465|475542|P2|STARTED|Part 1/Period 1 (United States)||3
193656|NCT00673465|475543|P1|STARTED|Part 1/Period 1 (United States)||3
193657|NCT00673595|475592|P2|NOT COMPLETED|Overall Study||0
193658|NCT00673595|475593|P1|NOT COMPLETED|Overall Study||0
193659|NCT00673595|475592|P2|COMPLETED|Overall Study||11
193660|NCT00673595|475593|P1|COMPLETED|Overall Study||8
193661|NCT00673595|475592|P2|STARTED|Overall Study||11
193662|NCT00673595|475593|P1|STARTED|Overall Study||8
193663|NCT00673660|475601|P1|NOT COMPLETED|Overall Study||107
193664|NCT00673660|475601|P1|COMPLETED|Overall Study||268
193665|NCT00673660|475601|P1|STARTED|Overall Study||375
193666|NCT00673673|475612|P1|NOT COMPLETED|Overall Study||36
193667|NCT00673673|475612|P1|COMPLETED|Overall Study||3
193668|NCT00673673|475612|P1|STARTED|Overall Study||39
193669|NCT00675259|475618|P1|NOT COMPLETED|Overall Study||14
193670|NCT00675259|475618|P1|COMPLETED|Overall Study||19
193671|NCT00675259|475618|P1|STARTED|Overall Study||33
193672|NCT00675415|475629|P2|NOT COMPLETED|Overall Study||8
193673|NCT00675415|475630|P1|NOT COMPLETED|Overall Study||8
193674|NCT00675415|475629|P2|COMPLETED|Overall Study||123
193675|NCT00675415|475630|P1|COMPLETED|Overall Study||124
193676|NCT00675415|475629|P2|STARTED|Overall Study||131
193677|NCT00675415|475630|P1|STARTED|Overall Study||132
193678|NCT00675428|475638|P2|NOT COMPLETED|Overall Study||3
193679|NCT00675428|475639|P1|NOT COMPLETED|Overall Study||3
193680|NCT00675428|475638|P2|COMPLETED|Overall Study||0
193681|NCT00675428|475639|P1|COMPLETED|Overall Study||0
193682|NCT00675428|475638|P2|STARTED|Overall Study||3
193683|NCT00675428|475639|P1|STARTED|Overall Study||3
193684|NCT00675441|475657|P1|NOT COMPLETED|Overall Study||3
193685|NCT00675441|475657|P1|COMPLETED|Overall Study||2
193686|NCT00675441|475657|P1|STARTED|Overall Study||5
193687|NCT00675506|475663|P2|NOT COMPLETED|Overall Study||12
193688|NCT00675506|475664|P1|NOT COMPLETED|Overall Study||12
193689|NCT00675506|475663|P2|COMPLETED|Overall Study||17
193690|NCT00675506|475664|P1|COMPLETED|Overall Study||19
193691|NCT00675506|475663|P2|Received Intervention|Overall Study||29
193692|NCT00675506|475664|P1|Received Intervention|Overall Study|Two subjects did not start treatment: 1) disclosed cancer history, 2) declined participation.|29
193693|NCT00675506|475663|P2|STARTED|Overall Study||29
193694|NCT00675506|475664|P1|STARTED|Overall Study||31
193695|NCT00675558|475679|P3|NOT COMPLETED|Second Operation||0
193696|NCT00675558|475680|P2|NOT COMPLETED|Second Operation||0
193697|NCT00675558|475681|P1|NOT COMPLETED|Second Operation||0
193698|NCT00675558|475679|P3|COMPLETED|Second Operation||10
193699|NCT00675558|475680|P2|COMPLETED|Second Operation||0
193700|NCT00675558|475681|P1|COMPLETED|Second Operation||0
193701|NCT00675558|475679|P3|STARTED|Second Operation|As predicted, only 10 SMO patients medically required a second operation, and thus met study goals.|10
193702|NCT00675558|475680|P2|STARTED|Second Operation|No medical reason, and none for the goals of the study, for MO pts to have a second procedure .|0
193703|NCT00675558|475681|P1|STARTED|Second Operation|No medical reason, and no study-related reason for non-obese pts to have a second procedure.|0
193704|NCT00675558|475679|P3|NOT COMPLETED|Surgery||0
193705|NCT00675558|475680|P2|NOT COMPLETED|Surgery||0
193706|NCT00675558|475681|P1|NOT COMPLETED|Surgery||0
193707|NCT00675558|475679|P3|COMPLETED|Surgery||30
193708|NCT00675558|475680|P2|COMPLETED|Surgery||10
193709|NCT00675558|475681|P1|COMPLETED|Surgery||10
193710|NCT00675558|475679|P3|STARTED|Surgery||30
193711|NCT00675558|475680|P2|STARTED|Surgery||10
193712|NCT00675558|475681|P1|STARTED|Surgery||10
193713|NCT00675584|475697|P2|NOT COMPLETED|Overall Study||26
193714|NCT00675584|475698|P1|NOT COMPLETED|Overall Study||39
193715|NCT00675584|475697|P2|COMPLETED|Overall Study||113
193716|NCT00675584|475698|P1|COMPLETED|Overall Study||100
193717|NCT00675584|475697|P2|STARTED|Overall Study||139
193718|NCT00675584|475698|P1|STARTED|Overall Study||139
193719|NCT00675597|475704|P1|NOT COMPLETED|Overall Study||3
193720|NCT00675597|475704|P1|COMPLETED|Overall Study||23
193721|NCT00675597|475704|P1|STARTED|Overall Study||26
193722|NCT00675766|475712|P4|NOT COMPLETED|Overall Study||26
193723|NCT00675766|475713|P3|NOT COMPLETED|Overall Study||21
193724|NCT00675766|475714|P2|NOT COMPLETED|Overall Study||5
193725|NCT00675766|475715|P1|NOT COMPLETED|Overall Study||6
193726|NCT00675766|475712|P4|COMPLETED|Overall Study||11
193727|NCT00675766|475713|P3|COMPLETED|Overall Study||29
193728|NCT00675766|475714|P2|COMPLETED|Overall Study||25
193729|NCT00675766|475715|P1|COMPLETED|Overall Study||100
193730|NCT00675766|475712|P4|Year 3|Overall Study||11
193731|NCT00675766|475713|P3|Year 3|Overall Study||29
193732|NCT00675766|475714|P2|Year 3|Overall Study||25
193733|NCT00675766|475715|P1|Year 3|Overall Study||100
193734|NCT00675766|475712|P4|Year 2|Overall Study||20
193735|NCT00675766|475713|P3|Year 2|Overall Study||34
193736|NCT00675766|475714|P2|Year 2|Overall Study||28
193737|NCT00675766|475715|P1|Year 2|Overall Study||105
193738|NCT00675766|475712|P4|STARTED|Overall Study||37
193739|NCT00675766|475713|P3|STARTED|Overall Study||50
193740|NCT00675766|475714|P2|STARTED|Overall Study||30
193741|NCT00675766|475715|P1|STARTED|Overall Study||106
193742|NCT00675792|475727|P2|NOT COMPLETED|Overall Study||0
193743|NCT00675792|475728|P1|NOT COMPLETED|Overall Study||0
193744|NCT00675792|475727|P2|COMPLETED|Overall Study||49
193745|NCT00675792|475728|P1|COMPLETED|Overall Study||51
193746|NCT00675792|475727|P2|STARTED|Overall Study||49
193747|NCT00675792|475728|P1|STARTED|Overall Study||51
193748|NCT00675909|475747|P3|NOT COMPLETED|Overall Study||0
193749|NCT00675909|475748|P2|NOT COMPLETED|Overall Study||0
193750|NCT00675909|475749|P1|NOT COMPLETED|Overall Study||0
193751|NCT00675909|475747|P3|COMPLETED|Overall Study||60
193752|NCT00675909|475748|P2|COMPLETED|Overall Study||60
193753|NCT00675909|475749|P1|COMPLETED|Overall Study||60
193754|NCT00675909|475747|P3|STARTED|Overall Study||60
193755|NCT00675909|475748|P2|STARTED|Overall Study||60
193756|NCT00675909|475749|P1|STARTED|Overall Study||60
193757|NCT00675922|475757|P1|NOT COMPLETED|Overall Study||0
193758|NCT00675922|475757|P1|COMPLETED|Overall Study||98
193759|NCT00675922|475757|P1|STARTED|Overall Study||98
193760|NCT00675948|475764|P2|NOT COMPLETED|Overall Study||3
193761|NCT00675948|475765|P1|NOT COMPLETED|Overall Study||39
193762|NCT00675948|475764|P2|COMPLETED|Overall Study||1
193763|NCT00675948|475765|P1|COMPLETED|Overall Study||0
193764|NCT00675948|475764|P2|STARTED|Overall Study||4
193765|NCT00675948|475765|P1|STARTED|Overall Study||39
193766|NCT00675987|475777|P2|NOT COMPLETED|Overall Study||0
193767|NCT00675987|475778|P1|NOT COMPLETED|Overall Study||0
193768|NCT00675987|475777|P2|COMPLETED|Overall Study||27
193769|NCT00675987|475778|P1|COMPLETED|Overall Study||26
193770|NCT00675987|475777|P2|STARTED|Overall Study||27
193771|NCT00675987|475778|P1|STARTED|Overall Study||26
193772|NCT00676026|475786|P1|NOT COMPLETED|Overall Study||0
193773|NCT00676026|475786|P1|COMPLETED|Overall Study||8
193774|NCT00676026|475786|P1|STARTED|Overall Study||8
193775|NCT00676065|475793|P3|NOT COMPLETED|Overall Study||0
193776|NCT00676065|475794|P2|NOT COMPLETED|Overall Study||0
193777|NCT00676065|475795|P1|NOT COMPLETED|Overall Study||0
193778|NCT00676065|475793|P3|COMPLETED|Overall Study||26341
193779|NCT00676065|475794|P2|COMPLETED|Overall Study||15428
193780|NCT00676065|475795|P1|COMPLETED|Overall Study||16534
193781|NCT00676065|475793|P3|STARTED|Overall Study||26341
193782|NCT00676065|475794|P2|STARTED|Overall Study||15428
193783|NCT00676065|475795|P1|STARTED|Overall Study||16534
193784|NCT00676091|475811|P2|NOT COMPLETED|Toddler Dose||0
193785|NCT00676091|475812|P1|NOT COMPLETED|Toddler Dose||3
193786|NCT00676091|475811|P2|COMPLETED|Toddler Dose||156
193787|NCT00676091|475812|P1|COMPLETED|Toddler Dose||153
193788|NCT00676091|475811|P2|STARTED|Toddler Dose||156
193789|NCT00676091|475812|P1|STARTED|Toddler Dose||156
193790|NCT00676091|475811|P2|NOT COMPLETED|After Infant Series||3
193791|NCT00676091|475812|P1|NOT COMPLETED|After Infant Series||1
193792|NCT00676091|475811|P2|COMPLETED|After Infant Series||156
193793|NCT00676091|475812|P1|COMPLETED|After Infant Series||156
193794|NCT00676091|475811|P2|STARTED|After Infant Series||159
193795|NCT00676091|475812|P1|STARTED|After Infant Series||157
193796|NCT00676091|475811|P2|NOT COMPLETED|Infant Series||18
193797|NCT00676091|475812|P1|NOT COMPLETED|Infant Series||20
193798|NCT00676091|475811|P2|COMPLETED|Infant Series||159
193799|NCT00676091|475812|P1|COMPLETED|Infant Series||157
193800|NCT00676091|475811|P2|Vaccinated Dose 3|Infant Series||161
193801|NCT00676091|475812|P1|Vaccinated Dose 3|Infant Series||158
193802|NCT00676091|475811|P2|Vaccinated Dose 2|Infant Series||162
193803|NCT00676091|475812|P1|Vaccinated Dose 2|Infant Series||159
193804|NCT00676091|475811|P2|Vaccinated Dose 1|Infant Series||162
193805|NCT00676091|475812|P1|Vaccinated Dose 1|Infant Series||163
193806|NCT00676091|475811|P2|STARTED|Infant Series||177
193807|NCT00676091|475812|P1|STARTED|Infant Series||177
193808|NCT00676130|475846|P2|NOT COMPLETED|Overall Study||4
193809|NCT00676130|475847|P1|NOT COMPLETED|Overall Study||3
193810|NCT00676130|475846|P2|COMPLETED|Overall Study||73
193811|NCT00676130|475847|P1|COMPLETED|Overall Study||73
193812|NCT00676130|475846|P2|STARTED|Overall Study||77
193813|NCT00676130|475847|P1|STARTED|Overall Study||76
193814|NCT00676143|475857|P2|NOT COMPLETED|Overall Study||260
193815|NCT00676143|475858|P1|NOT COMPLETED|Overall Study||156
193816|NCT00676143|475857|P2|COMPLETED|Overall Study||398
193817|NCT00676143|475858|P1|COMPLETED|Overall Study||285
193818|NCT00676143|475857|P2|Treated|Overall Study||654
193819|NCT00676143|475858|P1|Treated|Overall Study||439
193820|NCT00676143|475857|P2|STARTED|Overall Study||658
193821|NCT00676143|475858|P1|STARTED|Overall Study||441
193822|NCT00676182|475898|P1|NOT COMPLETED|Overall Study||0
193823|NCT00676182|475898|P1|COMPLETED|Overall Study||75
193824|NCT00676182|475898|P1|STARTED|Overall Study||75
193825|NCT00676195|475911|P1|NOT COMPLETED|Overall Study||3
193826|NCT00676195|475911|P1|COMPLETED|Overall Study||21
193827|NCT00676195|475911|P1|STARTED|Overall Study||24
193828|NCT00676208|475921|P2|NOT COMPLETED|Overall Study||6
193829|NCT00676208|475922|P1|NOT COMPLETED|Overall Study||2
193830|NCT00676208|475921|P2|COMPLETED|Overall Study||13
193831|NCT00676208|475922|P1|COMPLETED|Overall Study||12
193832|NCT00676208|475921|P2|STARTED|Overall Study||19
193833|NCT00676208|475922|P1|STARTED|Overall Study||14
193834|NCT00676338|475934|P4|NOT COMPLETED|Overall Study||23
193835|NCT00676338|475935|P3|NOT COMPLETED|Overall Study||30
193836|NCT00676338|475936|P2|NOT COMPLETED|Overall Study||33
193837|NCT00676338|475937|P1|NOT COMPLETED|Overall Study||38
193838|NCT00676338|475934|P4|COMPLETED|Overall Study||140
193839|NCT00676338|475935|P3|COMPLETED|Overall Study||133
193840|NCT00676338|475936|P2|COMPLETED|Overall Study||213
193841|NCT00676338|475937|P1|COMPLETED|Overall Study||210
193842|NCT00676338|475934|P4|STARTED|Overall Study||163
193843|NCT00676338|475935|P3|STARTED|Overall Study||163
193844|NCT00676338|475936|P2|STARTED|Overall Study||246
193845|NCT00676338|475937|P1|STARTED|Overall Study||248
193846|NCT00676364|475989|P2|NOT COMPLETED|Overall Study||0
193847|NCT00676364|475990|P1|NOT COMPLETED|Overall Study||0
193848|NCT00676364|475989|P2|COMPLETED|Overall Study||57
193849|NCT00676364|475990|P1|COMPLETED|Overall Study||57
193850|NCT00676364|475989|P2|STARTED|Overall Study||57
193851|NCT00676364|475990|P1|STARTED|Overall Study||57
193852|NCT00676403|476004|P6|NOT COMPLETED|Overall Study||5
193853|NCT00676403|476005|P5|NOT COMPLETED|Overall Study||1
193854|NCT00676403|476006|P4|NOT COMPLETED|Overall Study||5
193855|NCT00676403|476007|P3|NOT COMPLETED|Overall Study||1
193856|NCT00676403|476008|P2|NOT COMPLETED|Overall Study||2
193857|NCT00676403|476009|P1|NOT COMPLETED|Overall Study||2
193858|NCT00676403|476004|P6|COMPLETED|Overall Study||18
193859|NCT00676403|476005|P5|COMPLETED|Overall Study||23
193860|NCT00676403|476006|P4|COMPLETED|Overall Study||17
193861|NCT00676403|476007|P3|COMPLETED|Overall Study||22
193862|NCT00676403|476008|P2|COMPLETED|Overall Study||20
193863|NCT00676403|476009|P1|COMPLETED|Overall Study||21
193864|NCT00676403|476004|P6|STARTED|Overall Study||23
193865|NCT00676403|476005|P5|STARTED|Overall Study||24
193866|NCT00676403|476006|P4|STARTED|Overall Study||22
193867|NCT00676403|476007|P3|STARTED|Overall Study||23
193868|NCT00676403|476008|P2|STARTED|Overall Study||22
193869|NCT00676403|476009|P1|STARTED|Overall Study||23
193870|NCT00676455|476137|P1|NOT COMPLETED|Overall Study||0
193871|NCT00676455|476137|P1|COMPLETED|Overall Study||14
193872|NCT00676455|476137|P1|STARTED|Overall Study||14
193873|NCT00676494|476142|P1|NOT COMPLETED|Overall Study||14
193874|NCT00676494|476142|P1|COMPLETED|Overall Study||158
193875|NCT00676494|476142|P1|STARTED|Overall Study||172
193876|NCT00676520|476148|P1|NOT COMPLETED|Overall Study||731
193877|NCT00676520|476148|P1|COMPLETED|Overall Study||7309
193878|NCT00676520|476148|P1|STARTED|Overall Study||8040
193879|NCT00676585|476207|P2|NOT COMPLETED|Overall Study||0
193880|NCT00676585|476208|P1|NOT COMPLETED|Overall Study||0
193881|NCT00676585|476207|P2|COMPLETED|Overall Study||25
193882|NCT00676585|476208|P1|COMPLETED|Overall Study||25
193883|NCT00676585|476207|P2|STARTED|Overall Study||25
193884|NCT00676585|476208|P1|STARTED|Overall Study||25
193885|NCT00676650|476220|P2|NOT COMPLETED|Overall Study||289
193886|NCT00676650|476221|P1|NOT COMPLETED|Overall Study||584
193887|NCT00676650|476220|P2|COMPLETED|Overall Study||0
193888|NCT00676650|476221|P1|COMPLETED|Overall Study||0
193889|NCT00676650|476220|P2|Treated|Overall Study||285
193890|NCT00676650|476221|P1|Treated|Overall Study||581
193891|NCT00676650|476220|P2|STARTED|Overall Study||289
193892|NCT00676650|476221|P1|STARTED|Overall Study||584
193893|NCT00676676|476239|P1|NOT COMPLETED|Overall Study||0
193894|NCT00676676|476239|P1|COMPLETED|Overall Study||9
193895|NCT00676676|476239|P1|STARTED|Overall Study||9
193896|NCT00676689|476243|P1|NOT COMPLETED|Overall Study||61
193897|NCT00676689|476243|P1|COMPLETED|Overall Study||20
193898|NCT00676689|476243|P1|1 Year Follow-up|Overall Study||64
193899|NCT00676689|476243|P1|30 Day Follow-up|Overall Study||78
193900|NCT00676689|476243|P1|Procedure|Overall Study|Two enrolled patients did not meet eligibility criteria and did not undergo the study procedure.|79
193901|NCT00676689|476243|P1|STARTED|Overall Study||81
193902|NCT00676715|476253|P4|NOT COMPLETED|Overall Study||40
193903|NCT00676715|476254|P3|NOT COMPLETED|Overall Study||41
193904|NCT00676715|476255|P2|NOT COMPLETED|Overall Study||47
193905|NCT00676715|476256|P1|NOT COMPLETED|Overall Study||40
193906|NCT00676715|476253|P4|COMPLETED|Overall Study||14
193907|NCT00676715|476254|P3|COMPLETED|Overall Study||14
193908|NCT00676715|476255|P2|COMPLETED|Overall Study||8
193909|NCT00676715|476256|P1|COMPLETED|Overall Study||14
193910|NCT00676715|476253|P4|STARTED|Overall Study||54
193911|NCT00676715|476254|P3|STARTED|Overall Study||55
193912|NCT00676715|476255|P2|STARTED|Overall Study||55
193913|NCT00676715|476256|P1|STARTED|Overall Study||54
193914|NCT00676780|476286|P1|NOT COMPLETED|Overall Study||7
193915|NCT00676780|476286|P1|COMPLETED|Overall Study||26
193916|NCT00676780|476286|P1|STARTED|Overall Study||33
193917|NCT00676793|476292|P1|NOT COMPLETED|Overall Study||13
193918|NCT00676793|476292|P1|COMPLETED|Overall Study||19
193919|NCT00676793|476292|P1|STARTED|Overall Study||32
193920|NCT00676806|476299|P2|NOT COMPLETED|Overall Study||0
193921|NCT00676806|476300|P1|NOT COMPLETED|Overall Study||0
193922|NCT00676806|476299|P2|COMPLETED|Overall Study||3
193923|NCT00676806|476300|P1|COMPLETED|Overall Study||3
193924|NCT00676806|476299|P2|STARTED|Overall Study||3
193925|NCT00676806|476300|P1|STARTED|Overall Study||3
193926|NCT00676897|476318|P2|NOT COMPLETED|Overall Study||0
193927|NCT00676897|476319|P1|NOT COMPLETED|Overall Study||0
193928|NCT00676897|476318|P2|COMPLETED|Overall Study||10
193929|NCT00676897|476319|P1|COMPLETED|Overall Study||8
193930|NCT00676897|476318|P2|STARTED|Overall Study||10
193931|NCT00676897|476319|P1|STARTED|Overall Study||8
193932|NCT00677014|476330|P3|NOT COMPLETED|Overall Study||49
193933|NCT00677014|476331|P2|NOT COMPLETED|Overall Study||41
193934|NCT00677014|476332|P1|NOT COMPLETED|Overall Study||44
193935|NCT00677014|476330|P3|COMPLETED|Overall Study||283
193936|NCT00677014|476331|P2|COMPLETED|Overall Study||282
193937|NCT00677014|476332|P1|COMPLETED|Overall Study||281
193938|NCT00677014|476330|P3|STARTED|Overall Study||332
193939|NCT00677014|476331|P2|STARTED|Overall Study||323
193940|NCT00677014|476332|P1|STARTED|Overall Study||325
193941|NCT00677092|476340|P1|NOT COMPLETED|Overall Study||6
193942|NCT00677092|476340|P1|COMPLETED|Overall Study||6
193943|NCT00677092|476340|P1|Received Study Treatment|Overall Study||11
193944|NCT00677092|476340|P1|STARTED|Overall Study||12
193945|NCT00677235|476351|P2|NOT COMPLETED|Overall Study||38
193946|NCT00677235|476352|P1|NOT COMPLETED|Overall Study||41
193947|NCT00677235|476351|P2|COMPLETED|Overall Study||94
193948|NCT00677235|476352|P1|COMPLETED|Overall Study||97
193949|NCT00677235|476351|P2|STARTED|Overall Study||132
193950|NCT00677235|476352|P1|STARTED|Overall Study||138
193951|NCT00677352|476394|P2|NOT COMPLETED|Tapering Phase||10
193952|NCT00677352|476395|P1|NOT COMPLETED|Tapering Phase||6
193953|NCT00677352|476394|P2|COMPLETED|Tapering Phase||112
193954|NCT00677352|476395|P1|COMPLETED|Tapering Phase||126
193955|NCT00677352|476394|P2|STARTED|Tapering Phase||122
193956|NCT00677352|476395|P1|STARTED|Tapering Phase||132
193957|NCT00677352|476394|P2|NOT COMPLETED|Treatment Phase||42
193958|NCT00677352|476395|P1|NOT COMPLETED|Treatment Phase||25
193959|NCT00677352|476394|P2|COMPLETED|Treatment Phase||122
193960|NCT00677352|476395|P1|COMPLETED|Treatment Phase||132
193961|NCT00677352|476394|P2|STARTED|Treatment Phase|2 subjects were not teated, therefore 162 subjects were treated with paroxetine.|164
193962|NCT00677352|476395|P1|STARTED|Treatment Phase|All 157 subjects were treated with Sertraline.|157
193963|NCT00677365|476417|P4|NOT COMPLETED|Overall Study||3
193964|NCT00677365|476418|P3|NOT COMPLETED|Overall Study||2
193965|NCT00677365|476419|P2|NOT COMPLETED|Overall Study||1
193966|NCT00677365|476420|P1|NOT COMPLETED|Overall Study||2
193967|NCT00677365|476417|P4|COMPLETED|Overall Study||36
193968|NCT00677365|476418|P3|COMPLETED|Overall Study||35
193969|NCT00677365|476419|P2|COMPLETED|Overall Study||37
193970|NCT00677365|476420|P1|COMPLETED|Overall Study||35
193971|NCT00677365|476417|P4|STARTED|Overall Study||39
193972|NCT00677365|476418|P3|STARTED|Overall Study||37
193973|NCT00677365|476419|P2|STARTED|Overall Study||38
193974|NCT00677365|476420|P1|STARTED|Overall Study||37
193975|NCT00677534|476450|P1|NOT COMPLETED|After Paricalcitol Restart (Weeks 13-14)||0
193976|NCT00677534|476450|P1|COMPLETED|After Paricalcitol Restart (Weeks 13-14)||7
193977|NCT00677534|476450|P1|STARTED|After Paricalcitol Restart (Weeks 13-14)||7
193978|NCT00677534|476450|P1|NOT COMPLETED|Cholecalciferol (Weeks 5-12)||0
193979|NCT00677534|476450|P1|COMPLETED|Cholecalciferol (Weeks 5-12)||7
193980|NCT00677534|476450|P1|STARTED|Cholecalciferol (Weeks 5-12)||7
193981|NCT00677534|476450|P1|NOT COMPLETED|Washout (Weeks 1-4)||3
193982|NCT00677534|476450|P1|COMPLETED|Washout (Weeks 1-4)||7
193983|NCT00677534|476450|P1|STARTED|Washout (Weeks 1-4)||10
193984|NCT00677690|476456|P2|NOT COMPLETED|Overall Study||0
193985|NCT00677690|476457|P1|NOT COMPLETED|Overall Study||0
193986|NCT00677690|476456|P2|COMPLETED|Overall Study||41
193987|NCT00677690|476457|P1|COMPLETED|Overall Study||42
193988|NCT00677690|476456|P2|STARTED|Overall Study||41
193989|NCT00677690|476457|P1|STARTED|Overall Study||42
193990|NCT00670449|476475|P4|NOT COMPLETED|Overall Study||8
193991|NCT00670449|476476|P3|NOT COMPLETED|Overall Study||9
193992|NCT00670449|476477|P2|NOT COMPLETED|Overall Study||10
193993|NCT00670449|476478|P1|NOT COMPLETED|Overall Study||9
193994|NCT00670449|476475|P4|COMPLETED|Overall Study||15
193995|NCT00670449|476476|P3|COMPLETED|Overall Study||18
193996|NCT00670449|476477|P2|COMPLETED|Overall Study||36
193997|NCT00670449|476478|P1|COMPLETED|Overall Study||38
193998|NCT00670449|476475|P4|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|17
193999|NCT00670449|476476|P3|Switched to 0.5mg (Open Label)|Overall Study||23
194000|NCT00670449|476477|P2|Switched to 0.5mg (Open Label)|Overall Study|Following protocol amendment, study became open-label with all patients receiving FTY720 0.5 mg/day|41
194001|NCT00670449|476478|P1|Switched to 0.5mg (Open Label)|Overall Study||45
194002|NCT00670449|476475|P4|STARTED|Overall Study||23
194003|NCT00670449|476476|P3|STARTED|Overall Study||27
194004|NCT00670449|476477|P2|STARTED|Overall Study||46
194005|NCT00670449|476478|P1|STARTED|Overall Study||47
194006|NCT00670462|476504|P2|NOT COMPLETED|Overall Study||31
194007|NCT00670462|476505|P1|NOT COMPLETED|Overall Study||30
194008|NCT00670462|476504|P2|COMPLETED|Overall Study||76
194009|NCT00670462|476505|P1|COMPLETED|Overall Study||76
194010|NCT00670462|476504|P2|STARTED|Overall Study||107
194011|NCT00670462|476505|P1|STARTED|Overall Study||106
194012|NCT00670540|476533|P1|NOT COMPLETED|Overall Study||3325
194013|NCT00670540|476533|P1|COMPLETED|Overall Study|total recruited for the follow up|4931
194014|NCT00670540|476533|P1|STARTED|Overall Study||8256
194018|NCT00670709|476551|P2|NOT COMPLETED|Overall Study||0
194019|NCT00670709|476552|P1|NOT COMPLETED|Overall Study||0
194020|NCT00670709|476551|P2|COMPLETED|Overall Study||15
194021|NCT00670709|476552|P1|COMPLETED|Overall Study||27
194022|NCT00670709|476551|P2|STARTED|Overall Study||15
194023|NCT00670709|476552|P1|STARTED|Overall Study||27
194024|NCT00670748|476564|P4|NOT COMPLETED|Overall Study||1
194025|NCT00670748|476565|P3|NOT COMPLETED|Overall Study||2
194026|NCT00670748|476566|P2|NOT COMPLETED|Overall Study||2
194027|NCT00670748|476567|P1|NOT COMPLETED|Overall Study||3
194028|NCT00670748|476564|P4|COMPLETED|Overall Study||4
194029|NCT00670748|476565|P3|COMPLETED|Overall Study||5
194030|NCT00670748|476566|P2|COMPLETED|Overall Study||14
194031|NCT00670748|476567|P1|COMPLETED|Overall Study||14
194032|NCT00670748|476564|P4|STARTED|Overall Study||5
194033|NCT00670748|476565|P3|STARTED|Overall Study||7
194034|NCT00670748|476566|P2|STARTED|Overall Study||16
194035|NCT00670748|476567|P1|STARTED|Overall Study||17
194036|NCT00670800|476587|P2|NOT COMPLETED|Overall Study||2
194037|NCT00670800|476588|P1|NOT COMPLETED|Overall Study||0
194038|NCT00670800|476587|P2|COMPLETED|Overall Study|Two controls were found to have insulin resistance and were excluded from analysis.|5
194039|NCT00670800|476588|P1|COMPLETED|Overall Study||7
194040|NCT00670800|476587|P2|STARTED|Overall Study||7
194041|NCT00670800|476588|P1|STARTED|Overall Study||7
194042|NCT00677807|476607|P3|NOT COMPLETED|Overall Study||20
194043|NCT00677807|476608|P2|NOT COMPLETED|Overall Study||11
194044|NCT00677807|476609|P1|NOT COMPLETED|Overall Study||18
194045|NCT00677807|476607|P3|COMPLETED|Overall Study||105
194046|NCT00677807|476608|P2|COMPLETED|Overall Study||135
194047|NCT00677807|476609|P1|COMPLETED|Overall Study||126
194048|NCT00677807|476607|P3|Safety/ITT: Received Study Drug|Overall Study|One patient did not take study medication.|124
194049|NCT00677807|476608|P2|Safety/ITT: Received Study Drug|Overall Study||146
194050|NCT00677807|476609|P1|Safety/ITT: Received Study Drug|Overall Study||144
194051|NCT00677807|476607|P3|STARTED|Overall Study||125
194052|NCT00677807|476608|P2|STARTED|Overall Study||146
194053|NCT00677807|476609|P1|STARTED|Overall Study||144
194054|NCT00677820|476640|P2|NOT COMPLETED|Overall Study||0
194055|NCT00677820|476641|P1|NOT COMPLETED|Overall Study||1
194056|NCT00677820|476640|P2|COMPLETED|Overall Study||60
194057|NCT00677820|476641|P1|COMPLETED|Overall Study||239
194058|NCT00677820|476640|P2|STARTED|Overall Study||60
194059|NCT00677820|476641|P1|STARTED|Overall Study||240
194060|NCT00677833|476663|P4|NOT COMPLETED|Overall Study||3
194061|NCT00677833|476664|P3|NOT COMPLETED|Overall Study||2
194062|NCT00677833|476665|P2|NOT COMPLETED|Overall Study||0
194063|NCT00677833|476666|P1|NOT COMPLETED|Overall Study||4
194064|NCT00677833|476663|P4|COMPLETED|Overall Study||128
194065|NCT00677833|476664|P3|COMPLETED|Overall Study||122
194066|NCT00677833|476665|P2|COMPLETED|Overall Study||51
194067|NCT00677833|476666|P1|COMPLETED|Overall Study||51
194068|NCT00677833|476663|P4|STARTED|Overall Study||131
194069|NCT00677833|476664|P3|STARTED|Overall Study||124
194070|NCT00677833|476665|P2|STARTED|Overall Study||51
194071|NCT00677833|476666|P1|STARTED|Overall Study||55
194072|NCT00677898|476716|P2|NOT COMPLETED|Overall Study||18
194073|NCT00677898|476717|P1|NOT COMPLETED|Overall Study||20
194074|NCT00677898|476716|P2|COMPLETED|Overall Study||102
194075|NCT00677898|476717|P1|COMPLETED|Overall Study||99
194076|NCT00677898|476716|P2|STARTED|Overall Study||120
194077|NCT00677898|476717|P1|STARTED|Overall Study||119
194078|NCT00677924|476735|P2|NOT COMPLETED|Overall Study||0
194079|NCT00677924|476736|P1|NOT COMPLETED|Overall Study||0
194080|NCT00677924|476735|P2|COMPLETED|Overall Study||6
194081|NCT00677924|476736|P1|COMPLETED|Overall Study||3
194082|NCT00677924|476735|P2|STARTED|Overall Study||6
194083|NCT00677924|476736|P1|STARTED|Overall Study||3
194084|NCT00678015|476744|P1|NOT COMPLETED|Overall Study||0
194085|NCT00678015|476744|P1|COMPLETED|Overall Study||12
194086|NCT00678015|476744|P1|STARTED|Overall Study||12
194087|NCT00678041|476753|P2|NOT COMPLETED|Overall Study||5
194088|NCT00678041|476754|P1|NOT COMPLETED|Overall Study||5
194089|NCT00678041|476753|P2|COMPLETED|Overall Study||0
194090|NCT00678041|476754|P1|COMPLETED|Overall Study||0
194091|NCT00678041|476753|P2|STARTED|Overall Study||5
194092|NCT00678041|476754|P1|STARTED|Overall Study||5
194093|NCT00679055|476768|P2|NOT COMPLETED|Overall Study||5
194094|NCT00679055|476769|P1|NOT COMPLETED|Overall Study||2
194095|NCT00679055|476768|P2|COMPLETED|Overall Study||1
194096|NCT00679055|476769|P1|COMPLETED|Overall Study||6
194097|NCT00679055|476768|P2|STARTED|Overall Study||6
194098|NCT00679055|476769|P1|STARTED|Overall Study||8
194099|NCT00679081|476779|P1|NOT COMPLETED|Overall Study||1
194100|NCT00679081|476779|P1|COMPLETED|Overall Study||14
194101|NCT00679081|476779|P1|STARTED|Overall Study|Study design was within-subject control.|15
194102|NCT00679172|476792|P5|NOT COMPLETED|Overall Study||0
194103|NCT00679172|476793|P4|NOT COMPLETED|Overall Study||1
194104|NCT00679172|476794|P3|NOT COMPLETED|Overall Study||1
194105|NCT00679172|476795|P2|NOT COMPLETED|Overall Study||1
194106|NCT00679172|476796|P1|NOT COMPLETED|Overall Study||1
194107|NCT00679172|476792|P5|COMPLETED|Overall Study||37
194108|NCT00679172|476793|P4|COMPLETED|Overall Study||38
194109|NCT00679172|476794|P3|COMPLETED|Overall Study||35
194110|NCT00679172|476795|P2|COMPLETED|Overall Study||37
194111|NCT00679172|476796|P1|COMPLETED|Overall Study||36
194112|NCT00679172|476792|P5|STARTED|Overall Study||37
194113|NCT00679172|476793|P4|STARTED|Overall Study||39
194114|NCT00679172|476794|P3|STARTED|Overall Study||36
194115|NCT00679172|476795|P2|STARTED|Overall Study||38
194116|NCT00679172|476796|P1|STARTED|Overall Study||37
194117|NCT00679211|476859|P1|NOT COMPLETED|Overall Study||110
194118|NCT00679211|476859|P1|COMPLETED|Overall Study||0
194119|NCT00679211|476859|P1|STARTED|Overall Study||110
194120|NCT00679263|476874|P3|NOT COMPLETED|Visit 2/Dose 1||0
194121|NCT00679263|476875|P2|NOT COMPLETED|Visit 2/Dose 1||1
194122|NCT00679263|476876|P1|NOT COMPLETED|Visit 2/Dose 1||2
194123|NCT00679263|476874|P3|COMPLETED|Visit 2/Dose 1||11
194124|NCT00679263|476875|P2|COMPLETED|Visit 2/Dose 1||5
194125|NCT00679263|476876|P1|COMPLETED|Visit 2/Dose 1||9
194126|NCT00679263|476874|P3|STARTED|Visit 2/Dose 1||11
194127|NCT00679263|476875|P2|STARTED|Visit 2/Dose 1||6
194128|NCT00679263|476876|P1|STARTED|Visit 2/Dose 1||11
194129|NCT00679263|476874|P3|NOT COMPLETED|Visit 3/Dose 2||0
194130|NCT00679263|476875|P2|NOT COMPLETED|Visit 3/Dose 2||5
194131|NCT00679263|476876|P1|NOT COMPLETED|Visit 3/Dose 2||1
194132|NCT00679263|476874|P3|COMPLETED|Visit 3/Dose 2||11
194133|NCT00679263|476875|P2|COMPLETED|Visit 3/Dose 2||6
194134|NCT00679263|476876|P1|COMPLETED|Visit 3/Dose 2||9
194135|NCT00679263|476874|P3|STARTED|Visit 3/Dose 2||11
194136|NCT00679263|476875|P2|STARTED|Visit 3/Dose 2||11
194137|NCT00679263|476876|P1|STARTED|Visit 3/Dose 2||10
194138|NCT00679302|476889|P2|NOT COMPLETED|Overall Study||4
194139|NCT00679302|476890|P1|NOT COMPLETED|Overall Study||8
194140|NCT00679302|476889|P2|COMPLETED|Overall Study||73
194141|NCT00679302|476890|P1|COMPLETED|Overall Study||76
194142|NCT00679302|476889|P2|STARTED|Overall Study||77
194143|NCT00679302|476890|P1|STARTED|Overall Study||84
194144|NCT00679341|476900|P2|NOT COMPLETED|Overall Study||51
194145|NCT00679341|476901|P1|NOT COMPLETED|Overall Study||53
194146|NCT00679341|476900|P2|COMPLETED|Overall Study||19
194147|NCT00679341|476901|P1|COMPLETED|Overall Study||14
194148|NCT00679341|476900|P2|STARTED|Overall Study||70
194149|NCT00679341|476901|P1|STARTED|Overall Study||67
194150|NCT00679354|476919|P1|NOT COMPLETED|Overall Study||30
194151|NCT00679354|476919|P1|COMPLETED|Overall Study||0
194152|NCT00679354|476919|P1|STARTED|Overall Study||30
194153|NCT00679367|476923|P1|NOT COMPLETED|Overall Study||12
194154|NCT00679367|476923|P1|COMPLETED|Overall Study||4
194155|NCT00679367|476923|P1|STARTED|Overall Study||16
194156|NCT00679380|476933|P4|NOT COMPLETED|Overall Study||28
194157|NCT00679380|476934|P3|NOT COMPLETED|Overall Study||35
194158|NCT00679380|476935|P2|NOT COMPLETED|Overall Study||33
194159|NCT00679380|476936|P1|NOT COMPLETED|Overall Study||42
194160|NCT00679380|476933|P4|COMPLETED|Overall Study||61
194161|NCT00679380|476934|P3|COMPLETED|Overall Study||68
194162|NCT00679380|476935|P2|COMPLETED|Overall Study||76
194163|NCT00679380|476936|P1|COMPLETED|Overall Study||67
194164|NCT00679380|476933|P4|STARTED|Overall Study||89
194165|NCT00679380|476934|P3|STARTED|Overall Study||103
194166|NCT00679380|476935|P2|STARTED|Overall Study||109
194167|NCT00679380|476936|P1|STARTED|Overall Study||109
194168|NCT00679432|476958|P4|NOT COMPLETED|Overall Study||32
194169|NCT00679432|476959|P3|NOT COMPLETED|Overall Study||53
194170|NCT00679432|476960|P2|NOT COMPLETED|Overall Study||38
194171|NCT00679432|476961|P1|NOT COMPLETED|Overall Study||37
194172|NCT00679432|476958|P4|COMPLETED|Overall Study||95
194173|NCT00679432|476959|P3|COMPLETED|Overall Study||76
194174|NCT00679432|476960|P2|COMPLETED|Overall Study||89
194175|NCT00679432|476961|P1|COMPLETED|Overall Study||89
194176|NCT00679432|476958|P4|STARTED|Overall Study||127
194177|NCT00679432|476959|P3|STARTED|Overall Study||129
194178|NCT00679432|476960|P2|STARTED|Overall Study||127
194179|NCT00679432|476961|P1|STARTED|Overall Study||126
194180|NCT00679627|476981|P2|NOT COMPLETED|Overall Study||685
194181|NCT00679627|476982|P1|NOT COMPLETED|Overall Study||699
194182|NCT00679627|476981|P2|COMPLETED|Overall Study||339
194183|NCT00679627|476982|P1|COMPLETED|Overall Study||322
194184|NCT00679627|476981|P2|STARTED|Overall Study||1024
194185|NCT00679627|476982|P1|STARTED|Overall Study||1021
194186|NCT00679783|477011|P7|NOT COMPLETED|Overall Study||1
194187|NCT00679783|477012|P6|NOT COMPLETED|Overall Study||0
194188|NCT00679783|477013|P5|NOT COMPLETED|Overall Study||1
194189|NCT00679783|477014|P4|NOT COMPLETED|Overall Study||20
194190|NCT00679783|477015|P3|NOT COMPLETED|Overall Study||1
194191|NCT00679783|477016|P2|NOT COMPLETED|Overall Study||3
194192|NCT00679783|477017|P1|NOT COMPLETED|Overall Study||2
194193|NCT00679783|477011|P7|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|15
194194|NCT00679783|477012|P6|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|5
194195|NCT00679783|477013|P5|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|4
194196|NCT00679783|477014|P4|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|25
194197|NCT00679783|477015|P3|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
194198|NCT00679783|477016|P2|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|10
194199|NCT00679783|477017|P1|COMPLETED|Overall Study|Patients who discontinued treatment following disease progression.|2
194200|NCT00679783|477011|P7|STARTED|Overall Study|Gave Informed consent and passed screening|16
194201|NCT00679783|477012|P6|STARTED|Overall Study|Gave Informed consent and passed screening|5
194202|NCT00679783|477013|P5|STARTED|Overall Study|Gave Informed consent and passed screening|5
194203|NCT00679783|477014|P4|STARTED|Overall Study|Gave Informed consent and passed screening|45
194204|NCT00679783|477015|P3|STARTED|Overall Study|Gave Informed consent and passed screening|3
194205|NCT00679783|477016|P2|STARTED|Overall Study|Gave Informed consent and passed screening|13
194206|NCT00679783|477017|P1|STARTED|Overall Study|Gave Informed consent and passed screening|4
194207|NCT00679913|477070|P2|NOT COMPLETED|Overall Study||13
194208|NCT00679913|477071|P1|NOT COMPLETED|Overall Study||18
194209|NCT00679913|477070|P2|COMPLETED|Overall Study||86
194210|NCT00679913|477071|P1|COMPLETED|Overall Study||83
194211|NCT00679913|477070|P2|STARTED|Overall Study||99
194212|NCT00679913|477071|P1|STARTED|Overall Study||101
194213|NCT00679939|477081|P2|NOT COMPLETED|24-Week Open-Label (OL) Period||4
194214|NCT00679939|477082|P1|NOT COMPLETED|24-Week Open-Label (OL) Period||7
194215|NCT00679939|477081|P2|COMPLETED|24-Week Open-Label (OL) Period||80
194216|NCT00679939|477082|P1|COMPLETED|24-Week Open-Label (OL) Period||69
194217|NCT00679939|477081|P2|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|84
194218|NCT00679939|477082|P1|STARTED|24-Week Open-Label (OL) Period|One participant who completed the DB Period did not receive the OL dose of MET.|76
194219|NCT00679939|477081|P2|NOT COMPLETED|52-Week Double-Blind (DB) Period||27
194220|NCT00679939|477082|P1|NOT COMPLETED|52-Week Double-Blind (DB) Period||37
194221|NCT00679939|477081|P2|COMPLETED|52-Week Double-Blind (DB) Period||85
194222|NCT00679939|477082|P1|COMPLETED|52-Week Double-Blind (DB) Period||77
194223|NCT00679939|477081|P2|STARTED|52-Week Double-Blind (DB) Period||112
194224|NCT00679939|477082|P1|STARTED|52-Week Double-Blind (DB) Period||114
194225|NCT00679952|477233|P2|NOT COMPLETED|Overall Study||0
194226|NCT00679952|477234|P1|NOT COMPLETED|Overall Study||0
194227|NCT00679952|477233|P2|COMPLETED|Overall Study||82
194228|NCT00679952|477234|P1|COMPLETED|Overall Study||86
194229|NCT00679952|477233|P2|STARTED|Overall Study||82
194230|NCT00679952|477234|P1|STARTED|Overall Study||86
194231|NCT00680017|477242|P2|NOT COMPLETED|Overall Study||12
194232|NCT00680017|477243|P1|NOT COMPLETED|Overall Study||17
194233|NCT00680017|477242|P2|COMPLETED|Overall Study||128
194234|NCT00680017|477243|P1|COMPLETED|Overall Study||123
194235|NCT00680017|477242|P2|STARTED|Overall Study||140
194236|NCT00680017|477243|P1|STARTED|Overall Study||140
194237|NCT00680043|477254|P3|NOT COMPLETED|Overall Study||4
194238|NCT00680043|477255|P2|NOT COMPLETED|Overall Study||1
194239|NCT00680043|477256|P1|NOT COMPLETED|Overall Study||2
194240|NCT00680043|477254|P3|COMPLETED|Overall Study||34
194241|NCT00680043|477255|P2|COMPLETED|Overall Study||36
194242|NCT00680043|477256|P1|COMPLETED|Overall Study||37
194243|NCT00680043|477254|P3|STARTED|Overall Study||38
194244|NCT00680043|477255|P2|STARTED|Overall Study||37
194245|NCT00680043|477256|P1|STARTED|Overall Study||39
194246|NCT00680056|477272|P2|NOT COMPLETED|Second Intervention||1
194247|NCT00680056|477273|P1|NOT COMPLETED|Second Intervention||3
194248|NCT00680056|477272|P2|COMPLETED|Second Intervention||14
194249|NCT00680056|477273|P1|COMPLETED|Second Intervention||12
194250|NCT00680056|477272|P2|STARTED|Second Intervention||15
194251|NCT00680056|477273|P1|STARTED|Second Intervention||15
194252|NCT00680056|477272|P2|NOT COMPLETED|Washout Period of One Week||0
194253|NCT00680056|477273|P1|NOT COMPLETED|Washout Period of One Week||0
194254|NCT00680056|477272|P2|COMPLETED|Washout Period of One Week||15
194255|NCT00680056|477273|P1|COMPLETED|Washout Period of One Week||15
194256|NCT00680056|477272|P2|STARTED|Washout Period of One Week||15
194257|NCT00680056|477273|P1|STARTED|Washout Period of One Week||15
194258|NCT00680056|477272|P2|NOT COMPLETED|First Intervention||2
194259|NCT00680056|477273|P1|NOT COMPLETED|First Intervention||1
194260|NCT00680056|477272|P2|COMPLETED|First Intervention||15
194261|NCT00680056|477273|P1|COMPLETED|First Intervention||15
194262|NCT00680056|477272|P2|STARTED|First Intervention||17
194263|NCT00680056|477273|P1|STARTED|First Intervention||16
194264|NCT00680121|477283|P2|NOT COMPLETED|Overall Study||23
194265|NCT00680121|477284|P1|NOT COMPLETED|Overall Study||27
194266|NCT00680121|477283|P2|COMPLETED|Overall Study||37
194267|NCT00680121|477284|P1|COMPLETED|Overall Study||33
194268|NCT00680121|477283|P2|STARTED|Overall Study||60
194269|NCT00680121|477284|P1|STARTED|Overall Study||60
194270|NCT00680186|477298|P2|NOT COMPLETED|Overall Study||116
194271|NCT00680186|477299|P1|NOT COMPLETED|Overall Study||125
194272|NCT00680186|477298|P2|COMPLETED|Overall Study|Completed planned observation time.|1172
194273|NCT00680186|477299|P1|COMPLETED|Overall Study|Completed planned observation time.|1155
194274|NCT00680186|477298|P2|STARTED|Overall Study|Started treatment.|1288
194275|NCT00680186|477299|P1|STARTED|Overall Study|Started treatment.|1280
194276|NCT00680225|477323|P1|NOT COMPLETED|Overall Study||2
194277|NCT00680225|477323|P1|COMPLETED|Overall Study||8
194278|NCT00680225|477323|P1|STARTED|Overall Study||10
194279|NCT00680316|477330|P2|NOT COMPLETED|Overall Study||0
194280|NCT00680316|477331|P1|NOT COMPLETED|Overall Study||0
194281|NCT00680316|477330|P2|COMPLETED|Overall Study||2
194282|NCT00680316|477331|P1|COMPLETED|Overall Study||1
194283|NCT00680316|477330|P2|STARTED|Overall Study||2
194284|NCT00680316|477331|P1|STARTED|Overall Study||1
194285|NCT00680368|477343|P1|NOT COMPLETED|Overall Study||15
194286|NCT00680368|477343|P1|COMPLETED|Overall Study|15 residents excluded because their attending physician was not participating in the study|97
194287|NCT00680368|477343|P1|STARTED|Overall Study||112
194288|NCT00680407|477352|P3|NOT COMPLETED|Overall Study||3
194289|NCT00680407|477353|P2|NOT COMPLETED|Overall Study||5
194290|NCT00680407|477354|P1|NOT COMPLETED|Overall Study||8
194291|NCT00680407|477352|P3|COMPLETED|Overall Study||22
194292|NCT00680407|477353|P2|COMPLETED|Overall Study||22
194293|NCT00680407|477354|P1|COMPLETED|Overall Study||18
194294|NCT00680407|477352|P3|STARTED|Overall Study||25
194295|NCT00680407|477353|P2|STARTED|Overall Study||27
194296|NCT00680407|477354|P1|STARTED|Overall Study||26
194297|NCT00680459|477370|P2|NOT COMPLETED|Overall Study||0
194298|NCT00680459|477371|P1|NOT COMPLETED|Overall Study||0
194299|NCT00680459|477370|P2|COMPLETED|Overall Study||6
194300|NCT00680459|477371|P1|COMPLETED|Overall Study||7
194301|NCT00680459|477370|P2|STARTED|Overall Study||6
194302|NCT00680459|477371|P1|STARTED|Overall Study||7
194303|NCT00680524|477381|P1|NOT COMPLETED|Overall Study||3
194304|NCT00680524|477381|P1|COMPLETED|Overall Study||17
194305|NCT00680524|477381|P1|STARTED|Overall Study||20
194306|NCT00680628|477387|P2|NOT COMPLETED|Overall Study||0
194307|NCT00680628|477388|P1|NOT COMPLETED|Overall Study||0
194308|NCT00680628|477387|P2|COMPLETED|Overall Study||40
194309|NCT00680628|477388|P1|COMPLETED|Overall Study||43
194310|NCT00680628|477387|P2|STARTED|Overall Study||40
194311|NCT00680628|477388|P1|STARTED|Overall Study||43
194312|NCT00680706|477400|P2|NOT COMPLETED|Overall Study||5
194313|NCT00680706|477401|P1|NOT COMPLETED|Overall Study||7
194314|NCT00680706|477400|P2|COMPLETED|Overall Study||55
194315|NCT00680706|477401|P1|COMPLETED|Overall Study||63
194316|NCT00680706|477400|P2|STARTED|Overall Study||60
194317|NCT00680706|477401|P1|STARTED|Overall Study||70
194318|NCT00680745|477413|P4|NOT COMPLETED|Overall Study||13
194319|NCT00680745|477414|P3|NOT COMPLETED|Overall Study||10
194320|NCT00680745|477415|P2|NOT COMPLETED|Overall Study||13
194321|NCT00680745|477416|P1|NOT COMPLETED|Overall Study||14
194322|NCT00680745|477413|P4|COMPLETED|Overall Study||133
194323|NCT00680745|477414|P3|COMPLETED|Overall Study||141
194324|NCT00680745|477415|P2|COMPLETED|Overall Study||132
194325|NCT00680745|477416|P1|COMPLETED|Overall Study||140
194326|NCT00680745|477413|P4|STARTED|Overall Study|Safety Analysis Set|146
194327|NCT00680745|477414|P3|STARTED|Overall Study|Safety Analysis Set|151
194328|NCT00680745|477415|P2|STARTED|Overall Study|Safety Analysis Set|145
194329|NCT00680745|477416|P1|STARTED|Overall Study|Safety Analysis Set|154
194330|NCT00680771|477448|P2|NOT COMPLETED|Overall Study||2
194331|NCT00680771|477449|P1|NOT COMPLETED|Overall Study||6
194332|NCT00680771|477448|P2|COMPLETED|Overall Study||11
194333|NCT00680771|477449|P1|COMPLETED|Overall Study||9
194334|NCT00680771|477448|P2|STARTED|Overall Study||13
194335|NCT00680771|477449|P1|STARTED|Overall Study||15
194336|NCT00680797|477459|P4|NOT COMPLETED|Overall Study||0
194337|NCT00680797|477460|P3|NOT COMPLETED|Overall Study||0
194338|NCT00680797|477461|P2|NOT COMPLETED|Overall Study||0
194339|NCT00680797|477462|P1|NOT COMPLETED|Overall Study||0
194340|NCT00680797|477459|P4|COMPLETED|Overall Study||8
194341|NCT00680797|477460|P3|COMPLETED|Overall Study||8
194342|NCT00680797|477461|P2|COMPLETED|Overall Study||8
194343|NCT00680797|477462|P1|COMPLETED|Overall Study||9
194344|NCT00680797|477459|P4|STARTED|Overall Study||8
194345|NCT00680797|477460|P3|STARTED|Overall Study||8
194346|NCT00680797|477461|P2|STARTED|Overall Study||8
194347|NCT00680797|477462|P1|STARTED|Overall Study||9
194348|NCT00680836|477474|P2|NOT COMPLETED|Overall Study||2
194349|NCT00680836|477475|P1|NOT COMPLETED|Overall Study||8
194350|NCT00680836|477474|P2|COMPLETED|Overall Study||25
194351|NCT00680836|477475|P1|COMPLETED|Overall Study||19
194352|NCT00680836|477474|P2|STARTED|Overall Study||27
194353|NCT00680836|477475|P1|STARTED|Overall Study||27
194354|NCT00680862|477491|P1|NOT COMPLETED|Overall Study||0
194355|NCT00680862|477491|P1|COMPLETED|Overall Study||25
194356|NCT00680862|477491|P1|STARTED|Overall Study||25
194357|NCT00680901|477497|P2|NOT COMPLETED|Overall Study||76
194358|NCT00680901|477498|P1|NOT COMPLETED|Overall Study||73
194359|NCT00680901|477497|P2|COMPLETED|Overall Study||197
194360|NCT00680901|477498|P1|COMPLETED|Overall Study||199
194361|NCT00680901|477497|P2|Ongoing: In Follow Up|Overall Study||41
194362|NCT00680901|477498|P1|Ongoing: In Follow Up|Overall Study||45
194363|NCT00680901|477497|P2|Ongoing: On Study Treatment|Overall Study||13
194364|NCT00680901|477498|P1|Ongoing: On Study Treatment|Overall Study||16
194365|NCT00680901|477497|P2|STARTED|Overall Study||273
194366|NCT00680901|477498|P1|STARTED|Overall Study||272
194367|NCT00680914|477532|P2|NOT COMPLETED|Overall Study||4
194368|NCT00680914|477533|P1|NOT COMPLETED|Overall Study||10
194369|NCT00680914|477532|P2|COMPLETED|Overall Study||125
194370|NCT00680914|477533|P1|COMPLETED|Overall Study||364
194371|NCT00680914|477532|P2|STARTED|Overall Study||129
194372|NCT00680914|477533|P1|STARTED|Overall Study||374
194373|NCT00680953|477568|P3|NOT COMPLETED|Overall Study||47
194374|NCT00680953|477569|P2|NOT COMPLETED|Overall Study||95
194375|NCT00680953|477570|P1|NOT COMPLETED|Overall Study||86
194376|NCT00680953|477568|P3|COMPLETED|Overall Study||204
194377|NCT00680953|477569|P2|COMPLETED|Overall Study||416
194378|NCT00680953|477570|P1|COMPLETED|Overall Study||414
194379|NCT00680953|477568|P3|STARTED|Overall Study||251
194380|NCT00680953|477569|P2|STARTED|Overall Study||511
194381|NCT00680953|477570|P1|STARTED|Overall Study||500
194382|NCT00681044|477584|P1|NOT COMPLETED|Overall Study||0
194383|NCT00681044|477584|P1|COMPLETED|Overall Study||4
194384|NCT00681044|477584|P1|STARTED|Overall Study||4
194385|NCT00681109|477595|P3|NOT COMPLETED|Overall Study||0
194386|NCT00681109|477596|P2|NOT COMPLETED|Overall Study||6
194387|NCT00681109|477597|P1|NOT COMPLETED|Overall Study||2
194388|NCT00681109|477595|P3|COMPLETED|Overall Study||15
194389|NCT00681109|477596|P2|COMPLETED|Overall Study||24
194390|NCT00681109|477597|P1|COMPLETED|Overall Study||28
194391|NCT00681109|477595|P3|STARTED|Overall Study||15
194392|NCT00681109|477596|P2|STARTED|Overall Study||30
194393|NCT00681109|477597|P1|STARTED|Overall Study||30
194394|NCT00681187|477607|P2|NOT COMPLETED|Overall Study||2
194395|NCT00681187|477608|P1|NOT COMPLETED|Overall Study||1
194396|NCT00681187|477607|P2|COMPLETED|Overall Study||13
194397|NCT00681187|477608|P1|COMPLETED|Overall Study||10
194398|NCT00681187|477607|P2|STARTED|Overall Study||15
194399|NCT00681187|477608|P1|STARTED|Overall Study||11
194400|NCT00681265|477640|P1|NOT COMPLETED|Overall Study||0
194401|NCT00681265|477640|P1|COMPLETED|Overall Study||16
194402|NCT00681265|477640|P1|STARTED|Overall Study||16
194403|NCT00681291|477650|P2|NOT COMPLETED|Overall Study||27
194404|NCT00681291|477651|P1|NOT COMPLETED|Overall Study||13
194405|NCT00681291|477650|P2|COMPLETED|Overall Study||57
194406|NCT00681291|477651|P1|COMPLETED|Overall Study||75
194407|NCT00681291|477650|P2|STARTED|Overall Study||84
194408|NCT00681291|477651|P1|STARTED|Overall Study||88
194409|NCT00673712|477665|P2|NOT COMPLETED|Overall Study||0
194410|NCT00673712|477666|P1|NOT COMPLETED|Overall Study||0
194411|NCT00673712|477665|P2|COMPLETED|Overall Study||326
194412|NCT00673712|477666|P1|COMPLETED|Overall Study||321
194413|NCT00673712|477665|P2|STARTED|Overall Study||326
194414|NCT00673712|477666|P1|STARTED|Overall Study||321
194415|NCT00673738|477676|P1|NOT COMPLETED|Overall Study||0
194416|NCT00673738|477676|P1|COMPLETED|Overall Study||27
194417|NCT00673738|477676|P1|STARTED|Overall Study||27
194418|NCT00673764|477682|P2|NOT COMPLETED|Overall Study||0
194419|NCT00673764|477683|P1|NOT COMPLETED|Overall Study||0
194420|NCT00673764|477682|P2|COMPLETED|Overall Study||24
194421|NCT00673764|477683|P1|COMPLETED|Overall Study||24
194422|NCT00673764|477682|P2|STARTED|Overall Study||24
194423|NCT00673764|477683|P1|STARTED|Overall Study||24
194424|NCT00673816|477691|P1|NOT COMPLETED|Overall Study||2
194425|NCT00673816|477691|P1|COMPLETED|Overall Study||0
194426|NCT00673816|477691|P1|STARTED|Overall Study||2
194427|NCT00673855|477698|P2|NOT COMPLETED|Second Intervention||0
194428|NCT00673855|477699|P1|NOT COMPLETED|Second Intervention||0
194429|NCT00673855|477698|P2|COMPLETED|Second Intervention||10
194430|NCT00673855|477699|P1|COMPLETED|Second Intervention||10
194431|NCT00673855|477698|P2|STARTED|Second Intervention||10
194432|NCT00673855|477699|P1|STARTED|Second Intervention||10
194433|NCT00673855|477698|P2|NOT COMPLETED|First Intervention||0
194434|NCT00673855|477699|P1|NOT COMPLETED|First Intervention||0
194435|NCT00673855|477698|P2|COMPLETED|First Intervention||10
194436|NCT00673855|477699|P1|COMPLETED|First Intervention||10
194437|NCT00673855|477698|P2|STARTED|First Intervention||10
194438|NCT00673855|477699|P1|STARTED|First Intervention||10
194439|NCT00673881|477705|P1|NOT COMPLETED|Overall Study||1
194440|NCT00673881|477705|P1|COMPLETED|Overall Study||24
194441|NCT00673881|477705|P1|STARTED|Overall Study||25
194442|NCT00673933|477712|P1|NOT COMPLETED|Overall Study||3
194443|NCT00673933|477712|P1|COMPLETED|Overall Study||17
194444|NCT00673933|477712|P1|STARTED|Overall Study||20
194445|NCT00673959|477728|P2|NOT COMPLETED|Overall Study||0
194446|NCT00673959|477729|P1|NOT COMPLETED|Overall Study||0
194447|NCT00673959|477728|P2|COMPLETED|Overall Study||10
194448|NCT00673959|477729|P1|COMPLETED|Overall Study||10
194449|NCT00673959|477728|P2|STARTED|Overall Study||10
194450|NCT00673959|477729|P1|STARTED|Overall Study||10
194451|NCT00674115|477735|P4|NOT COMPLETED|Third Intervention||0
194452|NCT00674115|477736|P3|NOT COMPLETED|Third Intervention||0
194453|NCT00674115|477737|P2|NOT COMPLETED|Third Intervention||0
194454|NCT00674115|477738|P1|NOT COMPLETED|Third Intervention||0
194455|NCT00674115|477735|P4|COMPLETED|Third Intervention||0
194456|NCT00674115|477736|P3|COMPLETED|Third Intervention||0
194457|NCT00674115|477737|P2|COMPLETED|Third Intervention||16
194458|NCT00674115|477738|P1|COMPLETED|Third Intervention||14
194459|NCT00674115|477735|P4|STARTED|Third Intervention||0
194460|NCT00674115|477736|P3|STARTED|Third Intervention||0
194461|NCT00674115|477737|P2|STARTED|Third Intervention||16
194462|NCT00674115|477738|P1|STARTED|Third Intervention||14
194463|NCT00674115|477735|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
194464|NCT00674115|477736|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
194465|NCT00674115|477737|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
194466|NCT00674115|477738|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
194467|NCT00674115|477735|P4|COMPLETED|Washout Period of 2 Weeks||0
194468|NCT00674115|477736|P3|COMPLETED|Washout Period of 2 Weeks||0
194469|NCT00674115|477737|P2|COMPLETED|Washout Period of 2 Weeks||16
194470|NCT00674115|477738|P1|COMPLETED|Washout Period of 2 Weeks||14
194471|NCT00674115|477735|P4|STARTED|Washout Period of 2 Weeks||0
194472|NCT00674115|477736|P3|STARTED|Washout Period of 2 Weeks||0
194473|NCT00674115|477737|P2|STARTED|Washout Period of 2 Weeks||16
194474|NCT00674115|477738|P1|STARTED|Washout Period of 2 Weeks||14
194475|NCT00674115|477735|P4|NOT COMPLETED|Second Intervention||0
194476|NCT00674115|477736|P3|NOT COMPLETED|Second Intervention||0
194477|NCT00674115|477737|P2|NOT COMPLETED|Second Intervention||0
194478|NCT00674115|477738|P1|NOT COMPLETED|Second Intervention||0
194479|NCT00674115|477735|P4|COMPLETED|Second Intervention||16
194480|NCT00674115|477736|P3|COMPLETED|Second Intervention||14
194481|NCT00674115|477737|P2|COMPLETED|Second Intervention||16
194482|NCT00674115|477738|P1|COMPLETED|Second Intervention||14
194483|NCT00674115|477735|P4|STARTED|Second Intervention||16
194484|NCT00674115|477736|P3|STARTED|Second Intervention||14
194485|NCT00674115|477737|P2|STARTED|Second Intervention||16
194486|NCT00674115|477738|P1|STARTED|Second Intervention||14
194487|NCT00674115|477735|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
194488|NCT00674115|477736|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
194489|NCT00674115|477737|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
194490|NCT00674115|477738|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
194491|NCT00674115|477735|P4|COMPLETED|Washout Period of 2 Weeks||16
194492|NCT00674115|477736|P3|COMPLETED|Washout Period of 2 Weeks||14
194493|NCT00674115|477737|P2|COMPLETED|Washout Period of 2 Weeks||16
194494|NCT00674115|477738|P1|COMPLETED|Washout Period of 2 Weeks||14
194495|NCT00674115|477735|P4|STARTED|Washout Period of 2 Weeks||16
194496|NCT00674115|477736|P3|STARTED|Washout Period of 2 Weeks||14
194497|NCT00674115|477737|P2|STARTED|Washout Period of 2 Weeks||16
194498|NCT00674115|477738|P1|STARTED|Washout Period of 2 Weeks||14
194499|NCT00674115|477735|P4|NOT COMPLETED|First Intervention||0
194500|NCT00674115|477736|P3|NOT COMPLETED|First Intervention||0
194501|NCT00674115|477737|P2|NOT COMPLETED|First Intervention||0
194502|NCT00674115|477738|P1|NOT COMPLETED|First Intervention||0
194503|NCT00674115|477735|P4|COMPLETED|First Intervention||16
194504|NCT00674115|477736|P3|COMPLETED|First Intervention||14
194505|NCT00674115|477737|P2|COMPLETED|First Intervention||16
194506|NCT00674115|477738|P1|COMPLETED|First Intervention||14
194507|NCT00674115|477735|P4|STARTED|First Intervention||16
194508|NCT00674115|477736|P3|STARTED|First Intervention||14
194509|NCT00674115|477737|P2|STARTED|First Intervention||16
194510|NCT00674115|477738|P1|STARTED|First Intervention||14
194511|NCT00674128|477749|P2|NOT COMPLETED|Overall Study||23
194512|NCT00674128|477750|P1|NOT COMPLETED|Overall Study||25
194513|NCT00674128|477749|P2|COMPLETED|Overall Study||21
194514|NCT00674128|477750|P1|COMPLETED|Overall Study||25
194515|NCT00674128|477749|P2|STARTED|Overall Study||44
194516|NCT00674128|477750|P1|STARTED|Overall Study||50
194517|NCT00674154|477758|P2|NOT COMPLETED|Overall Study||3
194518|NCT00674154|477759|P1|NOT COMPLETED|Overall Study||3
194519|NCT00674154|477758|P2|COMPLETED|Overall Study||20
194520|NCT00674154|477759|P1|COMPLETED|Overall Study||20
194521|NCT00674154|477758|P2|STARTED|Overall Study||23
194522|NCT00674154|477759|P1|STARTED|Overall Study||23
194523|NCT00674206|477765|P1|NOT COMPLETED|Overall Study||0
194524|NCT00674206|477765|P1|COMPLETED|Overall Study||6
194525|NCT00674206|477765|P1|STARTED|Overall Study||6
194526|NCT00674323|477773|P3|NOT COMPLETED|Overall Study||0
194527|NCT00674323|477774|P2|NOT COMPLETED|Overall Study||1
194528|NCT00674323|477775|P1|NOT COMPLETED|Overall Study||1
194529|NCT00674323|477773|P3|COMPLETED|Overall Study||21
194530|NCT00674323|477774|P2|COMPLETED|Overall Study||20
194531|NCT00674323|477775|P1|COMPLETED|Overall Study||18
194532|NCT00674323|477773|P3|STARTED|Overall Study||21
194533|NCT00674323|477774|P2|STARTED|Overall Study||21
194534|NCT00674323|477775|P1|STARTED|Overall Study||19
194535|NCT00674362|477794|P2|NOT COMPLETED|Open Label||0
194536|NCT00674362|477795|P1|NOT COMPLETED|Open Label||2
194537|NCT00674362|477794|P2|COMPLETED|Open Label||7
194538|NCT00674362|477795|P1|COMPLETED|Open Label||18
194539|NCT00674362|477794|P2|STARTED|Open Label||7
194540|NCT00674362|477795|P1|STARTED|Open Label||20
194541|NCT00674362|477794|P2|NOT COMPLETED|Double Blind||18
194542|NCT00674362|477795|P1|NOT COMPLETED|Double Blind||12
194543|NCT00674362|477794|P2|COMPLETED|Double Blind||80
194544|NCT00674362|477795|P1|COMPLETED|Double Blind||84
194545|NCT00674362|477794|P2|STARTED|Double Blind||98
194546|NCT00674362|477795|P1|STARTED|Double Blind||96
194547|NCT00674466|477863|P3|NOT COMPLETED|Overall Study||9
194548|NCT00674466|477864|P2|NOT COMPLETED|Overall Study||8
194549|NCT00674466|477865|P1|NOT COMPLETED|Overall Study||7
194550|NCT00674466|477863|P3|COMPLETED|Overall Study||21
194551|NCT00674466|477864|P2|COMPLETED|Overall Study||22
194552|NCT00674466|477865|P1|COMPLETED|Overall Study||23
194553|NCT00674466|477863|P3|STARTED|Overall Study||30
194554|NCT00674466|477864|P2|STARTED|Overall Study||30
194555|NCT00674466|477865|P1|STARTED|Overall Study||30
194556|NCT00674492|477879|P1|NOT COMPLETED|Overall Study||0
194557|NCT00674492|477879|P1|COMPLETED|Overall Study||21
194558|NCT00674492|477879|P1|STARTED|Overall Study||21
194559|NCT00674609|477886|P3|NOT COMPLETED|Overall Study||8
194560|NCT00674609|477887|P2|NOT COMPLETED|Overall Study||13
194561|NCT00674609|477888|P1|NOT COMPLETED|Overall Study||12
194562|NCT00674609|477886|P3|COMPLETED|Overall Study||51
194563|NCT00674609|477887|P2|COMPLETED|Overall Study||45
194564|NCT00674609|477888|P1|COMPLETED|Overall Study||48
194565|NCT00674609|477886|P3|STARTED|Overall Study||59
194566|NCT00674609|477887|P2|STARTED|Overall Study||58
194567|NCT00674609|477888|P1|STARTED|Overall Study||60
194568|NCT00674622|477923|P3|NOT COMPLETED|Overall Study||0
194569|NCT00674622|477924|P2|NOT COMPLETED|Overall Study||4
194570|NCT00674622|477925|P1|NOT COMPLETED|Overall Study||1
194571|NCT00674622|477923|P3|COMPLETED|Overall Study||22
194572|NCT00674622|477924|P2|COMPLETED|Overall Study||18
194573|NCT00674622|477925|P1|COMPLETED|Overall Study||21
194574|NCT00674622|477923|P3|STARTED|Overall Study||22
194575|NCT00674622|477924|P2|STARTED|Overall Study||22
194576|NCT00674622|477925|P1|STARTED|Overall Study||22
194577|NCT00674661|477947|P2|NOT COMPLETED|Overall Study||15
194578|NCT00674661|477948|P1|NOT COMPLETED|Overall Study||11
194579|NCT00674661|477947|P2|COMPLETED|Overall Study||48
194580|NCT00674661|477948|P1|COMPLETED|Overall Study||56
194581|NCT00674661|477947|P2|STARTED|Overall Study||63
194582|NCT00674661|477948|P1|STARTED|Overall Study||67
194583|NCT00674700|477957|P3|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
194584|NCT00674700|477958|P2|NOT COMPLETED|Year 2 Follow-up Without Treatment||12
194585|NCT00674700|477959|P1|NOT COMPLETED|Year 2 Follow-up Without Treatment||6
194586|NCT00674700|477957|P3|COMPLETED|Year 2 Follow-up Without Treatment||141
194587|NCT00674700|477958|P2|COMPLETED|Year 2 Follow-up Without Treatment||123
194588|NCT00674700|477959|P1|COMPLETED|Year 2 Follow-up Without Treatment||133
194589|NCT00674700|477957|P3|STARTED|Year 2 Follow-up Without Treatment||153
194590|NCT00674700|477958|P2|STARTED|Year 2 Follow-up Without Treatment||135
194591|NCT00674700|477959|P1|STARTED|Year 2 Follow-up Without Treatment||139
194592|NCT00674700|477957|P3|NOT COMPLETED|Year 1||17
194593|NCT00674700|477958|P2|NOT COMPLETED|Year 1||34
194594|NCT00674700|477959|P1|NOT COMPLETED|Year 1||31
194595|NCT00674700|477957|P3|COMPLETED|Year 1||153
194596|NCT00674700|477958|P2|COMPLETED|Year 1||135
194597|NCT00674700|477959|P1|COMPLETED|Year 1||139
194598|NCT00674700|477957|P3|STARTED|Year 1||170
194599|NCT00674700|477958|P2|STARTED|Year 1||169
194600|NCT00674700|477959|P1|STARTED|Year 1||170
194601|NCT00674739|477973|P3|NOT COMPLETED|Overall Study||32
194602|NCT00674739|477974|P2|NOT COMPLETED|Overall Study||59
194603|NCT00674739|477975|P1|NOT COMPLETED|Overall Study||57
194604|NCT00674739|477973|P3|COMPLETED|Overall Study||65
194605|NCT00674739|477974|P2|COMPLETED|Overall Study||136
194606|NCT00674739|477975|P1|COMPLETED|Overall Study||121
194607|NCT00674739|477973|P3|STARTED|Overall Study||97
194608|NCT00674739|477974|P2|STARTED|Overall Study||195
194609|NCT00674739|477975|P1|STARTED|Overall Study||178
194610|NCT00674765|477991|P2|NOT COMPLETED|Overall Study||29
194611|NCT00674765|477992|P1|NOT COMPLETED|Overall Study||36
194612|NCT00674765|477991|P2|COMPLETED|Overall Study||46
194613|NCT00674765|477992|P1|COMPLETED|Overall Study||45
194614|NCT00674765|477991|P2|STARTED|Overall Study||75
194615|NCT00674765|477992|P1|STARTED|Overall Study||81
194616|NCT00674817|477998|P1|NOT COMPLETED|Period 6||0
194617|NCT00674817|477998|P1|COMPLETED|Period 6||38
194618|NCT00674817|477998|P1|STARTED|Period 6||38
194619|NCT00674817|477998|P1|NOT COMPLETED|Period 5||0
194620|NCT00674817|477998|P1|COMPLETED|Period 5||38
194621|NCT00674817|477998|P1|STARTED|Period 5||38
194622|NCT00674817|477998|P1|NOT COMPLETED|Period 4||1
194623|NCT00674817|477998|P1|COMPLETED|Period 4||38
194624|NCT00674817|477998|P1|STARTED|Period 4||39
194625|NCT00674817|477998|P1|NOT COMPLETED|Period 3||2
194626|NCT00674817|477998|P1|COMPLETED|Period 3||39
194627|NCT00674817|477998|P1|STARTED|Period 3||41
194628|NCT00674817|477998|P1|NOT COMPLETED|Period 2||0
194629|NCT00674817|477998|P1|COMPLETED|Period 2||41
194630|NCT00674817|477998|P1|STARTED|Period 2||41
194631|NCT00674817|477998|P1|NOT COMPLETED|Period 1||3
194632|NCT00674817|477998|P1|COMPLETED|Period 1||41
194633|NCT00674817|477998|P1|STARTED|Period 1||44
194634|NCT00674973|478146|P2|NOT COMPLETED|Overall Study||102
194635|NCT00674973|478147|P1|NOT COMPLETED|Overall Study||100
194636|NCT00674973|478146|P2|COMPLETED|Overall Study|Completed double-blind treatment.|2
194637|NCT00674973|478147|P1|COMPLETED|Overall Study|Completed double-blind treatment.|3
194638|NCT00674973|478146|P2|Switch to Open-Label Erlotinib|Overall Study||0
194639|NCT00674973|478147|P1|Switch to Open-Label Erlotinib|Overall Study|Participants with PD were given opportunity to switch.|57
194640|NCT00674973|478146|P2|STARTED|Overall Study||104
194641|NCT00674973|478147|P1|STARTED|Overall Study||103
194642|NCT00674986|478163|P2|NOT COMPLETED|Overall Study||81
194643|NCT00674986|478164|P1|NOT COMPLETED|Overall Study||43
194644|NCT00674986|478163|P2|COMPLETED|Overall Study||188
194645|NCT00674986|478164|P1|COMPLETED|Overall Study||187
194646|NCT00674986|478163|P2|Intent to Treat Population|Overall Study||256
194647|NCT00674986|478164|P1|Intent to Treat Population|Overall Study||227
194648|NCT00674986|478163|P2|STARTED|Overall Study||269
194649|NCT00674986|478164|P1|STARTED|Overall Study||230
194650|NCT00675103|478183|P1|NOT COMPLETED|Overall Study||3
194651|NCT00675103|478183|P1|COMPLETED|Overall Study||4
194652|NCT00675103|478183|P1|STARTED|Overall Study||7
194653|NCT00681473|478188|P1|NOT COMPLETED|Overall Study||0
194654|NCT00681473|478188|P1|COMPLETED|Overall Study|All 20 patients completed RT and tolerated treatment well.|20
194655|NCT00681473|478188|P1|STARTED|Overall Study|20 patients with WHO Grade 2 Glioma were enrolled.|20
194656|NCT00681538|478196|P2|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||2
194657|NCT00681538|478197|P1|NOT COMPLETED|Phase B- Responders;12 Week Double-blind||15
194658|NCT00681538|478196|P2|COMPLETED|Phase B- Responders;12 Week Double-blind||115
194659|NCT00681538|478197|P1|COMPLETED|Phase B- Responders;12 Week Double-blind||109
194660|NCT00681538|478196|P2|STARTED|Phase B- Responders;12 Week Double-blind||117
194661|NCT00681538|478197|P1|STARTED|Phase B- Responders;12 Week Double-blind||124
194662|NCT00681538|478196|P2|NOT COMPLETED|Phase A- 4 Weeks Single Blind||0
194663|NCT00681538|478197|P1|NOT COMPLETED|Phase A- 4 Weeks Single Blind||34
194664|NCT00681538|478196|P2|COMPLETED|Phase A- 4 Weeks Single Blind||0
194665|NCT00681538|478197|P1|COMPLETED|Phase A- 4 Weeks Single Blind||538
194666|NCT00681538|478196|P2|STARTED|Phase A- 4 Weeks Single Blind||0
194667|NCT00681538|478197|P1|STARTED|Phase A- 4 Weeks Single Blind||572
194668|NCT00681564|478229|P2|NOT COMPLETED|Overall Study||8
194669|NCT00681564|478230|P1|NOT COMPLETED|Overall Study||6
194670|NCT00681564|478229|P2|COMPLETED|Overall Study||47
194671|NCT00681564|478230|P1|COMPLETED|Overall Study||41
194672|NCT00681564|478229|P2|STARTED|Overall Study||55
194673|NCT00681564|478230|P1|STARTED|Overall Study||47
194674|NCT00681590|478260|P2|NOT COMPLETED|Overall Study||12
194675|NCT00681590|478261|P1|NOT COMPLETED|Overall Study||2
194676|NCT00681590|478260|P2|COMPLETED|Overall Study||59
194677|NCT00681590|478261|P1|COMPLETED|Overall Study||32
194678|NCT00681590|478260|P2|STARTED|Overall Study||71
194679|NCT00681590|478261|P1|STARTED|Overall Study||34
194680|NCT00681629|478271|P2|NOT COMPLETED|Overall Study||2
194681|NCT00681629|478272|P1|NOT COMPLETED|Overall Study||5
194682|NCT00681629|478271|P2|COMPLETED|Overall Study||0
194683|NCT00681629|478272|P1|COMPLETED|Overall Study||0
194684|NCT00681629|478271|P2|STARTED|Overall Study|It was planned to recruit 100 patient|2
194685|NCT00681629|478272|P1|STARTED|Overall Study|It was planned to recruit 100 patient|5
194686|NCT00681668|478316|P1|NOT COMPLETED|Overall Study||2
194687|NCT00681668|478316|P1|COMPLETED|Overall Study||3
194688|NCT00681668|478316|P1|STARTED|Overall Study||5
194689|NCT00682357|478326|P3|NOT COMPLETED|Overall Study||0
194690|NCT00682357|478327|P2|NOT COMPLETED|Overall Study||0
194691|NCT00682357|478328|P1|NOT COMPLETED|Overall Study||0
194692|NCT00682357|478326|P3|COMPLETED|Overall Study||5
194693|NCT00682357|478327|P2|COMPLETED|Overall Study||10
194694|NCT00682357|478328|P1|COMPLETED|Overall Study||10
194695|NCT00682357|478326|P3|STARTED|Overall Study||5
194696|NCT00682357|478327|P2|STARTED|Overall Study||10
194697|NCT00682357|478328|P1|STARTED|Overall Study||10
194698|NCT00682461|478347|P2|NOT COMPLETED|Overall Study||31
194699|NCT00682461|478348|P1|NOT COMPLETED|Overall Study||25
194700|NCT00682461|478347|P2|COMPLETED|Overall Study||69
194701|NCT00682461|478348|P1|COMPLETED|Overall Study||75
194702|NCT00682461|478347|P2|STARTED|Overall Study||100
194703|NCT00682461|478348|P1|STARTED|Overall Study||100
194704|NCT00682539|478365|P3|NOT COMPLETED|Ranibizumab vs Triamcinolone||8
194705|NCT00682539|478366|P2|NOT COMPLETED|Ranibizumab vs Triamcinolone||3
194706|NCT00682539|478367|P1|NOT COMPLETED|Ranibizumab vs Triamcinolone||0
194707|NCT00682539|478365|P3|COMPLETED|Ranibizumab vs Triamcinolone||10
194708|NCT00682539|478366|P2|COMPLETED|Ranibizumab vs Triamcinolone||15
194709|NCT00682539|478367|P1|COMPLETED|Ranibizumab vs Triamcinolone||0
194710|NCT00682539|478365|P3|STARTED|Ranibizumab vs Triamcinolone|Both periods recruited independently following the same criteria.|18
194711|NCT00682539|478366|P2|STARTED|Ranibizumab vs Triamcinolone|None of the patients of the 1st period was included in the second period.|18
194712|NCT00682539|478367|P1|STARTED|Ranibizumab vs Triamcinolone|Two independent periods.|0
194713|NCT00682539|478365|P3|NOT COMPLETED|Bevacizumab vs Triamcinolone||0
194714|NCT00682539|478366|P2|NOT COMPLETED|Bevacizumab vs Triamcinolone||1
194715|NCT00682539|478367|P1|NOT COMPLETED|Bevacizumab vs Triamcinolone||3
194716|NCT00682539|478365|P3|COMPLETED|Bevacizumab vs Triamcinolone||0
194717|NCT00682539|478366|P2|COMPLETED|Bevacizumab vs Triamcinolone||15
194718|NCT00682539|478367|P1|COMPLETED|Bevacizumab vs Triamcinolone||15
194719|NCT00682539|478365|P3|STARTED|Bevacizumab vs Triamcinolone||0
194720|NCT00682539|478366|P2|STARTED|Bevacizumab vs Triamcinolone||16
194721|NCT00682539|478367|P1|STARTED|Bevacizumab vs Triamcinolone||18
194722|NCT00682565|478381|P3|NOT COMPLETED|Overall Study||0
194723|NCT00682565|478382|P2|NOT COMPLETED|Overall Study||2
194724|NCT00682565|478383|P1|NOT COMPLETED|Overall Study||1
194725|NCT00682565|478381|P3|COMPLETED|Overall Study||29
194726|NCT00682565|478382|P2|COMPLETED|Overall Study||32
194727|NCT00682565|478383|P1|COMPLETED|Overall Study||30
194728|NCT00682565|478381|P3|STARTED|Overall Study||29
194729|NCT00682565|478382|P2|STARTED|Overall Study||34
194730|NCT00682565|478383|P1|STARTED|Overall Study||31
194731|NCT00682643|478406|P2|NOT COMPLETED|Overall Study||169
194732|NCT00682643|478407|P1|NOT COMPLETED|Overall Study||78
194733|NCT00682643|478406|P2|COMPLETED|Overall Study||199
194734|NCT00682643|478407|P1|COMPLETED|Overall Study||104
194735|NCT00682643|478406|P2|STARTED|Overall Study||368
194736|NCT00682643|478407|P1|STARTED|Overall Study||182
194737|NCT00682734|478442|P3|NOT COMPLETED|48 Hour Follow-up||11
194738|NCT00682734|478443|P2|NOT COMPLETED|48 Hour Follow-up||6
194739|NCT00682734|478444|P1|NOT COMPLETED|48 Hour Follow-up||6
194740|NCT00682734|478442|P3|COMPLETED|48 Hour Follow-up||106
194741|NCT00682734|478443|P2|COMPLETED|48 Hour Follow-up||111
194742|NCT00682734|478444|P1|COMPLETED|48 Hour Follow-up||107
194743|NCT00682734|478442|P3|STARTED|48 Hour Follow-up||117
194744|NCT00682734|478443|P2|STARTED|48 Hour Follow-up||117
194745|NCT00682734|478444|P1|STARTED|48 Hour Follow-up||113
194746|NCT00682734|478442|P3|NOT COMPLETED|Emergency Department Portion||1
194747|NCT00682734|478443|P2|NOT COMPLETED|Emergency Department Portion||1
194748|NCT00682734|478444|P1|NOT COMPLETED|Emergency Department Portion||0
194749|NCT00682734|478442|P3|COMPLETED|Emergency Department Portion||117
194750|NCT00682734|478443|P2|COMPLETED|Emergency Department Portion||117
194751|NCT00682734|478444|P1|COMPLETED|Emergency Department Portion||113
194752|NCT00682734|478442|P3|STARTED|Emergency Department Portion||118
194753|NCT00682734|478443|P2|STARTED|Emergency Department Portion||118
194754|NCT00682734|478444|P1|STARTED|Emergency Department Portion||113
194755|NCT00682786|478454|P2|NOT COMPLETED|Overall Study||3
194756|NCT00682786|478455|P1|NOT COMPLETED|Overall Study||2
194757|NCT00682786|478454|P2|COMPLETED|Overall Study||34
194758|NCT00682786|478455|P1|COMPLETED|Overall Study||96
194759|NCT00682786|478454|P2|STARTED|Overall Study||37
194760|NCT00682786|478455|P1|STARTED|Overall Study||98
194761|NCT00682838|478489|P4|NOT COMPLETED|Overall Study||0
194762|NCT00682838|478490|P3|NOT COMPLETED|Overall Study||0
194763|NCT00682838|478491|P2|NOT COMPLETED|Overall Study||0
194764|NCT00682838|478492|P1|NOT COMPLETED|Overall Study||0
194765|NCT00682838|478489|P4|COMPLETED|Overall Study||73
194766|NCT00682838|478490|P3|COMPLETED|Overall Study||75
194767|NCT00682838|478491|P2|COMPLETED|Overall Study||67
194768|NCT00682838|478492|P1|COMPLETED|Overall Study||65
194769|NCT00682838|478489|P4|STARTED|Overall Study||73
194770|NCT00682838|478490|P3|STARTED|Overall Study||75
194771|NCT00682838|478491|P2|STARTED|Overall Study||67
194772|NCT00682838|478492|P1|STARTED|Overall Study||65
194773|NCT00682851|478504|P2|NOT COMPLETED|Overall Study||0
194774|NCT00682851|478505|P1|NOT COMPLETED|Overall Study||0
194775|NCT00682851|478504|P2|COMPLETED|Overall Study||268
194776|NCT00682851|478505|P1|COMPLETED|Overall Study||251
194777|NCT00682851|478504|P2|STARTED|Overall Study||268
194778|NCT00682851|478505|P1|STARTED|Overall Study||251
194779|NCT00682890|478519|P2|NOT COMPLETED|Overall Study||2
194780|NCT00682890|478520|P1|NOT COMPLETED|Overall Study||2
194781|NCT00682890|478519|P2|COMPLETED|Overall Study||9
194782|NCT00682890|478520|P1|COMPLETED|Overall Study||10
194783|NCT00682890|478519|P2|STARTED|Overall Study||11
194784|NCT00682890|478520|P1|STARTED|Overall Study||12
194785|NCT00683020|478530|P2|NOT COMPLETED|Overall Study||55
194786|NCT00683020|478531|P1|NOT COMPLETED|Overall Study||55
194787|NCT00683020|478530|P2|COMPLETED|Overall Study||125
194788|NCT00683020|478531|P1|COMPLETED|Overall Study||127
194789|NCT00683020|478530|P2|STARTED|Overall Study||180
194790|NCT00683020|478531|P1|STARTED|Overall Study||182
194791|NCT00683046|478559|P1|NOT COMPLETED|Overall Study||0
194792|NCT00683046|478559|P1|COMPLETED|Overall Study||204
194793|NCT00683046|478559|P1|STARTED|Overall Study||204
194794|NCT00683085|478564|P1|NOT COMPLETED|Overall Study||0
194795|NCT00683085|478564|P1|COMPLETED|Overall Study||2
194796|NCT00683085|478564|P1|STARTED|Overall Study||2
194797|NCT00683163|478571|P2|NOT COMPLETED|Overall Study||0
194798|NCT00683163|478572|P1|NOT COMPLETED|Overall Study||0
194799|NCT00683163|478571|P2|COMPLETED|Overall Study||22
194800|NCT00683163|478572|P1|COMPLETED|Overall Study||22
194801|NCT00683163|478571|P2|STARTED|Overall Study||22
194802|NCT00683163|478572|P1|STARTED|Overall Study||22
194803|NCT00683293|478582|P2|NOT COMPLETED|Overall Study||3
194804|NCT00683293|478583|P1|NOT COMPLETED|Overall Study||2
194805|NCT00683293|478582|P2|COMPLETED|Overall Study||47
194806|NCT00683293|478583|P1|COMPLETED|Overall Study||48
194807|NCT00683293|478582|P2|STARTED|Overall Study||50
194808|NCT00683293|478583|P1|STARTED|Overall Study||50
194809|NCT00683332|478591|P1|NOT COMPLETED|Overall Study||0
194810|NCT00683332|478591|P1|COMPLETED|Overall Study||621
194811|NCT00683332|478591|P1|STARTED|Overall Study||621
194812|NCT00683384|478595|P1|NOT COMPLETED|Overall Study||2
194813|NCT00683384|478595|P1|COMPLETED|Overall Study||91
194814|NCT00683384|478595|P1|STARTED|Overall Study||93
194815|NCT00683410|478599|P1|NOT COMPLETED|Overall Study||0
194816|NCT00683410|478599|P1|COMPLETED|Overall Study||3366
194817|NCT00683410|478599|P1|Vaccinated Dose 4|Overall Study||175
194818|NCT00683410|478599|P1|Vaccinated Dose 3|Overall Study||817
194819|NCT00683410|478599|P1|Vaccinated Dose 2|Overall Study||1623
194820|NCT00683410|478599|P1|Vaccinated Dose 1|Overall Study||3240
194821|NCT00683410|478599|P1|STARTED|Overall Study||3366
194822|NCT00683449|478608|P5|NOT COMPLETED|Overall Study||0
194823|NCT00683449|478609|P4|NOT COMPLETED|Overall Study||0
194824|NCT00683449|478610|P3|NOT COMPLETED|Overall Study||0
194825|NCT00683449|478611|P2|NOT COMPLETED|Overall Study||1
194826|NCT00683449|478612|P1|NOT COMPLETED|Overall Study||0
194827|NCT00683449|478608|P5|COMPLETED|Overall Study||2
194828|NCT00683449|478609|P4|COMPLETED|Overall Study||6
194829|NCT00683449|478610|P3|COMPLETED|Overall Study||3
194830|NCT00683449|478611|P2|COMPLETED|Overall Study||12
194831|NCT00683449|478612|P1|COMPLETED|Overall Study||5
194832|NCT00683449|478608|P5|STARTED|Overall Study||2
194833|NCT00683449|478609|P4|STARTED|Overall Study||6
194834|NCT00683449|478610|P3|STARTED|Overall Study||3
194835|NCT00683449|478611|P2|STARTED|Overall Study||13
194836|NCT00683449|478612|P1|STARTED|Overall Study||5
194837|NCT00683475|478636|P2|NOT COMPLETED|Overall Study||3
194838|NCT00683475|478637|P1|NOT COMPLETED|Overall Study||4
194839|NCT00683475|478636|P2|COMPLETED|Overall Study||66
194840|NCT00683475|478637|P1|COMPLETED|Overall Study||65
194841|NCT00683475|478636|P2|Received Any Quantity of Study Drug|Overall Study||66
194842|NCT00683475|478637|P1|Received Any Quantity of Study Drug|Overall Study||66
194843|NCT00683475|478636|P2|STARTED|Overall Study||69
194844|NCT00683475|478637|P1|STARTED|Overall Study||69
194845|NCT00683592|478669|P2|NOT COMPLETED|Overall Study||46
194846|NCT00683592|478670|P1|NOT COMPLETED|Overall Study||47
194847|NCT00683592|478669|P2|COMPLETED|Overall Study||195
194848|NCT00683592|478670|P1|COMPLETED|Overall Study||193
194849|NCT00683592|478669|P2|Safety Population|Overall Study||233
194850|NCT00683592|478670|P1|Safety Population|Overall Study||235
194851|NCT00683592|478669|P2|Intent to Treat Population|Overall Study||232
194852|NCT00683592|478670|P1|Intent to Treat Population|Overall Study||231
194853|NCT00683592|478669|P2|STARTED|Overall Study||241
194854|NCT00683592|478670|P1|STARTED|Overall Study||240
194855|NCT00683618|478689|P3|NOT COMPLETED|Extension Treatment Period||0
194856|NCT00683618|478690|P2|NOT COMPLETED|Extension Treatment Period||0
194857|NCT00683618|478691|P1|NOT COMPLETED|Extension Treatment Period||3
194858|NCT00683618|478689|P3|COMPLETED|Extension Treatment Period||0
194859|NCT00683618|478690|P2|COMPLETED|Extension Treatment Period||23
194860|NCT00683618|478691|P1|COMPLETED|Extension Treatment Period||33
194861|NCT00683618|478689|P3|STARTED|Extension Treatment Period||0
194862|NCT00683618|478690|P2|STARTED|Extension Treatment Period||23
194863|NCT00683618|478691|P1|STARTED|Extension Treatment Period||36
194864|NCT00683618|478689|P3|NOT COMPLETED|Randomised Treatment Period||6
194865|NCT00683618|478690|P2|NOT COMPLETED|Randomised Treatment Period||2
194866|NCT00683618|478691|P1|NOT COMPLETED|Randomised Treatment Period||6
194867|NCT00683618|478689|P3|COMPLETED|Randomised Treatment Period||140
194868|NCT00683618|478690|P2|COMPLETED|Randomised Treatment Period||143
194869|NCT00683618|478691|P1|COMPLETED|Randomised Treatment Period||139
194870|NCT00683618|478689|P3|STARTED|Randomised Treatment Period||146
194871|NCT00683618|478690|P2|STARTED|Randomised Treatment Period||145
194872|NCT00683618|478691|P1|STARTED|Randomised Treatment Period||145
194873|NCT00683657|478741|P2|NOT COMPLETED|Overall Study||1
194874|NCT00683657|478742|P1|NOT COMPLETED|Overall Study||1
194875|NCT00683657|478741|P2|COMPLETED|Overall Study||46
194876|NCT00683657|478742|P1|COMPLETED|Overall Study||45
194877|NCT00683657|478741|P2|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|47
194878|NCT00683657|478742|P1|Randomized Subjects Data Set|Overall Study|Randomized subjects who took at least 1 dose of double-blind study medication.|46
194879|NCT00683657|478741|P2|STARTED|Overall Study||47
194880|NCT00683657|478742|P1|STARTED|Overall Study||46
194881|NCT00683696|478758|P2|NOT COMPLETED|Overall Study||405
194882|NCT00683696|478759|P1|NOT COMPLETED|Overall Study||404
194883|NCT00683696|478758|P2|COMPLETED|Overall Study||0
194884|NCT00683696|478759|P1|COMPLETED|Overall Study||0
194885|NCT00683696|478758|P2|STARTED|Overall Study||405
194886|NCT00683696|478759|P1|STARTED|Overall Study||404
194887|NCT00683774|478768|P2|NOT COMPLETED|Overall Study||1
194888|NCT00683774|478769|P1|NOT COMPLETED|Overall Study||3
194889|NCT00683774|478768|P2|COMPLETED|Overall Study||9
194890|NCT00683774|478769|P1|COMPLETED|Overall Study||8
194891|NCT00683774|478768|P2|STARTED|Overall Study||10
194892|NCT00683774|478769|P1|STARTED|Overall Study||11
194893|NCT00683787|478780|P3|NOT COMPLETED|Overall Study||2
194894|NCT00683787|478781|P2|NOT COMPLETED|Overall Study||3
194895|NCT00683787|478782|P1|NOT COMPLETED|Overall Study||3
194896|NCT00683787|478780|P3|COMPLETED|Overall Study||0
194897|NCT00683787|478781|P2|COMPLETED|Overall Study||0
194898|NCT00683787|478782|P1|COMPLETED|Overall Study||0
194899|NCT00683787|478780|P3|STARTED|Overall Study||2
194900|NCT00683787|478781|P2|STARTED|Overall Study||3
194901|NCT00683787|478782|P1|STARTED|Overall Study||3
194902|NCT00683800|478801|P2|NOT COMPLETED|Overall Study||366
194903|NCT00683800|478802|P1|NOT COMPLETED|Overall Study||432
194904|NCT00683800|478801|P2|COMPLETED|Overall Study||719
194905|NCT00683800|478802|P1|COMPLETED|Overall Study||669
194906|NCT00683800|478801|P2|Treated|Overall Study||1052
194907|NCT00683800|478802|P1|Treated|Overall Study||1066
194908|NCT00683800|478801|P2|STARTED|Overall Study||1085
194909|NCT00683800|478802|P1|STARTED|Overall Study||1101
194910|NCT00683826|478869|P1|NOT COMPLETED|Overall Study||1
194911|NCT00683826|478869|P1|COMPLETED|Overall Study||7
194912|NCT00683826|478869|P1|4g Leucine|Overall Study||7
194913|NCT00683826|478869|P1|8g Leucine|Overall Study||8
194914|NCT00683826|478869|P1|0g Leucine|Overall Study||8
194915|NCT00683826|478869|P1|STARTED|Overall Study||8
194916|NCT00683852|478879|P3|NOT COMPLETED|30-Day Phase 2 Period||9
194917|NCT00683852|478880|P2|NOT COMPLETED|30-Day Phase 2 Period||5
194918|NCT00683852|478881|P1|NOT COMPLETED|30-Day Phase 2 Period||6
194919|NCT00683852|478879|P3|COMPLETED|30-Day Phase 2 Period||75
194920|NCT00683852|478880|P2|COMPLETED|30-Day Phase 2 Period||78
194921|NCT00683852|478881|P1|COMPLETED|30-Day Phase 2 Period||48
194922|NCT00683852|478879|P3|STARTED|30-Day Phase 2 Period||84
194923|NCT00683852|478880|P2|STARTED|30-Day Phase 2 Period||83
194924|NCT00683852|478881|P1|STARTED|30-Day Phase 2 Period||54
194925|NCT00683852|478879|P3|NOT COMPLETED|30-Day Phase 1 Period||1
194926|NCT00683852|478880|P2|NOT COMPLETED|30-Day Phase 1 Period||1
194927|NCT00683852|478881|P1|NOT COMPLETED|30-Day Phase 1 Period||2
194928|NCT00683852|478879|P3|COMPLETED|30-Day Phase 1 Period||84
194929|NCT00683852|478880|P2|COMPLETED|30-Day Phase 1 Period||83
194930|NCT00683852|478881|P1|COMPLETED|30-Day Phase 1 Period||54
194931|NCT00683852|478879|P3|STARTED|30-Day Phase 1 Period||85
194932|NCT00683852|478880|P2|STARTED|30-Day Phase 1 Period||84
194933|NCT00683852|478881|P1|STARTED|30-Day Phase 1 Period||56
194934|NCT00683878|478915|P3|NOT COMPLETED|Overall Study||14
194935|NCT00683878|478916|P2|NOT COMPLETED|Overall Study||16
194936|NCT00683878|478917|P1|NOT COMPLETED|Overall Study||23
194937|NCT00683878|478915|P3|COMPLETED|Overall Study||126
194938|NCT00683878|478916|P2|COMPLETED|Overall Study||125
194939|NCT00683878|478917|P1|COMPLETED|Overall Study||116
194940|NCT00683878|478915|P3|STARTED|Overall Study||140
194941|NCT00683878|478916|P2|STARTED|Overall Study||141
194942|NCT00683878|478917|P1|STARTED|Overall Study||139
194943|NCT00683904|478945|P2|NOT COMPLETED|Dose Level 2||2
194944|NCT00683904|478946|P1|NOT COMPLETED|Dose Level 2||0
194945|NCT00683904|478945|P2|COMPLETED|Dose Level 2||4
194946|NCT00683904|478946|P1|COMPLETED|Dose Level 2||0
194947|NCT00683904|478945|P2|STARTED|Dose Level 2||6
194948|NCT00683904|478946|P1|STARTED|Dose Level 2||0
194949|NCT00683904|478945|P2|NOT COMPLETED|Dose Level 1||0
194950|NCT00683904|478946|P1|NOT COMPLETED|Dose Level 1||3
194951|NCT00683904|478945|P2|COMPLETED|Dose Level 1||0
194952|NCT00683904|478946|P1|COMPLETED|Dose Level 1||3
194953|NCT00683904|478945|P2|STARTED|Dose Level 1||0
194954|NCT00683904|478946|P1|STARTED|Dose Level 1||6
194955|NCT00683917|478982|P1|NOT COMPLETED|Overall Study||10
194956|NCT00683917|478982|P1|COMPLETED|Overall Study||0
194957|NCT00683917|478982|P1|STARTED|Overall Study||10
194958|NCT00683930|478993|P3|NOT COMPLETED|Overall Study||9
194959|NCT00683930|478994|P2|NOT COMPLETED|Overall Study||3
194960|NCT00683930|478995|P1|NOT COMPLETED|Overall Study||7
194961|NCT00683930|478993|P3|COMPLETED|Overall Study||28
194962|NCT00683930|478994|P2|COMPLETED|Overall Study||18
194963|NCT00683930|478995|P1|COMPLETED|Overall Study||29
194964|NCT00683930|478993|P3|STARTED|Overall Study||37
194965|NCT00683930|478994|P2|STARTED|Overall Study|One subject not included: no study drug dispensed.|21
194966|NCT00683930|478995|P1|STARTED|Overall Study|One subject not included: no study drug dispensed.|36
194967|NCT00684021|479014|P4|NOT COMPLETED|Overall Study||2
194968|NCT00684021|479015|P3|NOT COMPLETED|Overall Study||2
194969|NCT00684021|479016|P2|NOT COMPLETED|Overall Study||2
194970|NCT00684021|479017|P1|NOT COMPLETED|Overall Study||2
194971|NCT00684021|479014|P4|COMPLETED|Overall Study||15
194972|NCT00684021|479015|P3|COMPLETED|Overall Study||34
194973|NCT00684021|479016|P2|COMPLETED|Overall Study||22
194974|NCT00684021|479017|P1|COMPLETED|Overall Study||41
194975|NCT00684021|479014|P4|STARTED|Overall Study||17
194976|NCT00684021|479015|P3|STARTED|Overall Study||36
194977|NCT00684021|479016|P2|STARTED|Overall Study||24
194978|NCT00684021|479017|P1|STARTED|Overall Study||43
194979|NCT00684047|479058|P3|NOT COMPLETED|Overall Study||5
194980|NCT00684047|479059|P2|NOT COMPLETED|Overall Study||16
194981|NCT00684047|479060|P1|NOT COMPLETED|Overall Study||13
194982|NCT00684047|479058|P3|COMPLETED|Overall Study||52
194983|NCT00684047|479059|P2|COMPLETED|Overall Study||94
194984|NCT00684047|479060|P1|COMPLETED|Overall Study||59
194985|NCT00684047|479058|P3|STARTED|Overall Study||57
194986|NCT00684047|479059|P2|STARTED|Overall Study||110
194987|NCT00684047|479060|P1|STARTED|Overall Study||72
194988|NCT00684060|479072|P2|NOT COMPLETED|Overall Study||3
194989|NCT00684060|479073|P1|NOT COMPLETED|Overall Study||3
194990|NCT00684060|479072|P2|COMPLETED|Overall Study||26
194991|NCT00684060|479073|P1|COMPLETED|Overall Study||55
194992|NCT00684060|479072|P2|STARTED|Overall Study||29
194993|NCT00684060|479073|P1|STARTED|Overall Study||58
194994|NCT00684073|479093|P1|NOT COMPLETED|Treatment (Days 1 Through 5)||1
194995|NCT00684073|479093|P1|COMPLETED|Treatment (Days 1 Through 5)|number of subjects who had a Day 5 visit (and therefore completed study)|52
194996|NCT00684073|479093|P1|STARTED|Treatment (Days 1 Through 5)|number of subjects who had a Day 1 visit|53
194997|NCT00684073|479093|P1|NOT COMPLETED|Selection||7
194998|NCT00684073|479093|P1|COMPLETED|Selection|number of subjects who had a Day 1 visit|53
194999|NCT00684073|479093|P1|STARTED|Selection||60
195000|NCT00684138|479103|P2|NOT COMPLETED|Overall Study||8
195001|NCT00684138|479104|P1|NOT COMPLETED|Overall Study||3
195002|NCT00684138|479103|P2|COMPLETED|Overall Study||131
195003|NCT00684138|479104|P1|COMPLETED|Overall Study||138
195004|NCT00684138|479103|P2|STARTED|Overall Study||139
195005|NCT00684138|479104|P1|STARTED|Overall Study||141
195006|NCT00684177|479122|P2|NOT COMPLETED|Overall Study||23
195007|NCT00684177|479123|P1|NOT COMPLETED|Overall Study||21
195008|NCT00684177|479122|P2|COMPLETED|Overall Study||141
195009|NCT00684177|479123|P1|COMPLETED|Overall Study||322
195010|NCT00684177|479122|P2|STARTED|Overall Study||164
195011|NCT00684177|479123|P1|STARTED|Overall Study||343
195012|NCT00684203|479145|P6|NOT COMPLETED|Overall Study||0
195013|NCT00684203|479146|P5|NOT COMPLETED|Overall Study||0
195014|NCT00684203|479147|P4|NOT COMPLETED|Overall Study||0
195015|NCT00684203|479148|P3|NOT COMPLETED|Overall Study||9
195016|NCT00684203|479149|P2|NOT COMPLETED|Overall Study||8
195017|NCT00684203|479150|P1|NOT COMPLETED|Overall Study||9
195018|NCT00684203|479145|P6|COMPLETED|Overall Study||2
195019|NCT00684203|479146|P5|COMPLETED|Overall Study||17
195020|NCT00684203|479147|P4|COMPLETED|Overall Study||6
195021|NCT00684203|479148|P3|COMPLETED|Overall Study||12
195022|NCT00684203|479149|P2|COMPLETED|Overall Study||23
195023|NCT00684203|479150|P1|COMPLETED|Overall Study||31
195024|NCT00684203|479145|P6|STARTED|Overall Study||2
195025|NCT00684203|479146|P5|STARTED|Overall Study||17
195026|NCT00684203|479147|P4|STARTED|Overall Study||6
195027|NCT00684203|479148|P3|STARTED|Overall Study||21
195028|NCT00684203|479149|P2|STARTED|Overall Study||31
195029|NCT00684203|479150|P1|STARTED|Overall Study||40
195030|NCT00684242|479209|P1|NOT COMPLETED|Overall Study||0
195031|NCT00684242|479209|P1|COMPLETED|Overall Study||3
195032|NCT00684242|479209|P1|STARTED|Overall Study||3
195033|NCT00684255|479213|P1|NOT COMPLETED|Overall Study||0
195034|NCT00684255|479213|P1|COMPLETED|Overall Study||1
195035|NCT00684255|479213|P1|STARTED|Overall Study||1
195036|NCT00684307|479223|P5|NOT COMPLETED|Overall Study||25
195037|NCT00684307|479224|P4|NOT COMPLETED|Overall Study||32
195038|NCT00684307|479225|P3|NOT COMPLETED|Overall Study||28
195039|NCT00684307|479226|P2|NOT COMPLETED|Overall Study||22
195040|NCT00684307|479227|P1|NOT COMPLETED|Overall Study||24
195041|NCT00684307|479223|P5|COMPLETED|Overall Study||293
195042|NCT00684307|479224|P4|COMPLETED|Overall Study||128
195043|NCT00684307|479225|P3|COMPLETED|Overall Study||128
195044|NCT00684307|479226|P2|COMPLETED|Overall Study||129
195045|NCT00684307|479227|P1|COMPLETED|Overall Study||140
195046|NCT00684307|479223|P5|On Treatment Period Completed|Overall Study||293
195047|NCT00684307|479224|P4|On Treatment Period Completed|Overall Study||128
195048|NCT00684307|479225|P3|On Treatment Period Completed|Overall Study||128
195049|NCT00684307|479226|P2|On Treatment Period Completed|Overall Study||129
195050|NCT00684307|479227|P1|On Treatment Period Completed|Overall Study|Patients who completed treatment|140
195051|NCT00684307|479223|P5|On Treatment Period Started|Overall Study||318
195052|NCT00684307|479224|P4|On Treatment Period Started|Overall Study||160
195053|NCT00684307|479225|P3|On Treatment Period Started|Overall Study||156
195054|NCT00684307|479226|P2|On Treatment Period Started|Overall Study||151
195055|NCT00684307|479227|P1|On Treatment Period Started|Overall Study||164
195056|NCT00684307|479223|P5|STARTED|Overall Study||318
195057|NCT00684307|479224|P4|STARTED|Overall Study||160
195058|NCT00684307|479225|P3|STARTED|Overall Study||156
195059|NCT00684307|479226|P2|STARTED|Overall Study||151
195060|NCT00684307|479227|P1|STARTED|Overall Study|Patients who received treatment|164
195061|NCT00684320|479296|P2|NOT COMPLETED|Overall Study||0
195062|NCT00684320|479297|P1|NOT COMPLETED|Overall Study||4
195063|NCT00684320|479296|P2|COMPLETED|Overall Study||22
195064|NCT00684320|479297|P1|COMPLETED|Overall Study||22
195065|NCT00684320|479296|P2|STARTED|Overall Study||22
195066|NCT00684320|479297|P1|STARTED|Overall Study||26
195067|NCT00684411|479305|P1|NOT COMPLETED|Overall Study||12
195068|NCT00684411|479305|P1|COMPLETED|Overall Study||0
195069|NCT00684411|479305|P1|Disease Evaluable|Overall Study||11
195070|NCT00684411|479305|P1|STARTED|Overall Study||12
195071|NCT00684424|479311|P1|NOT COMPLETED|Overall Study||5
195072|NCT00684424|479311|P1|COMPLETED|Overall Study||194
195073|NCT00684424|479311|P1|STARTED|Overall Study||199
195074|NCT00684515|479329|P3|NOT COMPLETED|Overall Study||1
195075|NCT00684515|479330|P2|NOT COMPLETED|Overall Study||3
195076|NCT00684515|479331|P1|NOT COMPLETED|Overall Study||4
195077|NCT00684515|479329|P3|COMPLETED|Overall Study||27
195078|NCT00684515|479330|P2|COMPLETED|Overall Study||26
195079|NCT00684515|479331|P1|COMPLETED|Overall Study||29
195080|NCT00684515|479329|P3|STARTED|Overall Study||28
195081|NCT00684515|479330|P2|STARTED|Overall Study||29
195082|NCT00684515|479331|P1|STARTED|Overall Study||33
195083|NCT00684541|479356|P2|NOT COMPLETED|Overall Study||3
195084|NCT00684541|479357|P1|NOT COMPLETED|Overall Study||3
195085|NCT00684541|479356|P2|COMPLETED|Overall Study||23
195086|NCT00684541|479357|P1|COMPLETED|Overall Study||20
195087|NCT00684541|479356|P2|STARTED|Overall Study||26
195088|NCT00684541|479357|P1|STARTED|Overall Study||23
195089|NCT00684554|479367|P2|NOT COMPLETED|Overall Study||0
195090|NCT00684554|479368|P1|NOT COMPLETED|Overall Study||0
195091|NCT00684554|479367|P2|COMPLETED|Overall Study||10
195092|NCT00684554|479368|P1|COMPLETED|Overall Study||10
195093|NCT00684554|479367|P2|STARTED|Overall Study||10
195094|NCT00684554|479368|P1|STARTED|Overall Study||10
195095|NCT00684567|479376|P1|NOT COMPLETED|Monotherapy Period||14
195096|NCT00684567|479376|P1|COMPLETED|Monotherapy Period||9
195097|NCT00684567|479376|P1|STARTED|Monotherapy Period|5 subjects completed radiotherapy combined therapy phase but did not proceed to monotherapy phase.|23
195098|NCT00684567|479376|P1|NOT COMPLETED|Concomitant Radiotherapy Period||2
195099|NCT00684567|479376|P1|COMPLETED|Concomitant Radiotherapy Period||28
195100|NCT00684567|479376|P1|STARTED|Concomitant Radiotherapy Period||30
195101|NCT00684593|479386|P2|NOT COMPLETED|Overall Study||2
195102|NCT00684593|479387|P1|NOT COMPLETED|Overall Study||0
195103|NCT00684593|479386|P2|COMPLETED|Overall Study||8
195104|NCT00684593|479387|P1|COMPLETED|Overall Study||21
195105|NCT00684593|479386|P2|STARTED|Overall Study||10
195106|NCT00684593|479387|P1|STARTED|Overall Study||21
195107|NCT00678210|479403|P4|NOT COMPLETED|Overall Study||20
195108|NCT00678210|479404|P3|NOT COMPLETED|Overall Study||6
195109|NCT00678210|479405|P2|NOT COMPLETED|Overall Study||11
195110|NCT00678210|479406|P1|NOT COMPLETED|Overall Study||11
195111|NCT00678210|479403|P4|COMPLETED|Overall Study||30
195112|NCT00678210|479404|P3|COMPLETED|Overall Study||43
195113|NCT00678210|479405|P2|COMPLETED|Overall Study||38
195114|NCT00678210|479406|P1|COMPLETED|Overall Study||38
195115|NCT00678210|479403|P4|STARTED|Overall Study||50
195116|NCT00678210|479404|P3|STARTED|Overall Study||49
195117|NCT00678210|479405|P2|STARTED|Overall Study||49
195118|NCT00678210|479406|P1|STARTED|Overall Study||49
195119|NCT00678249|479443|P3|NOT COMPLETED|Overall Study||0
195120|NCT00678249|479444|P2|NOT COMPLETED|Overall Study||0
195121|NCT00678249|479445|P1|NOT COMPLETED|Overall Study||0
195122|NCT00678249|479443|P3|COMPLETED|Overall Study||37
195123|NCT00678249|479444|P2|COMPLETED|Overall Study||93
195124|NCT00678249|479445|P1|COMPLETED|Overall Study||97
195125|NCT00678249|479443|P3|STARTED|Overall Study||37
195126|NCT00678249|479444|P2|STARTED|Overall Study||93
195127|NCT00678249|479445|P1|STARTED|Overall Study||97
195128|NCT00678288|479479|P2|NOT COMPLETED|Overall Study||6
195129|NCT00678288|479480|P1|NOT COMPLETED|Overall Study||10
195130|NCT00678288|479479|P2|COMPLETED|Overall Study||0
195131|NCT00678288|479480|P1|COMPLETED|Overall Study||0
195132|NCT00678288|479479|P2|STARTED|Overall Study||6
195133|NCT00678288|479480|P1|STARTED|Overall Study||10
195134|NCT00678379|479497|P3|NOT COMPLETED|Overall Study||4
195135|NCT00678379|479498|P2|NOT COMPLETED|Overall Study||3
195136|NCT00678379|479499|P1|NOT COMPLETED|Overall Study||6
195137|NCT00678379|479497|P3|COMPLETED|Overall Study||36
195138|NCT00678379|479498|P2|COMPLETED|Overall Study||37
195139|NCT00678379|479499|P1|COMPLETED|Overall Study||34
195140|NCT00678379|479497|P3|STARTED|Overall Study||40
195141|NCT00678379|479498|P2|STARTED|Overall Study||40
195142|NCT00678379|479499|P1|STARTED|Overall Study||40
195143|NCT00678392|479527|P2|NOT COMPLETED|Overall Study||362
195144|NCT00678392|479528|P1|NOT COMPLETED|Overall Study||361
195145|NCT00678392|479527|P2|COMPLETED|Overall Study||0
195146|NCT00678392|479528|P1|COMPLETED|Overall Study||0
195147|NCT00678392|479527|P2|Treated|Overall Study||355
195148|NCT00678392|479528|P1|Treated|Overall Study||359
195149|NCT00678392|479527|P2|STARTED|Overall Study||362
195150|NCT00678392|479528|P1|STARTED|Overall Study||361
195151|NCT00678418|479562|P2|NOT COMPLETED|Part B (Open Label)||0
195152|NCT00678418|479563|P1|NOT COMPLETED|Part B (Open Label)||43
195153|NCT00678418|479562|P2|COMPLETED|Part B (Open Label)||0
195154|NCT00678418|479563|P1|COMPLETED|Part B (Open Label)||71
195155|NCT00678418|479562|P2|STARTED|Part B (Open Label)||0
195156|NCT00678418|479563|P1|STARTED|Part B (Open Label)|All participants who received placebo in Part A were switched to open-label VIVITROL in Part B.|114
195157|NCT00678418|479562|P2|NOT COMPLETED|Part A (Double Blind)||77
195158|NCT00678418|479563|P1|NOT COMPLETED|Part A (Double Blind)||59
195159|NCT00678418|479562|P2|COMPLETED|Part A (Double Blind)||47
195160|NCT00678418|479563|P1|COMPLETED|Part A (Double Blind)||67
195161|NCT00678418|479562|P2|STARTED|Part A (Double Blind)||124
195162|NCT00678418|479563|P1|STARTED|Part A (Double Blind)||126
195163|NCT00678470|479577|P1|NOT COMPLETED|Overall Study||3
195164|NCT00678470|479577|P1|COMPLETED|Overall Study||15
195165|NCT00678470|479577|P1|STARTED|Overall Study||18
195166|NCT00678535|479583|P2|NOT COMPLETED|Overall Study||98
195167|NCT00678535|479584|P1|NOT COMPLETED|Overall Study||93
195168|NCT00678535|479583|P2|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|351
195169|NCT00678535|479584|P1|COMPLETED|Overall Study|subjects who died before or at 31 March 2012|362
195170|NCT00678535|479583|P2|STARTED|Overall Study|ITT population|449
195171|NCT00678535|479584|P1|STARTED|Overall Study|ITT population|455
195172|NCT00678574|479602|P2|NOT COMPLETED|Overall Study||0
195173|NCT00678574|479603|P1|NOT COMPLETED|Overall Study||0
195174|NCT00678574|479602|P2|COMPLETED|Overall Study||27
195175|NCT00678574|479603|P1|COMPLETED|Overall Study||18
195176|NCT00678574|479602|P2|STARTED|Overall Study||27
195177|NCT00678574|479603|P1|STARTED|Overall Study||18
195178|NCT00678587|479611|P2|NOT COMPLETED|Overall Study||18
195179|NCT00678587|479612|P1|NOT COMPLETED|Overall Study||20
195180|NCT00678587|479611|P2|COMPLETED|Overall Study||127
195181|NCT00678587|479612|P1|COMPLETED|Overall Study||127
195182|NCT00678587|479611|P2|STARTED|Overall Study||145
195183|NCT00678587|479612|P1|STARTED|Overall Study||147
195184|NCT00678639|479646|P2|NOT COMPLETED|Overall Study||0
195185|NCT00678639|479647|P1|NOT COMPLETED|Overall Study||2
195186|NCT00678639|479646|P2|COMPLETED|Overall Study||57
195187|NCT00678639|479647|P1|COMPLETED|Overall Study||51
195188|NCT00678639|479646|P2|Hospital Discharge|Overall Study||57
195189|NCT00678639|479647|P1|Hospital Discharge|Overall Study||53
195190|NCT00678639|479646|P2|STARTED|Overall Study||57
195191|NCT00678639|479647|P1|STARTED|Overall Study||53
195192|NCT00678691|479662|P2|NOT COMPLETED|Overall Study||4
195193|NCT00678691|479663|P1|NOT COMPLETED|Overall Study||6
195194|NCT00678691|479662|P2|COMPLETED|Overall Study||24
195195|NCT00678691|479663|P1|COMPLETED|Overall Study||21
195196|NCT00678691|479662|P2|STARTED|Overall Study||28
195197|NCT00678691|479663|P1|STARTED|Overall Study||27
195198|NCT00678795|479671|P2|NOT COMPLETED|Overall Study||6
195199|NCT00678795|479672|P1|NOT COMPLETED|Overall Study||11
195200|NCT00678795|479671|P2|COMPLETED|Overall Study||62
195201|NCT00678795|479672|P1|COMPLETED|Overall Study||56
195202|NCT00678795|479671|P2|STARTED|Overall Study||68
195203|NCT00678795|479672|P1|STARTED|Overall Study||67
195204|NCT00678834|479695|P3|NOT COMPLETED|Overall Study||9
195205|NCT00678834|479696|P2|NOT COMPLETED|Overall Study||0
195206|NCT00678834|479697|P1|NOT COMPLETED|Overall Study||16
195207|NCT00678834|479695|P3|COMPLETED|Overall Study||16
195208|NCT00678834|479696|P2|COMPLETED|Overall Study||15
195209|NCT00678834|479697|P1|COMPLETED|Overall Study||24
195210|NCT00678834|479695|P3|STARTED|Overall Study||25
195211|NCT00678834|479696|P2|STARTED|Overall Study||15
195212|NCT00678834|479697|P1|STARTED|Overall Study||40
195213|NCT00678899|479715|P1|NOT COMPLETED|Overall Study||1
195214|NCT00678899|479715|P1|COMPLETED|Overall Study||49
195215|NCT00678899|479715|P1|STARTED|Overall Study||50
195216|NCT00684645|479722|P1|NOT COMPLETED|Overall Study||114
195217|NCT00684645|479722|P1|COMPLETED|Overall Study||72
195218|NCT00684645|479722|P1|STARTED|Overall Study||186
195219|NCT00684671|479743|P3|NOT COMPLETED|Overall Study||0
195220|NCT00684671|479744|P2|NOT COMPLETED|Overall Study||0
195221|NCT00684671|479745|P1|NOT COMPLETED|Overall Study||3
195222|NCT00684671|479743|P3|COMPLETED|Overall Study||164
195223|NCT00684671|479744|P2|COMPLETED|Overall Study||170
195224|NCT00684671|479745|P1|COMPLETED|Overall Study||169
195225|NCT00684671|479743|P3|STARTED|Overall Study||164
195226|NCT00684671|479744|P2|STARTED|Overall Study||170
195227|NCT00684671|479745|P1|STARTED|Overall Study||172
195228|NCT00684723|479774|P2|NOT COMPLETED|Second Intervention||0
195229|NCT00684723|479775|P1|NOT COMPLETED|Second Intervention||0
195230|NCT00684723|479774|P2|COMPLETED|Second Intervention||27
195231|NCT00684723|479775|P1|COMPLETED|Second Intervention||27
195232|NCT00684723|479774|P2|STARTED|Second Intervention||27
195233|NCT00684723|479775|P1|STARTED|Second Intervention||27
195234|NCT00684723|479774|P2|NOT COMPLETED|Washout Period of 7 Days||0
195235|NCT00684723|479775|P1|NOT COMPLETED|Washout Period of 7 Days||0
195236|NCT00684723|479774|P2|COMPLETED|Washout Period of 7 Days||27
195237|NCT00684723|479775|P1|COMPLETED|Washout Period of 7 Days||27
195238|NCT00684723|479774|P2|STARTED|Washout Period of 7 Days||27
195239|NCT00684723|479775|P1|STARTED|Washout Period of 7 Days||27
195240|NCT00684723|479774|P2|NOT COMPLETED|First Intervention||0
195241|NCT00684723|479775|P1|NOT COMPLETED|First Intervention||0
195242|NCT00684723|479774|P2|COMPLETED|First Intervention||27
195243|NCT00684723|479775|P1|COMPLETED|First Intervention||27
195244|NCT00684723|479774|P2|STARTED|First Intervention||27
195245|NCT00684723|479775|P1|STARTED|First Intervention||27
195246|NCT00684749|479785|P1|NOT COMPLETED|Overall Study||0
195247|NCT00684749|479785|P1|COMPLETED|Overall Study||142
195248|NCT00684749|479785|P1|STARTED|Overall Study||142
195249|NCT00684762|479789|P2|NOT COMPLETED|Second Intervention||0
195250|NCT00684762|479790|P1|NOT COMPLETED|Second Intervention||0
195251|NCT00684762|479789|P2|COMPLETED|Second Intervention||14
195252|NCT00684762|479790|P1|COMPLETED|Second Intervention||14
195253|NCT00684762|479789|P2|STARTED|Second Intervention||14
195254|NCT00684762|479790|P1|STARTED|Second Intervention||14
195255|NCT00684762|479789|P2|NOT COMPLETED|Washout Period of 7 Days||2
195256|NCT00684762|479790|P1|NOT COMPLETED|Washout Period of 7 Days||2
195257|NCT00684762|479789|P2|COMPLETED|Washout Period of 7 Days||14
195258|NCT00684762|479790|P1|COMPLETED|Washout Period of 7 Days||14
195259|NCT00684762|479789|P2|STARTED|Washout Period of 7 Days||16
195260|NCT00684762|479790|P1|STARTED|Washout Period of 7 Days||16
195261|NCT00684762|479789|P2|NOT COMPLETED|First Intervention||0
195262|NCT00684762|479790|P1|NOT COMPLETED|First Intervention||0
195263|NCT00684762|479789|P2|COMPLETED|First Intervention||16
195264|NCT00684762|479790|P1|COMPLETED|First Intervention||16
195265|NCT00684762|479789|P2|STARTED|First Intervention||16
195266|NCT00684762|479790|P1|STARTED|First Intervention||16
195267|NCT00684814|479800|P2|NOT COMPLETED|Second Intervention||0
195268|NCT00684814|479801|P1|NOT COMPLETED|Second Intervention||1
195269|NCT00684814|479800|P2|COMPLETED|Second Intervention||15
195270|NCT00684814|479801|P1|COMPLETED|Second Intervention||16
195271|NCT00684814|479800|P2|STARTED|Second Intervention||15
195272|NCT00684814|479801|P1|STARTED|Second Intervention||17
195273|NCT00684814|479800|P2|NOT COMPLETED|Washout Period of 7 Days||4
195274|NCT00684814|479801|P1|NOT COMPLETED|Washout Period of 7 Days||2
195275|NCT00684814|479800|P2|COMPLETED|Washout Period of 7 Days||15
195276|NCT00684814|479801|P1|COMPLETED|Washout Period of 7 Days||17
195277|NCT00684814|479800|P2|STARTED|Washout Period of 7 Days||19
195278|NCT00684814|479801|P1|STARTED|Washout Period of 7 Days||19
195279|NCT00684814|479800|P2|NOT COMPLETED|First Intervention||0
195280|NCT00684814|479801|P1|NOT COMPLETED|First Intervention||0
195281|NCT00684814|479800|P2|COMPLETED|First Intervention||19
195282|NCT00684814|479801|P1|COMPLETED|First Intervention||19
195283|NCT00684814|479800|P2|STARTED|First Intervention||19
195284|NCT00684814|479801|P1|STARTED|First Intervention||19
195285|NCT00686036|479813|P2|NOT COMPLETED|Overall Study||6
195286|NCT00686036|479814|P1|NOT COMPLETED|Overall Study||9
195287|NCT00686036|479813|P2|COMPLETED|Overall Study||2
195288|NCT00686036|479814|P1|COMPLETED|Overall Study||0
195289|NCT00686036|479813|P2|STARTED|Overall Study||8
195290|NCT00686036|479814|P1|STARTED|Overall Study||9
195291|NCT00686075|479836|P10|NOT COMPLETED|Overall Study||10
195292|NCT00686075|479837|P9|NOT COMPLETED|Overall Study||6
195293|NCT00686075|479838|P8|NOT COMPLETED|Overall Study||2
195294|NCT00686075|479839|P7|NOT COMPLETED|Overall Study||0
195295|NCT00686075|479840|P6|NOT COMPLETED|Overall Study||3
195296|NCT00686075|479841|P5|NOT COMPLETED|Overall Study||4
195297|NCT00686075|479842|P4|NOT COMPLETED|Overall Study||9
195298|NCT00686075|479843|P3|NOT COMPLETED|Overall Study||6
195299|NCT00686075|479844|P2|NOT COMPLETED|Overall Study||10
195300|NCT00686075|479845|P1|NOT COMPLETED|Overall Study||8
195301|NCT00686075|479836|P10|COMPLETED|Overall Study||69
195302|NCT00686075|479837|P9|COMPLETED|Overall Study||75
195303|NCT00686075|479838|P8|COMPLETED|Overall Study||76
195304|NCT00686075|479839|P7|COMPLETED|Overall Study||82
195305|NCT00686075|479840|P6|COMPLETED|Overall Study||37
195306|NCT00686075|479841|P5|COMPLETED|Overall Study||36
195307|NCT00686075|479842|P4|COMPLETED|Overall Study||71
195308|NCT00686075|479843|P3|COMPLETED|Overall Study||74
195309|NCT00686075|479844|P2|COMPLETED|Overall Study||71
195310|NCT00686075|479845|P1|COMPLETED|Overall Study||71
195311|NCT00686075|479836|P10|Treated|Overall Study||78
195312|NCT00686075|479837|P9|Treated|Overall Study||80
195313|NCT00686075|479838|P8|Treated|Overall Study||77
195314|NCT00686075|479839|P7|Treated|Overall Study||82
195315|NCT00686075|479840|P6|Treated|Overall Study||40
195316|NCT00686075|479841|P5|Treated|Overall Study||40
195317|NCT00686075|479842|P4|Treated|Overall Study||80
195318|NCT00686075|479843|P3|Treated|Overall Study||80
195319|NCT00686075|479844|P2|Treated|Overall Study||79
195320|NCT00686075|479845|P1|Treated|Overall Study||78
195321|NCT00686075|479836|P10|STARTED|Overall Study||79
195322|NCT00686075|479837|P9|STARTED|Overall Study||81
195323|NCT00686075|479838|P8|STARTED|Overall Study||78
195324|NCT00686075|479839|P7|STARTED|Overall Study||82
195325|NCT00686075|479840|P6|STARTED|Overall Study||40
195326|NCT00686075|479841|P5|STARTED|Overall Study||40
195327|NCT00686075|479842|P4|STARTED|Overall Study||80
195328|NCT00686075|479843|P3|STARTED|Overall Study||80
195329|NCT00686075|479844|P2|STARTED|Overall Study||81
195330|NCT00686075|479845|P1|STARTED|Overall Study||79
195331|NCT00686127|480039|P2|NOT COMPLETED|Overall Study||6
195332|NCT00686127|480040|P1|NOT COMPLETED|Overall Study||14
195333|NCT00686127|480039|P2|COMPLETED|Overall Study||1
195334|NCT00686127|480040|P1|COMPLETED|Overall Study|Patients withdrew from the study because they did not like wearing the patch.|0
195335|NCT00686127|480039|P2|STARTED|Overall Study||7
195336|NCT00686127|480040|P1|STARTED|Overall Study||14
195337|NCT00686166|480046|P1|NOT COMPLETED|Overall Study||20
195338|NCT00686166|480046|P1|COMPLETED|Overall Study||63
195339|NCT00686166|480046|P1|Eligible and Began Protocol Therapy|Overall Study||74
195340|NCT00686166|480046|P1|Eligible|Overall Study||78
195341|NCT00686166|480046|P1|STARTED|Overall Study||83
195342|NCT00686205|480058|P2|NOT COMPLETED|Overall Study||981
195343|NCT00686205|480059|P1|NOT COMPLETED|Overall Study||6007
195344|NCT00686205|480058|P2|COMPLETED|Overall Study||1524
195345|NCT00686205|480059|P1|COMPLETED|Overall Study||15599
195346|NCT00686205|480058|P2|STARTED|Overall Study||2505
195347|NCT00686205|480059|P1|STARTED|Overall Study||21606
195348|NCT00686231|480068|P3|NOT COMPLETED|Overall Study||0
195349|NCT00686231|480069|P2|NOT COMPLETED|Overall Study||0
195350|NCT00686231|480070|P1|NOT COMPLETED|Overall Study||0
195351|NCT00686231|480068|P3|COMPLETED|Overall Study||20
195352|NCT00686231|480069|P2|COMPLETED|Overall Study||20
195353|NCT00686231|480070|P1|COMPLETED|Overall Study||20
195354|NCT00686231|480068|P3|STARTED|Overall Study||20
195355|NCT00686231|480069|P2|STARTED|Overall Study||20
195356|NCT00686231|480070|P1|STARTED|Overall Study||20
195357|NCT00686257|480080|P2|NOT COMPLETED|Overall Study||0
195358|NCT00686257|480081|P1|NOT COMPLETED|Overall Study||0
195359|NCT00686257|480080|P2|COMPLETED|Overall Study||31
195360|NCT00686257|480081|P1|COMPLETED|Overall Study||29
195361|NCT00686257|480080|P2|STARTED|Overall Study||31
195362|NCT00686257|480081|P1|STARTED|Overall Study||29
195363|NCT00686335|480087|P1|NOT COMPLETED|Treatment Period||0
195364|NCT00686335|480087|P1|COMPLETED|Treatment Period||7
195365|NCT00686335|480087|P1|STARTED|Treatment Period||7
195366|NCT00686335|480087|P1|NOT COMPLETED|Run-in Period||5
195367|NCT00686335|480087|P1|COMPLETED|Run-in Period||7
195368|NCT00686335|480087|P1|STARTED|Run-in Period||12
195369|NCT00686517|480096|P3|NOT COMPLETED|Follow-up||10
195370|NCT00686517|480097|P2|NOT COMPLETED|Follow-up||10
195371|NCT00686517|480098|P1|NOT COMPLETED|Follow-up||8
195372|NCT00686517|480096|P3|COMPLETED|Follow-up||29
195373|NCT00686517|480097|P2|COMPLETED|Follow-up||28
195374|NCT00686517|480098|P1|COMPLETED|Follow-up||29
195375|NCT00686517|480096|P3|STARTED|Follow-up||39
195376|NCT00686517|480097|P2|STARTED|Follow-up||38
195377|NCT00686517|480098|P1|STARTED|Follow-up||37
195378|NCT00686517|480096|P3|NOT COMPLETED|Treatment||1
195379|NCT00686517|480097|P2|NOT COMPLETED|Treatment||3
195380|NCT00686517|480098|P1|NOT COMPLETED|Treatment||6
195381|NCT00686517|480096|P3|COMPLETED|Treatment||42
195382|NCT00686517|480097|P2|COMPLETED|Treatment||40
195383|NCT00686517|480098|P1|COMPLETED|Treatment||38
195384|NCT00686517|480096|P3|Completed Final Treatment Visit|Treatment|Included 1 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
195385|NCT00686517|480097|P2|Completed Final Treatment Visit|Treatment|Included 3 that discontinued the treatment before completion,but performed the Final Treatment Visit|43
195386|NCT00686517|480098|P1|Completed Final Treatment Visit|Treatment|Included 6 that discontinued the treatment before completion,but performed the Final Treatment Visit|44
195387|NCT00686517|480096|P3|STARTED|Treatment||43
195388|NCT00686517|480097|P2|STARTED|Treatment||43
195389|NCT00686517|480098|P1|STARTED|Treatment||44
195390|NCT00686543|480125|P4|NOT COMPLETED|Overall Study||3
195391|NCT00686543|480126|P3|NOT COMPLETED|Overall Study||5
195392|NCT00686543|480127|P2|NOT COMPLETED|Overall Study||1
195393|NCT00686543|480128|P1|NOT COMPLETED|Overall Study||14
195394|NCT00686543|480125|P4|COMPLETED|Overall Study||17
195395|NCT00686543|480126|P3|COMPLETED|Overall Study||15
195396|NCT00686543|480127|P2|COMPLETED|Overall Study||20
195397|NCT00686543|480128|P1|COMPLETED|Overall Study||0
195398|NCT00686543|480125|P4|STARTED|Overall Study||20
195399|NCT00686543|480126|P3|STARTED|Overall Study||20
195400|NCT00686543|480127|P2|STARTED|Overall Study||21
195401|NCT00686543|480128|P1|STARTED|Overall Study||14
195402|NCT00686595|480146|P1|NOT COMPLETED|Overall Study||7
195403|NCT00686595|480146|P1|COMPLETED|Overall Study||31
195404|NCT00686595|480146|P1|STARTED|Overall Study||38
195405|NCT00686634|480171|P1|NOT COMPLETED|Overall Study||6
195406|NCT00686634|480171|P1|COMPLETED|Overall Study||102
195407|NCT00686634|480171|P1|STARTED|Overall Study||108
195408|NCT00686647|480178|P1|NOT COMPLETED|Overall Study||2
195409|NCT00686647|480178|P1|COMPLETED|Overall Study||91
195410|NCT00686647|480178|P1|STARTED|Overall Study||93
195411|NCT00686686|480184|P1|NOT COMPLETED|Overall Study||6
195412|NCT00686686|480184|P1|COMPLETED|Overall Study||17
195413|NCT00686686|480184|P1|STARTED|Overall Study||23
195414|NCT00686699|480194|P2|NOT COMPLETED|Treatment Period 2||0
195415|NCT00686699|480195|P1|NOT COMPLETED|Treatment Period 2||0
195416|NCT00686699|480194|P2|COMPLETED|Treatment Period 2||5
195417|NCT00686699|480195|P1|COMPLETED|Treatment Period 2||4
195418|NCT00686699|480194|P2|STARTED|Treatment Period 2||5
195419|NCT00686699|480195|P1|STARTED|Treatment Period 2||4
195420|NCT00686699|480194|P2|NOT COMPLETED|Treatment Period 1||2
195421|NCT00686699|480195|P1|NOT COMPLETED|Treatment Period 1||0
195422|NCT00686699|480194|P2|COMPLETED|Treatment Period 1||5
195423|NCT00686699|480195|P1|COMPLETED|Treatment Period 1||4
195424|NCT00686699|480194|P2|STARTED|Treatment Period 1||7
195425|NCT00686699|480195|P1|STARTED|Treatment Period 1||4
195426|NCT00686712|480222|P3|NOT COMPLETED|Overall Study||13
195427|NCT00686712|480223|P2|NOT COMPLETED|Overall Study||11
195428|NCT00686712|480224|P1|NOT COMPLETED|Overall Study||10
195429|NCT00686712|480222|P3|COMPLETED|Overall Study||17
195430|NCT00686712|480223|P2|COMPLETED|Overall Study||14
195431|NCT00686712|480224|P1|COMPLETED|Overall Study||20
195432|NCT00686712|480222|P3|STARTED|Overall Study||30
195433|NCT00686712|480223|P2|STARTED|Overall Study||25
195434|NCT00686712|480224|P1|STARTED|Overall Study||30
195435|NCT00686725|480252|P2|NOT COMPLETED|Overall Study||42
195436|NCT00686725|480253|P1|NOT COMPLETED|Overall Study||46
195437|NCT00686725|480252|P2|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|10
195438|NCT00686725|480253|P1|COMPLETED|Overall Study|Completers were defined as those who completed the established treatment.|1
195439|NCT00686725|480252|P2|STARTED|Overall Study||52
195440|NCT00686725|480253|P1|STARTED|Overall Study||47
195441|NCT00686777|480275|P1|NOT COMPLETED|Overall Study||10
195442|NCT00686777|480275|P1|COMPLETED|Overall Study|Of 10 noncompleters, 6 had AEs including 4 meeting protocol prespecified AE discontinuance criteria.|65
195443|NCT00686777|480275|P1|Completed 24 Weeks of Follow-up|Overall Study||70
195444|NCT00686777|480275|P1|Included in Follow-up (All Treated)|Overall Study||75
195445|NCT00686777|480275|P1|Completed 48 Weeks of Treatment|Overall Study||65
195446|NCT00686777|480275|P1|Completed 24 Weeks of Treatment|Overall Study||69
195447|NCT00686777|480275|P1|STARTED|Overall Study||75
195448|NCT00686790|480281|P1|NOT COMPLETED|Overall Study||16
195449|NCT00686790|480281|P1|COMPLETED|Overall Study||32
195450|NCT00686790|480281|P1|STARTED|Overall Study||48
195451|NCT00686803|480292|P3|NOT COMPLETED|Overall Study||0
195452|NCT00686803|480293|P2|NOT COMPLETED|Overall Study||0
195453|NCT00686803|480294|P1|NOT COMPLETED|Overall Study||0
195454|NCT00686803|480292|P3|COMPLETED|Overall Study||3
195455|NCT00686803|480293|P2|COMPLETED|Overall Study||12
195456|NCT00686803|480294|P1|COMPLETED|Overall Study||6
195457|NCT00686803|480292|P3|STARTED|Overall Study||3
195458|NCT00686803|480293|P2|STARTED|Overall Study||12
195459|NCT00686803|480294|P1|STARTED|Overall Study||6
195460|NCT00686842|480305|P1|NOT COMPLETED|Overall Study||0
195461|NCT00686842|480305|P1|COMPLETED|Overall Study||17
195462|NCT00686842|480305|P1|STARTED|Overall Study||17
195463|NCT00686855|480311|P2|NOT COMPLETED|Overall Study||1
195464|NCT00686855|480312|P1|NOT COMPLETED|Overall Study||1
195465|NCT00686855|480311|P2|COMPLETED|Overall Study||17
195466|NCT00686855|480312|P1|COMPLETED|Overall Study||27
195467|NCT00686855|480311|P2|STARTED|Overall Study||18
195468|NCT00686855|480312|P1|STARTED|Overall Study||28
195469|NCT00686881|480320|P2|NOT COMPLETED|Overall Study||81
195470|NCT00686881|480321|P1|NOT COMPLETED|Overall Study||82
195471|NCT00686881|480320|P2|COMPLETED|Overall Study||53
195472|NCT00686881|480321|P1|COMPLETED|Overall Study||45
195473|NCT00686881|480320|P2|STARTED|Overall Study|After randomization, 6 participants withdrew consent and did not receive study drug.|134
195474|NCT00686881|480321|P1|STARTED|Overall Study|After randomization, 2 participants withdrew consent and did not receive study drug.|127
195475|NCT00686894|480331|P1|NOT COMPLETED|Overall Study||6
195476|NCT00686894|480331|P1|COMPLETED|Overall Study||1
195477|NCT00686894|480331|P1|STARTED|Overall Study||7
195478|NCT00686959|480337|P2|NOT COMPLETED|Overall Study||117
195479|NCT00686959|480338|P1|NOT COMPLETED|Overall Study||124
195480|NCT00686959|480337|P2|COMPLETED|Overall Study|Study completion includes death due to any cause.|180
195481|NCT00686959|480338|P1|COMPLETED|Overall Study|Study completion includes death due to any cause|177
195482|NCT00686959|480337|P2|Entered Consolidation Phase|Overall Study||202
195483|NCT00686959|480338|P1|Entered Consolidation Phase|Overall Study||229
195484|NCT00686959|480337|P2|Received at Least One Dose of Study Drug|Overall Study||272
195485|NCT00686959|480338|P1|Received at Least One Dose of Study Drug|Overall Study||283
195486|NCT00686959|480337|P2|STARTED|Overall Study||297
195487|NCT00686959|480338|P1|STARTED|Overall Study||301
195488|NCT00686972|480356|P1|NOT COMPLETED|Overall Study||51
195489|NCT00686972|480356|P1|COMPLETED|Overall Study||0
195490|NCT00686972|480356|P1|STARTED|Overall Study||51
195491|NCT00686998|480363|P3|NOT COMPLETED|Overall Study||4
195492|NCT00686998|480364|P2|NOT COMPLETED|Overall Study||8
195493|NCT00686998|480365|P1|NOT COMPLETED|Overall Study||13
195494|NCT00686998|480363|P3|COMPLETED|Overall Study||18
195495|NCT00686998|480364|P2|COMPLETED|Overall Study||33
195496|NCT00686998|480365|P1|COMPLETED|Overall Study||30
195497|NCT00686998|480363|P3|Completed Scheduled Treatment|Overall Study||18
195498|NCT00686998|480364|P2|Completed Scheduled Treatment|Overall Study||33
195499|NCT00686998|480365|P1|Completed Scheduled Treatment|Overall Study||30
195500|NCT00686998|480363|P3|Eligible for Efficacy Analysis|Overall Study||21
195501|NCT00686998|480364|P2|Eligible for Efficacy Analysis|Overall Study||39
195502|NCT00686998|480365|P1|Eligible for Efficacy Analysis|Overall Study||42
195503|NCT00686998|480363|P3|Received Treatment|Overall Study||22
195504|NCT00686998|480364|P2|Received Treatment|Overall Study||41
195505|NCT00686998|480365|P1|Received Treatment|Overall Study||43
195506|NCT00686998|480363|P3|Randomized|Overall Study||22
195507|NCT00686998|480364|P2|Randomized|Overall Study||41
195508|NCT00686998|480365|P1|Randomized|Overall Study||43
195509|NCT00686998|480363|P3|STARTED|Overall Study|Randomized & received study medication|22
195510|NCT00686998|480364|P2|STARTED|Overall Study|Randomized & received study medication|41
195511|NCT00686998|480365|P1|STARTED|Overall Study|Randomized & received study medication|43
195512|NCT00687076|480375|P2|NOT COMPLETED|Overall Study||30
195513|NCT00687076|480376|P1|NOT COMPLETED|Overall Study||32
195514|NCT00687076|480375|P2|COMPLETED|Overall Study||21
195515|NCT00687076|480376|P1|COMPLETED|Overall Study||19
195516|NCT00687076|480375|P2|STARTED|Overall Study||51
195517|NCT00687076|480376|P1|STARTED|Overall Study||51
195518|NCT00687167|480384|P2|NOT COMPLETED|Second Intervention||0
195519|NCT00687167|480385|P1|NOT COMPLETED|Second Intervention||0
195520|NCT00687167|480384|P2|COMPLETED|Second Intervention||17
195521|NCT00687167|480385|P1|COMPLETED|Second Intervention||17
195522|NCT00687167|480384|P2|STARTED|Second Intervention||17
195523|NCT00687167|480385|P1|STARTED|Second Intervention||17
195524|NCT00687167|480384|P2|NOT COMPLETED|Washout Period of 28 Days||0
195525|NCT00687167|480385|P1|NOT COMPLETED|Washout Period of 28 Days||0
195526|NCT00687167|480384|P2|COMPLETED|Washout Period of 28 Days||17
195527|NCT00687167|480385|P1|COMPLETED|Washout Period of 28 Days||17
195528|NCT00687167|480384|P2|STARTED|Washout Period of 28 Days||17
195529|NCT00687167|480385|P1|STARTED|Washout Period of 28 Days||17
195530|NCT00687167|480384|P2|NOT COMPLETED|First Intervention||0
195531|NCT00687167|480385|P1|NOT COMPLETED|First Intervention||0
195532|NCT00687167|480384|P2|COMPLETED|First Intervention||17
195533|NCT00687167|480385|P1|COMPLETED|First Intervention||17
195534|NCT00687167|480384|P2|STARTED|First Intervention||17
195535|NCT00687167|480385|P1|STARTED|First Intervention||17
195536|NCT00687193|480399|P6|NOT COMPLETED|Overall Study||4
195537|NCT00687193|480400|P5|NOT COMPLETED|Overall Study||2
195538|NCT00687193|480401|P4|NOT COMPLETED|Overall Study||4
195539|NCT00687193|480402|P3|NOT COMPLETED|Overall Study||2
195540|NCT00687193|480403|P2|NOT COMPLETED|Overall Study||4
195541|NCT00687193|480404|P1|NOT COMPLETED|Overall Study||2
195542|NCT00687193|480399|P6|COMPLETED|Overall Study||48
195543|NCT00687193|480400|P5|COMPLETED|Overall Study||52
195544|NCT00687193|480401|P4|COMPLETED|Overall Study||49
195545|NCT00687193|480402|P3|COMPLETED|Overall Study||50
195546|NCT00687193|480403|P2|COMPLETED|Overall Study||49
195547|NCT00687193|480404|P1|COMPLETED|Overall Study||51
195548|NCT00687193|480399|P6|STARTED|Overall Study|One participant withdrew after randomization but prior to treatment.|52
195549|NCT00687193|480400|P5|STARTED|Overall Study||54
195550|NCT00687193|480401|P4|STARTED|Overall Study||53
195551|NCT00687193|480402|P3|STARTED|Overall Study||52
195552|NCT00687193|480403|P2|STARTED|Overall Study||53
195553|NCT00687193|480404|P1|STARTED|Overall Study||53
195554|NCT00687219|480568|P1|NOT COMPLETED|Overall Study||51
195555|NCT00687219|480568|P1|COMPLETED|Overall Study||51
195556|NCT00687219|480568|P1|STARTED|Overall Study||102
195557|NCT00687297|480576|P2|NOT COMPLETED|Maintenance||1
195558|NCT00687297|480577|P1|NOT COMPLETED|Maintenance||3
195559|NCT00687297|480576|P2|COMPLETED|Maintenance||25
195560|NCT00687297|480577|P1|COMPLETED|Maintenance||29
195561|NCT00687297|480576|P2|STARTED|Maintenance||26
195562|NCT00687297|480577|P1|STARTED|Maintenance||32
195563|NCT00687297|480576|P2|NOT COMPLETED|Induction||55
195564|NCT00687297|480577|P1|NOT COMPLETED|Induction||45
195565|NCT00687297|480576|P2|COMPLETED|Induction||26
195566|NCT00687297|480577|P1|COMPLETED|Induction||32
195567|NCT00687297|480576|P2|STARTED|Induction||81
195568|NCT00687297|480577|P1|STARTED|Induction||77
195569|NCT00687297|480576|P2|NOT COMPLETED|Randomization||1
195570|NCT00687297|480577|P1|NOT COMPLETED|Randomization||3
195571|NCT00687297|480576|P2|COMPLETED|Randomization||81
195572|NCT00687297|480577|P1|COMPLETED|Randomization||77
195573|NCT00687297|480576|P2|STARTED|Randomization||82
195574|NCT00687297|480577|P1|STARTED|Randomization||80
195575|NCT00687323|480587|P1|NOT COMPLETED|Overall Study||180
195576|NCT00687323|480587|P1|COMPLETED|Overall Study|Number of participants alive at one year|15
195577|NCT00687323|480587|P1|Received Treatment|Overall Study||47
195578|NCT00687323|480587|P1|STARTED|Overall Study|Number of screened participants|195
195579|NCT00687362|480601|P1|NOT COMPLETED|Overall Study||3
195580|NCT00687362|480601|P1|COMPLETED|Overall Study|Completed protocol at Week 24|19
195581|NCT00687362|480601|P1|STARTED|Overall Study||22
195582|NCT00687401|480605|P1|NOT COMPLETED|Overall Study||30
195583|NCT00687401|480605|P1|COMPLETED|Overall Study||129
195584|NCT00687401|480605|P1|STARTED|Overall Study|215 participants enrolled in the study, of which 56 failed screening and did not receive study drug.|159
195585|NCT00687440|480610|P1|NOT COMPLETED|Overall Study||12
195586|NCT00687440|480610|P1|COMPLETED|Overall Study||15
195587|NCT00687440|480610|P1|STARTED|Overall Study|Number of screened participants|27
195588|NCT00687453|480616|P2|NOT COMPLETED|Overall Study||6
195589|NCT00687453|480617|P1|NOT COMPLETED|Overall Study||3
195590|NCT00687453|480616|P2|COMPLETED|Overall Study||7
195591|NCT00687453|480617|P1|COMPLETED|Overall Study||8
195592|NCT00687453|480616|P2|STARTED|Overall Study||13
195593|NCT00687453|480617|P1|STARTED|Overall Study||11
195594|NCT00687531|480623|P1|NOT COMPLETED|Overall Study||135
195595|NCT00687531|480623|P1|COMPLETED|Overall Study||250
195596|NCT00687531|480623|P1|RECEIVED TREATMENT|Overall Study||281
195597|NCT00687531|480623|P1|STARTED|Overall Study|Completed screening procedures|385
195598|NCT00687544|480637|P1|NOT COMPLETED|Overall Study||11
195599|NCT00687544|480637|P1|COMPLETED|Overall Study||0
195600|NCT00687544|480637|P1|STARTED|Overall Study||11
195601|NCT00687609|480646|P1|NOT COMPLETED|Overall Study||3
195602|NCT00687609|480646|P1|COMPLETED|Overall Study||4
195603|NCT00687609|480646|P1|STARTED|Overall Study||7
195604|NCT00687674|480660|P1|NOT COMPLETED|Overall Study||2
195605|NCT00687674|480660|P1|COMPLETED|Overall Study||11
195606|NCT00687674|480660|P1|STARTED|Overall Study||13
195607|NCT00687713|480669|P2|NOT COMPLETED|Overall Study||40
195608|NCT00687713|480670|P1|NOT COMPLETED|Overall Study||32
195609|NCT00687713|480669|P2|COMPLETED|Overall Study||64
195610|NCT00687713|480670|P1|COMPLETED|Overall Study||68
195611|NCT00687713|480669|P2|STARTED|Overall Study||104
195612|NCT00687713|480670|P1|STARTED|Overall Study||100
195613|NCT00687804|480681|P3|NOT COMPLETED|Open-Label Extension Study||11
195614|NCT00687804|480682|P2|NOT COMPLETED|Open-Label Extension Study||11
195615|NCT00687804|480683|P1|NOT COMPLETED|Open-Label Extension Study||10
195616|NCT00687804|480681|P3|COMPLETED|Open-Label Extension Study||63
195617|NCT00687804|480682|P2|COMPLETED|Open-Label Extension Study||72
195618|NCT00687804|480683|P1|COMPLETED|Open-Label Extension Study||73
195619|NCT00687804|480681|P3|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||15
195620|NCT00687804|480682|P2|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||21
195621|NCT00687804|480683|P1|Did Not Receive Ranibizumab in Extension|Open-Label Extension Study||16
195622|NCT00687804|480681|P3|STARTED|Open-Label Extension Study||74
195623|NCT00687804|480682|P2|STARTED|Open-Label Extension Study||83
195624|NCT00687804|480683|P1|STARTED|Open-Label Extension Study||83
195625|NCT00687804|480681|P3|NOT COMPLETED|Core Study||13
195626|NCT00687804|480682|P2|NOT COMPLETED|Core Study||15
195627|NCT00687804|480683|P1|NOT COMPLETED|Core Study||14
195628|NCT00687804|480681|P3|COMPLETED|Core Study||98
195629|NCT00687804|480682|P2|COMPLETED|Core Study||103
195630|NCT00687804|480683|P1|COMPLETED|Core Study||102
195631|NCT00687804|480681|P3|STARTED|Core Study||111
195632|NCT00687804|480682|P2|STARTED|Core Study||118
195633|NCT00687804|480683|P1|STARTED|Core Study||116
195634|NCT00687830|480728|P2|NOT COMPLETED|Overall Study||0
195635|NCT00687830|480729|P1|NOT COMPLETED|Overall Study||0
195636|NCT00687830|480728|P2|COMPLETED|Overall Study||68
195637|NCT00687830|480729|P1|COMPLETED|Overall Study||68
195638|NCT00687830|480728|P2|STARTED|Overall Study||68
195639|NCT00687830|480729|P1|STARTED|Overall Study||68
195640|NCT00687856|480737|P1|NOT COMPLETED|Overall Study||0
195641|NCT00687856|480737|P1|COMPLETED|Overall Study||211
195642|NCT00687856|480737|P1|STARTED|Overall Study||211
195643|NCT00687908|480743|P2|NOT COMPLETED|Overall Study||42
195644|NCT00687908|480744|P1|NOT COMPLETED|Overall Study||18
195645|NCT00687908|480743|P2|COMPLETED|Overall Study||78
195646|NCT00687908|480744|P1|COMPLETED|Overall Study||105
195647|NCT00687908|480743|P2|STARTED|Overall Study||120
195648|NCT00687908|480744|P1|STARTED|Overall Study||123
195649|NCT00687973|480760|P2|NOT COMPLETED|Overall Study||38
195650|NCT00687973|480761|P1|NOT COMPLETED|Overall Study||24
195651|NCT00687973|480760|P2|COMPLETED|Overall Study||162
195652|NCT00687973|480761|P1|COMPLETED|Overall Study||169
195653|NCT00687973|480760|P2|STARTED|Overall Study||200
195654|NCT00687973|480761|P1|STARTED|Overall Study||193
195655|NCT00688064|480790|P2|NOT COMPLETED|Overall Study||26
195656|NCT00688064|480791|P1|NOT COMPLETED|Overall Study||21
195657|NCT00688064|480790|P2|COMPLETED|Overall Study||201
195658|NCT00688064|480791|P1|COMPLETED|Overall Study||211
195659|NCT00688064|480790|P2|STARTED|Overall Study||227
195660|NCT00688064|480791|P1|STARTED|Overall Study||232
195661|NCT00688103|480807|P2|NOT COMPLETED|Overall Study||13
195662|NCT00688103|480808|P1|NOT COMPLETED|Overall Study||30
195663|NCT00688103|480807|P2|COMPLETED|Overall Study||64
195664|NCT00688103|480808|P1|COMPLETED|Overall Study||44
195665|NCT00688103|480807|P2|Actually Treated|Overall Study||76
195666|NCT00688103|480808|P1|Actually Treated|Overall Study||71
195667|NCT00688103|480807|P2|STARTED|Overall Study||77
195668|NCT00688103|480808|P1|STARTED|Overall Study||74
195669|NCT00688467|480820|P2|NOT COMPLETED|Treatment Period 2||2
195670|NCT00688467|480821|P1|NOT COMPLETED|Treatment Period 2||0
195671|NCT00688467|480820|P2|COMPLETED|Treatment Period 2||6
195672|NCT00688467|480821|P1|COMPLETED|Treatment Period 2||7
195673|NCT00688467|480820|P2|STARTED|Treatment Period 2||8
195674|NCT00688467|480821|P1|STARTED|Treatment Period 2||7
195675|NCT00688467|480820|P2|NOT COMPLETED|Treatment Period 1||2
195676|NCT00688467|480821|P1|NOT COMPLETED|Treatment Period 1||2
195677|NCT00688467|480820|P2|COMPLETED|Treatment Period 1||8
195678|NCT00688467|480821|P1|COMPLETED|Treatment Period 1||7
195679|NCT00688467|480820|P2|STARTED|Treatment Period 1||10
195680|NCT00688467|480821|P1|STARTED|Treatment Period 1||9
195681|NCT00681811|480853|P2|NOT COMPLETED|Overall Study||4
195682|NCT00681811|480854|P1|NOT COMPLETED|Overall Study||3
195683|NCT00681811|480853|P2|COMPLETED|Overall Study||1
195684|NCT00681811|480854|P1|COMPLETED|Overall Study||3
195685|NCT00681811|480853|P2|STARTED|Overall Study||5
195686|NCT00681811|480854|P1|STARTED|Overall Study||6
195687|NCT00681824|480885|P3|NOT COMPLETED|Overall Study||1
195688|NCT00681824|480886|P2|NOT COMPLETED|Overall Study||1
195689|NCT00681824|480887|P1|NOT COMPLETED|Overall Study||1
195690|NCT00681824|480885|P3|COMPLETED|Overall Study||33
195691|NCT00681824|480886|P2|COMPLETED|Overall Study||12
195692|NCT00681824|480887|P1|COMPLETED|Overall Study||27
195693|NCT00681824|480885|P3|STARTED|Overall Study||34
195694|NCT00681824|480886|P2|STARTED|Overall Study||13
195695|NCT00681824|480887|P1|STARTED|Overall Study||28
195696|NCT00681863|480903|P1|NOT COMPLETED|Overall Study||23
195697|NCT00681863|480903|P1|COMPLETED|Overall Study||22
195698|NCT00681863|480903|P1|STARTED|Overall Study||45
195699|NCT00681889|480948|P1|NOT COMPLETED|Overall Study||0
195700|NCT00681889|480948|P1|COMPLETED|Overall Study||9
195701|NCT00681889|480948|P1|STARTED|Overall Study||9
195702|NCT00688519|480954|P2|NOT COMPLETED|Overall Study||15
195703|NCT00688519|480955|P1|NOT COMPLETED|Overall Study||19
195704|NCT00688519|480954|P2|COMPLETED|Overall Study||98
195705|NCT00688519|480955|P1|COMPLETED|Overall Study||204
195706|NCT00688519|480954|P2|STARTED|Overall Study||113
195707|NCT00688519|480955|P1|STARTED|Overall Study||223
195708|NCT00688545|480973|P2|NOT COMPLETED|Overall Study||15
195709|NCT00688545|480974|P1|NOT COMPLETED|Overall Study||5
195710|NCT00688545|480973|P2|COMPLETED|Overall Study||204
195711|NCT00688545|480974|P1|COMPLETED|Overall Study||50
195712|NCT00688545|480973|P2|Switched Treatment at Least Once|Overall Study||13
195713|NCT00688545|480974|P1|Switched Treatment at Least Once|Overall Study||6
195714|NCT00688545|480973|P2|STARTED|Overall Study||219
195715|NCT00688545|480974|P1|STARTED|Overall Study||55
195716|NCT00688636|480984|P2|NOT COMPLETED|Overall Study||1
195717|NCT00688636|480985|P1|NOT COMPLETED|Overall Study||2
195718|NCT00688636|480984|P2|COMPLETED|Overall Study||12
195719|NCT00688636|480985|P1|COMPLETED|Overall Study||9
195720|NCT00688636|480984|P2|STARTED|Overall Study||13
195721|NCT00688636|480985|P1|STARTED|Overall Study||11
195722|NCT00688662|481001|P2|NOT COMPLETED|Overall Study||18
195723|NCT00688662|481002|P1|NOT COMPLETED|Overall Study||23
195724|NCT00688662|481001|P2|COMPLETED|Overall Study||55
195725|NCT00688662|481002|P1|COMPLETED|Overall Study||118
195726|NCT00688662|481001|P2|STARTED|Overall Study||73
195727|NCT00688662|481002|P1|STARTED|Overall Study||141
195728|NCT00688688|481013|P3|NOT COMPLETED|Overall Study||192
195729|NCT00688688|481014|P2|NOT COMPLETED|Overall Study||179
195730|NCT00688688|481015|P1|NOT COMPLETED|Overall Study||186
195731|NCT00688688|481013|P3|COMPLETED|Overall Study||621
195732|NCT00688688|481014|P2|COMPLETED|Overall Study||645
195733|NCT00688688|481015|P1|COMPLETED|Overall Study||629
195734|NCT00688688|481013|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|488
195735|NCT00688688|481014|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|483
195736|NCT00688688|481015|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|All FAS patients who had at least 1 incontinence episode at Baseline.|479
195737|NCT00688688|481013|P3|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|791
195738|NCT00688688|481014|P2|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|802
195739|NCT00688688|481015|P1|Full Analysis Set (FAS)|Overall Study|All treated patients with a baseline and at least 1 post-baseline micturition measurement.|789
195740|NCT00688688|481013|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
195741|NCT00688688|481014|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|820
195742|NCT00688688|481015|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|812
195743|NCT00688688|481013|P3|STARTED|Overall Study||813
195744|NCT00688688|481014|P2|STARTED|Overall Study||824
195745|NCT00688688|481015|P1|STARTED|Overall Study||815
195746|NCT00688701|481107|P4|NOT COMPLETED|Overall Study||11
195747|NCT00688701|481108|P3|NOT COMPLETED|Overall Study||10
195748|NCT00688701|481109|P2|NOT COMPLETED|Overall Study||5
195749|NCT00688701|481110|P1|NOT COMPLETED|Overall Study||4
195750|NCT00688701|481107|P4|COMPLETED|Overall Study||108
195751|NCT00688701|481108|P3|COMPLETED|Overall Study||110
195752|NCT00688701|481109|P2|COMPLETED|Overall Study||56
195753|NCT00688701|481110|P1|COMPLETED|Overall Study||57
195754|NCT00688701|481107|P4|Subgroup for Standardized Meal Test|Overall Study||65
195755|NCT00688701|481108|P3|Subgroup for Standardized Meal Test|Overall Study||60
195756|NCT00688701|481109|P2|Subgroup for Standardized Meal Test|Overall Study||35
195757|NCT00688701|481110|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|27
195758|NCT00688701|481107|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||118
195759|NCT00688701|481108|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||120
195760|NCT00688701|481109|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||60
195761|NCT00688701|481110|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|61
195762|NCT00688701|481107|P4|Treated/Safety Population|Overall Study||119
195763|NCT00688701|481108|P3|Treated/Safety Population|Overall Study||120
195764|NCT00688701|481109|P2|Treated/Safety Population|Overall Study||61
195765|NCT00688701|481110|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|61
195766|NCT00688701|481107|P4|STARTED|Overall Study||119
195767|NCT00688701|481108|P3|STARTED|Overall Study||120
195768|NCT00688701|481109|P2|STARTED|Overall Study||61
195769|NCT00688701|481110|P1|STARTED|Overall Study|Randomized|61
195770|NCT00688740|481150|P2|NOT COMPLETED|Overall Study||35
195771|NCT00688740|481151|P1|NOT COMPLETED|Overall Study||66
195772|NCT00688740|481150|P2|COMPLETED|Overall Study||711
195773|NCT00688740|481151|P1|COMPLETED|Overall Study||679
195774|NCT00688740|481150|P2|STARTED|Overall Study||746
195775|NCT00688740|481151|P1|STARTED|Overall Study||745
195776|NCT00688753|481161|P1|NOT COMPLETED|Overall Study||92
195777|NCT00688753|481161|P1|COMPLETED|Overall Study||0
195778|NCT00688753|481161|P1|STARTED|Overall Study||92
195779|NCT00689611|481172|P2|NOT COMPLETED|Overall Study||46
195780|NCT00689611|481173|P1|NOT COMPLETED|Overall Study||41
195781|NCT00689611|481172|P2|COMPLETED|Overall Study||146
195782|NCT00689611|481173|P1|COMPLETED|Overall Study||159
195783|NCT00689611|481172|P2|STARTED|Overall Study||192
195784|NCT00689611|481173|P1|STARTED|Overall Study||200
195785|NCT00689793|481183|P2|NOT COMPLETED|Overall Study||5
195786|NCT00689793|481184|P1|NOT COMPLETED|Overall Study||4
195787|NCT00689793|481183|P2|COMPLETED|Overall Study||71
195788|NCT00689793|481184|P1|COMPLETED|Overall Study||74
195789|NCT00689793|481183|P2|STARTED|Overall Study||76
195790|NCT00689793|481184|P1|STARTED|Overall Study||78
195791|NCT00689819|481202|P2|NOT COMPLETED|Overall Study||15
195792|NCT00689819|481203|P1|NOT COMPLETED|Overall Study||20
195793|NCT00689819|481202|P2|COMPLETED|Overall Study||43
195794|NCT00689819|481203|P1|COMPLETED|Overall Study||45
195795|NCT00689819|481202|P2|STARTED|Overall Study||58
195796|NCT00689819|481203|P1|STARTED|Overall Study||65
195797|NCT00689871|481215|P4|NOT COMPLETED|Overall Study||7
195798|NCT00689871|481216|P3|NOT COMPLETED|Overall Study||73
195799|NCT00689871|481217|P2|NOT COMPLETED|Overall Study||52
195800|NCT00689871|481218|P1|NOT COMPLETED|Overall Study||175
195801|NCT00689871|481215|P4|COMPLETED|Overall Study|4 Patients discontinued|8
195802|NCT00689871|481216|P3|COMPLETED|Overall Study|28 Patients discontinued|74
195803|NCT00689871|481217|P2|COMPLETED|Overall Study|35 Patients discontinued|46
195804|NCT00689871|481218|P1|COMPLETED|Overall Study|35 Patients discontinued|280
195805|NCT00689871|481215|P4|STARTED|Overall Study|25 Implants|15
195806|NCT00689871|481216|P3|STARTED|Overall Study|288 Implants|147
195807|NCT00689871|481217|P2|STARTED|Overall Study|127 Implants|98
195808|NCT00689871|481218|P1|STARTED|Overall Study|908 Implants|455
195809|NCT00689884|481232|P1|NOT COMPLETED|Overall Study||0
195810|NCT00689884|481232|P1|COMPLETED|Overall Study||7
195811|NCT00689884|481232|P1|STARTED|Overall Study||7
195812|NCT00689936|481240|P3|NOT COMPLETED|Long-Term Follow Up Phase||144
195813|NCT00689936|481241|P2|NOT COMPLETED|Long-Term Follow Up Phase||188
195814|NCT00689936|481242|P1|NOT COMPLETED|Long-Term Follow Up Phase||127
195815|NCT00689936|481240|P3|COMPLETED|Long-Term Follow Up Phase||315
195816|NCT00689936|481241|P2|COMPLETED|Long-Term Follow Up Phase||275
195817|NCT00689936|481242|P1|COMPLETED|Long-Term Follow Up Phase||255
195818|NCT00689936|481240|P3|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|459
195819|NCT00689936|481241|P2|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|463
195820|NCT00689936|481242|P1|STARTED|Long-Term Follow Up Phase|Includes participants from both the active treatment phase and from the PFS follow-up phase.|382
195821|NCT00689936|481240|P3|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
195822|NCT00689936|481241|P2|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
195823|NCT00689936|481242|P1|NOT COMPLETED|Progression Free Survival-PFS-Follow-Up||0
195824|NCT00689936|481240|P3|COMPLETED|Progression Free Survival-PFS-Follow-Up||273
195825|NCT00689936|481241|P2|COMPLETED|Progression Free Survival-PFS-Follow-Up||300
195826|NCT00689936|481242|P1|COMPLETED|Progression Free Survival-PFS-Follow-Up||87
195827|NCT00689936|481240|P3|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 12 cycles MPT and did not experience progressive disease.|273
195828|NCT00689936|481241|P2|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who completed 18 cycles (Rd18) and did not experience progressive disease.|300
195829|NCT00689936|481242|P1|STARTED|Progression Free Survival-PFS-Follow-Up|Includes participants who discontinued treatment for reasons other than progressive disease.|87
195830|NCT00689936|481240|P3|NOT COMPLETED|Active Treatment Phase||547
195831|NCT00689936|481241|P2|NOT COMPLETED|Active Treatment Phase||541
195832|NCT00689936|481242|P1|NOT COMPLETED|Active Treatment Phase||535
195833|NCT00689936|481240|P3|COMPLETED|Active Treatment Phase||0
195834|NCT00689936|481241|P2|COMPLETED|Active Treatment Phase||0
195835|NCT00689936|481242|P1|COMPLETED|Active Treatment Phase||0
195836|NCT00689936|481240|P3|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|6
195837|NCT00689936|481241|P2|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|1
195838|NCT00689936|481242|P1|Untreated|Active Treatment Phase|Participants randomized, but did not receive any study drug treatment.|3
195839|NCT00689936|481240|P3|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|541
195840|NCT00689936|481241|P2|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|540
195841|NCT00689936|481242|P1|Safety Population|Active Treatment Phase|Safety population = all randomized participants who received at least 1 dose of study treatment.|532
195842|NCT00689936|481240|P3|STARTED|Active Treatment Phase||547
195843|NCT00689936|481241|P2|STARTED|Active Treatment Phase||541
195844|NCT00689936|481242|P1|STARTED|Active Treatment Phase||535
195845|NCT00690040|481384|P2|NOT COMPLETED|Overall Study||0
195846|NCT00690040|481385|P1|NOT COMPLETED|Overall Study||0
195847|NCT00690040|481384|P2|COMPLETED|Overall Study||148
195848|NCT00690040|481385|P1|COMPLETED|Overall Study||145
195849|NCT00690040|481384|P2|STARTED|Overall Study||148
195850|NCT00690040|481385|P1|STARTED|Overall Study||145
195851|NCT00690339|481395|P4|NOT COMPLETED|Overall Study||25
195852|NCT00690339|481396|P3|NOT COMPLETED|Overall Study||57
195853|NCT00690339|481397|P2|NOT COMPLETED|Overall Study||81
195854|NCT00690339|481398|P1|NOT COMPLETED|Overall Study||117
195855|NCT00690339|481395|P4|COMPLETED|Overall Study||43
195856|NCT00690339|481396|P3|COMPLETED|Overall Study||99
195857|NCT00690339|481397|P2|COMPLETED|Overall Study||144
195858|NCT00690339|481398|P1|COMPLETED|Overall Study||375
195859|NCT00690339|481395|P4|STARTED|Overall Study||68
195860|NCT00690339|481396|P3|STARTED|Overall Study||156
195861|NCT00690339|481397|P2|STARTED|Overall Study||225
195862|NCT00690339|481398|P1|STARTED|Overall Study||492
195863|NCT00690430|481414|P3|NOT COMPLETED|Extension Phase||13
195864|NCT00690430|481415|P2|NOT COMPLETED|Extension Phase||5
195865|NCT00690430|481416|P1|NOT COMPLETED|Extension Phase||18
195866|NCT00690430|481414|P3|COMPLETED|Extension Phase||2
195867|NCT00690430|481415|P2|COMPLETED|Extension Phase||1
195868|NCT00690430|481416|P1|COMPLETED|Extension Phase||2
195869|NCT00690430|481414|P3|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|15
195870|NCT00690430|481415|P2|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|6
195871|NCT00690430|481416|P1|STARTED|Extension Phase|Only those patients (except from UK) who received clinical benefit could extend therapy in extension|20
195872|NCT00690430|481414|P3|NOT COMPLETED|Core Phase||0
195873|NCT00690430|481415|P2|NOT COMPLETED|Core Phase||23
195874|NCT00690430|481416|P1|NOT COMPLETED|Core Phase||18
195875|NCT00690430|481414|P3|COMPLETED|Core Phase||0
195876|NCT00690430|481415|P2|COMPLETED|Core Phase||34
195877|NCT00690430|481416|P1|COMPLETED|Core Phase||35
195878|NCT00690430|481414|P3|STARTED|Core Phase|This arm belongs to Extension Phase.|0
195879|NCT00690430|481415|P2|STARTED|Core Phase||57
195880|NCT00690430|481416|P1|STARTED|Core Phase|"Started indicates Full Analysis Set (FAS) and Safety Set."|53
195881|NCT00690443|481445|P2|NOT COMPLETED|Overall Study||2
195882|NCT00690443|481446|P1|NOT COMPLETED|Overall Study||1
195883|NCT00690443|481445|P2|COMPLETED|Overall Study||19
195884|NCT00690443|481446|P1|COMPLETED|Overall Study||22
195885|NCT00690443|481445|P2|STARTED|Overall Study||21
195886|NCT00690443|481446|P1|STARTED|Overall Study||23
195887|NCT00690482|481456|P2|NOT COMPLETED|Overall Study||3
195888|NCT00690482|481457|P1|NOT COMPLETED|Overall Study||4
195889|NCT00690482|481456|P2|COMPLETED|Overall Study||54
195890|NCT00690482|481457|P1|COMPLETED|Overall Study||57
195891|NCT00690482|481456|P2|STARTED|Overall Study||57
195892|NCT00690482|481457|P1|STARTED|Overall Study||61
195893|NCT00690495|481491|P2|NOT COMPLETED|Overall Study||0
195894|NCT00690495|481492|P1|NOT COMPLETED|Overall Study||0
195895|NCT00690495|481491|P2|COMPLETED|Overall Study||50
195896|NCT00690495|481492|P1|COMPLETED|Overall Study||50
195897|NCT00690495|481491|P2|Primary Endpoint|Overall Study||50
195898|NCT00690495|481492|P1|Primary Endpoint|Overall Study||50
195899|NCT00690495|481491|P2|STARTED|Overall Study||50
195900|NCT00690495|481492|P1|STARTED|Overall Study||50
195901|NCT00690573|481498|P1|NOT COMPLETED|Overall Study||9
195902|NCT00690573|481498|P1|COMPLETED|Overall Study||16
195903|NCT00690573|481498|P1|STARTED|Overall Study||25
195904|NCT00690612|481506|P1|NOT COMPLETED|Overall Study||3
195905|NCT00690612|481506|P1|COMPLETED|Overall Study||32
195906|NCT00690612|481506|P1|STARTED|Overall Study||35
195907|NCT00690755|481518|P7|NOT COMPLETED|Overall Study||0
195908|NCT00690755|481519|P6|NOT COMPLETED|Overall Study||4
195909|NCT00690755|481520|P5|NOT COMPLETED|Overall Study||0
195910|NCT00690755|481521|P4|NOT COMPLETED|Overall Study||5
195911|NCT00690755|481522|P3|NOT COMPLETED|Overall Study||46
195912|NCT00690755|481523|P2|NOT COMPLETED|Overall Study||0
195913|NCT00690755|481524|P1|NOT COMPLETED|Overall Study||2
195914|NCT00690755|481518|P7|COMPLETED|Overall Study||0
195915|NCT00690755|481519|P6|COMPLETED|Overall Study||6
195916|NCT00690755|481520|P5|COMPLETED|Overall Study||0
195917|NCT00690755|481521|P4|COMPLETED|Overall Study||15
195918|NCT00690755|481522|P3|COMPLETED|Overall Study||51
195919|NCT00690755|481523|P2|COMPLETED|Overall Study||0
195920|NCT00690755|481524|P1|COMPLETED|Overall Study|Patient recruitment ended on 12/31/2010|28
195921|NCT00690755|481518|P7|STARTED|Overall Study||0
195922|NCT00690755|481519|P6|STARTED|Overall Study||10
195923|NCT00690755|481520|P5|STARTED|Overall Study||0
195924|NCT00690755|481521|P4|STARTED|Overall Study||20
195925|NCT00690755|481522|P3|STARTED|Overall Study||97
195926|NCT00690755|481523|P2|STARTED|Overall Study||0
195927|NCT00690755|481524|P1|STARTED|Overall Study||30
195928|NCT00690794|481542|P2|NOT COMPLETED|Overall Study||35
195929|NCT00690794|481543|P1|NOT COMPLETED|Overall Study||21
195930|NCT00690794|481542|P2|COMPLETED|Overall Study||328
195931|NCT00690794|481543|P1|COMPLETED|Overall Study||342
195932|NCT00690794|481542|P2|STARTED|Overall Study||363
195933|NCT00690794|481543|P1|STARTED|Overall Study||363
195934|NCT00690820|481553|P2|NOT COMPLETED|Period 2||0
195935|NCT00690820|481554|P1|NOT COMPLETED|Period 2||0
195936|NCT00690820|481553|P2|COMPLETED|Period 2||8
195937|NCT00690820|481554|P1|COMPLETED|Period 2||8
195938|NCT00690820|481553|P2|STARTED|Period 2||8
195939|NCT00690820|481554|P1|STARTED|Period 2||8
195940|NCT00690820|481553|P2|NOT COMPLETED|Period 1||1
195941|NCT00690820|481554|P1|NOT COMPLETED|Period 1||0
195942|NCT00690820|481553|P2|COMPLETED|Period 1||8
195943|NCT00690820|481554|P1|COMPLETED|Period 1||8
195944|NCT00690820|481553|P2|STARTED|Period 1||9
195945|NCT00690820|481554|P1|STARTED|Period 1||8
195946|NCT00690833|481574|P1|NOT COMPLETED|Overall Study||2
195947|NCT00690833|481574|P1|COMPLETED|Overall Study||39
195948|NCT00690833|481574|P1|STARTED|Overall Study||41
195949|NCT00690898|481578|P1|NOT COMPLETED|TREATMENT||26
195950|NCT00690898|481578|P1|COMPLETED|TREATMENT||64
195951|NCT00690898|481578|P1|STARTED|TREATMENT|Total number of patients treated.|90
195952|NCT00690898|481578|P1|NOT COMPLETED|SCREENING||18
195953|NCT00690898|481578|P1|COMPLETED|SCREENING|Number of patients included in the study.|90
195954|NCT00690898|481578|P1|STARTED|SCREENING|Total of patients screened for the study.|108
195955|NCT00691015|481592|P1|NOT COMPLETED|Overall Study||1
195956|NCT00691015|481592|P1|COMPLETED|Overall Study||47
195957|NCT00691015|481592|P1|STARTED|Overall Study||48
195958|NCT00691028|481606|P4|NOT COMPLETED|Double-blind Period||0
195959|NCT00691028|481607|P3|NOT COMPLETED|Double-blind Period||9
195960|NCT00691028|481608|P2|NOT COMPLETED|Double-blind Period||13
195961|NCT00691028|481609|P1|NOT COMPLETED|Double-blind Period||13
195962|NCT00691028|481606|P4|COMPLETED|Double-blind Period||0
195963|NCT00691028|481607|P3|COMPLETED|Double-blind Period||95
195964|NCT00691028|481608|P2|COMPLETED|Double-blind Period||91
195965|NCT00691028|481609|P1|COMPLETED|Double-blind Period||86
195966|NCT00691028|481606|P4|STARTED|Double-blind Period||0
195967|NCT00691028|481607|P3|STARTED|Double-blind Period||104
195968|NCT00691028|481608|P2|STARTED|Double-blind Period||104
195969|NCT00691028|481609|P1|STARTED|Double-blind Period||99
195970|NCT00691028|481606|P4|NOT COMPLETED|Open-label Period||20
195971|NCT00691028|481607|P3|NOT COMPLETED|Open-label Period||0
195972|NCT00691028|481608|P2|NOT COMPLETED|Open-label Period||0
195973|NCT00691028|481609|P1|NOT COMPLETED|Open-label Period||0
195974|NCT00691028|481606|P4|COMPLETED|Open-label Period||307
195975|NCT00691028|481607|P3|COMPLETED|Open-label Period||0
195976|NCT00691028|481608|P2|COMPLETED|Open-label Period||0
195977|NCT00691028|481609|P1|COMPLETED|Open-label Period||0
195978|NCT00691028|481606|P4|STARTED|Open-label Period||327
195979|NCT00691028|481607|P3|STARTED|Open-label Period||0
195980|NCT00691028|481608|P2|STARTED|Open-label Period||0
195981|NCT00691028|481609|P1|STARTED|Open-label Period||0
195982|NCT00691054|481642|P1|NOT COMPLETED|Overall Study||1
195983|NCT00691054|481642|P1|COMPLETED|Overall Study||19
195984|NCT00691054|481642|P1|STARTED|Overall Study||20
195985|NCT00691093|481651|P1|NOT COMPLETED|Overall Study||7
195986|NCT00691093|481651|P1|COMPLETED|Overall Study||816
195987|NCT00691093|481651|P1|STARTED|Overall Study||823
195988|NCT00691132|481687|P2|NOT COMPLETED|Overall Study||13
195989|NCT00691132|481688|P1|NOT COMPLETED|Overall Study||12
195990|NCT00691132|481687|P2|COMPLETED|Overall Study|45 completed, but 4 excluded b/c urinary measures indicated they did not smoke study cigarettes.|41
195991|NCT00691132|481688|P1|COMPLETED|Overall Study||41
195992|NCT00691132|481687|P2|STARTED|Overall Study|107 total randomized. Approximately 1/2 per arm.|54
195993|NCT00691132|481688|P1|STARTED|Overall Study||53
195994|NCT00691197|481709|P2|NOT COMPLETED|Overall Study||5
195995|NCT00691197|481710|P1|NOT COMPLETED|Overall Study||11
195996|NCT00691197|481709|P2|COMPLETED|Overall Study||75
195997|NCT00691197|481710|P1|COMPLETED|Overall Study||155
195998|NCT00691197|481709|P2|STARTED|Overall Study||80
195999|NCT00691197|481710|P1|STARTED|Overall Study||166
196000|NCT00691210|481730|P8|NOT COMPLETED|Overall Study||0
196001|NCT00691210|481731|P7|NOT COMPLETED|Overall Study||0
196002|NCT00691210|481732|P6|NOT COMPLETED|Overall Study||1
196003|NCT00691210|481733|P5|NOT COMPLETED|Overall Study||0
196004|NCT00691210|481734|P4|NOT COMPLETED|Overall Study||3
196005|NCT00691210|481735|P3|NOT COMPLETED|Overall Study||0
196006|NCT00691210|481736|P2|NOT COMPLETED|Overall Study||0
196007|NCT00691210|481737|P1|NOT COMPLETED|Overall Study||0
196008|NCT00691210|481730|P8|COMPLETED|Overall Study||0
196009|NCT00691210|481731|P7|COMPLETED|Overall Study||6
196010|NCT00691210|481732|P6|COMPLETED|Overall Study||6
196011|NCT00691210|481733|P5|COMPLETED|Overall Study||5
196012|NCT00691210|481734|P4|COMPLETED|Overall Study||6
196013|NCT00691210|481735|P3|COMPLETED|Overall Study||3
196014|NCT00691210|481736|P2|COMPLETED|Overall Study||5
196015|NCT00691210|481737|P1|COMPLETED|Overall Study||3
196016|NCT00691210|481730|P8|STARTED|Overall Study||0
196017|NCT00691210|481731|P7|STARTED|Overall Study||6
196018|NCT00691210|481732|P6|STARTED|Overall Study||7
196019|NCT00691210|481733|P5|STARTED|Overall Study||5
196020|NCT00691210|481734|P4|STARTED|Overall Study||9
196021|NCT00691210|481735|P3|STARTED|Overall Study||3
196022|NCT00691210|481736|P2|STARTED|Overall Study||5
196023|NCT00691210|481737|P1|STARTED|Overall Study||3
196024|NCT00691327|481757|P2|NOT COMPLETED|Overall Study||2508
196025|NCT00691327|481758|P1|NOT COMPLETED|Overall Study||2841
196026|NCT00691327|481757|P2|COMPLETED|Overall Study||36766
196027|NCT00691327|481758|P1|COMPLETED|Overall Study||42214
196028|NCT00691327|481757|P2|STARTED|Overall Study||39274
196029|NCT00691327|481758|P1|STARTED|Overall Study||45055
196030|NCT00691483|481768|P2|NOT COMPLETED|Overall Study||25
196031|NCT00691483|481769|P1|NOT COMPLETED|Overall Study||68
196032|NCT00691483|481768|P2|COMPLETED|Overall Study||141
196033|NCT00691483|481769|P1|COMPLETED|Overall Study|Completed refers to completion of the study.|425
196034|NCT00691483|481768|P2|Received Treatment|Overall Study||165
196035|NCT00691483|481769|P1|Received Treatment|Overall Study||486
196036|NCT00691483|481768|P2|STARTED|Overall Study||166
196037|NCT00691483|481769|P1|STARTED|Overall Study||493
196038|NCT00691652|481785|P1|NOT COMPLETED|Overall Study||1
196039|NCT00691652|481785|P1|COMPLETED|Overall Study||1
196040|NCT00691652|481785|P1|STARTED|Overall Study||2
196041|NCT00691665|481791|P2|NOT COMPLETED|Overall Study||0
196042|NCT00691665|481792|P1|NOT COMPLETED|Overall Study||0
196043|NCT00691665|481791|P2|COMPLETED|Overall Study||65
196044|NCT00691665|481792|P1|COMPLETED|Overall Study||65
196045|NCT00691665|481791|P2|STARTED|Overall Study||65
196046|NCT00691665|481792|P1|STARTED|Overall Study||65
196047|NCT00691704|481804|P1|NOT COMPLETED|Two Years of Maintenance Therapy||13
196048|NCT00691704|481804|P1|COMPLETED|Two Years of Maintenance Therapy||3
196049|NCT00691704|481804|P1|STARTED|Two Years of Maintenance Therapy||16
196050|NCT00691704|481804|P1|NOT COMPLETED|Induction Therapy||2
196051|NCT00691704|481804|P1|COMPLETED|Induction Therapy||16
196052|NCT00691704|481804|P1|STARTED|Induction Therapy||18
196053|NCT00691808|481815|P3|NOT COMPLETED|Overall Study||0
196054|NCT00691808|481816|P2|NOT COMPLETED|Overall Study||1
196055|NCT00691808|481817|P1|NOT COMPLETED|Overall Study||0
196056|NCT00691808|481815|P3|COMPLETED|Overall Study||32
196057|NCT00691808|481816|P2|COMPLETED|Overall Study||35
196058|NCT00691808|481817|P1|COMPLETED|Overall Study||35
196059|NCT00691808|481815|P3|STARTED|Overall Study||32
196060|NCT00691808|481816|P2|STARTED|Overall Study||36
196061|NCT00691808|481817|P1|STARTED|Overall Study||35
196062|NCT00691938|481865|P7|NOT COMPLETED|Overall Study||0
196063|NCT00691938|481866|P6|NOT COMPLETED|Overall Study||0
196064|NCT00691938|481867|P5|NOT COMPLETED|Overall Study||0
196065|NCT00691938|481868|P4|NOT COMPLETED|Overall Study||0
196066|NCT00691938|481869|P3|NOT COMPLETED|Overall Study||0
196067|NCT00691938|481870|P2|NOT COMPLETED|Overall Study||0
196068|NCT00691938|481871|P1|NOT COMPLETED|Overall Study||1
196069|NCT00691938|481865|P7|COMPLETED|Overall Study||14
196070|NCT00691938|481866|P6|COMPLETED|Overall Study||6
196071|NCT00691938|481867|P5|COMPLETED|Overall Study||10
196072|NCT00691938|481868|P4|COMPLETED|Overall Study||8
196073|NCT00691938|481869|P3|COMPLETED|Overall Study||6
196074|NCT00691938|481870|P2|COMPLETED|Overall Study||3
196075|NCT00691938|481871|P1|COMPLETED|Overall Study||4
196076|NCT00691938|481865|P7|STARTED|Overall Study||14
196077|NCT00691938|481866|P6|STARTED|Overall Study||6
196078|NCT00691938|481867|P5|STARTED|Overall Study||10
196079|NCT00691938|481868|P4|STARTED|Overall Study||8
196080|NCT00691938|481869|P3|STARTED|Overall Study||6
196081|NCT00691938|481870|P2|STARTED|Overall Study||3
196082|NCT00691938|481871|P1|STARTED|Overall Study||5
196083|NCT00692003|481894|P2|NOT COMPLETED|Overall Study||1
196084|NCT00692003|481895|P1|NOT COMPLETED|Overall Study||5
196085|NCT00692003|481894|P2|COMPLETED|Overall Study||0
196086|NCT00692003|481895|P1|COMPLETED|Overall Study||0
196087|NCT00692003|481894|P2|STARTED|Overall Study||1
196088|NCT00692003|481895|P1|STARTED|Overall Study||5
196089|NCT00684983|481905|P2|NOT COMPLETED|Overall Study||0
196090|NCT00684983|481906|P1|NOT COMPLETED|Overall Study||0
196091|NCT00684983|481905|P2|COMPLETED|Overall Study|One major violation patient in Arm B is included in the primary analysis per protocol.|45
196092|NCT00684983|481906|P1|COMPLETED|Overall Study||19
196093|NCT00684983|481905|P2|STARTED|Overall Study||45
196094|NCT00684983|481906|P1|STARTED|Overall Study||19
196095|NCT00684996|481912|P1|NOT COMPLETED|Overall Study||5
196096|NCT00684996|481912|P1|COMPLETED|Overall Study||0
196097|NCT00684996|481912|P1|Eligible|Overall Study||5
196098|NCT00684996|481912|P1|STARTED|Overall Study||5
196099|NCT00685035|481925|P2|NOT COMPLETED|Period 3: 2nd Intervention||0
196100|NCT00685035|481926|P1|NOT COMPLETED|Period 3: 2nd Intervention||0
196101|NCT00685035|481925|P2|COMPLETED|Period 3: 2nd Intervention||8
196102|NCT00685035|481926|P1|COMPLETED|Period 3: 2nd Intervention||8
196103|NCT00685035|481925|P2|STARTED|Period 3: 2nd Intervention||8
196104|NCT00685035|481926|P1|STARTED|Period 3: 2nd Intervention||8
196105|NCT00685035|481925|P2|NOT COMPLETED|Period 2: 2-day Washout||0
196106|NCT00685035|481926|P1|NOT COMPLETED|Period 2: 2-day Washout||0
196107|NCT00685035|481925|P2|COMPLETED|Period 2: 2-day Washout||8
196108|NCT00685035|481926|P1|COMPLETED|Period 2: 2-day Washout||8
196109|NCT00685035|481925|P2|STARTED|Period 2: 2-day Washout||8
196110|NCT00685035|481926|P1|STARTED|Period 2: 2-day Washout||8
196111|NCT00685035|481925|P2|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||0
196112|NCT00685035|481926|P1|NOT COMPLETED|Period 1: First Intervention: 30 Minutes||1
196113|NCT00685035|481925|P2|COMPLETED|Period 1: First Intervention: 30 Minutes||8
196114|NCT00685035|481926|P1|COMPLETED|Period 1: First Intervention: 30 Minutes||8
196115|NCT00685035|481925|P2|STARTED|Period 1: First Intervention: 30 Minutes||8
196116|NCT00685035|481926|P1|STARTED|Period 1: First Intervention: 30 Minutes||9
196117|NCT00685139|481950|P2|NOT COMPLETED|Second Intervention||0
196118|NCT00685139|481951|P1|NOT COMPLETED|Second Intervention||0
196119|NCT00685139|481950|P2|COMPLETED|Second Intervention||17
196120|NCT00685139|481951|P1|COMPLETED|Second Intervention||17
196121|NCT00685139|481950|P2|STARTED|Second Intervention||17
196122|NCT00685139|481951|P1|STARTED|Second Intervention||17
196123|NCT00685139|481950|P2|NOT COMPLETED|Washout Period of 28 Days||0
196124|NCT00685139|481951|P1|NOT COMPLETED|Washout Period of 28 Days||0
196125|NCT00685139|481950|P2|COMPLETED|Washout Period of 28 Days||17
196126|NCT00685139|481951|P1|COMPLETED|Washout Period of 28 Days||17
196127|NCT00685139|481950|P2|STARTED|Washout Period of 28 Days||17
196128|NCT00685139|481951|P1|STARTED|Washout Period of 28 Days||17
196129|NCT00685139|481950|P2|NOT COMPLETED|First Intervention||0
196130|NCT00685139|481951|P1|NOT COMPLETED|First Intervention||0
196131|NCT00685139|481950|P2|COMPLETED|First Intervention||17
196132|NCT00685139|481951|P1|COMPLETED|First Intervention||17
196133|NCT00685139|481950|P2|STARTED|First Intervention||17
196134|NCT00685139|481951|P1|STARTED|First Intervention||17
196135|NCT00685165|481959|P2|NOT COMPLETED|Second Intervention||0
196136|NCT00685165|481960|P1|NOT COMPLETED|Second Intervention||0
196137|NCT00685165|481959|P2|COMPLETED|Second Intervention||11
196138|NCT00685165|481960|P1|COMPLETED|Second Intervention||10
196139|NCT00685165|481959|P2|STARTED|Second Intervention||11
196140|NCT00685165|481960|P1|STARTED|Second Intervention||10
196141|NCT00685165|481959|P2|NOT COMPLETED|Washout Period of 14 Days||0
196142|NCT00685165|481960|P1|NOT COMPLETED|Washout Period of 14 Days||1
196143|NCT00685165|481959|P2|COMPLETED|Washout Period of 14 Days||11
196144|NCT00685165|481960|P1|COMPLETED|Washout Period of 14 Days|adverse event- possible upper respiratory infection|10
196145|NCT00685165|481959|P2|STARTED|Washout Period of 14 Days||11
196146|NCT00685165|481960|P1|STARTED|Washout Period of 14 Days||11
196147|NCT00685165|481959|P2|NOT COMPLETED|First Intervention||0
196148|NCT00685165|481960|P1|NOT COMPLETED|First Intervention||0
196149|NCT00685165|481959|P2|COMPLETED|First Intervention||11
196150|NCT00685165|481960|P1|COMPLETED|First Intervention||11
196151|NCT00685165|481959|P2|STARTED|First Intervention||11
196152|NCT00685165|481960|P1|STARTED|First Intervention||11
196153|NCT00685178|481974|P4|NOT COMPLETED|Overall Study||14
196154|NCT00685178|481975|P3|NOT COMPLETED|Overall Study||12
196155|NCT00685178|481976|P2|NOT COMPLETED|Overall Study||19
196156|NCT00685178|481977|P1|NOT COMPLETED|Overall Study||13
196157|NCT00685178|481974|P4|COMPLETED|Overall Study||33
196158|NCT00685178|481975|P3|COMPLETED|Overall Study||27
196159|NCT00685178|481976|P2|COMPLETED|Overall Study||26
196160|NCT00685178|481977|P1|COMPLETED|Overall Study||27
196161|NCT00685178|481974|P4|STARTED|Overall Study||47
196162|NCT00685178|481975|P3|STARTED|Overall Study||39
196163|NCT00685178|481976|P2|STARTED|Overall Study||45
196164|NCT00685178|481977|P1|STARTED|Overall Study||40
196165|NCT00685295|481993|P2|NOT COMPLETED|Overall Study||0
196166|NCT00685295|481994|P1|NOT COMPLETED|Overall Study||0
196167|NCT00685295|481993|P2|COMPLETED|Overall Study||30
196168|NCT00685295|481994|P1|COMPLETED|Overall Study||30
196169|NCT00685295|481993|P2|STARTED|Overall Study||30
196170|NCT00685295|481994|P1|STARTED|Overall Study||30
196171|NCT00685334|482006|P2|NOT COMPLETED|Overall Study||7
196172|NCT00685334|482007|P1|NOT COMPLETED|Overall Study||10
196173|NCT00685334|482006|P2|COMPLETED|Overall Study||3
196174|NCT00685334|482007|P1|COMPLETED|Overall Study||2
196175|NCT00685334|482006|P2|STARTED|Overall Study||10
196176|NCT00685334|482007|P1|STARTED|Overall Study||12
196177|NCT00685373|482015|P1|NOT COMPLETED|Overall Study||15
196178|NCT00685373|482015|P1|COMPLETED|Overall Study||151
196179|NCT00685373|482015|P1|STARTED|Overall Study||166
196180|NCT00685399|482029|P8|NOT COMPLETED|Extension||0
196181|NCT00685399|482030|P7|NOT COMPLETED|Extension||0
196182|NCT00685399|482031|P6|NOT COMPLETED|Extension||0
196183|NCT00685399|482032|P5|NOT COMPLETED|Extension||0
196184|NCT00685399|482033|P4|NOT COMPLETED|Extension||7
196185|NCT00685399|482034|P3|NOT COMPLETED|Extension||0
196186|NCT00685399|482035|P2|NOT COMPLETED|Extension||0
196187|NCT00685399|482036|P1|NOT COMPLETED|Extension||0
196188|NCT00685399|482029|P8|COMPLETED|Extension||0
196189|NCT00685399|482030|P7|COMPLETED|Extension||0
196190|NCT00685399|482031|P6|COMPLETED|Extension||0
196191|NCT00685399|482032|P5|COMPLETED|Extension||0
196192|NCT00685399|482033|P4|COMPLETED|Extension||21
196193|NCT00685399|482034|P3|COMPLETED|Extension||0
196194|NCT00685399|482035|P2|COMPLETED|Extension||0
196195|NCT00685399|482036|P1|COMPLETED|Extension||0
196196|NCT00685399|482029|P8|STARTED|Extension||0
196197|NCT00685399|482030|P7|STARTED|Extension||0
196198|NCT00685399|482031|P6|STARTED|Extension||0
196199|NCT00685399|482032|P5|STARTED|Extension||0
196200|NCT00685399|482033|P4|STARTED|Extension||28
196201|NCT00685399|482034|P3|STARTED|Extension||0
196202|NCT00685399|482035|P2|STARTED|Extension||0
196203|NCT00685399|482036|P1|STARTED|Extension||0
196204|NCT00685399|482029|P8|NOT COMPLETED|Treatment Period 2||2
196205|NCT00685399|482030|P7|NOT COMPLETED|Treatment Period 2||0
196206|NCT00685399|482031|P6|NOT COMPLETED|Treatment Period 2||2
196207|NCT00685399|482032|P5|NOT COMPLETED|Treatment Period 2||0
196208|NCT00685399|482033|P4|NOT COMPLETED|Treatment Period 2||0
196209|NCT00685399|482034|P3|NOT COMPLETED|Treatment Period 2||3
196210|NCT00685399|482035|P2|NOT COMPLETED|Treatment Period 2||12
196211|NCT00685399|482036|P1|NOT COMPLETED|Treatment Period 2||0
196212|NCT00685399|482029|P8|COMPLETED|Treatment Period 2||10
196213|NCT00685399|482030|P7|COMPLETED|Treatment Period 2||13
196214|NCT00685399|482031|P6|COMPLETED|Treatment Period 2||10
196215|NCT00685399|482032|P5|COMPLETED|Treatment Period 2||4
196309|NCT00685763|482251|P1|NOT COMPLETED|Overall Study||2
196216|NCT00685399|482033|P4|COMPLETED|Treatment Period 2|in extension period only|0
196217|NCT00685399|482034|P3|COMPLETED|Treatment Period 2||2
196218|NCT00685399|482035|P2|COMPLETED|Treatment Period 2||2
196219|NCT00685399|482036|P1|COMPLETED|Treatment Period 2||0
196220|NCT00685399|482029|P8|STARTED|Treatment Period 2||12
196221|NCT00685399|482030|P7|STARTED|Treatment Period 2||13
196222|NCT00685399|482031|P6|STARTED|Treatment Period 2||12
196223|NCT00685399|482032|P5|STARTED|Treatment Period 2||4
196224|NCT00685399|482033|P4|STARTED|Treatment Period 2|in extension period only|0
196225|NCT00685399|482034|P3|STARTED|Treatment Period 2||5
196226|NCT00685399|482035|P2|STARTED|Treatment Period 2||14
196227|NCT00685399|482036|P1|STARTED|Treatment Period 2||0
196228|NCT00685399|482029|P8|NOT COMPLETED|Treatment Period 1||0
196229|NCT00685399|482030|P7|NOT COMPLETED|Treatment Period 1||0
196230|NCT00685399|482031|P6|NOT COMPLETED|Treatment Period 1||0
196231|NCT00685399|482032|P5|NOT COMPLETED|Treatment Period 1||0
196232|NCT00685399|482033|P4|NOT COMPLETED|Treatment Period 1||0
196233|NCT00685399|482034|P3|NOT COMPLETED|Treatment Period 1||0
196234|NCT00685399|482035|P2|NOT COMPLETED|Treatment Period 1||0
196235|NCT00685399|482036|P1|NOT COMPLETED|Treatment Period 1||6
196236|NCT00685399|482029|P8|COMPLETED|Treatment Period 1||0
196237|NCT00685399|482030|P7|COMPLETED|Treatment Period 1||0
196238|NCT00685399|482031|P6|COMPLETED|Treatment Period 1||0
196239|NCT00685399|482032|P5|COMPLETED|Treatment Period 1||0
196240|NCT00685399|482033|P4|COMPLETED|Treatment Period 1||0
196241|NCT00685399|482034|P3|COMPLETED|Treatment Period 1||0
196242|NCT00685399|482035|P2|COMPLETED|Treatment Period 1||0
196243|NCT00685399|482036|P1|COMPLETED|Treatment Period 1||10
196244|NCT00685399|482029|P8|STARTED|Treatment Period 1||0
196245|NCT00685399|482030|P7|STARTED|Treatment Period 1||0
196246|NCT00685399|482031|P6|STARTED|Treatment Period 1||0
196247|NCT00685399|482032|P5|STARTED|Treatment Period 1||0
196248|NCT00685399|482033|P4|STARTED|Treatment Period 1||0
196249|NCT00685399|482034|P3|STARTED|Treatment Period 1||0
196250|NCT00685399|482035|P2|STARTED|Treatment Period 1||0
196251|NCT00685399|482036|P1|STARTED|Treatment Period 1||16
196252|NCT00685477|482069|P6|NOT COMPLETED|Overall Study||0
196253|NCT00685477|482070|P5|NOT COMPLETED|Overall Study||0
196254|NCT00685477|482071|P4|NOT COMPLETED|Overall Study||0
196255|NCT00685477|482072|P3|NOT COMPLETED|Overall Study||0
196256|NCT00685477|482073|P2|NOT COMPLETED|Overall Study||0
196257|NCT00685477|482074|P1|NOT COMPLETED|Overall Study||0
196258|NCT00685477|482069|P6|COMPLETED|Overall Study||10
196259|NCT00685477|482070|P5|COMPLETED|Overall Study||10
196260|NCT00685477|482071|P4|COMPLETED|Overall Study||10
196261|NCT00685477|482072|P3|COMPLETED|Overall Study||10
196262|NCT00685477|482073|P2|COMPLETED|Overall Study||10
196263|NCT00685477|482074|P1|COMPLETED|Overall Study||10
196264|NCT00685477|482069|P6|STARTED|Overall Study||10
196265|NCT00685477|482070|P5|STARTED|Overall Study||10
196266|NCT00685477|482071|P4|STARTED|Overall Study||10
196267|NCT00685477|482072|P3|STARTED|Overall Study||10
196268|NCT00685477|482073|P2|STARTED|Overall Study||10
196269|NCT00685477|482074|P1|STARTED|Overall Study||10
196270|NCT00685516|482086|P3|NOT COMPLETED|Overall Study||7
196271|NCT00685516|482087|P2|NOT COMPLETED|Overall Study||5
196272|NCT00685516|482088|P1|NOT COMPLETED|Overall Study||8
196273|NCT00685516|482086|P3|COMPLETED|Overall Study||26
196274|NCT00685516|482087|P2|COMPLETED|Overall Study||33
196275|NCT00685516|482088|P1|COMPLETED|Overall Study||34
196276|NCT00685516|482086|P3|STARTED|Overall Study||33
196277|NCT00685516|482087|P2|STARTED|Overall Study||38
196278|NCT00685516|482088|P1|STARTED|Overall Study||42
196279|NCT00685659|482108|P3|NOT COMPLETED|Overall Study||15
196280|NCT00685659|482109|P2|NOT COMPLETED|Overall Study||25
196281|NCT00685659|482110|P1|NOT COMPLETED|Overall Study||31
196282|NCT00685659|482108|P3|COMPLETED|Overall Study||92
196283|NCT00685659|482109|P2|COMPLETED|Overall Study||81
196284|NCT00685659|482110|P1|COMPLETED|Overall Study||77
196285|NCT00685659|482108|P3|STARTED|Overall Study||107
196286|NCT00685659|482109|P2|STARTED|Overall Study||106
196287|NCT00685659|482110|P1|STARTED|Overall Study||108
196288|NCT00685685|482205|P2|NOT COMPLETED|Second Intervention||0
196289|NCT00685685|482206|P1|NOT COMPLETED|Second Intervention||0
196290|NCT00685685|482205|P2|COMPLETED|Second Intervention||26
196291|NCT00685685|482206|P1|COMPLETED|Second Intervention||25
196292|NCT00685685|482205|P2|STARTED|Second Intervention||26
196293|NCT00685685|482206|P1|STARTED|Second Intervention||25
196294|NCT00685685|482205|P2|NOT COMPLETED|Washout Period of 7 Days||1
196295|NCT00685685|482206|P1|NOT COMPLETED|Washout Period of 7 Days||2
196296|NCT00685685|482205|P2|COMPLETED|Washout Period of 7 Days||26
196297|NCT00685685|482206|P1|COMPLETED|Washout Period of 7 Days||25
196298|NCT00685685|482205|P2|STARTED|Washout Period of 7 Days||27
196299|NCT00685685|482206|P1|STARTED|Washout Period of 7 Days||27
196300|NCT00685685|482205|P2|NOT COMPLETED|First Intervention||0
196301|NCT00685685|482206|P1|NOT COMPLETED|First Intervention||0
196302|NCT00685685|482205|P2|COMPLETED|First Intervention||27
196303|NCT00685685|482206|P1|COMPLETED|First Intervention||27
196304|NCT00685685|482205|P2|STARTED|First Intervention||27
196305|NCT00685685|482206|P1|STARTED|First Intervention||27
196306|NCT00685698|482216|P1|NOT COMPLETED|Overall Study||13
196307|NCT00685698|482216|P1|COMPLETED|Overall Study||25
196308|NCT00685698|482216|P1|STARTED|Overall Study||38
196310|NCT00685763|482251|P1|COMPLETED|Overall Study||11
196311|NCT00685763|482251|P1|STARTED|Overall Study||13
196312|NCT00685802|482255|P2|NOT COMPLETED|Second Intervention||0
196313|NCT00685802|482256|P1|NOT COMPLETED|Second Intervention||0
196314|NCT00685802|482255|P2|COMPLETED|Second Intervention||15
196315|NCT00685802|482256|P1|COMPLETED|Second Intervention||14
196316|NCT00685802|482255|P2|STARTED|Second Intervention||15
196317|NCT00685802|482256|P1|STARTED|Second Intervention||14
196318|NCT00685802|482255|P2|NOT COMPLETED|Washout Period of 7 Days||1
196319|NCT00685802|482256|P1|NOT COMPLETED|Washout Period of 7 Days||2
196320|NCT00685802|482255|P2|COMPLETED|Washout Period of 7 Days||15
196321|NCT00685802|482256|P1|COMPLETED|Washout Period of 7 Days||14
196322|NCT00685802|482255|P2|STARTED|Washout Period of 7 Days||16
196323|NCT00685802|482256|P1|STARTED|Washout Period of 7 Days||16
196324|NCT00685802|482255|P2|NOT COMPLETED|First Intervention||0
196325|NCT00685802|482256|P1|NOT COMPLETED|First Intervention||0
196326|NCT00685802|482255|P2|COMPLETED|First Intervention||16
196327|NCT00685802|482256|P1|COMPLETED|First Intervention||16
196328|NCT00685802|482255|P2|STARTED|First Intervention||16
196329|NCT00685802|482256|P1|STARTED|First Intervention||16
196330|NCT00685880|482268|P2|NOT COMPLETED|Overall Study||0
196331|NCT00685880|482269|P1|NOT COMPLETED|Overall Study||0
196332|NCT00685880|482268|P2|COMPLETED|Overall Study||2
196333|NCT00685880|482269|P1|COMPLETED|Overall Study||0
196334|NCT00685880|482268|P2|STARTED|Overall Study||2
196335|NCT00685880|482269|P1|STARTED|Overall Study||0
196336|NCT00685945|482275|P1|NOT COMPLETED|Sildenafil + L-NMMA + Bradykinin||0
196337|NCT00685945|482275|P1|COMPLETED|Sildenafil + L-NMMA + Bradykinin||12
196338|NCT00685945|482275|P1|STARTED|Sildenafil + L-NMMA + Bradykinin||12
196339|NCT00685945|482275|P1|NOT COMPLETED|Isosorbide + L-NMMA + Bradykinin||0
196340|NCT00685945|482275|P1|COMPLETED|Isosorbide + L-NMMA + Bradykinin||11
196341|NCT00685945|482275|P1|STARTED|Isosorbide + L-NMMA + Bradykinin||11
196342|NCT00685945|482275|P1|NOT COMPLETED|L-NMMA + Bradykinin||1
196343|NCT00685945|482275|P1|COMPLETED|L-NMMA + Bradykinin||23
196344|NCT00685945|482275|P1|STARTED|L-NMMA + Bradykinin||24
196345|NCT00685945|482275|P1|NOT COMPLETED|Control (Bradykinin Infusion)||0
196346|NCT00685945|482275|P1|COMPLETED|Control (Bradykinin Infusion)||24
196347|NCT00685945|482275|P1|STARTED|Control (Bradykinin Infusion)|A total of 24 subjects received an infusion of bradykinin|24
196348|NCT00692185|482292|P2|NOT COMPLETED|Overall Study||3
196349|NCT00692185|482293|P1|NOT COMPLETED|Overall Study||3
196350|NCT00692185|482292|P2|COMPLETED|Overall Study||9
196351|NCT00692185|482293|P1|COMPLETED|Overall Study||8
196352|NCT00692185|482292|P2|STARTED|Overall Study||12
196353|NCT00692185|482293|P1|STARTED|Overall Study||11
196354|NCT00692198|482301|P2|NOT COMPLETED|Overall Study||0
196355|NCT00692198|482302|P1|NOT COMPLETED|Overall Study||0
196356|NCT00692198|482301|P2|COMPLETED|Overall Study||370
196357|NCT00692198|482302|P1|COMPLETED|Overall Study||368
196358|NCT00692198|482301|P2|STARTED|Overall Study||370
196359|NCT00692198|482302|P1|STARTED|Overall Study||368
196360|NCT00692211|482337|P2|NOT COMPLETED|Overall Study||0
196361|NCT00692211|482338|P1|NOT COMPLETED|Overall Study||0
196362|NCT00692211|482337|P2|COMPLETED|Overall Study||202
196363|NCT00692211|482338|P1|COMPLETED|Overall Study||202
196364|NCT00692211|482337|P2|STARTED|Overall Study||202
196365|NCT00692211|482338|P1|STARTED|Overall Study||202
196366|NCT00692237|482346|P2|NOT COMPLETED|Overall Study||4
196367|NCT00692237|482347|P1|NOT COMPLETED|Overall Study||1
196368|NCT00692237|482346|P2|COMPLETED|Overall Study||25
196369|NCT00692237|482347|P1|COMPLETED|Overall Study||29
196370|NCT00692237|482346|P2|STARTED|Overall Study||29
196371|NCT00692237|482347|P1|STARTED|Overall Study||30
196372|NCT00692341|482358|P3|NOT COMPLETED|Overall Study||0
196373|NCT00692341|482359|P2|NOT COMPLETED|Overall Study||0
196374|NCT00692341|482360|P1|NOT COMPLETED|Overall Study||0
196375|NCT00692341|482358|P3|COMPLETED|Overall Study||8
196376|NCT00692341|482359|P2|COMPLETED|Overall Study||8
196377|NCT00692341|482360|P1|COMPLETED|Overall Study||8
196378|NCT00692341|482358|P3|STARTED|Overall Study||8
196379|NCT00692341|482359|P2|STARTED|Overall Study||8
196380|NCT00692341|482360|P1|STARTED|Overall Study||8
196381|NCT00696618|482407|P3|NOT COMPLETED|Overall Study||0
196382|NCT00696618|482408|P2|NOT COMPLETED|Overall Study||0
196383|NCT00696618|482409|P1|NOT COMPLETED|Overall Study||0
196384|NCT00696618|482407|P3|COMPLETED|Overall Study||3
196385|NCT00696618|482408|P2|COMPLETED|Overall Study||3
196386|NCT00696618|482409|P1|COMPLETED|Overall Study||3
196387|NCT00696618|482407|P3|STARTED|Overall Study||3
196388|NCT00696618|482408|P2|STARTED|Overall Study||3
196389|NCT00696618|482409|P1|STARTED|Overall Study||3
196390|NCT00696696|482423|P1|NOT COMPLETED|Overall Study||18
196391|NCT00696696|482423|P1|COMPLETED|Overall Study|number of patients off treatment due to progression of disease only|26
196392|NCT00696696|482423|P1|STARTED|Overall Study||44
196393|NCT00696761|482433|P4|NOT COMPLETED|Overall Study||10
196394|NCT00696761|482434|P3|NOT COMPLETED|Overall Study||11
196395|NCT00696761|482435|P2|NOT COMPLETED|Overall Study||26
196396|NCT00696761|482436|P1|NOT COMPLETED|Overall Study||20
196397|NCT00696761|482433|P4|COMPLETED|Overall Study||44
196398|NCT00696761|482434|P3|COMPLETED|Overall Study||30
196399|NCT00696761|482435|P2|COMPLETED|Overall Study||50
196400|NCT00696761|482436|P1|COMPLETED|Overall Study||41
196401|NCT00696761|482433|P4|STARTED|Overall Study||54
196402|NCT00696761|482434|P3|STARTED|Overall Study||41
196403|NCT00696761|482435|P2|STARTED|Overall Study||76
196404|NCT00696761|482436|P1|STARTED|Overall Study||61
196405|NCT00696774|482453|P3|NOT COMPLETED|Period III||0
196406|NCT00696774|482454|P2|NOT COMPLETED|Period III||7
196407|NCT00696774|482455|P1|NOT COMPLETED|Period III||7
196408|NCT00696774|482453|P3|COMPLETED|Period III||0
196409|NCT00696774|482454|P2|COMPLETED|Period III|82 participants were reported at Week 8; 81 completed Week 8 as 1 participant decided to withdraw.|81
196410|NCT00696774|482455|P1|COMPLETED|Period III||106
196411|NCT00696774|482453|P3|STARTED|Period III||0
196412|NCT00696774|482454|P2|STARTED|Period III|91 reported at Week 4; 88 start Period 3 (1 adverse event, 1 protocol violation, 1 lack of efficacy)|88
196413|NCT00696774|482455|P1|STARTED|Period III|115 reported at Week 4; 113 started Period 3 (1 lost to follow-up and 1 protocol violation).|113
196414|NCT00696774|482453|P3|NOT COMPLETED|Period II||36
196415|NCT00696774|482454|P2|NOT COMPLETED|Period II||0
196416|NCT00696774|482455|P1|NOT COMPLETED|Period II||0
196417|NCT00696774|482453|P3|COMPLETED|Period II||0
196418|NCT00696774|482454|P2|COMPLETED|Period II||91
196419|NCT00696774|482455|P1|COMPLETED|Period II||115
196420|NCT00696774|482453|P3|STARTED|Period II|1 participant did not receive study drug and was not included in the safety analyses.|36
196421|NCT00696774|482454|P2|STARTED|Period II||91
196422|NCT00696774|482455|P1|STARTED|Period II||115
196423|NCT00696787|482492|P3|NOT COMPLETED|Overall Study||26
196424|NCT00696787|482493|P2|NOT COMPLETED|Overall Study||20
196425|NCT00696787|482494|P1|NOT COMPLETED|Overall Study||15
196426|NCT00696787|482492|P3|COMPLETED|Overall Study||17
196427|NCT00696787|482493|P2|COMPLETED|Overall Study||22
196428|NCT00696787|482494|P1|COMPLETED|Overall Study||25
196429|NCT00696787|482492|P3|STARTED|Overall Study||43
196430|NCT00696787|482493|P2|STARTED|Overall Study||42
196431|NCT00696787|482494|P1|STARTED|Overall Study||40
196432|NCT00696800|482507|P2|NOT COMPLETED|Overall Study||48
196433|NCT00696800|482508|P1|NOT COMPLETED|Overall Study||85
196434|NCT00696800|482507|P2|COMPLETED|Overall Study|Participants who had embryos transferred|704
196435|NCT00696800|482508|P1|COMPLETED|Overall Study|Participants who had embryos transferred|672
196436|NCT00696800|482507|P2|Treated (ITT)|Overall Study|The ITT group|750
196437|NCT00696800|482508|P1|Treated (ITT)|Overall Study|The ITT group|756
196438|NCT00696800|482507|P2|STARTED|Overall Study||752
196439|NCT00696800|482508|P1|STARTED|Overall Study||757
196440|NCT00696878|482558|P1|NOT COMPLETED|Overall Study||504
196441|NCT00696878|482558|P1|COMPLETED|Overall Study||178
196442|NCT00696878|482558|P1|STARTED|Overall Study||682
196443|NCT00697073|482630|P1|NOT COMPLETED|Overall Study||9
196444|NCT00697073|482630|P1|COMPLETED|Overall Study||59
196445|NCT00697073|482630|P1|STARTED|Overall Study||68
196446|NCT00697112|482634|P1|NOT COMPLETED|Overall Study||10
196447|NCT00697112|482634|P1|COMPLETED|Overall Study||43
196448|NCT00697112|482634|P1|Met the Inclusion Criteria|Overall Study||52
196449|NCT00697112|482634|P1|STARTED|Overall Study||53
196450|NCT00697190|482658|P2|NOT COMPLETED|Second Intervention||0
196451|NCT00697190|482659|P1|NOT COMPLETED|Second Intervention||0
196452|NCT00697190|482658|P2|COMPLETED|Second Intervention||20
196453|NCT00697190|482659|P1|COMPLETED|Second Intervention||18
196454|NCT00697190|482658|P2|STARTED|Second Intervention||20
196455|NCT00697190|482659|P1|STARTED|Second Intervention|one subject moved away between the first period and second period.|18
196456|NCT00697190|482658|P2|NOT COMPLETED|First Intervention||0
196457|NCT00697190|482659|P1|NOT COMPLETED|First Intervention||0
196458|NCT00697190|482658|P2|COMPLETED|First Intervention||20
196459|NCT00697190|482659|P1|COMPLETED|First Intervention||19
196460|NCT00697190|482658|P2|STARTED|First Intervention||20
196461|NCT00697190|482659|P1|STARTED|First Intervention||19
196462|NCT00697255|482695|P2|NOT COMPLETED|Stage 1b||2
196463|NCT00697255|482696|P1|NOT COMPLETED|Stage 1b||0
196464|NCT00697255|482695|P2|COMPLETED|Stage 1b|Participants who completed 1b received hCG bolus injection and did not proceed further in the trial|1
196465|NCT00697255|482696|P1|COMPLETED|Stage 1b||0
196466|NCT00697255|482695|P2|STARTED|Stage 1b|After enrollment in Stage 1a completed, a new cohort of participants enrolled in Stage 1b.|3
196467|NCT00697255|482696|P1|STARTED|Stage 1b||0
196468|NCT00697255|482695|P2|NOT COMPLETED|Stage 1a||0
196469|NCT00697255|482696|P1|NOT COMPLETED|Stage 1a||3
196470|NCT00697255|482695|P2|COMPLETED|Stage 1a||0
196471|NCT00697255|482696|P1|COMPLETED|Stage 1a|Participants who completed 1a received hCG bolus injection and did not proceed further in the trial|2
196472|NCT00697255|482695|P2|STARTED|Stage 1a||0
196473|NCT00697255|482696|P1|STARTED|Stage 1a||5
196474|NCT00697515|482712|P2|NOT COMPLETED|Second Intervention (Crossover Period)||1
196475|NCT00697515|482713|P1|NOT COMPLETED|Second Intervention (Crossover Period)||1
196476|NCT00697515|482712|P2|COMPLETED|Second Intervention (Crossover Period)||51
196477|NCT00697515|482713|P1|COMPLETED|Second Intervention (Crossover Period)||52
196478|NCT00697515|482712|P2|STARTED|Second Intervention (Crossover Period)||52
196479|NCT00697515|482713|P1|STARTED|Second Intervention (Crossover Period)||53
196480|NCT00697515|482712|P2|NOT COMPLETED|First Intervention (Crossover Period)||12
196481|NCT00697515|482713|P1|NOT COMPLETED|First Intervention (Crossover Period)||10
196482|NCT00697515|482712|P2|COMPLETED|First Intervention (Crossover Period)||52
196483|NCT00697515|482713|P1|COMPLETED|First Intervention (Crossover Period)||53
196484|NCT00697515|482712|P2|STARTED|First Intervention (Crossover Period)||64
196485|NCT00697515|482713|P1|STARTED|First Intervention (Crossover Period)||63
196486|NCT00697515|482712|P2|NOT COMPLETED|Dose Optimization Period||0
196487|NCT00697515|482713|P1|NOT COMPLETED|Dose Optimization Period||15
196488|NCT00697515|482712|P2|COMPLETED|Dose Optimization Period||0
196489|NCT00697515|482713|P1|COMPLETED|Dose Optimization Period||127
196490|NCT00697515|482712|P2|STARTED|Dose Optimization Period||0
196491|NCT00697515|482713|P1|STARTED|Dose Optimization Period||142
196492|NCT00697541|482743|P2|NOT COMPLETED|Overall Study||1
196493|NCT00697541|482744|P1|NOT COMPLETED|Overall Study||2
196494|NCT00697541|482743|P2|COMPLETED|Overall Study||9
196495|NCT00697541|482744|P1|COMPLETED|Overall Study||8
196496|NCT00697541|482743|P2|STARTED|Overall Study||10
196497|NCT00697541|482744|P1|STARTED|Overall Study||10
196498|NCT00697593|482754|P1|NOT COMPLETED|Overall Study||19
196499|NCT00697593|482754|P1|COMPLETED|Overall Study||51
196500|NCT00697593|482754|P1|STARTED|Overall Study||70
196501|NCT00697619|482787|P2|NOT COMPLETED|Overall Study||8
196502|NCT00697619|482788|P1|NOT COMPLETED|Overall Study||6
196503|NCT00697619|482787|P2|COMPLETED|Overall Study||22
196504|NCT00697619|482788|P1|COMPLETED|Overall Study||24
196505|NCT00697619|482787|P2|STARTED|Overall Study||30
196506|NCT00697619|482788|P1|STARTED|Overall Study||30
196507|NCT00697697|482796|P2|NOT COMPLETED|Overall Study||54
196508|NCT00697697|482797|P1|NOT COMPLETED|Overall Study||49
196509|NCT00697697|482796|P2|COMPLETED|Overall Study||44
196510|NCT00697697|482797|P1|COMPLETED|Overall Study||45
196511|NCT00697697|482796|P2|STARTED|Overall Study||98
196512|NCT00697697|482797|P1|STARTED|Overall Study||94
196513|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196514|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196515|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196516|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196517|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196518|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196519|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196520|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196521|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
196522|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196523|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196524|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196525|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196526|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196527|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196528|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196529|NCT00697788|482805|P8|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||2
196530|NCT00697788|482806|P7|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196531|NCT00697788|482807|P6|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196532|NCT00697788|482808|P5|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196533|NCT00697788|482809|P4|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196534|NCT00697788|482810|P3|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196535|NCT00697788|482811|P2|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196536|NCT00697788|482812|P1|STARTED|Dexmedetomidine 2.5 mcg/kg/hr Infusion||0
196537|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196538|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196539|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196540|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196541|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196542|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196543|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196544|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196545|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196546|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
196547|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196548|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196549|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196550|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196551|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196552|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196553|NCT00697788|482805|P8|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196554|NCT00697788|482806|P7|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||2
196555|NCT00697788|482807|P6|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196556|NCT00697788|482808|P5|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196557|NCT00697788|482809|P4|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196558|NCT00697788|482810|P3|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196559|NCT00697788|482811|P2|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196560|NCT00697788|482812|P1|STARTED|Dexmedetomidine 2.2 mcg/kg/hr Infusion||0
196561|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196562|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196563|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196564|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196565|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196566|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196567|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196568|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196569|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196570|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196571|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
196572|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196573|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196574|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196575|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196576|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196577|NCT00697788|482805|P8|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196578|NCT00697788|482806|P7|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196579|NCT00697788|482807|P6|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||2
196580|NCT00697788|482808|P5|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196581|NCT00697788|482809|P4|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196582|NCT00697788|482810|P3|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196583|NCT00697788|482811|P2|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196584|NCT00697788|482812|P1|STARTED|Dexmedetomidine 1.9 mcg/kg/hr Infusion||0
196585|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196586|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196587|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196588|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||1
196589|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196590|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196591|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196592|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196593|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196594|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196595|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196596|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||2
196597|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196598|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196599|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196600|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196601|NCT00697788|482805|P8|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196602|NCT00697788|482806|P7|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196603|NCT00697788|482807|P6|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196604|NCT00697788|482808|P5|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||3
196605|NCT00697788|482809|P4|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196606|NCT00697788|482810|P3|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196607|NCT00697788|482811|P2|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196608|NCT00697788|482812|P1|STARTED|Dexmedetomidine 1.6 mcg.kg.hr Infusion||0
196609|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196610|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196611|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196612|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196613|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196614|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196615|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196616|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196617|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196618|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196619|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196620|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196621|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
196622|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196623|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196624|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196625|NCT00697788|482805|P8|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196626|NCT00697788|482806|P7|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196627|NCT00697788|482807|P6|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196628|NCT00697788|482808|P5|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196629|NCT00697788|482809|P4|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||3
196630|NCT00697788|482810|P3|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196631|NCT00697788|482811|P2|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196632|NCT00697788|482812|P1|STARTED|Dexmedetomidine 1.3 mcg.kg/hr Infusion||0
196633|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196634|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196635|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196636|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196637|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196638|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196639|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196640|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196641|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196642|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196643|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196644|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196645|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196646|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||3
196647|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196648|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196649|NCT00697788|482805|P8|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196650|NCT00697788|482806|P7|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196651|NCT00697788|482807|P6|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196652|NCT00697788|482808|P5|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196653|NCT00697788|482809|P4|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196654|NCT00697788|482810|P3|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion|2 participants did not begin this infusion due to hypotension (MAP<50)|3
196655|NCT00697788|482811|P2|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196656|NCT00697788|482812|P1|STARTED|Dexmedetomidine 1.0 mcg/kg/hr Infusion||0
196657|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196658|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196659|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196660|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196661|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196662|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196663|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||2
196664|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196665|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196666|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196667|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196668|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196669|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196670|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196671|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||5
196672|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196673|NCT00697788|482805|P8|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196674|NCT00697788|482806|P7|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196675|NCT00697788|482807|P6|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196676|NCT00697788|482808|P5|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196677|NCT00697788|482809|P4|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196678|NCT00697788|482810|P3|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196679|NCT00697788|482811|P2|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion|1 participant did not begin infusion due to hypotension (MAP<50)|7
196680|NCT00697788|482812|P1|STARTED|Dexmedetomidine 0.7 mcg/kg/hr Infusion||0
196681|NCT00697788|482805|P8|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196682|NCT00697788|482806|P7|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196683|NCT00697788|482807|P6|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196684|NCT00697788|482808|P5|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196685|NCT00697788|482809|P4|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196686|NCT00697788|482810|P3|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196687|NCT00697788|482811|P2|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196688|NCT00697788|482812|P1|NOT COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196689|NCT00697788|482805|P8|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196690|NCT00697788|482806|P7|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196691|NCT00697788|482807|P6|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196692|NCT00697788|482808|P5|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196693|NCT00697788|482809|P4|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196694|NCT00697788|482810|P3|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196695|NCT00697788|482811|P2|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||0
196696|NCT00697788|482812|P1|COMPLETED|Dexmedetomidine Bolus 1 mcg/kg||8
196697|NCT00697788|482805|P8|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
196698|NCT00697788|482806|P7|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
196699|NCT00697788|482807|P6|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
196700|NCT00697788|482808|P5|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
196701|NCT00697788|482809|P4|STARTED|Dexmedetomidine Bolus 1 mcg/kg||0
196702|NCT00697788|482810|P3|STARTED|Dexmedetomidine Bolus 1 mcg/kg|2 participants did not begin the ascending (1.0 mcg/kg/hr) due to MAP<50|0
196703|NCT00697788|482811|P2|STARTED|Dexmedetomidine Bolus 1 mcg/kg|One participant did not begin infusion due to hypotension (mean pressure <50)|0
196704|NCT00697788|482812|P1|STARTED|Dexmedetomidine Bolus 1 mcg/kg||8
196705|NCT00697801|482857|P3|NOT COMPLETED|Overall Study||24
196706|NCT00697801|482858|P2|NOT COMPLETED|Overall Study||12
196707|NCT00697801|482859|P1|NOT COMPLETED|Overall Study||12
196708|NCT00697801|482857|P3|COMPLETED|Overall Study||45
196709|NCT00697801|482858|P2|COMPLETED|Overall Study||58
196710|NCT00697801|482859|P1|COMPLETED|Overall Study||57
196711|NCT00697801|482857|P3|STARTED|Overall Study||69
196712|NCT00697801|482858|P2|STARTED|Overall Study||70
196713|NCT00697801|482859|P1|STARTED|Overall Study||69
196714|NCT00697827|482875|P2|NOT COMPLETED|Overall Study||1
196715|NCT00697827|482876|P1|NOT COMPLETED|Overall Study||2
196716|NCT00697827|482875|P2|COMPLETED|Overall Study||15
196717|NCT00697827|482876|P1|COMPLETED|Overall Study||26
196718|NCT00697827|482875|P2|STARTED|Overall Study||16
196719|NCT00697827|482876|P1|STARTED|Overall Study||28
196720|NCT00698009|482884|P1|NOT COMPLETED|Overall Study||1
196721|NCT00698009|482884|P1|COMPLETED|Overall Study||0
196722|NCT00698009|482884|P1|STARTED|Overall Study||1
196723|NCT00698022|482891|P3|NOT COMPLETED|Overall Study||2
196724|NCT00698022|482892|P2|NOT COMPLETED|Overall Study||10
196725|NCT00698022|482893|P1|NOT COMPLETED|Overall Study||16
196726|NCT00698022|482891|P3|COMPLETED|Overall Study||14
196727|NCT00698022|482892|P2|COMPLETED|Overall Study||20
196728|NCT00698022|482893|P1|COMPLETED|Overall Study||14
196729|NCT00698022|482891|P3|STARTED|Overall Study||16
196730|NCT00698022|482892|P2|STARTED|Overall Study||30
196731|NCT00698022|482893|P1|STARTED|Overall Study||30
196732|NCT00698035|482903|P2|NOT COMPLETED|Overall Study||2
196733|NCT00698035|482904|P1|NOT COMPLETED|Overall Study||4
196734|NCT00698035|482903|P2|COMPLETED|Overall Study||34
196735|NCT00698035|482904|P1|COMPLETED|Overall Study||35
196736|NCT00698035|482903|P2|STARTED|Overall Study||36
196737|NCT00698035|482904|P1|STARTED|Overall Study||39
196738|NCT00698139|482924|P3|NOT COMPLETED|Overall Study||0
196739|NCT00698139|482925|P2|NOT COMPLETED|Overall Study||0
196740|NCT00698139|482926|P1|NOT COMPLETED|Overall Study||0
196741|NCT00698139|482924|P3|COMPLETED|Overall Study||1
196742|NCT00698139|482925|P2|COMPLETED|Overall Study||1
196743|NCT00698139|482926|P1|COMPLETED|Overall Study||1
196744|NCT00698139|482924|P3|2nd Visit|Overall Study|1 subject in the Intervention Group did not have a 2nd visit (per design).|0
196745|NCT00698139|482925|P2|2nd Visit|Overall Study||1
196746|NCT00698139|482926|P1|2nd Visit|Overall Study||1
196747|NCT00698139|482924|P3|STARTED|Overall Study||1
196748|NCT00698139|482925|P2|STARTED|Overall Study||1
196749|NCT00698139|482926|P1|STARTED|Overall Study||1
196750|NCT00698204|482942|P2|NOT COMPLETED|Overall Study||0
196751|NCT00698204|482943|P1|NOT COMPLETED|Overall Study||1
196752|NCT00698204|482942|P2|COMPLETED|Overall Study||20
196753|NCT00698204|482943|P1|COMPLETED|Overall Study||19
196754|NCT00698204|482942|P2|STARTED|Overall Study||20
196755|NCT00698204|482943|P1|STARTED|Overall Study||20
196756|NCT00698451|482951|P1|NOT COMPLETED|Overall Study||39
196757|NCT00698451|482951|P1|COMPLETED|Overall Study||15
196758|NCT00698451|482951|P1|STARTED|Overall Study||54
196759|NCT00698516|482956|P1|NOT COMPLETED|Overall Study||5
196760|NCT00698516|482956|P1|COMPLETED|Overall Study||45
196761|NCT00698516|482956|P1|STARTED|Overall Study||50
196762|NCT00698581|482976|P2|NOT COMPLETED|Overall Study||12
196763|NCT00698581|482977|P1|NOT COMPLETED|Overall Study||45
196764|NCT00698581|482976|P2|COMPLETED|Overall Study||8
196765|NCT00698581|482977|P1|COMPLETED|Overall Study||23
196766|NCT00698581|482976|P2|STARTED|Overall Study||20
196767|NCT00698581|482977|P1|STARTED|Overall Study||68
196768|NCT00698646|482991|P3|NOT COMPLETED|Overall Study||29
196769|NCT00698646|482992|P2|NOT COMPLETED|Overall Study||31
196770|NCT00698646|482993|P1|NOT COMPLETED|Overall Study||36
196771|NCT00698646|482991|P3|COMPLETED|Overall Study||99
196772|NCT00698646|482992|P2|COMPLETED|Overall Study||97
196773|NCT00698646|482993|P1|COMPLETED|Overall Study||92
196774|NCT00698646|482991|P3|STARTED|Overall Study||128
196775|NCT00698646|482992|P2|STARTED|Overall Study||128
196776|NCT00698646|482993|P1|STARTED|Overall Study||128
196777|NCT00698685|483016|P1|NOT COMPLETED|Overall Study||2
196778|NCT00698685|483016|P1|COMPLETED|Overall Study||12
196779|NCT00698685|483016|P1|STARTED|Overall Study||14
196780|NCT00698815|483024|P3|NOT COMPLETED|Overall Study||10
196781|NCT00698815|483025|P2|NOT COMPLETED|Overall Study||14
196782|NCT00698815|483026|P1|NOT COMPLETED|Overall Study||10
196783|NCT00698815|483024|P3|COMPLETED|Overall Study||31
196784|NCT00698815|483025|P2|COMPLETED|Overall Study||33
196785|NCT00698815|483026|P1|COMPLETED|Overall Study||32
196786|NCT00698815|483024|P3|STARTED|Overall Study||41
196787|NCT00698815|483025|P2|STARTED|Overall Study||47
196788|NCT00698815|483026|P1|STARTED|Overall Study||42
196789|NCT00698841|483043|P1|NOT COMPLETED|Overall Study||18
196790|NCT00698841|483043|P1|COMPLETED|Overall Study||33
196791|NCT00698841|483043|P1|STARTED|Overall Study||51
196792|NCT00698867|483054|P1|NOT COMPLETED|Overall Study||91
196793|NCT00698867|483054|P1|COMPLETED|Overall Study||27
196794|NCT00698867|483054|P1|Subjects With 4 Year Data|Overall Study||34
196795|NCT00698867|483054|P1|Subjects With 3 Year Data|Overall Study||35
196796|NCT00698867|483054|P1|Subjects With 2 Year Data|Overall Study||55
196797|NCT00698867|483054|P1|Subjects With 1 Year Data|Overall Study||68
196798|NCT00698867|483054|P1|STARTED|Overall Study||118
196799|NCT00698932|483066|P2|NOT COMPLETED|Overall Study||36
196800|NCT00698932|483067|P1|NOT COMPLETED|Overall Study||22
196801|NCT00698932|483066|P2|COMPLETED|Overall Study|Completed 24 Weeks of treatment|248
196802|NCT00698932|483067|P1|COMPLETED|Overall Study|Completed 24 Weeks of treatment|262
196803|NCT00698932|483066|P2|STARTED|Overall Study|Randomized and treated|284
196804|NCT00698932|483067|P1|STARTED|Overall Study|Randomized and treated|284
196805|NCT00688844|483083|P1|NOT COMPLETED|Overall Study||10
196806|NCT00688844|483083|P1|COMPLETED|Overall Study||48
196807|NCT00688844|483083|P1|STARTED|Overall Study||58
196808|NCT00688870|483095|P2|NOT COMPLETED|Toddler Dose||0
196809|NCT00688870|483096|P1|NOT COMPLETED|Toddler Dose||0
196810|NCT00688870|483095|P2|COMPLETED|Toddler Dose||84
196811|NCT00688870|483096|P1|COMPLETED|Toddler Dose||80
196812|NCT00688870|483095|P2|STARTED|Toddler Dose||84
196813|NCT00688870|483096|P1|STARTED|Toddler Dose||80
196814|NCT00688870|483095|P2|NOT COMPLETED|After Infant Series||0
196815|NCT00688870|483096|P1|NOT COMPLETED|After Infant Series||0
196816|NCT00688870|483095|P2|COMPLETED|After Infant Series||84
196817|NCT00688870|483096|P1|COMPLETED|After Infant Series||80
196818|NCT00688870|483095|P2|STARTED|After Infant Series||84
196819|NCT00688870|483096|P1|STARTED|After Infant Series||80
196820|NCT00688870|483095|P2|NOT COMPLETED|Infant Series||0
196821|NCT00688870|483096|P1|NOT COMPLETED|Infant Series||4
196822|NCT00688870|483095|P2|COMPLETED|Infant Series||84
196823|NCT00688870|483096|P1|COMPLETED|Infant Series||80
196824|NCT00688870|483095|P2|Vaccinated Dose 3|Infant Series||84
196825|NCT00688870|483096|P1|Vaccinated Dose 3|Infant Series||80
196826|NCT00688870|483095|P2|Vaccinated Dose 2|Infant Series||84
196827|NCT00688870|483096|P1|Vaccinated Dose 2|Infant Series||80
196828|NCT00688870|483095|P2|Vaccinated Dose 1|Infant Series||84
196829|NCT00688870|483096|P1|Vaccinated Dose 1|Infant Series||83
196830|NCT00688870|483095|P2|STARTED|Infant Series||84
196831|NCT00688870|483096|P1|STARTED|Infant Series||84
196832|NCT00689026|483130|P2|NOT COMPLETED|Overall Study||6
196833|NCT00689026|483131|P1|NOT COMPLETED|Overall Study||13
196834|NCT00689026|483130|P2|COMPLETED|Overall Study||24
196835|NCT00689026|483131|P1|COMPLETED|Overall Study||17
196836|NCT00689026|483130|P2|STARTED|Overall Study||30
196837|NCT00689026|483131|P1|STARTED|Overall Study||30
196838|NCT00689052|483139|P2|NOT COMPLETED|Overall Study||30
196839|NCT00689052|483140|P1|NOT COMPLETED|Overall Study||31
196840|NCT00689052|483139|P2|COMPLETED|Overall Study||0
196841|NCT00689052|483140|P1|COMPLETED|Overall Study||0
196842|NCT00689052|483139|P2|STARTED|Overall Study||30
196843|NCT00689052|483140|P1|STARTED|Overall Study||31
196844|NCT00689091|483172|P2|NOT COMPLETED|Overall Study||1394
196845|NCT00689091|483173|P1|NOT COMPLETED|Overall Study||1371
196846|NCT00689091|483172|P2|COMPLETED|Overall Study||9376
196847|NCT00689091|483173|P1|COMPLETED|Overall Study||9460
196848|NCT00689091|483172|P2|STARTED|Overall Study||10770
196849|NCT00689091|483173|P1|STARTED|Overall Study||10831
196850|NCT00689104|483183|P4|NOT COMPLETED|Overall Study||50
196851|NCT00689104|483184|P3|NOT COMPLETED|Overall Study||45
196852|NCT00689104|483185|P2|NOT COMPLETED|Overall Study||57
196853|NCT00689104|483186|P1|NOT COMPLETED|Overall Study||44
196854|NCT00689104|483183|P4|COMPLETED|Overall Study||445
196855|NCT00689104|483184|P3|COMPLETED|Overall Study||453
196856|NCT00689104|483185|P2|COMPLETED|Overall Study||440
196857|NCT00689104|483186|P1|COMPLETED|Overall Study||453
196858|NCT00689104|483183|P4|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|300
196859|NCT00689104|483184|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|281
196860|NCT00689104|483185|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|293
196861|NCT00689104|483186|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at baseline.|291
196862|NCT00689104|483183|P4|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|475
196863|NCT00689104|483184|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|478
196864|NCT00689104|483185|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|473
196865|NCT00689104|483186|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 postbaseline micturition measurement.|480
196866|NCT00689104|483183|P4|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|495
196867|NCT00689104|483184|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|496
196868|NCT00689104|483185|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|493
196869|NCT00689104|483186|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|494
196870|NCT00689104|483183|P4|STARTED|Overall Study||495
196871|NCT00689104|483184|P3|STARTED|Overall Study||498
196872|NCT00689104|483185|P2|STARTED|Overall Study||497
196873|NCT00689104|483186|P1|STARTED|Overall Study||497
196874|NCT00689117|483320|P4|NOT COMPLETED|Overall Study||31
196875|NCT00689117|483321|P3|NOT COMPLETED|Overall Study||59
196876|NCT00689117|483322|P2|NOT COMPLETED|Overall Study||51
196877|NCT00689117|483323|P1|NOT COMPLETED|Overall Study||62
196878|NCT00689117|483320|P4|COMPLETED|Overall Study||211
196879|NCT00689117|483321|P3|COMPLETED|Overall Study||405
196880|NCT00689117|483322|P2|COMPLETED|Overall Study||416
196881|NCT00689117|483323|P1|COMPLETED|Overall Study||414
196882|NCT00689117|483320|P4|STARTED|Overall Study||242
196883|NCT00689117|483321|P3|STARTED|Overall Study||464
196884|NCT00689117|483322|P2|STARTED|Overall Study||467
196885|NCT00689117|483323|P1|STARTED|Overall Study||476
196886|NCT00689221|483351|P2|NOT COMPLETED|Overall Study||36
196887|NCT00689221|483352|P1|NOT COMPLETED|Overall Study||39
196888|NCT00689221|483351|P2|COMPLETED|Overall Study||237
196889|NCT00689221|483352|P1|COMPLETED|Overall Study||233
196890|NCT00689221|483351|P2|STARTED|Overall Study||273
196891|NCT00689221|483352|P1|STARTED|Overall Study||272
196892|NCT00689260|483379|P2|NOT COMPLETED|Overall Study||0
196893|NCT00689260|483380|P1|NOT COMPLETED|Overall Study||2
196894|NCT00689260|483379|P2|COMPLETED|Overall Study||21
196895|NCT00689260|483380|P1|COMPLETED|Overall Study||19
196896|NCT00689260|483379|P2|STARTED|Overall Study||21
196897|NCT00689260|483380|P1|STARTED|Overall Study||21
196898|NCT00689299|483399|P3|NOT COMPLETED|Overall Study||5
196899|NCT00689299|483400|P2|NOT COMPLETED|Overall Study||3
196900|NCT00689299|483401|P1|NOT COMPLETED|Overall Study||7
196901|NCT00689299|483399|P3|COMPLETED|Overall Study||49
196902|NCT00689299|483400|P2|COMPLETED|Overall Study||54
196903|NCT00689299|483401|P1|COMPLETED|Overall Study||51
196904|NCT00689299|483399|P3|STARTED|Overall Study||54
196905|NCT00689299|483400|P2|STARTED|Overall Study||57
196906|NCT00689299|483401|P1|STARTED|Overall Study||58
196907|NCT00689338|483409|P1|NOT COMPLETED|Overall Study||143
196908|NCT00689338|483409|P1|COMPLETED|Overall Study||73
196909|NCT00689338|483409|P1|STARTED|Overall Study||216
196910|NCT00689351|483421|P2|NOT COMPLETED|Toddler Dose||0
196911|NCT00689351|483422|P1|NOT COMPLETED|Toddler Dose||0
196912|NCT00689351|483421|P2|COMPLETED|Toddler Dose||88
196913|NCT00689351|483422|P1|COMPLETED|Toddler Dose||84
196914|NCT00689351|483421|P2|STARTED|Toddler Dose||88
196915|NCT00689351|483422|P1|STARTED|Toddler Dose||84
196916|NCT00689351|483421|P2|NOT COMPLETED|After Infant Series||0
196917|NCT00689351|483422|P1|NOT COMPLETED|After Infant Series||1
196918|NCT00689351|483421|P2|COMPLETED|After Infant Series||88
196919|NCT00689351|483422|P1|COMPLETED|After Infant Series||84
196920|NCT00689351|483421|P2|STARTED|After Infant Series||88
196921|NCT00689351|483422|P1|STARTED|After Infant Series||85
196922|NCT00689351|483421|P2|NOT COMPLETED|Infant Series of Dosing||1
196923|NCT00689351|483422|P1|NOT COMPLETED|Infant Series of Dosing||6
196924|NCT00689351|483421|P2|COMPLETED|Infant Series of Dosing||88
196925|NCT00689351|483422|P1|COMPLETED|Infant Series of Dosing||85
196926|NCT00689351|483421|P2|Vaccinated Dose 3|Infant Series of Dosing||88
196927|NCT00689351|483422|P1|Vaccinated Dose 3|Infant Series of Dosing||85
196928|NCT00689351|483421|P2|Vaccinated Dose 2|Infant Series of Dosing||88
196929|NCT00689351|483422|P1|Vaccinated Dose 2|Infant Series of Dosing||86
196930|NCT00689351|483421|P2|Vaccinated Dose 1|Infant Series of Dosing||89
196931|NCT00689351|483422|P1|Vaccinated Dose 1|Infant Series of Dosing||88
196932|NCT00689351|483421|P2|STARTED|Infant Series of Dosing||89
196933|NCT00689351|483422|P1|STARTED|Infant Series of Dosing||91
196934|NCT00689390|483456|P2|NOT COMPLETED|Overall Study||10
196935|NCT00689390|483457|P1|NOT COMPLETED|Overall Study||426
196936|NCT00689390|483456|P2|COMPLETED|Overall Study||37
196937|NCT00689390|483457|P1|COMPLETED|Overall Study||1481
196938|NCT00689390|483456|P2|STARTED|Overall Study||47
196939|NCT00689390|483457|P1|STARTED|Overall Study||1907
196940|NCT00689481|483475|P2|NOT COMPLETED|Overall Study||14
196941|NCT00689481|483476|P1|NOT COMPLETED|Overall Study||24
196942|NCT00689481|483475|P2|COMPLETED|Overall Study||95
196943|NCT00689481|483476|P1|COMPLETED|Overall Study||190
196944|NCT00689481|483475|P2|STARTED|Overall Study||109
196945|NCT00689481|483476|P1|STARTED|Overall Study||214
196946|NCT00699140|483492|P1|NOT COMPLETED|Overall Study||0
196947|NCT00699140|483492|P1|COMPLETED|Overall Study||18
196948|NCT00699140|483492|P1|STARTED|Overall Study||18
196949|NCT00699153|483506|P2|NOT COMPLETED|Overall Study||2
196950|NCT00699153|483507|P1|NOT COMPLETED|Overall Study||3
196951|NCT00699153|483506|P2|COMPLETED|Overall Study||200
196952|NCT00699153|483507|P1|COMPLETED|Overall Study||200
196953|NCT00699153|483506|P2|STARTED|Overall Study|Intent to treat population|202
196954|NCT00699153|483507|P1|STARTED|Overall Study|Intent to treat population|203
196955|NCT00699192|483522|P3|NOT COMPLETED|Overall Study||11
196956|NCT00699192|483523|P2|NOT COMPLETED|Overall Study||12
196957|NCT00699192|483524|P1|NOT COMPLETED|Overall Study||16
196958|NCT00699192|483522|P3|COMPLETED|Overall Study||261
196959|NCT00699192|483523|P2|COMPLETED|Overall Study||260
196960|NCT00699192|483524|P1|COMPLETED|Overall Study||259
196961|NCT00699192|483522|P3|STARTED|Overall Study||272
196962|NCT00699192|483523|P2|STARTED|Overall Study||272
196963|NCT00699192|483524|P1|STARTED|Overall Study||275
196964|NCT00699283|483546|P2|NOT COMPLETED|Overall Study||8
196965|NCT00699283|483547|P1|NOT COMPLETED|Overall Study||33
196966|NCT00699283|483546|P2|COMPLETED|Overall Study||7
196967|NCT00699283|483547|P1|COMPLETED|Overall Study||14
196968|NCT00699283|483546|P2|STARTED|Overall Study||15
196969|NCT00699283|483547|P1|STARTED|Overall Study||47
196970|NCT00699335|483552|P1|NOT COMPLETED|Overall Study||228
196971|NCT00699335|483552|P1|COMPLETED|Overall Study||5080
196972|NCT00699335|483552|P1|STARTED|Overall Study||5308
196973|NCT00699348|483583|P1|NOT COMPLETED|Overall Study||90
196974|NCT00699348|483583|P1|COMPLETED|Overall Study||261
196975|NCT00699348|483583|P1|STARTED|Overall Study||351
196976|NCT00699374|483594|P2|NOT COMPLETED|Overall Study||544
196977|NCT00699374|483595|P1|NOT COMPLETED|Overall Study||530
196978|NCT00699374|483594|P2|COMPLETED|Overall Study||0
196979|NCT00699374|483595|P1|COMPLETED|Overall Study||0
196980|NCT00699374|483594|P2|Treated|Overall Study||542
196981|NCT00699374|483595|P1|Treated|Overall Study||526
196982|NCT00699374|483594|P2|STARTED|Overall Study||544
196983|NCT00699374|483595|P1|STARTED|Overall Study||530
196984|NCT00699400|483610|P6|NOT COMPLETED|Overall Study||11
196985|NCT00699400|483611|P5|NOT COMPLETED|Overall Study||0
196986|NCT00699400|483612|P4|NOT COMPLETED|Overall Study||0
196987|NCT00699400|483613|P3|NOT COMPLETED|Overall Study||0
196988|NCT00699400|483614|P2|NOT COMPLETED|Overall Study||0
196989|NCT00699400|483615|P1|NOT COMPLETED|Overall Study||0
196990|NCT00699400|483610|P6|COMPLETED|Overall Study||0
196991|NCT00699400|483611|P5|COMPLETED|Overall Study||4
196992|NCT00699400|483612|P4|COMPLETED|Overall Study||6
196993|NCT00699400|483613|P3|COMPLETED|Overall Study||138
196994|NCT00699400|483614|P2|COMPLETED|Overall Study||3
196995|NCT00699400|483615|P1|COMPLETED|Overall Study||42
196996|NCT00699400|483610|P6|STARTED|Overall Study||11
196997|NCT00699400|483611|P5|STARTED|Overall Study||4
196998|NCT00699400|483612|P4|STARTED|Overall Study||6
196999|NCT00699400|483613|P3|STARTED|Overall Study||138
197000|NCT00699400|483614|P2|STARTED|Overall Study||3
197001|NCT00699400|483615|P1|STARTED|Overall Study||42
197002|NCT00699413|483649|P2|NOT COMPLETED|Overall Study||2
197003|NCT00699413|483650|P1|NOT COMPLETED|Overall Study||0
197004|NCT00699413|483649|P2|COMPLETED|Overall Study||2
197005|NCT00699413|483650|P1|COMPLETED|Overall Study||4
197006|NCT00699413|483649|P2|STARTED|Overall Study||4
197007|NCT00699413|483650|P1|STARTED|Overall Study||4
197008|NCT00699608|483656|P6|NOT COMPLETED|Third Intervention||0
197009|NCT00699608|483657|P5|NOT COMPLETED|Third Intervention||0
197010|NCT00699608|483658|P4|NOT COMPLETED|Third Intervention||0
197011|NCT00699608|483659|P3|NOT COMPLETED|Third Intervention||0
197012|NCT00699608|483660|P2|NOT COMPLETED|Third Intervention||0
197013|NCT00699608|483661|P1|NOT COMPLETED|Third Intervention||0
197014|NCT00699608|483656|P6|COMPLETED|Third Intervention||15
197015|NCT00699608|483657|P5|COMPLETED|Third Intervention||14
197016|NCT00699608|483658|P4|COMPLETED|Third Intervention||14
197017|NCT00699608|483659|P3|COMPLETED|Third Intervention||13
197018|NCT00699608|483660|P2|COMPLETED|Third Intervention||15
197019|NCT00699608|483661|P1|COMPLETED|Third Intervention||16
197020|NCT00699608|483656|P6|STARTED|Third Intervention||15
197021|NCT00699608|483657|P5|STARTED|Third Intervention||14
197022|NCT00699608|483658|P4|STARTED|Third Intervention||14
197023|NCT00699608|483659|P3|STARTED|Third Intervention||13
197024|NCT00699608|483660|P2|STARTED|Third Intervention||15
197025|NCT00699608|483661|P1|STARTED|Third Intervention||16
197026|NCT00699608|483656|P6|NOT COMPLETED|Second 4-14 Day Washout Period||0
197027|NCT00699608|483657|P5|NOT COMPLETED|Second 4-14 Day Washout Period||0
197028|NCT00699608|483658|P4|NOT COMPLETED|Second 4-14 Day Washout Period||0
197029|NCT00699608|483659|P3|NOT COMPLETED|Second 4-14 Day Washout Period||0
197030|NCT00699608|483660|P2|NOT COMPLETED|Second 4-14 Day Washout Period||0
197031|NCT00699608|483661|P1|NOT COMPLETED|Second 4-14 Day Washout Period||0
197032|NCT00699608|483656|P6|COMPLETED|Second 4-14 Day Washout Period||15
197033|NCT00699608|483657|P5|COMPLETED|Second 4-14 Day Washout Period||14
197034|NCT00699608|483658|P4|COMPLETED|Second 4-14 Day Washout Period||14
197035|NCT00699608|483659|P3|COMPLETED|Second 4-14 Day Washout Period||13
197036|NCT00699608|483660|P2|COMPLETED|Second 4-14 Day Washout Period||15
197037|NCT00699608|483661|P1|COMPLETED|Second 4-14 Day Washout Period||16
197038|NCT00699608|483656|P6|STARTED|Second 4-14 Day Washout Period||15
197039|NCT00699608|483657|P5|STARTED|Second 4-14 Day Washout Period||14
197040|NCT00699608|483658|P4|STARTED|Second 4-14 Day Washout Period||14
197041|NCT00699608|483659|P3|STARTED|Second 4-14 Day Washout Period||13
197042|NCT00699608|483660|P2|STARTED|Second 4-14 Day Washout Period||15
197043|NCT00699608|483661|P1|STARTED|Second 4-14 Day Washout Period||16
197044|NCT00699608|483656|P6|NOT COMPLETED|Second Intervention||0
197045|NCT00699608|483657|P5|NOT COMPLETED|Second Intervention||0
197046|NCT00699608|483658|P4|NOT COMPLETED|Second Intervention||1
197047|NCT00699608|483659|P3|NOT COMPLETED|Second Intervention||1
197048|NCT00699608|483660|P2|NOT COMPLETED|Second Intervention||0
197049|NCT00699608|483661|P1|NOT COMPLETED|Second Intervention||0
197050|NCT00699608|483656|P6|COMPLETED|Second Intervention||15
197051|NCT00699608|483657|P5|COMPLETED|Second Intervention||14
197052|NCT00699608|483658|P4|COMPLETED|Second Intervention||14
197053|NCT00699608|483659|P3|COMPLETED|Second Intervention||13
197054|NCT00699608|483660|P2|COMPLETED|Second Intervention||15
197055|NCT00699608|483661|P1|COMPLETED|Second Intervention||16
197056|NCT00699608|483656|P6|STARTED|Second Intervention||15
197057|NCT00699608|483657|P5|STARTED|Second Intervention||14
197058|NCT00699608|483658|P4|STARTED|Second Intervention||15
197059|NCT00699608|483659|P3|STARTED|Second Intervention||14
197060|NCT00699608|483660|P2|STARTED|Second Intervention||15
197061|NCT00699608|483661|P1|STARTED|Second Intervention||16
197062|NCT00699608|483656|P6|NOT COMPLETED|First 4-14 Day Washout Period||0
197063|NCT00699608|483657|P5|NOT COMPLETED|First 4-14 Day Washout Period||0
197064|NCT00699608|483658|P4|NOT COMPLETED|First 4-14 Day Washout Period||0
197065|NCT00699608|483659|P3|NOT COMPLETED|First 4-14 Day Washout Period||0
197066|NCT00699608|483660|P2|NOT COMPLETED|First 4-14 Day Washout Period||0
197067|NCT00699608|483661|P1|NOT COMPLETED|First 4-14 Day Washout Period||0
197068|NCT00699608|483656|P6|COMPLETED|First 4-14 Day Washout Period||15
197069|NCT00699608|483657|P5|COMPLETED|First 4-14 Day Washout Period||14
197070|NCT00699608|483658|P4|COMPLETED|First 4-14 Day Washout Period||15
197071|NCT00699608|483659|P3|COMPLETED|First 4-14 Day Washout Period||14
197072|NCT00699608|483660|P2|COMPLETED|First 4-14 Day Washout Period||15
197073|NCT00699608|483661|P1|COMPLETED|First 4-14 Day Washout Period||16
197074|NCT00699608|483656|P6|STARTED|First 4-14 Day Washout Period||15
197075|NCT00699608|483657|P5|STARTED|First 4-14 Day Washout Period||14
197076|NCT00699608|483658|P4|STARTED|First 4-14 Day Washout Period||15
197077|NCT00699608|483659|P3|STARTED|First 4-14 Day Washout Period||14
197078|NCT00699608|483660|P2|STARTED|First 4-14 Day Washout Period||15
197079|NCT00699608|483661|P1|STARTED|First 4-14 Day Washout Period||16
197080|NCT00699608|483656|P6|NOT COMPLETED|First Intervention||0
197081|NCT00699608|483657|P5|NOT COMPLETED|First Intervention||1
197082|NCT00699608|483658|P4|NOT COMPLETED|First Intervention||0
197083|NCT00699608|483659|P3|NOT COMPLETED|First Intervention||1
197084|NCT00699608|483660|P2|NOT COMPLETED|First Intervention||0
197085|NCT00699608|483661|P1|NOT COMPLETED|First Intervention||0
197086|NCT00699608|483656|P6|COMPLETED|First Intervention||15
197087|NCT00699608|483657|P5|COMPLETED|First Intervention||14
197088|NCT00699608|483658|P4|COMPLETED|First Intervention||15
197089|NCT00699608|483659|P3|COMPLETED|First Intervention||14
197090|NCT00699608|483660|P2|COMPLETED|First Intervention||15
197091|NCT00699608|483661|P1|COMPLETED|First Intervention||16
197092|NCT00699608|483656|P6|STARTED|First Intervention||15
197093|NCT00699608|483657|P5|STARTED|First Intervention||15
197094|NCT00699608|483658|P4|STARTED|First Intervention||15
197095|NCT00699608|483659|P3|STARTED|First Intervention||15
197096|NCT00699608|483660|P2|STARTED|First Intervention||15
197097|NCT00699608|483661|P1|STARTED|First Intervention||16
197098|NCT00699660|483713|P2|NOT COMPLETED|Overall Study||8
197099|NCT00699660|483714|P1|NOT COMPLETED|Overall Study||14
197100|NCT00699660|483713|P2|COMPLETED|Overall Study||208
197101|NCT00699660|483714|P1|COMPLETED|Overall Study||176
197102|NCT00699660|483713|P2|STARTED|Overall Study||216
197103|NCT00699660|483714|P1|STARTED|Overall Study||190
197104|NCT00699699|483726|P1|NOT COMPLETED|Overall Study||57
197105|NCT00699699|483726|P1|COMPLETED|Overall Study||1223
197106|NCT00699699|483726|P1|STARTED|Overall Study||1280
197107|NCT00699751|483735|P2|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||9
197108|NCT00699751|483736|P1|NOT COMPLETED|Period 2:Switched From Placebo to Xofigo||0
197109|NCT00699751|483735|P2|COMPLETED|Period 2:Switched From Placebo to Xofigo|Completed all 6 injections|17
197110|NCT00699751|483736|P1|COMPLETED|Period 2:Switched From Placebo to Xofigo||0
197111|NCT00699751|483735|P2|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
197112|NCT00699751|483736|P1|Completed 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
197113|NCT00699751|483735|P2|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||15
197114|NCT00699751|483736|P1|Entered 3-Year Follow-up Period|Period 2:Switched From Placebo to Xofigo||0
197115|NCT00699751|483735|P2|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||24
197116|NCT00699751|483736|P1|Participants Received Treatment|Period 2:Switched From Placebo to Xofigo||0
197117|NCT00699751|483735|P2|STARTED|Period 2:Switched From Placebo to Xofigo|Participants in the placebo group switched to Xofigo treatment|26
197118|NCT00699751|483736|P1|STARTED|Period 2:Switched From Placebo to Xofigo||0
197119|NCT00699751|483735|P2|NOT COMPLETED|Period 1: Without/Before Drug Switch||162
197120|NCT00699751|483736|P1|NOT COMPLETED|Period 1: Without/Before Drug Switch||225
197121|NCT00699751|483735|P2|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|145
197122|NCT00699751|483736|P1|COMPLETED|Period 1: Without/Before Drug Switch|Completed all 6 injections|389
197123|NCT00699751|483735|P2|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||12
197124|NCT00699751|483736|P1|Completed 3-Year Follow-up Period|Period 1: Without/Before Drug Switch||49
197125|NCT00699751|483735|P2|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|168
197126|NCT00699751|483736|P1|Entered 3-Year Follow-up Period|Period 1: Without/Before Drug Switch|Participants were not required to complete all 6 injections to enter to 3-year follow-up period.|407
197127|NCT00699751|483735|P2|Participants Received Treatment|Period 1: Without/Before Drug Switch||301
197128|NCT00699751|483736|P1|Participants Received Treatment|Period 1: Without/Before Drug Switch||600
197129|NCT00699751|483735|P2|STARTED|Period 1: Without/Before Drug Switch||307
197130|NCT00699751|483736|P1|STARTED|Period 1: Without/Before Drug Switch||614
197131|NCT00699816|483823|P2|NOT COMPLETED|Overall Study||3
197132|NCT00699816|483824|P1|NOT COMPLETED|Overall Study||1
197133|NCT00699816|483823|P2|COMPLETED|Overall Study||112
197134|NCT00699816|483824|P1|COMPLETED|Overall Study||114
197135|NCT00699816|483823|P2|STARTED|Overall Study||115
197136|NCT00699816|483824|P1|STARTED|Overall Study||115
197137|NCT00699842|483843|P3|NOT COMPLETED|Overall Study||0
197138|NCT00699842|483844|P2|NOT COMPLETED|Overall Study||1
197139|NCT00699842|483845|P1|NOT COMPLETED|Overall Study||0
197140|NCT00699842|483843|P3|COMPLETED|Overall Study||0
197141|NCT00699842|483844|P2|COMPLETED|Overall Study||4
197142|NCT00699842|483845|P1|COMPLETED|Overall Study||3
197143|NCT00699842|483843|P3|STARTED|Overall Study||0
197144|NCT00699842|483844|P2|STARTED|Overall Study||5
197145|NCT00699842|483845|P1|STARTED|Overall Study||3
197146|NCT00699972|483859|P3|NOT COMPLETED|Overall Study||35
197147|NCT00699972|483860|P2|NOT COMPLETED|Overall Study||19
197148|NCT00699972|483861|P1|NOT COMPLETED|Overall Study||16
197149|NCT00699972|483859|P3|COMPLETED|Overall Study||100
197150|NCT00699972|483860|P2|COMPLETED|Overall Study||114
197151|NCT00699972|483861|P1|COMPLETED|Overall Study||106
197152|NCT00699972|483859|P3|STARTED|Overall Study||135
197153|NCT00699972|483860|P2|STARTED|Overall Study||133
197154|NCT00699972|483861|P1|STARTED|Overall Study||122
197155|NCT00699998|483879|P4|NOT COMPLETED|Overall Study||82
197156|NCT00699998|483880|P3|NOT COMPLETED|Overall Study||206
197157|NCT00699998|483881|P2|NOT COMPLETED|Overall Study||86
197158|NCT00699998|483882|P1|NOT COMPLETED|Overall Study||199
197159|NCT00699998|483879|P4|COMPLETED|Overall Study||958
197160|NCT00699998|483880|P3|COMPLETED|Overall Study||3417
197161|NCT00699998|483881|P2|COMPLETED|Overall Study||957
197162|NCT00699998|483882|P1|COMPLETED|Overall Study||3421
197163|NCT00699998|483879|P4|Received at Least 1 Dose of Study Drug|Overall Study||1027
197164|NCT00699998|483880|P3|Received at Least 1 Dose of Study Drug|Overall Study||3590
197165|NCT00699998|483881|P2|Received at Least 1 Dose of Study Drug|Overall Study||1033
197166|NCT00699998|483882|P1|Received at Least 1 Dose of Study Drug|Overall Study||3590
197167|NCT00699998|483879|P4|STARTED|Overall Study||1040
197168|NCT00699998|483880|P3|STARTED|Overall Study||3623
197169|NCT00699998|483881|P2|STARTED|Overall Study||1043
197170|NCT00699998|483882|P1|STARTED|Overall Study||3620
197171|NCT00700011|483926|P2|NOT COMPLETED|Overall Study||1
197172|NCT00700011|483927|P1|NOT COMPLETED|Overall Study||0
197173|NCT00700011|483926|P2|COMPLETED|Overall Study||1
197174|NCT00700011|483927|P1|COMPLETED|Overall Study||8
197175|NCT00700011|483926|P2|STARTED|Overall Study||2
197176|NCT00700011|483927|P1|STARTED|Overall Study||8
197177|NCT00700063|483947|P8|NOT COMPLETED|Overall Study||0
197178|NCT00700063|483948|P7|NOT COMPLETED|Overall Study||0
197179|NCT00700063|483949|P6|NOT COMPLETED|Overall Study||0
197180|NCT00700063|483950|P5|NOT COMPLETED|Overall Study||2
197181|NCT00700063|483951|P4|NOT COMPLETED|Overall Study||2
197182|NCT00700063|483952|P3|NOT COMPLETED|Overall Study||0
197183|NCT00700063|483953|P2|NOT COMPLETED|Overall Study||0
197184|NCT00700063|483954|P1|NOT COMPLETED|Overall Study||1
197185|NCT00700063|483947|P8|COMPLETED|Overall Study||33
197186|NCT00700063|483948|P7|COMPLETED|Overall Study||32
197187|NCT00700063|483949|P6|COMPLETED|Overall Study||34
197188|NCT00700063|483950|P5|COMPLETED|Overall Study||31
197189|NCT00700063|483951|P4|COMPLETED|Overall Study||31
197190|NCT00700063|483952|P3|COMPLETED|Overall Study||33
197191|NCT00700063|483953|P2|COMPLETED|Overall Study||34
197192|NCT00700063|483954|P1|COMPLETED|Overall Study||32
197193|NCT00700063|483947|P8|STARTED|Overall Study||33
197194|NCT00700063|483948|P7|STARTED|Overall Study||32
197195|NCT00700063|483949|P6|STARTED|Overall Study||34
197196|NCT00700063|483950|P5|STARTED|Overall Study||33
197197|NCT00700063|483951|P4|STARTED|Overall Study||33
197198|NCT00700063|483952|P3|STARTED|Overall Study||33
197199|NCT00700063|483953|P2|STARTED|Overall Study||34
197200|NCT00700063|483954|P1|STARTED|Overall Study||33
197201|NCT00700102|484062|P2|NOT COMPLETED|Overall Study||395
197202|NCT00700102|484063|P1|NOT COMPLETED|Overall Study||402
197203|NCT00700102|484062|P2|COMPLETED|Overall Study||14
197204|NCT00700102|484063|P1|COMPLETED|Overall Study||9
197205|NCT00700102|484062|P2|Received at Least One Dose|Overall Study||403
197206|NCT00700102|484063|P1|Received at Least One Dose|Overall Study||407
197207|NCT00700102|484062|P2|Intention to Treat|Overall Study||409
197208|NCT00700102|484063|P1|Intention to Treat|Overall Study||410
197209|NCT00700102|484062|P2|STARTED|Overall Study||409
197210|NCT00700102|484063|P1|STARTED|Overall Study||411
197211|NCT00700115|484081|P2|NOT COMPLETED|Overall Study||1
197212|NCT00700115|484082|P1|NOT COMPLETED|Overall Study||1
197213|NCT00700115|484081|P2|COMPLETED|Overall Study||19
197214|NCT00700115|484082|P1|COMPLETED|Overall Study||39
197215|NCT00700115|484081|P2|STARTED|Overall Study||20
197216|NCT00700115|484082|P1|STARTED|Overall Study||40
197217|NCT00700141|484090|P1|NOT COMPLETED|Overall Study||0
197218|NCT00700141|484090|P1|COMPLETED|Overall Study||482
197219|NCT00700141|484090|P1|STARTED|Overall Study||482
197220|NCT00700180|484097|P2|NOT COMPLETED|Overall Study||149
197221|NCT00700180|484098|P1|NOT COMPLETED|Overall Study||154
197222|NCT00700180|484097|P2|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
197223|NCT00700180|484098|P1|COMPLETED|Overall Study|Clinical cutoff date: July 11, 2011|0
197224|NCT00700180|484097|P2|STARTED|Overall Study||149
197225|NCT00700180|484098|P1|STARTED|Overall Study||154
197226|NCT00700271|484122|P2|NOT COMPLETED|Overall Study||12
197227|NCT00700271|484123|P1|NOT COMPLETED|Overall Study||14
197228|NCT00700271|484122|P2|COMPLETED|Overall Study||256
197229|NCT00700271|484123|P1|COMPLETED|Overall Study||264
197230|NCT00700271|484122|P2|STARTED|Overall Study||268
197231|NCT00700271|484123|P1|STARTED|Overall Study||278
197232|NCT00700310|484153|P4|NOT COMPLETED|Overall Study||26
197233|NCT00700310|484154|P3|NOT COMPLETED|Overall Study||16
197234|NCT00700310|484155|P2|NOT COMPLETED|Overall Study||26
197235|NCT00700310|484156|P1|NOT COMPLETED|Overall Study||21
197236|NCT00700310|484153|P4|COMPLETED|Overall Study||145
197237|NCT00700310|484154|P3|COMPLETED|Overall Study||158
197238|NCT00700310|484155|P2|COMPLETED|Overall Study||154
197239|NCT00700310|484156|P1|COMPLETED|Overall Study||166
197240|NCT00700310|484153|P4|STARTED|Overall Study||171
197241|NCT00700310|484154|P3|STARTED|Overall Study||174
197242|NCT00700310|484155|P2|STARTED|Overall Study||180
197243|NCT00700310|484156|P1|STARTED|Overall Study||187
197244|NCT00700375|484176|P2|NOT COMPLETED|Overall Study||0
197245|NCT00700375|484177|P1|NOT COMPLETED|Overall Study||0
197246|NCT00700375|484176|P2|COMPLETED|Overall Study||29
197247|NCT00700375|484177|P1|COMPLETED|Overall Study||30
197248|NCT00700375|484176|P2|2 Days After Creatinine Mesurement|Overall Study||29
197249|NCT00700375|484177|P1|2 Days After Creatinine Mesurement|Overall Study||30
197250|NCT00700375|484176|P2|STARTED|Overall Study||29
197251|NCT00700375|484177|P1|STARTED|Overall Study||30
197252|NCT00700401|484183|P1|NOT COMPLETED|Overall Study||94
197253|NCT00700401|484183|P1|COMPLETED|Overall Study||168
197254|NCT00700401|484183|P1|STARTED|Overall Study||262
197255|NCT00700427|484194|P5|NOT COMPLETED|Study Period 4 (Open-Label Extension)||84
197256|NCT00700427|484195|P4|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
197257|NCT00700427|484196|P3|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
197258|NCT00700427|484197|P2|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
197259|NCT00700427|484198|P1|NOT COMPLETED|Study Period 4 (Open-Label Extension)||0
197260|NCT00700427|484194|P5|COMPLETED|Study Period 4 (Open-Label Extension)||96
197261|NCT00700427|484195|P4|COMPLETED|Study Period 4 (Open-Label Extension)||0
197262|NCT00700427|484196|P3|COMPLETED|Study Period 4 (Open-Label Extension)||0
197263|NCT00700427|484197|P2|COMPLETED|Study Period 4 (Open-Label Extension)||0
197264|NCT00700427|484198|P1|COMPLETED|Study Period 4 (Open-Label Extension)||0
197265|NCT00700427|484194|P5|STARTED|Study Period 4 (Open-Label Extension)||180
197266|NCT00700427|484195|P4|STARTED|Study Period 4 (Open-Label Extension)||0
197267|NCT00700427|484196|P3|STARTED|Study Period 4 (Open-Label Extension)||0
197268|NCT00700427|484197|P2|STARTED|Study Period 4 (Open-Label Extension)||0
197269|NCT00700427|484198|P1|STARTED|Study Period 4 (Open-Label Extension)||0
197270|NCT00700427|484194|P5|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
197271|NCT00700427|484195|P4|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||93
197272|NCT00700427|484196|P3|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||82
197273|NCT00700427|484197|P2|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
197274|NCT00700427|484198|P1|NOT COMPLETED|Study Period 3B (Randomized Withdrawal)||0
197275|NCT00700427|484194|P5|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
197276|NCT00700427|484195|P4|COMPLETED|Study Period 3B (Randomized Withdrawal)||165
197277|NCT00700427|484196|P3|COMPLETED|Study Period 3B (Randomized Withdrawal)||184
197278|NCT00700427|484197|P2|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
197279|NCT00700427|484198|P1|COMPLETED|Study Period 3B (Randomized Withdrawal)||0
197280|NCT00700427|484194|P5|STARTED|Study Period 3B (Randomized Withdrawal)||0
197281|NCT00700427|484195|P4|STARTED|Study Period 3B (Randomized Withdrawal)||258
197282|NCT00700427|484196|P3|STARTED|Study Period 3B (Randomized Withdrawal)||266
197283|NCT00700427|484197|P2|STARTED|Study Period 3B (Randomized Withdrawal)||0
197284|NCT00700427|484198|P1|STARTED|Study Period 3B (Randomized Withdrawal)||0
197285|NCT00700427|484194|P5|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
197286|NCT00700427|484195|P4|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
197287|NCT00700427|484196|P3|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
197288|NCT00700427|484197|P2|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||481
197289|NCT00700427|484198|P1|NOT COMPLETED|Study Period 3A (Blinded Maintenance)||0
197290|NCT00700427|484194|P5|COMPLETED|Study Period 3A (Blinded Maintenance)||0
197291|NCT00700427|484195|P4|COMPLETED|Study Period 3A (Blinded Maintenance)||0
197292|NCT00700427|484196|P3|COMPLETED|Study Period 3A (Blinded Maintenance)||0
197293|NCT00700427|484197|P2|COMPLETED|Study Period 3A (Blinded Maintenance)||524
197294|NCT00700427|484198|P1|COMPLETED|Study Period 3A (Blinded Maintenance)||0
197295|NCT00700427|484194|P5|STARTED|Study Period 3A (Blinded Maintenance)||0
197296|NCT00700427|484195|P4|STARTED|Study Period 3A (Blinded Maintenance)||0
197297|NCT00700427|484196|P3|STARTED|Study Period 3A (Blinded Maintenance)||0
197298|NCT00700427|484197|P2|STARTED|Study Period 3A (Blinded Maintenance)||1005
197299|NCT00700427|484198|P1|STARTED|Study Period 3A (Blinded Maintenance)||0
197300|NCT00700427|484194|P5|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197301|NCT00700427|484195|P4|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197302|NCT00700427|484196|P3|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197303|NCT00700427|484197|P2|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197304|NCT00700427|484198|P1|NOT COMPLETED|Study Period 2 (Open-Label Acute Trx)||1011
197305|NCT00700427|484194|P5|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197306|NCT00700427|484195|P4|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197307|NCT00700427|484196|P3|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197308|NCT00700427|484197|P2|COMPLETED|Study Period 2 (Open-Label Acute Trx)||0
197309|NCT00700427|484198|P1|COMPLETED|Study Period 2 (Open-Label Acute Trx)|One participant was mistakenly recorded as completed. The reason for discontinuation is unknown.|1006
197310|NCT00700427|484194|P5|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
197311|NCT00700427|484195|P4|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
197312|NCT00700427|484196|P3|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
197313|NCT00700427|484197|P2|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||0
197314|NCT00700427|484198|P1|Received at Least One Dose of Study Drug|Study Period 2 (Open-Label Acute Trx)||2011
197315|NCT00700427|484194|P5|STARTED|Study Period 2 (Open-Label Acute Trx)||0
197316|NCT00700427|484195|P4|STARTED|Study Period 2 (Open-Label Acute Trx)||0
197317|NCT00700427|484196|P3|STARTED|Study Period 2 (Open-Label Acute Trx)||0
197318|NCT00700427|484197|P2|STARTED|Study Period 2 (Open-Label Acute Trx)||0
197319|NCT00700427|484198|P1|STARTED|Study Period 2 (Open-Label Acute Trx)||2017
197320|NCT00700440|484220|P1|NOT COMPLETED|Overall Study||0
197321|NCT00700440|484220|P1|COMPLETED|Overall Study||100
197322|NCT00700440|484220|P1|STARTED|Overall Study||100
197323|NCT00700570|484226|P2|NOT COMPLETED|Overall Study||26
197324|NCT00700570|484227|P1|NOT COMPLETED|Overall Study||11
197325|NCT00700570|484226|P2|COMPLETED|Overall Study||0
197326|NCT00700570|484227|P1|COMPLETED|Overall Study||8
197327|NCT00700570|484226|P2|STARTED|Overall Study||26
197328|NCT00700570|484227|P1|STARTED|Overall Study||19
197329|NCT00700622|484241|P2|NOT COMPLETED|Overall Study||5
197330|NCT00700622|484242|P1|NOT COMPLETED|Overall Study||13
197331|NCT00700622|484241|P2|COMPLETED|Overall Study||60
197332|NCT00700622|484242|P1|COMPLETED|Overall Study||52
197333|NCT00700622|484241|P2|STARTED|Overall Study||65
197334|NCT00700622|484242|P1|STARTED|Overall Study||65
197335|NCT00700635|484251|P3|NOT COMPLETED|Overall Study||1
197336|NCT00700635|484252|P2|NOT COMPLETED|Overall Study||8
197337|NCT00700635|484253|P1|NOT COMPLETED|Overall Study||11
197338|NCT00700635|484251|P3|COMPLETED|Overall Study||110
197339|NCT00700635|484252|P2|COMPLETED|Overall Study||103
197340|NCT00700635|484253|P1|COMPLETED|Overall Study||100
197341|NCT00700635|484251|P3|STARTED|Overall Study||111
197342|NCT00700635|484252|P2|STARTED|Overall Study||111
197343|NCT00700635|484253|P1|STARTED|Overall Study||111
197344|NCT00700713|484276|P3|NOT COMPLETED|Overall Study||2
197345|NCT00700713|484277|P2|NOT COMPLETED|Overall Study||0
197346|NCT00700713|484278|P1|NOT COMPLETED|Overall Study||1
197347|NCT00700713|484276|P3|COMPLETED|Overall Study||65
197348|NCT00700713|484277|P2|COMPLETED|Overall Study||66
197349|NCT00700713|484278|P1|COMPLETED|Overall Study||47
197350|NCT00700713|484276|P3|STARTED|Overall Study||67
197351|NCT00700713|484277|P2|STARTED|Overall Study||66
197352|NCT00700713|484278|P1|STARTED|Overall Study||48
197353|NCT00700739|484294|P2|NOT COMPLETED|Overall Study||4
197354|NCT00700739|484295|P1|NOT COMPLETED|Overall Study||4
197355|NCT00700739|484294|P2|COMPLETED|Overall Study||12
197356|NCT00700739|484295|P1|COMPLETED|Overall Study||18
197357|NCT00700739|484294|P2|STARTED|Overall Study||16
197358|NCT00700739|484295|P1|STARTED|Overall Study||22
197359|NCT00700752|484331|P2|NOT COMPLETED|Second Intervention||0
197360|NCT00700752|484332|P1|NOT COMPLETED|Second Intervention||0
197361|NCT00700752|484331|P2|COMPLETED|Second Intervention||18
197362|NCT00700752|484332|P1|COMPLETED|Second Intervention||20
197363|NCT00700752|484331|P2|STARTED|Second Intervention||18
197364|NCT00700752|484332|P1|STARTED|Second Intervention||20
197365|NCT00700752|484331|P2|NOT COMPLETED|First Intervention||2
197366|NCT00700752|484332|P1|NOT COMPLETED|First Intervention||0
197367|NCT00700752|484331|P2|COMPLETED|First Intervention||18
197368|NCT00700752|484332|P1|COMPLETED|First Intervention||20
197369|NCT00700752|484331|P2|STARTED|First Intervention||20
197370|NCT00700752|484332|P1|STARTED|First Intervention||20
197371|NCT00700804|484340|P2|NOT COMPLETED|Overall Study||4
197372|NCT00700804|484341|P1|NOT COMPLETED|Overall Study||3
197373|NCT00700804|484340|P2|COMPLETED|Overall Study||13
197374|NCT00700804|484341|P1|COMPLETED|Overall Study||14
197375|NCT00700804|484340|P2|STARTED|Overall Study||17
197376|NCT00700804|484341|P1|STARTED|Overall Study||17
197377|NCT00700817|484354|P5|NOT COMPLETED|Week 52-78 (Extension Period 2)||5
197378|NCT00700817|484355|P4|NOT COMPLETED|Week 52-78 (Extension Period 2)||8
197379|NCT00700817|484356|P3|NOT COMPLETED|Week 52-78 (Extension Period 2)||0
197380|NCT00700817|484357|P2|NOT COMPLETED|Week 52-78 (Extension Period 2)||15
197381|NCT00700817|484358|P1|NOT COMPLETED|Week 52-78 (Extension Period 2)||10
197382|NCT00700817|484354|P5|COMPLETED|Week 52-78 (Extension Period 2)||63
197383|NCT00700817|484355|P4|COMPLETED|Week 52-78 (Extension Period 2)||59
197384|NCT00700817|484356|P3|COMPLETED|Week 52-78 (Extension Period 2)||0
197385|NCT00700817|484357|P2|COMPLETED|Week 52-78 (Extension Period 2)||135
197386|NCT00700817|484358|P1|COMPLETED|Week 52-78 (Extension Period 2)||124
197387|NCT00700817|484354|P5|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|68
197388|NCT00700817|484355|P4|STARTED|Week 52-78 (Extension Period 2)|Re-randomised from sita treatment group. Some subjects withdrew before entry to extension period 2.|67
197389|NCT00700817|484356|P3|STARTED|Week 52-78 (Extension Period 2)|Re-randomised to lira 1.2 or 1.8 mg|0
197390|NCT00700817|484357|P2|STARTED|Week 52-78 (Extension Period 2)||150
197391|NCT00700817|484358|P1|STARTED|Week 52-78 (Extension Period 2)|Subject withdrew before entry to extension period 2|134
197392|NCT00700817|484354|P5|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
197393|NCT00700817|484355|P4|NOT COMPLETED|Week 26-52 (Extension Period 1)||0
197394|NCT00700817|484356|P3|NOT COMPLETED|Week 26-52 (Extension Period 1)||15
197395|NCT00700817|484357|P2|NOT COMPLETED|Week 26-52 (Extension Period 1)||26
197396|NCT00700817|484358|P1|NOT COMPLETED|Week 26-52 (Extension Period 1)||20
197397|NCT00700817|484354|P5|COMPLETED|Week 26-52 (Extension Period 1)||0
197398|NCT00700817|484355|P4|COMPLETED|Week 26-52 (Extension Period 1)||0
197399|NCT00700817|484356|P3|COMPLETED|Week 26-52 (Extension Period 1)||151
197400|NCT00700817|484357|P2|COMPLETED|Week 26-52 (Extension Period 1)||150
197401|NCT00700817|484358|P1|COMPLETED|Week 26-52 (Extension Period 1)||135
197402|NCT00700817|484354|P5|STARTED|Week 26-52 (Extension Period 1)||0
197403|NCT00700817|484355|P4|STARTED|Week 26-52 (Extension Period 1)||0
197404|NCT00700817|484356|P3|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|166
197487|NCT00701090|484797|P1|STARTED|Overall Study||516
197405|NCT00700817|484357|P2|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|176
197406|NCT00700817|484358|P1|STARTED|Week 26-52 (Extension Period 1)|Subjects withdrew before entry to extension period 1|155
197407|NCT00700817|484354|P5|NOT COMPLETED|Week 0-26 (Main Period)||0
197408|NCT00700817|484355|P4|NOT COMPLETED|Week 0-26 (Main Period)||0
197409|NCT00700817|484356|P3|NOT COMPLETED|Week 0-26 (Main Period)||25
197410|NCT00700817|484357|P2|NOT COMPLETED|Week 0-26 (Main Period)||30
197411|NCT00700817|484358|P1|NOT COMPLETED|Week 0-26 (Main Period)||56
197412|NCT00700817|484354|P5|COMPLETED|Week 0-26 (Main Period)||0
197413|NCT00700817|484355|P4|COMPLETED|Week 0-26 (Main Period)||0
197414|NCT00700817|484356|P3|COMPLETED|Week 0-26 (Main Period)||194
197415|NCT00700817|484357|P2|COMPLETED|Week 0-26 (Main Period)||191
197416|NCT00700817|484358|P1|COMPLETED|Week 0-26 (Main Period)||169
197417|NCT00700817|484354|P5|Exposed|Week 0-26 (Main Period)||0
197418|NCT00700817|484355|P4|Exposed|Week 0-26 (Main Period)||0
197419|NCT00700817|484356|P3|Exposed|Week 0-26 (Main Period)||219
197420|NCT00700817|484357|P2|Exposed|Week 0-26 (Main Period)|3 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|218
197421|NCT00700817|484358|P1|Exposed|Week 0-26 (Main Period)|4 subjects withdrew before exposure to trial drug and were not included in Full Analysis Set (FAS)|221
197422|NCT00700817|484354|P5|STARTED|Week 0-26 (Main Period)||0
197423|NCT00700817|484355|P4|STARTED|Week 0-26 (Main Period)||0
197424|NCT00700817|484356|P3|STARTED|Week 0-26 (Main Period)|Randomised|219
197425|NCT00700817|484357|P2|STARTED|Week 0-26 (Main Period)|Randomised|221
197426|NCT00700817|484358|P1|STARTED|Week 0-26 (Main Period)|Randomised|225
197427|NCT00700973|484740|P2|NOT COMPLETED|Overall Study||7
197428|NCT00700973|484741|P1|NOT COMPLETED|Overall Study||8
197429|NCT00700973|484740|P2|COMPLETED|Overall Study||63
197430|NCT00700973|484741|P1|COMPLETED|Overall Study||63
197431|NCT00700973|484740|P2|STARTED|Overall Study||70
197432|NCT00700973|484741|P1|STARTED|Overall Study||71
197433|NCT00700999|484749|P2|NOT COMPLETED|Overall Study||9
197434|NCT00700999|484750|P1|NOT COMPLETED|Overall Study||15
197435|NCT00700999|484749|P2|COMPLETED|Overall Study||20
197436|NCT00700999|484750|P1|COMPLETED|Overall Study||21
197437|NCT00700999|484749|P2|Second MRI Scan|Overall Study||18
197438|NCT00700999|484750|P1|Second MRI Scan|Overall Study||19
197439|NCT00700999|484749|P2|First MRI Scan|Overall Study||22
197440|NCT00700999|484750|P1|First MRI Scan|Overall Study||29
197441|NCT00700999|484749|P2|STARTED|Overall Study||29
197442|NCT00700999|484750|P1|STARTED|Overall Study||36
197443|NCT00701038|484758|P2|NOT COMPLETED|Overall Study||4
197444|NCT00701038|484759|P1|NOT COMPLETED|Overall Study||4
197445|NCT00701038|484758|P2|COMPLETED|Overall Study||23
197446|NCT00701038|484759|P1|COMPLETED|Overall Study||23
197447|NCT00701038|484758|P2|STARTED|Overall Study||27
197448|NCT00701038|484759|P1|STARTED|Overall Study||27
197449|NCT00701051|484767|P3|NOT COMPLETED|Detraining Intervention (Optional)||0
197450|NCT00701051|484768|P2|NOT COMPLETED|Detraining Intervention (Optional)||0
197451|NCT00701051|484769|P1|NOT COMPLETED|Detraining Intervention (Optional)||0
197452|NCT00701051|484767|P3|COMPLETED|Detraining Intervention (Optional)||6
197453|NCT00701051|484768|P2|COMPLETED|Detraining Intervention (Optional)||6
197454|NCT00701051|484769|P1|COMPLETED|Detraining Intervention (Optional)||0
197455|NCT00701051|484767|P3|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
197456|NCT00701051|484768|P2|STARTED|Detraining Intervention (Optional)|Participation in this period was optional.|6
197457|NCT00701051|484769|P1|STARTED|Detraining Intervention (Optional)||0
197458|NCT00701051|484767|P3|NOT COMPLETED|Exercise Intervention||3
197459|NCT00701051|484768|P2|NOT COMPLETED|Exercise Intervention||5
197460|NCT00701051|484769|P1|NOT COMPLETED|Exercise Intervention||0
197461|NCT00701051|484767|P3|COMPLETED|Exercise Intervention||9
197462|NCT00701051|484768|P2|COMPLETED|Exercise Intervention||14
197463|NCT00701051|484769|P1|COMPLETED|Exercise Intervention||0
197464|NCT00701051|484767|P3|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|12
197465|NCT00701051|484768|P2|STARTED|Exercise Intervention|Participants assigned to group after Period 1: Screening|19
197466|NCT00701051|484769|P1|STARTED|Exercise Intervention|Participants assigned to Normal or Impaired glucose tolerance arm after screening.|0
197467|NCT00701051|484767|P3|NOT COMPLETED|Screening||0
197468|NCT00701051|484768|P2|NOT COMPLETED|Screening||0
197469|NCT00701051|484769|P1|NOT COMPLETED|Screening||59
197470|NCT00701051|484767|P3|COMPLETED|Screening||0
197471|NCT00701051|484768|P2|COMPLETED|Screening||0
197472|NCT00701051|484769|P1|COMPLETED|Screening|Arm assignment not known until baseline testing; both arms included in this number|31
197473|NCT00701051|484767|P3|STARTED|Screening||0
197474|NCT00701051|484768|P2|STARTED|Screening||0
197475|NCT00701051|484769|P1|STARTED|Screening|Arm assignment not known until baseline testing; both arms included in this number|90
197476|NCT00701064|484787|P2|NOT COMPLETED|Overall Study||4
197477|NCT00701064|484788|P1|NOT COMPLETED|Overall Study||4
197478|NCT00701064|484787|P2|COMPLETED|Overall Study||32
197479|NCT00701064|484788|P1|COMPLETED|Overall Study||31
197480|NCT00701064|484787|P2|STARTED|Overall Study||36
197481|NCT00701064|484788|P1|STARTED|Overall Study||35
197482|NCT00701090|484796|P2|NOT COMPLETED|Overall Study||51
197483|NCT00701090|484797|P1|NOT COMPLETED|Overall Study||48
197484|NCT00701090|484796|P2|COMPLETED|Overall Study||468
197485|NCT00701090|484797|P1|COMPLETED|Overall Study||468
197486|NCT00701090|484796|P2|STARTED|Overall Study||519
197488|NCT00701103|484824|P11|NOT COMPLETED|Overall Study||11
197489|NCT00701103|484825|P10|NOT COMPLETED|Overall Study||11
197490|NCT00701103|484826|P9|NOT COMPLETED|Overall Study||9
197491|NCT00701103|484827|P8|NOT COMPLETED|Overall Study||7
197492|NCT00701103|484828|P7|NOT COMPLETED|Overall Study||8
197493|NCT00701103|484829|P6|NOT COMPLETED|Overall Study||6
197494|NCT00701103|484830|P5|NOT COMPLETED|Overall Study||6
197495|NCT00701103|484831|P4|NOT COMPLETED|Overall Study||6
197496|NCT00701103|484832|P3|NOT COMPLETED|Overall Study||8
197497|NCT00701103|484833|P2|NOT COMPLETED|Overall Study||3
197498|NCT00701103|484834|P1|NOT COMPLETED|Overall Study||5
197499|NCT00701103|484824|P11|COMPLETED|Overall Study||0
197500|NCT00701103|484825|P10|COMPLETED|Overall Study||0
197501|NCT00701103|484826|P9|COMPLETED|Overall Study||0
197502|NCT00701103|484827|P8|COMPLETED|Overall Study||0
197503|NCT00701103|484828|P7|COMPLETED|Overall Study||0
197504|NCT00701103|484829|P6|COMPLETED|Overall Study||0
197505|NCT00701103|484830|P5|COMPLETED|Overall Study||0
197506|NCT00701103|484831|P4|COMPLETED|Overall Study||0
197507|NCT00701103|484832|P3|COMPLETED|Overall Study||0
197508|NCT00701103|484833|P2|COMPLETED|Overall Study||0
197509|NCT00701103|484834|P1|COMPLETED|Overall Study||0
197510|NCT00701103|484824|P11|STARTED|Overall Study||11
197511|NCT00701103|484825|P10|STARTED|Overall Study||11
197512|NCT00701103|484826|P9|STARTED|Overall Study||9
197513|NCT00701103|484827|P8|STARTED|Overall Study||7
197514|NCT00701103|484828|P7|STARTED|Overall Study||8
197515|NCT00701103|484829|P6|STARTED|Overall Study||6
197516|NCT00701103|484830|P5|STARTED|Overall Study||6
197517|NCT00701103|484831|P4|STARTED|Overall Study||6
197518|NCT00701103|484832|P3|STARTED|Overall Study||8
197519|NCT00701103|484833|P2|STARTED|Overall Study||3
197520|NCT00701103|484834|P1|STARTED|Overall Study||5
197521|NCT00701129|484938|P1|NOT COMPLETED|Overall Study||2
197522|NCT00701129|484938|P1|COMPLETED|Overall Study||2
197523|NCT00701129|484938|P1|Full Analysis Set (FAS)|Overall Study|All enrolled patients who signed informed consent, received at least 1 dose of alglucosidase alfa.|4
197524|NCT00701129|484938|P1|STARTED|Overall Study||4
197525|NCT00701311|484949|P1|NOT COMPLETED|Overall Study||8
197526|NCT00701311|484949|P1|COMPLETED|Overall Study|Eight subjects did not complete full period of treatment but their data was included in analysis.|9
197527|NCT00701311|484949|P1|STARTED|Overall Study||17
197528|NCT00701363|484957|P4|NOT COMPLETED|Treatment Phase 2||0
197529|NCT00701363|484958|P3|NOT COMPLETED|Treatment Phase 2||2
197530|NCT00701363|484959|P2|NOT COMPLETED|Treatment Phase 2||0
197531|NCT00701363|484960|P1|NOT COMPLETED|Treatment Phase 2||0
197532|NCT00701363|484957|P4|COMPLETED|Treatment Phase 2||26
197533|NCT00701363|484958|P3|COMPLETED|Treatment Phase 2||68
197534|NCT00701363|484959|P2|COMPLETED|Treatment Phase 2||13
197535|NCT00701363|484960|P1|COMPLETED|Treatment Phase 2||0
197536|NCT00701363|484957|P4|STARTED|Treatment Phase 2||26
197537|NCT00701363|484958|P3|STARTED|Treatment Phase 2||70
197538|NCT00701363|484959|P2|STARTED|Treatment Phase 2||13
197539|NCT00701363|484960|P1|STARTED|Treatment Phase 2||0
197540|NCT00701363|484957|P4|NOT COMPLETED|Treatment Phase 1||0
197541|NCT00701363|484958|P3|NOT COMPLETED|Treatment Phase 1||0
197542|NCT00701363|484959|P2|NOT COMPLETED|Treatment Phase 1||0
197543|NCT00701363|484960|P1|NOT COMPLETED|Treatment Phase 1||15
197544|NCT00701363|484957|P4|COMPLETED|Treatment Phase 1||0
197545|NCT00701363|484958|P3|COMPLETED|Treatment Phase 1||0
197546|NCT00701363|484959|P2|COMPLETED|Treatment Phase 1||0
197547|NCT00701363|484960|P1|COMPLETED|Treatment Phase 1||109
197548|NCT00701363|484957|P4|STARTED|Treatment Phase 1||0
197549|NCT00701363|484958|P3|STARTED|Treatment Phase 1||0
197550|NCT00701363|484959|P2|STARTED|Treatment Phase 1||0
197551|NCT00701363|484960|P1|STARTED|Treatment Phase 1||124
197552|NCT00701363|484957|P4|NOT COMPLETED|Screening (Pre-assignment) Phase||0
197553|NCT00701363|484958|P3|NOT COMPLETED|Screening (Pre-assignment) Phase||0
197554|NCT00701363|484959|P2|NOT COMPLETED|Screening (Pre-assignment) Phase||0
197555|NCT00701363|484960|P1|NOT COMPLETED|Screening (Pre-assignment) Phase||4
197556|NCT00701363|484957|P4|COMPLETED|Screening (Pre-assignment) Phase||0
197557|NCT00701363|484958|P3|COMPLETED|Screening (Pre-assignment) Phase||0
197558|NCT00701363|484959|P2|COMPLETED|Screening (Pre-assignment) Phase||0
197559|NCT00701363|484960|P1|COMPLETED|Screening (Pre-assignment) Phase||124
197560|NCT00701363|484957|P4|STARTED|Screening (Pre-assignment) Phase||0
197561|NCT00701363|484958|P3|STARTED|Screening (Pre-assignment) Phase||0
197562|NCT00701363|484959|P2|STARTED|Screening (Pre-assignment) Phase||0
197563|NCT00701363|484960|P1|STARTED|Screening (Pre-assignment) Phase||128
197564|NCT00701389|485000|P4|NOT COMPLETED|Period 4||0
197565|NCT00701389|485001|P3|NOT COMPLETED|Period 4||0
197566|NCT00701389|485002|P2|NOT COMPLETED|Period 4||0
197567|NCT00701389|485003|P1|NOT COMPLETED|Period 4||0
197568|NCT00701389|485000|P4|COMPLETED|Period 4||6
197569|NCT00701389|485001|P3|COMPLETED|Period 4||6
197570|NCT00701389|485002|P2|COMPLETED|Period 4||6
197571|NCT00701389|485003|P1|COMPLETED|Period 4||6
197572|NCT00701389|485000|P4|STARTED|Period 4||6
197573|NCT00701389|485001|P3|STARTED|Period 4||6
197574|NCT00701389|485002|P2|STARTED|Period 4||6
197575|NCT00701389|485003|P1|STARTED|Period 4||6
197576|NCT00701389|485000|P4|NOT COMPLETED|Period 3||0
197577|NCT00701389|485001|P3|NOT COMPLETED|Period 3||0
197578|NCT00701389|485002|P2|NOT COMPLETED|Period 3||0
197579|NCT00701389|485003|P1|NOT COMPLETED|Period 3||0
197580|NCT00701389|485000|P4|COMPLETED|Period 3||6
197581|NCT00701389|485001|P3|COMPLETED|Period 3||6
197582|NCT00701389|485002|P2|COMPLETED|Period 3||6
197583|NCT00701389|485003|P1|COMPLETED|Period 3||6
197584|NCT00701389|485000|P4|STARTED|Period 3||6
197585|NCT00701389|485001|P3|STARTED|Period 3||6
197586|NCT00701389|485002|P2|STARTED|Period 3||6
197587|NCT00701389|485003|P1|STARTED|Period 3||6
197588|NCT00701389|485000|P4|NOT COMPLETED|Period 2||0
197589|NCT00701389|485001|P3|NOT COMPLETED|Period 2||0
197590|NCT00701389|485002|P2|NOT COMPLETED|Period 2||0
197591|NCT00701389|485003|P1|NOT COMPLETED|Period 2||0
197592|NCT00701389|485000|P4|COMPLETED|Period 2||6
197593|NCT00701389|485001|P3|COMPLETED|Period 2||6
197594|NCT00701389|485002|P2|COMPLETED|Period 2||6
197595|NCT00701389|485003|P1|COMPLETED|Period 2||6
197596|NCT00701389|485000|P4|STARTED|Period 2||6
197597|NCT00701389|485001|P3|STARTED|Period 2||6
197598|NCT00701389|485002|P2|STARTED|Period 2||6
197599|NCT00701389|485003|P1|STARTED|Period 2||6
197600|NCT00701389|485000|P4|NOT COMPLETED|Period 1||0
197601|NCT00701389|485001|P3|NOT COMPLETED|Period 1||0
197602|NCT00701389|485002|P2|NOT COMPLETED|Period 1||0
197603|NCT00701389|485003|P1|NOT COMPLETED|Period 1||0
197604|NCT00701389|485000|P4|COMPLETED|Period 1||6
197605|NCT00701389|485001|P3|COMPLETED|Period 1||6
197606|NCT00701389|485002|P2|COMPLETED|Period 1||6
197607|NCT00701389|485003|P1|COMPLETED|Period 1||6
197608|NCT00701389|485000|P4|STARTED|Period 1||6
197609|NCT00701389|485001|P3|STARTED|Period 1||6
197610|NCT00701389|485002|P2|STARTED|Period 1||6
197611|NCT00701389|485003|P1|STARTED|Period 1||6
197612|NCT00701415|485023|P2|NOT COMPLETED|Overall Study||1
197613|NCT00701415|485024|P1|NOT COMPLETED|Overall Study||1
197614|NCT00701415|485023|P2|COMPLETED|Overall Study||14
197615|NCT00701415|485024|P1|COMPLETED|Overall Study||15
197616|NCT00701415|485023|P2|STARTED|Overall Study||15
197617|NCT00701415|485024|P1|STARTED|Overall Study||16
197618|NCT00701441|485036|P2|NOT COMPLETED|Overall Study||4
197619|NCT00701441|485037|P1|NOT COMPLETED|Overall Study||0
197620|NCT00701441|485036|P2|COMPLETED|Overall Study||12
197621|NCT00701441|485037|P1|COMPLETED|Overall Study||9
197622|NCT00701441|485036|P2|STARTED|Overall Study||16
197623|NCT00701441|485037|P1|STARTED|Overall Study||9
197624|NCT00701558|485047|P1|NOT COMPLETED|Overall Study||15
197625|NCT00701558|485047|P1|COMPLETED|Overall Study||4
197626|NCT00701558|485047|P1|STARTED|Overall Study||19
197627|NCT00701636|485055|P2|NOT COMPLETED|Overall Study||0
197628|NCT00701636|485056|P1|NOT COMPLETED|Overall Study||0
197629|NCT00701636|485055|P2|COMPLETED|Overall Study||15
197630|NCT00701636|485056|P1|COMPLETED|Overall Study||15
197631|NCT00701636|485055|P2|STARTED|Overall Study||15
197632|NCT00701636|485056|P1|STARTED|Overall Study||15
197633|NCT00701662|485061|P1|NOT COMPLETED|Overall Study||1
197634|NCT00701662|485061|P1|COMPLETED|Overall Study||7
197635|NCT00701662|485061|P1|STARTED|Overall Study||8
197636|NCT00701675|485081|P3|NOT COMPLETED|Overall Study||7
197637|NCT00701675|485082|P2|NOT COMPLETED|Overall Study||8
197638|NCT00701675|485083|P1|NOT COMPLETED|Overall Study||4
197639|NCT00701675|485081|P3|COMPLETED|Overall Study||7
197640|NCT00701675|485082|P2|COMPLETED|Overall Study||6
197641|NCT00701675|485083|P1|COMPLETED|Overall Study||10
197642|NCT00701675|485081|P3|STARTED|Overall Study||14
197643|NCT00701675|485082|P2|STARTED|Overall Study||14
197644|NCT00701675|485083|P1|STARTED|Overall Study||14
197645|NCT00701727|485091|P2|NOT COMPLETED|Second Treatment Period||0
197646|NCT00701727|485092|P1|NOT COMPLETED|Second Treatment Period||2
197647|NCT00701727|485091|P2|COMPLETED|Second Treatment Period||13
197648|NCT00701727|485092|P1|COMPLETED|Second Treatment Period||13
197649|NCT00701727|485091|P2|STARTED|Second Treatment Period||13
197650|NCT00701727|485092|P1|STARTED|Second Treatment Period||15
197651|NCT00701727|485091|P2|NOT COMPLETED|First Treatment Period||2
197652|NCT00701727|485092|P1|NOT COMPLETED|First Treatment Period||1
197653|NCT00701727|485091|P2|COMPLETED|First Treatment Period||13
197654|NCT00701727|485092|P1|COMPLETED|First Treatment Period||15
197655|NCT00701727|485091|P2|STARTED|First Treatment Period||15
197656|NCT00701727|485092|P1|STARTED|First Treatment Period||16
197657|NCT00701779|485110|P1|NOT COMPLETED|Overall Study||9
197658|NCT00701779|485110|P1|COMPLETED|Overall Study||54
197659|NCT00701779|485110|P1|12 Month|Overall Study||54
197660|NCT00701779|485110|P1|9 Month|Overall Study||56
197661|NCT00701779|485110|P1|6 Month|Overall Study||58
197662|NCT00701779|485110|P1|3 Month|Overall Study||60
197663|NCT00701779|485110|P1|STARTED|Overall Study||63
197664|NCT00701805|485123|P4|NOT COMPLETED|Overall Study||4
197665|NCT00701805|485124|P3|NOT COMPLETED|Overall Study||7
197666|NCT00701805|485125|P2|NOT COMPLETED|Overall Study||4
197667|NCT00701805|485126|P1|NOT COMPLETED|Overall Study||3
197668|NCT00701805|485123|P4|COMPLETED|Overall Study||22
197669|NCT00701805|485124|P3|COMPLETED|Overall Study||16
197670|NCT00701805|485125|P2|COMPLETED|Overall Study||25
197671|NCT00701805|485126|P1|COMPLETED|Overall Study||23
197672|NCT00701805|485123|P4|STARTED|Overall Study||26
197673|NCT00701805|485124|P3|STARTED|Overall Study||23
197674|NCT00701805|485125|P2|STARTED|Overall Study||29
197675|NCT00701805|485126|P1|STARTED|Overall Study||26
197676|NCT00701935|485178|P2|NOT COMPLETED|Overall Study||11
197677|NCT00701935|485179|P1|NOT COMPLETED|Overall Study||16
197678|NCT00701935|485178|P2|COMPLETED|Overall Study||26
197679|NCT00701935|485179|P1|COMPLETED|Overall Study||27
197680|NCT00701935|485178|P2|STARTED|Overall Study||37
197681|NCT00701935|485179|P1|STARTED|Overall Study||43
197682|NCT00694018|485211|P2|NOT COMPLETED|Overall Study||9
197683|NCT00694018|485212|P1|NOT COMPLETED|Overall Study||13
197684|NCT00694018|485211|P2|COMPLETED|Overall Study||102
197685|NCT00694018|485212|P1|COMPLETED|Overall Study||105
197686|NCT00694018|485211|P2|6 Months|Overall Study||101
197687|NCT00694018|485212|P1|6 Months|Overall Study||106
197688|NCT00694018|485211|P2|STARTED|Overall Study||111
197689|NCT00694018|485212|P1|STARTED|Overall Study||118
197690|NCT00694070|485218|P1|NOT COMPLETED|Overall Study||0
197691|NCT00694070|485218|P1|COMPLETED|Overall Study||51
197692|NCT00694070|485218|P1|STARTED|Overall Study||51
197693|NCT00694096|485224|P1|NOT COMPLETED|Overall Study||5
197694|NCT00694096|485224|P1|COMPLETED|Overall Study||20
197695|NCT00694096|485224|P1|STARTED|Overall Study||25
197696|NCT00694109|485230|P1|NOT COMPLETED|Overall Study||117
197697|NCT00694109|485230|P1|COMPLETED|Overall Study||25
197698|NCT00694109|485230|P1|Completed Consented Length of Treatment|Overall Study||60
197699|NCT00694109|485230|P1|Consented 2 Years Additional Treatment|Overall Study||42
197700|NCT00694109|485230|P1|Treated|Overall Study||141
197701|NCT00694109|485230|P1|STARTED|Overall Study|This does not include 2 patients from phase 2 trial with very different treatment experience.|142
197702|NCT00694122|485254|P2|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
197703|NCT00694122|485255|P1|NOT COMPLETED|Second Intervention (3-4 Weeks)||0
197704|NCT00694122|485254|P2|COMPLETED|Second Intervention (3-4 Weeks)||5
197705|NCT00694122|485255|P1|COMPLETED|Second Intervention (3-4 Weeks)||10
197706|NCT00694122|485254|P2|STARTED|Second Intervention (3-4 Weeks)||5
197707|NCT00694122|485255|P1|STARTED|Second Intervention (3-4 Weeks)||10
197708|NCT00694122|485254|P2|NOT COMPLETED|Washout (1 Day)||0
197709|NCT00694122|485255|P1|NOT COMPLETED|Washout (1 Day)||0
197710|NCT00694122|485254|P2|COMPLETED|Washout (1 Day)||5
197711|NCT00694122|485255|P1|COMPLETED|Washout (1 Day)||10
197712|NCT00694122|485254|P2|STARTED|Washout (1 Day)||5
197713|NCT00694122|485255|P1|STARTED|Washout (1 Day)||10
197714|NCT00694122|485254|P2|NOT COMPLETED|First Intervention (3-4 Weeks)||2
197715|NCT00694122|485255|P1|NOT COMPLETED|First Intervention (3-4 Weeks)||10
197716|NCT00694122|485254|P2|COMPLETED|First Intervention (3-4 Weeks)||5
197717|NCT00694122|485255|P1|COMPLETED|First Intervention (3-4 Weeks)||10
197718|NCT00694122|485254|P2|STARTED|First Intervention (3-4 Weeks)|Started on NPH then on Lantus.|7
197719|NCT00694122|485255|P1|STARTED|First Intervention (3-4 Weeks)|Started Lantus then on NPH.|20
197720|NCT00694161|485271|P1|NOT COMPLETED|Part 2 (After Week 6 up to Month 12)||3
197721|NCT00694161|485271|P1|COMPLETED|Part 2 (After Week 6 up to Month 12)||32
197722|NCT00694161|485271|P1|STARTED|Part 2 (After Week 6 up to Month 12)||35
197723|NCT00694161|485271|P1|NOT COMPLETED|Part 1 (up to Week 6)||0
197724|NCT00694161|485271|P1|COMPLETED|Part 1 (up to Week 6)||35
197725|NCT00694161|485271|P1|STARTED|Part 1 (up to Week 6)||35
197726|NCT00694304|485310|P1|NOT COMPLETED|Overall Study||207
197727|NCT00694304|485310|P1|COMPLETED|Overall Study||328
197728|NCT00694304|485310|P1|STARTED|Overall Study||535
197729|NCT00694356|485326|P3|NOT COMPLETED|Overall Study||6
197730|NCT00694356|485327|P2|NOT COMPLETED|Overall Study||6
197731|NCT00694356|485328|P1|NOT COMPLETED|Overall Study||3
197732|NCT00694356|485326|P3|COMPLETED|Overall Study||0
197733|NCT00694356|485327|P2|COMPLETED|Overall Study||0
197734|NCT00694356|485328|P1|COMPLETED|Overall Study||0
197735|NCT00694356|485326|P3|STARTED|Overall Study||6
197736|NCT00694356|485327|P2|STARTED|Overall Study||6
197737|NCT00694356|485328|P1|STARTED|Overall Study||3
197738|NCT00694369|485368|P5|NOT COMPLETED|Overall Study||6
197739|NCT00694369|485369|P4|NOT COMPLETED|Overall Study||3
197740|NCT00694369|485370|P3|NOT COMPLETED|Overall Study||2
197741|NCT00694369|485371|P2|NOT COMPLETED|Overall Study||3
197742|NCT00694369|485372|P1|NOT COMPLETED|Overall Study||1
197743|NCT00694369|485368|P5|COMPLETED|Overall Study||56
197744|NCT00694369|485369|P4|COMPLETED|Overall Study||189
197745|NCT00694369|485370|P3|COMPLETED|Overall Study||95
197746|NCT00694369|485371|P2|COMPLETED|Overall Study||188
197747|NCT00694369|485372|P1|COMPLETED|Overall Study||45
197748|NCT00694369|485368|P5|STARTED|Overall Study||62
197749|NCT00694369|485369|P4|STARTED|Overall Study||192
197750|NCT00694369|485370|P3|STARTED|Overall Study||97
197751|NCT00694369|485371|P2|STARTED|Overall Study||191
197752|NCT00694369|485372|P1|STARTED|Overall Study||46
197753|NCT00694551|485392|P3|NOT COMPLETED|Overall Study||1
197754|NCT00694551|485393|P2|NOT COMPLETED|Overall Study||0
197755|NCT00694551|485394|P1|NOT COMPLETED|Overall Study||1
197756|NCT00694551|485392|P3|COMPLETED|Overall Study||8
197757|NCT00694551|485393|P2|COMPLETED|Overall Study||10
197758|NCT00694551|485394|P1|COMPLETED|Overall Study||9
197759|NCT00694551|485392|P3|STARTED|Overall Study||9
197760|NCT00694551|485393|P2|STARTED|Overall Study||10
197761|NCT00694551|485394|P1|STARTED|Overall Study||10
197762|NCT00694564|485408|P1|NOT COMPLETED|Overall Study||2
197763|NCT00694564|485408|P1|COMPLETED|Overall Study||6
197764|NCT00694564|485408|P1|STARTED|Overall Study||8
197765|NCT00694603|485412|P1|NOT COMPLETED|Overall Study||0
197766|NCT00694603|485412|P1|COMPLETED|Overall Study||18
197767|NCT00694603|485412|P1|STARTED|Overall Study||18
197768|NCT00695019|485420|P3|NOT COMPLETED|Overall Study||10
197769|NCT00695019|485421|P2|NOT COMPLETED|Overall Study||14
197770|NCT00695019|485422|P1|NOT COMPLETED|Overall Study||13
197771|NCT00695019|485420|P3|COMPLETED|Overall Study||47
197772|NCT00695019|485421|P2|COMPLETED|Overall Study||39
197773|NCT00695019|485422|P1|COMPLETED|Overall Study||46
197774|NCT00695019|485420|P3|STARTED|Overall Study||57
197775|NCT00695019|485421|P2|STARTED|Overall Study||53
197776|NCT00695019|485422|P1|STARTED|Overall Study||59
197777|NCT00695097|485453|P2|NOT COMPLETED|Overall Study||0
197778|NCT00695097|485454|P1|NOT COMPLETED|Overall Study||1
197779|NCT00695097|485453|P2|COMPLETED|Overall Study||5
197780|NCT00695097|485454|P1|COMPLETED|Overall Study||9
197781|NCT00695097|485453|P2|STARTED|Overall Study||5
197782|NCT00695097|485454|P1|STARTED|Overall Study||10
197783|NCT00695136|485460|P1|NOT COMPLETED|Overall Study||2
197784|NCT00695136|485460|P1|COMPLETED|Overall Study||5
197785|NCT00695136|485460|P1|STARTED|Overall Study|7|7
197786|NCT00695188|485466|P2|NOT COMPLETED|Overall Study||0
197787|NCT00695188|485467|P1|NOT COMPLETED|Overall Study||0
197788|NCT00695188|485466|P2|COMPLETED|Overall Study||9
197789|NCT00695188|485467|P1|COMPLETED|Overall Study||10
197790|NCT00695188|485466|P2|STARTED|Overall Study||9
197791|NCT00695188|485467|P1|STARTED|Overall Study||10
197792|NCT00695292|485473|P1|NOT COMPLETED|Overall Study||0
197793|NCT00695292|485473|P1|COMPLETED|Overall Study||37
197794|NCT00695292|485473|P1|STARTED|Overall Study||37
197795|NCT00695318|485480|P2|NOT COMPLETED|Overall Study||1
197796|NCT00695318|485481|P1|NOT COMPLETED|Overall Study||5
197797|NCT00695318|485480|P2|COMPLETED|Overall Study||6
197798|NCT00695318|485481|P1|COMPLETED|Overall Study||5
197799|NCT00695318|485480|P2|STARTED|Overall Study||7
197800|NCT00695318|485481|P1|STARTED|Overall Study||10
197801|NCT00695396|485495|P3|NOT COMPLETED|Overall Study||8
197802|NCT00695396|485496|P2|NOT COMPLETED|Overall Study||8
197803|NCT00695396|485497|P1|NOT COMPLETED|Overall Study||7
197804|NCT00695396|485495|P3|COMPLETED|Overall Study||1
197805|NCT00695396|485496|P2|COMPLETED|Overall Study||0
197806|NCT00695396|485497|P1|COMPLETED|Overall Study||1
197807|NCT00695396|485495|P3|STARTED|Overall Study||9
197808|NCT00695396|485496|P2|STARTED|Overall Study||8
197809|NCT00695396|485497|P1|STARTED|Overall Study||8
197810|NCT00695435|485511|P3|NOT COMPLETED|Overall Study||0
197811|NCT00695435|485512|P2|NOT COMPLETED|Overall Study||0
197812|NCT00695435|485513|P1|NOT COMPLETED|Overall Study||0
197813|NCT00695435|485511|P3|COMPLETED|Overall Study||7
197814|NCT00695435|485512|P2|COMPLETED|Overall Study||7
197815|NCT00695435|485513|P1|COMPLETED|Overall Study||7
197816|NCT00695435|485511|P3|STARTED|Overall Study||7
197817|NCT00695435|485512|P2|STARTED|Overall Study||7
197818|NCT00695435|485513|P1|STARTED|Overall Study||7
197819|NCT00695500|485526|P2|NOT COMPLETED|Overall Study||5
197820|NCT00695500|485527|P1|NOT COMPLETED|Overall Study||3
197821|NCT00695500|485526|P2|COMPLETED|Overall Study||17
197822|NCT00695500|485527|P1|COMPLETED|Overall Study||21
197823|NCT00695500|485526|P2|STARTED|Overall Study||22
197824|NCT00695500|485527|P1|STARTED|Overall Study||24
197825|NCT00695565|485539|P2|NOT COMPLETED|Overall Study||9
197826|NCT00695565|485540|P1|NOT COMPLETED|Overall Study||13
197827|NCT00695565|485539|P2|COMPLETED|Overall Study||81
197828|NCT00695565|485540|P1|COMPLETED|Overall Study||77
197829|NCT00695565|485539|P2|STARTED|Overall Study||90
197830|NCT00695565|485540|P1|STARTED|Overall Study||90
197831|NCT00695669|485576|P4|NOT COMPLETED|Overall Study||4
197832|NCT00695669|485577|P3|NOT COMPLETED|Overall Study||3
197833|NCT00695669|485578|P2|NOT COMPLETED|Overall Study||4
197834|NCT00695669|485579|P1|NOT COMPLETED|Overall Study||4
197835|NCT00695669|485576|P4|COMPLETED|Overall Study||74
197836|NCT00695669|485577|P3|COMPLETED|Overall Study||75
197837|NCT00695669|485578|P2|COMPLETED|Overall Study||74
197838|NCT00695669|485579|P1|COMPLETED|Overall Study||74
197839|NCT00695669|485576|P4|STARTED|Overall Study||78
197840|NCT00695669|485577|P3|STARTED|Overall Study||78
197841|NCT00695669|485578|P2|STARTED|Overall Study||78
197842|NCT00695669|485579|P1|STARTED|Overall Study||78
197843|NCT00695864|485653|P1|NOT COMPLETED|Ondansetron||5
197844|NCT00695864|485653|P1|COMPLETED|Ondansetron||9
197845|NCT00695864|485653|P1|STARTED|Ondansetron||14
197846|NCT00695864|485653|P1|NOT COMPLETED|Placebo||5
197847|NCT00695864|485653|P1|COMPLETED|Placebo||9
197848|NCT00695864|485653|P1|STARTED|Placebo||14
197849|NCT00695903|485661|P2|NOT COMPLETED|Had Test of Cure (TOC) Assessment||1
197850|NCT00695903|485662|P1|NOT COMPLETED|Had Test of Cure (TOC) Assessment||2
197851|NCT00695903|485661|P2|COMPLETED|Had Test of Cure (TOC) Assessment||3
197852|NCT00695903|485662|P1|COMPLETED|Had Test of Cure (TOC) Assessment||5
197853|NCT00695903|485661|P2|STARTED|Had Test of Cure (TOC) Assessment||4
197854|NCT00695903|485662|P1|STARTED|Had Test of Cure (TOC) Assessment||7
197855|NCT00695903|485661|P2|NOT COMPLETED|Had End of Therapy (EOT) Assessment||15
197856|NCT00695903|485662|P1|NOT COMPLETED|Had End of Therapy (EOT) Assessment||12
197857|NCT00695903|485661|P2|COMPLETED|Had End of Therapy (EOT) Assessment||4
197858|NCT00695903|485662|P1|COMPLETED|Had End of Therapy (EOT) Assessment||7
197859|NCT00695903|485661|P2|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||6
197860|NCT00695903|485662|P1|Met Continuation Criteria|Had End of Therapy (EOT) Assessment||9
197861|NCT00695903|485661|P2|STARTED|Had End of Therapy (EOT) Assessment||19
197862|NCT00695903|485662|P1|STARTED|Had End of Therapy (EOT) Assessment||19
197863|NCT00695955|485674|P1|NOT COMPLETED|Cohort 2||104
197864|NCT00695955|485674|P1|COMPLETED|Cohort 2||203
197865|NCT00695955|485674|P1|STARTED|Cohort 2||307
197866|NCT00695955|485674|P1|NOT COMPLETED|Cohort 1||102
197867|NCT00695955|485674|P1|COMPLETED|Cohort 1||260
197868|NCT00695955|485674|P1|STARTED|Cohort 1||362
197869|NCT00696020|485688|P4|NOT COMPLETED|Overall Study||4
197870|NCT00696020|485689|P3|NOT COMPLETED|Overall Study||3
197871|NCT00696020|485690|P2|NOT COMPLETED|Overall Study||2
197872|NCT00696020|485691|P1|NOT COMPLETED|Overall Study||4
197873|NCT00696020|485688|P4|COMPLETED|Overall Study||84
197874|NCT00696020|485689|P3|COMPLETED|Overall Study||90
197875|NCT00696020|485690|P2|COMPLETED|Overall Study||87
197876|NCT00696020|485691|P1|COMPLETED|Overall Study||86
197877|NCT00696020|485688|P4|STARTED|Overall Study||88
197878|NCT00696020|485689|P3|STARTED|Overall Study||93
197879|NCT00696020|485690|P2|STARTED|Overall Study||89
197880|NCT00696020|485691|P1|STARTED|Overall Study||90
197881|NCT00696072|485801|P2|NOT COMPLETED|Overall Study||63
197882|NCT00696072|485802|P1|NOT COMPLETED|Overall Study||57
197883|NCT00696072|485801|P2|COMPLETED|Overall Study||0
197884|NCT00696072|485802|P1|COMPLETED|Overall Study||0
197885|NCT00696072|485801|P2|STARTED|Overall Study||63
197886|NCT00696072|485802|P1|STARTED|Overall Study||57
197887|NCT00696241|485824|P5|NOT COMPLETED|Overall Study||12
197888|NCT00696241|485825|P4|NOT COMPLETED|Overall Study||14
197889|NCT00696241|485826|P3|NOT COMPLETED|Overall Study||24
197890|NCT00696241|485827|P2|NOT COMPLETED|Overall Study||22
197891|NCT00696241|485828|P1|NOT COMPLETED|Overall Study||24
197892|NCT00696241|485824|P5|COMPLETED|Overall Study||130
197893|NCT00696241|485825|P4|COMPLETED|Overall Study||268
197894|NCT00696241|485826|P3|COMPLETED|Overall Study||261
197895|NCT00696241|485827|P2|COMPLETED|Overall Study||261
197896|NCT00696241|485828|P1|COMPLETED|Overall Study||259
197897|NCT00696241|485824|P5|STARTED|Overall Study||142
197898|NCT00696241|485825|P4|STARTED|Overall Study||282
197899|NCT00696241|485826|P3|STARTED|Overall Study||285
197900|NCT00696241|485827|P2|STARTED|Overall Study||283
197901|NCT00696241|485828|P1|STARTED|Overall Study||283
197902|NCT00696293|485910|P1|NOT COMPLETED|Overall Study||2
197903|NCT00696293|485910|P1|COMPLETED|Overall Study||28
197904|NCT00696293|485910|P1|STARTED|Overall Study||30
197905|NCT00696384|485915|P3|NOT COMPLETED|Double Blind Phase||6
197906|NCT00696384|485916|P2|NOT COMPLETED|Double Blind Phase||11
197907|NCT00696384|485917|P1|NOT COMPLETED|Double Blind Phase||0
197908|NCT00696384|485915|P3|COMPLETED|Double Blind Phase||145
197909|NCT00696384|485916|P2|COMPLETED|Double Blind Phase||137
197910|NCT00696384|485917|P1|COMPLETED|Double Blind Phase||0
197911|NCT00696384|485915|P3|STARTED|Double Blind Phase||151
197912|NCT00696384|485916|P2|STARTED|Double Blind Phase||148
197913|NCT00696384|485917|P1|STARTED|Double Blind Phase||0
197914|NCT00696384|485915|P3|NOT COMPLETED|Open Label Phase||0
197915|NCT00696384|485916|P2|NOT COMPLETED|Open Label Phase||0
197916|NCT00696384|485917|P1|NOT COMPLETED|Open Label Phase||119
197917|NCT00696384|485915|P3|COMPLETED|Open Label Phase||0
197918|NCT00696384|485916|P2|COMPLETED|Open Label Phase||0
197919|NCT00696384|485917|P1|COMPLETED|Open Label Phase||299
197920|NCT00696384|485915|P3|STARTED|Open Label Phase||0
197921|NCT00696384|485916|P2|STARTED|Open Label Phase||0
197922|NCT00696384|485917|P1|STARTED|Open Label Phase||418
197923|NCT00696423|485933|P2|NOT COMPLETED|Overall Study||5
197924|NCT00696423|485934|P1|NOT COMPLETED|Overall Study||0
197925|NCT00696423|485933|P2|COMPLETED|Overall Study||218
197926|NCT00696423|485934|P1|COMPLETED|Overall Study||244
197927|NCT00696423|485933|P2|STARTED|Overall Study||223
197928|NCT00696423|485934|P1|STARTED|Overall Study||244
197929|NCT00696436|485969|P5|NOT COMPLETED|Overall Study||13
197930|NCT00696436|485970|P4|NOT COMPLETED|Overall Study||22
197931|NCT00696436|485971|P3|NOT COMPLETED|Overall Study||28
197932|NCT00696436|485972|P2|NOT COMPLETED|Overall Study||30
197933|NCT00696436|485973|P1|NOT COMPLETED|Overall Study||23
197934|NCT00696436|485969|P5|COMPLETED|Overall Study||141
197935|NCT00696436|485970|P4|COMPLETED|Overall Study||268
197936|NCT00696436|485971|P3|COMPLETED|Overall Study||254
197937|NCT00696436|485972|P2|COMPLETED|Overall Study||255
197938|NCT00696436|485973|P1|COMPLETED|Overall Study||257
197939|NCT00696436|485969|P5|STARTED|Overall Study|Randomized participants only.|154
197940|NCT00696436|485970|P4|STARTED|Overall Study|Randomized participants only.|290
197941|NCT00696436|485971|P3|STARTED|Overall Study|Randomized participants only.|282
197942|NCT00696436|485972|P2|STARTED|Overall Study|Randomized participants only. One participant treated but not randomized and is not included.|285
197943|NCT00696436|485973|P1|STARTED|Overall Study|Randomized participants only.|280
197944|NCT00696449|486059|P4|NOT COMPLETED|Overall Study||3
197945|NCT00696449|486060|P3|NOT COMPLETED|Overall Study||1
197946|NCT00696449|486061|P2|NOT COMPLETED|Overall Study||6
197947|NCT00696449|486062|P1|NOT COMPLETED|Overall Study||3
197948|NCT00696449|486059|P4|COMPLETED|Overall Study||13
197949|NCT00696449|486060|P3|COMPLETED|Overall Study||14
197950|NCT00696449|486061|P2|COMPLETED|Overall Study||9
197951|NCT00696449|486062|P1|COMPLETED|Overall Study||12
197952|NCT00696449|486059|P4|STARTED|Overall Study||16
197953|NCT00696449|486060|P3|STARTED|Overall Study||15
197954|NCT00696449|486061|P2|STARTED|Overall Study||15
197955|NCT00696449|486062|P1|STARTED|Overall Study||15
197956|NCT00696488|486072|P1|NOT COMPLETED|Overall Study||0
197957|NCT00696488|486072|P1|COMPLETED|Overall Study||20
197958|NCT00696488|486072|P1|STARTED|Overall Study||20
197959|NCT00702143|486079|P3|NOT COMPLETED|Overall Study||1
197960|NCT00702143|486080|P2|NOT COMPLETED|Overall Study||0
197961|NCT00702143|486081|P1|NOT COMPLETED|Overall Study||0
197962|NCT00702143|486079|P3|COMPLETED|Overall Study||78
197963|NCT00702143|486080|P2|COMPLETED|Overall Study||60
197964|NCT00702143|486081|P1|COMPLETED|Overall Study||45
197965|NCT00702143|486079|P3|STARTED|Overall Study||79
197966|NCT00702143|486080|P2|STARTED|Overall Study||60
197967|NCT00702143|486081|P1|STARTED|Overall Study||45
197968|NCT00702208|486093|P1|NOT COMPLETED|Overall Study||31
197969|NCT00702208|486093|P1|COMPLETED|Overall Study||167
197970|NCT00702208|486093|P1|STARTED|Overall Study||198
197971|NCT00702221|486101|P2|NOT COMPLETED|Overall Study||3
197972|NCT00702221|486102|P1|NOT COMPLETED|Overall Study||4
197973|NCT00702221|486101|P2|COMPLETED|Overall Study||7
197974|NCT00702221|486102|P1|COMPLETED|Overall Study||6
197975|NCT00702221|486101|P2|STARTED|Overall Study||10
197976|NCT00702221|486102|P1|STARTED|Overall Study||10
197977|NCT00702234|486108|P2|NOT COMPLETED|Follow-up Study: Fetuses/Infants||27
197978|NCT00702234|486109|P1|NOT COMPLETED|Follow-up Study: Fetuses/Infants||0
197979|NCT00702234|486108|P2|COMPLETED|Follow-up Study: Fetuses/Infants|All 288 who completed were live born infants|288
197980|NCT00702234|486109|P1|COMPLETED|Follow-up Study: Fetuses/Infants||0
197981|NCT00702234|486108|P2|Live Born Infants|Follow-up Study: Fetuses/Infants|Of the 11 that were not live born infants, outcome is known for 8 (fetus was lost) and unknown for 3|304
197982|NCT00702234|486109|P1|Live Born Infants|Follow-up Study: Fetuses/Infants||0
197983|NCT00702234|486108|P2|STARTED|Follow-up Study: Fetuses/Infants|Fetuses present 10 weeks after fresh ET and/or at enrollment of expectant mother in follow-up study|315
197984|NCT00702234|486109|P1|STARTED|Follow-up Study: Fetuses/Infants||0
197985|NCT00702234|486108|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers||0
197986|NCT00702234|486109|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers||22
197987|NCT00702234|486108|P2|COMPLETED|Follow-up Study: Expectant Mothers||0
197988|NCT00702234|486109|P1|COMPLETED|Follow-up Study: Expectant Mothers||246
197989|NCT00702234|486108|P2|STARTED|Follow-up Study: Expectant Mothers||0
197990|NCT00702234|486109|P1|STARTED|Follow-up Study: Expectant Mothers|"A participant could enter follow-up study without meeting definition for Completion of base study"|268
197991|NCT00702234|486108|P2|NOT COMPLETED|Base Study (NCT00696878)||0
197992|NCT00702234|486109|P1|NOT COMPLETED|Base Study (NCT00696878)||504
197993|NCT00702234|486108|P2|COMPLETED|Base Study (NCT00696878)||0
197994|NCT00702234|486109|P1|COMPLETED|Base Study (NCT00696878)||178
197995|NCT00702234|486108|P2|STARTED|Base Study (NCT00696878)||0
197996|NCT00702234|486109|P1|STARTED|Base Study (NCT00696878)||682
197997|NCT00702273|486120|P2|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||29
197998|NCT00702273|486121|P1|NOT COMPLETED|Follow Up Study P05716 (NCT00702273)||20
197999|NCT00702273|486120|P2|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|147
198000|NCT00702273|486121|P1|COMPLETED|Follow Up Study P05716 (NCT00702273)|Participants with embryo transfer in any FTET cycle|148
198001|NCT00702273|486120|P2|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study, who had at least one embryo thawed for a FTET cycle|176
198002|NCT00702273|486121|P1|STARTED|Follow Up Study P05716 (NCT00702273)|Participants from base study,who had at least one embryo thawed for a FTET cycle.|168
198003|NCT00702273|486120|P2|NOT COMPLETED|Base Study P05787 (NCT00696800)||48
198004|NCT00702273|486121|P1|NOT COMPLETED|Base Study P05787 (NCT00696800)||85
198005|NCT00702273|486120|P2|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|704
198006|NCT00702273|486121|P1|COMPLETED|Base Study P05787 (NCT00696800)|To complete study, participants from the base study P05787 (NCT00696800) had embryos transferred|672
198007|NCT00702273|486120|P2|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|750
198008|NCT00702273|486121|P1|Treated|Base Study P05787 (NCT00696800)|Participants from the Intent to Treat group (ITT) from the base study P05787 (NCT00696800)|756
198009|NCT00702273|486120|P2|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|752
198010|NCT00702273|486121|P1|STARTED|Base Study P05787 (NCT00696800)|Participants randomized to the base study P05787 (NCT00696800)|757
198011|NCT00702299|486139|P1|NOT COMPLETED|Overall Study||0
198012|NCT00702299|486139|P1|COMPLETED|Overall Study||15
198013|NCT00702299|486139|P1|STARTED|Overall Study||15
198014|NCT00702325|486152|P2|NOT COMPLETED|Overall Study||53
198015|NCT00702325|486153|P1|NOT COMPLETED|Overall Study||38
198016|NCT00702325|486152|P2|COMPLETED|Overall Study|Completed participants based on randomized population (155) minus discontinued participants (53).|102
198017|NCT00702325|486153|P1|COMPLETED|Overall Study|Completed participants based on randomized population (156) minus discontinued participants (38).|118
198018|NCT00702325|486152|P2|STARTED|Overall Study|Randomized|155
198019|NCT00702325|486153|P1|STARTED|Overall Study|Randomized|156
198020|NCT00702338|486205|P3|NOT COMPLETED|Follow-up Study: Infant FU||2
198021|NCT00702338|486206|P2|NOT COMPLETED|Follow-up Study: Infant FU||0
198022|NCT00702338|486207|P1|NOT COMPLETED|Follow-up Study: Infant FU||0
198023|NCT00702338|486205|P3|COMPLETED|Follow-up Study: Infant FU||0
198024|NCT00702338|486206|P2|COMPLETED|Follow-up Study: Infant FU||0
198025|NCT00702338|486207|P1|COMPLETED|Follow-up Study: Infant FU||0
198099|NCT00702845|486281|P2|COMPLETED|Overall Study||121
198026|NCT00702338|486205|P3|STARTED|Follow-up Study: Infant FU|Participants died on day of delivery, did not complete follow-up visit at 4-12 weeks postpartum.|2
198027|NCT00702338|486206|P2|STARTED|Follow-up Study: Infant FU||0
198028|NCT00702338|486207|P1|STARTED|Follow-up Study: Infant FU||0
198029|NCT00702338|486205|P3|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
198030|NCT00702338|486206|P2|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||1
198031|NCT00702338|486207|P1|NOT COMPLETED|Follow-up Study: Expectant Mothers FU||0
198032|NCT00702338|486205|P3|COMPLETED|Follow-up Study: Expectant Mothers FU||0
198033|NCT00702338|486206|P2|COMPLETED|Follow-up Study: Expectant Mothers FU|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|0
198034|NCT00702338|486207|P1|COMPLETED|Follow-up Study: Expectant Mothers FU||0
198035|NCT00702338|486205|P3|STARTED|Follow-up Study: Expectant Mothers FU||0
198036|NCT00702338|486206|P2|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|1
198037|NCT00702338|486207|P1|STARTED|Follow-up Study: Expectant Mothers FU|To enroll in follow-up study, confirmed pregnancy at ≥10 wks after hCG bolus injection was required|0
198038|NCT00702338|486205|P3|NOT COMPLETED|Base Study (NCT00697255)||0
198039|NCT00702338|486206|P2|NOT COMPLETED|Base Study (NCT00697255)||2
198040|NCT00702338|486207|P1|NOT COMPLETED|Base Study (NCT00697255)||3
198041|NCT00702338|486205|P3|COMPLETED|Base Study (NCT00697255)||0
198042|NCT00702338|486206|P2|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|1
198043|NCT00702338|486207|P1|COMPLETED|Base Study (NCT00697255)|To complete the study, participants must have received hCG bolus injection.|2
198044|NCT00702338|486205|P3|STARTED|Base Study (NCT00697255)||0
198045|NCT00702338|486206|P2|STARTED|Base Study (NCT00697255)||3
198046|NCT00702338|486207|P1|STARTED|Base Study (NCT00697255)||5
198047|NCT00702364|486223|P2|NOT COMPLETED|Overall Study||4
198048|NCT00702364|486224|P1|NOT COMPLETED|Overall Study||2
198049|NCT00702364|486223|P2|COMPLETED|Overall Study||25
198050|NCT00702364|486224|P1|COMPLETED|Overall Study||24
198051|NCT00702364|486223|P2|STARTED|Overall Study||29
198052|NCT00702364|486224|P1|STARTED|Overall Study||26
198053|NCT00702377|486238|P2|NOT COMPLETED|Overall Study||3
198054|NCT00702377|486239|P1|NOT COMPLETED|Overall Study||1
198055|NCT00702377|486238|P2|COMPLETED|Overall Study||53
198056|NCT00702377|486239|P1|COMPLETED|Overall Study||52
198057|NCT00702377|486238|P2|STARTED|Overall Study||56
198058|NCT00702377|486239|P1|STARTED|Overall Study||53
198059|NCT00702403|486249|P1|NOT COMPLETED|From Engraftment to Study Completion||27
198060|NCT00702403|486249|P1|COMPLETED|From Engraftment to Study Completion||13
198061|NCT00702403|486249|P1|Patient Drop-outs|From Engraftment to Study Completion||27
198062|NCT00702403|486249|P1|STARTED|From Engraftment to Study Completion||40
198063|NCT00702403|486249|P1|NOT COMPLETED|From Consent to Engraftment||17
198064|NCT00702403|486249|P1|COMPLETED|From Consent to Engraftment|40 of 57 originally consented subjects remained eligible at engraftment (= the 2nd ITT population)|40
198065|NCT00702403|486249|P1|Ineligible for Study Drug|From Consent to Engraftment||17
198066|NCT00702403|486249|P1|STARTED|From Consent to Engraftment|"57 agreed to participate and completed informed consent (= the 1st intention to treat population)"|57
198067|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||24
198068|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 8 (App 84 Wks)||329
198069|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 8 (App 84 Wks)||353
198070|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||24
198071|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 7 (App 72 Wks)||353
198072|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 7 (App 72 Wks)||377
198073|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||19
198074|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 6 (App 60 Wks)||377
198075|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 6 (App 60 Wks)||396
198076|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||32
198077|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 5 (App 48 Wks)||396
198078|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 5 (App 48 Wks)||428
198079|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||22
198080|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 4 (App 36 Wks)||428
198081|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 4 (App 36 Wks)||450
198082|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||25
198083|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 3 (App 24 Wks)||450
198084|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 3 (App 24 Wks)||475
198085|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||20
198086|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 2 (App 12 Wks)||475
198087|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 2 (App 12 Wks)||495
198088|NCT00702754|486257|P1|NOT COMPLETED|MYOBLOC Treatment Session 1 (Time 0)||7
198089|NCT00702754|486257|P1|COMPLETED|MYOBLOC Treatment Session 1 (Time 0)|Approximately 70% of subjects completed at least 2 years of treatment.|495
198090|NCT00702754|486257|P1|STARTED|MYOBLOC Treatment Session 1 (Time 0)||502
198091|NCT00702780|486270|P2|NOT COMPLETED|Overall Study||8
198092|NCT00702780|486271|P1|NOT COMPLETED|Overall Study||9
198093|NCT00702780|486270|P2|COMPLETED|Overall Study||29
198094|NCT00702780|486271|P1|COMPLETED|Overall Study||28
198095|NCT00702780|486270|P2|STARTED|Overall Study||37
198096|NCT00702780|486271|P1|STARTED|Overall Study||37
198097|NCT00702845|486281|P2|NOT COMPLETED|Overall Study||8
198098|NCT00702845|486282|P1|NOT COMPLETED|Overall Study||22
198100|NCT00702845|486282|P1|COMPLETED|Overall Study||246
198101|NCT00702845|486281|P2|Randomized|Overall Study||128
198102|NCT00702845|486282|P1|Randomized|Overall Study||268
198103|NCT00702845|486281|P2|STARTED|Overall Study|Includes one treated participant who was not randomized|129
198104|NCT00702845|486282|P1|STARTED|Overall Study||268
198105|NCT00702884|486320|P1|NOT COMPLETED|Overall Study||0
198106|NCT00702884|486320|P1|COMPLETED|Overall Study||25
198107|NCT00702884|486320|P1|STARTED|Overall Study||25
198108|NCT00702923|486332|P1|NOT COMPLETED|Overall Study||1
198109|NCT00702923|486332|P1|COMPLETED|Overall Study||11
198110|NCT00702923|486332|P1|STARTED|Overall Study||12
198111|NCT00702949|486344|P3|NOT COMPLETED|Overall Study||8
198112|NCT00702949|486345|P2|NOT COMPLETED|Overall Study||9
198113|NCT00702949|486346|P1|NOT COMPLETED|Overall Study||5
198114|NCT00702949|486344|P3|COMPLETED|Overall Study||54
198115|NCT00702949|486345|P2|COMPLETED|Overall Study||57
198116|NCT00702949|486346|P1|COMPLETED|Overall Study||58
198117|NCT00702949|486344|P3|Evaluable for Primary Endpoint|Overall Study||51
198118|NCT00702949|486345|P2|Evaluable for Primary Endpoint|Overall Study||56
198119|NCT00702949|486346|P1|Evaluable for Primary Endpoint|Overall Study||56
198120|NCT00702949|486344|P3|STARTED|Overall Study||62
198121|NCT00702949|486345|P2|STARTED|Overall Study||66
198122|NCT00702949|486346|P1|STARTED|Overall Study||63
198123|NCT00703014|486373|P4|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||42
198124|NCT00703014|486374|P3|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||47
198125|NCT00703014|486375|P2|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
198126|NCT00703014|486376|P1|NOT COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
198127|NCT00703014|486373|P4|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|284
198128|NCT00703014|486374|P3|COMPLETED|Fetuses/Infants Follow Up Trial P05712|Infants in P05712 with Follow Up Completed|305
198129|NCT00703014|486375|P2|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
198130|NCT00703014|486376|P1|COMPLETED|Fetuses/Infants Follow Up Trial P05712||0
198131|NCT00703014|486373|P4|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|315
198132|NCT00703014|486374|P3|Live Born Infants|Fetuses/Infants Follow Up Trial P05712|Live born infants in Follow Up Trail P05712|344
198133|NCT00703014|486375|P2|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
198134|NCT00703014|486376|P1|Live Born Infants|Fetuses/Infants Follow Up Trial P05712||0
198135|NCT00703014|486373|P4|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|326
198136|NCT00703014|486374|P3|STARTED|Fetuses/Infants Follow Up Trial P05712|Fetuses in Follow Up Trial P05712|352
198137|NCT00703014|486375|P2|STARTED|Fetuses/Infants Follow Up Trial P05712||0
198138|NCT00703014|486376|P1|STARTED|Fetuses/Infants Follow Up Trial P05712||0
198139|NCT00703014|486373|P4|NOT COMPLETED|Mothers Follow Up Trial P05712||0
198140|NCT00703014|486374|P3|NOT COMPLETED|Mothers Follow Up Trial P05712||0
198141|NCT00703014|486375|P2|NOT COMPLETED|Mothers Follow Up Trial P05712||32
198142|NCT00703014|486376|P1|NOT COMPLETED|Mothers Follow Up Trial P05712||33
198143|NCT00703014|486373|P4|COMPLETED|Mothers Follow Up Trial P05712||0
198144|NCT00703014|486374|P3|COMPLETED|Mothers Follow Up Trial P05712||0
198145|NCT00703014|486375|P2|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|235
198146|NCT00703014|486376|P1|COMPLETED|Mothers Follow Up Trial P05712|Completed Follow Up in Trial P05712|241
198147|NCT00703014|486373|P4|STARTED|Mothers Follow Up Trial P05712||0
198148|NCT00703014|486374|P3|STARTED|Mothers Follow Up Trial P05712||0
198149|NCT00703014|486375|P2|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|267
198150|NCT00703014|486376|P1|STARTED|Mothers Follow Up Trial P05712|Eligible participants who completed Base Trial P05787 and then enrolled in Follow Up Trial P05712|274
198151|NCT00703014|486373|P4|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
198152|NCT00703014|486374|P3|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
198153|NCT00703014|486375|P2|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||466
198154|NCT00703014|486376|P1|NOT COMPLETED|Mothers Base Trial P05787 (NCT00696800)||462
198155|NCT00703014|486373|P4|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
198156|NCT00703014|486374|P3|COMPLETED|Mothers Base Trial P05787 (NCT00696800)||0
198157|NCT00703014|486375|P2|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|286
198158|NCT00703014|486376|P1|COMPLETED|Mothers Base Trial P05787 (NCT00696800)|ITT group in P05712, ongoing pregnancy at 10 weeks after ET in Base Trial P05787 (NCT006968000)|295
198159|NCT00703014|486373|P4|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
198160|NCT00703014|486374|P3|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)||0
198161|NCT00703014|486375|P2|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|704
198162|NCT00703014|486376|P1|Embryo Transfer|Mothers Base Trial P05787 (NCT00696800)|Embryo transfer (ET) in Base Trial P05787 (NCT006968000)|672
198163|NCT00703014|486373|P4|Treated|Mothers Base Trial P05787 (NCT00696800)||0
198164|NCT00703014|486374|P3|Treated|Mothers Base Trial P05787 (NCT00696800)||0
198165|NCT00703014|486375|P2|Treated|Mothers Base Trial P05787 (NCT00696800)|ITT group in Base Trial P05787 (NCT006968000)|750
198166|NCT00703014|486376|P1|Treated|Mothers Base Trial P05787 (NCT00696800)|Intent-To-Treat (ITT) group in Base Trial P05787 (NCT00696800)|756
198167|NCT00703014|486373|P4|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
198168|NCT00703014|486374|P3|STARTED|Mothers Base Trial P05787 (NCT00696800)||0
198169|NCT00703014|486375|P2|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|752
198170|NCT00703014|486376|P1|STARTED|Mothers Base Trial P05787 (NCT00696800)|Randomized in Base Trial P05787 (NCT00696800)|757
198171|NCT00703053|486403|P9|NOT COMPLETED|Overall Study||1
198172|NCT00703053|486404|P8|NOT COMPLETED|Overall Study||6
198173|NCT00703053|486405|P7|NOT COMPLETED|Overall Study||7
198174|NCT00703053|486406|P6|NOT COMPLETED|Overall Study||6
198175|NCT00703053|486407|P5|NOT COMPLETED|Overall Study||1
198176|NCT00703053|486408|P4|NOT COMPLETED|Overall Study||3
198177|NCT00703053|486409|P3|NOT COMPLETED|Overall Study||3
198178|NCT00703053|486410|P2|NOT COMPLETED|Overall Study||2
198179|NCT00703053|486411|P1|NOT COMPLETED|Overall Study||1
198180|NCT00703053|486403|P9|COMPLETED|Overall Study||102
198181|NCT00703053|486404|P8|COMPLETED|Overall Study||91
198182|NCT00703053|486405|P7|COMPLETED|Overall Study||45
198183|NCT00703053|486406|P6|COMPLETED|Overall Study||43
198184|NCT00703053|486407|P5|COMPLETED|Overall Study||50
198185|NCT00703053|486408|P4|COMPLETED|Overall Study||46
198186|NCT00703053|486409|P3|COMPLETED|Overall Study||48
198187|NCT00703053|486410|P2|COMPLETED|Overall Study||24
198188|NCT00703053|486411|P1|COMPLETED|Overall Study||26
198189|NCT00703053|486403|P9|STARTED|Overall Study||103
198190|NCT00703053|486404|P8|STARTED|Overall Study||97
198191|NCT00703053|486405|P7|STARTED|Overall Study||52
198192|NCT00703053|486406|P6|STARTED|Overall Study||49
198193|NCT00703053|486407|P5|STARTED|Overall Study||51
198194|NCT00703053|486408|P4|STARTED|Overall Study||49
198195|NCT00703053|486409|P3|STARTED|Overall Study||51
198196|NCT00703053|486410|P2|STARTED|Overall Study||26
198197|NCT00703053|486411|P1|STARTED|Overall Study||27
198198|NCT00703092|486595|P1|NOT COMPLETED|Overall Study||2
198199|NCT00703092|486595|P1|COMPLETED|Overall Study||0
198200|NCT00703092|486595|P1|STARTED|Overall Study||2
198201|NCT00703118|486602|P3|NOT COMPLETED|Overall Study||22
198202|NCT00703118|486603|P2|NOT COMPLETED|Overall Study||16
198203|NCT00703118|486604|P1|NOT COMPLETED|Overall Study||21
198204|NCT00703118|486602|P3|COMPLETED|Overall Study||110
198205|NCT00703118|486603|P2|COMPLETED|Overall Study||248
198206|NCT00703118|486604|P1|COMPLETED|Overall Study||245
198207|NCT00703118|486602|P3|STARTED|Overall Study||132
198208|NCT00703118|486603|P2|STARTED|Overall Study||264
198209|NCT00703118|486604|P1|STARTED|Overall Study||266
198210|NCT00703157|486637|P2|NOT COMPLETED|Overall Study||2
198211|NCT00703157|486638|P1|NOT COMPLETED|Overall Study||4
198212|NCT00703157|486637|P2|COMPLETED|Overall Study||24
198213|NCT00703157|486638|P1|COMPLETED|Overall Study||22
198214|NCT00703157|486637|P2|24 Months FU|Overall Study||24
198215|NCT00703157|486638|P1|24 Months FU|Overall Study||22
198216|NCT00703157|486637|P2|6 Months FU|Overall Study||25
198217|NCT00703157|486638|P1|6 Months FU|Overall Study||25
198218|NCT00703157|486637|P2|STARTED|Overall Study||26
198219|NCT00703157|486638|P1|STARTED|Overall Study||26
198220|NCT00703261|486671|P2|NOT COMPLETED|Overall Study||6
198221|NCT00703261|486672|P1|NOT COMPLETED|Overall Study||6
198222|NCT00703261|486671|P2|COMPLETED|Overall Study||35
198223|NCT00703261|486672|P1|COMPLETED|Overall Study||36
198224|NCT00703261|486671|P2|STARTED|Overall Study||41
198225|NCT00703261|486672|P1|STARTED|Overall Study||42
198226|NCT00703326|486681|P2|NOT COMPLETED|Overall Study||225
198227|NCT00703326|486682|P1|NOT COMPLETED|Overall Study||447
198228|NCT00703326|486681|P2|COMPLETED|Overall Study||160
198229|NCT00703326|486682|P1|COMPLETED|Overall Study||312
198230|NCT00703326|486681|P2|Received at Least 1 Dose of Study Drug|Overall Study||382
198231|NCT00703326|486682|P1|Received at Least 1 Dose of Study Drug|Overall Study||752
198232|NCT00703326|486681|P2|STARTED|Overall Study||385
198233|NCT00703326|486682|P1|STARTED|Overall Study||759
198234|NCT00703339|486702|P1|NOT COMPLETED|Overall Study||0
198235|NCT00703339|486702|P1|COMPLETED|Overall Study||1
198236|NCT00703339|486702|P1|STARTED|Overall Study||1
198237|NCT00703391|486708|P2|NOT COMPLETED|Overall Study||0
198238|NCT00703391|486709|P1|NOT COMPLETED|Overall Study||0
198239|NCT00703391|486708|P2|COMPLETED|Overall Study||6
198240|NCT00703391|486709|P1|COMPLETED|Overall Study||12
198241|NCT00703391|486708|P2|STARTED|Overall Study||6
198242|NCT00703391|486709|P1|STARTED|Overall Study||12
198243|NCT00703508|486753|P1|NOT COMPLETED|Overall Study||0
198244|NCT00703508|486753|P1|COMPLETED|Overall Study||26
198245|NCT00703508|486753|P1|STARTED|Overall Study||26
198246|NCT00703534|486767|P2|NOT COMPLETED|Overall Study||25
198247|NCT00703534|486768|P1|NOT COMPLETED|Overall Study||30
198248|NCT00703534|486767|P2|COMPLETED|Overall Study||218
198249|NCT00703534|486768|P1|COMPLETED|Overall Study||205
198250|NCT00703534|486767|P2|STARTED|Overall Study||243
198251|NCT00703534|486768|P1|STARTED|Overall Study||235
198252|NCT00703677|486774|P1|NOT COMPLETED|Overall Study||3
198253|NCT00703677|486774|P1|COMPLETED|Overall Study||14
198254|NCT00703677|486774|P1|STARTED|Overall Study||17
198255|NCT00703729|486789|P2|NOT COMPLETED|Overall Study||3
198256|NCT00703729|486790|P1|NOT COMPLETED|Overall Study||0
198257|NCT00703729|486789|P2|COMPLETED|Overall Study||21
198258|NCT00703729|486790|P1|COMPLETED|Overall Study||25
198259|NCT00703729|486789|P2|STARTED|Overall Study||24
198260|NCT00703729|486790|P1|STARTED|Overall Study||25
198261|NCT00703781|486826|P2|NOT COMPLETED|Overall Study||2
198262|NCT00703781|486827|P1|NOT COMPLETED|Overall Study||2
198263|NCT00703781|486826|P2|COMPLETED|Overall Study||61
198264|NCT00703781|486827|P1|COMPLETED|Overall Study||61
198265|NCT00703781|486826|P2|STARTED|Overall Study||63
198266|NCT00703781|486827|P1|STARTED|Overall Study||63
198267|NCT00703846|486835|P1|NOT COMPLETED|Overall Study||137
198268|NCT00703846|486835|P1|COMPLETED|Overall Study||363
198269|NCT00703846|486835|P1|STARTED|Overall Study||500
198270|NCT00703885|486849|P1|NOT COMPLETED|Overall Study||0
198271|NCT00703885|486849|P1|COMPLETED|Overall Study||16
198272|NCT00703885|486849|P1|STARTED|Overall Study||16
198273|NCT00703911|486854|P1|NOT COMPLETED|Overall Study||10
198274|NCT00703911|486854|P1|COMPLETED|Overall Study||92
198275|NCT00703911|486854|P1|STARTED|Overall Study||102
198276|NCT00703924|486884|P2|NOT COMPLETED|Overall Study||1
198277|NCT00703924|486885|P1|NOT COMPLETED|Overall Study||1
198278|NCT00703924|486884|P2|COMPLETED|Overall Study||41
198279|NCT00703924|486885|P1|COMPLETED|Overall Study||49
198280|NCT00703924|486884|P2|STARTED|Overall Study||42
198281|NCT00703924|486885|P1|STARTED|Overall Study||50
198282|NCT00703937|486903|P2|NOT COMPLETED|Overall Study||93
198283|NCT00703937|486904|P1|NOT COMPLETED|Overall Study||65
198284|NCT00703937|486903|P2|COMPLETED|Overall Study||267
198285|NCT00703937|486904|P1|COMPLETED|Overall Study||278
198286|NCT00703937|486903|P2|STARTED|Overall Study||360
198287|NCT00703937|486904|P1|STARTED|Overall Study||343
198288|NCT00703963|486912|P2|NOT COMPLETED|Overall Study||14
198289|NCT00703963|486913|P1|NOT COMPLETED|Overall Study||7
198290|NCT00703963|486912|P2|COMPLETED|Overall Study||86
198291|NCT00703963|486913|P1|COMPLETED|Overall Study||93
198292|NCT00703963|486912|P2|STARTED|Overall Study||100
198293|NCT00703963|486913|P1|STARTED|Overall Study||100
198294|NCT00703976|486925|P2|NOT COMPLETED|Overall Study||0
198295|NCT00703976|486926|P1|NOT COMPLETED|Overall Study||0
198296|NCT00703976|486925|P2|COMPLETED|Overall Study||41
198297|NCT00703976|486926|P1|COMPLETED|Overall Study||37
198298|NCT00703976|486925|P2|STARTED|Overall Study||41
198299|NCT00703976|486926|P1|STARTED|Overall Study||37
198300|NCT00704028|486936|P2|NOT COMPLETED|Overall Study||21
198301|NCT00704028|486937|P1|NOT COMPLETED|Overall Study||12
198302|NCT00704028|486936|P2|COMPLETED|Overall Study||57
198303|NCT00704028|486937|P1|COMPLETED|Overall Study||70
198304|NCT00704028|486936|P2|STARTED|Overall Study|A subject randomized to iron dextran never received study drug and was d/c due to subject request.|78
198305|NCT00704028|486937|P1|STARTED|Overall Study||82
198306|NCT00704132|486945|P2|NOT COMPLETED|Overall Study||2
198307|NCT00704132|486946|P1|NOT COMPLETED|Overall Study||1
198308|NCT00704132|486945|P2|COMPLETED|Overall Study||22
198309|NCT00704132|486946|P1|COMPLETED|Overall Study||25
198310|NCT00704132|486945|P2|STARTED|Overall Study||24
198311|NCT00704132|486946|P1|STARTED|Overall Study||26
198312|NCT00704171|486954|P2|NOT COMPLETED|Overall Study||0
198313|NCT00704171|486955|P1|NOT COMPLETED|Overall Study||1
198314|NCT00704171|486954|P2|COMPLETED|Overall Study|All control subjects completed the study.|59
198315|NCT00704171|486955|P1|COMPLETED|Overall Study|One subject withdrew consent prior to study completion. No reason given.|61
198316|NCT00704171|486954|P2|STARTED|Overall Study||59
198317|NCT00704171|486955|P1|STARTED|Overall Study||62
198318|NCT00704184|486976|P5|NOT COMPLETED|Open-Label Treatment||3
198319|NCT00704184|486977|P4|NOT COMPLETED|Open-Label Treatment||5
198320|NCT00704184|486978|P3|NOT COMPLETED|Open-Label Treatment||4
198321|NCT00704184|486979|P2|NOT COMPLETED|Open-Label Treatment||2
198322|NCT00704184|486980|P1|NOT COMPLETED|Open-Label Treatment||1
198323|NCT00704184|486976|P5|COMPLETED|Open-Label Treatment||16
198324|NCT00704184|486977|P4|COMPLETED|Open-Label Treatment||13
198325|NCT00704184|486978|P3|COMPLETED|Open-Label Treatment||16
198326|NCT00704184|486979|P2|COMPLETED|Open-Label Treatment||16
198327|NCT00704184|486980|P1|COMPLETED|Open-Label Treatment||18
198328|NCT00704184|486976|P5|STARTED|Open-Label Treatment||19
198329|NCT00704184|486977|P4|STARTED|Open-Label Treatment||18
198330|NCT00704184|486978|P3|STARTED|Open-Label Treatment||20
198331|NCT00704184|486979|P2|STARTED|Open-Label Treatment||18
198332|NCT00704184|486980|P1|STARTED|Open-Label Treatment||19
198333|NCT00704184|486976|P5|NOT COMPLETED|Double-Blind Treatment||0
198334|NCT00704184|486977|P4|NOT COMPLETED|Double-Blind Treatment||0
198335|NCT00704184|486978|P3|NOT COMPLETED|Double-Blind Treatment||0
198336|NCT00704184|486979|P2|NOT COMPLETED|Double-Blind Treatment||0
198337|NCT00704184|486980|P1|NOT COMPLETED|Double-Blind Treatment||1
198338|NCT00704184|486976|P5|COMPLETED|Double-Blind Treatment||19
198339|NCT00704184|486977|P4|COMPLETED|Double-Blind Treatment||18
198340|NCT00704184|486978|P3|COMPLETED|Double-Blind Treatment||20
198341|NCT00704184|486979|P2|COMPLETED|Double-Blind Treatment||18
198342|NCT00704184|486980|P1|COMPLETED|Double-Blind Treatment||19
198343|NCT00704184|486976|P5|Treated|Double-Blind Treatment||19
198344|NCT00704184|486977|P4|Treated|Double-Blind Treatment||18
198345|NCT00704184|486978|P3|Treated|Double-Blind Treatment||20
198346|NCT00704184|486979|P2|Treated|Double-Blind Treatment||18
198347|NCT00704184|486980|P1|Treated|Double-Blind Treatment|One participant was randomized to placebo but withdrew prior to receiving study medication.|19
198348|NCT00704184|486976|P5|STARTED|Double-Blind Treatment||19
198349|NCT00704184|486977|P4|STARTED|Double-Blind Treatment||18
198350|NCT00704184|486978|P3|STARTED|Double-Blind Treatment||20
198351|NCT00704184|486979|P2|STARTED|Double-Blind Treatment||18
198352|NCT00704184|486980|P1|STARTED|Double-Blind Treatment||20
198353|NCT00704340|487019|P2|NOT COMPLETED|Overall Study||2
198354|NCT00704340|487020|P1|NOT COMPLETED|Overall Study||2
198355|NCT00704340|487019|P2|COMPLETED|Overall Study||115
198356|NCT00704340|487020|P1|COMPLETED|Overall Study||118
198357|NCT00704340|487019|P2|STARTED|Overall Study||117
198358|NCT00704340|487020|P1|STARTED|Overall Study||120
198359|NCT00704353|487032|P2|NOT COMPLETED|Overall Study||114
198360|NCT00704353|487033|P1|NOT COMPLETED|Overall Study||98
198361|NCT00704353|487032|P2|COMPLETED|Overall Study||255
198362|NCT00704353|487033|P1|COMPLETED|Overall Study||268
198363|NCT00704353|487032|P2|STARTED|Overall Study||369
198364|NCT00704353|487033|P1|STARTED|Overall Study||366
198365|NCT00704379|487041|P2|NOT COMPLETED|Overall Study||7
198366|NCT00704379|487042|P1|NOT COMPLETED|Overall Study||7
198367|NCT00704379|487041|P2|COMPLETED|Overall Study||41
198368|NCT00704379|487042|P1|COMPLETED|Overall Study||39
198369|NCT00704379|487041|P2|STARTED|Overall Study||48
198370|NCT00704379|487042|P1|STARTED|Overall Study||46
198371|NCT00704405|487063|P5|NOT COMPLETED|Overall Study (C Population)||0
198372|NCT00704405|487064|P4|NOT COMPLETED|Overall Study (C Population)||1
198373|NCT00704405|487065|P3|NOT COMPLETED|Overall Study (C Population)||1
198374|NCT00704405|487066|P2|NOT COMPLETED|Overall Study (C Population)||3
198375|NCT00704405|487067|P1|NOT COMPLETED|Overall Study (C Population)||1
198376|NCT00704405|487063|P5|COMPLETED|Overall Study (C Population)||14
198377|NCT00704405|487064|P4|COMPLETED|Overall Study (C Population)||14
198378|NCT00704405|487065|P3|COMPLETED|Overall Study (C Population)||14
198379|NCT00704405|487066|P2|COMPLETED|Overall Study (C Population)||11
198380|NCT00704405|487067|P1|COMPLETED|Overall Study (C Population)||15
198381|NCT00704405|487063|P5|STARTED|Overall Study (C Population)||14
198382|NCT00704405|487064|P4|STARTED|Overall Study (C Population)||15
198383|NCT00704405|487065|P3|STARTED|Overall Study (C Population)||15
198384|NCT00704405|487066|P2|STARTED|Overall Study (C Population)||14
198385|NCT00704405|487067|P1|STARTED|Overall Study (C Population)||16
198386|NCT00704405|487063|P5|NOT COMPLETED|Overall Study (NC Population)||5
198387|NCT00704405|487064|P4|NOT COMPLETED|Overall Study (NC Population)||4
198388|NCT00704405|487065|P3|NOT COMPLETED|Overall Study (NC Population)||3
198389|NCT00704405|487066|P2|NOT COMPLETED|Overall Study (NC Population)||4
198390|NCT00704405|487067|P1|NOT COMPLETED|Overall Study (NC Population)||5
198391|NCT00704405|487063|P5|COMPLETED|Overall Study (NC Population)||37
198392|NCT00704405|487064|P4|COMPLETED|Overall Study (NC Population)||38
198393|NCT00704405|487065|P3|COMPLETED|Overall Study (NC Population)||38
198394|NCT00704405|487066|P2|COMPLETED|Overall Study (NC Population)||40
198395|NCT00704405|487067|P1|COMPLETED|Overall Study (NC Population)||37
198396|NCT00704405|487063|P5|STARTED|Overall Study (NC Population)||42
198397|NCT00704405|487064|P4|STARTED|Overall Study (NC Population)||42
198398|NCT00704405|487065|P3|STARTED|Overall Study (NC Population)||41
198399|NCT00704405|487066|P2|STARTED|Overall Study (NC Population)||44
198400|NCT00704405|487067|P1|STARTED|Overall Study (NC Population)||42
198401|NCT00704418|487097|P2|NOT COMPLETED|Overall Study||6
198402|NCT00704418|487098|P1|NOT COMPLETED|Overall Study||5
198403|NCT00704418|487097|P2|COMPLETED|Overall Study||72
198404|NCT00704418|487098|P1|COMPLETED|Overall Study||73
198405|NCT00704418|487097|P2|STARTED|Overall Study||78
198406|NCT00704418|487098|P1|STARTED|Overall Study||78
198407|NCT00704522|487108|P2|NOT COMPLETED|Overall Study||45
198408|NCT00704522|487109|P1|NOT COMPLETED|Overall Study||183
198409|NCT00704522|487108|P2|COMPLETED|Overall Study||75
198410|NCT00704522|487109|P1|COMPLETED|Overall Study||298
198411|NCT00704522|487108|P2|STARTED|Overall Study||120
198412|NCT00704522|487109|P1|STARTED|Overall Study||481
198413|NCT00704535|487116|P1|NOT COMPLETED|Overall Study||146
198414|NCT00704535|487116|P1|COMPLETED|Overall Study||3959
198415|NCT00704535|487116|P1|STARTED|Overall Study||4105
198416|NCT00704717|487127|P1|NOT COMPLETED|Overall Study||0
198417|NCT00704717|487127|P1|COMPLETED|Overall Study||185
198418|NCT00704717|487127|P1|STARTED|Overall Study||185
198419|NCT00704730|487133|P2|NOT COMPLETED|Overall Study||96
198420|NCT00704730|487134|P1|NOT COMPLETED|Overall Study||121
198421|NCT00704730|487133|P2|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|15
198422|NCT00704730|487134|P1|COMPLETED|Overall Study|Continuing study treatment at the time of data cut-off.|98
198423|NCT00704730|487133|P2|STARTED|Overall Study|Randomized|111
198424|NCT00704730|487134|P1|STARTED|Overall Study|Randomized|219
198425|NCT00704769|487150|P1|NOT COMPLETED|Overall Study||0
198426|NCT00704769|487150|P1|COMPLETED|Overall Study||591
198427|NCT00704769|487150|P1|STARTED|Overall Study||591
198428|NCT00704808|487155|P1|NOT COMPLETED|Overall Study||131
198429|NCT00704808|487155|P1|COMPLETED|Overall Study||49
198430|NCT00704808|487155|P1|STARTED|Overall Study||180
198431|NCT00704847|487161|P2|NOT COMPLETED|Overall Study||170
198432|NCT00704847|487162|P1|NOT COMPLETED|Overall Study||221
198433|NCT00704847|487161|P2|COMPLETED|Overall Study||339
198434|NCT00704847|487162|P1|COMPLETED|Overall Study||300
198435|NCT00704847|487161|P2|STARTED|Overall Study||509
198436|NCT00704847|487162|P1|STARTED|Overall Study||521
198437|NCT00704912|487173|P3|NOT COMPLETED|Overall Study||7
198438|NCT00704912|487174|P2|NOT COMPLETED|Overall Study||4
198439|NCT00704912|487175|P1|NOT COMPLETED|Overall Study||6
198440|NCT00704912|487173|P3|COMPLETED|Overall Study||43
198441|NCT00704912|487174|P2|COMPLETED|Overall Study||45
198442|NCT00704912|487175|P1|COMPLETED|Overall Study||44
198443|NCT00704912|487173|P3|STARTED|Overall Study||50
198444|NCT00704912|487174|P2|STARTED|Overall Study||49
198445|NCT00704912|487175|P1|STARTED|Overall Study||50
198446|NCT00704938|487194|P2|NOT COMPLETED|Overall Study||0
198447|NCT00704938|487195|P1|NOT COMPLETED|Overall Study||0
198448|NCT00704938|487194|P2|COMPLETED|Overall Study||1
198449|NCT00704938|487195|P1|COMPLETED|Overall Study||2
198450|NCT00704938|487194|P2|STARTED|Overall Study||1
198451|NCT00704938|487195|P1|STARTED|Overall Study||2
198452|NCT00704964|487203|P1|NOT COMPLETED|Overall Study||328
198453|NCT00704964|487203|P1|COMPLETED|Overall Study|Number of participants who completed therapy as scheduled.|418
198454|NCT00704964|487203|P1|STARTED|Overall Study|Number of participants who took at least one dose of study medication.|746
198455|NCT00705003|487211|P3|NOT COMPLETED|Treated||3
198456|NCT00705003|487212|P2|NOT COMPLETED|Treated||6
198457|NCT00705003|487213|P1|NOT COMPLETED|Treated||13
198458|NCT00705003|487211|P3|COMPLETED|Treated||30
198459|NCT00705003|487212|P2|COMPLETED|Treated||28
198460|NCT00705003|487213|P1|COMPLETED|Treated||54
198461|NCT00705003|487211|P3|STARTED|Treated||33
198462|NCT00705003|487212|P2|STARTED|Treated||34
198463|NCT00705003|487213|P1|STARTED|Treated||67
198464|NCT00705003|487211|P3|NOT COMPLETED|Enrolled||1
198465|NCT00705003|487212|P2|NOT COMPLETED|Enrolled||3
198466|NCT00705003|487213|P1|NOT COMPLETED|Enrolled||4
198467|NCT00705003|487211|P3|COMPLETED|Enrolled||33
198468|NCT00705003|487212|P2|COMPLETED|Enrolled||34
198469|NCT00705003|487213|P1|COMPLETED|Enrolled||67
198470|NCT00705003|487211|P3|STARTED|Enrolled||34
198471|NCT00705003|487212|P2|STARTED|Enrolled||37
198472|NCT00705003|487213|P1|STARTED|Enrolled||71
198473|NCT00705016|487236|P3|NOT COMPLETED|Overall Study||58
198474|NCT00705016|487237|P2|NOT COMPLETED|Overall Study||58
198475|NCT00705016|487238|P1|NOT COMPLETED|Overall Study||60
198476|NCT00705016|487236|P3|COMPLETED|Overall Study||4
198477|NCT00705016|487237|P2|COMPLETED|Overall Study||2
198478|NCT00705016|487238|P1|COMPLETED|Overall Study||2
198479|NCT00705016|487236|P3|STARTED|Overall Study||62
198480|NCT00705016|487237|P2|STARTED|Overall Study||60
198481|NCT00705016|487238|P1|STARTED|Overall Study||62
198482|NCT00705081|487266|P2|NOT COMPLETED|Overall Study||0
198483|NCT00705081|487267|P1|NOT COMPLETED|Overall Study||0
198484|NCT00705081|487266|P2|COMPLETED|Overall Study||198
198485|NCT00705081|487267|P1|COMPLETED|Overall Study||255
198486|NCT00705081|487266|P2|STARTED|Overall Study||198
198487|NCT00705081|487267|P1|STARTED|Overall Study||255
198488|NCT00705107|487277|P1|NOT COMPLETED|Overall Study||49
198489|NCT00705107|487277|P1|COMPLETED|Overall Study||218
198490|NCT00705107|487277|P1|STARTED|Overall Study||267
198491|NCT00705146|487284|P2|NOT COMPLETED|Overall Study||1
198492|NCT00705146|487285|P1|NOT COMPLETED|Overall Study||1
198493|NCT00705146|487284|P2|COMPLETED|Overall Study||23
198494|NCT00705146|487285|P1|COMPLETED|Overall Study||31
198495|NCT00705146|487284|P2|STARTED|Overall Study||24
198496|NCT00705146|487285|P1|STARTED|Overall Study||32
198497|NCT00705159|487297|P4|NOT COMPLETED|Overall Study||4
198498|NCT00705159|487298|P3|NOT COMPLETED|Overall Study||5
198499|NCT00705159|487299|P2|NOT COMPLETED|Overall Study||2
198500|NCT00705159|487300|P1|NOT COMPLETED|Overall Study||0
198501|NCT00705159|487297|P4|COMPLETED|Overall Study||30
198502|NCT00705159|487298|P3|COMPLETED|Overall Study||29
198503|NCT00705159|487299|P2|COMPLETED|Overall Study||33
198504|NCT00705159|487300|P1|COMPLETED|Overall Study||34
198505|NCT00705159|487297|P4|STARTED|Overall Study||34
198506|NCT00705159|487298|P3|STARTED|Overall Study||34
198507|NCT00705159|487299|P2|STARTED|Overall Study||35
198508|NCT00705159|487300|P1|STARTED|Overall Study||34
198509|NCT00705224|487318|P1|NOT COMPLETED|Overall Study||11
198510|NCT00705224|487318|P1|COMPLETED|Overall Study||239
198511|NCT00705224|487318|P1|STARTED|Overall Study||250
198512|NCT00692406|487330|P1|NOT COMPLETED|Overall Study||57
198513|NCT00692406|487330|P1|COMPLETED|Overall Study|This group quit smoking before their second scan.|23
198514|NCT00692406|487330|P1|STARTED|Overall Study|Initially this group was assigned to quit smoking before the second scan.|80
198515|NCT00692419|487343|P2|NOT COMPLETED|Overall Study||18
198516|NCT00692419|487344|P1|NOT COMPLETED|Overall Study||16
198517|NCT00692419|487343|P2|COMPLETED|Overall Study||102
198518|NCT00692419|487344|P1|COMPLETED|Overall Study||84
198519|NCT00692419|487343|P2|STARTED|Overall Study||120
198520|NCT00692419|487344|P1|STARTED|Overall Study||100
198521|NCT00692692|487354|P2|NOT COMPLETED|Overall Study||0
198522|NCT00692692|487355|P1|NOT COMPLETED|Overall Study||0
198523|NCT00692692|487354|P2|COMPLETED|Overall Study||16
198524|NCT00692692|487355|P1|COMPLETED|Overall Study||20
198525|NCT00692692|487354|P2|STARTED|Overall Study||16
198526|NCT00692692|487355|P1|STARTED|Overall Study||20
198527|NCT00692770|487363|P2|NOT COMPLETED|Overall Study||558
198528|NCT00692770|487364|P1|NOT COMPLETED|Overall Study||556
198529|NCT00692770|487363|P2|COMPLETED|Overall Study||0
198530|NCT00692770|487364|P1|COMPLETED|Overall Study||0
198531|NCT00692770|487363|P2|Participants Received Treatment|Overall Study||554
198532|NCT00692770|487364|P1|Participants Received Treatment|Overall Study||553
198533|NCT00692770|487363|P2|STARTED|Overall Study||558
198534|NCT00692770|487364|P1|STARTED|Overall Study||556
198535|NCT00692913|487384|P2|NOT COMPLETED|Overall Study||30
198536|NCT00692913|487385|P1|NOT COMPLETED|Overall Study||29
198537|NCT00692913|487384|P2|COMPLETED|Overall Study||228
198538|NCT00692913|487385|P1|COMPLETED|Overall Study||228
198539|NCT00692913|487384|P2|STARTED|Overall Study||258
198540|NCT00692913|487385|P1|STARTED|Overall Study||257
198541|NCT00693017|487407|P2|NOT COMPLETED|Overall Study||2
198542|NCT00693017|487408|P1|NOT COMPLETED|Overall Study||2
198543|NCT00693017|487407|P2|COMPLETED|Overall Study||0
198544|NCT00693017|487408|P1|COMPLETED|Overall Study||0
198545|NCT00693017|487407|P2|STARTED|Overall Study||2
198546|NCT00693017|487408|P1|STARTED|Overall Study||2
198547|NCT00693160|487418|P2|NOT COMPLETED|Overall Study||0
198548|NCT00693160|487419|P1|NOT COMPLETED|Overall Study||0
198549|NCT00693160|487418|P2|COMPLETED|Overall Study||16
198550|NCT00693160|487419|P1|COMPLETED|Overall Study||14
198551|NCT00693160|487418|P2|STARTED|Overall Study||16
198552|NCT00693160|487419|P1|STARTED|Overall Study||14
198553|NCT00693225|487429|P2|NOT COMPLETED|Overall Study||5
198554|NCT00693225|487430|P1|NOT COMPLETED|Overall Study||2
198555|NCT00693225|487429|P2|COMPLETED|Overall Study||43
198556|NCT00693225|487430|P1|COMPLETED|Overall Study||41
198557|NCT00693225|487429|P2|STARTED|Overall Study||48
198558|NCT00693225|487430|P1|STARTED|Overall Study||43
198559|NCT00693238|487442|P2|NOT COMPLETED|Overall Study||0
198560|NCT00693238|487443|P1|NOT COMPLETED|Overall Study||0
198561|NCT00693238|487442|P2|COMPLETED|Overall Study||106
198562|NCT00693238|487443|P1|COMPLETED|Overall Study||122
198563|NCT00693238|487442|P2|STARTED|Overall Study||106
198564|NCT00693238|487443|P1|STARTED|Overall Study||122
198565|NCT00693303|487449|P1|NOT COMPLETED|Overall Study||0
198566|NCT00693303|487449|P1|COMPLETED|Overall Study||21
198567|NCT00693303|487449|P1|STARTED|Overall Study||21
198568|NCT00693420|487455|P2|NOT COMPLETED|Overall Study||15
198569|NCT00693420|487456|P1|NOT COMPLETED|Overall Study||6
198570|NCT00693420|487455|P2|COMPLETED|Overall Study||126
198571|NCT00693420|487456|P1|COMPLETED|Overall Study||131
198572|NCT00693420|487455|P2|STARTED|Overall Study||141
198573|NCT00693420|487456|P1|STARTED|Overall Study||137
198574|NCT00693472|487484|P4|NOT COMPLETED|Part 2||2
198575|NCT00693472|487485|P3|NOT COMPLETED|Part 2||2
198576|NCT00693472|487486|P2|NOT COMPLETED|Part 2||0
198577|NCT00693472|487487|P1|NOT COMPLETED|Part 2||0
198578|NCT00693472|487484|P4|COMPLETED|Part 2||4
198579|NCT00693472|487485|P3|COMPLETED|Part 2||6
198580|NCT00693472|487486|P2|COMPLETED|Part 2||0
198581|NCT00693472|487487|P1|COMPLETED|Part 2||0
198582|NCT00693472|487484|P4|STARTED|Part 2||6
198583|NCT00693472|487485|P3|STARTED|Part 2||8
198584|NCT00693472|487486|P2|STARTED|Part 2||0
198585|NCT00693472|487487|P1|STARTED|Part 2||0
198586|NCT00693472|487484|P4|NOT COMPLETED|Part 1||0
198587|NCT00693472|487485|P3|NOT COMPLETED|Part 1||0
198588|NCT00693472|487486|P2|NOT COMPLETED|Part 1||4
198589|NCT00693472|487487|P1|NOT COMPLETED|Part 1||6
198590|NCT00693472|487484|P4|COMPLETED|Part 1||0
198591|NCT00693472|487485|P3|COMPLETED|Part 1||0
198592|NCT00693472|487486|P2|COMPLETED|Part 1||9
198593|NCT00693472|487487|P1|COMPLETED|Part 1||13
198594|NCT00693472|487484|P4|STARTED|Part 1||0
198595|NCT00693472|487485|P3|STARTED|Part 1||0
198596|NCT00693472|487486|P2|STARTED|Part 1||13
198597|NCT00693472|487487|P1|STARTED|Part 1||19
198598|NCT00693485|487508|P3|NOT COMPLETED|Overall Study||0
198599|NCT00693485|487509|P2|NOT COMPLETED|Overall Study||2
198600|NCT00693485|487510|P1|NOT COMPLETED|Overall Study||0
198601|NCT00693485|487508|P3|COMPLETED|Overall Study||24
198602|NCT00693485|487509|P2|COMPLETED|Overall Study||19
198603|NCT00693485|487510|P1|COMPLETED|Overall Study||25
198604|NCT00693485|487508|P3|STARTED|Overall Study||24
198605|NCT00693485|487509|P2|STARTED|Overall Study||21
198606|NCT00693485|487510|P1|STARTED|Overall Study||25
198607|NCT00693498|487523|P2|NOT COMPLETED|Overall Study||0
198608|NCT00693498|487524|P1|NOT COMPLETED|Overall Study||0
198609|NCT00693498|487523|P2|COMPLETED|Overall Study||81
198610|NCT00693498|487524|P1|COMPLETED|Overall Study||81
198611|NCT00693498|487523|P2|STARTED|Overall Study||81
198612|NCT00693498|487524|P1|STARTED|Overall Study||81
198613|NCT00693628|487532|P2|NOT COMPLETED|Overall Study||0
198614|NCT00693628|487533|P1|NOT COMPLETED|Overall Study||0
198615|NCT00693628|487532|P2|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment.|0
198616|NCT00693628|487533|P1|COMPLETED|Overall Study|Only 4 patients enrolled in study. No data indicating their group assignment|0
198617|NCT00693628|487532|P2|STARTED|Overall Study|No data is available indicating to which group patients were assigned .|0
198618|NCT00693628|487533|P1|STARTED|Overall Study|No data is available indicating to which group patients were assigned.|0
198619|NCT00693654|487541|P2|NOT COMPLETED|Overall Study||0
198620|NCT00693654|487542|P1|NOT COMPLETED|Overall Study||0
198621|NCT00693654|487541|P2|COMPLETED|Overall Study||14
198622|NCT00693654|487542|P1|COMPLETED|Overall Study||14
198623|NCT00693654|487541|P2|STARTED|Overall Study||14
198624|NCT00693654|487542|P1|STARTED|Overall Study||14
198625|NCT00693693|487553|P3|NOT COMPLETED|Overall Study||2
198626|NCT00693693|487554|P2|NOT COMPLETED|Overall Study||1
198627|NCT00693693|487555|P1|NOT COMPLETED|Overall Study||1
198628|NCT00693693|487553|P3|COMPLETED|Overall Study||7
198629|NCT00693693|487554|P2|COMPLETED|Overall Study||8
198630|NCT00693693|487555|P1|COMPLETED|Overall Study||6
198631|NCT00693693|487553|P3|STARTED|Overall Study||9
198632|NCT00693693|487554|P2|STARTED|Overall Study||9
198633|NCT00693693|487555|P1|STARTED|Overall Study||7
198634|NCT00693706|487565|P2|NOT COMPLETED|Overall Study||1
198635|NCT00693706|487566|P1|NOT COMPLETED|Overall Study||0
198636|NCT00693706|487565|P2|COMPLETED|Overall Study||98
198637|NCT00693706|487566|P1|COMPLETED|Overall Study||101
198638|NCT00693706|487565|P2|STARTED|Overall Study||99
198639|NCT00693706|487566|P1|STARTED|Overall Study||101
198640|NCT00693719|487590|P1|NOT COMPLETED|Overall Study||0
198641|NCT00693719|487590|P1|COMPLETED|Overall Study||31
198642|NCT00693719|487590|P1|STARTED|Overall Study||31
198643|NCT00693784|487595|P1|NOT COMPLETED|Overall Study||4
198644|NCT00693784|487595|P1|COMPLETED|Overall Study||11
198645|NCT00693784|487595|P1|104-week Extended Follow-up|Overall Study||11
198646|NCT00693784|487595|P1|52-week Extended Follow-up|Overall Study||13
198647|NCT00693784|487595|P1|26-Week Primary Endpoint|Overall Study||15
198648|NCT00693784|487595|P1|STARTED|Overall Study||15
198649|NCT00693992|487603|P2|NOT COMPLETED|Overall Study||0
198650|NCT00693992|487604|P1|NOT COMPLETED|Overall Study||0
198651|NCT00693992|487603|P2|COMPLETED|Overall Study||104
198652|NCT00693992|487604|P1|COMPLETED|Overall Study||106
198653|NCT00693992|487603|P2|STARTED|Overall Study||104
198654|NCT00693992|487604|P1|STARTED|Overall Study||106
198655|NCT00699491|487626|P6|NOT COMPLETED|Overall Study||0
198656|NCT00699491|487627|P5|NOT COMPLETED|Overall Study||0
198657|NCT00699491|487628|P4|NOT COMPLETED|Overall Study||0
198658|NCT00699491|487629|P3|NOT COMPLETED|Overall Study||0
198659|NCT00699491|487630|P2|NOT COMPLETED|Overall Study||0
198660|NCT00699491|487631|P1|NOT COMPLETED|Overall Study||0
198661|NCT00699491|487626|P6|COMPLETED|Overall Study||22
198662|NCT00699491|487627|P5|COMPLETED|Overall Study||8
198663|NCT00699491|487628|P4|COMPLETED|Overall Study||6
198664|NCT00699491|487629|P3|COMPLETED|Overall Study||7
198665|NCT00699491|487630|P2|COMPLETED|Overall Study||2
198666|NCT00699491|487631|P1|COMPLETED|Overall Study||3
198667|NCT00699491|487626|P6|STARTED|Overall Study||22
198668|NCT00699491|487627|P5|STARTED|Overall Study||8
198669|NCT00699491|487628|P4|STARTED|Overall Study||6
198670|NCT00699491|487629|P3|STARTED|Overall Study||7
198671|NCT00699491|487630|P2|STARTED|Overall Study||2
198672|NCT00699491|487631|P1|STARTED|Overall Study||3
198673|NCT00699582|487653|P3|NOT COMPLETED|Overall Study||28
198674|NCT00699582|487654|P2|NOT COMPLETED|Overall Study||22
198675|NCT00699582|487655|P1|NOT COMPLETED|Overall Study||18
198676|NCT00699582|487653|P3|COMPLETED|Overall Study||93
198677|NCT00699582|487654|P2|COMPLETED|Overall Study||108
198678|NCT00699582|487655|P1|COMPLETED|Overall Study||120
198679|NCT00699582|487653|P3|STARTED|Overall Study||121
198680|NCT00699582|487654|P2|STARTED|Overall Study||130
198681|NCT00699582|487655|P1|STARTED|Overall Study||138
198682|NCT00705250|487669|P1|NOT COMPLETED|Overall Study||2
198683|NCT00705250|487669|P1|COMPLETED|Overall Study||34
198684|NCT00705250|487669|P1|STARTED|Overall Study||36
198685|NCT00705263|487673|P1|NOT COMPLETED|Overall Study||2
198686|NCT00705263|487673|P1|COMPLETED|Overall Study||108
198687|NCT00705263|487673|P1|STARTED|Overall Study|113 patients started the treatment; however, data were available for only 110 patients.|110
198688|NCT00705289|487677|P1|NOT COMPLETED|Overall Study||131
198689|NCT00705289|487677|P1|COMPLETED|Overall Study||597
198690|NCT00705289|487677|P1|STARTED|Overall Study||728
198691|NCT00705341|487703|P4|NOT COMPLETED|Phase 2: Trial||4
198692|NCT00705341|487704|P3|NOT COMPLETED|Phase 2: Trial||7
198693|NCT00705341|487705|P2|NOT COMPLETED|Phase 2: Trial||0
198694|NCT00705341|487706|P1|NOT COMPLETED|Phase 2: Trial||0
198695|NCT00705341|487703|P4|COMPLETED|Phase 2: Trial||28
198696|NCT00705341|487704|P3|COMPLETED|Phase 2: Trial||23
198697|NCT00705341|487705|P2|COMPLETED|Phase 2: Trial||0
198698|NCT00705341|487706|P1|COMPLETED|Phase 2: Trial||0
198699|NCT00705341|487703|P4|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|32
198700|NCT00705341|487704|P3|STARTED|Phase 2: Trial|This group was randomized from asthmatic controls in phase 1 if they met criteria to be in phase 2|30
198701|NCT00705341|487705|P2|STARTED|Phase 2: Trial||0
198702|NCT00705341|487706|P1|STARTED|Phase 2: Trial||0
198703|NCT00705341|487703|P4|NOT COMPLETED|Phase 1:Control Challenge||0
198704|NCT00705341|487704|P3|NOT COMPLETED|Phase 1:Control Challenge||0
198705|NCT00705341|487705|P2|NOT COMPLETED|Phase 1:Control Challenge||0
198706|NCT00705341|487706|P1|NOT COMPLETED|Phase 1:Control Challenge||0
198707|NCT00705341|487703|P4|COMPLETED|Phase 1:Control Challenge||0
198708|NCT00705341|487704|P3|COMPLETED|Phase 1:Control Challenge||0
198709|NCT00705341|487705|P2|COMPLETED|Phase 1:Control Challenge|Nonasthmatic controls did not advance to phase 2 due to design of study|93
198710|NCT00705341|487706|P1|COMPLETED|Phase 1:Control Challenge|If participants in this group met criteria, they were randomized into phase 2|126
198711|NCT00705341|487703|P4|STARTED|Phase 1:Control Challenge||0
198712|NCT00705341|487704|P3|STARTED|Phase 1:Control Challenge||0
198713|NCT00705341|487705|P2|STARTED|Phase 1:Control Challenge||93
198714|NCT00705341|487706|P1|STARTED|Phase 1:Control Challenge||126
198715|NCT00705367|487716|P2|NOT COMPLETED|Long-term Extension Period||0
198716|NCT00705367|487717|P1|NOT COMPLETED|Long-term Extension Period||9
198717|NCT00705367|487716|P2|COMPLETED|Long-term Extension Period||0
198718|NCT00705367|487717|P1|COMPLETED|Long-term Extension Period||0
198719|NCT00705367|487716|P2|STARTED|Long-term Extension Period||0
198720|NCT00705367|487717|P1|STARTED|Long-term Extension Period||9
198721|NCT00705367|487716|P2|NOT COMPLETED|Short-term Period||0
198722|NCT00705367|487717|P1|NOT COMPLETED|Short-term Period||0
198723|NCT00705367|487716|P2|COMPLETED|Short-term Period||3
198724|NCT00705367|487717|P1|COMPLETED|Short-term Period||6
198725|NCT00705367|487716|P2|STARTED|Short-term Period||3
198726|NCT00705367|487717|P1|STARTED|Short-term Period||6
198727|NCT00705406|487744|P2|NOT COMPLETED|Overall Study||5
198728|NCT00705406|487745|P1|NOT COMPLETED|Overall Study||4
198729|NCT00705406|487744|P2|COMPLETED|Overall Study||197
198730|NCT00705406|487745|P1|COMPLETED|Overall Study||199
198731|NCT00705406|487744|P2|STARTED|Overall Study||202
198732|NCT00705406|487745|P1|STARTED|Overall Study||203
198733|NCT00705432|487773|P6|NOT COMPLETED|Follow-up Period (Upto Week 72)||7
198734|NCT00705432|487774|P5|NOT COMPLETED|Follow-up Period (Upto Week 72)||6
198735|NCT00705432|487775|P4|NOT COMPLETED|Follow-up Period (Upto Week 72)||14
198736|NCT00705432|487776|P3|NOT COMPLETED|Follow-up Period (Upto Week 72)||25
198737|NCT00705432|487777|P2|NOT COMPLETED|Follow-up Period (Upto Week 72)||43
198738|NCT00705432|487778|P1|NOT COMPLETED|Follow-up Period (Upto Week 72)||71
198739|NCT00705432|487773|P6|COMPLETED|Follow-up Period (Upto Week 72)||46
198740|NCT00705432|487774|P5|COMPLETED|Follow-up Period (Upto Week 72)||38
198741|NCT00705432|487775|P4|COMPLETED|Follow-up Period (Upto Week 72)||28
198742|NCT00705432|487776|P3|COMPLETED|Follow-up Period (Upto Week 72)||266
198743|NCT00705432|487777|P2|COMPLETED|Follow-up Period (Upto Week 72)||252
198744|NCT00705432|487778|P1|COMPLETED|Follow-up Period (Upto Week 72)||207
198745|NCT00705432|487773|P6|STARTED|Follow-up Period (Upto Week 72)||53
198746|NCT00705432|487774|P5|STARTED|Follow-up Period (Upto Week 72)||44
198747|NCT00705432|487775|P4|STARTED|Follow-up Period (Upto Week 72)||42
198748|NCT00705432|487776|P3|STARTED|Follow-up Period (Upto Week 72)||291
198749|NCT00705432|487777|P2|STARTED|Follow-up Period (Upto Week 72)||295
198750|NCT00705432|487778|P1|STARTED|Follow-up Period (Upto Week 72)||278
198751|NCT00705432|487773|P6|NOT COMPLETED|Treatment Period||30
198752|NCT00705432|487774|P5|NOT COMPLETED|Treatment Period||28
198753|NCT00705432|487775|P4|NOT COMPLETED|Treatment Period||41
198754|NCT00705432|487776|P3|NOT COMPLETED|Treatment Period||121
198755|NCT00705432|487777|P2|NOT COMPLETED|Treatment Period||111
198756|NCT00705432|487778|P1|NOT COMPLETED|Treatment Period||163
198757|NCT00705432|487773|P6|COMPLETED|Treatment Period||25
198758|NCT00705432|487774|P5|COMPLETED|Treatment Period||24
198759|NCT00705432|487775|P4|COMPLETED|Treatment Period||11
198760|NCT00705432|487776|P3|COMPLETED|Treatment Period||190
198761|NCT00705432|487777|P2|COMPLETED|Treatment Period||205
198762|NCT00705432|487778|P1|COMPLETED|Treatment Period||148
198763|NCT00705432|487773|P6|STARTED BOCEPREVIR/PLACEBO|Treatment Period||55
198764|NCT00705432|487774|P5|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
198765|NCT00705432|487775|P4|STARTED BOCEPREVIR/PLACEBO|Treatment Period||47
198766|NCT00705432|487776|P3|STARTED BOCEPREVIR/PLACEBO|Treatment Period||299
198767|NCT00705432|487777|P2|STARTED BOCEPREVIR/PLACEBO|Treatment Period||303
198768|NCT00705432|487778|P1|STARTED BOCEPREVIR/PLACEBO|Treatment Period||297
198769|NCT00705432|487773|P6|STARTED|Treatment Period||55
198770|NCT00705432|487774|P5|STARTED|Treatment Period||52
198771|NCT00705432|487775|P4|STARTED|Treatment Period||52
198772|NCT00705432|487776|P3|STARTED|Treatment Period||311
198773|NCT00705432|487777|P2|STARTED|Treatment Period||316
198774|NCT00705432|487778|P1|STARTED|Treatment Period||311
198775|NCT00705523|487815|P2|NOT COMPLETED|Overall Study||3
198776|NCT00705523|487816|P1|NOT COMPLETED|Overall Study||2
198777|NCT00705523|487815|P2|COMPLETED|Overall Study||18
198778|NCT00705523|487816|P1|COMPLETED|Overall Study||17
198779|NCT00705523|487815|P2|STARTED|Overall Study||21
198780|NCT00705523|487816|P1|STARTED|Overall Study||19
198781|NCT00705536|487826|P4|NOT COMPLETED|Completed Study||0
198782|NCT00705536|487827|P3|NOT COMPLETED|Completed Study||0
198783|NCT00705536|487828|P2|NOT COMPLETED|Completed Study||0
198784|NCT00705536|487829|P1|NOT COMPLETED|Completed Study||0
198785|NCT00705536|487826|P4|COMPLETED|Completed Study||6
198786|NCT00705536|487827|P3|COMPLETED|Completed Study||7
198787|NCT00705536|487828|P2|COMPLETED|Completed Study||6
198788|NCT00705536|487829|P1|COMPLETED|Completed Study||6
198789|NCT00705536|487826|P4|STARTED|Completed Study||6
198790|NCT00705536|487827|P3|STARTED|Completed Study||7
198791|NCT00705536|487828|P2|STARTED|Completed Study||6
198792|NCT00705536|487829|P1|STARTED|Completed Study||6
198793|NCT00705536|487826|P4|NOT COMPLETED|Start Period 2||0
198794|NCT00705536|487827|P3|NOT COMPLETED|Start Period 2||0
198795|NCT00705536|487828|P2|NOT COMPLETED|Start Period 2||0
198796|NCT00705536|487829|P1|NOT COMPLETED|Start Period 2||0
198797|NCT00705536|487826|P4|COMPLETED|Start Period 2||6
198798|NCT00705536|487827|P3|COMPLETED|Start Period 2||7
198799|NCT00705536|487828|P2|COMPLETED|Start Period 2||6
198800|NCT00705536|487829|P1|COMPLETED|Start Period 2||6
198801|NCT00705536|487826|P4|STARTED|Start Period 2||6
198802|NCT00705536|487827|P3|STARTED|Start Period 2||7
198803|NCT00705536|487828|P2|STARTED|Start Period 2||6
198804|NCT00705536|487829|P1|STARTED|Start Period 2||6
198805|NCT00705536|487826|P4|NOT COMPLETED|Washout Period of at Least 6 Days||0
198806|NCT00705536|487827|P3|NOT COMPLETED|Washout Period of at Least 6 Days||0
198807|NCT00705536|487828|P2|NOT COMPLETED|Washout Period of at Least 6 Days||0
198808|NCT00705536|487829|P1|NOT COMPLETED|Washout Period of at Least 6 Days||0
198809|NCT00705536|487826|P4|COMPLETED|Washout Period of at Least 6 Days||6
198810|NCT00705536|487827|P3|COMPLETED|Washout Period of at Least 6 Days||7
198811|NCT00705536|487828|P2|COMPLETED|Washout Period of at Least 6 Days||6
198812|NCT00705536|487829|P1|COMPLETED|Washout Period of at Least 6 Days||6
198813|NCT00705536|487826|P4|STARTED|Washout Period of at Least 6 Days||6
198814|NCT00705536|487827|P3|STARTED|Washout Period of at Least 6 Days||7
198815|NCT00705536|487828|P2|STARTED|Washout Period of at Least 6 Days||6
198816|NCT00705536|487829|P1|STARTED|Washout Period of at Least 6 Days||6
198817|NCT00705536|487826|P4|NOT COMPLETED|Start Period 1||1
198818|NCT00705536|487827|P3|NOT COMPLETED|Start Period 1||0
198819|NCT00705536|487828|P2|NOT COMPLETED|Start Period 1||0
198820|NCT00705536|487829|P1|NOT COMPLETED|Start Period 1||0
198821|NCT00705536|487826|P4|COMPLETED|Start Period 1||6
198822|NCT00705536|487827|P3|COMPLETED|Start Period 1||7
198823|NCT00705536|487828|P2|COMPLETED|Start Period 1||6
198824|NCT00705536|487829|P1|COMPLETED|Start Period 1||6
198825|NCT00705536|487826|P4|Received at Least 1 Dose of Study Drug|Start Period 1||7
198826|NCT00705536|487827|P3|Received at Least 1 Dose of Study Drug|Start Period 1||7
198827|NCT00705536|487828|P2|Received at Least 1 Dose of Study Drug|Start Period 1||6
198828|NCT00705536|487829|P1|Received at Least 1 Dose of Study Drug|Start Period 1||6
198829|NCT00705536|487826|P4|STARTED|Start Period 1||7
198830|NCT00705536|487827|P3|STARTED|Start Period 1||7
198831|NCT00705536|487828|P2|STARTED|Start Period 1||6
198832|NCT00705536|487829|P1|STARTED|Start Period 1||6
198833|NCT00705575|487890|P2|NOT COMPLETED|Overall Study||46
198834|NCT00705575|487891|P1|NOT COMPLETED|Overall Study||23
198835|NCT00705575|487890|P2|COMPLETED|Overall Study||293
198836|NCT00705575|487891|P1|COMPLETED|Overall Study||326
198837|NCT00705575|487890|P2|STARTED|Overall Study||339
198838|NCT00705575|487891|P1|STARTED|Overall Study||349
198839|NCT00708305|487903|P4|NOT COMPLETED|Period 4||0
198840|NCT00708305|487904|P3|NOT COMPLETED|Period 4||0
198841|NCT00708305|487905|P2|NOT COMPLETED|Period 4||0
198842|NCT00708305|487906|P1|NOT COMPLETED|Period 4||0
198843|NCT00708305|487903|P4|COMPLETED|Period 4||14
198844|NCT00708305|487904|P3|COMPLETED|Period 4||14
198845|NCT00708305|487905|P2|COMPLETED|Period 4||14
198846|NCT00708305|487906|P1|COMPLETED|Period 4||12
198847|NCT00708305|487903|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
198848|NCT00708305|487904|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
198849|NCT00708305|487905|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|14
198850|NCT00708305|487906|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
198851|NCT00708305|487903|P4|NOT COMPLETED|Period 3||0
198852|NCT00708305|487904|P3|NOT COMPLETED|Period 3||0
198853|NCT00708305|487905|P2|NOT COMPLETED|Period 3||2
198854|NCT00708305|487906|P1|NOT COMPLETED|Period 3||1
198855|NCT00708305|487903|P4|COMPLETED|Period 3||14
198856|NCT00708305|487904|P3|COMPLETED|Period 3||14
198857|NCT00708305|487905|P2|COMPLETED|Period 3||12
198858|NCT00708305|487906|P1|COMPLETED|Period 3||14
198859|NCT00708305|487903|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
198860|NCT00708305|487904|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
198861|NCT00708305|487905|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|14
198862|NCT00708305|487906|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|15
198863|NCT00708305|487903|P4|NOT COMPLETED|Period 2||1
198864|NCT00708305|487904|P3|NOT COMPLETED|Period 2||0
198865|NCT00708305|487905|P2|NOT COMPLETED|Period 2||2
198866|NCT00708305|487906|P1|NOT COMPLETED|Period 2||1
198867|NCT00708305|487903|P4|COMPLETED|Period 2||14
198868|NCT00708305|487904|P3|COMPLETED|Period 2||16
198869|NCT00708305|487905|P2|COMPLETED|Period 2||13
198870|NCT00708305|487906|P1|COMPLETED|Period 2||14
198871|NCT00708305|487903|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
198872|NCT00708305|487904|P3|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|16
198873|NCT00708305|487905|P2|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
198874|NCT00708305|487906|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|15
198875|NCT00708305|487903|P4|NOT COMPLETED|Period 1||2
198876|NCT00708305|487904|P3|NOT COMPLETED|Period 1||1
198877|NCT00708305|487905|P2|NOT COMPLETED|Period 1||0
198878|NCT00708305|487906|P1|NOT COMPLETED|Period 1||1
198879|NCT00708305|487903|P4|COMPLETED|Period 1||14
198880|NCT00708305|487904|P3|COMPLETED|Period 1||16
198881|NCT00708305|487905|P2|COMPLETED|Period 1||16
198882|NCT00708305|487906|P1|COMPLETED|Period 1||15
198883|NCT00708305|487903|P4|STARTED|Period 1||16
198884|NCT00708305|487904|P3|STARTED|Period 1||17
198885|NCT00708305|487905|P2|STARTED|Period 1||16
198886|NCT00708305|487906|P1|STARTED|Period 1||16
198887|NCT00708422|487940|P2|NOT COMPLETED|Overall Study||1
198888|NCT00708422|487941|P1|NOT COMPLETED|Overall Study||4
198889|NCT00708422|487940|P2|COMPLETED|Overall Study||114
198890|NCT00708422|487941|P1|COMPLETED|Overall Study||112
198891|NCT00708422|487940|P2|STARTED|Overall Study||115
198892|NCT00708422|487941|P1|STARTED|Overall Study||116
198893|NCT00708435|487951|P2|NOT COMPLETED|Overall Study||17
198894|NCT00708435|487952|P1|NOT COMPLETED|Overall Study||25
198895|NCT00708435|487951|P2|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|92
198896|NCT00708435|487952|P1|COMPLETED|Overall Study|These data are 'on-study' results collected up to the subject's Day 45 visit.|82
198897|NCT00708435|487951|P2|STARTED|Overall Study||109
198898|NCT00708435|487952|P1|STARTED|Overall Study||107
198899|NCT00708461|487979|P2|NOT COMPLETED|Overall Study||200
198900|NCT00708461|487980|P1|NOT COMPLETED|Overall Study||141
198901|NCT00708461|487979|P2|COMPLETED|Overall Study||795
198902|NCT00708461|487980|P1|COMPLETED|Overall Study||611
198903|NCT00708461|487979|P2|STARTED|Overall Study||995
198904|NCT00708461|487980|P1|STARTED|Overall Study||752
198905|NCT00708500|487989|P3|NOT COMPLETED|FOLLOWUP||15
198906|NCT00708500|487990|P2|NOT COMPLETED|FOLLOWUP||15
198907|NCT00708500|487991|P1|NOT COMPLETED|FOLLOWUP||40
198908|NCT00708500|487989|P3|COMPLETED|FOLLOWUP||143
198909|NCT00708500|487990|P2|COMPLETED|FOLLOWUP||136
198910|NCT00708500|487991|P1|COMPLETED|FOLLOWUP||37
198911|NCT00708500|487989|P3|STARTED|FOLLOWUP||158
198912|NCT00708500|487990|P2|STARTED|FOLLOWUP||151
198913|NCT00708500|487991|P1|STARTED|FOLLOWUP||77
198914|NCT00708500|487989|P3|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
198915|NCT00708500|487990|P2|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||52
198916|NCT00708500|487991|P1|NOT COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||55
198917|NCT00708500|487989|P3|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||105
198918|NCT00708500|487990|P2|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||104
198919|NCT00708500|487991|P1|COMPLETED|Tx: RECEIVING BOCEPREVIR/PLACEBO||23
198920|NCT00708500|487989|P3|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||160
198921|NCT00708500|487990|P2|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||156
198922|NCT00708500|487991|P1|STARTED|Tx: RECEIVING BOCEPREVIR/PLACEBO||78
198923|NCT00708500|487989|P3|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
198924|NCT00708500|487990|P2|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||6
198925|NCT00708500|487991|P1|NOT COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||2
198926|NCT00708500|487989|P3|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||160
198927|NCT00708500|487990|P2|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||156
198928|NCT00708500|487991|P1|COMPLETED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||78
198929|NCT00708500|487989|P3|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||161
198930|NCT00708500|487990|P2|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
198931|NCT00708500|487991|P1|Treated With PEG2b + RBV|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
198932|NCT00708500|487989|P3|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
198933|NCT00708500|487990|P2|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||162
198934|NCT00708500|487991|P1|STARTED|Treatment (Tx): 4 WEEK LEAD-IN PERIOD||80
198935|NCT00708526|488010|P2|NOT COMPLETED|Return of Cognitive Function||0
198936|NCT00708526|488011|P1|NOT COMPLETED|Return of Cognitive Function||0
198937|NCT00708526|488010|P2|COMPLETED|Return of Cognitive Function||11
198938|NCT00708526|488011|P1|COMPLETED|Return of Cognitive Function||11
198939|NCT00708526|488010|P2|STARTED|Return of Cognitive Function||11
198940|NCT00708526|488011|P1|STARTED|Return of Cognitive Function||11
198941|NCT00708526|488010|P2|NOT COMPLETED|Wake up After Anesthesia||0
198942|NCT00708526|488011|P1|NOT COMPLETED|Wake up After Anesthesia||0
198943|NCT00708526|488010|P2|COMPLETED|Wake up After Anesthesia||11
198944|NCT00708526|488011|P1|COMPLETED|Wake up After Anesthesia||11
198945|NCT00708526|488010|P2|STARTED|Wake up After Anesthesia||11
198946|NCT00708526|488011|P1|STARTED|Wake up After Anesthesia||11
198947|NCT00708643|488021|P2|NOT COMPLETED|Overall Study||1
198948|NCT00708643|488022|P1|NOT COMPLETED|Overall Study||0
198949|NCT00708643|488021|P2|COMPLETED|Overall Study||39
198950|NCT00708643|488022|P1|COMPLETED|Overall Study||40
198951|NCT00708643|488021|P2|STARTED|Overall Study||40
198952|NCT00708643|488022|P1|STARTED|Overall Study||40
198953|NCT00708682|488038|P1|NOT COMPLETED|Toddler Dose||8
198954|NCT00708682|488038|P1|COMPLETED|Toddler Dose||183
198955|NCT00708682|488038|P1|STARTED|Toddler Dose||191
198956|NCT00708682|488038|P1|NOT COMPLETED|After Infant Series||1
198957|NCT00708682|488038|P1|COMPLETED|After Infant Series||191
198958|NCT00708682|488038|P1|STARTED|After Infant Series||192
198959|NCT00708682|488038|P1|NOT COMPLETED|Infant Series||33
198960|NCT00708682|488038|P1|COMPLETED|Infant Series||192
198961|NCT00708682|488038|P1|Vaccinated Dose 3|Infant Series||194
198962|NCT00708682|488038|P1|Vaccinated Dose 2|Infant Series||214
198963|NCT00708682|488038|P1|Vaccinated Dose 1|Infant Series||223
198964|NCT00708682|488038|P1|STARTED|Infant Series||225
198965|NCT00708708|488057|P1|NOT COMPLETED|Overall Study||742
198966|NCT00708708|488057|P1|COMPLETED|Overall Study|Included participants completed total observation period and participants with planned study end.|213
198967|NCT00708708|488057|P1|STARTED|Overall Study||955
198968|NCT00708721|488105|P4|NOT COMPLETED|Overall Study||0
198969|NCT00708721|488106|P3|NOT COMPLETED|Overall Study||0
198970|NCT00708721|488107|P2|NOT COMPLETED|Overall Study||0
198971|NCT00708721|488108|P1|NOT COMPLETED|Overall Study||0
198972|NCT00708721|488105|P4|COMPLETED|Overall Study||2
198973|NCT00708721|488106|P3|COMPLETED|Overall Study||3
198974|NCT00708721|488107|P2|COMPLETED|Overall Study||4
198975|NCT00708721|488108|P1|COMPLETED|Overall Study||2
198976|NCT00708721|488105|P4|STARTED|Overall Study||2
198977|NCT00708721|488106|P3|STARTED|Overall Study||3
198978|NCT00708721|488107|P2|STARTED|Overall Study||4
198979|NCT00708721|488108|P1|STARTED|Overall Study||2
198980|NCT00708734|488121|P1|NOT COMPLETED|Overall Study||7
198981|NCT00708734|488121|P1|COMPLETED|Overall Study|Ten subjects enrolled, three completed the intervention and all follow up sessions.|3
198982|NCT00708734|488121|P1|STARTED|Overall Study|94 subjects were screened, 45 did not meet criteria, and 39 declined participation after screening.|10
198983|NCT00708851|488125|P1|NOT COMPLETED|Overall Study||0
198984|NCT00708851|488125|P1|COMPLETED|Overall Study||12
198985|NCT00708851|488125|P1|STARTED|Overall Study||12
198986|NCT00708877|488133|P1|NOT COMPLETED|Overall Study||0
198987|NCT00708877|488133|P1|COMPLETED|Overall Study||5
198988|NCT00708877|488133|P1|STARTED|Overall Study||5
198989|NCT00708942|488142|P5|NOT COMPLETED|Overall Study||1
198990|NCT00708942|488143|P4|NOT COMPLETED|Overall Study||0
198991|NCT00708942|488144|P3|NOT COMPLETED|Overall Study||2
198992|NCT00708942|488145|P2|NOT COMPLETED|Overall Study||1
198993|NCT00708942|488146|P1|NOT COMPLETED|Overall Study||7
198994|NCT00708942|488142|P5|COMPLETED|Overall Study||2
198995|NCT00708942|488143|P4|COMPLETED|Overall Study||10
198996|NCT00708942|488144|P3|COMPLETED|Overall Study||9
198997|NCT00708942|488145|P2|COMPLETED|Overall Study||11
198998|NCT00708942|488146|P1|COMPLETED|Overall Study||40
198999|NCT00708942|488142|P5|STARTED|Overall Study||3
199000|NCT00708942|488143|P4|STARTED|Overall Study||10
199001|NCT00708942|488144|P3|STARTED|Overall Study||11
199002|NCT00708942|488145|P2|STARTED|Overall Study||12
199003|NCT00708942|488146|P1|STARTED|Overall Study||47
199004|NCT00709059|488168|P1|NOT COMPLETED|Overall Study||94
199005|NCT00709059|488168|P1|COMPLETED|Overall Study||444
199006|NCT00709059|488168|P1|STARTED|Overall Study||538
199007|NCT00709098|488175|P3|NOT COMPLETED|Open-label Period||14
199008|NCT00709098|488176|P2|NOT COMPLETED|Open-label Period||0
199009|NCT00709098|488177|P1|NOT COMPLETED|Open-label Period||0
199010|NCT00709098|488175|P3|COMPLETED|Open-label Period||18
199011|NCT00709098|488176|P2|COMPLETED|Open-label Period||0
199012|NCT00709098|488177|P1|COMPLETED|Open-label Period||0
199013|NCT00709098|488175|P3|STARTED|Open-label Period|The open-label period was only made available to patients in US centers|32
199014|NCT00709098|488176|P2|STARTED|Open-label Period||0
199015|NCT00709098|488177|P1|STARTED|Open-label Period||0
199016|NCT00709098|488175|P3|NOT COMPLETED|Double-blind Period||0
199017|NCT00709098|488176|P2|NOT COMPLETED|Double-blind Period||8
199018|NCT00709098|488177|P1|NOT COMPLETED|Double-blind Period||6
199019|NCT00709098|488175|P3|COMPLETED|Double-blind Period||0
199020|NCT00709098|488176|P2|COMPLETED|Double-blind Period||16
199021|NCT00709098|488177|P1|COMPLETED|Double-blind Period||19
199022|NCT00709098|488175|P3|STARTED|Double-blind Period||0
199023|NCT00709098|488176|P2|STARTED|Double-blind Period||24
199024|NCT00709098|488177|P1|STARTED|Double-blind Period||25
199025|NCT00709111|488196|P1|NOT COMPLETED|Overall Study||2
199026|NCT00709111|488196|P1|COMPLETED|Overall Study||32
199027|NCT00709111|488196|P1|Week 22/24|Overall Study||33
199028|NCT00709111|488196|P1|STARTED|Overall Study||34
199029|NCT00709124|488236|P2|NOT COMPLETED|Overall Study||1
199030|NCT00709124|488237|P1|NOT COMPLETED|Overall Study||4
199031|NCT00709124|488236|P2|COMPLETED|Overall Study||17
199032|NCT00709124|488237|P1|COMPLETED|Overall Study||12
199033|NCT00709124|488236|P2|STARTED|Overall Study||18
199034|NCT00709124|488237|P1|STARTED|Overall Study||16
199035|NCT00709228|488243|P1|NOT COMPLETED|Overall Study||332
199036|NCT00709228|488243|P1|COMPLETED|Overall Study|Number completed is defined as participants who completed the follow-up period.|164
199037|NCT00709228|488243|P1|STARTED|Overall Study||496
199038|NCT00709319|488247|P1|NOT COMPLETED|Overall Study||6
199039|NCT00709319|488247|P1|COMPLETED|Overall Study||81
199040|NCT00709319|488247|P1|STARTED|Overall Study||87
199041|NCT00709592|488257|P2|NOT COMPLETED|Overall Study||1
199042|NCT00709592|488258|P1|NOT COMPLETED|Overall Study||0
199043|NCT00709592|488257|P2|COMPLETED|Overall Study||22
199044|NCT00709592|488258|P1|COMPLETED|Overall Study||19
199045|NCT00709592|488257|P2|STARTED|Overall Study||23
199046|NCT00709592|488258|P1|STARTED|Overall Study||19
199047|NCT00709618|488278|P1|NOT COMPLETED|Overall Study||30
199048|NCT00709618|488278|P1|COMPLETED|Overall Study||14
199049|NCT00709618|488278|P1|STARTED|Overall Study||44
199050|NCT00709722|488288|P1|NOT COMPLETED|Overall Study||1
199051|NCT00709722|488288|P1|COMPLETED|Overall Study||20
199052|NCT00709722|488288|P1|STARTED|Overall Study||21
199053|NCT00709735|488296|P2|NOT COMPLETED|Overall Study||2
199054|NCT00709735|488297|P1|NOT COMPLETED|Overall Study||3
199055|NCT00709735|488296|P2|COMPLETED|Overall Study||10
199056|NCT00709735|488297|P1|COMPLETED|Overall Study||8
199057|NCT00709735|488296|P2|STARTED|Overall Study||12
199058|NCT00709735|488297|P1|STARTED|Overall Study||11
199059|NCT00709761|488305|P1|NOT COMPLETED|Overall Study||47
199060|NCT00709761|488305|P1|COMPLETED|Overall Study||13
199061|NCT00709761|488305|P1|Ongoing|Overall Study|At time of clinical data cut off, 11 participants were on study treatment; 29 were in follow up.|40
199062|NCT00709761|488305|P1|STARTED|Overall Study||60
199063|NCT00709826|488316|P2|NOT COMPLETED|Overall Study||1
199064|NCT00709826|488317|P1|NOT COMPLETED|Overall Study||2
199065|NCT00709826|488316|P2|COMPLETED|Overall Study||38
199066|NCT00709826|488317|P1|COMPLETED|Overall Study||68
199067|NCT00709826|488316|P2|STARTED|Overall Study||39
199068|NCT00709826|488317|P1|STARTED|Overall Study||70
199069|NCT00709852|488325|P2|NOT COMPLETED|Period 2||2
199070|NCT00709852|488326|P1|NOT COMPLETED|Period 2||9
199071|NCT00709852|488325|P2|COMPLETED|Period 2||169
199072|NCT00709852|488326|P1|COMPLETED|Period 2||211
199073|NCT00709852|488325|P2|STARTED|Period 2||171
199074|NCT00709852|488326|P1|STARTED|Period 2||220
199075|NCT00709852|488325|P2|NOT COMPLETED|Period 1||3
199076|NCT00709852|488326|P1|NOT COMPLETED|Period 1||8
199077|NCT00709852|488325|P2|COMPLETED|Period 1||171
199078|NCT00709852|488326|P1|COMPLETED|Period 1||220
199079|NCT00709852|488325|P2|STARTED|Period 1||174
199080|NCT00709852|488326|P1|STARTED|Period 1||228
199081|NCT00709878|488483|P4|NOT COMPLETED|Overall Study||0
199082|NCT00709878|488484|P3|NOT COMPLETED|Overall Study||0
199083|NCT00709878|488485|P2|NOT COMPLETED|Overall Study||0
199084|NCT00709878|488486|P1|NOT COMPLETED|Overall Study||0
199085|NCT00709878|488483|P4|COMPLETED|Overall Study||8
199086|NCT00709878|488484|P3|COMPLETED|Overall Study||8
199087|NCT00709878|488485|P2|COMPLETED|Overall Study||8
199088|NCT00709878|488486|P1|COMPLETED|Overall Study||8
199089|NCT00709878|488483|P4|STARTED|Overall Study||8
199090|NCT00709878|488484|P3|STARTED|Overall Study||8
199091|NCT00709878|488485|P2|STARTED|Overall Study||8
199092|NCT00709878|488486|P1|STARTED|Overall Study||8
199093|NCT00709891|488496|P1|NOT COMPLETED|Longitudinal Follow-up Phase||4982
199094|NCT00709891|488496|P1|COMPLETED|Longitudinal Follow-up Phase||5020
199095|NCT00709891|488496|P1|STARTED|Longitudinal Follow-up Phase|Only participants who met study criteria in the Baseline phase started the Follow-up phase.|10002
199096|NCT00709891|488496|P1|NOT COMPLETED|Baseline, Cross-sectional Phase||1450
199097|NCT00709891|488496|P1|COMPLETED|Baseline, Cross-sectional Phase||45758
199098|NCT00709891|488496|P1|STARTED|Baseline, Cross-sectional Phase||47208
199099|NCT00709956|488503|P2|NOT COMPLETED|Overall Study||4
199100|NCT00709956|488504|P1|NOT COMPLETED|Overall Study||3
199101|NCT00709956|488503|P2|COMPLETED|Overall Study||33
199102|NCT00709956|488504|P1|COMPLETED|Overall Study||30
199103|NCT00709956|488503|P2|Double-blind Crossover-period|Overall Study|Days 2 and 3|33
199104|NCT00709956|488504|P1|Double-blind Crossover-period|Overall Study|Days 2 and 3|31
199105|NCT00709956|488503|P2|STARTED|Overall Study|Day 1 Single-blind placebo run-in|37
199106|NCT00709956|488504|P1|STARTED|Overall Study|Day 1 Single-blind placebo run-in|33
199107|NCT00710021|488515|P3|NOT COMPLETED|Overall Study||1
199108|NCT00710021|488516|P2|NOT COMPLETED|Overall Study||3
199109|NCT00710021|488517|P1|NOT COMPLETED|Overall Study||1
199110|NCT00710021|488515|P3|COMPLETED|Overall Study||18
199111|NCT00710021|488516|P2|COMPLETED|Overall Study||16
199112|NCT00710021|488517|P1|COMPLETED|Overall Study||18
199113|NCT00710021|488515|P3|Modified Intent-to-Treat (mITT)|Overall Study|1 subject who did not take study drug was excluded from mITT|18
199114|NCT00710021|488516|P2|Modified Intent-to-Treat (mITT)|Overall Study|2 subjects who did not take study drug were excluded from mITT|17
199355|NCT00710970|489048|P1|NOT COMPLETED|Overall Study||10
199115|NCT00710021|488517|P1|Modified Intent-to-Treat (mITT)|Overall Study||19
199116|NCT00710021|488515|P3|STARTED|Overall Study||19
199117|NCT00710021|488516|P2|STARTED|Overall Study||19
199118|NCT00710021|488517|P1|STARTED|Overall Study||19
199119|NCT00710203|488630|P1|NOT COMPLETED|Overall Study||0
199120|NCT00710203|488630|P1|COMPLETED|Overall Study||10
199121|NCT00710203|488630|P1|STARTED|Overall Study||10
199122|NCT00710385|488656|P1|NOT COMPLETED|Overall Study||5
199123|NCT00710385|488656|P1|COMPLETED|Overall Study||12
199124|NCT00710385|488656|P1|STARTED|Overall Study|19 participants signed consent for the study 2 withdrew before any study procedures were initiated.|17
199125|NCT00710424|488675|P2|NOT COMPLETED|Overall Study||23
199126|NCT00710424|488676|P1|NOT COMPLETED|Overall Study||44
199127|NCT00710424|488675|P2|COMPLETED|Overall Study||125
199128|NCT00710424|488676|P1|COMPLETED|Overall Study||105
199129|NCT00710424|488675|P2|STARTED|Overall Study||148
199130|NCT00710424|488676|P1|STARTED|Overall Study||149
199131|NCT00710554|488702|P2|NOT COMPLETED|Overall Study||24
199132|NCT00710554|488703|P1|NOT COMPLETED|Overall Study||49
199133|NCT00710554|488702|P2|COMPLETED|Overall Study||94
199134|NCT00710554|488703|P1|COMPLETED|Overall Study||79
199135|NCT00710554|488702|P2|STARTED|Overall Study||118
199136|NCT00710554|488703|P1|STARTED|Overall Study||128
199137|NCT00710593|488731|P2|NOT COMPLETED|Overall Study||5
199138|NCT00710593|488732|P1|NOT COMPLETED|Overall Study||15
199139|NCT00710593|488731|P2|COMPLETED|Overall Study|25 completed study and vaccine. 2 did not receive all vaccine, but completed all study visits.|25
199140|NCT00710593|488732|P1|COMPLETED|Overall Study|54 completed study and vaccine. 6 did not receive all vaccine, but completed all study visits.|54
199141|NCT00710593|488731|P2|STARTED|Overall Study||30
199142|NCT00710593|488732|P1|STARTED|Overall Study||69
199143|NCT00710606|488775|P2|NOT COMPLETED|Overall Study||2
199144|NCT00710606|488776|P1|NOT COMPLETED|Overall Study||0
199145|NCT00710606|488775|P2|COMPLETED|Overall Study||18
199146|NCT00710606|488776|P1|COMPLETED|Overall Study||20
199147|NCT00710606|488775|P2|STARTED|Overall Study||20
199148|NCT00710606|488776|P1|STARTED|Overall Study||20
199149|NCT00702468|488788|P2|NOT COMPLETED|Overall Study||16
199150|NCT00702468|488789|P1|NOT COMPLETED|Overall Study||3
199151|NCT00702468|488788|P2|COMPLETED|Overall Study||2
199152|NCT00702468|488789|P1|COMPLETED|Overall Study||15
199153|NCT00702468|488788|P2|STARTED|Overall Study||18
199154|NCT00702468|488789|P1|STARTED|Overall Study||18
199155|NCT00702507|488811|P1|NOT COMPLETED|Follow-up Phase||27
199156|NCT00702507|488811|P1|COMPLETED|Follow-up Phase||132
199157|NCT00702507|488811|P1|STARTED|Follow-up Phase||159
199158|NCT00702507|488811|P1|NOT COMPLETED|Initial Treatment Phase||41
199159|NCT00702507|488811|P1|COMPLETED|Initial Treatment Phase||159
199160|NCT00702507|488811|P1|STARTED|Initial Treatment Phase||200
199161|NCT00702520|488825|P4|NOT COMPLETED|Follow-up Study P05783||0
199162|NCT00702520|488826|P3|NOT COMPLETED|Follow-up Study P05783||0
199163|NCT00702520|488827|P2|NOT COMPLETED|Follow-up Study P05783||0
199164|NCT00702520|488828|P1|NOT COMPLETED|Follow-up Study P05783||0
199165|NCT00702520|488825|P4|COMPLETED|Follow-up Study P05783||11
199166|NCT00702520|488826|P3|COMPLETED|Follow-up Study P05783||8
199167|NCT00702520|488827|P2|COMPLETED|Follow-up Study P05783||8
199168|NCT00702520|488828|P1|COMPLETED|Follow-up Study P05783||7
199169|NCT00702520|488825|P4|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 150 ug.|11
199170|NCT00702520|488826|P3|STARTED|Follow-up Study P05783|This is the number of infants born from mothers administered Corifollitropin alpha 100 ug.|8
199171|NCT00702520|488827|P2|STARTED|Follow-up Study P05783||8
199172|NCT00702520|488828|P1|STARTED|Follow-up Study P05783||7
199173|NCT00702520|488825|P4|NOT COMPLETED|Base Study P05788 - Follow-Up||0
199174|NCT00702520|488826|P3|NOT COMPLETED|Base Study P05788 - Follow-Up||0
199175|NCT00702520|488827|P2|NOT COMPLETED|Base Study P05788 - Follow-Up||10
199176|NCT00702520|488828|P1|NOT COMPLETED|Base Study P05788 - Follow-Up||15
199177|NCT00702520|488825|P4|COMPLETED|Base Study P05788 - Follow-Up||0
199178|NCT00702520|488826|P3|COMPLETED|Base Study P05788 - Follow-Up||0
199179|NCT00702520|488827|P2|COMPLETED|Base Study P05788 - Follow-Up||8
199180|NCT00702520|488828|P1|COMPLETED|Base Study P05788 - Follow-Up||7
199181|NCT00702520|488825|P4|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
199182|NCT00702520|488826|P3|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||0
199183|NCT00702520|488827|P2|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||8
199184|NCT00702520|488828|P1|Ongoing Pregnancy at 10 Weeks|Base Study P05788 - Follow-Up||7
199185|NCT00702520|488825|P4|STARTED|Base Study P05788 - Follow-Up||0
199186|NCT00702520|488826|P3|STARTED|Base Study P05788 - Follow-Up||0
199187|NCT00702520|488827|P2|STARTED|Base Study P05788 - Follow-Up||18
199188|NCT00702520|488828|P1|STARTED|Base Study P05788 - Follow-Up||22
199189|NCT00702520|488825|P4|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
199190|NCT00702520|488826|P3|NOT COMPLETED|Base Study P05788 - Embryo Transfer||0
199191|NCT00702520|488827|P2|NOT COMPLETED|Base Study P05788 - Embryo Transfer||6
199192|NCT00702520|488828|P1|NOT COMPLETED|Base Study P05788 - Embryo Transfer||3
199193|NCT00702520|488825|P4|COMPLETED|Base Study P05788 - Embryo Transfer||0
199194|NCT00702520|488826|P3|COMPLETED|Base Study P05788 - Embryo Transfer||0
199195|NCT00702520|488827|P2|COMPLETED|Base Study P05788 - Embryo Transfer||18
199196|NCT00702520|488828|P1|COMPLETED|Base Study P05788 - Embryo Transfer||22
199197|NCT00702520|488825|P4|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
199198|NCT00702520|488826|P3|Embryo Transfer|Base Study P05788 - Embryo Transfer||0
199199|NCT00702520|488827|P2|Embryo Transfer|Base Study P05788 - Embryo Transfer||18
199200|NCT00702520|488828|P1|Embryo Transfer|Base Study P05788 - Embryo Transfer||22
199201|NCT00702520|488825|P4|STARTED|Base Study P05788 - Embryo Transfer||0
199202|NCT00702520|488826|P3|STARTED|Base Study P05788 - Embryo Transfer||0
199203|NCT00702520|488827|P2|STARTED|Base Study P05788 - Embryo Transfer||24
199204|NCT00702520|488828|P1|STARTED|Base Study P05788 - Embryo Transfer||25
199205|NCT00702520|488825|P4|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
199206|NCT00702520|488826|P3|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
199207|NCT00702520|488827|P2|NOT COMPLETED|Base Study P05788 - Assigned Treatment||1
199208|NCT00702520|488828|P1|NOT COMPLETED|Base Study P05788 - Assigned Treatment||0
199209|NCT00702520|488825|P4|COMPLETED|Base Study P05788 - Assigned Treatment||0
199210|NCT00702520|488826|P3|COMPLETED|Base Study P05788 - Assigned Treatment||0
199211|NCT00702520|488827|P2|COMPLETED|Base Study P05788 - Assigned Treatment||24
199212|NCT00702520|488828|P1|COMPLETED|Base Study P05788 - Assigned Treatment||25
199213|NCT00702520|488825|P4|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
199214|NCT00702520|488826|P3|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||0
199215|NCT00702520|488827|P2|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||24
199216|NCT00702520|488828|P1|Treated With hCG and Had Oocyte Pick-up|Base Study P05788 - Assigned Treatment||25
199217|NCT00702520|488825|P4|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
199218|NCT00702520|488826|P3|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||0
199219|NCT00702520|488827|P2|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||24
199220|NCT00702520|488828|P1|Treated With Corifollitropin Alpha|Base Study P05788 - Assigned Treatment||25
199221|NCT00702520|488825|P4|STARTED|Base Study P05788 - Assigned Treatment||0
199222|NCT00702520|488826|P3|STARTED|Base Study P05788 - Assigned Treatment||0
199223|NCT00702520|488827|P2|STARTED|Base Study P05788 - Assigned Treatment||25
199224|NCT00702520|488828|P1|STARTED|Base Study P05788 - Assigned Treatment||25
199225|NCT00702546|488846|P2|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||1
199226|NCT00702546|488847|P1|NOT COMPLETED|Follow Up Study P05711 (NCT00702546)||5
199227|NCT00702546|488846|P2|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|24
199228|NCT00702546|488847|P1|COMPLETED|Follow Up Study P05711 (NCT00702546)|Participants with embryo transfer in any FTET cycle|72
199229|NCT00702546|488846|P2|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|25
199230|NCT00702546|488847|P1|STARTED|Follow Up Study P05711 (NCT00702546)|Participants from base study P05690 with at least one embryo thawed for use in FTET cycle.|77
199231|NCT00702546|488846|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
199232|NCT00702546|488847|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
199233|NCT00702546|488846|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
199234|NCT00702546|488847|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
199235|NCT00702546|488846|P2|STARTED|Base Study P05690 (NCT00702845)||128
199236|NCT00702546|488847|P1|STARTED|Base Study P05690 (NCT00702845)||268
199237|NCT00702624|488867|P4|NOT COMPLETED|Fetuses/Infant Follow-up||0
199238|NCT00702624|488868|P3|NOT COMPLETED|Fetuses/Infant Follow-up||10
199239|NCT00702624|488869|P2|NOT COMPLETED|Fetuses/Infant Follow-up||0
199240|NCT00702624|488870|P1|NOT COMPLETED|Fetuses/Infant Follow-up||0
199241|NCT00702624|488867|P4|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|55
199242|NCT00702624|488868|P3|COMPLETED|Fetuses/Infant Follow-up|To complete the study, infants must have completed a follow-up visit at 4-12 weeks postpartum.|78
199243|NCT00702624|488869|P2|COMPLETED|Fetuses/Infant Follow-up||0
199244|NCT00702624|488870|P1|COMPLETED|Fetuses/Infant Follow-up||0
199245|NCT00702624|488867|P4|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy.|55
199246|NCT00702624|488868|P3|Live Born Infants|Fetuses/Infant Follow-up|Infants born to eligible mothers were followed for safety and efficacy|80
199247|NCT00702624|488869|P2|Live Born Infants|Fetuses/Infant Follow-up||0
199248|NCT00702624|488870|P1|Live Born Infants|Fetuses/Infant Follow-up||0
199249|NCT00702624|488867|P4|STARTED|Fetuses/Infant Follow-up||55
199250|NCT00702624|488868|P3|STARTED|Fetuses/Infant Follow-up||88
199251|NCT00702624|488869|P2|STARTED|Fetuses/Infant Follow-up||0
199252|NCT00702624|488870|P1|STARTED|Fetuses/Infant Follow-up||0
199253|NCT00702624|488867|P4|NOT COMPLETED|Expectant Mother Follow-up||0
199254|NCT00702624|488868|P3|NOT COMPLETED|Expectant Mother Follow-up||0
199255|NCT00702624|488869|P2|NOT COMPLETED|Expectant Mother Follow-up||0
199256|NCT00702624|488870|P1|NOT COMPLETED|Expectant Mother Follow-up||7
199257|NCT00702624|488867|P4|COMPLETED|Expectant Mother Follow-up||0
199258|NCT00702624|488868|P3|COMPLETED|Expectant Mother Follow-up||0
199259|NCT00702624|488869|P2|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|45
199260|NCT00702624|488870|P1|COMPLETED|Expectant Mother Follow-up|To complete the study, participants must have completed a follow-up visit at 4-12 weeks postpartum.|61
199261|NCT00702624|488867|P4|STARTED|Expectant Mother Follow-up||0
199262|NCT00702624|488868|P3|STARTED|Expectant Mother Follow-up||0
199263|NCT00702624|488869|P2|STARTED|Expectant Mother Follow-up||45
199264|NCT00702624|488870|P1|STARTED|Expectant Mother Follow-up||68
199265|NCT00702624|488867|P4|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
199266|NCT00702624|488868|P3|NOT COMPLETED|Base Study P05690 (NCT00702845)||0
199267|NCT00702624|488869|P2|NOT COMPLETED|Base Study P05690 (NCT00702845)||7
199268|NCT00702624|488870|P1|NOT COMPLETED|Base Study P05690 (NCT00702845)||22
199269|NCT00702624|488867|P4|COMPLETED|Base Study P05690 (NCT00702845)||0
199270|NCT00702624|488868|P3|COMPLETED|Base Study P05690 (NCT00702845)||0
199271|NCT00702624|488869|P2|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|121
199272|NCT00702624|488870|P1|COMPLETED|Base Study P05690 (NCT00702845)|To complete study, participants from the base study P05690 (NCT00702845) had embryos transferred.|246
199273|NCT00702624|488867|P4|STARTED|Base Study P05690 (NCT00702845)||0
199274|NCT00702624|488868|P3|STARTED|Base Study P05690 (NCT00702845)||0
199275|NCT00702624|488869|P2|STARTED|Base Study P05690 (NCT00702845)||128
199276|NCT00702624|488870|P1|STARTED|Base Study P05690 (NCT00702845)||268
199277|NCT00702650|488886|P1|NOT COMPLETED|Overall Study||20
199278|NCT00702650|488886|P1|COMPLETED|Overall Study||135
199279|NCT00702650|488886|P1|STARTED|Overall Study||155
199280|NCT00702689|488904|P1|NOT COMPLETED|Overall Study||6
199281|NCT00702689|488904|P1|COMPLETED|Overall Study||14
199282|NCT00702689|488904|P1|STARTED|Overall Study||20
199283|NCT00702702|488918|P1|NOT COMPLETED|Overall Study||56
199284|NCT00702702|488918|P1|COMPLETED|Overall Study||0
199285|NCT00702702|488918|P1|STARTED|Overall Study||56
199286|NCT00702715|488928|P2|NOT COMPLETED|Overall Study||0
199287|NCT00702715|488929|P1|NOT COMPLETED|Overall Study||1
199288|NCT00702715|488928|P2|COMPLETED|Overall Study||33
199289|NCT00702715|488929|P1|COMPLETED|Overall Study||34
199290|NCT00702715|488928|P2|STARTED|Overall Study|One subject was enrolled but did not start study|33
199291|NCT00702715|488929|P1|STARTED|Overall Study||35
199292|NCT00710749|488939|P2|NOT COMPLETED|Second Intervention||0
199293|NCT00710749|488940|P1|NOT COMPLETED|Second Intervention||0
199294|NCT00710749|488939|P2|COMPLETED|Second Intervention||30
199295|NCT00710749|488940|P1|COMPLETED|Second Intervention||29
199296|NCT00710749|488939|P2|STARTED|Second Intervention||30
199297|NCT00710749|488940|P1|STARTED|Second Intervention||29
199298|NCT00710749|488939|P2|NOT COMPLETED|First Intervention||0
199299|NCT00710749|488940|P1|NOT COMPLETED|First Intervention||1
199300|NCT00710749|488939|P2|COMPLETED|First Intervention||30
199301|NCT00710749|488940|P1|COMPLETED|First Intervention||29
199302|NCT00710749|488939|P2|STARTED|First Intervention||30
199303|NCT00710749|488940|P1|STARTED|First Intervention||30
199304|NCT00710749|488939|P2|NOT COMPLETED|Clinic Baseline Recording||0
199305|NCT00710749|488940|P1|NOT COMPLETED|Clinic Baseline Recording||0
199306|NCT00710749|488939|P2|COMPLETED|Clinic Baseline Recording||30
199307|NCT00710749|488940|P1|COMPLETED|Clinic Baseline Recording||30
199308|NCT00710749|488939|P2|STARTED|Clinic Baseline Recording||30
199309|NCT00710749|488940|P1|STARTED|Clinic Baseline Recording||30
199310|NCT00710762|488950|P2|NOT COMPLETED|Overall Study||40
199311|NCT00710762|488951|P1|NOT COMPLETED|Overall Study||39
199312|NCT00710762|488950|P2|COMPLETED|Overall Study||0
199313|NCT00710762|488951|P1|COMPLETED|Overall Study||5
199314|NCT00710762|488950|P2|STARTED|Overall Study||40
199315|NCT00710762|488951|P1|STARTED|Overall Study||44
199316|NCT00710814|488969|P2|NOT COMPLETED|Overall Study||3
199317|NCT00710814|488970|P1|NOT COMPLETED|Overall Study||1
199318|NCT00710814|488969|P2|COMPLETED|Overall Study||13
199319|NCT00710814|488970|P1|COMPLETED|Overall Study||14
199320|NCT00710814|488969|P2|STARTED|Overall Study||16
199321|NCT00710814|488970|P1|STARTED|Overall Study||15
199322|NCT00710840|488978|P2|NOT COMPLETED|Overall Study||3
199323|NCT00710840|488979|P1|NOT COMPLETED|Overall Study||0
199324|NCT00710840|488978|P2|COMPLETED|Overall Study||19
199325|NCT00710840|488979|P1|COMPLETED|Overall Study||22
199326|NCT00710840|488978|P2|STARTED|Overall Study||22
199327|NCT00710840|488979|P1|STARTED|Overall Study||22
199328|NCT00710866|488993|P2|NOT COMPLETED|Overall Study||6
199329|NCT00710866|488994|P1|NOT COMPLETED|Overall Study||9
199330|NCT00710866|488993|P2|COMPLETED|Overall Study||128
199331|NCT00710866|488994|P1|COMPLETED|Overall Study||124
199332|NCT00710866|488993|P2|STARTED|Overall Study||134
199333|NCT00710866|488994|P1|STARTED|Overall Study||133
199334|NCT00710879|489016|P2|NOT COMPLETED|Overall Study||4
199335|NCT00710879|489017|P1|NOT COMPLETED|Overall Study||2
199336|NCT00710879|489016|P2|COMPLETED|Overall Study||113
199337|NCT00710879|489017|P1|COMPLETED|Overall Study||58
199338|NCT00710879|489016|P2|STARTED|Overall Study||117
199339|NCT00710879|489017|P1|STARTED|Overall Study||60
199340|NCT00710905|489027|P1|NOT COMPLETED|Overall Study||16
199341|NCT00710905|489027|P1|COMPLETED|Overall Study||34
199342|NCT00710905|489027|P1|STARTED|Overall Study||50
199343|NCT00710931|489031|P1|NOT COMPLETED|Overall Study||5
199344|NCT00710931|489031|P1|COMPLETED|Overall Study||29
199345|NCT00710931|489031|P1|STARTED|Overall Study||34
199346|NCT00710944|489038|P3|NOT COMPLETED|Overall Study||2
199347|NCT00710944|489039|P2|NOT COMPLETED|Overall Study||9
199348|NCT00710944|489040|P1|NOT COMPLETED|Overall Study||10
199349|NCT00710944|489038|P3|COMPLETED|Overall Study||17
199350|NCT00710944|489039|P2|COMPLETED|Overall Study||49
199351|NCT00710944|489040|P1|COMPLETED|Overall Study||45
199352|NCT00710944|489038|P3|STARTED|Overall Study||19
199353|NCT00710944|489039|P2|STARTED|Overall Study||58
199354|NCT00710944|489040|P1|STARTED|Overall Study||55
199356|NCT00710970|489048|P1|COMPLETED|Overall Study||18
199357|NCT00710970|489048|P1|STARTED|Overall Study||28
199358|NCT00710996|489055|P3|NOT COMPLETED|Overall Study||0
199359|NCT00710996|489056|P2|NOT COMPLETED|Overall Study||4
199360|NCT00710996|489057|P1|NOT COMPLETED|Overall Study||1
199361|NCT00710996|489055|P3|COMPLETED|Overall Study||21
199362|NCT00710996|489056|P2|COMPLETED|Overall Study||16
199363|NCT00710996|489057|P1|COMPLETED|Overall Study||16
199364|NCT00710996|489055|P3|STARTED|Overall Study||21
199365|NCT00710996|489056|P2|STARTED|Overall Study||20
199366|NCT00710996|489057|P1|STARTED|Overall Study||17
199367|NCT00711009|489067|P2|NOT COMPLETED|Overall Study||19
199368|NCT00711009|489068|P1|NOT COMPLETED|Overall Study||15
199369|NCT00711009|489067|P2|COMPLETED|Overall Study||82
199370|NCT00711009|489068|P1|COMPLETED|Overall Study||90
199371|NCT00711009|489067|P2|STARTED|Overall Study||101
199372|NCT00711009|489068|P1|STARTED|Overall Study||105
199373|NCT00711022|489236|P1|NOT COMPLETED|Overall Study||11
199374|NCT00711022|489236|P1|COMPLETED|Overall Study||40
199375|NCT00711022|489236|P1|STARTED|Overall Study||51
199376|NCT00711958|489242|P2|NOT COMPLETED|Overall Study||23
199377|NCT00711958|489243|P1|NOT COMPLETED|Overall Study||33
199378|NCT00711958|489242|P2|COMPLETED|Overall Study||17
199379|NCT00711958|489243|P1|COMPLETED|Overall Study||41
199380|NCT00711958|489242|P2|STARTED|Overall Study||40
199381|NCT00711958|489243|P1|STARTED|Overall Study||74
199382|NCT00711971|489252|P3|NOT COMPLETED|Overall Study||1
199383|NCT00711971|489253|P2|NOT COMPLETED|Overall Study||4
199384|NCT00711971|489254|P1|NOT COMPLETED|Overall Study||3
199385|NCT00711971|489252|P3|COMPLETED|Overall Study||41
199386|NCT00711971|489253|P2|COMPLETED|Overall Study||38
199387|NCT00711971|489254|P1|COMPLETED|Overall Study||39
199388|NCT00711971|489252|P3|STARTED|Overall Study||42
199389|NCT00711971|489253|P2|STARTED|Overall Study||42
199390|NCT00711971|489254|P1|STARTED|Overall Study||42
199391|NCT00711997|489288|P2|NOT COMPLETED|Overall Study||0
199392|NCT00711997|489289|P1|NOT COMPLETED|Overall Study||0
199393|NCT00711997|489288|P2|COMPLETED|Overall Study||6
199394|NCT00711997|489289|P1|COMPLETED|Overall Study||3
199395|NCT00711997|489288|P2|STARTED|Overall Study||6
199396|NCT00711997|489289|P1|STARTED|Overall Study||3
199397|NCT00712010|489299|P1|NOT COMPLETED|7th and Last Protein Testing (1 Day)||0
199398|NCT00712010|489299|P1|COMPLETED|7th and Last Protein Testing (1 Day)||23
199399|NCT00712010|489299|P1|STARTED|7th and Last Protein Testing (1 Day)||23
199400|NCT00712010|489299|P1|NOT COMPLETED|Washout (7 Days)||0
199401|NCT00712010|489299|P1|COMPLETED|Washout (7 Days)||23
199402|NCT00712010|489299|P1|STARTED|Washout (7 Days)||23
199403|NCT00712010|489299|P1|NOT COMPLETED|6th Protein Testing (1 Day)||0
199404|NCT00712010|489299|P1|COMPLETED|6th Protein Testing (1 Day)||23
199405|NCT00712010|489299|P1|STARTED|6th Protein Testing (1 Day)||23
199406|NCT00712010|489299|P1|NOT COMPLETED|Washout (7 Days)||0
199407|NCT00712010|489299|P1|COMPLETED|Washout (7 Days)||23
199408|NCT00712010|489299|P1|STARTED|Washout (7 Days)||23
199409|NCT00712010|489299|P1|NOT COMPLETED|5th Protein Testing (1 Day)||0
199410|NCT00712010|489299|P1|COMPLETED|5th Protein Testing (1 Day)||23
199411|NCT00712010|489299|P1|STARTED|5th Protein Testing (1 Day)||23
199412|NCT00712010|489299|P1|NOT COMPLETED|Washout (7 Days)||1
199413|NCT00712010|489299|P1|COMPLETED|Washout (7 Days)||23
199414|NCT00712010|489299|P1|STARTED|Washout (7 Days)||24
199415|NCT00712010|489299|P1|NOT COMPLETED|4th Protein Testing (1 Day)||0
199416|NCT00712010|489299|P1|COMPLETED|4th Protein Testing (1 Day)||24
199417|NCT00712010|489299|P1|STARTED|4th Protein Testing (1 Day)||24
199418|NCT00712010|489299|P1|NOT COMPLETED|Washout (7 Days)||0
199419|NCT00712010|489299|P1|COMPLETED|Washout (7 Days)||24
199420|NCT00712010|489299|P1|STARTED|Washout (7 Days)||24
199421|NCT00712010|489299|P1|NOT COMPLETED|3rd Protein Testing (1 Day)||0
199422|NCT00712010|489299|P1|COMPLETED|3rd Protein Testing (1 Day)||24
199423|NCT00712010|489299|P1|STARTED|3rd Protein Testing (1 Day)||24
199424|NCT00712010|489299|P1|NOT COMPLETED|Washout (7 Days)||0
199425|NCT00712010|489299|P1|COMPLETED|Washout (7 Days)||24
199426|NCT00712010|489299|P1|STARTED|Washout (7 Days)||24
199427|NCT00712010|489299|P1|NOT COMPLETED|2nd Protein Testing (1 Day)||0
199428|NCT00712010|489299|P1|COMPLETED|2nd Protein Testing (1 Day)||24
199429|NCT00712010|489299|P1|STARTED|2nd Protein Testing (1 Day)||24
199430|NCT00712010|489299|P1|NOT COMPLETED|Washout (7 Days)||0
199431|NCT00712010|489299|P1|COMPLETED|Washout (7 Days)||24
199432|NCT00712010|489299|P1|STARTED|Washout (7 Days)||24
199433|NCT00712010|489299|P1|NOT COMPLETED|1st Protein Testing (1 Day)||0
199434|NCT00712010|489299|P1|COMPLETED|1st Protein Testing (1 Day)||24
199435|NCT00712010|489299|P1|STARTED|1st Protein Testing (1 Day)|1 subject withdrew his consent form before to starting the 1st intervention|24
199436|NCT00712075|489325|P3|NOT COMPLETED|Overall Study||11
199437|NCT00712075|489326|P2|NOT COMPLETED|Overall Study||4
199438|NCT00712075|489327|P1|NOT COMPLETED|Overall Study||5
199439|NCT00712075|489325|P3|COMPLETED|Overall Study||14
199440|NCT00712075|489326|P2|COMPLETED|Overall Study||26
199441|NCT00712075|489327|P1|COMPLETED|Overall Study||17
199442|NCT00712075|489325|P3|STARTED|Overall Study||25
199443|NCT00712075|489326|P2|STARTED|Overall Study||30
199444|NCT00712075|489327|P1|STARTED|Overall Study||22
199445|NCT00712166|489343|P2|NOT COMPLETED|Overall Study||1
199446|NCT00712166|489344|P1|NOT COMPLETED|Overall Study||0
199447|NCT00712166|489343|P2|COMPLETED|Overall Study||75
199448|NCT00712166|489344|P1|COMPLETED|Overall Study||81
199449|NCT00712166|489343|P2|STARTED|Overall Study||76
199450|NCT00712166|489344|P1|STARTED|Overall Study||81
199451|NCT00712179|489368|P1|NOT COMPLETED|Overall Study||12
199452|NCT00712179|489368|P1|COMPLETED|Overall Study|Data from 4 subjects was excluded due to noise in recorded EMG signal, so 33 subjects were analysed.|37
199453|NCT00712179|489368|P1|STARTED|Overall Study||49
199454|NCT00712244|489376|P4|NOT COMPLETED|Overall Study||1
199455|NCT00712244|489377|P3|NOT COMPLETED|Overall Study||2
199456|NCT00712244|489378|P2|NOT COMPLETED|Overall Study||1
199457|NCT00712244|489379|P1|NOT COMPLETED|Overall Study||4
199458|NCT00712244|489376|P4|COMPLETED|Overall Study||26
199459|NCT00712244|489377|P3|COMPLETED|Overall Study||25
199460|NCT00712244|489378|P2|COMPLETED|Overall Study||28
199461|NCT00712244|489379|P1|COMPLETED|Overall Study||25
199462|NCT00712244|489376|P4|STARTED|Overall Study||27
199463|NCT00712244|489377|P3|STARTED|Overall Study||27
199464|NCT00712244|489378|P2|STARTED|Overall Study||29
199465|NCT00712244|489379|P1|STARTED|Overall Study||29
199466|NCT00712335|489426|P5|NOT COMPLETED|Overall Study||0
199467|NCT00712335|489427|P4|NOT COMPLETED|Overall Study||5
199468|NCT00712335|489428|P3|NOT COMPLETED|Overall Study||5
199469|NCT00712335|489429|P2|NOT COMPLETED|Overall Study||17
199470|NCT00712335|489430|P1|NOT COMPLETED|Overall Study||3
199471|NCT00712335|489426|P5|COMPLETED|Overall Study||30
199472|NCT00712335|489427|P4|COMPLETED|Overall Study||19
199473|NCT00712335|489428|P3|COMPLETED|Overall Study||6
199474|NCT00712335|489429|P2|COMPLETED|Overall Study||15
199475|NCT00712335|489430|P1|COMPLETED|Overall Study||5
199476|NCT00712335|489426|P5|STARTED|Overall Study||30
199477|NCT00712335|489427|P4|STARTED|Overall Study||24
199478|NCT00712335|489428|P3|STARTED|Overall Study||11
199479|NCT00712335|489429|P2|STARTED|Overall Study||32
199480|NCT00712335|489430|P1|STARTED|Overall Study||8
199481|NCT00712348|489472|P1|NOT COMPLETED|Overall Study||1
199482|NCT00712348|489472|P1|COMPLETED|Overall Study||30
199483|NCT00712348|489472|P1|STARTED|Overall Study||31
199484|NCT00712530|489482|P3|NOT COMPLETED|Overall Study||0
199485|NCT00712530|489483|P2|NOT COMPLETED|Overall Study||0
199486|NCT00712530|489484|P1|NOT COMPLETED|Overall Study||0
199487|NCT00712530|489482|P3|COMPLETED|Overall Study||3
199488|NCT00712530|489483|P2|COMPLETED|Overall Study||3
199489|NCT00712530|489484|P1|COMPLETED|Overall Study||3
199572|NCT00713206|489710|P1|NOT COMPLETED|Overall Study||7
199490|NCT00712530|489482|P3|STARTED|Overall Study|Screened 4 patients, but one failed to meet entry criteria due to a history of bleeding and diabetes|3
199491|NCT00712530|489483|P2|STARTED|Overall Study||3
199492|NCT00712530|489484|P1|STARTED|Overall Study||3
199493|NCT00712543|489509|P2|NOT COMPLETED|Day 8-14||2
199494|NCT00712543|489510|P1|NOT COMPLETED|Day 8-14||0
199495|NCT00712543|489509|P2|COMPLETED|Day 8-14||25
199496|NCT00712543|489510|P1|COMPLETED|Day 8-14||23
199497|NCT00712543|489509|P2|STARTED|Day 8-14||27
199498|NCT00712543|489510|P1|STARTED|Day 8-14||23
199499|NCT00712543|489509|P2|NOT COMPLETED|Day 1-7||0
199500|NCT00712543|489510|P1|NOT COMPLETED|Day 1-7||0
199501|NCT00712543|489509|P2|COMPLETED|Day 1-7||27
199502|NCT00712543|489510|P1|COMPLETED|Day 1-7||23
199503|NCT00712543|489509|P2|STARTED|Day 1-7||27
199504|NCT00712543|489510|P1|STARTED|Day 1-7||23
199505|NCT00712673|489519|P4|NOT COMPLETED|Overall Study||70
199506|NCT00712673|489520|P3|NOT COMPLETED|Overall Study||57
199507|NCT00712673|489521|P2|NOT COMPLETED|Overall Study||21
199508|NCT00712673|489522|P1|NOT COMPLETED|Overall Study||21
199509|NCT00712673|489519|P4|COMPLETED|Overall Study||185
199510|NCT00712673|489520|P3|COMPLETED|Overall Study||198
199511|NCT00712673|489521|P2|COMPLETED|Overall Study||64
199512|NCT00712673|489522|P1|COMPLETED|Overall Study||64
199513|NCT00712673|489519|P4|Subgroup for Standardized Meal Test|Overall Study||0
199514|NCT00712673|489520|P3|Subgroup for Standardized Meal Test|Overall Study||255
199515|NCT00712673|489521|P2|Subgroup for Standardized Meal Test|Overall Study||0
199516|NCT00712673|489522|P1|Subgroup for Standardized Meal Test|Overall Study|Patients from morning injection arms where standardized meal test was performed.|85
199517|NCT00712673|489519|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||255
199518|NCT00712673|489520|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||255
199519|NCT00712673|489521|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||85
199520|NCT00712673|489522|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|85
199521|NCT00712673|489519|P4|Safety Population|Overall Study||255
199522|NCT00712673|489520|P3|Safety Population|Overall Study||255
199523|NCT00712673|489521|P2|Safety Population|Overall Study||85
199524|NCT00712673|489522|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|85
199525|NCT00712673|489519|P4|STARTED|Overall Study||255
199526|NCT00712673|489520|P3|STARTED|Overall Study||255
199527|NCT00712673|489521|P2|STARTED|Overall Study||85
199528|NCT00712673|489522|P1|STARTED|Overall Study|Randomized.|85
199529|NCT00712725|489592|P8|NOT COMPLETED|Overall Study||11
199530|NCT00712725|489593|P7|NOT COMPLETED|Overall Study||22
199531|NCT00712725|489594|P6|NOT COMPLETED|Overall Study||16
199532|NCT00712725|489595|P5|NOT COMPLETED|Overall Study||19
199533|NCT00712725|489596|P4|NOT COMPLETED|Overall Study||17
199534|NCT00712725|489597|P3|NOT COMPLETED|Overall Study||10
199535|NCT00712725|489598|P2|NOT COMPLETED|Overall Study||6
199536|NCT00712725|489599|P1|NOT COMPLETED|Overall Study||29
199537|NCT00712725|489592|P8|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|63
199538|NCT00712725|489593|P7|COMPLETED|Overall Study|One patient received study drug. The remaining patients discontinued prior to receiving study drug.|61
199539|NCT00712725|489594|P6|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|68
199540|NCT00712725|489595|P5|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
199541|NCT00712725|489596|P4|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|67
199542|NCT00712725|489597|P3|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|47
199543|NCT00712725|489598|P2|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|33
199544|NCT00712725|489599|P1|COMPLETED|Overall Study|"The Not Completed patients discontinued prior to receiving study medication."|140
199545|NCT00712725|489592|P8|STARTED|Overall Study||74
199546|NCT00712725|489593|P7|STARTED|Overall Study||83
199547|NCT00712725|489594|P6|STARTED|Overall Study||84
199548|NCT00712725|489595|P5|STARTED|Overall Study||86
199549|NCT00712725|489596|P4|STARTED|Overall Study||84
199550|NCT00712725|489597|P3|STARTED|Overall Study||57
199551|NCT00712725|489598|P2|STARTED|Overall Study||39
199552|NCT00712725|489599|P1|STARTED|Overall Study||169
199553|NCT00712920|489660|P3|NOT COMPLETED|Overall Study||12
199554|NCT00712920|489661|P2|NOT COMPLETED|Overall Study||17
199555|NCT00712920|489662|P1|NOT COMPLETED|Overall Study||17
199556|NCT00712920|489660|P3|COMPLETED|Overall Study||180
199557|NCT00712920|489661|P2|COMPLETED|Overall Study||180
199558|NCT00712920|489662|P1|COMPLETED|Overall Study||175
199559|NCT00712920|489660|P3|STARTED|Overall Study||192
199560|NCT00712920|489661|P2|STARTED|Overall Study|3 subjects were randomized in error|197
199561|NCT00712920|489662|P1|STARTED|Overall Study||192
199562|NCT00712959|489684|P2|NOT COMPLETED|Overall Study||3
199563|NCT00712959|489685|P1|NOT COMPLETED|Overall Study||19
199564|NCT00712959|489684|P2|COMPLETED|Overall Study||404
199565|NCT00712959|489685|P1|COMPLETED|Overall Study||342
199566|NCT00712959|489684|P2|STARTED|Overall Study||407
199567|NCT00712959|489685|P1|STARTED|Overall Study||361
199568|NCT00712985|489703|P1|NOT COMPLETED|Overall Study||5
199569|NCT00712985|489703|P1|COMPLETED|Overall Study||13
199570|NCT00712985|489703|P1|STARTED|Overall Study||18
199571|NCT00713206|489709|P2|NOT COMPLETED|Overall Study||3
199573|NCT00713206|489709|P2|COMPLETED|Overall Study||27
199574|NCT00713206|489710|P1|COMPLETED|Overall Study||55
199575|NCT00713206|489709|P2|STARTED|Overall Study||30
199576|NCT00713206|489710|P1|STARTED|Overall Study||62
199577|NCT00713219|489716|P1|NOT COMPLETED|Overall Study||2
199578|NCT00713219|489716|P1|COMPLETED|Overall Study||12
199579|NCT00713219|489716|P1|STARTED|Overall Study||14
199580|NCT00713258|489722|P2|NOT COMPLETED|Overall Study||6
199581|NCT00713258|489723|P1|NOT COMPLETED|Overall Study||5
199582|NCT00713258|489722|P2|COMPLETED|Overall Study||28
199583|NCT00713258|489723|P1|COMPLETED|Overall Study||36
199584|NCT00713258|489722|P2|STARTED|Overall Study||34
199585|NCT00713258|489723|P1|STARTED|Overall Study||41
199586|NCT00713310|489733|P2|NOT COMPLETED|Overall Study||6
199587|NCT00713310|489734|P1|NOT COMPLETED|Overall Study||5
199588|NCT00713310|489733|P2|COMPLETED|Overall Study||36
199589|NCT00713310|489734|P1|COMPLETED|Overall Study||36
199590|NCT00713310|489733|P2|mITT Population|Overall Study|1 subject randomized to high dose not dosed so not included in the mITT population.|41
199591|NCT00713310|489734|P1|mITT Population|Overall Study||41
199592|NCT00713310|489733|P2|STARTED|Overall Study||42
199593|NCT00713310|489734|P1|STARTED|Overall Study||41
199594|NCT00713323|489742|P1|NOT COMPLETED|Overall Study||146
199595|NCT00713323|489742|P1|COMPLETED|Overall Study||234
199596|NCT00713323|489742|P1|STARTED|Overall Study||380
199597|NCT00713349|489753|P1|NOT COMPLETED|Overall Study||1
199598|NCT00713349|489753|P1|COMPLETED|Overall Study||24
199599|NCT00713349|489753|P1|STARTED|Overall Study||25
199600|NCT00713479|489759|P2|NOT COMPLETED|Next Medication Condition||0
199601|NCT00713479|489760|P1|NOT COMPLETED|Next Medication Condition||0
199602|NCT00713479|489759|P2|COMPLETED|Next Medication Condition||6
199603|NCT00713479|489760|P1|COMPLETED|Next Medication Condition||2
199604|NCT00713479|489759|P2|STARTED|Next Medication Condition||6
199605|NCT00713479|489760|P1|STARTED|Next Medication Condition||2
199606|NCT00713479|489759|P2|NOT COMPLETED|Washout||0
199607|NCT00713479|489760|P1|NOT COMPLETED|Washout||0
199608|NCT00713479|489759|P2|COMPLETED|Washout||6
199609|NCT00713479|489760|P1|COMPLETED|Washout||2
199610|NCT00713479|489759|P2|STARTED|Washout||6
199611|NCT00713479|489760|P1|STARTED|Washout||2
199612|NCT00713479|489759|P2|NOT COMPLETED|First Medication Condition||0
199613|NCT00713479|489760|P1|NOT COMPLETED|First Medication Condition||4
199614|NCT00713479|489759|P2|COMPLETED|First Medication Condition||6
199615|NCT00713479|489760|P1|COMPLETED|First Medication Condition||2
199616|NCT00713479|489759|P2|STARTED|First Medication Condition||6
199617|NCT00713479|489760|P1|STARTED|First Medication Condition||6
199618|NCT00713544|489778|P6|NOT COMPLETED|Overall Study||9
199619|NCT00713544|489779|P5|NOT COMPLETED|Overall Study||8
199620|NCT00713544|489780|P4|NOT COMPLETED|Overall Study||10
199621|NCT00713544|489781|P3|NOT COMPLETED|Overall Study||11
199622|NCT00713544|489782|P2|NOT COMPLETED|Overall Study||6
199623|NCT00713544|489783|P1|NOT COMPLETED|Overall Study||7
199624|NCT00713544|489778|P6|COMPLETED|Overall Study||67
199625|NCT00713544|489779|P5|COMPLETED|Overall Study||57
199626|NCT00713544|489780|P4|COMPLETED|Overall Study||66
199627|NCT00713544|489781|P3|COMPLETED|Overall Study||41
199628|NCT00713544|489782|P2|COMPLETED|Overall Study||46
199629|NCT00713544|489783|P1|COMPLETED|Overall Study||45
199630|NCT00713544|489778|P6|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|76
199631|NCT00713544|489779|P5|STARTED|Overall Study||65
199632|NCT00713544|489780|P4|STARTED|Overall Study||76
199633|NCT00713544|489781|P3|STARTED|Overall Study|Participants randomised. One of these participants did not subsequently receive treatment.|52
199634|NCT00713544|489782|P2|STARTED|Overall Study||52
199635|NCT00713544|489783|P1|STARTED|Overall Study||52
199636|NCT00713596|489824|P3|NOT COMPLETED|Overall Study||2
199637|NCT00713596|489825|P2|NOT COMPLETED|Overall Study||3
199638|NCT00713596|489826|P1|NOT COMPLETED|Overall Study||2
199639|NCT00713596|489824|P3|COMPLETED|Overall Study||6
199640|NCT00713596|489825|P2|COMPLETED|Overall Study||5
199641|NCT00713596|489826|P1|COMPLETED|Overall Study||7
199642|NCT00713596|489824|P3|STARTED|Overall Study||8
199643|NCT00713596|489825|P2|STARTED|Overall Study||8
199644|NCT00713596|489826|P1|STARTED|Overall Study||9
199645|NCT00713609|489843|P6|NOT COMPLETED|Overall Study||8
199646|NCT00713609|489844|P5|NOT COMPLETED|Overall Study||19
199647|NCT00713609|489845|P4|NOT COMPLETED|Overall Study||9
199648|NCT00713609|489846|P3|NOT COMPLETED|Overall Study||15
199649|NCT00713609|489847|P2|NOT COMPLETED|Overall Study||15
199650|NCT00713609|489848|P1|NOT COMPLETED|Overall Study||21
199651|NCT00713609|489843|P6|COMPLETED|Overall Study||47
199652|NCT00713609|489844|P5|COMPLETED|Overall Study||87
199653|NCT00713609|489845|P4|COMPLETED|Overall Study||99
199654|NCT00713609|489846|P3|COMPLETED|Overall Study||92
199655|NCT00713609|489847|P2|COMPLETED|Overall Study||90
199656|NCT00713609|489848|P1|COMPLETED|Overall Study||85
199657|NCT00713609|489843|P6|STARTED|Overall Study||55
199658|NCT00713609|489844|P5|STARTED|Overall Study||106
199659|NCT00713609|489845|P4|STARTED|Overall Study||108
199660|NCT00713609|489846|P3|STARTED|Overall Study||107
199661|NCT00713609|489847|P2|STARTED|Overall Study||105
199662|NCT00713609|489848|P1|STARTED|Overall Study||106
199663|NCT00713648|489880|P1|NOT COMPLETED|Overall Study||8
199664|NCT00713648|489880|P1|COMPLETED|Overall Study||33
199665|NCT00713648|489880|P1|STARTED|Overall Study||41
199666|NCT00713661|489891|P4|NOT COMPLETED|Overall Study||0
199667|NCT00713661|489892|P3|NOT COMPLETED|Overall Study||0
199668|NCT00713661|489893|P2|NOT COMPLETED|Overall Study||0
199669|NCT00713661|489894|P1|NOT COMPLETED|Overall Study||0
199670|NCT00713661|489891|P4|COMPLETED|Overall Study||5
199671|NCT00713661|489892|P3|COMPLETED|Overall Study||4
199672|NCT00713661|489893|P2|COMPLETED|Overall Study||9
199673|NCT00713661|489894|P1|COMPLETED|Overall Study||7
199674|NCT00713661|489891|P4|STARTED|Overall Study||5
199675|NCT00713661|489892|P3|STARTED|Overall Study||4
199676|NCT00713661|489893|P2|STARTED|Overall Study||9
199677|NCT00713661|489894|P1|STARTED|Overall Study||7
199678|NCT00713700|489908|P1|NOT COMPLETED|Overall Study||4
199679|NCT00713700|489908|P1|COMPLETED|Overall Study||188
199680|NCT00713700|489908|P1|STARTED|Overall Study||192
199681|NCT00713817|489915|P2|NOT COMPLETED|Overall Study||0
199682|NCT00713817|489916|P1|NOT COMPLETED|Overall Study||0
199683|NCT00713817|489915|P2|COMPLETED|Overall Study||9
199684|NCT00713817|489916|P1|COMPLETED|Overall Study||10
199685|NCT00713817|489915|P2|STARTED|Overall Study||9
199686|NCT00713817|489916|P1|STARTED|Overall Study||10
199687|NCT00713830|489936|P2|NOT COMPLETED|Overall Study||177
199688|NCT00713830|489937|P1|NOT COMPLETED|Overall Study||82
199689|NCT00713830|489936|P2|COMPLETED|Overall Study||396
199690|NCT00713830|489937|P1|COMPLETED|Overall Study||204
199691|NCT00713830|489936|P2|Subgroup for Standardized Meal Test|Overall Study||313
199692|NCT00713830|489937|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal challenge test was performed.|155
199693|NCT00713830|489936|P2|Safety Population|Overall Study|1 patient randomized to placebo received Lixisenatide (at least one dose)|574
199694|NCT00713830|489937|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|285
199695|NCT00713830|489936|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||570
199696|NCT00713830|489937|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|286
199697|NCT00713830|489936|P2|STARTED|Overall Study||573
199698|NCT00713830|489937|P1|STARTED|Overall Study|Randomized.|286
199699|NCT00714051|489975|P2|NOT COMPLETED|Overall Study||1
199700|NCT00714051|489976|P1|NOT COMPLETED|Overall Study||1
199701|NCT00714051|489975|P2|COMPLETED|Overall Study||27
199702|NCT00714051|489976|P1|COMPLETED|Overall Study||26
199703|NCT00714051|489975|P2|STARTED|Overall Study||28
199704|NCT00714051|489976|P1|STARTED|Overall Study||27
199705|NCT00714168|489984|P2|NOT COMPLETED|Overall Study||59
199706|NCT00714168|489985|P1|NOT COMPLETED|Overall Study||44
199707|NCT00714168|489984|P2|COMPLETED|Overall Study||139
199708|NCT00714168|489985|P1|COMPLETED|Overall Study||121
199709|NCT00714168|489984|P2|STARTED|Overall Study||198
199710|NCT00714168|489985|P1|STARTED|Overall Study||165
199711|NCT00714233|490003|P4|NOT COMPLETED|Overall Study||4
199712|NCT00714233|490004|P3|NOT COMPLETED|Overall Study||1
199713|NCT00714233|490005|P2|NOT COMPLETED|Overall Study||1
199714|NCT00714233|490006|P1|NOT COMPLETED|Overall Study||4
199715|NCT00714233|490003|P4|COMPLETED|Overall Study||6
199716|NCT00714233|490004|P3|COMPLETED|Overall Study||10
199717|NCT00714233|490005|P2|COMPLETED|Overall Study||10
199718|NCT00714233|490006|P1|COMPLETED|Overall Study||6
199719|NCT00714233|490003|P4|STARTED|Overall Study||10
199720|NCT00714233|490004|P3|STARTED|Overall Study||11
199721|NCT00714233|490005|P2|STARTED|Overall Study||11
199722|NCT00714233|490006|P1|STARTED|Overall Study||10
199723|NCT00714259|490033|P1|NOT COMPLETED|Overall Study||2
199724|NCT00714259|490033|P1|COMPLETED|Overall Study||3
199725|NCT00714259|490033|P1|STARTED|Overall Study||5
199726|NCT00714285|490047|P4|NOT COMPLETED|Overall Study||1
199727|NCT00714285|490048|P3|NOT COMPLETED|Overall Study||0
199728|NCT00714285|490049|P2|NOT COMPLETED|Overall Study||3
199729|NCT00714285|490050|P1|NOT COMPLETED|Overall Study||0
199730|NCT00714285|490047|P4|COMPLETED|Overall Study|Completed upto Day 180|104
199731|NCT00714285|490048|P3|COMPLETED|Overall Study|Completed upto Day 180|105
199732|NCT00714285|490049|P2|COMPLETED|Overall Study|Completed upto Day 180|102
199733|NCT00714285|490050|P1|COMPLETED|Overall Study|Completed upto Day 180|105
199734|NCT00714285|490047|P4|STARTED|Overall Study||105
199735|NCT00714285|490048|P3|STARTED|Overall Study||105
199736|NCT00714285|490049|P2|STARTED|Overall Study||105
199737|NCT00714285|490050|P1|STARTED|Overall Study||105
199738|NCT00714311|490102|P2|NOT COMPLETED|Overall Study||22
199739|NCT00714311|490103|P1|NOT COMPLETED|Overall Study||13
199740|NCT00714311|490102|P2|COMPLETED|Overall Study||30
199741|NCT00714311|490103|P1|COMPLETED|Overall Study||39
199742|NCT00714311|490102|P2|STARTED|Overall Study||52
199743|NCT00714311|490103|P1|STARTED|Overall Study||52
199744|NCT00714389|490109|P1|NOT COMPLETED|Overall Study||0
199745|NCT00714389|490109|P1|COMPLETED|Overall Study||12
199746|NCT00714389|490109|P1|STARTED|Overall Study||12
199747|NCT00705679|490119|P5|NOT COMPLETED|Overall Study||69
199748|NCT00705679|490120|P4|NOT COMPLETED|Overall Study||80
199749|NCT00705679|490121|P3|NOT COMPLETED|Overall Study||115
199750|NCT00705679|490122|P2|NOT COMPLETED|Overall Study||139
199751|NCT00705679|490123|P1|NOT COMPLETED|Overall Study||65
199752|NCT00705679|490119|P5|COMPLETED|Overall Study||934
199753|NCT00705679|490120|P4|COMPLETED|Overall Study||927
199754|NCT00705679|490121|P3|COMPLETED|Overall Study||894
199755|NCT00705679|490122|P2|COMPLETED|Overall Study||864
199756|NCT00705679|490123|P1|COMPLETED|Overall Study||942
199757|NCT00705679|490119|P5|STARTED|Overall Study||1003
199758|NCT00705679|490120|P4|STARTED|Overall Study||1007
199759|NCT00705679|490121|P3|STARTED|Overall Study||1009
199760|NCT00705679|490122|P2|STARTED|Overall Study||1003
199761|NCT00705679|490123|P1|STARTED|Overall Study||1007
199762|NCT00705718|490160|P2|NOT COMPLETED|Overall Study||22
199763|NCT00705718|490161|P1|NOT COMPLETED|Overall Study||7
199764|NCT00705718|490160|P2|COMPLETED|Overall Study||128
199765|NCT00705718|490161|P1|COMPLETED|Overall Study||37
199766|NCT00705718|490160|P2|12 Month Follow up|Overall Study|4 Deaths, 12 Subjects Not due for next visit, 4 Subjects Missed Visit|128
199767|NCT00705718|490161|P1|12 Month Follow up|Overall Study|2 Deaths|37
199768|NCT00705718|490160|P2|6 Month Follow up|Overall Study|2 Deaths, 5 Subjects Missed Visit|143
199769|NCT00705718|490161|P1|6 Month Follow up|Overall Study|3 Deaths|40
199770|NCT00705718|490160|P2|1 Month Follow up|Overall Study|1 Subject Missed Visit|149
199771|NCT00705718|490161|P1|1 Month Follow up|Overall Study|1 Death|43
199772|NCT00705718|490160|P2|STARTED|Overall Study||150
199773|NCT00705718|490161|P1|STARTED|Overall Study||44
199774|NCT00705757|490180|P3|NOT COMPLETED|Overall Study||11
199775|NCT00705757|490181|P2|NOT COMPLETED|Overall Study||8
199776|NCT00705757|490182|P1|NOT COMPLETED|Overall Study||13
199777|NCT00705757|490180|P3|COMPLETED|Overall Study||17
199778|NCT00705757|490181|P2|COMPLETED|Overall Study||21
199779|NCT00705757|490182|P1|COMPLETED|Overall Study||19
199780|NCT00705757|490180|P3|STARTED|Overall Study||28
199781|NCT00705757|490181|P2|STARTED|Overall Study||29
199782|NCT00705757|490182|P1|STARTED|Overall Study||32
199783|NCT00705783|490192|P3|NOT COMPLETED|Depot Maintenance Phase||131
199784|NCT00705783|490193|P2|NOT COMPLETED|Depot Maintenance Phase||246
199785|NCT00705783|490194|P1|NOT COMPLETED|Depot Maintenance Phase||0
199786|NCT00705783|490192|P3|COMPLETED|Depot Maintenance Phase||3
199787|NCT00705783|490193|P2|COMPLETED|Depot Maintenance Phase||23
199788|NCT00705783|490194|P1|COMPLETED|Depot Maintenance Phase||0
199789|NCT00705783|490192|P3|STARTED|Depot Maintenance Phase||134
199790|NCT00705783|490193|P2|STARTED|Depot Maintenance Phase||269
199791|NCT00705783|490194|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the aripiprazole and placebo depot groups in this phase of the study.|0
199792|NCT00705783|490192|P3|NOT COMPLETED|Depot Stabilization Phase||0
199793|NCT00705783|490193|P2|NOT COMPLETED|Depot Stabilization Phase||0
199794|NCT00705783|490194|P1|NOT COMPLETED|Depot Stabilization Phase||173
199795|NCT00705783|490192|P3|COMPLETED|Depot Stabilization Phase||0
199796|NCT00705783|490193|P2|COMPLETED|Depot Stabilization Phase||0
199797|NCT00705783|490194|P1|COMPLETED|Depot Stabilization Phase||403
199798|NCT00705783|490192|P3|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
199799|NCT00705783|490193|P2|STARTED|Depot Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
199800|NCT00705783|490194|P1|STARTED|Depot Stabilization Phase||576
199801|NCT00705783|490192|P3|NOT COMPLETED|Oral Stabilization Phase||0
199802|NCT00705783|490193|P2|NOT COMPLETED|Oral Stabilization Phase||0
199803|NCT00705783|490194|P1|NOT COMPLETED|Oral Stabilization Phase||134
199804|NCT00705783|490192|P3|COMPLETED|Oral Stabilization Phase||0
199805|NCT00705783|490193|P2|COMPLETED|Oral Stabilization Phase||0
199806|NCT00705783|490194|P1|COMPLETED|Oral Stabilization Phase||576
199807|NCT00705783|490192|P3|Received Study Medication|Oral Stabilization Phase||0
199808|NCT00705783|490193|P2|Received Study Medication|Oral Stabilization Phase||0
199809|NCT00705783|490194|P1|Received Study Medication|Oral Stabilization Phase||709
199810|NCT00705783|490192|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
199811|NCT00705783|490193|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
199812|NCT00705783|490194|P1|STARTED|Oral Stabilization Phase|210 of the 710 patients who started this phase enrolled in this study directly into this phase.|710
199813|NCT00705783|490192|P3|NOT COMPLETED|Conversion Phase||0
199814|NCT00705783|490193|P2|NOT COMPLETED|Conversion Phase||0
199815|NCT00705783|490194|P1|NOT COMPLETED|Conversion Phase||133
199816|NCT00705783|490192|P3|COMPLETED|Conversion Phase||0
199817|NCT00705783|490193|P2|COMPLETED|Conversion Phase||0
199818|NCT00705783|490194|P1|COMPLETED|Conversion Phase||500
199819|NCT00705783|490192|P3|Received Study Medication|Conversion Phase||0
199820|NCT00705783|490193|P2|Received Study Medication|Conversion Phase||0
199821|NCT00705783|490194|P1|Received Study Medication|Conversion Phase||632
199822|NCT00705783|490192|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
199823|NCT00705783|490193|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
199824|NCT00705783|490194|P1|STARTED|Conversion Phase||633
199825|NCT00705874|490228|P7|NOT COMPLETED|Overall Study||0
199826|NCT00705874|490229|P6|NOT COMPLETED|Overall Study||4
199827|NCT00705874|490230|P5|NOT COMPLETED|Overall Study||12
199828|NCT00705874|490231|P4|NOT COMPLETED|Overall Study||1
199829|NCT00705874|490232|P3|NOT COMPLETED|Overall Study||2
199830|NCT00705874|490233|P2|NOT COMPLETED|Overall Study||1
199831|NCT00705874|490234|P1|NOT COMPLETED|Overall Study||2
199832|NCT00705874|490228|P7|COMPLETED|Overall Study||3
199833|NCT00705874|490229|P6|COMPLETED|Overall Study||28
199834|NCT00705874|490230|P5|COMPLETED|Overall Study||36
199835|NCT00705874|490231|P4|COMPLETED|Overall Study||33
199836|NCT00705874|490232|P3|COMPLETED|Overall Study||32
199837|NCT00705874|490233|P2|COMPLETED|Overall Study||8
199838|NCT00705874|490234|P1|COMPLETED|Overall Study||10
199839|NCT00705874|490228|P7|STARTED|Overall Study||3
199840|NCT00705874|490229|P6|STARTED|Overall Study||32
199841|NCT00705874|490230|P5|STARTED|Overall Study||48
199842|NCT00705874|490231|P4|STARTED|Overall Study||34
199843|NCT00705874|490232|P3|STARTED|Overall Study||34
199844|NCT00705874|490233|P2|STARTED|Overall Study||9
199845|NCT00705874|490234|P1|STARTED|Overall Study||12
199846|NCT00705939|490253|P3|NOT COMPLETED|Overall Study||4
199847|NCT00705939|490254|P2|NOT COMPLETED|Overall Study||2
199848|NCT00705939|490255|P1|NOT COMPLETED|Overall Study||0
199849|NCT00705939|490253|P3|COMPLETED|Overall Study||14
199850|NCT00705939|490254|P2|COMPLETED|Overall Study||12
199851|NCT00705939|490255|P1|COMPLETED|Overall Study||12
199852|NCT00705939|490253|P3|STARTED|Overall Study|1 subject enrolled but not treated in this protocol.|18
199853|NCT00705939|490254|P2|STARTED|Overall Study||14
199854|NCT00705939|490255|P1|STARTED|Overall Study||12
199855|NCT00706004|490278|P1|NOT COMPLETED|Overall Study||2
199856|NCT00706004|490278|P1|COMPLETED|Overall Study||7
199857|NCT00706004|490278|P1|STARTED|Overall Study||9
199858|NCT00706095|490306|P3|NOT COMPLETED|Overall Study||5
199859|NCT00706095|490307|P2|NOT COMPLETED|Overall Study||7
199860|NCT00706095|490308|P1|NOT COMPLETED|Overall Study||6
199861|NCT00706095|490306|P3|COMPLETED|Overall Study||0
199862|NCT00706095|490307|P2|COMPLETED|Overall Study||0
199863|NCT00706095|490308|P1|COMPLETED|Overall Study||0
199864|NCT00706095|490306|P3|STARTED|Overall Study||5
199865|NCT00706095|490307|P2|STARTED|Overall Study||7
199866|NCT00706095|490308|P1|STARTED|Overall Study||6
199867|NCT00706121|490326|P4|NOT COMPLETED|Overall Study||352
199868|NCT00706121|490327|P3|NOT COMPLETED|Overall Study||404
199869|NCT00706121|490328|P2|NOT COMPLETED|Overall Study||396
199870|NCT00706121|490329|P1|NOT COMPLETED|Overall Study||396
199871|NCT00706121|490326|P4|COMPLETED|Overall Study||1577
199872|NCT00706121|490327|P3|COMPLETED|Overall Study||1626
199873|NCT00706121|490328|P2|COMPLETED|Overall Study||1700
199874|NCT00706121|490329|P1|COMPLETED|Overall Study||1643
199875|NCT00706121|490326|P4|STARTED|Overall Study||1929
199876|NCT00706121|490327|P3|STARTED|Overall Study||2030
199877|NCT00706121|490328|P2|STARTED|Overall Study||2096
199878|NCT00706121|490329|P1|STARTED|Overall Study||2039
199879|NCT00706134|490359|P4|NOT COMPLETED|Overall Study||11
199880|NCT00706134|490360|P3|NOT COMPLETED|Overall Study||6
199881|NCT00706134|490361|P2|NOT COMPLETED|Overall Study||19
199882|NCT00706134|490362|P1|NOT COMPLETED|Overall Study||20
199883|NCT00706134|490359|P4|COMPLETED|Overall Study||175
199884|NCT00706134|490360|P3|COMPLETED|Overall Study||183
199885|NCT00706134|490361|P2|COMPLETED|Overall Study||173
199886|NCT00706134|490362|P1|COMPLETED|Overall Study||169
199887|NCT00706134|490359|P4|Entered Double-blind Period|Overall Study||186
199888|NCT00706134|490360|P3|Entered Double-blind Period|Overall Study||189
199889|NCT00706134|490361|P2|Entered Double-blind Period|Overall Study||192
199890|NCT00706134|490362|P1|Entered Double-blind Period|Overall Study||187
199891|NCT00706134|490359|P4|STARTED|Overall Study||186
199892|NCT00706134|490360|P3|STARTED|Overall Study||189
199893|NCT00706134|490361|P2|STARTED|Overall Study||192
199894|NCT00706134|490362|P1|STARTED|Overall Study||189
199895|NCT00706329|490392|P1|NOT COMPLETED|Overall Study||0
199896|NCT00706329|490392|P1|COMPLETED|Overall Study||25
199897|NCT00706329|490392|P1|STARTED|Overall Study||25
199898|NCT00706342|490396|P1|NOT COMPLETED|Overall Study||18
199899|NCT00706342|490396|P1|COMPLETED|Overall Study||0
199900|NCT00706342|490396|P1|STARTED|Overall Study||18
199901|NCT00706355|490409|P4|NOT COMPLETED|Period 4: PF-04217903 150 mg||4
199902|NCT00706355|490410|P3|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
199903|NCT00706355|490411|P2|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
199904|NCT00706355|490412|P1|NOT COMPLETED|Period 4: PF-04217903 150 mg||0
199905|NCT00706355|490409|P4|COMPLETED|Period 4: PF-04217903 150 mg||0
199906|NCT00706355|490410|P3|COMPLETED|Period 4: PF-04217903 150 mg||0
199907|NCT00706355|490411|P2|COMPLETED|Period 4: PF-04217903 150 mg||0
199908|NCT00706355|490412|P1|COMPLETED|Period 4: PF-04217903 150 mg||0
199909|NCT00706355|490409|P4|STARTED|Period 4: PF-04217903 150 mg||4
199910|NCT00706355|490410|P3|STARTED|Period 4: PF-04217903 150 mg||0
199911|NCT00706355|490411|P2|STARTED|Period 4: PF-04217903 150 mg||0
199912|NCT00706355|490412|P1|STARTED|Period 4: PF-04217903 150 mg||0
199913|NCT00706355|490409|P4|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
199914|NCT00706355|490410|P3|NOT COMPLETED|Period 3: PF-04217903 200 mg||2
199915|NCT00706355|490411|P2|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
199916|NCT00706355|490412|P1|NOT COMPLETED|Period 3: PF-04217903 200 mg||0
199917|NCT00706355|490409|P4|COMPLETED|Period 3: PF-04217903 200 mg||0
199918|NCT00706355|490410|P3|COMPLETED|Period 3: PF-04217903 200 mg||0
199919|NCT00706355|490411|P2|COMPLETED|Period 3: PF-04217903 200 mg||0
199920|NCT00706355|490412|P1|COMPLETED|Period 3: PF-04217903 200 mg||0
199921|NCT00706355|490409|P4|STARTED|Period 3: PF-04217903 200 mg||0
199922|NCT00706355|490410|P3|STARTED|Period 3: PF-04217903 200 mg||2
199923|NCT00706355|490411|P2|STARTED|Period 3: PF-04217903 200 mg||0
199924|NCT00706355|490412|P1|STARTED|Period 3: PF-04217903 200 mg||0
199925|NCT00706355|490409|P4|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
199926|NCT00706355|490410|P3|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
199927|NCT00706355|490411|P2|NOT COMPLETED|Period 2: PF-04217903 100 mg||7
199928|NCT00706355|490412|P1|NOT COMPLETED|Period 2: PF-04217903 100 mg||0
199929|NCT00706355|490409|P4|COMPLETED|Period 2: PF-04217903 100 mg||0
199930|NCT00706355|490410|P3|COMPLETED|Period 2: PF-04217903 100 mg||0
199931|NCT00706355|490411|P2|COMPLETED|Period 2: PF-04217903 100 mg||0
199932|NCT00706355|490412|P1|COMPLETED|Period 2: PF-04217903 100 mg||0
199933|NCT00706355|490409|P4|STARTED|Period 2: PF-04217903 100 mg||0
199934|NCT00706355|490410|P3|STARTED|Period 2: PF-04217903 100 mg||0
199935|NCT00706355|490411|P2|STARTED|Period 2: PF-04217903 100 mg||7
199936|NCT00706355|490412|P1|STARTED|Period 2: PF-04217903 100 mg||0
199937|NCT00706355|490409|P4|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
199938|NCT00706355|490410|P3|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
199939|NCT00706355|490411|P2|NOT COMPLETED|Period 1: PF-04217903 50 mg||0
199940|NCT00706355|490412|P1|NOT COMPLETED|Period 1: PF-04217903 50 mg||3
199941|NCT00706355|490409|P4|COMPLETED|Period 1: PF-04217903 50 mg||0
199942|NCT00706355|490410|P3|COMPLETED|Period 1: PF-04217903 50 mg||0
199943|NCT00706355|490411|P2|COMPLETED|Period 1: PF-04217903 50 mg||0
199944|NCT00706355|490412|P1|COMPLETED|Period 1: PF-04217903 50 mg||0
199945|NCT00706355|490409|P4|STARTED|Period 1: PF-04217903 50 mg||0
199946|NCT00706355|490410|P3|STARTED|Period 1: PF-04217903 50 mg||0
199947|NCT00706355|490411|P2|STARTED|Period 1: PF-04217903 50 mg||0
199948|NCT00706355|490412|P1|STARTED|Period 1: PF-04217903 50 mg||3
199949|NCT00706433|490468|P4|NOT COMPLETED|Overall Study||2
199950|NCT00706433|490469|P3|NOT COMPLETED|Overall Study||10
199951|NCT00706433|490470|P2|NOT COMPLETED|Overall Study||3
199952|NCT00706433|490471|P1|NOT COMPLETED|Overall Study||5
199953|NCT00706433|490468|P4|COMPLETED|Overall Study||64
199954|NCT00706433|490469|P3|COMPLETED|Overall Study||57
199955|NCT00706433|490470|P2|COMPLETED|Overall Study||62
199956|NCT00706433|490471|P1|COMPLETED|Overall Study||63
199957|NCT00706433|490468|P4|STARTED|Overall Study||66
199958|NCT00706433|490469|P3|STARTED|Overall Study||67
199959|NCT00706433|490470|P2|STARTED|Overall Study||65
199960|NCT00706433|490471|P1|STARTED|Overall Study||68
199961|NCT00706446|490791|P6|NOT COMPLETED|Overall Study||38
199962|NCT00706446|490792|P5|NOT COMPLETED|Overall Study||44
199963|NCT00706446|490793|P4|NOT COMPLETED|Overall Study||22
199964|NCT00706446|490794|P3|NOT COMPLETED|Overall Study||37
199965|NCT00706446|490795|P2|NOT COMPLETED|Overall Study||49
199966|NCT00706446|490796|P1|NOT COMPLETED|Overall Study||26
199967|NCT00706446|490791|P6|COMPLETED|Overall Study||7
199968|NCT00706446|490792|P5|COMPLETED|Overall Study||10
199969|NCT00706446|490793|P4|COMPLETED|Overall Study||4
199970|NCT00706446|490794|P3|COMPLETED|Overall Study||7
199971|NCT00706446|490795|P2|COMPLETED|Overall Study||8
199972|NCT00706446|490796|P1|COMPLETED|Overall Study||3
199973|NCT00706446|490791|P6|STARTED|Overall Study||45
199974|NCT00706446|490792|P5|STARTED|Overall Study||54
199975|NCT00706446|490793|P4|STARTED|Overall Study||26
199976|NCT00706446|490794|P3|STARTED|Overall Study||44
199977|NCT00706446|490795|P2|STARTED|Overall Study||57
199978|NCT00706446|490796|P1|STARTED|Overall Study||29
199979|NCT00706485|490834|P1|NOT COMPLETED|Overall Study||0
199980|NCT00706485|490834|P1|COMPLETED|Overall Study||5
199981|NCT00706485|490834|P1|STARTED|Overall Study||5
199982|NCT00706550|490842|P2|NOT COMPLETED|Overall Study||28
199983|NCT00706550|490843|P1|NOT COMPLETED|Overall Study||7
199984|NCT00706550|490842|P2|COMPLETED|Overall Study||36
199985|NCT00706550|490843|P1|COMPLETED|Overall Study||36
199986|NCT00706550|490842|P2|STARTED|Overall Study||64
199987|NCT00706550|490843|P1|STARTED|Overall Study||43
199988|NCT00706563|490861|P2|NOT COMPLETED|Overall Study||0
199989|NCT00706563|490862|P1|NOT COMPLETED|Overall Study||0
199990|NCT00706563|490861|P2|COMPLETED|Overall Study||59
199991|NCT00706563|490862|P1|COMPLETED|Overall Study||61
199992|NCT00706563|490861|P2|STARTED|Overall Study||59
199993|NCT00706563|490862|P1|STARTED|Overall Study||61
199994|NCT00706589|490886|P2|NOT COMPLETED|Overall Study||4
199995|NCT00706589|490887|P1|NOT COMPLETED|Overall Study||3
199996|NCT00706589|490886|P2|COMPLETED|Overall Study||25
199997|NCT00706589|490887|P1|COMPLETED|Overall Study||29
199998|NCT00706589|490886|P2|STARTED|Overall Study||29
199999|NCT00706589|490887|P1|STARTED|Overall Study||32
200000|NCT00706628|490897|P4|NOT COMPLETED|Overall Study||3
200001|NCT00706628|490898|P3|NOT COMPLETED|Overall Study||16
200002|NCT00706628|490899|P2|NOT COMPLETED|Overall Study||21
200003|NCT00706628|490900|P1|NOT COMPLETED|Overall Study||47
200004|NCT00706628|490897|P4|COMPLETED|Overall Study||0
200005|NCT00706628|490898|P3|COMPLETED|Overall Study||0
200006|NCT00706628|490899|P2|COMPLETED|Overall Study||0
200007|NCT00706628|490900|P1|COMPLETED|Overall Study||0
200008|NCT00706628|490897|P4|STARTED|Overall Study||3
200009|NCT00706628|490898|P3|STARTED|Overall Study||16
200010|NCT00706628|490899|P2|STARTED|Overall Study||21
200011|NCT00706628|490900|P1|STARTED|Overall Study||47
200012|NCT00706641|490948|P1|NOT COMPLETED|Radical Cystectomy||1
200013|NCT00706641|490948|P1|COMPLETED|Radical Cystectomy||22
200014|NCT00706641|490948|P1|STARTED|Radical Cystectomy||23
200015|NCT00706641|490948|P1|NOT COMPLETED|Dasatinib Administration||2
200016|NCT00706641|490948|P1|COMPLETED|Dasatinib Administration||23
200017|NCT00706641|490948|P1|Toxicity Evaluation|Dasatinib Administration||24
200018|NCT00706641|490948|P1|STARTED|Dasatinib Administration||25
200019|NCT00706654|490961|P4|NOT COMPLETED|Depot Maintenance Phase||70
200020|NCT00706654|490962|P3|NOT COMPLETED|Depot Maintenance Phase||88
200021|NCT00706654|490963|P2|NOT COMPLETED|Depot Maintenance Phase||69
200022|NCT00706654|490964|P1|NOT COMPLETED|Depot Maintenance Phase||0
200023|NCT00706654|490961|P4|COMPLETED|Depot Maintenance Phase||61
200024|NCT00706654|490962|P3|COMPLETED|Depot Maintenance Phase||178
200025|NCT00706654|490963|P2|COMPLETED|Depot Maintenance Phase||196
200026|NCT00706654|490964|P1|COMPLETED|Depot Maintenance Phase||0
200027|NCT00706654|490961|P4|STARTED|Depot Maintenance Phase||131
200028|NCT00706654|490962|P3|STARTED|Depot Maintenance Phase||266
200029|NCT00706654|490963|P2|STARTED|Depot Maintenance Phase||265
200030|NCT00706654|490964|P1|STARTED|Depot Maintenance Phase|Patients were randomized into the 3 aripiprazole treatment groups in this phase of the study.|0
200031|NCT00706654|490961|P4|NOT COMPLETED|Oral Stabilization Phase||0
200032|NCT00706654|490962|P3|NOT COMPLETED|Oral Stabilization Phase||0
200033|NCT00706654|490963|P2|NOT COMPLETED|Oral Stabilization Phase||0
200034|NCT00706654|490964|P1|NOT COMPLETED|Oral Stabilization Phase||180
200035|NCT00706654|490961|P4|COMPLETED|Oral Stabilization Phase||0
200036|NCT00706654|490962|P3|COMPLETED|Oral Stabilization Phase||0
200037|NCT00706654|490963|P2|COMPLETED|Oral Stabilization Phase||0
200038|NCT00706654|490964|P1|COMPLETED|Oral Stabilization Phase||662
200039|NCT00706654|490961|P4|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
200040|NCT00706654|490962|P3|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
200041|NCT00706654|490963|P2|STARTED|Oral Stabilization Phase|There were no patients in this reporting group in this phase of the study.|0
200042|NCT00706654|490964|P1|STARTED|Oral Stabilization Phase|228 of the 842 patients who started this phase enrolled directly into this phase of the study.|842
200043|NCT00706654|490961|P4|NOT COMPLETED|Conversion Phase||0
200044|NCT00706654|490962|P3|NOT COMPLETED|Conversion Phase||0
200045|NCT00706654|490963|P2|NOT COMPLETED|Conversion Phase||0
200046|NCT00706654|490964|P1|NOT COMPLETED|Conversion Phase||95
200047|NCT00706654|490961|P4|COMPLETED|Conversion Phase||0
200048|NCT00706654|490962|P3|COMPLETED|Conversion Phase||0
200049|NCT00706654|490963|P2|COMPLETED|Conversion Phase||0
200050|NCT00706654|490964|P1|COMPLETED|Conversion Phase||614
200051|NCT00706654|490961|P4|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
200052|NCT00706654|490962|P3|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
200053|NCT00706654|490963|P2|STARTED|Conversion Phase|There were no patients in this reporting group in this phase of the study.|0
200054|NCT00706654|490964|P1|STARTED|Conversion Phase||709
200055|NCT00706706|490983|P1|NOT COMPLETED|Overall Study||105
200056|NCT00706706|490983|P1|COMPLETED|Overall Study||0
200057|NCT00706706|490983|P1|STARTED|Overall Study||105
200058|NCT00706719|490993|P3|NOT COMPLETED|Overall Study||4
200059|NCT00706719|490994|P2|NOT COMPLETED|Overall Study||1
200060|NCT00706719|490995|P1|NOT COMPLETED|Overall Study||0
200061|NCT00706719|490993|P3|COMPLETED|Overall Study||1
200062|NCT00706719|490994|P2|COMPLETED|Overall Study||6
200063|NCT00706719|490995|P1|COMPLETED|Overall Study||5
200064|NCT00706719|490993|P3|STARTED|Overall Study||5
200065|NCT00706719|490994|P2|STARTED|Overall Study||7
200066|NCT00706719|490995|P1|STARTED|Overall Study||5
200067|NCT00706784|491012|P2|NOT COMPLETED|Overall Study||0
200068|NCT00706784|491013|P1|NOT COMPLETED|Overall Study||0
200069|NCT00706784|491012|P2|COMPLETED|Overall Study||3
200070|NCT00706784|491013|P1|COMPLETED|Overall Study||3
200071|NCT00706784|491012|P2|STARTED|Overall Study||3
200072|NCT00706784|491013|P1|STARTED|Overall Study||3
200073|NCT00706797|491021|P2|NOT COMPLETED|Overall Study||71
200074|NCT00706797|491022|P1|NOT COMPLETED|Overall Study||69
200075|NCT00706797|491021|P2|COMPLETED|Overall Study||0
200076|NCT00706797|491022|P1|COMPLETED|Overall Study||1
200077|NCT00706797|491021|P2|Safety Population|Overall Study||71
200078|NCT00706797|491022|P1|Safety Population|Overall Study|Safety population=all randomly assigned subjects who had at least 1 dose of study treatment.|63
200079|NCT00706797|491021|P2|STARTED|Overall Study||71
200080|NCT00706797|491022|P1|STARTED|Overall Study||70
200081|NCT00706810|491062|P1|NOT COMPLETED|Overall Study||1
200082|NCT00706810|491062|P1|COMPLETED|Overall Study||7
200083|NCT00706810|491062|P1|STARTED|Overall Study||8
200084|NCT00706823|491069|P2|NOT COMPLETED|Overall Study||0
200085|NCT00706823|491070|P1|NOT COMPLETED|Overall Study||0
200086|NCT00706823|491069|P2|COMPLETED|Overall Study||25
200087|NCT00706823|491070|P1|COMPLETED|Overall Study||25
200088|NCT00706823|491069|P2|STARTED|Overall Study||25
200089|NCT00706823|491070|P1|STARTED|Overall Study||25
200090|NCT00706836|491086|P1|NOT COMPLETED|Overall Study||0
200091|NCT00706836|491086|P1|COMPLETED|Overall Study||16
200092|NCT00706836|491086|P1|STARTED|Overall Study||16
200093|NCT00706849|491096|P2|NOT COMPLETED|Follow-up Period||3
200094|NCT00706849|491097|P1|NOT COMPLETED|Follow-up Period||0
200095|NCT00706849|491096|P2|COMPLETED|Follow-up Period||25
200096|NCT00706849|491097|P1|COMPLETED|Follow-up Period||3
200097|NCT00706849|491096|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|28
200098|NCT00706849|491097|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|3
200099|NCT00706849|491096|P2|NOT COMPLETED|Treatment Period||10
200100|NCT00706849|491097|P1|NOT COMPLETED|Treatment Period||0
200101|NCT00706849|491096|P2|COMPLETED|Treatment Period|55 patients entered the open-label extension study (301012-CS6; NCT00694109).|73
200102|NCT00706849|491097|P1|COMPLETED|Treatment Period|38 patients entered the open-label extension study (301012-CS6; NCT00694109).|41
200103|NCT00706849|491096|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement.|82
200104|NCT00706849|491097|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|41
200105|NCT00706849|491096|P2|STARTED|Treatment Period||83
200106|NCT00706849|491097|P1|STARTED|Treatment Period||41
200107|NCT00706901|491144|P3|NOT COMPLETED|Overall Study||8
200108|NCT00706901|491145|P2|NOT COMPLETED|Overall Study||5
200109|NCT00706901|491146|P1|NOT COMPLETED|Overall Study||8
200110|NCT00706901|491144|P3|COMPLETED|Overall Study||51
200111|NCT00706901|491145|P2|COMPLETED|Overall Study||57
200112|NCT00706901|491146|P1|COMPLETED|Overall Study||51
200113|NCT00706901|491144|P3|STARTED|Overall Study||59
200114|NCT00706901|491145|P2|STARTED|Overall Study||62
200115|NCT00706901|491146|P1|STARTED|Overall Study||59
200116|NCT00706914|491172|P3|NOT COMPLETED|Overall Study||1
200117|NCT00706914|491173|P2|NOT COMPLETED|Overall Study||4
200118|NCT00706914|491174|P1|NOT COMPLETED|Overall Study||6
200119|NCT00706914|491172|P3|COMPLETED|Overall Study||30
200120|NCT00706914|491173|P2|COMPLETED|Overall Study||58
200121|NCT00706914|491174|P1|COMPLETED|Overall Study||57
200122|NCT00706914|491172|P3|STARTED|Overall Study||31
200123|NCT00706914|491173|P2|STARTED|Overall Study||62
200124|NCT00706914|491174|P1|STARTED|Overall Study||63
200125|NCT00706966|491194|P1|NOT COMPLETED|Overall Study||1
200126|NCT00706966|491194|P1|COMPLETED|Overall Study||9
200127|NCT00706966|491194|P1|STARTED|Overall Study||10
200128|NCT00706979|491229|P2|NOT COMPLETED|Overall Study||0
200129|NCT00706979|491230|P1|NOT COMPLETED|Overall Study||0
200130|NCT00706979|491229|P2|COMPLETED|Overall Study||423
200131|NCT00706979|491230|P1|COMPLETED|Overall Study||426
200132|NCT00706979|491229|P2|STARTED|Overall Study||423
200133|NCT00706979|491230|P1|STARTED|Overall Study||426
200134|NCT00706992|491249|P7|NOT COMPLETED|Overall Study||3
200135|NCT00706992|491250|P6|NOT COMPLETED|Overall Study||2
200136|NCT00706992|491251|P5|NOT COMPLETED|Overall Study||4
200137|NCT00706992|491252|P4|NOT COMPLETED|Overall Study||2
200138|NCT00706992|491253|P3|NOT COMPLETED|Overall Study||6
200139|NCT00706992|491254|P2|NOT COMPLETED|Overall Study||5
200140|NCT00706992|491255|P1|NOT COMPLETED|Overall Study||5
200141|NCT00706992|491249|P7|COMPLETED|Overall Study||3
200142|NCT00706992|491250|P6|COMPLETED|Overall Study||3
200143|NCT00706992|491251|P5|COMPLETED|Overall Study||2
200144|NCT00706992|491252|P4|COMPLETED|Overall Study||6
200145|NCT00706992|491253|P3|COMPLETED|Overall Study||3
200146|NCT00706992|491254|P2|COMPLETED|Overall Study||3
200147|NCT00706992|491255|P1|COMPLETED|Overall Study||3
200148|NCT00706992|491249|P7|STARTED|Overall Study||6
200149|NCT00706992|491250|P6|STARTED|Overall Study||5
200150|NCT00706992|491251|P5|STARTED|Overall Study||6
200151|NCT00706992|491252|P4|STARTED|Overall Study||8
200152|NCT00706992|491253|P3|STARTED|Overall Study||9
200153|NCT00706992|491254|P2|STARTED|Overall Study||8
200154|NCT00706992|491255|P1|STARTED|Overall Study||8
200155|NCT00707031|491274|P2|NOT COMPLETED|Overall Study||99
200156|NCT00707031|491275|P1|NOT COMPLETED|Overall Study||104
200157|NCT00707031|491274|P2|COMPLETED|Overall Study||220
200158|NCT00707031|491275|P1|COMPLETED|Overall Study||216
200159|NCT00707031|491274|P2|Modified Intent-to-Treat Population|Overall Study||315
200160|NCT00707031|491275|P1|Modified Intent-to-Treat Population|Overall Study|All patients who received at least 1 dose;had baseline;at least 1 post-baseline efficacy assessment.|315
200161|NCT00707031|491274|P2|Treated/Safety Population|Overall Study||316
200162|NCT00707031|491275|P1|Treated/Safety Population|Overall Study|All patients who received at least 1 dose, regardless of amount of treatment administered.|318
200163|NCT00707031|491274|P2|STARTED|Overall Study||319
200164|NCT00707031|491275|P1|STARTED|Overall Study|Randomized|320
200165|NCT00707057|491299|P2|NOT COMPLETED|Overall Study||4
200166|NCT00707057|491300|P1|NOT COMPLETED|Overall Study||8
200167|NCT00707057|491299|P2|COMPLETED|Overall Study||83
200168|NCT00707057|491300|P1|COMPLETED|Overall Study||161
200169|NCT00707057|491299|P2|STARTED|Overall Study||87
200170|NCT00707057|491300|P1|STARTED|Overall Study||169
200171|NCT00707161|491332|P1|NOT COMPLETED|Overall Study||6
200172|NCT00707161|491332|P1|COMPLETED|Overall Study||0
200173|NCT00707161|491332|P1|STARTED|Overall Study|3 deceased (1-Huntsman Cancer Institute, 2- LDS Hospital).|6
200174|NCT00707174|491338|P2|NOT COMPLETED|Overall Study||7
200175|NCT00707174|491339|P1|NOT COMPLETED|Overall Study||5
200176|NCT00707174|491338|P2|COMPLETED|Overall Study||37
200177|NCT00707174|491339|P1|COMPLETED|Overall Study||41
200178|NCT00707174|491338|P2|STARTED|Overall Study||44
200179|NCT00707174|491339|P1|STARTED|Overall Study||46
200180|NCT00707239|491348|P3|NOT COMPLETED|Overall Study||14
200181|NCT00707239|491349|P2|NOT COMPLETED|Overall Study||11
200182|NCT00707239|491350|P1|NOT COMPLETED|Overall Study||19
200183|NCT00707239|491348|P3|COMPLETED|Overall Study||21
200184|NCT00707239|491349|P2|COMPLETED|Overall Study||25
200185|NCT00707239|491350|P1|COMPLETED|Overall Study||18
200186|NCT00707239|491348|P3|Treated|Overall Study||34
200187|NCT00707239|491349|P2|Treated|Overall Study||35
200188|NCT00707239|491350|P1|Treated|Overall Study||36
200189|NCT00707239|491348|P3|STARTED|Overall Study||35
200190|NCT00707239|491349|P2|STARTED|Overall Study||36
200191|NCT00707239|491350|P1|STARTED|Overall Study||37
200192|NCT00707343|491396|P1|NOT COMPLETED|Overall Study||0
200193|NCT00707343|491396|P1|COMPLETED|Overall Study||15
200194|NCT00707343|491396|P1|STARTED|Overall Study||15
200195|NCT00707447|491402|P2|NOT COMPLETED|Overall Study||8
200196|NCT00707447|491403|P1|NOT COMPLETED|Overall Study||8
200197|NCT00707447|491402|P2|COMPLETED|Overall Study||85
200198|NCT00707447|491403|P1|COMPLETED|Overall Study||81
200199|NCT00707447|491402|P2|STARTED|Overall Study||93
200200|NCT00707447|491403|P1|STARTED|Overall Study||89
200201|NCT00707486|491427|P1|NOT COMPLETED|Overall Study||1
200202|NCT00707486|491427|P1|COMPLETED|Overall Study||71
200203|NCT00707486|491427|P1|STARTED|Overall Study||72
200204|NCT00707577|491438|P2|NOT COMPLETED|Overall Study||38
200205|NCT00707577|491439|P1|NOT COMPLETED|Overall Study||54
200206|NCT00707577|491438|P2|COMPLETED|Overall Study||118
200207|NCT00707577|491439|P1|COMPLETED|Overall Study||120
200208|NCT00707577|491438|P2|STARTED|Overall Study||156
200209|NCT00707577|491439|P1|STARTED|Overall Study||174
200210|NCT00707655|491447|P2|NOT COMPLETED|Overall Study||2
200211|NCT00707655|491448|P1|NOT COMPLETED|Overall Study||0
200212|NCT00707655|491447|P2|COMPLETED|Overall Study||3
200213|NCT00707655|491448|P1|COMPLETED|Overall Study||3
200214|NCT00707655|491447|P2|STARTED|Overall Study||5
200215|NCT00707655|491448|P1|STARTED|Overall Study||3
200216|NCT00707746|491460|P2|NOT COMPLETED|Follow-up Period||0
200217|NCT00707746|491461|P1|NOT COMPLETED|Follow-up Period||0
200218|NCT00707746|491460|P2|COMPLETED|Follow-up Period||21
200219|NCT00707746|491461|P1|COMPLETED|Follow-up Period||12
200220|NCT00707746|491460|P2|STARTED|Follow-up Period||21
200221|NCT00707746|491461|P1|STARTED|Follow-up Period||12
200222|NCT00707746|491460|P2|NOT COMPLETED|Treatment Period||5
200223|NCT00707746|491461|P1|NOT COMPLETED|Treatment Period||2
200224|NCT00707746|491460|P2|COMPLETED|Treatment Period||17
200225|NCT00707746|491461|P1|COMPLETED|Treatment Period||10
200226|NCT00707746|491460|P2|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|21
200227|NCT00707746|491461|P1|Full Analysis Set (FAS) and Safety Set|Treatment Period|FAS: Treated patients with a valid baseline & post-baseline LDL-C measurement|12
200228|NCT00707746|491460|P2|STARTED|Treatment Period||22
200229|NCT00707746|491461|P1|STARTED|Treatment Period||12
200230|NCT00707759|491509|P2|NOT COMPLETED|Overall Study||2
200231|NCT00707759|491510|P1|NOT COMPLETED|Overall Study||2
200232|NCT00707759|491509|P2|COMPLETED|Overall Study||12
200233|NCT00707759|491510|P1|COMPLETED|Overall Study||12
200234|NCT00707759|491509|P2|STARTED|Overall Study||14
200235|NCT00707759|491510|P1|STARTED|Overall Study||14
200236|NCT00707863|491518|P2|NOT COMPLETED|Overall Study||3
200237|NCT00707863|491519|P1|NOT COMPLETED|Overall Study||0
200238|NCT00707863|491518|P2|COMPLETED|Overall Study||8
200239|NCT00707863|491519|P1|COMPLETED|Overall Study||6
200240|NCT00707863|491518|P2|STARTED|Overall Study||11
200241|NCT00707863|491519|P1|STARTED|Overall Study||6
200242|NCT00707915|491525|P1|NOT COMPLETED|Overall Study||0
200243|NCT00707915|491525|P1|COMPLETED|Overall Study||30
200244|NCT00707915|491525|P1|Effects of Discontinuing Benzodiazepine|Overall Study||30
200245|NCT00707915|491525|P1|STARTED|Overall Study||30
200246|NCT00707954|491539|P5|NOT COMPLETED|Overall Study||1
200247|NCT00707954|491540|P4|NOT COMPLETED|Overall Study||0
200248|NCT00707954|491541|P3|NOT COMPLETED|Overall Study||0
200249|NCT00707954|491542|P2|NOT COMPLETED|Overall Study||0
200250|NCT00707954|491543|P1|NOT COMPLETED|Overall Study||0
200251|NCT00707954|491539|P5|COMPLETED|Overall Study||9
200252|NCT00707954|491540|P4|COMPLETED|Overall Study||13
200253|NCT00707954|491541|P3|COMPLETED|Overall Study||14
200254|NCT00707954|491542|P2|COMPLETED|Overall Study||12
200255|NCT00707954|491543|P1|COMPLETED|Overall Study||12
200256|NCT00707954|491539|P5|STARTED|Overall Study||10
200257|NCT00707954|491540|P4|STARTED|Overall Study||13
200258|NCT00707954|491541|P3|STARTED|Overall Study||14
200259|NCT00707954|491542|P2|STARTED|Overall Study||12
200260|NCT00707954|491543|P1|STARTED|Overall Study||12
200261|NCT00707967|491558|P3|NOT COMPLETED|Overall Study||0
200262|NCT00707967|491559|P2|NOT COMPLETED|Overall Study||0
200263|NCT00707967|491560|P1|NOT COMPLETED|Overall Study||0
200264|NCT00707967|491558|P3|COMPLETED|Overall Study||7
200265|NCT00707967|491559|P2|COMPLETED|Overall Study||8
200266|NCT00707967|491560|P1|COMPLETED|Overall Study||22
200267|NCT00707967|491558|P3|STARTED|Overall Study||7
200268|NCT00707967|491559|P2|STARTED|Overall Study||8
200269|NCT00707967|491560|P1|STARTED|Overall Study||22
200270|NCT00707980|491619|P1|NOT COMPLETED|Overall Study||310
200271|NCT00707980|491619|P1|COMPLETED|Overall Study||526
200272|NCT00707980|491619|P1|Received Treatment|Overall Study||834
200273|NCT00707980|491619|P1|STARTED|Overall Study||836
200274|NCT00707993|491636|P2|NOT COMPLETED|Overall Study||94
200275|NCT00707993|491637|P1|NOT COMPLETED|Overall Study||89
200276|NCT00707993|491636|P2|COMPLETED|Overall Study||125
200277|NCT00707993|491637|P1|COMPLETED|Overall Study||133
200278|NCT00707993|491636|P2|STARTED|Overall Study||219
200279|NCT00707993|491637|P1|STARTED|Overall Study||222
200280|NCT00708019|491681|P2|NOT COMPLETED|Overall Study||15
200281|NCT00708019|491682|P1|NOT COMPLETED|Overall Study||15
200282|NCT00708019|491681|P2|COMPLETED|Overall Study||78
200283|NCT00708019|491682|P1|COMPLETED|Overall Study||77
200284|NCT00708019|491681|P2|STARTED|Overall Study||93
200285|NCT00708019|491682|P1|STARTED|Overall Study||92
200286|NCT00708032|491692|P2|NOT COMPLETED|Overall Study||16
200287|NCT00708032|491693|P1|NOT COMPLETED|Overall Study||10
200288|NCT00708032|491692|P2|COMPLETED|Overall Study||22
200289|NCT00708032|491693|P1|COMPLETED|Overall Study||26
200290|NCT00708032|491692|P2|STARTED|Overall Study||38
200291|NCT00708032|491693|P1|STARTED|Overall Study||36
200292|NCT00708071|491707|P1|NOT COMPLETED|Overall Study||0
200293|NCT00708071|491707|P1|COMPLETED|Overall Study||45
200294|NCT00708071|491707|P1|STARTED|Overall Study|Randomized and treated|45
200295|NCT00708097|491785|P5|NOT COMPLETED|Period 5||0
200296|NCT00708097|491786|P4|NOT COMPLETED|Period 5||0
200297|NCT00708097|491787|P3|NOT COMPLETED|Period 5||0
200298|NCT00708097|491788|P2|NOT COMPLETED|Period 5||0
200299|NCT00708097|491789|P1|NOT COMPLETED|Period 5||0
200300|NCT00708097|491785|P5|COMPLETED|Period 5||12
200301|NCT00708097|491786|P4|COMPLETED|Period 5||10
200302|NCT00708097|491787|P3|COMPLETED|Period 5||11
200303|NCT00708097|491788|P2|COMPLETED|Period 5||9
200304|NCT00708097|491789|P1|COMPLETED|Period 5||8
200305|NCT00708097|491785|P5|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|12
200306|NCT00708097|491786|P4|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|10
200307|NCT00708097|491787|P3|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|11
200308|NCT00708097|491788|P2|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|9
200309|NCT00708097|491789|P1|STARTED|Period 5|Due to crossover design, a different set of subjects received this treatment compared to Period 4.|8
200310|NCT00708097|491785|P5|NOT COMPLETED|Period 4||0
200311|NCT00708097|491786|P4|NOT COMPLETED|Period 4||0
200312|NCT00708097|491787|P3|NOT COMPLETED|Period 4||0
200313|NCT00708097|491788|P2|NOT COMPLETED|Period 4||0
200314|NCT00708097|491789|P1|NOT COMPLETED|Period 4||0
200315|NCT00708097|491785|P5|COMPLETED|Period 4||8
200316|NCT00708097|491786|P4|COMPLETED|Period 4||11
200317|NCT00708097|491787|P3|COMPLETED|Period 4||10
200318|NCT00708097|491788|P2|COMPLETED|Period 4||9
200319|NCT00708097|491789|P1|COMPLETED|Period 4||12
200320|NCT00708097|491785|P5|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|8
200321|NCT00708097|491786|P4|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|11
200322|NCT00708097|491787|P3|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|10
200323|NCT00708097|491788|P2|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|9
200324|NCT00708097|491789|P1|STARTED|Period 4|Due to crossover design, a different set of subjects received this treatment compared to Period 3.|12
200325|NCT00708097|491785|P5|NOT COMPLETED|Period 3||0
200326|NCT00708097|491786|P4|NOT COMPLETED|Period 3||0
200327|NCT00708097|491787|P3|NOT COMPLETED|Period 3||0
200328|NCT00708097|491788|P2|NOT COMPLETED|Period 3||0
200329|NCT00708097|491789|P1|NOT COMPLETED|Period 3||0
200330|NCT00708097|491785|P5|COMPLETED|Period 3||10
200331|NCT00708097|491786|P4|COMPLETED|Period 3||10
200332|NCT00708097|491787|P3|COMPLETED|Period 3||10
200333|NCT00708097|491788|P2|COMPLETED|Period 3||11
200334|NCT00708097|491789|P1|COMPLETED|Period 3||9
200335|NCT00708097|491785|P5|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
200336|NCT00708097|491786|P4|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
200337|NCT00708097|491787|P3|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|10
200338|NCT00708097|491788|P2|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|11
200339|NCT00708097|491789|P1|STARTED|Period 3|Due to crossover design, a different set of subjects received this treatment compared to Period 2.|9
200340|NCT00708097|491785|P5|NOT COMPLETED|Period 2||0
200341|NCT00708097|491786|P4|NOT COMPLETED|Period 2||1
200342|NCT00708097|491787|P3|NOT COMPLETED|Period 2||1
200343|NCT00708097|491788|P2|NOT COMPLETED|Period 2||1
200344|NCT00708097|491789|P1|NOT COMPLETED|Period 2||0
200345|NCT00708097|491785|P5|COMPLETED|Period 2||10
200346|NCT00708097|491786|P4|COMPLETED|Period 2||10
200347|NCT00708097|491787|P3|COMPLETED|Period 2||9
200348|NCT00708097|491788|P2|COMPLETED|Period 2||11
200349|NCT00708097|491789|P1|COMPLETED|Period 2||10
200350|NCT00708097|491785|P5|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
200351|NCT00708097|491786|P4|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|11
200352|NCT00708097|491787|P3|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
200353|NCT00708097|491788|P2|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|12
200354|NCT00708097|491789|P1|STARTED|Period 2|Due to crossover design, a different set of subjects received this treatment compared to Period 1.|10
200355|NCT00708097|491785|P5|NOT COMPLETED|Period 1||1
200356|NCT00708097|491786|P4|NOT COMPLETED|Period 1||2
200357|NCT00708097|491787|P3|NOT COMPLETED|Period 1||0
200358|NCT00708097|491788|P2|NOT COMPLETED|Period 1||1
200359|NCT00708097|491789|P1|NOT COMPLETED|Period 1||0
200360|NCT00708097|491785|P5|COMPLETED|Period 1||10
200361|NCT00708097|491786|P4|COMPLETED|Period 1||9
200362|NCT00708097|491787|P3|COMPLETED|Period 1||12
200363|NCT00708097|491788|P2|COMPLETED|Period 1||11
200364|NCT00708097|491789|P1|COMPLETED|Period 1||11
200365|NCT00708097|491785|P5|STARTED|Period 1||11
200366|NCT00708097|491786|P4|STARTED|Period 1||11
200367|NCT00708097|491787|P3|STARTED|Period 1||12
200368|NCT00708097|491788|P2|STARTED|Period 1||12
200369|NCT00708097|491789|P1|STARTED|Period 1||11
200370|NCT00708110|491823|P4|NOT COMPLETED|Overall Study||0
200371|NCT00708110|491824|P3|NOT COMPLETED|Overall Study||0
200372|NCT00708110|491825|P2|NOT COMPLETED|Overall Study||0
200373|NCT00708110|491826|P1|NOT COMPLETED|Overall Study||0
200374|NCT00708110|491823|P4|COMPLETED|Overall Study||10
200375|NCT00708110|491824|P3|COMPLETED|Overall Study||9
200376|NCT00708110|491825|P2|COMPLETED|Overall Study||9
200377|NCT00708110|491826|P1|COMPLETED|Overall Study||7
200378|NCT00708110|491823|P4|STARTED|Overall Study||10
200379|NCT00708110|491824|P3|STARTED|Overall Study||9
200380|NCT00708110|491825|P2|STARTED|Overall Study||9
200381|NCT00708110|491826|P1|STARTED|Overall Study||7
200382|NCT00708123|491932|P5|NOT COMPLETED|Period 5||0
200383|NCT00708123|491933|P4|NOT COMPLETED|Period 5||0
200384|NCT00708123|491934|P3|NOT COMPLETED|Period 5||0
200385|NCT00708123|491935|P2|NOT COMPLETED|Period 5||0
200386|NCT00708123|491936|P1|NOT COMPLETED|Period 5||0
200387|NCT00708123|491932|P5|COMPLETED|Period 5||10
200388|NCT00708123|491933|P4|COMPLETED|Period 5||11
200389|NCT00708123|491934|P3|COMPLETED|Period 5||11
200390|NCT00708123|491935|P2|COMPLETED|Period 5||10
200391|NCT00708123|491936|P1|COMPLETED|Period 5||10
200392|NCT00708123|491932|P5|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
200393|NCT00708123|491933|P4|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
200394|NCT00708123|491934|P3|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|11
200395|NCT00708123|491935|P2|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
200396|NCT00708123|491936|P1|STARTED|Period 5|Due to crossover design, different set of participants received this treatment compared to Period 4|10
200397|NCT00708123|491932|P5|NOT COMPLETED|Period 4||0
200398|NCT00708123|491933|P4|NOT COMPLETED|Period 4||0
200399|NCT00708123|491934|P3|NOT COMPLETED|Period 4||0
200400|NCT00708123|491935|P2|NOT COMPLETED|Period 4||1
200401|NCT00708123|491936|P1|NOT COMPLETED|Period 4||0
200402|NCT00708123|491932|P5|COMPLETED|Period 4||11
200403|NCT00708123|491933|P4|COMPLETED|Period 4||10
200404|NCT00708123|491934|P3|COMPLETED|Period 4||10
200405|NCT00708123|491935|P2|COMPLETED|Period 4||11
200406|NCT00708123|491936|P1|COMPLETED|Period 4||10
200407|NCT00708123|491932|P5|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|11
200754|NCT00716417|492634|P2|COMPLETED|Overall Study||0
200408|NCT00708123|491933|P4|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
200409|NCT00708123|491934|P3|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
200410|NCT00708123|491935|P2|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|12
200411|NCT00708123|491936|P1|STARTED|Period 4|Due to crossover design, different set of participants received this treatment compared to Period 3|10
200412|NCT00708123|491932|P5|NOT COMPLETED|Period 3||0
200413|NCT00708123|491933|P4|NOT COMPLETED|Period 3||1
200414|NCT00708123|491934|P3|NOT COMPLETED|Period 3||1
200415|NCT00708123|491935|P2|NOT COMPLETED|Period 3||0
200416|NCT00708123|491936|P1|NOT COMPLETED|Period 3||0
200417|NCT00708123|491932|P5|COMPLETED|Period 3||10
200418|NCT00708123|491933|P4|COMPLETED|Period 3||11
200419|NCT00708123|491934|P3|COMPLETED|Period 3||10
200420|NCT00708123|491935|P2|COMPLETED|Period 3||10
200421|NCT00708123|491936|P1|COMPLETED|Period 3||12
200422|NCT00708123|491932|P5|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
200423|NCT00708123|491933|P4|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
200424|NCT00708123|491934|P3|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|11
200425|NCT00708123|491935|P2|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|10
200426|NCT00708123|491936|P1|STARTED|Period 3|Due to crossover design, different set of participants received this treatment compared to Period 2|12
200427|NCT00708123|491932|P5|NOT COMPLETED|Period 2||0
200428|NCT00708123|491933|P4|NOT COMPLETED|Period 2||1
200429|NCT00708123|491934|P3|NOT COMPLETED|Period 2||0
200430|NCT00708123|491935|P2|NOT COMPLETED|Period 2||0
200431|NCT00708123|491936|P1|NOT COMPLETED|Period 2||1
200432|NCT00708123|491932|P5|COMPLETED|Period 2||11
200433|NCT00708123|491933|P4|COMPLETED|Period 2||10
200434|NCT00708123|491934|P3|COMPLETED|Period 2||12
200435|NCT00708123|491935|P2|COMPLETED|Period 2||12
200436|NCT00708123|491936|P1|COMPLETED|Period 2||10
200437|NCT00708123|491932|P5|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
200438|NCT00708123|491933|P4|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
200439|NCT00708123|491934|P3|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
200440|NCT00708123|491935|P2|STARTED|Period 2|Due to crossover design,different set of participants received this treatment compared to Period 1|12
200441|NCT00708123|491936|P1|STARTED|Period 2|Due to crossover design, different set of participants received this treatment compared to Period 1|11
200442|NCT00708123|491932|P5|NOT COMPLETED|Period 1||0
200443|NCT00708123|491933|P4|NOT COMPLETED|Period 1||1
200444|NCT00708123|491934|P3|NOT COMPLETED|Period 1||1
200445|NCT00708123|491935|P2|NOT COMPLETED|Period 1||1
200446|NCT00708123|491936|P1|NOT COMPLETED|Period 1||0
200447|NCT00708123|491932|P5|COMPLETED|Period 1||12
200448|NCT00708123|491933|P4|COMPLETED|Period 1||11
200449|NCT00708123|491934|P3|COMPLETED|Period 1||11
200450|NCT00708123|491935|P2|COMPLETED|Period 1||11
200451|NCT00708123|491936|P1|COMPLETED|Period 1||12
200452|NCT00708123|491932|P5|STARTED|Period 1||12
200453|NCT00708123|491933|P4|STARTED|Period 1||12
200454|NCT00708123|491934|P3|STARTED|Period 1||12
200455|NCT00708123|491935|P2|STARTED|Period 1||12
200456|NCT00708123|491936|P1|STARTED|Period 1||12
200457|NCT00708162|491958|P2|NOT COMPLETED|Open-Label Phase||30
200458|NCT00708162|491959|P1|NOT COMPLETED|Open-Label Phase||44
200459|NCT00708162|491958|P2|COMPLETED|Open-Label Phase||121
200460|NCT00708162|491959|P1|COMPLETED|Open-Label Phase||152
200461|NCT00708162|491958|P2|STARTED|Open-Label Phase|58 participants completing the Randomized Phase did not continue to the Open-Label Phase.|151
200462|NCT00708162|491959|P1|STARTED|Open-Label Phase|9 participants completing the Randomized Phase did not continue to the Open-Label Phase.|196
200463|NCT00708162|491958|P2|NOT COMPLETED|Randomized Phase||154
200464|NCT00708162|491959|P1|NOT COMPLETED|Randomized Phase||156
200465|NCT00708162|491958|P2|COMPLETED|Randomized Phase||209
200466|NCT00708162|491959|P1|COMPLETED|Randomized Phase||205
200467|NCT00708162|491958|P2|Randomized and Treated|Randomized Phase||358
200468|NCT00708162|491959|P1|Randomized and Treated|Randomized Phase||354
200469|NCT00708162|491958|P2|STARTED|Randomized Phase||363
200470|NCT00708162|491959|P1|STARTED|Randomized Phase||361
200471|NCT00708175|492002|P2|NOT COMPLETED|Overall Study||21
200472|NCT00708175|492003|P1|NOT COMPLETED|Overall Study||18
200473|NCT00708175|492002|P2|COMPLETED|Overall Study||57
200474|NCT00708175|492003|P1|COMPLETED|Overall Study||60
200475|NCT00708175|492002|P2|STARTED|Overall Study||78
200476|NCT00708175|492003|P1|STARTED|Overall Study||78
200477|NCT00708201|492019|P2|NOT COMPLETED|Overall Study||6
200478|NCT00708201|492020|P1|NOT COMPLETED|Overall Study||7
200479|NCT00708201|492019|P2|COMPLETED|Overall Study||137
200480|NCT00708201|492020|P1|COMPLETED|Overall Study||130
200481|NCT00708201|492019|P2|Received at Least 1 Dose of Study Drug|Overall Study||137
200482|NCT00708201|492020|P1|Received at Least 1 Dose of Study Drug|Overall Study||130
200483|NCT00708201|492019|P2|STARTED|Overall Study||143
200484|NCT00708201|492020|P1|STARTED|Overall Study||137
200485|NCT00708214|492045|P3|NOT COMPLETED|Overall Study||8
200486|NCT00708214|492046|P2|NOT COMPLETED|Overall Study||13
200487|NCT00708214|492047|P1|NOT COMPLETED|Overall Study||7
200488|NCT00708214|492045|P3|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
200489|NCT00708214|492046|P2|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
200490|NCT00708214|492047|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date (04 Jan 2010)|0
200491|NCT00708214|492045|P3|STARTED|Overall Study||8
200492|NCT00708214|492046|P2|STARTED|Overall Study||13
200493|NCT00708214|492047|P1|STARTED|Overall Study||7
200494|NCT00714493|492088|P1|NOT COMPLETED|Overall Study||49
200495|NCT00714493|492088|P1|COMPLETED|Overall Study||154
200496|NCT00714493|492088|P1|STARTED|Overall Study||203
200497|NCT00714571|492104|P6|NOT COMPLETED|Stage 2||0
200498|NCT00714571|492105|P5|NOT COMPLETED|Stage 2||0
200499|NCT00714571|492106|P4|NOT COMPLETED|Stage 2||0
200500|NCT00714571|492107|P3|NOT COMPLETED|Stage 2||0
200501|NCT00714571|492108|P2|NOT COMPLETED|Stage 2||0
200502|NCT00714571|492109|P1|NOT COMPLETED|Stage 2||0
200503|NCT00714571|492104|P6|COMPLETED|Stage 2||15
200504|NCT00714571|492105|P5|COMPLETED|Stage 2||15
200505|NCT00714571|492106|P4|COMPLETED|Stage 2||0
200506|NCT00714571|492107|P3|COMPLETED|Stage 2||0
200507|NCT00714571|492108|P2|COMPLETED|Stage 2||0
200508|NCT00714571|492109|P1|COMPLETED|Stage 2||0
200509|NCT00714571|492104|P6|STARTED|Stage 2||15
200510|NCT00714571|492105|P5|STARTED|Stage 2||15
200511|NCT00714571|492106|P4|STARTED|Stage 2||0
200512|NCT00714571|492107|P3|STARTED|Stage 2||0
200513|NCT00714571|492108|P2|STARTED|Stage 2||0
200514|NCT00714571|492109|P1|STARTED|Stage 2||0
200515|NCT00714571|492104|P6|NOT COMPLETED|Stage 1||0
200516|NCT00714571|492105|P5|NOT COMPLETED|Stage 1||0
200517|NCT00714571|492106|P4|NOT COMPLETED|Stage 1||0
200518|NCT00714571|492107|P3|NOT COMPLETED|Stage 1||1
200519|NCT00714571|492108|P2|NOT COMPLETED|Stage 1||0
200520|NCT00714571|492109|P1|NOT COMPLETED|Stage 1||0
200521|NCT00714571|492104|P6|COMPLETED|Stage 1||0
200522|NCT00714571|492105|P5|COMPLETED|Stage 1||0
200523|NCT00714571|492106|P4|COMPLETED|Stage 1||14
200524|NCT00714571|492107|P3|COMPLETED|Stage 1||10
200525|NCT00714571|492108|P2|COMPLETED|Stage 1||15
200526|NCT00714571|492109|P1|COMPLETED|Stage 1|1 patient excluded who completed training but did not disclose ongoing chemotherapy for cancer|12
200527|NCT00714571|492104|P6|STARTED|Stage 1||0
200528|NCT00714571|492105|P5|STARTED|Stage 1||0
200529|NCT00714571|492106|P4|STARTED|Stage 1||14
200530|NCT00714571|492107|P3|STARTED|Stage 1||11
200531|NCT00714571|492108|P2|STARTED|Stage 1|11 allocated to intervention, but 1 withdrew before the first intervention session|15
200532|NCT00714571|492109|P1|STARTED|Stage 1||12
200533|NCT00714688|492126|P3|NOT COMPLETED|Overall Study||37
200534|NCT00714688|492127|P2|NOT COMPLETED|Overall Study||35
200535|NCT00714688|492128|P1|NOT COMPLETED|Overall Study||29
200536|NCT00714688|492126|P3|COMPLETED|Overall Study||55
200537|NCT00714688|492127|P2|COMPLETED|Overall Study||55
200538|NCT00714688|492128|P1|COMPLETED|Overall Study||68
200539|NCT00714688|492126|P3|STARTED|Overall Study||92
200540|NCT00714688|492127|P2|STARTED|Overall Study||90
200541|NCT00714688|492128|P1|STARTED|Overall Study||97
200542|NCT00714714|492145|P1|NOT COMPLETED|Overall Study||1
200543|NCT00714714|492145|P1|COMPLETED|Overall Study||24
200544|NCT00714714|492145|P1|STARTED|Overall Study||25
200545|NCT00715299|492151|P1|NOT COMPLETED|Overall Study||6
200546|NCT00715299|492151|P1|COMPLETED|Overall Study||30
200547|NCT00715299|492151|P1|STARTED|Overall Study|A total of 38 participants were consented to the study, but only 36 made it to day one of testing.|36
200548|NCT00715390|492155|P1|NOT COMPLETED|Overall Study||0
200549|NCT00715390|492155|P1|COMPLETED|Overall Study|These were broken down to different types of dysrhythymia.|234
200550|NCT00715390|492155|P1|Eligible|Overall Study||234
200551|NCT00715390|492155|P1|STARTED|Overall Study|114,209 Anesthetic records were screened to identify 234 records.|234
200552|NCT00715403|492166|P7|NOT COMPLETED|Overall Study||1
200553|NCT00715403|492167|P6|NOT COMPLETED|Overall Study||19
200554|NCT00715403|492168|P5|NOT COMPLETED|Overall Study||6
200555|NCT00715403|492169|P4|NOT COMPLETED|Overall Study||9
200556|NCT00715403|492170|P3|NOT COMPLETED|Overall Study||4
200557|NCT00715403|492171|P2|NOT COMPLETED|Overall Study||1
200558|NCT00715403|492172|P1|NOT COMPLETED|Overall Study||1
200559|NCT00715403|492166|P7|COMPLETED|Overall Study||0
200560|NCT00715403|492167|P6|COMPLETED|Overall Study||0
200561|NCT00715403|492168|P5|COMPLETED|Overall Study||0
200562|NCT00715403|492169|P4|COMPLETED|Overall Study||0
200563|NCT00715403|492170|P3|COMPLETED|Overall Study||0
200564|NCT00715403|492171|P2|COMPLETED|Overall Study||0
200565|NCT00715403|492172|P1|COMPLETED|Overall Study||0
200566|NCT00715403|492166|P7|STARTED|Overall Study||1
200567|NCT00715403|492167|P6|STARTED|Overall Study||19
200568|NCT00715403|492168|P5|STARTED|Overall Study||6
200569|NCT00715403|492169|P4|STARTED|Overall Study||9
200570|NCT00715403|492170|P3|STARTED|Overall Study||4
200571|NCT00715403|492171|P2|STARTED|Overall Study||1
200572|NCT00715403|492172|P1|STARTED|Overall Study||1
200573|NCT00715559|492307|P1|NOT COMPLETED|Overall Study||1
200574|NCT00715559|492307|P1|COMPLETED|Overall Study||2
200575|NCT00715559|492307|P1|STARTED|Overall Study||3
200576|NCT00715624|492316|P2|NOT COMPLETED|Overall Study||116
200577|NCT00715624|492317|P1|NOT COMPLETED|Overall Study||52
200578|NCT00715624|492316|P2|COMPLETED|Overall Study||213
200579|NCT00715624|492317|P1|COMPLETED|Overall Study||115
200580|NCT00715624|492316|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||327
200581|NCT00715624|492317|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|166
200582|NCT00715624|492316|P2|Treated/Safety Population|Overall Study||328
200583|NCT00715624|492317|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|167
200584|NCT00715624|492316|P2|STARTED|Overall Study||329
200585|NCT00715624|492317|P1|STARTED|Overall Study|Randomized|167
200586|NCT00715650|492347|P2|NOT COMPLETED|Follow-up||5
200587|NCT00715650|492348|P1|NOT COMPLETED|Follow-up||13
200588|NCT00715650|492347|P2|COMPLETED|Follow-up||37
200589|NCT00715650|492348|P1|COMPLETED|Follow-up||29
200590|NCT00715650|492347|P2|Completed Month 6 Follow-up|Follow-up||37
200591|NCT00715650|492348|P1|Completed Month 6 Follow-up|Follow-up||29
200592|NCT00715650|492347|P2|Completed Month 3 Follow-up|Follow-up||40
200593|NCT00715650|492348|P1|Completed Month 3 Follow-up|Follow-up||35
200594|NCT00715650|492347|P2|Completed Month 1 Follow-up|Follow-up||38
200595|NCT00715650|492348|P1|Completed Month 1 Follow-up|Follow-up||40
200596|NCT00715650|492347|P2|STARTED|Follow-up||42
200597|NCT00715650|492348|P1|STARTED|Follow-up||42
200598|NCT00715650|492347|P2|NOT COMPLETED|Intervention||3
200599|NCT00715650|492348|P1|NOT COMPLETED|Intervention||5
200600|NCT00715650|492347|P2|COMPLETED|Intervention||42
200601|NCT00715650|492348|P1|COMPLETED|Intervention||42
200602|NCT00715650|492347|P2|Attended ≥ 3 Sessions|Intervention||17
200603|NCT00715650|492348|P1|Attended ≥ 3 Sessions|Intervention||23
200604|NCT00715650|492347|P2|Attended ≥ 2 Sessions|Intervention||33
200605|NCT00715650|492348|P1|Attended ≥ 2 Sessions|Intervention||36
200606|NCT00715650|492347|P2|Received Any Session|Intervention||38
200607|NCT00715650|492348|P1|Received Any Session|Intervention||39
200608|NCT00715650|492347|P2|STARTED|Intervention||45
200609|NCT00715650|492348|P1|STARTED|Intervention||47
200610|NCT00715676|492363|P3|NOT COMPLETED|Overall Study||32
200611|NCT00715676|492364|P2|NOT COMPLETED|Overall Study||11
200612|NCT00715676|492365|P1|NOT COMPLETED|Overall Study||6
200613|NCT00715676|492363|P3|COMPLETED|Overall Study||21
200614|NCT00715676|492364|P2|COMPLETED|Overall Study||43
200615|NCT00715676|492365|P1|COMPLETED|Overall Study||43
200616|NCT00715676|492363|P3|STARTED|Overall Study||53
200617|NCT00715676|492364|P2|STARTED|Overall Study||54
200618|NCT00715676|492365|P1|STARTED|Overall Study|1 additional subject was enrolled in the placebo group but discontinued before taking any study drug|49
200619|NCT00715741|492395|P4|NOT COMPLETED|Overall Study||0
200620|NCT00715741|492396|P3|NOT COMPLETED|Overall Study||0
200621|NCT00715741|492397|P2|NOT COMPLETED|Overall Study||0
200622|NCT00715741|492398|P1|NOT COMPLETED|Overall Study||0
200623|NCT00715741|492395|P4|COMPLETED|Overall Study||25
200624|NCT00715741|492396|P3|COMPLETED|Overall Study||25
200625|NCT00715741|492397|P2|COMPLETED|Overall Study||25
200626|NCT00715741|492398|P1|COMPLETED|Overall Study||25
200627|NCT00715741|492395|P4|STARTED|Overall Study||25
200628|NCT00715741|492396|P3|STARTED|Overall Study||25
200629|NCT00715741|492397|P2|STARTED|Overall Study||25
200630|NCT00715741|492398|P1|STARTED|Overall Study||25
200631|NCT00715754|492420|P1|NOT COMPLETED|Overall Study||0
200632|NCT00715754|492420|P1|COMPLETED|Overall Study||47
200633|NCT00715754|492420|P1|STARTED|Overall Study||47
200634|NCT00715884|492428|P2|NOT COMPLETED|Overall Study||1
200635|NCT00715884|492429|P1|NOT COMPLETED|Overall Study||8
200636|NCT00715884|492428|P2|COMPLETED|Overall Study||225
200637|NCT00715884|492429|P1|COMPLETED|Overall Study||444
200638|NCT00715884|492428|P2|STARTED|Overall Study||226
200639|NCT00715884|492429|P1|STARTED|Overall Study||452
200640|NCT00715910|492475|P6|NOT COMPLETED|Booster and ESFU Phase||13
200641|NCT00715910|492476|P5|NOT COMPLETED|Booster and ESFU Phase||2
200642|NCT00715910|492477|P4|NOT COMPLETED|Booster and ESFU Phase||11
200643|NCT00715910|492478|P3|NOT COMPLETED|Booster and ESFU Phase||0
200644|NCT00715910|492479|P2|NOT COMPLETED|Booster and ESFU Phase||0
200645|NCT00715910|492480|P1|NOT COMPLETED|Booster and ESFU Phase||0
200646|NCT00715910|492475|P6|COMPLETED|Booster and ESFU Phase||88
200647|NCT00715910|492476|P5|COMPLETED|Booster and ESFU Phase||36
200648|NCT00715910|492477|P4|COMPLETED|Booster and ESFU Phase||172
200649|NCT00715910|492478|P3|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
200650|NCT00715910|492479|P2|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
200651|NCT00715910|492480|P1|COMPLETED|Booster and ESFU Phase|Group not applicable during booster phase|0
200652|NCT00715910|492475|P6|STARTED|Booster and ESFU Phase||101
200653|NCT00715910|492476|P5|STARTED|Booster and ESFU Phase||38
200654|NCT00715910|492477|P4|STARTED|Booster and ESFU Phase||183
200655|NCT00715910|492478|P3|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
200656|NCT00715910|492479|P2|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
200657|NCT00715910|492480|P1|STARTED|Booster and ESFU Phase|Group not applicable during booster phase|0
200658|NCT00715910|492475|P6|NOT COMPLETED|Year 5||0
200659|NCT00715910|492476|P5|NOT COMPLETED|Year 5||0
200660|NCT00715910|492477|P4|NOT COMPLETED|Year 5||0
200661|NCT00715910|492478|P3|NOT COMPLETED|Year 5||0
200662|NCT00715910|492479|P2|NOT COMPLETED|Year 5||0
200663|NCT00715910|492480|P1|NOT COMPLETED|Year 5||0
200664|NCT00715910|492475|P6|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
200665|NCT00715910|492476|P5|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
200666|NCT00715910|492477|P4|COMPLETED|Year 5|Group not applicable during Year 5 Persistence phase|0
200667|NCT00715910|492478|P3|COMPLETED|Year 5||38
200668|NCT00715910|492479|P2|COMPLETED|Year 5||56
200669|NCT00715910|492480|P1|COMPLETED|Year 5||218
200670|NCT00715910|492475|P6|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
200671|NCT00715910|492476|P5|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
200672|NCT00715910|492477|P4|STARTED|Year 5|Group not applicable during Year 5 Persistence phase|0
200673|NCT00715910|492478|P3|STARTED|Year 5||38
200674|NCT00715910|492479|P2|STARTED|Year 5||56
200675|NCT00715910|492480|P1|STARTED|Year 5||218
200676|NCT00715910|492475|P6|NOT COMPLETED|Year 3||0
200677|NCT00715910|492476|P5|NOT COMPLETED|Year 3||0
200678|NCT00715910|492477|P4|NOT COMPLETED|Year 3||0
200679|NCT00715910|492478|P3|NOT COMPLETED|Year 3||0
200680|NCT00715910|492479|P2|NOT COMPLETED|Year 3||0
200681|NCT00715910|492480|P1|NOT COMPLETED|Year 3||0
200682|NCT00715910|492475|P6|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
200683|NCT00715910|492476|P5|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
200684|NCT00715910|492477|P4|COMPLETED|Year 3|Group not applicable during Year 3 Persistence phase|0
200685|NCT00715910|492478|P3|COMPLETED|Year 3||56
200686|NCT00715910|492479|P2|COMPLETED|Year 3||86
200687|NCT00715910|492480|P1|COMPLETED|Year 3||345
200688|NCT00715910|492475|P6|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
200689|NCT00715910|492476|P5|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
200690|NCT00715910|492477|P4|STARTED|Year 3|Group not applicable during Year 3 Persistence phase|0
200691|NCT00715910|492478|P3|STARTED|Year 3||56
200692|NCT00715910|492479|P2|STARTED|Year 3||86
200693|NCT00715910|492480|P1|STARTED|Year 3||345
200694|NCT00715910|492475|P6|NOT COMPLETED|Year 1||0
200695|NCT00715910|492476|P5|NOT COMPLETED|Year 1||0
200696|NCT00715910|492477|P4|NOT COMPLETED|Year 1||0
200697|NCT00715910|492478|P3|NOT COMPLETED|Year 1||0
200698|NCT00715910|492479|P2|NOT COMPLETED|Year 1||0
200699|NCT00715910|492480|P1|NOT COMPLETED|Year 1||0
200700|NCT00715910|492475|P6|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
200701|NCT00715910|492476|P5|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
200702|NCT00715910|492477|P4|COMPLETED|Year 1|Group not applicable during Year 1 Persistence phase|0
200703|NCT00715910|492478|P3|COMPLETED|Year 1||68
200704|NCT00715910|492479|P2|COMPLETED|Year 1||147
200705|NCT00715910|492480|P1|COMPLETED|Year 1||433
200706|NCT00715910|492475|P6|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
200707|NCT00715910|492476|P5|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
200708|NCT00715910|492477|P4|STARTED|Year 1|Group not applicable during Year 1 Persistence phase|0
200709|NCT00715910|492478|P3|STARTED|Year 1||68
200710|NCT00715910|492479|P2|STARTED|Year 1||147
200711|NCT00715910|492480|P1|STARTED|Year 1||433
200712|NCT00715949|492554|P1|NOT COMPLETED|Overall Study||4
200713|NCT00715949|492554|P1|COMPLETED|Overall Study|116 patients completed first test|116
200714|NCT00715949|492554|P1|STARTED|Overall Study|4 dropped because could not finish first test|120
200715|NCT00715962|492560|P2|NOT COMPLETED|Overall Study||2
200716|NCT00715962|492561|P1|NOT COMPLETED|Overall Study||6
200717|NCT00715962|492560|P2|COMPLETED|Overall Study||48
200718|NCT00715962|492561|P1|COMPLETED|Overall Study||44
200719|NCT00715962|492560|P2|STARTED|Overall Study||50
200720|NCT00715962|492561|P1|STARTED|Overall Study||50
200721|NCT00716079|492573|P2|NOT COMPLETED|Overall Study||15
200722|NCT00716079|492574|P1|NOT COMPLETED|Overall Study||9
200723|NCT00716079|492573|P2|COMPLETED|Overall Study||1421
200724|NCT00716079|492574|P1|COMPLETED|Overall Study||1394
200725|NCT00716079|492573|P2|STARTED|Overall Study||1436
200726|NCT00716079|492574|P1|STARTED|Overall Study||1403
200727|NCT00716092|492585|P3|NOT COMPLETED|Overall Study||0
200728|NCT00716092|492586|P2|NOT COMPLETED|Overall Study||1
200729|NCT00716092|492587|P1|NOT COMPLETED|Overall Study||2
200730|NCT00716092|492585|P3|COMPLETED|Overall Study||41
200731|NCT00716092|492586|P2|COMPLETED|Overall Study||39
200732|NCT00716092|492587|P1|COMPLETED|Overall Study||38
200733|NCT00716092|492585|P3|STARTED|Overall Study||41
200734|NCT00716092|492586|P2|STARTED|Overall Study||40
200735|NCT00716092|492587|P1|STARTED|Overall Study||40
200736|NCT00716417|492626|P10|NOT COMPLETED|Overall Study||3
200737|NCT00716417|492627|P9|NOT COMPLETED|Overall Study||5
200738|NCT00716417|492628|P8|NOT COMPLETED|Overall Study||3
200739|NCT00716417|492629|P7|NOT COMPLETED|Overall Study||7
200740|NCT00716417|492630|P6|NOT COMPLETED|Overall Study||3
200741|NCT00716417|492631|P5|NOT COMPLETED|Overall Study||1
200742|NCT00716417|492632|P4|NOT COMPLETED|Overall Study||11
200743|NCT00716417|492633|P3|NOT COMPLETED|Overall Study||5
200744|NCT00716417|492634|P2|NOT COMPLETED|Overall Study||6
200745|NCT00716417|492635|P1|NOT COMPLETED|Overall Study||3
200746|NCT00716417|492626|P10|COMPLETED|Overall Study||0
200747|NCT00716417|492627|P9|COMPLETED|Overall Study||0
200748|NCT00716417|492628|P8|COMPLETED|Overall Study||0
200749|NCT00716417|492629|P7|COMPLETED|Overall Study||0
200750|NCT00716417|492630|P6|COMPLETED|Overall Study||0
200751|NCT00716417|492631|P5|COMPLETED|Overall Study||0
200752|NCT00716417|492632|P4|COMPLETED|Overall Study||0
200753|NCT00716417|492633|P3|COMPLETED|Overall Study||0
200755|NCT00716417|492635|P1|COMPLETED|Overall Study||0
200756|NCT00716417|492626|P10|STARTED|Overall Study||3
200757|NCT00716417|492627|P9|STARTED|Overall Study||5
200758|NCT00716417|492628|P8|STARTED|Overall Study||3
200759|NCT00716417|492629|P7|STARTED|Overall Study||7
200760|NCT00716417|492630|P6|STARTED|Overall Study||3
200761|NCT00716417|492631|P5|STARTED|Overall Study||1
200762|NCT00716417|492632|P4|STARTED|Overall Study||11
200763|NCT00716417|492633|P3|STARTED|Overall Study||5
200764|NCT00716417|492634|P2|STARTED|Overall Study||6
200765|NCT00716417|492635|P1|STARTED|Overall Study||3
200766|NCT00716443|492679|P1|NOT COMPLETED|Overall Study||0
200767|NCT00716443|492679|P1|COMPLETED|Overall Study||51
200768|NCT00716443|492679|P1|STARTED|Overall Study||51
200769|NCT00716456|492715|P3|NOT COMPLETED|Overall Study||0
200770|NCT00716456|492716|P2|NOT COMPLETED|Overall Study||2
200771|NCT00716456|492717|P1|NOT COMPLETED|Overall Study||0
200772|NCT00716456|492715|P3|COMPLETED|Overall Study||13
200773|NCT00716456|492716|P2|COMPLETED|Overall Study||3
200774|NCT00716456|492717|P1|COMPLETED|Overall Study||3
200775|NCT00716456|492715|P3|STARTED|Overall Study||13
200776|NCT00716456|492716|P2|STARTED|Overall Study||5
200777|NCT00716456|492717|P1|STARTED|Overall Study||3
200778|NCT00716482|492725|P1|NOT COMPLETED|Overall Study||119
200779|NCT00716482|492725|P1|COMPLETED|Overall Study||1562
200780|NCT00716482|492725|P1|STARTED|Overall Study||1681
200781|NCT00716625|492735|P1|NOT COMPLETED|Overall Study||1
200782|NCT00716625|492735|P1|COMPLETED|Overall Study||1673
200783|NCT00716625|492735|P1|STARTED|Overall Study||1674
200784|NCT00716742|492763|P3|NOT COMPLETED|3 Year Follow-up||21
200785|NCT00716742|492764|P2|NOT COMPLETED|3 Year Follow-up||32
200786|NCT00716742|492765|P1|NOT COMPLETED|3 Year Follow-up||30
200787|NCT00716742|492763|P3|COMPLETED|3 Year Follow-up||29
200788|NCT00716742|492764|P2|COMPLETED|3 Year Follow-up||35
200789|NCT00716742|492765|P1|COMPLETED|3 Year Follow-up||26
200790|NCT00716742|492763|P3|STARTED|3 Year Follow-up||50
200791|NCT00716742|492764|P2|STARTED|3 Year Follow-up||67
200792|NCT00716742|492765|P1|STARTED|3 Year Follow-up||56
200793|NCT00716742|492763|P3|NOT COMPLETED|2 Year Follow-up||102
200794|NCT00716742|492764|P2|NOT COMPLETED|2 Year Follow-up||96
200795|NCT00716742|492765|P1|NOT COMPLETED|2 Year Follow-up||104
200796|NCT00716742|492763|P3|COMPLETED|2 Year Follow-up||50
200797|NCT00716742|492764|P2|COMPLETED|2 Year Follow-up||67
200798|NCT00716742|492765|P1|COMPLETED|2 Year Follow-up||56
200799|NCT00716742|492763|P3|STARTED|2 Year Follow-up||152
200800|NCT00716742|492764|P2|STARTED|2 Year Follow-up||163
200801|NCT00716742|492765|P1|STARTED|2 Year Follow-up||160
200802|NCT00716742|492763|P3|NOT COMPLETED|1 Year Follow-up||200
200803|NCT00716742|492764|P2|NOT COMPLETED|1 Year Follow-up||193
200804|NCT00716742|492765|P1|NOT COMPLETED|1 Year Follow-up||187
200805|NCT00716742|492763|P3|COMPLETED|1 Year Follow-up||152
200806|NCT00716742|492764|P2|COMPLETED|1 Year Follow-up||163
200807|NCT00716742|492765|P1|COMPLETED|1 Year Follow-up||160
200808|NCT00716742|492763|P3|STARTED|1 Year Follow-up||352
200809|NCT00716742|492764|P2|STARTED|1 Year Follow-up||356
200810|NCT00716742|492765|P1|STARTED|1 Year Follow-up||347
200811|NCT00716742|492763|P3|NOT COMPLETED|Baseline||13
200812|NCT00716742|492764|P2|NOT COMPLETED|Baseline||14
200813|NCT00716742|492765|P1|NOT COMPLETED|Baseline||17
200814|NCT00716742|492763|P3|COMPLETED|Baseline||352
200815|NCT00716742|492764|P2|COMPLETED|Baseline||356
200816|NCT00716742|492765|P1|COMPLETED|Baseline||347
200817|NCT00716742|492763|P3|STARTED|Baseline||365
200818|NCT00716742|492764|P2|STARTED|Baseline||370
200819|NCT00716742|492765|P1|STARTED|Baseline||364
200820|NCT00716807|492777|P4|NOT COMPLETED|Overall Study||0
200821|NCT00716807|492778|P3|NOT COMPLETED|Overall Study||0
200822|NCT00716807|492779|P2|NOT COMPLETED|Overall Study||0
200823|NCT00716807|492780|P1|NOT COMPLETED|Overall Study||0
200824|NCT00716807|492777|P4|COMPLETED|Overall Study||15
200825|NCT00716807|492778|P3|COMPLETED|Overall Study||18
200826|NCT00716807|492779|P2|COMPLETED|Overall Study||5
200827|NCT00716807|492780|P1|COMPLETED|Overall Study||8
200828|NCT00716807|492777|P4|STARTED|Overall Study||15
200829|NCT00716807|492778|P3|STARTED|Overall Study||18
200830|NCT00716807|492779|P2|STARTED|Overall Study||5
200831|NCT00716807|492780|P1|STARTED|Overall Study||8
200832|NCT00716820|492790|P1|NOT COMPLETED|Overall Study||0
200833|NCT00716820|492790|P1|COMPLETED|Overall Study||472
200834|NCT00716820|492790|P1|STARTED|Overall Study||472
200835|NCT00716859|492823|P2|NOT COMPLETED|Overall Study||5
200836|NCT00716859|492824|P1|NOT COMPLETED|Overall Study||9
200837|NCT00716859|492823|P2|COMPLETED|Overall Study||64
200838|NCT00716859|492824|P1|COMPLETED|Overall Study||61
200839|NCT00716859|492823|P2|Received Treatment|Overall Study||68
200840|NCT00716859|492824|P1|Received Treatment|Overall Study||69
200841|NCT00716859|492823|P2|STARTED|Overall Study||69
200842|NCT00716859|492824|P1|STARTED|Overall Study||70
200843|NCT00716963|492848|P6|NOT COMPLETED|Overall Study||0
200844|NCT00716963|492849|P5|NOT COMPLETED|Overall Study||0
200845|NCT00716963|492850|P4|NOT COMPLETED|Overall Study||0
200846|NCT00716963|492851|P3|NOT COMPLETED|Overall Study||0
200847|NCT00716963|492852|P2|NOT COMPLETED|Overall Study||0
200848|NCT00716963|492853|P1|NOT COMPLETED|Overall Study||1
200849|NCT00716963|492848|P6|COMPLETED|Overall Study||1
200850|NCT00716963|492849|P5|COMPLETED|Overall Study||1
200851|NCT00716963|492850|P4|COMPLETED|Overall Study||1
200852|NCT00716963|492851|P3|COMPLETED|Overall Study||1
200853|NCT00716963|492852|P2|COMPLETED|Overall Study||1
200854|NCT00716963|492853|P1|COMPLETED|Overall Study||1
200855|NCT00716963|492848|P6|STARTED|Overall Study||1
200856|NCT00716963|492849|P5|STARTED|Overall Study||1
200857|NCT00716963|492850|P4|STARTED|Overall Study||1
200858|NCT00716963|492851|P3|STARTED|Overall Study||1
200859|NCT00716963|492852|P2|STARTED|Overall Study||1
200860|NCT00716963|492853|P1|STARTED|Overall Study||2
200861|NCT00716976|492866|P2|NOT COMPLETED|Overall Study||9
200862|NCT00716976|492867|P1|NOT COMPLETED|Overall Study||20
200863|NCT00716976|492866|P2|COMPLETED|Overall Study||57
200864|NCT00716976|492867|P1|COMPLETED|Overall Study||45
200865|NCT00716976|492866|P2|STARTED|Overall Study||66
200866|NCT00716976|492867|P1|STARTED|Overall Study||65
200867|NCT00717041|492887|P1|NOT COMPLETED|Overall Study||0
200868|NCT00717041|492887|P1|COMPLETED|Overall Study||1206
200869|NCT00717041|492887|P1|STARTED|Overall Study||1206
200870|NCT00717054|492897|P2|NOT COMPLETED|Overall Study||0
200871|NCT00717054|492898|P1|NOT COMPLETED|Overall Study||0
200872|NCT00717054|492897|P2|COMPLETED|Overall Study||57
200873|NCT00717054|492898|P1|COMPLETED|Overall Study||58
200874|NCT00717054|492897|P2|STARTED|Overall Study||57
200875|NCT00717054|492898|P1|STARTED|Overall Study||58
200876|NCT00717067|492915|P5|NOT COMPLETED|Part 2: End Stage Renal Disease||0
200877|NCT00717067|492916|P4|NOT COMPLETED|Part 2: End Stage Renal Disease||0
200878|NCT00717067|492917|P3|NOT COMPLETED|Part 2: End Stage Renal Disease||0
200879|NCT00717067|492918|P2|NOT COMPLETED|Part 2: End Stage Renal Disease||0
200880|NCT00717067|492919|P1|NOT COMPLETED|Part 2: End Stage Renal Disease||0
200881|NCT00717067|492915|P5|COMPLETED|Part 2: End Stage Renal Disease||6
200882|NCT00717067|492916|P4|COMPLETED|Part 2: End Stage Renal Disease||0
200883|NCT00717067|492917|P3|COMPLETED|Part 2: End Stage Renal Disease||0
200884|NCT00717067|492918|P2|COMPLETED|Part 2: End Stage Renal Disease||0
200885|NCT00717067|492919|P1|COMPLETED|Part 2: End Stage Renal Disease||0
200886|NCT00717067|492915|P5|STARTED|Part 2: End Stage Renal Disease||6
200887|NCT00717067|492916|P4|STARTED|Part 2: End Stage Renal Disease||0
200888|NCT00717067|492917|P3|STARTED|Part 2: End Stage Renal Disease||0
200889|NCT00717067|492918|P2|STARTED|Part 2: End Stage Renal Disease||0
200890|NCT00717067|492919|P1|STARTED|Part 2: End Stage Renal Disease||0
200891|NCT00717067|492915|P5|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
200892|NCT00717067|492916|P4|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
200893|NCT00717067|492917|P3|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
200894|NCT00717067|492918|P2|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
200895|NCT00717067|492919|P1|NOT COMPLETED|Part 1b: Severe Renal Impairment||0
200896|NCT00717067|492915|P5|COMPLETED|Part 1b: Severe Renal Impairment||0
200897|NCT00717067|492916|P4|COMPLETED|Part 1b: Severe Renal Impairment||6
200898|NCT00717067|492917|P3|COMPLETED|Part 1b: Severe Renal Impairment||0
200899|NCT00717067|492918|P2|COMPLETED|Part 1b: Severe Renal Impairment||0
200900|NCT00717067|492919|P1|COMPLETED|Part 1b: Severe Renal Impairment||0
200901|NCT00717067|492915|P5|STARTED|Part 1b: Severe Renal Impairment||0
200902|NCT00717067|492916|P4|STARTED|Part 1b: Severe Renal Impairment||6
200903|NCT00717067|492917|P3|STARTED|Part 1b: Severe Renal Impairment||0
200904|NCT00717067|492918|P2|STARTED|Part 1b: Severe Renal Impairment||0
200905|NCT00717067|492919|P1|STARTED|Part 1b: Severe Renal Impairment||0
200906|NCT00717067|492915|P5|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
200907|NCT00717067|492916|P4|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
200908|NCT00717067|492917|P3|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||1
200909|NCT00717067|492918|P2|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
200910|NCT00717067|492919|P1|NOT COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
200911|NCT00717067|492915|P5|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
200912|NCT00717067|492916|P4|COMPLETED|Part 1a: Normal/Mild/Moderate Group||0
200913|NCT00717067|492917|P3|COMPLETED|Part 1a: Normal/Mild/Moderate Group||5
200914|NCT00717067|492918|P2|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
200915|NCT00717067|492919|P1|COMPLETED|Part 1a: Normal/Mild/Moderate Group||6
200916|NCT00717067|492915|P5|STARTED|Part 1a: Normal/Mild/Moderate Group||0
200917|NCT00717067|492916|P4|STARTED|Part 1a: Normal/Mild/Moderate Group||0
200918|NCT00717067|492917|P3|STARTED|Part 1a: Normal/Mild/Moderate Group||6
200919|NCT00717067|492918|P2|STARTED|Part 1a: Normal/Mild/Moderate Group||6
200920|NCT00717067|492919|P1|STARTED|Part 1a: Normal/Mild/Moderate Group||6
200921|NCT00717093|493003|P2|NOT COMPLETED|Overall Study||48
200922|NCT00717093|493004|P1|NOT COMPLETED|Overall Study||44
200923|NCT00717093|493003|P2|COMPLETED|Overall Study||170
200924|NCT00717093|493004|P1|COMPLETED|Overall Study||170
200925|NCT00717093|493003|P2|Received Treatment|Overall Study||218
200926|NCT00717093|493004|P1|Received Treatment|Overall Study||213
200927|NCT00717093|493003|P2|STARTED|Overall Study||218
200928|NCT00717093|493004|P1|STARTED|Overall Study||214
200929|NCT00717197|493016|P1|NOT COMPLETED|Overall Study||7
200930|NCT00717197|493016|P1|COMPLETED|Overall Study||23
200931|NCT00717197|493016|P1|STARTED|Overall Study||30
200932|NCT00717236|493022|P2|NOT COMPLETED|Open-Label Period||21
200933|NCT00717236|493023|P1|NOT COMPLETED|Open-Label Period||125
200934|NCT00717236|493022|P2|COMPLETED|Open-Label Period||163
200935|NCT00717236|493023|P1|COMPLETED|Open-Label Period||646
200936|NCT00717236|493022|P2|STARTED|Open-Label Period||184
200937|NCT00717236|493023|P1|STARTED|Open-Label Period||771
200938|NCT00717236|493022|P2|NOT COMPLETED|Double-Blind Period||28
200939|NCT00717236|493023|P1|NOT COMPLETED|Double-Blind Period||80
200940|NCT00717236|493022|P2|COMPLETED|Double-Blind Period||184
200941|NCT00717236|493023|P1|COMPLETED|Double-Blind Period||771
200942|NCT00717236|493022|P2|STARTED|Double-Blind Period||212
200943|NCT00717236|493023|P1|STARTED|Double-Blind Period||851
200944|NCT00717249|493094|P2|NOT COMPLETED|Overall Study||15
200945|NCT00717249|493095|P1|NOT COMPLETED|Overall Study||22
200946|NCT00717249|493094|P2|COMPLETED|Overall Study||150
200947|NCT00717249|493095|P1|COMPLETED|Overall Study||304
200948|NCT00717249|493094|P2|STARTED|Overall Study||165
200949|NCT00717249|493095|P1|STARTED|Overall Study||326
200950|NCT00717275|493107|P1|NOT COMPLETED|Overall Study||3
200951|NCT00717275|493107|P1|COMPLETED|Overall Study||0
200952|NCT00717275|493107|P1|STARTED|Overall Study||3
200953|NCT00717288|493114|P3|NOT COMPLETED|Overall Study||0
200954|NCT00717288|493115|P2|NOT COMPLETED|Overall Study||0
200955|NCT00717288|493116|P1|NOT COMPLETED|Overall Study||0
200956|NCT00717288|493114|P3|COMPLETED|Overall Study||25
200957|NCT00717288|493115|P2|COMPLETED|Overall Study||29
200958|NCT00717288|493116|P1|COMPLETED|Overall Study||28
200959|NCT00717288|493114|P3|STARTED|Overall Study||25
200960|NCT00717288|493115|P2|STARTED|Overall Study||29
200961|NCT00717288|493116|P1|STARTED|Overall Study||28
200962|NCT00717314|493132|P2|NOT COMPLETED|Overall Study||10
200963|NCT00717314|493133|P1|NOT COMPLETED|Overall Study||6
200964|NCT00717314|493132|P2|COMPLETED|Overall Study||34
200965|NCT00717314|493133|P1|COMPLETED|Overall Study||37
200966|NCT00717314|493132|P2|STARTED|Overall Study||44
200967|NCT00717314|493133|P1|STARTED|Overall Study||43
200968|NCT00717405|493151|P1|NOT COMPLETED|Overall Study||0
200969|NCT00717405|493151|P1|COMPLETED|Overall Study||52
200970|NCT00717405|493151|P1|STARTED|Overall Study||52
200971|NCT00717418|493172|P4|NOT COMPLETED|1-Year Follow-Up||4
200972|NCT00717418|493173|P3|NOT COMPLETED|1-Year Follow-Up||434
200973|NCT00717418|493174|P2|NOT COMPLETED|1-Year Follow-Up||51
200974|NCT00717418|493175|P1|NOT COMPLETED|1-Year Follow-Up||147
200975|NCT00717418|493172|P4|COMPLETED|1-Year Follow-Up||0
200976|NCT00717418|493173|P3|COMPLETED|1-Year Follow-Up||74
200977|NCT00717418|493174|P2|COMPLETED|1-Year Follow-Up||23
200978|NCT00717418|493175|P1|COMPLETED|1-Year Follow-Up||33
200979|NCT00717418|493172|P4|STARTED|1-Year Follow-Up||4
200980|NCT00717418|493173|P3|STARTED|1-Year Follow-Up||508
200981|NCT00717418|493174|P2|STARTED|1-Year Follow-Up||74
200982|NCT00717418|493175|P1|STARTED|1-Year Follow-Up||180
200983|NCT00717418|493172|P4|NOT COMPLETED|Baseline||15
200984|NCT00717418|493173|P3|NOT COMPLETED|Baseline||0
200985|NCT00717418|493174|P2|NOT COMPLETED|Baseline||0
200986|NCT00717418|493175|P1|NOT COMPLETED|Baseline||0
200987|NCT00717418|493172|P4|COMPLETED|Baseline||4
200988|NCT00717418|493173|P3|COMPLETED|Baseline||508
200989|NCT00717418|493174|P2|COMPLETED|Baseline||74
200990|NCT00717418|493175|P1|COMPLETED|Baseline||180
200991|NCT00717418|493172|P4|STARTED|Baseline||19
200992|NCT00717418|493173|P3|STARTED|Baseline||508
200993|NCT00717418|493174|P2|STARTED|Baseline||74
200994|NCT00717418|493175|P1|STARTED|Baseline||180
200995|NCT00717522|493180|P1|NOT COMPLETED|Overall Study||7
200996|NCT00717522|493180|P1|COMPLETED|Overall Study||0
200997|NCT00717522|493180|P1|STARTED|Overall Study||7
200998|NCT00717574|493187|P2|NOT COMPLETED|Overall Study||2
200999|NCT00717574|493188|P1|NOT COMPLETED|Overall Study||2
201000|NCT00717574|493187|P2|COMPLETED|Overall Study||14
201001|NCT00717574|493188|P1|COMPLETED|Overall Study||14
201002|NCT00717574|493187|P2|STARTED|Overall Study||16
201003|NCT00717574|493188|P1|STARTED|Overall Study||16
201004|NCT00717756|493194|P1|NOT COMPLETED|Overall Study||1
201005|NCT00717756|493194|P1|COMPLETED|Overall Study||40
201006|NCT00717756|493194|P1|STARTED|Overall Study||41
201007|NCT00705614|493200|P2|NOT COMPLETED|Switch to Remicade||49
201008|NCT00705614|493201|P1|NOT COMPLETED|Switch to Remicade||0
201009|NCT00705614|493200|P2|COMPLETED|Switch to Remicade||249
201010|NCT00705614|493201|P1|COMPLETED|Switch to Remicade||0
201011|NCT00705614|493200|P2|STARTED|Switch to Remicade||298
201012|NCT00705614|493201|P1|STARTED|Switch to Remicade||0
201013|NCT00705614|493200|P2|NOT COMPLETED|Initial Intervention||321
201014|NCT00705614|493201|P1|NOT COMPLETED|Initial Intervention||518
201015|NCT00705614|493200|P2|COMPLETED|Initial Intervention||800
201016|NCT00705614|493201|P1|COMPLETED|Initial Intervention||1023
201017|NCT00705614|493200|P2|STARTED|Initial Intervention||1121
201018|NCT00705614|493201|P1|STARTED|Initial Intervention||1541
201019|NCT00705653|493248|P1|NOT COMPLETED|Overall Study||0
201020|NCT00705653|493248|P1|COMPLETED|Overall Study||46
201021|NCT00705653|493248|P1|STARTED|Overall Study||46
201022|NCT00705666|493253|P1|NOT COMPLETED|Overall Study||339
201023|NCT00705666|493253|P1|COMPLETED|Overall Study||450
201024|NCT00705666|493253|P1|STARTED|Overall Study||789
201025|NCT00711087|493259|P2|NOT COMPLETED|Overall Study||0
201026|NCT00711087|493260|P1|NOT COMPLETED|Overall Study||1
201027|NCT00711087|493259|P2|COMPLETED|Overall Study||0
201028|NCT00711087|493260|P1|COMPLETED|Overall Study||0
201029|NCT00711087|493259|P2|STARTED|Overall Study||0
201030|NCT00711087|493260|P1|STARTED|Overall Study||1
201031|NCT00711100|493266|P1|NOT COMPLETED|Overall Study||13
201032|NCT00711100|493266|P1|COMPLETED|Overall Study||91
201033|NCT00711100|493266|P1|STARTED|Overall Study||104
201034|NCT00711113|493282|P1|NOT COMPLETED|Overall Study||11
201035|NCT00711113|493282|P1|COMPLETED|Overall Study||36
201036|NCT00711113|493282|P1|STARTED|Overall Study||47
201037|NCT00711191|493291|P3|NOT COMPLETED|Overall Study||12
201038|NCT00711191|493292|P2|NOT COMPLETED|Overall Study||5
201039|NCT00711191|493293|P1|NOT COMPLETED|Overall Study||3
201040|NCT00711191|493291|P3|COMPLETED|Overall Study||1
201041|NCT00711191|493292|P2|COMPLETED|Overall Study||1
201042|NCT00711191|493293|P1|COMPLETED|Overall Study||0
201043|NCT00711191|493291|P3|STARTED|Overall Study||13
201044|NCT00711191|493292|P2|STARTED|Overall Study||6
201045|NCT00711191|493293|P1|STARTED|Overall Study||3
201046|NCT00711347|493332|P2|NOT COMPLETED|Overall Study||0
201047|NCT00711347|493333|P1|NOT COMPLETED|Overall Study||0
201048|NCT00711347|493332|P2|COMPLETED|Overall Study||14
201049|NCT00711347|493333|P1|COMPLETED|Overall Study||14
201050|NCT00711347|493332|P2|STARTED|Overall Study||14
201051|NCT00711347|493333|P1|STARTED|Overall Study||14
201052|NCT00711425|493349|P1|NOT COMPLETED|Overall Study||4
201053|NCT00711425|493349|P1|COMPLETED|Overall Study||41
201054|NCT00711425|493349|P1|STARTED|Overall Study|Implant placement in 45 patients. Implant loading (baseline) in 44 patients.|45
201055|NCT00711477|493357|P2|NOT COMPLETED|Overall Study||3
201056|NCT00711477|493358|P1|NOT COMPLETED|Overall Study||3
201057|NCT00711477|493357|P2|COMPLETED|Overall Study||20
201058|NCT00711477|493358|P1|COMPLETED|Overall Study||20
201059|NCT00711477|493357|P2|STARTED|Overall Study||23
201060|NCT00711477|493358|P1|STARTED|Overall Study||23
201061|NCT00711490|493386|P1|NOT COMPLETED|Overall Study||0
201062|NCT00711490|493386|P1|COMPLETED|Overall Study||5
201063|NCT00711490|493386|P1|STARTED|Overall Study||5
201064|NCT00711516|493399|P2|NOT COMPLETED|Overall Study||3
201065|NCT00711516|493400|P1|NOT COMPLETED|Overall Study||1
201066|NCT00711516|493399|P2|COMPLETED|Overall Study||16
201067|NCT00711516|493400|P1|COMPLETED|Overall Study||20
201068|NCT00711516|493399|P2|STARTED|Overall Study||19
201069|NCT00711516|493400|P1|STARTED|Overall Study||21
201070|NCT00711529|493496|P2|NOT COMPLETED|Overall Study||6
201071|NCT00711529|493497|P1|NOT COMPLETED|Overall Study||4
201072|NCT00711529|493496|P2|COMPLETED|Overall Study||8
201073|NCT00711529|493497|P1|COMPLETED|Overall Study|2 women lost their hot flash diary, so only 7 patients were evaluable for primary endpoint.|9
201074|NCT00711529|493496|P2|STARTED|Overall Study||14
201075|NCT00711529|493497|P1|STARTED|Overall Study||13
201076|NCT00711555|493519|P1|NOT COMPLETED|Overall Study||3
201077|NCT00711555|493519|P1|COMPLETED|Overall Study||19
201078|NCT00711555|493519|P1|STARTED|Overall Study||22
201079|NCT00711594|493530|P4|NOT COMPLETED|Overall Study||62
201080|NCT00711594|493531|P3|NOT COMPLETED|Overall Study||6
201081|NCT00711594|493532|P2|NOT COMPLETED|Overall Study||3
201082|NCT00711594|493533|P1|NOT COMPLETED|Overall Study||3
201083|NCT00711594|493530|P4|COMPLETED|Overall Study||0
201084|NCT00711594|493531|P3|COMPLETED|Overall Study||0
201085|NCT00711594|493532|P2|COMPLETED|Overall Study||0
201086|NCT00711594|493533|P1|COMPLETED|Overall Study||0
201087|NCT00711594|493530|P4|STARTED|Overall Study||62
201088|NCT00711594|493531|P3|STARTED|Overall Study||6
201089|NCT00711594|493532|P2|STARTED|Overall Study||3
201090|NCT00711594|493533|P1|STARTED|Overall Study||3
201091|NCT00711646|493572|P2|NOT COMPLETED|Overall Study||3
201092|NCT00711646|493573|P1|NOT COMPLETED|Overall Study||12
201093|NCT00711646|493572|P2|COMPLETED|Overall Study||62
201094|NCT00711646|493573|P1|COMPLETED|Overall Study||112
201095|NCT00711646|493572|P2|STARTED|Overall Study||65
201096|NCT00711646|493573|P1|STARTED|Overall Study||124
201097|NCT00711802|493599|P8|NOT COMPLETED|Overall Study||2
201098|NCT00711802|493600|P7|NOT COMPLETED|Overall Study||5
201099|NCT00711802|493601|P6|NOT COMPLETED|Overall Study||8
201100|NCT00711802|493602|P5|NOT COMPLETED|Overall Study||14
201101|NCT00711802|493603|P4|NOT COMPLETED|Overall Study||3
201102|NCT00711802|493604|P3|NOT COMPLETED|Overall Study||6
201103|NCT00711802|493605|P2|NOT COMPLETED|Overall Study||6
201104|NCT00711802|493606|P1|NOT COMPLETED|Overall Study||2
201105|NCT00711802|493599|P8|COMPLETED|Overall Study||13
201106|NCT00711802|493600|P7|COMPLETED|Overall Study||25
201107|NCT00711802|493601|P6|COMPLETED|Overall Study||34
201108|NCT00711802|493602|P5|COMPLETED|Overall Study||69
201109|NCT00711802|493603|P4|COMPLETED|Overall Study||35
201110|NCT00711802|493604|P3|COMPLETED|Overall Study||69
201111|NCT00711802|493605|P2|COMPLETED|Overall Study||32
201112|NCT00711802|493606|P1|COMPLETED|Overall Study||73
201113|NCT00711802|493599|P8|Received at Least 1 Dose of Study Drug|Overall Study||15
201114|NCT00711802|493600|P7|Received at Least 1 Dose of Study Drug|Overall Study||30
201115|NCT00711802|493601|P6|Received at Least 1 Dose of Study Drug|Overall Study||42
201116|NCT00711802|493602|P5|Received at Least 1 Dose of Study Drug|Overall Study||81
201117|NCT00711802|493603|P4|Received at Least 1 Dose of Study Drug|Overall Study||38
201118|NCT00711802|493604|P3|Received at Least 1 Dose of Study Drug|Overall Study||73
201119|NCT00711802|493605|P2|Received at Least 1 Dose of Study Drug|Overall Study||37
201120|NCT00711802|493606|P1|Received at Least 1 Dose of Study Drug|Overall Study||73
201121|NCT00711802|493599|P8|STARTED|Overall Study||15
201122|NCT00711802|493600|P7|STARTED|Overall Study||30
201123|NCT00711802|493601|P6|STARTED|Overall Study||42
201124|NCT00711802|493602|P5|STARTED|Overall Study||83
201125|NCT00711802|493603|P4|STARTED|Overall Study||38
201126|NCT00711802|493604|P3|STARTED|Overall Study||75
201127|NCT00711802|493605|P2|STARTED|Overall Study||38
201128|NCT00711802|493606|P1|STARTED|Overall Study||75
201129|NCT00711828|493636|P1|NOT COMPLETED|Overall Study||0
201130|NCT00711828|493636|P1|COMPLETED|Overall Study||21
201131|NCT00711828|493636|P1|STARTED|Overall Study||21
201132|NCT00711867|493647|P2|NOT COMPLETED|Overall Study||4
201133|NCT00711867|493648|P1|NOT COMPLETED|Overall Study||5
201134|NCT00711867|493647|P2|COMPLETED|Overall Study|3 received additional warming. 1 missing primary measure.|21
201135|NCT00711867|493648|P1|COMPLETED|Overall Study|2 received additional warming. 3 missing primary measure.|25
201136|NCT00711867|493647|P2|STARTED|Overall Study||25
201137|NCT00711867|493648|P1|STARTED|Overall Study||30
201138|NCT00711880|493656|P2|NOT COMPLETED|Overall Study||7
201139|NCT00711880|493657|P1|NOT COMPLETED|Overall Study||13
201140|NCT00711880|493656|P2|COMPLETED|Overall Study||55
201141|NCT00711880|493657|P1|COMPLETED|Overall Study||50
201142|NCT00711880|493656|P2|STARTED|Overall Study||62
201143|NCT00711880|493657|P1|STARTED|Overall Study||63
201144|NCT00717860|493695|P2|NOT COMPLETED|Overall Study||28
201145|NCT00717860|493696|P1|NOT COMPLETED|Overall Study||27
201146|NCT00717860|493695|P2|COMPLETED|Overall Study||32
201147|NCT00717860|493696|P1|COMPLETED|Overall Study||34
201148|NCT00717860|493695|P2|STARTED|Overall Study||60
201149|NCT00717860|493696|P1|STARTED|Overall Study||61
201150|NCT00717873|493708|P2|NOT COMPLETED|Overall Study||0
201151|NCT00717873|493709|P1|NOT COMPLETED|Overall Study||0
201152|NCT00717873|493708|P2|COMPLETED|Overall Study||59
201153|NCT00717873|493709|P1|COMPLETED|Overall Study||46
201154|NCT00717873|493708|P2|STARTED|Overall Study||59
201155|NCT00717873|493709|P1|STARTED|Overall Study||46
201156|NCT00717886|493715|P1|NOT COMPLETED|Overall Study||4
201157|NCT00717886|493715|P1|COMPLETED|Overall Study||9
201158|NCT00717886|493715|P1|STARTED|Overall Study||13
201159|NCT00717912|493719|P6|NOT COMPLETED|Overall Study||0
201160|NCT00717912|493720|P5|NOT COMPLETED|Overall Study||0
201161|NCT00717912|493721|P4|NOT COMPLETED|Overall Study||0
201162|NCT00717912|493722|P3|NOT COMPLETED|Overall Study||0
201163|NCT00717912|493723|P2|NOT COMPLETED|Overall Study||0
201164|NCT00717912|493724|P1|NOT COMPLETED|Overall Study||0
201165|NCT00717912|493719|P6|COMPLETED|Overall Study||1
201166|NCT00717912|493720|P5|COMPLETED|Overall Study||1
201167|NCT00717912|493721|P4|COMPLETED|Overall Study||1
201168|NCT00717912|493722|P3|COMPLETED|Overall Study||1
201169|NCT00717912|493723|P2|COMPLETED|Overall Study||1
201170|NCT00717912|493724|P1|COMPLETED|Overall Study||1
201171|NCT00717912|493719|P6|STARTED|Overall Study||1
201172|NCT00717912|493720|P5|STARTED|Overall Study||1
201173|NCT00717912|493721|P4|STARTED|Overall Study||1
201174|NCT00717912|493722|P3|STARTED|Overall Study||1
201175|NCT00717912|493723|P2|STARTED|Overall Study||1
201176|NCT00717912|493724|P1|STARTED|Overall Study||1
201177|NCT00717977|493735|P1|NOT COMPLETED|Overall Study||0
201178|NCT00717977|493735|P1|COMPLETED|Overall Study||74
201179|NCT00717977|493735|P1|STARTED|Overall Study||74
201180|NCT00718042|493769|P6|NOT COMPLETED|Donor Follow-up||0
201181|NCT00718042|493770|P5|NOT COMPLETED|Donor Follow-up||19
201182|NCT00718042|493771|P4|NOT COMPLETED|Donor Follow-up||0
201183|NCT00718042|493772|P3|NOT COMPLETED|Donor Follow-up||0
201184|NCT00718042|493773|P2|NOT COMPLETED|Donor Follow-up||0
201185|NCT00718042|493774|P1|NOT COMPLETED|Donor Follow-up||13
201186|NCT00718042|493769|P6|COMPLETED|Donor Follow-up||0
201187|NCT00718042|493770|P5|COMPLETED|Donor Follow-up||24
201188|NCT00718042|493771|P4|COMPLETED|Donor Follow-up||0
201189|NCT00718042|493772|P3|COMPLETED|Donor Follow-up||0
201190|NCT00718042|493773|P2|COMPLETED|Donor Follow-up||0
201191|NCT00718042|493774|P1|COMPLETED|Donor Follow-up||23
201192|NCT00718042|493769|P6|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
201193|NCT00718042|493770|P5|STARTED|Donor Follow-up||43
201194|NCT00718042|493771|P4|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
201195|NCT00718042|493772|P3|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
201196|NCT00718042|493773|P2|STARTED|Donor Follow-up|Follow-up not performed for this specimen population.|0
201197|NCT00718042|493774|P1|STARTED|Donor Follow-up||36
201198|NCT00718042|493769|P6|NOT COMPLETED|ESA Chagas Testing||0
201199|NCT00718042|493770|P5|NOT COMPLETED|ESA Chagas Testing||0
201200|NCT00718042|493771|P4|NOT COMPLETED|ESA Chagas Testing||0
201201|NCT00718042|493772|P3|NOT COMPLETED|ESA Chagas Testing||0
201202|NCT00718042|493773|P2|NOT COMPLETED|ESA Chagas Testing||0
201203|NCT00718042|493774|P1|NOT COMPLETED|ESA Chagas Testing||0
201204|NCT00718042|493769|P6|COMPLETED|ESA Chagas Testing||330
201205|NCT00718042|493770|P5|COMPLETED|ESA Chagas Testing||43
201206|NCT00718042|493771|P4|COMPLETED|ESA Chagas Testing||110
201207|NCT00718042|493772|P3|COMPLETED|ESA Chagas Testing||524
201208|NCT00718042|493773|P2|COMPLETED|ESA Chagas Testing||287
201209|NCT00718042|493774|P1|COMPLETED|ESA Chagas Testing||36
201210|NCT00718042|493769|P6|STARTED|ESA Chagas Testing|Specimens only tested with ESA Chagas|330
201211|NCT00718042|493770|P5|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|43
201212|NCT00718042|493771|P4|STARTED|ESA Chagas Testing||110
201213|NCT00718042|493772|P3|STARTED|ESA Chagas Testing||524
201214|NCT00718042|493773|P2|STARTED|ESA Chagas Testing||287
201215|NCT00718042|493774|P1|STARTED|ESA Chagas Testing|Only specimens repeatedly reactive by screening assay or PRISM grayzone tested with ESA Chagas|36
201216|NCT00718042|493769|P6|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
201217|NCT00718042|493770|P5|NOT COMPLETED|ABBOTT PRISM Chagas Testing||38
201218|NCT00718042|493771|P4|NOT COMPLETED|ABBOTT PRISM Chagas Testing||0
201219|NCT00718042|493772|P3|NOT COMPLETED|ABBOTT PRISM Chagas Testing||1
201220|NCT00718042|493773|P2|NOT COMPLETED|ABBOTT PRISM Chagas Testing||2
201221|NCT00718042|493774|P1|NOT COMPLETED|ABBOTT PRISM Chagas Testing||64
201222|NCT00718042|493769|P6|COMPLETED|ABBOTT PRISM Chagas Testing||0
201223|NCT00718042|493770|P5|COMPLETED|ABBOTT PRISM Chagas Testing||25511
201224|NCT00718042|493771|P4|COMPLETED|ABBOTT PRISM Chagas Testing||110
201225|NCT00718042|493772|P3|COMPLETED|ABBOTT PRISM Chagas Testing||524
201226|NCT00718042|493773|P2|COMPLETED|ABBOTT PRISM Chagas Testing||287
201227|NCT00718042|493774|P1|COMPLETED|ABBOTT PRISM Chagas Testing||16249
201228|NCT00718042|493769|P6|STARTED|ABBOTT PRISM Chagas Testing|Specimens not screened with PRISM Chagas assay per protocol.|0
201229|NCT00718042|493770|P5|STARTED|ABBOTT PRISM Chagas Testing||25549
201230|NCT00718042|493771|P4|STARTED|ABBOTT PRISM Chagas Testing||110
201231|NCT00718042|493772|P3|STARTED|ABBOTT PRISM Chagas Testing||525
201232|NCT00718042|493773|P2|STARTED|ABBOTT PRISM Chagas Testing||289
201233|NCT00718042|493774|P1|STARTED|ABBOTT PRISM Chagas Testing||16313
201234|NCT00718081|493789|P3|NOT COMPLETED|Overall Study||21
201235|NCT00718081|493790|P2|NOT COMPLETED|Overall Study||4
201236|NCT00718081|493791|P1|NOT COMPLETED|Overall Study||7
201237|NCT00718081|493789|P3|COMPLETED|Overall Study||9
201238|NCT00718081|493790|P2|COMPLETED|Overall Study||25
201239|NCT00718081|493791|P1|COMPLETED|Overall Study||22
201240|NCT00718081|493789|P3|STARTED|Overall Study||30
201241|NCT00718081|493790|P2|STARTED|Overall Study||29
201242|NCT00718081|493791|P1|STARTED|Overall Study||29
201243|NCT00718523|493804|P2|NOT COMPLETED|Overall Study||24
201244|NCT00718523|493805|P1|NOT COMPLETED|Overall Study||18
201245|NCT00718523|493804|P2|COMPLETED|Overall Study||62
201246|NCT00718523|493805|P1|COMPLETED|Overall Study||66
201247|NCT00718523|493804|P2|STARTED|Overall Study||86
201248|NCT00718523|493805|P1|STARTED|Overall Study||84
201249|NCT00718640|493815|P1|NOT COMPLETED|Overall Study||7
201250|NCT00718640|493815|P1|COMPLETED|Overall Study||3
201251|NCT00718640|493815|P1|STARTED|Overall Study||10
201252|NCT00718770|493827|P1|NOT COMPLETED|Overall Study||8
201253|NCT00718770|493827|P1|COMPLETED|Overall Study||2
201254|NCT00718770|493827|P1|STARTED|Overall Study||10
201255|NCT00718809|493833|P2|NOT COMPLETED|Overall Study||9
201256|NCT00718809|493834|P1|NOT COMPLETED|Overall Study||12
201257|NCT00718809|493833|P2|COMPLETED|Overall Study||0
201258|NCT00718809|493834|P1|COMPLETED|Overall Study||0
201259|NCT00718809|493833|P2|STARTED|Overall Study||9
201260|NCT00718809|493834|P1|STARTED|Overall Study||12
201261|NCT00718861|493850|P2|NOT COMPLETED|Overall Study||18
201262|NCT00718861|493851|P1|NOT COMPLETED|Overall Study||21
201263|NCT00718861|493850|P2|COMPLETED|Overall Study||77
201264|NCT00718861|493851|P1|COMPLETED|Overall Study||74
201265|NCT00718861|493850|P2|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|69
201266|NCT00718861|493851|P1|Modified Intent to Treat|Overall Study|ITT patients with DXA total hip measure at extension 2 baseline and year 9|67
201267|NCT00718861|493850|P2|Safety Set|Overall Study||95
201268|NCT00718861|493851|P1|Safety Set|Overall Study|3 patients randomized but never received study drug|92
201269|NCT00718861|493850|P2|STARTED|Overall Study||95
201270|NCT00718861|493851|P1|STARTED|Overall Study|"Started indicates Randomized and Intent-to Treat (ITT) population"|95
201271|NCT00718887|493879|P2|NOT COMPLETED|Overall Study||9
201272|NCT00718887|493880|P1|NOT COMPLETED|Overall Study||5
201273|NCT00718887|493879|P2|COMPLETED|Overall Study||68
201274|NCT00718887|493880|P1|COMPLETED|Overall Study|Continued in study after 48 weeks|84
201275|NCT00718887|493879|P2|STARTED|Overall Study|Participants who received treatment.|77
201276|NCT00718887|493880|P1|STARTED|Overall Study|Participants who received treatment.|89
201277|NCT00719043|493909|P7|NOT COMPLETED|Overall Study||28
201278|NCT00719043|493910|P6|NOT COMPLETED|Overall Study||34
201279|NCT00719043|493911|P5|NOT COMPLETED|Overall Study||27
201280|NCT00719043|493912|P4|NOT COMPLETED|Overall Study||23
201281|NCT00719043|493913|P3|NOT COMPLETED|Overall Study||20
201282|NCT00719043|493914|P2|NOT COMPLETED|Overall Study||25
201283|NCT00719043|493915|P1|NOT COMPLETED|Overall Study||32
201284|NCT00719043|493909|P7|COMPLETED|Overall Study|Up to Day 909|92
201285|NCT00719043|493910|P6|COMPLETED|Overall Study|Up to Day 909|86
201286|NCT00719043|493911|P5|COMPLETED|Overall Study|Up to Day 909|95
201287|NCT00719043|493912|P4|COMPLETED|Overall Study|Up to Day 909|96
201288|NCT00719043|493913|P3|COMPLETED|Overall Study|Up to Day 909|99
201289|NCT00719043|493914|P2|COMPLETED|Overall Study|Up to Day 909|96
201290|NCT00719043|493915|P1|COMPLETED|Overall Study|Up to Day 909|88
201291|NCT00719043|493909|P7|STARTED|Overall Study||120
201292|NCT00719043|493910|P6|STARTED|Overall Study||120
201293|NCT00719043|493911|P5|STARTED|Overall Study||122
201294|NCT00719043|493912|P4|STARTED|Overall Study||119
201295|NCT00719043|493913|P3|STARTED|Overall Study||119
201296|NCT00719043|493914|P2|STARTED|Overall Study||121
201297|NCT00719043|493915|P1|STARTED|Overall Study||120
201298|NCT00719134|494037|P1|NOT COMPLETED|Overall Study||10
201299|NCT00719134|494037|P1|COMPLETED|Overall Study||66
201300|NCT00719134|494037|P1|STARTED|Overall Study||76
201301|NCT00719160|494043|P2|NOT COMPLETED|Overall Study||0
201302|NCT00719160|494044|P1|NOT COMPLETED|Overall Study||0
201303|NCT00719160|494043|P2|COMPLETED|Overall Study||6
201304|NCT00719160|494044|P1|COMPLETED|Overall Study||6
201305|NCT00719160|494043|P2|STARTED|Overall Study||6
201306|NCT00719160|494044|P1|STARTED|Overall Study||6
201307|NCT00719186|494053|P2|NOT COMPLETED|Overall Study||0
201308|NCT00719186|494054|P1|NOT COMPLETED|Overall Study||0
201309|NCT00719186|494053|P2|COMPLETED|Overall Study||374
201310|NCT00719186|494054|P1|COMPLETED|Overall Study||376
201311|NCT00719186|494053|P2|STARTED|Overall Study||374
201312|NCT00719186|494054|P1|STARTED|Overall Study||376
201313|NCT00719212|494066|P1|NOT COMPLETED|Overall Study||44
201314|NCT00719212|494066|P1|COMPLETED|Overall Study||17
201315|NCT00719212|494066|P1|STARTED|Overall Study||61
201316|NCT00719264|494078|P2|NOT COMPLETED|Overall Study||183
201317|NCT00719264|494079|P1|NOT COMPLETED|Overall Study||182
201318|NCT00719264|494078|P2|COMPLETED|Overall Study||0
201319|NCT00719264|494079|P1|COMPLETED|Overall Study||0
201320|NCT00719264|494078|P2|Safety Set|Overall Study||181
201321|NCT00719264|494079|P1|Safety Set|Overall Study||180
201322|NCT00719264|494078|P2|Full Analysis Set|Overall Study||183
201323|NCT00719264|494079|P1|Full Analysis Set|Overall Study||182
201324|NCT00719264|494078|P2|STARTED|Overall Study||183
201325|NCT00719264|494079|P1|STARTED|Overall Study||182
201326|NCT00719329|494101|P3|NOT COMPLETED|Overall Study||1
201327|NCT00719329|494102|P2|NOT COMPLETED|Overall Study||2
201328|NCT00719329|494103|P1|NOT COMPLETED|Overall Study||0
201329|NCT00719329|494101|P3|COMPLETED|Overall Study||646
201330|NCT00719329|494102|P2|COMPLETED|Overall Study||569
201331|NCT00719329|494103|P1|COMPLETED|Overall Study||705
201332|NCT00719329|494101|P3|Day 7 Swab|Overall Study||561
201333|NCT00719329|494102|P2|Day 7 Swab|Overall Study||467
201334|NCT00719329|494103|P1|Day 7 Swab|Overall Study||593
201335|NCT00719329|494101|P3|Day 3 Swab|Overall Study||578
201336|NCT00719329|494102|P2|Day 3 Swab|Overall Study||501
201337|NCT00719329|494103|P1|Day 3 Swab|Overall Study||614
201338|NCT00719329|494101|P3|Day 1 Swab|Overall Study||646
201339|NCT00719329|494102|P2|Day 1 Swab|Overall Study||569
201340|NCT00719329|494103|P1|Day 1 Swab|Overall Study||705
201341|NCT00719329|494101|P3|STARTED|Overall Study||647
201342|NCT00719329|494102|P2|STARTED|Overall Study||571
201343|NCT00719329|494103|P1|STARTED|Overall Study||705
201344|NCT00719355|494119|P2|NOT COMPLETED|Overall Study||13
201345|NCT00719355|494120|P1|NOT COMPLETED|Overall Study||18
201346|NCT00719355|494119|P2|COMPLETED|Overall Study||39
201347|NCT00719355|494120|P1|COMPLETED|Overall Study||33
201348|NCT00719355|494119|P2|Completed 32 Weeks|Overall Study||39
201349|NCT00719355|494120|P1|Completed 32 Weeks|Overall Study||33
201350|NCT00719355|494119|P2|Completed 24 Weeks|Overall Study||43
201351|NCT00719355|494120|P1|Completed 24 Weeks|Overall Study||34
201352|NCT00719355|494119|P2|Completed 12 Weeks|Overall Study||46
201353|NCT00719355|494120|P1|Completed 12 Weeks|Overall Study||43
201354|NCT00719355|494119|P2|Completed 6 Weeks|Overall Study||48
201355|NCT00719355|494120|P1|Completed 6 Weeks|Overall Study||49
201356|NCT00719355|494119|P2|STARTED|Overall Study||52
201357|NCT00719355|494120|P1|STARTED|Overall Study||51
201358|NCT00719472|494128|P1|NOT COMPLETED|Received Cycle 2 Treatment||68
201359|NCT00719472|494128|P1|COMPLETED|Received Cycle 2 Treatment||304
201360|NCT00719472|494128|P1|STARTED|Received Cycle 2 Treatment||372
201361|NCT00719472|494128|P1|NOT COMPLETED|Received Cycle 1 Treatment||53
201362|NCT00719472|494128|P1|COMPLETED|Received Cycle 1 Treatment||372
201363|NCT00719472|494128|P1|STARTED|Received Cycle 1 Treatment||425
201364|NCT00719472|494128|P1|NOT COMPLETED|Enrolled in Study||26
201365|NCT00719472|494128|P1|COMPLETED|Enrolled in Study||425
201366|NCT00719472|494128|P1|STARTED|Enrolled in Study||451
201367|NCT00719537|494139|P2|NOT COMPLETED|Overall Study||1
201368|NCT00719537|494140|P1|NOT COMPLETED|Overall Study||1
201369|NCT00719537|494139|P2|COMPLETED|Overall Study||0
201370|NCT00719537|494140|P1|COMPLETED|Overall Study||1
201371|NCT00719537|494139|P2|STARTED|Overall Study||1
201372|NCT00719537|494140|P1|STARTED|Overall Study||2
201373|NCT00719563|494148|P2|NOT COMPLETED|Overall Study||42
201374|NCT00719563|494149|P1|NOT COMPLETED|Overall Study||38
201375|NCT00719563|494148|P2|COMPLETED|Overall Study||128
201376|NCT00719563|494149|P1|COMPLETED|Overall Study||133
201377|NCT00719563|494148|P2|STARTED|Overall Study||170
201378|NCT00719563|494149|P1|STARTED|Overall Study||171
201379|NCT00719615|494182|P3|NOT COMPLETED|Overall Study||0
201380|NCT00719615|494183|P2|NOT COMPLETED|Overall Study||0
201381|NCT00719615|494184|P1|NOT COMPLETED|Overall Study||0
201382|NCT00719615|494182|P3|COMPLETED|Overall Study||24
201383|NCT00719615|494183|P2|COMPLETED|Overall Study||45
201384|NCT00719615|494184|P1|COMPLETED|Overall Study||42
201385|NCT00719615|494182|P3|STARTED|Overall Study||24
201386|NCT00719615|494183|P2|STARTED|Overall Study||45
201387|NCT00719615|494184|P1|STARTED|Overall Study||42
201388|NCT00719680|494192|P1|NOT COMPLETED|Overall Study||5
201389|NCT00719680|494192|P1|COMPLETED|Overall Study||16
201390|NCT00719680|494192|P1|STARTED|Overall Study||21
201391|NCT00719706|494214|P2|NOT COMPLETED|Overall Study||6
201392|NCT00719706|494215|P1|NOT COMPLETED|Overall Study||9
201393|NCT00719706|494214|P2|COMPLETED|Overall Study||14
201394|NCT00719706|494215|P1|COMPLETED|Overall Study||11
201395|NCT00719706|494214|P2|STARTED|Overall Study||20
201396|NCT00719706|494215|P1|STARTED|Overall Study||20
201397|NCT00719732|494229|P1|NOT COMPLETED|Overall Study||22
201398|NCT00719732|494229|P1|COMPLETED|Overall Study||196
201399|NCT00719732|494229|P1|STARTED|Overall Study||218
201400|NCT00719810|494236|P3|NOT COMPLETED|Overall Study||8
201401|NCT00719810|494237|P2|NOT COMPLETED|Overall Study||4
201402|NCT00719810|494238|P1|NOT COMPLETED|Overall Study||3
201403|NCT00719810|494236|P3|COMPLETED|Overall Study||42
201404|NCT00719810|494237|P2|COMPLETED|Overall Study||47
201405|NCT00719810|494238|P1|COMPLETED|Overall Study||46
201406|NCT00719810|494236|P3|STARTED|Overall Study||50
201407|NCT00719810|494237|P2|STARTED|Overall Study||51
201408|NCT00719810|494238|P1|STARTED|Overall Study||49
201409|NCT00719849|494251|P2|NOT COMPLETED|Overall Study||1
201410|NCT00719849|494252|P1|NOT COMPLETED|Overall Study||0
201411|NCT00719849|494251|P2|COMPLETED|Overall Study||8
201412|NCT00719849|494252|P1|COMPLETED|Overall Study||4
201413|NCT00719849|494251|P2|STARTED|Overall Study||9
201414|NCT00719849|494252|P1|STARTED|Overall Study||4
201415|NCT00719862|494290|P2|NOT COMPLETED|Overall Study||6
201416|NCT00719862|494291|P1|NOT COMPLETED|Overall Study||8
201417|NCT00719862|494290|P2|COMPLETED|Overall Study||233
201418|NCT00719862|494291|P1|COMPLETED|Overall Study||234
201419|NCT00719862|494290|P2|STARTED|Overall Study|1 subject was randomized in error|239
201420|NCT00719862|494291|P1|STARTED|Overall Study||242
201421|NCT00719901|494307|P1|NOT COMPLETED|Overall Study||11
201422|NCT00719901|494307|P1|COMPLETED|Overall Study||0
201423|NCT00719901|494307|P1|STARTED|Overall Study||11
201424|NCT00719914|494319|P2|NOT COMPLETED|Overall Study||0
201425|NCT00719914|494320|P1|NOT COMPLETED|Overall Study||0
201426|NCT00719914|494319|P2|COMPLETED|Overall Study||7
201427|NCT00719914|494320|P1|COMPLETED|Overall Study||10
201428|NCT00719914|494319|P2|STARTED|Overall Study||7
201429|NCT00719914|494320|P1|STARTED|Overall Study||10
201430|NCT00719953|494326|P1|NOT COMPLETED|Overall Study||4
201431|NCT00719953|494326|P1|COMPLETED|Overall Study||26
201432|NCT00719953|494326|P1|STARTED|Overall Study||30
201433|NCT00720057|494332|P2|NOT COMPLETED|Overall Study||3
201434|NCT00720057|494333|P1|NOT COMPLETED|Overall Study||1
201435|NCT00720057|494332|P2|COMPLETED|Overall Study||156
201436|NCT00720057|494333|P1|COMPLETED|Overall Study||152
201437|NCT00720057|494332|P2|STARTED|Overall Study||159
201438|NCT00720057|494333|P1|STARTED|Overall Study||153
201439|NCT00720083|494351|P2|NOT COMPLETED|Overall Study||2
201440|NCT00720083|494352|P1|NOT COMPLETED|Overall Study||1
201441|NCT00720083|494351|P2|COMPLETED|Overall Study||13
201442|NCT00720083|494352|P1|COMPLETED|Overall Study|Subjects with data for the primary analysis are considered to have completed the study.|16
201443|NCT00720083|494351|P2|STARTED|Overall Study||15
201444|NCT00720083|494352|P1|STARTED|Overall Study||17
201445|NCT00720096|494360|P2|NOT COMPLETED|Overall Study||2
201446|NCT00720096|494361|P1|NOT COMPLETED|Overall Study||0
201447|NCT00720096|494360|P2|COMPLETED|Overall Study||0
201448|NCT00720096|494361|P1|COMPLETED|Overall Study||2
201449|NCT00720096|494360|P2|STARTED|Overall Study||2
201450|NCT00720096|494361|P1|STARTED|Overall Study||2
201451|NCT00720109|494369|P3|NOT COMPLETED|Risk Stratification Period||8
201452|NCT00720109|494370|P2|NOT COMPLETED|Risk Stratification Period||15
201453|NCT00720109|494371|P1|NOT COMPLETED|Risk Stratification Period||0
201454|NCT00720109|494369|P3|COMPLETED|Risk Stratification Period||1
201455|NCT00720109|494370|P2|COMPLETED|Risk Stratification Period||33
201456|NCT00720109|494371|P1|COMPLETED|Risk Stratification Period||0
201457|NCT00720109|494369|P3|STARTED|Risk Stratification Period||9
201458|NCT00720109|494370|P2|STARTED|Risk Stratification Period||48
201459|NCT00720109|494371|P1|STARTED|Risk Stratification Period||0
201460|NCT00720109|494369|P3|NOT COMPLETED|Induction Period||0
201461|NCT00720109|494370|P2|NOT COMPLETED|Induction Period||0
201462|NCT00720109|494371|P1|NOT COMPLETED|Induction Period||6
201463|NCT00720109|494369|P3|COMPLETED|Induction Period||0
201464|NCT00720109|494370|P2|COMPLETED|Induction Period||0
201465|NCT00720109|494371|P1|COMPLETED|Induction Period||57
201466|NCT00720109|494369|P3|STARTED|Induction Period||0
201467|NCT00720109|494370|P2|STARTED|Induction Period||0
201468|NCT00720109|494371|P1|STARTED|Induction Period||63
201469|NCT00720122|494389|P1|NOT COMPLETED|Overall Study||9
201470|NCT00720122|494389|P1|COMPLETED|Overall Study||19
201471|NCT00720122|494389|P1|STARTED|Overall Study||28
201472|NCT00720226|494395|P2|NOT COMPLETED|Overall Study||4
201473|NCT00720226|494396|P1|NOT COMPLETED|Overall Study||7
201474|NCT00720226|494395|P2|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|48
201475|NCT00720226|494396|P1|COMPLETED|Overall Study|Participants not completing did not have 12 month CT scan|47
201476|NCT00720226|494395|P2|STARTED|Overall Study||52
201477|NCT00720226|494396|P1|STARTED|Overall Study||54
201478|NCT00720278|494407|P3|NOT COMPLETED|Overall Study||6
201479|NCT00720278|494408|P2|NOT COMPLETED|Overall Study||4
201480|NCT00720278|494409|P1|NOT COMPLETED|Overall Study||7
201481|NCT00720278|494407|P3|COMPLETED|Overall Study||172
201482|NCT00720278|494408|P2|COMPLETED|Overall Study||166
201483|NCT00720278|494409|P1|COMPLETED|Overall Study||171
201484|NCT00720278|494407|P3|STARTED|Overall Study|1 subject was randomized in error|178
201485|NCT00720278|494408|P2|STARTED|Overall Study|1 subject was randomized in error|170
201486|NCT00720278|494409|P1|STARTED|Overall Study|1 subject was randomized in error|178
201487|NCT00720330|494432|P3|NOT COMPLETED|Overall Study||0
201488|NCT00720330|494433|P2|NOT COMPLETED|Overall Study||0
201489|NCT00720330|494434|P1|NOT COMPLETED|Overall Study||0
201490|NCT00720330|494432|P3|COMPLETED|Overall Study||3
201491|NCT00720330|494433|P2|COMPLETED|Overall Study||4
201492|NCT00720330|494434|P1|COMPLETED|Overall Study||5
201493|NCT00720330|494432|P3|STARTED|Overall Study||3
201494|NCT00720330|494433|P2|STARTED|Overall Study||4
201495|NCT00720330|494434|P1|STARTED|Overall Study||5
201496|NCT00720343|494454|P1|NOT COMPLETED|Overall Study||6
201497|NCT00720343|494454|P1|COMPLETED|Overall Study|3 removed by physician. 3 unable to be determined; Columbia will never have access to this data.|48
201498|NCT00720343|494454|P1|STARTED|Overall Study||54
201499|NCT00720369|494462|P2|NOT COMPLETED|Overall Study||0
201500|NCT00720369|494463|P1|NOT COMPLETED|Overall Study||1
201501|NCT00720369|494462|P2|COMPLETED|Overall Study||8
201502|NCT00720369|494463|P1|COMPLETED|Overall Study|one subject discontinued due to an adverse event.|10
201503|NCT00720369|494462|P2|STARTED|Overall Study||8
201504|NCT00720369|494463|P1|STARTED|Overall Study||11
201505|NCT00720382|494473|P2|NOT COMPLETED|Overall Study||59
201506|NCT00720382|494474|P1|NOT COMPLETED|Overall Study||176
201507|NCT00720382|494473|P2|COMPLETED|Overall Study||178
201508|NCT00720382|494474|P1|COMPLETED|Overall Study||290
201509|NCT00720382|494473|P2|STARTED|Overall Study||237
201510|NCT00720382|494474|P1|STARTED|Overall Study||466
201511|NCT00720434|494486|P4|NOT COMPLETED|Open-Label Period (Week 5-72)||4
201512|NCT00720434|494487|P3|NOT COMPLETED|Open-Label Period (Week 5-72)||4
201513|NCT00720434|494488|P2|NOT COMPLETED|Open-Label Period (Week 5-72)||3
201514|NCT00720434|494489|P1|NOT COMPLETED|Open-Label Period (Week 5-72)||6
201515|NCT00720434|494486|P4|COMPLETED|Open-Label Period (Week 5-72)||4
201516|NCT00720434|494487|P3|COMPLETED|Open-Label Period (Week 5-72)||4
201517|NCT00720434|494488|P2|COMPLETED|Open-Label Period (Week 5-72)||5
201518|NCT00720434|494489|P1|COMPLETED|Open-Label Period (Week 5-72)||4
201519|NCT00720434|494486|P4|STARTED|Open-Label Period (Week 5-72)||8
201520|NCT00720434|494487|P3|STARTED|Open-Label Period (Week 5-72)||8
201521|NCT00720434|494488|P2|STARTED|Open-Label Period (Week 5-72)||8
201522|NCT00720434|494489|P1|STARTED|Open-Label Period (Week 5-72)||10
201523|NCT00720434|494486|P4|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
201524|NCT00720434|494487|P3|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
201525|NCT00720434|494488|P2|NOT COMPLETED|Double-Blind Period (Week 1-4)||1
201526|NCT00720434|494489|P1|NOT COMPLETED|Double-Blind Period (Week 1-4)||0
201527|NCT00720434|494486|P4|COMPLETED|Double-Blind Period (Week 1-4)||8
201528|NCT00720434|494487|P3|COMPLETED|Double-Blind Period (Week 1-4)||8
201529|NCT00720434|494488|P2|COMPLETED|Double-Blind Period (Week 1-4)||8
201530|NCT00720434|494489|P1|COMPLETED|Double-Blind Period (Week 1-4)||10
201531|NCT00720434|494486|P4|STARTED|Double-Blind Period (Week 1-4)||8
201532|NCT00720434|494487|P3|STARTED|Double-Blind Period (Week 1-4)||8
201533|NCT00720434|494488|P2|STARTED|Double-Blind Period (Week 1-4)||9
201534|NCT00720434|494489|P1|STARTED|Double-Blind Period (Week 1-4)||10
201535|NCT00720473|494513|P2|NOT COMPLETED|Overall Study||8
201536|NCT00720473|494514|P1|NOT COMPLETED|Overall Study||30
201537|NCT00720473|494513|P2|COMPLETED|Overall Study||16
201538|NCT00720473|494514|P1|COMPLETED|Overall Study||15
201539|NCT00720473|494513|P2|STARTED|Overall Study||24
201540|NCT00720473|494514|P1|STARTED|Overall Study||45
201541|NCT00720499|494538|P2|NOT COMPLETED|Treatment Period 2 (4 Weeks)||3
201542|NCT00720499|494539|P1|NOT COMPLETED|Treatment Period 2 (4 Weeks)||2
201543|NCT00720499|494538|P2|COMPLETED|Treatment Period 2 (4 Weeks)||67
201544|NCT00720499|494539|P1|COMPLETED|Treatment Period 2 (4 Weeks)||64
201545|NCT00720499|494538|P2|STARTED|Treatment Period 2 (4 Weeks)||70
201546|NCT00720499|494539|P1|STARTED|Treatment Period 2 (4 Weeks)||66
201547|NCT00720499|494538|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
201548|NCT00720499|494539|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
201549|NCT00720499|494538|P2|COMPLETED|Washout Period (2 Weeks)||70
201550|NCT00720499|494539|P1|COMPLETED|Washout Period (2 Weeks)||66
201551|NCT00720499|494538|P2|STARTED|Washout Period (2 Weeks)||70
201552|NCT00720499|494539|P1|STARTED|Washout Period (2 Weeks)||66
201553|NCT00720499|494538|P2|NOT COMPLETED|Treatment Period 1 (4 Weeks)||2
201554|NCT00720499|494539|P1|NOT COMPLETED|Treatment Period 1 (4 Weeks)||3
201555|NCT00720499|494538|P2|COMPLETED|Treatment Period 1 (4 Weeks)||70
201556|NCT00720499|494539|P1|COMPLETED|Treatment Period 1 (4 Weeks)||66
201557|NCT00720499|494538|P2|STARTED|Treatment Period 1 (4 Weeks)||72
201558|NCT00720499|494539|P1|STARTED|Treatment Period 1 (4 Weeks)||69
201559|NCT00720629|494601|P1|NOT COMPLETED|Overall Study||0
201560|NCT00720629|494601|P1|COMPLETED|Overall Study||8
201561|NCT00720629|494601|P1|STARTED|Overall Study||8
201562|NCT00720759|494615|P4|NOT COMPLETED|Overall Study||0
201563|NCT00720759|494616|P3|NOT COMPLETED|Overall Study||1
201564|NCT00720759|494617|P2|NOT COMPLETED|Overall Study||1
201565|NCT00720759|494618|P1|NOT COMPLETED|Overall Study||0
201566|NCT00720759|494615|P4|COMPLETED|Overall Study||6
201567|NCT00720759|494616|P3|COMPLETED|Overall Study||5
201568|NCT00720759|494617|P2|COMPLETED|Overall Study||5
201569|NCT00720759|494618|P1|COMPLETED|Overall Study||6
201570|NCT00720759|494615|P4|STARTED|Overall Study||6
201571|NCT00720759|494616|P3|STARTED|Overall Study||6
201572|NCT00720759|494617|P2|STARTED|Overall Study||6
201573|NCT00720759|494618|P1|STARTED|Overall Study||6
201574|NCT00720798|494628|P1|NOT COMPLETED|Overall Study||756
201575|NCT00720798|494628|P1|COMPLETED|Overall Study||1311
201576|NCT00720798|494628|P1|STARTED|Overall Study||2067
201577|NCT00714792|494649|P2|NOT COMPLETED|Overall Study||0
201578|NCT00714792|494650|P1|NOT COMPLETED|Overall Study||0
201579|NCT00714792|494649|P2|COMPLETED|Overall Study||8
201580|NCT00714792|494650|P1|COMPLETED|Overall Study||10
201581|NCT00714792|494649|P2|STARTED|Overall Study||8
201582|NCT00714792|494650|P1|STARTED|Overall Study||10
201583|NCT00714870|494658|P2|NOT COMPLETED|Overall Study||5
201584|NCT00714870|494659|P1|NOT COMPLETED|Overall Study||27
201585|NCT00714870|494658|P2|COMPLETED|Overall Study||22
201586|NCT00714870|494659|P1|COMPLETED|Overall Study||22
201587|NCT00714870|494658|P2|STARTED|Overall Study||27
201588|NCT00714870|494659|P1|STARTED|Overall Study||49
201589|NCT00714948|494665|P1|NOT COMPLETED|Overall Study||2
201590|NCT00714948|494665|P1|COMPLETED|Overall Study||0
201591|NCT00714948|494665|P1|STARTED|Overall Study||2
201592|NCT00715026|494669|P1|NOT COMPLETED|Overall Study||10
201593|NCT00715026|494669|P1|COMPLETED|Overall Study|20 unilateral subjects and 1 bilateral|21
201594|NCT00715026|494669|P1|Subjects That Received Surgery|Overall Study|24 unilateral subjects and 1 bilateral|25
201595|NCT00715026|494669|P1|STARTED|Overall Study|30 unilateral subjects and 1 bilateral|31
201596|NCT00715078|494677|P3|NOT COMPLETED|Overall Study||38
201597|NCT00715078|494678|P2|NOT COMPLETED|Overall Study||36
201598|NCT00715078|494679|P1|NOT COMPLETED|Overall Study||30
201599|NCT00715078|494677|P3|COMPLETED|Overall Study||3
201600|NCT00715078|494678|P2|COMPLETED|Overall Study||4
201601|NCT00715078|494679|P1|COMPLETED|Overall Study||11
201602|NCT00715078|494677|P3|Received ≥ 1 Leukapheresis|Overall Study||40
201603|NCT00715078|494678|P2|Received ≥ 1 Leukapheresis|Overall Study||40
201604|NCT00715078|494679|P1|Received ≥ 1 Leukapheresis|Overall Study||40
201605|NCT00715078|494677|P3|Received ≥ 1 Study Infusion|Overall Study||39
201606|NCT00715078|494678|P2|Received ≥ 1 Study Infusion|Overall Study||40
201607|NCT00715078|494679|P1|Received ≥ 1 Study Infusion|Overall Study||40
201608|NCT00715078|494677|P3|STARTED|Overall Study||41
201609|NCT00715078|494678|P2|STARTED|Overall Study||40
201610|NCT00715078|494679|P1|STARTED|Overall Study||41
201611|NCT00715104|494690|P3|NOT COMPLETED|Overall Study||0
201612|NCT00715104|494691|P2|NOT COMPLETED|Overall Study||0
201613|NCT00715104|494692|P1|NOT COMPLETED|Overall Study||0
201614|NCT00715104|494690|P3|COMPLETED|Overall Study||8
201615|NCT00715104|494691|P2|COMPLETED|Overall Study||16
201616|NCT00715104|494692|P1|COMPLETED|Overall Study||18
201617|NCT00715104|494690|P3|STARTED|Overall Study||8
201618|NCT00715104|494691|P2|STARTED|Overall Study||16
201619|NCT00715104|494692|P1|STARTED|Overall Study||18
201620|NCT00715117|494743|P2|NOT COMPLETED|Overall Study||1
201621|NCT00715117|494744|P1|NOT COMPLETED|Overall Study||0
201622|NCT00715117|494743|P2|COMPLETED|Overall Study|One subject flared and was rescued with steroids|5
201623|NCT00715117|494744|P1|COMPLETED|Overall Study||6
201624|NCT00715117|494743|P2|Completion fo 8 Week Study|Overall Study||6
201625|NCT00715117|494744|P1|Completion fo 8 Week Study|Overall Study||6
201626|NCT00715117|494743|P2|STARTED|Overall Study||6
201627|NCT00715117|494744|P1|STARTED|Overall Study||6
201628|NCT00715208|494757|P2|NOT COMPLETED|Overall Study||9
201629|NCT00715208|494758|P1|NOT COMPLETED|Overall Study||1
201630|NCT00715208|494757|P2|COMPLETED|Overall Study||39
201631|NCT00715208|494758|P1|COMPLETED|Overall Study||6
201632|NCT00715208|494757|P2|STARTED|Overall Study||48
201633|NCT00715208|494758|P1|STARTED|Overall Study||7
201634|NCT00720941|494774|P2|NOT COMPLETED|Overall Study||415
201635|NCT00720941|494775|P1|NOT COMPLETED|Overall Study||413
201636|NCT00720941|494774|P2|COMPLETED|Overall Study||138
201637|NCT00720941|494775|P1|COMPLETED|Overall Study||144
201638|NCT00720941|494774|P2|Ongoing|Overall Study||23
201639|NCT00720941|494775|P1|Ongoing|Overall Study||34
201640|NCT00720941|494774|P2|STARTED|Overall Study||553
201641|NCT00720941|494775|P1|STARTED|Overall Study||557
201642|NCT00721110|494819|P4|NOT COMPLETED|Overall Study||0
201643|NCT00721110|494820|P3|NOT COMPLETED|Overall Study||1
201644|NCT00721110|494821|P2|NOT COMPLETED|Overall Study||0
201645|NCT00721110|494822|P1|NOT COMPLETED|Overall Study||1
201646|NCT00721110|494819|P4|COMPLETED|Overall Study||16
201647|NCT00721110|494820|P3|COMPLETED|Overall Study||15
201648|NCT00721110|494821|P2|COMPLETED|Overall Study||16
201649|NCT00721110|494822|P1|COMPLETED|Overall Study||15
201650|NCT00721110|494819|P4|STARTED|Overall Study||16
201651|NCT00721110|494820|P3|STARTED|Overall Study||16
201652|NCT00721110|494821|P2|STARTED|Overall Study||16
201653|NCT00721110|494822|P1|STARTED|Overall Study||16
201654|NCT00721123|494848|P1|NOT COMPLETED|Overall Study||183
201655|NCT00721123|494848|P1|COMPLETED|Overall Study||355
201656|NCT00721123|494848|P1|STARTED|Overall Study||538
201657|NCT00721136|494926|P4|NOT COMPLETED|Overall Study||0
201658|NCT00721136|494927|P3|NOT COMPLETED|Overall Study||0
201659|NCT00721136|494928|P2|NOT COMPLETED|Overall Study||0
201660|NCT00721136|494929|P1|NOT COMPLETED|Overall Study||0
201661|NCT00721136|494926|P4|COMPLETED|Overall Study||8
201662|NCT00721136|494927|P3|COMPLETED|Overall Study||8
201663|NCT00721136|494928|P2|COMPLETED|Overall Study||42
201664|NCT00721136|494929|P1|COMPLETED|Overall Study||42
201665|NCT00721136|494926|P4|STARTED|Overall Study||8
201666|NCT00721136|494927|P3|STARTED|Overall Study||8
201667|NCT00721136|494928|P2|STARTED|Overall Study||42
201668|NCT00721136|494929|P1|STARTED|Overall Study||42
201669|NCT00721149|494947|P1|NOT COMPLETED|Overall Study||1
201670|NCT00721149|494947|P1|COMPLETED|Overall Study||9
201671|NCT00721149|494947|P1|STARTED|Overall Study|Enrollment was stopped after 10 subjects entered the trial.|10
201672|NCT00721162|494956|P1|NOT COMPLETED|Overall Study||0
201673|NCT00721162|494956|P1|COMPLETED|Overall Study||60
201674|NCT00721162|494956|P1|Received Any Amount of Study Drug|Overall Study||60
201675|NCT00721162|494956|P1|STARTED|Overall Study||60
201676|NCT00721175|494967|P2|NOT COMPLETED|Overall Study||0
201677|NCT00721175|494968|P1|NOT COMPLETED|Overall Study||0
201678|NCT00721175|494967|P2|COMPLETED|Overall Study||54
201679|NCT00721175|494968|P1|COMPLETED|Overall Study||54
201680|NCT00721175|494967|P2|STARTED|Overall Study||54
201681|NCT00721175|494968|P1|STARTED|Overall Study||54
201682|NCT00721188|494980|P1|NOT COMPLETED|Overall Study||0
201683|NCT00721188|494980|P1|COMPLETED|Overall Study||11
201684|NCT00721188|494980|P1|STARTED|Overall Study||11
201685|NCT00721214|494995|P1|NOT COMPLETED|Overall Study||4
201686|NCT00721214|494995|P1|COMPLETED|Overall Study||12
201687|NCT00721214|494995|P1|STARTED|Overall Study||16
201688|NCT00721227|495008|P2|NOT COMPLETED|Overall Study||0
201689|NCT00721227|495009|P1|NOT COMPLETED|Overall Study||4
201690|NCT00721227|495008|P2|COMPLETED|Overall Study||6
201691|NCT00721227|495009|P1|COMPLETED|Overall Study|3 subjects lost to follow up; 1 subject did not complete due to noncompliance of scheduled visits.|5
201692|NCT00721227|495008|P2|STARTED|Overall Study||6
201693|NCT00721227|495009|P1|STARTED|Overall Study||9
201694|NCT00722553|495019|P1|NOT COMPLETED|Overall Study||0
201695|NCT00722553|495019|P1|COMPLETED|Overall Study||30
201696|NCT00722553|495019|P1|STARTED|Overall Study||30
201697|NCT00722566|495029|P2|NOT COMPLETED|Overall Study||35
201698|NCT00722566|495030|P1|NOT COMPLETED|Overall Study||67
201699|NCT00722566|495029|P2|COMPLETED|Overall Study|Completed 8 cycles|39
201700|NCT00722566|495030|P1|COMPLETED|Overall Study|Completed 8 cycles|81
201701|NCT00722566|495029|P2|STARTED|Overall Study||74
201702|NCT00722566|495030|P1|STARTED|Overall Study|One patient randomized and not dosed|148
201703|NCT00722722|495041|P3|NOT COMPLETED|Overall Study||0
201704|NCT00722722|495042|P2|NOT COMPLETED|Overall Study||0
201705|NCT00722722|495043|P1|NOT COMPLETED|Overall Study||0
201706|NCT00722722|495041|P3|COMPLETED|Overall Study||10
201707|NCT00722722|495042|P2|COMPLETED|Overall Study||5
201708|NCT00722722|495043|P1|COMPLETED|Overall Study||3
201709|NCT00722722|495041|P3|STARTED|Overall Study||10
201710|NCT00722722|495042|P2|STARTED|Overall Study||5
201711|NCT00722722|495043|P1|STARTED|Overall Study||3
201712|NCT00722761|495053|P2|NOT COMPLETED|Overall Study||6
201713|NCT00722761|495054|P1|NOT COMPLETED|Overall Study||6
201714|NCT00722761|495053|P2|COMPLETED|Overall Study||8
201715|NCT00722761|495054|P1|COMPLETED|Overall Study||10
201716|NCT00722761|495053|P2|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||10
201717|NCT00722761|495054|P1|COMPLETED AT LEAST 1 FOLLOW-UP VISIT|Overall Study||15
201718|NCT00722761|495053|P2|STARTED|Overall Study||14
201719|NCT00722761|495054|P1|STARTED|Overall Study||16
201720|NCT00722800|495064|P2|NOT COMPLETED|Overall Study||0
201721|NCT00722800|495065|P1|NOT COMPLETED|Overall Study||2
201722|NCT00722800|495064|P2|COMPLETED|Overall Study||2
201723|NCT00722800|495065|P1|COMPLETED|Overall Study||0
201724|NCT00722800|495064|P2|STARTED|Overall Study||2
201725|NCT00722800|495065|P1|STARTED|Overall Study||2
201726|NCT00722865|495075|P1|NOT COMPLETED|Overall Study||2
201727|NCT00722865|495075|P1|COMPLETED|Overall Study||23
201728|NCT00722865|495075|P1|STARTED|Overall Study||25
201729|NCT00723008|495085|P2|NOT COMPLETED|4-Week Unblinded Treatment||1
201730|NCT00723008|495086|P1|NOT COMPLETED|4-Week Unblinded Treatment||1
201731|NCT00723008|495085|P2|COMPLETED|4-Week Unblinded Treatment||3
201732|NCT00723008|495086|P1|COMPLETED|4-Week Unblinded Treatment||4
201733|NCT00723008|495085|P2|STARTED|4-Week Unblinded Treatment||4
201734|NCT00723008|495086|P1|STARTED|4-Week Unblinded Treatment||5
201735|NCT00723008|495085|P2|NOT COMPLETED|4-Week Double Blinded||5
201736|NCT00723008|495086|P1|NOT COMPLETED|4-Week Double Blinded||5
201737|NCT00723008|495085|P2|COMPLETED|4-Week Double Blinded||4
201738|NCT00723008|495086|P1|COMPLETED|4-Week Double Blinded||5
201739|NCT00723008|495085|P2|STARTED|4-Week Double Blinded||9
201740|NCT00723008|495086|P1|STARTED|4-Week Double Blinded||10
201741|NCT00723008|495085|P2|NOT COMPLETED|Enrollment||0
201742|NCT00723008|495086|P1|NOT COMPLETED|Enrollment||1
201743|NCT00723008|495085|P2|COMPLETED|Enrollment||9
201744|NCT00723008|495086|P1|COMPLETED|Enrollment||10
201745|NCT00723008|495085|P2|STARTED|Enrollment||9
201746|NCT00723008|495086|P1|STARTED|Enrollment||11
201747|NCT00723021|495108|P5|NOT COMPLETED|Intervention Period 5||0
201748|NCT00723021|495109|P4|NOT COMPLETED|Intervention Period 5||0
201749|NCT00723021|495110|P3|NOT COMPLETED|Intervention Period 5||0
201750|NCT00723021|495111|P2|NOT COMPLETED|Intervention Period 5||0
201751|NCT00723021|495112|P1|NOT COMPLETED|Intervention Period 5||0
201752|NCT00723021|495108|P5|COMPLETED|Intervention Period 5||2
201753|NCT00723021|495109|P4|COMPLETED|Intervention Period 5||3
201754|NCT00723021|495110|P3|COMPLETED|Intervention Period 5||3
201755|NCT00723021|495111|P2|COMPLETED|Intervention Period 5||3
201756|NCT00723021|495112|P1|COMPLETED|Intervention Period 5||3
201757|NCT00723021|495108|P5|STARTED|Intervention Period 5||2
201758|NCT00723021|495109|P4|STARTED|Intervention Period 5||3
201759|NCT00723021|495110|P3|STARTED|Intervention Period 5||3
201760|NCT00723021|495111|P2|STARTED|Intervention Period 5||3
201761|NCT00723021|495112|P1|STARTED|Intervention Period 5||3
201762|NCT00723021|495108|P5|NOT COMPLETED|Intervention Period 4||1
201763|NCT00723021|495109|P4|NOT COMPLETED|Intervention Period 4||0
201764|NCT00723021|495110|P3|NOT COMPLETED|Intervention Period 4||0
201765|NCT00723021|495111|P2|NOT COMPLETED|Intervention Period 4||0
201766|NCT00723021|495112|P1|NOT COMPLETED|Intervention Period 4||0
201767|NCT00723021|495108|P5|COMPLETED|Intervention Period 4||2
201768|NCT00723021|495109|P4|COMPLETED|Intervention Period 4||3
201769|NCT00723021|495110|P3|COMPLETED|Intervention Period 4||3
201770|NCT00723021|495111|P2|COMPLETED|Intervention Period 4||3
201771|NCT00723021|495112|P1|COMPLETED|Intervention Period 4||3
201772|NCT00723021|495108|P5|STARTED|Intervention Period 4||3
201773|NCT00723021|495109|P4|STARTED|Intervention Period 4||3
201774|NCT00723021|495110|P3|STARTED|Intervention Period 4||3
201775|NCT00723021|495111|P2|STARTED|Intervention Period 4||3
201776|NCT00723021|495112|P1|STARTED|Intervention Period 4||3
201777|NCT00723021|495108|P5|NOT COMPLETED|Intervention Period 3||0
201778|NCT00723021|495109|P4|NOT COMPLETED|Intervention Period 3||0
201779|NCT00723021|495110|P3|NOT COMPLETED|Intervention Period 3||0
201780|NCT00723021|495111|P2|NOT COMPLETED|Intervention Period 3||0
201781|NCT00723021|495112|P1|NOT COMPLETED|Intervention Period 3||0
201782|NCT00723021|495108|P5|COMPLETED|Intervention Period 3||3
201783|NCT00723021|495109|P4|COMPLETED|Intervention Period 3||3
201784|NCT00723021|495110|P3|COMPLETED|Intervention Period 3||3
201785|NCT00723021|495111|P2|COMPLETED|Intervention Period 3||3
201786|NCT00723021|495112|P1|COMPLETED|Intervention Period 3||3
201787|NCT00723021|495108|P5|STARTED|Intervention Period 3||3
201788|NCT00723021|495109|P4|STARTED|Intervention Period 3||3
201789|NCT00723021|495110|P3|STARTED|Intervention Period 3||3
201790|NCT00723021|495111|P2|STARTED|Intervention Period 3||3
201791|NCT00723021|495112|P1|STARTED|Intervention Period 3||3
201792|NCT00723021|495108|P5|NOT COMPLETED|Intervention Period 2||0
201793|NCT00723021|495109|P4|NOT COMPLETED|Intervention Period 2||0
201794|NCT00723021|495110|P3|NOT COMPLETED|Intervention Period 2||0
201795|NCT00723021|495111|P2|NOT COMPLETED|Intervention Period 2||0
201796|NCT00723021|495112|P1|NOT COMPLETED|Intervention Period 2||0
201797|NCT00723021|495108|P5|COMPLETED|Intervention Period 2||3
201798|NCT00723021|495109|P4|COMPLETED|Intervention Period 2||3
201799|NCT00723021|495110|P3|COMPLETED|Intervention Period 2||3
201800|NCT00723021|495111|P2|COMPLETED|Intervention Period 2||3
201801|NCT00723021|495112|P1|COMPLETED|Intervention Period 2||3
201802|NCT00723021|495108|P5|STARTED|Intervention Period 2||3
201803|NCT00723021|495109|P4|STARTED|Intervention Period 2||3
201804|NCT00723021|495110|P3|STARTED|Intervention Period 2||3
201805|NCT00723021|495111|P2|STARTED|Intervention Period 2||3
201806|NCT00723021|495112|P1|STARTED|Intervention Period 2||3
201807|NCT00723021|495108|P5|NOT COMPLETED|Intervention Period 1||0
201808|NCT00723021|495109|P4|NOT COMPLETED|Intervention Period 1||0
201809|NCT00723021|495110|P3|NOT COMPLETED|Intervention Period 1||0
201810|NCT00723021|495111|P2|NOT COMPLETED|Intervention Period 1||0
201811|NCT00723021|495112|P1|NOT COMPLETED|Intervention Period 1||0
201812|NCT00723021|495108|P5|COMPLETED|Intervention Period 1||3
201813|NCT00723021|495109|P4|COMPLETED|Intervention Period 1||3
201814|NCT00723021|495110|P3|COMPLETED|Intervention Period 1||3
201815|NCT00723021|495111|P2|COMPLETED|Intervention Period 1||3
201816|NCT00723021|495112|P1|COMPLETED|Intervention Period 1||3
201817|NCT00723021|495108|P5|STARTED|Intervention Period 1||3
201818|NCT00723021|495109|P4|STARTED|Intervention Period 1||3
201819|NCT00723021|495110|P3|STARTED|Intervention Period 1||3
201820|NCT00723021|495111|P2|STARTED|Intervention Period 1||3
201821|NCT00723021|495112|P1|STARTED|Intervention Period 1||3
201822|NCT00723073|495166|P2|NOT COMPLETED|Overall Study||0
201823|NCT00723073|495167|P1|NOT COMPLETED|Overall Study||0
201824|NCT00723073|495166|P2|COMPLETED|Overall Study||174
201825|NCT00723073|495167|P1|COMPLETED|Overall Study||149
201826|NCT00723073|495166|P2|STARTED|Overall Study||174
201827|NCT00723073|495167|P1|STARTED|Overall Study||149
201828|NCT00723125|495193|P2|NOT COMPLETED|Overall Study||6
201829|NCT00723125|495194|P1|NOT COMPLETED|Overall Study||18
201830|NCT00723125|495193|P2|COMPLETED|Overall Study||21
201831|NCT00723125|495194|P1|COMPLETED|Overall Study||15
201832|NCT00723125|495193|P2|STARTED|Overall Study|27 evaluable Neo-adjuvant Of 27 patients neo-adjuvant, 24 DDAC Of 24 DDAC, 21 Avastin post-op|27
201833|NCT00723125|495194|P1|STARTED|Overall Study|33 pts Neo-adjuvant, 28 evaluable,DDAC: Of 28 pts,27 treated DDAC Avastin:Of 27,15 Avastin post-op|33
201834|NCT00723177|495207|P3|NOT COMPLETED|Overall Study||5
201835|NCT00723177|495208|P2|NOT COMPLETED|Overall Study||4
201836|NCT00723177|495209|P1|NOT COMPLETED|Overall Study||5
201837|NCT00723177|495207|P3|COMPLETED|Overall Study||10
201838|NCT00723177|495208|P2|COMPLETED|Overall Study||10
201839|NCT00723177|495209|P1|COMPLETED|Overall Study||10
201840|NCT00723177|495207|P3|STARTED|Overall Study||15
201841|NCT00723177|495208|P2|STARTED|Overall Study||14
201842|NCT00723177|495209|P1|STARTED|Overall Study||15
201843|NCT00723190|495220|P1|NOT COMPLETED|Overall Study||142
201928|NCT00723528|495361|P5|COMPLETED|Period 1: Controlled Period (CP)||0
201844|NCT00723190|495220|P1|COMPLETED|Overall Study|53 participants completed 6-month protocol and 108 participants completed 12-month protocol|161
201845|NCT00723190|495220|P1|SAFETY POPULATION|Overall Study||301
201846|NCT00723190|495220|P1|STARTED|Overall Study|Study CLON-301 (168 participants) and Study CLON-302 (135 participants)|303
201847|NCT00723203|495235|P1|NOT COMPLETED|Overall Study||3
201848|NCT00723203|495235|P1|COMPLETED|Overall Study||13
201849|NCT00723203|495235|P1|STARTED|Overall Study||16
201850|NCT00723229|495241|P2|NOT COMPLETED|Second Intervention||0
201851|NCT00723229|495242|P1|NOT COMPLETED|Second Intervention||0
201852|NCT00723229|495241|P2|COMPLETED|Second Intervention||20
201853|NCT00723229|495242|P1|COMPLETED|Second Intervention||18
201854|NCT00723229|495241|P2|STARTED|Second Intervention||20
201855|NCT00723229|495242|P1|STARTED|Second Intervention||18
201856|NCT00723229|495241|P2|NOT COMPLETED|First Intervention||3
201857|NCT00723229|495242|P1|NOT COMPLETED|First Intervention||7
201858|NCT00723229|495241|P2|COMPLETED|First Intervention||20
201859|NCT00723229|495242|P1|COMPLETED|First Intervention||18
201860|NCT00723229|495241|P2|STARTED|First Intervention||23
201861|NCT00723229|495242|P1|STARTED|First Intervention||25
201862|NCT00723255|495254|P1|NOT COMPLETED|Overall Study||4
201863|NCT00723255|495254|P1|COMPLETED|Overall Study|Eligible and treated patients|49
201864|NCT00723255|495254|P1|STARTED|Overall Study||53
201865|NCT00723294|495273|P1|NOT COMPLETED|Overall Study||13
201866|NCT00723294|495273|P1|COMPLETED|Overall Study||86
201867|NCT00723294|495273|P1|STARTED|Overall Study||99
201868|NCT00723450|495280|P3|NOT COMPLETED|Randomized Phase||67
201869|NCT00723450|495281|P2|NOT COMPLETED|Randomized Phase||65
201870|NCT00723450|495282|P1|NOT COMPLETED|Randomized Phase||0
201871|NCT00723450|495280|P3|COMPLETED|Randomized Phase||20
201872|NCT00723450|495281|P2|COMPLETED|Randomized Phase||21
201873|NCT00723450|495282|P1|COMPLETED|Randomized Phase||0
201874|NCT00723450|495280|P3|STARTED|Randomized Phase||87
201875|NCT00723450|495281|P2|STARTED|Randomized Phase||86
201876|NCT00723450|495282|P1|STARTED|Randomized Phase||0
201877|NCT00723450|495280|P3|NOT COMPLETED|Open-Label Phase||0
201878|NCT00723450|495281|P2|NOT COMPLETED|Open-Label Phase||0
201879|NCT00723450|495282|P1|NOT COMPLETED|Open-Label Phase||125
201880|NCT00723450|495280|P3|COMPLETED|Open-Label Phase||0
201881|NCT00723450|495281|P2|COMPLETED|Open-Label Phase||0
201882|NCT00723450|495282|P1|COMPLETED|Open-Label Phase||173
201883|NCT00723450|495280|P3|STARTED|Open-Label Phase||0
201884|NCT00723450|495281|P2|STARTED|Open-Label Phase||0
201885|NCT00723450|495282|P1|STARTED|Open-Label Phase||298
201886|NCT00723489|495327|P4|NOT COMPLETED|Overall Study||3
201887|NCT00723489|495328|P3|NOT COMPLETED|Overall Study||0
201888|NCT00723489|495329|P2|NOT COMPLETED|Overall Study||4
201889|NCT00723489|495330|P1|NOT COMPLETED|Overall Study||1
201890|NCT00723489|495327|P4|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
201891|NCT00723489|495328|P3|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|19
201892|NCT00723489|495329|P2|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|15
201893|NCT00723489|495330|P1|COMPLETED|Overall Study|Includes seroconverters and non-seroconverters|20
201894|NCT00723489|495327|P4|STARTED|Overall Study||23
201895|NCT00723489|495328|P3|STARTED|Overall Study||19
201896|NCT00723489|495329|P2|STARTED|Overall Study||19
201897|NCT00723489|495330|P1|STARTED|Overall Study||21
201898|NCT00723528|495359|P7|NOT COMPLETED|Period 2: After Controlled Period||4
201899|NCT00723528|495360|P6|NOT COMPLETED|Period 2: After Controlled Period||6
201900|NCT00723528|495361|P5|NOT COMPLETED|Period 2: After Controlled Period||2
201901|NCT00723528|495362|P4|NOT COMPLETED|Period 2: After Controlled Period||1
201902|NCT00723528|495363|P3|NOT COMPLETED|Period 2: After Controlled Period||0
201903|NCT00723528|495364|P2|NOT COMPLETED|Period 2: After Controlled Period||0
201904|NCT00723528|495365|P1|NOT COMPLETED|Period 2: After Controlled Period||0
201905|NCT00723528|495359|P7|COMPLETED|Period 2: After Controlled Period||54
201906|NCT00723528|495360|P6|COMPLETED|Period 2: After Controlled Period||58
201907|NCT00723528|495361|P5|COMPLETED|Period 2: After Controlled Period||11
201908|NCT00723528|495362|P4|COMPLETED|Period 2: After Controlled Period||14
201909|NCT00723528|495363|P3|COMPLETED|Period 2: After Controlled Period||0
201910|NCT00723528|495364|P2|COMPLETED|Period 2: After Controlled Period||0
201911|NCT00723528|495365|P1|COMPLETED|Period 2: After Controlled Period||0
201912|NCT00723528|495359|P7|STARTED|Period 2: After Controlled Period||58
201913|NCT00723528|495360|P6|STARTED|Period 2: After Controlled Period||64
201914|NCT00723528|495361|P5|STARTED|Period 2: After Controlled Period||13
201915|NCT00723528|495362|P4|STARTED|Period 2: After Controlled Period||15
201916|NCT00723528|495363|P3|STARTED|Period 2: After Controlled Period||0
201917|NCT00723528|495364|P2|STARTED|Period 2: After Controlled Period||0
201918|NCT00723528|495365|P1|STARTED|Period 2: After Controlled Period||0
201919|NCT00723528|495359|P7|NOT COMPLETED|Period 1: Controlled Period (CP)||0
201920|NCT00723528|495360|P6|NOT COMPLETED|Period 1: Controlled Period (CP)||0
201921|NCT00723528|495361|P5|NOT COMPLETED|Period 1: Controlled Period (CP)||0
201922|NCT00723528|495362|P4|NOT COMPLETED|Period 1: Controlled Period (CP)||0
201923|NCT00723528|495363|P3|NOT COMPLETED|Period 1: Controlled Period (CP)||4
201924|NCT00723528|495364|P2|NOT COMPLETED|Period 1: Controlled Period (CP)||0
201925|NCT00723528|495365|P1|NOT COMPLETED|Period 1: Controlled Period (CP)||4
201926|NCT00723528|495359|P7|COMPLETED|Period 1: Controlled Period (CP)||0
201927|NCT00723528|495360|P6|COMPLETED|Period 1: Controlled Period (CP)||0
201929|NCT00723528|495362|P4|COMPLETED|Period 1: Controlled Period (CP)||0
201930|NCT00723528|495363|P3|COMPLETED|Period 1: Controlled Period (CP)||58
201931|NCT00723528|495364|P2|COMPLETED|Period 1: Controlled Period (CP)||64
201932|NCT00723528|495365|P1|COMPLETED|Period 1: Controlled Period (CP)||28
201933|NCT00723528|495359|P7|STARTED|Period 1: Controlled Period (CP)||0
201934|NCT00723528|495360|P6|STARTED|Period 1: Controlled Period (CP)||0
201935|NCT00723528|495361|P5|STARTED|Period 1: Controlled Period (CP)||0
201936|NCT00723528|495362|P4|STARTED|Period 1: Controlled Period (CP)||0
201937|NCT00723528|495363|P3|STARTED|Period 1: Controlled Period (CP)||62
201938|NCT00723528|495364|P2|STARTED|Period 1: Controlled Period (CP)||64
201939|NCT00723528|495365|P1|STARTED|Period 1: Controlled Period (CP)||32
201940|NCT00723554|495423|P1|NOT COMPLETED|Overall Study||29
201941|NCT00723554|495423|P1|COMPLETED|Overall Study||34
201942|NCT00723554|495423|P1|STARTED|Overall Study||63
201943|NCT00723580|495470|P1|NOT COMPLETED|Overall Study||0
201944|NCT00723580|495470|P1|COMPLETED|Overall Study|Completion of repeated Measurements|1
201945|NCT00723580|495470|P1|Baseline Measurements|Overall Study|Actigraphic, Psychometric and Observational Baseline Data Collected.|1
201946|NCT00723580|495470|P1|STARTED|Overall Study|Study was extended with continued repeated measurements.|1
201947|NCT00723606|495476|P2|NOT COMPLETED|Overall Study||7
201948|NCT00723606|495477|P1|NOT COMPLETED|Overall Study||4
201949|NCT00723606|495476|P2|COMPLETED|Overall Study||180
201950|NCT00723606|495477|P1|COMPLETED|Overall Study||185
201951|NCT00723606|495476|P2|STARTED|Overall Study||187
201952|NCT00723606|495477|P1|STARTED|Overall Study||189
201953|NCT00723632|495493|P1|NOT COMPLETED|Overall Study||203
201954|NCT00723632|495493|P1|COMPLETED|Overall Study|Completed initial exam form and >= 1 follow up visit form; end of treatment and SVR status recorded|698
201955|NCT00723632|495493|P1|STARTED|Overall Study||901
201956|NCT00723645|495499|P1|NOT COMPLETED|Visit 3 (Week 72 Post-treatment)||0
201957|NCT00723645|495499|P1|COMPLETED|Visit 3 (Week 72 Post-treatment)||187
201958|NCT00723645|495499|P1|STARTED|Visit 3 (Week 72 Post-treatment)|61 discontinued before V3; 26 lost to followup, 34 HCV RNA+ at Wk 24,1 death,1 HCV RNA not available|187
201959|NCT00723645|495499|P1|NOT COMPLETED|Visit 2 (Week 24 Post-treatment)||0
201960|NCT00723645|495499|P1|COMPLETED|Visit 2 (Week 24 Post-treatment)||248
201961|NCT00723645|495499|P1|STARTED|Visit 2 (Week 24 Post-treatment)|10 discontinued before Visit 2; 7 lost to follow-up and 3 were HCV RNA+ before Wk 24|248
201962|NCT00723645|495499|P1|NOT COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||0
201963|NCT00723645|495499|P1|COMPLETED|Visit 1 (≤4 Weeks Post-treatment)||258
201964|NCT00723645|495499|P1|STARTED|Visit 1 (≤4 Weeks Post-treatment)||258
201965|NCT00723697|495504|P1|NOT COMPLETED|Overall Study||18
201966|NCT00723697|495504|P1|COMPLETED|Overall Study||1289
201967|NCT00723697|495504|P1|STARTED|Overall Study||1307
201968|NCT00723710|495512|P1|NOT COMPLETED|Overall Study||174
201969|NCT00723710|495512|P1|COMPLETED|Overall Study||120
201970|NCT00723710|495512|P1|STARTED|Overall Study||294
201971|NCT00723736|495516|P1|NOT COMPLETED|Overall Study||1
201972|NCT00723736|495516|P1|COMPLETED|Overall Study|Subject's caregiver did not wish to continue, reasons unrelated.|99
201973|NCT00723736|495516|P1|STARTED|Overall Study||100
201974|NCT00723749|495520|P1|NOT COMPLETED|Overall Study||163
201975|NCT00723749|495520|P1|COMPLETED|Overall Study||182
201976|NCT00723749|495520|P1|STARTED|Overall Study|384 patients were enrolled, 36 non-eligible datasets were excluded from analysis|345
201977|NCT00723788|495527|P1|NOT COMPLETED|Overall Study||0
201978|NCT00723788|495527|P1|COMPLETED|Overall Study||21
201979|NCT00723788|495527|P1|STARTED|Overall Study||21
201980|NCT00723801|495535|P2|NOT COMPLETED|Overall Study||3
201981|NCT00723801|495536|P1|NOT COMPLETED|Overall Study||3
201982|NCT00723801|495535|P2|COMPLETED|Overall Study||17
201983|NCT00723801|495536|P1|COMPLETED|Overall Study||17
201984|NCT00723801|495535|P2|STARTED|Overall Study||20
201985|NCT00723801|495536|P1|STARTED|Overall Study||20
201986|NCT00723827|495544|P1|NOT COMPLETED|Overall Study||0
201987|NCT00723827|495544|P1|COMPLETED|Overall Study||682
201988|NCT00723827|495544|P1|STARTED|Overall Study||682
201989|NCT00723840|495552|P1|NOT COMPLETED|Overall Study||82
201990|NCT00723840|495552|P1|COMPLETED|Overall Study||163
201991|NCT00723840|495552|P1|STARTED|Overall Study||245
201992|NCT00723892|495565|P2|NOT COMPLETED|Overall Study||87
201993|NCT00723892|495566|P1|NOT COMPLETED|Overall Study||107
201994|NCT00723892|495565|P2|COMPLETED|Overall Study||168
201995|NCT00723892|495566|P1|COMPLETED|Overall Study||206
201996|NCT00723892|495565|P2|STARTED|Overall Study||255
201997|NCT00723892|495566|P1|STARTED|Overall Study||313
201998|NCT00723931|495573|P1|NOT COMPLETED|Overall Study||0
201999|NCT00723931|495573|P1|COMPLETED|Overall Study||1267
202000|NCT00723931|495573|P1|STARTED|Overall Study||1267
202001|NCT00723944|495580|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
202002|NCT00723944|495581|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
202003|NCT00723944|495580|P2|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 108|37
202004|NCT00723944|495581|P1|COMPLETED|Two Year Post Placement Follow-up|number of individual implant units completing is 130|48
202005|NCT00723944|495580|P2|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 108|37
202006|NCT00723944|495581|P1|STARTED|Two Year Post Placement Follow-up|number of individual implant units is 130|48
202007|NCT00723944|495580|P2|NOT COMPLETED|One Year Post Placement Follow-up||4
202008|NCT00723944|495581|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
202086|NCT00724451|495686|P1|STARTED|Overall Study||1128
202009|NCT00723944|495580|P2|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 108|37
202010|NCT00723944|495581|P1|COMPLETED|One Year Post Placement Follow-up|number of individual implant units completing is 130|48
202011|NCT00723944|495580|P2|STARTED|One Year Post Placement Follow-up|number of individual implant units is 112|41
202012|NCT00723944|495581|P1|STARTED|One Year Post Placement Follow-up|number of individual implant units is 134|49
202013|NCT00723944|495580|P2|NOT COMPLETED|Permanent Prosthesis Placement||9
202014|NCT00723944|495581|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
202015|NCT00723944|495580|P2|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 112|41
202016|NCT00723944|495581|P1|COMPLETED|Permanent Prosthesis Placement|number of individual implant units completing is 134|49
202017|NCT00723944|495580|P2|STARTED|Permanent Prosthesis Placement|number of individual implant units is 138|50
202018|NCT00723944|495581|P1|STARTED|Permanent Prosthesis Placement|number of individual implant units is 148|52
202019|NCT00723944|495580|P2|NOT COMPLETED|Implant Placement Surgery||0
202020|NCT00723944|495581|P1|NOT COMPLETED|Implant Placement Surgery||0
202021|NCT00723944|495580|P2|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 138|50
202022|NCT00723944|495581|P1|COMPLETED|Implant Placement Surgery|number of individual implant units completing is 148|52
202023|NCT00723944|495580|P2|STARTED|Implant Placement Surgery|number of individual implant units is 138|50
202024|NCT00723944|495581|P1|STARTED|Implant Placement Surgery|number of individual implant units is 148|52
202025|NCT00723957|495589|P2|NOT COMPLETED|Overall Study||53
202026|NCT00723957|495590|P1|NOT COMPLETED|Overall Study||51
202027|NCT00723957|495589|P2|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|46
202028|NCT00723957|495590|P1|COMPLETED|Overall Study|Completed 6 cycles of study drug (maximum per protocol)|47
202029|NCT00723957|495589|P2|STARTED|Overall Study|Randomized|99
202030|NCT00723957|495590|P1|STARTED|Overall Study|Randomized|98
202031|NCT00724009|495612|P1|NOT COMPLETED|Overall Study||0
202032|NCT00724009|495612|P1|COMPLETED|Overall Study|One patient underwent conditioning but died 1 day before stem cell infusion due to sepsis.|29
202033|NCT00724009|495612|P1|STARTED|Overall Study||29
202034|NCT00724061|495623|P1|NOT COMPLETED|Maintenance Therapy||0
202035|NCT00724061|495623|P1|COMPLETED|Maintenance Therapy||2
202036|NCT00724061|495623|P1|STARTED|Maintenance Therapy||2
202037|NCT00724061|495623|P1|NOT COMPLETED|Dose Escalation Phase||5
202038|NCT00724061|495623|P1|COMPLETED|Dose Escalation Phase||2
202039|NCT00724061|495623|P1|STARTED|Dose Escalation Phase||7
202040|NCT00724126|495629|P2|NOT COMPLETED|Overall Study||15
202041|NCT00724126|495630|P1|NOT COMPLETED|Overall Study||19
202042|NCT00724126|495629|P2|COMPLETED|Overall Study||301
202043|NCT00724126|495630|P1|COMPLETED|Overall Study||302
202044|NCT00724126|495629|P2|STARTED|Overall Study||316
202045|NCT00724126|495630|P1|STARTED|Overall Study||321
202046|NCT00724152|495643|P3|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
202047|NCT00724152|495644|P2|NOT COMPLETED|Three-arm Study Period (+Standard Care)||2
202048|NCT00724152|495645|P1|NOT COMPLETED|Three-arm Study Period (+Standard Care)||1
202049|NCT00724152|495643|P3|COMPLETED|Three-arm Study Period (+Standard Care)||1
202050|NCT00724152|495644|P2|COMPLETED|Three-arm Study Period (+Standard Care)||0
202051|NCT00724152|495645|P1|COMPLETED|Three-arm Study Period (+Standard Care)||3
202052|NCT00724152|495643|P3|STARTED|Three-arm Study Period (+Standard Care)|3-group randomization began|2
202053|NCT00724152|495644|P2|STARTED|Three-arm Study Period (+Standard Care)||2
202054|NCT00724152|495645|P1|STARTED|Three-arm Study Period (+Standard Care)||4
202055|NCT00724152|495643|P3|NOT COMPLETED|Two-arm Study Period||0
202056|NCT00724152|495644|P2|NOT COMPLETED|Two-arm Study Period||2
202057|NCT00724152|495645|P1|NOT COMPLETED|Two-arm Study Period||3
202058|NCT00724152|495643|P3|COMPLETED|Two-arm Study Period||0
202059|NCT00724152|495644|P2|COMPLETED|Two-arm Study Period||9
202060|NCT00724152|495645|P1|COMPLETED|Two-arm Study Period||11
202061|NCT00724152|495643|P3|STARTED|Two-arm Study Period|Standard Care arm was added later (Period 2)|0
202062|NCT00724152|495644|P2|STARTED|Two-arm Study Period||11
202063|NCT00724152|495645|P1|STARTED|Two-arm Study Period||14
202064|NCT00724243|495660|P1|NOT COMPLETED|Overall Study||15
202065|NCT00724243|495660|P1|COMPLETED|Overall Study||18
202066|NCT00724243|495660|P1|STARTED|Overall Study||33
202067|NCT00724282|495665|P1|NOT COMPLETED|Overall Study||4
202068|NCT00724282|495665|P1|COMPLETED|Overall Study||16
202069|NCT00724282|495665|P1|STARTED|Overall Study||20
202070|NCT00724308|495671|P2|NOT COMPLETED|Overall Study||97
202071|NCT00724308|495672|P1|NOT COMPLETED|Overall Study||80
202072|NCT00724308|495671|P2|COMPLETED|Overall Study||210
202073|NCT00724308|495672|P1|COMPLETED|Overall Study||190
202074|NCT00724308|495671|P2|STARTED|Overall Study||307
202075|NCT00724308|495672|P1|STARTED|Overall Study||270
202076|NCT00724347|495678|P1|NOT COMPLETED|Overall Study||2
202077|NCT00724347|495678|P1|COMPLETED|Overall Study||16
202078|NCT00724347|495678|P1|Baseline Testing|Overall Study||18
202079|NCT00724347|495678|P1|STARTED|Overall Study|Training was the final step in the program, once the outcome tests had been developed.|18
202080|NCT00724373|495682|P1|NOT COMPLETED|Overall Study||171
202081|NCT00724373|495682|P1|COMPLETED|Overall Study||271
202082|NCT00724373|495682|P1|STARTED|Overall Study||442
202083|NCT00724451|495686|P1|NOT COMPLETED|Overall Study||802
202084|NCT00724451|495686|P1|COMPLETED|Overall Study|Completed defined as participants who completed anti-viral treatment.|326
202085|NCT00724451|495686|P1|Received Antiviral Treatment|Overall Study||500
202087|NCT00724464|495692|P1|NOT COMPLETED|Overall Study||23
202088|NCT00724464|495692|P1|COMPLETED|Overall Study||309
202089|NCT00724464|495692|P1|STARTED|Overall Study||332
202090|NCT00724477|495704|P1|NOT COMPLETED|Overall Study||0
202091|NCT00724477|495704|P1|COMPLETED|Overall Study||1663
202092|NCT00724477|495704|P1|STARTED|Overall Study|This safety population (SAF)analysed consisted of all patients who took at least one tablet of INEGY|1663
202093|NCT00724568|495708|P2|NOT COMPLETED|Overall Study||0
202094|NCT00724568|495709|P1|NOT COMPLETED|Overall Study||0
202095|NCT00724568|495708|P2|COMPLETED|Overall Study||32
202096|NCT00724568|495709|P1|COMPLETED|Overall Study||42
202097|NCT00724568|495708|P2|STARTED|Overall Study||32
202098|NCT00724568|495709|P1|STARTED|Overall Study||42
202099|NCT00724594|495718|P4|NOT COMPLETED|Overall Study||1
202100|NCT00724594|495719|P3|NOT COMPLETED|Overall Study||0
202101|NCT00724594|495720|P2|NOT COMPLETED|Overall Study||0
202102|NCT00724594|495721|P1|NOT COMPLETED|Overall Study||0
202103|NCT00724594|495718|P4|COMPLETED|Overall Study||10
202104|NCT00724594|495719|P3|COMPLETED|Overall Study||11
202105|NCT00724594|495720|P2|COMPLETED|Overall Study||12
202106|NCT00724594|495721|P1|COMPLETED|Overall Study||12
202107|NCT00724594|495718|P4|STARTED|Overall Study||11
202108|NCT00724594|495719|P3|STARTED|Overall Study||11
202109|NCT00724594|495720|P2|STARTED|Overall Study||12
202110|NCT00724594|495721|P1|STARTED|Overall Study||12
202111|NCT00724698|495744|P1|NOT COMPLETED|Overall Study||90
202112|NCT00724698|495744|P1|COMPLETED|Overall Study||2921
202113|NCT00724698|495744|P1|STARTED|Overall Study||3011
202114|NCT00724711|495749|P2|NOT COMPLETED|Overall Study||17
202115|NCT00724711|495750|P1|NOT COMPLETED|Overall Study||17
202116|NCT00724711|495749|P2|COMPLETED|Overall Study||139
202117|NCT00724711|495750|P1|COMPLETED|Overall Study||138
202118|NCT00724711|495749|P2|STARTED|Overall Study||156
202119|NCT00724711|495750|P1|STARTED|Overall Study||155
202120|NCT00724750|495784|P2|NOT COMPLETED|Overall Study||0
202121|NCT00724750|495785|P1|NOT COMPLETED|Overall Study||0
202122|NCT00724750|495784|P2|COMPLETED|Overall Study||42
202123|NCT00724750|495785|P1|COMPLETED|Overall Study||45
202124|NCT00724750|495784|P2|STARTED|Overall Study||42
202125|NCT00724750|495785|P1|STARTED|Overall Study||45
202126|NCT00724815|495803|P2|NOT COMPLETED|Overall Study||39
202127|NCT00724815|495804|P1|NOT COMPLETED|Overall Study||43
202128|NCT00724815|495803|P2|COMPLETED|Overall Study||226
202129|NCT00724815|495804|P1|COMPLETED|Overall Study||222
202130|NCT00724815|495803|P2|STARTED|Overall Study|subjects randomized|265
202131|NCT00724815|495804|P1|STARTED|Overall Study|subjects randomized|265
202132|NCT00724854|495818|P2|NOT COMPLETED|Overall Study||31
202133|NCT00724854|495819|P1|NOT COMPLETED|Overall Study||403
202134|NCT00724854|495818|P2|COMPLETED|Overall Study||41
202135|NCT00724854|495819|P1|COMPLETED|Overall Study||607
202136|NCT00724854|495818|P2|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|72
202137|NCT00724854|495819|P1|STARTED|Overall Study|Number enrolled was 1146. 64 participants were screen failures.|1010
202138|NCT00724867|495834|P1|NOT COMPLETED|Overall Study||128
202139|NCT00724867|495834|P1|COMPLETED|Overall Study||140
202140|NCT00724867|495834|P1|STARTED|Overall Study||268
202141|NCT00724893|495874|P2|NOT COMPLETED|Overall Study||458
202142|NCT00724893|495875|P1|NOT COMPLETED|Overall Study||364
202143|NCT00724893|495874|P2|COMPLETED|Overall Study||670
202144|NCT00724893|495875|P1|COMPLETED|Overall Study||938
202145|NCT00724893|495874|P2|STARTED|Overall Study||1128
202146|NCT00724893|495875|P1|STARTED|Overall Study||1302
202147|NCT00724932|495945|P2|NOT COMPLETED|Overall Study||3
202148|NCT00724932|495946|P1|NOT COMPLETED|Overall Study||5
202149|NCT00724932|495945|P2|COMPLETED|Overall Study||67
202150|NCT00724932|495946|P1|COMPLETED|Overall Study||65
202151|NCT00724932|495945|P2|STARTED|Overall Study||70
202152|NCT00724932|495946|P1|STARTED|Overall Study||70
202153|NCT00724945|496015|P2|NOT COMPLETED|Period 2||0
202154|NCT00724945|496016|P1|NOT COMPLETED|Period 2||4
202155|NCT00724945|496015|P2|COMPLETED|Period 2||54
202156|NCT00724945|496016|P1|COMPLETED|Period 2||51
202157|NCT00724945|496015|P2|STARTED|Period 2||54
202158|NCT00724945|496016|P1|STARTED|Period 2||55
202159|NCT00724945|496015|P2|NOT COMPLETED|Period 1||1
202160|NCT00724945|496016|P1|NOT COMPLETED|Period 1||3
202161|NCT00724945|496015|P2|COMPLETED|Period 1||54
202162|NCT00724945|496016|P1|COMPLETED|Period 1||55
202163|NCT00724945|496015|P2|STARTED|Period 1||55
202164|NCT00724945|496016|P1|STARTED|Period 1||58
202165|NCT00724958|496026|P1|NOT COMPLETED|Overall Study||182
202166|NCT00724958|496026|P1|COMPLETED|Overall Study||166
202167|NCT00724958|496026|P1|STARTED|Overall Study||348
202168|NCT00724984|496041|P6|NOT COMPLETED|Overall Study||5
202169|NCT00724984|496042|P5|NOT COMPLETED|Overall Study||4
202170|NCT00724984|496043|P4|NOT COMPLETED|Overall Study||2
202171|NCT00724984|496044|P3|NOT COMPLETED|Overall Study||0
202172|NCT00724984|496045|P2|NOT COMPLETED|Overall Study||1
202173|NCT00724984|496046|P1|NOT COMPLETED|Overall Study||1
202174|NCT00724984|496041|P6|COMPLETED|Overall Study||9
202175|NCT00724984|496042|P5|COMPLETED|Overall Study||12
202176|NCT00724984|496043|P4|COMPLETED|Overall Study||7
202177|NCT00724984|496044|P3|COMPLETED|Overall Study||3
202178|NCT00724984|496045|P2|COMPLETED|Overall Study||7
202179|NCT00724984|496046|P1|COMPLETED|Overall Study||4
202180|NCT00724984|496041|P6|STARTED|Overall Study||14
202181|NCT00724984|496042|P5|STARTED|Overall Study||16
202182|NCT00724984|496043|P4|STARTED|Overall Study||9
202183|NCT00724984|496044|P3|STARTED|Overall Study||3
202184|NCT00724984|496045|P2|STARTED|Overall Study||8
202185|NCT00724984|496046|P1|STARTED|Overall Study||5
202186|NCT00725010|496060|P1|NOT COMPLETED|Overall Study||25
202187|NCT00725010|496060|P1|COMPLETED|Overall Study||25
202188|NCT00725010|496060|P1|STARTED|Overall Study|Only in 50 of 64 participants the documentation of therapy and follow-up was received and evaluated.|50
202189|NCT00725049|496070|P2|NOT COMPLETED|Overall Study||0
202190|NCT00725049|496071|P1|NOT COMPLETED|Overall Study||0
202191|NCT00725049|496070|P2|COMPLETED|Overall Study||20
202192|NCT00725049|496071|P1|COMPLETED|Overall Study||17
202193|NCT00725049|496070|P2|STARTED|Overall Study||20
202194|NCT00725049|496071|P1|STARTED|Overall Study||17
202195|NCT00718120|496079|P2|NOT COMPLETED|Overall Study||0
202196|NCT00718120|496080|P1|NOT COMPLETED|Overall Study||0
202197|NCT00718120|496079|P2|COMPLETED|Overall Study||55
202198|NCT00718120|496080|P1|COMPLETED|Overall Study||55
202199|NCT00718120|496079|P2|STARTED|Overall Study||55
202200|NCT00718120|496080|P1|STARTED|Overall Study||55
202201|NCT00718237|496100|P2|NOT COMPLETED|Overall Study||15
202202|NCT00718237|496101|P1|NOT COMPLETED|Overall Study||13
202203|NCT00718237|496100|P2|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|366
202204|NCT00718237|496101|P1|COMPLETED|Overall Study|Subjects who continued follow-up until the last visit, regardless of number of vaccinations received|368
202205|NCT00718237|496100|P2|Vaccinated at Visit 3|Overall Study||369
202206|NCT00718237|496101|P1|Vaccinated at Visit 3|Overall Study||371
202207|NCT00718237|496100|P2|Vaccinated at Visit 2|Overall Study||374
202208|NCT00718237|496101|P1|Vaccinated at Visit 2|Overall Study||373
202209|NCT00718237|496100|P2|Vaccinated at Visit 1|Overall Study||381
202210|NCT00718237|496101|P1|Vaccinated at Visit 1|Overall Study||380
202211|NCT00718237|496100|P2|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
202212|NCT00718237|496101|P1|STARTED|Overall Study|Subjects who passed all entry criteria and who were randomized into the study|381
202213|NCT00718302|496113|P2|NOT COMPLETED|Overall Study||0
202214|NCT00718302|496114|P1|NOT COMPLETED|Overall Study||0
202215|NCT00718302|496113|P2|COMPLETED|Overall Study||114
202216|NCT00718302|496114|P1|COMPLETED|Overall Study||119
202217|NCT00718302|496113|P2|STARTED|Overall Study||114
202218|NCT00718302|496114|P1|STARTED|Overall Study||119
202219|NCT00718315|496131|P3|NOT COMPLETED|Overall Study||21
202220|NCT00718315|496132|P2|NOT COMPLETED|Overall Study||22
202221|NCT00718315|496133|P1|NOT COMPLETED|Overall Study||19
202222|NCT00718315|496131|P3|COMPLETED|Overall Study||46
202223|NCT00718315|496132|P2|COMPLETED|Overall Study||45
202224|NCT00718315|496133|P1|COMPLETED|Overall Study||48
202225|NCT00718315|496131|P3|STARTED|Overall Study||67
202226|NCT00718315|496132|P2|STARTED|Overall Study||67
202227|NCT00718315|496133|P1|STARTED|Overall Study||67
202228|NCT00718328|496167|P2|NOT COMPLETED|Overall Study||0
202229|NCT00718328|496168|P1|NOT COMPLETED|Overall Study||1
202230|NCT00718328|496167|P2|COMPLETED|Overall Study|Terminated due to poor enrollment|0
202231|NCT00718328|496168|P1|COMPLETED|Overall Study|Prematurely terminated due to poor enrollment|0
202232|NCT00718328|496167|P2|STARTED|Overall Study||0
202233|NCT00718328|496168|P1|STARTED|Overall Study||1
202234|NCT00725075|496177|P3|NOT COMPLETED|Overall Study||9
202235|NCT00725075|496178|P2|NOT COMPLETED|Overall Study||8
202236|NCT00725075|496179|P1|NOT COMPLETED|Overall Study||11
202237|NCT00725075|496177|P3|COMPLETED|Overall Study||61
202238|NCT00725075|496178|P2|COMPLETED|Overall Study||65
202239|NCT00725075|496179|P1|COMPLETED|Overall Study||61
202240|NCT00725075|496177|P3|Treated|Overall Study||70
202241|NCT00725075|496178|P2|Treated|Overall Study||73
202242|NCT00725075|496179|P1|Treated|Overall Study||71
202243|NCT00725075|496177|P3|STARTED|Overall Study||70
202244|NCT00725075|496178|P2|STARTED|Overall Study||73
202245|NCT00725075|496179|P1|STARTED|Overall Study||72
202246|NCT00725101|496223|P1|NOT COMPLETED|Overall Study||495
202247|NCT00725101|496223|P1|COMPLETED|Overall Study||1205
202248|NCT00725101|496223|P1|STARTED|Overall Study||1700
202249|NCT00725153|496243|P2|NOT COMPLETED|Period Two, 10 Hours of Wear||0
202250|NCT00725153|496244|P1|NOT COMPLETED|Period Two, 10 Hours of Wear||0
202251|NCT00725153|496243|P2|COMPLETED|Period Two, 10 Hours of Wear||28
202252|NCT00725153|496244|P1|COMPLETED|Period Two, 10 Hours of Wear||27
202253|NCT00725153|496243|P2|STARTED|Period Two, 10 Hours of Wear||28
202254|NCT00725153|496244|P1|STARTED|Period Two, 10 Hours of Wear||27
202255|NCT00725153|496243|P2|NOT COMPLETED|Period One, 10 Hours of Wear||0
202256|NCT00725153|496244|P1|NOT COMPLETED|Period One, 10 Hours of Wear||0
202257|NCT00725153|496243|P2|COMPLETED|Period One, 10 Hours of Wear||28
202258|NCT00725153|496244|P1|COMPLETED|Period One, 10 Hours of Wear||27
202259|NCT00725153|496243|P2|STARTED|Period One, 10 Hours of Wear||28
202260|NCT00725153|496244|P1|STARTED|Period One, 10 Hours of Wear||27
202261|NCT00725205|496250|P1|NOT COMPLETED|Overall Study||87
202262|NCT00725205|496250|P1|COMPLETED|Overall Study||207
202263|NCT00725205|496250|P1|STARTED|Overall Study||294
202264|NCT00725270|496258|P2|NOT COMPLETED|Overall Study||0
202265|NCT00725270|496259|P1|NOT COMPLETED|Overall Study||0
202266|NCT00725270|496258|P2|COMPLETED|Overall Study||7
202267|NCT00725270|496259|P1|COMPLETED|Overall Study||5
202268|NCT00725270|496258|P2|STARTED|Overall Study||7
202269|NCT00725270|496259|P1|STARTED|Overall Study||5
202270|NCT00725296|496267|P1|NOT COMPLETED|Overall Study||62
202271|NCT00725296|496267|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive infusions.|101
202272|NCT00725296|496267|P1|STARTED|Overall Study|163 of the 178 enrolled participants received at least one dose of Infliximab.|163
202273|NCT00725361|496276|P1|NOT COMPLETED|Overall Study||4
202274|NCT00725361|496276|P1|COMPLETED|Overall Study||16
202275|NCT00725361|496276|P1|STARTED|Overall Study||20
202276|NCT00727337|496288|P4|NOT COMPLETED|Overall Study||7
202277|NCT00727337|496289|P3|NOT COMPLETED|Overall Study||9
202278|NCT00727337|496290|P2|NOT COMPLETED|Overall Study||10
202279|NCT00727337|496291|P1|NOT COMPLETED|Overall Study||10
202280|NCT00727337|496288|P4|COMPLETED|Overall Study||61
202281|NCT00727337|496289|P3|COMPLETED|Overall Study||64
202282|NCT00727337|496290|P2|COMPLETED|Overall Study||63
202283|NCT00727337|496291|P1|COMPLETED|Overall Study||55
202284|NCT00727337|496288|P4|STARTED|Overall Study||68
202285|NCT00727337|496289|P3|STARTED|Overall Study||73
202286|NCT00727337|496290|P2|STARTED|Overall Study||73
202287|NCT00727337|496291|P1|STARTED|Overall Study||65
202288|NCT00727402|496301|P1|NOT COMPLETED|Overall Study||116
202289|NCT00727402|496301|P1|COMPLETED|Overall Study||89
202290|NCT00727402|496301|P1|STARTED|Overall Study||205
202291|NCT00727506|496311|P6|NOT COMPLETED|Overall Study||39
202292|NCT00727506|496312|P5|NOT COMPLETED|Overall Study||41
202293|NCT00727506|496313|P4|NOT COMPLETED|Overall Study||39
202294|NCT00727506|496314|P3|NOT COMPLETED|Overall Study||18
202295|NCT00727506|496315|P2|NOT COMPLETED|Overall Study||8
202296|NCT00727506|496316|P1|NOT COMPLETED|Overall Study||6
202297|NCT00727506|496311|P6|COMPLETED|Overall Study||0
202298|NCT00727506|496312|P5|COMPLETED|Overall Study||0
202299|NCT00727506|496313|P4|COMPLETED|Overall Study||0
202300|NCT00727506|496314|P3|COMPLETED|Overall Study||0
202301|NCT00727506|496315|P2|COMPLETED|Overall Study||0
202302|NCT00727506|496316|P1|COMPLETED|Overall Study||0
202303|NCT00727506|496311|P6|STARTED|Overall Study|Randomized|39
202304|NCT00727506|496312|P5|STARTED|Overall Study|Randomized|41
202305|NCT00727506|496313|P4|STARTED|Overall Study|Randomized|39
202306|NCT00727506|496314|P3|STARTED|Overall Study|Entered|18
202307|NCT00727506|496315|P2|STARTED|Overall Study|Entered|8
202308|NCT00727506|496316|P1|STARTED|Overall Study|Entered|6
202309|NCT00727558|496411|P2|NOT COMPLETED|Overall Study||3
202310|NCT00727558|496412|P1|NOT COMPLETED|Overall Study||2
202311|NCT00727558|496411|P2|COMPLETED|Overall Study||118
202312|NCT00727558|496412|P1|COMPLETED|Overall Study||125
202313|NCT00727558|496411|P2|STARTED|Overall Study||121
202314|NCT00727558|496412|P1|STARTED|Overall Study||127
202315|NCT00727571|496434|P4|NOT COMPLETED|Overall Study||6
202316|NCT00727571|496435|P3|NOT COMPLETED|Overall Study||30
202317|NCT00727571|496436|P2|NOT COMPLETED|Overall Study||55
202318|NCT00727571|496437|P1|NOT COMPLETED|Overall Study||1
202319|NCT00727571|496434|P4|COMPLETED|Overall Study||163
202320|NCT00727571|496435|P3|COMPLETED|Overall Study||135
202321|NCT00727571|496436|P2|COMPLETED|Overall Study||173
202322|NCT00727571|496437|P1|COMPLETED|Overall Study||231
202323|NCT00727571|496434|P4|STARTED|Overall Study||169
202324|NCT00727571|496435|P3|STARTED|Overall Study||165
202325|NCT00727571|496436|P2|STARTED|Overall Study||228
202326|NCT00727571|496437|P1|STARTED|Overall Study||232
202327|NCT00727597|496464|P2|NOT COMPLETED|Overall Study||0
202328|NCT00727597|496465|P1|NOT COMPLETED|Overall Study||0
202329|NCT00727597|496464|P2|COMPLETED|Overall Study||50
202330|NCT00727597|496465|P1|COMPLETED|Overall Study||51
202331|NCT00727597|496464|P2|STARTED|Overall Study||50
202332|NCT00727597|496465|P1|STARTED|Overall Study||51
202333|NCT00727636|496475|P2|NOT COMPLETED|Overall Study||0
202334|NCT00727636|496476|P1|NOT COMPLETED|Overall Study||4
202335|NCT00727636|496475|P2|COMPLETED|Overall Study||15
202336|NCT00727636|496476|P1|COMPLETED|Overall Study||33
202337|NCT00727636|496475|P2|STARTED|Overall Study||15
202338|NCT00727636|496476|P1|STARTED|Overall Study||37
202339|NCT00727649|496490|P2|NOT COMPLETED|Second Intervention (4-weeks)||3
202340|NCT00727649|496491|P1|NOT COMPLETED|Second Intervention (4-weeks)||1
202341|NCT00727649|496490|P2|COMPLETED|Second Intervention (4-weeks)||34
202342|NCT00727649|496491|P1|COMPLETED|Second Intervention (4-weeks)||29
202343|NCT00727649|496490|P2|STARTED|Second Intervention (4-weeks)||37
202344|NCT00727649|496491|P1|STARTED|Second Intervention (4-weeks)||30
202345|NCT00727649|496490|P2|NOT COMPLETED|Wash-out (2-weeks)||3
202346|NCT00727649|496491|P1|NOT COMPLETED|Wash-out (2-weeks)||4
202347|NCT00727649|496490|P2|COMPLETED|Wash-out (2-weeks)||37
202348|NCT00727649|496491|P1|COMPLETED|Wash-out (2-weeks)||30
202349|NCT00727649|496490|P2|STARTED|Wash-out (2-weeks)||40
202350|NCT00727649|496491|P1|STARTED|Wash-out (2-weeks)||34
202351|NCT00727649|496490|P2|NOT COMPLETED|First Intervention (4-weeks)||3
202352|NCT00727649|496491|P1|NOT COMPLETED|First Intervention (4-weeks)||3
202353|NCT00727649|496490|P2|COMPLETED|First Intervention (4-weeks)||40
202354|NCT00727649|496491|P1|COMPLETED|First Intervention (4-weeks)||34
202355|NCT00727649|496490|P2|STARTED|First Intervention (4-weeks)||43
202356|NCT00727649|496491|P1|STARTED|First Intervention (4-weeks)||37
202357|NCT00727714|496503|P1|NOT COMPLETED|Overall Study||2
202358|NCT00727714|496503|P1|COMPLETED|Overall Study||93
202359|NCT00727714|496503|P1|STARTED|Overall Study||95
202360|NCT00727740|496513|P2|NOT COMPLETED|Overall Study||0
202361|NCT00727740|496514|P1|NOT COMPLETED|Overall Study||0
202362|NCT00727740|496513|P2|COMPLETED|Overall Study||61
202363|NCT00727740|496514|P1|COMPLETED|Overall Study||56
202364|NCT00727740|496513|P2|STARTED|Overall Study||61
202365|NCT00727740|496514|P1|STARTED|Overall Study||56
202366|NCT00727844|496522|P4|NOT COMPLETED|Second Randomization||0
202367|NCT00727844|496523|P3|NOT COMPLETED|Second Randomization||0
202368|NCT00727844|496524|P2|NOT COMPLETED|Second Randomization||0
202369|NCT00727844|496525|P1|NOT COMPLETED|Second Randomization||0
202370|NCT00727844|496522|P4|COMPLETED|Second Randomization||16
202371|NCT00727844|496523|P3|COMPLETED|Second Randomization||17
202372|NCT00727844|496524|P2|COMPLETED|Second Randomization||0
202373|NCT00727844|496525|P1|COMPLETED|Second Randomization||0
202374|NCT00727844|496522|P4|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|16
202375|NCT00727844|496523|P3|STARTED|Second Randomization|6 patients excluded before 2nd randomization: 2 had withdrawn and 4 already dose reduced due to AE|17
202376|NCT00727844|496524|P2|STARTED|Second Randomization||0
202377|NCT00727844|496525|P1|STARTED|Second Randomization||0
202378|NCT00727844|496522|P4|NOT COMPLETED|Initial Randomization||0
202379|NCT00727844|496523|P3|NOT COMPLETED|Initial Randomization||0
202380|NCT00727844|496524|P2|NOT COMPLETED|Initial Randomization||0
202381|NCT00727844|496525|P1|NOT COMPLETED|Initial Randomization||2
202382|NCT00727844|496522|P4|COMPLETED|Initial Randomization||0
202383|NCT00727844|496523|P3|COMPLETED|Initial Randomization||0
202384|NCT00727844|496524|P2|COMPLETED|Initial Randomization||20
202385|NCT00727844|496525|P1|COMPLETED|Initial Randomization||19
202386|NCT00727844|496522|P4|Included in MITT Analysis|Initial Randomization||0
202387|NCT00727844|496523|P3|Included in MITT Analysis|Initial Randomization||0
202388|NCT00727844|496524|P2|Included in MITT Analysis|Initial Randomization||20
202389|NCT00727844|496525|P1|Included in MITT Analysis|Initial Randomization||19
202390|NCT00727844|496522|P4|STARTED|Initial Randomization||0
202391|NCT00727844|496523|P3|STARTED|Initial Randomization||0
202392|NCT00727844|496524|P2|STARTED|Initial Randomization||20
202393|NCT00727844|496525|P1|STARTED|Initial Randomization|2 patients withdrawn before receiving any linezolid owing to baseline neuropathy|21
202394|NCT00727857|496533|P3|NOT COMPLETED|Overall Study||68
202395|NCT00727857|496534|P2|NOT COMPLETED|Overall Study||64
202396|NCT00727857|496535|P1|NOT COMPLETED|Overall Study||44
202397|NCT00727857|496533|P3|COMPLETED|Overall Study||142
202398|NCT00727857|496534|P2|COMPLETED|Overall Study||125
202399|NCT00727857|496535|P1|COMPLETED|Overall Study||157
202400|NCT00727857|496533|P3|STARTED|Overall Study||210
202401|NCT00727857|496534|P2|STARTED|Overall Study||189
202402|NCT00727857|496535|P1|STARTED|Overall Study||201
202403|NCT00727909|496621|P4|NOT COMPLETED|Overall Study||5
202404|NCT00727909|496622|P3|NOT COMPLETED|Overall Study||9
202405|NCT00727909|496623|P2|NOT COMPLETED|Overall Study||11
202406|NCT00727909|496624|P1|NOT COMPLETED|Overall Study||5
202407|NCT00727909|496621|P4|COMPLETED|Overall Study||70
202408|NCT00727909|496622|P3|COMPLETED|Overall Study||58
202409|NCT00727909|496623|P2|COMPLETED|Overall Study||61
202410|NCT00727909|496624|P1|COMPLETED|Overall Study||60
202411|NCT00727909|496621|P4|STARTED|Overall Study||75
202412|NCT00727909|496622|P3|STARTED|Overall Study||67
202413|NCT00727909|496623|P2|STARTED|Overall Study||72
202414|NCT00727909|496624|P1|STARTED|Overall Study||65
202415|NCT00727961|496628|P1|NOT COMPLETED|Overall Study||37
202416|NCT00727961|496628|P1|COMPLETED|Overall Study||21
202417|NCT00727961|496628|P1|STARTED|Overall Study||58
202418|NCT00728130|496638|P1|NOT COMPLETED|Overall Study||3
202419|NCT00728130|496638|P1|COMPLETED|Overall Study||19
202420|NCT00728130|496638|P1|STARTED|Overall Study||22
202421|NCT00728182|496645|P2|NOT COMPLETED|Overall Study||3
202422|NCT00728182|496646|P1|NOT COMPLETED|Overall Study||3
202423|NCT00728182|496645|P2|COMPLETED|Overall Study||90
202424|NCT00728182|496646|P1|COMPLETED|Overall Study||89
202425|NCT00728182|496645|P2|STARTED|Overall Study||93
202426|NCT00728182|496646|P1|STARTED|Overall Study||92
202427|NCT00728260|496674|P1|NOT COMPLETED|Overall Study||0
202428|NCT00728260|496674|P1|COMPLETED|Overall Study||1421
202429|NCT00728260|496674|P1|STARTED|Overall Study||1421
202430|NCT00728416|496682|P2|NOT COMPLETED|Overall Study||2
202431|NCT00728416|496683|P1|NOT COMPLETED|Overall Study||2
202432|NCT00728416|496682|P2|COMPLETED|Overall Study||163
202433|NCT00728416|496683|P1|COMPLETED|Overall Study||166
202434|NCT00728416|496682|P2|STARTED|Overall Study||165
202435|NCT00728416|496683|P1|STARTED|Overall Study||168
202436|NCT00728468|496691|P1|NOT COMPLETED|Overall Study||16
202437|NCT00728468|496691|P1|COMPLETED|Overall Study||0
202438|NCT00728468|496691|P1|Treated|Overall Study||15
202439|NCT00728468|496691|P1|STARTED|Overall Study||16
202440|NCT00728481|496715|P2|NOT COMPLETED|Overall Study||4
202441|NCT00728481|496716|P1|NOT COMPLETED|Overall Study||1
202442|NCT00728481|496715|P2|COMPLETED|Overall Study||28
202443|NCT00728481|496716|P1|COMPLETED|Overall Study||18
202444|NCT00728481|496715|P2|STARTED|Overall Study||32
202445|NCT00728481|496716|P1|STARTED|Overall Study||19
202446|NCT00728494|496734|P2|NOT COMPLETED|Overall Study||7
202447|NCT00728494|496735|P1|NOT COMPLETED|Overall Study||9
202448|NCT00728494|496734|P2|COMPLETED|Overall Study||32
202449|NCT00728494|496735|P1|COMPLETED|Overall Study||51
202450|NCT00728494|496734|P2|STARTED|Overall Study||39
202451|NCT00728494|496735|P1|STARTED|Overall Study||60
202452|NCT00728507|496753|P2|NOT COMPLETED|Overall Study||8
202453|NCT00728507|496754|P1|NOT COMPLETED|Overall Study||2
202454|NCT00728507|496753|P2|COMPLETED|Overall Study||51
202455|NCT00728507|496754|P1|COMPLETED|Overall Study||60
202456|NCT00728507|496753|P2|STARTED|Overall Study||59
202457|NCT00728507|496754|P1|STARTED|Overall Study||62
202458|NCT00728689|496764|P2|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
202459|NCT00728689|496765|P1|NOT COMPLETED|Second Intervention (Days 11 - 13)||0
202460|NCT00728689|496764|P2|COMPLETED|Second Intervention (Days 11 - 13)||6
202461|NCT00728689|496765|P1|COMPLETED|Second Intervention (Days 11 - 13)||5
202462|NCT00728689|496764|P2|STARTED|Second Intervention (Days 11 - 13)||6
202463|NCT00728689|496765|P1|STARTED|Second Intervention (Days 11 - 13)||5
202464|NCT00728689|496764|P2|NOT COMPLETED|Washout Period (Days 4 - 10)||0
202465|NCT00728689|496765|P1|NOT COMPLETED|Washout Period (Days 4 - 10)||1
202466|NCT00728689|496764|P2|COMPLETED|Washout Period (Days 4 - 10)||6
202467|NCT00728689|496765|P1|COMPLETED|Washout Period (Days 4 - 10)|Death in family during the Washout period. Completed First Intervention period with ST-246 Form I.|5
202468|NCT00728689|496764|P2|STARTED|Washout Period (Days 4 - 10)||6
202469|NCT00728689|496765|P1|STARTED|Washout Period (Days 4 - 10)||6
202470|NCT00728689|496764|P2|NOT COMPLETED|First Intervention (Days 1 - 3)||0
202471|NCT00728689|496765|P1|NOT COMPLETED|First Intervention (Days 1 - 3)||0
202472|NCT00728689|496764|P2|COMPLETED|First Intervention (Days 1 - 3)||6
202473|NCT00728689|496765|P1|COMPLETED|First Intervention (Days 1 - 3)||6
202474|NCT00728689|496764|P2|STARTED|First Intervention (Days 1 - 3)||6
202475|NCT00728689|496765|P1|STARTED|First Intervention (Days 1 - 3)||6
202476|NCT00728728|496783|P2|NOT COMPLETED|Overall Study||12
202477|NCT00728728|496784|P1|NOT COMPLETED|Overall Study||4
202478|NCT00728728|496783|P2|COMPLETED|Overall Study||34
202479|NCT00728728|496784|P1|COMPLETED|Overall Study||38
202480|NCT00728728|496783|P2|STARTED|Overall Study||46
202481|NCT00728728|496784|P1|STARTED|Overall Study||42
202482|NCT00728754|496804|P2|NOT COMPLETED|Two Year Post Placement Follow-up||0
202483|NCT00728754|496805|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
202484|NCT00728754|496804|P2|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 68|28
202485|NCT00728754|496805|P1|COMPLETED|Two Year Post Placement Follow-up|individual test implant units completed= 65|24
202486|NCT00728754|496804|P2|STARTED|Two Year Post Placement Follow-up|individual control implant units is 68|28
202487|NCT00728754|496805|P1|STARTED|Two Year Post Placement Follow-up|individual test implant units is 65|24
202488|NCT00728754|496804|P2|NOT COMPLETED|One Year Post Placement Follow-up||0
202489|NCT00728754|496805|P1|NOT COMPLETED|One Year Post Placement Follow-up||1
202490|NCT00728754|496804|P2|COMPLETED|One Year Post Placement Follow-up|individual control implant units completed= 68|28
202491|NCT00728754|496805|P1|COMPLETED|One Year Post Placement Follow-up|individual test implant units completing is 65|24
202492|NCT00728754|496804|P2|STARTED|One Year Post Placement Follow-up|individual control implant units is 68|28
202493|NCT00728754|496805|P1|STARTED|One Year Post Placement Follow-up|individual test implant units is 66|25
202494|NCT00728754|496804|P2|NOT COMPLETED|Permanent Prosthesis Placement||4
202495|NCT00728754|496805|P1|NOT COMPLETED|Permanent Prosthesis Placement||4
202496|NCT00728754|496804|P2|COMPLETED|Permanent Prosthesis Placement|Individual control implant units completed = 68|28
202497|NCT00728754|496805|P1|COMPLETED|Permanent Prosthesis Placement|Individual test implant units completed = 66|25
202498|NCT00728754|496804|P2|STARTED|Permanent Prosthesis Placement|Individual control implant units is 78|32
202499|NCT00728754|496805|P1|STARTED|Permanent Prosthesis Placement|Individual test implant units is 75|29
202500|NCT00728754|496804|P2|NOT COMPLETED|Implant Placement Surgery||0
202501|NCT00728754|496805|P1|NOT COMPLETED|Implant Placement Surgery||0
202502|NCT00728754|496804|P2|COMPLETED|Implant Placement Surgery|Individual control implant units completed = 78|32
202503|NCT00728754|496805|P1|COMPLETED|Implant Placement Surgery|Individual test implant units completed = 75|29
202504|NCT00728754|496804|P2|STARTED|Implant Placement Surgery|Individual control implant units is 78|32
202505|NCT00728754|496805|P1|STARTED|Implant Placement Surgery|Individual test implant units is 75|29
202506|NCT00728845|496813|P2|NOT COMPLETED|Overall Study||0
202507|NCT00728845|496814|P1|NOT COMPLETED|Overall Study||0
202508|NCT00728845|496813|P2|COMPLETED|Overall Study||0
202509|NCT00728845|496814|P1|COMPLETED|Overall Study||8
202510|NCT00728845|496813|P2|STARTED|Overall Study||0
202511|NCT00728845|496814|P1|STARTED|Overall Study||8
202512|NCT00728884|496828|P1|NOT COMPLETED|Two Year Post Placement Follow-up||0
202513|NCT00728884|496828|P1|COMPLETED|Two Year Post Placement Follow-up||145
202514|NCT00728884|496828|P1|STARTED|Two Year Post Placement Follow-up||145
202515|NCT00728884|496828|P1|NOT COMPLETED|One Year Post Placement Follow-up||4
202516|NCT00728884|496828|P1|COMPLETED|One Year Post Placement Follow-up||145
202517|NCT00728884|496828|P1|STARTED|One Year Post Placement Follow-up||149
202518|NCT00728884|496828|P1|NOT COMPLETED|Permanent Prosthesis Placement||13
202519|NCT00728884|496828|P1|COMPLETED|Permanent Prosthesis Placement||149
202520|NCT00728884|496828|P1|STARTED|Permanent Prosthesis Placement||162
202521|NCT00728884|496828|P1|NOT COMPLETED|Implant Placement Surgery||0
202522|NCT00728884|496828|P1|COMPLETED|Implant Placement Surgery||162
202523|NCT00728884|496828|P1|STARTED|Implant Placement Surgery||162
202524|NCT00728910|496832|P1|NOT COMPLETED|Atorvastatin+ABT335+ER Niacin||0
202525|NCT00728910|496832|P1|COMPLETED|Atorvastatin+ABT335+ER Niacin||22
202526|NCT00728910|496832|P1|STARTED|Atorvastatin+ABT335+ER Niacin||22
202527|NCT00728910|496832|P1|NOT COMPLETED|Atorvastatin+ABT335||0
202528|NCT00728910|496832|P1|COMPLETED|Atorvastatin+ABT335||22
202529|NCT00728910|496832|P1|STARTED|Atorvastatin+ABT335||22
202530|NCT00728910|496832|P1|NOT COMPLETED|Atorvastatin||3
202531|NCT00728910|496832|P1|COMPLETED|Atorvastatin||22
202532|NCT00728910|496832|P1|STARTED|Atorvastatin||25
202533|NCT00728923|496844|P1|NOT COMPLETED|Overall Study||0
202534|NCT00728923|496844|P1|COMPLETED|Overall Study||9
202535|NCT00728923|496844|P1|STARTED|Overall Study||9
202536|NCT00728962|496849|P1|NOT COMPLETED|Two Year Post Placement Follow-up||3
202537|NCT00728962|496849|P1|COMPLETED|Two Year Post Placement Follow-up||59
202538|NCT00728962|496849|P1|STARTED|Two Year Post Placement Follow-up||62
202539|NCT00728962|496849|P1|NOT COMPLETED|One Year Post Placement Follow-up||0
202540|NCT00728962|496849|P1|COMPLETED|One Year Post Placement Follow-up||62
202541|NCT00728962|496849|P1|STARTED|One Year Post Placement Follow-up||62
202542|NCT00728962|496849|P1|NOT COMPLETED|Permanent Prosthesis Placement||3
202543|NCT00728962|496849|P1|COMPLETED|Permanent Prosthesis Placement||62
202544|NCT00728962|496849|P1|STARTED|Permanent Prosthesis Placement||65
202545|NCT00728962|496849|P1|NOT COMPLETED|Implant Placement Surgery||10
202546|NCT00728962|496849|P1|COMPLETED|Implant Placement Surgery||65
202547|NCT00728962|496849|P1|STARTED|Implant Placement Surgery||75
202548|NCT00728988|496855|P2|NOT COMPLETED|Overall Study||88
202549|NCT00728988|496856|P1|NOT COMPLETED|Overall Study||93
202550|NCT00728988|496855|P2|COMPLETED|Overall Study||164
202551|NCT00728988|496856|P1|COMPLETED|Overall Study||154
202552|NCT00728988|496855|P2|Full Analysis Set|Overall Study||172
202553|NCT00728988|496856|P1|Full Analysis Set|Overall Study||163
202554|NCT00728988|496855|P2|Treated|Overall Study||250
202555|NCT00728988|496856|P1|Treated|Overall Study||245
202556|NCT00728988|496855|P2|STARTED|Overall Study||252
202557|NCT00728988|496856|P1|STARTED|Overall Study||247
202558|NCT00729157|496874|P1|NOT COMPLETED|Overall Study||1
202559|NCT00729157|496874|P1|COMPLETED|Overall Study||40
202560|NCT00729157|496874|P1|STARTED|Overall Study||41
202561|NCT00729183|496884|P2|NOT COMPLETED|Overall Study||15
202562|NCT00729183|496885|P1|NOT COMPLETED|Overall Study||25
202563|NCT00729183|496884|P2|COMPLETED|Overall Study|Completed 24 month visit|90
202564|NCT00729183|496885|P1|COMPLETED|Overall Study|Completed 24 month visit|84
202565|NCT00729183|496884|P2|STARTED|Overall Study||105
202566|NCT00729183|496885|P1|STARTED|Overall Study||109
202567|NCT00729248|496917|P1|NOT COMPLETED|Overall Study||2
202568|NCT00729248|496917|P1|COMPLETED|Overall Study||10
202569|NCT00729248|496917|P1|STARTED|Overall Study||12
202570|NCT00729326|496924|P2|NOT COMPLETED|Overall Study||9
202571|NCT00729326|496925|P1|NOT COMPLETED|Overall Study||10
202572|NCT00729326|496924|P2|COMPLETED|Overall Study||33
202573|NCT00729326|496925|P1|COMPLETED|Overall Study||31
202574|NCT00729326|496924|P2|STARTED|Overall Study||42
202575|NCT00729326|496925|P1|STARTED|Overall Study||41
202576|NCT00729365|496970|P3|NOT COMPLETED|Overall Study||7
202577|NCT00729365|496971|P2|NOT COMPLETED|Overall Study||6
202578|NCT00729365|496972|P1|NOT COMPLETED|Overall Study||33
202579|NCT00729365|496970|P3|COMPLETED|Overall Study|Study terminated|0
202580|NCT00729365|496971|P2|COMPLETED|Overall Study|Study Terminated|0
202581|NCT00729365|496972|P1|COMPLETED|Overall Study|Study terminated|0
202582|NCT00729365|496970|P3|STARTED|Overall Study||7
202583|NCT00729365|496971|P2|STARTED|Overall Study||6
202584|NCT00729365|496972|P1|STARTED|Overall Study||33
202585|NCT00729430|496985|P2|NOT COMPLETED|Overall Study||50
202586|NCT00729430|496986|P1|NOT COMPLETED|Overall Study||47
202587|NCT00729430|496985|P2|COMPLETED|Overall Study||128
202588|NCT00729430|496986|P1|COMPLETED|Overall Study||133
202589|NCT00729430|496985|P2|STARTED|Overall Study||178
202590|NCT00729430|496986|P1|STARTED|Overall Study||180
202591|NCT00729469|497000|P2|NOT COMPLETED|Overall Study||47
202592|NCT00729469|497001|P1|NOT COMPLETED|Overall Study||53
202593|NCT00729469|497000|P2|COMPLETED|Overall Study||416
202594|NCT00729469|497001|P1|COMPLETED|Overall Study||403
202595|NCT00729469|497000|P2|STARTED|Overall Study||463
202596|NCT00729469|497001|P1|STARTED|Overall Study||456
202597|NCT00729482|497037|P1|NOT COMPLETED|Overall Study||0
202598|NCT00729482|497037|P1|COMPLETED|Overall Study||54
202599|NCT00729482|497037|P1|STARTED|Overall Study||54
202600|NCT00729521|497047|P3|NOT COMPLETED|Overall Study||0
202601|NCT00729521|497048|P2|NOT COMPLETED|Overall Study||0
202602|NCT00729521|497049|P1|NOT COMPLETED|Overall Study||0
202603|NCT00729521|497047|P3|COMPLETED|Overall Study|Average annual population over 65 years old.|7701
202604|NCT00729521|497048|P2|COMPLETED|Overall Study|Average annual population over 65 years old.|14842
202605|NCT00729521|497049|P1|COMPLETED|Overall Study|Average annual population over 65 years old.|12494
202606|NCT00729521|497047|P3|STARTED|Overall Study|5 communities in Facilitative System with average annual pop. of 7,701 residents over 65 years.|7701
202607|NCT00729521|497048|P2|STARTED|Overall Study|Five communities with average annual population of 14,842 residents over 65 years old.|14842
202608|NCT00729521|497049|P1|STARTED|Overall Study|10 communities in Control with average annual population of 12,494 residents over 65 years old.|12494
202609|NCT00729560|497057|P1|NOT COMPLETED|Overall Study||3
202610|NCT00729560|497057|P1|COMPLETED|Overall Study||5
202611|NCT00729560|497057|P1|STARTED|Overall Study|Arm assignment can not be determined as study was ended prior to unblinding and no key found.|8
202612|NCT00729612|497061|P1|NOT COMPLETED|Overall Study||10
202613|NCT00729612|497061|P1|COMPLETED|Overall Study||53
202614|NCT00729612|497061|P1|Died After Cycle 2 Before Response Eval|Overall Study||1
202615|NCT00729612|497061|P1|Received Cycle 2|Overall Study||54
202616|NCT00729612|497061|P1|Did Not Receive Cycle 2|Overall Study||7
202617|NCT00729612|497061|P1|Received Cycle 1|Overall Study||62
202618|NCT00729612|497061|P1|Died Before Cycle 1|Overall Study||1
202619|NCT00729612|497061|P1|STARTED|Overall Study||63
202620|NCT00729651|497070|P2|NOT COMPLETED|Overall Study||18
202621|NCT00729651|497071|P1|NOT COMPLETED|Overall Study||19
202622|NCT00729651|497070|P2|COMPLETED|Overall Study||152
202623|NCT00729651|497071|P1|COMPLETED|Overall Study||154
202624|NCT00729651|497070|P2|STARTED|Overall Study||170
202625|NCT00729651|497071|P1|STARTED|Overall Study||173
202626|NCT00729677|497083|P1|NOT COMPLETED|Overall Study||0
202627|NCT00729677|497083|P1|COMPLETED|Overall Study||64
202628|NCT00729677|497083|P1|STARTED|Overall Study||64
202629|NCT00729690|497097|P3|NOT COMPLETED|Overall Study||2
202630|NCT00729690|497098|P2|NOT COMPLETED|Overall Study||2
202631|NCT00729690|497099|P1|NOT COMPLETED|Overall Study||0
202632|NCT00729690|497097|P3|COMPLETED|Overall Study||14
202633|NCT00729690|497098|P2|COMPLETED|Overall Study||14
202634|NCT00729690|497099|P1|COMPLETED|Overall Study||16
202635|NCT00729690|497097|P3|STARTED|Overall Study||16
202636|NCT00729690|497098|P2|STARTED|Overall Study||16
202637|NCT00729690|497099|P1|STARTED|Overall Study||16
202638|NCT00729781|497116|P1|NOT COMPLETED|Long-term Follow-up Study||0
202639|NCT00729781|497116|P1|COMPLETED|Long-term Follow-up Study|All subjects completed the original study, but 3 did not consent to enroll in the follow-up study.|42
202640|NCT00729781|497116|P1|STARTED|Long-term Follow-up Study|Enrollment in the long-term follow-up required contact and a new Informed Consent.|42
202641|NCT00729781|497116|P1|NOT COMPLETED|Original Study||0
202642|NCT00729781|497116|P1|COMPLETED|Original Study||45
202643|NCT00729781|497116|P1|STARTED|Original Study||45
202644|NCT00729807|497122|P1|NOT COMPLETED|Overall Study||0
202645|NCT00729807|497122|P1|COMPLETED|Overall Study||6
202646|NCT00729807|497122|P1|STARTED|Overall Study||6
202647|NCT00721253|497128|P3|NOT COMPLETED|Overall Study||0
202648|NCT00721253|497129|P2|NOT COMPLETED|Overall Study||0
202649|NCT00721253|497130|P1|NOT COMPLETED|Overall Study||0
202650|NCT00721253|497128|P3|COMPLETED|Overall Study||0
202651|NCT00721253|497129|P2|COMPLETED|Overall Study||22
202652|NCT00721253|497130|P1|COMPLETED|Overall Study||20
202653|NCT00721253|497128|P3|STARTED|Overall Study|There were no subjects that were implanted with the Tecnis lens.|0
202654|NCT00721253|497129|P2|STARTED|Overall Study||22
202655|NCT00721253|497130|P1|STARTED|Overall Study||20
202656|NCT00721279|497142|P2|NOT COMPLETED|Overall Study||24
202657|NCT00721279|497143|P1|NOT COMPLETED|Overall Study||36
202658|NCT00721279|497142|P2|COMPLETED|Overall Study||73
202659|NCT00721279|497143|P1|COMPLETED|Overall Study||416
202660|NCT00721279|497142|P2|STARTED|Overall Study||97
202661|NCT00721279|497143|P1|STARTED|Overall Study||452
202662|NCT00721357|497157|P2|NOT COMPLETED|Overall Study||0
202663|NCT00721357|497158|P1|NOT COMPLETED|Overall Study||0
202664|NCT00721357|497157|P2|COMPLETED|Overall Study||15
202665|NCT00721357|497158|P1|COMPLETED|Overall Study||15
202666|NCT00721357|497157|P2|STARTED|Overall Study||15
202667|NCT00721357|497158|P1|STARTED|Overall Study||15
202668|NCT00721396|497168|P4|NOT COMPLETED|Overall Study||10
202669|NCT00721396|497169|P3|NOT COMPLETED|Overall Study||10
202670|NCT00721396|497170|P2|NOT COMPLETED|Overall Study||36
202671|NCT00721396|497171|P1|NOT COMPLETED|Overall Study||30
202672|NCT00721396|497168|P4|COMPLETED|Overall Study||302
202673|NCT00721396|497169|P3|COMPLETED|Overall Study||308
202674|NCT00721396|497170|P2|COMPLETED|Overall Study||592
202675|NCT00721396|497171|P1|COMPLETED|Overall Study||597
202676|NCT00721396|497168|P4|STARTED|Overall Study||312
202677|NCT00721396|497169|P3|STARTED|Overall Study||318
202678|NCT00721396|497170|P2|STARTED|Overall Study||628
202679|NCT00721396|497171|P1|STARTED|Overall Study||627
202680|NCT00721409|497210|P3|NOT COMPLETED|Overall Study||81
202681|NCT00721409|497211|P2|NOT COMPLETED|Overall Study||84
202682|NCT00721409|497212|P1|NOT COMPLETED|Overall Study||12
202683|NCT00721409|497210|P3|COMPLETED|Overall Study||0
202684|NCT00721409|497211|P2|COMPLETED|Overall Study||0
202685|NCT00721409|497212|P1|COMPLETED|Overall Study||0
202686|NCT00721409|497210|P3|Treated|Overall Study||77
202687|NCT00721409|497211|P2|Treated|Overall Study||83
202688|NCT00721409|497212|P1|Treated|Overall Study||12
202689|NCT00721409|497210|P3|STARTED|Overall Study||81
202690|NCT00721409|497211|P2|STARTED|Overall Study||84
202691|NCT00721409|497212|P1|STARTED|Overall Study||12
202692|NCT00721500|497335|P4|NOT COMPLETED|Period Three||0
202693|NCT00721500|497336|P3|NOT COMPLETED|Period Three||0
202694|NCT00721500|497337|P2|NOT COMPLETED|Period Three||0
202695|NCT00721500|497338|P1|NOT COMPLETED|Period Three||0
202696|NCT00721500|497335|P4|COMPLETED|Period Three||6
202697|NCT00721500|497336|P3|COMPLETED|Period Three||6
202698|NCT00721500|497337|P2|COMPLETED|Period Three||7
202699|NCT00721500|497338|P1|COMPLETED|Period Three||6
202700|NCT00721500|497335|P4|STARTED|Period Three||6
202701|NCT00721500|497336|P3|STARTED|Period Three||6
202702|NCT00721500|497337|P2|STARTED|Period Three||7
202703|NCT00721500|497338|P1|STARTED|Period Three||6
202704|NCT00721500|497335|P4|NOT COMPLETED|Period Two||0
202705|NCT00721500|497336|P3|NOT COMPLETED|Period Two||0
202706|NCT00721500|497337|P2|NOT COMPLETED|Period Two||0
202707|NCT00721500|497338|P1|NOT COMPLETED|Period Two||0
202708|NCT00721500|497335|P4|COMPLETED|Period Two||6
202709|NCT00721500|497336|P3|COMPLETED|Period Two||6
202710|NCT00721500|497337|P2|COMPLETED|Period Two||7
202711|NCT00721500|497338|P1|COMPLETED|Period Two||6
202712|NCT00721500|497335|P4|STARTED|Period Two||6
202713|NCT00721500|497336|P3|STARTED|Period Two||6
202714|NCT00721500|497337|P2|STARTED|Period Two||7
202715|NCT00721500|497338|P1|STARTED|Period Two||6
202716|NCT00721500|497335|P4|NOT COMPLETED|Period One||0
202717|NCT00721500|497336|P3|NOT COMPLETED|Period One||0
202718|NCT00721500|497337|P2|NOT COMPLETED|Period One||0
202719|NCT00721500|497338|P1|NOT COMPLETED|Period One||0
202720|NCT00721500|497335|P4|COMPLETED|Period One||6
202721|NCT00721500|497336|P3|COMPLETED|Period One||6
202722|NCT00721500|497337|P2|COMPLETED|Period One||7
202723|NCT00721500|497338|P1|COMPLETED|Period One||6
202724|NCT00721500|497335|P4|STARTED|Period One||6
202725|NCT00721500|497336|P3|STARTED|Period One||6
202726|NCT00721500|497337|P2|STARTED|Period One||7
202727|NCT00721500|497338|P1|STARTED|Period One||6
202728|NCT00721539|497356|P1|NOT COMPLETED|Overall Study||0
202729|NCT00721539|497356|P1|COMPLETED|Overall Study||9
202730|NCT00721539|497356|P1|STARTED|Overall Study||9
202731|NCT00721578|497363|P2|NOT COMPLETED|Overall Study||2
202732|NCT00721578|497364|P1|NOT COMPLETED|Overall Study||2
202733|NCT00721578|497363|P2|COMPLETED|Overall Study||9
202734|NCT00721578|497364|P1|COMPLETED|Overall Study||10
202735|NCT00721578|497363|P2|STARTED|Overall Study||11
202736|NCT00721578|497364|P1|STARTED|Overall Study||12
202737|NCT00721617|497376|P1|NOT COMPLETED|8 Hours Into Intralipid/Dextrose||0
202738|NCT00721617|497376|P1|COMPLETED|8 Hours Into Intralipid/Dextrose||12
202739|NCT00721617|497376|P1|STARTED|8 Hours Into Intralipid/Dextrose||12
202740|NCT00721617|497376|P1|NOT COMPLETED|4 Hours Into Intralipid/Dextrose||0
202741|NCT00721617|497376|P1|COMPLETED|4 Hours Into Intralipid/Dextrose||12
202742|NCT00721617|497376|P1|STARTED|4 Hours Into Intralipid/Dextrose||12
202743|NCT00721617|497376|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||0
202744|NCT00721617|497376|P1|COMPLETED|0 Hour (Baseline) of Intralipid/Dextrose||12
202745|NCT00721617|497376|P1|STARTED|0 Hour (Baseline) of Intralipid/Dextrose||12
202746|NCT00721617|497376|P1|NOT COMPLETED|8 Hours Into Dextrose Infusion||0
202747|NCT00721617|497376|P1|COMPLETED|8 Hours Into Dextrose Infusion||12
202748|NCT00721617|497376|P1|STARTED|8 Hours Into Dextrose Infusion||12
202749|NCT00721617|497376|P1|NOT COMPLETED|4 Hours Into Dextrose Infusion||0
202750|NCT00721617|497376|P1|COMPLETED|4 Hours Into Dextrose Infusion||12
202751|NCT00721617|497376|P1|STARTED|4 Hours Into Dextrose Infusion||12
202752|NCT00721617|497376|P1|NOT COMPLETED|0 Hour (Baseline) of Dextrose Infusion||0
202753|NCT00721617|497376|P1|COMPLETED|0 Hour (Baseline) of Dextrose Infusion||12
202754|NCT00721617|497376|P1|STARTED|0 Hour (Baseline) of Dextrose Infusion||12
202755|NCT00721617|497376|P1|NOT COMPLETED|8 Hours Into Intralipid Infusion||0
202756|NCT00721617|497376|P1|COMPLETED|8 Hours Into Intralipid Infusion||12
202757|NCT00721617|497376|P1|STARTED|8 Hours Into Intralipid Infusion||12
202758|NCT00721617|497376|P1|NOT COMPLETED|4 Hours Into Intralipid Infusion||0
202759|NCT00721617|497376|P1|COMPLETED|4 Hours Into Intralipid Infusion||12
202760|NCT00721617|497376|P1|STARTED|4 Hours Into Intralipid Infusion||12
202761|NCT00721617|497376|P1|NOT COMPLETED|0 Hour (Baseline) of Intralipid Infusion||0
202762|NCT00721617|497376|P1|COMPLETED|0 Hour (Baseline) of Intralipid Infusion||12
202763|NCT00721617|497376|P1|STARTED|0 Hour (Baseline) of Intralipid Infusion||12
202764|NCT00721617|497376|P1|NOT COMPLETED|8 Hours Into Saline Infusion||0
202765|NCT00721617|497376|P1|COMPLETED|8 Hours Into Saline Infusion||12
202766|NCT00721617|497376|P1|STARTED|8 Hours Into Saline Infusion||12
202767|NCT00721617|497376|P1|NOT COMPLETED|4 Hours Into Saline Infusion||0
202768|NCT00721617|497376|P1|COMPLETED|4 Hours Into Saline Infusion||12
202769|NCT00721617|497376|P1|STARTED|4 Hours Into Saline Infusion||12
202770|NCT00721617|497376|P1|NOT COMPLETED|0 Hour (Baseline) of Saline Infusion||0
202771|NCT00721617|497376|P1|COMPLETED|0 Hour (Baseline) of Saline Infusion||12
202772|NCT00721617|497376|P1|STARTED|0 Hour (Baseline) of Saline Infusion||12
202773|NCT00721630|497400|P1|NOT COMPLETED|Overall Study||1
202774|NCT00721630|497400|P1|COMPLETED|Overall Study||23
202775|NCT00721630|497400|P1|STARTED|Overall Study||24
202776|NCT00721734|497410|P5|NOT COMPLETED|Overall Study||6
202777|NCT00721734|497411|P4|NOT COMPLETED|Overall Study||6
202778|NCT00721734|497412|P3|NOT COMPLETED|Overall Study||8
202779|NCT00721734|497413|P2|NOT COMPLETED|Overall Study||12
202780|NCT00721734|497414|P1|NOT COMPLETED|Overall Study||8
202781|NCT00721734|497410|P5|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
202782|NCT00721734|497411|P4|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
202783|NCT00721734|497412|P3|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|2
202784|NCT00721734|497413|P2|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|0
202785|NCT00721734|497414|P1|COMPLETED|Overall Study|Completed 12 cycles of carfilzomib treatment|4
202786|NCT00721734|497410|P5|STARTED|Overall Study||8
202787|NCT00721734|497411|P4|STARTED|Overall Study||8
202788|NCT00721734|497412|P3|STARTED|Overall Study||10
202789|NCT00721734|497413|P2|STARTED|Overall Study||12
202790|NCT00721734|497414|P1|STARTED|Overall Study||12
202791|NCT00721955|497529|P3|NOT COMPLETED|Overall Study||2
202792|NCT00721955|497530|P2|NOT COMPLETED|Overall Study||0
202793|NCT00721955|497531|P1|NOT COMPLETED|Overall Study||0
202794|NCT00721955|497529|P3|COMPLETED|Overall Study||103
202795|NCT00721955|497530|P2|COMPLETED|Overall Study||104
202796|NCT00721955|497531|P1|COMPLETED|Overall Study||105
202797|NCT00721955|497529|P3|STARTED|Overall Study||105
202798|NCT00721955|497530|P2|STARTED|Overall Study||104
202799|NCT00721955|497531|P1|STARTED|Overall Study||105
202800|NCT00721968|497547|P2|NOT COMPLETED|Overall Study||0
202801|NCT00721968|497548|P1|NOT COMPLETED|Overall Study||2
202802|NCT00721968|497547|P2|COMPLETED|Overall Study||17
202803|NCT00721968|497548|P1|COMPLETED|Overall Study||25
202804|NCT00721968|497547|P2|STARTED|Overall Study||17
202805|NCT00721968|497548|P1|STARTED|Overall Study||27
202806|NCT00722020|497558|P2|NOT COMPLETED|Overall Study||0
202807|NCT00722020|497559|P1|NOT COMPLETED|Overall Study||0
202808|NCT00722020|497558|P2|COMPLETED|Overall Study||24
202809|NCT00722020|497559|P1|COMPLETED|Overall Study||19
202810|NCT00722020|497558|P2|STARTED|Overall Study||24
202811|NCT00722020|497559|P1|STARTED|Overall Study||19
202812|NCT00722072|497567|P1|NOT COMPLETED|Overall Study||3
202813|NCT00722072|497567|P1|COMPLETED|Overall Study||9
202814|NCT00722072|497567|P1|STARTED|Overall Study||12
202815|NCT00722124|497574|P3|NOT COMPLETED|Overall Study||20
202816|NCT00722124|497575|P2|NOT COMPLETED|Overall Study||14
202817|NCT00722124|497576|P1|NOT COMPLETED|Overall Study||17
202818|NCT00722124|497574|P3|COMPLETED|Overall Study||20
202819|NCT00722124|497575|P2|COMPLETED|Overall Study||26
202820|NCT00722124|497576|P1|COMPLETED|Overall Study||23
202821|NCT00722124|497574|P3|STARTED|Overall Study||40
202822|NCT00722124|497575|P2|STARTED|Overall Study||40
202823|NCT00722124|497576|P1|STARTED|Overall Study||40
202824|NCT00722137|497586|P2|NOT COMPLETED|Overall Study||45
202825|NCT00722137|497587|P1|NOT COMPLETED|Overall Study||48
202826|NCT00722137|497586|P2|COMPLETED|Overall Study||199
202827|NCT00722137|497587|P1|COMPLETED|Overall Study||195
202828|NCT00722137|497586|P2|STARTED|Overall Study||244
202829|NCT00722137|497587|P1|STARTED|Overall Study||243
202830|NCT00722371|497618|P7|NOT COMPLETED|Overall Study||51
202831|NCT00722371|497619|P6|NOT COMPLETED|Overall Study||53
202832|NCT00722371|497620|P5|NOT COMPLETED|Overall Study||48
202833|NCT00722371|497621|P4|NOT COMPLETED|Overall Study||63
202834|NCT00722371|497622|P3|NOT COMPLETED|Overall Study||65
202835|NCT00722371|497623|P2|NOT COMPLETED|Overall Study||72
202836|NCT00722371|497624|P1|NOT COMPLETED|Overall Study||56
202837|NCT00722371|497618|P7|COMPLETED|Overall Study||179
202838|NCT00722371|497619|P6|COMPLETED|Overall Study||178
202839|NCT00722371|497620|P5|COMPLETED|Overall Study||182
202840|NCT00722371|497621|P4|COMPLETED|Overall Study||167
202841|NCT00722371|497622|P3|COMPLETED|Overall Study||168
202842|NCT00722371|497623|P2|COMPLETED|Overall Study||158
202843|NCT00722371|497624|P1|COMPLETED|Overall Study||175
202844|NCT00722371|497618|P7|STARTED|Overall Study||230
202845|NCT00722371|497619|P6|STARTED|Overall Study||231
202846|NCT00722371|497620|P5|STARTED|Overall Study||230
202847|NCT00722371|497621|P4|STARTED|Overall Study||230
202848|NCT00722371|497622|P3|STARTED|Overall Study||233
202849|NCT00722371|497623|P2|STARTED|Overall Study||230
202850|NCT00722371|497624|P1|STARTED|Overall Study||231
202851|NCT00722423|497677|P2|NOT COMPLETED|Overall Study||1
202852|NCT00722423|497678|P1|NOT COMPLETED|Overall Study||0
202853|NCT00722423|497677|P2|COMPLETED|Overall Study||181
202854|NCT00722423|497678|P1|COMPLETED|Overall Study||182
202855|NCT00722423|497677|P2|STARTED|Overall Study||182
202856|NCT00722423|497678|P1|STARTED|Overall Study||182
202857|NCT00722436|497688|P2|NOT COMPLETED|Overall Study||0
202858|NCT00722436|497689|P1|NOT COMPLETED|Overall Study||0
202859|NCT00722436|497688|P2|COMPLETED|Overall Study||11
202860|NCT00722436|497689|P1|COMPLETED|Overall Study||9
202861|NCT00722436|497688|P2|STARTED|Overall Study||11
202862|NCT00722436|497689|P1|STARTED|Overall Study||9
202863|NCT00729833|497701|P4|NOT COMPLETED|Overall Study||6
202864|NCT00729833|497702|P3|NOT COMPLETED|Overall Study||12
202865|NCT00729833|497703|P2|NOT COMPLETED|Overall Study||7
202866|NCT00729833|497704|P1|NOT COMPLETED|Overall Study||20
202867|NCT00729833|497701|P4|COMPLETED|Overall Study||0
202868|NCT00729833|497702|P3|COMPLETED|Overall Study||0
202869|NCT00729833|497703|P2|COMPLETED|Overall Study||0
202870|NCT00729833|497704|P1|COMPLETED|Overall Study||0
202871|NCT00729833|497701|P4|STARTED|Overall Study||6
202872|NCT00729833|497702|P3|STARTED|Overall Study||12
202873|NCT00729833|497703|P2|STARTED|Overall Study||7
202874|NCT00729833|497704|P1|STARTED|Overall Study||20
202875|NCT00729846|497745|P2|NOT COMPLETED|Overall Study||0
202876|NCT00729846|497746|P1|NOT COMPLETED|Overall Study||0
202877|NCT00729846|497745|P2|COMPLETED|Overall Study||11
202878|NCT00729846|497746|P1|COMPLETED|Overall Study||11
202879|NCT00729846|497745|P2|STARTED|Overall Study||11
202880|NCT00729846|497746|P1|STARTED|Overall Study||11
202881|NCT00729859|497755|P3|NOT COMPLETED|Overall Study||0
202882|NCT00729859|497756|P2|NOT COMPLETED|Overall Study||2
202883|NCT00729859|497757|P1|NOT COMPLETED|Overall Study||0
202884|NCT00729859|497755|P3|COMPLETED|Overall Study||8
202885|NCT00729859|497756|P2|COMPLETED|Overall Study||6
202886|NCT00729859|497757|P1|COMPLETED|Overall Study||8
202887|NCT00729859|497755|P3|STARTED|Overall Study||8
202888|NCT00729859|497756|P2|STARTED|Overall Study||8
202889|NCT00729859|497757|P1|STARTED|Overall Study||8
202890|NCT00729924|497792|P1|NOT COMPLETED|Overall Study||0
202891|NCT00729924|497792|P1|COMPLETED|Overall Study||40
202892|NCT00729924|497792|P1|STARTED|Overall Study||40
202893|NCT00729937|497805|P6|NOT COMPLETED|Overall Study||37
202894|NCT00729937|497806|P5|NOT COMPLETED|Overall Study||28
202895|NCT00729937|497807|P4|NOT COMPLETED|Overall Study||34
202896|NCT00729937|497808|P3|NOT COMPLETED|Overall Study||29
202897|NCT00729937|497809|P2|NOT COMPLETED|Overall Study||88
202898|NCT00729937|497810|P1|NOT COMPLETED|Overall Study||74
202899|NCT00729937|497805|P6|COMPLETED|Overall Study||214
202900|NCT00729937|497806|P5|COMPLETED|Overall Study||221
202901|NCT00729937|497807|P4|COMPLETED|Overall Study||215
202902|NCT00729937|497808|P3|COMPLETED|Overall Study||222
202903|NCT00729937|497809|P2|COMPLETED|Overall Study||548
202904|NCT00729937|497810|P1|COMPLETED|Overall Study||555
202905|NCT00729937|497805|P6|STARTED|Overall Study||251
202906|NCT00729937|497806|P5|STARTED|Overall Study||249
202907|NCT00729937|497807|P4|STARTED|Overall Study||249
202908|NCT00729937|497808|P3|STARTED|Overall Study||251
202909|NCT00729937|497809|P2|STARTED|Overall Study||636
202910|NCT00729937|497810|P1|STARTED|Overall Study||629
202911|NCT00730015|498007|P3|NOT COMPLETED|Overall Study||32
202912|NCT00730015|498008|P2|NOT COMPLETED|Overall Study||40
202913|NCT00730015|498009|P1|NOT COMPLETED|Overall Study||31
202914|NCT00730015|498007|P3|COMPLETED|Overall Study||177
202915|NCT00730015|498008|P2|COMPLETED|Overall Study||177
202916|NCT00730015|498009|P1|COMPLETED|Overall Study||186
202917|NCT00730015|498007|P3|STARTED|Overall Study||209
202918|NCT00730015|498008|P2|STARTED|Overall Study||217
202919|NCT00730015|498009|P1|STARTED|Overall Study||217
202920|NCT00730028|498048|P5|NOT COMPLETED|Overall Study||82
202921|NCT00730028|498049|P4|NOT COMPLETED|Overall Study||56
202922|NCT00730028|498050|P3|NOT COMPLETED|Overall Study||45
202923|NCT00730028|498051|P2|NOT COMPLETED|Overall Study||66
202924|NCT00730028|498052|P1|NOT COMPLETED|Overall Study||60
202925|NCT00730028|498048|P5|COMPLETED|Overall Study||175
202926|NCT00730028|498049|P4|COMPLETED|Overall Study||207
202927|NCT00730028|498050|P3|COMPLETED|Overall Study||221
202928|NCT00730028|498051|P2|COMPLETED|Overall Study||194
202929|NCT00730028|498052|P1|COMPLETED|Overall Study||204
202930|NCT00730028|498048|P5|STARTED|Overall Study||257
202931|NCT00730028|498049|P4|STARTED|Overall Study||263
202932|NCT00730028|498050|P3|STARTED|Overall Study||266
202933|NCT00730028|498051|P2|STARTED|Overall Study||260
202934|NCT00730028|498052|P1|STARTED|Overall Study||264
202935|NCT00730041|498101|P2|NOT COMPLETED|Overall Study||2
202936|NCT00730041|498102|P1|NOT COMPLETED|Overall Study||0
202937|NCT00730041|498101|P2|COMPLETED|Overall Study|One subject did not return for the final PSG or final visit, and one missed only the final visit.|23
202938|NCT00730041|498102|P1|COMPLETED|Overall Study||26
202939|NCT00730041|498101|P2|STARTED|Overall Study|4/25 (16.0%) female, 21/25 (84.0%) male|25
202940|NCT00730041|498102|P1|STARTED|Overall Study|4/26 (15.4%) female, 22/26 (84.6%) male|26
202941|NCT00730132|498120|P1|NOT COMPLETED|Overall Study||155
202942|NCT00730132|498120|P1|COMPLETED|Overall Study||557
202943|NCT00730132|498120|P1|STARTED|Overall Study||712
202944|NCT00731614|498138|P2|NOT COMPLETED|Overall Study||13
202945|NCT00731614|498139|P1|NOT COMPLETED|Overall Study||7
202946|NCT00731614|498138|P2|COMPLETED|Overall Study||18
202947|NCT00731614|498139|P1|COMPLETED|Overall Study||16
202948|NCT00731614|498138|P2|12 Weeks Posttreatment|Overall Study||23
202949|NCT00731614|498139|P1|12 Weeks Posttreatment|Overall Study||18
202950|NCT00731614|498138|P2|End of Treatment|Overall Study||24
202951|NCT00731614|498139|P1|End of Treatment|Overall Study||16
202952|NCT00731614|498138|P2|STARTED|Overall Study||31
202953|NCT00731614|498139|P1|STARTED|Overall Study||23
202954|NCT00731640|498147|P2|NOT COMPLETED|Overall Study||0
202955|NCT00731640|498148|P1|NOT COMPLETED|Overall Study||0
202956|NCT00731640|498147|P2|COMPLETED|Overall Study||32
202957|NCT00731640|498148|P1|COMPLETED|Overall Study||20
202958|NCT00731640|498147|P2|STARTED|Overall Study||32
202959|NCT00731640|498148|P1|STARTED|Overall Study||20
202960|NCT00731653|498160|P1|NOT COMPLETED|Overall Study||9
202961|NCT00731653|498160|P1|COMPLETED|Overall Study||72
202962|NCT00731653|498160|P1|STARTED|Overall Study||81
202963|NCT00731666|498164|P1|NOT COMPLETED|Overall Study||12
202964|NCT00731666|498164|P1|COMPLETED|Overall Study||28
202965|NCT00731666|498164|P1|STARTED|Overall Study||40
202966|NCT00731679|498172|P2|NOT COMPLETED|Overall Study||26
202967|NCT00731679|498173|P1|NOT COMPLETED|Overall Study||22
202968|NCT00731679|498172|P2|COMPLETED|Overall Study||283
202969|NCT00731679|498173|P1|COMPLETED|Overall Study||292
202970|NCT00731679|498172|P2|STARTED|Overall Study||309
202971|NCT00731679|498173|P1|STARTED|Overall Study||314
202972|NCT00731692|498184|P3|NOT COMPLETED|Extension Phase||301
202973|NCT00731692|498185|P2|NOT COMPLETED|Extension Phase||196
202974|NCT00731692|498186|P1|NOT COMPLETED|Extension Phase||74
202975|NCT00731692|498184|P3|COMPLETED|Extension Phase||0
202976|NCT00731692|498185|P2|COMPLETED|Extension Phase||0
202977|NCT00731692|498186|P1|COMPLETED|Extension Phase||0
202978|NCT00731692|498184|P3|STARTED|Extension Phase||301
202979|NCT00731692|498185|P2|STARTED|Extension Phase||196
202980|NCT00731692|498186|P1|STARTED|Extension Phase||74
202981|NCT00731692|498184|P3|NOT COMPLETED|Core Study (36 Months)||170
202982|NCT00731692|498185|P2|NOT COMPLETED|Core Study (36 Months)||116
202983|NCT00731692|498186|P1|NOT COMPLETED|Core Study (36 Months)||68
202984|NCT00731692|498184|P3|COMPLETED|Core Study (36 Months)||317
202985|NCT00731692|498185|P2|COMPLETED|Core Study (36 Months)||220
202986|NCT00731692|498186|P1|COMPLETED|Core Study (36 Months)||79
202987|NCT00731692|498184|P3|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
202988|NCT00731692|498185|P2|Post Protocol Amendment 5 Switch|Core Study (36 Months)|post protocol amendment 121 patients switch to 0.5 mg dose from 125mg dose|121
202989|NCT00731692|498186|P1|Post Protocol Amendment 5 Switch|Core Study (36 Months)||0
202990|NCT00731692|498184|P3|Pharmacokinetic Analysis Set|Core Study (36 Months)||0
202991|NCT00731692|498185|P2|Pharmacokinetic Analysis Set|Core Study (36 Months)||249
202992|NCT00731692|498186|P1|Pharmacokinetic Analysis Set|Core Study (36 Months)||102
202993|NCT00731692|498184|P3|Full Analysis Set (FAS)|Core Study (36 Months)||487
202994|NCT00731692|498185|P2|Full Analysis Set (FAS)|Core Study (36 Months)||336
202995|NCT00731692|498186|P1|Full Analysis Set (FAS)|Core Study (36 Months)||0
202996|NCT00731692|498184|P3|Safety Set (SAF)|Core Study (36 Months)||487
202997|NCT00731692|498185|P2|Safety Set (SAF)|Core Study (36 Months)||336
202998|NCT00731692|498186|P1|Safety Set (SAF)|Core Study (36 Months)||0
202999|NCT00731692|498184|P3|STARTED|Core Study (36 Months)||487
203000|NCT00731692|498185|P2|STARTED|Core Study (36 Months)||336
203001|NCT00731692|498186|P1|STARTED|Core Study (36 Months)||147
203002|NCT00731731|498233|P3|NOT COMPLETED|Overall Study||3
203003|NCT00731731|498234|P2|NOT COMPLETED|Overall Study||0
203004|NCT00731731|498235|P1|NOT COMPLETED|Overall Study||0
203005|NCT00731731|498233|P3|COMPLETED|Overall Study||107
203006|NCT00731731|498234|P2|COMPLETED|Overall Study||3
203007|NCT00731731|498235|P1|COMPLETED|Overall Study||12
203008|NCT00731731|498233|P3|STARTED|Overall Study||110
203009|NCT00731731|498234|P2|STARTED|Overall Study||3
203010|NCT00731731|498235|P1|STARTED|Overall Study||12
203011|NCT00731783|498252|P2|NOT COMPLETED|12 Month Follow-Up Visit||7
203012|NCT00731783|498253|P1|NOT COMPLETED|12 Month Follow-Up Visit||6
203013|NCT00731783|498252|P2|COMPLETED|12 Month Follow-Up Visit||58
203014|NCT00731783|498253|P1|COMPLETED|12 Month Follow-Up Visit||68
203015|NCT00731783|498252|P2|STARTED|12 Month Follow-Up Visit||65
203016|NCT00731783|498253|P1|STARTED|12 Month Follow-Up Visit||74
203017|NCT00731783|498252|P2|NOT COMPLETED|Six Month Follow-Up Visit||3
203018|NCT00731783|498253|P1|NOT COMPLETED|Six Month Follow-Up Visit||6
203019|NCT00731783|498252|P2|COMPLETED|Six Month Follow-Up Visit||64
203020|NCT00731783|498253|P1|COMPLETED|Six Month Follow-Up Visit||71
203021|NCT00731783|498252|P2|STARTED|Six Month Follow-Up Visit||67
203022|NCT00731783|498253|P1|STARTED|Six Month Follow-Up Visit||77
203023|NCT00731783|498252|P2|NOT COMPLETED|Three Month Follow-Up Visit||16
203024|NCT00731783|498253|P1|NOT COMPLETED|Three Month Follow-Up Visit||7
203025|NCT00731783|498252|P2|COMPLETED|Three Month Follow-Up Visit||57
203026|NCT00731783|498253|P1|COMPLETED|Three Month Follow-Up Visit||72
203027|NCT00731783|498252|P2|STARTED|Three Month Follow-Up Visit||73
203028|NCT00731783|498253|P1|STARTED|Three Month Follow-Up Visit||79
203029|NCT00731783|498252|P2|NOT COMPLETED|One Month Follow-Up Visit||22
203030|NCT00731783|498253|P1|NOT COMPLETED|One Month Follow-Up Visit||14
203031|NCT00731783|498252|P2|COMPLETED|One Month Follow-Up Visit||69
203032|NCT00731783|498253|P1|COMPLETED|One Month Follow-Up Visit||78
203033|NCT00731783|498252|P2|STARTED|One Month Follow-Up Visit||91
203034|NCT00731783|498253|P1|STARTED|One Month Follow-Up Visit||92
203035|NCT00731822|498275|P2|NOT COMPLETED|Overall Study||1
203036|NCT00731822|498276|P1|NOT COMPLETED|Overall Study||4
203037|NCT00731822|498275|P2|COMPLETED|Overall Study||39
203038|NCT00731822|498276|P1|COMPLETED|Overall Study||16
203039|NCT00731822|498275|P2|STARTED|Overall Study||40
203040|NCT00731822|498276|P1|STARTED|Overall Study||20
203041|NCT00731874|498290|P2|NOT COMPLETED|Overall Study||0
203042|NCT00731874|498291|P1|NOT COMPLETED|Overall Study||0
203043|NCT00731874|498290|P2|COMPLETED|Overall Study||13
203044|NCT00731874|498291|P1|COMPLETED|Overall Study||10
203045|NCT00731874|498290|P2|STARTED|Overall Study||13
203046|NCT00731874|498291|P1|STARTED|Overall Study||10
203047|NCT00731939|498299|P1|NOT COMPLETED|Overall Study||34
203048|NCT00731939|498299|P1|COMPLETED|Overall Study||90
203049|NCT00731939|498299|P1|STARTED|Overall Study||124
203050|NCT00732030|498347|P1|NOT COMPLETED|Overall Study||2
203051|NCT00732030|498347|P1|COMPLETED|Overall Study||24
203052|NCT00732030|498347|P1|STARTED|Overall Study||26
203053|NCT00732069|498354|P6|NOT COMPLETED|Third Study Drug||0
203054|NCT00732069|498355|P5|NOT COMPLETED|Third Study Drug||0
203055|NCT00732069|498356|P4|NOT COMPLETED|Third Study Drug||0
203056|NCT00732069|498357|P3|NOT COMPLETED|Third Study Drug||0
203057|NCT00732069|498358|P2|NOT COMPLETED|Third Study Drug||0
203058|NCT00732069|498359|P1|NOT COMPLETED|Third Study Drug||0
203059|NCT00732069|498354|P6|COMPLETED|Third Study Drug||2
203060|NCT00732069|498355|P5|COMPLETED|Third Study Drug||3
203061|NCT00732069|498356|P4|COMPLETED|Third Study Drug||2
203062|NCT00732069|498357|P3|COMPLETED|Third Study Drug||3
203063|NCT00732069|498358|P2|COMPLETED|Third Study Drug||3
203064|NCT00732069|498359|P1|COMPLETED|Third Study Drug||2
203065|NCT00732069|498354|P6|STARTED|Third Study Drug||2
203066|NCT00732069|498355|P5|STARTED|Third Study Drug||3
203067|NCT00732069|498356|P4|STARTED|Third Study Drug||2
203068|NCT00732069|498357|P3|STARTED|Third Study Drug||3
203069|NCT00732069|498358|P2|STARTED|Third Study Drug||3
203070|NCT00732069|498359|P1|STARTED|Third Study Drug||2
203071|NCT00732069|498354|P6|NOT COMPLETED|Washout After Second Study Drug||0
203072|NCT00732069|498355|P5|NOT COMPLETED|Washout After Second Study Drug||0
203073|NCT00732069|498356|P4|NOT COMPLETED|Washout After Second Study Drug||0
203074|NCT00732069|498357|P3|NOT COMPLETED|Washout After Second Study Drug||0
203075|NCT00732069|498358|P2|NOT COMPLETED|Washout After Second Study Drug||0
203076|NCT00732069|498359|P1|NOT COMPLETED|Washout After Second Study Drug||0
203077|NCT00732069|498354|P6|COMPLETED|Washout After Second Study Drug||2
203078|NCT00732069|498355|P5|COMPLETED|Washout After Second Study Drug||3
203079|NCT00732069|498356|P4|COMPLETED|Washout After Second Study Drug||2
203080|NCT00732069|498357|P3|COMPLETED|Washout After Second Study Drug||3
203081|NCT00732069|498358|P2|COMPLETED|Washout After Second Study Drug||3
203082|NCT00732069|498359|P1|COMPLETED|Washout After Second Study Drug||2
203083|NCT00732069|498354|P6|STARTED|Washout After Second Study Drug||2
203084|NCT00732069|498355|P5|STARTED|Washout After Second Study Drug||3
203085|NCT00732069|498356|P4|STARTED|Washout After Second Study Drug||2
203086|NCT00732069|498357|P3|STARTED|Washout After Second Study Drug||3
203087|NCT00732069|498358|P2|STARTED|Washout After Second Study Drug||3
203088|NCT00732069|498359|P1|STARTED|Washout After Second Study Drug||2
203089|NCT00732069|498354|P6|NOT COMPLETED|Second Study Drug||0
203090|NCT00732069|498355|P5|NOT COMPLETED|Second Study Drug||0
203091|NCT00732069|498356|P4|NOT COMPLETED|Second Study Drug||0
203092|NCT00732069|498357|P3|NOT COMPLETED|Second Study Drug||0
203093|NCT00732069|498358|P2|NOT COMPLETED|Second Study Drug||0
203094|NCT00732069|498359|P1|NOT COMPLETED|Second Study Drug||0
203095|NCT00732069|498354|P6|COMPLETED|Second Study Drug||2
203096|NCT00732069|498355|P5|COMPLETED|Second Study Drug||3
203097|NCT00732069|498356|P4|COMPLETED|Second Study Drug||2
203098|NCT00732069|498357|P3|COMPLETED|Second Study Drug||3
203099|NCT00732069|498358|P2|COMPLETED|Second Study Drug||3
203100|NCT00732069|498359|P1|COMPLETED|Second Study Drug||2
203101|NCT00732069|498354|P6|STARTED|Second Study Drug||2
203102|NCT00732069|498355|P5|STARTED|Second Study Drug||3
203103|NCT00732069|498356|P4|STARTED|Second Study Drug||2
203104|NCT00732069|498357|P3|STARTED|Second Study Drug||3
203105|NCT00732069|498358|P2|STARTED|Second Study Drug||3
203106|NCT00732069|498359|P1|STARTED|Second Study Drug||2
203107|NCT00732069|498354|P6|NOT COMPLETED|Washout After First Study Drug||0
203108|NCT00732069|498355|P5|NOT COMPLETED|Washout After First Study Drug||0
203109|NCT00732069|498356|P4|NOT COMPLETED|Washout After First Study Drug||0
203110|NCT00732069|498357|P3|NOT COMPLETED|Washout After First Study Drug||0
203111|NCT00732069|498358|P2|NOT COMPLETED|Washout After First Study Drug||0
203112|NCT00732069|498359|P1|NOT COMPLETED|Washout After First Study Drug||1
203113|NCT00732069|498354|P6|COMPLETED|Washout After First Study Drug||2
203114|NCT00732069|498355|P5|COMPLETED|Washout After First Study Drug||3
203115|NCT00732069|498356|P4|COMPLETED|Washout After First Study Drug||2
203116|NCT00732069|498357|P3|COMPLETED|Washout After First Study Drug||3
203117|NCT00732069|498358|P2|COMPLETED|Washout After First Study Drug||3
203118|NCT00732069|498359|P1|COMPLETED|Washout After First Study Drug||2
203119|NCT00732069|498354|P6|STARTED|Washout After First Study Drug||2
203120|NCT00732069|498355|P5|STARTED|Washout After First Study Drug||3
203121|NCT00732069|498356|P4|STARTED|Washout After First Study Drug||2
203122|NCT00732069|498357|P3|STARTED|Washout After First Study Drug||3
203123|NCT00732069|498358|P2|STARTED|Washout After First Study Drug||3
203124|NCT00732069|498359|P1|STARTED|Washout After First Study Drug||3
203125|NCT00732069|498354|P6|NOT COMPLETED|First Study Drug||0
203126|NCT00732069|498355|P5|NOT COMPLETED|First Study Drug||0
203127|NCT00732069|498356|P4|NOT COMPLETED|First Study Drug||0
203128|NCT00732069|498357|P3|NOT COMPLETED|First Study Drug||0
203129|NCT00732069|498358|P2|NOT COMPLETED|First Study Drug||0
203130|NCT00732069|498359|P1|NOT COMPLETED|First Study Drug||0
203131|NCT00732069|498354|P6|COMPLETED|First Study Drug||2
203132|NCT00732069|498355|P5|COMPLETED|First Study Drug||3
203133|NCT00732069|498356|P4|COMPLETED|First Study Drug||2
203134|NCT00732069|498357|P3|COMPLETED|First Study Drug||3
203135|NCT00732069|498358|P2|COMPLETED|First Study Drug||3
203136|NCT00732069|498359|P1|COMPLETED|First Study Drug||3
203137|NCT00732069|498354|P6|STARTED|First Study Drug||2
203138|NCT00732069|498355|P5|STARTED|First Study Drug||3
203139|NCT00732069|498356|P4|STARTED|First Study Drug||2
203140|NCT00732069|498357|P3|STARTED|First Study Drug||3
203141|NCT00732069|498358|P2|STARTED|First Study Drug||3
203142|NCT00732069|498359|P1|STARTED|First Study Drug||3
203143|NCT00732160|498374|P4|NOT COMPLETED|Overall Study||2
203144|NCT00732160|498375|P3|NOT COMPLETED|Overall Study||3
203145|NCT00732160|498376|P2|NOT COMPLETED|Overall Study||4
203146|NCT00732160|498377|P1|NOT COMPLETED|Overall Study||5
203147|NCT00732160|498374|P4|COMPLETED|Overall Study||3
203148|NCT00732160|498375|P3|COMPLETED|Overall Study||3
203149|NCT00732160|498376|P2|COMPLETED|Overall Study||1
203150|NCT00732160|498377|P1|COMPLETED|Overall Study||2
203151|NCT00732160|498374|P4|LS Aldosterone|Overall Study||5
203152|NCT00732160|498375|P3|LS Aldosterone|Overall Study||6
203153|NCT00732160|498376|P2|LS Aldosterone|Overall Study||1
203154|NCT00732160|498377|P1|LS Aldosterone|Overall Study||2
203155|NCT00732160|498374|P4|LS Vehicle|Overall Study||5
203156|NCT00732160|498375|P3|LS Vehicle|Overall Study||6
203157|NCT00732160|498376|P2|LS Vehicle|Overall Study||1
203158|NCT00732160|498377|P1|LS Vehicle|Overall Study||2
203159|NCT00732160|498374|P4|HS Aldosterone|Overall Study||3
203160|NCT00732160|498375|P3|HS Aldosterone|Overall Study||3
203161|NCT00732160|498376|P2|HS Aldosterone|Overall Study||5
203162|NCT00732160|498377|P1|HS Aldosterone|Overall Study||7
203163|NCT00732160|498374|P4|HS Vehicle|Overall Study||3
203164|NCT00732160|498375|P3|HS Vehicle|Overall Study||3
203165|NCT00732160|498376|P2|HS Vehicle|Overall Study||5
203166|NCT00732160|498377|P1|HS Vehicle|Overall Study||7
203167|NCT00732160|498374|P4|STARTED|Overall Study||5
203168|NCT00732160|498375|P3|STARTED|Overall Study||6
203169|NCT00732160|498376|P2|STARTED|Overall Study||5
203170|NCT00732160|498377|P1|STARTED|Overall Study||7
203171|NCT00732199|498393|P2|NOT COMPLETED|Overall Study||26
203172|NCT00732199|498394|P1|NOT COMPLETED|Overall Study||34
203173|NCT00732199|498393|P2|COMPLETED|Overall Study||16
203174|NCT00732199|498394|P1|COMPLETED|Overall Study||16
203175|NCT00732199|498393|P2|STARTED|Overall Study||42
203176|NCT00732199|498394|P1|STARTED|Overall Study||50
203177|NCT00732212|498409|P2|NOT COMPLETED|Overall Study||0
203178|NCT00732212|498410|P1|NOT COMPLETED|Overall Study||0
203179|NCT00732212|498409|P2|COMPLETED|Overall Study||123
203180|NCT00732212|498410|P1|COMPLETED|Overall Study||112
203181|NCT00732212|498409|P2|Temporarily Suspended|Overall Study||50
203182|NCT00732212|498410|P1|Temporarily Suspended|Overall Study|Study was suspended for a 9 month period by the VA DMC because of slow enrollment, then restarted.|50
203183|NCT00732212|498409|P2|STARTED|Overall Study||123
203184|NCT00732212|498410|P1|STARTED|Overall Study||112
203185|NCT00732225|498445|P5|NOT COMPLETED|Overall Study||6
203186|NCT00732225|498446|P4|NOT COMPLETED|Overall Study||4
203187|NCT00732225|498447|P3|NOT COMPLETED|Overall Study||3
203188|NCT00732225|498448|P2|NOT COMPLETED|Overall Study||8
203189|NCT00732225|498449|P1|NOT COMPLETED|Overall Study||11
203190|NCT00732225|498445|P5|COMPLETED|Overall Study|48 eyes of 48 patients|48
203191|NCT00732225|498446|P4|COMPLETED|Overall Study|29 eyes of 29 patients|29
203192|NCT00732225|498447|P3|COMPLETED|Overall Study|23 eyes of 23 patients|23
203193|NCT00732225|498448|P2|COMPLETED|Overall Study|33 eyes of 32 patients|32
203194|NCT00732225|498449|P1|COMPLETED|Overall Study|64 eyes of 60 patients|60
203195|NCT00732225|498445|P5|STARTED|Overall Study|55 eyes of 54 patients|54
203196|NCT00732225|498446|P4|STARTED|Overall Study|33 eyes of 33 patients|33
203197|NCT00732225|498447|P3|STARTED|Overall Study|26 eyes of 26 patients|26
203198|NCT00732225|498448|P2|STARTED|Overall Study|41 eyes of 40 patients|40
203199|NCT00732225|498449|P1|STARTED|Overall Study|76 eyes of 71 patients|71
203200|NCT00732238|498498|P2|NOT COMPLETED|Overall Study||1
203201|NCT00732238|498499|P1|NOT COMPLETED|Overall Study||5
203202|NCT00732238|498498|P2|COMPLETED|Overall Study||27
203203|NCT00732238|498499|P1|COMPLETED|Overall Study||28
203204|NCT00732238|498498|P2|STARTED|Overall Study||28
203205|NCT00732238|498499|P1|STARTED|Overall Study||33
203206|NCT00732303|498507|P1|NOT COMPLETED|Overall Study||2
203207|NCT00732303|498507|P1|COMPLETED|Overall Study||6
203208|NCT00732303|498507|P1|STARTED|Overall Study||8
203209|NCT00732381|498515|P2|NOT COMPLETED|Overall Study||1
203210|NCT00732381|498516|P1|NOT COMPLETED|Overall Study||2
203211|NCT00732381|498515|P2|COMPLETED|Overall Study||174
203212|NCT00732381|498516|P1|COMPLETED|Overall Study||174
203213|NCT00732381|498515|P2|STARTED|Overall Study||175
203214|NCT00732381|498516|P1|STARTED|Overall Study||176
203215|NCT00732472|498528|P4|NOT COMPLETED|Overall Study||3
203216|NCT00732472|498529|P3|NOT COMPLETED|Overall Study||1
203217|NCT00732472|498530|P2|NOT COMPLETED|Overall Study||3
203218|NCT00732472|498531|P1|NOT COMPLETED|Overall Study||0
203219|NCT00732472|498528|P4|COMPLETED|Overall Study||6
203220|NCT00732472|498529|P3|COMPLETED|Overall Study||9
203221|NCT00732472|498530|P2|COMPLETED|Overall Study||7
203222|NCT00732472|498531|P1|COMPLETED|Overall Study||9
203223|NCT00732472|498528|P4|STARTED|Overall Study||9
203224|NCT00732472|498529|P3|STARTED|Overall Study||10
203225|NCT00732472|498530|P2|STARTED|Overall Study|One par. (counted as 2 on outputs) was randomized/dosed with UMEC 250 µg on 2 separate occasions.|10
203226|NCT00732472|498531|P1|STARTED|Overall Study||9
203227|NCT00732615|498631|P2|NOT COMPLETED|Overall Study||5
203228|NCT00732615|498632|P1|NOT COMPLETED|Overall Study||7
203229|NCT00732615|498631|P2|COMPLETED|Overall Study||79
203230|NCT00732615|498632|P1|COMPLETED|Overall Study||33
203231|NCT00732615|498631|P2|STARTED|Overall Study||84
203232|NCT00732615|498632|P1|STARTED|Overall Study||40
203233|NCT00732641|498646|P2|NOT COMPLETED|Overall Study||112
203234|NCT00732641|498647|P1|NOT COMPLETED|Overall Study||106
203235|NCT00732641|498646|P2|COMPLETED|Overall Study||9
203236|NCT00732641|498647|P1|COMPLETED|Overall Study||17
203237|NCT00732641|498646|P2|STARTED|Overall Study||121
203238|NCT00732641|498647|P1|STARTED|Overall Study||123
203239|NCT00732654|498668|P3|NOT COMPLETED|Overall Study||0
203240|NCT00732654|498669|P2|NOT COMPLETED|Overall Study||1
203241|NCT00732654|498670|P1|NOT COMPLETED|Overall Study||0
203242|NCT00732654|498668|P3|COMPLETED|Overall Study||10
203243|NCT00732654|498669|P2|COMPLETED|Overall Study||9
203244|NCT00732654|498670|P1|COMPLETED|Overall Study||10
203245|NCT00732654|498668|P3|STARTED|Overall Study||10
203246|NCT00732654|498669|P2|STARTED|Overall Study||10
203247|NCT00732654|498670|P1|STARTED|Overall Study||10
203248|NCT00732680|498687|P1|NOT COMPLETED|Overall Study||0
203249|NCT00732680|498687|P1|COMPLETED|Overall Study||9
203250|NCT00732680|498687|P1|STARTED|Overall Study||9
203251|NCT00732758|498693|P2|NOT COMPLETED|Overall Study||16
203252|NCT00732758|498694|P1|NOT COMPLETED|Overall Study||8
203253|NCT00732758|498693|P2|COMPLETED|Overall Study||63
203254|NCT00732758|498694|P1|COMPLETED|Overall Study||70
203255|NCT00732758|498693|P2|STARTED|Overall Study||79
203256|NCT00732758|498694|P1|STARTED|Overall Study||78
203257|NCT00732875|498706|P1|NOT COMPLETED|Overall Study||35
203258|NCT00732875|498706|P1|COMPLETED|Overall Study|These participants continued treatment until trial was completed by Sponsor.|57
203259|NCT00732875|498706|P1|STARTED|Overall Study||92
203260|NCT00732901|498714|P2|NOT COMPLETED|Overall Study||0
203261|NCT00732901|498715|P1|NOT COMPLETED|Overall Study||0
203262|NCT00732901|498714|P2|COMPLETED|Overall Study||12
203263|NCT00732901|498715|P1|COMPLETED|Overall Study||11
203264|NCT00732901|498714|P2|STARTED|Overall Study||12
203265|NCT00732901|498715|P1|STARTED|Overall Study||11
203266|NCT00732940|498727|P2|NOT COMPLETED|Overall Study||3
203267|NCT00732940|498728|P1|NOT COMPLETED|Overall Study||2
203268|NCT00732940|498727|P2|COMPLETED|Overall Study||25
203269|NCT00732940|498728|P1|COMPLETED|Overall Study||26
203270|NCT00732940|498727|P2|STARTED|Overall Study||28
203271|NCT00732940|498728|P1|STARTED|Overall Study||28
203272|NCT00732992|498798|P2|NOT COMPLETED|Overall Study||6
203273|NCT00732992|498799|P1|NOT COMPLETED|Overall Study||6
203274|NCT00732992|498798|P2|COMPLETED|Overall Study||0
203275|NCT00732992|498799|P1|COMPLETED|Overall Study||0
203276|NCT00732992|498798|P2|STARTED|Overall Study||6
203277|NCT00732992|498799|P1|STARTED|Overall Study||6
203278|NCT00733005|498818|P2|NOT COMPLETED|Overall Study||3
203279|NCT00733005|498819|P1|NOT COMPLETED|Overall Study||2
203280|NCT00733005|498818|P2|COMPLETED|Overall Study||159
203281|NCT00733005|498819|P1|COMPLETED|Overall Study||160
203282|NCT00733005|498818|P2|STARTED|Overall Study||162
203283|NCT00733005|498819|P1|STARTED|Overall Study||162
203284|NCT00733096|498830|P3|NOT COMPLETED|Overall Study||0
203285|NCT00733096|498831|P2|NOT COMPLETED|Overall Study||0
203286|NCT00733096|498832|P1|NOT COMPLETED|Overall Study||0
203287|NCT00733096|498830|P3|COMPLETED|Overall Study||30
203288|NCT00733096|498831|P2|COMPLETED|Overall Study||26
203289|NCT00733096|498832|P1|COMPLETED|Overall Study||28
203290|NCT00733096|498830|P3|STARTED|Overall Study||30
203291|NCT00733096|498831|P2|STARTED|Overall Study||26
203292|NCT00733096|498832|P1|STARTED|Overall Study||28
203293|NCT00733135|498849|P1|NOT COMPLETED|Overall Study||2
203294|NCT00733135|498849|P1|COMPLETED|Overall Study||131
203295|NCT00733135|498849|P1|STARTED|Overall Study||133
203296|NCT00733226|498860|P2|NOT COMPLETED|Overall Study||0
203297|NCT00733226|498861|P1|NOT COMPLETED|Overall Study||5
203298|NCT00733226|498860|P2|COMPLETED|Overall Study||40
203299|NCT00733226|498861|P1|COMPLETED|Overall Study||35
203300|NCT00733226|498860|P2|STARTED|Overall Study||40
203301|NCT00733226|498861|P1|STARTED|Overall Study||40
203302|NCT00733278|498877|P1|NOT COMPLETED|Overall Study||0
203303|NCT00733278|498877|P1|COMPLETED|Overall Study||7
203304|NCT00733278|498877|P1|STARTED|Overall Study||7
203305|NCT00733291|498884|P4|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
203306|NCT00733291|498885|P3|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
203307|NCT00733291|498886|P2|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
203308|NCT00733291|498887|P1|NOT COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||0
203309|NCT00733291|498884|P4|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
203310|NCT00733291|498885|P3|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
203311|NCT00733291|498886|P2|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||17
203312|NCT00733291|498887|P1|COMPLETED|Second Intervention, 2 Hrs (+/- 30 Min)||12
203313|NCT00733291|498884|P4|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
203314|NCT00733291|498885|P3|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
203315|NCT00733291|498886|P2|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||17
203316|NCT00733291|498887|P1|STARTED|Second Intervention, 2 Hrs (+/- 30 Min)||12
203317|NCT00733291|498884|P4|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
203318|NCT00733291|498885|P3|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
203319|NCT00733291|498886|P2|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||0
203320|NCT00733291|498887|P1|NOT COMPLETED|Washout Period, 3 Days (+/-1 Day)||1
203321|NCT00733291|498884|P4|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
203322|NCT00733291|498885|P3|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
203323|NCT00733291|498886|P2|COMPLETED|Washout Period, 3 Days (+/-1 Day)||17
203324|NCT00733291|498887|P1|COMPLETED|Washout Period, 3 Days (+/-1 Day)||12
203325|NCT00733291|498884|P4|STARTED|Washout Period, 3 Days (+/-1 Day)||17
203326|NCT00733291|498885|P3|STARTED|Washout Period, 3 Days (+/-1 Day)||17
203327|NCT00733291|498886|P2|STARTED|Washout Period, 3 Days (+/-1 Day)||17
203328|NCT00733291|498887|P1|STARTED|Washout Period, 3 Days (+/-1 Day)||13
203329|NCT00733291|498884|P4|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
203330|NCT00733291|498885|P3|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
203331|NCT00733291|498886|P2|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
203332|NCT00733291|498887|P1|NOT COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||0
203333|NCT00733291|498884|P4|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
203334|NCT00733291|498885|P3|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
203335|NCT00733291|498886|P2|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||17
203336|NCT00733291|498887|P1|COMPLETED|First Intervention, 2 Hrs (+/- 30 Min)||13
203337|NCT00733291|498884|P4|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
203338|NCT00733291|498885|P3|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
203339|NCT00733291|498886|P2|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||17
203340|NCT00733291|498887|P1|STARTED|First Intervention, 2 Hrs (+/- 30 Min)||13
203341|NCT00733330|498911|P2|NOT COMPLETED|Overall Study||4
203342|NCT00733330|498912|P1|NOT COMPLETED|Overall Study||2
203343|NCT00733330|498911|P2|COMPLETED|Overall Study||48
203344|NCT00733330|498912|P1|COMPLETED|Overall Study||30
203345|NCT00733330|498911|P2|STARTED|Overall Study||52
203346|NCT00733330|498912|P1|STARTED|Overall Study||32
203347|NCT00733369|498996|P2|NOT COMPLETED|Overall Study||9
203348|NCT00733369|498997|P1|NOT COMPLETED|Overall Study||10
203349|NCT00733369|498996|P2|COMPLETED|Overall Study||47
203350|NCT00733369|498997|P1|COMPLETED|Overall Study||40
203351|NCT00733369|498996|P2|STARTED|Overall Study||56
203352|NCT00733369|498997|P1|STARTED|Overall Study||50
203353|NCT00733421|499115|P2|NOT COMPLETED|Overall Study||1
203354|NCT00733421|499116|P1|NOT COMPLETED|Overall Study||1
203355|NCT00733421|499115|P2|COMPLETED|Overall Study|All but one randomised patient|49
203356|NCT00733421|499116|P1|COMPLETED|Overall Study|All but one randomsied patient|49
203357|NCT00733421|499115|P2|STARTED|Overall Study|November 2008|50
203358|NCT00733421|499116|P1|STARTED|Overall Study|November 2008|50
203359|NCT00733499|499140|P2|NOT COMPLETED|24 Months Follow-up||1
203360|NCT00733499|499141|P1|NOT COMPLETED|24 Months Follow-up||0
203361|NCT00733499|499140|P2|COMPLETED|24 Months Follow-up||95
203362|NCT00733499|499141|P1|COMPLETED|24 Months Follow-up||99
203363|NCT00733499|499140|P2|STARTED|24 Months Follow-up||96
203364|NCT00733499|499141|P1|STARTED|24 Months Follow-up||99
203365|NCT00733499|499140|P2|NOT COMPLETED|12 Months Follow-up||1
203366|NCT00733499|499141|P1|NOT COMPLETED|12 Months Follow-up||2
203367|NCT00733499|499140|P2|COMPLETED|12 Months Follow-up||96
203368|NCT00733499|499141|P1|COMPLETED|12 Months Follow-up||99
203369|NCT00733499|499140|P2|STARTED|12 Months Follow-up||97
203370|NCT00733499|499141|P1|STARTED|12 Months Follow-up||101
203371|NCT00733499|499140|P2|NOT COMPLETED|6 Months Follow-up||3
203372|NCT00733499|499141|P1|NOT COMPLETED|6 Months Follow-up||0
203373|NCT00733499|499140|P2|COMPLETED|6 Months Follow-up||97
203374|NCT00733499|499141|P1|COMPLETED|6 Months Follow-up||101
203375|NCT00733499|499140|P2|STARTED|6 Months Follow-up||100
203376|NCT00733499|499141|P1|STARTED|6 Months Follow-up||101
203377|NCT00733499|499140|P2|NOT COMPLETED|3 Months Follow-up||2
203378|NCT00733499|499141|P1|NOT COMPLETED|3 Months Follow-up||1
203379|NCT00733499|499140|P2|COMPLETED|3 Months Follow-up||100
203380|NCT00733499|499141|P1|COMPLETED|3 Months Follow-up||101
203381|NCT00733499|499140|P2|STARTED|3 Months Follow-up||102
203382|NCT00733499|499141|P1|STARTED|3 Months Follow-up||102
203383|NCT00733499|499140|P2|NOT COMPLETED|Pre-operative||1
203384|NCT00733499|499141|P1|NOT COMPLETED|Pre-operative||0
203385|NCT00733499|499140|P2|COMPLETED|Pre-operative||102
203386|NCT00733499|499141|P1|COMPLETED|Pre-operative||102
203387|NCT00733499|499140|P2|STARTED|Pre-operative||103
203388|NCT00733499|499141|P1|STARTED|Pre-operative||102
203389|NCT00733512|499147|P1|NOT COMPLETED|Overall Study||0
203390|NCT00733512|499147|P1|COMPLETED|Overall Study||146
203391|NCT00733512|499147|P1|STARTED|Overall Study||146
203392|NCT00733746|499152|P1|NOT COMPLETED|Overall Study||5
203393|NCT00733746|499152|P1|COMPLETED|Overall Study||114
203394|NCT00733746|499152|P1|STARTED|Overall Study||119
203395|NCT00733824|499165|P5|NOT COMPLETED|Phase II||0
203396|NCT00733824|499166|P4|NOT COMPLETED|Phase II||0
203397|NCT00733824|499167|P3|NOT COMPLETED|Phase II||0
203398|NCT00733824|499168|P2|NOT COMPLETED|Phase II||0
203399|NCT00733824|499169|P1|NOT COMPLETED|Phase II||0
203400|NCT00733824|499165|P5|COMPLETED|Phase II||36
203401|NCT00733824|499166|P4|COMPLETED|Phase II||0
203402|NCT00733824|499167|P3|COMPLETED|Phase II||0
203403|NCT00733824|499168|P2|COMPLETED|Phase II||0
203404|NCT00733824|499169|P1|COMPLETED|Phase II||0
203405|NCT00733824|499165|P5|STARTED|Phase II||36
203406|NCT00733824|499166|P4|STARTED|Phase II||0
203407|NCT00733824|499167|P3|STARTED|Phase II||0
203408|NCT00733824|499168|P2|STARTED|Phase II||0
203409|NCT00733824|499169|P1|STARTED|Phase II||0
203410|NCT00733824|499165|P5|NOT COMPLETED|Phase I||0
203411|NCT00733824|499166|P4|NOT COMPLETED|Phase I||0
203412|NCT00733824|499167|P3|NOT COMPLETED|Phase I||0
203413|NCT00733824|499168|P2|NOT COMPLETED|Phase I||0
203414|NCT00733824|499169|P1|NOT COMPLETED|Phase I||1
203415|NCT00733824|499165|P5|COMPLETED|Phase I||0
203416|NCT00733824|499166|P4|COMPLETED|Phase I||6
203417|NCT00733824|499167|P3|COMPLETED|Phase I||6
203418|NCT00733824|499168|P2|COMPLETED|Phase I||3
203419|NCT00733824|499169|P1|COMPLETED|Phase I||9
203420|NCT00733824|499165|P5|STARTED|Phase I||0
203421|NCT00733824|499166|P4|STARTED|Phase I||6
203422|NCT00733824|499167|P3|STARTED|Phase I||6
203423|NCT00733824|499168|P2|STARTED|Phase I||3
203424|NCT00733824|499169|P1|STARTED|Phase I||10
203425|NCT00733954|499190|P2|NOT COMPLETED|Overall Study||2
203426|NCT00733954|499191|P1|NOT COMPLETED|Overall Study||8
203427|NCT00733954|499190|P2|COMPLETED|Overall Study||123
203428|NCT00733954|499191|P1|COMPLETED|Overall Study||116
203429|NCT00733954|499190|P2|STARTED|Overall Study||125
203430|NCT00733954|499191|P1|STARTED|Overall Study||124
203431|NCT00733993|499235|P2|NOT COMPLETED|Overall Study||0
203432|NCT00733993|499236|P1|NOT COMPLETED|Overall Study||0
203433|NCT00733993|499235|P2|COMPLETED|Overall Study||10
203434|NCT00733993|499236|P1|COMPLETED|Overall Study||13
203435|NCT00733993|499235|P2|STARTED|Overall Study||10
203436|NCT00733993|499236|P1|STARTED|Overall Study||13
203437|NCT00734071|499271|P2|NOT COMPLETED|Overall Study||27
203438|NCT00734071|499272|P1|NOT COMPLETED|Overall Study||38
203439|NCT00734071|499271|P2|COMPLETED|Overall Study||125
203440|NCT00734071|499272|P1|COMPLETED|Overall Study||114
203441|NCT00734071|499271|P2|Treated|Overall Study||148
203442|NCT00734071|499272|P1|Treated|Overall Study||151
203443|NCT00734071|499271|P2|STARTED|Overall Study||152
203444|NCT00734071|499272|P1|STARTED|Overall Study||152
203445|NCT00725452|499326|P1|NOT COMPLETED|Overall Study||11
203446|NCT00725452|499326|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Infliximab infusions.|15
203447|NCT00725452|499326|P1|STARTED|Overall Study||26
203448|NCT00725491|499337|P2|NOT COMPLETED|Overall Study||18
203449|NCT00725491|499338|P1|NOT COMPLETED|Overall Study||9
203450|NCT00725491|499337|P2|COMPLETED|Overall Study||102
203451|NCT00725491|499338|P1|COMPLETED|Overall Study||104
203452|NCT00725491|499337|P2|STARTED|Overall Study|Intent-to-Treat Group|120
203453|NCT00725491|499338|P1|STARTED|Overall Study|Intent-to-Treat Group|113
203454|NCT00725504|499344|P1|NOT COMPLETED|Overall Study||0
203455|NCT00725504|499344|P1|COMPLETED|Overall Study||71
203456|NCT00725504|499344|P1|STARTED|Overall Study||71
203457|NCT00725530|499351|P2|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
203458|NCT00725530|499352|P1|NOT COMPLETED|Second Intervention, 7 Days (+0/-1)||0
203459|NCT00725530|499351|P2|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
203460|NCT00725530|499352|P1|COMPLETED|Second Intervention, 7 Days (+0/-1)||27
203461|NCT00725530|499351|P2|STARTED|Second Intervention, 7 Days (+0/-1)||27
203462|NCT00725530|499352|P1|STARTED|Second Intervention, 7 Days (+0/-1)||27
203463|NCT00725530|499351|P2|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
203464|NCT00725530|499352|P1|NOT COMPLETED|First Intervention, 7 Days (+0/-1)||0
203465|NCT00725530|499351|P2|COMPLETED|First Intervention, 7 Days (+0/-1)||27
203466|NCT00725530|499352|P1|COMPLETED|First Intervention, 7 Days (+0/-1)||27
203467|NCT00725530|499351|P2|STARTED|First Intervention, 7 Days (+0/-1)||27
203468|NCT00725530|499352|P1|STARTED|First Intervention, 7 Days (+0/-1)||27
203469|NCT00725543|499358|P1|NOT COMPLETED|Overall Study||153
203470|NCT00725543|499358|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|205
203471|NCT00725543|499358|P1|STARTED|Overall Study||358
203472|NCT00725608|499367|P1|NOT COMPLETED|Overall Study||167
203473|NCT00725608|499367|P1|COMPLETED|Overall Study|1 patient terminated treatment at day 368 and was counted as dropout|140
203474|NCT00725608|499367|P1|STARTED|Overall Study|339 patients enrolled, 32 non-eligible datasets excluded from final general and safety analysis|307
203475|NCT00725621|499373|P1|NOT COMPLETED|Overall Study||271
203476|NCT00725621|499373|P1|COMPLETED|Overall Study|Completed was defined as the number of participants who received 9 consecutive Remicade infusions.|245
203477|NCT00725621|499373|P1|STARTED|Overall Study|Started was defined as the number of participants who received at least one infusion of Remicade.|516
203478|NCT00725712|499398|P2|NOT COMPLETED|Overall Study||26
203479|NCT00725712|499399|P1|NOT COMPLETED|Overall Study||48
203480|NCT00725712|499398|P2|COMPLETED|Overall Study||0
203481|NCT00725712|499399|P1|COMPLETED|Overall Study||0
203482|NCT00725712|499398|P2|STARTED|Overall Study||26
203483|NCT00725712|499399|P1|STARTED|Overall Study||48
203484|NCT00725725|499438|P3|NOT COMPLETED|Overall Study||5
203485|NCT00725725|499439|P2|NOT COMPLETED|Overall Study||4
203486|NCT00725725|499440|P1|NOT COMPLETED|Overall Study||4
203487|NCT00725725|499438|P3|COMPLETED|Overall Study||12
203488|NCT00725725|499439|P2|COMPLETED|Overall Study||11
203489|NCT00725725|499440|P1|COMPLETED|Overall Study||10
203490|NCT00725725|499438|P3|Treated|Overall Study||14
203491|NCT00725725|499439|P2|Treated|Overall Study||15
203492|NCT00725725|499440|P1|Treated|Overall Study||11
203493|NCT00725725|499438|P3|STARTED|Overall Study||17
203494|NCT00725725|499439|P2|STARTED|Overall Study||15
203495|NCT00725725|499440|P1|STARTED|Overall Study||14
203496|NCT00725751|499483|P2|NOT COMPLETED|Overall Study||108
203497|NCT00725751|499484|P1|NOT COMPLETED|Overall Study||34
203498|NCT00725751|499483|P2|COMPLETED|Overall Study||150
203499|NCT00725751|499484|P1|COMPLETED|Overall Study||56
203500|NCT00725751|499483|P2|STARTED|Overall Study||258
203501|NCT00725751|499484|P1|STARTED|Overall Study||90
203502|NCT00725842|499493|P1|NOT COMPLETED|Overall Study||40
203503|NCT00725842|499493|P1|COMPLETED|Overall Study||57
203504|NCT00725842|499493|P1|Participants Eligible for Analysis|Overall Study||90
203505|NCT00725842|499493|P1|STARTED|Overall Study||97
203506|NCT00725920|499502|P2|NOT COMPLETED|Overall Study||6
203507|NCT00725920|499503|P1|NOT COMPLETED|Overall Study||3
203508|NCT00725920|499502|P2|COMPLETED|Overall Study||12
203509|NCT00725920|499503|P1|COMPLETED|Overall Study||14
203510|NCT00725920|499502|P2|STARTED|Overall Study||18
203511|NCT00725920|499503|P1|STARTED|Overall Study||17
203512|NCT00725985|499512|P12|NOT COMPLETED|LTFU (No Cladribine Treatment)||14
203513|NCT00725985|499513|P11|NOT COMPLETED|LTFU (No Cladribine Treatment)||36
203514|NCT00725985|499514|P10|NOT COMPLETED|LTFU (No Cladribine Treatment)||34
203515|NCT00725985|499515|P9|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203516|NCT00725985|499516|P8|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203517|NCT00725985|499517|P7|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203518|NCT00725985|499518|P6|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203519|NCT00725985|499519|P5|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203520|NCT00725985|499520|P4|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203521|NCT00725985|499521|P3|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203522|NCT00725985|499522|P2|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203523|NCT00725985|499523|P1|NOT COMPLETED|LTFU (No Cladribine Treatment)||0
203524|NCT00725985|499512|P12|COMPLETED|LTFU (No Cladribine Treatment)||0
203525|NCT00725985|499513|P11|COMPLETED|LTFU (No Cladribine Treatment)||0
203526|NCT00725985|499514|P10|COMPLETED|LTFU (No Cladribine Treatment)||0
203527|NCT00725985|499515|P9|COMPLETED|LTFU (No Cladribine Treatment)||0
203528|NCT00725985|499516|P8|COMPLETED|LTFU (No Cladribine Treatment)||0
203529|NCT00725985|499517|P7|COMPLETED|LTFU (No Cladribine Treatment)||0
203530|NCT00725985|499518|P6|COMPLETED|LTFU (No Cladribine Treatment)||0
203531|NCT00725985|499519|P5|COMPLETED|LTFU (No Cladribine Treatment)||0
203532|NCT00725985|499520|P4|COMPLETED|LTFU (No Cladribine Treatment)||0
203533|NCT00725985|499521|P3|COMPLETED|LTFU (No Cladribine Treatment)||0
203534|NCT00725985|499522|P2|COMPLETED|LTFU (No Cladribine Treatment)||0
203535|NCT00725985|499523|P1|COMPLETED|LTFU (No Cladribine Treatment)||0
203536|NCT00725985|499512|P12|STARTED|LTFU (No Cladribine Treatment)||14
203537|NCT00725985|499513|P11|STARTED|LTFU (No Cladribine Treatment)||36
203538|NCT00725985|499514|P10|STARTED|LTFU (No Cladribine Treatment)||34
203539|NCT00725985|499515|P9|STARTED|LTFU (No Cladribine Treatment)||0
203540|NCT00725985|499516|P8|STARTED|LTFU (No Cladribine Treatment)||0
203541|NCT00725985|499517|P7|STARTED|LTFU (No Cladribine Treatment)||0
203542|NCT00725985|499518|P6|STARTED|LTFU (No Cladribine Treatment)||0
203543|NCT00725985|499519|P5|STARTED|LTFU (No Cladribine Treatment)||0
203544|NCT00725985|499520|P4|STARTED|LTFU (No Cladribine Treatment)||0
203545|NCT00725985|499521|P3|STARTED|LTFU (No Cladribine Treatment)||0
203546|NCT00725985|499522|P2|STARTED|LTFU (No Cladribine Treatment)||0
203547|NCT00725985|499523|P1|STARTED|LTFU (No Cladribine Treatment)||0
203548|NCT00725985|499512|P12|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203549|NCT00725985|499513|P11|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203550|NCT00725985|499514|P10|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203551|NCT00725985|499515|P9|NOT COMPLETED|LTFU (With Cladribine Treatment)||17
203552|NCT00725985|499516|P8|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
203553|NCT00725985|499517|P7|NOT COMPLETED|LTFU (With Cladribine Treatment)||9
203554|NCT00725985|499518|P6|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203555|NCT00725985|499519|P5|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203556|NCT00725985|499520|P4|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203557|NCT00725985|499521|P3|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203558|NCT00725985|499522|P2|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203559|NCT00725985|499523|P1|NOT COMPLETED|LTFU (With Cladribine Treatment)||0
203560|NCT00725985|499512|P12|COMPLETED|LTFU (With Cladribine Treatment)||0
203561|NCT00725985|499513|P11|COMPLETED|LTFU (With Cladribine Treatment)||0
203562|NCT00725985|499514|P10|COMPLETED|LTFU (With Cladribine Treatment)||0
203563|NCT00725985|499515|P9|COMPLETED|LTFU (With Cladribine Treatment)||0
203564|NCT00725985|499516|P8|COMPLETED|LTFU (With Cladribine Treatment)||0
203565|NCT00725985|499517|P7|COMPLETED|LTFU (With Cladribine Treatment)||0
203566|NCT00725985|499518|P6|COMPLETED|LTFU (With Cladribine Treatment)||0
203567|NCT00725985|499519|P5|COMPLETED|LTFU (With Cladribine Treatment)||0
203568|NCT00725985|499520|P4|COMPLETED|LTFU (With Cladribine Treatment)||0
203569|NCT00725985|499521|P3|COMPLETED|LTFU (With Cladribine Treatment)||0
203570|NCT00725985|499522|P2|COMPLETED|LTFU (With Cladribine Treatment)||0
203571|NCT00725985|499523|P1|COMPLETED|LTFU (With Cladribine Treatment)||0
203572|NCT00725985|499512|P12|STARTED|LTFU (With Cladribine Treatment)||0
203573|NCT00725985|499513|P11|STARTED|LTFU (With Cladribine Treatment)||0
203574|NCT00725985|499514|P10|STARTED|LTFU (With Cladribine Treatment)||0
203575|NCT00725985|499515|P9|STARTED|LTFU (With Cladribine Treatment)||17
203576|NCT00725985|499516|P8|STARTED|LTFU (With Cladribine Treatment)||9
203577|NCT00725985|499517|P7|STARTED|LTFU (With Cladribine Treatment)||9
203578|NCT00725985|499518|P6|STARTED|LTFU (With Cladribine Treatment)||0
203579|NCT00725985|499519|P5|STARTED|LTFU (With Cladribine Treatment)||0
203580|NCT00725985|499520|P4|STARTED|LTFU (With Cladribine Treatment)||0
203581|NCT00725985|499521|P3|STARTED|LTFU (With Cladribine Treatment)||0
203582|NCT00725985|499522|P2|STARTED|LTFU (With Cladribine Treatment)||0
203583|NCT00725985|499523|P1|STARTED|LTFU (With Cladribine Treatment)||0
203584|NCT00725985|499512|P12|NOT COMPLETED|OLMP||0
203585|NCT00725985|499513|P11|NOT COMPLETED|OLMP||0
203586|NCT00725985|499514|P10|NOT COMPLETED|OLMP||0
203587|NCT00725985|499515|P9|NOT COMPLETED|OLMP||0
203588|NCT00725985|499516|P8|NOT COMPLETED|OLMP||0
203589|NCT00725985|499517|P7|NOT COMPLETED|OLMP||0
203590|NCT00725985|499518|P6|NOT COMPLETED|OLMP||53
203591|NCT00725985|499519|P5|NOT COMPLETED|OLMP||23
203592|NCT00725985|499520|P4|NOT COMPLETED|OLMP||18
203593|NCT00725985|499521|P3|NOT COMPLETED|OLMP||0
203594|NCT00725985|499522|P2|NOT COMPLETED|OLMP||0
203595|NCT00725985|499523|P1|NOT COMPLETED|OLMP||0
203596|NCT00725985|499512|P12|COMPLETED|OLMP||0
203597|NCT00725985|499513|P11|COMPLETED|OLMP||0
203598|NCT00725985|499514|P10|COMPLETED|OLMP||0
203599|NCT00725985|499515|P9|COMPLETED|OLMP||0
203600|NCT00725985|499516|P8|COMPLETED|OLMP||0
203601|NCT00725985|499517|P7|COMPLETED|OLMP||0
203602|NCT00725985|499518|P6|COMPLETED|OLMP||7
203603|NCT00725985|499519|P5|COMPLETED|OLMP||2
203604|NCT00725985|499520|P4|COMPLETED|OLMP||6
203605|NCT00725985|499521|P3|COMPLETED|OLMP||0
203606|NCT00725985|499522|P2|COMPLETED|OLMP||0
203607|NCT00725985|499523|P1|COMPLETED|OLMP||0
203608|NCT00725985|499512|P12|STARTED|OLMP||0
203609|NCT00725985|499513|P11|STARTED|OLMP||0
203610|NCT00725985|499514|P10|STARTED|OLMP||0
203611|NCT00725985|499515|P9|STARTED|OLMP||0
203612|NCT00725985|499516|P8|STARTED|OLMP||0
203613|NCT00725985|499517|P7|STARTED|OLMP||0
203614|NCT00725985|499518|P6|STARTED|OLMP||60
203615|NCT00725985|499519|P5|STARTED|OLMP||25
203616|NCT00725985|499520|P4|STARTED|OLMP||24
203617|NCT00725985|499521|P3|STARTED|OLMP||0
203618|NCT00725985|499522|P2|STARTED|OLMP||0
203619|NCT00725985|499523|P1|STARTED|OLMP||0
203620|NCT00725985|499512|P12|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203621|NCT00725985|499513|P11|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203622|NCT00725985|499514|P10|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203623|NCT00725985|499515|P9|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203624|NCT00725985|499516|P8|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203625|NCT00725985|499517|P7|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203626|NCT00725985|499518|P6|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203627|NCT00725985|499519|P5|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203628|NCT00725985|499520|P4|NOT COMPLETED|ITP (Up to 96 Weeks)||0
203629|NCT00725985|499521|P3|NOT COMPLETED|ITP (Up to 96 Weeks)||102
203630|NCT00725985|499522|P2|NOT COMPLETED|ITP (Up to 96 Weeks)||75
203631|NCT00725985|499523|P1|NOT COMPLETED|ITP (Up to 96 Weeks)||101
203632|NCT00725985|499512|P12|COMPLETED|ITP (Up to 96 Weeks)||0
203633|NCT00725985|499513|P11|COMPLETED|ITP (Up to 96 Weeks)||0
203634|NCT00725985|499514|P10|COMPLETED|ITP (Up to 96 Weeks)||0
203635|NCT00725985|499515|P9|COMPLETED|ITP (Up to 96 Weeks)||0
203636|NCT00725985|499516|P8|COMPLETED|ITP (Up to 96 Weeks)||0
203637|NCT00725985|499517|P7|COMPLETED|ITP (Up to 96 Weeks)||0
203638|NCT00725985|499518|P6|COMPLETED|ITP (Up to 96 Weeks)||0
203639|NCT00725985|499519|P5|COMPLETED|ITP (Up to 96 Weeks)||0
203640|NCT00725985|499520|P4|COMPLETED|ITP (Up to 96 Weeks)||0
203641|NCT00725985|499521|P3|COMPLETED|ITP (Up to 96 Weeks)||104
203642|NCT00725985|499522|P2|COMPLETED|ITP (Up to 96 Weeks)||131
203643|NCT00725985|499523|P1|COMPLETED|ITP (Up to 96 Weeks)||104
203644|NCT00725985|499512|P12|Treated|ITP (Up to 96 Weeks)||0
203645|NCT00725985|499513|P11|Treated|ITP (Up to 96 Weeks)||0
203646|NCT00725985|499514|P10|Treated|ITP (Up to 96 Weeks)||0
203647|NCT00725985|499515|P9|Treated|ITP (Up to 96 Weeks)||0
203648|NCT00725985|499516|P8|Treated|ITP (Up to 96 Weeks)||0
203649|NCT00725985|499517|P7|Treated|ITP (Up to 96 Weeks)||0
203650|NCT00725985|499518|P6|Treated|ITP (Up to 96 Weeks)||0
203651|NCT00725985|499519|P5|Treated|ITP (Up to 96 Weeks)||0
203652|NCT00725985|499520|P4|Treated|ITP (Up to 96 Weeks)||0
203653|NCT00725985|499521|P3|Treated|ITP (Up to 96 Weeks)||206
203654|NCT00725985|499522|P2|Treated|ITP (Up to 96 Weeks)||206
203655|NCT00725985|499523|P1|Treated|ITP (Up to 96 Weeks)||204
203656|NCT00725985|499512|P12|STARTED|ITP (Up to 96 Weeks)||0
203657|NCT00725985|499513|P11|STARTED|ITP (Up to 96 Weeks)||0
203658|NCT00725985|499514|P10|STARTED|ITP (Up to 96 Weeks)||0
203659|NCT00725985|499515|P9|STARTED|ITP (Up to 96 Weeks)||0
203660|NCT00725985|499516|P8|STARTED|ITP (Up to 96 Weeks)||0
203661|NCT00725985|499517|P7|STARTED|ITP (Up to 96 Weeks)||0
203662|NCT00725985|499518|P6|STARTED|ITP (Up to 96 Weeks)||0
203663|NCT00725985|499519|P5|STARTED|ITP (Up to 96 Weeks)||0
203664|NCT00725985|499520|P4|STARTED|ITP (Up to 96 Weeks)||0
203665|NCT00725985|499521|P3|STARTED|ITP (Up to 96 Weeks)||206
203666|NCT00725985|499522|P2|STARTED|ITP (Up to 96 Weeks)||206
203667|NCT00725985|499523|P1|STARTED|ITP (Up to 96 Weeks)||205
203668|NCT00726037|499549|P1|NOT COMPLETED|Overall Study||0
203669|NCT00726037|499549|P1|COMPLETED|Overall Study||7
203670|NCT00726037|499549|P1|STARTED|Overall Study||7
203671|NCT00726063|499556|P2|NOT COMPLETED|Overall Study||7
203672|NCT00726063|499557|P1|NOT COMPLETED|Overall Study||9
203673|NCT00726063|499556|P2|COMPLETED|Overall Study|Number of implants = 239|112
203674|NCT00726063|499557|P1|COMPLETED|Overall Study|Number of implants =230|113
203675|NCT00726063|499556|P2|STARTED|Overall Study|Number of implants= 246|119
203676|NCT00726063|499557|P1|STARTED|Overall Study|Number of implants= 239|122
203677|NCT00726180|499563|P1|NOT COMPLETED|Overall Study||0
203678|NCT00726180|499563|P1|COMPLETED|Overall Study||1
203679|NCT00726180|499563|P1|STARTED|Overall Study||1
203680|NCT00726232|499573|P6|NOT COMPLETED|Overall Study||4
203681|NCT00726232|499574|P5|NOT COMPLETED|Overall Study||5
203682|NCT00726232|499575|P4|NOT COMPLETED|Overall Study||1
203683|NCT00726232|499576|P3|NOT COMPLETED|Overall Study||0
203684|NCT00726232|499577|P2|NOT COMPLETED|Overall Study||1
203685|NCT00726232|499578|P1|NOT COMPLETED|Overall Study||5
203686|NCT00726232|499573|P6|COMPLETED|Overall Study||5
203687|NCT00726232|499574|P5|COMPLETED|Overall Study||17
203688|NCT00726232|499575|P4|COMPLETED|Overall Study||7
203689|NCT00726232|499576|P3|COMPLETED|Overall Study||7
203690|NCT00726232|499577|P2|COMPLETED|Overall Study||7
203691|NCT00726232|499578|P1|COMPLETED|Overall Study|Represents patients ongoing in the study as of the data cut-off date of 18 June 2010.|14
203692|NCT00726232|499573|P6|STARTED|Overall Study||9
203693|NCT00726232|499574|P5|STARTED|Overall Study|The starting dose selected for the ET expansion cohort was 25 mg bid hence the sample size is larger|22
203694|NCT00726232|499575|P4|STARTED|Overall Study||8
203695|NCT00726232|499576|P3|STARTED|Overall Study||7
203696|NCT00726232|499577|P2|STARTED|Overall Study||8
203697|NCT00726232|499578|P1|STARTED|Overall Study|The starting dose selected for the PV expansion cohort was 10 mg bid hence the sample size is larger|19
203698|NCT00726375|499622|P1|NOT COMPLETED|Overall Study||0
203699|NCT00726375|499622|P1|COMPLETED|Overall Study||34
203700|NCT00726375|499622|P1|STARTED|Overall Study||34
203701|NCT00726414|499627|P2|NOT COMPLETED|Second Intervention||0
203702|NCT00726414|499628|P1|NOT COMPLETED|Second Intervention||0
203703|NCT00726414|499627|P2|COMPLETED|Second Intervention||11
203704|NCT00726414|499628|P1|COMPLETED|Second Intervention||11
203705|NCT00726414|499627|P2|STARTED|Second Intervention||11
203706|NCT00726414|499628|P1|STARTED|Second Intervention||11
203707|NCT00726414|499627|P2|NOT COMPLETED|Washout Period of 7 Days||0
203708|NCT00726414|499628|P1|NOT COMPLETED|Washout Period of 7 Days||0
203709|NCT00726414|499627|P2|COMPLETED|Washout Period of 7 Days||11
203710|NCT00726414|499628|P1|COMPLETED|Washout Period of 7 Days||11
203711|NCT00726414|499627|P2|STARTED|Washout Period of 7 Days||11
203712|NCT00726414|499628|P1|STARTED|Washout Period of 7 Days||11
203713|NCT00726414|499627|P2|NOT COMPLETED|First Intervention||0
203714|NCT00726414|499628|P1|NOT COMPLETED|First Intervention||0
203715|NCT00726414|499627|P2|COMPLETED|First Intervention||11
203716|NCT00726414|499628|P1|COMPLETED|First Intervention||11
203717|NCT00726414|499627|P2|STARTED|First Intervention||11
203718|NCT00726414|499628|P1|STARTED|First Intervention||11
203719|NCT00726453|499640|P2|NOT COMPLETED|38 mm Length Group||3
203720|NCT00726453|499641|P1|NOT COMPLETED|38 mm Length Group||0
203721|NCT00726453|499640|P2|COMPLETED|38 mm Length Group|This sub-study completed the primary endpoint in March 2012 results not yet available.|111
203722|NCT00726453|499641|P1|COMPLETED|38 mm Length Group||0
203723|NCT00726453|499640|P2|STARTED|38 mm Length Group||114
203724|NCT00726453|499641|P1|STARTED|38 mm Length Group||0
203725|NCT00726453|499640|P2|NOT COMPLETED|Primary Enrollment Group||0
203726|NCT00726453|499641|P1|NOT COMPLETED|Primary Enrollment Group||31
203727|NCT00726453|499640|P2|COMPLETED|Primary Enrollment Group||0
203728|NCT00726453|499641|P1|COMPLETED|Primary Enrollment Group||1371
203729|NCT00726453|499640|P2|STARTED|Primary Enrollment Group||0
203730|NCT00726453|499641|P1|STARTED|Primary Enrollment Group||1402
203731|NCT00726557|499651|P1|NOT COMPLETED|Overall Study||128
203732|NCT00726557|499651|P1|COMPLETED|Overall Study|Completed is defined as those who finished the follow-up period.|118
203733|NCT00726557|499651|P1|STARTED|Overall Study||246
203734|NCT00726609|499656|P1|NOT COMPLETED|Overall Study||98
203735|NCT00726609|499656|P1|COMPLETED|Overall Study|For 26 participants in the Missing category, it is unknown if they completed the study.|116
203736|NCT00726609|499656|P1|STARTED|Overall Study||214
203737|NCT00726622|499662|P2|NOT COMPLETED|Overall Study||3
203738|NCT00726622|499663|P1|NOT COMPLETED|Overall Study||18
203739|NCT00726622|499662|P2|COMPLETED|Overall Study||240
203740|NCT00726622|499663|P1|COMPLETED|Overall Study||225
203741|NCT00726622|499662|P2|STARTED|Overall Study||243
203742|NCT00726622|499663|P1|STARTED|Overall Study||243
203743|NCT00726661|499683|P2|NOT COMPLETED|Overall Study||418
203744|NCT00726661|499684|P1|NOT COMPLETED|Overall Study||814
203745|NCT00726661|499683|P2|COMPLETED|Overall Study||17
203746|NCT00726661|499684|P1|COMPLETED|Overall Study||18
203747|NCT00726661|499683|P2|STARTED|Overall Study||435
203748|NCT00726661|499684|P1|STARTED|Overall Study||832
203749|NCT00726713|499701|P2|NOT COMPLETED|Overall Study||7
203750|NCT00726713|499702|P1|NOT COMPLETED|Overall Study||7
203751|NCT00726713|499701|P2|COMPLETED|Overall Study||101
203752|NCT00726713|499702|P1|COMPLETED|Overall Study||99
203753|NCT00726713|499701|P2|STARTED|Overall Study||108
203754|NCT00726713|499702|P1|STARTED|Overall Study||106
203755|NCT00726739|499730|P2|NOT COMPLETED|Overall Study||0
203756|NCT00726739|499731|P1|NOT COMPLETED|Overall Study||1
203757|NCT00726739|499730|P2|COMPLETED|Overall Study||10
203758|NCT00726739|499731|P1|COMPLETED|Overall Study|1 patient failed during screening due to brain metastasis.|10
203759|NCT00726739|499730|P2|STARTED|Overall Study||10
203760|NCT00726739|499731|P1|STARTED|Overall Study||11
203761|NCT00726752|499745|P1|NOT COMPLETED|Overall Study||6
203762|NCT00726752|499745|P1|COMPLETED|Overall Study||0
203763|NCT00726752|499745|P1|STARTED|Overall Study||6
203764|NCT00726830|499761|P2|NOT COMPLETED|Overall Study||0
203765|NCT00726830|499762|P1|NOT COMPLETED|Overall Study||0
203766|NCT00726830|499761|P2|COMPLETED|Overall Study||0
203767|NCT00726830|499762|P1|COMPLETED|Overall Study||1
203768|NCT00726830|499761|P2|STARTED|Overall Study||0
203769|NCT00726830|499762|P1|STARTED|Overall Study||1
203770|NCT00726882|499768|P1|NOT COMPLETED|Overall Study||22
203771|NCT00726882|499768|P1|COMPLETED|Overall Study||13
203772|NCT00726882|499768|P1|Received ABT-333 in Study M10-351|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00696904/M10-351).|6
203773|NCT00726882|499768|P1|Received ABT-333 in Study M10-380|Overall Study|Participants who received ABT-333 (and not placebo) in previous study (NCT00851890/M10-380).|22
203774|NCT00726882|499768|P1|STARTED|Overall Study||35
203775|NCT00726895|499774|P2|NOT COMPLETED|Second Intervention||0
203776|NCT00726895|499775|P1|NOT COMPLETED|Second Intervention||0
203777|NCT00726895|499774|P2|COMPLETED|Second Intervention||11
203778|NCT00726895|499775|P1|COMPLETED|Second Intervention||12
203779|NCT00726895|499774|P2|STARTED|Second Intervention||11
203780|NCT00726895|499775|P1|STARTED|Second Intervention||12
203781|NCT00726895|499774|P2|NOT COMPLETED|Washout Period of 7 Days||1
203782|NCT00726895|499775|P1|NOT COMPLETED|Washout Period of 7 Days||0
203783|NCT00726895|499774|P2|COMPLETED|Washout Period of 7 Days||11
203784|NCT00726895|499775|P1|COMPLETED|Washout Period of 7 Days||12
203785|NCT00726895|499774|P2|STARTED|Washout Period of 7 Days||12
203786|NCT00726895|499775|P1|STARTED|Washout Period of 7 Days||12
203787|NCT00726895|499774|P2|NOT COMPLETED|First Intervention||0
203788|NCT00726895|499775|P1|NOT COMPLETED|First Intervention||0
203789|NCT00726895|499774|P2|COMPLETED|First Intervention||12
203790|NCT00726895|499775|P1|COMPLETED|First Intervention||12
203791|NCT00726895|499774|P2|STARTED|First Intervention||12
203792|NCT00726895|499775|P1|STARTED|First Intervention||12
203793|NCT00726986|499788|P1|NOT COMPLETED|Maintenance Phase||3
203794|NCT00726986|499788|P1|COMPLETED|Maintenance Phase||0
203795|NCT00726986|499788|P1|STARTED|Maintenance Phase||3
203796|NCT00726986|499788|P1|NOT COMPLETED|Induction Phase||15
203797|NCT00726986|499788|P1|COMPLETED|Induction Phase||3
203798|NCT00726986|499788|P1|Maintance|Induction Phase||3
203799|NCT00726986|499788|P1|STARTED|Induction Phase||18
203800|NCT00726999|499797|P2|NOT COMPLETED|Overall Study||1
203801|NCT00726999|499798|P1|NOT COMPLETED|Overall Study||3
203802|NCT00726999|499797|P2|COMPLETED|Overall Study||30
203803|NCT00726999|499798|P1|COMPLETED|Overall Study||29
203804|NCT00726999|499797|P2|STARTED|Overall Study||31
203805|NCT00726999|499798|P1|STARTED|Overall Study||32
203806|NCT00727025|499808|P1|NOT COMPLETED|Overall Study||23
203807|NCT00727025|499808|P1|COMPLETED|Overall Study||51
203808|NCT00727025|499808|P1|STARTED|Overall Study||74
203809|NCT00727064|499820|P2|NOT COMPLETED|Overall Study||0
203810|NCT00727064|499821|P1|NOT COMPLETED|Overall Study||0
203811|NCT00727064|499820|P2|COMPLETED|Overall Study||7
203812|NCT00727064|499821|P1|COMPLETED|Overall Study||7
203813|NCT00727064|499820|P2|STARTED|Overall Study||7
203814|NCT00727064|499821|P1|STARTED|Overall Study||7
203815|NCT00727090|499839|P2|NOT COMPLETED|Overall Study||0
203816|NCT00727090|499840|P1|NOT COMPLETED|Overall Study||0
203817|NCT00727090|499839|P2|COMPLETED|Overall Study||3
203818|NCT00727090|499840|P1|COMPLETED|Overall Study||3
203819|NCT00727090|499839|P2|STARTED|Overall Study||3
203820|NCT00727090|499840|P1|STARTED|Overall Study||3
203821|NCT00727194|499856|P3|NOT COMPLETED|Treatment Period 2||0
203822|NCT00727194|499857|P2|NOT COMPLETED|Treatment Period 2||1
203823|NCT00727194|499858|P1|NOT COMPLETED|Treatment Period 2||0
203824|NCT00727194|499856|P3|COMPLETED|Treatment Period 2||0
203825|NCT00727194|499857|P2|COMPLETED|Treatment Period 2||5
203826|NCT00727194|499858|P1|COMPLETED|Treatment Period 2||6
203827|NCT00727194|499856|P3|STARTED|Treatment Period 2||0
203828|NCT00727194|499857|P2|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
203829|NCT00727194|499858|P1|STARTED|Treatment Period 2|Sponsor terminated study early; 2 patients (total) exited study without starting Treatment Period 2.|6
203830|NCT00727194|499856|P3|NOT COMPLETED|Washout Period||0
203831|NCT00727194|499857|P2|NOT COMPLETED|Washout Period||0
203832|NCT00727194|499858|P1|NOT COMPLETED|Washout Period||0
203833|NCT00727194|499856|P3|COMPLETED|Washout Period||0
203834|NCT00727194|499857|P2|COMPLETED|Washout Period||7
203835|NCT00727194|499858|P1|COMPLETED|Washout Period||7
203836|NCT00727194|499856|P3|STARTED|Washout Period||0
203837|NCT00727194|499857|P2|STARTED|Washout Period||7
203838|NCT00727194|499858|P1|STARTED|Washout Period||7
203839|NCT00727194|499856|P3|NOT COMPLETED|Treatment Period 1||0
203840|NCT00727194|499857|P2|NOT COMPLETED|Treatment Period 1||0
203841|NCT00727194|499858|P1|NOT COMPLETED|Treatment Period 1||0
203842|NCT00727194|499856|P3|COMPLETED|Treatment Period 1||0
203843|NCT00727194|499857|P2|COMPLETED|Treatment Period 1||7
203844|NCT00727194|499858|P1|COMPLETED|Treatment Period 1||7
203845|NCT00727194|499856|P3|STARTED|Treatment Period 1||0
203846|NCT00727194|499857|P2|STARTED|Treatment Period 1||7
203847|NCT00727194|499858|P1|STARTED|Treatment Period 1||7
203848|NCT00727194|499856|P3|NOT COMPLETED|Screening Period||16
203849|NCT00727194|499857|P2|NOT COMPLETED|Screening Period||0
203850|NCT00727194|499858|P1|NOT COMPLETED|Screening Period||0
203851|NCT00727194|499856|P3|COMPLETED|Screening Period||0
203852|NCT00727194|499857|P2|COMPLETED|Screening Period||7
203853|NCT00727194|499858|P1|COMPLETED|Screening Period||7
203854|NCT00727194|499856|P3|STARTED|Screening Period||16
203855|NCT00727194|499857|P2|STARTED|Screening Period||7
203856|NCT00727194|499858|P1|STARTED|Screening Period||7
203857|NCT00727220|499894|P2|NOT COMPLETED|Overall Study||4
203858|NCT00727220|499895|P1|NOT COMPLETED|Overall Study||1
203859|NCT00727220|499894|P2|COMPLETED|Overall Study||17
203860|NCT00727220|499895|P1|COMPLETED|Overall Study||20
203861|NCT00727220|499894|P2|STARTED|Overall Study||21
203862|NCT00727220|499895|P1|STARTED|Overall Study||21
203863|NCT00727246|499905|P4|NOT COMPLETED|Overall Study||2
203864|NCT00727246|499906|P3|NOT COMPLETED|Overall Study||1
203865|NCT00727246|499907|P2|NOT COMPLETED|Overall Study||1
203866|NCT00727246|499908|P1|NOT COMPLETED|Overall Study||0
203867|NCT00727246|499905|P4|COMPLETED|Overall Study||3
203868|NCT00727246|499906|P3|COMPLETED|Overall Study||7
203869|NCT00727246|499907|P2|COMPLETED|Overall Study||2
203870|NCT00727246|499908|P1|COMPLETED|Overall Study||3
203871|NCT00727246|499905|P4|STARTED|Overall Study||5
203872|NCT00727246|499906|P3|STARTED|Overall Study||8
203873|NCT00727246|499907|P2|STARTED|Overall Study||3
203874|NCT00727246|499908|P1|STARTED|Overall Study||3
203875|NCT00727259|499922|P1|NOT COMPLETED|Overall Study||1055
203876|NCT00727259|499922|P1|COMPLETED|Overall Study||940
203877|NCT00727259|499922|P1|STARTED|Overall Study||1995
203878|NCT00727272|499927|P3|NOT COMPLETED|Period III||0
203879|NCT00727272|499928|P2|NOT COMPLETED|Period III||0
203880|NCT00727272|499929|P1|NOT COMPLETED|Period III||0
203881|NCT00727272|499927|P3|COMPLETED|Period III||7
203882|NCT00727272|499928|P2|COMPLETED|Period III||9
203883|NCT00727272|499929|P1|COMPLETED|Period III||9
203884|NCT00727272|499927|P3|STARTED|Period III||7
203885|NCT00727272|499928|P2|STARTED|Period III||9
203886|NCT00727272|499929|P1|STARTED|Period III||9
203887|NCT00727272|499927|P3|NOT COMPLETED|Washout Period B||1
203888|NCT00727272|499928|P2|NOT COMPLETED|Washout Period B||0
203889|NCT00727272|499929|P1|NOT COMPLETED|Washout Period B||0
203890|NCT00727272|499927|P3|COMPLETED|Washout Period B|personal reasons|7
203891|NCT00727272|499928|P2|COMPLETED|Washout Period B||9
203892|NCT00727272|499929|P1|COMPLETED|Washout Period B||9
203893|NCT00727272|499927|P3|STARTED|Washout Period B||8
203894|NCT00727272|499928|P2|STARTED|Washout Period B||9
203895|NCT00727272|499929|P1|STARTED|Washout Period B||9
203896|NCT00727272|499927|P3|NOT COMPLETED|Period II||0
203897|NCT00727272|499928|P2|NOT COMPLETED|Period II||0
203898|NCT00727272|499929|P1|NOT COMPLETED|Period II||0
203899|NCT00727272|499927|P3|COMPLETED|Period II||8
203900|NCT00727272|499928|P2|COMPLETED|Period II||9
203901|NCT00727272|499929|P1|COMPLETED|Period II||9
203902|NCT00727272|499927|P3|STARTED|Period II||8
203903|NCT00727272|499928|P2|STARTED|Period II||9
203904|NCT00727272|499929|P1|STARTED|Period II||9
203905|NCT00727272|499927|P3|NOT COMPLETED|Washout Period A||1
203906|NCT00727272|499928|P2|NOT COMPLETED|Washout Period A||0
203907|NCT00727272|499929|P1|NOT COMPLETED|Washout Period A||0
203908|NCT00727272|499927|P3|COMPLETED|Washout Period A|positive pregnancy test - recorded as an adverse event|8
203909|NCT00727272|499928|P2|COMPLETED|Washout Period A||9
203910|NCT00727272|499929|P1|COMPLETED|Washout Period A||9
203911|NCT00727272|499927|P3|STARTED|Washout Period A||9
203912|NCT00727272|499928|P2|STARTED|Washout Period A||9
203913|NCT00727272|499929|P1|STARTED|Washout Period A||9
203914|NCT00727272|499927|P3|NOT COMPLETED|Period I||0
203915|NCT00727272|499928|P2|NOT COMPLETED|Period I||0
203916|NCT00727272|499929|P1|NOT COMPLETED|Period I||0
203917|NCT00727272|499927|P3|COMPLETED|Period I||9
203918|NCT00727272|499928|P2|COMPLETED|Period I||9
203919|NCT00727272|499929|P1|COMPLETED|Period I||9
203920|NCT00727272|499927|P3|STARTED|Period I||9
203921|NCT00727272|499928|P2|STARTED|Period I||9
203922|NCT00727272|499929|P1|STARTED|Period I||9
203923|NCT00727298|499946|P1|NOT COMPLETED|Overall Study||1257
203924|NCT00727298|499946|P1|COMPLETED|Overall Study||3228
203925|NCT00727298|499946|P1|STARTED|Overall Study||4485
203926|NCT00727311|499952|P1|NOT COMPLETED|Overall Study||1107
203927|NCT00727311|499952|P1|COMPLETED|Overall Study||1195
203928|NCT00727311|499952|P1|STARTED|Overall Study||2302
203929|NCT00734097|499959|P1|NOT COMPLETED|Open Label||16
203930|NCT00734097|499959|P1|COMPLETED|Open Label|16 patients discontinued after randomization|301
203931|NCT00734097|499959|P1|Per Protocol|Open Label||301
203932|NCT00734097|499959|P1|Full Analysis|Open Label||311
203933|NCT00734097|499959|P1|Safety Analysis|Open Label||317
203934|NCT00734097|499959|P1|STARTED|Open Label|Full analysis performed in 311|317
203935|NCT00734097|499959|P1|NOT COMPLETED|Screening||20
203936|NCT00734097|499959|P1|COMPLETED|Screening|20 participants were screening failure.|317
203937|NCT00734097|499959|P1|STARTED|Screening||337
203938|NCT00734149|499974|P1|NOT COMPLETED|Overall Study||1
203939|NCT00734149|499974|P1|COMPLETED|Overall Study||44
203940|NCT00734149|499974|P1|STARTED|Overall Study||45
203941|NCT00734162|499985|P4|NOT COMPLETED|Open-Label Phase||3
203942|NCT00734162|499986|P3|NOT COMPLETED|Open-Label Phase||1
203943|NCT00734162|499987|P2|NOT COMPLETED|Open-Label Phase||2
203944|NCT00734162|499988|P1|NOT COMPLETED|Open-Label Phase||3
203945|NCT00734162|499985|P4|COMPLETED|Open-Label Phase||36
203946|NCT00734162|499986|P3|COMPLETED|Open-Label Phase||12
203947|NCT00734162|499987|P2|COMPLETED|Open-Label Phase||39
203948|NCT00734162|499988|P1|COMPLETED|Open-Label Phase||7
203949|NCT00734162|499985|P4|STARTED|Open-Label Phase|2 participants switched to open-label treatment before completing double-blind period (elevated ALT)|39
203950|NCT00734162|499986|P3|STARTED|Open-Label Phase||13
203951|NCT00734162|499987|P2|STARTED|Open-Label Phase||41
203952|NCT00734162|499988|P1|STARTED|Open-Label Phase||10
203953|NCT00734162|499985|P4|NOT COMPLETED|Randomized Phase (Through Week 72)||4
203954|NCT00734162|499986|P3|NOT COMPLETED|Randomized Phase (Through Week 72)||0
203955|NCT00734162|499987|P2|NOT COMPLETED|Randomized Phase (Through Week 72)||1
203956|NCT00734162|499988|P1|NOT COMPLETED|Randomized Phase (Through Week 72)||0
203957|NCT00734162|499985|P4|COMPLETED|Randomized Phase (Through Week 72)||37
203958|NCT00734162|499986|P3|COMPLETED|Randomized Phase (Through Week 72)||13
203959|NCT00734162|499987|P2|COMPLETED|Randomized Phase (Through Week 72)||41
203960|NCT00734162|499988|P1|COMPLETED|Randomized Phase (Through Week 72)||10
203961|NCT00734162|499985|P4|STARTED|Randomized Phase (Through Week 72)||41
203962|NCT00734162|499986|P3|STARTED|Randomized Phase (Through Week 72)||13
203963|NCT00734162|499987|P2|STARTED|Randomized Phase (Through Week 72)||42
203964|NCT00734162|499988|P1|STARTED|Randomized Phase (Through Week 72)||10
203965|NCT00734214|500214|P2|NOT COMPLETED|Overall Study||4
203966|NCT00734214|500215|P1|NOT COMPLETED|Overall Study||4
203967|NCT00734214|500214|P2|COMPLETED|Overall Study||126
203968|NCT00734214|500215|P1|COMPLETED|Overall Study||124
203969|NCT00734214|500214|P2|STARTED|Overall Study||130
203970|NCT00734214|500215|P1|STARTED|Overall Study||128
203971|NCT00734305|500223|P7|NOT COMPLETED|Overall Study||0
203972|NCT00734305|500224|P6|NOT COMPLETED|Overall Study||0
203973|NCT00734305|500225|P5|NOT COMPLETED|Overall Study||0
203974|NCT00734305|500226|P4|NOT COMPLETED|Overall Study||0
203975|NCT00734305|500227|P3|NOT COMPLETED|Overall Study||0
203976|NCT00734305|500228|P2|NOT COMPLETED|Overall Study||0
203977|NCT00734305|500229|P1|NOT COMPLETED|Overall Study||1
203978|NCT00734305|500223|P7|COMPLETED|Overall Study||18
203979|NCT00734305|500224|P6|COMPLETED|Overall Study||4
203980|NCT00734305|500225|P5|COMPLETED|Overall Study||5
203981|NCT00734305|500226|P4|COMPLETED|Overall Study||3
203982|NCT00734305|500227|P3|COMPLETED|Overall Study||4
203983|NCT00734305|500228|P2|COMPLETED|Overall Study||3
203984|NCT00734305|500229|P1|COMPLETED|Overall Study|1 patient was enrolled but did not meet eligibility criteria at C1W1, and thus was never dosed|6
203985|NCT00734305|500223|P7|STARTED|Overall Study||18
203986|NCT00734305|500224|P6|STARTED|Overall Study||4
203987|NCT00734305|500225|P5|STARTED|Overall Study||5
203988|NCT00734305|500226|P4|STARTED|Overall Study||3
203989|NCT00734305|500227|P3|STARTED|Overall Study||4
203990|NCT00734305|500228|P2|STARTED|Overall Study||3
203991|NCT00734305|500229|P1|STARTED|Overall Study||7
203992|NCT00734344|500260|P2|NOT COMPLETED|Overall Study||0
203993|NCT00734344|500261|P1|NOT COMPLETED|Overall Study||0
203994|NCT00734344|500260|P2|COMPLETED|Overall Study||9
203995|NCT00734344|500261|P1|COMPLETED|Overall Study||9
203996|NCT00734344|500260|P2|STARTED|Overall Study||9
203997|NCT00734344|500261|P1|STARTED|Overall Study||9
203998|NCT00734409|500331|P2|NOT COMPLETED|Overall Study||0
203999|NCT00734409|500332|P1|NOT COMPLETED|Overall Study||0
204000|NCT00734409|500331|P2|COMPLETED|Overall Study||145
204001|NCT00734409|500332|P1|COMPLETED|Overall Study||155
204002|NCT00734409|500331|P2|STARTED|Overall Study||145
204003|NCT00734409|500332|P1|STARTED|Overall Study||155
204004|NCT00734799|500344|P2|NOT COMPLETED|Overall Study||4
204005|NCT00734799|500345|P1|NOT COMPLETED|Overall Study||0
204006|NCT00734799|500344|P2|COMPLETED|Overall Study||9
204007|NCT00734799|500345|P1|COMPLETED|Overall Study||9
204008|NCT00734799|500344|P2|STARTED|Overall Study||13
204009|NCT00734799|500345|P1|STARTED|Overall Study||9
204010|NCT00734851|500353|P1|NOT COMPLETED|Overall Study||21
204011|NCT00734851|500353|P1|COMPLETED|Overall Study||13
204012|NCT00734851|500353|P1|STARTED|Overall Study||34
204013|NCT00734929|500365|P2|NOT COMPLETED|Overall Study||5
204014|NCT00734929|500366|P1|NOT COMPLETED|Overall Study||6
204015|NCT00734929|500365|P2|COMPLETED|Overall Study||53
204016|NCT00734929|500366|P1|COMPLETED|Overall Study||51
204017|NCT00734929|500365|P2|STARTED|Overall Study||58
204018|NCT00734929|500366|P1|STARTED|Overall Study||57
204019|NCT00734968|500396|P2|NOT COMPLETED|Overall Study||1
204020|NCT00734968|500397|P1|NOT COMPLETED|Overall Study||1
204021|NCT00734968|500396|P2|COMPLETED|Overall Study||75
204022|NCT00734968|500397|P1|COMPLETED|Overall Study||76
204023|NCT00734968|500396|P2|STARTED|Overall Study||76
204024|NCT00734968|500397|P1|STARTED|Overall Study||77
204025|NCT00734994|500407|P1|NOT COMPLETED|Overall Study||1
204026|NCT00734994|500407|P1|COMPLETED|Overall Study||14
204027|NCT00734994|500407|P1|STARTED|Overall Study||15
204028|NCT00735007|500412|P1|NOT COMPLETED|Overall Study||5
204029|NCT00735007|500412|P1|COMPLETED|Overall Study||101
204030|NCT00735007|500412|P1|STARTED|Overall Study||106
204031|NCT00735072|500439|P2|NOT COMPLETED|Overall Study||1
204032|NCT00735072|500440|P1|NOT COMPLETED|Overall Study||1
204033|NCT00735072|500439|P2|COMPLETED|Overall Study||21
204034|NCT00735072|500440|P1|COMPLETED|Overall Study||22
204035|NCT00735072|500439|P2|STARTED|Overall Study||22
204036|NCT00735072|500440|P1|STARTED|Overall Study||23
204037|NCT00735306|500446|P1|NOT COMPLETED|Overall Study||0
204038|NCT00735306|500446|P1|COMPLETED|Overall Study||12
204039|NCT00735306|500446|P1|STARTED|Overall Study||12
204040|NCT00735371|500456|P4|NOT COMPLETED|Overall Study||10
204041|NCT00735371|500457|P3|NOT COMPLETED|Overall Study||11
204042|NCT00735371|500458|P2|NOT COMPLETED|Overall Study||13
204043|NCT00735371|500459|P1|NOT COMPLETED|Overall Study||15
204044|NCT00735371|500456|P4|COMPLETED|Overall Study||69
204045|NCT00735371|500457|P3|COMPLETED|Overall Study||67
204046|NCT00735371|500458|P2|COMPLETED|Overall Study||66
204047|NCT00735371|500459|P1|COMPLETED|Overall Study||63
204048|NCT00735371|500456|P4|STARTED|Overall Study||79
204049|NCT00735371|500457|P3|STARTED|Overall Study||78
204050|NCT00735371|500458|P2|STARTED|Overall Study||79
204051|NCT00735371|500459|P1|STARTED|Overall Study||78
204052|NCT00735397|500477|P1|NOT COMPLETED|Overall Study||1183
204053|NCT00735397|500477|P1|COMPLETED|Overall Study||35
204054|NCT00735397|500477|P1|STARTED|Overall Study||1218
204055|NCT00735436|500487|P1|NOT COMPLETED|Overall Study||0
204056|NCT00735436|500487|P1|COMPLETED|Overall Study||18
204057|NCT00735436|500487|P1|STARTED|Overall Study||18
204058|NCT00735449|500498|P2|NOT COMPLETED|Overall Study||6
204059|NCT00735449|500499|P1|NOT COMPLETED|Overall Study||7
204060|NCT00735449|500498|P2|COMPLETED|Overall Study||96
204061|NCT00735449|500499|P1|COMPLETED|Overall Study||95
204062|NCT00735449|500498|P2|STARTED|Overall Study||102
204063|NCT00735449|500499|P1|STARTED|Overall Study||102
204064|NCT00735462|500516|P3|NOT COMPLETED|Overall Study||28
204065|NCT00735462|500517|P2|NOT COMPLETED|Overall Study||55
204066|NCT00735462|500518|P1|NOT COMPLETED|Overall Study||63
204067|NCT00735462|500516|P3|COMPLETED|Overall Study||77
204068|NCT00735462|500517|P2|COMPLETED|Overall Study||149
204069|NCT00735462|500518|P1|COMPLETED|Overall Study||139
204070|NCT00735462|500516|P3|STARTED|Overall Study||105
204071|NCT00735462|500517|P2|STARTED|Overall Study||204
204072|NCT00735462|500518|P1|STARTED|Overall Study||202
204073|NCT00735475|500531|P2|NOT COMPLETED|Overall Study||11
204074|NCT00735475|500532|P1|NOT COMPLETED|Overall Study||8
204075|NCT00735475|500531|P2|COMPLETED|Overall Study||626
204076|NCT00735475|500532|P1|COMPLETED|Overall Study||623
204077|NCT00735475|500531|P2|STARTED|Overall Study||637
204078|NCT00735475|500532|P1|STARTED|Overall Study||631
204079|NCT00735553|500553|P1|NOT COMPLETED|Overall Study||77
204080|NCT00735553|500553|P1|COMPLETED|Overall Study||0
204081|NCT00735553|500553|P1|STARTED|Overall Study||77
204082|NCT00735618|500561|P1|NOT COMPLETED|Overall Study||0
204083|NCT00735618|500561|P1|COMPLETED|Overall Study||19
204084|NCT00735618|500561|P1|STARTED|Overall Study||19
204085|NCT00735644|500570|P5|NOT COMPLETED|Overall Study||0
204086|NCT00735644|500571|P4|NOT COMPLETED|Overall Study||1
204087|NCT00735644|500572|P3|NOT COMPLETED|Overall Study||1
204088|NCT00735644|500573|P2|NOT COMPLETED|Overall Study||2
204089|NCT00735644|500574|P1|NOT COMPLETED|Overall Study||0
204090|NCT00735644|500570|P5|COMPLETED|Overall Study||102
204091|NCT00735644|500571|P4|COMPLETED|Overall Study||198
204092|NCT00735644|500572|P3|COMPLETED|Overall Study||295
204093|NCT00735644|500573|P2|COMPLETED|Overall Study||298
204094|NCT00735644|500574|P1|COMPLETED|Overall Study||303
204095|NCT00735644|500570|P5|STARTED|Overall Study||102
204096|NCT00735644|500571|P4|STARTED|Overall Study||199
204097|NCT00735644|500572|P3|STARTED|Overall Study||296
204098|NCT00735644|500573|P2|STARTED|Overall Study||300
204099|NCT00735644|500574|P1|STARTED|Overall Study||303
204100|NCT00735670|500613|P2|NOT COMPLETED|Overall Study||5
204101|NCT00735670|500614|P1|NOT COMPLETED|Overall Study||4
204102|NCT00735670|500613|P2|COMPLETED|Overall Study||6
204103|NCT00735670|500614|P1|COMPLETED|Overall Study||6
204104|NCT00735670|500613|P2|STARTED|Overall Study||11
204105|NCT00735670|500614|P1|STARTED|Overall Study||10
204106|NCT00735696|500622|P1|NOT COMPLETED|Overall Study||2
204107|NCT00735696|500622|P1|COMPLETED|Overall Study||39
204108|NCT00735696|500622|P1|Received Any Quantity of Study Drug|Overall Study||40
204109|NCT00735696|500622|P1|STARTED|Overall Study||41
204110|NCT00735709|500638|P4|NOT COMPLETED|Overall Study||18
204111|NCT00735709|500639|P3|NOT COMPLETED|Overall Study||11
204112|NCT00735709|500640|P2|NOT COMPLETED|Overall Study||13
204113|NCT00735709|500641|P1|NOT COMPLETED|Overall Study||13
204114|NCT00735709|500638|P4|COMPLETED|Overall Study||122
204115|NCT00735709|500639|P3|COMPLETED|Overall Study||129
204116|NCT00735709|500640|P2|COMPLETED|Overall Study||127
204117|NCT00735709|500641|P1|COMPLETED|Overall Study||127
204118|NCT00735709|500638|P4|Treated|Overall Study||139
204119|NCT00735709|500639|P3|Treated|Overall Study||140
204120|NCT00735709|500640|P2|Treated|Overall Study||140
204121|NCT00735709|500641|P1|Treated|Overall Study||140
204122|NCT00735709|500638|P4|STARTED|Overall Study||140
204123|NCT00735709|500639|P3|STARTED|Overall Study||140
204124|NCT00735709|500640|P2|STARTED|Overall Study||140
204125|NCT00735709|500641|P1|STARTED|Overall Study||140
204126|NCT00735787|500753|P2|NOT COMPLETED|Period 2||1
204127|NCT00735787|500754|P1|NOT COMPLETED|Period 2||5
204128|NCT00735787|500753|P2|COMPLETED|Period 2||40
204129|NCT00735787|500754|P1|COMPLETED|Period 2||13
204130|NCT00735787|500753|P2|STARTED|Period 2||41
204131|NCT00735787|500754|P1|STARTED|Period 2||18
204132|NCT00735787|500753|P2|NOT COMPLETED|Period 1||8
204133|NCT00735787|500754|P1|NOT COMPLETED|Period 1||6
204134|NCT00735787|500753|P2|COMPLETED|Period 1||41
204135|NCT00735787|500754|P1|COMPLETED|Period 1|Per visit window, 18 completed; 17 completed per subject case report form.|17
204136|NCT00735787|500753|P2|STARTED|Period 1||49
204137|NCT00735787|500754|P1|STARTED|Period 1||23
204138|NCT00735839|500800|P2|NOT COMPLETED|Overall Study||0
204139|NCT00735839|500801|P1|NOT COMPLETED|Overall Study||0
204140|NCT00735839|500800|P2|COMPLETED|Overall Study||10
204141|NCT00735839|500801|P1|COMPLETED|Overall Study||30
204142|NCT00735839|500800|P2|STARTED|Overall Study||10
204143|NCT00735839|500801|P1|STARTED|Overall Study||30
204144|NCT00735904|500809|P1|NOT COMPLETED|Overall Study||38
204145|NCT00735904|500809|P1|COMPLETED|Overall Study||0
204146|NCT00735904|500809|P1|STARTED|Overall Study||38
204147|NCT00735917|500816|P1|NOT COMPLETED|Overall Study||0
204148|NCT00735917|500816|P1|COMPLETED|Overall Study||19
204149|NCT00735917|500816|P1|STARTED|Overall Study||19
204150|NCT00735943|500824|P1|NOT COMPLETED|Overall Study||2
204151|NCT00735943|500824|P1|COMPLETED|Overall Study||20
204152|NCT00735943|500824|P1|STARTED|Overall Study||22
204153|NCT00735969|500841|P1|NOT COMPLETED|Overall Study||0
204154|NCT00735969|500841|P1|COMPLETED|Overall Study||21
204155|NCT00735969|500841|P1|STARTED|Overall Study||21
204156|NCT00736034|500845|P1|NOT COMPLETED|Overall Study||2
204157|NCT00736034|500845|P1|COMPLETED|Overall Study||16
204158|NCT00736034|500845|P1|STARTED|Overall Study||18
204159|NCT00736073|500851|P2|NOT COMPLETED|Overall Study||0
204160|NCT00736073|500852|P1|NOT COMPLETED|Overall Study||0
204161|NCT00736073|500851|P2|COMPLETED|Overall Study||39
204162|NCT00736073|500852|P1|COMPLETED|Overall Study||34
204163|NCT00736073|500851|P2|STARTED|Overall Study||39
204164|NCT00736073|500852|P1|STARTED|Overall Study||34
204165|NCT00736099|500864|P2|NOT COMPLETED|Overall Study||58
204166|NCT00736099|500865|P1|NOT COMPLETED|Overall Study||183
204167|NCT00736099|500864|P2|COMPLETED|Overall Study|Number who completed treatment.|531
204168|NCT00736099|500865|P1|COMPLETED|Overall Study|Number who completed treatment.|1349
204169|NCT00736099|500864|P2|STARTED|Overall Study|Number who started treatment.|589
204170|NCT00736099|500865|P1|STARTED|Overall Study|Number who started treatment.|1532
204171|NCT00736125|500963|P2|NOT COMPLETED|Overall Study||2
204172|NCT00736125|500964|P1|NOT COMPLETED|Overall Study||1
204173|NCT00736125|500963|P2|COMPLETED|Overall Study||8
204174|NCT00736125|500964|P1|COMPLETED|Overall Study||9
204175|NCT00736125|500963|P2|STARTED|Overall Study||10
204176|NCT00736125|500964|P1|STARTED|Overall Study||10
204177|NCT00736190|500972|P1|NOT COMPLETED|Overall Study||3
204178|NCT00736190|500972|P1|COMPLETED|Overall Study||87
204179|NCT00736190|500972|P1|STARTED|Overall Study||90
204180|NCT00736229|500988|P3|NOT COMPLETED|Overall Study||0
204181|NCT00736229|500989|P2|NOT COMPLETED|Overall Study||0
204182|NCT00736229|500990|P1|NOT COMPLETED|Overall Study||0
204183|NCT00736229|500988|P3|COMPLETED|Overall Study||84
204184|NCT00736229|500989|P2|COMPLETED|Overall Study||71
204185|NCT00736229|500990|P1|COMPLETED|Overall Study|All patients received bolus and fixed infusion of study drug, thus completed the study|40
204186|NCT00736229|500988|P3|STARTED|Overall Study|Historic Control|84
204187|NCT00736229|500989|P2|STARTED|Overall Study|Historic control|71
204188|NCT00736229|500990|P1|STARTED|Overall Study|Actively Enrolled|40
204189|NCT00736242|501003|P1|NOT COMPLETED|Overall Study||125
204190|NCT00736242|501003|P1|COMPLETED|Overall Study||107
204191|NCT00736242|501003|P1|Participants in Safety Analysis Set|Overall Study||229
204192|NCT00736242|501003|P1|STARTED|Overall Study||232
204193|NCT00736255|501016|P2|NOT COMPLETED|Overall Study||1
204194|NCT00736255|501017|P1|NOT COMPLETED|Overall Study||3
204195|NCT00736255|501016|P2|COMPLETED|Overall Study||14
204196|NCT00736255|501017|P1|COMPLETED|Overall Study||14
204197|NCT00736255|501016|P2|STARTED|Overall Study||15
204198|NCT00736255|501017|P1|STARTED|Overall Study||17
204199|NCT00736333|501027|P1|NOT COMPLETED|Overall Study||111
204200|NCT00736333|501027|P1|COMPLETED|Overall Study||56
204201|NCT00736333|501027|P1|STARTED|Overall Study||167
204202|NCT00736385|501038|P2|NOT COMPLETED|Overall Study||3
204203|NCT00736385|501039|P1|NOT COMPLETED|Overall Study||2
204204|NCT00736385|501038|P2|COMPLETED|Overall Study||2
204205|NCT00736385|501039|P1|COMPLETED|Overall Study||2
204206|NCT00736385|501038|P2|STARTED|Overall Study||5
204207|NCT00736385|501039|P1|STARTED|Overall Study||4
204208|NCT00736476|501053|P2|NOT COMPLETED|Overall Study||0
204209|NCT00736476|501054|P1|NOT COMPLETED|Overall Study||1
204210|NCT00736476|501053|P2|COMPLETED|Overall Study||27
204211|NCT00736476|501054|P1|COMPLETED|Overall Study||35
204212|NCT00736476|501053|P2|STARTED|Overall Study||27
204213|NCT00736476|501054|P1|STARTED|Overall Study||36
204214|NCT00736489|501074|P6|NOT COMPLETED|Period 6||0
204215|NCT00736489|501075|P5|NOT COMPLETED|Period 6||0
204216|NCT00736489|501076|P4|NOT COMPLETED|Period 6||0
204217|NCT00736489|501077|P3|NOT COMPLETED|Period 6||0
204218|NCT00736489|501078|P2|NOT COMPLETED|Period 6||0
204219|NCT00736489|501079|P1|NOT COMPLETED|Period 6||0
204220|NCT00736489|501074|P6|COMPLETED|Period 6||5
204221|NCT00736489|501075|P5|COMPLETED|Period 6||7
204222|NCT00736489|501076|P4|COMPLETED|Period 6||7
204223|NCT00736489|501077|P3|COMPLETED|Period 6||6
204224|NCT00736489|501078|P2|COMPLETED|Period 6||5
204225|NCT00736489|501079|P1|COMPLETED|Period 6||5
204226|NCT00736489|501074|P6|STARTED|Period 6||5
204227|NCT00736489|501075|P5|STARTED|Period 6||7
204228|NCT00736489|501076|P4|STARTED|Period 6||7
204229|NCT00736489|501077|P3|STARTED|Period 6||6
204230|NCT00736489|501078|P2|STARTED|Period 6||5
204231|NCT00736489|501079|P1|STARTED|Period 6||5
204232|NCT00736489|501074|P6|NOT COMPLETED|Period 5||0
204233|NCT00736489|501075|P5|NOT COMPLETED|Period 5||0
204234|NCT00736489|501076|P4|NOT COMPLETED|Period 5||0
204235|NCT00736489|501077|P3|NOT COMPLETED|Period 5||0
204236|NCT00736489|501078|P2|NOT COMPLETED|Period 5||0
204237|NCT00736489|501079|P1|NOT COMPLETED|Period 5||0
204238|NCT00736489|501074|P6|COMPLETED|Period 5||5
204239|NCT00736489|501075|P5|COMPLETED|Period 5||7
204240|NCT00736489|501076|P4|COMPLETED|Period 5||7
204241|NCT00736489|501077|P3|COMPLETED|Period 5||6
204242|NCT00736489|501078|P2|COMPLETED|Period 5||5
204243|NCT00736489|501079|P1|COMPLETED|Period 5||5
204244|NCT00736489|501074|P6|STARTED|Period 5||5
204245|NCT00736489|501075|P5|STARTED|Period 5||7
204246|NCT00736489|501076|P4|STARTED|Period 5||7
204247|NCT00736489|501077|P3|STARTED|Period 5||6
204248|NCT00736489|501078|P2|STARTED|Period 5||5
204249|NCT00736489|501079|P1|STARTED|Period 5||5
204250|NCT00736489|501074|P6|NOT COMPLETED|Period 4||0
204251|NCT00736489|501075|P5|NOT COMPLETED|Period 4||0
204252|NCT00736489|501076|P4|NOT COMPLETED|Period 4||0
204253|NCT00736489|501077|P3|NOT COMPLETED|Period 4||0
204254|NCT00736489|501078|P2|NOT COMPLETED|Period 4||0
204255|NCT00736489|501079|P1|NOT COMPLETED|Period 4||0
204256|NCT00736489|501074|P6|COMPLETED|Period 4||5
204257|NCT00736489|501075|P5|COMPLETED|Period 4||7
204258|NCT00736489|501076|P4|COMPLETED|Period 4||7
204259|NCT00736489|501077|P3|COMPLETED|Period 4||6
204260|NCT00736489|501078|P2|COMPLETED|Period 4||5
204261|NCT00736489|501079|P1|COMPLETED|Period 4||5
204262|NCT00736489|501074|P6|STARTED|Period 4||5
204263|NCT00736489|501075|P5|STARTED|Period 4||7
204264|NCT00736489|501076|P4|STARTED|Period 4||7
204265|NCT00736489|501077|P3|STARTED|Period 4||6
204266|NCT00736489|501078|P2|STARTED|Period 4||5
204267|NCT00736489|501079|P1|STARTED|Period 4||5
204268|NCT00736489|501074|P6|NOT COMPLETED|Period 3||0
204269|NCT00736489|501075|P5|NOT COMPLETED|Period 3||0
204270|NCT00736489|501076|P4|NOT COMPLETED|Period 3||0
204271|NCT00736489|501077|P3|NOT COMPLETED|Period 3||0
204272|NCT00736489|501078|P2|NOT COMPLETED|Period 3||0
204273|NCT00736489|501079|P1|NOT COMPLETED|Period 3||0
204274|NCT00736489|501074|P6|COMPLETED|Period 3||5
204275|NCT00736489|501075|P5|COMPLETED|Period 3||7
204276|NCT00736489|501076|P4|COMPLETED|Period 3||7
204277|NCT00736489|501077|P3|COMPLETED|Period 3||6
204278|NCT00736489|501078|P2|COMPLETED|Period 3||5
204279|NCT00736489|501079|P1|COMPLETED|Period 3||5
204280|NCT00736489|501074|P6|STARTED|Period 3||5
204281|NCT00736489|501075|P5|STARTED|Period 3||7
204282|NCT00736489|501076|P4|STARTED|Period 3||7
204283|NCT00736489|501077|P3|STARTED|Period 3||6
204284|NCT00736489|501078|P2|STARTED|Period 3||5
204285|NCT00736489|501079|P1|STARTED|Period 3||5
204286|NCT00736489|501074|P6|NOT COMPLETED|Period 2||0
204287|NCT00736489|501075|P5|NOT COMPLETED|Period 2||0
204288|NCT00736489|501076|P4|NOT COMPLETED|Period 2||0
204289|NCT00736489|501077|P3|NOT COMPLETED|Period 2||0
204290|NCT00736489|501078|P2|NOT COMPLETED|Period 2||0
204291|NCT00736489|501079|P1|NOT COMPLETED|Period 2||0
204292|NCT00736489|501074|P6|COMPLETED|Period 2||5
204293|NCT00736489|501075|P5|COMPLETED|Period 2||7
204294|NCT00736489|501076|P4|COMPLETED|Period 2||7
204295|NCT00736489|501077|P3|COMPLETED|Period 2||6
204296|NCT00736489|501078|P2|COMPLETED|Period 2||5
204297|NCT00736489|501079|P1|COMPLETED|Period 2||5
204298|NCT00736489|501074|P6|STARTED|Period 2||5
204299|NCT00736489|501075|P5|STARTED|Period 2||7
204300|NCT00736489|501076|P4|STARTED|Period 2||7
204301|NCT00736489|501077|P3|STARTED|Period 2||6
204302|NCT00736489|501078|P2|STARTED|Period 2||5
204303|NCT00736489|501079|P1|STARTED|Period 2||5
204304|NCT00736489|501074|P6|NOT COMPLETED|Period 1||1
204305|NCT00736489|501075|P5|NOT COMPLETED|Period 1||0
204306|NCT00736489|501076|P4|NOT COMPLETED|Period 1||0
204307|NCT00736489|501077|P3|NOT COMPLETED|Period 1||0
204308|NCT00736489|501078|P2|NOT COMPLETED|Period 1||0
204309|NCT00736489|501079|P1|NOT COMPLETED|Period 1||1
204310|NCT00736489|501074|P6|COMPLETED|Period 1||5
204311|NCT00736489|501075|P5|COMPLETED|Period 1||7
204312|NCT00736489|501076|P4|COMPLETED|Period 1||7
204313|NCT00736489|501077|P3|COMPLETED|Period 1||6
204314|NCT00736489|501078|P2|COMPLETED|Period 1||5
204315|NCT00736489|501079|P1|COMPLETED|Period 1||5
204316|NCT00736489|501074|P6|STARTED|Period 1||6
204317|NCT00736489|501075|P5|STARTED|Period 1||7
204318|NCT00736489|501076|P4|STARTED|Period 1||7
204319|NCT00736489|501077|P3|STARTED|Period 1||6
204320|NCT00736489|501078|P2|STARTED|Period 1||5
204321|NCT00736489|501079|P1|STARTED|Period 1|Cross-over study|6
204322|NCT00736502|501231|P1|NOT COMPLETED|Overall Study||65
204323|NCT00736502|501231|P1|COMPLETED|Overall Study||213
204324|NCT00736502|501231|P1|STARTED|Overall Study|Entered and treated.|278
204325|NCT00736580|501239|P2|NOT COMPLETED|Overall Study||0
204326|NCT00736580|501240|P1|NOT COMPLETED|Overall Study||0
204327|NCT00736580|501239|P2|COMPLETED|Overall Study||123
204328|NCT00736580|501240|P1|COMPLETED|Overall Study||117
204329|NCT00736580|501239|P2|STARTED|Overall Study||123
204330|NCT00736580|501240|P1|STARTED|Overall Study||117
204331|NCT00736723|501248|P2|NOT COMPLETED|Overall Study||3
204332|NCT00736723|501249|P1|NOT COMPLETED|Overall Study||4
204333|NCT00736723|501248|P2|COMPLETED|Overall Study||18
204334|NCT00736723|501249|P1|COMPLETED|Overall Study||26
204335|NCT00736723|501248|P2|STARTED|Overall Study||21
204336|NCT00736723|501249|P1|STARTED|Overall Study||30
204337|NCT00736840|501255|P1|NOT COMPLETED|Overall Study||13
204338|NCT00736840|501255|P1|COMPLETED|Overall Study|9 subjects-no biopsy results, 2-no breath test, 2 no biopsy results and no complete breath test|401
204339|NCT00736840|501255|P1|STARTED|Overall Study||414
204340|NCT00736853|501260|P3|NOT COMPLETED|Double-Blind Period||48
204341|NCT00736853|501261|P2|NOT COMPLETED|Double-Blind Period||24
204342|NCT00736853|501262|P1|NOT COMPLETED|Double-Blind Period||0
204343|NCT00736853|501260|P3|COMPLETED|Double-Blind Period||45
204344|NCT00736853|501261|P2|COMPLETED|Double-Blind Period||70
204345|NCT00736853|501262|P1|COMPLETED|Double-Blind Period||0
204346|NCT00736853|501260|P3|STARTED|Double-Blind Period||93
204347|NCT00736853|501261|P2|STARTED|Double-Blind Period||94
204348|NCT00736853|501262|P1|STARTED|Double-Blind Period||0
204349|NCT00736853|501260|P3|NOT COMPLETED|Open-Label Period||0
204350|NCT00736853|501261|P2|NOT COMPLETED|Open-Label Period||0
204351|NCT00736853|501262|P1|NOT COMPLETED|Open-Label Period||132
204352|NCT00736853|501260|P3|COMPLETED|Open-Label Period||0
204353|NCT00736853|501261|P2|COMPLETED|Open-Label Period||0
204354|NCT00736853|501262|P1|COMPLETED|Open-Label Period||187
204355|NCT00736853|501260|P3|Treated|Open-Label Period||0
204356|NCT00736853|501261|P2|Treated|Open-Label Period||0
204357|NCT00736853|501262|P1|Treated|Open-Label Period||277
204358|NCT00736853|501260|P3|STARTED|Open-Label Period||0
204359|NCT00736853|501261|P2|STARTED|Open-Label Period||0
204360|NCT00736853|501262|P1|STARTED|Open-Label Period||319
204361|NCT00736879|501306|P4|NOT COMPLETED|Follow up Period - No Drug Treatment||0
204362|NCT00736879|501307|P3|NOT COMPLETED|Follow up Period - No Drug Treatment||0
204363|NCT00736879|501308|P2|NOT COMPLETED|Follow up Period - No Drug Treatment||3
204364|NCT00736879|501309|P1|NOT COMPLETED|Follow up Period - No Drug Treatment||1
204365|NCT00736879|501306|P4|COMPLETED|Follow up Period - No Drug Treatment||62
204366|NCT00736879|501307|P3|COMPLETED|Follow up Period - No Drug Treatment||66
204367|NCT00736879|501308|P2|COMPLETED|Follow up Period - No Drug Treatment||67
204368|NCT00736879|501309|P1|COMPLETED|Follow up Period - No Drug Treatment||65
204369|NCT00736879|501306|P4|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|62
204370|NCT00736879|501307|P3|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
204371|NCT00736879|501308|P2|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|70
204372|NCT00736879|501309|P1|STARTED|Follow up Period - No Drug Treatment|Those not completing 24 weeks of treatment can still remain in the trial for 4 weeks of follow up.|66
204373|NCT00736879|501306|P4|NOT COMPLETED|Double Blind Treatment Period||5
204374|NCT00736879|501307|P3|NOT COMPLETED|Double Blind Treatment Period||7
204375|NCT00736879|501308|P2|NOT COMPLETED|Double Blind Treatment Period||4
204376|NCT00736879|501309|P1|NOT COMPLETED|Double Blind Treatment Period||3
204377|NCT00736879|501306|P4|COMPLETED|Double Blind Treatment Period||63
204378|NCT00736879|501307|P3|COMPLETED|Double Blind Treatment Period||67
204379|NCT00736879|501308|P2|COMPLETED|Double Blind Treatment Period||68
204380|NCT00736879|501309|P1|COMPLETED|Double Blind Treatment Period||65
204381|NCT00736879|501306|P4|STARTED|Double Blind Treatment Period||68
204382|NCT00736879|501307|P3|STARTED|Double Blind Treatment Period||74
204383|NCT00736879|501308|P2|STARTED|Double Blind Treatment Period||72
204384|NCT00736879|501309|P1|STARTED|Double Blind Treatment Period||68
204385|NCT00736944|501363|P1|NOT COMPLETED|Definitive Treatment||1
204386|NCT00736944|501363|P1|COMPLETED|Definitive Treatment||28
204387|NCT00736944|501363|P1|STARTED|Definitive Treatment||29
204388|NCT00736944|501363|P1|NOT COMPLETED|Induction||1
204389|NCT00736944|501363|P1|COMPLETED|Induction||29
204390|NCT00736944|501363|P1|STARTED|Induction||30
204391|NCT00736957|501390|P1|NOT COMPLETED|Overall Study||122
204392|NCT00736957|501390|P1|COMPLETED|Overall Study||97
204393|NCT00736957|501390|P1|Treated|Overall Study||190
204394|NCT00736957|501390|P1|STARTED|Overall Study||219
204395|NCT00736996|501403|P3|NOT COMPLETED|Overall Study||2
204396|NCT00736996|501404|P2|NOT COMPLETED|Overall Study||9
204397|NCT00736996|501405|P1|NOT COMPLETED|Overall Study||1
204398|NCT00736996|501403|P3|COMPLETED|Overall Study||25
204399|NCT00736996|501404|P2|COMPLETED|Overall Study||17
204400|NCT00736996|501405|P1|COMPLETED|Overall Study||24
204401|NCT00736996|501403|P3|STARTED|Overall Study||27
204402|NCT00736996|501404|P2|STARTED|Overall Study||26
204403|NCT00736996|501405|P1|STARTED|Overall Study||25
204404|NCT00737048|501422|P3|NOT COMPLETED|Overall Study||4
204405|NCT00737048|501423|P2|NOT COMPLETED|Overall Study||6
204406|NCT00737048|501424|P1|NOT COMPLETED|Overall Study||3
204407|NCT00737048|501422|P3|COMPLETED|Overall Study||126
204408|NCT00737048|501423|P2|COMPLETED|Overall Study||60
204409|NCT00737048|501424|P1|COMPLETED|Overall Study||129
204410|NCT00737048|501422|P3|STARTED|Overall Study||130
204411|NCT00737048|501423|P2|STARTED|Overall Study||66
204412|NCT00737048|501424|P1|STARTED|Overall Study||132
204413|NCT00737061|501465|P1|NOT COMPLETED|1 Year Wearing Period||17
204414|NCT00737061|501465|P1|COMPLETED|1 Year Wearing Period||553
204415|NCT00737061|501465|P1|STARTED|1 Year Wearing Period||570
204416|NCT00737061|501465|P1|NOT COMPLETED|Waiting Period||75
204417|NCT00737061|501465|P1|COMPLETED|Waiting Period||570
204418|NCT00737061|501465|P1|STARTED|Waiting Period||645
204419|NCT00737100|501482|P3|NOT COMPLETED|Overall Study||7
204420|NCT00737100|501483|P2|NOT COMPLETED|Overall Study||7
204421|NCT00737100|501484|P1|NOT COMPLETED|Overall Study||7
204422|NCT00737100|501482|P3|COMPLETED|Overall Study||169
204423|NCT00737100|501483|P2|COMPLETED|Overall Study||159
204424|NCT00737100|501484|P1|COMPLETED|Overall Study||161
204425|NCT00737100|501482|P3|STARTED|Overall Study||176
204426|NCT00737100|501483|P2|STARTED|Overall Study||166
204427|NCT00737100|501484|P1|STARTED|Overall Study||168
204428|NCT00737178|501530|P2|NOT COMPLETED|Overall Study||9
204429|NCT00737178|501531|P1|NOT COMPLETED|Overall Study||5
204430|NCT00737178|501530|P2|COMPLETED|Overall Study||76
204431|NCT00737178|501531|P1|COMPLETED|Overall Study||66
204432|NCT00737178|501530|P2|STARTED|Overall Study||85
204433|NCT00737178|501531|P1|STARTED|Overall Study||71
204434|NCT00737204|501543|P2|NOT COMPLETED|Overall Study||6
204435|NCT00737204|501544|P1|NOT COMPLETED|Overall Study||0
204436|NCT00737204|501543|P2|COMPLETED|Overall Study||28
204437|NCT00737204|501544|P1|COMPLETED|Overall Study||36
204438|NCT00737204|501543|P2|STARTED|Overall Study||34
204439|NCT00737204|501544|P1|STARTED|Overall Study||36
204440|NCT00737243|501556|P1|NOT COMPLETED|Overall Study||95
204441|NCT00737243|501556|P1|COMPLETED|Overall Study||194
204442|NCT00737243|501556|P1|Empiric CUP Therapy|Overall Study||29
204443|NCT00737243|501556|P1|Site Specific Therapy Less Responsive|Overall Study||79
204444|NCT00737243|501556|P1|Site Specific Therapy More Responsive|Overall Study||115
204445|NCT00737243|501556|P1|Not Treated|Overall Study|16 pts no longer met eligibility criteria; 13 came off study due to physician or pt preference.|29
204446|NCT00737243|501556|P1|Treated|Overall Study||223
204447|NCT00737243|501556|P1|Insufficient Tissue for Assay, Withdrawn|Overall Study||37
204448|NCT00737243|501556|P1|Successful Assay Performed|Overall Study||252
204449|NCT00737243|501556|P1|STARTED|Overall Study||289
204450|NCT00730236|501562|P1|NOT COMPLETED|Overall Study||6
204451|NCT00730236|501562|P1|COMPLETED|Overall Study||23
204452|NCT00730236|501562|P1|STARTED|Overall Study||29
204453|NCT00730275|501581|P4|NOT COMPLETED|Overall Study||1
204454|NCT00730275|501582|P3|NOT COMPLETED|Overall Study||0
204455|NCT00730275|501583|P2|NOT COMPLETED|Overall Study||0
204456|NCT00730275|501584|P1|NOT COMPLETED|Overall Study||0
204457|NCT00730275|501581|P4|COMPLETED|Overall Study||8
204458|NCT00730275|501582|P3|COMPLETED|Overall Study||8
204459|NCT00730275|501583|P2|COMPLETED|Overall Study||9
204460|NCT00730275|501584|P1|COMPLETED|Overall Study||9
204461|NCT00730275|501581|P4|STARTED|Overall Study||9
204462|NCT00730275|501582|P3|STARTED|Overall Study||8
204463|NCT00730275|501583|P2|STARTED|Overall Study||9
204464|NCT00730275|501584|P1|STARTED|Overall Study||9
204465|NCT00730327|501612|P2|NOT COMPLETED|Overall Study||37
204466|NCT00730327|501613|P1|NOT COMPLETED|Overall Study||27
204467|NCT00730327|501612|P2|COMPLETED|Overall Study||93
204468|NCT00730327|501613|P1|COMPLETED|Overall Study|Completed defined as subjects who completed the Week 52 follow-up visit.|98
204469|NCT00730327|501612|P2|Completed Week 26|Overall Study||99
204470|NCT00730327|501613|P1|Completed Week 26|Overall Study|Week 26 was halfway through the study, at which point the BIB group had their balloon removed.|125
204471|NCT00730327|501612|P2|STARTED|Overall Study||130
204472|NCT00730327|501613|P1|STARTED|Overall Study|Started is defined as subjects that began treatment.|125
204473|NCT00730353|501634|P1|NOT COMPLETED|Overall Study||0
204474|NCT00730353|501634|P1|COMPLETED|Overall Study||28
204475|NCT00730353|501634|P1|STARTED|Overall Study||28
204476|NCT00730483|501642|P1|NOT COMPLETED|Overall Study||7
204477|NCT00730483|501642|P1|COMPLETED|Overall Study||6
204478|NCT00730483|501642|P1|6 Months After First DEB-TACE|Overall Study||10
204479|NCT00730483|501642|P1|1 Month After First DEB-TACE|Overall Study||13
204480|NCT00730483|501642|P1|STARTED|Overall Study||13
204481|NCT00730639|501655|P5|NOT COMPLETED|Overall Study||131
204482|NCT00730639|501656|P4|NOT COMPLETED|Overall Study||54
204483|NCT00730639|501657|P3|NOT COMPLETED|Overall Study||86
204484|NCT00730639|501658|P2|NOT COMPLETED|Overall Study||18
204485|NCT00730639|501659|P1|NOT COMPLETED|Overall Study||17
204486|NCT00730639|501655|P5|COMPLETED|Overall Study||0
204487|NCT00730639|501656|P4|COMPLETED|Overall Study||0
204488|NCT00730639|501657|P3|COMPLETED|Overall Study||0
204489|NCT00730639|501658|P2|COMPLETED|Overall Study||0
204490|NCT00730639|501659|P1|COMPLETED|Overall Study||0
204491|NCT00730639|501655|P5|STARTED|Overall Study||131
204492|NCT00730639|501656|P4|STARTED|Overall Study||54
204493|NCT00730639|501657|P3|STARTED|Overall Study||86
204494|NCT00730639|501658|P2|STARTED|Overall Study||18
204495|NCT00730639|501659|P1|STARTED|Overall Study||17
204496|NCT00730691|501728|P5|NOT COMPLETED|Overall Study||50
204497|NCT00730691|501729|P4|NOT COMPLETED|Overall Study||45
204498|NCT00730691|501730|P3|NOT COMPLETED|Overall Study||39
204499|NCT00730691|501731|P2|NOT COMPLETED|Overall Study||36
204500|NCT00730691|501732|P1|NOT COMPLETED|Overall Study||36
204501|NCT00730691|501728|P5|COMPLETED|Overall Study||106
204502|NCT00730691|501729|P4|COMPLETED|Overall Study||111
204503|NCT00730691|501730|P3|COMPLETED|Overall Study||117
204504|NCT00730691|501731|P2|COMPLETED|Overall Study||120
204505|NCT00730691|501732|P1|COMPLETED|Overall Study||121
204506|NCT00730691|501728|P5|STARTED|Overall Study||156
204507|NCT00730691|501729|P4|STARTED|Overall Study||156
204508|NCT00730691|501730|P3|STARTED|Overall Study|One participant was randomized by error. Reason not completed is reported as Other.|156
204509|NCT00730691|501731|P2|STARTED|Overall Study||156
204510|NCT00730691|501732|P1|STARTED|Overall Study||157
204511|NCT00730730|501819|P1|NOT COMPLETED|Overall Study||0
204512|NCT00730730|501819|P1|COMPLETED|Overall Study||50
204513|NCT00730730|501819|P1|STARTED|Overall Study||50
204514|NCT00730756|501828|P2|NOT COMPLETED|Overall Study||5
204515|NCT00730756|501829|P1|NOT COMPLETED|Overall Study||4
204516|NCT00730756|501828|P2|COMPLETED|Overall Study||48
204517|NCT00730756|501829|P1|COMPLETED|Overall Study||45
204518|NCT00730756|501828|P2|STARTED|Overall Study||53
204519|NCT00730756|501829|P1|STARTED|Overall Study||49
204520|NCT00730847|501851|P1|NOT COMPLETED|Overall Study||131
204521|NCT00730847|501851|P1|COMPLETED|Overall Study||465
204522|NCT00730847|501851|P1|STARTED|Overall Study||596
204523|NCT00730912|501861|P3|NOT COMPLETED|Overall Study||1
204524|NCT00730912|501862|P2|NOT COMPLETED|Overall Study||0
204525|NCT00730912|501863|P1|NOT COMPLETED|Overall Study||0
204526|NCT00730912|501861|P3|COMPLETED|Overall Study||103
204527|NCT00730912|501862|P2|COMPLETED|Overall Study||104
204528|NCT00730912|501863|P1|COMPLETED|Overall Study||53
204529|NCT00730912|501861|P3|STARTED|Overall Study||104
204530|NCT00730912|501862|P2|STARTED|Overall Study||104
204531|NCT00730912|501863|P1|STARTED|Overall Study||53
204532|NCT00730925|501874|P1|NOT COMPLETED|Overall Study||41
204533|NCT00730925|501874|P1|COMPLETED|Overall Study|On treatment at analysis cut-off date|0
204534|NCT00730925|501874|P1|STARTED|Overall Study||41
204535|NCT00730964|501881|P1|NOT COMPLETED|Overall Study||0
204536|NCT00730964|501881|P1|COMPLETED|Overall Study||1039
204537|NCT00730964|501881|P1|STARTED|Overall Study||1039
204538|NCT00731042|501888|P2|NOT COMPLETED|Second Intervention||2
204539|NCT00731042|501889|P1|NOT COMPLETED|Second Intervention||0
204540|NCT00731042|501888|P2|COMPLETED|Second Intervention|2 subjects did not met inclusion criteria for Period 2 Visual scoring skin condition|15
204541|NCT00731042|501889|P1|COMPLETED|Second Intervention||16
204542|NCT00731042|501888|P2|STARTED|Second Intervention||17
204543|NCT00731042|501889|P1|STARTED|Second Intervention||16
204544|NCT00731042|501888|P2|NOT COMPLETED|Wash-out||0
204545|NCT00731042|501889|P1|NOT COMPLETED|Wash-out||0
204546|NCT00731042|501888|P2|COMPLETED|Wash-out||17
204547|NCT00731042|501889|P1|COMPLETED|Wash-out||16
204548|NCT00731042|501888|P2|STARTED|Wash-out||17
204549|NCT00731042|501889|P1|STARTED|Wash-out||16
204550|NCT00731042|501888|P2|NOT COMPLETED|First Intervention||0
204551|NCT00731042|501889|P1|NOT COMPLETED|First Intervention||0
204552|NCT00731042|501888|P2|COMPLETED|First Intervention||17
204553|NCT00731042|501889|P1|COMPLETED|First Intervention||16
204554|NCT00731042|501888|P2|STARTED|First Intervention||17
204555|NCT00731042|501889|P1|STARTED|First Intervention||16
204556|NCT00731055|501895|P1|NOT COMPLETED|Overall Study||0
204557|NCT00731055|501895|P1|COMPLETED|Overall Study||16
204558|NCT00731055|501895|P1|Received Varenicline 2.0 mg|Overall Study||16
204559|NCT00731055|501895|P1|Received Varenicline 1.0 mg|Overall Study||16
204560|NCT00731055|501895|P1|Received Varenicline 0.5 mg|Overall Study||16
204561|NCT00731055|501895|P1|Received Placebo|Overall Study||16
204562|NCT00731055|501895|P1|STARTED|Overall Study|This is a within-subjects study design.|16
204563|NCT00731094|501904|P2|NOT COMPLETED|Overall Study||11
204564|NCT00731094|501905|P1|NOT COMPLETED|Overall Study||18
204565|NCT00731094|501904|P2|COMPLETED|Overall Study||105
204566|NCT00731094|501905|P1|COMPLETED|Overall Study||98
204567|NCT00731094|501904|P2|Month 6|Overall Study||107
204568|NCT00731094|501905|P1|Month 6|Overall Study||101
204569|NCT00731094|501904|P2|STARTED|Overall Study||116
204570|NCT00731094|501905|P1|STARTED|Overall Study||116
204571|NCT00731120|501978|P3|NOT COMPLETED|Overall Study||36
204572|NCT00731120|501979|P2|NOT COMPLETED|Overall Study||43
204573|NCT00731120|501980|P1|NOT COMPLETED|Overall Study||42
204574|NCT00731120|501978|P3|COMPLETED|Overall Study||116
204575|NCT00731120|501979|P2|COMPLETED|Overall Study||109
204576|NCT00731120|501980|P1|COMPLETED|Overall Study||111
204577|NCT00731120|501978|P3|Treated|Overall Study||152
204578|NCT00731120|501979|P2|Treated|Overall Study||151
204579|NCT00731120|501980|P1|Treated|Overall Study||153
204580|NCT00731120|501978|P3|STARTED|Overall Study||152
204581|NCT00731120|501979|P2|STARTED|Overall Study||152
204582|NCT00731120|501980|P1|STARTED|Overall Study||153
204583|NCT00731133|502015|P1|NOT COMPLETED|Overall Study||10
204584|NCT00731133|502015|P1|COMPLETED|Overall Study||5
204585|NCT00731133|502015|P1|STARTED|Overall Study||15
204586|NCT00731198|502022|P2|NOT COMPLETED|Overall Study||6
204587|NCT00731198|502023|P1|NOT COMPLETED|Overall Study||6
204588|NCT00731198|502022|P2|COMPLETED|Overall Study||319
204589|NCT00731198|502023|P1|COMPLETED|Overall Study||319
204590|NCT00731198|502022|P2|STARTED|Overall Study||325
204591|NCT00731198|502023|P1|STARTED|Overall Study||325
204592|NCT00731211|502029|P1|NOT COMPLETED|Overall Study||0
204593|NCT00731211|502029|P1|COMPLETED|Overall Study||55
204594|NCT00731211|502029|P1|STARTED|Overall Study|2 patients ineligible (papillary histologic type-1 pt. Previous treatment with everolimus alone-1 pt|55
204595|NCT00731341|502034|P1|NOT COMPLETED|Overall Study||0
204596|NCT00731341|502034|P1|COMPLETED|Overall Study||3
204597|NCT00731341|502034|P1|STARTED|Overall Study||3
204598|NCT00731484|502043|P1|NOT COMPLETED|Overall Study||0
204599|NCT00731484|502043|P1|COMPLETED|Overall Study||233
204600|NCT00731484|502043|P1|STARTED|Overall Study||233
204601|NCT00731549|502047|P1|NOT COMPLETED|Overall Study||223
204602|NCT00731549|502047|P1|COMPLETED|Overall Study||858
204603|NCT00731549|502047|P1|STARTED|Overall Study||1081
204604|NCT00737282|502062|P1|NOT COMPLETED|Overall Study||175
204605|NCT00737282|502062|P1|COMPLETED|Overall Study||0
204606|NCT00737282|502062|P1|STARTED|Overall Study||175
204607|NCT00737360|502068|P1|NOT COMPLETED|Overall Study||0
204608|NCT00737360|502068|P1|COMPLETED|Overall Study||27
204609|NCT00737360|502068|P1|STARTED|Overall Study||27
204610|NCT00737438|502075|P1|NOT COMPLETED|Overall Study||3
204611|NCT00737438|502075|P1|COMPLETED|Overall Study||20
204612|NCT00737438|502075|P1|STARTED|Overall Study||23
204613|NCT00737464|502079|P1|NOT COMPLETED|Overall Study||18
204614|NCT00737464|502079|P1|COMPLETED|Overall Study||114
204615|NCT00737464|502079|P1|STARTED|Overall Study||132
204616|NCT00737477|502100|P1|NOT COMPLETED|Overall Study||34
204617|NCT00737477|502100|P1|COMPLETED|Overall Study||62
204618|NCT00737477|502100|P1|STARTED|Overall Study||96
204619|NCT00737529|502116|P1|NOT COMPLETED|Overall Study||112
204620|NCT00737529|502116|P1|COMPLETED|Overall Study|Completed equals participants ongoing on treatment at the time of the data cut-off of 02 July 2012|22
204621|NCT00737529|502116|P1|STARTED|Overall Study||134
204622|NCT00737568|502132|P2|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||18
204623|NCT00737568|502133|P1|NOT COMPLETED|Treatment-Free Follow-up (TFFU) Period||26
204624|NCT00737568|502132|P2|COMPLETED|Treatment-Free Follow-up (TFFU) Period||19
204625|NCT00737568|502133|P1|COMPLETED|Treatment-Free Follow-up (TFFU) Period||12
204626|NCT00737568|502132|P2|STARTED|Treatment-Free Follow-up (TFFU) Period|4 participants not completing the 240 week treatment period enrolled in the TFFU period.|37
204627|NCT00737568|502133|P1|STARTED|Treatment-Free Follow-up (TFFU) Period|1 participant not completing the 240 week treatment period enrolled in the TFFU period.|38
204628|NCT00737568|502132|P2|NOT COMPLETED|Treatment Period Through Week 240||21
204629|NCT00737568|502133|P1|NOT COMPLETED|Treatment Period Through Week 240||20
204630|NCT00737568|502132|P2|COMPLETED|Treatment Period Through Week 240||118
204631|NCT00737568|502133|P1|COMPLETED|Treatment Period Through Week 240||121
204632|NCT00737568|502132|P2|STARTED|Treatment Period Through Week 240||139
204633|NCT00737568|502133|P1|STARTED|Treatment Period Through Week 240||141
204634|NCT00737594|502166|P3|NOT COMPLETED|Overall Study||0
204635|NCT00737594|502167|P2|NOT COMPLETED|Overall Study||0
204636|NCT00737594|502168|P1|NOT COMPLETED|Overall Study||0
204637|NCT00737594|502166|P3|COMPLETED|Overall Study||0
204638|NCT00737594|502167|P2|COMPLETED|Overall Study||0
204639|NCT00737594|502168|P1|COMPLETED|Overall Study||0
204640|NCT00737594|502166|P3|STARTED|Overall Study||0
204641|NCT00737594|502167|P2|STARTED|Overall Study||0
204642|NCT00737594|502168|P1|STARTED|Overall Study||0
204643|NCT00740714|502179|P3|NOT COMPLETED|Overall Study||29
204644|NCT00740714|502180|P2|NOT COMPLETED|Overall Study||19
204645|NCT00740714|502181|P1|NOT COMPLETED|Overall Study||17
204646|NCT00740714|502179|P3|COMPLETED|Overall Study||174
204647|NCT00740714|502180|P2|COMPLETED|Overall Study||182
204648|NCT00740714|502181|P1|COMPLETED|Overall Study||179
204649|NCT00740714|502179|P3|Active Patients at Study Termination|Overall Study||33
204650|NCT00740714|502180|P2|Active Patients at Study Termination|Overall Study||12
204651|NCT00740714|502181|P1|Active Patients at Study Termination|Overall Study||24
204652|NCT00740714|502179|P3|Reaching Endpoint Before May 6, 2011|Overall Study||94
204653|NCT00740714|502180|P2|Reaching Endpoint Before May 6, 2011|Overall Study||87
204654|NCT00740714|502181|P1|Reaching Endpoint Before May 6, 2011|Overall Study||86
204655|NCT00740714|502179|P3|STARTED|Overall Study|Randomized throughout the recruitment period|203
204656|NCT00740714|502180|P2|STARTED|Overall Study|Randomized throughout the recruitment period|201
204657|NCT00740714|502181|P1|STARTED|Overall Study|Randomized throughout the recruitment period|196
204658|NCT00740727|502255|P1|NOT COMPLETED|Overall Study||0
204659|NCT00740727|502255|P1|COMPLETED|Overall Study||18
204660|NCT00740727|502255|P1|STARTED|Overall Study||18
204661|NCT00740779|502264|P3|NOT COMPLETED|Overall Study||13
204662|NCT00740779|502265|P2|NOT COMPLETED|Overall Study||14
204663|NCT00740779|502266|P1|NOT COMPLETED|Overall Study||9
204664|NCT00740779|502264|P3|COMPLETED|Overall Study||41
204665|NCT00740779|502265|P2|COMPLETED|Overall Study||31
204666|NCT00740779|502266|P1|COMPLETED|Overall Study||43
204667|NCT00740779|502264|P3|STARTED|Overall Study||54
204668|NCT00740779|502265|P2|STARTED|Overall Study||45
204669|NCT00740779|502266|P1|STARTED|Overall Study||52
204670|NCT00740792|502278|P4|NOT COMPLETED|Overall Study||10
204671|NCT00740792|502279|P3|NOT COMPLETED|Overall Study||9
204672|NCT00740792|502280|P2|NOT COMPLETED|Overall Study||8
204673|NCT00740792|502281|P1|NOT COMPLETED|Overall Study||10
204674|NCT00740792|502278|P4|COMPLETED|Overall Study||190
204675|NCT00740792|502279|P3|COMPLETED|Overall Study||180
204676|NCT00740792|502280|P2|COMPLETED|Overall Study||186
204677|NCT00740792|502281|P1|COMPLETED|Overall Study||183
204678|NCT00740792|502278|P4|STARTED|Overall Study||200
204679|NCT00740792|502279|P3|STARTED|Overall Study||189
204680|NCT00740792|502280|P2|STARTED|Overall Study||194
204681|NCT00740792|502281|P1|STARTED|Overall Study||193
204682|NCT00740831|502302|P3|NOT COMPLETED|Overall Study||6
204683|NCT00740831|502303|P2|NOT COMPLETED|Overall Study||3
204684|NCT00740831|502304|P1|NOT COMPLETED|Overall Study||4
204685|NCT00740831|502302|P3|COMPLETED|Overall Study|Patients who completed part A (visit 6)|95
204686|NCT00740831|502303|P2|COMPLETED|Overall Study|Patients who completed part A (visit 6)|100
204687|NCT00740831|502304|P1|COMPLETED|Overall Study|Patients who completed part A (visit 6)|93
204688|NCT00740831|502302|P3|STARTED|Overall Study|Safety population|101
204689|NCT00740831|502303|P2|STARTED|Overall Study|Safety population|103
204690|NCT00740831|502304|P1|STARTED|Overall Study|Safety population|97
204691|NCT00740857|502324|P3|NOT COMPLETED|Overall Study||0
204692|NCT00740857|502325|P2|NOT COMPLETED|Overall Study||0
204693|NCT00740857|502326|P1|NOT COMPLETED|Overall Study||1
204694|NCT00740857|502324|P3|COMPLETED|Overall Study||90
204695|NCT00740857|502325|P2|COMPLETED|Overall Study||88
204696|NCT00740857|502326|P1|COMPLETED|Overall Study||32
204697|NCT00740857|502324|P3|STARTED|Overall Study||90
204698|NCT00740857|502325|P2|STARTED|Overall Study||88
204699|NCT00740857|502326|P1|STARTED|Overall Study||33
204700|NCT00740870|502355|P1|NOT COMPLETED|Overall Study||21
204701|NCT00740870|502355|P1|COMPLETED|Overall Study||150
204702|NCT00740870|502355|P1|STARTED|Overall Study||171
204703|NCT00741013|502370|P3|NOT COMPLETED|Overall Study||1
204704|NCT00741013|502371|P2|NOT COMPLETED|Overall Study||2
204705|NCT00741013|502372|P1|NOT COMPLETED|Overall Study||1
204706|NCT00741013|502370|P3|COMPLETED|Overall Study||6
204707|NCT00741013|502371|P2|COMPLETED|Overall Study||6
204708|NCT00741013|502372|P1|COMPLETED|Overall Study||6
204709|NCT00741013|502370|P3|STARTED|Overall Study||7
204710|NCT00741013|502371|P2|STARTED|Overall Study||8
204711|NCT00741013|502372|P1|STARTED|Overall Study||7
204712|NCT00741026|502383|P1|NOT COMPLETED|Overall Study||0
204713|NCT00741026|502383|P1|COMPLETED|Overall Study||15
204714|NCT00741026|502383|P1|STARTED|Overall Study||15
204715|NCT00741039|502413|P2|NOT COMPLETED|Overall Study||0
204716|NCT00741039|502414|P1|NOT COMPLETED|Overall Study||2
204717|NCT00741039|502413|P2|COMPLETED|Overall Study||25
204718|NCT00741039|502414|P1|COMPLETED|Overall Study||100
204719|NCT00741039|502413|P2|STARTED|Overall Study||25
204720|NCT00741039|502414|P1|STARTED|Overall Study||102
204721|NCT00741091|502420|P1|NOT COMPLETED|Overall Study||57
204722|NCT00741091|502420|P1|COMPLETED|Overall Study||1040
204723|NCT00741091|502420|P1|STARTED|Overall Study||1097
204724|NCT00741104|502428|P1|NOT COMPLETED|Overall Study||0
204725|NCT00741104|502428|P1|COMPLETED|Overall Study||363
204726|NCT00741104|502428|P1|STARTED|Overall Study||363
204727|NCT00741156|502435|P1|NOT COMPLETED|Overall Study||0
204728|NCT00741156|502435|P1|COMPLETED|Overall Study||12
204729|NCT00741156|502435|P1|STARTED|Overall Study||12
204730|NCT00741273|502452|P2|NOT COMPLETED|Overall Study||0
204731|NCT00741273|502453|P1|NOT COMPLETED|Overall Study||0
204732|NCT00741273|502452|P2|COMPLETED|Overall Study||8
204733|NCT00741273|502453|P1|COMPLETED|Overall Study||8
204734|NCT00741273|502452|P2|STARTED|Overall Study||8
204735|NCT00741273|502453|P1|STARTED|Overall Study||8
204736|NCT00741286|502471|P2|NOT COMPLETED|Overall Study||19
204737|NCT00741286|502472|P1|NOT COMPLETED|Overall Study||20
204738|NCT00741286|502471|P2|COMPLETED|Overall Study||81
204739|NCT00741286|502472|P1|COMPLETED|Overall Study||83
204740|NCT00741286|502471|P2|STARTED|Overall Study||100
204741|NCT00741286|502472|P1|STARTED|Overall Study||103
204742|NCT00741338|502482|P2|NOT COMPLETED|Overall Study||1
204743|NCT00741338|502483|P1|NOT COMPLETED|Overall Study||0
204744|NCT00741338|502482|P2|COMPLETED|Overall Study||2
204745|NCT00741338|502483|P1|COMPLETED|Overall Study||3
204746|NCT00741338|502482|P2|STARTED|Overall Study||3
204747|NCT00741338|502483|P1|STARTED|Overall Study||3
204748|NCT00741390|502491|P4|NOT COMPLETED|Visit 2||1
204749|NCT00741390|502492|P3|NOT COMPLETED|Visit 2||1
204750|NCT00741390|502493|P2|NOT COMPLETED|Visit 2||0
204751|NCT00741390|502494|P1|NOT COMPLETED|Visit 2||0
204752|NCT00741390|502491|P4|COMPLETED|Visit 2||60
204753|NCT00741390|502492|P3|COMPLETED|Visit 2||54
204754|NCT00741390|502493|P2|COMPLETED|Visit 2||61
204755|NCT00741390|502494|P1|COMPLETED|Visit 2||59
204756|NCT00741390|502491|P4|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|61
204757|NCT00741390|502492|P3|STARTED|Visit 2||55
204758|NCT00741390|502493|P2|STARTED|Visit 2|2 subjects lost to follow-up between Visit 1 and Visit 2.|61
204759|NCT00741390|502494|P1|STARTED|Visit 2|1 subject lost to follow-up between Visit 1 and Visit 2.|59
204760|NCT00741390|502491|P4|NOT COMPLETED|Visit 1||1
204761|NCT00741390|502492|P3|NOT COMPLETED|Visit 1||7
204762|NCT00741390|502493|P2|NOT COMPLETED|Visit 1||0
204763|NCT00741390|502494|P1|NOT COMPLETED|Visit 1||2
204764|NCT00741390|502491|P4|COMPLETED|Visit 1||62
204765|NCT00741390|502492|P3|COMPLETED|Visit 1||55
204766|NCT00741390|502493|P2|COMPLETED|Visit 1||63
204767|NCT00741390|502494|P1|COMPLETED|Visit 1||60
204768|NCT00741390|502491|P4|STARTED|Visit 1||63
204769|NCT00741390|502492|P3|STARTED|Visit 1||62
204770|NCT00741390|502493|P2|STARTED|Visit 1||63
204771|NCT00741390|502494|P1|STARTED|Visit 1||62
204772|NCT00741468|502513|P1|NOT COMPLETED|Overall Study||0
204773|NCT00741468|502513|P1|COMPLETED|Overall Study||18
204774|NCT00741468|502513|P1|STARTED|Overall Study||18
204775|NCT00741598|502523|P2|NOT COMPLETED|Overall Study||9
204776|NCT00741598|502524|P1|NOT COMPLETED|Overall Study||9
204777|NCT00741598|502523|P2|COMPLETED|Overall Study||30
204778|NCT00741598|502524|P1|COMPLETED|Overall Study||24
204779|NCT00741598|502523|P2|STARTED|Overall Study||39
204780|NCT00741598|502524|P1|STARTED|Overall Study||33
204781|NCT00741611|502541|P3|NOT COMPLETED|Overall Study||3
204782|NCT00741611|502542|P2|NOT COMPLETED|Overall Study||2
204783|NCT00741611|502543|P1|NOT COMPLETED|Overall Study||0
204784|NCT00741611|502541|P3|COMPLETED|Overall Study||26
204785|NCT00741611|502542|P2|COMPLETED|Overall Study||1
204786|NCT00741611|502543|P1|COMPLETED|Overall Study||4
204787|NCT00741611|502541|P3|STARTED|Overall Study||29
204788|NCT00741611|502542|P2|STARTED|Overall Study||3
204789|NCT00741611|502543|P1|STARTED|Overall Study||4
204790|NCT00741819|502560|P1|NOT COMPLETED|Overall Study||8
204791|NCT00741819|502560|P1|COMPLETED|Overall Study||65
204792|NCT00741819|502560|P1|STARTED|Overall Study||73
204793|NCT00741858|502573|P2|NOT COMPLETED|Overall Study||0
204794|NCT00741858|502574|P1|NOT COMPLETED|Overall Study||0
204795|NCT00741858|502573|P2|COMPLETED|Overall Study||18
204796|NCT00741858|502574|P1|COMPLETED|Overall Study||16
204797|NCT00741858|502573|P2|STARTED|Overall Study||18
204798|NCT00741858|502574|P1|STARTED|Overall Study||16
204799|NCT00741936|502582|P2|NOT COMPLETED|Overall Study||8
204800|NCT00741936|502583|P1|NOT COMPLETED|Overall Study||9
204801|NCT00741936|502582|P2|COMPLETED|Overall Study||52
204802|NCT00741936|502583|P1|COMPLETED|Overall Study||51
204803|NCT00741936|502582|P2|STARTED|Overall Study||60
204804|NCT00741936|502583|P1|STARTED|Overall Study||60
204805|NCT00741988|502611|P2|NOT COMPLETED|Overall Study||4
204806|NCT00741988|502612|P1|NOT COMPLETED|Overall Study||4
204807|NCT00741988|502611|P2|COMPLETED|Overall Study||36
204808|NCT00741988|502612|P1|COMPLETED|Overall Study||38
204809|NCT00741988|502611|P2|STARTED|Overall Study||40
204810|NCT00741988|502612|P1|STARTED|Overall Study||42
204811|NCT00742053|502622|P1|NOT COMPLETED|Overall Study||0
204812|NCT00742053|502622|P1|COMPLETED|Overall Study||7
204813|NCT00742053|502622|P1|STARTED|Overall Study||7
204814|NCT00742079|502628|P2|NOT COMPLETED|Overall Study||1
204815|NCT00742079|502629|P1|NOT COMPLETED|Overall Study||0
204816|NCT00742079|502628|P2|COMPLETED|Overall Study||9
204817|NCT00742079|502629|P1|COMPLETED|Overall Study||11
204818|NCT00742079|502628|P2|Week 2 (Received Dose 2)|Overall Study||9
204819|NCT00742079|502629|P1|Week 2 (Received Dose 2)|Overall Study||11
204820|NCT00742079|502628|P2|Baseline/Week 1 (Received Dose 1)|Overall Study||9
204821|NCT00742079|502629|P1|Baseline/Week 1 (Received Dose 1)|Overall Study||11
204822|NCT00742079|502628|P2|STARTED|Overall Study||10
204823|NCT00742079|502629|P1|STARTED|Overall Study||11
204824|NCT00742170|502637|P2|NOT COMPLETED|Overall Study||5
204825|NCT00742170|502638|P1|NOT COMPLETED|Overall Study||2
204826|NCT00742170|502637|P2|COMPLETED|Overall Study||24
204827|NCT00742170|502638|P1|COMPLETED|Overall Study||24
204828|NCT00742170|502637|P2|STARTED|Overall Study||29
204829|NCT00742170|502638|P1|STARTED|Overall Study||26
204830|NCT00742183|502648|P2|NOT COMPLETED|Overall Study||12
204831|NCT00742183|502649|P1|NOT COMPLETED|Overall Study||9
204832|NCT00742183|502648|P2|COMPLETED|Overall Study||39
204833|NCT00742183|502649|P1|COMPLETED|Overall Study||40
204834|NCT00742183|502648|P2|STARTED|Overall Study||51
204835|NCT00742183|502649|P1|STARTED|Overall Study|50 subjects randomised, one of them did not receive any treatment.|49
204836|NCT00742209|502660|P5|NOT COMPLETED|Overall Study||25
204837|NCT00742209|502661|P4|NOT COMPLETED|Overall Study||37
204838|NCT00742209|502662|P3|NOT COMPLETED|Overall Study||46
204839|NCT00742209|502663|P2|NOT COMPLETED|Overall Study||18
204840|NCT00742209|502664|P1|NOT COMPLETED|Overall Study||34
204841|NCT00742209|502660|P5|COMPLETED|Overall Study||37
204842|NCT00742209|502661|P4|COMPLETED|Overall Study||97
204843|NCT00742209|502662|P3|COMPLETED|Overall Study||88
204844|NCT00742209|502663|P2|COMPLETED|Overall Study||49
204845|NCT00742209|502664|P1|COMPLETED|Overall Study||95
204846|NCT00742209|502660|P5|STARTED|Overall Study||62
204847|NCT00742209|502661|P4|STARTED|Overall Study||134
204848|NCT00742209|502662|P3|STARTED|Overall Study||134
204849|NCT00742209|502663|P2|STARTED|Overall Study||67
204850|NCT00742209|502664|P1|STARTED|Overall Study||129
204851|NCT00742235|502767|P2|NOT COMPLETED|Overall Study||31
204852|NCT00742235|502768|P1|NOT COMPLETED|Overall Study||0
204853|NCT00742235|502767|P2|COMPLETED|Overall Study||36
204854|NCT00742235|502768|P1|COMPLETED|Overall Study||32
204855|NCT00742235|502767|P2|STARTED|Overall Study||67
204856|NCT00742235|502768|P1|STARTED|Overall Study||32
204857|NCT00742274|502778|P2|NOT COMPLETED|Overall Study||3
204858|NCT00742274|502779|P1|NOT COMPLETED|Overall Study||3
204859|NCT00742274|502778|P2|COMPLETED|Overall Study||28
204860|NCT00742274|502779|P1|COMPLETED|Overall Study||27
204861|NCT00742274|502778|P2|STARTED|Overall Study||31
204862|NCT00742274|502779|P1|STARTED|Overall Study||30
204863|NCT00742313|502787|P2|NOT COMPLETED|Overall Study||0
204864|NCT00742313|502788|P1|NOT COMPLETED|Overall Study||1
204865|NCT00742313|502787|P2|COMPLETED|Overall Study||19
204866|NCT00742313|502788|P1|COMPLETED|Overall Study||24
204867|NCT00742313|502787|P2|STARTED|Overall Study||19
204868|NCT00742313|502788|P1|STARTED|Overall Study||25
204869|NCT00742326|502796|P2|NOT COMPLETED|Overall Study||1
204870|NCT00742326|502797|P1|NOT COMPLETED|Overall Study||0
204871|NCT00742326|502796|P2|COMPLETED|Overall Study||6
204872|NCT00742326|502797|P1|COMPLETED|Overall Study||6
204873|NCT00742326|502796|P2|STARTED|Overall Study||7
204874|NCT00742326|502797|P1|STARTED|Overall Study||6
204875|NCT00742391|502807|P2|NOT COMPLETED|Overall Study||1
204876|NCT00742391|502808|P1|NOT COMPLETED|Overall Study||4
204877|NCT00742391|502807|P2|COMPLETED|Overall Study||128
204878|NCT00742391|502808|P1|COMPLETED|Overall Study||122
204879|NCT00742391|502807|P2|STARTED|Overall Study||129
204880|NCT00742391|502808|P1|STARTED|Overall Study||126
204881|NCT00742417|502818|P2|NOT COMPLETED|Maintenance II||0
204882|NCT00742417|502819|P1|NOT COMPLETED|Maintenance II||0
204883|NCT00742417|502818|P2|COMPLETED|Maintenance II||19
204884|NCT00742417|502819|P1|COMPLETED|Maintenance II||16
204885|NCT00742417|502818|P2|STARTED|Maintenance II||19
204886|NCT00742417|502819|P1|STARTED|Maintenance II||16
204887|NCT00742417|502818|P2|NOT COMPLETED|Maintenance I||0
204888|NCT00742417|502819|P1|NOT COMPLETED|Maintenance I||0
204889|NCT00742417|502818|P2|COMPLETED|Maintenance I||19
204890|NCT00742417|502819|P1|COMPLETED|Maintenance I||16
204891|NCT00742417|502818|P2|STARTED|Maintenance I||19
204892|NCT00742417|502819|P1|STARTED|Maintenance I||16
204893|NCT00742417|502818|P2|NOT COMPLETED|Intensive Period||1
204894|NCT00742417|502819|P1|NOT COMPLETED|Intensive Period||3
204895|NCT00742417|502818|P2|COMPLETED|Intensive Period|19 control patients completed all the 6 plasma exchange during the Intensive Period|19
204896|NCT00742417|502819|P1|COMPLETED|Intensive Period|16 patients completed all the 6 plasma exchange with Albutein 5% during the Intensive Period|16
204897|NCT00742417|502818|P2|STARTED|Intensive Period||20
204898|NCT00742417|502819|P1|STARTED|Intensive Period||19
204899|NCT00742417|502818|P2|NOT COMPLETED|Randomized||1
204900|NCT00742417|502819|P1|NOT COMPLETED|Randomized||2
204901|NCT00742417|502818|P2|COMPLETED|Randomized||20
204902|NCT00742417|502819|P1|COMPLETED|Randomized||19
204903|NCT00742417|502818|P2|STARTED|Randomized||21
204904|NCT00742417|502819|P1|STARTED|Randomized||21
204905|NCT00742508|502843|P2|NOT COMPLETED|4-Week Exploratory Evaluation Period||1
204906|NCT00742508|502844|P1|NOT COMPLETED|4-Week Exploratory Evaluation Period||0
204907|NCT00742508|502843|P2|COMPLETED|4-Week Exploratory Evaluation Period||7
204908|NCT00742508|502844|P1|COMPLETED|4-Week Exploratory Evaluation Period||0
204909|NCT00742508|502843|P2|STARTED|4-Week Exploratory Evaluation Period||8
204910|NCT00742508|502844|P1|STARTED|4-Week Exploratory Evaluation Period||0
204911|NCT00742508|502843|P2|NOT COMPLETED|8-Week Primary Evaluation Period||11
204912|NCT00742508|502844|P1|NOT COMPLETED|8-Week Primary Evaluation Period||11
204913|NCT00742508|502843|P2|COMPLETED|8-Week Primary Evaluation Period||8
204914|NCT00742508|502844|P1|COMPLETED|8-Week Primary Evaluation Period||11
204915|NCT00742508|502843|P2|STARTED|8-Week Primary Evaluation Period||19
204916|NCT00742508|502844|P1|STARTED|8-Week Primary Evaluation Period||22
204917|NCT00742625|502906|P1|NOT COMPLETED|Consolidation||21
204918|NCT00742625|502906|P1|COMPLETED|Consolidation||20
204919|NCT00742625|502906|P1|STARTED|Consolidation||41
204920|NCT00742625|502906|P1|NOT COMPLETED|Remission Induction||54
204921|NCT00742625|502906|P1|COMPLETED|Remission Induction||41
204922|NCT00742625|502906|P1|STARTED|Remission Induction||95
204923|NCT00742781|502915|P1|NOT COMPLETED|Overall Study||3
204924|NCT00742781|502915|P1|COMPLETED|Overall Study||18
204925|NCT00742781|502915|P1|STARTED|Overall Study||21
204926|NCT00742872|502926|P2|NOT COMPLETED|Overall Study||8
204927|NCT00742872|502927|P1|NOT COMPLETED|Overall Study||12
204928|NCT00742872|502926|P2|COMPLETED|Overall Study||12
204929|NCT00742872|502927|P1|COMPLETED|Overall Study||9
204930|NCT00742872|502926|P2|STARTED|Overall Study||20
204931|NCT00742872|502927|P1|STARTED|Overall Study||21
204932|NCT00742885|502935|P2|NOT COMPLETED|Overall Study||0
204933|NCT00742885|502936|P1|NOT COMPLETED|Overall Study||1
204934|NCT00742885|502935|P2|COMPLETED|Overall Study|to Day 182|50
204935|NCT00742885|502936|P1|COMPLETED|Overall Study|to Day 182|49
204936|NCT00742885|502935|P2|STARTED|Overall Study||50
204937|NCT00742885|502936|P1|STARTED|Overall Study||50
204938|NCT00742924|502986|P4|NOT COMPLETED|Overall Study||6
204939|NCT00742924|502987|P3|NOT COMPLETED|Overall Study||4
204940|NCT00742924|502988|P2|NOT COMPLETED|Overall Study||2
204941|NCT00742924|502989|P1|NOT COMPLETED|Overall Study||5
204942|NCT00742924|502986|P4|COMPLETED|Overall Study||0
204943|NCT00742924|502987|P3|COMPLETED|Overall Study||2
204944|NCT00742924|502988|P2|COMPLETED|Overall Study||4
204945|NCT00742924|502989|P1|COMPLETED|Overall Study||1
204946|NCT00742924|502986|P4|STARTED|Overall Study||6
204947|NCT00742924|502987|P3|STARTED|Overall Study||6
204948|NCT00742924|502988|P2|STARTED|Overall Study||6
204949|NCT00742924|502989|P1|STARTED|Overall Study||6
204950|NCT00743093|503001|P2|NOT COMPLETED|Extended Dosing Period||0
204951|NCT00743093|503002|P1|NOT COMPLETED|Extended Dosing Period||3
204952|NCT00743093|503001|P2|COMPLETED|Extended Dosing Period||1
204953|NCT00743093|503002|P1|COMPLETED|Extended Dosing Period||48
204954|NCT00743093|503001|P2|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|1
204955|NCT00743093|503002|P1|STARTED|Extended Dosing Period|Subjects not meeting stopping criteria after base continued into the extended dosing.|51
204956|NCT00743093|503001|P2|NOT COMPLETED|Base Study Period||5
204957|NCT00743093|503002|P1|NOT COMPLETED|Base Study Period||19
204958|NCT00743093|503001|P2|COMPLETED|Base Study Period||47
204959|NCT00743093|503002|P1|COMPLETED|Base Study Period||205
204960|NCT00743093|503001|P2|STARTED|Base Study Period||52
204961|NCT00743093|503002|P1|STARTED|Base Study Period||224
204962|NCT00743106|503012|P2|NOT COMPLETED|Overall Study||5
204963|NCT00743106|503013|P1|NOT COMPLETED|Overall Study||8
204964|NCT00743106|503012|P2|COMPLETED|Overall Study||43
204965|NCT00743106|503013|P1|COMPLETED|Overall Study||34
204966|NCT00743106|503012|P2|STARTED|Overall Study||48
204967|NCT00743106|503013|P1|STARTED|Overall Study||42
204968|NCT00734474|503028|P9|NOT COMPLETED|Overall Study||82
204969|NCT00734474|503029|P8|NOT COMPLETED|Overall Study||129
204970|NCT00734474|503030|P7|NOT COMPLETED|Overall Study||24
204971|NCT00734474|503031|P6|NOT COMPLETED|Overall Study||25
204972|NCT00734474|503032|P5|NOT COMPLETED|Overall Study||118
204973|NCT00734474|503033|P4|NOT COMPLETED|Overall Study||10
204974|NCT00734474|503034|P3|NOT COMPLETED|Overall Study||112
204975|NCT00734474|503035|P2|NOT COMPLETED|Overall Study||30
204976|NCT00734474|503036|P1|NOT COMPLETED|Overall Study||15
204977|NCT00734474|503028|P9|COMPLETED|Overall Study||95
204978|NCT00734474|503029|P8|COMPLETED|Overall Study||186
204979|NCT00734474|503030|P7|COMPLETED|Overall Study||0
204980|NCT00734474|503031|P6|COMPLETED|Overall Study||0
204981|NCT00734474|503032|P5|COMPLETED|Overall Study||184
204982|NCT00734474|503033|P4|COMPLETED|Overall Study||0
204983|NCT00734474|503034|P3|COMPLETED|Overall Study||192
204984|NCT00734474|503035|P2|COMPLETED|Overall Study||0
204985|NCT00734474|503036|P1|COMPLETED|Overall Study||0
204986|NCT00734474|503028|P9|Completed 52-Week Visit|Overall Study||112
204987|NCT00734474|503029|P8|Completed 52-Week Visit|Overall Study||238
204988|NCT00734474|503030|P7|Completed 52-Week Visit|Overall Study||0
204989|NCT00734474|503031|P6|Completed 52-Week Visit|Overall Study||0
204990|NCT00734474|503032|P5|Completed 52-Week Visit|Overall Study||243
204991|NCT00734474|503033|P4|Completed 52-Week Visit|Overall Study||0
204992|NCT00734474|503034|P3|Completed 52-Week Visit|Overall Study||238
204993|NCT00734474|503035|P2|Completed 52-Week Visit|Overall Study||0
204994|NCT00734474|503036|P1|Completed 52-Week Visit|Overall Study||0
204995|NCT00734474|503028|P9|Completed 26-Week Visit|Overall Study||124
204996|NCT00734474|503029|P8|Completed 26-Week Visit|Overall Study||270
204997|NCT00734474|503030|P7|Completed 26-Week Visit|Overall Study||2
204998|NCT00734474|503031|P6|Completed 26-Week Visit|Overall Study||2
204999|NCT00734474|503032|P5|Completed 26-Week Visit|Overall Study||268
205000|NCT00734474|503033|P4|Completed 26-Week Visit|Overall Study||2
205001|NCT00734474|503034|P3|Completed 26-Week Visit|Overall Study||258
205002|NCT00734474|503035|P2|Completed 26-Week Visit|Overall Study||0
205003|NCT00734474|503036|P1|Completed 26-Week Visit|Overall Study||0
205004|NCT00734474|503028|P9|Entered Study After Dose Decision Point|Overall Study||139
205005|NCT00734474|503029|P8|Entered Study After Dose Decision Point|Overall Study||273
205006|NCT00734474|503030|P7|Entered Study After Dose Decision Point|Overall Study||0
205007|NCT00734474|503031|P6|Entered Study After Dose Decision Point|Overall Study||0
205008|NCT00734474|503032|P5|Entered Study After Dose Decision Point|Overall Study||281
205009|NCT00734474|503033|P4|Entered Study After Dose Decision Point|Overall Study||0
205010|NCT00734474|503034|P3|Entered Study After Dose Decision Point|Overall Study||279
205011|NCT00734474|503035|P2|Entered Study After Dose Decision Point|Overall Study||0
205012|NCT00734474|503036|P1|Entered Study After Dose Decision Point|Overall Study||0
205013|NCT00734474|503028|P9|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|34
205014|NCT00734474|503029|P8|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (comparator arm).|42
205015|NCT00734474|503030|P7|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|23
205016|NCT00734474|503031|P6|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|21
205017|NCT00734474|503032|P5|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|21
205018|NCT00734474|503033|P4|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
205019|NCT00734474|503034|P3|Completed Up to Dose Decision Point|Overall Study|These participants continued the study after the dose decision point (selected arm).|24
205020|NCT00734474|503035|P2|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|25
205021|NCT00734474|503036|P1|Completed Up to Dose Decision Point|Overall Study|These participants discontinued the study after the dose decision point.|8
205022|NCT00734474|503028|P9|Entered Study Before Dose Decision Point|Overall Study||38
205023|NCT00734474|503029|P8|Entered Study Before Dose Decision Point|Overall Study||42
205024|NCT00734474|503030|P7|Entered Study Before Dose Decision Point|Overall Study||24
205025|NCT00734474|503031|P6|Entered Study Before Dose Decision Point|Overall Study||25
205026|NCT00734474|503032|P5|Entered Study Before Dose Decision Point|Overall Study||21
205027|NCT00734474|503033|P4|Entered Study Before Dose Decision Point|Overall Study||10
205028|NCT00734474|503034|P3|Entered Study Before Dose Decision Point|Overall Study||25
205029|NCT00734474|503035|P2|Entered Study Before Dose Decision Point|Overall Study||30
205030|NCT00734474|503036|P1|Entered Study Before Dose Decision Point|Overall Study||15
205031|NCT00734474|503028|P9|Received at Least 1 Dose of Study Drug|Overall Study||177
205032|NCT00734474|503029|P8|Received at Least 1 Dose of Study Drug|Overall Study||315
205033|NCT00734474|503030|P7|Received at Least 1 Dose of Study Drug|Overall Study||24
205034|NCT00734474|503031|P6|Received at Least 1 Dose of Study Drug|Overall Study||25
205035|NCT00734474|503032|P5|Received at Least 1 Dose of Study Drug|Overall Study||302
205036|NCT00734474|503033|P4|Received at Least 1 Dose of Study Drug|Overall Study||10
205037|NCT00734474|503034|P3|Received at Least 1 Dose of Study Drug|Overall Study||304
205038|NCT00734474|503035|P2|Received at Least 1 Dose of Study Drug|Overall Study||30
205039|NCT00734474|503036|P1|Received at Least 1 Dose of Study Drug|Overall Study||15
205040|NCT00734474|503028|P9|STARTED|Overall Study||177
205041|NCT00734474|503029|P8|STARTED|Overall Study||315
205042|NCT00734474|503030|P7|STARTED|Overall Study||24
205043|NCT00734474|503031|P6|STARTED|Overall Study||25
205044|NCT00734474|503032|P5|STARTED|Overall Study||302
205045|NCT00734474|503033|P4|STARTED|Overall Study||10
205046|NCT00734474|503034|P3|STARTED|Overall Study||304
205047|NCT00734474|503035|P2|STARTED|Overall Study||30
205048|NCT00734474|503036|P1|STARTED|Overall Study||15
205049|NCT00734500|503203|P1|NOT COMPLETED|Overall Study||1
205050|NCT00734500|503203|P1|COMPLETED|Overall Study||14
205051|NCT00734500|503203|P1|STARTED|Overall Study||15
205052|NCT00734539|503210|P2|NOT COMPLETED|Long Term Follow up||31
205053|NCT00734539|503211|P1|NOT COMPLETED|Long Term Follow up||34
205054|NCT00734539|503210|P2|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|107
205055|NCT00734539|503211|P1|COMPLETED|Long Term Follow up|Number of participants who completed the 18-22 months follow-up|118
205056|NCT00734539|503210|P2|STARTED|Long Term Follow up||138
205057|NCT00734539|503211|P1|STARTED|Long Term Follow up||152
205058|NCT00734539|503210|P2|NOT COMPLETED|Main Study||35
205059|NCT00734539|503211|P1|NOT COMPLETED|Main Study||37
205060|NCT00734539|503210|P2|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|138
205061|NCT00734539|503211|P1|COMPLETED|Main Study|Number of subjects who participated through hospital discharge or study end|152
205062|NCT00734539|503210|P2|STARTED|Main Study||173
205063|NCT00734539|503211|P1|STARTED|Main Study||189
205064|NCT00734578|503242|P3|NOT COMPLETED|Overall Study||25
205065|NCT00734578|503243|P2|NOT COMPLETED|Overall Study||25
205066|NCT00734578|503244|P1|NOT COMPLETED|Overall Study||33
205067|NCT00734578|503242|P3|COMPLETED|Overall Study||129
205068|NCT00734578|503243|P2|COMPLETED|Overall Study||128
205069|NCT00734578|503244|P1|COMPLETED|Overall Study||121
205070|NCT00734578|503242|P3|STARTED|Overall Study||154
205071|NCT00734578|503243|P2|STARTED|Overall Study||153
205072|NCT00734578|503244|P1|STARTED|Overall Study||154
205073|NCT00734591|503278|P2|NOT COMPLETED|Prospective Period||44
205074|NCT00734591|503279|P1|NOT COMPLETED|Prospective Period||51
205075|NCT00734591|503278|P2|COMPLETED|Prospective Period||1229
205076|NCT00734591|503279|P1|COMPLETED|Prospective Period||1307
205077|NCT00734591|503278|P2|STARTED|Prospective Period||1273
205078|NCT00734591|503279|P1|STARTED|Prospective Period||1358
205079|NCT00734591|503278|P2|NOT COMPLETED|Screening for Prospective Period||2291
205080|NCT00734591|503279|P1|NOT COMPLETED|Screening for Prospective Period||2517
205081|NCT00734591|503278|P2|COMPLETED|Screening for Prospective Period||1273
205082|NCT00734591|503279|P1|COMPLETED|Screening for Prospective Period||1358
205083|NCT00734591|503278|P2|STARTED|Screening for Prospective Period||3564
205084|NCT00734591|503279|P1|STARTED|Screening for Prospective Period||3875
205085|NCT00734591|503278|P2|NOT COMPLETED|Retrospective Period||0
205086|NCT00734591|503279|P1|NOT COMPLETED|Retrospective Period||0
205087|NCT00734591|503278|P2|COMPLETED|Retrospective Period||3564
205088|NCT00734591|503279|P1|COMPLETED|Retrospective Period||3875
205089|NCT00734591|503278|P2|STARTED|Retrospective Period||3564
205090|NCT00734591|503279|P1|STARTED|Retrospective Period||3875
205091|NCT00734604|503297|P6|NOT COMPLETED|Overall Study||6
205092|NCT00734604|503298|P5|NOT COMPLETED|Overall Study||8
205093|NCT00734604|503299|P4|NOT COMPLETED|Overall Study||9
205094|NCT00734604|503300|P3|NOT COMPLETED|Overall Study||6
205095|NCT00734604|503301|P2|NOT COMPLETED|Overall Study||12
205096|NCT00734604|503302|P1|NOT COMPLETED|Overall Study||3
205097|NCT00734604|503297|P6|COMPLETED|Overall Study||58
205098|NCT00734604|503298|P5|COMPLETED|Overall Study||55
205099|NCT00734604|503299|P4|COMPLETED|Overall Study||54
205100|NCT00734604|503300|P3|COMPLETED|Overall Study||57
205101|NCT00734604|503301|P2|COMPLETED|Overall Study||51
205102|NCT00734604|503302|P1|COMPLETED|Overall Study||59
205103|NCT00734604|503297|P6|STARTED|Overall Study||64
205104|NCT00734604|503298|P5|STARTED|Overall Study||63
205105|NCT00734604|503299|P4|STARTED|Overall Study||63
205106|NCT00734604|503300|P3|STARTED|Overall Study||63
205107|NCT00734604|503301|P2|STARTED|Overall Study||63
205108|NCT00734604|503302|P1|STARTED|Overall Study||62
205109|NCT00734617|503352|P2|NOT COMPLETED|Overall Study||102
205110|NCT00734617|503353|P1|NOT COMPLETED|Overall Study||107
205111|NCT00734617|503352|P2|COMPLETED|Overall Study||128
205112|NCT00734617|503353|P1|COMPLETED|Overall Study||142
205113|NCT00734617|503352|P2|STARTED|Overall Study||230
205114|NCT00734617|503353|P1|STARTED|Overall Study||249
205115|NCT00734630|503361|P2|NOT COMPLETED|Overall Study||33
205116|NCT00734630|503362|P1|NOT COMPLETED|Overall Study||29
205117|NCT00734630|503361|P2|COMPLETED|Overall Study||200
205118|NCT00734630|503362|P1|COMPLETED|Overall Study||229
205119|NCT00734630|503361|P2|STARTED|Overall Study||233
205120|NCT00734630|503362|P1|STARTED|Overall Study||258
205121|NCT00734656|503370|P4|NOT COMPLETED|Lab Session 4||1
205122|NCT00734656|503371|P3|NOT COMPLETED|Lab Session 4||0
205123|NCT00734656|503372|P2|NOT COMPLETED|Lab Session 4||0
205124|NCT00734656|503373|P1|NOT COMPLETED|Lab Session 4||0
205125|NCT00734656|503370|P4|COMPLETED|Lab Session 4||19
205126|NCT00734656|503371|P3|COMPLETED|Lab Session 4||16
205127|NCT00734656|503372|P2|COMPLETED|Lab Session 4||18
205128|NCT00734656|503373|P1|COMPLETED|Lab Session 4||20
205129|NCT00734656|503370|P4|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
205130|NCT00734656|503371|P3|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|16
205131|NCT00734656|503372|P2|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|18
205132|NCT00734656|503373|P1|STARTED|Lab Session 4|subjects cross-over to different treatment condition with each lab session in factorial design,|20
205133|NCT00734656|503370|P4|NOT COMPLETED|Washout 3||1
205134|NCT00734656|503371|P3|NOT COMPLETED|Washout 3||0
205135|NCT00734656|503372|P2|NOT COMPLETED|Washout 3||0
205136|NCT00734656|503373|P1|NOT COMPLETED|Washout 3||1
205137|NCT00734656|503370|P4|COMPLETED|Washout 3||18
205138|NCT00734656|503371|P3|COMPLETED|Washout 3||20
205139|NCT00734656|503372|P2|COMPLETED|Washout 3||19
205140|NCT00734656|503373|P1|COMPLETED|Washout 3||17
205141|NCT00734656|503370|P4|STARTED|Washout 3||19
205142|NCT00734656|503371|P3|STARTED|Washout 3||20
205143|NCT00734656|503372|P2|STARTED|Washout 3||19
205144|NCT00734656|503373|P1|STARTED|Washout 3||18
205145|NCT00734656|503370|P4|NOT COMPLETED|Lab Session 3||0
205146|NCT00734656|503371|P3|NOT COMPLETED|Lab Session 3||0
205147|NCT00734656|503372|P2|NOT COMPLETED|Lab Session 3||0
205148|NCT00734656|503373|P1|NOT COMPLETED|Lab Session 3||0
205149|NCT00734656|503370|P4|COMPLETED|Lab Session 3||19
205150|NCT00734656|503371|P3|COMPLETED|Lab Session 3||20
205151|NCT00734656|503372|P2|COMPLETED|Lab Session 3||19
205152|NCT00734656|503373|P1|COMPLETED|Lab Session 3||18
205153|NCT00734656|503370|P4|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
205154|NCT00734656|503371|P3|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|20
205155|NCT00734656|503372|P2|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|19
205156|NCT00734656|503373|P1|STARTED|Lab Session 3|subjects cross-over to different treatment condition with each lab session in factorial design,|18
205157|NCT00734656|503370|P4|NOT COMPLETED|Washout 2||0
205158|NCT00734656|503371|P3|NOT COMPLETED|Washout 2||1
205159|NCT00734656|503372|P2|NOT COMPLETED|Washout 2||1
205160|NCT00734656|503373|P1|NOT COMPLETED|Washout 2||1
205161|NCT00734656|503370|P4|COMPLETED|Washout 2||19
205162|NCT00734656|503371|P3|COMPLETED|Washout 2||20
205163|NCT00734656|503372|P2|COMPLETED|Washout 2||20
205164|NCT00734656|503373|P1|COMPLETED|Washout 2||17
205165|NCT00734656|503370|P4|STARTED|Washout 2||19
205166|NCT00734656|503371|P3|STARTED|Washout 2||21
205167|NCT00734656|503372|P2|STARTED|Washout 2||21
205168|NCT00734656|503373|P1|STARTED|Washout 2||18
205169|NCT00734656|503370|P4|NOT COMPLETED|Lab Session 2||1
205170|NCT00734656|503371|P3|NOT COMPLETED|Lab Session 2||0
205171|NCT00734656|503372|P2|NOT COMPLETED|Lab Session 2||0
205172|NCT00734656|503373|P1|NOT COMPLETED|Lab Session 2||1
205173|NCT00734656|503370|P4|COMPLETED|Lab Session 2||19
205174|NCT00734656|503371|P3|COMPLETED|Lab Session 2||21
205175|NCT00734656|503372|P2|COMPLETED|Lab Session 2||21
205176|NCT00734656|503373|P1|COMPLETED|Lab Session 2||18
205177|NCT00734656|503370|P4|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|20
205178|NCT00734656|503371|P3|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
205270|NCT00743431|503475|P1|STARTED|Overall Study||224
205179|NCT00734656|503372|P2|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|21
205180|NCT00734656|503373|P1|STARTED|Lab Session 2|subjects cross-over to different treatment condition with each lab session in factorial design,|19
205181|NCT00734656|503370|P4|NOT COMPLETED|Washout 1||3
205182|NCT00734656|503371|P3|NOT COMPLETED|Washout 1||2
205183|NCT00734656|503372|P2|NOT COMPLETED|Washout 1||5
205184|NCT00734656|503373|P1|NOT COMPLETED|Washout 1||1
205185|NCT00734656|503370|P4|COMPLETED|Washout 1||18
205186|NCT00734656|503371|P3|COMPLETED|Washout 1||24
205187|NCT00734656|503372|P2|COMPLETED|Washout 1||18
205188|NCT00734656|503373|P1|COMPLETED|Washout 1||21
205189|NCT00734656|503370|P4|STARTED|Washout 1||21
205190|NCT00734656|503371|P3|STARTED|Washout 1||26
205191|NCT00734656|503372|P2|STARTED|Washout 1||23
205192|NCT00734656|503373|P1|STARTED|Washout 1||22
205193|NCT00734656|503370|P4|NOT COMPLETED|Lab Session 1||0
205194|NCT00734656|503371|P3|NOT COMPLETED|Lab Session 1||0
205195|NCT00734656|503372|P2|NOT COMPLETED|Lab Session 1||0
205196|NCT00734656|503373|P1|NOT COMPLETED|Lab Session 1||2
205197|NCT00734656|503370|P4|COMPLETED|Lab Session 1||21
205198|NCT00734656|503371|P3|COMPLETED|Lab Session 1||26
205199|NCT00734656|503372|P2|COMPLETED|Lab Session 1||23
205200|NCT00734656|503373|P1|COMPLETED|Lab Session 1||22
205201|NCT00734656|503370|P4|STARTED|Lab Session 1||21
205202|NCT00734656|503371|P3|STARTED|Lab Session 1||26
205203|NCT00734656|503372|P2|STARTED|Lab Session 1||23
205204|NCT00734656|503373|P1|STARTED|Lab Session 1||24
205205|NCT00734734|503395|P1|NOT COMPLETED|Overall Study||0
205206|NCT00734734|503395|P1|COMPLETED|Overall Study||64
205207|NCT00734734|503395|P1|STARTED|Overall Study||64
205208|NCT00734747|503402|P1|NOT COMPLETED|6 Month Follow-up||3
205209|NCT00734747|503402|P1|COMPLETED|6 Month Follow-up||66
205210|NCT00734747|503402|P1|STARTED|6 Month Follow-up||69
205211|NCT00734747|503402|P1|NOT COMPLETED|SRS Procedure||3
205212|NCT00734747|503402|P1|COMPLETED|SRS Procedure||69
205213|NCT00734747|503402|P1|STARTED|SRS Procedure||72
205214|NCT00743197|503411|P2|NOT COMPLETED|Overall Study||2
205215|NCT00743197|503412|P1|NOT COMPLETED|Overall Study||1
205216|NCT00743197|503411|P2|COMPLETED|Overall Study||0
205217|NCT00743197|503412|P1|COMPLETED|Overall Study||0
205218|NCT00743197|503411|P2|STARTED|Overall Study||2
205219|NCT00743197|503412|P1|STARTED|Overall Study||1
205220|NCT00743249|503420|P2|NOT COMPLETED|Overall Study||6
205221|NCT00743249|503421|P1|NOT COMPLETED|Overall Study||2
205222|NCT00743249|503420|P2|COMPLETED|Overall Study||24
205223|NCT00743249|503421|P1|COMPLETED|Overall Study||28
205224|NCT00743249|503420|P2|STARTED|Overall Study||30
205225|NCT00743249|503421|P1|STARTED|Overall Study||30
205226|NCT00743262|503429|P1|NOT COMPLETED|Overall Study||0
205227|NCT00743262|503429|P1|COMPLETED|Overall Study||15
205228|NCT00743262|503429|P1|STARTED|Overall Study||15
205229|NCT00743275|503437|P2|NOT COMPLETED|Overall Study||1
205230|NCT00743275|503438|P1|NOT COMPLETED|Overall Study||0
205231|NCT00743275|503437|P2|COMPLETED|Overall Study||60
205232|NCT00743275|503438|P1|COMPLETED|Overall Study||59
205233|NCT00743275|503437|P2|STARTED|Overall Study||61
205234|NCT00743275|503438|P1|STARTED|Overall Study||59
205235|NCT00743288|503450|P7|NOT COMPLETED|Overall Study||9
205236|NCT00743288|503451|P6|NOT COMPLETED|Overall Study||5
205237|NCT00743288|503452|P5|NOT COMPLETED|Overall Study||6
205238|NCT00743288|503453|P4|NOT COMPLETED|Overall Study||7
205239|NCT00743288|503454|P3|NOT COMPLETED|Overall Study||5
205240|NCT00743288|503455|P2|NOT COMPLETED|Overall Study||3
205241|NCT00743288|503456|P1|NOT COMPLETED|Overall Study||3
205242|NCT00743288|503450|P7|COMPLETED|Overall Study||0
205243|NCT00743288|503451|P6|COMPLETED|Overall Study||1
205244|NCT00743288|503452|P5|COMPLETED|Overall Study||0
205245|NCT00743288|503453|P4|COMPLETED|Overall Study||0
205246|NCT00743288|503454|P3|COMPLETED|Overall Study||1
205247|NCT00743288|503455|P2|COMPLETED|Overall Study||0
205248|NCT00743288|503456|P1|COMPLETED|Overall Study||0
205249|NCT00743288|503450|P7|STARTED|Overall Study|6 subjects were enrolled in phase 1 and 3 subjects were enrolled as part of the phase 2 expansion.|9
205250|NCT00743288|503451|P6|STARTED|Overall Study||6
205251|NCT00743288|503452|P5|STARTED|Overall Study||6
205252|NCT00743288|503453|P4|STARTED|Overall Study||7
205253|NCT00743288|503454|P3|STARTED|Overall Study||6
205254|NCT00743288|503455|P2|STARTED|Overall Study||3
205255|NCT00743288|503456|P1|STARTED|Overall Study||3
205256|NCT00743366|503468|P2|NOT COMPLETED|Intervention 2 (8 Days)||0
205257|NCT00743366|503469|P1|NOT COMPLETED|Intervention 2 (8 Days)||0
205258|NCT00743366|503468|P2|COMPLETED|Intervention 2 (8 Days)||7
205259|NCT00743366|503469|P1|COMPLETED|Intervention 2 (8 Days)||7
205260|NCT00743366|503468|P2|STARTED|Intervention 2 (8 Days)||7
205261|NCT00743366|503469|P1|STARTED|Intervention 2 (8 Days)||7
205262|NCT00743366|503468|P2|NOT COMPLETED|Intervention 1 (8 Days)||3
205263|NCT00743366|503469|P1|NOT COMPLETED|Intervention 1 (8 Days)||3
205264|NCT00743366|503468|P2|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
205265|NCT00743366|503469|P1|COMPLETED|Intervention 1 (8 Days)|A total of 6 participants withdrew before completion of the final inpatient phase|7
205266|NCT00743366|503468|P2|STARTED|Intervention 1 (8 Days)||10
205267|NCT00743366|503469|P1|STARTED|Intervention 1 (8 Days)||10
205268|NCT00743431|503475|P1|NOT COMPLETED|Overall Study||126
205269|NCT00743431|503475|P1|COMPLETED|Overall Study||98
205271|NCT00743444|503479|P2|NOT COMPLETED|Second Intervention||0
205272|NCT00743444|503480|P1|NOT COMPLETED|Second Intervention||0
205273|NCT00743444|503479|P2|COMPLETED|Second Intervention||11
205274|NCT00743444|503480|P1|COMPLETED|Second Intervention||14
205275|NCT00743444|503479|P2|STARTED|Second Intervention||11
205276|NCT00743444|503480|P1|STARTED|Second Intervention||14
205277|NCT00743444|503479|P2|NOT COMPLETED|Washout Period||1
205278|NCT00743444|503480|P1|NOT COMPLETED|Washout Period||0
205279|NCT00743444|503479|P2|COMPLETED|Washout Period||11
205280|NCT00743444|503480|P1|COMPLETED|Washout Period||14
205281|NCT00743444|503479|P2|STARTED|Washout Period||12
205282|NCT00743444|503480|P1|STARTED|Washout Period||14
205283|NCT00743444|503479|P2|NOT COMPLETED|First Intervention||1
205284|NCT00743444|503480|P1|NOT COMPLETED|First Intervention||0
205285|NCT00743444|503479|P2|COMPLETED|First Intervention||12
205286|NCT00743444|503480|P1|COMPLETED|First Intervention||14
205287|NCT00743444|503479|P2|STARTED|First Intervention||13
205288|NCT00743444|503480|P1|STARTED|First Intervention||14
205289|NCT00745368|503489|P1|NOT COMPLETED|Overall Study||3
205290|NCT00745368|503489|P1|COMPLETED|Overall Study|3 male subjects were unable to provide a sample and are not included in the results|16
205291|NCT00745368|503489|P1|STARTED|Overall Study|Of the 28 subjects who enrolled, 19 participated in a study visit|19
205292|NCT00745498|503503|P3|NOT COMPLETED|Overall Study||8
205293|NCT00745498|503504|P2|NOT COMPLETED|Overall Study||6
205294|NCT00745498|503505|P1|NOT COMPLETED|Overall Study||5
205295|NCT00745498|503503|P3|COMPLETED|Overall Study||34
205296|NCT00745498|503504|P2|COMPLETED|Overall Study||37
205297|NCT00745498|503505|P1|COMPLETED|Overall Study||36
205298|NCT00745498|503503|P3|STARTED|Overall Study||42
205299|NCT00745498|503504|P2|STARTED|Overall Study||43
205300|NCT00745498|503505|P1|STARTED|Overall Study||41
205301|NCT00745823|503521|P2|NOT COMPLETED|Overall Study||386
205302|NCT00745823|503522|P1|NOT COMPLETED|Overall Study||385
205303|NCT00745823|503521|P2|COMPLETED|Overall Study||3
205304|NCT00745823|503522|P1|COMPLETED|Overall Study||1
205305|NCT00745823|503521|P2|TREATED Week 0 - 96|Overall Study||388
205306|NCT00745823|503522|P1|TREATED Week 0 - 96|Overall Study||382
205307|NCT00745823|503521|P2|STARTED|Overall Study||389
205308|NCT00745823|503522|P1|STARTED|Overall Study||386
205309|NCT00745875|503548|P2|NOT COMPLETED|Overall Study||4
205310|NCT00745875|503549|P1|NOT COMPLETED|Overall Study||4
205311|NCT00745875|503548|P2|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|26
205408|NCT00746512|503715|P4|NOT COMPLETED|Overall Study||0
205312|NCT00745875|503549|P1|COMPLETED|Overall Study|Completed – Number of patients discontinued study treatment at data cut-off (17th January 2010)|32
205313|NCT00745875|503548|P2|STARTED|Overall Study|Started – Number of patients randomised|30
205314|NCT00745875|503549|P1|STARTED|Overall Study|Started – Number of patients randomised|36
205315|NCT00745901|503559|P2|NOT COMPLETED|Overall Study||21
205316|NCT00745901|503560|P1|NOT COMPLETED|Overall Study||24
205317|NCT00745901|503559|P2|COMPLETED|Overall Study||156
205318|NCT00745901|503560|P1|COMPLETED|Overall Study||154
205319|NCT00745901|503559|P2|STARTED|Overall Study|Number of Patients Randomized|177
205320|NCT00745901|503560|P1|STARTED|Overall Study|Number of Patients Randomized|178
205321|NCT00745940|503606|P2|NOT COMPLETED|Overall Study||10
205322|NCT00745940|503607|P1|NOT COMPLETED|Overall Study||19
205323|NCT00745940|503606|P2|COMPLETED|Overall Study||38
205324|NCT00745940|503607|P1|COMPLETED|Overall Study||38
205325|NCT00745940|503606|P2|STARTED|Overall Study||48
205326|NCT00745940|503607|P1|STARTED|Overall Study||57
205327|NCT00746096|503623|P2|NOT COMPLETED|Overall Study||3
205328|NCT00746096|503624|P1|NOT COMPLETED|Overall Study||10
205329|NCT00746096|503623|P2|COMPLETED|Overall Study||54
205330|NCT00746096|503624|P1|COMPLETED|Overall Study||48
205331|NCT00746096|503623|P2|STARTED|Overall Study||57
205332|NCT00746096|503624|P1|STARTED|Overall Study||58
205333|NCT00746187|503634|P2|NOT COMPLETED|Overall Study||2
205334|NCT00746187|503635|P1|NOT COMPLETED|Overall Study||3
205335|NCT00746187|503634|P2|COMPLETED|Overall Study||16
205336|NCT00746187|503635|P1|COMPLETED|Overall Study||15
205337|NCT00746187|503634|P2|STARTED|Overall Study||18
205338|NCT00746187|503635|P1|STARTED|Overall Study||18
205339|NCT00746239|503641|P1|NOT COMPLETED|Overall Study||6
205340|NCT00746239|503641|P1|COMPLETED|Overall Study|11 subjects total were enrolled - 6 withdrew from study and 5 competed|5
205341|NCT00746239|503641|P1|STARTED|Overall Study||11
205342|NCT00746330|503649|P4|NOT COMPLETED|Period 4||0
205343|NCT00746330|503650|P3|NOT COMPLETED|Period 4||0
205344|NCT00746330|503651|P2|NOT COMPLETED|Period 4||0
205345|NCT00746330|503652|P1|NOT COMPLETED|Period 4||0
205346|NCT00746330|503649|P4|COMPLETED|Period 4||7
205347|NCT00746330|503650|P3|COMPLETED|Period 4||8
205348|NCT00746330|503651|P2|COMPLETED|Period 4||9
205349|NCT00746330|503652|P1|COMPLETED|Period 4||7
205350|NCT00746330|503649|P4|STARTED|Period 4||7
205351|NCT00746330|503650|P3|STARTED|Period 4||8
205352|NCT00746330|503651|P2|STARTED|Period 4||9
205353|NCT00746330|503652|P1|STARTED|Period 4||7
205354|NCT00746330|503649|P4|NOT COMPLETED|Period 3||0
205355|NCT00746330|503650|P3|NOT COMPLETED|Period 3||0
205356|NCT00746330|503651|P2|NOT COMPLETED|Period 3||0
205357|NCT00746330|503652|P1|NOT COMPLETED|Period 3||0
205358|NCT00746330|503649|P4|COMPLETED|Period 3||7
205359|NCT00746330|503650|P3|COMPLETED|Period 3||8
205360|NCT00746330|503651|P2|COMPLETED|Period 3||9
205361|NCT00746330|503652|P1|COMPLETED|Period 3||7
205362|NCT00746330|503649|P4|STARTED|Period 3||7
205363|NCT00746330|503650|P3|STARTED|Period 3||8
205364|NCT00746330|503651|P2|STARTED|Period 3||9
205365|NCT00746330|503652|P1|STARTED|Period 3||7
205366|NCT00746330|503649|P4|NOT COMPLETED|Period 2||0
205367|NCT00746330|503650|P3|NOT COMPLETED|Period 2||0
205368|NCT00746330|503651|P2|NOT COMPLETED|Period 2||0
205369|NCT00746330|503652|P1|NOT COMPLETED|Period 2||0
205370|NCT00746330|503649|P4|COMPLETED|Period 2||7
205371|NCT00746330|503650|P3|COMPLETED|Period 2||8
205372|NCT00746330|503651|P2|COMPLETED|Period 2||9
205373|NCT00746330|503652|P1|COMPLETED|Period 2||7
205374|NCT00746330|503649|P4|STARTED|Period 2||7
205375|NCT00746330|503650|P3|STARTED|Period 2||8
205376|NCT00746330|503651|P2|STARTED|Period 2||9
205377|NCT00746330|503652|P1|STARTED|Period 2||7
205378|NCT00746330|503649|P4|NOT COMPLETED|Period 1||0
205379|NCT00746330|503650|P3|NOT COMPLETED|Period 1||1
205380|NCT00746330|503651|P2|NOT COMPLETED|Period 1||0
205381|NCT00746330|503652|P1|NOT COMPLETED|Period 1||0
205382|NCT00746330|503649|P4|COMPLETED|Period 1||7
205383|NCT00746330|503650|P3|COMPLETED|Period 1||8
205384|NCT00746330|503651|P2|COMPLETED|Period 1||9
205385|NCT00746330|503652|P1|COMPLETED|Period 1||7
205386|NCT00746330|503649|P4|STARTED|Period 1||7
205387|NCT00746330|503650|P3|STARTED|Period 1||9
205388|NCT00746330|503651|P2|STARTED|Period 1||9
205389|NCT00746330|503652|P1|STARTED|Period 1||7
205390|NCT00746356|503680|P2|NOT COMPLETED|Overall Study||7
205391|NCT00746356|503681|P1|NOT COMPLETED|Overall Study||11
205392|NCT00746356|503680|P2|COMPLETED|Overall Study||40
205393|NCT00746356|503681|P1|COMPLETED|Overall Study||70
205394|NCT00746356|503680|P2|STARTED|Overall Study||47
205395|NCT00746356|503681|P1|STARTED|Overall Study||81
205396|NCT00746395|503691|P2|NOT COMPLETED|Overall Study||0
205397|NCT00746395|503692|P1|NOT COMPLETED|Overall Study||0
205398|NCT00746395|503691|P2|COMPLETED|Overall Study||20
205399|NCT00746395|503692|P1|COMPLETED|Overall Study||20
205400|NCT00746395|503691|P2|STARTED|Overall Study||20
205401|NCT00746395|503692|P1|STARTED|Overall Study||20
205402|NCT00746421|503702|P2|NOT COMPLETED|Overall Study||2
205403|NCT00746421|503703|P1|NOT COMPLETED|Overall Study||7
205404|NCT00746421|503702|P2|COMPLETED|Overall Study||9
205405|NCT00746421|503703|P1|COMPLETED|Overall Study||5
205406|NCT00746421|503702|P2|STARTED|Overall Study||11
205407|NCT00746421|503703|P1|STARTED|Overall Study||12
205409|NCT00746512|503716|P3|NOT COMPLETED|Overall Study||0
205410|NCT00746512|503717|P2|NOT COMPLETED|Overall Study||0
205411|NCT00746512|503718|P1|NOT COMPLETED|Overall Study||0
205412|NCT00746512|503715|P4|COMPLETED|Overall Study||9
205413|NCT00746512|503716|P3|COMPLETED|Overall Study||18
205414|NCT00746512|503717|P2|COMPLETED|Overall Study||10
205415|NCT00746512|503718|P1|COMPLETED|Overall Study||8
205416|NCT00746512|503715|P4|STARTED|Overall Study||9
205417|NCT00746512|503716|P3|STARTED|Overall Study||18
205418|NCT00746512|503717|P2|STARTED|Overall Study||10
205419|NCT00746512|503718|P1|STARTED|Overall Study||8
205420|NCT00746551|503734|P2|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
205421|NCT00746551|503735|P1|NOT COMPLETED|At Delivery (GA of 39 Weeks)||15
205422|NCT00746551|503734|P2|COMPLETED|At Delivery (GA of 39 Weeks)||25
205423|NCT00746551|503735|P1|COMPLETED|At Delivery (GA of 39 Weeks)||25
205424|NCT00746551|503734|P2|STARTED|At Delivery (GA of 39 Weeks)||40
205425|NCT00746551|503735|P1|STARTED|At Delivery (GA of 39 Weeks)||40
205426|NCT00746551|503734|P2|NOT COMPLETED|At Gestational Age of 36 Weeks||4
205427|NCT00746551|503735|P1|NOT COMPLETED|At Gestational Age of 36 Weeks||2
205428|NCT00746551|503734|P2|COMPLETED|At Gestational Age of 36 Weeks||36
205429|NCT00746551|503735|P1|COMPLETED|At Gestational Age of 36 Weeks||38
205430|NCT00746551|503734|P2|STARTED|At Gestational Age of 36 Weeks||40
205431|NCT00746551|503735|P1|STARTED|At Gestational Age of 36 Weeks||40
205432|NCT00746564|503743|P1|NOT COMPLETED|Overall Study||2
205433|NCT00746564|503743|P1|COMPLETED|Overall Study||73
205434|NCT00746564|503743|P1|STARTED|Overall Study||75
205435|NCT00746590|503756|P1|NOT COMPLETED|Overall Study||1
205436|NCT00746590|503756|P1|COMPLETED|Overall Study||0
205437|NCT00746590|503756|P1|STARTED|Overall Study||1
205438|NCT00746668|503760|P7|NOT COMPLETED|Overall Study||0
205439|NCT00746668|503761|P6|NOT COMPLETED|Overall Study||0
205440|NCT00746668|503762|P5|NOT COMPLETED|Overall Study||0
205441|NCT00746668|503763|P4|NOT COMPLETED|Overall Study||0
205442|NCT00746668|503764|P3|NOT COMPLETED|Overall Study||0
205443|NCT00746668|503765|P2|NOT COMPLETED|Overall Study||0
205444|NCT00746668|503766|P1|NOT COMPLETED|Overall Study||0
205445|NCT00746668|503760|P7|COMPLETED|Overall Study||5
205446|NCT00746668|503761|P6|COMPLETED|Overall Study||5
205447|NCT00746668|503762|P5|COMPLETED|Overall Study||5
205448|NCT00746668|503763|P4|COMPLETED|Overall Study||5
205449|NCT00746668|503764|P3|COMPLETED|Overall Study||5
205450|NCT00746668|503765|P2|COMPLETED|Overall Study||5
205451|NCT00746668|503766|P1|COMPLETED|Overall Study||6
205452|NCT00746668|503760|P7|STARTED|Overall Study||5
205453|NCT00746668|503761|P6|STARTED|Overall Study||5
205454|NCT00746668|503762|P5|STARTED|Overall Study||5
205455|NCT00746668|503763|P4|STARTED|Overall Study||5
205456|NCT00746668|503764|P3|STARTED|Overall Study||5
205457|NCT00746668|503765|P2|STARTED|Overall Study||5
205458|NCT00746668|503766|P1|STARTED|Overall Study||6
205459|NCT00746694|503779|P1|NOT COMPLETED|Overall Study||0
205460|NCT00746694|503779|P1|COMPLETED|Overall Study||154
205461|NCT00746694|503779|P1|STARTED|Overall Study||154
205462|NCT00746733|503784|P2|NOT COMPLETED|Fourth Intervention||0
205463|NCT00746733|503785|P1|NOT COMPLETED|Fourth Intervention||0
205464|NCT00746733|503784|P2|COMPLETED|Fourth Intervention||11
205465|NCT00746733|503785|P1|COMPLETED|Fourth Intervention||10
205466|NCT00746733|503784|P2|STARTED|Fourth Intervention||11
205467|NCT00746733|503785|P1|STARTED|Fourth Intervention||10
205468|NCT00746733|503784|P2|NOT COMPLETED|Third Intervention||1
205469|NCT00746733|503785|P1|NOT COMPLETED|Third Intervention||1
205470|NCT00746733|503784|P2|COMPLETED|Third Intervention||11
205471|NCT00746733|503785|P1|COMPLETED|Third Intervention||10
205472|NCT00746733|503784|P2|STARTED|Third Intervention||12
205473|NCT00746733|503785|P1|STARTED|Third Intervention||11
205474|NCT00746733|503784|P2|NOT COMPLETED|Second Intervention||0
205475|NCT00746733|503785|P1|NOT COMPLETED|Second Intervention||1
205476|NCT00746733|503784|P2|COMPLETED|Second Intervention||12
205477|NCT00746733|503785|P1|COMPLETED|Second Intervention||11
205478|NCT00746733|503784|P2|STARTED|Second Intervention||12
205479|NCT00746733|503785|P1|STARTED|Second Intervention||12
205480|NCT00746733|503784|P2|NOT COMPLETED|First Intervention||0
205481|NCT00746733|503785|P1|NOT COMPLETED|First Intervention||0
205482|NCT00746733|503784|P2|COMPLETED|First Intervention||12
205483|NCT00746733|503785|P1|COMPLETED|First Intervention||12
205484|NCT00746733|503784|P2|STARTED|First Intervention||12
205485|NCT00746733|503785|P1|STARTED|First Intervention||12
205486|NCT00746785|503848|P3|NOT COMPLETED|Overall Study||27
205487|NCT00746785|503849|P2|NOT COMPLETED|Overall Study||25
205488|NCT00746785|503850|P1|NOT COMPLETED|Overall Study||29
205489|NCT00746785|503848|P3|COMPLETED|Overall Study||13
205490|NCT00746785|503849|P2|COMPLETED|Overall Study||21
205491|NCT00746785|503850|P1|COMPLETED|Overall Study||14
205492|NCT00746785|503848|P3|STARTED|Overall Study||40
205493|NCT00746785|503849|P2|STARTED|Overall Study||46
205494|NCT00746785|503850|P1|STARTED|Overall Study||43
205495|NCT00746798|503862|P4|NOT COMPLETED|Overall Study||0
205496|NCT00746798|503863|P3|NOT COMPLETED|Overall Study||3
205497|NCT00746798|503864|P2|NOT COMPLETED|Overall Study||2
205498|NCT00746798|503865|P1|NOT COMPLETED|Overall Study||1
205499|NCT00746798|503862|P4|COMPLETED|Overall Study||120
205500|NCT00746798|503863|P3|COMPLETED|Overall Study||110
205501|NCT00746798|503864|P2|COMPLETED|Overall Study||122
205502|NCT00746798|503865|P1|COMPLETED|Overall Study||121
205503|NCT00746798|503862|P4|STARTED|Overall Study||120
205504|NCT00746798|503863|P3|STARTED|Overall Study||113
205505|NCT00746798|503864|P2|STARTED|Overall Study||124
205506|NCT00746798|503865|P1|STARTED|Overall Study||122
205507|NCT00746863|503889|P2|NOT COMPLETED|Overall Study||0
205508|NCT00746863|503890|P1|NOT COMPLETED|Overall Study||0
205509|NCT00746863|503889|P2|COMPLETED|Overall Study||21
205510|NCT00746863|503890|P1|COMPLETED|Overall Study||21
205511|NCT00746863|503889|P2|STARTED|Overall Study||21
205512|NCT00746863|503890|P1|STARTED|Overall Study||21
205513|NCT00746889|503906|P2|NOT COMPLETED|Overall Study||4
205514|NCT00746889|503907|P1|NOT COMPLETED|Overall Study||4
205515|NCT00746889|503906|P2|COMPLETED|Overall Study||35
205516|NCT00746889|503907|P1|COMPLETED|Overall Study||36
205517|NCT00746889|503906|P2|STARTED|Overall Study||39
205518|NCT00746889|503907|P1|STARTED|Overall Study||40
205519|NCT00746941|503919|P4|NOT COMPLETED|Overall Study||13
205520|NCT00746941|503920|P3|NOT COMPLETED|Overall Study||2
205521|NCT00746941|503921|P2|NOT COMPLETED|Overall Study||4
205522|NCT00746941|503922|P1|NOT COMPLETED|Overall Study||7
205523|NCT00746941|503919|P4|COMPLETED|Overall Study||7
205524|NCT00746941|503920|P3|COMPLETED|Overall Study||3
205525|NCT00746941|503921|P2|COMPLETED|Overall Study||1
205526|NCT00746941|503922|P1|COMPLETED|Overall Study||0
205527|NCT00746941|503919|P4|STARTED|Overall Study||20
205528|NCT00746941|503920|P3|STARTED|Overall Study||5
205529|NCT00746941|503921|P2|STARTED|Overall Study||5
205530|NCT00746941|503922|P1|STARTED|Overall Study||7
205531|NCT00746954|503948|P3|NOT COMPLETED|Overall Study||0
205532|NCT00746954|503949|P2|NOT COMPLETED|Overall Study||0
205533|NCT00746954|503950|P1|NOT COMPLETED|Overall Study||0
205534|NCT00746954|503948|P3|COMPLETED|Overall Study||2
205535|NCT00746954|503949|P2|COMPLETED|Overall Study||3
205536|NCT00746954|503950|P1|COMPLETED|Overall Study||3
205537|NCT00746954|503948|P3|STARTED|Overall Study||2
205538|NCT00746954|503949|P2|STARTED|Overall Study||3
205539|NCT00746954|503950|P1|STARTED|Overall Study||3
205540|NCT00747006|503959|P3|NOT COMPLETED|Overall Study||1
205541|NCT00747006|503960|P2|NOT COMPLETED|Overall Study||1
205542|NCT00747006|503961|P1|NOT COMPLETED|Overall Study||3
205543|NCT00747006|503959|P3|COMPLETED|Overall Study||2
205544|NCT00747006|503960|P2|COMPLETED|Overall Study||7
205545|NCT00747006|503961|P1|COMPLETED|Overall Study||4
205546|NCT00747006|503959|P3|STARTED|Overall Study||3
205547|NCT00747006|503960|P2|STARTED|Overall Study||8
205548|NCT00747006|503961|P1|STARTED|Overall Study||7
205549|NCT00747149|504029|P2|NOT COMPLETED|Overall Study||43
205550|NCT00747149|504030|P1|NOT COMPLETED|Overall Study||1
205551|NCT00747149|504029|P2|COMPLETED|Overall Study||401
205552|NCT00747149|504030|P1|COMPLETED|Overall Study||153
205553|NCT00747149|504029|P2|STARTED|Overall Study||444
205554|NCT00747149|504030|P1|STARTED|Overall Study||154
205555|NCT00747214|504044|P2|NOT COMPLETED|Overall Study||3
205556|NCT00747214|504045|P1|NOT COMPLETED|Overall Study||8
205557|NCT00747214|504044|P2|COMPLETED|Overall Study||29
205558|NCT00747214|504045|P1|COMPLETED|Overall Study||19
205559|NCT00747214|504044|P2|STARTED|Overall Study||32
205560|NCT00747214|504045|P1|STARTED|Overall Study||27
205561|NCT00747227|504059|P2|NOT COMPLETED|Overall Study||4
205562|NCT00747227|504060|P1|NOT COMPLETED|Overall Study||6
205563|NCT00747227|504059|P2|COMPLETED|Overall Study||120
205564|NCT00747227|504060|P1|COMPLETED|Overall Study||120
205565|NCT00747227|504059|P2|STARTED|Overall Study||124
205566|NCT00747227|504060|P1|STARTED|Overall Study||126
205567|NCT00747344|504074|P4|NOT COMPLETED|After Controlled Period||1
205568|NCT00747344|504075|P3|NOT COMPLETED|After Controlled Period||0
205569|NCT00747344|504076|P2|NOT COMPLETED|After Controlled Period||0
205570|NCT00747344|504077|P1|NOT COMPLETED|After Controlled Period||0
205571|NCT00747344|504074|P4|COMPLETED|After Controlled Period||56
205572|NCT00747344|504075|P3|COMPLETED|After Controlled Period||55
205573|NCT00747344|504076|P2|COMPLETED|After Controlled Period||0
205574|NCT00747344|504077|P1|COMPLETED|After Controlled Period||0
205575|NCT00747344|504074|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|57
205576|NCT00747344|504075|P3|STARTED|After Controlled Period||55
205577|NCT00747344|504076|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
205578|NCT00747344|504077|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
205579|NCT00747344|504074|P4|NOT COMPLETED|Controlled Period||0
205580|NCT00747344|504075|P3|NOT COMPLETED|Controlled Period||0
205581|NCT00747344|504076|P2|NOT COMPLETED|Controlled Period||4
205582|NCT00747344|504077|P1|NOT COMPLETED|Controlled Period||5
205583|NCT00747344|504074|P4|COMPLETED|Controlled Period||0
205584|NCT00747344|504075|P3|COMPLETED|Controlled Period||0
205585|NCT00747344|504076|P2|COMPLETED|Controlled Period||57
205586|NCT00747344|504077|P1|COMPLETED|Controlled Period||55
205587|NCT00747344|504074|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
205588|NCT00747344|504075|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
205589|NCT00747344|504076|P2|STARTED|Controlled Period||61
205590|NCT00747344|504077|P1|STARTED|Controlled Period||60
205591|NCT00747435|504089|P1|NOT COMPLETED|Overall Study||6
205592|NCT00747435|504089|P1|COMPLETED|Overall Study||67
205593|NCT00747435|504089|P1|STARTED|Overall Study||73
205594|NCT00747461|504097|P1|NOT COMPLETED|Overall Study||5
205595|NCT00747461|504097|P1|COMPLETED|Overall Study||0
205596|NCT00747461|504097|P1|STARTED|Overall Study||5
205597|NCT00747474|504102|P12|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205598|NCT00747474|504103|P11|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205599|NCT00747474|504104|P10|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205600|NCT00747474|504105|P9|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205601|NCT00747474|504106|P8|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205602|NCT00747474|504107|P7|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205603|NCT00747474|504108|P6|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205604|NCT00747474|504109|P5|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205605|NCT00747474|504110|P4|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205606|NCT00747474|504111|P3|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205607|NCT00747474|504112|P2|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205608|NCT00747474|504113|P1|NOT COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205609|NCT00747474|504102|P12|COMPLETED|Cohort 12 (60 mg/m^2) Period||6
205610|NCT00747474|504103|P11|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205611|NCT00747474|504104|P10|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205612|NCT00747474|504105|P9|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205613|NCT00747474|504106|P8|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205614|NCT00747474|504107|P7|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205615|NCT00747474|504108|P6|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205616|NCT00747474|504109|P5|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205617|NCT00747474|504110|P4|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205618|NCT00747474|504111|P3|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205619|NCT00747474|504112|P2|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205620|NCT00747474|504113|P1|COMPLETED|Cohort 12 (60 mg/m^2) Period||0
205621|NCT00747474|504102|P12|STARTED|Cohort 12 (60 mg/m^2) Period||6
205622|NCT00747474|504103|P11|STARTED|Cohort 12 (60 mg/m^2) Period||0
205623|NCT00747474|504104|P10|STARTED|Cohort 12 (60 mg/m^2) Period||0
205624|NCT00747474|504105|P9|STARTED|Cohort 12 (60 mg/m^2) Period||0
205625|NCT00747474|504106|P8|STARTED|Cohort 12 (60 mg/m^2) Period||0
205626|NCT00747474|504107|P7|STARTED|Cohort 12 (60 mg/m^2) Period||0
205627|NCT00747474|504108|P6|STARTED|Cohort 12 (60 mg/m^2) Period||0
205628|NCT00747474|504109|P5|STARTED|Cohort 12 (60 mg/m^2) Period||0
205629|NCT00747474|504110|P4|STARTED|Cohort 12 (60 mg/m^2) Period||0
205630|NCT00747474|504111|P3|STARTED|Cohort 12 (60 mg/m^2) Period||0
205631|NCT00747474|504112|P2|STARTED|Cohort 12 (60 mg/m^2) Period||0
205632|NCT00747474|504113|P1|STARTED|Cohort 12 (60 mg/m^2) Period||0
205633|NCT00747474|504102|P12|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205634|NCT00747474|504103|P11|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205635|NCT00747474|504104|P10|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205636|NCT00747474|504105|P9|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205637|NCT00747474|504106|P8|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205638|NCT00747474|504107|P7|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205639|NCT00747474|504108|P6|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205640|NCT00747474|504109|P5|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205641|NCT00747474|504110|P4|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205642|NCT00747474|504111|P3|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205643|NCT00747474|504112|P2|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205644|NCT00747474|504113|P1|NOT COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205645|NCT00747474|504102|P12|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205646|NCT00747474|504103|P11|COMPLETED|Cohort 11 (50 mg/m^2) Period||5
205647|NCT00747474|504104|P10|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205648|NCT00747474|504105|P9|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205649|NCT00747474|504106|P8|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205650|NCT00747474|504107|P7|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205651|NCT00747474|504108|P6|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205652|NCT00747474|504109|P5|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205653|NCT00747474|504110|P4|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205654|NCT00747474|504111|P3|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205655|NCT00747474|504112|P2|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205656|NCT00747474|504113|P1|COMPLETED|Cohort 11 (50 mg/m^2) Period||0
205657|NCT00747474|504102|P12|STARTED|Cohort 11 (50 mg/m^2) Period||0
205658|NCT00747474|504103|P11|STARTED|Cohort 11 (50 mg/m^2) Period||5
205659|NCT00747474|504104|P10|STARTED|Cohort 11 (50 mg/m^2) Period||0
205660|NCT00747474|504105|P9|STARTED|Cohort 11 (50 mg/m^2) Period||0
205661|NCT00747474|504106|P8|STARTED|Cohort 11 (50 mg/m^2) Period||0
205662|NCT00747474|504107|P7|STARTED|Cohort 11 (50 mg/m^2) Period||0
205663|NCT00747474|504108|P6|STARTED|Cohort 11 (50 mg/m^2) Period||0
205664|NCT00747474|504109|P5|STARTED|Cohort 11 (50 mg/m^2) Period||0
205665|NCT00747474|504110|P4|STARTED|Cohort 11 (50 mg/m^2) Period||0
205666|NCT00747474|504111|P3|STARTED|Cohort 11 (50 mg/m^2) Period||0
205667|NCT00747474|504112|P2|STARTED|Cohort 11 (50 mg/m^2) Period||0
205668|NCT00747474|504113|P1|STARTED|Cohort 11 (50 mg/m^2) Period||0
205669|NCT00747474|504102|P12|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205670|NCT00747474|504103|P11|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205671|NCT00747474|504104|P10|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205672|NCT00747474|504105|P9|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205673|NCT00747474|504106|P8|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205674|NCT00747474|504107|P7|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205675|NCT00747474|504108|P6|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205676|NCT00747474|504109|P5|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205677|NCT00747474|504110|P4|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205678|NCT00747474|504111|P3|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205679|NCT00747474|504112|P2|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205680|NCT00747474|504113|P1|NOT COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205681|NCT00747474|504102|P12|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205682|NCT00747474|504103|P11|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205683|NCT00747474|504104|P10|COMPLETED|Cohort 10 (40 mg/m^2) Period||7
205684|NCT00747474|504105|P9|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205685|NCT00747474|504106|P8|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205686|NCT00747474|504107|P7|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205687|NCT00747474|504108|P6|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205688|NCT00747474|504109|P5|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205689|NCT00747474|504110|P4|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205690|NCT00747474|504111|P3|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205691|NCT00747474|504112|P2|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205692|NCT00747474|504113|P1|COMPLETED|Cohort 10 (40 mg/m^2) Period||0
205693|NCT00747474|504102|P12|STARTED|Cohort 10 (40 mg/m^2) Period||0
205694|NCT00747474|504103|P11|STARTED|Cohort 10 (40 mg/m^2) Period||0
205695|NCT00747474|504104|P10|STARTED|Cohort 10 (40 mg/m^2) Period||7
205696|NCT00747474|504105|P9|STARTED|Cohort 10 (40 mg/m^2) Period||0
205697|NCT00747474|504106|P8|STARTED|Cohort 10 (40 mg/m^2) Period||0
205698|NCT00747474|504107|P7|STARTED|Cohort 10 (40 mg/m^2) Period||0
205699|NCT00747474|504108|P6|STARTED|Cohort 10 (40 mg/m^2) Period||0
205700|NCT00747474|504109|P5|STARTED|Cohort 10 (40 mg/m^2) Period||0
205701|NCT00747474|504110|P4|STARTED|Cohort 10 (40 mg/m^2) Period||0
205702|NCT00747474|504111|P3|STARTED|Cohort 10 (40 mg/m^2) Period||0
205703|NCT00747474|504112|P2|STARTED|Cohort 10 (40 mg/m^2) Period||0
205704|NCT00747474|504113|P1|STARTED|Cohort 10 (40 mg/m^2) Period||0
205705|NCT00747474|504102|P12|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205706|NCT00747474|504103|P11|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205707|NCT00747474|504104|P10|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205708|NCT00747474|504105|P9|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205709|NCT00747474|504106|P8|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205710|NCT00747474|504107|P7|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205711|NCT00747474|504108|P6|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205712|NCT00747474|504109|P5|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205713|NCT00747474|504110|P4|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205714|NCT00747474|504111|P3|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205715|NCT00747474|504112|P2|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205716|NCT00747474|504113|P1|NOT COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205717|NCT00747474|504102|P12|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205718|NCT00747474|504103|P11|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205719|NCT00747474|504104|P10|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205720|NCT00747474|504105|P9|COMPLETED|Cohort 9 (35 mg/m^2) Period||4
205721|NCT00747474|504106|P8|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205722|NCT00747474|504107|P7|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205723|NCT00747474|504108|P6|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205724|NCT00747474|504109|P5|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205725|NCT00747474|504110|P4|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205726|NCT00747474|504111|P3|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205727|NCT00747474|504112|P2|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205728|NCT00747474|504113|P1|COMPLETED|Cohort 9 (35 mg/m^2) Period||0
205729|NCT00747474|504102|P12|STARTED|Cohort 9 (35 mg/m^2) Period||0
205730|NCT00747474|504103|P11|STARTED|Cohort 9 (35 mg/m^2) Period||0
205731|NCT00747474|504104|P10|STARTED|Cohort 9 (35 mg/m^2) Period||0
205732|NCT00747474|504105|P9|STARTED|Cohort 9 (35 mg/m^2) Period||4
205733|NCT00747474|504106|P8|STARTED|Cohort 9 (35 mg/m^2) Period||0
205734|NCT00747474|504107|P7|STARTED|Cohort 9 (35 mg/m^2) Period||0
205735|NCT00747474|504108|P6|STARTED|Cohort 9 (35 mg/m^2) Period||0
205736|NCT00747474|504109|P5|STARTED|Cohort 9 (35 mg/m^2) Period||0
205737|NCT00747474|504110|P4|STARTED|Cohort 9 (35 mg/m^2) Period||0
205738|NCT00747474|504111|P3|STARTED|Cohort 9 (35 mg/m^2) Period||0
205739|NCT00747474|504112|P2|STARTED|Cohort 9 (35 mg/m^2) Period||0
205740|NCT00747474|504113|P1|STARTED|Cohort 9 (35 mg/m^2) Period||0
205741|NCT00747474|504102|P12|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205742|NCT00747474|504103|P11|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205743|NCT00747474|504104|P10|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205744|NCT00747474|504105|P9|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205745|NCT00747474|504106|P8|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||1
205746|NCT00747474|504107|P7|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205747|NCT00747474|504108|P6|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205748|NCT00747474|504109|P5|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205749|NCT00747474|504110|P4|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205750|NCT00747474|504111|P3|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205751|NCT00747474|504112|P2|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205752|NCT00747474|504113|P1|NOT COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205753|NCT00747474|504102|P12|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205754|NCT00747474|504103|P11|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205755|NCT00747474|504104|P10|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205756|NCT00747474|504105|P9|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205757|NCT00747474|504106|P8|COMPLETED|Cohort 8 (40 mg/m^2) Period||5
205758|NCT00747474|504107|P7|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205759|NCT00747474|504108|P6|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205760|NCT00747474|504109|P5|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205761|NCT00747474|504110|P4|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205762|NCT00747474|504111|P3|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205763|NCT00747474|504112|P2|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205764|NCT00747474|504113|P1|COMPLETED|Cohort 8 (40 mg/m^2) Period||0
205765|NCT00747474|504102|P12|STARTED|Cohort 8 (40 mg/m^2) Period||0
205766|NCT00747474|504103|P11|STARTED|Cohort 8 (40 mg/m^2) Period||0
205767|NCT00747474|504104|P10|STARTED|Cohort 8 (40 mg/m^2) Period||0
205768|NCT00747474|504105|P9|STARTED|Cohort 8 (40 mg/m^2) Period||0
205769|NCT00747474|504106|P8|STARTED|Cohort 8 (40 mg/m^2) Period||6
205770|NCT00747474|504107|P7|STARTED|Cohort 8 (40 mg/m^2) Period||0
205771|NCT00747474|504108|P6|STARTED|Cohort 8 (40 mg/m^2) Period||0
205772|NCT00747474|504109|P5|STARTED|Cohort 8 (40 mg/m^2) Period||0
205773|NCT00747474|504110|P4|STARTED|Cohort 8 (40 mg/m^2) Period||0
205774|NCT00747474|504111|P3|STARTED|Cohort 8 (40 mg/m^2) Period||0
205775|NCT00747474|504112|P2|STARTED|Cohort 8 (40 mg/m^2) Period||0
205776|NCT00747474|504113|P1|STARTED|Cohort 8 (40 mg/m^2) Period||0
205777|NCT00747474|504102|P12|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205778|NCT00747474|504103|P11|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205779|NCT00747474|504104|P10|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205780|NCT00747474|504105|P9|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205781|NCT00747474|504106|P8|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205782|NCT00747474|504107|P7|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205783|NCT00747474|504108|P6|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205784|NCT00747474|504109|P5|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205785|NCT00747474|504110|P4|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205786|NCT00747474|504111|P3|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205787|NCT00747474|504112|P2|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205788|NCT00747474|504113|P1|NOT COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205789|NCT00747474|504102|P12|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205790|NCT00747474|504103|P11|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205791|NCT00747474|504104|P10|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205792|NCT00747474|504105|P9|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205793|NCT00747474|504106|P8|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205794|NCT00747474|504107|P7|COMPLETED|Cohort 7 (30 mg/m^2) Period||4
205795|NCT00747474|504108|P6|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205796|NCT00747474|504109|P5|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205797|NCT00747474|504110|P4|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205798|NCT00747474|504111|P3|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205799|NCT00747474|504112|P2|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205800|NCT00747474|504113|P1|COMPLETED|Cohort 7 (30 mg/m^2) Period||0
205801|NCT00747474|504102|P12|STARTED|Cohort 7 (30 mg/m^2) Period||0
205802|NCT00747474|504103|P11|STARTED|Cohort 7 (30 mg/m^2) Period||0
205803|NCT00747474|504104|P10|STARTED|Cohort 7 (30 mg/m^2) Period||0
205804|NCT00747474|504105|P9|STARTED|Cohort 7 (30 mg/m^2) Period||0
205805|NCT00747474|504106|P8|STARTED|Cohort 7 (30 mg/m^2) Period||0
205806|NCT00747474|504107|P7|STARTED|Cohort 7 (30 mg/m^2) Period||4
205807|NCT00747474|504108|P6|STARTED|Cohort 7 (30 mg/m^2) Period||0
205808|NCT00747474|504109|P5|STARTED|Cohort 7 (30 mg/m^2) Period||0
205809|NCT00747474|504110|P4|STARTED|Cohort 7 (30 mg/m^2) Period||0
205810|NCT00747474|504111|P3|STARTED|Cohort 7 (30 mg/m^2) Period||0
205811|NCT00747474|504112|P2|STARTED|Cohort 7 (30 mg/m^2) Period||0
205812|NCT00747474|504113|P1|STARTED|Cohort 7 (30 mg/m^2) Period||0
205813|NCT00747474|504102|P12|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205814|NCT00747474|504103|P11|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205815|NCT00747474|504104|P10|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205816|NCT00747474|504105|P9|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205817|NCT00747474|504106|P8|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205818|NCT00747474|504107|P7|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205819|NCT00747474|504108|P6|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205820|NCT00747474|504109|P5|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205821|NCT00747474|504110|P4|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205822|NCT00747474|504111|P3|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205823|NCT00747474|504112|P2|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205824|NCT00747474|504113|P1|NOT COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205825|NCT00747474|504102|P12|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205826|NCT00747474|504103|P11|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205827|NCT00747474|504104|P10|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205828|NCT00747474|504105|P9|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205829|NCT00747474|504106|P8|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205830|NCT00747474|504107|P7|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205831|NCT00747474|504108|P6|COMPLETED|Cohort 6 (20 mg/m^2) Period||4
205832|NCT00747474|504109|P5|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205833|NCT00747474|504110|P4|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205834|NCT00747474|504111|P3|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205835|NCT00747474|504112|P2|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205836|NCT00747474|504113|P1|COMPLETED|Cohort 6 (20 mg/m^2) Period||0
205837|NCT00747474|504102|P12|STARTED|Cohort 6 (20 mg/m^2) Period||0
205838|NCT00747474|504103|P11|STARTED|Cohort 6 (20 mg/m^2) Period||0
205839|NCT00747474|504104|P10|STARTED|Cohort 6 (20 mg/m^2) Period||0
205840|NCT00747474|504105|P9|STARTED|Cohort 6 (20 mg/m^2) Period||0
205841|NCT00747474|504106|P8|STARTED|Cohort 6 (20 mg/m^2) Period||0
205842|NCT00747474|504107|P7|STARTED|Cohort 6 (20 mg/m^2) Period||0
205843|NCT00747474|504108|P6|STARTED|Cohort 6 (20 mg/m^2) Period||4
205844|NCT00747474|504109|P5|STARTED|Cohort 6 (20 mg/m^2) Period||0
205845|NCT00747474|504110|P4|STARTED|Cohort 6 (20 mg/m^2) Period||0
205846|NCT00747474|504111|P3|STARTED|Cohort 6 (20 mg/m^2) Period||0
205847|NCT00747474|504112|P2|STARTED|Cohort 6 (20 mg/m^2) Period||0
205848|NCT00747474|504113|P1|STARTED|Cohort 6 (20 mg/m^2) Period||0
205849|NCT00747474|504102|P12|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205850|NCT00747474|504103|P11|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205851|NCT00747474|504104|P10|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205852|NCT00747474|504105|P9|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205853|NCT00747474|504106|P8|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205854|NCT00747474|504107|P7|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205855|NCT00747474|504108|P6|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205856|NCT00747474|504109|P5|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205857|NCT00747474|504110|P4|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205858|NCT00747474|504111|P3|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205859|NCT00747474|504112|P2|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205860|NCT00747474|504113|P1|NOT COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205861|NCT00747474|504102|P12|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205862|NCT00747474|504103|P11|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205863|NCT00747474|504104|P10|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205864|NCT00747474|504105|P9|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205865|NCT00747474|504106|P8|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205866|NCT00747474|504107|P7|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205867|NCT00747474|504108|P6|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205868|NCT00747474|504109|P5|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||4
205869|NCT00747474|504110|P4|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205870|NCT00747474|504111|P3|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205871|NCT00747474|504112|P2|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205872|NCT00747474|504113|P1|COMPLETED|Cohort 5 (13.5 mg/m^2) Period||0
205873|NCT00747474|504102|P12|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205874|NCT00747474|504103|P11|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205875|NCT00747474|504104|P10|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205876|NCT00747474|504105|P9|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205877|NCT00747474|504106|P8|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205878|NCT00747474|504107|P7|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205879|NCT00747474|504108|P6|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205880|NCT00747474|504109|P5|STARTED|Cohort 5 (13.5 mg/m^2) Period||4
205881|NCT00747474|504110|P4|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205882|NCT00747474|504111|P3|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205883|NCT00747474|504112|P2|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205884|NCT00747474|504113|P1|STARTED|Cohort 5 (13.5 mg/m^2) Period||0
205885|NCT00747474|504102|P12|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205886|NCT00747474|504103|P11|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205887|NCT00747474|504104|P10|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205888|NCT00747474|504105|P9|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205889|NCT00747474|504106|P8|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205890|NCT00747474|504107|P7|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205891|NCT00747474|504108|P6|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205892|NCT00747474|504109|P5|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205893|NCT00747474|504110|P4|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205894|NCT00747474|504111|P3|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205895|NCT00747474|504112|P2|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205896|NCT00747474|504113|P1|NOT COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205897|NCT00747474|504102|P12|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205898|NCT00747474|504103|P11|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205899|NCT00747474|504104|P10|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205900|NCT00747474|504105|P9|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205901|NCT00747474|504106|P8|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205902|NCT00747474|504107|P7|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205903|NCT00747474|504108|P6|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205904|NCT00747474|504109|P5|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205905|NCT00747474|504110|P4|COMPLETED|Cohort 4 (9 mg/m^2) Period||4
205906|NCT00747474|504111|P3|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205907|NCT00747474|504112|P2|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205908|NCT00747474|504113|P1|COMPLETED|Cohort 4 (9 mg/m^2) Period||0
205909|NCT00747474|504102|P12|STARTED|Cohort 4 (9 mg/m^2) Period||0
205910|NCT00747474|504103|P11|STARTED|Cohort 4 (9 mg/m^2) Period||0
205911|NCT00747474|504104|P10|STARTED|Cohort 4 (9 mg/m^2) Period||0
205912|NCT00747474|504105|P9|STARTED|Cohort 4 (9 mg/m^2) Period||0
205913|NCT00747474|504106|P8|STARTED|Cohort 4 (9 mg/m^2) Period||0
205914|NCT00747474|504107|P7|STARTED|Cohort 4 (9 mg/m^2) Period||0
205915|NCT00747474|504108|P6|STARTED|Cohort 4 (9 mg/m^2) Period||0
205916|NCT00747474|504109|P5|STARTED|Cohort 4 (9 mg/m^2) Period||0
205917|NCT00747474|504110|P4|STARTED|Cohort 4 (9 mg/m^2) Period||4
205918|NCT00747474|504111|P3|STARTED|Cohort 4 (9 mg/m^2) Period||0
205919|NCT00747474|504112|P2|STARTED|Cohort 4 (9 mg/m^2) Period||0
205920|NCT00747474|504113|P1|STARTED|Cohort 4 (9 mg/m^2) Period||0
205921|NCT00747474|504102|P12|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205922|NCT00747474|504103|P11|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205923|NCT00747474|504104|P10|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205924|NCT00747474|504105|P9|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205925|NCT00747474|504106|P8|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205926|NCT00747474|504107|P7|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205927|NCT00747474|504108|P6|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205928|NCT00747474|504109|P5|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205929|NCT00747474|504110|P4|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205930|NCT00747474|504111|P3|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205931|NCT00747474|504112|P2|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205932|NCT00747474|504113|P1|NOT COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205933|NCT00747474|504102|P12|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205934|NCT00747474|504103|P11|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205935|NCT00747474|504104|P10|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205936|NCT00747474|504105|P9|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205937|NCT00747474|504106|P8|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205938|NCT00747474|504107|P7|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205939|NCT00747474|504108|P6|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205940|NCT00747474|504109|P5|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205941|NCT00747474|504110|P4|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205942|NCT00747474|504111|P3|COMPLETED|Cohort 3 (6 mg/m^2) Period||3
205943|NCT00747474|504112|P2|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205944|NCT00747474|504113|P1|COMPLETED|Cohort 3 (6 mg/m^2) Period||0
205945|NCT00747474|504102|P12|STARTED|Cohort 3 (6 mg/m^2) Period||0
205946|NCT00747474|504103|P11|STARTED|Cohort 3 (6 mg/m^2) Period||0
205947|NCT00747474|504104|P10|STARTED|Cohort 3 (6 mg/m^2) Period||0
205948|NCT00747474|504105|P9|STARTED|Cohort 3 (6 mg/m^2) Period||0
205949|NCT00747474|504106|P8|STARTED|Cohort 3 (6 mg/m^2) Period||0
205950|NCT00747474|504107|P7|STARTED|Cohort 3 (6 mg/m^2) Period||0
205951|NCT00747474|504108|P6|STARTED|Cohort 3 (6 mg/m^2) Period||0
205952|NCT00747474|504109|P5|STARTED|Cohort 3 (6 mg/m^2) Period||0
205953|NCT00747474|504110|P4|STARTED|Cohort 3 (6 mg/m^2) Period||0
205954|NCT00747474|504111|P3|STARTED|Cohort 3 (6 mg/m^2) Period||3
205955|NCT00747474|504112|P2|STARTED|Cohort 3 (6 mg/m^2) Period||0
205956|NCT00747474|504113|P1|STARTED|Cohort 3 (6 mg/m^2) Period||0
205957|NCT00747474|504102|P12|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205958|NCT00747474|504103|P11|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205959|NCT00747474|504104|P10|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205960|NCT00747474|504105|P9|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205961|NCT00747474|504106|P8|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205962|NCT00747474|504107|P7|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205963|NCT00747474|504108|P6|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205964|NCT00747474|504109|P5|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205965|NCT00747474|504110|P4|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205966|NCT00747474|504111|P3|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205967|NCT00747474|504112|P2|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205968|NCT00747474|504113|P1|NOT COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205969|NCT00747474|504102|P12|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205970|NCT00747474|504103|P11|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205971|NCT00747474|504104|P10|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205972|NCT00747474|504105|P9|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205973|NCT00747474|504106|P8|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205974|NCT00747474|504107|P7|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205975|NCT00747474|504108|P6|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205976|NCT00747474|504109|P5|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205977|NCT00747474|504110|P4|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205978|NCT00747474|504111|P3|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205979|NCT00747474|504112|P2|COMPLETED|Cohort 2 (3 mg/m^2) Period||4
205980|NCT00747474|504113|P1|COMPLETED|Cohort 2 (3 mg/m^2) Period||0
205981|NCT00747474|504102|P12|STARTED|Cohort 2 (3 mg/m^2) Period||0
205982|NCT00747474|504103|P11|STARTED|Cohort 2 (3 mg/m^2) Period||0
205983|NCT00747474|504104|P10|STARTED|Cohort 2 (3 mg/m^2) Period||0
205984|NCT00747474|504105|P9|STARTED|Cohort 2 (3 mg/m^2) Period||0
205985|NCT00747474|504106|P8|STARTED|Cohort 2 (3 mg/m^2) Period||0
205986|NCT00747474|504107|P7|STARTED|Cohort 2 (3 mg/m^2) Period||0
205987|NCT00747474|504108|P6|STARTED|Cohort 2 (3 mg/m^2) Period||0
205988|NCT00747474|504109|P5|STARTED|Cohort 2 (3 mg/m^2) Period||0
205989|NCT00747474|504110|P4|STARTED|Cohort 2 (3 mg/m^2) Period||0
205990|NCT00747474|504111|P3|STARTED|Cohort 2 (3 mg/m^2) Period||0
205991|NCT00747474|504112|P2|STARTED|Cohort 2 (3 mg/m^2) Period||4
205992|NCT00747474|504113|P1|STARTED|Cohort 2 (3 mg/m^2) Period||0
205993|NCT00747474|504102|P12|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
205994|NCT00747474|504103|P11|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
205995|NCT00747474|504104|P10|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
205996|NCT00747474|504105|P9|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
205997|NCT00747474|504106|P8|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
205998|NCT00747474|504107|P7|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
205999|NCT00747474|504108|P6|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206000|NCT00747474|504109|P5|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206001|NCT00747474|504110|P4|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206002|NCT00747474|504111|P3|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206003|NCT00747474|504112|P2|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206004|NCT00747474|504113|P1|NOT COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206005|NCT00747474|504102|P12|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206006|NCT00747474|504103|P11|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206007|NCT00747474|504104|P10|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206008|NCT00747474|504105|P9|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206009|NCT00747474|504106|P8|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206010|NCT00747474|504107|P7|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206011|NCT00747474|504108|P6|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206012|NCT00747474|504109|P5|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206013|NCT00747474|504110|P4|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206014|NCT00747474|504111|P3|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206015|NCT00747474|504112|P2|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||0
206016|NCT00747474|504113|P1|COMPLETED|Cohort 1 (1.5 mg/m^2) Period||3
206017|NCT00747474|504102|P12|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206018|NCT00747474|504103|P11|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206019|NCT00747474|504104|P10|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206020|NCT00747474|504105|P9|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206021|NCT00747474|504106|P8|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206022|NCT00747474|504107|P7|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206023|NCT00747474|504108|P6|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206024|NCT00747474|504109|P5|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206025|NCT00747474|504110|P4|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206026|NCT00747474|504111|P3|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206027|NCT00747474|504112|P2|STARTED|Cohort 1 (1.5 mg/m^2) Period||0
206028|NCT00747474|504113|P1|STARTED|Cohort 1 (1.5 mg/m^2) Period||3
206029|NCT00747552|504139|P1|NOT COMPLETED|Overall Study||0
206030|NCT00747552|504139|P1|COMPLETED|Overall Study||30
206031|NCT00747552|504139|P1|STARTED|Overall Study|This number does not include the 2 who were enrolled but had no data collected on them.|30
206032|NCT00747565|504146|P2|NOT COMPLETED|Overall Study||7
206033|NCT00747565|504147|P1|NOT COMPLETED|Overall Study||14
206034|NCT00747565|504146|P2|COMPLETED|Overall Study||116
206035|NCT00747565|504147|P1|COMPLETED|Overall Study|118 multifocal subjects in the original study plus 215 multifocal subejcts in the expansion study.|333
206036|NCT00747565|504146|P2|STARTED|Overall Study||123
206037|NCT00747565|504147|P1|STARTED|Overall Study|125 multifocal subjects in original study plus 222 multifocal subjects in the expansion study.|347
206038|NCT00747617|504157|P2|NOT COMPLETED|Overall Study||1
206039|NCT00747617|504158|P1|NOT COMPLETED|Overall Study||3
206040|NCT00747617|504157|P2|COMPLETED|Overall Study||11
206041|NCT00747617|504158|P1|COMPLETED|Overall Study||10
206042|NCT00747617|504157|P2|STARTED|Overall Study||12
206043|NCT00747617|504158|P1|STARTED|Overall Study||13
206044|NCT00747643|504166|P2|NOT COMPLETED|Overall Study||27
206045|NCT00747643|504167|P1|NOT COMPLETED|Overall Study||36
206046|NCT00747643|504166|P2|COMPLETED|Overall Study||54
206047|NCT00747643|504167|P1|COMPLETED|Overall Study||46
206048|NCT00747643|504166|P2|STARTED|Overall Study||81
206049|NCT00747643|504167|P1|STARTED|Overall Study||82
206050|NCT00747747|504182|P3|NOT COMPLETED|Overall Study||0
206051|NCT00747747|504183|P2|NOT COMPLETED|Overall Study||0
206052|NCT00747747|504184|P1|NOT COMPLETED|Overall Study||0
206053|NCT00747747|504182|P3|COMPLETED|Overall Study|17 with acute episode + 4 with recurrent episode|21
206054|NCT00747747|504183|P2|COMPLETED|Overall Study|11 with acute episode + 3 with recurrent episode|14
206055|NCT00747747|504184|P1|COMPLETED|Overall Study|13 with acute episode + 1 with recurrent episode|14
206056|NCT00747747|504182|P3|STARTED|Overall Study||21
206057|NCT00747747|504183|P2|STARTED|Overall Study||14
206058|NCT00747747|504184|P1|STARTED|Overall Study||14
206059|NCT00738283|504207|P1|NOT COMPLETED|Overall Study||4
206060|NCT00738283|504207|P1|COMPLETED|Overall Study||13
206061|NCT00738283|504207|P1|STARTED|Overall Study||17
206062|NCT00738361|504211|P1|NOT COMPLETED|Overall Study||0
206063|NCT00738361|504211|P1|COMPLETED|Overall Study||4
206064|NCT00738361|504211|P1|STARTED|Overall Study||4
206065|NCT00738374|504220|P4|NOT COMPLETED|Maintenance Treatment/Observation Phase||12
206066|NCT00738374|504221|P3|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
206067|NCT00738374|504222|P2|NOT COMPLETED|Maintenance Treatment/Observation Phase||7
206068|NCT00738374|504223|P1|NOT COMPLETED|Maintenance Treatment/Observation Phase||0
206069|NCT00738374|504220|P4|COMPLETED|Maintenance Treatment/Observation Phase||20
206070|NCT00738374|504221|P3|COMPLETED|Maintenance Treatment/Observation Phase||27
206071|NCT00738374|504222|P2|COMPLETED|Maintenance Treatment/Observation Phase||0
206072|NCT00738374|504223|P1|COMPLETED|Maintenance Treatment/Observation Phase||0
206073|NCT00738374|504220|P4|STARTED|Maintenance Treatment/Observation Phase||32
206074|NCT00738374|504221|P3|STARTED|Maintenance Treatment/Observation Phase||34
206075|NCT00738374|504222|P2|STARTED|Maintenance Treatment/Observation Phase||7
206076|NCT00738374|504223|P1|STARTED|Maintenance Treatment/Observation Phase|Participants were randomized to either maintenance therapy or observation at the end of induction.|0
206077|NCT00738374|504220|P4|NOT COMPLETED|Induction Treatment Phase||0
206078|NCT00738374|504221|P3|NOT COMPLETED|Induction Treatment Phase||0
206079|NCT00738374|504222|P2|NOT COMPLETED|Induction Treatment Phase||0
206080|NCT00738374|504223|P1|NOT COMPLETED|Induction Treatment Phase||24
206081|NCT00738374|504220|P4|COMPLETED|Induction Treatment Phase||0
206082|NCT00738374|504221|P3|COMPLETED|Induction Treatment Phase||0
206083|NCT00738374|504222|P2|COMPLETED|Induction Treatment Phase||0
206084|NCT00738374|504223|P1|COMPLETED|Induction Treatment Phase||73
206173|NCT00739102|504428|P1|NOT COMPLETED|Overall Study||15
206085|NCT00738374|504220|P4|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
206086|NCT00738374|504221|P3|STARTED|Induction Treatment Phase|Participants were randomized at the end of the Induction Treatment Phase.|0
206087|NCT00738374|504222|P2|STARTED|Induction Treatment Phase||0
206088|NCT00738374|504223|P1|STARTED|Induction Treatment Phase||97
206089|NCT00738400|504257|P2|NOT COMPLETED|Overall Study||7
206090|NCT00738400|504258|P1|NOT COMPLETED|Overall Study||4
206091|NCT00738400|504257|P2|COMPLETED|Overall Study||67
206092|NCT00738400|504258|P1|COMPLETED|Overall Study||72
206093|NCT00738400|504257|P2|ITT (Intent To Treatment) Population|Overall Study|No post-baseline efficacy measurement in 2 participants|70
206094|NCT00738400|504258|P1|ITT (Intent To Treatment) Population|Overall Study||75
206095|NCT00738400|504257|P2|Received Treatment, Safety Population|Overall Study|Two invalid participants (no evidence that these randomized participants took study medication).|72
206096|NCT00738400|504258|P1|Received Treatment, Safety Population|Overall Study|One invalid participant (no evidence that this randomized participant took study medication).|75
206097|NCT00738400|504257|P2|STARTED|Overall Study||74
206098|NCT00738400|504258|P1|STARTED|Overall Study||76
206099|NCT00738426|504278|P2|NOT COMPLETED|Overall Study||3
206100|NCT00738426|504279|P1|NOT COMPLETED|Overall Study||2
206101|NCT00738426|504278|P2|COMPLETED|Overall Study||32
206102|NCT00738426|504279|P1|COMPLETED|Overall Study||35
206103|NCT00738426|504278|P2|STARTED|Overall Study||35
206104|NCT00738426|504279|P1|STARTED|Overall Study||37
206105|NCT00738530|504287|P2|NOT COMPLETED|Overall Study||238
206106|NCT00738530|504288|P1|NOT COMPLETED|Overall Study||234
206107|NCT00738530|504287|P2|COMPLETED|Overall Study||84
206108|NCT00738530|504288|P1|COMPLETED|Overall Study||93
206109|NCT00738530|504287|P2|Treated|Overall Study||316
206110|NCT00738530|504288|P1|Treated|Overall Study||325
206111|NCT00738530|504287|P2|STARTED|Overall Study||322
206112|NCT00738530|504288|P1|STARTED|Overall Study||327
206113|NCT00738543|504312|P1|NOT COMPLETED|Control||0
206114|NCT00738543|504312|P1|COMPLETED|Control||48
206115|NCT00738543|504312|P1|STARTED|Control||48
206116|NCT00738543|504312|P1|NOT COMPLETED|Sodium Hypochlorite||0
206117|NCT00738543|504312|P1|COMPLETED|Sodium Hypochlorite||48
206118|NCT00738543|504312|P1|STARTED|Sodium Hypochlorite||48
206119|NCT00738543|504312|P1|NOT COMPLETED|Povidone Iodine||0
206120|NCT00738543|504312|P1|COMPLETED|Povidone Iodine||48
206121|NCT00738543|504312|P1|STARTED|Povidone Iodine||48
206122|NCT00738673|504322|P2|NOT COMPLETED|Overall Study||11
206123|NCT00738673|504323|P1|NOT COMPLETED|Overall Study||24
206124|NCT00738673|504322|P2|COMPLETED|Overall Study||1
206125|NCT00738673|504323|P1|COMPLETED|Overall Study||1
206126|NCT00738673|504322|P2|Intent to Treat Population|Overall Study||12
206127|NCT00738673|504323|P1|Intent to Treat Population|Overall Study||24
206128|NCT00738673|504322|P2|STARTED|Overall Study||12
206129|NCT00738673|504323|P1|STARTED|Overall Study||25
206130|NCT00738699|504353|P2|NOT COMPLETED|Overall Study||140
206131|NCT00738699|504354|P1|NOT COMPLETED|Overall Study||275
206132|NCT00738699|504353|P2|COMPLETED|Overall Study||0
206133|NCT00738699|504354|P1|COMPLETED|Overall Study||0
206134|NCT00738699|504353|P2|Participants Treated|Overall Study||139
206135|NCT00738699|504354|P1|Participants Treated|Overall Study||273
206136|NCT00738699|504353|P2|Participants Not Treated|Overall Study||1
206137|NCT00738699|504354|P1|Participants Not Treated|Overall Study||2
206138|NCT00738699|504353|P2|STARTED|Overall Study||140
206139|NCT00738699|504354|P1|STARTED|Overall Study||275
206140|NCT00738881|504372|P2|NOT COMPLETED|Overall Study||2
206141|NCT00738881|504373|P1|NOT COMPLETED|Overall Study||0
206142|NCT00738881|504372|P2|COMPLETED|Overall Study||10
206143|NCT00738881|504373|P1|COMPLETED|Overall Study||11
206144|NCT00738881|504372|P2|STARTED|Overall Study||12
206145|NCT00738881|504373|P1|STARTED|Overall Study||11
206146|NCT00738972|504389|P4|NOT COMPLETED|Overall Study||1
206147|NCT00738972|504390|P3|NOT COMPLETED|Overall Study||0
206148|NCT00738972|504391|P2|NOT COMPLETED|Overall Study||0
206149|NCT00738972|504392|P1|NOT COMPLETED|Overall Study||0
206150|NCT00738972|504389|P4|COMPLETED|Overall Study||2
206151|NCT00738972|504390|P3|COMPLETED|Overall Study||3
206152|NCT00738972|504391|P2|COMPLETED|Overall Study||3
206153|NCT00738972|504392|P1|COMPLETED|Overall Study||3
206154|NCT00738972|504389|P4|STARTED|Overall Study||3
206155|NCT00738972|504390|P3|STARTED|Overall Study||3
206156|NCT00738972|504391|P2|STARTED|Overall Study||3
206157|NCT00738972|504392|P1|STARTED|Overall Study||3
206158|NCT00739024|504404|P2|NOT COMPLETED|Overall Study||0
206159|NCT00739024|504405|P1|NOT COMPLETED|Overall Study||0
206160|NCT00739024|504404|P2|COMPLETED|Overall Study||6
206161|NCT00739024|504405|P1|COMPLETED|Overall Study||7
206162|NCT00739024|504404|P2|STARTED|Overall Study||6
206163|NCT00739024|504405|P1|STARTED|Overall Study||7
206164|NCT00739050|504411|P2|NOT COMPLETED|Overall Study||0
206165|NCT00739050|504412|P1|NOT COMPLETED|Overall Study||1
206166|NCT00739050|504411|P2|COMPLETED|Overall Study||0
206167|NCT00739050|504412|P1|COMPLETED|Overall Study|These 3 patients completing treatment did not complete the required procedures during the trial.|3
206168|NCT00739050|504411|P2|STARTED|Overall Study||0
206169|NCT00739050|504412|P1|STARTED|Overall Study||4
206170|NCT00739063|504424|P1|NOT COMPLETED|Overall Study||8
206171|NCT00739063|504424|P1|COMPLETED|Overall Study||3
206172|NCT00739063|504424|P1|STARTED|Overall Study||11
206174|NCT00739102|504428|P1|COMPLETED|Overall Study|Completed 12-Month Follow-up|235
206175|NCT00739102|504428|P1|STARTED|Overall Study||250
206176|NCT00739297|504444|P7|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
206177|NCT00739297|504445|P6|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||1
206178|NCT00739297|504446|P5|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
206179|NCT00739297|504447|P4|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
206180|NCT00739297|504448|P3|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
206181|NCT00739297|504449|P2|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
206182|NCT00739297|504450|P1|NOT COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||0
206183|NCT00739297|504444|P7|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||65
206184|NCT00739297|504445|P6|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
206185|NCT00739297|504446|P5|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||7
206186|NCT00739297|504447|P4|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||15
206187|NCT00739297|504448|P3|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||8
206188|NCT00739297|504449|P2|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||11
206189|NCT00739297|504450|P1|COMPLETED|Fourth Intervention(Visit 9 to Visit 10)||16
206190|NCT00739297|504444|P7|STARTED|Fourth Intervention(Visit 9 to Visit 10)||66
206191|NCT00739297|504445|P6|STARTED|Fourth Intervention(Visit 9 to Visit 10)||9
206192|NCT00739297|504446|P5|STARTED|Fourth Intervention(Visit 9 to Visit 10)||7
206193|NCT00739297|504447|P4|STARTED|Fourth Intervention(Visit 9 to Visit 10)||15
206194|NCT00739297|504448|P3|STARTED|Fourth Intervention(Visit 9 to Visit 10)||8
206195|NCT00739297|504449|P2|STARTED|Fourth Intervention(Visit 9 to Visit 10)||11
206196|NCT00739297|504450|P1|STARTED|Fourth Intervention(Visit 9 to Visit 10)||16
206197|NCT00739297|504444|P7|NOT COMPLETED|Third Washout Period of 4-7 Days||0
206198|NCT00739297|504445|P6|NOT COMPLETED|Third Washout Period of 4-7 Days||0
206199|NCT00739297|504446|P5|NOT COMPLETED|Third Washout Period of 4-7 Days||0
206200|NCT00739297|504447|P4|NOT COMPLETED|Third Washout Period of 4-7 Days||0
206201|NCT00739297|504448|P3|NOT COMPLETED|Third Washout Period of 4-7 Days||0
206202|NCT00739297|504449|P2|NOT COMPLETED|Third Washout Period of 4-7 Days||0
206203|NCT00739297|504450|P1|NOT COMPLETED|Third Washout Period of 4-7 Days||0
206204|NCT00739297|504444|P7|COMPLETED|Third Washout Period of 4-7 Days||66
206205|NCT00739297|504445|P6|COMPLETED|Third Washout Period of 4-7 Days||8
206206|NCT00739297|504446|P5|COMPLETED|Third Washout Period of 4-7 Days||6
206207|NCT00739297|504447|P4|COMPLETED|Third Washout Period of 4-7 Days||18
206208|NCT00739297|504448|P3|COMPLETED|Third Washout Period of 4-7 Days||6
206209|NCT00739297|504449|P2|COMPLETED|Third Washout Period of 4-7 Days||12
206210|NCT00739297|504450|P1|COMPLETED|Third Washout Period of 4-7 Days||16
206211|NCT00739297|504444|P7|STARTED|Third Washout Period of 4-7 Days||66
206212|NCT00739297|504445|P6|STARTED|Third Washout Period of 4-7 Days||8
206213|NCT00739297|504446|P5|STARTED|Third Washout Period of 4-7 Days||6
206214|NCT00739297|504447|P4|STARTED|Third Washout Period of 4-7 Days||18
206215|NCT00739297|504448|P3|STARTED|Third Washout Period of 4-7 Days||6
206216|NCT00739297|504449|P2|STARTED|Third Washout Period of 4-7 Days||12
206217|NCT00739297|504450|P1|STARTED|Third Washout Period of 4-7 Days||16
206218|NCT00739297|504444|P7|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
206219|NCT00739297|504445|P6|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
206220|NCT00739297|504446|P5|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
206221|NCT00739297|504447|P4|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
206222|NCT00739297|504448|P3|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
206223|NCT00739297|504449|P2|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
206224|NCT00739297|504450|P1|NOT COMPLETED|Third Intervention (Visit 7 to Visit 8)||0
206225|NCT00739297|504444|P7|COMPLETED|Third Intervention (Visit 7 to Visit 8)||66
206226|NCT00739297|504445|P6|COMPLETED|Third Intervention (Visit 7 to Visit 8)||8
206227|NCT00739297|504446|P5|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
206228|NCT00739297|504447|P4|COMPLETED|Third Intervention (Visit 7 to Visit 8)||18
206229|NCT00739297|504448|P3|COMPLETED|Third Intervention (Visit 7 to Visit 8)||6
206230|NCT00739297|504449|P2|COMPLETED|Third Intervention (Visit 7 to Visit 8)||12
206231|NCT00739297|504450|P1|COMPLETED|Third Intervention (Visit 7 to Visit 8)||16
206232|NCT00739297|504444|P7|STARTED|Third Intervention (Visit 7 to Visit 8)||66
206233|NCT00739297|504445|P6|STARTED|Third Intervention (Visit 7 to Visit 8)||8
206234|NCT00739297|504446|P5|STARTED|Third Intervention (Visit 7 to Visit 8)||6
206235|NCT00739297|504447|P4|STARTED|Third Intervention (Visit 7 to Visit 8)||18
206236|NCT00739297|504448|P3|STARTED|Third Intervention (Visit 7 to Visit 8)||6
206237|NCT00739297|504449|P2|STARTED|Third Intervention (Visit 7 to Visit 8)||12
206238|NCT00739297|504450|P1|STARTED|Third Intervention (Visit 7 to Visit 8)||16
206239|NCT00739297|504444|P7|NOT COMPLETED|Second Washout Period of 4-7 Days||0
206240|NCT00739297|504445|P6|NOT COMPLETED|Second Washout Period of 4-7 Days||0
206241|NCT00739297|504446|P5|NOT COMPLETED|Second Washout Period of 4-7 Days||0
206242|NCT00739297|504447|P4|NOT COMPLETED|Second Washout Period of 4-7 Days||0
206243|NCT00739297|504448|P3|NOT COMPLETED|Second Washout Period of 4-7 Days||0
206244|NCT00739297|504449|P2|NOT COMPLETED|Second Washout Period of 4-7 Days||0
206245|NCT00739297|504450|P1|NOT COMPLETED|Second Washout Period of 4-7 Days||0
206246|NCT00739297|504444|P7|COMPLETED|Second Washout Period of 4-7 Days||66
206247|NCT00739297|504445|P6|COMPLETED|Second Washout Period of 4-7 Days||10
206248|NCT00739297|504446|P5|COMPLETED|Second Washout Period of 4-7 Days||6
206249|NCT00739297|504447|P4|COMPLETED|Second Washout Period of 4-7 Days||14
206250|NCT00739297|504448|P3|COMPLETED|Second Washout Period of 4-7 Days||10
206251|NCT00739297|504449|P2|COMPLETED|Second Washout Period of 4-7 Days||8
206252|NCT00739297|504450|P1|COMPLETED|Second Washout Period of 4-7 Days||18
206253|NCT00739297|504444|P7|STARTED|Second Washout Period of 4-7 Days||66
206254|NCT00739297|504445|P6|STARTED|Second Washout Period of 4-7 Days||10
206255|NCT00739297|504446|P5|STARTED|Second Washout Period of 4-7 Days||6
206256|NCT00739297|504447|P4|STARTED|Second Washout Period of 4-7 Days||14
206257|NCT00739297|504448|P3|STARTED|Second Washout Period of 4-7 Days||10
206258|NCT00739297|504449|P2|STARTED|Second Washout Period of 4-7 Days||8
206259|NCT00739297|504450|P1|STARTED|Second Washout Period of 4-7 Days||18
206260|NCT00739297|504444|P7|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
206261|NCT00739297|504445|P6|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
206262|NCT00739297|504446|P5|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
206263|NCT00739297|504447|P4|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
206264|NCT00739297|504448|P3|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
206265|NCT00739297|504449|P2|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
206266|NCT00739297|504450|P1|NOT COMPLETED|Second Intervention (Visit 5 to Visit 6)||0
206267|NCT00739297|504444|P7|COMPLETED|Second Intervention (Visit 5 to Visit 6)||66
206268|NCT00739297|504445|P6|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
206269|NCT00739297|504446|P5|COMPLETED|Second Intervention (Visit 5 to Visit 6)||6
206270|NCT00739297|504447|P4|COMPLETED|Second Intervention (Visit 5 to Visit 6)||14
206271|NCT00739297|504448|P3|COMPLETED|Second Intervention (Visit 5 to Visit 6)||10
206272|NCT00739297|504449|P2|COMPLETED|Second Intervention (Visit 5 to Visit 6)||8
206273|NCT00739297|504450|P1|COMPLETED|Second Intervention (Visit 5 to Visit 6)||18
206274|NCT00739297|504444|P7|STARTED|Second Intervention (Visit 5 to Visit 6)||66
206275|NCT00739297|504445|P6|STARTED|Second Intervention (Visit 5 to Visit 6)||10
206276|NCT00739297|504446|P5|STARTED|Second Intervention (Visit 5 to Visit 6)||6
206277|NCT00739297|504447|P4|STARTED|Second Intervention (Visit 5 to Visit 6)||14
206278|NCT00739297|504448|P3|STARTED|Second Intervention (Visit 5 to Visit 6)||10
206279|NCT00739297|504449|P2|STARTED|Second Intervention (Visit 5 to Visit 6)||8
206280|NCT00739297|504450|P1|STARTED|Second Intervention (Visit 5 to Visit 6)||18
206281|NCT00739297|504444|P7|NOT COMPLETED|First Washout Period of 4-7 Days||2
206282|NCT00739297|504445|P6|NOT COMPLETED|First Washout Period of 4-7 Days||0
206283|NCT00739297|504446|P5|NOT COMPLETED|First Washout Period of 4-7 Days||0
206284|NCT00739297|504447|P4|NOT COMPLETED|First Washout Period of 4-7 Days||2
206285|NCT00739297|504448|P3|NOT COMPLETED|First Washout Period of 4-7 Days||0
206286|NCT00739297|504449|P2|NOT COMPLETED|First Washout Period of 4-7 Days||0
206287|NCT00739297|504450|P1|NOT COMPLETED|First Washout Period of 4-7 Days||0
206288|NCT00739297|504444|P7|COMPLETED|First Washout Period of 4-7 Days||66
206289|NCT00739297|504445|P6|COMPLETED|First Washout Period of 4-7 Days||9
206290|NCT00739297|504446|P5|COMPLETED|First Washout Period of 4-7 Days||6
206291|NCT00739297|504447|P4|COMPLETED|First Washout Period of 4-7 Days||17
206292|NCT00739297|504448|P3|COMPLETED|First Washout Period of 4-7 Days||6
206293|NCT00739297|504449|P2|COMPLETED|First Washout Period of 4-7 Days||11
206294|NCT00739297|504450|P1|COMPLETED|First Washout Period of 4-7 Days||17
206295|NCT00739297|504444|P7|STARTED|First Washout Period of 4-7 Days||68
206296|NCT00739297|504445|P6|STARTED|First Washout Period of 4-7 Days||9
206297|NCT00739297|504446|P5|STARTED|First Washout Period of 4-7 Days||6
206298|NCT00739297|504447|P4|STARTED|First Washout Period of 4-7 Days||19
206299|NCT00739297|504448|P3|STARTED|First Washout Period of 4-7 Days||6
206300|NCT00739297|504449|P2|STARTED|First Washout Period of 4-7 Days||11
206301|NCT00739297|504450|P1|STARTED|First Washout Period of 4-7 Days||17
206302|NCT00739297|504444|P7|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
206303|NCT00739297|504445|P6|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
206304|NCT00739297|504446|P5|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
206305|NCT00739297|504447|P4|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
206306|NCT00739297|504448|P3|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
206307|NCT00739297|504449|P2|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
206308|NCT00739297|504450|P1|NOT COMPLETED|First Intervention (Visit 3 to Visit 4)||0
206309|NCT00739297|504444|P7|COMPLETED|First Intervention (Visit 3 to Visit 4)||68
206310|NCT00739297|504445|P6|COMPLETED|First Intervention (Visit 3 to Visit 4)||9
206311|NCT00739297|504446|P5|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
206312|NCT00739297|504447|P4|COMPLETED|First Intervention (Visit 3 to Visit 4)||19
206313|NCT00739297|504448|P3|COMPLETED|First Intervention (Visit 3 to Visit 4)||6
206314|NCT00739297|504449|P2|COMPLETED|First Intervention (Visit 3 to Visit 4)||11
206315|NCT00739297|504450|P1|COMPLETED|First Intervention (Visit 3 to Visit 4)||17
206316|NCT00739297|504444|P7|STARTED|First Intervention (Visit 3 to Visit 4)||68
206317|NCT00739297|504445|P6|STARTED|First Intervention (Visit 3 to Visit 4)||9
206318|NCT00739297|504446|P5|STARTED|First Intervention (Visit 3 to Visit 4)||6
206319|NCT00739297|504447|P4|STARTED|First Intervention (Visit 3 to Visit 4)||19
206320|NCT00739297|504448|P3|STARTED|First Intervention (Visit 3 to Visit 4)||6
206321|NCT00739297|504449|P2|STARTED|First Intervention (Visit 3 to Visit 4)||11
206322|NCT00739297|504450|P1|STARTED|First Intervention (Visit 3 to Visit 4)||17
206323|NCT00739310|504478|P1|NOT COMPLETED|Overall Study||7
206324|NCT00739310|504478|P1|COMPLETED|Overall Study||22
206325|NCT00739310|504478|P1|STARTED|Overall Study||29
206326|NCT00739336|504485|P2|NOT COMPLETED|Overall Study||0
206327|NCT00739336|504486|P1|NOT COMPLETED|Overall Study||4
206328|NCT00739336|504485|P2|COMPLETED|Overall Study||24
206329|NCT00739336|504486|P1|COMPLETED|Overall Study||17
206330|NCT00739336|504485|P2|STARTED|Overall Study||24
206331|NCT00739336|504486|P1|STARTED|Overall Study||21
206332|NCT00739583|504500|P2|NOT COMPLETED|Overall Study||0
206333|NCT00739583|504501|P1|NOT COMPLETED|Overall Study||0
206334|NCT00739583|504500|P2|COMPLETED|Overall Study||10
206335|NCT00739583|504501|P1|COMPLETED|Overall Study||10
206336|NCT00739583|504500|P2|STARTED|Overall Study||10
206337|NCT00739583|504501|P1|STARTED|Overall Study||10
206338|NCT00739596|504513|P2|NOT COMPLETED|Overall Study||17
206339|NCT00739596|504514|P1|NOT COMPLETED|Overall Study||25
206340|NCT00739596|504513|P2|COMPLETED|Overall Study||149
206341|NCT00739596|504514|P1|COMPLETED|Overall Study||141
206342|NCT00739596|504513|P2|STARTED|Overall Study||166
206343|NCT00739596|504514|P1|STARTED|Overall Study||166
206344|NCT00739648|504530|P2|NOT COMPLETED|Overall Study||53
206345|NCT00739648|504531|P1|NOT COMPLETED|Overall Study||26
206346|NCT00739648|504530|P2|COMPLETED|Overall Study||161
206347|NCT00739648|504531|P1|COMPLETED|Overall Study||82
206348|NCT00739648|504530|P2|STARTED|Overall Study||214
206349|NCT00739648|504531|P1|STARTED|Overall Study||108
206350|NCT00739661|504545|P2|NOT COMPLETED|Overall Study||42
206351|NCT00739661|504546|P1|NOT COMPLETED|Overall Study||46
206352|NCT00739661|504545|P2|COMPLETED|Overall Study||10
206353|NCT00739661|504546|P1|COMPLETED|Overall Study||6
206354|NCT00739661|504545|P2|STARTED|Overall Study||52
206355|NCT00739661|504546|P1|STARTED|Overall Study||52
206356|NCT00739674|504558|P2|NOT COMPLETED|Overall Study||122
206357|NCT00739674|504559|P1|NOT COMPLETED|Overall Study||181
206358|NCT00739674|504558|P2|COMPLETED|Overall Study||335
206359|NCT00739674|504559|P1|COMPLETED|Overall Study||354
206360|NCT00739674|504558|P2|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|400
206361|NCT00739674|504559|P1|Intent-to-treat (ITT) Population|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|463
206362|NCT00739674|504558|P2|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|9
206363|NCT00739674|504559|P1|Dietician Consultation >30 Days|Overall Study|Patients with dietician consultations >30 days after visit 1 were not included in the data analysis.|1
206364|NCT00739674|504558|P2|No Follow-up Data|Overall Study||18
206365|NCT00739674|504559|P1|No Follow-up Data|Overall Study||33
206366|NCT00739674|504558|P2|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|13
206367|NCT00739674|504559|P1|Site 212 Removal|Overall Study|lack of source documentation & frequent discrepancies between source notes and case report entries.|19
206368|NCT00739674|504558|P2|Screening Failures|Overall Study|ITT population took at least one dose of the study medication and had one follow-up visit.|17
206369|NCT00739674|504559|P1|Screening Failures|Overall Study||19
206370|NCT00739674|504558|P2|STARTED|Overall Study||457
206371|NCT00739674|504559|P1|STARTED|Overall Study||535
206372|NCT00739765|504588|P3|NOT COMPLETED|Overall Study||11
206373|NCT00739765|504589|P2|NOT COMPLETED|Overall Study||11
206374|NCT00739765|504590|P1|NOT COMPLETED|Overall Study||6
206375|NCT00739765|504588|P3|COMPLETED|Overall Study||21
206376|NCT00739765|504589|P2|COMPLETED|Overall Study||27
206377|NCT00739765|504590|P1|COMPLETED|Overall Study||34
206378|NCT00739765|504588|P3|STARTED|Overall Study||32
206379|NCT00739765|504589|P2|STARTED|Overall Study||38
206380|NCT00739765|504590|P1|STARTED|Overall Study||40
206381|NCT00739882|504603|P2|NOT COMPLETED|Open-label Period||5
206382|NCT00739882|504604|P1|NOT COMPLETED|Open-label Period||10
206383|NCT00739882|504603|P2|COMPLETED|Open-label Period||9
206384|NCT00739882|504604|P1|COMPLETED|Open-label Period||7
206385|NCT00739882|504603|P2|STARTED|Open-label Period||14
206386|NCT00739882|504604|P1|STARTED|Open-label Period||17
206387|NCT00739882|504603|P2|NOT COMPLETED|Double-blind Period||11
206388|NCT00739882|504604|P1|NOT COMPLETED|Double-blind Period||19
206389|NCT00739882|504603|P2|COMPLETED|Double-blind Period||14
206390|NCT00739882|504604|P1|COMPLETED|Double-blind Period||32
206391|NCT00739882|504603|P2|STARTED|Double-blind Period||25
206392|NCT00739882|504604|P1|STARTED|Double-blind Period||51
206393|NCT00739908|504624|P2|NOT COMPLETED|Overall Study||25
206394|NCT00739908|504625|P1|NOT COMPLETED|Overall Study||25
206395|NCT00739908|504624|P2|COMPLETED|Overall Study||118
206396|NCT00739908|504625|P1|COMPLETED|Overall Study||117
206397|NCT00739908|504624|P2|STARTED|Overall Study||143
206398|NCT00739908|504625|P1|STARTED|Overall Study||142
206399|NCT00739934|504643|P1|NOT COMPLETED|Voriconazole Oral||3
206400|NCT00739934|504643|P1|COMPLETED|Voriconazole Oral||31
206401|NCT00739934|504643|P1|STARTED|Voriconazole Oral||34
206402|NCT00739934|504643|P1|NOT COMPLETED|Voriconazole IV||6
206403|NCT00739934|504643|P1|COMPLETED|Voriconazole IV||34
206404|NCT00739934|504643|P1|STARTED|Voriconazole IV||40
206405|NCT00739973|504672|P9|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||14
206406|NCT00739973|504673|P8|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||10
206407|NCT00739973|504674|P7|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||13
206408|NCT00739973|504675|P6|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
206409|NCT00739973|504676|P5|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
206410|NCT00739973|504677|P4|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||12
206411|NCT00739973|504678|P3|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||19
206412|NCT00739973|504679|P2|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||20
206413|NCT00739973|504680|P1|NOT COMPLETED|Double-blind:Randomized Period (8 Weeks)||30
206414|NCT00739973|504672|P9|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
206415|NCT00739973|504673|P8|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
206416|NCT00739973|504674|P7|COMPLETED|Double-blind:Randomized Period (8 Weeks)||170
206417|NCT00739973|504675|P6|COMPLETED|Double-blind:Randomized Period (8 Weeks)||169
206418|NCT00739973|504676|P5|COMPLETED|Double-blind:Randomized Period (8 Weeks)||162
206419|NCT00739973|504677|P4|COMPLETED|Double-blind:Randomized Period (8 Weeks)||173
206420|NCT00739973|504678|P3|COMPLETED|Double-blind:Randomized Period (8 Weeks)||184
206421|NCT00739973|504679|P2|COMPLETED|Double-blind:Randomized Period (8 Weeks)||175
206422|NCT00739973|504680|P1|COMPLETED|Double-blind:Randomized Period (8 Weeks)||168
206423|NCT00739973|504672|P9|STARTED|Double-blind:Randomized Period (8 Weeks)||184
206424|NCT00739973|504673|P8|STARTED|Double-blind:Randomized Period (8 Weeks)||178
206425|NCT00739973|504674|P7|STARTED|Double-blind:Randomized Period (8 Weeks)|2 pts. were mis-randomized, so discontinued from single-blind and were untreated in double-blind.|183
206426|NCT00739973|504675|P6|STARTED|Double-blind:Randomized Period (8 Weeks)||181
206427|NCT00739973|504676|P5|STARTED|Double-blind:Randomized Period (8 Weeks)||181
206428|NCT00739973|504677|P4|STARTED|Double-blind:Randomized Period (8 Weeks)||185
206429|NCT00739973|504678|P3|STARTED|Double-blind:Randomized Period (8 Weeks)||203
206430|NCT00739973|504679|P2|STARTED|Double-blind:Randomized Period (8 Weeks)|One pt. was mis-randomized, so discontinued from single-blind and was untreated in the double-blind.|195
206431|NCT00739973|504680|P1|STARTED|Double-blind:Randomized Period (8 Weeks)||198
206432|NCT00739973|504672|P9|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206433|NCT00739973|504673|P8|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206434|NCT00739973|504674|P7|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206435|NCT00739973|504675|P6|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206436|NCT00739973|504676|P5|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206437|NCT00739973|504677|P4|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206438|NCT00739973|504678|P3|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206439|NCT00739973|504679|P2|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206440|NCT00739973|504680|P1|NOT COMPLETED|Single-blind Period (2 to 4 Weeks)||1009
206441|NCT00739973|504672|P9|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206442|NCT00739973|504673|P8|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206443|NCT00739973|504674|P7|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206444|NCT00739973|504675|P6|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206445|NCT00739973|504676|P5|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206446|NCT00739973|504677|P4|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206447|NCT00739973|504678|P3|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206448|NCT00739973|504679|P2|COMPLETED|Single-blind Period (2 to 4 Weeks)||0
206449|NCT00739973|504680|P1|COMPLETED|Single-blind Period (2 to 4 Weeks)||1685
206450|NCT00739973|504672|P9|STARTED|Single-blind Period (2 to 4 Weeks)||0
206451|NCT00739973|504673|P8|STARTED|Single-blind Period (2 to 4 Weeks)||0
206452|NCT00739973|504674|P7|STARTED|Single-blind Period (2 to 4 Weeks)||0
206453|NCT00739973|504675|P6|STARTED|Single-blind Period (2 to 4 Weeks)||0
206454|NCT00739973|504676|P5|STARTED|Single-blind Period (2 to 4 Weeks)||0
206455|NCT00739973|504677|P4|STARTED|Single-blind Period (2 to 4 Weeks)||0
206456|NCT00739973|504678|P3|STARTED|Single-blind Period (2 to 4 Weeks)||0
206457|NCT00739973|504679|P2|STARTED|Single-blind Period (2 to 4 Weeks)||0
206458|NCT00739973|504680|P1|STARTED|Single-blind Period (2 to 4 Weeks)|In this period, participants were enrolled to only Placebo arm.|2694
206459|NCT00739999|504768|P2|NOT COMPLETED|Overall Study||0
206460|NCT00739999|504769|P1|NOT COMPLETED|Overall Study||0
206461|NCT00739999|504768|P2|COMPLETED|Overall Study||24
206462|NCT00739999|504769|P1|COMPLETED|Overall Study||15
206463|NCT00739999|504768|P2|STARTED|Overall Study||24
206464|NCT00739999|504769|P1|STARTED|Overall Study||15
206465|NCT00740051|504842|P2|NOT COMPLETED|Overall Study||32
206466|NCT00740051|504843|P1|NOT COMPLETED|Overall Study||18
206467|NCT00740051|504842|P2|COMPLETED|Overall Study||119
206468|NCT00740051|504843|P1|COMPLETED|Overall Study||58
206469|NCT00740051|504842|P2|STARTED|Overall Study||151
206470|NCT00740051|504843|P1|STARTED|Overall Study||76
206471|NCT00740181|504863|P1|NOT COMPLETED|Overall Study||0
206472|NCT00740181|504863|P1|COMPLETED|Overall Study||9
206473|NCT00740181|504863|P1|STARTED|Overall Study||9
206474|NCT00740207|504869|P2|NOT COMPLETED|Overall Study||0
206475|NCT00740207|504870|P1|NOT COMPLETED|Overall Study||0
206476|NCT00740207|504869|P2|COMPLETED|Overall Study||16
206477|NCT00740207|504870|P1|COMPLETED|Overall Study||17
206478|NCT00740207|504869|P2|STARTED|Overall Study||16
206479|NCT00740207|504870|P1|STARTED|Overall Study||17
206480|NCT00740220|504882|P1|NOT COMPLETED|Overall Study||9
206481|NCT00740220|504882|P1|COMPLETED|Overall Study||88
206482|NCT00740220|504882|P1|STARTED|Overall Study||97
206483|NCT00740480|504886|P1|NOT COMPLETED|Overall Study||2
206484|NCT00740480|504886|P1|COMPLETED|Overall Study||23
206485|NCT00740480|504886|P1|STARTED|Overall Study||25
206486|NCT00740584|504890|P1|NOT COMPLETED|Overall Study||1
206487|NCT00740584|504890|P1|COMPLETED|Overall Study||11
206488|NCT00740584|504890|P1|STARTED|Overall Study||12
206489|NCT00740597|504894|P1|NOT COMPLETED|Overall Study||1
206490|NCT00740597|504894|P1|COMPLETED|Overall Study||0
206491|NCT00740597|504894|P1|STARTED|Overall Study||1
206492|NCT00740636|504900|P2|NOT COMPLETED|Overall Study||4
206493|NCT00740636|504901|P1|NOT COMPLETED|Overall Study||2
206494|NCT00740636|504900|P2|COMPLETED|Overall Study||63
206495|NCT00740636|504901|P1|COMPLETED|Overall Study||23
206496|NCT00740636|504900|P2|STARTED|Overall Study||67
206497|NCT00740636|504901|P1|STARTED|Overall Study||25
206498|NCT00747812|504909|P2|NOT COMPLETED|Overall Study||3
206499|NCT00747812|504910|P1|NOT COMPLETED|Overall Study||5
206500|NCT00747812|504909|P2|COMPLETED|Overall Study||0
206501|NCT00747812|504910|P1|COMPLETED|Overall Study||0
206502|NCT00747812|504909|P2|STARTED|Overall Study|4 subjects were randomized to the Control Group; 1 was not implanted due to early enrollment closure|3
206503|NCT00747812|504910|P1|STARTED|Overall Study||5
206504|NCT00747916|504918|P1|NOT COMPLETED|Overall Study||0
206505|NCT00747916|504918|P1|COMPLETED|Overall Study||3
206506|NCT00747916|504918|P1|STARTED|Overall Study||3
206507|NCT00748072|504925|P2|NOT COMPLETED|Overall Study||0
206508|NCT00748072|504926|P1|NOT COMPLETED|Overall Study||0
206509|NCT00748072|504925|P2|COMPLETED|Overall Study||80
206510|NCT00748072|504926|P1|COMPLETED|Overall Study||82
206511|NCT00748072|504925|P2|STARTED|Overall Study||80
206512|NCT00748072|504926|P1|STARTED|Overall Study||82
206513|NCT00748085|504932|P1|NOT COMPLETED|Overall Study||0
206514|NCT00748085|504932|P1|COMPLETED|Overall Study|No analysis -study terminated for business reasons.|5
206515|NCT00748085|504932|P1|STARTED|Overall Study||5
206516|NCT00748098|504937|P2|NOT COMPLETED|Second Taper Period||0
206517|NCT00748098|504938|P1|NOT COMPLETED|Second Taper Period||0
206518|NCT00748098|504937|P2|COMPLETED|Second Taper Period||61
206519|NCT00748098|504938|P1|COMPLETED|Second Taper Period||53
206520|NCT00748098|504937|P2|STARTED|Second Taper Period||61
206521|NCT00748098|504938|P1|STARTED|Second Taper Period||53
206522|NCT00748098|504937|P2|NOT COMPLETED|Second Treatment Intervention Period||3
206523|NCT00748098|504938|P1|NOT COMPLETED|Second Treatment Intervention Period||6
206524|NCT00748098|504937|P2|COMPLETED|Second Treatment Intervention Period||61
206525|NCT00748098|504938|P1|COMPLETED|Second Treatment Intervention Period||53
206526|NCT00748098|504937|P2|STARTED|Second Treatment Intervention Period||64
206527|NCT00748098|504938|P1|STARTED|Second Treatment Intervention Period||59
206528|NCT00748098|504937|P2|NOT COMPLETED|1-Week Washout Period||1
206529|NCT00748098|504938|P1|NOT COMPLETED|1-Week Washout Period||2
206530|NCT00748098|504937|P2|COMPLETED|1-Week Washout Period||64
206531|NCT00748098|504938|P1|COMPLETED|1-Week Washout Period||59
206532|NCT00748098|504937|P2|STARTED|1-Week Washout Period||65
206533|NCT00748098|504938|P1|STARTED|1-Week Washout Period||61
206534|NCT00748098|504937|P2|NOT COMPLETED|First Taper Period||1
206535|NCT00748098|504938|P1|NOT COMPLETED|First Taper Period||3
206536|NCT00748098|504937|P2|COMPLETED|First Taper Period||65
206537|NCT00748098|504938|P1|COMPLETED|First Taper Period||61
206538|NCT00748098|504937|P2|STARTED|First Taper Period||66
206539|NCT00748098|504938|P1|STARTED|First Taper Period||64
206540|NCT00748098|504937|P2|NOT COMPLETED|First Treatment Intervention Period||1
206541|NCT00748098|504938|P1|NOT COMPLETED|First Treatment Intervention Period||5
206542|NCT00748098|504937|P2|COMPLETED|First Treatment Intervention Period||66
206543|NCT00748098|504938|P1|COMPLETED|First Treatment Intervention Period||64
206544|NCT00748098|504937|P2|STARTED|First Treatment Intervention Period||67
206545|NCT00748098|504938|P1|STARTED|First Treatment Intervention Period||69
206546|NCT00748826|504998|P1|NOT COMPLETED|Overall Study||301
206547|NCT00748826|504998|P1|COMPLETED|Overall Study||207
206548|NCT00748826|504998|P1|STARTED|Overall Study|Of 576 total enrolled, 68 out of scope participants were not used for analyses|508
206549|NCT00748865|505005|P2|NOT COMPLETED|Overall Study||0
206550|NCT00748865|505006|P1|NOT COMPLETED|Overall Study||0
206551|NCT00748865|505005|P2|COMPLETED|Overall Study||10
206552|NCT00748865|505006|P1|COMPLETED|Overall Study||10
206553|NCT00748865|505005|P2|STARTED|Overall Study||10
206554|NCT00748865|505006|P1|STARTED|Overall Study||10
206555|NCT00748956|505015|P3|NOT COMPLETED|Overall Study||0
206556|NCT00748956|505016|P2|NOT COMPLETED|Overall Study||0
206557|NCT00748956|505017|P1|NOT COMPLETED|Overall Study||0
206558|NCT00748956|505015|P3|COMPLETED|Overall Study||5
206559|NCT00748956|505016|P2|COMPLETED|Overall Study||5
206560|NCT00748956|505017|P1|COMPLETED|Overall Study||0
206561|NCT00748956|505015|P3|STARTED|Overall Study||5
206562|NCT00748956|505016|P2|STARTED|Overall Study||5
206563|NCT00748956|505017|P1|STARTED|Overall Study||0
206564|NCT00748969|505042|P2|NOT COMPLETED|Overall Study||0
206565|NCT00748969|505043|P1|NOT COMPLETED|Overall Study||0
206566|NCT00748969|505042|P2|COMPLETED|Overall Study||1
206567|NCT00748969|505043|P1|COMPLETED|Overall Study||1
206568|NCT00748969|505042|P2|STARTED|Overall Study||1
206569|NCT00748969|505043|P1|STARTED|Overall Study||1
206570|NCT00748982|505051|P2|NOT COMPLETED|Overall Study||0
206571|NCT00748982|505052|P1|NOT COMPLETED|Overall Study||0
206572|NCT00748982|505051|P2|COMPLETED|Overall Study||4
206573|NCT00748982|505052|P1|COMPLETED|Overall Study||12
206574|NCT00748982|505051|P2|STARTED|Overall Study||4
206575|NCT00748982|505052|P1|STARTED|Overall Study||12
206576|NCT00749073|505064|P1|NOT COMPLETED|Overall Study||0
206577|NCT00749073|505064|P1|COMPLETED|Overall Study||10
206578|NCT00749073|505064|P1|STARTED|Overall Study||10
206579|NCT00749190|505077|P7|NOT COMPLETED|Overall Study||1
206580|NCT00749190|505078|P6|NOT COMPLETED|Overall Study||5
206581|NCT00749190|505079|P5|NOT COMPLETED|Overall Study||0
206582|NCT00749190|505080|P4|NOT COMPLETED|Overall Study||5
206583|NCT00749190|505081|P3|NOT COMPLETED|Overall Study||1
206584|NCT00749190|505082|P2|NOT COMPLETED|Overall Study||5
206585|NCT00749190|505083|P1|NOT COMPLETED|Overall Study||5
206586|NCT00749190|505077|P7|COMPLETED|Overall Study||70
206587|NCT00749190|505078|P6|COMPLETED|Overall Study||65
206588|NCT00749190|505079|P5|COMPLETED|Overall Study||70
206589|NCT00749190|505080|P4|COMPLETED|Overall Study||66
206590|NCT00749190|505081|P3|COMPLETED|Overall Study||70
206591|NCT00749190|505082|P2|COMPLETED|Overall Study||66
206592|NCT00749190|505083|P1|COMPLETED|Overall Study||66
206593|NCT00749190|505077|P7|STARTED|Overall Study||71
206594|NCT00749190|505078|P6|STARTED|Overall Study||70
206595|NCT00749190|505079|P5|STARTED|Overall Study||70
206596|NCT00749190|505080|P4|STARTED|Overall Study||71
206597|NCT00749190|505081|P3|STARTED|Overall Study||71
206598|NCT00749190|505082|P2|STARTED|Overall Study||71
206599|NCT00749190|505083|P1|STARTED|Overall Study||71
206600|NCT00749268|505164|P2|NOT COMPLETED|Overall Study||36
206601|NCT00749268|505165|P1|NOT COMPLETED|Overall Study||34
206602|NCT00749268|505164|P2|COMPLETED|Overall Study||74
206603|NCT00749268|505165|P1|COMPLETED|Overall Study||72
206604|NCT00749268|505164|P2|STARTED|Overall Study||110
206605|NCT00749268|505165|P1|STARTED|Overall Study||106
206606|NCT00749398|505187|P1|NOT COMPLETED|Overall Study||53
206607|NCT00749398|505187|P1|COMPLETED|Overall Study||71
206608|NCT00749398|505187|P1|STARTED|Overall Study|Nine participants were excluded because they did not fulfill the inclusion criteria.|124
206609|NCT00749463|505204|P3|NOT COMPLETED|Overall Study||1
206610|NCT00749463|505205|P2|NOT COMPLETED|Overall Study||4
206611|NCT00749463|505206|P1|NOT COMPLETED|Overall Study||1
206612|NCT00749463|505204|P3|COMPLETED|Overall Study||149
206613|NCT00749463|505205|P2|COMPLETED|Overall Study||60
206614|NCT00749463|505206|P1|COMPLETED|Overall Study||85
206615|NCT00749463|505204|P3|STARTED|Overall Study||150
206616|NCT00749463|505205|P2|STARTED|Overall Study||64
206617|NCT00749463|505206|P1|STARTED|Overall Study||86
206618|NCT00749476|505232|P1|NOT COMPLETED|Overall Study||0
206619|NCT00749476|505232|P1|COMPLETED|Overall Study||1
206620|NCT00749476|505232|P1|STARTED|Overall Study||1
206621|NCT00749580|505238|P2|NOT COMPLETED|Overall Study||9
206622|NCT00749580|505239|P1|NOT COMPLETED|Overall Study||4
206623|NCT00749580|505238|P2|COMPLETED|Overall Study||16
206624|NCT00749580|505239|P1|COMPLETED|Overall Study|December 2010|17
206625|NCT00749580|505238|P2|STARTED|Overall Study||25
206626|NCT00749580|505239|P1|STARTED|Overall Study|September 2008|21
206627|NCT00749671|505249|P2|NOT COMPLETED|Overall Study||0
206628|NCT00749671|505250|P1|NOT COMPLETED|Overall Study||0
206629|NCT00749671|505249|P2|COMPLETED|Overall Study||9
206630|NCT00749671|505250|P1|COMPLETED|Overall Study||11
206631|NCT00749671|505249|P2|STARTED|Overall Study||9
206632|NCT00749671|505250|P1|STARTED|Overall Study||11
206633|NCT00749684|505258|P1|NOT COMPLETED|Overall Study||82
206634|NCT00749684|505258|P1|COMPLETED|Overall Study||56
206635|NCT00749684|505258|P1|STARTED|Overall Study||138
206636|NCT00749775|505263|P1|NOT COMPLETED|Overall Study||107
206637|NCT00749775|505263|P1|COMPLETED|Overall Study||3210
206638|NCT00749775|505263|P1|STARTED|Overall Study||3317
206639|NCT00749931|505281|P3|NOT COMPLETED|Overall Study||0
206640|NCT00749931|505282|P2|NOT COMPLETED|Overall Study||0
206641|NCT00749931|505283|P1|NOT COMPLETED|Overall Study||0
206642|NCT00749931|505281|P3|COMPLETED|Overall Study||68
206643|NCT00749931|505282|P2|COMPLETED|Overall Study||298
206644|NCT00749931|505283|P1|COMPLETED|Overall Study||298
206645|NCT00749931|505281|P3|STARTED|Overall Study||68
206646|NCT00749931|505282|P2|STARTED|Overall Study||298
206647|NCT00749931|505283|P1|STARTED|Overall Study||298
206648|NCT00749944|505294|P2|NOT COMPLETED|Overall Study||1
206649|NCT00749944|505295|P1|NOT COMPLETED|Overall Study||5
206650|NCT00749944|505294|P2|COMPLETED|Overall Study||54
206651|NCT00749944|505295|P1|COMPLETED|Overall Study||50
206652|NCT00749944|505294|P2|STARTED|Overall Study||55
206653|NCT00749944|505295|P1|STARTED|Overall Study||55
206654|NCT00749957|505363|P2|NOT COMPLETED|Overall Study||0
206655|NCT00749957|505364|P1|NOT COMPLETED|Overall Study||0
206656|NCT00749957|505363|P2|COMPLETED|Overall Study||6
206657|NCT00749957|505364|P1|COMPLETED|Overall Study||6
206658|NCT00749957|505363|P2|STARTED|Overall Study||6
206659|NCT00749957|505364|P1|STARTED|Overall Study||6
206660|NCT00749996|505376|P2|NOT COMPLETED|Overall Study||13
206661|NCT00749996|505377|P1|NOT COMPLETED|Overall Study||18
206662|NCT00749996|505376|P2|COMPLETED|Overall Study||58
206663|NCT00749996|505377|P1|COMPLETED|Overall Study||57
206664|NCT00749996|505376|P2|24 Months Follow up|Overall Study|Withdrawn (n=3). Lost to follow-up (n=3)|58
206665|NCT00749996|505377|P1|24 Months Follow up|Overall Study|Withdrawn (n=5) Accidental death (n=1) Lost to follow up (n=7)|57
206666|NCT00749996|505376|P2|12 Months Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=4). Lost to follow-up (n=1)|60
206667|NCT00749996|505377|P1|12 Months Follow-up|Overall Study|Withdrawn(n=4). Visit not done (n=2)|68
206668|NCT00749996|505376|P2|6 Months Follow-up|Overall Study|Withdrawn (n=3). Visit not done (n=3)|63
206669|NCT00749996|505377|P1|6 Months Follow-up|Overall Study|Visit not done (n=3)|71
206670|NCT00749996|505376|P2|3 Months Follow-up|Overall Study|Visit not done (n=1)|68
206671|NCT00749996|505377|P1|3 Months Follow-up|Overall Study|Visit not done (n=2)|72
206672|NCT00749996|505376|P2|6 Weeks Follow-up|Overall Study|Withdrawn (n=2). Visit not done (n=2)|67
206673|NCT00749996|505377|P1|6 Weeks Follow-up|Overall Study|Withdrawn (n=1). Visit not done (n=2)|72
206674|NCT00749996|505376|P2|STARTED|Overall Study|5 pts were removed due to compliance issue. 1 pt was randomized but not treated (Non-eligible)|71
206675|NCT00749996|505377|P1|STARTED|Overall Study|4 pts were removed due to compliance issue. 2 pts were randomized but not treated (non-eligible)|75
206676|NCT00750061|505387|P2|NOT COMPLETED|Overall Study||2
206677|NCT00750061|505388|P1|NOT COMPLETED|Overall Study||2
206678|NCT00750061|505387|P2|COMPLETED|Overall Study||18
206679|NCT00750061|505388|P1|COMPLETED|Overall Study||18
206680|NCT00750061|505387|P2|STARTED|Overall Study||20
206681|NCT00750061|505388|P1|STARTED|Overall Study||20
206682|NCT00750139|505400|P4|NOT COMPLETED|Overall Study||46
206683|NCT00750139|505401|P3|NOT COMPLETED|Overall Study||101
206684|NCT00750139|505402|P2|NOT COMPLETED|Overall Study||59
206685|NCT00750139|505403|P1|NOT COMPLETED|Overall Study||89
206686|NCT00750139|505400|P4|COMPLETED|Overall Study||73
206687|NCT00750139|505401|P3|COMPLETED|Overall Study||135
206688|NCT00750139|505402|P2|COMPLETED|Overall Study||59
206689|NCT00750139|505403|P1|COMPLETED|Overall Study||145
206690|NCT00750139|505400|P4|STARTED|Overall Study||119
206691|NCT00750139|505401|P3|STARTED|Overall Study||236
206692|NCT00750139|505402|P2|STARTED|Overall Study||118
206693|NCT00750139|505403|P1|STARTED|Overall Study||234
206694|NCT00750152|505419|P2|NOT COMPLETED|Overall Study||27
206695|NCT00750152|505420|P1|NOT COMPLETED|Overall Study||22
206696|NCT00750152|505419|P2|COMPLETED|Overall Study||141
206697|NCT00750152|505420|P1|COMPLETED|Overall Study||144
206698|NCT00750152|505419|P2|STARTED|Overall Study||168
206699|NCT00750152|505420|P1|STARTED|Overall Study||166
206700|NCT00750191|505430|P2|NOT COMPLETED|Overall Study||10
206701|NCT00750191|505431|P1|NOT COMPLETED|Overall Study||5
206702|NCT00750191|505430|P2|COMPLETED|Overall Study||20
206703|NCT00750191|505431|P1|COMPLETED|Overall Study||22
206704|NCT00750191|505430|P2|STARTED|Overall Study||30
206705|NCT00750191|505431|P1|STARTED|Overall Study||27
206706|NCT00750204|505445|P2|NOT COMPLETED|Overall Study||1
206707|NCT00750204|505446|P1|NOT COMPLETED|Overall Study||1
206708|NCT00750204|505445|P2|COMPLETED|Overall Study||0
206709|NCT00750204|505446|P1|COMPLETED|Overall Study||0
206710|NCT00750204|505445|P2|STARTED|Overall Study||1
206711|NCT00750204|505446|P1|STARTED|Overall Study||1
206712|NCT00750269|505457|P5|NOT COMPLETED|Overall Study||10
206713|NCT00750269|505458|P4|NOT COMPLETED|Overall Study||5
206714|NCT00750269|505459|P3|NOT COMPLETED|Overall Study||4
206715|NCT00750269|505460|P2|NOT COMPLETED|Overall Study||1
206716|NCT00750269|505461|P1|NOT COMPLETED|Overall Study||0
206717|NCT00750269|505457|P5|COMPLETED|Overall Study||33
206718|NCT00750269|505458|P4|COMPLETED|Overall Study||38
206719|NCT00750269|505459|P3|COMPLETED|Overall Study||14
206720|NCT00750269|505460|P2|COMPLETED|Overall Study||7
206721|NCT00750269|505461|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study|8
206722|NCT00750269|505457|P5|STARTED|Overall Study||43
206723|NCT00750269|505458|P4|STARTED|Overall Study||43
206724|NCT00750269|505459|P3|STARTED|Overall Study||18
206725|NCT00750269|505460|P2|STARTED|Overall Study||8
206726|NCT00750269|505461|P1|STARTED|Overall Study||8
206727|NCT00750282|505510|P4|NOT COMPLETED|Overall Study||1
206728|NCT00750282|505511|P3|NOT COMPLETED|Overall Study||1
206729|NCT00750282|505512|P2|NOT COMPLETED|Overall Study||1
206730|NCT00750282|505513|P1|NOT COMPLETED|Overall Study||0
206731|NCT00750282|505510|P4|COMPLETED|Overall Study||147
206732|NCT00750282|505511|P3|COMPLETED|Overall Study||125
206733|NCT00750282|505512|P2|COMPLETED|Overall Study||81
206734|NCT00750282|505513|P1|COMPLETED|Overall Study||69
206735|NCT00750282|505510|P4|STARTED|Overall Study||148
206736|NCT00750282|505511|P3|STARTED|Overall Study||126
206737|NCT00750282|505512|P2|STARTED|Overall Study||82
206738|NCT00750282|505513|P1|STARTED|Overall Study||69
206739|NCT00750308|505537|P12|NOT COMPLETED|Fourth Treatment||0
206740|NCT00750308|505538|P11|NOT COMPLETED|Fourth Treatment||0
206741|NCT00750308|505539|P10|NOT COMPLETED|Fourth Treatment||0
206742|NCT00750308|505540|P9|NOT COMPLETED|Fourth Treatment||0
206743|NCT00750308|505541|P8|NOT COMPLETED|Fourth Treatment||0
206744|NCT00750308|505542|P7|NOT COMPLETED|Fourth Treatment||0
206745|NCT00750308|505543|P6|NOT COMPLETED|Fourth Treatment||0
206746|NCT00750308|505544|P5|NOT COMPLETED|Fourth Treatment||0
206747|NCT00750308|505545|P4|NOT COMPLETED|Fourth Treatment||0
206748|NCT00750308|505546|P3|NOT COMPLETED|Fourth Treatment||0
206749|NCT00750308|505547|P2|NOT COMPLETED|Fourth Treatment||0
206750|NCT00750308|505548|P1|NOT COMPLETED|Fourth Treatment||0
206751|NCT00750308|505537|P12|COMPLETED|Fourth Treatment||1
206752|NCT00750308|505538|P11|COMPLETED|Fourth Treatment||1
206753|NCT00750308|505539|P10|COMPLETED|Fourth Treatment||2
206754|NCT00750308|505540|P9|COMPLETED|Fourth Treatment||1
206755|NCT00750308|505541|P8|COMPLETED|Fourth Treatment||2
206756|NCT00750308|505542|P7|COMPLETED|Fourth Treatment||2
206757|NCT00750308|505543|P6|COMPLETED|Fourth Treatment||2
206758|NCT00750308|505544|P5|COMPLETED|Fourth Treatment||1
206759|NCT00750308|505545|P4|COMPLETED|Fourth Treatment||1
206760|NCT00750308|505546|P3|COMPLETED|Fourth Treatment||2
206761|NCT00750308|505547|P2|COMPLETED|Fourth Treatment||1
206762|NCT00750308|505548|P1|COMPLETED|Fourth Treatment||2
206763|NCT00750308|505537|P12|STARTED|Fourth Treatment||1
206764|NCT00750308|505538|P11|STARTED|Fourth Treatment||1
206765|NCT00750308|505539|P10|STARTED|Fourth Treatment||2
206766|NCT00750308|505540|P9|STARTED|Fourth Treatment||1
206767|NCT00750308|505541|P8|STARTED|Fourth Treatment||2
206768|NCT00750308|505542|P7|STARTED|Fourth Treatment||2
206769|NCT00750308|505543|P6|STARTED|Fourth Treatment||2
206770|NCT00750308|505544|P5|STARTED|Fourth Treatment||1
206771|NCT00750308|505545|P4|STARTED|Fourth Treatment||1
206772|NCT00750308|505546|P3|STARTED|Fourth Treatment||2
206773|NCT00750308|505547|P2|STARTED|Fourth Treatment||1
206774|NCT00750308|505548|P1|STARTED|Fourth Treatment||2
206775|NCT00750308|505537|P12|NOT COMPLETED|Washout||0
206776|NCT00750308|505538|P11|NOT COMPLETED|Washout||0
206777|NCT00750308|505539|P10|NOT COMPLETED|Washout||0
206778|NCT00750308|505540|P9|NOT COMPLETED|Washout||0
206779|NCT00750308|505541|P8|NOT COMPLETED|Washout||0
206780|NCT00750308|505542|P7|NOT COMPLETED|Washout||0
206781|NCT00750308|505543|P6|NOT COMPLETED|Washout||0
206782|NCT00750308|505544|P5|NOT COMPLETED|Washout||0
206783|NCT00750308|505545|P4|NOT COMPLETED|Washout||0
206784|NCT00750308|505546|P3|NOT COMPLETED|Washout||0
206785|NCT00750308|505547|P2|NOT COMPLETED|Washout||0
206786|NCT00750308|505548|P1|NOT COMPLETED|Washout||0
206787|NCT00750308|505537|P12|COMPLETED|Washout||1
206788|NCT00750308|505538|P11|COMPLETED|Washout||1
206789|NCT00750308|505539|P10|COMPLETED|Washout||2
206790|NCT00750308|505540|P9|COMPLETED|Washout||1
206791|NCT00750308|505541|P8|COMPLETED|Washout||2
206792|NCT00750308|505542|P7|COMPLETED|Washout||2
206793|NCT00750308|505543|P6|COMPLETED|Washout||2
206794|NCT00750308|505544|P5|COMPLETED|Washout||1
206795|NCT00750308|505545|P4|COMPLETED|Washout||1
206796|NCT00750308|505546|P3|COMPLETED|Washout||2
206797|NCT00750308|505547|P2|COMPLETED|Washout||1
206798|NCT00750308|505548|P1|COMPLETED|Washout||2
206799|NCT00750308|505537|P12|STARTED|Washout||1
206800|NCT00750308|505538|P11|STARTED|Washout||1
206801|NCT00750308|505539|P10|STARTED|Washout||2
206802|NCT00750308|505540|P9|STARTED|Washout||1
206803|NCT00750308|505541|P8|STARTED|Washout||2
206804|NCT00750308|505542|P7|STARTED|Washout||2
206805|NCT00750308|505543|P6|STARTED|Washout||2
206806|NCT00750308|505544|P5|STARTED|Washout||1
206807|NCT00750308|505545|P4|STARTED|Washout||1
206808|NCT00750308|505546|P3|STARTED|Washout||2
206809|NCT00750308|505547|P2|STARTED|Washout||1
206810|NCT00750308|505548|P1|STARTED|Washout||2
206811|NCT00750308|505537|P12|NOT COMPLETED|Third Treatment||0
206812|NCT00750308|505538|P11|NOT COMPLETED|Third Treatment||0
206813|NCT00750308|505539|P10|NOT COMPLETED|Third Treatment||0
206814|NCT00750308|505540|P9|NOT COMPLETED|Third Treatment||0
206815|NCT00750308|505541|P8|NOT COMPLETED|Third Treatment||0
206816|NCT00750308|505542|P7|NOT COMPLETED|Third Treatment||0
206817|NCT00750308|505543|P6|NOT COMPLETED|Third Treatment||0
206818|NCT00750308|505544|P5|NOT COMPLETED|Third Treatment||0
206819|NCT00750308|505545|P4|NOT COMPLETED|Third Treatment||0
206820|NCT00750308|505546|P3|NOT COMPLETED|Third Treatment||0
206821|NCT00750308|505547|P2|NOT COMPLETED|Third Treatment||1
206822|NCT00750308|505548|P1|NOT COMPLETED|Third Treatment||0
206823|NCT00750308|505537|P12|COMPLETED|Third Treatment||1
206824|NCT00750308|505538|P11|COMPLETED|Third Treatment||1
206825|NCT00750308|505539|P10|COMPLETED|Third Treatment||2
206826|NCT00750308|505540|P9|COMPLETED|Third Treatment||1
206827|NCT00750308|505541|P8|COMPLETED|Third Treatment||2
206828|NCT00750308|505542|P7|COMPLETED|Third Treatment||2
206829|NCT00750308|505543|P6|COMPLETED|Third Treatment||2
206830|NCT00750308|505544|P5|COMPLETED|Third Treatment||1
206831|NCT00750308|505545|P4|COMPLETED|Third Treatment||1
206832|NCT00750308|505546|P3|COMPLETED|Third Treatment||2
206833|NCT00750308|505547|P2|COMPLETED|Third Treatment||1
206834|NCT00750308|505548|P1|COMPLETED|Third Treatment||2
206835|NCT00750308|505537|P12|STARTED|Third Treatment||1
206836|NCT00750308|505538|P11|STARTED|Third Treatment||1
206837|NCT00750308|505539|P10|STARTED|Third Treatment||2
206838|NCT00750308|505540|P9|STARTED|Third Treatment||1
206839|NCT00750308|505541|P8|STARTED|Third Treatment||2
206840|NCT00750308|505542|P7|STARTED|Third Treatment||2
206841|NCT00750308|505543|P6|STARTED|Third Treatment||2
206842|NCT00750308|505544|P5|STARTED|Third Treatment||1
206843|NCT00750308|505545|P4|STARTED|Third Treatment||1
206844|NCT00750308|505546|P3|STARTED|Third Treatment||2
206845|NCT00750308|505547|P2|STARTED|Third Treatment||2
206846|NCT00750308|505548|P1|STARTED|Third Treatment||2
206847|NCT00750308|505537|P12|NOT COMPLETED|Washout||0
206848|NCT00750308|505538|P11|NOT COMPLETED|Washout||0
206849|NCT00750308|505539|P10|NOT COMPLETED|Washout||0
206850|NCT00750308|505540|P9|NOT COMPLETED|Washout||0
206851|NCT00750308|505541|P8|NOT COMPLETED|Washout||0
206852|NCT00750308|505542|P7|NOT COMPLETED|Washout||0
206853|NCT00750308|505543|P6|NOT COMPLETED|Washout||0
206854|NCT00750308|505544|P5|NOT COMPLETED|Washout||0
206855|NCT00750308|505545|P4|NOT COMPLETED|Washout||0
206856|NCT00750308|505546|P3|NOT COMPLETED|Washout||0
206857|NCT00750308|505547|P2|NOT COMPLETED|Washout||0
206858|NCT00750308|505548|P1|NOT COMPLETED|Washout||0
206859|NCT00750308|505537|P12|COMPLETED|Washout||1
206860|NCT00750308|505538|P11|COMPLETED|Washout||1
206861|NCT00750308|505539|P10|COMPLETED|Washout||2
206862|NCT00750308|505540|P9|COMPLETED|Washout||1
206863|NCT00750308|505541|P8|COMPLETED|Washout||2
206864|NCT00750308|505542|P7|COMPLETED|Washout||2
206865|NCT00750308|505543|P6|COMPLETED|Washout||2
206866|NCT00750308|505544|P5|COMPLETED|Washout||1
206867|NCT00750308|505545|P4|COMPLETED|Washout||1
206868|NCT00750308|505546|P3|COMPLETED|Washout||2
206869|NCT00750308|505547|P2|COMPLETED|Washout||2
206870|NCT00750308|505548|P1|COMPLETED|Washout||2
206871|NCT00750308|505537|P12|STARTED|Washout||1
206872|NCT00750308|505538|P11|STARTED|Washout||1
206873|NCT00750308|505539|P10|STARTED|Washout||2
206874|NCT00750308|505540|P9|STARTED|Washout||1
206875|NCT00750308|505541|P8|STARTED|Washout||2
206876|NCT00750308|505542|P7|STARTED|Washout||2
206877|NCT00750308|505543|P6|STARTED|Washout||2
206878|NCT00750308|505544|P5|STARTED|Washout||1
206879|NCT00750308|505545|P4|STARTED|Washout||1
206880|NCT00750308|505546|P3|STARTED|Washout||2
206881|NCT00750308|505547|P2|STARTED|Washout||2
206882|NCT00750308|505548|P1|STARTED|Washout||2
206883|NCT00750308|505537|P12|NOT COMPLETED|Second Treatment||0
206884|NCT00750308|505538|P11|NOT COMPLETED|Second Treatment||0
206885|NCT00750308|505539|P10|NOT COMPLETED|Second Treatment||0
206886|NCT00750308|505540|P9|NOT COMPLETED|Second Treatment||1
206887|NCT00750308|505541|P8|NOT COMPLETED|Second Treatment||0
206888|NCT00750308|505542|P7|NOT COMPLETED|Second Treatment||0
206889|NCT00750308|505543|P6|NOT COMPLETED|Second Treatment||1
206890|NCT00750308|505544|P5|NOT COMPLETED|Second Treatment||1
206891|NCT00750308|505545|P4|NOT COMPLETED|Second Treatment||0
206892|NCT00750308|505546|P3|NOT COMPLETED|Second Treatment||0
206893|NCT00750308|505547|P2|NOT COMPLETED|Second Treatment||0
206894|NCT00750308|505548|P1|NOT COMPLETED|Second Treatment||0
206895|NCT00750308|505537|P12|COMPLETED|Second Treatment||1
206896|NCT00750308|505538|P11|COMPLETED|Second Treatment||1
206897|NCT00750308|505539|P10|COMPLETED|Second Treatment||2
206898|NCT00750308|505540|P9|COMPLETED|Second Treatment||1
206899|NCT00750308|505541|P8|COMPLETED|Second Treatment||2
206900|NCT00750308|505542|P7|COMPLETED|Second Treatment||2
206901|NCT00750308|505543|P6|COMPLETED|Second Treatment||2
206902|NCT00750308|505544|P5|COMPLETED|Second Treatment||1
206903|NCT00750308|505545|P4|COMPLETED|Second Treatment||1
206904|NCT00750308|505546|P3|COMPLETED|Second Treatment||2
206905|NCT00750308|505547|P2|COMPLETED|Second Treatment||2
206906|NCT00750308|505548|P1|COMPLETED|Second Treatment||2
206907|NCT00750308|505537|P12|STARTED|Second Treatment||1
206908|NCT00750308|505538|P11|STARTED|Second Treatment||1
206909|NCT00750308|505539|P10|STARTED|Second Treatment||2
206910|NCT00750308|505540|P9|STARTED|Second Treatment||2
206911|NCT00750308|505541|P8|STARTED|Second Treatment||2
206912|NCT00750308|505542|P7|STARTED|Second Treatment||2
206913|NCT00750308|505543|P6|STARTED|Second Treatment||3
206914|NCT00750308|505544|P5|STARTED|Second Treatment||2
206915|NCT00750308|505545|P4|STARTED|Second Treatment||1
206916|NCT00750308|505546|P3|STARTED|Second Treatment||2
206917|NCT00750308|505547|P2|STARTED|Second Treatment||2
206918|NCT00750308|505548|P1|STARTED|Second Treatment||2
206919|NCT00750308|505537|P12|NOT COMPLETED|Washout||0
206920|NCT00750308|505538|P11|NOT COMPLETED|Washout||0
206921|NCT00750308|505539|P10|NOT COMPLETED|Washout||0
206922|NCT00750308|505540|P9|NOT COMPLETED|Washout||0
206923|NCT00750308|505541|P8|NOT COMPLETED|Washout||0
206924|NCT00750308|505542|P7|NOT COMPLETED|Washout||0
206925|NCT00750308|505543|P6|NOT COMPLETED|Washout||0
206926|NCT00750308|505544|P5|NOT COMPLETED|Washout||0
206927|NCT00750308|505545|P4|NOT COMPLETED|Washout||0
206928|NCT00750308|505546|P3|NOT COMPLETED|Washout||0
206929|NCT00750308|505547|P2|NOT COMPLETED|Washout||0
206930|NCT00750308|505548|P1|NOT COMPLETED|Washout||0
206931|NCT00750308|505537|P12|COMPLETED|Washout||1
206932|NCT00750308|505538|P11|COMPLETED|Washout||1
206933|NCT00750308|505539|P10|COMPLETED|Washout||2
206934|NCT00750308|505540|P9|COMPLETED|Washout||2
206935|NCT00750308|505541|P8|COMPLETED|Washout||2
206936|NCT00750308|505542|P7|COMPLETED|Washout||2
206937|NCT00750308|505543|P6|COMPLETED|Washout||3
206938|NCT00750308|505544|P5|COMPLETED|Washout||2
206939|NCT00750308|505545|P4|COMPLETED|Washout||1
206940|NCT00750308|505546|P3|COMPLETED|Washout||2
206941|NCT00750308|505547|P2|COMPLETED|Washout||2
206942|NCT00750308|505548|P1|COMPLETED|Washout||2
206943|NCT00750308|505537|P12|STARTED|Washout||1
206944|NCT00750308|505538|P11|STARTED|Washout||1
206945|NCT00750308|505539|P10|STARTED|Washout||2
206946|NCT00750308|505540|P9|STARTED|Washout||2
206947|NCT00750308|505541|P8|STARTED|Washout||2
206948|NCT00750308|505542|P7|STARTED|Washout||2
206949|NCT00750308|505543|P6|STARTED|Washout||3
206950|NCT00750308|505544|P5|STARTED|Washout||2
206951|NCT00750308|505545|P4|STARTED|Washout||1
206952|NCT00750308|505546|P3|STARTED|Washout||2
206953|NCT00750308|505547|P2|STARTED|Washout||2
206954|NCT00750308|505548|P1|STARTED|Washout||2
206955|NCT00750308|505537|P12|NOT COMPLETED|First Treatment||1
206956|NCT00750308|505538|P11|NOT COMPLETED|First Treatment||1
206957|NCT00750308|505539|P10|NOT COMPLETED|First Treatment||0
206958|NCT00750308|505540|P9|NOT COMPLETED|First Treatment||0
206959|NCT00750308|505541|P8|NOT COMPLETED|First Treatment||1
206960|NCT00750308|505542|P7|NOT COMPLETED|First Treatment||0
206961|NCT00750308|505543|P6|NOT COMPLETED|First Treatment||0
206962|NCT00750308|505544|P5|NOT COMPLETED|First Treatment||0
206963|NCT00750308|505545|P4|NOT COMPLETED|First Treatment||1
206964|NCT00750308|505546|P3|NOT COMPLETED|First Treatment||0
206965|NCT00750308|505547|P2|NOT COMPLETED|First Treatment||1
206966|NCT00750308|505548|P1|NOT COMPLETED|First Treatment||0
206967|NCT00750308|505537|P12|COMPLETED|First Treatment||1
206968|NCT00750308|505538|P11|COMPLETED|First Treatment||1
206969|NCT00750308|505539|P10|COMPLETED|First Treatment||2
206970|NCT00750308|505540|P9|COMPLETED|First Treatment||2
206971|NCT00750308|505541|P8|COMPLETED|First Treatment||2
206972|NCT00750308|505542|P7|COMPLETED|First Treatment||2
206973|NCT00750308|505543|P6|COMPLETED|First Treatment||3
206974|NCT00750308|505544|P5|COMPLETED|First Treatment||2
206975|NCT00750308|505545|P4|COMPLETED|First Treatment||1
206976|NCT00750308|505546|P3|COMPLETED|First Treatment||2
206977|NCT00750308|505547|P2|COMPLETED|First Treatment||2
206978|NCT00750308|505548|P1|COMPLETED|First Treatment||2
206979|NCT00750308|505537|P12|STARTED|First Treatment||2
206980|NCT00750308|505538|P11|STARTED|First Treatment||2
206981|NCT00750308|505539|P10|STARTED|First Treatment||2
206982|NCT00750308|505540|P9|STARTED|First Treatment||2
206983|NCT00750308|505541|P8|STARTED|First Treatment||3
206984|NCT00750308|505542|P7|STARTED|First Treatment||2
206985|NCT00750308|505543|P6|STARTED|First Treatment||3
206986|NCT00750308|505544|P5|STARTED|First Treatment||2
206987|NCT00750308|505545|P4|STARTED|First Treatment||2
206988|NCT00750308|505546|P3|STARTED|First Treatment||2
206989|NCT00750308|505547|P2|STARTED|First Treatment||3
206990|NCT00750308|505548|P1|STARTED|First Treatment|One female withdrew due to muscle pain|2
206991|NCT00750360|505568|P6|NOT COMPLETED|Overall Study||0
206992|NCT00750360|505569|P5|NOT COMPLETED|Overall Study||0
206993|NCT00750360|505570|P4|NOT COMPLETED|Overall Study||0
206994|NCT00750360|505571|P3|NOT COMPLETED|Overall Study||0
206995|NCT00750360|505572|P2|NOT COMPLETED|Overall Study||0
206996|NCT00750360|505573|P1|NOT COMPLETED|Overall Study||0
206997|NCT00750360|505568|P6|COMPLETED|Overall Study||71
206998|NCT00750360|505569|P5|COMPLETED|Overall Study||46
206999|NCT00750360|505570|P4|COMPLETED|Overall Study||79
207000|NCT00750360|505571|P3|COMPLETED|Overall Study||384
207001|NCT00750360|505572|P2|COMPLETED|Overall Study||1
207002|NCT00750360|505573|P1|COMPLETED|Overall Study||294
207003|NCT00750360|505568|P6|STARTED|Overall Study||71
207004|NCT00750360|505569|P5|STARTED|Overall Study||46
207005|NCT00750360|505570|P4|STARTED|Overall Study||79
207006|NCT00750360|505571|P3|STARTED|Overall Study||384
207007|NCT00750360|505572|P2|STARTED|Overall Study|"One subject enrolled in this group was not vaccinated and as such not included as STARTED."|1
207008|NCT00750360|505573|P1|STARTED|Overall Study|"Seven subjects enrolled in this group were not vaccinated and as such not included as STARTED."|294
207009|NCT00750373|505607|P2|NOT COMPLETED|Overall Study||0
207010|NCT00750373|505608|P1|NOT COMPLETED|Overall Study||0
207011|NCT00750373|505607|P2|COMPLETED|Overall Study||37
207012|NCT00750373|505608|P1|COMPLETED|Overall Study||39
207013|NCT00750373|505607|P2|STARTED|Overall Study||37
207014|NCT00750373|505608|P1|STARTED|Overall Study||39
207015|NCT00750737|505616|P2|NOT COMPLETED|Overall Study||3
207016|NCT00750737|505617|P1|NOT COMPLETED|Overall Study||3
207017|NCT00750737|505616|P2|COMPLETED|Overall Study||19
207018|NCT00750737|505617|P1|COMPLETED|Overall Study||21
207019|NCT00750737|505616|P2|STARTED|Overall Study||22
207020|NCT00750737|505617|P1|STARTED|Overall Study||24
207021|NCT00750815|505627|P2|NOT COMPLETED|Overall Study||0
207022|NCT00750815|505628|P1|NOT COMPLETED|Overall Study||0
207023|NCT00750815|505627|P2|COMPLETED|Overall Study||46
207024|NCT00750815|505628|P1|COMPLETED|Overall Study||12
207025|NCT00750815|505627|P2|STARTED|Overall Study||46
207026|NCT00750815|505628|P1|STARTED|Overall Study||12
207027|NCT00750867|505639|P1|NOT COMPLETED|Overall Study||2
207028|NCT00750867|505639|P1|COMPLETED|Overall Study||7
207029|NCT00750867|505639|P1|STARTED|Overall Study||9
207030|NCT00750880|505644|P1|NOT COMPLETED|Overall Study||215
207031|NCT00750880|505644|P1|COMPLETED|Overall Study||1466
207032|NCT00750880|505644|P1|STARTED|Overall Study||1681
207033|NCT00750893|505667|P1|NOT COMPLETED|Overall Study||542
207034|NCT00750893|505667|P1|COMPLETED|Overall Study||2569
207035|NCT00750893|505667|P1|STARTED|Overall Study||3111
207036|NCT00750919|505682|P1|NOT COMPLETED|Overall Study||58
207037|NCT00750919|505682|P1|COMPLETED|Overall Study||126
207038|NCT00750919|505682|P1|STARTED|Overall Study||184
207039|NCT00751036|505692|P2|NOT COMPLETED|Overall Study||46
207040|NCT00751036|505693|P1|NOT COMPLETED|Overall Study||48
207041|NCT00751036|505692|P2|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
207042|NCT00751036|505693|P1|COMPLETED|Overall Study|Reason Not Completed = Reason for End of Treatment|0
207043|NCT00751036|505692|P2|STARTED|Overall Study|Started = Treated|46
207044|NCT00751036|505693|P1|STARTED|Overall Study|Started = Treated|48
207045|NCT00751114|505707|P2|NOT COMPLETED|Overall Study||32
207046|NCT00751114|505708|P1|NOT COMPLETED|Overall Study||38
207047|NCT00751114|505707|P2|COMPLETED|Overall Study||233
207048|NCT00751114|505708|P1|COMPLETED|Overall Study||212
207049|NCT00751114|505707|P2|mITT Population|Overall Study||253
207050|NCT00751114|505708|P1|mITT Population|Overall Study|modified Intent-To-Treat population: treated patients with at least 1 on-treatment efficacy measure|227
207051|NCT00751114|505707|P2|TREATED = Safety Population|Overall Study||264
207052|NCT00751114|505708|P1|TREATED = Safety Population|Overall Study|safety population: randomized patients who received at least one dose of investigational product|237
207053|NCT00751114|505707|P2|STARTED|Overall Study||265
207054|NCT00751114|505708|P1|STARTED|Overall Study|randomized|250
207055|NCT00751140|505731|P1|NOT COMPLETED|Overall Study||1
207056|NCT00751140|505731|P1|COMPLETED|Overall Study||19
207057|NCT00751140|505731|P1|STARTED|Overall Study||20
207058|NCT00751179|505741|P2|NOT COMPLETED|Overall Study||15
207059|NCT00751179|505742|P1|NOT COMPLETED|Overall Study||14
207060|NCT00751179|505741|P2|COMPLETED|Overall Study||70
207061|NCT00751179|505742|P1|COMPLETED|Overall Study||62
207062|NCT00751179|505741|P2|STARTED|Overall Study|5 of 85 randomized were not treated with succinylcholine|85
207063|NCT00751179|505742|P1|STARTED|Overall Study|10 of 76 randomized were not treated with sugammadex; 4 of these 10 received rocuronium only|76
207064|NCT00751296|505762|P1|NOT COMPLETED|Overall Study||2
207065|NCT00751296|505762|P1|COMPLETED|Overall Study||25
207066|NCT00751296|505762|P1|STARTED|Overall Study|The start date of the study was 25 August 2006.|27
207067|NCT00737633|505769|P2|NOT COMPLETED|Overall Study||57
207068|NCT00737633|505770|P1|NOT COMPLETED|Overall Study||44
207069|NCT00737633|505769|P2|COMPLETED|Overall Study||0
207070|NCT00737633|505770|P1|COMPLETED|Overall Study||0
207071|NCT00737633|505769|P2|STARTED|Overall Study||57
207072|NCT00737633|505770|P1|STARTED|Overall Study||44
207073|NCT00737672|505780|P2|NOT COMPLETED|Overall Study||83
207074|NCT00737672|505781|P1|NOT COMPLETED|Overall Study||80
207075|NCT00737672|505780|P2|COMPLETED|Overall Study||65
207076|NCT00737672|505781|P1|COMPLETED|Overall Study||65
207077|NCT00737672|505780|P2|Per Protocol Population|Overall Study||138
207078|NCT00737672|505781|P1|Per Protocol Population|Overall Study||131
207079|NCT00737672|505780|P2|Exclusions Due to Protocol Deviations|Overall Study||10
207080|NCT00737672|505781|P1|Exclusions Due to Protocol Deviations|Overall Study||14
207081|NCT00737672|505780|P2|STARTED|Overall Study||148
207082|NCT00737672|505781|P1|STARTED|Overall Study||145
207083|NCT00737711|505817|P1|NOT COMPLETED|Overall Study||31
207084|NCT00737711|505817|P1|COMPLETED|Overall Study||158
207085|NCT00737711|505817|P1|STARTED|Overall Study||189
207086|NCT00737737|505850|P2|NOT COMPLETED|Overall Study||0
207087|NCT00737737|505851|P1|NOT COMPLETED|Overall Study||0
207088|NCT00737737|505850|P2|COMPLETED|Overall Study||2
207089|NCT00737737|505851|P1|COMPLETED|Overall Study||2
207090|NCT00737737|505850|P2|STARTED|Overall Study||2
207091|NCT00737737|505851|P1|STARTED|Overall Study||2
207092|NCT00738023|505861|P2|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
207093|NCT00738023|505862|P1|NOT COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
207094|NCT00738023|505861|P2|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||0
207095|NCT00738023|505862|P1|COMPLETED|Intralipid Infusion (Post 6 Wks of Drug)||19
207096|NCT00738023|505861|P2|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||0
207097|NCT00738023|505862|P1|STARTED|Intralipid Infusion (Post 6 Wks of Drug)||19
207098|NCT00738023|505861|P2|NOT COMPLETED|Saline Infusion||0
207099|NCT00738023|505862|P1|NOT COMPLETED|Saline Infusion||0
207100|NCT00738023|505861|P2|COMPLETED|Saline Infusion||0
207101|NCT00738023|505862|P1|COMPLETED|Saline Infusion||19
207102|NCT00738023|505861|P2|STARTED|Saline Infusion||0
207103|NCT00738023|505862|P1|STARTED|Saline Infusion||19
207104|NCT00738023|505861|P2|NOT COMPLETED|Intralipid Infusion||0
207105|NCT00738023|505862|P1|NOT COMPLETED|Intralipid Infusion||0
207106|NCT00738023|505861|P2|COMPLETED|Intralipid Infusion||13
207107|NCT00738023|505862|P1|COMPLETED|Intralipid Infusion||19
207108|NCT00738023|505861|P2|STARTED|Intralipid Infusion||13
207109|NCT00738023|505862|P1|STARTED|Intralipid Infusion||19
207110|NCT00738049|505872|P2|NOT COMPLETED|Washout||0
207111|NCT00738049|505873|P1|NOT COMPLETED|Washout||0
207112|NCT00738049|505872|P2|COMPLETED|Washout||7
207113|NCT00738049|505873|P1|COMPLETED|Washout||13
207114|NCT00738049|505872|P2|STARTED|Washout||7
207115|NCT00738049|505873|P1|STARTED|Washout||13
207116|NCT00738049|505872|P2|NOT COMPLETED|2nd Intervention(14 Days)||0
207117|NCT00738049|505873|P1|NOT COMPLETED|2nd Intervention(14 Days)||0
207118|NCT00738049|505872|P2|COMPLETED|2nd Intervention(14 Days)||7
207119|NCT00738049|505873|P1|COMPLETED|2nd Intervention(14 Days)||13
207120|NCT00738049|505872|P2|STARTED|2nd Intervention(14 Days)||7
207121|NCT00738049|505873|P1|STARTED|2nd Intervention(14 Days)||13
207122|NCT00738049|505872|P2|NOT COMPLETED|1st Intervention(14 Days)||0
207123|NCT00738049|505873|P1|NOT COMPLETED|1st Intervention(14 Days)||0
207124|NCT00738049|505872|P2|COMPLETED|1st Intervention(14 Days)||7
207125|NCT00738049|505873|P1|COMPLETED|1st Intervention(14 Days)||13
207126|NCT00738049|505872|P2|STARTED|1st Intervention(14 Days)||7
207127|NCT00738049|505873|P1|STARTED|1st Intervention(14 Days)||13
207128|NCT00738062|505888|P3|NOT COMPLETED|Open-Label Extension||0
207129|NCT00738062|505889|P2|NOT COMPLETED|Open-Label Extension||0
207130|NCT00738062|505890|P1|NOT COMPLETED|Open-Label Extension||17
207131|NCT00738062|505888|P3|COMPLETED|Open-Label Extension||0
207132|NCT00738062|505889|P2|COMPLETED|Open-Label Extension||0
207133|NCT00738062|505890|P1|COMPLETED|Open-Label Extension||57
207134|NCT00738062|505888|P3|STARTED|Open-Label Extension||0
207135|NCT00738062|505889|P2|STARTED|Open-Label Extension||0
207136|NCT00738062|505890|P1|STARTED|Open-Label Extension|One patient completed double blind randomization but did not enter the open label extension|74
207137|NCT00738062|505888|P3|NOT COMPLETED|2 Week Randomized Withdrawal||0
207138|NCT00738062|505889|P2|NOT COMPLETED|2 Week Randomized Withdrawal||0
207139|NCT00738062|505890|P1|NOT COMPLETED|2 Week Randomized Withdrawal||0
207140|NCT00738062|505888|P3|COMPLETED|2 Week Randomized Withdrawal||37
207141|NCT00738062|505889|P2|COMPLETED|2 Week Randomized Withdrawal||38
207142|NCT00738062|505890|P1|COMPLETED|2 Week Randomized Withdrawal||0
207143|NCT00738062|505888|P3|STARTED|2 Week Randomized Withdrawal||37
207144|NCT00738062|505889|P2|STARTED|2 Week Randomized Withdrawal||38
207145|NCT00738062|505890|P1|STARTED|2 Week Randomized Withdrawal|Patients completing the open label titration phase were randomized to either Droxidopa or Placebo|0
207146|NCT00738062|505888|P3|NOT COMPLETED|Open Label Treatment||0
207147|NCT00738062|505889|P2|NOT COMPLETED|Open Label Treatment||0
207148|NCT00738062|505890|P1|NOT COMPLETED|Open Label Treatment||28
207149|NCT00738062|505888|P3|COMPLETED|Open Label Treatment||0
207150|NCT00738062|505889|P2|COMPLETED|Open Label Treatment||0
207151|NCT00738062|505890|P1|COMPLETED|Open Label Treatment||75
207152|NCT00738062|505888|P3|STARTED|Open Label Treatment||0
207153|NCT00738062|505889|P2|STARTED|Open Label Treatment||0
207154|NCT00738062|505890|P1|STARTED|Open Label Treatment||103
207155|NCT00743483|505915|P1|NOT COMPLETED|Treatment Period||1
207156|NCT00743483|505915|P1|COMPLETED|Treatment Period||13
207157|NCT00743483|505915|P1|STARTED|Treatment Period||14
207158|NCT00743483|505915|P1|NOT COMPLETED|Baseline Period||1
207159|NCT00743483|505915|P1|COMPLETED|Baseline Period||14
207160|NCT00743483|505915|P1|STARTED|Baseline Period||15
207161|NCT00743509|505919|P1|NOT COMPLETED|Overall Study||2
207162|NCT00743509|505919|P1|COMPLETED|Overall Study||47
207163|NCT00743509|505919|P1|STARTED|Overall Study||49
207164|NCT00743574|505924|P1|NOT COMPLETED|Overall Study||24
207165|NCT00743574|505924|P1|COMPLETED|Overall Study||12
207166|NCT00743574|505924|P1|Dropped Out After Initiating Trial|Overall Study||3
207167|NCT00743574|505924|P1|Further Exclusions|Overall Study||8
207168|NCT00743574|505924|P1|Dropped Out Before Eligibility Testing|Overall Study||13
207169|NCT00743574|505924|P1|STARTED|Overall Study||36
207170|NCT00743652|505938|P5|NOT COMPLETED|Overall Study||0
207171|NCT00743652|505939|P4|NOT COMPLETED|Overall Study||4
207172|NCT00743652|505940|P3|NOT COMPLETED|Overall Study||2
207173|NCT00743652|505941|P2|NOT COMPLETED|Overall Study||3
207174|NCT00743652|505942|P1|NOT COMPLETED|Overall Study||10
207175|NCT00743652|505938|P5|COMPLETED|Overall Study||79
207176|NCT00743652|505939|P4|COMPLETED|Overall Study||63
207177|NCT00743652|505940|P3|COMPLETED|Overall Study||23
207178|NCT00743652|505941|P2|COMPLETED|Overall Study||48
207179|NCT00743652|505942|P1|COMPLETED|Overall Study||141
207180|NCT00743652|505938|P5|Toddler Dose|Overall Study||0
207181|NCT00743652|505939|P4|Toddler Dose|Overall Study||0
207182|NCT00743652|505940|P3|Toddler Dose|Overall Study||16
207183|NCT00743652|505941|P2|Toddler Dose|Overall Study||23
207184|NCT00743652|505942|P1|Toddler Dose|Overall Study||15
207185|NCT00743652|505938|P5|Vaccinated Dose 3|Overall Study||0
207186|NCT00743652|505939|P4|Vaccinated Dose 3|Overall Study||0
207187|NCT00743652|505940|P3|Vaccinated Dose 3|Overall Study||0
207188|NCT00743652|505941|P2|Vaccinated Dose 3|Overall Study||0
207189|NCT00743652|505942|P1|Vaccinated Dose 3|Overall Study||74
207190|NCT00743652|505938|P5|Vaccinated Dose 2|Overall Study||0
207191|NCT00743652|505939|P4|Vaccinated Dose 2|Overall Study||49
207192|NCT00743652|505940|P3|Vaccinated Dose 2|Overall Study||0
207193|NCT00743652|505941|P2|Vaccinated Dose 2|Overall Study||41
207194|NCT00743652|505942|P1|Vaccinated Dose 2|Overall Study||112
207195|NCT00743652|505938|P5|Vaccinated Dose 1|Overall Study||79
207196|NCT00743652|505939|P4|Vaccinated Dose 1|Overall Study||66
207197|NCT00743652|505940|P3|Vaccinated Dose 1|Overall Study||25
207198|NCT00743652|505941|P2|Vaccinated Dose 1|Overall Study||51
207199|NCT00743652|505942|P1|Vaccinated Dose 1|Overall Study||151
207200|NCT00743652|505938|P5|STARTED|Overall Study||79
207201|NCT00743652|505939|P4|STARTED|Overall Study||67
207202|NCT00743652|505940|P3|STARTED|Overall Study||25
207203|NCT00743652|505941|P2|STARTED|Overall Study||51
207204|NCT00743652|505942|P1|STARTED|Overall Study||151
207205|NCT00743717|506019|P2|NOT COMPLETED|Overall Study||0
207206|NCT00743717|506020|P1|NOT COMPLETED|Overall Study||0
207207|NCT00743717|506019|P2|COMPLETED|Overall Study||2
207208|NCT00743717|506020|P1|COMPLETED|Overall Study||2
207209|NCT00743717|506019|P2|STARTED|Overall Study||2
207210|NCT00743717|506020|P1|STARTED|Overall Study||2
207211|NCT00743730|506029|P3|NOT COMPLETED|Overall Study||5
207212|NCT00743730|506030|P2|NOT COMPLETED|Overall Study||4
207213|NCT00743730|506031|P1|NOT COMPLETED|Overall Study||5
207214|NCT00743730|506029|P3|COMPLETED|Overall Study||28
207215|NCT00743730|506030|P2|COMPLETED|Overall Study||30
207216|NCT00743730|506031|P1|COMPLETED|Overall Study||22
207217|NCT00743730|506029|P3|STARTED|Overall Study||33
207218|NCT00743730|506030|P2|STARTED|Overall Study||34
207219|NCT00743730|506031|P1|STARTED|Overall Study||27
207220|NCT00744042|506042|P1|NOT COMPLETED|Overall Study||1
207221|NCT00744042|506042|P1|COMPLETED|Overall Study||10
207222|NCT00744042|506042|P1|STARTED|Overall Study||11
207223|NCT00744055|506057|P2|NOT COMPLETED|Overall Study||14
207224|NCT00744055|506058|P1|NOT COMPLETED|Overall Study||7
207225|NCT00744055|506057|P2|COMPLETED|Overall Study||32
207226|NCT00744055|506058|P1|COMPLETED|Overall Study||43
207227|NCT00744055|506057|P2|STARTED|Overall Study||46
207228|NCT00744055|506058|P1|STARTED|Overall Study||50
207229|NCT00744237|506069|P3|NOT COMPLETED|Overall Study||15
207230|NCT00744237|506070|P2|NOT COMPLETED|Overall Study||27
207231|NCT00744237|506071|P1|NOT COMPLETED|Overall Study||27
207232|NCT00744237|506069|P3|COMPLETED|Overall Study||59
207233|NCT00744237|506070|P2|COMPLETED|Overall Study||46
207234|NCT00744237|506071|P1|COMPLETED|Overall Study||56
207235|NCT00744237|506069|P3|STARTED|Overall Study||74
207236|NCT00744237|506070|P2|STARTED|Overall Study||73
207237|NCT00744237|506071|P1|STARTED|Overall Study||83
207238|NCT00744263|506084|P2|NOT COMPLETED|Overall Study||5320
207239|NCT00744263|506085|P1|NOT COMPLETED|Overall Study||5236
207240|NCT00744263|506084|P2|COMPLETED|Overall Study||36936
207241|NCT00744263|506085|P1|COMPLETED|Overall Study||37004
207242|NCT00744263|506084|P2|STARTED|Overall Study||42256
207243|NCT00744263|506085|P1|STARTED|Overall Study||42240
207244|NCT00744328|506108|P3|NOT COMPLETED|Overall Study||8
207245|NCT00744328|506109|P2|NOT COMPLETED|Overall Study||8
207246|NCT00744328|506110|P1|NOT COMPLETED|Overall Study||7
207247|NCT00744328|506108|P3|COMPLETED|Overall Study||21
207248|NCT00744328|506109|P2|COMPLETED|Overall Study||22
207249|NCT00744328|506110|P1|COMPLETED|Overall Study||19
207250|NCT00744328|506108|P3|STARTED|Overall Study||29
207251|NCT00744328|506109|P2|STARTED|Overall Study||30
207252|NCT00744328|506110|P1|STARTED|Overall Study||26
207253|NCT00744380|506120|P2|NOT COMPLETED|Overall Study||0
207254|NCT00744380|506121|P1|NOT COMPLETED|Overall Study||0
207255|NCT00744380|506120|P2|COMPLETED|Overall Study||11
207256|NCT00744380|506121|P1|COMPLETED|Overall Study||12
207257|NCT00744380|506120|P2|STARTED|Overall Study||11
207258|NCT00744380|506121|P1|STARTED|Overall Study||12
207259|NCT00744497|506143|P2|NOT COMPLETED|Overall Study||762
207260|NCT00744497|506144|P1|NOT COMPLETED|Overall Study||760
207261|NCT00744497|506143|P2|COMPLETED|Overall Study||0
207262|NCT00744497|506144|P1|COMPLETED|Overall Study||0
207263|NCT00744497|506143|P2|Received Treatment|Overall Study||761
207264|NCT00744497|506144|P1|Received Treatment|Overall Study||757
207265|NCT00744497|506143|P2|STARTED|Overall Study|Randomized|762
207266|NCT00744497|506144|P1|STARTED|Overall Study|Randomized|760
207267|NCT00744523|506180|P2|NOT COMPLETED|30 Days After the Procedure||5
207268|NCT00744523|506181|P1|NOT COMPLETED|30 Days After the Procedure||0
207269|NCT00744523|506180|P2|COMPLETED|30 Days After the Procedure||220
207270|NCT00744523|506181|P1|COMPLETED|30 Days After the Procedure||37
207271|NCT00744523|506180|P2|STARTED|30 Days After the Procedure||225
207272|NCT00744523|506181|P1|STARTED|30 Days After the Procedure||37
207273|NCT00744523|506180|P2|NOT COMPLETED|Procedure||0
207274|NCT00744523|506181|P1|NOT COMPLETED|Procedure||0
207275|NCT00744523|506180|P2|COMPLETED|Procedure||225
207276|NCT00744523|506181|P1|COMPLETED|Procedure||37
207277|NCT00744523|506180|P2|STARTED|Procedure||225
207278|NCT00744523|506181|P1|STARTED|Procedure||37
207279|NCT00744627|506201|P2|NOT COMPLETED|Overall Study||22
207280|NCT00744627|506202|P1|NOT COMPLETED|Overall Study||25
207281|NCT00744627|506201|P2|COMPLETED|Overall Study||128
207282|NCT00744627|506202|P1|COMPLETED|Overall Study||126
207283|NCT00744627|506201|P2|Treated|Overall Study||150
207284|NCT00744627|506202|P1|Treated|Overall Study||150
207285|NCT00744627|506201|P2|STARTED|Overall Study||150
207286|NCT00744627|506202|P1|STARTED|Overall Study||151
207287|NCT00744653|506256|P1|NOT COMPLETED|Overall Study||16
207288|NCT00744653|506256|P1|COMPLETED|Overall Study||1
207289|NCT00744653|506256|P1|STARTED|Overall Study||17
207290|NCT00744692|506262|P1|NOT COMPLETED|Overall Study||0
207291|NCT00744692|506262|P1|COMPLETED|Overall Study||22
207292|NCT00744692|506262|P1|STARTED|Overall Study||22
207293|NCT00744757|506274|P1|NOT COMPLETED|Overall Study||21
207294|NCT00744757|506274|P1|COMPLETED|Overall Study||16
207295|NCT00744757|506274|P1|STARTED|Overall Study||37
207296|NCT00744848|506289|P2|NOT COMPLETED|Overall Study||0
207297|NCT00744848|506290|P1|NOT COMPLETED|Overall Study||0
207298|NCT00744848|506289|P2|COMPLETED|Overall Study||101
207299|NCT00744848|506290|P1|COMPLETED|Overall Study||103
207300|NCT00744848|506289|P2|STARTED|Overall Study||101
207301|NCT00744848|506290|P1|STARTED|Overall Study||103
207302|NCT00744874|506296|P1|NOT COMPLETED|Overall Study||4
207303|NCT00744874|506296|P1|COMPLETED|Overall Study||51
207304|NCT00744874|506296|P1|STARTED|Overall Study||55
207305|NCT00744939|506316|P1|NOT COMPLETED|Overall Study||91
207306|NCT00744939|506316|P1|COMPLETED|Overall Study||77
207307|NCT00744939|506316|P1|Treatment Received|Overall Study||141
207308|NCT00744939|506316|P1|STARTED|Overall Study||168
207309|NCT00744978|506354|P2|NOT COMPLETED|Period 2||1
207310|NCT00744978|506355|P1|NOT COMPLETED|Period 2||0
207311|NCT00744978|506354|P2|COMPLETED|Period 2||28
207312|NCT00744978|506355|P1|COMPLETED|Period 2||26
207313|NCT00744978|506354|P2|STARTED|Period 2||29
207314|NCT00744978|506355|P1|STARTED|Period 2||26
207315|NCT00744978|506354|P2|NOT COMPLETED|Placebo Washout||0
207316|NCT00744978|506355|P1|NOT COMPLETED|Placebo Washout||0
207317|NCT00744978|506354|P2|COMPLETED|Placebo Washout||29
207318|NCT00744978|506355|P1|COMPLETED|Placebo Washout||26
207319|NCT00744978|506354|P2|STARTED|Placebo Washout||29
207320|NCT00744978|506355|P1|STARTED|Placebo Washout||26
207321|NCT00744978|506354|P2|NOT COMPLETED|Period 1||5
207322|NCT00744978|506355|P1|NOT COMPLETED|Period 1||6
207323|NCT00744978|506354|P2|COMPLETED|Period 1||29
207324|NCT00744978|506355|P1|COMPLETED|Period 1||26
207325|NCT00744978|506354|P2|Treated|Period 1||33
207326|NCT00744978|506355|P1|Treated|Period 1||31
207327|NCT00744978|506354|P2|STARTED|Period 1||34
207328|NCT00744978|506355|P1|STARTED|Period 1||32
207329|NCT00745030|506405|P2|NOT COMPLETED|Overall Study||0
207330|NCT00745030|506406|P1|NOT COMPLETED|Overall Study||0
207331|NCT00745030|506405|P2|COMPLETED|Overall Study||2
207332|NCT00745030|506406|P1|COMPLETED|Overall Study||1
207333|NCT00745030|506405|P2|STARTED|Overall Study||2
207334|NCT00745030|506406|P1|STARTED|Overall Study||1
207335|NCT00745095|506418|P6|NOT COMPLETED|Overall Study||123
207336|NCT00745095|506419|P5|NOT COMPLETED|Overall Study||122
207337|NCT00745095|506420|P4|NOT COMPLETED|Overall Study||3
207338|NCT00745095|506421|P3|NOT COMPLETED|Overall Study||3
207339|NCT00745095|506422|P2|NOT COMPLETED|Overall Study||2
207340|NCT00745095|506423|P1|NOT COMPLETED|Overall Study||1
207341|NCT00745095|506418|P6|COMPLETED|Overall Study||27
207342|NCT00745095|506419|P5|COMPLETED|Overall Study||28
207343|NCT00745095|506420|P4|COMPLETED|Overall Study||12
207344|NCT00745095|506421|P3|COMPLETED|Overall Study||12
207345|NCT00745095|506422|P2|COMPLETED|Overall Study||13
207346|NCT00745095|506423|P1|COMPLETED|Overall Study||14
207347|NCT00745095|506418|P6|STARTED|Overall Study||150
207348|NCT00745095|506419|P5|STARTED|Overall Study||150
207349|NCT00745095|506420|P4|STARTED|Overall Study||15
207350|NCT00745095|506421|P3|STARTED|Overall Study||15
207351|NCT00745095|506422|P2|STARTED|Overall Study||15
207352|NCT00745095|506423|P1|STARTED|Overall Study||15
207353|NCT00745251|506445|P2|NOT COMPLETED|Overall Study||3
207354|NCT00745251|506446|P1|NOT COMPLETED|Overall Study||2
207355|NCT00745251|506445|P2|COMPLETED|Overall Study||19
207356|NCT00745251|506446|P1|COMPLETED|Overall Study||21
207357|NCT00745251|506445|P2|STARTED|Overall Study||22
207358|NCT00745251|506446|P1|STARTED|Overall Study||23
207359|NCT00745290|506456|P2|NOT COMPLETED|Overall Study||0
207360|NCT00745290|506457|P1|NOT COMPLETED|Overall Study||0
207361|NCT00745290|506456|P2|COMPLETED|Overall Study||122
207362|NCT00745290|506457|P1|COMPLETED|Overall Study||123
207363|NCT00745290|506456|P2|STARTED|Overall Study||122
207364|NCT00745290|506457|P1|STARTED|Overall Study||123
207365|NCT00751348|506465|P2|NOT COMPLETED|Overall Study||2
207366|NCT00751348|506466|P1|NOT COMPLETED|Overall Study||6
207367|NCT00751348|506465|P2|COMPLETED|Overall Study||159
207368|NCT00751348|506466|P1|COMPLETED|Overall Study||307
207369|NCT00751348|506465|P2|STARTED|Overall Study||161
207370|NCT00751348|506466|P1|STARTED|Overall Study||313
207371|NCT00751400|506488|P1|NOT COMPLETED|Overall Study||10
207372|NCT00751400|506488|P1|COMPLETED|Overall Study||487
207373|NCT00751400|506488|P1|Subjects Provided Detailed Use Data|Overall Study||467
207374|NCT00751400|506488|P1|Subjects Consumed Drug|Overall Study||485
207375|NCT00751400|506488|P1|Subjects Provided Drug|Overall Study||497
207376|NCT00751400|506488|P1|STARTED|Overall Study||497
207377|NCT00751530|506503|P2|NOT COMPLETED|Overall Study||0
207378|NCT00751530|506504|P1|NOT COMPLETED|Overall Study||0
207379|NCT00751530|506503|P2|COMPLETED|Overall Study||110
207380|NCT00751530|506504|P1|COMPLETED|Overall Study||332
207381|NCT00751530|506503|P2|STARTED|Overall Study||110
207382|NCT00751530|506504|P1|STARTED|Overall Study||332
207383|NCT00751621|506518|P1|NOT COMPLETED|Overall Study||4
207384|NCT00751621|506518|P1|COMPLETED|Overall Study||36
207385|NCT00751621|506518|P1|STARTED|Overall Study||40
207386|NCT00751634|506535|P1|NOT COMPLETED|Overall Study||0
207387|NCT00751634|506535|P1|COMPLETED|Overall Study||20
207388|NCT00751634|506535|P1|STARTED|Overall Study||20
207389|NCT00751777|506545|P2|NOT COMPLETED|Overall Study||3
207390|NCT00751777|506546|P1|NOT COMPLETED|Overall Study||11
207391|NCT00751777|506545|P2|COMPLETED|Overall Study|Day 194: study completion for placebo group|36
207392|NCT00751777|506546|P1|COMPLETED|Overall Study|Day 380: study completion for LT group|70
207393|NCT00751777|506545|P2|STARTED|Overall Study||39
207394|NCT00751777|506546|P1|STARTED|Overall Study||81
207395|NCT00751790|506556|P1|NOT COMPLETED|Overall Study||5
207396|NCT00751790|506556|P1|COMPLETED|Overall Study||115
207397|NCT00751790|506556|P1|STARTED|Overall Study||120
207398|NCT00751881|506563|P3|NOT COMPLETED|Extension Study Period||66
207399|NCT00751881|506564|P2|NOT COMPLETED|Extension Study Period||71
207400|NCT00751881|506565|P1|NOT COMPLETED|Extension Study Period||65
207401|NCT00751881|506563|P3|COMPLETED|Extension Study Period||167
207402|NCT00751881|506564|P2|COMPLETED|Extension Study Period||194
207403|NCT00751881|506565|P1|COMPLETED|Extension Study Period||188
207404|NCT00751881|506563|P3|STARTED|Extension Study Period|11 participants completed core treatment period but did not enter in extension treatment period.|233
207405|NCT00751881|506564|P2|STARTED|Extension Study Period|8 participants completed core treatment period but did not enter in extension treatment period.|265
207406|NCT00751881|506565|P1|STARTED|Extension Study Period|10 participants completed core treatment period but did not enter in extension treatment period.|253
207407|NCT00751881|506563|P3|NOT COMPLETED|Core Treatment Period||128
207408|NCT00751881|506564|P2|NOT COMPLETED|Core Treatment Period||135
207409|NCT00751881|506565|P1|NOT COMPLETED|Core Treatment Period||126
207410|NCT00751881|506563|P3|COMPLETED|Core Treatment Period||244
207411|NCT00751881|506564|P2|COMPLETED|Core Treatment Period||273
207412|NCT00751881|506565|P1|COMPLETED|Core Treatment Period||263
207496|NCT00752726|506778|P2|STARTED|Overall Study||66
207413|NCT00751881|506563|P3|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 1 participant placebo (at least 1 dose)|370
207414|NCT00751881|506564|P2|Treated|Core Treatment Period|1 participant received placebo (at least 1 dose)|407
207415|NCT00751881|506565|P1|Treated|Core Treatment Period|1 participant received teriflunomide 7 mg and 2 participants teriflunomide 14 mg (at least 1 dose)|388
207416|NCT00751881|506563|P3|STARTED|Core Treatment Period|Randomized|372
207417|NCT00751881|506564|P2|STARTED|Core Treatment Period|Randomized|408
207418|NCT00751881|506565|P1|STARTED|Core Treatment Period|Randomized|389
207419|NCT00751933|506612|P4|NOT COMPLETED|Overall Study||1
207420|NCT00751933|506613|P3|NOT COMPLETED|Overall Study||1
207421|NCT00751933|506614|P2|NOT COMPLETED|Overall Study||1
207422|NCT00751933|506615|P1|NOT COMPLETED|Overall Study||0
207423|NCT00751933|506612|P4|COMPLETED|Overall Study||0
207424|NCT00751933|506613|P3|COMPLETED|Overall Study||0
207425|NCT00751933|506614|P2|COMPLETED|Overall Study||0
207426|NCT00751933|506615|P1|COMPLETED|Overall Study||0
207427|NCT00751933|506612|P4|STARTED|Overall Study||1
207428|NCT00751933|506613|P3|STARTED|Overall Study||1
207429|NCT00751933|506614|P2|STARTED|Overall Study||1
207430|NCT00751933|506615|P1|STARTED|Overall Study||0
207431|NCT00751972|506622|P2|NOT COMPLETED|Overall Study||0
207432|NCT00751972|506623|P1|NOT COMPLETED|Overall Study||0
207433|NCT00751972|506622|P2|COMPLETED|Overall Study||499
207434|NCT00751972|506623|P1|COMPLETED|Overall Study||140
207435|NCT00751972|506622|P2|STARTED|Overall Study||499
207436|NCT00751972|506623|P1|STARTED|Overall Study||140
207437|NCT00751998|506635|P1|NOT COMPLETED|Overall Study||20
207438|NCT00751998|506635|P1|COMPLETED|Overall Study||277
207439|NCT00751998|506635|P1|STARTED|Overall Study||297
207440|NCT00752089|506639|P1|NOT COMPLETED|Overall Study||6
207441|NCT00752089|506639|P1|COMPLETED|Overall Study||14
207442|NCT00752089|506639|P1|Received Placebo|Overall Study||18
207443|NCT00752089|506639|P1|Received NaF|Overall Study||18
207444|NCT00752089|506639|P1|Received NaF/KNO3/ 0% Isopentane|Overall Study||17
207445|NCT00752089|506639|P1|Received NaF/ KNO3/ 2% Isopentane|Overall Study||19
207446|NCT00752089|506639|P1|STARTED|Overall Study||20
207447|NCT00752128|506653|P1|NOT COMPLETED|Overall Study||4
207448|NCT00752128|506653|P1|COMPLETED|Overall Study||2345
207449|NCT00752128|506653|P1|STARTED|Overall Study||2349
207450|NCT00752232|506665|P7|NOT COMPLETED|Overall Study||0
207451|NCT00752232|506666|P6|NOT COMPLETED|Overall Study||1
207452|NCT00752232|506667|P5|NOT COMPLETED|Overall Study||3
207453|NCT00752232|506668|P4|NOT COMPLETED|Overall Study||1
207454|NCT00752232|506669|P3|NOT COMPLETED|Overall Study||1
207455|NCT00752232|506670|P2|NOT COMPLETED|Overall Study||0
207456|NCT00752232|506671|P1|NOT COMPLETED|Overall Study||2
207457|NCT00752232|506665|P7|COMPLETED|Overall Study||4
207458|NCT00752232|506666|P6|COMPLETED|Overall Study||5
207459|NCT00752232|506667|P5|COMPLETED|Overall Study||3
207460|NCT00752232|506668|P4|COMPLETED|Overall Study||5
207461|NCT00752232|506669|P3|COMPLETED|Overall Study||5
207462|NCT00752232|506670|P2|COMPLETED|Overall Study||6
207463|NCT00752232|506671|P1|COMPLETED|Overall Study||4
207464|NCT00752232|506665|P7|STARTED|Overall Study||4
207465|NCT00752232|506666|P6|STARTED|Overall Study||6
207466|NCT00752232|506667|P5|STARTED|Overall Study||6
207467|NCT00752232|506668|P4|STARTED|Overall Study||6
207468|NCT00752232|506669|P3|STARTED|Overall Study||6
207469|NCT00752232|506670|P2|STARTED|Overall Study||6
207470|NCT00752232|506671|P1|STARTED|Overall Study||6
207471|NCT00752609|506745|P2|NOT COMPLETED|Overall Study||2
207472|NCT00752609|506746|P1|NOT COMPLETED|Overall Study||9
207473|NCT00752609|506745|P2|COMPLETED|Overall Study||47
207474|NCT00752609|506746|P1|COMPLETED|Overall Study||44
207475|NCT00752609|506745|P2|Full Analysis Set|Overall Study||49
207476|NCT00752609|506746|P1|Full Analysis Set|Overall Study|One patient withdrew consent before receiving any study medication.|52
207477|NCT00752609|506745|P2|STARTED|Overall Study||49
207478|NCT00752609|506746|P1|STARTED|Overall Study||53
207479|NCT00752622|506765|P1|NOT COMPLETED|Interventional Phase||8
207480|NCT00752622|506765|P1|COMPLETED|Interventional Phase|8 participants received at least 1 infusion of interventional treatment, but none completed trial|0
207481|NCT00752622|506765|P1|STARTED|Interventional Phase|5 participants randomized into increased dose group and 3 randomized into shortened interval group|8
207482|NCT00752622|506765|P1|NOT COMPLETED|Observational Phase||43
207483|NCT00752622|506765|P1|COMPLETED|Observational Phase|14 completed without loss of response 8 had loss of response & randomized into interventional phase|22
207484|NCT00752622|506765|P1|STARTED|Observational Phase||65
207485|NCT00752622|506765|P1|NOT COMPLETED|Induction Phase||35
207486|NCT00752622|506765|P1|COMPLETED|Induction Phase||65
207487|NCT00752622|506765|P1|STARTED|Induction Phase|The ELIG population comprised of 98 participants|100
207488|NCT00752726|506778|P2|NOT COMPLETED|Overall Study||13
207489|NCT00752726|506779|P1|NOT COMPLETED|Overall Study||11
207490|NCT00752726|506778|P2|COMPLETED|Overall Study||53
207491|NCT00752726|506779|P1|COMPLETED|Overall Study||54
207492|NCT00752726|506778|P2|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|61
207493|NCT00752726|506779|P1|Intention to Treat (ITT) Population|Overall Study|ITT population had atleast 1 post treatment efficacy measurement.|62
207494|NCT00752726|506778|P2|Safety Population|Overall Study|2 participants were never dosed with the study medication.|64
207495|NCT00752726|506779|P1|Safety Population|Overall Study|2 participants were never dosed with the study medication.|63
207497|NCT00752726|506779|P1|STARTED|Overall Study||65
207498|NCT00752791|506804|P1|NOT COMPLETED|Overall Study||16
207499|NCT00752791|506804|P1|COMPLETED|Overall Study||43
207500|NCT00752791|506804|P1|STARTED|Overall Study||59
207501|NCT00752895|506816|P2|NOT COMPLETED|Overall Study||3
207502|NCT00752895|506817|P1|NOT COMPLETED|Overall Study||8
207503|NCT00752895|506816|P2|COMPLETED|Overall Study||143
207504|NCT00752895|506817|P1|COMPLETED|Overall Study||139
207505|NCT00752895|506816|P2|STARTED|Overall Study||146
207506|NCT00752895|506817|P1|STARTED|Overall Study||147
207507|NCT00752973|506825|P1|NOT COMPLETED|Overall Study||0
207508|NCT00752973|506825|P1|COMPLETED|Overall Study||12
207509|NCT00752973|506825|P1|STARTED|Overall Study||12
207510|NCT00752986|506838|P3|NOT COMPLETED|Overall Study||2
207511|NCT00752986|506839|P2|NOT COMPLETED|Overall Study||1
207512|NCT00752986|506840|P1|NOT COMPLETED|Overall Study||5
207513|NCT00752986|506838|P3|COMPLETED|Overall Study||9
207514|NCT00752986|506839|P2|COMPLETED|Overall Study||11
207515|NCT00752986|506840|P1|COMPLETED|Overall Study||11
207516|NCT00752986|506838|P3|STARTED|Overall Study||11
207517|NCT00752986|506839|P2|STARTED|Overall Study||12
207518|NCT00752986|506840|P1|STARTED|Overall Study||16
207519|NCT00753012|506859|P2|NOT COMPLETED|Overall Study||1
207520|NCT00753012|506860|P1|NOT COMPLETED|Overall Study||8
207521|NCT00753012|506859|P2|COMPLETED|Overall Study||8
207522|NCT00753012|506860|P1|COMPLETED|Overall Study||7
207523|NCT00753012|506859|P2|STARTED|Overall Study||9
207524|NCT00753012|506860|P1|STARTED|Overall Study||15
207525|NCT00753142|506873|P3|NOT COMPLETED|Overall Study||0
207526|NCT00753142|506874|P2|NOT COMPLETED|Overall Study||0
207527|NCT00753142|506875|P1|NOT COMPLETED|Overall Study||0
207528|NCT00753142|506873|P3|COMPLETED|Overall Study||13
207529|NCT00753142|506874|P2|COMPLETED|Overall Study||7
207530|NCT00753142|506875|P1|COMPLETED|Overall Study||8
207531|NCT00753142|506873|P3|STARTED|Overall Study||13
207532|NCT00753142|506874|P2|STARTED|Overall Study||7
207533|NCT00753142|506875|P1|STARTED|Overall Study||8
207534|NCT00753220|506883|P1|NOT COMPLETED|Overall Study||5
207535|NCT00753220|506883|P1|COMPLETED|Overall Study||2
207536|NCT00753220|506883|P1|STARTED|Overall Study||7
207537|NCT00753272|506889|P2|NOT COMPLETED|Overall Study||4907
207538|NCT00753272|506890|P1|NOT COMPLETED|Overall Study||4982
207539|NCT00753272|506889|P2|COMPLETED|Overall Study||16895
207540|NCT00753272|506890|P1|COMPLETED|Overall Study||16911
207541|NCT00753272|506889|P2|STARTED|Overall Study||21802
207542|NCT00753272|506890|P1|STARTED|Overall Study||21893
207543|NCT00753298|506958|P2|NOT COMPLETED|Overall Study||4
207544|NCT00753298|506959|P1|NOT COMPLETED|Overall Study||8
207545|NCT00753298|506958|P2|COMPLETED|Overall Study||94
207546|NCT00753298|506959|P1|COMPLETED|Overall Study||89
207547|NCT00753298|506958|P2|STARTED|Overall Study||98
207548|NCT00753298|506959|P1|STARTED|Overall Study||97
207549|NCT00753337|506975|P1|NOT COMPLETED|Overall Study||0
207550|NCT00753337|506975|P1|COMPLETED|Overall Study||123
207551|NCT00753337|506975|P1|STARTED|Overall Study||123
207552|NCT00753363|506991|P2|NOT COMPLETED|Overall Study||39
207553|NCT00753363|506992|P1|NOT COMPLETED|Overall Study||40
207554|NCT00753363|506991|P2|COMPLETED|Overall Study||21
207555|NCT00753363|506992|P1|COMPLETED|Overall Study||19
207556|NCT00753363|506991|P2|STARTED|Overall Study||60
207557|NCT00753363|506992|P1|STARTED|Overall Study||59
207558|NCT00753415|507007|P10|NOT COMPLETED|Part B||1
207559|NCT00753415|507008|P9|NOT COMPLETED|Part B||3
207560|NCT00753415|507009|P8|NOT COMPLETED|Part B||1
207561|NCT00753415|507010|P7|NOT COMPLETED|Part B||0
207562|NCT00753415|507011|P6|NOT COMPLETED|Part B||0
207563|NCT00753415|507012|P5|NOT COMPLETED|Part B||0
207564|NCT00753415|507013|P4|NOT COMPLETED|Part B||0
207565|NCT00753415|507014|P3|NOT COMPLETED|Part B||0
207566|NCT00753415|507015|P2|NOT COMPLETED|Part B||0
207567|NCT00753415|507016|P1|NOT COMPLETED|Part B||0
207568|NCT00753415|507007|P10|COMPLETED|Part B||8
207569|NCT00753415|507008|P9|COMPLETED|Part B||6
207570|NCT00753415|507009|P8|COMPLETED|Part B||6
207571|NCT00753415|507010|P7|COMPLETED|Part B||2
207572|NCT00753415|507011|P6|COMPLETED|Part B||1
207573|NCT00753415|507012|P5|COMPLETED|Part B||0
207574|NCT00753415|507013|P4|COMPLETED|Part B||0
207575|NCT00753415|507014|P3|COMPLETED|Part B||0
207576|NCT00753415|507015|P2|COMPLETED|Part B||0
207577|NCT00753415|507016|P1|COMPLETED|Part B||0
207578|NCT00753415|507007|P10|STARTED|Part B|Of 10 eligible participants who completed Part A, 9 chose to enter Part B|9
207579|NCT00753415|507008|P9|STARTED|Part B|9 participants who completed Part A were eligible and enrolled in Part B|9
207580|NCT00753415|507009|P8|STARTED|Part B|Of 8 eligible participants who completed Part A, 7 chose to enter Part B|7
207581|NCT00753415|507010|P7|STARTED|Part B|Of 3 eligible participants who completed Part A, 2 chose to enter Part B|2
207582|NCT00753415|507011|P6|STARTED|Part B|Of 2 eligible participants who completed Part A, 1 chose to enter Part B|1
207583|NCT00753415|507012|P5|STARTED|Part B||0
207584|NCT00753415|507013|P4|STARTED|Part B||0
207585|NCT00753415|507014|P3|STARTED|Part B||0
207586|NCT00753415|507015|P2|STARTED|Part B||0
207587|NCT00753415|507016|P1|STARTED|Part B||0
207588|NCT00753415|507007|P10|NOT COMPLETED|Part A||0
207589|NCT00753415|507008|P9|NOT COMPLETED|Part A||0
207590|NCT00753415|507009|P8|NOT COMPLETED|Part A||0
207591|NCT00753415|507010|P7|NOT COMPLETED|Part A||0
207592|NCT00753415|507011|P6|NOT COMPLETED|Part A||0
207593|NCT00753415|507012|P5|NOT COMPLETED|Part A||0
207594|NCT00753415|507013|P4|NOT COMPLETED|Part A||2
207595|NCT00753415|507014|P3|NOT COMPLETED|Part A||2
207596|NCT00753415|507015|P2|NOT COMPLETED|Part A||0
207597|NCT00753415|507016|P1|NOT COMPLETED|Part A||1
207598|NCT00753415|507007|P10|COMPLETED|Part A||0
207599|NCT00753415|507008|P9|COMPLETED|Part A||0
207600|NCT00753415|507009|P8|COMPLETED|Part A||0
207601|NCT00753415|507010|P7|COMPLETED|Part A||0
207602|NCT00753415|507011|P6|COMPLETED|Part A||0
207603|NCT00753415|507012|P5|COMPLETED|Part A||10
207604|NCT00753415|507013|P4|COMPLETED|Part A||9
207605|NCT00753415|507014|P3|COMPLETED|Part A||8
207606|NCT00753415|507015|P2|COMPLETED|Part A||3
207607|NCT00753415|507016|P1|COMPLETED|Part A||2
207608|NCT00753415|507007|P10|STARTED|Part A||0
207609|NCT00753415|507008|P9|STARTED|Part A||0
207610|NCT00753415|507009|P8|STARTED|Part A||0
207611|NCT00753415|507010|P7|STARTED|Part A||0
207612|NCT00753415|507011|P6|STARTED|Part A||0
207613|NCT00753415|507012|P5|STARTED|Part A||10
207614|NCT00753415|507013|P4|STARTED|Part A||11
207615|NCT00753415|507014|P3|STARTED|Part A||10
207616|NCT00753415|507015|P2|STARTED|Part A||3
207617|NCT00753415|507016|P1|STARTED|Part A||3
207618|NCT00753454|507058|P1|NOT COMPLETED|Overall Study||14
207619|NCT00753454|507058|P1|COMPLETED|Overall Study||154
207620|NCT00753454|507058|P1|STARTED|Overall Study||168
207621|NCT00753506|507089|P2|NOT COMPLETED|Overall Study||2
207622|NCT00753506|507090|P1|NOT COMPLETED|Overall Study||7
207623|NCT00753506|507089|P2|COMPLETED|Overall Study||31
207624|NCT00753506|507090|P1|COMPLETED|Overall Study||26
207625|NCT00753506|507089|P2|STARTED|Overall Study||33
207626|NCT00753506|507090|P1|STARTED|Overall Study||33
207627|NCT00753519|507098|P2|NOT COMPLETED|Overall Study||2
207628|NCT00753519|507099|P1|NOT COMPLETED|Overall Study||0
207629|NCT00753519|507098|P2|COMPLETED|Overall Study||13
207630|NCT00753519|507099|P1|COMPLETED|Overall Study||13
207631|NCT00753519|507098|P2|STARTED|Overall Study||15
207632|NCT00753519|507099|P1|STARTED|Overall Study||13
207633|NCT00753545|507121|P2|NOT COMPLETED|Overall Study||118
207634|NCT00753545|507122|P1|NOT COMPLETED|Overall Study||108
207635|NCT00753545|507121|P2|COMPLETED|Overall Study|Patients completing the Study|11
207636|NCT00753545|507122|P1|COMPLETED|Overall Study|Patients completing the Study|28
207637|NCT00753545|507121|P2|STARTED|Overall Study|Patients randomized|129
207638|NCT00753545|507122|P1|STARTED|Overall Study|Patients randomized|136
207639|NCT00753623|507160|P2|NOT COMPLETED|Phase II (14 Days)||1
207640|NCT00753623|507161|P1|NOT COMPLETED|Phase II (14 Days)||0
207641|NCT00753623|507160|P2|COMPLETED|Phase II (14 Days)||7
207642|NCT00753623|507161|P1|COMPLETED|Phase II (14 Days)||8
207643|NCT00753623|507160|P2|STARTED|Phase II (14 Days)||8
207644|NCT00753623|507161|P1|STARTED|Phase II (14 Days)||8
207645|NCT00753623|507160|P2|NOT COMPLETED|Washout (7 Days)||0
207646|NCT00753623|507161|P1|NOT COMPLETED|Washout (7 Days)||1
207647|NCT00753623|507160|P2|COMPLETED|Washout (7 Days)||8
207648|NCT00753623|507161|P1|COMPLETED|Washout (7 Days)||8
207649|NCT00753623|507160|P2|STARTED|Washout (7 Days)||8
207650|NCT00753623|507161|P1|STARTED|Washout (7 Days)||9
207651|NCT00753623|507160|P2|NOT COMPLETED|Phase I (14 Days)||4
207652|NCT00753623|507161|P1|NOT COMPLETED|Phase I (14 Days)||2
207653|NCT00753623|507160|P2|COMPLETED|Phase I (14 Days)||8
207654|NCT00753623|507161|P1|COMPLETED|Phase I (14 Days)||9
207655|NCT00753623|507160|P2|STARTED|Phase I (14 Days)||12
207656|NCT00753623|507161|P1|STARTED|Phase I (14 Days)||11
207657|NCT00753636|507167|P1|NOT COMPLETED|Overall Study||6
207658|NCT00753636|507167|P1|COMPLETED|Overall Study||25
207659|NCT00753636|507167|P1|STARTED|Overall Study||31
207660|NCT00753649|507179|P2|NOT COMPLETED|Overall Study||0
207661|NCT00753649|507180|P1|NOT COMPLETED|Overall Study||7
207662|NCT00753649|507179|P2|COMPLETED|Overall Study||112
207663|NCT00753649|507180|P1|COMPLETED|Overall Study||105
207664|NCT00753649|507179|P2|STARTED|Overall Study||112
207665|NCT00753649|507180|P1|STARTED|Overall Study||112
207666|NCT00753675|507203|P3|NOT COMPLETED|Overall Study||56
207667|NCT00753675|507204|P2|NOT COMPLETED|Overall Study||59
207668|NCT00753675|507205|P1|NOT COMPLETED|Overall Study||59
207669|NCT00753675|507203|P3|COMPLETED|Overall Study||0
207670|NCT00753675|507204|P2|COMPLETED|Overall Study||0
207671|NCT00753675|507205|P1|COMPLETED|Overall Study||0
207672|NCT00753675|507203|P3|STARTED|Overall Study||56
207673|NCT00753675|507204|P2|STARTED|Overall Study||59
207674|NCT00753675|507205|P1|STARTED|Overall Study||59
207675|NCT00753688|507227|P2|NOT COMPLETED|Overall Study||246
207676|NCT00753688|507228|P1|NOT COMPLETED|Overall Study||123
207677|NCT00753688|507227|P2|COMPLETED|Overall Study||0
207678|NCT00753688|507228|P1|COMPLETED|Overall Study||0
207679|NCT00753688|507227|P2|Ongoing - in Follow-up|Overall Study||31
207680|NCT00753688|507228|P1|Ongoing - in Follow-up|Overall Study||15
207681|NCT00753688|507227|P2|STARTED|Overall Study||246
207682|NCT00753688|507228|P1|STARTED|Overall Study||123
207683|NCT00753714|507256|P2|NOT COMPLETED|Overall Study||62
207684|NCT00753714|507257|P1|NOT COMPLETED|Overall Study||60
207685|NCT00753714|507256|P2|COMPLETED|Overall Study||1
207686|NCT00753714|507257|P1|COMPLETED|Overall Study||1
207687|NCT00753714|507256|P2|STARTED|Overall Study||63
207688|NCT00753714|507257|P1|STARTED|Overall Study||61
207689|NCT00753766|507273|P2|NOT COMPLETED|Overall Study||0
207690|NCT00753766|507274|P1|NOT COMPLETED|Overall Study||1
207691|NCT00753766|507273|P2|COMPLETED|Overall Study||0
207692|NCT00753766|507274|P1|COMPLETED|Overall Study||0
207693|NCT00753766|507273|P2|STARTED|Overall Study||0
207694|NCT00753766|507274|P1|STARTED|Overall Study||1
207695|NCT00753896|507282|P1|NOT COMPLETED|Overall Study||16
207696|NCT00753896|507282|P1|COMPLETED|Overall Study||118
207697|NCT00753896|507282|P1|STARTED|Overall Study||134
207698|NCT00753922|507300|P4|NOT COMPLETED|Overall Study||23
207699|NCT00753922|507301|P3|NOT COMPLETED|Overall Study||63
207700|NCT00753922|507302|P2|NOT COMPLETED|Overall Study||94
207701|NCT00753922|507303|P1|NOT COMPLETED|Overall Study||246
207702|NCT00753922|507300|P4|COMPLETED|Overall Study||37
207703|NCT00753922|507301|P3|COMPLETED|Overall Study||82
207704|NCT00753922|507302|P2|COMPLETED|Overall Study||157
207705|NCT00753922|507303|P1|COMPLETED|Overall Study||306
207706|NCT00753922|507300|P4|STARTED|Overall Study||60
207707|NCT00753922|507301|P3|STARTED|Overall Study||145
207708|NCT00753922|507302|P2|STARTED|Overall Study||251
207709|NCT00753922|507303|P1|STARTED|Overall Study||552
207710|NCT00753948|507336|P3|NOT COMPLETED|Overall Study||0
207711|NCT00753948|507337|P2|NOT COMPLETED|Overall Study||0
207712|NCT00753948|507338|P1|NOT COMPLETED|Overall Study||0
207713|NCT00753948|507336|P3|COMPLETED|Overall Study||7
207714|NCT00753948|507337|P2|COMPLETED|Overall Study||7
207715|NCT00753948|507338|P1|COMPLETED|Overall Study||9
207716|NCT00753948|507336|P3|STARTED|Overall Study||7
207717|NCT00753948|507337|P2|STARTED|Overall Study||7
207718|NCT00753948|507338|P1|STARTED|Overall Study||9
207719|NCT00754013|507348|P2|NOT COMPLETED|Overall Study||5
207720|NCT00754013|507349|P1|NOT COMPLETED|Overall Study||4
207721|NCT00754013|507348|P2|COMPLETED|Overall Study||0
207722|NCT00754013|507349|P1|COMPLETED|Overall Study||0
207723|NCT00754013|507348|P2|STARTED|Overall Study||5
207724|NCT00754013|507349|P1|STARTED|Overall Study||4
207725|NCT00754065|507359|P2|NOT COMPLETED|Overall Study||80
207726|NCT00754065|507360|P1|NOT COMPLETED|Overall Study||81
207727|NCT00754065|507359|P2|COMPLETED|Overall Study||126
207728|NCT00754065|507360|P1|COMPLETED|Overall Study||122
207729|NCT00754065|507359|P2|Cycle 6|Overall Study||153
207730|NCT00754065|507360|P1|Cycle 6|Overall Study||141
207731|NCT00754065|507359|P2|Participants Received Treatment|Overall Study||204
207732|NCT00754065|507360|P1|Participants Received Treatment|Overall Study||191
207733|NCT00754065|507359|P2|STARTED|Overall Study||206
207734|NCT00754065|507360|P1|STARTED|Overall Study||203
207735|NCT00754130|507604|P6|NOT COMPLETED|Period 2 (5 Days)||0
207736|NCT00754130|507605|P5|NOT COMPLETED|Period 2 (5 Days)||0
207737|NCT00754130|507606|P4|NOT COMPLETED|Period 2 (5 Days)||0
207738|NCT00754130|507607|P3|NOT COMPLETED|Period 2 (5 Days)||0
207739|NCT00754130|507608|P2|NOT COMPLETED|Period 2 (5 Days)||0
207740|NCT00754130|507609|P1|NOT COMPLETED|Period 2 (5 Days)||0
207741|NCT00754130|507604|P6|COMPLETED|Period 2 (5 Days)||4
207742|NCT00754130|507605|P5|COMPLETED|Period 2 (5 Days)||2
207743|NCT00754130|507606|P4|COMPLETED|Period 2 (5 Days)||2
207744|NCT00754130|507607|P3|COMPLETED|Period 2 (5 Days)||4
207745|NCT00754130|507608|P2|COMPLETED|Period 2 (5 Days)||2
207746|NCT00754130|507609|P1|COMPLETED|Period 2 (5 Days)||2
207747|NCT00754130|507604|P6|STARTED|Period 2 (5 Days)|One participant received MK-0941 35 mg starting with Dose 3 on Day 3.|4
207748|NCT00754130|507605|P5|STARTED|Period 2 (5 Days)||2
207749|NCT00754130|507606|P4|STARTED|Period 2 (5 Days)||2
207750|NCT00754130|507607|P3|STARTED|Period 2 (5 Days)||4
207751|NCT00754130|507608|P2|STARTED|Period 2 (5 Days)||2
207752|NCT00754130|507609|P1|STARTED|Period 2 (5 Days)|One participant received MK-0941 15 mg starting with Dose 2 on Day 2.|2
207753|NCT00754130|507604|P6|NOT COMPLETED|Washout Period (>=8 Days)||0
207754|NCT00754130|507605|P5|NOT COMPLETED|Washout Period (>=8 Days)||0
207755|NCT00754130|507606|P4|NOT COMPLETED|Washout Period (>=8 Days)||0
207756|NCT00754130|507607|P3|NOT COMPLETED|Washout Period (>=8 Days)||0
207757|NCT00754130|507608|P2|NOT COMPLETED|Washout Period (>=8 Days)||0
207758|NCT00754130|507609|P1|NOT COMPLETED|Washout Period (>=8 Days)||0
207759|NCT00754130|507604|P6|COMPLETED|Washout Period (>=8 Days)||4
207760|NCT00754130|507605|P5|COMPLETED|Washout Period (>=8 Days)||2
207761|NCT00754130|507606|P4|COMPLETED|Washout Period (>=8 Days)||2
207762|NCT00754130|507607|P3|COMPLETED|Washout Period (>=8 Days)||4
207763|NCT00754130|507608|P2|COMPLETED|Washout Period (>=8 Days)||2
207764|NCT00754130|507609|P1|COMPLETED|Washout Period (>=8 Days)||2
207765|NCT00754130|507604|P6|STARTED|Washout Period (>=8 Days)||4
207766|NCT00754130|507605|P5|STARTED|Washout Period (>=8 Days)||2
207767|NCT00754130|507606|P4|STARTED|Washout Period (>=8 Days)||2
207768|NCT00754130|507607|P3|STARTED|Washout Period (>=8 Days)||4
207769|NCT00754130|507608|P2|STARTED|Washout Period (>=8 Days)||2
207770|NCT00754130|507609|P1|STARTED|Washout Period (>=8 Days)||2
207771|NCT00754130|507604|P6|NOT COMPLETED|Period 1 (5 Days)||0
207772|NCT00754130|507605|P5|NOT COMPLETED|Period 1 (5 Days)||0
207773|NCT00754130|507606|P4|NOT COMPLETED|Period 1 (5 Days)||0
207774|NCT00754130|507607|P3|NOT COMPLETED|Period 1 (5 Days)||0
207775|NCT00754130|507608|P2|NOT COMPLETED|Period 1 (5 Days)||0
207776|NCT00754130|507609|P1|NOT COMPLETED|Period 1 (5 Days)||0
207777|NCT00754130|507604|P6|COMPLETED|Period 1 (5 Days)||4
207778|NCT00754130|507605|P5|COMPLETED|Period 1 (5 Days)||2
207779|NCT00754130|507606|P4|COMPLETED|Period 1 (5 Days)||2
207780|NCT00754130|507607|P3|COMPLETED|Period 1 (5 Days)||4
207781|NCT00754130|507608|P2|COMPLETED|Period 1 (5 Days)||2
207782|NCT00754130|507609|P1|COMPLETED|Period 1 (5 Days)||2
207783|NCT00754130|507604|P6|STARTED|Period 1 (5 Days)|One participant received MK-0941 10 mg in both Periods 1 and 2.|4
207784|NCT00754130|507605|P5|STARTED|Period 1 (5 Days)||2
207785|NCT00754130|507606|P4|STARTED|Period 1 (5 Days)||2
207786|NCT00754130|507607|P3|STARTED|Period 1 (5 Days)||4
207787|NCT00754130|507608|P2|STARTED|Period 1 (5 Days)||2
207788|NCT00754130|507609|P1|STARTED|Period 1 (5 Days)||2
207789|NCT00754156|507652|P2|NOT COMPLETED|Overall Study||0
207790|NCT00754156|507653|P1|NOT COMPLETED|Overall Study||0
207791|NCT00754156|507652|P2|COMPLETED|Overall Study||6
207792|NCT00754156|507653|P1|COMPLETED|Overall Study||8
207793|NCT00754156|507652|P2|STARTED|Overall Study||6
207794|NCT00754156|507653|P1|STARTED|Overall Study||8
207795|NCT00754234|507671|P1|NOT COMPLETED|Overall Study||3
207796|NCT00754234|507671|P1|COMPLETED|Overall Study|2 participants did not receive the Day 1,4,5,6 menu and 1 did not receive the Day 2 menu|13
207797|NCT00754234|507671|P1|STARTED|Overall Study|7 Menus were consumed in randomized order|16
207798|NCT00748189|507677|P2|NOT COMPLETED|Overall Study||221
207799|NCT00748189|507678|P1|NOT COMPLETED|Overall Study||225
207800|NCT00748189|507677|P2|COMPLETED|Overall Study||0
207801|NCT00748189|507678|P1|COMPLETED|Overall Study|This participant was entered incorrectly by the site and has not completed the 5 year follow-up.|1
207802|NCT00748189|507677|P2|Ongoing|Overall Study|One par. was incorrectly recorded as withdrawn due to “Study Terminated by Sponsor” and is ongoing.|162
207803|NCT00748189|507678|P1|Ongoing|Overall Study||155
207804|NCT00748189|507677|P2|STARTED|Overall Study||221
207805|NCT00748189|507678|P1|STARTED|Overall Study||226
207806|NCT00748241|507732|P1|NOT COMPLETED|Overall Study||8
207807|NCT00748241|507732|P1|COMPLETED|Overall Study||11
207808|NCT00748241|507732|P1|STARTED|Overall Study||19
207809|NCT00748553|507742|P2|NOT COMPLETED|Overall Study||1
207810|NCT00748553|507743|P1|NOT COMPLETED|Overall Study||3
207811|NCT00748553|507742|P2|COMPLETED|Overall Study||13
207812|NCT00748553|507743|P1|COMPLETED|Overall Study||13
207813|NCT00748553|507742|P2|STARTED|Overall Study||14
207814|NCT00748553|507743|P1|STARTED|Overall Study||16
207815|NCT00748566|507750|P1|NOT COMPLETED|Overall Study||112
207816|NCT00748566|507750|P1|COMPLETED|Overall Study||60
207817|NCT00748566|507750|P1|STARTED|Overall Study||172
207818|NCT00748579|507780|P2|NOT COMPLETED|Overall Study||0
207819|NCT00748579|507781|P1|NOT COMPLETED|Overall Study||0
207820|NCT00748579|507780|P2|COMPLETED|Overall Study||0
207821|NCT00748579|507781|P1|COMPLETED|Overall Study||2
207822|NCT00748579|507780|P2|STARTED|Overall Study||0
207823|NCT00748579|507781|P1|STARTED|Overall Study||2
207824|NCT00748657|507787|P1|NOT COMPLETED|Overall Study||0
207825|NCT00748657|507787|P1|COMPLETED|Overall Study||36
207826|NCT00748657|507787|P1|STARTED|Overall Study||36
207827|NCT00748709|507793|P1|NOT COMPLETED|Overall Study||20
207828|NCT00748709|507793|P1|COMPLETED|Overall Study||0
207829|NCT00748709|507793|P1|STARTED|Overall Study|Treated|20
207830|NCT00754325|507807|P2|NOT COMPLETED|Progression and Cross-over||21
207831|NCT00754325|507808|P1|NOT COMPLETED|Progression and Cross-over||0
207832|NCT00754325|507807|P2|COMPLETED|Progression and Cross-over||0
207833|NCT00754325|507808|P1|COMPLETED|Progression and Cross-over||0
207834|NCT00754325|507807|P2|STARTED|Progression and Cross-over|Progressive disease participants in Arm 2 could add dasatinib (Arm 2b) at investigator discretion.|21
207835|NCT00754325|507808|P1|STARTED|Progression and Cross-over|Arm 1 participants with dasatinib-related toxicity stop dasatinib, continue fulvestrant (Arm 1b).|0
207836|NCT00754325|507807|P2|NOT COMPLETED|Initial Treatment||49
207837|NCT00754325|507808|P1|NOT COMPLETED|Initial Treatment||50
207838|NCT00754325|507807|P2|COMPLETED|Initial Treatment||0
207839|NCT00754325|507808|P1|COMPLETED|Initial Treatment||0
207840|NCT00754325|507807|P2|STARTED|Initial Treatment||49
207841|NCT00754325|507808|P1|STARTED|Initial Treatment||50
207842|NCT00754338|507831|P4|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
207843|NCT00754338|507832|P3|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
207844|NCT00754338|507833|P2|NOT COMPLETED|Second Intervention for Phase1&Phase2||1
207845|NCT00754338|507834|P1|NOT COMPLETED|Second Intervention for Phase1&Phase2||0
207846|NCT00754338|507831|P4|COMPLETED|Second Intervention for Phase1&Phase2||18
207847|NCT00754338|507832|P3|COMPLETED|Second Intervention for Phase1&Phase2||16
207848|NCT00754338|507833|P2|COMPLETED|Second Intervention for Phase1&Phase2||17
207849|NCT00754338|507834|P1|COMPLETED|Second Intervention for Phase1&Phase2||17
207850|NCT00754338|507831|P4|STARTED|Second Intervention for Phase1&Phase2||19
207851|NCT00754338|507832|P3|STARTED|Second Intervention for Phase1&Phase2||16
207852|NCT00754338|507833|P2|STARTED|Second Intervention for Phase1&Phase2||18
207853|NCT00754338|507834|P1|STARTED|Second Intervention for Phase1&Phase2||17
207854|NCT00754338|507831|P4|NOT COMPLETED|First Intervention for Phase1&Phase2||0
207855|NCT00754338|507832|P3|NOT COMPLETED|First Intervention for Phase1&Phase2||3
207856|NCT00754338|507833|P2|NOT COMPLETED|First Intervention for Phase1&Phase2||3
207857|NCT00754338|507834|P1|NOT COMPLETED|First Intervention for Phase1&Phase2||0
207858|NCT00754338|507831|P4|COMPLETED|First Intervention for Phase1&Phase2||19
207859|NCT00754338|507832|P3|COMPLETED|First Intervention for Phase1&Phase2||16
207860|NCT00754338|507833|P2|COMPLETED|First Intervention for Phase1&Phase2||18
207861|NCT00754338|507834|P1|COMPLETED|First Intervention for Phase1&Phase2||17
207862|NCT00754338|507831|P4|STARTED|First Intervention for Phase1&Phase2||19
207863|NCT00754338|507832|P3|STARTED|First Intervention for Phase1&Phase2||19
207864|NCT00754338|507833|P2|STARTED|First Intervention for Phase1&Phase2||21
207865|NCT00754338|507834|P1|STARTED|First Intervention for Phase1&Phase2||17
207866|NCT00754377|507866|P2|NOT COMPLETED|Overall Study||0
207867|NCT00754377|507867|P1|NOT COMPLETED|Overall Study||0
207868|NCT00754377|507866|P2|COMPLETED|Overall Study||42
207869|NCT00754377|507867|P1|COMPLETED|Overall Study||50
207870|NCT00754377|507866|P2|STARTED|Overall Study||42
207871|NCT00754377|507867|P1|STARTED|Overall Study||50
207872|NCT00754390|507875|P1|NOT COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||1
207873|NCT00754390|507875|P1|COMPLETED|Ca/Phytate Test Meal 4 (Randomized)||10
207874|NCT00754390|507875|P1|STARTED|Ca/Phytate Test Meal 4 (Randomized)||11
207875|NCT00754390|507875|P1|NOT COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||1
207876|NCT00754390|507875|P1|COMPLETED|Ca/Phytate Test Meal 3 (Randomized)||11
207877|NCT00754390|507875|P1|STARTED|Ca/Phytate Test Meal 3 (Randomized)||12
207878|NCT00754390|507875|P1|NOT COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||0
207879|NCT00754390|507875|P1|COMPLETED|Ca/Phytate Test Meal 2 (Randomized)||12
207880|NCT00754390|507875|P1|STARTED|Ca/Phytate Test Meal 2 (Randomized)||12
207881|NCT00754390|507875|P1|NOT COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||5
207882|NCT00754390|507875|P1|COMPLETED|Ca/Phytate Test Meal 1 (Randomized)||12
207883|NCT00754390|507875|P1|STARTED|Ca/Phytate Test Meal 1 (Randomized)||17
207884|NCT00754442|507884|P2|NOT COMPLETED|Overall Study||3
207885|NCT00754442|507885|P1|NOT COMPLETED|Overall Study||5
207886|NCT00754442|507884|P2|COMPLETED|Overall Study||6
207887|NCT00754442|507885|P1|COMPLETED|Overall Study||6
207888|NCT00754442|507884|P2|STARTED|Overall Study|patients 9|9
207889|NCT00754442|507885|P1|STARTED|Overall Study|controls 11|11
207890|NCT00754468|507894|P2|NOT COMPLETED|Overall Study||0
207891|NCT00754468|507895|P1|NOT COMPLETED|Overall Study||0
207892|NCT00754468|507894|P2|COMPLETED|Overall Study||3
207893|NCT00754468|507895|P1|COMPLETED|Overall Study||4
207894|NCT00754468|507894|P2|STARTED|Overall Study||3
207895|NCT00754468|507895|P1|STARTED|Overall Study||4
207896|NCT00754494|507906|P3|NOT COMPLETED|Overall Study||1
207897|NCT00754494|507907|P2|NOT COMPLETED|Overall Study||0
207898|NCT00754494|507908|P1|NOT COMPLETED|Overall Study||2
207899|NCT00754494|507906|P3|COMPLETED|Overall Study||14
207900|NCT00754494|507907|P2|COMPLETED|Overall Study||15
207901|NCT00754494|507908|P1|COMPLETED|Overall Study||13
207902|NCT00754494|507906|P3|STARTED|Overall Study||15
207903|NCT00754494|507907|P2|STARTED|Overall Study||15
207904|NCT00754494|507908|P1|STARTED|Overall Study||15
207905|NCT00754546|507952|P1|NOT COMPLETED|Overall Study||0
207906|NCT00754546|507952|P1|COMPLETED|Overall Study||20
207907|NCT00754546|507952|P1|STARTED|Overall Study||20
207908|NCT00754559|507966|P1|NOT COMPLETED|Overall Study||47
207909|NCT00754559|507966|P1|COMPLETED|Overall Study||239
207910|NCT00754559|507966|P1|STARTED|Overall Study||286
207911|NCT00754572|507990|P1|NOT COMPLETED|Overall Study||71
207912|NCT00754572|507990|P1|COMPLETED|Overall Study||347
207913|NCT00754572|507990|P1|STARTED|Overall Study||418
207914|NCT00757484|508017|P1|NOT COMPLETED|Overall Study||0
207915|NCT00757484|508017|P1|COMPLETED|Overall Study||491
207916|NCT00757484|508017|P1|STARTED|Overall Study||491
207917|NCT00757588|508026|P2|NOT COMPLETED|Period 2: Long-term (52-week) Phase||9
207918|NCT00757588|508027|P1|NOT COMPLETED|Period 2: Long-term (52-week) Phase||22
207919|NCT00757588|508026|P2|COMPLETED|Period 2: Long-term (52-week) Phase||125
207920|NCT00757588|508027|P1|COMPLETED|Period 2: Long-term (52-week) Phase||246
207921|NCT00757588|508026|P2|STARTED|Period 2: Long-term (52-week) Phase||134
207922|NCT00757588|508027|P1|STARTED|Period 2: Long-term (52-week) Phase|270 participants completed short-term phase; 2 of these did not enter long-term phase.|268
207923|NCT00757588|508026|P2|NOT COMPLETED|Period 1: Short-term (24-week) Phase||17
207924|NCT00757588|508027|P1|NOT COMPLETED|Period 1: Short-term (24-week) Phase||36
207925|NCT00757588|508026|P2|COMPLETED|Period 1: Short-term (24-week) Phase||134
207926|NCT00757588|508027|P1|COMPLETED|Period 1: Short-term (24-week) Phase|Does not include 2 who completed Period 1 but were erroneously reported in the CSR as noncompleters.|268
207927|NCT00757588|508026|P2|STARTED|Period 1: Short-term (24-week) Phase||151
207928|NCT00757588|508027|P1|STARTED|Period 1: Short-term (24-week) Phase||304
207929|NCT00757601|508059|P12|NOT COMPLETED|Period 5||0
207930|NCT00757601|508060|P11|NOT COMPLETED|Period 5||0
207931|NCT00757601|508061|P10|NOT COMPLETED|Period 5||0
207932|NCT00757601|508062|P9|NOT COMPLETED|Period 5||0
207933|NCT00757601|508063|P8|NOT COMPLETED|Period 5||0
207934|NCT00757601|508064|P7|NOT COMPLETED|Period 5||0
207935|NCT00757601|508065|P6|NOT COMPLETED|Period 5||0
207936|NCT00757601|508066|P5|NOT COMPLETED|Period 5||0
207937|NCT00757601|508067|P4|NOT COMPLETED|Period 5||0
207938|NCT00757601|508068|P3|NOT COMPLETED|Period 5||0
207939|NCT00757601|508069|P2|NOT COMPLETED|Period 5||0
207940|NCT00757601|508070|P1|NOT COMPLETED|Period 5||0
207941|NCT00757601|508059|P12|COMPLETED|Period 5||1
207942|NCT00757601|508060|P11|COMPLETED|Period 5||2
207943|NCT00757601|508061|P10|COMPLETED|Period 5||1
207944|NCT00757601|508062|P9|COMPLETED|Period 5||2
207945|NCT00757601|508063|P8|COMPLETED|Period 5||2
207946|NCT00757601|508064|P7|COMPLETED|Period 5||2
207947|NCT00757601|508065|P6|COMPLETED|Period 5||2
207948|NCT00757601|508066|P5|COMPLETED|Period 5||2
207949|NCT00757601|508067|P4|COMPLETED|Period 5||2
207950|NCT00757601|508068|P3|COMPLETED|Period 5||2
207951|NCT00757601|508069|P2|COMPLETED|Period 5||2
207952|NCT00757601|508070|P1|COMPLETED|Period 5||2
207953|NCT00757601|508059|P12|STARTED|Period 5||1
207954|NCT00757601|508060|P11|STARTED|Period 5||2
207955|NCT00757601|508061|P10|STARTED|Period 5||1
207956|NCT00757601|508062|P9|STARTED|Period 5||2
207957|NCT00757601|508063|P8|STARTED|Period 5||2
207958|NCT00757601|508064|P7|STARTED|Period 5||2
207959|NCT00757601|508065|P6|STARTED|Period 5||2
207960|NCT00757601|508066|P5|STARTED|Period 5||2
207961|NCT00757601|508067|P4|STARTED|Period 5||2
207962|NCT00757601|508068|P3|STARTED|Period 5||2
207963|NCT00757601|508069|P2|STARTED|Period 5||2
207964|NCT00757601|508070|P1|STARTED|Period 5||2
207965|NCT00757601|508059|P12|NOT COMPLETED|Period 4||1
207966|NCT00757601|508060|P11|NOT COMPLETED|Period 4||0
207967|NCT00757601|508061|P10|NOT COMPLETED|Period 4||1
207968|NCT00757601|508062|P9|NOT COMPLETED|Period 4||0
207969|NCT00757601|508063|P8|NOT COMPLETED|Period 4||0
207970|NCT00757601|508064|P7|NOT COMPLETED|Period 4||0
207971|NCT00757601|508065|P6|NOT COMPLETED|Period 4||0
207972|NCT00757601|508066|P5|NOT COMPLETED|Period 4||0
207973|NCT00757601|508067|P4|NOT COMPLETED|Period 4||0
207974|NCT00757601|508068|P3|NOT COMPLETED|Period 4||0
207975|NCT00757601|508069|P2|NOT COMPLETED|Period 4||0
207976|NCT00757601|508070|P1|NOT COMPLETED|Period 4||0
207977|NCT00757601|508059|P12|COMPLETED|Period 4|Replacement participant discontinued after receiving placebo to 230mg MK1006 and was not replaced|1
207978|NCT00757601|508060|P11|COMPLETED|Period 4||2
207979|NCT00757601|508061|P10|COMPLETED|Period 4|One participant discontinued after receiving the 230 mg dose of MK1006 and was not replaced|1
207980|NCT00757601|508062|P9|COMPLETED|Period 4||2
207981|NCT00757601|508063|P8|COMPLETED|Period 4||2
207982|NCT00757601|508064|P7|COMPLETED|Period 4||2
207983|NCT00757601|508065|P6|COMPLETED|Period 4||2
207984|NCT00757601|508066|P5|COMPLETED|Period 4||2
207985|NCT00757601|508067|P4|COMPLETED|Period 4||2
207986|NCT00757601|508068|P3|COMPLETED|Period 4||2
207987|NCT00757601|508069|P2|COMPLETED|Period 4||2
207988|NCT00757601|508070|P1|COMPLETED|Period 4||2
207989|NCT00757601|508059|P12|STARTED|Period 4||2
207990|NCT00757601|508060|P11|STARTED|Period 4||2
207991|NCT00757601|508061|P10|STARTED|Period 4||2
207992|NCT00757601|508062|P9|STARTED|Period 4||2
207993|NCT00757601|508063|P8|STARTED|Period 4||2
207994|NCT00757601|508064|P7|STARTED|Period 4||2
207995|NCT00757601|508065|P6|STARTED|Period 4||2
207996|NCT00757601|508066|P5|STARTED|Period 4||2
207997|NCT00757601|508067|P4|STARTED|Period 4||2
207998|NCT00757601|508068|P3|STARTED|Period 4||2
207999|NCT00757601|508069|P2|STARTED|Period 4||2
208000|NCT00757601|508070|P1|STARTED|Period 4||2
208001|NCT00757601|508059|P12|NOT COMPLETED|Period 3||0
208002|NCT00757601|508060|P11|NOT COMPLETED|Period 3||0
208003|NCT00757601|508061|P10|NOT COMPLETED|Period 3||0
208004|NCT00757601|508062|P9|NOT COMPLETED|Period 3||0
208005|NCT00757601|508063|P8|NOT COMPLETED|Period 3||0
208006|NCT00757601|508064|P7|NOT COMPLETED|Period 3||0
208007|NCT00757601|508065|P6|NOT COMPLETED|Period 3||0
208008|NCT00757601|508066|P5|NOT COMPLETED|Period 3||0
208009|NCT00757601|508067|P4|NOT COMPLETED|Period 3||0
208010|NCT00757601|508068|P3|NOT COMPLETED|Period 3||0
208011|NCT00757601|508069|P2|NOT COMPLETED|Period 3||0
208012|NCT00757601|508070|P1|NOT COMPLETED|Period 3||0
208013|NCT00757601|508059|P12|COMPLETED|Period 3||2
208014|NCT00757601|508060|P11|COMPLETED|Period 3||2
208015|NCT00757601|508061|P10|COMPLETED|Period 3||2
208016|NCT00757601|508062|P9|COMPLETED|Period 3||2
208017|NCT00757601|508063|P8|COMPLETED|Period 3||2
208018|NCT00757601|508064|P7|COMPLETED|Period 3||2
208019|NCT00757601|508065|P6|COMPLETED|Period 3||2
208020|NCT00757601|508066|P5|COMPLETED|Period 3||2
208021|NCT00757601|508067|P4|COMPLETED|Period 3||2
208022|NCT00757601|508068|P3|COMPLETED|Period 3||2
208023|NCT00757601|508069|P2|COMPLETED|Period 3||2
208024|NCT00757601|508070|P1|COMPLETED|Period 3||2
208025|NCT00757601|508059|P12|STARTED|Period 3||2
208026|NCT00757601|508060|P11|STARTED|Period 3||2
208027|NCT00757601|508061|P10|STARTED|Period 3||2
208028|NCT00757601|508062|P9|STARTED|Period 3||2
208029|NCT00757601|508063|P8|STARTED|Period 3||2
208030|NCT00757601|508064|P7|STARTED|Period 3||2
208031|NCT00757601|508065|P6|STARTED|Period 3||2
208032|NCT00757601|508066|P5|STARTED|Period 3||2
208033|NCT00757601|508067|P4|STARTED|Period 3||2
208034|NCT00757601|508068|P3|STARTED|Period 3||2
208035|NCT00757601|508069|P2|STARTED|Period 3||2
208036|NCT00757601|508070|P1|STARTED|Period 3||2
208037|NCT00757601|508059|P12|NOT COMPLETED|Period 2||1
208038|NCT00757601|508060|P11|NOT COMPLETED|Period 2||0
208039|NCT00757601|508061|P10|NOT COMPLETED|Period 2||0
208040|NCT00757601|508062|P9|NOT COMPLETED|Period 2||0
208041|NCT00757601|508063|P8|NOT COMPLETED|Period 2||0
208042|NCT00757601|508064|P7|NOT COMPLETED|Period 2||0
208043|NCT00757601|508065|P6|NOT COMPLETED|Period 2||0
208044|NCT00757601|508066|P5|NOT COMPLETED|Period 2||0
208045|NCT00757601|508067|P4|NOT COMPLETED|Period 2||0
208046|NCT00757601|508068|P3|NOT COMPLETED|Period 2||0
208047|NCT00757601|508069|P2|NOT COMPLETED|Period 2||0
208048|NCT00757601|508070|P1|NOT COMPLETED|Period 2||0
208049|NCT00757601|508059|P12|COMPLETED|Period 2|One participant discontinued the study after Period 2 and was replaced by another participant.|2
208050|NCT00757601|508060|P11|COMPLETED|Period 2||2
208051|NCT00757601|508061|P10|COMPLETED|Period 2||2
208052|NCT00757601|508062|P9|COMPLETED|Period 2||2
208053|NCT00757601|508063|P8|COMPLETED|Period 2||2
208054|NCT00757601|508064|P7|COMPLETED|Period 2||2
208055|NCT00757601|508065|P6|COMPLETED|Period 2||2
208056|NCT00757601|508066|P5|COMPLETED|Period 2||2
208057|NCT00757601|508067|P4|COMPLETED|Period 2||2
208058|NCT00757601|508068|P3|COMPLETED|Period 2||2
208059|NCT00757601|508069|P2|COMPLETED|Period 2||2
208060|NCT00757601|508070|P1|COMPLETED|Period 2||2
208061|NCT00757601|508059|P12|STARTED|Period 2||3
208062|NCT00757601|508060|P11|STARTED|Period 2||2
208063|NCT00757601|508061|P10|STARTED|Period 2||2
208064|NCT00757601|508062|P9|STARTED|Period 2||2
208065|NCT00757601|508063|P8|STARTED|Period 2||2
208066|NCT00757601|508064|P7|STARTED|Period 2||2
208067|NCT00757601|508065|P6|STARTED|Period 2||2
208068|NCT00757601|508066|P5|STARTED|Period 2||2
208069|NCT00757601|508067|P4|STARTED|Period 2||2
208070|NCT00757601|508068|P3|STARTED|Period 2||2
208071|NCT00757601|508069|P2|STARTED|Period 2||2
208072|NCT00757601|508070|P1|STARTED|Period 2||2
208073|NCT00757601|508059|P12|NOT COMPLETED|Period 1||0
208074|NCT00757601|508060|P11|NOT COMPLETED|Period 1||0
208075|NCT00757601|508061|P10|NOT COMPLETED|Period 1||0
208076|NCT00757601|508062|P9|NOT COMPLETED|Period 1||0
208077|NCT00757601|508063|P8|NOT COMPLETED|Period 1||0
208078|NCT00757601|508064|P7|NOT COMPLETED|Period 1||0
208079|NCT00757601|508065|P6|NOT COMPLETED|Period 1||0
208080|NCT00757601|508066|P5|NOT COMPLETED|Period 1||0
208081|NCT00757601|508067|P4|NOT COMPLETED|Period 1||0
208082|NCT00757601|508068|P3|NOT COMPLETED|Period 1||0
208083|NCT00757601|508069|P2|NOT COMPLETED|Period 1||0
208084|NCT00757601|508070|P1|NOT COMPLETED|Period 1||0
208085|NCT00757601|508059|P12|COMPLETED|Period 1||3
208086|NCT00757601|508060|P11|COMPLETED|Period 1||2
208087|NCT00757601|508061|P10|COMPLETED|Period 1||2
208088|NCT00757601|508062|P9|COMPLETED|Period 1||2
208089|NCT00757601|508063|P8|COMPLETED|Period 1||2
208090|NCT00757601|508064|P7|COMPLETED|Period 1||2
208091|NCT00757601|508065|P6|COMPLETED|Period 1||2
208092|NCT00757601|508066|P5|COMPLETED|Period 1||2
208093|NCT00757601|508067|P4|COMPLETED|Period 1||2
208094|NCT00757601|508068|P3|COMPLETED|Period 1||2
208095|NCT00757601|508069|P2|COMPLETED|Period 1||2
208096|NCT00757601|508070|P1|COMPLETED|Period 1||2
208097|NCT00757601|508059|P12|STARTED|Period 1||3
208098|NCT00757601|508060|P11|STARTED|Period 1||2
208099|NCT00757601|508061|P10|STARTED|Period 1||2
208100|NCT00757601|508062|P9|STARTED|Period 1||2
208101|NCT00757601|508063|P8|STARTED|Period 1||2
208102|NCT00757601|508064|P7|STARTED|Period 1||2
208103|NCT00757601|508065|P6|STARTED|Period 1||2
208104|NCT00757601|508066|P5|STARTED|Period 1||2
208105|NCT00757601|508067|P4|STARTED|Period 1||2
208106|NCT00757601|508068|P3|STARTED|Period 1||2
208107|NCT00757601|508069|P2|STARTED|Period 1||2
208108|NCT00757601|508070|P1|STARTED|Period 1||2
208109|NCT00757627|508179|P1|NOT COMPLETED|Overall Study||81
208110|NCT00757627|508179|P1|COMPLETED|Overall Study||419
208111|NCT00757627|508179|P1|STARTED|Overall Study||500
208112|NCT00757666|508194|P2|NOT COMPLETED|Overall Study||23
208113|NCT00757666|508195|P1|NOT COMPLETED|Overall Study||22
208114|NCT00757666|508194|P2|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|11
208115|NCT00757666|508195|P1|COMPLETED|Overall Study|Number of patients with complete CPX test results from 1 month and 2 month visits|12
208116|NCT00757666|508194|P2|STARTED|Overall Study||34
208117|NCT00757666|508195|P1|STARTED|Overall Study||34
208118|NCT00757705|508209|P1|NOT COMPLETED|Overall Study||121
208119|NCT00757705|508209|P1|COMPLETED|Overall Study||178
208120|NCT00757705|508209|P1|STARTED|Overall Study||299
208121|NCT00757783|508223|P2|NOT COMPLETED|Overall Study||6
208122|NCT00757783|508224|P1|NOT COMPLETED|Overall Study||5
208123|NCT00757783|508223|P2|COMPLETED|Overall Study||25
208124|NCT00757783|508224|P1|COMPLETED|Overall Study||29
208125|NCT00757783|508223|P2|STARTED|Overall Study||31
208126|NCT00757783|508224|P1|STARTED|Overall Study||34
208127|NCT00757822|508262|P2|NOT COMPLETED|Overall Study||31
208128|NCT00757822|508263|P1|NOT COMPLETED|Overall Study||28
208129|NCT00757822|508262|P2|COMPLETED|Overall Study||57
208130|NCT00757822|508263|P1|COMPLETED|Overall Study||64
208131|NCT00757822|508262|P2|Data Lock, Unblinding Analysis|Overall Study||57
208132|NCT00757822|508263|P1|Data Lock, Unblinding Analysis|Overall Study||64
208133|NCT00757822|508262|P2|Withdrawn-protocol Deviation|Overall Study||8
208134|NCT00757822|508263|P1|Withdrawn-protocol Deviation|Overall Study||9
208135|NCT00757822|508262|P2|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk < 2|9
208136|NCT00757822|508263|P1|Withdrawn-low-risk for PONV|Overall Study|K score for PONV risk<2|12
208137|NCT00757822|508262|P2|Data Entry, QC Assessment|Overall Study||74
208138|NCT00757822|508263|P1|Data Entry, QC Assessment|Overall Study||85
208139|NCT00757822|508262|P2|2-6 wk Post-op Assessment|Overall Study||74
208140|NCT00757822|508263|P1|2-6 wk Post-op Assessment|Overall Study||85
208141|NCT00757822|508262|P2|24-48 hr Telephone Assessment|Overall Study||74
208142|NCT00757822|508263|P1|24-48 hr Telephone Assessment|Overall Study||85
208143|NCT00757822|508262|P2|DOS: Post-operative Assessments|Overall Study||74
208144|NCT00757822|508263|P1|DOS: Post-operative Assessments|Overall Study||85
208145|NCT00757822|508262|P2|Received Study Intervention|Overall Study||74
208146|NCT00757822|508263|P1|Received Study Intervention|Overall Study||85
208147|NCT00757822|508262|P2|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|11
208148|NCT00757822|508263|P1|DOS Withdrawn by Investigator|Overall Study|No longer met inclusion criteria or developed exclusion criteria on DOS|6
208149|NCT00757822|508262|P2|Withdrawal by Subject-no Intervention|Overall Study||3
208150|NCT00757822|508263|P1|Withdrawal by Subject-no Intervention|Overall Study||1
208151|NCT00757822|508262|P2|Day of Surgery (DOS) Assessment|Overall Study||88
208152|NCT00757822|508263|P1|Day of Surgery (DOS) Assessment|Overall Study||92
208153|NCT00757822|508262|P2|STARTED|Overall Study||88
208154|NCT00757822|508263|P1|STARTED|Overall Study||92
208155|NCT00757848|508285|P2|NOT COMPLETED|Overall Study||2
208156|NCT00757848|508286|P1|NOT COMPLETED|Overall Study||3
208157|NCT00757848|508285|P2|COMPLETED|Overall Study||27
208158|NCT00757848|508286|P1|COMPLETED|Overall Study||24
208159|NCT00757848|508285|P2|STARTED|Overall Study||29
208160|NCT00757848|508286|P1|STARTED|Overall Study||27
208161|NCT00758043|508334|P4|NOT COMPLETED|Overall Study||100
208162|NCT00758043|508335|P3|NOT COMPLETED|Overall Study||39
208163|NCT00758043|508336|P2|NOT COMPLETED|Overall Study||41
208164|NCT00758043|508337|P1|NOT COMPLETED|Overall Study||1
208165|NCT00758043|508334|P4|COMPLETED|Overall Study||0
208166|NCT00758043|508335|P3|COMPLETED|Overall Study||79
208167|NCT00758043|508336|P2|COMPLETED|Overall Study||119
208168|NCT00758043|508337|P1|COMPLETED|Overall Study||161
208169|NCT00758043|508334|P4|STARTED|Overall Study||100
208170|NCT00758043|508335|P3|STARTED|Overall Study||118
208171|NCT00758043|508336|P2|STARTED|Overall Study||160
208172|NCT00758043|508337|P1|STARTED|Overall Study||162
208173|NCT00758069|508366|P3|NOT COMPLETED|Overall Study||1
208174|NCT00758069|508367|P2|NOT COMPLETED|Overall Study||0
208175|NCT00758069|508368|P1|NOT COMPLETED|Overall Study||1
208176|NCT00758069|508366|P3|COMPLETED|Overall Study||27
208177|NCT00758069|508367|P2|COMPLETED|Overall Study||25
208178|NCT00758069|508368|P1|COMPLETED|Overall Study||26
208179|NCT00758069|508366|P3|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|28
208180|NCT00758069|508367|P2|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|25
208181|NCT00758069|508368|P1|STARTED|Overall Study|Study enrolled slightly more than the target of N=20|27
208182|NCT00758160|508379|P1|NOT COMPLETED|Overall Study||66
208183|NCT00758160|508379|P1|COMPLETED|Overall Study||230
208184|NCT00758160|508379|P1|STARTED|Overall Study||296
208185|NCT00758290|508399|P2|NOT COMPLETED|Overall Study||0
208186|NCT00758290|508400|P1|NOT COMPLETED|Overall Study||0
208187|NCT00758290|508399|P2|COMPLETED|Overall Study||12
208188|NCT00758290|508400|P1|COMPLETED|Overall Study||11
208189|NCT00758290|508399|P2|STARTED|Overall Study||12
208190|NCT00758290|508400|P1|STARTED|Overall Study||11
208191|NCT00758342|508406|P2|NOT COMPLETED|Overall Study||1
208192|NCT00758342|508407|P1|NOT COMPLETED|Overall Study||4
208193|NCT00758342|508406|P2|COMPLETED|Overall Study||17
208194|NCT00758342|508407|P1|COMPLETED|Overall Study||15
208195|NCT00758342|508406|P2|STARTED|Overall Study||18
208196|NCT00758342|508407|P1|STARTED|Overall Study||19
208197|NCT00758394|508417|P4|NOT COMPLETED|4th Intervention||0
208198|NCT00758394|508418|P3|NOT COMPLETED|4th Intervention||0
208199|NCT00758394|508419|P2|NOT COMPLETED|4th Intervention||0
208200|NCT00758394|508420|P1|NOT COMPLETED|4th Intervention||0
208201|NCT00758394|508417|P4|COMPLETED|4th Intervention||7
208202|NCT00758394|508418|P3|COMPLETED|4th Intervention||6
208203|NCT00758394|508419|P2|COMPLETED|4th Intervention||6
208204|NCT00758394|508420|P1|COMPLETED|4th Intervention||7
208205|NCT00758394|508417|P4|STARTED|4th Intervention||7
208206|NCT00758394|508418|P3|STARTED|4th Intervention||6
208207|NCT00758394|508419|P2|STARTED|4th Intervention||6
208208|NCT00758394|508420|P1|STARTED|4th Intervention||7
208209|NCT00758394|508417|P4|NOT COMPLETED|Washout After 3rd Intervention||0
208210|NCT00758394|508418|P3|NOT COMPLETED|Washout After 3rd Intervention||0
208211|NCT00758394|508419|P2|NOT COMPLETED|Washout After 3rd Intervention||0
208212|NCT00758394|508420|P1|NOT COMPLETED|Washout After 3rd Intervention||0
208213|NCT00758394|508417|P4|COMPLETED|Washout After 3rd Intervention||7
208214|NCT00758394|508418|P3|COMPLETED|Washout After 3rd Intervention||6
208215|NCT00758394|508419|P2|COMPLETED|Washout After 3rd Intervention||6
208216|NCT00758394|508420|P1|COMPLETED|Washout After 3rd Intervention||7
208217|NCT00758394|508417|P4|STARTED|Washout After 3rd Intervention||7
208218|NCT00758394|508418|P3|STARTED|Washout After 3rd Intervention||6
208219|NCT00758394|508419|P2|STARTED|Washout After 3rd Intervention||6
208220|NCT00758394|508420|P1|STARTED|Washout After 3rd Intervention||7
208221|NCT00758394|508417|P4|NOT COMPLETED|3rd Intervention||1
208222|NCT00758394|508418|P3|NOT COMPLETED|3rd Intervention||0
208223|NCT00758394|508419|P2|NOT COMPLETED|3rd Intervention||0
208224|NCT00758394|508420|P1|NOT COMPLETED|3rd Intervention||1
208225|NCT00758394|508417|P4|COMPLETED|3rd Intervention||7
208226|NCT00758394|508418|P3|COMPLETED|3rd Intervention||6
208227|NCT00758394|508419|P2|COMPLETED|3rd Intervention||6
208228|NCT00758394|508420|P1|COMPLETED|3rd Intervention||7
208229|NCT00758394|508417|P4|STARTED|3rd Intervention||8
208230|NCT00758394|508418|P3|STARTED|3rd Intervention||6
208231|NCT00758394|508419|P2|STARTED|3rd Intervention||6
208232|NCT00758394|508420|P1|STARTED|3rd Intervention||8
208233|NCT00758394|508417|P4|NOT COMPLETED|Washout After 2nd Intervention||0
208234|NCT00758394|508418|P3|NOT COMPLETED|Washout After 2nd Intervention||0
208235|NCT00758394|508419|P2|NOT COMPLETED|Washout After 2nd Intervention||0
208236|NCT00758394|508420|P1|NOT COMPLETED|Washout After 2nd Intervention||0
208237|NCT00758394|508417|P4|COMPLETED|Washout After 2nd Intervention||8
208238|NCT00758394|508418|P3|COMPLETED|Washout After 2nd Intervention||6
208239|NCT00758394|508419|P2|COMPLETED|Washout After 2nd Intervention||6
208240|NCT00758394|508420|P1|COMPLETED|Washout After 2nd Intervention||8
208241|NCT00758394|508417|P4|STARTED|Washout After 2nd Intervention||8
208242|NCT00758394|508418|P3|STARTED|Washout After 2nd Intervention||6
208243|NCT00758394|508419|P2|STARTED|Washout After 2nd Intervention||6
208244|NCT00758394|508420|P1|STARTED|Washout After 2nd Intervention||8
208245|NCT00758394|508417|P4|NOT COMPLETED|2nd Intervention Order||0
208246|NCT00758394|508418|P3|NOT COMPLETED|2nd Intervention Order||0
208247|NCT00758394|508419|P2|NOT COMPLETED|2nd Intervention Order||1
208248|NCT00758394|508420|P1|NOT COMPLETED|2nd Intervention Order||0
208249|NCT00758394|508417|P4|COMPLETED|2nd Intervention Order||8
208250|NCT00758394|508418|P3|COMPLETED|2nd Intervention Order||6
208251|NCT00758394|508419|P2|COMPLETED|2nd Intervention Order||6
208252|NCT00758394|508420|P1|COMPLETED|2nd Intervention Order||8
208253|NCT00758394|508417|P4|STARTED|2nd Intervention Order||8
208254|NCT00758394|508418|P3|STARTED|2nd Intervention Order||6
208255|NCT00758394|508419|P2|STARTED|2nd Intervention Order||7
208256|NCT00758394|508420|P1|STARTED|2nd Intervention Order||8
208257|NCT00758394|508417|P4|NOT COMPLETED|Washout After 1st Intervention||0
208258|NCT00758394|508418|P3|NOT COMPLETED|Washout After 1st Intervention||0
208259|NCT00758394|508419|P2|NOT COMPLETED|Washout After 1st Intervention||0
208260|NCT00758394|508420|P1|NOT COMPLETED|Washout After 1st Intervention||0
208261|NCT00758394|508417|P4|COMPLETED|Washout After 1st Intervention||8
208262|NCT00758394|508418|P3|COMPLETED|Washout After 1st Intervention||6
208263|NCT00758394|508419|P2|COMPLETED|Washout After 1st Intervention||7
208264|NCT00758394|508420|P1|COMPLETED|Washout After 1st Intervention||8
208265|NCT00758394|508417|P4|STARTED|Washout After 1st Intervention||8
208266|NCT00758394|508418|P3|STARTED|Washout After 1st Intervention||6
208267|NCT00758394|508419|P2|STARTED|Washout After 1st Intervention||7
208268|NCT00758394|508420|P1|STARTED|Washout After 1st Intervention||8
208269|NCT00758394|508417|P4|NOT COMPLETED|1st Intervention||0
208270|NCT00758394|508418|P3|NOT COMPLETED|1st Intervention||0
208271|NCT00758394|508419|P2|NOT COMPLETED|1st Intervention||0
208272|NCT00758394|508420|P1|NOT COMPLETED|1st Intervention||0
208273|NCT00758394|508417|P4|COMPLETED|1st Intervention||8
208274|NCT00758394|508418|P3|COMPLETED|1st Intervention||6
208275|NCT00758394|508419|P2|COMPLETED|1st Intervention||7
208276|NCT00758394|508420|P1|COMPLETED|1st Intervention||8
208277|NCT00758394|508417|P4|STARTED|1st Intervention||8
208278|NCT00758394|508418|P3|STARTED|1st Intervention||6
208279|NCT00758394|508419|P2|STARTED|1st Intervention||7
208280|NCT00758394|508420|P1|STARTED|1st Intervention||8
208281|NCT00758420|508432|P2|NOT COMPLETED|Overall Study||0
208282|NCT00758420|508433|P1|NOT COMPLETED|Overall Study||0
208283|NCT00758420|508432|P2|COMPLETED|Overall Study||38
208284|NCT00758420|508433|P1|COMPLETED|Overall Study||39
208285|NCT00758420|508432|P2|STARTED|Overall Study||38
208286|NCT00758420|508433|P1|STARTED|Overall Study||39
208287|NCT00758459|508441|P2|NOT COMPLETED|Overall Study||4
208288|NCT00758459|508442|P1|NOT COMPLETED|Overall Study||3
208289|NCT00758459|508441|P2|COMPLETED|Overall Study||35
208290|NCT00758459|508442|P1|COMPLETED|Overall Study||32
208291|NCT00758459|508441|P2|STARTED|Overall Study||39
208292|NCT00758459|508442|P1|STARTED|Overall Study||35
208293|NCT00758485|508476|P2|NOT COMPLETED|Overall Study||3
208294|NCT00758485|508477|P1|NOT COMPLETED|Overall Study||1
208295|NCT00758485|508476|P2|COMPLETED|Overall Study||67
208296|NCT00758485|508477|P1|COMPLETED|Overall Study||69
208297|NCT00758485|508476|P2|TREATED|Overall Study||68
208298|NCT00758485|508477|P1|TREATED|Overall Study||69
208299|NCT00758485|508476|P2|STARTED|Overall Study||70
208300|NCT00758485|508477|P1|STARTED|Overall Study||70
208301|NCT00758498|508490|P3|NOT COMPLETED|Overall Study||5
208302|NCT00758498|508491|P2|NOT COMPLETED|Overall Study||2
208303|NCT00758498|508492|P1|NOT COMPLETED|Overall Study||3
208304|NCT00758498|508490|P3|COMPLETED|Overall Study||137
208305|NCT00758498|508491|P2|COMPLETED|Overall Study||141
208306|NCT00758498|508492|P1|COMPLETED|Overall Study||139
208307|NCT00758498|508490|P3|STARTED|Overall Study||142
208308|NCT00758498|508491|P2|STARTED|Overall Study||143
208309|NCT00758498|508492|P1|STARTED|Overall Study||142
208310|NCT00758550|508577|P2|NOT COMPLETED|Overall Study||0
208311|NCT00758550|508578|P1|NOT COMPLETED|Overall Study||0
208312|NCT00758550|508577|P2|COMPLETED|Overall Study||30
208313|NCT00758550|508578|P1|COMPLETED|Overall Study||30
208314|NCT00758550|508577|P2|STARTED|Overall Study||30
208315|NCT00758550|508578|P1|STARTED|Overall Study||30
208316|NCT00758563|508588|P2|NOT COMPLETED|Overall Study||0
208317|NCT00758563|508589|P1|NOT COMPLETED|Overall Study||0
208318|NCT00758563|508588|P2|COMPLETED|Overall Study||8
208319|NCT00758563|508589|P1|COMPLETED|Overall Study||7
208320|NCT00758563|508588|P2|STARTED|Overall Study||8
208321|NCT00758563|508589|P1|STARTED|Overall Study||7
208322|NCT00758576|508593|P1|NOT COMPLETED|Overall Study||1
208323|NCT00758576|508593|P1|COMPLETED|Overall Study||63
208324|NCT00758576|508593|P1|STARTED|Overall Study||64
208325|NCT00758589|508603|P4|NOT COMPLETED|Overall Study||6
208326|NCT00758589|508604|P3|NOT COMPLETED|Overall Study||6
208327|NCT00758589|508605|P2|NOT COMPLETED|Overall Study||3
208328|NCT00758589|508606|P1|NOT COMPLETED|Overall Study||3
208329|NCT00758589|508603|P4|COMPLETED|Overall Study||85
208330|NCT00758589|508604|P3|COMPLETED|Overall Study||86
208331|NCT00758589|508605|P2|COMPLETED|Overall Study||87
208332|NCT00758589|508606|P1|COMPLETED|Overall Study||92
208333|NCT00758589|508603|P4|STARTED|Overall Study||91
208334|NCT00758589|508604|P3|STARTED|Overall Study||92
208335|NCT00758589|508605|P2|STARTED|Overall Study||90
208336|NCT00758589|508606|P1|STARTED|Overall Study||95
208337|NCT00758602|508674|P2|NOT COMPLETED|Overall Study||22
208338|NCT00758602|508675|P1|NOT COMPLETED|Overall Study||19
208339|NCT00758602|508674|P2|COMPLETED|Overall Study||84
208340|NCT00758602|508675|P1|COMPLETED|Overall Study||85
208341|NCT00758602|508674|P2|STARTED|Overall Study||106
208342|NCT00758602|508675|P1|STARTED|Overall Study||104
208343|NCT00758667|508699|P2|NOT COMPLETED|Overall Study||0
208344|NCT00758667|508700|P1|NOT COMPLETED|Overall Study||0
208345|NCT00758667|508699|P2|COMPLETED|Overall Study||11
208346|NCT00758667|508700|P1|COMPLETED|Overall Study||9
208347|NCT00758667|508699|P2|STARTED|Overall Study||11
208348|NCT00758667|508700|P1|STARTED|Overall Study||9
208349|NCT00758680|508708|P10|NOT COMPLETED|Overall Study||1
208350|NCT00758680|508709|P9|NOT COMPLETED|Overall Study||2
208351|NCT00758680|508710|P8|NOT COMPLETED|Overall Study||1
208352|NCT00758680|508711|P7|NOT COMPLETED|Overall Study||1
208353|NCT00758680|508712|P6|NOT COMPLETED|Overall Study||0
208354|NCT00758680|508713|P5|NOT COMPLETED|Overall Study||0
208355|NCT00758680|508714|P4|NOT COMPLETED|Overall Study||0
208356|NCT00758680|508715|P3|NOT COMPLETED|Overall Study||0
208357|NCT00758680|508716|P2|NOT COMPLETED|Overall Study||0
208358|NCT00758680|508717|P1|NOT COMPLETED|Overall Study||0
208359|NCT00758680|508708|P10|COMPLETED|Overall Study||28
208360|NCT00758680|508709|P9|COMPLETED|Overall Study||18
208361|NCT00758680|508710|P8|COMPLETED|Overall Study||19
208362|NCT00758680|508711|P7|COMPLETED|Overall Study||6
208363|NCT00758680|508712|P6|COMPLETED|Overall Study||6
208364|NCT00758680|508713|P5|COMPLETED|Overall Study||6
208365|NCT00758680|508714|P4|COMPLETED|Overall Study||6
208366|NCT00758680|508715|P3|COMPLETED|Overall Study||6
208367|NCT00758680|508716|P2|COMPLETED|Overall Study||6
208368|NCT00758680|508717|P1|COMPLETED|Overall Study||6
208369|NCT00758680|508708|P10|STARTED|Overall Study||29
208370|NCT00758680|508709|P9|STARTED|Overall Study||20
208371|NCT00758680|508710|P8|STARTED|Overall Study||20
208372|NCT00758680|508711|P7|STARTED|Overall Study||7
208373|NCT00758680|508712|P6|STARTED|Overall Study||6
208374|NCT00758680|508713|P5|STARTED|Overall Study||6
208375|NCT00758680|508714|P4|STARTED|Overall Study||6
208376|NCT00758680|508715|P3|STARTED|Overall Study||6
208377|NCT00758680|508716|P2|STARTED|Overall Study||6
208378|NCT00758680|508717|P1|STARTED|Overall Study||6
208379|NCT00758706|508759|P2|NOT COMPLETED|Overall Study||4
208380|NCT00758706|508760|P1|NOT COMPLETED|Overall Study||4
208381|NCT00758706|508759|P2|COMPLETED|Overall Study||25
208382|NCT00758706|508760|P1|COMPLETED|Overall Study||22
208383|NCT00758706|508759|P2|STARTED|Overall Study||29
208384|NCT00758706|508760|P1|STARTED|Overall Study||26
208385|NCT00758745|508798|P2|NOT COMPLETED|Overall Study||21
208386|NCT00758745|508799|P1|NOT COMPLETED|Overall Study||21
208387|NCT00758745|508798|P2|COMPLETED|Overall Study||60
208388|NCT00758745|508799|P1|COMPLETED|Overall Study||60
208389|NCT00758745|508798|P2|STARTED|Overall Study||81
208390|NCT00758745|508799|P1|STARTED|Overall Study||81
208391|NCT00758758|508813|P8|NOT COMPLETED|Overall Study||0
208392|NCT00758758|508814|P7|NOT COMPLETED|Overall Study||14
208393|NCT00758758|508815|P6|NOT COMPLETED|Overall Study||14
208394|NCT00758758|508816|P5|NOT COMPLETED|Overall Study||2
208395|NCT00758758|508817|P4|NOT COMPLETED|Overall Study||2
208396|NCT00758758|508818|P3|NOT COMPLETED|Overall Study||18
208397|NCT00758758|508819|P2|NOT COMPLETED|Overall Study||25
208398|NCT00758758|508820|P1|NOT COMPLETED|Overall Study||3
208399|NCT00758758|508813|P8|COMPLETED|Overall Study||0
208400|NCT00758758|508814|P7|COMPLETED|Overall Study||17
208401|NCT00758758|508815|P6|COMPLETED|Overall Study||36
208402|NCT00758758|508816|P5|COMPLETED|Overall Study||1
208403|NCT00758758|508817|P4|COMPLETED|Overall Study||4
208404|NCT00758758|508818|P3|COMPLETED|Overall Study||35
208405|NCT00758758|508819|P2|COMPLETED|Overall Study||49
208406|NCT00758758|508820|P1|COMPLETED|Overall Study||11
208407|NCT00758758|508813|P8|STARTED|Overall Study||0
208408|NCT00758758|508814|P7|STARTED|Overall Study||31
208409|NCT00758758|508815|P6|STARTED|Overall Study||50
208410|NCT00758758|508816|P5|STARTED|Overall Study||3
208411|NCT00758758|508817|P4|STARTED|Overall Study||6
208412|NCT00758758|508818|P3|STARTED|Overall Study||53
208413|NCT00758758|508819|P2|STARTED|Overall Study||74
208414|NCT00758758|508820|P1|STARTED|Overall Study||14
208415|NCT00758771|508848|P2|NOT COMPLETED|Overall Study||5
208416|NCT00758771|508849|P1|NOT COMPLETED|Overall Study||3
208417|NCT00758771|508848|P2|COMPLETED|Overall Study||15
208418|NCT00758771|508849|P1|COMPLETED|Overall Study||15
208419|NCT00758771|508848|P2|STARTED|Overall Study||20
208420|NCT00758771|508849|P1|STARTED|Overall Study||18
208421|NCT00758836|508859|P4|NOT COMPLETED|Overall Study||32
208422|NCT00758836|508860|P3|NOT COMPLETED|Overall Study||38
208423|NCT00758836|508861|P2|NOT COMPLETED|Overall Study||26
208424|NCT00758836|508862|P1|NOT COMPLETED|Overall Study||24
208425|NCT00758836|508859|P4|COMPLETED|Overall Study||138
208426|NCT00758836|508860|P3|COMPLETED|Overall Study||133
208427|NCT00758836|508861|P2|COMPLETED|Overall Study||145
208428|NCT00758836|508862|P1|COMPLETED|Overall Study||147
208429|NCT00758836|508859|P4|Treated|Overall Study||138
208430|NCT00758836|508860|P3|Treated|Overall Study||133
208431|NCT00758836|508861|P2|Treated|Overall Study||145
208432|NCT00758836|508862|P1|Treated|Overall Study||147
208433|NCT00758836|508859|P4|STARTED|Overall Study||170
208434|NCT00758836|508860|P3|STARTED|Overall Study||171
208435|NCT00758836|508861|P2|STARTED|Overall Study||171
208436|NCT00758836|508862|P1|STARTED|Overall Study||171
208437|NCT00759031|508886|P2|NOT COMPLETED|Second Intervention (1 Day)||0
208438|NCT00759031|508887|P1|NOT COMPLETED|Second Intervention (1 Day)||0
208439|NCT00759031|508886|P2|COMPLETED|Second Intervention (1 Day)||8
208440|NCT00759031|508887|P1|COMPLETED|Second Intervention (1 Day)||8
208441|NCT00759031|508886|P2|STARTED|Second Intervention (1 Day)||8
208442|NCT00759031|508887|P1|STARTED|Second Intervention (1 Day)||8
208443|NCT00759031|508886|P2|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
208444|NCT00759031|508887|P1|NOT COMPLETED|Washout After 1st Intervention (1 Week)||0
208445|NCT00759031|508886|P2|COMPLETED|Washout After 1st Intervention (1 Week)||8
208446|NCT00759031|508887|P1|COMPLETED|Washout After 1st Intervention (1 Week)||8
208447|NCT00759031|508886|P2|STARTED|Washout After 1st Intervention (1 Week)||8
208448|NCT00759031|508887|P1|STARTED|Washout After 1st Intervention (1 Week)||8
208449|NCT00759031|508886|P2|NOT COMPLETED|First Intervention (1 Day)||1
208450|NCT00759031|508887|P1|NOT COMPLETED|First Intervention (1 Day)||2
208451|NCT00759031|508886|P2|COMPLETED|First Intervention (1 Day)||8
208452|NCT00759031|508887|P1|COMPLETED|First Intervention (1 Day)||8
208453|NCT00759031|508886|P2|STARTED|First Intervention (1 Day)||9
208454|NCT00759031|508887|P1|STARTED|First Intervention (1 Day)||10
208455|NCT00759096|508893|P1|NOT COMPLETED|Overall Study||0
208456|NCT00759096|508893|P1|COMPLETED|Overall Study||30
208457|NCT00759096|508893|P1|STARTED|Overall Study||30
208458|NCT00759109|508899|P2|NOT COMPLETED|Overall Study||35
208459|NCT00759109|508900|P1|NOT COMPLETED|Overall Study||39
208460|NCT00759109|508899|P2|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|41
208461|NCT00759109|508900|P1|COMPLETED|Overall Study|From both arms combined, 7 discontinued due to death and there were 8 deaths during follow up.|35
208462|NCT00759109|508899|P2|STARTED|Overall Study||76
208463|NCT00759109|508900|P1|STARTED|Overall Study||74
208464|NCT00759148|508918|P2|NOT COMPLETED|Overall Study||32
208465|NCT00759148|508919|P1|NOT COMPLETED|Overall Study||14
208466|NCT00759148|508918|P2|COMPLETED|Overall Study||554
208467|NCT00759148|508919|P1|COMPLETED|Overall Study||579
208468|NCT00759148|508918|P2|STARTED|Overall Study||586
208469|NCT00759148|508919|P1|STARTED|Overall Study||593
208470|NCT00759161|508927|P1|NOT COMPLETED|Overall Study||0
208471|NCT00759161|508927|P1|COMPLETED|Overall Study||35
208472|NCT00759161|508927|P1|STARTED|Overall Study||35
208473|NCT00759174|508942|P2|NOT COMPLETED|Overall Study||2
208474|NCT00759174|508943|P1|NOT COMPLETED|Overall Study||0
208475|NCT00759174|508942|P2|COMPLETED|Overall Study||595
208476|NCT00759174|508943|P1|COMPLETED|Overall Study||76
208477|NCT00759174|508942|P2|STARTED|Overall Study||597
208478|NCT00759174|508943|P1|STARTED|Overall Study||76
208479|NCT00759187|508955|P3|NOT COMPLETED|Overall Study||0
208480|NCT00759187|508956|P2|NOT COMPLETED|Overall Study||0
208481|NCT00759187|508957|P1|NOT COMPLETED|Overall Study||0
208482|NCT00759187|508955|P3|COMPLETED|Overall Study||9
208483|NCT00759187|508956|P2|COMPLETED|Overall Study||8
208484|NCT00759187|508957|P1|COMPLETED|Overall Study||8
208485|NCT00759187|508955|P3|STARTED|Overall Study||9
208486|NCT00759187|508956|P2|STARTED|Overall Study||8
208487|NCT00759187|508957|P1|STARTED|Overall Study||8
208488|NCT00759330|508969|P4|NOT COMPLETED|Overall Study||2
208489|NCT00759330|508970|P3|NOT COMPLETED|Overall Study||0
208490|NCT00759330|508971|P2|NOT COMPLETED|Overall Study||1
208491|NCT00759330|508972|P1|NOT COMPLETED|Overall Study||1
208492|NCT00759330|508969|P4|COMPLETED|Overall Study||41
208493|NCT00759330|508970|P3|COMPLETED|Overall Study||22
208494|NCT00759330|508971|P2|COMPLETED|Overall Study||41
208495|NCT00759330|508972|P1|COMPLETED|Overall Study||19
208496|NCT00759330|508969|P4|STARTED|Overall Study||43
208497|NCT00759330|508970|P3|STARTED|Overall Study||22
208498|NCT00759330|508971|P2|STARTED|Overall Study||42
208499|NCT00759330|508972|P1|STARTED|Overall Study||20
208500|NCT00759356|509020|P2|NOT COMPLETED|Overall Study||3
208501|NCT00759356|509021|P1|NOT COMPLETED|Overall Study||1
208502|NCT00759356|509020|P2|COMPLETED|Overall Study||15
208503|NCT00759356|509021|P1|COMPLETED|Overall Study||17
208504|NCT00759356|509020|P2|STARTED|Overall Study||18
208505|NCT00759356|509021|P1|STARTED|Overall Study||18
208506|NCT00759395|509035|P2|NOT COMPLETED|Overall Study||2
208507|NCT00759395|509036|P1|NOT COMPLETED|Overall Study||2
208508|NCT00759395|509035|P2|COMPLETED|Overall Study||7
208509|NCT00759395|509036|P1|COMPLETED|Overall Study||11
208510|NCT00759395|509035|P2|STARTED|Overall Study||9
208511|NCT00759395|509036|P1|STARTED|Overall Study||13
208512|NCT00759473|509055|P5|NOT COMPLETED|Overall Study||0
208513|NCT00759473|509056|P4|NOT COMPLETED|Overall Study||0
208514|NCT00759473|509057|P3|NOT COMPLETED|Overall Study||0
208515|NCT00759473|509058|P2|NOT COMPLETED|Overall Study||0
208516|NCT00759473|509059|P1|NOT COMPLETED|Overall Study||0
208517|NCT00759473|509055|P5|COMPLETED|Overall Study||24
208518|NCT00759473|509056|P4|COMPLETED|Overall Study||23
208519|NCT00759473|509057|P3|COMPLETED|Overall Study||12
208520|NCT00759473|509058|P2|COMPLETED|Overall Study||10
208521|NCT00759473|509059|P1|COMPLETED|Overall Study||10
208522|NCT00759473|509055|P5|STARTED|Overall Study||24
208523|NCT00759473|509056|P4|STARTED|Overall Study||23
208524|NCT00759473|509057|P3|STARTED|Overall Study||12
208525|NCT00759473|509058|P2|STARTED|Overall Study||10
208526|NCT00759473|509059|P1|STARTED|Overall Study||10
208527|NCT00759525|509071|P2|NOT COMPLETED|Second Intervention (14 Days)||0
208528|NCT00759525|509072|P1|NOT COMPLETED|Second Intervention (14 Days)||0
208529|NCT00759525|509071|P2|COMPLETED|Second Intervention (14 Days)||8
208530|NCT00759525|509072|P1|COMPLETED|Second Intervention (14 Days)||7
208531|NCT00759525|509071|P2|STARTED|Second Intervention (14 Days)||8
208532|NCT00759525|509072|P1|STARTED|Second Intervention (14 Days)||7
208533|NCT00759525|509071|P2|NOT COMPLETED|Washout (14 Days)||0
208534|NCT00759525|509072|P1|NOT COMPLETED|Washout (14 Days)||0
208535|NCT00759525|509071|P2|COMPLETED|Washout (14 Days)||8
208536|NCT00759525|509072|P1|COMPLETED|Washout (14 Days)||7
208537|NCT00759525|509071|P2|STARTED|Washout (14 Days)||8
208538|NCT00759525|509072|P1|STARTED|Washout (14 Days)||7
208539|NCT00759525|509071|P2|NOT COMPLETED|First Intervention (14 Days)||0
208540|NCT00759525|509072|P1|NOT COMPLETED|First Intervention (14 Days)||0
208541|NCT00759525|509071|P2|COMPLETED|First Intervention (14 Days)||8
208542|NCT00759525|509072|P1|COMPLETED|First Intervention (14 Days)||7
208543|NCT00759525|509071|P2|STARTED|First Intervention (14 Days)||8
208544|NCT00759525|509072|P1|STARTED|First Intervention (14 Days)||7
208545|NCT00759564|509083|P5|NOT COMPLETED|Second Intervention Period (4 Days)||0
208546|NCT00759564|509084|P4|NOT COMPLETED|Second Intervention Period (4 Days)||0
208547|NCT00759564|509085|P3|NOT COMPLETED|Second Intervention Period (4 Days)||0
208548|NCT00759564|509086|P2|NOT COMPLETED|Second Intervention Period (4 Days)||0
208549|NCT00759564|509087|P1|NOT COMPLETED|Second Intervention Period (4 Days)||0
208550|NCT00759564|509083|P5|COMPLETED|Second Intervention Period (4 Days)||3
208551|NCT00759564|509084|P4|COMPLETED|Second Intervention Period (4 Days)||1
208552|NCT00759564|509085|P3|COMPLETED|Second Intervention Period (4 Days)||8
208553|NCT00759564|509086|P2|COMPLETED|Second Intervention Period (4 Days)||8
208554|NCT00759564|509087|P1|COMPLETED|Second Intervention Period (4 Days)||8
208555|NCT00759564|509083|P5|STARTED|Second Intervention Period (4 Days)||3
208556|NCT00759564|509084|P4|STARTED|Second Intervention Period (4 Days)||1
208557|NCT00759564|509085|P3|STARTED|Second Intervention Period (4 Days)||8
208558|NCT00759564|509086|P2|STARTED|Second Intervention Period (4 Days)||8
208559|NCT00759564|509087|P1|STARTED|Second Intervention Period (4 Days)||8
208560|NCT00759564|509083|P5|NOT COMPLETED|Washout Period (at Least 14 Days)||1
208561|NCT00759564|509084|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
208562|NCT00759564|509085|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
208563|NCT00759564|509086|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
208564|NCT00759564|509087|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
208565|NCT00759564|509083|P5|COMPLETED|Washout Period (at Least 14 Days)||3
208566|NCT00759564|509084|P4|COMPLETED|Washout Period (at Least 14 Days)||1
208567|NCT00759564|509085|P3|COMPLETED|Washout Period (at Least 14 Days)||8
208568|NCT00759564|509086|P2|COMPLETED|Washout Period (at Least 14 Days)||8
208569|NCT00759564|509087|P1|COMPLETED|Washout Period (at Least 14 Days)||8
208570|NCT00759564|509083|P5|STARTED|Washout Period (at Least 14 Days)||4
208571|NCT00759564|509084|P4|STARTED|Washout Period (at Least 14 Days)||1
208572|NCT00759564|509085|P3|STARTED|Washout Period (at Least 14 Days)||8
208573|NCT00759564|509086|P2|STARTED|Washout Period (at Least 14 Days)||8
208574|NCT00759564|509087|P1|STARTED|Washout Period (at Least 14 Days)||8
208575|NCT00759564|509083|P5|NOT COMPLETED|First Intervention Period (4 Days)||0
208576|NCT00759564|509084|P4|NOT COMPLETED|First Intervention Period (4 Days)||0
208577|NCT00759564|509085|P3|NOT COMPLETED|First Intervention Period (4 Days)||0
208578|NCT00759564|509086|P2|NOT COMPLETED|First Intervention Period (4 Days)||0
208579|NCT00759564|509087|P1|NOT COMPLETED|First Intervention Period (4 Days)||0
208580|NCT00759564|509083|P5|COMPLETED|First Intervention Period (4 Days)||4
208581|NCT00759564|509084|P4|COMPLETED|First Intervention Period (4 Days)||1
208582|NCT00759564|509085|P3|COMPLETED|First Intervention Period (4 Days)||8
208583|NCT00759564|509086|P2|COMPLETED|First Intervention Period (4 Days)||8
208584|NCT00759564|509087|P1|COMPLETED|First Intervention Period (4 Days)||8
208585|NCT00759564|509083|P5|STARTED|First Intervention Period (4 Days)||4
208586|NCT00759564|509084|P4|STARTED|First Intervention Period (4 Days)||1
208587|NCT00759564|509085|P3|STARTED|First Intervention Period (4 Days)||8
208588|NCT00759564|509086|P2|STARTED|First Intervention Period (4 Days)||8
208589|NCT00759564|509087|P1|STARTED|First Intervention Period (4 Days)||8
208590|NCT00759577|509227|P1|NOT COMPLETED|Overall Study||0
208591|NCT00759577|509227|P1|COMPLETED|Overall Study||36
208592|NCT00759577|509227|P1|STARTED|Overall Study||36
208593|NCT00759603|509231|P1|NOT COMPLETED|Overall Study||0
208594|NCT00759603|509231|P1|COMPLETED|Overall Study||59
208595|NCT00759603|509231|P1|STARTED|Overall Study||59
208596|NCT00759642|509235|P1|NOT COMPLETED|Overall Study||0
208597|NCT00759642|509235|P1|COMPLETED|Overall Study||33
208598|NCT00759642|509235|P1|STARTED|Overall Study||33
208599|NCT00759655|509239|P1|NOT COMPLETED|Overall Study||1
208600|NCT00759655|509239|P1|COMPLETED|Overall Study||0
208601|NCT00759655|509239|P1|STARTED|Overall Study||1
208602|NCT00759668|509252|P2|NOT COMPLETED|Overall Study||3
208603|NCT00759668|509253|P1|NOT COMPLETED|Overall Study||1
208604|NCT00759668|509252|P2|COMPLETED|Overall Study||15
208605|NCT00759668|509253|P1|COMPLETED|Overall Study||16
208606|NCT00759668|509252|P2|STARTED|Overall Study||18
208607|NCT00759668|509253|P1|STARTED|Overall Study||17
208608|NCT00759681|509271|P2|NOT COMPLETED|Overall Study||10
208609|NCT00759681|509272|P1|NOT COMPLETED|Overall Study||10
208610|NCT00759681|509271|P2|COMPLETED|Overall Study||100
208611|NCT00759681|509272|P1|COMPLETED|Overall Study||97
208612|NCT00759681|509271|P2|STARTED|Overall Study||110
208613|NCT00759681|509272|P1|STARTED|Overall Study||107
208614|NCT00759707|509280|P1|NOT COMPLETED|Overall Study||0
208615|NCT00759707|509280|P1|COMPLETED|Overall Study||19
208616|NCT00759707|509280|P1|STARTED|Overall Study||19
208617|NCT00759759|509286|P2|NOT COMPLETED|Overall Study||1
208618|NCT00759759|509287|P1|NOT COMPLETED|Overall Study||4
208619|NCT00759759|509286|P2|COMPLETED|Overall Study||17
208620|NCT00759759|509287|P1|COMPLETED|Overall Study||14
208621|NCT00759759|509286|P2|STARTED|Overall Study||18
208622|NCT00759759|509287|P1|STARTED|Overall Study||18
208623|NCT00759772|509301|P2|NOT COMPLETED|Overall Study||0
208624|NCT00759772|509302|P1|NOT COMPLETED|Overall Study||0
208625|NCT00759772|509301|P2|COMPLETED|Overall Study||11
208626|NCT00759772|509302|P1|COMPLETED|Overall Study||12
208627|NCT00759772|509301|P2|STARTED|Overall Study||11
208628|NCT00759772|509302|P1|STARTED|Overall Study||12
208629|NCT00759785|509310|P2|NOT COMPLETED|Overall Study||5
208630|NCT00759785|509311|P1|NOT COMPLETED|Overall Study||12
208631|NCT00759785|509310|P2|COMPLETED|Overall Study||17
208632|NCT00759785|509311|P1|COMPLETED|Overall Study||14
208633|NCT00759785|509310|P2|Treated|Overall Study||20
208634|NCT00759785|509311|P1|Treated|Overall Study||25
208635|NCT00759785|509310|P2|STARTED|Overall Study||22
208636|NCT00759785|509311|P1|STARTED|Overall Study||26
208637|NCT00759811|509325|P2|NOT COMPLETED|Overall Study||1
208638|NCT00759811|509326|P1|NOT COMPLETED|Overall Study||2
208639|NCT00759811|509325|P2|COMPLETED|Overall Study||24
208640|NCT00759811|509326|P1|COMPLETED|Overall Study||23
208641|NCT00759811|509325|P2|STARTED|Overall Study||25
208642|NCT00759811|509326|P1|STARTED|Overall Study||25
208643|NCT00759863|509334|P2|NOT COMPLETED|Overall Study||18
208644|NCT00759863|509335|P1|NOT COMPLETED|Overall Study||20
208645|NCT00759863|509334|P2|COMPLETED|Overall Study||80
208646|NCT00759863|509335|P1|COMPLETED|Overall Study||124
208647|NCT00759863|509334|P2|STARTED|Overall Study||98
208648|NCT00759863|509335|P1|STARTED|Overall Study||144
208649|NCT00759902|509347|P2|NOT COMPLETED|Overall Study||1
208650|NCT00759902|509348|P1|NOT COMPLETED|Overall Study||0
208651|NCT00759902|509347|P2|COMPLETED|Overall Study||17
208652|NCT00759902|509348|P1|COMPLETED|Overall Study||18
208653|NCT00759902|509347|P2|STARTED|Overall Study||18
208654|NCT00759902|509348|P1|STARTED|Overall Study||18
208655|NCT00759915|509362|P2|NOT COMPLETED|Overall Study||1
208656|NCT00759915|509363|P1|NOT COMPLETED|Overall Study||1
208657|NCT00759915|509362|P2|COMPLETED|Overall Study||17
208658|NCT00759915|509363|P1|COMPLETED|Overall Study||17
208659|NCT00759915|509362|P2|STARTED|Overall Study||18
208660|NCT00759915|509363|P1|STARTED|Overall Study||18
208661|NCT00759941|509377|P2|NOT COMPLETED|Overall Study||1
208662|NCT00759941|509378|P1|NOT COMPLETED|Overall Study||3
208663|NCT00759941|509377|P2|COMPLETED|Overall Study||43
208664|NCT00759941|509378|P1|COMPLETED|Overall Study||39
208665|NCT00759941|509377|P2|STARTED|Overall Study||44
208666|NCT00759941|509378|P1|STARTED|Overall Study||42
208667|NCT00759954|509392|P2|NOT COMPLETED|Overall Study||2
208668|NCT00759954|509393|P1|NOT COMPLETED|Overall Study||2
208669|NCT00759954|509392|P2|COMPLETED|Overall Study|Two participants (#202 and #228) did not enter Period 2.|16
208670|NCT00759954|509393|P1|COMPLETED|Overall Study|One participant(#225) did not enter Period 2 and one participant (#203)dropped out during Period 2|16
208671|NCT00759954|509392|P2|STARTED|Overall Study|All assigned participants entered trial|18
208672|NCT00759954|509393|P1|STARTED|Overall Study|All assigned participants entered trial|18
208673|NCT00759967|509405|P2|NOT COMPLETED|Second Intervention||0
208674|NCT00759967|509406|P1|NOT COMPLETED|Second Intervention||2
208675|NCT00759967|509405|P2|COMPLETED|Second Intervention||9
208676|NCT00759967|509406|P1|COMPLETED|Second Intervention||8
208677|NCT00759967|509405|P2|STARTED|Second Intervention||9
208678|NCT00759967|509406|P1|STARTED|Second Intervention||10
208679|NCT00759967|509405|P2|NOT COMPLETED|First Intervention||0
208680|NCT00759967|509406|P1|NOT COMPLETED|First Intervention||0
208681|NCT00759967|509405|P2|COMPLETED|First Intervention||9
208682|NCT00759967|509406|P1|COMPLETED|First Intervention||10
208683|NCT00759967|509405|P2|STARTED|First Intervention||9
208684|NCT00759967|509406|P1|STARTED|First Intervention||10
208685|NCT00760019|509424|P4|NOT COMPLETED|Overall Study||0
208686|NCT00760019|509425|P3|NOT COMPLETED|Overall Study||0
208687|NCT00760019|509426|P2|NOT COMPLETED|Overall Study||0
208688|NCT00760019|509427|P1|NOT COMPLETED|Overall Study||0
208689|NCT00760019|509424|P4|COMPLETED|Overall Study||14
208690|NCT00760019|509425|P3|COMPLETED|Overall Study||14
208691|NCT00760019|509426|P2|COMPLETED|Overall Study||15
208692|NCT00760019|509427|P1|COMPLETED|Overall Study||15
208693|NCT00760019|509424|P4|STARTED|Overall Study||14
208694|NCT00760019|509425|P3|STARTED|Overall Study||14
208695|NCT00760019|509426|P2|STARTED|Overall Study||15
208696|NCT00760019|509427|P1|STARTED|Overall Study||15
208697|NCT00760084|509433|P1|NOT COMPLETED|Overall Study||10
208698|NCT00760084|509433|P1|COMPLETED|Overall Study||0
208699|NCT00760084|509433|P1|STARTED|Overall Study||10
208700|NCT00760214|509440|P3|NOT COMPLETED|Overall Study||41
208701|NCT00760214|509441|P2|NOT COMPLETED|Overall Study||30
208702|NCT00760214|509442|P1|NOT COMPLETED|Overall Study||30
208703|NCT00760214|509440|P3|COMPLETED|Overall Study||255
208704|NCT00760214|509441|P2|COMPLETED|Overall Study||264
208705|NCT00760214|509442|P1|COMPLETED|Overall Study||265
208706|NCT00760214|509440|P3|STARTED|Overall Study||296
208707|NCT00760214|509441|P2|STARTED|Overall Study||294
208708|NCT00760214|509442|P1|STARTED|Overall Study||295
208709|NCT00760266|509485|P2|NOT COMPLETED|Overall Study||18
208710|NCT00760266|509486|P1|NOT COMPLETED|Overall Study||24
208711|NCT00760266|509485|P2|COMPLETED|Overall Study||205
208712|NCT00760266|509486|P1|COMPLETED|Overall Study||204
208713|NCT00760266|509485|P2|STARTED|Overall Study||223
208714|NCT00760266|509486|P1|STARTED|Overall Study||228
208715|NCT00761735|509500|P1|NOT COMPLETED|Overall Study||14
208716|NCT00761735|509500|P1|COMPLETED|Overall Study||80
208717|NCT00761735|509500|P1|STARTED|Overall Study||94
208718|NCT00761748|509512|P2|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
208719|NCT00761748|509513|P1|NOT COMPLETED|Second Intervention (21 +/- 3 Days)||0
208720|NCT00761748|509512|P2|COMPLETED|Second Intervention (21 +/- 3 Days)||7
208721|NCT00761748|509513|P1|COMPLETED|Second Intervention (21 +/- 3 Days)||17
208722|NCT00761748|509512|P2|STARTED|Second Intervention (21 +/- 3 Days)||7
208723|NCT00761748|509513|P1|STARTED|Second Intervention (21 +/- 3 Days)||17
208724|NCT00761748|509512|P2|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
208725|NCT00761748|509513|P1|NOT COMPLETED|First Intervention (21 +/- 3 Days)||3
208726|NCT00761748|509512|P2|COMPLETED|First Intervention (21 +/- 3 Days)||7
208727|NCT00761748|509513|P1|COMPLETED|First Intervention (21 +/- 3 Days)||17
208728|NCT00761748|509512|P2|STARTED|First Intervention (21 +/- 3 Days)||10
208729|NCT00761748|509513|P1|STARTED|First Intervention (21 +/- 3 Days)||20
208730|NCT00761761|509521|P2|NOT COMPLETED|Overall Study||1
208731|NCT00761761|509522|P1|NOT COMPLETED|Overall Study||6
208732|NCT00761761|509521|P2|COMPLETED|Overall Study||29
208733|NCT00761761|509522|P1|COMPLETED|Overall Study||24
208734|NCT00761761|509521|P2|STARTED|Overall Study||30
208735|NCT00761761|509522|P1|STARTED|Overall Study||30
208736|NCT00761865|509536|P2|NOT COMPLETED|Overall Study||7
208737|NCT00761865|509537|P1|NOT COMPLETED|Overall Study||8
208738|NCT00761865|509536|P2|COMPLETED|Overall Study||11
208739|NCT00761865|509537|P1|COMPLETED|Overall Study||8
208740|NCT00761865|509536|P2|STARTED|Overall Study||18
208741|NCT00761865|509537|P1|STARTED|Overall Study||16
208742|NCT00761930|509548|P3|NOT COMPLETED|Overall Study||0
208743|NCT00761930|509549|P2|NOT COMPLETED|Overall Study||0
208744|NCT00761930|509550|P1|NOT COMPLETED|Overall Study||0
208745|NCT00761930|509548|P3|COMPLETED|Overall Study||35
208746|NCT00761930|509549|P2|COMPLETED|Overall Study||34
208747|NCT00761930|509550|P1|COMPLETED|Overall Study||34
208748|NCT00761930|509548|P3|STARTED|Overall Study||35
208749|NCT00761930|509549|P2|STARTED|Overall Study||34
208750|NCT00761930|509550|P1|STARTED|Overall Study||34
208751|NCT00761956|509566|P2|NOT COMPLETED|Overall Study||54
208752|NCT00761956|509567|P1|NOT COMPLETED|Overall Study||35
208753|NCT00761956|509566|P2|COMPLETED|Overall Study||48
208754|NCT00761956|509567|P1|COMPLETED|Overall Study||52
208755|NCT00761956|509566|P2|STARTED|Overall Study||102
208756|NCT00761956|509567|P1|STARTED|Overall Study||87
208757|NCT00761969|509577|P2|NOT COMPLETED|Overall Study||140
208758|NCT00761969|509578|P1|NOT COMPLETED|Overall Study||200
208759|NCT00761969|509577|P2|COMPLETED|Overall Study||573
208760|NCT00761969|509578|P1|COMPLETED|Overall Study||542
208761|NCT00761969|509577|P2|STARTED|Overall Study||713
208762|NCT00761969|509578|P1|STARTED|Overall Study||742
208763|NCT00762021|509588|P2|NOT COMPLETED|Overall Study||8
208764|NCT00762021|509589|P1|NOT COMPLETED|Overall Study||8
208765|NCT00762021|509588|P2|COMPLETED|Overall Study||44
208766|NCT00762021|509589|P1|COMPLETED|Overall Study||44
208767|NCT00762021|509588|P2|STARTED|Overall Study||52
208768|NCT00762021|509589|P1|STARTED|Overall Study||52
208769|NCT00762034|509601|P2|NOT COMPLETED|Maintenance Period||298
208770|NCT00762034|509602|P1|NOT COMPLETED|Maintenance Period||294
208771|NCT00762034|509601|P2|COMPLETED|Maintenance Period||0
208772|NCT00762034|509602|P1|COMPLETED|Maintenance Period||0
208773|NCT00762034|509601|P2|Received at Least 1 Dose of Study Drug|Maintenance Period||298
208774|NCT00762034|509602|P1|Received at Least 1 Dose of Study Drug|Maintenance Period||294
208775|NCT00762034|509601|P2|STARTED|Maintenance Period||298
208776|NCT00762034|509602|P1|STARTED|Maintenance Period||294
208777|NCT00762034|509601|P2|NOT COMPLETED|Induction Period||169
208778|NCT00762034|509602|P1|NOT COMPLETED|Induction Period||178
208779|NCT00762034|509601|P2|COMPLETED|Induction Period||298
208780|NCT00762034|509602|P1|COMPLETED|Induction Period||294
208781|NCT00762034|509601|P2|Received at Least 1 Dose of Study Drug|Induction Period||443
208782|NCT00762034|509602|P1|Received at Least 1 Dose of Study Drug|Induction Period||442
208783|NCT00762034|509601|P2|STARTED|Induction Period||467
208784|NCT00762034|509602|P1|STARTED|Induction Period||472
208785|NCT00762073|509663|P4|NOT COMPLETED|Overall Study||3
208786|NCT00762073|509664|P3|NOT COMPLETED|Overall Study||2
208787|NCT00762073|509665|P2|NOT COMPLETED|Overall Study||4
208788|NCT00762073|509666|P1|NOT COMPLETED|Overall Study||4
208789|NCT00762073|509663|P4|COMPLETED|Overall Study||17
208790|NCT00762073|509664|P3|COMPLETED|Overall Study|One participant was enrolled and randomized then withdrew consent and did not receive study drug.|18
208791|NCT00762073|509665|P2|COMPLETED|Overall Study||17
208792|NCT00762073|509666|P1|COMPLETED|Overall Study||17
208793|NCT00762073|509663|P4|STARTED|Overall Study||20
208794|NCT00762073|509664|P3|STARTED|Overall Study||20
208795|NCT00762073|509665|P2|STARTED|Overall Study||21
208796|NCT00762073|509666|P1|STARTED|Overall Study||21
208797|NCT00762086|509730|P2|NOT COMPLETED|Overall Study||4
208798|NCT00762086|509731|P1|NOT COMPLETED|Overall Study||6
208799|NCT00762086|509730|P2|COMPLETED|Overall Study||24
208800|NCT00762086|509731|P1|COMPLETED|Overall Study||33
208801|NCT00762086|509730|P2|STARTED|Overall Study||28
208802|NCT00762086|509731|P1|STARTED|Overall Study||39
208803|NCT00762164|509739|P2|NOT COMPLETED|Overall Study||2
208804|NCT00762164|509740|P1|NOT COMPLETED|Overall Study||3
208805|NCT00762164|509739|P2|COMPLETED|Overall Study||15
208806|NCT00762164|509740|P1|COMPLETED|Overall Study||14
208807|NCT00762164|509739|P2|STARTED|Overall Study||17
208808|NCT00762164|509740|P1|STARTED|Overall Study||17
208809|NCT00762177|509751|P3|NOT COMPLETED|3rd Treatment Period||0
208810|NCT00762177|509752|P2|NOT COMPLETED|3rd Treatment Period||0
208811|NCT00762177|509753|P1|NOT COMPLETED|3rd Treatment Period||0
208812|NCT00762177|509751|P3|COMPLETED|3rd Treatment Period||8
208813|NCT00762177|509752|P2|COMPLETED|3rd Treatment Period||8
208814|NCT00762177|509753|P1|COMPLETED|3rd Treatment Period||8
208815|NCT00762177|509751|P3|STARTED|3rd Treatment Period||8
208816|NCT00762177|509752|P2|STARTED|3rd Treatment Period||8
208817|NCT00762177|509753|P1|STARTED|3rd Treatment Period||8
208818|NCT00762177|509751|P3|NOT COMPLETED|Washout After 2nd Treatment||0
208819|NCT00762177|509752|P2|NOT COMPLETED|Washout After 2nd Treatment||0
208820|NCT00762177|509753|P1|NOT COMPLETED|Washout After 2nd Treatment||0
208821|NCT00762177|509751|P3|COMPLETED|Washout After 2nd Treatment||8
208822|NCT00762177|509752|P2|COMPLETED|Washout After 2nd Treatment||8
208823|NCT00762177|509753|P1|COMPLETED|Washout After 2nd Treatment||8
208824|NCT00762177|509751|P3|STARTED|Washout After 2nd Treatment||8
208825|NCT00762177|509752|P2|STARTED|Washout After 2nd Treatment||8
208826|NCT00762177|509753|P1|STARTED|Washout After 2nd Treatment||8
208827|NCT00762177|509751|P3|NOT COMPLETED|2nd Treatment Period||0
208828|NCT00762177|509752|P2|NOT COMPLETED|2nd Treatment Period||0
208829|NCT00762177|509753|P1|NOT COMPLETED|2nd Treatment Period||0
208830|NCT00762177|509751|P3|COMPLETED|2nd Treatment Period||8
208831|NCT00762177|509752|P2|COMPLETED|2nd Treatment Period||8
208832|NCT00762177|509753|P1|COMPLETED|2nd Treatment Period||8
208833|NCT00762177|509751|P3|STARTED|2nd Treatment Period||8
208834|NCT00762177|509752|P2|STARTED|2nd Treatment Period||8
208835|NCT00762177|509753|P1|STARTED|2nd Treatment Period||8
208836|NCT00762177|509751|P3|NOT COMPLETED|Washout After 1st Treatment||0
208837|NCT00762177|509752|P2|NOT COMPLETED|Washout After 1st Treatment||0
208838|NCT00762177|509753|P1|NOT COMPLETED|Washout After 1st Treatment||0
208839|NCT00762177|509751|P3|COMPLETED|Washout After 1st Treatment||8
208840|NCT00762177|509752|P2|COMPLETED|Washout After 1st Treatment||8
208841|NCT00762177|509753|P1|COMPLETED|Washout After 1st Treatment||8
208842|NCT00762177|509751|P3|STARTED|Washout After 1st Treatment||8
208843|NCT00762177|509752|P2|STARTED|Washout After 1st Treatment||8
208844|NCT00762177|509753|P1|STARTED|Washout After 1st Treatment||8
208845|NCT00762177|509751|P3|NOT COMPLETED|1st Treatment Period||0
208846|NCT00762177|509752|P2|NOT COMPLETED|1st Treatment Period||0
208847|NCT00762177|509753|P1|NOT COMPLETED|1st Treatment Period||0
208848|NCT00762177|509751|P3|COMPLETED|1st Treatment Period||8
208849|NCT00762177|509752|P2|COMPLETED|1st Treatment Period||8
208850|NCT00762177|509753|P1|COMPLETED|1st Treatment Period||8
208851|NCT00762177|509751|P3|STARTED|1st Treatment Period||8
208852|NCT00762177|509752|P2|STARTED|1st Treatment Period||8
208853|NCT00762177|509753|P1|STARTED|1st Treatment Period||8
208854|NCT00762216|509830|P1|NOT COMPLETED|Overall Study||0
208855|NCT00762216|509830|P1|COMPLETED|Overall Study||71
208856|NCT00762216|509830|P1|STARTED|Overall Study||71
208857|NCT00762229|509837|P2|NOT COMPLETED|Overall Study||2
208858|NCT00762229|509838|P1|NOT COMPLETED|Overall Study||1
208859|NCT00762229|509837|P2|COMPLETED|Overall Study||22
208860|NCT00762229|509838|P1|COMPLETED|Overall Study||14
208861|NCT00762229|509837|P2|STARTED|Overall Study||24
208862|NCT00762229|509838|P1|STARTED|Overall Study||15
208863|NCT00762268|509848|P2|NOT COMPLETED|Overall Study||2
208864|NCT00762268|509849|P1|NOT COMPLETED|Overall Study||1
208865|NCT00762268|509848|P2|COMPLETED|Overall Study||8
208866|NCT00762268|509849|P1|COMPLETED|Overall Study||9
208867|NCT00762268|509848|P2|STARTED|Overall Study||10
208868|NCT00762268|509849|P1|STARTED|Overall Study||10
208869|NCT00762320|509855|P1|NOT COMPLETED|Overall Study||0
208870|NCT00762320|509855|P1|COMPLETED|Overall Study||8
208871|NCT00762320|509855|P1|STARTED|Overall Study||8
208872|NCT00762359|509872|P2|NOT COMPLETED|Overall Study||57
208873|NCT00762359|509873|P1|NOT COMPLETED|Overall Study||59
208874|NCT00762359|509872|P2|COMPLETED|Overall Study||178
208875|NCT00762359|509873|P1|COMPLETED|Overall Study||167
208876|NCT00762359|509872|P2|STARTED|Overall Study||235
208877|NCT00762359|509873|P1|STARTED|Overall Study||226
208878|NCT00762385|509973|P2|NOT COMPLETED|Second Intervention||3
208879|NCT00762385|509974|P1|NOT COMPLETED|Second Intervention||3
208880|NCT00762385|509973|P2|COMPLETED|Second Intervention||39
208881|NCT00762385|509974|P1|COMPLETED|Second Intervention||46
208882|NCT00762385|509973|P2|STARTED|Second Intervention||42
208883|NCT00762385|509974|P1|STARTED|Second Intervention||49
208884|NCT00762385|509973|P2|NOT COMPLETED|First Intervention||4
208885|NCT00762385|509974|P1|NOT COMPLETED|First Intervention||2
208886|NCT00762385|509973|P2|COMPLETED|First Intervention||42
208887|NCT00762385|509974|P1|COMPLETED|First Intervention||49
208888|NCT00762385|509973|P2|STARTED|First Intervention||46
208889|NCT00762385|509974|P1|STARTED|First Intervention||51
208890|NCT00762411|509986|P2|NOT COMPLETED|Safety Follow Up (SFU)-Optional||118
208891|NCT00762411|509987|P1|NOT COMPLETED|Safety Follow Up (SFU)-Optional||84
208892|NCT00762411|509986|P2|COMPLETED|Safety Follow Up (SFU)-Optional||312
208893|NCT00762411|509987|P1|COMPLETED|Safety Follow Up (SFU)-Optional||228
208894|NCT00762411|509986|P2|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|430
208895|NCT00762411|509987|P1|STARTED|Safety Follow Up (SFU)-Optional|SFU was optional; pts entered from initial treatment and delayed start or did not enter SFU.|312
208896|NCT00762411|509986|P2|NOT COMPLETED|Delayed Start||26
208897|NCT00762411|509987|P1|NOT COMPLETED|Delayed Start||17
208898|NCT00762411|509986|P2|COMPLETED|Delayed Start||8
208899|NCT00762411|509987|P1|COMPLETED|Delayed Start||5
208900|NCT00762411|509986|P2|STARTED|Delayed Start||34
208901|NCT00762411|509987|P1|STARTED|Delayed Start||22
208902|NCT00762411|509986|P2|NOT COMPLETED|Initial Treatment||521
208903|NCT00762411|509987|P1|NOT COMPLETED|Initial Treatment||534
208904|NCT00762411|509986|P2|COMPLETED|Initial Treatment||34
208905|NCT00762411|509987|P1|COMPLETED|Initial Treatment||22
208906|NCT00762411|509986|P2|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants who received at least 1 dose of study drug.|553
208907|NCT00762411|509987|P1|Intent-to-treat (ITT)|Initial Treatment|ITT population included all randomized participants(pts) who received at least 1 dose of study drug.|555
208908|NCT00762411|509986|P2|STARTED|Initial Treatment||555
208909|NCT00762411|509987|P1|STARTED|Initial Treatment||556
208910|NCT00762424|510053|P2|NOT COMPLETED|Overall Study||0
208911|NCT00762424|510054|P1|NOT COMPLETED|Overall Study||0
208912|NCT00762424|510053|P2|COMPLETED|Overall Study||25
208913|NCT00762424|510054|P1|COMPLETED|Overall Study||28
208914|NCT00762424|510053|P2|STARTED|Overall Study||25
208915|NCT00762424|510054|P1|STARTED|Overall Study||28
208916|NCT00762450|510063|P3|NOT COMPLETED|3rd Treatment Period||0
208917|NCT00762450|510064|P2|NOT COMPLETED|3rd Treatment Period||0
208918|NCT00762450|510065|P1|NOT COMPLETED|3rd Treatment Period||0
208919|NCT00762450|510063|P3|COMPLETED|3rd Treatment Period||2
208920|NCT00762450|510064|P2|COMPLETED|3rd Treatment Period||2
208921|NCT00762450|510065|P1|COMPLETED|3rd Treatment Period||2
208922|NCT00762450|510063|P3|STARTED|3rd Treatment Period||2
208923|NCT00762450|510064|P2|STARTED|3rd Treatment Period||2
208924|NCT00762450|510065|P1|STARTED|3rd Treatment Period||2
208925|NCT00762450|510063|P3|NOT COMPLETED|Washout After 2nd Treatment Period||0
208926|NCT00762450|510064|P2|NOT COMPLETED|Washout After 2nd Treatment Period||0
208927|NCT00762450|510065|P1|NOT COMPLETED|Washout After 2nd Treatment Period||0
208928|NCT00762450|510063|P3|COMPLETED|Washout After 2nd Treatment Period||2
208929|NCT00762450|510064|P2|COMPLETED|Washout After 2nd Treatment Period||2
208930|NCT00762450|510065|P1|COMPLETED|Washout After 2nd Treatment Period||2
208931|NCT00762450|510063|P3|STARTED|Washout After 2nd Treatment Period||2
208932|NCT00762450|510064|P2|STARTED|Washout After 2nd Treatment Period||2
208933|NCT00762450|510065|P1|STARTED|Washout After 2nd Treatment Period||2
208934|NCT00762450|510063|P3|NOT COMPLETED|2nd Treatment Period||0
208935|NCT00762450|510064|P2|NOT COMPLETED|2nd Treatment Period||0
208936|NCT00762450|510065|P1|NOT COMPLETED|2nd Treatment Period||0
208937|NCT00762450|510063|P3|COMPLETED|2nd Treatment Period||2
208938|NCT00762450|510064|P2|COMPLETED|2nd Treatment Period||2
208939|NCT00762450|510065|P1|COMPLETED|2nd Treatment Period||2
208940|NCT00762450|510063|P3|STARTED|2nd Treatment Period||2
208941|NCT00762450|510064|P2|STARTED|2nd Treatment Period||2
208942|NCT00762450|510065|P1|STARTED|2nd Treatment Period||2
208943|NCT00762450|510063|P3|NOT COMPLETED|Washout After 1st Treatment Period||0
208944|NCT00762450|510064|P2|NOT COMPLETED|Washout After 1st Treatment Period||0
208945|NCT00762450|510065|P1|NOT COMPLETED|Washout After 1st Treatment Period||0
208946|NCT00762450|510063|P3|COMPLETED|Washout After 1st Treatment Period||2
208947|NCT00762450|510064|P2|COMPLETED|Washout After 1st Treatment Period||2
208948|NCT00762450|510065|P1|COMPLETED|Washout After 1st Treatment Period||2
208949|NCT00762450|510063|P3|STARTED|Washout After 1st Treatment Period||2
208950|NCT00762450|510064|P2|STARTED|Washout After 1st Treatment Period||2
208951|NCT00762450|510065|P1|STARTED|Washout After 1st Treatment Period||2
208952|NCT00762450|510063|P3|NOT COMPLETED|1st Treatment Period||0
208953|NCT00762450|510064|P2|NOT COMPLETED|1st Treatment Period||0
208954|NCT00762450|510065|P1|NOT COMPLETED|1st Treatment Period||0
208955|NCT00762450|510063|P3|COMPLETED|1st Treatment Period||2
208956|NCT00762450|510064|P2|COMPLETED|1st Treatment Period||2
208957|NCT00762450|510065|P1|COMPLETED|1st Treatment Period||2
208958|NCT00762450|510063|P3|STARTED|1st Treatment Period||2
208959|NCT00762450|510064|P2|STARTED|1st Treatment Period||2
208960|NCT00762450|510065|P1|STARTED|1st Treatment Period||2
208961|NCT00762463|510075|P4|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||2
208962|NCT00762463|510076|P3|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||4
208963|NCT00762463|510077|P2|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||1
208964|NCT00762463|510078|P1|NOT COMPLETED|Extension Phase (Week 6 to Week 12)||3
208965|NCT00762463|510075|P4|COMPLETED|Extension Phase (Week 6 to Week 12)||52
208966|NCT00762463|510076|P3|COMPLETED|Extension Phase (Week 6 to Week 12)||50
208967|NCT00762463|510077|P2|COMPLETED|Extension Phase (Week 6 to Week 12)||54
208968|NCT00762463|510078|P1|COMPLETED|Extension Phase (Week 6 to Week 12)||52
208969|NCT00762463|510075|P4|STARTED|Extension Phase (Week 6 to Week 12)||54
208970|NCT00762463|510076|P3|STARTED|Extension Phase (Week 6 to Week 12)||54
208971|NCT00762463|510077|P2|STARTED|Extension Phase (Week 6 to Week 12)||55
208972|NCT00762463|510078|P1|STARTED|Extension Phase (Week 6 to Week 12)||55
208973|NCT00762463|510075|P4|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
208974|NCT00762463|510076|P3|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||0
208975|NCT00762463|510077|P2|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||1
208976|NCT00762463|510078|P1|NOT COMPLETED|Enrollment in Extension Phase (Week 6)||4
208977|NCT00762463|510075|P4|COMPLETED|Enrollment in Extension Phase (Week 6)||0
208978|NCT00762463|510076|P3|COMPLETED|Enrollment in Extension Phase (Week 6)||0
208979|NCT00762463|510077|P2|COMPLETED|Enrollment in Extension Phase (Week 6)||109
208980|NCT00762463|510078|P1|COMPLETED|Enrollment in Extension Phase (Week 6)||109
208981|NCT00762463|510075|P4|STARTED|Enrollment in Extension Phase (Week 6)||0
208982|NCT00762463|510076|P3|STARTED|Enrollment in Extension Phase (Week 6)||0
208983|NCT00762463|510077|P2|STARTED|Enrollment in Extension Phase (Week 6)||110
208984|NCT00762463|510078|P1|STARTED|Enrollment in Extension Phase (Week 6)||113
208985|NCT00762463|510075|P4|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
208986|NCT00762463|510076|P3|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||0
208987|NCT00762463|510077|P2|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||10
208988|NCT00762463|510078|P1|NOT COMPLETED|Double-blind Phase (Baseline to Week 6)||7
208989|NCT00762463|510075|P4|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
208990|NCT00762463|510076|P3|COMPLETED|Double-blind Phase (Baseline to Week 6)||0
208991|NCT00762463|510077|P2|COMPLETED|Double-blind Phase (Baseline to Week 6)||110
208992|NCT00762463|510078|P1|COMPLETED|Double-blind Phase (Baseline to Week 6)||113
208993|NCT00762463|510075|P4|STARTED|Double-blind Phase (Baseline to Week 6)||0
208994|NCT00762463|510076|P3|STARTED|Double-blind Phase (Baseline to Week 6)||0
208995|NCT00762463|510077|P2|STARTED|Double-blind Phase (Baseline to Week 6)||120
208996|NCT00762463|510078|P1|STARTED|Double-blind Phase (Baseline to Week 6)||120
208997|NCT00762476|510162|P2|NOT COMPLETED|Overall Study||36
208998|NCT00762476|510163|P1|NOT COMPLETED|Overall Study||23
208999|NCT00762476|510162|P2|COMPLETED|Overall Study||169
209000|NCT00762476|510163|P1|COMPLETED|Overall Study||183
209001|NCT00762476|510162|P2|STARTED|Overall Study||205
209002|NCT00762476|510163|P1|STARTED|Overall Study||206
209003|NCT00762502|510176|P3|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
209004|NCT00762502|510177|P2|NOT COMPLETED|Month 3 to Month 6 (Period 2)||1
209005|NCT00762502|510178|P1|NOT COMPLETED|Month 3 to Month 6 (Period 2)||0
209006|NCT00762502|510176|P3|COMPLETED|Month 3 to Month 6 (Period 2)||23
209007|NCT00762502|510177|P2|COMPLETED|Month 3 to Month 6 (Period 2)||4
209008|NCT00762502|510178|P1|COMPLETED|Month 3 to Month 6 (Period 2)||9
209009|NCT00762502|510176|P3|STARTED|Month 3 to Month 6 (Period 2)||23
209010|NCT00762502|510177|P2|STARTED|Month 3 to Month 6 (Period 2)||5
209011|NCT00762502|510178|P1|STARTED|Month 3 to Month 6 (Period 2)||9
209012|NCT00762502|510176|P3|NOT COMPLETED|Baseline to Month 3 (Period 1)||19
209013|NCT00762502|510177|P2|NOT COMPLETED|Baseline to Month 3 (Period 1)||6
209014|NCT00762502|510178|P1|NOT COMPLETED|Baseline to Month 3 (Period 1)||10
209015|NCT00762502|510176|P3|COMPLETED|Baseline to Month 3 (Period 1)||32
209016|NCT00762502|510177|P2|COMPLETED|Baseline to Month 3 (Period 1)||19
209017|NCT00762502|510178|P1|COMPLETED|Baseline to Month 3 (Period 1)||26
209018|NCT00762502|510176|P3|STARTED|Baseline to Month 3 (Period 1)||51
209019|NCT00762502|510177|P2|STARTED|Baseline to Month 3 (Period 1)||25
209020|NCT00762502|510178|P1|STARTED|Baseline to Month 3 (Period 1)||36
209021|NCT00762515|510192|P2|NOT COMPLETED|Overall Study||0
209022|NCT00762515|510193|P1|NOT COMPLETED|Overall Study||0
209023|NCT00762515|510192|P2|COMPLETED|Overall Study||22
209024|NCT00762515|510193|P1|COMPLETED|Overall Study||22
209025|NCT00762515|510192|P2|STARTED|Overall Study||22
209026|NCT00762515|510193|P1|STARTED|Overall Study||22
209027|NCT00762528|510203|P2|NOT COMPLETED|Overall Study||0
209028|NCT00762528|510204|P1|NOT COMPLETED|Overall Study||0
209029|NCT00762528|510203|P2|COMPLETED|Overall Study||25
209030|NCT00762528|510204|P1|COMPLETED|Overall Study||24
209031|NCT00762528|510203|P2|STARTED|Overall Study||25
209032|NCT00762528|510204|P1|STARTED|Overall Study||24
209033|NCT00762606|510226|P2|NOT COMPLETED|Overall Study||13
209034|NCT00762606|510227|P1|NOT COMPLETED|Overall Study||18
209035|NCT00762606|510226|P2|COMPLETED|Overall Study||38
209036|NCT00762606|510227|P1|COMPLETED|Overall Study||37
209037|NCT00762606|510226|P2|STARTED|Overall Study||51
209038|NCT00762606|510227|P1|STARTED|Overall Study||55
209039|NCT00762619|510237|P2|NOT COMPLETED|Overall Study||0
209040|NCT00762619|510238|P1|NOT COMPLETED|Overall Study||0
209041|NCT00762619|510237|P2|COMPLETED|Overall Study||50
209042|NCT00762619|510238|P1|COMPLETED|Overall Study||55
209043|NCT00762619|510237|P2|STARTED|Overall Study||50
209044|NCT00762619|510238|P1|STARTED|Overall Study||55
209045|NCT00762645|510380|P2|NOT COMPLETED|Overall Study||2
209046|NCT00762645|510381|P1|NOT COMPLETED|Overall Study||4
209047|NCT00762645|510380|P2|COMPLETED|Overall Study||12
209048|NCT00762645|510381|P1|COMPLETED|Overall Study||12
209049|NCT00762645|510380|P2|STARTED|Overall Study||14
209050|NCT00762645|510381|P1|STARTED|Overall Study||16
209051|NCT00762723|510392|P3|NOT COMPLETED|Overall Study||3
209052|NCT00762723|510393|P2|NOT COMPLETED|Overall Study||5
209053|NCT00762723|510394|P1|NOT COMPLETED|Overall Study||5
209054|NCT00762723|510392|P3|COMPLETED|Overall Study||0
209055|NCT00762723|510393|P2|COMPLETED|Overall Study||6
209056|NCT00762723|510394|P1|COMPLETED|Overall Study||0
209057|NCT00762723|510392|P3|STARTED|Overall Study||3
209058|NCT00762723|510393|P2|STARTED|Overall Study||11
209059|NCT00762723|510394|P1|STARTED|Overall Study||5
209060|NCT00762762|510404|P2|NOT COMPLETED|Overall Study||10
209061|NCT00762762|510405|P1|NOT COMPLETED|Overall Study||8
209062|NCT00762762|510404|P2|COMPLETED|Overall Study||20
209063|NCT00762762|510405|P1|COMPLETED|Overall Study||22
209064|NCT00762762|510404|P2|STARTED|Overall Study||30
209065|NCT00762762|510405|P1|STARTED|Overall Study||30
209066|NCT00762788|510425|P6|NOT COMPLETED|Overall Study||21
209067|NCT00762788|510426|P5|NOT COMPLETED|Overall Study||13
209068|NCT00762788|510427|P4|NOT COMPLETED|Overall Study||26
209069|NCT00762788|510428|P3|NOT COMPLETED|Overall Study||21
209070|NCT00762788|510429|P2|NOT COMPLETED|Overall Study||37
209071|NCT00762788|510430|P1|NOT COMPLETED|Overall Study||26
209072|NCT00762788|510425|P6|COMPLETED|Overall Study||31
209073|NCT00762788|510426|P5|COMPLETED|Overall Study||30
209074|NCT00762788|510427|P4|COMPLETED|Overall Study||38
209075|NCT00762788|510428|P3|COMPLETED|Overall Study||21
209076|NCT00762788|510429|P2|COMPLETED|Overall Study||21
209077|NCT00762788|510430|P1|COMPLETED|Overall Study||29
209078|NCT00762788|510425|P6|STARTED|Overall Study||52
209079|NCT00762788|510426|P5|STARTED|Overall Study||43
209080|NCT00762788|510427|P4|STARTED|Overall Study||64
209081|NCT00762788|510428|P3|STARTED|Overall Study||42
209082|NCT00762788|510429|P2|STARTED|Overall Study||58
209083|NCT00762788|510430|P1|STARTED|Overall Study||55
209084|NCT00762853|510452|P2|NOT COMPLETED|Second Treatment Period||0
209085|NCT00762853|510453|P1|NOT COMPLETED|Second Treatment Period||0
209086|NCT00762853|510452|P2|COMPLETED|Second Treatment Period||10
209087|NCT00762853|510453|P1|COMPLETED|Second Treatment Period||10
209088|NCT00762853|510452|P2|STARTED|Second Treatment Period||10
209089|NCT00762853|510453|P1|STARTED|Second Treatment Period||10
209090|NCT00762853|510452|P2|NOT COMPLETED|1 Week Washout After Treatment 1||0
209091|NCT00762853|510453|P1|NOT COMPLETED|1 Week Washout After Treatment 1||0
209092|NCT00762853|510452|P2|COMPLETED|1 Week Washout After Treatment 1||10
209093|NCT00762853|510453|P1|COMPLETED|1 Week Washout After Treatment 1||10
209094|NCT00762853|510452|P2|STARTED|1 Week Washout After Treatment 1||10
209095|NCT00762853|510453|P1|STARTED|1 Week Washout After Treatment 1||10
209096|NCT00762853|510452|P2|NOT COMPLETED|First Treatment Period||0
209097|NCT00762853|510453|P1|NOT COMPLETED|First Treatment Period||0
209098|NCT00762853|510452|P2|COMPLETED|First Treatment Period||10
209099|NCT00762853|510453|P1|COMPLETED|First Treatment Period||10
209100|NCT00762853|510452|P2|STARTED|First Treatment Period||10
209101|NCT00762853|510453|P1|STARTED|First Treatment Period||10
209102|NCT00762892|510461|P2|NOT COMPLETED|Overall Study||6
209103|NCT00762892|510462|P1|NOT COMPLETED|Overall Study||5
209104|NCT00762892|510461|P2|COMPLETED|Overall Study||8
209105|NCT00762892|510462|P1|COMPLETED|Overall Study||9
209106|NCT00762892|510461|P2|STARTED|Overall Study||14
209107|NCT00762892|510462|P1|STARTED|Overall Study||14
209108|NCT00762970|510479|P3|NOT COMPLETED|Overall Study||1
209109|NCT00762970|510480|P2|NOT COMPLETED|Overall Study||9
209110|NCT00762970|510481|P1|NOT COMPLETED|Overall Study||12
209111|NCT00762970|510479|P3|COMPLETED|Overall Study||46
209112|NCT00762970|510480|P2|COMPLETED|Overall Study||35
209113|NCT00762970|510481|P1|COMPLETED|Overall Study||34
209114|NCT00762970|510479|P3|STARTED|Overall Study||47
209115|NCT00762970|510480|P2|STARTED|Overall Study||44
209116|NCT00762970|510481|P1|STARTED|Overall Study||46
209117|NCT00762996|510492|P4|NOT COMPLETED|Period Two||0
209118|NCT00762996|510493|P3|NOT COMPLETED|Period Two||0
209119|NCT00762996|510494|P2|NOT COMPLETED|Period Two||0
209120|NCT00762996|510495|P1|NOT COMPLETED|Period Two||0
209121|NCT00762996|510492|P4|COMPLETED|Period Two||16
209122|NCT00762996|510493|P3|COMPLETED|Period Two||13
209123|NCT00762996|510494|P2|COMPLETED|Period Two||16
209124|NCT00762996|510495|P1|COMPLETED|Period Two||15
209125|NCT00762996|510492|P4|STARTED|Period Two||16
209126|NCT00762996|510493|P3|STARTED|Period Two||13
209127|NCT00762996|510494|P2|STARTED|Period Two||16
209128|NCT00762996|510495|P1|STARTED|Period Two||15
209129|NCT00762996|510492|P4|NOT COMPLETED|Period One||1
209130|NCT00762996|510493|P3|NOT COMPLETED|Period One||4
209131|NCT00762996|510494|P2|NOT COMPLETED|Period One||0
209132|NCT00762996|510495|P1|NOT COMPLETED|Period One||0
209133|NCT00762996|510492|P4|COMPLETED|Period One||16
209134|NCT00762996|510493|P3|COMPLETED|Period One||13
209135|NCT00762996|510494|P2|COMPLETED|Period One||16
209136|NCT00762996|510495|P1|COMPLETED|Period One||15
209137|NCT00762996|510492|P4|STARTED|Period One||17
209138|NCT00762996|510493|P3|STARTED|Period One||17
209139|NCT00762996|510494|P2|STARTED|Period One||16
209140|NCT00762996|510495|P1|STARTED|Period One||15
209141|NCT00763009|510505|P1|NOT COMPLETED|Overall Study||1
209142|NCT00763009|510505|P1|COMPLETED|Overall Study||7
209143|NCT00763009|510505|P1|STARTED|Overall Study||8
209144|NCT00763048|510511|P2|NOT COMPLETED|Overall Study||0
209145|NCT00763048|510512|P1|NOT COMPLETED|Overall Study||0
209146|NCT00763048|510511|P2|COMPLETED|Overall Study||18
209147|NCT00763048|510512|P1|COMPLETED|Overall Study||21
209148|NCT00763048|510511|P2|STARTED|Overall Study||18
209149|NCT00763048|510512|P1|STARTED|Overall Study||21
209150|NCT00763061|510538|P2|NOT COMPLETED|Overall Study||13
209151|NCT00763061|510539|P1|NOT COMPLETED|Overall Study||5
209152|NCT00763061|510538|P2|COMPLETED|Overall Study||44
209153|NCT00763061|510539|P1|COMPLETED|Overall Study||49
209154|NCT00763061|510538|P2|STARTED|Overall Study||57
209155|NCT00763061|510539|P1|STARTED|Overall Study||54
209156|NCT00763139|510551|P2|NOT COMPLETED|Overall Study||3
209157|NCT00763139|510552|P1|NOT COMPLETED|Overall Study||5
209158|NCT00763139|510551|P2|COMPLETED|Overall Study||14
209159|NCT00763139|510552|P1|COMPLETED|Overall Study||12
209160|NCT00763139|510551|P2|STARTED|Overall Study||17
209161|NCT00763139|510552|P1|STARTED|Overall Study||17
209162|NCT00763243|510572|P1|NOT COMPLETED|6-Month Follow-Up Period||0
209163|NCT00763243|510572|P1|COMPLETED|6-Month Follow-Up Period||9
209164|NCT00763243|510572|P1|STARTED|6-Month Follow-Up Period||9
209165|NCT00763243|510572|P1|NOT COMPLETED|1-Month Follow-Up Period||0
209166|NCT00763243|510572|P1|COMPLETED|1-Month Follow-Up Period||9
209167|NCT00763243|510572|P1|STARTED|1-Month Follow-Up Period||9
209168|NCT00763243|510572|P1|NOT COMPLETED|Training Period||0
209169|NCT00763243|510572|P1|COMPLETED|Training Period||9
209170|NCT00763243|510572|P1|STARTED|Training Period||9
209171|NCT00763243|510572|P1|NOT COMPLETED|Waiting Period||0
209172|NCT00763243|510572|P1|COMPLETED|Waiting Period||9
209173|NCT00763243|510572|P1|STARTED|Waiting Period||9
209174|NCT00763256|510596|P2|NOT COMPLETED|Overall Study||10
209175|NCT00763256|510597|P1|NOT COMPLETED|Overall Study||7
209176|NCT00763256|510596|P2|COMPLETED|Overall Study||8
209177|NCT00763256|510597|P1|COMPLETED|Overall Study||8
209178|NCT00763256|510596|P2|STARTED|Overall Study||18
209179|NCT00763256|510597|P1|STARTED|Overall Study||15
209180|NCT00763269|510613|P2|NOT COMPLETED|Overall Study||13
209181|NCT00763269|510614|P1|NOT COMPLETED|Overall Study||12
209182|NCT00763269|510613|P2|COMPLETED|Overall Study||299
209183|NCT00763269|510614|P1|COMPLETED|Overall Study||302
209184|NCT00763269|510613|P2|STARTED|Overall Study||312
209185|NCT00763269|510614|P1|STARTED|Overall Study||314
209186|NCT00763282|510628|P2|NOT COMPLETED|Overall Study||34
209187|NCT00763282|510629|P1|NOT COMPLETED|Overall Study||32
209188|NCT00763282|510628|P2|COMPLETED|Overall Study||38
209189|NCT00763282|510629|P1|COMPLETED|Overall Study||40
209190|NCT00763282|510628|P2|STARTED|Overall Study||72
209191|NCT00763282|510629|P1|STARTED|Overall Study||72
209192|NCT00763321|510646|P3|NOT COMPLETED|Double-blind Period||29
209193|NCT00763321|510647|P2|NOT COMPLETED|Double-blind Period||21
209194|NCT00763321|510648|P1|NOT COMPLETED|Double-blind Period||0
209195|NCT00763321|510646|P3|COMPLETED|Double-blind Period||84
209196|NCT00763321|510647|P2|COMPLETED|Double-blind Period||88
209197|NCT00763321|510648|P1|COMPLETED|Double-blind Period||0
209198|NCT00763321|510646|P3|STARTED|Double-blind Period||113
209199|NCT00763321|510647|P2|STARTED|Double-blind Period||109
209200|NCT00763321|510648|P1|STARTED|Double-blind Period||0
209201|NCT00763321|510646|P3|NOT COMPLETED|Open-label Period||0
209202|NCT00763321|510647|P2|NOT COMPLETED|Open-label Period||0
209203|NCT00763321|510648|P1|NOT COMPLETED|Open-label Period||63
209204|NCT00763321|510646|P3|COMPLETED|Open-label Period||0
209205|NCT00763321|510647|P2|COMPLETED|Open-label Period||0
209206|NCT00763321|510648|P1|COMPLETED|Open-label Period||222
209207|NCT00763321|510646|P3|STARTED|Open-label Period||0
209208|NCT00763321|510647|P2|STARTED|Open-label Period||0
209209|NCT00763321|510648|P1|STARTED|Open-label Period||285
209210|NCT00763360|510660|P3|NOT COMPLETED|Overall Study||0
209211|NCT00763360|510661|P2|NOT COMPLETED|Overall Study||2
209212|NCT00763360|510662|P1|NOT COMPLETED|Overall Study||0
209213|NCT00763360|510660|P3|COMPLETED|Overall Study||63
209214|NCT00763360|510661|P2|COMPLETED|Overall Study||58
209215|NCT00763360|510662|P1|COMPLETED|Overall Study||61
209216|NCT00763360|510660|P3|STARTED|Overall Study||63
209217|NCT00763360|510661|P2|STARTED|Overall Study||60
209218|NCT00763360|510662|P1|STARTED|Overall Study||61
209219|NCT00763386|510681|P2|NOT COMPLETED|Overall Study||40
209220|NCT00763386|510682|P1|NOT COMPLETED|Overall Study||48
209221|NCT00763386|510681|P2|COMPLETED|Overall Study||127
209222|NCT00763386|510682|P1|COMPLETED|Overall Study||116
209223|NCT00763386|510681|P2|STARTED|Overall Study||167
209224|NCT00763386|510682|P1|STARTED|Overall Study||164
209225|NCT00763412|510692|P2|NOT COMPLETED|Overall Study||4
209226|NCT00763412|510693|P1|NOT COMPLETED|Overall Study||4
209227|NCT00763412|510692|P2|COMPLETED|Overall Study||4
209228|NCT00763412|510693|P1|COMPLETED|Overall Study||4
209229|NCT00763412|510692|P2|STARTED|Overall Study||8
209230|NCT00763412|510693|P1|STARTED|Overall Study||8
209231|NCT00763451|510719|P4|NOT COMPLETED|Overall Study||30
209232|NCT00763451|510720|P3|NOT COMPLETED|Overall Study||40
209233|NCT00763451|510721|P2|NOT COMPLETED|Overall Study||22
209234|NCT00763451|510722|P1|NOT COMPLETED|Overall Study||13
209235|NCT00763451|510719|P4|COMPLETED|Overall Study||131
209236|NCT00763451|510720|P3|COMPLETED|Overall Study||121
209237|NCT00763451|510721|P2|COMPLETED|Overall Study||60
209238|NCT00763451|510722|P1|COMPLETED|Overall Study||67
209239|NCT00763451|510719|P4|Modified Intent-to-Treat(mITT)Population|Overall Study||160
209240|NCT00763451|510720|P3|Modified Intent-to-Treat(mITT)Population|Overall Study||160
209241|NCT00763451|510721|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||80
209242|NCT00763451|510722|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|79
209243|NCT00763451|510719|P4|Treated/Safety Population|Overall Study||161
209244|NCT00763451|510720|P3|Treated/Safety Population|Overall Study||161
209245|NCT00763451|510721|P2|Treated/Safety Population|Overall Study||81
209246|NCT00763451|510722|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|79
209247|NCT00763451|510719|P4|STARTED|Overall Study||161
209248|NCT00763451|510720|P3|STARTED|Overall Study||161
209249|NCT00763451|510721|P2|STARTED|Overall Study||82
209250|NCT00763451|510722|P1|STARTED|Overall Study|Randomized.|80
209251|NCT00763490|510754|P1|NOT COMPLETED|Overall Study||0
209252|NCT00763490|510754|P1|COMPLETED|Overall Study||20
209253|NCT00763490|510754|P1|STARTED|Overall Study||20
209254|NCT00763698|510761|P1|NOT COMPLETED|Overall Study||10
209255|NCT00763698|510761|P1|COMPLETED|Overall Study||76
209256|NCT00763698|510761|P1|STARTED|Overall Study||86
209257|NCT00763750|510767|P1|NOT COMPLETED|Overall Study||0
209258|NCT00763750|510767|P1|COMPLETED|Overall Study||25
209259|NCT00763750|510767|P1|STARTED|Overall Study||25
209260|NCT00763815|510773|P2|NOT COMPLETED|Overall Study||84
209261|NCT00763815|510774|P1|NOT COMPLETED|Overall Study||52
209262|NCT00763815|510773|P2|COMPLETED|Overall Study||239
209263|NCT00763815|510774|P1|COMPLETED|Overall Study||109
209264|NCT00763815|510773|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||320
209356|NCT00755716|511103|P1|NOT COMPLETED|Overall Study||8
209357|NCT00755716|511101|P3|COMPLETED|Overall Study||16
209265|NCT00763815|510774|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|159
209266|NCT00763815|510773|P2|Treated/Safety Population|Overall Study||323
209267|NCT00763815|510774|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|161
209268|NCT00763815|510773|P2|STARTED|Overall Study||323
209269|NCT00763815|510774|P1|STARTED|Overall Study|Randomized.|161
209270|NCT00763867|510800|P2|NOT COMPLETED|Overall Study||12
209271|NCT00763867|510801|P1|NOT COMPLETED|Overall Study||5
209272|NCT00763867|510800|P2|COMPLETED|Overall Study||101
209273|NCT00763867|510801|P1|COMPLETED|Overall Study||98
209274|NCT00763867|510800|P2|STARTED|Overall Study||113
209275|NCT00763867|510801|P1|STARTED|Overall Study||103
209276|NCT00763919|510895|P1|NOT COMPLETED|Overall Study||13
209277|NCT00763919|510895|P1|COMPLETED|Overall Study||30
209278|NCT00763919|510895|P1|STARTED|Overall Study||43
209279|NCT00763958|510923|P2|NOT COMPLETED|Overall Study||11
209280|NCT00763958|510924|P1|NOT COMPLETED|Overall Study||14
209281|NCT00763958|510923|P2|COMPLETED|Overall Study||5
209282|NCT00763958|510924|P1|COMPLETED|Overall Study||14
209283|NCT00763958|510923|P2|STARTED|Overall Study||16
209284|NCT00763958|510924|P1|STARTED|Overall Study||28
209285|NCT00763971|510937|P3|NOT COMPLETED|Overall Study||69
209286|NCT00763971|510938|P2|NOT COMPLETED|Overall Study||38
209287|NCT00763971|510939|P1|NOT COMPLETED|Overall Study||33
209288|NCT00763971|510937|P3|COMPLETED|Overall Study||42
209289|NCT00763971|510938|P2|COMPLETED|Overall Study||74
209290|NCT00763971|510939|P1|COMPLETED|Overall Study||80
209291|NCT00763971|510937|P3|STARTED|Overall Study||111
209292|NCT00763971|510938|P2|STARTED|Overall Study||112
209293|NCT00763971|510939|P1|STARTED|Overall Study||113
209294|NCT00755040|510970|P2|NOT COMPLETED|Overall Study||34
209295|NCT00755040|510971|P1|NOT COMPLETED|Overall Study||43
209296|NCT00755040|510970|P2|COMPLETED|Overall Study||47
209297|NCT00755040|510971|P1|COMPLETED|Overall Study||40
209298|NCT00755040|510970|P2|STARTED|Overall Study||81
209299|NCT00755040|510971|P1|STARTED|Overall Study||83
209300|NCT00755079|510981|P2|NOT COMPLETED|Overall Study||6
209301|NCT00755079|510982|P1|NOT COMPLETED|Overall Study||1
209302|NCT00755079|510981|P2|COMPLETED|Overall Study||16
209303|NCT00755079|510982|P1|COMPLETED|Overall Study||17
209304|NCT00755079|510981|P2|STARTED|Overall Study||22
209305|NCT00755079|510982|P1|STARTED|Overall Study||18
209306|NCT00755105|510993|P3|NOT COMPLETED|Overall Study||4
209307|NCT00755105|510994|P2|NOT COMPLETED|Overall Study||11
209308|NCT00755105|510995|P1|NOT COMPLETED|Overall Study||9
209309|NCT00755105|510993|P3|COMPLETED|Overall Study||5
209310|NCT00755105|510994|P2|COMPLETED|Overall Study||19
209311|NCT00755105|510995|P1|COMPLETED|Overall Study||29
209312|NCT00755105|510993|P3|STARTED|Overall Study||9
209313|NCT00755105|510994|P2|STARTED|Overall Study||30
209314|NCT00755105|510995|P1|STARTED|Overall Study||38
209315|NCT00755131|511005|P2|NOT COMPLETED|Overall Study||0
209316|NCT00755131|511006|P1|NOT COMPLETED|Overall Study||0
209317|NCT00755131|511005|P2|COMPLETED|Overall Study||38
209318|NCT00755131|511006|P1|COMPLETED|Overall Study||37
209319|NCT00755131|511005|P2|STARTED|Overall Study||38
209320|NCT00755131|511006|P1|STARTED|Overall Study||37
209321|NCT00755196|511016|P1|NOT COMPLETED|Overall Study||2
209322|NCT00755196|511016|P1|COMPLETED|Overall Study||28
209323|NCT00755196|511016|P1|STARTED|Overall Study||30
209324|NCT00755222|511023|P2|NOT COMPLETED|Overall Study||2
209325|NCT00755222|511024|P1|NOT COMPLETED|Overall Study||8
209326|NCT00755222|511023|P2|COMPLETED|Overall Study||34
209327|NCT00755222|511024|P1|COMPLETED|Overall Study||103
209328|NCT00755222|511023|P2|STARTED|Overall Study||36
209329|NCT00755222|511024|P1|STARTED|Overall Study||111
209330|NCT00755235|511040|P2|NOT COMPLETED|Overall Study||9
209331|NCT00755235|511041|P1|NOT COMPLETED|Overall Study||2
209332|NCT00755235|511040|P2|COMPLETED|Overall Study||93
209333|NCT00755235|511041|P1|COMPLETED|Overall Study||104
209334|NCT00755235|511040|P2|STARTED|Overall Study||102
209335|NCT00755235|511041|P1|STARTED|Overall Study||106
209336|NCT00755261|511049|P1|NOT COMPLETED|Overall Study||2
209337|NCT00755261|511049|P1|COMPLETED|Overall Study||4
209338|NCT00755261|511049|P1|STARTED|Overall Study||6
209339|NCT00755274|511055|P2|NOT COMPLETED|Overall Study||0
209340|NCT00755274|511056|P1|NOT COMPLETED|Overall Study||0
209341|NCT00755274|511055|P2|COMPLETED|Overall Study||8
209342|NCT00755274|511056|P1|COMPLETED|Overall Study||24
209343|NCT00755274|511055|P2|STARTED|Overall Study||8
209344|NCT00755274|511056|P1|STARTED|Overall Study||24
209345|NCT00755417|511079|P3|NOT COMPLETED|Overall Study||42
209346|NCT00755417|511080|P2|NOT COMPLETED|Overall Study||55
209347|NCT00755417|511081|P1|NOT COMPLETED|Overall Study||62
209348|NCT00755417|511079|P3|COMPLETED|Overall Study||135
209349|NCT00755417|511080|P2|COMPLETED|Overall Study||126
209350|NCT00755417|511081|P1|COMPLETED|Overall Study||112
209351|NCT00755417|511079|P3|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|177
209352|NCT00755417|511080|P2|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|181
209353|NCT00755417|511081|P1|STARTED|Overall Study|Number of patients that received assigned treatment; ITT and safety populations|174
209354|NCT00755716|511101|P3|NOT COMPLETED|Overall Study||3
209355|NCT00755716|511102|P2|NOT COMPLETED|Overall Study||8
209358|NCT00755716|511102|P2|COMPLETED|Overall Study||11
209359|NCT00755716|511103|P1|COMPLETED|Overall Study||11
209360|NCT00755716|511101|P3|STARTED|Overall Study||19
209361|NCT00755716|511102|P2|STARTED|Overall Study||19
209362|NCT00755716|511103|P1|STARTED|Overall Study||19
209363|NCT00755755|511117|P3|NOT COMPLETED|Overall Study||3
209364|NCT00755755|511118|P2|NOT COMPLETED|Overall Study||8
209365|NCT00755755|511119|P1|NOT COMPLETED|Overall Study||6
209366|NCT00755755|511117|P3|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|45
209367|NCT00755755|511118|P2|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|90
209368|NCT00755755|511119|P1|COMPLETED|Overall Study|Patients who completed the overall study up to the follow-up visit (visit 6)|89
209369|NCT00755755|511117|P3|STARTED|Overall Study|Safety population|48
209370|NCT00755755|511118|P2|STARTED|Overall Study|Safety population|98
209371|NCT00755755|511119|P1|STARTED|Overall Study|Safety population|95
209372|NCT00755807|511132|P2|NOT COMPLETED|Open-label Extension Phase||16
209373|NCT00755807|511133|P1|NOT COMPLETED|Open-label Extension Phase||18
209374|NCT00755807|511132|P2|COMPLETED|Open-label Extension Phase||93
209375|NCT00755807|511133|P1|COMPLETED|Open-label Extension Phase||82
209376|NCT00755807|511132|P2|STARTED|Open-label Extension Phase||109
209377|NCT00755807|511133|P1|STARTED|Open-label Extension Phase||100
209378|NCT00755807|511132|P2|NOT COMPLETED|Acute Phase||12
209379|NCT00755807|511133|P1|NOT COMPLETED|Acute Phase||18
209380|NCT00755807|511132|P2|COMPLETED|Acute Phase||109
209381|NCT00755807|511133|P1|COMPLETED|Acute Phase||100
209382|NCT00755807|511132|P2|STARTED|Acute Phase||121
209383|NCT00755807|511133|P1|STARTED|Acute Phase||118
209384|NCT00755846|511200|P6|NOT COMPLETED|Overall Study||14
209385|NCT00755846|511201|P5|NOT COMPLETED|Overall Study||17
209386|NCT00755846|511202|P4|NOT COMPLETED|Overall Study||13
209387|NCT00755846|511203|P3|NOT COMPLETED|Overall Study||12
209388|NCT00755846|511204|P2|NOT COMPLETED|Overall Study||17
209389|NCT00755846|511205|P1|NOT COMPLETED|Overall Study||25
209390|NCT00755846|511200|P6|COMPLETED|Overall Study||31
209391|NCT00755846|511201|P5|COMPLETED|Overall Study||27
209392|NCT00755846|511202|P4|COMPLETED|Overall Study||32
209393|NCT00755846|511203|P3|COMPLETED|Overall Study||32
209394|NCT00755846|511204|P2|COMPLETED|Overall Study||27
209395|NCT00755846|511205|P1|COMPLETED|Overall Study||18
209396|NCT00755846|511200|P6|STARTED|Overall Study||45
209397|NCT00755846|511201|P5|STARTED|Overall Study||44
209398|NCT00755846|511202|P4|STARTED|Overall Study||45
209399|NCT00755846|511203|P3|STARTED|Overall Study||44
209400|NCT00755846|511204|P2|STARTED|Overall Study||44
209401|NCT00755846|511205|P1|STARTED|Overall Study||43
209402|NCT00755911|511305|P2|NOT COMPLETED|Overall Study||0
209403|NCT00755911|511306|P1|NOT COMPLETED|Overall Study||0
209404|NCT00755911|511305|P2|COMPLETED|Overall Study||12
209405|NCT00755911|511306|P1|COMPLETED|Overall Study||12
209406|NCT00755911|511305|P2|STARTED|Overall Study||12
209407|NCT00755911|511306|P1|STARTED|Overall Study||12
209408|NCT00755937|511314|P1|NOT COMPLETED|Observational Follow-up||148
209409|NCT00755937|511314|P1|COMPLETED|Observational Follow-up|Subjects followed until end of study/subjects for whom end of participation data were collected|244
209410|NCT00755937|511314|P1|STARTED|Observational Follow-up||392
209411|NCT00755937|511314|P1|NOT COMPLETED|Recruitment||164
209412|NCT00755937|511314|P1|COMPLETED|Recruitment|Subjects who had a baseline visit and at least 1 additional follow-up visit (analyzed population)|392
209413|NCT00755937|511314|P1|STARTED|Recruitment|Subjects registered in the program|556
209414|NCT00756002|511326|P2|NOT COMPLETED|Placebo Run-out||0
209415|NCT00756002|511327|P1|NOT COMPLETED|Placebo Run-out||0
209416|NCT00756002|511326|P2|COMPLETED|Placebo Run-out||0
209417|NCT00756002|511327|P1|COMPLETED|Placebo Run-out||114
209418|NCT00756002|511326|P2|STARTED|Placebo Run-out||0
209419|NCT00756002|511327|P1|STARTED|Placebo Run-out||114
209420|NCT00756002|511326|P2|NOT COMPLETED|Double-Blind Treatment Period||15
209421|NCT00756002|511327|P1|NOT COMPLETED|Double-Blind Treatment Period||15
209422|NCT00756002|511326|P2|COMPLETED|Double-Blind Treatment Period||115
209423|NCT00756002|511327|P1|COMPLETED|Double-Blind Treatment Period||114
209424|NCT00756002|511326|P2|STARTED|Double-Blind Treatment Period||130
209425|NCT00756002|511327|P1|STARTED|Double-Blind Treatment Period||129
209426|NCT00756002|511326|P2|NOT COMPLETED|Placebo Run-in||0
209427|NCT00756002|511327|P1|NOT COMPLETED|Placebo Run-in||229
209428|NCT00756002|511326|P2|COMPLETED|Placebo Run-in||0
209429|NCT00756002|511327|P1|COMPLETED|Placebo Run-in||259
209430|NCT00756002|511326|P2|STARTED|Placebo Run-in||0
209431|NCT00756002|511327|P1|STARTED|Placebo Run-in||488
209432|NCT00756093|511421|P4|NOT COMPLETED|Fourth Intervention||0
209433|NCT00756093|511422|P3|NOT COMPLETED|Fourth Intervention||0
209434|NCT00756093|511423|P2|NOT COMPLETED|Fourth Intervention||0
209435|NCT00756093|511424|P1|NOT COMPLETED|Fourth Intervention||0
209436|NCT00756093|511421|P4|COMPLETED|Fourth Intervention||5
209437|NCT00756093|511422|P3|COMPLETED|Fourth Intervention||5
209438|NCT00756093|511423|P2|COMPLETED|Fourth Intervention||5
209439|NCT00756093|511424|P1|COMPLETED|Fourth Intervention||5
209440|NCT00756093|511421|P4|STARTED|Fourth Intervention||5
209441|NCT00756093|511422|P3|STARTED|Fourth Intervention||5
209442|NCT00756093|511423|P2|STARTED|Fourth Intervention||5
209443|NCT00756093|511424|P1|STARTED|Fourth Intervention||5
209444|NCT00756093|511421|P4|NOT COMPLETED|Third Intervention||0
209445|NCT00756093|511422|P3|NOT COMPLETED|Third Intervention||0
209446|NCT00756093|511423|P2|NOT COMPLETED|Third Intervention||0
209447|NCT00756093|511424|P1|NOT COMPLETED|Third Intervention||0
209448|NCT00756093|511421|P4|COMPLETED|Third Intervention||5
209449|NCT00756093|511422|P3|COMPLETED|Third Intervention||5
209450|NCT00756093|511423|P2|COMPLETED|Third Intervention||5
209451|NCT00756093|511424|P1|COMPLETED|Third Intervention||5
209452|NCT00756093|511421|P4|STARTED|Third Intervention||5
209453|NCT00756093|511422|P3|STARTED|Third Intervention||5
209454|NCT00756093|511423|P2|STARTED|Third Intervention||5
209455|NCT00756093|511424|P1|STARTED|Third Intervention||5
209456|NCT00756093|511421|P4|NOT COMPLETED|Second Intervention||0
209457|NCT00756093|511422|P3|NOT COMPLETED|Second Intervention||0
209458|NCT00756093|511423|P2|NOT COMPLETED|Second Intervention||0
209459|NCT00756093|511424|P1|NOT COMPLETED|Second Intervention||0
209460|NCT00756093|511421|P4|COMPLETED|Second Intervention||5
209461|NCT00756093|511422|P3|COMPLETED|Second Intervention||5
209462|NCT00756093|511423|P2|COMPLETED|Second Intervention||5
209463|NCT00756093|511424|P1|COMPLETED|Second Intervention||5
209464|NCT00756093|511421|P4|STARTED|Second Intervention||5
209465|NCT00756093|511422|P3|STARTED|Second Intervention||5
209466|NCT00756093|511423|P2|STARTED|Second Intervention||5
209467|NCT00756093|511424|P1|STARTED|Second Intervention||5
209468|NCT00756093|511421|P4|NOT COMPLETED|First Intervention||0
209469|NCT00756093|511422|P3|NOT COMPLETED|First Intervention||0
209470|NCT00756093|511423|P2|NOT COMPLETED|First Intervention||0
209471|NCT00756093|511424|P1|NOT COMPLETED|First Intervention||0
209472|NCT00756093|511421|P4|COMPLETED|First Intervention||5
209473|NCT00756093|511422|P3|COMPLETED|First Intervention||5
209474|NCT00756093|511423|P2|COMPLETED|First Intervention||5
209475|NCT00756093|511424|P1|COMPLETED|First Intervention||5
209476|NCT00756093|511421|P4|STARTED|First Intervention||5
209477|NCT00756093|511422|P3|STARTED|First Intervention||5
209478|NCT00756093|511423|P2|STARTED|First Intervention||5
209479|NCT00756093|511424|P1|STARTED|First Intervention||5
209480|NCT00756236|511437|P3|NOT COMPLETED|Overall Study||0
209481|NCT00756236|511438|P2|NOT COMPLETED|Overall Study||0
209482|NCT00756236|511439|P1|NOT COMPLETED|Overall Study||0
209483|NCT00756236|511437|P3|COMPLETED|Overall Study||20
209484|NCT00756236|511438|P2|COMPLETED|Overall Study||20
209485|NCT00756236|511439|P1|COMPLETED|Overall Study||20
209486|NCT00756236|511437|P3|STARTED|Overall Study||20
209487|NCT00756236|511438|P2|STARTED|Overall Study||20
209488|NCT00756236|511439|P1|STARTED|Overall Study||20
209489|NCT00756314|511449|P2|NOT COMPLETED|Overall Study||59
209490|NCT00756314|511450|P1|NOT COMPLETED|Overall Study||2
209491|NCT00756314|511449|P2|COMPLETED|Overall Study|"4 participants did not do the follow up, 55 discontinued and were analyzed by intention to treat"|64
209492|NCT00756314|511450|P1|COMPLETED|Overall Study|"2 participants discontinued the intervention and were analyzed by intention to treat analysis."|121
209493|NCT00756314|511449|P2|STARTED|Overall Study||123
209494|NCT00756314|511450|P1|STARTED|Overall Study||123
209495|NCT00756444|511466|P2|NOT COMPLETED|Overall Study||21
209496|NCT00756444|511467|P1|NOT COMPLETED|Overall Study||15
209497|NCT00756444|511466|P2|COMPLETED|Overall Study||13
209498|NCT00756444|511467|P1|COMPLETED|Overall Study||18
209499|NCT00756444|511466|P2|STARTED|Overall Study||34
209500|NCT00756444|511467|P1|STARTED|Overall Study||33
209501|NCT00756457|511478|P2|NOT COMPLETED|Overall Study||2
209502|NCT00756457|511479|P1|NOT COMPLETED|Overall Study||1
209503|NCT00756457|511478|P2|COMPLETED|Overall Study|One participant moved overseas; the other participant resumed cancer treatment|17
209504|NCT00756457|511479|P1|COMPLETED|Overall Study|One participant in the Active treatment group decided to have surgery after the 2 week follow-up.|19
209505|NCT00756457|511478|P2|STARTED|Overall Study||19
209506|NCT00756457|511479|P1|STARTED|Overall Study||20
209507|NCT00756470|511507|P1|NOT COMPLETED|Overall Study||5
209508|NCT00756470|511507|P1|COMPLETED|Overall Study||10
209509|NCT00756470|511507|P1|STARTED|Overall Study||15
209510|NCT00756548|511514|P2|NOT COMPLETED|Overall Study||0
209511|NCT00756548|511515|P1|NOT COMPLETED|Overall Study||2
209512|NCT00756548|511514|P2|COMPLETED|Overall Study||185
209513|NCT00756548|511515|P1|COMPLETED|Overall Study||184
209514|NCT00756548|511514|P2|STARTED|Overall Study||185
209515|NCT00756548|511515|P1|STARTED|Overall Study||186
209516|NCT00756561|511541|P1|NOT COMPLETED|Overall Study||0
209517|NCT00756561|511541|P1|COMPLETED|Overall Study||10
209518|NCT00756561|511541|P1|STARTED|Overall Study||10
209519|NCT00756574|511548|P2|NOT COMPLETED|Overall Study||11
209520|NCT00756574|511549|P1|NOT COMPLETED|Overall Study||13
209521|NCT00756574|511548|P2|COMPLETED|Overall Study||210
209522|NCT00756574|511549|P1|COMPLETED|Overall Study||212
209523|NCT00756574|511548|P2|STARTED|Overall Study||221
209524|NCT00756574|511549|P1|STARTED|Overall Study||225
209525|NCT00756678|511559|P1|NOT COMPLETED|Overall Study||1
209526|NCT00756678|511559|P1|COMPLETED|Overall Study||50
209527|NCT00756678|511559|P1|STARTED|Overall Study||51
209528|NCT00756730|511572|P2|NOT COMPLETED|Overall Study||2
209529|NCT00756730|511573|P1|NOT COMPLETED|Overall Study||0
209530|NCT00756730|511572|P2|COMPLETED|Overall Study||22
209531|NCT00756730|511573|P1|COMPLETED|Overall Study||25
209532|NCT00756730|511572|P2|STARTED|Overall Study||24
209533|NCT00756730|511573|P1|STARTED|Overall Study||25
209534|NCT00756886|511595|P2|NOT COMPLETED|Overall Study||7
209535|NCT00756886|511596|P1|NOT COMPLETED|Overall Study||11
209536|NCT00756886|511595|P2|COMPLETED|Overall Study||25
209537|NCT00756886|511596|P1|COMPLETED|Overall Study||30
209538|NCT00756886|511595|P2|STARTED|Overall Study||32
209539|NCT00756886|511596|P1|STARTED|Overall Study||41
209540|NCT00756938|511605|P4|NOT COMPLETED|Optional Extension||37
209541|NCT00756938|511606|P3|NOT COMPLETED|Optional Extension||0
209542|NCT00756938|511607|P2|NOT COMPLETED|Optional Extension||0
209543|NCT00756938|511608|P1|NOT COMPLETED|Optional Extension||0
209544|NCT00756938|511605|P4|COMPLETED|Optional Extension||53
209545|NCT00756938|511606|P3|COMPLETED|Optional Extension||0
209546|NCT00756938|511607|P2|COMPLETED|Optional Extension||0
209547|NCT00756938|511608|P1|COMPLETED|Optional Extension||0
209548|NCT00756938|511605|P4|STARTED|Optional Extension|7 participants who completed base study opted not to enter extension|90
209549|NCT00756938|511606|P3|STARTED|Optional Extension||0
209550|NCT00756938|511607|P2|STARTED|Optional Extension||0
209551|NCT00756938|511608|P1|STARTED|Optional Extension||0
209552|NCT00756938|511605|P4|NOT COMPLETED|12-week Base Study||0
209553|NCT00756938|511606|P3|NOT COMPLETED|12-week Base Study||2
209554|NCT00756938|511607|P2|NOT COMPLETED|12-week Base Study||0
209555|NCT00756938|511608|P1|NOT COMPLETED|12-week Base Study||2
209556|NCT00756938|511605|P4|COMPLETED|12-week Base Study||0
209557|NCT00756938|511606|P3|COMPLETED|12-week Base Study||32
209558|NCT00756938|511607|P2|COMPLETED|12-week Base Study||34
209559|NCT00756938|511608|P1|COMPLETED|12-week Base Study||31
209560|NCT00756938|511605|P4|STARTED|12-week Base Study||0
209561|NCT00756938|511606|P3|STARTED|12-week Base Study||34
209562|NCT00756938|511607|P2|STARTED|12-week Base Study||34
209563|NCT00756938|511608|P1|STARTED|12-week Base Study||33
209564|NCT00756964|511636|P2|NOT COMPLETED|Overall Study||0
209565|NCT00756964|511637|P1|NOT COMPLETED|Overall Study||0
209566|NCT00756964|511636|P2|COMPLETED|Overall Study||13
209567|NCT00756964|511637|P1|COMPLETED|Overall Study||13
209568|NCT00756964|511636|P2|STARTED|Overall Study||13
209569|NCT00756964|511637|P1|STARTED|Overall Study||13
209570|NCT00756977|511645|P2|NOT COMPLETED|Overall Study||11
209571|NCT00756977|511646|P1|NOT COMPLETED|Overall Study||21
209572|NCT00756977|511645|P2|COMPLETED|Overall Study||187
209573|NCT00756977|511646|P1|COMPLETED|Overall Study||175
209574|NCT00756977|511645|P2|STARTED|Overall Study||198
209575|NCT00756977|511646|P1|STARTED|Overall Study||196
209576|NCT00757003|511672|P1|NOT COMPLETED|Overall Study||49
209577|NCT00757003|511672|P1|COMPLETED|Overall Study||51
209578|NCT00757003|511672|P1|STARTED|Overall Study||100
209579|NCT00757172|511678|P1|NOT COMPLETED|Overall Study||11
209580|NCT00757172|511678|P1|COMPLETED|Overall Study|Participants underwent surgery.|54
209581|NCT00757172|511678|P1|STARTED|Overall Study||65
209582|NCT00757237|511688|P2|NOT COMPLETED|Overall Study||25
209583|NCT00757237|511689|P1|NOT COMPLETED|Overall Study||13
209584|NCT00757237|511688|P2|COMPLETED|Overall Study||111
209585|NCT00757237|511689|P1|COMPLETED|Overall Study||124
209586|NCT00757237|511688|P2|Treated|Overall Study||132
209587|NCT00757237|511689|P1|Treated|Overall Study||136
209588|NCT00757237|511688|P2|STARTED|Overall Study||136
209589|NCT00757237|511689|P1|STARTED|Overall Study||137
209590|NCT00764309|511717|P1|NOT COMPLETED|Overall Study||0
209591|NCT00764309|511717|P1|COMPLETED|Overall Study|Completed=off study. Major Reasons for off study: AE-13; withdrawn by sponsor-10; Lack of efficacy-3|31
209592|NCT00764309|511717|P1|STARTED|Overall Study|Number of participants treated.|31
209593|NCT00764322|511726|P1|NOT COMPLETED|Overall Study||20
209594|NCT00764322|511726|P1|COMPLETED|Overall Study||480
209595|NCT00764322|511726|P1|STARTED|Overall Study||500
209596|NCT00764361|511745|P2|NOT COMPLETED|Overall Study||4
209597|NCT00764361|511746|P1|NOT COMPLETED|Overall Study||2
209598|NCT00764361|511745|P2|COMPLETED|Overall Study||3
209599|NCT00764361|511746|P1|COMPLETED|Overall Study||6
209600|NCT00764361|511745|P2|STARTED|Overall Study||7
209601|NCT00764361|511746|P1|STARTED|Overall Study||8
209602|NCT00764465|511758|P6|NOT COMPLETED|Overall Study||1
209603|NCT00764465|511759|P5|NOT COMPLETED|Overall Study||1
209604|NCT00764465|511760|P4|NOT COMPLETED|Overall Study||1
209605|NCT00764465|511761|P3|NOT COMPLETED|Overall Study||1
209606|NCT00764465|511762|P2|NOT COMPLETED|Overall Study||1
209607|NCT00764465|511763|P1|NOT COMPLETED|Overall Study||2
209608|NCT00764465|511758|P6|COMPLETED|Overall Study||7
209609|NCT00764465|511759|P5|COMPLETED|Overall Study||6
209610|NCT00764465|511760|P4|COMPLETED|Overall Study||6
209611|NCT00764465|511761|P3|COMPLETED|Overall Study||6
209612|NCT00764465|511762|P2|COMPLETED|Overall Study||6
209613|NCT00764465|511763|P1|COMPLETED|Overall Study||7
209614|NCT00764465|511758|P6|STARTED|Overall Study||8
209615|NCT00764465|511759|P5|STARTED|Overall Study||7
209616|NCT00764465|511760|P4|STARTED|Overall Study||7
209617|NCT00764465|511761|P3|STARTED|Overall Study||7
209618|NCT00764465|511762|P2|STARTED|Overall Study||7
209619|NCT00764465|511763|P1|STARTED|Overall Study||9
209620|NCT00764478|511792|P3|NOT COMPLETED|Overall Study||8
209621|NCT00764478|511793|P2|NOT COMPLETED|Overall Study||22
209622|NCT00764478|511794|P1|NOT COMPLETED|Overall Study||15
209623|NCT00764478|511792|P3|COMPLETED|Overall Study||118
209624|NCT00764478|511793|P2|COMPLETED|Overall Study||97
209625|NCT00764478|511794|P1|COMPLETED|Overall Study||107
209626|NCT00764478|511792|P3|STARTED|Overall Study||126
209627|NCT00764478|511793|P2|STARTED|Overall Study||119
209628|NCT00764478|511794|P1|STARTED|Overall Study||122
209629|NCT00764504|511871|P3|NOT COMPLETED|Overall Study||103
209630|NCT00764504|511872|P2|NOT COMPLETED|Overall Study||70
209631|NCT00764504|511873|P1|NOT COMPLETED|Overall Study||66
209632|NCT00764504|511871|P3|COMPLETED|Overall Study||131
209633|NCT00764504|511872|P2|COMPLETED|Overall Study||71
209634|NCT00764504|511873|P1|COMPLETED|Overall Study||75
209635|NCT00764504|511871|P3|STARTED|Overall Study||234
209636|NCT00764504|511872|P2|STARTED|Overall Study||141
209637|NCT00764504|511873|P1|STARTED|Overall Study||141
209638|NCT00767000|511904|P5|NOT COMPLETED|Optional 104-week Extension||4
209639|NCT00767000|511905|P4|NOT COMPLETED|Optional 104-week Extension||2
209640|NCT00767000|511906|P3|NOT COMPLETED|Optional 104-week Extension||7
209641|NCT00767000|511907|P2|NOT COMPLETED|Optional 104-week Extension||3
209642|NCT00767000|511908|P1|NOT COMPLETED|Optional 104-week Extension||7
209643|NCT00767000|511904|P5|COMPLETED|Optional 104-week Extension||0
209644|NCT00767000|511905|P4|COMPLETED|Optional 104-week Extension||0
209645|NCT00767000|511906|P3|COMPLETED|Optional 104-week Extension||0
209646|NCT00767000|511907|P2|COMPLETED|Optional 104-week Extension||0
209647|NCT00767000|511908|P1|COMPLETED|Optional 104-week Extension||0
209648|NCT00767000|511904|P5|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|4
209649|NCT00767000|511905|P4|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|2
209650|NCT00767000|511906|P3|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
209651|NCT00767000|511907|P2|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|3
209652|NCT00767000|511908|P1|STARTED|Optional 104-week Extension|The extension study was optional. Not all participants completing the 54-week study continued.|7
209653|NCT00767000|511904|P5|NOT COMPLETED|54-week Study||224
209654|NCT00767000|511905|P4|NOT COMPLETED|54-week Study||225
209655|NCT00767000|511906|P3|NOT COMPLETED|54-week Study||109
209656|NCT00767000|511907|P2|NOT COMPLETED|54-week Study||113
209657|NCT00767000|511908|P1|NOT COMPLETED|54-week Study||108
209658|NCT00767000|511904|P5|COMPLETED|54-week Study||7
209659|NCT00767000|511905|P4|COMPLETED|54-week Study||4
209660|NCT00767000|511906|P3|COMPLETED|54-week Study||8
209661|NCT00767000|511907|P2|COMPLETED|54-week Study||4
209662|NCT00767000|511908|P1|COMPLETED|54-week Study||11
209663|NCT00767000|511904|P5|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|231
209755|NCT00767806|512133|P2|NOT COMPLETED|Overall Study||47
209756|NCT00767806|512134|P1|NOT COMPLETED|Overall Study||51
209664|NCT00767000|511905|P4|STARTED|54-week Study|Includes additional participants enrolled to enhance evaluation of the safety profile of MK-0941|229
209665|NCT00767000|511906|P3|STARTED|54-week Study||117
209666|NCT00767000|511907|P2|STARTED|54-week Study||117
209667|NCT00767000|511908|P1|STARTED|54-week Study||119
209668|NCT00767039|511952|P2|NOT COMPLETED|Overall Study||2
209669|NCT00767039|511953|P1|NOT COMPLETED|Overall Study||5
209670|NCT00767039|511952|P2|COMPLETED|Overall Study||23
209671|NCT00767039|511953|P1|COMPLETED|Overall Study||22
209672|NCT00767039|511952|P2|STARTED|Overall Study||25
209673|NCT00767039|511953|P1|STARTED|Overall Study|Two early deaths and 3 late deaths occurred in this group|27
209674|NCT00767104|511981|P2|NOT COMPLETED|Overall Study||2
209675|NCT00767104|511982|P1|NOT COMPLETED|Overall Study||1
209676|NCT00767104|511981|P2|COMPLETED|Overall Study||18
209677|NCT00767104|511982|P1|COMPLETED|Overall Study||19
209678|NCT00767104|511981|P2|STARTED|Overall Study||20
209679|NCT00767104|511982|P1|STARTED|Overall Study||20
209680|NCT00767325|511990|P1|NOT COMPLETED|Overall Study||15
209681|NCT00767325|511990|P1|COMPLETED|Overall Study||89
209682|NCT00767325|511990|P1|STARTED|Overall Study||104
209683|NCT00767338|512003|P4|NOT COMPLETED|Overall Study||0
209684|NCT00767338|512004|P3|NOT COMPLETED|Overall Study||0
209685|NCT00767338|512005|P2|NOT COMPLETED|Overall Study||2
209686|NCT00767338|512006|P1|NOT COMPLETED|Overall Study||1
209687|NCT00767338|512003|P4|COMPLETED|Overall Study||0
209688|NCT00767338|512004|P3|COMPLETED|Overall Study||0
209689|NCT00767338|512005|P2|COMPLETED|Overall Study||0
209690|NCT00767338|512006|P1|COMPLETED|Overall Study||0
209691|NCT00767338|512003|P4|STARTED|Overall Study||0
209692|NCT00767338|512004|P3|STARTED|Overall Study||0
209693|NCT00767338|512005|P2|STARTED|Overall Study||2
209694|NCT00767338|512006|P1|STARTED|Overall Study||1
209695|NCT00767364|512018|P2|NOT COMPLETED|Overall Study||0
209696|NCT00767364|512019|P1|NOT COMPLETED|Overall Study||0
209697|NCT00767364|512018|P2|COMPLETED|Overall Study||3
209698|NCT00767364|512019|P1|COMPLETED|Overall Study||5
209699|NCT00767364|512018|P2|STARTED|Overall Study||3
209700|NCT00767364|512019|P1|STARTED|Overall Study||5
209701|NCT00767455|512027|P1|NOT COMPLETED|Overall Study||19
209702|NCT00767455|512027|P1|COMPLETED|Overall Study||40
209703|NCT00767455|512027|P1|STARTED|Overall Study||59
209704|NCT00767507|512037|P4|NOT COMPLETED|Overall Study||3
209705|NCT00767507|512038|P3|NOT COMPLETED|Overall Study||0
209706|NCT00767507|512039|P2|NOT COMPLETED|Overall Study||0
209707|NCT00767507|512040|P1|NOT COMPLETED|Overall Study||0
209708|NCT00767507|512037|P4|COMPLETED|Overall Study||101
209709|NCT00767507|512038|P3|COMPLETED|Overall Study||106
209710|NCT00767507|512039|P2|COMPLETED|Overall Study||6
209711|NCT00767507|512040|P1|COMPLETED|Overall Study||5
209712|NCT00767507|512037|P4|STARTED|Overall Study||104
209713|NCT00767507|512038|P3|STARTED|Overall Study||106
209714|NCT00767507|512039|P2|STARTED|Overall Study||6
209715|NCT00767507|512040|P1|STARTED|Overall Study||5
209716|NCT00767520|512066|P2|NOT COMPLETED|Overall Study||17
209717|NCT00767520|512067|P1|NOT COMPLETED|Overall Study||11
209718|NCT00767520|512066|P2|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-56, study drug toxicity-2,AE-1,Death-1|61
209719|NCT00767520|512067|P1|COMPLETED|Overall Study|Completed=Off-treatment; Major reasons: disease progression-50, study drug toxicity-10,AE-3,Death-2|68
209720|NCT00767520|512066|P2|STARTED|Overall Study||78
209721|NCT00767520|512067|P1|STARTED|Overall Study||79
209722|NCT00767572|512089|P1|NOT COMPLETED|Second Intervention (12 Weeks)||0
209723|NCT00767572|512089|P1|COMPLETED|Second Intervention (12 Weeks)||12
209724|NCT00767572|512089|P1|STARTED|Second Intervention (12 Weeks)||12
209725|NCT00767572|512089|P1|NOT COMPLETED|Washout (4 Weeks)||0
209726|NCT00767572|512089|P1|COMPLETED|Washout (4 Weeks)||12
209727|NCT00767572|512089|P1|STARTED|Washout (4 Weeks)||12
209728|NCT00767572|512089|P1|NOT COMPLETED|First Intervention (12 Weeks)||0
209729|NCT00767572|512089|P1|COMPLETED|First Intervention (12 Weeks)||12
209730|NCT00767572|512089|P1|STARTED|First Intervention (12 Weeks)||12
209731|NCT00767624|512097|P2|NOT COMPLETED|Overall Study||17
209732|NCT00767624|512098|P1|NOT COMPLETED|Overall Study||24
209733|NCT00767624|512097|P2|COMPLETED|Overall Study||58
209734|NCT00767624|512098|P1|COMPLETED|Overall Study||51
209735|NCT00767624|512097|P2|STARTED|Overall Study||75
209736|NCT00767624|512098|P1|STARTED|Overall Study||75
209737|NCT00767676|512106|P1|NOT COMPLETED|Overall Study||54
209738|NCT00767676|512106|P1|COMPLETED|Overall Study||205
209739|NCT00767676|512106|P1|STARTED|Overall Study||259
209740|NCT00767767|512115|P5|NOT COMPLETED|Overall Study||0
209741|NCT00767767|512116|P4|NOT COMPLETED|Overall Study||0
209742|NCT00767767|512117|P3|NOT COMPLETED|Overall Study||0
209743|NCT00767767|512118|P2|NOT COMPLETED|Overall Study||0
209744|NCT00767767|512119|P1|NOT COMPLETED|Overall Study||0
209745|NCT00767767|512115|P5|COMPLETED|Overall Study||3
209746|NCT00767767|512116|P4|COMPLETED|Overall Study||3
209747|NCT00767767|512117|P3|COMPLETED|Overall Study||20
209748|NCT00767767|512118|P2|COMPLETED|Overall Study||20
209749|NCT00767767|512119|P1|COMPLETED|Overall Study||21
209750|NCT00767767|512115|P5|STARTED|Overall Study||3
209751|NCT00767767|512116|P4|STARTED|Overall Study||3
209752|NCT00767767|512117|P3|STARTED|Overall Study||20
209753|NCT00767767|512118|P2|STARTED|Overall Study||20
209754|NCT00767767|512119|P1|STARTED|Overall Study||21
209757|NCT00767806|512133|P2|COMPLETED|Overall Study||156
209758|NCT00767806|512134|P1|COMPLETED|Overall Study||147
209759|NCT00767806|512133|P2|STARTED|Overall Study||203
209760|NCT00767806|512134|P1|STARTED|Overall Study||198
209761|NCT00768040|512192|P2|NOT COMPLETED|Overall Study||3
209762|NCT00768040|512193|P1|NOT COMPLETED|Overall Study||4
209763|NCT00768040|512192|P2|COMPLETED|Overall Study||16
209764|NCT00768040|512193|P1|COMPLETED|Overall Study||16
209765|NCT00768040|512192|P2|STARTED|Overall Study||19
209766|NCT00768040|512193|P1|STARTED|Overall Study|"Started indicates randomized, safety and full analysis set."|20
209767|NCT00768053|512199|P1|NOT COMPLETED|Overall Study||11
209768|NCT00768053|512199|P1|COMPLETED|Overall Study||97
209769|NCT00768053|512199|P1|STARTED|Overall Study||108
209770|NCT00768066|512231|P3|NOT COMPLETED|Overall Study||0
209771|NCT00768066|512232|P2|NOT COMPLETED|Overall Study||3
209772|NCT00768066|512233|P1|NOT COMPLETED|Overall Study||3
209773|NCT00768066|512231|P3|COMPLETED|Overall Study||21
209774|NCT00768066|512232|P2|COMPLETED|Overall Study||19
209775|NCT00768066|512233|P1|COMPLETED|Overall Study||19
209776|NCT00768066|512231|P3|STARTED|Overall Study||21
209777|NCT00768066|512232|P2|STARTED|Overall Study||22
209778|NCT00768066|512233|P1|STARTED|Overall Study||22
209779|NCT00768118|512265|P1|NOT COMPLETED|Overall Study||0
209780|NCT00768118|512265|P1|COMPLETED|Overall Study||11
209781|NCT00768118|512265|P1|STARTED|Overall Study||11
209782|NCT00768144|512269|P1|NOT COMPLETED|Overall Study||36
209783|NCT00768144|512269|P1|COMPLETED|Overall Study||0
209784|NCT00768144|512269|P1|STARTED|Overall Study||36
209785|NCT00768222|512277|P2|NOT COMPLETED|Overall Study||4
209786|NCT00768222|512278|P1|NOT COMPLETED|Overall Study||4
209787|NCT00768222|512277|P2|COMPLETED|Overall Study||47
209788|NCT00768222|512278|P1|COMPLETED|Overall Study||46
209789|NCT00768222|512277|P2|STARTED|Overall Study||51
209790|NCT00768222|512278|P1|STARTED|Overall Study||50
209791|NCT00768300|512302|P2|NOT COMPLETED|Overall Study||163
209792|NCT00768300|512303|P1|NOT COMPLETED|Overall Study||329
209793|NCT00768300|512302|P2|COMPLETED|Overall Study||1
209794|NCT00768300|512303|P1|COMPLETED|Overall Study||1
209795|NCT00768300|512302|P2|Randomized and Treated|Overall Study||163
209796|NCT00768300|512303|P1|Randomized and Treated|Overall Study||329
209797|NCT00768300|512302|P2|STARTED|Overall Study||164
209798|NCT00768300|512303|P1|STARTED|Overall Study||330
209799|NCT00768430|512327|P2|NOT COMPLETED|7 Day Endpoint||3
209800|NCT00768430|512328|P1|NOT COMPLETED|7 Day Endpoint||2
209801|NCT00768430|512327|P2|COMPLETED|7 Day Endpoint||22
209802|NCT00768430|512328|P1|COMPLETED|7 Day Endpoint||45
209803|NCT00768430|512327|P2|STARTED|7 Day Endpoint||25
209804|NCT00768430|512328|P1|STARTED|7 Day Endpoint||47
209805|NCT00768430|512327|P2|NOT COMPLETED|24 Hour Endpoint||0
209806|NCT00768430|512328|P1|NOT COMPLETED|24 Hour Endpoint||1
209807|NCT00768430|512327|P2|COMPLETED|24 Hour Endpoint||25
209808|NCT00768430|512328|P1|COMPLETED|24 Hour Endpoint||47
209809|NCT00768430|512327|P2|STARTED|24 Hour Endpoint||25
209810|NCT00768430|512328|P1|STARTED|24 Hour Endpoint||48
209811|NCT00768521|512334|P2|NOT COMPLETED|Period 2||0
209812|NCT00768521|512335|P1|NOT COMPLETED|Period 2||0
209813|NCT00768521|512334|P2|COMPLETED|Period 2||11
209814|NCT00768521|512335|P1|COMPLETED|Period 2||9
209815|NCT00768521|512334|P2|STARTED|Period 2||11
209816|NCT00768521|512335|P1|STARTED|Period 2||9
209817|NCT00768521|512334|P2|NOT COMPLETED|Period 1||0
209818|NCT00768521|512335|P1|NOT COMPLETED|Period 1||0
209819|NCT00768521|512334|P2|COMPLETED|Period 1||11
209820|NCT00768521|512335|P1|COMPLETED|Period 1||9
209821|NCT00768521|512334|P2|STARTED|Period 1||11
209822|NCT00768521|512335|P1|STARTED|Period 1||9
209823|NCT00768560|512349|P6|NOT COMPLETED|Intervention Set 3||0
209824|NCT00768560|512350|P5|NOT COMPLETED|Intervention Set 3||0
209825|NCT00768560|512351|P4|NOT COMPLETED|Intervention Set 3||0
209826|NCT00768560|512352|P3|NOT COMPLETED|Intervention Set 3||0
209827|NCT00768560|512353|P2|NOT COMPLETED|Intervention Set 3||0
209828|NCT00768560|512354|P1|NOT COMPLETED|Intervention Set 3||0
209829|NCT00768560|512349|P6|COMPLETED|Intervention Set 3||6
209830|NCT00768560|512350|P5|COMPLETED|Intervention Set 3||6
209831|NCT00768560|512351|P4|COMPLETED|Intervention Set 3||6
209832|NCT00768560|512352|P3|COMPLETED|Intervention Set 3||6
209833|NCT00768560|512353|P2|COMPLETED|Intervention Set 3||5
209834|NCT00768560|512354|P1|COMPLETED|Intervention Set 3||5
209835|NCT00768560|512349|P6|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
209836|NCT00768560|512350|P5|STARTED|Intervention Set 3|40 mg BID for 2 weeks|6
209837|NCT00768560|512351|P4|STARTED|Intervention Set 3|80 mg OD for 2 weeks|6
209838|NCT00768560|512352|P3|STARTED|Intervention Set 3|40 mg OD for 2 weeks|6
209839|NCT00768560|512353|P2|STARTED|Intervention Set 3|40 mg BID for 2 weeks|5
209840|NCT00768560|512354|P1|STARTED|Intervention Set 3|80 mg OD for 2 weeks|5
209841|NCT00768560|512349|P6|NOT COMPLETED|Intervention Set 2||0
209842|NCT00768560|512350|P5|NOT COMPLETED|Intervention Set 2||0
209843|NCT00768560|512351|P4|NOT COMPLETED|Intervention Set 2||0
209844|NCT00768560|512352|P3|NOT COMPLETED|Intervention Set 2||0
209845|NCT00768560|512353|P2|NOT COMPLETED|Intervention Set 2||0
209846|NCT00768560|512354|P1|NOT COMPLETED|Intervention Set 2||0
209847|NCT00768560|512349|P6|COMPLETED|Intervention Set 2||6
209848|NCT00768560|512350|P5|COMPLETED|Intervention Set 2||6
209849|NCT00768560|512351|P4|COMPLETED|Intervention Set 2||6
209850|NCT00768560|512352|P3|COMPLETED|Intervention Set 2||6
209851|NCT00768560|512353|P2|COMPLETED|Intervention Set 2||5
209852|NCT00768560|512354|P1|COMPLETED|Intervention Set 2||5
209853|NCT00768560|512349|P6|STARTED|Intervention Set 2|40 mg BID for 2 weeks|6
209854|NCT00768560|512350|P5|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
209855|NCT00768560|512351|P4|STARTED|Intervention Set 2|40 mg OD for 2 weeks|6
209856|NCT00768560|512352|P3|STARTED|Intervention Set 2|80 mg OD for 2 weeks|6
209857|NCT00768560|512353|P2|STARTED|Intervention Set 2|80 mg OD for 2 weeks|5
209858|NCT00768560|512354|P1|STARTED|Intervention Set 2|40 mg BID for 2 weeks|5
209859|NCT00768560|512349|P6|NOT COMPLETED|Intervention Set 1||0
209860|NCT00768560|512350|P5|NOT COMPLETED|Intervention Set 1||0
209861|NCT00768560|512351|P4|NOT COMPLETED|Intervention Set 1||0
209862|NCT00768560|512352|P3|NOT COMPLETED|Intervention Set 1||0
209863|NCT00768560|512353|P2|NOT COMPLETED|Intervention Set 1||1
209864|NCT00768560|512354|P1|NOT COMPLETED|Intervention Set 1||0
209865|NCT00768560|512349|P6|COMPLETED|Intervention Set 1||6
209866|NCT00768560|512350|P5|COMPLETED|Intervention Set 1||6
209867|NCT00768560|512351|P4|COMPLETED|Intervention Set 1||6
209868|NCT00768560|512352|P3|COMPLETED|Intervention Set 1||6
209869|NCT00768560|512353|P2|COMPLETED|Intervention Set 1||5
209870|NCT00768560|512354|P1|COMPLETED|Intervention Set 1||5
209871|NCT00768560|512349|P6|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
209872|NCT00768560|512350|P5|Subjects Received Treatment|Intervention Set 1|80 mg OD for 2 weeks|6
209873|NCT00768560|512351|P4|Subjects Received Treatment|Intervention Set 1|40 mg BID for 2 weeks|6
209874|NCT00768560|512352|P3|Subjects Received Treatment|Intervention Set 1|40 mg twice daily (BID) for 2 weeks|6
209875|NCT00768560|512353|P2|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|6
209876|NCT00768560|512354|P1|Subjects Received Treatment|Intervention Set 1|40 mg OD for 2 weeks|5
209877|NCT00768560|512349|P6|STARTED|Intervention Set 1|3-period/treatment crossover|6
209878|NCT00768560|512350|P5|STARTED|Intervention Set 1|3-period/treatment crossover|6
209879|NCT00768560|512351|P4|STARTED|Intervention Set 1|3-period/treatment crossover|6
209880|NCT00768560|512352|P3|STARTED|Intervention Set 1|3-period/treatment crossover|6
209881|NCT00768560|512353|P2|STARTED|Intervention Set 1|3-period/treatment crossover|6
209882|NCT00768560|512354|P1|STARTED|Intervention Set 1|3-period/treatment crossover|5
209883|NCT00768599|512383|P3|NOT COMPLETED|Overall Study||12
209884|NCT00768599|512384|P2|NOT COMPLETED|Overall Study||16
209885|NCT00768599|512385|P1|NOT COMPLETED|Overall Study||11
209886|NCT00768599|512383|P3|COMPLETED|Overall Study||35
209887|NCT00768599|512384|P2|COMPLETED|Overall Study||27
209888|NCT00768599|512385|P1|COMPLETED|Overall Study||34
209889|NCT00768599|512383|P3|STARTED|Overall Study||47
209890|NCT00768599|512384|P2|STARTED|Overall Study||43
209891|NCT00768599|512385|P1|STARTED|Overall Study||45
209892|NCT00768651|512408|P1|NOT COMPLETED|Overall Study||1
209893|NCT00768651|512408|P1|COMPLETED|Overall Study||7
209894|NCT00768651|512408|P1|STARTED|Overall Study||8
209895|NCT00768755|512417|P4|NOT COMPLETED|Phase 2||57
209896|NCT00768755|512418|P3|NOT COMPLETED|Phase 2||58
209897|NCT00768755|512419|P2|NOT COMPLETED|Phase 2||55
209898|NCT00768755|512420|P1|NOT COMPLETED|Phase 2||0
209899|NCT00768755|512417|P4|COMPLETED|Phase 2||0
209900|NCT00768755|512418|P3|COMPLETED|Phase 2||0
209901|NCT00768755|512419|P2|COMPLETED|Phase 2||0
209902|NCT00768755|512420|P1|COMPLETED|Phase 2||0
209903|NCT00768755|512417|P4|Treated|Phase 2||55
209904|NCT00768755|512418|P3|Treated|Phase 2||58
209905|NCT00768755|512419|P2|Treated|Phase 2||55
209906|NCT00768755|512420|P1|Treated|Phase 2||0
209907|NCT00768755|512417|P4|STARTED|Phase 2||57
209908|NCT00768755|512418|P3|STARTED|Phase 2||58
209909|NCT00768755|512419|P2|STARTED|Phase 2||55
209910|NCT00768755|512420|P1|STARTED|Phase 2||0
209911|NCT00768755|512417|P4|NOT COMPLETED|Phase 1||0
209912|NCT00768755|512418|P3|NOT COMPLETED|Phase 1||0
209913|NCT00768755|512419|P2|NOT COMPLETED|Phase 1||0
209914|NCT00768755|512420|P1|NOT COMPLETED|Phase 1||10
209915|NCT00768755|512417|P4|COMPLETED|Phase 1||0
209916|NCT00768755|512418|P3|COMPLETED|Phase 1||0
209917|NCT00768755|512419|P2|COMPLETED|Phase 1||0
209918|NCT00768755|512420|P1|COMPLETED|Phase 1||0
209919|NCT00768755|512417|P4|STARTED|Phase 1||0
209920|NCT00768755|512418|P3|STARTED|Phase 1||0
209921|NCT00768755|512419|P2|STARTED|Phase 1||0
209922|NCT00768755|512420|P1|STARTED|Phase 1||10
209923|NCT00768898|512444|P1|NOT COMPLETED|Overall Study||2
209924|NCT00768898|512444|P1|COMPLETED|Overall Study||28
209925|NCT00768898|512444|P1|STARTED|Overall Study||30
209926|NCT00768989|512466|P2|NOT COMPLETED|On or After Week 36||27
209927|NCT00768989|512467|P1|NOT COMPLETED|On or After Week 36||51
209928|NCT00768989|512466|P2|COMPLETED|On or After Week 36||0
209929|NCT00768989|512467|P1|COMPLETED|On or After Week 36||0
209930|NCT00768989|512466|P2|STARTED|On or After Week 36||27
209931|NCT00768989|512467|P1|STARTED|On or After Week 36||51
209932|NCT00768989|512466|P2|NOT COMPLETED|Week 24 to Prior to Week 36||0
209933|NCT00768989|512467|P1|NOT COMPLETED|Week 24 to Prior to Week 36||8
209934|NCT00768989|512466|P2|COMPLETED|Week 24 to Prior to Week 36||27
209935|NCT00768989|512467|P1|COMPLETED|Week 24 to Prior to Week 36||51
209936|NCT00768989|512466|P2|STARTED|Week 24 to Prior to Week 36||27
209937|NCT00768989|512467|P1|STARTED|Week 24 to Prior to Week 36||59
209938|NCT00768989|512466|P2|NOT COMPLETED|Prior to Week 24||3
209939|NCT00768989|512467|P1|NOT COMPLETED|Prior to Week 24||4
209940|NCT00768989|512466|P2|COMPLETED|Prior to Week 24||27
209941|NCT00768989|512467|P1|COMPLETED|Prior to Week 24||59
209942|NCT00768989|512466|P2|STARTED|Prior to Week 24||30
209943|NCT00768989|512467|P1|STARTED|Prior to Week 24||63
209944|NCT00769015|512517|P2|NOT COMPLETED|Overall Study||16
209945|NCT00769015|512518|P1|NOT COMPLETED|Overall Study||9
209946|NCT00769015|512517|P2|COMPLETED|Overall Study||76
209947|NCT00769015|512518|P1|COMPLETED|Overall Study||87
209948|NCT00769015|512517|P2|STARTED|Overall Study||92
209949|NCT00769015|512518|P1|STARTED|Overall Study||96
209950|NCT00769067|512538|P2|NOT COMPLETED|Overall Study||94
209951|NCT00769067|512539|P1|NOT COMPLETED|Overall Study||94
209952|NCT00769067|512538|P2|COMPLETED|Overall Study||0
209953|NCT00769067|512539|P1|COMPLETED|Overall Study||0
209954|NCT00769067|512538|P2|Treated|Overall Study|One participant was not treated: refused treatment for reason other than an adverse event (AE).|93
209955|NCT00769067|512539|P1|Treated|Overall Study||94
209956|NCT00769067|512538|P2|STARTED|Overall Study||94
209957|NCT00769067|512539|P1|STARTED|Overall Study||94
209958|NCT00769119|512566|P2|NOT COMPLETED|Overall Study||3
209959|NCT00769119|512567|P1|NOT COMPLETED|Overall Study||2
209960|NCT00769119|512566|P2|COMPLETED|Overall Study||13
209961|NCT00769119|512567|P1|COMPLETED|Overall Study||20
209962|NCT00769119|512566|P2|STARTED|Overall Study||16
209963|NCT00769119|512567|P1|STARTED|Overall Study||22
209964|NCT00769132|512611|P4|NOT COMPLETED|Period 4||0
209965|NCT00769132|512612|P3|NOT COMPLETED|Period 4||0
209966|NCT00769132|512613|P2|NOT COMPLETED|Period 4||1
209967|NCT00769132|512614|P1|NOT COMPLETED|Period 4||0
209968|NCT00769132|512611|P4|COMPLETED|Period 4||5
209969|NCT00769132|512612|P3|COMPLETED|Period 4||6
209970|NCT00769132|512613|P2|COMPLETED|Period 4||5
209971|NCT00769132|512614|P1|COMPLETED|Period 4||5
209972|NCT00769132|512611|P4|STARTED|Period 4||5
209973|NCT00769132|512612|P3|STARTED|Period 4||6
209974|NCT00769132|512613|P2|STARTED|Period 4||6
209975|NCT00769132|512614|P1|STARTED|Period 4||5
209976|NCT00769132|512611|P4|NOT COMPLETED|Period 3||0
209977|NCT00769132|512612|P3|NOT COMPLETED|Period 3||0
209978|NCT00769132|512613|P2|NOT COMPLETED|Period 3||0
209979|NCT00769132|512614|P1|NOT COMPLETED|Period 3||1
209980|NCT00769132|512611|P4|COMPLETED|Period 3||5
209981|NCT00769132|512612|P3|COMPLETED|Period 3||6
209982|NCT00769132|512613|P2|COMPLETED|Period 3||6
209983|NCT00769132|512614|P1|COMPLETED|Period 3||5
209984|NCT00769132|512611|P4|STARTED|Period 3||5
209985|NCT00769132|512612|P3|STARTED|Period 3||6
209986|NCT00769132|512613|P2|STARTED|Period 3||6
209987|NCT00769132|512614|P1|STARTED|Period 3||6
209988|NCT00769132|512611|P4|NOT COMPLETED|Period 2||1
209989|NCT00769132|512612|P3|NOT COMPLETED|Period 2||0
209990|NCT00769132|512613|P2|NOT COMPLETED|Period 2||0
209991|NCT00769132|512614|P1|NOT COMPLETED|Period 2||0
209992|NCT00769132|512611|P4|COMPLETED|Period 2||5
209993|NCT00769132|512612|P3|COMPLETED|Period 2||6
209994|NCT00769132|512613|P2|COMPLETED|Period 2||6
209995|NCT00769132|512614|P1|COMPLETED|Period 2||6
209996|NCT00769132|512611|P4|STARTED|Period 2||6
209997|NCT00769132|512612|P3|STARTED|Period 2||6
209998|NCT00769132|512613|P2|STARTED|Period 2||6
209999|NCT00769132|512614|P1|STARTED|Period 2||6
210000|NCT00769132|512611|P4|NOT COMPLETED|Period 1||1
210001|NCT00769132|512612|P3|NOT COMPLETED|Period 1||0
210002|NCT00769132|512613|P2|NOT COMPLETED|Period 1||0
210003|NCT00769132|512614|P1|NOT COMPLETED|Period 1||1
210004|NCT00769132|512611|P4|COMPLETED|Period 1||6
210005|NCT00769132|512612|P3|COMPLETED|Period 1||6
210006|NCT00769132|512613|P2|COMPLETED|Period 1||6
210007|NCT00769132|512614|P1|COMPLETED|Period 1||6
210008|NCT00769132|512611|P4|STARTED|Period 1||7
210009|NCT00769132|512612|P3|STARTED|Period 1||6
210010|NCT00769132|512613|P2|STARTED|Period 1||6
210011|NCT00769132|512614|P1|STARTED|Period 1||7
210012|NCT00769184|512628|P2|NOT COMPLETED|No Treatment (6 Weeks)||1
210013|NCT00769184|512629|P1|NOT COMPLETED|No Treatment (6 Weeks)||1
210014|NCT00769184|512628|P2|COMPLETED|No Treatment (6 Weeks)||6
210015|NCT00769184|512629|P1|COMPLETED|No Treatment (6 Weeks)||5
210016|NCT00769184|512628|P2|STARTED|No Treatment (6 Weeks)||7
210017|NCT00769184|512629|P1|STARTED|No Treatment (6 Weeks)||6
210018|NCT00769184|512628|P2|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
210019|NCT00769184|512629|P1|NOT COMPLETED|+LCD / +Placebo Only (4 Weeks)||0
210020|NCT00769184|512628|P2|COMPLETED|+LCD / +Placebo Only (4 Weeks)||7
210021|NCT00769184|512629|P1|COMPLETED|+LCD / +Placebo Only (4 Weeks)||6
210022|NCT00769184|512628|P2|STARTED|+LCD / +Placebo Only (4 Weeks)||7
210023|NCT00769184|512629|P1|STARTED|+LCD / +Placebo Only (4 Weeks)||6
210024|NCT00769184|512628|P2|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
210025|NCT00769184|512629|P1|NOT COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||1
210026|NCT00769184|512628|P2|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
210027|NCT00769184|512629|P1|COMPLETED|Corticosteroid + LCD/ +Placebo (2 Weeks)||6
210028|NCT00769184|512628|P2|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||8
210029|NCT00769184|512629|P1|STARTED|Corticosteroid + LCD/ +Placebo (2 Weeks)||7
210030|NCT00769314|512639|P2|NOT COMPLETED|Overall Study||13
210031|NCT00769314|512640|P1|NOT COMPLETED|Overall Study||17
210032|NCT00769314|512639|P2|COMPLETED|Overall Study||384
210033|NCT00769314|512640|P1|COMPLETED|Overall Study||361
210034|NCT00769314|512639|P2|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|397
210035|NCT00769314|512640|P1|STARTED|Overall Study|The number of participants started is defined as those that were randomized and received treatment.|378
210036|NCT00754624|512666|P1|NOT COMPLETED|Overall Study||69
210037|NCT00754624|512666|P1|COMPLETED|Overall Study||160
210038|NCT00754624|512666|P1|STARTED|Overall Study||229
210039|NCT00754650|512676|P1|NOT COMPLETED|Overall Study||2
210040|NCT00754650|512676|P1|COMPLETED|Overall Study||0
210041|NCT00754650|512676|P1|STARTED|Overall Study||2
210042|NCT00754741|512684|P3|NOT COMPLETED|Overall Study||54
210043|NCT00754741|512685|P2|NOT COMPLETED|Overall Study||69
210044|NCT00754741|512686|P1|NOT COMPLETED|Overall Study||57
210045|NCT00754741|512684|P3|COMPLETED|Overall Study||502
210046|NCT00754741|512685|P2|COMPLETED|Overall Study||500
210047|NCT00754741|512686|P1|COMPLETED|Overall Study||510
210048|NCT00754741|512684|P3|STARTED|Overall Study||556
210049|NCT00754741|512685|P2|STARTED|Overall Study||569
210050|NCT00754741|512686|P1|STARTED|Overall Study||567
210051|NCT00754767|512735|P2|NOT COMPLETED|Overall Study||0
210052|NCT00754767|512736|P1|NOT COMPLETED|Overall Study||0
210053|NCT00754767|512735|P2|COMPLETED|Overall Study||0
210054|NCT00754767|512736|P1|COMPLETED|Overall Study||2
210055|NCT00754767|512735|P2|STARTED|Overall Study||0
210056|NCT00754767|512736|P1|STARTED|Overall Study||2
210057|NCT00754793|512744|P2|NOT COMPLETED|Overall Study||1
210058|NCT00754793|512745|P1|NOT COMPLETED|Overall Study||0
210059|NCT00754793|512744|P2|COMPLETED|Overall Study||1
210060|NCT00754793|512745|P1|COMPLETED|Overall Study||1
210061|NCT00754793|512744|P2|STARTED|Overall Study||2
210062|NCT00754793|512745|P1|STARTED|Overall Study||1
210063|NCT00754832|512751|P2|NOT COMPLETED|Second 6 Weeks Intervention||2
210064|NCT00754832|512752|P1|NOT COMPLETED|Second 6 Weeks Intervention||0
210065|NCT00754832|512751|P2|COMPLETED|Second 6 Weeks Intervention||24
210066|NCT00754832|512752|P1|COMPLETED|Second 6 Weeks Intervention||17
210067|NCT00754832|512751|P2|STARTED|Second 6 Weeks Intervention||26
210068|NCT00754832|512752|P1|STARTED|Second 6 Weeks Intervention||17
210069|NCT00754832|512751|P2|NOT COMPLETED|2 Weeks Washout||2
210070|NCT00754832|512752|P1|NOT COMPLETED|2 Weeks Washout||1
210071|NCT00754832|512751|P2|COMPLETED|2 Weeks Washout||26
210072|NCT00754832|512752|P1|COMPLETED|2 Weeks Washout||17
210073|NCT00754832|512751|P2|STARTED|2 Weeks Washout||28
210074|NCT00754832|512752|P1|STARTED|2 Weeks Washout||18
210075|NCT00754832|512751|P2|NOT COMPLETED|First 6 Weeks Intervention||2
210076|NCT00754832|512752|P1|NOT COMPLETED|First 6 Weeks Intervention||8
210077|NCT00754832|512751|P2|COMPLETED|First 6 Weeks Intervention||28
210078|NCT00754832|512752|P1|COMPLETED|First 6 Weeks Intervention||18
210079|NCT00754832|512751|P2|STARTED|First 6 Weeks Intervention||30
210080|NCT00754832|512752|P1|STARTED|First 6 Weeks Intervention||26
210081|NCT00754923|512762|P1|NOT COMPLETED|Overall Study||0
210082|NCT00754923|512762|P1|COMPLETED|Overall Study||11
210083|NCT00754923|512762|P1|STARTED|Overall Study||11
210084|NCT00760383|512769|P2|NOT COMPLETED|Overall Study||7
210085|NCT00760383|512770|P1|NOT COMPLETED|Overall Study||5
210086|NCT00760383|512769|P2|COMPLETED|Overall Study||12
210087|NCT00760383|512770|P1|COMPLETED|Overall Study||16
210088|NCT00760383|512769|P2|STARTED|Overall Study||19
210089|NCT00760383|512770|P1|STARTED|Overall Study||21
210090|NCT00760435|512782|P2|NOT COMPLETED|Overall Study||5
210091|NCT00760435|512783|P1|NOT COMPLETED|Overall Study||4
210092|NCT00760435|512782|P2|COMPLETED|Overall Study||93
210093|NCT00760435|512783|P1|COMPLETED|Overall Study||94
210094|NCT00760435|512782|P2|STARTED|Overall Study||98
210095|NCT00760435|512783|P1|STARTED|Overall Study||98
210096|NCT00760461|512795|P1|NOT COMPLETED|Overall Study||44
210097|NCT00760461|512795|P1|COMPLETED|Overall Study||0
210098|NCT00760461|512795|P1|STARTED|Overall Study||44
210099|NCT00760474|512799|P2|NOT COMPLETED|Period 2 (P2)||1
210100|NCT00760474|512800|P1|NOT COMPLETED|Period 2 (P2)||1
210101|NCT00760474|512799|P2|COMPLETED|Period 2 (P2)||11
210102|NCT00760474|512800|P1|COMPLETED|Period 2 (P2)||11
210103|NCT00760474|512799|P2|STARTED|Period 2 (P2)||12
210104|NCT00760474|512800|P1|STARTED|Period 2 (P2)||12
210105|NCT00760474|512799|P2|NOT COMPLETED|Placebo Washout Period||1
210106|NCT00760474|512800|P1|NOT COMPLETED|Placebo Washout Period||0
210107|NCT00760474|512799|P2|COMPLETED|Placebo Washout Period||12
210108|NCT00760474|512800|P1|COMPLETED|Placebo Washout Period||12
210109|NCT00760474|512799|P2|STARTED|Placebo Washout Period||13
210110|NCT00760474|512800|P1|STARTED|Placebo Washout Period||12
210111|NCT00760474|512799|P2|NOT COMPLETED|Period 1 (P1)||1
210112|NCT00760474|512800|P1|NOT COMPLETED|Period 1 (P1)||1
210113|NCT00760474|512799|P2|COMPLETED|Period 1 (P1)||13
210114|NCT00760474|512800|P1|COMPLETED|Period 1 (P1)||12
210115|NCT00760474|512799|P2|Overall Number of Unique Participants|Period 1 (P1)||13
210116|NCT00760474|512800|P1|Overall Number of Unique Participants|Period 1 (P1)||12
210117|NCT00760474|512799|P2|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|14
210118|NCT00760474|512800|P1|Treated|Period 1 (P1)|1 participant discontinued in P1; re-entered with new identification number and completed P1, P2.|13
210119|NCT00760474|512799|P2|STARTED|Period 1 (P1)||14
210120|NCT00760474|512800|P1|STARTED|Period 1 (P1)||13
210121|NCT00760487|512836|P1|NOT COMPLETED|Overall Study||3
210122|NCT00760487|512836|P1|COMPLETED|Overall Study||117
210123|NCT00760487|512836|P1|STARTED|Overall Study||120
210124|NCT00760526|512844|P2|NOT COMPLETED|Overall Study||4
210125|NCT00760526|512845|P1|NOT COMPLETED|Overall Study||5
210126|NCT00760526|512844|P2|COMPLETED|Overall Study||68
210127|NCT00760526|512845|P1|COMPLETED|Overall Study||69
210128|NCT00760526|512844|P2|STARTED|Overall Study||72
210129|NCT00760526|512845|P1|STARTED|Overall Study||74
210130|NCT00760552|512872|P2|NOT COMPLETED|Overall Study||10
210131|NCT00760552|512873|P1|NOT COMPLETED|Overall Study||13
210132|NCT00760552|512872|P2|COMPLETED|Overall Study||52
210133|NCT00760552|512873|P1|COMPLETED|Overall Study||48
210134|NCT00760552|512872|P2|STARTED|Overall Study||62
210135|NCT00760552|512873|P1|STARTED|Overall Study||61
210136|NCT00760578|512883|P4|NOT COMPLETED|Overall Study||4
210137|NCT00760578|512884|P3|NOT COMPLETED|Overall Study||5
210138|NCT00760578|512885|P2|NOT COMPLETED|Overall Study||2
210139|NCT00760578|512886|P1|NOT COMPLETED|Overall Study||3
210140|NCT00760578|512883|P4|COMPLETED|Overall Study||18
210141|NCT00760578|512884|P3|COMPLETED|Overall Study||16
210142|NCT00760578|512885|P2|COMPLETED|Overall Study||19
210143|NCT00760578|512886|P1|COMPLETED|Overall Study||19
210144|NCT00760578|512883|P4|Entered Drug Treatment Period|Overall Study||22
210145|NCT00760578|512884|P3|Entered Drug Treatment Period|Overall Study||19
210146|NCT00760578|512885|P2|Entered Drug Treatment Period|Overall Study||20
210147|NCT00760578|512886|P1|Entered Drug Treatment Period|Overall Study||21
210148|NCT00760578|512883|P4|STARTED|Overall Study||22
210149|NCT00760578|512884|P3|STARTED|Overall Study||21
210150|NCT00760578|512885|P2|STARTED|Overall Study||21
210151|NCT00760578|512886|P1|STARTED|Overall Study||22
210152|NCT00760617|512923|P3|NOT COMPLETED|Overall Study||5
210153|NCT00760617|512924|P2|NOT COMPLETED|Overall Study||2
210154|NCT00760617|512925|P1|NOT COMPLETED|Overall Study||5
210155|NCT00760617|512923|P3|COMPLETED|Overall Study||111
210156|NCT00760617|512924|P2|COMPLETED|Overall Study||142
210157|NCT00760617|512925|P1|COMPLETED|Overall Study||261
210158|NCT00760617|512923|P3|STARTED|Overall Study||116
210159|NCT00760617|512924|P2|STARTED|Overall Study||144
210160|NCT00760617|512925|P1|STARTED|Overall Study||266
210161|NCT00760669|512996|P1|NOT COMPLETED|Overall Study||30
210162|NCT00760669|512996|P1|COMPLETED|Overall Study||1031
210163|NCT00760669|512996|P1|STARTED|Overall Study||1061
210164|NCT00760747|513012|P2|NOT COMPLETED|Study Period III||3
210165|NCT00760747|513013|P1|NOT COMPLETED|Study Period III||3
210166|NCT00760747|513012|P2|COMPLETED|Study Period III||38
210167|NCT00760747|513013|P1|COMPLETED|Study Period III||41
210168|NCT00760747|513012|P2|STARTED|Study Period III||41
210169|NCT00760747|513013|P1|STARTED|Study Period III||44
210170|NCT00760747|513012|P2|NOT COMPLETED|Study Period II||14
210171|NCT00760747|513013|P1|NOT COMPLETED|Study Period II||13
210172|NCT00760747|513012|P2|COMPLETED|Study Period II||41
210173|NCT00760747|513013|P1|COMPLETED|Study Period II||44
210174|NCT00760747|513012|P2|Received at Least One Dose of Study Drug|Study Period II||54
210175|NCT00760747|513013|P1|Received at Least One Dose of Study Drug|Study Period II||57
210176|NCT00760747|513012|P2|STARTED|Study Period II||55
210177|NCT00760747|513013|P1|STARTED|Study Period II||57
210178|NCT00760838|513043|P2|NOT COMPLETED|Overall Study||2
210179|NCT00760838|513044|P1|NOT COMPLETED|Overall Study||5
210180|NCT00760838|513043|P2|COMPLETED|Overall Study||53
210181|NCT00760838|513044|P1|COMPLETED|Overall Study||49
210182|NCT00760838|513043|P2|STARTED|Overall Study||55
210183|NCT00760838|513044|P1|STARTED|Overall Study||54
210184|NCT00760877|513062|P2|NOT COMPLETED|Overall Study||26
210185|NCT00760877|513063|P1|NOT COMPLETED|Overall Study||45
210186|NCT00760877|513062|P2|COMPLETED|Overall Study||77
210187|NCT00760877|513063|P1|COMPLETED|Overall Study||59
210188|NCT00760877|513062|P2|Safety Set|Overall Study||103
210189|NCT00760877|513063|P1|Safety Set|Overall Study||101
210190|NCT00760877|513062|P2|Cross-over to Nilotinib|Overall Study||46
210191|NCT00760877|513063|P1|Cross-over to Nilotinib|Overall Study|Not applicable: cross-over occurred from imatinib to nilotinib only.|0
210192|NCT00760877|513062|P2|STARTED|Overall Study||103
210193|NCT00760877|513063|P1|STARTED|Overall Study||104
210194|NCT00761007|513083|P4|NOT COMPLETED|Overall Study||7
210195|NCT00761007|513084|P3|NOT COMPLETED|Overall Study||18
210196|NCT00761007|513085|P2|NOT COMPLETED|Overall Study||11
210197|NCT00761007|513086|P1|NOT COMPLETED|Overall Study||13
210198|NCT00761007|513083|P4|COMPLETED|Overall Study||131
210199|NCT00761007|513084|P3|COMPLETED|Overall Study||121
210200|NCT00761007|513085|P2|COMPLETED|Overall Study||124
210201|NCT00761007|513086|P1|COMPLETED|Overall Study||129
210202|NCT00761007|513083|P4|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||136
210203|NCT00761007|513084|P3|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||135
210204|NCT00761007|513085|P2|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||133
210205|NCT00761007|513086|P1|ITT (>= 1 Assessment Post-Randomisation)|Overall Study||140
210206|NCT00761007|513083|P4|Safety (>=1 Dose of Study Medication)|Overall Study||137
210207|NCT00761007|513084|P3|Safety (>=1 Dose of Study Medication)|Overall Study||139
210208|NCT00761007|513085|P2|Safety (>=1 Dose of Study Medication)|Overall Study||135
210209|NCT00761007|513086|P1|Safety (>=1 Dose of Study Medication)|Overall Study||140
210210|NCT00761007|513083|P4|STARTED|Overall Study||138
210211|NCT00761007|513084|P3|STARTED|Overall Study||139
210212|NCT00761007|513085|P2|STARTED|Overall Study||135
210213|NCT00761007|513086|P1|STARTED|Overall Study||142
210214|NCT00761137|513108|P1|NOT COMPLETED|Overall Study||0
210215|NCT00761137|513108|P1|COMPLETED|Overall Study||19
210216|NCT00761137|513108|P1|3 mg Tropicamide|Overall Study||19
210217|NCT00761137|513108|P1|1 mg Tropicamide|Overall Study||19
210218|NCT00761137|513108|P1|0.3 mg Tropicamide|Overall Study||19
210219|NCT00761137|513108|P1|Placebo|Overall Study||19
210220|NCT00761137|513108|P1|STARTED|Overall Study||19
210221|NCT00761150|513122|P3|NOT COMPLETED|Double-blind Period||29
210222|NCT00761150|513123|P2|NOT COMPLETED|Double-blind Period||14
210223|NCT00761150|513124|P1|NOT COMPLETED|Double-blind Period||0
210224|NCT00761150|513122|P3|COMPLETED|Double-blind Period||89
210225|NCT00761150|513123|P2|COMPLETED|Double-blind Period||106
210226|NCT00761150|513124|P1|COMPLETED|Double-blind Period||0
210227|NCT00761150|513122|P3|STARTED|Double-blind Period||118
210228|NCT00761150|513123|P2|STARTED|Double-blind Period||120
210229|NCT00761150|513124|P1|STARTED|Double-blind Period||0
210230|NCT00761150|513122|P3|NOT COMPLETED|Open-label Period||0
210231|NCT00761150|513123|P2|NOT COMPLETED|Open-label Period||0
210232|NCT00761150|513124|P1|NOT COMPLETED|Open-label Period||70
210233|NCT00761150|513122|P3|COMPLETED|Open-label Period||0
210234|NCT00761150|513123|P2|COMPLETED|Open-label Period||0
210235|NCT00761150|513124|P1|COMPLETED|Open-label Period||238
210236|NCT00761150|513122|P3|STARTED|Open-label Period||0
210237|NCT00761150|513123|P2|STARTED|Open-label Period||0
210238|NCT00761150|513124|P1|STARTED|Open-label Period||308
210239|NCT00761176|513135|P2|NOT COMPLETED|Overall Study||1
210240|NCT00761176|513136|P1|NOT COMPLETED|Overall Study||2
210241|NCT00761176|513135|P2|COMPLETED|Overall Study||3
210242|NCT00761176|513136|P1|COMPLETED|Overall Study||2
210243|NCT00761176|513135|P2|STARTED|Overall Study||4
210244|NCT00761176|513136|P1|STARTED|Overall Study||4
210245|NCT00761189|513142|P1|NOT COMPLETED|Overall Study||185
210246|NCT00761189|513142|P1|COMPLETED|Overall Study||306
210247|NCT00761189|513142|P1|STARTED|Overall Study||491
210248|NCT00761202|513159|P2|NOT COMPLETED|Overall Study||2
210249|NCT00761202|513160|P1|NOT COMPLETED|Overall Study||1
210250|NCT00761202|513159|P2|COMPLETED|Overall Study||26
210251|NCT00761202|513160|P1|COMPLETED|Overall Study||21
210252|NCT00761202|513159|P2|STARTED|Overall Study||28
210253|NCT00761202|513160|P1|STARTED|Overall Study||22
210254|NCT00761215|513179|P3|NOT COMPLETED|Overall Study||8
210255|NCT00761215|513180|P2|NOT COMPLETED|Overall Study||4
210256|NCT00761215|513181|P1|NOT COMPLETED|Overall Study||9
210257|NCT00761215|513179|P3|COMPLETED|Overall Study||56
210258|NCT00761215|513180|P2|COMPLETED|Overall Study||60
210259|NCT00761215|513181|P1|COMPLETED|Overall Study||55
210260|NCT00761215|513179|P3|STARTED|Overall Study||64
210261|NCT00761215|513180|P2|STARTED|Overall Study||64
210262|NCT00761215|513181|P1|STARTED|Overall Study||64
210263|NCT00761280|513206|P2|NOT COMPLETED|First Dose to End of Study||11
210264|NCT00761280|513207|P1|NOT COMPLETED|First Dose to End of Study||12
210265|NCT00761280|513206|P2|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
210266|NCT00761280|513207|P1|COMPLETED|First Dose to End of Study|Study was discontinued early due to the inability to recruit a sufficient number of participants.|0
210267|NCT00761280|513206|P2|STARTED|First Dose to End of Study||11
210268|NCT00761280|513207|P1|STARTED|First Dose to End of Study||12
210269|NCT00761280|513206|P2|NOT COMPLETED|Randomization to First Dose||2
210270|NCT00761280|513207|P1|NOT COMPLETED|Randomization to First Dose||2
210271|NCT00761280|513206|P2|COMPLETED|Randomization to First Dose||11
210272|NCT00761280|513207|P1|COMPLETED|Randomization to First Dose||12
210273|NCT00761280|513206|P2|First Dose of Study Drug / Chemotherapy|Randomization to First Dose|Safety population|11
210274|NCT00761280|513207|P1|First Dose of Study Drug / Chemotherapy|Randomization to First Dose||12
210275|NCT00761280|513206|P2|Catheter Surgery|Randomization to First Dose|Not applicable to control group|0
210276|NCT00761280|513207|P1|Catheter Surgery|Randomization to First Dose|Safety population|13
210277|NCT00761280|513206|P2|STARTED|Randomization to First Dose||13
210278|NCT00761280|513207|P1|STARTED|Randomization to First Dose||14
210279|NCT00761306|513235|P1|NOT COMPLETED|Overall Study||20
210280|NCT00761306|513235|P1|COMPLETED|Overall Study||54
210281|NCT00761306|513235|P1|STARTED|Overall Study||74
210282|NCT00761319|513246|P2|NOT COMPLETED|Overall Study||34
210283|NCT00761319|513247|P1|NOT COMPLETED|Overall Study||48
210284|NCT00761319|513246|P2|COMPLETED|Overall Study||318
210285|NCT00761319|513247|P1|COMPLETED|Overall Study||305
210286|NCT00761319|513246|P2|STARTED|Overall Study||352
210287|NCT00761319|513247|P1|STARTED|Overall Study||353
210288|NCT00761345|513255|P1|NOT COMPLETED|Overall Study||3
210289|NCT00761345|513255|P1|COMPLETED|Overall Study||24
210290|NCT00761345|513255|P1|STARTED|Overall Study||27
210291|NCT00761462|513261|P2|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||51
210292|NCT00761462|513262|P1|NOT COMPLETED|2 or 5 Years Long-term Safety Follow-up||154
210293|NCT00761462|513261|P2|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 2 year safety Follow-up.|456
210294|NCT00761462|513262|P1|COMPLETED|2 or 5 Years Long-term Safety Follow-up|Patients under safety evaluation at end of 5 year safety Follow-up.|333
210295|NCT00761462|513261|P2|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||507
210296|NCT00761462|513262|P1|1 Year Follow-up|2 or 5 Years Long-term Safety Follow-up||485
210297|NCT00761462|513261|P2|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||507
210298|NCT00761462|513262|P1|4-6 Weeks Post Treatment|2 or 5 Years Long-term Safety Follow-up||487
210299|NCT00761462|513261|P2|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|507
210300|NCT00761462|513262|P1|STARTED|2 or 5 Years Long-term Safety Follow-up|Patients with confirmed intake of study drug entering long-term safety evaluation|487
210301|NCT00761462|513261|P2|NOT COMPLETED|Treatment||12
210302|NCT00761462|513262|P1|NOT COMPLETED|Treatment||23
210303|NCT00761462|513261|P2|COMPLETED|Treatment|Patients with confirmed intake of study drug|507
210304|NCT00761462|513262|P1|COMPLETED|Treatment|Patients with confirmed intake of study drug|487
210305|NCT00761462|513261|P2|STARTED|Treatment|Patients enrolled in study group|519
210306|NCT00761462|513262|P1|STARTED|Treatment|Patients enrolled in study group|510
210307|NCT00761514|513270|P1|NOT COMPLETED|Overall Study||7
210308|NCT00761514|513270|P1|COMPLETED|Overall Study||7
210309|NCT00761514|513270|P1|STARTED|Overall Study||14
210310|NCT00761527|513275|P1|NOT COMPLETED|Overall Study||22
210311|NCT00761527|513275|P1|COMPLETED|Overall Study||2958
210312|NCT00761527|513275|P1|Received One Dose of Study Medication|Overall Study||2978
210313|NCT00761527|513275|P1|STARTED|Overall Study||2980
210314|NCT00761579|513282|P1|NOT COMPLETED|Overall Study||92
210315|NCT00761579|513282|P1|COMPLETED|Overall Study||98
210316|NCT00761579|513282|P1|STARTED|Overall Study||190
210317|NCT00761592|513317|P2|NOT COMPLETED|Overall Study||1
210318|NCT00761592|513318|P1|NOT COMPLETED|Overall Study||1
210319|NCT00761592|513317|P2|COMPLETED|Overall Study||32
210320|NCT00761592|513318|P1|COMPLETED|Overall Study||31
210321|NCT00761592|513317|P2|STARTED|Overall Study||33
210322|NCT00761592|513318|P1|STARTED|Overall Study||32
210323|NCT00761605|513332|P1|NOT COMPLETED|Overall Study||141
210324|NCT00761605|513332|P1|COMPLETED|Overall Study||246
210325|NCT00761605|513332|P1|STARTED|Overall Study||387
210326|NCT00761631|513363|P6|NOT COMPLETED|Overall Study||5
210327|NCT00761631|513364|P5|NOT COMPLETED|Overall Study||22
210328|NCT00761631|513365|P4|NOT COMPLETED|Overall Study||3
210329|NCT00761631|513366|P3|NOT COMPLETED|Overall Study||16
210330|NCT00761631|513367|P2|NOT COMPLETED|Overall Study||7
210331|NCT00761631|513368|P1|NOT COMPLETED|Overall Study||15
210332|NCT00761631|513363|P6|COMPLETED|Overall Study||294
210333|NCT00761631|513364|P5|COMPLETED|Overall Study||277
210334|NCT00761631|513365|P4|COMPLETED|Overall Study||116
210335|NCT00761631|513366|P3|COMPLETED|Overall Study||160
210336|NCT00761631|513367|P2|COMPLETED|Overall Study||174
210337|NCT00761631|513368|P1|COMPLETED|Overall Study||111
210338|NCT00761631|513363|P6|Vaccinated Dose 2|Overall Study||0
210339|NCT00761631|513364|P5|Vaccinated Dose 2|Overall Study||0
210340|NCT00761631|513365|P4|Vaccinated Dose 2|Overall Study||0
210341|NCT00761631|513366|P3|Vaccinated Dose 2|Overall Study||165
210342|NCT00761631|513367|P2|Vaccinated Dose 2|Overall Study||0
210343|NCT00761631|513368|P1|Vaccinated Dose 2|Overall Study||112
210344|NCT00761631|513363|P6|Vaccinated Dose 1|Overall Study||298
210345|NCT00761631|513364|P5|Vaccinated Dose 1|Overall Study||294
210346|NCT00761631|513365|P4|Vaccinated Dose 1|Overall Study||118
210347|NCT00761631|513366|P3|Vaccinated Dose 1|Overall Study||175
210348|NCT00761631|513367|P2|Vaccinated Dose 1|Overall Study||179
210349|NCT00761631|513368|P1|Vaccinated Dose 1|Overall Study||124
210350|NCT00761631|513363|P6|STARTED|Overall Study||299
210351|NCT00761631|513364|P5|STARTED|Overall Study||299
210352|NCT00761631|513365|P4|STARTED|Overall Study||119
210353|NCT00761631|513366|P3|STARTED|Overall Study||176
210354|NCT00761631|513367|P2|STARTED|Overall Study||181
210355|NCT00761631|513368|P1|STARTED|Overall Study||126
210356|NCT00769561|513405|P2|NOT COMPLETED|Overall Study||5
210357|NCT00769561|513406|P1|NOT COMPLETED|Overall Study||3
210358|NCT00769561|513405|P2|COMPLETED|Overall Study||24
210359|NCT00769561|513406|P1|COMPLETED|Overall Study||26
210360|NCT00769561|513405|P2|STARTED|Overall Study||29
210361|NCT00769561|513406|P1|STARTED|Overall Study||29
210362|NCT00769652|513428|P2|NOT COMPLETED|Overall Study||0
210363|NCT00769652|513429|P1|NOT COMPLETED|Overall Study||0
210364|NCT00769652|513428|P2|COMPLETED|Overall Study||1
210365|NCT00769652|513429|P1|COMPLETED|Overall Study||6
210366|NCT00769652|513428|P2|STARTED|Overall Study||1
210367|NCT00769652|513429|P1|STARTED|Overall Study||6
210368|NCT00769704|513441|P2|NOT COMPLETED|Overall Study||199
210369|NCT00769704|513442|P1|NOT COMPLETED|Overall Study||111
210370|NCT00769704|513441|P2|COMPLETED|Overall Study||97
210371|NCT00769704|513442|P1|COMPLETED|Overall Study||30
210372|NCT00769704|513441|P2|Received Treatment|Overall Study||292
210373|NCT00769704|513442|P1|Received Treatment|Overall Study||127
210374|NCT00769704|513441|P2|Intent-to-treat Population|Overall Study|Participants who were randomized once to study treatment; excludes 1 participant randomized 3 times|295
210375|NCT00769704|513442|P1|Intent-to-treat Population|Overall Study|All participants who were randomized once to study treatment|141
210376|NCT00769704|513441|P2|STARTED|Overall Study||296
210377|NCT00769704|513442|P1|STARTED|Overall Study||141
210378|NCT00770029|513462|P2|NOT COMPLETED|Overall Study||3
210379|NCT00770029|513463|P1|NOT COMPLETED|Overall Study||6
210380|NCT00770029|513462|P2|COMPLETED|Overall Study||89
210381|NCT00770029|513463|P1|COMPLETED|Overall Study||178
210382|NCT00770029|513462|P2|STARTED|Overall Study||92
210383|NCT00770029|513463|P1|STARTED|Overall Study||184
210384|NCT00770120|513477|P1|NOT COMPLETED|Overall Study||61
210385|NCT00770120|513477|P1|COMPLETED|Overall Study||0
210386|NCT00770120|513477|P1|Not Analyzable|Overall Study||1
210387|NCT00770120|513477|P1|Eligible|Overall Study||60
210388|NCT00770120|513477|P1|STARTED|Overall Study||61
210389|NCT00770146|513486|P2|NOT COMPLETED|Follow-up Period||20
210390|NCT00770146|513487|P1|NOT COMPLETED|Follow-up Period||11
210391|NCT00770146|513486|P2|COMPLETED|Follow-up Period||85
210392|NCT00770146|513487|P1|COMPLETED|Follow-up Period||42
210393|NCT00770146|513486|P2|STARTED|Follow-up Period||105
210394|NCT00770146|513487|P1|STARTED|Follow-up Period||53
210395|NCT00770146|513486|P2|NOT COMPLETED|Treatment Period||45
210396|NCT00770146|513487|P1|NOT COMPLETED|Treatment Period||9
210397|NCT00770146|513486|P2|COMPLETED|Treatment Period||60
210398|NCT00770146|513487|P1|COMPLETED|Treatment Period||44
210399|NCT00770146|513486|P2|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|101
210400|NCT00770146|513487|P1|Full Analysis Set|Treatment Period|Treated patients with a valid baseline & post-baseline LDL-C measurement|50
210401|NCT00770146|513486|P2|Treated|Treatment Period||105
210402|NCT00770146|513487|P1|Treated|Treatment Period||52
210403|NCT00770146|513486|P2|STARTED|Treatment Period||105
210404|NCT00770146|513487|P1|STARTED|Treatment Period||53
210405|NCT00770211|513533|P2|NOT COMPLETED|Overall Study||2
210406|NCT00770211|513534|P1|NOT COMPLETED|Overall Study||1
210407|NCT00770211|513533|P2|COMPLETED|Overall Study||87
210408|NCT00770211|513534|P1|COMPLETED|Overall Study||181
210409|NCT00770211|513533|P2|STARTED|Overall Study||89
210410|NCT00770211|513534|P1|STARTED|Overall Study||182
210411|NCT00770289|513548|P1|NOT COMPLETED|Overall Study||6
210412|NCT00770289|513548|P1|COMPLETED|Overall Study||845
210413|NCT00770289|513548|P1|STARTED|Overall Study||851
210414|NCT00770315|513561|P4|NOT COMPLETED|Overall Study||38
210415|NCT00770315|513562|P3|NOT COMPLETED|Overall Study||57
210416|NCT00770315|513563|P2|NOT COMPLETED|Overall Study||43
210417|NCT00770315|513564|P1|NOT COMPLETED|Overall Study||40
210418|NCT00770315|513561|P4|COMPLETED|Overall Study||160
210419|NCT00770315|513562|P3|COMPLETED|Overall Study||137
210420|NCT00770315|513563|P2|COMPLETED|Overall Study||152
210421|NCT00770315|513564|P1|COMPLETED|Overall Study||157
210422|NCT00770315|513561|P4|STARTED|Overall Study||198
210423|NCT00770315|513562|P3|STARTED|Overall Study||194
210424|NCT00770315|513563|P2|STARTED|Overall Study||195
210425|NCT00770315|513564|P1|STARTED|Overall Study||197
210426|NCT00770341|513593|P3|NOT COMPLETED|Overall Study||3
210427|NCT00770341|513594|P2|NOT COMPLETED|Overall Study||5
210428|NCT00770341|513595|P1|NOT COMPLETED|Overall Study||12
210429|NCT00770341|513593|P3|COMPLETED|Overall Study||8
210430|NCT00770341|513594|P2|COMPLETED|Overall Study||17
210431|NCT00770341|513595|P1|COMPLETED|Overall Study||77
210432|NCT00770341|513593|P3|STARTED|Overall Study|Number randomized|11
210433|NCT00770341|513594|P2|STARTED|Overall Study|Number randomized|22
210434|NCT00770341|513595|P1|STARTED|Overall Study|Number randomized|89
210435|NCT00770367|513621|P2|NOT COMPLETED|Second Intervention||0
210436|NCT00770367|513622|P1|NOT COMPLETED|Second Intervention||2
210437|NCT00770367|513621|P2|COMPLETED|Second Intervention||15
210438|NCT00770367|513622|P1|COMPLETED|Second Intervention||16
210439|NCT00770367|513621|P2|STARTED|Second Intervention||15
210440|NCT00770367|513622|P1|STARTED|Second Intervention||18
210441|NCT00770367|513621|P2|NOT COMPLETED|Washout Period of 4 Weeks||1
210442|NCT00770367|513622|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
210443|NCT00770367|513621|P2|COMPLETED|Washout Period of 4 Weeks||15
210444|NCT00770367|513622|P1|COMPLETED|Washout Period of 4 Weeks||18
210445|NCT00770367|513621|P2|STARTED|Washout Period of 4 Weeks||16
210446|NCT00770367|513622|P1|STARTED|Washout Period of 4 Weeks||18
210447|NCT00770367|513621|P2|NOT COMPLETED|First Intervention||2
210448|NCT00770367|513622|P1|NOT COMPLETED|First Intervention||0
210449|NCT00770367|513621|P2|COMPLETED|First Intervention||16
210450|NCT00770367|513622|P1|COMPLETED|First Intervention||18
210451|NCT00770367|513621|P2|STARTED|First Intervention||18
210452|NCT00770367|513622|P1|STARTED|First Intervention||18
210453|NCT00770432|513630|P2|NOT COMPLETED|Overall Study||7
210454|NCT00770432|513631|P1|NOT COMPLETED|Overall Study||4
210455|NCT00770432|513630|P2|COMPLETED|Overall Study||94
210456|NCT00770432|513631|P1|COMPLETED|Overall Study||98
210457|NCT00770432|513630|P2|STARTED|Overall Study||101
210458|NCT00770432|513631|P1|STARTED|Overall Study||102
210459|NCT00770484|513639|P2|NOT COMPLETED|Overall Study||0
210460|NCT00770484|513640|P1|NOT COMPLETED|Overall Study||1
210461|NCT00770484|513639|P2|COMPLETED|Overall Study||4
210462|NCT00770484|513640|P1|COMPLETED|Overall Study||7
210463|NCT00770484|513639|P2|STARTED|Overall Study||4
210464|NCT00770484|513640|P1|STARTED|Overall Study||8
210465|NCT00770510|513646|P1|NOT COMPLETED|Overall Study||5
210466|NCT00770510|513646|P1|COMPLETED|Overall Study||67
210467|NCT00770510|513646|P1|STARTED|Overall Study||72
210468|NCT00770562|513685|P2|NOT COMPLETED|Overall Study||1
210469|NCT00770562|513686|P1|NOT COMPLETED|Overall Study||1
210470|NCT00770562|513685|P2|COMPLETED|Overall Study||49
210471|NCT00770562|513686|P1|COMPLETED|Overall Study||52
210472|NCT00770562|513685|P2|STARTED|Overall Study||50
210473|NCT00770562|513686|P1|STARTED|Overall Study||53
210474|NCT00770588|513699|P2|NOT COMPLETED|Overall Study||95
210475|NCT00770588|513700|P1|NOT COMPLETED|Overall Study||81
210476|NCT00770588|513699|P2|COMPLETED|Overall Study||53
210477|NCT00770588|513700|P1|COMPLETED|Overall Study||67
210478|NCT00770588|513699|P2|STARTED|Overall Study||148
210479|NCT00770588|513700|P1|STARTED|Overall Study||148
210480|NCT00770653|513716|P2|NOT COMPLETED|Overall Study||29
210481|NCT00770653|513717|P1|NOT COMPLETED|Overall Study||32
210482|NCT00770653|513716|P2|COMPLETED|Overall Study||121
210483|NCT00770653|513717|P1|COMPLETED|Overall Study||123
210484|NCT00770653|513716|P2|STARTED|Overall Study||150
210485|NCT00770653|513717|P1|STARTED|Overall Study||155
210486|NCT00770692|513789|P4|NOT COMPLETED|Overall Study||11
210487|NCT00770692|513790|P3|NOT COMPLETED|Overall Study||14
210488|NCT00770692|513791|P2|NOT COMPLETED|Overall Study||9
210489|NCT00770692|513792|P1|NOT COMPLETED|Overall Study||12
210490|NCT00770692|513789|P4|COMPLETED|Overall Study||66
210491|NCT00770692|513790|P3|COMPLETED|Overall Study||70
210492|NCT00770692|513791|P2|COMPLETED|Overall Study||74
210493|NCT00770692|513792|P1|COMPLETED|Overall Study||69
210494|NCT00770692|513789|P4|STARTED|Overall Study||77
210495|NCT00770692|513790|P3|STARTED|Overall Study||84
210496|NCT00770692|513791|P2|STARTED|Overall Study||83
210497|NCT00770692|513792|P1|STARTED|Overall Study|"1 participant whose compliance was unknown, was regarded as a treatment compliance unknown"|81
210498|NCT00770757|513818|P1|NOT COMPLETED|Overall Study||0
210499|NCT00770757|513818|P1|COMPLETED|Overall Study||13
210500|NCT00770757|513818|P1|STARTED|Overall Study||13
210501|NCT00770770|513828|P2|NOT COMPLETED|Overall Study||1
210502|NCT00770770|513829|P1|NOT COMPLETED|Overall Study||10
210503|NCT00770770|513828|P2|COMPLETED|Overall Study||5
210504|NCT00770770|513829|P1|COMPLETED|Overall Study||4
210505|NCT00770770|513828|P2|STARTED|Overall Study||6
210506|NCT00770770|513829|P1|STARTED|Overall Study||14
210507|NCT00770809|513838|P3|NOT COMPLETED|Overall Study||23
210508|NCT00770809|513839|P2|NOT COMPLETED|Overall Study||10
210509|NCT00770809|513840|P1|NOT COMPLETED|Overall Study||17
210510|NCT00770809|513838|P3|COMPLETED|Overall Study||44
210511|NCT00770809|513839|P2|COMPLETED|Overall Study||110
210512|NCT00770809|513840|P1|COMPLETED|Overall Study||101
210513|NCT00770809|513838|P3|STARTED|Overall Study||67
210514|NCT00770809|513839|P2|STARTED|Overall Study||120
210515|NCT00770809|513840|P1|STARTED|Overall Study||118
210516|NCT00770861|513850|P2|NOT COMPLETED|Overall Study||16
210517|NCT00770861|513851|P1|NOT COMPLETED|Overall Study||10
210518|NCT00770861|513850|P2|COMPLETED|Overall Study||120
210519|NCT00770861|513851|P1|COMPLETED|Overall Study||131
210520|NCT00770861|513850|P2|STARTED|Overall Study||136
210521|NCT00770861|513851|P1|STARTED|Overall Study||141
210522|NCT00770913|513862|P3|NOT COMPLETED|Overall Study||13
210523|NCT00770913|513863|P2|NOT COMPLETED|Overall Study||8
210524|NCT00770913|513864|P1|NOT COMPLETED|Overall Study||11
210525|NCT00770913|513862|P3|COMPLETED|Overall Study||100
210526|NCT00770913|513863|P2|COMPLETED|Overall Study||103
210527|NCT00770913|513864|P1|COMPLETED|Overall Study||102
210528|NCT00770913|513862|P3|STARTED|Overall Study||113
210529|NCT00770913|513863|P2|STARTED|Overall Study||111
210530|NCT00770913|513864|P1|STARTED|Overall Study||113
210531|NCT00770965|513876|P4|NOT COMPLETED|Excluded Set||13
210532|NCT00770965|513877|P3|NOT COMPLETED|Excluded Set||14
210533|NCT00770965|513878|P2|NOT COMPLETED|Excluded Set||13
210534|NCT00770965|513879|P1|NOT COMPLETED|Excluded Set||15
210535|NCT00770965|513876|P4|COMPLETED|Excluded Set||2
210536|NCT00770965|513877|P3|COMPLETED|Excluded Set||2
210537|NCT00770965|513878|P2|COMPLETED|Excluded Set||3
210538|NCT00770965|513879|P1|COMPLETED|Excluded Set||3
210539|NCT00770965|513876|P4|STARTED|Excluded Set||15
210540|NCT00770965|513877|P3|STARTED|Excluded Set||16
210541|NCT00770965|513878|P2|STARTED|Excluded Set||16
210542|NCT00770965|513879|P1|STARTED|Excluded Set||18
210543|NCT00770965|513876|P4|NOT COMPLETED|Safety Set||1
210544|NCT00770965|513877|P3|NOT COMPLETED|Safety Set||1
210545|NCT00770965|513878|P2|NOT COMPLETED|Safety Set||0
210546|NCT00770965|513879|P1|NOT COMPLETED|Safety Set||0
210547|NCT00770965|513876|P4|COMPLETED|Safety Set||4
210548|NCT00770965|513877|P3|COMPLETED|Safety Set||3
210549|NCT00770965|513878|P2|COMPLETED|Safety Set||4
210550|NCT00770965|513879|P1|COMPLETED|Safety Set||2
210551|NCT00770965|513876|P4|STARTED|Safety Set||5
210552|NCT00770965|513877|P3|STARTED|Safety Set||4
210553|NCT00770965|513878|P2|STARTED|Safety Set||4
210554|NCT00770965|513879|P1|STARTED|Safety Set||2
210555|NCT00770991|513899|P2|NOT COMPLETED|Overall Study||5
210556|NCT00770991|513900|P1|NOT COMPLETED|Overall Study||5
210557|NCT00770991|513899|P2|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
210558|NCT00770991|513900|P1|COMPLETED|Overall Study|7 subjects completed 36 weeks (+/- 10 days)of treatment|7
210559|NCT00770991|513899|P2|STARTED|Overall Study|We anticipated 26-30 subjects with FAP 18 year or olders would need to be enrolled to randomize 18|12
210560|NCT00770991|513900|P1|STARTED|Overall Study|34 participants enrolled (signed informed consent). 24 subjects were eligible to be randomized.|12
210561|NCT00771056|513912|P1|NOT COMPLETED|Overall Study||5
210562|NCT00771056|513912|P1|COMPLETED|Overall Study||18
210563|NCT00771056|513912|P1|STARTED|Overall Study||23
210564|NCT00771173|513919|P2|NOT COMPLETED|Overall Study||17
210565|NCT00771173|513920|P1|NOT COMPLETED|Overall Study||22
210566|NCT00771173|513919|P2|COMPLETED|Overall Study||112
210567|NCT00771173|513920|P1|COMPLETED|Overall Study||107
210568|NCT00771173|513919|P2|STARTED|Overall Study||129
210569|NCT00771173|513920|P1|STARTED|Overall Study||129
210570|NCT00771238|513928|P2|NOT COMPLETED|Overall Study||0
210571|NCT00771238|513929|P1|NOT COMPLETED|Overall Study||0
210572|NCT00771238|513928|P2|COMPLETED|Overall Study||21
210573|NCT00771238|513929|P1|COMPLETED|Overall Study||31
210574|NCT00771238|513928|P2|STARTED|Overall Study||21
210575|NCT00771238|513929|P1|STARTED|Overall Study||31
210576|NCT00771264|513939|P2|NOT COMPLETED|Overall Study||5
210577|NCT00771264|513940|P1|NOT COMPLETED|Overall Study||7
210578|NCT00771264|513939|P2|COMPLETED|Overall Study||105
210579|NCT00771264|513940|P1|COMPLETED|Overall Study||103
210580|NCT00771264|513939|P2|STARTED|Overall Study||110
210581|NCT00771264|513940|P1|STARTED|Overall Study||110
210582|NCT00771277|513946|P1|NOT COMPLETED|Overall Study||0
210583|NCT00771277|513946|P1|COMPLETED|Overall Study||6
210584|NCT00771277|513946|P1|STARTED|Overall Study||6
210585|NCT00771316|513954|P2|NOT COMPLETED|Overall Study||1
210586|NCT00771316|513955|P1|NOT COMPLETED|Overall Study||2
210587|NCT00771316|513954|P2|COMPLETED|Overall Study||1
210588|NCT00771316|513955|P1|COMPLETED|Overall Study||2
210589|NCT00771316|513954|P2|STARTED|Overall Study||2
210590|NCT00771316|513955|P1|STARTED|Overall Study||4
210591|NCT00771407|513967|P2|NOT COMPLETED|Overall Study||25
210592|NCT00771407|513968|P1|NOT COMPLETED|Overall Study||20
210593|NCT00771407|513967|P2|COMPLETED|Overall Study||35
210594|NCT00771407|513968|P1|COMPLETED|Overall Study||40
210595|NCT00771407|513967|P2|STARTED|Overall Study||60
210596|NCT00771407|513968|P1|STARTED|Overall Study||60
210597|NCT00771472|513974|P2|NOT COMPLETED|Overall Study||4
210598|NCT00771472|513975|P1|NOT COMPLETED|Overall Study||6
210599|NCT00771472|513974|P2|COMPLETED|Overall Study||0
210600|NCT00771472|513975|P1|COMPLETED|Overall Study||0
210601|NCT00771472|513974|P2|STARTED|Overall Study||4
210602|NCT00771472|513975|P1|STARTED|Overall Study||6
210603|NCT00771537|514000|P16|NOT COMPLETED|Overall Study||0
210604|NCT00771537|514001|P15|NOT COMPLETED|Overall Study||0
210605|NCT00771537|514002|P14|NOT COMPLETED|Overall Study||0
210606|NCT00771537|514003|P13|NOT COMPLETED|Overall Study||0
210607|NCT00771537|514004|P12|NOT COMPLETED|Overall Study||0
210608|NCT00771537|514005|P11|NOT COMPLETED|Overall Study||0
210609|NCT00771537|514006|P10|NOT COMPLETED|Overall Study||0
210610|NCT00771537|514007|P9|NOT COMPLETED|Overall Study||0
210611|NCT00771537|514008|P8|NOT COMPLETED|Overall Study||0
210612|NCT00771537|514009|P7|NOT COMPLETED|Overall Study||0
210613|NCT00771537|514010|P6|NOT COMPLETED|Overall Study||0
210614|NCT00771537|514011|P5|NOT COMPLETED|Overall Study||0
210615|NCT00771537|514012|P4|NOT COMPLETED|Overall Study||0
210616|NCT00771537|514013|P3|NOT COMPLETED|Overall Study||0
210617|NCT00771537|514014|P2|NOT COMPLETED|Overall Study||0
210618|NCT00771537|514015|P1|NOT COMPLETED|Overall Study||0
210619|NCT00771537|514000|P16|COMPLETED|Overall Study||122
210620|NCT00771537|514001|P15|COMPLETED|Overall Study||124
210621|NCT00771537|514002|P14|COMPLETED|Overall Study||124
210622|NCT00771537|514003|P13|COMPLETED|Overall Study||128
210623|NCT00771537|514004|P12|COMPLETED|Overall Study||137
210624|NCT00771537|514005|P11|COMPLETED|Overall Study||133
210625|NCT00771537|514006|P10|COMPLETED|Overall Study||119
210626|NCT00771537|514007|P9|COMPLETED|Overall Study||115
210627|NCT00771537|514008|P8|COMPLETED|Overall Study||132
210628|NCT00771537|514009|P7|COMPLETED|Overall Study||128
210629|NCT00771537|514010|P6|COMPLETED|Overall Study||118
210630|NCT00771537|514011|P5|COMPLETED|Overall Study||127
210631|NCT00771537|514012|P4|COMPLETED|Overall Study||114
210632|NCT00771537|514013|P3|COMPLETED|Overall Study||151
210633|NCT00771537|514014|P2|COMPLETED|Overall Study||124
210634|NCT00771537|514015|P1|COMPLETED|Overall Study||135
210635|NCT00771537|514000|P16|STARTED|Overall Study||122
210636|NCT00771537|514001|P15|STARTED|Overall Study||124
210637|NCT00771537|514002|P14|STARTED|Overall Study||124
210638|NCT00771537|514003|P13|STARTED|Overall Study||128
210639|NCT00771537|514004|P12|STARTED|Overall Study||137
210640|NCT00771537|514005|P11|STARTED|Overall Study||133
210641|NCT00771537|514006|P10|STARTED|Overall Study||119
210642|NCT00771537|514007|P9|STARTED|Overall Study||115
210643|NCT00771537|514008|P8|STARTED|Overall Study||132
210644|NCT00771537|514009|P7|STARTED|Overall Study||128
210645|NCT00771537|514010|P6|STARTED|Overall Study||118
210646|NCT00771537|514011|P5|STARTED|Overall Study||127
210647|NCT00771537|514012|P4|STARTED|Overall Study||114
210648|NCT00771537|514013|P3|STARTED|Overall Study||151
210649|NCT00771537|514014|P2|STARTED|Overall Study||124
210650|NCT00771537|514015|P1|STARTED|Overall Study||135
210651|NCT00771602|514044|P3|NOT COMPLETED|Overall Study||0
210652|NCT00771602|514045|P2|NOT COMPLETED|Overall Study||0
210653|NCT00771602|514046|P1|NOT COMPLETED|Overall Study||0
210654|NCT00771602|514044|P3|COMPLETED|Overall Study||0
210655|NCT00771602|514045|P2|COMPLETED|Overall Study||0
210656|NCT00771602|514046|P1|COMPLETED|Overall Study||1
210657|NCT00771602|514044|P3|STARTED|Overall Study||0
210658|NCT00771602|514045|P2|STARTED|Overall Study||0
210659|NCT00771602|514046|P1|STARTED|Overall Study||1
210660|NCT00771615|514063|P9|NOT COMPLETED|Overall Study||0
210661|NCT00771615|514064|P8|NOT COMPLETED|Overall Study||1
210662|NCT00771615|514065|P7|NOT COMPLETED|Overall Study||1
210663|NCT00771615|514066|P6|NOT COMPLETED|Overall Study||1
210664|NCT00771615|514067|P5|NOT COMPLETED|Overall Study||0
210665|NCT00771615|514068|P4|NOT COMPLETED|Overall Study||1
210666|NCT00771615|514069|P3|NOT COMPLETED|Overall Study||1
210667|NCT00771615|514070|P2|NOT COMPLETED|Overall Study||2
210668|NCT00771615|514071|P1|NOT COMPLETED|Overall Study||1
210669|NCT00771615|514063|P9|COMPLETED|Overall Study|Up to Day 364|41
210670|NCT00771615|514064|P8|COMPLETED|Overall Study|Up to Day 364|58
210671|NCT00771615|514065|P7|COMPLETED|Overall Study|Up to Day 364|45
210672|NCT00771615|514066|P6|COMPLETED|Overall Study|Up to Day 364|60
210673|NCT00771615|514067|P5|COMPLETED|Overall Study|Up to Day 364|40
210674|NCT00771615|514068|P4|COMPLETED|Overall Study|Up to Day 364|59
210675|NCT00771615|514069|P3|COMPLETED|Overall Study|Up to Day 364|40
210676|NCT00771615|514070|P2|COMPLETED|Overall Study|Up to Day 364|70
210677|NCT00771615|514071|P1|COMPLETED|Overall Study|Up to Day 364|48
210678|NCT00771615|514063|P9|STARTED|Overall Study||41
210679|NCT00771615|514064|P8|STARTED|Overall Study||59
210680|NCT00771615|514065|P7|STARTED|Overall Study||46
210681|NCT00771615|514066|P6|STARTED|Overall Study||61
210682|NCT00771615|514067|P5|STARTED|Overall Study||40
210683|NCT00771615|514068|P4|STARTED|Overall Study||60
210684|NCT00771615|514069|P3|STARTED|Overall Study||41
210685|NCT00771615|514070|P2|STARTED|Overall Study||72
210686|NCT00771615|514071|P1|STARTED|Overall Study||49
210687|NCT00771667|514266|P10|NOT COMPLETED|Maintenance Phase||17
210688|NCT00771667|514267|P9|NOT COMPLETED|Maintenance Phase||22
210689|NCT00771667|514268|P8|NOT COMPLETED|Maintenance Phase||5
210690|NCT00771667|514269|P7|NOT COMPLETED|Maintenance Phase||10
210691|NCT00771667|514270|P6|NOT COMPLETED|Maintenance Phase||7
210692|NCT00771667|514271|P5|NOT COMPLETED|Maintenance Phase||2
210693|NCT00771667|514272|P4|NOT COMPLETED|Maintenance Phase||0
210694|NCT00771667|514273|P3|NOT COMPLETED|Maintenance Phase||0
210695|NCT00771667|514274|P2|NOT COMPLETED|Maintenance Phase||0
210696|NCT00771667|514275|P1|NOT COMPLETED|Maintenance Phase||0
210697|NCT00771667|514266|P10|COMPLETED|Maintenance Phase||92
210698|NCT00771667|514267|P9|COMPLETED|Maintenance Phase||88
210699|NCT00771667|514268|P8|COMPLETED|Maintenance Phase||67
210700|NCT00771667|514269|P7|COMPLETED|Maintenance Phase||63
210701|NCT00771667|514270|P6|COMPLETED|Maintenance Phase||78
210702|NCT00771667|514271|P5|COMPLETED|Maintenance Phase||26
210703|NCT00771667|514272|P4|COMPLETED|Maintenance Phase||0
210704|NCT00771667|514273|P3|COMPLETED|Maintenance Phase||0
210705|NCT00771667|514274|P2|COMPLETED|Maintenance Phase||0
210706|NCT00771667|514275|P1|COMPLETED|Maintenance Phase||0
210707|NCT00771667|514266|P10|STARTED|Maintenance Phase||109
210708|NCT00771667|514267|P9|STARTED|Maintenance Phase||110
210709|NCT00771667|514268|P8|STARTED|Maintenance Phase||72
210710|NCT00771667|514269|P7|STARTED|Maintenance Phase||73
210711|NCT00771667|514270|P6|STARTED|Maintenance Phase||85
210712|NCT00771667|514271|P5|STARTED|Maintenance Phase||28
210799|NCT00771927|514575|P1|NOT COMPLETED|Overall Study||255
210713|NCT00771667|514272|P4|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
210714|NCT00771667|514273|P3|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
210715|NCT00771667|514274|P2|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
210716|NCT00771667|514275|P1|STARTED|Maintenance Phase|"0 in column indicates this reporting group is not relevant to Maintenance period."|0
210717|NCT00771667|514266|P10|NOT COMPLETED|Induction Phase||0
210718|NCT00771667|514267|P9|NOT COMPLETED|Induction Phase||0
210719|NCT00771667|514268|P8|NOT COMPLETED|Induction Phase||0
210720|NCT00771667|514269|P7|NOT COMPLETED|Induction Phase||0
210721|NCT00771667|514270|P6|NOT COMPLETED|Induction Phase||0
210722|NCT00771667|514271|P5|NOT COMPLETED|Induction Phase||0
210723|NCT00771667|514272|P4|NOT COMPLETED|Induction Phase||8
210724|NCT00771667|514273|P3|NOT COMPLETED|Induction Phase||12
210725|NCT00771667|514274|P2|NOT COMPLETED|Induction Phase||10
210726|NCT00771667|514275|P1|NOT COMPLETED|Induction Phase||19
210727|NCT00771667|514266|P10|COMPLETED|Induction Phase||0
210728|NCT00771667|514267|P9|COMPLETED|Induction Phase||0
210729|NCT00771667|514268|P8|COMPLETED|Induction Phase||0
210730|NCT00771667|514269|P7|COMPLETED|Induction Phase||0
210731|NCT00771667|514270|P6|COMPLETED|Induction Phase||0
210732|NCT00771667|514271|P5|COMPLETED|Induction Phase||0
210733|NCT00771667|514272|P4|COMPLETED|Induction Phase||123
210734|NCT00771667|514273|P3|COMPLETED|Induction Phase||120
210735|NCT00771667|514274|P2|COMPLETED|Induction Phase||121
210736|NCT00771667|514275|P1|COMPLETED|Induction Phase||113
210737|NCT00771667|514266|P10|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
210738|NCT00771667|514267|P9|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
210739|NCT00771667|514268|P8|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
210740|NCT00771667|514269|P7|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
210741|NCT00771667|514270|P6|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
210742|NCT00771667|514271|P5|STARTED|Induction Phase|"0 in column indicates this reporting group is not relevant to Induction period."|0
210743|NCT00771667|514272|P4|STARTED|Induction Phase||131
210744|NCT00771667|514273|P3|STARTED|Induction Phase||132
210745|NCT00771667|514274|P2|STARTED|Induction Phase||131
210746|NCT00771667|514275|P1|STARTED|Induction Phase||132
210747|NCT00771745|514313|P2|NOT COMPLETED|Overall Study||0
210748|NCT00771745|514314|P1|NOT COMPLETED|Overall Study||0
210749|NCT00771745|514313|P2|COMPLETED|Overall Study||5
210750|NCT00771745|514314|P1|COMPLETED|Overall Study||6
210751|NCT00771745|514313|P2|STARTED|Overall Study||5
210752|NCT00771745|514314|P1|STARTED|Overall Study||6
210753|NCT00771758|514323|P3|NOT COMPLETED|Overall Study||2
210754|NCT00771758|514324|P2|NOT COMPLETED|Overall Study||12
210755|NCT00771758|514325|P1|NOT COMPLETED|Overall Study||8
210756|NCT00771758|514323|P3|COMPLETED|Overall Study||19
210757|NCT00771758|514324|P2|COMPLETED|Overall Study||31
210758|NCT00771758|514325|P1|COMPLETED|Overall Study||36
210759|NCT00771758|514323|P3|STARTED|Overall Study||21
210760|NCT00771758|514324|P2|STARTED|Overall Study||43
210761|NCT00771758|514325|P1|STARTED|Overall Study||44
210762|NCT00771810|514476|P3|NOT COMPLETED|Overall Study||7
210763|NCT00771810|514477|P2|NOT COMPLETED|Overall Study||5
210764|NCT00771810|514478|P1|NOT COMPLETED|Overall Study||5
210765|NCT00771810|514476|P3|COMPLETED|Overall Study||6
210766|NCT00771810|514477|P2|COMPLETED|Overall Study||6
210767|NCT00771810|514478|P1|COMPLETED|Overall Study||5
210768|NCT00771810|514476|P3|STARTED|Overall Study||13
210769|NCT00771810|514477|P2|STARTED|Overall Study||11
210770|NCT00771810|514478|P1|STARTED|Overall Study||10
210771|NCT00771849|514515|P2|NOT COMPLETED|Overall Study||4
210772|NCT00771849|514516|P1|NOT COMPLETED|Overall Study||2
210773|NCT00771849|514515|P2|COMPLETED|Overall Study||47
210774|NCT00771849|514516|P1|COMPLETED|Overall Study||50
210775|NCT00771849|514515|P2|STARTED|Overall Study|One subject was not vaccinated|51
210776|NCT00771849|514516|P1|STARTED|Overall Study||52
210777|NCT00771875|514527|P3|NOT COMPLETED|Overall Study||0
210778|NCT00771875|514528|P2|NOT COMPLETED|Overall Study||1
210779|NCT00771875|514529|P1|NOT COMPLETED|Overall Study||0
210780|NCT00771875|514527|P3|COMPLETED|Overall Study||10
210781|NCT00771875|514528|P2|COMPLETED|Overall Study||9
210782|NCT00771875|514529|P1|COMPLETED|Overall Study||10
210783|NCT00771875|514527|P3|STARTED|Overall Study||10
210784|NCT00771875|514528|P2|STARTED|Overall Study||10
210785|NCT00771875|514529|P1|STARTED|Overall Study||10
210786|NCT00771914|514559|P4|NOT COMPLETED|Overall Study||2
210787|NCT00771914|514560|P3|NOT COMPLETED|Overall Study||0
210788|NCT00771914|514561|P2|NOT COMPLETED|Overall Study||0
210789|NCT00771914|514562|P1|NOT COMPLETED|Overall Study||0
210790|NCT00771914|514559|P4|COMPLETED|Overall Study||6
210791|NCT00771914|514560|P3|COMPLETED|Overall Study||6
210792|NCT00771914|514561|P2|COMPLETED|Overall Study||6
210793|NCT00771914|514562|P1|COMPLETED|Overall Study||7
210794|NCT00771914|514559|P4|STARTED|Overall Study||8
210795|NCT00771914|514560|P3|STARTED|Overall Study||6
210796|NCT00771914|514561|P2|STARTED|Overall Study||6
210797|NCT00771914|514562|P1|STARTED|Overall Study||7
210798|NCT00771927|514574|P2|NOT COMPLETED|Overall Study||237
210800|NCT00771927|514574|P2|COMPLETED|Overall Study||256
210801|NCT00771927|514575|P1|COMPLETED|Overall Study||256
210802|NCT00771927|514574|P2|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|493
210803|NCT00771927|514575|P1|STARTED|Overall Study|Participant Flow and Baseline Characteristics refer to the Safety Set population.|511
210804|NCT00771953|514585|P2|NOT COMPLETED|Overall Study||10
210805|NCT00771953|514586|P1|NOT COMPLETED|Overall Study||10
210806|NCT00771953|514585|P2|COMPLETED|Overall Study||26
210807|NCT00771953|514586|P1|COMPLETED|Overall Study||26
210808|NCT00771953|514585|P2|STARTED|Overall Study||36
210809|NCT00771953|514586|P1|STARTED|Overall Study||36
210810|NCT00772005|514598|P4|NOT COMPLETED|Overall Study||26
210811|NCT00772005|514599|P3|NOT COMPLETED|Overall Study||28
210812|NCT00772005|514600|P2|NOT COMPLETED|Overall Study||30
210813|NCT00772005|514601|P1|NOT COMPLETED|Overall Study||25
210814|NCT00772005|514598|P4|COMPLETED|Overall Study||46
210815|NCT00772005|514599|P3|COMPLETED|Overall Study||44
210816|NCT00772005|514600|P2|COMPLETED|Overall Study||40
210817|NCT00772005|514601|P1|COMPLETED|Overall Study||46
210818|NCT00772005|514598|P4|STARTED|Overall Study|Two patients withdrew before taking any study drug.|72
210819|NCT00772005|514599|P3|STARTED|Overall Study|One patient withdrew before taking any study drug.|72
210820|NCT00772005|514600|P2|STARTED|Overall Study|One patient withdrew before taking any study drug.|70
210821|NCT00772005|514601|P1|STARTED|Overall Study||71
210822|NCT00772031|515289|P2|NOT COMPLETED|Overall Study||43
210823|NCT00772031|515290|P1|NOT COMPLETED|Overall Study||32
210824|NCT00772031|515289|P2|COMPLETED|Overall Study||52
210825|NCT00772031|515290|P1|COMPLETED|Overall Study||64
210826|NCT00772031|515289|P2|STARTED|Overall Study||95
210827|NCT00772031|515290|P1|STARTED|Overall Study||96
210828|NCT00772070|515314|P2|NOT COMPLETED|Overall Study||10
210829|NCT00772070|515315|P1|NOT COMPLETED|Overall Study||2
210830|NCT00772070|515314|P2|COMPLETED|Overall Study||61
210831|NCT00772070|515315|P1|COMPLETED|Overall Study|Two participants had vaccination errors, they were removed from analysis.|100
210832|NCT00772070|515314|P2|STARTED|Overall Study||71
210833|NCT00772070|515315|P1|STARTED|Overall Study||102
210834|NCT00772109|515329|P4|NOT COMPLETED|Overall Study||31
210835|NCT00772109|515330|P3|NOT COMPLETED|Overall Study||19
210836|NCT00772109|515331|P2|NOT COMPLETED|Overall Study||19
210837|NCT00772109|515332|P1|NOT COMPLETED|Overall Study||21
210838|NCT00772109|515329|P4|COMPLETED|Overall Study||1397
210839|NCT00772109|515330|P3|COMPLETED|Overall Study||936
210840|NCT00772109|515331|P2|COMPLETED|Overall Study||934
210841|NCT00772109|515332|P1|COMPLETED|Overall Study||935
210842|NCT00772109|515329|P4|STARTED|Overall Study||1428
210843|NCT00772109|515330|P3|STARTED|Overall Study||955
210844|NCT00772109|515331|P2|STARTED|Overall Study||953
210845|NCT00772109|515332|P1|STARTED|Overall Study||956
210846|NCT00772148|515356|P2|NOT COMPLETED|Maintenance Phase (Week 52)||5
210847|NCT00772148|515357|P1|NOT COMPLETED|Maintenance Phase (Week 52)||4
210848|NCT00772148|515356|P2|COMPLETED|Maintenance Phase (Week 52)||18
210849|NCT00772148|515357|P1|COMPLETED|Maintenance Phase (Week 52)||17
210850|NCT00772148|515356|P2|STARTED|Maintenance Phase (Week 52)||23
210851|NCT00772148|515357|P1|STARTED|Maintenance Phase (Week 52)||21
210852|NCT00772148|515356|P2|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||6
210853|NCT00772148|515357|P1|NOT COMPLETED|Pharmacokinetic Phase (14 Days)||8
210854|NCT00772148|515356|P2|COMPLETED|Pharmacokinetic Phase (14 Days)||23
210855|NCT00772148|515357|P1|COMPLETED|Pharmacokinetic Phase (14 Days)||21
210856|NCT00772148|515356|P2|STARTED|Pharmacokinetic Phase (14 Days)||29
210857|NCT00772148|515357|P1|STARTED|Pharmacokinetic Phase (14 Days)||29
210858|NCT00772304|515373|P1|NOT COMPLETED|Overall Study||0
210859|NCT00772304|515373|P1|COMPLETED|Overall Study||102
210860|NCT00772304|515373|P1|STARTED|Overall Study||102
210861|NCT00772369|515377|P1|NOT COMPLETED|Overall Study||1
210862|NCT00772369|515377|P1|COMPLETED|Overall Study||3213
210863|NCT00772369|515377|P1|STARTED|Overall Study||3214
210864|NCT00772382|515382|P1|NOT COMPLETED|Overall Study||55
210865|NCT00772382|515382|P1|COMPLETED|Overall Study||61
210866|NCT00772382|515382|P1|STARTED|Overall Study||116
210867|NCT00772447|515389|P2|NOT COMPLETED|Overall Study||24
210868|NCT00772447|515390|P1|NOT COMPLETED|Overall Study||20
210869|NCT00772447|515389|P2|COMPLETED|Overall Study||110
210870|NCT00772447|515390|P1|COMPLETED|Overall Study||111
210871|NCT00772447|515389|P2|STARTED|Overall Study||134
210872|NCT00772447|515390|P1|STARTED|Overall Study||131
210873|NCT00764660|515420|P2|NOT COMPLETED|Overall Study||11
210874|NCT00764660|515421|P1|NOT COMPLETED|Overall Study||22
210875|NCT00764660|515420|P2|COMPLETED|Overall Study||55
210876|NCT00764660|515421|P1|COMPLETED|Overall Study||53
210877|NCT00764660|515420|P2|STARTED|Overall Study||66
210878|NCT00764660|515421|P1|STARTED|Overall Study||75
210879|NCT00764673|515453|P1|NOT COMPLETED|Overall Study||12
210880|NCT00764673|515453|P1|COMPLETED|Overall Study||59
210881|NCT00764673|515453|P1|STARTED|Overall Study||71
210882|NCT00764790|515464|P3|NOT COMPLETED|Overall Study||30
210883|NCT00764790|515465|P2|NOT COMPLETED|Overall Study||41
210884|NCT00764790|515466|P1|NOT COMPLETED|Overall Study||38
210885|NCT00764790|515464|P3|COMPLETED|Overall Study||1074
210886|NCT00764790|515465|P2|COMPLETED|Overall Study||1065
210887|NCT00764790|515466|P1|COMPLETED|Overall Study||1069
210888|NCT00764790|515464|P3|STARTED|Overall Study||1104
210889|NCT00764790|515465|P2|STARTED|Overall Study||1106
210890|NCT00764790|515466|P1|STARTED|Overall Study||1107
210891|NCT00764868|515498|P1|NOT COMPLETED|Overall Study||113
210892|NCT00764868|515498|P1|COMPLETED|Overall Study||156
210893|NCT00764868|515498|P1|STARTED|Overall Study||269
210894|NCT00764881|515506|P2|NOT COMPLETED|Overall Study||10
210895|NCT00764881|515507|P1|NOT COMPLETED|Overall Study||16
210896|NCT00764881|515506|P2|COMPLETED|Overall Study||99
210897|NCT00764881|515507|P1|COMPLETED|Overall Study||92
210898|NCT00764881|515506|P2|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|107
210899|NCT00764881|515507|P1|Subjects Received Treatment|Overall Study|Full Analysis Set (FAS)|106
210900|NCT00764881|515506|P2|STARTED|Overall Study||109
210901|NCT00764881|515507|P1|STARTED|Overall Study||108
210902|NCT00764946|515734|P3|NOT COMPLETED|Overall Study||4
210903|NCT00764946|515735|P2|NOT COMPLETED|Overall Study||17
210904|NCT00764946|515736|P1|NOT COMPLETED|Overall Study||13
210905|NCT00764946|515734|P3|COMPLETED|Overall Study||18
210906|NCT00764946|515735|P2|COMPLETED|Overall Study||72
210907|NCT00764946|515736|P1|COMPLETED|Overall Study||85
210908|NCT00764946|515734|P3|TREATED|Overall Study||21
210909|NCT00764946|515735|P2|TREATED|Overall Study||88
210910|NCT00764946|515736|P1|TREATED|Overall Study||97
210911|NCT00764946|515734|P3|STARTED|Overall Study||22
210912|NCT00764946|515735|P2|STARTED|Overall Study||89
210913|NCT00764946|515736|P1|STARTED|Overall Study||98
210914|NCT00765037|515762|P1|NOT COMPLETED|Overall Study||6
210915|NCT00765037|515762|P1|COMPLETED|Overall Study|Subjects who came in for 1 year visit.|13
210916|NCT00765037|515762|P1|STARTED|Overall Study|Original number of eligible subjects who signed a consent form.|19
210917|NCT00765063|515766|P1|NOT COMPLETED|Overall Study||32
210918|NCT00765063|515766|P1|COMPLETED|Overall Study||30
210919|NCT00765063|515766|P1|STARTED|Overall Study||62
210920|NCT00765076|515785|P3|NOT COMPLETED|Overall Study||1
210921|NCT00765076|515786|P2|NOT COMPLETED|Overall Study||0
210922|NCT00765076|515787|P1|NOT COMPLETED|Overall Study||1
210923|NCT00765076|515785|P3|COMPLETED|Overall Study||49
210924|NCT00765076|515786|P2|COMPLETED|Overall Study||73
210925|NCT00765076|515787|P1|COMPLETED|Overall Study||68
210926|NCT00765076|515785|P3|STARTED|Overall Study||50
210927|NCT00765076|515786|P2|STARTED|Overall Study||73
210928|NCT00765076|515787|P1|STARTED|Overall Study||69
210929|NCT00765102|515840|P1|NOT COMPLETED|Overall Study||31
210930|NCT00765102|515840|P1|COMPLETED|Overall Study|Completed 8 cycles of treatment|1
210931|NCT00765102|515840|P1|STARTED|Overall Study||32
210932|NCT00765128|515864|P2|NOT COMPLETED|Overall Study||0
210933|NCT00765128|515865|P1|NOT COMPLETED|Overall Study||0
210934|NCT00765128|515864|P2|COMPLETED|Overall Study||9
210935|NCT00765128|515865|P1|COMPLETED|Overall Study||8
210936|NCT00765128|515864|P2|STARTED|Overall Study||9
210937|NCT00765128|515865|P1|STARTED|Overall Study||8
210938|NCT00765193|515873|P1|NOT COMPLETED|Full Body Examination||0
210939|NCT00765193|515873|P1|COMPLETED|Full Body Examination||14381
210940|NCT00765193|515873|P1|STARTED|Full Body Examination||14381
210941|NCT00765193|515873|P1|NOT COMPLETED|Problem Area Examination||0
210942|NCT00765193|515873|P1|COMPLETED|Problem Area Examination||14381
210943|NCT00765193|515873|P1|STARTED|Problem Area Examination||14381
210944|NCT00765206|515878|P4|NOT COMPLETED|Second Intervention||0
210945|NCT00765206|515879|P3|NOT COMPLETED|Second Intervention||0
210946|NCT00765206|515880|P2|NOT COMPLETED|Second Intervention||0
210947|NCT00765206|515881|P1|NOT COMPLETED|Second Intervention||0
210948|NCT00765206|515878|P4|COMPLETED|Second Intervention||15
210949|NCT00765206|515879|P3|COMPLETED|Second Intervention||15
210950|NCT00765206|515880|P2|COMPLETED|Second Intervention||15
210951|NCT00765206|515881|P1|COMPLETED|Second Intervention||15
210952|NCT00765206|515878|P4|STARTED|Second Intervention||15
210953|NCT00765206|515879|P3|STARTED|Second Intervention||15
210954|NCT00765206|515880|P2|STARTED|Second Intervention||15
210955|NCT00765206|515881|P1|STARTED|Second Intervention||15
210956|NCT00765206|515878|P4|NOT COMPLETED|Washout Period of 14 Days||0
210957|NCT00765206|515879|P3|NOT COMPLETED|Washout Period of 14 Days||0
210958|NCT00765206|515880|P2|NOT COMPLETED|Washout Period of 14 Days||0
210959|NCT00765206|515881|P1|NOT COMPLETED|Washout Period of 14 Days||0
210960|NCT00765206|515878|P4|COMPLETED|Washout Period of 14 Days||15
210961|NCT00765206|515879|P3|COMPLETED|Washout Period of 14 Days||15
210962|NCT00765206|515880|P2|COMPLETED|Washout Period of 14 Days||15
210963|NCT00765206|515881|P1|COMPLETED|Washout Period of 14 Days||15
210964|NCT00765206|515878|P4|STARTED|Washout Period of 14 Days||15
210965|NCT00765206|515879|P3|STARTED|Washout Period of 14 Days||15
210966|NCT00765206|515880|P2|STARTED|Washout Period of 14 Days||15
210967|NCT00765206|515881|P1|STARTED|Washout Period of 14 Days||15
210968|NCT00765206|515878|P4|NOT COMPLETED|First Intervention||0
210969|NCT00765206|515879|P3|NOT COMPLETED|First Intervention||0
210970|NCT00765206|515880|P2|NOT COMPLETED|First Intervention||0
210971|NCT00765206|515881|P1|NOT COMPLETED|First Intervention||0
210972|NCT00765206|515878|P4|COMPLETED|First Intervention||15
210973|NCT00765206|515879|P3|COMPLETED|First Intervention||15
210974|NCT00765206|515880|P2|COMPLETED|First Intervention||15
210975|NCT00765206|515881|P1|COMPLETED|First Intervention||15
210976|NCT00765206|515878|P4|STARTED|First Intervention||15
210977|NCT00765206|515879|P3|STARTED|First Intervention||15
210978|NCT00765206|515880|P2|STARTED|First Intervention||15
210979|NCT00765206|515881|P1|STARTED|First Intervention||15
210980|NCT00765232|515889|P2|NOT COMPLETED|Overall Study||0
210981|NCT00765232|515890|P1|NOT COMPLETED|Overall Study||0
210982|NCT00765232|515889|P2|COMPLETED|Overall Study||54
210983|NCT00765232|515890|P1|COMPLETED|Overall Study||57
210984|NCT00765232|515889|P2|STARTED|Overall Study||54
210985|NCT00765232|515890|P1|STARTED|Overall Study||57
210986|NCT00765245|515900|P2|NOT COMPLETED|Overall Study||2
210987|NCT00765245|515901|P1|NOT COMPLETED|Overall Study||13
210988|NCT00765245|515900|P2|COMPLETED|Overall Study||20
210989|NCT00765245|515901|P1|COMPLETED|Overall Study||9
210990|NCT00765245|515900|P2|STARTED|Overall Study||22
210991|NCT00765245|515901|P1|STARTED|Overall Study||22
210992|NCT00765336|515913|P2|NOT COMPLETED|Overall Study||16
210993|NCT00765336|515914|P1|NOT COMPLETED|Overall Study||19
210994|NCT00765336|515913|P2|COMPLETED|Overall Study||73
210995|NCT00765336|515914|P1|COMPLETED|Overall Study||72
210996|NCT00765336|515913|P2|STARTED|Overall Study||89
210997|NCT00765336|515914|P1|STARTED|Overall Study||91
210998|NCT00765362|515920|P1|NOT COMPLETED|Overall Study||137
210999|NCT00765362|515920|P1|COMPLETED|Overall Study||282
211000|NCT00765362|515920|P1|STARTED|Overall Study||419
211001|NCT00765375|515926|P1|NOT COMPLETED|Overall Study||0
211002|NCT00765375|515926|P1|COMPLETED|Overall Study||5
211003|NCT00765375|515926|P1|STARTED|Overall Study||5
211004|NCT00765388|515932|P2|NOT COMPLETED|Period 2||0
211005|NCT00765388|515933|P1|NOT COMPLETED|Period 2||0
211006|NCT00765388|515932|P2|COMPLETED|Period 2||6
211007|NCT00765388|515933|P1|COMPLETED|Period 2||15
211008|NCT00765388|515932|P2|STARTED|Period 2||6
211009|NCT00765388|515933|P1|STARTED|Period 2||15
211010|NCT00765388|515932|P2|NOT COMPLETED|Period 1||5
211011|NCT00765388|515933|P1|NOT COMPLETED|Period 1||1
211012|NCT00765388|515932|P2|COMPLETED|Period 1||6
211013|NCT00765388|515933|P1|COMPLETED|Period 1||15
211014|NCT00765388|515932|P2|STARTED|Period 1||11
211015|NCT00765388|515933|P1|STARTED|Period 1|A cross-over study|16
211016|NCT00765570|515963|P2|NOT COMPLETED|Overall Study||0
211017|NCT00765570|515964|P1|NOT COMPLETED|Overall Study||2
211018|NCT00765570|515963|P2|COMPLETED|Overall Study||3
211019|NCT00765570|515964|P1|COMPLETED|Overall Study||7
211020|NCT00765570|515963|P2|STARTED|Overall Study||3
211021|NCT00765570|515964|P1|STARTED|Overall Study||9
211022|NCT00765648|515974|P2|NOT COMPLETED|Overall Study||2
211023|NCT00765648|515975|P1|NOT COMPLETED|Overall Study||1
211024|NCT00765648|515974|P2|COMPLETED|Overall Study||114
211025|NCT00765648|515975|P1|COMPLETED|Overall Study||109
211026|NCT00765648|515974|P2|STARTED|Overall Study||116
211027|NCT00765648|515975|P1|STARTED|Overall Study||110
211028|NCT00765661|515993|P2|NOT COMPLETED|Overall Study||0
211029|NCT00765661|515994|P1|NOT COMPLETED|Overall Study||0
211030|NCT00765661|515993|P2|COMPLETED|Overall Study||31
211031|NCT00765661|515994|P1|COMPLETED|Overall Study||32
211032|NCT00765661|515993|P2|STARTED|Overall Study||31
211033|NCT00765661|515994|P1|STARTED|Overall Study||32
211034|NCT00765674|516010|P4|NOT COMPLETED|Overall Study||25
211035|NCT00765674|516011|P3|NOT COMPLETED|Overall Study||17
211036|NCT00765674|516012|P2|NOT COMPLETED|Overall Study||22
211037|NCT00765674|516013|P1|NOT COMPLETED|Overall Study||21
211038|NCT00765674|516010|P4|COMPLETED|Overall Study||285
211039|NCT00765674|516011|P3|COMPLETED|Overall Study||279
211040|NCT00765674|516012|P2|COMPLETED|Overall Study||276
211041|NCT00765674|516013|P1|COMPLETED|Overall Study||266
211042|NCT00765674|516010|P4|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|310
211043|NCT00765674|516011|P3|STARTED|Overall Study||296
211044|NCT00765674|516012|P2|STARTED|Overall Study|1 patient was randomized in error and discontinued without taking any double-blind study medication.|298
211045|NCT00765674|516013|P1|STARTED|Overall Study||287
211046|NCT00765726|516035|P1|NOT COMPLETED|Overall Study||9
211047|NCT00765726|516035|P1|COMPLETED|Overall Study||3
211048|NCT00765726|516035|P1|STARTED|Overall Study||12
211049|NCT00765765|516039|P1|NOT COMPLETED|Overall Study||0
211050|NCT00765765|516039|P1|COMPLETED|Overall Study||6
211051|NCT00765765|516039|P1|STARTED|Overall Study||6
211052|NCT00765817|516051|P2|NOT COMPLETED|Overall Study||22
211053|NCT00765817|516052|P1|NOT COMPLETED|Overall Study||26
211054|NCT00765817|516051|P2|COMPLETED|Overall Study||101
211055|NCT00765817|516052|P1|COMPLETED|Overall Study||112
211056|NCT00765817|516051|P2|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|123
211057|NCT00765817|516052|P1|STARTED|Overall Study|One subject withdrew prior to receiving study medication, not included in analysis set|138
211058|NCT00765843|516093|P3|NOT COMPLETED|Overall Study||3
211059|NCT00765843|516094|P2|NOT COMPLETED|Overall Study||4
211060|NCT00765843|516095|P1|NOT COMPLETED|Overall Study||1
211061|NCT00765843|516093|P3|COMPLETED|Overall Study||23
211062|NCT00765843|516094|P2|COMPLETED|Overall Study||21
211063|NCT00765843|516095|P1|COMPLETED|Overall Study||25
211064|NCT00765843|516093|P3|STARTED|Overall Study||26
211065|NCT00765843|516094|P2|STARTED|Overall Study||25
211066|NCT00765843|516095|P1|STARTED|Overall Study||26
211067|NCT00765882|516106|P3|NOT COMPLETED|Overall Study||36
211068|NCT00765882|516107|P2|NOT COMPLETED|Overall Study||40
211069|NCT00765882|516108|P1|NOT COMPLETED|Overall Study||24
211070|NCT00765882|516106|P3|COMPLETED|Overall Study||169
211071|NCT00765882|516107|P2|COMPLETED|Overall Study||173
211072|NCT00765882|516108|P1|COMPLETED|Overall Study||191
211073|NCT00765882|516106|P3|STARTED|Overall Study||205
211074|NCT00765882|516107|P2|STARTED|Overall Study||213
211075|NCT00765882|516108|P1|STARTED|Overall Study||215
211076|NCT00765895|516139|P2|NOT COMPLETED|Overall Study||0
211077|NCT00765895|516140|P1|NOT COMPLETED|Overall Study||0
211078|NCT00765895|516139|P2|COMPLETED|Overall Study||65
211079|NCT00765895|516140|P1|COMPLETED|Overall Study||65
211080|NCT00765895|516139|P2|STARTED|Overall Study||65
211081|NCT00765895|516140|P1|STARTED|Overall Study||65
211082|NCT00765947|516146|P1|NOT COMPLETED|Overall Study||24
211083|NCT00765947|516146|P1|COMPLETED|Overall Study||232
211084|NCT00765947|516146|P1|STARTED|Overall Study||256
211085|NCT00766051|516157|P2|NOT COMPLETED|Overall Study||0
211086|NCT00766051|516158|P1|NOT COMPLETED|Overall Study||2
211087|NCT00766051|516157|P2|COMPLETED|Overall Study||10
211088|NCT00766051|516158|P1|COMPLETED|Overall Study||10
211089|NCT00766051|516157|P2|STARTED|Overall Study||10
211090|NCT00766051|516158|P1|STARTED|Overall Study||12
211091|NCT00766090|516170|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||1
211092|NCT00766090|516171|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
211093|NCT00766090|516172|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
211094|NCT00766090|516173|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
211095|NCT00766090|516174|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
211096|NCT00766090|516175|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
211097|NCT00766090|516176|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||1
211098|NCT00766090|516177|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||1
211099|NCT00766090|516178|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||1
211100|NCT00766090|516179|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||0
211101|NCT00766090|516180|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||1
211102|NCT00766090|516181|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
211103|NCT00766090|516170|P12|COMPLETED|Treatment Period 3 (28 Days)||6
211104|NCT00766090|516171|P11|COMPLETED|Treatment Period 3 (28 Days)||7
211105|NCT00766090|516172|P10|COMPLETED|Treatment Period 3 (28 Days)||8
211106|NCT00766090|516173|P9|COMPLETED|Treatment Period 3 (28 Days)||6
211107|NCT00766090|516174|P8|COMPLETED|Treatment Period 3 (28 Days)||8
211108|NCT00766090|516175|P7|COMPLETED|Treatment Period 3 (28 Days)||6
211109|NCT00766090|516176|P6|COMPLETED|Treatment Period 3 (28 Days)||22
211110|NCT00766090|516177|P5|COMPLETED|Treatment Period 3 (28 Days)||20
211111|NCT00766090|516178|P4|COMPLETED|Treatment Period 3 (28 Days)||24
211112|NCT00766090|516179|P3|COMPLETED|Treatment Period 3 (28 Days)||20
211113|NCT00766090|516180|P2|COMPLETED|Treatment Period 3 (28 Days)||26
211114|NCT00766090|516181|P1|COMPLETED|Treatment Period 3 (28 Days)||22
211115|NCT00766090|516170|P12|STARTED|Treatment Period 3 (28 Days)||7
211116|NCT00766090|516171|P11|STARTED|Treatment Period 3 (28 Days)||7
211117|NCT00766090|516172|P10|STARTED|Treatment Period 3 (28 Days)||8
211118|NCT00766090|516173|P9|STARTED|Treatment Period 3 (28 Days)||6
211119|NCT00766090|516174|P8|STARTED|Treatment Period 3 (28 Days)||8
211120|NCT00766090|516175|P7|STARTED|Treatment Period 3 (28 Days)||6
211121|NCT00766090|516176|P6|STARTED|Treatment Period 3 (28 Days)||23
211122|NCT00766090|516177|P5|STARTED|Treatment Period 3 (28 Days)||21
211123|NCT00766090|516178|P4|STARTED|Treatment Period 3 (28 Days)||25
211124|NCT00766090|516179|P3|STARTED|Treatment Period 3 (28 Days)||20
211125|NCT00766090|516180|P2|STARTED|Treatment Period 3 (28 Days)||27
211126|NCT00766090|516181|P1|STARTED|Treatment Period 3 (28 Days)||22
211127|NCT00766090|516170|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
211128|NCT00766090|516171|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
211129|NCT00766090|516172|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
211130|NCT00766090|516173|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
211131|NCT00766090|516174|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
211132|NCT00766090|516175|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
211133|NCT00766090|516176|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
211134|NCT00766090|516177|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
211135|NCT00766090|516178|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
211136|NCT00766090|516179|P3|NOT COMPLETED|Washout Period 2 (14 Days)||1
211137|NCT00766090|516180|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
211138|NCT00766090|516181|P1|NOT COMPLETED|Washout Period 2 (14 Days)||0
211139|NCT00766090|516170|P12|COMPLETED|Washout Period 2 (14 Days)||7
211140|NCT00766090|516171|P11|COMPLETED|Washout Period 2 (14 Days)||7
211141|NCT00766090|516172|P10|COMPLETED|Washout Period 2 (14 Days)||8
211142|NCT00766090|516173|P9|COMPLETED|Washout Period 2 (14 Days)||6
211143|NCT00766090|516174|P8|COMPLETED|Washout Period 2 (14 Days)||8
211144|NCT00766090|516175|P7|COMPLETED|Washout Period 2 (14 Days)||6
211145|NCT00766090|516176|P6|COMPLETED|Washout Period 2 (14 Days)||23
211146|NCT00766090|516177|P5|COMPLETED|Washout Period 2 (14 Days)||21
211147|NCT00766090|516178|P4|COMPLETED|Washout Period 2 (14 Days)||25
211148|NCT00766090|516179|P3|COMPLETED|Washout Period 2 (14 Days)||20
211149|NCT00766090|516180|P2|COMPLETED|Washout Period 2 (14 Days)||27
211150|NCT00766090|516181|P1|COMPLETED|Washout Period 2 (14 Days)||22
211151|NCT00766090|516170|P12|STARTED|Washout Period 2 (14 Days)||7
211152|NCT00766090|516171|P11|STARTED|Washout Period 2 (14 Days)||7
211153|NCT00766090|516172|P10|STARTED|Washout Period 2 (14 Days)||8
211154|NCT00766090|516173|P9|STARTED|Washout Period 2 (14 Days)||6
211155|NCT00766090|516174|P8|STARTED|Washout Period 2 (14 Days)||8
211156|NCT00766090|516175|P7|STARTED|Washout Period 2 (14 Days)||6
211157|NCT00766090|516176|P6|STARTED|Washout Period 2 (14 Days)||23
211158|NCT00766090|516177|P5|STARTED|Washout Period 2 (14 Days)||21
211159|NCT00766090|516178|P4|STARTED|Washout Period 2 (14 Days)||25
211160|NCT00766090|516179|P3|STARTED|Washout Period 2 (14 Days)||21
211161|NCT00766090|516180|P2|STARTED|Washout Period 2 (14 Days)||27
211162|NCT00766090|516181|P1|STARTED|Washout Period 2 (14 Days)||22
211163|NCT00766090|516170|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211164|NCT00766090|516171|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211165|NCT00766090|516172|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211166|NCT00766090|516173|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211167|NCT00766090|516174|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211168|NCT00766090|516175|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211169|NCT00766090|516176|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211170|NCT00766090|516177|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||2
211171|NCT00766090|516178|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211172|NCT00766090|516179|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
211173|NCT00766090|516180|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211174|NCT00766090|516181|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
211175|NCT00766090|516170|P12|COMPLETED|Treatment Period 2 (28 Days)||7
211176|NCT00766090|516171|P11|COMPLETED|Treatment Period 2 (28 Days)||7
211177|NCT00766090|516172|P10|COMPLETED|Treatment Period 2 (28 Days)||8
211178|NCT00766090|516173|P9|COMPLETED|Treatment Period 2 (28 Days)||6
211179|NCT00766090|516174|P8|COMPLETED|Treatment Period 2 (28 Days)||8
211180|NCT00766090|516175|P7|COMPLETED|Treatment Period 2 (28 Days)||6
211181|NCT00766090|516176|P6|COMPLETED|Treatment Period 2 (28 Days)||23
211182|NCT00766090|516177|P5|COMPLETED|Treatment Period 2 (28 Days)||21
211183|NCT00766090|516178|P4|COMPLETED|Treatment Period 2 (28 Days)||25
211184|NCT00766090|516179|P3|COMPLETED|Treatment Period 2 (28 Days)||21
211185|NCT00766090|516180|P2|COMPLETED|Treatment Period 2 (28 Days)||27
211186|NCT00766090|516181|P1|COMPLETED|Treatment Period 2 (28 Days)||22
211187|NCT00766090|516170|P12|STARTED|Treatment Period 2 (28 Days)||7
211188|NCT00766090|516171|P11|STARTED|Treatment Period 2 (28 Days)||7
211189|NCT00766090|516172|P10|STARTED|Treatment Period 2 (28 Days)||8
211190|NCT00766090|516173|P9|STARTED|Treatment Period 2 (28 Days)||6
211191|NCT00766090|516174|P8|STARTED|Treatment Period 2 (28 Days)||8
211192|NCT00766090|516175|P7|STARTED|Treatment Period 2 (28 Days)||6
211193|NCT00766090|516176|P6|STARTED|Treatment Period 2 (28 Days)||23
211194|NCT00766090|516177|P5|STARTED|Treatment Period 2 (28 Days)||23
211195|NCT00766090|516178|P4|STARTED|Treatment Period 2 (28 Days)||25
211196|NCT00766090|516179|P3|STARTED|Treatment Period 2 (28 Days)||22
211197|NCT00766090|516180|P2|STARTED|Treatment Period 2 (28 Days)||27
211198|NCT00766090|516181|P1|STARTED|Treatment Period 2 (28 Days)||22
211199|NCT00766090|516170|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
211200|NCT00766090|516171|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
211201|NCT00766090|516172|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
211202|NCT00766090|516173|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
211203|NCT00766090|516174|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
211204|NCT00766090|516175|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
211205|NCT00766090|516176|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
211206|NCT00766090|516177|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
211207|NCT00766090|516178|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
211208|NCT00766090|516179|P3|NOT COMPLETED|Washout Period 1 (14 Days)||1
211209|NCT00766090|516180|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
211210|NCT00766090|516181|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
211211|NCT00766090|516170|P12|COMPLETED|Washout Period 1 (14 Days)||7
211212|NCT00766090|516171|P11|COMPLETED|Washout Period 1 (14 Days)||7
211213|NCT00766090|516172|P10|COMPLETED|Washout Period 1 (14 Days)||8
211214|NCT00766090|516173|P9|COMPLETED|Washout Period 1 (14 Days)||6
211215|NCT00766090|516174|P8|COMPLETED|Washout Period 1 (14 Days)||8
211216|NCT00766090|516175|P7|COMPLETED|Washout Period 1 (14 Days)||6
211217|NCT00766090|516176|P6|COMPLETED|Washout Period 1 (14 Days)||23
211218|NCT00766090|516177|P5|COMPLETED|Washout Period 1 (14 Days)||23
211219|NCT00766090|516178|P4|COMPLETED|Washout Period 1 (14 Days)||25
211220|NCT00766090|516179|P3|COMPLETED|Washout Period 1 (14 Days)||22
211221|NCT00766090|516180|P2|COMPLETED|Washout Period 1 (14 Days)||27
211222|NCT00766090|516181|P1|COMPLETED|Washout Period 1 (14 Days)||22
211223|NCT00766090|516170|P12|STARTED|Washout Period 1 (14 Days)||7
211224|NCT00766090|516171|P11|STARTED|Washout Period 1 (14 Days)||7
211225|NCT00766090|516172|P10|STARTED|Washout Period 1 (14 Days)||8
211226|NCT00766090|516173|P9|STARTED|Washout Period 1 (14 Days)||6
211227|NCT00766090|516174|P8|STARTED|Washout Period 1 (14 Days)||8
211228|NCT00766090|516175|P7|STARTED|Washout Period 1 (14 Days)||6
211229|NCT00766090|516176|P6|STARTED|Washout Period 1 (14 Days)||23
211230|NCT00766090|516177|P5|STARTED|Washout Period 1 (14 Days)||23
211231|NCT00766090|516178|P4|STARTED|Washout Period 1 (14 Days)||25
211232|NCT00766090|516179|P3|STARTED|Washout Period 1 (14 Days)||23
211233|NCT00766090|516180|P2|STARTED|Washout Period 1 (14 Days)||27
211234|NCT00766090|516181|P1|STARTED|Washout Period 1 (14 Days)||22
211235|NCT00766090|516170|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211236|NCT00766090|516171|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211237|NCT00766090|516172|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211238|NCT00766090|516173|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||1
211239|NCT00766090|516174|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211240|NCT00766090|516175|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211241|NCT00766090|516176|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211242|NCT00766090|516177|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211243|NCT00766090|516178|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||1
211244|NCT00766090|516179|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211245|NCT00766090|516180|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
211246|NCT00766090|516181|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||3
211247|NCT00766090|516170|P12|COMPLETED|Treatment Period 1 (28 Days)||7
211248|NCT00766090|516171|P11|COMPLETED|Treatment Period 1 (28 Days)||7
211249|NCT00766090|516172|P10|COMPLETED|Treatment Period 1 (28 Days)||8
211250|NCT00766090|516173|P9|COMPLETED|Treatment Period 1 (28 Days)||6
211251|NCT00766090|516174|P8|COMPLETED|Treatment Period 1 (28 Days)||8
211252|NCT00766090|516175|P7|COMPLETED|Treatment Period 1 (28 Days)||6
211253|NCT00766090|516176|P6|COMPLETED|Treatment Period 1 (28 Days)||23
211254|NCT00766090|516177|P5|COMPLETED|Treatment Period 1 (28 Days)||23
211255|NCT00766090|516178|P4|COMPLETED|Treatment Period 1 (28 Days)||25
211256|NCT00766090|516179|P3|COMPLETED|Treatment Period 1 (28 Days)||23
211257|NCT00766090|516180|P2|COMPLETED|Treatment Period 1 (28 Days)||27
211258|NCT00766090|516181|P1|COMPLETED|Treatment Period 1 (28 Days)||22
211259|NCT00766090|516170|P12|STARTED|Treatment Period 1 (28 Days)||7
211260|NCT00766090|516171|P11|STARTED|Treatment Period 1 (28 Days)||7
211261|NCT00766090|516172|P10|STARTED|Treatment Period 1 (28 Days)||8
211262|NCT00766090|516173|P9|STARTED|Treatment Period 1 (28 Days)||7
211263|NCT00766090|516174|P8|STARTED|Treatment Period 1 (28 Days)||8
211264|NCT00766090|516175|P7|STARTED|Treatment Period 1 (28 Days)||6
211265|NCT00766090|516176|P6|STARTED|Treatment Period 1 (28 Days)||23
211266|NCT00766090|516177|P5|STARTED|Treatment Period 1 (28 Days)||23
211267|NCT00766090|516178|P4|STARTED|Treatment Period 1 (28 Days)||26
211268|NCT00766090|516179|P3|STARTED|Treatment Period 1 (28 Days)||23
211269|NCT00766090|516180|P2|STARTED|Treatment Period 1 (28 Days)||27
211270|NCT00766090|516181|P1|STARTED|Treatment Period 1 (28 Days)||25
211271|NCT00766363|516224|P4|NOT COMPLETED|Overall Study||0
211272|NCT00766363|516225|P3|NOT COMPLETED|Overall Study||0
211273|NCT00766363|516226|P2|NOT COMPLETED|Overall Study||1
211274|NCT00766363|516227|P1|NOT COMPLETED|Overall Study||1
211275|NCT00766363|516224|P4|COMPLETED|Overall Study||12
211276|NCT00766363|516225|P3|COMPLETED|Overall Study||12
211277|NCT00766363|516226|P2|COMPLETED|Overall Study||12
211278|NCT00766363|516227|P1|COMPLETED|Overall Study||11
211279|NCT00766363|516224|P4|PK POPULATION|Overall Study||13
211280|NCT00766363|516225|P3|PK POPULATION|Overall Study||10
211281|NCT00766363|516226|P2|PK POPULATION|Overall Study||13
211282|NCT00766363|516227|P1|PK POPULATION|Overall Study||12
211283|NCT00766363|516224|P4|SAFETY POPULATION|Overall Study|Increased by one subject who took placebo due to treatment assignment error.|13
211284|NCT00766363|516225|P3|SAFETY POPULATION|Overall Study|Decreased by one subject who took placebo instead due to treatment assignment error.|11
211285|NCT00766363|516226|P2|SAFETY POPULATION|Overall Study||13
211286|NCT00766363|516227|P1|SAFETY POPULATION|Overall Study||12
211287|NCT00766363|516224|P4|STARTED|Overall Study|Number randomized.|12
211288|NCT00766363|516225|P3|STARTED|Overall Study|Number randomized.|12
211289|NCT00766363|516226|P2|STARTED|Overall Study||13
211290|NCT00766363|516227|P1|STARTED|Overall Study||12
211291|NCT00766376|516264|P1|NOT COMPLETED|Overall Study||27
211292|NCT00766376|516264|P1|COMPLETED|Overall Study||124
211293|NCT00766376|516264|P1|STARTED|Overall Study||151
211294|NCT00766415|516271|P2|NOT COMPLETED|Overall Study||1
211295|NCT00766415|516272|P1|NOT COMPLETED|Overall Study||0
211296|NCT00766415|516271|P2|COMPLETED|Overall Study||26
211297|NCT00766415|516272|P1|COMPLETED|Overall Study||25
211298|NCT00766415|516271|P2|STARTED|Overall Study||27
211299|NCT00766415|516272|P1|STARTED|Overall Study||25
211300|NCT00766467|516322|P2|NOT COMPLETED|Overall Study||8
211301|NCT00766467|516323|P1|NOT COMPLETED|Overall Study||11
211302|NCT00766467|516322|P2|COMPLETED|Overall Study||31
211303|NCT00766467|516323|P1|COMPLETED|Overall Study||31
211304|NCT00766467|516322|P2|Initiated Treatment|Overall Study||38
211305|NCT00766467|516323|P1|Initiated Treatment|Overall Study||39
211306|NCT00766467|516322|P2|STARTED|Overall Study||39
211307|NCT00766467|516323|P1|STARTED|Overall Study||42
211308|NCT00766493|516333|P1|NOT COMPLETED|30 Days Post-Procedure||12
211309|NCT00766493|516333|P1|COMPLETED|30 Days Post-Procedure||238
211310|NCT00766493|516333|P1|STARTED|30 Days Post-Procedure||250
211311|NCT00766493|516333|P1|NOT COMPLETED|Pre-Discharge||0
211312|NCT00766493|516333|P1|COMPLETED|Pre-Discharge||250
211313|NCT00766493|516333|P1|STARTED|Pre-Discharge||250
211314|NCT00766506|516343|P2|NOT COMPLETED|Overall Study||2
211315|NCT00766506|516344|P1|NOT COMPLETED|Overall Study||5
211316|NCT00766506|516343|P2|COMPLETED|Overall Study||48
211317|NCT00766506|516344|P1|COMPLETED|Overall Study||53
211318|NCT00766506|516343|P2|STARTED|Overall Study||50
211319|NCT00766506|516344|P1|STARTED|Overall Study||58
211320|NCT00766532|516368|P1|NOT COMPLETED|Overall Study||2
211321|NCT00766532|516368|P1|COMPLETED|Overall Study||10
211322|NCT00766532|516368|P1|STARTED|Overall Study||12
211323|NCT00766597|516372|P1|NOT COMPLETED|Overall Study||9
211324|NCT00766597|516372|P1|COMPLETED|Overall Study|Treatment duration is 48 weeks plus 5 years of follow-up|0
211325|NCT00766597|516372|P1|Completed Week 48|Overall Study|Week 48 is the second primary time point of analysis|0
211326|NCT00766597|516372|P1|Completed Week 24|Overall Study|Week 24 is the first primary time point of analysis|1
211327|NCT00766597|516372|P1|Without CCR5-tropic Virus|Overall Study|Not evaluable participants, did not receive the study drug|5
211328|NCT00766597|516372|P1|With CCR5-tropic Virus|Overall Study|Evaluable participants, received the study drug|4
211329|NCT00766597|516372|P1|STARTED|Overall Study|Screened participants who were evaluated for co-receptor tropism|9
211330|NCT00766636|516386|P2|NOT COMPLETED|Overall Study||2
211331|NCT00766636|516387|P1|NOT COMPLETED|Overall Study||3
211332|NCT00766636|516386|P2|COMPLETED|Overall Study||0
211333|NCT00766636|516387|P1|COMPLETED|Overall Study|Number that completed pre- and post-operative therapy as well as surgery.|0
211334|NCT00766636|516386|P2|STARTED|Overall Study||2
211335|NCT00766636|516387|P1|STARTED|Overall Study||3
211336|NCT00766649|516393|P1|NOT COMPLETED|Overall Study||10
211337|NCT00766649|516393|P1|COMPLETED|Overall Study||1
211338|NCT00766649|516393|P1|STARTED|Overall Study||11
211339|NCT00766675|516405|P1|NOT COMPLETED|Overall Study||40
211340|NCT00766675|516405|P1|COMPLETED|Overall Study||40
211341|NCT00766675|516405|P1|STARTED|Overall Study||80
211342|NCT00766753|516420|P2|NOT COMPLETED|Overall Study||0
211343|NCT00766753|516421|P1|NOT COMPLETED|Overall Study||0
211344|NCT00766753|516420|P2|COMPLETED|Overall Study||11
211345|NCT00766753|516421|P1|COMPLETED|Overall Study||11
211346|NCT00766753|516420|P2|Completed at Least Four Vaccines|Overall Study||9
211347|NCT00766753|516421|P1|Completed at Least Four Vaccines|Overall Study||10
211348|NCT00766753|516420|P2|Received at Least One Vaccine|Overall Study||11
211349|NCT00766753|516421|P1|Received at Least One Vaccine|Overall Study||11
211350|NCT00766753|516420|P2|STARTED|Overall Study||11
211351|NCT00766753|516421|P1|STARTED|Overall Study||11
211352|NCT00766831|516432|P1|NOT COMPLETED|Overall Study||115
211353|NCT00766831|516432|P1|COMPLETED|Overall Study||75
211354|NCT00766831|516432|P1|STARTED|Overall Study||190
211355|NCT00772538|516450|P2|NOT COMPLETED|Overall Study||26
211356|NCT00772538|516451|P1|NOT COMPLETED|Overall Study||20
211357|NCT00772538|516450|P2|COMPLETED|Overall Study||211
211358|NCT00772538|516451|P1|COMPLETED|Overall Study||202
211359|NCT00772538|516450|P2|STARTED|Overall Study||237
211360|NCT00772538|516451|P1|STARTED|Overall Study||222
211361|NCT00772577|516523|P2|NOT COMPLETED|Overall Study||23
211362|NCT00772577|516524|P1|NOT COMPLETED|Overall Study||23
211363|NCT00772577|516523|P2|COMPLETED|Overall Study||170
211364|NCT00772577|516524|P1|COMPLETED|Overall Study||170
211365|NCT00772577|516523|P2|STARTED|Overall Study||193
211366|NCT00772577|516524|P1|STARTED|Overall Study||193
211367|NCT00772590|516542|P4|NOT COMPLETED|Overall Study||0
211368|NCT00772590|516543|P3|NOT COMPLETED|Overall Study||0
211369|NCT00772590|516544|P2|NOT COMPLETED|Overall Study||0
211370|NCT00772590|516545|P1|NOT COMPLETED|Overall Study||0
211371|NCT00772590|516542|P4|COMPLETED|Overall Study||17
211372|NCT00772590|516543|P3|COMPLETED|Overall Study||18
211373|NCT00772590|516544|P2|COMPLETED|Overall Study||19
211374|NCT00772590|516545|P1|COMPLETED|Overall Study||19
211375|NCT00772590|516542|P4|STARTED|Overall Study||17
211376|NCT00772590|516543|P3|STARTED|Overall Study||18
211377|NCT00772590|516544|P2|STARTED|Overall Study||19
211378|NCT00772590|516545|P1|STARTED|Overall Study||19
211379|NCT00772603|516558|P3|NOT COMPLETED|Overall Study||26
211380|NCT00772603|516559|P2|NOT COMPLETED|Overall Study||40
211381|NCT00772603|516560|P1|NOT COMPLETED|Overall Study||52
211382|NCT00772603|516558|P3|COMPLETED|Overall Study||95
211383|NCT00772603|516559|P2|COMPLETED|Overall Study||82
211384|NCT00772603|516560|P1|COMPLETED|Overall Study||71
211385|NCT00772603|516558|P3|STARTED|Overall Study||121
211386|NCT00772603|516559|P2|STARTED|Overall Study||122
211387|NCT00772603|516560|P1|STARTED|Overall Study||123
211388|NCT00772629|516582|P2|NOT COMPLETED|Overall Study||0
211389|NCT00772629|516583|P1|NOT COMPLETED|Overall Study||1
211390|NCT00772629|516582|P2|COMPLETED|Overall Study||1
211391|NCT00772629|516583|P1|COMPLETED|Overall Study||16
211392|NCT00772629|516582|P2|STARTED|Overall Study||1
211393|NCT00772629|516583|P1|STARTED|Overall Study||17
211394|NCT00772668|516589|P1|NOT COMPLETED|Overall Study||3
211395|NCT00772668|516589|P1|COMPLETED|Overall Study||0
211396|NCT00772668|516589|P1|STARTED|Overall Study||3
211397|NCT00772707|516593|P1|NOT COMPLETED|Overall Study||3
211398|NCT00772707|516593|P1|COMPLETED|Overall Study||111
211399|NCT00772707|516593|P1|STARTED|Overall Study||114
211400|NCT00772772|516598|P1|NOT COMPLETED|Overall Study||0
211401|NCT00772772|516598|P1|COMPLETED|Overall Study||12
211402|NCT00772772|516598|P1|STARTED|Overall Study||12
211403|NCT00772941|516603|P1|NOT COMPLETED|Overall Study||682
211404|NCT00772941|516603|P1|COMPLETED|Overall Study||3257
211405|NCT00772941|516603|P1|STARTED|Overall Study||3939
211406|NCT00772954|516635|P3|NOT COMPLETED|Overall Study||1
211407|NCT00772954|516636|P2|NOT COMPLETED|Overall Study||0
211408|NCT00772954|516637|P1|NOT COMPLETED|Overall Study||0
211409|NCT00772954|516635|P3|COMPLETED|Overall Study||11
211410|NCT00772954|516636|P2|COMPLETED|Overall Study||12
211411|NCT00772954|516637|P1|COMPLETED|Overall Study||12
211412|NCT00772954|516635|P3|STARTED|Overall Study||12
211413|NCT00772954|516636|P2|STARTED|Overall Study||12
211414|NCT00772954|516637|P1|STARTED|Overall Study||12
211415|NCT00772967|516645|P6|NOT COMPLETED|Crossover Treatment 3||0
211416|NCT00772967|516646|P5|NOT COMPLETED|Crossover Treatment 3||1
211417|NCT00772967|516647|P4|NOT COMPLETED|Crossover Treatment 3||0
211418|NCT00772967|516648|P3|NOT COMPLETED|Crossover Treatment 3||0
211419|NCT00772967|516649|P2|NOT COMPLETED|Crossover Treatment 3||0
211420|NCT00772967|516650|P1|NOT COMPLETED|Crossover Treatment 3||0
211421|NCT00772967|516645|P6|COMPLETED|Crossover Treatment 3||3
211422|NCT00772967|516646|P5|COMPLETED|Crossover Treatment 3||3
211423|NCT00772967|516647|P4|COMPLETED|Crossover Treatment 3||3
211424|NCT00772967|516648|P3|COMPLETED|Crossover Treatment 3||3
211425|NCT00772967|516649|P2|COMPLETED|Crossover Treatment 3||4
211426|NCT00772967|516650|P1|COMPLETED|Crossover Treatment 3||3
211427|NCT00772967|516645|P6|STARTED|Crossover Treatment 3||3
211428|NCT00772967|516646|P5|STARTED|Crossover Treatment 3||4
211429|NCT00772967|516647|P4|STARTED|Crossover Treatment 3||3
211430|NCT00772967|516648|P3|STARTED|Crossover Treatment 3||3
211431|NCT00772967|516649|P2|STARTED|Crossover Treatment 3||4
211432|NCT00772967|516650|P1|STARTED|Crossover Treatment 3||3
211433|NCT00772967|516645|P6|NOT COMPLETED|Break 2 (4-7 Days)||0
211434|NCT00772967|516646|P5|NOT COMPLETED|Break 2 (4-7 Days)||0
211435|NCT00772967|516647|P4|NOT COMPLETED|Break 2 (4-7 Days)||0
211436|NCT00772967|516648|P3|NOT COMPLETED|Break 2 (4-7 Days)||0
211437|NCT00772967|516649|P2|NOT COMPLETED|Break 2 (4-7 Days)||0
211438|NCT00772967|516650|P1|NOT COMPLETED|Break 2 (4-7 Days)||0
211439|NCT00772967|516645|P6|COMPLETED|Break 2 (4-7 Days)||3
211440|NCT00772967|516646|P5|COMPLETED|Break 2 (4-7 Days)||4
211441|NCT00772967|516647|P4|COMPLETED|Break 2 (4-7 Days)||3
211442|NCT00772967|516648|P3|COMPLETED|Break 2 (4-7 Days)||3
211443|NCT00772967|516649|P2|COMPLETED|Break 2 (4-7 Days)||4
211444|NCT00772967|516650|P1|COMPLETED|Break 2 (4-7 Days)||3
211445|NCT00772967|516645|P6|STARTED|Break 2 (4-7 Days)||3
211446|NCT00772967|516646|P5|STARTED|Break 2 (4-7 Days)||4
211447|NCT00772967|516647|P4|STARTED|Break 2 (4-7 Days)||3
211448|NCT00772967|516648|P3|STARTED|Break 2 (4-7 Days)||3
211449|NCT00772967|516649|P2|STARTED|Break 2 (4-7 Days)||4
211450|NCT00772967|516650|P1|STARTED|Break 2 (4-7 Days)||3
211451|NCT00772967|516645|P6|NOT COMPLETED|Crossover Treatment 2||0
211452|NCT00772967|516646|P5|NOT COMPLETED|Crossover Treatment 2||0
211453|NCT00772967|516647|P4|NOT COMPLETED|Crossover Treatment 2||0
211454|NCT00772967|516648|P3|NOT COMPLETED|Crossover Treatment 2||0
211455|NCT00772967|516649|P2|NOT COMPLETED|Crossover Treatment 2||0
211456|NCT00772967|516650|P1|NOT COMPLETED|Crossover Treatment 2||0
211457|NCT00772967|516645|P6|COMPLETED|Crossover Treatment 2||3
211458|NCT00772967|516646|P5|COMPLETED|Crossover Treatment 2||4
211459|NCT00772967|516647|P4|COMPLETED|Crossover Treatment 2||3
211460|NCT00772967|516648|P3|COMPLETED|Crossover Treatment 2||3
211461|NCT00772967|516649|P2|COMPLETED|Crossover Treatment 2||4
211462|NCT00772967|516650|P1|COMPLETED|Crossover Treatment 2||3
211463|NCT00772967|516645|P6|STARTED|Crossover Treatment 2||3
211464|NCT00772967|516646|P5|STARTED|Crossover Treatment 2||4
211465|NCT00772967|516647|P4|STARTED|Crossover Treatment 2||3
211466|NCT00772967|516648|P3|STARTED|Crossover Treatment 2||3
211467|NCT00772967|516649|P2|STARTED|Crossover Treatment 2||4
211468|NCT00772967|516650|P1|STARTED|Crossover Treatment 2||3
211469|NCT00772967|516645|P6|NOT COMPLETED|Break 1 (4-7 Days)||0
211470|NCT00772967|516646|P5|NOT COMPLETED|Break 1 (4-7 Days)||0
211471|NCT00772967|516647|P4|NOT COMPLETED|Break 1 (4-7 Days)||0
211472|NCT00772967|516648|P3|NOT COMPLETED|Break 1 (4-7 Days)||0
211473|NCT00772967|516649|P2|NOT COMPLETED|Break 1 (4-7 Days)||1
211474|NCT00772967|516650|P1|NOT COMPLETED|Break 1 (4-7 Days)||0
211475|NCT00772967|516645|P6|COMPLETED|Break 1 (4-7 Days)||3
211476|NCT00772967|516646|P5|COMPLETED|Break 1 (4-7 Days)||4
211477|NCT00772967|516647|P4|COMPLETED|Break 1 (4-7 Days)||3
211478|NCT00772967|516648|P3|COMPLETED|Break 1 (4-7 Days)||3
211479|NCT00772967|516649|P2|COMPLETED|Break 1 (4-7 Days)||4
211480|NCT00772967|516650|P1|COMPLETED|Break 1 (4-7 Days)||3
211481|NCT00772967|516645|P6|STARTED|Break 1 (4-7 Days)||3
211482|NCT00772967|516646|P5|STARTED|Break 1 (4-7 Days)||4
211483|NCT00772967|516647|P4|STARTED|Break 1 (4-7 Days)||3
211484|NCT00772967|516648|P3|STARTED|Break 1 (4-7 Days)||3
211485|NCT00772967|516649|P2|STARTED|Break 1 (4-7 Days)||5
211486|NCT00772967|516650|P1|STARTED|Break 1 (4-7 Days)||3
211487|NCT00772967|516645|P6|NOT COMPLETED|Crossover Treatment 1||0
211488|NCT00772967|516646|P5|NOT COMPLETED|Crossover Treatment 1||0
211489|NCT00772967|516647|P4|NOT COMPLETED|Crossover Treatment 1||1
211490|NCT00772967|516648|P3|NOT COMPLETED|Crossover Treatment 1||0
211491|NCT00772967|516649|P2|NOT COMPLETED|Crossover Treatment 1||0
211492|NCT00772967|516650|P1|NOT COMPLETED|Crossover Treatment 1||0
211493|NCT00772967|516645|P6|COMPLETED|Crossover Treatment 1||3
211494|NCT00772967|516646|P5|COMPLETED|Crossover Treatment 1||4
211495|NCT00772967|516647|P4|COMPLETED|Crossover Treatment 1|The withdrawal is not included in any outcomes; but is part of the Adverse Event group for placebo|3
211496|NCT00772967|516648|P3|COMPLETED|Crossover Treatment 1||3
211497|NCT00772967|516649|P2|COMPLETED|Crossover Treatment 1||5
211498|NCT00772967|516650|P1|COMPLETED|Crossover Treatment 1||3
211499|NCT00772967|516645|P6|STARTED|Crossover Treatment 1||3
211500|NCT00772967|516646|P5|STARTED|Crossover Treatment 1||4
211501|NCT00772967|516647|P4|STARTED|Crossover Treatment 1||4
211502|NCT00772967|516648|P3|STARTED|Crossover Treatment 1||3
211503|NCT00772967|516649|P2|STARTED|Crossover Treatment 1||5
211504|NCT00772967|516650|P1|STARTED|Crossover Treatment 1||3
211505|NCT00773097|516667|P1|NOT COMPLETED|Overall Study||7
211506|NCT00773097|516667|P1|COMPLETED|Overall Study||39
211507|NCT00773097|516667|P1|STARTED|Overall Study||46
211508|NCT00773136|516673|P1|NOT COMPLETED|Overall Study||2
211509|NCT00773136|516673|P1|COMPLETED|Overall Study||19
211510|NCT00773136|516673|P1|STARTED|Overall Study||21
211511|NCT00773253|516680|P2|NOT COMPLETED|Second Intervention (Week 24-48)||0
211512|NCT00773253|516681|P1|NOT COMPLETED|Second Intervention (Week 24-48)||0
211513|NCT00773253|516680|P2|COMPLETED|Second Intervention (Week 24-48)||4
211514|NCT00773253|516681|P1|COMPLETED|Second Intervention (Week 24-48)||5
211515|NCT00773253|516680|P2|STARTED|Second Intervention (Week 24-48)||4
211516|NCT00773253|516681|P1|STARTED|Second Intervention (Week 24-48)||5
211517|NCT00773253|516680|P2|NOT COMPLETED|First Intervention (Week 0-24)||1
211518|NCT00773253|516681|P1|NOT COMPLETED|First Intervention (Week 0-24)||0
211519|NCT00773253|516680|P2|COMPLETED|First Intervention (Week 0-24)||4
211520|NCT00773253|516681|P1|COMPLETED|First Intervention (Week 0-24)||5
211521|NCT00773253|516680|P2|STARTED|First Intervention (Week 0-24)||5
211522|NCT00773253|516681|P1|STARTED|First Intervention (Week 0-24)||5
211523|NCT00773279|516687|P2|NOT COMPLETED|Period 2||6
211524|NCT00773279|516688|P1|NOT COMPLETED|Period 2||3
211525|NCT00773279|516687|P2|COMPLETED|Period 2||111
211526|NCT00773279|516688|P1|COMPLETED|Period 2||111
211527|NCT00773279|516687|P2|STARTED|Period 2||117
211528|NCT00773279|516688|P1|STARTED|Period 2||114
211529|NCT00773279|516687|P2|NOT COMPLETED|Period 1||4
211530|NCT00773279|516688|P1|NOT COMPLETED|Period 1||7
211531|NCT00773279|516687|P2|COMPLETED|Period 1||117
211532|NCT00773279|516688|P1|COMPLETED|Period 1||114
211533|NCT00773279|516687|P2|STARTED|Period 1||121
211534|NCT00773279|516688|P1|STARTED|Period 1||121
211535|NCT00773370|516709|P2|NOT COMPLETED|Overall Study||10
211536|NCT00773370|516710|P1|NOT COMPLETED|Overall Study||18
211537|NCT00773370|516709|P2|COMPLETED|Overall Study||23
211538|NCT00773370|516710|P1|COMPLETED|Overall Study||25
211539|NCT00773370|516709|P2|STARTED|Overall Study||33
211540|NCT00773370|516710|P1|STARTED|Overall Study||43
211541|NCT00773383|516722|P1|NOT COMPLETED|Overall Study||31
211542|NCT00773383|516722|P1|COMPLETED|Overall Study|this includes at the time of clinical cut-off (2/23/2010) there were 4 patients ongoing|4
211543|NCT00773383|516722|P1|Received Study Drug|Overall Study||34
211544|NCT00773383|516722|P1|STARTED|Overall Study||35
211545|NCT00773461|516744|P2|NOT COMPLETED|Overall Study||4
211546|NCT00773461|516745|P1|NOT COMPLETED|Overall Study||5
211547|NCT00773461|516744|P2|COMPLETED|Overall Study||135
211548|NCT00773461|516745|P1|COMPLETED|Overall Study||65
211549|NCT00773461|516744|P2|STARTED|Overall Study||139
211550|NCT00773461|516745|P1|STARTED|Overall Study||70
211551|NCT00773474|516783|P1|NOT COMPLETED|Overall Study||0
211552|NCT00773474|516783|P1|COMPLETED|Overall Study||29
211553|NCT00773474|516783|P1|STARTED|Overall Study||29
211554|NCT00773734|516794|P6|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
211555|NCT00773734|516795|P5|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
211556|NCT00773734|516796|P4|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
211557|NCT00773734|516797|P3|NOT COMPLETED|LTE Period: Week 52 to 6 Years||12
211558|NCT00773734|516798|P2|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
211559|NCT00773734|516799|P1|NOT COMPLETED|LTE Period: Week 52 to 6 Years||0
211560|NCT00773734|516794|P6|COMPLETED|LTE Period: Week 52 to 6 Years||0
211561|NCT00773734|516795|P5|COMPLETED|LTE Period: Week 52 to 6 Years||0
211562|NCT00773734|516796|P4|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|5
211563|NCT00773734|516797|P3|COMPLETED|LTE Period: Week 52 to 6 Years|Completed = Completed Long Term Extension study|4
211564|NCT00773734|516798|P2|COMPLETED|LTE Period: Week 52 to 6 Years||0
211565|NCT00773734|516799|P1|COMPLETED|LTE Period: Week 52 to 6 Years||0
211566|NCT00773734|516794|P6|STARTED|LTE Period: Week 52 to 6 Years||0
211567|NCT00773734|516795|P5|STARTED|LTE Period: Week 52 to 6 Years||0
211568|NCT00773734|516796|P4|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|17
211569|NCT00773734|516797|P3|STARTED|LTE Period: Week 52 to 6 Years|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|16
211570|NCT00773734|516798|P2|STARTED|LTE Period: Week 52 to 6 Years||0
211571|NCT00773734|516799|P1|STARTED|LTE Period: Week 52 to 6 Years||0
211572|NCT00773734|516794|P6|NOT COMPLETED|Extension: Active Treatment Week 24-52||8
211573|NCT00773734|516795|P5|NOT COMPLETED|Extension: Active Treatment Week 24-52||5
211574|NCT00773734|516796|P4|NOT COMPLETED|Extension: Active Treatment Week 24-52||10
211575|NCT00773734|516797|P3|NOT COMPLETED|Extension: Active Treatment Week 24-52||17
211576|NCT00773734|516798|P2|NOT COMPLETED|Extension: Active Treatment Week 24-52||13
211577|NCT00773734|516799|P1|NOT COMPLETED|Extension: Active Treatment Week 24-52||0
211578|NCT00773734|516794|P6|COMPLETED|Extension: Active Treatment Week 24-52||19
211579|NCT00773734|516795|P5|COMPLETED|Extension: Active Treatment Week 24-52||22
211580|NCT00773734|516796|P4|COMPLETED|Extension: Active Treatment Week 24-52||48
211581|NCT00773734|516797|P3|COMPLETED|Extension: Active Treatment Week 24-52||33
211582|NCT00773734|516798|P2|COMPLETED|Extension: Active Treatment Week 24-52|Those dosed APR 10 mg BID in extension study were randomly assigned APR 20 mg or 30 mg BID in LTE|34
211583|NCT00773734|516799|P1|COMPLETED|Extension: Active Treatment Week 24-52||0
211584|NCT00773734|516794|P6|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
211585|NCT00773734|516795|P5|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||4
211586|NCT00773734|516796|P4|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
211587|NCT00773734|516797|P3|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||10
211588|NCT00773734|516798|P2|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||5
211589|NCT00773734|516799|P1|Completed Extension and Continued LTE|Extension: Active Treatment Week 24-52||0
211590|NCT00773734|516794|P6|STARTED|Extension: Active Treatment Week 24-52||27
211591|NCT00773734|516795|P5|STARTED|Extension: Active Treatment Week 24-52||27
211592|NCT00773734|516796|P4|STARTED|Extension: Active Treatment Week 24-52||58
211593|NCT00773734|516797|P3|STARTED|Extension: Active Treatment Week 24-52||50
211594|NCT00773734|516798|P2|STARTED|Extension: Active Treatment Week 24-52||47
211595|NCT00773734|516799|P1|STARTED|Extension: Active Treatment Week 24-52||0
211596|NCT00773734|516794|P6|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||5
211597|NCT00773734|516795|P5|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||1
211598|NCT00773734|516796|P4|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||2
211599|NCT00773734|516797|P3|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||7
211600|NCT00773734|516798|P2|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||12
211601|NCT00773734|516799|P1|NOT COMPLETED|Core: Active Treatment Phase Week 16-24||0
211602|NCT00773734|516794|P6|COMPLETED|Core: Active Treatment Phase Week 16-24||31
211603|NCT00773734|516795|P5|COMPLETED|Core: Active Treatment Phase Week 16-24||33
211604|NCT00773734|516796|P4|COMPLETED|Core: Active Treatment Phase Week 16-24||65
211605|NCT00773734|516797|P3|COMPLETED|Core: Active Treatment Phase Week 16-24||59
211606|NCT00773734|516798|P2|COMPLETED|Core: Active Treatment Phase Week 16-24||65
211607|NCT00773734|516799|P1|COMPLETED|Core: Active Treatment Phase Week 16-24||0
211608|NCT00773734|516794|P6|STARTED|Core: Active Treatment Phase Week 16-24||36
211609|NCT00773734|516795|P5|STARTED|Core: Active Treatment Phase Week 16-24||34
211610|NCT00773734|516796|P4|STARTED|Core: Active Treatment Phase Week 16-24|3 participants elected not to continue from previous period|67
211611|NCT00773734|516797|P3|STARTED|Core: Active Treatment Phase Week 16-24||66
211612|NCT00773734|516798|P2|STARTED|Core: Active Treatment Phase Week 16-24|2 participants elected not to continue from previous period|77
211613|NCT00773734|516799|P1|STARTED|Core: Active Treatment Phase Week 16-24|Placebo participants were re-randomized at Week 16 to receive apremilast 20mg or 30mg PO BID.|0
211614|NCT00773734|516794|P6|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
211615|NCT00773734|516795|P5|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
211616|NCT00773734|516796|P4|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||18
211617|NCT00773734|516797|P3|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||21
211703|NCT00774397|517481|P6|NOT COMPLETED|Overall Study||22
211618|NCT00773734|516798|P2|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||10
211619|NCT00773734|516799|P1|NOT COMPLETED|Core: Placebo Controlled Phase Week 0-16||16
211620|NCT00773734|516794|P6|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
211621|NCT00773734|516795|P5|COMPLETED|Core: Placebo Controlled Phase Week 0-16||0
211622|NCT00773734|516796|P4|COMPLETED|Core: Placebo Controlled Phase Week 0-16|3 participants completed placebo controlled phase but elected not to continue|70
211623|NCT00773734|516797|P3|COMPLETED|Core: Placebo Controlled Phase Week 0-16||66
211624|NCT00773734|516798|P2|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|79
211625|NCT00773734|516799|P1|COMPLETED|Core: Placebo Controlled Phase Week 0-16|2 participants completed placebo controlled phase but elected not to continue|72
211626|NCT00773734|516794|P6|STARTED|Core: Placebo Controlled Phase Week 0-16||0
211627|NCT00773734|516795|P5|STARTED|Core: Placebo Controlled Phase Week 0-16||0
211628|NCT00773734|516796|P4|STARTED|Core: Placebo Controlled Phase Week 0-16||88
211629|NCT00773734|516797|P3|STARTED|Core: Placebo Controlled Phase Week 0-16||87
211630|NCT00773734|516798|P2|STARTED|Core: Placebo Controlled Phase Week 0-16||89
211631|NCT00773734|516799|P1|STARTED|Core: Placebo Controlled Phase Week 0-16||88
211632|NCT00773786|517361|P2|NOT COMPLETED|Second Intervention (1 Week)||0
211633|NCT00773786|517362|P1|NOT COMPLETED|Second Intervention (1 Week)||0
211634|NCT00773786|517361|P2|COMPLETED|Second Intervention (1 Week)||10
211635|NCT00773786|517362|P1|COMPLETED|Second Intervention (1 Week)||10
211636|NCT00773786|517361|P2|STARTED|Second Intervention (1 Week)||10
211637|NCT00773786|517362|P1|STARTED|Second Intervention (1 Week)||10
211638|NCT00773786|517361|P2|NOT COMPLETED|Washout (1 Week)||0
211639|NCT00773786|517362|P1|NOT COMPLETED|Washout (1 Week)||0
211640|NCT00773786|517361|P2|COMPLETED|Washout (1 Week)||10
211641|NCT00773786|517362|P1|COMPLETED|Washout (1 Week)||10
211642|NCT00773786|517361|P2|STARTED|Washout (1 Week)||10
211643|NCT00773786|517362|P1|STARTED|Washout (1 Week)||10
211644|NCT00773786|517361|P2|NOT COMPLETED|First Intervention (1 Week)||0
211645|NCT00773786|517362|P1|NOT COMPLETED|First Intervention (1 Week)||0
211646|NCT00773786|517361|P2|COMPLETED|First Intervention (1 Week)||10
211647|NCT00773786|517362|P1|COMPLETED|First Intervention (1 Week)||10
211648|NCT00773786|517361|P2|STARTED|First Intervention (1 Week)||10
211649|NCT00773786|517362|P1|STARTED|First Intervention (1 Week)||10
211650|NCT00773955|517372|P1|NOT COMPLETED|Overall Study||0
211651|NCT00773955|517372|P1|COMPLETED|Overall Study||15
211652|NCT00773955|517372|P1|STARTED|Overall Study||15
211653|NCT00773968|517379|P1|NOT COMPLETED|Overall Study||45
211654|NCT00773968|517379|P1|COMPLETED|Overall Study||95
211655|NCT00773968|517379|P1|Treated|Overall Study||111
211656|NCT00773968|517379|P1|STARTED|Overall Study||140
211657|NCT00774046|517388|P1|NOT COMPLETED|Autologous Transplant||0
211658|NCT00774046|517388|P1|COMPLETED|Autologous Transplant||4
211659|NCT00774046|517388|P1|STARTED|Autologous Transplant|2 patients died in remission and 1 relapsed without having received transplant|4
211660|NCT00774046|517388|P1|NOT COMPLETED|Stem Cell Mobilization||3
211661|NCT00774046|517388|P1|COMPLETED|Stem Cell Mobilization||7
211662|NCT00774046|517388|P1|STARTED|Stem Cell Mobilization|For mobilization, the patient must have had a CR and not been a candidate for allogeneic transplant|10
211663|NCT00774046|517388|P1|NOT COMPLETED|Induction Therapy||0
211664|NCT00774046|517388|P1|COMPLETED|Induction Therapy||32
211665|NCT00774046|517388|P1|STARTED|Induction Therapy||32
211666|NCT00774046|517388|P1|NOT COMPLETED|Enrollment||28
211667|NCT00774046|517388|P1|COMPLETED|Enrollment||32
211668|NCT00774046|517388|P1|STARTED|Enrollment||60
211669|NCT00774046|517388|P1|NOT COMPLETED|Screening||56
211670|NCT00774046|517388|P1|COMPLETED|Screening||60
211671|NCT00774046|517388|P1|STARTED|Screening||116
211672|NCT00774163|517400|P2|NOT COMPLETED|Overall Study||0
211673|NCT00774163|517401|P1|NOT COMPLETED|Overall Study||0
211674|NCT00774163|517400|P2|COMPLETED|Overall Study||15
211675|NCT00774163|517401|P1|COMPLETED|Overall Study||30
211676|NCT00774163|517400|P2|STARTED|Overall Study||15
211677|NCT00774163|517401|P1|STARTED|Overall Study||30
211678|NCT00774267|517443|P4|NOT COMPLETED|Overall Study||0
211679|NCT00774267|517444|P3|NOT COMPLETED|Overall Study||0
211680|NCT00774267|517445|P2|NOT COMPLETED|Overall Study||0
211681|NCT00774267|517446|P1|NOT COMPLETED|Overall Study||0
211682|NCT00774267|517443|P4|COMPLETED|Overall Study||135
211683|NCT00774267|517444|P3|COMPLETED|Overall Study||129
211684|NCT00774267|517445|P2|COMPLETED|Overall Study||111
211685|NCT00774267|517446|P1|COMPLETED|Overall Study||132
211686|NCT00774267|517443|P4|STARTED|Overall Study||135
211687|NCT00774267|517444|P3|STARTED|Overall Study||129
211688|NCT00774267|517445|P2|STARTED|Overall Study||111
211689|NCT00774267|517446|P1|STARTED|Overall Study||132
211690|NCT00774306|517460|P4|NOT COMPLETED|Overall Study||5
211691|NCT00774306|517461|P3|NOT COMPLETED|Overall Study||8
211692|NCT00774306|517462|P2|NOT COMPLETED|Overall Study||2
211693|NCT00774306|517463|P1|NOT COMPLETED|Overall Study||18
211694|NCT00774306|517460|P4|COMPLETED|Overall Study||2
211695|NCT00774306|517461|P3|COMPLETED|Overall Study||8
211696|NCT00774306|517462|P2|COMPLETED|Overall Study||3
211697|NCT00774306|517463|P1|COMPLETED|Overall Study||6
211698|NCT00774306|517460|P4|STARTED|Overall Study||7
211699|NCT00774306|517461|P3|STARTED|Overall Study||16
211700|NCT00774306|517462|P2|STARTED|Overall Study||5
211701|NCT00774306|517463|P1|STARTED|Overall Study||24
211702|NCT00774397|517480|P7|NOT COMPLETED|Overall Study||30
211704|NCT00774397|517482|P5|NOT COMPLETED|Overall Study||46
211705|NCT00774397|517483|P4|NOT COMPLETED|Overall Study||17
211706|NCT00774397|517484|P3|NOT COMPLETED|Overall Study||30
211707|NCT00774397|517485|P2|NOT COMPLETED|Overall Study||13
211708|NCT00774397|517486|P1|NOT COMPLETED|Overall Study||14
211709|NCT00774397|517480|P7|COMPLETED|Overall Study||41
211710|NCT00774397|517481|P6|COMPLETED|Overall Study||54
211711|NCT00774397|517482|P5|COMPLETED|Overall Study||97
211712|NCT00774397|517483|P4|COMPLETED|Overall Study||129
211713|NCT00774397|517484|P3|COMPLETED|Overall Study||113
211714|NCT00774397|517485|P2|COMPLETED|Overall Study||56
211715|NCT00774397|517486|P1|COMPLETED|Overall Study||57
211716|NCT00774397|517480|P7|STARTED|Overall Study||71
211717|NCT00774397|517481|P6|STARTED|Overall Study||76
211718|NCT00774397|517482|P5|STARTED|Overall Study||143
211719|NCT00774397|517483|P4|STARTED|Overall Study||146
211720|NCT00774397|517484|P3|STARTED|Overall Study||143
211721|NCT00774397|517485|P2|STARTED|Overall Study||69
211722|NCT00774397|517486|P1|STARTED|Overall Study||71
211723|NCT00774748|517718|P1|NOT COMPLETED|Overall Study||3
211724|NCT00774748|517718|P1|COMPLETED|Overall Study||18
211725|NCT00774748|517718|P1|STARTED|Overall Study||21
211726|NCT00774787|517726|P1|NOT COMPLETED|Overall Study||1
211727|NCT00774787|517726|P1|COMPLETED|Overall Study||26
211728|NCT00774787|517726|P1|STARTED|Overall Study||27
211729|NCT00774800|517733|P1|NOT COMPLETED|Intervention 4||1
211730|NCT00774800|517733|P1|COMPLETED|Intervention 4||21
211731|NCT00774800|517733|P1|Received at Least One Dose of Study Drug|Intervention 4||21
211732|NCT00774800|517733|P1|STARTED|Intervention 4||22
211733|NCT00774800|517733|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
211734|NCT00774800|517733|P1|COMPLETED|Washout (3 to 10 Days)||22
211735|NCT00774800|517733|P1|STARTED|Washout (3 to 10 Days)||22
211736|NCT00774800|517733|P1|NOT COMPLETED|Intervention 3||0
211737|NCT00774800|517733|P1|COMPLETED|Intervention 3||22
211738|NCT00774800|517733|P1|Received at Least One Dose of Study Drug|Intervention 3||22
211739|NCT00774800|517733|P1|STARTED|Intervention 3||22
211740|NCT00774800|517733|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
211741|NCT00774800|517733|P1|COMPLETED|Washout (3 to 10 Days)||22
211742|NCT00774800|517733|P1|STARTED|Washout (3 to 10 Days)||22
211743|NCT00774800|517733|P1|NOT COMPLETED|Intervention 2||0
211744|NCT00774800|517733|P1|COMPLETED|Intervention 2||22
211745|NCT00774800|517733|P1|Received at Least One Dose of Study Drug|Intervention 2||22
211746|NCT00774800|517733|P1|STARTED|Intervention 2||22
211747|NCT00774800|517733|P1|NOT COMPLETED|Washout (3 to 10 Days)||0
211748|NCT00774800|517733|P1|COMPLETED|Washout (3 to 10 Days)||22
211749|NCT00774800|517733|P1|STARTED|Washout (3 to 10 Days)||22
211750|NCT00774800|517733|P1|NOT COMPLETED|Intervention 1||0
211751|NCT00774800|517733|P1|COMPLETED|Intervention 1||22
211841|NCT00775450|518062|P5|NOT COMPLETED|Overall Study||2
211752|NCT00774800|517733|P1|Received at Least One Dose of Study Drug|Intervention 1||22
211753|NCT00774800|517733|P1|STARTED|Intervention 1||22
211754|NCT00774852|517757|P2|NOT COMPLETED|Overall Study||41
211755|NCT00774852|517758|P1|NOT COMPLETED|Overall Study||45
211756|NCT00774852|517757|P2|COMPLETED|Overall Study||27
211757|NCT00774852|517758|P1|COMPLETED|Overall Study||24
211758|NCT00774852|517757|P2|STARTED|Overall Study||68
211759|NCT00774852|517758|P1|STARTED|Overall Study||69
211760|NCT00774930|517808|P2|NOT COMPLETED|LTOLE Phase||17
211761|NCT00774930|517809|P1|NOT COMPLETED|LTOLE Phase||15
211762|NCT00774930|517808|P2|COMPLETED|LTOLE Phase||8
211763|NCT00774930|517809|P1|COMPLETED|LTOLE Phase||17
211764|NCT00774930|517808|P2|STARTED|LTOLE Phase|20 subjects from IOL did not enter LTOLE (12 completed IOL, 8 did not complete IOL).|25
211765|NCT00774930|517809|P1|STARTED|LTOLE Phase|24 subjects from IOL did not enter LTOLE (11 completed IOL, 13 did not complete IOL).|32
211766|NCT00774930|517808|P2|NOT COMPLETED|IOL Phase||9
211767|NCT00774930|517809|P1|NOT COMPLETED|IOL Phase||13
211768|NCT00774930|517808|P2|COMPLETED|IOL Phase||37
211769|NCT00774930|517809|P1|COMPLETED|IOL Phase||43
211770|NCT00774930|517808|P2|STARTED|IOL Phase|Includes 1 subject listed as completing and withdrawing from the DB phase due to brain radiation|46
211771|NCT00774930|517809|P1|STARTED|IOL Phase||56
211772|NCT00774930|517808|P2|NOT COMPLETED|DB Phase||22
211773|NCT00774930|517809|P1|NOT COMPLETED|DB Phase||14
211774|NCT00774930|517808|P2|COMPLETED|DB Phase|had diary data at least up to day 21 after 4th dose, regardless of missing diary data before day 21.|34
211775|NCT00774930|517809|P1|COMPLETED|DB Phase|Received 4 DB study injections AND continued to IOL phase OR|45
211776|NCT00774930|517808|P2|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|56
211777|NCT00774930|517809|P1|STARTED|DB Phase|One subject was randomised to receive lanreotide Autogel, but erroneously received placebo.|59
211778|NCT00774995|517839|P4|NOT COMPLETED|Overall Study||0
211779|NCT00774995|517840|P3|NOT COMPLETED|Overall Study||1
211780|NCT00774995|517841|P2|NOT COMPLETED|Overall Study||0
211781|NCT00774995|517842|P1|NOT COMPLETED|Overall Study||0
211782|NCT00774995|517839|P4|COMPLETED|Overall Study||16
211783|NCT00774995|517840|P3|COMPLETED|Overall Study||7
211784|NCT00774995|517841|P2|COMPLETED|Overall Study||16
211785|NCT00774995|517842|P1|COMPLETED|Overall Study||9
211786|NCT00774995|517839|P4|STARTED|Overall Study||16
211787|NCT00774995|517840|P3|STARTED|Overall Study||8
211788|NCT00774995|517841|P2|STARTED|Overall Study||16
211789|NCT00774995|517842|P1|STARTED|Overall Study||9
211790|NCT00775021|517880|P2|NOT COMPLETED|Second Intervention||1
211791|NCT00775021|517881|P1|NOT COMPLETED|Second Intervention||0
211792|NCT00775021|517880|P2|COMPLETED|Second Intervention||59
211793|NCT00775021|517881|P1|COMPLETED|Second Intervention||62
211794|NCT00775021|517880|P2|STARTED|Second Intervention||60
211795|NCT00775021|517881|P1|STARTED|Second Intervention||62
211796|NCT00775021|517880|P2|NOT COMPLETED|First Intervention||0
211797|NCT00775021|517881|P1|NOT COMPLETED|First Intervention||1
211798|NCT00775021|517880|P2|COMPLETED|First Intervention||60
211799|NCT00775021|517881|P1|COMPLETED|First Intervention||62
211800|NCT00775021|517880|P2|STARTED|First Intervention||60
211801|NCT00775021|517881|P1|STARTED|First Intervention||63
211802|NCT00775190|517897|P2|NOT COMPLETED|Overall Study||5
211803|NCT00775190|517898|P1|NOT COMPLETED|Overall Study||4
211804|NCT00775190|517897|P2|COMPLETED|Overall Study||0
211805|NCT00775190|517898|P1|COMPLETED|Overall Study||3
211806|NCT00775190|517897|P2|STARTED|Overall Study||5
211807|NCT00775190|517898|P1|STARTED|Overall Study||7
211808|NCT00775203|517922|P2|NOT COMPLETED|Overall Study||43
211809|NCT00775203|517923|P1|NOT COMPLETED|Overall Study||62
211810|NCT00775203|517922|P2|COMPLETED|Overall Study||163
211811|NCT00775203|517923|P1|COMPLETED|Overall Study||144
211812|NCT00775203|517922|P2|Received Study Medication|Overall Study||204
211813|NCT00775203|517923|P1|Received Study Medication|Overall Study||202
211814|NCT00775203|517922|P2|STARTED|Overall Study||206
211815|NCT00775203|517923|P1|STARTED|Overall Study||206
211816|NCT00775229|517957|P2|NOT COMPLETED|Overall Study||2
211817|NCT00775229|517958|P1|NOT COMPLETED|Overall Study||5
211818|NCT00775229|517957|P2|COMPLETED|Overall Study||24
211819|NCT00775229|517958|P1|COMPLETED|Overall Study||20
211820|NCT00775229|517957|P2|STARTED|Overall Study||26
211821|NCT00775229|517958|P1|STARTED|Overall Study||25
211822|NCT00775346|517968|P1|NOT COMPLETED|Overall Study||0
211823|NCT00775346|517968|P1|COMPLETED|Overall Study||92
211824|NCT00775346|517968|P1|STARTED|Overall Study||92
211825|NCT00775411|517972|P1|NOT COMPLETED|Overall Study||1
211826|NCT00775411|517972|P1|COMPLETED|Overall Study||43
211827|NCT00775411|517972|P1|STARTED|Overall Study||44
211828|NCT00775437|517978|P1|NOT COMPLETED|Overall Study||6
211829|NCT00775437|517978|P1|COMPLETED|Overall Study||26
211830|NCT00775437|517978|P1|STARTED|Overall Study||32
211831|NCT00769860|518030|P2|NOT COMPLETED|Overall Study||0
211832|NCT00769860|518031|P1|NOT COMPLETED|Overall Study||2
211833|NCT00769860|518030|P2|COMPLETED|Overall Study||8
211834|NCT00769860|518031|P1|COMPLETED|Overall Study||14
211835|NCT00769860|518030|P2|Month 8|Overall Study||8
211836|NCT00769860|518031|P1|Month 8|Overall Study||14
211837|NCT00769860|518030|P2|Month 4|Overall Study||8
211838|NCT00769860|518031|P1|Month 4|Overall Study||16
211839|NCT00769860|518030|P2|STARTED|Overall Study||8
211840|NCT00769860|518031|P1|STARTED|Overall Study||16
211842|NCT00775450|518063|P4|NOT COMPLETED|Overall Study||0
211843|NCT00775450|518064|P3|NOT COMPLETED|Overall Study||0
211844|NCT00775450|518065|P2|NOT COMPLETED|Overall Study||0
211845|NCT00775450|518066|P1|NOT COMPLETED|Overall Study||3
211846|NCT00775450|518062|P5|COMPLETED|Overall Study||199
211847|NCT00775450|518063|P4|COMPLETED|Overall Study||108
211848|NCT00775450|518064|P3|COMPLETED|Overall Study||105
211849|NCT00775450|518065|P2|COMPLETED|Overall Study||98
211850|NCT00775450|518066|P1|COMPLETED|Overall Study||292
211851|NCT00775450|518062|P5|STARTED|Overall Study||201
211852|NCT00775450|518063|P4|STARTED|Overall Study||108
211853|NCT00775450|518064|P3|STARTED|Overall Study||105
211854|NCT00775450|518065|P2|STARTED|Overall Study||98
211855|NCT00775450|518066|P1|STARTED|Overall Study||295
211856|NCT00775463|518095|P2|NOT COMPLETED|Overall Study||13
211857|NCT00775463|518096|P1|NOT COMPLETED|Overall Study||11
211858|NCT00775463|518095|P2|COMPLETED|Overall Study||59
211859|NCT00775463|518096|P1|COMPLETED|Overall Study||65
211860|NCT00775463|518095|P2|STARTED|Overall Study||72
211861|NCT00775463|518096|P1|STARTED|Overall Study||76
211862|NCT00775528|518128|P1|NOT COMPLETED|Overall Study||1
211863|NCT00775528|518128|P1|COMPLETED|Overall Study||18
211864|NCT00775528|518128|P1|STARTED|Overall Study|Started means number of patients who consented|19
211865|NCT00775593|518135|P1|NOT COMPLETED|Overall Study||7
211866|NCT00775593|518135|P1|COMPLETED|Overall Study||53
211867|NCT00775593|518135|P1|STARTED|Overall Study||60
211868|NCT00775606|518144|P2|NOT COMPLETED|Overall Study||0
211869|NCT00775606|518145|P1|NOT COMPLETED|Overall Study||3
211870|NCT00775606|518144|P2|COMPLETED|Overall Study||5
211871|NCT00775606|518145|P1|COMPLETED|Overall Study||5
211872|NCT00775606|518144|P2|STARTED|Overall Study||5
211873|NCT00775606|518145|P1|STARTED|Overall Study||8
211874|NCT00775645|518157|P2|NOT COMPLETED|Overall Study||20
211875|NCT00775645|518158|P1|NOT COMPLETED|Overall Study||17
211876|NCT00775645|518157|P2|COMPLETED|Overall Study||181
211877|NCT00775645|518158|P1|COMPLETED|Overall Study||191
211878|NCT00775645|518157|P2|STARTED|Overall Study||201
211879|NCT00775645|518158|P1|STARTED|Overall Study||208
211880|NCT00775658|518178|P2|NOT COMPLETED|Second Intervention||0
211881|NCT00775658|518179|P1|NOT COMPLETED|Second Intervention||0
211882|NCT00775658|518178|P2|COMPLETED|Second Intervention||11
211883|NCT00775658|518179|P1|COMPLETED|Second Intervention||10
211884|NCT00775658|518178|P2|STARTED|Second Intervention||11
211885|NCT00775658|518179|P1|STARTED|Second Intervention||10
211886|NCT00775658|518178|P2|NOT COMPLETED|First Intervention||0
211887|NCT00775658|518179|P1|NOT COMPLETED|First Intervention||0
211888|NCT00775658|518178|P2|COMPLETED|First Intervention||11
211889|NCT00775658|518179|P1|COMPLETED|First Intervention||10
211890|NCT00775658|518178|P2|STARTED|First Intervention||11
211891|NCT00775658|518179|P1|STARTED|First Intervention||10
211892|NCT00775671|518189|P2|NOT COMPLETED|Overall Study||0
211893|NCT00775671|518190|P1|NOT COMPLETED|Overall Study||0
211894|NCT00775671|518189|P2|COMPLETED|Overall Study||23
211895|NCT00775671|518190|P1|COMPLETED|Overall Study||23
211896|NCT00775671|518189|P2|STARTED|Overall Study||23
211897|NCT00775671|518190|P1|STARTED|Overall Study||23
211898|NCT00776230|518201|P3|NOT COMPLETED|Overall Study||5
211899|NCT00776230|518202|P2|NOT COMPLETED|Overall Study||3
211900|NCT00776230|518203|P1|NOT COMPLETED|Overall Study||3
211901|NCT00776230|518201|P3|COMPLETED|Overall Study||97
211902|NCT00776230|518202|P2|COMPLETED|Overall Study||100
211903|NCT00776230|518203|P1|COMPLETED|Overall Study||96
211904|NCT00776230|518201|P3|Enrolled and Vaccinated at Day 0|Overall Study||102
211905|NCT00776230|518202|P2|Enrolled and Vaccinated at Day 0|Overall Study||103
211906|NCT00776230|518203|P1|Enrolled and Vaccinated at Day 0|Overall Study||98
211907|NCT00776230|518201|P3|STARTED|Overall Study||102
211908|NCT00776230|518202|P2|STARTED|Overall Study||103
211909|NCT00776230|518203|P1|STARTED|Overall Study||99
211910|NCT00776295|518211|P1|NOT COMPLETED|Overall Study||0
211911|NCT00776295|518211|P1|COMPLETED|Overall Study||2
211912|NCT00776295|518211|P1|STARTED|Overall Study||2
211913|NCT00776555|518218|P2|NOT COMPLETED|Overall Study||0
211914|NCT00776555|518219|P1|NOT COMPLETED|Overall Study||3
211915|NCT00776555|518218|P2|COMPLETED|Overall Study||0
211916|NCT00776555|518219|P1|COMPLETED|Overall Study||0
211917|NCT00776555|518218|P2|STARTED|Overall Study||0
211918|NCT00776555|518219|P1|STARTED|Overall Study||3
211919|NCT00776594|518231|P2|NOT COMPLETED|Overall Study||2
211920|NCT00776594|518232|P1|NOT COMPLETED|Overall Study||4
211921|NCT00776594|518231|P2|COMPLETED|Overall Study||34
211922|NCT00776594|518232|P1|COMPLETED|Overall Study||62
211923|NCT00776594|518231|P2|STARTED|Overall Study||36
211924|NCT00776594|518232|P1|STARTED|Overall Study||66
211925|NCT00776659|518244|P1|NOT COMPLETED|Overall Study||26
211926|NCT00776659|518244|P1|COMPLETED|Overall Study||13
211927|NCT00776659|518244|P1|STARTED|Overall Study||39
211928|NCT00776789|518256|P2|NOT COMPLETED|Overall Study||3
211929|NCT00776789|518257|P1|NOT COMPLETED|Overall Study||3
211930|NCT00776789|518256|P2|COMPLETED|Overall Study||18
211931|NCT00776789|518257|P1|COMPLETED|Overall Study||17
211932|NCT00776789|518256|P2|STARTED|Overall Study||21
211933|NCT00776789|518257|P1|STARTED|Overall Study||20
211934|NCT00776919|518273|P4|NOT COMPLETED|Overall Study||39
211935|NCT00776919|518274|P3|NOT COMPLETED|Overall Study||32
211936|NCT00776919|518275|P2|NOT COMPLETED|Overall Study||33
211937|NCT00776919|518276|P1|NOT COMPLETED|Overall Study||27
211938|NCT00776919|518273|P4|COMPLETED|Overall Study||293
211939|NCT00776919|518274|P3|COMPLETED|Overall Study||296
211940|NCT00776919|518275|P2|COMPLETED|Overall Study||295
211941|NCT00776919|518276|P1|COMPLETED|Overall Study||300
211942|NCT00776919|518273|P4|STARTED|Overall Study||332
211943|NCT00776919|518274|P3|STARTED|Overall Study||328
211944|NCT00776919|518275|P2|STARTED|Overall Study||328
211945|NCT00776919|518276|P1|STARTED|Overall Study||327
211946|NCT00776984|518340|P2|NOT COMPLETED|Overall Study||21
211947|NCT00776984|518341|P1|NOT COMPLETED|Overall Study||31
211948|NCT00776984|518340|P2|COMPLETED|Overall Study||198
211949|NCT00776984|518341|P1|COMPLETED|Overall Study||203
211950|NCT00776984|518340|P2|STARTED|Overall Study||219
211951|NCT00776984|518341|P1|STARTED|Overall Study||234
211952|NCT00776997|518411|P1|NOT COMPLETED|Overall Study||2
211953|NCT00776997|518411|P1|COMPLETED|Overall Study|98 subjects evaluated at 12-months. Endpoint analysis based on all subjects treated (n=100)|98
211954|NCT00776997|518411|P1|STARTED|Overall Study||100
211955|NCT00777023|518421|P3|NOT COMPLETED|Overall Study||37
211956|NCT00777023|518422|P2|NOT COMPLETED|Overall Study||41
211957|NCT00777023|518423|P1|NOT COMPLETED|Overall Study||35
211958|NCT00777023|518421|P3|COMPLETED|Overall Study||146
211959|NCT00777023|518422|P2|COMPLETED|Overall Study||149
211960|NCT00777023|518423|P1|COMPLETED|Overall Study||151
211961|NCT00777023|518421|P3|STARTED|Overall Study|183 patients were randomized, and 183 received study treatment.|183
211962|NCT00777023|518422|P2|STARTED|Overall Study|190 patients were randomized, and 190 received study treatment.|190
211963|NCT00777023|518423|P1|STARTED|Overall Study|192 patients were randomized, but only 186 received study treatment.|186
211964|NCT00777049|518442|P2|NOT COMPLETED|Overall Study||1
211965|NCT00777049|518443|P1|NOT COMPLETED|Overall Study||1
211966|NCT00777049|518442|P2|COMPLETED|Overall Study||20
211967|NCT00777049|518443|P1|COMPLETED|Overall Study||32
211968|NCT00777049|518442|P2|STARTED|Overall Study||21
211969|NCT00777049|518443|P1|STARTED|Overall Study||33
211970|NCT00777062|518451|P2|NOT COMPLETED|Overall Study||5
211971|NCT00777062|518452|P1|NOT COMPLETED|Overall Study||3
211972|NCT00777062|518451|P2|COMPLETED|Overall Study||36
211973|NCT00777062|518452|P1|COMPLETED|Overall Study||36
211974|NCT00777062|518451|P2|STARTED|Overall Study||41
211975|NCT00777062|518452|P1|STARTED|Overall Study||39
211976|NCT00777153|518463|P3|NOT COMPLETED|Overall Study||37
211977|NCT00777153|518464|P2|NOT COMPLETED|Overall Study||83
211978|NCT00777153|518465|P1|NOT COMPLETED|Overall Study||90
211979|NCT00777153|518463|P3|COMPLETED|Overall Study||28
211980|NCT00777153|518464|P2|COMPLETED|Overall Study||46
211981|NCT00777153|518465|P1|COMPLETED|Overall Study||41
211982|NCT00777153|518463|P3|STARTED|Overall Study||65
211983|NCT00777153|518464|P2|STARTED|Overall Study||129
211984|NCT00777153|518465|P1|STARTED|Overall Study||131
211985|NCT00777179|518490|P2|NOT COMPLETED|Overall Study||0
211986|NCT00777179|518491|P1|NOT COMPLETED|Overall Study||0
211987|NCT00777179|518490|P2|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|42
211988|NCT00777179|518491|P1|COMPLETED|Overall Study|All participants' data within ITT set were included for final result.|75
211989|NCT00777179|518490|P2|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|42
211990|NCT00777179|518491|P1|STARTED|Overall Study|Number of participants for intent-to-treat (ITT) set population|75
211991|NCT00777205|518507|P2|NOT COMPLETED|Overall Study||71
211992|NCT00777205|518508|P1|NOT COMPLETED|Overall Study||31
211993|NCT00777205|518507|P2|COMPLETED|Overall Study||129
211994|NCT00777205|518508|P1|COMPLETED|Overall Study||212
211995|NCT00777205|518507|P2|Intervention Interruption|Overall Study|56 participants excluded from main analyses due to 2 mos interruption in study intervention|56
211996|NCT00777205|518508|P1|Intervention Interruption|Overall Study||0
211997|NCT00777205|518507|P2|STARTED|Overall Study||200
211998|NCT00777205|518508|P1|STARTED|Overall Study||243
211999|NCT00777257|518525|P3|NOT COMPLETED|Overall Study||9
212000|NCT00777257|518526|P2|NOT COMPLETED|Overall Study||12
212001|NCT00777257|518527|P1|NOT COMPLETED|Overall Study||11
212002|NCT00777257|518525|P3|COMPLETED|Overall Study||442
212003|NCT00777257|518526|P2|COMPLETED|Overall Study||438
212004|NCT00777257|518527|P1|COMPLETED|Overall Study||433
212005|NCT00777257|518525|P3|STARTED|Overall Study||451
212006|NCT00777257|518526|P2|STARTED|Overall Study||450
212007|NCT00777257|518527|P1|STARTED|Overall Study||444
212008|NCT00777335|518546|P2|NOT COMPLETED|Overall Study||0
212009|NCT00777335|518547|P1|NOT COMPLETED|Overall Study||0
212010|NCT00777335|518546|P2|COMPLETED|Overall Study||2
212011|NCT00777335|518547|P1|COMPLETED|Overall Study||2
212012|NCT00777335|518546|P2|STARTED|Overall Study||2
212013|NCT00777335|518547|P1|STARTED|Overall Study||2
212014|NCT00777556|518555|P1|NOT COMPLETED|Overall Study||66
212015|NCT00777556|518555|P1|COMPLETED|Overall Study|Completed all 3 follow-up visits|277
212016|NCT00777556|518555|P1|Used Product|Overall Study||297
212017|NCT00777556|518555|P1|Safety Population|Overall Study|Participants who used the product; two were given product in error (inappropriately self-selected)|299
212018|NCT00777556|518555|P1|Dispensed Product|Overall Study||307
212019|NCT00777556|518555|P1|STARTED|Overall Study|Enrolled; signed informed consent|343
212020|NCT00777608|518564|P2|NOT COMPLETED|Overall Study||6
212021|NCT00777608|518565|P1|NOT COMPLETED|Overall Study||4
212022|NCT00777608|518564|P2|COMPLETED|Overall Study||47
212023|NCT00777608|518565|P1|COMPLETED|Overall Study||49
212024|NCT00777608|518564|P2|STARTED|Overall Study||53
212025|NCT00777608|518565|P1|STARTED|Overall Study||53
212026|NCT00777634|518577|P2|NOT COMPLETED|Overall Study||1
212027|NCT00777634|518578|P1|NOT COMPLETED|Overall Study||5
212028|NCT00777634|518577|P2|COMPLETED|Overall Study||133
212029|NCT00777634|518578|P1|COMPLETED|Overall Study||129
212030|NCT00777634|518577|P2|STARTED|Overall Study||134
212031|NCT00777634|518578|P1|STARTED|Overall Study||134
212032|NCT00777764|518596|P2|NOT COMPLETED|Overall Study||1
212033|NCT00777764|518597|P1|NOT COMPLETED|Overall Study||0
212034|NCT00777764|518596|P2|COMPLETED|Overall Study||29
212035|NCT00777764|518597|P1|COMPLETED|Overall Study||30
212036|NCT00777764|518596|P2|STARTED|Overall Study||30
212037|NCT00777764|518597|P1|STARTED|Overall Study||30
212038|NCT00777790|518610|P3|NOT COMPLETED|Overall Study||0
212039|NCT00777790|518611|P2|NOT COMPLETED|Overall Study||0
212040|NCT00777790|518612|P1|NOT COMPLETED|Overall Study||0
212041|NCT00777790|518610|P3|COMPLETED|Overall Study||88
212042|NCT00777790|518611|P2|COMPLETED|Overall Study||77
212043|NCT00777790|518612|P1|COMPLETED|Overall Study||76
212044|NCT00777790|518610|P3|STARTED|Overall Study||88
212045|NCT00777790|518611|P2|STARTED|Overall Study||77
212046|NCT00777790|518612|P1|STARTED|Overall Study||76
212047|NCT00777803|518622|P2|NOT COMPLETED|Overall Study||7
212048|NCT00777803|518623|P1|NOT COMPLETED|Overall Study||15
212049|NCT00777803|518622|P2|COMPLETED|Overall Study||90
212050|NCT00777803|518623|P1|COMPLETED|Overall Study||269
212051|NCT00777803|518622|P2|STARTED|Overall Study||97
212052|NCT00777803|518623|P1|STARTED|Overall Study||284
212053|NCT00777855|518655|P2|NOT COMPLETED|Second Intervention||0
212054|NCT00777855|518656|P1|NOT COMPLETED|Second Intervention||0
212055|NCT00777855|518655|P2|COMPLETED|Second Intervention||5
212056|NCT00777855|518656|P1|COMPLETED|Second Intervention||5
212057|NCT00777855|518655|P2|STARTED|Second Intervention||5
212058|NCT00777855|518656|P1|STARTED|Second Intervention||5
212059|NCT00777855|518655|P2|NOT COMPLETED|Washout Period (>= 14 Days)||0
212060|NCT00777855|518656|P1|NOT COMPLETED|Washout Period (>= 14 Days)||0
212061|NCT00777855|518655|P2|COMPLETED|Washout Period (>= 14 Days)||5
212062|NCT00777855|518656|P1|COMPLETED|Washout Period (>= 14 Days)||5
212063|NCT00777855|518655|P2|STARTED|Washout Period (>= 14 Days)||5
212064|NCT00777855|518656|P1|STARTED|Washout Period (>= 14 Days)||5
212065|NCT00777855|518655|P2|NOT COMPLETED|First Intervention||0
212066|NCT00777855|518656|P1|NOT COMPLETED|First Intervention||0
212067|NCT00777855|518655|P2|COMPLETED|First Intervention||5
212068|NCT00777855|518656|P1|COMPLETED|First Intervention||5
212069|NCT00777855|518655|P2|STARTED|First Intervention||5
212070|NCT00777855|518656|P1|STARTED|First Intervention||5
212071|NCT00777946|518668|P3|NOT COMPLETED|Overall Study||16
212072|NCT00777946|518669|P2|NOT COMPLETED|Overall Study||6
212073|NCT00777946|518670|P1|NOT COMPLETED|Overall Study||21
212074|NCT00777946|518668|P3|COMPLETED|Overall Study||244
212075|NCT00777946|518669|P2|COMPLETED|Overall Study||271
212076|NCT00777946|518670|P1|COMPLETED|Overall Study||262
212077|NCT00777946|518668|P3|Safety & Full Analysis Sets|Overall Study||260
212078|NCT00777946|518669|P2|Safety & Full Analysis Sets|Overall Study||276
212079|NCT00777946|518670|P1|Safety & Full Analysis Sets|Overall Study||282
212080|NCT00777946|518668|P3|STARTED|Overall Study||260
212081|NCT00777946|518669|P2|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 5 mg group was randomized in error.|277
212082|NCT00777946|518670|P1|STARTED|Overall Study|1 patient in the Aliskiren 300 mg/Amlodipine 10 mg group was randomized in error.|283
212083|NCT00778102|518695|P2|NOT COMPLETED|Overall Study||22
212084|NCT00778102|518696|P1|NOT COMPLETED|Overall Study||21
212085|NCT00778102|518695|P2|COMPLETED|Overall Study||19
212086|NCT00778102|518696|P1|COMPLETED|Overall Study||18
212087|NCT00778102|518695|P2|STARTED|Overall Study||41
212088|NCT00778102|518696|P1|STARTED|Overall Study||39
212089|NCT00778167|518731|P3|NOT COMPLETED|Overall Study||0
212090|NCT00778167|518732|P2|NOT COMPLETED|Overall Study||0
212091|NCT00778167|518733|P1|NOT COMPLETED|Overall Study||0
212092|NCT00778167|518731|P3|COMPLETED|Overall Study||4
212093|NCT00778167|518732|P2|COMPLETED|Overall Study||8
212094|NCT00778167|518733|P1|COMPLETED|Overall Study||6
212095|NCT00778167|518731|P3|STARTED|Overall Study||4
212096|NCT00778167|518732|P2|STARTED|Overall Study||8
212097|NCT00778167|518733|P1|STARTED|Overall Study||6
212098|NCT00778258|518750|P9|NOT COMPLETED|Overall Study||4
212099|NCT00778258|518751|P8|NOT COMPLETED|Overall Study||15
212100|NCT00778258|518752|P7|NOT COMPLETED|Overall Study||15
212101|NCT00778258|518753|P6|NOT COMPLETED|Overall Study||10
212102|NCT00778258|518754|P5|NOT COMPLETED|Overall Study||0
212103|NCT00778258|518755|P4|NOT COMPLETED|Overall Study||3
212104|NCT00778258|518756|P3|NOT COMPLETED|Overall Study||10
212105|NCT00778258|518757|P2|NOT COMPLETED|Overall Study||2
212106|NCT00778258|518758|P1|NOT COMPLETED|Overall Study||7
212107|NCT00778258|518750|P9|COMPLETED|Overall Study||6
212108|NCT00778258|518751|P8|COMPLETED|Overall Study||26
212109|NCT00778258|518752|P7|COMPLETED|Overall Study||19
212110|NCT00778258|518753|P6|COMPLETED|Overall Study||13
212111|NCT00778258|518754|P5|COMPLETED|Overall Study||6
212112|NCT00778258|518755|P4|COMPLETED|Overall Study||12
212113|NCT00778258|518756|P3|COMPLETED|Overall Study||10
212114|NCT00778258|518757|P2|COMPLETED|Overall Study||3
212115|NCT00778258|518758|P1|COMPLETED|Overall Study||9
212116|NCT00778258|518750|P9|STARTED|Overall Study||10
212117|NCT00778258|518751|P8|STARTED|Overall Study||41
212118|NCT00778258|518752|P7|STARTED|Overall Study||34
212119|NCT00778258|518753|P6|STARTED|Overall Study||23
212120|NCT00778258|518754|P5|STARTED|Overall Study||6
212121|NCT00778258|518755|P4|STARTED|Overall Study||15
212122|NCT00778258|518756|P3|STARTED|Overall Study||20
212123|NCT00778258|518757|P2|STARTED|Overall Study||5
212124|NCT00778258|518758|P1|STARTED|Overall Study||16
212125|NCT00778310|518812|P2|NOT COMPLETED|Overall Study||0
212126|NCT00778310|518813|P1|NOT COMPLETED|Overall Study||0
212127|NCT00778310|518812|P2|COMPLETED|Overall Study||26
212128|NCT00778310|518813|P1|COMPLETED|Overall Study||17
212129|NCT00778310|518812|P2|Usable Data|Overall Study||21
212130|NCT00778310|518813|P1|Usable Data|Overall Study||14
212131|NCT00778310|518812|P2|STARTED|Overall Study||26
212132|NCT00778310|518813|P1|STARTED|Overall Study||17
212133|NCT00778336|518825|P4|NOT COMPLETED|3 Month Follow Up||0
212134|NCT00778336|518826|P3|NOT COMPLETED|3 Month Follow Up||5
212135|NCT00778336|518827|P2|NOT COMPLETED|3 Month Follow Up||23
212136|NCT00778336|518828|P1|NOT COMPLETED|3 Month Follow Up||23
212137|NCT00778336|518825|P4|COMPLETED|3 Month Follow Up||12
212138|NCT00778336|518826|P3|COMPLETED|3 Month Follow Up||65
212139|NCT00778336|518827|P2|COMPLETED|3 Month Follow Up||144
212140|NCT00778336|518828|P1|COMPLETED|3 Month Follow Up||169
212141|NCT00778336|518825|P4|STARTED|3 Month Follow Up||12
212142|NCT00778336|518826|P3|STARTED|3 Month Follow Up||70
212143|NCT00778336|518827|P2|STARTED|3 Month Follow Up||167
212144|NCT00778336|518828|P1|STARTED|3 Month Follow Up||192
212145|NCT00778336|518825|P4|NOT COMPLETED|Index Procedure-Discharge||0
212146|NCT00778336|518826|P3|NOT COMPLETED|Index Procedure-Discharge||2
212147|NCT00778336|518827|P2|NOT COMPLETED|Index Procedure-Discharge||3
212148|NCT00778336|518828|P1|NOT COMPLETED|Index Procedure-Discharge||6
212149|NCT00778336|518825|P4|COMPLETED|Index Procedure-Discharge||12
212150|NCT00778336|518826|P3|COMPLETED|Index Procedure-Discharge||70
212151|NCT00778336|518827|P2|COMPLETED|Index Procedure-Discharge||167
212152|NCT00778336|518828|P1|COMPLETED|Index Procedure-Discharge||192
212153|NCT00778336|518825|P4|STARTED|Index Procedure-Discharge||12
212154|NCT00778336|518826|P3|STARTED|Index Procedure-Discharge||72
212155|NCT00778336|518827|P2|STARTED|Index Procedure-Discharge||170
212156|NCT00778336|518828|P1|STARTED|Index Procedure-Discharge||198
212157|NCT00778375|518846|P1|NOT COMPLETED|Overall Study||3
212158|NCT00778375|518846|P1|COMPLETED|Overall Study||119
212159|NCT00778375|518846|P1|STARTED|Overall Study||122
212160|NCT00772889|518859|P3|NOT COMPLETED|Overall Study||16
212161|NCT00772889|518860|P2|NOT COMPLETED|Overall Study||18
212162|NCT00772889|518861|P1|NOT COMPLETED|Overall Study||22
212163|NCT00772889|518859|P3|COMPLETED|Overall Study||187
212164|NCT00772889|518860|P2|COMPLETED|Overall Study||375
212165|NCT00772889|518861|P1|COMPLETED|Overall Study||353
212166|NCT00772889|518859|P3|Completed at Day 21|Overall Study||203
212167|NCT00772889|518860|P2|Completed at Day 21|Overall Study||390
212168|NCT00772889|518861|P1|Completed at Day 21|Overall Study||374
212169|NCT00772889|518859|P3|STARTED|Overall Study||203
212170|NCT00772889|518860|P2|STARTED|Overall Study||393
212171|NCT00772889|518861|P1|STARTED|Overall Study||375
212172|NCT00772915|518914|P1|NOT COMPLETED|Overall Study||15
212173|NCT00772915|518914|P1|COMPLETED|Overall Study||23
212174|NCT00772915|518914|P1|STARTED|Overall Study||38
212175|NCT00772928|518920|P2|NOT COMPLETED|Overall Study||41
212176|NCT00772928|518921|P1|NOT COMPLETED|Overall Study||44
212177|NCT00772928|518920|P2|COMPLETED|Overall Study||538
212178|NCT00772928|518921|P1|COMPLETED|Overall Study||543
212179|NCT00772928|518920|P2|STARTED|Overall Study||579
212180|NCT00772928|518921|P1|STARTED|Overall Study||587
212181|NCT00778622|518934|P3|NOT COMPLETED|Overall Study||15
212182|NCT00778622|518935|P2|NOT COMPLETED|Overall Study||15
212183|NCT00778622|518936|P1|NOT COMPLETED|Overall Study||16
212184|NCT00778622|518934|P3|COMPLETED|Overall Study||109
212185|NCT00778622|518935|P2|COMPLETED|Overall Study||107
212186|NCT00778622|518936|P1|COMPLETED|Overall Study||109
212187|NCT00778622|518934|P3|STARTED|Overall Study||124
212188|NCT00778622|518935|P2|STARTED|Overall Study||122
212189|NCT00778622|518936|P1|STARTED|Overall Study||125
212190|NCT00778648|518991|P2|NOT COMPLETED|Overall Study||5
212191|NCT00778648|518992|P1|NOT COMPLETED|Overall Study||9
212192|NCT00778648|518991|P2|COMPLETED|Overall Study||266
212193|NCT00778648|518992|P1|COMPLETED|Overall Study||263
212194|NCT00778648|518991|P2|STARTED|Overall Study||271
212195|NCT00778648|518992|P1|STARTED|Overall Study||272
212196|NCT00778817|518998|P1|NOT COMPLETED|Overall Study||4
212197|NCT00778817|518998|P1|COMPLETED|Overall Study||16
212198|NCT00778817|518998|P1|STARTED|Overall Study||20
212199|NCT00778830|519015|P2|NOT COMPLETED|Overall Study||1
212200|NCT00778830|519016|P1|NOT COMPLETED|Overall Study||0
212201|NCT00778830|519015|P2|COMPLETED|Overall Study||187
212202|NCT00778830|519016|P1|COMPLETED|Overall Study||101
212203|NCT00778830|519015|P2|STARTED|Overall Study||188
212204|NCT00778830|519016|P1|STARTED|Overall Study||101
212205|NCT00778869|519028|P1|NOT COMPLETED|Overall Study||0
212206|NCT00778869|519028|P1|COMPLETED|Overall Study||10
212207|NCT00778869|519028|P1|STARTED|Overall Study||10
212208|NCT00778895|519035|P3|NOT COMPLETED|ESFU Phase||2
212209|NCT00778895|519036|P2|NOT COMPLETED|ESFU Phase||12
212210|NCT00778895|519037|P1|NOT COMPLETED|ESFU Phase||11
212211|NCT00778895|519035|P3|COMPLETED|ESFU Phase||41
212212|NCT00778895|519036|P2|COMPLETED|ESFU Phase||155
212213|NCT00778895|519037|P1|COMPLETED|ESFU Phase||153
212214|NCT00778895|519035|P3|STARTED|ESFU Phase||43
212215|NCT00778895|519036|P2|STARTED|ESFU Phase||167
212216|NCT00778895|519037|P1|STARTED|ESFU Phase||164
212217|NCT00778895|519035|P3|NOT COMPLETED|Active Phase||0
212218|NCT00778895|519036|P2|NOT COMPLETED|Active Phase||6
212219|NCT00778895|519037|P1|NOT COMPLETED|Active Phase||7
212220|NCT00778895|519035|P3|COMPLETED|Active Phase||43
212221|NCT00778895|519036|P2|COMPLETED|Active Phase||161
212222|NCT00778895|519037|P1|COMPLETED|Active Phase||157
212223|NCT00778895|519035|P3|STARTED|Active Phase||43
212224|NCT00778895|519036|P2|STARTED|Active Phase||167
212225|NCT00778895|519037|P1|STARTED|Active Phase||164
212226|NCT00778921|519078|P3|NOT COMPLETED|Overall Study||28
212227|NCT00778921|519079|P2|NOT COMPLETED|Overall Study||19
212228|NCT00778921|519080|P1|NOT COMPLETED|Overall Study||18
212229|NCT00778921|519078|P3|COMPLETED|Overall Study||255
212230|NCT00778921|519079|P2|COMPLETED|Overall Study||266
212231|NCT00778921|519080|P1|COMPLETED|Overall Study||261
212232|NCT00778921|519078|P3|STARTED|Overall Study||283
212233|NCT00778921|519079|P2|STARTED|Overall Study||285
212234|NCT00778921|519080|P1|STARTED|Overall Study||279
212235|NCT00780338|519096|P2|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||5
212236|NCT00780338|519097|P1|NOT COMPLETED|Mid to Post (1 Year; 2 Years in Total)||13
212237|NCT00780338|519096|P2|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||159
212238|NCT00780338|519097|P1|COMPLETED|Mid to Post (1 Year; 2 Years in Total)||156
212239|NCT00780338|519096|P2|STARTED|Mid to Post (1 Year; 2 Years in Total)||164
212240|NCT00780338|519097|P1|STARTED|Mid to Post (1 Year; 2 Years in Total)||169
212241|NCT00780338|519096|P2|NOT COMPLETED|Baseline to Mid (1 Year)||38
212242|NCT00780338|519097|P1|NOT COMPLETED|Baseline to Mid (1 Year)||5
212243|NCT00780338|519096|P2|COMPLETED|Baseline to Mid (1 Year)||164
212244|NCT00780338|519097|P1|COMPLETED|Baseline to Mid (1 Year)||169
212245|NCT00780338|519096|P2|STARTED|Baseline to Mid (1 Year)||202
212246|NCT00780338|519097|P1|STARTED|Baseline to Mid (1 Year)||174
212247|NCT00780403|519125|P2|NOT COMPLETED|Second Intervention||0
212248|NCT00780403|519126|P1|NOT COMPLETED|Second Intervention||0
212249|NCT00780403|519125|P2|COMPLETED|Second Intervention||111
212250|NCT00780403|519126|P1|COMPLETED|Second Intervention||109
212251|NCT00780403|519125|P2|STARTED|Second Intervention||111
212252|NCT00780403|519126|P1|STARTED|Second Intervention||109
212253|NCT00780403|519125|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
212254|NCT00780403|519126|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
212255|NCT00780403|519125|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||111
212256|NCT00780403|519126|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
212257|NCT00780403|519125|P2|STARTED|Interval Between Doses (8-10 Minutes)||111
212258|NCT00780403|519126|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
212259|NCT00780403|519125|P2|NOT COMPLETED|First Intervention||0
212260|NCT00780403|519126|P1|NOT COMPLETED|First Intervention||0
212261|NCT00780403|519125|P2|COMPLETED|First Intervention||111
212262|NCT00780403|519126|P1|COMPLETED|First Intervention||109
212263|NCT00780403|519125|P2|STARTED|First Intervention||111
212264|NCT00780403|519126|P1|STARTED|First Intervention||109
212265|NCT00780416|519135|P2|NOT COMPLETED|Overall Study||9
212266|NCT00780416|519136|P1|NOT COMPLETED|Overall Study||12
212267|NCT00780416|519135|P2|COMPLETED|Overall Study||54
212268|NCT00780416|519136|P1|COMPLETED|Overall Study||114
212269|NCT00780416|519135|P2|STARTED|Overall Study||63
212270|NCT00780416|519136|P1|STARTED|Overall Study||126
212271|NCT00780455|519144|P2|NOT COMPLETED|Overall Study||0
212272|NCT00780455|519145|P1|NOT COMPLETED|Overall Study||0
212273|NCT00780455|519144|P2|COMPLETED|Overall Study||2
212274|NCT00780455|519145|P1|COMPLETED|Overall Study||2
212275|NCT00780455|519144|P2|STARTED|Overall Study||2
212276|NCT00780455|519145|P1|STARTED|Overall Study||2
212277|NCT00780481|519169|P1|NOT COMPLETED|Overall Study||0
212278|NCT00780481|519169|P1|COMPLETED|Overall Study||13
212279|NCT00780481|519169|P1|STARTED|Overall Study||13
212280|NCT00780572|519178|P2|NOT COMPLETED|Overall Study||0
212281|NCT00780572|519179|P1|NOT COMPLETED|Overall Study||0
212282|NCT00780572|519178|P2|COMPLETED|Overall Study||298
212283|NCT00780572|519179|P1|COMPLETED|Overall Study||297
212284|NCT00780572|519178|P2|STARTED|Overall Study||298
212285|NCT00780572|519179|P1|STARTED|Overall Study||297
212286|NCT00780676|519190|P5|NOT COMPLETED|Overall Study||0
212287|NCT00780676|519191|P4|NOT COMPLETED|Overall Study||0
212288|NCT00780676|519192|P3|NOT COMPLETED|Overall Study||0
212289|NCT00780676|519193|P2|NOT COMPLETED|Overall Study||0
212290|NCT00780676|519194|P1|NOT COMPLETED|Overall Study||0
212291|NCT00780676|519190|P5|COMPLETED|Overall Study||0
212292|NCT00780676|519191|P4|COMPLETED|Overall Study||0
212293|NCT00780676|519192|P3|COMPLETED|Overall Study||13
212294|NCT00780676|519193|P2|COMPLETED|Overall Study||8
212295|NCT00780676|519194|P1|COMPLETED|Overall Study||9
212296|NCT00780676|519190|P5|STARTED|Overall Study||0
212297|NCT00780676|519191|P4|STARTED|Overall Study||0
212298|NCT00780676|519192|P3|STARTED|Overall Study||13
212299|NCT00780676|519193|P2|STARTED|Overall Study||8
212300|NCT00780676|519194|P1|STARTED|Overall Study||9
212301|NCT00780741|519202|P2|NOT COMPLETED|Overall Study||10
212302|NCT00780741|519203|P1|NOT COMPLETED|Overall Study||7
212303|NCT00780741|519202|P2|COMPLETED|Overall Study|18 months of age (±4 weeks)|71
212304|NCT00780741|519203|P1|COMPLETED|Overall Study|18 months of age (±4 weeks)|75
212305|NCT00780741|519202|P2|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|67
212306|NCT00780741|519203|P1|6-Month Visit|Overall Study|6 months (±2 weeks) timed from randomization|73
212307|NCT00780741|519202|P2|STARTED|Overall Study|randomized|81
212308|NCT00780741|519203|P1|STARTED|Overall Study|randomized|82
212309|NCT00780910|519215|P1|NOT COMPLETED|Overall Study||2
212310|NCT00780910|519215|P1|COMPLETED|Overall Study||107
212311|NCT00780910|519215|P1|STARTED|Overall Study||109
212312|NCT00781079|519221|P2|NOT COMPLETED|Overall Study||17
212313|NCT00781079|519222|P1|NOT COMPLETED|Overall Study||27
212314|NCT00781079|519221|P2|COMPLETED|Overall Study||116
212315|NCT00781079|519222|P1|COMPLETED|Overall Study||122
212316|NCT00781079|519221|P2|STARTED|Overall Study||133
212317|NCT00781079|519222|P1|STARTED|Overall Study||149
212318|NCT00781274|519230|P1|NOT COMPLETED|Overall Study||2
212319|NCT00781274|519230|P1|COMPLETED|Overall Study||30
212320|NCT00781274|519230|P1|STARTED|Overall Study||32
212321|NCT00781326|519234|P1|NOT COMPLETED|Phase 2||0
212322|NCT00781326|519234|P1|COMPLETED|Phase 2||0
212323|NCT00781326|519234|P1|STARTED|Phase 2|Study terminated prior to enrollment into Phase II|0
212324|NCT00781326|519234|P1|NOT COMPLETED|Phase I||4
212325|NCT00781326|519234|P1|COMPLETED|Phase I||2
212326|NCT00781326|519234|P1|STARTED|Phase I|Nine subjects consented; 3 did not meet eligibility criteria. 6 started antidepressant treatment.|6
212327|NCT00781365|519240|P2|NOT COMPLETED|Overall Study||36
212328|NCT00781365|519241|P1|NOT COMPLETED|Overall Study||34
212329|NCT00781365|519240|P2|COMPLETED|Overall Study|completed both 6 and 12 month follow up|186
212330|NCT00781365|519241|P1|COMPLETED|Overall Study|completed both 6 and 12 month follow up|194
212331|NCT00781365|519240|P2|STARTED|Overall Study||222
212332|NCT00781365|519241|P1|STARTED|Overall Study||228
212333|NCT00781391|519254|P3|NOT COMPLETED|Overall Study||784
212334|NCT00781391|519255|P2|NOT COMPLETED|Overall Study||807
212335|NCT00781391|519256|P1|NOT COMPLETED|Overall Study||879
212336|NCT00781391|519254|P3|COMPLETED|Overall Study||6250
212337|NCT00781391|519255|P2|COMPLETED|Overall Study||6228
212338|NCT00781391|519256|P1|COMPLETED|Overall Study||6157
212339|NCT00781391|519254|P3|Per Protocol Analysis Set|Overall Study||6982
212340|NCT00781391|519255|P2|Per Protocol Analysis Set|Overall Study||6995
212341|NCT00781391|519256|P1|Per Protocol Analysis Set|Overall Study||6993
212342|NCT00781391|519254|P3|mITT Analysis Set (Received Drug)|Overall Study||7002
212343|NCT00781391|519255|P2|mITT Analysis Set (Received Drug)|Overall Study||7012
212344|NCT00781391|519256|P1|mITT Analysis Set (Received Drug)|Overall Study||7012
212345|NCT00781391|519254|P3|Safety Analysis Set (Received Drug)|Overall Study||7002
212346|NCT00781391|519255|P2|Safety Analysis Set (Received Drug)|Overall Study||7012
212347|NCT00781391|519256|P1|Safety Analysis Set (Received Drug)|Overall Study||7012
212348|NCT00781391|519254|P3|STARTED|Overall Study||7034
212349|NCT00781391|519255|P2|STARTED|Overall Study||7035
212350|NCT00781391|519256|P1|STARTED|Overall Study||7036
212351|NCT00781456|519290|P2|NOT COMPLETED|Overall Study||16
212352|NCT00781456|519291|P1|NOT COMPLETED|Overall Study||21
212353|NCT00781456|519290|P2|COMPLETED|Overall Study||35
212354|NCT00781456|519291|P1|COMPLETED|Overall Study||37
212355|NCT00781456|519290|P2|Received Study Drug|Overall Study||49
212356|NCT00781456|519291|P1|Received Study Drug|Overall Study||57
212357|NCT00781456|519290|P2|STARTED|Overall Study||51
212358|NCT00781456|519291|P1|STARTED|Overall Study||58
212359|NCT00781508|519313|P2|NOT COMPLETED|Overall Study||0
212360|NCT00781508|519314|P1|NOT COMPLETED|Overall Study||0
212361|NCT00781508|519313|P2|COMPLETED|Overall Study||5
212362|NCT00781508|519314|P1|COMPLETED|Overall Study||5
212363|NCT00781508|519313|P2|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
212364|NCT00781508|519314|P1|STARTED|Overall Study|"First Intervention (1 day), Washout (48 hours), Second Intervention (1 day)"|5
212365|NCT00781599|519324|P2|NOT COMPLETED|Overall Study||4
212366|NCT00781599|519325|P1|NOT COMPLETED|Overall Study||7
212367|NCT00781599|519324|P2|COMPLETED|Overall Study||32
212368|NCT00781599|519325|P1|COMPLETED|Overall Study||29
212369|NCT00781599|519324|P2|STARTED|Overall Study||36
212370|NCT00781599|519325|P1|STARTED|Overall Study||36
212371|NCT00781859|519339|P2|NOT COMPLETED|Overall Study||9
212372|NCT00781859|519340|P1|NOT COMPLETED|Overall Study||19
212373|NCT00781859|519339|P2|COMPLETED|Overall Study||98
212374|NCT00781859|519340|P1|COMPLETED|Overall Study||200
212375|NCT00781859|519339|P2|STARTED|Overall Study||107
212376|NCT00781859|519340|P1|STARTED|Overall Study||219
212377|NCT00781937|519350|P2|NOT COMPLETED|Follow up Period (Week 56-68)||5
212378|NCT00781937|519351|P1|NOT COMPLETED|Follow up Period (Week 56-68)||6
212379|NCT00781937|519350|P2|COMPLETED|Follow up Period (Week 56-68)||141
212380|NCT00781937|519351|P1|COMPLETED|Follow up Period (Week 56-68)||153
212381|NCT00781937|519350|P2|STARTED|Follow up Period (Week 56-68)||146
212382|NCT00781937|519351|P1|STARTED|Follow up Period (Week 56-68)||159
212383|NCT00781937|519350|P2|NOT COMPLETED|Main Trial Period Through Week 56||64
212384|NCT00781937|519351|P1|NOT COMPLETED|Main Trial Period Through Week 56||53
212385|NCT00781937|519350|P2|COMPLETED|Main Trial Period Through Week 56||146
212386|NCT00781937|519351|P1|COMPLETED|Main Trial Period Through Week 56||159
212387|NCT00781937|519350|P2|STARTED|Main Trial Period Through Week 56||210
212388|NCT00781937|519351|P1|STARTED|Main Trial Period Through Week 56||212
212389|NCT00781950|519409|P2|NOT COMPLETED|Overall Study||13
212390|NCT00781950|519410|P1|NOT COMPLETED|Overall Study||11
212391|NCT00781950|519409|P2|COMPLETED|Overall Study||45
212392|NCT00781950|519410|P1|COMPLETED|Overall Study||41
212393|NCT00781950|519409|P2|STARTED|Overall Study||58
212394|NCT00781950|519410|P1|STARTED|Overall Study||52
212395|NCT00781963|519421|P3|NOT COMPLETED|Overall Study||2
212396|NCT00781963|519422|P2|NOT COMPLETED|Overall Study||9
212397|NCT00781963|519423|P1|NOT COMPLETED|Overall Study||8
212398|NCT00781963|519421|P3|COMPLETED|Overall Study||51
212399|NCT00781963|519422|P2|COMPLETED|Overall Study||43
212400|NCT00781963|519423|P1|COMPLETED|Overall Study||46
212401|NCT00781963|519421|P3|6-month Follow-up|Overall Study||52
212402|NCT00781963|519422|P2|6-month Follow-up|Overall Study||44
212403|NCT00781963|519423|P1|6-month Follow-up|Overall Study||48
212404|NCT00781963|519421|P3|Post-treatment|Overall Study||53
212405|NCT00781963|519422|P2|Post-treatment|Overall Study||45
212406|NCT00781963|519423|P1|Post-treatment|Overall Study||52
212407|NCT00781963|519421|P3|STARTED|Overall Study||53
212408|NCT00781963|519422|P2|STARTED|Overall Study||52
212409|NCT00781963|519423|P1|STARTED|Overall Study||54
212410|NCT00782067|519431|P1|NOT COMPLETED|Overall Study||95
212411|NCT00782067|519431|P1|COMPLETED|Overall Study||21
212412|NCT00782067|519431|P1|Primary Efficacy Population (PEP)|Overall Study||89
212413|NCT00782067|519431|P1|Treatment Ongoing|Overall Study||21
212414|NCT00782067|519431|P1|STARTED|Overall Study||116
212415|NCT00782171|519440|P2|NOT COMPLETED|Overall Study||19
212416|NCT00782171|519441|P1|NOT COMPLETED|Overall Study||22
212417|NCT00782171|519440|P2|COMPLETED|Overall Study||115
212418|NCT00782171|519441|P1|COMPLETED|Overall Study||124
212419|NCT00782171|519440|P2|Surgery (Baseline)|Overall Study||128
212420|NCT00782171|519441|P1|Surgery (Baseline)|Overall Study||138
212421|NCT00782171|519440|P2|1 Year|Overall Study||120
212422|NCT00782171|519441|P1|1 Year|Overall Study||131
212423|NCT00782171|519440|P2|20-23 Weeks|Overall Study||124
212424|NCT00782171|519441|P1|20-23 Weeks|Overall Study||135
212425|NCT00782171|519440|P2|STARTED|Overall Study||134
212426|NCT00782171|519441|P1|STARTED|Overall Study||146
212427|NCT00782184|519475|P2|NOT COMPLETED|Overall Study||5
212428|NCT00782184|519476|P1|NOT COMPLETED|Overall Study||4
212429|NCT00782184|519475|P2|COMPLETED|Overall Study||125
212430|NCT00782184|519476|P1|COMPLETED|Overall Study||116
212431|NCT00782184|519475|P2|STARTED|Overall Study||130
212432|NCT00782184|519476|P1|STARTED|Overall Study||120
212433|NCT00782210|519514|P3|NOT COMPLETED|Overall Study||35
212434|NCT00782210|519515|P2|NOT COMPLETED|Overall Study||35
212435|NCT00782210|519516|P1|NOT COMPLETED|Overall Study||50
212436|NCT00782210|519514|P3|COMPLETED|Overall Study||172
212437|NCT00782210|519515|P2|COMPLETED|Overall Study||173
212438|NCT00782210|519516|P1|COMPLETED|Overall Study||159
212439|NCT00782210|519514|P3|STARTED|Overall Study||207
212440|NCT00782210|519515|P2|STARTED|Overall Study||208
212441|NCT00782210|519516|P1|STARTED|Overall Study||209
212442|NCT00782288|519710|P3|NOT COMPLETED|Overall Study||0
212443|NCT00782288|519711|P2|NOT COMPLETED|Overall Study||0
212444|NCT00782288|519712|P1|NOT COMPLETED|Overall Study||0
212445|NCT00782288|519710|P3|COMPLETED|Overall Study||8
212446|NCT00782288|519711|P2|COMPLETED|Overall Study||8
212447|NCT00782288|519712|P1|COMPLETED|Overall Study||8
212448|NCT00782288|519710|P3|STARTED|Overall Study||8
212449|NCT00782288|519711|P2|STARTED|Overall Study||8
212450|NCT00782288|519712|P1|STARTED|Overall Study||8
212451|NCT00782340|519757|P3|NOT COMPLETED|Randomized Double Blind||0
212452|NCT00782340|519758|P2|NOT COMPLETED|Randomized Double Blind||0
212453|NCT00782340|519759|P1|NOT COMPLETED|Randomized Double Blind||0
212454|NCT00782340|519757|P3|COMPLETED|Randomized Double Blind||80
212455|NCT00782340|519758|P2|COMPLETED|Randomized Double Blind||82
212456|NCT00782340|519759|P1|COMPLETED|Randomized Double Blind||0
212457|NCT00782340|519757|P3|STARTED|Randomized Double Blind||80
212458|NCT00782340|519758|P2|STARTED|Randomized Double Blind||82
212459|NCT00782340|519759|P1|STARTED|Randomized Double Blind||0
212460|NCT00782340|519757|P3|NOT COMPLETED|Open Label Titration||0
212461|NCT00782340|519758|P2|NOT COMPLETED|Open Label Titration||0
212462|NCT00782340|519759|P1|NOT COMPLETED|Open Label Titration||101
212463|NCT00782340|519757|P3|COMPLETED|Open Label Titration||0
212464|NCT00782340|519758|P2|COMPLETED|Open Label Titration||0
212465|NCT00782340|519759|P1|COMPLETED|Open Label Titration||162
212466|NCT00782340|519757|P3|STARTED|Open Label Titration||0
212467|NCT00782340|519758|P2|STARTED|Open Label Titration||0
212468|NCT00782340|519759|P1|STARTED|Open Label Titration||263
212469|NCT00782379|519782|P1|NOT COMPLETED|Overall Study||0
212470|NCT00782379|519782|P1|COMPLETED|Overall Study||20
212471|NCT00782379|519782|P1|STARTED|Overall Study||20
212472|NCT00782418|519796|P7|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
212473|NCT00782418|519797|P6|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
212474|NCT00782418|519798|P5|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
212475|NCT00782418|519799|P4|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
212476|NCT00782418|519800|P3|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
212477|NCT00782418|519801|P2|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
212478|NCT00782418|519802|P1|NOT COMPLETED|Period 2 Procedure/Treatment Groups||0
212479|NCT00782418|519796|P7|COMPLETED|Period 2 Procedure/Treatment Groups||4
212480|NCT00782418|519797|P6|COMPLETED|Period 2 Procedure/Treatment Groups||4
212481|NCT00782418|519798|P5|COMPLETED|Period 2 Procedure/Treatment Groups||3
212482|NCT00782418|519799|P4|COMPLETED|Period 2 Procedure/Treatment Groups||1
212483|NCT00782418|519800|P3|COMPLETED|Period 2 Procedure/Treatment Groups||4
212484|NCT00782418|519801|P2|COMPLETED|Period 2 Procedure/Treatment Groups||4
212485|NCT00782418|519802|P1|COMPLETED|Period 2 Procedure/Treatment Groups||3
212486|NCT00782418|519796|P7|STARTED|Period 2 Procedure/Treatment Groups||4
212487|NCT00782418|519797|P6|STARTED|Period 2 Procedure/Treatment Groups||4
212488|NCT00782418|519798|P5|STARTED|Period 2 Procedure/Treatment Groups||3
212489|NCT00782418|519799|P4|STARTED|Period 2 Procedure/Treatment Groups||1
212490|NCT00782418|519800|P3|STARTED|Period 2 Procedure/Treatment Groups||4
212491|NCT00782418|519801|P2|STARTED|Period 2 Procedure/Treatment Groups||4
212492|NCT00782418|519802|P1|STARTED|Period 2 Procedure/Treatment Groups||3
212493|NCT00782418|519796|P7|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
212494|NCT00782418|519797|P6|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
212495|NCT00782418|519798|P5|NOT COMPLETED|Period 1 Procedure/Treatment Groups||1
212496|NCT00782418|519799|P4|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
212497|NCT00782418|519800|P3|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
212498|NCT00782418|519801|P2|NOT COMPLETED|Period 1 Procedure/Treatment Groups||0
212499|NCT00782418|519802|P1|NOT COMPLETED|Period 1 Procedure/Treatment Groups||2
212500|NCT00782418|519796|P7|COMPLETED|Period 1 Procedure/Treatment Groups||4
212501|NCT00782418|519797|P6|COMPLETED|Period 1 Procedure/Treatment Groups||4
212502|NCT00782418|519798|P5|COMPLETED|Period 1 Procedure/Treatment Groups||4
212503|NCT00782418|519799|P4|COMPLETED|Period 1 Procedure/Treatment Groups||2
212504|NCT00782418|519800|P3|COMPLETED|Period 1 Procedure/Treatment Groups||4
212505|NCT00782418|519801|P2|COMPLETED|Period 1 Procedure/Treatment Groups||4
212506|NCT00782418|519802|P1|COMPLETED|Period 1 Procedure/Treatment Groups||1
212507|NCT00782418|519796|P7|STARTED|Period 1 Procedure/Treatment Groups||4
212508|NCT00782418|519797|P6|STARTED|Period 1 Procedure/Treatment Groups||5
212509|NCT00782418|519798|P5|STARTED|Period 1 Procedure/Treatment Groups||5
212510|NCT00782418|519799|P4|STARTED|Period 1 Procedure/Treatment Groups||2
212511|NCT00782418|519800|P3|STARTED|Period 1 Procedure/Treatment Groups||4
212512|NCT00782418|519801|P2|STARTED|Period 1 Procedure/Treatment Groups||4
212513|NCT00782418|519802|P1|STARTED|Period 1 Procedure/Treatment Groups||3
212514|NCT00782483|519822|P1|NOT COMPLETED|Overall Study||6
212515|NCT00782483|519822|P1|COMPLETED|Overall Study||0
212516|NCT00782483|519822|P1|STARTED|Overall Study|6 subjects enrolled beginning on 04/27/2009 with last enrollment on 04/13/2010.|6
212517|NCT00782496|519828|P2|NOT COMPLETED|Overall Study||15
212518|NCT00782496|519829|P1|NOT COMPLETED|Overall Study||14
212519|NCT00782496|519828|P2|COMPLETED|Overall Study||90
212520|NCT00782496|519829|P1|COMPLETED|Overall Study||92
212521|NCT00782496|519828|P2|STARTED|Overall Study||105
212522|NCT00782496|519829|P1|STARTED|Overall Study||106
212523|NCT00782509|519839|P3|NOT COMPLETED|Overall Study||36
212524|NCT00782509|519840|P2|NOT COMPLETED|Overall Study||24
212525|NCT00782509|519841|P1|NOT COMPLETED|Overall Study||41
212526|NCT00782509|519839|P3|COMPLETED|Overall Study||181
212527|NCT00782509|519840|P2|COMPLETED|Overall Study||185
212528|NCT00782509|519841|P1|COMPLETED|Overall Study||175
212529|NCT00782509|519839|P3|STARTED|Overall Study||217
212530|NCT00782509|519840|P2|STARTED|Overall Study||209
212531|NCT00782509|519841|P1|STARTED|Overall Study||216
212532|NCT00782626|520032|P1|NOT COMPLETED|Overall Study||7
212533|NCT00782626|520032|P1|COMPLETED|Overall Study||16
212534|NCT00782626|520032|P1|STARTED|Overall Study||23
212535|NCT00782639|520038|P2|NOT COMPLETED|Overall Study||0
212536|NCT00782639|520039|P1|NOT COMPLETED|Overall Study||0
212537|NCT00782639|520038|P2|COMPLETED|Overall Study|This study was terminated due to low enrollment.|11
212538|NCT00782639|520039|P1|COMPLETED|Overall Study|This study was terminated due to low enrollment.|12
212539|NCT00782639|520038|P2|STARTED|Overall Study||11
212540|NCT00782639|520039|P1|STARTED|Overall Study||12
212541|NCT00782717|520057|P2|NOT COMPLETED|Overall Study||28
212542|NCT00782717|520058|P1|NOT COMPLETED|Overall Study||15
212543|NCT00782717|520057|P2|COMPLETED|Overall Study||102
212544|NCT00782717|520058|P1|COMPLETED|Overall Study||118
212545|NCT00782717|520057|P2|STARTED|Overall Study||130
212546|NCT00782717|520058|P1|STARTED|Overall Study||133
212547|NCT00775944|520070|P4|NOT COMPLETED|Overall Study||16
212548|NCT00775944|520071|P3|NOT COMPLETED|Overall Study||16
212549|NCT00775944|520072|P2|NOT COMPLETED|Overall Study||9
212550|NCT00775944|520073|P1|NOT COMPLETED|Overall Study||15
212551|NCT00775944|520070|P4|COMPLETED|Overall Study|16 participants withdrew consent|632
212552|NCT00775944|520071|P3|COMPLETED|Overall Study|16 participants withdrew consent|632
212553|NCT00775944|520072|P2|COMPLETED|Overall Study|9 participants withdrew consent|638
212554|NCT00775944|520073|P1|COMPLETED|Overall Study|15 participants withdrew consent|633
212555|NCT00775944|520070|P4|STARTED|Overall Study||648
212556|NCT00775944|520071|P3|STARTED|Overall Study||648
212557|NCT00775944|520072|P2|STARTED|Overall Study||647
212558|NCT00775944|520073|P1|STARTED|Overall Study||648
212559|NCT00775983|520101|P2|NOT COMPLETED|Overall Study||2
212560|NCT00775983|520102|P1|NOT COMPLETED|Overall Study||1
212561|NCT00775983|520101|P2|COMPLETED|Overall Study||34
212562|NCT00775983|520102|P1|COMPLETED|Overall Study||35
212563|NCT00775983|520101|P2|STARTED|Overall Study||36
212564|NCT00775983|520102|P1|STARTED|Overall Study||36
212565|NCT00776009|520116|P6|NOT COMPLETED|Period 3: Third Intervention||0
212566|NCT00776009|520117|P5|NOT COMPLETED|Period 3: Third Intervention||0
212567|NCT00776009|520118|P4|NOT COMPLETED|Period 3: Third Intervention||0
212568|NCT00776009|520119|P3|NOT COMPLETED|Period 3: Third Intervention||0
212569|NCT00776009|520120|P2|NOT COMPLETED|Period 3: Third Intervention||0
212570|NCT00776009|520121|P1|NOT COMPLETED|Period 3: Third Intervention||1
212571|NCT00776009|520116|P6|COMPLETED|Period 3: Third Intervention||26
212572|NCT00776009|520117|P5|COMPLETED|Period 3: Third Intervention||26
212573|NCT00776009|520118|P4|COMPLETED|Period 3: Third Intervention||27
212574|NCT00776009|520119|P3|COMPLETED|Period 3: Third Intervention||27
212575|NCT00776009|520120|P2|COMPLETED|Period 3: Third Intervention||27
212576|NCT00776009|520121|P1|COMPLETED|Period 3: Third Intervention||24
212577|NCT00776009|520116|P6|STARTED|Period 3: Third Intervention||26
212578|NCT00776009|520117|P5|STARTED|Period 3: Third Intervention||26
212579|NCT00776009|520118|P4|STARTED|Period 3: Third Intervention||27
212580|NCT00776009|520119|P3|STARTED|Period 3: Third Intervention||27
212581|NCT00776009|520120|P2|STARTED|Period 3: Third Intervention||27
212582|NCT00776009|520121|P1|STARTED|Period 3: Third Intervention||25
212583|NCT00776009|520116|P6|NOT COMPLETED|Period 2: Second Intervention||1
212584|NCT00776009|520117|P5|NOT COMPLETED|Period 2: Second Intervention||0
212585|NCT00776009|520118|P4|NOT COMPLETED|Period 2: Second Intervention||0
212586|NCT00776009|520119|P3|NOT COMPLETED|Period 2: Second Intervention||1
212587|NCT00776009|520120|P2|NOT COMPLETED|Period 2: Second Intervention||0
212588|NCT00776009|520121|P1|NOT COMPLETED|Period 2: Second Intervention||1
212589|NCT00776009|520116|P6|COMPLETED|Period 2: Second Intervention||26
212590|NCT00776009|520117|P5|COMPLETED|Period 2: Second Intervention||26
212591|NCT00776009|520118|P4|COMPLETED|Period 2: Second Intervention||27
212592|NCT00776009|520119|P3|COMPLETED|Period 2: Second Intervention||27
212593|NCT00776009|520120|P2|COMPLETED|Period 2: Second Intervention||27
212594|NCT00776009|520121|P1|COMPLETED|Period 2: Second Intervention||25
212595|NCT00776009|520116|P6|STARTED|Period 2: Second Intervention||27
212596|NCT00776009|520117|P5|STARTED|Period 2: Second Intervention||26
212597|NCT00776009|520118|P4|STARTED|Period 2: Second Intervention||27
212598|NCT00776009|520119|P3|STARTED|Period 2: Second Intervention||28
212599|NCT00776009|520120|P2|STARTED|Period 2: Second Intervention||27
212600|NCT00776009|520121|P1|STARTED|Period 2: Second Intervention||26
212601|NCT00776009|520116|P6|NOT COMPLETED|Period 1: First Intervention||0
212602|NCT00776009|520117|P5|NOT COMPLETED|Period 1: First Intervention||2
212603|NCT00776009|520118|P4|NOT COMPLETED|Period 1: First Intervention||0
212604|NCT00776009|520119|P3|NOT COMPLETED|Period 1: First Intervention||1
212605|NCT00776009|520120|P2|NOT COMPLETED|Period 1: First Intervention||1
212606|NCT00776009|520121|P1|NOT COMPLETED|Period 1: First Intervention||0
212607|NCT00776009|520116|P6|COMPLETED|Period 1: First Intervention||27
212608|NCT00776009|520117|P5|COMPLETED|Period 1: First Intervention||26
212609|NCT00776009|520118|P4|COMPLETED|Period 1: First Intervention||27
212610|NCT00776009|520119|P3|COMPLETED|Period 1: First Intervention||28
212611|NCT00776009|520120|P2|COMPLETED|Period 1: First Intervention||27
212612|NCT00776009|520121|P1|COMPLETED|Period 1: First Intervention||26
212613|NCT00776009|520116|P6|STARTED|Period 1: First Intervention||27
212614|NCT00776009|520117|P5|STARTED|Period 1: First Intervention||28
212615|NCT00776009|520118|P4|STARTED|Period 1: First Intervention||27
212616|NCT00776009|520119|P3|STARTED|Period 1: First Intervention||29
212617|NCT00776009|520120|P2|STARTED|Period 1: First Intervention||28
212618|NCT00776009|520121|P1|STARTED|Period 1: First Intervention||26
212619|NCT00776100|520143|P2|NOT COMPLETED|Overall Study||0
212620|NCT00776100|520144|P1|NOT COMPLETED|Overall Study||1
212621|NCT00776100|520143|P2|COMPLETED|Overall Study||1
212622|NCT00776100|520144|P1|COMPLETED|Overall Study||0
212623|NCT00776100|520143|P2|STARTED|Overall Study||1
212624|NCT00776100|520144|P1|STARTED|Overall Study||1
212625|NCT00782821|520164|P4|NOT COMPLETED|Overall Study||2
212626|NCT00782821|520165|P3|NOT COMPLETED|Overall Study||1
212627|NCT00782821|520166|P2|NOT COMPLETED|Overall Study||0
212628|NCT00782821|520167|P1|NOT COMPLETED|Overall Study||0
212629|NCT00782821|520164|P4|COMPLETED|Overall Study||8
212630|NCT00782821|520165|P3|COMPLETED|Overall Study||9
212631|NCT00782821|520166|P2|COMPLETED|Overall Study||10
212632|NCT00782821|520167|P1|COMPLETED|Overall Study||10
212633|NCT00782821|520164|P4|STARTED|Overall Study||10
212634|NCT00782821|520165|P3|STARTED|Overall Study||10
212635|NCT00782821|520166|P2|STARTED|Overall Study||10
212636|NCT00782821|520167|P1|STARTED|Overall Study||10
212637|NCT00782834|520193|P1|NOT COMPLETED|Treatment Phase||1
212638|NCT00782834|520193|P1|COMPLETED|Treatment Phase||13
212639|NCT00782834|520193|P1|STARTED|Treatment Phase||14
212640|NCT00782834|520193|P1|NOT COMPLETED|Screened Patients||1
212641|NCT00782834|520193|P1|COMPLETED|Screened Patients|1 pt ineligible d/t arrhythmia|14
212642|NCT00782834|520193|P1|STARTED|Screened Patients||15
212643|NCT00783094|520201|P3|NOT COMPLETED|Open-Label Extension Period||30
212644|NCT00783094|520202|P2|NOT COMPLETED|Open-Label Extension Period||19
212645|NCT00783094|520203|P1|NOT COMPLETED|Open-Label Extension Period||22
212646|NCT00783094|520201|P3|COMPLETED|Open-Label Extension Period||101
212647|NCT00783094|520202|P2|COMPLETED|Open-Label Extension Period||109
212648|NCT00783094|520203|P1|COMPLETED|Open-Label Extension Period||113
212649|NCT00783094|520201|P3|STARTED|Open-Label Extension Period||131
212650|NCT00783094|520202|P2|STARTED|Open-Label Extension Period||128
212651|NCT00783094|520203|P1|STARTED|Open-Label Extension Period||135
212652|NCT00783094|520201|P3|NOT COMPLETED|Randomized Double-Blind Treatment Period||9
212653|NCT00783094|520202|P2|NOT COMPLETED|Randomized Double-Blind Treatment Period||12
212654|NCT00783094|520203|P1|NOT COMPLETED|Randomized Double-Blind Treatment Period||7
212655|NCT00783094|520201|P3|COMPLETED|Randomized Double-Blind Treatment Period||131
212656|NCT00783094|520202|P2|COMPLETED|Randomized Double-Blind Treatment Period||128
212657|NCT00783094|520203|P1|COMPLETED|Randomized Double-Blind Treatment Period||135
212658|NCT00783094|520201|P3|STARTED|Randomized Double-Blind Treatment Period||140
212659|NCT00783094|520202|P2|STARTED|Randomized Double-Blind Treatment Period||140
212660|NCT00783094|520203|P1|STARTED|Randomized Double-Blind Treatment Period||142
212661|NCT00783614|520283|P4|NOT COMPLETED|Overall Study||0
212662|NCT00783614|520284|P3|NOT COMPLETED|Overall Study||0
212663|NCT00783614|520285|P2|NOT COMPLETED|Overall Study||0
212664|NCT00783614|520286|P1|NOT COMPLETED|Overall Study||0
212665|NCT00783614|520283|P4|COMPLETED|Overall Study||5
212666|NCT00783614|520284|P3|COMPLETED|Overall Study||5
212667|NCT00783614|520285|P2|COMPLETED|Overall Study||6
212668|NCT00783614|520286|P1|COMPLETED|Overall Study||6
212669|NCT00783614|520283|P4|STARTED|Overall Study||5
212670|NCT00783614|520284|P3|STARTED|Overall Study||5
212671|NCT00783614|520285|P2|STARTED|Overall Study||6
212672|NCT00783614|520286|P1|STARTED|Overall Study||6
212673|NCT00783692|520299|P7|NOT COMPLETED|Maintenance Phase||249
212674|NCT00783692|520300|P6|NOT COMPLETED|Maintenance Phase||72
212675|NCT00783692|520301|P5|NOT COMPLETED|Maintenance Phase||81
212676|NCT00783692|520302|P4|NOT COMPLETED|Maintenance Phase||89
212677|NCT00783692|520303|P3|NOT COMPLETED|Maintenance Phase||0
212678|NCT00783692|520304|P2|NOT COMPLETED|Maintenance Phase||0
212679|NCT00783692|520305|P1|NOT COMPLETED|Maintenance Phase||95
212680|NCT00783692|520299|P7|COMPLETED|Maintenance Phase||163
212681|NCT00783692|520300|P6|COMPLETED|Maintenance Phase||82
212682|NCT00783692|520301|P5|COMPLETED|Maintenance Phase||73
212683|NCT00783692|520302|P4|COMPLETED|Maintenance Phase||64
212684|NCT00783692|520303|P3|COMPLETED|Maintenance Phase||0
212685|NCT00783692|520304|P2|COMPLETED|Maintenance Phase||0
212686|NCT00783692|520305|P1|COMPLETED|Maintenance Phase||42
212687|NCT00783692|520299|P7|STARTED|Maintenance Phase||412
212688|NCT00783692|520300|P6|STARTED|Maintenance Phase||154
212689|NCT00783692|520301|P5|STARTED|Maintenance Phase||154
212690|NCT00783692|520302|P4|STARTED|Maintenance Phase||153
212691|NCT00783692|520303|P3|STARTED|Maintenance Phase||0
212692|NCT00783692|520304|P2|STARTED|Maintenance Phase||0
212693|NCT00783692|520305|P1|STARTED|Maintenance Phase||137
212694|NCT00783692|520299|P7|NOT COMPLETED|Induction Phase||0
212695|NCT00783692|520300|P6|NOT COMPLETED|Induction Phase||0
212696|NCT00783692|520301|P5|NOT COMPLETED|Induction Phase||0
212697|NCT00783692|520302|P4|NOT COMPLETED|Induction Phase||0
212698|NCT00783692|520303|P3|NOT COMPLETED|Induction Phase||74
212699|NCT00783692|520304|P2|NOT COMPLETED|Induction Phase||21
212700|NCT00783692|520305|P1|NOT COMPLETED|Induction Phase||11
212701|NCT00783692|520299|P7|COMPLETED|Induction Phase||0
212702|NCT00783692|520300|P6|COMPLETED|Induction Phase||0
212703|NCT00783692|520301|P5|COMPLETED|Induction Phase||0
212704|NCT00783692|520302|P4|COMPLETED|Induction Phase||0
212705|NCT00783692|520303|P3|COMPLETED|Induction Phase||674
212706|NCT00783692|520304|P2|COMPLETED|Induction Phase||199
212707|NCT00783692|520305|P1|COMPLETED|Induction Phase||137
212708|NCT00783692|520299|P7|Treated|Induction Phase||0
212709|NCT00783692|520300|P6|Treated|Induction Phase||0
212710|NCT00783692|520301|P5|Treated|Induction Phase||0
212711|NCT00783692|520302|P4|Treated|Induction Phase||0
212712|NCT00783692|520303|P3|Treated|Induction Phase||747
212713|NCT00783692|520304|P2|Treated|Induction Phase||220
212714|NCT00783692|520305|P1|Treated|Induction Phase||148
212715|NCT00783692|520299|P7|STARTED|Induction Phase||0
212716|NCT00783692|520300|P6|STARTED|Induction Phase||0
212717|NCT00783692|520301|P5|STARTED|Induction Phase||0
212718|NCT00783692|520302|P4|STARTED|Induction Phase||0
212719|NCT00783692|520303|P3|STARTED|Induction Phase||748
212720|NCT00783692|520304|P2|STARTED|Induction Phase||220
212721|NCT00783692|520305|P1|STARTED|Induction Phase||148
212722|NCT00783705|520330|P2|NOT COMPLETED|Overall Study||5
212723|NCT00783705|520331|P1|NOT COMPLETED|Overall Study||6
212724|NCT00783705|520330|P2|COMPLETED|Overall Study||36
212725|NCT00783705|520331|P1|COMPLETED|Overall Study||38
212726|NCT00783705|520330|P2|STARTED|Overall Study||41
212727|NCT00783705|520331|P1|STARTED|Overall Study||44
212728|NCT00783718|520376|P7|NOT COMPLETED|Maintenance Phase||195
212729|NCT00783718|520377|P6|NOT COMPLETED|Maintenance Phase||41
212730|NCT00783718|520378|P5|NOT COMPLETED|Maintenance Phase||45
212731|NCT00783718|520379|P4|NOT COMPLETED|Maintenance Phase||78
212732|NCT00783718|520380|P3|NOT COMPLETED|Maintenance Phase||0
212733|NCT00783718|520381|P2|NOT COMPLETED|Maintenance Phase||0
212734|NCT00783718|520382|P1|NOT COMPLETED|Maintenance Phase||105
212735|NCT00783718|520376|P7|COMPLETED|Maintenance Phase||135
212736|NCT00783718|520377|P6|COMPLETED|Maintenance Phase||84
212737|NCT00783718|520378|P5|COMPLETED|Maintenance Phase||77
212738|NCT00783718|520379|P4|COMPLETED|Maintenance Phase||48
212739|NCT00783718|520380|P3|COMPLETED|Maintenance Phase||0
212740|NCT00783718|520381|P2|COMPLETED|Maintenance Phase||0
212741|NCT00783718|520382|P1|COMPLETED|Maintenance Phase||30
212742|NCT00783718|520376|P7|STARTED|Maintenance Phase||330
212743|NCT00783718|520377|P6|STARTED|Maintenance Phase||125
212744|NCT00783718|520378|P5|STARTED|Maintenance Phase||122
212745|NCT00783718|520379|P4|STARTED|Maintenance Phase||126
212746|NCT00783718|520380|P3|STARTED|Maintenance Phase||0
212747|NCT00783718|520381|P2|STARTED|Maintenance Phase||0
212748|NCT00783718|520382|P1|STARTED|Maintenance Phase||135
212749|NCT00783718|520376|P7|NOT COMPLETED|Induction Phase||0
212750|NCT00783718|520377|P6|NOT COMPLETED|Induction Phase||0
212751|NCT00783718|520378|P5|NOT COMPLETED|Induction Phase||0
212752|NCT00783718|520379|P4|NOT COMPLETED|Induction Phase||0
212753|NCT00783718|520380|P3|NOT COMPLETED|Induction Phase||36
212754|NCT00783718|520381|P2|NOT COMPLETED|Induction Phase||7
212755|NCT00783718|520382|P1|NOT COMPLETED|Induction Phase||14
212756|NCT00783718|520376|P7|COMPLETED|Induction Phase||0
212757|NCT00783718|520377|P6|COMPLETED|Induction Phase||0
212758|NCT00783718|520378|P5|COMPLETED|Induction Phase||0
212759|NCT00783718|520379|P4|COMPLETED|Induction Phase||0
212760|NCT00783718|520380|P3|COMPLETED|Induction Phase||485
212761|NCT00783718|520381|P2|COMPLETED|Induction Phase||218
212762|NCT00783718|520382|P1|COMPLETED|Induction Phase||135
212763|NCT00783718|520376|P7|STARTED|Induction Phase||0
212764|NCT00783718|520377|P6|STARTED|Induction Phase||0
212765|NCT00783718|520378|P5|STARTED|Induction Phase||0
212766|NCT00783718|520379|P4|STARTED|Induction Phase||0
212767|NCT00783718|520380|P3|STARTED|Induction Phase||521
212768|NCT00783718|520381|P2|STARTED|Induction Phase||225
212769|NCT00783718|520382|P1|STARTED|Induction Phase||149
212770|NCT00783796|520408|P1|NOT COMPLETED|Overall Study||6
212771|NCT00783796|520408|P1|COMPLETED|Overall Study||144
212772|NCT00783796|520408|P1|STARTED|Overall Study||150
212773|NCT00783835|520510|P1|NOT COMPLETED|Overall Study||10
212774|NCT00783835|520510|P1|COMPLETED|Overall Study||50
212775|NCT00783835|520510|P1|STARTED|Overall Study||60
212776|NCT00783952|520522|P1|NOT COMPLETED|Overall Study||0
212777|NCT00783952|520522|P1|COMPLETED|Overall Study||8
212778|NCT00783952|520522|P1|STARTED|Overall Study||8
212779|NCT00783965|520529|P2|NOT COMPLETED|Second Intervention (24 Months)||9
212780|NCT00783965|520530|P1|NOT COMPLETED|Second Intervention (24 Months)||0
212781|NCT00783965|520529|P2|COMPLETED|Second Intervention (24 Months)||16
212782|NCT00783965|520530|P1|COMPLETED|Second Intervention (24 Months)||2
212783|NCT00783965|520529|P2|STARTED|Second Intervention (24 Months)||25
212784|NCT00783965|520530|P1|STARTED|Second Intervention (24 Months)||2
212785|NCT00783965|520529|P2|NOT COMPLETED|First Intervention (12 Months)||4
212786|NCT00783965|520530|P1|NOT COMPLETED|First Intervention (12 Months)||3
212787|NCT00783965|520529|P2|COMPLETED|First Intervention (12 Months)||25
212788|NCT00783965|520530|P1|COMPLETED|First Intervention (12 Months)||2
212789|NCT00783965|520529|P2|STARTED|First Intervention (12 Months)||29
212790|NCT00783965|520530|P1|STARTED|First Intervention (12 Months)||5
212791|NCT00784030|520540|P2|NOT COMPLETED|Overall Study||0
212792|NCT00784030|520541|P1|NOT COMPLETED|Overall Study||0
212793|NCT00784030|520540|P2|COMPLETED|Overall Study||10
212794|NCT00784030|520541|P1|COMPLETED|Overall Study||13
212795|NCT00784030|520540|P2|STARTED|Overall Study||10
212796|NCT00784030|520541|P1|STARTED|Overall Study||13
212797|NCT00784095|520550|P3|NOT COMPLETED|Overall Study||1
212798|NCT00784095|520551|P2|NOT COMPLETED|Overall Study||1
212799|NCT00784095|520552|P1|NOT COMPLETED|Overall Study||0
212800|NCT00784095|520550|P3|COMPLETED|Overall Study||11
212801|NCT00784095|520551|P2|COMPLETED|Overall Study||11
212802|NCT00784095|520552|P1|COMPLETED|Overall Study||12
212803|NCT00784095|520550|P3|STARTED|Overall Study||12
212804|NCT00784095|520551|P2|STARTED|Overall Study||12
212805|NCT00784095|520552|P1|STARTED|Overall Study||12
212806|NCT00784134|520574|P2|NOT COMPLETED|Overall Study||6
212807|NCT00784134|520575|P1|NOT COMPLETED|Overall Study||3
212808|NCT00784134|520574|P2|COMPLETED|Overall Study||245
212809|NCT00784134|520575|P1|COMPLETED|Overall Study||246
212810|NCT00784134|520574|P2|STARTED|Overall Study||251
212811|NCT00784134|520575|P1|STARTED|Overall Study||249
212812|NCT00784147|520673|P2|NOT COMPLETED|Overall Study||9
212813|NCT00784147|520674|P1|NOT COMPLETED|Overall Study||8
212814|NCT00784147|520673|P2|COMPLETED|Overall Study||45
212815|NCT00784147|520674|P1|COMPLETED|Overall Study||51
212816|NCT00784147|520673|P2|STARTED|Overall Study||54
212817|NCT00784147|520674|P1|STARTED|Overall Study||59
212818|NCT00784238|520692|P1|NOT COMPLETED|Overall Study||119
212819|NCT00784238|520692|P1|COMPLETED|Overall Study||170
212820|NCT00784238|520692|P1|STARTED|Overall Study||289
212821|NCT00784277|520737|P7|NOT COMPLETED|ER Treatment||15
212822|NCT00784277|520738|P6|NOT COMPLETED|ER Treatment||24
212823|NCT00784277|520739|P5|NOT COMPLETED|ER Treatment||9
212824|NCT00784277|520740|P4|NOT COMPLETED|ER Treatment||0
212825|NCT00784277|520741|P3|NOT COMPLETED|ER Treatment||0
212826|NCT00784277|520742|P2|NOT COMPLETED|ER Treatment||0
212827|NCT00784277|520743|P1|NOT COMPLETED|ER Treatment||0
212828|NCT00784277|520737|P7|COMPLETED|ER Treatment||76
212829|NCT00784277|520738|P6|COMPLETED|ER Treatment||226
212830|NCT00784277|520739|P5|COMPLETED|ER Treatment||113
212831|NCT00784277|520740|P4|COMPLETED|ER Treatment||0
212832|NCT00784277|520741|P3|COMPLETED|ER Treatment||0
212833|NCT00784277|520742|P2|COMPLETED|ER Treatment||0
212834|NCT00784277|520743|P1|COMPLETED|ER Treatment||0
212835|NCT00784277|520737|P7|STARTED|ER Treatment|9 participants who had completed IR treatment have not taken any ER treatment.|91
212836|NCT00784277|520738|P6|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|250
212837|NCT00784277|520739|P5|STARTED|ER Treatment|10 participants who had completed IR treatment have not taken any ER treatment.|122
212838|NCT00784277|520740|P4|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
212839|NCT00784277|520741|P3|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
212840|NCT00784277|520742|P2|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
212841|NCT00784277|520743|P1|STARTED|ER Treatment|"0 in IR column indicates this reporting group is not relevant to ER phase."|0
212842|NCT00784277|520737|P7|NOT COMPLETED|IR Treatment||0
212843|NCT00784277|520738|P6|NOT COMPLETED|IR Treatment||0
212844|NCT00784277|520739|P5|NOT COMPLETED|IR Treatment||0
212845|NCT00784277|520740|P4|NOT COMPLETED|IR Treatment||43
212846|NCT00784277|520741|P3|NOT COMPLETED|IR Treatment||28
212847|NCT00784277|520742|P2|NOT COMPLETED|IR Treatment||17
212848|NCT00784277|520743|P1|NOT COMPLETED|IR Treatment||16
212849|NCT00784277|520737|P7|COMPLETED|IR Treatment||0
212850|NCT00784277|520738|P6|COMPLETED|IR Treatment||0
212851|NCT00784277|520739|P5|COMPLETED|IR Treatment||0
212852|NCT00784277|520740|P4|COMPLETED|IR Treatment||100
212853|NCT00784277|520741|P3|COMPLETED|IR Treatment||126
212854|NCT00784277|520742|P2|COMPLETED|IR Treatment||134
212855|NCT00784277|520743|P1|COMPLETED|IR Treatment||132
212856|NCT00784277|520737|P7|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
212857|NCT00784277|520738|P6|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
212858|NCT00784277|520739|P5|STARTED|IR Treatment|"0 in ER column indicates this reporting group is not relevant to IR phase."|0
212859|NCT00784277|520740|P4|STARTED|IR Treatment||143
212860|NCT00784277|520741|P3|STARTED|IR Treatment||154
212861|NCT00784277|520742|P2|STARTED|IR Treatment||151
212862|NCT00784277|520743|P1|STARTED|IR Treatment||148
212863|NCT00784368|520763|P3|NOT COMPLETED|Overall Study||11
212864|NCT00784368|520764|P2|NOT COMPLETED|Overall Study||11
212865|NCT00784368|520765|P1|NOT COMPLETED|Overall Study||8
212866|NCT00784368|520763|P3|COMPLETED|Overall Study||12
212867|NCT00784368|520764|P2|COMPLETED|Overall Study||5
212868|NCT00784368|520765|P1|COMPLETED|Overall Study||8
212869|NCT00784368|520763|P3|STARTED|Overall Study||23
212870|NCT00784368|520764|P2|STARTED|Overall Study||16
212871|NCT00784368|520765|P1|STARTED|Overall Study||16
212872|NCT00784459|520801|P2|NOT COMPLETED|Overall Study||2
212873|NCT00784459|520802|P1|NOT COMPLETED|Overall Study||0
212874|NCT00784459|520801|P2|COMPLETED|Overall Study||11
212875|NCT00784459|520802|P1|COMPLETED|Overall Study||11
212876|NCT00784459|520801|P2|STARTED|Overall Study||13
212877|NCT00784459|520802|P1|STARTED|Overall Study||11
212878|NCT00784550|520812|P2|NOT COMPLETED|Overall Study||42
212879|NCT00784550|520813|P1|NOT COMPLETED|Overall Study||36
212880|NCT00784550|520812|P2|COMPLETED|Overall Study||127
212881|NCT00784550|520813|P1|COMPLETED|Overall Study||137
212882|NCT00784550|520812|P2|STARTED|Overall Study||169
212883|NCT00784550|520813|P1|STARTED|Overall Study||173
212884|NCT00784563|520832|P3|NOT COMPLETED|Year 3||3
212885|NCT00784563|520833|P2|NOT COMPLETED|Year 3||0
212886|NCT00784563|520834|P1|NOT COMPLETED|Year 3||0
212887|NCT00784563|520832|P3|COMPLETED|Year 3||14
212888|NCT00784563|520833|P2|COMPLETED|Year 3||0
212889|NCT00784563|520834|P1|COMPLETED|Year 3||0
212890|NCT00784563|520832|P3|STARTED|Year 3||17
212891|NCT00784563|520833|P2|STARTED|Year 3||0
212892|NCT00784563|520834|P1|STARTED|Year 3||0
212893|NCT00784563|520832|P3|NOT COMPLETED|Years 1 & 2||0
212894|NCT00784563|520833|P2|NOT COMPLETED|Years 1 & 2||5
212895|NCT00784563|520834|P1|NOT COMPLETED|Years 1 & 2||3
212896|NCT00784563|520832|P3|COMPLETED|Years 1 & 2||0
212897|NCT00784563|520833|P2|COMPLETED|Years 1 & 2||17
212898|NCT00784563|520834|P1|COMPLETED|Years 1 & 2||18
212899|NCT00784563|520832|P3|STARTED|Years 1 & 2||0
212900|NCT00784563|520833|P2|STARTED|Years 1 & 2||22
212901|NCT00784563|520834|P1|STARTED|Years 1 & 2||21
212902|NCT00784654|520850|P3|NOT COMPLETED|Randomized Withdrawal Period||63
212903|NCT00784654|520851|P2|NOT COMPLETED|Randomized Withdrawal Period||18
212904|NCT00784654|520852|P1|NOT COMPLETED|Randomized Withdrawal Period||0
212905|NCT00784654|520850|P3|COMPLETED|Randomized Withdrawal Period||16
212906|NCT00784654|520851|P2|COMPLETED|Randomized Withdrawal Period||60
212907|NCT00784654|520852|P1|COMPLETED|Randomized Withdrawal Period||0
212908|NCT00784654|520850|P3|STARTED|Randomized Withdrawal Period||79
212909|NCT00784654|520851|P2|STARTED|Randomized Withdrawal Period||78
212910|NCT00784654|520852|P1|STARTED|Randomized Withdrawal Period||0
212911|NCT00784654|520850|P3|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
212912|NCT00784654|520851|P2|NOT COMPLETED|Open-Label Period (Non-Randomized)||0
212913|NCT00784654|520852|P1|NOT COMPLETED|Open-Label Period (Non-Randomized)||111
212914|NCT00784654|520850|P3|COMPLETED|Open-Label Period (Non-Randomized)||0
212915|NCT00784654|520851|P2|COMPLETED|Open-Label Period (Non-Randomized)||0
212916|NCT00784654|520852|P1|COMPLETED|Open-Label Period (Non-Randomized)||165
212917|NCT00784654|520850|P3|STARTED|Open-Label Period (Non-Randomized)||0
212918|NCT00784654|520851|P2|STARTED|Open-Label Period (Non-Randomized)||0
212919|NCT00784654|520852|P1|STARTED|Open-Label Period (Non-Randomized)||276
212920|NCT00784719|520891|P7|NOT COMPLETED|Overall Study||5
212921|NCT00784719|520892|P6|NOT COMPLETED|Overall Study||3
212922|NCT00784719|520893|P5|NOT COMPLETED|Overall Study||6
212923|NCT00784719|520894|P4|NOT COMPLETED|Overall Study||0
212924|NCT00784719|520895|P3|NOT COMPLETED|Overall Study||1
212925|NCT00784719|520896|P2|NOT COMPLETED|Overall Study||3
212926|NCT00784719|520897|P1|NOT COMPLETED|Overall Study||3
212927|NCT00784719|520891|P7|COMPLETED|Overall Study||42
212928|NCT00784719|520892|P6|COMPLETED|Overall Study||41
212929|NCT00784719|520893|P5|COMPLETED|Overall Study||42
212930|NCT00784719|520894|P4|COMPLETED|Overall Study||48
212931|NCT00784719|520895|P3|COMPLETED|Overall Study||46
212932|NCT00784719|520896|P2|COMPLETED|Overall Study||43
212933|NCT00784719|520897|P1|COMPLETED|Overall Study||44
212934|NCT00784719|520891|P7|STARTED|Overall Study||47
212935|NCT00784719|520892|P6|STARTED|Overall Study||44
212936|NCT00784719|520893|P5|STARTED|Overall Study||48
212937|NCT00784719|520894|P4|STARTED|Overall Study||48
212938|NCT00784719|520895|P3|STARTED|Overall Study||47
212939|NCT00784719|520896|P2|STARTED|Overall Study||46
212940|NCT00784719|520897|P1|STARTED|Overall Study||47
212941|NCT00784784|521069|P2|NOT COMPLETED|Overall Study||2
212942|NCT00784784|521070|P1|NOT COMPLETED|Overall Study||2
212943|NCT00784784|521069|P2|COMPLETED|Overall Study||40
212944|NCT00784784|521070|P1|COMPLETED|Overall Study||20
212945|NCT00784784|521069|P2|STARTED|Overall Study||42
212946|NCT00784784|521070|P1|STARTED|Overall Study||22
212947|NCT00784810|521080|P2|NOT COMPLETED|Overall Study||49
212948|NCT00784810|521081|P1|NOT COMPLETED|Overall Study||63
212949|NCT00784810|521080|P2|COMPLETED|Overall Study||74
212950|NCT00784810|521081|P1|COMPLETED|Overall Study||61
212951|NCT00784810|521080|P2|STARTED|Overall Study||123
212952|NCT00784810|521081|P1|STARTED|Overall Study||124
212953|NCT00784836|521089|P1|NOT COMPLETED|Overall Study||3
212954|NCT00784836|521089|P1|COMPLETED|Overall Study|The study was terminated early by the Sponsor for business reason not related to safety.|0
212955|NCT00784836|521089|P1|STARTED|Overall Study||3
212956|NCT00784849|521094|P1|NOT COMPLETED|Overall Study||0
212957|NCT00784849|521094|P1|COMPLETED|Overall Study||62
212958|NCT00784849|521094|P1|STARTED|Overall Study||62
212959|NCT00784875|521104|P4|NOT COMPLETED|Period D||1
212960|NCT00784875|521105|P3|NOT COMPLETED|Period D||6
212961|NCT00784875|521106|P2|NOT COMPLETED|Period D||4
212962|NCT00784875|521107|P1|NOT COMPLETED|Period D||5
212963|NCT00784875|521104|P4|COMPLETED|Period D||87
212964|NCT00784875|521105|P3|COMPLETED|Period D||88
212965|NCT00784875|521106|P2|COMPLETED|Period D||85
212966|NCT00784875|521107|P1|COMPLETED|Period D||86
212967|NCT00784875|521104|P4|STARTED|Period D||88
212968|NCT00784875|521105|P3|STARTED|Period D||94
212969|NCT00784875|521106|P2|STARTED|Period D||89
212970|NCT00784875|521107|P1|STARTED|Period D||91
212971|NCT00784875|521104|P4|NOT COMPLETED|Period C||7
212972|NCT00784875|521105|P3|NOT COMPLETED|Period C||13
212973|NCT00784875|521106|P2|NOT COMPLETED|Period C||6
212974|NCT00784875|521107|P1|NOT COMPLETED|Period C||7
212975|NCT00784875|521104|P4|COMPLETED|Period C||91
212976|NCT00784875|521105|P3|COMPLETED|Period C||84
212977|NCT00784875|521106|P2|COMPLETED|Period C||91
212978|NCT00784875|521107|P1|COMPLETED|Period C||96
212979|NCT00784875|521104|P4|STARTED|Period C||98
212980|NCT00784875|521105|P3|STARTED|Period C||97
212981|NCT00784875|521106|P2|STARTED|Period C||97
212982|NCT00784875|521107|P1|STARTED|Period C||103
212983|NCT00784875|521104|P4|NOT COMPLETED|Period B - Efficacy Endpoint||19
212984|NCT00784875|521105|P3|NOT COMPLETED|Period B - Efficacy Endpoint||21
212985|NCT00784875|521106|P2|NOT COMPLETED|Period B - Efficacy Endpoint||12
212986|NCT00784875|521107|P1|NOT COMPLETED|Period B - Efficacy Endpoint||14
212987|NCT00784875|521104|P4|COMPLETED|Period B - Efficacy Endpoint||98
212988|NCT00784875|521105|P3|COMPLETED|Period B - Efficacy Endpoint||96
212989|NCT00784875|521106|P2|COMPLETED|Period B - Efficacy Endpoint||101
212990|NCT00784875|521107|P1|COMPLETED|Period B - Efficacy Endpoint||100
212991|NCT00784875|521104|P4|Cohort 2|Period B - Efficacy Endpoint||101
212992|NCT00784875|521105|P3|Cohort 2|Period B - Efficacy Endpoint||102
212993|NCT00784875|521106|P2|Cohort 2|Period B - Efficacy Endpoint||102
212994|NCT00784875|521107|P1|Cohort 2|Period B - Efficacy Endpoint||102
212995|NCT00784875|521104|P4|STARTED|Period B - Efficacy Endpoint||117
212996|NCT00784875|521105|P3|STARTED|Period B - Efficacy Endpoint||117
212997|NCT00784875|521106|P2|STARTED|Period B - Efficacy Endpoint||113
212998|NCT00784875|521107|P1|STARTED|Period B - Efficacy Endpoint||114
212999|NCT00784875|521104|P4|NOT COMPLETED|Period A - Baseline||182
213000|NCT00784875|521105|P3|NOT COMPLETED|Period A - Baseline||0
213001|NCT00784875|521106|P2|NOT COMPLETED|Period A - Baseline||0
213002|NCT00784875|521107|P1|NOT COMPLETED|Period A - Baseline||0
213003|NCT00784875|521104|P4|COMPLETED|Period A - Baseline||461
213004|NCT00784875|521105|P3|COMPLETED|Period A - Baseline||0
213005|NCT00784875|521106|P2|COMPLETED|Period A - Baseline||0
213006|NCT00784875|521107|P1|COMPLETED|Period A - Baseline||0
213007|NCT00784875|521104|P4|STARTED|Period A - Baseline||643
213008|NCT00784875|521105|P3|STARTED|Period A - Baseline||0
213009|NCT00784875|521106|P2|STARTED|Period A - Baseline||0
213010|NCT00784875|521107|P1|STARTED|Period A - Baseline||0
213011|NCT00784927|521221|P1|NOT COMPLETED|Overall Study||3
213012|NCT00784927|521221|P1|COMPLETED|Overall Study||33
213013|NCT00784927|521221|P1|STARTED|Overall Study||36
213014|NCT00784979|521229|P1|NOT COMPLETED|Overall Study||6
213015|NCT00784979|521229|P1|COMPLETED|Overall Study||20
213016|NCT00784979|521229|P1|STARTED|Overall Study||26
213017|NCT00785044|521233|P1|NOT COMPLETED|Overall Study||496
213018|NCT00785044|521233|P1|COMPLETED|Overall Study|Data for 471 participants (MBG313) combined with data from MBG311 and MBG312 for efficacy analysis|468
213019|NCT00785044|521233|P1|Enrolled Participants|Overall Study|Out of 964 from MBG311 and MBG312 HF participants, 471 enrolled into the extension MBG313 study.|471
213020|NCT00785044|521233|P1|STARTED|Overall Study|Eligible to participate in MBG313|964
213021|NCT00785213|521238|P1|NOT COMPLETED|Rosiglitazone With Quinine Sulfate||1
213022|NCT00785213|521238|P1|COMPLETED|Rosiglitazone With Quinine Sulfate||18
213023|NCT00785213|521238|P1|STARTED|Rosiglitazone With Quinine Sulfate||19
213024|NCT00785213|521238|P1|NOT COMPLETED|Quinine Sulfate Alone||4
213025|NCT00785213|521238|P1|COMPLETED|Quinine Sulfate Alone||19
213026|NCT00785213|521238|P1|STARTED|Quinine Sulfate Alone||23
213027|NCT00785213|521238|P1|NOT COMPLETED|2 Day Washout Period||0
213028|NCT00785213|521238|P1|COMPLETED|2 Day Washout Period||23
213029|NCT00785213|521238|P1|STARTED|2 Day Washout Period||23
213030|NCT00785213|521238|P1|NOT COMPLETED|Rosiglitazone Alone||0
213031|NCT00785213|521238|P1|COMPLETED|Rosiglitazone Alone||23
213032|NCT00785213|521238|P1|STARTED|Rosiglitazone Alone||23
213033|NCT00785291|521252|P3|NOT COMPLETED|Overall Study||106
213034|NCT00785291|521253|P2|NOT COMPLETED|Overall Study||149
213035|NCT00785291|521254|P1|NOT COMPLETED|Overall Study||136
213036|NCT00785291|521252|P3|COMPLETED|Overall Study||139
213037|NCT00785291|521253|P2|COMPLETED|Overall Study||122
213038|NCT00785291|521254|P1|COMPLETED|Overall Study||147
213039|NCT00785291|521252|P3|STARTED|Overall Study||245
213040|NCT00785291|521253|P2|STARTED|Overall Study||271
213041|NCT00785291|521254|P1|STARTED|Overall Study||283
213042|NCT00785356|521277|P1|NOT COMPLETED|Overall Study||8
213043|NCT00785356|521277|P1|COMPLETED|Overall Study||0
213044|NCT00785356|521277|P1|STARTED|Overall Study||8
213045|NCT00785486|521285|P1|NOT COMPLETED|Midazolam With Qualaquin at Steady State||0
213046|NCT00785486|521285|P1|COMPLETED|Midazolam With Qualaquin at Steady State||23
213047|NCT00785486|521285|P1|STARTED|Midazolam With Qualaquin at Steady State||23
213048|NCT00785486|521285|P1|NOT COMPLETED|Qualaquin Alone at Steady State||0
213049|NCT00785486|521285|P1|COMPLETED|Qualaquin Alone at Steady State||23
213050|NCT00785486|521285|P1|STARTED|Qualaquin Alone at Steady State||23
213051|NCT00785486|521285|P1|NOT COMPLETED|3 Day Washout||0
213052|NCT00785486|521285|P1|COMPLETED|3 Day Washout||23
213053|NCT00785486|521285|P1|STARTED|3 Day Washout||23
213054|NCT00785486|521285|P1|NOT COMPLETED|Midazolam Alone||1
213055|NCT00785486|521285|P1|COMPLETED|Midazolam Alone|one participant withdrew for personal reasons after first midazolam dose|23
213056|NCT00785486|521285|P1|STARTED|Midazolam Alone||24
213057|NCT00785512|521308|P2|NOT COMPLETED|Overall Study||4
213058|NCT00785512|521309|P1|NOT COMPLETED|Overall Study||3
213059|NCT00785512|521308|P2|COMPLETED|Overall Study||101
213060|NCT00785512|521309|P1|COMPLETED|Overall Study||99
213061|NCT00785512|521308|P2|STARTED|Overall Study||105
213062|NCT00785512|521309|P1|STARTED|Overall Study||102
213063|NCT00785577|521323|P5|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
213064|NCT00785577|521324|P4|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
213065|NCT00785577|521325|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
213066|NCT00785577|521326|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
213067|NCT00785577|521327|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
213068|NCT00785577|521323|P5|COMPLETED|Study Period 3: 1-Week Washout Phase||26
213069|NCT00785577|521324|P4|COMPLETED|Study Period 3: 1-Week Washout Phase||35
213070|NCT00785577|521325|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||25
213071|NCT00785577|521326|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||36
213072|NCT00785577|521327|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||78
213073|NCT00785577|521323|P5|STARTED|Study Period 3: 1-Week Washout Phase||27
213074|NCT00785577|521324|P4|STARTED|Study Period 3: 1-Week Washout Phase||36
213075|NCT00785577|521325|P3|STARTED|Study Period 3: 1-Week Washout Phase||25
213076|NCT00785577|521326|P2|STARTED|Study Period 3: 1-Week Washout Phase||36
213077|NCT00785577|521327|P1|STARTED|Study Period 3: 1-Week Washout Phase||78
213078|NCT00785577|521323|P5|NOT COMPLETED|Study Period 2: Therapy Phase||20
213079|NCT00785577|521324|P4|NOT COMPLETED|Study Period 2: Therapy Phase||13
213080|NCT00785577|521325|P3|NOT COMPLETED|Study Period 2: Therapy Phase||18
213081|NCT00785577|521326|P2|NOT COMPLETED|Study Period 2: Therapy Phase||9
213082|NCT00785577|521327|P1|NOT COMPLETED|Study Period 2: Therapy Phase||11
213083|NCT00785577|521323|P5|COMPLETED|Study Period 2: Therapy Phase||27
213084|NCT00785577|521324|P4|COMPLETED|Study Period 2: Therapy Phase||36
213085|NCT00785577|521325|P3|COMPLETED|Study Period 2: Therapy Phase||25
213086|NCT00785577|521326|P2|COMPLETED|Study Period 2: Therapy Phase||36
213087|NCT00785577|521327|P1|COMPLETED|Study Period 2: Therapy Phase||78
213088|NCT00785577|521323|P5|STARTED|Study Period 2: Therapy Phase||47
213089|NCT00785577|521324|P4|STARTED|Study Period 2: Therapy Phase||49
213090|NCT00785577|521325|P3|STARTED|Study Period 2: Therapy Phase||43
213091|NCT00785577|521326|P2|STARTED|Study Period 2: Therapy Phase||45
213092|NCT00785577|521327|P1|STARTED|Study Period 2: Therapy Phase||89
213093|NCT00785629|521467|P4|NOT COMPLETED|Overall Study||16
213094|NCT00785629|521468|P3|NOT COMPLETED|Overall Study||10
213095|NCT00785629|521469|P2|NOT COMPLETED|Overall Study||5
213096|NCT00785629|521470|P1|NOT COMPLETED|Overall Study||8
213097|NCT00785629|521467|P4|COMPLETED|Overall Study|16 not completed|41
213098|NCT00785629|521468|P3|COMPLETED|Overall Study|10 not completed|18
213099|NCT00785629|521469|P2|COMPLETED|Overall Study|5 not completed|25
213100|NCT00785629|521470|P1|COMPLETED|Overall Study|8 not completed|22
213101|NCT00785629|521467|P4|STARTED|Overall Study||57
213102|NCT00785629|521468|P3|STARTED|Overall Study||28
213103|NCT00785629|521469|P2|STARTED|Overall Study||30
213104|NCT00785629|521470|P1|STARTED|Overall Study||30
213105|NCT00785707|521478|P1|NOT COMPLETED|Overall Study||7
213106|NCT00785707|521478|P1|COMPLETED|Overall Study||24
213107|NCT00785707|521478|P1|STARTED|Overall Study||31
213108|NCT00785772|521483|P1|NOT COMPLETED|Overall Study||0
213109|NCT00785772|521483|P1|COMPLETED|Overall Study||1
213110|NCT00785772|521483|P1|STARTED|Overall Study||1
213111|NCT00785785|521491|P2|NOT COMPLETED|Optional Extension Phase||125
213112|NCT00785785|521492|P1|NOT COMPLETED|Optional Extension Phase||39
213113|NCT00785785|521491|P2|COMPLETED|Optional Extension Phase||0
213114|NCT00785785|521492|P1|COMPLETED|Optional Extension Phase||0
213115|NCT00785785|521491|P2|STARTED|Optional Extension Phase|crossover extension phase was optional|125
213116|NCT00785785|521492|P1|STARTED|Optional Extension Phase|crossover extension phase was optional|39
213117|NCT00785785|521491|P2|NOT COMPLETED|Core Phase up to 36 Months||320
213118|NCT00785785|521492|P1|NOT COMPLETED|Core Phase up to 36 Months||324
213119|NCT00785785|521491|P2|COMPLETED|Core Phase up to 36 Months||0
213120|NCT00785785|521492|P1|COMPLETED|Core Phase up to 36 Months||0
213121|NCT00785785|521491|P2|STARTED|Core Phase up to 36 Months||320
213122|NCT00785785|521492|P1|STARTED|Core Phase up to 36 Months||324
213123|NCT00785798|521500|P1|NOT COMPLETED|Overall Study||1
213124|NCT00785798|521500|P1|COMPLETED|Overall Study||16
213125|NCT00785798|521500|P1|STARTED|Overall Study||17
213126|NCT00785980|521505|P1|NOT COMPLETED|Quinine Sulfate With Ciprofloxacin||0
213127|NCT00785980|521505|P1|COMPLETED|Quinine Sulfate With Ciprofloxacin||21
213128|NCT00785980|521505|P1|STARTED|Quinine Sulfate With Ciprofloxacin||21
213129|NCT00785980|521505|P1|NOT COMPLETED|Ciprofloxacin Alone||0
213130|NCT00785980|521505|P1|COMPLETED|Ciprofloxacin Alone||21
213131|NCT00785980|521505|P1|STARTED|Ciprofloxacin Alone||21
213132|NCT00785980|521505|P1|NOT COMPLETED|7 Day Washout Period||3
213133|NCT00785980|521505|P1|COMPLETED|7 Day Washout Period||21
213134|NCT00785980|521505|P1|STARTED|7 Day Washout Period||24
213135|NCT00785980|521505|P1|NOT COMPLETED|Quinine Sulfate Alone||0
213136|NCT00785980|521505|P1|COMPLETED|Quinine Sulfate Alone||24
213137|NCT00785980|521505|P1|STARTED|Quinine Sulfate Alone||24
213138|NCT00778999|521518|P2|NOT COMPLETED|Overall Study||34
213139|NCT00778999|521519|P1|NOT COMPLETED|Overall Study||28
213140|NCT00778999|521518|P2|COMPLETED|Overall Study||185
213141|NCT00778999|521519|P1|COMPLETED|Overall Study||195
213142|NCT00778999|521518|P2|STARTED|Overall Study||219
213143|NCT00778999|521519|P1|STARTED|Overall Study||223
213144|NCT00779025|521525|P1|NOT COMPLETED|Overall Study||1
213145|NCT00779025|521525|P1|COMPLETED|Overall Study||81
213146|NCT00779025|521525|P1|STARTED|Overall Study||82
213147|NCT00779038|521534|P1|NOT COMPLETED|Overall Study||13
213148|NCT00779038|521534|P1|COMPLETED|Overall Study||0
213149|NCT00779038|521534|P1|STARTED|Overall Study||13
213150|NCT00779116|521543|P2|NOT COMPLETED|Second Intervention||0
213151|NCT00779116|521544|P1|NOT COMPLETED|Second Intervention||0
213152|NCT00779116|521543|P2|COMPLETED|Second Intervention||108
213153|NCT00779116|521544|P1|COMPLETED|Second Intervention||109
213154|NCT00779116|521543|P2|STARTED|Second Intervention||108
213155|NCT00779116|521544|P1|STARTED|Second Intervention||109
213156|NCT00779116|521543|P2|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
213157|NCT00779116|521544|P1|NOT COMPLETED|Interval Between Doses (8-10 Minutes)||0
213158|NCT00779116|521543|P2|COMPLETED|Interval Between Doses (8-10 Minutes)||108
213159|NCT00779116|521544|P1|COMPLETED|Interval Between Doses (8-10 Minutes)||109
213160|NCT00779116|521543|P2|STARTED|Interval Between Doses (8-10 Minutes)||108
213161|NCT00779116|521544|P1|STARTED|Interval Between Doses (8-10 Minutes)||109
213162|NCT00779116|521543|P2|NOT COMPLETED|First Intervention||0
213163|NCT00779116|521544|P1|NOT COMPLETED|First Intervention||0
213164|NCT00779116|521543|P2|COMPLETED|First Intervention||108
213165|NCT00779116|521544|P1|COMPLETED|First Intervention||109
213166|NCT00779116|521543|P2|STARTED|First Intervention||108
213167|NCT00779116|521544|P1|STARTED|First Intervention||109
213168|NCT00779142|521551|P1|NOT COMPLETED|Overall Study||3
213169|NCT00779142|521551|P1|COMPLETED|Overall Study|Only 2 patients were actually enrolled.|2
213170|NCT00779142|521551|P1|STARTED|Overall Study|5 patients signed consent and were screened.|5
213171|NCT00779155|521557|P2|NOT COMPLETED|Overall Study||0
213172|NCT00779155|521558|P1|NOT COMPLETED|Overall Study||0
213173|NCT00779155|521557|P2|COMPLETED|Overall Study||6
213174|NCT00779155|521558|P1|COMPLETED|Overall Study||6
213175|NCT00779155|521557|P2|STARTED|Overall Study||6
213176|NCT00779155|521558|P1|STARTED|Overall Study||6
213177|NCT00779246|521566|P2|NOT COMPLETED|Overall Study||53
213178|NCT00779246|521567|P1|NOT COMPLETED|Overall Study||33
213179|NCT00779246|521566|P2|COMPLETED|Overall Study||715
213180|NCT00779246|521567|P1|COMPLETED|Overall Study||717
213181|NCT00779246|521566|P2|STARTED|Overall Study||768
213182|NCT00779246|521567|P1|STARTED|Overall Study||750
213183|NCT00779259|521573|P1|NOT COMPLETED|Theophylline With Quinine||0
213184|NCT00779259|521573|P1|COMPLETED|Theophylline With Quinine||22
213185|NCT00779259|521573|P1|STARTED|Theophylline With Quinine||22
213186|NCT00779259|521573|P1|NOT COMPLETED|Quinine Alone||2
213187|NCT00779259|521573|P1|COMPLETED|Quinine Alone||22
213188|NCT00779259|521573|P1|STARTED|Quinine Alone||24
213189|NCT00779259|521573|P1|NOT COMPLETED|4 Day Washout Period||0
213190|NCT00779259|521573|P1|COMPLETED|4 Day Washout Period||24
213191|NCT00779259|521573|P1|STARTED|4 Day Washout Period||24
213192|NCT00779259|521573|P1|NOT COMPLETED|Theophylline Alone||0
213193|NCT00779259|521573|P1|COMPLETED|Theophylline Alone||24
213194|NCT00779259|521573|P1|STARTED|Theophylline Alone||24
213195|NCT00779285|521592|P1|NOT COMPLETED|Overall Study||0
213196|NCT00779285|521592|P1|COMPLETED|Overall Study||1
213197|NCT00779285|521592|P1|STARTED|Overall Study||1
213198|NCT00779311|521601|P5|NOT COMPLETED|Overall Study||0
213199|NCT00779311|521602|P4|NOT COMPLETED|Overall Study||0
213200|NCT00779311|521603|P3|NOT COMPLETED|Overall Study||0
213201|NCT00779311|521604|P2|NOT COMPLETED|Overall Study||0
213202|NCT00779311|521605|P1|NOT COMPLETED|Overall Study||0
213203|NCT00779311|521601|P5|COMPLETED|Overall Study||0
213204|NCT00779311|521602|P4|COMPLETED|Overall Study||0
213205|NCT00779311|521603|P3|COMPLETED|Overall Study||0
213206|NCT00779311|521604|P2|COMPLETED|Overall Study||0
213207|NCT00779311|521605|P1|COMPLETED|Overall Study||8
213208|NCT00779311|521601|P5|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
213209|NCT00779311|521602|P4|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
213210|NCT00779311|521603|P3|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
213211|NCT00779311|521604|P2|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||0
213212|NCT00779311|521605|P1|Dose Limiting Toxicity (DLT) Evaluation|Overall Study||6
213213|NCT00779311|521601|P5|STARTED|Overall Study||0
213214|NCT00779311|521602|P4|STARTED|Overall Study||0
213215|NCT00779311|521603|P3|STARTED|Overall Study||0
213216|NCT00779311|521604|P2|STARTED|Overall Study||0
213217|NCT00779311|521605|P1|STARTED|Overall Study|2 of 6 patients were not evaluable for DLT assessment and were replaced for a total of 8 enrolled.|8
213218|NCT00779467|521631|P4|NOT COMPLETED|Overall Study||19
213219|NCT00779467|521632|P3|NOT COMPLETED|Overall Study||10
213220|NCT00779467|521633|P2|NOT COMPLETED|Overall Study||5
213221|NCT00779467|521634|P1|NOT COMPLETED|Overall Study||15
213222|NCT00779467|521631|P4|COMPLETED|Overall Study||35
213223|NCT00779467|521632|P3|COMPLETED|Overall Study||38
213224|NCT00779467|521633|P2|COMPLETED|Overall Study||40
213225|NCT00779467|521634|P1|COMPLETED|Overall Study||38
213226|NCT00779467|521631|P4|STARTED|Overall Study||54
213227|NCT00779467|521632|P3|STARTED|Overall Study||48
213228|NCT00779467|521633|P2|STARTED|Overall Study||45
213229|NCT00779467|521634|P1|STARTED|Overall Study||53
213230|NCT00779506|521672|P1|NOT COMPLETED|Overall Study||29
213231|NCT00779506|521672|P1|COMPLETED|Overall Study||67
213232|NCT00779506|521672|P1|Withdrawal Treatment|Overall Study||27
213233|NCT00779506|521672|P1|Treatment Complete|Overall Study||67
213234|NCT00779506|521672|P1|MITT|Overall Study||89
213235|NCT00779506|521672|P1|Assigned|Overall Study||94
213236|NCT00779506|521672|P1|Screen Failed|Overall Study||2
213237|NCT00779506|521672|P1|Enrolled|Overall Study||96
213238|NCT00779506|521672|P1|STARTED|Overall Study||96
213239|NCT00779558|521684|P2|NOT COMPLETED|Overall Study||7
213240|NCT00779558|521685|P1|NOT COMPLETED|Overall Study||4
213241|NCT00779558|521684|P2|COMPLETED|Overall Study||37
213242|NCT00779558|521685|P1|COMPLETED|Overall Study||53
213243|NCT00779558|521684|P2|STARTED|Overall Study||44
213244|NCT00779558|521685|P1|STARTED|Overall Study||57
213245|NCT00779584|521708|P9|NOT COMPLETED|Overall Study||2
213246|NCT00779584|521709|P8|NOT COMPLETED|Overall Study||3
213247|NCT00779584|521710|P7|NOT COMPLETED|Overall Study||8
213248|NCT00779584|521711|P6|NOT COMPLETED|Overall Study||6
213249|NCT00779584|521712|P5|NOT COMPLETED|Overall Study||7
213250|NCT00779584|521713|P4|NOT COMPLETED|Overall Study||6
213251|NCT00779584|521714|P3|NOT COMPLETED|Overall Study||7
213252|NCT00779584|521715|P2|NOT COMPLETED|Overall Study||3
213253|NCT00779584|521716|P1|NOT COMPLETED|Overall Study||3
213254|NCT00779584|521708|P9|COMPLETED|Overall Study||0
213255|NCT00779584|521709|P8|COMPLETED|Overall Study||0
213256|NCT00779584|521710|P7|COMPLETED|Overall Study||0
213257|NCT00779584|521711|P6|COMPLETED|Overall Study||0
213258|NCT00779584|521712|P5|COMPLETED|Overall Study||0
213259|NCT00779584|521713|P4|COMPLETED|Overall Study||0
213260|NCT00779584|521714|P3|COMPLETED|Overall Study||0
213261|NCT00779584|521715|P2|COMPLETED|Overall Study||0
213262|NCT00779584|521716|P1|COMPLETED|Overall Study||0
213263|NCT00779584|521708|P9|Treated|Overall Study||2
213264|NCT00779584|521709|P8|Treated|Overall Study||3
213265|NCT00779584|521710|P7|Treated|Overall Study||8
213266|NCT00779584|521711|P6|Treated|Overall Study||4
213267|NCT00779584|521712|P5|Treated|Overall Study||7
213268|NCT00779584|521713|P4|Treated|Overall Study||6
213269|NCT00779584|521714|P3|Treated|Overall Study||7
213270|NCT00779584|521715|P2|Treated|Overall Study||3
213271|NCT00779584|521716|P1|Treated|Overall Study||3
213272|NCT00779584|521708|P9|STARTED|Overall Study||2
213273|NCT00779584|521709|P8|STARTED|Overall Study||3
213274|NCT00779584|521710|P7|STARTED|Overall Study||8
213275|NCT00779584|521711|P6|STARTED|Overall Study||6
213276|NCT00779584|521712|P5|STARTED|Overall Study||7
213277|NCT00779584|521713|P4|STARTED|Overall Study||6
213278|NCT00779584|521714|P3|STARTED|Overall Study||7
213279|NCT00779584|521715|P2|STARTED|Overall Study||3
213280|NCT00779584|521716|P1|STARTED|Overall Study||3
213281|NCT00779675|521790|P1|NOT COMPLETED|Extended Treatment Period||46
213282|NCT00779675|521790|P1|COMPLETED|Extended Treatment Period||147
213283|NCT00779675|521790|P1|STARTED|Extended Treatment Period|Clinical responders during the treatment period could enter the extended treatment period.|193
213284|NCT00779675|521790|P1|NOT COMPLETED|Treatment Period||332
213285|NCT00779675|521790|P1|COMPLETED|Treatment Period||328
213286|NCT00779675|521790|P1|STARTED|Treatment Period|One of the 660 participants did not receive study treatment.|660
213287|NCT00779701|521809|P1|NOT COMPLETED|Overall Study||0
213288|NCT00779701|521809|P1|COMPLETED|Overall Study||27
213289|NCT00779701|521809|P1|STARTED|Overall Study||27
213290|NCT00779766|521815|P2|NOT COMPLETED|Overall Study||68
213291|NCT00779766|521816|P1|NOT COMPLETED|Overall Study||85
213292|NCT00779766|521815|P2|COMPLETED|Overall Study|Among those 2814 subjects, 1408 completed the study and 1406 had an unknown completion status.|2957
213293|NCT00779766|521816|P1|COMPLETED|Overall Study|Among those 2831 subjects, 1432 completed the study and 1399 had an unknown completion status.|2941
213294|NCT00779766|521815|P2|STARTED|Overall Study||3025
213295|NCT00779766|521816|P1|STARTED|Overall Study||3026
213296|NCT00779779|521894|P1|NOT COMPLETED|Overall Study||24
213297|NCT00779779|521894|P1|COMPLETED|Overall Study||498
213298|NCT00779779|521894|P1|STARTED|Overall Study||522
213299|NCT00779857|521901|P1|NOT COMPLETED|Overall Study||6
213300|NCT00779857|521901|P1|COMPLETED|Overall Study|12 Month Post procedure, 64 subjects available for evaluation|64
213301|NCT00779857|521901|P1|3 Month Post Procedure|Overall Study|3 month follow-up, 65 of the subjects were available for evaluation.|65
213302|NCT00779857|521901|P1|30 Day Post Procedure|Overall Study|2 missed Visit|68
213303|NCT00779857|521901|P1|STARTED|Overall Study|70 patients treated|70
213304|NCT00780273|521906|P1|NOT COMPLETED|Overall Study||2
213305|NCT00780273|521906|P1|COMPLETED|Overall Study||17
213306|NCT00780273|521906|P1|STARTED|Overall Study||19
213307|NCT00786032|521915|P1|NOT COMPLETED|Overall Study||24
213308|NCT00786032|521915|P1|COMPLETED|Overall Study||3
213309|NCT00786032|521915|P1|Independent Users|Overall Study|All data analyses were based on the 14 independent users.|14
213310|NCT00786032|521915|P1|STARTED|Overall Study||27
213311|NCT00786188|521927|P2|NOT COMPLETED|Overall Study||1
213312|NCT00786188|521928|P1|NOT COMPLETED|Overall Study||5
213313|NCT00786188|521927|P2|COMPLETED|Overall Study||51
213314|NCT00786188|521928|P1|COMPLETED|Overall Study||45
213315|NCT00786188|521927|P2|STARTED|Overall Study||52
213316|NCT00786188|521928|P1|STARTED|Overall Study||50
213317|NCT00793780|521956|P2|NOT COMPLETED|Overall Study||1
213318|NCT00793780|521957|P1|NOT COMPLETED|Overall Study||2
213319|NCT00793780|521956|P2|COMPLETED|Overall Study||11
213320|NCT00793780|521957|P1|COMPLETED|Overall Study||10
213321|NCT00793780|521956|P2|Collected Baseline Data|Overall Study||12
213322|NCT00793780|521957|P1|Collected Baseline Data|Overall Study||11
213323|NCT00793780|521956|P2|Randomization|Overall Study||12
213324|NCT00793780|521957|P1|Randomization|Overall Study||12
213325|NCT00793780|521956|P2|STARTED|Overall Study||12
213326|NCT00793780|521957|P1|STARTED|Overall Study||12
213327|NCT00793793|521985|P12|NOT COMPLETED|Overall Study||6
213328|NCT00793793|521986|P11|NOT COMPLETED|Overall Study||3
213329|NCT00793793|521987|P10|NOT COMPLETED|Overall Study||9
213330|NCT00793793|521988|P9|NOT COMPLETED|Overall Study||9
213331|NCT00793793|521989|P8|NOT COMPLETED|Overall Study||0
213332|NCT00793793|521990|P7|NOT COMPLETED|Overall Study||4
213333|NCT00793793|521991|P6|NOT COMPLETED|Overall Study||2
213334|NCT00793793|521992|P5|NOT COMPLETED|Overall Study||2
213335|NCT00793793|521993|P4|NOT COMPLETED|Overall Study||3
213336|NCT00793793|521994|P3|NOT COMPLETED|Overall Study||2
213337|NCT00793793|521995|P2|NOT COMPLETED|Overall Study||1
213338|NCT00793793|521996|P1|NOT COMPLETED|Overall Study||0
213339|NCT00793793|521985|P12|COMPLETED|Overall Study||1
213340|NCT00793793|521986|P11|COMPLETED|Overall Study||3
213341|NCT00793793|521987|P10|COMPLETED|Overall Study||6
213342|NCT00793793|521988|P9|COMPLETED|Overall Study||6
213343|NCT00793793|521989|P8|COMPLETED|Overall Study||6
213344|NCT00793793|521990|P7|COMPLETED|Overall Study||3
213345|NCT00793793|521991|P6|COMPLETED|Overall Study||4
213346|NCT00793793|521992|P5|COMPLETED|Overall Study||4
213347|NCT00793793|521993|P4|COMPLETED|Overall Study||4
213348|NCT00793793|521994|P3|COMPLETED|Overall Study||5
213349|NCT00793793|521995|P2|COMPLETED|Overall Study||5
213350|NCT00793793|521996|P1|COMPLETED|Overall Study||8
213351|NCT00793793|521985|P12|STARTED|Overall Study||7
213352|NCT00793793|521986|P11|STARTED|Overall Study||6
213353|NCT00793793|521987|P10|STARTED|Overall Study||15
213354|NCT00793793|521988|P9|STARTED|Overall Study||15
213355|NCT00793793|521989|P8|STARTED|Overall Study||6
213356|NCT00793793|521990|P7|STARTED|Overall Study||7
213357|NCT00793793|521991|P6|STARTED|Overall Study||6
213358|NCT00793793|521992|P5|STARTED|Overall Study||6
213359|NCT00793793|521993|P4|STARTED|Overall Study||7
213360|NCT00793793|521994|P3|STARTED|Overall Study||7
213361|NCT00793793|521995|P2|STARTED|Overall Study||6
213362|NCT00793793|521996|P1|STARTED|Overall Study||8
213363|NCT00793819|522371|P2|NOT COMPLETED|Overall Study||9
213364|NCT00793819|522372|P1|NOT COMPLETED|Overall Study||14
213365|NCT00793819|522371|P2|COMPLETED|Overall Study||89
213366|NCT00793819|522372|P1|COMPLETED|Overall Study||97
213367|NCT00793819|522371|P2|STARTED|Overall Study||98
213368|NCT00793819|522372|P1|STARTED|Overall Study||111
213369|NCT00793871|522378|P1|NOT COMPLETED|Overall Study||60
213370|NCT00793871|522378|P1|COMPLETED|Overall Study||0
213371|NCT00793871|522378|P1|Received Treatment|Overall Study||59
213372|NCT00793871|522378|P1|STARTED|Overall Study||60
213373|NCT00793910|522392|P2|NOT COMPLETED|Overall Study||7
213374|NCT00793910|522393|P1|NOT COMPLETED|Overall Study||5
213375|NCT00793910|522392|P2|COMPLETED|Overall Study||46
213376|NCT00793910|522393|P1|COMPLETED|Overall Study||48
213377|NCT00793910|522392|P2|STARTED|Overall Study||53
213378|NCT00793910|522393|P1|STARTED|Overall Study||53
213379|NCT00794118|522407|P1|NOT COMPLETED|Overall Study||27
213380|NCT00794118|522407|P1|COMPLETED|Overall Study||272
213381|NCT00794118|522407|P1|STARTED|Overall Study||299
213382|NCT00794144|522465|P2|NOT COMPLETED|Overall Study||3
213383|NCT00794144|522466|P1|NOT COMPLETED|Overall Study||3
213384|NCT00794144|522465|P2|COMPLETED|Overall Study||63
213385|NCT00794144|522466|P1|COMPLETED|Overall Study||63
213386|NCT00794144|522465|P2|STARTED|Overall Study||66
213387|NCT00794144|522466|P1|STARTED|Overall Study||66
213388|NCT00794157|522475|P3|NOT COMPLETED|Overall Study||19
213389|NCT00794157|522476|P2|NOT COMPLETED|Overall Study||10
213390|NCT00794157|522477|P1|NOT COMPLETED|Overall Study||10
213391|NCT00794157|522475|P3|COMPLETED|Overall Study||98
213392|NCT00794157|522476|P2|COMPLETED|Overall Study||106
213393|NCT00794157|522477|P1|COMPLETED|Overall Study||104
213394|NCT00794157|522475|P3|STARTED|Overall Study||117
213395|NCT00794157|522476|P2|STARTED|Overall Study||116
213396|NCT00794157|522477|P1|STARTED|Overall Study||114
213397|NCT00794170|522499|P2|NOT COMPLETED|Overall Study||3
213398|NCT00794170|522500|P1|NOT COMPLETED|Overall Study||7
213399|NCT00794170|522499|P2|COMPLETED|Overall Study||152
213400|NCT00794170|522500|P1|COMPLETED|Overall Study||150
213401|NCT00794170|522499|P2|STARTED|Overall Study||155
213402|NCT00794170|522500|P1|STARTED|Overall Study||157
213403|NCT00794196|522508|P2|NOT COMPLETED|Overall Study||23
213404|NCT00794196|522509|P1|NOT COMPLETED|Overall Study||5
213405|NCT00794196|522508|P2|COMPLETED|Overall Study||64
213406|NCT00794196|522509|P1|COMPLETED|Overall Study||87
213407|NCT00794196|522508|P2|STARTED|Overall Study||87
213408|NCT00794196|522509|P1|STARTED|Overall Study||92
213409|NCT00794313|522517|P3|NOT COMPLETED|Overall Study||0
213410|NCT00794313|522518|P2|NOT COMPLETED|Overall Study||0
213411|NCT00794313|522519|P1|NOT COMPLETED|Overall Study||0
213412|NCT00794313|522517|P3|COMPLETED|Overall Study||1
213413|NCT00794313|522518|P2|COMPLETED|Overall Study||1
213414|NCT00794313|522519|P1|COMPLETED|Overall Study||1
213415|NCT00794313|522517|P3|STARTED|Overall Study||1
213416|NCT00794313|522518|P2|STARTED|Overall Study||1
213417|NCT00794313|522519|P1|STARTED|Overall Study||1
213418|NCT00794365|522530|P1|NOT COMPLETED|Overall Study||79
213419|NCT00794365|522530|P1|COMPLETED|Overall Study||251
213420|NCT00794365|522530|P1|STARTED|Overall Study||330
213421|NCT00794469|522536|P1|NOT COMPLETED|Overall Study||0
213422|NCT00794469|522536|P1|COMPLETED|Overall Study||21
213423|NCT00794469|522536|P1|STARTED|Overall Study||21
213424|NCT00794508|522541|P1|NOT COMPLETED|Overall Study||0
213425|NCT00794508|522541|P1|COMPLETED|Overall Study||10
213426|NCT00794508|522541|P1|STARTED|Overall Study||10
213427|NCT00794547|522547|P2|NOT COMPLETED|Overall Study||0
213428|NCT00794547|522548|P1|NOT COMPLETED|Overall Study||0
213429|NCT00794547|522547|P2|COMPLETED|Overall Study||16
213430|NCT00794547|522548|P1|COMPLETED|Overall Study||18
213431|NCT00794547|522547|P2|STARTED|Overall Study||16
213432|NCT00794547|522548|P1|STARTED|Overall Study||18
213433|NCT00794560|522559|P4|NOT COMPLETED|Overall Study||4
213434|NCT00794560|522560|P3|NOT COMPLETED|Overall Study||4
213435|NCT00794560|522561|P2|NOT COMPLETED|Overall Study||4
213436|NCT00794560|522562|P1|NOT COMPLETED|Overall Study||3
213437|NCT00794560|522559|P4|COMPLETED|Overall Study||34
213438|NCT00794560|522560|P3|COMPLETED|Overall Study||40
213439|NCT00794560|522561|P2|COMPLETED|Overall Study||32
213440|NCT00794560|522562|P1|COMPLETED|Overall Study||33
213441|NCT00794560|522559|P4|STARTED|Overall Study||38
213442|NCT00794560|522560|P3|STARTED|Overall Study||44
213443|NCT00794560|522561|P2|STARTED|Overall Study||36
213444|NCT00794560|522562|P1|STARTED|Overall Study||36
213445|NCT00794664|522578|P2|NOT COMPLETED|Follow-up Period||5
213446|NCT00794664|522579|P1|NOT COMPLETED|Follow-up Period||1
213447|NCT00794664|522578|P2|COMPLETED|Follow-up Period||28
213448|NCT00794664|522579|P1|COMPLETED|Follow-up Period||15
213449|NCT00794664|522578|P2|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|33
213450|NCT00794664|522579|P1|STARTED|Follow-up Period|Participants enrolled in the open-label extension (NCT00694109) or continued in the follow-up period|16
213451|NCT00794664|522578|P2|NOT COMPLETED|Treatment Period||12
213452|NCT00794664|522579|P1|NOT COMPLETED|Treatment Period||1
213453|NCT00794664|522578|P2|COMPLETED|Treatment Period|6 participants enrolled in open-label extension study NCT00694109|27
213454|NCT00794664|522579|P1|COMPLETED|Treatment Period|3 participants enrolled in open-label extension study NCT00694109|18
213455|NCT00794664|522578|P2|STARTED|Treatment Period||39
213456|NCT00794664|522579|P1|STARTED|Treatment Period||19
213457|NCT00794677|522625|P2|NOT COMPLETED|Second Intervention||0
213458|NCT00794677|522626|P1|NOT COMPLETED|Second Intervention||0
213459|NCT00794677|522625|P2|COMPLETED|Second Intervention||13
213460|NCT00794677|522626|P1|COMPLETED|Second Intervention||11
213461|NCT00794677|522625|P2|STARTED|Second Intervention||13
213462|NCT00794677|522626|P1|STARTED|Second Intervention||11
213463|NCT00794677|522625|P2|NOT COMPLETED|First Intervention||0
213464|NCT00794677|522626|P1|NOT COMPLETED|First Intervention||2
213465|NCT00794677|522625|P2|COMPLETED|First Intervention||13
213466|NCT00794677|522626|P1|COMPLETED|First Intervention||11
213467|NCT00794677|522625|P2|STARTED|First Intervention||13
213468|NCT00794677|522626|P1|STARTED|First Intervention||13
213469|NCT00794820|522646|P1|NOT COMPLETED|Overall Study||16
213470|NCT00794820|522646|P1|COMPLETED|Overall Study||50
213471|NCT00794820|522646|P1|STARTED|Overall Study||66
213472|NCT00794924|522654|P2|NOT COMPLETED|Overall Study||70
213473|NCT00794924|522655|P1|NOT COMPLETED|Overall Study||60
213474|NCT00794924|522654|P2|COMPLETED|Overall Study||101
213475|NCT00794924|522655|P1|COMPLETED|Overall Study||114
213476|NCT00794924|522654|P2|STARTED|Overall Study|14 patients refused to start the study|171
213477|NCT00794924|522655|P1|STARTED|Overall Study|14 patients refused to start the study|174
213478|NCT00794963|522661|P2|NOT COMPLETED|Overall Study||4
213479|NCT00794963|522662|P1|NOT COMPLETED|Overall Study||1
213480|NCT00794963|522661|P2|COMPLETED|Overall Study||0
213481|NCT00794963|522662|P1|COMPLETED|Overall Study||3
213482|NCT00794963|522661|P2|STARTED|Overall Study||4
213483|NCT00794963|522662|P1|STARTED|Overall Study||4
213484|NCT00795002|522670|P2|NOT COMPLETED|Overall Study||2
213485|NCT00795002|522671|P1|NOT COMPLETED|Overall Study||2
213486|NCT00795002|522670|P2|COMPLETED|Overall Study||37
213487|NCT00795002|522671|P1|COMPLETED|Overall Study||37
213488|NCT00795002|522670|P2|STARTED|Overall Study||39
213489|NCT00795002|522671|P1|STARTED|Overall Study||39
213490|NCT00795132|522677|P1|NOT COMPLETED|Overall Study||3
213491|NCT00795132|522677|P1|COMPLETED|Overall Study||44
213492|NCT00795132|522677|P1|STARTED|Overall Study||47
213493|NCT00795145|522691|P7|NOT COMPLETED|Cohort 2||0
213494|NCT00795145|522692|P6|NOT COMPLETED|Cohort 2||0
213495|NCT00795145|522693|P5|NOT COMPLETED|Cohort 2||0
213496|NCT00795145|522694|P4|NOT COMPLETED|Cohort 2||0
213497|NCT00795145|522695|P3|NOT COMPLETED|Cohort 2||0
213498|NCT00795145|522696|P2|NOT COMPLETED|Cohort 2||0
213499|NCT00795145|522697|P1|NOT COMPLETED|Cohort 2||0
213500|NCT00795145|522691|P7|COMPLETED|Cohort 2||10
213501|NCT00795145|522692|P6|COMPLETED|Cohort 2||10
213502|NCT00795145|522693|P5|COMPLETED|Cohort 2||10
213503|NCT00795145|522694|P4|COMPLETED|Cohort 2||10
213504|NCT00795145|522695|P3|COMPLETED|Cohort 2||0
213505|NCT00795145|522696|P2|COMPLETED|Cohort 2||0
213506|NCT00795145|522697|P1|COMPLETED|Cohort 2||0
213507|NCT00795145|522691|P7|STARTED|Cohort 2||10
213508|NCT00795145|522692|P6|STARTED|Cohort 2||10
213509|NCT00795145|522693|P5|STARTED|Cohort 2||10
213510|NCT00795145|522694|P4|STARTED|Cohort 2||10
213511|NCT00795145|522695|P3|STARTED|Cohort 2||0
213512|NCT00795145|522696|P2|STARTED|Cohort 2||0
213513|NCT00795145|522697|P1|STARTED|Cohort 2||0
213514|NCT00795145|522691|P7|NOT COMPLETED|Cohort 1||0
213515|NCT00795145|522692|P6|NOT COMPLETED|Cohort 1||0
213516|NCT00795145|522693|P5|NOT COMPLETED|Cohort 1||0
213517|NCT00795145|522694|P4|NOT COMPLETED|Cohort 1||0
213518|NCT00795145|522695|P3|NOT COMPLETED|Cohort 1||0
213519|NCT00795145|522696|P2|NOT COMPLETED|Cohort 1||0
213520|NCT00795145|522697|P1|NOT COMPLETED|Cohort 1||0
213521|NCT00795145|522691|P7|COMPLETED|Cohort 1||0
213522|NCT00795145|522692|P6|COMPLETED|Cohort 1||0
213523|NCT00795145|522693|P5|COMPLETED|Cohort 1||0
213524|NCT00795145|522694|P4|COMPLETED|Cohort 1||0
213525|NCT00795145|522695|P3|COMPLETED|Cohort 1||3
213526|NCT00795145|522696|P2|COMPLETED|Cohort 1||3
213527|NCT00795145|522697|P1|COMPLETED|Cohort 1||3
213528|NCT00795145|522691|P7|STARTED|Cohort 1||0
213529|NCT00795145|522692|P6|STARTED|Cohort 1||0
213530|NCT00795145|522693|P5|STARTED|Cohort 1||0
213531|NCT00795145|522694|P4|STARTED|Cohort 1||0
213532|NCT00795145|522695|P3|STARTED|Cohort 1||3
213533|NCT00795145|522696|P2|STARTED|Cohort 1||3
213534|NCT00795145|522697|P1|STARTED|Cohort 1||3
213535|NCT00795184|522741|P2|NOT COMPLETED|Overall Study||13
213536|NCT00795184|522742|P1|NOT COMPLETED|Overall Study||8
213537|NCT00795184|522741|P2|COMPLETED|Overall Study|44 patients analysable, completed all 3 imaging procedures|44
213538|NCT00795184|522742|P1|COMPLETED|Overall Study|57 patients analysable, completed all 3 imaging procedures|57
213539|NCT00795184|522741|P2|STARTED|Overall Study||57
213540|NCT00795184|522742|P1|STARTED|Overall Study||65
213541|NCT00795210|522754|P3|NOT COMPLETED|Overall Study||2
213542|NCT00795210|522755|P2|NOT COMPLETED|Overall Study||1
213543|NCT00795210|522756|P1|NOT COMPLETED|Overall Study||0
213544|NCT00795210|522754|P3|COMPLETED|Overall Study||3
213545|NCT00795210|522755|P2|COMPLETED|Overall Study||11
213546|NCT00795210|522756|P1|COMPLETED|Overall Study||8
213547|NCT00795210|522754|P3|STARTED|Overall Study||5
213548|NCT00795210|522755|P2|STARTED|Overall Study||12
213549|NCT00795210|522756|P1|STARTED|Overall Study||8
213550|NCT00795288|522769|P2|NOT COMPLETED|Overall Study||0
213551|NCT00795288|522770|P1|NOT COMPLETED|Overall Study||0
213552|NCT00795288|522769|P2|COMPLETED|Overall Study||21
213553|NCT00795288|522770|P1|COMPLETED|Overall Study||21
213554|NCT00795288|522769|P2|STARTED|Overall Study||21
213555|NCT00795288|522770|P1|STARTED|Overall Study||21
213556|NCT00795340|522782|P2|NOT COMPLETED|Overall Study||0
213557|NCT00795340|522783|P1|NOT COMPLETED|Overall Study||7
213558|NCT00795340|522782|P2|COMPLETED|Overall Study||153
213559|NCT00795340|522783|P1|COMPLETED|Overall Study||146
213560|NCT00795340|522782|P2|STARTED|Overall Study||153
213561|NCT00795340|522783|P1|STARTED|Overall Study||153
213562|NCT00795366|522795|P2|NOT COMPLETED|Overall Study||0
213563|NCT00795366|522796|P1|NOT COMPLETED|Overall Study||0
213564|NCT00795366|522795|P2|COMPLETED|Overall Study||54
213565|NCT00795366|522796|P1|COMPLETED|Overall Study||42
213566|NCT00795366|522795|P2|STARTED|Overall Study||54
213567|NCT00795366|522796|P1|STARTED|Overall Study||42
213568|NCT00795509|522802|P1|NOT COMPLETED|Overall Study||31
213569|NCT00795509|522802|P1|COMPLETED|Overall Study||343
213570|NCT00795509|522802|P1|STARTED|Overall Study||374
213571|NCT00795535|522807|P1|NOT COMPLETED|Overall Study||20
213572|NCT00795535|522807|P1|COMPLETED|Overall Study||75
213573|NCT00795535|522807|P1|STARTED|Overall Study||95
213574|NCT00795600|522816|P2|NOT COMPLETED|Overall Study||4
213575|NCT00795600|522817|P1|NOT COMPLETED|Overall Study||4
213576|NCT00795600|522816|P2|COMPLETED|Overall Study||31
213577|NCT00795600|522817|P1|COMPLETED|Overall Study||21
213578|NCT00795600|522816|P2|Exposed to Drug|Overall Study||35
213579|NCT00795600|522817|P1|Exposed to Drug|Overall Study|1 patient did not take study medication because the patient withdrew consent|24
213580|NCT00795600|522816|P2|STARTED|Overall Study||35
213581|NCT00795600|522817|P1|STARTED|Overall Study||25
213582|NCT00795639|522939|P2|NOT COMPLETED|Overall Study||26
213583|NCT00795639|522940|P1|NOT COMPLETED|Overall Study||21
213584|NCT00795639|522939|P2|COMPLETED|Overall Study||66
213585|NCT00795639|522940|P1|COMPLETED|Overall Study||70
213586|NCT00795639|522939|P2|Randomized and Not Treated|Overall Study||1
213587|NCT00795639|522940|P1|Randomized and Not Treated|Overall Study||0
213588|NCT00795639|522939|P2|STARTED|Overall Study||92
213589|NCT00795639|522940|P1|STARTED|Overall Study||91
213590|NCT00795704|522952|P2|NOT COMPLETED|Overall Study||3
213591|NCT00795704|522953|P1|NOT COMPLETED|Overall Study||4
213592|NCT00795704|522952|P2|COMPLETED|Overall Study||9
213593|NCT00795704|522953|P1|COMPLETED|Overall Study||8
213594|NCT00795704|522952|P2|STARTED|Overall Study||12
213595|NCT00795704|522953|P1|STARTED|Overall Study||12
213596|NCT00795717|522965|P2|NOT COMPLETED|Phase II||1
213597|NCT00795717|522966|P1|NOT COMPLETED|Phase II||0
213598|NCT00795717|522965|P2|COMPLETED|Phase II||18
213599|NCT00795717|522966|P1|COMPLETED|Phase II||18
213600|NCT00795717|522965|P2|STARTED|Phase II||19
213601|NCT00795717|522966|P1|STARTED|Phase II||18
213602|NCT00795717|522965|P2|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
213603|NCT00795717|522966|P1|NOT COMPLETED|Phase I Followed by Wash Out x 4 Weeks||2
213604|NCT00795717|522965|P2|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||19
213605|NCT00795717|522966|P1|COMPLETED|Phase I Followed by Wash Out x 4 Weeks||18
213606|NCT00795717|522965|P2|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to placebo first|21
213607|NCT00795717|522966|P1|STARTED|Phase I Followed by Wash Out x 4 Weeks|Randomized to treatment first|20
213608|NCT00795769|522976|P1|NOT COMPLETED|Overall Study||0
213609|NCT00795769|522976|P1|COMPLETED|Overall Study||49
213610|NCT00795769|522976|P1|STARTED|Overall Study||49
213611|NCT00795886|522980|P1|NOT COMPLETED|Overall Study||10
213612|NCT00795886|522980|P1|COMPLETED|Overall Study||53
213613|NCT00795886|522980|P1|STARTED|Overall Study||63
213614|NCT00795951|522986|P1|NOT COMPLETED|Overall Study||2
213615|NCT00795951|522986|P1|COMPLETED|Overall Study||100
213616|NCT00795951|522986|P1|STARTED|Overall Study||102
213617|NCT00796003|523025|P2|NOT COMPLETED|Overall Study||29
213618|NCT00796003|523026|P1|NOT COMPLETED|Overall Study||3
213619|NCT00796003|523025|P2|COMPLETED|Overall Study|Includes 2 participants from Phase I (20 mg/m2) group|7
213620|NCT00796003|523026|P1|COMPLETED|Overall Study||0
213621|NCT00796003|523025|P2|Treated|Overall Study|Number of participants treated|34
213622|NCT00796003|523026|P1|Treated|Overall Study|Number of participants treated|3
213623|NCT00796003|523025|P2|STARTED|Overall Study|Number of participants enrolled. Includes 6 participants from Phase I (20 mg/m2) group|36
213624|NCT00796003|523026|P1|STARTED|Overall Study|Number of participants enrolled|3
213625|NCT00796120|523049|P2|NOT COMPLETED|Overall Study||60
213626|NCT00796120|523050|P1|NOT COMPLETED|Overall Study||61
213627|NCT00796120|523049|P2|COMPLETED|Overall Study||0
213628|NCT00796120|523050|P1|COMPLETED|Overall Study||0
213629|NCT00796120|523049|P2|Treated|Overall Study||57
213630|NCT00796120|523050|P1|Treated|Overall Study||61
213631|NCT00796120|523049|P2|STARTED|Overall Study||60
213632|NCT00796120|523050|P1|STARTED|Overall Study||61
213633|NCT00783198|523067|P3|NOT COMPLETED|Overall Study||42
213634|NCT00783198|523068|P2|NOT COMPLETED|Overall Study||43
213635|NCT00783198|523069|P1|NOT COMPLETED|Overall Study||57
213636|NCT00783198|523067|P3|COMPLETED|Overall Study||146
213637|NCT00783198|523068|P2|COMPLETED|Overall Study||144
213638|NCT00783198|523069|P1|COMPLETED|Overall Study||133
213639|NCT00783198|523067|P3|STARTED|Overall Study||188
213640|NCT00783198|523068|P2|STARTED|Overall Study||187
213641|NCT00783198|523069|P1|STARTED|Overall Study||190
213642|NCT00783224|523093|P4|NOT COMPLETED|Overall Study||2
213643|NCT00783224|523094|P3|NOT COMPLETED|Overall Study||1
213644|NCT00783224|523095|P2|NOT COMPLETED|Overall Study||0
213645|NCT00783224|523096|P1|NOT COMPLETED|Overall Study||0
213646|NCT00783224|523093|P4|COMPLETED|Overall Study||140
213647|NCT00783224|523094|P3|COMPLETED|Overall Study||142
213648|NCT00783224|523095|P2|COMPLETED|Overall Study||34
213649|NCT00783224|523096|P1|COMPLETED|Overall Study||32
213650|NCT00783224|523093|P4|STARTED|Overall Study||142
213651|NCT00783224|523094|P3|STARTED|Overall Study||143
213652|NCT00783224|523095|P2|STARTED|Overall Study||34
213653|NCT00783224|523096|P1|STARTED|Overall Study||32
213654|NCT00783263|523109|P4|NOT COMPLETED|Overall Study||3
213655|NCT00783263|523110|P3|NOT COMPLETED|Overall Study||3
213656|NCT00783263|523111|P2|NOT COMPLETED|Overall Study||2
213657|NCT00783263|523112|P1|NOT COMPLETED|Overall Study||4
213658|NCT00783263|523109|P4|COMPLETED|Overall Study||118
213659|NCT00783263|523110|P3|COMPLETED|Overall Study||119
213660|NCT00783263|523111|P2|COMPLETED|Overall Study||96
213661|NCT00783263|523112|P1|COMPLETED|Overall Study||95
213662|NCT00783263|523109|P4|STARTED|Overall Study||121
213663|NCT00783263|523110|P3|STARTED|Overall Study||122
213664|NCT00783263|523111|P2|STARTED|Overall Study||98
213665|NCT00783263|523112|P1|STARTED|Overall Study||99
213666|NCT00783302|523138|P1|NOT COMPLETED|Overall Study||35
213667|NCT00783302|523138|P1|COMPLETED|Overall Study||850
213668|NCT00783302|523138|P1|STARTED|Overall Study||885
213669|NCT00783432|523158|P2|NOT COMPLETED|Overall Study||78
213670|NCT00783432|523159|P1|NOT COMPLETED|Overall Study||85
213671|NCT00783432|523158|P2|COMPLETED|Overall Study||354
213672|NCT00783432|523159|P1|COMPLETED|Overall Study||345
213673|NCT00783432|523158|P2|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|432
213674|NCT00783432|523159|P1|STARTED|Overall Study|This includes 2 subjects that received a randomization number but did not receive study drug|430
213675|NCT00796224|523171|P2|NOT COMPLETED|Overall Study||1
213676|NCT00796224|523172|P1|NOT COMPLETED|Overall Study||1
213677|NCT00796224|523171|P2|COMPLETED|Overall Study||18
213678|NCT00796224|523172|P1|COMPLETED|Overall Study||18
213679|NCT00796224|523171|P2|STARTED|Overall Study||19
213680|NCT00796224|523172|P1|STARTED|Overall Study||19
213681|NCT00796302|523192|P2|NOT COMPLETED|Overall Study||18
213682|NCT00796302|523193|P1|NOT COMPLETED|Overall Study||13
213683|NCT00796302|523192|P2|COMPLETED|Overall Study||66
213684|NCT00796302|523193|P1|COMPLETED|Overall Study||71
213685|NCT00796302|523192|P2|STARTED|Overall Study||84
213686|NCT00796302|523193|P1|STARTED|Overall Study||84
213687|NCT00796315|523205|P3|NOT COMPLETED|Overall Study||0
213688|NCT00796315|523206|P2|NOT COMPLETED|Overall Study||1
213689|NCT00796315|523207|P1|NOT COMPLETED|Overall Study||0
213690|NCT00796315|523205|P3|COMPLETED|Overall Study||15
213691|NCT00796315|523206|P2|COMPLETED|Overall Study||16
213692|NCT00796315|523207|P1|COMPLETED|Overall Study||9
213693|NCT00796315|523205|P3|STARTED|Overall Study||15
213694|NCT00796315|523206|P2|STARTED|Overall Study||17
213695|NCT00796315|523207|P1|STARTED|Overall Study||9
213696|NCT00796328|523218|P1|NOT COMPLETED|Overall Study||6
213697|NCT00796328|523218|P1|COMPLETED|Overall Study||40
213698|NCT00796328|523218|P1|STARTED|Overall Study||46
213699|NCT00796367|523225|P3|NOT COMPLETED|Overall Study||47
213700|NCT00796367|523226|P2|NOT COMPLETED|Overall Study||25
213701|NCT00796367|523227|P1|NOT COMPLETED|Overall Study||30
213702|NCT00796367|523225|P3|COMPLETED|Overall Study||248
213703|NCT00796367|523226|P2|COMPLETED|Overall Study||129
213704|NCT00796367|523227|P1|COMPLETED|Overall Study||197
213705|NCT00796367|523225|P3|STARTED|Overall Study||295
213706|NCT00796367|523226|P2|STARTED|Overall Study|one participant signed ICF but withdrew from study prior to first dosing in OB-305|154
213707|NCT00796367|523227|P1|STARTED|Overall Study||227
213708|NCT00796419|523240|P2|NOT COMPLETED|Overall Study||1
213709|NCT00796419|523241|P1|NOT COMPLETED|Overall Study||0
213710|NCT00796419|523240|P2|COMPLETED|Overall Study||13
213711|NCT00796419|523241|P1|COMPLETED|Overall Study||13
213712|NCT00796419|523240|P2|STARTED|Overall Study||14
213713|NCT00796419|523241|P1|STARTED|Overall Study||13
213714|NCT00796510|523253|P2|NOT COMPLETED|Overall Study||0
213715|NCT00796510|523254|P1|NOT COMPLETED|Overall Study||3
213716|NCT00796510|523253|P2|COMPLETED|Overall Study||0
213717|NCT00796510|523254|P1|COMPLETED|Overall Study||0
213718|NCT00796510|523253|P2|STARTED|Overall Study||0
213719|NCT00796510|523254|P1|STARTED|Overall Study||3
213720|NCT00796523|523266|P2|NOT COMPLETED|Overall Study||7
213721|NCT00796523|523267|P1|NOT COMPLETED|Overall Study||9
213722|NCT00796523|523266|P2|COMPLETED|Overall Study||17
213723|NCT00796523|523267|P1|COMPLETED|Overall Study||18
213724|NCT00796523|523266|P2|STARTED|Overall Study||24
213725|NCT00796523|523267|P1|STARTED|Overall Study||27
213726|NCT00796549|523275|P1|NOT COMPLETED|Overall Study||218
213727|NCT00796549|523275|P1|COMPLETED|Overall Study||0
213728|NCT00796549|523275|P1|Entered|Overall Study|entered and treated|69
213729|NCT00796549|523275|P1|STARTED|Overall Study|Excluding duplicate records for 5 patients who were screened twice|218
213730|NCT00796991|523293|P3|NOT COMPLETED|Overall Study||14
213731|NCT00796991|523294|P2|NOT COMPLETED|Overall Study||12
213732|NCT00796991|523295|P1|NOT COMPLETED|Overall Study||15
213733|NCT00796991|523293|P3|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|6
213734|NCT00796991|523294|P2|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|7
213735|NCT00796991|523295|P1|COMPLETED|Overall Study|Participants continued treatment into maintenance phase.|5
213736|NCT00796991|523293|P3|STARTED|Overall Study||20
213737|NCT00796991|523294|P2|STARTED|Overall Study||19
213738|NCT00796991|523295|P1|STARTED|Overall Study||20
213739|NCT00797108|523396|P3|NOT COMPLETED|Overall Study||6
213740|NCT00797108|523397|P2|NOT COMPLETED|Overall Study||2
213741|NCT00797108|523398|P1|NOT COMPLETED|Overall Study||4
213742|NCT00797108|523396|P3|COMPLETED|Overall Study||6
213743|NCT00797108|523397|P2|COMPLETED|Overall Study||9
213744|NCT00797108|523398|P1|COMPLETED|Overall Study||8
213745|NCT00797108|523396|P3|Treated|Overall Study||12
213746|NCT00797108|523397|P2|Treated|Overall Study||11
213747|NCT00797108|523398|P1|Treated|Overall Study||10
213748|NCT00797108|523396|P3|STARTED|Overall Study||12
213749|NCT00797108|523397|P2|STARTED|Overall Study||11
213750|NCT00797108|523398|P1|STARTED|Overall Study||12
213751|NCT00797212|523430|P1|NOT COMPLETED|Overall Study||0
213752|NCT00797212|523430|P1|COMPLETED|Overall Study||50
213753|NCT00797212|523430|P1|STARTED|Overall Study||50
213754|NCT00797277|523438|P2|NOT COMPLETED|Overall Study||0
213755|NCT00797277|523439|P1|NOT COMPLETED|Overall Study||0
213756|NCT00797277|523438|P2|COMPLETED|Overall Study||30
213757|NCT00797277|523439|P1|COMPLETED|Overall Study||37
213758|NCT00797277|523438|P2|STARTED|Overall Study||30
213759|NCT00797277|523439|P1|STARTED|Overall Study||37
213760|NCT00797316|523449|P2|NOT COMPLETED|Overall Study||32
213761|NCT00797316|523450|P1|NOT COMPLETED|Overall Study||23
213762|NCT00797316|523449|P2|COMPLETED|Overall Study||233
213763|NCT00797316|523450|P1|COMPLETED|Overall Study||244
213764|NCT00797316|523449|P2|STARTED|Overall Study||265
213765|NCT00797316|523450|P1|STARTED|Overall Study||267
213766|NCT00797459|523464|P1|NOT COMPLETED|Overall Study||0
213767|NCT00797459|523464|P1|COMPLETED|Overall Study||60
213768|NCT00797459|523464|P1|STARTED|Overall Study||60
213769|NCT00797511|523472|P1|NOT COMPLETED|Overall Study||1
213770|NCT00797511|523472|P1|COMPLETED|Overall Study||131
213771|NCT00797511|523472|P1|STARTED|Overall Study||132
213772|NCT00797563|523480|P1|NOT COMPLETED|Overall Study||1
213773|NCT00797563|523480|P1|COMPLETED|Overall Study||101
213774|NCT00797563|523480|P1|STARTED|Overall Study|number of subjects|102
213775|NCT00797667|523489|P3|NOT COMPLETED|Overall Study||127
213776|NCT00797667|523490|P2|NOT COMPLETED|Overall Study||259
213777|NCT00797667|523491|P1|NOT COMPLETED|Overall Study||260
213778|NCT00797667|523489|P3|COMPLETED|Overall Study||4
213779|NCT00797667|523490|P2|COMPLETED|Overall Study||5
213780|NCT00797667|523491|P1|COMPLETED|Overall Study||5
213781|NCT00797667|523489|P3|Treated|Overall Study||130
213782|NCT00797667|523490|P2|Treated|Overall Study||263
213783|NCT00797667|523491|P1|Treated|Overall Study||263
213784|NCT00797667|523489|P3|STARTED|Overall Study||131
213785|NCT00797667|523490|P2|STARTED|Overall Study||264
213786|NCT00797667|523491|P1|STARTED|Overall Study||265
213787|NCT00797797|523519|P2|NOT COMPLETED|Overall Study||43
213788|NCT00797797|523520|P1|NOT COMPLETED|Overall Study||55
213789|NCT00797797|523519|P2|COMPLETED|Overall Study||141
213790|NCT00797797|523520|P1|COMPLETED|Overall Study||123
213791|NCT00797797|523519|P2|STARTED|Overall Study||184
213792|NCT00797797|523520|P1|STARTED|Overall Study|Two patients took no background stable dose of pregabalin after randomization and are not included.|178
213793|NCT00797823|523531|P3|NOT COMPLETED|Second Period (Crossover)||0
213794|NCT00797823|523532|P2|NOT COMPLETED|Second Period (Crossover)||0
213795|NCT00797823|523533|P1|NOT COMPLETED|Second Period (Crossover)||0
213796|NCT00797823|523531|P3|COMPLETED|Second Period (Crossover)||0
213797|NCT00797823|523532|P2|COMPLETED|Second Period (Crossover)||4
213798|NCT00797823|523533|P1|COMPLETED|Second Period (Crossover)||3
213799|NCT00797823|523531|P3|STARTED|Second Period (Crossover)||0
213800|NCT00797823|523532|P2|STARTED|Second Period (Crossover)||4
213801|NCT00797823|523533|P1|STARTED|Second Period (Crossover)||3
213802|NCT00797823|523531|P3|NOT COMPLETED|First Period (Initial Randomization)||0
213803|NCT00797823|523532|P2|NOT COMPLETED|First Period (Initial Randomization)||0
213804|NCT00797823|523533|P1|NOT COMPLETED|First Period (Initial Randomization)||1
213805|NCT00797823|523531|P3|COMPLETED|First Period (Initial Randomization)||0
213806|NCT00797823|523532|P2|COMPLETED|First Period (Initial Randomization)||4
213807|NCT00797823|523533|P1|COMPLETED|First Period (Initial Randomization)||3
213808|NCT00797823|523531|P3|STARTED|First Period (Initial Randomization)|Pilot studies only performed during initial period.|0
213809|NCT00797823|523532|P2|STARTED|First Period (Initial Randomization)||4
213810|NCT00797823|523533|P1|STARTED|First Period (Initial Randomization)||4
213811|NCT00797823|523531|P3|NOT COMPLETED|Pilot Studies||0
213812|NCT00797823|523532|P2|NOT COMPLETED|Pilot Studies||0
213813|NCT00797823|523533|P1|NOT COMPLETED|Pilot Studies||0
213814|NCT00797823|523531|P3|COMPLETED|Pilot Studies||6
213815|NCT00797823|523532|P2|COMPLETED|Pilot Studies||0
213816|NCT00797823|523533|P1|COMPLETED|Pilot Studies||0
213817|NCT00797823|523531|P3|STARTED|Pilot Studies||6
213818|NCT00797823|523532|P2|STARTED|Pilot Studies|Not involved in pilot studies|0
213819|NCT00797823|523533|P1|STARTED|Pilot Studies|Not involved in pilot studies|0
213820|NCT00797862|523545|P3|NOT COMPLETED|Overall Study||86
213821|NCT00797862|523546|P2|NOT COMPLETED|Overall Study||68
213822|NCT00797862|523547|P1|NOT COMPLETED|Overall Study||124
213823|NCT00797862|523545|P3|COMPLETED|Overall Study||230
213824|NCT00797862|523546|P2|COMPLETED|Overall Study||250
213825|NCT00797862|523547|P1|COMPLETED|Overall Study||496
213826|NCT00797862|523545|P3|Entered Double-Blind Treatment (FAS)|Overall Study||315
213827|NCT00797862|523546|P2|Entered Double-Blind Treatment (FAS)|Overall Study||315
213828|NCT00797862|523547|P1|Entered Double-Blind Treatment (FAS)|Overall Study||617
213829|NCT00797862|523545|P3|STARTED|Overall Study|1 participant was mis-randomized and discontinued. Only 315 participants received study drug.|316
213830|NCT00797862|523546|P2|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 315 participants received study drug.|318
213831|NCT00797862|523547|P1|STARTED|Overall Study|3 participants were mis-randomized and discontinued. Only 617 participants received study drug.|620
213832|NCT00797966|523577|P6|NOT COMPLETED|Phase A+||28
213833|NCT00797966|523578|P5|NOT COMPLETED|Phase A+||0
213834|NCT00797966|523579|P4|NOT COMPLETED|Phase A+||0
213835|NCT00797966|523580|P3|NOT COMPLETED|Phase A+||0
213836|NCT00797966|523581|P2|NOT COMPLETED|Phase A+||0
213837|NCT00797966|523582|P1|NOT COMPLETED|Phase A+||0
213838|NCT00797966|523577|P6|COMPLETED|Phase A+||207
213839|NCT00797966|523578|P5|COMPLETED|Phase A+||0
213840|NCT00797966|523579|P4|COMPLETED|Phase A+||0
213841|NCT00797966|523580|P3|COMPLETED|Phase A+||0
213842|NCT00797966|523581|P2|COMPLETED|Phase A+||0
213843|NCT00797966|523582|P1|COMPLETED|Phase A+||0
213844|NCT00797966|523577|P6|STARTED|Phase A+||235
213845|NCT00797966|523578|P5|STARTED|Phase A+||0
213846|NCT00797966|523579|P4|STARTED|Phase A+||0
213847|NCT00797966|523580|P3|STARTED|Phase A+||0
213848|NCT00797966|523581|P2|STARTED|Phase A+||0
213849|NCT00797966|523582|P1|STARTED|Phase A+||0
213850|NCT00797966|523577|P6|NOT COMPLETED|Phase B||0
213851|NCT00797966|523578|P5|NOT COMPLETED|Phase B||0
213852|NCT00797966|523579|P4|NOT COMPLETED|Phase B||16
213853|NCT00797966|523580|P3|NOT COMPLETED|Phase B||21
213854|NCT00797966|523581|P2|NOT COMPLETED|Phase B||18
213855|NCT00797966|523582|P1|NOT COMPLETED|Phase B||11
213856|NCT00797966|523577|P6|COMPLETED|Phase B||0
213857|NCT00797966|523578|P5|COMPLETED|Phase B||0
213858|NCT00797966|523579|P4|COMPLETED|Phase B||110
213859|NCT00797966|523580|P3|COMPLETED|Phase B||100
213860|NCT00797966|523581|P2|COMPLETED|Phase B||102
213861|NCT00797966|523582|P1|COMPLETED|Phase B||51
213862|NCT00797966|523577|P6|STARTED|Phase B||0
213863|NCT00797966|523578|P5|STARTED|Phase B||0
213864|NCT00797966|523579|P4|STARTED|Phase B|Randomized participants.|126
213865|NCT00797966|523580|P3|STARTED|Phase B|Randomized participants.|121
213866|NCT00797966|523581|P2|STARTED|Phase B|Randomized participants.|120
213867|NCT00797966|523582|P1|STARTED|Phase B|Randomized participants.|62
213868|NCT00797966|523577|P6|NOT COMPLETED|Phase A||0
213869|NCT00797966|523578|P5|NOT COMPLETED|Phase A||185
213870|NCT00797966|523579|P4|NOT COMPLETED|Phase A||0
213871|NCT00797966|523580|P3|NOT COMPLETED|Phase A||0
213872|NCT00797966|523581|P2|NOT COMPLETED|Phase A||0
213873|NCT00797966|523582|P1|NOT COMPLETED|Phase A||0
213874|NCT00797966|523577|P6|COMPLETED|Phase A||0
213875|NCT00797966|523578|P5|COMPLETED|Phase A||664
213876|NCT00797966|523579|P4|COMPLETED|Phase A||0
213877|NCT00797966|523580|P3|COMPLETED|Phase A||0
213878|NCT00797966|523581|P2|COMPLETED|Phase A||0
213879|NCT00797966|523582|P1|COMPLETED|Phase A||0
213880|NCT00797966|523577|P6|STARTED|Phase A||0
213881|NCT00797966|523578|P5|STARTED|Phase A|850 participants entered Phase A; 849 participants were treated.|849
213882|NCT00797966|523579|P4|STARTED|Phase A||0
213883|NCT00797966|523580|P3|STARTED|Phase A||0
213884|NCT00797966|523581|P2|STARTED|Phase A||0
213885|NCT00797966|523582|P1|STARTED|Phase A||0
213886|NCT00798018|523648|P4|NOT COMPLETED|Overall Study||0
213887|NCT00798018|523649|P3|NOT COMPLETED|Overall Study||0
213888|NCT00798018|523650|P2|NOT COMPLETED|Overall Study||0
213889|NCT00798018|523651|P1|NOT COMPLETED|Overall Study||0
213890|NCT00798018|523648|P4|COMPLETED|Overall Study||25
213891|NCT00798018|523649|P3|COMPLETED|Overall Study||25
213892|NCT00798018|523650|P2|COMPLETED|Overall Study||25
213893|NCT00798018|523651|P1|COMPLETED|Overall Study||25
213894|NCT00798018|523648|P4|STARTED|Overall Study||25
213895|NCT00798018|523649|P3|STARTED|Overall Study||25
213896|NCT00798018|523650|P2|STARTED|Overall Study||25
213897|NCT00798018|523651|P1|STARTED|Overall Study||25
213898|NCT00798096|523661|P1|NOT COMPLETED|Overall Study||2
213899|NCT00798096|523661|P1|COMPLETED|Overall Study|Completion of Study is defined as a minimum of 8 weeks of treatment or early disease progression|16
213900|NCT00798096|523661|P1|STARTED|Overall Study|Treatment with 200 mg bid, oral Fostamatanib until disease progression, toxicity or withdrawal|18
213901|NCT00798135|523668|P1|NOT COMPLETED|Overall Study||13
213902|NCT00798135|523668|P1|COMPLETED|Overall Study||0
213903|NCT00798135|523668|P1|STARTED|Overall Study||13
213904|NCT00798161|523681|P7|NOT COMPLETED|Overall Study||10
213905|NCT00798161|523682|P6|NOT COMPLETED|Overall Study||11
213906|NCT00798161|523683|P5|NOT COMPLETED|Overall Study||16
213907|NCT00798161|523684|P4|NOT COMPLETED|Overall Study||21
213908|NCT00798161|523685|P3|NOT COMPLETED|Overall Study||21
213909|NCT00798161|523686|P2|NOT COMPLETED|Overall Study||17
213910|NCT00798161|523687|P1|NOT COMPLETED|Overall Study||18
213911|NCT00798161|523681|P7|COMPLETED|Overall Study||56
213912|NCT00798161|523682|P6|COMPLETED|Overall Study||132
213913|NCT00798161|523683|P5|COMPLETED|Overall Study||127
213914|NCT00798161|523684|P4|COMPLETED|Overall Study||121
213915|NCT00798161|523685|P3|COMPLETED|Overall Study||126
213916|NCT00798161|523686|P2|COMPLETED|Overall Study||127
213917|NCT00798161|523687|P1|COMPLETED|Overall Study||54
213918|NCT00798161|523681|P7|STARTED|Overall Study||66
213919|NCT00798161|523682|P6|STARTED|Overall Study||143
213920|NCT00798161|523683|P5|STARTED|Overall Study||143
213921|NCT00798161|523684|P4|STARTED|Overall Study||142
213922|NCT00798161|523685|P3|STARTED|Overall Study||147
213923|NCT00798161|523686|P2|STARTED|Overall Study||144
213924|NCT00798161|523687|P1|STARTED|Overall Study||72
213925|NCT00798304|523797|P3|NOT COMPLETED|Overall Study||10
213926|NCT00798304|523798|P2|NOT COMPLETED|Overall Study||22
213927|NCT00798304|523799|P1|NOT COMPLETED|Overall Study||14
213928|NCT00798304|523797|P3|COMPLETED|Overall Study||0
213929|NCT00798304|523798|P2|COMPLETED|Overall Study||0
213930|NCT00798304|523799|P1|COMPLETED|Overall Study||0
213931|NCT00798304|523797|P3|STARTED|Overall Study||10
213932|NCT00798304|523798|P2|STARTED|Overall Study||22
213933|NCT00798304|523799|P1|STARTED|Overall Study||14
213934|NCT00798317|523827|P2|NOT COMPLETED|Overall Study||7
213935|NCT00798317|523828|P1|NOT COMPLETED|Overall Study||10
213936|NCT00798317|523827|P2|COMPLETED|Overall Study||74
213937|NCT00798317|523828|P1|COMPLETED|Overall Study||235
213938|NCT00798317|523827|P2|STARTED|Overall Study||81
213939|NCT00798317|523828|P1|STARTED|Overall Study||245
213940|NCT00798369|523842|P6|NOT COMPLETED|Overall Study||3
213941|NCT00798369|523843|P5|NOT COMPLETED|Overall Study||1
213942|NCT00798369|523844|P4|NOT COMPLETED|Overall Study||1
213943|NCT00798369|523845|P3|NOT COMPLETED|Overall Study||2
213944|NCT00798369|523846|P2|NOT COMPLETED|Overall Study||1
213945|NCT00798369|523847|P1|NOT COMPLETED|Overall Study||1
213946|NCT00798369|523842|P6|COMPLETED|Overall Study||54
213947|NCT00798369|523843|P5|COMPLETED|Overall Study||27
213948|NCT00798369|523844|P4|COMPLETED|Overall Study||28
213949|NCT00798369|523845|P3|COMPLETED|Overall Study||27
213950|NCT00798369|523846|P2|COMPLETED|Overall Study||28
213951|NCT00798369|523847|P1|COMPLETED|Overall Study||27
213952|NCT00798369|523842|P6|STARTED|Overall Study||57
213953|NCT00798369|523843|P5|STARTED|Overall Study||28
213954|NCT00798369|523844|P4|STARTED|Overall Study||29
213955|NCT00798369|523845|P3|STARTED|Overall Study||29
213956|NCT00798369|523846|P2|STARTED|Overall Study||29
213957|NCT00798369|523847|P1|STARTED|Overall Study||28
213958|NCT00798434|523894|P2|NOT COMPLETED|Open-Label||32
213959|NCT00798434|523895|P1|NOT COMPLETED|Open-Label||42
213960|NCT00798434|523894|P2|COMPLETED|Open-Label||282
213961|NCT00798434|523895|P1|COMPLETED|Open-Label||299
213962|NCT00798434|523894|P2|Received Treatment|Open-Label||313
213963|NCT00798434|523895|P1|Received Treatment|Open-Label||341
213964|NCT00798434|523894|P2|STARTED|Open-Label||314
213965|NCT00798434|523895|P1|STARTED|Open-Label||341
213966|NCT00798434|523894|P2|NOT COMPLETED|Double-Blind||84
213967|NCT00798434|523895|P1|NOT COMPLETED|Double-Blind||55
213968|NCT00798434|523894|P2|COMPLETED|Double-Blind||314
213969|NCT00798434|523895|P1|COMPLETED|Double-Blind||341
213970|NCT00798434|523894|P2|Received Treatment|Double-Blind||392
213971|NCT00798434|523895|P1|Received Treatment|Double-Blind||393
213972|NCT00798434|523894|P2|STARTED|Double-Blind||398
213973|NCT00798434|523895|P1|STARTED|Double-Blind||396
213974|NCT00798486|523975|P1|NOT COMPLETED|Overall Study||0
213975|NCT00798486|523975|P1|COMPLETED|Overall Study||110
213976|NCT00798486|523975|P1|STARTED|Overall Study||110
213977|NCT00798577|523984|P2|NOT COMPLETED|Overall Study||0
213978|NCT00798577|523985|P1|NOT COMPLETED|Overall Study||0
213979|NCT00798577|523984|P2|COMPLETED|Overall Study||7
213980|NCT00798577|523985|P1|COMPLETED|Overall Study||17
213981|NCT00798577|523984|P2|STARTED|Overall Study||7
213982|NCT00798577|523985|P1|STARTED|Overall Study||17
213983|NCT00798590|524001|P2|NOT COMPLETED|Overall Study||8
213984|NCT00798590|524002|P1|NOT COMPLETED|Overall Study||11
213985|NCT00798590|524001|P2|COMPLETED|Overall Study||0
213986|NCT00798590|524002|P1|COMPLETED|Overall Study||0
213987|NCT00798590|524001|P2|STARTED|Overall Study||8
213988|NCT00798590|524002|P1|STARTED|Overall Study||11
213989|NCT00798603|524010|P1|NOT COMPLETED|Overall Study||35
213990|NCT00798603|524010|P1|COMPLETED|Overall Study||27
213991|NCT00798603|524010|P1|STARTED|Overall Study||62
213992|NCT00798655|524030|P1|NOT COMPLETED|Overall Study||2
213993|NCT00798655|524030|P1|COMPLETED|Overall Study||44
213994|NCT00798655|524030|P1|STARTED|Overall Study||46
213995|NCT00798707|524038|P3|NOT COMPLETED|Overall Study||22
213996|NCT00798707|524039|P2|NOT COMPLETED|Overall Study||33
213997|NCT00798707|524040|P1|NOT COMPLETED|Overall Study||26
213998|NCT00798707|524038|P3|COMPLETED|Overall Study||215
213999|NCT00798707|524039|P2|COMPLETED|Overall Study||204
214000|NCT00798707|524040|P1|COMPLETED|Overall Study||209
214001|NCT00798707|524038|P3|Treated|Overall Study||236
214002|NCT00798707|524039|P2|Treated|Overall Study||232
214003|NCT00798707|524040|P1|Treated|Overall Study||231
214004|NCT00798707|524038|P3|STARTED|Overall Study||237
214005|NCT00798707|524039|P2|STARTED|Overall Study||237
214006|NCT00798707|524040|P1|STARTED|Overall Study||235
214007|NCT00798720|524090|P1|NOT COMPLETED|Overall Study||0
214008|NCT00798720|524090|P1|COMPLETED|Overall Study||18
214009|NCT00798720|524090|P1|STARTED|Overall Study||18
214010|NCT00798759|524099|P2|NOT COMPLETED|Overall Study||13
214011|NCT00798759|524100|P1|NOT COMPLETED|Overall Study||8
214012|NCT00798759|524099|P2|COMPLETED|Overall Study||106
214013|NCT00798759|524100|P1|COMPLETED|Overall Study||109
214014|NCT00798759|524099|P2|STARTED|Overall Study||119
214015|NCT00798759|524100|P1|STARTED|Overall Study||117
214016|NCT00798889|524108|P1|NOT COMPLETED|Overall Study||314
214017|NCT00798889|524108|P1|COMPLETED|Overall Study||0
214018|NCT00798889|524108|P1|Treated|Overall Study||311
214019|NCT00798889|524108|P1|STARTED|Overall Study||314
214020|NCT00798967|524114|P2|NOT COMPLETED|Overall Study||4
214021|NCT00798967|524115|P1|NOT COMPLETED|Overall Study||4
214022|NCT00798967|524114|P2|COMPLETED|Overall Study||39
214023|NCT00798967|524115|P1|COMPLETED|Overall Study||39
214024|NCT00798967|524114|P2|Discontinued During Dosing Period|Overall Study||4
214025|NCT00798967|524115|P1|Discontinued During Dosing Period|Overall Study||4
214026|NCT00798967|524114|P2|STARTED|Overall Study||43
214027|NCT00798967|524115|P1|STARTED|Overall Study||43
214028|NCT00799227|524123|P1|NOT COMPLETED|Overall Study||3
214029|NCT00799227|524123|P1|COMPLETED|Overall Study||53
214030|NCT00799227|524123|P1|STARTED|Overall Study||56
214031|NCT00799292|524132|P2|NOT COMPLETED|Overall Study||0
214032|NCT00799292|524133|P1|NOT COMPLETED|Overall Study||0
214033|NCT00799292|524132|P2|COMPLETED|Overall Study||29
214034|NCT00799292|524133|P1|COMPLETED|Overall Study||29
214035|NCT00799292|524132|P2|STARTED|Overall Study||29
214036|NCT00799292|524133|P1|STARTED|Overall Study||29
214037|NCT00799396|524137|P1|NOT COMPLETED|Clopidogrel Plus Aspirin||6
214038|NCT00799396|524137|P1|COMPLETED|Clopidogrel Plus Aspirin||663
214039|NCT00799396|524137|P1|STARTED|Clopidogrel Plus Aspirin||669
214040|NCT00799396|524137|P1|NOT COMPLETED|Clopidogrel Treatment||13
214041|NCT00799396|524137|P1|COMPLETED|Clopidogrel Treatment||669
214042|NCT00799396|524137|P1|STARTED|Clopidogrel Treatment||682
214043|NCT00799409|524145|P3|NOT COMPLETED|Overall Study||0
214044|NCT00799409|524146|P2|NOT COMPLETED|Overall Study||0
214045|NCT00799409|524147|P1|NOT COMPLETED|Overall Study||7
214046|NCT00799409|524145|P3|COMPLETED|Overall Study||35
214047|NCT00799409|524146|P2|COMPLETED|Overall Study||36
214048|NCT00799409|524147|P1|COMPLETED|Overall Study||0
214049|NCT00799409|524145|P3|STARTED|Overall Study||35
214050|NCT00799409|524146|P2|STARTED|Overall Study||36
214051|NCT00799409|524147|P1|STARTED|Overall Study||7
214052|NCT00799422|524227|P6|NOT COMPLETED|Third Week of Wear||0
214053|NCT00799422|524228|P5|NOT COMPLETED|Third Week of Wear||0
214054|NCT00799422|524229|P4|NOT COMPLETED|Third Week of Wear||0
214055|NCT00799422|524230|P3|NOT COMPLETED|Third Week of Wear||0
214056|NCT00799422|524231|P2|NOT COMPLETED|Third Week of Wear||0
214057|NCT00799422|524232|P1|NOT COMPLETED|Third Week of Wear||0
214058|NCT00799422|524227|P6|COMPLETED|Third Week of Wear||4
214059|NCT00799422|524228|P5|COMPLETED|Third Week of Wear||4
214060|NCT00799422|524229|P4|COMPLETED|Third Week of Wear||3
214061|NCT00799422|524230|P3|COMPLETED|Third Week of Wear||3
214062|NCT00799422|524231|P2|COMPLETED|Third Week of Wear||4
214063|NCT00799422|524232|P1|COMPLETED|Third Week of Wear||4
214064|NCT00799422|524227|P6|STARTED|Third Week of Wear||4
214065|NCT00799422|524228|P5|STARTED|Third Week of Wear||4
214066|NCT00799422|524229|P4|STARTED|Third Week of Wear||3
214067|NCT00799422|524230|P3|STARTED|Third Week of Wear||3
214068|NCT00799422|524231|P2|STARTED|Third Week of Wear||4
214069|NCT00799422|524232|P1|STARTED|Third Week of Wear||4
214070|NCT00799422|524227|P6|NOT COMPLETED|Second Week of Wear||0
214071|NCT00799422|524228|P5|NOT COMPLETED|Second Week of Wear||0
214072|NCT00799422|524229|P4|NOT COMPLETED|Second Week of Wear||0
214073|NCT00799422|524230|P3|NOT COMPLETED|Second Week of Wear||0
214074|NCT00799422|524231|P2|NOT COMPLETED|Second Week of Wear||0
214075|NCT00799422|524232|P1|NOT COMPLETED|Second Week of Wear||0
214076|NCT00799422|524227|P6|COMPLETED|Second Week of Wear||4
214077|NCT00799422|524228|P5|COMPLETED|Second Week of Wear||4
214078|NCT00799422|524229|P4|COMPLETED|Second Week of Wear||3
214079|NCT00799422|524230|P3|COMPLETED|Second Week of Wear||3
214080|NCT00799422|524231|P2|COMPLETED|Second Week of Wear||4
214081|NCT00799422|524232|P1|COMPLETED|Second Week of Wear||4
214082|NCT00799422|524227|P6|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|4
214083|NCT00799422|524228|P5|STARTED|Second Week of Wear||4
214084|NCT00799422|524229|P4|STARTED|Second Week of Wear|One subject discontinued between First and Second 3 weeks (adverse event)|3
214085|NCT00799422|524230|P3|STARTED|Second Week of Wear||3
214086|NCT00799422|524231|P2|STARTED|Second Week of Wear||4
214087|NCT00799422|524232|P1|STARTED|Second Week of Wear||4
214088|NCT00799422|524227|P6|NOT COMPLETED|First Week of Wear||0
214089|NCT00799422|524228|P5|NOT COMPLETED|First Week of Wear||0
214090|NCT00799422|524229|P4|NOT COMPLETED|First Week of Wear||1
214091|NCT00799422|524230|P3|NOT COMPLETED|First Week of Wear||1
214092|NCT00799422|524231|P2|NOT COMPLETED|First Week of Wear||0
214093|NCT00799422|524232|P1|NOT COMPLETED|First Week of Wear||0
214094|NCT00799422|524227|P6|COMPLETED|First Week of Wear||5
214095|NCT00799422|524228|P5|COMPLETED|First Week of Wear||4
214096|NCT00799422|524229|P4|COMPLETED|First Week of Wear||4
214097|NCT00799422|524230|P3|COMPLETED|First Week of Wear||3
214098|NCT00799422|524231|P2|COMPLETED|First Week of Wear||4
214099|NCT00799422|524232|P1|COMPLETED|First Week of Wear||4
214100|NCT00799422|524227|P6|STARTED|First Week of Wear||5
214101|NCT00799422|524228|P5|STARTED|First Week of Wear||4
214102|NCT00799422|524229|P4|STARTED|First Week of Wear||5
214103|NCT00799422|524230|P3|STARTED|First Week of Wear||4
214104|NCT00799422|524231|P2|STARTED|First Week of Wear||4
214105|NCT00799422|524232|P1|STARTED|First Week of Wear||4
214106|NCT00799474|524246|P1|NOT COMPLETED|Overall Study||0
214107|NCT00799474|524246|P1|COMPLETED|Overall Study||609
214108|NCT00799474|524246|P1|STARTED|Overall Study||609
214109|NCT00799487|524255|P3|NOT COMPLETED|Double-Blind Assessment Period||2
214110|NCT00799487|524256|P2|NOT COMPLETED|Double-Blind Assessment Period||1
214111|NCT00799487|524257|P1|NOT COMPLETED|Double-Blind Assessment Period||0
214112|NCT00799487|524255|P3|COMPLETED|Double-Blind Assessment Period||32
214113|NCT00799487|524256|P2|COMPLETED|Double-Blind Assessment Period||33
214114|NCT00799487|524257|P1|COMPLETED|Double-Blind Assessment Period||0
214115|NCT00799487|524255|P3|STARTED|Double-Blind Assessment Period||34
214116|NCT00799487|524256|P2|STARTED|Double-Blind Assessment Period||34
214117|NCT00799487|524257|P1|STARTED|Double-Blind Assessment Period||0
214118|NCT00799487|524255|P3|NOT COMPLETED|Dose Adjustment Period||0
214119|NCT00799487|524256|P2|NOT COMPLETED|Dose Adjustment Period||0
214120|NCT00799487|524257|P1|NOT COMPLETED|Dose Adjustment Period||21
214121|NCT00799487|524255|P3|COMPLETED|Dose Adjustment Period||34
214122|NCT00799487|524256|P2|COMPLETED|Dose Adjustment Period||34
214123|NCT00799487|524257|P1|COMPLETED|Dose Adjustment Period||0
214124|NCT00799487|524255|P3|STARTED|Dose Adjustment Period||34
214125|NCT00799487|524256|P2|STARTED|Dose Adjustment Period||34
214126|NCT00799487|524257|P1|STARTED|Dose Adjustment Period||21
214127|NCT00786422|524337|P1|NOT COMPLETED|Follow-up Period||3
214128|NCT00786422|524337|P1|COMPLETED|Follow-up Period||17
214129|NCT00786422|524337|P1|STARTED|Follow-up Period|Participants entered follow-up period. No reason documents for those not entering this period|20
214130|NCT00786422|524337|P1|NOT COMPLETED|Rivaroxaban Treatment||11
214131|NCT00786422|524337|P1|COMPLETED|Rivaroxaban Treatment||14
214132|NCT00786422|524337|P1|STARTED|Rivaroxaban Treatment||25
214133|NCT00786474|524355|P2|NOT COMPLETED|Overall Study||43
214134|NCT00786474|524356|P1|NOT COMPLETED|Overall Study||37
214135|NCT00786474|524355|P2|COMPLETED|Overall Study||891
214136|NCT00786474|524356|P1|COMPLETED|Overall Study||913
214137|NCT00786474|524355|P2|STARTED|Overall Study||934
214138|NCT00786474|524356|P1|STARTED|Overall Study||950
214139|NCT00786487|524372|P4|NOT COMPLETED|Overall Study||0
214140|NCT00786487|524373|P3|NOT COMPLETED|Overall Study||0
214141|NCT00786487|524374|P2|NOT COMPLETED|Overall Study||0
214142|NCT00786487|524375|P1|NOT COMPLETED|Overall Study||0
214143|NCT00786487|524372|P4|COMPLETED|Overall Study||7
214144|NCT00786487|524373|P3|COMPLETED|Overall Study||9
214145|NCT00786487|524374|P2|COMPLETED|Overall Study||7
214146|NCT00786487|524375|P1|COMPLETED|Overall Study||10
214147|NCT00786487|524372|P4|STARTED|Overall Study||7
214148|NCT00786487|524373|P3|STARTED|Overall Study||9
214149|NCT00786487|524374|P2|STARTED|Overall Study||7
214150|NCT00786487|524375|P1|STARTED|Overall Study||10
214151|NCT00786565|524385|P1|NOT COMPLETED|Post Surgery||2
214152|NCT00786565|524385|P1|COMPLETED|Post Surgery|67 Participants (134 eyes) completed the study.|67
214153|NCT00786565|524385|P1|STARTED|Post Surgery||69
214154|NCT00786565|524385|P1|NOT COMPLETED|Enrollment Prior to Surgery||6
214155|NCT00786565|524385|P1|COMPLETED|Enrollment Prior to Surgery|69 participants - Akreos Advanced Optic Lens in one eye and Akreos Adapt Lens in the fellow eye.|69
214156|NCT00786565|524385|P1|STARTED|Enrollment Prior to Surgery||75
214157|NCT00786643|524425|P2|NOT COMPLETED|Overall Study||0
214158|NCT00786643|524426|P1|NOT COMPLETED|Overall Study||0
214159|NCT00786643|524425|P2|COMPLETED|Overall Study||28
214160|NCT00786643|524426|P1|COMPLETED|Overall Study||20
214161|NCT00786643|524425|P2|STARTED|Overall Study||28
214162|NCT00786643|524426|P1|STARTED|Overall Study||20
214163|NCT00786682|524436|P1|NOT COMPLETED|Overall Study||0
214164|NCT00786682|524436|P1|COMPLETED|Overall Study||11
214165|NCT00786682|524436|P1|STARTED|Overall Study||11
214166|NCT00786799|524444|P2|NOT COMPLETED|Overall Study||1
214167|NCT00786799|524445|P1|NOT COMPLETED|Overall Study||1
214168|NCT00786799|524444|P2|COMPLETED|Overall Study||12
214169|NCT00786799|524445|P1|COMPLETED|Overall Study||13
214170|NCT00786799|524444|P2|STARTED|Overall Study||13
214171|NCT00786799|524445|P1|STARTED|Overall Study||14
214172|NCT00786838|524456|P1|NOT COMPLETED|Overall Study||49
214173|NCT00786838|524456|P1|COMPLETED|Overall Study||26
214174|NCT00786838|524456|P1|STARTED|Overall Study||75
214175|NCT00786864|524483|P2|NOT COMPLETED|Overall Study||1
214176|NCT00786864|524484|P1|NOT COMPLETED|Overall Study||1
214177|NCT00786864|524483|P2|COMPLETED|Overall Study|1 child lost to study immediately post-intervention as she left the school|32
214178|NCT00786864|524484|P1|COMPLETED|Overall Study|1 child excluded at the 3 month follow-up, as he sustained a serious back injury|38
214179|NCT00786864|524483|P2|STARTED|Overall Study||33
214180|NCT00786864|524484|P1|STARTED|Overall Study||39
214181|NCT00786916|524499|P3|NOT COMPLETED|Overall Study||0
214182|NCT00786916|524500|P2|NOT COMPLETED|Overall Study||0
214183|NCT00786916|524501|P1|NOT COMPLETED|Overall Study||0
214184|NCT00786916|524499|P3|COMPLETED|Overall Study||34
214185|NCT00786916|524500|P2|COMPLETED|Overall Study||36
214186|NCT00786916|524501|P1|COMPLETED|Overall Study||39
214187|NCT00786916|524499|P3|STARTED|Overall Study||34
214188|NCT00786916|524500|P2|STARTED|Overall Study||36
214189|NCT00786916|524501|P1|STARTED|Overall Study||39
214190|NCT00786994|524513|P4|NOT COMPLETED|Overall Study||6
214191|NCT00786994|524514|P3|NOT COMPLETED|Overall Study||2
214192|NCT00786994|524515|P2|NOT COMPLETED|Overall Study||15
214193|NCT00786994|524516|P1|NOT COMPLETED|Overall Study||10
214194|NCT00786994|524513|P4|COMPLETED|Overall Study||22
214195|NCT00786994|524514|P3|COMPLETED|Overall Study||24
214196|NCT00786994|524515|P2|COMPLETED|Overall Study||39
214197|NCT00786994|524516|P1|COMPLETED|Overall Study||47
214198|NCT00786994|524513|P4|ITT|Overall Study||28
214199|NCT00786994|524514|P3|ITT|Overall Study||25
214200|NCT00786994|524515|P2|ITT|Overall Study||51
214201|NCT00786994|524516|P1|ITT|Overall Study||53
214202|NCT00786994|524513|P4|STARTED|Overall Study||28
214203|NCT00786994|524514|P3|STARTED|Overall Study||26
214204|NCT00786994|524515|P2|STARTED|Overall Study||54
214205|NCT00786994|524516|P1|STARTED|Overall Study||57
214206|NCT00787020|524527|P2|NOT COMPLETED|Overall Study||0
214207|NCT00787020|524528|P1|NOT COMPLETED|Overall Study||0
214208|NCT00787020|524527|P2|COMPLETED|Overall Study||13
214209|NCT00787020|524528|P1|COMPLETED|Overall Study||24
214210|NCT00787020|524527|P2|STARTED|Overall Study||13
214211|NCT00787020|524528|P1|STARTED|Overall Study||24
214212|NCT00787124|524540|P2|NOT COMPLETED|Overall Study||0
214213|NCT00787124|524541|P1|NOT COMPLETED|Overall Study||0
214214|NCT00787124|524540|P2|COMPLETED|Overall Study||4
214215|NCT00787124|524541|P1|COMPLETED|Overall Study||4
214216|NCT00787124|524540|P2|STARTED|Overall Study||4
214217|NCT00787124|524541|P1|STARTED|Overall Study||4
214218|NCT00787137|524552|P3|NOT COMPLETED|Overall Study||1
214219|NCT00787137|524553|P2|NOT COMPLETED|Overall Study||0
214220|NCT00787137|524554|P1|NOT COMPLETED|Overall Study||0
214221|NCT00787137|524552|P3|COMPLETED|Overall Study||4
214222|NCT00787137|524553|P2|COMPLETED|Overall Study||6
214223|NCT00787137|524554|P1|COMPLETED|Overall Study||6
214224|NCT00787137|524552|P3|STARTED|Overall Study||5
214225|NCT00787137|524553|P2|STARTED|Overall Study||6
214226|NCT00787137|524554|P1|STARTED|Overall Study||6
214227|NCT00787150|524577|P3|NOT COMPLETED|Overall Study||5
214228|NCT00787150|524578|P2|NOT COMPLETED|Overall Study||7
214229|NCT00787150|524579|P1|NOT COMPLETED|Overall Study||9
214230|NCT00787150|524577|P3|COMPLETED|Overall Study||66
214231|NCT00787150|524578|P2|COMPLETED|Overall Study||65
214232|NCT00787150|524579|P1|COMPLETED|Overall Study||66
214233|NCT00787150|524577|P3|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|71
214234|NCT00787150|524578|P2|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|72
214329|NCT00787800|524923|P1|NOT COMPLETED|Overall Study||3
214235|NCT00787150|524579|P1|STARTED|Overall Study|Of 222 participants enrolled 4 discontinued before dosing, made a total of 218 participants started.|75
214236|NCT00787189|524623|P2|NOT COMPLETED|Overall Study||2
214237|NCT00787189|524624|P1|NOT COMPLETED|Overall Study||2
214238|NCT00787189|524623|P2|COMPLETED|Overall Study|To study end point.|30
214239|NCT00787189|524624|P1|COMPLETED|Overall Study|To study end point.|30
214240|NCT00787189|524623|P2|STARTED|Overall Study||32
214241|NCT00787189|524624|P1|STARTED|Overall Study||32
214242|NCT00787202|524635|P5|NOT COMPLETED|Overall Study||4
214243|NCT00787202|524636|P4|NOT COMPLETED|Overall Study||2
214244|NCT00787202|524637|P3|NOT COMPLETED|Overall Study||7
214245|NCT00787202|524638|P2|NOT COMPLETED|Overall Study||11
214246|NCT00787202|524639|P1|NOT COMPLETED|Overall Study||14
214247|NCT00787202|524635|P5|COMPLETED|Overall Study||45
214248|NCT00787202|524636|P4|COMPLETED|Overall Study||31
214249|NCT00787202|524637|P3|COMPLETED|Overall Study||26
214250|NCT00787202|524638|P2|COMPLETED|Overall Study||20
214251|NCT00787202|524639|P1|COMPLETED|Overall Study||35
214252|NCT00787202|524635|P5|Treated|Overall Study||49
214253|NCT00787202|524636|P4|Treated|Overall Study||33
214254|NCT00787202|524637|P3|Treated|Overall Study||33
214255|NCT00787202|524638|P2|Treated|Overall Study||31
214256|NCT00787202|524639|P1|Treated|Overall Study||48
214257|NCT00787202|524635|P5|STARTED|Overall Study||49
214258|NCT00787202|524636|P4|STARTED|Overall Study||33
214259|NCT00787202|524637|P3|STARTED|Overall Study||33
214260|NCT00787202|524638|P2|STARTED|Overall Study||31
214261|NCT00787202|524639|P1|STARTED|Overall Study||49
214262|NCT00787241|524693|P3|NOT COMPLETED|Overall Study||0
214263|NCT00787241|524694|P2|NOT COMPLETED|Overall Study||0
214264|NCT00787241|524695|P1|NOT COMPLETED|Overall Study||0
214265|NCT00787241|524693|P3|COMPLETED|Overall Study||41
214266|NCT00787241|524694|P2|COMPLETED|Overall Study||143
214267|NCT00787241|524695|P1|COMPLETED|Overall Study||261
214268|NCT00787241|524693|P3|STARTED|Overall Study||41
214269|NCT00787241|524694|P2|STARTED|Overall Study||143
214270|NCT00787241|524695|P1|STARTED|Overall Study||261
214271|NCT00787254|524711|P2|NOT COMPLETED|Overall Study||82
214272|NCT00787254|524712|P1|NOT COMPLETED|Overall Study||76
214273|NCT00787254|524711|P2|COMPLETED|Overall Study||99
214274|NCT00787254|524712|P1|COMPLETED|Overall Study||109
214275|NCT00787254|524711|P2|STARTED|Overall Study||181
214276|NCT00787254|524712|P1|STARTED|Overall Study||185
214277|NCT00787267|524812|P1|NOT COMPLETED|Overall Study||12
214278|NCT00787267|524812|P1|COMPLETED|Overall Study|Received at least one dose of study drug|25
214279|NCT00787267|524812|P1|STARTED|Overall Study|Signed a consent form|37
214280|NCT00787319|524820|P1|NOT COMPLETED|Overall Study||63
214281|NCT00787319|524820|P1|COMPLETED|Overall Study||45
214282|NCT00787319|524820|P1|STARTED|Overall Study||108
214283|NCT00787332|524834|P2|NOT COMPLETED|Overall Study||0
214284|NCT00787332|524835|P1|NOT COMPLETED|Overall Study||0
214285|NCT00787332|524834|P2|COMPLETED|Overall Study||8
214286|NCT00787332|524835|P1|COMPLETED|Overall Study||8
214287|NCT00787332|524834|P2|STARTED|Overall Study||8
214288|NCT00787332|524835|P1|STARTED|Overall Study||8
214289|NCT00787527|524841|P1|NOT COMPLETED|Overall Study||3
214290|NCT00787527|524841|P1|COMPLETED|Overall Study||11
214291|NCT00787527|524841|P1|STARTED|Overall Study||14
214292|NCT00787566|524852|P3|NOT COMPLETED|Overall Study||0
214293|NCT00787566|524853|P2|NOT COMPLETED|Overall Study||1
214294|NCT00787566|524854|P1|NOT COMPLETED|Overall Study||0
214295|NCT00787566|524852|P3|COMPLETED|Overall Study||22
214296|NCT00787566|524853|P2|COMPLETED|Overall Study|1 patient withdrew from the study due to an AE related to chemotherapy agent administration.|24
214297|NCT00787566|524854|P1|COMPLETED|Overall Study||21
214298|NCT00787566|524852|P3|STARTED|Overall Study||22
214299|NCT00787566|524853|P2|STARTED|Overall Study||25
214300|NCT00787566|524854|P1|STARTED|Overall Study||21
214301|NCT00787605|524864|P2|NOT COMPLETED|Overall Study||56
214302|NCT00787605|524865|P1|NOT COMPLETED|Overall Study||46
214303|NCT00787605|524864|P2|COMPLETED|Overall Study||376
214304|NCT00787605|524865|P1|COMPLETED|Overall Study||382
214305|NCT00787605|524864|P2|STARTED|Overall Study||432
214306|NCT00787605|524865|P1|STARTED|Overall Study||428
214307|NCT00787618|524884|P3|NOT COMPLETED|Overall Study||0
214308|NCT00787618|524885|P2|NOT COMPLETED|Overall Study||0
214309|NCT00787618|524886|P1|NOT COMPLETED|Overall Study||0
214310|NCT00787618|524884|P3|COMPLETED|Overall Study||3
214311|NCT00787618|524885|P2|COMPLETED|Overall Study||0
214312|NCT00787618|524886|P1|COMPLETED|Overall Study||3
214313|NCT00787618|524884|P3|STARTED|Overall Study||3
214314|NCT00787618|524885|P2|STARTED|Overall Study||0
214315|NCT00787618|524886|P1|STARTED|Overall Study||3
214316|NCT00787644|524896|P2|NOT COMPLETED|Overall Study||2
214317|NCT00787644|524897|P1|NOT COMPLETED|Overall Study||2
214318|NCT00787644|524896|P2|COMPLETED|Overall Study||9
214319|NCT00787644|524897|P1|COMPLETED|Overall Study||10
214320|NCT00787644|524896|P2|STARTED|Overall Study||11
214321|NCT00787644|524897|P1|STARTED|Overall Study||12
214322|NCT00787761|524903|P1|NOT COMPLETED|Overall Study||0
214323|NCT00787761|524903|P1|COMPLETED|Overall Study||24
214324|NCT00787761|524903|P1|STARTED|Overall Study||24
214325|NCT00787787|524914|P1|NOT COMPLETED|Overall Study||7
214326|NCT00787787|524914|P1|COMPLETED|Overall Study||0
214327|NCT00787787|524914|P1|STARTED|Overall Study||7
214328|NCT00787800|524922|P2|NOT COMPLETED|Overall Study||7
214330|NCT00787800|524922|P2|COMPLETED|Overall Study||43
214331|NCT00787800|524923|P1|COMPLETED|Overall Study||47
214332|NCT00787800|524922|P2|STARTED|Overall Study||50
214333|NCT00787800|524923|P1|STARTED|Overall Study||50
214334|NCT00787891|524941|P2|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
214335|NCT00787891|524942|P1|NOT COMPLETED|Maintenance Double-blind Phase (Part 2)||7
214336|NCT00787891|524941|P2|COMPLETED|Maintenance Double-blind Phase (Part 2)||24
214337|NCT00787891|524942|P1|COMPLETED|Maintenance Double-blind Phase (Part 2)||26
214338|NCT00787891|524941|P2|STARTED|Maintenance Double-blind Phase (Part 2)||31
214339|NCT00787891|524942|P1|STARTED|Maintenance Double-blind Phase (Part 2)||33
214340|NCT00787891|524941|P2|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||9
214341|NCT00787891|524942|P1|NOT COMPLETED|Short-term Double-blind Phase (Part 1)||10
214342|NCT00787891|524941|P2|COMPLETED|Short-term Double-blind Phase (Part 1)||53
214343|NCT00787891|524942|P1|COMPLETED|Short-term Double-blind Phase (Part 1)||55
214344|NCT00787891|524941|P2|STARTED|Short-term Double-blind Phase (Part 1)||62
214345|NCT00787891|524942|P1|STARTED|Short-term Double-blind Phase (Part 1)||65
214346|NCT00787904|524962|P2|NOT COMPLETED|Overall Study||0
214347|NCT00787904|524963|P1|NOT COMPLETED|Overall Study||0
214348|NCT00787904|524962|P2|COMPLETED|Overall Study||13
214349|NCT00787904|524963|P1|COMPLETED|Overall Study||6
214350|NCT00787904|524962|P2|STARTED|Overall Study||13
214351|NCT00787904|524963|P1|STARTED|Overall Study||6
214352|NCT00787917|524973|P2|NOT COMPLETED|Open Label||0
214353|NCT00787917|524974|P1|NOT COMPLETED|Open Label||4
214354|NCT00787917|524973|P2|COMPLETED|Open Label||0
214355|NCT00787917|524974|P1|COMPLETED|Open Label||3
214356|NCT00787917|524973|P2|STARTED|Open Label|"Placebo was not an arm in open label treatment."|0
214357|NCT00787917|524974|P1|STARTED|Open Label||7
214358|NCT00787917|524973|P2|NOT COMPLETED|Blinded Treatment||2
214359|NCT00787917|524974|P1|NOT COMPLETED|Blinded Treatment||5
214360|NCT00787917|524973|P2|COMPLETED|Blinded Treatment||3
214361|NCT00787917|524974|P1|COMPLETED|Blinded Treatment||4
214362|NCT00787917|524973|P2|STARTED|Blinded Treatment||5
214363|NCT00787917|524974|P1|STARTED|Blinded Treatment||9
214364|NCT00787930|524991|P1|NOT COMPLETED|Continuation Treatment -- up to 12 Month||3
214365|NCT00787930|524991|P1|COMPLETED|Continuation Treatment -- up to 12 Month||16
214366|NCT00787930|524991|P1|STARTED|Continuation Treatment -- up to 12 Month||19
214367|NCT00787930|524991|P1|NOT COMPLETED|Acute Treatment -- 3 Weeks||0
214368|NCT00787930|524991|P1|COMPLETED|Acute Treatment -- 3 Weeks||19
214369|NCT00787930|524991|P1|STARTED|Acute Treatment -- 3 Weeks||19
214370|NCT00787943|525004|P1|NOT COMPLETED|Overall Study||0
214371|NCT00787943|525004|P1|COMPLETED|Overall Study||10
214372|NCT00787943|525004|P1|STARTED|Overall Study||10
214373|NCT00788008|525014|P2|NOT COMPLETED|Overall Study||0
214374|NCT00788008|525015|P1|NOT COMPLETED|Overall Study||0
214375|NCT00788008|525014|P2|COMPLETED|Overall Study||101
214376|NCT00788008|525015|P1|COMPLETED|Overall Study||98
214377|NCT00788008|525014|P2|STARTED|Overall Study||101
214378|NCT00788008|525015|P1|STARTED|Overall Study||98
214379|NCT00788073|525023|P2|NOT COMPLETED|Placebo Then STX209||1
214380|NCT00788073|525024|P1|NOT COMPLETED|Placebo Then STX209||2
214381|NCT00788073|525023|P2|COMPLETED|Placebo Then STX209||29
214382|NCT00788073|525024|P1|COMPLETED|Placebo Then STX209||27
214383|NCT00788073|525023|P2|STARTED|Placebo Then STX209||30
214384|NCT00788073|525024|P1|STARTED|Placebo Then STX209||29
214385|NCT00788073|525023|P2|NOT COMPLETED|STX209 Then Placebo||3
214386|NCT00788073|525024|P1|NOT COMPLETED|STX209 Then Placebo||1
214387|NCT00788073|525023|P2|COMPLETED|STX209 Then Placebo||30
214388|NCT00788073|525024|P1|COMPLETED|STX209 Then Placebo||29
214389|NCT00788073|525023|P2|STARTED|STX209 Then Placebo||33
214390|NCT00788073|525024|P1|STARTED|STX209 Then Placebo||30
214391|NCT00788255|525032|P1|NOT COMPLETED|Overall Study||0
214392|NCT00788255|525032|P1|COMPLETED|Overall Study||25
214393|NCT00788255|525032|P1|Oxytocin: 0 μU/mL|Overall Study||25
214394|NCT00788255|525032|P1|Oxytocin Infusion 3: 32.9μU/mL|Overall Study||25
214395|NCT00788255|525032|P1|Oxytocin Infusion 2: 30.1μU/mL|Overall Study||25
214396|NCT00788255|525032|P1|Oxytocin Infusion 1: 22.5 μU/mL|Overall Study||25
214397|NCT00788255|525032|P1|STARTED|Overall Study||25
214398|NCT00788372|525045|P1|NOT COMPLETED|Period 2 (Week 4 to Week 52)||32
214399|NCT00788372|525045|P1|COMPLETED|Period 2 (Week 4 to Week 52)||79
214400|NCT00788372|525045|P1|STARTED|Period 2 (Week 4 to Week 52)||111
214401|NCT00788372|525045|P1|NOT COMPLETED|Period 1 (up to 4 Weeks)||31
214402|NCT00788372|525045|P1|COMPLETED|Period 1 (up to 4 Weeks)||111
214403|NCT00788372|525045|P1|STARTED|Period 1 (up to 4 Weeks)||142
214404|NCT00788593|525059|P3|NOT COMPLETED|Second Intervention Period||1
214405|NCT00788593|525060|P2|NOT COMPLETED|Second Intervention Period||1
214406|NCT00788593|525061|P1|NOT COMPLETED|Second Intervention Period||0
214407|NCT00788593|525059|P3|COMPLETED|Second Intervention Period||36
214408|NCT00788593|525060|P2|COMPLETED|Second Intervention Period||37
214409|NCT00788593|525061|P1|COMPLETED|Second Intervention Period||0
214410|NCT00788593|525059|P3|STARTED|Second Intervention Period||37
214411|NCT00788593|525060|P2|STARTED|Second Intervention Period||38
214412|NCT00788593|525061|P1|STARTED|Second Intervention Period||0
214413|NCT00788593|525059|P3|NOT COMPLETED|First Intervention Period||0
214414|NCT00788593|525060|P2|NOT COMPLETED|First Intervention Period||1
214415|NCT00788593|525061|P1|NOT COMPLETED|First Intervention Period||0
214416|NCT00788593|525059|P3|COMPLETED|First Intervention Period||37
214417|NCT00788593|525060|P2|COMPLETED|First Intervention Period||38
214418|NCT00788593|525061|P1|COMPLETED|First Intervention Period||0
214419|NCT00788593|525059|P3|STARTED|First Intervention Period||37
214420|NCT00788593|525060|P2|STARTED|First Intervention Period||39
214421|NCT00788593|525061|P1|STARTED|First Intervention Period||0
214422|NCT00788593|525059|P3|NOT COMPLETED|Placebo Run-in Phase||0
214423|NCT00788593|525060|P2|NOT COMPLETED|Placebo Run-in Phase||0
214424|NCT00788593|525061|P1|NOT COMPLETED|Placebo Run-in Phase||6
214425|NCT00788593|525059|P3|COMPLETED|Placebo Run-in Phase||0
214426|NCT00788593|525060|P2|COMPLETED|Placebo Run-in Phase||0
214427|NCT00788593|525061|P1|COMPLETED|Placebo Run-in Phase||76
214428|NCT00788593|525059|P3|STARTED|Placebo Run-in Phase||0
214429|NCT00788593|525060|P2|STARTED|Placebo Run-in Phase||0
214430|NCT00788593|525061|P1|STARTED|Placebo Run-in Phase||82
214431|NCT00788697|525078|P1|NOT COMPLETED|Overall Study||109
214432|NCT00788697|525078|P1|COMPLETED|Overall Study||240
214433|NCT00788697|525078|P1|STARTED|Overall Study||349
214434|NCT00788710|525128|P3|NOT COMPLETED|Overall Study||6
214435|NCT00788710|525129|P2|NOT COMPLETED|Overall Study||8
214436|NCT00788710|525130|P1|NOT COMPLETED|Overall Study||5
214437|NCT00788710|525128|P3|COMPLETED|Overall Study||138
214438|NCT00788710|525129|P2|COMPLETED|Overall Study||134
214439|NCT00788710|525130|P1|COMPLETED|Overall Study||139
214440|NCT00788710|525128|P3|STARTED|Overall Study||144
214441|NCT00788710|525129|P2|STARTED|Overall Study||142
214442|NCT00788710|525130|P1|STARTED|Overall Study||144
214443|NCT00788775|525146|P2|NOT COMPLETED|Overall Study||8
214444|NCT00788775|525147|P1|NOT COMPLETED|Overall Study||10
214445|NCT00788775|525146|P2|COMPLETED|Overall Study||1
214446|NCT00788775|525147|P1|COMPLETED|Overall Study||1
214447|NCT00788775|525146|P2|Treated|Overall Study||8
214448|NCT00788775|525147|P1|Treated|Overall Study||11
214449|NCT00788775|525146|P2|STARTED|Overall Study||9
214450|NCT00788775|525147|P1|STARTED|Overall Study||11
214451|NCT00788957|525163|P6|NOT COMPLETED|Part 3||11
214452|NCT00788957|525164|P5|NOT COMPLETED|Part 3||9
214453|NCT00788957|525165|P4|NOT COMPLETED|Part 3||0
214454|NCT00788957|525166|P3|NOT COMPLETED|Part 3||0
214455|NCT00788957|525167|P2|NOT COMPLETED|Part 3||0
214456|NCT00788957|525168|P1|NOT COMPLETED|Part 3||0
214457|NCT00788957|525163|P6|COMPLETED|Part 3|Completed the safety follow-up visit|1
214458|NCT00788957|525164|P5|COMPLETED|Part 3|Completed the safety follow-up visit|4
214459|NCT00788957|525165|P4|COMPLETED|Part 3||0
214460|NCT00788957|525166|P3|COMPLETED|Part 3||0
214461|NCT00788957|525167|P2|COMPLETED|Part 3||0
214462|NCT00788957|525168|P1|COMPLETED|Part 3||0
214463|NCT00788957|525163|P6|STARTED|Part 3||12
214464|NCT00788957|525164|P5|STARTED|Part 3||13
214465|NCT00788957|525165|P4|STARTED|Part 3||0
214466|NCT00788957|525166|P3|STARTED|Part 3||0
214467|NCT00788957|525167|P2|STARTED|Part 3||0
214468|NCT00788957|525168|P1|STARTED|Part 3||0
214469|NCT00788957|525163|P6|NOT COMPLETED|Part 2||0
214470|NCT00788957|525164|P5|NOT COMPLETED|Part 2||0
214471|NCT00788957|525165|P4|NOT COMPLETED|Part 2||41
214472|NCT00788957|525166|P3|NOT COMPLETED|Part 2||44
214473|NCT00788957|525167|P2|NOT COMPLETED|Part 2||42
214474|NCT00788957|525168|P1|NOT COMPLETED|Part 2||0
214475|NCT00788957|525163|P6|COMPLETED|Part 2||0
214476|NCT00788957|525164|P5|COMPLETED|Part 2||0
214477|NCT00788957|525165|P4|COMPLETED|Part 2|Completed the safety follow-up visit|5
214478|NCT00788957|525166|P3|COMPLETED|Part 2|Completed the safety follow-up visit|4
214479|NCT00788957|525167|P2|COMPLETED|Part 2|Completed the safety follow-up visit at the end of the study|6
214480|NCT00788957|525168|P1|COMPLETED|Part 2||0
214481|NCT00788957|525163|P6|STARTED|Part 2||0
214482|NCT00788957|525164|P5|STARTED|Part 2||0
214483|NCT00788957|525165|P4|STARTED|Part 2||46
214484|NCT00788957|525166|P3|STARTED|Part 2||48
214485|NCT00788957|525167|P2|STARTED|Part 2||48
214486|NCT00788957|525168|P1|STARTED|Part 2||0
214487|NCT00788957|525163|P6|NOT COMPLETED|Part 1||0
214488|NCT00788957|525164|P5|NOT COMPLETED|Part 1||0
214489|NCT00788957|525165|P4|NOT COMPLETED|Part 1||0
214490|NCT00788957|525166|P3|NOT COMPLETED|Part 1||0
214491|NCT00788957|525167|P2|NOT COMPLETED|Part 1||0
214492|NCT00788957|525168|P1|NOT COMPLETED|Part 1||9
214493|NCT00788957|525163|P6|COMPLETED|Part 1||0
214494|NCT00788957|525164|P5|COMPLETED|Part 1||0
214495|NCT00788957|525165|P4|COMPLETED|Part 1||0
214496|NCT00788957|525166|P3|COMPLETED|Part 1||0
214497|NCT00788957|525167|P2|COMPLETED|Part 1||0
214498|NCT00788957|525168|P1|COMPLETED|Part 1|Completed the safety follow-up visit|2
214499|NCT00788957|525163|P6|STARTED|Part 1||0
214500|NCT00788957|525164|P5|STARTED|Part 1||0
214501|NCT00788957|525165|P4|STARTED|Part 1||0
214502|NCT00788957|525166|P3|STARTED|Part 1||0
214503|NCT00788957|525167|P2|STARTED|Part 1||0
214504|NCT00788957|525168|P1|STARTED|Part 1||11
214505|NCT00789035|525227|P5|NOT COMPLETED|Overall Study||6
214506|NCT00789035|525228|P4|NOT COMPLETED|Overall Study||1
214507|NCT00789035|525229|P3|NOT COMPLETED|Overall Study||1
214508|NCT00789035|525230|P2|NOT COMPLETED|Overall Study||7
214509|NCT00789035|525231|P1|NOT COMPLETED|Overall Study||6
214510|NCT00789035|525227|P5|COMPLETED|Overall Study||74
214511|NCT00789035|525228|P4|COMPLETED|Overall Study||81
214512|NCT00789035|525229|P3|COMPLETED|Overall Study||80
214513|NCT00789035|525230|P2|COMPLETED|Overall Study||74
214514|NCT00789035|525231|P1|COMPLETED|Overall Study||76
214515|NCT00789035|525227|P5|STARTED|Overall Study||80
214516|NCT00789035|525228|P4|STARTED|Overall Study||82
214517|NCT00789035|525229|P3|STARTED|Overall Study||81
214518|NCT00789035|525230|P2|STARTED|Overall Study||81
214519|NCT00789035|525231|P1|STARTED|Overall Study||82
214520|NCT00789074|525288|P2|NOT COMPLETED|Overall Study||13
214521|NCT00789074|525289|P1|NOT COMPLETED|Overall Study||11
214522|NCT00789074|525288|P2|COMPLETED|Overall Study||35
214523|NCT00789074|525289|P1|COMPLETED|Overall Study||42
214524|NCT00789074|525288|P2|STARTED|Overall Study||48
214525|NCT00789074|525289|P1|STARTED|Overall Study||53
214526|NCT00789113|525305|P1|NOT COMPLETED|Overall Study||0
214527|NCT00789113|525305|P1|COMPLETED|Overall Study||12
214528|NCT00789113|525305|P1|STARTED|Overall Study||12
214529|NCT00789191|525312|P2|NOT COMPLETED|Overall Study||19
214530|NCT00789191|525313|P1|NOT COMPLETED|Overall Study||14
214531|NCT00789191|525312|P2|COMPLETED|Overall Study||92
214532|NCT00789191|525313|P1|COMPLETED|Overall Study||97
214533|NCT00789191|525312|P2|Exposed|Overall Study|1 non-compliance|110
214534|NCT00789191|525313|P1|Exposed|Overall Study|2 withdrew informed consent. 1 randomised by mistake. 1 non-compliance|107
214535|NCT00789191|525312|P2|STARTED|Overall Study||111
214536|NCT00789191|525313|P1|STARTED|Overall Study||111
214537|NCT00789256|525343|P2|NOT COMPLETED|Overall Study||0
214538|NCT00789256|525344|P1|NOT COMPLETED|Overall Study||0
214539|NCT00789256|525343|P2|COMPLETED|Overall Study||12
214540|NCT00789256|525344|P1|COMPLETED|Overall Study|Strata 1 had 5 responders and continued accrual, but the study was closed due to low accrual.|14
214541|NCT00789256|525343|P2|STARTED|Overall Study||12
214542|NCT00789256|525344|P1|STARTED|Overall Study||14
214543|NCT00789321|525352|P2|NOT COMPLETED|Overall Study||1
214544|NCT00789321|525353|P1|NOT COMPLETED|Overall Study||0
214545|NCT00789321|525352|P2|COMPLETED|Overall Study||22
214546|NCT00789321|525353|P1|COMPLETED|Overall Study||24
214547|NCT00789321|525352|P2|STARTED|Overall Study||23
214548|NCT00789321|525353|P1|STARTED|Overall Study||24
214549|NCT00789373|525361|P3|NOT COMPLETED|Maintenance||180
214550|NCT00789373|525362|P2|NOT COMPLETED|Maintenance||359
214551|NCT00789373|525363|P1|NOT COMPLETED|Maintenance||0
214552|NCT00789373|525361|P3|COMPLETED|Maintenance||0
214553|NCT00789373|525362|P2|COMPLETED|Maintenance||0
214554|NCT00789373|525363|P1|COMPLETED|Maintenance||0
214555|NCT00789373|525361|P3|STARTED|Maintenance||180
214556|NCT00789373|525362|P2|STARTED|Maintenance||359
214557|NCT00789373|525363|P1|STARTED|Maintenance||0
214558|NCT00789373|525361|P3|NOT COMPLETED|Induction||0
214559|NCT00789373|525362|P2|NOT COMPLETED|Induction||0
214560|NCT00789373|525363|P1|NOT COMPLETED|Induction||399
214561|NCT00789373|525361|P3|COMPLETED|Induction||0
214562|NCT00789373|525362|P2|COMPLETED|Induction||0
214563|NCT00789373|525363|P1|COMPLETED|Induction|1 patient received maintenance therapy post-induction but was never randomized.|540
214564|NCT00789373|525361|P3|STARTED|Induction||0
214565|NCT00789373|525362|P2|STARTED|Induction||0
214566|NCT00789373|525363|P1|STARTED|Induction||939
214567|NCT00789438|525391|P3|NOT COMPLETED|Overall Study||0
214568|NCT00789438|525392|P2|NOT COMPLETED|Overall Study||0
214569|NCT00789438|525393|P1|NOT COMPLETED|Overall Study||0
214570|NCT00789438|525391|P3|COMPLETED|Overall Study||28
214571|NCT00789438|525392|P2|COMPLETED|Overall Study||20
214572|NCT00789438|525393|P1|COMPLETED|Overall Study||21
214573|NCT00789438|525391|P3|STARTED|Overall Study||28
214574|NCT00789438|525392|P2|STARTED|Overall Study||20
214575|NCT00789438|525393|P1|STARTED|Overall Study||21
214576|NCT00789477|525406|P5|NOT COMPLETED|Overall Study||7
214577|NCT00789477|525407|P4|NOT COMPLETED|Overall Study||10
214578|NCT00789477|525408|P3|NOT COMPLETED|Overall Study||11
214579|NCT00789477|525409|P2|NOT COMPLETED|Overall Study||6
214580|NCT00789477|525410|P1|NOT COMPLETED|Overall Study||11
214581|NCT00789477|525406|P5|COMPLETED|Overall Study||38
214582|NCT00789477|525407|P4|COMPLETED|Overall Study||34
214583|NCT00789477|525408|P3|COMPLETED|Overall Study||33
214584|NCT00789477|525409|P2|COMPLETED|Overall Study||38
214585|NCT00789477|525410|P1|COMPLETED|Overall Study||33
214586|NCT00789477|525406|P5|Participants Received Treatment|Overall Study|SAF|45
214587|NCT00789477|525407|P4|Participants Received Treatment|Overall Study|SAF|42
214588|NCT00789477|525408|P3|Participants Received Treatment|Overall Study|SAF|44
214589|NCT00789477|525409|P2|Participants Received Treatment|Overall Study|SAF|44
214590|NCT00789477|525410|P1|Participants Received Treatment|Overall Study|safety analysis set (SAF)|44
214591|NCT00789477|525406|P5|STARTED|Overall Study|randomized|45
214592|NCT00789477|525407|P4|STARTED|Overall Study|randomized|44
214593|NCT00789477|525408|P3|STARTED|Overall Study|randomized|44
214594|NCT00789477|525409|P2|STARTED|Overall Study|randomized|44
214595|NCT00789477|525410|P1|STARTED|Overall Study|randomized|44
214596|NCT00789529|525444|P2|NOT COMPLETED|Overall Study||1
214597|NCT00789529|525445|P1|NOT COMPLETED|Overall Study||1
214598|NCT00789529|525444|P2|COMPLETED|Overall Study||15
214599|NCT00789529|525445|P1|COMPLETED|Overall Study||15
214600|NCT00789529|525444|P2|STARTED|Overall Study||16
214601|NCT00789529|525445|P1|STARTED|Overall Study||16
214602|NCT00789555|525456|P3|NOT COMPLETED|Overall Study||159
214603|NCT00789555|525457|P2|NOT COMPLETED|Overall Study||139
214604|NCT00789555|525458|P1|NOT COMPLETED|Overall Study||159
214605|NCT00789555|525456|P3|COMPLETED|Overall Study||263
214606|NCT00789555|525457|P2|COMPLETED|Overall Study||278
214607|NCT00789555|525458|P1|COMPLETED|Overall Study||262
214608|NCT00789555|525456|P3|STARTED|Overall Study||422
214609|NCT00789555|525457|P2|STARTED|Overall Study||417
214610|NCT00789555|525458|P1|STARTED|Overall Study||421
214611|NCT00789581|525483|P2|NOT COMPLETED|Adjuvant Therapy||57
214612|NCT00789581|525484|P1|NOT COMPLETED|Adjuvant Therapy||40
214613|NCT00789581|525483|P2|COMPLETED|Adjuvant Therapy||234
214614|NCT00789581|525484|P1|COMPLETED|Adjuvant Therapy||255
214615|NCT00789581|525483|P2|STARTED|Adjuvant Therapy||291
214616|NCT00789581|525484|P1|STARTED|Adjuvant Therapy||295
214617|NCT00789581|525483|P2|NOT COMPLETED|AC Therapy||17
214618|NCT00789581|525484|P1|NOT COMPLETED|AC Therapy||11
214619|NCT00789581|525483|P2|COMPLETED|AC Therapy||291
214620|NCT00789581|525484|P1|COMPLETED|AC Therapy||295
214621|NCT00789581|525483|P2|STARTED|AC Therapy||308
214622|NCT00789581|525484|P1|STARTED|AC Therapy||306
214623|NCT00789672|525494|P2|NOT COMPLETED|Overall Study||0
214624|NCT00789672|525495|P1|NOT COMPLETED|Overall Study||0
214625|NCT00789672|525494|P2|COMPLETED|Overall Study||17
214626|NCT00789672|525495|P1|COMPLETED|Overall Study||16
214627|NCT00789672|525494|P2|STARTED|Overall Study||17
214628|NCT00789672|525495|P1|STARTED|Overall Study||16
214629|NCT00789685|525525|P1|NOT COMPLETED|Overall Study||12
214630|NCT00789685|525525|P1|COMPLETED|Overall Study|Completed the study to Day 28|25
214631|NCT00789685|525525|P1|STARTED|Overall Study||37
214632|NCT00789698|525535|P4|NOT COMPLETED|Overall Study||52
214633|NCT00789698|525536|P3|NOT COMPLETED|Overall Study||27
214634|NCT00789698|525537|P2|NOT COMPLETED|Overall Study||33
214635|NCT00789698|525538|P1|NOT COMPLETED|Overall Study||40
214636|NCT00789698|525535|P4|COMPLETED|Overall Study||33
214637|NCT00789698|525536|P3|COMPLETED|Overall Study||29
214638|NCT00789698|525537|P2|COMPLETED|Overall Study||46
214639|NCT00789698|525538|P1|COMPLETED|Overall Study||32
214640|NCT00789698|525535|P4|STARTED|Overall Study||85
214641|NCT00789698|525536|P3|STARTED|Overall Study||56
214642|NCT00789698|525537|P2|STARTED|Overall Study||79
214643|NCT00789698|525538|P1|STARTED|Overall Study||72
214644|NCT00789724|525554|P2|NOT COMPLETED|Overall Study||0
214645|NCT00789724|525555|P1|NOT COMPLETED|Overall Study||0
214646|NCT00789724|525554|P2|COMPLETED|Overall Study||5
214647|NCT00789724|525555|P1|COMPLETED|Overall Study||5
214648|NCT00789724|525554|P2|STARTED|Overall Study||5
214649|NCT00789724|525555|P1|STARTED|Overall Study||5
214650|NCT00789737|525563|P2|NOT COMPLETED|Overall Study||55
214651|NCT00789737|525564|P1|NOT COMPLETED|Overall Study||48
214652|NCT00789737|525563|P2|COMPLETED|Overall Study||126
214653|NCT00789737|525564|P1|COMPLETED|Overall Study||128
214654|NCT00789737|525563|P2|STARTED|Overall Study||181
214655|NCT00789737|525564|P1|STARTED|Overall Study||176
214656|NCT00789750|525596|P2|NOT COMPLETED|Overall Study||60
214657|NCT00789750|525597|P1|NOT COMPLETED|Overall Study||59
214658|NCT00789750|525596|P2|COMPLETED|Overall Study||222
214659|NCT00789750|525597|P1|COMPLETED|Overall Study||221
214660|NCT00789750|525596|P2|Intent to Treat Set|Overall Study||276
214661|NCT00789750|525597|P1|Intent to Treat Set|Overall Study||271
214662|NCT00789750|525596|P2|Safety Set|Overall Study||277
214663|NCT00789750|525597|P1|Safety Set|Overall Study||274
214664|NCT00789750|525596|P2|Dropped During run-in Period|Overall Study||5
214665|NCT00789750|525597|P1|Dropped During run-in Period|Overall Study||6
214666|NCT00789750|525596|P2|STARTED|Overall Study||282
214667|NCT00789750|525597|P1|STARTED|Overall Study||280
214668|NCT00789802|525642|P3|NOT COMPLETED|Overall Study||6
214669|NCT00789802|525643|P2|NOT COMPLETED|Overall Study||7
214670|NCT00789802|525644|P1|NOT COMPLETED|Overall Study||10
214671|NCT00789802|525642|P3|COMPLETED|Overall Study||37
214672|NCT00789802|525643|P2|COMPLETED|Overall Study||35
214673|NCT00789802|525644|P1|COMPLETED|Overall Study||34
214674|NCT00789802|525642|P3|STARTED|Overall Study||43
214675|NCT00789802|525643|P2|STARTED|Overall Study||42
214676|NCT00789802|525644|P1|STARTED|Overall Study||44
214677|NCT00789815|525654|P2|NOT COMPLETED|Overall Study||1
214678|NCT00789815|525655|P1|NOT COMPLETED|Overall Study||7
214679|NCT00789815|525654|P2|COMPLETED|Overall Study||249
214680|NCT00789815|525655|P1|COMPLETED|Overall Study||243
214681|NCT00789815|525654|P2|STARTED|Overall Study||250
214682|NCT00789815|525655|P1|STARTED|Overall Study||250
214683|NCT00789828|525677|P2|NOT COMPLETED|Open-label Extension Period (4 Years)||0
214684|NCT00789828|525678|P1|NOT COMPLETED|Open-label Extension Period (4 Years)||29
214685|NCT00789828|525677|P2|COMPLETED|Open-label Extension Period (4 Years)||0
214686|NCT00789828|525678|P1|COMPLETED|Open-label Extension Period (4 Years)||82
214687|NCT00789828|525677|P2|STARTED|Open-label Extension Period (4 Years)|No participant received placebo.|0
214688|NCT00789828|525678|P1|STARTED|Open-label Extension Period (4 Years)|Of 117 participants only 111 completed the core period and continued in the extension period|111
214689|NCT00789828|525677|P2|NOT COMPLETED|Core Period (48 Weeks)||6
214690|NCT00789828|525678|P1|NOT COMPLETED|Core Period (48 Weeks)||0
214691|NCT00789828|525677|P2|COMPLETED|Core Period (48 Weeks)||33
214692|NCT00789828|525678|P1|COMPLETED|Core Period (48 Weeks)||78
214693|NCT00789828|525677|P2|STARTED|Core Period (48 Weeks)||39
214694|NCT00789828|525678|P1|STARTED|Core Period (48 Weeks)||78
214695|NCT00789854|525713|P3|NOT COMPLETED|Overall Study||47
214696|NCT00789854|525714|P2|NOT COMPLETED|Overall Study||35
214697|NCT00789854|525715|P1|NOT COMPLETED|Overall Study||49
214698|NCT00789854|525713|P3|COMPLETED|Overall Study||182
214699|NCT00789854|525714|P2|COMPLETED|Overall Study||196
214700|NCT00789854|525715|P1|COMPLETED|Overall Study||179
214701|NCT00789854|525713|P3|STARTED|Overall Study||229
214702|NCT00789854|525714|P2|STARTED|Overall Study||231
214703|NCT00789854|525715|P1|STARTED|Overall Study||228
214704|NCT00789880|525816|P6|NOT COMPLETED|Overall Study||0
214705|NCT00789880|525817|P5|NOT COMPLETED|Overall Study||3
214706|NCT00789880|525818|P4|NOT COMPLETED|Overall Study||1
214707|NCT00789880|525819|P3|NOT COMPLETED|Overall Study||0
214708|NCT00789880|525820|P2|NOT COMPLETED|Overall Study||1
214709|NCT00789880|525821|P1|NOT COMPLETED|Overall Study||1
214710|NCT00789880|525816|P6|COMPLETED|Overall Study||8
214711|NCT00789880|525817|P5|COMPLETED|Overall Study||15
214712|NCT00789880|525818|P4|COMPLETED|Overall Study||15
214713|NCT00789880|525819|P3|COMPLETED|Overall Study||8
214714|NCT00789880|525820|P2|COMPLETED|Overall Study||15
214715|NCT00789880|525821|P1|COMPLETED|Overall Study||15
214716|NCT00789880|525816|P6|STARTED|Overall Study||8
214717|NCT00789880|525817|P5|STARTED|Overall Study||18
214718|NCT00789880|525818|P4|STARTED|Overall Study||16
214719|NCT00789880|525819|P3|STARTED|Overall Study||8
214720|NCT00789880|525820|P2|STARTED|Overall Study||16
214721|NCT00789880|525821|P1|STARTED|Overall Study||16
214722|NCT00789958|525847|P1|NOT COMPLETED|Overall Study||37
214723|NCT00789958|525847|P1|COMPLETED|Overall Study||68
214724|NCT00789958|525847|P1|Eligible and Analyzable|Overall Study||79
214725|NCT00789958|525847|P1|STARTED|Overall Study||105
214726|NCT00789997|525862|P2|NOT COMPLETED|Overall Study||2
214727|NCT00789997|525863|P1|NOT COMPLETED|Overall Study||1
214728|NCT00789997|525862|P2|COMPLETED|Overall Study||38
214729|NCT00789997|525863|P1|COMPLETED|Overall Study||40
214730|NCT00789997|525862|P2|STARTED|Overall Study||40
214731|NCT00789997|525863|P1|STARTED|Overall Study||41
214732|NCT00790023|525874|P3|NOT COMPLETED|Overall Study||21
214733|NCT00790023|525875|P2|NOT COMPLETED|Overall Study||10
214734|NCT00790023|525876|P1|NOT COMPLETED|Overall Study||11
214735|NCT00790023|525874|P3|COMPLETED|Overall Study||214
214736|NCT00790023|525875|P2|COMPLETED|Overall Study||225
214737|NCT00790023|525876|P1|COMPLETED|Overall Study||226
214738|NCT00790023|525874|P3|STARTED|Overall Study||235
214739|NCT00790023|525875|P2|STARTED|Overall Study||235
214740|NCT00790023|525876|P1|STARTED|Overall Study||237
214741|NCT00790036|525966|P2|NOT COMPLETED|Overall Study||121
214742|NCT00790036|525967|P1|NOT COMPLETED|Overall Study||195
214743|NCT00790036|525966|P2|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|249
214744|NCT00790036|525967|P1|COMPLETED|Overall Study|completed = treatment duration completed as per protocol|177
214745|NCT00790036|525966|P2|Untreated Participants|Overall Study|not treated due to administrative problems and subject withdrawal of consent.|6
214746|NCT00790036|525967|P1|Untreated Participants|Overall Study|not treated due to administrative problems, protocol deviation, and subject withdrawal of consent.|4
214747|NCT00790036|525966|P2|STARTED|Overall Study||370
214748|NCT00790036|525967|P1|STARTED|Overall Study||372
214749|NCT00790062|525981|P3|NOT COMPLETED|Overall Study||0
214750|NCT00790062|525982|P2|NOT COMPLETED|Overall Study||0
214751|NCT00790062|525983|P1|NOT COMPLETED|Overall Study||0
214752|NCT00790062|525981|P3|COMPLETED|Overall Study||658
214753|NCT00790062|525982|P2|COMPLETED|Overall Study||481
214754|NCT00790062|525983|P1|COMPLETED|Overall Study||659
214755|NCT00790062|525981|P3|STARTED|Overall Study||658
214756|NCT00790062|525982|P2|STARTED|Overall Study||481
214757|NCT00790062|525983|P1|STARTED|Overall Study||659
214758|NCT00790192|526016|P4|NOT COMPLETED|Overall Study||48
214759|NCT00790192|526017|P3|NOT COMPLETED|Overall Study||23
214760|NCT00790192|526018|P2|NOT COMPLETED|Overall Study||28
214761|NCT00790192|526019|P1|NOT COMPLETED|Overall Study||36
214762|NCT00790192|526016|P4|COMPLETED|Overall Study||74
214763|NCT00790192|526017|P3|COMPLETED|Overall Study||97
214764|NCT00790192|526018|P2|COMPLETED|Overall Study||93
214765|NCT00790192|526019|P1|COMPLETED|Overall Study||89
214766|NCT00790192|526016|P4|STARTED|Overall Study||122
214767|NCT00790192|526017|P3|STARTED|Overall Study||120
214768|NCT00790192|526018|P2|STARTED|Overall Study||121
214769|NCT00790192|526019|P1|STARTED|Overall Study||125
214770|NCT00790205|526035|P2|NOT COMPLETED|Overall Study||434
214771|NCT00790205|526036|P1|NOT COMPLETED|Overall Study||360
214772|NCT00790205|526035|P2|COMPLETED|Overall Study||6905
214773|NCT00790205|526036|P1|COMPLETED|Overall Study||6972
214774|NCT00790205|526035|P2|Treated|Overall Study||7274
214775|NCT00790205|526036|P1|Treated|Overall Study||7266
214776|NCT00790205|526035|P2|STARTED|Overall Study||7339
214777|NCT00790205|526036|P1|STARTED|Overall Study||7332
214778|NCT00790218|526076|P3|NOT COMPLETED|Overall Study||0
214779|NCT00790218|526077|P2|NOT COMPLETED|Overall Study||0
214780|NCT00790218|526078|P1|NOT COMPLETED|Overall Study||1
214781|NCT00790218|526076|P3|COMPLETED|Overall Study||7
214782|NCT00790218|526077|P2|COMPLETED|Overall Study||6
214783|NCT00790218|526078|P1|COMPLETED|Overall Study||5
214784|NCT00790218|526076|P3|STARTED|Overall Study||7
214785|NCT00790218|526077|P2|STARTED|Overall Study||6
214786|NCT00790218|526078|P1|STARTED|Overall Study||6
214787|NCT00790270|526089|P3|NOT COMPLETED|Overall Study||0
214788|NCT00790270|526090|P2|NOT COMPLETED|Overall Study||0
214789|NCT00790270|526091|P1|NOT COMPLETED|Overall Study||0
214790|NCT00790270|526089|P3|COMPLETED|Overall Study||20
214791|NCT00790270|526090|P2|COMPLETED|Overall Study||20
214792|NCT00790270|526091|P1|COMPLETED|Overall Study||21
214793|NCT00790270|526089|P3|STARTED|Overall Study||20
214794|NCT00790270|526090|P2|STARTED|Overall Study||20
214795|NCT00790270|526091|P1|STARTED|Overall Study||21
214796|NCT00790296|526104|P2|NOT COMPLETED|Overall Study||2
214797|NCT00790296|526105|P1|NOT COMPLETED|Overall Study||1
214798|NCT00790296|526104|P2|COMPLETED|Overall Study||4
214799|NCT00790296|526105|P1|COMPLETED|Overall Study||4
214800|NCT00790296|526104|P2|STARTED|Overall Study||6
214801|NCT00790296|526105|P1|STARTED|Overall Study||5
214802|NCT00790400|526113|P2|NOT COMPLETED|Everolimus Period (Core or Extension)||0
214803|NCT00790400|526114|P1|NOT COMPLETED|Everolimus Period (Core or Extension)||29
214804|NCT00790400|526113|P2|COMPLETED|Everolimus Period (Core or Extension)||0
214805|NCT00790400|526114|P1|COMPLETED|Everolimus Period (Core or Extension)|Treatment duration completed as per protocol|83
214806|NCT00790400|526113|P2|STARTED|Everolimus Period (Core or Extension)|"Placebo randomized patients who switched to Everolimus are reported in Everolimus arm."|0
214807|NCT00790400|526114|P1|STARTED|Everolimus Period (Core or Extension)|112 pts had Everolimus during core and/or extension (6 from placebo did not switch to Eve. in ext.)|112
214808|NCT00790400|526113|P2|NOT COMPLETED|Double-blind Period (Core Phase)||13
214809|NCT00790400|526114|P1|NOT COMPLETED|Double-blind Period (Core Phase)||7
214810|NCT00790400|526113|P2|COMPLETED|Double-blind Period (Core Phase)|Completed = 1st received Placebo in the Core phase, switched to Everolimus in Extension phase|26
214811|NCT00790400|526114|P1|COMPLETED|Double-blind Period (Core Phase)|Completed = Completed the Core phase & moved to Extension phase|72
214812|NCT00790400|526113|P2|STARTED|Double-blind Period (Core Phase)||39
214813|NCT00790400|526114|P1|STARTED|Double-blind Period (Core Phase)||79
214814|NCT00790452|526143|P2|NOT COMPLETED|Overall Study||0
214815|NCT00790452|526144|P1|NOT COMPLETED|Overall Study||1
214816|NCT00790452|526143|P2|COMPLETED|Overall Study||0
214817|NCT00790452|526144|P1|COMPLETED|Overall Study||0
214818|NCT00790452|526143|P2|STARTED|Overall Study||0
214819|NCT00790452|526144|P1|STARTED|Overall Study||1
214820|NCT00790556|526150|P2|NOT COMPLETED|Treatment Period 2||0
214821|NCT00790556|526151|P1|NOT COMPLETED|Treatment Period 2||0
214822|NCT00790556|526150|P2|COMPLETED|Treatment Period 2||6
214823|NCT00790556|526151|P1|COMPLETED|Treatment Period 2||6
214824|NCT00790556|526150|P2|STARTED|Treatment Period 2||6
214825|NCT00790556|526151|P1|STARTED|Treatment Period 2||6
214826|NCT00790556|526150|P2|NOT COMPLETED|Washout After Period 1||0
214827|NCT00790556|526151|P1|NOT COMPLETED|Washout After Period 1||0
214828|NCT00790556|526150|P2|COMPLETED|Washout After Period 1||6
214829|NCT00790556|526151|P1|COMPLETED|Washout After Period 1||6
214830|NCT00790556|526150|P2|STARTED|Washout After Period 1||6
214831|NCT00790556|526151|P1|STARTED|Washout After Period 1||6
214832|NCT00790556|526150|P2|NOT COMPLETED|Treatment Period 1||0
214833|NCT00790556|526151|P1|NOT COMPLETED|Treatment Period 1||2
214834|NCT00790556|526150|P2|COMPLETED|Treatment Period 1||6
214835|NCT00790556|526151|P1|COMPLETED|Treatment Period 1||6
214836|NCT00790556|526150|P2|STARTED|Treatment Period 1||6
214837|NCT00790556|526151|P1|STARTED|Treatment Period 1||8
214838|NCT00790569|526164|P3|NOT COMPLETED|End of Study (12 Month Interview)||50
214839|NCT00790569|526165|P2|NOT COMPLETED|End of Study (12 Month Interview)||19
214840|NCT00790569|526166|P1|NOT COMPLETED|End of Study (12 Month Interview)||66
214841|NCT00790569|526164|P3|COMPLETED|End of Study (12 Month Interview)||83
214842|NCT00790569|526165|P2|COMPLETED|End of Study (12 Month Interview)||26
214843|NCT00790569|526166|P1|COMPLETED|End of Study (12 Month Interview)||71
214844|NCT00790569|526164|P3|STARTED|End of Study (12 Month Interview)||133
214845|NCT00790569|526165|P2|STARTED|End of Study (12 Month Interview)||45
214846|NCT00790569|526166|P1|STARTED|End of Study (12 Month Interview)||137
214847|NCT00790569|526164|P3|NOT COMPLETED|End of Treatment (6 Month Interview)||26
214848|NCT00790569|526165|P2|NOT COMPLETED|End of Treatment (6 Month Interview)||10
214849|NCT00790569|526166|P1|NOT COMPLETED|End of Treatment (6 Month Interview)||22
214850|NCT00790569|526164|P3|COMPLETED|End of Treatment (6 Month Interview)||107
214851|NCT00790569|526165|P2|COMPLETED|End of Treatment (6 Month Interview)||35
214852|NCT00790569|526166|P1|COMPLETED|End of Treatment (6 Month Interview)||115
214853|NCT00790569|526164|P3|STARTED|End of Treatment (6 Month Interview)||133
214854|NCT00790569|526165|P2|STARTED|End of Treatment (6 Month Interview)||45
214855|NCT00790569|526166|P1|STARTED|End of Treatment (6 Month Interview)||137
214856|NCT00790647|526189|P1|NOT COMPLETED|Overall Study||1
214857|NCT00790647|526189|P1|COMPLETED|Overall Study||9
214858|NCT00790647|526189|P1|STARTED|Overall Study||10
214859|NCT00790673|526200|P4|NOT COMPLETED|Overall Study||0
214860|NCT00790673|526201|P3|NOT COMPLETED|Overall Study||0
214861|NCT00790673|526202|P2|NOT COMPLETED|Overall Study||0
214862|NCT00790673|526203|P1|NOT COMPLETED|Overall Study||0
214863|NCT00790673|526200|P4|COMPLETED|Overall Study||8
214864|NCT00790673|526201|P3|COMPLETED|Overall Study||12
214865|NCT00790673|526202|P2|COMPLETED|Overall Study||6
214866|NCT00790673|526203|P1|COMPLETED|Overall Study||6
214867|NCT00790673|526200|P4|STARTED|Overall Study||8
214868|NCT00790673|526201|P3|STARTED|Overall Study||12
214869|NCT00790673|526202|P2|STARTED|Overall Study||6
214870|NCT00790673|526203|P1|STARTED|Overall Study||6
214871|NCT00791258|526213|P1|NOT COMPLETED|Overall Study||263
214872|NCT00791258|526213|P1|COMPLETED|Overall Study||736
214873|NCT00791258|526213|P1|STARTED|Overall Study||999
214874|NCT00791323|526277|P2|NOT COMPLETED|Overall Study||0
214875|NCT00791323|526278|P1|NOT COMPLETED|Overall Study||0
214876|NCT00791323|526277|P2|COMPLETED|Overall Study||3
214877|NCT00791323|526278|P1|COMPLETED|Overall Study||6
214878|NCT00791323|526277|P2|STARTED|Overall Study||3
214879|NCT00791323|526278|P1|STARTED|Overall Study||6
214880|NCT00791336|526284|P1|NOT COMPLETED|Overall Study||0
214881|NCT00791336|526284|P1|COMPLETED|Overall Study||1
214882|NCT00791336|526284|P1|STARTED|Overall Study||1
214883|NCT00791388|526295|P5|NOT COMPLETED|Period 4 - 400 mg Dose Group||4
214884|NCT00791388|526296|P4|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
214885|NCT00791388|526297|P3|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
214886|NCT00791388|526298|P2|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
214887|NCT00791388|526299|P1|NOT COMPLETED|Period 4 - 400 mg Dose Group||0
214888|NCT00791388|526295|P5|COMPLETED|Period 4 - 400 mg Dose Group||4
214889|NCT00791388|526296|P4|COMPLETED|Period 4 - 400 mg Dose Group||0
214890|NCT00791388|526297|P3|COMPLETED|Period 4 - 400 mg Dose Group||0
214891|NCT00791388|526298|P2|COMPLETED|Period 4 - 400 mg Dose Group||0
214892|NCT00791388|526299|P1|COMPLETED|Period 4 - 400 mg Dose Group||4
214893|NCT00791388|526295|P5|STARTED|Period 4 - 400 mg Dose Group||8
214894|NCT00791388|526296|P4|STARTED|Period 4 - 400 mg Dose Group||0
214895|NCT00791388|526297|P3|STARTED|Period 4 - 400 mg Dose Group||0
214896|NCT00791388|526298|P2|STARTED|Period 4 - 400 mg Dose Group||0
214897|NCT00791388|526299|P1|STARTED|Period 4 - 400 mg Dose Group||4
214898|NCT00791388|526295|P5|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
214899|NCT00791388|526296|P4|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
214900|NCT00791388|526297|P3|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
214901|NCT00791388|526298|P2|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
214902|NCT00791388|526299|P1|NOT COMPLETED|Period 3 - 200 mg Dose Group||0
214903|NCT00791388|526295|P5|COMPLETED|Period 3 - 200 mg Dose Group||0
214904|NCT00791388|526296|P4|COMPLETED|Period 3 - 200 mg Dose Group||8
214905|NCT00791388|526297|P3|COMPLETED|Period 3 - 200 mg Dose Group||0
214906|NCT00791388|526298|P2|COMPLETED|Period 3 - 200 mg Dose Group||0
214907|NCT00791388|526299|P1|COMPLETED|Period 3 - 200 mg Dose Group||3
214908|NCT00791388|526295|P5|STARTED|Period 3 - 200 mg Dose Group||0
214909|NCT00791388|526296|P4|STARTED|Period 3 - 200 mg Dose Group||8
214910|NCT00791388|526297|P3|STARTED|Period 3 - 200 mg Dose Group||0
214911|NCT00791388|526298|P2|STARTED|Period 3 - 200 mg Dose Group||0
214912|NCT00791388|526299|P1|STARTED|Period 3 - 200 mg Dose Group||3
214913|NCT00791388|526295|P5|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
214914|NCT00791388|526296|P4|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
214915|NCT00791388|526297|P3|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
214916|NCT00791388|526298|P2|NOT COMPLETED|Period 2 - 100 mg Dose Group||0
214917|NCT00791388|526299|P1|NOT COMPLETED|Period 2 - 100 mg Dose Group||1
214918|NCT00791388|526295|P5|COMPLETED|Period 2 - 100 mg Dose Group||0
214919|NCT00791388|526296|P4|COMPLETED|Period 2 - 100 mg Dose Group||0
214920|NCT00791388|526297|P3|COMPLETED|Period 2 - 100 mg Dose Group||8
214921|NCT00791388|526298|P2|COMPLETED|Period 2 - 100 mg Dose Group||0
214922|NCT00791388|526299|P1|COMPLETED|Period 2 - 100 mg Dose Group||2
214923|NCT00791388|526295|P5|STARTED|Period 2 - 100 mg Dose Group||0
214924|NCT00791388|526296|P4|STARTED|Period 2 - 100 mg Dose Group||0
214925|NCT00791388|526297|P3|STARTED|Period 2 - 100 mg Dose Group||8
214926|NCT00791388|526298|P2|STARTED|Period 2 - 100 mg Dose Group||0
214927|NCT00791388|526299|P1|STARTED|Period 2 - 100 mg Dose Group||3
214928|NCT00791388|526295|P5|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
214929|NCT00791388|526296|P4|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
214930|NCT00791388|526297|P3|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
214931|NCT00791388|526298|P2|NOT COMPLETED|Period 1 - 50 mg Dose Group||1
214932|NCT00791388|526299|P1|NOT COMPLETED|Period 1 - 50 mg Dose Group||0
214933|NCT00791388|526295|P5|COMPLETED|Period 1 - 50 mg Dose Group||0
214934|NCT00791388|526296|P4|COMPLETED|Period 1 - 50 mg Dose Group||0
214935|NCT00791388|526297|P3|COMPLETED|Period 1 - 50 mg Dose Group||0
214936|NCT00791388|526298|P2|COMPLETED|Period 1 - 50 mg Dose Group||7
214937|NCT00791388|526299|P1|COMPLETED|Period 1 - 50 mg Dose Group||3
214938|NCT00791388|526295|P5|STARTED|Period 1 - 50 mg Dose Group||0
214939|NCT00791388|526296|P4|STARTED|Period 1 - 50 mg Dose Group||0
214940|NCT00791388|526297|P3|STARTED|Period 1 - 50 mg Dose Group||0
214941|NCT00791388|526298|P2|STARTED|Period 1 - 50 mg Dose Group||8
214942|NCT00791388|526299|P1|STARTED|Period 1 - 50 mg Dose Group||3
214943|NCT00791479|526332|P6|NOT COMPLETED|Overall Study||3
214944|NCT00791479|526333|P5|NOT COMPLETED|Overall Study||3
214945|NCT00791479|526334|P4|NOT COMPLETED|Overall Study||4
214946|NCT00791479|526335|P3|NOT COMPLETED|Overall Study||0
214947|NCT00791479|526336|P2|NOT COMPLETED|Overall Study||3
214948|NCT00791479|526337|P1|NOT COMPLETED|Overall Study||2
214949|NCT00791479|526332|P6|COMPLETED|Overall Study||29
214950|NCT00791479|526333|P5|COMPLETED|Overall Study||0
214951|NCT00791479|526334|P4|COMPLETED|Overall Study||25
214952|NCT00791479|526335|P3|COMPLETED|Overall Study||34
214953|NCT00791479|526336|P2|COMPLETED|Overall Study||31
214954|NCT00791479|526337|P1|COMPLETED|Overall Study||33
214955|NCT00791479|526332|P6|Received at Least One Dose of Study Drug|Overall Study||32
214956|NCT00791479|526333|P5|Received at Least One Dose of Study Drug|Overall Study||3
214957|NCT00791479|526334|P4|Received at Least One Dose of Study Drug|Overall Study||29
214958|NCT00791479|526335|P3|Received at Least One Dose of Study Drug|Overall Study||34
214959|NCT00791479|526336|P2|Received at Least One Dose of Study Drug|Overall Study||34
214960|NCT00791479|526337|P1|Received at Least One Dose of Study Drug|Overall Study||35
214961|NCT00791479|526332|P6|STARTED|Overall Study||32
214962|NCT00791479|526333|P5|STARTED|Overall Study|3mg LY2189265 discont. Replaced with 1.5mg dose based on dose finding Study H9X-MC-GBCF; NCT00734474|3
214963|NCT00791479|526334|P4|STARTED|Overall Study||29
214964|NCT00791479|526335|P3|STARTED|Overall Study||34
214965|NCT00791479|526336|P2|STARTED|Overall Study||34
214966|NCT00791479|526337|P1|STARTED|Overall Study||35
214967|NCT00791492|526433|P2|NOT COMPLETED|Overall Study||3
214968|NCT00791492|526434|P1|NOT COMPLETED|Overall Study||6
214969|NCT00791492|526433|P2|COMPLETED|Overall Study||38
214970|NCT00791492|526434|P1|COMPLETED|Overall Study||39
214971|NCT00791492|526433|P2|TREATED|Overall Study||41
214972|NCT00791492|526434|P1|TREATED|Overall Study||44
214973|NCT00791492|526433|P2|STARTED|Overall Study||41
214974|NCT00791492|526434|P1|STARTED|Overall Study||45
214975|NCT00791518|526476|P1|NOT COMPLETED|Overall Study||93
214976|NCT00791518|526476|P1|COMPLETED|Overall Study||991
214977|NCT00791518|526476|P1|STARTED|Overall Study||1084
214978|NCT00791557|526502|P1|NOT COMPLETED|Overall Study||1
214979|NCT00791557|526502|P1|COMPLETED|Overall Study||1
214980|NCT00791557|526502|P1|STARTED|Overall Study||2
214981|NCT00791648|526508|P2|NOT COMPLETED|Overall Study||2
214982|NCT00791648|526509|P1|NOT COMPLETED|Overall Study||0
214983|NCT00791648|526508|P2|COMPLETED|Overall Study||307
214984|NCT00791648|526509|P1|COMPLETED|Overall Study||308
214985|NCT00791648|526508|P2|STARTED|Overall Study||309
214986|NCT00791648|526509|P1|STARTED|Overall Study||308
214987|NCT00791661|526528|P3|NOT COMPLETED|Period 3||0
214988|NCT00791661|526529|P2|NOT COMPLETED|Period 3||0
214989|NCT00791661|526530|P1|NOT COMPLETED|Period 3||0
214990|NCT00791661|526528|P3|COMPLETED|Period 3||6
214991|NCT00791661|526529|P2|COMPLETED|Period 3||8
214992|NCT00791661|526530|P1|COMPLETED|Period 3||8
214993|NCT00791661|526528|P3|Received Matching Placebo to MK-1006|Period 3||1
214994|NCT00791661|526529|P2|Received Matching Placebo to MK-1006|Period 3||2
214995|NCT00791661|526530|P1|Received Matching Placebo to MK-1006|Period 3||2
214996|NCT00791661|526528|P3|Received MK-1006|Period 3||5
214997|NCT00791661|526529|P2|Received MK-1006|Period 3||6
214998|NCT00791661|526530|P1|Received MK-1006|Period 3||6
214999|NCT00791661|526528|P3|STARTED|Period 3||6
215000|NCT00791661|526529|P2|STARTED|Period 3||8
215001|NCT00791661|526530|P1|STARTED|Period 3||8
215002|NCT00791661|526528|P3|NOT COMPLETED|7 Day Wash-out||0
215003|NCT00791661|526529|P2|NOT COMPLETED|7 Day Wash-out||0
215004|NCT00791661|526530|P1|NOT COMPLETED|7 Day Wash-out||0
215005|NCT00791661|526528|P3|COMPLETED|7 Day Wash-out||6
215006|NCT00791661|526529|P2|COMPLETED|7 Day Wash-out||8
215007|NCT00791661|526530|P1|COMPLETED|7 Day Wash-out||8
215008|NCT00791661|526528|P3|STARTED|7 Day Wash-out||6
215009|NCT00791661|526529|P2|STARTED|7 Day Wash-out||8
215010|NCT00791661|526530|P1|STARTED|7 Day Wash-out||8
215011|NCT00791661|526528|P3|NOT COMPLETED|Period 2||0
215012|NCT00791661|526529|P2|NOT COMPLETED|Period 2||0
215013|NCT00791661|526530|P1|NOT COMPLETED|Period 2||0
215014|NCT00791661|526528|P3|COMPLETED|Period 2||6
215015|NCT00791661|526529|P2|COMPLETED|Period 2||8
215016|NCT00791661|526530|P1|COMPLETED|Period 2||8
215017|NCT00791661|526528|P3|Received Matching Placebo to MK-1006|Period 2||2
215018|NCT00791661|526529|P2|Received Matching Placebo to MK-1006|Period 2||2
215019|NCT00791661|526530|P1|Received Matching Placebo to MK-1006|Period 2||2
215020|NCT00791661|526528|P3|Received MK-1006|Period 2||4
215021|NCT00791661|526529|P2|Received MK-1006|Period 2||6
215022|NCT00791661|526530|P1|Received MK-1006|Period 2||6
215023|NCT00791661|526528|P3|STARTED|Period 2||6
215024|NCT00791661|526529|P2|STARTED|Period 2||8
215025|NCT00791661|526530|P1|STARTED|Period 2||8
215026|NCT00791661|526528|P3|NOT COMPLETED|7 Day Wash-out||2
215027|NCT00791661|526529|P2|NOT COMPLETED|7 Day Wash-out||0
215028|NCT00791661|526530|P1|NOT COMPLETED|7 Day Wash-out||0
215029|NCT00791661|526528|P3|COMPLETED|7 Day Wash-out||6
215030|NCT00791661|526529|P2|COMPLETED|7 Day Wash-out||8
215031|NCT00791661|526530|P1|COMPLETED|7 Day Wash-out||8
215032|NCT00791661|526528|P3|STARTED|7 Day Wash-out||8
215033|NCT00791661|526529|P2|STARTED|7 Day Wash-out||8
215034|NCT00791661|526530|P1|STARTED|7 Day Wash-out||8
215035|NCT00791661|526528|P3|NOT COMPLETED|Period 1||0
215036|NCT00791661|526529|P2|NOT COMPLETED|Period 1||0
215037|NCT00791661|526530|P1|NOT COMPLETED|Period 1||0
215038|NCT00791661|526528|P3|COMPLETED|Period 1||8
215039|NCT00791661|526529|P2|COMPLETED|Period 1||8
215040|NCT00791661|526530|P1|COMPLETED|Period 1||8
215041|NCT00791661|526528|P3|Received Matching Placebo to MK-1006|Period 1||2
215042|NCT00791661|526529|P2|Received Matching Placebo to MK-1006|Period 1||2
215043|NCT00791661|526530|P1|Received Matching Placebo to MK-1006|Period 1||2
215044|NCT00791661|526528|P3|Received MK-1006|Period 1||6
215045|NCT00791661|526529|P2|Received MK-1006|Period 1||6
215046|NCT00791661|526530|P1|Received MK-1006|Period 1||6
215047|NCT00791661|526528|P3|STARTED|Period 1||8
215048|NCT00791661|526529|P2|STARTED|Period 1||8
215049|NCT00791661|526530|P1|STARTED|Period 1||8
215050|NCT00791700|526625|P4|NOT COMPLETED|Overall Study||18
215051|NCT00791700|526626|P3|NOT COMPLETED|Overall Study||4
215052|NCT00791700|526627|P2|NOT COMPLETED|Overall Study||5
215053|NCT00791700|526628|P1|NOT COMPLETED|Overall Study||4
215054|NCT00791700|526625|P4|COMPLETED|Overall Study|Two participants discontinued treatment after the lower bound (days 313 and 314) of Week 48 window.|25
215055|NCT00791700|526626|P3|COMPLETED|Overall Study||9
215056|NCT00791700|526627|P2|COMPLETED|Overall Study||26
215057|NCT00791700|526628|P1|COMPLETED|Overall Study||12
215058|NCT00791700|526625|P4|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|43
215059|NCT00791700|526626|P3|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|13
215060|NCT00791700|526627|P2|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|31
215061|NCT00791700|526628|P1|STARTED|Overall Study|Please note that the data presented here is Subject Discontinuations Through Week 48.|16
215062|NCT00791765|526715|P2|NOT COMPLETED|Weeks 13 to 24||8
215063|NCT00791765|526716|P1|NOT COMPLETED|Weeks 13 to 24||5
215064|NCT00791765|526715|P2|COMPLETED|Weeks 13 to 24||49
215065|NCT00791765|526716|P1|COMPLETED|Weeks 13 to 24||49
215066|NCT00791765|526715|P2|STARTED|Weeks 13 to 24|1 participant discontinued due to an adverse event after completing 12 weeks.|57
215067|NCT00791765|526716|P1|STARTED|Weeks 13 to 24||54
215068|NCT00791765|526715|P2|NOT COMPLETED|Weeks 1 to 12||4
215069|NCT00791765|526716|P1|NOT COMPLETED|Weeks 1 to 12||8
215070|NCT00791765|526715|P2|COMPLETED|Weeks 1 to 12||58
215071|NCT00791765|526716|P1|COMPLETED|Weeks 1 to 12||54
215072|NCT00791765|526715|P2|Treated|Weeks 1 to 12||59
215073|NCT00791765|526716|P1|Treated|Weeks 1 to 12||62
215074|NCT00791765|526715|P2|STARTED|Weeks 1 to 12||62
215075|NCT00791765|526716|P1|STARTED|Weeks 1 to 12||62
215076|NCT00791778|526729|P2|NOT COMPLETED|Follow-up||1
215077|NCT00791778|526730|P1|NOT COMPLETED|Follow-up||5
215078|NCT00791778|526729|P2|COMPLETED|Follow-up|Includes 78 participants with study follow-up terminated by sponsor and 12 deaths|90
215079|NCT00791778|526730|P1|COMPLETED|Follow-up|Includes 79 participants with study follow-up terminated by sponsor and 16 deaths|95
215080|NCT00791778|526729|P2|STARTED|Follow-up||91
215081|NCT00791778|526730|P1|STARTED|Follow-up||100
215082|NCT00791778|526729|P2|NOT COMPLETED|Double-blind Treatment||48
215083|NCT00791778|526730|P1|NOT COMPLETED|Double-blind Treatment||77
215084|NCT00791778|526729|P2|COMPLETED|Double-blind Treatment|includes: 75 subjects with progression|75
215085|NCT00791778|526730|P1|COMPLETED|Double-blind Treatment|includes: 42 subjects with progression, 4 subjects transferred to a continuation study|46
215086|NCT00791778|526729|P2|STARTED|Double-blind Treatment||123
215087|NCT00791778|526730|P1|STARTED|Double-blind Treatment||123
215088|NCT00791817|526784|P2|NOT COMPLETED|2: Single Dose||0
215089|NCT00791817|526785|P1|NOT COMPLETED|2: Single Dose||0
215090|NCT00791817|526784|P2|COMPLETED|2: Single Dose||5
215091|NCT00791817|526785|P1|COMPLETED|2: Single Dose||5
215092|NCT00791817|526784|P2|STARTED|2: Single Dose||5
215093|NCT00791817|526785|P1|STARTED|2: Single Dose||5
215094|NCT00791817|526784|P2|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
215095|NCT00791817|526785|P1|NOT COMPLETED|1: Single Dose Followed by Week Washout||0
215096|NCT00791817|526784|P2|COMPLETED|1: Single Dose Followed by Week Washout||5
215097|NCT00791817|526785|P1|COMPLETED|1: Single Dose Followed by Week Washout||5
215098|NCT00791817|526784|P2|STARTED|1: Single Dose Followed by Week Washout||5
215099|NCT00791817|526785|P1|STARTED|1: Single Dose Followed by Week Washout||5
215100|NCT00791908|526791|P1|NOT COMPLETED|Overall Study||0
215101|NCT00791908|526791|P1|COMPLETED|Overall Study||15
215102|NCT00791908|526791|P1|STARTED|Overall Study||15
215103|NCT00791921|526801|P2|NOT COMPLETED|Overall Study||96
215104|NCT00791921|526802|P1|NOT COMPLETED|Overall Study||34
215105|NCT00791921|526801|P2|COMPLETED|Overall Study||18
215106|NCT00791921|526802|P1|COMPLETED|Overall Study||82
215107|NCT00791921|526801|P2|STARTED|Overall Study||114
215108|NCT00791921|526802|P1|STARTED|Overall Study||116
215109|NCT00791934|526810|P1|NOT COMPLETED|Overall Study||15
215110|NCT00791934|526810|P1|COMPLETED|Overall Study|Follow-up extended to 1 yr. 13 subjects chose not to participate in the extension.|48
215111|NCT00791934|526810|P1|STARTED|Overall Study||63
215112|NCT00791973|526820|P2|NOT COMPLETED|Second Intervention (1 Week)||0
215113|NCT00791973|526821|P1|NOT COMPLETED|Second Intervention (1 Week)||0
215114|NCT00791973|526820|P2|COMPLETED|Second Intervention (1 Week)||7
215115|NCT00791973|526821|P1|COMPLETED|Second Intervention (1 Week)||8
215116|NCT00791973|526820|P2|STARTED|Second Intervention (1 Week)||7
215117|NCT00791973|526821|P1|STARTED|Second Intervention (1 Week)||8
215118|NCT00791973|526820|P2|NOT COMPLETED|Washout (1 Week)||0
215119|NCT00791973|526821|P1|NOT COMPLETED|Washout (1 Week)||0
215120|NCT00791973|526820|P2|COMPLETED|Washout (1 Week)||7
215121|NCT00791973|526821|P1|COMPLETED|Washout (1 Week)||8
215122|NCT00791973|526820|P2|STARTED|Washout (1 Week)||7
215123|NCT00791973|526821|P1|STARTED|Washout (1 Week)||8
215124|NCT00791973|526820|P2|NOT COMPLETED|First Intervention (1 Week)||0
215125|NCT00791973|526821|P1|NOT COMPLETED|First Intervention (1 Week)||0
215126|NCT00791973|526820|P2|COMPLETED|First Intervention (1 Week)||7
215127|NCT00791973|526821|P1|COMPLETED|First Intervention (1 Week)||8
215128|NCT00791973|526820|P2|STARTED|First Intervention (1 Week)||7
215129|NCT00791973|526821|P1|STARTED|First Intervention (1 Week)||8
215130|NCT00791999|526833|P4|NOT COMPLETED|Overall Study||52
215131|NCT00791999|526834|P3|NOT COMPLETED|Overall Study||20
215132|NCT00791999|526835|P2|NOT COMPLETED|Overall Study||16
215133|NCT00791999|526836|P1|NOT COMPLETED|Overall Study||21
215134|NCT00791999|526833|P4|COMPLETED|Overall Study||25
215135|NCT00791999|526834|P3|COMPLETED|Overall Study||65
215136|NCT00791999|526835|P2|COMPLETED|Overall Study||66
215137|NCT00791999|526836|P1|COMPLETED|Overall Study||51
215138|NCT00791999|526833|P4|STARTED|Overall Study||77
215139|NCT00791999|526834|P3|STARTED|Overall Study||85
215140|NCT00791999|526835|P2|STARTED|Overall Study||82
215141|NCT00791999|526836|P1|STARTED|Overall Study||72
215142|NCT00792103|526850|P1|NOT COMPLETED|Overall Study||133
215143|NCT00792103|526850|P1|COMPLETED|Overall Study||65
215144|NCT00792103|526850|P1|STARTED|Overall Study|15 subjects were enrolled but did not treat for a total of 183 subjects in the safety population|198
215145|NCT00792116|526860|P2|NOT COMPLETED|Overall Study||1
215146|NCT00792116|526861|P1|NOT COMPLETED|Overall Study||1
215147|NCT00792116|526860|P2|COMPLETED|Overall Study||54
215148|NCT00792116|526861|P1|COMPLETED|Overall Study||52
215149|NCT00792116|526860|P2|STARTED|Overall Study||55
215150|NCT00792116|526861|P1|STARTED|Overall Study||53
215151|NCT00792259|526874|P3|NOT COMPLETED|Overall Study||0
215152|NCT00792259|526875|P2|NOT COMPLETED|Overall Study||0
215153|NCT00792259|526876|P1|NOT COMPLETED|Overall Study||1
215154|NCT00792259|526874|P3|COMPLETED|Overall Study||13
215155|NCT00792259|526875|P2|COMPLETED|Overall Study||20
215156|NCT00792259|526876|P1|COMPLETED|Overall Study||14
215157|NCT00792259|526874|P3|STARTED|Overall Study||13
215158|NCT00792259|526875|P2|STARTED|Overall Study||20
215159|NCT00792259|526876|P1|STARTED|Overall Study||15
215160|NCT00792298|526884|P8|NOT COMPLETED|Treatment Period 2||2
215161|NCT00792298|526885|P7|NOT COMPLETED|Treatment Period 2||1
215162|NCT00792298|526886|P6|NOT COMPLETED|Treatment Period 2||0
215163|NCT00792298|526887|P5|NOT COMPLETED|Treatment Period 2||2
215164|NCT00792298|526888|P4|NOT COMPLETED|Treatment Period 2||2
215165|NCT00792298|526889|P3|NOT COMPLETED|Treatment Period 2||1
215166|NCT00792298|526890|P2|NOT COMPLETED|Treatment Period 2||1
215167|NCT00792298|526891|P1|NOT COMPLETED|Treatment Period 2||1
215168|NCT00792298|526884|P8|COMPLETED|Treatment Period 2||28
215169|NCT00792298|526885|P7|COMPLETED|Treatment Period 2||28
215170|NCT00792298|526886|P6|COMPLETED|Treatment Period 2||27
215171|NCT00792298|526887|P5|COMPLETED|Treatment Period 2||30
215172|NCT00792298|526888|P4|COMPLETED|Treatment Period 2||26
215173|NCT00792298|526889|P3|COMPLETED|Treatment Period 2||30
215174|NCT00792298|526890|P2|COMPLETED|Treatment Period 2||30
215175|NCT00792298|526891|P1|COMPLETED|Treatment Period 2||29
215176|NCT00792298|526884|P8|STARTED|Treatment Period 2||30
215177|NCT00792298|526885|P7|STARTED|Treatment Period 2||29
215178|NCT00792298|526886|P6|STARTED|Treatment Period 2||27
215179|NCT00792298|526887|P5|STARTED|Treatment Period 2||32
215180|NCT00792298|526888|P4|STARTED|Treatment Period 2||28
215181|NCT00792298|526889|P3|STARTED|Treatment Period 2||31
215182|NCT00792298|526890|P2|STARTED|Treatment Period 2||31
215183|NCT00792298|526891|P1|STARTED|Treatment Period 2||30
215184|NCT00792298|526884|P8|NOT COMPLETED|Washout||0
215185|NCT00792298|526885|P7|NOT COMPLETED|Washout||0
215186|NCT00792298|526886|P6|NOT COMPLETED|Washout||2
215187|NCT00792298|526887|P5|NOT COMPLETED|Washout||0
215188|NCT00792298|526888|P4|NOT COMPLETED|Washout||0
215189|NCT00792298|526889|P3|NOT COMPLETED|Washout||1
215190|NCT00792298|526890|P2|NOT COMPLETED|Washout||0
215191|NCT00792298|526891|P1|NOT COMPLETED|Washout||0
215192|NCT00792298|526884|P8|COMPLETED|Washout||30
215193|NCT00792298|526885|P7|COMPLETED|Washout||29
215194|NCT00792298|526886|P6|COMPLETED|Washout||27
215195|NCT00792298|526887|P5|COMPLETED|Washout||32
215196|NCT00792298|526888|P4|COMPLETED|Washout||28
215197|NCT00792298|526889|P3|COMPLETED|Washout||31
215198|NCT00792298|526890|P2|COMPLETED|Washout||31
215199|NCT00792298|526891|P1|COMPLETED|Washout||30
215200|NCT00792298|526884|P8|STARTED|Washout||30
215201|NCT00792298|526885|P7|STARTED|Washout|2 participants discontinued therapy during Period 1 but entered the Washout as allowed per protocol|29
215202|NCT00792298|526886|P6|STARTED|Washout||29
215203|NCT00792298|526887|P5|STARTED|Washout||32
215204|NCT00792298|526888|P4|STARTED|Washout||28
215205|NCT00792298|526889|P3|STARTED|Washout|1 participant discontinued therapy during Period 1 but entered the Washout as allowed per protocol|32
215206|NCT00792298|526890|P2|STARTED|Washout||31
215207|NCT00792298|526891|P1|STARTED|Washout||30
215208|NCT00792298|526884|P8|NOT COMPLETED|Treatment Period 1||1
215209|NCT00792298|526885|P7|NOT COMPLETED|Treatment Period 1||4
215210|NCT00792298|526886|P6|NOT COMPLETED|Treatment Period 1||3
215211|NCT00792298|526887|P5|NOT COMPLETED|Treatment Period 1||0
215212|NCT00792298|526888|P4|NOT COMPLETED|Treatment Period 1||4
215213|NCT00792298|526889|P3|NOT COMPLETED|Treatment Period 1||2
215214|NCT00792298|526890|P2|NOT COMPLETED|Treatment Period 1||1
215215|NCT00792298|526891|P1|NOT COMPLETED|Treatment Period 1||1
215216|NCT00792298|526884|P8|COMPLETED|Treatment Period 1||30
215217|NCT00792298|526885|P7|COMPLETED|Treatment Period 1||27
215218|NCT00792298|526886|P6|COMPLETED|Treatment Period 1||29
215219|NCT00792298|526887|P5|COMPLETED|Treatment Period 1||32
215220|NCT00792298|526888|P4|COMPLETED|Treatment Period 1||28
215221|NCT00792298|526889|P3|COMPLETED|Treatment Period 1||31
215222|NCT00792298|526890|P2|COMPLETED|Treatment Period 1||31
215223|NCT00792298|526891|P1|COMPLETED|Treatment Period 1||30
215224|NCT00792298|526884|P8|STARTED|Treatment Period 1||31
215225|NCT00792298|526885|P7|STARTED|Treatment Period 1||31
215226|NCT00792298|526886|P6|STARTED|Treatment Period 1||32
215227|NCT00792298|526887|P5|STARTED|Treatment Period 1||32
215228|NCT00792298|526888|P4|STARTED|Treatment Period 1||32
215229|NCT00792298|526889|P3|STARTED|Treatment Period 1||33
215230|NCT00792298|526890|P2|STARTED|Treatment Period 1||32
215231|NCT00792298|526891|P1|STARTED|Treatment Period 1||31
215232|NCT00792428|526920|P2|NOT COMPLETED|Overall Study||0
215233|NCT00792428|526921|P1|NOT COMPLETED|Overall Study||0
215234|NCT00792428|526920|P2|COMPLETED|Overall Study||10
215235|NCT00792428|526921|P1|COMPLETED|Overall Study||10
215236|NCT00792428|526920|P2|STARTED|Overall Study||10
215237|NCT00792428|526921|P1|STARTED|Overall Study||10
215238|NCT00792610|526929|P1|NOT COMPLETED|Overall Study||0
215239|NCT00792610|526929|P1|COMPLETED|Overall Study||127
215240|NCT00792610|526929|P1|Youths|Overall Study||127
215241|NCT00792610|526929|P1|STARTED|Overall Study||127
215242|NCT00792623|526933|P1|NOT COMPLETED|Overall Study||7
215243|NCT00792623|526933|P1|COMPLETED|Overall Study||22
215244|NCT00792623|526933|P1|STARTED|Overall Study||29
215245|NCT00792636|526949|P3|NOT COMPLETED|Overall Study||81
215246|NCT00792636|526950|P2|NOT COMPLETED|Overall Study||81
215247|NCT00792636|526951|P1|NOT COMPLETED|Overall Study||68
215248|NCT00792636|526949|P3|COMPLETED|Overall Study||55
215249|NCT00792636|526950|P2|COMPLETED|Overall Study||55
215250|NCT00792636|526951|P1|COMPLETED|Overall Study||67
215251|NCT00792636|526949|P3|STARTED|Overall Study||136
215252|NCT00792636|526950|P2|STARTED|Overall Study||136
215253|NCT00792636|526951|P1|STARTED|Overall Study||135
215254|NCT00792688|526991|P3|NOT COMPLETED|Overall Study||0
215255|NCT00792688|526992|P2|NOT COMPLETED|Overall Study||0
215256|NCT00792688|526993|P1|NOT COMPLETED|Overall Study||0
215257|NCT00792688|526991|P3|COMPLETED|Overall Study||9
215258|NCT00792688|526992|P2|COMPLETED|Overall Study||8
215259|NCT00792688|526993|P1|COMPLETED|Overall Study||9
215260|NCT00792688|526991|P3|STARTED|Overall Study||9
215261|NCT00792688|526992|P2|STARTED|Overall Study||8
215262|NCT00792688|526993|P1|STARTED|Overall Study||9
215263|NCT00792701|527006|P2|NOT COMPLETED|Overall Study||44
215264|NCT00792701|527007|P1|NOT COMPLETED|Overall Study||19
215265|NCT00792701|527006|P2|COMPLETED|Overall Study||22
215266|NCT00792701|527007|P1|COMPLETED|Overall Study||0
215267|NCT00792701|527006|P2|Eligible and Analyzable|Overall Study||44
215268|NCT00792701|527007|P1|Eligible and Analyzable|Overall Study||17
215269|NCT00792701|527006|P2|Eligible|Overall Study||63
215270|NCT00792701|527007|P1|Eligible|Overall Study||18
215271|NCT00792701|527006|P2|STARTED|Overall Study||66
215272|NCT00792701|527007|P1|STARTED|Overall Study||19
215273|NCT00792805|527021|P3|NOT COMPLETED|Overall Study||33
215274|NCT00792805|527022|P2|NOT COMPLETED|Overall Study||26
215275|NCT00792805|527023|P1|NOT COMPLETED|Overall Study||22
215276|NCT00792805|527021|P3|COMPLETED|Overall Study||154
215277|NCT00792805|527022|P2|COMPLETED|Overall Study||162
215278|NCT00792805|527023|P1|COMPLETED|Overall Study||166
215279|NCT00792805|527021|P3|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|186
215280|NCT00792805|527022|P2|Exposed to Study Medication or Placebo|Overall Study||188
215281|NCT00792805|527023|P1|Exposed to Study Medication or Placebo|Overall Study|One patient in this group did not receive any study treatment.|187
215282|NCT00792805|527021|P3|STARTED|Overall Study||187
215283|NCT00792805|527022|P2|STARTED|Overall Study||188
215284|NCT00792805|527023|P1|STARTED|Overall Study||188
215285|NCT00792922|527035|P4|NOT COMPLETED|At 3 Years||0
215286|NCT00792922|527036|P3|NOT COMPLETED|At 3 Years||0
215287|NCT00792922|527037|P2|NOT COMPLETED|At 3 Years||0
215288|NCT00792922|527038|P1|NOT COMPLETED|At 3 Years||0
215289|NCT00792922|527035|P4|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215290|NCT00792922|527036|P3|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215291|NCT00792922|527037|P2|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215292|NCT00792922|527038|P1|COMPLETED|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215293|NCT00792922|527035|P4|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215294|NCT00792922|527036|P3|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215295|NCT00792922|527037|P2|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215296|NCT00792922|527038|P1|Tanzania|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215297|NCT00792922|527035|P4|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215298|NCT00792922|527036|P3|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215299|NCT00792922|527037|P2|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215300|NCT00792922|527038|P1|Gambia|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215301|NCT00792922|527035|P4|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215302|NCT00792922|527036|P3|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215303|NCT00792922|527037|P2|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215304|NCT00792922|527038|P1|Niger|At 3 Years|the trial was conducted at community level and data reported per community basis|0
215305|NCT00792922|527035|P4|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
215306|NCT00792922|527036|P3|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
215307|NCT00792922|527037|P2|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
215308|NCT00792922|527038|P1|STARTED|At 3 Years|"In Tanzania, units in treatment arm analyzed with antibiotic arm as tf rate was not <5% by 18 months
the trial was conducted at community level and data reported per community basis"|0
215309|NCT00792922|527035|P4|NOT COMPLETED|At Baseline||0
215310|NCT00792922|527036|P3|NOT COMPLETED|At Baseline||0
215311|NCT00792922|527037|P2|NOT COMPLETED|At Baseline||0
215312|NCT00792922|527038|P1|NOT COMPLETED|At Baseline||0
215313|NCT00792922|527035|P4|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215314|NCT00792922|527036|P3|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215315|NCT00792922|527037|P2|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215316|NCT00792922|527038|P1|COMPLETED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215317|NCT00792922|527035|P4|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
215318|NCT00792922|527036|P3|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
215319|NCT00792922|527037|P2|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
215320|NCT00792922|527038|P1|Tanzania|At Baseline|the trial was conducted at community level and data reported per community basis|0
215321|NCT00792922|527035|P4|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
215322|NCT00792922|527036|P3|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
215323|NCT00792922|527037|P2|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
215324|NCT00792922|527038|P1|Gambia|At Baseline|the trial was conducted at community level and data reported per community basis|0
215325|NCT00792922|527035|P4|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
215326|NCT00792922|527036|P3|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
215327|NCT00792922|527037|P2|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
215328|NCT00792922|527038|P1|Niger|At Baseline|the trial was conducted at community level and data reported per community basis|0
215329|NCT00792922|527035|P4|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215330|NCT00792922|527036|P3|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215331|NCT00792922|527037|P2|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215332|NCT00792922|527038|P1|STARTED|At Baseline|the trial was conducted at community level and data reported per community basis|0
215333|NCT00792935|527054|P2|NOT COMPLETED|Overall Study||3
215334|NCT00792935|527055|P1|NOT COMPLETED|Overall Study||4
215335|NCT00792935|527054|P2|COMPLETED|Overall Study||68
215336|NCT00792935|527055|P1|COMPLETED|Overall Study||68
215337|NCT00792935|527054|P2|STARTED|Overall Study||71
215338|NCT00792935|527055|P1|STARTED|Overall Study||72
215339|NCT00792948|527063|P1|NOT COMPLETED|Overall Study||28
215340|NCT00792948|527063|P1|COMPLETED|Overall Study|Patients who completed induction/consolidation step|69
215341|NCT00792948|527063|P1|STARTED|Overall Study|Patients registered to induction/consolidation step|97
215342|NCT00793104|527072|P1|NOT COMPLETED|Overall Study||1
215343|NCT00793104|527072|P1|COMPLETED|Overall Study||9
215344|NCT00793104|527072|P1|STARTED|Overall Study||10
215345|NCT00793169|527080|P1|NOT COMPLETED|Overall Study||0
215346|NCT00793169|527080|P1|COMPLETED|Overall Study||19
215347|NCT00793169|527080|P1|STARTED|Overall Study||19
215348|NCT00793325|527084|P1|NOT COMPLETED|Overall Study||19
215349|NCT00793325|527084|P1|COMPLETED|Overall Study||890
215350|NCT00793325|527084|P1|STARTED|Overall Study||909
215351|NCT00793403|527108|P1|NOT COMPLETED|Overall Study||73
215352|NCT00793403|527108|P1|COMPLETED|Overall Study||220
215353|NCT00793403|527108|P1|STARTED|Overall Study||293
215354|NCT00793455|527157|P2|NOT COMPLETED|Overall Study||0
215355|NCT00793455|527158|P1|NOT COMPLETED|Overall Study||0
215356|NCT00793455|527157|P2|COMPLETED|Overall Study||314
215357|NCT00793455|527158|P1|COMPLETED|Overall Study||314
215358|NCT00793455|527157|P2|STARTED|Overall Study||314
215359|NCT00793455|527158|P1|STARTED|Overall Study||314
215360|NCT00793520|527168|P2|NOT COMPLETED|Placebo Crossover to Milnacipran||1
215361|NCT00793520|527169|P1|NOT COMPLETED|Placebo Crossover to Milnacipran||0
215362|NCT00793520|527168|P2|COMPLETED|Placebo Crossover to Milnacipran||0
215363|NCT00793520|527169|P1|COMPLETED|Placebo Crossover to Milnacipran||0
215364|NCT00793520|527168|P2|STARTED|Placebo Crossover to Milnacipran||1
215365|NCT00793520|527169|P1|STARTED|Placebo Crossover to Milnacipran||0
215366|NCT00793520|527168|P2|NOT COMPLETED|Milnacipran Crossover to Placebo||0
215367|NCT00793520|527169|P1|NOT COMPLETED|Milnacipran Crossover to Placebo||1
215368|NCT00793520|527168|P2|COMPLETED|Milnacipran Crossover to Placebo||0
215369|NCT00793520|527169|P1|COMPLETED|Milnacipran Crossover to Placebo||0
215370|NCT00793520|527168|P2|STARTED|Milnacipran Crossover to Placebo||0
215371|NCT00793520|527169|P1|STARTED|Milnacipran Crossover to Placebo||1
215372|NCT00793546|527179|P2|NOT COMPLETED|Overall Study||28
215373|NCT00793546|527180|P1|NOT COMPLETED|Overall Study||14
215374|NCT00793546|527179|P2|COMPLETED|Overall Study||0
215375|NCT00793546|527180|P1|COMPLETED|Overall Study||0
215376|NCT00793546|527179|P2|STARTED|Overall Study||28
215377|NCT00793546|527180|P1|STARTED|Overall Study||14
215378|NCT00793572|527208|P1|NOT COMPLETED|Overall Study||0
215379|NCT00793572|527208|P1|COMPLETED|Overall Study||32
215380|NCT00793572|527208|P1|STARTED|Overall Study||32
215381|NCT00793585|527219|P2|NOT COMPLETED|Overall Study||3
215382|NCT00793585|527220|P1|NOT COMPLETED|Overall Study||2
215383|NCT00793585|527219|P2|COMPLETED|Overall Study||18
215384|NCT00793585|527220|P1|COMPLETED|Overall Study||17
215385|NCT00793585|527219|P2|STARTED|Overall Study||21
215386|NCT00793585|527220|P1|STARTED|Overall Study||19
215387|NCT00793611|527230|P2|NOT COMPLETED|Overall Study||0
215388|NCT00793611|527231|P1|NOT COMPLETED|Overall Study||0
215389|NCT00793611|527230|P2|COMPLETED|Overall Study||10
215390|NCT00793611|527231|P1|COMPLETED|Overall Study||10
215391|NCT00793611|527230|P2|STARTED|Overall Study||10
215392|NCT00793611|527231|P1|STARTED|Overall Study||10
215393|NCT00793624|527245|P4|NOT COMPLETED|Overall Study||43
215394|NCT00793624|527246|P3|NOT COMPLETED|Overall Study||39
215395|NCT00793624|527247|P2|NOT COMPLETED|Overall Study||36
215396|NCT00793624|527248|P1|NOT COMPLETED|Overall Study||57
215397|NCT00793624|527245|P4|COMPLETED|Overall Study||184
215398|NCT00793624|527246|P3|COMPLETED|Overall Study||186
215399|NCT00793624|527247|P2|COMPLETED|Overall Study||191
215400|NCT00793624|527248|P1|COMPLETED|Overall Study||168
215401|NCT00793624|527245|P4|STARTED|Overall Study||227
215402|NCT00793624|527246|P3|STARTED|Overall Study||225
215403|NCT00793624|527247|P2|STARTED|Overall Study||227
215404|NCT00793624|527248|P1|STARTED|Overall Study||225
215405|NCT00793650|527516|P2|NOT COMPLETED|Overall Study||0
215406|NCT00793650|527517|P1|NOT COMPLETED|Overall Study||0
215407|NCT00793650|527516|P2|COMPLETED|Overall Study||20
215408|NCT00793650|527517|P1|COMPLETED|Overall Study||19
215409|NCT00793650|527516|P2|STARTED|Overall Study||20
215410|NCT00793650|527517|P1|STARTED|Overall Study||19
215411|NCT00787839|527525|P1|NOT COMPLETED|Overall Study||404
215412|NCT00787839|527525|P1|COMPLETED|Overall Study||1535
215413|NCT00787839|527525|P1|Complete GCT, OGTT, A1c, Demographics|Overall Study||1535
215414|NCT00787839|527525|P1|Completed GCT Screening|Overall Study||1876
215415|NCT00787839|527525|P1|Consented|Overall Study|consented|1939
215416|NCT00787839|527525|P1|STARTED|Overall Study||1939
215417|NCT00787852|527548|P2|NOT COMPLETED|Overall Study||0
215418|NCT00787852|527549|P1|NOT COMPLETED|Overall Study||1
215419|NCT00787852|527548|P2|COMPLETED|Overall Study||5
215420|NCT00787852|527549|P1|COMPLETED|Overall Study|1 patient withdrew consent prior to starting|5
215421|NCT00787852|527548|P2|STARTED|Overall Study|The study was terminated prior to enrolled to group 2|5
215422|NCT00787852|527549|P1|STARTED|Overall Study||6
215423|NCT00799578|527555|P1|NOT COMPLETED|Overall Study||2
215424|NCT00799578|527555|P1|COMPLETED|Overall Study||11
215425|NCT00799578|527555|P1|STARTED|Overall Study||13
215426|NCT00799591|527559|P1|NOT COMPLETED|Overall Study||66
215427|NCT00799591|527559|P1|COMPLETED|Overall Study||90
215428|NCT00799591|527559|P1|STARTED|Overall Study||156
215429|NCT00799604|527573|P3|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
215430|NCT00799604|527574|P2|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
215431|NCT00799604|527575|P1|NOT COMPLETED|Bolus 2 (With Anesthesia)||0
215432|NCT00799604|527573|P3|COMPLETED|Bolus 2 (With Anesthesia)||3
215433|NCT00799604|527574|P2|COMPLETED|Bolus 2 (With Anesthesia)||12
215434|NCT00799604|527575|P1|COMPLETED|Bolus 2 (With Anesthesia)||6
215435|NCT00799604|527573|P3|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|3
215436|NCT00799604|527574|P2|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|12
215437|NCT00799604|527575|P1|STARTED|Bolus 2 (With Anesthesia)|Dose determined per discretion of investigator at 250, 500 or 125μg, based on response to Bolus 1.|6
215438|NCT00799604|527573|P3|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
215439|NCT00799604|527574|P2|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
215440|NCT00799604|527575|P1|NOT COMPLETED|Bolus 1 (Pre-anesthesia)||0
215441|NCT00799604|527573|P3|COMPLETED|Bolus 1 (Pre-anesthesia)||10
215442|NCT00799604|527574|P2|COMPLETED|Bolus 1 (Pre-anesthesia)||10
215443|NCT00799604|527575|P1|COMPLETED|Bolus 1 (Pre-anesthesia)||10
215444|NCT00799604|527573|P3|STARTED|Bolus 1 (Pre-anesthesia)||10
215445|NCT00799604|527574|P2|STARTED|Bolus 1 (Pre-anesthesia)||10
215446|NCT00799604|527575|P1|STARTED|Bolus 1 (Pre-anesthesia)||10
215447|NCT00799617|527601|P2|NOT COMPLETED|Anemia Trial||3
215448|NCT00799617|527602|P1|NOT COMPLETED|Anemia Trial||3
215449|NCT00799617|527601|P2|COMPLETED|Anemia Trial||32
215450|NCT00799617|527602|P1|COMPLETED|Anemia Trial||24
215451|NCT00799617|527601|P2|STARTED|Anemia Trial||35
215452|NCT00799617|527602|P1|STARTED|Anemia Trial||27
215453|NCT00799617|527601|P2|NOT COMPLETED|Cognitive Function Trial||1
215454|NCT00799617|527602|P1|NOT COMPLETED|Cognitive Function Trial||0
215455|NCT00799617|527601|P2|COMPLETED|Cognitive Function Trial||245
215456|NCT00799617|527602|P1|COMPLETED|Cognitive Function Trial||247
215457|NCT00799617|527601|P2|STARTED|Cognitive Function Trial||246
215458|NCT00799617|527602|P1|STARTED|Cognitive Function Trial||247
215459|NCT00799617|527601|P2|NOT COMPLETED|Bone Trial||16
215460|NCT00799617|527602|P1|NOT COMPLETED|Bone Trial||6
215461|NCT00799617|527601|P2|COMPLETED|Bone Trial||85
215462|NCT00799617|527602|P1|COMPLETED|Bone Trial||104
215463|NCT00799617|527601|P2|STARTED|Bone Trial||101
215464|NCT00799617|527602|P1|STARTED|Bone Trial||110
215465|NCT00799617|527601|P2|NOT COMPLETED|Cardiovascular Trial||17
215466|NCT00799617|527602|P1|NOT COMPLETED|Cardiovascular Trial||15
215467|NCT00799617|527601|P2|COMPLETED|Cardiovascular Trial||65
215468|NCT00799617|527602|P1|COMPLETED|Cardiovascular Trial||73
215469|NCT00799617|527601|P2|STARTED|Cardiovascular Trial||82
215470|NCT00799617|527602|P1|STARTED|Cardiovascular Trial||88
215471|NCT00799617|527601|P2|NOT COMPLETED|Vitality Trial||22
215472|NCT00799617|527602|P1|NOT COMPLETED|Vitality Trial||7
215473|NCT00799617|527601|P2|COMPLETED|Vitality Trial||216
215474|NCT00799617|527602|P1|COMPLETED|Vitality Trial||229
215475|NCT00799617|527601|P2|STARTED|Vitality Trial||238
215476|NCT00799617|527602|P1|STARTED|Vitality Trial||236
215477|NCT00799617|527601|P2|NOT COMPLETED|Physical Function Trial||11
215478|NCT00799617|527602|P1|NOT COMPLETED|Physical Function Trial||6
215479|NCT00799617|527601|P2|COMPLETED|Physical Function Trial||185
215480|NCT00799617|527602|P1|COMPLETED|Physical Function Trial||185
215481|NCT00799617|527601|P2|STARTED|Physical Function Trial||196
215482|NCT00799617|527602|P1|STARTED|Physical Function Trial||191
215483|NCT00799617|527601|P2|NOT COMPLETED|Sexual Funtion Trial||21
215484|NCT00799617|527602|P1|NOT COMPLETED|Sexual Funtion Trial||16
215485|NCT00799617|527601|P2|COMPLETED|Sexual Funtion Trial||215
215486|NCT00799617|527602|P1|COMPLETED|Sexual Funtion Trial||218
215487|NCT00799617|527601|P2|STARTED|Sexual Funtion Trial||236
215488|NCT00799617|527602|P1|STARTED|Sexual Funtion Trial||234
215489|NCT00799617|527601|P2|NOT COMPLETED|Main Testosterone Trial||21
215490|NCT00799617|527602|P1|NOT COMPLETED|Main Testosterone Trial||19
215491|NCT00799617|527601|P2|COMPLETED|Main Testosterone Trial||374
215492|NCT00799617|527602|P1|COMPLETED|Main Testosterone Trial|Participants qualified for 1 of the 3 main trials (sexual function, physical function, vitality).|376
215493|NCT00799617|527601|P2|STARTED|Main Testosterone Trial||395
215494|NCT00799617|527602|P1|STARTED|Main Testosterone Trial||395
215495|NCT00799643|527682|P2|NOT COMPLETED|Overall Study||27
215496|NCT00799643|527683|P1|NOT COMPLETED|Overall Study||25
215497|NCT00799643|527682|P2|COMPLETED|Overall Study||119
215498|NCT00799643|527683|P1|COMPLETED|Overall Study||115
215499|NCT00799643|527682|P2|STARTED|Overall Study||146
215500|NCT00799643|527683|P1|STARTED|Overall Study||140
215501|NCT00799708|527694|P3|NOT COMPLETED|Overall Study||0
215502|NCT00799708|527695|P2|NOT COMPLETED|Overall Study||0
215503|NCT00799708|527696|P1|NOT COMPLETED|Overall Study||1
215504|NCT00799708|527694|P3|COMPLETED|Overall Study||11
215505|NCT00799708|527695|P2|COMPLETED|Overall Study||6
215506|NCT00799708|527696|P1|COMPLETED|Overall Study||9
215507|NCT00799708|527694|P3|STARTED|Overall Study||11
215508|NCT00799708|527695|P2|STARTED|Overall Study||6
215509|NCT00799708|527696|P1|STARTED|Overall Study||10
215510|NCT00799773|527708|P2|NOT COMPLETED|Overall Study||0
215511|NCT00799773|527709|P1|NOT COMPLETED|Overall Study||0
215512|NCT00799773|527708|P2|COMPLETED|Overall Study||1
215513|NCT00799773|527709|P1|COMPLETED|Overall Study||2
215514|NCT00799773|527708|P2|STARTED|Overall Study||1
215515|NCT00799773|527709|P1|STARTED|Overall Study||2
215516|NCT00799825|527737|P1|NOT COMPLETED|Overall Study||48
215517|NCT00799825|527737|P1|COMPLETED|Overall Study||296
215518|NCT00799825|527737|P1|STARTED|Overall Study||344
215519|NCT00800345|527743|P1|NOT COMPLETED|Overall Study||0
215520|NCT00800345|527743|P1|COMPLETED|Overall Study||33
215521|NCT00800345|527743|P1|STARTED|Overall Study||33
215522|NCT00800384|527750|P2|NOT COMPLETED|Overall Study||43
215523|NCT00800384|527751|P1|NOT COMPLETED|Overall Study||41
215524|NCT00800384|527750|P2|COMPLETED|Overall Study||1210
215525|NCT00800384|527751|P1|COMPLETED|Overall Study||1206
215526|NCT00800384|527750|P2|STARTED|Overall Study||1253
215527|NCT00800384|527751|P1|STARTED|Overall Study||1247
215528|NCT00800436|527766|P7|NOT COMPLETED|Overall Study||0
215529|NCT00800436|527767|P6|NOT COMPLETED|Overall Study||0
215530|NCT00800436|527768|P5|NOT COMPLETED|Overall Study||0
215531|NCT00800436|527769|P4|NOT COMPLETED|Overall Study||1
215532|NCT00800436|527770|P3|NOT COMPLETED|Overall Study||1
215533|NCT00800436|527771|P2|NOT COMPLETED|Overall Study||0
215534|NCT00800436|527772|P1|NOT COMPLETED|Overall Study||0
215535|NCT00800436|527766|P7|COMPLETED|Overall Study||20
215536|NCT00800436|527767|P6|COMPLETED|Overall Study||20
215537|NCT00800436|527768|P5|COMPLETED|Overall Study||6
215538|NCT00800436|527769|P4|COMPLETED|Overall Study||5
215539|NCT00800436|527770|P3|COMPLETED|Overall Study||5
215540|NCT00800436|527771|P2|COMPLETED|Overall Study||6
215541|NCT00800436|527772|P1|COMPLETED|Overall Study||6
215542|NCT00800436|527766|P7|STARTED|Overall Study||20
215543|NCT00800436|527767|P6|STARTED|Overall Study||20
215544|NCT00800436|527768|P5|STARTED|Overall Study||6
215545|NCT00800436|527769|P4|STARTED|Overall Study||6
215546|NCT00800436|527770|P3|STARTED|Overall Study||6
215547|NCT00800436|527771|P2|STARTED|Overall Study||6
215548|NCT00800436|527772|P1|STARTED|Overall Study||6
215549|NCT00800540|527816|P2|NOT COMPLETED|Period 2: 6 Weeks||1
215550|NCT00800540|527817|P1|NOT COMPLETED|Period 2: 6 Weeks||0
215551|NCT00800540|527816|P2|COMPLETED|Period 2: 6 Weeks||16
215552|NCT00800540|527817|P1|COMPLETED|Period 2: 6 Weeks||16
215553|NCT00800540|527816|P2|STARTED|Period 2: 6 Weeks||17
215554|NCT00800540|527817|P1|STARTED|Period 2: 6 Weeks||16
215555|NCT00800540|527816|P2|NOT COMPLETED|Washout: 4 Weeks||0
215556|NCT00800540|527817|P1|NOT COMPLETED|Washout: 4 Weeks||0
215557|NCT00800540|527816|P2|COMPLETED|Washout: 4 Weeks||17
215558|NCT00800540|527817|P1|COMPLETED|Washout: 4 Weeks||16
215559|NCT00800540|527816|P2|STARTED|Washout: 4 Weeks||17
215560|NCT00800540|527817|P1|STARTED|Washout: 4 Weeks||16
215561|NCT00800540|527816|P2|NOT COMPLETED|Period One: 6 Weeks||1
215562|NCT00800540|527817|P1|NOT COMPLETED|Period One: 6 Weeks||1
215563|NCT00800540|527816|P2|COMPLETED|Period One: 6 Weeks||17
215564|NCT00800540|527817|P1|COMPLETED|Period One: 6 Weeks||16
215565|NCT00800540|527816|P2|STARTED|Period One: 6 Weeks||18
215566|NCT00800540|527817|P1|STARTED|Period One: 6 Weeks||17
215567|NCT00800683|527847|P2|NOT COMPLETED|Overall Study||19
215568|NCT00800683|527848|P1|NOT COMPLETED|Overall Study||17
215569|NCT00800683|527847|P2|COMPLETED|Overall Study|Number who completed treatment|49
215570|NCT00800683|527848|P1|COMPLETED|Overall Study|Number who completed treatment|48
215571|NCT00800683|527847|P2|STARTED|Overall Study|Number who started treatment|68
215572|NCT00800683|527848|P1|STARTED|Overall Study|Number who started treatment|65
215573|NCT00800735|527894|P1|NOT COMPLETED|Overall Study||14
215574|NCT00800735|527894|P1|COMPLETED|Overall Study||16
215575|NCT00800735|527894|P1|STARTED|Overall Study||30
215576|NCT00800839|527898|P1|NOT COMPLETED|Overall Study||7
215577|NCT00800839|527898|P1|COMPLETED|Overall Study||49
215578|NCT00800839|527898|P1|STARTED|Overall Study||56
215579|NCT00800865|527909|P2|NOT COMPLETED|Overall Study||0
215580|NCT00800865|527910|P1|NOT COMPLETED|Overall Study||0
215581|NCT00800865|527909|P2|COMPLETED|Overall Study||16
215582|NCT00800865|527910|P1|COMPLETED|Overall Study||15
215583|NCT00800865|527909|P2|STARTED|Overall Study||16
215584|NCT00800865|527910|P1|STARTED|Overall Study||15
215585|NCT00800982|527920|P2|NOT COMPLETED|Overall Study||3
215586|NCT00800982|527921|P1|NOT COMPLETED|Overall Study||2
215587|NCT00800982|527920|P2|COMPLETED|Overall Study||12
215588|NCT00800982|527921|P1|COMPLETED|Overall Study||13
215589|NCT00800982|527920|P2|STARTED|Overall Study||15
215590|NCT00800982|527921|P1|STARTED|Overall Study||15
215591|NCT00801099|527927|P1|NOT COMPLETED|Overall Study||101
215592|NCT00801099|527927|P1|COMPLETED|Overall Study||175
215593|NCT00801099|527927|P1|STARTED|Overall Study||276
215594|NCT00801138|527935|P4|NOT COMPLETED|Overall Study||0
215595|NCT00801138|527936|P3|NOT COMPLETED|Overall Study||0
215596|NCT00801138|527937|P2|NOT COMPLETED|Overall Study||0
215597|NCT00801138|527938|P1|NOT COMPLETED|Overall Study||0
215598|NCT00801138|527935|P4|COMPLETED|Overall Study||54
215599|NCT00801138|527936|P3|COMPLETED|Overall Study||54
215600|NCT00801138|527937|P2|COMPLETED|Overall Study||56
215601|NCT00801138|527938|P1|COMPLETED|Overall Study||54
215602|NCT00801138|527935|P4|STARTED|Overall Study||54
215603|NCT00801138|527936|P3|STARTED|Overall Study||54
215604|NCT00801138|527937|P2|STARTED|Overall Study||56
215605|NCT00801138|527938|P1|STARTED|Overall Study||54
215606|NCT00801229|527962|P2|NOT COMPLETED|Received Study Drug/Placebo||4
215607|NCT00801229|527963|P1|NOT COMPLETED|Received Study Drug/Placebo||4
215608|NCT00801229|527962|P2|COMPLETED|Received Study Drug/Placebo||30
215609|NCT00801229|527963|P1|COMPLETED|Received Study Drug/Placebo||31
215610|NCT00801229|527962|P2|STARTED|Received Study Drug/Placebo||34
215611|NCT00801229|527963|P1|STARTED|Received Study Drug/Placebo||35
215612|NCT00801229|527962|P2|NOT COMPLETED|Signed Consent||3
215613|NCT00801229|527963|P1|NOT COMPLETED|Signed Consent||3
215614|NCT00801229|527962|P2|COMPLETED|Signed Consent||34
215615|NCT00801229|527963|P1|COMPLETED|Signed Consent||35
215616|NCT00801229|527962|P2|STARTED|Signed Consent||37
215617|NCT00801229|527963|P1|STARTED|Signed Consent||38
215618|NCT00801242|527969|P1|NOT COMPLETED|Overall Study||52
215619|NCT00801242|527969|P1|COMPLETED|Overall Study|42, 10, and 0 participants withdrew during Cycles 1, 2, and 3 (i.e. 168 completed the trial).|168
215620|NCT00801242|527969|P1|Started Cycle 3|Overall Study||2
215621|NCT00801242|527969|P1|Started Cycle 2|Overall Study||35
215622|NCT00801242|527969|P1|FAS, Off-treatment Cycle 1|Overall Study|Completed 7 months induction period and were enrolled in the off-treatment period of cycle 1.|191
215623|NCT00801242|527969|P1|Full Analysis Set (FAS), Cycle 1|Overall Study|Randomized participants who received ≥1 dose and had ≥1 efficacy assessment.|213
215624|NCT00801242|527969|P1|Safety Analysis Set|Overall Study|Randomized participants who received ≥1 dose of degarelix.|216
215625|NCT00801242|527969|P1|STARTED|Overall Study|Randomized participants.|220
215626|NCT00801632|527980|P1|NOT COMPLETED|Overall Study||1
215627|NCT00801632|527980|P1|COMPLETED|Overall Study||4
215628|NCT00801632|527980|P1|STARTED|Overall Study||5
215629|NCT00801684|527991|P1|NOT COMPLETED|Overall Study||0
215630|NCT00801684|527991|P1|COMPLETED|Overall Study||24
215631|NCT00801684|527991|P1|STARTED|Overall Study||24
215632|NCT00801801|528013|P1|NOT COMPLETED|Overall Study||0
215633|NCT00801801|528013|P1|COMPLETED|Overall Study||5
215634|NCT00801801|528013|P1|STARTED|Overall Study||5
215635|NCT00801827|528018|P1|NOT COMPLETED|Overall Study||0
215636|NCT00801827|528018|P1|COMPLETED|Overall Study||5
215637|NCT00801827|528018|P1|STARTED|Overall Study|2 others consented but due to scheduling did not complete|5
215638|NCT00801892|528024|P2|NOT COMPLETED|Overall Study||0
215639|NCT00801892|528025|P1|NOT COMPLETED|Overall Study||0
215640|NCT00801892|528024|P2|COMPLETED|Overall Study||12
215641|NCT00801892|528025|P1|COMPLETED|Overall Study||11
215642|NCT00801892|528024|P2|STARTED|Overall Study||12
215643|NCT00801892|528025|P1|STARTED|Overall Study||11
215644|NCT00801983|528033|P2|NOT COMPLETED|Period 2||1
215645|NCT00801983|528034|P1|NOT COMPLETED|Period 2||2
215646|NCT00801983|528033|P2|COMPLETED|Period 2||32
215647|NCT00801983|528034|P1|COMPLETED|Period 2||38
215648|NCT00801983|528033|P2|STARTED|Period 2||33
215649|NCT00801983|528034|P1|STARTED|Period 2||40
215650|NCT00801983|528033|P2|NOT COMPLETED|Period 1||8
215651|NCT00801983|528034|P1|NOT COMPLETED|Period 1||4
215652|NCT00801983|528033|P2|COMPLETED|Period 1||33
215653|NCT00801983|528034|P1|COMPLETED|Period 1||40
215654|NCT00801983|528033|P2|STARTED|Period 1||41
215655|NCT00801983|528034|P1|STARTED|Period 1||44
215656|NCT00802074|528046|P6|NOT COMPLETED|Overall Study||0
215657|NCT00802074|528047|P5|NOT COMPLETED|Overall Study||0
215658|NCT00802074|528048|P4|NOT COMPLETED|Overall Study||0
215659|NCT00802074|528049|P3|NOT COMPLETED|Overall Study||1
215660|NCT00802074|528050|P2|NOT COMPLETED|Overall Study||1
215661|NCT00802074|528051|P1|NOT COMPLETED|Overall Study||2
215662|NCT00802074|528046|P6|COMPLETED|Overall Study||7
215663|NCT00802074|528047|P5|COMPLETED|Overall Study||7
215664|NCT00802074|528048|P4|COMPLETED|Overall Study||7
215665|NCT00802074|528049|P3|COMPLETED|Overall Study||6
215666|NCT00802074|528050|P2|COMPLETED|Overall Study||7
215667|NCT00802074|528051|P1|COMPLETED|Overall Study||7
215668|NCT00802074|528046|P6|STARTED|Overall Study||7
215669|NCT00802074|528047|P5|STARTED|Overall Study||7
215670|NCT00802074|528048|P4|STARTED|Overall Study||7
215671|NCT00802074|528049|P3|STARTED|Overall Study||7
215672|NCT00802074|528050|P2|STARTED|Overall Study||8
215673|NCT00802074|528051|P1|STARTED|Overall Study||9
215674|NCT00802100|528086|P3|NOT COMPLETED|Overall Study||4
215675|NCT00802100|528087|P2|NOT COMPLETED|Overall Study||7
215676|NCT00802100|528088|P1|NOT COMPLETED|Overall Study||6
215677|NCT00802100|528086|P3|COMPLETED|Overall Study||2
215678|NCT00802100|528087|P2|COMPLETED|Overall Study||2
215679|NCT00802100|528088|P1|COMPLETED|Overall Study||0
215680|NCT00802100|528086|P3|STARTED|Overall Study||6
215681|NCT00802100|528087|P2|STARTED|Overall Study||9
215682|NCT00802100|528088|P1|STARTED|Overall Study||6
215683|NCT00802178|528097|P1|NOT COMPLETED|Overall Study||113
215684|NCT00802178|528097|P1|COMPLETED|Overall Study||2335
215685|NCT00802178|528097|P1|STARTED|Overall Study||2448
215686|NCT00802204|528106|P2|NOT COMPLETED|Overall Study||1
215687|NCT00802204|528107|P1|NOT COMPLETED|Overall Study||1
215688|NCT00802204|528106|P2|COMPLETED|Overall Study||18
215689|NCT00802204|528107|P1|COMPLETED|Overall Study||8
215690|NCT00802204|528106|P2|STARTED|Overall Study||19
215691|NCT00802204|528107|P1|STARTED|Overall Study||9
215692|NCT00802360|528135|P4|NOT COMPLETED|Overall Study||22
215693|NCT00802360|528136|P3|NOT COMPLETED|Overall Study||25
215694|NCT00802360|528137|P2|NOT COMPLETED|Overall Study||26
215695|NCT00802360|528138|P1|NOT COMPLETED|Overall Study||24
215696|NCT00802360|528135|P4|COMPLETED|Overall Study||17
215697|NCT00802360|528136|P3|COMPLETED|Overall Study||17
215698|NCT00802360|528137|P2|COMPLETED|Overall Study||16
215699|NCT00802360|528138|P1|COMPLETED|Overall Study||18
215700|NCT00802360|528135|P4|STARTED|Overall Study||39
215701|NCT00802360|528136|P3|STARTED|Overall Study||42
215702|NCT00802360|528137|P2|STARTED|Overall Study||42
215703|NCT00802360|528138|P1|STARTED|Overall Study||42
215704|NCT00802412|528180|P2|NOT COMPLETED|Overall Study||1
215705|NCT00802412|528181|P1|NOT COMPLETED|Overall Study||2
215706|NCT00802412|528180|P2|COMPLETED|Overall Study||66
215707|NCT00802412|528181|P1|COMPLETED|Overall Study||63
215708|NCT00802412|528180|P2|STARTED|Overall Study||67
215709|NCT00802412|528181|P1|STARTED|Overall Study||65
215710|NCT00802503|528191|P2|NOT COMPLETED|Overall Study||20
215711|NCT00802503|528192|P1|NOT COMPLETED|Overall Study||10
215712|NCT00802503|528191|P2|COMPLETED|Overall Study||133
215713|NCT00802503|528192|P1|COMPLETED|Overall Study||142
215714|NCT00802503|528191|P2|STARTED|Overall Study||153
215715|NCT00802503|528192|P1|STARTED|Overall Study||152
215716|NCT00802529|528216|P2|NOT COMPLETED|Overall Study||1
215717|NCT00802529|528217|P1|NOT COMPLETED|Overall Study||0
215718|NCT00802529|528216|P2|COMPLETED|Overall Study||29
215719|NCT00802529|528217|P1|COMPLETED|Overall Study|2 patients crossed-over to gentamicin after steroids failed to control vertigo (as per protocol).|30
215720|NCT00802529|528216|P2|STARTED|Overall Study||30
215721|NCT00802529|528217|P1|STARTED|Overall Study||30
215722|NCT00802633|528229|P2|NOT COMPLETED|Overall Study||0
215723|NCT00802633|528230|P1|NOT COMPLETED|Overall Study||0
215724|NCT00802633|528229|P2|COMPLETED|Overall Study||40
215725|NCT00802633|528230|P1|COMPLETED|Overall Study||40
215726|NCT00802633|528229|P2|STARTED|Overall Study||40
215727|NCT00802633|528230|P1|STARTED|Overall Study||40
215728|NCT00802659|528242|P4|NOT COMPLETED|Overall Study||0
215729|NCT00802659|528243|P3|NOT COMPLETED|Overall Study||0
215730|NCT00802659|528244|P2|NOT COMPLETED|Overall Study||1
215731|NCT00802659|528245|P1|NOT COMPLETED|Overall Study||0
215732|NCT00802659|528242|P4|COMPLETED|Overall Study||0
215733|NCT00802659|528243|P3|COMPLETED|Overall Study||0
215734|NCT00802659|528244|P2|COMPLETED|Overall Study||1
215735|NCT00802659|528245|P1|COMPLETED|Overall Study||0
215736|NCT00802659|528242|P4|STARTED|Overall Study||0
215737|NCT00802659|528243|P3|STARTED|Overall Study||0
215738|NCT00802659|528244|P2|STARTED|Overall Study||2
215739|NCT00802659|528245|P1|STARTED|Overall Study||0
215740|NCT00802672|528274|P3|NOT COMPLETED|Overall Study||34
215741|NCT00802672|528275|P2|NOT COMPLETED|Overall Study||52
215742|NCT00802672|528276|P1|NOT COMPLETED|Overall Study||68
215743|NCT00802672|528274|P3|COMPLETED|Overall Study||77
215744|NCT00802672|528275|P2|COMPLETED|Overall Study||174
215745|NCT00802672|528276|P1|COMPLETED|Overall Study||156
215746|NCT00802672|528274|P3|STARTED|Overall Study||111
215747|NCT00802672|528275|P2|STARTED|Overall Study||226
215748|NCT00802672|528276|P1|STARTED|Overall Study||224
215749|NCT00802685|528292|P2|NOT COMPLETED|Overall Study||0
215750|NCT00802685|528293|P1|NOT COMPLETED|Overall Study||0
215751|NCT00802685|528292|P2|COMPLETED|Overall Study||51
215752|NCT00802685|528293|P1|COMPLETED|Overall Study||54
215753|NCT00802685|528292|P2|STARTED|Overall Study||51
215754|NCT00802685|528293|P1|STARTED|Overall Study||54
215755|NCT00802737|528304|P3|NOT COMPLETED|Overall Study||1
215756|NCT00802737|528305|P2|NOT COMPLETED|Overall Study||11
215757|NCT00802737|528306|P1|NOT COMPLETED|Overall Study||17
215758|NCT00802737|528304|P3|COMPLETED|Overall Study||0
215759|NCT00802737|528305|P2|COMPLETED|Overall Study||0
215760|NCT00802737|528306|P1|COMPLETED|Overall Study||0
215761|NCT00802737|528304|P3|STARTED|Overall Study||1
215762|NCT00802737|528305|P2|STARTED|Overall Study||11
215763|NCT00802737|528306|P1|STARTED|Overall Study||17
215764|NCT00790738|528354|P2|NOT COMPLETED|Overall Study||3
215765|NCT00790738|528355|P1|NOT COMPLETED|Overall Study||2
215766|NCT00790738|528354|P2|COMPLETED|Overall Study||3
215767|NCT00790738|528355|P1|COMPLETED|Overall Study||3
215768|NCT00790738|528354|P2|STARTED|Overall Study||6
215769|NCT00790738|528355|P1|STARTED|Overall Study||5
215770|NCT00790751|528369|P4|NOT COMPLETED|Overall Study||21
215771|NCT00790751|528370|P3|NOT COMPLETED|Overall Study||20
215772|NCT00790751|528371|P2|NOT COMPLETED|Overall Study||30
215773|NCT00790751|528372|P1|NOT COMPLETED|Overall Study||25
215774|NCT00790751|528369|P4|COMPLETED|Overall Study||141
215775|NCT00790751|528370|P3|COMPLETED|Overall Study||141
215776|NCT00790751|528371|P2|COMPLETED|Overall Study||131
215777|NCT00790751|528372|P1|COMPLETED|Overall Study||137
215778|NCT00790751|528369|P4|STARTED|Overall Study||162
215779|NCT00790751|528370|P3|STARTED|Overall Study||161
215780|NCT00790751|528371|P2|STARTED|Overall Study||161
215781|NCT00790751|528372|P1|STARTED|Overall Study||162
215782|NCT00790790|528393|P3|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
215783|NCT00790790|528394|P2|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||1
215784|NCT00790790|528395|P1|NOT COMPLETED|Study Period 3: 1-Week Washout Phase||0
215785|NCT00790790|528393|P3|COMPLETED|Study Period 3: 1-Week Washout Phase||26
215786|NCT00790790|528394|P2|COMPLETED|Study Period 3: 1-Week Washout Phase||31
215787|NCT00790790|528395|P1|COMPLETED|Study Period 3: 1-Week Washout Phase||37
215788|NCT00790790|528393|P3|STARTED|Study Period 3: 1-Week Washout Phase||27
215789|NCT00790790|528394|P2|STARTED|Study Period 3: 1-Week Washout Phase||32
215790|NCT00790790|528395|P1|STARTED|Study Period 3: 1-Week Washout Phase||37
215791|NCT00790790|528393|P3|NOT COMPLETED|Study Period 2: Therapy Phase||21
215792|NCT00790790|528394|P2|NOT COMPLETED|Study Period 2: Therapy Phase||18
215793|NCT00790790|528395|P1|NOT COMPLETED|Study Period 2: Therapy Phase||12
215794|NCT00790790|528393|P3|COMPLETED|Study Period 2: Therapy Phase||27
215795|NCT00790790|528394|P2|COMPLETED|Study Period 2: Therapy Phase||32
215796|NCT00790790|528395|P1|COMPLETED|Study Period 2: Therapy Phase||37
215797|NCT00790790|528393|P3|STARTED|Study Period 2: Therapy Phase||48
215798|NCT00790790|528394|P2|STARTED|Study Period 2: Therapy Phase||50
215799|NCT00790790|528395|P1|STARTED|Study Period 2: Therapy Phase||49
215800|NCT00790803|528468|P1|NOT COMPLETED|Overall Study||0
215801|NCT00790803|528468|P1|COMPLETED|Overall Study||5
215802|NCT00790803|528468|P1|STARTED|Overall Study||5
215803|NCT00790855|528476|P1|NOT COMPLETED|Overall Study||0
215804|NCT00790855|528476|P1|COMPLETED|Overall Study||25
215805|NCT00790855|528476|P1|STARTED|Overall Study||25
215806|NCT00790907|528484|P3|NOT COMPLETED|Overall Study||339
215807|NCT00790907|528485|P2|NOT COMPLETED|Overall Study||340
215808|NCT00790907|528486|P1|NOT COMPLETED|Overall Study||455
215809|NCT00790907|528484|P3|COMPLETED|Overall Study||663
215810|NCT00790907|528485|P2|COMPLETED|Overall Study||684
215811|NCT00790907|528486|P1|COMPLETED|Overall Study||754
215812|NCT00790907|528484|P3|STARTED|Overall Study||1002
215813|NCT00790907|528485|P2|STARTED|Overall Study||1024
215814|NCT00790907|528486|P1|STARTED|Overall Study||1209
215815|NCT00791037|528507|P1|NOT COMPLETED|Overall Study||0
215816|NCT00791037|528507|P1|COMPLETED|Overall Study||23
215817|NCT00791037|528507|P1|Skeletal or Bone-only Disease by FDG-PET|Overall Study||1
215818|NCT00791037|528507|P1|Primary Outcome|Overall Study||19
215819|NCT00791037|528507|P1|STARTED|Overall Study||23
215820|NCT00791076|528514|P1|NOT COMPLETED|Overall Study||8
215821|NCT00791076|528514|P1|COMPLETED|Overall Study||0
215822|NCT00791076|528514|P1|STARTED|Overall Study||8
215823|NCT00791089|528524|P2|NOT COMPLETED|Overall Study||1
215824|NCT00791089|528525|P1|NOT COMPLETED|Overall Study||0
215825|NCT00791089|528524|P2|COMPLETED|Overall Study||5
215826|NCT00791089|528525|P1|COMPLETED|Overall Study||6
215827|NCT00791089|528524|P2|STARTED|Overall Study||6
215828|NCT00791089|528525|P1|STARTED|Overall Study||6
215829|NCT00791102|528531|P2|NOT COMPLETED|Period 2||0
215830|NCT00791102|528532|P1|NOT COMPLETED|Period 2||0
215831|NCT00791102|528531|P2|COMPLETED|Period 2||10
215832|NCT00791102|528532|P1|COMPLETED|Period 2||10
215833|NCT00791102|528531|P2|STARTED|Period 2||10
215834|NCT00791102|528532|P1|STARTED|Period 2||10
215835|NCT00791102|528531|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
215836|NCT00791102|528532|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
215837|NCT00791102|528531|P2|COMPLETED|Washout Period of 2 Weeks||10
215838|NCT00791102|528532|P1|COMPLETED|Washout Period of 2 Weeks||10
215839|NCT00791102|528531|P2|STARTED|Washout Period of 2 Weeks||10
215840|NCT00791102|528532|P1|STARTED|Washout Period of 2 Weeks||10
215841|NCT00791102|528531|P2|NOT COMPLETED|Period 1||0
215842|NCT00791102|528532|P1|NOT COMPLETED|Period 1||0
215843|NCT00791102|528531|P2|COMPLETED|Period 1||10
215844|NCT00791102|528532|P1|COMPLETED|Period 1||10
215845|NCT00791102|528531|P2|STARTED|Period 1||10
215846|NCT00791102|528532|P1|STARTED|Period 1||10
215847|NCT00791128|528548|P1|NOT COMPLETED|Overall Study||9
215848|NCT00791128|528548|P1|COMPLETED|Overall Study||13
215849|NCT00791128|528548|P1|STARTED|Overall Study||22
215850|NCT00796614|528557|P4|NOT COMPLETED|Overall Study||1
215851|NCT00796614|528558|P3|NOT COMPLETED|Overall Study||3
215852|NCT00796614|528559|P2|NOT COMPLETED|Overall Study||4
215853|NCT00796614|528560|P1|NOT COMPLETED|Overall Study||5
215854|NCT00796614|528557|P4|COMPLETED|Overall Study||40
215855|NCT00796614|528558|P3|COMPLETED|Overall Study||36
215856|NCT00796614|528559|P2|COMPLETED|Overall Study||36
215857|NCT00796614|528560|P1|COMPLETED|Overall Study||36
215858|NCT00796614|528557|P4|Not Treated|Overall Study||0
215859|NCT00796614|528558|P3|Not Treated|Overall Study||1
215860|NCT00796614|528559|P2|Not Treated|Overall Study||0
215861|NCT00796614|528560|P1|Not Treated|Overall Study||0
215862|NCT00796614|528557|P4|STARTED|Overall Study||41
215863|NCT00796614|528558|P3|STARTED|Overall Study||39
215864|NCT00796614|528559|P2|STARTED|Overall Study||40
215865|NCT00796614|528560|P1|STARTED|Overall Study||41
215866|NCT00796653|528606|P4|NOT COMPLETED|Overall Study||40
215867|NCT00796653|528607|P3|NOT COMPLETED|Overall Study||36
215868|NCT00796653|528608|P2|NOT COMPLETED|Overall Study||37
215869|NCT00796653|528609|P1|NOT COMPLETED|Overall Study||51
215870|NCT00796653|528606|P4|COMPLETED|Overall Study||193
215871|NCT00796653|528607|P3|COMPLETED|Overall Study||198
215872|NCT00796653|528608|P2|COMPLETED|Overall Study||195
215873|NCT00796653|528609|P1|COMPLETED|Overall Study||184
215874|NCT00796653|528606|P4|STARTED|Overall Study||233
215875|NCT00796653|528607|P3|STARTED|Overall Study||234
215876|NCT00796653|528608|P2|STARTED|Overall Study||232
215877|NCT00796653|528609|P1|STARTED|Overall Study||235
215878|NCT00796666|528877|P2|NOT COMPLETED|Overall Study||64
215879|NCT00796666|528878|P1|NOT COMPLETED|Overall Study||67
215880|NCT00796666|528877|P2|COMPLETED|Overall Study||0
215881|NCT00796666|528878|P1|COMPLETED|Overall Study||0
215882|NCT00796666|528877|P2|Randomized and Not Treated|Overall Study||0
215883|NCT00796666|528878|P1|Randomized and Not Treated|Overall Study||1
215884|NCT00796666|528877|P2|Treated|Overall Study||64
215885|NCT00796666|528878|P1|Treated|Overall Study||66
215886|NCT00796666|528877|P2|STARTED|Overall Study||64
215887|NCT00796666|528878|P1|STARTED|Overall Study||67
215888|NCT00796705|528912|P4|NOT COMPLETED|Overall Study||0
215889|NCT00796705|528913|P3|NOT COMPLETED|Overall Study||0
215890|NCT00796705|528914|P2|NOT COMPLETED|Overall Study||0
215891|NCT00796705|528915|P1|NOT COMPLETED|Overall Study||0
215892|NCT00796705|528912|P4|COMPLETED|Overall Study||2
215893|NCT00796705|528913|P3|COMPLETED|Overall Study||4
215894|NCT00796705|528914|P2|COMPLETED|Overall Study||4
215895|NCT00796705|528915|P1|COMPLETED|Overall Study||3
215896|NCT00796705|528912|P4|STARTED|Overall Study||2
215897|NCT00796705|528913|P3|STARTED|Overall Study||4
215898|NCT00796705|528914|P2|STARTED|Overall Study||4
215899|NCT00796705|528915|P1|STARTED|Overall Study||3
215900|NCT00796718|528951|P1|NOT COMPLETED|Overall Study||9
215901|NCT00796718|528951|P1|COMPLETED|Overall Study||53
215902|NCT00796718|528951|P1|STARTED|Overall Study||62
215903|NCT00796744|528961|P3|NOT COMPLETED|Overall Study||1
215904|NCT00796744|528962|P2|NOT COMPLETED|Overall Study||0
215905|NCT00796744|528963|P1|NOT COMPLETED|Overall Study||0
215906|NCT00796744|528961|P3|COMPLETED|Overall Study||27
215907|NCT00796744|528962|P2|COMPLETED|Overall Study||26
215908|NCT00796744|528963|P1|COMPLETED|Overall Study||24
215909|NCT00796744|528961|P3|STARTED|Overall Study||28
215910|NCT00796744|528962|P2|STARTED|Overall Study||26
215911|NCT00796744|528963|P1|STARTED|Overall Study||24
215912|NCT00796757|528980|P1|NOT COMPLETED|Overall Study||86
215913|NCT00796757|528980|P1|COMPLETED|Overall Study||60
215914|NCT00796757|528980|P1|STARTED|Overall Study||146
215915|NCT00796822|528994|P2|NOT COMPLETED|Overall Study||0
215916|NCT00796822|528995|P1|NOT COMPLETED|Overall Study||3
215917|NCT00796822|528994|P2|COMPLETED|Overall Study||13
215918|NCT00796822|528995|P1|COMPLETED|Overall Study||10
215919|NCT00796822|528994|P2|STARTED|Overall Study||13
215920|NCT00796822|528995|P1|STARTED|Overall Study||13
215921|NCT00796926|529003|P2|NOT COMPLETED|Overall Study||0
215922|NCT00796926|529004|P1|NOT COMPLETED|Overall Study||1
215923|NCT00796926|529003|P2|COMPLETED|Overall Study||15
215924|NCT00796926|529004|P1|COMPLETED|Overall Study||14
215925|NCT00796926|529003|P2|STARTED|Overall Study||15
215926|NCT00796926|529004|P1|STARTED|Overall Study||15
215927|NCT00802841|529012|P2|NOT COMPLETED|Overall Study||95
215928|NCT00802841|529013|P1|NOT COMPLETED|Overall Study||96
215929|NCT00802841|529012|P2|COMPLETED|Overall Study||0
215930|NCT00802841|529013|P1|COMPLETED|Overall Study||0
215931|NCT00802841|529012|P2|Cross-over Set|Overall Study||56
215932|NCT00802841|529013|P1|Cross-over Set|Overall Study||13
215933|NCT00802841|529012|P2|Safety Set|Overall Study||93
215934|NCT00802841|529013|P1|Safety Set|Overall Study||96
215935|NCT00802841|529012|P2|Full Analysis Set|Overall Study||95
215936|NCT00802841|529013|P1|Full Analysis Set|Overall Study||96
215937|NCT00802841|529012|P2|STARTED|Overall Study||95
215938|NCT00802841|529013|P1|STARTED|Overall Study||96
215939|NCT00802867|529035|P1|NOT COMPLETED|Overall Study||13
215940|NCT00802867|529035|P1|COMPLETED|Overall Study||976
215941|NCT00802867|529035|P1|STARTED|Overall Study||989
215942|NCT00802880|529043|P1|NOT COMPLETED|Overall Study||0
215943|NCT00802880|529043|P1|COMPLETED|Overall Study||80
215944|NCT00802880|529043|P1|STARTED|Overall Study||80
215945|NCT00802893|529062|P1|NOT COMPLETED|Overall Study||3
215946|NCT00802893|529062|P1|COMPLETED|Overall Study||0
215947|NCT00802893|529062|P1|STARTED|Overall Study||3
215948|NCT00802997|529069|P2|NOT COMPLETED|6 Month to 9 Months||0
215949|NCT00802997|529070|P1|NOT COMPLETED|6 Month to 9 Months||2
215950|NCT00802997|529069|P2|COMPLETED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
215951|NCT00802997|529070|P1|COMPLETED|6 Month to 9 Months||25
215952|NCT00802997|529069|P2|STARTED|6 Month to 9 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
215953|NCT00802997|529070|P1|STARTED|6 Month to 9 Months||27
215954|NCT00802997|529069|P2|NOT COMPLETED|3 Months to 6 Months||0
215955|NCT00802997|529070|P1|NOT COMPLETED|3 Months to 6 Months||7
215956|NCT00802997|529069|P2|COMPLETED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
215957|NCT00802997|529070|P1|COMPLETED|3 Months to 6 Months||27
215958|NCT00802997|529069|P2|STARTED|3 Months to 6 Months|Sham subjects unblinded at 3 Months. None continued in sham group.|0
215959|NCT00802997|529070|P1|STARTED|3 Months to 6 Months||34
215960|NCT00802997|529069|P2|NOT COMPLETED|Baseline to 3 Months||0
215961|NCT00802997|529070|P1|NOT COMPLETED|Baseline to 3 Months||0
215962|NCT00802997|529069|P2|COMPLETED|Baseline to 3 Months||17
215963|NCT00802997|529070|P1|COMPLETED|Baseline to 3 Months||34
215964|NCT00802997|529069|P2|STARTED|Baseline to 3 Months||17
215965|NCT00802997|529070|P1|STARTED|Baseline to 3 Months||34
215966|NCT00803010|529082|P2|NOT COMPLETED|Overall Study||0
215967|NCT00803010|529083|P1|NOT COMPLETED|Overall Study||0
215968|NCT00803010|529082|P2|COMPLETED|Overall Study||37
215969|NCT00803010|529083|P1|COMPLETED|Overall Study||37
215970|NCT00803010|529082|P2|STARTED|Overall Study||37
215971|NCT00803010|529083|P1|STARTED|Overall Study||37
215972|NCT00803023|529097|P4|NOT COMPLETED|Overall Study||8
215973|NCT00803023|529098|P3|NOT COMPLETED|Overall Study||11
215974|NCT00803023|529099|P2|NOT COMPLETED|Overall Study||8
215975|NCT00803023|529100|P1|NOT COMPLETED|Overall Study||5
215976|NCT00803023|529097|P4|COMPLETED|Overall Study||25
215977|NCT00803023|529098|P3|COMPLETED|Overall Study||20
215978|NCT00803023|529099|P2|COMPLETED|Overall Study||25
215979|NCT00803023|529100|P1|COMPLETED|Overall Study||27
215980|NCT00803023|529097|P4|STARTED|Overall Study||33
215981|NCT00803023|529098|P3|STARTED|Overall Study||31
215982|NCT00803023|529099|P2|STARTED|Overall Study||33
215983|NCT00803023|529100|P1|STARTED|Overall Study||32
215984|NCT00803049|529114|P4|NOT COMPLETED|Overall Study||102
215985|NCT00803049|529115|P3|NOT COMPLETED|Overall Study||44
215986|NCT00803049|529116|P2|NOT COMPLETED|Overall Study||118
215987|NCT00803049|529117|P1|NOT COMPLETED|Overall Study||61
215988|NCT00803049|529114|P4|COMPLETED|Overall Study||151
215989|NCT00803049|529115|P3|COMPLETED|Overall Study||64
215990|NCT00803049|529116|P2|COMPLETED|Overall Study||134
215991|NCT00803049|529117|P1|COMPLETED|Overall Study||68
215992|NCT00803049|529114|P4|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|250
215993|NCT00803049|529115|P3|Safety Population|Overall Study|1 participant received Teriflunomide 7 mg and analysed in Teriflunomide 7 mg/7 mg arm|107
215994|NCT00803049|529116|P2|Safety Population|Overall Study|Included 1 participant from Placebo/Teriflunomide 14 mg and 1 from Teriflunomide14 mg/14 mg arm|254
215995|NCT00803049|529117|P1|Safety Population|Overall Study||129
215996|NCT00803049|529114|P4|Treated|Overall Study||251
215997|NCT00803049|529115|P3|Treated|Overall Study||108
215998|NCT00803049|529116|P2|Treated|Overall Study||252
215999|NCT00803049|529117|P1|Treated|Overall Study||129
216000|NCT00803049|529114|P4|STARTED|Overall Study|Randomized in extension study|253
216001|NCT00803049|529115|P3|STARTED|Overall Study|Randomized in extension study|108
216002|NCT00803049|529116|P2|STARTED|Overall Study|Randomized in extension study|252
216003|NCT00803049|529117|P1|STARTED|Overall Study|Randomized in extension study|129
216004|NCT00803062|529151|P4|NOT COMPLETED|Overall Study||0
216005|NCT00803062|529152|P3|NOT COMPLETED|Overall Study||0
216006|NCT00803062|529153|P2|NOT COMPLETED|Overall Study||0
216007|NCT00803062|529154|P1|NOT COMPLETED|Overall Study||0
216008|NCT00803062|529151|P4|COMPLETED|Overall Study||112
216009|NCT00803062|529152|P3|COMPLETED|Overall Study||111
216010|NCT00803062|529153|P2|COMPLETED|Overall Study||115
216011|NCT00803062|529154|P1|COMPLETED|Overall Study||114
216012|NCT00803062|529151|P4|STARTED|Overall Study||112
216013|NCT00803062|529152|P3|STARTED|Overall Study||111
216014|NCT00803062|529153|P2|STARTED|Overall Study||115
216015|NCT00803062|529154|P1|STARTED|Overall Study||114
216016|NCT00803101|529174|P2|NOT COMPLETED|Overall Study||22
216017|NCT00803101|529175|P1|NOT COMPLETED|Overall Study||18
216018|NCT00803101|529174|P2|COMPLETED|Overall Study||66
216019|NCT00803101|529175|P1|COMPLETED|Overall Study||70
216020|NCT00803101|529174|P2|STARTED|Overall Study||88
216021|NCT00803101|529175|P1|STARTED|Overall Study||88
216022|NCT00803114|529195|P2|NOT COMPLETED|Overall Study||0
216023|NCT00803114|529196|P1|NOT COMPLETED|Overall Study||0
216024|NCT00803114|529195|P2|COMPLETED|Overall Study||115
216025|NCT00803114|529196|P1|COMPLETED|Overall Study||113
216026|NCT00803114|529195|P2|STARTED|Overall Study||115
216027|NCT00803114|529196|P1|STARTED|Overall Study||113
216028|NCT00803179|529206|P1|NOT COMPLETED|Overall Study||3
216029|NCT00803179|529206|P1|COMPLETED|Overall Study||2
216030|NCT00803179|529206|P1|STARTED|Overall Study||5
216031|NCT00803244|529212|P2|NOT COMPLETED|Overall Study||15
216032|NCT00803244|529213|P1|NOT COMPLETED|Overall Study||7
216033|NCT00803244|529212|P2|COMPLETED|Overall Study||178
216034|NCT00803244|529213|P1|COMPLETED|Overall Study||181
216035|NCT00803244|529212|P2|STARTED|Overall Study||193
216036|NCT00803244|529213|P1|STARTED|Overall Study||188
216037|NCT00803270|529223|P2|NOT COMPLETED|Overall Study||2
216038|NCT00803270|529224|P1|NOT COMPLETED|Overall Study||1
216039|NCT00803270|529223|P2|COMPLETED|Overall Study||12
216040|NCT00803270|529224|P1|COMPLETED|Overall Study||12
216041|NCT00803270|529223|P2|STARTED|Overall Study||14
216042|NCT00803270|529224|P1|STARTED|Overall Study||13
216043|NCT00803283|529234|P2|NOT COMPLETED|Overall Study||0
216044|NCT00803283|529235|P1|NOT COMPLETED|Overall Study||0
216045|NCT00803283|529234|P2|COMPLETED|Overall Study||1
216046|NCT00803283|529235|P1|COMPLETED|Overall Study||1
216047|NCT00803283|529234|P2|STARTED|Overall Study||1
216048|NCT00803283|529235|P1|STARTED|Overall Study||1
216049|NCT00803361|529261|P2|NOT COMPLETED|Overall Study||28
216050|NCT00803361|529262|P1|NOT COMPLETED|Overall Study||26
216051|NCT00803361|529261|P2|COMPLETED|Overall Study||74
216052|NCT00803361|529262|P1|COMPLETED|Overall Study||82
216053|NCT00803361|529261|P2|STARTED|Overall Study||102
216054|NCT00803361|529262|P1|STARTED|Overall Study||108
216055|NCT00803400|529282|P2|NOT COMPLETED|Overall Study||24
216056|NCT00803400|529283|P1|NOT COMPLETED|Overall Study||20
216057|NCT00803400|529282|P2|COMPLETED|Overall Study||51
216058|NCT00803400|529283|P1|COMPLETED|Overall Study||55
216059|NCT00803400|529282|P2|STARTED|Overall Study||75
216060|NCT00803400|529283|P1|STARTED|Overall Study||75
216061|NCT00803413|529297|P4|NOT COMPLETED|Overall Period||0
216062|NCT00803413|529298|P3|NOT COMPLETED|Overall Period||0
216063|NCT00803413|529299|P2|NOT COMPLETED|Overall Period||0
216064|NCT00803413|529300|P1|NOT COMPLETED|Overall Period||0
216065|NCT00803413|529297|P4|COMPLETED|Overall Period||30
216066|NCT00803413|529298|P3|COMPLETED|Overall Period||29
216067|NCT00803413|529299|P2|COMPLETED|Overall Period||32
216068|NCT00803413|529300|P1|COMPLETED|Overall Period||28
216069|NCT00803413|529297|P4|STARTED|Overall Period||30
216070|NCT00803413|529298|P3|STARTED|Overall Period||29
216071|NCT00803413|529299|P2|STARTED|Overall Period||32
216072|NCT00803413|529300|P1|STARTED|Overall Period||28
216073|NCT00803517|529312|P2|NOT COMPLETED|Overall Study||0
216074|NCT00803517|529313|P1|NOT COMPLETED|Overall Study||0
216075|NCT00803517|529312|P2|COMPLETED|Overall Study||12
216076|NCT00803517|529313|P1|COMPLETED|Overall Study||12
216077|NCT00803517|529312|P2|STARTED|Overall Study||12
216078|NCT00803517|529313|P1|STARTED|Overall Study||12
216079|NCT00803543|529321|P2|NOT COMPLETED|Overall Study||12
216080|NCT00803543|529322|P1|NOT COMPLETED|Overall Study||24
216081|NCT00803543|529321|P2|COMPLETED|Overall Study||22
216082|NCT00803543|529322|P1|COMPLETED|Overall Study||45
216083|NCT00803543|529321|P2|STARTED|Overall Study||34
216084|NCT00803543|529322|P1|STARTED|Overall Study||69
216085|NCT00803595|529337|P3|NOT COMPLETED|Overall Study||16
216086|NCT00803595|529338|P2|NOT COMPLETED|Overall Study||8
216087|NCT00803595|529339|P1|NOT COMPLETED|Overall Study||15
216088|NCT00803595|529337|P3|COMPLETED|Overall Study||322
216089|NCT00803595|529338|P2|COMPLETED|Overall Study||319
216090|NCT00803595|529339|P1|COMPLETED|Overall Study||322
216091|NCT00803595|529337|P3|STARTED|Overall Study||338
216092|NCT00803595|529338|P2|STARTED|Overall Study||327
216093|NCT00803595|529339|P1|STARTED|Overall Study||337
216094|NCT00803634|529352|P2|NOT COMPLETED|Overall Study||5
216095|NCT00803634|529353|P1|NOT COMPLETED|Overall Study||6
216096|NCT00803634|529352|P2|COMPLETED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|48
216097|NCT00803634|529353|P1|COMPLETED|Overall Study|All patients dosed with clevidipine [Safety population]|45
216098|NCT00803634|529352|P2|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with SOC antihypertensive therapy and confirmed to have AHF [mITT population]|41
216099|NCT00803634|529353|P1|mITT (Dosed & Have Confirmed AHF)|Overall Study|All patients dosed with clevidipine and confirmed to have AHF [mITT population]|44
216100|NCT00803634|529352|P2|STARTED|Overall Study|All patients dosed with SOC antihypertensive therapy [Safety population]|53
216101|NCT00803634|529353|P1|STARTED|Overall Study|All patients dosed with clevidipine [Safety population]|51
216102|NCT00803647|529379|P1|NOT COMPLETED|Overall Study||0
216103|NCT00803647|529379|P1|COMPLETED|Overall Study||20
216104|NCT00803647|529379|P1|STARTED|Overall Study||20
216105|NCT00803686|529390|P4|NOT COMPLETED|Part 2, Period 3||0
216106|NCT00803686|529391|P3|NOT COMPLETED|Part 2, Period 3||0
216107|NCT00803686|529392|P2|NOT COMPLETED|Part 2, Period 3||0
216108|NCT00803686|529393|P1|NOT COMPLETED|Part 2, Period 3||0
216109|NCT00803686|529390|P4|COMPLETED|Part 2, Period 3|All who started this period completed|4
216110|NCT00803686|529391|P3|COMPLETED|Part 2, Period 3|All who started this period completed|5
216111|NCT00803686|529392|P2|COMPLETED|Part 2, Period 3|No subjects were treated in this period.|0
216112|NCT00803686|529393|P1|COMPLETED|Part 2, Period 3|No subjects were treated in this period|0
216113|NCT00803686|529390|P4|STARTED|Part 2, Period 3|Of the 6 eligible, 2 elected not to continue into Period 3.|4
216114|NCT00803686|529391|P3|STARTED|Part 2, Period 3|Of the 6 eligible, 1 elected not to continue into Period 3.|5
216115|NCT00803686|529392|P2|STARTED|Part 2, Period 3|No subjects were treated in this period.|0
216116|NCT00803686|529393|P1|STARTED|Part 2, Period 3|No subjects were treated in this period|0
216117|NCT00803686|529390|P4|NOT COMPLETED|Part 1, Period 2||0
216118|NCT00803686|529391|P3|NOT COMPLETED|Part 1, Period 2||0
216119|NCT00803686|529392|P2|NOT COMPLETED|Part 1, Period 2||0
216120|NCT00803686|529393|P1|NOT COMPLETED|Part 1, Period 2||0
216121|NCT00803686|529390|P4|COMPLETED|Part 1, Period 2|No subjects treated.|0
216122|NCT00803686|529391|P3|COMPLETED|Part 1, Period 2|No subjects treated.|0
216123|NCT00803686|529392|P2|COMPLETED|Part 1, Period 2||6
216124|NCT00803686|529393|P1|COMPLETED|Part 1, Period 2||6
216125|NCT00803686|529390|P4|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
216126|NCT00803686|529391|P3|STARTED|Part 1, Period 2|No subjects were to be treated until after Periods 1 and 2.|0
216127|NCT00803686|529392|P2|STARTED|Part 1, Period 2||6
216128|NCT00803686|529393|P1|STARTED|Part 1, Period 2||6
216129|NCT00803686|529390|P4|NOT COMPLETED|Part 1, Period 1||0
216130|NCT00803686|529391|P3|NOT COMPLETED|Part 1, Period 1||0
216131|NCT00803686|529392|P2|NOT COMPLETED|Part 1, Period 1||0
216132|NCT00803686|529393|P1|NOT COMPLETED|Part 1, Period 1||0
216133|NCT00803686|529390|P4|COMPLETED|Part 1, Period 1||0
216134|NCT00803686|529391|P3|COMPLETED|Part 1, Period 1||0
216135|NCT00803686|529392|P2|COMPLETED|Part 1, Period 1||6
216136|NCT00803686|529393|P1|COMPLETED|Part 1, Period 1||6
216137|NCT00803686|529390|P4|STARTED|Part 1, Period 1||0
216138|NCT00803686|529391|P3|STARTED|Part 1, Period 1||0
216139|NCT00803686|529392|P2|STARTED|Part 1, Period 1||6
216140|NCT00803686|529393|P1|STARTED|Part 1, Period 1||6
216141|NCT00803712|529413|P2|NOT COMPLETED|Overall Study||27
216142|NCT00803712|529414|P1|NOT COMPLETED|Overall Study||36
216143|NCT00803712|529413|P2|COMPLETED|Overall Study|128 participants randomized to the control group completed the study|128
216144|NCT00803712|529414|P1|COMPLETED|Overall Study|118 participants randomized to the cinacalcet group completed the study|118
216145|NCT00803712|529413|P2|Safety Analysis Set|Overall Study|Randomized to the control group|154
216235|NCT00804648|529660|P5|STARTED|Third Invervention||4
216146|NCT00803712|529414|P1|Safety Analysis Set|Overall Study|Rz'ed to cinacalcet and received at least 1 dose, or to control but received cinacalcet throughout|155
216147|NCT00803712|529413|P2|Full Analysis Set|Overall Study|151 participants randomized and had at least one PTH concentration available after study day 1.|151
216148|NCT00803712|529414|P1|Full Analysis Set|Overall Study|153 participants randomized and had at least one PTH concentration available after study day 1.|153
216149|NCT00803712|529413|P2|STARTED|Overall Study|155 participants were randomized to the control group|155
216150|NCT00803712|529414|P1|STARTED|Overall Study|154 participants were randomized to the cinacalcet group|154
216151|NCT00803738|529480|P2|NOT COMPLETED|Overall Study||110
216152|NCT00803738|529481|P1|NOT COMPLETED|Overall Study||94
216153|NCT00803738|529480|P2|COMPLETED|Overall Study||176
216154|NCT00803738|529481|P1|COMPLETED|Overall Study||192
216155|NCT00803738|529480|P2|STARTED|Overall Study||286
216156|NCT00803738|529481|P1|STARTED|Overall Study||286
216157|NCT00803751|529493|P2|NOT COMPLETED|Overall Study||0
216158|NCT00803751|529494|P1|NOT COMPLETED|Overall Study||0
216159|NCT00803751|529493|P2|COMPLETED|Overall Study||23
216160|NCT00803751|529494|P1|COMPLETED|Overall Study||26
216161|NCT00803751|529493|P2|STARTED|Overall Study||23
216162|NCT00803751|529494|P1|STARTED|Overall Study||26
216163|NCT00803777|529510|P1|NOT COMPLETED|Overall Study||0
216164|NCT00803777|529510|P1|COMPLETED|Overall Study||147
216165|NCT00803777|529510|P1|STARTED|Overall Study||147
216166|NCT00803790|529520|P4|NOT COMPLETED|Period 2||1
216167|NCT00803790|529521|P3|NOT COMPLETED|Period 2||1
216168|NCT00803790|529522|P2|NOT COMPLETED|Period 2||0
216169|NCT00803790|529523|P1|NOT COMPLETED|Period 2||2
216170|NCT00803790|529520|P4|COMPLETED|Period 2||30
216171|NCT00803790|529521|P3|COMPLETED|Period 2||30
216172|NCT00803790|529522|P2|COMPLETED|Period 2||114
216173|NCT00803790|529523|P1|COMPLETED|Period 2||114
216174|NCT00803790|529520|P4|STARTED|Period 2||31
216175|NCT00803790|529521|P3|STARTED|Period 2||31
216176|NCT00803790|529522|P2|STARTED|Period 2||114
216177|NCT00803790|529523|P1|STARTED|Period 2||116
216178|NCT00803790|529520|P4|NOT COMPLETED|Period 1||4
216179|NCT00803790|529521|P3|NOT COMPLETED|Period 1||1
216180|NCT00803790|529522|P2|NOT COMPLETED|Period 1||12
216181|NCT00803790|529523|P1|NOT COMPLETED|Period 1||9
216182|NCT00803790|529520|P4|COMPLETED|Period 1||31
216183|NCT00803790|529521|P3|COMPLETED|Period 1||31
216184|NCT00803790|529522|P2|COMPLETED|Period 1||114
216185|NCT00803790|529523|P1|COMPLETED|Period 1||116
216186|NCT00803790|529520|P4|STARTED|Period 1||35
216187|NCT00803790|529521|P3|STARTED|Period 1||32
216188|NCT00803790|529522|P2|STARTED|Period 1||126
216189|NCT00803790|529523|P1|STARTED|Period 1||125
216190|NCT00803959|529536|P2|NOT COMPLETED|Overall Study||51
216191|NCT00803959|529537|P1|NOT COMPLETED|Overall Study||56
216192|NCT00803959|529536|P2|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=264).|264
216193|NCT00803959|529537|P1|COMPLETED|Overall Study|Because it is a non-inferiority trial, the PP analysis was the main analysis (n=259).|259
216194|NCT00803959|529536|P2|ITT Analysis With Primary Outcome Data|Overall Study||272
216195|NCT00803959|529537|P1|ITT Analysis With Primary Outcome Data|Overall Study||266
216196|NCT00803959|529536|P2|STARTED|Overall Study||315
216197|NCT00803959|529537|P1|STARTED|Overall Study||315
216198|NCT00804193|529570|P3|NOT COMPLETED|Overall Study||32
216199|NCT00804193|529571|P2|NOT COMPLETED|Overall Study||44
216200|NCT00804193|529572|P1|NOT COMPLETED|Overall Study||39
216201|NCT00804193|529570|P3|COMPLETED|Overall Study||77
216202|NCT00804193|529571|P2|COMPLETED|Overall Study||180
216203|NCT00804193|529572|P1|COMPLETED|Overall Study||181
216204|NCT00804193|529570|P3|STARTED|Overall Study||109
216205|NCT00804193|529571|P2|STARTED|Overall Study||224
216206|NCT00804193|529572|P1|STARTED|Overall Study||220
216207|NCT00804570|529588|P2|NOT COMPLETED|Overall Study||94
216208|NCT00804570|529589|P1|NOT COMPLETED|Overall Study||72
216209|NCT00804570|529588|P2|COMPLETED|Overall Study||94
216210|NCT00804570|529589|P1|COMPLETED|Overall Study||115
216211|NCT00804570|529588|P2|STARTED|Overall Study||188
216212|NCT00804570|529589|P1|STARTED|Overall Study||187
216213|NCT00804596|529645|P1|NOT COMPLETED|Overall Study||0
216214|NCT00804596|529645|P1|COMPLETED|Overall Study||74
216215|NCT00804596|529645|P1|STARTED|Overall Study||74
216216|NCT00804609|529652|P2|NOT COMPLETED|Overall Study||1
216217|NCT00804609|529653|P1|NOT COMPLETED|Overall Study||0
216218|NCT00804609|529652|P2|COMPLETED|Overall Study||14
216219|NCT00804609|529653|P1|COMPLETED|Overall Study||15
216220|NCT00804609|529652|P2|STARTED|Overall Study||15
216221|NCT00804609|529653|P1|STARTED|Overall Study||15
216222|NCT00804648|529659|P6|NOT COMPLETED|Third Invervention||0
216223|NCT00804648|529660|P5|NOT COMPLETED|Third Invervention||0
216224|NCT00804648|529661|P4|NOT COMPLETED|Third Invervention||0
216225|NCT00804648|529662|P3|NOT COMPLETED|Third Invervention||0
216226|NCT00804648|529663|P2|NOT COMPLETED|Third Invervention||0
216227|NCT00804648|529664|P1|NOT COMPLETED|Third Invervention||0
216228|NCT00804648|529659|P6|COMPLETED|Third Invervention||8
216229|NCT00804648|529660|P5|COMPLETED|Third Invervention||4
216230|NCT00804648|529661|P4|COMPLETED|Third Invervention||4
216231|NCT00804648|529662|P3|COMPLETED|Third Invervention||6
216232|NCT00804648|529663|P2|COMPLETED|Third Invervention||5
216233|NCT00804648|529664|P1|COMPLETED|Third Invervention||3
216234|NCT00804648|529659|P6|STARTED|Third Invervention||8
216236|NCT00804648|529661|P4|STARTED|Third Invervention||4
216237|NCT00804648|529662|P3|STARTED|Third Invervention||6
216238|NCT00804648|529663|P2|STARTED|Third Invervention||5
216239|NCT00804648|529664|P1|STARTED|Third Invervention||3
216240|NCT00804648|529659|P6|NOT COMPLETED|Second Intervention||0
216241|NCT00804648|529660|P5|NOT COMPLETED|Second Intervention||0
216242|NCT00804648|529661|P4|NOT COMPLETED|Second Intervention||0
216243|NCT00804648|529662|P3|NOT COMPLETED|Second Intervention||0
216244|NCT00804648|529663|P2|NOT COMPLETED|Second Intervention||0
216245|NCT00804648|529664|P1|NOT COMPLETED|Second Intervention||0
216246|NCT00804648|529659|P6|COMPLETED|Second Intervention||8
216247|NCT00804648|529660|P5|COMPLETED|Second Intervention||4
216248|NCT00804648|529661|P4|COMPLETED|Second Intervention||4
216249|NCT00804648|529662|P3|COMPLETED|Second Intervention||6
216250|NCT00804648|529663|P2|COMPLETED|Second Intervention||5
216251|NCT00804648|529664|P1|COMPLETED|Second Intervention||3
216252|NCT00804648|529659|P6|STARTED|Second Intervention||8
216253|NCT00804648|529660|P5|STARTED|Second Intervention||4
216254|NCT00804648|529661|P4|STARTED|Second Intervention||4
216255|NCT00804648|529662|P3|STARTED|Second Intervention||6
216256|NCT00804648|529663|P2|STARTED|Second Intervention||5
216257|NCT00804648|529664|P1|STARTED|Second Intervention||3
216258|NCT00804648|529659|P6|NOT COMPLETED|First Intervention||0
216259|NCT00804648|529660|P5|NOT COMPLETED|First Intervention||0
216260|NCT00804648|529661|P4|NOT COMPLETED|First Intervention||0
216261|NCT00804648|529662|P3|NOT COMPLETED|First Intervention||0
216262|NCT00804648|529663|P2|NOT COMPLETED|First Intervention||0
216263|NCT00804648|529664|P1|NOT COMPLETED|First Intervention||0
216264|NCT00804648|529659|P6|COMPLETED|First Intervention||8
216265|NCT00804648|529660|P5|COMPLETED|First Intervention||4
216266|NCT00804648|529661|P4|COMPLETED|First Intervention||4
216267|NCT00804648|529662|P3|COMPLETED|First Intervention||6
216268|NCT00804648|529663|P2|COMPLETED|First Intervention||5
216269|NCT00804648|529664|P1|COMPLETED|First Intervention||3
216270|NCT00804648|529659|P6|STARTED|First Intervention||8
216271|NCT00804648|529660|P5|STARTED|First Intervention||4
216272|NCT00804648|529661|P4|STARTED|First Intervention||4
216273|NCT00804648|529662|P3|STARTED|First Intervention||6
216274|NCT00804648|529663|P2|STARTED|First Intervention||5
216275|NCT00804648|529664|P1|STARTED|First Intervention||3
216276|NCT00804687|529705|P6|NOT COMPLETED|Period 5: Treatment Period||0
216277|NCT00804687|529706|P5|NOT COMPLETED|Period 5: Treatment Period||1
216278|NCT00804687|529707|P4|NOT COMPLETED|Period 5: Treatment Period||0
216279|NCT00804687|529708|P3|NOT COMPLETED|Period 5: Treatment Period||1
216280|NCT00804687|529709|P2|NOT COMPLETED|Period 5: Treatment Period||0
216281|NCT00804687|529710|P1|NOT COMPLETED|Period 5: Treatment Period||1
216282|NCT00804687|529705|P6|COMPLETED|Period 5: Treatment Period||8
216283|NCT00804687|529706|P5|COMPLETED|Period 5: Treatment Period||8
216284|NCT00804687|529707|P4|COMPLETED|Period 5: Treatment Period||8
216285|NCT00804687|529708|P3|COMPLETED|Period 5: Treatment Period||8
216286|NCT00804687|529709|P2|COMPLETED|Period 5: Treatment Period||9
216287|NCT00804687|529710|P1|COMPLETED|Period 5: Treatment Period||8
216288|NCT00804687|529705|P6|STARTED|Period 5: Treatment Period||8
216289|NCT00804687|529706|P5|STARTED|Period 5: Treatment Period||9
216290|NCT00804687|529707|P4|STARTED|Period 5: Treatment Period||8
216291|NCT00804687|529708|P3|STARTED|Period 5: Treatment Period||9
216292|NCT00804687|529709|P2|STARTED|Period 5: Treatment Period||9
216293|NCT00804687|529710|P1|STARTED|Period 5: Treatment Period||9
216294|NCT00804687|529705|P6|NOT COMPLETED|Period 4: Washout Period||0
216295|NCT00804687|529706|P5|NOT COMPLETED|Period 4: Washout Period||0
216296|NCT00804687|529707|P4|NOT COMPLETED|Period 4: Washout Period||0
216297|NCT00804687|529708|P3|NOT COMPLETED|Period 4: Washout Period||0
216298|NCT00804687|529709|P2|NOT COMPLETED|Period 4: Washout Period||0
216299|NCT00804687|529710|P1|NOT COMPLETED|Period 4: Washout Period||0
216300|NCT00804687|529705|P6|COMPLETED|Period 4: Washout Period||8
216301|NCT00804687|529706|P5|COMPLETED|Period 4: Washout Period||9
216302|NCT00804687|529707|P4|COMPLETED|Period 4: Washout Period||8
216303|NCT00804687|529708|P3|COMPLETED|Period 4: Washout Period||9
216304|NCT00804687|529709|P2|COMPLETED|Period 4: Washout Period||9
216305|NCT00804687|529710|P1|COMPLETED|Period 4: Washout Period||9
216306|NCT00804687|529705|P6|STARTED|Period 4: Washout Period||8
216307|NCT00804687|529706|P5|STARTED|Period 4: Washout Period||9
216308|NCT00804687|529707|P4|STARTED|Period 4: Washout Period||8
216309|NCT00804687|529708|P3|STARTED|Period 4: Washout Period||9
216310|NCT00804687|529709|P2|STARTED|Period 4: Washout Period||9
216311|NCT00804687|529710|P1|STARTED|Period 4: Washout Period||9
216312|NCT00804687|529705|P6|NOT COMPLETED|Period 3: Treatment Period||0
216313|NCT00804687|529706|P5|NOT COMPLETED|Period 3: Treatment Period||0
216314|NCT00804687|529707|P4|NOT COMPLETED|Period 3: Treatment Period||1
216315|NCT00804687|529708|P3|NOT COMPLETED|Period 3: Treatment Period||0
216316|NCT00804687|529709|P2|NOT COMPLETED|Period 3: Treatment Period||0
216317|NCT00804687|529710|P1|NOT COMPLETED|Period 3: Treatment Period||0
216318|NCT00804687|529705|P6|COMPLETED|Period 3: Treatment Period||8
216319|NCT00804687|529706|P5|COMPLETED|Period 3: Treatment Period||9
216320|NCT00804687|529707|P4|COMPLETED|Period 3: Treatment Period||8
216321|NCT00804687|529708|P3|COMPLETED|Period 3: Treatment Period||9
216322|NCT00804687|529709|P2|COMPLETED|Period 3: Treatment Period||9
216323|NCT00804687|529710|P1|COMPLETED|Period 3: Treatment Period||9
216324|NCT00804687|529705|P6|STARTED|Period 3: Treatment Period||8
216325|NCT00804687|529706|P5|STARTED|Period 3: Treatment Period||9
216326|NCT00804687|529707|P4|STARTED|Period 3: Treatment Period||9
216327|NCT00804687|529708|P3|STARTED|Period 3: Treatment Period||9
216328|NCT00804687|529709|P2|STARTED|Period 3: Treatment Period||9
216329|NCT00804687|529710|P1|STARTED|Period 3: Treatment Period||9
216330|NCT00804687|529705|P6|NOT COMPLETED|Period 2: Washout Period||0
216331|NCT00804687|529706|P5|NOT COMPLETED|Period 2: Washout Period||0
216332|NCT00804687|529707|P4|NOT COMPLETED|Period 2: Washout Period||0
216333|NCT00804687|529708|P3|NOT COMPLETED|Period 2: Washout Period||0
216334|NCT00804687|529709|P2|NOT COMPLETED|Period 2: Washout Period||0
216335|NCT00804687|529710|P1|NOT COMPLETED|Period 2: Washout Period||0
216336|NCT00804687|529705|P6|COMPLETED|Period 2: Washout Period||8
216337|NCT00804687|529706|P5|COMPLETED|Period 2: Washout Period||9
216338|NCT00804687|529707|P4|COMPLETED|Period 2: Washout Period||9
216339|NCT00804687|529708|P3|COMPLETED|Period 2: Washout Period||9
216340|NCT00804687|529709|P2|COMPLETED|Period 2: Washout Period||9
216341|NCT00804687|529710|P1|COMPLETED|Period 2: Washout Period||9
216342|NCT00804687|529705|P6|STARTED|Period 2: Washout Period||8
216343|NCT00804687|529706|P5|STARTED|Period 2: Washout Period||9
216344|NCT00804687|529707|P4|STARTED|Period 2: Washout Period||9
216345|NCT00804687|529708|P3|STARTED|Period 2: Washout Period||9
216346|NCT00804687|529709|P2|STARTED|Period 2: Washout Period||9
216347|NCT00804687|529710|P1|STARTED|Period 2: Washout Period||9
216348|NCT00804687|529705|P6|NOT COMPLETED|Period 1: Treatment Period||0
216349|NCT00804687|529706|P5|NOT COMPLETED|Period 1: Treatment Period||0
216350|NCT00804687|529707|P4|NOT COMPLETED|Period 1: Treatment Period||0
216351|NCT00804687|529708|P3|NOT COMPLETED|Period 1: Treatment Period||0
216352|NCT00804687|529709|P2|NOT COMPLETED|Period 1: Treatment Period||0
216353|NCT00804687|529710|P1|NOT COMPLETED|Period 1: Treatment Period||0
216354|NCT00804687|529705|P6|COMPLETED|Period 1: Treatment Period||8
216355|NCT00804687|529706|P5|COMPLETED|Period 1: Treatment Period||9
216356|NCT00804687|529707|P4|COMPLETED|Period 1: Treatment Period||9
216357|NCT00804687|529708|P3|COMPLETED|Period 1: Treatment Period||9
216358|NCT00804687|529709|P2|COMPLETED|Period 1: Treatment Period||9
216359|NCT00804687|529710|P1|COMPLETED|Period 1: Treatment Period||9
216360|NCT00804687|529705|P6|STARTED|Period 1: Treatment Period||8
216361|NCT00804687|529706|P5|STARTED|Period 1: Treatment Period||9
216362|NCT00804687|529707|P4|STARTED|Period 1: Treatment Period||9
216363|NCT00804687|529708|P3|STARTED|Period 1: Treatment Period||9
216364|NCT00804687|529709|P2|STARTED|Period 1: Treatment Period||9
216365|NCT00804687|529710|P1|STARTED|Period 1: Treatment Period||9
216366|NCT00804713|529727|P1|NOT COMPLETED|Overall Study||0
216367|NCT00804713|529727|P1|COMPLETED|Overall Study||1978
216368|NCT00804713|529727|P1|STARTED|Overall Study||1978
216369|NCT00804843|529737|P2|NOT COMPLETED|Overall Study||7
216370|NCT00804843|529738|P1|NOT COMPLETED|Overall Study||10
216371|NCT00804843|529737|P2|COMPLETED|Overall Study||43
216372|NCT00804843|529738|P1|COMPLETED|Overall Study||40
216373|NCT00804843|529737|P2|STARTED|Overall Study||50
216374|NCT00804843|529738|P1|STARTED|Overall Study||50
216375|NCT00804908|529751|P3|NOT COMPLETED|Overall Study||114
216376|NCT00804908|529752|P2|NOT COMPLETED|Overall Study||116
216377|NCT00804908|529753|P1|NOT COMPLETED|Overall Study||115
216378|NCT00804908|529751|P3|COMPLETED|Overall Study||1
216379|NCT00804908|529752|P2|COMPLETED|Overall Study||0
216380|NCT00804908|529753|P1|COMPLETED|Overall Study||0
216381|NCT00804908|529751|P3|STARTED|Overall Study||115
216382|NCT00804908|529752|P2|STARTED|Overall Study||116
216383|NCT00804908|529753|P1|STARTED|Overall Study||115
216384|NCT00804986|529788|P6|NOT COMPLETED|Overall Study||10
216385|NCT00804986|529789|P5|NOT COMPLETED|Overall Study||9
216386|NCT00804986|529790|P4|NOT COMPLETED|Overall Study||8
216387|NCT00804986|529791|P3|NOT COMPLETED|Overall Study||2
216388|NCT00804986|529792|P2|NOT COMPLETED|Overall Study||8
216389|NCT00804986|529793|P1|NOT COMPLETED|Overall Study||1
216390|NCT00804986|529788|P6|COMPLETED|Overall Study||31
216391|NCT00804986|529789|P5|COMPLETED|Overall Study||34
216392|NCT00804986|529790|P4|COMPLETED|Overall Study||34
216393|NCT00804986|529791|P3|COMPLETED|Overall Study||40
216394|NCT00804986|529792|P2|COMPLETED|Overall Study||35
216395|NCT00804986|529793|P1|COMPLETED|Overall Study||35
216396|NCT00804986|529788|P6|STARTED|Overall Study||41
216397|NCT00804986|529789|P5|STARTED|Overall Study||43
216398|NCT00804986|529790|P4|STARTED|Overall Study||42
216399|NCT00804986|529791|P3|STARTED|Overall Study||42
216400|NCT00804986|529792|P2|STARTED|Overall Study||43
216401|NCT00804986|529793|P1|STARTED|Overall Study||36
216402|NCT00805025|529885|P1|NOT COMPLETED|Overall Study||49
216403|NCT00805025|529885|P1|COMPLETED|Overall Study||82
216404|NCT00805025|529885|P1|Enrolled and Treated|Overall Study||89
216405|NCT00805025|529885|P1|STARTED|Overall Study||131
216406|NCT00805038|529893|P2|NOT COMPLETED|Overall Study||0
216407|NCT00805038|529894|P1|NOT COMPLETED|Overall Study||0
216408|NCT00805038|529893|P2|COMPLETED|Overall Study||92
216409|NCT00805038|529894|P1|COMPLETED|Overall Study||75
216410|NCT00805038|529893|P2|STARTED|Overall Study||92
216411|NCT00805038|529894|P1|STARTED|Overall Study||75
216412|NCT00805142|529902|P2|NOT COMPLETED|Maintenance Period||2
216413|NCT00805142|529903|P1|NOT COMPLETED|Maintenance Period||0
216414|NCT00805142|529902|P2|COMPLETED|Maintenance Period||30
216415|NCT00805142|529903|P1|COMPLETED|Maintenance Period||30
216416|NCT00805142|529902|P2|STARTED|Maintenance Period||32
216417|NCT00805142|529903|P1|STARTED|Maintenance Period||30
216418|NCT00805142|529902|P2|NOT COMPLETED|Titration Period||10
216419|NCT00805142|529903|P1|NOT COMPLETED|Titration Period||6
216420|NCT00805142|529902|P2|COMPLETED|Titration Period||32
216421|NCT00805142|529903|P1|COMPLETED|Titration Period||30
216422|NCT00805142|529902|P2|STARTED|Titration Period||42
216423|NCT00805142|529903|P1|STARTED|Titration Period||36
216424|NCT00805194|529929|P2|NOT COMPLETED|Overall Study||654
216425|NCT00805194|529930|P1|NOT COMPLETED|Overall Study||649
216426|NCT00805194|529929|P2|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013).|5
216427|NCT00805194|529930|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 February 2013)|6
216428|NCT00805194|529929|P2|STARTED|Overall Study|randomised patients|659
216429|NCT00805194|529930|P1|STARTED|Overall Study|randomised patients|655
216430|NCT00805285|529962|P1|NOT COMPLETED|Overall Study||1
216431|NCT00805285|529962|P1|COMPLETED|Overall Study||0
216432|NCT00805285|529962|P1|STARTED|Overall Study||1
216433|NCT00805389|529975|P5|NOT COMPLETED|Overall Study||13
216434|NCT00805389|529976|P4|NOT COMPLETED|Overall Study||17
216435|NCT00805389|529977|P3|NOT COMPLETED|Overall Study||12
216436|NCT00805389|529978|P2|NOT COMPLETED|Overall Study||5
216437|NCT00805389|529979|P1|NOT COMPLETED|Overall Study||7
216438|NCT00805389|529975|P5|COMPLETED|Overall Study||129
216439|NCT00805389|529976|P4|COMPLETED|Overall Study||128
216440|NCT00805389|529977|P3|COMPLETED|Overall Study||129
216441|NCT00805389|529978|P2|COMPLETED|Overall Study||137
216442|NCT00805389|529979|P1|COMPLETED|Overall Study||136
216443|NCT00805389|529975|P5|STARTED|Overall Study||142
216444|NCT00805389|529976|P4|STARTED|Overall Study||145
216445|NCT00805389|529977|P3|STARTED|Overall Study||141
216446|NCT00805389|529978|P2|STARTED|Overall Study||142
216447|NCT00805389|529979|P1|STARTED|Overall Study||143
216448|NCT00805467|530225|P4|NOT COMPLETED|Overall Study||237
216449|NCT00805467|530226|P3|NOT COMPLETED|Overall Study||103
216450|NCT00805467|530227|P2|NOT COMPLETED|Overall Study||34
216451|NCT00805467|530228|P1|NOT COMPLETED|Overall Study||0
216452|NCT00805467|530225|P4|COMPLETED|Overall Study|Ongoing when study terminated|144
216453|NCT00805467|530226|P3|COMPLETED|Overall Study|Ongoing when study terminated|80
216454|NCT00805467|530227|P2|COMPLETED|Overall Study|Ongoing when study terminated|25
216455|NCT00805467|530228|P1|COMPLETED|Overall Study|Ongoing when study terminated|1
216456|NCT00805467|530225|P4|Enrolled But Did Not Receive Treatment|Overall Study||0
216457|NCT00805467|530226|P3|Enrolled But Did Not Receive Treatment|Overall Study||0
216458|NCT00805467|530227|P2|Enrolled But Did Not Receive Treatment|Overall Study||0
216459|NCT00805467|530228|P1|Enrolled But Did Not Receive Treatment|Overall Study||0
216460|NCT00805467|530225|P4|STARTED|Overall Study|Patients who received treatment|381
216461|NCT00805467|530226|P3|STARTED|Overall Study|Patients who received treatment|183
216462|NCT00805467|530227|P2|STARTED|Overall Study|Patients who received treatment|59
216463|NCT00805467|530228|P1|STARTED|Overall Study|Patients who received treatment|1
216464|NCT00805480|530250|P4|NOT COMPLETED|Overall Study||5
216465|NCT00805480|530251|P3|NOT COMPLETED|Overall Study||12
216466|NCT00805480|530252|P2|NOT COMPLETED|Overall Study||7
216467|NCT00805480|530253|P1|NOT COMPLETED|Overall Study||14
216468|NCT00805480|530250|P4|COMPLETED|Overall Study||5
216469|NCT00805480|530251|P3|COMPLETED|Overall Study||19
216470|NCT00805480|530252|P2|COMPLETED|Overall Study||22
216471|NCT00805480|530253|P1|COMPLETED|Overall Study||16
216472|NCT00805480|530250|P4|Pharmacodynamic Analysis Set|Overall Study||10
216473|NCT00805480|530251|P3|Pharmacodynamic Analysis Set|Overall Study||29
216474|NCT00805480|530252|P2|Pharmacodynamic Analysis Set|Overall Study||25
216475|NCT00805480|530253|P1|Pharmacodynamic Analysis Set|Overall Study||30
216476|NCT00805480|530250|P4|STARTED|Overall Study||10
216477|NCT00805480|530251|P3|STARTED|Overall Study||31
216478|NCT00805480|530252|P2|STARTED|Overall Study||29
216479|NCT00805480|530253|P1|STARTED|Overall Study||30
216480|NCT00805493|530281|P3|NOT COMPLETED|Overall Study||1
216481|NCT00805493|530282|P2|NOT COMPLETED|Overall Study||0
216482|NCT00805493|530283|P1|NOT COMPLETED|Overall Study||2
216483|NCT00805493|530281|P3|COMPLETED|Overall Study||0
216484|NCT00805493|530282|P2|COMPLETED|Overall Study||2
216485|NCT00805493|530283|P1|COMPLETED|Overall Study||1
216486|NCT00805493|530281|P3|STARTED|Overall Study||1
216487|NCT00805493|530282|P2|STARTED|Overall Study||2
216488|NCT00805493|530283|P1|STARTED|Overall Study||3
216489|NCT00805545|530296|P2|NOT COMPLETED|Overall Study||3
216490|NCT00805545|530297|P1|NOT COMPLETED|Overall Study||6
216491|NCT00805545|530296|P2|COMPLETED|Overall Study||197
216492|NCT00805545|530297|P1|COMPLETED|Overall Study||194
216493|NCT00805545|530296|P2|STARTED|Overall Study||200
216494|NCT00805545|530297|P1|STARTED|Overall Study||200
216495|NCT00799903|530305|P2|NOT COMPLETED|Overall Study||278
216496|NCT00799903|530306|P1|NOT COMPLETED|Overall Study||273
216497|NCT00799903|530305|P2|COMPLETED|Overall Study||7646
216498|NCT00799903|530306|P1|COMPLETED|Overall Study||7631
216499|NCT00799903|530305|P2|STARTED|Overall Study||7924
216500|NCT00799903|530306|P1|STARTED|Overall Study||7904
216501|NCT00800202|530328|P2|NOT COMPLETED|Overall Study||24
216502|NCT00800202|530329|P1|NOT COMPLETED|Overall Study||67
216503|NCT00800202|530328|P2|COMPLETED|Overall Study||0
216504|NCT00800202|530329|P1|COMPLETED|Overall Study||0
216505|NCT00800202|530328|P2|STARTED|Overall Study||24
216506|NCT00800202|530329|P1|STARTED|Overall Study||67
216507|NCT00800254|530349|P2|NOT COMPLETED|Overall Study||6
216508|NCT00800254|530350|P1|NOT COMPLETED|Overall Study||5
216509|NCT00800254|530349|P2|COMPLETED|Overall Study||25
216510|NCT00800254|530350|P1|COMPLETED|Overall Study||30
216511|NCT00800254|530349|P2|3.5 Weeks Post-operatively|Overall Study||31
216512|NCT00800254|530350|P1|3.5 Weeks Post-operatively|Overall Study||31
216513|NCT00800254|530349|P2|STARTED|Overall Study||31
216514|NCT00800254|530350|P1|STARTED|Overall Study||35
216515|NCT00805675|530373|P3|NOT COMPLETED|Overall Study||1
216516|NCT00805675|530374|P2|NOT COMPLETED|Overall Study||0
216517|NCT00805675|530375|P1|NOT COMPLETED|Overall Study||0
216518|NCT00805675|530373|P3|COMPLETED|Overall Study||15
216519|NCT00805675|530374|P2|COMPLETED|Overall Study||14
216520|NCT00805675|530375|P1|COMPLETED|Overall Study||16
216521|NCT00805675|530373|P3|STARTED|Overall Study||16
216522|NCT00805675|530374|P2|STARTED|Overall Study||14
216523|NCT00805675|530375|P1|STARTED|Overall Study||16
216524|NCT00805740|530409|P2|NOT COMPLETED|Overall Study||4
216525|NCT00805740|530410|P1|NOT COMPLETED|Overall Study||11
216526|NCT00805740|530409|P2|COMPLETED|Overall Study||9
216527|NCT00805740|530410|P1|COMPLETED|Overall Study||17
216528|NCT00805740|530409|P2|Treated|Overall Study||13
216529|NCT00805740|530410|P1|Treated|Overall Study||26
216530|NCT00805740|530409|P2|STARTED|Overall Study||13
216531|NCT00805740|530410|P1|STARTED|Overall Study||28
216532|NCT00805766|530432|P1|NOT COMPLETED|Increased Dose Period||13
216533|NCT00805766|530432|P1|COMPLETED|Increased Dose Period||26
216534|NCT00805766|530432|P1|STARTED|Increased Dose Period||39
216535|NCT00805766|530432|P1|NOT COMPLETED|Screening Period||6
216536|NCT00805766|530432|P1|COMPLETED|Screening Period||39
216537|NCT00805766|530432|P1|STARTED|Screening Period||45
216538|NCT00805792|530439|P1|NOT COMPLETED|Overall Study||5
216539|NCT00805792|530439|P1|COMPLETED|Overall Study||28
216540|NCT00805792|530439|P1|STARTED|Overall Study||33
216541|NCT00805870|530449|P2|NOT COMPLETED|Overall Study||0
216542|NCT00805870|530450|P1|NOT COMPLETED|Overall Study||0
216543|NCT00805870|530449|P2|COMPLETED|Overall Study||10
216544|NCT00805870|530450|P1|COMPLETED|Overall Study||10
216545|NCT00805870|530449|P2|STARTED|Overall Study||10
216546|NCT00805870|530450|P1|STARTED|Overall Study||10
216547|NCT00805935|530466|P4|NOT COMPLETED|Overall Study||11
216548|NCT00805935|530467|P3|NOT COMPLETED|Overall Study||15
216549|NCT00805935|530468|P2|NOT COMPLETED|Overall Study||19
216550|NCT00805935|530469|P1|NOT COMPLETED|Overall Study||13
216551|NCT00805935|530466|P4|COMPLETED|Overall Study||19
216552|NCT00805935|530467|P3|COMPLETED|Overall Study||13
216553|NCT00805935|530468|P2|COMPLETED|Overall Study||8
216554|NCT00805935|530469|P1|COMPLETED|Overall Study||12
216555|NCT00805935|530466|P4|STARTED|Overall Study||30
216556|NCT00805935|530467|P3|STARTED|Overall Study||28
216557|NCT00805935|530468|P2|STARTED|Overall Study||27
216558|NCT00805935|530469|P1|STARTED|Overall Study||25
216559|NCT00805961|530521|P1|NOT COMPLETED|Maintenance Treatment||34
216560|NCT00805961|530521|P1|COMPLETED|Maintenance Treatment||23
216561|NCT00805961|530521|P1|STARTED|Maintenance Treatment||57
216562|NCT00805961|530521|P1|NOT COMPLETED|Treatment-Free Interval||7
216563|NCT00805961|530521|P1|COMPLETED|Treatment-Free Interval||57
216564|NCT00805961|530521|P1|STARTED|Treatment-Free Interval||64
216565|NCT00805961|530521|P1|NOT COMPLETED|Modality Therapy||4
216566|NCT00805961|530521|P1|COMPLETED|Modality Therapy||64
216567|NCT00805961|530521|P1|STARTED|Modality Therapy||68
216568|NCT00807846|530529|P2|NOT COMPLETED|Overall Study||4
216569|NCT00807846|530530|P1|NOT COMPLETED|Overall Study||12
216570|NCT00807846|530529|P2|COMPLETED|Overall Study||94
216571|NCT00807846|530530|P1|COMPLETED|Overall Study||88
216572|NCT00807846|530529|P2|STARTED|Overall Study||98
216573|NCT00807846|530530|P1|STARTED|Overall Study||100
216574|NCT00807885|530571|P9|NOT COMPLETED|Overall Study||0
216575|NCT00807885|530572|P8|NOT COMPLETED|Overall Study||0
216576|NCT00807885|530573|P7|NOT COMPLETED|Overall Study||0
216577|NCT00807885|530574|P6|NOT COMPLETED|Overall Study||1
216578|NCT00807885|530575|P5|NOT COMPLETED|Overall Study||0
216579|NCT00807885|530576|P4|NOT COMPLETED|Overall Study||0
216580|NCT00807885|530577|P3|NOT COMPLETED|Overall Study||0
216581|NCT00807885|530578|P2|NOT COMPLETED|Overall Study||0
216582|NCT00807885|530579|P1|NOT COMPLETED|Overall Study||0
216583|NCT00807885|530571|P9|COMPLETED|Overall Study||11
216584|NCT00807885|530572|P8|COMPLETED|Overall Study||11
216585|NCT00807885|530573|P7|COMPLETED|Overall Study||12
216586|NCT00807885|530574|P6|COMPLETED|Overall Study|Subject completed treatment, but lost to follow-up|11
216587|NCT00807885|530575|P5|COMPLETED|Overall Study||12
216588|NCT00807885|530576|P4|COMPLETED|Overall Study||10
216589|NCT00807885|530577|P3|COMPLETED|Overall Study||11
216590|NCT00807885|530578|P2|COMPLETED|Overall Study||11
216591|NCT00807885|530579|P1|COMPLETED|Overall Study||10
216592|NCT00807885|530571|P9|STARTED|Overall Study||11
216593|NCT00807885|530572|P8|STARTED|Overall Study||11
216594|NCT00807885|530573|P7|STARTED|Overall Study||12
216595|NCT00807885|530574|P6|STARTED|Overall Study||12
216596|NCT00807885|530575|P5|STARTED|Overall Study||12
216597|NCT00807885|530576|P4|STARTED|Overall Study||10
216598|NCT00807885|530577|P3|STARTED|Overall Study||11
216599|NCT00807885|530578|P2|STARTED|Overall Study||11
216600|NCT00807885|530579|P1|STARTED|Overall Study||10
216601|NCT00807937|530630|P4|NOT COMPLETED|Overall Study||15
216602|NCT00807937|530631|P3|NOT COMPLETED|Overall Study||14
216603|NCT00807937|530632|P2|NOT COMPLETED|Overall Study||25
216604|NCT00807937|530633|P1|NOT COMPLETED|Overall Study||27
216605|NCT00807937|530630|P4|COMPLETED|Overall Study||77
216606|NCT00807937|530631|P3|COMPLETED|Overall Study||78
216607|NCT00807937|530632|P2|COMPLETED|Overall Study||67
216608|NCT00807937|530633|P1|COMPLETED|Overall Study||66
216609|NCT00807937|530630|P4|STARTED|Overall Study||92
216610|NCT00807937|530631|P3|STARTED|Overall Study||92
216611|NCT00807937|530632|P2|STARTED|Overall Study||92
216612|NCT00807937|530633|P1|STARTED|Overall Study||93
216613|NCT00807989|530661|P2|NOT COMPLETED|Overall Study||2
216614|NCT00807989|530662|P1|NOT COMPLETED|Overall Study||3
216615|NCT00807989|530661|P2|COMPLETED|Overall Study||98
216616|NCT00807989|530662|P1|COMPLETED|Overall Study||104
216617|NCT00807989|530661|P2|STARTED|Overall Study||100
216618|NCT00807989|530662|P1|STARTED|Overall Study||107
216619|NCT00808015|530672|P1|NOT COMPLETED|Overall Study||344
216620|NCT00808015|530672|P1|COMPLETED|Overall Study||1033
216621|NCT00808015|530672|P1|Treated|Overall Study||1373
216622|NCT00808015|530672|P1|STARTED|Overall Study||1377
216623|NCT00808028|530688|P4|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||23
216624|NCT00808028|530689|P3|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||29
216625|NCT00808028|530690|P2|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||0
216626|NCT00808028|530691|P1|NOT COMPLETED|Stage 2 (Followed up to 48 Months )||11
216627|NCT00808028|530688|P4|COMPLETED|Stage 2 (Followed up to 48 Months )||128
216628|NCT00808028|530689|P3|COMPLETED|Stage 2 (Followed up to 48 Months )||141
216629|NCT00808028|530690|P2|COMPLETED|Stage 2 (Followed up to 48 Months )||0
216630|NCT00808028|530691|P1|COMPLETED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|69
216631|NCT00808028|530688|P4|STARTED|Stage 2 (Followed up to 48 Months )||151
216632|NCT00808028|530689|P3|STARTED|Stage 2 (Followed up to 48 Months )||170
216633|NCT00808028|530690|P2|STARTED|Stage 2 (Followed up to 48 Months )||0
216719|NCT00808340|530916|P1|STARTED|Third Intervention||4
216634|NCT00808028|530691|P1|STARTED|Stage 2 (Followed up to 48 Months )|Out of 511 completed participants in Stage 1, 89 did not enter Stage 2|80
216635|NCT00808028|530688|P4|NOT COMPLETED|Stage 1 (6 Months)||15
216636|NCT00808028|530689|P3|NOT COMPLETED|Stage 1 (6 Months)||7
216637|NCT00808028|530690|P2|NOT COMPLETED|Stage 1 (6 Months)||1
216638|NCT00808028|530691|P1|NOT COMPLETED|Stage 1 (6 Months)||5
216639|NCT00808028|530688|P4|COMPLETED|Stage 1 (6 Months)||183
216640|NCT00808028|530689|P3|COMPLETED|Stage 1 (6 Months)||191
216641|NCT00808028|530690|P2|COMPLETED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|21
216642|NCT00808028|530691|P1|COMPLETED|Stage 1 (6 Months)||116
216643|NCT00808028|530688|P4|STARTED|Stage 1 (6 Months)||198
216644|NCT00808028|530689|P3|STARTED|Stage 1 (6 Months)||198
216645|NCT00808028|530690|P2|STARTED|Stage 1 (6 Months)|Participants in rLP2086 60 mcg group participated only in Stage 1 and were not eligible for Stage 2|22
216646|NCT00808028|530691|P1|STARTED|Stage 1 (6 Months)||121
216647|NCT00808067|530729|P2|NOT COMPLETED|Overall Study||518
216648|NCT00808067|530730|P1|NOT COMPLETED|Overall Study||481
216649|NCT00808067|530729|P2|COMPLETED|Overall Study||2438
216650|NCT00808067|530730|P1|COMPLETED|Overall Study||2446
216651|NCT00808067|530729|P2|STARTED|Overall Study|Number of patients which are treated.|2956
216652|NCT00808067|530730|P1|STARTED|Overall Study|Number of patients which are treated.|2927
216653|NCT00808080|530762|P1|NOT COMPLETED|Overall Study||6
216654|NCT00808080|530762|P1|COMPLETED|Overall Study||0
216655|NCT00808080|530762|P1|STARTED|Overall Study||6
216656|NCT00808132|530771|P5|NOT COMPLETED|Overall Study||100
216657|NCT00808132|530772|P4|NOT COMPLETED|Overall Study||69
216658|NCT00808132|530773|P3|NOT COMPLETED|Overall Study||54
216659|NCT00808132|530774|P2|NOT COMPLETED|Overall Study||88
216660|NCT00808132|530775|P1|NOT COMPLETED|Overall Study||98
216661|NCT00808132|530771|P5|COMPLETED|Overall Study||383
216662|NCT00808132|530772|P4|COMPLETED|Overall Study||159
216663|NCT00808132|530773|P3|COMPLETED|Overall Study||185
216664|NCT00808132|530774|P2|COMPLETED|Overall Study||393
216665|NCT00808132|530775|P1|COMPLETED|Overall Study||357
216666|NCT00808132|530771|P5|Treated|Overall Study||474
216667|NCT00808132|530772|P4|Treated|Overall Study||220
216668|NCT00808132|530773|P3|Treated|Overall Study||230
216669|NCT00808132|530774|P2|Treated|Overall Study||474
216670|NCT00808132|530775|P1|Treated|Overall Study||445
216671|NCT00808132|530771|P5|STARTED|Overall Study||483
216672|NCT00808132|530772|P4|STARTED|Overall Study||228
216673|NCT00808132|530773|P3|STARTED|Overall Study||239
216674|NCT00808132|530774|P2|STARTED|Overall Study||481
216675|NCT00808132|530775|P1|STARTED|Overall Study||455
216676|NCT00808236|530849|P2|NOT COMPLETED|Overall Study||91
216677|NCT00808236|530850|P1|NOT COMPLETED|Overall Study||82
216678|NCT00808236|530849|P2|COMPLETED|Overall Study||13
216679|NCT00808236|530850|P1|COMPLETED|Overall Study||14
216680|NCT00808236|530849|P2|Admitted to Hospital|Overall Study|Died during transport to hospital(1)|42
216681|NCT00808236|530850|P1|Admitted to Hospital|Overall Study|Died during transport to hospital(2); DNAR determination was made at hospital(1)|30
216682|NCT00808236|530849|P2|Achieved ROSC|Overall Study||43
216683|NCT00808236|530850|P1|Achieved ROSC|Overall Study||33
216684|NCT00808236|530849|P2|Included in Analysis|Overall Study|Crossed over & withdrawn (1); Lost to Follow-Up: taken to non-participating hospital (1)|99
216685|NCT00808236|530850|P1|Included in Analysis|Overall Study|Lost to Follow-Up: taken to non-participating hospital (1)|83
216686|NCT00808236|530849|P2|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: Terminal(1); Asphyxia(1), In-hospital(1)|101
216687|NCT00808236|530850|P1|Met Eligibility Criteria|Overall Study|Pre-defined exclusions: DNAR(4); had pulse(2); CVA(2); Drug OD(2); On home oxygen(1); Unwitnessed(1)|84
216688|NCT00808236|530849|P2|STARTED|Overall Study||104
216689|NCT00808236|530850|P1|STARTED|Overall Study||96
216690|NCT00808249|530882|P4|NOT COMPLETED|Overall Study||16
216691|NCT00808249|530883|P3|NOT COMPLETED|Overall Study||22
216692|NCT00808249|530884|P2|NOT COMPLETED|Overall Study||15
216693|NCT00808249|530885|P1|NOT COMPLETED|Overall Study||17
216694|NCT00808249|530882|P4|COMPLETED|Overall Study||90
216695|NCT00808249|530883|P3|COMPLETED|Overall Study||83
216696|NCT00808249|530884|P2|COMPLETED|Overall Study||91
216697|NCT00808249|530885|P1|COMPLETED|Overall Study||90
216698|NCT00808249|530882|P4|STARTED|Overall Study||106
216699|NCT00808249|530883|P3|STARTED|Overall Study||105
216700|NCT00808249|530884|P2|STARTED|Overall Study||106
216701|NCT00808249|530885|P1|STARTED|Overall Study||107
216702|NCT00808340|530911|P6|NOT COMPLETED|Third Intervention||0
216703|NCT00808340|530912|P5|NOT COMPLETED|Third Intervention||0
216704|NCT00808340|530913|P4|NOT COMPLETED|Third Intervention||0
216705|NCT00808340|530914|P3|NOT COMPLETED|Third Intervention||0
216706|NCT00808340|530915|P2|NOT COMPLETED|Third Intervention||0
216707|NCT00808340|530916|P1|NOT COMPLETED|Third Intervention||0
216708|NCT00808340|530911|P6|COMPLETED|Third Intervention||6
216709|NCT00808340|530912|P5|COMPLETED|Third Intervention||5
216710|NCT00808340|530913|P4|COMPLETED|Third Intervention||3
216711|NCT00808340|530914|P3|COMPLETED|Third Intervention||7
216712|NCT00808340|530915|P2|COMPLETED|Third Intervention||9
216713|NCT00808340|530916|P1|COMPLETED|Third Intervention||4
216714|NCT00808340|530911|P6|STARTED|Third Intervention||6
216715|NCT00808340|530912|P5|STARTED|Third Intervention||5
216716|NCT00808340|530913|P4|STARTED|Third Intervention||3
216717|NCT00808340|530914|P3|STARTED|Third Intervention||7
216718|NCT00808340|530915|P2|STARTED|Third Intervention||9
216720|NCT00808340|530911|P6|NOT COMPLETED|Second Intervention||0
216721|NCT00808340|530912|P5|NOT COMPLETED|Second Intervention||0
216722|NCT00808340|530913|P4|NOT COMPLETED|Second Intervention||0
216723|NCT00808340|530914|P3|NOT COMPLETED|Second Intervention||0
216724|NCT00808340|530915|P2|NOT COMPLETED|Second Intervention||0
216725|NCT00808340|530916|P1|NOT COMPLETED|Second Intervention||0
216726|NCT00808340|530911|P6|COMPLETED|Second Intervention||6
216727|NCT00808340|530912|P5|COMPLETED|Second Intervention||5
216728|NCT00808340|530913|P4|COMPLETED|Second Intervention||3
216729|NCT00808340|530914|P3|COMPLETED|Second Intervention||7
216730|NCT00808340|530915|P2|COMPLETED|Second Intervention||9
216731|NCT00808340|530916|P1|COMPLETED|Second Intervention||4
216732|NCT00808340|530911|P6|STARTED|Second Intervention||6
216733|NCT00808340|530912|P5|STARTED|Second Intervention||5
216734|NCT00808340|530913|P4|STARTED|Second Intervention||3
216735|NCT00808340|530914|P3|STARTED|Second Intervention||7
216736|NCT00808340|530915|P2|STARTED|Second Intervention||9
216737|NCT00808340|530916|P1|STARTED|Second Intervention||4
216738|NCT00808340|530911|P6|NOT COMPLETED|First Intervention||0
216739|NCT00808340|530912|P5|NOT COMPLETED|First Intervention||0
216740|NCT00808340|530913|P4|NOT COMPLETED|First Intervention||0
216741|NCT00808340|530914|P3|NOT COMPLETED|First Intervention||0
216742|NCT00808340|530915|P2|NOT COMPLETED|First Intervention||0
216743|NCT00808340|530916|P1|NOT COMPLETED|First Intervention||0
216744|NCT00808340|530911|P6|COMPLETED|First Intervention||6
216745|NCT00808340|530912|P5|COMPLETED|First Intervention||5
216746|NCT00808340|530913|P4|COMPLETED|First Intervention||3
216747|NCT00808340|530914|P3|COMPLETED|First Intervention||7
216748|NCT00808340|530915|P2|COMPLETED|First Intervention||9
216749|NCT00808340|530916|P1|COMPLETED|First Intervention||4
216750|NCT00808340|530911|P6|STARTED|First Intervention||6
216751|NCT00808340|530912|P5|STARTED|First Intervention||5
216752|NCT00808340|530913|P4|STARTED|First Intervention||3
216753|NCT00808340|530914|P3|STARTED|First Intervention||7
216754|NCT00808340|530915|P2|STARTED|First Intervention||9
216755|NCT00808340|530916|P1|STARTED|First Intervention||4
216756|NCT00808405|530935|P2|NOT COMPLETED|Overall Study||0
216757|NCT00808405|530936|P1|NOT COMPLETED|Overall Study||0
216758|NCT00808405|530935|P2|COMPLETED|Overall Study||27
216759|NCT00808405|530936|P1|COMPLETED|Overall Study||61
216760|NCT00808405|530935|P2|STARTED|Overall Study||27
216761|NCT00808405|530936|P1|STARTED|Overall Study||61
216762|NCT00808444|530946|P2|NOT COMPLETED|Overall Study||1
216763|NCT00808444|530947|P1|NOT COMPLETED|Overall Study||1
216764|NCT00808444|530946|P2|COMPLETED|Overall Study||232
216765|NCT00808444|530947|P1|COMPLETED|Overall Study||232
216766|NCT00808444|530946|P2|STARTED|Overall Study||233
216767|NCT00808444|530947|P1|STARTED|Overall Study||233
216768|NCT00808470|530987|P2|NOT COMPLETED|Overall Study||0
216769|NCT00808470|530988|P1|NOT COMPLETED|Overall Study||2
216770|NCT00808470|530987|P2|COMPLETED|Overall Study||35
216771|NCT00808470|530988|P1|COMPLETED|Overall Study||35
216772|NCT00808470|530987|P2|STARTED|Overall Study||35
216773|NCT00808470|530988|P1|STARTED|Overall Study||37
216774|NCT00808483|531002|P2|NOT COMPLETED|From 5 Months to 12 Months||0
216775|NCT00808483|531003|P1|NOT COMPLETED|From 5 Months to 12 Months||1
216776|NCT00808483|531002|P2|COMPLETED|From 5 Months to 12 Months||32
216777|NCT00808483|531003|P1|COMPLETED|From 5 Months to 12 Months||32
216778|NCT00808483|531002|P2|STARTED|From 5 Months to 12 Months||32
216779|NCT00808483|531003|P1|STARTED|From 5 Months to 12 Months||33
216780|NCT00808483|531002|P2|NOT COMPLETED|From 3 to 5 Months After Surgery||1
216781|NCT00808483|531003|P1|NOT COMPLETED|From 3 to 5 Months After Surgery||2
216782|NCT00808483|531002|P2|COMPLETED|From 3 to 5 Months After Surgery||32
216783|NCT00808483|531003|P1|COMPLETED|From 3 to 5 Months After Surgery||33
216784|NCT00808483|531002|P2|STARTED|From 3 to 5 Months After Surgery||33
216785|NCT00808483|531003|P1|STARTED|From 3 to 5 Months After Surgery||35
216786|NCT00808509|531025|P2|NOT COMPLETED|Observation Phase||0
216787|NCT00808509|531026|P1|NOT COMPLETED|Observation Phase||0
216788|NCT00808509|531025|P2|COMPLETED|Observation Phase||15
216789|NCT00808509|531026|P1|COMPLETED|Observation Phase||16
216790|NCT00808509|531025|P2|STARTED|Observation Phase|The observation phase was open to all participants|15
216791|NCT00808509|531026|P1|STARTED|Observation Phase|The observation phase was open to all participants|16
216792|NCT00808509|531025|P2|NOT COMPLETED|Randomized Phase||5
216793|NCT00808509|531026|P1|NOT COMPLETED|Randomized Phase||2
216794|NCT00808509|531025|P2|COMPLETED|Randomized Phase|Includes participants who received rescue therapy & follow-up for 12 weeks|11
216795|NCT00808509|531026|P1|COMPLETED|Randomized Phase||15
216796|NCT00808509|531025|P2|Received Rescue Therapy|Randomized Phase||9
216797|NCT00808509|531026|P1|Received Rescue Therapy|Randomized Phase||0
216798|NCT00808509|531025|P2|STARTED|Randomized Phase||16
216799|NCT00808509|531026|P1|STARTED|Randomized Phase||17
216800|NCT00808639|531122|P1|NOT COMPLETED|Overall Study||1
216801|NCT00808639|531122|P1|COMPLETED|Overall Study|One patient went off treatment due to disease progression before surgery.|38
216802|NCT00808639|531122|P1|STARTED|Overall Study||39
216803|NCT00808769|531128|P2|NOT COMPLETED|Second Intervention||0
216804|NCT00808769|531129|P1|NOT COMPLETED|Second Intervention||0
216805|NCT00808769|531128|P2|COMPLETED|Second Intervention||15
216806|NCT00808769|531129|P1|COMPLETED|Second Intervention||15
216807|NCT00808769|531128|P2|STARTED|Second Intervention||15
216808|NCT00808769|531129|P1|STARTED|Second Intervention||15
216809|NCT00808769|531128|P2|NOT COMPLETED|First Intervention||0
216810|NCT00808769|531129|P1|NOT COMPLETED|First Intervention||0
216811|NCT00808769|531128|P2|COMPLETED|First Intervention||15
216812|NCT00808769|531129|P1|COMPLETED|First Intervention||15
216813|NCT00808769|531128|P2|STARTED|First Intervention||15
216814|NCT00808769|531129|P1|STARTED|First Intervention||15
216815|NCT00808808|531138|P3|NOT COMPLETED|Overall Study||2557
216816|NCT00808808|531139|P2|NOT COMPLETED|Overall Study||2437
216817|NCT00808808|531140|P1|NOT COMPLETED|Overall Study||2817
216818|NCT00808808|531138|P3|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1830
216819|NCT00808808|531139|P2|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1320
216820|NCT00808808|531140|P1|COMPLETED|Overall Study|Completed includes vaccinated employees who completed surveys.|1261
216821|NCT00808808|531138|P3|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|2132
216822|NCT00808808|531139|P2|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1489
216823|NCT00808808|531140|P1|Vaccinated|Overall Study|Vaccinated includes all employees who were vaccinated at the employee vaccination clinics.|1392
216824|NCT00808808|531138|P3|STARTED|Overall Study|Started includes all employees at participating sites.|4387
216825|NCT00808808|531139|P2|STARTED|Overall Study|Started includes all employees at participating sites|3757
216826|NCT00808808|531140|P1|STARTED|Overall Study|Started includes all employees at participating sites.|4078
216827|NCT00808834|531166|P2|NOT COMPLETED|Period 2||0
216828|NCT00808834|531167|P1|NOT COMPLETED|Period 2||0
216829|NCT00808834|531166|P2|COMPLETED|Period 2||99
216830|NCT00808834|531167|P1|COMPLETED|Period 2||97
216831|NCT00808834|531166|P2|STARTED|Period 2||99
216832|NCT00808834|531167|P1|STARTED|Period 2||97
216833|NCT00808834|531166|P2|NOT COMPLETED|Period 1||0
216834|NCT00808834|531167|P1|NOT COMPLETED|Period 1||0
216835|NCT00808834|531166|P2|COMPLETED|Period 1||99
216836|NCT00808834|531167|P1|COMPLETED|Period 1||97
216837|NCT00808834|531166|P2|STARTED|Period 1||99
216838|NCT00808834|531167|P1|STARTED|Period 1||97
216839|NCT00808899|531173|P1|NOT COMPLETED|Overall Study||4
216840|NCT00808899|531173|P1|COMPLETED|Overall Study||0
216841|NCT00808899|531173|P1|STARTED|Overall Study||4
216842|NCT00809055|531179|P2|NOT COMPLETED|Overall Study||7
216843|NCT00809055|531180|P1|NOT COMPLETED|Overall Study||9
216844|NCT00809055|531179|P2|COMPLETED|Overall Study||30
216845|NCT00809055|531180|P1|COMPLETED|Overall Study||28
216846|NCT00809055|531179|P2|STARTED|Overall Study||37
216847|NCT00809055|531180|P1|STARTED|Overall Study||37
216848|NCT00809094|531206|P2|NOT COMPLETED|Overall Study||1
216849|NCT00809094|531207|P1|NOT COMPLETED|Overall Study||0
216850|NCT00809094|531206|P2|COMPLETED|Overall Study||33
216851|NCT00809094|531207|P1|COMPLETED|Overall Study||36
216852|NCT00809094|531206|P2|STARTED|Overall Study||34
216853|NCT00809094|531207|P1|STARTED|Overall Study||36
216854|NCT00809133|531239|P14|NOT COMPLETED|Overall Study||7
216855|NCT00809133|531240|P13|NOT COMPLETED|Overall Study||5
216856|NCT00809133|531241|P12|NOT COMPLETED|Overall Study||8
216857|NCT00809133|531242|P11|NOT COMPLETED|Overall Study||6
216858|NCT00809133|531243|P10|NOT COMPLETED|Overall Study||9
216859|NCT00809133|531244|P9|NOT COMPLETED|Overall Study||3
216860|NCT00809133|531245|P8|NOT COMPLETED|Overall Study||8
216861|NCT00809133|531246|P7|NOT COMPLETED|Overall Study||6
216862|NCT00809133|531247|P6|NOT COMPLETED|Overall Study||7
216863|NCT00809133|531248|P5|NOT COMPLETED|Overall Study||5
216864|NCT00809133|531249|P4|NOT COMPLETED|Overall Study||3
216865|NCT00809133|531250|P3|NOT COMPLETED|Overall Study||6
216866|NCT00809133|531251|P2|NOT COMPLETED|Overall Study||7
216867|NCT00809133|531252|P1|NOT COMPLETED|Overall Study||3
216868|NCT00809133|531239|P14|COMPLETED|Overall Study||0
216869|NCT00809133|531240|P13|COMPLETED|Overall Study||0
216870|NCT00809133|531241|P12|COMPLETED|Overall Study||0
216871|NCT00809133|531242|P11|COMPLETED|Overall Study||0
216872|NCT00809133|531243|P10|COMPLETED|Overall Study||0
216873|NCT00809133|531244|P9|COMPLETED|Overall Study||0
216874|NCT00809133|531245|P8|COMPLETED|Overall Study||0
216875|NCT00809133|531246|P7|COMPLETED|Overall Study||0
216876|NCT00809133|531247|P6|COMPLETED|Overall Study||0
216877|NCT00809133|531248|P5|COMPLETED|Overall Study||0
216878|NCT00809133|531249|P4|COMPLETED|Overall Study||0
216879|NCT00809133|531250|P3|COMPLETED|Overall Study||0
216880|NCT00809133|531251|P2|COMPLETED|Overall Study||0
216881|NCT00809133|531252|P1|COMPLETED|Overall Study||0
216882|NCT00809133|531239|P14|STARTED|Overall Study||7
216883|NCT00809133|531240|P13|STARTED|Overall Study||5
216884|NCT00809133|531241|P12|STARTED|Overall Study||8
216885|NCT00809133|531242|P11|STARTED|Overall Study||6
216886|NCT00809133|531243|P10|STARTED|Overall Study||9
216887|NCT00809133|531244|P9|STARTED|Overall Study||3
216888|NCT00809133|531245|P8|STARTED|Overall Study||8
216889|NCT00809133|531246|P7|STARTED|Overall Study||6
216890|NCT00809133|531247|P6|STARTED|Overall Study||7
216891|NCT00809133|531248|P5|STARTED|Overall Study||5
216892|NCT00809133|531249|P4|STARTED|Overall Study||3
216893|NCT00809133|531250|P3|STARTED|Overall Study||6
216894|NCT00809133|531251|P2|STARTED|Overall Study||7
216895|NCT00809133|531252|P1|STARTED|Overall Study||3
216896|NCT00809146|531406|P2|NOT COMPLETED|Overall Study||0
216897|NCT00809146|531407|P1|NOT COMPLETED|Overall Study||0
216898|NCT00809146|531406|P2|COMPLETED|Overall Study||445
216899|NCT00809146|531407|P1|COMPLETED|Overall Study||448
216900|NCT00809146|531406|P2|STARTED|Overall Study||445
216901|NCT00809146|531407|P1|STARTED|Overall Study||448
216902|NCT00809159|531435|P6|NOT COMPLETED|Part 1 and 2||3
216903|NCT00809159|531436|P5|NOT COMPLETED|Part 1 and 2||6
216904|NCT00809159|531437|P4|NOT COMPLETED|Part 1 and 2||5
216905|NCT00809159|531438|P3|NOT COMPLETED|Part 1 and 2||10
216906|NCT00809159|531439|P2|NOT COMPLETED|Part 1 and 2||0
216907|NCT00809159|531440|P1|NOT COMPLETED|Part 1 and 2||0
216908|NCT00809159|531435|P6|COMPLETED|Part 1 and 2||3
216909|NCT00809159|531436|P5|COMPLETED|Part 1 and 2||6
216910|NCT00809159|531437|P4|COMPLETED|Part 1 and 2||7
216911|NCT00809159|531438|P3|COMPLETED|Part 1 and 2||20
216912|NCT00809159|531439|P2|COMPLETED|Part 1 and 2||0
216913|NCT00809159|531440|P1|COMPLETED|Part 1 and 2||0
216914|NCT00809159|531435|P6|PD Analysis Set|Part 1 and 2||6
216915|NCT00809159|531436|P5|PD Analysis Set|Part 1 and 2||12
216916|NCT00809159|531437|P4|PD Analysis Set|Part 1 and 2||12
216917|NCT00809159|531438|P3|PD Analysis Set|Part 1 and 2||28
216918|NCT00809159|531439|P2|PD Analysis Set|Part 1 and 2||0
216919|NCT00809159|531440|P1|PD Analysis Set|Part 1 and 2||0
216920|NCT00809159|531435|P6|PK Analysis Set|Part 1 and 2||6
216921|NCT00809159|531436|P5|PK Analysis Set|Part 1 and 2||12
216922|NCT00809159|531437|P4|PK Analysis Set|Part 1 and 2||12
216923|NCT00809159|531438|P3|PK Analysis Set|Part 1 and 2||30
216924|NCT00809159|531439|P2|PK Analysis Set|Part 1 and 2||0
216925|NCT00809159|531440|P1|PK Analysis Set|Part 1 and 2||0
216926|NCT00809159|531435|P6|STARTED|Part 1 and 2||6
216927|NCT00809159|531436|P5|STARTED|Part 1 and 2||12
216928|NCT00809159|531437|P4|STARTED|Part 1 and 2||12
216929|NCT00809159|531438|P3|STARTED|Part 1 and 2||30
216930|NCT00809159|531439|P2|STARTED|Part 1 and 2||0
216931|NCT00809159|531440|P1|STARTED|Part 1 and 2||0
216932|NCT00809159|531435|P6|NOT COMPLETED|Part 1||0
216933|NCT00809159|531436|P5|NOT COMPLETED|Part 1||0
216934|NCT00809159|531437|P4|NOT COMPLETED|Part 1||0
216935|NCT00809159|531438|P3|NOT COMPLETED|Part 1||0
216936|NCT00809159|531439|P2|NOT COMPLETED|Part 1||3
216937|NCT00809159|531440|P1|NOT COMPLETED|Part 1||8
216938|NCT00809159|531435|P6|COMPLETED|Part 1||0
216939|NCT00809159|531436|P5|COMPLETED|Part 1||0
216940|NCT00809159|531437|P4|COMPLETED|Part 1||0
216941|NCT00809159|531438|P3|COMPLETED|Part 1||0
216942|NCT00809159|531439|P2|COMPLETED|Part 1||3
216943|NCT00809159|531440|P1|COMPLETED|Part 1||16
216944|NCT00809159|531435|P6|PD Analysis Set|Part 1||0
216945|NCT00809159|531436|P5|PD Analysis Set|Part 1||0
216946|NCT00809159|531437|P4|PD Analysis Set|Part 1||0
216947|NCT00809159|531438|P3|PD Analysis Set|Part 1||0
216948|NCT00809159|531439|P2|PD Analysis Set|Part 1||6
216949|NCT00809159|531440|P1|PD Analysis Set|Part 1||23
216950|NCT00809159|531435|P6|PK Analysis Set|Part 1||0
216951|NCT00809159|531436|P5|PK Analysis Set|Part 1||0
216952|NCT00809159|531437|P4|PK Analysis Set|Part 1||0
216953|NCT00809159|531438|P3|PK Analysis Set|Part 1||0
216954|NCT00809159|531439|P2|PK Analysis Set|Part 1||6
216955|NCT00809159|531440|P1|PK Analysis Set|Part 1||24
216956|NCT00809159|531435|P6|STARTED|Part 1||0
216957|NCT00809159|531436|P5|STARTED|Part 1||0
216958|NCT00809159|531437|P4|STARTED|Part 1||0
216959|NCT00809159|531438|P3|STARTED|Part 1||0
216960|NCT00809159|531439|P2|STARTED|Part 1||6
216961|NCT00809159|531440|P1|STARTED|Part 1||24
216962|NCT00809185|531504|P1|NOT COMPLETED|Overall Study||0
216963|NCT00809185|531504|P1|COMPLETED|Overall Study||7
216964|NCT00809185|531504|P1|STARTED|Overall Study||7
216965|NCT00809276|531508|P1|NOT COMPLETED|Overall Study||0
216966|NCT00809276|531508|P1|COMPLETED|Overall Study||92
216967|NCT00809276|531508|P1|STARTED|Overall Study||92
216968|NCT00809328|531512|P1|NOT COMPLETED|Overall Study||29
216969|NCT00809328|531512|P1|COMPLETED|Overall Study||73
216970|NCT00809328|531512|P1|STARTED|Overall Study||102
216971|NCT00809445|531523|P3|NOT COMPLETED|6 Month Follow-up||24
216972|NCT00809445|531524|P2|NOT COMPLETED|6 Month Follow-up||23
216973|NCT00809445|531525|P1|NOT COMPLETED|6 Month Follow-up||24
216974|NCT00809445|531523|P3|COMPLETED|6 Month Follow-up||395
216975|NCT00809445|531524|P2|COMPLETED|6 Month Follow-up||410
216976|NCT00809445|531525|P1|COMPLETED|6 Month Follow-up||405
216977|NCT00809445|531523|P3|STARTED|6 Month Follow-up||419
216978|NCT00809445|531524|P2|STARTED|6 Month Follow-up||433
216979|NCT00809445|531525|P1|STARTED|6 Month Follow-up||429
216980|NCT00809445|531523|P3|NOT COMPLETED|1 Month Follow-up||4
216981|NCT00809445|531524|P2|NOT COMPLETED|1 Month Follow-up||4
216982|NCT00809445|531525|P1|NOT COMPLETED|1 Month Follow-up||2
216983|NCT00809445|531523|P3|COMPLETED|1 Month Follow-up||415
216984|NCT00809445|531524|P2|COMPLETED|1 Month Follow-up||429
216985|NCT00809445|531525|P1|COMPLETED|1 Month Follow-up||427
216986|NCT00809445|531523|P3|STARTED|1 Month Follow-up||419
216987|NCT00809445|531524|P2|STARTED|1 Month Follow-up||433
216988|NCT00809445|531525|P1|STARTED|1 Month Follow-up||429
216989|NCT00809458|531544|P2|NOT COMPLETED|Overall Study||1
216990|NCT00809458|531545|P1|NOT COMPLETED|Overall Study||1
216991|NCT00809458|531544|P2|COMPLETED|Overall Study||5
216992|NCT00809458|531545|P1|COMPLETED|Overall Study||8
216993|NCT00809458|531544|P2|STARTED|Overall Study||6
216994|NCT00809458|531545|P1|STARTED|Overall Study||9
216995|NCT00809471|531558|P3|NOT COMPLETED|Overall Study||17
216996|NCT00809471|531559|P2|NOT COMPLETED|Overall Study||20
216997|NCT00809471|531560|P1|NOT COMPLETED|Overall Study||20
216998|NCT00809471|531558|P3|COMPLETED|Overall Study||114
216999|NCT00809471|531559|P2|COMPLETED|Overall Study||109
217000|NCT00809471|531560|P1|COMPLETED|Overall Study||110
217001|NCT00809471|531558|P3|STARTED|Overall Study||131
217002|NCT00809471|531559|P2|STARTED|Overall Study||129
217003|NCT00809471|531560|P1|STARTED|Overall Study||130
217004|NCT00809523|531576|P2|NOT COMPLETED|Overall Study||4
217005|NCT00809523|531577|P1|NOT COMPLETED|Overall Study||7
217006|NCT00809523|531576|P2|COMPLETED|Overall Study||48
217007|NCT00809523|531577|P1|COMPLETED|Overall Study||47
217008|NCT00809523|531576|P2|STARTED|Overall Study||52
217009|NCT00809523|531577|P1|STARTED|Overall Study||54
217010|NCT00809614|531589|P2|NOT COMPLETED|Overall Study||4
217011|NCT00809614|531590|P1|NOT COMPLETED|Overall Study||3
217012|NCT00809614|531589|P2|COMPLETED|Overall Study||10
217013|NCT00809614|531590|P1|COMPLETED|Overall Study||25
217014|NCT00809614|531589|P2|Pharmacodynamic (PD) Set|Overall Study||13
217015|NCT00809614|531590|P1|Pharmacodynamic (PD) Set|Overall Study||24
217016|NCT00809614|531589|P2|Pharmacokinetic Safety Set|Overall Study||14
217017|NCT00809614|531590|P1|Pharmacokinetic Safety Set|Overall Study||27
217018|NCT00809614|531589|P2|STARTED|Overall Study||14
217019|NCT00809614|531590|P1|STARTED|Overall Study||28
217020|NCT00809757|531621|P3|NOT COMPLETED|Overall Study||11
217021|NCT00809757|531622|P2|NOT COMPLETED|Overall Study||5
217022|NCT00809757|531623|P1|NOT COMPLETED|Overall Study||6
217023|NCT00809757|531621|P3|COMPLETED|Overall Study||53
217024|NCT00809757|531622|P2|COMPLETED|Overall Study||60
217025|NCT00809757|531623|P1|COMPLETED|Overall Study||62
217026|NCT00809757|531621|P3|STARTED|Overall Study||64
217027|NCT00809757|531622|P2|STARTED|Overall Study||65
217028|NCT00809757|531623|P1|STARTED|Overall Study||68
217029|NCT00809809|531708|P2|NOT COMPLETED|Overall Study||2
217030|NCT00809809|531709|P1|NOT COMPLETED|Overall Study||3
217031|NCT00809809|531708|P2|COMPLETED|Overall Study|2 dropped from the study when it was discovered they met the exclusion criteria|77
217032|NCT00809809|531709|P1|COMPLETED|Overall Study|3 dropped from the study when it was discovered they met the exclusion criteria|75
217033|NCT00809809|531708|P2|STARTED|Overall Study||79
217034|NCT00809809|531709|P1|STARTED|Overall Study||78
217035|NCT00809835|531719|P4|NOT COMPLETED|Overall Study||2
217036|NCT00809835|531720|P3|NOT COMPLETED|Overall Study||11
217037|NCT00809835|531721|P2|NOT COMPLETED|Overall Study||7
217038|NCT00809835|531722|P1|NOT COMPLETED|Overall Study||8
217039|NCT00809835|531719|P4|COMPLETED|Overall Study||25
217040|NCT00809835|531720|P3|COMPLETED|Overall Study||27
217041|NCT00809835|531721|P2|COMPLETED|Overall Study||20
217042|NCT00809835|531722|P1|COMPLETED|Overall Study||20
217043|NCT00809835|531719|P4|STARTED|Overall Study||27
217044|NCT00809835|531720|P3|STARTED|Overall Study||38
217045|NCT00809835|531721|P2|STARTED|Overall Study||27
217046|NCT00809835|531722|P1|STARTED|Overall Study||28
217047|NCT00809848|531745|P5|NOT COMPLETED|Overall Study||3
217048|NCT00809848|531746|P4|NOT COMPLETED|Overall Study||1
217049|NCT00809848|531747|P3|NOT COMPLETED|Overall Study||0
217050|NCT00809848|531748|P2|NOT COMPLETED|Overall Study||0
217051|NCT00809848|531749|P1|NOT COMPLETED|Overall Study||0
217052|NCT00809848|531745|P5|COMPLETED|Overall Study||34
217053|NCT00809848|531746|P4|COMPLETED|Overall Study||30
217054|NCT00809848|531747|P3|COMPLETED|Overall Study||34
217055|NCT00809848|531748|P2|COMPLETED|Overall Study||34
217056|NCT00809848|531749|P1|COMPLETED|Overall Study||36
217057|NCT00809848|531745|P5|STARTED|Overall Study||37
217058|NCT00809848|531746|P4|STARTED|Overall Study||31
217059|NCT00809848|531747|P3|STARTED|Overall Study||34
217060|NCT00809848|531748|P2|STARTED|Overall Study||34
217061|NCT00809848|531749|P1|STARTED|Overall Study||36
217062|NCT00809926|531768|P2|NOT COMPLETED|Overall Study||23
217063|NCT00809926|531769|P1|NOT COMPLETED|Overall Study||31
217064|NCT00809926|531768|P2|COMPLETED|Overall Study||196
217065|NCT00809926|531769|P1|COMPLETED|Overall Study||201
217066|NCT00809926|531768|P2|STARTED|Overall Study||219
217067|NCT00809926|531769|P1|STARTED|Overall Study||232
217068|NCT00809965|531796|P3|NOT COMPLETED|Overall Study||844
217069|NCT00809965|531797|P2|NOT COMPLETED|Overall Study||775
217070|NCT00809965|531798|P1|NOT COMPLETED|Overall Study||783
217071|NCT00809965|531796|P3|COMPLETED|Overall Study||4332
217072|NCT00809965|531797|P2|COMPLETED|Overall Study||4399
217073|NCT00809965|531798|P1|COMPLETED|Overall Study||4393
217074|NCT00809965|531796|P3|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5115
217075|NCT00809965|531797|P2|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5114
217076|NCT00809965|531798|P1|Modified Intent-to-Treat Population|Overall Study|All randomized participants excluding 3 sites without regard to treatment exposure|5113
217077|NCT00809965|531796|P3|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5110
217078|NCT00809965|531797|P2|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5115
217079|NCT00809965|531798|P1|Treated/Safety Population|Overall Study|All randomized participants who received at least one dose of study drug|5125
217080|NCT00809965|531796|P3|STARTED|Overall Study||5176
217081|NCT00809965|531797|P2|STARTED|Overall Study||5174
217082|NCT00809965|531798|P1|STARTED|Overall Study||5176
217083|NCT00810043|531820|P3|NOT COMPLETED|Overall Study||8
217084|NCT00810043|531821|P2|NOT COMPLETED|Overall Study||1
217085|NCT00810043|531822|P1|NOT COMPLETED|Overall Study||4
217086|NCT00810043|531820|P3|COMPLETED|Overall Study||0
217087|NCT00810043|531821|P2|COMPLETED|Overall Study||54
217088|NCT00810043|531822|P1|COMPLETED|Overall Study||53
217089|NCT00810043|531820|P3|STARTED|Overall Study||8
217090|NCT00810043|531821|P2|STARTED|Overall Study||55
217091|NCT00810043|531822|P1|STARTED|Overall Study||57
217092|NCT00810069|531843|P3|NOT COMPLETED|Double-Blind Period II||72
217093|NCT00810069|531844|P2|NOT COMPLETED|Double-Blind Period II||56
217094|NCT00810069|531845|P1|NOT COMPLETED|Double-Blind Period II||0
217095|NCT00810069|531843|P3|COMPLETED|Double-Blind Period II||212
217096|NCT00810069|531844|P2|COMPLETED|Double-Blind Period II||226
217097|NCT00810069|531845|P1|COMPLETED|Double-Blind Period II||0
217098|NCT00810069|531843|P3|STARTED|Double-Blind Period II|At Week 8 - delayed intervention divided by response to treatment (nonresponders or responders).|284
217099|NCT00810069|531844|P2|STARTED|Double-Blind Period II||282
217100|NCT00810069|531845|P1|STARTED|Double-Blind Period II||0
217101|NCT00810069|531843|P3|NOT COMPLETED|Lead-in Period I||0
217102|NCT00810069|531844|P2|NOT COMPLETED|Lead-in Period I||0
217103|NCT00810069|531845|P1|NOT COMPLETED|Lead-in Period I||274
217104|NCT00810069|531843|P3|COMPLETED|Lead-in Period I||0
217105|NCT00810069|531844|P2|COMPLETED|Lead-in Period I||0
217106|NCT00810069|531845|P1|COMPLETED|Lead-in Period I||566
217107|NCT00810069|531843|P3|STARTED|Lead-in Period I||0
217108|NCT00810069|531844|P2|STARTED|Lead-in Period I||0
217109|NCT00810069|531845|P1|STARTED|Lead-in Period I||840
217110|NCT00810082|531890|P2|NOT COMPLETED|Overall Study||4
217111|NCT00810082|531891|P1|NOT COMPLETED|Overall Study||0
217112|NCT00810082|531890|P2|COMPLETED|Overall Study||27
217113|NCT00810082|531891|P1|COMPLETED|Overall Study||34
217114|NCT00810082|531890|P2|STARTED|Overall Study||31
217115|NCT00810082|531891|P1|STARTED|Overall Study||34
217116|NCT00810095|531897|P1|NOT COMPLETED|Overall Study||0
217117|NCT00810095|531897|P1|COMPLETED|Overall Study||40
217118|NCT00810095|531897|P1|STARTED|Overall Study||40
217119|NCT00810108|531906|P2|NOT COMPLETED|Overall Study||0
217120|NCT00810108|531907|P1|NOT COMPLETED|Overall Study||1
217121|NCT00810108|531906|P2|COMPLETED|Overall Study||7
217122|NCT00810108|531907|P1|COMPLETED|Overall Study||5
217123|NCT00810108|531906|P2|STARTED|Overall Study||7
217124|NCT00810108|531907|P1|STARTED|Overall Study||6
217125|NCT00810199|531914|P2|NOT COMPLETED|Overall Study||82
217126|NCT00810199|531915|P1|NOT COMPLETED|Overall Study||59
217127|NCT00810199|531914|P2|COMPLETED|Overall Study|Completed=Completed Treatment|195
217128|NCT00810199|531915|P1|COMPLETED|Overall Study||220
217129|NCT00810199|531914|P2|Completed Week 104|Overall Study||201
217130|NCT00810199|531915|P1|Completed Week 104|Overall Study||222
217131|NCT00810199|531914|P2|Completed Week 52|Overall Study||229
217132|NCT00810199|531915|P1|Completed Week 52|Overall Study||243
217133|NCT00810199|531914|P2|Completed Week 24|Overall Study||250
217134|NCT00810199|531915|P1|Completed Week 24|Overall Study||259
217135|NCT00810199|531914|P2|Received Study Drug|Overall Study||276
217136|NCT00810199|531915|P1|Received Study Drug|Overall Study||277
217137|NCT00810199|531914|P2|STARTED|Overall Study||277
217138|NCT00810199|531915|P1|STARTED|Overall Study||279
217139|NCT00810277|531991|P1|NOT COMPLETED|Overall Study||1
217140|NCT00810277|531991|P1|COMPLETED|Overall Study||13
217141|NCT00810277|531991|P1|STARTED|Overall Study||14
217142|NCT00810303|532004|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 21-30||0
217143|NCT00810303|532004|P1|COMPLETED|Ezetimibe and Efavirenz - Day 21-30||12
217144|NCT00810303|532004|P1|STARTED|Ezetimibe and Efavirenz - Day 21-30||12
217145|NCT00810303|532004|P1|NOT COMPLETED|Ezetimibe and Efavirenz - Day 16-20||0
217146|NCT00810303|532004|P1|COMPLETED|Ezetimibe and Efavirenz - Day 16-20||12
217147|NCT00810303|532004|P1|STARTED|Ezetimibe and Efavirenz - Day 16-20||12
217148|NCT00810303|532004|P1|NOT COMPLETED|Ezetimibe Alone - Day 6-15||0
217149|NCT00810303|532004|P1|COMPLETED|Ezetimibe Alone - Day 6-15||12
217150|NCT00810303|532004|P1|STARTED|Ezetimibe Alone - Day 6-15||12
217151|NCT00810303|532004|P1|NOT COMPLETED|Efavirenz Alone - Day 1-5||0
217152|NCT00810303|532004|P1|COMPLETED|Efavirenz Alone - Day 1-5||12
217153|NCT00810303|532004|P1|STARTED|Efavirenz Alone - Day 1-5||12
217154|NCT00810342|532031|P2|NOT COMPLETED|12-month Followup||11
217155|NCT00810342|532032|P1|NOT COMPLETED|12-month Followup||12
217156|NCT00810342|532031|P2|COMPLETED|12-month Followup||136
217157|NCT00810342|532032|P1|COMPLETED|12-month Followup||113
217158|NCT00810342|532031|P2|STARTED|12-month Followup||147
217159|NCT00810342|532032|P1|STARTED|12-month Followup||125
217160|NCT00810342|532031|P2|NOT COMPLETED|6-month Follow-up||8
217161|NCT00810342|532032|P1|NOT COMPLETED|6-month Follow-up||24
217162|NCT00810342|532031|P2|COMPLETED|6-month Follow-up||147
217163|NCT00810342|532032|P1|COMPLETED|6-month Follow-up||125
217164|NCT00810342|532031|P2|STARTED|6-month Follow-up||155
217165|NCT00810342|532032|P1|STARTED|6-month Follow-up||149
217166|NCT00810342|532031|P2|NOT COMPLETED|Month 1 Follow-up||2
217167|NCT00810342|532032|P1|NOT COMPLETED|Month 1 Follow-up||5
217168|NCT00810342|532031|P2|COMPLETED|Month 1 Follow-up||155
217169|NCT00810342|532032|P1|COMPLETED|Month 1 Follow-up||149
217170|NCT00810342|532031|P2|STARTED|Month 1 Follow-up||157
217171|NCT00810342|532032|P1|STARTED|Month 1 Follow-up||154
217172|NCT00810355|532043|P3|NOT COMPLETED|Overall Study||11
217173|NCT00810355|532044|P2|NOT COMPLETED|Overall Study||17
217174|NCT00810355|532045|P1|NOT COMPLETED|Overall Study||14
217175|NCT00810355|532043|P3|COMPLETED|Overall Study||14
217176|NCT00810355|532044|P2|COMPLETED|Overall Study||8
217177|NCT00810355|532045|P1|COMPLETED|Overall Study||11
217178|NCT00810355|532043|P3|STARTED|Overall Study||25
217179|NCT00810355|532044|P2|STARTED|Overall Study||25
217180|NCT00810355|532045|P1|STARTED|Overall Study||25
217181|NCT00810368|532061|P2|NOT COMPLETED|Overall Study||2
217182|NCT00810368|532062|P1|NOT COMPLETED|Overall Study||6
217183|NCT00810368|532061|P2|COMPLETED|Overall Study||13
217184|NCT00810368|532062|P1|COMPLETED|Overall Study||12
217185|NCT00810368|532061|P2|STARTED|Overall Study||15
217186|NCT00810368|532062|P1|STARTED|Overall Study||18
217187|NCT00810394|532080|P1|NOT COMPLETED|Overall Study||3
217188|NCT00810394|532080|P1|COMPLETED|Overall Study||47
217189|NCT00810394|532080|P1|Cycle 3 400mg Twice Daily|Overall Study||5
217190|NCT00810394|532080|P1|Cycle 3 800 mg Twice Daily|Overall Study||4
217191|NCT00810394|532080|P1|Cycle 2 400mg Once Daily|Overall Study||22
217192|NCT00810394|532080|P1|Cycle 2 600mg Twice Daily|Overall Study||13
217193|NCT00810394|532080|P1|STARTED|Overall Study||50
217194|NCT00811655|532086|P1|NOT COMPLETED|Overall Study||1
217195|NCT00811655|532086|P1|COMPLETED|Overall Study||5
217196|NCT00811655|532086|P1|STARTED|Overall Study||6
217197|NCT00811720|532100|P2|NOT COMPLETED|All Treated Patients||164
217198|NCT00811720|532101|P1|NOT COMPLETED|All Treated Patients||96
217199|NCT00811720|532100|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|138
217200|NCT00811720|532101|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|200
217201|NCT00811720|532100|P2|STARTED|All Treated Patients||302
217202|NCT00811720|532101|P1|STARTED|All Treated Patients||296
217203|NCT00811720|532100|P2|NOT COMPLETED|All Randomised Patients||4
217204|NCT00811720|532101|P1|NOT COMPLETED|All Randomised Patients||2
217205|NCT00811720|532100|P2|COMPLETED|All Randomised Patients||302
217206|NCT00811720|532101|P1|COMPLETED|All Randomised Patients||296
217207|NCT00811720|532100|P2|STARTED|All Randomised Patients||306
217208|NCT00811720|532101|P1|STARTED|All Randomised Patients||298
217209|NCT00811733|532121|P2|NOT COMPLETED|Overall Study||10
217210|NCT00811733|532122|P1|NOT COMPLETED|Overall Study||11
217211|NCT00811733|532121|P2|COMPLETED|Overall Study||12
217212|NCT00811733|532122|P1|COMPLETED|Overall Study||4
217213|NCT00811733|532121|P2|STARTED|Overall Study||22
217214|NCT00811733|532122|P1|STARTED|Overall Study||15
217215|NCT00811798|532168|P1|NOT COMPLETED|Overall Study||0
217216|NCT00811798|532168|P1|COMPLETED|Overall Study||92
217217|NCT00811798|532168|P1|STARTED|Overall Study||92
217218|NCT00811850|532172|P1|NOT COMPLETED|Treatment Period 3: Combigan® or Cosopt®||0
217219|NCT00811850|532172|P1|COMPLETED|Treatment Period 3: Combigan® or Cosopt®||15
217220|NCT00811850|532172|P1|STARTED|Treatment Period 3: Combigan® or Cosopt®||15
217221|NCT00811850|532172|P1|NOT COMPLETED|Treatment Period 2: Wash Out||0
217222|NCT00811850|532172|P1|COMPLETED|Treatment Period 2: Wash Out||15
217223|NCT00811850|532172|P1|STARTED|Treatment Period 2: Wash Out||15
217224|NCT00811850|532172|P1|NOT COMPLETED|Treatment Period 1: Combigan® or Cosopt®||0
217225|NCT00811850|532172|P1|COMPLETED|Treatment Period 1: Combigan® or Cosopt®||15
217226|NCT00811850|532172|P1|STARTED|Treatment Period 1: Combigan® or Cosopt®||15
217227|NCT00811928|532194|P2|NOT COMPLETED|Overall Study||33
217228|NCT00811928|532195|P1|NOT COMPLETED|Overall Study||39
217229|NCT00811928|532194|P2|COMPLETED|Overall Study||90
217230|NCT00811928|532195|P1|COMPLETED|Overall Study||90
217231|NCT00811928|532194|P2|STARTED|Overall Study||123
217232|NCT00811928|532195|P1|STARTED|Overall Study||129
217233|NCT00811941|532215|P2|NOT COMPLETED|All Treated Patients||191
217234|NCT00811941|532216|P1|NOT COMPLETED|All Treated Patients||52
217235|NCT00811941|532215|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|310
217236|NCT00811941|532216|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|112
217237|NCT00811941|532215|P2|STARTED|All Treated Patients||501
217238|NCT00811941|532216|P1|STARTED|All Treated Patients||164
217239|NCT00811941|532215|P2|NOT COMPLETED|All Randomised Patients||8
217240|NCT00811941|532216|P1|NOT COMPLETED|All Randomised Patients||2
217241|NCT00811941|532215|P2|COMPLETED|All Randomised Patients||501
217242|NCT00811941|532216|P1|COMPLETED|All Randomised Patients||164
217243|NCT00811941|532215|P2|STARTED|All Randomised Patients||509
217244|NCT00811941|532216|P1|STARTED|All Randomised Patients||166
217245|NCT00811954|532255|P3|NOT COMPLETED|Overall Study||101
217246|NCT00811954|532256|P2|NOT COMPLETED|Overall Study||72
217247|NCT00811954|532257|P1|NOT COMPLETED|Overall Study||89
217248|NCT00811954|532255|P3|COMPLETED|Overall Study||500
217249|NCT00811954|532256|P2|COMPLETED|Overall Study||531
217250|NCT00811954|532257|P1|COMPLETED|Overall Study||516
217251|NCT00811954|532255|P3|STARTED|Overall Study||601
217252|NCT00811954|532256|P2|STARTED|Overall Study||603
217253|NCT00811954|532257|P1|STARTED|Overall Study||605
217254|NCT00812006|532322|P3|NOT COMPLETED|Overall Study||6
217255|NCT00812006|532323|P2|NOT COMPLETED|Overall Study||3
217256|NCT00812006|532324|P1|NOT COMPLETED|Overall Study||6
217257|NCT00812006|532322|P3|COMPLETED|Overall Study||30
217258|NCT00812006|532323|P2|COMPLETED|Overall Study||33
217259|NCT00812006|532324|P1|COMPLETED|Overall Study||30
217260|NCT00812006|532322|P3|STARTED|Overall Study||36
217261|NCT00812006|532323|P2|STARTED|Overall Study||36
217262|NCT00812006|532324|P1|STARTED|Overall Study||36
217263|NCT00812097|532342|P4|NOT COMPLETED|Overall Study||35
217264|NCT00812097|532343|P3|NOT COMPLETED|Overall Study||57
217265|NCT00812097|532344|P2|NOT COMPLETED|Overall Study||89
217266|NCT00812097|532345|P1|NOT COMPLETED|Overall Study||245
217267|NCT00812097|532342|P4|COMPLETED|Overall Study||34
217268|NCT00812097|532343|P3|COMPLETED|Overall Study||67
217269|NCT00812097|532344|P2|COMPLETED|Overall Study||101
217270|NCT00812097|532345|P1|COMPLETED|Overall Study||327
217271|NCT00812097|532342|P4|STARTED|Overall Study||69
217272|NCT00812097|532343|P3|STARTED|Overall Study||124
217273|NCT00812097|532344|P2|STARTED|Overall Study||190
217274|NCT00812097|532345|P1|STARTED|Overall Study||572
217275|NCT00812110|532371|P1|NOT COMPLETED|Overall Study||0
217276|NCT00812110|532371|P1|COMPLETED|Overall Study||292
217277|NCT00812110|532371|P1|STARTED|Overall Study||292
217278|NCT00812253|532378|P2|NOT COMPLETED|Overall Study||3
217279|NCT00812253|532379|P1|NOT COMPLETED|Overall Study||6
217280|NCT00812253|532378|P2|COMPLETED|Overall Study||39
217281|NCT00812253|532379|P1|COMPLETED|Overall Study||26
217282|NCT00812253|532378|P2|STARTED|Overall Study||42
217283|NCT00812253|532379|P1|STARTED|Overall Study||32
217284|NCT00812331|532394|P5|NOT COMPLETED|Overall Study||0
217285|NCT00812331|532395|P4|NOT COMPLETED|Overall Study||0
217286|NCT00812331|532396|P3|NOT COMPLETED|Overall Study||0
217287|NCT00812331|532397|P2|NOT COMPLETED|Overall Study||0
217288|NCT00812331|532398|P1|NOT COMPLETED|Overall Study||1
217289|NCT00812331|532394|P5|COMPLETED|Overall Study||8
217290|NCT00812331|532395|P4|COMPLETED|Overall Study||7
217291|NCT00812331|532396|P3|COMPLETED|Overall Study||8
217292|NCT00812331|532397|P2|COMPLETED|Overall Study||8
217293|NCT00812331|532398|P1|COMPLETED|Overall Study||5
217294|NCT00812331|532394|P5|STARTED|Overall Study||8
217295|NCT00812331|532395|P4|STARTED|Overall Study||7
217296|NCT00812331|532396|P3|STARTED|Overall Study||8
217297|NCT00812331|532397|P2|STARTED|Overall Study||8
217298|NCT00812331|532398|P1|STARTED|Overall Study||6
217299|NCT00812461|532473|P2|NOT COMPLETED|All Treated Patients||147
217300|NCT00812461|532474|P1|NOT COMPLETED|All Treated Patients||132
217301|NCT00812461|532473|P2|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|194
217302|NCT00812461|532474|P1|COMPLETED|All Treated Patients|Patients who had the final visit of the study protocol|205
217303|NCT00812461|532473|P2|STARTED|All Treated Patients||341
217304|NCT00812461|532474|P1|STARTED|All Treated Patients||337
217305|NCT00812461|532473|P2|NOT COMPLETED|All Randomised Patients||17
217306|NCT00812461|532474|P1|NOT COMPLETED|All Randomised Patients||23
217307|NCT00812461|532473|P2|COMPLETED|All Randomised Patients||341
217308|NCT00812461|532474|P1|COMPLETED|All Randomised Patients||337
217309|NCT00812461|532473|P2|STARTED|All Randomised Patients||358
217310|NCT00812461|532474|P1|STARTED|All Randomised Patients||360
217311|NCT00812487|532494|P2|NOT COMPLETED|Overall Study||3
217312|NCT00812487|532495|P1|NOT COMPLETED|Overall Study||6
217313|NCT00812487|532494|P2|COMPLETED|Overall Study||39
217314|NCT00812487|532495|P1|COMPLETED|Overall Study||26
217315|NCT00812487|532494|P2|STARTED|Overall Study||42
217316|NCT00812487|532495|P1|STARTED|Overall Study||32
217317|NCT00812565|532527|P8|NOT COMPLETED|Overall Study||1
217318|NCT00812565|532528|P7|NOT COMPLETED|Overall Study||0
217319|NCT00812565|532529|P6|NOT COMPLETED|Overall Study||1
217320|NCT00812565|532530|P5|NOT COMPLETED|Overall Study||1
217321|NCT00812565|532531|P4|NOT COMPLETED|Overall Study||2
217322|NCT00812565|532532|P3|NOT COMPLETED|Overall Study||0
217323|NCT00812565|532533|P2|NOT COMPLETED|Overall Study||1
217324|NCT00812565|532534|P1|NOT COMPLETED|Overall Study||3
217325|NCT00812565|532527|P8|COMPLETED|Overall Study||6
217326|NCT00812565|532528|P7|COMPLETED|Overall Study||8
217327|NCT00812565|532529|P6|COMPLETED|Overall Study||6
217328|NCT00812565|532530|P5|COMPLETED|Overall Study||6
217329|NCT00812565|532531|P4|COMPLETED|Overall Study||5
217330|NCT00812565|532532|P3|COMPLETED|Overall Study||7
217331|NCT00812565|532533|P2|COMPLETED|Overall Study||6
217332|NCT00812565|532534|P1|COMPLETED|Overall Study||5
217333|NCT00812565|532527|P8|STARTED|Overall Study||7
217334|NCT00812565|532528|P7|STARTED|Overall Study||8
217335|NCT00812565|532529|P6|STARTED|Overall Study||7
217336|NCT00812565|532530|P5|STARTED|Overall Study||7
217337|NCT00812565|532531|P4|STARTED|Overall Study||7
217338|NCT00812565|532532|P3|STARTED|Overall Study||7
217339|NCT00812565|532533|P2|STARTED|Overall Study||7
217340|NCT00812565|532534|P1|STARTED|Overall Study||8
217341|NCT00812604|532658|P2|NOT COMPLETED|Overall Study||5
217342|NCT00812604|532659|P1|NOT COMPLETED|Overall Study||5
217343|NCT00812604|532658|P2|COMPLETED|Overall Study||22
217344|NCT00812604|532659|P1|COMPLETED|Overall Study||23
217345|NCT00812604|532658|P2|STARTED|Overall Study||27
217346|NCT00812604|532659|P1|STARTED|Overall Study||28
217347|NCT00812812|532669|P2|NOT COMPLETED|Overall Study||4
217348|NCT00812812|532670|P1|NOT COMPLETED|Overall Study||3
217349|NCT00812812|532669|P2|COMPLETED|Overall Study||25
217350|NCT00812812|532670|P1|COMPLETED|Overall Study||24
217351|NCT00812812|532669|P2|STARTED|Overall Study||29
217352|NCT00812812|532670|P1|STARTED|Overall Study||27
217353|NCT00812877|532685|P2|NOT COMPLETED|Overall Study||51
217354|NCT00812877|532686|P1|NOT COMPLETED|Overall Study||37
217355|NCT00812877|532685|P2|COMPLETED|Overall Study||130
217356|NCT00812877|532686|P1|COMPLETED|Overall Study||158
217357|NCT00812877|532685|P2|STARTED|Overall Study||181
217358|NCT00812877|532686|P1|STARTED|Overall Study||195
217359|NCT00812916|532694|P1|NOT COMPLETED|Overall Study||3
217360|NCT00812916|532694|P1|COMPLETED|Overall Study||203
217361|NCT00812916|532694|P1|CFAE - Guided Ablation|Overall Study||203
217362|NCT00812916|532694|P1|Data Available|Overall Study||205
217363|NCT00812916|532694|P1|STARTED|Overall Study|206 enrolled (consented)|206
217364|NCT00812955|532707|P4|NOT COMPLETED|Overall Study||8
217365|NCT00812955|532708|P3|NOT COMPLETED|Overall Study||6
217366|NCT00812955|532709|P2|NOT COMPLETED|Overall Study||7
217367|NCT00812955|532710|P1|NOT COMPLETED|Overall Study||10
217368|NCT00812955|532707|P4|COMPLETED|Overall Study||110
217369|NCT00812955|532708|P3|COMPLETED|Overall Study||113
217370|NCT00812955|532709|P2|COMPLETED|Overall Study||111
217371|NCT00812955|532710|P1|COMPLETED|Overall Study||109
217372|NCT00812955|532707|P4|STARTED|Overall Study||118
217373|NCT00812955|532708|P3|STARTED|Overall Study||119
217374|NCT00812955|532709|P2|STARTED|Overall Study||118
217375|NCT00812955|532710|P1|STARTED|Overall Study||119
217376|NCT00812968|532730|P1|NOT COMPLETED|Overall Study||11
217377|NCT00812968|532730|P1|COMPLETED|Overall Study||0
217378|NCT00812968|532730|P1|STARTED|Overall Study||11
217379|NCT00812981|532763|P2|NOT COMPLETED|Overall Study||1
217380|NCT00812981|532764|P1|NOT COMPLETED|Overall Study||0
217381|NCT00812981|532763|P2|COMPLETED|Overall Study||159
217382|NCT00812981|532764|P1|COMPLETED|Overall Study||160
217383|NCT00812981|532763|P2|STARTED|Overall Study||160
217384|NCT00812981|532764|P1|STARTED|Overall Study||160
217385|NCT00813098|532805|P3|NOT COMPLETED|Overall Study||2
217386|NCT00813098|532806|P2|NOT COMPLETED|Overall Study||8
217387|NCT00813098|532807|P1|NOT COMPLETED|Overall Study||3
217388|NCT00813098|532805|P3|COMPLETED|Overall Study||50
217389|NCT00813098|532806|P2|COMPLETED|Overall Study||46
217390|NCT00813098|532807|P1|COMPLETED|Overall Study||46
217391|NCT00813098|532805|P3|STARTED|Overall Study||52
217392|NCT00813098|532806|P2|STARTED|Overall Study||54
217393|NCT00813098|532807|P1|STARTED|Overall Study||49
217394|NCT00813111|532832|P2|NOT COMPLETED|Overall Study||0
217395|NCT00813111|532833|P1|NOT COMPLETED|Overall Study||2
217396|NCT00813111|532832|P2|COMPLETED|Overall Study||70
217397|NCT00813111|532833|P1|COMPLETED|Overall Study||64
217398|NCT00813111|532832|P2|STARTED|Overall Study||70
217399|NCT00813111|532833|P1|STARTED|Overall Study||66
217400|NCT00813150|532841|P2|NOT COMPLETED|Long Term Follow-up||31
217401|NCT00813150|532842|P1|NOT COMPLETED|Long Term Follow-up||24
217402|NCT00813150|532841|P2|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|0
217403|NCT00813150|532842|P1|COMPLETED|Long Term Follow-up|Number of participants who completed follow-up phase|2
217404|NCT00813150|532841|P2|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|31
217481|NCT00813709|532978|P4|NOT COMPLETED|Double Blind Period||0
217405|NCT00813150|532842|P1|STARTED|Long Term Follow-up|Number of participants who entered follow-up phase|26
217406|NCT00813150|532841|P2|NOT COMPLETED|Treatment Period||32
217407|NCT00813150|532842|P1|NOT COMPLETED|Treatment Period||32
217408|NCT00813150|532841|P2|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|15
217409|NCT00813150|532842|P1|COMPLETED|Treatment Period|Participants who completed 8 cycles of treatment|14
217410|NCT00813150|532841|P2|Intent-to-treat Participants|Treatment Period||47
217411|NCT00813150|532842|P1|Intent-to-treat Participants|Treatment Period||43
217412|NCT00813150|532841|P2|STARTED|Treatment Period|Number of randomized and treated participants|47
217413|NCT00813150|532842|P1|STARTED|Treatment Period|Number of randomized and treated participants|46
217414|NCT00813319|532856|P2|NOT COMPLETED|Overall Study||0
217415|NCT00813319|532857|P1|NOT COMPLETED|Overall Study||0
217416|NCT00813319|532856|P2|COMPLETED|Overall Study|104 out of 108 have complete follow-up data, there were 4 missing charts 7 months post-randomization|108
217417|NCT00813319|532857|P1|COMPLETED|Overall Study|100 out of 108 have complete follow-up data, there were 8 missing charts 7 months post-randomization|108
217418|NCT00813319|532856|P2|STARTED|Overall Study||108
217419|NCT00813319|532857|P1|STARTED|Overall Study||108
217420|NCT00813488|532867|P2|NOT COMPLETED|Open-label Extension||7
217421|NCT00813488|532868|P1|NOT COMPLETED|Open-label Extension||12
217422|NCT00813488|532867|P2|COMPLETED|Open-label Extension|This group received standard of care (including immediate-release oxycodone)|59
217423|NCT00813488|532868|P1|COMPLETED|Open-label Extension|This group received FBT open--label|53
217424|NCT00813488|532867|P2|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|66
217425|NCT00813488|532868|P1|STARTED|Open-label Extension|Patients completing double-blind periods were randomized to FBT or standard of care for open-label|65
217426|NCT00813488|532867|P2|NOT COMPLETED|Double-blind Treatment Period 2||1
217427|NCT00813488|532868|P1|NOT COMPLETED|Double-blind Treatment Period 2||5
217428|NCT00813488|532867|P2|COMPLETED|Double-blind Treatment Period 2||65
217429|NCT00813488|532868|P1|COMPLETED|Double-blind Treatment Period 2||66
217430|NCT00813488|532867|P2|STARTED|Double-blind Treatment Period 2||66
217431|NCT00813488|532868|P1|STARTED|Double-blind Treatment Period 2||71
217432|NCT00813488|532867|P2|NOT COMPLETED|Double-blind Treatment Period 1||5
217433|NCT00813488|532868|P1|NOT COMPLETED|Double-blind Treatment Period 1||1
217434|NCT00813488|532867|P2|COMPLETED|Double-blind Treatment Period 1||66
217435|NCT00813488|532868|P1|COMPLETED|Double-blind Treatment Period 1||71
217436|NCT00813488|532867|P2|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|71
217437|NCT00813488|532868|P1|STARTED|Double-blind Treatment Period 1|After titration subjects were re-randomized to these two treatment arms|72
217438|NCT00813488|532867|P2|NOT COMPLETED|Titration Period 2||10
217439|NCT00813488|532868|P1|NOT COMPLETED|Titration Period 2||16
217440|NCT00813488|532867|P2|COMPLETED|Titration Period 2||79
217441|NCT00813488|532868|P1|COMPLETED|Titration Period 2||64
217442|NCT00813488|532867|P2|STARTED|Titration Period 2||89
217443|NCT00813488|532868|P1|STARTED|Titration Period 2||80
217444|NCT00813488|532867|P2|NOT COMPLETED|Titration Period 1||17
217445|NCT00813488|532868|P1|NOT COMPLETED|Titration Period 1||27
217446|NCT00813488|532867|P2|COMPLETED|Titration Period 1||89
217447|NCT00813488|532868|P1|COMPLETED|Titration Period 1||80
217448|NCT00813488|532867|P2|STARTED|Titration Period 1||106
217449|NCT00813488|532868|P1|STARTED|Titration Period 1||107
217450|NCT00813592|532964|P1|NOT COMPLETED|Overall Study||2
217451|NCT00813592|532964|P1|COMPLETED|Overall Study||0
217452|NCT00813592|532964|P1|Response Assessment|Overall Study|One patient met the response assessment.|1
217453|NCT00813592|532964|P1|Treated|Overall Study|Two patients were treated.|2
217454|NCT00813592|532964|P1|STARTED|Overall Study||2
217455|NCT00813709|532976|P6|NOT COMPLETED|Open Label Period||11
217456|NCT00813709|532977|P5|NOT COMPLETED|Open Label Period||10
217457|NCT00813709|532978|P4|NOT COMPLETED|Open Label Period||20
217458|NCT00813709|532979|P3|NOT COMPLETED|Open Label Period||0
217459|NCT00813709|532980|P2|NOT COMPLETED|Open Label Period||0
217460|NCT00813709|532981|P1|NOT COMPLETED|Open Label Period||0
217461|NCT00813709|532976|P6|COMPLETED|Open Label Period||35
217462|NCT00813709|532977|P5|COMPLETED|Open Label Period||41
217463|NCT00813709|532978|P4|COMPLETED|Open Label Period||38
217464|NCT00813709|532979|P3|COMPLETED|Open Label Period||0
217465|NCT00813709|532980|P2|COMPLETED|Open Label Period||0
217466|NCT00813709|532981|P1|COMPLETED|Open Label Period||0
217467|NCT00813709|532976|P6|Treated|Open Label Period||45
217468|NCT00813709|532977|P5|Treated|Open Label Period||51
217469|NCT00813709|532978|P4|Treated|Open Label Period||57
217470|NCT00813709|532979|P3|Treated|Open Label Period||0
217471|NCT00813709|532980|P2|Treated|Open Label Period||0
217472|NCT00813709|532981|P1|Treated|Open Label Period||0
217473|NCT00813709|532976|P6|STARTED|Open Label Period|28 participants in OL period initially + 18 participants from DB converted to CDMS during the study|46
217474|NCT00813709|532977|P5|STARTED|Open Label Period|25 participants in OL period initially + 26 participants from DB converted to CDMS during the study|51
217475|NCT00813709|532978|P4|STARTED|Open Label Period|49 participants in OL period initially + 9 participants from DB converted to CDMS during the study|58
217476|NCT00813709|532979|P3|STARTED|Open Label Period||0
217477|NCT00813709|532980|P2|STARTED|Open Label Period||0
217478|NCT00813709|532981|P1|STARTED|Open Label Period||0
217479|NCT00813709|532976|P6|NOT COMPLETED|Double Blind Period||0
217480|NCT00813709|532977|P5|NOT COMPLETED|Double Blind Period||0
217482|NCT00813709|532979|P3|NOT COMPLETED|Double Blind Period||31
217483|NCT00813709|532980|P2|NOT COMPLETED|Double Blind Period||41
217484|NCT00813709|532981|P1|NOT COMPLETED|Double Blind Period||31
217485|NCT00813709|532976|P6|COMPLETED|Double Blind Period||0
217486|NCT00813709|532977|P5|COMPLETED|Double Blind Period||0
217487|NCT00813709|532978|P4|COMPLETED|Double Blind Period||0
217488|NCT00813709|532979|P3|COMPLETED|Double Blind Period||68
217489|NCT00813709|532980|P2|COMPLETED|Double Blind Period||76
217490|NCT00813709|532981|P1|COMPLETED|Double Blind Period||53
217491|NCT00813709|532976|P6|Treated|Double Blind Period||0
217492|NCT00813709|532977|P5|Treated|Double Blind Period||0
217493|NCT00813709|532978|P4|Treated|Double Blind Period||0
217494|NCT00813709|532979|P3|Treated|Double Blind Period||98
217495|NCT00813709|532980|P2|Treated|Double Blind Period||114
217496|NCT00813709|532981|P1|Treated|Double Blind Period||83
217497|NCT00813709|532976|P6|STARTED|Double Blind Period||0
217498|NCT00813709|532977|P5|STARTED|Double Blind Period||0
217499|NCT00813709|532978|P4|STARTED|Double Blind Period||0
217500|NCT00813709|532979|P3|STARTED|Double Blind Period||99
217501|NCT00813709|532980|P2|STARTED|Double Blind Period||117
217502|NCT00813709|532981|P1|STARTED|Double Blind Period||84
217503|NCT00813748|533063|P2|NOT COMPLETED|Skin Test Substudy||1
217504|NCT00813748|533064|P1|NOT COMPLETED|Skin Test Substudy||0
217505|NCT00813748|533063|P2|COMPLETED|Skin Test Substudy||7
217506|NCT00813748|533064|P1|COMPLETED|Skin Test Substudy||3
217507|NCT00813748|533063|P2|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|8
217508|NCT00813748|533064|P1|STARTED|Skin Test Substudy|Included participants who discontinued omalizumab for at least 16 weeks but not more than 18 months.|3
217509|NCT00813748|533063|P2|NOT COMPLETED|Main Observational Study||0
217510|NCT00813748|533064|P1|NOT COMPLETED|Main Observational Study||0
217511|NCT00813748|533063|P2|COMPLETED|Main Observational Study||88
217512|NCT00813748|533064|P1|COMPLETED|Main Observational Study||30
217513|NCT00813748|533063|P2|STARTED|Main Observational Study||88
217514|NCT00813748|533064|P1|STARTED|Main Observational Study||30
217515|NCT00813761|533092|P4|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||5
217516|NCT00813761|533093|P3|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
217517|NCT00813761|533094|P2|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||9
217518|NCT00813761|533095|P1|NOT COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||16
217519|NCT00813761|533092|P4|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||100
217520|NCT00813761|533093|P3|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||94
217521|NCT00813761|533094|P2|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||91
217522|NCT00813761|533095|P1|COMPLETED|Phase 2 (4 Weeks to 24 Weeks)||101
217523|NCT00813761|533092|P4|STARTED|Phase 2 (4 Weeks to 24 Weeks)||105
217524|NCT00813761|533093|P3|STARTED|Phase 2 (4 Weeks to 24 Weeks)||103
217525|NCT00813761|533094|P2|STARTED|Phase 2 (4 Weeks to 24 Weeks)||100
217526|NCT00813761|533095|P1|STARTED|Phase 2 (4 Weeks to 24 Weeks)||117
217527|NCT00813761|533092|P4|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||2
217528|NCT00813761|533093|P3|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||12
217529|NCT00813761|533094|P2|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||3
217530|NCT00813761|533095|P1|NOT COMPLETED|Phase 1 (Baseline to 4 Weeks)||4
217531|NCT00813761|533092|P4|COMPLETED|Phase 1 (Baseline to 4 Weeks)||105
217532|NCT00813761|533093|P3|COMPLETED|Phase 1 (Baseline to 4 Weeks)||103
217533|NCT00813761|533094|P2|COMPLETED|Phase 1 (Baseline to 4 Weeks)||100
217534|NCT00813761|533095|P1|COMPLETED|Phase 1 (Baseline to 4 Weeks)||117
217535|NCT00813761|533092|P4|STARTED|Phase 1 (Baseline to 4 Weeks)||107
217536|NCT00813761|533093|P3|STARTED|Phase 1 (Baseline to 4 Weeks)||115
217537|NCT00813761|533094|P2|STARTED|Phase 1 (Baseline to 4 Weeks)||103
217538|NCT00813761|533095|P1|STARTED|Phase 1 (Baseline to 4 Weeks)||121
217539|NCT00813800|533143|P1|NOT COMPLETED|Overall Study||6
217540|NCT00813800|533143|P1|COMPLETED|Overall Study||5
217541|NCT00813800|533143|P1|STARTED|Overall Study||11
217542|NCT00813813|533151|P2|NOT COMPLETED|Overall Study||9
217543|NCT00813813|533152|P1|NOT COMPLETED|Overall Study||3
217544|NCT00813813|533151|P2|COMPLETED|Overall Study||16
217545|NCT00813813|533152|P1|COMPLETED|Overall Study||4
217546|NCT00813813|533151|P2|STARTED|Overall Study||25
217547|NCT00813813|533152|P1|STARTED|Overall Study||7
217548|NCT00813904|533168|P1|NOT COMPLETED|Overall Study||1
217549|NCT00813904|533168|P1|COMPLETED|Overall Study||30
217550|NCT00813904|533168|P1|STARTED|Overall Study||31
217551|NCT00813917|533176|P2|NOT COMPLETED|Overall Study||6
217552|NCT00813917|533177|P1|NOT COMPLETED|Overall Study||6
217553|NCT00813917|533176|P2|COMPLETED|Overall Study||32
217554|NCT00813917|533177|P1|COMPLETED|Overall Study||32
217555|NCT00813917|533176|P2|STARTED|Overall Study||38
217556|NCT00813917|533177|P1|STARTED|Overall Study||38
217557|NCT00813943|533186|P3|NOT COMPLETED|Overall Study||3
217558|NCT00813943|533187|P2|NOT COMPLETED|Overall Study||5
217559|NCT00813943|533188|P1|NOT COMPLETED|Overall Study||5
217560|NCT00813943|533186|P3|COMPLETED|Overall Study||86
217561|NCT00813943|533187|P2|COMPLETED|Overall Study||83
217562|NCT00813943|533188|P1|COMPLETED|Overall Study||83
217563|NCT00813943|533186|P3|STARTED|Overall Study||89
217564|NCT00813943|533187|P2|STARTED|Overall Study||88
217565|NCT00813943|533188|P1|STARTED|Overall Study||88
217566|NCT00813982|533216|P1|NOT COMPLETED|Overall Study||0
217567|NCT00813982|533216|P1|COMPLETED|Overall Study||59
217568|NCT00813982|533216|P1|STARTED|Overall Study||59
217569|NCT00813995|533224|P2|NOT COMPLETED|Overall Study||16
217570|NCT00813995|533225|P1|NOT COMPLETED|Overall Study||23
217571|NCT00813995|533224|P2|COMPLETED|Overall Study||182
217572|NCT00813995|533225|P1|COMPLETED|Overall Study||174
217573|NCT00813995|533224|P2|STARTED|Overall Study||198
217574|NCT00813995|533225|P1|STARTED|Overall Study||197
217575|NCT00806026|533245|P6|NOT COMPLETED|Overall Study||32
217576|NCT00806026|533246|P5|NOT COMPLETED|Overall Study||30
217577|NCT00806026|533247|P4|NOT COMPLETED|Overall Study||29
217578|NCT00806026|533248|P3|NOT COMPLETED|Overall Study||93
217579|NCT00806026|533249|P2|NOT COMPLETED|Overall Study||101
217580|NCT00806026|533250|P1|NOT COMPLETED|Overall Study||92
217581|NCT00806026|533245|P6|COMPLETED|Overall Study||29
217582|NCT00806026|533246|P5|COMPLETED|Overall Study||29
217583|NCT00806026|533247|P4|COMPLETED|Overall Study||32
217584|NCT00806026|533248|P3|COMPLETED|Overall Study||89
217585|NCT00806026|533249|P2|COMPLETED|Overall Study||82
217586|NCT00806026|533250|P1|COMPLETED|Overall Study||93
217587|NCT00806026|533245|P6|Treated|Overall Study||61
217588|NCT00806026|533246|P5|Treated|Overall Study||59
217589|NCT00806026|533247|P4|Treated|Overall Study||59
217590|NCT00806026|533248|P3|Treated|Overall Study||180
217591|NCT00806026|533249|P2|Treated|Overall Study||178
217592|NCT00806026|533250|P1|Treated|Overall Study||182
217593|NCT00806026|533245|P6|STARTED|Overall Study||61
217594|NCT00806026|533246|P5|STARTED|Overall Study||59
217595|NCT00806026|533247|P4|STARTED|Overall Study||61
217596|NCT00806026|533248|P3|STARTED|Overall Study||182
217597|NCT00806026|533249|P2|STARTED|Overall Study||183
217598|NCT00806026|533250|P1|STARTED|Overall Study||185
217599|NCT00806078|533347|P2|NOT COMPLETED|Second Intervention||0
217600|NCT00806078|533348|P1|NOT COMPLETED|Second Intervention||0
217601|NCT00806078|533347|P2|COMPLETED|Second Intervention||9
217602|NCT00806078|533348|P1|COMPLETED|Second Intervention||9
217603|NCT00806078|533347|P2|STARTED|Second Intervention||9
217604|NCT00806078|533348|P1|STARTED|Second Intervention||9
217605|NCT00806078|533347|P2|NOT COMPLETED|7 Day Washout Period||0
217606|NCT00806078|533348|P1|NOT COMPLETED|7 Day Washout Period||0
217607|NCT00806078|533347|P2|COMPLETED|7 Day Washout Period||9
217608|NCT00806078|533348|P1|COMPLETED|7 Day Washout Period||9
217609|NCT00806078|533347|P2|STARTED|7 Day Washout Period||9
217610|NCT00806078|533348|P1|STARTED|7 Day Washout Period||9
217611|NCT00806078|533347|P2|NOT COMPLETED|First Intervention||0
217612|NCT00806078|533348|P1|NOT COMPLETED|First Intervention||0
217613|NCT00806078|533347|P2|COMPLETED|First Intervention||9
217614|NCT00806078|533348|P1|COMPLETED|First Intervention||9
217615|NCT00806078|533347|P2|STARTED|First Intervention||9
217616|NCT00806078|533348|P1|STARTED|First Intervention||9
217617|NCT00806195|533362|P4|NOT COMPLETED|Overall Study||106
217618|NCT00806195|533363|P3|NOT COMPLETED|Overall Study||270
217619|NCT00806195|533364|P2|NOT COMPLETED|Overall Study||162
217620|NCT00806195|533365|P1|NOT COMPLETED|Overall Study||514
217621|NCT00806195|533362|P4|COMPLETED|Overall Study||383
217622|NCT00806195|533363|P3|COMPLETED|Overall Study||1139
217623|NCT00806195|533364|P2|COMPLETED|Overall Study||1321
217624|NCT00806195|533365|P1|COMPLETED|Overall Study||3849
217625|NCT00806195|533362|P4|STARTED|Overall Study||489
217626|NCT00806195|533363|P3|STARTED|Overall Study||1409
217627|NCT00806195|533364|P2|STARTED|Overall Study||1483
217628|NCT00806195|533365|P1|STARTED|Overall Study||4363
217629|NCT00806221|533377|P1|NOT COMPLETED|Overall Study||2
217630|NCT00806221|533377|P1|COMPLETED|Overall Study||20
217631|NCT00806221|533377|P1|STARTED|Overall Study||22
217632|NCT00806234|533387|P3|NOT COMPLETED|Overall Study||12
217633|NCT00806234|533388|P2|NOT COMPLETED|Overall Study||12
217634|NCT00806234|533389|P1|NOT COMPLETED|Overall Study||13
217635|NCT00806234|533387|P3|COMPLETED|Overall Study||37
217636|NCT00806234|533388|P2|COMPLETED|Overall Study||19
217637|NCT00806234|533389|P1|COMPLETED|Overall Study||34
217638|NCT00806234|533387|P3|STARTED|Overall Study||49
217639|NCT00806234|533388|P2|STARTED|Overall Study||31
217640|NCT00806234|533389|P1|STARTED|Overall Study||47
217641|NCT00806260|533412|P6|NOT COMPLETED|Period 3||0
217642|NCT00806260|533413|P5|NOT COMPLETED|Period 3||0
217643|NCT00806260|533414|P4|NOT COMPLETED|Period 3||0
217644|NCT00806260|533415|P3|NOT COMPLETED|Period 3||1
217645|NCT00806260|533416|P2|NOT COMPLETED|Period 3||1
217646|NCT00806260|533417|P1|NOT COMPLETED|Period 3||1
217647|NCT00806260|533412|P6|COMPLETED|Period 3||0
217648|NCT00806260|533413|P5|COMPLETED|Period 3||0
217649|NCT00806260|533414|P4|COMPLETED|Period 3||12
217650|NCT00806260|533415|P3|COMPLETED|Period 3||5
217651|NCT00806260|533416|P2|COMPLETED|Period 3||7
217652|NCT00806260|533417|P1|COMPLETED|Period 3||12
217653|NCT00806260|533412|P6|STARTED|Period 3||0
217654|NCT00806260|533413|P5|STARTED|Period 3||0
217655|NCT00806260|533414|P4|STARTED|Period 3||12
217656|NCT00806260|533415|P3|STARTED|Period 3||6
217657|NCT00806260|533416|P2|STARTED|Period 3||8
217658|NCT00806260|533417|P1|STARTED|Period 3||13
217659|NCT00806260|533412|P6|NOT COMPLETED|Period 2||0
217660|NCT00806260|533413|P5|NOT COMPLETED|Period 2||0
217661|NCT00806260|533414|P4|NOT COMPLETED|Period 2||2
217662|NCT00806260|533415|P3|NOT COMPLETED|Period 2||2
217663|NCT00806260|533416|P2|NOT COMPLETED|Period 2||0
217664|NCT00806260|533417|P1|NOT COMPLETED|Period 2||2
217665|NCT00806260|533412|P6|COMPLETED|Period 2||0
217666|NCT00806260|533413|P5|COMPLETED|Period 2||0
217667|NCT00806260|533414|P4|COMPLETED|Period 2||12
217668|NCT00806260|533415|P3|COMPLETED|Period 2||6
217669|NCT00806260|533416|P2|COMPLETED|Period 2||8
217670|NCT00806260|533417|P1|COMPLETED|Period 2||13
217671|NCT00806260|533412|P6|STARTED|Period 2||0
217672|NCT00806260|533413|P5|STARTED|Period 2||0
217673|NCT00806260|533414|P4|STARTED|Period 2||14
217674|NCT00806260|533415|P3|STARTED|Period 2||8
217675|NCT00806260|533416|P2|STARTED|Period 2||8
217676|NCT00806260|533417|P1|STARTED|Period 2||15
217677|NCT00806260|533412|P6|NOT COMPLETED|Period 1 (1 Day)||0
217678|NCT00806260|533413|P5|NOT COMPLETED|Period 1 (1 Day)||3
217679|NCT00806260|533414|P4|NOT COMPLETED|Period 1 (1 Day)||0
217680|NCT00806260|533415|P3|NOT COMPLETED|Period 1 (1 Day)||0
217681|NCT00806260|533416|P2|NOT COMPLETED|Period 1 (1 Day)||0
217682|NCT00806260|533417|P1|NOT COMPLETED|Period 1 (1 Day)||0
217683|NCT00806260|533412|P6|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|17
217684|NCT00806260|533413|P5|COMPLETED|Period 1 (1 Day)|did not move onto Periods 2 and 3 due to adjusted design of study|15
217685|NCT00806260|533414|P4|COMPLETED|Period 1 (1 Day)||14
217686|NCT00806260|533415|P3|COMPLETED|Period 1 (1 Day)||8
217687|NCT00806260|533416|P2|COMPLETED|Period 1 (1 Day)||8
217688|NCT00806260|533417|P1|COMPLETED|Period 1 (1 Day)||15
217689|NCT00806260|533412|P6|STARTED|Period 1 (1 Day)||17
217690|NCT00806260|533413|P5|STARTED|Period 1 (1 Day)||18
217691|NCT00806260|533414|P4|STARTED|Period 1 (1 Day)||14
217692|NCT00806260|533415|P3|STARTED|Period 1 (1 Day)||8
217693|NCT00806260|533416|P2|STARTED|Period 1 (1 Day)||8
217694|NCT00806260|533417|P1|STARTED|Period 1 (1 Day)||15
217695|NCT00806351|533431|P2|NOT COMPLETED|Overall Study||4
217696|NCT00806351|533432|P1|NOT COMPLETED|Overall Study||5
217697|NCT00806351|533431|P2|COMPLETED|Overall Study||2
217698|NCT00806351|533432|P1|COMPLETED|Overall Study||10
217699|NCT00806351|533431|P2|STARTED|Overall Study||6
217700|NCT00806351|533432|P1|STARTED|Overall Study||15
217701|NCT00806390|533465|P2|NOT COMPLETED|Overall Study||0
217702|NCT00806390|533466|P1|NOT COMPLETED|Overall Study||0
217703|NCT00806390|533465|P2|COMPLETED|Overall Study||8
217704|NCT00806390|533466|P1|COMPLETED|Overall Study||7
217705|NCT00806390|533465|P2|STARTED|Overall Study||8
217706|NCT00806390|533466|P1|STARTED|Overall Study||7
217707|NCT00806403|533474|P2|NOT COMPLETED|Overall Study||3
217708|NCT00806403|533475|P1|NOT COMPLETED|Overall Study||4
217709|NCT00806403|533474|P2|COMPLETED|Overall Study||98
217710|NCT00806403|533475|P1|COMPLETED|Overall Study||100
217711|NCT00806403|533474|P2|STARTED|Overall Study||101
217712|NCT00806403|533475|P1|STARTED|Overall Study||104
217713|NCT00806416|533489|P4|NOT COMPLETED|Period 2 - Part II||0
217714|NCT00806416|533490|P3|NOT COMPLETED|Period 2 - Part II||0
217715|NCT00806416|533491|P2|NOT COMPLETED|Period 2 - Part II||0
217716|NCT00806416|533492|P1|NOT COMPLETED|Period 2 - Part II||0
217717|NCT00806416|533489|P4|COMPLETED|Period 2 - Part II||14
217718|NCT00806416|533490|P3|COMPLETED|Period 2 - Part II||14
217719|NCT00806416|533491|P2|COMPLETED|Period 2 - Part II||0
217720|NCT00806416|533492|P1|COMPLETED|Period 2 - Part II||0
217721|NCT00806416|533489|P4|STARTED|Period 2 - Part II||14
217722|NCT00806416|533490|P3|STARTED|Period 2 - Part II||14
217723|NCT00806416|533491|P2|STARTED|Period 2 - Part II||0
217724|NCT00806416|533492|P1|STARTED|Period 2 - Part II||0
217725|NCT00806416|533489|P4|NOT COMPLETED|Period 1 - Part II||2
217726|NCT00806416|533490|P3|NOT COMPLETED|Period 1 - Part II||0
217727|NCT00806416|533491|P2|NOT COMPLETED|Period 1 - Part II||0
217728|NCT00806416|533492|P1|NOT COMPLETED|Period 1 - Part II||0
217729|NCT00806416|533489|P4|COMPLETED|Period 1 - Part II||14
217730|NCT00806416|533490|P3|COMPLETED|Period 1 - Part II||14
217731|NCT00806416|533491|P2|COMPLETED|Period 1 - Part II||0
217732|NCT00806416|533492|P1|COMPLETED|Period 1 - Part II||0
217733|NCT00806416|533489|P4|STARTED|Period 1 - Part II||16
217734|NCT00806416|533490|P3|STARTED|Period 1 - Part II||14
217735|NCT00806416|533491|P2|STARTED|Period 1 - Part II||0
217736|NCT00806416|533492|P1|STARTED|Period 1 - Part II||0
217737|NCT00806416|533489|P4|NOT COMPLETED|Period 2 - Part I||0
217738|NCT00806416|533490|P3|NOT COMPLETED|Period 2 - Part I||0
217739|NCT00806416|533491|P2|NOT COMPLETED|Period 2 - Part I||0
217740|NCT00806416|533492|P1|NOT COMPLETED|Period 2 - Part I||0
217741|NCT00806416|533489|P4|COMPLETED|Period 2 - Part I||0
217742|NCT00806416|533490|P3|COMPLETED|Period 2 - Part I||0
217743|NCT00806416|533491|P2|COMPLETED|Period 2 - Part I||103
217744|NCT00806416|533492|P1|COMPLETED|Period 2 - Part I||104
217745|NCT00806416|533489|P4|STARTED|Period 2 - Part I||0
217746|NCT00806416|533490|P3|STARTED|Period 2 - Part I||0
217747|NCT00806416|533491|P2|STARTED|Period 2 - Part I||103
217748|NCT00806416|533492|P1|STARTED|Period 2 - Part I||104
217749|NCT00806416|533489|P4|NOT COMPLETED|Period 1 - Part I||0
217750|NCT00806416|533490|P3|NOT COMPLETED|Period 1 - Part I||0
217751|NCT00806416|533491|P2|NOT COMPLETED|Period 1 - Part I||4
217752|NCT00806416|533492|P1|NOT COMPLETED|Period 1 - Part I||3
217753|NCT00806416|533489|P4|COMPLETED|Period 1 - Part I||0
217754|NCT00806416|533490|P3|COMPLETED|Period 1 - Part I||0
217755|NCT00806416|533491|P2|COMPLETED|Period 1 - Part I||103
217756|NCT00806416|533492|P1|COMPLETED|Period 1 - Part I||104
217757|NCT00806416|533489|P4|STARTED|Period 1 - Part I||0
217758|NCT00806416|533490|P3|STARTED|Period 1 - Part I||0
217759|NCT00806416|533491|P2|STARTED|Period 1 - Part I||107
217760|NCT00806416|533492|P1|STARTED|Period 1 - Part I||107
217761|NCT00806442|533503|P2|NOT COMPLETED|Overall Study||7
217762|NCT00806442|533504|P1|NOT COMPLETED|Overall Study||4
217763|NCT00806442|533503|P2|COMPLETED|Overall Study||14
217764|NCT00806442|533504|P1|COMPLETED|Overall Study||14
217765|NCT00806442|533503|P2|Second Intervention (3 Wks)|Overall Study||14
217766|NCT00806442|533504|P1|Second Intervention (3 Wks)|Overall Study||15
217767|NCT00806442|533503|P2|Washout (3 Wks)|Overall Study||14
217768|NCT00806442|533504|P1|Washout (3 Wks)|Overall Study||15
217769|NCT00806442|533503|P2|First Intervention (3 Wks)|Overall Study||21
217770|NCT00806442|533504|P1|First Intervention (3 Wks)|Overall Study||18
217771|NCT00806442|533503|P2|STARTED|Overall Study||21
217772|NCT00806442|533504|P1|STARTED|Overall Study||18
217773|NCT00806494|533524|P1|NOT COMPLETED|Overall Study||80
217774|NCT00806494|533524|P1|COMPLETED|Overall Study||251
217775|NCT00806494|533524|P1|STARTED|Overall Study||331
217776|NCT00806546|533548|P1|NOT COMPLETED|Overall Study||307
217777|NCT00806546|533548|P1|COMPLETED|Overall Study||207
217778|NCT00806546|533548|P1|STARTED|Overall Study|35 subjects were enrolled but did not treat for a total of 479 subjects in the safety population|514
217779|NCT00806585|533557|P5|NOT COMPLETED|Overall Study||31
217780|NCT00806585|533558|P4|NOT COMPLETED|Overall Study||15
217781|NCT00806585|533559|P3|NOT COMPLETED|Overall Study||32
217782|NCT00806585|533560|P2|NOT COMPLETED|Overall Study||31
217783|NCT00806585|533561|P1|NOT COMPLETED|Overall Study||32
217784|NCT00806585|533557|P5|COMPLETED|Overall Study||106
217785|NCT00806585|533558|P4|COMPLETED|Overall Study||56
217786|NCT00806585|533559|P3|COMPLETED|Overall Study||109
217787|NCT00806585|533560|P2|COMPLETED|Overall Study||103
217788|NCT00806585|533561|P1|COMPLETED|Overall Study||105
217789|NCT00806585|533557|P5|STARTED|Overall Study||137
217790|NCT00806585|533558|P4|STARTED|Overall Study||71
217791|NCT00806585|533559|P3|STARTED|Overall Study||141
217792|NCT00806585|533560|P2|STARTED|Overall Study||134
217793|NCT00806585|533561|P1|STARTED|Overall Study||137
217794|NCT00806598|533593|P1|NOT COMPLETED|Overall Study||0
217795|NCT00806598|533593|P1|COMPLETED|Overall Study||48
217796|NCT00806598|533593|P1|STARTED|Overall Study||48
217797|NCT00806624|533600|P3|NOT COMPLETED|Overall Study||6
217798|NCT00806624|533601|P2|NOT COMPLETED|Overall Study||12
217799|NCT00806624|533602|P1|NOT COMPLETED|Overall Study||9
217800|NCT00806624|533600|P3|COMPLETED|Overall Study||69
217801|NCT00806624|533601|P2|COMPLETED|Overall Study||68
217802|NCT00806624|533602|P1|COMPLETED|Overall Study||70
217803|NCT00806624|533600|P3|STARTED|Overall Study||75
217804|NCT00806624|533601|P2|STARTED|Overall Study||80
217805|NCT00806624|533602|P1|STARTED|Overall Study||79
217806|NCT00806676|533613|P3|NOT COMPLETED|Overall Study||6
217807|NCT00806676|533614|P2|NOT COMPLETED|Overall Study||0
217808|NCT00806676|533615|P1|NOT COMPLETED|Overall Study||4
217809|NCT00806676|533613|P3|COMPLETED|Overall Study||23
217810|NCT00806676|533614|P2|COMPLETED|Overall Study||9
217811|NCT00806676|533615|P1|COMPLETED|Overall Study||25
217812|NCT00806676|533613|P3|STARTED|Overall Study||29
217813|NCT00806676|533614|P2|STARTED|Overall Study||9
217814|NCT00806676|533615|P1|STARTED|Overall Study||29
217815|NCT00806819|533646|P2|NOT COMPLETED|Overall Study||358
217816|NCT00806819|533647|P1|NOT COMPLETED|Overall Study||346
217817|NCT00806819|533646|P2|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|2
217818|NCT00806819|533647|P1|COMPLETED|Overall Study|On-treatment at analysis DBL date (15 February 2013)|7
217819|NCT00806819|533646|P2|STARTED|Overall Study|randomised patients|360
217820|NCT00806819|533647|P1|STARTED|Overall Study|randomised patients|353
217821|NCT00806988|533681|P2|NOT COMPLETED|Overall Study||43
217822|NCT00806988|533682|P1|NOT COMPLETED|Overall Study||27
217823|NCT00806988|533681|P2|COMPLETED|Overall Study||108
217824|NCT00806988|533682|P1|COMPLETED|Overall Study||123
217825|NCT00806988|533681|P2|STARTED|Overall Study||151
217826|NCT00806988|533682|P1|STARTED|Overall Study||150
217827|NCT00807001|533695|P5|NOT COMPLETED|Overall Study||0
217828|NCT00807001|533696|P4|NOT COMPLETED|Overall Study||0
217829|NCT00807001|533697|P3|NOT COMPLETED|Overall Study||0
217830|NCT00807001|533698|P2|NOT COMPLETED|Overall Study||1
217831|NCT00807001|533699|P1|NOT COMPLETED|Overall Study||0
217832|NCT00807001|533695|P5|COMPLETED|Overall Study||9
217833|NCT00807001|533696|P4|COMPLETED|Overall Study||8
217834|NCT00807001|533697|P3|COMPLETED|Overall Study||8
217835|NCT00807001|533698|P2|COMPLETED|Overall Study||7
217836|NCT00807001|533699|P1|COMPLETED|Overall Study||8
217837|NCT00807001|533695|P5|STARTED|Overall Study||9
217838|NCT00807001|533696|P4|STARTED|Overall Study||8
217839|NCT00807001|533697|P3|STARTED|Overall Study||8
217840|NCT00807001|533698|P2|STARTED|Overall Study||8
217841|NCT00807001|533699|P1|STARTED|Overall Study|For all groups, number of subjects who received at least one dose of study drug.|8
217842|NCT00807014|533718|P2|NOT COMPLETED|Overall Study||27
217843|NCT00807014|533719|P1|NOT COMPLETED|Overall Study||27
217844|NCT00807014|533718|P2|COMPLETED|Overall Study||58
217845|NCT00807014|533719|P1|COMPLETED|Overall Study||56
217846|NCT00807014|533718|P2|STARTED|Overall Study||85
217847|NCT00807014|533719|P1|STARTED|Overall Study||83
217848|NCT00807040|533747|P2|NOT COMPLETED|Overall Study||41
217849|NCT00807040|533748|P1|NOT COMPLETED|Overall Study||36
217850|NCT00807040|533747|P2|COMPLETED|Overall Study||84
217851|NCT00807040|533748|P1|COMPLETED|Overall Study||90
217852|NCT00807040|533747|P2|STARTED|Overall Study||125
217853|NCT00807040|533748|P1|STARTED|Overall Study||126
217854|NCT00807092|533758|P2|NOT COMPLETED|Overall Study||4
217855|NCT00807092|533759|P1|NOT COMPLETED|Overall Study||1
217856|NCT00807092|533758|P2|COMPLETED|Overall Study||69
217857|NCT00807092|533759|P1|COMPLETED|Overall Study||71
217858|NCT00807092|533758|P2|Exposed to Drug|Overall Study||73
217859|NCT00807092|533759|P1|Exposed to Drug|Overall Study|Subject was randomised, but not exposed to any trial drug|71
217860|NCT00807092|533758|P2|STARTED|Overall Study||73
217861|NCT00807092|533759|P1|STARTED|Overall Study||72
217862|NCT00807209|533790|P3|NOT COMPLETED|Overall Study||0
217863|NCT00807209|533791|P2|NOT COMPLETED|Overall Study||0
217864|NCT00807209|533792|P1|NOT COMPLETED|Overall Study||0
217865|NCT00807209|533790|P3|COMPLETED|Overall Study||1
217866|NCT00807209|533791|P2|COMPLETED|Overall Study||1
217867|NCT00807209|533792|P1|COMPLETED|Overall Study||1
217868|NCT00807209|533790|P3|STARTED|Overall Study||1
217869|NCT00807209|533791|P2|STARTED|Overall Study||1
217870|NCT00807209|533792|P1|STARTED|Overall Study||1
217871|NCT00807235|533802|P2|NOT COMPLETED|Overall Study||0
217872|NCT00807235|533803|P1|NOT COMPLETED|Overall Study||1
217873|NCT00807235|533802|P2|COMPLETED|Overall Study||6
217874|NCT00807235|533803|P1|COMPLETED|Overall Study||10
217875|NCT00807235|533802|P2|STARTED|Overall Study||6
217876|NCT00807235|533803|P1|STARTED|Overall Study||11
217877|NCT00807248|533837|P4|NOT COMPLETED|Overall Study||14
217878|NCT00807248|533838|P3|NOT COMPLETED|Overall Study||18
217879|NCT00807248|533839|P2|NOT COMPLETED|Overall Study||12
217880|NCT00807248|533840|P1|NOT COMPLETED|Overall Study||21
217881|NCT00807248|533837|P4|COMPLETED|Overall Study||126
217882|NCT00807248|533838|P3|COMPLETED|Overall Study||121
217883|NCT00807248|533839|P2|COMPLETED|Overall Study||128
217884|NCT00807248|533840|P1|COMPLETED|Overall Study||50
217885|NCT00807248|533837|P4|STARTED|Overall Study||140
217886|NCT00807248|533838|P3|STARTED|Overall Study||139
217887|NCT00807248|533839|P2|STARTED|Overall Study||140
217888|NCT00807248|533840|P1|STARTED|Overall Study||71
217889|NCT00807365|533882|P1|NOT COMPLETED|Overall Study||5
217890|NCT00807365|533882|P1|COMPLETED|Overall Study||0
217891|NCT00807365|533882|P1|STARTED|Overall Study||5
217892|NCT00807456|533886|P1|NOT COMPLETED|Overall Study||0
217893|NCT00807456|533886|P1|COMPLETED|Overall Study||65
217894|NCT00807456|533886|P1|STARTED|Overall Study||65
217895|NCT00807560|533892|P2|NOT COMPLETED|Overall Study||0
217896|NCT00807560|533893|P1|NOT COMPLETED|Overall Study||0
217897|NCT00807560|533892|P2|COMPLETED|Overall Study||39
217898|NCT00807560|533893|P1|COMPLETED|Overall Study||38
217899|NCT00807560|533892|P2|STARTED|Overall Study||39
217900|NCT00807560|533893|P1|STARTED|Overall Study||38
217901|NCT00807573|533927|P1|NOT COMPLETED|Overall Study||2
217902|NCT00807573|533927|P1|COMPLETED|Overall Study||42
217903|NCT00807573|533927|P1|STARTED|Overall Study||44
217904|NCT00814138|533933|P2|NOT COMPLETED|Overall Study||7
217905|NCT00814138|533934|P1|NOT COMPLETED|Overall Study||1
217906|NCT00814138|533933|P2|COMPLETED|Overall Study||18
217907|NCT00814138|533934|P1|COMPLETED|Overall Study||24
217908|NCT00814138|533933|P2|STARTED|Overall Study||25
217909|NCT00814138|533934|P1|STARTED|Overall Study||25
217910|NCT00814164|533952|P1|NOT COMPLETED|Overall Study||19
217911|NCT00814164|533952|P1|COMPLETED|Overall Study||2
217912|NCT00814164|533952|P1|STARTED|Overall Study||21
217913|NCT00814177|533965|P2|NOT COMPLETED|Overall Study||0
217914|NCT00814177|533966|P1|NOT COMPLETED|Overall Study||0
217915|NCT00814177|533965|P2|COMPLETED|Overall Study||80
217916|NCT00814177|533966|P1|COMPLETED|Overall Study||80
217917|NCT00814177|533965|P2|STARTED|Overall Study||80
217918|NCT00814177|533966|P1|STARTED|Overall Study||80
217919|NCT00814255|533975|P3|NOT COMPLETED|Overall Study||1
217920|NCT00814255|533976|P2|NOT COMPLETED|Overall Study||0
217921|NCT00814255|533977|P1|NOT COMPLETED|Overall Study||1
217922|NCT00814255|533975|P3|COMPLETED|Overall Study||7
217923|NCT00814255|533976|P2|COMPLETED|Overall Study||7
217924|NCT00814255|533977|P1|COMPLETED|Overall Study||7
217925|NCT00814255|533975|P3|STARTED|Overall Study||8
217926|NCT00814255|533976|P2|STARTED|Overall Study||7
217927|NCT00814255|533977|P1|STARTED|Overall Study||8
217928|NCT00814307|534001|P4|NOT COMPLETED|Overall Study||10
217929|NCT00814307|534002|P3|NOT COMPLETED|Overall Study||7
217930|NCT00814307|534003|P2|NOT COMPLETED|Overall Study||27
217931|NCT00814307|534004|P1|NOT COMPLETED|Overall Study||12
217932|NCT00814307|534001|P4|COMPLETED|Overall Study||51
217933|NCT00814307|534002|P3|COMPLETED|Overall Study||54
217934|NCT00814307|534003|P2|COMPLETED|Overall Study||218
217935|NCT00814307|534004|P1|COMPLETED|Overall Study||232
217936|NCT00814307|534001|P4|Treated|Overall Study||61
217937|NCT00814307|534002|P3|Treated|Overall Study||61
217938|NCT00814307|534003|P2|Treated|Overall Study||245
217939|NCT00814307|534004|P1|Treated|Overall Study||243
217940|NCT00814307|534001|P4|STARTED|Overall Study||61
217941|NCT00814307|534002|P3|STARTED|Overall Study||61
217942|NCT00814307|534003|P2|STARTED|Overall Study||245
217943|NCT00814307|534004|P1|STARTED|Overall Study||244
217944|NCT00814320|534168|P2|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||10
217945|NCT00814320|534169|P1|NOT COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||3
218032|NCT00815347|534416|P1|COMPLETED|Overall Study||7
217946|NCT00814320|534168|P2|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)|Three participants who switched to safety follow-up remained in the study.|60
217947|NCT00814320|534169|P1|COMPLETED|Epoch 2 After Ramp-up (SC/rHuPH20)||8
217948|NCT00814320|534168|P2|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||70
217949|NCT00814320|534169|P1|STARTED|Epoch 2 After Ramp-up (SC/rHuPH20)||11
217950|NCT00814320|534168|P2|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||0
217951|NCT00814320|534169|P1|NOT COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||2
217952|NCT00814320|534168|P2|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||70
217953|NCT00814320|534169|P1|COMPLETED|"Epoch 2 Ramp-up (Ramp-up)"||11
217954|NCT00814320|534168|P2|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||70
217955|NCT00814320|534169|P1|STARTED|"Epoch 2 Ramp-up (Ramp-up)"||13
217956|NCT00814320|534168|P2|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||1
217957|NCT00814320|534169|P1|NOT COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||0
217958|NCT00814320|534168|P2|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||70
217959|NCT00814320|534169|P1|COMPLETED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
217960|NCT00814320|534168|P2|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||71
217961|NCT00814320|534169|P1|STARTED|Between Epoch 1 (IV) and Epoch 2 Ramp-up||13
217962|NCT00814320|534168|P2|NOT COMPLETED|Epoch 1 (IV Treatment)||2
217963|NCT00814320|534169|P1|NOT COMPLETED|Epoch 1 (IV Treatment)||1
217964|NCT00814320|534168|P2|COMPLETED|Epoch 1 (IV Treatment)||71
217965|NCT00814320|534169|P1|COMPLETED|Epoch 1 (IV Treatment)||13
217966|NCT00814320|534168|P2|STARTED|Epoch 1 (IV Treatment)||73
217967|NCT00814320|534169|P1|STARTED|Epoch 1 (IV Treatment)||14
217968|NCT00814333|534299|P2|NOT COMPLETED|Treatment Period||0
217969|NCT00814333|534300|P1|NOT COMPLETED|Treatment Period||0
217970|NCT00814333|534299|P2|COMPLETED|Treatment Period||0
217971|NCT00814333|534300|P1|COMPLETED|Treatment Period||0
217972|NCT00814333|534299|P2|STARTED|Treatment Period||0
217973|NCT00814333|534300|P1|STARTED|Treatment Period||0
217974|NCT00814333|534299|P2|NOT COMPLETED|Enrollment||0
217975|NCT00814333|534300|P1|NOT COMPLETED|Enrollment||1
217976|NCT00814333|534299|P2|COMPLETED|Enrollment||0
217977|NCT00814333|534300|P1|COMPLETED|Enrollment||0
217978|NCT00814333|534299|P2|STARTED|Enrollment||0
217979|NCT00814333|534300|P1|STARTED|Enrollment||1
217980|NCT00814346|534308|P2|NOT COMPLETED|Open Phase (17 Months)||0
217981|NCT00814346|534309|P1|NOT COMPLETED|Open Phase (17 Months)||10
217982|NCT00814346|534308|P2|COMPLETED|Open Phase (17 Months)||0
217983|NCT00814346|534309|P1|COMPLETED|Open Phase (17 Months)||31
217984|NCT00814346|534308|P2|AD|Open Phase (17 Months)||0
217985|NCT00814346|534309|P1|AD|Open Phase (17 Months)|Open period was not proposed to AD subjects.|0
217986|NCT00814346|534308|P2|MC|Open Phase (17 Months)||0
217987|NCT00814346|534309|P1|MC|Open Phase (17 Months)||20
217988|NCT00814346|534308|P2|CNE|Open Phase (17 Months)||0
217989|NCT00814346|534309|P1|CNE|Open Phase (17 Months)||21
217990|NCT00814346|534308|P2|STARTED|Open Phase (17 Months)|This was an open period, without placebo arm, the number of subject on placebo is 0.|0
217991|NCT00814346|534309|P1|STARTED|Open Phase (17 Months)|Open period was treated with EGB761®. 41 subjects accepted follow-up open period(21 in CNE,20 in MC)|41
217992|NCT00814346|534308|P2|NOT COMPLETED|Double-blind Phase (4 Weeks)||3
217993|NCT00814346|534309|P1|NOT COMPLETED|Double-blind Phase (4 Weeks)||0
217994|NCT00814346|534308|P2|COMPLETED|Double-blind Phase (4 Weeks)||23
217995|NCT00814346|534309|P1|COMPLETED|Double-blind Phase (4 Weeks)||23
217996|NCT00814346|534308|P2|AD|Double-blind Phase (4 Weeks)||2
217997|NCT00814346|534309|P1|AD|Double-blind Phase (4 Weeks)||3
217998|NCT00814346|534308|P2|MC|Double-blind Phase (4 Weeks)||11
217999|NCT00814346|534309|P1|MC|Double-blind Phase (4 Weeks)||10
218000|NCT00814346|534308|P2|CNE|Double-blind Phase (4 Weeks)||13
218001|NCT00814346|534309|P1|CNE|Double-blind Phase (4 Weeks)||10
218002|NCT00814346|534308|P2|STARTED|Double-blind Phase (4 Weeks)||26
218003|NCT00814346|534309|P1|STARTED|Double-blind Phase (4 Weeks)||23
218004|NCT00814463|534373|P1|NOT COMPLETED|Overall Study||1
218005|NCT00814463|534373|P1|COMPLETED|Overall Study||0
218006|NCT00814463|534373|P1|STARTED|Overall Study||1
218007|NCT00815087|534379|P2|NOT COMPLETED|Overall Study||0
218008|NCT00815087|534380|P1|NOT COMPLETED|Overall Study||0
218009|NCT00815087|534379|P2|COMPLETED|Overall Study||10
218010|NCT00815087|534380|P1|COMPLETED|Overall Study||10
218011|NCT00815087|534379|P2|STARTED|Overall Study||10
218012|NCT00815087|534380|P1|STARTED|Overall Study||10
218013|NCT00815191|534388|P2|NOT COMPLETED|Overall Study||1
218014|NCT00815191|534389|P1|NOT COMPLETED|Overall Study||1
218015|NCT00815191|534388|P2|COMPLETED|Overall Study||34
218016|NCT00815191|534389|P1|COMPLETED|Overall Study||37
218017|NCT00815191|534388|P2|STARTED|Overall Study||35
218018|NCT00815191|534389|P1|STARTED|Overall Study||38
218019|NCT00815295|534398|P3|NOT COMPLETED|Overall Study||3
218020|NCT00815295|534399|P2|NOT COMPLETED|Overall Study||1
218021|NCT00815295|534400|P1|NOT COMPLETED|Overall Study||0
218022|NCT00815295|534398|P3|COMPLETED|Overall Study||9
218023|NCT00815295|534399|P2|COMPLETED|Overall Study||7
218024|NCT00815295|534400|P1|COMPLETED|Overall Study||8
218025|NCT00815295|534398|P3|STARTED|Overall Study||12
218026|NCT00815295|534399|P2|STARTED|Overall Study||8
218027|NCT00815295|534400|P1|STARTED|Overall Study||8
218028|NCT00815308|534410|P1|NOT COMPLETED|Overall Study||10
218029|NCT00815308|534410|P1|COMPLETED|Overall Study||45
218030|NCT00815308|534410|P1|STARTED|Overall Study||55
218031|NCT00815347|534416|P1|NOT COMPLETED|Overall Study||4
218033|NCT00815347|534416|P1|STARTED|Overall Study||11
218034|NCT00815360|534434|P2|NOT COMPLETED|Overall Study||0
218035|NCT00815360|534435|P1|NOT COMPLETED|Overall Study||0
218036|NCT00815360|534434|P2|COMPLETED|Overall Study||11
218037|NCT00815360|534435|P1|COMPLETED|Overall Study||11
218038|NCT00815360|534434|P2|STARTED|Overall Study||11
218039|NCT00815360|534435|P1|STARTED|Overall Study||11
218040|NCT00815490|534445|P2|NOT COMPLETED|Overall Study||0
218041|NCT00815490|534446|P1|NOT COMPLETED|Overall Study||0
218042|NCT00815490|534445|P2|COMPLETED|Overall Study||9
218043|NCT00815490|534446|P1|COMPLETED|Overall Study||9
218044|NCT00815490|534445|P2|STARTED|Overall Study||9
218045|NCT00815490|534446|P1|STARTED|Overall Study||9
218046|NCT00815516|534454|P2|NOT COMPLETED|Overall Study||1
218047|NCT00815516|534455|P1|NOT COMPLETED|Overall Study||4
218048|NCT00815516|534454|P2|COMPLETED|Overall Study||9
218049|NCT00815516|534455|P1|COMPLETED|Overall Study||16
218050|NCT00815516|534454|P2|STARTED|Overall Study||10
218051|NCT00815516|534455|P1|STARTED|Overall Study||20
218052|NCT00815659|534484|P1|NOT COMPLETED|Overall Study||23
218053|NCT00815659|534484|P1|COMPLETED|Overall Study||74
218054|NCT00815659|534484|P1|STARTED|Overall Study||97
218055|NCT00815685|534527|P1|NOT COMPLETED|Overall Study||22
218056|NCT00815685|534527|P1|COMPLETED|Overall Study|Complete pre and post-treatment serum samples were available for 14 participants.|14
218057|NCT00815685|534527|P1|STARTED|Overall Study||36
218058|NCT00815698|534534|P2|NOT COMPLETED|Overall Study||0
218059|NCT00815698|534535|P1|NOT COMPLETED|Overall Study||0
218060|NCT00815698|534534|P2|COMPLETED|Overall Study||171
218061|NCT00815698|534535|P1|COMPLETED|Overall Study||163
218062|NCT00815698|534534|P2|STARTED|Overall Study||171
218063|NCT00815698|534535|P1|STARTED|Overall Study||163
218064|NCT00815776|534546|P3|NOT COMPLETED|Overall Study||6
218065|NCT00815776|534547|P2|NOT COMPLETED|Overall Study||8
218066|NCT00815776|534548|P1|NOT COMPLETED|Overall Study||8
218067|NCT00815776|534546|P3|COMPLETED|Overall Study||22
218068|NCT00815776|534547|P2|COMPLETED|Overall Study||56
218069|NCT00815776|534548|P1|COMPLETED|Overall Study||52
218070|NCT00815776|534546|P3|STARTED|Overall Study||28
218071|NCT00815776|534547|P2|STARTED|Overall Study||64
218072|NCT00815776|534548|P1|STARTED|Overall Study||60
218073|NCT00815919|534562|P1|NOT COMPLETED|Overall Study||4
218074|NCT00815919|534562|P1|COMPLETED|Overall Study||18
218075|NCT00815919|534562|P1|STARTED|Overall Study||22
218076|NCT00816023|534574|P4|NOT COMPLETED|Overall Study||12
218077|NCT00816023|534575|P3|NOT COMPLETED|Overall Study||9
218078|NCT00816023|534576|P2|NOT COMPLETED|Overall Study||6
218079|NCT00816023|534577|P1|NOT COMPLETED|Overall Study||9
218080|NCT00816023|534574|P4|COMPLETED|Overall Study||62
218081|NCT00816023|534575|P3|COMPLETED|Overall Study||60
218082|NCT00816023|534576|P2|COMPLETED|Overall Study||56
218083|NCT00816023|534577|P1|COMPLETED|Overall Study||62
218084|NCT00816023|534574|P4|Completed Therapy|Overall Study||63
218085|NCT00816023|534575|P3|Completed Therapy|Overall Study||61
218086|NCT00816023|534576|P2|Completed Therapy|Overall Study||59
218087|NCT00816023|534577|P1|Completed Therapy|Overall Study||65
218088|NCT00816023|534574|P4|STARTED|Overall Study||74
218089|NCT00816023|534575|P3|STARTED|Overall Study||69
218090|NCT00816023|534576|P2|STARTED|Overall Study||62
218091|NCT00816023|534577|P1|STARTED|Overall Study||71
218092|NCT00816036|534593|P2|NOT COMPLETED|Overall Study||108
218093|NCT00816036|534594|P1|NOT COMPLETED|Overall Study||176
218094|NCT00816036|534593|P2|COMPLETED|Overall Study||287
218095|NCT00816036|534594|P1|COMPLETED|Overall Study||327
218096|NCT00816036|534593|P2|STARTED|Overall Study||395
218097|NCT00816036|534594|P1|STARTED|Overall Study||503
218098|NCT00816101|534607|P3|NOT COMPLETED|Overall Study||0
218099|NCT00816101|534608|P2|NOT COMPLETED|Overall Study||0
218100|NCT00816101|534609|P1|NOT COMPLETED|Overall Study||0
218101|NCT00816101|534607|P3|COMPLETED|Overall Study||5
218102|NCT00816101|534608|P2|COMPLETED|Overall Study||8
218103|NCT00816101|534609|P1|COMPLETED|Overall Study||13
218104|NCT00816101|534607|P3|STARTED|Overall Study||5
218105|NCT00816101|534608|P2|STARTED|Overall Study||8
218106|NCT00816101|534609|P1|STARTED|Overall Study||13
218107|NCT00816166|534625|P2|NOT COMPLETED|Overall Study||12
218108|NCT00816166|534626|P1|NOT COMPLETED|Overall Study||10
218109|NCT00816166|534625|P2|COMPLETED|Overall Study||41
218110|NCT00816166|534626|P1|COMPLETED|Overall Study||49
218111|NCT00816166|534625|P2|ITT Population (Met Eligibility)|Overall Study||53
218112|NCT00816166|534626|P1|ITT Population (Met Eligibility)|Overall Study|Of 59 randomized to Stent Arm, 1 subject failed to meet eligibility and was excluded from the ITT|58
218113|NCT00816166|534625|P2|STARTED|Overall Study|Of 53 randomized to Medical Therapy Arm, 9 were treated with Stent+Medical Therapy|53
218114|NCT00816166|534626|P1|STARTED|Overall Study|Of 59 randomized to Stent Arm, 4 were treated with Medical Therapy Only|59
218115|NCT00816348|534632|P1|NOT COMPLETED|Overall Study||0
218116|NCT00816348|534632|P1|COMPLETED|Overall Study||15
218117|NCT00816348|534632|P1|STARTED|Overall Study||15
218118|NCT00816400|534645|P9|NOT COMPLETED|Overall Study||6
218119|NCT00816400|534646|P8|NOT COMPLETED|Overall Study||5
218120|NCT00816400|534647|P7|NOT COMPLETED|Overall Study||2
218121|NCT00816400|534648|P6|NOT COMPLETED|Overall Study||3
218122|NCT00816400|534649|P5|NOT COMPLETED|Overall Study||2
218123|NCT00816400|534650|P4|NOT COMPLETED|Overall Study||3
218124|NCT00816400|534651|P3|NOT COMPLETED|Overall Study||5
218125|NCT00816400|534652|P2|NOT COMPLETED|Overall Study||3
218126|NCT00816400|534653|P1|NOT COMPLETED|Overall Study||2
218127|NCT00816400|534645|P9|COMPLETED|Overall Study||0
218128|NCT00816400|534646|P8|COMPLETED|Overall Study||1
218129|NCT00816400|534647|P7|COMPLETED|Overall Study||1
218130|NCT00816400|534648|P6|COMPLETED|Overall Study||0
218131|NCT00816400|534649|P5|COMPLETED|Overall Study||1
218132|NCT00816400|534650|P4|COMPLETED|Overall Study||0
218133|NCT00816400|534651|P3|COMPLETED|Overall Study||0
218134|NCT00816400|534652|P2|COMPLETED|Overall Study||0
218135|NCT00816400|534653|P1|COMPLETED|Overall Study||1
218136|NCT00816400|534645|P9|STARTED|Overall Study||6
218137|NCT00816400|534646|P8|STARTED|Overall Study||6
218138|NCT00816400|534647|P7|STARTED|Overall Study||3
218139|NCT00816400|534648|P6|STARTED|Overall Study||3
218140|NCT00816400|534649|P5|STARTED|Overall Study||3
218141|NCT00816400|534650|P4|STARTED|Overall Study||3
218142|NCT00816400|534651|P3|STARTED|Overall Study||5
218143|NCT00816400|534652|P2|STARTED|Overall Study||3
218144|NCT00816400|534653|P1|STARTED|Overall Study||3
218145|NCT00816556|534840|P3|NOT COMPLETED|Overall Study||3
218146|NCT00816556|534841|P2|NOT COMPLETED|Overall Study||2
218147|NCT00816556|534842|P1|NOT COMPLETED|Overall Study||2
218148|NCT00816556|534840|P3|COMPLETED|Overall Study||19
218149|NCT00816556|534841|P2|COMPLETED|Overall Study||19
218150|NCT00816556|534842|P1|COMPLETED|Overall Study||18
218151|NCT00816556|534840|P3|STARTED|Overall Study||22
218152|NCT00816556|534841|P2|STARTED|Overall Study||21
218153|NCT00816556|534842|P1|STARTED|Overall Study||20
218154|NCT00816595|534858|P2|NOT COMPLETED|Overall Study||0
218155|NCT00816595|534859|P1|NOT COMPLETED|Overall Study||2
218156|NCT00816595|534858|P2|COMPLETED|Overall Study||33
218157|NCT00816595|534859|P1|COMPLETED|Overall Study||33
218158|NCT00816595|534858|P2|STARTED|Overall Study||33
218159|NCT00816595|534859|P1|STARTED|Overall Study||35
218160|NCT00816777|534871|P2|NOT COMPLETED|Overall Study||0
218161|NCT00816777|534872|P1|NOT COMPLETED|Overall Study||0
218162|NCT00816777|534871|P2|COMPLETED|Overall Study||2
218163|NCT00816777|534872|P1|COMPLETED|Overall Study||2
218164|NCT00816777|534871|P2|STARTED|Overall Study||2
218165|NCT00816777|534872|P1|STARTED|Overall Study||2
218166|NCT00816829|534880|P2|NOT COMPLETED|Overall Study||0
218167|NCT00816829|534881|P1|NOT COMPLETED|Overall Study||0
218168|NCT00816829|534880|P2|COMPLETED|Overall Study||18
218169|NCT00816829|534881|P1|COMPLETED|Overall Study||16
218170|NCT00816829|534880|P2|STARTED|Overall Study||18
218171|NCT00816829|534881|P1|STARTED|Overall Study||16
218172|NCT00816907|534907|P2|NOT COMPLETED|Overall Study||17
218173|NCT00816907|534908|P1|NOT COMPLETED|Overall Study||13
218174|NCT00816907|534907|P2|COMPLETED|Overall Study||58
218175|NCT00816907|534908|P1|COMPLETED|Overall Study||58
218176|NCT00816907|534907|P2|STARTED|Overall Study||75
218177|NCT00816907|534908|P1|STARTED|Overall Study||71
218178|NCT00817206|534930|P2|NOT COMPLETED|Overall Study||9
218179|NCT00817206|534931|P1|NOT COMPLETED|Overall Study||21
218180|NCT00817206|534930|P2|COMPLETED|Overall Study||154
218181|NCT00817206|534931|P1|COMPLETED|Overall Study||142
218182|NCT00817206|534930|P2|STARTED|Overall Study||163
218183|NCT00817206|534931|P1|STARTED|Overall Study||163
218184|NCT00817219|534937|P1|NOT COMPLETED|Overall Study||0
218185|NCT00817219|534937|P1|COMPLETED|Overall Study||33
218186|NCT00817219|534937|P1|STARTED|Overall Study||33
218187|NCT00817336|534952|P2|NOT COMPLETED|Overall Study||1
218188|NCT00817336|534953|P1|NOT COMPLETED|Overall Study||1
218189|NCT00817336|534952|P2|COMPLETED|Overall Study||7
218190|NCT00817336|534953|P1|COMPLETED|Overall Study||7
218191|NCT00817336|534952|P2|STARTED|Overall Study||8
218192|NCT00817336|534953|P1|STARTED|Overall Study||8
218193|NCT00817479|534966|P2|NOT COMPLETED|Overall Study||1
218194|NCT00817479|534967|P1|NOT COMPLETED|Overall Study||1
218195|NCT00817479|534966|P2|COMPLETED|Overall Study||13
218196|NCT00817479|534967|P1|COMPLETED|Overall Study||5
218197|NCT00817479|534966|P2|STARTED|Overall Study||14
218198|NCT00817479|534967|P1|STARTED|Overall Study||6
218199|NCT00817531|534975|P1|NOT COMPLETED|Overall Study||2
218200|NCT00817531|534975|P1|COMPLETED|Overall Study|20 out of 22 patients finished study treatment. 2 patients stopped the treatment after the 1st week.|20
218201|NCT00817531|534975|P1|STARTED|Overall Study|22 patients were eligible for this study and started the treatment.|22
218202|NCT00810511|534981|P2|NOT COMPLETED|Overall Study||4
218203|NCT00810511|534982|P1|NOT COMPLETED|Overall Study||10
218204|NCT00810511|534981|P2|COMPLETED|Overall Study||102
218205|NCT00810511|534982|P1|COMPLETED|Overall Study||97
218206|NCT00810511|534981|P2|STARTED|Overall Study||106
218207|NCT00810511|534982|P1|STARTED|Overall Study||107
218208|NCT00810576|534988|P1|NOT COMPLETED|Overall Study||0
218209|NCT00810576|534988|P1|COMPLETED|Overall Study||1
218210|NCT00810576|534988|P1|STARTED|Overall Study||1
218211|NCT00810602|534992|P2|NOT COMPLETED|Overall Study||3
218212|NCT00810602|534993|P1|NOT COMPLETED|Overall Study||8
218213|NCT00810602|534992|P2|COMPLETED|Overall Study||31
218214|NCT00810602|534993|P1|COMPLETED|Overall Study||19
218215|NCT00810602|534992|P2|STARTED|Overall Study||34
218216|NCT00810602|534993|P1|STARTED|Overall Study||27
218217|NCT00810641|535003|P3|NOT COMPLETED|Overall Study||2
218218|NCT00810641|535004|P2|NOT COMPLETED|Overall Study||1
218219|NCT00810641|535005|P1|NOT COMPLETED|Overall Study||0
218220|NCT00810641|535003|P3|COMPLETED|Overall Study||49
218221|NCT00810641|535004|P2|COMPLETED|Overall Study||53
218222|NCT00810641|535005|P1|COMPLETED|Overall Study||52
218223|NCT00810641|535003|P3|STARTED|Overall Study||51
218224|NCT00810641|535004|P2|STARTED|Overall Study||54
218225|NCT00810641|535005|P1|STARTED|Overall Study||52
218226|NCT00810693|535016|P3|NOT COMPLETED|Follow-up Period (FUP)||4
218227|NCT00810693|535017|P2|NOT COMPLETED|Follow-up Period (FUP)||3
218228|NCT00810693|535018|P1|NOT COMPLETED|Follow-up Period (FUP)||8
218229|NCT00810693|535016|P3|COMPLETED|Follow-up Period (FUP)||12
218230|NCT00810693|535017|P2|COMPLETED|Follow-up Period (FUP)||4
218231|NCT00810693|535018|P1|COMPLETED|Follow-up Period (FUP)||15
218232|NCT00810693|535016|P3|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|16
218233|NCT00810693|535017|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|7
218234|NCT00810693|535018|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|23
218235|NCT00810693|535016|P3|NOT COMPLETED|Treatment Period||16
218236|NCT00810693|535017|P2|NOT COMPLETED|Treatment Period||7
218237|NCT00810693|535018|P1|NOT COMPLETED|Treatment Period||17
218238|NCT00810693|535016|P3|COMPLETED|Treatment Period||111
218239|NCT00810693|535017|P2|COMPLETED|Treatment Period||57
218240|NCT00810693|535018|P1|COMPLETED|Treatment Period||237
218241|NCT00810693|535016|P3|Participants Received Treatment|Treatment Period||126
218242|NCT00810693|535017|P2|Participants Received Treatment|Treatment Period||63
218243|NCT00810693|535018|P1|Participants Received Treatment|Treatment Period||254
218244|NCT00810693|535016|P3|STARTED|Treatment Period|1 randomized but not treated|127
218245|NCT00810693|535017|P2|STARTED|Treatment Period|1 randomized but not treated|64
218246|NCT00810693|535018|P1|STARTED|Treatment Period||254
218247|NCT00810719|535047|P1|NOT COMPLETED|Overall Study||0
218248|NCT00810719|535047|P1|COMPLETED|Overall Study||30
218249|NCT00810719|535047|P1|STARTED|Overall Study||30
218250|NCT00810771|535056|P3|NOT COMPLETED|Overall Study||0
218251|NCT00810771|535057|P2|NOT COMPLETED|Overall Study||0
218252|NCT00810771|535058|P1|NOT COMPLETED|Overall Study||0
218253|NCT00810771|535056|P3|COMPLETED|Overall Study||84
218254|NCT00810771|535057|P2|COMPLETED|Overall Study||234
218255|NCT00810771|535058|P1|COMPLETED|Overall Study||232
218256|NCT00810771|535056|P3|STARTED|Overall Study||84
218257|NCT00810771|535057|P2|STARTED|Overall Study||234
218258|NCT00810771|535058|P1|STARTED|Overall Study||232
218259|NCT00810901|535080|P2|NOT COMPLETED|Overall Study||58
218260|NCT00810901|535081|P1|NOT COMPLETED|Overall Study||88
218261|NCT00810901|535080|P2|COMPLETED|Overall Study||118
218262|NCT00810901|535081|P1|COMPLETED|Overall Study||165
218263|NCT00810901|535080|P2|6-month Follow-up|Overall Study||122
218264|NCT00810901|535081|P1|6-month Follow-up|Overall Study||181
218265|NCT00810901|535080|P2|1-month Follow up|Overall Study||146
218266|NCT00810901|535081|P1|1-month Follow up|Overall Study||242
218267|NCT00810901|535080|P2|STARTED|Overall Study||176
218268|NCT00810901|535081|P1|STARTED|Overall Study||253
218269|NCT00811018|535089|P1|NOT COMPLETED|Overall Study||968
218270|NCT00811018|535089|P1|COMPLETED|Overall Study||224
218271|NCT00811018|535089|P1|STARTED|Overall Study||1192
218272|NCT00811057|535108|P3|NOT COMPLETED|Overall Study||10
218273|NCT00811057|535109|P2|NOT COMPLETED|Overall Study||10
218274|NCT00811057|535110|P1|NOT COMPLETED|Overall Study||5
218275|NCT00811057|535108|P3|COMPLETED|Overall Study||87
218276|NCT00811057|535109|P2|COMPLETED|Overall Study||104
218277|NCT00811057|535110|P1|COMPLETED|Overall Study||85
218278|NCT00811057|535108|P3|STARTED|Overall Study||97
218279|NCT00811057|535109|P2|STARTED|Overall Study||114
218280|NCT00811057|535110|P1|STARTED|Overall Study||90
218281|NCT00811070|535127|P6|NOT COMPLETED|Overall Study||1
218282|NCT00811070|535128|P5|NOT COMPLETED|Overall Study||5
218283|NCT00811070|535129|P4|NOT COMPLETED|Overall Study||2
218284|NCT00811070|535130|P3|NOT COMPLETED|Overall Study||0
218285|NCT00811070|535131|P2|NOT COMPLETED|Overall Study||1
218286|NCT00811070|535132|P1|NOT COMPLETED|Overall Study||1
218287|NCT00811070|535127|P6|COMPLETED|Overall Study||10
218288|NCT00811070|535128|P5|COMPLETED|Overall Study||2
218289|NCT00811070|535129|P4|COMPLETED|Overall Study||26
218290|NCT00811070|535130|P3|COMPLETED|Overall Study||3
218291|NCT00811070|535131|P2|COMPLETED|Overall Study||6
218292|NCT00811070|535132|P1|COMPLETED|Overall Study||6
218293|NCT00811070|535127|P6|STARTED|Overall Study||11
218294|NCT00811070|535128|P5|STARTED|Overall Study||7
218295|NCT00811070|535129|P4|STARTED|Overall Study||28
218296|NCT00811070|535130|P3|STARTED|Overall Study||3
218297|NCT00811070|535131|P2|STARTED|Overall Study||7
218298|NCT00811070|535132|P1|STARTED|Overall Study||7
218299|NCT00811135|535189|P1|NOT COMPLETED|Overall Study||88
218300|NCT00811135|535189|P1|COMPLETED|Overall Study||0
218301|NCT00811135|535189|P1|STARTED|Overall Study||88
218302|NCT00811174|535201|P1|NOT COMPLETED|Overall Study||3
218303|NCT00811174|535201|P1|COMPLETED|Overall Study||2
218304|NCT00811174|535201|P1|STARTED|Overall Study||5
218305|NCT00811252|535215|P3|NOT COMPLETED|Overall Study||23
218306|NCT00811252|535216|P2|NOT COMPLETED|Overall Study||20
218307|NCT00811252|535217|P1|NOT COMPLETED|Overall Study||17
218308|NCT00811252|535215|P3|COMPLETED|Overall Study||128
218309|NCT00811252|535216|P2|COMPLETED|Overall Study||136
218310|NCT00811252|535217|P1|COMPLETED|Overall Study||128
218311|NCT00811252|535215|P3|STARTED|Overall Study||151
218312|NCT00811252|535216|P2|STARTED|Overall Study||156
218313|NCT00811252|535217|P1|STARTED|Overall Study||145
218314|NCT00811382|535263|P2|NOT COMPLETED|Overall Study||0
218315|NCT00811382|535264|P1|NOT COMPLETED|Overall Study||0
218316|NCT00811382|535263|P2|COMPLETED|Overall Study||75
218317|NCT00811382|535264|P1|COMPLETED|Overall Study||88
218318|NCT00811382|535263|P2|STARTED|Overall Study||75
218319|NCT00811382|535264|P1|STARTED|Overall Study||88
218320|NCT00811395|535282|P6|NOT COMPLETED|Extension Treatment||2
218321|NCT00811395|535283|P5|NOT COMPLETED|Extension Treatment||0
218322|NCT00811395|535284|P4|NOT COMPLETED|Extension Treatment||3
218323|NCT00811395|535285|P3|NOT COMPLETED|Extension Treatment||3
218324|NCT00811395|535286|P2|NOT COMPLETED|Extension Treatment||6
218325|NCT00811395|535287|P1|NOT COMPLETED|Extension Treatment||2
218326|NCT00811395|535282|P6|COMPLETED|Extension Treatment|completed 48-week treatment|27
218327|NCT00811395|535283|P5|COMPLETED|Extension Treatment|completed 48-week treatment|30
218328|NCT00811395|535284|P4|COMPLETED|Extension Treatment|completed 48-week treatment|34
218329|NCT00811395|535285|P3|COMPLETED|Extension Treatment|completed 48-week treatment|24
218330|NCT00811395|535286|P2|COMPLETED|Extension Treatment|completed 48-week treatment|22
218331|NCT00811395|535287|P1|COMPLETED|Extension Treatment|completed 48-week treatment|29
218332|NCT00811395|535282|P6|STARTED|Extension Treatment|continued initial treatment|29
218333|NCT00811395|535283|P5|STARTED|Extension Treatment|continued initial treatment|30
218334|NCT00811395|535284|P4|STARTED|Extension Treatment|continued initial treatment|37
218335|NCT00811395|535285|P3|STARTED|Extension Treatment|continued initial treatment|27
218336|NCT00811395|535286|P2|STARTED|Extension Treatment|continued initial treatment|28
218337|NCT00811395|535287|P1|STARTED|Extension Treatment|continued initial treatment|31
218338|NCT00811395|535282|P6|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||6
218339|NCT00811395|535283|P5|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||5
218340|NCT00811395|535284|P4|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
218341|NCT00811395|535285|P3|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||2
218342|NCT00811395|535286|P2|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||4
218343|NCT00811395|535287|P1|NOT COMPLETED|Initial Treatment (PDY6045 or PDY6046)||3
218344|NCT00811395|535282|P6|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|35
218345|NCT00811395|535283|P5|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|37
218346|NCT00811395|535284|P4|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6046/NCT00475865 record)|38
218347|NCT00811395|535285|P3|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|36
218348|NCT00811395|535286|P2|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|33
218349|NCT00811395|535287|P1|COMPLETED|Initial Treatment (PDY6045 or PDY6046)|completed 24-week treatment (for more information see PDY6045/NCT00489489 record)|38
218350|NCT00811395|535282|P6|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
218351|NCT00811395|535283|P5|STARTED|Initial Treatment (PDY6045 or PDY6046)||42
218352|NCT00811395|535284|P4|STARTED|Initial Treatment (PDY6045 or PDY6046)||40
218353|NCT00811395|535285|P3|STARTED|Initial Treatment (PDY6045 or PDY6046)||38
218354|NCT00811395|535286|P2|STARTED|Initial Treatment (PDY6045 or PDY6046)|One participant received 7 mg instead of 14 mg as per randomization|37
218355|NCT00811395|535287|P1|STARTED|Initial Treatment (PDY6045 or PDY6046)||41
218356|NCT00811434|535349|P2|NOT COMPLETED|Second Intervention||0
218357|NCT00811434|535350|P1|NOT COMPLETED|Second Intervention||0
218358|NCT00811434|535349|P2|COMPLETED|Second Intervention||5
218359|NCT00811434|535350|P1|COMPLETED|Second Intervention||4
218360|NCT00811434|535349|P2|STARTED|Second Intervention||5
218361|NCT00811434|535350|P1|STARTED|Second Intervention||4
218362|NCT00811434|535349|P2|NOT COMPLETED|Washout (1 Month)||0
218363|NCT00811434|535350|P1|NOT COMPLETED|Washout (1 Month)||0
218364|NCT00811434|535349|P2|COMPLETED|Washout (1 Month)||5
218365|NCT00811434|535350|P1|COMPLETED|Washout (1 Month)||4
218366|NCT00811434|535349|P2|STARTED|Washout (1 Month)||5
218367|NCT00811434|535350|P1|STARTED|Washout (1 Month)||4
218368|NCT00811434|535349|P2|NOT COMPLETED|First Intervention||0
218369|NCT00811434|535350|P1|NOT COMPLETED|First Intervention||3
218370|NCT00811434|535349|P2|COMPLETED|First Intervention||5
218371|NCT00811434|535350|P1|COMPLETED|First Intervention||4
218372|NCT00811434|535349|P2|STARTED|First Intervention||5
218373|NCT00811434|535350|P1|STARTED|First Intervention||7
218374|NCT00811473|535360|P2|NOT COMPLETED|Overall Study||26
218375|NCT00811473|535361|P1|NOT COMPLETED|Overall Study||23
218376|NCT00811473|535360|P2|COMPLETED|Overall Study||74
218377|NCT00811473|535361|P1|COMPLETED|Overall Study||70
218378|NCT00811473|535360|P2|STARTED|Overall Study||100
218379|NCT00811473|535361|P1|STARTED|Overall Study||93
218380|NCT00811564|535379|P2|NOT COMPLETED|Overall Study||2
218381|NCT00811564|535380|P1|NOT COMPLETED|Overall Study||9
218382|NCT00811564|535379|P2|COMPLETED|Overall Study||73
218383|NCT00811564|535380|P1|COMPLETED|Overall Study||64
218384|NCT00811564|535379|P2|STARTED|Overall Study||75
218385|NCT00811564|535380|P1|STARTED|Overall Study||73
218386|NCT00811577|535388|P2|NOT COMPLETED|Overall Study||1
218387|NCT00811577|535389|P1|NOT COMPLETED|Overall Study||10
218388|NCT00811577|535388|P2|COMPLETED|Overall Study||23
218389|NCT00811577|535389|P1|COMPLETED|Overall Study||116
218390|NCT00811577|535388|P2|STARTED|Overall Study||24
218391|NCT00811577|535389|P1|STARTED|Overall Study||126
218392|NCT00811590|535438|P1|NOT COMPLETED|Overall Study||0
218393|NCT00811590|535438|P1|COMPLETED|Overall Study||3
218394|NCT00811590|535438|P1|STARTED|Overall Study||3
218395|NCT00811642|535442|P1|NOT COMPLETED|Overall Study||15
218396|NCT00811642|535442|P1|COMPLETED|Overall Study|The Per Protocol Set (PPS) includes the 47 participants who completed the study per protocol.|47
218397|NCT00811642|535442|P1|STARTED|Overall Study|63 participants were screened and enrolled; 62 participants from Safety Set (SS) started study drug.|62
218398|NCT00817596|535452|P1|NOT COMPLETED|Overall Study||48
218399|NCT00817596|535452|P1|COMPLETED|Overall Study||62
218400|NCT00817596|535452|P1|STARTED|Overall Study||110
218401|NCT00817778|535458|P2|NOT COMPLETED|Overall Study||3
218402|NCT00817778|535459|P1|NOT COMPLETED|Overall Study||3
218403|NCT00817778|535458|P2|COMPLETED|Overall Study||5
218404|NCT00817778|535459|P1|COMPLETED|Overall Study||16
218405|NCT00817778|535458|P2|STARTED|Overall Study||8
218406|NCT00817778|535459|P1|STARTED|Overall Study||19
218407|NCT00817804|535486|P2|NOT COMPLETED|Overall Study||0
218408|NCT00817804|535487|P1|NOT COMPLETED|Overall Study||0
218409|NCT00817804|535486|P2|COMPLETED|Overall Study||2
218410|NCT00817804|535487|P1|COMPLETED|Overall Study||1
218411|NCT00817804|535486|P2|STARTED|Overall Study||2
218412|NCT00817804|535487|P1|STARTED|Overall Study||1
218413|NCT00817843|535493|P2|NOT COMPLETED|Second Period (6 Weeks)||1
218414|NCT00817843|535494|P1|NOT COMPLETED|Second Period (6 Weeks)||0
218415|NCT00817843|535493|P2|COMPLETED|Second Period (6 Weeks)||44
218416|NCT00817843|535494|P1|COMPLETED|Second Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|41
218417|NCT00817843|535493|P2|STARTED|Second Period (6 Weeks)||45
218418|NCT00817843|535494|P1|STARTED|Second Period (6 Weeks)||41
218419|NCT00817843|535493|P2|NOT COMPLETED|Washout Period (6 Weeks)||1
218420|NCT00817843|535494|P1|NOT COMPLETED|Washout Period (6 Weeks)||1
218421|NCT00817843|535493|P2|COMPLETED|Washout Period (6 Weeks)||45
218422|NCT00817843|535494|P1|COMPLETED|Washout Period (6 Weeks)||41
218423|NCT00817843|535493|P2|STARTED|Washout Period (6 Weeks)||46
218424|NCT00817843|535494|P1|STARTED|Washout Period (6 Weeks)||42
218425|NCT00817843|535493|P2|NOT COMPLETED|First Period (6 Weeks)||4
218426|NCT00817843|535494|P1|NOT COMPLETED|First Period (6 Weeks)||8
218427|NCT00817843|535493|P2|COMPLETED|First Period (6 Weeks)||46
218428|NCT00817843|535494|P1|COMPLETED|First Period (6 Weeks)|All patients with >=1 postrandomization dose and measurement were analyzed|42
218429|NCT00817843|535493|P2|STARTED|First Period (6 Weeks)||50
218430|NCT00817843|535494|P1|STARTED|First Period (6 Weeks)||50
218431|NCT00818519|535501|P2|NOT COMPLETED|Overall Study||19
218432|NCT00818519|535502|P1|NOT COMPLETED|Overall Study||14
218433|NCT00818519|535501|P2|COMPLETED|Overall Study||71
218434|NCT00818519|535502|P1|COMPLETED|Overall Study||75
218435|NCT00818519|535501|P2|Participants Received Treatment|Overall Study|= Baseline|86
218436|NCT00818519|535502|P1|Participants Received Treatment|Overall Study|= Baseline|87
218437|NCT00818519|535501|P2|STARTED|Overall Study|4 excluded from FAS because study drug intake unknown or never administered|90
218438|NCT00818519|535502|P1|STARTED|Overall Study|2 excluded from FAS because study drug intake unknown or never administered|89
218439|NCT00818623|535540|P8|NOT COMPLETED|Overall Study||1
218440|NCT00818623|535541|P7|NOT COMPLETED|Overall Study||4
218441|NCT00818623|535542|P6|NOT COMPLETED|Overall Study||3
218442|NCT00818623|535543|P5|NOT COMPLETED|Overall Study||4
218443|NCT00818623|535544|P4|NOT COMPLETED|Overall Study||5
218444|NCT00818623|535545|P3|NOT COMPLETED|Overall Study||4
218445|NCT00818623|535546|P2|NOT COMPLETED|Overall Study||4
218446|NCT00818623|535547|P1|NOT COMPLETED|Overall Study||2
218447|NCT00818623|535540|P8|COMPLETED|Overall Study||26
218448|NCT00818623|535541|P7|COMPLETED|Overall Study||23
218449|NCT00818623|535542|P6|COMPLETED|Overall Study||21
218450|NCT00818623|535543|P5|COMPLETED|Overall Study||23
218451|NCT00818623|535544|P4|COMPLETED|Overall Study||19
218452|NCT00818623|535545|P3|COMPLETED|Overall Study||9
218453|NCT00818623|535546|P2|COMPLETED|Overall Study||8
218454|NCT00818623|535547|P1|COMPLETED|Overall Study||24
218455|NCT00818623|535540|P8|Intent-to-treat (ITT) Population|Overall Study||27
218456|NCT00818623|535541|P7|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
218457|NCT00818623|535542|P6|Intent-to-treat (ITT) Population|Overall Study||24
218458|NCT00818623|535543|P5|Intent-to-treat (ITT) Population|Overall Study|Three participants in this group were randomized but never received any treatment.|24
218459|NCT00818623|535544|P4|Intent-to-treat (ITT) Population|Overall Study||24
218460|NCT00818623|535545|P3|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|12
218461|NCT00818623|535546|P2|Intent-to-treat (ITT) Population|Overall Study||12
218462|NCT00818623|535547|P1|Intent-to-treat (ITT) Population|Overall Study|One participant in this group was randomized but never received any treatment.|25
218463|NCT00818623|535540|P8|STARTED|Overall Study||27
218464|NCT00818623|535541|P7|STARTED|Overall Study||27
218465|NCT00818623|535542|P6|STARTED|Overall Study||24
218466|NCT00818623|535543|P5|STARTED|Overall Study||27
218467|NCT00818623|535544|P4|STARTED|Overall Study||24
218468|NCT00818623|535545|P3|STARTED|Overall Study||13
218469|NCT00818623|535546|P2|STARTED|Overall Study||12
218470|NCT00818623|535547|P1|STARTED|Overall Study||26
218471|NCT00818649|535621|P1|NOT COMPLETED|Overall Study||4
218472|NCT00818649|535621|P1|COMPLETED|Overall Study||12
218473|NCT00818649|535621|P1|STARTED|Overall Study||16
218474|NCT00818662|535631|P4|NOT COMPLETED|Overall Study||16
218475|NCT00818662|535632|P3|NOT COMPLETED|Overall Study||9
218476|NCT00818662|535633|P2|NOT COMPLETED|Overall Study||33
218477|NCT00818662|535634|P1|NOT COMPLETED|Overall Study||23
218478|NCT00818662|535631|P4|COMPLETED|Overall Study||47
218479|NCT00818662|535632|P3|COMPLETED|Overall Study||49
218480|NCT00818662|535633|P2|COMPLETED|Overall Study||102
218481|NCT00818662|535634|P1|COMPLETED|Overall Study||104
218482|NCT00818662|535631|P4|STARTED|Overall Study||63
218483|NCT00818662|535632|P3|STARTED|Overall Study||58
218484|NCT00818662|535633|P2|STARTED|Overall Study||135
218485|NCT00818662|535634|P1|STARTED|Overall Study||127
218486|NCT00818753|535723|P3|NOT COMPLETED|Overall Study||1
218487|NCT00818753|535724|P2|NOT COMPLETED|Overall Study||0
218488|NCT00818753|535725|P1|NOT COMPLETED|Overall Study||3
218489|NCT00818753|535723|P3|COMPLETED|Overall Study||9
218490|NCT00818753|535724|P2|COMPLETED|Overall Study||21
218491|NCT00818753|535725|P1|COMPLETED|Overall Study||19
218492|NCT00818753|535723|P3|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|10
218493|NCT00818753|535724|P2|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|21
218494|NCT00818753|535725|P1|STARTED|Overall Study|There were 53 participants randomised, but only 51 were treated.|22
218495|NCT00818766|535747|P2|NOT COMPLETED|Overall Study||10
218496|NCT00818766|535748|P1|NOT COMPLETED|Overall Study||15
218497|NCT00818766|535747|P2|COMPLETED|Overall Study||116
218498|NCT00818766|535748|P1|COMPLETED|Overall Study||110
218499|NCT00818766|535747|P2|Intent-to-Treat Population|Overall Study|2 participants were randomized twice but only counted once (per first randomization).|124
218500|NCT00818766|535748|P1|Intent-to-Treat Population|Overall Study|1 participant was randomized twice but only counted once (per first randomization).|121
218501|NCT00818766|535747|P2|Received Allocated Intervention|Overall Study||126
218502|NCT00818766|535748|P1|Received Allocated Intervention|Overall Study|1 withdrew consent, 1 had active infection and 1 was given open-label antibiotic after surgery.|122
218503|NCT00818766|535747|P2|STARTED|Overall Study||126
218504|NCT00818766|535748|P1|STARTED|Overall Study||125
218505|NCT00818779|535776|P2|NOT COMPLETED|Overall Study||1
218506|NCT00818779|535777|P1|NOT COMPLETED|Overall Study||6
218507|NCT00818779|535776|P2|COMPLETED|Overall Study||15
218508|NCT00818779|535777|P1|COMPLETED|Overall Study||16
218509|NCT00818779|535776|P2|STARTED|Overall Study||16
218510|NCT00818779|535777|P1|STARTED|Overall Study||22
218511|NCT00818805|535783|P2|NOT COMPLETED|Second Intervention||0
218512|NCT00818805|535784|P1|NOT COMPLETED|Second Intervention||0
218513|NCT00818805|535783|P2|COMPLETED|Second Intervention||25
218514|NCT00818805|535784|P1|COMPLETED|Second Intervention||25
218515|NCT00818805|535783|P2|STARTED|Second Intervention||25
218516|NCT00818805|535784|P1|STARTED|Second Intervention||25
218517|NCT00818805|535783|P2|NOT COMPLETED|First Intervention||0
218518|NCT00818805|535784|P1|NOT COMPLETED|First Intervention||0
218519|NCT00818805|535783|P2|COMPLETED|First Intervention||25
218520|NCT00818805|535784|P1|COMPLETED|First Intervention||25
218521|NCT00818805|535783|P2|STARTED|First Intervention||25
218522|NCT00818805|535784|P1|STARTED|First Intervention||25
218523|NCT00818883|535796|P2|NOT COMPLETED|Overall Study||46
218524|NCT00818883|535797|P1|NOT COMPLETED|Overall Study||51
218525|NCT00818883|535796|P2|COMPLETED|Overall Study||260
218526|NCT00818883|535797|P1|COMPLETED|Overall Study||252
218527|NCT00818883|535796|P2|STARTED|Overall Study||306
218528|NCT00818883|535797|P1|STARTED|Overall Study||303
218529|NCT00818961|535831|P1|NOT COMPLETED|Overall Study||0
218530|NCT00818961|535831|P1|COMPLETED|Overall Study||36
218531|NCT00818961|535831|P1|STARTED|Overall Study||36
218532|NCT00819013|535849|P4|NOT COMPLETED|Overall Study||4
218533|NCT00819013|535850|P3|NOT COMPLETED|Overall Study||5
218534|NCT00819013|535851|P2|NOT COMPLETED|Overall Study||1
218535|NCT00819013|535852|P1|NOT COMPLETED|Overall Study||3
218536|NCT00819013|535849|P4|COMPLETED|Overall Study||17
218537|NCT00819013|535850|P3|COMPLETED|Overall Study||16
218538|NCT00819013|535851|P2|COMPLETED|Overall Study||22
218539|NCT00819013|535852|P1|COMPLETED|Overall Study||19
218540|NCT00819013|535849|P4|STARTED|Overall Study||21
218541|NCT00819013|535850|P3|STARTED|Overall Study||21
218542|NCT00819013|535851|P2|STARTED|Overall Study||23
218543|NCT00819013|535852|P1|STARTED|Overall Study||22
218544|NCT00819039|535905|P3|NOT COMPLETED|Overall Study||1
218545|NCT00819039|535906|P2|NOT COMPLETED|Overall Study||0
218546|NCT00819039|535907|P1|NOT COMPLETED|Overall Study||2
218547|NCT00819039|535905|P3|COMPLETED|Overall Study||24
218548|NCT00819039|535906|P2|COMPLETED|Overall Study||27
218549|NCT00819039|535907|P1|COMPLETED|Overall Study||44
218550|NCT00819039|535905|P3|STARTED|Overall Study||25
218551|NCT00819039|535906|P2|STARTED|Overall Study||27
218552|NCT00819039|535907|P1|STARTED|Overall Study||46
218553|NCT00819052|535935|P2|NOT COMPLETED|Overall Study||14
218554|NCT00819052|535936|P1|NOT COMPLETED|Overall Study||6
218555|NCT00819052|535935|P2|COMPLETED|Overall Study||281
218556|NCT00819052|535936|P1|COMPLETED|Overall Study||142
218557|NCT00819052|535935|P2|STARTED|Overall Study||295
218558|NCT00819052|535936|P1|STARTED|Overall Study||148
218559|NCT00819091|536050|P2|NOT COMPLETED|Overall Study||10
218560|NCT00819091|536051|P1|NOT COMPLETED|Overall Study||7
218561|NCT00819091|536050|P2|COMPLETED|Overall Study||151
218562|NCT00819091|536051|P1|COMPLETED|Overall Study||77
218563|NCT00819091|536050|P2|STARTED|Overall Study||161
218564|NCT00819091|536051|P1|STARTED|Overall Study||84
218565|NCT00819156|536081|P6|NOT COMPLETED|Overall Study||8
218566|NCT00819156|536082|P5|NOT COMPLETED|Overall Study||6
218567|NCT00819156|536083|P4|NOT COMPLETED|Overall Study||2
218568|NCT00819156|536084|P3|NOT COMPLETED|Overall Study||6
218569|NCT00819156|536085|P2|NOT COMPLETED|Overall Study||10
218570|NCT00819156|536086|P1|NOT COMPLETED|Overall Study||10
218571|NCT00819156|536081|P6|COMPLETED|Overall Study||23
218572|NCT00819156|536082|P5|COMPLETED|Overall Study||27
218573|NCT00819156|536083|P4|COMPLETED|Overall Study||28
218574|NCT00819156|536084|P3|COMPLETED|Overall Study||26
218575|NCT00819156|536085|P2|COMPLETED|Overall Study||23
218576|NCT00819156|536086|P1|COMPLETED|Overall Study||20
218577|NCT00819156|536081|P6|Randomised and Treated (ITT Population)|Overall Study||30
218578|NCT00819156|536082|P5|Randomised and Treated (ITT Population)|Overall Study||33
218579|NCT00819156|536083|P4|Randomised and Treated (ITT Population)|Overall Study||30
218580|NCT00819156|536084|P3|Randomised and Treated (ITT Population)|Overall Study||32
218581|NCT00819156|536085|P2|Randomised and Treated (ITT Population)|Overall Study||32
218582|NCT00819156|536086|P1|Randomised and Treated (ITT Population)|Overall Study||30
218583|NCT00819156|536081|P6|STARTED|Overall Study||31
218584|NCT00819156|536082|P5|STARTED|Overall Study||33
218585|NCT00819156|536083|P4|STARTED|Overall Study||30
218586|NCT00819156|536084|P3|STARTED|Overall Study||32
218587|NCT00819156|536085|P2|STARTED|Overall Study||33
218588|NCT00819156|536086|P1|STARTED|Overall Study||30
218589|NCT00819182|536177|P3|NOT COMPLETED|Overall Study||1
218590|NCT00819182|536178|P2|NOT COMPLETED|Overall Study||8
218591|NCT00819182|536179|P1|NOT COMPLETED|Overall Study||13
218592|NCT00819182|536177|P3|COMPLETED|Overall Study||43
218593|NCT00819182|536178|P2|COMPLETED|Overall Study||78
218594|NCT00819182|536179|P1|COMPLETED|Overall Study||75
218595|NCT00819182|536177|P3|Week 16 Visit|Overall Study||43
218596|NCT00819182|536178|P2|Week 16 Visit|Overall Study||78
218597|NCT00819182|536179|P1|Week 16 Visit|Overall Study||75
218686|NCT00819403|536549|P2|STARTED|First Intervention (6 Weeks)||8
218598|NCT00819182|536177|P3|STARTED|Overall Study|Consented participants allocated to this arm.|44
218599|NCT00819182|536178|P2|STARTED|Overall Study|Consented participants allocated to this arm.|86
218600|NCT00819182|536179|P1|STARTED|Overall Study|Consented participants allocated to this arm.|88
218601|NCT00819234|536209|P10|NOT COMPLETED|Overall Study||7
218602|NCT00819234|536210|P9|NOT COMPLETED|Overall Study||6
218603|NCT00819234|536211|P8|NOT COMPLETED|Overall Study||9
218604|NCT00819234|536212|P7|NOT COMPLETED|Overall Study||5
218605|NCT00819234|536213|P6|NOT COMPLETED|Overall Study||7
218606|NCT00819234|536214|P5|NOT COMPLETED|Overall Study||1
218607|NCT00819234|536215|P4|NOT COMPLETED|Overall Study||6
218608|NCT00819234|536216|P3|NOT COMPLETED|Overall Study||8
218609|NCT00819234|536217|P2|NOT COMPLETED|Overall Study||15
218610|NCT00819234|536218|P1|NOT COMPLETED|Overall Study||10
218611|NCT00819234|536209|P10|COMPLETED|Overall Study||30
218612|NCT00819234|536210|P9|COMPLETED|Overall Study||31
218613|NCT00819234|536211|P8|COMPLETED|Overall Study||20
218614|NCT00819234|536212|P7|COMPLETED|Overall Study||8
218615|NCT00819234|536213|P6|COMPLETED|Overall Study||7
218616|NCT00819234|536214|P5|COMPLETED|Overall Study||12
218617|NCT00819234|536215|P4|COMPLETED|Overall Study||22
218618|NCT00819234|536216|P3|COMPLETED|Overall Study||28
218619|NCT00819234|536217|P2|COMPLETED|Overall Study||20
218620|NCT00819234|536218|P1|COMPLETED|Overall Study||21
218621|NCT00819234|536209|P10|STARTED|Overall Study||37
218622|NCT00819234|536210|P9|STARTED|Overall Study||37
218623|NCT00819234|536211|P8|STARTED|Overall Study||29
218624|NCT00819234|536212|P7|STARTED|Overall Study||13
218625|NCT00819234|536213|P6|STARTED|Overall Study||14
218626|NCT00819234|536214|P5|STARTED|Overall Study||13
218627|NCT00819234|536215|P4|STARTED|Overall Study||28
218628|NCT00819234|536216|P3|STARTED|Overall Study||36
218629|NCT00819234|536217|P2|STARTED|Overall Study||35
218630|NCT00819234|536218|P1|STARTED|Overall Study||31
218631|NCT00819247|536379|P3|NOT COMPLETED|Overall Study||14
218632|NCT00819247|536380|P2|NOT COMPLETED|Overall Study||16
218633|NCT00819247|536381|P1|NOT COMPLETED|Overall Study||11
218634|NCT00819247|536379|P3|COMPLETED|Overall Study||26
218635|NCT00819247|536380|P2|COMPLETED|Overall Study||30
218636|NCT00819247|536381|P1|COMPLETED|Overall Study||32
218637|NCT00819247|536379|P3|Per Protocol Population|Overall Study|One participant - baseline testosterone outside normal range.|38
218638|NCT00819247|536380|P2|Per Protocol Population|Overall Study|Two participants - prohibited drugs|44
218639|NCT00819247|536381|P1|Per Protocol Population|Overall Study|One participant- baseline testosterone outside normal range. Three participants- prohibited drugs.|38
218640|NCT00819247|536379|P3|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|39
218641|NCT00819247|536380|P2|Intent-to-treat Population|Overall Study||46
218642|NCT00819247|536381|P1|Intent-to-treat Population|Overall Study|One randomised participant withdrew at Day 1.|42
218643|NCT00819247|536379|P3|Randomized|Overall Study||40
218644|NCT00819247|536380|P2|Randomized|Overall Study||46
218645|NCT00819247|536381|P1|Randomized|Overall Study||43
218646|NCT00819247|536379|P3|STARTED|Overall Study||40
218647|NCT00819247|536380|P2|STARTED|Overall Study||46
218648|NCT00819247|536381|P1|STARTED|Overall Study||43
218649|NCT00819260|536407|P1|NOT COMPLETED|Overall Study||0
218650|NCT00819260|536407|P1|COMPLETED|Overall Study||31
218651|NCT00819260|536407|P1|STARTED|Overall Study||31
218652|NCT00819286|536421|P2|NOT COMPLETED|Overall Study||25
218653|NCT00819286|536422|P1|NOT COMPLETED|Overall Study||14
218654|NCT00819286|536421|P2|COMPLETED|Overall Study||45
218655|NCT00819286|536422|P1|COMPLETED|Overall Study||56
218656|NCT00819286|536421|P2|STARTED|Overall Study||70
218657|NCT00819286|536422|P1|STARTED|Overall Study||70
218658|NCT00819390|536434|P4|NOT COMPLETED|Overall Study||0
218659|NCT00819390|536435|P3|NOT COMPLETED|Overall Study||1
218660|NCT00819390|536436|P2|NOT COMPLETED|Overall Study||1
218661|NCT00819390|536437|P1|NOT COMPLETED|Overall Study||3
218662|NCT00819390|536434|P4|COMPLETED|Overall Study||19
218663|NCT00819390|536435|P3|COMPLETED|Overall Study||17
218664|NCT00819390|536436|P2|COMPLETED|Overall Study||16
218665|NCT00819390|536437|P1|COMPLETED|Overall Study||13
218666|NCT00819390|536434|P4|STARTED|Overall Study||19
218667|NCT00819390|536435|P3|STARTED|Overall Study||18
218668|NCT00819390|536436|P2|STARTED|Overall Study||17
218669|NCT00819390|536437|P1|STARTED|Overall Study||16
218670|NCT00819403|536549|P2|NOT COMPLETED|Second Intervention (6 Weeks)||0
218671|NCT00819403|536550|P1|NOT COMPLETED|Second Intervention (6 Weeks)||0
218672|NCT00819403|536549|P2|COMPLETED|Second Intervention (6 Weeks)||8
218673|NCT00819403|536550|P1|COMPLETED|Second Intervention (6 Weeks)||7
218674|NCT00819403|536549|P2|STARTED|Second Intervention (6 Weeks)||8
218675|NCT00819403|536550|P1|STARTED|Second Intervention (6 Weeks)||7
218676|NCT00819403|536549|P2|NOT COMPLETED|Washout (14 Days)||0
218677|NCT00819403|536550|P1|NOT COMPLETED|Washout (14 Days)||0
218678|NCT00819403|536549|P2|COMPLETED|Washout (14 Days)||8
218679|NCT00819403|536550|P1|COMPLETED|Washout (14 Days)||7
218680|NCT00819403|536549|P2|STARTED|Washout (14 Days)||8
218681|NCT00819403|536550|P1|STARTED|Washout (14 Days)||7
218682|NCT00819403|536549|P2|NOT COMPLETED|First Intervention (6 Weeks)||0
218683|NCT00819403|536550|P1|NOT COMPLETED|First Intervention (6 Weeks)||0
218684|NCT00819403|536549|P2|COMPLETED|First Intervention (6 Weeks)||8
218685|NCT00819403|536550|P1|COMPLETED|First Intervention (6 Weeks)||7
218687|NCT00819403|536550|P1|STARTED|First Intervention (6 Weeks)||7
218688|NCT00819507|536558|P1|NOT COMPLETED|Overall Study||0
218689|NCT00819507|536558|P1|COMPLETED|Overall Study||25
218690|NCT00819507|536558|P1|STARTED|Overall Study||25
218691|NCT00819585|536570|P7|NOT COMPLETED|Overall Study||13
218692|NCT00819585|536571|P6|NOT COMPLETED|Overall Study||2
218693|NCT00819585|536572|P5|NOT COMPLETED|Overall Study||3
218694|NCT00819585|536573|P4|NOT COMPLETED|Overall Study||5
218695|NCT00819585|536574|P3|NOT COMPLETED|Overall Study||6
218696|NCT00819585|536575|P2|NOT COMPLETED|Overall Study||6
218697|NCT00819585|536576|P1|NOT COMPLETED|Overall Study||6
218698|NCT00819585|536570|P7|COMPLETED|Overall Study||95
218699|NCT00819585|536571|P6|COMPLETED|Overall Study||52
218700|NCT00819585|536572|P5|COMPLETED|Overall Study||50
218701|NCT00819585|536573|P4|COMPLETED|Overall Study||49
218702|NCT00819585|536574|P3|COMPLETED|Overall Study||48
218703|NCT00819585|536575|P2|COMPLETED|Overall Study||48
218704|NCT00819585|536576|P1|COMPLETED|Overall Study||49
218705|NCT00819585|536570|P7|Safety Population|Overall Study||108
218706|NCT00819585|536571|P6|Safety Population|Overall Study|A pt. who was randomized to repeated dose regimen, found as HIV +ve, didn't take any study drug.|53
218707|NCT00819585|536572|P5|Safety Population|Overall Study||53
218708|NCT00819585|536573|P4|Safety Population|Overall Study||54
218709|NCT00819585|536574|P3|Safety Population|Overall Study||54
218710|NCT00819585|536575|P2|Safety Population|Overall Study||54
218711|NCT00819585|536576|P1|Safety Population|Overall Study||55
218712|NCT00819585|536570|P7|STARTED|Overall Study||108
218713|NCT00819585|536571|P6|STARTED|Overall Study||54
218714|NCT00819585|536572|P5|STARTED|Overall Study||53
218715|NCT00819585|536573|P4|STARTED|Overall Study||54
218716|NCT00819585|536574|P3|STARTED|Overall Study||54
218717|NCT00819585|536575|P2|STARTED|Overall Study||54
218718|NCT00819585|536576|P1|STARTED|Overall Study|"Started indicates randomized as well as full analysis set."|55
218719|NCT00819637|536636|P3|NOT COMPLETED|Overall Study||0
218720|NCT00819637|536637|P2|NOT COMPLETED|Overall Study||0
218721|NCT00819637|536638|P1|NOT COMPLETED|Overall Study||0
218722|NCT00819637|536636|P3|COMPLETED|Overall Study||0
218723|NCT00819637|536637|P2|COMPLETED|Overall Study||0
218724|NCT00819637|536638|P1|COMPLETED|Overall Study||2
218725|NCT00819637|536636|P3|STARTED|Overall Study||0
218726|NCT00819637|536637|P2|STARTED|Overall Study||0
218727|NCT00819637|536638|P1|STARTED|Overall Study||2
218728|NCT00819741|536648|P2|NOT COMPLETED|Overall Study||14
218729|NCT00819741|536649|P1|NOT COMPLETED|Overall Study||22
218730|NCT00819741|536648|P2|COMPLETED|Overall Study||201
218731|NCT00819741|536649|P1|COMPLETED|Overall Study||196
218732|NCT00819741|536648|P2|Exposed to Drug|Overall Study|One subject after randomisation was not exposed to the treatment due to non-compliance|214
218733|NCT00819741|536649|P1|Exposed to Drug|Overall Study||218
218734|NCT00819741|536648|P2|STARTED|Overall Study||215
218735|NCT00819741|536649|P1|STARTED|Overall Study||218
218736|NCT00819767|536685|P2|NOT COMPLETED|Overall Study||2
218737|NCT00819767|536686|P1|NOT COMPLETED|Overall Study||1
218738|NCT00819767|536685|P2|COMPLETED|Overall Study||33
218739|NCT00819767|536686|P1|COMPLETED|Overall Study||32
218740|NCT00819767|536685|P2|STARTED|Overall Study||35
218741|NCT00819767|536686|P1|STARTED|Overall Study||33
218742|NCT00819780|536698|P2|NOT COMPLETED|Overall Study||21
218743|NCT00819780|536699|P1|NOT COMPLETED|Overall Study||28
218744|NCT00819780|536698|P2|COMPLETED|Overall Study|Indicates participants who ended study treatment|122
218745|NCT00819780|536699|P1|COMPLETED|Overall Study|Indicates participants who ended study treatment|114
218746|NCT00819780|536698|P2|Received Study Treatment|Overall Study||139
218747|NCT00819780|536699|P1|Received Study Treatment|Overall Study||139
218748|NCT00819780|536698|P2|STARTED|Overall Study||143
218749|NCT00819780|536699|P1|STARTED|Overall Study||142
218750|NCT00819832|536737|P6|NOT COMPLETED|Overall Study||0
218751|NCT00819832|536738|P5|NOT COMPLETED|Overall Study||0
218752|NCT00819832|536739|P4|NOT COMPLETED|Overall Study||0
218753|NCT00819832|536740|P3|NOT COMPLETED|Overall Study||0
218754|NCT00819832|536741|P2|NOT COMPLETED|Overall Study||0
218755|NCT00819832|536742|P1|NOT COMPLETED|Overall Study||3
218756|NCT00819832|536737|P6|COMPLETED|Overall Study||0
218757|NCT00819832|536738|P5|COMPLETED|Overall Study||0
218758|NCT00819832|536739|P4|COMPLETED|Overall Study||0
218759|NCT00819832|536740|P3|COMPLETED|Overall Study||0
218760|NCT00819832|536741|P2|COMPLETED|Overall Study||0
218761|NCT00819832|536742|P1|COMPLETED|Overall Study||0
218762|NCT00819832|536737|P6|STARTED|Overall Study||0
218763|NCT00819832|536738|P5|STARTED|Overall Study||0
218764|NCT00819832|536739|P4|STARTED|Overall Study||0
218765|NCT00819832|536740|P3|STARTED|Overall Study||0
218766|NCT00819832|536741|P2|STARTED|Overall Study||0
218767|NCT00819832|536742|P1|STARTED|Overall Study|No patient data analysis.|3
218768|NCT00819910|536760|P4|NOT COMPLETED|Overall Study||1
218769|NCT00819910|536761|P3|NOT COMPLETED|Overall Study||3
218770|NCT00819910|536762|P2|NOT COMPLETED|Overall Study||1
218771|NCT00819910|536763|P1|NOT COMPLETED|Overall Study||2
218772|NCT00819910|536760|P4|COMPLETED|Overall Study||10
218773|NCT00819910|536761|P3|COMPLETED|Overall Study||7
218774|NCT00819910|536762|P2|COMPLETED|Overall Study||9
218775|NCT00819910|536763|P1|COMPLETED|Overall Study||8
218776|NCT00819910|536760|P4|STARTED|Overall Study||11
218777|NCT00819910|536761|P3|STARTED|Overall Study||10
218778|NCT00819910|536762|P2|STARTED|Overall Study||10
218779|NCT00819910|536763|P1|STARTED|Overall Study||10
218780|NCT00820222|536791|P2|NOT COMPLETED|Overall Study||211
218781|NCT00820222|536792|P1|NOT COMPLETED|Overall Study||201
218782|NCT00820222|536791|P2|COMPLETED|Overall Study||58
218783|NCT00820222|536792|P1|COMPLETED|Overall Study||70
218784|NCT00820222|536791|P2|Ongoing|Overall Study||191
218785|NCT00820222|536792|P1|Ongoing|Overall Study||185
218786|NCT00820222|536791|P2|STARTED|Overall Study||269
218787|NCT00820222|536792|P1|STARTED|Overall Study||271
218788|NCT00820248|536820|P2|NOT COMPLETED|Overall Study||1
218789|NCT00820248|536821|P1|NOT COMPLETED|Overall Study||4
218790|NCT00820248|536820|P2|COMPLETED|Overall Study||159
218791|NCT00820248|536821|P1|COMPLETED|Overall Study||156
218792|NCT00820248|536820|P2|Received Protocol Treatment|Overall Study||159
218793|NCT00820248|536821|P1|Received Protocol Treatment|Overall Study||156
218794|NCT00820248|536820|P2|STARTED|Overall Study||160
218795|NCT00820248|536821|P1|STARTED|Overall Study||160
218796|NCT00820443|536829|P1|NOT COMPLETED|24 Month||43
218797|NCT00820443|536829|P1|COMPLETED|24 Month||202
218798|NCT00820443|536829|P1|STARTED|24 Month||245
218799|NCT00820443|536829|P1|NOT COMPLETED|12 Month||24
218800|NCT00820443|536829|P1|COMPLETED|12 Month||226
218801|NCT00820443|536829|P1|STARTED|12 Month||250
218802|NCT00820443|536829|P1|NOT COMPLETED|6 Month||20
218803|NCT00820443|536829|P1|COMPLETED|6 Month||233
218804|NCT00820443|536829|P1|STARTED|6 Month||253
218805|NCT00820443|536829|P1|NOT COMPLETED|3 Month||9
218806|NCT00820443|536829|P1|COMPLETED|3 Month||244
218807|NCT00820443|536829|P1|STARTED|3 Month||253
218808|NCT00820443|536829|P1|NOT COMPLETED|Immediately||5
218809|NCT00820443|536829|P1|COMPLETED|Immediately||248
218810|NCT00820443|536829|P1|STARTED|Immediately||253
218811|NCT00820443|536829|P1|NOT COMPLETED|Op||0
218812|NCT00820443|536829|P1|COMPLETED|Op||253
218813|NCT00820443|536829|P1|STARTED|Op||253
218814|NCT00820443|536829|P1|NOT COMPLETED|Pre-Op||0
218815|NCT00820443|536829|P1|COMPLETED|Pre-Op||253
218816|NCT00820443|536829|P1|STARTED|Pre-Op||253
218817|NCT00820534|536839|P2|NOT COMPLETED|Overall Study||0
218818|NCT00820534|536840|P1|NOT COMPLETED|Overall Study||0
218819|NCT00820534|536839|P2|COMPLETED|Overall Study||62
218820|NCT00820534|536840|P1|COMPLETED|Overall Study||64
218821|NCT00820534|536839|P2|STARTED|Overall Study||62
218822|NCT00820534|536840|P1|STARTED|Overall Study||64
218823|NCT00820573|536852|P4|NOT COMPLETED|Overall Study||0
218824|NCT00820573|536853|P3|NOT COMPLETED|Overall Study||0
218825|NCT00820573|536854|P2|NOT COMPLETED|Overall Study||0
218826|NCT00820573|536855|P1|NOT COMPLETED|Overall Study||0
218827|NCT00820573|536852|P4|COMPLETED|Overall Study||4
218828|NCT00820573|536853|P3|COMPLETED|Overall Study||4
218829|NCT00820573|536854|P2|COMPLETED|Overall Study||4
218830|NCT00820573|536855|P1|COMPLETED|Overall Study||4
218831|NCT00820573|536852|P4|STARTED|Overall Study||4
218832|NCT00820573|536853|P3|STARTED|Overall Study||4
218833|NCT00820573|536854|P2|STARTED|Overall Study||4
218834|NCT00820573|536855|P1|STARTED|Overall Study||4
218835|NCT00820612|536879|P2|NOT COMPLETED|Overall Study||0
218836|NCT00820612|536880|P1|NOT COMPLETED|Overall Study||0
218837|NCT00820612|536879|P2|COMPLETED|Overall Study||295
218838|NCT00820612|536880|P1|COMPLETED|Overall Study||307
218839|NCT00820612|536879|P2|STARTED|Overall Study||295
218840|NCT00820612|536880|P1|STARTED|Overall Study||307
218841|NCT00820664|536889|P3|NOT COMPLETED|Overall Study||0
218842|NCT00820664|536890|P2|NOT COMPLETED|Overall Study||0
218843|NCT00820664|536891|P1|NOT COMPLETED|Overall Study||0
218844|NCT00820664|536889|P3|COMPLETED|Overall Study||9
218845|NCT00820664|536890|P2|COMPLETED|Overall Study||11
218846|NCT00820664|536891|P1|COMPLETED|Overall Study||9
218847|NCT00820664|536889|P3|STARTED|Overall Study||9
218848|NCT00820664|536890|P2|STARTED|Overall Study||11
218849|NCT00820664|536891|P1|STARTED|Overall Study||9
218850|NCT00820755|536899|P3|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
218851|NCT00820755|536900|P2|NOT COMPLETED|Period 2: Maintenance Therapy Phase||45
218852|NCT00820755|536901|P1|NOT COMPLETED|Period 2: Maintenance Therapy Phase||0
218853|NCT00820755|536899|P3|COMPLETED|Period 2: Maintenance Therapy Phase||109
218854|NCT00820755|536900|P2|COMPLETED|Period 2: Maintenance Therapy Phase||112
218855|NCT00820755|536901|P1|COMPLETED|Period 2: Maintenance Therapy Phase||0
218856|NCT00820755|536899|P3|STARTED|Period 2: Maintenance Therapy Phase||154
218857|NCT00820755|536900|P2|STARTED|Period 2: Maintenance Therapy Phase||157
218858|NCT00820755|536901|P1|STARTED|Period 2: Maintenance Therapy Phase||0
218859|NCT00820755|536899|P3|NOT COMPLETED|Period 1: Combination Therapy Phase||0
218860|NCT00820755|536900|P2|NOT COMPLETED|Period 1: Combination Therapy Phase||0
218861|NCT00820755|536901|P1|NOT COMPLETED|Period 1: Combination Therapy Phase||270
218862|NCT00820755|536899|P3|COMPLETED|Period 1: Combination Therapy Phase||0
218863|NCT00820755|536900|P2|COMPLETED|Period 1: Combination Therapy Phase||0
218864|NCT00820755|536901|P1|COMPLETED|Period 1: Combination Therapy Phase|2 of 313 participants excluded from maintenance phase analysis (reason: not eligible)|313
218865|NCT00820755|536899|P3|STARTED|Period 1: Combination Therapy Phase||0
218866|NCT00820755|536900|P2|STARTED|Period 1: Combination Therapy Phase||0
218867|NCT00820755|536901|P1|STARTED|Period 1: Combination Therapy Phase||583
218868|NCT00820872|536922|P1|NOT COMPLETED|Overall Study||0
218869|NCT00820872|536922|P1|COMPLETED|Overall Study||30
218870|NCT00820872|536922|P1|STARTED|Overall Study||30
218871|NCT00814489|536929|P3|NOT COMPLETED|Overall Study||1
218872|NCT00814489|536930|P2|NOT COMPLETED|Overall Study||0
218873|NCT00814489|536931|P1|NOT COMPLETED|Overall Study||2
218874|NCT00814489|536929|P3|COMPLETED|Overall Study||7
218875|NCT00814489|536930|P2|COMPLETED|Overall Study||17
218876|NCT00814489|536931|P1|COMPLETED|Overall Study||13
218877|NCT00814489|536929|P3|STARTED|Overall Study||8
218878|NCT00814489|536930|P2|STARTED|Overall Study||17
218879|NCT00814489|536931|P1|STARTED|Overall Study||15
218880|NCT00814502|536965|P2|NOT COMPLETED|Overall Study||2
218881|NCT00814502|536966|P1|NOT COMPLETED|Overall Study||1
218882|NCT00814502|536965|P2|COMPLETED|Overall Study||7
218883|NCT00814502|536966|P1|COMPLETED|Overall Study||7
218884|NCT00814502|536965|P2|STARTED|Overall Study||9
218885|NCT00814502|536966|P1|STARTED|Overall Study||8
218886|NCT00814580|536978|P2|NOT COMPLETED|Overall Study||47
218887|NCT00814580|536979|P1|NOT COMPLETED|Overall Study||31
218888|NCT00814580|536978|P2|COMPLETED|Overall Study||141
218889|NCT00814580|536979|P1|COMPLETED|Overall Study||163
218890|NCT00814580|536978|P2|STARTED|Overall Study||188
218891|NCT00814580|536979|P1|STARTED|Overall Study||194
218892|NCT00814632|537107|P1|NOT COMPLETED|Overall Study||2
218893|NCT00814632|537107|P1|COMPLETED|Overall Study|Two subjects withdrew early due to lack of efficacy.|7
218894|NCT00814632|537107|P1|STARTED|Overall Study|Ten were allocated to treatment intervention however one was not treated due to lactose allergy.|9
218895|NCT00814658|537113|P2|NOT COMPLETED|Overall Study||4
218896|NCT00814658|537114|P1|NOT COMPLETED|Overall Study||4
218897|NCT00814658|537113|P2|COMPLETED|Overall Study||8
218898|NCT00814658|537114|P1|COMPLETED|Overall Study||5
218899|NCT00814658|537113|P2|STARTED|Overall Study||12
218900|NCT00814658|537114|P1|STARTED|Overall Study||9
218901|NCT00814671|537183|P3|NOT COMPLETED|Overall Study||2
218902|NCT00814671|537184|P2|NOT COMPLETED|Overall Study||4
218903|NCT00814671|537185|P1|NOT COMPLETED|Overall Study||7
218904|NCT00814671|537183|P3|COMPLETED|Overall Study||49
218905|NCT00814671|537184|P2|COMPLETED|Overall Study||44
218906|NCT00814671|537185|P1|COMPLETED|Overall Study||47
218907|NCT00814671|537183|P3|STARTED|Overall Study||51
218908|NCT00814671|537184|P2|STARTED|Overall Study||48
218909|NCT00814671|537185|P1|STARTED|Overall Study||54
218910|NCT00814697|537196|P1|NOT COMPLETED|Overall Study||0
218911|NCT00814697|537196|P1|COMPLETED|Overall Study||12
218912|NCT00814697|537196|P1|STARTED|Overall Study||12
218913|NCT00814710|537202|P2|NOT COMPLETED|Overall Study||3
218914|NCT00814710|537203|P1|NOT COMPLETED|Overall Study||8
218915|NCT00814710|537202|P2|COMPLETED|Overall Study||117
218916|NCT00814710|537203|P1|COMPLETED|Overall Study||232
218917|NCT00814710|537202|P2|STARTED|Overall Study||120
218918|NCT00814710|537203|P1|STARTED|Overall Study||240
218919|NCT00814775|537243|P2|NOT COMPLETED|Overall Study||0
218920|NCT00814775|537244|P1|NOT COMPLETED|Overall Study||0
218921|NCT00814775|537243|P2|COMPLETED|Overall Study||20
218922|NCT00814775|537244|P1|COMPLETED|Overall Study||23
218923|NCT00814775|537243|P2|STARTED|Overall Study||20
218924|NCT00814775|537244|P1|STARTED|Overall Study||23
218925|NCT00814788|537252|P1|NOT COMPLETED|Overall Study||0
218926|NCT00814788|537252|P1|COMPLETED|Overall Study||24
218927|NCT00814788|537252|P1|STARTED|Overall Study||24
218928|NCT00814801|537261|P3|NOT COMPLETED|Overall Study||43
218929|NCT00814801|537262|P2|NOT COMPLETED|Overall Study||38
218930|NCT00814801|537263|P1|NOT COMPLETED|Overall Study||34
218931|NCT00814801|537261|P3|COMPLETED|Overall Study||151
218932|NCT00814801|537262|P2|COMPLETED|Overall Study||154
218933|NCT00814801|537263|P1|COMPLETED|Overall Study||160
218934|NCT00814801|537261|P3|STARTED|Overall Study||194
218935|NCT00814801|537262|P2|STARTED|Overall Study||192
218936|NCT00814801|537263|P1|STARTED|Overall Study||194
218937|NCT00814879|537285|P2|NOT COMPLETED|By Week 48||3
218938|NCT00814879|537286|P1|NOT COMPLETED|By Week 48||2
218939|NCT00814879|537285|P2|COMPLETED|By Week 48||26
218940|NCT00814879|537286|P1|COMPLETED|By Week 48||25
218941|NCT00814879|537285|P2|STARTED|By Week 48||29
218942|NCT00814879|537286|P1|STARTED|By Week 48||27
218943|NCT00814879|537285|P2|NOT COMPLETED|By Week 24||1
218944|NCT00814879|537286|P1|NOT COMPLETED|By Week 24||1
218945|NCT00814879|537285|P2|COMPLETED|By Week 24||29
218946|NCT00814879|537286|P1|COMPLETED|By Week 24||27
218947|NCT00814879|537285|P2|STARTED|By Week 24||30
218948|NCT00814879|537286|P1|STARTED|By Week 24||28
218949|NCT00814892|537302|P1|NOT COMPLETED|Overall Study||2
218950|NCT00814892|537302|P1|COMPLETED|Overall Study||0
218951|NCT00814892|537302|P1|STARTED|Overall Study||2
218952|NCT00814970|537312|P1|NOT COMPLETED|Overall Study||50
218953|NCT00814970|537312|P1|COMPLETED|Overall Study||146
218954|NCT00814970|537312|P1|STARTED|Overall Study||196
218955|NCT00814983|537335|P2|NOT COMPLETED|Overall Study||0
218956|NCT00814983|537336|P1|NOT COMPLETED|Overall Study||3
218957|NCT00814983|537335|P2|COMPLETED|Overall Study||0
218958|NCT00814983|537336|P1|COMPLETED|Overall Study||12
218959|NCT00814983|537335|P2|STARTED|Overall Study||0
218960|NCT00814983|537336|P1|STARTED|Overall Study||15
218961|NCT00815035|537348|P3|NOT COMPLETED|Open Label Extension Phase||6
218962|NCT00815035|537349|P2|NOT COMPLETED|Open Label Extension Phase||0
218963|NCT00815035|537350|P1|NOT COMPLETED|Open Label Extension Phase||0
218964|NCT00815035|537348|P3|COMPLETED|Open Label Extension Phase||9
218965|NCT00815035|537349|P2|COMPLETED|Open Label Extension Phase||0
218966|NCT00815035|537350|P1|COMPLETED|Open Label Extension Phase||0
218967|NCT00815035|537348|P3|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|15
218968|NCT00815035|537349|P2|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
218969|NCT00815035|537350|P1|STARTED|Open Label Extension Phase|After unblinding, subjects completing the blinded phase moved to the open-label phase of the study|0
218970|NCT00815035|537348|P3|NOT COMPLETED|Blinded Phase||0
218971|NCT00815035|537349|P2|NOT COMPLETED|Blinded Phase||0
218972|NCT00815035|537350|P1|NOT COMPLETED|Blinded Phase||1
218973|NCT00815035|537348|P3|COMPLETED|Blinded Phase||0
218974|NCT00815035|537349|P2|COMPLETED|Blinded Phase||6
218975|NCT00815035|537350|P1|COMPLETED|Blinded Phase||9
218976|NCT00815035|537348|P3|STARTED|Blinded Phase||0
218977|NCT00815035|537349|P2|STARTED|Blinded Phase||6
218978|NCT00815035|537350|P1|STARTED|Blinded Phase||10
218979|NCT00821041|537368|P2|NOT COMPLETED|Overall Study||0
218980|NCT00821041|537369|P1|NOT COMPLETED|Overall Study||0
218981|NCT00821041|537368|P2|COMPLETED|Overall Study||59
218982|NCT00821041|537369|P1|COMPLETED|Overall Study||59
218983|NCT00821041|537368|P2|STARTED|Overall Study||59
218984|NCT00821041|537369|P1|STARTED|Overall Study||59
218985|NCT00821093|537379|P2|NOT COMPLETED|Overall Study||40
218986|NCT00821093|537380|P1|NOT COMPLETED|Overall Study||49
218987|NCT00821093|537379|P2|COMPLETED|Overall Study||523
218988|NCT00821093|537380|P1|COMPLETED|Overall Study||511
218989|NCT00821093|537379|P2|Exposed to Drug|Overall Study||562
218990|NCT00821093|537380|P1|Exposed to Drug|Overall Study||559
218991|NCT00821093|537379|P2|STARTED|Overall Study||563
218992|NCT00821093|537380|P1|STARTED|Overall Study||560
218993|NCT00821119|537390|P2|NOT COMPLETED|Overall Study||0
218994|NCT00821119|537391|P1|NOT COMPLETED|Overall Study||0
218995|NCT00821119|537390|P2|COMPLETED|Overall Study||100
218996|NCT00821119|537391|P1|COMPLETED|Overall Study||100
218997|NCT00821119|537390|P2|STARTED|Overall Study||100
218998|NCT00821119|537391|P1|STARTED|Overall Study||100
218999|NCT00821184|537403|P2|NOT COMPLETED|Overall Study||0
219000|NCT00821184|537404|P1|NOT COMPLETED|Overall Study||0
219001|NCT00821184|537403|P2|COMPLETED|Overall Study||6
219002|NCT00821184|537404|P1|COMPLETED|Overall Study||6
219003|NCT00821184|537403|P2|STARTED|Overall Study||6
219004|NCT00821184|537404|P1|STARTED|Overall Study||6
219005|NCT00821236|537413|P1|NOT COMPLETED|Overall Study||3
219006|NCT00821236|537413|P1|COMPLETED|Overall Study||37
219007|NCT00821236|537413|P1|STARTED|Overall Study||40
219008|NCT00821327|537427|P1|NOT COMPLETED|Overall Study||35
219009|NCT00821327|537427|P1|COMPLETED|Overall Study||1
219010|NCT00821327|537427|P1|STARTED|Overall Study||36
219011|NCT00822510|537435|P2|NOT COMPLETED|Overall Study||5
219012|NCT00822510|537436|P1|NOT COMPLETED|Overall Study||3
219013|NCT00822510|537435|P2|COMPLETED|Overall Study||36
219014|NCT00822510|537436|P1|COMPLETED|Overall Study||35
219015|NCT00822510|537435|P2|STARTED|Overall Study||41
219016|NCT00822510|537436|P1|STARTED|Overall Study||38
219017|NCT00822523|537457|P3|NOT COMPLETED|Overall Study||0
219018|NCT00822523|537458|P2|NOT COMPLETED|Overall Study||0
219019|NCT00822523|537459|P1|NOT COMPLETED|Overall Study||0
219020|NCT00822523|537457|P3|COMPLETED|Overall Study||4
219021|NCT00822523|537458|P2|COMPLETED|Overall Study||4
219022|NCT00822523|537459|P1|COMPLETED|Overall Study||5
219023|NCT00822523|537457|P3|STARTED|Overall Study||4
219024|NCT00822523|537458|P2|STARTED|Overall Study||4
219025|NCT00822523|537459|P1|STARTED|Overall Study||5
219026|NCT00822588|537505|P2|NOT COMPLETED|Overall Study||4
219027|NCT00822588|537506|P1|NOT COMPLETED|Overall Study||7
219028|NCT00822588|537505|P2|COMPLETED|Overall Study|APT/ITT analysis set|110
219029|NCT00822588|537506|P1|COMPLETED|Overall Study|APT/ITT analysis set|106
219030|NCT00822588|537505|P2|STARTED|Overall Study|4 participants excluded before surgery. No baseline data available|114
219031|NCT00822588|537506|P1|STARTED|Overall Study|7 participants excluded before surgery. No baseline data available|113
219032|NCT00822679|537514|P2|NOT COMPLETED|Overall Study||0
219033|NCT00822679|537515|P1|NOT COMPLETED|Overall Study||0
219034|NCT00822679|537514|P2|COMPLETED|Overall Study||0
219035|NCT00822679|537515|P1|COMPLETED|Overall Study||0
219036|NCT00822679|537514|P2|STARTED|Overall Study||0
219037|NCT00822679|537515|P1|STARTED|Overall Study||0
219038|NCT00822692|537523|P2|NOT COMPLETED|Overall Study||25
219039|NCT00822692|537524|P1|NOT COMPLETED|Overall Study||17
219040|NCT00822692|537523|P2|COMPLETED|Overall Study|June 1 , 2009|51
219041|NCT00822692|537524|P1|COMPLETED|Overall Study|June 1, 2009|46
219042|NCT00822692|537523|P2|STARTED|Overall Study|July 1, 2008|76
219043|NCT00822692|537524|P1|STARTED|Overall Study|July 1, 2008|63
219044|NCT00822757|537532|P2|NOT COMPLETED|Overall Study||0
219045|NCT00822757|537533|P1|NOT COMPLETED|Overall Study||0
219046|NCT00822757|537532|P2|COMPLETED|Overall Study||10
219047|NCT00822757|537533|P1|COMPLETED|Overall Study||41
219048|NCT00822757|537532|P2|STARTED|Overall Study||10
219049|NCT00822757|537533|P1|STARTED|Overall Study||41
219050|NCT00822770|537543|P1|NOT COMPLETED|Overall Study||0
219051|NCT00822770|537543|P1|COMPLETED|Overall Study||47
219052|NCT00822770|537543|P1|STARTED|Overall Study||47
219053|NCT00822900|537549|P2|NOT COMPLETED|Overall Study||93
219054|NCT00822900|537550|P1|NOT COMPLETED|Overall Study||108
219055|NCT00822900|537549|P2|COMPLETED|Overall Study||347
219056|NCT00822900|537550|P1|COMPLETED|Overall Study||334
219057|NCT00822900|537549|P2|STARTED|Overall Study||440
219058|NCT00822900|537550|P1|STARTED|Overall Study||442
219059|NCT00822926|537580|P2|NOT COMPLETED|Second Injection Visit||1
219060|NCT00822926|537581|P1|NOT COMPLETED|Second Injection Visit||1
219061|NCT00822926|537580|P2|COMPLETED|Second Injection Visit||2
219062|NCT00822926|537581|P1|COMPLETED|Second Injection Visit||1
219063|NCT00822926|537580|P2|STARTED|Second Injection Visit||3
219064|NCT00822926|537581|P1|STARTED|Second Injection Visit||2
219065|NCT00822926|537580|P2|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
219066|NCT00822926|537581|P1|NOT COMPLETED|Washout (Varies Based on Scheduling)||0
219067|NCT00822926|537580|P2|COMPLETED|Washout (Varies Based on Scheduling)||3
219068|NCT00822926|537581|P1|COMPLETED|Washout (Varies Based on Scheduling)||2
219069|NCT00822926|537580|P2|STARTED|Washout (Varies Based on Scheduling)||3
219070|NCT00822926|537581|P1|STARTED|Washout (Varies Based on Scheduling)||2
219071|NCT00822926|537580|P2|NOT COMPLETED|First Injection Visit||0
219072|NCT00822926|537581|P1|NOT COMPLETED|First Injection Visit||0
219073|NCT00822926|537580|P2|COMPLETED|First Injection Visit||3
219074|NCT00822926|537581|P1|COMPLETED|First Injection Visit||2
219075|NCT00822926|537580|P2|STARTED|First Injection Visit||3
219076|NCT00822926|537581|P1|STARTED|First Injection Visit||2
219077|NCT00823043|537593|P2|NOT COMPLETED|Overall Study||0
219078|NCT00823043|537594|P1|NOT COMPLETED|Overall Study||0
219079|NCT00823043|537593|P2|COMPLETED|Overall Study||39
219080|NCT00823043|537594|P1|COMPLETED|Overall Study||64
219081|NCT00823043|537593|P2|STARTED|Overall Study||39
219082|NCT00823043|537594|P1|STARTED|Overall Study||64
219083|NCT00823069|537605|P1|NOT COMPLETED|Overall Study||0
219084|NCT00823069|537605|P1|COMPLETED|Overall Study||60
219085|NCT00823069|537605|P1|STARTED|Overall Study||60
219086|NCT00823082|537614|P2|NOT COMPLETED|Overall Study||1
219087|NCT00823082|537615|P1|NOT COMPLETED|Overall Study||0
219088|NCT00823082|537614|P2|COMPLETED|Overall Study||99
219089|NCT00823082|537615|P1|COMPLETED|Overall Study||100
219090|NCT00823082|537614|P2|Intent-to-Treat/Per Protocol Populations|Overall Study||94
219091|NCT00823082|537615|P1|Intent-to-Treat/Per Protocol Populations|Overall Study||100
219092|NCT00823082|537614|P2|Safety Population|Overall Study||99
219093|NCT00823082|537615|P1|Safety Population|Overall Study||100
219094|NCT00823082|537614|P2|STARTED|Overall Study||100
219095|NCT00823082|537615|P1|STARTED|Overall Study||100
219096|NCT00823095|537649|P1|NOT COMPLETED|Overall Study||0
219097|NCT00823095|537649|P1|COMPLETED|Overall Study||7
219098|NCT00823095|537649|P1|STARTED|Overall Study||7
219099|NCT00823199|537654|P1|NOT COMPLETED|Overall Study||2
219100|NCT00823199|537654|P1|COMPLETED|Overall Study||8
219101|NCT00823199|537654|P1|STARTED|Overall Study||10
219102|NCT00823212|537662|P2|NOT COMPLETED|Overall Study||33
219103|NCT00823212|537663|P1|NOT COMPLETED|Overall Study||35
219104|NCT00823212|537662|P2|COMPLETED|Overall Study|12-month follow-up|735
219105|NCT00823212|537663|P1|COMPLETED|Overall Study|12-month follow-up|727
219106|NCT00823212|537662|P2|STARTED|Overall Study||768
219107|NCT00823212|537663|P1|STARTED|Overall Study||762
219108|NCT00823264|537747|P2|NOT COMPLETED|Overall Study||0
219109|NCT00823264|537748|P1|NOT COMPLETED|Overall Study||2
219110|NCT00823264|537747|P2|COMPLETED|Overall Study||7
219111|NCT00823264|537748|P1|COMPLETED|Overall Study||8
219112|NCT00823264|537747|P2|STARTED|Overall Study||7
219113|NCT00823264|537748|P1|STARTED|Overall Study||10
219114|NCT00823303|537756|P2|NOT COMPLETED|Overall Study||11
219115|NCT00823303|537757|P1|NOT COMPLETED|Overall Study||9
219116|NCT00823303|537756|P2|COMPLETED|Overall Study||45
219117|NCT00823303|537757|P1|COMPLETED|Overall Study||45
219118|NCT00823303|537756|P2|STARTED|Overall Study||56
219119|NCT00823303|537757|P1|STARTED|Overall Study||54
219120|NCT00823472|537765|P2|NOT COMPLETED|Overall Study||28
219121|NCT00823472|537766|P1|NOT COMPLETED|Overall Study||24
219122|NCT00823472|537765|P2|COMPLETED|Overall Study||39
219123|NCT00823472|537766|P1|COMPLETED|Overall Study||56
219124|NCT00823472|537765|P2|STARTED|Overall Study||67
219125|NCT00823472|537766|P1|STARTED|Overall Study||80
219126|NCT00823615|537774|P2|NOT COMPLETED|Period 2||2
219127|NCT00823615|537775|P1|NOT COMPLETED|Period 2||3
219128|NCT00823615|537774|P2|COMPLETED|Period 2||17
219129|NCT00823615|537775|P1|COMPLETED|Period 2||16
219130|NCT00823615|537774|P2|STARTED|Period 2||19
219131|NCT00823615|537775|P1|STARTED|Period 2||19
219132|NCT00823615|537774|P2|NOT COMPLETED|Period 1||0
219133|NCT00823615|537775|P1|NOT COMPLETED|Period 1||0
219134|NCT00823615|537774|P2|COMPLETED|Period 1||19
219135|NCT00823615|537775|P1|COMPLETED|Period 1||19
219136|NCT00823615|537774|P2|STARTED|Period 1||19
219137|NCT00823615|537775|P1|STARTED|Period 1||19
219138|NCT00823719|537785|P2|NOT COMPLETED|Overall Study||11
219139|NCT00823719|537786|P1|NOT COMPLETED|Overall Study||6
219140|NCT00823719|537785|P2|COMPLETED|Overall Study||24
219141|NCT00823719|537786|P1|COMPLETED|Overall Study||20
219142|NCT00823719|537785|P2|STARTED|Overall Study||35
219143|NCT00823719|537786|P1|STARTED|Overall Study||26
219144|NCT00823797|537841|P2|NOT COMPLETED|Overall Study||0
219145|NCT00823797|537842|P1|NOT COMPLETED|Overall Study||0
219146|NCT00823797|537841|P2|COMPLETED|Overall Study||16
219147|NCT00823797|537842|P1|COMPLETED|Overall Study||29
219148|NCT00823797|537841|P2|STARTED|Overall Study||16
219149|NCT00823797|537842|P1|STARTED|Overall Study||29
219150|NCT00823823|537855|P2|NOT COMPLETED|Overall Study||6
219151|NCT00823823|537856|P1|NOT COMPLETED|Overall Study||8
219152|NCT00823823|537855|P2|COMPLETED|Overall Study||101
219153|NCT00823823|537856|P1|COMPLETED|Overall Study||101
219154|NCT00823823|537855|P2|STARTED|Overall Study||107
219155|NCT00823823|537856|P1|STARTED|Overall Study||109
219156|NCT00823836|537866|P2|NOT COMPLETED|Long-term Phase||5
219157|NCT00823836|537867|P1|NOT COMPLETED|Long-term Phase||5
219158|NCT00823836|537866|P2|COMPLETED|Long-term Phase||79
219159|NCT00823836|537867|P1|COMPLETED|Long-term Phase||68
219160|NCT00823836|537866|P2|STARTED|Long-term Phase||84
219161|NCT00823836|537867|P1|STARTED|Long-term Phase||73
219162|NCT00823836|537866|P2|NOT COMPLETED|NV and PR/XR Switching Phases||29
219163|NCT00823836|537867|P1|NOT COMPLETED|NV and PR/XR Switching Phases||32
219164|NCT00823836|537866|P2|COMPLETED|NV and PR/XR Switching Phases||117
219165|NCT00823836|537867|P1|COMPLETED|NV and PR/XR Switching Phases||124
219166|NCT00823836|537866|P2|STARTED|NV and PR/XR Switching Phases||146
219167|NCT00823836|537867|P1|STARTED|NV and PR/XR Switching Phases||156
219168|NCT00823901|537973|P2|NOT COMPLETED|Overall Study||2
219169|NCT00823901|537974|P1|NOT COMPLETED|Overall Study||4
219170|NCT00823901|537973|P2|COMPLETED|Overall Study|Discontinued intervention (n=1) Only baseline completed (n=1)|38
219171|NCT00823901|537974|P1|COMPLETED|Overall Study|Discontinued intervention (n=2) Only baseline completed (n=2)|39
219172|NCT00823901|537973|P2|STARTED|Overall Study|Randomized to placebo gel|40
219173|NCT00823901|537974|P1|STARTED|Overall Study|Randomized to clindamycin/tretinoin gel|43
219174|NCT00823966|537980|P1|NOT COMPLETED|Overall Study||0
219175|NCT00823966|537980|P1|COMPLETED|Overall Study||3
219176|NCT00823966|537980|P1|STARTED|Overall Study||3
219177|NCT00823979|537988|P3|NOT COMPLETED|Overall Study||24
219178|NCT00823979|537989|P2|NOT COMPLETED|Overall Study||32
219179|NCT00823979|537990|P1|NOT COMPLETED|Overall Study||29
219180|NCT00823979|537988|P3|COMPLETED|Overall Study||11
219181|NCT00823979|537989|P2|COMPLETED|Overall Study||3
219182|NCT00823979|537990|P1|COMPLETED|Overall Study||6
219183|NCT00823979|537988|P3|Treated|Overall Study||34
219184|NCT00823979|537989|P2|Treated|Overall Study||32
219185|NCT00823979|537990|P1|Treated|Overall Study||31
219186|NCT00823979|537988|P3|STARTED|Overall Study||35
219187|NCT00823979|537989|P2|STARTED|Overall Study||35
219188|NCT00823979|537990|P1|STARTED|Overall Study||35
219189|NCT00824005|538030|P2|NOT COMPLETED|Overall Study||2
219190|NCT00824005|538031|P1|NOT COMPLETED|Overall Study||0
219191|NCT00824005|538030|P2|COMPLETED|Overall Study||59
219192|NCT00824005|538031|P1|COMPLETED|Overall Study||31
219193|NCT00824005|538030|P2|STARTED|Overall Study||61
219194|NCT00824005|538031|P1|STARTED|Overall Study||31
219195|NCT00824044|538065|P2|NOT COMPLETED|Overall Study||6
219196|NCT00824044|538066|P1|NOT COMPLETED|Overall Study||9
219197|NCT00824044|538065|P2|COMPLETED|Overall Study||10
219198|NCT00824044|538066|P1|COMPLETED|Overall Study||14
219199|NCT00824044|538065|P2|STARTED|Overall Study||16
219200|NCT00824044|538066|P1|STARTED|Overall Study||23
219201|NCT00824070|538075|P3|NOT COMPLETED|Overall Study||0
219202|NCT00824070|538076|P2|NOT COMPLETED|Overall Study||0
219203|NCT00824070|538077|P1|NOT COMPLETED|Overall Study||0
219204|NCT00824070|538075|P3|COMPLETED|Overall Study||36
219205|NCT00824070|538076|P2|COMPLETED|Overall Study||35
219206|NCT00824070|538077|P1|COMPLETED|Overall Study||34
219207|NCT00824070|538075|P3|STARTED|Overall Study||36
219208|NCT00824070|538076|P2|STARTED|Overall Study||35
219209|NCT00824070|538077|P1|STARTED|Overall Study||34
219210|NCT00824161|538085|P1|NOT COMPLETED|Overall Study||2
219211|NCT00824161|538085|P1|COMPLETED|Overall Study||26
219212|NCT00824161|538085|P1|STARTED|Overall Study||28
219213|NCT00824265|538093|P2|NOT COMPLETED|Overall Study||80
219214|NCT00824265|538094|P1|NOT COMPLETED|Overall Study||64
219215|NCT00824265|538093|P2|COMPLETED|Overall Study||102
219216|NCT00824265|538094|P1|COMPLETED|Overall Study||119
219217|NCT00824265|538093|P2|STARTED|Overall Study||182
219218|NCT00824265|538094|P1|STARTED|Overall Study||183
219219|NCT00824291|538155|P2|NOT COMPLETED|Overall Study||35
219220|NCT00824291|538156|P1|NOT COMPLETED|Overall Study||54
219221|NCT00824291|538155|P2|COMPLETED|Overall Study||107
219222|NCT00824291|538156|P1|COMPLETED|Overall Study||231
219223|NCT00824291|538155|P2|STARTED|Overall Study||142
219224|NCT00824291|538156|P1|STARTED|Overall Study||285
219225|NCT00824369|538182|P6|NOT COMPLETED|Overall Study||1
219226|NCT00824369|538183|P5|NOT COMPLETED|Overall Study||1
219227|NCT00824369|538184|P4|NOT COMPLETED|Overall Study||2
219228|NCT00824369|538185|P3|NOT COMPLETED|Overall Study||1
219229|NCT00824369|538186|P2|NOT COMPLETED|Overall Study||0
219230|NCT00824369|538187|P1|NOT COMPLETED|Overall Study||1
219231|NCT00824369|538182|P6|COMPLETED|Overall Study||16
219232|NCT00824369|538183|P5|COMPLETED|Overall Study||11
219233|NCT00824369|538184|P4|COMPLETED|Overall Study||9
219234|NCT00824369|538185|P3|COMPLETED|Overall Study||2
219235|NCT00824369|538186|P2|COMPLETED|Overall Study||4
219236|NCT00824369|538187|P1|COMPLETED|Overall Study||4
219237|NCT00824369|538182|P6|STARTED|Overall Study||17
219238|NCT00824369|538183|P5|STARTED|Overall Study||12
219239|NCT00824369|538184|P4|STARTED|Overall Study||11
219240|NCT00824369|538185|P3|STARTED|Overall Study||3
219241|NCT00824369|538186|P2|STARTED|Overall Study||4
219242|NCT00824369|538187|P1|STARTED|Overall Study||5
219243|NCT00824382|538229|P4|NOT COMPLETED|Overall Study||5
219244|NCT00824382|538230|P3|NOT COMPLETED|Overall Study||3
219245|NCT00824382|538231|P2|NOT COMPLETED|Overall Study||2
219246|NCT00824382|538232|P1|NOT COMPLETED|Overall Study||5
219247|NCT00824382|538229|P4|COMPLETED|Overall Study||81
219248|NCT00824382|538230|P3|COMPLETED|Overall Study||76
219249|NCT00824382|538231|P2|COMPLETED|Overall Study||82
219250|NCT00824382|538232|P1|COMPLETED|Overall Study||74
219251|NCT00824382|538229|P4|STARTED|Overall Study||86
219252|NCT00824382|538230|P3|STARTED|Overall Study||79
219253|NCT00824382|538231|P2|STARTED|Overall Study||84
219254|NCT00824382|538232|P1|STARTED|Overall Study||79
219255|NCT00824408|538307|P5|NOT COMPLETED|Randomized Phase||46
219256|NCT00824408|538308|P4|NOT COMPLETED|Randomized Phase||46
219257|NCT00824408|538309|P3|NOT COMPLETED|Randomized Phase||36
219258|NCT00824408|538310|P2|NOT COMPLETED|Randomized Phase||0
219259|NCT00824408|538311|P1|NOT COMPLETED|Randomized Phase||0
219260|NCT00824408|538307|P5|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
219261|NCT00824408|538308|P4|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
219262|NCT00824408|538309|P3|COMPLETED|Randomized Phase|On-treatment at data cutoff (21Dec2012)|1
219263|NCT00824408|538310|P2|COMPLETED|Randomized Phase||0
219264|NCT00824408|538311|P1|COMPLETED|Randomized Phase||0
219265|NCT00824408|538307|P5|STARTED|Randomized Phase||47
219266|NCT00824408|538308|P4|STARTED|Randomized Phase||47
219267|NCT00824408|538309|P3|STARTED|Randomized Phase||37
219268|NCT00824408|538310|P2|STARTED|Randomized Phase||0
219269|NCT00824408|538311|P1|STARTED|Randomized Phase||0
219270|NCT00824408|538307|P5|NOT COMPLETED|Run-in Phase||0
219271|NCT00824408|538308|P4|NOT COMPLETED|Run-in Phase||0
219272|NCT00824408|538309|P3|NOT COMPLETED|Run-in Phase||0
219273|NCT00824408|538310|P2|NOT COMPLETED|Run-in Phase||6
219274|NCT00824408|538311|P1|NOT COMPLETED|Run-in Phase||6
219275|NCT00824408|538307|P5|COMPLETED|Run-in Phase||0
219276|NCT00824408|538308|P4|COMPLETED|Run-in Phase||0
219277|NCT00824408|538309|P3|COMPLETED|Run-in Phase||0
219278|NCT00824408|538310|P2|COMPLETED|Run-in Phase||0
219279|NCT00824408|538311|P1|COMPLETED|Run-in Phase||0
219280|NCT00824408|538307|P5|STARTED|Run-in Phase||0
219281|NCT00824408|538308|P4|STARTED|Run-in Phase||0
219282|NCT00824408|538309|P3|STARTED|Run-in Phase||0
219283|NCT00824408|538310|P2|STARTED|Run-in Phase||6
219284|NCT00824408|538311|P1|STARTED|Run-in Phase||6
219285|NCT00824421|538362|P3|NOT COMPLETED|Overall Study||14
219286|NCT00824421|538363|P2|NOT COMPLETED|Overall Study||22
219287|NCT00824421|538364|P1|NOT COMPLETED|Overall Study||17
219288|NCT00824421|538362|P3|COMPLETED|Overall Study||49
219289|NCT00824421|538363|P2|COMPLETED|Overall Study||44
219290|NCT00824421|538364|P1|COMPLETED|Overall Study||49
219291|NCT00824421|538362|P3|Treated|Overall Study||63
219292|NCT00824421|538363|P2|Treated|Overall Study||65
219293|NCT00824421|538364|P1|Treated|Overall Study||65
219294|NCT00824421|538362|P3|STARTED|Overall Study||63
219295|NCT00824421|538363|P2|STARTED|Overall Study||66
219296|NCT00824421|538364|P1|STARTED|Overall Study||66
219297|NCT00824434|538410|P1|NOT COMPLETED|Overall Study||0
219298|NCT00824434|538410|P1|COMPLETED|Overall Study||100
219299|NCT00824434|538410|P1|STARTED|Overall Study||100
219300|NCT00824460|538435|P6|NOT COMPLETED|Overall Study||8
219301|NCT00824460|538436|P5|NOT COMPLETED|Overall Study||9
219302|NCT00824460|538437|P4|NOT COMPLETED|Overall Study||12
219303|NCT00824460|538438|P3|NOT COMPLETED|Overall Study||5
219304|NCT00824460|538439|P2|NOT COMPLETED|Overall Study||9
219305|NCT00824460|538440|P1|NOT COMPLETED|Overall Study||8
219306|NCT00824460|538435|P6|COMPLETED|Overall Study||18
219307|NCT00824460|538436|P5|COMPLETED|Overall Study||15
219308|NCT00824460|538437|P4|COMPLETED|Overall Study||15
219309|NCT00824460|538438|P3|COMPLETED|Overall Study||20
219310|NCT00824460|538439|P2|COMPLETED|Overall Study||17
219311|NCT00824460|538440|P1|COMPLETED|Overall Study||18
219312|NCT00824460|538435|P6|STARTED|Overall Study||26
219313|NCT00824460|538436|P5|STARTED|Overall Study||24
219314|NCT00824460|538437|P4|STARTED|Overall Study||27
219315|NCT00824460|538438|P3|STARTED|Overall Study||25
219316|NCT00824460|538439|P2|STARTED|Overall Study||26
219317|NCT00824460|538440|P1|STARTED|Overall Study||26
219318|NCT00824473|538474|P2|NOT COMPLETED|Overall Study||13
219319|NCT00824473|538475|P1|NOT COMPLETED|Overall Study||15
219320|NCT00824473|538474|P2|COMPLETED|Overall Study||238
219321|NCT00824473|538475|P1|COMPLETED|Overall Study||240
219322|NCT00824473|538474|P2|STARTED|Overall Study||251
219323|NCT00824473|538475|P1|STARTED|Overall Study|1 subject was randomized in error|255
219324|NCT00824512|538493|P2|NOT COMPLETED|Overall Study||0
219325|NCT00824512|538494|P1|NOT COMPLETED|Overall Study||0
219326|NCT00824512|538493|P2|COMPLETED|Overall Study||11
219327|NCT00824512|538494|P1|COMPLETED|Overall Study||11
219328|NCT00824512|538493|P2|STARTED|Overall Study||11
219329|NCT00824512|538494|P1|STARTED|Overall Study||11
219330|NCT00824538|538542|P1|NOT COMPLETED|Overall Study||2
219331|NCT00824538|538542|P1|COMPLETED|Overall Study||11
219332|NCT00824538|538542|P1|STARTED|Overall Study|13 patients entered the study|13
219333|NCT00824564|538550|P2|NOT COMPLETED|Overall Study||10
219334|NCT00824564|538551|P1|NOT COMPLETED|Overall Study||8
219335|NCT00824564|538550|P2|COMPLETED|Overall Study||30
219336|NCT00824564|538551|P1|COMPLETED|Overall Study||34
219337|NCT00824564|538550|P2|Treated|Overall Study||40
219338|NCT00824564|538551|P1|Treated|Overall Study||41
219339|NCT00824564|538550|P2|STARTED|Overall Study||40
219340|NCT00824564|538551|P1|STARTED|Overall Study||42
219341|NCT00824616|538571|P2|NOT COMPLETED|Overall Study||7
219342|NCT00824616|538572|P1|NOT COMPLETED|Overall Study||6
219343|NCT00824616|538571|P2|COMPLETED|Overall Study||27
219344|NCT00824616|538572|P1|COMPLETED|Overall Study||28
219345|NCT00824616|538571|P2|STARTED|Overall Study||34
219346|NCT00824616|538572|P1|STARTED|Overall Study||34
219347|NCT00824655|538582|P2|NOT COMPLETED|Toddler Dose (12 Months of Age)||0
219348|NCT00824655|538583|P1|NOT COMPLETED|Toddler Dose (12 Months of Age)||2
219349|NCT00824655|538582|P2|COMPLETED|Toddler Dose (12 Months of Age)||116
219350|NCT00824655|538583|P1|COMPLETED|Toddler Dose (12 Months of Age)||116
219351|NCT00824655|538582|P2|STARTED|Toddler Dose (12 Months of Age)||116
219352|NCT00824655|538583|P1|STARTED|Toddler Dose (12 Months of Age)||118
219353|NCT00824655|538582|P2|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
219354|NCT00824655|538583|P1|NOT COMPLETED|After Infant Dose (6 Months of Age)||0
219355|NCT00824655|538582|P2|COMPLETED|After Infant Dose (6 Months of Age)||0
219356|NCT00824655|538583|P1|COMPLETED|After Infant Dose (6 Months of Age)||118
219357|NCT00824655|538582|P2|STARTED|After Infant Dose (6 Months of Age)||0
219358|NCT00824655|538583|P1|STARTED|After Infant Dose (6 Months of Age)||118
219359|NCT00824655|538582|P2|NOT COMPLETED|Infant Series (5 Months of Age)||0
219360|NCT00824655|538583|P1|NOT COMPLETED|Infant Series (5 Months of Age)||0
219361|NCT00824655|538582|P2|COMPLETED|Infant Series (5 Months of Age)||0
219362|NCT00824655|538583|P1|COMPLETED|Infant Series (5 Months of Age)||118
219363|NCT00824655|538582|P2|STARTED|Infant Series (5 Months of Age)||0
219364|NCT00824655|538583|P1|STARTED|Infant Series (5 Months of Age)||118
219365|NCT00824720|538604|P3|NOT COMPLETED|Overall Study||1
219366|NCT00824720|538605|P2|NOT COMPLETED|Overall Study||1
219367|NCT00824720|538606|P1|NOT COMPLETED|Overall Study||3
219368|NCT00824720|538604|P3|COMPLETED|Overall Study||19
219369|NCT00824720|538605|P2|COMPLETED|Overall Study||15
219370|NCT00824720|538606|P1|COMPLETED|Overall Study||16
219371|NCT00824720|538604|P3|STARTED|Overall Study||20
219372|NCT00824720|538605|P2|STARTED|Overall Study|1 subject in the low dose group did not receive device - unable to insert.|16
219373|NCT00824720|538606|P1|STARTED|Overall Study|3 subjects in the high dose group did not receive device - unable to insert.|19
219374|NCT00824733|538620|P1|NOT COMPLETED|Overall Study||0
219375|NCT00824733|538620|P1|COMPLETED|Overall Study||6
219376|NCT00824733|538620|P1|STARTED|Overall Study||6
219377|NCT00824746|538626|P1|NOT COMPLETED|Overall Study||0
219378|NCT00824746|538626|P1|COMPLETED|Overall Study||23
219379|NCT00824746|538626|P1|STARTED|Overall Study||23
219380|NCT00824772|538632|P1|NOT COMPLETED|Overall Study||8
219381|NCT00824772|538632|P1|COMPLETED|Overall Study||196
219382|NCT00824772|538632|P1|STARTED|Overall Study||204
219383|NCT00824824|538639|P2|NOT COMPLETED|Overall Study||0
219384|NCT00824824|538640|P1|NOT COMPLETED|Overall Study||0
219385|NCT00824824|538639|P2|COMPLETED|Overall Study||3
219386|NCT00824824|538640|P1|COMPLETED|Overall Study||4
219387|NCT00824824|538639|P2|STARTED|Overall Study||3
219388|NCT00824824|538640|P1|STARTED|Overall Study||4
219389|NCT00824850|538648|P2|NOT COMPLETED|Overall Study||1
219390|NCT00824850|538649|P1|NOT COMPLETED|Overall Study||0
219391|NCT00824850|538648|P2|COMPLETED|Overall Study||36
219392|NCT00824850|538649|P1|COMPLETED|Overall Study||38
219393|NCT00824850|538648|P2|Received Vaccination 13vPnC|Overall Study||36
219394|NCT00824850|538649|P1|Received Vaccination 13vPnC|Overall Study||38
219395|NCT00824850|538648|P2|STARTED|Overall Study||37
219396|NCT00824850|538649|P1|STARTED|Overall Study||38
219397|NCT00817999|538695|P2|NOT COMPLETED|No Grapefruit Juice||0
219398|NCT00817999|538696|P1|NOT COMPLETED|No Grapefruit Juice||0
219399|NCT00817999|538695|P2|COMPLETED|No Grapefruit Juice||17
219400|NCT00817999|538696|P1|COMPLETED|No Grapefruit Juice||15
219401|NCT00817999|538695|P2|STARTED|No Grapefruit Juice||17
219402|NCT00817999|538696|P1|STARTED|No Grapefruit Juice||15
219403|NCT00817999|538695|P2|NOT COMPLETED|Grapefruit Juice||0
219404|NCT00817999|538696|P1|NOT COMPLETED|Grapefruit Juice||0
219405|NCT00817999|538695|P2|COMPLETED|Grapefruit Juice||17
219406|NCT00817999|538696|P1|COMPLETED|Grapefruit Juice||15
219407|NCT00817999|538695|P2|STARTED|Grapefruit Juice||17
219408|NCT00817999|538696|P1|STARTED|Grapefruit Juice||15
219409|NCT00818116|538704|P1|NOT COMPLETED|Overall Study||0
219410|NCT00818116|538704|P1|COMPLETED|Overall Study||34
219411|NCT00818116|538704|P1|STARTED|Overall Study||34
219412|NCT00818168|538708|P1|NOT COMPLETED|Overall Study||70
219413|NCT00818168|538708|P1|COMPLETED|Overall Study|Includes 78 participants whose completer/non-completer status was not reported (missing)|250
219414|NCT00818168|538708|P1|STARTED|Overall Study||320
219415|NCT00818207|538718|P2|NOT COMPLETED|Overall Study||267
219416|NCT00818207|538719|P1|NOT COMPLETED|Overall Study||222
219417|NCT00818207|538718|P2|COMPLETED|Overall Study||417
219418|NCT00818207|538719|P1|COMPLETED|Overall Study||474
219419|NCT00818207|538718|P2|STARTED|Overall Study||684
219420|NCT00818207|538719|P1|STARTED|Overall Study||696
219421|NCT00818246|538733|P1|NOT COMPLETED|Overall Study||5
219422|NCT00818246|538733|P1|COMPLETED|Overall Study|split-face study|35
219423|NCT00818246|538733|P1|STARTED|Overall Study||40
219424|NCT00818259|538747|P9|NOT COMPLETED|Part V||0
219425|NCT00818259|538748|P8|NOT COMPLETED|Part V||1
219426|NCT00818259|538749|P7|NOT COMPLETED|Part V||0
219427|NCT00818259|538750|P6|NOT COMPLETED|Part V||0
219428|NCT00818259|538751|P5|NOT COMPLETED|Part V||0
219429|NCT00818259|538752|P4|NOT COMPLETED|Part V||0
219430|NCT00818259|538753|P3|NOT COMPLETED|Part V||0
219431|NCT00818259|538754|P2|NOT COMPLETED|Part V||0
219432|NCT00818259|538755|P1|NOT COMPLETED|Part V||0
219433|NCT00818259|538747|P9|COMPLETED|Part V||6
219434|NCT00818259|538748|P8|COMPLETED|Part V||16
219435|NCT00818259|538749|P7|COMPLETED|Part V||0
219436|NCT00818259|538750|P6|COMPLETED|Part V||0
219437|NCT00818259|538751|P5|COMPLETED|Part V||0
219438|NCT00818259|538752|P4|COMPLETED|Part V||0
219439|NCT00818259|538753|P3|COMPLETED|Part V||0
219440|NCT00818259|538754|P2|COMPLETED|Part V||0
219441|NCT00818259|538755|P1|COMPLETED|Part V||0
219442|NCT00818259|538747|P9|STARTED|Part V|Newly enrolled participants|6
219443|NCT00818259|538748|P8|STARTED|Part V|Participants continuing from Part IV|17
219444|NCT00818259|538749|P7|STARTED|Part V||0
219445|NCT00818259|538750|P6|STARTED|Part V||0
219446|NCT00818259|538751|P5|STARTED|Part V||0
219447|NCT00818259|538752|P4|STARTED|Part V||0
219448|NCT00818259|538753|P3|STARTED|Part V||0
219449|NCT00818259|538754|P2|STARTED|Part V||0
219450|NCT00818259|538755|P1|STARTED|Part V||0
219451|NCT00818259|538747|P9|NOT COMPLETED|Part IV||0
219452|NCT00818259|538748|P8|NOT COMPLETED|Part IV||0
219453|NCT00818259|538749|P7|NOT COMPLETED|Part IV||0
219454|NCT00818259|538750|P6|NOT COMPLETED|Part IV||1
219455|NCT00818259|538751|P5|NOT COMPLETED|Part IV||0
219456|NCT00818259|538752|P4|NOT COMPLETED|Part IV||0
219457|NCT00818259|538753|P3|NOT COMPLETED|Part IV||0
219458|NCT00818259|538754|P2|NOT COMPLETED|Part IV||0
219459|NCT00818259|538755|P1|NOT COMPLETED|Part IV||0
219460|NCT00818259|538747|P9|COMPLETED|Part IV||0
219461|NCT00818259|538748|P8|COMPLETED|Part IV||0
219462|NCT00818259|538749|P7|COMPLETED|Part IV||5
219463|NCT00818259|538750|P6|COMPLETED|Part IV||14
219464|NCT00818259|538751|P5|COMPLETED|Part IV||0
219465|NCT00818259|538752|P4|COMPLETED|Part IV||0
219466|NCT00818259|538753|P3|COMPLETED|Part IV||0
219467|NCT00818259|538754|P2|COMPLETED|Part IV||0
219468|NCT00818259|538755|P1|COMPLETED|Part IV||0
219469|NCT00818259|538747|P9|STARTED|Part IV||0
219470|NCT00818259|538748|P8|STARTED|Part IV||0
219471|NCT00818259|538749|P7|STARTED|Part IV|Newly enrolled participants|5
219472|NCT00818259|538750|P6|STARTED|Part IV|Participants continuing from Part III|15
219473|NCT00818259|538751|P5|STARTED|Part IV||0
219474|NCT00818259|538752|P4|STARTED|Part IV||0
219475|NCT00818259|538753|P3|STARTED|Part IV||0
219476|NCT00818259|538754|P2|STARTED|Part IV||0
219477|NCT00818259|538755|P1|STARTED|Part IV||0
219478|NCT00818259|538747|P9|NOT COMPLETED|Part III||0
219479|NCT00818259|538748|P8|NOT COMPLETED|Part III||0
219480|NCT00818259|538749|P7|NOT COMPLETED|Part III||0
219481|NCT00818259|538750|P6|NOT COMPLETED|Part III||0
219482|NCT00818259|538751|P5|NOT COMPLETED|Part III||0
219483|NCT00818259|538752|P4|NOT COMPLETED|Part III||0
219484|NCT00818259|538753|P3|NOT COMPLETED|Part III||0
219485|NCT00818259|538754|P2|NOT COMPLETED|Part III||0
219486|NCT00818259|538755|P1|NOT COMPLETED|Part III||0
219487|NCT00818259|538747|P9|COMPLETED|Part III||0
219488|NCT00818259|538748|P8|COMPLETED|Part III||0
219489|NCT00818259|538749|P7|COMPLETED|Part III||0
219490|NCT00818259|538750|P6|COMPLETED|Part III||0
219491|NCT00818259|538751|P5|COMPLETED|Part III||19
219492|NCT00818259|538752|P4|COMPLETED|Part III||0
219493|NCT00818259|538753|P3|COMPLETED|Part III||0
219494|NCT00818259|538754|P2|COMPLETED|Part III||0
219495|NCT00818259|538755|P1|COMPLETED|Part III||0
219496|NCT00818259|538747|P9|STARTED|Part III||0
219497|NCT00818259|538748|P8|STARTED|Part III||0
219498|NCT00818259|538749|P7|STARTED|Part III||0
219499|NCT00818259|538750|P6|STARTED|Part III||0
219500|NCT00818259|538751|P5|STARTED|Part III|Newly enrolled participants|19
219501|NCT00818259|538752|P4|STARTED|Part III||0
219502|NCT00818259|538753|P3|STARTED|Part III||0
219503|NCT00818259|538754|P2|STARTED|Part III||0
219504|NCT00818259|538755|P1|STARTED|Part III||0
219505|NCT00818259|538747|P9|NOT COMPLETED|Part II||0
219506|NCT00818259|538748|P8|NOT COMPLETED|Part II||0
219507|NCT00818259|538749|P7|NOT COMPLETED|Part II||0
219508|NCT00818259|538750|P6|NOT COMPLETED|Part II||0
219509|NCT00818259|538751|P5|NOT COMPLETED|Part II||0
219510|NCT00818259|538752|P4|NOT COMPLETED|Part II||2
219511|NCT00818259|538753|P3|NOT COMPLETED|Part II||1
219512|NCT00818259|538754|P2|NOT COMPLETED|Part II||0
219513|NCT00818259|538755|P1|NOT COMPLETED|Part II||0
219514|NCT00818259|538747|P9|COMPLETED|Part II||0
219515|NCT00818259|538748|P8|COMPLETED|Part II||0
219516|NCT00818259|538749|P7|COMPLETED|Part II||0
219517|NCT00818259|538750|P6|COMPLETED|Part II||0
219518|NCT00818259|538751|P5|COMPLETED|Part II||0
219519|NCT00818259|538752|P4|COMPLETED|Part II||18
219520|NCT00818259|538753|P3|COMPLETED|Part II||18
219521|NCT00818259|538754|P2|COMPLETED|Part II||0
219522|NCT00818259|538755|P1|COMPLETED|Part II||0
219523|NCT00818259|538747|P9|Treated|Part II||0
219524|NCT00818259|538748|P8|Treated|Part II||0
219525|NCT00818259|538749|P7|Treated|Part II||0
219526|NCT00818259|538750|P6|Treated|Part II||0
219527|NCT00818259|538751|P5|Treated|Part II||0
219528|NCT00818259|538752|P4|Treated|Part II||19
219529|NCT00818259|538753|P3|Treated|Part II||19
219530|NCT00818259|538754|P2|Treated|Part II||0
219531|NCT00818259|538755|P1|Treated|Part II||0
219532|NCT00818259|538747|P9|STARTED|Part II||0
219533|NCT00818259|538748|P8|STARTED|Part II||0
219534|NCT00818259|538749|P7|STARTED|Part II||0
219535|NCT00818259|538750|P6|STARTED|Part II||0
219536|NCT00818259|538751|P5|STARTED|Part II||0
219537|NCT00818259|538752|P4|STARTED|Part II|Newly enrolled participants|20
219538|NCT00818259|538753|P3|STARTED|Part II|Newly enrolled participants|19
219539|NCT00818259|538754|P2|STARTED|Part II||0
219540|NCT00818259|538755|P1|STARTED|Part II||0
219541|NCT00818259|538747|P9|NOT COMPLETED|Part I||0
219542|NCT00818259|538748|P8|NOT COMPLETED|Part I||0
219543|NCT00818259|538749|P7|NOT COMPLETED|Part I||0
219544|NCT00818259|538750|P6|NOT COMPLETED|Part I||0
219545|NCT00818259|538751|P5|NOT COMPLETED|Part I||0
219546|NCT00818259|538752|P4|NOT COMPLETED|Part I||0
219547|NCT00818259|538753|P3|NOT COMPLETED|Part I||0
219548|NCT00818259|538754|P2|NOT COMPLETED|Part I||0
219549|NCT00818259|538755|P1|NOT COMPLETED|Part I||1
219550|NCT00818259|538747|P9|COMPLETED|Part I||0
219551|NCT00818259|538748|P8|COMPLETED|Part I||0
219552|NCT00818259|538749|P7|COMPLETED|Part I||0
219553|NCT00818259|538750|P6|COMPLETED|Part I||0
219554|NCT00818259|538751|P5|COMPLETED|Part I||0
219555|NCT00818259|538752|P4|COMPLETED|Part I||0
219556|NCT00818259|538753|P3|COMPLETED|Part I||0
219557|NCT00818259|538754|P2|COMPLETED|Part I||11
219558|NCT00818259|538755|P1|COMPLETED|Part I||11
219559|NCT00818259|538747|P9|STARTED|Part I||0
219560|NCT00818259|538748|P8|STARTED|Part I||0
219561|NCT00818259|538749|P7|STARTED|Part I||0
219562|NCT00818259|538750|P6|STARTED|Part I||0
219563|NCT00818259|538751|P5|STARTED|Part I||0
219564|NCT00818259|538752|P4|STARTED|Part I||0
219565|NCT00818259|538753|P3|STARTED|Part I||0
219566|NCT00818259|538754|P2|STARTED|Part I|Newly enrolled participants|11
219567|NCT00818259|538755|P1|STARTED|Part I|Newly enrolled participants|12
219568|NCT00818259|538747|P9|NOT COMPLETED|Randomization||0
219569|NCT00818259|538748|P8|NOT COMPLETED|Randomization||0
219570|NCT00818259|538749|P7|NOT COMPLETED|Randomization||0
219571|NCT00818259|538750|P6|NOT COMPLETED|Randomization||0
219572|NCT00818259|538751|P5|NOT COMPLETED|Randomization||0
219573|NCT00818259|538752|P4|NOT COMPLETED|Randomization||0
219574|NCT00818259|538753|P3|NOT COMPLETED|Randomization||0
219575|NCT00818259|538754|P2|NOT COMPLETED|Randomization||0
219576|NCT00818259|538755|P1|NOT COMPLETED|Randomization||0
219577|NCT00818259|538747|P9|COMPLETED|Randomization||6
219578|NCT00818259|538748|P8|COMPLETED|Randomization||0
219579|NCT00818259|538749|P7|COMPLETED|Randomization||5
219580|NCT00818259|538750|P6|COMPLETED|Randomization||0
219581|NCT00818259|538751|P5|COMPLETED|Randomization||19
219582|NCT00818259|538752|P4|COMPLETED|Randomization||20
219583|NCT00818259|538753|P3|COMPLETED|Randomization||19
219584|NCT00818259|538754|P2|COMPLETED|Randomization||11
219585|NCT00818259|538755|P1|COMPLETED|Randomization||12
219586|NCT00818259|538747|P9|STARTED|Randomization||6
219587|NCT00818259|538748|P8|STARTED|Randomization||0
219588|NCT00818259|538749|P7|STARTED|Randomization||5
219589|NCT00818259|538750|P6|STARTED|Randomization||0
219590|NCT00818259|538751|P5|STARTED|Randomization||19
219591|NCT00818259|538752|P4|STARTED|Randomization||20
219592|NCT00818259|538753|P3|STARTED|Randomization||19
219593|NCT00818259|538754|P2|STARTED|Randomization||11
219594|NCT00818259|538755|P1|STARTED|Randomization||12
219595|NCT00818272|538827|P1|NOT COMPLETED|Overall Study||74
219596|NCT00818272|538827|P1|COMPLETED|Overall Study||74
219597|NCT00818272|538827|P1|STARTED|Overall Study||148
219598|NCT00818324|538835|P1|NOT COMPLETED|Overall Study||27
219599|NCT00818324|538835|P1|COMPLETED|Overall Study||127
219600|NCT00818324|538835|P1|STARTED|Overall Study||154
219601|NCT00818337|538840|P1|NOT COMPLETED|Overall Study||0
219602|NCT00818337|538840|P1|COMPLETED|Overall Study||36
219603|NCT00818337|538840|P1|STARTED|Overall Study||36
219604|NCT00818389|538847|P2|NOT COMPLETED|Overall Study||6
219605|NCT00818389|538848|P1|NOT COMPLETED|Overall Study||4
219606|NCT00818389|538847|P2|COMPLETED|Overall Study|6 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|38
219607|NCT00818389|538848|P1|COMPLETED|Overall Study|4 subjects terminated study early before 1st interim analysis. Study terminated early for futility.|36
219608|NCT00818389|538847|P2|STARTED|Overall Study||44
219609|NCT00818389|538848|P1|STARTED|Overall Study||40
219610|NCT00818441|538860|P2|NOT COMPLETED|Overall Study||30
219611|NCT00818441|538861|P1|NOT COMPLETED|Overall Study||89
219612|NCT00818441|538860|P2|COMPLETED|Overall Study||0
219613|NCT00818441|538861|P1|COMPLETED|Overall Study||0
219614|NCT00818441|538860|P2|STARTED|Overall Study||30
219615|NCT00818441|538861|P1|STARTED|Overall Study||89
219616|NCT00818454|538881|P4|NOT COMPLETED|Treatment Period 3||1
219617|NCT00818454|538882|P3|NOT COMPLETED|Treatment Period 3||0
219618|NCT00818454|538883|P2|NOT COMPLETED|Treatment Period 3||0
219619|NCT00818454|538884|P1|NOT COMPLETED|Treatment Period 3||0
219620|NCT00818454|538881|P4|COMPLETED|Treatment Period 3||138
219621|NCT00818454|538882|P3|COMPLETED|Treatment Period 3||26
219622|NCT00818454|538883|P2|COMPLETED|Treatment Period 3||0
219623|NCT00818454|538884|P1|COMPLETED|Treatment Period 3||0
219624|NCT00818454|538881|P4|STARTED|Treatment Period 3||139
219625|NCT00818454|538882|P3|STARTED|Treatment Period 3||26
219626|NCT00818454|538883|P2|STARTED|Treatment Period 3||0
219627|NCT00818454|538884|P1|STARTED|Treatment Period 3||0
219628|NCT00818454|538881|P4|NOT COMPLETED|Treatment Period 2||0
219629|NCT00818454|538882|P3|NOT COMPLETED|Treatment Period 2||0
219630|NCT00818454|538883|P2|NOT COMPLETED|Treatment Period 2||1
219631|NCT00818454|538884|P1|NOT COMPLETED|Treatment Period 2||2
219632|NCT00818454|538881|P4|COMPLETED|Treatment Period 2||0
219633|NCT00818454|538882|P3|COMPLETED|Treatment Period 2||0
219634|NCT00818454|538883|P2|COMPLETED|Treatment Period 2||106
219635|NCT00818454|538884|P1|COMPLETED|Treatment Period 2||106
219636|NCT00818454|538881|P4|STARTED|Treatment Period 2||0
219637|NCT00818454|538882|P3|STARTED|Treatment Period 2||0
219638|NCT00818454|538883|P2|STARTED|Treatment Period 2||107
219639|NCT00818454|538884|P1|STARTED|Treatment Period 2||108
219640|NCT00818454|538881|P4|NOT COMPLETED|Washout Period of 1 Week||0
219641|NCT00818454|538882|P3|NOT COMPLETED|Washout Period of 1 Week||0
219642|NCT00818454|538883|P2|NOT COMPLETED|Washout Period of 1 Week||3
219643|NCT00818454|538884|P1|NOT COMPLETED|Washout Period of 1 Week||4
219644|NCT00818454|538881|P4|COMPLETED|Washout Period of 1 Week||0
219645|NCT00818454|538882|P3|COMPLETED|Washout Period of 1 Week||0
219646|NCT00818454|538883|P2|COMPLETED|Washout Period of 1 Week||107
219647|NCT00818454|538884|P1|COMPLETED|Washout Period of 1 Week||108
219648|NCT00818454|538881|P4|STARTED|Washout Period of 1 Week||0
219649|NCT00818454|538882|P3|STARTED|Washout Period of 1 Week||0
219650|NCT00818454|538883|P2|STARTED|Washout Period of 1 Week||110
219651|NCT00818454|538884|P1|STARTED|Washout Period of 1 Week||112
219652|NCT00818454|538881|P4|NOT COMPLETED|Treatment Period 1||0
219653|NCT00818454|538882|P3|NOT COMPLETED|Treatment Period 1||0
219654|NCT00818454|538883|P2|NOT COMPLETED|Treatment Period 1||1
219655|NCT00818454|538884|P1|NOT COMPLETED|Treatment Period 1||3
219656|NCT00818454|538881|P4|COMPLETED|Treatment Period 1||0
219657|NCT00818454|538882|P3|COMPLETED|Treatment Period 1||0
219658|NCT00818454|538883|P2|COMPLETED|Treatment Period 1||110
219659|NCT00818454|538884|P1|COMPLETED|Treatment Period 1||112
219660|NCT00818454|538881|P4|STARTED|Treatment Period 1||0
219661|NCT00818454|538882|P3|STARTED|Treatment Period 1||0
219662|NCT00818454|538883|P2|STARTED|Treatment Period 1||111
219663|NCT00818454|538884|P1|STARTED|Treatment Period 1||115
219664|NCT00825162|538913|P3|NOT COMPLETED|Overall Study||6
219665|NCT00825162|538914|P2|NOT COMPLETED|Overall Study||21
219666|NCT00825162|538915|P1|NOT COMPLETED|Overall Study||28
219667|NCT00825162|538913|P3|COMPLETED|Overall Study||396
219668|NCT00825162|538914|P2|COMPLETED|Overall Study||859
219669|NCT00825162|538915|P1|COMPLETED|Overall Study||682
219670|NCT00825162|538913|P3|STARTED|Overall Study||402
219671|NCT00825162|538914|P2|STARTED|Overall Study||880
219672|NCT00825162|538915|P1|STARTED|Overall Study||710
219673|NCT00825175|538941|P2|NOT COMPLETED|Overall Study||5
219674|NCT00825175|538942|P1|NOT COMPLETED|Overall Study||0
219675|NCT00825175|538941|P2|COMPLETED|Overall Study||7
219676|NCT00825175|538942|P1|COMPLETED|Overall Study||10
219677|NCT00825175|538941|P2|STARTED|Overall Study||12
219678|NCT00825175|538942|P1|STARTED|Overall Study||10
219679|NCT00825565|538948|P1|NOT COMPLETED|Overall Study||0
219680|NCT00825565|538948|P1|COMPLETED|Overall Study||8
219681|NCT00825565|538948|P1|STARTED|Overall Study||8
219682|NCT00825630|538957|P4|NOT COMPLETED|Overall Study||0
219683|NCT00825630|538958|P3|NOT COMPLETED|Overall Study||0
219684|NCT00825630|538959|P2|NOT COMPLETED|Overall Study||0
219685|NCT00825630|538960|P1|NOT COMPLETED|Overall Study||0
219686|NCT00825630|538957|P4|COMPLETED|Overall Study||13
219687|NCT00825630|538958|P3|COMPLETED|Overall Study||19
219688|NCT00825630|538959|P2|COMPLETED|Overall Study||62
219689|NCT00825630|538960|P1|COMPLETED|Overall Study||29
219690|NCT00825630|538957|P4|STARTED|Overall Study||13
219691|NCT00825630|538958|P3|STARTED|Overall Study||19
219692|NCT00825630|538959|P2|STARTED|Overall Study||62
219693|NCT00825630|538960|P1|STARTED|Overall Study||29
219694|NCT00825682|538972|P2|NOT COMPLETED|Overall Study||5
219695|NCT00825682|538973|P1|NOT COMPLETED|Overall Study||13
219696|NCT00825682|538972|P2|COMPLETED|Overall Study||20
219697|NCT00825682|538973|P1|COMPLETED|Overall Study||34
219698|NCT00825682|538972|P2|STARTED|Overall Study||25
219699|NCT00825682|538973|P1|STARTED|Overall Study||47
219700|NCT00825734|538983|P3|NOT COMPLETED|Phase II||76
219701|NCT00825734|538984|P2|NOT COMPLETED|Phase II||0
219702|NCT00825734|538985|P1|NOT COMPLETED|Phase II||0
219703|NCT00825734|538983|P3|COMPLETED|Phase II||0
219704|NCT00825734|538984|P2|COMPLETED|Phase II||0
219705|NCT00825734|538985|P1|COMPLETED|Phase II||0
219706|NCT00825734|538983|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I and 73 additional patients enrolled for Phase II|76
219707|NCT00825734|538984|P2|STARTED|Phase II||0
219708|NCT00825734|538985|P1|STARTED|Phase II||0
219709|NCT00825734|538983|P3|NOT COMPLETED|Phase I||0
219710|NCT00825734|538984|P2|NOT COMPLETED|Phase I||3
219711|NCT00825734|538985|P1|NOT COMPLETED|Phase I||4
219712|NCT00825734|538983|P3|COMPLETED|Phase I||3
219882|NCT00826280|539197|P1|NOT COMPLETED|Overall Study||48
219713|NCT00825734|538984|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
219714|NCT00825734|538985|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
219715|NCT00825734|538983|P3|STARTED|Phase I||3
219716|NCT00825734|538984|P2|STARTED|Phase I||3
219717|NCT00825734|538985|P1|STARTED|Phase I||4
219718|NCT00825786|538995|P2|NOT COMPLETED|Overall Study||0
219719|NCT00825786|538996|P1|NOT COMPLETED|Overall Study||0
219720|NCT00825786|538995|P2|COMPLETED|Overall Study||51
219721|NCT00825786|538996|P1|COMPLETED|Overall Study||52
219722|NCT00825786|538995|P2|STARTED|Overall Study||51
219723|NCT00825786|538996|P1|STARTED|Overall Study||52
219724|NCT00825812|539018|P4|NOT COMPLETED|Overall Study||10
219725|NCT00825812|539019|P3|NOT COMPLETED|Overall Study||6
219726|NCT00825812|539020|P2|NOT COMPLETED|Overall Study||1
219727|NCT00825812|539021|P1|NOT COMPLETED|Overall Study||0
219728|NCT00825812|539018|P4|COMPLETED|Overall Study||111
219729|NCT00825812|539019|P3|COMPLETED|Overall Study||120
219730|NCT00825812|539020|P2|COMPLETED|Overall Study||31
219731|NCT00825812|539021|P1|COMPLETED|Overall Study||29
219732|NCT00825812|539018|P4|TREATED|Overall Study||111
219733|NCT00825812|539019|P3|TREATED|Overall Study||120
219734|NCT00825812|539020|P2|TREATED|Overall Study||31
219735|NCT00825812|539021|P1|TREATED|Overall Study||29
219736|NCT00825812|539018|P4|STARTED|Overall Study||121
219737|NCT00825812|539019|P3|STARTED|Overall Study||126
219738|NCT00825812|539020|P2|STARTED|Overall Study||32
219739|NCT00825812|539021|P1|STARTED|Overall Study||29
219740|NCT00825825|539035|P6|NOT COMPLETED|Third Medication Period (14 Days)||2
219741|NCT00825825|539036|P5|NOT COMPLETED|Third Medication Period (14 Days)||0
219742|NCT00825825|539037|P4|NOT COMPLETED|Third Medication Period (14 Days)||0
219743|NCT00825825|539038|P3|NOT COMPLETED|Third Medication Period (14 Days)||0
219744|NCT00825825|539039|P2|NOT COMPLETED|Third Medication Period (14 Days)||2
219745|NCT00825825|539040|P1|NOT COMPLETED|Third Medication Period (14 Days)||0
219746|NCT00825825|539035|P6|COMPLETED|Third Medication Period (14 Days)||1
219747|NCT00825825|539036|P5|COMPLETED|Third Medication Period (14 Days)||3
219748|NCT00825825|539037|P4|COMPLETED|Third Medication Period (14 Days)||3
219749|NCT00825825|539038|P3|COMPLETED|Third Medication Period (14 Days)||2
219750|NCT00825825|539039|P2|COMPLETED|Third Medication Period (14 Days)||2
219751|NCT00825825|539040|P1|COMPLETED|Third Medication Period (14 Days)||1
219752|NCT00825825|539035|P6|STARTED|Third Medication Period (14 Days)||3
219753|NCT00825825|539036|P5|STARTED|Third Medication Period (14 Days)||3
219754|NCT00825825|539037|P4|STARTED|Third Medication Period (14 Days)||3
219755|NCT00825825|539038|P3|STARTED|Third Medication Period (14 Days)||2
219756|NCT00825825|539039|P2|STARTED|Third Medication Period (14 Days)||4
219757|NCT00825825|539040|P1|STARTED|Third Medication Period (14 Days)||1
219758|NCT00825825|539035|P6|NOT COMPLETED|Second Washout Period (14 Days)||0
219759|NCT00825825|539036|P5|NOT COMPLETED|Second Washout Period (14 Days)||0
219760|NCT00825825|539037|P4|NOT COMPLETED|Second Washout Period (14 Days)||0
219761|NCT00825825|539038|P3|NOT COMPLETED|Second Washout Period (14 Days)||0
219762|NCT00825825|539039|P2|NOT COMPLETED|Second Washout Period (14 Days)||0
219763|NCT00825825|539040|P1|NOT COMPLETED|Second Washout Period (14 Days)||0
219764|NCT00825825|539035|P6|COMPLETED|Second Washout Period (14 Days)||3
219765|NCT00825825|539036|P5|COMPLETED|Second Washout Period (14 Days)||3
219766|NCT00825825|539037|P4|COMPLETED|Second Washout Period (14 Days)||3
219767|NCT00825825|539038|P3|COMPLETED|Second Washout Period (14 Days)||2
219768|NCT00825825|539039|P2|COMPLETED|Second Washout Period (14 Days)||4
219769|NCT00825825|539040|P1|COMPLETED|Second Washout Period (14 Days)||1
219770|NCT00825825|539035|P6|STARTED|Second Washout Period (14 Days)||3
219771|NCT00825825|539036|P5|STARTED|Second Washout Period (14 Days)||3
219772|NCT00825825|539037|P4|STARTED|Second Washout Period (14 Days)||3
219773|NCT00825825|539038|P3|STARTED|Second Washout Period (14 Days)||2
219774|NCT00825825|539039|P2|STARTED|Second Washout Period (14 Days)||4
219775|NCT00825825|539040|P1|STARTED|Second Washout Period (14 Days)||1
219776|NCT00825825|539035|P6|NOT COMPLETED|Second Medication Period (14 Days)||0
219777|NCT00825825|539036|P5|NOT COMPLETED|Second Medication Period (14 Days)||1
219778|NCT00825825|539037|P4|NOT COMPLETED|Second Medication Period (14 Days)||2
219779|NCT00825825|539038|P3|NOT COMPLETED|Second Medication Period (14 Days)||0
219780|NCT00825825|539039|P2|NOT COMPLETED|Second Medication Period (14 Days)||0
219781|NCT00825825|539040|P1|NOT COMPLETED|Second Medication Period (14 Days)||2
219782|NCT00825825|539035|P6|COMPLETED|Second Medication Period (14 Days)||3
219783|NCT00825825|539036|P5|COMPLETED|Second Medication Period (14 Days)||3
219784|NCT00825825|539037|P4|COMPLETED|Second Medication Period (14 Days)||3
219785|NCT00825825|539038|P3|COMPLETED|Second Medication Period (14 Days)||2
219786|NCT00825825|539039|P2|COMPLETED|Second Medication Period (14 Days)||4
219787|NCT00825825|539040|P1|COMPLETED|Second Medication Period (14 Days)||1
219788|NCT00825825|539035|P6|STARTED|Second Medication Period (14 Days)||3
219789|NCT00825825|539036|P5|STARTED|Second Medication Period (14 Days)||4
219790|NCT00825825|539037|P4|STARTED|Second Medication Period (14 Days)||5
219791|NCT00825825|539038|P3|STARTED|Second Medication Period (14 Days)||2
219792|NCT00825825|539039|P2|STARTED|Second Medication Period (14 Days)||4
219793|NCT00825825|539040|P1|STARTED|Second Medication Period (14 Days)||3
219794|NCT00825825|539035|P6|NOT COMPLETED|First Washout Period (14 Days)||0
219795|NCT00825825|539036|P5|NOT COMPLETED|First Washout Period (14 Days)||0
219796|NCT00825825|539037|P4|NOT COMPLETED|First Washout Period (14 Days)||0
219797|NCT00825825|539038|P3|NOT COMPLETED|First Washout Period (14 Days)||0
219798|NCT00825825|539039|P2|NOT COMPLETED|First Washout Period (14 Days)||0
219799|NCT00825825|539040|P1|NOT COMPLETED|First Washout Period (14 Days)||0
219800|NCT00825825|539035|P6|COMPLETED|First Washout Period (14 Days)||3
219801|NCT00825825|539036|P5|COMPLETED|First Washout Period (14 Days)||4
219802|NCT00825825|539037|P4|COMPLETED|First Washout Period (14 Days)||5
219803|NCT00825825|539038|P3|COMPLETED|First Washout Period (14 Days)||2
219804|NCT00825825|539039|P2|COMPLETED|First Washout Period (14 Days)||4
219805|NCT00825825|539040|P1|COMPLETED|First Washout Period (14 Days)||3
219806|NCT00825825|539035|P6|STARTED|First Washout Period (14 Days)||3
219807|NCT00825825|539036|P5|STARTED|First Washout Period (14 Days)||4
219808|NCT00825825|539037|P4|STARTED|First Washout Period (14 Days)||5
219809|NCT00825825|539038|P3|STARTED|First Washout Period (14 Days)||2
219810|NCT00825825|539039|P2|STARTED|First Washout Period (14 Days)||4
219811|NCT00825825|539040|P1|STARTED|First Washout Period (14 Days)||3
219812|NCT00825825|539035|P6|NOT COMPLETED|First Medication Period (14 Days)||2
219813|NCT00825825|539036|P5|NOT COMPLETED|First Medication Period (14 Days)||0
219814|NCT00825825|539037|P4|NOT COMPLETED|First Medication Period (14 Days)||0
219815|NCT00825825|539038|P3|NOT COMPLETED|First Medication Period (14 Days)||1
219816|NCT00825825|539039|P2|NOT COMPLETED|First Medication Period (14 Days)||0
219817|NCT00825825|539040|P1|NOT COMPLETED|First Medication Period (14 Days)||3
219818|NCT00825825|539035|P6|COMPLETED|First Medication Period (14 Days)||3
219819|NCT00825825|539036|P5|COMPLETED|First Medication Period (14 Days)||4
219820|NCT00825825|539037|P4|COMPLETED|First Medication Period (14 Days)||5
219821|NCT00825825|539038|P3|COMPLETED|First Medication Period (14 Days)||2
219822|NCT00825825|539039|P2|COMPLETED|First Medication Period (14 Days)||4
219823|NCT00825825|539040|P1|COMPLETED|First Medication Period (14 Days)||3
219824|NCT00825825|539035|P6|STARTED|First Medication Period (14 Days)||5
219825|NCT00825825|539036|P5|STARTED|First Medication Period (14 Days)||4
219826|NCT00825825|539037|P4|STARTED|First Medication Period (14 Days)||5
219827|NCT00825825|539038|P3|STARTED|First Medication Period (14 Days)||3
219828|NCT00825825|539039|P2|STARTED|First Medication Period (14 Days)||4
219829|NCT00825825|539040|P1|STARTED|First Medication Period (14 Days)||6
219830|NCT00825916|539055|P3|NOT COMPLETED|Overall Study||1
219831|NCT00825916|539056|P2|NOT COMPLETED|Overall Study||2
219832|NCT00825916|539057|P1|NOT COMPLETED|Overall Study||4
219833|NCT00825916|539055|P3|COMPLETED|Overall Study||19
219834|NCT00825916|539056|P2|COMPLETED|Overall Study||18
219835|NCT00825916|539057|P1|COMPLETED|Overall Study||15
219836|NCT00825916|539055|P3|STARTED|Overall Study||20
219837|NCT00825916|539056|P2|STARTED|Overall Study||20
219838|NCT00825916|539057|P1|STARTED|Overall Study||19
219839|NCT00825994|539098|P1|NOT COMPLETED|Overall Study||5
219840|NCT00825994|539098|P1|COMPLETED|Overall Study||19
219841|NCT00825994|539098|P1|STARTED|Overall Study||24
219842|NCT00826007|539105|P2|NOT COMPLETED|Overall Study||0
219843|NCT00826007|539106|P1|NOT COMPLETED|Overall Study||0
219844|NCT00826007|539105|P2|COMPLETED|Overall Study||279
219845|NCT00826007|539106|P1|COMPLETED|Overall Study|Retrospective review|308
219846|NCT00826007|539105|P2|STARTED|Overall Study||279
219847|NCT00826007|539106|P1|STARTED|Overall Study|Retrospective review|308
219848|NCT00826111|539113|P2|NOT COMPLETED|Overall Study||2
219849|NCT00826111|539114|P1|NOT COMPLETED|Overall Study||7
219850|NCT00826111|539113|P2|COMPLETED|Overall Study||3
219851|NCT00826111|539114|P1|COMPLETED|Overall Study||7
219852|NCT00826111|539113|P2|STARTED|Overall Study||5
219853|NCT00826111|539114|P1|STARTED|Overall Study||14
219854|NCT00826176|539138|P2|NOT COMPLETED|Overall Study||0
219855|NCT00826176|539139|P1|NOT COMPLETED|Overall Study||13
219856|NCT00826176|539138|P2|COMPLETED|Overall Study|treated and completed|36
219857|NCT00826176|539139|P1|COMPLETED|Overall Study|treated and completed|115
219858|NCT00826176|539138|P2|STARTED|Overall Study|enrolled|36
219859|NCT00826176|539139|P1|STARTED|Overall Study|enrolled|128
219860|NCT00826202|539151|P2|NOT COMPLETED|Overall Study||13
219861|NCT00826202|539152|P1|NOT COMPLETED|Overall Study||10
219862|NCT00826202|539151|P2|COMPLETED|Overall Study||11
219863|NCT00826202|539152|P1|COMPLETED|Overall Study||10
219864|NCT00826202|539151|P2|Completed Visit 4 (1st Efficacy Visit)|Overall Study||20
219865|NCT00826202|539152|P1|Completed Visit 4 (1st Efficacy Visit)|Overall Study||15
219866|NCT00826202|539151|P2|STARTED|Overall Study||24
219867|NCT00826202|539152|P1|STARTED|Overall Study||20
219868|NCT00826228|539164|P1|NOT COMPLETED|Overall Study||1
219869|NCT00826228|539164|P1|COMPLETED|Overall Study||11
219870|NCT00826228|539164|P1|STARTED|Overall Study||12
219871|NCT00826267|539172|P3|NOT COMPLETED|Overall Study||0
219872|NCT00826267|539173|P2|NOT COMPLETED|Overall Study||0
219873|NCT00826267|539174|P1|NOT COMPLETED|Overall Study||1
219874|NCT00826267|539172|P3|COMPLETED|Overall Study||11
219875|NCT00826267|539173|P2|COMPLETED|Overall Study||8
219876|NCT00826267|539174|P1|COMPLETED|Overall Study||9
219877|NCT00826267|539172|P3|STARTED|Overall Study||11
219878|NCT00826267|539173|P2|STARTED|Overall Study||8
219879|NCT00826267|539174|P1|STARTED|Overall Study||10
219880|NCT00826280|539195|P3|NOT COMPLETED|Overall Study||46
219881|NCT00826280|539196|P2|NOT COMPLETED|Overall Study||46
219883|NCT00826280|539195|P3|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|71
219884|NCT00826280|539196|P2|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|70
219885|NCT00826280|539197|P1|COMPLETED|Overall Study|Ending Population equals FAS, all randomized subjects with interpretable MPI scans|66
219886|NCT00826280|539195|P3|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|72
219887|NCT00826280|539196|P2|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|71
219888|NCT00826280|539197|P1|Completed Treatment|Overall Study|Subjects who completed treatment but had ≥ 1 non-interpretable scan were not included in FAS|66
219889|NCT00826280|539195|P3|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
219890|NCT00826280|539196|P2|Safety Analysis Set|Overall Study|SAF was all randomized subjects who received at least one dose of regadenoson|116
219891|NCT00826280|539197|P1|Safety Analysis Set|Overall Study|Safety Analysis Set (SAF) was all randomized subjects who received at least one dose of regadenoson|113
219892|NCT00826280|539195|P3|STARTED|Overall Study||117
219893|NCT00826280|539196|P2|STARTED|Overall Study||116
219894|NCT00826280|539197|P1|STARTED|Overall Study||114
219895|NCT00826449|539225|P1|NOT COMPLETED|Overall Study||5
219896|NCT00826449|539225|P1|COMPLETED|Overall Study||42
219897|NCT00826449|539225|P1|Phase II|Overall Study||35
219898|NCT00826449|539225|P1|Phase I|Overall Study||12
219899|NCT00826449|539225|P1|STARTED|Overall Study||47
219900|NCT00826540|539231|P1|NOT COMPLETED|Overall Study||4
219901|NCT00826540|539231|P1|COMPLETED|Overall Study||79
219902|NCT00826540|539231|P1|STARTED|Overall Study||83
219903|NCT00826618|539235|P1|NOT COMPLETED|Overall Study||1
219904|NCT00826618|539235|P1|COMPLETED|Overall Study||5
219905|NCT00826618|539235|P1|STARTED|Overall Study||6
219906|NCT00826800|539239|P1|NOT COMPLETED|Overall Study||0
219907|NCT00826800|539239|P1|COMPLETED|Overall Study||2
219908|NCT00826800|539239|P1|STARTED|Overall Study||2
219909|NCT00826943|539243|P6|NOT COMPLETED|Overall Study||0
219910|NCT00826943|539244|P5|NOT COMPLETED|Overall Study||1
219911|NCT00826943|539245|P4|NOT COMPLETED|Overall Study||0
219912|NCT00826943|539246|P3|NOT COMPLETED|Overall Study||0
219913|NCT00826943|539247|P2|NOT COMPLETED|Overall Study||0
219914|NCT00826943|539248|P1|NOT COMPLETED|Overall Study||0
219915|NCT00826943|539243|P6|COMPLETED|Overall Study||2
219916|NCT00826943|539244|P5|COMPLETED|Overall Study||6
219917|NCT00826943|539245|P4|COMPLETED|Overall Study||5
219918|NCT00826943|539246|P3|COMPLETED|Overall Study||4
219919|NCT00826943|539247|P2|COMPLETED|Overall Study||6
219920|NCT00826943|539248|P1|COMPLETED|Overall Study||6
219921|NCT00826943|539243|P6|STARTED|Overall Study||2
219922|NCT00826943|539244|P5|STARTED|Overall Study||7
219923|NCT00826943|539245|P4|STARTED|Overall Study||5
219924|NCT00826943|539246|P3|STARTED|Overall Study||4
219925|NCT00826943|539247|P2|STARTED|Overall Study||6
219926|NCT00826943|539248|P1|STARTED|Overall Study||6
219927|NCT00827073|539264|P2|NOT COMPLETED|Overall Study||0
219928|NCT00827073|539265|P1|NOT COMPLETED|Overall Study||0
219929|NCT00827073|539264|P2|COMPLETED|Overall Study||20
219930|NCT00827073|539265|P1|COMPLETED|Overall Study||20
219931|NCT00827073|539264|P2|STARTED|Overall Study||20
219932|NCT00827073|539265|P1|STARTED|Overall Study||20
219933|NCT00827099|539273|P1|NOT COMPLETED|Overall Study||0
219934|NCT00827099|539273|P1|COMPLETED|Overall Study||5
219935|NCT00827099|539273|P1|STARTED|Overall Study||5
219936|NCT00827112|539284|P2|NOT COMPLETED|Overall Study||12
219937|NCT00827112|539285|P1|NOT COMPLETED|Overall Study||15
219938|NCT00827112|539284|P2|COMPLETED|Overall Study||52
219939|NCT00827112|539285|P1|COMPLETED|Overall Study||50
219940|NCT00827112|539284|P2|Treated|Overall Study||61
219941|NCT00827112|539285|P1|Treated|Overall Study||60
219942|NCT00827112|539284|P2|STARTED|Overall Study||64
219943|NCT00827112|539285|P1|STARTED|Overall Study||65
219944|NCT00827242|539320|P2|NOT COMPLETED|Overall Study||12
219945|NCT00827242|539321|P1|NOT COMPLETED|Overall Study||13
219946|NCT00827242|539320|P2|COMPLETED|Overall Study||152
219947|NCT00827242|539321|P1|COMPLETED|Overall Study||148
219948|NCT00827242|539320|P2|STARTED|Overall Study||164
219949|NCT00827242|539321|P1|STARTED|Overall Study||161
219950|NCT00827255|539357|P1|NOT COMPLETED|Overall Study||0
219951|NCT00827255|539357|P1|COMPLETED|Overall Study||35
219952|NCT00827255|539357|P1|STARTED|Overall Study||35
219953|NCT00827372|539362|P1|NOT COMPLETED|Overall Study||8
219954|NCT00827372|539362|P1|COMPLETED|Overall Study||2
219955|NCT00827372|539362|P1|STARTED|Overall Study||10
219956|NCT00827502|539370|P1|NOT COMPLETED|Overall Study||21
219957|NCT00827502|539370|P1|COMPLETED|Overall Study||400
219958|NCT00827502|539370|P1|Received Treatment (Number Treated)|Overall Study||410
219959|NCT00827502|539370|P1|STARTED|Overall Study||421
219960|NCT00827541|539378|P2|NOT COMPLETED|Overall Study||11
219961|NCT00827541|539379|P1|NOT COMPLETED|Overall Study||4
219962|NCT00827541|539378|P2|COMPLETED|Overall Study||85
219963|NCT00827541|539379|P1|COMPLETED|Overall Study||15
219964|NCT00827541|539378|P2|STARTED|Overall Study||96
219965|NCT00827541|539379|P1|STARTED|Overall Study||19
219966|NCT00827567|539391|P1|NOT COMPLETED|Overall Study||4
219967|NCT00827567|539391|P1|COMPLETED|Overall Study|2 screen failures, 4 withdrew from study to go on to other therapies|0
219968|NCT00827567|539391|P1|STARTED|Overall Study||4
219969|NCT00827606|539397|P2|NOT COMPLETED|Overall Study||38
219970|NCT00827606|539398|P1|NOT COMPLETED|Overall Study||27
219971|NCT00827606|539397|P2|COMPLETED|Overall Study||94
219972|NCT00827606|539398|P1|COMPLETED|Overall Study||112
219973|NCT00827606|539397|P2|STARTED|Overall Study||132
219974|NCT00827606|539398|P1|STARTED|Overall Study||139
219975|NCT00827632|539461|P2|NOT COMPLETED|Overall Study||23
219976|NCT00827632|539462|P1|NOT COMPLETED|Overall Study||22
219977|NCT00827632|539461|P2|COMPLETED|Overall Study||75
219978|NCT00827632|539462|P1|COMPLETED|Overall Study||106
219979|NCT00827632|539461|P2|STARTED|Overall Study||98
219980|NCT00827632|539462|P1|STARTED|Overall Study||128
219981|NCT00827827|539470|P2|NOT COMPLETED|Overall Study||0
219982|NCT00827827|539471|P1|NOT COMPLETED|Overall Study||8
219983|NCT00827827|539470|P2|COMPLETED|Overall Study||16
219984|NCT00827827|539471|P1|COMPLETED|Overall Study||14
219985|NCT00827827|539470|P2|STARTED|Overall Study||16
219986|NCT00827827|539471|P1|STARTED|Overall Study||22
219987|NCT00827918|539516|P3|NOT COMPLETED|Overall Study||21
219988|NCT00827918|539517|P2|NOT COMPLETED|Overall Study||9
219989|NCT00827918|539518|P1|NOT COMPLETED|Overall Study||28
219990|NCT00827918|539516|P3|COMPLETED|Overall Study||62
219991|NCT00827918|539517|P2|COMPLETED|Overall Study||38
219992|NCT00827918|539518|P1|COMPLETED|Overall Study||58
219993|NCT00827918|539516|P3|STARTED|Overall Study||83
219994|NCT00827918|539517|P2|STARTED|Overall Study||47
219995|NCT00827918|539518|P1|STARTED|Overall Study||86
219996|NCT00827931|539546|P2|NOT COMPLETED|Overall Study||6
219997|NCT00827931|539547|P1|NOT COMPLETED|Overall Study||6
219998|NCT00827931|539546|P2|COMPLETED|Overall Study||39
219999|NCT00827931|539547|P1|COMPLETED|Overall Study||43
220000|NCT00827931|539546|P2|STARTED|Overall Study||45
220001|NCT00827931|539547|P1|STARTED|Overall Study||49
220002|NCT00827944|539567|P2|NOT COMPLETED|Overall Study||59
220003|NCT00827944|539568|P1|NOT COMPLETED|Overall Study||63
220004|NCT00827944|539567|P2|COMPLETED|Overall Study||240
220005|NCT00827944|539568|P1|COMPLETED|Overall Study||241
220006|NCT00827944|539567|P2|STARTED|Overall Study||299
220007|NCT00827944|539568|P1|STARTED|Overall Study||304
220008|NCT00827983|539588|P2|NOT COMPLETED|Overall Study||16
220009|NCT00827983|539589|P1|NOT COMPLETED|Overall Study||18
220010|NCT00827983|539588|P2|COMPLETED|Overall Study|patients who performed the pregnancy test|328
220011|NCT00827983|539589|P1|COMPLETED|Overall Study|patients who performed the pregnancy test|321
220012|NCT00827983|539588|P2|STARTED|Overall Study|all randomised patients|344
220013|NCT00827983|539589|P1|STARTED|Overall Study|All randomised patients|339
220014|NCT00821431|539601|P2|NOT COMPLETED|Overall Study||5
220015|NCT00821431|539602|P1|NOT COMPLETED|Overall Study||15
220016|NCT00821431|539601|P2|COMPLETED|Overall Study||47
220017|NCT00821431|539602|P1|COMPLETED|Overall Study||23
220018|NCT00821431|539601|P2|STARTED|Overall Study||52
220019|NCT00821431|539602|P1|STARTED|Overall Study||38
220020|NCT00821509|539613|P3|NOT COMPLETED|Overall Study||34
220021|NCT00821509|539614|P2|NOT COMPLETED|Overall Study||11
220022|NCT00821509|539615|P1|NOT COMPLETED|Overall Study||12
220023|NCT00821509|539613|P3|COMPLETED|Overall Study|This is a result of 50 lost-to-follow-up and 16 new recruits|190
220024|NCT00821509|539614|P2|COMPLETED|Overall Study|This is a result of 57 lost-to-follow-up and 46 new recruits|191
220025|NCT00821509|539615|P1|COMPLETED|Overall Study|This is a result of 56 lost-to-follow-up and 44 new recruits|245
220026|NCT00821509|539613|P3|STARTED|Overall Study||224
220027|NCT00821509|539614|P2|STARTED|Overall Study||202
220028|NCT00821509|539615|P1|STARTED|Overall Study||257
220029|NCT00821587|539628|P2|NOT COMPLETED|Overall Study||1
220030|NCT00821587|539629|P1|NOT COMPLETED|Overall Study||0
220031|NCT00821587|539628|P2|COMPLETED|Overall Study||18
220032|NCT00821587|539629|P1|COMPLETED|Overall Study||20
220033|NCT00821587|539628|P2|STARTED|Overall Study||19
220034|NCT00821587|539629|P1|STARTED|Overall Study||20
220035|NCT00821678|539637|P2|NOT COMPLETED|Overall Study||14
220036|NCT00821678|539638|P1|NOT COMPLETED|Overall Study||21
220037|NCT00821678|539637|P2|COMPLETED|Overall Study||118
220038|NCT00821678|539638|P1|COMPLETED|Overall Study||112
220039|NCT00821678|539637|P2|STARTED|Overall Study||132
220040|NCT00821678|539638|P1|STARTED|Overall Study||133
220041|NCT00821821|539657|P3|NOT COMPLETED|Overall Study||0
220042|NCT00821821|539658|P2|NOT COMPLETED|Overall Study||0
220043|NCT00821821|539659|P1|NOT COMPLETED|Overall Study||0
220044|NCT00821821|539657|P3|COMPLETED|Overall Study||11
220045|NCT00821821|539658|P2|COMPLETED|Overall Study||13
220046|NCT00821821|539659|P1|COMPLETED|Overall Study||12
220047|NCT00821821|539657|P3|STARTED|Overall Study||11
220048|NCT00821821|539658|P2|STARTED|Overall Study||13
220049|NCT00821821|539659|P1|STARTED|Overall Study||12
220050|NCT00821873|539669|P1|NOT COMPLETED|Overall Study||4
220051|NCT00821873|539669|P1|COMPLETED|Overall Study||5
220052|NCT00821873|539669|P1|STARTED|Overall Study||9
220053|NCT00821886|539673|P1|NOT COMPLETED|Overall Study||9
220054|NCT00821886|539673|P1|COMPLETED|Overall Study||49
220055|NCT00821886|539673|P1|STARTED|Overall Study|Two patients were enrolled, but subsequently found to be ineligible|58
220056|NCT00821951|539680|P1|NOT COMPLETED|Overall Study||5
220057|NCT00821951|539680|P1|COMPLETED|Overall Study||12
220058|NCT00821951|539680|P1|STARTED|Overall Study||17
220059|NCT00821964|539684|P1|NOT COMPLETED|Overall Study||6
220060|NCT00821964|539684|P1|COMPLETED|Overall Study||9
220061|NCT00821964|539684|P1|Evaluable for Pathologic Response|Overall Study||7
220062|NCT00821964|539684|P1|Evaluable for Clinical Response|Overall Study||14
220063|NCT00821964|539684|P1|STARTED|Overall Study||15
220064|NCT00822172|539692|P2|NOT COMPLETED|Overall Study||19
220065|NCT00822172|539693|P1|NOT COMPLETED|Overall Study||15
220066|NCT00822172|539692|P2|COMPLETED|Overall Study||64
220067|NCT00822172|539693|P1|COMPLETED|Overall Study||65
220068|NCT00822172|539692|P2|STARTED|Overall Study||83
220069|NCT00822172|539693|P1|STARTED|Overall Study||80
220070|NCT00822185|539704|P5|NOT COMPLETED|Overall Study||0
220071|NCT00822185|539705|P4|NOT COMPLETED|Overall Study||0
220072|NCT00822185|539706|P3|NOT COMPLETED|Overall Study||0
220073|NCT00822185|539707|P2|NOT COMPLETED|Overall Study||0
220074|NCT00822185|539708|P1|NOT COMPLETED|Overall Study||0
220075|NCT00822185|539704|P5|COMPLETED|Overall Study||8
220076|NCT00822185|539705|P4|COMPLETED|Overall Study||6
220077|NCT00822185|539706|P3|COMPLETED|Overall Study||6
220078|NCT00822185|539707|P2|COMPLETED|Overall Study||6
220079|NCT00822185|539708|P1|COMPLETED|Overall Study||6
220080|NCT00822185|539704|P5|STARTED|Overall Study||8
220081|NCT00822185|539705|P4|STARTED|Overall Study||6
220082|NCT00822185|539706|P3|STARTED|Overall Study||6
220083|NCT00822185|539707|P2|STARTED|Overall Study||6
220084|NCT00822185|539708|P1|STARTED|Overall Study||6
220085|NCT00822237|539775|P2|NOT COMPLETED|Dose 2 Vaccination||11
220086|NCT00822237|539776|P1|NOT COMPLETED|Dose 2 Vaccination||4
220087|NCT00822237|539775|P2|COMPLETED|Dose 2 Vaccination||262
220088|NCT00822237|539776|P1|COMPLETED|Dose 2 Vaccination||270
220089|NCT00822237|539775|P2|STARTED|Dose 2 Vaccination|Number who received second dose|273
220090|NCT00822237|539776|P1|STARTED|Dose 2 Vaccination|Number who received second dose|274
220091|NCT00822237|539775|P2|NOT COMPLETED|Dose 1 Vaccination||26
220092|NCT00822237|539776|P1|NOT COMPLETED|Dose 1 Vaccination||25
220093|NCT00822237|539775|P2|COMPLETED|Dose 1 Vaccination||273
220094|NCT00822237|539776|P1|COMPLETED|Dose 1 Vaccination||274
220095|NCT00822237|539775|P2|STARTED|Dose 1 Vaccination|Number randomized|299
220096|NCT00822237|539776|P1|STARTED|Dose 1 Vaccination|Number randomized|299
220097|NCT00822328|539783|P2|NOT COMPLETED|Overall Study||0
220098|NCT00822328|539784|P1|NOT COMPLETED|Overall Study||0
220099|NCT00822328|539783|P2|COMPLETED|Overall Study||12
220100|NCT00822328|539784|P1|COMPLETED|Overall Study||12
220101|NCT00822328|539783|P2|STARTED|Overall Study||12
220102|NCT00822328|539784|P1|STARTED|Overall Study||12
220103|NCT00822354|539794|P2|NOT COMPLETED|Second Intervention (28 Days)||0
220104|NCT00822354|539795|P1|NOT COMPLETED|Second Intervention (28 Days)||1
220105|NCT00822354|539794|P2|COMPLETED|Second Intervention (28 Days)||5
220106|NCT00822354|539795|P1|COMPLETED|Second Intervention (28 Days)||3
220107|NCT00822354|539794|P2|STARTED|Second Intervention (28 Days)||5
220108|NCT00822354|539795|P1|STARTED|Second Intervention (28 Days)||4
220109|NCT00822354|539794|P2|NOT COMPLETED|Washout (7 Days)||0
220110|NCT00822354|539795|P1|NOT COMPLETED|Washout (7 Days)||0
220111|NCT00822354|539794|P2|COMPLETED|Washout (7 Days)||5
220112|NCT00822354|539795|P1|COMPLETED|Washout (7 Days)||4
220113|NCT00822354|539794|P2|STARTED|Washout (7 Days)||5
220114|NCT00822354|539795|P1|STARTED|Washout (7 Days)||4
220115|NCT00822354|539794|P2|NOT COMPLETED|First Intervention (28 Days)||0
220116|NCT00822354|539795|P1|NOT COMPLETED|First Intervention (28 Days)||1
220117|NCT00822354|539794|P2|COMPLETED|First Intervention (28 Days)||5
220118|NCT00822354|539795|P1|COMPLETED|First Intervention (28 Days)||4
220119|NCT00822354|539794|P2|STARTED|First Intervention (28 Days)||5
220120|NCT00822354|539795|P1|STARTED|First Intervention (28 Days)||5
220121|NCT00828061|539823|P6|NOT COMPLETED|Period 3||0
220122|NCT00828061|539824|P5|NOT COMPLETED|Period 3||0
220123|NCT00828061|539825|P4|NOT COMPLETED|Period 3||0
220124|NCT00828061|539826|P3|NOT COMPLETED|Period 3||0
220125|NCT00828061|539827|P2|NOT COMPLETED|Period 3||0
220126|NCT00828061|539828|P1|NOT COMPLETED|Period 3||0
220127|NCT00828061|539823|P6|COMPLETED|Period 3||3
220128|NCT00828061|539824|P5|COMPLETED|Period 3||3
220129|NCT00828061|539825|P4|COMPLETED|Period 3||3
220130|NCT00828061|539826|P3|COMPLETED|Period 3||3
220131|NCT00828061|539827|P2|COMPLETED|Period 3||3
220132|NCT00828061|539828|P1|COMPLETED|Period 3||4
220133|NCT00828061|539823|P6|STARTED|Period 3||3
220134|NCT00828061|539824|P5|STARTED|Period 3||3
220135|NCT00828061|539825|P4|STARTED|Period 3||3
220136|NCT00828061|539826|P3|STARTED|Period 3||3
220137|NCT00828061|539827|P2|STARTED|Period 3||3
220138|NCT00828061|539828|P1|STARTED|Period 3||4
220139|NCT00828061|539823|P6|NOT COMPLETED|Period 2||0
220140|NCT00828061|539824|P5|NOT COMPLETED|Period 2||0
220141|NCT00828061|539825|P4|NOT COMPLETED|Period 2||0
220142|NCT00828061|539826|P3|NOT COMPLETED|Period 2||0
220143|NCT00828061|539827|P2|NOT COMPLETED|Period 2||0
220144|NCT00828061|539828|P1|NOT COMPLETED|Period 2||0
220145|NCT00828061|539823|P6|COMPLETED|Period 2||3
220146|NCT00828061|539824|P5|COMPLETED|Period 2||3
220147|NCT00828061|539825|P4|COMPLETED|Period 2||3
220148|NCT00828061|539826|P3|COMPLETED|Period 2||3
220149|NCT00828061|539827|P2|COMPLETED|Period 2||3
220150|NCT00828061|539828|P1|COMPLETED|Period 2||4
220151|NCT00828061|539823|P6|STARTED|Period 2||3
220152|NCT00828061|539824|P5|STARTED|Period 2||3
220153|NCT00828061|539825|P4|STARTED|Period 2||3
220154|NCT00828061|539826|P3|STARTED|Period 2||3
220155|NCT00828061|539827|P2|STARTED|Period 2||3
220156|NCT00828061|539828|P1|STARTED|Period 2||4
220157|NCT00828061|539823|P6|NOT COMPLETED|Period 1||0
220158|NCT00828061|539824|P5|NOT COMPLETED|Period 1||0
220159|NCT00828061|539825|P4|NOT COMPLETED|Period 1||0
220160|NCT00828061|539826|P3|NOT COMPLETED|Period 1||0
220161|NCT00828061|539827|P2|NOT COMPLETED|Period 1||0
220162|NCT00828061|539828|P1|NOT COMPLETED|Period 1||0
220163|NCT00828061|539823|P6|COMPLETED|Period 1||3
220164|NCT00828061|539824|P5|COMPLETED|Period 1||3
220165|NCT00828061|539825|P4|COMPLETED|Period 1||3
220166|NCT00828061|539826|P3|COMPLETED|Period 1||3
220167|NCT00828061|539827|P2|COMPLETED|Period 1||3
220168|NCT00828061|539828|P1|COMPLETED|Period 1||4
220169|NCT00828061|539823|P6|STARTED|Period 1||3
220170|NCT00828061|539824|P5|STARTED|Period 1||3
220171|NCT00828061|539825|P4|STARTED|Period 1||3
220172|NCT00828061|539826|P3|STARTED|Period 1||3
220173|NCT00828061|539827|P2|STARTED|Period 1||3
220174|NCT00828061|539828|P1|STARTED|Period 1||4
220175|NCT00828074|539841|P3|NOT COMPLETED|Overall Study||0
220176|NCT00828074|539842|P2|NOT COMPLETED|Overall Study||0
220177|NCT00828074|539843|P1|NOT COMPLETED|Overall Study||0
220178|NCT00828074|539841|P3|COMPLETED|Overall Study||35
220179|NCT00828074|539842|P2|COMPLETED|Overall Study||5
220180|NCT00828074|539843|P1|COMPLETED|Overall Study||6
220181|NCT00828074|539841|P3|STARTED|Overall Study||35
220182|NCT00828074|539842|P2|STARTED|Overall Study||5
220183|NCT00828074|539843|P1|STARTED|Overall Study||6
220184|NCT00828113|539857|P2|NOT COMPLETED|Overall Study||31
220185|NCT00828113|539858|P1|NOT COMPLETED|Overall Study||30
220186|NCT00828113|539857|P2|COMPLETED|Overall Study||20
220187|NCT00828113|539858|P1|COMPLETED|Overall Study||20
220188|NCT00828113|539857|P2|STARTED|Overall Study||51
220189|NCT00828113|539858|P1|STARTED|Overall Study||50
220190|NCT00828139|539868|P4|NOT COMPLETED|Overall Study||51
220191|NCT00828139|539869|P3|NOT COMPLETED|Overall Study||55
220192|NCT00828139|539870|P2|NOT COMPLETED|Overall Study||41
220193|NCT00828139|539871|P1|NOT COMPLETED|Overall Study||41
220194|NCT00828139|539868|P4|COMPLETED|Overall Study||0
220195|NCT00828139|539869|P3|COMPLETED|Overall Study||0
220196|NCT00828139|539870|P2|COMPLETED|Overall Study||0
220197|NCT00828139|539871|P1|COMPLETED|Overall Study||1
220198|NCT00828139|539868|P4|STARTED|Overall Study||51
220199|NCT00828139|539869|P3|STARTED|Overall Study||55
220200|NCT00828139|539870|P2|STARTED|Overall Study||41
220201|NCT00828139|539871|P1|STARTED|Overall Study||42
220202|NCT00828178|539891|P2|NOT COMPLETED|Overall Study||2
220203|NCT00828178|539892|P1|NOT COMPLETED|Overall Study||0
220204|NCT00828178|539891|P2|COMPLETED|Overall Study|Two patients did not complete the study.|43
220205|NCT00828178|539892|P1|COMPLETED|Overall Study||42
220206|NCT00828178|539891|P2|STARTED|Overall Study|Eighty seven participants were randomized.|45
220207|NCT00828178|539892|P1|STARTED|Overall Study||42
220208|NCT00828191|539904|P2|NOT COMPLETED|Overall Study||10
220209|NCT00828191|539905|P1|NOT COMPLETED|Overall Study||8
220210|NCT00828191|539904|P2|COMPLETED|Overall Study|Patients with at least one embryo transferred.|390
220211|NCT00828191|539905|P1|COMPLETED|Overall Study|Patients with at least one embryo transferred.|392
220212|NCT00828191|539904|P2|STARTED|Overall Study|Randomized patients|400
220213|NCT00828191|539905|P1|STARTED|Overall Study|Randomized patients|400
220214|NCT00828204|539917|P2|NOT COMPLETED|Extension Study||3
220215|NCT00828204|539918|P1|NOT COMPLETED|Extension Study||0
220216|NCT00828204|539917|P2|COMPLETED|Extension Study||61
220217|NCT00828204|539918|P1|COMPLETED|Extension Study||0
220218|NCT00828204|539917|P2|STARTED|Extension Study|Participation in Extension Study was optional for Main Subset participants completing Main Study.|64
220219|NCT00828204|539918|P1|STARTED|Extension Study|Participation in the Extension Study was not offered to Initial Subset after completing Main Study.|0
220220|NCT00828204|539917|P2|NOT COMPLETED|Main Study: After Study Restart||3
220221|NCT00828204|539918|P1|NOT COMPLETED|Main Study: After Study Restart||0
220222|NCT00828204|539917|P2|COMPLETED|Main Study: After Study Restart||71
220223|NCT00828204|539918|P1|COMPLETED|Main Study: After Study Restart||0
220224|NCT00828204|539917|P2|Continued With Autoinjector Injections|Main Study: After Study Restart||72
220225|NCT00828204|539918|P1|Continued With Autoinjector Injections|Main Study: After Study Restart||0
220226|NCT00828204|539917|P2|Completed Manual Injection|Main Study: After Study Restart||74
220227|NCT00828204|539918|P1|Completed Manual Injection|Main Study: After Study Restart||0
220228|NCT00828204|539917|P2|STARTED|Main Study: After Study Restart|After a protocol amendment, the Main Subset participants were enrolled.|74
220229|NCT00828204|539918|P1|STARTED|Main Study: After Study Restart|Initial Subset participants did not continue after the study was suspended.|0
220230|NCT00828204|539917|P2|NOT COMPLETED|Main Study: Prior to Study Suspension||0
220231|NCT00828204|539918|P1|NOT COMPLETED|Main Study: Prior to Study Suspension||14
220232|NCT00828204|539917|P2|COMPLETED|Main Study: Prior to Study Suspension||0
220233|NCT00828204|539918|P1|COMPLETED|Main Study: Prior to Study Suspension||7
220234|NCT00828204|539917|P2|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||0
220235|NCT00828204|539918|P1|Continued With Autoinjector Injections|Main Study: Prior to Study Suspension||19
220236|NCT00828204|539917|P2|Completed Manual Injection|Main Study: Prior to Study Suspension||0
220237|NCT00828204|539918|P1|Completed Manual Injection|Main Study: Prior to Study Suspension||21
220238|NCT00828204|539917|P2|STARTED|Main Study: Prior to Study Suspension|Main Subset was not enrolled until after study suspension (period 2, below).|0
220239|NCT00828204|539918|P1|STARTED|Main Study: Prior to Study Suspension||21
220240|NCT00828295|539937|P2|NOT COMPLETED|Overall Study||0
220241|NCT00828295|539938|P1|NOT COMPLETED|Overall Study||0
220242|NCT00828295|539937|P2|COMPLETED|Overall Study||75
220243|NCT00828295|539938|P1|COMPLETED|Overall Study||75
220244|NCT00828295|539937|P2|STARTED|Overall Study||75
220245|NCT00828295|539938|P1|STARTED|Overall Study||75
220246|NCT00828308|539946|P1|NOT COMPLETED|Overall Study||0
220247|NCT00828308|539946|P1|COMPLETED|Overall Study||16
220248|NCT00828308|539946|P1|STARTED|Overall Study||16
220249|NCT00828321|539952|P2|NOT COMPLETED|Second Intervention||1
220250|NCT00828321|539953|P1|NOT COMPLETED|Second Intervention||0
220251|NCT00828321|539952|P2|COMPLETED|Second Intervention||19
220252|NCT00828321|539953|P1|COMPLETED|Second Intervention||18
220253|NCT00828321|539952|P2|STARTED|Second Intervention||20
220254|NCT00828321|539953|P1|STARTED|Second Intervention||18
220255|NCT00828321|539952|P2|NOT COMPLETED|Washout of 42 Days||0
220256|NCT00828321|539953|P1|NOT COMPLETED|Washout of 42 Days||2
220257|NCT00828321|539952|P2|COMPLETED|Washout of 42 Days||20
220258|NCT00828321|539953|P1|COMPLETED|Washout of 42 Days||18
220259|NCT00828321|539952|P2|STARTED|Washout of 42 Days||20
220260|NCT00828321|539953|P1|STARTED|Washout of 42 Days||20
220261|NCT00828321|539952|P2|NOT COMPLETED|First Intervention||0
220262|NCT00828321|539953|P1|NOT COMPLETED|First Intervention||0
220263|NCT00828321|539952|P2|COMPLETED|First Intervention||20
220264|NCT00828321|539953|P1|COMPLETED|First Intervention||20
220265|NCT00828321|539952|P2|STARTED|First Intervention||20
220266|NCT00828321|539953|P1|STARTED|First Intervention||20
220267|NCT00828347|539967|P2|NOT COMPLETED|Overall Study||0
220268|NCT00828347|539968|P1|NOT COMPLETED|Overall Study||0
220269|NCT00828347|539967|P2|COMPLETED|Overall Study||11
220270|NCT00828347|539968|P1|COMPLETED|Overall Study||12
220271|NCT00828347|539967|P2|STARTED|Overall Study||11
220272|NCT00828347|539968|P1|STARTED|Overall Study||12
220273|NCT00829166|539976|P2|NOT COMPLETED|Overall Study||496
220274|NCT00829166|539977|P1|NOT COMPLETED|Overall Study||495
220275|NCT00829166|539976|P2|COMPLETED|Overall Study||0
220276|NCT00829166|539977|P1|COMPLETED|Overall Study||0
220277|NCT00829166|539976|P2|Treated|Overall Study||488
220278|NCT00829166|539977|P1|Treated|Overall Study||490
220279|NCT00829166|539976|P2|STARTED|Overall Study||496
220280|NCT00829166|539977|P1|STARTED|Overall Study||495
220281|NCT00829179|540016|P1|NOT COMPLETED|Overall Study||1
220282|NCT00829179|540016|P1|COMPLETED|Overall Study||19
220283|NCT00829179|540016|P1|STARTED|Overall Study||20
220284|NCT00829244|540022|P2|NOT COMPLETED|Overall Study||21
220285|NCT00829244|540023|P1|NOT COMPLETED|Overall Study||14
220286|NCT00829244|540022|P2|COMPLETED|Overall Study||83
220287|NCT00829244|540023|P1|COMPLETED|Overall Study||82
220288|NCT00829244|540022|P2|STARTED|Overall Study||104
220289|NCT00829244|540023|P1|STARTED|Overall Study||96
220290|NCT00829283|540055|P2|NOT COMPLETED|Overall Study||25
220291|NCT00829283|540056|P1|NOT COMPLETED|Overall Study||7
220292|NCT00829283|540055|P2|COMPLETED|Overall Study||127
220293|NCT00829283|540056|P1|COMPLETED|Overall Study||32
220294|NCT00829283|540055|P2|STARTED|Overall Study||152
220295|NCT00829283|540056|P1|STARTED|Overall Study||39
220296|NCT00829296|540066|P2|NOT COMPLETED|Overall Study||4
220297|NCT00829296|540067|P1|NOT COMPLETED|Overall Study||5
220298|NCT00829296|540066|P2|COMPLETED|Overall Study||32
220299|NCT00829296|540067|P1|COMPLETED|Overall Study||29
220300|NCT00829296|540066|P2|STARTED|Overall Study||36
220301|NCT00829296|540067|P1|STARTED|Overall Study||34
220302|NCT00829309|540081|P2|NOT COMPLETED|Second Intervention||0
220303|NCT00829309|540082|P1|NOT COMPLETED|Second Intervention||0
220304|NCT00829309|540081|P2|COMPLETED|Second Intervention||8
220305|NCT00829309|540082|P1|COMPLETED|Second Intervention||7
220306|NCT00829309|540081|P2|STARTED|Second Intervention||8
220307|NCT00829309|540082|P1|STARTED|Second Intervention||7
220308|NCT00829309|540081|P2|NOT COMPLETED|Washout: 7 Days||0
220309|NCT00829309|540082|P1|NOT COMPLETED|Washout: 7 Days||1
220310|NCT00829309|540081|P2|COMPLETED|Washout: 7 Days||8
220311|NCT00829309|540082|P1|COMPLETED|Washout: 7 Days||7
220312|NCT00829309|540081|P2|STARTED|Washout: 7 Days||8
220313|NCT00829309|540082|P1|STARTED|Washout: 7 Days||8
220314|NCT00829309|540081|P2|NOT COMPLETED|First Intervention||0
220315|NCT00829309|540082|P1|NOT COMPLETED|First Intervention||0
220316|NCT00829309|540081|P2|COMPLETED|First Intervention||8
220317|NCT00829309|540082|P1|COMPLETED|First Intervention||8
220318|NCT00829309|540081|P2|STARTED|First Intervention||8
220319|NCT00829309|540082|P1|STARTED|First Intervention||8
220320|NCT00829387|540092|P2|NOT COMPLETED|Overall Study||3
220321|NCT00829387|540093|P1|NOT COMPLETED|Overall Study||3
220322|NCT00829387|540092|P2|COMPLETED|Overall Study||21
220323|NCT00829387|540093|P1|COMPLETED|Overall Study||20
220324|NCT00829387|540092|P2|STARTED|Overall Study||24
220325|NCT00829387|540093|P1|STARTED|Overall Study||23
220326|NCT00829426|540111|P2|NOT COMPLETED|Second Intervention||0
220327|NCT00829426|540112|P1|NOT COMPLETED|Second Intervention||0
220328|NCT00829426|540111|P2|COMPLETED|Second Intervention||16
220329|NCT00829426|540112|P1|COMPLETED|Second Intervention||15
220330|NCT00829426|540111|P2|STARTED|Second Intervention||16
220331|NCT00829426|540112|P1|STARTED|Second Intervention||15
220332|NCT00829426|540111|P2|NOT COMPLETED|Washout: 7 Days||0
220333|NCT00829426|540112|P1|NOT COMPLETED|Washout: 7 Days||1
220334|NCT00829426|540111|P2|COMPLETED|Washout: 7 Days||16
220335|NCT00829426|540112|P1|COMPLETED|Washout: 7 Days||15
220336|NCT00829426|540111|P2|STARTED|Washout: 7 Days||16
220337|NCT00829426|540112|P1|STARTED|Washout: 7 Days||16
220338|NCT00829426|540111|P2|NOT COMPLETED|First Intervention||0
220339|NCT00829426|540112|P1|NOT COMPLETED|First Intervention||0
220340|NCT00829426|540111|P2|COMPLETED|First Intervention||16
220341|NCT00829426|540112|P1|COMPLETED|First Intervention||16
220342|NCT00829426|540111|P2|STARTED|First Intervention||16
220343|NCT00829426|540112|P1|STARTED|First Intervention||16
220344|NCT00829439|540120|P4|NOT COMPLETED|Overall Study||0
220345|NCT00829439|540121|P3|NOT COMPLETED|Overall Study||1
220346|NCT00829439|540122|P2|NOT COMPLETED|Overall Study||0
220347|NCT00829439|540123|P1|NOT COMPLETED|Overall Study||0
220348|NCT00829439|540120|P4|COMPLETED|Overall Study||4
220349|NCT00829439|540121|P3|COMPLETED|Overall Study||5
220350|NCT00829439|540122|P2|COMPLETED|Overall Study||3
220351|NCT00829439|540123|P1|COMPLETED|Overall Study||3
220352|NCT00829439|540120|P4|STARTED|Overall Study||4
220353|NCT00829439|540121|P3|STARTED|Overall Study||6
220354|NCT00829439|540122|P2|STARTED|Overall Study||3
220355|NCT00829439|540123|P1|STARTED|Overall Study||3
220356|NCT00829452|540129|P2|NOT COMPLETED|Second Intervention||1
220357|NCT00829452|540130|P1|NOT COMPLETED|Second Intervention||0
220358|NCT00829452|540129|P2|COMPLETED|Second Intervention||17
220359|NCT00829452|540130|P1|COMPLETED|Second Intervention||20
220360|NCT00829452|540129|P2|STARTED|Second Intervention||18
220361|NCT00829452|540130|P1|STARTED|Second Intervention||20
220362|NCT00829452|540129|P2|NOT COMPLETED|Washout of 42 Days||1
220363|NCT00829452|540130|P1|NOT COMPLETED|Washout of 42 Days||0
220364|NCT00829452|540129|P2|COMPLETED|Washout of 42 Days||18
220365|NCT00829452|540130|P1|COMPLETED|Washout of 42 Days||20
220366|NCT00829452|540129|P2|STARTED|Washout of 42 Days||19
220367|NCT00829452|540130|P1|STARTED|Washout of 42 Days||20
220368|NCT00829452|540129|P2|NOT COMPLETED|First Intervention||1
220369|NCT00829452|540130|P1|NOT COMPLETED|First Intervention||0
220370|NCT00829452|540129|P2|COMPLETED|First Intervention||19
220371|NCT00829452|540130|P1|COMPLETED|First Intervention||20
220372|NCT00829452|540129|P2|STARTED|First Intervention||20
220373|NCT00829452|540130|P1|STARTED|First Intervention||20
220374|NCT00829504|540144|P2|NOT COMPLETED|Second Intervention||0
220375|NCT00829504|540145|P1|NOT COMPLETED|Second Intervention||1
220376|NCT00829504|540144|P2|COMPLETED|Second Intervention||22
220377|NCT00829504|540145|P1|COMPLETED|Second Intervention||19
220378|NCT00829504|540144|P2|STARTED|Second Intervention||22
220379|NCT00829504|540145|P1|STARTED|Second Intervention||20
220380|NCT00829504|540144|P2|NOT COMPLETED|Washout of 7 Days||0
220381|NCT00829504|540145|P1|NOT COMPLETED|Washout of 7 Days||1
220382|NCT00829504|540144|P2|COMPLETED|Washout of 7 Days||22
220383|NCT00829504|540145|P1|COMPLETED|Washout of 7 Days||20
220384|NCT00829504|540144|P2|STARTED|Washout of 7 Days||22
220385|NCT00829504|540145|P1|STARTED|Washout of 7 Days||21
220386|NCT00829504|540144|P2|NOT COMPLETED|First Intervention||0
220387|NCT00829504|540145|P1|NOT COMPLETED|First Intervention||1
220388|NCT00829504|540144|P2|COMPLETED|First Intervention||22
220389|NCT00829504|540145|P1|COMPLETED|First Intervention||21
220390|NCT00829504|540144|P2|STARTED|First Intervention||22
220391|NCT00829504|540145|P1|STARTED|First Intervention||22
220392|NCT00829530|540155|P2|NOT COMPLETED|Second Intervention||0
220393|NCT00829530|540156|P1|NOT COMPLETED|Second Intervention||1
220394|NCT00829530|540155|P2|COMPLETED|Second Intervention||18
220395|NCT00829530|540156|P1|COMPLETED|Second Intervention||19
220396|NCT00829530|540155|P2|STARTED|Second Intervention||18
220397|NCT00829530|540156|P1|STARTED|Second Intervention||20
220398|NCT00829530|540155|P2|NOT COMPLETED|Washout of 42 Days||0
220399|NCT00829530|540156|P1|NOT COMPLETED|Washout of 42 Days||0
220400|NCT00829530|540155|P2|COMPLETED|Washout of 42 Days||18
220401|NCT00829530|540156|P1|COMPLETED|Washout of 42 Days||20
220402|NCT00829530|540155|P2|STARTED|Washout of 42 Days||18
220403|NCT00829530|540156|P1|STARTED|Washout of 42 Days||20
220404|NCT00829530|540155|P2|NOT COMPLETED|First Intervention||2
220405|NCT00829530|540156|P1|NOT COMPLETED|First Intervention||0
220406|NCT00829530|540155|P2|COMPLETED|First Intervention||18
220407|NCT00829530|540156|P1|COMPLETED|First Intervention||20
220408|NCT00829530|540155|P2|STARTED|First Intervention||20
220409|NCT00829530|540156|P1|STARTED|First Intervention||20
220410|NCT00829621|540170|P2|NOT COMPLETED|Overall Study||4
220411|NCT00829621|540171|P1|NOT COMPLETED|Overall Study||4
220412|NCT00829621|540170|P2|COMPLETED|Overall Study||8
220413|NCT00829621|540171|P1|COMPLETED|Overall Study||4
220414|NCT00829621|540170|P2|STARTED|Overall Study||12
220415|NCT00829621|540171|P1|STARTED|Overall Study||8
220416|NCT00829673|540179|P2|NOT COMPLETED|Second Intervention||0
220417|NCT00829673|540180|P1|NOT COMPLETED|Second Intervention||0
220418|NCT00829673|540179|P2|COMPLETED|Second Intervention||12
220419|NCT00829673|540180|P1|COMPLETED|Second Intervention||11
220420|NCT00829673|540179|P2|STARTED|Second Intervention||12
220421|NCT00829673|540180|P1|STARTED|Second Intervention||11
220422|NCT00829673|540179|P2|NOT COMPLETED|Washout of 7 Days||0
220423|NCT00829673|540180|P1|NOT COMPLETED|Washout of 7 Days||1
220424|NCT00829673|540179|P2|COMPLETED|Washout of 7 Days||12
220425|NCT00829673|540180|P1|COMPLETED|Washout of 7 Days||11
220426|NCT00829673|540179|P2|STARTED|Washout of 7 Days||12
220427|NCT00829673|540180|P1|STARTED|Washout of 7 Days||12
220428|NCT00829673|540179|P2|NOT COMPLETED|First Intervention||0
220429|NCT00829673|540180|P1|NOT COMPLETED|First Intervention||0
220430|NCT00829673|540179|P2|COMPLETED|First Intervention||12
220431|NCT00829673|540180|P1|COMPLETED|First Intervention||12
220432|NCT00829673|540179|P2|STARTED|First Intervention||12
220433|NCT00829673|540180|P1|STARTED|First Intervention||12
220434|NCT00829686|540190|P2|NOT COMPLETED|Overall Study||0
220435|NCT00829686|540191|P1|NOT COMPLETED|Overall Study||0
220436|NCT00829686|540190|P2|COMPLETED|Overall Study||18
220437|NCT00829686|540191|P1|COMPLETED|Overall Study||13
220438|NCT00829686|540190|P2|STARTED|Overall Study||18
220439|NCT00829686|540191|P1|STARTED|Overall Study||13
220440|NCT00829712|540199|P2|NOT COMPLETED|Second Intervention||0
220441|NCT00829712|540200|P1|NOT COMPLETED|Second Intervention||0
220442|NCT00829712|540199|P2|COMPLETED|Second Intervention||11
220443|NCT00829712|540200|P1|COMPLETED|Second Intervention||12
220444|NCT00829712|540199|P2|STARTED|Second Intervention||11
220445|NCT00829712|540200|P1|STARTED|Second Intervention||12
220446|NCT00829712|540199|P2|NOT COMPLETED|Washout of 7 Days||1
220447|NCT00829712|540200|P1|NOT COMPLETED|Washout of 7 Days||0
220448|NCT00829712|540199|P2|COMPLETED|Washout of 7 Days||11
220449|NCT00829712|540200|P1|COMPLETED|Washout of 7 Days||12
220450|NCT00829712|540199|P2|STARTED|Washout of 7 Days||12
220451|NCT00829712|540200|P1|STARTED|Washout of 7 Days||12
220452|NCT00829712|540199|P2|NOT COMPLETED|First Intervention||0
220453|NCT00829712|540200|P1|NOT COMPLETED|First Intervention||0
220454|NCT00829712|540199|P2|COMPLETED|First Intervention||12
220455|NCT00829712|540200|P1|COMPLETED|First Intervention||12
220456|NCT00829712|540199|P2|STARTED|First Intervention||12
220457|NCT00829712|540200|P1|STARTED|First Intervention||12
220458|NCT00829738|540208|P1|NOT COMPLETED|Overall Study||8
220459|NCT00829738|540208|P1|COMPLETED|Overall Study||4180
220460|NCT00829738|540208|P1|STARTED|Overall Study||4188
220461|NCT00829764|540226|P2|NOT COMPLETED|Second Intervention||0
220462|NCT00829764|540227|P1|NOT COMPLETED|Second Intervention||0
220463|NCT00829764|540226|P2|COMPLETED|Second Intervention||14
220464|NCT00829764|540227|P1|COMPLETED|Second Intervention||13
220465|NCT00829764|540226|P2|STARTED|Second Intervention||14
220466|NCT00829764|540227|P1|STARTED|Second Intervention||13
220467|NCT00829764|540226|P2|NOT COMPLETED|Washout of 14 Days||0
220468|NCT00829764|540227|P1|NOT COMPLETED|Washout of 14 Days||0
220469|NCT00829764|540226|P2|COMPLETED|Washout of 14 Days||14
220470|NCT00829764|540227|P1|COMPLETED|Washout of 14 Days||13
220471|NCT00829764|540226|P2|STARTED|Washout of 14 Days||14
220472|NCT00829764|540227|P1|STARTED|Washout of 14 Days||13
220473|NCT00829764|540226|P2|NOT COMPLETED|First Intervention||1
220474|NCT00829764|540227|P1|NOT COMPLETED|First Intervention||2
220475|NCT00829764|540226|P2|COMPLETED|First Intervention||14
220476|NCT00829764|540227|P1|COMPLETED|First Intervention||13
220477|NCT00829764|540226|P2|STARTED|First Intervention||15
220478|NCT00829764|540227|P1|STARTED|First Intervention||15
220479|NCT00829790|540237|P2|NOT COMPLETED|Second Intervention||0
220480|NCT00829790|540238|P1|NOT COMPLETED|Second Intervention||0
220481|NCT00829790|540237|P2|COMPLETED|Second Intervention||14
220482|NCT00829790|540238|P1|COMPLETED|Second Intervention||15
220483|NCT00829790|540237|P2|STARTED|Second Intervention||14
220484|NCT00829790|540238|P1|STARTED|Second Intervention||15
220485|NCT00829790|540237|P2|NOT COMPLETED|Washout of 14 Days||1
220486|NCT00829790|540238|P1|NOT COMPLETED|Washout of 14 Days||0
220487|NCT00829790|540237|P2|COMPLETED|Washout of 14 Days||14
220488|NCT00829790|540238|P1|COMPLETED|Washout of 14 Days||15
220489|NCT00829790|540237|P2|STARTED|Washout of 14 Days||15
220490|NCT00829790|540238|P1|STARTED|Washout of 14 Days||15
220491|NCT00829790|540237|P2|NOT COMPLETED|First Intervention||0
220492|NCT00829790|540238|P1|NOT COMPLETED|First Intervention||0
220493|NCT00829790|540237|P2|COMPLETED|First Intervention||15
220494|NCT00829790|540238|P1|COMPLETED|First Intervention||15
220495|NCT00829790|540237|P2|STARTED|First Intervention||15
220496|NCT00829790|540238|P1|STARTED|First Intervention||15
220497|NCT00829829|540249|P3|NOT COMPLETED|Overall Study||11
220498|NCT00829829|540250|P2|NOT COMPLETED|Overall Study||16
220499|NCT00829829|540251|P1|NOT COMPLETED|Overall Study||22
220500|NCT00829829|540249|P3|COMPLETED|Overall Study||70
220501|NCT00829829|540250|P2|COMPLETED|Overall Study||64
220502|NCT00829829|540251|P1|COMPLETED|Overall Study||58
220503|NCT00829829|540249|P3|Treated|Overall Study||81
220504|NCT00829829|540250|P2|Treated|Overall Study||80
220505|NCT00829829|540251|P1|Treated|Overall Study||79
220506|NCT00829829|540249|P3|STARTED|Overall Study||81
220507|NCT00829829|540250|P2|STARTED|Overall Study||80
220508|NCT00829829|540251|P1|STARTED|Overall Study||80
220509|NCT00829868|540276|P2|NOT COMPLETED|Second Intervention||0
220510|NCT00829868|540277|P1|NOT COMPLETED|Second Intervention||0
220511|NCT00829868|540276|P2|COMPLETED|Second Intervention||21
220512|NCT00829868|540277|P1|COMPLETED|Second Intervention||20
220513|NCT00829868|540276|P2|STARTED|Second Intervention||21
220514|NCT00829868|540277|P1|STARTED|Second Intervention||20
220515|NCT00829868|540276|P2|NOT COMPLETED|Washout||0
220516|NCT00829868|540277|P1|NOT COMPLETED|Washout||1
220517|NCT00829868|540276|P2|COMPLETED|Washout||21
220518|NCT00829868|540277|P1|COMPLETED|Washout||20
220519|NCT00829868|540276|P2|STARTED|Washout||21
220520|NCT00829868|540277|P1|STARTED|Washout||21
220521|NCT00829868|540276|P2|NOT COMPLETED|First Intervention||0
220522|NCT00829868|540277|P1|NOT COMPLETED|First Intervention||0
220523|NCT00829868|540276|P2|COMPLETED|First Intervention||21
220524|NCT00829868|540277|P1|COMPLETED|First Intervention||21
220525|NCT00829868|540276|P2|STARTED|First Intervention||21
220526|NCT00829868|540277|P1|STARTED|First Intervention||21
220527|NCT00829933|540289|P4|NOT COMPLETED|Overall Study||14
220528|NCT00829933|540290|P3|NOT COMPLETED|Overall Study||13
220529|NCT00829933|540291|P2|NOT COMPLETED|Overall Study||13
220530|NCT00829933|540292|P1|NOT COMPLETED|Overall Study||14
220531|NCT00829933|540289|P4|COMPLETED|Overall Study||120
220532|NCT00829933|540290|P3|COMPLETED|Overall Study||119
220533|NCT00829933|540291|P2|COMPLETED|Overall Study||122
220534|NCT00829933|540292|P1|COMPLETED|Overall Study||121
220535|NCT00829933|540289|P4|Baseline Analysis Population|Overall Study||129
220536|NCT00829933|540290|P3|Baseline Analysis Population|Overall Study||131
220537|NCT00829933|540291|P2|Baseline Analysis Population|Overall Study||134
220538|NCT00829933|540292|P1|Baseline Analysis Population|Overall Study||131
220539|NCT00829933|540289|P4|STARTED|Overall Study||134
220540|NCT00829933|540290|P3|STARTED|Overall Study||132
220541|NCT00829933|540291|P2|STARTED|Overall Study||135
220542|NCT00829933|540292|P1|STARTED|Overall Study||135
220543|NCT00829985|540304|P2|NOT COMPLETED|Overall Study||4
220544|NCT00829985|540305|P1|NOT COMPLETED|Overall Study||9
220545|NCT00829985|540304|P2|COMPLETED|Overall Study||22
220546|NCT00829985|540305|P1|COMPLETED|Overall Study||19
220547|NCT00829985|540304|P2|STARTED|Overall Study||26
220548|NCT00829985|540305|P1|STARTED|Overall Study||28
220549|NCT00829998|540321|P2|NOT COMPLETED|Second Intervention||0
220550|NCT00829998|540322|P1|NOT COMPLETED|Second Intervention||0
220551|NCT00829998|540321|P2|COMPLETED|Second Intervention||19
220552|NCT00829998|540322|P1|COMPLETED|Second Intervention||21
220553|NCT00829998|540321|P2|STARTED|Second Intervention||19
220554|NCT00829998|540322|P1|STARTED|Second Intervention||21
220555|NCT00829998|540321|P2|NOT COMPLETED|Washout||1
220556|NCT00829998|540322|P1|NOT COMPLETED|Washout||0
220557|NCT00829998|540321|P2|COMPLETED|Washout||19
220558|NCT00829998|540322|P1|COMPLETED|Washout||21
220559|NCT00829998|540321|P2|STARTED|Washout||20
220560|NCT00829998|540322|P1|STARTED|Washout||21
220561|NCT00829998|540321|P2|NOT COMPLETED|First Intervention||0
220562|NCT00829998|540322|P1|NOT COMPLETED|First Intervention||0
220563|NCT00829998|540321|P2|COMPLETED|First Intervention||20
220564|NCT00829998|540322|P1|COMPLETED|First Intervention||21
220565|NCT00829998|540321|P2|STARTED|First Intervention||20
220566|NCT00829998|540322|P1|STARTED|First Intervention||21
220567|NCT00830024|540332|P2|NOT COMPLETED|Second Intervention||0
220568|NCT00830024|540333|P1|NOT COMPLETED|Second Intervention||0
220569|NCT00830024|540332|P2|COMPLETED|Second Intervention||18
220570|NCT00830024|540333|P1|COMPLETED|Second Intervention||17
220571|NCT00830024|540332|P2|STARTED|Second Intervention||18
220572|NCT00830024|540333|P1|STARTED|Second Intervention||17
220573|NCT00830024|540332|P2|NOT COMPLETED|Washout: 7 Days||0
220574|NCT00830024|540333|P1|NOT COMPLETED|Washout: 7 Days||1
220575|NCT00830024|540332|P2|COMPLETED|Washout: 7 Days||18
220576|NCT00830024|540333|P1|COMPLETED|Washout: 7 Days||17
220577|NCT00830024|540332|P2|STARTED|Washout: 7 Days||18
220578|NCT00830024|540333|P1|STARTED|Washout: 7 Days||18
220579|NCT00830024|540332|P2|NOT COMPLETED|First Intervention||0
220580|NCT00830024|540333|P1|NOT COMPLETED|First Intervention||0
220581|NCT00830024|540332|P2|COMPLETED|First Intervention||18
220582|NCT00830024|540333|P1|COMPLETED|First Intervention||18
220583|NCT00830024|540332|P2|STARTED|First Intervention||18
220584|NCT00830024|540333|P1|STARTED|First Intervention||18
220585|NCT00830037|540343|P2|NOT COMPLETED|Overall Study||19
220586|NCT00830037|540344|P1|NOT COMPLETED|Overall Study||18
220587|NCT00830037|540343|P2|COMPLETED|Overall Study||50
220588|NCT00830037|540344|P1|COMPLETED|Overall Study||49
220589|NCT00830037|540343|P2|STARTED|Overall Study||69
220590|NCT00830037|540344|P1|STARTED|Overall Study||67
220591|NCT00830076|540352|P1|NOT COMPLETED|Placebo Sitagliptin + Placebo Metformin||0
220592|NCT00830076|540352|P1|COMPLETED|Placebo Sitagliptin + Placebo Metformin||18
220593|NCT00830076|540352|P1|STARTED|Placebo Sitagliptin + Placebo Metformin||18
220594|NCT00830076|540352|P1|NOT COMPLETED|7-day Washout||0
220595|NCT00830076|540352|P1|COMPLETED|7-day Washout||18
220596|NCT00830076|540352|P1|STARTED|7-day Washout||18
220597|NCT00830076|540352|P1|NOT COMPLETED|Sitagliptin + Metformin||0
220598|NCT00830076|540352|P1|COMPLETED|Sitagliptin + Metformin||18
220599|NCT00830076|540352|P1|STARTED|Sitagliptin + Metformin||18
220600|NCT00830076|540352|P1|NOT COMPLETED|7-day Washout||0
220601|NCT00830076|540352|P1|COMPLETED|7-day Washout||18
220602|NCT00830076|540352|P1|STARTED|7-day Washout||18
220603|NCT00830076|540352|P1|NOT COMPLETED|Metformin + Placebo Sitagliptin||0
220604|NCT00830076|540352|P1|COMPLETED|Metformin + Placebo Sitagliptin||18
220605|NCT00830076|540352|P1|STARTED|Metformin + Placebo Sitagliptin||18
220606|NCT00830076|540352|P1|NOT COMPLETED|7-day Washout||0
220607|NCT00830076|540352|P1|COMPLETED|7-day Washout||18
220608|NCT00830076|540352|P1|STARTED|7-day Washout||18
220609|NCT00830076|540352|P1|NOT COMPLETED|Sitagliptin + Placebo Metformin||0
220610|NCT00830076|540352|P1|COMPLETED|Sitagliptin + Placebo Metformin||18
220611|NCT00830076|540352|P1|STARTED|Sitagliptin + Placebo Metformin||18
220612|NCT00830115|540361|P1|NOT COMPLETED|Overall Study||3
220613|NCT00830115|540361|P1|COMPLETED|Overall Study||1042
220614|NCT00830115|540361|P1|STARTED|Overall Study||1045
220615|NCT00830128|540377|P1|NOT COMPLETED|Overall Study||19
220616|NCT00830128|540377|P1|COMPLETED|Overall Study||87
220617|NCT00830128|540377|P1|STARTED|Overall Study||106
220618|NCT00830167|540394|P2|NOT COMPLETED|Overall Study||43
220619|NCT00830167|540395|P1|NOT COMPLETED|Overall Study||40
220620|NCT00830167|540394|P2|COMPLETED|Overall Study||207
220621|NCT00830167|540395|P1|COMPLETED|Overall Study||208
220622|NCT00830167|540394|P2|STARTED|Overall Study|Treated|250
220623|NCT00830167|540395|P1|STARTED|Overall Study|Treated|248
220624|NCT00830206|540467|P2|NOT COMPLETED|Second Intervention||0
220625|NCT00830206|540468|P1|NOT COMPLETED|Second Intervention||0
220626|NCT00830206|540467|P2|COMPLETED|Second Intervention||39
220627|NCT00830206|540468|P1|COMPLETED|Second Intervention||39
220628|NCT00830206|540467|P2|STARTED|Second Intervention||39
220629|NCT00830206|540468|P1|STARTED|Second Intervention||39
220630|NCT00830206|540467|P2|NOT COMPLETED|Washout: 21 Days||1
220631|NCT00830206|540468|P1|NOT COMPLETED|Washout: 21 Days||1
220632|NCT00830206|540467|P2|COMPLETED|Washout: 21 Days||39
220633|NCT00830206|540468|P1|COMPLETED|Washout: 21 Days||39
220634|NCT00830206|540467|P2|STARTED|Washout: 21 Days||40
220635|NCT00830206|540468|P1|STARTED|Washout: 21 Days||40
220636|NCT00830206|540467|P2|NOT COMPLETED|First Intervention||0
220637|NCT00830206|540468|P1|NOT COMPLETED|First Intervention||0
220638|NCT00830206|540467|P2|COMPLETED|First Intervention||40
220639|NCT00830206|540468|P1|COMPLETED|First Intervention||40
220640|NCT00830206|540467|P2|STARTED|First Intervention||40
220641|NCT00830206|540468|P1|STARTED|First Intervention||40
220642|NCT00830219|540478|P2|NOT COMPLETED|Second Intervention||0
220643|NCT00830219|540479|P1|NOT COMPLETED|Second Intervention||0
220644|NCT00830219|540478|P2|COMPLETED|Second Intervention||22
220645|NCT00830219|540479|P1|COMPLETED|Second Intervention||22
220646|NCT00830219|540478|P2|STARTED|Second Intervention||22
220647|NCT00830219|540479|P1|STARTED|Second Intervention||22
220648|NCT00830219|540478|P2|NOT COMPLETED|Washout of 7 Days||1
220649|NCT00830219|540479|P1|NOT COMPLETED|Washout of 7 Days||1
220650|NCT00830219|540478|P2|COMPLETED|Washout of 7 Days||22
220651|NCT00830219|540479|P1|COMPLETED|Washout of 7 Days||22
220652|NCT00830219|540478|P2|STARTED|Washout of 7 Days||23
220653|NCT00830219|540479|P1|STARTED|Washout of 7 Days||23
220654|NCT00830219|540478|P2|NOT COMPLETED|First Intervention||0
220655|NCT00830219|540479|P1|NOT COMPLETED|First Intervention||0
220656|NCT00830219|540478|P2|COMPLETED|First Intervention||23
220657|NCT00830219|540479|P1|COMPLETED|First Intervention||23
220658|NCT00830219|540478|P2|STARTED|First Intervention||23
220659|NCT00830219|540479|P1|STARTED|First Intervention||23
220660|NCT00830232|540489|P2|NOT COMPLETED|Overall Study||0
220661|NCT00830232|540490|P1|NOT COMPLETED|Overall Study||0
220662|NCT00830232|540489|P2|COMPLETED|Overall Study||20
220663|NCT00830232|540490|P1|COMPLETED|Overall Study||20
220664|NCT00830232|540489|P2|STARTED|Overall Study||20
220665|NCT00830232|540490|P1|STARTED|Overall Study||20
220666|NCT00830258|540498|P2|NOT COMPLETED|Second Intervention||0
220667|NCT00830258|540499|P1|NOT COMPLETED|Second Intervention||0
220668|NCT00830258|540498|P2|COMPLETED|Second Intervention||30
220669|NCT00830258|540499|P1|COMPLETED|Second Intervention||28
220670|NCT00830258|540498|P2|STARTED|Second Intervention||30
220671|NCT00830258|540499|P1|STARTED|Second Intervention||28
220672|NCT00830258|540498|P2|NOT COMPLETED|Washout: 7 Days||0
220673|NCT00830258|540499|P1|NOT COMPLETED|Washout: 7 Days||1
220674|NCT00830258|540498|P2|COMPLETED|Washout: 7 Days||30
220675|NCT00830258|540499|P1|COMPLETED|Washout: 7 Days||28
220676|NCT00830258|540498|P2|STARTED|Washout: 7 Days||30
220677|NCT00830258|540499|P1|STARTED|Washout: 7 Days||29
220678|NCT00830258|540498|P2|NOT COMPLETED|First Intervention||0
220679|NCT00830258|540499|P1|NOT COMPLETED|First Intervention||1
220680|NCT00830258|540498|P2|COMPLETED|First Intervention||30
220681|NCT00830258|540499|P1|COMPLETED|First Intervention||29
220682|NCT00830258|540498|P2|STARTED|First Intervention||30
220683|NCT00830258|540499|P1|STARTED|First Intervention||30
220684|NCT00830284|540507|P1|NOT COMPLETED|Overall Study||2
220685|NCT00830284|540507|P1|COMPLETED|Overall Study||10
220686|NCT00830284|540507|P1|STARTED|Overall Study|The study was started in our Medical Surgical ICU October of 2008.|12
220687|NCT00830310|540512|P1|NOT COMPLETED|Overall Study||13
220688|NCT00830310|540512|P1|COMPLETED|Overall Study||30
220689|NCT00830310|540512|P1|STARTED|Overall Study||43
220690|NCT00830336|540526|P2|NOT COMPLETED|Second Intervention||0
220691|NCT00830336|540527|P1|NOT COMPLETED|Second Intervention||0
220692|NCT00830336|540526|P2|COMPLETED|Second Intervention||40
220693|NCT00830336|540527|P1|COMPLETED|Second Intervention||39
220694|NCT00830336|540526|P2|STARTED|Second Intervention||40
220695|NCT00830336|540527|P1|STARTED|Second Intervention||39
220696|NCT00830336|540526|P2|NOT COMPLETED|Washout: 21 Days||0
220697|NCT00830336|540527|P1|NOT COMPLETED|Washout: 21 Days||1
220698|NCT00830336|540526|P2|COMPLETED|Washout: 21 Days||40
220699|NCT00830336|540527|P1|COMPLETED|Washout: 21 Days||39
220700|NCT00830336|540526|P2|STARTED|Washout: 21 Days||40
220701|NCT00830336|540527|P1|STARTED|Washout: 21 Days||40
220702|NCT00830336|540526|P2|NOT COMPLETED|First Intervention||0
220703|NCT00830336|540527|P1|NOT COMPLETED|First Intervention||0
220704|NCT00830336|540526|P2|COMPLETED|First Intervention||40
220705|NCT00830336|540527|P1|COMPLETED|First Intervention||40
220706|NCT00830336|540526|P2|STARTED|First Intervention||40
220707|NCT00830336|540527|P1|STARTED|First Intervention||40
220708|NCT00830362|540537|P2|NOT COMPLETED|Overall Study||4
220709|NCT00830362|540538|P1|NOT COMPLETED|Overall Study||4
220710|NCT00830362|540537|P2|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|20
220711|NCT00830362|540538|P1|COMPLETED|Overall Study|The enrolled subjects that completed all 3 testing sessions (were not lost to follow-up).|23
220712|NCT00830362|540537|P2|Completed Sessions 1 and 2|Overall Study|Received palcebo and completed both Test and Retrieval sessions (Session 1 and 2).|24
220713|NCT00830362|540538|P1|Completed Sessions 1 and 2|Overall Study|Received propranolol and completed both Test and Retrieval sessions (Session 1 and 2).|26
220714|NCT00830362|540537|P2|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|24
220715|NCT00830362|540538|P1|STARTED|Overall Study|They received Propranolol and completed Test Session (Session 1). One subject left after day 1.|27
220716|NCT00830375|540544|P1|NOT COMPLETED|Overall Study||1
220717|NCT00830375|540544|P1|COMPLETED|Overall Study||9
220718|NCT00830375|540544|P1|STARTED|Overall Study||10
220719|NCT00830388|540548|P1|NOT COMPLETED|Overall Study||0
220720|NCT00830388|540548|P1|COMPLETED|Overall Study||11
220721|NCT00830388|540548|P1|STARTED|Overall Study||11
220722|NCT00830440|540555|P2|NOT COMPLETED|Overall Study||0
220723|NCT00830440|540556|P1|NOT COMPLETED|Overall Study||8
220724|NCT00830440|540555|P2|COMPLETED|Overall Study||11
220725|NCT00830440|540556|P1|COMPLETED|Overall Study||24
220726|NCT00830440|540555|P2|Completed 24 Week Follow up|Overall Study||0
220727|NCT00830440|540556|P1|Completed 24 Week Follow up|Overall Study||3
220728|NCT00830440|540555|P2|Completed 16 Week Follow up|Overall Study||0
220729|NCT00830440|540556|P1|Completed 16 Week Follow up|Overall Study||4
220730|NCT00830440|540555|P2|Completed 12 Week Follow up|Overall Study||11
220731|NCT00830440|540556|P1|Completed 12 Week Follow up|Overall Study||24
220732|NCT00830440|540555|P2|Received Device|Overall Study||0
220733|NCT00830440|540556|P1|Received Device|Overall Study||26
220734|NCT00830440|540555|P2|STARTED|Overall Study||11
220735|NCT00830440|540556|P1|STARTED|Overall Study||32
220736|NCT00830765|540568|P2|NOT COMPLETED|Overall Study||2
220737|NCT00830765|540569|P1|NOT COMPLETED|Overall Study||3
220738|NCT00830765|540568|P2|COMPLETED|Overall Study||69
220739|NCT00830765|540569|P1|COMPLETED|Overall Study||70
220740|NCT00830765|540568|P2|STARTED|Overall Study||71
220741|NCT00830765|540569|P1|STARTED|Overall Study||73
220742|NCT00830791|540581|P6|NOT COMPLETED|Overall Study||0
220743|NCT00830791|540582|P5|NOT COMPLETED|Overall Study||0
220744|NCT00830791|540583|P4|NOT COMPLETED|Overall Study||0
220745|NCT00830791|540584|P3|NOT COMPLETED|Overall Study||0
220746|NCT00830791|540585|P2|NOT COMPLETED|Overall Study||0
220747|NCT00830791|540586|P1|NOT COMPLETED|Overall Study||0
220748|NCT00830791|540581|P6|COMPLETED|Overall Study||0
220749|NCT00830791|540582|P5|COMPLETED|Overall Study||0
220750|NCT00830791|540583|P4|COMPLETED|Overall Study||8
220751|NCT00830791|540584|P3|COMPLETED|Overall Study||8
220752|NCT00830791|540585|P2|COMPLETED|Overall Study||8
220753|NCT00830791|540586|P1|COMPLETED|Overall Study||8
220754|NCT00830791|540581|P6|STARTED|Overall Study||0
220755|NCT00830791|540582|P5|STARTED|Overall Study||0
220756|NCT00830791|540583|P4|STARTED|Overall Study||8
220757|NCT00830791|540584|P3|STARTED|Overall Study||8
220758|NCT00830791|540585|P2|STARTED|Overall Study||8
220759|NCT00830791|540586|P1|STARTED|Overall Study||8
220760|NCT00830804|540633|P1|NOT COMPLETED|Overall Study||15
220761|NCT00830804|540633|P1|COMPLETED|Overall Study||97
220762|NCT00830804|540633|P1|STARTED|Overall Study|113 subjects enrolled. One subject never started study treatment and was excluded in all analysis.|112
220763|NCT00830947|540655|P2|NOT COMPLETED|Overall Study||4
220764|NCT00830947|540656|P1|NOT COMPLETED|Overall Study||4
220765|NCT00830947|540655|P2|COMPLETED|Overall Study||18
220766|NCT00830947|540656|P1|COMPLETED|Overall Study||19
220767|NCT00830947|540655|P2|STARTED|Overall Study||22
220768|NCT00830947|540656|P1|STARTED|Overall Study||23
220769|NCT00830960|540668|P6|NOT COMPLETED|Overall Study||37
220770|NCT00830960|540669|P5|NOT COMPLETED|Overall Study||32
220771|NCT00830960|540670|P4|NOT COMPLETED|Overall Study||32
220772|NCT00830960|540671|P3|NOT COMPLETED|Overall Study||29
220773|NCT00830960|540672|P2|NOT COMPLETED|Overall Study||28
220774|NCT00830960|540673|P1|NOT COMPLETED|Overall Study||33
220775|NCT00830960|540668|P6|COMPLETED|Overall Study||63
220776|NCT00830960|540669|P5|COMPLETED|Overall Study|6 participants not completed due to death; 1 additional death occurred after study discontinuation.|64
220777|NCT00830960|540670|P4|COMPLETED|Overall Study||106
220778|NCT00830960|540671|P3|COMPLETED|Overall Study||108
220779|NCT00830960|540672|P2|COMPLETED|Overall Study||96
220780|NCT00830960|540673|P1|COMPLETED|Overall Study||91
220781|NCT00830960|540668|P6|Received at Least 1 Dose of Study Drug|Overall Study||93
220782|NCT00830960|540669|P5|Received at Least 1 Dose of Study Drug|Overall Study||91
220783|NCT00830960|540670|P4|Received at Least 1 Dose of Study Drug|Overall Study||135
220784|NCT00830960|540671|P3|Received at Least 1 Dose of Study Drug|Overall Study||133
220785|NCT00830960|540672|P2|Received at Least 1 Dose of Study Drug|Overall Study||122
220786|NCT00830960|540673|P1|Received at Least 1 Dose of Study Drug|Overall Study|Baseline Characteristics (below) include those who received ≥1 dose study drug, not all who STARTED.|117
220787|NCT00830960|540668|P6|STARTED|Overall Study|Total 720 participants were randomized; 1 was not included in a cohort as baseline weight missing.|100
220788|NCT00830960|540669|P5|STARTED|Overall Study||96
220789|NCT00830960|540670|P4|STARTED|Overall Study||138
220790|NCT00830960|540671|P3|STARTED|Overall Study||137
220791|NCT00830960|540672|P2|STARTED|Overall Study||124
220792|NCT00830960|540673|P1|STARTED|Overall Study|"Number of participants STARTED equals the number of participants randomized."|124
220793|NCT00831129|540789|P2|NOT COMPLETED|Overall Study||10
220794|NCT00831129|540790|P1|NOT COMPLETED|Overall Study||0
220795|NCT00831129|540789|P2|COMPLETED|Overall Study||23
220796|NCT00831129|540790|P1|COMPLETED|Overall Study||20
220797|NCT00831129|540789|P2|STARTED|Overall Study||33
220798|NCT00831129|540790|P1|STARTED|Overall Study||20
220799|NCT00831233|540828|P2|NOT COMPLETED|Overall Study||1
220800|NCT00831233|540829|P1|NOT COMPLETED|Overall Study||3
220801|NCT00831233|540828|P2|COMPLETED|Overall Study||12
220802|NCT00831233|540829|P1|COMPLETED|Overall Study||26
220803|NCT00831233|540828|P2|Per Protocol (PP) Analysis Set|Overall Study||11
220804|NCT00831233|540829|P1|Per Protocol (PP) Analysis Set|Overall Study||26
220805|NCT00831233|540828|P2|Full Analysis Set (FAS)|Overall Study||13
220806|NCT00831233|540829|P1|Full Analysis Set (FAS)|Overall Study|2 participants were randomised but never treated.|27
220807|NCT00831233|540828|P2|STARTED|Overall Study|ITT population.|13
220808|NCT00831233|540829|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|29
220809|NCT00831272|540857|P4|NOT COMPLETED|Overall Study||10
220810|NCT00831272|540858|P3|NOT COMPLETED|Overall Study||10
220811|NCT00831272|540859|P2|NOT COMPLETED|Overall Study||7
220812|NCT00831272|540860|P1|NOT COMPLETED|Overall Study||8
220813|NCT00831272|540857|P4|COMPLETED|Overall Study||56
220814|NCT00831272|540858|P3|COMPLETED|Overall Study||63
220815|NCT00831272|540859|P2|COMPLETED|Overall Study||37
220816|NCT00831272|540860|P1|COMPLETED|Overall Study||30
220817|NCT00831272|540857|P4|STARTED|Overall Study||66
220818|NCT00831272|540858|P3|STARTED|Overall Study||73
220819|NCT00831272|540859|P2|STARTED|Overall Study||44
220820|NCT00831272|540860|P1|STARTED|Overall Study||38
220821|NCT00831311|540872|P2|NOT COMPLETED|Overall Study||8
220822|NCT00831311|540873|P1|NOT COMPLETED|Overall Study||12
220823|NCT00831311|540872|P2|COMPLETED|Overall Study||304
220824|NCT00831311|540873|P1|COMPLETED|Overall Study||300
220825|NCT00831311|540872|P2|STARTED|Overall Study||312
220826|NCT00831311|540873|P1|STARTED|Overall Study||312
220827|NCT00831389|540891|P1|NOT COMPLETED|Overall Study||1
220828|NCT00831389|540891|P1|COMPLETED|Overall Study||12
220829|NCT00831389|540891|P1|STARTED|Overall Study||13
220830|NCT00831415|540915|P1|NOT COMPLETED|Overall Study||75
220831|NCT00831415|540915|P1|COMPLETED|Overall Study|In addition to Completers for Study includes 2 participants who discontinued after on-therapy period|229
220832|NCT00831415|540915|P1|"Study Completers"|Overall Study|Defined as participants whose conclusion of study participation status was “study completed.”|227
220833|NCT00831415|540915|P1|"Completers for Exposure"|Overall Study|Participants with ≥ 301 days of exposure to study drug and completed study day 308 evaluations.|227
220834|NCT00831415|540915|P1|STARTED|Overall Study||304
220835|NCT00831428|540922|P1|NOT COMPLETED|Overall Study||0
220836|NCT00831428|540922|P1|COMPLETED|Overall Study||97
220837|NCT00831428|540922|P1|STARTED|Overall Study||97
220838|NCT00831441|540928|P2|NOT COMPLETED|Follow Up (30 Days)||174
220839|NCT00831441|540929|P1|NOT COMPLETED|Follow Up (30 Days)||133
220840|NCT00831441|540928|P2|COMPLETED|Follow Up (30 Days)||3355
220841|NCT00831441|540929|P1|COMPLETED|Follow Up (30 Days)||3375
220842|NCT00831441|540928|P2|STARTED|Follow Up (30 Days)|3529 participants entered the follow up period.|3529
220843|NCT00831441|540929|P1|STARTED|Follow Up (30 Days)|3508 participants entered the follow up period.|3508
220844|NCT00831441|540928|P2|NOT COMPLETED|Randomized||3705
220845|NCT00831441|540929|P1|NOT COMPLETED|Randomized||3687
220846|NCT00831441|540928|P2|COMPLETED|Randomized||0
220847|NCT00831441|540929|P1|COMPLETED|Randomized||0
220848|NCT00831441|540928|P2|Treated|Randomized||3672
220849|NCT00831441|540929|P1|Treated|Randomized||3643
220850|NCT00831441|540928|P2|STARTED|Randomized||3705
220851|NCT00831441|540929|P1|STARTED|Randomized||3687
220852|NCT00831480|540957|P1|NOT COMPLETED|Overall Study||2
220853|NCT00831480|540957|P1|COMPLETED|Overall Study||7
220854|NCT00831480|540957|P1|STARTED|Overall Study||9
220855|NCT00831493|540961|P1|NOT COMPLETED|Overall Study||1
220856|NCT00831493|540961|P1|COMPLETED|Overall Study||2
220857|NCT00831493|540961|P1|STARTED|Overall Study||3
220858|NCT00825227|540967|P2|NOT COMPLETED|Overall Study||0
220859|NCT00825227|540968|P1|NOT COMPLETED|Overall Study||0
220860|NCT00825227|540967|P2|COMPLETED|Overall Study||4
220861|NCT00825227|540968|P1|COMPLETED|Overall Study||6
220862|NCT00825227|540967|P2|STARTED|Overall Study||4
220863|NCT00825227|540968|P1|STARTED|Overall Study||6
220864|NCT00825266|540976|P2|NOT COMPLETED|Overall Study||0
220865|NCT00825266|540977|P1|NOT COMPLETED|Overall Study||0
220866|NCT00825266|540976|P2|COMPLETED|Overall Study||1
220867|NCT00825266|540977|P1|COMPLETED|Overall Study||1
220868|NCT00825266|540976|P2|STARTED|Overall Study||1
220869|NCT00825266|540977|P1|STARTED|Overall Study||1
220870|NCT00825305|540989|P2|NOT COMPLETED|Overall Study||23
220871|NCT00825305|540990|P1|NOT COMPLETED|Overall Study||17
220872|NCT00825305|540989|P2|COMPLETED|Overall Study||252
220873|NCT00825305|540990|P1|COMPLETED|Overall Study||533
220874|NCT00825305|540989|P2|STARTED|Overall Study||275
220875|NCT00825305|540990|P1|STARTED|Overall Study||550
220876|NCT00825318|541002|P1|NOT COMPLETED|Overall Study||1
220877|NCT00825318|541002|P1|COMPLETED|Overall Study||12
220878|NCT00825318|541002|P1|STARTED|Overall Study||13
220879|NCT00825344|541012|P2|NOT COMPLETED|Overall Study||1
220880|NCT00825344|541013|P1|NOT COMPLETED|Overall Study||1
220881|NCT00825344|541012|P2|COMPLETED|Overall Study||42
220882|NCT00825344|541013|P1|COMPLETED|Overall Study||33
220883|NCT00825344|541012|P2|STARTED|Overall Study||43
220884|NCT00825344|541013|P1|STARTED|Overall Study||34
220885|NCT00825500|541026|P3|NOT COMPLETED|Overall Study||0
220886|NCT00825500|541027|P2|NOT COMPLETED|Overall Study||0
220887|NCT00825500|541028|P1|NOT COMPLETED|Overall Study||0
220888|NCT00825500|541026|P3|COMPLETED|Overall Study||120
220889|NCT00825500|541027|P2|COMPLETED|Overall Study||121
220890|NCT00825500|541028|P1|COMPLETED|Overall Study||125
220891|NCT00825500|541026|P3|STARTED|Overall Study||120
220892|NCT00825500|541027|P2|STARTED|Overall Study||121
220893|NCT00825500|541028|P1|STARTED|Overall Study||125
220894|NCT00831675|541041|P2|NOT COMPLETED|Overall Study||0
220895|NCT00831675|541042|P1|NOT COMPLETED|Overall Study||0
220896|NCT00831675|541041|P2|COMPLETED|Overall Study||18
220897|NCT00831675|541042|P1|COMPLETED|Overall Study||12
220898|NCT00831675|541041|P2|STARTED|Overall Study||18
220899|NCT00831675|541042|P1|STARTED|Overall Study||12
220900|NCT00831701|541056|P2|NOT COMPLETED|Overall Study||5
220901|NCT00831701|541057|P1|NOT COMPLETED|Overall Study||5
220902|NCT00831701|541056|P2|COMPLETED|Overall Study||45
220903|NCT00831701|541057|P1|COMPLETED|Overall Study||45
220904|NCT00831701|541056|P2|STARTED|Overall Study||50
220905|NCT00831701|541057|P1|STARTED|Overall Study||50
220906|NCT00831753|541073|P2|NOT COMPLETED|Overall Study||0
220907|NCT00831753|541074|P1|NOT COMPLETED|Overall Study||0
220908|NCT00831753|541073|P2|COMPLETED|Overall Study||131
220909|NCT00831753|541074|P1|COMPLETED|Overall Study||132
220910|NCT00831753|541073|P2|STARTED|Overall Study||131
220911|NCT00831753|541074|P1|STARTED|Overall Study||132
220912|NCT00831766|541088|P2|NOT COMPLETED|Overall Study||0
220913|NCT00831766|541089|P1|NOT COMPLETED|Overall Study||0
220914|NCT00831766|541088|P2|COMPLETED|Overall Study||28
220915|NCT00831766|541089|P1|COMPLETED|Overall Study||23
220916|NCT00831766|541088|P2|STARTED|Overall Study||28
220917|NCT00831766|541089|P1|STARTED|Overall Study||23
220918|NCT00831779|541097|P2|NOT COMPLETED|Overall Study||1
220919|NCT00831779|541098|P1|NOT COMPLETED|Overall Study||1
220920|NCT00831779|541097|P2|COMPLETED|Overall Study||22
220921|NCT00831779|541098|P1|COMPLETED|Overall Study||20
220922|NCT00831779|541097|P2|STARTED|Overall Study||23
220923|NCT00831779|541098|P1|STARTED|Overall Study||21
220924|NCT00831844|541116|P10|NOT COMPLETED|Overall Study||0
220925|NCT00831844|541117|P9|NOT COMPLETED|Overall Study||9
220926|NCT00831844|541118|P8|NOT COMPLETED|Overall Study||10
220927|NCT00831844|541119|P7|NOT COMPLETED|Overall Study||10
220928|NCT00831844|541120|P6|NOT COMPLETED|Overall Study||19
220929|NCT00831844|541121|P5|NOT COMPLETED|Overall Study||14
220930|NCT00831844|541122|P4|NOT COMPLETED|Overall Study||10
220931|NCT00831844|541123|P3|NOT COMPLETED|Overall Study||20
220932|NCT00831844|541124|P2|NOT COMPLETED|Overall Study||12
220933|NCT00831844|541125|P1|NOT COMPLETED|Overall Study||10
220934|NCT00831844|541116|P10|COMPLETED|Overall Study||0
220935|NCT00831844|541117|P9|COMPLETED|Overall Study||0
220936|NCT00831844|541118|P8|COMPLETED|Overall Study||0
220937|NCT00831844|541119|P7|COMPLETED|Overall Study||0
220938|NCT00831844|541120|P6|COMPLETED|Overall Study||1
220939|NCT00831844|541121|P5|COMPLETED|Overall Study||0
220940|NCT00831844|541122|P4|COMPLETED|Overall Study||0
220941|NCT00831844|541123|P3|COMPLETED|Overall Study||1
220942|NCT00831844|541124|P2|COMPLETED|Overall Study||0
220943|NCT00831844|541125|P1|COMPLETED|Overall Study||0
220944|NCT00831844|541116|P10|STARTED|Overall Study||0
220945|NCT00831844|541117|P9|STARTED|Overall Study||9
220946|NCT00831844|541118|P8|STARTED|Overall Study||10
220947|NCT00831844|541119|P7|STARTED|Overall Study||10
220948|NCT00831844|541120|P6|STARTED|Overall Study||20
220949|NCT00831844|541121|P5|STARTED|Overall Study||14
220950|NCT00831844|541122|P4|STARTED|Overall Study||10
220951|NCT00831844|541123|P3|STARTED|Overall Study||21
220952|NCT00831844|541124|P2|STARTED|Overall Study||12
220953|NCT00831844|541125|P1|STARTED|Overall Study||10
220954|NCT00832819|541150|P3|NOT COMPLETED|Overall Study||1
220955|NCT00832819|541151|P2|NOT COMPLETED|Overall Study||1
220956|NCT00832819|541152|P1|NOT COMPLETED|Overall Study||0
220957|NCT00832819|541150|P3|COMPLETED|Overall Study||15
220958|NCT00832819|541151|P2|COMPLETED|Overall Study||5
220959|NCT00832819|541152|P1|COMPLETED|Overall Study||6
220960|NCT00832819|541150|P3|STARTED|Overall Study||16
220961|NCT00832819|541151|P2|STARTED|Overall Study||6
220962|NCT00832819|541152|P1|STARTED|Overall Study||6
220963|NCT00832871|541158|P1|NOT COMPLETED|Overall Study||0
220964|NCT00832871|541158|P1|COMPLETED|Overall Study||4
220965|NCT00832871|541158|P1|STARTED|Overall Study||4
220966|NCT00832975|541164|P1|NOT COMPLETED|Overall Study||39
220967|NCT00832975|541164|P1|COMPLETED|Overall Study||118
220968|NCT00832975|541164|P1|STARTED|Overall Study||157
220969|NCT00833027|541169|P1|NOT COMPLETED|Overall Study||211
220970|NCT00833027|541169|P1|COMPLETED|Overall Study||397
220971|NCT00833027|541169|P1|STARTED|Overall Study||608
220972|NCT00833040|541174|P6|NOT COMPLETED|Overall Study||1
220973|NCT00833040|541175|P5|NOT COMPLETED|Overall Study||0
220974|NCT00833040|541176|P4|NOT COMPLETED|Overall Study||0
220975|NCT00833040|541177|P3|NOT COMPLETED|Overall Study||0
220976|NCT00833040|541178|P2|NOT COMPLETED|Overall Study||0
220977|NCT00833040|541179|P1|NOT COMPLETED|Overall Study||0
220978|NCT00833040|541174|P6|COMPLETED|Overall Study||4
220979|NCT00833040|541175|P5|COMPLETED|Overall Study||5
220980|NCT00833040|541176|P4|COMPLETED|Overall Study||6
220981|NCT00833040|541177|P3|COMPLETED|Overall Study||6
220982|NCT00833040|541178|P2|COMPLETED|Overall Study||6
220983|NCT00833040|541179|P1|COMPLETED|Overall Study||6
220984|NCT00833040|541174|P6|STARTED|Overall Study||5
220985|NCT00833040|541175|P5|STARTED|Overall Study||5
220986|NCT00833040|541176|P4|STARTED|Overall Study||6
220987|NCT00833040|541177|P3|STARTED|Overall Study||6
220988|NCT00833040|541178|P2|STARTED|Overall Study||6
220989|NCT00833040|541179|P1|STARTED|Overall Study||6
220990|NCT00833053|541186|P2|NOT COMPLETED|Overall Study||3
220991|NCT00833053|541187|P1|NOT COMPLETED|Overall Study||9
220992|NCT00833053|541186|P2|COMPLETED|Overall Study||17
220993|NCT00833053|541187|P1|COMPLETED|Overall Study||10
220994|NCT00833053|541186|P2|STARTED|Overall Study||20
220995|NCT00833053|541187|P1|STARTED|Overall Study||19
220996|NCT00833092|541207|P2|NOT COMPLETED|Overall Study||7
220997|NCT00833092|541208|P1|NOT COMPLETED|Overall Study||4
220998|NCT00833092|541207|P2|COMPLETED|Overall Study||50
220999|NCT00833092|541208|P1|COMPLETED|Overall Study||50
221000|NCT00833092|541207|P2|STARTED|Overall Study||57
221001|NCT00833092|541208|P1|STARTED|Overall Study||54
221002|NCT00833248|541216|P2|NOT COMPLETED|Overall Study||3
221003|NCT00833248|541217|P1|NOT COMPLETED|Overall Study||4
221004|NCT00833248|541216|P2|COMPLETED|Overall Study||62
221005|NCT00833248|541217|P1|COMPLETED|Overall Study||177
221006|NCT00833248|541216|P2|Safety Analysis Set|Overall Study||64
221007|NCT00833248|541217|P1|Safety Analysis Set|Overall Study||181
221008|NCT00833248|541216|P2|Per Protocol (PP) Analysis Set|Overall Study||57
221009|NCT00833248|541217|P1|Per Protocol (PP) Analysis Set|Overall Study||164
221010|NCT00833248|541216|P2|Full Analysis Set (FAS)|Overall Study||64
221011|NCT00833248|541217|P1|Full Analysis Set (FAS)|Overall Study||180
221012|NCT00833248|541216|P2|STARTED|Overall Study||65
221013|NCT00833248|541217|P1|STARTED|Overall Study||181
221014|NCT00833365|541241|P2|NOT COMPLETED|Overall Study||0
221015|NCT00833365|541242|P1|NOT COMPLETED|Overall Study||0
221016|NCT00833365|541241|P2|COMPLETED|Overall Study||6
221017|NCT00833365|541242|P1|COMPLETED|Overall Study||9
221018|NCT00833365|541241|P2|STARTED|Overall Study||6
221019|NCT00833365|541242|P1|STARTED|Overall Study||9
221020|NCT00833417|541252|P2|NOT COMPLETED|Overall Study||71
221021|NCT00833417|541253|P1|NOT COMPLETED|Overall Study||33
221022|NCT00833417|541252|P2|COMPLETED|Overall Study||0
221023|NCT00833417|541253|P1|COMPLETED|Overall Study||0
221024|NCT00833417|541252|P2|STARTED|Overall Study||71
221025|NCT00833417|541253|P1|STARTED|Overall Study||33
221026|NCT00833443|541268|P2|NOT COMPLETED|Overall Study||28
221027|NCT00833443|541269|P1|NOT COMPLETED|Overall Study||20
221028|NCT00833443|541268|P2|COMPLETED|Overall Study||15
221029|NCT00833443|541269|P1|COMPLETED|Overall Study||21
221030|NCT00833443|541268|P2|STARTED|Overall Study||43
221031|NCT00833443|541269|P1|STARTED|Overall Study||41
221032|NCT00833469|541281|P1|NOT COMPLETED|Overall Study||2
221033|NCT00833469|541281|P1|COMPLETED|Overall Study||3
221034|NCT00833469|541281|P1|STARTED|Overall Study||5
221035|NCT00833482|541289|P6|NOT COMPLETED|Days 21-30||0
221036|NCT00833482|541290|P5|NOT COMPLETED|Days 21-30||1
221037|NCT00833482|541291|P4|NOT COMPLETED|Days 21-30||0
221038|NCT00833482|541292|P3|NOT COMPLETED|Days 21-30||1
221039|NCT00833482|541293|P2|NOT COMPLETED|Days 21-30||0
221040|NCT00833482|541294|P1|NOT COMPLETED|Days 21-30||0
221041|NCT00833482|541289|P6|COMPLETED|Days 21-30||0
221042|NCT00833482|541290|P5|COMPLETED|Days 21-30||7
221043|NCT00833482|541291|P4|COMPLETED|Days 21-30||0
221044|NCT00833482|541292|P3|COMPLETED|Days 21-30||20
221045|NCT00833482|541293|P2|COMPLETED|Days 21-30||0
221046|NCT00833482|541294|P1|COMPLETED|Days 21-30||0
221047|NCT00833482|541289|P6|STARTED|Days 21-30||0
221048|NCT00833482|541290|P5|STARTED|Days 21-30||8
221049|NCT00833482|541291|P4|STARTED|Days 21-30||0
221050|NCT00833482|541292|P3|STARTED|Days 21-30||21
221051|NCT00833482|541293|P2|STARTED|Days 21-30||0
221052|NCT00833482|541294|P1|STARTED|Days 21-30||0
221053|NCT00833482|541289|P6|NOT COMPLETED|Days 11-20||0
221054|NCT00833482|541290|P5|NOT COMPLETED|Days 11-20||0
221055|NCT00833482|541291|P4|NOT COMPLETED|Days 11-20||0
221056|NCT00833482|541292|P3|NOT COMPLETED|Days 11-20||0
221057|NCT00833482|541293|P2|NOT COMPLETED|Days 11-20||3
221058|NCT00833482|541294|P1|NOT COMPLETED|Days 11-20||0
221059|NCT00833482|541289|P6|COMPLETED|Days 11-20||8
221060|NCT00833482|541290|P5|COMPLETED|Days 11-20||0
221061|NCT00833482|541291|P4|COMPLETED|Days 11-20||0
221062|NCT00833482|541292|P3|COMPLETED|Days 11-20||0
221063|NCT00833482|541293|P2|COMPLETED|Days 11-20||21
221064|NCT00833482|541294|P1|COMPLETED|Days 11-20||0
221065|NCT00833482|541289|P6|STARTED|Days 11-20|Participants who received treatment.|8
221066|NCT00833482|541290|P5|STARTED|Days 11-20||0
221067|NCT00833482|541291|P4|STARTED|Days 11-20||0
221068|NCT00833482|541292|P3|STARTED|Days 11-20||0
221069|NCT00833482|541293|P2|STARTED|Days 11-20|Participants who received treatment.|24
221070|NCT00833482|541294|P1|STARTED|Days 11-20||0
221071|NCT00833482|541289|P6|NOT COMPLETED|Days 1-3||0
221072|NCT00833482|541290|P5|NOT COMPLETED|Days 1-3||0
221073|NCT00833482|541291|P4|NOT COMPLETED|Days 1-3||0
221074|NCT00833482|541292|P3|NOT COMPLETED|Days 1-3||0
221075|NCT00833482|541293|P2|NOT COMPLETED|Days 1-3||0
221076|NCT00833482|541294|P1|NOT COMPLETED|Days 1-3||0
221077|NCT00833482|541289|P6|COMPLETED|Days 1-3||0
221078|NCT00833482|541290|P5|COMPLETED|Days 1-3||0
221079|NCT00833482|541291|P4|COMPLETED|Days 1-3||8
221080|NCT00833482|541292|P3|COMPLETED|Days 1-3||0
221081|NCT00833482|541293|P2|COMPLETED|Days 1-3||0
221082|NCT00833482|541294|P1|COMPLETED|Days 1-3||24
221083|NCT00833482|541289|P6|STARTED|Days 1-3||0
221084|NCT00833482|541290|P5|STARTED|Days 1-3||0
221085|NCT00833482|541291|P4|STARTED|Days 1-3||8
221086|NCT00833482|541292|P3|STARTED|Days 1-3||0
221087|NCT00833482|541293|P2|STARTED|Days 1-3|Participants who received treatment|0
221088|NCT00833482|541294|P1|STARTED|Days 1-3|Participants who received treatment|24
221089|NCT00833521|541352|P2|NOT COMPLETED|Second Intervention||0
221090|NCT00833521|541353|P1|NOT COMPLETED|Second Intervention||0
221091|NCT00833521|541352|P2|COMPLETED|Second Intervention||19
221092|NCT00833521|541353|P1|COMPLETED|Second Intervention||19
221093|NCT00833521|541352|P2|STARTED|Second Intervention||19
221094|NCT00833521|541353|P1|STARTED|Second Intervention||19
221095|NCT00833521|541352|P2|NOT COMPLETED|First Intervention||0
221096|NCT00833521|541353|P1|NOT COMPLETED|First Intervention||0
221097|NCT00833521|541352|P2|COMPLETED|First Intervention||19
221098|NCT00833521|541353|P1|COMPLETED|First Intervention||19
221099|NCT00833521|541352|P2|STARTED|First Intervention||19
221100|NCT00833521|541353|P1|STARTED|First Intervention||19
221101|NCT00833547|541363|P2|NOT COMPLETED|Overall Study||2
221102|NCT00833547|541364|P1|NOT COMPLETED|Overall Study||2
221103|NCT00833547|541363|P2|COMPLETED|Overall Study||10
221104|NCT00833547|541364|P1|COMPLETED|Overall Study||11
221105|NCT00833547|541363|P2|STARTED|Overall Study||12
221106|NCT00833547|541364|P1|STARTED|Overall Study||13
221107|NCT00833560|541372|P1|NOT COMPLETED|Overall Study||42
221108|NCT00833560|541372|P1|COMPLETED|Overall Study||353
221109|NCT00833560|541372|P1|STARTED|Overall Study||395
221110|NCT00833586|541381|P2|NOT COMPLETED|Second Intervention||0
221111|NCT00833586|541382|P1|NOT COMPLETED|Second Intervention||0
221112|NCT00833586|541381|P2|COMPLETED|Second Intervention||14
221113|NCT00833586|541382|P1|COMPLETED|Second Intervention||14
221114|NCT00833586|541381|P2|STARTED|Second Intervention||14
221115|NCT00833586|541382|P1|STARTED|Second Intervention||14
221116|NCT00833586|541381|P2|NOT COMPLETED|Washout: 14 Days||0
221117|NCT00833586|541382|P1|NOT COMPLETED|Washout: 14 Days||0
221118|NCT00833586|541381|P2|COMPLETED|Washout: 14 Days||14
221119|NCT00833586|541382|P1|COMPLETED|Washout: 14 Days||14
221120|NCT00833586|541381|P2|STARTED|Washout: 14 Days||14
221121|NCT00833586|541382|P1|STARTED|Washout: 14 Days||14
221122|NCT00833586|541381|P2|NOT COMPLETED|First Intervention||0
221123|NCT00833586|541382|P1|NOT COMPLETED|First Intervention||0
221124|NCT00833586|541381|P2|COMPLETED|First Intervention||14
221125|NCT00833586|541382|P1|COMPLETED|First Intervention||14
221126|NCT00833586|541381|P2|STARTED|First Intervention||14
221127|NCT00833586|541382|P1|STARTED|First Intervention||14
221128|NCT00833638|541393|P3|NOT COMPLETED|Phase 3: Open-label Extension Phase||2
221129|NCT00833638|541394|P2|NOT COMPLETED|Phase 3: Open-label Extension Phase||3
221130|NCT00833638|541395|P1|NOT COMPLETED|Phase 3: Open-label Extension Phase||1
221131|NCT00833638|541393|P3|COMPLETED|Phase 3: Open-label Extension Phase||122
221132|NCT00833638|541394|P2|COMPLETED|Phase 3: Open-label Extension Phase||105
221133|NCT00833638|541395|P1|COMPLETED|Phase 3: Open-label Extension Phase||110
221134|NCT00833638|541393|P3|STARTED|Phase 3: Open-label Extension Phase||124
221135|NCT00833638|541394|P2|STARTED|Phase 3: Open-label Extension Phase||108
221136|NCT00833638|541395|P1|STARTED|Phase 3: Open-label Extension Phase||111
221137|NCT00833638|541393|P3|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||9
221138|NCT00833638|541394|P2|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
221139|NCT00833638|541395|P1|NOT COMPLETED|Phase 2: Double-blind Treatment Phase||10
221140|NCT00833638|541393|P3|COMPLETED|Phase 2: Double-blind Treatment Phase||124
221141|NCT00833638|541394|P2|COMPLETED|Phase 2: Double-blind Treatment Phase||108
221142|NCT00833638|541395|P1|COMPLETED|Phase 2: Double-blind Treatment Phase||111
221143|NCT00833638|541393|P3|STARTED|Phase 2: Double-blind Treatment Phase||133
221144|NCT00833638|541394|P2|STARTED|Phase 2: Double-blind Treatment Phase||118
221145|NCT00833638|541395|P1|STARTED|Phase 2: Double-blind Treatment Phase||121
221146|NCT00833664|541437|P2|NOT COMPLETED|Second Intervention||0
221147|NCT00833664|541438|P1|NOT COMPLETED|Second Intervention||0
221148|NCT00833664|541437|P2|COMPLETED|Second Intervention||11
221149|NCT00833664|541438|P1|COMPLETED|Second Intervention||10
221150|NCT00833664|541437|P2|STARTED|Second Intervention||11
221151|NCT00833664|541438|P1|STARTED|Second Intervention||10
221152|NCT00833664|541437|P2|NOT COMPLETED|Washout: 14 Days||0
221153|NCT00833664|541438|P1|NOT COMPLETED|Washout: 14 Days||1
221154|NCT00833664|541437|P2|COMPLETED|Washout: 14 Days||11
221155|NCT00833664|541438|P1|COMPLETED|Washout: 14 Days||10
221156|NCT00833664|541437|P2|STARTED|Washout: 14 Days||11
221157|NCT00833664|541438|P1|STARTED|Washout: 14 Days||11
221158|NCT00833664|541437|P2|NOT COMPLETED|First Intervention||0
221159|NCT00833664|541438|P1|NOT COMPLETED|First Intervention||0
221160|NCT00833664|541437|P2|COMPLETED|First Intervention||11
221161|NCT00833664|541438|P1|COMPLETED|First Intervention||11
221162|NCT00833664|541437|P2|STARTED|First Intervention||11
221163|NCT00833664|541438|P1|STARTED|First Intervention||11
221164|NCT00833690|541449|P3|NOT COMPLETED|Overall Study||0
221165|NCT00833690|541450|P2|NOT COMPLETED|Overall Study||2
221166|NCT00833690|541451|P1|NOT COMPLETED|Overall Study||4
221167|NCT00833690|541449|P3|COMPLETED|Overall Study||26
221168|NCT00833690|541450|P2|COMPLETED|Overall Study||22
221169|NCT00833690|541451|P1|COMPLETED|Overall Study||21
221170|NCT00833690|541449|P3|STARTED|Overall Study||26
221171|NCT00833690|541450|P2|STARTED|Overall Study||24
221172|NCT00833690|541451|P1|STARTED|Overall Study||25
221173|NCT00833703|541575|P2|NOT COMPLETED|Overall Study||1
221174|NCT00833703|541576|P1|NOT COMPLETED|Overall Study||0
221175|NCT00833703|541575|P2|COMPLETED|Overall Study|Completed follow-up|25
221176|NCT00833703|541576|P1|COMPLETED|Overall Study|Completed follow-up|23
221177|NCT00833703|541575|P2|Completed Treatment|Overall Study||24
221178|NCT00833703|541576|P1|Completed Treatment|Overall Study||22
221179|NCT00833703|541575|P2|Treated|Overall Study||26
221180|NCT00833703|541576|P1|Treated|Overall Study||23
221181|NCT00833703|541575|P2|STARTED|Overall Study|Included|26
221182|NCT00833703|541576|P1|STARTED|Overall Study|Included|23
221183|NCT00833755|541590|P4|NOT COMPLETED|Overall Study||6
221184|NCT00833755|541591|P3|NOT COMPLETED|Overall Study||2
221185|NCT00833755|541592|P2|NOT COMPLETED|Overall Study||5
221186|NCT00833755|541593|P1|NOT COMPLETED|Overall Study||4
221187|NCT00833755|541590|P4|COMPLETED|Overall Study||17
221188|NCT00833755|541591|P3|COMPLETED|Overall Study||20
221189|NCT00833755|541592|P2|COMPLETED|Overall Study||13
221190|NCT00833755|541593|P1|COMPLETED|Overall Study||12
221191|NCT00833755|541590|P4|STARTED|Overall Study||23
221192|NCT00833755|541591|P3|STARTED|Overall Study||22
221193|NCT00833755|541592|P2|STARTED|Overall Study||18
221194|NCT00833755|541593|P1|STARTED|Overall Study||16
221195|NCT00833781|541613|P2|NOT COMPLETED|Overall Study||0
221196|NCT00833781|541614|P1|NOT COMPLETED|Overall Study||0
221197|NCT00833781|541613|P2|COMPLETED|Overall Study||5
221198|NCT00833781|541614|P1|COMPLETED|Overall Study||10
221199|NCT00833781|541613|P2|STARTED|Overall Study||5
221200|NCT00833781|541614|P1|STARTED|Overall Study||10
221201|NCT00833794|541627|P2|NOT COMPLETED|Double-blind Phase||49
221202|NCT00833794|541628|P1|NOT COMPLETED|Double-blind Phase||106
221203|NCT00833794|541627|P2|COMPLETED|Double-blind Phase||165
221204|NCT00833794|541628|P1|COMPLETED|Double-blind Phase||326
221205|NCT00833794|541627|P2|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 214 were randomized to Placebo|214
221206|NCT00833794|541628|P1|STARTED|Double-blind Phase|Of the 646 patients who completed the Open-Label phase, 432 were randomized to Tramadol Once A Day|432
221207|NCT00833794|541627|P2|NOT COMPLETED|Open-label Phase||0
221208|NCT00833794|541628|P1|NOT COMPLETED|Open-label Phase||382
221209|NCT00833794|541627|P2|COMPLETED|Open-label Phase||0
221210|NCT00833794|541628|P1|COMPLETED|Open-label Phase|Randomized in double-blind phase|646
221211|NCT00833794|541627|P2|Received Open-Label Treatment|Open-label Phase||0
221212|NCT00833794|541628|P1|Received Open-Label Treatment|Open-label Phase||1023
221213|NCT00833794|541627|P2|Entered run-in Period|Open-label Phase||0
221214|NCT00833794|541628|P1|Entered run-in Period|Open-label Phase||1027
221215|NCT00833794|541627|P2|STARTED|Open-label Phase|No Placebo arm during open-label phase.|0
221216|NCT00833794|541628|P1|STARTED|Open-label Phase|Enrolled. Population described in the baseline characteristics is 1023 patients (Open-Label safety).|1028
221217|NCT00833833|541660|P6|NOT COMPLETED|Phase 2 (as of 01 April 2011)||61
221218|NCT00833833|541661|P5|NOT COMPLETED|Phase 2 (as of 01 April 2011)||55
221219|NCT00833833|541662|P4|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
221220|NCT00833833|541663|P3|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
221221|NCT00833833|541664|P2|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
221222|NCT00833833|541665|P1|NOT COMPLETED|Phase 2 (as of 01 April 2011)||0
221223|NCT00833833|541660|P6|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|47
221224|NCT00833833|541661|P5|COMPLETED|Phase 2 (as of 01 April 2011)|Confirmed progressive disease|58
221225|NCT00833833|541662|P4|COMPLETED|Phase 2 (as of 01 April 2011)||0
221226|NCT00833833|541663|P3|COMPLETED|Phase 2 (as of 01 April 2011)||0
221227|NCT00833833|541664|P2|COMPLETED|Phase 2 (as of 01 April 2011)||0
221228|NCT00833833|541665|P1|COMPLETED|Phase 2 (as of 01 April 2011)||0
221229|NCT00833833|541660|P6|Safety Population|Phase 2 (as of 01 April 2011)||107
221230|NCT00833833|541661|P5|Safety Population|Phase 2 (as of 01 April 2011)||112
221231|NCT00833833|541662|P4|Safety Population|Phase 2 (as of 01 April 2011)||0
221232|NCT00833833|541663|P3|Safety Population|Phase 2 (as of 01 April 2011)||0
221233|NCT00833833|541664|P2|Safety Population|Phase 2 (as of 01 April 2011)||0
221234|NCT00833833|541665|P1|Safety Population|Phase 2 (as of 01 April 2011)||0
221235|NCT00833833|541660|P6|STARTED|Phase 2 (as of 01 April 2011)||108
221236|NCT00833833|541661|P5|STARTED|Phase 2 (as of 01 April 2011)||113
221237|NCT00833833|541662|P4|STARTED|Phase 2 (as of 01 April 2011)||0
221238|NCT00833833|541663|P3|STARTED|Phase 2 (as of 01 April 2011)||0
221239|NCT00833833|541664|P2|STARTED|Phase 2 (as of 01 April 2011)||0
221240|NCT00833833|541665|P1|STARTED|Phase 2 (as of 01 April 2011)||0
221241|NCT00833833|541660|P6|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
221242|NCT00833833|541661|P5|NOT COMPLETED|Phase 1 (as of 01 April 2011)||0
221243|NCT00833833|541662|P4|NOT COMPLETED|Phase 1 (as of 01 April 2011)||6
221244|NCT00833833|541663|P3|NOT COMPLETED|Phase 1 (as of 01 April 2011)||9
221245|NCT00833833|541664|P2|NOT COMPLETED|Phase 1 (as of 01 April 2011)||5
221246|NCT00833833|541665|P1|NOT COMPLETED|Phase 1 (as of 01 April 2011)||4
221247|NCT00833833|541660|P6|COMPLETED|Phase 1 (as of 01 April 2011)||0
221248|NCT00833833|541661|P5|COMPLETED|Phase 1 (as of 01 April 2011)||0
221249|NCT00833833|541662|P4|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|4
221250|NCT00833833|541663|P3|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|5
221251|NCT00833833|541664|P2|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|3
221252|NCT00833833|541665|P1|COMPLETED|Phase 1 (as of 01 April 2011)|Confirmed progressive disease|2
221253|NCT00833833|541660|P6|STARTED|Phase 1 (as of 01 April 2011)||0
221254|NCT00833833|541661|P5|STARTED|Phase 1 (as of 01 April 2011)||0
221255|NCT00833833|541662|P4|STARTED|Phase 1 (as of 01 April 2011)||10
221256|NCT00833833|541663|P3|STARTED|Phase 1 (as of 01 April 2011)||14
221257|NCT00833833|541664|P2|STARTED|Phase 1 (as of 01 April 2011)||8
221258|NCT00833833|541665|P1|STARTED|Phase 1 (as of 01 April 2011)||6
221259|NCT00833859|541703|P1|NOT COMPLETED|Overall Study||0
221260|NCT00833859|541703|P1|COMPLETED|Overall Study||2
221261|NCT00833859|541703|P1|STARTED|Overall Study||2
221262|NCT00833898|541709|P2|NOT COMPLETED|Overall Study||36
221263|NCT00833898|541710|P1|NOT COMPLETED|Overall Study||40
221264|NCT00833898|541709|P2|COMPLETED|Overall Study||38
221265|NCT00833898|541710|P1|COMPLETED|Overall Study||34
221266|NCT00833898|541709|P2|Month 12 (Post Transplantation)|Overall Study||50
221267|NCT00833898|541710|P1|Month 12 (Post Transplantation)|Overall Study||50
221268|NCT00833898|541709|P2|Month 6 (Post Transplantation)|Overall Study||54
221269|NCT00833898|541710|P1|Month 6 (Post Transplantation)|Overall Study||59
221270|NCT00833898|541709|P2|Month 3 (Post Transplantation)|Overall Study||64
221271|NCT00833898|541710|P1|Month 3 (Post Transplantation)|Overall Study||66
221272|NCT00833898|541709|P2|Month 1 (Post Transplantation)|Overall Study||74
221273|NCT00833898|541710|P1|Month 1 (Post Transplantation)|Overall Study||72
221274|NCT00833898|541709|P2|STARTED|Overall Study||74
221275|NCT00833898|541710|P1|STARTED|Overall Study||74
221276|NCT00833911|541756|P1|NOT COMPLETED|Maintenance Phase II||10
221277|NCT00833911|541756|P1|COMPLETED|Maintenance Phase II||166
221278|NCT00833911|541756|P1|STARTED|Maintenance Phase II|97 patients chose not to continue into Maintenance Phase II|176
221279|NCT00833911|541756|P1|NOT COMPLETED|Maintenance Phase I||98
221280|NCT00833911|541756|P1|COMPLETED|Maintenance Phase I||273
221281|NCT00833911|541756|P1|STARTED|Maintenance Phase I||371
221282|NCT00833911|541756|P1|NOT COMPLETED|Titration||21
221283|NCT00833911|541756|P1|COMPLETED|Titration||371
221284|NCT00833911|541756|P1|STARTED|Titration||392
221285|NCT00833924|541764|P1|NOT COMPLETED|Overall Study||109
221286|NCT00833924|541764|P1|COMPLETED|Overall Study||11
221287|NCT00833924|541764|P1|12-month|Overall Study||113
221288|NCT00833924|541764|P1|30-day|Overall Study||120
221289|NCT00833924|541764|P1|STARTED|Overall Study||120
221290|NCT00833937|541771|P2|NOT COMPLETED|Second Intervention||0
221291|NCT00833937|541772|P1|NOT COMPLETED|Second Intervention||0
221292|NCT00833937|541771|P2|COMPLETED|Second Intervention||12
221293|NCT00833937|541772|P1|COMPLETED|Second Intervention||11
221294|NCT00833937|541771|P2|STARTED|Second Intervention||12
221295|NCT00833937|541772|P1|STARTED|Second Intervention||11
221296|NCT00833937|541771|P2|NOT COMPLETED|Washout||0
221297|NCT00833937|541772|P1|NOT COMPLETED|Washout||1
221298|NCT00833937|541771|P2|COMPLETED|Washout||12
221299|NCT00833937|541772|P1|COMPLETED|Washout||11
221300|NCT00833937|541771|P2|STARTED|Washout||12
221301|NCT00833937|541772|P1|STARTED|Washout||12
221302|NCT00833937|541771|P2|NOT COMPLETED|First Intervention||0
221303|NCT00833937|541772|P1|NOT COMPLETED|First Intervention||0
221304|NCT00833937|541771|P2|COMPLETED|First Intervention||12
221305|NCT00833937|541772|P1|COMPLETED|First Intervention||12
221306|NCT00833937|541771|P2|STARTED|First Intervention||12
221307|NCT00833937|541772|P1|STARTED|First Intervention||12
221308|NCT00833976|541780|P1|NOT COMPLETED|Overall Study||51
221309|NCT00833976|541780|P1|COMPLETED|Overall Study||14
221310|NCT00833976|541780|P1|STARTED|Overall Study||65
221311|NCT00834041|541788|P2|NOT COMPLETED|Overall Study||1
221312|NCT00834041|541789|P1|NOT COMPLETED|Overall Study||1
221313|NCT00834041|541788|P2|COMPLETED|Overall Study||19
221314|NCT00834041|541789|P1|COMPLETED|Overall Study||18
221315|NCT00834041|541788|P2|STARTED|Overall Study||20
221316|NCT00834041|541789|P1|STARTED|Overall Study||19
221317|NCT00834067|541805|P2|NOT COMPLETED|Second Intervention||0
221318|NCT00834067|541806|P1|NOT COMPLETED|Second Intervention||0
221319|NCT00834067|541805|P2|COMPLETED|Second Intervention||29
221320|NCT00834067|541806|P1|COMPLETED|Second Intervention||30
221321|NCT00834067|541805|P2|STARTED|Second Intervention||29
221322|NCT00834067|541806|P1|STARTED|Second Intervention||30
221323|NCT00834067|541805|P2|NOT COMPLETED|Washout of 21 Days||1
221324|NCT00834067|541806|P1|NOT COMPLETED|Washout of 21 Days||0
221325|NCT00834067|541805|P2|COMPLETED|Washout of 21 Days||29
221326|NCT00834067|541806|P1|COMPLETED|Washout of 21 Days||30
221327|NCT00834067|541805|P2|STARTED|Washout of 21 Days||30
221328|NCT00834067|541806|P1|STARTED|Washout of 21 Days||30
221329|NCT00834067|541805|P2|NOT COMPLETED|First Intervention||0
221330|NCT00834067|541806|P1|NOT COMPLETED|First Intervention||0
221331|NCT00834067|541805|P2|COMPLETED|First Intervention||30
221332|NCT00834067|541806|P1|COMPLETED|First Intervention||30
221333|NCT00834067|541805|P2|STARTED|First Intervention||30
221334|NCT00834067|541806|P1|STARTED|First Intervention||30
221335|NCT00834080|541826|P1|NOT COMPLETED|Overall Study||23
221336|NCT00834080|541826|P1|COMPLETED|Overall Study||15
221337|NCT00834080|541826|P1|STARTED|Overall Study||38
221338|NCT00834132|541832|P2|NOT COMPLETED|Second Intervention||0
221339|NCT00834132|541833|P1|NOT COMPLETED|Second Intervention||0
221340|NCT00834132|541832|P2|COMPLETED|Second Intervention||12
221341|NCT00834132|541833|P1|COMPLETED|Second Intervention||12
221342|NCT00834132|541832|P2|STARTED|Second Intervention||12
221343|NCT00834132|541833|P1|STARTED|Second Intervention||12
221344|NCT00834132|541832|P2|NOT COMPLETED|Washout: 21 Days||0
221345|NCT00834132|541833|P1|NOT COMPLETED|Washout: 21 Days||0
221346|NCT00834132|541832|P2|COMPLETED|Washout: 21 Days||12
221347|NCT00834132|541833|P1|COMPLETED|Washout: 21 Days||12
221348|NCT00834132|541832|P2|STARTED|Washout: 21 Days||12
221349|NCT00834132|541833|P1|STARTED|Washout: 21 Days||12
221350|NCT00834132|541832|P2|NOT COMPLETED|First Intervention||0
221351|NCT00834132|541833|P1|NOT COMPLETED|First Intervention||0
221352|NCT00834132|541832|P2|COMPLETED|First Intervention||12
221353|NCT00834132|541833|P1|COMPLETED|First Intervention||12
221354|NCT00834132|541832|P2|STARTED|First Intervention||12
221355|NCT00834132|541833|P1|STARTED|First Intervention||12
221356|NCT00834171|541843|P2|NOT COMPLETED|Overall Study||0
221357|NCT00834171|541844|P1|NOT COMPLETED|Overall Study||0
221358|NCT00834171|541843|P2|COMPLETED|Overall Study||7
221359|NCT00834171|541844|P1|COMPLETED|Overall Study||43
221360|NCT00834171|541843|P2|STARTED|Overall Study||7
221361|NCT00834171|541844|P1|STARTED|Overall Study||43
221362|NCT00834197|541852|P2|NOT COMPLETED|Second Intervention||0
221363|NCT00834197|541853|P1|NOT COMPLETED|Second Intervention||0
221364|NCT00834197|541852|P2|COMPLETED|Second Intervention||16
221365|NCT00834197|541853|P1|COMPLETED|Second Intervention||16
221366|NCT00834197|541852|P2|STARTED|Second Intervention||16
221367|NCT00834197|541853|P1|STARTED|Second Intervention||16
221368|NCT00834197|541852|P2|NOT COMPLETED|Washout of 14 Days||0
221369|NCT00834197|541853|P1|NOT COMPLETED|Washout of 14 Days||0
221370|NCT00834197|541852|P2|COMPLETED|Washout of 14 Days||16
221371|NCT00834197|541853|P1|COMPLETED|Washout of 14 Days||16
221372|NCT00834197|541852|P2|STARTED|Washout of 14 Days||16
221373|NCT00834197|541853|P1|STARTED|Washout of 14 Days||16
221374|NCT00834197|541852|P2|NOT COMPLETED|First Intervention||0
221375|NCT00834197|541853|P1|NOT COMPLETED|First Intervention||0
221376|NCT00834197|541852|P2|COMPLETED|First Intervention||16
221377|NCT00834197|541853|P1|COMPLETED|First Intervention||16
221378|NCT00834197|541852|P2|STARTED|First Intervention||16
221379|NCT00834197|541853|P1|STARTED|First Intervention||16
221380|NCT00834210|541863|P2|NOT COMPLETED|Overall Study||8
221381|NCT00834210|541864|P1|NOT COMPLETED|Overall Study||3
221382|NCT00834210|541863|P2|COMPLETED|Overall Study||77
221383|NCT00834210|541864|P1|COMPLETED|Overall Study||83
221384|NCT00834210|541863|P2|STARTED|Overall Study||85
221385|NCT00834210|541864|P1|STARTED|Overall Study||86
221386|NCT00834236|541878|P2|NOT COMPLETED|Overall Study||0
221387|NCT00834236|541879|P1|NOT COMPLETED|Overall Study||0
221388|NCT00834236|541878|P2|COMPLETED|Overall Study||47
221389|NCT00834236|541879|P1|COMPLETED|Overall Study||29
221390|NCT00834236|541878|P2|STARTED|Overall Study||47
221391|NCT00834236|541879|P1|STARTED|Overall Study||29
221392|NCT00834249|541887|P2|NOT COMPLETED|Second Intervention||0
221393|NCT00834249|541888|P1|NOT COMPLETED|Second Intervention||1
221394|NCT00834249|541887|P2|COMPLETED|Second Intervention||8
221395|NCT00834249|541888|P1|COMPLETED|Second Intervention||7
221396|NCT00834249|541887|P2|STARTED|Second Intervention||8
221397|NCT00834249|541888|P1|STARTED|Second Intervention||8
221398|NCT00834249|541887|P2|NOT COMPLETED|Washout: 7 Days||1
221399|NCT00834249|541888|P1|NOT COMPLETED|Washout: 7 Days||1
221400|NCT00834249|541887|P2|COMPLETED|Washout: 7 Days||8
221401|NCT00834249|541888|P1|COMPLETED|Washout: 7 Days||8
221402|NCT00834249|541887|P2|STARTED|Washout: 7 Days||9
221403|NCT00834249|541888|P1|STARTED|Washout: 7 Days||9
221404|NCT00834249|541887|P2|NOT COMPLETED|First Intervention||0
221405|NCT00834249|541888|P1|NOT COMPLETED|First Intervention||0
221406|NCT00834249|541887|P2|COMPLETED|First Intervention||9
221407|NCT00834249|541888|P1|COMPLETED|First Intervention||9
221408|NCT00834249|541887|P2|STARTED|First Intervention||9
221409|NCT00834249|541888|P1|STARTED|First Intervention||9
221410|NCT00834275|541904|P2|NOT COMPLETED|Second Intervention||0
221411|NCT00834275|541905|P1|NOT COMPLETED|Second Intervention||0
221412|NCT00834275|541904|P2|COMPLETED|Second Intervention||13
221413|NCT00834275|541905|P1|COMPLETED|Second Intervention||13
221414|NCT00834275|541904|P2|STARTED|Second Intervention||13
221415|NCT00834275|541905|P1|STARTED|Second Intervention||13
221416|NCT00834275|541904|P2|NOT COMPLETED|Washout of 7 Days||0
221417|NCT00834275|541905|P1|NOT COMPLETED|Washout of 7 Days||0
221418|NCT00834275|541904|P2|COMPLETED|Washout of 7 Days||13
221419|NCT00834275|541905|P1|COMPLETED|Washout of 7 Days||13
221420|NCT00834275|541904|P2|STARTED|Washout of 7 Days||13
221421|NCT00834275|541905|P1|STARTED|Washout of 7 Days||13
221422|NCT00834275|541904|P2|NOT COMPLETED|First Intervention||0
221423|NCT00834275|541905|P1|NOT COMPLETED|First Intervention||0
221424|NCT00834275|541904|P2|COMPLETED|First Intervention||13
221425|NCT00834275|541905|P1|COMPLETED|First Intervention||13
221426|NCT00834275|541904|P2|STARTED|First Intervention||13
221427|NCT00834275|541905|P1|STARTED|First Intervention||13
221428|NCT00834288|541915|P2|NOT COMPLETED|Treatment Phase II||0
221429|NCT00834288|541916|P1|NOT COMPLETED|Treatment Phase II||0
221430|NCT00834288|541915|P2|COMPLETED|Treatment Phase II||13
221431|NCT00834288|541916|P1|COMPLETED|Treatment Phase II||13
221432|NCT00834288|541915|P2|STARTED|Treatment Phase II||13
221433|NCT00834288|541916|P1|STARTED|Treatment Phase II||13
221434|NCT00834288|541915|P2|NOT COMPLETED|Treatment Phase I||0
221435|NCT00834288|541916|P1|NOT COMPLETED|Treatment Phase I||0
221436|NCT00834288|541915|P2|COMPLETED|Treatment Phase I||13
221437|NCT00834288|541916|P1|COMPLETED|Treatment Phase I||13
221438|NCT00834288|541915|P2|STARTED|Treatment Phase I||13
221439|NCT00834288|541916|P1|STARTED|Treatment Phase I||13
221440|NCT00834340|541938|P2|NOT COMPLETED|Second Intervention||0
221441|NCT00834340|541939|P1|NOT COMPLETED|Second Intervention||0
221442|NCT00834340|541938|P2|COMPLETED|Second Intervention||16
221443|NCT00834340|541939|P1|COMPLETED|Second Intervention||14
221444|NCT00834340|541938|P2|STARTED|Second Intervention||16
221445|NCT00834340|541939|P1|STARTED|Second Intervention||14
221446|NCT00834340|541938|P2|NOT COMPLETED|Washout||0
221447|NCT00834340|541939|P1|NOT COMPLETED|Washout||2
221448|NCT00834340|541938|P2|COMPLETED|Washout||16
221449|NCT00834340|541939|P1|COMPLETED|Washout||14
221450|NCT00834340|541938|P2|STARTED|Washout||16
221451|NCT00834340|541939|P1|STARTED|Washout||16
221452|NCT00834340|541938|P2|NOT COMPLETED|First Intervention||0
221453|NCT00834340|541939|P1|NOT COMPLETED|First Intervention||0
221454|NCT00834340|541938|P2|COMPLETED|First Intervention||16
221455|NCT00834340|541939|P1|COMPLETED|First Intervention||16
221456|NCT00834340|541938|P2|STARTED|First Intervention||16
221457|NCT00834340|541939|P1|STARTED|First Intervention||16
221458|NCT00834366|541949|P2|NOT COMPLETED|Treatment Period 2||0
221459|NCT00834366|541950|P1|NOT COMPLETED|Treatment Period 2||0
221460|NCT00834366|541949|P2|COMPLETED|Treatment Period 2||12
221461|NCT00834366|541950|P1|COMPLETED|Treatment Period 2||12
221462|NCT00834366|541949|P2|STARTED|Treatment Period 2||12
221463|NCT00834366|541950|P1|STARTED|Treatment Period 2||12
221464|NCT00834366|541949|P2|NOT COMPLETED|Treatment Period 1||1
221465|NCT00834366|541950|P1|NOT COMPLETED|Treatment Period 1||1
221466|NCT00834366|541949|P2|COMPLETED|Treatment Period 1||12
221467|NCT00834366|541950|P1|COMPLETED|Treatment Period 1||12
221468|NCT00834366|541949|P2|STARTED|Treatment Period 1||13
221469|NCT00834366|541950|P1|STARTED|Treatment Period 1||13
221470|NCT00834405|541966|P2|NOT COMPLETED|Overall Study||0
221471|NCT00834405|541967|P1|NOT COMPLETED|Overall Study||0
221472|NCT00834405|541966|P2|COMPLETED|Overall Study||17
221473|NCT00834405|541967|P1|COMPLETED|Overall Study||20
221474|NCT00834405|541966|P2|STARTED|Overall Study||17
221475|NCT00834405|541967|P1|STARTED|Overall Study||20
221476|NCT00834418|541975|P2|NOT COMPLETED|Overall Study||2
221477|NCT00834418|541976|P1|NOT COMPLETED|Overall Study||0
221478|NCT00834418|541975|P2|COMPLETED|Overall Study||40
221479|NCT00834418|541976|P1|COMPLETED|Overall Study||42
221480|NCT00834418|541975|P2|STARTED|Overall Study||42
221481|NCT00834418|541976|P1|STARTED|Overall Study||42
221482|NCT00834431|541984|P2|NOT COMPLETED|Second Intervention||0
221483|NCT00834431|541985|P1|NOT COMPLETED|Second Intervention||0
221484|NCT00834431|541984|P2|COMPLETED|Second Intervention||16
221485|NCT00834431|541985|P1|COMPLETED|Second Intervention||18
221486|NCT00834431|541984|P2|STARTED|Second Intervention||16
221487|NCT00834431|541985|P1|STARTED|Second Intervention||18
221488|NCT00834431|541984|P2|NOT COMPLETED|Washout of 7 Days||1
221489|NCT00834431|541985|P1|NOT COMPLETED|Washout of 7 Days||0
221490|NCT00834431|541984|P2|COMPLETED|Washout of 7 Days||16
221491|NCT00834431|541985|P1|COMPLETED|Washout of 7 Days||18
221492|NCT00834431|541984|P2|STARTED|Washout of 7 Days||17
221493|NCT00834431|541985|P1|STARTED|Washout of 7 Days||18
221494|NCT00834431|541984|P2|NOT COMPLETED|First Intervention||1
221495|NCT00834431|541985|P1|NOT COMPLETED|First Intervention||0
221496|NCT00834431|541984|P2|COMPLETED|First Intervention||17
221497|NCT00834431|541985|P1|COMPLETED|First Intervention||18
221498|NCT00834431|541984|P2|STARTED|First Intervention||18
221499|NCT00834431|541985|P1|STARTED|First Intervention||18
221500|NCT00834444|541995|P2|NOT COMPLETED|Second Intervention||0
221501|NCT00834444|541996|P1|NOT COMPLETED|Second Intervention||1
221502|NCT00834444|541995|P2|COMPLETED|Second Intervention||16
221503|NCT00834444|541996|P1|COMPLETED|Second Intervention||16
221504|NCT00834444|541995|P2|STARTED|Second Intervention||16
221505|NCT00834444|541996|P1|STARTED|Second Intervention||17
221506|NCT00834444|541995|P2|NOT COMPLETED|Washout of 7 Days||1
221507|NCT00834444|541996|P1|NOT COMPLETED|Washout of 7 Days||0
221508|NCT00834444|541995|P2|COMPLETED|Washout of 7 Days||16
221509|NCT00834444|541996|P1|COMPLETED|Washout of 7 Days||17
221510|NCT00834444|541995|P2|STARTED|Washout of 7 Days||17
221511|NCT00834444|541996|P1|STARTED|Washout of 7 Days||17
221512|NCT00834444|541995|P2|NOT COMPLETED|First Intervention||1
221513|NCT00834444|541996|P1|NOT COMPLETED|First Intervention||1
221514|NCT00834444|541995|P2|COMPLETED|First Intervention||17
221515|NCT00834444|541996|P1|COMPLETED|First Intervention||17
221516|NCT00834444|541995|P2|STARTED|First Intervention||18
221517|NCT00834444|541996|P1|STARTED|First Intervention||18
221518|NCT00834483|542006|P2|NOT COMPLETED|Overall Study||0
221519|NCT00834483|542007|P1|NOT COMPLETED|Overall Study||0
221520|NCT00834483|542006|P2|COMPLETED|Overall Study||29
221521|NCT00834483|542007|P1|COMPLETED|Overall Study||31
221522|NCT00834483|542006|P2|STARTED|Overall Study||29
221523|NCT00834483|542007|P1|STARTED|Overall Study||31
221524|NCT00834522|542019|P2|NOT COMPLETED|Second Intervention||0
221525|NCT00834522|542020|P1|NOT COMPLETED|Second Intervention||0
221526|NCT00834522|542019|P2|COMPLETED|Second Intervention||39
221527|NCT00834522|542020|P1|COMPLETED|Second Intervention||37
221528|NCT00834522|542019|P2|STARTED|Second Intervention||39
221529|NCT00834522|542020|P1|STARTED|Second Intervention||37
221530|NCT00834522|542019|P2|NOT COMPLETED|Washout||1
221531|NCT00834522|542020|P1|NOT COMPLETED|Washout||3
221532|NCT00834522|542019|P2|COMPLETED|Washout||39
221533|NCT00834522|542020|P1|COMPLETED|Washout||37
221534|NCT00834522|542019|P2|STARTED|Washout||40
221535|NCT00834522|542020|P1|STARTED|Washout||40
221536|NCT00834522|542019|P2|NOT COMPLETED|First Intervention||0
221537|NCT00834522|542020|P1|NOT COMPLETED|First Intervention||0
221538|NCT00834522|542019|P2|COMPLETED|First Intervention||40
221539|NCT00834522|542020|P1|COMPLETED|First Intervention||40
221540|NCT00834522|542019|P2|STARTED|First Intervention||40
221541|NCT00834522|542020|P1|STARTED|First Intervention||40
221542|NCT00834535|542030|P2|NOT COMPLETED|Second Intervention||0
221543|NCT00834535|542031|P1|NOT COMPLETED|Second Intervention||0
221544|NCT00834535|542030|P2|COMPLETED|Second Intervention||16
221545|NCT00834535|542031|P1|COMPLETED|Second Intervention||16
221546|NCT00834535|542030|P2|STARTED|Second Intervention||16
221547|NCT00834535|542031|P1|STARTED|Second Intervention||16
221548|NCT00834535|542030|P2|NOT COMPLETED|Washout of 7 Days||0
221549|NCT00834535|542031|P1|NOT COMPLETED|Washout of 7 Days||0
221550|NCT00834535|542030|P2|COMPLETED|Washout of 7 Days||16
221551|NCT00834535|542031|P1|COMPLETED|Washout of 7 Days||16
221552|NCT00834535|542030|P2|STARTED|Washout of 7 Days||16
221553|NCT00834535|542031|P1|STARTED|Washout of 7 Days||16
221554|NCT00834535|542030|P2|NOT COMPLETED|First Intervention||0
221555|NCT00834535|542031|P1|NOT COMPLETED|First Intervention||0
221556|NCT00834535|542030|P2|COMPLETED|First Intervention||16
221557|NCT00834535|542031|P1|COMPLETED|First Intervention||16
221558|NCT00834535|542030|P2|STARTED|First Intervention||16
221559|NCT00834535|542031|P1|STARTED|First Intervention||16
221560|NCT00834561|542041|P2|NOT COMPLETED|Second Intervention||0
221561|NCT00834561|542042|P1|NOT COMPLETED|Second Intervention||0
221562|NCT00834561|542041|P2|COMPLETED|Second Intervention||16
221563|NCT00834561|542042|P1|COMPLETED|Second Intervention||16
221564|NCT00834561|542041|P2|STARTED|Second Intervention||16
221565|NCT00834561|542042|P1|STARTED|Second Intervention||16
221566|NCT00834561|542041|P2|NOT COMPLETED|First Intervention||0
221567|NCT00834561|542042|P1|NOT COMPLETED|First Intervention||0
221568|NCT00834561|542041|P2|COMPLETED|First Intervention||16
221569|NCT00834561|542042|P1|COMPLETED|First Intervention||16
221570|NCT00834561|542041|P2|STARTED|First Intervention||16
221571|NCT00834561|542042|P1|STARTED|First Intervention||16
221572|NCT00834574|542052|P2|NOT COMPLETED|Second Intervention||0
221573|NCT00834574|542053|P1|NOT COMPLETED|Second Intervention||0
221574|NCT00834574|542052|P2|COMPLETED|Second Intervention||16
221575|NCT00834574|542053|P1|COMPLETED|Second Intervention||16
221576|NCT00834574|542052|P2|STARTED|Second Intervention||16
221577|NCT00834574|542053|P1|STARTED|Second Intervention||16
221578|NCT00834574|542052|P2|NOT COMPLETED|Washout of 7 Days||0
221579|NCT00834574|542053|P1|NOT COMPLETED|Washout of 7 Days||0
221580|NCT00834574|542052|P2|COMPLETED|Washout of 7 Days||16
221581|NCT00834574|542053|P1|COMPLETED|Washout of 7 Days||16
221582|NCT00834574|542052|P2|STARTED|Washout of 7 Days||16
221583|NCT00834574|542053|P1|STARTED|Washout of 7 Days||16
221584|NCT00834574|542052|P2|NOT COMPLETED|First Intervention||0
221585|NCT00834574|542053|P1|NOT COMPLETED|First Intervention||0
221586|NCT00834574|542052|P2|COMPLETED|First Intervention||16
221587|NCT00834574|542053|P1|COMPLETED|First Intervention||16
221588|NCT00834574|542052|P2|STARTED|First Intervention||16
221589|NCT00834574|542053|P1|STARTED|First Intervention||16
221590|NCT00834587|542063|P2|NOT COMPLETED|Second Intervention||0
221591|NCT00834587|542064|P1|NOT COMPLETED|Second Intervention||0
221592|NCT00834587|542063|P2|COMPLETED|Second Intervention||20
221593|NCT00834587|542064|P1|COMPLETED|Second Intervention||19
221594|NCT00834587|542063|P2|STARTED|Second Intervention||20
221595|NCT00834587|542064|P1|STARTED|Second Intervention||19
221596|NCT00834587|542063|P2|NOT COMPLETED|Washout: 7 Days||0
221597|NCT00834587|542064|P1|NOT COMPLETED|Washout: 7 Days||1
221598|NCT00834587|542063|P2|COMPLETED|Washout: 7 Days||20
221599|NCT00834587|542064|P1|COMPLETED|Washout: 7 Days||19
221600|NCT00834587|542063|P2|STARTED|Washout: 7 Days||20
221601|NCT00834587|542064|P1|STARTED|Washout: 7 Days||20
221602|NCT00834587|542063|P2|NOT COMPLETED|First Intervention||0
221603|NCT00834587|542064|P1|NOT COMPLETED|First Intervention||0
221604|NCT00834587|542063|P2|COMPLETED|First Intervention||20
221605|NCT00834587|542064|P1|COMPLETED|First Intervention||20
221606|NCT00834587|542063|P2|STARTED|First Intervention||20
221607|NCT00834587|542064|P1|STARTED|First Intervention||20
221608|NCT00834613|542080|P2|NOT COMPLETED|Second Intervention||0
221609|NCT00834613|542081|P1|NOT COMPLETED|Second Intervention||0
221610|NCT00834613|542080|P2|COMPLETED|Second Intervention||16
221611|NCT00834613|542081|P1|COMPLETED|Second Intervention||15
221612|NCT00834613|542080|P2|STARTED|Second Intervention||16
221613|NCT00834613|542081|P1|STARTED|Second Intervention||15
221614|NCT00834613|542080|P2|NOT COMPLETED|Washout of 7 Days||0
221615|NCT00834613|542081|P1|NOT COMPLETED|Washout of 7 Days||0
221616|NCT00834613|542080|P2|COMPLETED|Washout of 7 Days||16
221617|NCT00834613|542081|P1|COMPLETED|Washout of 7 Days||15
221618|NCT00834613|542080|P2|STARTED|Washout of 7 Days||16
221619|NCT00834613|542081|P1|STARTED|Washout of 7 Days||15
221620|NCT00834613|542080|P2|NOT COMPLETED|First Intervention||0
221621|NCT00834613|542081|P1|NOT COMPLETED|First Intervention||1
221622|NCT00834613|542080|P2|COMPLETED|First Intervention||16
221623|NCT00834613|542081|P1|COMPLETED|First Intervention||15
221624|NCT00834613|542080|P2|STARTED|First Intervention||16
221625|NCT00834613|542081|P1|STARTED|First Intervention||16
221626|NCT00834626|542089|P1|NOT COMPLETED|Overall Study||0
221627|NCT00834626|542089|P1|COMPLETED|Overall Study||30
221628|NCT00834626|542089|P1|1 Year Follow-up|Overall Study||30
221629|NCT00834626|542089|P1|STARTED|Overall Study||30
221630|NCT00834639|542098|P2|NOT COMPLETED|Second Intervention||2
221631|NCT00834639|542099|P1|NOT COMPLETED|Second Intervention||0
221632|NCT00834639|542098|P2|COMPLETED|Second Intervention||10
221633|NCT00834639|542099|P1|COMPLETED|Second Intervention||12
221634|NCT00834639|542098|P2|STARTED|Second Intervention||12
221635|NCT00834639|542099|P1|STARTED|Second Intervention||12
221636|NCT00834639|542098|P2|NOT COMPLETED|Washout of 7 Days||0
221637|NCT00834639|542099|P1|NOT COMPLETED|Washout of 7 Days||0
221638|NCT00834639|542098|P2|COMPLETED|Washout of 7 Days||12
221639|NCT00834639|542099|P1|COMPLETED|Washout of 7 Days||12
221640|NCT00834639|542098|P2|STARTED|Washout of 7 Days||12
221641|NCT00834639|542099|P1|STARTED|Washout of 7 Days||12
221642|NCT00834639|542098|P2|NOT COMPLETED|First Intervention||0
221643|NCT00834639|542099|P1|NOT COMPLETED|First Intervention||0
221644|NCT00834639|542098|P2|COMPLETED|First Intervention||12
221645|NCT00834639|542099|P1|COMPLETED|First Intervention||12
221646|NCT00834639|542098|P2|STARTED|First Intervention||12
221647|NCT00834639|542099|P1|STARTED|First Intervention||12
221648|NCT00834678|542107|P1|NOT COMPLETED|Overall Study||0
221649|NCT00834678|542107|P1|COMPLETED|Overall Study||11
221650|NCT00834678|542107|P1|STARTED|Overall Study||11
221651|NCT00834717|542120|P2|NOT COMPLETED|Second Intervention||0
221652|NCT00834717|542121|P1|NOT COMPLETED|Second Intervention||0
221653|NCT00834717|542120|P2|COMPLETED|Second Intervention||19
221654|NCT00834717|542121|P1|COMPLETED|Second Intervention||19
221655|NCT00834717|542120|P2|STARTED|Second Intervention||19
221656|NCT00834717|542121|P1|STARTED|Second Intervention||19
221657|NCT00834717|542120|P2|NOT COMPLETED|First Intervention||1
221658|NCT00834717|542121|P1|NOT COMPLETED|First Intervention||1
221659|NCT00834717|542120|P2|COMPLETED|First Intervention||19
221660|NCT00834717|542121|P1|COMPLETED|First Intervention||19
221661|NCT00834717|542120|P2|STARTED|First Intervention||20
221662|NCT00834717|542121|P1|STARTED|First Intervention||20
221663|NCT00834743|542131|P2|NOT COMPLETED|Second Intervention||0
221664|NCT00834743|542132|P1|NOT COMPLETED|Second Intervention||1
221665|NCT00834743|542131|P2|COMPLETED|Second Intervention||16
221666|NCT00834743|542132|P1|COMPLETED|Second Intervention||15
221667|NCT00834743|542131|P2|STARTED|Second Intervention||16
221668|NCT00834743|542132|P1|STARTED|Second Intervention||16
221669|NCT00834743|542131|P2|NOT COMPLETED|Washout of 7 Days||0
221670|NCT00834743|542132|P1|NOT COMPLETED|Washout of 7 Days||0
221671|NCT00834743|542131|P2|COMPLETED|Washout of 7 Days||16
221672|NCT00834743|542132|P1|COMPLETED|Washout of 7 Days||16
221673|NCT00834743|542131|P2|STARTED|Washout of 7 Days||16
221674|NCT00834743|542132|P1|STARTED|Washout of 7 Days||16
221675|NCT00834743|542131|P2|NOT COMPLETED|First Intervention||0
221676|NCT00834743|542132|P1|NOT COMPLETED|First Intervention||0
221677|NCT00834743|542131|P2|COMPLETED|First Intervention||16
221678|NCT00834743|542132|P1|COMPLETED|First Intervention||16
221679|NCT00834743|542131|P2|STARTED|First Intervention||16
221680|NCT00834743|542132|P1|STARTED|First Intervention||16
221681|NCT00834756|542142|P2|NOT COMPLETED|Second Intervention||0
221682|NCT00834756|542143|P1|NOT COMPLETED|Second Intervention||0
221683|NCT00834756|542142|P2|COMPLETED|Second Intervention||18
221684|NCT00834756|542143|P1|COMPLETED|Second Intervention||16
221685|NCT00834756|542142|P2|STARTED|Second Intervention||18
221686|NCT00834756|542143|P1|STARTED|Second Intervention||16
221687|NCT00834756|542142|P2|NOT COMPLETED|Washout: 21 Days||0
221688|NCT00834756|542143|P1|NOT COMPLETED|Washout: 21 Days||1
221689|NCT00834756|542142|P2|COMPLETED|Washout: 21 Days||18
221690|NCT00834756|542143|P1|COMPLETED|Washout: 21 Days||16
221691|NCT00834756|542142|P2|STARTED|Washout: 21 Days||18
221692|NCT00834756|542143|P1|STARTED|Washout: 21 Days||17
221693|NCT00834756|542142|P2|NOT COMPLETED|First Intervention||0
221694|NCT00834756|542143|P1|NOT COMPLETED|First Intervention||1
221695|NCT00834756|542142|P2|COMPLETED|First Intervention||18
221696|NCT00834756|542143|P1|COMPLETED|First Intervention||17
221697|NCT00834756|542142|P2|STARTED|First Intervention||18
221698|NCT00834756|542143|P1|STARTED|First Intervention||18
221699|NCT00834795|542153|P2|NOT COMPLETED|Second Intervention||0
221700|NCT00834795|542154|P1|NOT COMPLETED|Second Intervention||1
221701|NCT00834795|542153|P2|COMPLETED|Second Intervention||17
221702|NCT00834795|542154|P1|COMPLETED|Second Intervention||17
221703|NCT00834795|542153|P2|STARTED|Second Intervention||17
221704|NCT00834795|542154|P1|STARTED|Second Intervention||18
221705|NCT00834795|542153|P2|NOT COMPLETED|Washout: 7 Days||1
221706|NCT00834795|542154|P1|NOT COMPLETED|Washout: 7 Days||0
221707|NCT00834795|542153|P2|COMPLETED|Washout: 7 Days||17
221708|NCT00834795|542154|P1|COMPLETED|Washout: 7 Days||18
221709|NCT00834795|542153|P2|STARTED|Washout: 7 Days||18
221710|NCT00834795|542154|P1|STARTED|Washout: 7 Days||18
221711|NCT00834795|542153|P2|NOT COMPLETED|First Intervention||0
221712|NCT00834795|542154|P1|NOT COMPLETED|First Intervention||0
221713|NCT00834795|542153|P2|COMPLETED|First Intervention||18
221714|NCT00834795|542154|P1|COMPLETED|First Intervention||18
221715|NCT00834795|542153|P2|STARTED|First Intervention||18
221716|NCT00834795|542154|P1|STARTED|First Intervention||18
221717|NCT00834808|542165|P3|NOT COMPLETED|Treatment Period 3 (Day 15)||0
221718|NCT00834808|542166|P2|NOT COMPLETED|Treatment Period 3 (Day 15)||0
221719|NCT00834808|542167|P1|NOT COMPLETED|Treatment Period 3 (Day 15)||0
221720|NCT00834808|542165|P3|COMPLETED|Treatment Period 3 (Day 15)||9
221721|NCT00834808|542166|P2|COMPLETED|Treatment Period 3 (Day 15)||9
221722|NCT00834808|542167|P1|COMPLETED|Treatment Period 3 (Day 15)||9
221723|NCT00834808|542165|P3|STARTED|Treatment Period 3 (Day 15)||9
221724|NCT00834808|542166|P2|STARTED|Treatment Period 3 (Day 15)||9
221725|NCT00834808|542167|P1|STARTED|Treatment Period 3 (Day 15)||9
221726|NCT00834808|542165|P3|NOT COMPLETED|Treatment Period 2 (Day 8)||0
221727|NCT00834808|542166|P2|NOT COMPLETED|Treatment Period 2 (Day 8)||0
221728|NCT00834808|542167|P1|NOT COMPLETED|Treatment Period 2 (Day 8)||0
221729|NCT00834808|542165|P3|COMPLETED|Treatment Period 2 (Day 8)||9
221730|NCT00834808|542166|P2|COMPLETED|Treatment Period 2 (Day 8)||9
221731|NCT00834808|542167|P1|COMPLETED|Treatment Period 2 (Day 8)||9
221732|NCT00834808|542165|P3|STARTED|Treatment Period 2 (Day 8)||9
221733|NCT00834808|542166|P2|STARTED|Treatment Period 2 (Day 8)||9
221734|NCT00834808|542167|P1|STARTED|Treatment Period 2 (Day 8)||9
221735|NCT00834808|542165|P3|NOT COMPLETED|Treatment Period 1 (Day 1)||0
221736|NCT00834808|542166|P2|NOT COMPLETED|Treatment Period 1 (Day 1)||0
221737|NCT00834808|542167|P1|NOT COMPLETED|Treatment Period 1 (Day 1)||0
221738|NCT00834808|542165|P3|COMPLETED|Treatment Period 1 (Day 1)||9
221739|NCT00834808|542166|P2|COMPLETED|Treatment Period 1 (Day 1)||9
221740|NCT00834808|542167|P1|COMPLETED|Treatment Period 1 (Day 1)||9
221741|NCT00834808|542165|P3|STARTED|Treatment Period 1 (Day 1)||9
221742|NCT00834808|542166|P2|STARTED|Treatment Period 1 (Day 1)||9
221743|NCT00834808|542167|P1|STARTED|Treatment Period 1 (Day 1)||9
221744|NCT00834834|542189|P2|NOT COMPLETED|Overall Study||3
221745|NCT00834834|542190|P1|NOT COMPLETED|Overall Study||4
221746|NCT00834834|542189|P2|COMPLETED|Overall Study||39
221747|NCT00834834|542190|P1|COMPLETED|Overall Study||38
221748|NCT00834834|542189|P2|STARTED|Overall Study||42
221749|NCT00834834|542190|P1|STARTED|Overall Study||42
221750|NCT00834873|542200|P2|NOT COMPLETED|Second Intervention||0
221751|NCT00834873|542201|P1|NOT COMPLETED|Second Intervention||0
221752|NCT00834873|542200|P2|COMPLETED|Second Intervention||11
221753|NCT00834873|542201|P1|COMPLETED|Second Intervention||12
221754|NCT00834873|542200|P2|STARTED|Second Intervention||11
221755|NCT00834873|542201|P1|STARTED|Second Intervention||12
221756|NCT00834873|542200|P2|NOT COMPLETED|Washout: 7 Days||0
221757|NCT00834873|542201|P1|NOT COMPLETED|Washout: 7 Days||0
221758|NCT00834873|542200|P2|COMPLETED|Washout: 7 Days||11
221759|NCT00834873|542201|P1|COMPLETED|Washout: 7 Days||12
221760|NCT00834873|542200|P2|STARTED|Washout: 7 Days||11
221761|NCT00834873|542201|P1|STARTED|Washout: 7 Days||12
221762|NCT00834873|542200|P2|NOT COMPLETED|First Intervention||1
221763|NCT00834873|542201|P1|NOT COMPLETED|First Intervention||0
221764|NCT00834873|542200|P2|COMPLETED|First Intervention||11
221765|NCT00834873|542201|P1|COMPLETED|First Intervention||12
221766|NCT00834873|542200|P2|STARTED|First Intervention||12
221767|NCT00834873|542201|P1|STARTED|First Intervention||12
221768|NCT00834886|542213|P4|NOT COMPLETED|Overall Study||0
221769|NCT00834886|542214|P3|NOT COMPLETED|Overall Study||1
221770|NCT00834886|542215|P2|NOT COMPLETED|Overall Study||1
221771|NCT00834886|542216|P1|NOT COMPLETED|Overall Study||0
221772|NCT00834886|542213|P4|COMPLETED|Overall Study||10
221773|NCT00834886|542214|P3|COMPLETED|Overall Study||9
221774|NCT00834886|542215|P2|COMPLETED|Overall Study||9
221775|NCT00834886|542216|P1|COMPLETED|Overall Study||10
221776|NCT00834886|542213|P4|STARTED|Overall Study||10
221777|NCT00834886|542214|P3|STARTED|Overall Study||10
221778|NCT00834886|542215|P2|STARTED|Overall Study||10
221779|NCT00834886|542216|P1|STARTED|Overall Study||10
221780|NCT00834899|542236|P2|NOT COMPLETED|Overall Study||1
221781|NCT00834899|542237|P1|NOT COMPLETED|Overall Study||1
221782|NCT00834899|542236|P2|COMPLETED|Overall Study|One patient was withdrawn early because she did not meet eligibility criteria.|3
221783|NCT00834899|542237|P1|COMPLETED|Overall Study|One patient withdrew consent following completion of the study drug infusion.|8
221784|NCT00834899|542236|P2|STARTED|Overall Study||4
221785|NCT00834899|542237|P1|STARTED|Overall Study||9
221786|NCT00834912|542255|P6|NOT COMPLETED|Treatment Period 3||0
221787|NCT00834912|542256|P5|NOT COMPLETED|Treatment Period 3||0
221788|NCT00834912|542257|P4|NOT COMPLETED|Treatment Period 3||0
221789|NCT00834912|542258|P3|NOT COMPLETED|Treatment Period 3||0
221790|NCT00834912|542259|P2|NOT COMPLETED|Treatment Period 3||0
221791|NCT00834912|542260|P1|NOT COMPLETED|Treatment Period 3||0
221792|NCT00834912|542255|P6|COMPLETED|Treatment Period 3||6
221793|NCT00834912|542256|P5|COMPLETED|Treatment Period 3||5
221794|NCT00834912|542257|P4|COMPLETED|Treatment Period 3||5
221795|NCT00834912|542258|P3|COMPLETED|Treatment Period 3||5
221796|NCT00834912|542259|P2|COMPLETED|Treatment Period 3||5
221797|NCT00834912|542260|P1|COMPLETED|Treatment Period 3||6
221798|NCT00834912|542255|P6|STARTED|Treatment Period 3||6
221799|NCT00834912|542256|P5|STARTED|Treatment Period 3||5
221800|NCT00834912|542257|P4|STARTED|Treatment Period 3||5
221801|NCT00834912|542258|P3|STARTED|Treatment Period 3||5
221802|NCT00834912|542259|P2|STARTED|Treatment Period 3||5
221803|NCT00834912|542260|P1|STARTED|Treatment Period 3||6
221804|NCT00834912|542255|P6|NOT COMPLETED|Treatment Period 2||0
221805|NCT00834912|542256|P5|NOT COMPLETED|Treatment Period 2||1
221806|NCT00834912|542257|P4|NOT COMPLETED|Treatment Period 2||0
221807|NCT00834912|542258|P3|NOT COMPLETED|Treatment Period 2||1
221808|NCT00834912|542259|P2|NOT COMPLETED|Treatment Period 2||0
221809|NCT00834912|542260|P1|NOT COMPLETED|Treatment Period 2||0
221810|NCT00834912|542255|P6|COMPLETED|Treatment Period 2||6
221811|NCT00834912|542256|P5|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
221812|NCT00834912|542257|P4|COMPLETED|Treatment Period 2||5
221813|NCT00834912|542258|P3|COMPLETED|Treatment Period 2|One subject completed treatment period 2 but did not enter treatment period 3|5
221814|NCT00834912|542259|P2|COMPLETED|Treatment Period 2||5
221815|NCT00834912|542260|P1|COMPLETED|Treatment Period 2||6
221816|NCT00834912|542255|P6|STARTED|Treatment Period 2||6
221817|NCT00834912|542256|P5|STARTED|Treatment Period 2||6
221818|NCT00834912|542257|P4|STARTED|Treatment Period 2||5
221819|NCT00834912|542258|P3|STARTED|Treatment Period 2||6
221820|NCT00834912|542259|P2|STARTED|Treatment Period 2||5
221821|NCT00834912|542260|P1|STARTED|Treatment Period 2||6
221822|NCT00834912|542255|P6|NOT COMPLETED|Treatment Period 1||0
221823|NCT00834912|542256|P5|NOT COMPLETED|Treatment Period 1||0
221824|NCT00834912|542257|P4|NOT COMPLETED|Treatment Period 1||1
221825|NCT00834912|542258|P3|NOT COMPLETED|Treatment Period 1||0
221826|NCT00834912|542259|P2|NOT COMPLETED|Treatment Period 1||1
221827|NCT00834912|542260|P1|NOT COMPLETED|Treatment Period 1||0
221828|NCT00834912|542255|P6|COMPLETED|Treatment Period 1||6
221829|NCT00834912|542256|P5|COMPLETED|Treatment Period 1||6
221830|NCT00834912|542257|P4|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
221831|NCT00834912|542258|P3|COMPLETED|Treatment Period 1||6
221832|NCT00834912|542259|P2|COMPLETED|Treatment Period 1|One subject completed all of treatment period 1 assessments but did not enter treatment period 2|5
221833|NCT00834912|542260|P1|COMPLETED|Treatment Period 1||6
221834|NCT00834912|542255|P6|STARTED|Treatment Period 1||6
221835|NCT00834912|542256|P5|STARTED|Treatment Period 1||6
221836|NCT00834912|542257|P4|STARTED|Treatment Period 1||6
221837|NCT00834912|542258|P3|STARTED|Treatment Period 1||6
221838|NCT00834912|542259|P2|STARTED|Treatment Period 1||6
221839|NCT00834912|542260|P1|STARTED|Treatment Period 1||6
221840|NCT00834964|542282|P2|NOT COMPLETED|Second Intervention||0
221841|NCT00834964|542283|P1|NOT COMPLETED|Second Intervention||0
221842|NCT00834964|542282|P2|COMPLETED|Second Intervention||15
221843|NCT00834964|542283|P1|COMPLETED|Second Intervention||15
221844|NCT00834964|542282|P2|STARTED|Second Intervention||15
221845|NCT00834964|542283|P1|STARTED|Second Intervention||15
221846|NCT00834964|542282|P2|NOT COMPLETED|Washout: 7 Days||0
221847|NCT00834964|542283|P1|NOT COMPLETED|Washout: 7 Days||0
221848|NCT00834964|542282|P2|COMPLETED|Washout: 7 Days||15
221849|NCT00834964|542283|P1|COMPLETED|Washout: 7 Days||15
221850|NCT00834964|542282|P2|STARTED|Washout: 7 Days||15
221851|NCT00834964|542283|P1|STARTED|Washout: 7 Days||15
221852|NCT00834964|542282|P2|NOT COMPLETED|First Intervention||0
221853|NCT00834964|542283|P1|NOT COMPLETED|First Intervention||0
221854|NCT00834964|542282|P2|COMPLETED|First Intervention||15
221855|NCT00834964|542283|P1|COMPLETED|First Intervention||15
221856|NCT00834964|542282|P2|STARTED|First Intervention||15
221857|NCT00834964|542283|P1|STARTED|First Intervention||15
221858|NCT00834977|542299|P2|NOT COMPLETED|Second Intervention||0
221859|NCT00834977|542300|P1|NOT COMPLETED|Second Intervention||0
221860|NCT00834977|542299|P2|COMPLETED|Second Intervention||24
221861|NCT00834977|542300|P1|COMPLETED|Second Intervention||24
221862|NCT00834977|542299|P2|STARTED|Second Intervention||24
221863|NCT00834977|542300|P1|STARTED|Second Intervention||24
221864|NCT00834977|542299|P2|NOT COMPLETED|First Intervention||0
221865|NCT00834977|542300|P1|NOT COMPLETED|First Intervention||0
221866|NCT00834977|542299|P2|COMPLETED|First Intervention||24
221867|NCT00834977|542300|P1|COMPLETED|First Intervention||24
221868|NCT00834977|542299|P2|STARTED|First Intervention||24
221869|NCT00834977|542300|P1|STARTED|First Intervention||24
221870|NCT00834990|542322|P2|NOT COMPLETED|Second Intervention||0
221871|NCT00834990|542323|P1|NOT COMPLETED|Second Intervention||0
221872|NCT00834990|542322|P2|COMPLETED|Second Intervention||11
221873|NCT00834990|542323|P1|COMPLETED|Second Intervention||12
221874|NCT00834990|542322|P2|STARTED|Second Intervention||11
221875|NCT00834990|542323|P1|STARTED|Second Intervention||12
221876|NCT00834990|542322|P2|NOT COMPLETED|Washout of 7 Days||0
221877|NCT00834990|542323|P1|NOT COMPLETED|Washout of 7 Days||0
221878|NCT00834990|542322|P2|COMPLETED|Washout of 7 Days||11
221879|NCT00834990|542323|P1|COMPLETED|Washout of 7 Days||12
221880|NCT00834990|542322|P2|STARTED|Washout of 7 Days||11
221881|NCT00834990|542323|P1|STARTED|Washout of 7 Days||12
221882|NCT00834990|542322|P2|NOT COMPLETED|First Intervention||0
221883|NCT00834990|542323|P1|NOT COMPLETED|First Intervention||0
221884|NCT00834990|542322|P2|COMPLETED|First Intervention||11
221885|NCT00834990|542323|P1|COMPLETED|First Intervention||12
221886|NCT00834990|542322|P2|STARTED|First Intervention||11
221887|NCT00834990|542323|P1|STARTED|First Intervention||12
221888|NCT00835003|542333|P2|NOT COMPLETED|Overall Study||0
221889|NCT00835003|542334|P1|NOT COMPLETED|Overall Study||0
221890|NCT00835003|542333|P2|COMPLETED|Overall Study||638
221891|NCT00835003|542334|P1|COMPLETED|Overall Study||636
221892|NCT00835003|542333|P2|STARTED|Overall Study||638
221893|NCT00835003|542334|P1|STARTED|Overall Study||636
221894|NCT00835042|542342|P2|NOT COMPLETED|Second Intervention||0
221895|NCT00835042|542343|P1|NOT COMPLETED|Second Intervention||0
221896|NCT00835042|542342|P2|COMPLETED|Second Intervention||24
221897|NCT00835042|542343|P1|COMPLETED|Second Intervention||26
221898|NCT00835042|542342|P2|STARTED|Second Intervention||24
221899|NCT00835042|542343|P1|STARTED|Second Intervention||26
221900|NCT00835042|542342|P2|NOT COMPLETED|Washout of 21 Days||2
221901|NCT00835042|542343|P1|NOT COMPLETED|Washout of 21 Days||0
221902|NCT00835042|542342|P2|COMPLETED|Washout of 21 Days||24
221903|NCT00835042|542343|P1|COMPLETED|Washout of 21 Days||26
221904|NCT00835042|542342|P2|STARTED|Washout of 21 Days||26
221905|NCT00835042|542343|P1|STARTED|Washout of 21 Days||26
221906|NCT00835042|542342|P2|NOT COMPLETED|First Intervention||2
221907|NCT00835042|542343|P1|NOT COMPLETED|First Intervention||4
221908|NCT00835042|542342|P2|COMPLETED|First Intervention||26
221909|NCT00835042|542343|P1|COMPLETED|First Intervention||26
221910|NCT00835042|542342|P2|STARTED|First Intervention||28
221911|NCT00835042|542343|P1|STARTED|First Intervention||30
221912|NCT00835068|542365|P2|NOT COMPLETED|Overall Study||1
221913|NCT00835068|542366|P1|NOT COMPLETED|Overall Study||10
221914|NCT00835068|542365|P2|COMPLETED|Overall Study||0
221915|NCT00835068|542366|P1|COMPLETED|Overall Study||47
221916|NCT00835068|542365|P2|STARTED|Overall Study||1
221917|NCT00835068|542366|P1|STARTED|Overall Study||57
221918|NCT00835081|542386|P2|NOT COMPLETED|Second Intervention||0
221919|NCT00835081|542387|P1|NOT COMPLETED|Second Intervention||0
221920|NCT00835081|542386|P2|COMPLETED|Second Intervention||13
221921|NCT00835081|542387|P1|COMPLETED|Second Intervention||12
221922|NCT00835081|542386|P2|STARTED|Second Intervention||13
221923|NCT00835081|542387|P1|STARTED|Second Intervention||12
221924|NCT00835081|542386|P2|NOT COMPLETED|Washout of 7 Days||0
221925|NCT00835081|542387|P1|NOT COMPLETED|Washout of 7 Days||1
221926|NCT00835081|542386|P2|COMPLETED|Washout of 7 Days||13
221927|NCT00835081|542387|P1|COMPLETED|Washout of 7 Days||12
221928|NCT00835081|542386|P2|STARTED|Washout of 7 Days||13
221929|NCT00835081|542387|P1|STARTED|Washout of 7 Days||13
221930|NCT00835081|542386|P2|NOT COMPLETED|First Intervention||0
221931|NCT00835081|542387|P1|NOT COMPLETED|First Intervention||0
221932|NCT00835081|542386|P2|COMPLETED|First Intervention||13
221933|NCT00835081|542387|P1|COMPLETED|First Intervention||13
221934|NCT00835081|542386|P2|STARTED|First Intervention||13
221935|NCT00835081|542387|P1|STARTED|First Intervention||13
221936|NCT00835120|542395|P1|NOT COMPLETED|Overall Study||8
221937|NCT00835120|542395|P1|COMPLETED|Overall Study||26
221938|NCT00835120|542395|P1|STARTED|Overall Study||34
221939|NCT00835146|542405|P2|NOT COMPLETED|Second Intervention||0
221940|NCT00835146|542406|P1|NOT COMPLETED|Second Intervention||0
221941|NCT00835146|542405|P2|COMPLETED|Second Intervention||14
221942|NCT00835146|542406|P1|COMPLETED|Second Intervention||14
221943|NCT00835146|542405|P2|STARTED|Second Intervention||14
221944|NCT00835146|542406|P1|STARTED|Second Intervention||14
221945|NCT00835146|542405|P2|NOT COMPLETED|Washout of 5 Weeks||0
221946|NCT00835146|542406|P1|NOT COMPLETED|Washout of 5 Weeks||0
221947|NCT00835146|542405|P2|COMPLETED|Washout of 5 Weeks||14
221948|NCT00835146|542406|P1|COMPLETED|Washout of 5 Weeks||14
221949|NCT00835146|542405|P2|STARTED|Washout of 5 Weeks||14
221950|NCT00835146|542406|P1|STARTED|Washout of 5 Weeks||14
221951|NCT00835146|542405|P2|NOT COMPLETED|First Intervention||0
221952|NCT00835146|542406|P1|NOT COMPLETED|First Intervention||0
221953|NCT00835146|542405|P2|COMPLETED|First Intervention||14
221954|NCT00835146|542406|P1|COMPLETED|First Intervention||14
221955|NCT00835146|542405|P2|STARTED|First Intervention||14
221956|NCT00835146|542406|P1|STARTED|First Intervention||14
221957|NCT00828412|542414|P2|NOT COMPLETED|Overall Study||2
221958|NCT00828412|542415|P1|NOT COMPLETED|Overall Study||9
221959|NCT00828412|542414|P2|COMPLETED|Overall Study||48
221960|NCT00828412|542415|P1|COMPLETED|Overall Study||41
221961|NCT00828412|542414|P2|STARTED|Overall Study||50
221962|NCT00828412|542415|P1|STARTED|Overall Study||50
221963|NCT00828464|542421|P1|NOT COMPLETED|Overall Study||1
221964|NCT00828464|542421|P1|COMPLETED|Overall Study||29
221965|NCT00828464|542421|P1|STARTED|Overall Study||30
221966|NCT00828516|542438|P1|NOT COMPLETED|Clinical Phase: Series 2||0
221967|NCT00828516|542438|P1|COMPLETED|Clinical Phase: Series 2||30
221968|NCT00828516|542438|P1|STARTED|Clinical Phase: Series 2||30
221969|NCT00828516|542438|P1|NOT COMPLETED|Clinical Phase: Series 1||2
221970|NCT00828516|542438|P1|COMPLETED|Clinical Phase: Series 1||33
221971|NCT00828516|542438|P1|STARTED|Clinical Phase: Series 1||35
221972|NCT00828542|542445|P2|NOT COMPLETED|Overall Study||3
221973|NCT00828542|542446|P1|NOT COMPLETED|Overall Study||3
221974|NCT00828542|542445|P2|COMPLETED|Overall Study||20
221975|NCT00828542|542446|P1|COMPLETED|Overall Study||20
221976|NCT00828542|542445|P2|STARTED|Overall Study||23
221977|NCT00828542|542446|P1|STARTED|Overall Study||23
221978|NCT00828568|542455|P3|NOT COMPLETED|Treated - Received at Least One Dose||5
221979|NCT00828568|542456|P2|NOT COMPLETED|Treated - Received at Least One Dose||29
221980|NCT00828568|542457|P1|NOT COMPLETED|Treated - Received at Least One Dose||30
221981|NCT00828568|542455|P3|COMPLETED|Treated - Received at Least One Dose||55
221982|NCT00828568|542456|P2|COMPLETED|Treated - Received at Least One Dose||150
221983|NCT00828568|542457|P1|COMPLETED|Treated - Received at Least One Dose||153
221984|NCT00828568|542455|P3|STARTED|Treated - Received at Least One Dose||60
221985|NCT00828568|542456|P2|STARTED|Treated - Received at Least One Dose||179
221986|NCT00828568|542457|P1|STARTED|Treated - Received at Least One Dose||183
221987|NCT00828568|542455|P3|NOT COMPLETED|Randomized||2
221988|NCT00828568|542456|P2|NOT COMPLETED|Randomized||0
221989|NCT00828568|542457|P1|NOT COMPLETED|Randomized||1
221990|NCT00828568|542455|P3|COMPLETED|Randomized||60
221991|NCT00828568|542456|P2|COMPLETED|Randomized||179
221992|NCT00828568|542457|P1|COMPLETED|Randomized||183
221993|NCT00828568|542455|P3|STARTED|Randomized||62
221994|NCT00828568|542456|P2|STARTED|Randomized||179
221995|NCT00828568|542457|P1|STARTED|Randomized||184
221996|NCT00828711|542473|P3|NOT COMPLETED|Overall Study||0
221997|NCT00828711|542474|P2|NOT COMPLETED|Overall Study||0
221998|NCT00828711|542475|P1|NOT COMPLETED|Overall Study||1
221999|NCT00828711|542473|P3|COMPLETED|Overall Study||131
222000|NCT00828711|542474|P2|COMPLETED|Overall Study||125
222001|NCT00828711|542475|P1|COMPLETED|Overall Study||117
222002|NCT00828711|542473|P3|STARTED|Overall Study||131
222003|NCT00828711|542474|P2|STARTED|Overall Study||125
222004|NCT00828711|542475|P1|STARTED|Overall Study||118
222005|NCT00828750|542504|P1|NOT COMPLETED|Overall Study||4
222006|NCT00828750|542504|P1|COMPLETED|Overall Study||15
222007|NCT00828750|542504|P1|STARTED|Overall Study||19
222008|NCT00828841|542518|P3|NOT COMPLETED|Overall Study||4
222009|NCT00828841|542519|P2|NOT COMPLETED|Overall Study||4
222010|NCT00828841|542520|P1|NOT COMPLETED|Overall Study||4
222011|NCT00828841|542518|P3|COMPLETED|Overall Study||126
222012|NCT00828841|542519|P2|COMPLETED|Overall Study||232
222013|NCT00828841|542520|P1|COMPLETED|Overall Study||231
222014|NCT00828841|542518|P3|STARTED|Overall Study||130
222015|NCT00828841|542519|P2|STARTED|Overall Study||236
222016|NCT00828841|542520|P1|STARTED|Overall Study||235
222017|NCT00828945|542533|P1|NOT COMPLETED|Overall Study||41
222018|NCT00828945|542533|P1|COMPLETED|Overall Study||216
222019|NCT00828945|542533|P1|STARTED|Overall Study||257
222020|NCT00828984|542550|P3|NOT COMPLETED|Overall Study||9
222021|NCT00828984|542551|P2|NOT COMPLETED|Overall Study||16
222022|NCT00828984|542552|P1|NOT COMPLETED|Overall Study||14
222023|NCT00828984|542550|P3|COMPLETED|Overall Study||19
222024|NCT00828984|542551|P2|COMPLETED|Overall Study||15
222025|NCT00828984|542552|P1|COMPLETED|Overall Study||14
222026|NCT00828984|542550|P3|Post Intervention Follow-Up|Overall Study||19
222027|NCT00828984|542551|P2|Post Intervention Follow-Up|Overall Study||16
222028|NCT00828984|542552|P1|Post Intervention Follow-Up|Overall Study||15
222029|NCT00828984|542550|P3|Flexible Sigmoidoscopy|Overall Study||19
222030|NCT00828984|542551|P2|Flexible Sigmoidoscopy|Overall Study||19
222031|NCT00828984|542552|P1|Flexible Sigmoidoscopy|Overall Study||20
222032|NCT00828984|542550|P3|Treatment|Overall Study||24
222033|NCT00828984|542551|P2|Treatment|Overall Study||26
222034|NCT00828984|542552|P1|Treatment|Overall Study||24
222035|NCT00828984|542550|P3|Randomization|Overall Study||28
222036|NCT00828984|542551|P2|Randomization|Overall Study||31
222037|NCT00828984|542552|P1|Randomization|Overall Study||28
222038|NCT00828984|542550|P3|STARTED|Overall Study||28
222039|NCT00828984|542551|P2|STARTED|Overall Study||31
222040|NCT00828984|542552|P1|STARTED|Overall Study||28
222041|NCT00829010|542580|P5|NOT COMPLETED|Overall Study||2
222042|NCT00829010|542581|P4|NOT COMPLETED|Overall Study||8
222043|NCT00829010|542582|P3|NOT COMPLETED|Overall Study||3
222044|NCT00829010|542583|P2|NOT COMPLETED|Overall Study||9
222045|NCT00829010|542584|P1|NOT COMPLETED|Overall Study||10
222046|NCT00829010|542580|P5|COMPLETED|Overall Study||98
222047|NCT00829010|542581|P4|COMPLETED|Overall Study||92
222048|NCT00829010|542582|P3|COMPLETED|Overall Study||97
222049|NCT00829010|542583|P2|COMPLETED|Overall Study||92
222050|NCT00829010|542584|P1|COMPLETED|Overall Study||73
222051|NCT00829010|542580|P5|STARTED|Overall Study||100
222052|NCT00829010|542581|P4|STARTED|Overall Study||100
222053|NCT00829010|542582|P3|STARTED|Overall Study||100
222054|NCT00829010|542583|P2|STARTED|Overall Study||101
222055|NCT00829010|542584|P1|STARTED|Overall Study||83
222056|NCT00829036|542746|P1|NOT COMPLETED|Overall Study||0
222057|NCT00829036|542746|P1|COMPLETED|Overall Study||24
222058|NCT00829036|542746|P1|STARTED|Overall Study||24
222059|NCT00829049|542752|P2|NOT COMPLETED|Overall Study||20
222060|NCT00829049|542753|P1|NOT COMPLETED|Overall Study||17
222061|NCT00829049|542752|P2|COMPLETED|Overall Study||68
222062|NCT00829049|542753|P1|COMPLETED|Overall Study||60
222063|NCT00829049|542752|P2|STARTED|Overall Study||88
222064|NCT00829049|542753|P1|STARTED|Overall Study||77
222065|NCT00835159|542767|P2|NOT COMPLETED|Overall Study||0
222066|NCT00835159|542768|P1|NOT COMPLETED|Overall Study||0
222067|NCT00835159|542767|P2|COMPLETED|Overall Study||17
222068|NCT00835159|542768|P1|COMPLETED|Overall Study||11
222069|NCT00835159|542767|P2|STARTED|Overall Study||17
222070|NCT00835159|542768|P1|STARTED|Overall Study||11
222071|NCT00835172|542776|P2|NOT COMPLETED|Second Intervention||0
222072|NCT00835172|542777|P1|NOT COMPLETED|Second Intervention||0
222073|NCT00835172|542776|P2|COMPLETED|Second Intervention||15
222074|NCT00835172|542777|P1|COMPLETED|Second Intervention||16
222075|NCT00835172|542776|P2|STARTED|Second Intervention||15
222076|NCT00835172|542777|P1|STARTED|Second Intervention||16
222077|NCT00835172|542776|P2|NOT COMPLETED|Washout||1
222078|NCT00835172|542777|P1|NOT COMPLETED|Washout||0
222079|NCT00835172|542776|P2|COMPLETED|Washout||15
222080|NCT00835172|542777|P1|COMPLETED|Washout||16
222081|NCT00835172|542776|P2|STARTED|Washout||16
222082|NCT00835172|542777|P1|STARTED|Washout||16
222083|NCT00835172|542776|P2|NOT COMPLETED|First Intervention||0
222084|NCT00835172|542777|P1|NOT COMPLETED|First Intervention||0
222085|NCT00835172|542776|P2|COMPLETED|First Intervention||16
222086|NCT00835172|542777|P1|COMPLETED|First Intervention||16
222087|NCT00835172|542776|P2|STARTED|First Intervention||16
222088|NCT00835172|542777|P1|STARTED|First Intervention||16
222089|NCT00835185|542785|P1|NOT COMPLETED|Overall Study||0
222090|NCT00835185|542785|P1|COMPLETED|Overall Study||44
222091|NCT00835185|542785|P1|Received at Least 1 Dose of Study Drug|Overall Study||44
222092|NCT00835185|542785|P1|STARTED|Overall Study||44
222093|NCT00835198|542808|P2|NOT COMPLETED|Overall Study||7
222094|NCT00835198|542809|P1|NOT COMPLETED|Overall Study||8
222095|NCT00835198|542808|P2|COMPLETED|Overall Study||74
222096|NCT00835198|542809|P1|COMPLETED|Overall Study||74
222097|NCT00835198|542808|P2|STARTED|Overall Study||81
222098|NCT00835198|542809|P1|STARTED|Overall Study||82
222099|NCT00835211|542823|P2|NOT COMPLETED|Second Intervention||0
222100|NCT00835211|542824|P1|NOT COMPLETED|Second Intervention||0
222101|NCT00835211|542823|P2|COMPLETED|Second Intervention||22
222102|NCT00835211|542824|P1|COMPLETED|Second Intervention||21
222103|NCT00835211|542823|P2|STARTED|Second Intervention||22
222104|NCT00835211|542824|P1|STARTED|Second Intervention||21
222105|NCT00835211|542823|P2|NOT COMPLETED|Washout: 7 Days||1
222106|NCT00835211|542824|P1|NOT COMPLETED|Washout: 7 Days||3
222107|NCT00835211|542823|P2|COMPLETED|Washout: 7 Days||22
222108|NCT00835211|542824|P1|COMPLETED|Washout: 7 Days||21
222109|NCT00835211|542823|P2|STARTED|Washout: 7 Days||23
222110|NCT00835211|542824|P1|STARTED|Washout: 7 Days||24
222111|NCT00835211|542823|P2|NOT COMPLETED|First Intervention||1
222112|NCT00835211|542824|P1|NOT COMPLETED|First Intervention||0
222113|NCT00835211|542823|P2|COMPLETED|First Intervention||23
222114|NCT00835211|542824|P1|COMPLETED|First Intervention||24
222115|NCT00835211|542823|P2|STARTED|First Intervention||24
222116|NCT00835211|542824|P1|STARTED|First Intervention||24
222117|NCT00835224|542832|P1|NOT COMPLETED|Overall Study||10
222118|NCT00835224|542832|P1|COMPLETED|Overall Study||24
222119|NCT00835224|542832|P1|STARTED|Overall Study||34
222120|NCT00835237|542848|P2|NOT COMPLETED|Overall Study||0
222121|NCT00835237|542849|P1|NOT COMPLETED|Overall Study||6
222122|NCT00835237|542848|P2|COMPLETED|Overall Study||445
222123|NCT00835237|542849|P1|COMPLETED|Overall Study||881
222124|NCT00835237|542848|P2|STARTED|Overall Study||445
222125|NCT00835237|542849|P1|STARTED|Overall Study||887
222126|NCT00835263|542875|P2|NOT COMPLETED|Second Intervention||0
222127|NCT00835263|542876|P1|NOT COMPLETED|Second Intervention||1
222128|NCT00835263|542875|P2|COMPLETED|Second Intervention||16
222129|NCT00835263|542876|P1|COMPLETED|Second Intervention||15
222130|NCT00835263|542875|P2|STARTED|Second Intervention||16
222131|NCT00835263|542876|P1|STARTED|Second Intervention||16
222132|NCT00835263|542875|P2|NOT COMPLETED|First Intervention||0
222133|NCT00835263|542876|P1|NOT COMPLETED|First Intervention||0
222134|NCT00835263|542875|P2|COMPLETED|First Intervention||16
222135|NCT00835263|542876|P1|COMPLETED|First Intervention||16
222136|NCT00835263|542875|P2|STARTED|First Intervention||16
222137|NCT00835263|542876|P1|STARTED|First Intervention||16
222138|NCT00835276|542886|P2|NOT COMPLETED|Second Intervention||0
222139|NCT00835276|542887|P1|NOT COMPLETED|Second Intervention||0
222140|NCT00835276|542886|P2|COMPLETED|Second Intervention||24
222141|NCT00835276|542887|P1|COMPLETED|Second Intervention||24
222142|NCT00835276|542886|P2|STARTED|Second Intervention||24
222143|NCT00835276|542887|P1|STARTED|Second Intervention||24
222144|NCT00835276|542886|P2|NOT COMPLETED|Washout of 7 Days||0
222145|NCT00835276|542887|P1|NOT COMPLETED|Washout of 7 Days||0
222146|NCT00835276|542886|P2|COMPLETED|Washout of 7 Days||24
222147|NCT00835276|542887|P1|COMPLETED|Washout of 7 Days||24
222148|NCT00835276|542886|P2|STARTED|Washout of 7 Days||24
222149|NCT00835276|542887|P1|STARTED|Washout of 7 Days||24
222150|NCT00835276|542886|P2|NOT COMPLETED|First Intervention||0
222151|NCT00835276|542887|P1|NOT COMPLETED|First Intervention||0
222152|NCT00835276|542886|P2|COMPLETED|First Intervention||24
222153|NCT00835276|542887|P1|COMPLETED|First Intervention||24
222154|NCT00835276|542886|P2|STARTED|First Intervention||24
222155|NCT00835276|542887|P1|STARTED|First Intervention||24
222156|NCT00835341|542897|P2|NOT COMPLETED|Overall Study||12
222157|NCT00835341|542898|P1|NOT COMPLETED|Overall Study||3
222158|NCT00835341|542897|P2|COMPLETED|Overall Study||46
222159|NCT00835341|542898|P1|COMPLETED|Overall Study||32
222160|NCT00835341|542897|P2|STARTED|Overall Study||58
222161|NCT00835341|542898|P1|STARTED|Overall Study||35
222162|NCT00835354|542906|P2|NOT COMPLETED|Second Intervention||0
222163|NCT00835354|542907|P1|NOT COMPLETED|Second Intervention||0
222164|NCT00835354|542906|P2|COMPLETED|Second Intervention||12
222165|NCT00835354|542907|P1|COMPLETED|Second Intervention||13
222166|NCT00835354|542906|P2|STARTED|Second Intervention||12
222167|NCT00835354|542907|P1|STARTED|Second Intervention||13
222168|NCT00835354|542906|P2|NOT COMPLETED|Washout of 7 Days||0
222169|NCT00835354|542907|P1|NOT COMPLETED|Washout of 7 Days||0
222170|NCT00835354|542906|P2|COMPLETED|Washout of 7 Days||12
222171|NCT00835354|542907|P1|COMPLETED|Washout of 7 Days||13
222172|NCT00835354|542906|P2|STARTED|Washout of 7 Days||12
222173|NCT00835354|542907|P1|STARTED|Washout of 7 Days||13
222174|NCT00835354|542906|P2|NOT COMPLETED|First Intervention||1
222175|NCT00835354|542907|P1|NOT COMPLETED|First Intervention||0
222176|NCT00835354|542906|P2|COMPLETED|First Intervention||12
222177|NCT00835354|542907|P1|COMPLETED|First Intervention||13
222178|NCT00835354|542906|P2|STARTED|First Intervention||13
222179|NCT00835354|542907|P1|STARTED|First Intervention||13
222180|NCT00835367|542917|P2|NOT COMPLETED|Second Intervention||1
222181|NCT00835367|542918|P1|NOT COMPLETED|Second Intervention||1
222182|NCT00835367|542917|P2|COMPLETED|Second Intervention||33
222183|NCT00835367|542918|P1|COMPLETED|Second Intervention||30
222184|NCT00835367|542917|P2|STARTED|Second Intervention||34
222185|NCT00835367|542918|P1|STARTED|Second Intervention||31
222186|NCT00835367|542917|P2|NOT COMPLETED|Washout||0
222187|NCT00835367|542918|P1|NOT COMPLETED|Washout||3
222188|NCT00835367|542917|P2|COMPLETED|Washout||34
222189|NCT00835367|542918|P1|COMPLETED|Washout||31
222190|NCT00835367|542917|P2|STARTED|Washout||34
222191|NCT00835367|542918|P1|STARTED|Washout||34
222192|NCT00835367|542917|P2|NOT COMPLETED|First Intervention||0
222193|NCT00835367|542918|P1|NOT COMPLETED|First Intervention||0
222194|NCT00835367|542917|P2|COMPLETED|First Intervention||34
222195|NCT00835367|542918|P1|COMPLETED|First Intervention||34
222196|NCT00835367|542917|P2|STARTED|First Intervention||34
222197|NCT00835367|542918|P1|STARTED|First Intervention||34
222198|NCT00835380|542938|P1|NOT COMPLETED|Overall Study||2
222199|NCT00835380|542938|P1|COMPLETED|Overall Study||78
222200|NCT00835380|542938|P1|STARTED|Overall Study||80
222201|NCT00835406|542945|P2|NOT COMPLETED|Period: Second Intervention||0
222202|NCT00835406|542946|P1|NOT COMPLETED|Period: Second Intervention||0
222203|NCT00835406|542945|P2|COMPLETED|Period: Second Intervention||67
222204|NCT00835406|542946|P1|COMPLETED|Period: Second Intervention||68
222205|NCT00835406|542945|P2|STARTED|Period: Second Intervention||67
222206|NCT00835406|542946|P1|STARTED|Period: Second Intervention||68
222207|NCT00835406|542945|P2|NOT COMPLETED|Period: Washout of 7 Days||2
222208|NCT00835406|542946|P1|NOT COMPLETED|Period: Washout of 7 Days||0
222209|NCT00835406|542945|P2|COMPLETED|Period: Washout of 7 Days||67
222210|NCT00835406|542946|P1|COMPLETED|Period: Washout of 7 Days||68
222211|NCT00835406|542945|P2|STARTED|Period: Washout of 7 Days||69
222212|NCT00835406|542946|P1|STARTED|Period: Washout of 7 Days||68
222213|NCT00835406|542945|P2|NOT COMPLETED|Period: First Intervention||1
222214|NCT00835406|542946|P1|NOT COMPLETED|Period: First Intervention||2
222215|NCT00835406|542945|P2|COMPLETED|Period: First Intervention||69
222216|NCT00835406|542946|P1|COMPLETED|Period: First Intervention||68
222217|NCT00835406|542945|P2|STARTED|Period: First Intervention||70
222218|NCT00835406|542946|P1|STARTED|Period: First Intervention||70
222219|NCT00835484|542954|P2|NOT COMPLETED|Second Intervention||0
222220|NCT00835484|542955|P1|NOT COMPLETED|Second Intervention||0
222221|NCT00835484|542954|P2|COMPLETED|Second Intervention||16
222222|NCT00835484|542955|P1|COMPLETED|Second Intervention||16
222223|NCT00835484|542954|P2|STARTED|Second Intervention||16
222224|NCT00835484|542955|P1|STARTED|Second Intervention||16
222225|NCT00835484|542954|P2|NOT COMPLETED|Washout of 7 Days||0
222226|NCT00835484|542955|P1|NOT COMPLETED|Washout of 7 Days||0
222227|NCT00835484|542954|P2|COMPLETED|Washout of 7 Days||16
222228|NCT00835484|542955|P1|COMPLETED|Washout of 7 Days||16
222229|NCT00835484|542954|P2|STARTED|Washout of 7 Days||16
222230|NCT00835484|542955|P1|STARTED|Washout of 7 Days||16
222231|NCT00835484|542954|P2|NOT COMPLETED|First Intervention||0
222232|NCT00835484|542955|P1|NOT COMPLETED|First Intervention||0
222233|NCT00835484|542954|P2|COMPLETED|First Intervention||16
222234|NCT00835484|542955|P1|COMPLETED|First Intervention||16
222235|NCT00835484|542954|P2|STARTED|First Intervention||16
222236|NCT00835484|542955|P1|STARTED|First Intervention||16
222237|NCT00835861|542965|P2|NOT COMPLETED|Overall Study||2
222238|NCT00835861|542966|P1|NOT COMPLETED|Overall Study||1
222239|NCT00835861|542965|P2|COMPLETED|Overall Study||14
222240|NCT00835861|542966|P1|COMPLETED|Overall Study||14
222241|NCT00835861|542965|P2|STARTED|Overall Study||16
222242|NCT00835861|542966|P1|STARTED|Overall Study||15
222243|NCT00835900|542990|P2|NOT COMPLETED|Overall Study||6
222244|NCT00835900|542991|P1|NOT COMPLETED|Overall Study||5
222245|NCT00835900|542990|P2|COMPLETED|Overall Study||22
222246|NCT00835900|542991|P1|COMPLETED|Overall Study||27
222247|NCT00835900|542990|P2|STARTED|Overall Study||28
222248|NCT00835900|542991|P1|STARTED|Overall Study||32
222249|NCT00835926|543001|P2|NOT COMPLETED|Overall Study||0
222250|NCT00835926|543002|P1|NOT COMPLETED|Overall Study||0
222251|NCT00835926|543001|P2|COMPLETED|Overall Study||60
222252|NCT00835926|543002|P1|COMPLETED|Overall Study||61
222253|NCT00835926|543001|P2|STARTED|Overall Study||60
222254|NCT00835926|543002|P1|STARTED|Overall Study||61
222255|NCT00835978|543018|P4|NOT COMPLETED|Overall Study||10
222256|NCT00835978|543019|P3|NOT COMPLETED|Overall Study||91
222257|NCT00835978|543020|P2|NOT COMPLETED|Overall Study||56
222258|NCT00835978|543021|P1|NOT COMPLETED|Overall Study||56
222259|NCT00835978|543018|P4|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
222260|NCT00835978|543019|P3|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
222261|NCT00835978|543020|P2|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
222262|NCT00835978|543021|P1|COMPLETED|Overall Study|Study Completion: 29 Feb 2016. Treatment discontinued due to objective progression/relapse & death|0
222263|NCT00835978|543018|P4|Treated|Overall Study||10
222264|NCT00835978|543019|P3|Treated|Overall Study||91
222265|NCT00835978|543020|P2|Treated|Overall Study||56
222266|NCT00835978|543021|P1|Treated|Overall Study||56
222267|NCT00835978|543018|P4|STARTED|Overall Study||10
222268|NCT00835978|543019|P3|STARTED|Overall Study||91
222269|NCT00835978|543020|P2|STARTED|Overall Study||56
222270|NCT00835978|543021|P1|STARTED|Overall Study||56
222271|NCT00835991|543081|P2|NOT COMPLETED|Second Intervention||0
222272|NCT00835991|543082|P1|NOT COMPLETED|Second Intervention||0
222273|NCT00835991|543081|P2|COMPLETED|Second Intervention||26
222274|NCT00835991|543082|P1|COMPLETED|Second Intervention||27
222275|NCT00835991|543081|P2|STARTED|Second Intervention||26
222276|NCT00835991|543082|P1|STARTED|Second Intervention||27
222277|NCT00835991|543081|P2|NOT COMPLETED|Washout||3
222278|NCT00835991|543082|P1|NOT COMPLETED|Washout||3
222279|NCT00835991|543081|P2|COMPLETED|Washout||26
222280|NCT00835991|543082|P1|COMPLETED|Washout||27
222281|NCT00835991|543081|P2|STARTED|Washout||29
222282|NCT00835991|543082|P1|STARTED|Washout||30
222283|NCT00835991|543081|P2|NOT COMPLETED|First Intervention||1
222284|NCT00835991|543082|P1|NOT COMPLETED|First Intervention||0
222285|NCT00835991|543081|P2|COMPLETED|First Intervention||29
222286|NCT00835991|543082|P1|COMPLETED|First Intervention||30
222287|NCT00835991|543081|P2|STARTED|First Intervention||30
222288|NCT00835991|543082|P1|STARTED|First Intervention||30
222289|NCT00836004|543098|P2|NOT COMPLETED|Second Intervention||0
222290|NCT00836004|543099|P1|NOT COMPLETED|Second Intervention||0
222291|NCT00836004|543098|P2|COMPLETED|Second Intervention||12
222292|NCT00836004|543099|P1|COMPLETED|Second Intervention||12
222293|NCT00836004|543098|P2|STARTED|Second Intervention||12
222294|NCT00836004|543099|P1|STARTED|Second Intervention||12
222295|NCT00836004|543098|P2|NOT COMPLETED|Washout: 7 Days||0
222296|NCT00836004|543099|P1|NOT COMPLETED|Washout: 7 Days||0
222297|NCT00836004|543098|P2|COMPLETED|Washout: 7 Days||12
222298|NCT00836004|543099|P1|COMPLETED|Washout: 7 Days||12
222299|NCT00836004|543098|P2|STARTED|Washout: 7 Days||12
222300|NCT00836004|543099|P1|STARTED|Washout: 7 Days||12
222301|NCT00836004|543098|P2|NOT COMPLETED|First Intervention||0
222302|NCT00836004|543099|P1|NOT COMPLETED|First Intervention||0
222303|NCT00836004|543098|P2|COMPLETED|First Intervention||12
222304|NCT00836004|543099|P1|COMPLETED|First Intervention||12
222305|NCT00836004|543098|P2|STARTED|First Intervention||12
222306|NCT00836004|543099|P1|STARTED|First Intervention||12
222307|NCT00836017|543107|P1|NOT COMPLETED|Overall Study||544
222308|NCT00836017|543107|P1|COMPLETED|Overall Study||502
222309|NCT00836017|543107|P1|STARTED|Overall Study||1046
222310|NCT00836056|543117|P2|NOT COMPLETED|Second Intervention||0
222311|NCT00836056|543118|P1|NOT COMPLETED|Second Intervention||0
222312|NCT00836056|543117|P2|COMPLETED|Second Intervention||12
222313|NCT00836056|543118|P1|COMPLETED|Second Intervention||11
222314|NCT00836056|543117|P2|STARTED|Second Intervention||12
222315|NCT00836056|543118|P1|STARTED|Second Intervention||11
222316|NCT00836056|543117|P2|NOT COMPLETED|Washout: 7 Days||0
222317|NCT00836056|543118|P1|NOT COMPLETED|Washout: 7 Days||0
222318|NCT00836056|543117|P2|COMPLETED|Washout: 7 Days||12
222319|NCT00836056|543118|P1|COMPLETED|Washout: 7 Days||11
222320|NCT00836056|543117|P2|STARTED|Washout: 7 Days||12
222321|NCT00836056|543118|P1|STARTED|Washout: 7 Days||11
222322|NCT00836056|543117|P2|NOT COMPLETED|First Intervention||0
222323|NCT00836056|543118|P1|NOT COMPLETED|First Intervention||1
222324|NCT00836056|543117|P2|COMPLETED|First Intervention||12
222325|NCT00836056|543118|P1|COMPLETED|First Intervention||11
222326|NCT00836056|543117|P2|STARTED|First Intervention||12
222327|NCT00836056|543118|P1|STARTED|First Intervention||12
222328|NCT00836095|543128|P2|NOT COMPLETED|Overall Study||3
222329|NCT00836095|543129|P1|NOT COMPLETED|Overall Study||0
222330|NCT00836095|543128|P2|COMPLETED|Overall Study||27
222331|NCT00836095|543129|P1|COMPLETED|Overall Study||22
222332|NCT00836095|543128|P2|STARTED|Overall Study||30
222333|NCT00836095|543129|P1|STARTED|Overall Study||22
222334|NCT00836277|543137|P1|NOT COMPLETED|Overall Study||6
222335|NCT00836277|543137|P1|COMPLETED|Overall Study||18
222336|NCT00836277|543137|P1|STARTED|Overall Study||24
222337|NCT00836342|543148|P3|NOT COMPLETED|Overall Study||0
222338|NCT00836342|543149|P2|NOT COMPLETED|Overall Study||0
222339|NCT00836342|543150|P1|NOT COMPLETED|Overall Study||0
222340|NCT00836342|543148|P3|COMPLETED|Overall Study||36
222341|NCT00836342|543149|P2|COMPLETED|Overall Study||23
222342|NCT00836342|543150|P1|COMPLETED|Overall Study||22
222343|NCT00836342|543148|P3|STARTED|Overall Study||36
222344|NCT00836342|543149|P2|STARTED|Overall Study||23
222345|NCT00836342|543150|P1|STARTED|Overall Study||22
222346|NCT00836355|543165|P4|NOT COMPLETED|Overall Study||0
222347|NCT00836355|543166|P3|NOT COMPLETED|Overall Study||0
222348|NCT00836355|543167|P2|NOT COMPLETED|Overall Study||0
222349|NCT00836355|543168|P1|NOT COMPLETED|Overall Study||0
222350|NCT00836355|543165|P4|COMPLETED|Overall Study||2
222351|NCT00836355|543166|P3|COMPLETED|Overall Study||0
222352|NCT00836355|543167|P2|COMPLETED|Overall Study||4
222353|NCT00836355|543168|P1|COMPLETED|Overall Study||0
222354|NCT00836355|543165|P4|STARTED|Overall Study||2
222355|NCT00836355|543166|P3|STARTED|Overall Study||0
222356|NCT00836355|543167|P2|STARTED|Overall Study||4
222357|NCT00836355|543168|P1|STARTED|Overall Study||0
222358|NCT00836407|543188|P2|NOT COMPLETED|Overall Study||8
222359|NCT00836407|543189|P1|NOT COMPLETED|Overall Study||11
222360|NCT00836407|543188|P2|COMPLETED|Overall Study||7
222361|NCT00836407|543189|P1|COMPLETED|Overall Study||4
222362|NCT00836407|543188|P2|STARTED|Overall Study||15
222363|NCT00836407|543189|P1|STARTED|Overall Study||15
222364|NCT00836433|543199|P2|NOT COMPLETED|Overall Study||7
222365|NCT00836433|543200|P1|NOT COMPLETED|Overall Study||12
222366|NCT00836433|543199|P2|COMPLETED|Overall Study||321
222367|NCT00836433|543200|P1|COMPLETED|Overall Study||349
222368|NCT00836433|543199|P2|STARTED|Overall Study||328
222369|NCT00836433|543200|P1|STARTED|Overall Study||361
222370|NCT00836472|543210|P2|NOT COMPLETED|Second Intervention||0
222371|NCT00836472|543211|P1|NOT COMPLETED|Second Intervention||0
222372|NCT00836472|543210|P2|COMPLETED|Second Intervention||27
222373|NCT00836472|543211|P1|COMPLETED|Second Intervention||28
222374|NCT00836472|543210|P2|STARTED|Second Intervention||27
222375|NCT00836472|543211|P1|STARTED|Second Intervention||28
222376|NCT00836472|543210|P2|NOT COMPLETED|Washout||3
222377|NCT00836472|543211|P1|NOT COMPLETED|Washout||2
222378|NCT00836472|543210|P2|COMPLETED|Washout||27
222379|NCT00836472|543211|P1|COMPLETED|Washout||28
222380|NCT00836472|543210|P2|STARTED|Washout||30
222381|NCT00836472|543211|P1|STARTED|Washout||30
222382|NCT00836472|543210|P2|NOT COMPLETED|First Intervention||0
222383|NCT00836472|543211|P1|NOT COMPLETED|First Intervention||0
222384|NCT00836472|543210|P2|COMPLETED|First Intervention||30
222385|NCT00836472|543211|P1|COMPLETED|First Intervention||30
222386|NCT00836472|543210|P2|STARTED|First Intervention||30
222387|NCT00836472|543211|P1|STARTED|First Intervention||30
222388|NCT00836498|543227|P2|NOT COMPLETED|Overall Study||1
222389|NCT00836498|543228|P1|NOT COMPLETED|Overall Study||4
222390|NCT00836498|543227|P2|COMPLETED|Overall Study||21
222568|NCT00838097|543579|P1|STARTED|Overall Study||321
222391|NCT00836498|543228|P1|COMPLETED|Overall Study|Participant who discontinued the study vaccination due to AE completed the 180-day safety follow-up.|40
222392|NCT00836498|543227|P2|STARTED|Overall Study||22
222393|NCT00836498|543228|P1|STARTED|Overall Study||44
222394|NCT00836641|543260|P2|NOT COMPLETED|Overall Study||0
222395|NCT00836641|543261|P1|NOT COMPLETED|Overall Study||0
222396|NCT00836641|543260|P2|COMPLETED|Overall Study||34
222397|NCT00836641|543261|P1|COMPLETED|Overall Study||36
222398|NCT00836641|543260|P2|STARTED|Overall Study||34
222399|NCT00836641|543261|P1|STARTED|Overall Study||36
222400|NCT00836693|543270|P2|NOT COMPLETED|Overall Study||6
222401|NCT00836693|543271|P1|NOT COMPLETED|Overall Study||17
222402|NCT00836693|543270|P2|COMPLETED|Overall Study||64
222403|NCT00836693|543271|P1|COMPLETED|Overall Study||130
222404|NCT00836693|543270|P2|STARTED|Overall Study||70
222405|NCT00836693|543271|P1|STARTED|Overall Study||147
222406|NCT00836706|543313|P2|NOT COMPLETED|Second Intervention||0
222407|NCT00836706|543314|P1|NOT COMPLETED|Second Intervention||0
222408|NCT00836706|543313|P2|COMPLETED|Second Intervention||11
222409|NCT00836706|543314|P1|COMPLETED|Second Intervention||11
222410|NCT00836706|543313|P2|STARTED|Second Intervention||11
222411|NCT00836706|543314|P1|STARTED|Second Intervention||11
222412|NCT00836706|543313|P2|NOT COMPLETED|Washout: 7 Days||1
222413|NCT00836706|543314|P1|NOT COMPLETED|Washout: 7 Days||0
222414|NCT00836706|543313|P2|COMPLETED|Washout: 7 Days||11
222415|NCT00836706|543314|P1|COMPLETED|Washout: 7 Days||11
222416|NCT00836706|543313|P2|STARTED|Washout: 7 Days||12
222417|NCT00836706|543314|P1|STARTED|Washout: 7 Days||11
222418|NCT00836706|543313|P2|NOT COMPLETED|First Intervention||0
222419|NCT00836706|543314|P1|NOT COMPLETED|First Intervention||0
222420|NCT00836706|543313|P2|COMPLETED|First Intervention||12
222421|NCT00836706|543314|P1|COMPLETED|First Intervention||11
222422|NCT00836706|543313|P2|STARTED|First Intervention||12
222423|NCT00836706|543314|P1|STARTED|First Intervention||11
222424|NCT00836719|543322|P1|NOT COMPLETED|Overall Study||0
222425|NCT00836719|543322|P1|COMPLETED|Overall Study||10
222426|NCT00836719|543322|P1|STARTED|Overall Study||10
222427|NCT00836745|543327|P1|NOT COMPLETED|Overall Study||21
222428|NCT00836745|543327|P1|COMPLETED|Overall Study||15
222429|NCT00836745|543327|P1|STARTED|Overall Study||36
222430|NCT00836875|543336|P2|NOT COMPLETED|Overall Study||3
222431|NCT00836875|543337|P1|NOT COMPLETED|Overall Study||3
222432|NCT00836875|543336|P2|COMPLETED|Overall Study||17
222433|NCT00836875|543337|P1|COMPLETED|Overall Study||8
222434|NCT00836875|543336|P2|STARTED|Overall Study||20
222435|NCT00836875|543337|P1|STARTED|Overall Study||11
222436|NCT00836901|543353|P2|NOT COMPLETED|Second Intervention||0
222437|NCT00836901|543354|P1|NOT COMPLETED|Second Intervention||0
222438|NCT00836901|543353|P2|COMPLETED|Second Intervention||28
222439|NCT00836901|543354|P1|COMPLETED|Second Intervention||23
222440|NCT00836901|543353|P2|STARTED|Second Intervention||28
222441|NCT00836901|543354|P1|STARTED|Second Intervention||23
222442|NCT00836901|543353|P2|NOT COMPLETED|First Intervention||0
222443|NCT00836901|543354|P1|NOT COMPLETED|First Intervention||1
222444|NCT00836901|543353|P2|COMPLETED|First Intervention||28
222445|NCT00836901|543354|P1|COMPLETED|First Intervention||23
222446|NCT00836901|543353|P2|STARTED|First Intervention||28
222447|NCT00836901|543354|P1|STARTED|First Intervention||24
222448|NCT00836953|543368|P1|NOT COMPLETED|Overall Study||2
222449|NCT00836953|543368|P1|COMPLETED|Overall Study||31
222450|NCT00836953|543368|P1|STARTED|Overall Study||33
222451|NCT00837031|543374|P1|NOT COMPLETED|Overall Study||0
222452|NCT00837031|543374|P1|COMPLETED|Overall Study||72
222453|NCT00837031|543374|P1|STARTED|Overall Study||72
222454|NCT00837148|543380|P1|NOT COMPLETED|Overall Study||2
222455|NCT00837148|543380|P1|COMPLETED|Overall Study||35
222456|NCT00837148|543380|P1|STARTED|Overall Study||37
222457|NCT00837161|543384|P1|NOT COMPLETED|Overall Study||2
222458|NCT00837161|543384|P1|COMPLETED|Overall Study||9
222459|NCT00837161|543384|P1|STARTED|Overall Study||11
222460|NCT00837200|543392|P1|NOT COMPLETED|Overall Study||0
222461|NCT00837200|543392|P1|COMPLETED|Overall Study||13
222462|NCT00837200|543392|P1|STARTED|Overall Study||13
222463|NCT00837213|543400|P2|NOT COMPLETED|Overall Study||5
222464|NCT00837213|543401|P1|NOT COMPLETED|Overall Study||6
222465|NCT00837213|543400|P2|COMPLETED|Overall Study||12
222466|NCT00837213|543401|P1|COMPLETED|Overall Study||10
222467|NCT00837213|543400|P2|STARTED|Overall Study||17
222468|NCT00837213|543401|P1|STARTED|Overall Study||16
222469|NCT00837252|543421|P1|NOT COMPLETED|Overall Study||0
222470|NCT00837252|543421|P1|COMPLETED|Overall Study||5
222471|NCT00837252|543421|P1|STARTED|Overall Study||5
222472|NCT00837330|543438|P2|NOT COMPLETED|Overall Study||3
222473|NCT00837330|543439|P1|NOT COMPLETED|Overall Study||1
222474|NCT00837330|543438|P2|COMPLETED|Overall Study||7
222475|NCT00837330|543439|P1|COMPLETED|Overall Study||9
222476|NCT00837330|543438|P2|STARTED|Overall Study||10
222477|NCT00837330|543439|P1|STARTED|Overall Study||10
222478|NCT00837434|543447|P2|NOT COMPLETED|Overall Study||1
222479|NCT00837434|543448|P1|NOT COMPLETED|Overall Study||9
222480|NCT00837434|543447|P2|COMPLETED|Overall Study||19
222481|NCT00837434|543448|P1|COMPLETED|Overall Study||34
222482|NCT00837434|543447|P2|STARTED|Overall Study||20
222483|NCT00837434|543448|P1|STARTED|Overall Study||43
222484|NCT00837447|543466|P1|NOT COMPLETED|Overall Study||0
222485|NCT00837447|543466|P1|COMPLETED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
222486|NCT00837447|543466|P1|STARTED|Overall Study|Each of the 54 pts received a Nexgen CR on one side and a Nexgen CR-Flex on the contralateral side.|54
222487|NCT00837486|543473|P2|NOT COMPLETED|Long-term Follow-up Phase - Open Label||0
222488|NCT00837486|543474|P1|NOT COMPLETED|Long-term Follow-up Phase - Open Label||5
222489|NCT00837486|543473|P2|COMPLETED|Long-term Follow-up Phase - Open Label||0
222490|NCT00837486|543474|P1|COMPLETED|Long-term Follow-up Phase - Open Label||24
222491|NCT00837486|543473|P2|STARTED|Long-term Follow-up Phase - Open Label||0
222492|NCT00837486|543474|P1|STARTED|Long-term Follow-up Phase - Open Label|All subjects received open-label stimulation during this phase.|29
222493|NCT00837486|543473|P2|NOT COMPLETED|Blinded-treatment Phase||0
222494|NCT00837486|543474|P1|NOT COMPLETED|Blinded-treatment Phase||1
222495|NCT00837486|543473|P2|COMPLETED|Blinded-treatment Phase||14
222496|NCT00837486|543474|P1|COMPLETED|Blinded-treatment Phase|One subject did not receive the allocated intervention.|15
222497|NCT00837486|543473|P2|STARTED|Blinded-treatment Phase||14
222498|NCT00837486|543474|P1|STARTED|Blinded-treatment Phase||16
222499|NCT00837512|543486|P2|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
222500|NCT00837512|543487|P1|NOT COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||0
222501|NCT00837512|543486|P2|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
222502|NCT00837512|543487|P1|COMPLETED|2nd Intervention (6 Hrs) - RANDOMIZED||8
222503|NCT00837512|543486|P2|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
222504|NCT00837512|543487|P1|STARTED|2nd Intervention (6 Hrs) - RANDOMIZED||8
222505|NCT00837512|543486|P2|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
222506|NCT00837512|543487|P1|NOT COMPLETED|Both Arms: Washout (7-28 Days)||0
222507|NCT00837512|543486|P2|COMPLETED|Both Arms: Washout (7-28 Days)||8
222508|NCT00837512|543487|P1|COMPLETED|Both Arms: Washout (7-28 Days)||8
222509|NCT00837512|543486|P2|STARTED|Both Arms: Washout (7-28 Days)||8
222510|NCT00837512|543487|P1|STARTED|Both Arms: Washout (7-28 Days)||8
222511|NCT00837512|543486|P2|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
222512|NCT00837512|543487|P1|NOT COMPLETED|First Intervention (6hrs) - RANDOMIZED||0
222513|NCT00837512|543486|P2|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
222514|NCT00837512|543487|P1|COMPLETED|First Intervention (6hrs) - RANDOMIZED||8
222515|NCT00837512|543486|P2|STARTED|First Intervention (6hrs) - RANDOMIZED||8
222516|NCT00837512|543487|P1|STARTED|First Intervention (6hrs) - RANDOMIZED||8
222517|NCT00837577|543495|P2|NOT COMPLETED|Open-label Period||9
222518|NCT00837577|543496|P1|NOT COMPLETED|Open-label Period||8
222519|NCT00837577|543495|P2|COMPLETED|Open-label Period||54
222520|NCT00837577|543496|P1|COMPLETED|Open-label Period||60
222521|NCT00837577|543495|P2|STARTED|Open-label Period||63
222522|NCT00837577|543496|P1|STARTED|Open-label Period||68
222523|NCT00837577|543495|P2|NOT COMPLETED|Double-blind Period||0
222524|NCT00837577|543496|P1|NOT COMPLETED|Double-blind Period||2
222525|NCT00837577|543495|P2|COMPLETED|Double-blind Period||63
222526|NCT00837577|543496|P1|COMPLETED|Double-blind Period||68
222527|NCT00837577|543495|P2|STARTED|Double-blind Period||63
222528|NCT00837577|543496|P1|STARTED|Double-blind Period||70
222529|NCT00837616|543509|P2|NOT COMPLETED|Overall Study||1
222530|NCT00837616|543510|P1|NOT COMPLETED|Overall Study||0
222531|NCT00837616|543509|P2|COMPLETED|Overall Study||20
222532|NCT00837616|543510|P1|COMPLETED|Overall Study||20
222533|NCT00837616|543509|P2|STARTED|Overall Study||21
222534|NCT00837616|543510|P1|STARTED|Overall Study||20
222535|NCT00837759|543534|P1|NOT COMPLETED|Overall Study||4
222536|NCT00837759|543534|P1|COMPLETED|Overall Study||3
222537|NCT00837759|543534|P1|STARTED|Overall Study||7
222538|NCT00837824|543545|P2|NOT COMPLETED|Overall Study||0
222539|NCT00837824|543546|P1|NOT COMPLETED|Overall Study||0
222540|NCT00837824|543545|P2|COMPLETED|Overall Study||9
222541|NCT00837824|543546|P1|COMPLETED|Overall Study||11
222542|NCT00837824|543545|P2|STARTED|Overall Study||9
222543|NCT00837824|543546|P1|STARTED|Overall Study||11
222544|NCT00837876|543555|P1|NOT COMPLETED|Overall Study||37
222545|NCT00837876|543555|P1|COMPLETED|Overall Study||0
222546|NCT00837876|543555|P1|STARTED|Overall Study||37
222547|NCT00837967|543562|P2|NOT COMPLETED|Second Intervention||0
222548|NCT00837967|543563|P1|NOT COMPLETED|Second Intervention||0
222549|NCT00837967|543562|P2|COMPLETED|Second Intervention||12
222550|NCT00837967|543563|P1|COMPLETED|Second Intervention||11
222551|NCT00837967|543562|P2|STARTED|Second Intervention||12
222552|NCT00837967|543563|P1|STARTED|Second Intervention||11
222553|NCT00837967|543562|P2|NOT COMPLETED|Washout Period of 7 - 14 Days||0
222554|NCT00837967|543563|P1|NOT COMPLETED|Washout Period of 7 - 14 Days||2
222555|NCT00837967|543562|P2|COMPLETED|Washout Period of 7 - 14 Days||12
222556|NCT00837967|543563|P1|COMPLETED|Washout Period of 7 - 14 Days||11
222557|NCT00837967|543562|P2|STARTED|Washout Period of 7 - 14 Days||12
222558|NCT00837967|543563|P1|STARTED|Washout Period of 7 - 14 Days||13
222559|NCT00837967|543562|P2|NOT COMPLETED|First Intervention||0
222560|NCT00837967|543563|P1|NOT COMPLETED|First Intervention||0
222561|NCT00837967|543562|P2|COMPLETED|First Intervention||12
222562|NCT00837967|543563|P1|COMPLETED|First Intervention||13
222563|NCT00837967|543562|P2|STARTED|First Intervention||12
222564|NCT00837967|543563|P1|STARTED|First Intervention||13
222565|NCT00838097|543579|P1|NOT COMPLETED|Overall Study||176
222566|NCT00838097|543579|P1|COMPLETED|Overall Study||145
222567|NCT00838097|543579|P1|Received Darbepoetin Alfa|Overall Study||319
222569|NCT00838110|543589|P4|NOT COMPLETED|Overall Study||18
222570|NCT00838110|543590|P3|NOT COMPLETED|Overall Study||17
222571|NCT00838110|543591|P2|NOT COMPLETED|Overall Study||22
222572|NCT00838110|543592|P1|NOT COMPLETED|Overall Study||22
222573|NCT00838110|543589|P4|COMPLETED|Overall Study||226
222574|NCT00838110|543590|P3|COMPLETED|Overall Study||226
222575|NCT00838110|543591|P2|COMPLETED|Overall Study||106
222576|NCT00838110|543592|P1|COMPLETED|Overall Study||105
222577|NCT00838110|543589|P4|Treated|Overall Study||244
222578|NCT00838110|543590|P3|Treated|Overall Study||243
222579|NCT00838110|543591|P2|Treated|Overall Study||127
222580|NCT00838110|543592|P1|Treated|Overall Study||127
222581|NCT00838110|543589|P4|STARTED|Overall Study||244
222582|NCT00838110|543590|P3|STARTED|Overall Study||243
222583|NCT00838110|543591|P2|STARTED|Overall Study||128
222584|NCT00838110|543592|P1|STARTED|Overall Study||127
222585|NCT00838136|543614|P2|NOT COMPLETED|Second Intervention||1
222586|NCT00838136|543615|P1|NOT COMPLETED|Second Intervention||0
222587|NCT00838136|543614|P2|COMPLETED|Second Intervention||15
222588|NCT00838136|543615|P1|COMPLETED|Second Intervention||16
222589|NCT00838136|543614|P2|STARTED|Second Intervention||16
222590|NCT00838136|543615|P1|STARTED|Second Intervention||16
222591|NCT00838136|543614|P2|NOT COMPLETED|First Intervention||0
222592|NCT00838136|543615|P1|NOT COMPLETED|First Intervention||0
222593|NCT00838136|543614|P2|COMPLETED|First Intervention||16
222594|NCT00838136|543615|P1|COMPLETED|First Intervention||16
222595|NCT00838136|543614|P2|STARTED|First Intervention||16
222596|NCT00838136|543615|P1|STARTED|First Intervention||16
222597|NCT00838162|543627|P4|NOT COMPLETED|Overall Study||0
222598|NCT00838162|543628|P3|NOT COMPLETED|Overall Study||0
222599|NCT00838162|543629|P2|NOT COMPLETED|Overall Study||0
222600|NCT00838162|543630|P1|NOT COMPLETED|Overall Study||0
222601|NCT00838162|543627|P4|COMPLETED|Overall Study||8
222602|NCT00838162|543628|P3|COMPLETED|Overall Study||8
222603|NCT00838162|543629|P2|COMPLETED|Overall Study||8
222604|NCT00838162|543630|P1|COMPLETED|Overall Study||9
222605|NCT00838162|543627|P4|STARTED|Overall Study||8
222606|NCT00838162|543628|P3|STARTED|Overall Study||8
222607|NCT00838162|543629|P2|STARTED|Overall Study||8
222608|NCT00838162|543630|P1|STARTED|Overall Study||9
222609|NCT00838201|543674|P2|NOT COMPLETED|Overall Study||53
222610|NCT00838201|543675|P1|NOT COMPLETED|Overall Study||42
222611|NCT00838201|543674|P2|COMPLETED|Overall Study||145
222612|NCT00838201|543675|P1|COMPLETED|Overall Study||144
222613|NCT00838201|543674|P2|STARTED|Overall Study||198
222614|NCT00838201|543675|P1|STARTED|Overall Study||186
222615|NCT00838279|543683|P2|NOT COMPLETED|Second Intervention||0
222616|NCT00838279|543684|P1|NOT COMPLETED|Second Intervention||0
222617|NCT00838279|543683|P2|COMPLETED|Second Intervention||15
222618|NCT00838279|543684|P1|COMPLETED|Second Intervention||15
222619|NCT00838279|543683|P2|STARTED|Second Intervention||15
222620|NCT00838279|543684|P1|STARTED|Second Intervention||15
222621|NCT00838279|543683|P2|NOT COMPLETED|Washout||1
222622|NCT00838279|543684|P1|NOT COMPLETED|Washout||1
222623|NCT00838279|543683|P2|COMPLETED|Washout||15
222624|NCT00838279|543684|P1|COMPLETED|Washout||15
222625|NCT00838279|543683|P2|STARTED|Washout||16
222626|NCT00838279|543684|P1|STARTED|Washout||16
222627|NCT00838279|543683|P2|NOT COMPLETED|First Intervention||0
222628|NCT00838279|543684|P1|NOT COMPLETED|First Intervention||0
222629|NCT00838279|543683|P2|COMPLETED|First Intervention||16
222630|NCT00838279|543684|P1|COMPLETED|First Intervention||16
222631|NCT00838279|543683|P2|STARTED|First Intervention||16
222632|NCT00838279|543684|P1|STARTED|First Intervention||16
222633|NCT00831987|543694|P2|NOT COMPLETED|Overall Study||0
222634|NCT00831987|543695|P1|NOT COMPLETED|Overall Study||0
222635|NCT00831987|543694|P2|COMPLETED|Overall Study||60
222636|NCT00831987|543695|P1|COMPLETED|Overall Study||60
222637|NCT00831987|543694|P2|STARTED|Overall Study||60
222638|NCT00831987|543695|P1|STARTED|Overall Study||60
222639|NCT00832000|543707|P2|NOT COMPLETED|Overall Study||1
222640|NCT00832000|543708|P1|NOT COMPLETED|Overall Study||6
222641|NCT00832000|543707|P2|COMPLETED|Overall Study||29
222642|NCT00832000|543708|P1|COMPLETED|Overall Study||23
222643|NCT00832000|543707|P2|Crossed Over to Opposite Intervention|Overall Study|Mexiletine 200 mg orally three times daily|29
222644|NCT00832000|543708|P1|Crossed Over to Opposite Intervention|Overall Study|Placebo|25
222645|NCT00832000|543707|P2|STARTED|Overall Study|Placebo|30
222646|NCT00832000|543708|P1|STARTED|Overall Study|Mexiletine 200 mg orally three times daily|29
222647|NCT00832078|543744|P2|NOT COMPLETED|Test Day 2 - 2 Period||0
222648|NCT00832078|543745|P1|NOT COMPLETED|Test Day 2 - 2 Period||1
222649|NCT00832078|543744|P2|COMPLETED|Test Day 2 - 2 Period||10
222650|NCT00832078|543745|P1|COMPLETED|Test Day 2 - 2 Period||12
222651|NCT00832078|543744|P2|STARTED|Test Day 2 - 2 Period||10
222652|NCT00832078|543745|P1|STARTED|Test Day 2 - 2 Period||13
222653|NCT00832078|543744|P2|NOT COMPLETED|Test Day 2 - 1 Period||0
222654|NCT00832078|543745|P1|NOT COMPLETED|Test Day 2 - 1 Period||0
222655|NCT00832078|543744|P2|COMPLETED|Test Day 2 - 1 Period||10
222656|NCT00832078|543745|P1|COMPLETED|Test Day 2 - 1 Period||13
222657|NCT00832078|543744|P2|STARTED|Test Day 2 - 1 Period||10
222658|NCT00832078|543745|P1|STARTED|Test Day 2 - 1 Period||13
222659|NCT00832078|543744|P2|NOT COMPLETED|Test Day 1-2 Period||2
222660|NCT00832078|543745|P1|NOT COMPLETED|Test Day 1-2 Period||0
222661|NCT00832078|543744|P2|COMPLETED|Test Day 1-2 Period||10
222662|NCT00832078|543745|P1|COMPLETED|Test Day 1-2 Period||13
222663|NCT00832078|543744|P2|STARTED|Test Day 1-2 Period||12
222664|NCT00832078|543745|P1|STARTED|Test Day 1-2 Period||13
222665|NCT00832078|543744|P2|NOT COMPLETED|Test Day 1- 1 Period||0
222666|NCT00832078|543745|P1|NOT COMPLETED|Test Day 1- 1 Period||0
222667|NCT00832078|543744|P2|COMPLETED|Test Day 1- 1 Period||12
222668|NCT00832078|543745|P1|COMPLETED|Test Day 1- 1 Period||13
222669|NCT00832078|543744|P2|STARTED|Test Day 1- 1 Period||12
222670|NCT00832078|543745|P1|STARTED|Test Day 1- 1 Period||13
222671|NCT00832091|543753|P2|NOT COMPLETED|Overall Study||2
222672|NCT00832091|543754|P1|NOT COMPLETED|Overall Study||5
222673|NCT00832091|543753|P2|COMPLETED|Overall Study||53
222674|NCT00832091|543754|P1|COMPLETED|Overall Study||12
222675|NCT00832091|543753|P2|STARTED|Overall Study||55
222676|NCT00832091|543754|P1|STARTED|Overall Study||17
222677|NCT00832117|543764|P1|NOT COMPLETED|Overall Study||12
222678|NCT00832117|543764|P1|COMPLETED|Overall Study||17
222679|NCT00832117|543764|P1|STARTED|Overall Study||29
222680|NCT00832130|543783|P2|NOT COMPLETED|Overall Study||0
222681|NCT00832130|543784|P1|NOT COMPLETED|Overall Study||0
222682|NCT00832130|543783|P2|COMPLETED|Overall Study||70
222683|NCT00832130|543784|P1|COMPLETED|Overall Study||69
222684|NCT00832130|543783|P2|STARTED|Overall Study||70
222685|NCT00832130|543784|P1|STARTED|Overall Study||69
222686|NCT00832260|543804|P1|NOT COMPLETED|Overall Study||0
222687|NCT00832260|543804|P1|COMPLETED|Overall Study||70
222688|NCT00832260|543804|P1|STARTED|Overall Study||70
222689|NCT00832299|543809|P1|NOT COMPLETED|Overall Study||0
222690|NCT00832299|543809|P1|COMPLETED|Overall Study||2
222691|NCT00832299|543809|P1|STARTED|Overall Study||2
222692|NCT00832338|543813|P1|NOT COMPLETED|Overall Study||0
222693|NCT00832338|543813|P1|COMPLETED|Overall Study||23
222694|NCT00832338|543813|P1|STARTED|Overall Study||23
222695|NCT00832377|543817|P1|NOT COMPLETED|Overall Study||1
222696|NCT00832377|543817|P1|COMPLETED|Overall Study||36
222697|NCT00832377|543817|P1|STARTED|Overall Study||37
222698|NCT00832390|543827|P3|NOT COMPLETED|Overall Study||0
222699|NCT00832390|543828|P2|NOT COMPLETED|Overall Study||0
222700|NCT00832390|543829|P1|NOT COMPLETED|Overall Study||0
222701|NCT00832390|543827|P3|COMPLETED|Overall Study||1
222702|NCT00832390|543828|P2|COMPLETED|Overall Study||16
222703|NCT00832390|543829|P1|COMPLETED|Overall Study||12
222704|NCT00832390|543827|P3|STARTED|Overall Study||1
222705|NCT00832390|543828|P2|STARTED|Overall Study||16
222706|NCT00832390|543829|P1|STARTED|Overall Study||12
222707|NCT00832416|543841|P4|NOT COMPLETED|Overall Study||83
222708|NCT00832416|543842|P3|NOT COMPLETED|Overall Study||61
222709|NCT00832416|543843|P2|NOT COMPLETED|Overall Study||53
222710|NCT00832416|543844|P1|NOT COMPLETED|Overall Study||46
222711|NCT00832416|543841|P4|COMPLETED|Overall Study||144
222712|NCT00832416|543842|P3|COMPLETED|Overall Study||54
222713|NCT00832416|543843|P2|COMPLETED|Overall Study||60
222714|NCT00832416|543844|P1|COMPLETED|Overall Study||64
222715|NCT00832416|543841|P4|STARTED|Overall Study||227
222716|NCT00832416|543842|P3|STARTED|Overall Study||115
222717|NCT00832416|543843|P2|STARTED|Overall Study||113
222718|NCT00832416|543844|P1|STARTED|Overall Study||110
222719|NCT00832455|543882|P1|NOT COMPLETED|Overall Study||72
222720|NCT00832455|543882|P1|COMPLETED|Overall Study||373
222721|NCT00832455|543882|P1|Week 12|Overall Study||373
222722|NCT00832455|543882|P1|Week 8 (Optional)|Overall Study||247
222723|NCT00832455|543882|P1|Week 4|Overall Study||411
222724|NCT00832455|543882|P1|Baseline|Overall Study|420 –patients that received at least one dose of study medication and had 1 follow-up visit (ITT)|420
222725|NCT00832455|543882|P1|STARTED|Overall Study|445 – number of patients that signed the informed consent form (Safety population)|445
222726|NCT00832520|543902|P1|NOT COMPLETED|Overall Study||0
222727|NCT00832520|543902|P1|COMPLETED|Overall Study||13
222728|NCT00832520|543902|P1|STARTED|Overall Study||13
222729|NCT00832572|543908|P2|NOT COMPLETED|Period 2||0
222730|NCT00832572|543909|P1|NOT COMPLETED|Period 2||0
222731|NCT00832572|543908|P2|COMPLETED|Period 2||2
222732|NCT00832572|543909|P1|COMPLETED|Period 2||3
222733|NCT00832572|543908|P2|STARTED|Period 2||2
222734|NCT00832572|543909|P1|STARTED|Period 2||3
222735|NCT00832572|543908|P2|NOT COMPLETED|Period 1||0
222736|NCT00832572|543909|P1|NOT COMPLETED|Period 1||0
222737|NCT00832572|543908|P2|COMPLETED|Period 1||2
222738|NCT00832572|543909|P1|COMPLETED|Period 1||3
222739|NCT00832572|543908|P2|STARTED|Period 1||2
222740|NCT00832572|543909|P1|STARTED|Period 1||3
222741|NCT00832585|543921|P1|NOT COMPLETED|Overall Study||2
222742|NCT00832585|543921|P1|COMPLETED|Overall Study|Only three subjects completed all of the visits for the study as per protocol.|3
222743|NCT00832585|543921|P1|STARTED|Overall Study|Eight subjects were screened but only 5 started the study and received study drug.|5
222744|NCT00832624|543926|P1|NOT COMPLETED|Overall Study||10
222745|NCT00832624|543926|P1|COMPLETED|Overall Study||0
222746|NCT00832624|543926|P1|STARTED|Overall Study||10
222747|NCT00832637|543930|P1|NOT COMPLETED|Overall Study||0
222748|NCT00832637|543930|P1|COMPLETED|Overall Study||33
222749|NCT00832637|543930|P1|STARTED|Overall Study||33
222750|NCT00832650|543941|P3|NOT COMPLETED|Overall Study||1
222751|NCT00832650|543942|P2|NOT COMPLETED|Overall Study||0
222752|NCT00832650|543943|P1|NOT COMPLETED|Overall Study||0
222753|NCT00832650|543941|P3|COMPLETED|Overall Study||22
222754|NCT00832650|543942|P2|COMPLETED|Overall Study||12
222755|NCT00832650|543943|P1|COMPLETED|Overall Study||25
222756|NCT00832650|543941|P3|Treated|Overall Study||22
222757|NCT00832650|543942|P2|Treated|Overall Study||12
222758|NCT00832650|543943|P1|Treated|Overall Study||25
222759|NCT00832650|543941|P3|STARTED|Overall Study||23
222760|NCT00832650|543942|P2|STARTED|Overall Study||12
222761|NCT00832650|543943|P1|STARTED|Overall Study||25
222762|NCT00838331|543975|P1|NOT COMPLETED|Aged Blood Transfusion||9
222763|NCT00838331|543975|P1|COMPLETED|Aged Blood Transfusion||8
222764|NCT00838331|543975|P1|STARTED|Aged Blood Transfusion||17
222765|NCT00838331|543975|P1|NOT COMPLETED|Fresh Blood Transfusion||0
222766|NCT00838331|543975|P1|COMPLETED|Fresh Blood Transfusion||17
222767|NCT00838331|543975|P1|STARTED|Fresh Blood Transfusion||17
222768|NCT00838513|543979|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
222769|NCT00838513|543979|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
222770|NCT00838513|543979|P1|STARTED|Post Treatment Period (Patients Who Disc||5
222771|NCT00838513|543979|P1|NOT COMPLETED|Extension Treatment Period||1
222772|NCT00838513|543979|P1|COMPLETED|Extension Treatment Period||18
222773|NCT00838513|543979|P1|STARTED|Extension Treatment Period||19
222774|NCT00838513|543979|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
222775|NCT00838513|543979|P1|COMPLETED|Treatment Period (26 Weeks)||20
222776|NCT00838513|543979|P1|STARTED|Treatment Period (26 Weeks)||20
222777|NCT00838513|543979|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
222778|NCT00838513|543979|P1|COMPLETED|Observation Period (8 Weeks)||20
222779|NCT00838513|543979|P1|STARTED|Observation Period (8 Weeks)||20
222780|NCT00838513|543979|P1|NOT COMPLETED|Screening Period||3
222781|NCT00838513|543979|P1|COMPLETED|Screening Period||20
222782|NCT00838513|543979|P1|STARTED|Screening Period||23
222783|NCT00838526|543997|P2|NOT COMPLETED|Overall Study||39
222784|NCT00838526|543998|P1|NOT COMPLETED|Overall Study||24
222785|NCT00838526|543997|P2|COMPLETED|Overall Study||137
222786|NCT00838526|543998|P1|COMPLETED|Overall Study||35
222787|NCT00838526|543997|P2|STARTED|Overall Study|Treated|176
222788|NCT00838526|543998|P1|STARTED|Overall Study|Treated|59
222789|NCT00838578|544006|P1|NOT COMPLETED|Overall Study||2
222790|NCT00838578|544006|P1|COMPLETED|Overall Study||63
222791|NCT00838578|544006|P1|STARTED|Overall Study|In this Ph 1/2 study, 65 subjects were enrolled; 2 were protocol violators, so only 63 treated.|65
222792|NCT00838630|544016|P2|NOT COMPLETED|Second Intervention||0
222793|NCT00838630|544017|P1|NOT COMPLETED|Second Intervention||0
222794|NCT00838630|544016|P2|COMPLETED|Second Intervention||18
222795|NCT00838630|544017|P1|COMPLETED|Second Intervention||16
222796|NCT00838630|544016|P2|STARTED|Second Intervention||18
222797|NCT00838630|544017|P1|STARTED|Second Intervention||16
222798|NCT00838630|544016|P2|NOT COMPLETED|Washout: 7 Days||0
222799|NCT00838630|544017|P1|NOT COMPLETED|Washout: 7 Days||1
222800|NCT00838630|544016|P2|COMPLETED|Washout: 7 Days||18
222801|NCT00838630|544017|P1|COMPLETED|Washout: 7 Days||16
222802|NCT00838630|544016|P2|STARTED|Washout: 7 Days||18
222803|NCT00838630|544017|P1|STARTED|Washout: 7 Days||17
222804|NCT00838630|544016|P2|NOT COMPLETED|First Intervention||0
222805|NCT00838630|544017|P1|NOT COMPLETED|First Intervention||1
222806|NCT00838630|544016|P2|COMPLETED|First Intervention||18
222807|NCT00838630|544017|P1|COMPLETED|First Intervention||17
222808|NCT00838630|544016|P2|STARTED|First Intervention||18
222809|NCT00838630|544017|P1|STARTED|First Intervention||18
222810|NCT00842985|544025|P1|NOT COMPLETED|Fourth Intervention||0
222811|NCT00842985|544025|P1|COMPLETED|Fourth Intervention||15
222812|NCT00842985|544025|P1|STARTED|Fourth Intervention||15
222813|NCT00842985|544025|P1|NOT COMPLETED|Washout Period of GE 4 Days||0
222814|NCT00842985|544025|P1|COMPLETED|Washout Period of GE 4 Days||15
222815|NCT00842985|544025|P1|STARTED|Washout Period of GE 4 Days||15
222816|NCT00842985|544025|P1|NOT COMPLETED|Third Intervention||0
222817|NCT00842985|544025|P1|COMPLETED|Third Intervention||15
222818|NCT00842985|544025|P1|STARTED|Third Intervention||15
222819|NCT00842985|544025|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
222820|NCT00842985|544025|P1|COMPLETED|Washout Period of GE 4 Days||15
222821|NCT00842985|544025|P1|STARTED|Washout Period of GE 4 Days||17
222822|NCT00842985|544025|P1|NOT COMPLETED|Second Intervention||1
222823|NCT00842985|544025|P1|COMPLETED|Second Intervention||17
222824|NCT00842985|544025|P1|STARTED|Second Intervention||18
222825|NCT00842985|544025|P1|NOT COMPLETED|Washout Period of GE 4 Days||2
222826|NCT00842985|544025|P1|COMPLETED|Washout Period of GE 4 Days||18
222827|NCT00842985|544025|P1|STARTED|Washout Period of GE 4 Days||20
222828|NCT00842985|544025|P1|NOT COMPLETED|First Intervention||6
222829|NCT00842985|544025|P1|COMPLETED|First Intervention|Completed 1st Intervention|20
222830|NCT00842985|544025|P1|STARTED|First Intervention|Signed Consent|26
222831|NCT00842985|544025|P1|NOT COMPLETED|Screening||27
222832|NCT00842985|544025|P1|COMPLETED|Screening||26
222833|NCT00842985|544025|P1|STARTED|Screening||53
222834|NCT00843024|544036|P6|NOT COMPLETED|Double-blind Treatment Phase||25
222835|NCT00843024|544037|P5|NOT COMPLETED|Double-blind Treatment Phase||20
222836|NCT00843024|544038|P4|NOT COMPLETED|Double-blind Treatment Phase||23
222837|NCT00843024|544039|P3|NOT COMPLETED|Double-blind Treatment Phase||31
222838|NCT00843024|544040|P2|NOT COMPLETED|Double-blind Treatment Phase||0
222839|NCT00843024|544041|P1|NOT COMPLETED|Double-blind Treatment Phase||0
222840|NCT00843024|544036|P6|COMPLETED|Double-blind Treatment Phase||152
222841|NCT00843024|544037|P5|COMPLETED|Double-blind Treatment Phase||97
222842|NCT00843024|544038|P4|COMPLETED|Double-blind Treatment Phase||96
222843|NCT00843024|544039|P3|COMPLETED|Double-blind Treatment Phase||145
222844|NCT00843024|544040|P2|COMPLETED|Double-blind Treatment Phase||0
222845|NCT00843024|544041|P1|COMPLETED|Double-blind Treatment Phase||0
222846|NCT00843024|544036|P6|STARTED|Double-blind Treatment Phase||177
222847|NCT00843024|544037|P5|STARTED|Double-blind Treatment Phase||117
222848|NCT00843024|544038|P4|STARTED|Double-blind Treatment Phase||119
222849|NCT00843024|544039|P3|STARTED|Double-blind Treatment Phase||176
222850|NCT00843024|544040|P2|STARTED|Double-blind Treatment Phase||0
222851|NCT00843024|544041|P1|STARTED|Double-blind Treatment Phase||0
222852|NCT00843024|544036|P6|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
222853|NCT00843024|544037|P5|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
222854|NCT00843024|544038|P4|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
222855|NCT00843024|544039|P3|NOT COMPLETED|Single-blind Placebo Run-In Phase||0
222856|NCT00843024|544040|P2|NOT COMPLETED|Single-blind Placebo Run-In Phase||136
222857|NCT00843024|544041|P1|NOT COMPLETED|Single-blind Placebo Run-In Phase||140
222858|NCT00843024|544036|P6|COMPLETED|Single-blind Placebo Run-In Phase||0
222859|NCT00843024|544037|P5|COMPLETED|Single-blind Placebo Run-In Phase||0
222860|NCT00843024|544038|P4|COMPLETED|Single-blind Placebo Run-In Phase||0
222861|NCT00843024|544039|P3|COMPLETED|Single-blind Placebo Run-In Phase||0
222862|NCT00843024|544040|P2|COMPLETED|Single-blind Placebo Run-In Phase||321
222863|NCT00843024|544041|P1|COMPLETED|Single-blind Placebo Run-In Phase||268
222864|NCT00843024|544036|P6|STARTED|Single-blind Placebo Run-In Phase||0
222865|NCT00843024|544037|P5|STARTED|Single-blind Placebo Run-In Phase||0
222866|NCT00843024|544038|P4|STARTED|Single-blind Placebo Run-In Phase||0
222867|NCT00843024|544039|P3|STARTED|Single-blind Placebo Run-In Phase||0
222868|NCT00843024|544040|P2|STARTED|Single-blind Placebo Run-In Phase||457
222869|NCT00843024|544041|P1|STARTED|Single-blind Placebo Run-In Phase||408
222870|NCT00843050|544106|P1|NOT COMPLETED|Overall Study||13
222871|NCT00843050|544106|P1|COMPLETED|Overall Study||0
222872|NCT00843050|544106|P1|STARTED|Overall Study||13
222873|NCT00843115|544112|P1|NOT COMPLETED|Overall Study||66
222874|NCT00843115|544112|P1|COMPLETED|Overall Study||304
222875|NCT00843115|544112|P1|STARTED|Overall Study||370
222876|NCT00843167|544160|P2|NOT COMPLETED|Follow-up||0
222877|NCT00843167|544161|P1|NOT COMPLETED|Follow-up||0
222878|NCT00843167|544160|P2|COMPLETED|Follow-up||24
222879|NCT00843167|544161|P1|COMPLETED|Follow-up||24
222880|NCT00843167|544160|P2|Completed Final Visit|Follow-up||24
222881|NCT00843167|544161|P1|Completed Final Visit|Follow-up||24
222882|NCT00843167|544160|P2|STARTED|Follow-up||24
222883|NCT00843167|544161|P1|STARTED|Follow-up||24
222884|NCT00843167|544160|P2|NOT COMPLETED|Treatment Period||8
222885|NCT00843167|544161|P1|NOT COMPLETED|Treatment Period||3
222886|NCT00843167|544160|P2|COMPLETED|Treatment Period||19
222887|NCT00843167|544161|P1|COMPLETED|Treatment Period||24
222888|NCT00843167|544160|P2|STARTED|Treatment Period||27
222889|NCT00843167|544161|P1|STARTED|Treatment Period||27
222890|NCT00843180|544176|P2|NOT COMPLETED|Overall Study||0
222891|NCT00843180|544177|P1|NOT COMPLETED|Overall Study||0
222892|NCT00843180|544176|P2|COMPLETED|Overall Study||7
222893|NCT00843180|544177|P1|COMPLETED|Overall Study||16
222894|NCT00843180|544176|P2|STARTED|Overall Study||7
222895|NCT00843180|544177|P1|STARTED|Overall Study||16
222896|NCT00843284|544189|P1|NOT COMPLETED|Overall Study||72
222897|NCT00843284|544189|P1|COMPLETED|Overall Study||619
222898|NCT00843284|544189|P1|STARTED|Overall Study||691
222899|NCT00843310|544197|P1|NOT COMPLETED|Overall Study||7
222900|NCT00843310|544197|P1|COMPLETED|Overall Study||1
222901|NCT00843310|544197|P1|STARTED|Overall Study||8
222902|NCT00843349|544205|P4|NOT COMPLETED|Overall Study||1
222903|NCT00843349|544206|P3|NOT COMPLETED|Overall Study||0
222904|NCT00843349|544207|P2|NOT COMPLETED|Overall Study||0
222905|NCT00843349|544208|P1|NOT COMPLETED|Overall Study||3
222906|NCT00843349|544205|P4|COMPLETED|Overall Study||10
222907|NCT00843349|544206|P3|COMPLETED|Overall Study||10
222908|NCT00843349|544207|P2|COMPLETED|Overall Study||11
222909|NCT00843349|544208|P1|COMPLETED|Overall Study||8
222910|NCT00843349|544205|P4|STARTED|Overall Study||11
222911|NCT00843349|544206|P3|STARTED|Overall Study||10
222912|NCT00843349|544207|P2|STARTED|Overall Study||11
222913|NCT00843349|544208|P1|STARTED|Overall Study||11
222914|NCT00843466|544224|P2|NOT COMPLETED|Overall Study||0
222915|NCT00843466|544225|P1|NOT COMPLETED|Overall Study||0
222916|NCT00843466|544224|P2|COMPLETED|Overall Study||18
222917|NCT00843466|544225|P1|COMPLETED|Overall Study||24
222918|NCT00843466|544224|P2|STARTED|Overall Study||18
222919|NCT00843466|544225|P1|STARTED|Overall Study||24
222920|NCT00843479|544233|P2|NOT COMPLETED|Overall Study||0
222921|NCT00843479|544234|P1|NOT COMPLETED|Overall Study||0
222922|NCT00843479|544233|P2|COMPLETED|Overall Study||12
222923|NCT00843479|544234|P1|COMPLETED|Overall Study||12
222924|NCT00843479|544233|P2|STARTED|Overall Study||12
222925|NCT00843479|544234|P1|STARTED|Overall Study||12
222926|NCT00843492|544252|P2|NOT COMPLETED|Overall Study||14
222927|NCT00843492|544253|P1|NOT COMPLETED|Overall Study||8
222928|NCT00843492|544252|P2|COMPLETED|Overall Study||607
222929|NCT00843492|544253|P1|COMPLETED|Overall Study||614
222930|NCT00843492|544252|P2|STARTED|Overall Study||621
222931|NCT00843492|544253|P1|STARTED|Overall Study||622
222932|NCT00843622|544273|P2|NOT COMPLETED|Overall Study||55
222933|NCT00843622|544274|P1|NOT COMPLETED|Overall Study||43
222934|NCT00843622|544273|P2|COMPLETED|Overall Study||70
222935|NCT00843622|544274|P1|COMPLETED|Overall Study||82
222936|NCT00843622|544273|P2|STARTED|Overall Study||125
222937|NCT00843622|544274|P1|STARTED|Overall Study||125
222938|NCT00843635|544283|P3|NOT COMPLETED|Overall Study||0
222939|NCT00843635|544284|P2|NOT COMPLETED|Overall Study||2
222940|NCT00843635|544285|P1|NOT COMPLETED|Overall Study||2
222941|NCT00843635|544283|P3|COMPLETED|Overall Study||5
222942|NCT00843635|544284|P2|COMPLETED|Overall Study||13
222943|NCT00843635|544285|P1|COMPLETED|Overall Study||13
222944|NCT00843635|544283|P3|STARTED|Overall Study||5
222945|NCT00843635|544284|P2|STARTED|Overall Study||15
222946|NCT00843635|544285|P1|STARTED|Overall Study||15
222947|NCT00843713|544305|P2|NOT COMPLETED|Overall Study||0
222948|NCT00843713|544306|P1|NOT COMPLETED|Overall Study||0
222949|NCT00843713|544305|P2|COMPLETED|Overall Study||26
222950|NCT00843713|544306|P1|COMPLETED|Overall Study||30
222951|NCT00843713|544305|P2|STARTED|Overall Study||26
222952|NCT00843713|544306|P1|STARTED|Overall Study||30
222953|NCT00843778|544312|P1|NOT COMPLETED|Overall Study||35
222954|NCT00843778|544312|P1|COMPLETED|Overall Study||96
222955|NCT00843778|544312|P1|STARTED|Overall Study||131
222956|NCT00843830|544345|P1|NOT COMPLETED|Overall Study||0
222957|NCT00843830|544345|P1|COMPLETED|Overall Study||4
222958|NCT00843830|544345|P1|STARTED|Overall Study||4
222959|NCT00843843|544352|P2|NOT COMPLETED|Overall Study||2
222960|NCT00843843|544353|P1|NOT COMPLETED|Overall Study||2
222961|NCT00843843|544352|P2|COMPLETED|Overall Study||6
222962|NCT00843843|544353|P1|COMPLETED|Overall Study||6
222963|NCT00843843|544352|P2|STARTED|Overall Study||8
222964|NCT00843843|544353|P1|STARTED|Overall Study||8
222965|NCT00843986|544363|P2|NOT COMPLETED|Overall Study||1
222966|NCT00843986|544364|P1|NOT COMPLETED|Overall Study||1
222967|NCT00843986|544363|P2|COMPLETED|Overall Study||5
222968|NCT00843986|544364|P1|COMPLETED|Overall Study||2
223057|NCT00844558|544790|P2|COMPLETED|Overall Study||18
222969|NCT00843986|544363|P2|Completed Treatment (Infusion)|Overall Study||6
222970|NCT00843986|544364|P1|Completed Treatment (Infusion)|Overall Study||2
222971|NCT00843986|544363|P2|STARTED|Overall Study||6
222972|NCT00843986|544364|P1|STARTED|Overall Study||3
222973|NCT00844051|544392|P2|NOT COMPLETED|Overall Study||0
222974|NCT00844051|544393|P1|NOT COMPLETED|Overall Study||0
222975|NCT00844051|544392|P2|COMPLETED|Overall Study||2368
222976|NCT00844051|544393|P1|COMPLETED|Overall Study||2087
222977|NCT00844051|544392|P2|STARTED|Overall Study||2368
222978|NCT00844051|544393|P1|STARTED|Overall Study||2087
222979|NCT00844090|544403|P2|NOT COMPLETED|Overall Study||8
222980|NCT00844090|544404|P1|NOT COMPLETED|Overall Study||6
222981|NCT00844090|544403|P2|COMPLETED|Overall Study||46
222982|NCT00844090|544404|P1|COMPLETED|Overall Study||46
222983|NCT00844090|544403|P2|STARTED|Overall Study||54
222984|NCT00844090|544404|P1|STARTED|Overall Study||52
222985|NCT00844194|544412|P2|NOT COMPLETED|Overall Study||8
222986|NCT00844194|544413|P1|NOT COMPLETED|Overall Study||25
222987|NCT00844194|544412|P2|COMPLETED|Overall Study||22
222988|NCT00844194|544413|P1|COMPLETED|Overall Study||53
222989|NCT00844194|544412|P2|STARTED|Overall Study||30
222990|NCT00844194|544413|P1|STARTED|Overall Study||78
222991|NCT00844298|544617|P1|NOT COMPLETED|Overall Study||0
222992|NCT00844298|544617|P1|COMPLETED|Overall Study||91
222993|NCT00844298|544617|P1|STARTED|Overall Study||91
222994|NCT00844376|544621|P2|NOT COMPLETED|Period 2: Second Intervention||0
222995|NCT00844376|544622|P1|NOT COMPLETED|Period 2: Second Intervention||0
222996|NCT00844376|544621|P2|COMPLETED|Period 2: Second Intervention||6
222997|NCT00844376|544622|P1|COMPLETED|Period 2: Second Intervention|Total subjects administered Test drug = 12; total subjects administered Reference drug = 11.|5
222998|NCT00844376|544621|P2|STARTED|Period 2: Second Intervention||6
222999|NCT00844376|544622|P1|STARTED|Period 2: Second Intervention||5
223000|NCT00844376|544621|P2|NOT COMPLETED|Period 1: First Intervention||0
223001|NCT00844376|544622|P1|NOT COMPLETED|Period 1: First Intervention||1
223002|NCT00844376|544621|P2|COMPLETED|Period 1: First Intervention||6
223003|NCT00844376|544622|P1|COMPLETED|Period 1: First Intervention||5
223004|NCT00844376|544621|P2|STARTED|Period 1: First Intervention||6
223005|NCT00844376|544622|P1|STARTED|Period 1: First Intervention||6
223006|NCT00844415|544640|P1|NOT COMPLETED|Overall Study||1
223007|NCT00844415|544640|P1|COMPLETED|Overall Study|Completed.|8
223008|NCT00844415|544640|P1|Pat. Received Single Dose 75mg|Overall Study||1
223009|NCT00844415|544640|P1|Pat. Received 125mg Followed by 150mg|Overall Study||2
223010|NCT00844415|544640|P1|Pat. Received 100mg Followed by 125mg|Overall Study||3
223011|NCT00844415|544640|P1|Pat. Received 75mg Followed by 100mg|Overall Study||3
223012|NCT00844415|544640|P1|STARTED|Overall Study|Entered and treated.|9
223013|NCT00844428|544654|P1|NOT COMPLETED|Post Treatment Period (Patients Who Disc||1
223014|NCT00844428|544654|P1|COMPLETED|Post Treatment Period (Patients Who Disc||4
223015|NCT00844428|544654|P1|STARTED|Post Treatment Period (Patients Who Disc||5
223016|NCT00844428|544654|P1|NOT COMPLETED|Extension Treatment Period||1
223017|NCT00844428|544654|P1|COMPLETED|Extension Treatment Period||18
223018|NCT00844428|544654|P1|STARTED|Extension Treatment Period||19
223019|NCT00844428|544654|P1|NOT COMPLETED|Treatment Period (26 Weeks)||0
223020|NCT00844428|544654|P1|COMPLETED|Treatment Period (26 Weeks)||20
223021|NCT00844428|544654|P1|STARTED|Treatment Period (26 Weeks)||20
223022|NCT00844428|544654|P1|NOT COMPLETED|Observation Period (8 Weeks)||0
223023|NCT00844428|544654|P1|COMPLETED|Observation Period (8 Weeks)||20
223024|NCT00844428|544654|P1|STARTED|Observation Period (8 Weeks)||20
223025|NCT00844428|544654|P1|NOT COMPLETED|Screening Period||3
223026|NCT00844428|544654|P1|COMPLETED|Screening Period||20
223027|NCT00844428|544654|P1|STARTED|Screening Period||23
223028|NCT00844480|544672|P2|NOT COMPLETED|Overall Study||3
223029|NCT00844480|544673|P1|NOT COMPLETED|Overall Study||2
223030|NCT00844480|544672|P2|COMPLETED|Overall Study||6
223031|NCT00844480|544673|P1|COMPLETED|Overall Study||6
223032|NCT00844480|544672|P2|STARTED|Overall Study||9
223033|NCT00844480|544673|P1|STARTED|Overall Study||8
223034|NCT00844519|544683|P2|NOT COMPLETED|Overall Study||1
223035|NCT00844519|544684|P1|NOT COMPLETED|Overall Study||2
223036|NCT00844519|544683|P2|COMPLETED|Overall Study||25
223037|NCT00844519|544684|P1|COMPLETED|Overall Study||24
223038|NCT00844519|544683|P2|STARTED|Overall Study||26
223039|NCT00844519|544684|P1|STARTED|Overall Study||26
223040|NCT00844532|544690|P1|NOT COMPLETED|Overall Study||39
223041|NCT00844532|544690|P1|COMPLETED|Overall Study||112
223042|NCT00844532|544690|P1|STARTED|Overall Study||151
223043|NCT00844545|544774|P1|NOT COMPLETED|Post Treatment Period||1
223044|NCT00844545|544774|P1|COMPLETED|Post Treatment Period||5
223045|NCT00844545|544774|P1|STARTED|Post Treatment Period||6
223046|NCT00844545|544774|P1|NOT COMPLETED|Extension Treatment Period||2
223047|NCT00844545|544774|P1|COMPLETED|Extension Treatment Period||11
223048|NCT00844545|544774|P1|STARTED|Extension Treatment Period||13
223049|NCT00844545|544774|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
223050|NCT00844545|544774|P1|COMPLETED|Treatment Period (26 Weeks)||15
223051|NCT00844545|544774|P1|STARTED|Treatment Period (26 Weeks)||17
223052|NCT00844545|544774|P1|NOT COMPLETED|Screening Period||0
223053|NCT00844545|544774|P1|COMPLETED|Screening Period||17
223054|NCT00844545|544774|P1|STARTED|Screening Period||17
223055|NCT00844558|544790|P2|NOT COMPLETED|Overall Study||4
223056|NCT00844558|544791|P1|NOT COMPLETED|Overall Study||12
223058|NCT00844558|544791|P1|COMPLETED|Overall Study||24
223059|NCT00844558|544790|P2|12 Month Visit|Overall Study|-Discontinued intervention (n=0)|18
223060|NCT00844558|544791|P1|12 Month Visit|Overall Study|Discontinued intervention (n=4)|24
223061|NCT00844558|544790|P2|6 Month Visit|Overall Study|-Discontinued intervention (n=1)|18
223062|NCT00844558|544791|P1|6 Month Visit|Overall Study|Discontinued intervention (n=1)|28
223063|NCT00844558|544790|P2|3 Month Visit|Overall Study|"Lost to follow-up (n=1)
Discontinued Intervention (n=1)"|19
223064|NCT00844558|544791|P1|3 Month Visit|Overall Study|Discontinued intervention (n=4)|29
223065|NCT00844558|544790|P2|Received Allocated Intervention|Overall Study||21
223066|NCT00844558|544791|P1|Received Allocated Intervention|Overall Study||33
223067|NCT00844558|544790|P2|STARTED|Overall Study|"Received allocated intervention (n=21)
Did not receive allocated intervention (n=1)"|22
223068|NCT00844558|544791|P1|STARTED|Overall Study|"Received allocated intervention (n=33)
Did not receive allocated intervention (n=3)"|36
223069|NCT00844597|544813|P6|NOT COMPLETED|Overall Study||0
223070|NCT00844597|544814|P5|NOT COMPLETED|Overall Study||0
223071|NCT00844597|544815|P4|NOT COMPLETED|Overall Study||1
223072|NCT00844597|544816|P3|NOT COMPLETED|Overall Study||0
223073|NCT00844597|544817|P2|NOT COMPLETED|Overall Study||0
223074|NCT00844597|544818|P1|NOT COMPLETED|Overall Study||0
223075|NCT00844597|544813|P6|COMPLETED|Overall Study||4
223076|NCT00844597|544814|P5|COMPLETED|Overall Study||4
223077|NCT00844597|544815|P4|COMPLETED|Overall Study||2
223078|NCT00844597|544816|P3|COMPLETED|Overall Study||2
223079|NCT00844597|544817|P2|COMPLETED|Overall Study||2
223080|NCT00844597|544818|P1|COMPLETED|Overall Study||4
223081|NCT00844597|544813|P6|STARTED|Overall Study||4
223082|NCT00844597|544814|P5|STARTED|Overall Study||4
223083|NCT00844597|544815|P4|STARTED|Overall Study||3
223084|NCT00844597|544816|P3|STARTED|Overall Study||2
223085|NCT00844597|544817|P2|STARTED|Overall Study||2
223086|NCT00844597|544818|P1|STARTED|Overall Study||4
223087|NCT00844649|544838|P2|NOT COMPLETED|Overall Study||418
223088|NCT00844649|544839|P1|NOT COMPLETED|Overall Study||405
223089|NCT00844649|544838|P2|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|12
223090|NCT00844649|544839|P1|COMPLETED|Overall Study|Completed = participants remaining on treatment at the time of the data cut off 17 Sept 2012|26
223091|NCT00844649|544838|P2|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|402
223092|NCT00844649|544839|P1|Treated Population|Overall Study|Treated population = all randomized patients who received at least one dose of study drug|421
223093|NCT00844649|544838|P2|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|430
223094|NCT00844649|544839|P1|STARTED|Overall Study|Started = Intent to Treat Population and includes all randomized participants|431
223095|NCT00844714|544857|P1|NOT COMPLETED|Overall Study||0
223096|NCT00844714|544857|P1|COMPLETED|Overall Study||20
223097|NCT00844714|544857|P1|STARTED|Overall Study||20
223098|NCT00844753|544865|P4|NOT COMPLETED|Overall Study||11
223099|NCT00844753|544866|P3|NOT COMPLETED|Overall Study||7
223100|NCT00844753|544867|P2|NOT COMPLETED|Overall Study||3
223101|NCT00844753|544868|P1|NOT COMPLETED|Overall Study||8
223102|NCT00844753|544865|P4|COMPLETED|Overall Study||21
223103|NCT00844753|544866|P3|COMPLETED|Overall Study||25
223104|NCT00844753|544867|P2|COMPLETED|Overall Study||29
223105|NCT00844753|544868|P1|COMPLETED|Overall Study||24
223106|NCT00844753|544865|P4|STARTED|Overall Study||32
223107|NCT00844753|544866|P3|STARTED|Overall Study||32
223108|NCT00844753|544867|P2|STARTED|Overall Study||32
223109|NCT00844753|544868|P1|STARTED|Overall Study||32
223110|NCT00844805|544882|P4|NOT COMPLETED|Follow-Up Phase||9
223111|NCT00844805|544883|P3|NOT COMPLETED|Follow-Up Phase||9
223112|NCT00844805|544884|P2|NOT COMPLETED|Follow-Up Phase||0
223113|NCT00844805|544885|P1|NOT COMPLETED|Follow-Up Phase||0
223114|NCT00844805|544882|P4|COMPLETED|Follow-Up Phase||32
223115|NCT00844805|544883|P3|COMPLETED|Follow-Up Phase||32
223116|NCT00844805|544884|P2|COMPLETED|Follow-Up Phase||0
223117|NCT00844805|544885|P1|COMPLETED|Follow-Up Phase||0
223118|NCT00844805|544882|P4|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
223119|NCT00844805|544883|P3|STARTED|Follow-Up Phase|Participants who met partial remission criteria at the end of treatment entered the Follow-Up Phase.|41
223120|NCT00844805|544884|P2|STARTED|Follow-Up Phase||0
223121|NCT00844805|544885|P1|STARTED|Follow-Up Phase||0
223122|NCT00844805|544882|P4|NOT COMPLETED|Treatment Phase||0
223123|NCT00844805|544883|P3|NOT COMPLETED|Treatment Phase||0
223124|NCT00844805|544884|P2|NOT COMPLETED|Treatment Phase||7
223125|NCT00844805|544885|P1|NOT COMPLETED|Treatment Phase||10
223126|NCT00844805|544882|P4|COMPLETED|Treatment Phase||0
223127|NCT00844805|544883|P3|COMPLETED|Treatment Phase||0
223128|NCT00844805|544884|P2|COMPLETED|Treatment Phase||45
223129|NCT00844805|544885|P1|COMPLETED|Treatment Phase||96
223130|NCT00844805|544882|P4|STARTED|Treatment Phase||0
223131|NCT00844805|544883|P3|STARTED|Treatment Phase||0
223132|NCT00844805|544884|P2|STARTED|Treatment Phase||52
223133|NCT00844805|544885|P1|STARTED|Treatment Phase||106
223134|NCT00844831|544925|P1|NOT COMPLETED|Overall Study||6
223135|NCT00844831|544925|P1|COMPLETED|Overall Study||19
223136|NCT00844831|544925|P1|STARTED|Overall Study||25
223137|NCT00844844|544933|P1|NOT COMPLETED|Post Treatment Period||1
223138|NCT00844844|544933|P1|COMPLETED|Post Treatment Period||5
223139|NCT00844844|544933|P1|STARTED|Post Treatment Period||6
223140|NCT00844844|544933|P1|NOT COMPLETED|Extension Treatment Period||2
223141|NCT00844844|544933|P1|COMPLETED|Extension Treatment Period||11
223142|NCT00844844|544933|P1|STARTED|Extension Treatment Period||13
223143|NCT00844844|544933|P1|NOT COMPLETED|Treatment Period (26 Weeks)||2
223144|NCT00844844|544933|P1|COMPLETED|Treatment Period (26 Weeks)||15
223145|NCT00844844|544933|P1|STARTED|Treatment Period (26 Weeks)||17
223146|NCT00844844|544933|P1|NOT COMPLETED|Screening Period||0
223147|NCT00844844|544933|P1|COMPLETED|Screening Period||17
223148|NCT00844844|544933|P1|STARTED|Screening Period||17
223149|NCT00844857|544949|P2|NOT COMPLETED|Overall Study||37
223150|NCT00844857|544950|P1|NOT COMPLETED|Overall Study||78
223151|NCT00844857|544949|P2|COMPLETED|Overall Study||60
223152|NCT00844857|544950|P1|COMPLETED|Overall Study||116
223153|NCT00844857|544949|P2|Population Analyzed|Overall Study|randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|85
223154|NCT00844857|544950|P1|Population Analyzed|Overall Study|Randomized participants who took at least 1 dose of study drug excluding 2 GCP noncompliant sites.|170
223155|NCT00844857|544949|P2|STARTED|Overall Study||97
223156|NCT00844857|544950|P1|STARTED|Overall Study||194
223157|NCT00844883|544994|P1|NOT COMPLETED|Overall Study||4
223158|NCT00844883|544994|P1|COMPLETED|Overall Study||46
223159|NCT00844883|544994|P1|Patients Who Received TACE|Overall Study|2 patients withdrawn at Week 1 prior to TACE for intolerance to sorafenib|48
223160|NCT00844883|544994|P1|STARTED|Overall Study||50
223161|NCT00844896|545006|P2|NOT COMPLETED|Overall Study||17
223162|NCT00844896|545007|P1|NOT COMPLETED|Overall Study||12
223163|NCT00844896|545006|P2|COMPLETED|Overall Study||11
223164|NCT00844896|545007|P1|COMPLETED|Overall Study||17
223165|NCT00844896|545006|P2|STARTED|Overall Study||28
223166|NCT00844896|545007|P1|STARTED|Overall Study||29
223167|NCT00845000|545035|P6|NOT COMPLETED|Period 3||0
223168|NCT00845000|545036|P5|NOT COMPLETED|Period 3||0
223169|NCT00845000|545037|P4|NOT COMPLETED|Period 3||0
223170|NCT00845000|545038|P3|NOT COMPLETED|Period 3||0
223171|NCT00845000|545039|P2|NOT COMPLETED|Period 3||0
223172|NCT00845000|545040|P1|NOT COMPLETED|Period 3||0
223173|NCT00845000|545035|P6|COMPLETED|Period 3||2
223174|NCT00845000|545036|P5|COMPLETED|Period 3||2
223175|NCT00845000|545037|P4|COMPLETED|Period 3||2
223176|NCT00845000|545038|P3|COMPLETED|Period 3||2
223177|NCT00845000|545039|P2|COMPLETED|Period 3||2
223178|NCT00845000|545040|P1|COMPLETED|Period 3||2
223179|NCT00845000|545035|P6|STARTED|Period 3||2
223180|NCT00845000|545036|P5|STARTED|Period 3||2
223181|NCT00845000|545037|P4|STARTED|Period 3||2
223182|NCT00845000|545038|P3|STARTED|Period 3||2
223183|NCT00845000|545039|P2|STARTED|Period 3||2
223184|NCT00845000|545040|P1|STARTED|Period 3||2
223185|NCT00845000|545035|P6|NOT COMPLETED|Period 2||0
223186|NCT00845000|545036|P5|NOT COMPLETED|Period 2||0
223187|NCT00845000|545037|P4|NOT COMPLETED|Period 2||0
223188|NCT00845000|545038|P3|NOT COMPLETED|Period 2||0
223189|NCT00845000|545039|P2|NOT COMPLETED|Period 2||0
223190|NCT00845000|545040|P1|NOT COMPLETED|Period 2||0
223191|NCT00845000|545035|P6|COMPLETED|Period 2||2
223192|NCT00845000|545036|P5|COMPLETED|Period 2||2
223193|NCT00845000|545037|P4|COMPLETED|Period 2||2
223194|NCT00845000|545038|P3|COMPLETED|Period 2||2
223195|NCT00845000|545039|P2|COMPLETED|Period 2||2
223196|NCT00845000|545040|P1|COMPLETED|Period 2||2
223197|NCT00845000|545035|P6|STARTED|Period 2||2
223198|NCT00845000|545036|P5|STARTED|Period 2||2
223199|NCT00845000|545037|P4|STARTED|Period 2||2
223200|NCT00845000|545038|P3|STARTED|Period 2||2
223201|NCT00845000|545039|P2|STARTED|Period 2||2
223202|NCT00845000|545040|P1|STARTED|Period 2||2
223203|NCT00845000|545035|P6|NOT COMPLETED|Period 1||0
223204|NCT00845000|545036|P5|NOT COMPLETED|Period 1||0
223205|NCT00845000|545037|P4|NOT COMPLETED|Period 1||0
223206|NCT00845000|545038|P3|NOT COMPLETED|Period 1||0
223207|NCT00845000|545039|P2|NOT COMPLETED|Period 1||0
223208|NCT00845000|545040|P1|NOT COMPLETED|Period 1||0
223209|NCT00845000|545035|P6|COMPLETED|Period 1||2
223210|NCT00845000|545036|P5|COMPLETED|Period 1||2
223211|NCT00845000|545037|P4|COMPLETED|Period 1||2
223212|NCT00845000|545038|P3|COMPLETED|Period 1||2
223213|NCT00845000|545039|P2|COMPLETED|Period 1||2
223214|NCT00845000|545040|P1|COMPLETED|Period 1||2
223215|NCT00845000|545035|P6|STARTED|Period 1||2
223216|NCT00845000|545036|P5|STARTED|Period 1||2
223217|NCT00845000|545037|P4|STARTED|Period 1||2
223218|NCT00845000|545038|P3|STARTED|Period 1||2
223219|NCT00845000|545039|P2|STARTED|Period 1||2
223220|NCT00845000|545040|P1|STARTED|Period 1||2
223221|NCT00845065|545059|P2|NOT COMPLETED|Overall Study||55
223222|NCT00845065|545060|P1|NOT COMPLETED|Overall Study||47
223223|NCT00845065|545059|P2|COMPLETED|Overall Study||79
223224|NCT00845065|545060|P1|COMPLETED|Overall Study||20
223225|NCT00845065|545059|P2|STARTED|Overall Study||134
223226|NCT00845065|545060|P1|STARTED|Overall Study||67
223227|NCT00845130|545076|P2|NOT COMPLETED|Overall Study||3
223228|NCT00845130|545077|P1|NOT COMPLETED|Overall Study||4
223229|NCT00845130|545076|P2|COMPLETED|Overall Study||19
223230|NCT00845130|545077|P1|COMPLETED|Overall Study||16
223231|NCT00845130|545076|P2|STARTED|Overall Study||22
223232|NCT00845130|545077|P1|STARTED|Overall Study||20
223233|NCT00845182|545088|P3|NOT COMPLETED|Overall Study||6
223234|NCT00845182|545089|P2|NOT COMPLETED|Overall Study||4
223235|NCT00845182|545090|P1|NOT COMPLETED|Overall Study||3
223236|NCT00845182|545088|P3|COMPLETED|Overall Study||9
223237|NCT00845182|545089|P2|COMPLETED|Overall Study||11
223238|NCT00845182|545090|P1|COMPLETED|Overall Study||10
223239|NCT00845182|545088|P3|STARTED|Overall Study||15
223240|NCT00845182|545089|P2|STARTED|Overall Study||15
223241|NCT00845182|545090|P1|STARTED|Overall Study||13
223242|NCT00845195|545103|P2|NOT COMPLETED|Overall Study||0
223243|NCT00845195|545104|P1|NOT COMPLETED|Overall Study||0
223244|NCT00845195|545103|P2|COMPLETED|Overall Study||75
223245|NCT00845195|545104|P1|COMPLETED|Overall Study||75
223246|NCT00845195|545103|P2|STARTED|Overall Study||75
223247|NCT00845195|545104|P1|STARTED|Overall Study||75
223248|NCT00845429|545119|P3|NOT COMPLETED|Overall Study||20
223249|NCT00845429|545120|P2|NOT COMPLETED|Overall Study||15
223250|NCT00845429|545121|P1|NOT COMPLETED|Overall Study||14
223251|NCT00845429|545119|P3|COMPLETED|Overall Study||224
223252|NCT00845429|545120|P2|COMPLETED|Overall Study||226
223253|NCT00845429|545121|P1|COMPLETED|Overall Study||230
223254|NCT00845429|545119|P3|STARTED|Overall Study||244
223255|NCT00845429|545120|P2|STARTED|Overall Study||241
223256|NCT00845429|545121|P1|STARTED|Overall Study||244
223257|NCT00845481|545138|P1|NOT COMPLETED|Overall Study||0
223258|NCT00845481|545138|P1|COMPLETED|Overall Study||24
223259|NCT00845481|545138|P1|STARTED|Overall Study||24
223260|NCT00835497|545149|P2|NOT COMPLETED|Second Intervention||0
223261|NCT00835497|545150|P1|NOT COMPLETED|Second Intervention||0
223262|NCT00835497|545149|P2|COMPLETED|Second Intervention||20
223263|NCT00835497|545150|P1|COMPLETED|Second Intervention||20
223264|NCT00835497|545149|P2|STARTED|Second Intervention||20
223265|NCT00835497|545150|P1|STARTED|Second Intervention||20
223266|NCT00835497|545149|P2|NOT COMPLETED|Washout: 7 Days||0
223267|NCT00835497|545150|P1|NOT COMPLETED|Washout: 7 Days||0
223268|NCT00835497|545149|P2|COMPLETED|Washout: 7 Days||20
223269|NCT00835497|545150|P1|COMPLETED|Washout: 7 Days||20
223270|NCT00835497|545149|P2|STARTED|Washout: 7 Days||20
223271|NCT00835497|545150|P1|STARTED|Washout: 7 Days||20
223272|NCT00835497|545149|P2|NOT COMPLETED|First Intervention||0
223273|NCT00835497|545150|P1|NOT COMPLETED|First Intervention||0
223274|NCT00835497|545149|P2|COMPLETED|First Intervention||20
223275|NCT00835497|545150|P1|COMPLETED|First Intervention||20
223276|NCT00835497|545149|P2|STARTED|First Intervention||20
223277|NCT00835497|545150|P1|STARTED|First Intervention||20
223278|NCT00835510|545167|P3|NOT COMPLETED|Overall Study||38
223279|NCT00835510|545168|P2|NOT COMPLETED|Overall Study||69
223280|NCT00835510|545169|P1|NOT COMPLETED|Overall Study||76
223281|NCT00835510|545167|P3|COMPLETED|Overall Study||70
223282|NCT00835510|545168|P2|COMPLETED|Overall Study||152
223283|NCT00835510|545169|P1|COMPLETED|Overall Study||143
223284|NCT00835510|545167|P3|Positive Fungal Culture|Overall Study||71
223285|NCT00835510|545168|P2|Positive Fungal Culture|Overall Study||155
223286|NCT00835510|545169|P1|Positive Fungal Culture|Overall Study||149
223287|NCT00835510|545167|P3|STARTED|Overall Study||108
223288|NCT00835510|545168|P2|STARTED|Overall Study||221
223289|NCT00835510|545169|P1|STARTED|Overall Study||219
223290|NCT00835536|545191|P2|NOT COMPLETED|Second Intervention||0
223291|NCT00835536|545192|P1|NOT COMPLETED|Second Intervention||0
223292|NCT00835536|545191|P2|COMPLETED|Second Intervention||14
223293|NCT00835536|545192|P1|COMPLETED|Second Intervention||12
223294|NCT00835536|545191|P2|STARTED|Second Intervention||14
223295|NCT00835536|545192|P1|STARTED|Second Intervention||12
223296|NCT00835536|545191|P2|NOT COMPLETED|Washout of 5 Weeks||0
223297|NCT00835536|545192|P1|NOT COMPLETED|Washout of 5 Weeks||1
223298|NCT00835536|545191|P2|COMPLETED|Washout of 5 Weeks||14
223299|NCT00835536|545192|P1|COMPLETED|Washout of 5 Weeks||12
223300|NCT00835536|545191|P2|STARTED|Washout of 5 Weeks||14
223301|NCT00835536|545192|P1|STARTED|Washout of 5 Weeks||13
223302|NCT00835536|545191|P2|NOT COMPLETED|First Intervention||0
223303|NCT00835536|545192|P1|NOT COMPLETED|First Intervention||0
223304|NCT00835536|545191|P2|COMPLETED|First Intervention||14
223305|NCT00835536|545192|P1|COMPLETED|First Intervention||13
223306|NCT00835536|545191|P2|STARTED|First Intervention||14
223307|NCT00835536|545192|P1|STARTED|First Intervention||13
223308|NCT00835549|545200|P2|NOT COMPLETED|Second Intervention||0
223309|NCT00835549|545201|P1|NOT COMPLETED|Second Intervention||0
223310|NCT00835549|545200|P2|COMPLETED|Second Intervention||16
223311|NCT00835549|545201|P1|COMPLETED|Second Intervention||14
223312|NCT00835549|545200|P2|STARTED|Second Intervention||16
223313|NCT00835549|545201|P1|STARTED|Second Intervention||14
223314|NCT00835549|545200|P2|NOT COMPLETED|Washout of 7 Days||0
223315|NCT00835549|545201|P1|NOT COMPLETED|Washout of 7 Days||2
223316|NCT00835549|545200|P2|COMPLETED|Washout of 7 Days||16
223317|NCT00835549|545201|P1|COMPLETED|Washout of 7 Days||14
223318|NCT00835549|545200|P2|STARTED|Washout of 7 Days||16
223319|NCT00835549|545201|P1|STARTED|Washout of 7 Days||16
223320|NCT00835549|545200|P2|NOT COMPLETED|First Intervention||0
223321|NCT00835549|545201|P1|NOT COMPLETED|First Intervention||0
223322|NCT00835549|545200|P2|COMPLETED|First Intervention||16
223323|NCT00835549|545201|P1|COMPLETED|First Intervention||16
223324|NCT00835549|545200|P2|STARTED|First Intervention||16
223325|NCT00835549|545201|P1|STARTED|First Intervention||16
223326|NCT00835575|545211|P2|NOT COMPLETED|Second Intervention||0
223327|NCT00835575|545212|P1|NOT COMPLETED|Second Intervention||0
223328|NCT00835575|545211|P2|COMPLETED|Second Intervention||16
223329|NCT00835575|545212|P1|COMPLETED|Second Intervention||15
223330|NCT00835575|545211|P2|STARTED|Second Intervention||16
223331|NCT00835575|545212|P1|STARTED|Second Intervention||15
223332|NCT00835575|545211|P2|NOT COMPLETED|Washout of 14 Days||0
223333|NCT00835575|545212|P1|NOT COMPLETED|Washout of 14 Days||1
223334|NCT00835575|545211|P2|COMPLETED|Washout of 14 Days||16
223335|NCT00835575|545212|P1|COMPLETED|Washout of 14 Days||15
223336|NCT00835575|545211|P2|STARTED|Washout of 14 Days||16
223337|NCT00835575|545212|P1|STARTED|Washout of 14 Days||16
223338|NCT00835575|545211|P2|NOT COMPLETED|First Intervention||0
223339|NCT00835575|545212|P1|NOT COMPLETED|First Intervention||0
223340|NCT00835575|545211|P2|COMPLETED|First Intervention||16
223341|NCT00835575|545212|P1|COMPLETED|First Intervention||16
223342|NCT00835575|545211|P2|STARTED|First Intervention||16
223343|NCT00835575|545212|P1|STARTED|First Intervention||16
223344|NCT00835588|545222|P2|NOT COMPLETED|Second Intervention||0
223345|NCT00835588|545223|P1|NOT COMPLETED|Second Intervention||0
223346|NCT00835588|545222|P2|COMPLETED|Second Intervention||50
223347|NCT00835588|545223|P1|COMPLETED|Second Intervention||50
223348|NCT00835588|545222|P2|STARTED|Second Intervention||50
223349|NCT00835588|545223|P1|STARTED|Second Intervention||50
223350|NCT00835588|545222|P2|NOT COMPLETED|Washout: 5 Days||0
223351|NCT00835588|545223|P1|NOT COMPLETED|Washout: 5 Days||0
223352|NCT00835588|545222|P2|COMPLETED|Washout: 5 Days||50
223353|NCT00835588|545223|P1|COMPLETED|Washout: 5 Days||50
223354|NCT00835588|545222|P2|STARTED|Washout: 5 Days||50
223355|NCT00835588|545223|P1|STARTED|Washout: 5 Days||50
223356|NCT00835588|545222|P2|NOT COMPLETED|First Intervention||0
223357|NCT00835588|545223|P1|NOT COMPLETED|First Intervention||0
223358|NCT00835588|545222|P2|COMPLETED|First Intervention||50
223359|NCT00835588|545223|P1|COMPLETED|First Intervention||50
223360|NCT00835588|545222|P2|STARTED|First Intervention||50
223361|NCT00835588|545223|P1|STARTED|First Intervention||50
223362|NCT00835614|545233|P2|NOT COMPLETED|Second Intervention||0
223363|NCT00835614|545234|P1|NOT COMPLETED|Second Intervention||0
223364|NCT00835614|545233|P2|COMPLETED|Second Intervention||13
223365|NCT00835614|545234|P1|COMPLETED|Second Intervention||13
223366|NCT00835614|545233|P2|STARTED|Second Intervention||13
223367|NCT00835614|545234|P1|STARTED|Second Intervention||13
223368|NCT00835614|545233|P2|NOT COMPLETED|Washout of 7 Days||0
223369|NCT00835614|545234|P1|NOT COMPLETED|Washout of 7 Days||0
223370|NCT00835614|545233|P2|COMPLETED|Washout of 7 Days||13
223371|NCT00835614|545234|P1|COMPLETED|Washout of 7 Days||13
223372|NCT00835614|545233|P2|STARTED|Washout of 7 Days||13
223373|NCT00835614|545234|P1|STARTED|Washout of 7 Days||13
223374|NCT00835614|545233|P2|NOT COMPLETED|First Intervention||0
223375|NCT00835614|545234|P1|NOT COMPLETED|First Intervention||0
223376|NCT00835614|545233|P2|COMPLETED|First Intervention||13
223377|NCT00835614|545234|P1|COMPLETED|First Intervention||13
223378|NCT00835614|545233|P2|STARTED|First Intervention||13
223379|NCT00835614|545234|P1|STARTED|First Intervention||13
223380|NCT00835640|545244|P2|NOT COMPLETED|Second Intervention||0
223381|NCT00835640|545245|P1|NOT COMPLETED|Second Intervention||1
223382|NCT00835640|545244|P2|COMPLETED|Second Intervention||12
223383|NCT00835640|545245|P1|COMPLETED|Second Intervention||11
223384|NCT00835640|545244|P2|STARTED|Second Intervention||12
223385|NCT00835640|545245|P1|STARTED|Second Intervention||12
223386|NCT00835640|545244|P2|NOT COMPLETED|Washout of 7 Days||0
223387|NCT00835640|545245|P1|NOT COMPLETED|Washout of 7 Days||0
223388|NCT00835640|545244|P2|COMPLETED|Washout of 7 Days||12
223389|NCT00835640|545245|P1|COMPLETED|Washout of 7 Days||12
223390|NCT00835640|545244|P2|STARTED|Washout of 7 Days||12
223391|NCT00835640|545245|P1|STARTED|Washout of 7 Days||12
223392|NCT00835640|545244|P2|NOT COMPLETED|First Intervention||0
223393|NCT00835640|545245|P1|NOT COMPLETED|First Intervention||0
223394|NCT00835640|545244|P2|COMPLETED|First Intervention||12
223395|NCT00835640|545245|P1|COMPLETED|First Intervention||12
223396|NCT00835640|545244|P2|STARTED|First Intervention||12
223397|NCT00835640|545245|P1|STARTED|First Intervention||12
223398|NCT00835666|545255|P2|NOT COMPLETED|Second Intervention||0
223399|NCT00835666|545256|P1|NOT COMPLETED|Second Intervention||0
223400|NCT00835666|545255|P2|COMPLETED|Second Intervention||16
223401|NCT00835666|545256|P1|COMPLETED|Second Intervention||14
223402|NCT00835666|545255|P2|STARTED|Second Intervention||16
223403|NCT00835666|545256|P1|STARTED|Second Intervention||14
223404|NCT00835666|545255|P2|NOT COMPLETED|Washout||0
223405|NCT00835666|545256|P1|NOT COMPLETED|Washout||2
223406|NCT00835666|545255|P2|COMPLETED|Washout||16
223407|NCT00835666|545256|P1|COMPLETED|Washout||14
223408|NCT00835666|545255|P2|STARTED|Washout||16
223409|NCT00835666|545256|P1|STARTED|Washout||16
223410|NCT00835666|545255|P2|NOT COMPLETED|First Intervention||0
223411|NCT00835666|545256|P1|NOT COMPLETED|First Intervention||0
223412|NCT00835666|545255|P2|COMPLETED|First Intervention||16
223413|NCT00835666|545256|P1|COMPLETED|First Intervention||16
223414|NCT00835666|545255|P2|STARTED|First Intervention||16
223415|NCT00835666|545256|P1|STARTED|First Intervention||16
223416|NCT00835679|545268|P4|NOT COMPLETED|Overall Study||0
223417|NCT00835679|545269|P3|NOT COMPLETED|Overall Study||0
223418|NCT00835679|545270|P2|NOT COMPLETED|Overall Study||0
223419|NCT00835679|545271|P1|NOT COMPLETED|Overall Study||1
223420|NCT00835679|545268|P4|COMPLETED|Overall Study||0
223421|NCT00835679|545269|P3|COMPLETED|Overall Study||0
223422|NCT00835679|545270|P2|COMPLETED|Overall Study||0
223423|NCT00835679|545271|P1|COMPLETED|Overall Study||8
223424|NCT00835679|545268|P4|STARTED|Overall Study||0
223425|NCT00835679|545269|P3|STARTED|Overall Study||0
223426|NCT00835679|545270|P2|STARTED|Overall Study|This study closed prematurely, thus no patients went on Cohort B, C or D.|0
223427|NCT00835679|545271|P1|STARTED|Overall Study||9
223428|NCT00835692|545295|P2|NOT COMPLETED|Second Intervention||0
223429|NCT00835692|545296|P1|NOT COMPLETED|Second Intervention||0
223430|NCT00835692|545295|P2|COMPLETED|Second Intervention||28
223431|NCT00835692|545296|P1|COMPLETED|Second Intervention||27
223432|NCT00835692|545295|P2|STARTED|Second Intervention||28
223433|NCT00835692|545296|P1|STARTED|Second Intervention||27
223434|NCT00835692|545295|P2|NOT COMPLETED|Washout||0
223435|NCT00835692|545296|P1|NOT COMPLETED|Washout||0
223436|NCT00835692|545295|P2|COMPLETED|Washout||28
223437|NCT00835692|545296|P1|COMPLETED|Washout||27
223438|NCT00835692|545295|P2|STARTED|Washout||28
223439|NCT00835692|545296|P1|STARTED|Washout||27
223440|NCT00835692|545295|P2|NOT COMPLETED|First Intervention||0
223441|NCT00835692|545296|P1|NOT COMPLETED|First Intervention||1
223442|NCT00835692|545295|P2|COMPLETED|First Intervention||28
223443|NCT00835692|545296|P1|COMPLETED|First Intervention||27
223444|NCT00835692|545295|P2|STARTED|First Intervention||28
223445|NCT00835692|545296|P1|STARTED|First Intervention||28
223446|NCT00835705|545306|P2|NOT COMPLETED|Second Intervention||0
223447|NCT00835705|545307|P1|NOT COMPLETED|Second Intervention||1
223448|NCT00835705|545306|P2|COMPLETED|Second Intervention||28
223449|NCT00835705|545307|P1|COMPLETED|Second Intervention||22
223450|NCT00835705|545306|P2|STARTED|Second Intervention||28
223451|NCT00835705|545307|P1|STARTED|Second Intervention||23
223452|NCT00835705|545306|P2|NOT COMPLETED|First Intervention||0
223453|NCT00835705|545307|P1|NOT COMPLETED|First Intervention||1
223454|NCT00835705|545306|P2|COMPLETED|First Intervention||28
223455|NCT00835705|545307|P1|COMPLETED|First Intervention||23
223456|NCT00835705|545306|P2|STARTED|First Intervention||28
223457|NCT00835705|545307|P1|STARTED|First Intervention||24
223458|NCT00835731|545323|P2|NOT COMPLETED|Overall Study||1
223459|NCT00835731|545324|P1|NOT COMPLETED|Overall Study||2
223460|NCT00835731|545323|P2|COMPLETED|Overall Study||60
223461|NCT00835731|545324|P1|COMPLETED|Overall Study||62
223462|NCT00835731|545323|P2|STARTED|Overall Study||61
223463|NCT00835731|545324|P1|STARTED|Overall Study||64
223464|NCT00835796|545340|P2|NOT COMPLETED|Second Intervention||0
223465|NCT00835796|545341|P1|NOT COMPLETED|Second Intervention||0
223466|NCT00835796|545340|P2|COMPLETED|Second Intervention||9
223467|NCT00835796|545341|P1|COMPLETED|Second Intervention||10
223468|NCT00835796|545340|P2|STARTED|Second Intervention||9
223469|NCT00835796|545341|P1|STARTED|Second Intervention||10
223470|NCT00835796|545340|P2|NOT COMPLETED|Washout||0
223471|NCT00835796|545341|P1|NOT COMPLETED|Washout||0
223472|NCT00835796|545340|P2|COMPLETED|Washout||9
223473|NCT00835796|545341|P1|COMPLETED|Washout||10
223474|NCT00835796|545340|P2|STARTED|Washout||9
223475|NCT00835796|545341|P1|STARTED|Washout||10
223476|NCT00835796|545340|P2|NOT COMPLETED|First Intervention||1
223477|NCT00835796|545341|P1|NOT COMPLETED|First Intervention||0
223478|NCT00835796|545340|P2|COMPLETED|First Intervention||9
223479|NCT00835796|545341|P1|COMPLETED|First Intervention||10
223480|NCT00835796|545340|P2|STARTED|First Intervention||10
223481|NCT00835796|545341|P1|STARTED|First Intervention||10
223482|NCT00845663|545351|P2|NOT COMPLETED|Overall Study||0
223483|NCT00845663|545352|P1|NOT COMPLETED|Overall Study||0
223484|NCT00845663|545351|P2|COMPLETED|Overall Study||49
223485|NCT00845663|545352|P1|COMPLETED|Overall Study||49
223486|NCT00845663|545351|P2|STARTED|Overall Study||49
223487|NCT00845663|545352|P1|STARTED|Overall Study||49
223488|NCT00845676|545400|P1|NOT COMPLETED|Overall Study||2
223489|NCT00845676|545400|P1|COMPLETED|Overall Study||19
223490|NCT00845676|545400|P1|STARTED|Overall Study||21
223491|NCT00845702|545404|P1|NOT COMPLETED|Dotarem MRA||0
223492|NCT00845702|545404|P1|COMPLETED|Dotarem MRA||32
223493|NCT00845702|545404|P1|STARTED|Dotarem MRA||32
223494|NCT00845702|545404|P1|NOT COMPLETED|TOF MRA||1
223495|NCT00845702|545404|P1|COMPLETED|TOF MRA|One patient did not perform study MRA procedures.|32
223496|NCT00845702|545404|P1|STARTED|TOF MRA||33
223497|NCT00845728|545412|P2|NOT COMPLETED|Overall Study||342
223498|NCT00845728|545413|P1|NOT COMPLETED|Overall Study||386
223499|NCT00845728|545412|P2|COMPLETED|Overall Study||1379
223500|NCT00845728|545413|P1|COMPLETED|Overall Study||1337
223501|NCT00845728|545412|P2|Exposed|Overall Study||1718
223502|NCT00845728|545413|P1|Exposed|Overall Study||1721
223503|NCT00845728|545412|P2|STARTED|Overall Study||1721
223504|NCT00845728|545413|P1|STARTED|Overall Study||1723
223505|NCT00845832|545424|P3|NOT COMPLETED|Extended Safety Follow-Up||7
223506|NCT00845832|545425|P2|NOT COMPLETED|Extended Safety Follow-Up||0
223507|NCT00845832|545426|P1|NOT COMPLETED|Extended Safety Follow-Up||0
223508|NCT00845832|545424|P3|COMPLETED|Extended Safety Follow-Up||0
223509|NCT00845832|545425|P2|COMPLETED|Extended Safety Follow-Up||5
223510|NCT00845832|545426|P1|COMPLETED|Extended Safety Follow-Up||2
223511|NCT00845832|545424|P3|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|7
223512|NCT00845832|545425|P2|STARTED|Extended Safety Follow-Up|Only participants who remained B cell depleted required extended safety follow-up.|5
223513|NCT00845832|545426|P1|STARTED|Extended Safety Follow-Up||2
223514|NCT00845832|545424|P3|NOT COMPLETED|Safety Follow-Up||0
223515|NCT00845832|545425|P2|NOT COMPLETED|Safety Follow-Up||0
223516|NCT00845832|545426|P1|NOT COMPLETED|Safety Follow-Up||1
223517|NCT00845832|545424|P3|COMPLETED|Safety Follow-Up||12
223518|NCT00845832|545425|P2|COMPLETED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|9
223519|NCT00845832|545426|P1|COMPLETED|Safety Follow-Up||2
223520|NCT00845832|545424|P3|STARTED|Safety Follow-Up|One participant each from the placebo and TCZ (2 mg/kg) groups were re-assigned to this group.|12
223521|NCT00845832|545425|P2|STARTED|Safety Follow-Up|All participants who withdrew from study were asked to return for safety follow-up.|9
223522|NCT00845832|545426|P1|STARTED|Safety Follow-Up|One participant from this group was re-assigned to TCZ (4 mg/kg) group.|3
223523|NCT00845832|545424|P3|NOT COMPLETED|Treatment Period||0
223524|NCT00845832|545425|P2|NOT COMPLETED|Treatment Period||3
223525|NCT00845832|545426|P1|NOT COMPLETED|Treatment Period||1
223526|NCT00845832|545424|P3|COMPLETED|Treatment Period||10
223527|NCT00845832|545425|P2|COMPLETED|Treatment Period||7
223528|NCT00845832|545426|P1|COMPLETED|Treatment Period||3
223529|NCT00845832|545424|P3|STARTED|Treatment Period||10
223530|NCT00845832|545425|P2|STARTED|Treatment Period||10
223531|NCT00845832|545426|P1|STARTED|Treatment Period||4
223532|NCT00845975|545472|P2|NOT COMPLETED|Overall Study||0
223533|NCT00845975|545473|P1|NOT COMPLETED|Overall Study||0
223534|NCT00845975|545472|P2|COMPLETED|Overall Study||9
223535|NCT00845975|545473|P1|COMPLETED|Overall Study||9
223536|NCT00845975|545472|P2|STARTED|Overall Study||9
223537|NCT00845975|545473|P1|STARTED|Overall Study||9
223538|NCT00846027|545483|P1|NOT COMPLETED|Overall Study||90
223539|NCT00846027|545483|P1|COMPLETED|Overall Study||0
223540|NCT00846027|545483|P1|Received Treatment|Overall Study||83
223541|NCT00846027|545483|P1|STARTED|Overall Study||90
223542|NCT00846066|545492|P2|NOT COMPLETED|Overall Study||0
223543|NCT00846066|545493|P1|NOT COMPLETED|Overall Study||0
223544|NCT00846066|545492|P2|COMPLETED|Overall Study||29
223545|NCT00846066|545493|P1|COMPLETED|Overall Study||27
223546|NCT00846066|545492|P2|STARTED|Overall Study||29
223547|NCT00846066|545493|P1|STARTED|Overall Study||27
223548|NCT00846287|545507|P2|NOT COMPLETED|Overall Study||5
223549|NCT00846287|545508|P1|NOT COMPLETED|Overall Study||10
223550|NCT00846287|545507|P2|COMPLETED|Overall Study||10
223551|NCT00846287|545508|P1|COMPLETED|Overall Study||6
223552|NCT00846287|545507|P2|STARTED|Overall Study||15
223553|NCT00846287|545508|P1|STARTED|Overall Study||16
223554|NCT00846365|545519|P3|NOT COMPLETED|Overall Study||33
223555|NCT00846365|545520|P2|NOT COMPLETED|Overall Study||49
223556|NCT00846365|545521|P1|NOT COMPLETED|Overall Study||55
223557|NCT00846365|545519|P3|COMPLETED|Overall Study||323
223558|NCT00846365|545520|P2|COMPLETED|Overall Study||308
223559|NCT00846365|545521|P1|COMPLETED|Overall Study||317
223560|NCT00846365|545519|P3|STARTED|Overall Study||356
223561|NCT00846365|545520|P2|STARTED|Overall Study||357
223562|NCT00846365|545521|P1|STARTED|Overall Study||372
223563|NCT00846391|545577|P3|NOT COMPLETED|Overall Study||3
223564|NCT00846391|545578|P2|NOT COMPLETED|Overall Study||2
223565|NCT00846391|545579|P1|NOT COMPLETED|Overall Study||1
223566|NCT00846391|545577|P3|COMPLETED|Overall Study||3
223567|NCT00846391|545578|P2|COMPLETED|Overall Study||2
223568|NCT00846391|545579|P1|COMPLETED|Overall Study||3
223569|NCT00846391|545577|P3|STARTED|Overall Study||6
223570|NCT00846391|545578|P2|STARTED|Overall Study||4
223571|NCT00846391|545579|P1|STARTED|Overall Study||4
223572|NCT00846495|545589|P2|NOT COMPLETED|Overall Study||3
223573|NCT00846495|545590|P1|NOT COMPLETED|Overall Study||8
223574|NCT00846495|545589|P2|COMPLETED|Overall Study||24
223575|NCT00846495|545590|P1|COMPLETED|Overall Study||20
223576|NCT00846495|545589|P2|STARTED|Overall Study||27
223577|NCT00846495|545590|P1|STARTED|Overall Study||28
223578|NCT00846521|545610|P1|NOT COMPLETED|Overall Study||11
223579|NCT00846521|545610|P1|COMPLETED|Overall Study||12
223580|NCT00846521|545610|P1|STARTED|Overall Study||23
223581|NCT00846547|545615|P1|NOT COMPLETED|Overall Study||7
223582|NCT00846547|545615|P1|COMPLETED|Overall Study||25
223583|NCT00846547|545615|P1|STARTED|Overall Study||32
223584|NCT00846573|545622|P4|NOT COMPLETED|Overall Study||0
223585|NCT00846573|545623|P3|NOT COMPLETED|Overall Study||0
223586|NCT00846573|545624|P2|NOT COMPLETED|Overall Study||0
223587|NCT00846573|545625|P1|NOT COMPLETED|Overall Study||0
223588|NCT00846573|545622|P4|COMPLETED|Overall Study||0
223589|NCT00846573|545623|P3|COMPLETED|Overall Study||7
223590|NCT00846573|545624|P2|COMPLETED|Overall Study||2
223591|NCT00846573|545625|P1|COMPLETED|Overall Study||5
223592|NCT00846573|545622|P4|STARTED|Overall Study||0
223593|NCT00846573|545623|P3|STARTED|Overall Study||7
223594|NCT00846573|545624|P2|STARTED|Overall Study||2
223595|NCT00846573|545625|P1|STARTED|Overall Study||5
223596|NCT00846586|545635|P2|NOT COMPLETED|Overall Study||35
223597|NCT00846586|545636|P1|NOT COMPLETED|Overall Study||39
223598|NCT00846586|545635|P2|COMPLETED|Overall Study||529
223599|NCT00846586|545636|P1|COMPLETED|Overall Study||531
223600|NCT00846586|545635|P2|Received Study Drug|Overall Study|Three patients were not exposed to study treatment in this group.|561
223601|NCT00846586|545636|P1|Received Study Drug|Overall Study||570
223602|NCT00846586|545635|P2|STARTED|Overall Study||564
223603|NCT00846586|545636|P1|STARTED|Overall Study||570
223604|NCT00846651|545654|P2|NOT COMPLETED|Overall Study||4
223605|NCT00846651|545655|P1|NOT COMPLETED|Overall Study||4
223606|NCT00846651|545654|P2|COMPLETED|Overall Study||37
223607|NCT00846651|545655|P1|COMPLETED|Overall Study||37
223608|NCT00846651|545654|P2|STARTED|Overall Study||41
223609|NCT00846651|545655|P1|STARTED|Overall Study||41
223610|NCT00846768|545669|P4|NOT COMPLETED|Overall Study||0
223611|NCT00846768|545670|P3|NOT COMPLETED|Overall Study||0
223612|NCT00846768|545671|P2|NOT COMPLETED|Overall Study||1
223613|NCT00846768|545672|P1|NOT COMPLETED|Overall Study||0
223614|NCT00846768|545669|P4|COMPLETED|Overall Study||12
223615|NCT00846768|545670|P3|COMPLETED|Overall Study||12
223616|NCT00846768|545671|P2|COMPLETED|Overall Study||11
223617|NCT00846768|545672|P1|COMPLETED|Overall Study||11
223618|NCT00846768|545669|P4|STARTED|Overall Study||12
223619|NCT00846768|545670|P3|STARTED|Overall Study||12
223620|NCT00846768|545671|P2|STARTED|Overall Study||12
223621|NCT00846768|545672|P1|STARTED|Overall Study||11
223622|NCT00846807|545742|P1|NOT COMPLETED|Overall Study||632
223623|NCT00846807|545742|P1|COMPLETED|Overall Study|Completed treatment.|4660
223624|NCT00846807|545742|P1|STARTED|Overall Study|Entered and treated.|5292
223625|NCT00846846|545750|P1|NOT COMPLETED|Overall Study||75
223626|NCT00846846|545750|P1|COMPLETED|Overall Study|Study ongoing but not recruiting participants.|943
223627|NCT00846846|545750|P1|STARTED|Overall Study||1018
223628|NCT00846885|545757|P2|NOT COMPLETED|Second Intervention||0
223629|NCT00846885|545758|P1|NOT COMPLETED|Second Intervention||0
223630|NCT00846885|545757|P2|COMPLETED|Second Intervention||14
223631|NCT00846885|545758|P1|COMPLETED|Second Intervention||14
223632|NCT00846885|545757|P2|STARTED|Second Intervention||14
223633|NCT00846885|545758|P1|STARTED|Second Intervention||14
223634|NCT00846885|545757|P2|NOT COMPLETED|Washout of 7 Days||0
223635|NCT00846885|545758|P1|NOT COMPLETED|Washout of 7 Days||0
223636|NCT00846885|545757|P2|COMPLETED|Washout of 7 Days||14
223637|NCT00846885|545758|P1|COMPLETED|Washout of 7 Days||14
223638|NCT00846885|545757|P2|STARTED|Washout of 7 Days||14
223639|NCT00846885|545758|P1|STARTED|Washout of 7 Days||14
223640|NCT00846885|545757|P2|NOT COMPLETED|First Intervention||0
223641|NCT00846885|545758|P1|NOT COMPLETED|First Intervention||0
223642|NCT00846885|545757|P2|COMPLETED|First Intervention||14
223643|NCT00846885|545758|P1|COMPLETED|First Intervention||14
223644|NCT00846885|545757|P2|STARTED|First Intervention||14
223645|NCT00846885|545758|P1|STARTED|First Intervention||14
223646|NCT00847002|545768|P2|NOT COMPLETED|Overall Study||0
223647|NCT00847002|545769|P1|NOT COMPLETED|Overall Study||0
223648|NCT00847002|545768|P2|COMPLETED|Overall Study||4
223649|NCT00847002|545769|P1|COMPLETED|Overall Study||4
223650|NCT00847002|545768|P2|STARTED|Overall Study||4
223651|NCT00847002|545769|P1|STARTED|Overall Study||4
223652|NCT00847015|545777|P1|NOT COMPLETED|Overall Study||3
223653|NCT00847015|545777|P1|COMPLETED|Overall Study||15
223654|NCT00847015|545777|P1|STARTED|Overall Study||18
223655|NCT00847132|545785|P2|NOT COMPLETED|Overall Study||1
223656|NCT00847132|545786|P1|NOT COMPLETED|Overall Study||1
223657|NCT00847132|545785|P2|COMPLETED|Overall Study||84
223658|NCT00847132|545786|P1|COMPLETED|Overall Study||89
223659|NCT00847132|545785|P2|STARTED|Overall Study||85
223660|NCT00847132|545786|P1|STARTED|Overall Study||90
223661|NCT00847145|545802|P8|NOT COMPLETED|Overall Study||4
223662|NCT00847145|545803|P7|NOT COMPLETED|Overall Study||9
223663|NCT00847145|545804|P6|NOT COMPLETED|Overall Study||4
223664|NCT00847145|545805|P5|NOT COMPLETED|Overall Study||6
223665|NCT00847145|545806|P4|NOT COMPLETED|Overall Study||1
223666|NCT00847145|545807|P3|NOT COMPLETED|Overall Study||11
223667|NCT00847145|545808|P2|NOT COMPLETED|Overall Study||6
223668|NCT00847145|545809|P1|NOT COMPLETED|Overall Study||6
223669|NCT00847145|545802|P8|COMPLETED|Overall Study||136
223670|NCT00847145|545803|P7|COMPLETED|Overall Study||143
223671|NCT00847145|545804|P6|COMPLETED|Overall Study||152
223672|NCT00847145|545805|P5|COMPLETED|Overall Study||131
223673|NCT00847145|545806|P4|COMPLETED|Overall Study||116
223674|NCT00847145|545807|P3|COMPLETED|Overall Study||274
223675|NCT00847145|545808|P2|COMPLETED|Overall Study||627
223676|NCT00847145|545809|P1|COMPLETED|Overall Study||623
223677|NCT00847145|545802|P8|STARTED|Overall Study||140
223678|NCT00847145|545803|P7|STARTED|Overall Study||152
223679|NCT00847145|545804|P6|STARTED|Overall Study||156
223680|NCT00847145|545805|P5|STARTED|Overall Study||137
223681|NCT00847145|545806|P4|STARTED|Overall Study||117
223682|NCT00847145|545807|P3|STARTED|Overall Study||285
223683|NCT00847145|545808|P2|STARTED|Overall Study||633
223684|NCT00847145|545809|P1|STARTED|Overall Study||629
223685|NCT00847197|545859|P2|NOT COMPLETED|Overall Study||5
223686|NCT00847197|545860|P1|NOT COMPLETED|Overall Study||24
223687|NCT00847197|545859|P2|COMPLETED|Overall Study||70
223688|NCT00847197|545860|P1|COMPLETED|Overall Study||92
223689|NCT00847197|545859|P2|STARTED|Overall Study||75
223690|NCT00847197|545860|P1|STARTED|Overall Study||116
223691|NCT00847210|545872|P2|NOT COMPLETED|Overall Study||0
223692|NCT00847210|545873|P1|NOT COMPLETED|Overall Study||0
223693|NCT00847210|545872|P2|COMPLETED|Overall Study||18
223694|NCT00847210|545873|P1|COMPLETED|Overall Study||18
223695|NCT00847210|545872|P2|STARTED|Overall Study||18
223696|NCT00847210|545873|P1|STARTED|Overall Study||18
223697|NCT00847288|545895|P2|NOT COMPLETED|Overall Study||47
223698|NCT00847288|545896|P1|NOT COMPLETED|Overall Study||30
223699|NCT00847288|545895|P2|COMPLETED|Overall Study||780
223700|NCT00847288|545896|P1|COMPLETED|Overall Study||811
223701|NCT00847288|545895|P2|STARTED|Overall Study||827
223702|NCT00847288|545896|P1|STARTED|Overall Study||841
223703|NCT00847301|545908|P1|NOT COMPLETED|Overall Study||54
223704|NCT00847301|545908|P1|COMPLETED|Overall Study||374
223705|NCT00847301|545908|P1|STARTED|Overall Study||428
223706|NCT00847405|545918|P2|NOT COMPLETED|Second Intervention||0
223707|NCT00847405|545919|P1|NOT COMPLETED|Second Intervention||0
223708|NCT00847405|545918|P2|COMPLETED|Second Intervention||13
223709|NCT00847405|545919|P1|COMPLETED|Second Intervention||13
223710|NCT00847405|545918|P2|STARTED|Second Intervention||13
223711|NCT00847405|545919|P1|STARTED|Second Intervention||13
223712|NCT00847405|545918|P2|NOT COMPLETED|Washout of 7 Days||0
223713|NCT00847405|545919|P1|NOT COMPLETED|Washout of 7 Days||1
223714|NCT00847405|545918|P2|COMPLETED|Washout of 7 Days||13
223715|NCT00847405|545919|P1|COMPLETED|Washout of 7 Days||13
223716|NCT00847405|545918|P2|STARTED|Washout of 7 Days||13
223717|NCT00847405|545919|P1|STARTED|Washout of 7 Days||14
223718|NCT00847405|545918|P2|NOT COMPLETED|First Intervention||1
223719|NCT00847405|545919|P1|NOT COMPLETED|First Intervention||0
223720|NCT00847405|545918|P2|COMPLETED|First Intervention||13
223721|NCT00847405|545919|P1|COMPLETED|First Intervention||14
223722|NCT00847405|545918|P2|STARTED|First Intervention||14
223723|NCT00847405|545919|P1|STARTED|First Intervention||14
223724|NCT00847509|545927|P1|NOT COMPLETED|Overall Study||11
223725|NCT00847509|545927|P1|COMPLETED|Overall Study||38
223726|NCT00847509|545927|P1|STARTED|Overall Study||49
223727|NCT00847535|545931|P3|NOT COMPLETED|Overall Study||1
223728|NCT00847535|545932|P2|NOT COMPLETED|Overall Study||2
223729|NCT00847535|545933|P1|NOT COMPLETED|Overall Study||2
223730|NCT00847535|545931|P3|COMPLETED|Overall Study||15
223731|NCT00847535|545932|P2|COMPLETED|Overall Study||22
223732|NCT00847535|545933|P1|COMPLETED|Overall Study||22
223733|NCT00847535|545931|P3|200 Million AMDC|Overall Study||8
223734|NCT00847535|545932|P2|200 Million AMDC|Overall Study||0
223735|NCT00847535|545933|P1|200 Million AMDC|Overall Study||0
223736|NCT00847535|545931|P3|100 Million AMDC|Overall Study||8
223737|NCT00847535|545932|P2|100 Million AMDC|Overall Study||8
223738|NCT00847535|545933|P1|100 Million AMDC|Overall Study||8
223739|NCT00847535|545931|P3|50 Million AMDC|Overall Study||0
223740|NCT00847535|545932|P2|50 Million AMDC|Overall Study||8
223741|NCT00847535|545933|P1|50 Million AMDC|Overall Study||8
223742|NCT00847535|545931|P3|10 Million AMDC|Overall Study||0
223743|NCT00847535|545932|P2|10 Million AMDC|Overall Study||8
223744|NCT00847535|545933|P1|10 Million AMDC|Overall Study||8
223745|NCT00847535|545931|P3|STARTED|Overall Study||16
223746|NCT00847535|545932|P2|STARTED|Overall Study||24
223747|NCT00847535|545933|P1|STARTED|Overall Study||24
223748|NCT00847561|545943|P2|NOT COMPLETED|Overall Study||4
223749|NCT00847561|545944|P1|NOT COMPLETED|Overall Study||13
223750|NCT00847561|545943|P2|COMPLETED|Overall Study||62
223751|NCT00847561|545944|P1|COMPLETED|Overall Study||57
223752|NCT00847561|545943|P2|STARTED|Overall Study||66
223753|NCT00847561|545944|P1|STARTED|Overall Study||70
223754|NCT00847587|545952|P2|NOT COMPLETED|Overall Study||0
223755|NCT00847587|545953|P1|NOT COMPLETED|Overall Study||1
223756|NCT00847587|545952|P2|COMPLETED|Overall Study||34
223757|NCT00847587|545953|P1|COMPLETED|Overall Study|Patient declined study after randomization.|34
223758|NCT00847587|545952|P2|STARTED|Overall Study||34
223759|NCT00847587|545953|P1|STARTED|Overall Study||35
223760|NCT00847613|545965|P4|NOT COMPLETED|Overall Study||79
223761|NCT00847613|545966|P3|NOT COMPLETED|Overall Study||81
223762|NCT00847613|545967|P2|NOT COMPLETED|Overall Study||319
223763|NCT00847613|545968|P1|NOT COMPLETED|Overall Study||321
223764|NCT00847613|545965|P4|COMPLETED|Overall Study||0
223765|NCT00847613|545966|P3|COMPLETED|Overall Study||0
223766|NCT00847613|545967|P2|COMPLETED|Overall Study||0
223767|NCT00847613|545968|P1|COMPLETED|Overall Study||0
223768|NCT00847613|545965|P4|Treated|Overall Study||79
223769|NCT00847613|545966|P3|Treated|Overall Study||81
223770|NCT00847613|545967|P2|Treated|Overall Study||316
223771|NCT00847613|545968|P1|Treated|Overall Study||321
223772|NCT00847613|545965|P4|STARTED|Overall Study||79
223773|NCT00847613|545966|P3|STARTED|Overall Study||81
223774|NCT00847613|545967|P2|STARTED|Overall Study||319
223775|NCT00847613|545968|P1|STARTED|Overall Study||321
223776|NCT00847626|546217|P11|NOT COMPLETED|Overall Study||20
223777|NCT00847626|546218|P10|NOT COMPLETED|Overall Study||14
223778|NCT00847626|546219|P9|NOT COMPLETED|Overall Study||14
223779|NCT00847626|546220|P8|NOT COMPLETED|Overall Study||19
223780|NCT00847626|546221|P7|NOT COMPLETED|Overall Study||22
223781|NCT00847626|546222|P6|NOT COMPLETED|Overall Study||37
223782|NCT00847626|546223|P5|NOT COMPLETED|Overall Study||28
223783|NCT00847626|546224|P4|NOT COMPLETED|Overall Study||31
223784|NCT00847626|546225|P3|NOT COMPLETED|Overall Study||16
223785|NCT00847626|546226|P2|NOT COMPLETED|Overall Study||23
223786|NCT00847626|546227|P1|NOT COMPLETED|Overall Study||21
223787|NCT00847626|546217|P11|COMPLETED|Overall Study||142
223788|NCT00847626|546218|P10|COMPLETED|Overall Study||139
223789|NCT00847626|546219|P9|COMPLETED|Overall Study||141
223790|NCT00847626|546220|P8|COMPLETED|Overall Study||141
223791|NCT00847626|546221|P7|COMPLETED|Overall Study||135
223792|NCT00847626|546222|P6|COMPLETED|Overall Study||125
223793|NCT00847626|546223|P5|COMPLETED|Overall Study||125
223794|NCT00847626|546224|P4|COMPLETED|Overall Study||125
223795|NCT00847626|546225|P3|COMPLETED|Overall Study||131
223796|NCT00847626|546226|P2|COMPLETED|Overall Study||131
223797|NCT00847626|546227|P1|COMPLETED|Overall Study||135
223798|NCT00847626|546217|P11|STARTED|Overall Study||162
223799|NCT00847626|546218|P10|STARTED|Overall Study||153
223800|NCT00847626|546219|P9|STARTED|Overall Study||155
223801|NCT00847626|546220|P8|STARTED|Overall Study|Includes participant who was treated with double-blind study medication but not randomized.|160
223802|NCT00847626|546221|P7|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|157
223803|NCT00847626|546222|P6|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|162
223804|NCT00847626|546223|P5|STARTED|Overall Study||153
223805|NCT00847626|546224|P4|STARTED|Overall Study||156
223806|NCT00847626|546225|P3|STARTED|Overall Study|Includes participant who was randomized but did not receive study medication.|147
223807|NCT00847626|546226|P2|STARTED|Overall Study||154
223808|NCT00847626|546227|P1|STARTED|Overall Study||156
223809|NCT00847665|546424|P2|NOT COMPLETED|Overall Study||0
223810|NCT00847665|546425|P1|NOT COMPLETED|Overall Study||1
223811|NCT00847665|546424|P2|COMPLETED|Overall Study||165
223812|NCT00847665|546425|P1|COMPLETED|Overall Study||164
223813|NCT00847665|546424|P2|STARTED|Overall Study||165
223814|NCT00847665|546425|P1|STARTED|Overall Study||165
223815|NCT00847704|546437|P1|NOT COMPLETED|Overall Study||1
223816|NCT00847704|546437|P1|COMPLETED|Overall Study||2
223817|NCT00847704|546437|P1|STARTED|Overall Study||3
223818|NCT00847808|546446|P1|NOT COMPLETED|Overall Study||15
223819|NCT00847808|546446|P1|COMPLETED|Overall Study||163
223820|NCT00847808|546446|P1|STARTED|Overall Study||178
223821|NCT00847886|546465|P2|NOT COMPLETED|Overall Study||1
223822|NCT00847886|546466|P1|NOT COMPLETED|Overall Study||0
223823|NCT00847886|546465|P2|COMPLETED|Overall Study||3
223824|NCT00847886|546466|P1|COMPLETED|Overall Study||12
223825|NCT00847886|546465|P2|STARTED|Overall Study||4
223826|NCT00847886|546466|P1|STARTED|Overall Study||12
223827|NCT00847912|546494|P2|NOT COMPLETED|Overall Study||13
223828|NCT00847912|546495|P1|NOT COMPLETED|Overall Study||9
223829|NCT00847912|546494|P2|COMPLETED|Overall Study||464
223830|NCT00847912|546495|P1|COMPLETED|Overall Study||468
223831|NCT00847912|546494|P2|STARTED|Overall Study||477
223832|NCT00847912|546495|P1|STARTED|Overall Study||477
223833|NCT00848016|546503|P1|NOT COMPLETED|Overall Study||0
223834|NCT00848016|546503|P1|COMPLETED|Overall Study||29
223835|NCT00848016|546503|P1|STARTED|Overall Study||29
223836|NCT00848042|546512|P3|NOT COMPLETED|Overall Study||0
223837|NCT00848042|546513|P2|NOT COMPLETED|Overall Study||2
223838|NCT00848042|546514|P1|NOT COMPLETED|Overall Study||4
223839|NCT00848042|546512|P3|COMPLETED|Overall Study||1
223840|NCT00848042|546513|P2|COMPLETED|Overall Study||3
223841|NCT00848042|546514|P1|COMPLETED|Overall Study||1
223842|NCT00848042|546512|P3|Month 6|Overall Study||1
223843|NCT00848042|546513|P2|Month 6|Overall Study||3
223844|NCT00848042|546514|P1|Month 6|Overall Study||1
223845|NCT00848042|546512|P3|Month 5|Overall Study||1
223846|NCT00848042|546513|P2|Month 5|Overall Study||3
223847|NCT00848042|546514|P1|Month 5|Overall Study||1
223848|NCT00848042|546512|P3|Month 4|Overall Study||1
223849|NCT00848042|546513|P2|Month 4|Overall Study||4
223850|NCT00848042|546514|P1|Month 4|Overall Study||1
223851|NCT00848042|546512|P3|Month 3|Overall Study||1
223852|NCT00848042|546513|P2|Month 3|Overall Study||4
223853|NCT00848042|546514|P1|Month 3|Overall Study||1
223854|NCT00848042|546512|P3|Month 2|Overall Study||1
223855|NCT00848042|546513|P2|Month 2|Overall Study||5
223856|NCT00848042|546514|P1|Month 2|Overall Study||1
223857|NCT00848042|546512|P3|Month 1|Overall Study||1
223858|NCT00848042|546513|P2|Month 1|Overall Study||5
223859|NCT00848042|546514|P1|Month 1|Overall Study||4
223860|NCT00848042|546512|P3|Day 15|Overall Study||1
223861|NCT00848042|546513|P2|Day 15|Overall Study||5
223862|NCT00848042|546514|P1|Day 15|Overall Study||4
223863|NCT00848042|546512|P3|Day 8|Overall Study||1
223864|NCT00848042|546513|P2|Day 8|Overall Study||5
223865|NCT00848042|546514|P1|Day 8|Overall Study||5
223866|NCT00848042|546512|P3|Day 3|Overall Study||1
223867|NCT00848042|546513|P2|Day 3|Overall Study||5
223868|NCT00848042|546514|P1|Day 3|Overall Study||5
223869|NCT00848042|546512|P3|Day 2|Overall Study||1
223870|NCT00848042|546513|P2|Day 2|Overall Study||5
223871|NCT00848042|546514|P1|Day 2|Overall Study||5
223872|NCT00848042|546512|P3|Day 1|Overall Study||1
223873|NCT00848042|546513|P2|Day 1|Overall Study||5
223874|NCT00848042|546514|P1|Day 1|Overall Study||5
223875|NCT00848042|546512|P3|STARTED|Overall Study||1
223876|NCT00848042|546513|P2|STARTED|Overall Study||5
223877|NCT00848042|546514|P1|STARTED|Overall Study||5
223878|NCT00848081|546527|P2|NOT COMPLETED|Overall Study||18
223879|NCT00848081|546528|P1|NOT COMPLETED|Overall Study||20
223880|NCT00848081|546527|P2|COMPLETED|Overall Study||140
223881|NCT00848081|546528|P1|COMPLETED|Overall Study||140
223882|NCT00848081|546527|P2|STARTED|Overall Study||158
223883|NCT00848081|546528|P1|STARTED|Overall Study||160
223884|NCT00848107|546542|P1|NOT COMPLETED|Overall Study||21
223885|NCT00848107|546542|P1|COMPLETED|Overall Study||94
223886|NCT00848107|546542|P1|STARTED|Overall Study||115
223887|NCT00848120|546550|P1|NOT COMPLETED|Overall Study||1
223888|NCT00848120|546550|P1|COMPLETED|Overall Study||28
223889|NCT00848120|546550|P1|STARTED|Overall Study||29
223890|NCT00848172|546564|P2|NOT COMPLETED|Visit 3 - Follow Up||0
223891|NCT00848172|546565|P1|NOT COMPLETED|Visit 3 - Follow Up||0
223892|NCT00848172|546564|P2|COMPLETED|Visit 3 - Follow Up||8
223893|NCT00848172|546565|P1|COMPLETED|Visit 3 - Follow Up||10
223894|NCT00848172|546564|P2|STARTED|Visit 3 - Follow Up||8
223895|NCT00848172|546565|P1|STARTED|Visit 3 - Follow Up||10
223896|NCT00848172|546564|P2|NOT COMPLETED|Visit 2 - Drug Administration||1
223897|NCT00848172|546565|P1|NOT COMPLETED|Visit 2 - Drug Administration||0
223898|NCT00848172|546564|P2|COMPLETED|Visit 2 - Drug Administration||8
223899|NCT00848172|546565|P1|COMPLETED|Visit 2 - Drug Administration||10
223900|NCT00848172|546564|P2|STARTED|Visit 2 - Drug Administration||9
223901|NCT00848172|546565|P1|STARTED|Visit 2 - Drug Administration||10
223902|NCT00848185|546579|P3|NOT COMPLETED|Overall Study||0
223903|NCT00848185|546580|P2|NOT COMPLETED|Overall Study||0
223904|NCT00848185|546581|P1|NOT COMPLETED|Overall Study||0
223905|NCT00848185|546579|P3|COMPLETED|Overall Study||32
223906|NCT00848185|546580|P2|COMPLETED|Overall Study||32
223907|NCT00848185|546581|P1|COMPLETED|Overall Study||32
223908|NCT00848185|546579|P3|STARTED|Overall Study||32
223909|NCT00848185|546580|P2|STARTED|Overall Study||32
223910|NCT00848185|546581|P1|STARTED|Overall Study||32
223911|NCT00848198|546589|P1|NOT COMPLETED|Overall Study||15
223912|NCT00848198|546589|P1|COMPLETED|Overall Study||299
223913|NCT00848198|546589|P1|STARTED|Overall Study||314
223914|NCT00848211|546631|P4|NOT COMPLETED|Overall Study||0
223915|NCT00848211|546632|P3|NOT COMPLETED|Overall Study||1
223916|NCT00848211|546633|P2|NOT COMPLETED|Overall Study||1
223917|NCT00848211|546634|P1|NOT COMPLETED|Overall Study||0
223918|NCT00848211|546631|P4|COMPLETED|Overall Study||5
223919|NCT00848211|546632|P3|COMPLETED|Overall Study||5
223920|NCT00848211|546633|P2|COMPLETED|Overall Study||6
223921|NCT00848211|546634|P1|COMPLETED|Overall Study||6
223922|NCT00848211|546631|P4|STARTED|Overall Study||5
223923|NCT00848211|546632|P3|STARTED|Overall Study||6
223924|NCT00848211|546633|P2|STARTED|Overall Study||7
223925|NCT00848211|546634|P1|STARTED|Overall Study||6
223926|NCT00848237|546652|P1|NOT COMPLETED|Overall Study||539
223927|NCT00848237|546652|P1|COMPLETED|Overall Study||4982
223928|NCT00848237|546652|P1|STARTED|Overall Study||5521
223929|NCT00848250|546663|P2|NOT COMPLETED|Overall Study||1
223930|NCT00848250|546664|P1|NOT COMPLETED|Overall Study||0
223931|NCT00848250|546663|P2|COMPLETED|Overall Study||9
223932|NCT00848250|546664|P1|COMPLETED|Overall Study||11
223933|NCT00848250|546663|P2|STARTED|Overall Study||10
223934|NCT00848250|546664|P1|STARTED|Overall Study||11
223935|NCT00848354|546684|P2|NOT COMPLETED|Phase 2 Year 2||7
223936|NCT00848354|546685|P1|NOT COMPLETED|Phase 2 Year 2||23
223937|NCT00848354|546684|P2|COMPLETED|Phase 2 Year 2||113
223938|NCT00848354|546685|P1|COMPLETED|Phase 2 Year 2||218
223939|NCT00848354|546684|P2|STARTED|Phase 2 Year 2|Randomized Phase 1 treatment assignment.|120
223940|NCT00848354|546685|P1|STARTED|Phase 2 Year 2|"Randomized Phase 1 treatment assignment.
1 participant discontinued between Year 1 and Year 2."|241
223941|NCT00848354|546684|P2|NOT COMPLETED|Phase 2 Year 1||6
223942|NCT00848354|546685|P1|NOT COMPLETED|Phase 2 Year 1||18
223943|NCT00848354|546684|P2|COMPLETED|Phase 2 Year 1||120
223944|NCT00848354|546685|P1|COMPLETED|Phase 2 Year 1||242
223945|NCT00848354|546684|P2|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 3 participants discontinued between Phase 1 and Phase 2.|126
223946|NCT00848354|546685|P1|STARTED|Phase 2 Year 1|Randomized Phase 1 treatment assignment. 9 participants discontinued between Phase 1 and Phase 2.|260
223947|NCT00848354|546684|P2|NOT COMPLETED|Phase 1||14
223948|NCT00848354|546685|P1|NOT COMPLETED|Phase 1||12
223949|NCT00848354|546684|P2|COMPLETED|Phase 1||129
223950|NCT00848354|546685|P1|COMPLETED|Phase 1||269
223951|NCT00848354|546684|P2|STARTED|Phase 1||143
223952|NCT00848354|546685|P1|STARTED|Phase 1|One participant was randomized to the Etanercept + Methotrexate group but received SSZ in error.|281
223953|NCT00848367|546837|P2|NOT COMPLETED|Overall Study||9
223954|NCT00848367|546838|P1|NOT COMPLETED|Overall Study||9
223955|NCT00848367|546837|P2|COMPLETED|Overall Study||41
223956|NCT00848367|546838|P1|COMPLETED|Overall Study||43
223957|NCT00848367|546837|P2|STARTED|Overall Study||50
223958|NCT00848367|546838|P1|STARTED|Overall Study||52
223959|NCT00840632|546848|P2|NOT COMPLETED|Second Intervention||0
223960|NCT00840632|546849|P1|NOT COMPLETED|Second Intervention||0
223961|NCT00840632|546848|P2|COMPLETED|Second Intervention||18
223962|NCT00840632|546849|P1|COMPLETED|Second Intervention||19
223963|NCT00840632|546848|P2|STARTED|Second Intervention||18
223964|NCT00840632|546849|P1|STARTED|Second Intervention||19
223965|NCT00840632|546848|P2|NOT COMPLETED|Washout||1
223966|NCT00840632|546849|P1|NOT COMPLETED|Washout||1
223967|NCT00840632|546848|P2|COMPLETED|Washout||18
223968|NCT00840632|546849|P1|COMPLETED|Washout||19
223969|NCT00840632|546848|P2|STARTED|Washout||19
223970|NCT00840632|546849|P1|STARTED|Washout||20
223971|NCT00840632|546848|P2|NOT COMPLETED|First Intervention||1
223972|NCT00840632|546849|P1|NOT COMPLETED|First Intervention||0
223973|NCT00840632|546848|P2|COMPLETED|First Intervention||19
223974|NCT00840632|546849|P1|COMPLETED|First Intervention||20
223975|NCT00840632|546848|P2|STARTED|First Intervention||20
223976|NCT00840632|546849|P1|STARTED|First Intervention||20
223977|NCT00840658|546867|P4|NOT COMPLETED|Overall Study||4
223978|NCT00840658|546868|P3|NOT COMPLETED|Overall Study||5
223979|NCT00840658|546869|P2|NOT COMPLETED|Overall Study||3
223980|NCT00840658|546870|P1|NOT COMPLETED|Overall Study||5
223981|NCT00840658|546867|P4|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|142
223982|NCT00840658|546868|P3|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
223983|NCT00840658|546869|P2|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|143
223984|NCT00840658|546870|P1|COMPLETED|Overall Study|"We defined completed as having at least one follow-up visit"|139
223985|NCT00840658|546867|P4|STARTED|Overall Study||146
223986|NCT00840658|546868|P3|STARTED|Overall Study||148
223987|NCT00840658|546869|P2|STARTED|Overall Study||146
223988|NCT00840658|546870|P1|STARTED|Overall Study||144
223989|NCT00840840|546882|P2|NOT COMPLETED|Period 2||0
223990|NCT00840840|546883|P1|NOT COMPLETED|Period 2||0
223991|NCT00840840|546882|P2|COMPLETED|Period 2||24
223992|NCT00840840|546883|P1|COMPLETED|Period 2||23
223993|NCT00840840|546882|P2|STARTED|Period 2||24
223994|NCT00840840|546883|P1|STARTED|Period 2|One subject was withdrawn due to AE after Period 1|23
223995|NCT00840840|546882|P2|NOT COMPLETED|Period 1||0
223996|NCT00840840|546883|P1|NOT COMPLETED|Period 1||0
223997|NCT00840840|546882|P2|COMPLETED|Period 1||24
223998|NCT00840840|546883|P1|COMPLETED|Period 1||24
223999|NCT00840840|546882|P2|STARTED|Period 1||24
224000|NCT00840840|546883|P1|STARTED|Period 1||24
224001|NCT00840866|546899|P2|NOT COMPLETED|Second Intervention||0
224002|NCT00840866|546900|P1|NOT COMPLETED|Second Intervention||0
224003|NCT00840866|546899|P2|COMPLETED|Second Intervention||19
224004|NCT00840866|546900|P1|COMPLETED|Second Intervention||20
224005|NCT00840866|546899|P2|STARTED|Second Intervention||19
224006|NCT00840866|546900|P1|STARTED|Second Intervention||20
224007|NCT00840866|546899|P2|NOT COMPLETED|Washout of 7 Days||0
224008|NCT00840866|546900|P1|NOT COMPLETED|Washout of 7 Days||0
224009|NCT00840866|546899|P2|COMPLETED|Washout of 7 Days||19
224010|NCT00840866|546900|P1|COMPLETED|Washout of 7 Days||20
224011|NCT00840866|546899|P2|STARTED|Washout of 7 Days||19
224012|NCT00840866|546900|P1|STARTED|Washout of 7 Days||20
224013|NCT00840866|546899|P2|NOT COMPLETED|First Intervention||0
224014|NCT00840866|546900|P1|NOT COMPLETED|First Intervention||0
224015|NCT00840866|546899|P2|COMPLETED|First Intervention||19
224016|NCT00840866|546900|P1|COMPLETED|First Intervention||20
224017|NCT00840866|546899|P2|STARTED|First Intervention||19
224018|NCT00840866|546900|P1|STARTED|First Intervention||20
224019|NCT00840879|546910|P2|NOT COMPLETED|Second Intervention||0
224020|NCT00840879|546911|P1|NOT COMPLETED|Second Intervention||1
224021|NCT00840879|546910|P2|COMPLETED|Second Intervention||14
224022|NCT00840879|546911|P1|COMPLETED|Second Intervention||13
224023|NCT00840879|546910|P2|STARTED|Second Intervention||14
224024|NCT00840879|546911|P1|STARTED|Second Intervention||14
224025|NCT00840879|546910|P2|NOT COMPLETED|Washout: 14 Days||0
224026|NCT00840879|546911|P1|NOT COMPLETED|Washout: 14 Days||0
224027|NCT00840879|546910|P2|COMPLETED|Washout: 14 Days||14
224028|NCT00840879|546911|P1|COMPLETED|Washout: 14 Days||14
224029|NCT00840879|546910|P2|STARTED|Washout: 14 Days||14
224030|NCT00840879|546911|P1|STARTED|Washout: 14 Days||14
224031|NCT00840879|546910|P2|NOT COMPLETED|First Intervention||0
224032|NCT00840879|546911|P1|NOT COMPLETED|First Intervention||0
224033|NCT00840879|546910|P2|COMPLETED|First Intervention||14
224034|NCT00840879|546911|P1|COMPLETED|First Intervention||14
224035|NCT00840879|546910|P2|STARTED|First Intervention||14
224036|NCT00840879|546911|P1|STARTED|First Intervention||14
224037|NCT00840996|546921|P2|NOT COMPLETED|Overall Study||0
224038|NCT00840996|546922|P1|NOT COMPLETED|Overall Study||1
224039|NCT00840996|546921|P2|COMPLETED|Overall Study||58
224040|NCT00840996|546922|P1|COMPLETED|Overall Study||57
224041|NCT00840996|546921|P2|STARTED|Overall Study||58
224042|NCT00840996|546922|P1|STARTED|Overall Study||58
224043|NCT00841035|546940|P1|NOT COMPLETED|Phase 2 of Overall Study||0
224044|NCT00841035|546940|P1|COMPLETED|Phase 2 of Overall Study||6
224045|NCT00841035|546940|P1|STARTED|Phase 2 of Overall Study||6
224046|NCT00841035|546940|P1|NOT COMPLETED|Phase 1 Overall Study||13
224047|NCT00841035|546940|P1|COMPLETED|Phase 1 Overall Study||6
224048|NCT00841035|546940|P1|STARTED|Phase 1 Overall Study|2 phase enrollment,1st phase enrolled with cancer by fine needle aspiration in endoscopic ultrasound|19
224049|NCT00841087|546947|P2|NOT COMPLETED|Overall Study||0
224050|NCT00841087|546948|P1|NOT COMPLETED|Overall Study||0
224051|NCT00841087|546947|P2|COMPLETED|Overall Study||32
224052|NCT00841087|546948|P1|COMPLETED|Overall Study||33
224053|NCT00841087|546947|P2|STARTED|Overall Study||32
224054|NCT00841087|546948|P1|STARTED|Overall Study||33
224055|NCT00841204|546968|P2|NOT COMPLETED|Overall Study||0
224056|NCT00841204|546969|P1|NOT COMPLETED|Overall Study||0
224057|NCT00841204|546968|P2|COMPLETED|Overall Study||25
224058|NCT00841204|546969|P1|COMPLETED|Overall Study||25
224059|NCT00841204|546968|P2|STARTED|Overall Study||25
224060|NCT00841204|546969|P1|STARTED|Overall Study||25
224061|NCT00841269|546979|P1|NOT COMPLETED|Overall Study||2
224062|NCT00841269|546979|P1|COMPLETED|Overall Study||5
224063|NCT00841269|546979|P1|STARTED|Overall Study||7
224064|NCT00841321|546985|P2|NOT COMPLETED|Overall Study||3
224065|NCT00841321|546986|P1|NOT COMPLETED|Overall Study||1
224066|NCT00841321|546985|P2|COMPLETED|Overall Study||58
224067|NCT00841321|546986|P1|COMPLETED|Overall Study||58
224068|NCT00841321|546985|P2|STARTED|Overall Study||61
224069|NCT00841321|546986|P1|STARTED|Overall Study||59
224070|NCT00841412|546998|P2|NOT COMPLETED|Overall Study||30
224071|NCT00841412|546999|P1|NOT COMPLETED|Overall Study||40
224072|NCT00841412|546998|P2|COMPLETED|Overall Study||50
224073|NCT00841412|546999|P1|COMPLETED|Overall Study|130 residents completed all study phases across both groups, including follow-up.|80
224074|NCT00841412|546998|P2|STARTED|Overall Study|80 residents were in the delayed intervention group, but all residents received intervention.|80
224075|NCT00841412|546999|P1|STARTED|Overall Study|200 of 222 consented residents completed baseline assessments across both groups.|120
224076|NCT00841542|547005|P2|NOT COMPLETED|Period 2||0
224077|NCT00841542|547006|P1|NOT COMPLETED|Period 2||0
224078|NCT00841542|547005|P2|COMPLETED|Period 2||14
224079|NCT00841542|547006|P1|COMPLETED|Period 2||13
224080|NCT00841542|547005|P2|STARTED|Period 2||14
224081|NCT00841542|547006|P1|STARTED|Period 2||13
224082|NCT00841542|547005|P2|NOT COMPLETED|Period 1||0
224083|NCT00841542|547006|P1|NOT COMPLETED|Period 1||1
224084|NCT00841542|547005|P2|COMPLETED|Period 1||14
224085|NCT00841542|547006|P1|COMPLETED|Period 1||13
224086|NCT00841542|547005|P2|STARTED|Period 1||14
224087|NCT00841542|547006|P1|STARTED|Period 1||14
224088|NCT00841555|547017|P3|NOT COMPLETED|Overall Study||0
224089|NCT00841555|547018|P2|NOT COMPLETED|Overall Study||0
224090|NCT00841555|547019|P1|NOT COMPLETED|Overall Study||0
224091|NCT00841555|547017|P3|COMPLETED|Overall Study||3
224092|NCT00841555|547018|P2|COMPLETED|Overall Study||3
224093|NCT00841555|547019|P1|COMPLETED|Overall Study||3
224094|NCT00841555|547017|P3|STARTED|Overall Study||3
224095|NCT00841555|547018|P2|STARTED|Overall Study||3
224096|NCT00841555|547019|P1|STARTED|Overall Study||3
224097|NCT00841659|547029|P2|NOT COMPLETED|Second Intervention||0
224098|NCT00841659|547030|P1|NOT COMPLETED|Second Intervention||0
224099|NCT00841659|547029|P2|COMPLETED|Second Intervention||12
224100|NCT00841659|547030|P1|COMPLETED|Second Intervention||11
224101|NCT00841659|547029|P2|STARTED|Second Intervention||12
224102|NCT00841659|547030|P1|STARTED|Second Intervention||11
224103|NCT00841659|547029|P2|NOT COMPLETED|Washout: 2 Weeks||0
224104|NCT00841659|547030|P1|NOT COMPLETED|Washout: 2 Weeks||1
224105|NCT00841659|547029|P2|COMPLETED|Washout: 2 Weeks||12
224106|NCT00841659|547030|P1|COMPLETED|Washout: 2 Weeks||11
224107|NCT00841659|547029|P2|STARTED|Washout: 2 Weeks||12
224108|NCT00841659|547030|P1|STARTED|Washout: 2 Weeks||12
224109|NCT00841659|547029|P2|NOT COMPLETED|First Intervention||0
224110|NCT00841659|547030|P1|NOT COMPLETED|First Intervention||0
224111|NCT00841659|547029|P2|COMPLETED|First Intervention||12
224112|NCT00841659|547030|P1|COMPLETED|First Intervention||12
224113|NCT00841659|547029|P2|STARTED|First Intervention||12
224114|NCT00841659|547030|P1|STARTED|First Intervention||12
224115|NCT00841672|547040|P2|NOT COMPLETED|Overall Study||32
224116|NCT00841672|547041|P1|NOT COMPLETED|Overall Study||20
224117|NCT00841672|547040|P2|COMPLETED|Overall Study||209
224118|NCT00841672|547041|P1|COMPLETED|Overall Study||224
224119|NCT00841672|547040|P2|STARTED|Overall Study||241
224120|NCT00841672|547041|P1|STARTED|Overall Study|One patient was mis-randomized and was not treated in the double-blind treatment period.|244
224121|NCT00841698|547057|P2|NOT COMPLETED|Second Intervention||0
224122|NCT00841698|547058|P1|NOT COMPLETED|Second Intervention||0
224123|NCT00841698|547057|P2|COMPLETED|Second Intervention||25
224124|NCT00841698|547058|P1|COMPLETED|Second Intervention||24
224125|NCT00841698|547057|P2|STARTED|Second Intervention||25
224126|NCT00841698|547058|P1|STARTED|Second Intervention||24
224127|NCT00841698|547057|P2|NOT COMPLETED|Washout: 2 Weeks||0
224128|NCT00841698|547058|P1|NOT COMPLETED|Washout: 2 Weeks||0
224129|NCT00841698|547057|P2|COMPLETED|Washout: 2 Weeks||25
224130|NCT00841698|547058|P1|COMPLETED|Washout: 2 Weeks||24
224131|NCT00841698|547057|P2|STARTED|Washout: 2 Weeks||25
224132|NCT00841698|547058|P1|STARTED|Washout: 2 Weeks||24
224133|NCT00841698|547057|P2|NOT COMPLETED|First Intervention||0
224134|NCT00841698|547058|P1|NOT COMPLETED|First Intervention||1
224135|NCT00841698|547057|P2|COMPLETED|First Intervention||25
224136|NCT00841698|547058|P1|COMPLETED|First Intervention||24
224137|NCT00841698|547057|P2|STARTED|First Intervention||25
224138|NCT00841698|547058|P1|STARTED|First Intervention||25
224139|NCT00841763|547068|P4|NOT COMPLETED|Overall Study||3
224140|NCT00841763|547069|P3|NOT COMPLETED|Overall Study||8
224141|NCT00841763|547070|P2|NOT COMPLETED|Overall Study||57
224142|NCT00841763|547071|P1|NOT COMPLETED|Overall Study||162
224143|NCT00841763|547068|P4|COMPLETED|Overall Study||53
224144|NCT00841763|547069|P3|COMPLETED|Overall Study||211
224145|NCT00841763|547070|P2|COMPLETED|Overall Study||624
224146|NCT00841763|547071|P1|COMPLETED|Overall Study||2529
224147|NCT00841763|547068|P4|STARTED|Overall Study||56
224148|NCT00841763|547069|P3|STARTED|Overall Study||219
224149|NCT00841763|547070|P2|STARTED|Overall Study||681
224150|NCT00841763|547071|P1|STARTED|Overall Study||2691
224151|NCT00841776|547133|P2|NOT COMPLETED|Overall Study||3
224152|NCT00841776|547134|P1|NOT COMPLETED|Overall Study||2
224153|NCT00841776|547133|P2|COMPLETED|Overall Study||24
224154|NCT00841776|547134|P1|COMPLETED|Overall Study||25
224155|NCT00841776|547133|P2|STARTED|Overall Study||27
224156|NCT00841776|547134|P1|STARTED|Overall Study||27
224157|NCT00841815|547152|P2|NOT COMPLETED|Period 2||0
224158|NCT00841815|547153|P1|NOT COMPLETED|Period 2||0
224159|NCT00841815|547152|P2|COMPLETED|Period 2||13
224160|NCT00841815|547153|P1|COMPLETED|Period 2||14
224161|NCT00841815|547152|P2|STARTED|Period 2||13
224162|NCT00841815|547153|P1|STARTED|Period 2||14
224163|NCT00841815|547152|P2|NOT COMPLETED|Washout||1
224164|NCT00841815|547153|P1|NOT COMPLETED|Washout||0
224165|NCT00841815|547152|P2|COMPLETED|Washout||13
224166|NCT00841815|547153|P1|COMPLETED|Washout||14
224167|NCT00841815|547152|P2|STARTED|Washout||14
224168|NCT00841815|547153|P1|STARTED|Washout||14
224169|NCT00841815|547152|P2|NOT COMPLETED|Period 1||0
224170|NCT00841815|547153|P1|NOT COMPLETED|Period 1||0
224171|NCT00841815|547152|P2|COMPLETED|Period 1||14
224172|NCT00841815|547153|P1|COMPLETED|Period 1||14
224173|NCT00841815|547152|P2|STARTED|Period 1||14
224174|NCT00841815|547153|P1|STARTED|Period 1||14
224175|NCT00841906|547163|P2|NOT COMPLETED|Overall Study||0
224176|NCT00841906|547164|P1|NOT COMPLETED|Overall Study||2
224177|NCT00841906|547163|P2|COMPLETED|Overall Study||15
224178|NCT00841906|547164|P1|COMPLETED|Overall Study||15
224179|NCT00841906|547163|P2|STARTED|Overall Study||15
224180|NCT00841906|547164|P1|STARTED|Overall Study||17
224181|NCT00841971|547178|P2|NOT COMPLETED|Overall Study||1
224182|NCT00841971|547179|P1|NOT COMPLETED|Overall Study||2
224183|NCT00841971|547178|P2|COMPLETED|Overall Study||99
224184|NCT00841971|547179|P1|COMPLETED|Overall Study||98
224185|NCT00841971|547178|P2|STARTED|Overall Study||100
224186|NCT00841971|547179|P1|STARTED|Overall Study||100
224187|NCT00842023|547189|P2|NOT COMPLETED|Overall Study||0
224188|NCT00842023|547190|P1|NOT COMPLETED|Overall Study||0
224189|NCT00842023|547189|P2|COMPLETED|Overall Study||44
224190|NCT00842023|547190|P1|COMPLETED|Overall Study||45
224191|NCT00842023|547189|P2|STARTED|Overall Study||44
224192|NCT00842023|547190|P1|STARTED|Overall Study||45
224193|NCT00842075|547202|P2|NOT COMPLETED|Overall Study||0
224194|NCT00842075|547203|P1|NOT COMPLETED|Overall Study||0
224195|NCT00842075|547202|P2|COMPLETED|Overall Study||5
224196|NCT00842075|547203|P1|COMPLETED|Overall Study||5
224197|NCT00842075|547202|P2|STARTED|Overall Study||5
224198|NCT00842075|547203|P1|STARTED|Overall Study||5
224199|NCT00842153|547213|P2|NOT COMPLETED|Overall Study||3
224200|NCT00842153|547214|P1|NOT COMPLETED|Overall Study||1
224201|NCT00842153|547213|P2|COMPLETED|Overall Study||27
224202|NCT00842153|547214|P1|COMPLETED|Overall Study||27
224203|NCT00842153|547213|P2|STARTED|Overall Study||30
224204|NCT00842153|547214|P1|STARTED|Overall Study||28
224205|NCT00842231|547252|P1|NOT COMPLETED|Overall Study||0
224206|NCT00842231|547252|P1|COMPLETED|Overall Study||40
224207|NCT00842231|547252|P1|STARTED|Overall Study||40
224208|NCT00842244|547258|P1|NOT COMPLETED|Overall Study||21
224209|NCT00842244|547258|P1|COMPLETED|Overall Study||1
224210|NCT00842244|547258|P1|STARTED|Overall Study||22
224211|NCT00842257|547277|P1|NOT COMPLETED|Overall Study||1
224212|NCT00842257|547277|P1|COMPLETED|Overall Study||19
224213|NCT00842257|547277|P1|STARTED|Overall Study||20
224214|NCT00842335|547284|P1|NOT COMPLETED|Overall Study||0
224215|NCT00842335|547284|P1|COMPLETED|Overall Study||18
224216|NCT00842335|547284|P1|STARTED|Overall Study||18
224217|NCT00842348|547293|P2|NOT COMPLETED|Study 729||38
224218|NCT00842348|547294|P1|NOT COMPLETED|Study 729||26
224219|NCT00842348|547293|P2|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|9
224220|NCT00842348|547294|P1|COMPLETED|Study 729|Enrolled in Study 729 and received at least one dose of open label lanreotide Autogel.|16
224221|NCT00842348|547293|P2|STARTED|Study 729||47
224222|NCT00842348|547294|P1|STARTED|Study 729||42
224223|NCT00842348|547293|P2|NOT COMPLETED|Patients Randomised in Study 726||56
224224|NCT00842348|547294|P1|NOT COMPLETED|Patients Randomised in Study 726||59
224225|NCT00842348|547293|P2|COMPLETED|Patients Randomised in Study 726|15 patients had stable disease and 32 patients had progressive disease.|47
224226|NCT00842348|547294|P1|COMPLETED|Patients Randomised in Study 726|41 patients had stable disease and 1 patient had progressive disease.|42
224227|NCT00842348|547293|P2|STARTED|Patients Randomised in Study 726||103
224228|NCT00842348|547294|P1|STARTED|Patients Randomised in Study 726||101
224229|NCT00842361|547306|P2|NOT COMPLETED|Overall Study||2
224230|NCT00842361|547307|P1|NOT COMPLETED|Overall Study||1
224231|NCT00842361|547306|P2|COMPLETED|Overall Study||31
224232|NCT00842361|547307|P1|COMPLETED|Overall Study||32
224233|NCT00842361|547306|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|32
224234|NCT00842361|547307|P1|Exposed|Overall Study||33
224235|NCT00842361|547306|P2|STARTED|Overall Study||33
224236|NCT00842361|547307|P1|STARTED|Overall Study||33
224237|NCT00842543|547329|P4|NOT COMPLETED|Overall Study||4
224238|NCT00842543|547330|P3|NOT COMPLETED|Overall Study||3
224239|NCT00842543|547331|P2|NOT COMPLETED|Overall Study||0
224240|NCT00842543|547332|P1|NOT COMPLETED|Overall Study||2
224241|NCT00842543|547329|P4|COMPLETED|Overall Study||4
224242|NCT00842543|547330|P3|COMPLETED|Overall Study||10
224243|NCT00842543|547331|P2|COMPLETED|Overall Study||5
224244|NCT00842543|547332|P1|COMPLETED|Overall Study||11
224245|NCT00842543|547329|P4|STARTED|Overall Study||8
224246|NCT00842543|547330|P3|STARTED|Overall Study||13
224247|NCT00842543|547331|P2|STARTED|Overall Study||5
224248|NCT00842543|547332|P1|STARTED|Overall Study||13
224249|NCT00842608|547348|P4|NOT COMPLETED|Overall Study||0
224250|NCT00842608|547349|P3|NOT COMPLETED|Overall Study||0
224251|NCT00842608|547350|P2|NOT COMPLETED|Overall Study||0
224252|NCT00842608|547351|P1|NOT COMPLETED|Overall Study||0
224253|NCT00842608|547348|P4|COMPLETED|Overall Study||100
224254|NCT00842608|547349|P3|COMPLETED|Overall Study||99
224255|NCT00842608|547350|P2|COMPLETED|Overall Study||176
224256|NCT00842608|547351|P1|COMPLETED|Overall Study||170
224257|NCT00842608|547348|P4|STARTED|Overall Study||100
224258|NCT00842608|547349|P3|STARTED|Overall Study||99
224259|NCT00842608|547350|P2|STARTED|Overall Study||176
224260|NCT00842608|547351|P1|STARTED|Overall Study||170
224261|NCT00842712|547376|P7|NOT COMPLETED|Randomized Part||6
224262|NCT00842712|547377|P6|NOT COMPLETED|Randomized Part||1
224263|NCT00842712|547378|P5|NOT COMPLETED|Randomized Part||0
224264|NCT00842712|547379|P4|NOT COMPLETED|Randomized Part||0
224265|NCT00842712|547380|P3|NOT COMPLETED|Randomized Part||0
224266|NCT00842712|547381|P2|NOT COMPLETED|Randomized Part||0
224267|NCT00842712|547382|P1|NOT COMPLETED|Randomized Part||0
224268|NCT00842712|547376|P7|COMPLETED|Randomized Part||78
224269|NCT00842712|547377|P6|COMPLETED|Randomized Part||50
224270|NCT00842712|547378|P5|COMPLETED|Randomized Part||85
224271|NCT00842712|547379|P4|COMPLETED|Randomized Part||0
224272|NCT00842712|547380|P3|COMPLETED|Randomized Part||0
224273|NCT00842712|547381|P2|COMPLETED|Randomized Part||0
224274|NCT00842712|547382|P1|COMPLETED|Randomized Part||0
224275|NCT00842712|547376|P7|Treated|Randomized Part||80
224276|NCT00842712|547377|P6|Treated|Randomized Part||50
224277|NCT00842712|547378|P5|Treated|Randomized Part||85
224278|NCT00842712|547379|P4|Treated|Randomized Part||0
224279|NCT00842712|547380|P3|Treated|Randomized Part||0
224280|NCT00842712|547381|P2|Treated|Randomized Part||0
224281|NCT00842712|547382|P1|Treated|Randomized Part||0
224282|NCT00842712|547376|P7|STARTED|Randomized Part||84
224283|NCT00842712|547377|P6|STARTED|Randomized Part||51
224284|NCT00842712|547378|P5|STARTED|Randomized Part||85
224285|NCT00842712|547379|P4|STARTED|Randomized Part||0
224286|NCT00842712|547380|P3|STARTED|Randomized Part||0
224287|NCT00842712|547381|P2|STARTED|Randomized Part||0
224288|NCT00842712|547382|P1|STARTED|Randomized Part||0
224289|NCT00842712|547376|P7|NOT COMPLETED|Safety Run-in Part||0
224290|NCT00842712|547377|P6|NOT COMPLETED|Safety Run-in Part||0
224291|NCT00842712|547378|P5|NOT COMPLETED|Safety Run-in Part||0
224292|NCT00842712|547379|P4|NOT COMPLETED|Safety Run-in Part||1
224293|NCT00842712|547380|P3|NOT COMPLETED|Safety Run-in Part||0
224294|NCT00842712|547381|P2|NOT COMPLETED|Safety Run-in Part||2
224295|NCT00842712|547382|P1|NOT COMPLETED|Safety Run-in Part||3
224296|NCT00842712|547376|P7|COMPLETED|Safety Run-in Part||0
224297|NCT00842712|547377|P6|COMPLETED|Safety Run-in Part||0
224298|NCT00842712|547378|P5|COMPLETED|Safety Run-in Part||0
224299|NCT00842712|547379|P4|COMPLETED|Safety Run-in Part||2
224300|NCT00842712|547380|P3|COMPLETED|Safety Run-in Part||3
224301|NCT00842712|547381|P2|COMPLETED|Safety Run-in Part||1
224302|NCT00842712|547382|P1|COMPLETED|Safety Run-in Part||0
224303|NCT00842712|547376|P7|STARTED|Safety Run-in Part||0
224304|NCT00842712|547377|P6|STARTED|Safety Run-in Part||0
224305|NCT00842712|547378|P5|STARTED|Safety Run-in Part||0
224306|NCT00842712|547379|P4|STARTED|Safety Run-in Part||3
224307|NCT00842712|547380|P3|STARTED|Safety Run-in Part||3
224308|NCT00842712|547381|P2|STARTED|Safety Run-in Part||3
224309|NCT00842712|547382|P1|STARTED|Safety Run-in Part||3
224310|NCT00842751|547410|P1|NOT COMPLETED|Overall Study||0
224311|NCT00842751|547410|P1|COMPLETED|Overall Study||11
224312|NCT00842751|547410|P1|STARTED|Overall Study||11
224313|NCT00842829|547426|P3|NOT COMPLETED|Continuation Period||61
224314|NCT00842829|547427|P2|NOT COMPLETED|Continuation Period||0
224315|NCT00842829|547428|P1|NOT COMPLETED|Continuation Period||0
224316|NCT00842829|547426|P3|COMPLETED|Continuation Period||27
224317|NCT00842829|547427|P2|COMPLETED|Continuation Period||0
224318|NCT00842829|547428|P1|COMPLETED|Continuation Period||0
224319|NCT00842829|547426|P3|Continuation Safety Analysis Set|Continuation Period|Received at least one dose of study drug|87
224320|NCT00842829|547427|P2|Continuation Safety Analysis Set|Continuation Period||0
224321|NCT00842829|547428|P1|Continuation Safety Analysis Set|Continuation Period||0
224322|NCT00842829|547426|P3|STARTED|Continuation Period|Eligible for Continuation Period|88
224323|NCT00842829|547427|P2|STARTED|Continuation Period||0
224324|NCT00842829|547428|P1|STARTED|Continuation Period||0
224325|NCT00842829|547426|P3|NOT COMPLETED|Treatment Period||63
224326|NCT00842829|547427|P2|NOT COMPLETED|Treatment Period||0
224327|NCT00842829|547428|P1|NOT COMPLETED|Treatment Period||0
224328|NCT00842829|547426|P3|COMPLETED|Treatment Period||218
224329|NCT00842829|547427|P2|COMPLETED|Treatment Period||0
224330|NCT00842829|547428|P1|COMPLETED|Treatment Period||0
224331|NCT00842829|547426|P3|Safety Analysis Set|Treatment Period|Received at least one dose of study drug|223
224332|NCT00842829|547427|P2|Safety Analysis Set|Treatment Period||0
224333|NCT00842829|547428|P1|Safety Analysis Set|Treatment Period||0
224334|NCT00842829|547426|P3|STARTED|Treatment Period||281
224335|NCT00842829|547427|P2|STARTED|Treatment Period||0
224336|NCT00842829|547428|P1|STARTED|Treatment Period||0
224337|NCT00842829|547426|P3|NOT COMPLETED|Dose Titration Period||0
224338|NCT00842829|547427|P2|NOT COMPLETED|Dose Titration Period||23
224339|NCT00842829|547428|P1|NOT COMPLETED|Dose Titration Period||26
224340|NCT00842829|547426|P3|COMPLETED|Dose Titration Period||0
224341|NCT00842829|547427|P2|COMPLETED|Dose Titration Period||151
224342|NCT00842829|547428|P1|COMPLETED|Dose Titration Period||130
224343|NCT00842829|547426|P3|Titration Safety Analysis Set|Dose Titration Period||0
224344|NCT00842829|547427|P2|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|167
224345|NCT00842829|547428|P1|Titration Safety Analysis Set|Dose Titration Period|Received at least one dose of study drug|145
224346|NCT00842829|547426|P3|STARTED|Dose Titration Period||0
224347|NCT00842829|547427|P2|STARTED|Dose Titration Period||174
224348|NCT00842829|547428|P1|STARTED|Dose Titration Period||156
224349|NCT00842946|547464|P2|NOT COMPLETED|Overall Study||5
224350|NCT00842946|547465|P1|NOT COMPLETED|Overall Study||5
224351|NCT00842946|547464|P2|COMPLETED|Overall Study||19
224352|NCT00842946|547465|P1|COMPLETED|Overall Study||16
224353|NCT00842946|547464|P2|STARTED|Overall Study||24
224354|NCT00842946|547465|P1|STARTED|Overall Study||21
224355|NCT00848484|547473|P2|NOT COMPLETED|Second Intervention (Treatment Period 2)||1
224356|NCT00848484|547474|P1|NOT COMPLETED|Second Intervention (Treatment Period 2)||0
224357|NCT00848484|547473|P2|COMPLETED|Second Intervention (Treatment Period 2)||20
224358|NCT00848484|547474|P1|COMPLETED|Second Intervention (Treatment Period 2)||25
224359|NCT00848484|547473|P2|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
224360|NCT00848484|547474|P1|With Reduced Dose at Treatment Period 2|Second Intervention (Treatment Period 2)||0
224361|NCT00848484|547473|P2|STARTED|Second Intervention (Treatment Period 2)||21
224362|NCT00848484|547474|P1|STARTED|Second Intervention (Treatment Period 2)||25
224363|NCT00848484|547473|P2|NOT COMPLETED|Washout Period of Two Weeks||3
224364|NCT00848484|547474|P1|NOT COMPLETED|Washout Period of Two Weeks||0
224365|NCT00848484|547473|P2|COMPLETED|Washout Period of Two Weeks||21
224366|NCT00848484|547474|P1|COMPLETED|Washout Period of Two Weeks||25
224367|NCT00848484|547473|P2|STARTED|Washout Period of Two Weeks||24
224368|NCT00848484|547474|P1|STARTED|Washout Period of Two Weeks||25
224369|NCT00848484|547473|P2|NOT COMPLETED|First Intervention (Treatment Period 1)||3
224370|NCT00848484|547474|P1|NOT COMPLETED|First Intervention (Treatment Period 1)||2
224371|NCT00848484|547473|P2|COMPLETED|First Intervention (Treatment Period 1)||24
224372|NCT00848484|547474|P1|COMPLETED|First Intervention (Treatment Period 1)||25
224373|NCT00848484|547473|P2|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||1
224374|NCT00848484|547474|P1|With Reduced Dose at Treatment Period 1|First Intervention (Treatment Period 1)||2
224375|NCT00848484|547473|P2|STARTED|First Intervention (Treatment Period 1)||27
224376|NCT00848484|547474|P1|STARTED|First Intervention (Treatment Period 1)||27
224377|NCT00848497|547492|P2|NOT COMPLETED|Overall Study||1
224378|NCT00848497|547493|P1|NOT COMPLETED|Overall Study||2
224379|NCT00848497|547492|P2|COMPLETED|Overall Study||0
224380|NCT00848497|547493|P1|COMPLETED|Overall Study||0
224381|NCT00848497|547492|P2|STARTED|Overall Study|Completed Visit 4|1
224382|NCT00848497|547493|P1|STARTED|Overall Study||2
224383|NCT00848510|547509|P4|NOT COMPLETED|Overall Study||0
224384|NCT00848510|547510|P3|NOT COMPLETED|Overall Study||0
224385|NCT00848510|547511|P2|NOT COMPLETED|Overall Study||0
224386|NCT00848510|547512|P1|NOT COMPLETED|Overall Study||0
224387|NCT00848510|547509|P4|COMPLETED|Overall Study||10
224388|NCT00848510|547510|P3|COMPLETED|Overall Study||8
224389|NCT00848510|547511|P2|COMPLETED|Overall Study||13
224390|NCT00848510|547512|P1|COMPLETED|Overall Study||10
224391|NCT00848510|547509|P4|STARTED|Overall Study||10
224392|NCT00848510|547510|P3|STARTED|Overall Study||8
224393|NCT00848510|547511|P2|STARTED|Overall Study||13
224394|NCT00848510|547512|P1|STARTED|Overall Study||10
224395|NCT00848536|547560|P2|NOT COMPLETED|Overall Study||7
224396|NCT00848536|547561|P1|NOT COMPLETED|Overall Study||4
224397|NCT00848536|547560|P2|COMPLETED|Overall Study||179
224398|NCT00848536|547561|P1|COMPLETED|Overall Study||181
224399|NCT00848536|547560|P2|STARTED|Overall Study||186
224400|NCT00848536|547561|P1|STARTED|Overall Study||185
224401|NCT00848549|547573|P2|NOT COMPLETED|E2090-E044-314 (Extension Study)||24
224402|NCT00848549|547574|P1|NOT COMPLETED|E2090-E044-314 (Extension Study)||17
224403|NCT00848549|547573|P2|COMPLETED|E2090-E044-314 (Extension Study)||134
224404|NCT00848549|547574|P1|COMPLETED|E2090-E044-314 (Extension Study)||120
224405|NCT00848549|547573|P2|STARTED|E2090-E044-314 (Extension Study)||158
224406|NCT00848549|547574|P1|STARTED|E2090-E044-314 (Extension Study)||137
224407|NCT00848549|547573|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||34
224408|NCT00848549|547574|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Transition||24
224409|NCT00848549|547573|P2|COMPLETED|E2090-E044-310 (Base Study) Transition||158
224410|NCT00848549|547574|P1|COMPLETED|E2090-E044-310 (Base Study) Transition||137
224411|NCT00848549|547573|P2|STARTED|E2090-E044-310 (Base Study) Transition||192
224412|NCT00848549|547574|P1|STARTED|E2090-E044-310 (Base Study) Transition||161
224413|NCT00848549|547573|P2|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||109
224414|NCT00848549|547574|P1|NOT COMPLETED|E2090-E044-310 (Base Study) Disposition||121
224415|NCT00848549|547573|P2|COMPLETED|E2090-E044-310 (Base Study) Disposition||192
224416|NCT00848549|547574|P1|COMPLETED|E2090-E044-310 (Base Study) Disposition||161
224417|NCT00848549|547573|P2|STARTED|E2090-E044-310 (Base Study) Disposition||301
224418|NCT00848549|547574|P1|STARTED|E2090-E044-310 (Base Study) Disposition||282
224419|NCT00848744|547590|P1|NOT COMPLETED|Overall Study||0
224420|NCT00848744|547590|P1|COMPLETED|Overall Study||10
224421|NCT00848744|547590|P1|STARTED|Overall Study||10
224422|NCT00848783|547598|P3|NOT COMPLETED|Overall Study||0
224423|NCT00848783|547599|P2|NOT COMPLETED|Overall Study||2
224424|NCT00848783|547600|P1|NOT COMPLETED|Overall Study||3
224425|NCT00848783|547598|P3|COMPLETED|Overall Study||1
224426|NCT00848783|547599|P2|COMPLETED|Overall Study||1
224427|NCT00848783|547600|P1|COMPLETED|Overall Study||1
224428|NCT00848783|547598|P3|STARTED|Overall Study||1
224429|NCT00848783|547599|P2|STARTED|Overall Study||3
224430|NCT00848783|547600|P1|STARTED|Overall Study||4
224431|NCT00849472|547606|P1|NOT COMPLETED|Pazopanib Postsurgery Treatment||26
224432|NCT00849472|547606|P1|COMPLETED|Pazopanib Postsurgery Treatment||16
224433|NCT00849472|547606|P1|STARTED|Pazopanib Postsurgery Treatment|36 participants completed PPT; 7 participants who discontinued PPT resumed treatment postsurgery.|42
224434|NCT00849472|547606|P1|NOT COMPLETED|Pazopanib Presurgery Treatment (PPT)||58
224435|NCT00849472|547606|P1|COMPLETED|Pazopanib Presurgery Treatment (PPT)||36
224436|NCT00849472|547606|P1|STARTED|Pazopanib Presurgery Treatment (PPT)||94
224437|NCT00849472|547606|P1|NOT COMPLETED|Weekly Paclitaxel||16
224438|NCT00849472|547606|P1|COMPLETED|Weekly Paclitaxel||78
224439|NCT00849472|547606|P1|STARTED|Weekly Paclitaxel|One par. was deemed ineligible after completing AC therapy and did not start paclitaxel+pazopanib.|94
224440|NCT00849472|547606|P1|NOT COMPLETED|Doxorubicin and Cyclophosphamide (AC)||6
224441|NCT00849472|547606|P1|COMPLETED|Doxorubicin and Cyclophosphamide (AC)||95
224442|NCT00849472|547606|P1|STARTED|Doxorubicin and Cyclophosphamide (AC)||101
224443|NCT00849485|547622|P2|NOT COMPLETED|Second Intervention||0
224444|NCT00849485|547623|P1|NOT COMPLETED|Second Intervention||0
224445|NCT00849485|547622|P2|COMPLETED|Second Intervention||11
224446|NCT00849485|547623|P1|COMPLETED|Second Intervention||11
224447|NCT00849485|547622|P2|STARTED|Second Intervention||11
224448|NCT00849485|547623|P1|STARTED|Second Intervention||11
224449|NCT00849485|547622|P2|NOT COMPLETED|Washout: 7 Days||0
224450|NCT00849485|547623|P1|NOT COMPLETED|Washout: 7 Days||0
224451|NCT00849485|547622|P2|COMPLETED|Washout: 7 Days||11
224452|NCT00849485|547623|P1|COMPLETED|Washout: 7 Days||11
224453|NCT00849485|547622|P2|STARTED|Washout: 7 Days||11
224454|NCT00849485|547623|P1|STARTED|Washout: 7 Days||11
224455|NCT00849485|547622|P2|NOT COMPLETED|First Intervention||0
224456|NCT00849485|547623|P1|NOT COMPLETED|First Intervention||0
224457|NCT00849485|547622|P2|COMPLETED|First Intervention||11
224458|NCT00849485|547623|P1|COMPLETED|First Intervention||11
224459|NCT00849485|547622|P2|STARTED|First Intervention||11
224460|NCT00849485|547623|P1|STARTED|First Intervention||11
224461|NCT00849524|547631|P1|NOT COMPLETED|Overall Study||3
224462|NCT00849524|547631|P1|COMPLETED|Overall Study||3
224463|NCT00849524|547631|P1|STARTED|Overall Study||6
224464|NCT00849680|547645|P8|NOT COMPLETED|Overall Study||8
224465|NCT00849680|547646|P7|NOT COMPLETED|Overall Study||17
224466|NCT00849680|547647|P6|NOT COMPLETED|Overall Study||15
224467|NCT00849680|547648|P5|NOT COMPLETED|Overall Study||10
224468|NCT00849680|547649|P4|NOT COMPLETED|Overall Study||14
224469|NCT00849680|547650|P3|NOT COMPLETED|Overall Study||15
224470|NCT00849680|547651|P2|NOT COMPLETED|Overall Study||3
224471|NCT00849680|547652|P1|NOT COMPLETED|Overall Study||11
224472|NCT00849680|547645|P8|COMPLETED|Overall Study||23
224473|NCT00849680|547646|P7|COMPLETED|Overall Study||61
224474|NCT00849680|547647|P6|COMPLETED|Overall Study||27
224475|NCT00849680|547648|P5|COMPLETED|Overall Study||32
224476|NCT00849680|547649|P4|COMPLETED|Overall Study||28
224477|NCT00849680|547650|P3|COMPLETED|Overall Study||27
224478|NCT00849680|547651|P2|COMPLETED|Overall Study||10
224479|NCT00849680|547652|P1|COMPLETED|Overall Study||16
224480|NCT00849680|547645|P8|STARTED|Overall Study||31
224481|NCT00849680|547646|P7|STARTED|Overall Study||78
224482|NCT00849680|547647|P6|STARTED|Overall Study||42
224483|NCT00849680|547648|P5|STARTED|Overall Study||42
224484|NCT00849680|547649|P4|STARTED|Overall Study||42
224485|NCT00849680|547650|P3|STARTED|Overall Study||42
224486|NCT00849680|547651|P2|STARTED|Overall Study||13
224487|NCT00849680|547652|P1|STARTED|Overall Study||27
224488|NCT00849693|547698|P4|NOT COMPLETED|Extension Phase||38
224489|NCT00849693|547699|P3|NOT COMPLETED|Extension Phase||35
224490|NCT00849693|547700|P2|NOT COMPLETED|Extension Phase||30
224491|NCT00849693|547701|P1|NOT COMPLETED|Extension Phase||30
224492|NCT00849693|547698|P4|COMPLETED|Extension Phase||44
224493|NCT00849693|547699|P3|COMPLETED|Extension Phase||49
224494|NCT00849693|547700|P2|COMPLETED|Extension Phase||50
224495|NCT00849693|547701|P1|COMPLETED|Extension Phase||43
224496|NCT00849693|547698|P4|STARTED|Extension Phase||82
224497|NCT00849693|547699|P3|STARTED|Extension Phase||84
224498|NCT00849693|547700|P2|STARTED|Extension Phase||80
224499|NCT00849693|547701|P1|STARTED|Extension Phase||73
224500|NCT00849693|547698|P4|NOT COMPLETED|Acute Treatment Phase||37
224501|NCT00849693|547699|P3|NOT COMPLETED|Acute Treatment Phase||33
224502|NCT00849693|547700|P2|NOT COMPLETED|Acute Treatment Phase||35
224503|NCT00849693|547701|P1|NOT COMPLETED|Acute Treatment Phase||33
224504|NCT00849693|547698|P4|COMPLETED|Acute Treatment Phase|3 didn't enter extension phase|85
224505|NCT00849693|547699|P3|COMPLETED|Acute Treatment Phase||84
224506|NCT00849693|547700|P2|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase|81
224507|NCT00849693|547701|P1|COMPLETED|Acute Treatment Phase|2 didn't enter extension phase.|75
224508|NCT00849693|547698|P4|STARTED|Acute Treatment Phase||122
224509|NCT00849693|547699|P3|STARTED|Acute Treatment Phase||117
224510|NCT00849693|547700|P2|STARTED|Acute Treatment Phase||116
224511|NCT00849693|547701|P1|STARTED|Acute Treatment Phase||108
224512|NCT00849797|547762|P2|NOT COMPLETED|Second Intervention||0
224513|NCT00849797|547763|P1|NOT COMPLETED|Second Intervention||0
224514|NCT00849797|547762|P2|COMPLETED|Second Intervention||57
224515|NCT00849797|547763|P1|COMPLETED|Second Intervention||59
224516|NCT00849797|547762|P2|STARTED|Second Intervention||57
224517|NCT00849797|547763|P1|STARTED|Second Intervention||59
224518|NCT00849797|547762|P2|NOT COMPLETED|Washout: One Week||2
224519|NCT00849797|547763|P1|NOT COMPLETED|Washout: One Week||0
224520|NCT00849797|547762|P2|COMPLETED|Washout: One Week||57
224521|NCT00849797|547763|P1|COMPLETED|Washout: One Week||59
224522|NCT00849797|547762|P2|STARTED|Washout: One Week||59
224523|NCT00849797|547763|P1|STARTED|Washout: One Week||59
224524|NCT00849797|547762|P2|NOT COMPLETED|First Intervention||1
224525|NCT00849797|547763|P1|NOT COMPLETED|First Intervention||1
224526|NCT00849797|547762|P2|COMPLETED|First Intervention||59
224527|NCT00849797|547763|P1|COMPLETED|First Intervention||59
224528|NCT00849797|547762|P2|STARTED|First Intervention||60
224529|NCT00849797|547763|P1|STARTED|First Intervention||60
224530|NCT00849810|547777|P1|NOT COMPLETED|Overall Study||0
224531|NCT00849810|547777|P1|COMPLETED|Overall Study||1
224532|NCT00849810|547777|P1|STARTED|Overall Study||1
224533|NCT00849862|547783|P2|NOT COMPLETED|Second Intervention||0
224534|NCT00849862|547784|P1|NOT COMPLETED|Second Intervention||0
224535|NCT00849862|547783|P2|COMPLETED|Second Intervention||11
224536|NCT00849862|547784|P1|COMPLETED|Second Intervention||11
224537|NCT00849862|547783|P2|STARTED|Second Intervention||11
224538|NCT00849862|547784|P1|STARTED|Second Intervention||11
224539|NCT00849862|547783|P2|NOT COMPLETED|Washout: 7 Days||0
224540|NCT00849862|547784|P1|NOT COMPLETED|Washout: 7 Days||0
224541|NCT00849862|547783|P2|COMPLETED|Washout: 7 Days||11
224542|NCT00849862|547784|P1|COMPLETED|Washout: 7 Days||11
224543|NCT00849862|547783|P2|STARTED|Washout: 7 Days||11
224544|NCT00849862|547784|P1|STARTED|Washout: 7 Days||11
224545|NCT00849862|547783|P2|NOT COMPLETED|First Intervention||0
224546|NCT00849862|547784|P1|NOT COMPLETED|First Intervention||0
224547|NCT00849862|547783|P2|COMPLETED|First Intervention||11
224548|NCT00849862|547784|P1|COMPLETED|First Intervention||11
224549|NCT00849862|547783|P2|STARTED|First Intervention||11
224550|NCT00849862|547784|P1|STARTED|First Intervention||11
224551|NCT00849875|547795|P1|NOT COMPLETED|Overall Study||47
224552|NCT00849875|547795|P1|COMPLETED|Overall Study||1
224553|NCT00849875|547795|P1|STARTED|Overall Study||48
224554|NCT00849901|547878|P3|NOT COMPLETED|Extension Phase||17
224555|NCT00849901|547879|P2|NOT COMPLETED|Extension Phase||26
224556|NCT00849901|547880|P1|NOT COMPLETED|Extension Phase||27
224557|NCT00849901|547878|P3|COMPLETED|Extension Phase||69
224558|NCT00849901|547879|P2|COMPLETED|Extension Phase||65
224559|NCT00849901|547880|P1|COMPLETED|Extension Phase||56
224560|NCT00849901|547878|P3|STARTED|Extension Phase||86
224561|NCT00849901|547879|P2|STARTED|Extension Phase||91
224562|NCT00849901|547880|P1|STARTED|Extension Phase||83
224563|NCT00849901|547878|P3|NOT COMPLETED|Acute Treatment Phase||16
224564|NCT00849901|547879|P2|NOT COMPLETED|Acute Treatment Phase||26
224565|NCT00849901|547880|P1|NOT COMPLETED|Acute Treatment Phase||30
224566|NCT00849901|547878|P3|COMPLETED|Acute Treatment Phase|1 didn't enter extension phase.|87
224567|NCT00849901|547879|P2|COMPLETED|Acute Treatment Phase||91
224568|NCT00849901|547880|P1|COMPLETED|Acute Treatment Phase|4 didn't enter extension phase.|87
224569|NCT00849901|547878|P3|STARTED|Acute Treatment Phase||103
224570|NCT00849901|547879|P2|STARTED|Acute Treatment Phase||117
224571|NCT00849901|547880|P1|STARTED|Acute Treatment Phase||117
224572|NCT00849940|547924|P1|NOT COMPLETED|Overall Study||4
224573|NCT00849940|547924|P1|COMPLETED|Overall Study||68
224574|NCT00849940|547924|P1|STARTED|Overall Study||72
224575|NCT00850031|547932|P1|NOT COMPLETED|Overall Study||17
224576|NCT00850031|547932|P1|COMPLETED|Overall Study||101
224577|NCT00850031|547932|P1|STARTED|Overall Study||118
224578|NCT00850070|547939|P2|NOT COMPLETED|Overall Study||1
224579|NCT00850070|547940|P1|NOT COMPLETED|Overall Study||3
224580|NCT00850070|547939|P2|COMPLETED|Overall Study||22
224581|NCT00850070|547940|P1|COMPLETED|Overall Study||20
224582|NCT00850070|547939|P2|STARTED|Overall Study||23
224583|NCT00850070|547940|P1|STARTED|Overall Study||23
224584|NCT00850096|547958|P2|NOT COMPLETED|Overall Study||2
224585|NCT00850096|547959|P1|NOT COMPLETED|Overall Study||3
224586|NCT00850096|547958|P2|COMPLETED|Overall Study||45
224587|NCT00850096|547959|P1|COMPLETED|Overall Study||44
224588|NCT00850096|547958|P2|STARTED|Overall Study||47
224589|NCT00850096|547959|P1|STARTED|Overall Study||47
224590|NCT00850135|547967|P1|NOT COMPLETED|Overall Study||1
224591|NCT00850135|547967|P1|COMPLETED|Overall Study||56
224592|NCT00850135|547967|P1|STARTED|Overall Study||57
224593|NCT00850174|547975|P2|NOT COMPLETED|Second Intervention||0
224594|NCT00850174|547976|P1|NOT COMPLETED|Second Intervention||1
224595|NCT00850174|547975|P2|COMPLETED|Second Intervention||28
224596|NCT00850174|547976|P1|COMPLETED|Second Intervention||29
224597|NCT00850174|547975|P2|STARTED|Second Intervention||28
224598|NCT00850174|547976|P1|STARTED|Second Intervention||30
224599|NCT00850174|547975|P2|NOT COMPLETED|Washout: One Week||2
224600|NCT00850174|547976|P1|NOT COMPLETED|Washout: One Week||0
224601|NCT00850174|547975|P2|COMPLETED|Washout: One Week||28
224602|NCT00850174|547976|P1|COMPLETED|Washout: One Week||30
224603|NCT00850174|547975|P2|STARTED|Washout: One Week||30
224604|NCT00850174|547976|P1|STARTED|Washout: One Week||30
224605|NCT00850174|547975|P2|NOT COMPLETED|First Intervention||0
224606|NCT00850174|547976|P1|NOT COMPLETED|First Intervention||0
224607|NCT00850174|547975|P2|COMPLETED|First Intervention||30
224608|NCT00850174|547976|P1|COMPLETED|First Intervention||30
224609|NCT00850174|547975|P2|STARTED|First Intervention||30
224610|NCT00850174|547976|P1|STARTED|First Intervention||30
224611|NCT00850200|547990|P1|NOT COMPLETED|Overall Study||1
224612|NCT00850200|547990|P1|COMPLETED|Overall Study||19
224613|NCT00850200|547990|P1|STARTED|Overall Study||20
224614|NCT00850343|548000|P4|NOT COMPLETED|Overall Study||13
224615|NCT00850343|548001|P3|NOT COMPLETED|Overall Study||14
224616|NCT00850343|548002|P2|NOT COMPLETED|Overall Study||3
224617|NCT00850343|548003|P1|NOT COMPLETED|Overall Study||46
224618|NCT00850343|548000|P4|COMPLETED|Overall Study||30
224619|NCT00850343|548001|P3|COMPLETED|Overall Study||29
224620|NCT00850343|548002|P2|COMPLETED|Overall Study||9
224621|NCT00850343|548003|P1|COMPLETED|Overall Study||64
224622|NCT00850343|548000|P4|Completed Week 52|Overall Study||37
224623|NCT00850343|548001|P3|Completed Week 52|Overall Study||37
224624|NCT00850343|548002|P2|Completed Week 52|Overall Study||11
224625|NCT00850343|548003|P1|Completed Week 52|Overall Study||88
224626|NCT00850343|548000|P4|Completed Week 24|Overall Study||39
224627|NCT00850343|548001|P3|Completed Week 24|Overall Study||39
224628|NCT00850343|548002|P2|Completed Week 24|Overall Study||12
224629|NCT00850343|548003|P1|Completed Week 24|Overall Study||94
224630|NCT00850343|548000|P4|STARTED|Overall Study||43
224631|NCT00850343|548001|P3|STARTED|Overall Study||43
224632|NCT00850343|548002|P2|STARTED|Overall Study||12
224633|NCT00850343|548003|P1|STARTED|Overall Study||110
224634|NCT00850395|548033|P1|NOT COMPLETED|Overall Study||10
224635|NCT00850395|548033|P1|COMPLETED|Overall Study||69
224636|NCT00850395|548033|P1|STARTED|Overall Study||79
224637|NCT00850421|548049|P1|NOT COMPLETED|Overall Study||17
224638|NCT00850421|548049|P1|COMPLETED|Overall Study||18
224639|NCT00850421|548049|P1|STARTED|Overall Study||35
224640|NCT00850460|548055|P2|NOT COMPLETED|Overall Study||4
224641|NCT00850460|548056|P1|NOT COMPLETED|Overall Study||4
224642|NCT00850460|548055|P2|COMPLETED|Overall Study||3
224643|NCT00850460|548056|P1|COMPLETED|Overall Study||3
224644|NCT00850460|548055|P2|Completion - Week 8|Overall Study||3
224645|NCT00850460|548056|P1|Completion - Week 8|Overall Study||3
224646|NCT00850460|548055|P2|Started - Week 0|Overall Study||7
224647|NCT00850460|548056|P1|Started - Week 0|Overall Study||7
224648|NCT00850460|548055|P2|STARTED|Overall Study||7
224649|NCT00850460|548056|P1|STARTED|Overall Study||7
224650|NCT00850499|548066|P2|NOT COMPLETED|Overall Study||2
224651|NCT00850499|548067|P1|NOT COMPLETED|Overall Study||3
224652|NCT00850499|548066|P2|COMPLETED|Overall Study||6
224653|NCT00850499|548067|P1|COMPLETED|Overall Study||1
224654|NCT00850499|548066|P2|STARTED|Overall Study||8
224655|NCT00850499|548067|P1|STARTED|Overall Study||4
224656|NCT00850538|548075|P1|NOT COMPLETED|Overall Study||41
224657|NCT00850538|548075|P1|COMPLETED|Overall Study||60
224658|NCT00850538|548075|P1|STARTED|Overall Study||101
224659|NCT00850564|548079|P1|NOT COMPLETED|Overall Study||2
224660|NCT00850564|548079|P1|COMPLETED|Overall Study||13
224661|NCT00850564|548079|P1|STARTED|Overall Study||15
224662|NCT00850603|548089|P5|NOT COMPLETED|Overall Study||0
224663|NCT00850603|548090|P4|NOT COMPLETED|Overall Study||0
224664|NCT00850603|548091|P3|NOT COMPLETED|Overall Study||0
224665|NCT00850603|548092|P2|NOT COMPLETED|Overall Study||0
224666|NCT00850603|548093|P1|NOT COMPLETED|Overall Study||0
224667|NCT00850603|548089|P5|COMPLETED|Overall Study||34
224668|NCT00850603|548090|P4|COMPLETED|Overall Study||34
224669|NCT00850603|548091|P3|COMPLETED|Overall Study||34
224670|NCT00850603|548092|P2|COMPLETED|Overall Study||34
224671|NCT00850603|548093|P1|COMPLETED|Overall Study||34
224672|NCT00850603|548089|P5|STARTED|Overall Study||34
224673|NCT00850603|548090|P4|STARTED|Overall Study||34
224674|NCT00850603|548091|P3|STARTED|Overall Study||34
224675|NCT00850603|548092|P2|STARTED|Overall Study||34
224676|NCT00850603|548093|P1|STARTED|Overall Study||34
224677|NCT00850720|548115|P1|NOT COMPLETED|Overall Study||0
224678|NCT00850720|548115|P1|COMPLETED|Overall Study||0
224679|NCT00850720|548115|P1|STARTED|Overall Study||0
224680|NCT00850759|548123|P4|NOT COMPLETED|Overall Study||3
224681|NCT00850759|548124|P3|NOT COMPLETED|Overall Study||5
224682|NCT00850759|548125|P2|NOT COMPLETED|Overall Study||5
224683|NCT00850759|548126|P1|NOT COMPLETED|Overall Study||7
224684|NCT00850759|548123|P4|COMPLETED|Overall Study||55
224685|NCT00850759|548124|P3|COMPLETED|Overall Study||52
224686|NCT00850759|548125|P2|COMPLETED|Overall Study||52
224687|NCT00850759|548126|P1|COMPLETED|Overall Study||52
224688|NCT00850759|548123|P4|STARTED|Overall Study||58
224689|NCT00850759|548124|P3|STARTED|Overall Study||57
224690|NCT00850759|548125|P2|STARTED|Overall Study||57
224691|NCT00850759|548126|P1|STARTED|Overall Study||59
224692|NCT00850889|548136|P1|NOT COMPLETED|Overall Study||0
224693|NCT00850889|548136|P1|COMPLETED|Overall Study||32
224694|NCT00850889|548136|P1|STARTED|Overall Study||32
224695|NCT00850993|548151|P4|NOT COMPLETED|Overall Study||0
224696|NCT00850993|548152|P3|NOT COMPLETED|Overall Study||0
224697|NCT00850993|548153|P2|NOT COMPLETED|Overall Study||1
224698|NCT00850993|548154|P1|NOT COMPLETED|Overall Study||0
224699|NCT00850993|548151|P4|COMPLETED|Overall Study||8
224700|NCT00850993|548152|P3|COMPLETED|Overall Study||18
224701|NCT00850993|548153|P2|COMPLETED|Overall Study||16
224702|NCT00850993|548154|P1|COMPLETED|Overall Study||15
224703|NCT00850993|548151|P4|STARTED|Overall Study||8
224704|NCT00850993|548152|P3|STARTED|Overall Study||18
224705|NCT00850993|548153|P2|STARTED|Overall Study||17
224706|NCT00850993|548154|P1|STARTED|Overall Study||15
224707|NCT00851006|548168|P2|NOT COMPLETED|Overall Study||0
224708|NCT00851006|548169|P1|NOT COMPLETED|Overall Study||0
224709|NCT00851006|548168|P2|COMPLETED|Overall Study||6
224710|NCT00851006|548169|P1|COMPLETED|Overall Study||7
224711|NCT00851006|548168|P2|STARTED|Overall Study||6
224712|NCT00851006|548169|P1|STARTED|Overall Study||7
224713|NCT00851084|548178|P2|NOT COMPLETED|Overall Study||119
224714|NCT00851084|548179|P1|NOT COMPLETED|Overall Study||117
224715|NCT00851084|548178|P2|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
224716|NCT00851084|548179|P1|COMPLETED|Overall Study|Participants continued treatment until they met treatment discontinuation criteria.|0
224717|NCT00851084|548178|P2|STARTED|Overall Study||119
224718|NCT00851084|548179|P1|STARTED|Overall Study||117
224719|NCT00851279|548195|P1|NOT COMPLETED|Overall Study||0
224720|NCT00851279|548195|P1|COMPLETED|Overall Study||53
224721|NCT00851279|548195|P1|STARTED|Overall Study||53
224722|NCT00851318|548203|P4|NOT COMPLETED|Overall Study||19
224723|NCT00851318|548204|P3|NOT COMPLETED|Overall Study||21
224724|NCT00851318|548205|P2|NOT COMPLETED|Overall Study||5
224725|NCT00851318|548206|P1|NOT COMPLETED|Overall Study||30
224726|NCT00851318|548203|P4|COMPLETED|Overall Study||73
224727|NCT00851318|548204|P3|COMPLETED|Overall Study||72
224728|NCT00851318|548205|P2|COMPLETED|Overall Study||14
224729|NCT00851318|548206|P1|COMPLETED|Overall Study||51
224730|NCT00851318|548203|P4|Completed Week 52|Overall Study||85
224731|NCT00851318|548204|P3|Completed Week 52|Overall Study||87
224732|NCT00851318|548205|P2|Completed Week 52|Overall Study||16
224733|NCT00851318|548206|P1|Completed Week 52|Overall Study||64
224734|NCT00851318|548203|P4|Completed Week 24|Overall Study||87
224735|NCT00851318|548204|P3|Completed Week 24|Overall Study||90
224736|NCT00851318|548205|P2|Completed Week 24|Overall Study||17
224737|NCT00851318|548206|P1|Completed Week 24|Overall Study||69
224738|NCT00851318|548203|P4|STARTED|Overall Study||92
224739|NCT00851318|548204|P3|STARTED|Overall Study||93
224740|NCT00851318|548205|P2|STARTED|Overall Study||19
224741|NCT00851318|548206|P1|STARTED|Overall Study||81
224742|NCT00851409|548236|P1|NOT COMPLETED|Overall Study||0
224743|NCT00851409|548236|P1|COMPLETED|Overall Study||25
224744|NCT00851409|548236|P1|STARTED|Overall Study||25
224745|NCT00851552|548241|P1|NOT COMPLETED|Overall Study||7
224746|NCT00851552|548241|P1|COMPLETED|Overall Study||2
224747|NCT00851552|548241|P1|STARTED|Overall Study||9
224748|NCT00851591|548248|P2|NOT COMPLETED|Overall Study||0
224749|NCT00851591|548249|P1|NOT COMPLETED|Overall Study||2
224750|NCT00851591|548248|P2|COMPLETED|Overall Study||1
224751|NCT00851591|548249|P1|COMPLETED|Overall Study||0
224752|NCT00851591|548248|P2|STARTED|Overall Study|One received treatment.|1
224753|NCT00851591|548249|P1|STARTED|Overall Study|These 2 participants did not receive treatment.|2
224754|NCT00851630|548257|P2|NOT COMPLETED|Overall Study||2
224755|NCT00851630|548258|P1|NOT COMPLETED|Overall Study||2
224756|NCT00851630|548257|P2|COMPLETED|Overall Study||33
224757|NCT00851630|548258|P1|COMPLETED|Overall Study||33
224758|NCT00851630|548257|P2|STARTED|Overall Study||35
224759|NCT00851630|548258|P1|STARTED|Overall Study||35
224760|NCT00851643|548276|P6|NOT COMPLETED|Extension Study (Up to 36 Months)||1
224761|NCT00851643|548277|P5|NOT COMPLETED|Extension Study (Up to 36 Months)||2
224762|NCT00851643|548278|P4|NOT COMPLETED|Extension Study (Up to 36 Months)||2
224763|NCT00851643|548279|P3|NOT COMPLETED|Extension Study (Up to 36 Months)||5
224764|NCT00851643|548280|P2|NOT COMPLETED|Extension Study (Up to 36 Months)||4
224765|NCT00851643|548281|P1|NOT COMPLETED|Extension Study (Up to 36 Months)||4
224766|NCT00851643|548276|P6|COMPLETED|Extension Study (Up to 36 Months)||14
224767|NCT00851643|548277|P5|COMPLETED|Extension Study (Up to 36 Months)||19
224768|NCT00851643|548278|P4|COMPLETED|Extension Study (Up to 36 Months)||5
224769|NCT00851643|548279|P3|COMPLETED|Extension Study (Up to 36 Months)||14
224770|NCT00851643|548280|P2|COMPLETED|Extension Study (Up to 36 Months)||15
224771|NCT00851643|548281|P1|COMPLETED|Extension Study (Up to 36 Months)||6
224772|NCT00851643|548276|P6|STARTED|Extension Study (Up to 36 Months)||15
224773|NCT00851643|548277|P5|STARTED|Extension Study (Up to 36 Months)||21
224774|NCT00851643|548278|P4|STARTED|Extension Study (Up to 36 Months)||7
224775|NCT00851643|548279|P3|STARTED|Extension Study (Up to 36 Months)||19
224776|NCT00851643|548280|P2|STARTED|Extension Study (Up to 36 Months)||19
224777|NCT00851643|548281|P1|STARTED|Extension Study (Up to 36 Months)||10
224778|NCT00851643|548276|P6|NOT COMPLETED|Base Study (Up to 12 Months)||1
224779|NCT00851643|548277|P5|NOT COMPLETED|Base Study (Up to 12 Months)||0
224780|NCT00851643|548278|P4|NOT COMPLETED|Base Study (Up to 12 Months)||0
224781|NCT00851643|548279|P3|NOT COMPLETED|Base Study (Up to 12 Months)||0
224782|NCT00851643|548280|P2|NOT COMPLETED|Base Study (Up to 12 Months)||0
224783|NCT00851643|548281|P1|NOT COMPLETED|Base Study (Up to 12 Months)||1
224784|NCT00851643|548276|P6|COMPLETED|Base Study (Up to 12 Months)||29
224785|NCT00851643|548277|P5|COMPLETED|Base Study (Up to 12 Months)||30
224786|NCT00851643|548278|P4|COMPLETED|Base Study (Up to 12 Months)||15
224787|NCT00851643|548279|P3|COMPLETED|Base Study (Up to 12 Months)||30
224788|NCT00851643|548280|P2|COMPLETED|Base Study (Up to 12 Months)||30
224789|NCT00851643|548281|P1|COMPLETED|Base Study (Up to 12 Months)||14
224790|NCT00851643|548276|P6|STARTED|Base Study (Up to 12 Months)||30
224791|NCT00851643|548277|P5|STARTED|Base Study (Up to 12 Months)||30
224792|NCT00851643|548278|P4|STARTED|Base Study (Up to 12 Months)||15
224793|NCT00851643|548279|P3|STARTED|Base Study (Up to 12 Months)||30
224794|NCT00851643|548280|P2|STARTED|Base Study (Up to 12 Months)||30
224795|NCT00851643|548281|P1|STARTED|Base Study (Up to 12 Months)||15
224796|NCT00851682|548302|P2|NOT COMPLETED|Overall Study||0
224797|NCT00851682|548303|P1|NOT COMPLETED|Overall Study||5
224798|NCT00851682|548302|P2|COMPLETED|Overall Study||5
224799|NCT00851682|548303|P1|COMPLETED|Overall Study||55
224800|NCT00851682|548302|P2|STARTED|Overall Study||5
224801|NCT00851682|548303|P1|STARTED|Overall Study||60
224802|NCT00851721|548313|P2|NOT COMPLETED|Overall Study||1
224803|NCT00851721|548314|P1|NOT COMPLETED|Overall Study||2
224804|NCT00851721|548313|P2|COMPLETED|Overall Study||16
224805|NCT00851721|548314|P1|COMPLETED|Overall Study||17
224806|NCT00851721|548313|P2|STARTED|Overall Study||17
224807|NCT00851721|548314|P1|STARTED|Overall Study||19
224808|NCT00851786|548404|P2|NOT COMPLETED|Overall Study||2
224809|NCT00851786|548405|P1|NOT COMPLETED|Overall Study||5
224810|NCT00851786|548404|P2|COMPLETED|Overall Study||97
224811|NCT00851786|548405|P1|COMPLETED|Overall Study||291
224812|NCT00851786|548404|P2|STARTED|Overall Study|Two subjects (one found ineligible and one withdrew consent) were off study with no vaccine.|99
224813|NCT00851786|548405|P1|STARTED|Overall Study|One subject cannot adhere to protocol requirement and was off study with no vaccine.|296
224814|NCT00851799|548416|P3|NOT COMPLETED|Overall Study||24
224815|NCT00851799|548417|P2|NOT COMPLETED|Overall Study||13
224816|NCT00851799|548418|P1|NOT COMPLETED|Overall Study||16
224817|NCT00851799|548416|P3|COMPLETED|Overall Study||89
224818|NCT00851799|548417|P2|COMPLETED|Overall Study||93
224819|NCT00851799|548418|P1|COMPLETED|Overall Study||93
224820|NCT00851799|548416|P3|STARTED|Overall Study||113
224821|NCT00851799|548417|P2|STARTED|Overall Study||106
224822|NCT00851799|548418|P1|STARTED|Overall Study||109
224823|NCT00851890|548508|P4|NOT COMPLETED|Overall Study||1
224824|NCT00851890|548509|P3|NOT COMPLETED|Overall Study||0
224825|NCT00851890|548510|P2|NOT COMPLETED|Overall Study||1
224826|NCT00851890|548511|P1|NOT COMPLETED|Overall Study||0
224827|NCT00851890|548508|P4|COMPLETED|Overall Study||5
224828|NCT00851890|548509|P3|COMPLETED|Overall Study||8
224829|NCT00851890|548510|P2|COMPLETED|Overall Study||7
224830|NCT00851890|548511|P1|COMPLETED|Overall Study||8
224831|NCT00851890|548508|P4|STARTED|Overall Study||6
224832|NCT00851890|548509|P3|STARTED|Overall Study||8
224833|NCT00851890|548510|P2|STARTED|Overall Study||8
224834|NCT00851890|548511|P1|STARTED|Overall Study||8
224835|NCT00851903|548568|P1|NOT COMPLETED|Overall Study||2
224836|NCT00851903|548568|P1|COMPLETED|Overall Study||110
224837|NCT00851903|548568|P1|Modified Intent-To-Treat Population|Overall Study|mITT population: patients treated by combination with at least 1 on-treatment efficacy measure|111
224838|NCT00851903|548568|P1|Treated by Combination|Overall Study|patients treated with at least one dose of insulin glargine AND one dose of sitagliptin|111
224918|NCT00839098|548706|P2|COMPLETED|Overall Study||11
224839|NCT00851903|548568|P1|Safety Population|Overall Study|patients treated with at least one dose of insulin glargine OR one dose of sitagliptin|112
224840|NCT00851903|548568|P1|STARTED|Overall Study||112
224841|NCT00838682|548580|P2|NOT COMPLETED|Overall Study||19
224842|NCT00838682|548581|P1|NOT COMPLETED|Overall Study||25
224843|NCT00838682|548580|P2|COMPLETED|Overall Study||33
224844|NCT00838682|548581|P1|COMPLETED|Overall Study||29
224845|NCT00838682|548580|P2|STARTED|Overall Study||52
224846|NCT00838682|548581|P1|STARTED|Overall Study||54
224847|NCT00838903|548601|P4|NOT COMPLETED|Follow-up Period (8 Weeks)||58
224848|NCT00838903|548602|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||64
224849|NCT00838903|548603|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||65
224850|NCT00838903|548604|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||26
224851|NCT00838903|548601|P4|COMPLETED|Follow-up Period (8 Weeks)||244
224852|NCT00838903|548602|P3|COMPLETED|Follow-up Period (8 Weeks)||243
224853|NCT00838903|548603|P2|COMPLETED|Follow-up Period (8 Weeks)||237
224854|NCT00838903|548604|P1|COMPLETED|Follow-up Period (8 Weeks)||75
224855|NCT00838903|548601|P4|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
224856|NCT00838903|548602|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|307
224857|NCT00838903|548603|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|302
224858|NCT00838903|548604|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
224859|NCT00838903|548601|P4|NOT COMPLETED|Treatment Period (156 Weeks)||110
224860|NCT00838903|548602|P3|NOT COMPLETED|Treatment Period (156 Weeks)||116
224861|NCT00838903|548603|P2|NOT COMPLETED|Treatment Period (156 Weeks)||112
224862|NCT00838903|548604|P1|NOT COMPLETED|Treatment Period (156 Weeks)||46
224863|NCT00838903|548601|P4|COMPLETED|Treatment Period (156 Weeks)||192
224864|NCT00838903|548602|P3|COMPLETED|Treatment Period (156 Weeks)||191
224865|NCT00838903|548603|P2|COMPLETED|Treatment Period (156 Weeks)||190
224866|NCT00838903|548604|P1|COMPLETED|Treatment Period (156 Weeks)||55
224867|NCT00838903|548601|P4|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
224868|NCT00838903|548602|P3|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
224869|NCT00838903|548603|P2|Missing Active Treatment Status|Treatment Period (156 Weeks)||0
224870|NCT00838903|548604|P1|Missing Active Treatment Status|Treatment Period (156 Weeks)||1
224871|NCT00838903|548601|P4|STARTED|Treatment Period (156 Weeks)||302
224872|NCT00838903|548602|P3|STARTED|Treatment Period (156 Weeks)||307
224873|NCT00838903|548603|P2|STARTED|Treatment Period (156 Weeks)||302
224874|NCT00838903|548604|P1|STARTED|Treatment Period (156 Weeks)||101
224875|NCT00838916|548648|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||51
224876|NCT00838916|548649|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||96
224877|NCT00838916|548648|P2|COMPLETED|Follow-up Period (8 Weeks)||190
224878|NCT00838916|548649|P1|COMPLETED|Follow-up Period (8 Weeks)||408
224879|NCT00838916|548648|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|241
224880|NCT00838916|548649|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|504
224881|NCT00838916|548648|P2|NOT COMPLETED|Treatment Period (156 Weeks)||77
224882|NCT00838916|548649|P1|NOT COMPLETED|Treatment Period (156 Weeks)||196
224883|NCT00838916|548648|P2|COMPLETED|Treatment Period (156 Weeks)||164
224884|NCT00838916|548649|P1|COMPLETED|Treatment Period (156 Weeks)||308
224885|NCT00838916|548648|P2|STARTED|Treatment Period (156 Weeks)||241
224886|NCT00838916|548649|P1|STARTED|Treatment Period (156 Weeks)||504
224887|NCT00838929|548677|P3|NOT COMPLETED|Overall Study||1
224888|NCT00838929|548678|P2|NOT COMPLETED|Overall Study||3
224889|NCT00838929|548679|P1|NOT COMPLETED|Overall Study||0
224890|NCT00838929|548677|P3|COMPLETED|Overall Study||5
224891|NCT00838929|548678|P2|COMPLETED|Overall Study||5
224892|NCT00838929|548679|P1|COMPLETED|Overall Study||3
224893|NCT00838929|548677|P3|STARTED|Overall Study||6
224894|NCT00838929|548678|P2|STARTED|Overall Study||8
224895|NCT00838929|548679|P1|STARTED|Overall Study||3
224896|NCT00839072|548685|P2|NOT COMPLETED|Second Intervention Period||0
224897|NCT00839072|548686|P1|NOT COMPLETED|Second Intervention Period||1
224898|NCT00839072|548685|P2|COMPLETED|Second Intervention Period||11
224899|NCT00839072|548686|P1|COMPLETED|Second Intervention Period||9
224900|NCT00839072|548685|P2|STARTED|Second Intervention Period||11
224901|NCT00839072|548686|P1|STARTED|Second Intervention Period||10
224902|NCT00839072|548685|P2|NOT COMPLETED|Washout Period of 7 Days||0
224903|NCT00839072|548686|P1|NOT COMPLETED|Washout Period of 7 Days||0
224904|NCT00839072|548685|P2|COMPLETED|Washout Period of 7 Days||11
224905|NCT00839072|548686|P1|COMPLETED|Washout Period of 7 Days||10
224906|NCT00839072|548685|P2|STARTED|Washout Period of 7 Days||11
224907|NCT00839072|548686|P1|STARTED|Washout Period of 7 Days||10
224908|NCT00839072|548685|P2|NOT COMPLETED|First Intervention Period||1
224909|NCT00839072|548686|P1|NOT COMPLETED|First Intervention Period||2
224910|NCT00839072|548685|P2|COMPLETED|First Intervention Period||11
224911|NCT00839072|548686|P1|COMPLETED|First Intervention Period||10
224912|NCT00839072|548685|P2|STARTED|First Intervention Period||12
224913|NCT00839072|548686|P1|STARTED|First Intervention Period||12
224914|NCT00839098|548705|P3|NOT COMPLETED|Overall Study||7
224915|NCT00839098|548706|P2|NOT COMPLETED|Overall Study||1
224916|NCT00839098|548707|P1|NOT COMPLETED|Overall Study||2
224917|NCT00839098|548705|P3|COMPLETED|Overall Study||6
224919|NCT00839098|548707|P1|COMPLETED|Overall Study||1
224920|NCT00839098|548705|P3|STARTED|Overall Study||13
224921|NCT00839098|548706|P2|STARTED|Overall Study||12
224922|NCT00839098|548707|P1|STARTED|Overall Study||3
224923|NCT00839241|548735|P2|NOT COMPLETED|Overall Study||17
224924|NCT00839241|548736|P1|NOT COMPLETED|Overall Study||5
224925|NCT00839241|548735|P2|COMPLETED|Overall Study||8
224926|NCT00839241|548736|P1|COMPLETED|Overall Study||15
224927|NCT00839241|548735|P2|STARTED|Overall Study||25
224928|NCT00839241|548736|P1|STARTED|Overall Study||20
224929|NCT00839306|548822|P2|NOT COMPLETED|Overall Study||43
224930|NCT00839306|548823|P1|NOT COMPLETED|Overall Study||25
224931|NCT00839306|548822|P2|COMPLETED|Overall Study||134
224932|NCT00839306|548823|P1|COMPLETED|Overall Study||35
224933|NCT00839306|548822|P2|STARTED|Overall Study|Treated|177
224934|NCT00839306|548823|P1|STARTED|Overall Study|Treated|60
224935|NCT00839319|548836|P5|NOT COMPLETED|Overall Study||0
224936|NCT00839319|548837|P4|NOT COMPLETED|Overall Study||3
224937|NCT00839319|548838|P3|NOT COMPLETED|Overall Study||3
224938|NCT00839319|548839|P2|NOT COMPLETED|Overall Study||1
224939|NCT00839319|548840|P1|NOT COMPLETED|Overall Study||2
224940|NCT00839319|548836|P5|COMPLETED|Overall Study||8
224941|NCT00839319|548837|P4|COMPLETED|Overall Study|1 withdrawn by investigator for syncopal reaction , 2 excluded from analysis (low serum LH)|5
224942|NCT00839319|548838|P3|COMPLETED|Overall Study|1 dropped out after Day 1 visit, 2 excluded from analysis (low serum LH)|5
224943|NCT00839319|548839|P2|COMPLETED|Overall Study|1 excluded from analysis (low serum LH)|7
224944|NCT00839319|548840|P1|COMPLETED|Overall Study|1 withdrew consent prior to procedures; 1 excluded from analysis (low serum LH)|6
224945|NCT00839319|548836|P5|STARTED|Overall Study||8
224946|NCT00839319|548837|P4|STARTED|Overall Study||8
224947|NCT00839319|548838|P3|STARTED|Overall Study||8
224948|NCT00839319|548839|P2|STARTED|Overall Study||8
224949|NCT00839319|548840|P1|STARTED|Overall Study||8
224950|NCT00839423|548871|P4|NOT COMPLETED|Overall Study||20
224951|NCT00839423|548872|P3|NOT COMPLETED|Overall Study||18
224952|NCT00839423|548873|P2|NOT COMPLETED|Overall Study||10
224953|NCT00839423|548874|P1|NOT COMPLETED|Overall Study||18
224954|NCT00839423|548871|P4|COMPLETED|Overall Study||93
224955|NCT00839423|548872|P3|COMPLETED|Overall Study||82
224956|NCT00839423|548873|P2|COMPLETED|Overall Study||98
224957|NCT00839423|548874|P1|COMPLETED|Overall Study||87
224958|NCT00839423|548871|P4|STARTED|Overall Study||113
224959|NCT00839423|548872|P3|STARTED|Overall Study||100
224960|NCT00839423|548873|P2|STARTED|Overall Study||108
224961|NCT00839423|548874|P1|STARTED|Overall Study||105
224962|NCT00839436|548915|P3|NOT COMPLETED|Overall Study||1
224963|NCT00839436|548916|P2|NOT COMPLETED|Overall Study||1
224964|NCT00839436|548917|P1|NOT COMPLETED|Overall Study||1
224965|NCT00839436|548915|P3|COMPLETED|Overall Study||0
224966|NCT00839436|548916|P2|COMPLETED|Overall Study||4
224967|NCT00839436|548917|P1|COMPLETED|Overall Study||2
224968|NCT00839436|548915|P3|STARTED|Overall Study||1
224969|NCT00839436|548916|P2|STARTED|Overall Study||5
224970|NCT00839436|548917|P1|STARTED|Overall Study||3
224971|NCT00839527|548928|P3|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||62
224972|NCT00839527|548929|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||56
224973|NCT00839527|548930|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||28
224974|NCT00839527|548928|P3|COMPLETED|Follow-up Period (FUP) (8 Weeks)||204
224975|NCT00839527|548929|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||217
224976|NCT00839527|548930|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||86
224977|NCT00839527|548928|P3|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Five par. did not participate in the FUP.|266
224978|NCT00839527|548929|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Four par. did not participate in the FUP.|273
224979|NCT00839527|548930|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|114
224980|NCT00839527|548928|P3|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||119
224981|NCT00839527|548929|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||118
224982|NCT00839527|548930|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||60
224983|NCT00839527|548928|P3|COMPLETED|Treatment Period (TP) (156 Weeks)||152
224984|NCT00839527|548929|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||159
224985|NCT00839527|548930|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||55
224986|NCT00839527|548928|P3|STARTED|Treatment Period (TP) (156 Weeks)||271
224987|NCT00839527|548929|P2|STARTED|Treatment Period (TP) (156 Weeks)||277
224988|NCT00839527|548930|P1|STARTED|Treatment Period (TP) (156 Weeks)||115
224989|NCT00839540|548965|P3|NOT COMPLETED|Overall Study||0
224990|NCT00839540|548966|P2|NOT COMPLETED|Overall Study||0
224991|NCT00839540|548967|P1|NOT COMPLETED|Overall Study||0
224992|NCT00839540|548965|P3|COMPLETED|Overall Study||5
224993|NCT00839540|548966|P2|COMPLETED|Overall Study||8
224994|NCT00839540|548967|P1|COMPLETED|Overall Study||8
224995|NCT00839540|548965|P3|STARTED|Overall Study||5
224996|NCT00839540|548966|P2|STARTED|Overall Study||8
224997|NCT00839540|548967|P1|STARTED|Overall Study||8
224998|NCT00839800|548977|P2|NOT COMPLETED|Overall Study||110
224999|NCT00839800|548978|P1|NOT COMPLETED|Overall Study||93
225000|NCT00839800|548977|P2|COMPLETED|Overall Study||932
225001|NCT00839800|548978|P1|COMPLETED|Overall Study||956
225002|NCT00839800|548977|P2|STARTED|Overall Study||1042
225003|NCT00839800|548978|P1|STARTED|Overall Study||1049
225004|NCT00839917|549010|P2|NOT COMPLETED|Overall Study||1
225005|NCT00839917|549011|P1|NOT COMPLETED|Overall Study||1
225006|NCT00839917|549010|P2|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|16
225007|NCT00839917|549011|P1|COMPLETED|Overall Study|Study completers were randomized participants who received study vaccination and had follow-up data|12
225008|NCT00839917|549010|P2|STARTED|Overall Study||17
225009|NCT00839917|549011|P1|STARTED|Overall Study||13
225010|NCT00839930|549049|P2|NOT COMPLETED|Second Intervention||0
225011|NCT00839930|549050|P1|NOT COMPLETED|Second Intervention||0
225012|NCT00839930|549049|P2|COMPLETED|Second Intervention||15
225013|NCT00839930|549050|P1|COMPLETED|Second Intervention||15
225014|NCT00839930|549049|P2|STARTED|Second Intervention||15
225015|NCT00839930|549050|P1|STARTED|Second Intervention||15
225016|NCT00839930|549049|P2|NOT COMPLETED|Washout: 7 Days||0
225017|NCT00839930|549050|P1|NOT COMPLETED|Washout: 7 Days||0
225018|NCT00839930|549049|P2|COMPLETED|Washout: 7 Days||15
225019|NCT00839930|549050|P1|COMPLETED|Washout: 7 Days||15
225020|NCT00839930|549049|P2|STARTED|Washout: 7 Days||15
225021|NCT00839930|549050|P1|STARTED|Washout: 7 Days||15
225022|NCT00839930|549049|P2|NOT COMPLETED|First Intervention||0
225023|NCT00839930|549050|P1|NOT COMPLETED|First Intervention||0
225024|NCT00839930|549049|P2|COMPLETED|First Intervention||15
225025|NCT00839930|549050|P1|COMPLETED|First Intervention||15
225026|NCT00839930|549049|P2|STARTED|First Intervention||15
225027|NCT00839930|549050|P1|STARTED|First Intervention||15
225028|NCT00839956|549058|P1|NOT COMPLETED|Overall Study||12
225029|NCT00839956|549058|P1|COMPLETED|Overall Study||19
225030|NCT00839956|549058|P1|STARTED|Overall Study||31
225031|NCT00839982|549065|P4|NOT COMPLETED|Overall Study||0
225032|NCT00839982|549066|P3|NOT COMPLETED|Overall Study||0
225033|NCT00839982|549067|P2|NOT COMPLETED|Overall Study||0
225034|NCT00839982|549068|P1|NOT COMPLETED|Overall Study||0
225035|NCT00839982|549065|P4|COMPLETED|Overall Study||3
225036|NCT00839982|549066|P3|COMPLETED|Overall Study||2
225037|NCT00839982|549067|P2|COMPLETED|Overall Study||26
225038|NCT00839982|549068|P1|COMPLETED|Overall Study||4
225039|NCT00839982|549065|P4|STARTED|Overall Study||3
225040|NCT00839982|549066|P3|STARTED|Overall Study||2
225041|NCT00839982|549067|P2|STARTED|Overall Study||26
225042|NCT00839982|549068|P1|STARTED|Overall Study||4
225043|NCT00840060|549084|P2|NOT COMPLETED|Overall Study||1
225044|NCT00840060|549085|P1|NOT COMPLETED|Overall Study||1
225045|NCT00840060|549084|P2|COMPLETED|Overall Study||19
225046|NCT00840060|549085|P1|COMPLETED|Overall Study||19
225047|NCT00840060|549084|P2|STARTED|Overall Study||20
225048|NCT00840060|549085|P1|STARTED|Overall Study||20
225049|NCT00840073|549095|P2|NOT COMPLETED|Second Intervention||1
225050|NCT00840073|549096|P1|NOT COMPLETED|Second Intervention||1
225051|NCT00840073|549095|P2|COMPLETED|Second Intervention||24
225052|NCT00840073|549096|P1|COMPLETED|Second Intervention||24
225053|NCT00840073|549095|P2|STARTED|Second Intervention||25
225054|NCT00840073|549096|P1|STARTED|Second Intervention||25
225055|NCT00840073|549095|P2|NOT COMPLETED|First Intervention||0
225056|NCT00840073|549096|P1|NOT COMPLETED|First Intervention||0
225057|NCT00840073|549095|P2|COMPLETED|First Intervention||25
225058|NCT00840073|549096|P1|COMPLETED|First Intervention||25
225059|NCT00840073|549095|P2|STARTED|First Intervention||25
225060|NCT00840073|549096|P1|STARTED|First Intervention||25
225061|NCT00840086|549108|P1|NOT COMPLETED|Overall Study||4
225062|NCT00840086|549108|P1|COMPLETED|Overall Study||146
225063|NCT00840086|549108|P1|STARTED|Overall Study||150
225064|NCT00840099|549117|P2|NOT COMPLETED|Period 2||0
225065|NCT00840099|549118|P1|NOT COMPLETED|Period 2||0
225066|NCT00840099|549117|P2|COMPLETED|Period 2||24
225067|NCT00840099|549118|P1|COMPLETED|Period 2||21
225068|NCT00840099|549117|P2|STARTED|Period 2||24
225069|NCT00840099|549118|P1|STARTED|Period 2|3 subjects were dismissed from study prior to period 2 dosing|21
225070|NCT00840099|549117|P2|NOT COMPLETED|Period 1||0
225071|NCT00840099|549118|P1|NOT COMPLETED|Period 1||0
225072|NCT00840099|549117|P2|COMPLETED|Period 1||24
225073|NCT00840099|549118|P1|COMPLETED|Period 1||24
225074|NCT00840099|549117|P2|STARTED|Period 1||24
225075|NCT00840099|549118|P1|STARTED|Period 1||24
225076|NCT00840203|549134|P2|NOT COMPLETED|Second Intervention||0
225077|NCT00840203|549135|P1|NOT COMPLETED|Second Intervention||0
225078|NCT00840203|549134|P2|COMPLETED|Second Intervention||34
225079|NCT00840203|549135|P1|COMPLETED|Second Intervention||35
225080|NCT00840203|549134|P2|STARTED|Second Intervention||34
225081|NCT00840203|549135|P1|STARTED|Second Intervention||35
225082|NCT00840203|549134|P2|NOT COMPLETED|Washout||0
225083|NCT00840203|549135|P1|NOT COMPLETED|Washout||1
225084|NCT00840203|549134|P2|COMPLETED|Washout||34
225085|NCT00840203|549135|P1|COMPLETED|Washout||35
225086|NCT00840203|549134|P2|STARTED|Washout||34
225087|NCT00840203|549135|P1|STARTED|Washout||36
225088|NCT00840203|549134|P2|NOT COMPLETED|First Intervention||1
225089|NCT00840203|549135|P1|NOT COMPLETED|First Intervention||1
225090|NCT00840203|549134|P2|COMPLETED|First Intervention||34
225091|NCT00840203|549135|P1|COMPLETED|First Intervention||36
225092|NCT00840203|549134|P2|STARTED|First Intervention||35
225093|NCT00840203|549135|P1|STARTED|First Intervention||37
225094|NCT00840216|549151|P2|NOT COMPLETED|Second Intervention||0
225095|NCT00840216|549152|P1|NOT COMPLETED|Second Intervention||0
225096|NCT00840216|549151|P2|COMPLETED|Second Intervention||11
225097|NCT00840216|549152|P1|COMPLETED|Second Intervention||10
225098|NCT00840216|549151|P2|STARTED|Second Intervention||11
225099|NCT00840216|549152|P1|STARTED|Second Intervention||10
225100|NCT00840216|549151|P2|NOT COMPLETED|Washout: 7 Days||0
225101|NCT00840216|549152|P1|NOT COMPLETED|Washout: 7 Days||1
225102|NCT00840216|549151|P2|COMPLETED|Washout: 7 Days||11
225103|NCT00840216|549152|P1|COMPLETED|Washout: 7 Days||10
225104|NCT00840216|549151|P2|STARTED|Washout: 7 Days||11
225105|NCT00840216|549152|P1|STARTED|Washout: 7 Days||11
225106|NCT00840216|549151|P2|NOT COMPLETED|First Intervention||0
225107|NCT00840216|549152|P1|NOT COMPLETED|First Intervention||0
225108|NCT00840216|549151|P2|COMPLETED|First Intervention||11
225109|NCT00840216|549152|P1|COMPLETED|First Intervention||11
225110|NCT00840216|549151|P2|STARTED|First Intervention||11
225111|NCT00840216|549152|P1|STARTED|First Intervention||11
225112|NCT00840281|549162|P2|NOT COMPLETED|Second Intervention||0
225113|NCT00840281|549163|P1|NOT COMPLETED|Second Intervention||0
225114|NCT00840281|549162|P2|COMPLETED|Second Intervention||19
225115|NCT00840281|549163|P1|COMPLETED|Second Intervention||19
225116|NCT00840281|549162|P2|STARTED|Second Intervention||19
225117|NCT00840281|549163|P1|STARTED|Second Intervention||19
225118|NCT00840281|549162|P2|NOT COMPLETED|Washout of 7 Days||0
225119|NCT00840281|549163|P1|NOT COMPLETED|Washout of 7 Days||0
225120|NCT00840281|549162|P2|COMPLETED|Washout of 7 Days||19
225121|NCT00840281|549163|P1|COMPLETED|Washout of 7 Days||19
225122|NCT00840281|549162|P2|STARTED|Washout of 7 Days||19
225123|NCT00840281|549163|P1|STARTED|Washout of 7 Days||19
225124|NCT00840281|549162|P2|NOT COMPLETED|First Intervention||0
225125|NCT00840281|549163|P1|NOT COMPLETED|First Intervention||0
225126|NCT00840281|549162|P2|COMPLETED|First Intervention||19
225127|NCT00840281|549163|P1|COMPLETED|First Intervention||19
225128|NCT00840281|549162|P2|STARTED|First Intervention||19
225129|NCT00840281|549163|P1|STARTED|First Intervention||19
225130|NCT00840294|549173|P2|NOT COMPLETED|Overall Study||5
225131|NCT00840294|549174|P1|NOT COMPLETED|Overall Study||3
225132|NCT00840294|549173|P2|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|38
225133|NCT00840294|549174|P1|COMPLETED|Overall Study|These are the subjects included in the baseline, outcomes, and adverse events tables|39
225134|NCT00840294|549173|P2|STARTED|Overall Study||43
225135|NCT00840294|549174|P1|STARTED|Overall Study||42
225136|NCT00840411|549184|P2|NOT COMPLETED|Second Intervention||0
225137|NCT00840411|549185|P1|NOT COMPLETED|Second Intervention||0
225138|NCT00840411|549184|P2|COMPLETED|Second Intervention||33
225139|NCT00840411|549185|P1|COMPLETED|Second Intervention||31
225140|NCT00840411|549184|P2|STARTED|Second Intervention||33
225141|NCT00840411|549185|P1|STARTED|Second Intervention||31
225142|NCT00840411|549184|P2|NOT COMPLETED|Washout||0
225143|NCT00840411|549185|P1|NOT COMPLETED|Washout||1
225144|NCT00840411|549184|P2|COMPLETED|Washout||33
225145|NCT00840411|549185|P1|COMPLETED|Washout||31
225146|NCT00840411|549184|P2|STARTED|Washout||33
225147|NCT00840411|549185|P1|STARTED|Washout||32
225148|NCT00840411|549184|P2|NOT COMPLETED|First Intervention||0
225149|NCT00840411|549185|P1|NOT COMPLETED|First Intervention||1
225150|NCT00840411|549184|P2|COMPLETED|First Intervention||33
225151|NCT00840411|549185|P1|COMPLETED|First Intervention||32
225152|NCT00840411|549184|P2|STARTED|First Intervention||33
225153|NCT00840411|549185|P1|STARTED|First Intervention||33
225154|NCT00840450|549193|P1|NOT COMPLETED|Overall Study||3
225155|NCT00840450|549193|P1|COMPLETED|Overall Study||9
225156|NCT00840450|549193|P1|STARTED|Overall Study||12
225157|NCT00840476|549201|P2|NOT COMPLETED|Second Intervention||0
225158|NCT00840476|549202|P1|NOT COMPLETED|Second Intervention||0
225159|NCT00840476|549201|P2|COMPLETED|Second Intervention||14
225160|NCT00840476|549202|P1|COMPLETED|Second Intervention||14
225161|NCT00840476|549201|P2|STARTED|Second Intervention||14
225162|NCT00840476|549202|P1|STARTED|Second Intervention||14
225163|NCT00840476|549201|P2|NOT COMPLETED|Washout: 14 Days||0
225164|NCT00840476|549202|P1|NOT COMPLETED|Washout: 14 Days||0
225165|NCT00840476|549201|P2|COMPLETED|Washout: 14 Days||14
225166|NCT00840476|549202|P1|COMPLETED|Washout: 14 Days||14
225167|NCT00840476|549201|P2|STARTED|Washout: 14 Days||14
225168|NCT00840476|549202|P1|STARTED|Washout: 14 Days||14
225169|NCT00840476|549201|P2|NOT COMPLETED|First Intervention||0
225170|NCT00840476|549202|P1|NOT COMPLETED|First Intervention||0
225171|NCT00840476|549201|P2|COMPLETED|First Intervention||14
225172|NCT00840476|549202|P1|COMPLETED|First Intervention||14
225173|NCT00840476|549201|P2|STARTED|First Intervention||14
225174|NCT00840476|549202|P1|STARTED|First Intervention||14
225175|NCT00845845|549212|P2|NOT COMPLETED|Overall Study||4
225176|NCT00845845|549213|P1|NOT COMPLETED|Overall Study||0
225177|NCT00845845|549212|P2|COMPLETED|Overall Study||2
225178|NCT00845845|549213|P1|COMPLETED|Overall Study||3
225179|NCT00845845|549212|P2|STARTED|Overall Study||6
225180|NCT00845845|549213|P1|STARTED|Overall Study||3
225181|NCT00845858|549224|P3|NOT COMPLETED|Overall Study||8
225182|NCT00845858|549225|P2|NOT COMPLETED|Overall Study||12
225183|NCT00845858|549226|P1|NOT COMPLETED|Overall Study||8
225184|NCT00845858|549224|P3|COMPLETED|Overall Study||87
225185|NCT00845858|549225|P2|COMPLETED|Overall Study||84
225186|NCT00845858|549226|P1|COMPLETED|Overall Study||88
225187|NCT00845858|549224|P3|STARTED|Overall Study||95
225282|NCT00853762|549654|P4|COMPLETED|Overall Study||0
225188|NCT00845858|549225|P2|STARTED|Overall Study|"95 subjects received allocated intervention.
1 subject was not eligible and was not dosed."|96
225189|NCT00845858|549226|P1|STARTED|Overall Study|"95 subjects received allocated intervention.
1 subject withdrew consent and was not dosed."|96
225190|NCT00845897|549240|P3|NOT COMPLETED|Overall Study||3
225191|NCT00845897|549241|P2|NOT COMPLETED|Overall Study||5
225192|NCT00845897|549242|P1|NOT COMPLETED|Overall Study||2
225193|NCT00845897|549240|P3|COMPLETED|Overall Study||2
225194|NCT00845897|549241|P2|COMPLETED|Overall Study||2
225195|NCT00845897|549242|P1|COMPLETED|Overall Study||3
225196|NCT00845897|549240|P3|STARTED|Overall Study||5
225197|NCT00845897|549241|P2|STARTED|Overall Study||7
225198|NCT00845897|549242|P1|STARTED|Overall Study||5
225199|NCT00852124|549255|P2|NOT COMPLETED|Overall Study||0
225200|NCT00852124|549256|P1|NOT COMPLETED|Overall Study||0
225201|NCT00852124|549255|P2|COMPLETED|Overall Study||0
225202|NCT00852124|549256|P1|COMPLETED|Overall Study||3
225203|NCT00852124|549255|P2|STARTED|Overall Study||0
225204|NCT00852124|549256|P1|STARTED|Overall Study||3
225205|NCT00852137|549263|P2|NOT COMPLETED|Overall Study||0
225206|NCT00852137|549264|P1|NOT COMPLETED|Overall Study||0
225207|NCT00852137|549263|P2|COMPLETED|Overall Study||3
225208|NCT00852137|549264|P1|COMPLETED|Overall Study||13
225209|NCT00852137|549263|P2|STARTED|Overall Study||3
225210|NCT00852137|549264|P1|STARTED|Overall Study||13
225211|NCT00853333|549287|P3|NOT COMPLETED|Overall Study||0
225212|NCT00853333|549288|P2|NOT COMPLETED|Overall Study||0
225213|NCT00853333|549289|P1|NOT COMPLETED|Overall Study||0
225214|NCT00853333|549287|P3|COMPLETED|Overall Study||31
225215|NCT00853333|549288|P2|COMPLETED|Overall Study||27
225216|NCT00853333|549289|P1|COMPLETED|Overall Study||28
225217|NCT00853333|549287|P3|STARTED|Overall Study||31
225218|NCT00853333|549288|P2|STARTED|Overall Study||27
225219|NCT00853333|549289|P1|STARTED|Overall Study||28
225220|NCT00853385|549302|P5|NOT COMPLETED|Overall Study||42
225221|NCT00853385|549303|P4|NOT COMPLETED|Overall Study||13
225222|NCT00853385|549304|P3|NOT COMPLETED|Overall Study||9
225223|NCT00853385|549305|P2|NOT COMPLETED|Overall Study||43
225224|NCT00853385|549306|P1|NOT COMPLETED|Overall Study||54
225225|NCT00853385|549302|P5|COMPLETED|Overall Study||162
225226|NCT00853385|549303|P4|COMPLETED|Overall Study||39
225227|NCT00853385|549304|P3|COMPLETED|Overall Study||47
225228|NCT00853385|549305|P2|COMPLETED|Overall Study||158
225229|NCT00853385|549306|P1|COMPLETED|Overall Study||150
225230|NCT00853385|549302|P5|STARTED|Overall Study||204
225231|NCT00853385|549303|P4|STARTED|Overall Study||52
225232|NCT00853385|549304|P3|STARTED|Overall Study||56
225233|NCT00853385|549305|P2|STARTED|Overall Study||201
225234|NCT00853385|549306|P1|STARTED|Overall Study||204
225235|NCT00853567|549522|P1|NOT COMPLETED|Overall Study||71
225236|NCT00853567|549522|P1|COMPLETED|Overall Study||0
225237|NCT00853567|549522|P1|STARTED|Overall Study||71
225238|NCT00853593|549530|P1|NOT COMPLETED|Overall Study||45
225239|NCT00853593|549530|P1|COMPLETED|Overall Study||152
225240|NCT00853593|549530|P1|Model 4396 Lead Attempted|Overall Study||164
225241|NCT00853593|549530|P1|Implant Attempted|Overall Study||193
225242|NCT00853593|549530|P1|STARTED|Overall Study||197
225243|NCT00853606|549555|P1|NOT COMPLETED|Overall Study||220
225244|NCT00853606|549555|P1|COMPLETED|Overall Study||492
225245|NCT00853606|549555|P1|STARTED|Overall Study||712
225246|NCT00853658|549564|P3|NOT COMPLETED|Overall Study||815
225247|NCT00853658|549565|P2|NOT COMPLETED|Overall Study||832
225248|NCT00853658|549566|P1|NOT COMPLETED|Overall Study||787
225249|NCT00853658|549564|P3|COMPLETED|Overall Study||1539
225250|NCT00853658|549565|P2|COMPLETED|Overall Study||1524
225251|NCT00853658|549566|P1|COMPLETED|Overall Study||1567
225252|NCT00853658|549564|P3|Safety Set|Overall Study||2345
225253|NCT00853658|549565|P2|Safety Set|Overall Study||2348
225254|NCT00853658|549566|P1|Safety Set|Overall Study||2347
225255|NCT00853658|549564|P3|Full Analysis Set (FAS)|Overall Study||2336
225256|NCT00853658|549565|P2|Full Analysis Set (FAS)|Overall Study||2340
225257|NCT00853658|549566|P1|Full Analysis Set (FAS)|Overall Study||2340
225258|NCT00853658|549564|P3|STARTED|Overall Study||2354
225259|NCT00853658|549565|P2|STARTED|Overall Study||2356
225260|NCT00853658|549566|P1|STARTED|Overall Study||2354
225261|NCT00853723|549583|P3|NOT COMPLETED|Overall Study||2
225262|NCT00853723|549584|P2|NOT COMPLETED|Overall Study||7
225263|NCT00853723|549585|P1|NOT COMPLETED|Overall Study||6
225264|NCT00853723|549583|P3|COMPLETED|Overall Study||33
225265|NCT00853723|549584|P2|COMPLETED|Overall Study||28
225266|NCT00853723|549585|P1|COMPLETED|Overall Study||29
225267|NCT00853723|549583|P3|STARTED|Overall Study||35
225268|NCT00853723|549584|P2|STARTED|Overall Study||35
225269|NCT00853723|549585|P1|STARTED|Overall Study||35
225270|NCT00853749|549631|P2|NOT COMPLETED|Overall Study||1
225271|NCT00853749|549632|P1|NOT COMPLETED|Overall Study||0
225272|NCT00853749|549631|P2|COMPLETED|Overall Study||38
225273|NCT00853749|549632|P1|COMPLETED|Overall Study||50
225274|NCT00853749|549631|P2|Vaccinated|Overall Study||39
225275|NCT00853749|549632|P1|Vaccinated|Overall Study||50
225276|NCT00853749|549631|P2|STARTED|Overall Study||39
225277|NCT00853749|549632|P1|STARTED|Overall Study||50
225278|NCT00853762|549654|P4|NOT COMPLETED|Overall Study||22
225279|NCT00853762|549655|P3|NOT COMPLETED|Overall Study||17
225280|NCT00853762|549656|P2|NOT COMPLETED|Overall Study||19
225281|NCT00853762|549657|P1|NOT COMPLETED|Overall Study||16
225283|NCT00853762|549655|P3|COMPLETED|Overall Study||0
225284|NCT00853762|549656|P2|COMPLETED|Overall Study||0
225285|NCT00853762|549657|P1|COMPLETED|Overall Study||0
225286|NCT00853762|549654|P4|STARTED|Overall Study||22
225287|NCT00853762|549655|P3|STARTED|Overall Study||17
225288|NCT00853762|549656|P2|STARTED|Overall Study||19
225289|NCT00853762|549657|P1|STARTED|Overall Study||16
225290|NCT00853827|549725|P2|NOT COMPLETED|Double Blind Period (103 Weeks)||109
225291|NCT00853827|549726|P1|NOT COMPLETED|Double Blind Period (103 Weeks)||104
225292|NCT00853827|549725|P2|COMPLETED|Double Blind Period (103 Weeks)||199
225293|NCT00853827|549726|P1|COMPLETED|Double Blind Period (103 Weeks)||201
225294|NCT00853827|549725|P2|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||233
225295|NCT00853827|549726|P1|Modified Full Analysis Set (mFAS)|Double Blind Period (103 Weeks)||225
225296|NCT00853827|549725|P2|STARTED|Double Blind Period (103 Weeks)||308
225297|NCT00853827|549726|P1|STARTED|Double Blind Period (103 Weeks)|"Started indicates number of patients in randomized set, full analysis set (FAS) and safety set."|305
225298|NCT00853827|549725|P2|NOT COMPLETED|Single Blind Period (1 Week)||0
225299|NCT00853827|549726|P1|NOT COMPLETED|Single Blind Period (1 Week)||39
225300|NCT00853827|549725|P2|COMPLETED|Single Blind Period (1 Week)||0
225301|NCT00853827|549726|P1|COMPLETED|Single Blind Period (1 Week)|Completed patients in single blind period|613
225302|NCT00853827|549725|P2|STARTED|Single Blind Period (1 Week)|This arm was only used in double blind period|0
225303|NCT00853827|549726|P1|STARTED|Single Blind Period (1 Week)|Enrolled patients in single blind|652
225304|NCT00853840|549738|P2|NOT COMPLETED|Period 2||0
225305|NCT00853840|549739|P1|NOT COMPLETED|Period 2||0
225306|NCT00853840|549738|P2|COMPLETED|Period 2||9
225307|NCT00853840|549739|P1|COMPLETED|Period 2||9
225308|NCT00853840|549738|P2|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
225309|NCT00853840|549739|P1|Vardenafil or Placebo (Day 3)|Period 2|Administered 1 hour post Maraviroc dosing|9
225310|NCT00853840|549738|P2|Maraviroc (Days 1 - 3)|Period 2||9
225311|NCT00853840|549739|P1|Maraviroc (Days 1 - 3)|Period 2||9
225312|NCT00853840|549738|P2|STARTED|Period 2||9
225313|NCT00853840|549739|P1|STARTED|Period 2||9
225314|NCT00853840|549738|P2|NOT COMPLETED|Period 1||0
225315|NCT00853840|549739|P1|NOT COMPLETED|Period 1||0
225316|NCT00853840|549738|P2|COMPLETED|Period 1||9
225317|NCT00853840|549739|P1|COMPLETED|Period 1||9
225318|NCT00853840|549738|P2|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
225319|NCT00853840|549739|P1|Vardenafil or Placebo (Day 4)|Period 1|Administered 1 hour post Maraviroc dosing|9
225320|NCT00853840|549738|P2|Maraviroc (Days 1 - 4)|Period 1||9
225321|NCT00853840|549739|P1|Maraviroc (Days 1 - 4)|Period 1||9
225322|NCT00853840|549738|P2|STARTED|Period 1||9
225323|NCT00853840|549739|P1|STARTED|Period 1||9
225324|NCT00853905|549756|P2|NOT COMPLETED|Overall Study||4
225325|NCT00853905|549757|P1|NOT COMPLETED|Overall Study||2
225326|NCT00853905|549756|P2|COMPLETED|Overall Study||36
225327|NCT00853905|549757|P1|COMPLETED|Overall Study||35
225328|NCT00853905|549756|P2|STARTED|Overall Study||40
225329|NCT00853905|549757|P1|STARTED|Overall Study||37
225330|NCT00853957|549765|P2|NOT COMPLETED|Overall Study||19
225331|NCT00853957|549766|P1|NOT COMPLETED|Overall Study||14
225332|NCT00853957|549765|P2|COMPLETED|Overall Study||204
225333|NCT00853957|549766|P1|COMPLETED|Overall Study||206
225334|NCT00853957|549765|P2|STARTED|Overall Study||223
225335|NCT00853957|549766|P1|STARTED|Overall Study||220
225336|NCT00853970|549784|P2|NOT COMPLETED|Overall Study||3
225337|NCT00853970|549785|P1|NOT COMPLETED|Overall Study||6
225338|NCT00853970|549784|P2|COMPLETED|Overall Study||144
225339|NCT00853970|549785|P1|COMPLETED|Overall Study||146
225340|NCT00853970|549784|P2|STARTED|Overall Study||147
225341|NCT00853970|549785|P1|STARTED|Overall Study||152
225342|NCT00853996|549793|P1|NOT COMPLETED|Overall Study||0
225343|NCT00853996|549793|P1|COMPLETED|Overall Study||25
225344|NCT00853996|549793|P1|STARTED|Overall Study||25
225345|NCT00854087|549805|P2|NOT COMPLETED|Overall Study||19
225346|NCT00854087|549806|P1|NOT COMPLETED|Overall Study||19
225347|NCT00854087|549805|P2|COMPLETED|Overall Study||40
225348|NCT00854087|549806|P1|COMPLETED|Overall Study||40
225349|NCT00854087|549805|P2|STARTED|Overall Study||59
225350|NCT00854087|549806|P1|STARTED|Overall Study||59
225351|NCT00854113|549823|P11|NOT COMPLETED|Overall Study||0
225352|NCT00854113|549824|P10|NOT COMPLETED|Overall Study||0
225353|NCT00854113|549825|P9|NOT COMPLETED|Overall Study||1
225354|NCT00854113|549826|P8|NOT COMPLETED|Overall Study||3
225355|NCT00854113|549827|P7|NOT COMPLETED|Overall Study||0
225356|NCT00854113|549828|P6|NOT COMPLETED|Overall Study||0
225357|NCT00854113|549829|P5|NOT COMPLETED|Overall Study||0
225358|NCT00854113|549830|P4|NOT COMPLETED|Overall Study||0
225359|NCT00854113|549831|P3|NOT COMPLETED|Overall Study||0
225360|NCT00854113|549832|P2|NOT COMPLETED|Overall Study||0
225361|NCT00854113|549833|P1|NOT COMPLETED|Overall Study||0
225362|NCT00854113|549823|P11|COMPLETED|Overall Study||6
225363|NCT00854113|549824|P10|COMPLETED|Overall Study||8
225364|NCT00854113|549825|P9|COMPLETED|Overall Study||7
225365|NCT00854113|549826|P8|COMPLETED|Overall Study||5
225366|NCT00854113|549827|P7|COMPLETED|Overall Study||12
225367|NCT00854113|549828|P6|COMPLETED|Overall Study||6
225368|NCT00854113|549829|P5|COMPLETED|Overall Study||6
225369|NCT00854113|549830|P4|COMPLETED|Overall Study||6
225370|NCT00854113|549831|P3|COMPLETED|Overall Study||6
225371|NCT00854113|549832|P2|COMPLETED|Overall Study||6
225372|NCT00854113|549833|P1|COMPLETED|Overall Study||6
225373|NCT00854113|549823|P11|STARTED|Overall Study||6
225374|NCT00854113|549824|P10|STARTED|Overall Study||8
225375|NCT00854113|549825|P9|STARTED|Overall Study||8
225376|NCT00854113|549826|P8|STARTED|Overall Study||8
225377|NCT00854113|549827|P7|STARTED|Overall Study||12
225378|NCT00854113|549828|P6|STARTED|Overall Study||6
225379|NCT00854113|549829|P5|STARTED|Overall Study||6
225380|NCT00854113|549830|P4|STARTED|Overall Study||6
225381|NCT00854113|549831|P3|STARTED|Overall Study||6
225382|NCT00854113|549832|P2|STARTED|Overall Study||6
225383|NCT00854113|549833|P1|STARTED|Overall Study||6
225384|NCT00854308|549936|P2|NOT COMPLETED|Overall Study||67
225385|NCT00854308|549937|P1|NOT COMPLETED|Overall Study||62
225386|NCT00854308|549936|P2|COMPLETED|Overall Study||1
225387|NCT00854308|549937|P1|COMPLETED|Overall Study|Completed participants in both arms were still receiving study drug when analyses were performed.|7
225388|NCT00854308|549936|P2|Received Study Drug|Overall Study||67
225389|NCT00854308|549937|P1|Received Study Drug|Overall Study||69
225390|NCT00854308|549936|P2|STARTED|Overall Study||68
225391|NCT00854308|549937|P1|STARTED|Overall Study||69
225392|NCT00854360|549955|P4|NOT COMPLETED|Overall Study||10
225393|NCT00854360|549956|P3|NOT COMPLETED|Overall Study||2
225394|NCT00854360|549957|P2|NOT COMPLETED|Overall Study||3
225395|NCT00854360|549958|P1|NOT COMPLETED|Overall Study||2
225396|NCT00854360|549955|P4|COMPLETED|Overall Study||114
225397|NCT00854360|549956|P3|COMPLETED|Overall Study||120
225398|NCT00854360|549957|P2|COMPLETED|Overall Study|One patient discontinued due to both an AE and study medication discontinuation.|120
225399|NCT00854360|549958|P1|COMPLETED|Overall Study||116
225400|NCT00854360|549955|P4|Intent to Treat / Safety Population|Overall Study|One patient did not receive any double-blind study medication.|123
225401|NCT00854360|549956|P3|Intent to Treat / Safety Population|Overall Study||122
225402|NCT00854360|549957|P2|Intent to Treat / Safety Population|Overall Study||123
225403|NCT00854360|549958|P1|Intent to Treat / Safety Population|Overall Study||118
225404|NCT00854360|549955|P4|STARTED|Overall Study||124
225405|NCT00854360|549956|P3|STARTED|Overall Study||122
225406|NCT00854360|549957|P2|STARTED|Overall Study||123
225407|NCT00854360|549958|P1|STARTED|Overall Study||118
225408|NCT00854373|549990|P2|NOT COMPLETED|Overall Study||4
225409|NCT00854373|549991|P1|NOT COMPLETED|Overall Study||2
225410|NCT00854373|549990|P2|COMPLETED|Overall Study||89
225411|NCT00854373|549991|P1|COMPLETED|Overall Study||93
225412|NCT00854373|549990|P2|STARTED|Overall Study||93
225413|NCT00854373|549991|P1|STARTED|Overall Study||95
225414|NCT00854581|550001|P1|NOT COMPLETED|Overall Study||2
225415|NCT00854581|550001|P1|COMPLETED|Overall Study||11
225416|NCT00854581|550001|P1|STARTED|Overall Study||13
225417|NCT00854594|550008|P2|NOT COMPLETED|Overall Study||0
225418|NCT00854594|550009|P1|NOT COMPLETED|Overall Study||0
225419|NCT00854594|550008|P2|COMPLETED|Overall Study||69
225420|NCT00854594|550009|P1|COMPLETED|Overall Study||48
225421|NCT00854594|550008|P2|STARTED|Overall Study|9 sites randomized to intervention, providers completed surveys before and/or after study period|69
225422|NCT00854594|550009|P1|STARTED|Overall Study|9 sites randomized to control arm, providers completed surveys before and/or after study period|48
225423|NCT00854607|550021|P1|NOT COMPLETED|2 Weeks After Start Anti-fungal Therapy||65
225424|NCT00854607|550021|P1|COMPLETED|2 Weeks After Start Anti-fungal Therapy||51
225425|NCT00854607|550021|P1|STARTED|2 Weeks After Start Anti-fungal Therapy||116
225426|NCT00854607|550021|P1|NOT COMPLETED|Enrollment||0
225427|NCT00854607|550021|P1|COMPLETED|Enrollment||116
225428|NCT00854607|550021|P1|STARTED|Enrollment||116
225429|NCT00854620|550054|P1|NOT COMPLETED|Overall Study||1
225430|NCT00854620|550054|P1|COMPLETED|Overall Study||8
225431|NCT00854620|550054|P1|STARTED|Overall Study||9
225432|NCT00854724|550060|P2|NOT COMPLETED|Second Intervention||1
225433|NCT00854724|550061|P1|NOT COMPLETED|Second Intervention||1
225434|NCT00854724|550060|P2|COMPLETED|Second Intervention||5
225435|NCT00854724|550061|P1|COMPLETED|Second Intervention||5
225436|NCT00854724|550060|P2|STARTED|Second Intervention||6
225437|NCT00854724|550061|P1|STARTED|Second Intervention||6
225438|NCT00854724|550060|P2|NOT COMPLETED|Washout||1
225439|NCT00854724|550061|P1|NOT COMPLETED|Washout||1
225440|NCT00854724|550060|P2|COMPLETED|Washout||6
225441|NCT00854724|550061|P1|COMPLETED|Washout||6
225442|NCT00854724|550060|P2|STARTED|Washout||7
225443|NCT00854724|550061|P1|STARTED|Washout||7
225444|NCT00854724|550060|P2|NOT COMPLETED|First Intervention||1
225445|NCT00854724|550061|P1|NOT COMPLETED|First Intervention||1
225446|NCT00854724|550060|P2|COMPLETED|First Intervention||7
225447|NCT00854724|550061|P1|COMPLETED|First Intervention||7
225448|NCT00854724|550060|P2|STARTED|First Intervention||8
225449|NCT00854724|550061|P1|STARTED|First Intervention||8
225450|NCT00854906|550067|P1|NOT COMPLETED|Overall Study||1
225451|NCT00854906|550067|P1|COMPLETED|Overall Study|There were 26 participants in this group. One person was excluded be causes of no ocular history.|25
225452|NCT00854906|550067|P1|STARTED|Overall Study|There were 26 participants whose eyes were measured in the KTBUT group.|26
225453|NCT00855062|550076|P2|NOT COMPLETED|Step2||6
225454|NCT00855062|550077|P1|NOT COMPLETED|Step2||6
225455|NCT00855062|550076|P2|COMPLETED|Step2||15
225456|NCT00855062|550077|P1|COMPLETED|Step2||13
225715|NCT00856492|550859|P2|NOT COMPLETED|Overall Study||1
225457|NCT00855062|550076|P2|STARTED|Step2|26 participants completed STEP1; however, only 21 out of the 26 decided to enroll in STEP2.|21
225458|NCT00855062|550077|P1|STARTED|Step2|26 participants completed STEP1; however, only 19 out of the 26 decided to enroll in STEP2.|19
225459|NCT00855062|550076|P2|NOT COMPLETED|Step1||11
225460|NCT00855062|550077|P1|NOT COMPLETED|Step1||10
225461|NCT00855062|550076|P2|COMPLETED|Step1||26
225462|NCT00855062|550077|P1|COMPLETED|Step1||26
225463|NCT00855062|550076|P2|STARTED|Step1||37
225464|NCT00855062|550077|P1|STARTED|Step1||36
225465|NCT00855166|550103|P2|NOT COMPLETED|Overall Study||8
225466|NCT00855166|550104|P1|NOT COMPLETED|Overall Study||5
225467|NCT00855166|550103|P2|COMPLETED|Overall Study||83
225468|NCT00855166|550104|P1|COMPLETED|Overall Study||86
225469|NCT00855166|550103|P2|STARTED|Overall Study|Of the 91 randomized participants only 89 were included in the full analysis set.|91
225470|NCT00855166|550104|P1|STARTED|Overall Study||91
225471|NCT00855218|550124|P2|NOT COMPLETED|Overall Study||153
225472|NCT00855218|550125|P1|NOT COMPLETED|Overall Study||154
225473|NCT00855218|550124|P2|COMPLETED|Overall Study||0
225474|NCT00855218|550125|P1|COMPLETED|Overall Study||0
225475|NCT00855218|550124|P2|Participants Received Treatment|Overall Study||151
225476|NCT00855218|550125|P1|Participants Received Treatment|Overall Study||153
225477|NCT00855218|550124|P2|STARTED|Overall Study||153
225478|NCT00855218|550125|P1|STARTED|Overall Study||154
225479|NCT00855309|550143|P2|NOT COMPLETED|Overall Study||0
225480|NCT00855309|550144|P1|NOT COMPLETED|Overall Study||1
225481|NCT00855309|550143|P2|COMPLETED|Overall Study||55
225482|NCT00855309|550144|P1|COMPLETED|Overall Study||56
225483|NCT00855309|550143|P2|STARTED|Overall Study||55
225484|NCT00855309|550144|P1|STARTED|Overall Study||57
225485|NCT00855439|550152|P2|NOT COMPLETED|Overall Study||0
225486|NCT00855439|550153|P1|NOT COMPLETED|Overall Study||3
225487|NCT00855439|550152|P2|COMPLETED|Overall Study||24
225488|NCT00855439|550153|P1|COMPLETED|Overall Study||19
225489|NCT00855439|550152|P2|STARTED|Overall Study||24
225490|NCT00855439|550153|P1|STARTED|Overall Study||22
225491|NCT00855465|550167|P2|NOT COMPLETED|Follow-up Period (FUP)||2
225492|NCT00855465|550168|P1|NOT COMPLETED|Follow-up Period (FUP)||8
225493|NCT00855465|550167|P2|COMPLETED|Follow-up Period (FUP)||2
225494|NCT00855465|550168|P1|COMPLETED|Follow-up Period (FUP)||9
225495|NCT00855465|550167|P2|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|4
225496|NCT00855465|550168|P1|STARTED|Follow-up Period (FUP)|Started FUP only if prematurely withdrawn from trt period or if not entering LTE study.|17
225497|NCT00855465|550167|P2|NOT COMPLETED|Treatment Period||5
225498|NCT00855465|550168|P1|NOT COMPLETED|Treatment Period||14
225499|NCT00855465|550167|P2|COMPLETED|Treatment Period||83
225500|NCT00855465|550168|P1|COMPLETED|Treatment Period||160
225501|NCT00855465|550167|P2|Participants Received Treatment|Treatment Period||88
225502|NCT00855465|550168|P1|Participants Received Treatment|Treatment Period|1 subject randomized but not treated|173
225503|NCT00855465|550167|P2|STARTED|Treatment Period||88
225504|NCT00855465|550168|P1|STARTED|Treatment Period||174
225505|NCT00855582|550259|P3|NOT COMPLETED|Overall Study||30
225506|NCT00855582|550260|P2|NOT COMPLETED|Overall Study||24
225507|NCT00855582|550261|P1|NOT COMPLETED|Overall Study||26
225508|NCT00855582|550259|P3|COMPLETED|Overall Study||170
225509|NCT00855582|550260|P2|COMPLETED|Overall Study||184
225510|NCT00855582|550261|P1|COMPLETED|Overall Study||172
225511|NCT00855582|550259|P3|STARTED|Overall Study||200
225512|NCT00855582|550260|P2|STARTED|Overall Study||208
225513|NCT00855582|550261|P1|STARTED|Overall Study||198
225514|NCT00855595|550350|P2|NOT COMPLETED|Overall Study||7
225515|NCT00855595|550351|P1|NOT COMPLETED|Overall Study||6
225516|NCT00855595|550350|P2|COMPLETED|Overall Study||94
225517|NCT00855595|550351|P1|COMPLETED|Overall Study||100
225518|NCT00855595|550350|P2|STARTED|Overall Study||101
225519|NCT00855595|550351|P1|STARTED|Overall Study||106
225520|NCT00855738|550387|P1|NOT COMPLETED|Overall Study||5
225521|NCT00855738|550387|P1|COMPLETED|Overall Study||106
225522|NCT00855738|550387|P1|At Least 1 Dose and 1 Endpoint|Overall Study|Received at least 1 dose of study drug and had data for at least 1 efficacy endpoint.|108
225523|NCT00855738|550387|P1|STARTED|Overall Study||111
225524|NCT00848926|550413|P1|NOT COMPLETED|Follow-up Period||12
225525|NCT00848926|550413|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [57] or study termination by sponsor [33]|90
225526|NCT00848926|550413|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|102
225527|NCT00848926|550413|P1|NOT COMPLETED|Treatment Period||84
225528|NCT00848926|550413|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|18
225529|NCT00848926|550413|P1|STARTED|Treatment Period||102
225530|NCT00848965|550429|P1|NOT COMPLETED|Overall Study||2
225531|NCT00848965|550429|P1|COMPLETED|Overall Study||57
225532|NCT00848965|550429|P1|STARTED|Overall Study||59
225533|NCT00849017|550474|P3|NOT COMPLETED|Follow-up Period (8 Weeks)||25
225534|NCT00849017|550475|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||18
225535|NCT00849017|550476|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||25
225536|NCT00849017|550474|P3|COMPLETED|Follow-up Period (8 Weeks)||74
225537|NCT00849017|550475|P2|COMPLETED|Follow-up Period (8 Weeks)||83
225538|NCT00849017|550476|P1|COMPLETED|Follow-up Period (8 Weeks)||76
225539|NCT00849017|550474|P3|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|99
225716|NCT00856492|550860|P1|NOT COMPLETED|Overall Study||1
225540|NCT00849017|550475|P2|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
225541|NCT00849017|550476|P1|STARTED|Follow-up Period (8 Weeks)|Participants withdrawing from the Treatment Period entered the Follow-up Period.|101
225542|NCT00849017|550474|P3|NOT COMPLETED|Treatment Period (156 Weeks)||42
225543|NCT00849017|550475|P2|NOT COMPLETED|Treatment Period (156 Weeks)||33
225544|NCT00849017|550476|P1|NOT COMPLETED|Treatment Period (156 Weeks)||43
225545|NCT00849017|550474|P3|COMPLETED|Treatment Period (156 Weeks)||57
225546|NCT00849017|550475|P2|COMPLETED|Treatment Period (156 Weeks)||68
225547|NCT00849017|550476|P1|COMPLETED|Treatment Period (156 Weeks)||58
225548|NCT00849017|550474|P3|STARTED|Treatment Period (156 Weeks)||99
225549|NCT00849017|550475|P2|STARTED|Treatment Period (156 Weeks)||101
225550|NCT00849017|550476|P1|STARTED|Treatment Period (156 Weeks)||101
225551|NCT00849056|550521|P2|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||25
225552|NCT00849056|550522|P1|NOT COMPLETED|Follow-up Period (FUP) (8 Weeks)||27
225553|NCT00849056|550521|P2|COMPLETED|Follow-up Period (FUP) (8 Weeks)||124
225554|NCT00849056|550522|P1|COMPLETED|Follow-up Period (FUP) (8 Weeks)||122
225555|NCT00849056|550521|P2|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. One par. did not participate in the FUP.|149
225556|NCT00849056|550522|P1|STARTED|Follow-up Period (FUP) (8 Weeks)|Par. withdrawing from the TP could enter the FUP. Two par. did not participate in the FUP.|149
225557|NCT00849056|550521|P2|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||50
225558|NCT00849056|550522|P1|NOT COMPLETED|Treatment Period (TP) (156 Weeks)||63
225559|NCT00849056|550521|P2|COMPLETED|Treatment Period (TP) (156 Weeks)||100
225560|NCT00849056|550522|P1|COMPLETED|Treatment Period (TP) (156 Weeks)||88
225561|NCT00849056|550521|P2|STARTED|Treatment Period (TP) (156 Weeks)||150
225562|NCT00849056|550522|P1|STARTED|Treatment Period (TP) (156 Weeks)||151
225563|NCT00849108|550547|P2|NOT COMPLETED|Cohort 2 Efficacy||10
225564|NCT00849108|550548|P1|NOT COMPLETED|Cohort 2 Efficacy||0
225565|NCT00849108|550547|P2|COMPLETED|Cohort 2 Efficacy||133
225566|NCT00849108|550548|P1|COMPLETED|Cohort 2 Efficacy||0
225567|NCT00849108|550547|P2|STARTED|Cohort 2 Efficacy||143
225656|NCT00856206|550714|P2|COMPLETED|Overall Study||824
225568|NCT00849108|550548|P1|STARTED|Cohort 2 Efficacy|Cohort 1 subjects did not participate in period 2: efficacy|0
225569|NCT00849108|550547|P2|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
225570|NCT00849108|550548|P1|NOT COMPLETED|Cohort 1 Dose Ranging and Dose Interval||1
225571|NCT00849108|550547|P2|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||0
225572|NCT00849108|550548|P1|COMPLETED|Cohort 1 Dose Ranging and Dose Interval||32
225573|NCT00849108|550547|P2|STARTED|Cohort 1 Dose Ranging and Dose Interval|Cohort 2(Pharm Stress) subjects did not participate in dose range, dose frequency|0
225574|NCT00849108|550548|P1|STARTED|Cohort 1 Dose Ranging and Dose Interval||33
225575|NCT00849121|550558|P2|NOT COMPLETED|Overall Study||0
225576|NCT00849121|550559|P1|NOT COMPLETED|Overall Study||0
225577|NCT00849121|550558|P2|COMPLETED|Overall Study||9
225578|NCT00849121|550559|P1|COMPLETED|Overall Study||8
225579|NCT00849121|550558|P2|STARTED|Overall Study||9
225580|NCT00849121|550559|P1|STARTED|Overall Study||8
225581|NCT00849147|550571|P1|NOT COMPLETED|Overall Study||5
225582|NCT00849147|550571|P1|COMPLETED|Overall Study||50
225583|NCT00849147|550571|P1|STARTED|Overall Study||55
225584|NCT00849186|550586|P1|NOT COMPLETED|Overall Study||10
225585|NCT00849186|550586|P1|COMPLETED|Overall Study||16
225586|NCT00849186|550586|P1|STARTED|Overall Study||26
225587|NCT00849212|550592|P1|NOT COMPLETED|Overall Study||7
225588|NCT00849212|550592|P1|COMPLETED|Overall Study||23
225589|NCT00849212|550592|P1|STARTED|Overall Study||30
225590|NCT00849290|550597|P1|NOT COMPLETED|Overall Study||55
225591|NCT00849290|550597|P1|COMPLETED|Overall Study||58
225592|NCT00849290|550597|P1|STARTED|Overall Study||113
225593|NCT00849381|550601|P1|NOT COMPLETED|Overall Study||145
225594|NCT00849381|550601|P1|COMPLETED|Overall Study|Out of the subjects who completed, 167 were enrolled at the center having compliance issues.|1092
225595|NCT00849381|550601|P1|STARTED|Overall Study|Out of the subjects who started, 243 were enrolled at the center having compliance issues.|1237
225596|NCT00855816|550609|P2|NOT COMPLETED|Overall Study||21
225597|NCT00855816|550610|P1|NOT COMPLETED|Overall Study||26
225598|NCT00855816|550609|P2|COMPLETED|Overall Study||12
225599|NCT00855816|550610|P1|COMPLETED|Overall Study||21
225600|NCT00855816|550609|P2|STARTED|Overall Study||33
225601|NCT00855816|550610|P1|STARTED|Overall Study||47
225602|NCT00855842|550616|P1|NOT COMPLETED|Overall Study||0
225603|NCT00855842|550616|P1|COMPLETED|Overall Study||4
225604|NCT00855842|550616|P1|STARTED|Overall Study||4
225605|NCT00855868|550622|P2|NOT COMPLETED|Overall Study||1
225606|NCT00855868|550623|P1|NOT COMPLETED|Overall Study||1
225607|NCT00855868|550622|P2|COMPLETED|Overall Study||14
225608|NCT00855868|550623|P1|COMPLETED|Overall Study||12
225609|NCT00855868|550622|P2|STARTED|Overall Study||15
225610|NCT00855868|550623|P1|STARTED|Overall Study||13
225611|NCT00855894|550629|P1|NOT COMPLETED|Overall Study||33
225612|NCT00855894|550629|P1|COMPLETED|Overall Study||8
225613|NCT00855894|550629|P1|STARTED|Overall Study||41
225614|NCT00855920|550640|P3|NOT COMPLETED|Overall Study||11
225615|NCT00855920|550641|P2|NOT COMPLETED|Overall Study||9
225616|NCT00855920|550642|P1|NOT COMPLETED|Overall Study||8
225617|NCT00855920|550640|P3|COMPLETED|Overall Study||64
225618|NCT00855920|550641|P2|COMPLETED|Overall Study||65
225619|NCT00855920|550642|P1|COMPLETED|Overall Study||68
225620|NCT00855920|550640|P3|Safety Population|Overall Study||75
225717|NCT00856492|550858|P3|COMPLETED|Overall Study||51
225621|NCT00855920|550641|P2|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|73
225622|NCT00855920|550642|P1|Safety Population|Overall Study|1 participant from Rilonacept+Indomethacin arm received Placebo (for Rilonacept)+Indomethacin|77
225623|NCT00855920|550640|P3|STARTED|Overall Study||75
225624|NCT00855920|550641|P2|STARTED|Overall Study||74
225625|NCT00855920|550642|P1|STARTED|Overall Study||76
225626|NCT00855933|550661|P2|NOT COMPLETED|Overall Study||1
225627|NCT00855933|550662|P1|NOT COMPLETED|Overall Study||0
225628|NCT00855933|550661|P2|COMPLETED|Overall Study||29
225629|NCT00855933|550662|P1|COMPLETED|Overall Study||30
225630|NCT00855933|550661|P2|STARTED|Overall Study||30
225631|NCT00855933|550662|P1|STARTED|Overall Study||30
225632|NCT00855959|550668|P1|NOT COMPLETED|Overall Study||9
225633|NCT00855959|550668|P1|COMPLETED|Overall Study||99
225634|NCT00855959|550668|P1|Patients Who Received Pulmicort Respules|Overall Study||105
225635|NCT00855959|550668|P1|STARTED|Overall Study||108
225636|NCT00856024|550683|P1|NOT COMPLETED|Overall Study||0
225637|NCT00856024|550683|P1|COMPLETED|Overall Study||902
225638|NCT00856024|550683|P1|STARTED|Overall Study||902
225639|NCT00856050|550695|P1|NOT COMPLETED|Overall Study||0
225640|NCT00856050|550695|P1|COMPLETED|Overall Study||26
225641|NCT00856050|550695|P1|STARTED|Overall Study||26
225642|NCT00856193|550699|P2|NOT COMPLETED|Period 2||2
225643|NCT00856193|550700|P1|NOT COMPLETED|Period 2||0
225644|NCT00856193|550699|P2|COMPLETED|Period 2||15
225645|NCT00856193|550700|P1|COMPLETED|Period 2||16
225646|NCT00856193|550699|P2|STARTED|Period 2||17
225647|NCT00856193|550700|P1|STARTED|Period 2||16
225648|NCT00856193|550699|P2|NOT COMPLETED|Period 1||0
225649|NCT00856193|550700|P1|NOT COMPLETED|Period 1||0
225650|NCT00856193|550699|P2|COMPLETED|Period 1||17
225651|NCT00856193|550700|P1|COMPLETED|Period 1||16
225652|NCT00856193|550699|P2|STARTED|Period 1||17
225653|NCT00856193|550700|P1|STARTED|Period 1||16
225654|NCT00856206|550714|P2|NOT COMPLETED|Overall Study||161
225655|NCT00856206|550715|P1|NOT COMPLETED|Overall Study||54
225657|NCT00856206|550715|P1|COMPLETED|Overall Study||276
225658|NCT00856206|550714|P2|STARTED|Overall Study||985
225659|NCT00856206|550715|P1|STARTED|Overall Study||330
225660|NCT00856232|550732|P3|NOT COMPLETED|Overall Study||0
225661|NCT00856232|550733|P2|NOT COMPLETED|Overall Study||0
225662|NCT00856232|550734|P1|NOT COMPLETED|Overall Study||0
225663|NCT00856232|550732|P3|COMPLETED|Overall Study||36
225664|NCT00856232|550733|P2|COMPLETED|Overall Study||29
225665|NCT00856232|550734|P1|COMPLETED|Overall Study||26
225666|NCT00856232|550732|P3|STARTED|Overall Study||36
225667|NCT00856232|550733|P2|STARTED|Overall Study||29
225668|NCT00856232|550734|P1|STARTED|Overall Study||26
225669|NCT00856245|550745|P1|NOT COMPLETED|Overall Study||5
225670|NCT00856245|550745|P1|COMPLETED|Overall Study||14
225671|NCT00856245|550745|P1|STARTED|Overall Study||19
225672|NCT00856284|550753|P3|NOT COMPLETED|Overall Study||447
225673|NCT00856284|550754|P2|NOT COMPLETED|Overall Study||392
225674|NCT00856284|550755|P1|NOT COMPLETED|Overall Study||408
225675|NCT00856284|550753|P3|COMPLETED|Overall Study||427
225676|NCT00856284|550754|P2|COMPLETED|Overall Study||493
225677|NCT00856284|550755|P1|COMPLETED|Overall Study||472
225678|NCT00856284|550753|P3|Received Study Drug|Overall Study||869
225679|NCT00856284|550754|P2|Received Study Drug|Overall Study||878
225680|NCT00856284|550755|P1|Received Study Drug|Overall Study||873
225681|NCT00856284|550753|P3|STARTED|Overall Study||874
225682|NCT00856284|550754|P2|STARTED|Overall Study||885
225683|NCT00856284|550755|P1|STARTED|Overall Study||880
225684|NCT00856297|550786|P5|NOT COMPLETED|Overall Study||0
225685|NCT00856297|550787|P4|NOT COMPLETED|Overall Study||0
225686|NCT00856297|550788|P3|NOT COMPLETED|Overall Study||0
225687|NCT00856297|550789|P2|NOT COMPLETED|Overall Study||0
225688|NCT00856297|550790|P1|NOT COMPLETED|Overall Study||2
225689|NCT00856297|550786|P5|COMPLETED|Overall Study||31
225690|NCT00856297|550787|P4|COMPLETED|Overall Study||44
225691|NCT00856297|550788|P3|COMPLETED|Overall Study||107
225692|NCT00856297|550789|P2|COMPLETED|Overall Study||76
225693|NCT00856297|550790|P1|COMPLETED|Overall Study||129
225694|NCT00856297|550786|P5|STARTED|Overall Study||31
225695|NCT00856297|550787|P4|STARTED|Overall Study||44
225696|NCT00856297|550788|P3|STARTED|Overall Study||107
225697|NCT00856297|550789|P2|STARTED|Overall Study||76
225698|NCT00856297|550790|P1|STARTED|Overall Study||131
225699|NCT00856323|550820|P1|NOT COMPLETED|Overall Study||2
225700|NCT00856323|550820|P1|COMPLETED|Overall Study||51
225701|NCT00856323|550820|P1|STARTED|Overall Study||53
225702|NCT00856349|550827|P1|NOT COMPLETED|Overall Study||1021
225703|NCT00856349|550827|P1|COMPLETED|Overall Study||3111
225704|NCT00856349|550827|P1|24 Month Follow-up|Overall Study||1698
225705|NCT00856349|550827|P1|18 Month Follow-up|Overall Study||2467
225706|NCT00856349|550827|P1|12 Month Follow-up|Overall Study||3228
225707|NCT00856349|550827|P1|STARTED|Overall Study||4132
225708|NCT00856388|550836|P1|NOT COMPLETED|Overall Study||1
225709|NCT00856388|550836|P1|COMPLETED|Overall Study||61
225710|NCT00856388|550836|P1|STARTED|Overall Study||62
225711|NCT00856414|550847|P1|NOT COMPLETED|Overall Study||0
225712|NCT00856414|550847|P1|COMPLETED|Overall Study||45
225713|NCT00856414|550847|P1|STARTED|Overall Study||45
225714|NCT00856492|550858|P3|NOT COMPLETED|Overall Study||2
225718|NCT00856492|550859|P2|COMPLETED|Overall Study||62
225719|NCT00856492|550860|P1|COMPLETED|Overall Study||98
225720|NCT00856492|550858|P3|Toxicity Eval|Overall Study||51
225721|NCT00856492|550859|P2|Toxicity Eval|Overall Study||60
225722|NCT00856492|550860|P1|Toxicity Eval|Overall Study||96
225723|NCT00856492|550858|P3|STARTED|Overall Study||53
225724|NCT00856492|550859|P2|STARTED|Overall Study||63
225725|NCT00856492|550860|P1|STARTED|Overall Study||99
225726|NCT00856518|550876|P2|NOT COMPLETED|Overall Study||2
225727|NCT00856518|550877|P1|NOT COMPLETED|Overall Study||4
225728|NCT00856518|550876|P2|COMPLETED|Overall Study||16
225729|NCT00856518|550877|P1|COMPLETED|Overall Study||20
225730|NCT00856518|550876|P2|STARTED|Overall Study||18
225731|NCT00856518|550877|P1|STARTED|Overall Study||24
225732|NCT00856544|550891|P4|NOT COMPLETED|Overall Study||13
225733|NCT00856544|550892|P3|NOT COMPLETED|Overall Study||8
225734|NCT00856544|550893|P2|NOT COMPLETED|Overall Study||66
225735|NCT00856544|550894|P1|NOT COMPLETED|Overall Study||57
225736|NCT00856544|550891|P4|COMPLETED|Overall Study||67
225737|NCT00856544|550892|P3|COMPLETED|Overall Study||71
225738|NCT00856544|550893|P2|COMPLETED|Overall Study||252
225739|NCT00856544|550894|P1|COMPLETED|Overall Study||261
225740|NCT00856544|550891|P4|Treated|Overall Study||80
225741|NCT00856544|550892|P3|Treated|Overall Study||79
225742|NCT00856544|550893|P2|Treated|Overall Study||318
225743|NCT00856544|550894|P1|Treated|Overall Study||315
225744|NCT00856544|550891|P4|STARTED|Overall Study||80
225745|NCT00856544|550892|P3|STARTED|Overall Study||79
225746|NCT00856544|550893|P2|STARTED|Overall Study||318
225747|NCT00856544|550894|P1|STARTED|Overall Study||318
225748|NCT00856557|551073|P2|NOT COMPLETED|Overall Study||16
225749|NCT00856557|551074|P1|NOT COMPLETED|Overall Study||12
225750|NCT00856557|551073|P2|COMPLETED|Overall Study||60
225751|NCT00856557|551074|P1|COMPLETED|Overall Study||50
225752|NCT00856557|551073|P2|With Patients With Contextual Flags|Overall Study||60
225753|NCT00856557|551074|P1|With Patients With Contextual Flags|Overall Study||50
225754|NCT00856557|551073|P2|Tested With Standardized Patients|Overall Study||76
225755|NCT00856557|551074|P1|Tested With Standardized Patients|Overall Study||62
225756|NCT00856557|551073|P2|Received Intervention/Control|Overall Study||76
225757|NCT00856557|551074|P1|Received Intervention/Control|Overall Study||62
225758|NCT00856557|551073|P2|STARTED|Overall Study||76
225759|NCT00856557|551074|P1|STARTED|Overall Study||62
225760|NCT00856583|551086|P2|NOT COMPLETED|Overall Study||2597
225761|NCT00856583|551087|P1|NOT COMPLETED|Overall Study||3137
225762|NCT00856583|551086|P2|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|2307
225763|NCT00856583|551087|P1|COMPLETED|Overall Study|Patients who were still on study drug at the time of study closure|1768
225764|NCT00856583|551086|P2|STARTED|Overall Study|Patients treated|4904
225765|NCT00856583|551087|P1|STARTED|Overall Study|Patients treated|4905
225766|NCT00856635|551117|P2|NOT COMPLETED|Overall Study||8
225767|NCT00856635|551118|P1|NOT COMPLETED|Overall Study||10
225768|NCT00856635|551117|P2|COMPLETED|Overall Study||14
225769|NCT00856635|551118|P1|COMPLETED|Overall Study||12
225770|NCT00856635|551117|P2|Received Study Drug|Overall Study||20
225771|NCT00856635|551118|P1|Received Study Drug|Overall Study||20
225772|NCT00856635|551117|P2|STARTED|Overall Study||22
225773|NCT00856635|551118|P1|STARTED|Overall Study||22
225774|NCT00856661|551126|P2|NOT COMPLETED|Overall Study||29
225775|NCT00856661|551127|P1|NOT COMPLETED|Overall Study||27
225776|NCT00856661|551126|P2|COMPLETED|Overall Study||106
225777|NCT00856661|551127|P1|COMPLETED|Overall Study||108
225778|NCT00856661|551126|P2|Randomized Not Treated|Overall Study||4
225779|NCT00856661|551127|P1|Randomized Not Treated|Overall Study||9
225780|NCT00856661|551126|P2|Treated|Overall Study||131
225781|NCT00856661|551127|P1|Treated|Overall Study||126
225782|NCT00856661|551126|P2|STARTED|Overall Study|Randomised|135
225783|NCT00856661|551127|P1|STARTED|Overall Study|Randomised|135
225784|NCT00856739|551142|P3|NOT COMPLETED|Overall Study||0
225785|NCT00856739|551143|P2|NOT COMPLETED|Overall Study||0
225786|NCT00856739|551144|P1|NOT COMPLETED|Overall Study||0
225787|NCT00856739|551142|P3|COMPLETED|Overall Study||55
225788|NCT00856739|551143|P2|COMPLETED|Overall Study||52
225789|NCT00856739|551144|P1|COMPLETED|Overall Study||70
225790|NCT00856739|551142|P3|STARTED|Overall Study||55
225791|NCT00856739|551143|P2|STARTED|Overall Study||52
225792|NCT00856739|551144|P1|STARTED|Overall Study||70
225793|NCT00856778|551155|P1|NOT COMPLETED|Overall Study||24
225794|NCT00856778|551155|P1|COMPLETED|Overall Study||74
225795|NCT00856778|551155|P1|STARTED|Overall Study||98
225796|NCT00856791|551171|P1|NOT COMPLETED|Overall Study||0
225797|NCT00856791|551171|P1|COMPLETED|Overall Study||1
225798|NCT00856791|551171|P1|STARTED|Overall Study||1
225799|NCT00856830|551180|P4|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
225800|NCT00856830|551181|P3|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
225801|NCT00856830|551182|P2|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
225802|NCT00856830|551183|P1|NOT COMPLETED|Regimen - B (Carboplatin & Etoposide)||0
225803|NCT00856830|551180|P4|COMPLETED|Regimen - B (Carboplatin & Etoposide)||12
225804|NCT00856830|551181|P3|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
225805|NCT00856830|551182|P2|COMPLETED|Regimen - B (Carboplatin & Etoposide)||6
225806|NCT00856830|551183|P1|COMPLETED|Regimen - B (Carboplatin & Etoposide)||3
225807|NCT00856830|551180|P4|STARTED|Regimen - B (Carboplatin & Etoposide)||12
225808|NCT00856830|551181|P3|STARTED|Regimen - B (Carboplatin & Etoposide)||6
225809|NCT00856830|551182|P2|STARTED|Regimen - B (Carboplatin & Etoposide)||6
225810|NCT00856830|551183|P1|STARTED|Regimen - B (Carboplatin & Etoposide)||3
225811|NCT00856830|551180|P4|NOT COMPLETED|Irinotecan & Bendamustine||3
225812|NCT00856830|551181|P3|NOT COMPLETED|Irinotecan & Bendamustine||0
225813|NCT00856830|551182|P2|NOT COMPLETED|Irinotecan & Bendamustine||0
225814|NCT00856830|551183|P1|NOT COMPLETED|Irinotecan & Bendamustine||0
225815|NCT00856830|551180|P4|COMPLETED|Irinotecan & Bendamustine||12
225816|NCT00856830|551181|P3|COMPLETED|Irinotecan & Bendamustine||6
225817|NCT00856830|551182|P2|COMPLETED|Irinotecan & Bendamustine||6
225818|NCT00856830|551183|P1|COMPLETED|Irinotecan & Bendamustine||3
225819|NCT00856830|551180|P4|Maximum Tolerated Dose|Irinotecan & Bendamustine||12
225820|NCT00856830|551181|P3|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
225821|NCT00856830|551182|P2|Maximum Tolerated Dose|Irinotecan & Bendamustine||6
225822|NCT00856830|551183|P1|Maximum Tolerated Dose|Irinotecan & Bendamustine||3
225823|NCT00856830|551180|P4|STARTED|Irinotecan & Bendamustine||15
225824|NCT00856830|551181|P3|STARTED|Irinotecan & Bendamustine||6
225825|NCT00856830|551182|P2|STARTED|Irinotecan & Bendamustine||6
225826|NCT00856830|551183|P1|STARTED|Irinotecan & Bendamustine||3
225827|NCT00856843|551191|P2|NOT COMPLETED|Overall Study||5
225828|NCT00856843|551192|P1|NOT COMPLETED|Overall Study||2
225829|NCT00856843|551191|P2|COMPLETED|Overall Study||63
225830|NCT00856843|551192|P1|COMPLETED|Overall Study||66
225831|NCT00856843|551191|P2|STARTED|Overall Study||68
225832|NCT00856843|551192|P1|STARTED|Overall Study||68
225833|NCT00856908|551226|P2|NOT COMPLETED|Overall Study||0
225834|NCT00856908|551227|P1|NOT COMPLETED|Overall Study||1
225835|NCT00856908|551226|P2|COMPLETED|Overall Study||5
225836|NCT00856908|551227|P1|COMPLETED|Overall Study||14
225837|NCT00856908|551226|P2|STARTED|Overall Study||5
225838|NCT00856908|551227|P1|STARTED|Overall Study||15
225839|NCT00856934|551255|P3|NOT COMPLETED|Overall Study||0
225840|NCT00856934|551256|P2|NOT COMPLETED|Overall Study||0
225841|NCT00856934|551257|P1|NOT COMPLETED|Overall Study||0
225842|NCT00856934|551255|P3|COMPLETED|Overall Study||15
225843|NCT00856934|551256|P2|COMPLETED|Overall Study||15
225844|NCT00856934|551257|P1|COMPLETED|Overall Study||15
225845|NCT00856934|551255|P3|STARTED|Overall Study||15
225846|NCT00856934|551256|P2|STARTED|Overall Study||15
225847|NCT00856934|551257|P1|STARTED|Overall Study||15
225848|NCT00856973|551268|P3|NOT COMPLETED|Overall Study||38
225849|NCT00856973|551269|P2|NOT COMPLETED|Overall Study||41
225850|NCT00856973|551270|P1|NOT COMPLETED|Overall Study||36
225851|NCT00856973|551268|P3|COMPLETED|Overall Study||123
225852|NCT00856973|551269|P2|COMPLETED|Overall Study||122
225853|NCT00856973|551270|P1|COMPLETED|Overall Study||126
225854|NCT00856973|551268|P3|STARTED|Overall Study||161
225855|NCT00856973|551269|P2|STARTED|Overall Study||163
225856|NCT00856973|551270|P1|STARTED|Overall Study||162
225857|NCT00856986|551340|P5|NOT COMPLETED|Extension Period, Weeks 26-52||0
225858|NCT00856986|551341|P4|NOT COMPLETED|Extension Period, Weeks 26-52||0
225859|NCT00856986|551342|P3|NOT COMPLETED|Extension Period, Weeks 26-52||38
225860|NCT00856986|551343|P2|NOT COMPLETED|Extension Period, Weeks 26-52||14
225861|NCT00856986|551344|P1|NOT COMPLETED|Extension Period, Weeks 26-52||19
225862|NCT00856986|551340|P5|COMPLETED|Extension Period, Weeks 26-52||0
225863|NCT00856986|551341|P4|COMPLETED|Extension Period, Weeks 26-52||0
225864|NCT00856986|551342|P3|COMPLETED|Extension Period, Weeks 26-52||432
225865|NCT00856986|551343|P2|COMPLETED|Extension Period, Weeks 26-52||130
225866|NCT00856986|551344|P1|COMPLETED|Extension Period, Weeks 26-52||108
225867|NCT00856986|551340|P5|Enrolled in Extension|Extension Period, Weeks 26-52||0
225868|NCT00856986|551341|P4|Enrolled in Extension|Extension Period, Weeks 26-52||0
225869|NCT00856986|551342|P3|Enrolled in Extension|Extension Period, Weeks 26-52||461
225870|NCT00856986|551343|P2|Enrolled in Extension|Extension Period, Weeks 26-52||140
225871|NCT00856986|551344|P1|Enrolled in Extension|Extension Period, Weeks 26-52||122
225872|NCT00856986|551340|P5|STARTED|Extension Period, Weeks 26-52||0
225873|NCT00856986|551341|P4|STARTED|Extension Period, Weeks 26-52||0
225874|NCT00856986|551342|P3|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 7 (Intensified Group)|470
225875|NCT00856986|551343|P2|STARTED|Extension Period, Weeks 26-52||144
225876|NCT00856986|551344|P1|STARTED|Extension Period, Weeks 26-52|Subjects with HbA1c ≥8.0% who accepted intensification with detemir = 17 (Intensified Group)|127
225877|NCT00856986|551340|P5|NOT COMPLETED|Main Period, Weeks 0-26||0
225878|NCT00856986|551341|P4|NOT COMPLETED|Main Period, Weeks 0-26||0
225879|NCT00856986|551342|P3|NOT COMPLETED|Main Period, Weeks 0-26||28
225880|NCT00856986|551343|P2|NOT COMPLETED|Main Period, Weeks 0-26||18
225881|NCT00856986|551344|P1|NOT COMPLETED|Main Period, Weeks 0-26||34
225882|NCT00856986|551340|P5|COMPLETED|Main Period, Weeks 0-26||0
225883|NCT00856986|551341|P4|COMPLETED|Main Period, Weeks 0-26||0
225884|NCT00856986|551342|P3|COMPLETED|Main Period, Weeks 0-26||470
225885|NCT00856986|551343|P2|COMPLETED|Main Period, Weeks 0-26||144
225886|NCT00856986|551344|P1|COMPLETED|Main Period, Weeks 0-26||127
225887|NCT00856986|551340|P5|STARTED|Main Period, Weeks 0-26||0
225888|NCT00856986|551341|P4|STARTED|Main Period, Weeks 0-26||0
225889|NCT00856986|551342|P3|STARTED|Main Period, Weeks 0-26||498
225890|NCT00856986|551343|P2|STARTED|Main Period, Weeks 0-26||162
225891|NCT00856986|551344|P1|STARTED|Main Period, Weeks 0-26||161
225892|NCT00856986|551340|P5|NOT COMPLETED|Run-in Period, Weeks -12-0||0
225893|NCT00856986|551341|P4|NOT COMPLETED|Run-in Period, Weeks -12-0||167
225894|NCT00856986|551342|P3|NOT COMPLETED|Run-in Period, Weeks -12-0||0
225895|NCT00856986|551343|P2|NOT COMPLETED|Run-in Period, Weeks -12-0||0
225896|NCT00856986|551344|P1|NOT COMPLETED|Run-in Period, Weeks -12-0||0
225897|NCT00856986|551340|P5|COMPLETED|Run-in Period, Weeks -12-0||0
225898|NCT00856986|551341|P4|COMPLETED|Run-in Period, Weeks -12-0|Subjects who withdrew during run-in and before randomisation were Early Withdrawals|0
225899|NCT00856986|551342|P3|COMPLETED|Run-in Period, Weeks -12-0||498
225900|NCT00856986|551343|P2|COMPLETED|Run-in Period, Weeks -12-0||162
225901|NCT00856986|551344|P1|COMPLETED|Run-in Period, Weeks -12-0||161
225902|NCT00856986|551340|P5|STARTED|Run-in Period, Weeks -12-0||0
225903|NCT00856986|551341|P4|STARTED|Run-in Period, Weeks -12-0||167
225904|NCT00856986|551342|P3|STARTED|Run-in Period, Weeks -12-0||498
225905|NCT00856986|551343|P2|STARTED|Run-in Period, Weeks -12-0||162
225906|NCT00856986|551344|P1|STARTED|Run-in Period, Weeks -12-0||161
225907|NCT00857220|551511|P1|NOT COMPLETED|Overall Study||183
225908|NCT00857220|551511|P1|COMPLETED|Overall Study||121
225909|NCT00857220|551511|P1|STARTED|Overall Study||304
225910|NCT00857233|551528|P1|NOT COMPLETED|Overall Study||55
225911|NCT00857233|551528|P1|COMPLETED|Overall Study||242
225912|NCT00857233|551528|P1|STARTED|Overall Study||297
225913|NCT00857246|551537|P1|NOT COMPLETED|ChemoRT||3
225914|NCT00857246|551537|P1|COMPLETED|ChemoRT||12
225915|NCT00857246|551537|P1|STARTED|ChemoRT|6 did not start adjuvant therapy due to disease-related complications or patient withdrawal.|15
225916|NCT00857246|551537|P1|NOT COMPLETED|Surgery (Curative)||6
225917|NCT00857246|551537|P1|COMPLETED|Surgery (Curative)||21
225918|NCT00857246|551537|P1|STARTED|Surgery (Curative)||27
225919|NCT00857246|551537|P1|NOT COMPLETED|Induction Regimen||3
225920|NCT00857246|551537|P1|COMPLETED|Induction Regimen||27
225921|NCT00857246|551537|P1|STARTED|Induction Regimen||30
225922|NCT00857259|551550|P3|NOT COMPLETED|Overall Study||1
225923|NCT00857259|551551|P2|NOT COMPLETED|Overall Study||0
225924|NCT00857259|551552|P1|NOT COMPLETED|Overall Study||1
225925|NCT00857259|551550|P3|COMPLETED|Overall Study||6
225926|NCT00857259|551551|P2|COMPLETED|Overall Study||1
225927|NCT00857259|551552|P1|COMPLETED|Overall Study||7
225928|NCT00857259|551550|P3|STARTED|Overall Study||7
225929|NCT00857259|551551|P2|STARTED|Overall Study||1
225930|NCT00857259|551552|P1|STARTED|Overall Study||8
225931|NCT00857272|551564|P2|NOT COMPLETED|Overall Study||9
225932|NCT00857272|551565|P1|NOT COMPLETED|Overall Study||9
225933|NCT00857272|551564|P2|COMPLETED|Overall Study||145
225934|NCT00857272|551565|P1|COMPLETED|Overall Study||145
225935|NCT00857272|551564|P2|STARTED|Overall Study|Includes 7 non-ITT patients that withdrew consent|154
225936|NCT00857272|551565|P1|STARTED|Overall Study|Includes 6 non-ITT patients that withdrew consent|154
225937|NCT00857285|551573|P2|NOT COMPLETED|Overall Study||6
225938|NCT00857285|551574|P1|NOT COMPLETED|Overall Study||12
225939|NCT00857285|551573|P2|COMPLETED|Overall Study||59
225940|NCT00857285|551574|P1|COMPLETED|Overall Study||53
225941|NCT00857285|551573|P2|STARTED|Overall Study||65
225942|NCT00857285|551574|P1|STARTED|Overall Study||65
225943|NCT00857311|551582|P4|NOT COMPLETED|Overall Study||0
225944|NCT00857311|551583|P3|NOT COMPLETED|Overall Study||0
225945|NCT00857311|551584|P2|NOT COMPLETED|Overall Study||0
225946|NCT00857311|551585|P1|NOT COMPLETED|Overall Study||1
225947|NCT00857311|551582|P4|COMPLETED|Overall Study||0
225948|NCT00857311|551583|P3|COMPLETED|Overall Study||8
225949|NCT00857311|551584|P2|COMPLETED|Overall Study||0
225950|NCT00857311|551585|P1|COMPLETED|Overall Study||8
225951|NCT00857311|551582|P4|STARTED|Overall Study||0
225952|NCT00857311|551583|P3|STARTED|Overall Study||8
225953|NCT00857311|551584|P2|STARTED|Overall Study||0
225954|NCT00857311|551585|P1|STARTED|Overall Study||9
225955|NCT00857415|551597|P2|NOT COMPLETED|Overall Study||0
225956|NCT00857415|551598|P1|NOT COMPLETED|Overall Study||117
225957|NCT00857415|551597|P2|COMPLETED|Overall Study||74
225958|NCT00857415|551598|P1|COMPLETED|Overall Study||35
225959|NCT00857415|551597|P2|Deceased Within One Year of AV-45 Scan|Overall Study|Subjects in the specificity cohort were not followed to autopsy|0
225960|NCT00857415|551598|P1|Deceased Within One Year of AV-45 Scan|Overall Study||37
225961|NCT00857415|551597|P2|STARTED|Overall Study||74
225962|NCT00857415|551598|P1|STARTED|Overall Study||152
225963|NCT00857454|551605|P1|NOT COMPLETED|Overall Study||20
225964|NCT00857454|551605|P1|COMPLETED|Overall Study||51
225965|NCT00857454|551605|P1|STARTED|Overall Study||71
225966|NCT00857506|551619|P3|NOT COMPLETED|Overall Study||18
225967|NCT00857506|551620|P2|NOT COMPLETED|Overall Study||15
225968|NCT00857506|551621|P1|NOT COMPLETED|Overall Study||15
225969|NCT00857506|551619|P3|COMPLETED|Overall Study||51
225970|NCT00857506|551620|P2|COMPLETED|Overall Study||37
225971|NCT00857506|551621|P1|COMPLETED|Overall Study||16
225972|NCT00857506|551619|P3|STARTED|Overall Study||69
225973|NCT00857506|551620|P2|STARTED|Overall Study||52
225974|NCT00857506|551621|P1|STARTED|Overall Study||31
225975|NCT00857532|551647|P1|NOT COMPLETED|Overall Study||0
225976|NCT00857532|551647|P1|COMPLETED|Overall Study||31
225977|NCT00857532|551647|P1|STARTED|Overall Study||31
225978|NCT00857584|551657|P2|NOT COMPLETED|Overall Study||5
225979|NCT00857584|551658|P1|NOT COMPLETED|Overall Study||4
225980|NCT00857584|551657|P2|COMPLETED|Overall Study||8
225981|NCT00857584|551658|P1|COMPLETED|Overall Study||10
225982|NCT00857584|551657|P2|Week 8|Overall Study||8
225983|NCT00857584|551658|P1|Week 8|Overall Study||10
225984|NCT00857584|551657|P2|Week 4|Overall Study||9
225985|NCT00857584|551658|P1|Week 4|Overall Study||11
225986|NCT00857584|551657|P2|Week 2|Overall Study||11
225987|NCT00857584|551658|P1|Week 2|Overall Study||14
225988|NCT00857584|551657|P2|Week 1|Overall Study||13
225989|NCT00857584|551658|P1|Week 1|Overall Study||14
225990|NCT00857584|551657|P2|STARTED|Overall Study||13
225991|NCT00857584|551658|P1|STARTED|Overall Study||14
225992|NCT00857623|551700|P2|NOT COMPLETED|Overall Study||10
225993|NCT00857623|551701|P1|NOT COMPLETED|Overall Study||14
225994|NCT00857623|551700|P2|COMPLETED|Overall Study||55
225995|NCT00857623|551701|P1|COMPLETED|Overall Study||48
225996|NCT00857623|551700|P2|STARTED|Overall Study||65
225997|NCT00857623|551701|P1|STARTED|Overall Study||62
225998|NCT00857649|551725|P2|NOT COMPLETED|Overall Study||32
225999|NCT00857649|551726|P1|NOT COMPLETED|Overall Study||31
226000|NCT00857649|551725|P2|COMPLETED|Overall Study||155
226001|NCT00857649|551726|P1|COMPLETED|Overall Study||151
226002|NCT00857649|551725|P2|STARTED|Overall Study||187
226003|NCT00857649|551726|P1|STARTED|Overall Study||182
226004|NCT00857714|551740|P1|NOT COMPLETED|Overall Study||0
226005|NCT00857714|551740|P1|COMPLETED|Overall Study||1
226006|NCT00857714|551740|P1|STARTED|Overall Study||1
226007|NCT00857766|551747|P2|NOT COMPLETED|Overall Study||30
226008|NCT00857766|551748|P1|NOT COMPLETED|Overall Study||31
226009|NCT00857766|551747|P2|COMPLETED|Overall Study||96
226010|NCT00857766|551748|P1|COMPLETED|Overall Study||92
226011|NCT00857766|551747|P2|STARTED|Overall Study||126
226012|NCT00857766|551748|P1|STARTED|Overall Study||123
226013|NCT00857792|551758|P1|NOT COMPLETED|Overall Study||12
226014|NCT00857792|551758|P1|COMPLETED|Overall Study||108
226015|NCT00857792|551758|P1|STARTED|Overall Study||120
226016|NCT00857818|551764|P2|NOT COMPLETED|Overall Study||8
226017|NCT00857818|551765|P1|NOT COMPLETED|Overall Study||11
226018|NCT00857818|551764|P2|COMPLETED|Overall Study||6
226019|NCT00857818|551765|P1|COMPLETED|Overall Study||3
226020|NCT00857818|551764|P2|Received Treatment|Overall Study||12
226021|NCT00857818|551765|P1|Received Treatment|Overall Study||14
226022|NCT00857818|551764|P2|STARTED|Overall Study||14
226023|NCT00857818|551765|P1|STARTED|Overall Study||14
226024|NCT00857896|551793|P1|NOT COMPLETED|Week 5 to Week 8||0
226025|NCT00857896|551793|P1|COMPLETED|Week 5 to Week 8||20
226026|NCT00857896|551793|P1|STARTED|Week 5 to Week 8||20
226027|NCT00857896|551793|P1|NOT COMPLETED|Baseline to Week 4||1
226028|NCT00857896|551793|P1|COMPLETED|Baseline to Week 4||20
226029|NCT00857896|551793|P1|STARTED|Baseline to Week 4||21
226030|NCT00857948|551809|P4|NOT COMPLETED|Overall Study||0
226031|NCT00857948|551810|P3|NOT COMPLETED|Overall Study||1
226032|NCT00857948|551811|P2|NOT COMPLETED|Overall Study||0
226033|NCT00857948|551812|P1|NOT COMPLETED|Overall Study||3
226034|NCT00857948|551809|P4|COMPLETED|Overall Study||23
226035|NCT00857948|551810|P3|COMPLETED|Overall Study||18
226036|NCT00857948|551811|P2|COMPLETED|Overall Study||18
226037|NCT00857948|551812|P1|COMPLETED|Overall Study||15
226038|NCT00857948|551809|P4|STARTED|Overall Study||23
226039|NCT00857948|551810|P3|STARTED|Overall Study||19
226040|NCT00857948|551811|P2|STARTED|Overall Study||18
226041|NCT00857948|551812|P1|STARTED|Overall Study||18
226042|NCT00857961|551834|P1|NOT COMPLETED|Overall Study||0
226043|NCT00857961|551834|P1|COMPLETED|Overall Study||21
226044|NCT00857961|551834|P1|STARTED|Overall Study||21
226045|NCT00858013|551870|P2|NOT COMPLETED|Overall Study||19
226046|NCT00858013|551871|P1|NOT COMPLETED|Overall Study||22
226047|NCT00858013|551870|P2|COMPLETED|Overall Study||23
226048|NCT00858013|551871|P1|COMPLETED|Overall Study||24
226049|NCT00858013|551870|P2|STARTED|Overall Study||42
226050|NCT00858013|551871|P1|STARTED|Overall Study||46
226051|NCT00858143|551885|P1|NOT COMPLETED|Overall Study||50
226052|NCT00858143|551885|P1|COMPLETED|Overall Study||261
226053|NCT00858143|551885|P1|STARTED|Overall Study|Baseline|311
226054|NCT00858208|551934|P1|NOT COMPLETED|Overall Study||79
226055|NCT00858208|551934|P1|COMPLETED|Overall Study||6
226056|NCT00858208|551934|P1|STARTED|Overall Study||85
226057|NCT00858247|551953|P2|NOT COMPLETED|Week 12 Follow-up||1
226058|NCT00858247|551954|P1|NOT COMPLETED|Week 12 Follow-up||0
226059|NCT00858247|551953|P2|COMPLETED|Week 12 Follow-up||23
226060|NCT00858247|551954|P1|COMPLETED|Week 12 Follow-up||23
226061|NCT00858247|551953|P2|STARTED|Week 12 Follow-up||24
226062|NCT00858247|551954|P1|STARTED|Week 12 Follow-up||23
226063|NCT00858247|551953|P2|NOT COMPLETED|Baseline Assessment||2
226064|NCT00858247|551954|P1|NOT COMPLETED|Baseline Assessment||2
226065|NCT00858247|551953|P2|COMPLETED|Baseline Assessment||24
226066|NCT00858247|551954|P1|COMPLETED|Baseline Assessment||23
226067|NCT00858247|551953|P2|STARTED|Baseline Assessment||26
226068|NCT00858247|551954|P1|STARTED|Baseline Assessment||25
226069|NCT00858390|551972|P2|NOT COMPLETED|Overall Study||0
226070|NCT00858390|551973|P1|NOT COMPLETED|Overall Study||0
226071|NCT00858390|551972|P2|COMPLETED|Overall Study||18
226072|NCT00858390|551973|P1|COMPLETED|Overall Study||18
226073|NCT00858390|551972|P2|STARTED|Overall Study||18
226074|NCT00858390|551973|P1|STARTED|Overall Study||18
226075|NCT00858403|551979|P1|NOT COMPLETED|Overall Study||5
226076|NCT00858403|551979|P1|COMPLETED|Overall Study||2
226077|NCT00858403|551979|P1|STARTED|Overall Study||7
226078|NCT00858442|551991|P2|NOT COMPLETED|Compression:Start to Finish||3
226079|NCT00858442|551992|P1|NOT COMPLETED|Compression:Start to Finish||1
226080|NCT00858442|551991|P2|COMPLETED|Compression:Start to Finish||20
226081|NCT00858442|551992|P1|COMPLETED|Compression:Start to Finish||20
226082|NCT00858442|551991|P2|STARTED|Compression:Start to Finish||23
226083|NCT00858442|551992|P1|STARTED|Compression:Start to Finish||21
226084|NCT00858442|551991|P2|NOT COMPLETED|From Surgery to Start Compression;||0
226085|NCT00858442|551992|P1|NOT COMPLETED|From Surgery to Start Compression;||0
226086|NCT00858442|551991|P2|COMPLETED|From Surgery to Start Compression;||23
226087|NCT00858442|551992|P1|COMPLETED|From Surgery to Start Compression;||21
226088|NCT00858442|551991|P2|STARTED|From Surgery to Start Compression;||23
226089|NCT00858442|551992|P1|STARTED|From Surgery to Start Compression;||21
226090|NCT00858468|552004|P2|NOT COMPLETED|Overall Study||0
226091|NCT00858468|552005|P1|NOT COMPLETED|Overall Study||0
226092|NCT00858468|552004|P2|COMPLETED|Overall Study||192
226093|NCT00858468|552005|P1|COMPLETED|Overall Study||201
226094|NCT00858468|552004|P2|STARTED|Overall Study||192
226095|NCT00858468|552005|P1|STARTED|Overall Study|1 enrolled participant was not vaccinated and removed from analysis|201
226096|NCT00858494|552017|P1|NOT COMPLETED|Overall Study||4
226097|NCT00858494|552017|P1|COMPLETED|Overall Study|2 participants dropped out before giving study medication. Symptoms resolved without a dose in 2.|45
226098|NCT00858494|552017|P1|STARTED|Overall Study||49
226099|NCT00858507|552024|P2|NOT COMPLETED|Overall Study||15
226100|NCT00858507|552025|P1|NOT COMPLETED|Overall Study||22
226101|NCT00858507|552024|P2|COMPLETED|Overall Study||101
226102|NCT00858507|552025|P1|COMPLETED|Overall Study||83
226103|NCT00858507|552024|P2|STARTED|Overall Study||116
226104|NCT00858507|552025|P1|STARTED|Overall Study||105
226105|NCT00858637|552033|P6|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
226106|NCT00858637|552034|P5|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
226107|NCT00858637|552035|P4|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
226108|NCT00858637|552036|P3|NOT COMPLETED|Placebo-controlled Withdrawal Phase||1
226109|NCT00858637|552037|P2|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
226110|NCT00858637|552038|P1|NOT COMPLETED|Placebo-controlled Withdrawal Phase||0
226111|NCT00858637|552033|P6|COMPLETED|Placebo-controlled Withdrawal Phase||58
226112|NCT00858637|552034|P5|COMPLETED|Placebo-controlled Withdrawal Phase||55
226113|NCT00858637|552035|P4|COMPLETED|Placebo-controlled Withdrawal Phase||0
226114|NCT00858637|552036|P3|COMPLETED|Placebo-controlled Withdrawal Phase||53
226115|NCT00858637|552037|P2|COMPLETED|Placebo-controlled Withdrawal Phase||49
226116|NCT00858637|552038|P1|COMPLETED|Placebo-controlled Withdrawal Phase||0
226117|NCT00858637|552033|P6|STARTED|Placebo-controlled Withdrawal Phase||59
226118|NCT00858637|552034|P5|STARTED|Placebo-controlled Withdrawal Phase||56
226119|NCT00858637|552035|P4|STARTED|Placebo-controlled Withdrawal Phase||0
226120|NCT00858637|552036|P3|STARTED|Placebo-controlled Withdrawal Phase||54
226121|NCT00858637|552037|P2|STARTED|Placebo-controlled Withdrawal Phase||49
226122|NCT00858637|552038|P1|STARTED|Placebo-controlled Withdrawal Phase||0
226123|NCT00858637|552033|P6|NOT COMPLETED|Active Comparison Phase||0
226124|NCT00858637|552034|P5|NOT COMPLETED|Active Comparison Phase||0
226125|NCT00858637|552035|P4|NOT COMPLETED|Active Comparison Phase||18
226126|NCT00858637|552036|P3|NOT COMPLETED|Active Comparison Phase||0
226127|NCT00858637|552037|P2|NOT COMPLETED|Active Comparison Phase||0
226128|NCT00858637|552038|P1|NOT COMPLETED|Active Comparison Phase||24
226129|NCT00858637|552033|P6|COMPLETED|Active Comparison Phase||0
226130|NCT00858637|552034|P5|COMPLETED|Active Comparison Phase||0
226131|NCT00858637|552035|P4|COMPLETED|Active Comparison Phase||115
226132|NCT00858637|552036|P3|COMPLETED|Active Comparison Phase||0
226133|NCT00858637|552037|P2|COMPLETED|Active Comparison Phase||0
226134|NCT00858637|552038|P1|COMPLETED|Active Comparison Phase||103
226135|NCT00858637|552033|P6|STARTED|Active Comparison Phase||0
226136|NCT00858637|552034|P5|STARTED|Active Comparison Phase||0
226137|NCT00858637|552035|P4|STARTED|Active Comparison Phase||133
226138|NCT00858637|552036|P3|STARTED|Active Comparison Phase||0
226139|NCT00858637|552037|P2|STARTED|Active Comparison Phase||0
226140|NCT00858637|552038|P1|STARTED|Active Comparison Phase||127
226141|NCT00852397|552051|P3|NOT COMPLETED|Overall Study||14
226142|NCT00852397|552052|P2|NOT COMPLETED|Overall Study||8
226143|NCT00852397|552053|P1|NOT COMPLETED|Overall Study||11
226144|NCT00852397|552051|P3|COMPLETED|Overall Study||36
226145|NCT00852397|552052|P2|COMPLETED|Overall Study||41
226146|NCT00852397|552053|P1|COMPLETED|Overall Study||41
226147|NCT00852397|552051|P3|Treated Participants|Overall Study||49
226148|NCT00852397|552052|P2|Treated Participants|Overall Study||49
226149|NCT00852397|552053|P1|Treated Participants|Overall Study||51
226150|NCT00852397|552051|P3|STARTED|Overall Study||50
226151|NCT00852397|552052|P2|STARTED|Overall Study||49
226152|NCT00852397|552053|P1|STARTED|Overall Study||52
226153|NCT00852475|552084|P2|NOT COMPLETED|Overall Study||4
226154|NCT00852475|552085|P1|NOT COMPLETED|Overall Study||3
226155|NCT00852475|552084|P2|COMPLETED|Overall Study||16
226156|NCT00852475|552085|P1|COMPLETED|Overall Study||23
226157|NCT00852475|552084|P2|STARTED|Overall Study||20
226158|NCT00852475|552085|P1|STARTED|Overall Study||26
226159|NCT00852527|552093|P2|NOT COMPLETED|Overall Study||0
226160|NCT00852527|552094|P1|NOT COMPLETED|Overall Study||0
226161|NCT00852527|552093|P2|COMPLETED|Overall Study||242
226162|NCT00852527|552094|P1|COMPLETED|Overall Study||196
226163|NCT00852527|552093|P2|STARTED|Overall Study||242
226164|NCT00852527|552094|P1|STARTED|Overall Study||196
226165|NCT00852540|552101|P2|NOT COMPLETED|Overall Study||18
226166|NCT00852540|552102|P1|NOT COMPLETED|Overall Study||36
226167|NCT00852540|552101|P2|COMPLETED|Overall Study||122
226168|NCT00852540|552102|P1|COMPLETED|Overall Study||234
226169|NCT00852540|552101|P2|STARTED|Overall Study||140
226170|NCT00852540|552102|P1|STARTED|Overall Study||270
226171|NCT00852592|552130|P2|NOT COMPLETED|Overall Study||4
226172|NCT00852592|552131|P1|NOT COMPLETED|Overall Study||3
226173|NCT00852592|552130|P2|COMPLETED|Overall Study||19
226174|NCT00852592|552131|P1|COMPLETED|Overall Study||20
226175|NCT00852592|552130|P2|STARTED|Overall Study||23
226176|NCT00852592|552131|P1|STARTED|Overall Study||23
226177|NCT00852631|552139|P1|NOT COMPLETED|Overall Study||11
226178|NCT00852631|552139|P1|COMPLETED|Overall Study||17
226179|NCT00852631|552139|P1|STARTED|Overall Study||28
226180|NCT00852761|552147|P2|NOT COMPLETED|Overall Study||0
226181|NCT00852761|552148|P1|NOT COMPLETED|Overall Study||0
226182|NCT00852761|552147|P2|COMPLETED|Overall Study||17
226183|NCT00852761|552148|P1|COMPLETED|Overall Study||17
226184|NCT00852761|552147|P2|STARTED|Overall Study||17
226185|NCT00852761|552148|P1|STARTED|Overall Study||17
226186|NCT00852917|552194|P4|NOT COMPLETED|Overall Study||93
226187|NCT00852917|552195|P3|NOT COMPLETED|Overall Study||58
226188|NCT00852917|552196|P2|NOT COMPLETED|Overall Study||46
226189|NCT00852917|552197|P1|NOT COMPLETED|Overall Study||44
226190|NCT00852917|552194|P4|COMPLETED|Overall Study||134
226191|NCT00852917|552195|P3|COMPLETED|Overall Study||50
226192|NCT00852917|552196|P2|COMPLETED|Overall Study||65
226193|NCT00852917|552197|P1|COMPLETED|Overall Study||62
226194|NCT00852917|552194|P4|STARTED|Overall Study||227
226195|NCT00852917|552195|P3|STARTED|Overall Study||108
226196|NCT00852917|552196|P2|STARTED|Overall Study||111
226197|NCT00852917|552197|P1|STARTED|Overall Study||106
226198|NCT00852930|552238|P3|NOT COMPLETED|Overall Study||2
226199|NCT00852930|552239|P2|NOT COMPLETED|Overall Study||1
226200|NCT00852930|552240|P1|NOT COMPLETED|Overall Study||1
226201|NCT00852930|552238|P3|COMPLETED|Overall Study||15
226202|NCT00852930|552239|P2|COMPLETED|Overall Study||16
226203|NCT00852930|552240|P1|COMPLETED|Overall Study||15
226204|NCT00852930|552238|P3|STARTED|Overall Study||17
226205|NCT00852930|552239|P2|STARTED|Overall Study||17
226206|NCT00852930|552240|P1|STARTED|Overall Study||16
226207|NCT00852969|552259|P2|NOT COMPLETED|Overall Study||2
226208|NCT00852969|552260|P1|NOT COMPLETED|Overall Study||0
226209|NCT00852969|552259|P2|COMPLETED|Overall Study||13
226210|NCT00852969|552260|P1|COMPLETED|Overall Study||15
226211|NCT00852969|552259|P2|STARTED|Overall Study||15
226212|NCT00852969|552260|P1|STARTED|Overall Study||15
226213|NCT00852995|552273|P5|NOT COMPLETED|Overall Study||4
226214|NCT00852995|552274|P4|NOT COMPLETED|Overall Study||5
226215|NCT00852995|552275|P3|NOT COMPLETED|Overall Study||5
226216|NCT00852995|552276|P2|NOT COMPLETED|Overall Study||1
226217|NCT00852995|552277|P1|NOT COMPLETED|Overall Study||8
226218|NCT00852995|552273|P5|COMPLETED|Overall Study||46
226219|NCT00852995|552274|P4|COMPLETED|Overall Study||40
226220|NCT00852995|552275|P3|COMPLETED|Overall Study||39
226221|NCT00852995|552276|P2|COMPLETED|Overall Study||42
226222|NCT00852995|552277|P1|COMPLETED|Overall Study||38
226223|NCT00852995|552273|P5|STARTED|Overall Study||50
226224|NCT00852995|552274|P4|STARTED|Overall Study||45
226225|NCT00852995|552275|P3|STARTED|Overall Study||44
226226|NCT00852995|552276|P2|STARTED|Overall Study||43
226227|NCT00852995|552277|P1|STARTED|Overall Study||46
226228|NCT00853021|552319|P1|NOT COMPLETED|Overall Study||5
226229|NCT00853021|552319|P1|COMPLETED|Overall Study||21
226230|NCT00853021|552319|P1|STARTED|Overall Study||26
226231|NCT00853073|552328|P2|NOT COMPLETED|Overall Study||2
226232|NCT00853073|552329|P1|NOT COMPLETED|Overall Study||3
226233|NCT00853073|552328|P2|COMPLETED|Overall Study||29
226234|NCT00853073|552329|P1|COMPLETED|Overall Study||29
226235|NCT00853073|552328|P2|STARTED|Overall Study||31
226236|NCT00853073|552329|P1|STARTED|Overall Study||32
226237|NCT00853099|552338|P4|NOT COMPLETED|Double-blind + Open-label Periods||147
226238|NCT00853099|552339|P3|NOT COMPLETED|Double-blind + Open-label Periods||0
226239|NCT00853099|552340|P2|NOT COMPLETED|Double-blind + Open-label Periods||0
226240|NCT00853099|552341|P1|NOT COMPLETED|Double-blind + Open-label Periods||0
226241|NCT00853099|552338|P4|COMPLETED|Double-blind + Open-label Periods||119
226242|NCT00853099|552339|P3|COMPLETED|Double-blind + Open-label Periods||0
226243|NCT00853099|552340|P2|COMPLETED|Double-blind + Open-label Periods||0
226244|NCT00853099|552341|P1|COMPLETED|Double-blind + Open-label Periods||0
226245|NCT00853099|552338|P4|STARTED|Double-blind + Open-label Periods|7 participants randomized to placebo did not receive any adalimumab; 1 participant was excluded.|266
226246|NCT00853099|552339|P3|STARTED|Double-blind + Open-label Periods||0
226247|NCT00853099|552340|P2|STARTED|Double-blind + Open-label Periods||0
226248|NCT00853099|552341|P1|STARTED|Double-blind + Open-label Periods||0
226249|NCT00853099|552338|P4|NOT COMPLETED|Double-blind Period||0
226250|NCT00853099|552339|P3|NOT COMPLETED|Double-blind Period||31
226251|NCT00853099|552340|P2|NOT COMPLETED|Double-blind Period||29
226252|NCT00853099|552341|P1|NOT COMPLETED|Double-blind Period||23
226253|NCT00853099|552338|P4|COMPLETED|Double-blind Period||0
226254|NCT00853099|552339|P3|COMPLETED|Double-blind Period|Participants who completed Week 52.|60
226255|NCT00853099|552340|P2|COMPLETED|Double-blind Period|Participants who completed Week 52.|58
226256|NCT00853099|552341|P1|COMPLETED|Double-blind Period|Participants who completed Week 52.|73
226257|NCT00853099|552338|P4|Completed Week 8|Double-blind Period||0
226258|NCT00853099|552339|P3|Completed Week 8|Double-blind Period||86
226259|NCT00853099|552340|P2|Completed Week 8|Double-blind Period||85
226260|NCT00853099|552341|P1|Completed Week 8|Double-blind Period||92
226261|NCT00853099|552338|P4|Treated|Double-blind Period||0
226262|NCT00853099|552339|P3|Treated|Double-blind Period|1 participant, incorrectly treated with open-label (rescue) study drug at Week 0, was excluded.|90
226263|NCT00853099|552340|P2|Treated|Double-blind Period||87
226264|NCT00853099|552341|P1|Treated|Double-blind Period||96
226265|NCT00853099|552338|P4|STARTED|Double-blind Period||0
226266|NCT00853099|552339|P3|STARTED|Double-blind Period||91
226267|NCT00853099|552340|P2|STARTED|Double-blind Period||87
226268|NCT00853099|552341|P1|STARTED|Double-blind Period||96
226269|NCT00853151|552385|P4|NOT COMPLETED|Overall Study||3
226270|NCT00853151|552386|P3|NOT COMPLETED|Overall Study||8
226271|NCT00853151|552387|P2|NOT COMPLETED|Overall Study||13
226272|NCT00853151|552388|P1|NOT COMPLETED|Overall Study||10
226273|NCT00853151|552385|P4|COMPLETED|Overall Study||15
226274|NCT00853151|552386|P3|COMPLETED|Overall Study||30
226275|NCT00853151|552387|P2|COMPLETED|Overall Study||24
226276|NCT00853151|552388|P1|COMPLETED|Overall Study||28
226277|NCT00853151|552385|P4|STARTED|Overall Study||18
226278|NCT00853151|552386|P3|STARTED|Overall Study||38
226279|NCT00853151|552387|P2|STARTED|Overall Study||37
226280|NCT00853151|552388|P1|STARTED|Overall Study||38
226281|NCT00853229|552532|P2|NOT COMPLETED|Phase 2: Cross Over||0
226282|NCT00853229|552533|P1|NOT COMPLETED|Phase 2: Cross Over||0
226283|NCT00853229|552532|P2|COMPLETED|Phase 2: Cross Over||0
226284|NCT00853229|552533|P1|COMPLETED|Phase 2: Cross Over||0
226285|NCT00853229|552532|P2|STARTED|Phase 2: Cross Over||0
226286|NCT00853229|552533|P1|STARTED|Phase 2: Cross Over||0
226287|NCT00853229|552532|P2|NOT COMPLETED|Phase 1: Initial Intervention||8
226288|NCT00853229|552533|P1|NOT COMPLETED|Phase 1: Initial Intervention||8
226289|NCT00853229|552532|P2|COMPLETED|Phase 1: Initial Intervention||0
226290|NCT00853229|552533|P1|COMPLETED|Phase 1: Initial Intervention||0
226291|NCT00853229|552532|P2|STARTED|Phase 1: Initial Intervention||8
226292|NCT00853229|552533|P1|STARTED|Phase 1: Initial Intervention||8
226293|NCT00853242|552546|P7|NOT COMPLETED|Overall Study||5
226294|NCT00853242|552547|P6|NOT COMPLETED|Overall Study||2
226295|NCT00853242|552548|P5|NOT COMPLETED|Overall Study||4
226296|NCT00853242|552549|P4|NOT COMPLETED|Overall Study||4
226297|NCT00853242|552550|P3|NOT COMPLETED|Overall Study||3
226298|NCT00853242|552551|P2|NOT COMPLETED|Overall Study||3
226299|NCT00853242|552552|P1|NOT COMPLETED|Overall Study||3
226300|NCT00853242|552546|P7|COMPLETED|Overall Study||44
226301|NCT00853242|552547|P6|COMPLETED|Overall Study||49
226302|NCT00853242|552548|P5|COMPLETED|Overall Study||46
226303|NCT00853242|552549|P4|COMPLETED|Overall Study||46
226304|NCT00853242|552550|P3|COMPLETED|Overall Study||46
226305|NCT00853242|552551|P2|COMPLETED|Overall Study||47
226306|NCT00853242|552552|P1|COMPLETED|Overall Study||47
226307|NCT00853242|552546|P7|Treated|Overall Study||48
226308|NCT00853242|552547|P6|Treated|Overall Study||51
226309|NCT00853242|552548|P5|Treated|Overall Study||50
226310|NCT00853242|552549|P4|Treated|Overall Study||50
226311|NCT00853242|552550|P3|Treated|Overall Study||48
226312|NCT00853242|552551|P2|Treated|Overall Study||49
226313|NCT00853242|552552|P1|Treated|Overall Study||50
226314|NCT00853242|552546|P7|STARTED|Overall Study||49
226315|NCT00853242|552547|P6|STARTED|Overall Study||51
226316|NCT00853242|552548|P5|STARTED|Overall Study||50
226317|NCT00853242|552549|P4|STARTED|Overall Study||50
226318|NCT00853242|552550|P3|STARTED|Overall Study||49
226319|NCT00853242|552551|P2|STARTED|Overall Study||50
226320|NCT00853242|552552|P1|STARTED|Overall Study||50
226321|NCT00858689|552592|P1|NOT COMPLETED|Overall Study||1
226322|NCT00858689|552592|P1|COMPLETED|Overall Study||19
226323|NCT00858689|552592|P1|STARTED|Overall Study||20
226324|NCT00858702|552599|P2|NOT COMPLETED|Overall Study||2
226325|NCT00858702|552600|P1|NOT COMPLETED|Overall Study||5
226326|NCT00858702|552599|P2|COMPLETED|Overall Study||50
226327|NCT00858702|552600|P1|COMPLETED|Overall Study||48
226328|NCT00858702|552599|P2|STARTED|Overall Study||52
226329|NCT00858702|552600|P1|STARTED|Overall Study||53
226330|NCT00858780|552610|P5|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||2
226331|NCT00858780|552611|P4|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226332|NCT00858780|552612|P3|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226333|NCT00858780|552613|P2|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226334|NCT00858780|552614|P1|NOT COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226335|NCT00858780|552610|P5|COMPLETED|OL Re-Treatment (Failure to Week 48)||41
226336|NCT00858780|552611|P4|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226337|NCT00858780|552612|P3|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226338|NCT00858780|552613|P2|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226339|NCT00858780|552614|P1|COMPLETED|OL Re-Treatment (Failure to Week 48)||0
226340|NCT00858780|552610|P5|STARTED|OL Re-Treatment (Failure to Week 48)|43 participants showed treatment failure in Period 2 and entered in Period 3.|43
226341|NCT00858780|552611|P4|STARTED|OL Re-Treatment (Failure to Week 48)||0
226342|NCT00858780|552612|P3|STARTED|OL Re-Treatment (Failure to Week 48)||0
226343|NCT00858780|552613|P2|STARTED|OL Re-Treatment (Failure to Week 48)||0
226344|NCT00858780|552614|P1|STARTED|OL Re-Treatment (Failure to Week 48)||0
226345|NCT00858780|552610|P5|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
226346|NCT00858780|552611|P4|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||1
226347|NCT00858780|552612|P3|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
226348|NCT00858780|552613|P2|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||2
226349|NCT00858780|552614|P1|NOT COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
226350|NCT00858780|552610|P5|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
226351|NCT00858780|552611|P4|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||22
226352|NCT00858780|552612|P3|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||25
226353|NCT00858780|552613|P2|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||21
226354|NCT00858780|552614|P1|COMPLETED|Double-Blind (Week 0 to Failure/Week 48)||0
226355|NCT00858780|552610|P5|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
226356|NCT00858780|552611|P4|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
226357|NCT00858780|552612|P3|STARTED|Double-Blind (Week 0 to Failure/Week 48)||27
226358|NCT00858780|552613|P2|STARTED|Double-Blind (Week 0 to Failure/Week 48)||23
226359|NCT00858780|552614|P1|STARTED|Double-Blind (Week 0 to Failure/Week 48)||0
226360|NCT00858780|552610|P5|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226361|NCT00858780|552611|P4|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226362|NCT00858780|552612|P3|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226363|NCT00858780|552613|P2|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226364|NCT00858780|552614|P1|NOT COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||18
226365|NCT00858780|552610|P5|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226366|NCT00858780|552611|P4|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226367|NCT00858780|552612|P3|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226368|NCT00858780|552613|P2|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226369|NCT00858780|552614|P1|COMPLETED|Open-Label (OL) Run-In(Week-8 to Week 0)||73
226370|NCT00858780|552610|P5|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226371|NCT00858780|552611|P4|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226372|NCT00858780|552612|P3|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226373|NCT00858780|552613|P2|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||0
226374|NCT00858780|552614|P1|STARTED|Open-Label (OL) Run-In(Week-8 to Week 0)||91
226375|NCT00858832|552689|P2|NOT COMPLETED|Overall Study||1
226376|NCT00858832|552690|P1|NOT COMPLETED|Overall Study||1
226377|NCT00858832|552689|P2|COMPLETED|Overall Study||22
226378|NCT00858832|552690|P1|COMPLETED|Overall Study||20
226379|NCT00858832|552689|P2|STARTED|Overall Study||23
226380|NCT00858832|552690|P1|STARTED|Overall Study|study terminated early due to enrollment deficiencies|21
226381|NCT00858845|552696|P1|NOT COMPLETED|Overall Study||1
226382|NCT00858845|552696|P1|COMPLETED|Overall Study||10
226383|NCT00858845|552696|P1|STARTED|Overall Study||11
226384|NCT00858858|552700|P1|NOT COMPLETED|Overall Study||18
226385|NCT00858858|552700|P1|COMPLETED|Overall Study||42
226386|NCT00858858|552700|P1|STARTED|Overall Study||60
226387|NCT00858962|552704|P1|NOT COMPLETED|Overall Study||0
226388|NCT00858962|552704|P1|COMPLETED|Overall Study||12
226389|NCT00858962|552704|P1|STARTED|Overall Study||12
226390|NCT00859014|552708|P1|NOT COMPLETED|Overall Study||5
226391|NCT00859014|552708|P1|COMPLETED|Overall Study||20
226392|NCT00859014|552708|P1|STARTED|Overall Study||25
226393|NCT00859430|552715|P2|NOT COMPLETED|Second Intervention||0
226394|NCT00859430|552716|P1|NOT COMPLETED|Second Intervention||0
226395|NCT00859430|552715|P2|COMPLETED|Second Intervention||10
226396|NCT00859430|552716|P1|COMPLETED|Second Intervention||11
226397|NCT00859430|552715|P2|STARTED|Second Intervention||10
226398|NCT00859430|552716|P1|STARTED|Second Intervention||11
226399|NCT00859430|552715|P2|NOT COMPLETED|First Intervention||1
226400|NCT00859430|552716|P1|NOT COMPLETED|First Intervention||0
226401|NCT00859430|552715|P2|COMPLETED|First Intervention||10
226402|NCT00859430|552716|P1|COMPLETED|First Intervention||11
226403|NCT00859430|552715|P2|STARTED|First Intervention||11
226404|NCT00859430|552716|P1|STARTED|First Intervention||11
226405|NCT00859469|552724|P1|NOT COMPLETED|Overall Study||28
226406|NCT00859469|552724|P1|COMPLETED|Overall Study||1
226407|NCT00859469|552724|P1|6 Cycles|Overall Study||16
226408|NCT00859469|552724|P1|STARTED|Overall Study||29
226409|NCT00859508|552732|P2|NOT COMPLETED|Overall Study||0
226410|NCT00859508|552733|P1|NOT COMPLETED|Overall Study||6
226411|NCT00859508|552732|P2|COMPLETED|Overall Study||37
226412|NCT00859508|552733|P1|COMPLETED|Overall Study||62
226413|NCT00859508|552732|P2|STARTED|Overall Study||37
226414|NCT00859508|552733|P1|STARTED|Overall Study||68
226415|NCT00859521|552741|P2|NOT COMPLETED|Second Intervention||0
226416|NCT00859521|552742|P1|NOT COMPLETED|Second Intervention||0
226417|NCT00859521|552741|P2|COMPLETED|Second Intervention||14
226418|NCT00859521|552742|P1|COMPLETED|Second Intervention||15
226419|NCT00859521|552741|P2|STARTED|Second Intervention||14
226420|NCT00859521|552742|P1|STARTED|Second Intervention||15
226421|NCT00859521|552741|P2|NOT COMPLETED|Washout||1
226422|NCT00859521|552742|P1|NOT COMPLETED|Washout||0
226423|NCT00859521|552741|P2|COMPLETED|Washout||14
226424|NCT00859521|552742|P1|COMPLETED|Washout||15
226425|NCT00859521|552741|P2|STARTED|Washout||15
226426|NCT00859521|552742|P1|STARTED|Washout||15
226427|NCT00859521|552741|P2|NOT COMPLETED|First Intervention||0
226428|NCT00859521|552742|P1|NOT COMPLETED|First Intervention||0
226429|NCT00859521|552741|P2|COMPLETED|First Intervention||15
226430|NCT00859521|552742|P1|COMPLETED|First Intervention||15
226431|NCT00859521|552741|P2|STARTED|First Intervention||15
226432|NCT00859521|552742|P1|STARTED|First Intervention||15
226433|NCT00859547|552750|P1|NOT COMPLETED|Overall Study||2
226434|NCT00859547|552750|P1|COMPLETED|Overall Study||28
226435|NCT00859547|552750|P1|STARTED|Overall Study||30
226436|NCT00859573|552763|P2|NOT COMPLETED|Overall Study||2
226437|NCT00859573|552764|P1|NOT COMPLETED|Overall Study||5
226438|NCT00859573|552763|P2|COMPLETED|Overall Study||1
226439|NCT00859573|552764|P1|COMPLETED|Overall Study||1
226440|NCT00859573|552763|P2|STARTED|Overall Study||3
226441|NCT00859573|552764|P1|STARTED|Overall Study||6
226442|NCT00859586|552770|P1|NOT COMPLETED|Overall Study||4
226443|NCT00859586|552770|P1|COMPLETED|Overall Study||4
226444|NCT00859586|552770|P1|STARTED|Overall Study||8
226445|NCT00859638|552776|P2|NOT COMPLETED|Overall Study||4
226446|NCT00859638|552777|P1|NOT COMPLETED|Overall Study||10
226447|NCT00859638|552776|P2|COMPLETED|Overall Study||55
226448|NCT00859638|552777|P1|COMPLETED|Overall Study||55
226449|NCT00859638|552776|P2|STARTED|Overall Study||59
226450|NCT00859638|552777|P1|STARTED|Overall Study||65
226451|NCT00859833|552783|P1|NOT COMPLETED|Overall Study||0
226452|NCT00859833|552783|P1|COMPLETED|Overall Study||30
226453|NCT00859833|552783|P1|STARTED|Overall Study||30
226454|NCT00859898|552791|P3|NOT COMPLETED|Overall Study||27
226455|NCT00859898|552792|P2|NOT COMPLETED|Overall Study||31
226456|NCT00859898|552793|P1|NOT COMPLETED|Overall Study||28
226457|NCT00859898|552791|P3|COMPLETED|Overall Study||181
226458|NCT00859898|552792|P2|COMPLETED|Overall Study||188
226459|NCT00859898|552793|P1|COMPLETED|Overall Study||183
226460|NCT00859898|552791|P3|STARTED|Overall Study||208
226461|NCT00859898|552792|P2|STARTED|Overall Study||219
226462|NCT00859898|552793|P1|STARTED|Overall Study||211
226463|NCT00859937|552836|P2|NOT COMPLETED|Overall Study||0
226464|NCT00859937|552837|P1|NOT COMPLETED|Overall Study||1
226465|NCT00859937|552836|P2|COMPLETED|Overall Study||14
226466|NCT00859937|552837|P1|COMPLETED|Overall Study||40
226467|NCT00859937|552836|P2|STARTED|Overall Study||14
226468|NCT00859937|552837|P1|STARTED|Overall Study||41
226469|NCT00859950|552851|P2|NOT COMPLETED|Overall Study||0
226470|NCT00859950|552852|P1|NOT COMPLETED|Overall Study||0
226471|NCT00859950|552851|P2|COMPLETED|Overall Study||21
226472|NCT00859950|552852|P1|COMPLETED|Overall Study||49
226473|NCT00859950|552851|P2|STARTED|Overall Study||21
226474|NCT00859950|552852|P1|STARTED|Overall Study||49
226475|NCT00860028|552860|P2|NOT COMPLETED|Smoking Cessation Phase||2
226476|NCT00860028|552861|P1|NOT COMPLETED|Smoking Cessation Phase||0
226477|NCT00860028|552860|P2|COMPLETED|Smoking Cessation Phase||12
226478|NCT00860028|552861|P1|COMPLETED|Smoking Cessation Phase||13
226479|NCT00860028|552860|P2|STARTED|Smoking Cessation Phase||14
226480|NCT00860028|552861|P1|STARTED|Smoking Cessation Phase||13
226481|NCT00860028|552860|P2|NOT COMPLETED|Placebo Controlled Pretreatment Period||1
226482|NCT00860028|552861|P1|NOT COMPLETED|Placebo Controlled Pretreatment Period||2
226483|NCT00860028|552860|P2|COMPLETED|Placebo Controlled Pretreatment Period||14
226484|NCT00860028|552861|P1|COMPLETED|Placebo Controlled Pretreatment Period||13
226485|NCT00860028|552860|P2|STARTED|Placebo Controlled Pretreatment Period||15
226486|NCT00860028|552861|P1|STARTED|Placebo Controlled Pretreatment Period||15
226487|NCT00860067|552874|P3|NOT COMPLETED|Overall Study||9
226488|NCT00860067|552875|P2|NOT COMPLETED|Overall Study||9
226489|NCT00860067|552876|P1|NOT COMPLETED|Overall Study||51
226490|NCT00860067|552874|P3|COMPLETED|Overall Study||292
226491|NCT00860067|552875|P2|COMPLETED|Overall Study||290
226492|NCT00860067|552876|P1|COMPLETED|Overall Study||1149
226493|NCT00860067|552874|P3|STARTED|Overall Study||301
226494|NCT00860067|552875|P2|STARTED|Overall Study||299
226495|NCT00860067|552876|P1|STARTED|Overall Study||1200
226496|NCT00860158|552934|P1|NOT COMPLETED|Overall Study||1
226497|NCT00860158|552934|P1|COMPLETED|Overall Study||0
226498|NCT00860158|552934|P1|STARTED|Overall Study||1
226499|NCT00860249|552945|P3|NOT COMPLETED|Overall Study||21
226500|NCT00860249|552946|P2|NOT COMPLETED|Overall Study||18
226501|NCT00860249|552947|P1|NOT COMPLETED|Overall Study||21
226502|NCT00860249|552945|P3|COMPLETED|Overall Study||0
226503|NCT00860249|552946|P2|COMPLETED|Overall Study||0
226504|NCT00860249|552947|P1|COMPLETED|Overall Study||0
226505|NCT00860249|552945|P3|STARTED|Overall Study||21
226506|NCT00860249|552946|P2|STARTED|Overall Study||18
226507|NCT00860249|552947|P1|STARTED|Overall Study||21
226508|NCT00860262|552961|P3|NOT COMPLETED|Overall Study||18
226509|NCT00860262|552962|P2|NOT COMPLETED|Overall Study||22
226510|NCT00860262|552963|P1|NOT COMPLETED|Overall Study||20
226511|NCT00860262|552961|P3|COMPLETED|Overall Study||202
226512|NCT00860262|552962|P2|COMPLETED|Overall Study||195
226513|NCT00860262|552963|P1|COMPLETED|Overall Study||401
226514|NCT00860262|552961|P3|STARTED|Overall Study||220
226515|NCT00860262|552962|P2|STARTED|Overall Study||217
226516|NCT00860262|552963|P1|STARTED|Overall Study||421
226517|NCT00860314|553075|P2|NOT COMPLETED|Overall Study||0
226518|NCT00860314|553076|P1|NOT COMPLETED|Overall Study||0
226519|NCT00860314|553075|P2|COMPLETED|Overall Study||48
226520|NCT00860314|553076|P1|COMPLETED|Overall Study||48
226521|NCT00860314|553075|P2|STARTED|Overall Study||48
226522|NCT00860314|553076|P1|STARTED|Overall Study||48
226523|NCT00860405|553090|P2|NOT COMPLETED|Overall Study||4
226524|NCT00860405|553091|P1|NOT COMPLETED|Overall Study||5
226525|NCT00860405|553090|P2|COMPLETED|Overall Study||26
226526|NCT00860405|553091|P1|COMPLETED|Overall Study|completed overall study|26
226527|NCT00860405|553090|P2|Day 28 Follow-up Performed|Overall Study||29
226528|NCT00860405|553091|P1|Day 28 Follow-up Performed|Overall Study||31
226529|NCT00860405|553090|P2|Completed Treatment|Overall Study||29
226530|NCT00860405|553091|P1|Completed Treatment|Overall Study||31
226531|NCT00860405|553090|P2|STARTED|Overall Study||30
226532|NCT00860405|553091|P1|STARTED|Overall Study||31
226533|NCT00860457|553113|P1|NOT COMPLETED|Overall Study||11
226534|NCT00860457|553113|P1|COMPLETED|Overall Study||11
226535|NCT00860457|553113|P1|STARTED|Overall Study||22
226536|NCT00860470|553119|P2|NOT COMPLETED|Overall Study||59
226537|NCT00860470|553120|P1|NOT COMPLETED|Overall Study||48
226538|NCT00860470|553119|P2|COMPLETED|Overall Study||22346
226539|NCT00860470|553120|P1|COMPLETED|Overall Study||22114
226540|NCT00860470|553119|P2|STARTED|Overall Study||22405
226541|NCT00860470|553120|P1|STARTED|Overall Study||22162
226542|NCT00860535|553144|P1|NOT COMPLETED|Overall Study||1
226543|NCT00860535|553144|P1|COMPLETED|Overall Study||8
226544|NCT00860535|553144|P1|DISCONTINUED|Overall Study|Participant did not meet inclusion criteria and did not complete the study.|1
226545|NCT00860535|553144|P1|STARTED|Overall Study||9
226546|NCT00860743|553155|P2|NOT COMPLETED|Overall Study||0
226547|NCT00860743|553156|P1|NOT COMPLETED|Overall Study||3
226548|NCT00860743|553155|P2|COMPLETED|Overall Study||23
226549|NCT00860743|553156|P1|COMPLETED|Overall Study||37
226550|NCT00860743|553155|P2|STARTED|Overall Study||23
226551|NCT00860743|553156|P1|STARTED|Overall Study||40
226552|NCT00860795|553164|P2|NOT COMPLETED|Overall Study||0
226553|NCT00860795|553165|P1|NOT COMPLETED|Overall Study||0
226554|NCT00860795|553164|P2|COMPLETED|Overall Study||10
226555|NCT00860795|553165|P1|COMPLETED|Overall Study|One participant discontinued study medication on day 5, but completed safety evaluations|10
226556|NCT00860795|553164|P2|Number to Complete Study Medication|Overall Study||10
226557|NCT00860795|553165|P1|Number to Complete Study Medication|Overall Study||9
226558|NCT00860795|553164|P2|STARTED|Overall Study||10
226559|NCT00860795|553165|P1|STARTED|Overall Study||10
226560|NCT00860847|553185|P2|NOT COMPLETED|Overall Study||5
226561|NCT00860847|553186|P1|NOT COMPLETED|Overall Study||4
226562|NCT00860847|553185|P2|COMPLETED|Overall Study||28
226563|NCT00860847|553186|P1|COMPLETED|Overall Study||28
226564|NCT00860847|553185|P2|STARTED|Overall Study||33
226565|NCT00860847|553186|P1|STARTED|Overall Study||32
226566|NCT00860951|553192|P1|NOT COMPLETED|Overall Study||7
226567|NCT00860951|553192|P1|COMPLETED|Overall Study||22
226568|NCT00860951|553192|P1|STARTED|Overall Study||29
226569|NCT00861146|553200|P2|NOT COMPLETED|Overall Study||8
226570|NCT00861146|553201|P1|NOT COMPLETED|Overall Study||20
226571|NCT00861146|553200|P2|COMPLETED|Overall Study||38
226572|NCT00861146|553201|P1|COMPLETED|Overall Study||85
226573|NCT00861146|553200|P2|Week 13 Assessment|Overall Study||38
226574|NCT00861146|553201|P1|Week 13 Assessment|Overall Study||85
226575|NCT00861146|553200|P2|Week 2 Assessment|Overall Study||45
226576|NCT00861146|553201|P1|Week 2 Assessment|Overall Study||97
226577|NCT00861146|553200|P2|STARTED|Overall Study||46
226578|NCT00861146|553201|P1|STARTED|Overall Study||105
226579|NCT00861198|553211|P1|NOT COMPLETED|Overall Study||5
226580|NCT00861198|553211|P1|COMPLETED|Overall Study||70
226581|NCT00861198|553211|P1|STARTED|Overall Study||75
226582|NCT00861263|553215|P1|NOT COMPLETED|Overall Study||0
226583|NCT00861263|553215|P1|COMPLETED|Overall Study||193
226584|NCT00861263|553215|P1|STARTED|Overall Study||193
226585|NCT00861341|553219|P1|NOT COMPLETED|Overall Study||2
226586|NCT00861341|553219|P1|COMPLETED|Overall Study||38
226587|NCT00861341|553219|P1|STARTED|Overall Study||40
226588|NCT00861471|553224|P1|NOT COMPLETED|Overall Study||9
226589|NCT00861471|553224|P1|COMPLETED|Overall Study||3
226590|NCT00861471|553224|P1|STARTED|Overall Study||12
226591|NCT00861601|553235|P3|NOT COMPLETED|Overall Study||0
226592|NCT00861601|553236|P2|NOT COMPLETED|Overall Study||0
226593|NCT00861601|553237|P1|NOT COMPLETED|Overall Study||0
226594|NCT00861601|553235|P3|COMPLETED|Overall Study||12
226595|NCT00861601|553236|P2|COMPLETED|Overall Study||14
226596|NCT00861601|553237|P1|COMPLETED|Overall Study||12
226597|NCT00861601|553235|P3|STARTED|Overall Study||12
226598|NCT00861601|553236|P2|STARTED|Overall Study||14
226599|NCT00861601|553237|P1|STARTED|Overall Study||12
226600|NCT00861614|553289|P2|NOT COMPLETED|Overall Study||368
226601|NCT00861614|553290|P1|NOT COMPLETED|Overall Study||371
226602|NCT00861614|553289|P2|COMPLETED|Overall Study||28
226603|NCT00861614|553290|P1|COMPLETED|Overall Study||22
226604|NCT00861614|553289|P2|STARTED|Overall Study||396
226605|NCT00861614|553290|P1|STARTED|Overall Study||393
226606|NCT00861692|553320|P1|NOT COMPLETED|Overall Study||6
226607|NCT00861692|553320|P1|COMPLETED|Overall Study||14
226608|NCT00861692|553320|P1|STARTED|Overall Study||20
226609|NCT00861705|553334|P4|NOT COMPLETED|Overall Study||1
226610|NCT00861705|553335|P3|NOT COMPLETED|Overall Study||0
226611|NCT00861705|553336|P2|NOT COMPLETED|Overall Study||3
226612|NCT00861705|553337|P1|NOT COMPLETED|Overall Study||7
226613|NCT00861705|553334|P4|COMPLETED|Overall Study||112
226614|NCT00861705|553335|P3|COMPLETED|Overall Study||113
226615|NCT00861705|553336|P2|COMPLETED|Overall Study||110
226616|NCT00861705|553337|P1|COMPLETED|Overall Study||108
226617|NCT00861705|553334|P4|STARTED|Overall Study||113
226618|NCT00861705|553335|P3|STARTED|Overall Study||113
226619|NCT00861705|553336|P2|STARTED|Overall Study||113
226620|NCT00861705|553337|P1|STARTED|Overall Study||115
226621|NCT00861744|553357|P4|NOT COMPLETED|Overall Study||33
226622|NCT00861744|553358|P3|NOT COMPLETED|Overall Study||24
226623|NCT00861744|553359|P2|NOT COMPLETED|Overall Study||29
226624|NCT00861744|553360|P1|NOT COMPLETED|Overall Study||17
226625|NCT00861744|553357|P4|COMPLETED|Overall Study||275
226626|NCT00861744|553358|P3|COMPLETED|Overall Study||280
226627|NCT00861744|553359|P2|COMPLETED|Overall Study||275
226628|NCT00861744|553360|P1|COMPLETED|Overall Study||287
226629|NCT00861744|553357|P4|STARTED|Overall Study||308
226630|NCT00861744|553358|P3|STARTED|Overall Study||304
226631|NCT00861744|553359|P2|STARTED|Overall Study||304
226632|NCT00861744|553360|P1|STARTED|Overall Study||304
226633|NCT00861757|553542|P4|NOT COMPLETED|Overall Study||9
226634|NCT00861757|553543|P3|NOT COMPLETED|Overall Study||18
226635|NCT00861757|553544|P2|NOT COMPLETED|Overall Study||15
226636|NCT00861757|553545|P1|NOT COMPLETED|Overall Study||9
226637|NCT00861757|553542|P4|COMPLETED|Overall Study||143
226638|NCT00861757|553543|P3|COMPLETED|Overall Study||137
226639|NCT00861757|553544|P2|COMPLETED|Overall Study||136
226640|NCT00861757|553545|P1|COMPLETED|Overall Study||145
226641|NCT00861757|553542|P4|STARTED|Overall Study||152
226642|NCT00861757|553543|P3|STARTED|Overall Study||155
226643|NCT00861757|553544|P2|STARTED|Overall Study||151
226644|NCT00861757|553545|P1|STARTED|Overall Study||154
226645|NCT00856180|553599|P1|NOT COMPLETED|Overall Study||20
226646|NCT00856180|553599|P1|COMPLETED|Overall Study||0
226647|NCT00856180|553599|P1|STARTED|Overall Study||20
226648|NCT00861913|553608|P1|NOT COMPLETED|Overall Study||0
226649|NCT00861913|553608|P1|COMPLETED|Overall Study||13
226650|NCT00861913|553608|P1|STARTED|Overall Study||13
226651|NCT00862082|553618|P2|NOT COMPLETED|Overall Study||1
226652|NCT00862082|553619|P1|NOT COMPLETED|Overall Study||5
226653|NCT00862082|553618|P2|COMPLETED|Overall Study||5
226654|NCT00862082|553619|P1|COMPLETED|Overall Study||3
226655|NCT00862082|553618|P2|STARTED|Overall Study||6
226656|NCT00862082|553619|P1|STARTED|Overall Study||8
226657|NCT00862121|553664|P2|NOT COMPLETED|Overall Study||8
226658|NCT00862121|553665|P1|NOT COMPLETED|Overall Study||1
226659|NCT00862121|553664|P2|COMPLETED|Overall Study||4
226660|NCT00862121|553665|P1|COMPLETED|Overall Study||7
226661|NCT00862121|553664|P2|Safety Analysis Set|Overall Study||11
226662|NCT00862121|553665|P1|Safety Analysis Set|Overall Study|The participant with no evaluable post-baseline CDAI score was included in the Safety Analysis Set.|8
226663|NCT00862121|553664|P2|Full Analysis Set (FAS)|Overall Study|One participant randomised in error (no IMP taken).|11
226664|NCT00862121|553665|P1|Full Analysis Set (FAS)|Overall Study|One participant had no evaluable post-baseline CDAI score.|7
226665|NCT00862121|553664|P2|STARTED|Overall Study|Randomised, intent-to-treat (ITT)|12
226666|NCT00862121|553665|P1|STARTED|Overall Study||8
226667|NCT00862134|553683|P2|NOT COMPLETED|Overall Study||12
226668|NCT00862134|553684|P1|NOT COMPLETED|Overall Study||11
226669|NCT00862134|553683|P2|COMPLETED|Overall Study||11
226670|NCT00862134|553684|P1|COMPLETED|Overall Study||8
226671|NCT00862134|553683|P2|STARTED|Overall Study||23
226672|NCT00862134|553684|P1|STARTED|Overall Study||19
226673|NCT00862186|553694|P1|NOT COMPLETED|Overall Study||0
226674|NCT00862186|553694|P1|COMPLETED|Overall Study||15
226675|NCT00862186|553694|P1|STARTED|Overall Study||15
226676|NCT00864851|553702|P3|NOT COMPLETED|Overall Study||0
226677|NCT00864851|553703|P2|NOT COMPLETED|Overall Study||1
226678|NCT00864851|553704|P1|NOT COMPLETED|Overall Study||3
226679|NCT00864851|553702|P3|COMPLETED|Overall Study||5
226680|NCT00864851|553703|P2|COMPLETED|Overall Study||18
226681|NCT00864851|553704|P1|COMPLETED|Overall Study||17
226682|NCT00864851|553702|P3|STARTED|Overall Study||5
226683|NCT00864851|553703|P2|STARTED|Overall Study||19
226684|NCT00864851|553704|P1|STARTED|Overall Study||20
226685|NCT00864916|553740|P2|NOT COMPLETED|Overall Study||4
226686|NCT00864916|553741|P1|NOT COMPLETED|Overall Study||6
226687|NCT00864916|553740|P2|COMPLETED|Overall Study||5
226688|NCT00864916|553741|P1|COMPLETED|Overall Study||4
226689|NCT00864916|553740|P2|STARTED|Overall Study||9
226690|NCT00864916|553741|P1|STARTED|Overall Study||10
226691|NCT00865020|553749|P2|NOT COMPLETED|Overall Study||51
226692|NCT00865020|553750|P1|NOT COMPLETED|Overall Study||49
226693|NCT00865020|553749|P2|COMPLETED|Overall Study||357
226694|NCT00865020|553750|P1|COMPLETED|Overall Study||365
226695|NCT00865020|553749|P2|STARTED|Overall Study||408
226696|NCT00865020|553750|P1|STARTED|Overall Study||414
226697|NCT00865046|553767|P3|NOT COMPLETED|Overall Study||1
226698|NCT00865046|553768|P2|NOT COMPLETED|Overall Study||5
226699|NCT00865046|553769|P1|NOT COMPLETED|Overall Study||6
226700|NCT00865046|553767|P3|COMPLETED|Overall Study||62
226701|NCT00865046|553768|P2|COMPLETED|Overall Study||59
226702|NCT00865046|553769|P1|COMPLETED|Overall Study||57
226703|NCT00865046|553767|P3|STARTED|Overall Study||63
226704|NCT00865046|553768|P2|STARTED|Overall Study||64
226705|NCT00865046|553769|P1|STARTED|Overall Study||63
226706|NCT00865098|553777|P1|NOT COMPLETED|Overall Study||1
226793|NCT00866047|553970|P1|COMPLETED|Treatment Period|Number who completed 16 cycles of treatment|10
226707|NCT00865098|553777|P1|COMPLETED|Overall Study|Discontinued from the study due to progressive disease, after completing planned treatment schedule|21
226708|NCT00865098|553777|P1|STARTED|Overall Study||22
226709|NCT00865124|553789|P3|NOT COMPLETED|Overall Study||0
226710|NCT00865124|553790|P2|NOT COMPLETED|Overall Study||1
226711|NCT00865124|553791|P1|NOT COMPLETED|Overall Study||4
226712|NCT00865124|553789|P3|COMPLETED|Overall Study||17
226713|NCT00865124|553790|P2|COMPLETED|Overall Study||24
226714|NCT00865124|553791|P1|COMPLETED|Overall Study||23
226715|NCT00865124|553789|P3|STARTED|Overall Study||17
226716|NCT00865124|553790|P2|STARTED|Overall Study||25
226717|NCT00865124|553791|P1|STARTED|Overall Study||27
226718|NCT00865189|553810|P2|NOT COMPLETED|Overall Study||19
226719|NCT00865189|553811|P1|NOT COMPLETED|Overall Study||12
226720|NCT00865189|553810|P2|COMPLETED|Overall Study||26
226721|NCT00865189|553811|P1|COMPLETED|Overall Study||34
226722|NCT00865189|553810|P2|STARTED|Overall Study||45
226723|NCT00865189|553811|P1|STARTED|Overall Study||46
226724|NCT00865202|553838|P2|NOT COMPLETED|Overall Study||0
226725|NCT00865202|553839|P1|NOT COMPLETED|Overall Study||0
226726|NCT00865202|553838|P2|COMPLETED|Overall Study||149
226727|NCT00865202|553839|P1|COMPLETED|Overall Study||152
226728|NCT00865202|553838|P2|STARTED|Overall Study||149
226729|NCT00865202|553839|P1|STARTED|Overall Study||152
226730|NCT00865306|553855|P2|NOT COMPLETED|One-Year Follow-Up||0
226731|NCT00865306|553856|P1|NOT COMPLETED|One-Year Follow-Up||0
226732|NCT00865306|553855|P2|COMPLETED|One-Year Follow-Up||15
226733|NCT00865306|553856|P1|COMPLETED|One-Year Follow-Up||29
226734|NCT00865306|553855|P2|STARTED|One-Year Follow-Up|Only controls who opted for CBT after the waitlist (n=17) were included. 2 were lost (15 included).|15
226735|NCT00865306|553856|P1|STARTED|One-Year Follow-Up||29
226736|NCT00865306|553855|P2|NOT COMPLETED|Controlled Trial||2
226737|NCT00865306|553856|P1|NOT COMPLETED|Controlled Trial||5
226738|NCT00865306|553855|P2|COMPLETED|Controlled Trial||28
226739|NCT00865306|553856|P1|COMPLETED|Controlled Trial||29
226740|NCT00865306|553855|P2|STARTED|Controlled Trial||30
226741|NCT00865306|553856|P1|STARTED|Controlled Trial|35 assigned to CBT. One child in trial had 0 anxiety disorders, so we excluded her from analysis.|34
226742|NCT00865345|553866|P1|NOT COMPLETED|Overall Study||2
226743|NCT00865345|553866|P1|COMPLETED|Overall Study||61
226744|NCT00865345|553866|P1|STARTED|Overall Study||63
226745|NCT00865514|553871|P1|NOT COMPLETED|Overall Study||2
226746|NCT00865514|553871|P1|COMPLETED|Overall Study||0
226747|NCT00865514|553871|P1|STARTED|Overall Study||2
226748|NCT00865709|553878|P2|NOT COMPLETED|Long Term Follow-up||49
226749|NCT00865709|553879|P1|NOT COMPLETED|Long Term Follow-up||46
226750|NCT00865709|553878|P2|COMPLETED|Long Term Follow-up||33
226751|NCT00865709|553879|P1|COMPLETED|Long Term Follow-up||24
226752|NCT00865709|553878|P2|STARTED|Long Term Follow-up||82
226753|NCT00865709|553879|P1|STARTED|Long Term Follow-up||70
226754|NCT00865709|553878|P2|NOT COMPLETED|Active Follow-up||1
226755|NCT00865709|553879|P1|NOT COMPLETED|Active Follow-up||8
226756|NCT00865709|553878|P2|COMPLETED|Active Follow-up||15
226757|NCT00865709|553879|P1|COMPLETED|Active Follow-up||17
226758|NCT00865709|553878|P2|STARTED|Active Follow-up||16
226759|NCT00865709|553879|P1|STARTED|Active Follow-up||25
226760|NCT00865709|553878|P2|NOT COMPLETED|Treatment||18
226761|NCT00865709|553879|P1|NOT COMPLETED|Treatment||30
226762|NCT00865709|553878|P2|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|83
226763|NCT00865709|553879|P1|COMPLETED|Treatment|Patients who continued treatment at data cut-off or discontinued treatment due to PD or death|67
226764|NCT00865709|553878|P2|Received Treatment|Treatment|Safety population|101
226765|NCT00865709|553879|P1|Received Treatment|Treatment|Safety population|97
226766|NCT00865709|553878|P2|STARTED|Treatment||101
226767|NCT00865709|553879|P1|STARTED|Treatment||97
226768|NCT00865904|553900|P5|NOT COMPLETED|Overall Study||1
226769|NCT00865904|553901|P4|NOT COMPLETED|Overall Study||1
226770|NCT00865904|553902|P3|NOT COMPLETED|Overall Study||0
226771|NCT00865904|553903|P2|NOT COMPLETED|Overall Study||0
226772|NCT00865904|553904|P1|NOT COMPLETED|Overall Study||2
226773|NCT00865904|553900|P5|COMPLETED|Overall Study|Completed 14-day follow-up.|19
226774|NCT00865904|553901|P4|COMPLETED|Overall Study|Completed 14-day follow-up.|17
226775|NCT00865904|553902|P3|COMPLETED|Overall Study|Completed 14-day follow-up.|18
226776|NCT00865904|553903|P2|COMPLETED|Overall Study|Completed 14-day follow-up.|18
226777|NCT00865904|553904|P1|COMPLETED|Overall Study|Completed 14-day follow-up.|17
226778|NCT00865904|553900|P5|STARTED|Overall Study|Randomized.|20
226779|NCT00865904|553901|P4|STARTED|Overall Study|Randomized.|18
226780|NCT00865904|553902|P3|STARTED|Overall Study|Randomized.|18
226781|NCT00865904|553903|P2|STARTED|Overall Study|Randomized.|18
226782|NCT00865904|553904|P1|STARTED|Overall Study|Randomized.|19
226783|NCT00866034|553961|P2|NOT COMPLETED|Overall Study||8
226784|NCT00866034|553962|P1|NOT COMPLETED|Overall Study||16
226785|NCT00866034|553961|P2|COMPLETED|Overall Study||301
226786|NCT00866034|553962|P1|COMPLETED|Overall Study||292
226787|NCT00866034|553961|P2|STARTED|Overall Study||309
226788|NCT00866034|553962|P1|STARTED|Overall Study||308
226789|NCT00866047|553970|P1|NOT COMPLETED|Follow-up Period||5
226790|NCT00866047|553970|P1|COMPLETED|Follow-up Period|Completed survival follow-up due to death [25] or study completion [28]|53
226791|NCT00866047|553970|P1|STARTED|Follow-up Period|All participants were to be followed after treatment|58
226792|NCT00866047|553970|P1|NOT COMPLETED|Treatment Period||48
226794|NCT00866047|553970|P1|STARTED|Treatment Period||58
226795|NCT00866177|553986|P1|NOT COMPLETED|Overall Study||152
226796|NCT00866177|553986|P1|COMPLETED|Overall Study||15
226797|NCT00866177|553986|P1|STARTED|Overall Study||167
226798|NCT00866281|553992|P2|NOT COMPLETED|Overall Study||15
226799|NCT00866281|553993|P1|NOT COMPLETED|Overall Study||7
226800|NCT00866281|553992|P2|COMPLETED|Overall Study||0
226801|NCT00866281|553993|P1|COMPLETED|Overall Study||0
226802|NCT00866281|553992|P2|STARTED|Overall Study||15
226803|NCT00866281|553993|P1|STARTED|Overall Study||7
226804|NCT00866294|554012|P3|NOT COMPLETED|Overall Study||11
226805|NCT00866294|554013|P2|NOT COMPLETED|Overall Study||20
226806|NCT00866294|554014|P1|NOT COMPLETED|Overall Study||33
226807|NCT00866294|554012|P3|COMPLETED|Overall Study||72
226808|NCT00866294|554013|P2|COMPLETED|Overall Study||141
226809|NCT00866294|554014|P1|COMPLETED|Overall Study||139
226810|NCT00866294|554012|P3|STARTED|Overall Study||83
226811|NCT00866294|554013|P2|STARTED|Overall Study||161
226812|NCT00866294|554014|P1|STARTED|Overall Study||172
226813|NCT00866307|554041|P3|NOT COMPLETED|Consolidation/Maintenance||16
226814|NCT00866307|554042|P2|NOT COMPLETED|Consolidation/Maintenance||9
226815|NCT00866307|554043|P1|NOT COMPLETED|Consolidation/Maintenance||0
226816|NCT00866307|554041|P3|COMPLETED|Consolidation/Maintenance||14
226817|NCT00866307|554042|P2|COMPLETED|Consolidation/Maintenance||45
226818|NCT00866307|554043|P1|COMPLETED|Consolidation/Maintenance||0
226819|NCT00866307|554041|P3|STARTED|Consolidation/Maintenance||30
226820|NCT00866307|554042|P2|STARTED|Consolidation/Maintenance||54
226821|NCT00866307|554043|P1|STARTED|Consolidation/Maintenance||0
226822|NCT00866307|554041|P3|NOT COMPLETED|Induction||0
226823|NCT00866307|554042|P2|NOT COMPLETED|Induction||0
226824|NCT00866307|554043|P1|NOT COMPLETED|Induction||20
226825|NCT00866307|554041|P3|COMPLETED|Induction||0
226826|NCT00866307|554042|P2|COMPLETED|Induction||0
226827|NCT00866307|554043|P1|COMPLETED|Induction||84
226828|NCT00866307|554041|P3|STARTED|Induction||0
226829|NCT00866307|554042|P2|STARTED|Induction||0
226830|NCT00866307|554043|P1|STARTED|Induction||104
226831|NCT00866320|554050|P1|NOT COMPLETED|Overall Study||6
226832|NCT00866320|554050|P1|COMPLETED|Overall Study|All patients that received treatment were analyzed.|43
226833|NCT00866320|554050|P1|STARTED|Overall Study||49
226834|NCT00866359|554059|P4|NOT COMPLETED|Observational Follow-Up Phase||0
226835|NCT00866359|554060|P3|NOT COMPLETED|Observational Follow-Up Phase||0
226836|NCT00866359|554061|P2|NOT COMPLETED|Observational Follow-Up Phase||0
226837|NCT00866359|554062|P1|NOT COMPLETED|Observational Follow-Up Phase||0
226838|NCT00866359|554059|P4|COMPLETED|Observational Follow-Up Phase||54
226839|NCT00866359|554060|P3|COMPLETED|Observational Follow-Up Phase||54
226840|NCT00866359|554061|P2|COMPLETED|Observational Follow-Up Phase||0
226841|NCT00866359|554062|P1|COMPLETED|Observational Follow-Up Phase||0
226842|NCT00866359|554059|P4|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
226843|NCT00866359|554060|P3|STARTED|Observational Follow-Up Phase|Includes those who entered the follow-up phase from both the placebo controlled or extension phase.|54
226844|NCT00866359|554061|P2|STARTED|Observational Follow-Up Phase||0
226845|NCT00866359|554062|P1|STARTED|Observational Follow-Up Phase||0
226846|NCT00866359|554059|P4|NOT COMPLETED|Extension Phase (Day 86 to 169)||3
226847|NCT00866359|554060|P3|NOT COMPLETED|Extension Phase (Day 86 to 169)||1
226848|NCT00866359|554061|P2|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
226849|NCT00866359|554062|P1|NOT COMPLETED|Extension Phase (Day 86 to 169)||0
226850|NCT00866359|554059|P4|COMPLETED|Extension Phase (Day 86 to 169)||47
226851|NCT00866359|554060|P3|COMPLETED|Extension Phase (Day 86 to 169)||44
226852|NCT00866359|554061|P2|COMPLETED|Extension Phase (Day 86 to 169)||0
226853|NCT00866359|554062|P1|COMPLETED|Extension Phase (Day 86 to 169)||0
226854|NCT00866359|554059|P4|STARTED|Extension Phase (Day 86 to 169)||50
226855|NCT00866359|554060|P3|STARTED|Extension Phase (Day 86 to 169)||45
226856|NCT00866359|554061|P2|STARTED|Extension Phase (Day 86 to 169)||0
226857|NCT00866359|554062|P1|STARTED|Extension Phase (Day 86 to 169)||0
226858|NCT00866359|554059|P4|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
226859|NCT00866359|554060|P3|NOT COMPLETED|Treatment Phase (Days 1 to 85)||0
226860|NCT00866359|554061|P2|NOT COMPLETED|Treatment Phase (Days 1 to 85)||5
226861|NCT00866359|554062|P1|NOT COMPLETED|Treatment Phase (Days 1 to 85)||11
226862|NCT00866359|554059|P4|COMPLETED|Treatment Phase (Days 1 to 85)||0
226863|NCT00866359|554060|P3|COMPLETED|Treatment Phase (Days 1 to 85)||0
226864|NCT00866359|554061|P2|COMPLETED|Treatment Phase (Days 1 to 85)||50
226865|NCT00866359|554062|P1|COMPLETED|Treatment Phase (Days 1 to 85)||45
226866|NCT00866359|554059|P4|STARTED|Treatment Phase (Days 1 to 85)||0
226867|NCT00866359|554060|P3|STARTED|Treatment Phase (Days 1 to 85)||0
226868|NCT00866359|554061|P2|STARTED|Treatment Phase (Days 1 to 85)||55
226869|NCT00866359|554062|P1|STARTED|Treatment Phase (Days 1 to 85)||56
226870|NCT00866606|554115|P1|NOT COMPLETED|Overall Study||4
226871|NCT00866606|554115|P1|COMPLETED|Overall Study||31
226872|NCT00866606|554115|P1|STARTED|Overall Study||35
226873|NCT00866658|554129|P2|NOT COMPLETED|Overall Study||21
226874|NCT00866658|554130|P1|NOT COMPLETED|Overall Study||13
226875|NCT00866658|554129|P2|COMPLETED|Overall Study||133
226876|NCT00866658|554130|P1|COMPLETED|Overall Study||144
226877|NCT00866658|554129|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||154
226965|NCT00867139|554382|P3|STARTED|Overall Study||4
226878|NCT00866658|554130|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|157
226879|NCT00866658|554129|P2|Safety Population|Overall Study||154
226880|NCT00866658|554130|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|157
226881|NCT00866658|554129|P2|STARTED|Overall Study||154
226882|NCT00866658|554130|P1|STARTED|Overall Study|Randomized.|157
226883|NCT00866697|554160|P2|NOT COMPLETED|Overall Study||377
226884|NCT00866697|554161|P1|NOT COMPLETED|Overall Study||373
226885|NCT00866697|554160|P2|COMPLETED|Overall Study||95
226886|NCT00866697|554161|P1|COMPLETED|Overall Study||95
226887|NCT00866697|554160|P2|Ongoing|Overall Study||312
226888|NCT00866697|554161|P1|Ongoing|Overall Study||335
226889|NCT00866697|554160|P2|STARTED|Overall Study||472
226890|NCT00866697|554161|P1|STARTED|Overall Study||468
226891|NCT00866723|554203|P1|NOT COMPLETED|Overall Study||5
226892|NCT00866723|554203|P1|COMPLETED|Overall Study||0
226893|NCT00866723|554203|P1|STARTED|Overall Study||5
226894|NCT00866775|554210|P2|NOT COMPLETED|Overall Study||52
226895|NCT00866775|554211|P1|NOT COMPLETED|Overall Study||36
226896|NCT00866775|554210|P2|COMPLETED|Overall Study||76
226897|NCT00866775|554211|P1|COMPLETED|Overall Study||29
226898|NCT00866775|554210|P2|STARTED|Overall Study||128
226899|NCT00866775|554211|P1|STARTED|Overall Study||65
226900|NCT00866788|554251|P4|NOT COMPLETED|Overall Study||5
226901|NCT00866788|554252|P3|NOT COMPLETED|Overall Study||2
226902|NCT00866788|554253|P2|NOT COMPLETED|Overall Study||6
226903|NCT00866788|554254|P1|NOT COMPLETED|Overall Study||6
226904|NCT00866788|554251|P4|COMPLETED|Overall Study||16
226905|NCT00866788|554252|P3|COMPLETED|Overall Study||23
226906|NCT00866788|554253|P2|COMPLETED|Overall Study||17
226907|NCT00866788|554254|P1|COMPLETED|Overall Study||15
226908|NCT00866788|554251|P4|STARTED|Overall Study||21
226909|NCT00866788|554252|P3|STARTED|Overall Study||25
226910|NCT00866788|554253|P2|STARTED|Overall Study||23
226911|NCT00866788|554254|P1|STARTED|Overall Study||21
226912|NCT00866814|554300|P1|NOT COMPLETED|Overall Study||20
226913|NCT00866814|554300|P1|COMPLETED|Overall Study||99
226914|NCT00866814|554300|P1|STARTED|Overall Study||119
226915|NCT00866905|554309|P1|NOT COMPLETED|Overall Study||33
226916|NCT00866905|554309|P1|COMPLETED|Overall Study||135
226917|NCT00866905|554309|P1|STARTED|Overall Study||168
226918|NCT00866918|554316|P2|NOT COMPLETED|Overall Study||12
226919|NCT00866918|554317|P1|NOT COMPLETED|Overall Study||16
226920|NCT00866918|554316|P2|COMPLETED|Overall Study||27
226921|NCT00866918|554317|P1|COMPLETED|Overall Study||53
226922|NCT00866918|554316|P2|STARTED|Overall Study||39
226923|NCT00866918|554317|P1|STARTED|Overall Study||69
226924|NCT00867009|554329|P1|NOT COMPLETED|Maintenance Period||4
226925|NCT00867009|554329|P1|COMPLETED|Maintenance Period|Participant was considered completed if they had PD, death, or stopped receiving study drug.|47
226926|NCT00867009|554329|P1|STARTED|Maintenance Period||51
226927|NCT00867009|554329|P1|NOT COMPLETED|Induction Period||62
226928|NCT00867009|554329|P1|COMPLETED|Induction Period|Participants continued on the study in the Maintenance Period.|51
226929|NCT00867009|554329|P1|Protocol Qualified (PQ) Population|Induction Period|Stage IIIB/IV NS-NSCLC, no concurrent chemotherapy, measurable disease, ≥1 dose study drug.|109
226930|NCT00867009|554329|P1|Received at Least 1 Dose of Study Drug|Induction Period||113
226931|NCT00867009|554329|P1|STARTED|Induction Period|Participants with Stage IIIB/IV non-squamous (NS) non-small cell lung cancer (NSCLC)|113
226932|NCT00867035|554338|P2|NOT COMPLETED|Baseline to 1 Week||0
226933|NCT00867035|554339|P1|NOT COMPLETED|Baseline to 1 Week||1
226934|NCT00867035|554338|P2|COMPLETED|Baseline to 1 Week||8
226935|NCT00867035|554339|P1|COMPLETED|Baseline to 1 Week||11
226936|NCT00867035|554338|P2|STARTED|Baseline to 1 Week||8
226937|NCT00867035|554339|P1|STARTED|Baseline to 1 Week||12
226938|NCT00867035|554338|P2|NOT COMPLETED|Baseline to 4 Hours||0
226939|NCT00867035|554339|P1|NOT COMPLETED|Baseline to 4 Hours||0
226940|NCT00867035|554338|P2|COMPLETED|Baseline to 4 Hours||8
226941|NCT00867035|554339|P1|COMPLETED|Baseline to 4 Hours||12
226942|NCT00867035|554338|P2|STARTED|Baseline to 4 Hours||8
226943|NCT00867035|554339|P1|STARTED|Baseline to 4 Hours||12
226944|NCT00867035|554338|P2|NOT COMPLETED|Baseline to 2 Hours||0
226945|NCT00867035|554339|P1|NOT COMPLETED|Baseline to 2 Hours||0
226946|NCT00867035|554338|P2|COMPLETED|Baseline to 2 Hours||8
226947|NCT00867035|554339|P1|COMPLETED|Baseline to 2 Hours||12
226948|NCT00867035|554338|P2|STARTED|Baseline to 2 Hours||8
226949|NCT00867035|554339|P1|STARTED|Baseline to 2 Hours||12
226950|NCT00867035|554338|P2|NOT COMPLETED|Baseline to 1 Hour||1
226951|NCT00867035|554339|P1|NOT COMPLETED|Baseline to 1 Hour||1
226952|NCT00867035|554338|P2|COMPLETED|Baseline to 1 Hour||8
226953|NCT00867035|554339|P1|COMPLETED|Baseline to 1 Hour||12
226954|NCT00867035|554338|P2|STARTED|Baseline to 1 Hour||9
226955|NCT00867035|554339|P1|STARTED|Baseline to 1 Hour||13
226956|NCT00867087|554365|P1|NOT COMPLETED|Overall Study||42
226957|NCT00867087|554365|P1|COMPLETED|Overall Study||21
226958|NCT00867087|554365|P1|STARTED|Overall Study||63
226959|NCT00867139|554382|P3|NOT COMPLETED|Overall Study||1
226960|NCT00867139|554383|P2|NOT COMPLETED|Overall Study||0
226961|NCT00867139|554384|P1|NOT COMPLETED|Overall Study||0
226962|NCT00867139|554382|P3|COMPLETED|Overall Study|One open-labeled patient withdrew on day 5.|3
226963|NCT00867139|554383|P2|COMPLETED|Overall Study||1
226964|NCT00867139|554384|P1|COMPLETED|Overall Study||2
226966|NCT00867139|554383|P2|STARTED|Overall Study||1
226967|NCT00867139|554384|P1|STARTED|Overall Study||2
226968|NCT00867165|554427|P2|NOT COMPLETED|Overall Study||0
226969|NCT00867165|554428|P1|NOT COMPLETED|Overall Study||4
226970|NCT00867165|554427|P2|COMPLETED|Overall Study||45
226971|NCT00867165|554428|P1|COMPLETED|Overall Study||89
226972|NCT00867165|554427|P2|STARTED|Overall Study||45
226973|NCT00867165|554428|P1|STARTED|Overall Study||93
226974|NCT00859027|554532|P2|NOT COMPLETED|Overall Study||5
226975|NCT00859027|554533|P1|NOT COMPLETED|Overall Study||5
226976|NCT00859027|554532|P2|COMPLETED|Overall Study||20
226977|NCT00859027|554533|P1|COMPLETED|Overall Study||20
226978|NCT00859027|554532|P2|STARTED|Overall Study||25
226979|NCT00859027|554533|P1|STARTED|Overall Study||25
226980|NCT00859040|554541|P2|NOT COMPLETED|Overall Study||0
226981|NCT00859040|554542|P1|NOT COMPLETED|Overall Study||0
226982|NCT00859040|554541|P2|COMPLETED|Overall Study||16
226983|NCT00859040|554542|P1|COMPLETED|Overall Study||18
226984|NCT00859040|554541|P2|STARTED|Overall Study||16
226985|NCT00859040|554542|P1|STARTED|Overall Study||18
226986|NCT00859053|554558|P4|NOT COMPLETED|Overall Study||0
226987|NCT00859053|554559|P3|NOT COMPLETED|Overall Study||0
226988|NCT00859053|554560|P2|NOT COMPLETED|Overall Study||0
226989|NCT00859053|554561|P1|NOT COMPLETED|Overall Study||0
226990|NCT00859053|554558|P4|COMPLETED|Overall Study||12
226991|NCT00859053|554559|P3|COMPLETED|Overall Study||6
226992|NCT00859053|554560|P2|COMPLETED|Overall Study||6
226993|NCT00859053|554561|P1|COMPLETED|Overall Study||6
226994|NCT00859053|554558|P4|STARTED|Overall Study||12
226995|NCT00859053|554559|P3|STARTED|Overall Study||6
226996|NCT00859053|554560|P2|STARTED|Overall Study||6
226997|NCT00859053|554561|P1|STARTED|Overall Study||6
226998|NCT00859131|554605|P2|NOT COMPLETED|Overall Study||0
226999|NCT00859131|554606|P1|NOT COMPLETED|Overall Study||0
227000|NCT00859131|554605|P2|COMPLETED|Overall Study||98
227001|NCT00859131|554606|P1|COMPLETED|Overall Study||102
227002|NCT00859131|554605|P2|STARTED|Overall Study||98
227003|NCT00859131|554606|P1|STARTED|Overall Study||102
227004|NCT00859222|554627|P5|NOT COMPLETED|Overall Study||15
227005|NCT00859222|554628|P4|NOT COMPLETED|Overall Study||24
227006|NCT00859222|554629|P3|NOT COMPLETED|Overall Study||6
227007|NCT00859222|554630|P2|NOT COMPLETED|Overall Study||3
227008|NCT00859222|554631|P1|NOT COMPLETED|Overall Study||3
227009|NCT00859222|554627|P5|COMPLETED|Overall Study||0
227010|NCT00859222|554628|P4|COMPLETED|Overall Study||0
227011|NCT00859222|554629|P3|COMPLETED|Overall Study||0
227012|NCT00859222|554630|P2|COMPLETED|Overall Study||0
227013|NCT00859222|554631|P1|COMPLETED|Overall Study||0
227014|NCT00859222|554627|P5|STARTED|Overall Study||15
227015|NCT00859222|554628|P4|STARTED|Overall Study||24
227016|NCT00859222|554629|P3|STARTED|Overall Study||6
227017|NCT00859222|554630|P2|STARTED|Overall Study||3
227018|NCT00859222|554631|P1|STARTED|Overall Study||3
227019|NCT00859313|554656|P1|NOT COMPLETED|Overall Study||4
227020|NCT00859313|554656|P1|COMPLETED|Overall Study||26
227021|NCT00859313|554656|P1|STARTED|Overall Study||30
227022|NCT00859339|554660|P1|NOT COMPLETED|Overall Study||0
227023|NCT00859339|554660|P1|COMPLETED|Overall Study||9
227024|NCT00859339|554660|P1|STARTED|Overall Study||9
227025|NCT00867321|554671|P6|NOT COMPLETED|Overall Study||0
227026|NCT00867321|554672|P5|NOT COMPLETED|Overall Study||0
227027|NCT00867321|554673|P4|NOT COMPLETED|Overall Study||0
227028|NCT00867321|554674|P3|NOT COMPLETED|Overall Study||0
227029|NCT00867321|554675|P2|NOT COMPLETED|Overall Study||1
227030|NCT00867321|554676|P1|NOT COMPLETED|Overall Study||0
227031|NCT00867321|554671|P6|COMPLETED|Overall Study||3
227032|NCT00867321|554672|P5|COMPLETED|Overall Study||5
227033|NCT00867321|554673|P4|COMPLETED|Overall Study||6
227034|NCT00867321|554674|P3|COMPLETED|Overall Study||3
227035|NCT00867321|554675|P2|COMPLETED|Overall Study||2
227036|NCT00867321|554676|P1|COMPLETED|Overall Study||4
227037|NCT00867321|554671|P6|STARTED|Overall Study||3
227038|NCT00867321|554672|P5|STARTED|Overall Study||5
227039|NCT00867321|554673|P4|STARTED|Overall Study||6
227040|NCT00867321|554674|P3|STARTED|Overall Study||3
227041|NCT00867321|554675|P2|STARTED|Overall Study||3
227042|NCT00867321|554676|P1|STARTED|Overall Study||4
227043|NCT00867360|554696|P2|NOT COMPLETED|Overall Study||1
227044|NCT00867360|554697|P1|NOT COMPLETED|Overall Study||1
227045|NCT00867360|554696|P2|COMPLETED|Overall Study||5
227046|NCT00867360|554697|P1|COMPLETED|Overall Study||3
227047|NCT00867360|554696|P2|STARTED|Overall Study||6
227048|NCT00867360|554697|P1|STARTED|Overall Study||4
227049|NCT00867451|554709|P2|NOT COMPLETED|Overall Study||0
227050|NCT00867451|554710|P1|NOT COMPLETED|Overall Study||0
227051|NCT00867451|554709|P2|COMPLETED|Overall Study||4
227052|NCT00867451|554710|P1|COMPLETED|Overall Study||4
227053|NCT00867451|554709|P2|STARTED|Overall Study||4
227054|NCT00867451|554710|P1|STARTED|Overall Study||4
227055|NCT00867490|554730|P1|NOT COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||0
227056|NCT00867490|554730|P1|COMPLETED|Phase 3 - Aliskiren+HCTZ+Amlodipine||61
227057|NCT00867490|554730|P1|STARTED|Phase 3 - Aliskiren+HCTZ+Amlodipine|The first 60 patients with systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg entered this phase.|61
227058|NCT00867490|554730|P1|NOT COMPLETED|Phase 2 - Aliskiren+HCTZ||3
227059|NCT00867490|554730|P1|COMPLETED|Phase 2 - Aliskiren+HCTZ||120
227060|NCT00867490|554730|P1|STARTED|Phase 2 - Aliskiren+HCTZ|Only patients with mean sitting diastolic BP ≥ 90 mmHg at the end of Phase 1 entered this phase.|123
227061|NCT00867490|554730|P1|NOT COMPLETED|Phase 1 - Candesartan+HCTZ||10
227062|NCT00867490|554730|P1|COMPLETED|Phase 1 - Candesartan+HCTZ||176
227063|NCT00867490|554730|P1|STARTED|Phase 1 - Candesartan+HCTZ||186
227064|NCT00867503|554747|P1|NOT COMPLETED|Overall Study||1
227065|NCT00867503|554747|P1|COMPLETED|Overall Study||9
227066|NCT00867503|554747|P1|STARTED|Overall Study||10
227067|NCT00867529|554753|P1|NOT COMPLETED|Overall Study||0
227068|NCT00867529|554753|P1|COMPLETED|Overall Study||63
227069|NCT00867529|554753|P1|STARTED|Overall Study||63
227070|NCT00867568|554758|P1|NOT COMPLETED|Overall Study||15
227071|NCT00867568|554758|P1|COMPLETED|Overall Study||3
227072|NCT00867568|554758|P1|STARTED|Overall Study||18
227073|NCT00869349|554769|P2|NOT COMPLETED|Overall Study||4
227074|NCT00869349|554770|P1|NOT COMPLETED|Overall Study||7
227075|NCT00869349|554769|P2|COMPLETED|Overall Study||36
227076|NCT00869349|554770|P1|COMPLETED|Overall Study||32
227077|NCT00869349|554769|P2|STARTED|Overall Study||40
227078|NCT00869349|554770|P1|STARTED|Overall Study||39
227079|NCT00869362|554782|P2|NOT COMPLETED|Overall Study||5
227080|NCT00869362|554783|P1|NOT COMPLETED|Overall Study||1
227081|NCT00869362|554782|P2|COMPLETED|Overall Study||11
227082|NCT00869362|554783|P1|COMPLETED|Overall Study||14
227083|NCT00869362|554782|P2|STARTED|Overall Study||16
227084|NCT00869362|554783|P1|STARTED|Overall Study||15
227085|NCT00869375|554793|P2|NOT COMPLETED|Overall Study||0
227086|NCT00869375|554794|P1|NOT COMPLETED|Overall Study||0
227087|NCT00869375|554793|P2|COMPLETED|Overall Study||3
227088|NCT00869375|554794|P1|COMPLETED|Overall Study||3
227089|NCT00869375|554793|P2|STARTED|Overall Study||3
227090|NCT00869375|554794|P1|STARTED|Overall Study||3
227091|NCT00869401|554805|P5|NOT COMPLETED|Overall Study||3
227092|NCT00869401|554806|P4|NOT COMPLETED|Overall Study||5
227093|NCT00869401|554807|P3|NOT COMPLETED|Overall Study||0
227094|NCT00869401|554808|P2|NOT COMPLETED|Overall Study||0
227095|NCT00869401|554809|P1|NOT COMPLETED|Overall Study||0
227096|NCT00869401|554805|P5|COMPLETED|Overall Study||63
227097|NCT00869401|554806|P4|COMPLETED|Overall Study||133
227098|NCT00869401|554807|P3|COMPLETED|Overall Study||7
227099|NCT00869401|554808|P2|COMPLETED|Overall Study||3
227100|NCT00869401|554809|P1|COMPLETED|Overall Study||3
227101|NCT00869401|554805|P5|STARTED|Overall Study||66
227102|NCT00869401|554806|P4|STARTED|Overall Study||138
227103|NCT00869401|554807|P3|STARTED|Overall Study||7
227104|NCT00869401|554808|P2|STARTED|Overall Study||3
227105|NCT00869401|554809|P1|STARTED|Overall Study||3
227106|NCT00869414|554825|P3|NOT COMPLETED|Overall Study||0
227107|NCT00869414|554826|P2|NOT COMPLETED|Overall Study||0
227108|NCT00869414|554827|P1|NOT COMPLETED|Overall Study||0
227109|NCT00869414|554825|P3|COMPLETED|Overall Study||0
227110|NCT00869414|554826|P2|COMPLETED|Overall Study||0
227111|NCT00869414|554827|P1|COMPLETED|Overall Study||0
227112|NCT00869414|554825|P3|STARTED|Overall Study||0
227113|NCT00869414|554826|P2|STARTED|Overall Study||0
227114|NCT00869414|554827|P1|STARTED|Overall Study||0
227115|NCT00869518|554840|P2|NOT COMPLETED|Overall Study||1
227116|NCT00869518|554841|P1|NOT COMPLETED|Overall Study||1
227117|NCT00869518|554840|P2|COMPLETED|Overall Study||5
227118|NCT00869518|554841|P1|COMPLETED|Overall Study||5
227119|NCT00869518|554840|P2|STARTED|Overall Study||6
227120|NCT00869518|554841|P1|STARTED|Overall Study||6
227121|NCT00869557|554855|P2|NOT COMPLETED|Extension Phase||3
227122|NCT00869557|554856|P1|NOT COMPLETED|Extension Phase||10
227123|NCT00869557|554855|P2|COMPLETED|Extension Phase||11
227124|NCT00869557|554856|P1|COMPLETED|Extension Phase||35
227125|NCT00869557|554855|P2|STARTED|Extension Phase|Seven participants completing randomized Atripla treatment did not enter open-label extension phase.|14
227126|NCT00869557|554856|P1|STARTED|Extension Phase||45
227127|NCT00869557|554855|P2|NOT COMPLETED|Randomized Phase||2
227128|NCT00869557|554856|P1|NOT COMPLETED|Randomized Phase||3
227129|NCT00869557|554855|P2|COMPLETED|Randomized Phase||21
227130|NCT00869557|554856|P1|COMPLETED|Randomized Phase||45
227131|NCT00869557|554855|P2|STARTED|Randomized Phase||23
227132|NCT00869557|554856|P1|STARTED|Randomized Phase||48
227133|NCT00869609|554875|P2|NOT COMPLETED|Overall Study||3
227134|NCT00869609|554876|P1|NOT COMPLETED|Overall Study||6
227135|NCT00869609|554875|P2|COMPLETED|Overall Study||26
227136|NCT00869609|554876|P1|COMPLETED|Overall Study||25
227137|NCT00869609|554875|P2|STARTED|Overall Study||29
227138|NCT00869609|554876|P1|STARTED|Overall Study||31
227139|NCT00869622|554902|P2|NOT COMPLETED|Overall Study||14
227140|NCT00869622|554903|P1|NOT COMPLETED|Overall Study||13
227141|NCT00869622|554902|P2|COMPLETED|Overall Study||26
227142|NCT00869622|554903|P1|COMPLETED|Overall Study||27
227143|NCT00869622|554902|P2|STARTED|Overall Study||40
227144|NCT00869622|554903|P1|STARTED|Overall Study||40
227145|NCT00869778|554914|P3|NOT COMPLETED|Overall Study||10
227146|NCT00869778|554915|P2|NOT COMPLETED|Overall Study||7
227147|NCT00869778|554916|P1|NOT COMPLETED|Overall Study||12
227148|NCT00869778|554914|P3|COMPLETED|Overall Study||110
227149|NCT00869778|554915|P2|COMPLETED|Overall Study||113
227150|NCT00869778|554916|P1|COMPLETED|Overall Study||108
227151|NCT00869778|554914|P3|STARTED|Overall Study||120
227152|NCT00869778|554915|P2|STARTED|Overall Study||120
227153|NCT00869778|554916|P1|STARTED|Overall Study||120
227154|NCT00869791|554951|P2|NOT COMPLETED|Period 2 Treatment for 7 Days||0
227155|NCT00869791|554952|P1|NOT COMPLETED|Period 2 Treatment for 7 Days||0
227156|NCT00869791|554951|P2|COMPLETED|Period 2 Treatment for 7 Days||13
227157|NCT00869791|554952|P1|COMPLETED|Period 2 Treatment for 7 Days||14
227158|NCT00869791|554951|P2|STARTED|Period 2 Treatment for 7 Days||13
227159|NCT00869791|554952|P1|STARTED|Period 2 Treatment for 7 Days||14
227160|NCT00869791|554951|P2|NOT COMPLETED|Period 1 Treatment for 7 Days||0
227161|NCT00869791|554952|P1|NOT COMPLETED|Period 1 Treatment for 7 Days||0
227162|NCT00869791|554951|P2|COMPLETED|Period 1 Treatment for 7 Days||13
227163|NCT00869791|554952|P1|COMPLETED|Period 1 Treatment for 7 Days||14
227164|NCT00869791|554951|P2|STARTED|Period 1 Treatment for 7 Days||13
227165|NCT00869791|554952|P1|STARTED|Period 1 Treatment for 7 Days||14
227166|NCT00869947|554972|P2|NOT COMPLETED|Overall Study||0
227167|NCT00869947|554973|P1|NOT COMPLETED|Overall Study||0
227168|NCT00869947|554972|P2|COMPLETED|Overall Study||8
227169|NCT00869947|554973|P1|COMPLETED|Overall Study||8
227170|NCT00869947|554972|P2|STARTED|Overall Study||8
227171|NCT00869947|554973|P1|STARTED|Overall Study||8
227172|NCT00869960|554986|P1|NOT COMPLETED|Overall Study||2
227173|NCT00869960|554986|P1|COMPLETED|Overall Study||22
227174|NCT00869960|554986|P1|STARTED|Overall Study||24
227175|NCT00869999|554997|P1|NOT COMPLETED|Overall Study||2
227176|NCT00869999|554997|P1|COMPLETED|Overall Study||24
227177|NCT00869999|554997|P1|STARTED|Overall Study||26
227178|NCT00870103|555003|P1|NOT COMPLETED|Overall Study||4
227179|NCT00870103|555003|P1|COMPLETED|Overall Study||60
227180|NCT00870103|555003|P1|STARTED|Overall Study||64
227181|NCT00870194|555010|P2|NOT COMPLETED|Overall Study||14
227182|NCT00870194|555011|P1|NOT COMPLETED|Overall Study||26
227183|NCT00870194|555010|P2|COMPLETED|Overall Study||114
227184|NCT00870194|555011|P1|COMPLETED|Overall Study||101
227185|NCT00870194|555010|P2|Per Protocol Set|Overall Study||111
227186|NCT00870194|555011|P1|Per Protocol Set|Overall Study||97
227187|NCT00870194|555010|P2|STARTED|Overall Study||128
227188|NCT00870194|555011|P1|STARTED|Overall Study||127
227189|NCT00870363|555053|P4|NOT COMPLETED|Overall Study||0
227190|NCT00870363|555054|P3|NOT COMPLETED|Overall Study||3
227191|NCT00870363|555055|P2|NOT COMPLETED|Overall Study||3
227192|NCT00870363|555056|P1|NOT COMPLETED|Overall Study||0
227193|NCT00870363|555053|P4|COMPLETED|Overall Study||12
227194|NCT00870363|555054|P3|COMPLETED|Overall Study||8
227195|NCT00870363|555055|P2|COMPLETED|Overall Study||8
227196|NCT00870363|555056|P1|COMPLETED|Overall Study||10
227197|NCT00870363|555053|P4|STARTED|Overall Study||12
227198|NCT00870363|555054|P3|STARTED|Overall Study||11
227199|NCT00870363|555055|P2|STARTED|Overall Study||11
227200|NCT00870363|555056|P1|STARTED|Overall Study||10
227201|NCT00870467|555092|P6|NOT COMPLETED|Open-label||3
227202|NCT00870467|555093|P5|NOT COMPLETED|Open-label||5
227203|NCT00870467|555094|P4|NOT COMPLETED|Open-label||7
227204|NCT00870467|555095|P3|NOT COMPLETED|Open-label||13
227205|NCT00870467|555096|P2|NOT COMPLETED|Open-label||0
227206|NCT00870467|555097|P1|NOT COMPLETED|Open-label||0
227207|NCT00870467|555092|P6|COMPLETED|Open-label||21
227208|NCT00870467|555093|P5|COMPLETED|Open-label||5
227209|NCT00870467|555094|P4|COMPLETED|Open-label||120
227210|NCT00870467|555095|P3|COMPLETED|Open-label||132
227211|NCT00870467|555096|P2|COMPLETED|Open-label||0
227212|NCT00870467|555097|P1|COMPLETED|Open-label||0
227213|NCT00870467|555092|P6|STARTED|Open-label||24
227214|NCT00870467|555093|P5|STARTED|Open-label||10
227215|NCT00870467|555094|P4|STARTED|Open-label||127
227216|NCT00870467|555095|P3|STARTED|Open-label||145
227217|NCT00870467|555096|P2|STARTED|Open-label||0
227218|NCT00870467|555097|P1|STARTED|Open-label||0
227219|NCT00870467|555092|P6|NOT COMPLETED|Double-blind||0
227220|NCT00870467|555093|P5|NOT COMPLETED|Double-blind||0
227221|NCT00870467|555094|P4|NOT COMPLETED|Double-blind||0
227222|NCT00870467|555095|P3|NOT COMPLETED|Double-blind||0
227223|NCT00870467|555096|P2|NOT COMPLETED|Double-blind||12
227224|NCT00870467|555097|P1|NOT COMPLETED|Double-blind||16
227225|NCT00870467|555092|P6|COMPLETED|Double-blind||0
227226|NCT00870467|555093|P5|COMPLETED|Double-blind||0
227227|NCT00870467|555094|P4|COMPLETED|Double-blind||0
227228|NCT00870467|555095|P3|COMPLETED|Double-blind||0
227229|NCT00870467|555096|P2|COMPLETED|Double-blind|24 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|151
227230|NCT00870467|555097|P1|COMPLETED|Double-blind|10 participants who completed 26 weeks received open-label adalimumab 40 mg eow as rescue therapy|155
227231|NCT00870467|555092|P6|STARTED|Double-blind||0
227232|NCT00870467|555093|P5|STARTED|Double-blind||0
227233|NCT00870467|555094|P4|STARTED|Double-blind||0
227234|NCT00870467|555095|P3|STARTED|Double-blind||0
227235|NCT00870467|555096|P2|STARTED|Double-blind||163
227236|NCT00870467|555097|P1|STARTED|Double-blind||171
227237|NCT00870545|555141|P1|NOT COMPLETED|Overall Study||17
227238|NCT00870545|555141|P1|COMPLETED|Overall Study||69
227239|NCT00870545|555141|P1|STARTED|Overall Study||86
227240|NCT00870584|555152|P2|NOT COMPLETED|Overall Study||13
227241|NCT00870584|555153|P1|NOT COMPLETED|Overall Study||16
227242|NCT00870584|555152|P2|COMPLETED|Overall Study||122
227243|NCT00870584|555153|P1|COMPLETED|Overall Study||120
227244|NCT00870584|555152|P2|STARTED|Overall Study||135
227245|NCT00870584|555153|P1|STARTED|Overall Study||136
227246|NCT00870688|555161|P1|NOT COMPLETED|Overall Study||4
227247|NCT00870688|555161|P1|COMPLETED|Overall Study||78
227248|NCT00870688|555161|P1|STARTED|Overall Study||82
227249|NCT00870740|555170|P6|NOT COMPLETED|Overall Study||17
227250|NCT00870740|555171|P5|NOT COMPLETED|Overall Study||11
227251|NCT00870740|555172|P4|NOT COMPLETED|Overall Study||12
227252|NCT00870740|555173|P3|NOT COMPLETED|Overall Study||10
227253|NCT00870740|555174|P2|NOT COMPLETED|Overall Study||9
227254|NCT00870740|555175|P1|NOT COMPLETED|Overall Study||12
227255|NCT00870740|555170|P6|COMPLETED|Overall Study||70
227256|NCT00870740|555171|P5|COMPLETED|Overall Study||77
227257|NCT00870740|555172|P4|COMPLETED|Overall Study||74
227258|NCT00870740|555173|P3|COMPLETED|Overall Study||76
227259|NCT00870740|555174|P2|COMPLETED|Overall Study||75
227260|NCT00870740|555175|P1|COMPLETED|Overall Study||74
227261|NCT00870740|555170|P6|STARTED|Overall Study|number randomized and dosed|87
227262|NCT00870740|555171|P5|STARTED|Overall Study|number randomized and dosed|88
227263|NCT00870740|555172|P4|STARTED|Overall Study|number randomized and dosed|86
227264|NCT00870740|555173|P3|STARTED|Overall Study|number randomized and dosed|86
227265|NCT00870740|555174|P2|STARTED|Overall Study|number randomized and dosed|84
227266|NCT00870740|555175|P1|STARTED|Overall Study|number randomized and dosed|86
227267|NCT00870896|555249|P1|NOT COMPLETED|Overall Study||0
227268|NCT00870896|555249|P1|COMPLETED|Overall Study||5
227269|NCT00870896|555249|P1|STARTED|Overall Study||5
227270|NCT00871000|555257|P2|NOT COMPLETED|Overall Study||0
227271|NCT00871000|555258|P1|NOT COMPLETED|Overall Study||1
227272|NCT00871000|555257|P2|COMPLETED|Overall Study||152
227273|NCT00871000|555258|P1|COMPLETED|Overall Study||150
227274|NCT00871000|555257|P2|STARTED|Overall Study||152
227275|NCT00871000|555258|P1|STARTED|Overall Study||151
227276|NCT00871117|555302|P2|NOT COMPLETED|Overall Study||10
227277|NCT00871117|555303|P1|NOT COMPLETED|Overall Study||5
227278|NCT00871117|555302|P2|COMPLETED|Overall Study||227
227279|NCT00871117|555303|P1|COMPLETED|Overall Study||234
227280|NCT00871117|555302|P2|STARTED|Overall Study||237
227281|NCT00871117|555303|P1|STARTED|Overall Study||239
227282|NCT00871143|555335|P2|NOT COMPLETED|Overall Study||0
227283|NCT00871143|555336|P1|NOT COMPLETED|Overall Study||0
227284|NCT00871143|555335|P2|COMPLETED|Overall Study||25
227285|NCT00871143|555336|P1|COMPLETED|Overall Study||21
227286|NCT00871143|555335|P2|STARTED|Overall Study||25
227287|NCT00871143|555336|P1|STARTED|Overall Study||21
227288|NCT00871169|555354|P1|NOT COMPLETED|Overall Study||3
227289|NCT00871169|555354|P1|COMPLETED|Overall Study||58
227290|NCT00871169|555354|P1|STARTED|Overall Study||61
227291|NCT00871234|555359|P1|NOT COMPLETED|Overall Study||5
227292|NCT00871234|555359|P1|COMPLETED|Overall Study||23
227293|NCT00871234|555359|P1|STARTED|Overall Study||28
227294|NCT00871286|555365|P2|NOT COMPLETED|Overall Study||6
227295|NCT00871286|555366|P1|NOT COMPLETED|Overall Study||0
227296|NCT00871286|555365|P2|COMPLETED|Overall Study||14
227297|NCT00871286|555366|P1|COMPLETED|Overall Study||20
227298|NCT00871286|555365|P2|STARTED|Overall Study||20
227299|NCT00871286|555366|P1|STARTED|Overall Study||20
227300|NCT00871338|555376|P2|NOT COMPLETED|After Booster||0
227301|NCT00871338|555377|P1|NOT COMPLETED|After Booster||0
227302|NCT00871338|555376|P2|COMPLETED|After Booster||135
227303|NCT00871338|555377|P1|COMPLETED|After Booster||139
227304|NCT00871338|555376|P2|STARTED|After Booster||135
227305|NCT00871338|555377|P1|STARTED|After Booster||139
227306|NCT00871338|555376|P2|NOT COMPLETED|Prior to Booster||3
227307|NCT00871338|555377|P1|NOT COMPLETED|Prior to Booster||2
227308|NCT00871338|555376|P2|COMPLETED|Prior to Booster||139
227309|NCT00871338|555377|P1|COMPLETED|Prior to Booster||140
227310|NCT00871338|555376|P2|STARTED|Prior to Booster||142
227311|NCT00871338|555377|P1|STARTED|Prior to Booster||142
227312|NCT00871351|555458|P3|NOT COMPLETED|Overall Study||0
227313|NCT00871351|555459|P2|NOT COMPLETED|Overall Study||1
227314|NCT00871351|555460|P1|NOT COMPLETED|Overall Study||4
227315|NCT00871351|555458|P3|COMPLETED|Overall Study||32
227316|NCT00871351|555459|P2|COMPLETED|Overall Study||45
227317|NCT00871351|555460|P1|COMPLETED|Overall Study||43
227318|NCT00871351|555458|P3|STARTED|Overall Study||32
227319|NCT00871351|555459|P2|STARTED|Overall Study||46
227320|NCT00871351|555460|P1|STARTED|Overall Study||47
227321|NCT00871377|555480|P6|NOT COMPLETED|Third Intervention (10 Weeks)||0
227322|NCT00871377|555481|P5|NOT COMPLETED|Third Intervention (10 Weeks)||0
227323|NCT00871377|555482|P4|NOT COMPLETED|Third Intervention (10 Weeks)||1
227324|NCT00871377|555483|P3|NOT COMPLETED|Third Intervention (10 Weeks)||0
227325|NCT00871377|555484|P2|NOT COMPLETED|Third Intervention (10 Weeks)||0
227326|NCT00871377|555485|P1|NOT COMPLETED|Third Intervention (10 Weeks)||0
227327|NCT00871377|555480|P6|COMPLETED|Third Intervention (10 Weeks)||3
227328|NCT00871377|555481|P5|COMPLETED|Third Intervention (10 Weeks)||4
227329|NCT00871377|555482|P4|COMPLETED|Third Intervention (10 Weeks)||3
227330|NCT00871377|555483|P3|COMPLETED|Third Intervention (10 Weeks)||3
227331|NCT00871377|555484|P2|COMPLETED|Third Intervention (10 Weeks)||4
227332|NCT00871377|555485|P1|COMPLETED|Third Intervention (10 Weeks)||2
227333|NCT00871377|555480|P6|STARTED|Third Intervention (10 Weeks)||3
227334|NCT00871377|555481|P5|STARTED|Third Intervention (10 Weeks)||4
227335|NCT00871377|555482|P4|STARTED|Third Intervention (10 Weeks)||4
227336|NCT00871377|555483|P3|STARTED|Third Intervention (10 Weeks)||3
227337|NCT00871377|555484|P2|STARTED|Third Intervention (10 Weeks)||4
227338|NCT00871377|555485|P1|STARTED|Third Intervention (10 Weeks)||2
227339|NCT00871377|555480|P6|NOT COMPLETED|Washout (6 Weeks)||1
227340|NCT00871377|555481|P5|NOT COMPLETED|Washout (6 Weeks)||0
227341|NCT00871377|555482|P4|NOT COMPLETED|Washout (6 Weeks)||0
227342|NCT00871377|555483|P3|NOT COMPLETED|Washout (6 Weeks)||0
227343|NCT00871377|555484|P2|NOT COMPLETED|Washout (6 Weeks)||0
227344|NCT00871377|555485|P1|NOT COMPLETED|Washout (6 Weeks)||0
227345|NCT00871377|555480|P6|COMPLETED|Washout (6 Weeks)||3
227346|NCT00871377|555481|P5|COMPLETED|Washout (6 Weeks)||4
227347|NCT00871377|555482|P4|COMPLETED|Washout (6 Weeks)||4
227348|NCT00871377|555483|P3|COMPLETED|Washout (6 Weeks)||3
227349|NCT00871377|555484|P2|COMPLETED|Washout (6 Weeks)||4
227350|NCT00871377|555485|P1|COMPLETED|Washout (6 Weeks)||2
227351|NCT00871377|555480|P6|STARTED|Washout (6 Weeks)||4
227352|NCT00871377|555481|P5|STARTED|Washout (6 Weeks)||4
227353|NCT00871377|555482|P4|STARTED|Washout (6 Weeks)||4
227354|NCT00871377|555483|P3|STARTED|Washout (6 Weeks)||3
227355|NCT00871377|555484|P2|STARTED|Washout (6 Weeks)||4
227356|NCT00871377|555485|P1|STARTED|Washout (6 Weeks)||2
227357|NCT00871377|555480|P6|NOT COMPLETED|Second Intervention (10 Weeks)||0
227358|NCT00871377|555481|P5|NOT COMPLETED|Second Intervention (10 Weeks)||0
227359|NCT00871377|555482|P4|NOT COMPLETED|Second Intervention (10 Weeks)||0
227360|NCT00871377|555483|P3|NOT COMPLETED|Second Intervention (10 Weeks)||0
227361|NCT00871377|555484|P2|NOT COMPLETED|Second Intervention (10 Weeks)||0
227362|NCT00871377|555485|P1|NOT COMPLETED|Second Intervention (10 Weeks)||0
227363|NCT00871377|555480|P6|COMPLETED|Second Intervention (10 Weeks)||4
227364|NCT00871377|555481|P5|COMPLETED|Second Intervention (10 Weeks)||4
227365|NCT00871377|555482|P4|COMPLETED|Second Intervention (10 Weeks)||4
227366|NCT00871377|555483|P3|COMPLETED|Second Intervention (10 Weeks)||3
227367|NCT00871377|555484|P2|COMPLETED|Second Intervention (10 Weeks)||4
227368|NCT00871377|555485|P1|COMPLETED|Second Intervention (10 Weeks)||2
227369|NCT00871377|555480|P6|STARTED|Second Intervention (10 Weeks)||4
227370|NCT00871377|555481|P5|STARTED|Second Intervention (10 Weeks)||4
227371|NCT00871377|555482|P4|STARTED|Second Intervention (10 Weeks)||4
227372|NCT00871377|555483|P3|STARTED|Second Intervention (10 Weeks)||3
227373|NCT00871377|555484|P2|STARTED|Second Intervention (10 Weeks)||4
227374|NCT00871377|555485|P1|STARTED|Second Intervention (10 Weeks)||2
227375|NCT00871377|555480|P6|NOT COMPLETED|Washout (6 Weeks)||0
227376|NCT00871377|555481|P5|NOT COMPLETED|Washout (6 Weeks)||0
227377|NCT00871377|555482|P4|NOT COMPLETED|Washout (6 Weeks)||0
227378|NCT00871377|555483|P3|NOT COMPLETED|Washout (6 Weeks)||0
227379|NCT00871377|555484|P2|NOT COMPLETED|Washout (6 Weeks)||0
227380|NCT00871377|555485|P1|NOT COMPLETED|Washout (6 Weeks)||1
227381|NCT00871377|555480|P6|COMPLETED|Washout (6 Weeks)||4
227382|NCT00871377|555481|P5|COMPLETED|Washout (6 Weeks)||4
227383|NCT00871377|555482|P4|COMPLETED|Washout (6 Weeks)||4
227384|NCT00871377|555483|P3|COMPLETED|Washout (6 Weeks)||3
227385|NCT00871377|555484|P2|COMPLETED|Washout (6 Weeks)||4
227386|NCT00871377|555485|P1|COMPLETED|Washout (6 Weeks)||2
227387|NCT00871377|555480|P6|STARTED|Washout (6 Weeks)||4
227388|NCT00871377|555481|P5|STARTED|Washout (6 Weeks)||4
227389|NCT00871377|555482|P4|STARTED|Washout (6 Weeks)||4
227390|NCT00871377|555483|P3|STARTED|Washout (6 Weeks)||3
227391|NCT00871377|555484|P2|STARTED|Washout (6 Weeks)||4
227392|NCT00871377|555485|P1|STARTED|Washout (6 Weeks)||3
227393|NCT00871377|555480|P6|NOT COMPLETED|First Intervention (10 Weeks)||1
227394|NCT00871377|555481|P5|NOT COMPLETED|First Intervention (10 Weeks)||0
227395|NCT00871377|555482|P4|NOT COMPLETED|First Intervention (10 Weeks)||0
227396|NCT00871377|555483|P3|NOT COMPLETED|First Intervention (10 Weeks)||1
227397|NCT00871377|555484|P2|NOT COMPLETED|First Intervention (10 Weeks)||0
227398|NCT00871377|555485|P1|NOT COMPLETED|First Intervention (10 Weeks)||0
227399|NCT00871377|555480|P6|COMPLETED|First Intervention (10 Weeks)||4
227400|NCT00871377|555481|P5|COMPLETED|First Intervention (10 Weeks)||4
227401|NCT00871377|555482|P4|COMPLETED|First Intervention (10 Weeks)||4
227402|NCT00871377|555483|P3|COMPLETED|First Intervention (10 Weeks)||3
227403|NCT00871377|555484|P2|COMPLETED|First Intervention (10 Weeks)||4
227404|NCT00871377|555485|P1|COMPLETED|First Intervention (10 Weeks)||3
227405|NCT00871377|555480|P6|STARTED|First Intervention (10 Weeks)||5
227406|NCT00871377|555481|P5|STARTED|First Intervention (10 Weeks)||4
227407|NCT00871377|555482|P4|STARTED|First Intervention (10 Weeks)||4
227408|NCT00871377|555483|P3|STARTED|First Intervention (10 Weeks)||4
227409|NCT00871377|555484|P2|STARTED|First Intervention (10 Weeks)||4
227410|NCT00871377|555485|P1|STARTED|First Intervention (10 Weeks)||3
227411|NCT00871403|555496|P3|NOT COMPLETED|Monotherapy Treatment Phase||1
227412|NCT00871403|555497|P2|NOT COMPLETED|Monotherapy Treatment Phase||13
227413|NCT00871403|555498|P1|NOT COMPLETED|Monotherapy Treatment Phase||0
227414|NCT00871403|555496|P3|COMPLETED|Monotherapy Treatment Phase||0
227415|NCT00871403|555497|P2|COMPLETED|Monotherapy Treatment Phase||0
227416|NCT00871403|555498|P1|COMPLETED|Monotherapy Treatment Phase||0
227417|NCT00871403|555496|P3|STARTED|Monotherapy Treatment Phase||1
227418|NCT00871403|555497|P2|STARTED|Monotherapy Treatment Phase||13
227419|NCT00871403|555498|P1|STARTED|Monotherapy Treatment Phase||0
227420|NCT00871403|555496|P3|NOT COMPLETED|Combination Treatment Phase||12
227421|NCT00871403|555497|P2|NOT COMPLETED|Combination Treatment Phase||49
227422|NCT00871403|555498|P1|NOT COMPLETED|Combination Treatment Phase||9
227506|NCT00862459|555697|P1|STARTED|Overall Study||72
227423|NCT00871403|555496|P3|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|23
227424|NCT00871403|555497|P2|COMPLETED|Combination Treatment Phase|These participants completed combination treatment|13
227425|NCT00871403|555498|P1|COMPLETED|Combination Treatment Phase|No particiapants completed Combination Treatement.|0
227426|NCT00871403|555496|P3|STARTED|Combination Treatment Phase||35
227427|NCT00871403|555497|P2|STARTED|Combination Treatment Phase||62
227428|NCT00871403|555498|P1|STARTED|Combination Treatment Phase||9
227429|NCT00871429|555511|P1|NOT COMPLETED|Overall Study||24
227430|NCT00871429|555511|P1|COMPLETED|Overall Study||75
227431|NCT00871429|555511|P1|STARTED|Overall Study||99
227432|NCT00871494|555519|P1|NOT COMPLETED|Overall Study||14
227433|NCT00871494|555519|P1|COMPLETED|Overall Study||62
227434|NCT00871494|555519|P1|STARTED|Overall Study||76
227435|NCT00871624|555528|P2|NOT COMPLETED|Overall Study||1
227436|NCT00871624|555529|P1|NOT COMPLETED|Overall Study||2
227437|NCT00871624|555528|P2|COMPLETED|Overall Study||17
227438|NCT00871624|555529|P1|COMPLETED|Overall Study||16
227439|NCT00871624|555528|P2|STARTED|Overall Study||18
227440|NCT00871624|555529|P1|STARTED|Overall Study||18
227441|NCT00871689|555535|P1|NOT COMPLETED|Overall Study||0
227442|NCT00871689|555535|P1|COMPLETED|Overall Study||2
227443|NCT00871689|555535|P1|STARTED|Overall Study||2
227444|NCT00871715|555549|P3|NOT COMPLETED|Overall Study||26
227445|NCT00871715|555550|P2|NOT COMPLETED|Overall Study||16
227446|NCT00871715|555551|P1|NOT COMPLETED|Overall Study||15
227447|NCT00871715|555549|P3|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|96
227448|NCT00871715|555550|P2|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
227449|NCT00871715|555551|P1|COMPLETED|Overall Study|"Completed refers to participants who completed the primary outcome, Wolf Motor Function Test."|104
227450|NCT00871715|555549|P3|6-mo Follow-up|Overall Study||112
227451|NCT00871715|555550|P2|6-mo Follow-up|Overall Study||113
227452|NCT00871715|555551|P1|6-mo Follow-up|Overall Study||110
227453|NCT00871715|555549|P3|Post-Intervention|Overall Study||115
227454|NCT00871715|555550|P2|Post-Intervention|Overall Study||115
227455|NCT00871715|555551|P1|Post-Intervention|Overall Study||112
227456|NCT00871715|555549|P3|STARTED|Overall Study||122
227457|NCT00871715|555550|P2|STARTED|Overall Study||120
227458|NCT00871715|555551|P1|STARTED|Overall Study||119
227459|NCT00871728|555569|P1|NOT COMPLETED|Overall Study||20
227460|NCT00871728|555569|P1|COMPLETED|Overall Study||112
227461|NCT00871728|555569|P1|Treated|Overall Study||130
227462|NCT00871728|555569|P1|STARTED|Overall Study||132
227463|NCT00871741|555581|P2|NOT COMPLETED|Overall Study||7
227464|NCT00871741|555582|P1|NOT COMPLETED|Overall Study||9
227465|NCT00871741|555581|P2|COMPLETED|Overall Study||0
227466|NCT00871741|555582|P1|COMPLETED|Overall Study||0
227467|NCT00871741|555581|P2|STARTED|Overall Study||7
227468|NCT00871741|555582|P1|STARTED|Overall Study||9
227469|NCT00871780|555596|P1|NOT COMPLETED|Overall Study||27
227470|NCT00871780|555596|P1|COMPLETED|Overall Study||197
227471|NCT00871780|555596|P1|Efficacy Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab and completed at least 1 on-treatment evaluation|215
227472|NCT00871780|555596|P1|Safety Analysis Population|Overall Study|participants who had ≥1 infusion of natalizumab during the study|218
227473|NCT00871780|555596|P1|STARTED|Overall Study|number enrolled|224
227474|NCT00871819|555614|P1|NOT COMPLETED|Overall Study||0
227475|NCT00871819|555614|P1|COMPLETED|Overall Study||20
227476|NCT00871819|555614|P1|STARTED|Overall Study||20
227477|NCT00862251|555621|P3|NOT COMPLETED|Overall Study||9
227478|NCT00862251|555622|P2|NOT COMPLETED|Overall Study||5
227479|NCT00862251|555623|P1|NOT COMPLETED|Overall Study||19
227480|NCT00862251|555621|P3|COMPLETED|Overall Study||315
227481|NCT00862251|555622|P2|COMPLETED|Overall Study||157
227482|NCT00862251|555623|P1|COMPLETED|Overall Study||303
227483|NCT00862251|555621|P3|STARTED|Overall Study||324
227484|NCT00862251|555622|P2|STARTED|Overall Study||162
227485|NCT00862251|555623|P1|STARTED|Overall Study||322
227486|NCT00862277|555679|P3|NOT COMPLETED|Overall Study||5
227487|NCT00862277|555680|P2|NOT COMPLETED|Overall Study||2
227488|NCT00862277|555681|P1|NOT COMPLETED|Overall Study||1
227489|NCT00862277|555679|P3|COMPLETED|Overall Study||100
227490|NCT00862277|555680|P2|COMPLETED|Overall Study||94
227491|NCT00862277|555681|P1|COMPLETED|Overall Study||560
227492|NCT00862277|555679|P3|STARTED|Overall Study||105
227493|NCT00862277|555680|P2|STARTED|Overall Study||96
227494|NCT00862277|555681|P1|STARTED|Overall Study||561
227495|NCT00862459|555695|P3|NOT COMPLETED|Overall Study||6
227496|NCT00862459|555696|P2|NOT COMPLETED|Overall Study||8
227497|NCT00862459|555697|P1|NOT COMPLETED|Overall Study||6
227498|NCT00862459|555695|P3|COMPLETED|Overall Study||66
227499|NCT00862459|555696|P2|COMPLETED|Overall Study||85
227500|NCT00862459|555697|P1|COMPLETED|Overall Study||66
227501|NCT00862459|555695|P3|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 68 received Gadobutrol and 69 received OptiMARK|69
227502|NCT00862459|555696|P2|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 90 received Gadobutrol and 88 received OptiMARK|90
227503|NCT00862459|555697|P1|Participants Received Treatment|Overall Study|Number reflects all treated participants of whom 67 received Gadobutrol and 70 received OptiMARK|70
227504|NCT00862459|555695|P3|STARTED|Overall Study||72
227505|NCT00862459|555696|P2|STARTED|Overall Study||93
227507|NCT00862537|555841|P1|NOT COMPLETED|Overall Study||7
227508|NCT00862537|555841|P1|COMPLETED|Overall Study||11
227509|NCT00862537|555841|P1|STARTED|Overall Study||18
227510|NCT00862563|555849|P4|NOT COMPLETED|Overall Study||5
227511|NCT00862563|555850|P3|NOT COMPLETED|Overall Study||6
227512|NCT00862563|555851|P2|NOT COMPLETED|Overall Study||4
227513|NCT00862563|555852|P1|NOT COMPLETED|Overall Study||4
227514|NCT00862563|555849|P4|COMPLETED|Overall Study||19
227515|NCT00862563|555850|P3|COMPLETED|Overall Study||15
227516|NCT00862563|555851|P2|COMPLETED|Overall Study||17
227517|NCT00862563|555852|P1|COMPLETED|Overall Study||15
227518|NCT00862563|555849|P4|STARTED|Overall Study||24
227519|NCT00862563|555850|P3|STARTED|Overall Study||21
227520|NCT00862563|555851|P2|STARTED|Overall Study||21
227521|NCT00862563|555852|P1|STARTED|Overall Study||19
227522|NCT00862641|555894|P4|NOT COMPLETED|Overall Study||4
227523|NCT00862641|555895|P3|NOT COMPLETED|Overall Study||1
227524|NCT00862641|555896|P2|NOT COMPLETED|Overall Study||4
227525|NCT00862641|555897|P1|NOT COMPLETED|Overall Study||1
227526|NCT00862641|555894|P4|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|316
227527|NCT00862641|555895|P3|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|151
227528|NCT00862641|555896|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|356
227529|NCT00862641|555897|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|176
227530|NCT00862641|555894|P4|STARTED|Overall Study||320
227531|NCT00862641|555895|P3|STARTED|Overall Study||152
227532|NCT00862641|555896|P2|STARTED|Overall Study||360
227533|NCT00862641|555897|P1|STARTED|Overall Study||177
227534|NCT00862654|555943|P4|NOT COMPLETED|Overall Study||6
227535|NCT00862654|555944|P3|NOT COMPLETED|Overall Study||6
227536|NCT00862654|555945|P2|NOT COMPLETED|Overall Study||8
227537|NCT00862654|555946|P1|NOT COMPLETED|Overall Study||6
227538|NCT00862654|555943|P4|COMPLETED|Overall Study||74
227539|NCT00862654|555944|P3|COMPLETED|Overall Study||76
227540|NCT00862654|555945|P2|COMPLETED|Overall Study||74
227541|NCT00862654|555946|P1|COMPLETED|Overall Study||76
227542|NCT00862654|555943|P4|STARTED|Overall Study||80
227543|NCT00862654|555944|P3|STARTED|Overall Study||82
227544|NCT00862654|555945|P2|STARTED|Overall Study||82
227545|NCT00862654|555946|P1|STARTED|Overall Study||82
227546|NCT00862719|555960|P4|NOT COMPLETED|Overall Study||1
227547|NCT00862719|555961|P3|NOT COMPLETED|Overall Study||4
227548|NCT00862719|555962|P2|NOT COMPLETED|Overall Study||6
227549|NCT00862719|555963|P1|NOT COMPLETED|Overall Study||10
227550|NCT00862719|555960|P4|COMPLETED|Overall Study||0
227551|NCT00862719|555961|P3|COMPLETED|Overall Study||0
227552|NCT00862719|555962|P2|COMPLETED|Overall Study||1
227553|NCT00862719|555963|P1|COMPLETED|Overall Study||7
227554|NCT00862719|555960|P4|STARTED|Overall Study||1
227555|NCT00862719|555961|P3|STARTED|Overall Study||4
227556|NCT00862719|555962|P2|STARTED|Overall Study||7
227557|NCT00862719|555963|P1|STARTED|Overall Study||17
227558|NCT00862745|555984|P2|NOT COMPLETED|Open-label Follow-up||49
227559|NCT00862745|555985|P1|NOT COMPLETED|Open-label Follow-up||39
227560|NCT00862745|555984|P2|COMPLETED|Open-label Follow-up||225
227561|NCT00862745|555985|P1|COMPLETED|Open-label Follow-up||229
227562|NCT00862745|555984|P2|STARTED|Open-label Follow-up|10 participants elected not to enter the open-label portion of the study after completing the RCT.|274
227563|NCT00862745|555985|P1|STARTED|Open-label Follow-up|19 participants elected not to enter the open-label portion of the study after completing the RCT.|268
227564|NCT00862745|555984|P2|NOT COMPLETED|Randomized Control Trial||39
227565|NCT00862745|555985|P1|NOT COMPLETED|Randomized Control Trial||38
227566|NCT00862745|555984|P2|COMPLETED|Randomized Control Trial||284
227567|NCT00862745|555985|P1|COMPLETED|Randomized Control Trial||284
227568|NCT00862745|555984|P2|STARTED|Randomized Control Trial||323
227569|NCT00862745|555985|P1|STARTED|Randomized Control Trial||322
227570|NCT00862784|555991|P1|NOT COMPLETED|Overall Study||0
227571|NCT00862784|555991|P1|COMPLETED|Overall Study||48
227572|NCT00862784|555991|P1|Received Any Amount of Study Drug|Overall Study||48
227573|NCT00862784|555991|P1|STARTED|Overall Study||48
227574|NCT00862810|556013|P2|NOT COMPLETED|Overall Study||4
227575|NCT00862810|556014|P1|NOT COMPLETED|Overall Study||4
227576|NCT00862810|556013|P2|COMPLETED|Overall Study||35
227577|NCT00862810|556014|P1|COMPLETED|Overall Study||29
227578|NCT00862810|556013|P2|STARTED|Overall Study||39
227579|NCT00862810|556014|P1|STARTED|Overall Study||33
227580|NCT00862823|556020|P2|NOT COMPLETED|Second Intervention||0
227581|NCT00862823|556021|P1|NOT COMPLETED|Second Intervention||0
227582|NCT00862823|556020|P2|COMPLETED|Second Intervention||9
227583|NCT00862823|556021|P1|COMPLETED|Second Intervention||5
227584|NCT00862823|556020|P2|STARTED|Second Intervention||9
227585|NCT00862823|556021|P1|STARTED|Second Intervention||5
227586|NCT00862823|556020|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
227587|NCT00862823|556021|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
227588|NCT00862823|556020|P2|COMPLETED|Washout Period of 2 Weeks||9
227589|NCT00862823|556021|P1|COMPLETED|Washout Period of 2 Weeks||5
227590|NCT00862823|556020|P2|STARTED|Washout Period of 2 Weeks||9
227591|NCT00862823|556021|P1|STARTED|Washout Period of 2 Weeks||5
227592|NCT00862823|556020|P2|NOT COMPLETED|First Intervention||1
227593|NCT00862823|556021|P1|NOT COMPLETED|First Intervention||1
227594|NCT00862823|556020|P2|COMPLETED|First Intervention||9
227595|NCT00862823|556021|P1|COMPLETED|First Intervention||5
227596|NCT00862823|556020|P2|STARTED|First Intervention||10
227597|NCT00862823|556021|P1|STARTED|First Intervention||6
227598|NCT00862836|556028|P1|NOT COMPLETED|Overall Study||1
227599|NCT00862836|556028|P1|COMPLETED|Overall Study||14
227600|NCT00862836|556028|P1|Evaluable for Activity (Tumour Response)|Overall Study||10
227601|NCT00862836|556028|P1|Evaluable for Safety/Toxicity|Overall Study|1 patient withdrew consent before first cycle|14
227602|NCT00862836|556028|P1|STARTED|Overall Study||15
227603|NCT00862849|556039|P6|NOT COMPLETED|Intervention 6||0
227604|NCT00862849|556040|P5|NOT COMPLETED|Intervention 6||0
227605|NCT00862849|556041|P4|NOT COMPLETED|Intervention 6||0
227606|NCT00862849|556042|P3|NOT COMPLETED|Intervention 6||0
227607|NCT00862849|556043|P2|NOT COMPLETED|Intervention 6||0
227608|NCT00862849|556044|P1|NOT COMPLETED|Intervention 6||0
227609|NCT00862849|556039|P6|COMPLETED|Intervention 6||3
227610|NCT00862849|556040|P5|COMPLETED|Intervention 6||4
227611|NCT00862849|556041|P4|COMPLETED|Intervention 6||4
227612|NCT00862849|556042|P3|COMPLETED|Intervention 6||3
227613|NCT00862849|556043|P2|COMPLETED|Intervention 6||3
227614|NCT00862849|556044|P1|COMPLETED|Intervention 6||3
227615|NCT00862849|556039|P6|STARTED|Intervention 6||3
227616|NCT00862849|556040|P5|STARTED|Intervention 6||4
227617|NCT00862849|556041|P4|STARTED|Intervention 6||4
227618|NCT00862849|556042|P3|STARTED|Intervention 6||3
227619|NCT00862849|556043|P2|STARTED|Intervention 6||3
227620|NCT00862849|556044|P1|STARTED|Intervention 6||3
227621|NCT00862849|556039|P6|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
227622|NCT00862849|556040|P5|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
227623|NCT00862849|556041|P4|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
227624|NCT00862849|556042|P3|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
227625|NCT00862849|556043|P2|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
227626|NCT00862849|556044|P1|NOT COMPLETED|Washout 5 (3 to 14 Days)||0
227627|NCT00862849|556039|P6|COMPLETED|Washout 5 (3 to 14 Days)||3
227628|NCT00862849|556040|P5|COMPLETED|Washout 5 (3 to 14 Days)||4
227629|NCT00862849|556041|P4|COMPLETED|Washout 5 (3 to 14 Days)||4
227630|NCT00862849|556042|P3|COMPLETED|Washout 5 (3 to 14 Days)||3
227631|NCT00862849|556043|P2|COMPLETED|Washout 5 (3 to 14 Days)||3
227632|NCT00862849|556044|P1|COMPLETED|Washout 5 (3 to 14 Days)||3
227633|NCT00862849|556039|P6|STARTED|Washout 5 (3 to 14 Days)||3
227634|NCT00862849|556040|P5|STARTED|Washout 5 (3 to 14 Days)||4
227635|NCT00862849|556041|P4|STARTED|Washout 5 (3 to 14 Days)||4
227636|NCT00862849|556042|P3|STARTED|Washout 5 (3 to 14 Days)||3
227637|NCT00862849|556043|P2|STARTED|Washout 5 (3 to 14 Days)||3
227638|NCT00862849|556044|P1|STARTED|Washout 5 (3 to 14 Days)||3
227639|NCT00862849|556039|P6|NOT COMPLETED|Intervention 5||0
227640|NCT00862849|556040|P5|NOT COMPLETED|Intervention 5||0
227641|NCT00862849|556041|P4|NOT COMPLETED|Intervention 5||0
227642|NCT00862849|556042|P3|NOT COMPLETED|Intervention 5||0
227643|NCT00862849|556043|P2|NOT COMPLETED|Intervention 5||0
227644|NCT00862849|556044|P1|NOT COMPLETED|Intervention 5||0
227645|NCT00862849|556039|P6|COMPLETED|Intervention 5||3
227646|NCT00862849|556040|P5|COMPLETED|Intervention 5||4
227647|NCT00862849|556041|P4|COMPLETED|Intervention 5||4
227648|NCT00862849|556042|P3|COMPLETED|Intervention 5||3
227649|NCT00862849|556043|P2|COMPLETED|Intervention 5||3
227650|NCT00862849|556044|P1|COMPLETED|Intervention 5||3
227651|NCT00862849|556039|P6|STARTED|Intervention 5||3
227652|NCT00862849|556040|P5|STARTED|Intervention 5||4
227653|NCT00862849|556041|P4|STARTED|Intervention 5||4
227654|NCT00862849|556042|P3|STARTED|Intervention 5||3
227655|NCT00862849|556043|P2|STARTED|Intervention 5||3
227656|NCT00862849|556044|P1|STARTED|Intervention 5||3
227657|NCT00862849|556039|P6|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
227658|NCT00862849|556040|P5|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
227659|NCT00862849|556041|P4|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
227660|NCT00862849|556042|P3|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
227661|NCT00862849|556043|P2|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
227662|NCT00862849|556044|P1|NOT COMPLETED|Washout 4 (3 to 14 Days)||0
227663|NCT00862849|556039|P6|COMPLETED|Washout 4 (3 to 14 Days)||3
227664|NCT00862849|556040|P5|COMPLETED|Washout 4 (3 to 14 Days)||4
227665|NCT00862849|556041|P4|COMPLETED|Washout 4 (3 to 14 Days)||4
227666|NCT00862849|556042|P3|COMPLETED|Washout 4 (3 to 14 Days)||3
227667|NCT00862849|556043|P2|COMPLETED|Washout 4 (3 to 14 Days)||3
227668|NCT00862849|556044|P1|COMPLETED|Washout 4 (3 to 14 Days)||3
227669|NCT00862849|556039|P6|STARTED|Washout 4 (3 to 14 Days)||3
227670|NCT00862849|556040|P5|STARTED|Washout 4 (3 to 14 Days)||4
227671|NCT00862849|556041|P4|STARTED|Washout 4 (3 to 14 Days)||4
227672|NCT00862849|556042|P3|STARTED|Washout 4 (3 to 14 Days)||3
227673|NCT00862849|556043|P2|STARTED|Washout 4 (3 to 14 Days)||3
227674|NCT00862849|556044|P1|STARTED|Washout 4 (3 to 14 Days)||3
227675|NCT00862849|556039|P6|NOT COMPLETED|Intervention 4||0
227676|NCT00862849|556040|P5|NOT COMPLETED|Intervention 4||0
227677|NCT00862849|556041|P4|NOT COMPLETED|Intervention 4||0
227678|NCT00862849|556042|P3|NOT COMPLETED|Intervention 4||0
227679|NCT00862849|556043|P2|NOT COMPLETED|Intervention 4||0
227680|NCT00862849|556044|P1|NOT COMPLETED|Intervention 4||0
227681|NCT00862849|556039|P6|COMPLETED|Intervention 4||3
227682|NCT00862849|556040|P5|COMPLETED|Intervention 4||4
227683|NCT00862849|556041|P4|COMPLETED|Intervention 4||4
227684|NCT00862849|556042|P3|COMPLETED|Intervention 4||3
227685|NCT00862849|556043|P2|COMPLETED|Intervention 4||3
227686|NCT00862849|556044|P1|COMPLETED|Intervention 4||3
227687|NCT00862849|556039|P6|STARTED|Intervention 4||3
227688|NCT00862849|556040|P5|STARTED|Intervention 4||4
227689|NCT00862849|556041|P4|STARTED|Intervention 4||4
227690|NCT00862849|556042|P3|STARTED|Intervention 4||3
227691|NCT00862849|556043|P2|STARTED|Intervention 4||3
227692|NCT00862849|556044|P1|STARTED|Intervention 4||3
227693|NCT00862849|556039|P6|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
227694|NCT00862849|556040|P5|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
227695|NCT00862849|556041|P4|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
227696|NCT00862849|556042|P3|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
227697|NCT00862849|556043|P2|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
227698|NCT00862849|556044|P1|NOT COMPLETED|Washout 3 (3 to 14 Days)||0
227699|NCT00862849|556039|P6|COMPLETED|Washout 3 (3 to 14 Days)||3
227700|NCT00862849|556040|P5|COMPLETED|Washout 3 (3 to 14 Days)||4
227701|NCT00862849|556041|P4|COMPLETED|Washout 3 (3 to 14 Days)||4
227702|NCT00862849|556042|P3|COMPLETED|Washout 3 (3 to 14 Days)||3
227703|NCT00862849|556043|P2|COMPLETED|Washout 3 (3 to 14 Days)||3
227704|NCT00862849|556044|P1|COMPLETED|Washout 3 (3 to 14 Days)||3
227705|NCT00862849|556039|P6|STARTED|Washout 3 (3 to 14 Days)||3
227706|NCT00862849|556040|P5|STARTED|Washout 3 (3 to 14 Days)||4
227707|NCT00862849|556041|P4|STARTED|Washout 3 (3 to 14 Days)||4
227708|NCT00862849|556042|P3|STARTED|Washout 3 (3 to 14 Days)||3
227709|NCT00862849|556043|P2|STARTED|Washout 3 (3 to 14 Days)||3
227710|NCT00862849|556044|P1|STARTED|Washout 3 (3 to 14 Days)||3
227711|NCT00862849|556039|P6|NOT COMPLETED|Intervention 3||0
227712|NCT00862849|556040|P5|NOT COMPLETED|Intervention 3||0
227713|NCT00862849|556041|P4|NOT COMPLETED|Intervention 3||0
227714|NCT00862849|556042|P3|NOT COMPLETED|Intervention 3||0
227715|NCT00862849|556043|P2|NOT COMPLETED|Intervention 3||0
227716|NCT00862849|556044|P1|NOT COMPLETED|Intervention 3||0
227717|NCT00862849|556039|P6|COMPLETED|Intervention 3||3
227718|NCT00862849|556040|P5|COMPLETED|Intervention 3||4
227719|NCT00862849|556041|P4|COMPLETED|Intervention 3||4
227720|NCT00862849|556042|P3|COMPLETED|Intervention 3||3
227721|NCT00862849|556043|P2|COMPLETED|Intervention 3||3
227722|NCT00862849|556044|P1|COMPLETED|Intervention 3||3
227723|NCT00862849|556039|P6|STARTED|Intervention 3||3
227724|NCT00862849|556040|P5|STARTED|Intervention 3||4
227725|NCT00862849|556041|P4|STARTED|Intervention 3||4
227726|NCT00862849|556042|P3|STARTED|Intervention 3||3
227727|NCT00862849|556043|P2|STARTED|Intervention 3||3
227728|NCT00862849|556044|P1|STARTED|Intervention 3||3
227729|NCT00862849|556039|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
227730|NCT00862849|556040|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
227731|NCT00862849|556041|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
227732|NCT00862849|556042|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
227733|NCT00862849|556043|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||1
227734|NCT00862849|556044|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
227735|NCT00862849|556039|P6|COMPLETED|Washout 2 (3 to 14 Days)||3
227736|NCT00862849|556040|P5|COMPLETED|Washout 2 (3 to 14 Days)||4
227737|NCT00862849|556041|P4|COMPLETED|Washout 2 (3 to 14 Days)||4
227738|NCT00862849|556042|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
227739|NCT00862849|556043|P2|COMPLETED|Washout 2 (3 to 14 Days)||3
227740|NCT00862849|556044|P1|COMPLETED|Washout 2 (3 to 14 Days)||3
227741|NCT00862849|556039|P6|STARTED|Washout 2 (3 to 14 Days)||3
227742|NCT00862849|556040|P5|STARTED|Washout 2 (3 to 14 Days)||4
227743|NCT00862849|556041|P4|STARTED|Washout 2 (3 to 14 Days)||4
227744|NCT00862849|556042|P3|STARTED|Washout 2 (3 to 14 Days)||3
227745|NCT00862849|556043|P2|STARTED|Washout 2 (3 to 14 Days)||4
227746|NCT00862849|556044|P1|STARTED|Washout 2 (3 to 14 Days)||3
227747|NCT00862849|556039|P6|NOT COMPLETED|Intervention 2||0
227748|NCT00862849|556040|P5|NOT COMPLETED|Intervention 2||0
227749|NCT00862849|556041|P4|NOT COMPLETED|Intervention 2||0
227750|NCT00862849|556042|P3|NOT COMPLETED|Intervention 2||0
227751|NCT00862849|556043|P2|NOT COMPLETED|Intervention 2||0
227752|NCT00862849|556044|P1|NOT COMPLETED|Intervention 2||0
227753|NCT00862849|556039|P6|COMPLETED|Intervention 2||3
227754|NCT00862849|556040|P5|COMPLETED|Intervention 2||4
227755|NCT00862849|556041|P4|COMPLETED|Intervention 2||4
227756|NCT00862849|556042|P3|COMPLETED|Intervention 2||3
227757|NCT00862849|556043|P2|COMPLETED|Intervention 2||4
227758|NCT00862849|556044|P1|COMPLETED|Intervention 2||3
227759|NCT00862849|556039|P6|STARTED|Intervention 2||3
227760|NCT00862849|556040|P5|STARTED|Intervention 2||4
227761|NCT00862849|556041|P4|STARTED|Intervention 2||4
227762|NCT00862849|556042|P3|STARTED|Intervention 2||3
227763|NCT00862849|556043|P2|STARTED|Intervention 2||4
227764|NCT00862849|556044|P1|STARTED|Intervention 2||3
227765|NCT00862849|556039|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
227766|NCT00862849|556040|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
227767|NCT00862849|556041|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
227768|NCT00862849|556042|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
227769|NCT00862849|556043|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||1
227770|NCT00862849|556044|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
227771|NCT00862849|556039|P6|COMPLETED|Washout 1 (3 to 14 Days)||3
227772|NCT00862849|556040|P5|COMPLETED|Washout 1 (3 to 14 Days)||4
227773|NCT00862849|556041|P4|COMPLETED|Washout 1 (3 to 14 Days)||4
227774|NCT00862849|556042|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
227775|NCT00862849|556043|P2|COMPLETED|Washout 1 (3 to 14 Days)||4
227776|NCT00862849|556044|P1|COMPLETED|Washout 1 (3 to 14 Days)||3
227777|NCT00862849|556039|P6|STARTED|Washout 1 (3 to 14 Days)||3
227778|NCT00862849|556040|P5|STARTED|Washout 1 (3 to 14 Days)||4
227779|NCT00862849|556041|P4|STARTED|Washout 1 (3 to 14 Days)||4
227780|NCT00862849|556042|P3|STARTED|Washout 1 (3 to 14 Days)||3
227781|NCT00862849|556043|P2|STARTED|Washout 1 (3 to 14 Days)||5
227782|NCT00862849|556044|P1|STARTED|Washout 1 (3 to 14 Days)||3
227783|NCT00862849|556039|P6|NOT COMPLETED|Intervention 1||0
227784|NCT00862849|556040|P5|NOT COMPLETED|Intervention 1||0
227785|NCT00862849|556041|P4|NOT COMPLETED|Intervention 1||0
227786|NCT00862849|556042|P3|NOT COMPLETED|Intervention 1||0
227787|NCT00862849|556043|P2|NOT COMPLETED|Intervention 1||0
227788|NCT00862849|556044|P1|NOT COMPLETED|Intervention 1||0
227789|NCT00862849|556039|P6|COMPLETED|Intervention 1||3
227790|NCT00862849|556040|P5|COMPLETED|Intervention 1||4
227791|NCT00862849|556041|P4|COMPLETED|Intervention 1||4
227792|NCT00862849|556042|P3|COMPLETED|Intervention 1||3
227793|NCT00862849|556043|P2|COMPLETED|Intervention 1||5
227794|NCT00862849|556044|P1|COMPLETED|Intervention 1||3
227795|NCT00862849|556039|P6|Received at Least One Dose of Study Drug|Intervention 1||3
227796|NCT00862849|556040|P5|Received at Least One Dose of Study Drug|Intervention 1||4
227797|NCT00862849|556041|P4|Received at Least One Dose of Study Drug|Intervention 1||4
227798|NCT00862849|556042|P3|Received at Least One Dose of Study Drug|Intervention 1||3
227799|NCT00862849|556043|P2|Received at Least One Dose of Study Drug|Intervention 1||5
227800|NCT00862849|556044|P1|Received at Least One Dose of Study Drug|Intervention 1||3
227801|NCT00862849|556039|P6|STARTED|Intervention 1||3
227802|NCT00862849|556040|P5|STARTED|Intervention 1||4
227803|NCT00862849|556041|P4|STARTED|Intervention 1||4
227804|NCT00862849|556042|P3|STARTED|Intervention 1||3
227805|NCT00862849|556043|P2|STARTED|Intervention 1||5
227806|NCT00862849|556044|P1|STARTED|Intervention 1||3
227807|NCT00862940|556069|P2|NOT COMPLETED|Overall Study||30
227808|NCT00862940|556070|P1|NOT COMPLETED|Overall Study||30
227809|NCT00862940|556069|P2|COMPLETED|Overall Study||114
227810|NCT00862940|556070|P1|COMPLETED|Overall Study||103
227811|NCT00862940|556069|P2|STARTED|Overall Study||144
227812|NCT00862940|556070|P1|STARTED|Overall Study||133
227813|NCT00863057|556086|P4|NOT COMPLETED|Period 4 (Weeks 16-20)||0
227814|NCT00863057|556087|P3|NOT COMPLETED|Period 4 (Weeks 16-20)||0
227815|NCT00863057|556088|P2|NOT COMPLETED|Period 4 (Weeks 16-20)||0
227816|NCT00863057|556089|P1|NOT COMPLETED|Period 4 (Weeks 16-20)||0
227817|NCT00863057|556086|P4|COMPLETED|Period 4 (Weeks 16-20)||2
227818|NCT00863057|556087|P3|COMPLETED|Period 4 (Weeks 16-20)||2
227819|NCT00863057|556088|P2|COMPLETED|Period 4 (Weeks 16-20)||1
227820|NCT00863057|556089|P1|COMPLETED|Period 4 (Weeks 16-20)||3
227821|NCT00863057|556086|P4|STARTED|Period 4 (Weeks 16-20)||2
227822|NCT00863057|556087|P3|STARTED|Period 4 (Weeks 16-20)||2
227823|NCT00863057|556088|P2|STARTED|Period 4 (Weeks 16-20)||1
227824|NCT00863057|556089|P1|STARTED|Period 4 (Weeks 16-20)||3
227825|NCT00863057|556086|P4|NOT COMPLETED|Period 3 (Weeks 11-15)||0
227826|NCT00863057|556087|P3|NOT COMPLETED|Period 3 (Weeks 11-15)||0
227827|NCT00863057|556088|P2|NOT COMPLETED|Period 3 (Weeks 11-15)||0
227828|NCT00863057|556089|P1|NOT COMPLETED|Period 3 (Weeks 11-15)||0
227829|NCT00863057|556086|P4|COMPLETED|Period 3 (Weeks 11-15)||2
227830|NCT00863057|556087|P3|COMPLETED|Period 3 (Weeks 11-15)||2
227831|NCT00863057|556088|P2|COMPLETED|Period 3 (Weeks 11-15)||1
227832|NCT00863057|556089|P1|COMPLETED|Period 3 (Weeks 11-15)||3
227833|NCT00863057|556086|P4|STARTED|Period 3 (Weeks 11-15)||2
227834|NCT00863057|556087|P3|STARTED|Period 3 (Weeks 11-15)||2
227835|NCT00863057|556088|P2|STARTED|Period 3 (Weeks 11-15)||1
227836|NCT00863057|556089|P1|STARTED|Period 3 (Weeks 11-15)||3
227837|NCT00863057|556086|P4|NOT COMPLETED|Period 2 (Weeks 6-10)||1
227838|NCT00863057|556087|P3|NOT COMPLETED|Period 2 (Weeks 6-10)||1
227839|NCT00863057|556088|P2|NOT COMPLETED|Period 2 (Weeks 6-10)||1
227840|NCT00863057|556089|P1|NOT COMPLETED|Period 2 (Weeks 6-10)||0
227841|NCT00863057|556086|P4|COMPLETED|Period 2 (Weeks 6-10)||2
227842|NCT00863057|556087|P3|COMPLETED|Period 2 (Weeks 6-10)||2
227843|NCT00863057|556088|P2|COMPLETED|Period 2 (Weeks 6-10)||1
227844|NCT00863057|556089|P1|COMPLETED|Period 2 (Weeks 6-10)||3
227845|NCT00863057|556086|P4|STARTED|Period 2 (Weeks 6-10)||3
227846|NCT00863057|556087|P3|STARTED|Period 2 (Weeks 6-10)||3
227847|NCT00863057|556088|P2|STARTED|Period 2 (Weeks 6-10)||2
227848|NCT00863057|556089|P1|STARTED|Period 2 (Weeks 6-10)||3
227849|NCT00863057|556086|P4|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
227850|NCT00863057|556087|P3|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||0
227851|NCT00863057|556088|P2|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||2
227852|NCT00863057|556089|P1|NOT COMPLETED|Milestones Period 1 (Weeks 0-5)||1
227853|NCT00863057|556086|P4|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
227854|NCT00863057|556087|P3|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
227855|NCT00863057|556088|P2|COMPLETED|Milestones Period 1 (Weeks 0-5)||2
227856|NCT00863057|556089|P1|COMPLETED|Milestones Period 1 (Weeks 0-5)||3
227857|NCT00863057|556086|P4|STARTED|Milestones Period 1 (Weeks 0-5)||4
227858|NCT00863057|556087|P3|STARTED|Milestones Period 1 (Weeks 0-5)||3
227859|NCT00863057|556088|P2|STARTED|Milestones Period 1 (Weeks 0-5)||4
227860|NCT00863057|556089|P1|STARTED|Milestones Period 1 (Weeks 0-5)||4
227861|NCT00863109|556129|P1|NOT COMPLETED|Follow-up Period||11
227862|NCT00863109|556129|P1|COMPLETED|Follow-up Period||48
227863|NCT00863109|556129|P1|STARTED|Follow-up Period|Follow-up performed on 53 who completed Treatment Period plus 6 who discontinued treatment|59
227864|NCT00863109|556129|P1|NOT COMPLETED|Treatment Period||77
227865|NCT00863109|556129|P1|COMPLETED|Treatment Period||53
227866|NCT00863109|556129|P1|STARTED|Treatment Period||130
227867|NCT00863317|556144|P2|NOT COMPLETED|Overall Study||9
227868|NCT00863317|556145|P1|NOT COMPLETED|Overall Study||8
227869|NCT00863317|556144|P2|COMPLETED|Overall Study||64
227870|NCT00863317|556145|P1|COMPLETED|Overall Study||60
227871|NCT00863317|556144|P2|STARTED|Overall Study||73
227872|NCT00863317|556145|P1|STARTED|Overall Study||68
227873|NCT00863330|556151|P1|NOT COMPLETED|Overall Study||6
227874|NCT00863330|556151|P1|COMPLETED|Overall Study||0
227875|NCT00863330|556151|P1|STARTED|Overall Study||6
227876|NCT00863343|556157|P2|NOT COMPLETED|Overall Study||0
227877|NCT00863343|556158|P1|NOT COMPLETED|Overall Study||0
227878|NCT00863343|556157|P2|COMPLETED|Overall Study||374
227879|NCT00863343|556158|P1|COMPLETED|Overall Study||17
227880|NCT00863343|556157|P2|STARTED|Overall Study||374
227881|NCT00863343|556158|P1|STARTED|Overall Study||17
227882|NCT00863356|556170|P1|NOT COMPLETED|Overall Study||0
227883|NCT00863356|556170|P1|COMPLETED|Overall Study||20
227884|NCT00863356|556170|P1|STARTED|Overall Study||20
227885|NCT00863434|556174|P1|NOT COMPLETED|Overall Study||0
227886|NCT00863434|556174|P1|COMPLETED|Overall Study||2
227887|NCT00863434|556174|P1|STARTED|Overall Study||2
227888|NCT00863512|556182|P2|NOT COMPLETED|Overall Study||0
227889|NCT00863512|556183|P1|NOT COMPLETED|Overall Study||14
227890|NCT00863512|556182|P2|COMPLETED|Overall Study||17
227891|NCT00863512|556183|P1|COMPLETED|Overall Study||3
227892|NCT00863512|556182|P2|STARTED|Overall Study||17
227893|NCT00863512|556183|P1|STARTED|Overall Study||17
227894|NCT00863551|556189|P1|NOT COMPLETED|Overall Study||0
227895|NCT00863551|556189|P1|COMPLETED|Overall Study||12
227896|NCT00863551|556189|P1|STARTED|Overall Study||12
227897|NCT00863655|556199|P2|NOT COMPLETED|Overall Study||239
227898|NCT00863655|556200|P1|NOT COMPLETED|Overall Study||485
227899|NCT00863655|556199|P2|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
227900|NCT00863655|556200|P1|COMPLETED|Overall Study|Completed means discontinued the treatment period.|0
227901|NCT00863655|556199|P2|STARTED|Overall Study||239
227902|NCT00863655|556200|P1|STARTED|Overall Study||485
227903|NCT00863707|556229|P2|NOT COMPLETED|Overall Study||3
227904|NCT00863707|556230|P1|NOT COMPLETED|Overall Study||4
227905|NCT00863707|556229|P2|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|334
227906|NCT00863707|556230|P1|COMPLETED|Overall Study|Completed Population is equal to Safety Analysis Set (SAF)|170
227907|NCT00863707|556229|P2|STARTED|Overall Study||337
227908|NCT00863707|556230|P1|STARTED|Overall Study||174
227909|NCT00863746|556238|P2|NOT COMPLETED|Survival Follow up||280
227910|NCT00863746|556239|P1|NOT COMPLETED|Survival Follow up||253
227911|NCT00863746|556238|P2|COMPLETED|Survival Follow up||51
227912|NCT00863746|556239|P1|COMPLETED|Survival Follow up||45
227913|NCT00863746|556238|P2|STARTED|Survival Follow up|331 patients of 339 patients (=353 randomized - 14 death) entered the survival follow-up.|331
227914|NCT00863746|556239|P1|STARTED|Survival Follow up|298 patients of 317 patients (= 346 randomized - 29 deaths) entered the survival follow-up|298
227915|NCT00863746|556238|P2|NOT COMPLETED|Treatment||35
227916|NCT00863746|556239|P1|NOT COMPLETED|Treatment||71
227917|NCT00863746|556238|P2|COMPLETED|Treatment||318
227918|NCT00863746|556239|P1|COMPLETED|Treatment||279
227919|NCT00863746|556238|P2|Participants Received Treatment|Treatment|Safety population|351
227920|NCT00863746|556239|P1|Participants Received Treatment|Treatment|Safety population|346
227921|NCT00863746|556238|P2|STARTED|Treatment||353
227922|NCT00863746|556239|P1|STARTED|Treatment||350
227923|NCT00863798|556266|P3|NOT COMPLETED|Overall Study||25
227924|NCT00863798|556267|P2|NOT COMPLETED|Overall Study||30
227925|NCT00863798|556268|P1|NOT COMPLETED|Overall Study||32
227926|NCT00863798|556266|P3|COMPLETED|Overall Study||202
227927|NCT00863798|556267|P2|COMPLETED|Overall Study||198
227928|NCT00863798|556268|P1|COMPLETED|Overall Study||195
227929|NCT00863798|556266|P3|Treated|Overall Study||224
227930|NCT00863798|556267|P2|Treated|Overall Study||226
227931|NCT00863798|556268|P1|Treated|Overall Study||223
227932|NCT00863798|556266|P3|STARTED|Overall Study||227
227933|NCT00863798|556267|P2|STARTED|Overall Study||228
227934|NCT00863798|556268|P1|STARTED|Overall Study||227
227935|NCT00864032|556318|P3|NOT COMPLETED|Overall Study||0
227936|NCT00864032|556319|P2|NOT COMPLETED|Overall Study||0
227937|NCT00864032|556320|P1|NOT COMPLETED|Overall Study||0
227938|NCT00864032|556318|P3|COMPLETED|Overall Study||0
227939|NCT00864032|556319|P2|COMPLETED|Overall Study||5
227940|NCT00864032|556320|P1|COMPLETED|Overall Study||3
227941|NCT00864032|556318|P3|STARTED|Overall Study||0
227942|NCT00864032|556319|P2|STARTED|Overall Study||5
227943|NCT00864032|556320|P1|STARTED|Overall Study||3
227944|NCT00864084|556326|P1|NOT COMPLETED|Overall Study||3
227945|NCT00864084|556326|P1|COMPLETED|Overall Study||11
227946|NCT00864084|556326|P1|STARTED|Overall Study||14
227947|NCT00864123|556351|P2|NOT COMPLETED|Overall Study||0
227948|NCT00864123|556352|P1|NOT COMPLETED|Overall Study||0
227949|NCT00864123|556351|P2|COMPLETED|Overall Study||15
227950|NCT00864123|556352|P1|COMPLETED|Overall Study||15
227951|NCT00864123|556351|P2|STARTED|Overall Study||15
227952|NCT00864123|556352|P1|STARTED|Overall Study||15
227953|NCT00864227|556362|P1|NOT COMPLETED|Overall Study||4
227954|NCT00864227|556362|P1|COMPLETED|Overall Study||50
227955|NCT00864227|556362|P1|STARTED|Overall Study||54
227956|NCT00864253|556379|P2|NOT COMPLETED|Overall Study||58
227957|NCT00864253|556380|P1|NOT COMPLETED|Overall Study||99
227958|NCT00864253|556379|P2|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|207
227959|NCT00864253|556380|P1|COMPLETED|Overall Study|Completed = defined as discontinuation due to progressive disease|165
227960|NCT00864253|556379|P2|Treated|Overall Study||258
227961|NCT00864253|556380|P1|Treated|Overall Study||257
227962|NCT00864253|556379|P2|STARTED|Overall Study||265
227963|NCT00864253|556380|P1|STARTED|Overall Study||264
227964|NCT00864383|556413|P3|NOT COMPLETED|Modified Intent to Treat||85
227965|NCT00864383|556414|P2|NOT COMPLETED|Modified Intent to Treat||87
227966|NCT00864383|556415|P1|NOT COMPLETED|Modified Intent to Treat||85
227967|NCT00864383|556413|P3|COMPLETED|Modified Intent to Treat||551
227968|NCT00864383|556414|P2|COMPLETED|Modified Intent to Treat||568
227969|NCT00864383|556415|P1|COMPLETED|Modified Intent to Treat||555
227970|NCT00864383|556413|P3|STARTED|Modified Intent to Treat||636
227971|NCT00864383|556414|P2|STARTED|Modified Intent to Treat||655
227972|NCT00864383|556415|P1|STARTED|Modified Intent to Treat||640
227973|NCT00864383|556413|P3|NOT COMPLETED|Per- Protocol||112
227974|NCT00864383|556414|P2|NOT COMPLETED|Per- Protocol||141
227975|NCT00864383|556415|P1|NOT COMPLETED|Per- Protocol||130
227976|NCT00864383|556413|P3|COMPLETED|Per- Protocol||524
227977|NCT00864383|556414|P2|COMPLETED|Per- Protocol||514
227978|NCT00864383|556415|P1|COMPLETED|Per- Protocol||510
227979|NCT00864383|556413|P3|STARTED|Per- Protocol||636
227980|NCT00864383|556414|P2|STARTED|Per- Protocol||655
227981|NCT00864383|556415|P1|STARTED|Per- Protocol||640
227982|NCT00864513|556447|P1|NOT COMPLETED|Overall Study||3
227983|NCT00864513|556447|P1|COMPLETED|Overall Study||12
227984|NCT00864513|556447|P1|STARTED|Overall Study||15
227985|NCT00864539|556460|P6|NOT COMPLETED|Overall Study||14
227986|NCT00864539|556461|P5|NOT COMPLETED|Overall Study||22
227987|NCT00864539|556462|P4|NOT COMPLETED|Overall Study||7
227988|NCT00864539|556463|P3|NOT COMPLETED|Overall Study||10
227989|NCT00864539|556464|P2|NOT COMPLETED|Overall Study||23
227990|NCT00864539|556465|P1|NOT COMPLETED|Overall Study||9
227991|NCT00864539|556460|P6|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|71
227992|NCT00864539|556461|P5|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|81
227993|NCT00864539|556462|P4|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|89
227994|NCT00864539|556463|P3|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|92
227995|NCT00864539|556464|P2|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|72
227996|NCT00864539|556465|P1|COMPLETED|Overall Study|Attrition was due to absence or unwillingness to donate blood.|95
227997|NCT00864539|556460|P6|STARTED|Overall Study||85
227998|NCT00864539|556461|P5|STARTED|Overall Study||103
227999|NCT00864539|556462|P4|STARTED|Overall Study||96
228000|NCT00864539|556463|P3|STARTED|Overall Study||102
228001|NCT00864539|556464|P2|STARTED|Overall Study||95
228002|NCT00864539|556465|P1|STARTED|Overall Study||104
228003|NCT00864682|556482|P3|NOT COMPLETED|Overall Study||2
228004|NCT00864682|556483|P2|NOT COMPLETED|Overall Study||1
228005|NCT00864682|556484|P1|NOT COMPLETED|Overall Study||2
228006|NCT00864682|556482|P3|COMPLETED|Overall Study||51
228007|NCT00864682|556483|P2|COMPLETED|Overall Study||50
228008|NCT00864682|556484|P1|COMPLETED|Overall Study||50
228009|NCT00864682|556482|P3|STARTED|Overall Study||53
228010|NCT00864682|556483|P2|STARTED|Overall Study||51
228011|NCT00864682|556484|P1|STARTED|Overall Study||52
228012|NCT00864708|556498|P1|NOT COMPLETED|Overall Study||0
228013|NCT00864708|556498|P1|COMPLETED|Overall Study||1
228014|NCT00864708|556498|P1|STARTED|Overall Study||1
228015|NCT00871871|556509|P4|NOT COMPLETED|Part II||4
228016|NCT00871871|556510|P3|NOT COMPLETED|Part II||4
228017|NCT00871871|556511|P2|NOT COMPLETED|Part II||0
228018|NCT00871871|556512|P1|NOT COMPLETED|Part II||0
228019|NCT00871871|556509|P4|COMPLETED|Part II||11
228020|NCT00871871|556510|P3|COMPLETED|Part II||9
228021|NCT00871871|556511|P2|COMPLETED|Part II||0
228022|NCT00871871|556512|P1|COMPLETED|Part II||0
228023|NCT00871871|556509|P4|STARTED|Part II||15
228024|NCT00871871|556510|P3|STARTED|Part II||13
228025|NCT00871871|556511|P2|STARTED|Part II||0
228026|NCT00871871|556512|P1|STARTED|Part II||0
228027|NCT00871871|556509|P4|NOT COMPLETED|Part I||0
228028|NCT00871871|556510|P3|NOT COMPLETED|Part I||0
228029|NCT00871871|556511|P2|NOT COMPLETED|Part I||3
228030|NCT00871871|556512|P1|NOT COMPLETED|Part I||3
228031|NCT00871871|556509|P4|COMPLETED|Part I||0
228032|NCT00871871|556510|P3|COMPLETED|Part I||0
228033|NCT00871871|556511|P2|COMPLETED|Part I||15
228034|NCT00871871|556512|P1|COMPLETED|Part I||15
228035|NCT00871871|556509|P4|STARTED|Part I||0
228036|NCT00871871|556510|P3|STARTED|Part I||0
228037|NCT00871871|556511|P2|STARTED|Part I||18
228038|NCT00871871|556512|P1|STARTED|Part I||18
228039|NCT00871975|556532|P1|NOT COMPLETED|Overall Study||22
228040|NCT00871975|556532|P1|COMPLETED|Overall Study||133
228041|NCT00871975|556532|P1|STARTED|Overall Study||155
228042|NCT00872001|556538|P2|NOT COMPLETED|Overall Study||131
228043|NCT00872001|556539|P1|NOT COMPLETED|Overall Study||136
228044|NCT00872001|556538|P2|COMPLETED|Overall Study||1413
228045|NCT00872001|556539|P1|COMPLETED|Overall Study||1400
228046|NCT00872001|556538|P2|STARTED|Overall Study||1544
228047|NCT00872001|556539|P1|STARTED|Overall Study||1536
228048|NCT00872027|556549|P2|NOT COMPLETED|Overall Study||0
228049|NCT00872027|556550|P1|NOT COMPLETED|Overall Study||0
228050|NCT00872027|556549|P2|COMPLETED|Overall Study||8
228051|NCT00872027|556550|P1|COMPLETED|Overall Study||7
228052|NCT00872027|556549|P2|STARTED|Overall Study||8
228053|NCT00872027|556550|P1|STARTED|Overall Study||7
228054|NCT00872079|556556|P1|NOT COMPLETED|Overall Study||0
228055|NCT00872079|556556|P1|COMPLETED|Overall Study||175
228056|NCT00872079|556556|P1|STARTED|Overall Study||175
228057|NCT00872170|556562|P2|NOT COMPLETED|Overall Study||0
228058|NCT00872170|556563|P1|NOT COMPLETED|Overall Study||1
228059|NCT00872170|556562|P2|COMPLETED|Overall Study||13
228060|NCT00872170|556563|P1|COMPLETED|Overall Study|One patient withdrew from study at week 2.|13
228061|NCT00872170|556562|P2|STARTED|Overall Study||13
228062|NCT00872170|556563|P1|STARTED|Overall Study||14
228063|NCT00872339|556581|P3|NOT COMPLETED|Overall Study||0
228064|NCT00872339|556582|P2|NOT COMPLETED|Overall Study||0
228065|NCT00872339|556583|P1|NOT COMPLETED|Overall Study||0
228066|NCT00872339|556581|P3|COMPLETED|Overall Study||37
228067|NCT00872339|556582|P2|COMPLETED|Overall Study||14
228068|NCT00872339|556583|P1|COMPLETED|Overall Study||201
228069|NCT00872339|556581|P3|STARTED|Overall Study||37
228070|NCT00872339|556582|P2|STARTED|Overall Study||14
228071|NCT00872339|556583|P1|STARTED|Overall Study||201
228072|NCT00872430|556594|P2|NOT COMPLETED|Second Intervention||0
228073|NCT00872430|556595|P1|NOT COMPLETED|Second Intervention||0
228074|NCT00872430|556594|P2|COMPLETED|Second Intervention||10
228075|NCT00872430|556595|P1|COMPLETED|Second Intervention||10
228076|NCT00872430|556594|P2|STARTED|Second Intervention||10
228077|NCT00872430|556595|P1|STARTED|Second Intervention||10
228078|NCT00872430|556594|P2|NOT COMPLETED|Washout Period||0
228079|NCT00872430|556595|P1|NOT COMPLETED|Washout Period||0
228080|NCT00872430|556594|P2|COMPLETED|Washout Period||10
228081|NCT00872430|556595|P1|COMPLETED|Washout Period||10
228082|NCT00872430|556594|P2|STARTED|Washout Period||10
228083|NCT00872430|556595|P1|STARTED|Washout Period||10
228084|NCT00872430|556594|P2|NOT COMPLETED|First Intervention||0
228085|NCT00872430|556595|P1|NOT COMPLETED|First Intervention||0
228086|NCT00872430|556594|P2|COMPLETED|First Intervention||10
228087|NCT00872430|556595|P1|COMPLETED|First Intervention||10
228088|NCT00872430|556594|P2|STARTED|First Intervention||10
228089|NCT00872430|556595|P1|STARTED|First Intervention||10
228090|NCT00872521|556604|P3|NOT COMPLETED|Secondary Endpoint Analysis||1
228091|NCT00872521|556605|P2|NOT COMPLETED|Secondary Endpoint Analysis||2
228092|NCT00872521|556606|P1|NOT COMPLETED|Secondary Endpoint Analysis||0
228093|NCT00872521|556604|P3|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|7
228094|NCT00872521|556605|P2|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|58
228095|NCT00872521|556606|P1|COMPLETED|Secondary Endpoint Analysis|Participants analyzed for secondary endpoint|20
228096|NCT00872521|556604|P3|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|8
228097|NCT00872521|556605|P2|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|60
228098|NCT00872521|556606|P1|STARTED|Secondary Endpoint Analysis|Completed 3-month follow-up|20
228099|NCT00872521|556604|P3|NOT COMPLETED|Completed 3-month Follow up||0
228100|NCT00872521|556605|P2|NOT COMPLETED|Completed 3-month Follow up||3
228101|NCT00872521|556606|P1|NOT COMPLETED|Completed 3-month Follow up||0
228102|NCT00872521|556604|P3|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|8
228103|NCT00872521|556605|P2|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|60
228104|NCT00872521|556606|P1|COMPLETED|Completed 3-month Follow up|Completed 3-month follow-up|20
228105|NCT00872521|556604|P3|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|8
228106|NCT00872521|556605|P2|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|63
228107|NCT00872521|556606|P1|STARTED|Completed 3-month Follow up|Participants analyzed for primary endpoint|20
228108|NCT00872521|556604|P3|NOT COMPLETED|Primary Endpoint Analysis||1
228109|NCT00872521|556605|P2|NOT COMPLETED|Primary Endpoint Analysis||5
228110|NCT00872521|556606|P1|NOT COMPLETED|Primary Endpoint Analysis||1
228111|NCT00872521|556604|P3|COMPLETED|Primary Endpoint Analysis|participants analyzed|8
228112|NCT00872521|556605|P2|COMPLETED|Primary Endpoint Analysis|participants analyzed|63
228113|NCT00872521|556606|P1|COMPLETED|Primary Endpoint Analysis|participants analyzed|20
228114|NCT00872521|556604|P3|STARTED|Primary Endpoint Analysis|Completed PAD induction|9
228115|NCT00872521|556605|P2|STARTED|Primary Endpoint Analysis|Completed PAD induction|68
228116|NCT00872521|556606|P1|STARTED|Primary Endpoint Analysis|Completed PAD induction|21
228117|NCT00872521|556604|P3|NOT COMPLETED|Completed PAD Induction||0
228118|NCT00872521|556605|P2|NOT COMPLETED|Completed PAD Induction||4
228119|NCT00872521|556606|P1|NOT COMPLETED|Completed PAD Induction||5
228120|NCT00872521|556604|P3|COMPLETED|Completed PAD Induction|Completed PAD induction|9
228121|NCT00872521|556605|P2|COMPLETED|Completed PAD Induction|Completed PAD induction|68
228122|NCT00872521|556606|P1|COMPLETED|Completed PAD Induction|Completed PAD induction|21
228123|NCT00872521|556604|P3|STARTED|Completed PAD Induction|Received allocated treatment|9
228124|NCT00872521|556605|P2|STARTED|Completed PAD Induction|Received allocated treatment|72
228125|NCT00872521|556606|P1|STARTED|Completed PAD Induction|Received allocated treatment|26
228126|NCT00872534|556654|P2|NOT COMPLETED|Overall Study||3
228127|NCT00872534|556655|P1|NOT COMPLETED|Overall Study||3
228128|NCT00872534|556654|P2|COMPLETED|Overall Study||101
228129|NCT00872534|556655|P1|COMPLETED|Overall Study||97
228130|NCT00872534|556654|P2|STARTED|Overall Study||104
228131|NCT00872534|556655|P1|STARTED|Overall Study||100
228132|NCT00872599|556661|P2|NOT COMPLETED|Second Drug During High Salt Intake||0
228133|NCT00872599|556662|P1|NOT COMPLETED|Second Drug During High Salt Intake||0
228134|NCT00872599|556661|P2|COMPLETED|Second Drug During High Salt Intake||16
228135|NCT00872599|556662|P1|COMPLETED|Second Drug During High Salt Intake||15
228136|NCT00872599|556661|P2|STARTED|Second Drug During High Salt Intake||16
228137|NCT00872599|556662|P1|STARTED|Second Drug During High Salt Intake||15
228138|NCT00872599|556661|P2|NOT COMPLETED|Second Washout Period||1
228139|NCT00872599|556662|P1|NOT COMPLETED|Second Washout Period||1
228140|NCT00872599|556661|P2|COMPLETED|Second Washout Period||16
228141|NCT00872599|556662|P1|COMPLETED|Second Washout Period||15
228142|NCT00872599|556661|P2|STARTED|Second Washout Period||17
228143|NCT00872599|556662|P1|STARTED|Second Washout Period||16
228144|NCT00872599|556661|P2|NOT COMPLETED|First Drug During High Salt Intake||0
228145|NCT00872599|556662|P1|NOT COMPLETED|First Drug During High Salt Intake||0
228146|NCT00872599|556661|P2|COMPLETED|First Drug During High Salt Intake||17
228147|NCT00872599|556662|P1|COMPLETED|First Drug During High Salt Intake||16
228148|NCT00872599|556661|P2|STARTED|First Drug During High Salt Intake||17
228149|NCT00872599|556662|P1|STARTED|First Drug During High Salt Intake||16
228150|NCT00872599|556661|P2|NOT COMPLETED|First Washout Period After Low Salt||0
228151|NCT00872599|556662|P1|NOT COMPLETED|First Washout Period After Low Salt||0
228152|NCT00872599|556661|P2|COMPLETED|First Washout Period After Low Salt||17
228153|NCT00872599|556662|P1|COMPLETED|First Washout Period After Low Salt||16
228154|NCT00872599|556661|P2|STARTED|First Washout Period After Low Salt||17
228155|NCT00872599|556662|P1|STARTED|First Washout Period After Low Salt||16
228156|NCT00872729|556670|P1|NOT COMPLETED|Overall Study||0
228157|NCT00872729|556670|P1|COMPLETED|Overall Study||9
228158|NCT00872729|556670|P1|STARTED|Overall Study||9
228159|NCT00872833|556700|P2|NOT COMPLETED|Overall Study||0
228160|NCT00872833|556701|P1|NOT COMPLETED|Overall Study||0
228161|NCT00872833|556700|P2|COMPLETED|Overall Study||17
228162|NCT00872833|556701|P1|COMPLETED|Overall Study||15
228163|NCT00872833|556700|P2|STARTED|Overall Study||17
228164|NCT00872833|556701|P1|STARTED|Overall Study||15
228165|NCT00872898|556713|P2|NOT COMPLETED|Part Two - Double Blind||6
228166|NCT00872898|556714|P1|NOT COMPLETED|Part Two - Double Blind||11
228167|NCT00872898|556713|P2|COMPLETED|Part Two - Double Blind||54
228168|NCT00872898|556714|P1|COMPLETED|Part Two - Double Blind||50
228169|NCT00872898|556713|P2|STARTED|Part Two - Double Blind||60
228170|NCT00872898|556714|P1|STARTED|Part Two - Double Blind||61
228171|NCT00872898|556713|P2|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
228172|NCT00872898|556714|P1|NOT COMPLETED|Part One - Open Label, Pharmacokinetics||0
228173|NCT00872898|556713|P2|COMPLETED|Part One - Open Label, Pharmacokinetics||4
228174|NCT00872898|556714|P1|COMPLETED|Part One - Open Label, Pharmacokinetics||0
228175|NCT00872898|556713|P2|STARTED|Part One - Open Label, Pharmacokinetics||4
228176|NCT00872898|556714|P1|STARTED|Part One - Open Label, Pharmacokinetics||0
228177|NCT00872989|556750|P2|NOT COMPLETED|Overall Study||63
228178|NCT00872989|556751|P1|NOT COMPLETED|Overall Study||65
228179|NCT00872989|556750|P2|COMPLETED|Overall Study||0
228180|NCT00872989|556751|P1|COMPLETED|Overall Study||1
228181|NCT00872989|556750|P2|STARTED|Overall Study||63
228182|NCT00872989|556751|P1|STARTED|Overall Study||66
228183|NCT00873015|556771|P4|NOT COMPLETED|Overall Study||0
228184|NCT00873015|556772|P3|NOT COMPLETED|Overall Study||0
228185|NCT00873015|556773|P2|NOT COMPLETED|Overall Study||1
228186|NCT00873015|556774|P1|NOT COMPLETED|Overall Study||0
228187|NCT00873015|556771|P4|COMPLETED|Overall Study||3
228188|NCT00873015|556772|P3|COMPLETED|Overall Study||3
228189|NCT00873015|556773|P2|COMPLETED|Overall Study||3
228190|NCT00873015|556774|P1|COMPLETED|Overall Study||9
228191|NCT00873015|556771|P4|STARTED|Overall Study||3
228192|NCT00873015|556772|P3|STARTED|Overall Study||3
228193|NCT00873015|556773|P2|STARTED|Overall Study||4
228194|NCT00873015|556774|P1|STARTED|Overall Study||9
228195|NCT00873041|556784|P3|NOT COMPLETED|Extension Study||2
228196|NCT00873041|556785|P2|NOT COMPLETED|Extension Study||0
228197|NCT00873041|556786|P1|NOT COMPLETED|Extension Study||1
228198|NCT00873041|556784|P3|COMPLETED|Extension Study||46
228199|NCT00873041|556785|P2|COMPLETED|Extension Study||44
228200|NCT00873041|556786|P1|COMPLETED|Extension Study||40
228201|NCT00873041|556784|P3|STARTED|Extension Study||48
228202|NCT00873041|556785|P2|STARTED|Extension Study||44
228203|NCT00873041|556786|P1|STARTED|Extension Study||41
228204|NCT00873041|556784|P3|NOT COMPLETED|Core Study||5
228205|NCT00873041|556785|P2|NOT COMPLETED|Core Study||6
228206|NCT00873041|556786|P1|NOT COMPLETED|Core Study||7
228207|NCT00873041|556784|P3|COMPLETED|Core Study||51
228208|NCT00873041|556785|P2|COMPLETED|Core Study||49
228209|NCT00873041|556786|P1|COMPLETED|Core Study||48
228210|NCT00873041|556784|P3|STARTED|Core Study||56
228211|NCT00873041|556785|P2|STARTED|Core Study||55
228212|NCT00873041|556786|P1|STARTED|Core Study||55
228213|NCT00873093|556845|P5|NOT COMPLETED|Overall Study||2
228214|NCT00873093|556846|P4|NOT COMPLETED|Overall Study||11
228215|NCT00873093|556847|P3|NOT COMPLETED|Overall Study||16
228216|NCT00873093|556848|P2|NOT COMPLETED|Overall Study||27
228217|NCT00873093|556849|P1|NOT COMPLETED|Overall Study||1
228218|NCT00873093|556845|P5|COMPLETED|Overall Study||8
228219|NCT00873093|556846|P4|COMPLETED|Overall Study||12
228220|NCT00873093|556847|P3|COMPLETED|Overall Study||33
228221|NCT00873093|556848|P2|COMPLETED|Overall Study||35
228222|NCT00873093|556849|P1|COMPLETED|Overall Study||3
228223|NCT00873093|556845|P5|STARTED|Overall Study||10
228224|NCT00873093|556846|P4|STARTED|Overall Study||23
228225|NCT00873093|556847|P3|STARTED|Overall Study||49
228226|NCT00873093|556848|P2|STARTED|Overall Study||62
228227|NCT00873093|556849|P1|STARTED|Overall Study||4
228228|NCT00873119|556905|P2|NOT COMPLETED|Overall Study||26
228229|NCT00873119|556906|P1|NOT COMPLETED|Overall Study||44
228230|NCT00873119|556905|P2|COMPLETED|Overall Study||19
228231|NCT00873119|556906|P1|COMPLETED|Overall Study|Of 42 patients treated with belinostat, 23 patients received 6 or more treatment cycles.|0
228232|NCT00873119|556905|P2|STARTED|Overall Study||45
228233|NCT00873119|556906|P1|STARTED|Overall Study||44
228234|NCT00873327|556922|P1|NOT COMPLETED|Overall Study||0
228235|NCT00873327|556922|P1|COMPLETED|Overall Study||32
228236|NCT00873327|556922|P1|STARTED|Overall Study||32
228237|NCT00873457|556926|P1|NOT COMPLETED|Overall Study||0
228238|NCT00873457|556926|P1|COMPLETED|Overall Study||16
228239|NCT00873457|556926|P1|STARTED|Overall Study||16
228240|NCT00873730|556935|P2|NOT COMPLETED|Overall Study||5
228241|NCT00873730|556936|P1|NOT COMPLETED|Overall Study||6
228242|NCT00873730|556935|P2|COMPLETED|Overall Study||49
228243|NCT00873730|556936|P1|COMPLETED|Overall Study||48
228244|NCT00873730|556935|P2|STARTED|Overall Study||54
228245|NCT00873730|556936|P1|STARTED|Overall Study||54
228246|NCT00873782|556972|P1|NOT COMPLETED|Overall Study||0
228247|NCT00873782|556972|P1|COMPLETED|Overall Study||16
228248|NCT00873782|556972|P1|STARTED|Overall Study||16
228249|NCT00873821|556978|P2|NOT COMPLETED|Overall Study||0
228250|NCT00873821|556979|P1|NOT COMPLETED|Overall Study||0
228251|NCT00873821|556978|P2|COMPLETED|Overall Study||22
228252|NCT00873821|556979|P1|COMPLETED|Overall Study||22
228253|NCT00873821|556978|P2|STARTED|Overall Study||22
228254|NCT00873821|556979|P1|STARTED|Overall Study||22
228255|NCT00873860|556993|P4|NOT COMPLETED|Overall Study||1
228256|NCT00873860|556994|P3|NOT COMPLETED|Overall Study||3
228257|NCT00873860|556995|P2|NOT COMPLETED|Overall Study||0
228258|NCT00873860|556996|P1|NOT COMPLETED|Overall Study||4
228259|NCT00873860|556993|P4|COMPLETED|Overall Study||47
228260|NCT00873860|556994|P3|COMPLETED|Overall Study||48
228261|NCT00873860|556995|P2|COMPLETED|Overall Study||47
228262|NCT00873860|556996|P1|COMPLETED|Overall Study||44
228263|NCT00873860|556993|P4|Treated|Overall Study||48
228264|NCT00873860|556994|P3|Treated|Overall Study||51
228265|NCT00873860|556995|P2|Treated|Overall Study||47
228266|NCT00873860|556996|P1|Treated|Overall Study||47
228267|NCT00873860|556993|P4|STARTED|Overall Study||48
228268|NCT00873860|556994|P3|STARTED|Overall Study||51
228269|NCT00873860|556995|P2|STARTED|Overall Study||47
228270|NCT00873860|556996|P1|STARTED|Overall Study||48
228271|NCT00873873|557069|P4|NOT COMPLETED|Overall Study||0
228272|NCT00873873|557070|P3|NOT COMPLETED|Overall Study||0
228273|NCT00873873|557071|P2|NOT COMPLETED|Overall Study||0
228274|NCT00873873|557072|P1|NOT COMPLETED|Overall Study||0
228275|NCT00873873|557069|P4|COMPLETED|Overall Study||18
228276|NCT00873873|557070|P3|COMPLETED|Overall Study||9
228277|NCT00873873|557071|P2|COMPLETED|Overall Study||8
228278|NCT00873873|557072|P1|COMPLETED|Overall Study||20
228279|NCT00873873|557069|P4|STARTED|Overall Study||18
228280|NCT00873873|557070|P3|STARTED|Overall Study||9
228281|NCT00873873|557071|P2|STARTED|Overall Study||8
228282|NCT00873873|557072|P1|STARTED|Overall Study||20
228283|NCT00873912|557088|P2|NOT COMPLETED|Overall Study||0
228284|NCT00873912|557089|P1|NOT COMPLETED|Overall Study||3
228285|NCT00873912|557088|P2|COMPLETED|Overall Study||60
228286|NCT00873912|557089|P1|COMPLETED|Overall Study||237
228287|NCT00873912|557088|P2|STARTED|Overall Study||60
228288|NCT00873912|557089|P1|STARTED|Overall Study||240
228289|NCT00874029|557103|P1|NOT COMPLETED|Overall Study||21
228290|NCT00874029|557103|P1|COMPLETED|Overall Study||116
228291|NCT00874029|557103|P1|STARTED|Overall Study||137
228292|NCT00874094|557117|P1|NOT COMPLETED|Overall Study||0
228293|NCT00874094|557117|P1|COMPLETED|Overall Study||15
228294|NCT00874094|557117|P1|STARTED|Overall Study||15
228295|NCT00874120|557126|P2|NOT COMPLETED|Second Intervention||0
228296|NCT00874120|557127|P1|NOT COMPLETED|Second Intervention||2
228297|NCT00874120|557126|P2|COMPLETED|Second Intervention||56
228298|NCT00874120|557127|P1|COMPLETED|Second Intervention||50
228299|NCT00874120|557126|P2|STARTED|Second Intervention||56
228300|NCT00874120|557127|P1|STARTED|Second Intervention||52
228301|NCT00874120|557126|P2|NOT COMPLETED|Wash-out Period||0
228302|NCT00874120|557127|P1|NOT COMPLETED|Wash-out Period||0
228303|NCT00874120|557126|P2|COMPLETED|Wash-out Period||56
228304|NCT00874120|557127|P1|COMPLETED|Wash-out Period||52
228305|NCT00874120|557126|P2|STARTED|Wash-out Period||56
228306|NCT00874120|557127|P1|STARTED|Wash-out Period||52
228307|NCT00874120|557126|P2|NOT COMPLETED|First Intervention||2
228308|NCT00874120|557127|P1|NOT COMPLETED|First Intervention||6
228309|NCT00874120|557126|P2|COMPLETED|First Intervention||56
228310|NCT00874120|557127|P1|COMPLETED|First Intervention||52
228311|NCT00874120|557126|P2|STARTED|First Intervention||58
228312|NCT00874120|557127|P1|STARTED|First Intervention||58
228313|NCT00874250|557133|P1|NOT COMPLETED|Overall Study||51
228314|NCT00874250|557133|P1|COMPLETED|Overall Study||0
228315|NCT00874250|557133|P1|STARTED|Overall Study||51
228316|NCT00874276|557147|P2|NOT COMPLETED|Overall Study||1
228317|NCT00874276|557148|P1|NOT COMPLETED|Overall Study||1
228318|NCT00874276|557147|P2|COMPLETED|Overall Study||7
228319|NCT00874276|557148|P1|COMPLETED|Overall Study||5
228320|NCT00874276|557147|P2|STARTED|Overall Study||8
228321|NCT00874276|557148|P1|STARTED|Overall Study||6
228322|NCT00874497|557158|P2|NOT COMPLETED|Overall Study||18
228323|NCT00874497|557159|P1|NOT COMPLETED|Overall Study||28
228324|NCT00874497|557158|P2|COMPLETED|Overall Study||15
228325|NCT00874497|557159|P1|COMPLETED|Overall Study||23
228326|NCT00874497|557158|P2|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|33
228327|NCT00874497|557159|P1|STARTED|Overall Study|This is the number of participants who were treated and were considered as safety population.|51
228328|NCT00874510|557199|P2|NOT COMPLETED|Year 2||0
228329|NCT00874510|557200|P1|NOT COMPLETED|Year 2||0
228330|NCT00874510|557199|P2|COMPLETED|Year 2||87
228331|NCT00874510|557200|P1|COMPLETED|Year 2||92
228332|NCT00874510|557199|P2|STARTED|Year 2||87
228333|NCT00874510|557200|P1|STARTED|Year 2||92
228334|NCT00874510|557199|P2|NOT COMPLETED|Year 1||0
228335|NCT00874510|557200|P1|NOT COMPLETED|Year 1||0
228336|NCT00874510|557199|P2|COMPLETED|Year 1||85
228337|NCT00874510|557200|P1|COMPLETED|Year 1||88
228338|NCT00874510|557199|P2|STARTED|Year 1||85
228339|NCT00874510|557200|P1|STARTED|Year 1||88
228340|NCT00874549|557210|P4|NOT COMPLETED|Overall Study||2
228341|NCT00874549|557211|P3|NOT COMPLETED|Overall Study||4
228342|NCT00874549|557212|P2|NOT COMPLETED|Overall Study||1
228343|NCT00874549|557213|P1|NOT COMPLETED|Overall Study||1
228344|NCT00874549|557210|P4|COMPLETED|Overall Study||56
228345|NCT00874549|557211|P3|COMPLETED|Overall Study||47
228346|NCT00874549|557212|P2|COMPLETED|Overall Study||55
228347|NCT00874549|557213|P1|COMPLETED|Overall Study||50
228348|NCT00874549|557210|P4|STARTED|Overall Study||58
228349|NCT00874549|557211|P3|STARTED|Overall Study||51
228350|NCT00874549|557212|P2|STARTED|Overall Study||56
228351|NCT00874549|557213|P1|STARTED|Overall Study||51
228352|NCT00867659|557279|P1|NOT COMPLETED|Overall Study||0
228353|NCT00867659|557279|P1|COMPLETED|Overall Study|January 2010|20
228354|NCT00867659|557279|P1|STARTED|Overall Study|October 2009|20
228355|NCT00868101|557286|P2|NOT COMPLETED|Overall Study||0
228356|NCT00868101|557287|P1|NOT COMPLETED|Overall Study||0
228357|NCT00868101|557286|P2|COMPLETED|Overall Study||10
228358|NCT00868101|557287|P1|COMPLETED|Overall Study||12
228359|NCT00868101|557286|P2|STARTED|Overall Study||10
228360|NCT00868101|557287|P1|STARTED|Overall Study||12
228361|NCT00868140|557301|P2|NOT COMPLETED|Overall Study||0
228362|NCT00868140|557302|P1|NOT COMPLETED|Overall Study||0
228363|NCT00868140|557301|P2|COMPLETED|Overall Study||25
228364|NCT00868140|557302|P1|COMPLETED|Overall Study||26
228365|NCT00868140|557301|P2|STARTED|Overall Study||25
228366|NCT00868140|557302|P1|STARTED|Overall Study||26
228367|NCT00868192|557318|P1|NOT COMPLETED|Overall Study||4
228368|NCT00868192|557318|P1|COMPLETED|Overall Study||34
228369|NCT00868192|557318|P1|STARTED|Overall Study||38
228370|NCT00868218|557337|P4|NOT COMPLETED|Overall Study||0
228371|NCT00868218|557338|P3|NOT COMPLETED|Overall Study||0
228372|NCT00868218|557339|P2|NOT COMPLETED|Overall Study||0
228373|NCT00868218|557340|P1|NOT COMPLETED|Overall Study||0
228374|NCT00868218|557337|P4|COMPLETED|Overall Study||15
228375|NCT00868218|557338|P3|COMPLETED|Overall Study||15
228376|NCT00868218|557339|P2|COMPLETED|Overall Study||15
228377|NCT00868218|557340|P1|COMPLETED|Overall Study||15
228378|NCT00868218|557337|P4|STARTED|Overall Study||15
228379|NCT00868218|557338|P3|STARTED|Overall Study||15
228380|NCT00868218|557339|P2|STARTED|Overall Study||15
228381|NCT00868218|557340|P1|STARTED|Overall Study||15
228382|NCT00868231|557358|P6|NOT COMPLETED|Treatment Period 3||0
228383|NCT00868231|557359|P5|NOT COMPLETED|Treatment Period 3||0
228384|NCT00868231|557360|P4|NOT COMPLETED|Treatment Period 3||0
228385|NCT00868231|557361|P3|NOT COMPLETED|Treatment Period 3||1
228386|NCT00868231|557362|P2|NOT COMPLETED|Treatment Period 3||0
228387|NCT00868231|557363|P1|NOT COMPLETED|Treatment Period 3||0
228388|NCT00868231|557358|P6|COMPLETED|Treatment Period 3||5
228389|NCT00868231|557359|P5|COMPLETED|Treatment Period 3||4
228390|NCT00868231|557360|P4|COMPLETED|Treatment Period 3||5
228391|NCT00868231|557361|P3|COMPLETED|Treatment Period 3||4
228392|NCT00868231|557362|P2|COMPLETED|Treatment Period 3||5
228393|NCT00868231|557363|P1|COMPLETED|Treatment Period 3||4
228394|NCT00868231|557358|P6|STARTED|Treatment Period 3||5
228395|NCT00868231|557359|P5|STARTED|Treatment Period 3||4
228396|NCT00868231|557360|P4|STARTED|Treatment Period 3||5
228397|NCT00868231|557361|P3|STARTED|Treatment Period 3||5
228398|NCT00868231|557362|P2|STARTED|Treatment Period 3||5
228399|NCT00868231|557363|P1|STARTED|Treatment Period 3||4
228400|NCT00868231|557358|P6|NOT COMPLETED|Treatment Period 2||0
228401|NCT00868231|557359|P5|NOT COMPLETED|Treatment Period 2||0
228402|NCT00868231|557360|P4|NOT COMPLETED|Treatment Period 2||0
228403|NCT00868231|557361|P3|NOT COMPLETED|Treatment Period 2||0
228404|NCT00868231|557362|P2|NOT COMPLETED|Treatment Period 2||0
228405|NCT00868231|557363|P1|NOT COMPLETED|Treatment Period 2||1
228406|NCT00868231|557358|P6|COMPLETED|Treatment Period 2||5
228407|NCT00868231|557359|P5|COMPLETED|Treatment Period 2||4
228408|NCT00868231|557360|P4|COMPLETED|Treatment Period 2||5
228409|NCT00868231|557361|P3|COMPLETED|Treatment Period 2||5
228410|NCT00868231|557362|P2|COMPLETED|Treatment Period 2||5
228411|NCT00868231|557363|P1|COMPLETED|Treatment Period 2||4
228412|NCT00868231|557358|P6|STARTED|Treatment Period 2||5
228413|NCT00868231|557359|P5|STARTED|Treatment Period 2||4
228414|NCT00868231|557360|P4|STARTED|Treatment Period 2||5
228415|NCT00868231|557361|P3|STARTED|Treatment Period 2||5
228416|NCT00868231|557362|P2|STARTED|Treatment Period 2||5
228417|NCT00868231|557363|P1|STARTED|Treatment Period 2||5
228418|NCT00868231|557358|P6|NOT COMPLETED|Treatment Period 1||0
228419|NCT00868231|557359|P5|NOT COMPLETED|Treatment Period 1||1
228420|NCT00868231|557360|P4|NOT COMPLETED|Treatment Period 1||0
228421|NCT00868231|557361|P3|NOT COMPLETED|Treatment Period 1||0
228422|NCT00868231|557362|P2|NOT COMPLETED|Treatment Period 1||0
228423|NCT00868231|557363|P1|NOT COMPLETED|Treatment Period 1||0
228424|NCT00868231|557358|P6|COMPLETED|Treatment Period 1||5
228425|NCT00868231|557359|P5|COMPLETED|Treatment Period 1||4
228426|NCT00868231|557360|P4|COMPLETED|Treatment Period 1||5
228427|NCT00868231|557361|P3|COMPLETED|Treatment Period 1||5
228428|NCT00868231|557362|P2|COMPLETED|Treatment Period 1||5
228429|NCT00868231|557363|P1|COMPLETED|Treatment Period 1||5
228430|NCT00868231|557358|P6|STARTED|Treatment Period 1||5
228431|NCT00868231|557359|P5|STARTED|Treatment Period 1||5
228432|NCT00868231|557360|P4|STARTED|Treatment Period 1||5
228433|NCT00868231|557361|P3|STARTED|Treatment Period 1||5
228434|NCT00868231|557362|P2|STARTED|Treatment Period 1||5
228435|NCT00868231|557363|P1|STARTED|Treatment Period 1||5
228436|NCT00868296|557406|P2|NOT COMPLETED|Overall Study||3
228437|NCT00868296|557407|P1|NOT COMPLETED|Overall Study||0
228438|NCT00868296|557406|P2|COMPLETED|Overall Study||43
228439|NCT00868296|557407|P1|COMPLETED|Overall Study||12
228440|NCT00868296|557406|P2|STARTED|Overall Study||46
228441|NCT00868296|557407|P1|STARTED|Overall Study||12
228442|NCT00868309|557417|P2|NOT COMPLETED|Overall Study||0
228443|NCT00868309|557418|P1|NOT COMPLETED|Overall Study||0
228444|NCT00868309|557417|P2|COMPLETED|Overall Study||6
228445|NCT00868309|557418|P1|COMPLETED|Overall Study||6
228446|NCT00868309|557417|P2|STARTED|Overall Study||6
228447|NCT00868309|557418|P1|STARTED|Overall Study||6
228448|NCT00868348|557428|P2|NOT COMPLETED|Overall Study||0
228449|NCT00868348|557429|P1|NOT COMPLETED|Overall Study||0
228450|NCT00868348|557428|P2|COMPLETED|Overall Study||30
228451|NCT00868348|557429|P1|COMPLETED|Overall Study||30
228452|NCT00868348|557428|P2|STARTED|Overall Study||30
228453|NCT00868348|557429|P1|STARTED|Overall Study||30
228454|NCT00868374|557447|P2|NOT COMPLETED|Overall Study||7
228455|NCT00868374|557448|P1|NOT COMPLETED|Overall Study||7
228456|NCT00868374|557447|P2|COMPLETED|Overall Study||4
228457|NCT00868374|557448|P1|COMPLETED|Overall Study||5
228458|NCT00868374|557447|P2|STARTED|Overall Study||11
228459|NCT00868374|557448|P1|STARTED|Overall Study||12
228460|NCT00868439|557456|P2|NOT COMPLETED|Overall Study||9
228461|NCT00868439|557457|P1|NOT COMPLETED|Overall Study||8
228462|NCT00868439|557456|P2|COMPLETED|Overall Study||40
228463|NCT00868439|557457|P1|COMPLETED|Overall Study||48
228464|NCT00868439|557456|P2|STARTED|Overall Study||49
228465|NCT00868439|557457|P1|STARTED|Overall Study||56
228466|NCT00868452|557475|P2|NOT COMPLETED|Overall Study||29
228467|NCT00868452|557476|P1|NOT COMPLETED|Overall Study||40
228468|NCT00868452|557475|P2|COMPLETED|Overall Study||136
228469|NCT00868452|557476|P1|COMPLETED|Overall Study||143
228470|NCT00868452|557475|P2|STARTED|Overall Study||165
228471|NCT00868452|557476|P1|STARTED|Overall Study||183
228472|NCT00868517|557489|P3|NOT COMPLETED|Overall Study||2
228473|NCT00868517|557490|P2|NOT COMPLETED|Overall Study||4
228474|NCT00868517|557491|P1|NOT COMPLETED|Overall Study||4
228475|NCT00868517|557489|P3|COMPLETED|Overall Study||9
228476|NCT00868517|557490|P2|COMPLETED|Overall Study||8
228477|NCT00868517|557491|P1|COMPLETED|Overall Study||8
228478|NCT00868517|557489|P3|STARTED|Overall Study||11
228479|NCT00868517|557490|P2|STARTED|Overall Study||12
228480|NCT00868517|557491|P1|STARTED|Overall Study||12
228481|NCT00868530|557514|P1|NOT COMPLETED|Overall Study||4
228482|NCT00868530|557514|P1|COMPLETED|Overall Study||49
228483|NCT00868530|557514|P1|STARTED|Overall Study||53
228484|NCT00868699|557529|P3|NOT COMPLETED|Overall Study||43
228485|NCT00868699|557530|P2|NOT COMPLETED|Overall Study||45
228486|NCT00868699|557531|P1|NOT COMPLETED|Overall Study||43
228487|NCT00868699|557529|P3|COMPLETED|Overall Study||123
228488|NCT00868699|557530|P2|COMPLETED|Overall Study||124
228489|NCT00868699|557531|P1|COMPLETED|Overall Study||127
228490|NCT00868699|557529|P3|Safety Population|Overall Study||164
228491|NCT00868699|557530|P2|Safety Population|Overall Study||167
228492|NCT00868699|557531|P1|Safety Population|Overall Study||168
228493|NCT00868699|557529|P3|Intent-to-Treat Population|Overall Study||161
228494|NCT00868699|557530|P2|Intent-to-Treat Population|Overall Study||162
228495|NCT00868699|557531|P1|Intent-to-Treat Population|Overall Study||162
228496|NCT00868699|557529|P3|STARTED|Overall Study||166
228497|NCT00868699|557530|P2|STARTED|Overall Study||169
228498|NCT00868699|557531|P1|STARTED|Overall Study||170
228499|NCT00868712|557548|P3|NOT COMPLETED|Overall Study||0
228500|NCT00868712|557549|P2|NOT COMPLETED|Overall Study||0
228501|NCT00868712|557550|P1|NOT COMPLETED|Overall Study||0
228502|NCT00868712|557548|P3|COMPLETED|Overall Study||28
228503|NCT00868712|557549|P2|COMPLETED|Overall Study||11
228504|NCT00868712|557550|P1|COMPLETED|Overall Study||31
228505|NCT00868712|557548|P3|STARTED|Overall Study||28
228506|NCT00868712|557549|P2|STARTED|Overall Study||11
228507|NCT00868712|557550|P1|STARTED|Overall Study||31
228508|NCT00868751|557561|P1|NOT COMPLETED|Overall Study||1
228509|NCT00868751|557561|P1|COMPLETED|Overall Study||0
228510|NCT00868751|557561|P1|STARTED|Overall Study||1
228511|NCT00868790|557569|P14|NOT COMPLETED|Post-study||0
228512|NCT00868790|557570|P13|NOT COMPLETED|Post-study||0
228513|NCT00868790|557571|P12|NOT COMPLETED|Post-study||0
228514|NCT00868790|557572|P11|NOT COMPLETED|Post-study||0
228515|NCT00868790|557573|P10|NOT COMPLETED|Post-study||1
228516|NCT00868790|557574|P9|NOT COMPLETED|Post-study||0
228517|NCT00868790|557575|P8|NOT COMPLETED|Post-study||2
228518|NCT00868790|557576|P7|NOT COMPLETED|Post-study||0
228519|NCT00868790|557577|P6|NOT COMPLETED|Post-study||0
228520|NCT00868790|557578|P5|NOT COMPLETED|Post-study||1
228521|NCT00868790|557579|P4|NOT COMPLETED|Post-study||0
228522|NCT00868790|557580|P3|NOT COMPLETED|Post-study||0
228523|NCT00868790|557581|P2|NOT COMPLETED|Post-study||0
228524|NCT00868790|557582|P1|NOT COMPLETED|Post-study||0
228525|NCT00868790|557569|P14|COMPLETED|Post-study||7
228526|NCT00868790|557570|P13|COMPLETED|Post-study||6
228527|NCT00868790|557571|P12|COMPLETED|Post-study||3
228528|NCT00868790|557572|P11|COMPLETED|Post-study||5
228529|NCT00868790|557573|P10|COMPLETED|Post-study||1
228530|NCT00868790|557574|P9|COMPLETED|Post-study||6
228531|NCT00868790|557575|P8|COMPLETED|Post-study||12
228532|NCT00868790|557576|P7|COMPLETED|Post-study||4
228533|NCT00868790|557577|P6|COMPLETED|Post-study||1
228534|NCT00868790|557578|P5|COMPLETED|Post-study||17
228535|NCT00868790|557579|P4|COMPLETED|Post-study||3
228536|NCT00868790|557580|P3|COMPLETED|Post-study||3
228537|NCT00868790|557581|P2|COMPLETED|Post-study||6
228538|NCT00868790|557582|P1|COMPLETED|Post-study||7
228539|NCT00868790|557569|P14|STARTED|Post-study||7
228540|NCT00868790|557570|P13|STARTED|Post-study||6
228541|NCT00868790|557571|P12|STARTED|Post-study||3
228542|NCT00868790|557572|P11|STARTED|Post-study||5
228543|NCT00868790|557573|P10|STARTED|Post-study||2
228544|NCT00868790|557574|P9|STARTED|Post-study||6
228545|NCT00868790|557575|P8|STARTED|Post-study||14
228546|NCT00868790|557576|P7|STARTED|Post-study||4
228547|NCT00868790|557577|P6|STARTED|Post-study||1
228548|NCT00868790|557578|P5|STARTED|Post-study||18
228549|NCT00868790|557579|P4|STARTED|Post-study||3
228550|NCT00868790|557580|P3|STARTED|Post-study||3
228551|NCT00868790|557581|P2|STARTED|Post-study||6
228552|NCT00868790|557582|P1|STARTED|Post-study||7
228553|NCT00868790|557569|P14|NOT COMPLETED|Period 4||1
228554|NCT00868790|557570|P13|NOT COMPLETED|Period 4||1
228555|NCT00868790|557571|P12|NOT COMPLETED|Period 4||1
228556|NCT00868790|557572|P11|NOT COMPLETED|Period 4||3
228557|NCT00868790|557573|P10|NOT COMPLETED|Period 4||0
228558|NCT00868790|557574|P9|NOT COMPLETED|Period 4||2
228559|NCT00868790|557575|P8|NOT COMPLETED|Period 4||3
228560|NCT00868790|557576|P7|NOT COMPLETED|Period 4||0
228561|NCT00868790|557577|P6|NOT COMPLETED|Period 4||0
228562|NCT00868790|557578|P5|NOT COMPLETED|Period 4||0
228563|NCT00868790|557579|P4|NOT COMPLETED|Period 4||0
228564|NCT00868790|557580|P3|NOT COMPLETED|Period 4||1
228565|NCT00868790|557581|P2|NOT COMPLETED|Period 4||0
228566|NCT00868790|557582|P1|NOT COMPLETED|Period 4||2
228567|NCT00868790|557569|P14|COMPLETED|Period 4||7
228568|NCT00868790|557570|P13|COMPLETED|Period 4||6
228569|NCT00868790|557571|P12|COMPLETED|Period 4||3
228570|NCT00868790|557572|P11|COMPLETED|Period 4||5
228571|NCT00868790|557573|P10|COMPLETED|Period 4||2
228572|NCT00868790|557574|P9|COMPLETED|Period 4||6
228573|NCT00868790|557575|P8|COMPLETED|Period 4||14
228574|NCT00868790|557576|P7|COMPLETED|Period 4||4
228575|NCT00868790|557577|P6|COMPLETED|Period 4||1
228576|NCT00868790|557578|P5|COMPLETED|Period 4||18
228577|NCT00868790|557579|P4|COMPLETED|Period 4||3
228578|NCT00868790|557580|P3|COMPLETED|Period 4|One non-completion due to abnormal alanine aminotransferase/aspartate aminotransferase (ALT/AST)|3
228579|NCT00868790|557581|P2|COMPLETED|Period 4||6
228580|NCT00868790|557582|P1|COMPLETED|Period 4||7
228581|NCT00868790|557569|P14|STARTED|Period 4||8
228582|NCT00868790|557570|P13|STARTED|Period 4||7
228583|NCT00868790|557571|P12|STARTED|Period 4||4
228584|NCT00868790|557572|P11|STARTED|Period 4||8
228585|NCT00868790|557573|P10|STARTED|Period 4||2
228586|NCT00868790|557574|P9|STARTED|Period 4||8
228587|NCT00868790|557575|P8|STARTED|Period 4||17
228588|NCT00868790|557576|P7|STARTED|Period 4||4
228589|NCT00868790|557577|P6|STARTED|Period 4||1
228590|NCT00868790|557578|P5|STARTED|Period 4||18
228591|NCT00868790|557579|P4|STARTED|Period 4||3
228592|NCT00868790|557580|P3|STARTED|Period 4||4
228593|NCT00868790|557581|P2|STARTED|Period 4||6
228594|NCT00868790|557582|P1|STARTED|Period 4||9
228595|NCT00868790|557569|P14|NOT COMPLETED|Period 3||0
228596|NCT00868790|557570|P13|NOT COMPLETED|Period 3||0
228597|NCT00868790|557571|P12|NOT COMPLETED|Period 3||0
228598|NCT00868790|557572|P11|NOT COMPLETED|Period 3||1
228599|NCT00868790|557573|P10|NOT COMPLETED|Period 3||1
228600|NCT00868790|557574|P9|NOT COMPLETED|Period 3||0
228601|NCT00868790|557575|P8|NOT COMPLETED|Period 3||0
228602|NCT00868790|557576|P7|NOT COMPLETED|Period 3||0
228603|NCT00868790|557577|P6|NOT COMPLETED|Period 3||0
228604|NCT00868790|557578|P5|NOT COMPLETED|Period 3||0
228605|NCT00868790|557579|P4|NOT COMPLETED|Period 3||1
228606|NCT00868790|557580|P3|NOT COMPLETED|Period 3||0
228607|NCT00868790|557581|P2|NOT COMPLETED|Period 3||0
228608|NCT00868790|557582|P1|NOT COMPLETED|Period 3||0
228609|NCT00868790|557569|P14|COMPLETED|Period 3||8
228610|NCT00868790|557570|P13|COMPLETED|Period 3||7
228611|NCT00868790|557571|P12|COMPLETED|Period 3||4
228612|NCT00868790|557572|P11|COMPLETED|Period 3||8
228613|NCT00868790|557573|P10|COMPLETED|Period 3||2
228614|NCT00868790|557574|P9|COMPLETED|Period 3||8
228615|NCT00868790|557575|P8|COMPLETED|Period 3||17
228616|NCT00868790|557576|P7|COMPLETED|Period 3||4
228617|NCT00868790|557577|P6|COMPLETED|Period 3||1
228618|NCT00868790|557578|P5|COMPLETED|Period 3||18
228619|NCT00868790|557579|P4|COMPLETED|Period 3||3
228620|NCT00868790|557580|P3|COMPLETED|Period 3||4
228621|NCT00868790|557581|P2|COMPLETED|Period 3||6
228622|NCT00868790|557582|P1|COMPLETED|Period 3||9
228623|NCT00868790|557569|P14|STARTED|Period 3||8
228624|NCT00868790|557570|P13|STARTED|Period 3||7
228625|NCT00868790|557571|P12|STARTED|Period 3||4
228626|NCT00868790|557572|P11|STARTED|Period 3||9
228627|NCT00868790|557573|P10|STARTED|Period 3||3
228628|NCT00868790|557574|P9|STARTED|Period 3||8
228629|NCT00868790|557575|P8|STARTED|Period 3||17
228630|NCT00868790|557576|P7|STARTED|Period 3||4
228631|NCT00868790|557577|P6|STARTED|Period 3||1
228632|NCT00868790|557578|P5|STARTED|Period 3||18
228633|NCT00868790|557579|P4|STARTED|Period 3||4
228634|NCT00868790|557580|P3|STARTED|Period 3||4
228635|NCT00868790|557581|P2|STARTED|Period 3||6
228636|NCT00868790|557582|P1|STARTED|Period 3||9
228637|NCT00868790|557569|P14|NOT COMPLETED|Period 2||1
228638|NCT00868790|557570|P13|NOT COMPLETED|Period 2||0
228639|NCT00868790|557571|P12|NOT COMPLETED|Period 2||0
228640|NCT00868790|557572|P11|NOT COMPLETED|Period 2||0
228641|NCT00868790|557573|P10|NOT COMPLETED|Period 2||0
228642|NCT00868790|557574|P9|NOT COMPLETED|Period 2||2
228643|NCT00868790|557575|P8|NOT COMPLETED|Period 2||0
228644|NCT00868790|557576|P7|NOT COMPLETED|Period 2||0
228645|NCT00868790|557577|P6|NOT COMPLETED|Period 2||1
228646|NCT00868790|557578|P5|NOT COMPLETED|Period 2||0
228647|NCT00868790|557579|P4|NOT COMPLETED|Period 2||0
228648|NCT00868790|557580|P3|NOT COMPLETED|Period 2||0
228649|NCT00868790|557581|P2|NOT COMPLETED|Period 2||1
228650|NCT00868790|557582|P1|NOT COMPLETED|Period 2||0
228651|NCT00868790|557569|P14|COMPLETED|Period 2||8
228652|NCT00868790|557570|P13|COMPLETED|Period 2||7
228653|NCT00868790|557571|P12|COMPLETED|Period 2||4
228654|NCT00868790|557572|P11|COMPLETED|Period 2||9
228655|NCT00868790|557573|P10|COMPLETED|Period 2||3
228656|NCT00868790|557574|P9|COMPLETED|Period 2||8
228657|NCT00868790|557575|P8|COMPLETED|Period 2||17
228658|NCT00868790|557576|P7|COMPLETED|Period 2||4
228659|NCT00868790|557577|P6|COMPLETED|Period 2||1
228660|NCT00868790|557578|P5|COMPLETED|Period 2||18
228661|NCT00868790|557579|P4|COMPLETED|Period 2||4
228662|NCT00868790|557580|P3|COMPLETED|Period 2||4
228663|NCT00868790|557581|P2|COMPLETED|Period 2||6
228664|NCT00868790|557582|P1|COMPLETED|Period 2||9
228665|NCT00868790|557569|P14|STARTED|Period 2||9
228666|NCT00868790|557570|P13|STARTED|Period 2||7
228667|NCT00868790|557571|P12|STARTED|Period 2||4
228668|NCT00868790|557572|P11|STARTED|Period 2||9
228669|NCT00868790|557573|P10|STARTED|Period 2||3
228670|NCT00868790|557574|P9|STARTED|Period 2||10
228671|NCT00868790|557575|P8|STARTED|Period 2||17
228672|NCT00868790|557576|P7|STARTED|Period 2||4
228673|NCT00868790|557577|P6|STARTED|Period 2||2
228674|NCT00868790|557578|P5|STARTED|Period 2||18
228675|NCT00868790|557579|P4|STARTED|Period 2||4
228676|NCT00868790|557580|P3|STARTED|Period 2||4
228677|NCT00868790|557581|P2|STARTED|Period 2||7
228678|NCT00868790|557582|P1|STARTED|Period 2||9
228679|NCT00868790|557569|P14|NOT COMPLETED|Period 1||2
228680|NCT00868790|557570|P13|NOT COMPLETED|Period 1||0
228681|NCT00868790|557571|P12|NOT COMPLETED|Period 1||0
228682|NCT00868790|557572|P11|NOT COMPLETED|Period 1||0
228683|NCT00868790|557573|P10|NOT COMPLETED|Period 1||0
228684|NCT00868790|557574|P9|NOT COMPLETED|Period 1||1
228685|NCT00868790|557575|P8|NOT COMPLETED|Period 1||3
228686|NCT00868790|557576|P7|NOT COMPLETED|Period 1||0
228687|NCT00868790|557577|P6|NOT COMPLETED|Period 1||1
228688|NCT00868790|557578|P5|NOT COMPLETED|Period 1||1
228689|NCT00868790|557579|P4|NOT COMPLETED|Period 1||0
228690|NCT00868790|557580|P3|NOT COMPLETED|Period 1||0
228691|NCT00868790|557581|P2|NOT COMPLETED|Period 1||1
228692|NCT00868790|557582|P1|NOT COMPLETED|Period 1||2
228693|NCT00868790|557569|P14|COMPLETED|Period 1||9
228694|NCT00868790|557570|P13|COMPLETED|Period 1||7
228695|NCT00868790|557571|P12|COMPLETED|Period 1||4
228696|NCT00868790|557572|P11|COMPLETED|Period 1||9
228697|NCT00868790|557573|P10|COMPLETED|Period 1||3
228698|NCT00868790|557574|P9|COMPLETED|Period 1||10
228699|NCT00868790|557575|P8|COMPLETED|Period 1||17
228700|NCT00868790|557576|P7|COMPLETED|Period 1||4
228701|NCT00868790|557577|P6|COMPLETED|Period 1||2
228702|NCT00868790|557578|P5|COMPLETED|Period 1||18
228703|NCT00868790|557579|P4|COMPLETED|Period 1||4
228704|NCT00868790|557580|P3|COMPLETED|Period 1||4
228705|NCT00868790|557581|P2|COMPLETED|Period 1||7
228706|NCT00868790|557582|P1|COMPLETED|Period 1||9
228707|NCT00868790|557569|P14|STARTED|Period 1||11
228708|NCT00868790|557570|P13|STARTED|Period 1||7
228709|NCT00868790|557571|P12|STARTED|Period 1||4
228710|NCT00868790|557572|P11|STARTED|Period 1||9
228711|NCT00868790|557573|P10|STARTED|Period 1||3
228712|NCT00868790|557574|P9|STARTED|Period 1||11
228713|NCT00868790|557575|P8|STARTED|Period 1||20
228714|NCT00868790|557576|P7|STARTED|Period 1||4
228715|NCT00868790|557577|P6|STARTED|Period 1||3
228716|NCT00868790|557578|P5|STARTED|Period 1||19
228717|NCT00868790|557579|P4|STARTED|Period 1||4
228718|NCT00868790|557580|P3|STARTED|Period 1||4
228719|NCT00868790|557581|P2|STARTED|Period 1||8
228720|NCT00868790|557582|P1|STARTED|Period 1||11
228721|NCT00868959|557619|P1|NOT COMPLETED|Overall Study||258
228722|NCT00868959|557619|P1|COMPLETED|Overall Study||559
228723|NCT00868959|557619|P1|STARTED|Overall Study|817 represents total number of subjects who provided informed consent.|817
228724|NCT00868998|557625|P1|NOT COMPLETED|Overall Study||5
228725|NCT00868998|557625|P1|COMPLETED|Overall Study||0
228726|NCT00868998|557625|P1|STARTED|Overall Study||5
228727|NCT00869050|557630|P1|NOT COMPLETED|Overall Study||3
228728|NCT00869050|557630|P1|COMPLETED|Overall Study||38
228729|NCT00869050|557630|P1|STARTED|Overall Study||41
228730|NCT00869089|557635|P1|NOT COMPLETED|Overall Study||3
228731|NCT00869089|557635|P1|COMPLETED|Overall Study||2
228732|NCT00869089|557635|P1|STARTED|Overall Study||5
228733|NCT00869128|557639|P2|NOT COMPLETED|Overall Study||6
228734|NCT00869128|557640|P1|NOT COMPLETED|Overall Study||6
228735|NCT00869128|557639|P2|COMPLETED|Overall Study||12
228736|NCT00869128|557640|P1|COMPLETED|Overall Study||12
228737|NCT00869128|557639|P2|STARTED|Overall Study||18
228738|NCT00869128|557640|P1|STARTED|Overall Study||18
228739|NCT00869141|557646|P2|NOT COMPLETED|Overall Study||0
228740|NCT00869141|557647|P1|NOT COMPLETED|Overall Study||0
228741|NCT00869141|557646|P2|COMPLETED|Overall Study||26
228742|NCT00869141|557647|P1|COMPLETED|Overall Study||26
228743|NCT00869141|557646|P2|STARTED|Overall Study||26
228744|NCT00869141|557647|P1|STARTED|Overall Study||26
228745|NCT00869167|557659|P2|NOT COMPLETED|Overall Study||1
228746|NCT00869167|557660|P1|NOT COMPLETED|Overall Study||0
228747|NCT00869167|557659|P2|COMPLETED|Overall Study||0
228748|NCT00869167|557660|P1|COMPLETED|Overall Study||2
228749|NCT00869167|557659|P2|STARTED|Overall Study||1
228750|NCT00869167|557660|P1|STARTED|Overall Study||2
228751|NCT00869258|557674|P1|NOT COMPLETED|Overall Study||1
228752|NCT00869258|557674|P1|COMPLETED|Overall Study||31
228753|NCT00869258|557674|P1|STARTED|Overall Study||32
228754|NCT00869323|557678|P1|NOT COMPLETED|Maintenance Therapy||1
228755|NCT00869323|557678|P1|COMPLETED|Maintenance Therapy||1
228756|NCT00869323|557678|P1|STARTED|Maintenance Therapy|One participant removed from study after completing induction therapy due to progressive disease.|2
228757|NCT00869323|557678|P1|NOT COMPLETED|Induction Therapy||0
228758|NCT00869323|557678|P1|COMPLETED|Induction Therapy||3
228759|NCT00869323|557678|P1|STARTED|Induction Therapy||3
228760|NCT00874770|557690|P4|NOT COMPLETED|Overall Study||5
228761|NCT00874770|557691|P3|NOT COMPLETED|Overall Study||4
228762|NCT00874770|557692|P2|NOT COMPLETED|Overall Study||1
228763|NCT00874770|557693|P1|NOT COMPLETED|Overall Study||5
228764|NCT00874770|557690|P4|COMPLETED|Overall Study||7
228765|NCT00874770|557691|P3|COMPLETED|Overall Study||8
228766|NCT00874770|557692|P2|COMPLETED|Overall Study||11
228767|NCT00874770|557693|P1|COMPLETED|Overall Study||7
228768|NCT00874770|557690|P4|STARTED|Overall Study||12
228769|NCT00874770|557691|P3|STARTED|Overall Study||12
228770|NCT00874770|557692|P2|STARTED|Overall Study||12
228771|NCT00874770|557693|P1|STARTED|Overall Study||12
228772|NCT00874822|557727|P1|NOT COMPLETED|Overall Study||8
228773|NCT00874822|557727|P1|COMPLETED|Overall Study||208
228774|NCT00874822|557727|P1|STARTED|Overall Study||216
228775|NCT00874848|557733|P2|NOT COMPLETED|Overall Study||28
228776|NCT00874848|557734|P1|NOT COMPLETED|Overall Study||59
228777|NCT00874848|557733|P2|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|1
228778|NCT00874848|557734|P1|COMPLETED|Overall Study|Pts who completed 18 tx cycles without progressive disease were defined as completing treatment.|0
228779|NCT00874848|557733|P2|Discontinued|Overall Study||28
228780|NCT00874848|557734|P1|Discontinued|Overall Study||59
228781|NCT00874848|557733|P2|STARTED|Overall Study||29
228782|NCT00874848|557734|P1|STARTED|Overall Study||59
228783|NCT00874887|557752|P2|NOT COMPLETED|Overall Study||0
228784|NCT00874887|557753|P1|NOT COMPLETED|Overall Study||0
228785|NCT00874887|557752|P2|COMPLETED|Overall Study||34
228786|NCT00874887|557753|P1|COMPLETED|Overall Study||32
228787|NCT00874887|557752|P2|STARTED|Overall Study||34
228788|NCT00874887|557753|P1|STARTED|Overall Study||32
228789|NCT00874939|557767|P1|NOT COMPLETED|Overall Study||4
228790|NCT00874939|557767|P1|COMPLETED|Overall Study||0
228791|NCT00874939|557767|P1|Treated|Overall Study||0
228792|NCT00874939|557767|P1|STARTED|Overall Study||4
228793|NCT00875017|557787|P6|NOT COMPLETED|Fourth Intervention||1
228794|NCT00875017|557788|P5|NOT COMPLETED|Fourth Intervention||0
228795|NCT00875017|557789|P4|NOT COMPLETED|Fourth Intervention||0
228796|NCT00875017|557790|P3|NOT COMPLETED|Fourth Intervention||0
228797|NCT00875017|557791|P2|NOT COMPLETED|Fourth Intervention||0
228798|NCT00875017|557792|P1|NOT COMPLETED|Fourth Intervention||0
228799|NCT00875017|557787|P6|COMPLETED|Fourth Intervention||4
228800|NCT00875017|557788|P5|COMPLETED|Fourth Intervention||3
228801|NCT00875017|557789|P4|COMPLETED|Fourth Intervention||4
228802|NCT00875017|557790|P3|COMPLETED|Fourth Intervention||2
228803|NCT00875017|557791|P2|COMPLETED|Fourth Intervention||3
228804|NCT00875017|557792|P1|COMPLETED|Fourth Intervention||3
228805|NCT00875017|557787|P6|STARTED|Fourth Intervention||5
228806|NCT00875017|557788|P5|STARTED|Fourth Intervention||3
228807|NCT00875017|557789|P4|STARTED|Fourth Intervention||4
228808|NCT00875017|557790|P3|STARTED|Fourth Intervention||2
228809|NCT00875017|557791|P2|STARTED|Fourth Intervention||3
228810|NCT00875017|557792|P1|STARTED|Fourth Intervention||3
228811|NCT00875017|557787|P6|NOT COMPLETED|Washout||0
228812|NCT00875017|557788|P5|NOT COMPLETED|Washout||1
228813|NCT00875017|557789|P4|NOT COMPLETED|Washout||0
228814|NCT00875017|557790|P3|NOT COMPLETED|Washout||0
228815|NCT00875017|557791|P2|NOT COMPLETED|Washout||0
228816|NCT00875017|557792|P1|NOT COMPLETED|Washout||0
228817|NCT00875017|557787|P6|COMPLETED|Washout||5
228818|NCT00875017|557788|P5|COMPLETED|Washout||3
228819|NCT00875017|557789|P4|COMPLETED|Washout||4
228820|NCT00875017|557790|P3|COMPLETED|Washout||2
228821|NCT00875017|557791|P2|COMPLETED|Washout||3
228822|NCT00875017|557792|P1|COMPLETED|Washout||3
228823|NCT00875017|557787|P6|STARTED|Washout||5
228824|NCT00875017|557788|P5|STARTED|Washout||4
228825|NCT00875017|557789|P4|STARTED|Washout||4
228826|NCT00875017|557790|P3|STARTED|Washout||2
228827|NCT00875017|557791|P2|STARTED|Washout||3
228828|NCT00875017|557792|P1|STARTED|Washout||3
228829|NCT00875017|557787|P6|NOT COMPLETED|Third Intervention||0
228830|NCT00875017|557788|P5|NOT COMPLETED|Third Intervention||0
228831|NCT00875017|557789|P4|NOT COMPLETED|Third Intervention||0
228832|NCT00875017|557790|P3|NOT COMPLETED|Third Intervention||1
228833|NCT00875017|557791|P2|NOT COMPLETED|Third Intervention||1
228834|NCT00875017|557792|P1|NOT COMPLETED|Third Intervention||0
228835|NCT00875017|557787|P6|COMPLETED|Third Intervention||5
228836|NCT00875017|557788|P5|COMPLETED|Third Intervention||4
228837|NCT00875017|557789|P4|COMPLETED|Third Intervention||4
228838|NCT00875017|557790|P3|COMPLETED|Third Intervention||2
228839|NCT00875017|557791|P2|COMPLETED|Third Intervention||3
228840|NCT00875017|557792|P1|COMPLETED|Third Intervention||3
228841|NCT00875017|557787|P6|STARTED|Third Intervention||5
228842|NCT00875017|557788|P5|STARTED|Third Intervention||4
228843|NCT00875017|557789|P4|STARTED|Third Intervention||4
228844|NCT00875017|557790|P3|STARTED|Third Intervention||3
228845|NCT00875017|557791|P2|STARTED|Third Intervention||4
228846|NCT00875017|557792|P1|STARTED|Third Intervention||3
228847|NCT00875017|557787|P6|NOT COMPLETED|Washout||0
228848|NCT00875017|557788|P5|NOT COMPLETED|Washout||0
228849|NCT00875017|557789|P4|NOT COMPLETED|Washout||0
228850|NCT00875017|557790|P3|NOT COMPLETED|Washout||0
228851|NCT00875017|557791|P2|NOT COMPLETED|Washout||1
228852|NCT00875017|557792|P1|NOT COMPLETED|Washout||0
228853|NCT00875017|557787|P6|COMPLETED|Washout||5
228854|NCT00875017|557788|P5|COMPLETED|Washout||4
228855|NCT00875017|557789|P4|COMPLETED|Washout||4
228856|NCT00875017|557790|P3|COMPLETED|Washout||3
228857|NCT00875017|557791|P2|COMPLETED|Washout||4
228858|NCT00875017|557792|P1|COMPLETED|Washout||3
228859|NCT00875017|557787|P6|STARTED|Washout||5
228860|NCT00875017|557788|P5|STARTED|Washout||4
228861|NCT00875017|557789|P4|STARTED|Washout||4
228862|NCT00875017|557790|P3|STARTED|Washout||3
228863|NCT00875017|557791|P2|STARTED|Washout||5
228864|NCT00875017|557792|P1|STARTED|Washout||3
228865|NCT00875017|557787|P6|NOT COMPLETED|Second Intervention||0
228866|NCT00875017|557788|P5|NOT COMPLETED|Second Intervention||0
228867|NCT00875017|557789|P4|NOT COMPLETED|Second Intervention||1
228868|NCT00875017|557790|P3|NOT COMPLETED|Second Intervention||0
228869|NCT00875017|557791|P2|NOT COMPLETED|Second Intervention||0
228870|NCT00875017|557792|P1|NOT COMPLETED|Second Intervention||0
228871|NCT00875017|557787|P6|COMPLETED|Second Intervention||5
228872|NCT00875017|557788|P5|COMPLETED|Second Intervention||4
228873|NCT00875017|557789|P4|COMPLETED|Second Intervention||4
228874|NCT00875017|557790|P3|COMPLETED|Second Intervention||3
228875|NCT00875017|557791|P2|COMPLETED|Second Intervention||5
228876|NCT00875017|557792|P1|COMPLETED|Second Intervention||3
228877|NCT00875017|557787|P6|STARTED|Second Intervention||5
228878|NCT00875017|557788|P5|STARTED|Second Intervention||4
228879|NCT00875017|557789|P4|STARTED|Second Intervention||5
228880|NCT00875017|557790|P3|STARTED|Second Intervention||3
228881|NCT00875017|557791|P2|STARTED|Second Intervention||5
228882|NCT00875017|557792|P1|STARTED|Second Intervention||3
228883|NCT00875017|557787|P6|NOT COMPLETED|Washout||0
228884|NCT00875017|557788|P5|NOT COMPLETED|Washout||0
228885|NCT00875017|557789|P4|NOT COMPLETED|Washout||0
228886|NCT00875017|557790|P3|NOT COMPLETED|Washout||1
228887|NCT00875017|557791|P2|NOT COMPLETED|Washout||0
228888|NCT00875017|557792|P1|NOT COMPLETED|Washout||0
228889|NCT00875017|557787|P6|COMPLETED|Washout||5
228890|NCT00875017|557788|P5|COMPLETED|Washout||4
228891|NCT00875017|557789|P4|COMPLETED|Washout||5
228892|NCT00875017|557790|P3|COMPLETED|Washout||3
228893|NCT00875017|557791|P2|COMPLETED|Washout||5
228894|NCT00875017|557792|P1|COMPLETED|Washout||3
228895|NCT00875017|557787|P6|STARTED|Washout||5
228896|NCT00875017|557788|P5|STARTED|Washout||4
228897|NCT00875017|557789|P4|STARTED|Washout||5
228898|NCT00875017|557790|P3|STARTED|Washout||4
228899|NCT00875017|557791|P2|STARTED|Washout||5
228900|NCT00875017|557792|P1|STARTED|Washout||3
228901|NCT00875017|557787|P6|NOT COMPLETED|First Intervention||0
228902|NCT00875017|557788|P5|NOT COMPLETED|First Intervention||1
228903|NCT00875017|557789|P4|NOT COMPLETED|First Intervention||1
228904|NCT00875017|557790|P3|NOT COMPLETED|First Intervention||1
228905|NCT00875017|557791|P2|NOT COMPLETED|First Intervention||0
228906|NCT00875017|557792|P1|NOT COMPLETED|First Intervention||2
228907|NCT00875017|557787|P6|COMPLETED|First Intervention||5
228908|NCT00875017|557788|P5|COMPLETED|First Intervention||4
228909|NCT00875017|557789|P4|COMPLETED|First Intervention||5
228910|NCT00875017|557790|P3|COMPLETED|First Intervention||4
228911|NCT00875017|557791|P2|COMPLETED|First Intervention||5
228912|NCT00875017|557792|P1|COMPLETED|First Intervention||3
228913|NCT00875017|557787|P6|STARTED|First Intervention||5
228914|NCT00875017|557788|P5|STARTED|First Intervention||5
228915|NCT00875017|557789|P4|STARTED|First Intervention||6
228916|NCT00875017|557790|P3|STARTED|First Intervention||5
228917|NCT00875017|557791|P2|STARTED|First Intervention||5
228918|NCT00875017|557792|P1|STARTED|First Intervention||5
228919|NCT00875420|557811|P5|NOT COMPLETED|Overall Study||2
228920|NCT00875420|557812|P4|NOT COMPLETED|Overall Study||2
228921|NCT00875420|557813|P3|NOT COMPLETED|Overall Study||3
228922|NCT00875420|557814|P2|NOT COMPLETED|Overall Study||2
228923|NCT00875420|557815|P1|NOT COMPLETED|Overall Study||2
228924|NCT00875420|557811|P5|COMPLETED|Overall Study||17
228925|NCT00875420|557812|P4|COMPLETED|Overall Study||16
228926|NCT00875420|557813|P3|COMPLETED|Overall Study||18
228927|NCT00875420|557814|P2|COMPLETED|Overall Study||18
228928|NCT00875420|557815|P1|COMPLETED|Overall Study||20
228929|NCT00875420|557811|P5|STARTED|Overall Study||19
228930|NCT00875420|557812|P4|STARTED|Overall Study||18
228931|NCT00875420|557813|P3|STARTED|Overall Study||21
228932|NCT00875420|557814|P2|STARTED|Overall Study||20
228933|NCT00875420|557815|P1|STARTED|Overall Study||22
228934|NCT00875433|557842|P1|NOT COMPLETED|Overall Study||60
228935|NCT00875433|557842|P1|COMPLETED|Overall Study||0
228936|NCT00875433|557842|P1|STARTED|Overall Study|Treated|60
228937|NCT00875485|557869|P2|NOT COMPLETED|Challenge Dose Epoch||0
228938|NCT00875485|557870|P1|NOT COMPLETED|Challenge Dose Epoch||1
228939|NCT00875485|557869|P2|COMPLETED|Challenge Dose Epoch||11
228940|NCT00875485|557870|P1|COMPLETED|Challenge Dose Epoch||7
228941|NCT00875485|557869|P2|STARTED|Challenge Dose Epoch||11
228942|NCT00875485|557870|P1|STARTED|Challenge Dose Epoch||8
228943|NCT00875485|557869|P2|NOT COMPLETED|Year 15||0
228944|NCT00875485|557870|P1|NOT COMPLETED|Year 15||0
228945|NCT00875485|557869|P2|COMPLETED|Year 15||111
228946|NCT00875485|557870|P1|COMPLETED|Year 15||98
228947|NCT00875485|557869|P2|STARTED|Year 15||111
228948|NCT00875485|557870|P1|STARTED|Year 15||98
228949|NCT00875485|557869|P2|NOT COMPLETED|Year 14||0
228950|NCT00875485|557870|P1|NOT COMPLETED|Year 14||0
228951|NCT00875485|557869|P2|COMPLETED|Year 14||113
228952|NCT00875485|557870|P1|COMPLETED|Year 14||100
228953|NCT00875485|557869|P2|STARTED|Year 14||113
228954|NCT00875485|557870|P1|STARTED|Year 14||100
228955|NCT00875485|557869|P2|NOT COMPLETED|Year 13||0
228956|NCT00875485|557870|P1|NOT COMPLETED|Year 13||0
228957|NCT00875485|557869|P2|COMPLETED|Year 13||113
228958|NCT00875485|557870|P1|COMPLETED|Year 13||102
228959|NCT00875485|557869|P2|STARTED|Year 13||113
228960|NCT00875485|557870|P1|STARTED|Year 13||102
228961|NCT00875485|557869|P2|NOT COMPLETED|Year 12||0
228962|NCT00875485|557870|P1|NOT COMPLETED|Year 12||0
228963|NCT00875485|557869|P2|COMPLETED|Year 12||109
228964|NCT00875485|557870|P1|COMPLETED|Year 12||101
228965|NCT00875485|557869|P2|STARTED|Year 12||109
228966|NCT00875485|557870|P1|STARTED|Year 12||101
228967|NCT00875485|557869|P2|NOT COMPLETED|Year 11||0
228968|NCT00875485|557870|P1|NOT COMPLETED|Year 11||0
228969|NCT00875485|557869|P2|COMPLETED|Year 11||111
228970|NCT00875485|557870|P1|COMPLETED|Year 11||99
228971|NCT00875485|557869|P2|STARTED|Year 11||111
228972|NCT00875485|557870|P1|STARTED|Year 11||99
228973|NCT00875550|557912|P2|NOT COMPLETED|Overall Study||10
228974|NCT00875550|557913|P1|NOT COMPLETED|Overall Study||12
228975|NCT00875550|557912|P2|COMPLETED|Overall Study||76
228976|NCT00875550|557913|P1|COMPLETED|Overall Study||77
228977|NCT00875550|557912|P2|STARTED|Overall Study||86
228978|NCT00875550|557913|P1|STARTED|Overall Study||89
228979|NCT00875563|557929|P1|NOT COMPLETED|Overall Study||24
228980|NCT00875563|557929|P1|COMPLETED|Overall Study||18
228981|NCT00875563|557929|P1|STARTED|Overall Study||42
228982|NCT00875589|557935|P2|NOT COMPLETED|Overall Study||0
228983|NCT00875589|557936|P1|NOT COMPLETED|Overall Study||0
228984|NCT00875589|557935|P2|COMPLETED|Overall Study||11
228985|NCT00875589|557936|P1|COMPLETED|Overall Study||15
228986|NCT00875589|557935|P2|STARTED|Overall Study||11
228987|NCT00875589|557936|P1|STARTED|Overall Study||15
228988|NCT00875615|557942|P1|NOT COMPLETED|Overall Study||1
228989|NCT00875615|557942|P1|COMPLETED|Overall Study||10
228990|NCT00875615|557942|P1|STARTED|Overall Study||11
228991|NCT00875706|557950|P3|NOT COMPLETED|Overall Study||0
228992|NCT00875706|557951|P2|NOT COMPLETED|Overall Study||0
228993|NCT00875706|557952|P1|NOT COMPLETED|Overall Study||1
228994|NCT00875706|557950|P3|COMPLETED|Overall Study||13
228995|NCT00875706|557951|P2|COMPLETED|Overall Study||24
228996|NCT00875706|557952|P1|COMPLETED|Overall Study||7
228997|NCT00875706|557950|P3|STARTED|Overall Study||13
228998|NCT00875706|557951|P2|STARTED|Overall Study||24
228999|NCT00875706|557952|P1|STARTED|Overall Study||8
229000|NCT00875797|557971|P2|NOT COMPLETED|Overall Study||3
229001|NCT00875797|557972|P1|NOT COMPLETED|Overall Study||6
229002|NCT00875797|557971|P2|COMPLETED|Overall Study||42
229003|NCT00875797|557972|P1|COMPLETED|Overall Study||39
229004|NCT00875797|557971|P2|STARTED|Overall Study||45
229005|NCT00875797|557972|P1|STARTED|Overall Study||45
229006|NCT00875810|557982|P1|NOT COMPLETED|Overall Study||46
229007|NCT00875810|557982|P1|COMPLETED|Overall Study||148
229008|NCT00875810|557982|P1|24 Months Follow up|Overall Study||148
229009|NCT00875810|557982|P1|12 Months Follow up|Overall Study||112
229010|NCT00875810|557982|P1|6 Months Follow up|Overall Study||80
229011|NCT00875810|557982|P1|3 Months Follow up|Overall Study||175
229012|NCT00875810|557982|P1|Discharged|Overall Study||177
229013|NCT00875810|557982|P1|Implanted|Overall Study||190
229014|NCT00875810|557982|P1|STARTED|Overall Study||194
229015|NCT00875836|557991|P2|NOT COMPLETED|Overall Study||40
229016|NCT00875836|557992|P1|NOT COMPLETED|Overall Study||43
229017|NCT00875836|557991|P2|COMPLETED|Overall Study||47
229018|NCT00875836|557992|P1|COMPLETED|Overall Study||45
229019|NCT00875836|557991|P2|STARTED|Overall Study||87
229020|NCT00875836|557992|P1|STARTED|Overall Study||88
229021|NCT00875979|558004|P2|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||47
229022|NCT00875979|558005|P1|NOT COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
229023|NCT00875979|558004|P2|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||11
229024|NCT00875979|558005|P1|COMPLETED|Dose Expansion Phase - 3.6 mg/kg||0
229025|NCT00875979|558004|P2|STARTED|Dose Expansion Phase - 3.6 mg/kg||58
229026|NCT00875979|558005|P1|STARTED|Dose Expansion Phase - 3.6 mg/kg||0
229027|NCT00875979|558004|P2|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||6
229028|NCT00875979|558005|P1|NOT COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
229029|NCT00875979|558004|P2|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
229030|NCT00875979|558005|P1|COMPLETED|Dose Escalation Phase - 3.6 mg/kg||0
229031|NCT00875979|558004|P2|STARTED|Dose Escalation Phase - 3.6 mg/kg||6
229032|NCT00875979|558005|P1|STARTED|Dose Escalation Phase - 3.6 mg/kg||0
229033|NCT00875979|558004|P2|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
229034|NCT00875979|558005|P1|NOT COMPLETED|Dose Escalation Phase - 3.0 mg/kg||3
229035|NCT00875979|558004|P2|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
229036|NCT00875979|558005|P1|COMPLETED|Dose Escalation Phase - 3.0 mg/kg||0
229037|NCT00875979|558004|P2|STARTED|Dose Escalation Phase - 3.0 mg/kg||0
229038|NCT00875979|558005|P1|STARTED|Dose Escalation Phase - 3.0 mg/kg||3
229039|NCT00876018|558018|P3|NOT COMPLETED|Overall Study||3
229040|NCT00876018|558019|P2|NOT COMPLETED|Overall Study||5
229041|NCT00876018|558020|P1|NOT COMPLETED|Overall Study||5
229042|NCT00876018|558018|P3|COMPLETED|Overall Study||97
229043|NCT00876018|558019|P2|COMPLETED|Overall Study||95
229044|NCT00876018|558020|P1|COMPLETED|Overall Study||95
229045|NCT00876018|558018|P3|STARTED|Overall Study||100
229046|NCT00876018|558019|P2|STARTED|Overall Study||100
229047|NCT00876018|558020|P1|STARTED|Overall Study||100
229048|NCT00876265|558073|P1|NOT COMPLETED|Overall Study||12
229049|NCT00876265|558073|P1|COMPLETED|Overall Study||106
229050|NCT00876265|558073|P1|STARTED|Overall Study||118
229051|NCT00876343|558082|P3|NOT COMPLETED|Overall Study||12
229052|NCT00876343|558083|P2|NOT COMPLETED|Overall Study||17
229053|NCT00876343|558084|P1|NOT COMPLETED|Overall Study||17
229054|NCT00876343|558082|P3|COMPLETED|Overall Study||183
229055|NCT00876343|558083|P2|COMPLETED|Overall Study||180
229056|NCT00876343|558084|P1|COMPLETED|Overall Study||177
229057|NCT00876343|558082|P3|STARTED|Overall Study||195
229058|NCT00876343|558083|P2|STARTED|Overall Study||197
229059|NCT00876343|558084|P1|STARTED|Overall Study||194
229060|NCT00876447|558100|P2|NOT COMPLETED|Overall Study||81
229061|NCT00876447|558101|P1|NOT COMPLETED|Overall Study||80
229062|NCT00876447|558100|P2|COMPLETED|Overall Study||122
229063|NCT00876447|558101|P1|COMPLETED|Overall Study||105
229064|NCT00876447|558100|P2|STARTED|Overall Study||203
229065|NCT00876447|558101|P1|STARTED|Overall Study||185
229066|NCT00876460|558167|P8|NOT COMPLETED|Mono Therapy Phase||3
229067|NCT00876460|558168|P7|NOT COMPLETED|Mono Therapy Phase||1
229068|NCT00876460|558169|P6|NOT COMPLETED|Mono Therapy Phase||0
229069|NCT00876460|558170|P5|NOT COMPLETED|Mono Therapy Phase||2
229070|NCT00876460|558171|P4|NOT COMPLETED|Mono Therapy Phase||1
229071|NCT00876460|558172|P3|NOT COMPLETED|Mono Therapy Phase||0
229072|NCT00876460|558173|P2|NOT COMPLETED|Mono Therapy Phase||1
229073|NCT00876460|558174|P1|NOT COMPLETED|Mono Therapy Phase||0
229074|NCT00876460|558167|P8|COMPLETED|Mono Therapy Phase||0
229075|NCT00876460|558168|P7|COMPLETED|Mono Therapy Phase||0
229076|NCT00876460|558169|P6|COMPLETED|Mono Therapy Phase||0
229077|NCT00876460|558170|P5|COMPLETED|Mono Therapy Phase||0
229078|NCT00876460|558171|P4|COMPLETED|Mono Therapy Phase||0
229079|NCT00876460|558172|P3|COMPLETED|Mono Therapy Phase||0
229080|NCT00876460|558173|P2|COMPLETED|Mono Therapy Phase||0
229081|NCT00876460|558174|P1|COMPLETED|Mono Therapy Phase||0
229082|NCT00876460|558167|P8|STARTED|Mono Therapy Phase|Three patients started mono therapy phase after discontinued from combination therapy phase.|3
229083|NCT00876460|558168|P7|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
229084|NCT00876460|558169|P6|STARTED|Mono Therapy Phase||0
229085|NCT00876460|558170|P5|STARTED|Mono Therapy Phase|Two patients started mono therapy phase after discontinued from combination therapy phase.|2
229086|NCT00876460|558171|P4|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
229087|NCT00876460|558172|P3|STARTED|Mono Therapy Phase||0
229088|NCT00876460|558173|P2|STARTED|Mono Therapy Phase|One patient started mono therapy phase after discontinued from combination therapy phase.|1
229089|NCT00876460|558174|P1|STARTED|Mono Therapy Phase||0
229090|NCT00876460|558167|P8|NOT COMPLETED|Combination Therapy Phase||6
229091|NCT00876460|558168|P7|NOT COMPLETED|Combination Therapy Phase||8
229092|NCT00876460|558169|P6|NOT COMPLETED|Combination Therapy Phase||3
229093|NCT00876460|558170|P5|NOT COMPLETED|Combination Therapy Phase||7
229094|NCT00876460|558171|P4|NOT COMPLETED|Combination Therapy Phase||6
229095|NCT00876460|558172|P3|NOT COMPLETED|Combination Therapy Phase||3
229096|NCT00876460|558173|P2|NOT COMPLETED|Combination Therapy Phase||7
229097|NCT00876460|558174|P1|NOT COMPLETED|Combination Therapy Phase||3
229098|NCT00876460|558167|P8|COMPLETED|Combination Therapy Phase||0
229099|NCT00876460|558168|P7|COMPLETED|Combination Therapy Phase||0
229100|NCT00876460|558169|P6|COMPLETED|Combination Therapy Phase||0
229101|NCT00876460|558170|P5|COMPLETED|Combination Therapy Phase||0
229102|NCT00876460|558171|P4|COMPLETED|Combination Therapy Phase||0
229103|NCT00876460|558172|P3|COMPLETED|Combination Therapy Phase||0
229104|NCT00876460|558173|P2|COMPLETED|Combination Therapy Phase||0
229105|NCT00876460|558174|P1|COMPLETED|Combination Therapy Phase||0
229106|NCT00876460|558167|P8|STARTED|Combination Therapy Phase||6
229107|NCT00876460|558168|P7|STARTED|Combination Therapy Phase||8
229108|NCT00876460|558169|P6|STARTED|Combination Therapy Phase||3
229109|NCT00876460|558170|P5|STARTED|Combination Therapy Phase||7
229110|NCT00876460|558171|P4|STARTED|Combination Therapy Phase||6
229111|NCT00876460|558172|P3|STARTED|Combination Therapy Phase||3
229112|NCT00876460|558173|P2|STARTED|Combination Therapy Phase||7
229113|NCT00876460|558174|P1|STARTED|Combination Therapy Phase||3
229114|NCT00876694|558246|P2|NOT COMPLETED|Overall Study||12
229115|NCT00876694|558247|P1|NOT COMPLETED|Overall Study||21
229116|NCT00876694|558246|P2|COMPLETED|Overall Study||49
229117|NCT00876694|558247|P1|COMPLETED|Overall Study||104
229118|NCT00876694|558246|P2|STARTED|Overall Study||61
229119|NCT00876694|558247|P1|STARTED|Overall Study||125
229120|NCT00876733|558269|P4|NOT COMPLETED|Overall Study||7
229121|NCT00876733|558270|P3|NOT COMPLETED|Overall Study||30
229122|NCT00876733|558271|P2|NOT COMPLETED|Overall Study||42
229123|NCT00876733|558272|P1|NOT COMPLETED|Overall Study||91
229124|NCT00876733|558269|P4|COMPLETED|Overall Study||14
229125|NCT00876733|558270|P3|COMPLETED|Overall Study||63
229126|NCT00876733|558271|P2|COMPLETED|Overall Study||161
229127|NCT00876733|558272|P1|COMPLETED|Overall Study||197
229128|NCT00876733|558269|P4|STARTED|Overall Study||21
229129|NCT00876733|558270|P3|STARTED|Overall Study||93
229130|NCT00876733|558271|P2|STARTED|Overall Study||203
229131|NCT00876733|558272|P1|STARTED|Overall Study||288
229132|NCT00876915|558381|P3|NOT COMPLETED|Overall Study||0
229133|NCT00876915|558382|P2|NOT COMPLETED|Overall Study||14
229134|NCT00876915|558383|P1|NOT COMPLETED|Overall Study||19
229135|NCT00876915|558381|P3|COMPLETED|Overall Study||101
229136|NCT00876915|558382|P2|COMPLETED|Overall Study||34
229137|NCT00876915|558383|P1|COMPLETED|Overall Study||31
229138|NCT00876915|558381|P3|Week 8|Overall Study||0
229139|NCT00876915|558382|P2|Week 8|Overall Study||36
229140|NCT00876915|558383|P1|Week 8|Overall Study||33
229141|NCT00876915|558381|P3|Week 4|Overall Study||0
229142|NCT00876915|558382|P2|Week 4|Overall Study||45
229143|NCT00876915|558383|P1|Week 4|Overall Study||38
229144|NCT00876915|558381|P3|STARTED|Overall Study||101
229145|NCT00876915|558382|P2|STARTED|Overall Study||48
229146|NCT00876915|558383|P1|STARTED|Overall Study||50
229147|NCT00876928|558405|P2|NOT COMPLETED|Overall Study||5
229148|NCT00876928|558406|P1|NOT COMPLETED|Overall Study||3
229149|NCT00876928|558405|P2|COMPLETED|Overall Study||56
229150|NCT00876928|558406|P1|COMPLETED|Overall Study||53
229151|NCT00876928|558405|P2|STARTED|Overall Study||61
229152|NCT00876928|558406|P1|STARTED|Overall Study||56
229153|NCT00877006|558416|P2|NOT COMPLETED|Long-Term Follow-up Period||210
229154|NCT00877006|558417|P1|NOT COMPLETED|Long-Term Follow-up Period||210
229155|NCT00877006|558416|P2|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
229156|NCT00877006|558417|P1|COMPLETED|Long-Term Follow-up Period|study is ongoing|0
229157|NCT00877006|558416|P2|STARTED|Long-Term Follow-up Period||210
229158|NCT00877006|558417|P1|STARTED|Long-Term Follow-up Period||210
229159|NCT00877006|558416|P2|NOT COMPLETED|Treatment Period||27
229160|NCT00877006|558417|P1|NOT COMPLETED|Treatment Period||21
229161|NCT00877006|558416|P2|COMPLETED|Treatment Period||196
229162|NCT00877006|558417|P1|COMPLETED|Treatment Period|treated for >=6 cycles|203
229163|NCT00877006|558416|P2|STARTED|Treatment Period||223
229164|NCT00877006|558417|P1|STARTED|Treatment Period||224
229165|NCT00877032|558450|P7|NOT COMPLETED|Overall Study||2
229166|NCT00877032|558451|P6|NOT COMPLETED|Overall Study||0
229167|NCT00877032|558452|P5|NOT COMPLETED|Overall Study||0
229168|NCT00877032|558453|P4|NOT COMPLETED|Overall Study||1
229169|NCT00877032|558454|P3|NOT COMPLETED|Overall Study||0
229170|NCT00877032|558455|P2|NOT COMPLETED|Overall Study||0
229171|NCT00877032|558456|P1|NOT COMPLETED|Overall Study||0
229172|NCT00877032|558450|P7|COMPLETED|Overall Study||18
229173|NCT00877032|558451|P6|COMPLETED|Overall Study||6
229174|NCT00877032|558452|P5|COMPLETED|Overall Study||6
229175|NCT00877032|558453|P4|COMPLETED|Overall Study||6
229176|NCT00877032|558454|P3|COMPLETED|Overall Study||6
229177|NCT00877032|558455|P2|COMPLETED|Overall Study||6
229178|NCT00877032|558456|P1|COMPLETED|Overall Study||6
229179|NCT00877032|558450|P7|Treated|Overall Study||18
229180|NCT00877032|558451|P6|Treated|Overall Study||6
229181|NCT00877032|558452|P5|Treated|Overall Study||6
229182|NCT00877032|558453|P4|Treated|Overall Study||6
229183|NCT00877032|558454|P3|Treated|Overall Study||6
229184|NCT00877032|558455|P2|Treated|Overall Study||6
229185|NCT00877032|558456|P1|Treated|Overall Study||6
229186|NCT00877032|558450|P7|STARTED|Overall Study||20
229187|NCT00877032|558451|P6|STARTED|Overall Study||6
229188|NCT00877032|558452|P5|STARTED|Overall Study||6
229189|NCT00877032|558453|P4|STARTED|Overall Study||7
229190|NCT00877032|558454|P3|STARTED|Overall Study||6
229191|NCT00877032|558455|P2|STARTED|Overall Study||6
229192|NCT00877032|558456|P1|STARTED|Overall Study||6
229193|NCT00877058|558558|P3|NOT COMPLETED|Overall Study||39
229194|NCT00877058|558559|P2|NOT COMPLETED|Overall Study||40
229195|NCT00877058|558560|P1|NOT COMPLETED|Overall Study||37
229196|NCT00877058|558558|P3|COMPLETED|Overall Study||75
229197|NCT00877058|558559|P2|COMPLETED|Overall Study||131
229198|NCT00877058|558560|P1|COMPLETED|Overall Study||137
229199|NCT00877058|558558|P3|STARTED|Overall Study||114
229200|NCT00877058|558559|P2|STARTED|Overall Study||171
229201|NCT00877058|558560|P1|STARTED|Overall Study||174
229202|NCT00877071|558574|P1|NOT COMPLETED|Overall Study||2
229203|NCT00877071|558574|P1|COMPLETED|Overall Study||0
229204|NCT00877071|558574|P1|STARTED|Overall Study||2
229205|NCT00877370|558581|P1|NOT COMPLETED|Overall Study||0
229206|NCT00877370|558581|P1|COMPLETED|Overall Study||8
229207|NCT00877370|558581|P1|STARTED|Overall Study||8
229208|NCT00877383|558587|P2|NOT COMPLETED|Overall Study||37
229209|NCT00877383|558588|P1|NOT COMPLETED|Overall Study||29
229210|NCT00877383|558587|P2|COMPLETED|Overall Study||533
229211|NCT00877383|558588|P1|COMPLETED|Overall Study||543
229212|NCT00877383|558587|P2|STARTED|Overall Study||570
229213|NCT00877383|558588|P1|STARTED|Overall Study||572
229214|NCT00877448|558611|P7|NOT COMPLETED|Overall Study||0
229215|NCT00877448|558612|P6|NOT COMPLETED|Overall Study||1
229216|NCT00877448|558613|P5|NOT COMPLETED|Overall Study||0
229217|NCT00877448|558614|P4|NOT COMPLETED|Overall Study||1
229218|NCT00877448|558615|P3|NOT COMPLETED|Overall Study||0
229219|NCT00877448|558616|P2|NOT COMPLETED|Overall Study||1
229220|NCT00877448|558617|P1|NOT COMPLETED|Overall Study||0
229221|NCT00877448|558611|P7|COMPLETED|Overall Study||3
229222|NCT00877448|558612|P6|COMPLETED|Overall Study||9
229223|NCT00877448|558613|P5|COMPLETED|Overall Study||10
229224|NCT00877448|558614|P4|COMPLETED|Overall Study||9
229225|NCT00877448|558615|P3|COMPLETED|Overall Study||10
229226|NCT00877448|558616|P2|COMPLETED|Overall Study||9
229227|NCT00877448|558617|P1|COMPLETED|Overall Study||10
229228|NCT00877448|558611|P7|STARTED|Overall Study||3
229229|NCT00877448|558612|P6|STARTED|Overall Study||10
229230|NCT00877448|558613|P5|STARTED|Overall Study||10
229231|NCT00877448|558614|P4|STARTED|Overall Study||10
229232|NCT00877448|558615|P3|STARTED|Overall Study||10
229233|NCT00877448|558616|P2|STARTED|Overall Study||10
229234|NCT00877448|558617|P1|STARTED|Overall Study||10
229235|NCT00877487|558640|P2|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||47
229236|NCT00877487|558641|P1|NOT COMPLETED|Double-blind Randomized Withdrawal Phase||6
229237|NCT00877487|558640|P2|COMPLETED|Double-blind Randomized Withdrawal Phase||13
229238|NCT00877487|558641|P1|COMPLETED|Double-blind Randomized Withdrawal Phase||50
229239|NCT00877487|558640|P2|STARTED|Double-blind Randomized Withdrawal Phase||60
229240|NCT00877487|558641|P1|STARTED|Double-blind Randomized Withdrawal Phase||56
229241|NCT00877487|558640|P2|NOT COMPLETED|Open-label Treatment Phase||0
229242|NCT00877487|558641|P1|NOT COMPLETED|Open-label Treatment Phase||7
229243|NCT00877487|558640|P2|COMPLETED|Open-label Treatment Phase||0
229244|NCT00877487|558641|P1|COMPLETED|Open-label Treatment Phase||116
229245|NCT00877487|558640|P2|STARTED|Open-label Treatment Phase||0
229246|NCT00877487|558641|P1|STARTED|Open-label Treatment Phase||123
229247|NCT00877604|558653|P2|NOT COMPLETED|Overall Study||3
229248|NCT00877604|558654|P1|NOT COMPLETED|Overall Study||2
229249|NCT00877604|558653|P2|COMPLETED|Overall Study||14
229250|NCT00877604|558654|P1|COMPLETED|Overall Study||15
229251|NCT00877604|558653|P2|STARTED|Overall Study||17
229252|NCT00877604|558654|P1|STARTED|Overall Study||17
229253|NCT00877773|558660|P1|NOT COMPLETED|Overall Study||44
229254|NCT00877773|558660|P1|COMPLETED|Overall Study|No participant reached to first restaging.|0
229255|NCT00877773|558660|P1|STARTED|Overall Study||44
229256|NCT00877799|558669|P5|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||1
229257|NCT00877799|558670|P4|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||2
229258|NCT00877799|558671|P3|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
229259|NCT00877799|558672|P2|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
229260|NCT00877799|558673|P1|NOT COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
229261|NCT00877799|558669|P5|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||19
229262|NCT00877799|558670|P4|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||24
229263|NCT00877799|558671|P3|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
229264|NCT00877799|558672|P2|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
229265|NCT00877799|558673|P1|COMPLETED|Cohort 2: Immediately Post-op (Day 0)||0
229266|NCT00877799|558669|P5|STARTED|Cohort 2: Immediately Post-op (Day 0)||20
229267|NCT00877799|558670|P4|STARTED|Cohort 2: Immediately Post-op (Day 0)||26
229268|NCT00877799|558671|P3|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
229269|NCT00877799|558672|P2|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
229270|NCT00877799|558673|P1|STARTED|Cohort 2: Immediately Post-op (Day 0)||0
229271|NCT00877799|558669|P5|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
229272|NCT00877799|558670|P4|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
229273|NCT00877799|558671|P3|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
229274|NCT00877799|558672|P2|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||5
229275|NCT00877799|558673|P1|NOT COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||3
229276|NCT00877799|558669|P5|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
229277|NCT00877799|558670|P4|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||0
229278|NCT00877799|558671|P3|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||18
229279|NCT00877799|558672|P2|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||17
229280|NCT00877799|558673|P1|COMPLETED|Cohort 1: 24 Hours After Surgery (Day 1)||22
229281|NCT00877799|558669|P5|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
229282|NCT00877799|558670|P4|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||0
229283|NCT00877799|558671|P3|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||21
229284|NCT00877799|558672|P2|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||22
229285|NCT00877799|558673|P1|STARTED|Cohort 1: 24 Hours After Surgery (Day 1)||25
229286|NCT00877877|558688|P1|NOT COMPLETED|Year 10||0
229287|NCT00877877|558688|P1|COMPLETED|Year 10||495
229288|NCT00877877|558688|P1|STARTED|Year 10||495
229289|NCT00877877|558688|P1|NOT COMPLETED|Year 9||0
229290|NCT00877877|558688|P1|COMPLETED|Year 9||507
229291|NCT00877877|558688|P1|STARTED|Year 9||507
229292|NCT00877877|558688|P1|NOT COMPLETED|Year 8||0
229293|NCT00877877|558688|P1|COMPLETED|Year 8||522
229294|NCT00877877|558688|P1|STARTED|Year 8||522
229295|NCT00877877|558688|P1|NOT COMPLETED|Year 7||0
229296|NCT00877877|558688|P1|COMPLETED|Year 7||523
229297|NCT00877877|558688|P1|STARTED|Year 7||523
229298|NCT00877877|558688|P1|NOT COMPLETED|Year 6||0
229299|NCT00877877|558688|P1|COMPLETED|Year 6||529
229300|NCT00877877|558688|P1|STARTED|Year 6||529
229301|NCT00877877|558688|P1|NOT COMPLETED|Year 5||0
229302|NCT00877877|558688|P1|COMPLETED|Year 5||397
229303|NCT00877877|558688|P1|STARTED|Year 5||397
229304|NCT00877890|558716|P2|NOT COMPLETED|Overall Study||30
229305|NCT00877890|558717|P1|NOT COMPLETED|Overall Study||20
229306|NCT00877890|558716|P2|COMPLETED|Overall Study||95
229307|NCT00877890|558717|P1|COMPLETED|Overall Study||109
229308|NCT00877890|558716|P2|Intent to Treat (ITT)|Overall Study||123
229309|NCT00877890|558717|P1|Intent to Treat (ITT)|Overall Study||129
229310|NCT00877890|558716|P2|STARTED|Overall Study||125
229311|NCT00877890|558717|P1|STARTED|Overall Study||129
229312|NCT00877929|558753|P2|NOT COMPLETED|Overall Study||35
229313|NCT00877929|558754|P1|NOT COMPLETED|Overall Study||20
229314|NCT00877929|558753|P2|COMPLETED|Overall Study||319
229315|NCT00877929|558754|P1|COMPLETED|Overall Study||332
229316|NCT00877929|558753|P2|STARTED|Overall Study||354
229317|NCT00877929|558754|P1|STARTED|Overall Study||352
229318|NCT00878501|558843|P3|NOT COMPLETED|Overall Study||8
229319|NCT00878501|558844|P2|NOT COMPLETED|Overall Study||7
229320|NCT00878501|558845|P1|NOT COMPLETED|Overall Study||17
229321|NCT00878501|558843|P3|COMPLETED|Overall Study||85
229322|NCT00878501|558844|P2|COMPLETED|Overall Study||37
229323|NCT00878501|558845|P1|COMPLETED|Overall Study||87
229324|NCT00878501|558843|P3|Interim Analysis|Overall Study||81
229325|NCT00878501|558844|P2|Interim Analysis|Overall Study||37
229326|NCT00878501|558845|P1|Interim Analysis|Overall Study||83
229327|NCT00878501|558843|P3|STARTED|Overall Study||93
229328|NCT00878501|558844|P2|STARTED|Overall Study||44
229329|NCT00878501|558845|P1|STARTED|Overall Study|One of these patients did not receive study drug since incorrectly enrolled (mis-randomisation)|104
229330|NCT00878553|558866|P5|NOT COMPLETED|PK Study||0
229331|NCT00878553|558867|P4|NOT COMPLETED|PK Study||1
229332|NCT00878553|558868|P3|NOT COMPLETED|PK Study||0
229333|NCT00878553|558869|P2|NOT COMPLETED|PK Study||0
229334|NCT00878553|558870|P1|NOT COMPLETED|PK Study||0
229335|NCT00878553|558866|P5|COMPLETED|PK Study||15
229336|NCT00878553|558867|P4|COMPLETED|PK Study|One patient withdrew consent after completing the Sleep Substudy and prior to starting PK substudy.|13
229337|NCT00878553|558868|P3|COMPLETED|PK Study||17
229338|NCT00878553|558869|P2|COMPLETED|PK Study||16
229339|NCT00878553|558870|P1|COMPLETED|PK Study|A total of 61 randomized patients completed this parallel group, single dose PK substudy.|0
229340|NCT00878553|558866|P5|STARTED|PK Study|During the PK period, 15 randomized participants received one bedtime dose of 20mg SKP-1041.|15
229341|NCT00878553|558867|P4|STARTED|PK Study|During the PK period, 14 participants were randomized to receive one bedtime dose of 15mg SKP-1041.|14
229342|NCT00878553|558868|P3|STARTED|PK Study|During the PK period, 17 randomized participants received one bedtime dose of 10mg SKP-1041.|17
229343|NCT00878553|558869|P2|STARTED|PK Study|During the PK period, 16 randomized participants received one bedtime dose of SKP-1041 placebo.|16
229344|NCT00878553|558870|P1|STARTED|PK Study|A total of 62 randomized patients started this parallel group, single dose PK substudy.|0
229345|NCT00878553|558866|P5|NOT COMPLETED|Sleep Study||0
229346|NCT00878553|558867|P4|NOT COMPLETED|Sleep Study||0
229347|NCT00878553|558868|P3|NOT COMPLETED|Sleep Study||0
229348|NCT00878553|558869|P2|NOT COMPLETED|Sleep Study||0
229349|NCT00878553|558870|P1|NOT COMPLETED|Sleep Study||5
229350|NCT00878553|558866|P5|COMPLETED|Sleep Study||0
229351|NCT00878553|558867|P4|COMPLETED|Sleep Study||0
229352|NCT00878553|558868|P3|COMPLETED|Sleep Study||0
229353|NCT00878553|558869|P2|COMPLETED|Sleep Study||0
229354|NCT00878553|558870|P1|COMPLETED|Sleep Study|5 patient withdraws result in greater than 5 lost patient data across groups due to CROSSOVER design|62
229355|NCT00878553|558866|P5|Number of Patients Receiving 20mg|Sleep Study||0
229356|NCT00878553|558867|P4|Number of Patients Receiving 20mg|Sleep Study||0
229357|NCT00878553|558868|P3|Number of Patients Receiving 20mg|Sleep Study||0
229358|NCT00878553|558869|P2|Number of Patients Receiving 20mg|Sleep Study||0
229359|NCT00878553|558870|P1|Number of Patients Receiving 20mg|Sleep Study||65
229360|NCT00878553|558866|P5|Number of Patients Receiving 15mg|Sleep Study||0
229361|NCT00878553|558867|P4|Number of Patients Receiving 15mg|Sleep Study||0
229362|NCT00878553|558868|P3|Number of Patients Receiving 15mg|Sleep Study||0
229363|NCT00878553|558869|P2|Number of Patients Receiving 15mg|Sleep Study||0
229364|NCT00878553|558870|P1|Number of Patients Receiving 15mg|Sleep Study||65
229365|NCT00878553|558866|P5|Number of Patients Receiving 10mg|Sleep Study||0
229366|NCT00878553|558867|P4|Number of Patients Receiving 10mg|Sleep Study||0
229367|NCT00878553|558868|P3|Number of Patients Receiving 10mg|Sleep Study||0
229368|NCT00878553|558869|P2|Number of Patients Receiving 10mg|Sleep Study||0
229369|NCT00878553|558870|P1|Number of Patients Receiving 10mg|Sleep Study||65
229370|NCT00878553|558866|P5|Number of Patients Receiving Placebo|Sleep Study||0
229371|NCT00878553|558867|P4|Number of Patients Receiving Placebo|Sleep Study||0
229372|NCT00878553|558868|P3|Number of Patients Receiving Placebo|Sleep Study||0
229373|NCT00878553|558869|P2|Number of Patients Receiving Placebo|Sleep Study||0
229374|NCT00878553|558870|P1|Number of Patients Receiving Placebo|Sleep Study||66
229375|NCT00878553|558866|P5|STARTED|Sleep Study||0
229376|NCT00878553|558867|P4|STARTED|Sleep Study||0
229377|NCT00878553|558868|P3|STARTED|Sleep Study||0
229378|NCT00878553|558869|P2|STARTED|Sleep Study||0
229379|NCT00878553|558870|P1|STARTED|Sleep Study|This Intention to Treat population includes all randomized patients; one dropped prior to treatment.|67
229380|NCT00878605|558930|P4|NOT COMPLETED|Overall Study||3
229381|NCT00878605|558931|P3|NOT COMPLETED|Overall Study||1
229382|NCT00878605|558932|P2|NOT COMPLETED|Overall Study||3
229383|NCT00878605|558933|P1|NOT COMPLETED|Overall Study||3
229384|NCT00878605|558930|P4|COMPLETED|Overall Study||6
229385|NCT00878605|558931|P3|COMPLETED|Overall Study||8
229386|NCT00878605|558932|P2|COMPLETED|Overall Study||7
229387|NCT00878605|558933|P1|COMPLETED|Overall Study||7
229388|NCT00878605|558930|P4|STARTED|Overall Study||9
229389|NCT00878605|558931|P3|STARTED|Overall Study||9
229390|NCT00878605|558932|P2|STARTED|Overall Study||10
229391|NCT00878605|558933|P1|STARTED|Overall Study||10
229392|NCT00878722|558951|P8|NOT COMPLETED|Overall Study||7
229393|NCT00878722|558952|P7|NOT COMPLETED|Overall Study||6
229394|NCT00878722|558953|P6|NOT COMPLETED|Overall Study||2
229395|NCT00878722|558954|P5|NOT COMPLETED|Overall Study||7
229396|NCT00878722|558955|P4|NOT COMPLETED|Overall Study||9
229397|NCT00878722|558956|P3|NOT COMPLETED|Overall Study||3
229398|NCT00878722|558957|P2|NOT COMPLETED|Overall Study||3
229399|NCT00878722|558958|P1|NOT COMPLETED|Overall Study||3
229400|NCT00878722|558951|P8|COMPLETED|Overall Study||0
229401|NCT00878722|558952|P7|COMPLETED|Overall Study||0
229402|NCT00878722|558953|P6|COMPLETED|Overall Study||1
229403|NCT00878722|558954|P5|COMPLETED|Overall Study||0
229404|NCT00878722|558955|P4|COMPLETED|Overall Study||0
229405|NCT00878722|558956|P3|COMPLETED|Overall Study||0
229406|NCT00878722|558957|P2|COMPLETED|Overall Study||0
229407|NCT00878722|558958|P1|COMPLETED|Overall Study||0
229408|NCT00878722|558951|P8|STARTED|Overall Study||7
229409|NCT00878722|558952|P7|STARTED|Overall Study||6
229410|NCT00878722|558953|P6|STARTED|Overall Study||3
229411|NCT00878722|558954|P5|STARTED|Overall Study||7
229412|NCT00878722|558955|P4|STARTED|Overall Study||9
229413|NCT00878722|558956|P3|STARTED|Overall Study||3
229414|NCT00878722|558957|P2|STARTED|Overall Study||3
229415|NCT00878722|558958|P1|STARTED|Overall Study||3
229416|NCT00878800|559046|P5|NOT COMPLETED|Overall Study||16
229417|NCT00878800|559047|P4|NOT COMPLETED|Overall Study||6
229418|NCT00878800|559048|P3|NOT COMPLETED|Overall Study||9
229419|NCT00878800|559049|P2|NOT COMPLETED|Overall Study||7
229420|NCT00878800|559050|P1|NOT COMPLETED|Overall Study||3
229421|NCT00878800|559046|P5|COMPLETED|Overall Study|Mean number of cycles administered: 6.4|0
229422|NCT00878800|559047|P4|COMPLETED|Overall Study|Mean number of cycles administered: 5.3|0
229423|NCT00878800|559048|P3|COMPLETED|Overall Study|Mean number of cycles administered: 3.0|0
229424|NCT00878800|559049|P2|COMPLETED|Overall Study|Mean number of cycles administered: 4.6|0
229425|NCT00878800|559050|P1|COMPLETED|Overall Study|Mean number of cycles administered: 4.0|0
229426|NCT00878800|559046|P5|STARTED|Overall Study||16
229427|NCT00878800|559047|P4|STARTED|Overall Study||6
229428|NCT00878800|559048|P3|STARTED|Overall Study||9
229429|NCT00878800|559049|P2|STARTED|Overall Study||7
229430|NCT00878800|559050|P1|STARTED|Overall Study||3
229431|NCT00878826|559080|P3|NOT COMPLETED|Overall Study||0
229432|NCT00878826|559081|P2|NOT COMPLETED|Overall Study||0
229433|NCT00878826|559082|P1|NOT COMPLETED|Overall Study||0
229434|NCT00878826|559080|P3|COMPLETED|Overall Study||2
229435|NCT00878826|559081|P2|COMPLETED|Overall Study||6
229436|NCT00878826|559082|P1|COMPLETED|Overall Study||3
229437|NCT00878826|559080|P3|STARTED|Overall Study||2
229438|NCT00878826|559081|P2|STARTED|Overall Study||6
229439|NCT00878826|559082|P1|STARTED|Overall Study||3
229440|NCT00878878|559101|P2|NOT COMPLETED|Overall Study||0
229441|NCT00878878|559102|P1|NOT COMPLETED|Overall Study||0
229442|NCT00878878|559101|P2|COMPLETED|Overall Study||15
229443|NCT00878878|559102|P1|COMPLETED|Overall Study||15
229444|NCT00878878|559101|P2|STARTED|Overall Study||15
229445|NCT00878878|559102|P1|STARTED|Overall Study||15
229446|NCT00878969|559115|P3|NOT COMPLETED|Overall Study||11
229447|NCT00878969|559116|P2|NOT COMPLETED|Overall Study||15
229448|NCT00878969|559117|P1|NOT COMPLETED|Overall Study||15
229449|NCT00878969|559115|P3|COMPLETED|Overall Study||15
229450|NCT00878969|559116|P2|COMPLETED|Overall Study||12
229451|NCT00878969|559117|P1|COMPLETED|Overall Study||10
229452|NCT00878969|559115|P3|STARTED|Overall Study||26
229453|NCT00878969|559116|P2|STARTED|Overall Study||27
229454|NCT00878969|559117|P1|STARTED|Overall Study||25
229455|NCT00879034|559125|P1|NOT COMPLETED|Overall Study||0
229456|NCT00879034|559125|P1|COMPLETED|Overall Study||5
229457|NCT00879034|559125|P1|Received Treatment|Overall Study||4
229458|NCT00879034|559125|P1|STARTED|Overall Study||5
229459|NCT00879190|559136|P2|NOT COMPLETED|Overall Study||0
229460|NCT00879190|559137|P1|NOT COMPLETED|Overall Study||0
229461|NCT00879190|559136|P2|COMPLETED|Overall Study||49
229462|NCT00879190|559137|P1|COMPLETED|Overall Study||43
229463|NCT00879190|559136|P2|STARTED|Overall Study||49
229464|NCT00879190|559137|P1|STARTED|Overall Study||43
229465|NCT00879229|559149|P2|NOT COMPLETED|Overall Study||14
229466|NCT00879229|559150|P1|NOT COMPLETED|Overall Study||22
229467|NCT00879229|559149|P2|COMPLETED|Overall Study||1
229468|NCT00879229|559150|P1|COMPLETED|Overall Study||3
229469|NCT00879229|559149|P2|STARTED|Overall Study||15
229470|NCT00879229|559150|P1|STARTED|Overall Study||25
229471|NCT00879255|559176|P2|NOT COMPLETED|Overall Study||19
229472|NCT00879255|559177|P1|NOT COMPLETED|Overall Study||16
229473|NCT00879255|559176|P2|COMPLETED|Overall Study|Completed 6-mo follow-up|45
229474|NCT00879255|559177|P1|COMPLETED|Overall Study|Completed 6-mo follow-up|45
229475|NCT00879255|559176|P2|Completed 3-mo Follow-up|Overall Study||49
229476|NCT00879255|559177|P1|Completed 3-mo Follow-up|Overall Study||48
229477|NCT00879255|559176|P2|Completed Posttreatment Follow-up|Overall Study||55
229478|NCT00879255|559177|P1|Completed Posttreatment Follow-up|Overall Study||50
229479|NCT00879255|559176|P2|Received Allocated Intervention:|Overall Study||56
229480|NCT00879255|559177|P1|Received Allocated Intervention:|Overall Study||51
229481|NCT00879255|559176|P2|STARTED|Overall Study||64
229482|NCT00879255|559177|P1|STARTED|Overall Study||61
229483|NCT00879333|559189|P2|NOT COMPLETED|Overall Study||217
229484|NCT00879333|559190|P1|NOT COMPLETED|Overall Study||428
229485|NCT00879333|559189|P2|COMPLETED|Overall Study||0
229486|NCT00879333|559190|P1|COMPLETED|Overall Study|Completed=Patients Still on Treatment; At data cutoff final analysis, 11 patients were on treatment|11
229487|NCT00879333|559189|P2|Discontinued Study Treatment|Overall Study||217
229488|NCT00879333|559190|P1|Discontinued Study Treatment|Overall Study||428
229489|NCT00879333|559189|P2|STARTED|Overall Study||217
229490|NCT00879333|559190|P1|STARTED|Overall Study||439
229491|NCT00879359|559208|P1|NOT COMPLETED|Overall Study||0
229492|NCT00879359|559208|P1|COMPLETED|Overall Study||15
229493|NCT00879359|559208|P1|STARTED|Overall Study||15
229494|NCT00879398|559214|P1|NOT COMPLETED|Overall Study||675
229495|NCT00879398|559214|P1|COMPLETED|Overall Study||2434
229496|NCT00879398|559214|P1|STARTED|Overall Study||3109
229497|NCT00879411|559224|P1|NOT COMPLETED|Overall Study||162
229498|NCT00879411|559224|P1|COMPLETED|Overall Study||539
229499|NCT00879411|559224|P1|STARTED|Overall Study||701
229500|NCT00879619|559230|P1|NOT COMPLETED|Overall Study||0
229501|NCT00879619|559230|P1|COMPLETED|Overall Study||4
229502|NCT00879619|559230|P1|STARTED|Overall Study||4
229503|NCT00879645|559243|P4|NOT COMPLETED|Overall Study||0
229504|NCT00879645|559244|P3|NOT COMPLETED|Overall Study||0
229505|NCT00879645|559245|P2|NOT COMPLETED|Overall Study||0
229506|NCT00879645|559246|P1|NOT COMPLETED|Overall Study||1
229507|NCT00879645|559243|P4|COMPLETED|Overall Study||7
229508|NCT00879645|559244|P3|COMPLETED|Overall Study||6
229509|NCT00879645|559245|P2|COMPLETED|Overall Study||6
229510|NCT00879645|559246|P1|COMPLETED|Overall Study||8
229511|NCT00879645|559243|P4|STARTED|Overall Study||7
229512|NCT00879645|559244|P3|STARTED|Overall Study||6
229513|NCT00879645|559245|P2|STARTED|Overall Study||6
229514|NCT00879645|559246|P1|STARTED|Overall Study||9
229515|NCT00879684|559264|P7|NOT COMPLETED|Stage 2: Expanded Cohort||13
229516|NCT00879684|559265|P6|NOT COMPLETED|Stage 2: Expanded Cohort||0
229517|NCT00879684|559266|P5|NOT COMPLETED|Stage 2: Expanded Cohort||0
229518|NCT00879684|559267|P4|NOT COMPLETED|Stage 2: Expanded Cohort||0
229519|NCT00879684|559268|P3|NOT COMPLETED|Stage 2: Expanded Cohort||0
229520|NCT00879684|559269|P2|NOT COMPLETED|Stage 2: Expanded Cohort||0
229521|NCT00879684|559270|P1|NOT COMPLETED|Stage 2: Expanded Cohort||0
229522|NCT00879684|559264|P7|COMPLETED|Stage 2: Expanded Cohort||0
229523|NCT00879684|559265|P6|COMPLETED|Stage 2: Expanded Cohort||0
229524|NCT00879684|559266|P5|COMPLETED|Stage 2: Expanded Cohort||0
229525|NCT00879684|559267|P4|COMPLETED|Stage 2: Expanded Cohort||0
229526|NCT00879684|559268|P3|COMPLETED|Stage 2: Expanded Cohort||0
229527|NCT00879684|559269|P2|COMPLETED|Stage 2: Expanded Cohort||0
229528|NCT00879684|559270|P1|COMPLETED|Stage 2: Expanded Cohort||0
229529|NCT00879684|559264|P7|STARTED|Stage 2: Expanded Cohort||13
229530|NCT00879684|559265|P6|STARTED|Stage 2: Expanded Cohort||0
229531|NCT00879684|559266|P5|STARTED|Stage 2: Expanded Cohort||0
229532|NCT00879684|559267|P4|STARTED|Stage 2: Expanded Cohort||0
229533|NCT00879684|559268|P3|STARTED|Stage 2: Expanded Cohort||0
229534|NCT00879684|559269|P2|STARTED|Stage 2: Expanded Cohort||0
229535|NCT00879684|559270|P1|STARTED|Stage 2: Expanded Cohort||0
229536|NCT00879684|559264|P7|NOT COMPLETED|Stage 1: Dose Escalation||0
229537|NCT00879684|559265|P6|NOT COMPLETED|Stage 1: Dose Escalation||3
229538|NCT00879684|559266|P5|NOT COMPLETED|Stage 1: Dose Escalation||3
229539|NCT00879684|559267|P4|NOT COMPLETED|Stage 1: Dose Escalation||6
229540|NCT00879684|559268|P3|NOT COMPLETED|Stage 1: Dose Escalation||3
229541|NCT00879684|559269|P2|NOT COMPLETED|Stage 1: Dose Escalation||3
229542|NCT00879684|559270|P1|NOT COMPLETED|Stage 1: Dose Escalation||3
229543|NCT00879684|559264|P7|COMPLETED|Stage 1: Dose Escalation||0
229544|NCT00879684|559265|P6|COMPLETED|Stage 1: Dose Escalation||0
229545|NCT00879684|559266|P5|COMPLETED|Stage 1: Dose Escalation||0
229546|NCT00879684|559267|P4|COMPLETED|Stage 1: Dose Escalation||0
229547|NCT00879684|559268|P3|COMPLETED|Stage 1: Dose Escalation||0
229548|NCT00879684|559269|P2|COMPLETED|Stage 1: Dose Escalation||0
229549|NCT00879684|559270|P1|COMPLETED|Stage 1: Dose Escalation||0
229550|NCT00879684|559264|P7|STARTED|Stage 1: Dose Escalation||0
229551|NCT00879684|559265|P6|STARTED|Stage 1: Dose Escalation||3
229552|NCT00879684|559266|P5|STARTED|Stage 1: Dose Escalation||3
229553|NCT00879684|559267|P4|STARTED|Stage 1: Dose Escalation||6
229554|NCT00879684|559268|P3|STARTED|Stage 1: Dose Escalation||3
229555|NCT00879684|559269|P2|STARTED|Stage 1: Dose Escalation||3
229556|NCT00879684|559270|P1|STARTED|Stage 1: Dose Escalation||3
229557|NCT00879697|559334|P2|NOT COMPLETED|Overall Study||2
229558|NCT00879697|559335|P1|NOT COMPLETED|Overall Study||2
229559|NCT00879697|559334|P2|COMPLETED|Overall Study|Two patients did not finish the trial|15
229560|NCT00879697|559335|P1|COMPLETED|Overall Study|Two patients did not finish the trial|15
229561|NCT00879697|559334|P2|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
229562|NCT00879697|559335|P1|STARTED|Overall Study|Seventeen patients achieved inclusion and exclusion criteria|17
229563|NCT00879710|559343|P4|NOT COMPLETED|Phase 2 6 Weeks||0
229564|NCT00879710|559344|P3|NOT COMPLETED|Phase 2 6 Weeks||0
229565|NCT00879710|559345|P2|NOT COMPLETED|Phase 2 6 Weeks||0
229566|NCT00879710|559346|P1|NOT COMPLETED|Phase 2 6 Weeks||0
229567|NCT00879710|559343|P4|COMPLETED|Phase 2 6 Weeks||13
229568|NCT00879710|559344|P3|COMPLETED|Phase 2 6 Weeks||10
229569|NCT00879710|559345|P2|COMPLETED|Phase 2 6 Weeks||14
229570|NCT00879710|559346|P1|COMPLETED|Phase 2 6 Weeks||10
229571|NCT00879710|559343|P4|STARTED|Phase 2 6 Weeks||13
229572|NCT00879710|559344|P3|STARTED|Phase 2 6 Weeks||10
229573|NCT00879710|559345|P2|STARTED|Phase 2 6 Weeks||14
229574|NCT00879710|559346|P1|STARTED|Phase 2 6 Weeks||10
229575|NCT00879710|559343|P4|NOT COMPLETED|Wash Out Period of 4 Weeks||0
229576|NCT00879710|559344|P3|NOT COMPLETED|Wash Out Period of 4 Weeks||0
229577|NCT00879710|559345|P2|NOT COMPLETED|Wash Out Period of 4 Weeks||0
229578|NCT00879710|559346|P1|NOT COMPLETED|Wash Out Period of 4 Weeks||0
229579|NCT00879710|559343|P4|COMPLETED|Wash Out Period of 4 Weeks||13
229580|NCT00879710|559344|P3|COMPLETED|Wash Out Period of 4 Weeks||10
229581|NCT00879710|559345|P2|COMPLETED|Wash Out Period of 4 Weeks||14
229582|NCT00879710|559346|P1|COMPLETED|Wash Out Period of 4 Weeks||10
229583|NCT00879710|559343|P4|STARTED|Wash Out Period of 4 Weeks||13
229584|NCT00879710|559344|P3|STARTED|Wash Out Period of 4 Weeks|The person who did not complete ezetimibe arm came back to complete simvastatin arm.|10
229585|NCT00879710|559345|P2|STARTED|Wash Out Period of 4 Weeks||14
229586|NCT00879710|559346|P1|STARTED|Wash Out Period of 4 Weeks||10
229587|NCT00879710|559343|P4|NOT COMPLETED|Phase 1 - 6 Weeks||4
229588|NCT00879710|559344|P3|NOT COMPLETED|Phase 1 - 6 Weeks||2
229589|NCT00879710|559345|P2|NOT COMPLETED|Phase 1 - 6 Weeks||3
229590|NCT00879710|559346|P1|NOT COMPLETED|Phase 1 - 6 Weeks||2
229591|NCT00879710|559343|P4|COMPLETED|Phase 1 - 6 Weeks||13
229592|NCT00879710|559344|P3|COMPLETED|Phase 1 - 6 Weeks||9
229593|NCT00879710|559345|P2|COMPLETED|Phase 1 - 6 Weeks||14
229594|NCT00879710|559346|P1|COMPLETED|Phase 1 - 6 Weeks||10
229595|NCT00879710|559343|P4|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|17
229596|NCT00879710|559344|P3|STARTED|Phase 1 - 6 Weeks|Started with ezetimibe 10 mg as the starting drug|11
229597|NCT00879710|559345|P2|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|17
229598|NCT00879710|559346|P1|STARTED|Phase 1 - 6 Weeks|Started with simvastatin 40 mg as the starting drug|12
229599|NCT00879775|559356|P2|NOT COMPLETED|Overall Study||1
229600|NCT00879775|559357|P1|NOT COMPLETED|Overall Study||2
229601|NCT00879775|559356|P2|COMPLETED|Overall Study||20
229602|NCT00879775|559357|P1|COMPLETED|Overall Study||18
229603|NCT00879775|559356|P2|STARTED|Overall Study||21
229604|NCT00879775|559357|P1|STARTED|Overall Study||20
229605|NCT00879814|559375|P4|NOT COMPLETED|Overall Study||5
229606|NCT00879814|559376|P3|NOT COMPLETED|Overall Study||3
229607|NCT00879814|559377|P2|NOT COMPLETED|Overall Study||2
229608|NCT00879814|559378|P1|NOT COMPLETED|Overall Study||4
229609|NCT00879814|559375|P4|COMPLETED|Overall Study||7
229610|NCT00879814|559376|P3|COMPLETED|Overall Study||9
229611|NCT00879814|559377|P2|COMPLETED|Overall Study||10
229612|NCT00879814|559378|P1|COMPLETED|Overall Study||8
229613|NCT00879814|559375|P4|STARTED|Overall Study||12
229614|NCT00879814|559376|P3|STARTED|Overall Study||12
229615|NCT00879814|559377|P2|STARTED|Overall Study||12
229616|NCT00879814|559378|P1|STARTED|Overall Study||12
229617|NCT00879879|559484|P1|NOT COMPLETED|Overall Study||3
229618|NCT00879879|559484|P1|COMPLETED|Overall Study||17
229619|NCT00879879|559484|P1|STARTED|Overall Study||20
229620|NCT00879970|559491|P5|NOT COMPLETED|Period 2 Vitamin D Randomization||7
229621|NCT00879970|559492|P4|NOT COMPLETED|Period 2 Vitamin D Randomization||4
229622|NCT00879970|559493|P3|NOT COMPLETED|Period 2 Vitamin D Randomization||0
229623|NCT00879970|559494|P2|NOT COMPLETED|Period 2 Vitamin D Randomization||0
229624|NCT00879970|559495|P1|NOT COMPLETED|Period 2 Vitamin D Randomization||0
229625|NCT00879970|559491|P5|COMPLETED|Period 2 Vitamin D Randomization||600
229626|NCT00879970|559492|P4|COMPLETED|Period 2 Vitamin D Randomization||610
229627|NCT00879970|559493|P3|COMPLETED|Period 2 Vitamin D Randomization||0
229628|NCT00879970|559494|P2|COMPLETED|Period 2 Vitamin D Randomization||0
229629|NCT00879970|559495|P1|COMPLETED|Period 2 Vitamin D Randomization||0
229630|NCT00879970|559491|P5|STARTED|Period 2 Vitamin D Randomization||607
229631|NCT00879970|559492|P4|STARTED|Period 2 Vitamin D Randomization||614
229632|NCT00879970|559493|P3|STARTED|Period 2 Vitamin D Randomization||0
229633|NCT00879970|559494|P2|STARTED|Period 2 Vitamin D Randomization||0
229634|NCT00879970|559495|P1|STARTED|Period 2 Vitamin D Randomization||0
229635|NCT00879970|559491|P5|NOT COMPLETED|Period 1 TZD Randomization||0
229636|NCT00879970|559492|P4|NOT COMPLETED|Period 1 TZD Randomization||0
229637|NCT00879970|559493|P3|NOT COMPLETED|Period 1 TZD Randomization||6
229638|NCT00879970|559494|P2|NOT COMPLETED|Period 1 TZD Randomization||4
229639|NCT00879970|559495|P1|NOT COMPLETED|Period 1 TZD Randomization||8
229640|NCT00879970|559491|P5|COMPLETED|Period 1 TZD Randomization||0
229641|NCT00879970|559492|P4|COMPLETED|Period 1 TZD Randomization||0
229642|NCT00879970|559493|P3|COMPLETED|Period 1 TZD Randomization||393
229643|NCT00879970|559494|P2|COMPLETED|Period 1 TZD Randomization||388
229644|NCT00879970|559495|P1|COMPLETED|Period 1 TZD Randomization||533
229645|NCT00879970|559491|P5|STARTED|Period 1 TZD Randomization||0
229646|NCT00879970|559492|P4|STARTED|Period 1 TZD Randomization||0
229647|NCT00879970|559493|P3|STARTED|Period 1 TZD Randomization||399
229648|NCT00879970|559494|P2|STARTED|Period 1 TZD Randomization||392
229649|NCT00879970|559495|P1|STARTED|Period 1 TZD Randomization||541
229650|NCT00879996|559579|P2|NOT COMPLETED|Overall Study||13
229651|NCT00879996|559580|P1|NOT COMPLETED|Overall Study||15
229652|NCT00879996|559579|P2|COMPLETED|Overall Study||13
229653|NCT00879996|559580|P1|COMPLETED|Overall Study||13
229654|NCT00879996|559579|P2|STARTED|Overall Study||26
229655|NCT00879996|559580|P1|STARTED|Overall Study||28
229656|NCT00880009|559592|P1|NOT COMPLETED|Overall Study||16
229657|NCT00880009|559592|P1|COMPLETED|Overall Study||0
229658|NCT00880009|559592|P1|STARTED|Overall Study||16
229659|NCT00880022|559616|P2|NOT COMPLETED|Overall Study||3
229660|NCT00880022|559617|P1|NOT COMPLETED|Overall Study||2
229661|NCT00880022|559616|P2|COMPLETED|Overall Study||21
229662|NCT00880022|559617|P1|COMPLETED|Overall Study||21
229663|NCT00880022|559616|P2|STARTED|Overall Study||24
229664|NCT00880022|559617|P1|STARTED|Overall Study||23
229665|NCT00880100|559623|P1|NOT COMPLETED|Treatment Phase With Ultrase® MT12||3
229666|NCT00880100|559623|P1|COMPLETED|Treatment Phase With Ultrase® MT12||45
229667|NCT00880100|559623|P1|STARTED|Treatment Phase With Ultrase® MT12||48
229668|NCT00880100|559623|P1|NOT COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||1
229669|NCT00880100|559623|P1|COMPLETED|Baseline Phase-Usual Pancreatic Enzymes||48
229670|NCT00880100|559623|P1|STARTED|Baseline Phase-Usual Pancreatic Enzymes||49
229671|NCT00880165|559636|P2|NOT COMPLETED|Overall Study||50
229672|NCT00880165|559637|P1|NOT COMPLETED|Overall Study||62
229673|NCT00880165|559636|P2|COMPLETED|Overall Study||98
229674|NCT00880165|559637|P1|COMPLETED|Overall Study||86
229675|NCT00880165|559636|P2|STARTED|Overall Study||148
229676|NCT00880165|559637|P1|STARTED|Overall Study||148
229677|NCT00880191|559649|P2|NOT COMPLETED|Overall Study||8
229678|NCT00880191|559650|P1|NOT COMPLETED|Overall Study||13
229679|NCT00880191|559649|P2|COMPLETED|Overall Study||198
229680|NCT00880191|559650|P1|COMPLETED|Overall Study||194
229681|NCT00880191|559649|P2|Available for Primary Endpoint Analysis|Overall Study||206
229682|NCT00880191|559650|P1|Available for Primary Endpoint Analysis|Overall Study||207
229683|NCT00880191|559649|P2|STARTED|Overall Study||206
229684|NCT00880191|559650|P1|STARTED|Overall Study||207
229685|NCT00880230|559668|P1|NOT COMPLETED|Overall Study||7
229686|NCT00880230|559668|P1|COMPLETED|Overall Study||134
229687|NCT00880230|559668|P1|STARTED|Overall Study||141
229688|NCT00880256|559688|P1|NOT COMPLETED|Overall Study||28
229689|NCT00880256|559688|P1|COMPLETED|Overall Study||65
229690|NCT00880256|559688|P1|STARTED|Overall Study||93
229691|NCT00880269|559695|P2|NOT COMPLETED|Overall Study||27
229692|NCT00880269|559696|P1|NOT COMPLETED|Overall Study||32
229693|NCT00880269|559695|P2|COMPLETED|Overall Study||0
229694|NCT00880269|559696|P1|COMPLETED|Overall Study||0
229695|NCT00880269|559695|P2|Discontinued Treatment|Overall Study||27
229696|NCT00880269|559696|P1|Discontinued Treatment|Overall Study||32
229697|NCT00880269|559695|P2|STARTED|Overall Study||27
229698|NCT00880269|559696|P1|STARTED|Overall Study||32
229699|NCT00880334|559714|P2|NOT COMPLETED|Overall Study||3
229700|NCT00880334|559715|P1|NOT COMPLETED|Overall Study||4
229701|NCT00880334|559714|P2|COMPLETED|Overall Study||72
229702|NCT00880334|559715|P1|COMPLETED|Overall Study||70
229703|NCT00880334|559714|P2|Eligible & Treated|Overall Study||72
229704|NCT00880334|559715|P1|Eligible & Treated|Overall Study||70
229705|NCT00880334|559714|P2|STARTED|Overall Study||75
229706|NCT00880334|559715|P1|STARTED|Overall Study||74
229707|NCT00880360|559729|P1|NOT COMPLETED|Overall Study||0
229708|NCT00880360|559729|P1|COMPLETED|Overall Study||19
229709|NCT00880360|559729|P1|STARTED|Overall Study||19
229710|NCT00880425|559733|P2|NOT COMPLETED|Overall Study||0
229711|NCT00880425|559734|P1|NOT COMPLETED|Overall Study||0
229712|NCT00880425|559733|P2|COMPLETED|Overall Study||27
229713|NCT00880425|559734|P1|COMPLETED|Overall Study||18
229714|NCT00880425|559733|P2|STARTED|Overall Study||27
229715|NCT00880425|559734|P1|STARTED|Overall Study||18
229716|NCT00880542|559742|P1|NOT COMPLETED|Follow-up Period||0
229717|NCT00880542|559742|P1|COMPLETED|Follow-up Period||7
229718|NCT00880542|559742|P1|STARTED|Follow-up Period|All 7 patients who started the treatment period completed the follow-up period.|7
229719|NCT00880542|559742|P1|NOT COMPLETED|Continued Treatment Period||0
229720|NCT00880542|559742|P1|COMPLETED|Continued Treatment Period||0
229812|NCT00880620|559838|P1|STARTED|Overall Study||92
229721|NCT00880542|559742|P1|STARTED|Continued Treatment Period|None of the 3 subjects from previous period met study criteria for continuation of therapy.|0
229722|NCT00880542|559742|P1|NOT COMPLETED|Post Surgical Evaluation||0
229723|NCT00880542|559742|P1|COMPLETED|Post Surgical Evaluation|none of the 3 subjects met study criteria for continuation of therapy.|3
229724|NCT00880542|559742|P1|STARTED|Post Surgical Evaluation||3
229725|NCT00880542|559742|P1|NOT COMPLETED|REP: Surgical Resection||1
229726|NCT00880542|559742|P1|COMPLETED|REP: Surgical Resection||3
229727|NCT00880542|559742|P1|STARTED|REP: Surgical Resection||4
229728|NCT00880542|559742|P1|NOT COMPLETED|Response Evaluation Period(REP): PET/CT||0
229729|NCT00880542|559742|P1|COMPLETED|Response Evaluation Period(REP): PET/CT||4
229730|NCT00880542|559742|P1|STARTED|Response Evaluation Period(REP): PET/CT||4
229731|NCT00880542|559742|P1|NOT COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||3
229732|NCT00880542|559742|P1|COMPLETED|Treatment Period (Sorafenib+Ifosfamide)||4
229733|NCT00880542|559742|P1|STARTED|Treatment Period (Sorafenib+Ifosfamide)||7
229734|NCT00880555|559750|P6|NOT COMPLETED|Overall Study||1
229735|NCT00880555|559751|P5|NOT COMPLETED|Overall Study||1
229736|NCT00880555|559752|P4|NOT COMPLETED|Overall Study||2
229737|NCT00880555|559753|P3|NOT COMPLETED|Overall Study||5
229738|NCT00880555|559754|P2|NOT COMPLETED|Overall Study||17
229739|NCT00880555|559755|P1|NOT COMPLETED|Overall Study||10
229740|NCT00880555|559750|P6|COMPLETED|Overall Study||0
229741|NCT00880555|559751|P5|COMPLETED|Overall Study||0
229742|NCT00880555|559752|P4|COMPLETED|Overall Study||0
229743|NCT00880555|559753|P3|COMPLETED|Overall Study||6
229744|NCT00880555|559754|P2|COMPLETED|Overall Study||23
229745|NCT00880555|559755|P1|COMPLETED|Overall Study||13
229746|NCT00880555|559750|P6|STARTED|Overall Study||1
229747|NCT00880555|559751|P5|STARTED|Overall Study||1
229748|NCT00880555|559752|P4|STARTED|Overall Study||2
229749|NCT00880555|559753|P3|STARTED|Overall Study||11
229750|NCT00880555|559754|P2|STARTED|Overall Study||40
229751|NCT00880555|559755|P1|STARTED|Overall Study||23
229752|NCT00880568|559775|P9|NOT COMPLETED|Overall Study||3
229753|NCT00880568|559776|P8|NOT COMPLETED|Overall Study||2
229754|NCT00880568|559777|P7|NOT COMPLETED|Overall Study||6
229755|NCT00880568|559778|P6|NOT COMPLETED|Overall Study||3
229756|NCT00880568|559779|P5|NOT COMPLETED|Overall Study||3
229757|NCT00880568|559780|P4|NOT COMPLETED|Overall Study||1
229758|NCT00880568|559781|P3|NOT COMPLETED|Overall Study||3
229759|NCT00880568|559782|P2|NOT COMPLETED|Overall Study||3
229760|NCT00880568|559783|P1|NOT COMPLETED|Overall Study||3
229761|NCT00880568|559775|P9|COMPLETED|Overall Study||0
229762|NCT00880568|559776|P8|COMPLETED|Overall Study||0
229763|NCT00880568|559777|P7|COMPLETED|Overall Study||0
229764|NCT00880568|559778|P6|COMPLETED|Overall Study||0
229765|NCT00880568|559779|P5|COMPLETED|Overall Study||0
229766|NCT00880568|559780|P4|COMPLETED|Overall Study||0
229767|NCT00880568|559781|P3|COMPLETED|Overall Study||0
229768|NCT00880568|559782|P2|COMPLETED|Overall Study||0
229769|NCT00880568|559783|P1|COMPLETED|Overall Study||0
229770|NCT00880568|559775|P9|STARTED|Overall Study||3
229771|NCT00880568|559776|P8|STARTED|Overall Study||2
229772|NCT00880568|559777|P7|STARTED|Overall Study||6
229773|NCT00880568|559778|P6|STARTED|Overall Study||3
229774|NCT00880568|559779|P5|STARTED|Overall Study||3
229775|NCT00880568|559780|P4|STARTED|Overall Study||1
229776|NCT00880568|559781|P3|STARTED|Overall Study||3
229777|NCT00880568|559782|P2|STARTED|Overall Study||3
229778|NCT00880568|559783|P1|STARTED|Overall Study||3
229779|NCT00880581|559826|P1|NOT COMPLETED|Cycle 2 Re-treatment||0
229780|NCT00880581|559826|P1|COMPLETED|Cycle 2 Re-treatment||24
229781|NCT00880581|559826|P1|STARTED|Cycle 2 Re-treatment|6 subjects with progessive disease were not treated and evaluated in Cycle 2|24
229782|NCT00880581|559826|P1|NOT COMPLETED|Cycle 1||0
229783|NCT00880581|559826|P1|COMPLETED|Cycle 1||30
229784|NCT00880581|559826|P1|STARTED|Cycle 1||30
229785|NCT00880620|559835|P4|NOT COMPLETED|Overall Study||24
229786|NCT00880620|559836|P3|NOT COMPLETED|Overall Study||21
229787|NCT00880620|559837|P2|NOT COMPLETED|Overall Study||15
229788|NCT00880620|559838|P1|NOT COMPLETED|Overall Study||21
229789|NCT00880620|559835|P4|COMPLETED|Overall Study||74
229790|NCT00880620|559836|P3|COMPLETED|Overall Study||83
229791|NCT00880620|559837|P2|COMPLETED|Overall Study||72
229792|NCT00880620|559838|P1|COMPLETED|Overall Study||71
229793|NCT00880620|559835|P4|Week 23|Overall Study||74
229794|NCT00880620|559836|P3|Week 23|Overall Study||85
229795|NCT00880620|559837|P2|Week 23|Overall Study||72
229796|NCT00880620|559838|P1|Week 23|Overall Study||71
229797|NCT00880620|559835|P4|Week 16|Overall Study||74
229798|NCT00880620|559836|P3|Week 16|Overall Study||87
229799|NCT00880620|559837|P2|Week 16|Overall Study||73
229800|NCT00880620|559838|P1|Week 16|Overall Study||74
229801|NCT00880620|559835|P4|Week 9|Overall Study||78
229802|NCT00880620|559836|P3|Week 9|Overall Study||88
229803|NCT00880620|559837|P2|Week 9|Overall Study||73
229804|NCT00880620|559838|P1|Week 9|Overall Study||80
229805|NCT00880620|559835|P4|Week 4|Overall Study||86
229806|NCT00880620|559836|P3|Week 4|Overall Study||94
229807|NCT00880620|559837|P2|Week 4|Overall Study||79
229808|NCT00880620|559838|P1|Week 4|Overall Study||88
229809|NCT00880620|559835|P4|STARTED|Overall Study||98
229810|NCT00880620|559836|P3|STARTED|Overall Study||104
229811|NCT00880620|559837|P2|STARTED|Overall Study||87
229813|NCT00880685|559852|P1|NOT COMPLETED|Memantine 30mg||0
229814|NCT00880685|559852|P1|COMPLETED|Memantine 30mg||9
229815|NCT00880685|559852|P1|STARTED|Memantine 30mg||9
229816|NCT00880685|559852|P1|NOT COMPLETED|Memantine 20mg||1
229817|NCT00880685|559852|P1|COMPLETED|Memantine 20mg||9
229818|NCT00880685|559852|P1|STARTED|Memantine 20mg||10
229819|NCT00880685|559852|P1|NOT COMPLETED|Memantine 10mg||2
229820|NCT00880685|559852|P1|COMPLETED|Memantine 10mg||10
229821|NCT00880685|559852|P1|STARTED|Memantine 10mg||12
229822|NCT00880698|559864|P4|NOT COMPLETED|Overall Study||3
229823|NCT00880698|559865|P3|NOT COMPLETED|Overall Study||1
229824|NCT00880698|559866|P2|NOT COMPLETED|Overall Study||3
229825|NCT00880698|559867|P1|NOT COMPLETED|Overall Study||1
229826|NCT00880698|559864|P4|COMPLETED|Overall Study||36
229827|NCT00880698|559865|P3|COMPLETED|Overall Study||36
229828|NCT00880698|559866|P2|COMPLETED|Overall Study||61
229829|NCT00880698|559867|P1|COMPLETED|Overall Study||61
229830|NCT00880698|559864|P4|STARTED|Overall Study||39
229831|NCT00880698|559865|P3|STARTED|Overall Study||37
229832|NCT00880698|559866|P2|STARTED|Overall Study||64
229833|NCT00880698|559867|P1|STARTED|Overall Study||62
229834|NCT00880750|559895|P2|NOT COMPLETED|Second Intervention||2
229835|NCT00880750|559896|P1|NOT COMPLETED|Second Intervention||4
229836|NCT00880750|559895|P2|COMPLETED|Second Intervention||30
229837|NCT00880750|559896|P1|COMPLETED|Second Intervention||26
229838|NCT00880750|559895|P2|STARTED|Second Intervention||32
229839|NCT00880750|559896|P1|STARTED|Second Intervention||30
229840|NCT00880750|559895|P2|NOT COMPLETED|Washout Period||0
229841|NCT00880750|559896|P1|NOT COMPLETED|Washout Period||0
229842|NCT00880750|559895|P2|COMPLETED|Washout Period||32
229843|NCT00880750|559896|P1|COMPLETED|Washout Period||30
229844|NCT00880750|559895|P2|STARTED|Washout Period||32
229845|NCT00880750|559896|P1|STARTED|Washout Period||30
229846|NCT00880750|559895|P2|NOT COMPLETED|First Intervention||1
229847|NCT00880750|559896|P1|NOT COMPLETED|First Intervention||9
229848|NCT00880750|559895|P2|COMPLETED|First Intervention||32
229849|NCT00880750|559896|P1|COMPLETED|First Intervention||30
229850|NCT00880750|559895|P2|STARTED|First Intervention||33
229851|NCT00880750|559896|P1|STARTED|First Intervention||39
229852|NCT00880763|559914|P4|NOT COMPLETED|Extension Period (Part 2)||3
229853|NCT00880763|559915|P3|NOT COMPLETED|Extension Period (Part 2)||3
229854|NCT00880763|559916|P2|NOT COMPLETED|Extension Period (Part 2)||3
229855|NCT00880763|559917|P1|NOT COMPLETED|Extension Period (Part 2)||0
229856|NCT00880763|559914|P4|COMPLETED|Extension Period (Part 2)||19
229857|NCT00880763|559915|P3|COMPLETED|Extension Period (Part 2)||20
229858|NCT00880763|559916|P2|COMPLETED|Extension Period (Part 2)||19
229859|NCT00880763|559917|P1|COMPLETED|Extension Period (Part 2)||23
229860|NCT00880763|559914|P4|STARTED|Extension Period (Part 2)||22
229861|NCT00880763|559915|P3|STARTED|Extension Period (Part 2)||23
229862|NCT00880763|559916|P2|STARTED|Extension Period (Part 2)||22
229863|NCT00880763|559917|P1|STARTED|Extension Period (Part 2)||23
229864|NCT00880763|559914|P4|NOT COMPLETED|Initial Treatment Period (Part 1)||0
229865|NCT00880763|559915|P3|NOT COMPLETED|Initial Treatment Period (Part 1)||0
229866|NCT00880763|559916|P2|NOT COMPLETED|Initial Treatment Period (Part 1)||0
229867|NCT00880763|559917|P1|NOT COMPLETED|Initial Treatment Period (Part 1)||0
229868|NCT00880763|559914|P4|COMPLETED|Initial Treatment Period (Part 1)||22
229869|NCT00880763|559915|P3|COMPLETED|Initial Treatment Period (Part 1)||23
229870|NCT00880763|559916|P2|COMPLETED|Initial Treatment Period (Part 1)||22
229871|NCT00880763|559917|P1|COMPLETED|Initial Treatment Period (Part 1)||23
229872|NCT00880763|559914|P4|STARTED|Initial Treatment Period (Part 1)||22
229873|NCT00880763|559915|P3|STARTED|Initial Treatment Period (Part 1)||23
229874|NCT00880763|559916|P2|STARTED|Initial Treatment Period (Part 1)||22
229875|NCT00880763|559917|P1|STARTED|Initial Treatment Period (Part 1)||23
229876|NCT00880906|559949|P2|NOT COMPLETED|Overall Study||7
229877|NCT00880906|559950|P1|NOT COMPLETED|Overall Study||12
229878|NCT00880906|559949|P2|COMPLETED|Overall Study||14
229879|NCT00880906|559950|P1|COMPLETED|Overall Study||17
229880|NCT00880906|559949|P2|STARTED|Overall Study||21
229881|NCT00880906|559950|P1|STARTED|Overall Study||29
229882|NCT00880919|559959|P3|NOT COMPLETED|Overall Study||6
229883|NCT00880919|559960|P2|NOT COMPLETED|Overall Study||14
229884|NCT00880919|559961|P1|NOT COMPLETED|Overall Study||15
229885|NCT00880919|559959|P3|COMPLETED|Overall Study||23
229886|NCT00880919|559960|P2|COMPLETED|Overall Study||19
229887|NCT00880919|559961|P1|COMPLETED|Overall Study||18
229888|NCT00880919|559959|P3|STARTED|Overall Study||29
229889|NCT00880919|559960|P2|STARTED|Overall Study||33
229890|NCT00880919|559961|P1|STARTED|Overall Study||33
229891|NCT00875212|559993|P1|NOT COMPLETED|CaGP and Fluoride Dentifrice||0
229892|NCT00875212|559993|P1|COMPLETED|CaGP and Fluoride Dentifrice||12
229893|NCT00875212|559993|P1|STARTED|CaGP and Fluoride Dentifrice||12
229894|NCT00875212|559993|P1|NOT COMPLETED|Fluoride Only Dentifrice||0
229895|NCT00875212|559993|P1|COMPLETED|Fluoride Only Dentifrice||12
229896|NCT00875212|559993|P1|STARTED|Fluoride Only Dentifrice||12
229897|NCT00875212|559993|P1|NOT COMPLETED|CaGP Only Dentifrice||0
229898|NCT00875212|559993|P1|COMPLETED|CaGP Only Dentifrice||12
229899|NCT00875212|559993|P1|STARTED|CaGP Only Dentifrice||12
229900|NCT00875212|559993|P1|NOT COMPLETED|Placebo Dentifrice||0
229901|NCT00875212|559993|P1|COMPLETED|Placebo Dentifrice|all participants completed this group|12
229902|NCT00875212|559993|P1|STARTED|Placebo Dentifrice||12
229903|NCT00875329|560004|P1|NOT COMPLETED|Overall Study||0
229904|NCT00875329|560004|P1|COMPLETED|Overall Study||97
229905|NCT00875329|560004|P1|STARTED|Overall Study||97
229906|NCT00875394|560011|P3|NOT COMPLETED|Overall Study||0
229907|NCT00875394|560012|P2|NOT COMPLETED|Overall Study||0
229908|NCT00875394|560013|P1|NOT COMPLETED|Overall Study||0
229909|NCT00875394|560011|P3|COMPLETED|Overall Study||9
229910|NCT00875394|560012|P2|COMPLETED|Overall Study||23
229911|NCT00875394|560013|P1|COMPLETED|Overall Study||36
229912|NCT00875394|560011|P3|STARTED|Overall Study||9
229913|NCT00875394|560012|P2|STARTED|Overall Study||23
229914|NCT00875394|560013|P1|STARTED|Overall Study||36
229915|NCT00881205|560023|P2|NOT COMPLETED|Overall Study||7
229916|NCT00881205|560024|P1|NOT COMPLETED|Overall Study||11
229917|NCT00881205|560023|P2|COMPLETED|Overall Study||34
229918|NCT00881205|560024|P1|COMPLETED|Overall Study||34
229919|NCT00881205|560023|P2|STARTED|Overall Study||41
229920|NCT00881205|560024|P1|STARTED|Overall Study||45
229921|NCT00882661|560034|P2|NOT COMPLETED|Treatment||26
229922|NCT00882661|560035|P1|NOT COMPLETED|Treatment||10
229923|NCT00882661|560034|P2|COMPLETED|Treatment||114
229924|NCT00882661|560035|P1|COMPLETED|Treatment||141
229925|NCT00882661|560034|P2|STARTED|Treatment||140
229926|NCT00882661|560035|P1|STARTED|Treatment||151
229927|NCT00882661|560034|P2|NOT COMPLETED|Investigational Training||0
229928|NCT00882661|560035|P1|NOT COMPLETED|Investigational Training||10
229929|NCT00882661|560034|P2|COMPLETED|Investigational Training||0
229930|NCT00882661|560035|P1|COMPLETED|Investigational Training||79
229931|NCT00882661|560034|P2|STARTED|Investigational Training||0
229932|NCT00882661|560035|P1|STARTED|Investigational Training||89
229933|NCT00882687|560067|P4|NOT COMPLETED|Overall Study||2
229934|NCT00882687|560068|P3|NOT COMPLETED|Overall Study||3
229935|NCT00882687|560069|P2|NOT COMPLETED|Overall Study||2
229936|NCT00882687|560070|P1|NOT COMPLETED|Overall Study||2
229937|NCT00882687|560067|P4|COMPLETED|Overall Study||13
229938|NCT00882687|560068|P3|COMPLETED|Overall Study||12
229939|NCT00882687|560069|P2|COMPLETED|Overall Study||13
229940|NCT00882687|560070|P1|COMPLETED|Overall Study||13
229941|NCT00882687|560067|P4|STARTED|Overall Study||15
229942|NCT00882687|560068|P3|STARTED|Overall Study||15
229943|NCT00882687|560069|P2|STARTED|Overall Study||15
229944|NCT00882687|560070|P1|STARTED|Overall Study||15
229945|NCT00882713|560100|P1|NOT COMPLETED|Overall Study||22
229946|NCT00882713|560100|P1|COMPLETED|Overall Study||172
229947|NCT00882713|560100|P1|STARTED|Overall Study||194
229948|NCT00882778|560122|P1|NOT COMPLETED|Overall Study||0
229949|NCT00882778|560122|P1|COMPLETED|Overall Study||86
229950|NCT00882778|560122|P1|STARTED|Overall Study||86
229951|NCT00882908|560158|P5|NOT COMPLETED|Overall Study||6
229952|NCT00882908|560159|P4|NOT COMPLETED|Overall Study||7
229953|NCT00882908|560160|P3|NOT COMPLETED|Overall Study||7
229954|NCT00882908|560161|P2|NOT COMPLETED|Overall Study||6
229955|NCT00882908|560162|P1|NOT COMPLETED|Overall Study||3
229956|NCT00882908|560158|P5|COMPLETED|Overall Study||71
229957|NCT00882908|560159|P4|COMPLETED|Overall Study||72
229958|NCT00882908|560160|P3|COMPLETED|Overall Study||70
229959|NCT00882908|560161|P2|COMPLETED|Overall Study||69
229960|NCT00882908|560162|P1|COMPLETED|Overall Study||75
229961|NCT00882908|560158|P5|STARTED|Overall Study||77
229962|NCT00882908|560159|P4|STARTED|Overall Study||79
229963|NCT00882908|560160|P3|STARTED|Overall Study||77
229964|NCT00882908|560161|P2|STARTED|Overall Study||75
229965|NCT00882908|560162|P1|STARTED|Overall Study||78
229966|NCT00882921|560237|P1|NOT COMPLETED|Overall Study||11
229967|NCT00882921|560237|P1|COMPLETED|Overall Study||15
229968|NCT00882921|560237|P1|STARTED|Overall Study||26
229969|NCT00883090|560242|P1|NOT COMPLETED|Overall Study||2
229970|NCT00883090|560242|P1|COMPLETED|Overall Study||13
229971|NCT00883090|560242|P1|STARTED|Overall Study|Of the 15 participants started, 14 were administered FXIII|15
229972|NCT00883103|560259|P2|NOT COMPLETED|Overall Study||0
229973|NCT00883103|560260|P1|NOT COMPLETED|Overall Study||0
229974|NCT00883103|560259|P2|COMPLETED|Overall Study||68
229975|NCT00883103|560260|P1|COMPLETED|Overall Study||69
229976|NCT00883103|560259|P2|STARTED|Overall Study||68
229977|NCT00883103|560260|P1|STARTED|Overall Study||69
229978|NCT00883116|560268|P2|NOT COMPLETED|Overall Study||219
229979|NCT00883116|560269|P1|NOT COMPLETED|Overall Study||209
229980|NCT00883116|560268|P2|COMPLETED|Overall Study||29
229981|NCT00883116|560269|P1|COMPLETED|Overall Study||39
229982|NCT00883116|560268|P2|Received Treatment|Overall Study||239
229983|NCT00883116|560269|P1|Received Treatment|Overall Study||248
229984|NCT00883116|560268|P2|STARTED|Overall Study||248
229985|NCT00883116|560269|P1|STARTED|Overall Study||248
229986|NCT00883129|560284|P2|NOT COMPLETED|Overall Study||36
229987|NCT00883129|560285|P1|NOT COMPLETED|Overall Study||20
229988|NCT00883129|560284|P2|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 16 of whom had prematurely withdrawn from drug treatment.|37
229989|NCT00883129|560285|P1|COMPLETED|Overall Study|53 subjects provided a 24 month outcome, 4 of whom had prematurely withdrawn from drug treatment.|49
229990|NCT00883129|560284|P2|STARTED|Overall Study||73
229991|NCT00883129|560285|P1|STARTED|Overall Study||69
229992|NCT00883168|560311|P4|NOT COMPLETED|Overall Study||15
229993|NCT00883168|560312|P3|NOT COMPLETED|Overall Study||19
229994|NCT00883168|560313|P2|NOT COMPLETED|Overall Study||15
229995|NCT00883168|560314|P1|NOT COMPLETED|Overall Study||14
229996|NCT00883168|560311|P4|COMPLETED|Overall Study||433
229997|NCT00883168|560312|P3|COMPLETED|Overall Study||431
229998|NCT00883168|560313|P2|COMPLETED|Overall Study||430
229999|NCT00883168|560314|P1|COMPLETED|Overall Study||434
230000|NCT00883168|560311|P4|STARTED|Overall Study||448
230001|NCT00883168|560312|P3|STARTED|Overall Study||450
230002|NCT00883168|560313|P2|STARTED|Overall Study||445
230003|NCT00883168|560314|P1|STARTED|Overall Study||448
230004|NCT00883181|560332|P1|NOT COMPLETED|Overall Study||278
230005|NCT00883181|560332|P1|COMPLETED|Overall Study|Completed planned chemotherapy|1069
230006|NCT00883181|560332|P1|STARTED|Overall Study|Full analysis set|1347
230007|NCT00883233|560545|P4|NOT COMPLETED|Overall Study||5
230008|NCT00883233|560546|P3|NOT COMPLETED|Overall Study||4
230009|NCT00883233|560547|P2|NOT COMPLETED|Overall Study||4
230010|NCT00883233|560548|P1|NOT COMPLETED|Overall Study||5
230011|NCT00883233|560545|P4|COMPLETED|Overall Study||25
230012|NCT00883233|560546|P3|COMPLETED|Overall Study||25
230013|NCT00883233|560547|P2|COMPLETED|Overall Study||28
230014|NCT00883233|560548|P1|COMPLETED|Overall Study||27
230015|NCT00883233|560545|P4|STARTED|Overall Study||30
230016|NCT00883233|560546|P3|STARTED|Overall Study||29
230017|NCT00883233|560547|P2|STARTED|Overall Study||32
230018|NCT00883233|560548|P1|STARTED|Overall Study||32
230019|NCT00883246|560558|P1|NOT COMPLETED|Overall Study||173
230020|NCT00883246|560558|P1|COMPLETED|Overall Study||626
230021|NCT00883246|560558|P1|STARTED|Overall Study||799
230022|NCT00883337|560579|P3|NOT COMPLETED|Extension Treatment Period||19
230023|NCT00883337|560580|P2|NOT COMPLETED|Extension Treatment Period||23
230024|NCT00883337|560581|P1|NOT COMPLETED|Extension Treatment Period||28
230025|NCT00883337|560579|P3|COMPLETED|Extension Treatment Period||40
230026|NCT00883337|560580|P2|COMPLETED|Extension Treatment Period||66
230027|NCT00883337|560581|P1|COMPLETED|Extension Treatment Period||61
230028|NCT00883337|560579|P3|STARTED|Extension Treatment Period|12 participants completed the core period but didn't enter the extension period.|59
230029|NCT00883337|560580|P2|STARTED|Extension Treatment Period||89
230030|NCT00883337|560581|P1|STARTED|Extension Treatment Period||89
230031|NCT00883337|560579|P3|NOT COMPLETED|Core Treatment Period||33
230032|NCT00883337|560580|P2|NOT COMPLETED|Core Treatment Period||22
230033|NCT00883337|560581|P1|NOT COMPLETED|Core Treatment Period||20
230034|NCT00883337|560579|P3|COMPLETED|Core Treatment Period||71
230035|NCT00883337|560580|P2|COMPLETED|Core Treatment Period||89
230036|NCT00883337|560581|P1|COMPLETED|Core Treatment Period||89
230037|NCT00883337|560579|P3|Treated|Core Treatment Period|3 participants refused treatment with Rebif®|101
230038|NCT00883337|560580|P2|Treated|Core Treatment Period|One participant received teriflunomide 7 mg instead of teriflunomide 14 mg|111
230039|NCT00883337|560581|P1|Treated|Core Treatment Period||109
230040|NCT00883337|560579|P3|STARTED|Core Treatment Period||104
230041|NCT00883337|560580|P2|STARTED|Core Treatment Period||111
230042|NCT00883337|560581|P1|STARTED|Core Treatment Period||109
230043|NCT00883389|560613|P1|NOT COMPLETED|Overall Study||0
230044|NCT00883389|560613|P1|COMPLETED|Overall Study||26
230045|NCT00883389|560613|P1|STARTED|Overall Study||26
230046|NCT00883493|560619|P2|NOT COMPLETED|Overall Study||50
230047|NCT00883493|560620|P1|NOT COMPLETED|Overall Study||46
230048|NCT00883493|560619|P2|COMPLETED|Overall Study||159
230049|NCT00883493|560620|P1|COMPLETED|Overall Study||166
230050|NCT00883493|560619|P2|Per Protocol Analysis Population|Overall Study||155
230051|NCT00883493|560620|P1|Per Protocol Analysis Population|Overall Study||162
230052|NCT00883493|560619|P2|Intention To Treat Analysis Population|Overall Study||195
230053|NCT00883493|560620|P1|Intention To Treat Analysis Population|Overall Study||204
230054|NCT00883493|560619|P2|STARTED|Overall Study||209
230055|NCT00883493|560620|P1|STARTED|Overall Study||212
230056|NCT00883558|560644|P3|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||1
230057|NCT00883558|560645|P2|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
230058|NCT00883558|560646|P1|NOT COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
230059|NCT00883558|560644|P3|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||22
230060|NCT00883558|560645|P2|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||19
230061|NCT00883558|560646|P1|COMPLETED|Second Treatment Cycle (Weeks 16 to 28)||0
230062|NCT00883558|560644|P3|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||23
230063|NCT00883558|560645|P2|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||19
230064|NCT00883558|560646|P1|Received at Least 1 Dose of Study Drug|Second Treatment Cycle (Weeks 16 to 28)||0
230065|NCT00883558|560644|P3|STARTED|Second Treatment Cycle (Weeks 16 to 28)||23
230066|NCT00883558|560645|P2|STARTED|Second Treatment Cycle (Weeks 16 to 28)||19
230067|NCT00883558|560646|P1|STARTED|Second Treatment Cycle (Weeks 16 to 28)||0
230068|NCT00883558|560644|P3|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||1
230069|NCT00883558|560645|P2|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||3
230070|NCT00883558|560646|P1|NOT COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
230071|NCT00883558|560644|P3|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||23
230072|NCT00883558|560645|P2|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||19
230073|NCT00883558|560646|P1|COMPLETED|First Treatment Cycle (Weeks 4 to 16)||0
230074|NCT00883558|560644|P3|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||24
230075|NCT00883558|560645|P2|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||22
230076|NCT00883558|560646|P1|Received at Least 1 Dose of Study Drug|First Treatment Cycle (Weeks 4 to 16)||0
230077|NCT00883558|560644|P3|STARTED|First Treatment Cycle (Weeks 4 to 16)||24
230078|NCT00883558|560645|P2|STARTED|First Treatment Cycle (Weeks 4 to 16)||22
230079|NCT00883558|560646|P1|STARTED|First Treatment Cycle (Weeks 4 to 16)||0
230080|NCT00883558|560644|P3|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
230081|NCT00883558|560645|P2|NOT COMPLETED|Titration Period (Weeks 0 to 4)||0
230082|NCT00883558|560646|P1|NOT COMPLETED|Titration Period (Weeks 0 to 4)||2
230083|NCT00883558|560644|P3|COMPLETED|Titration Period (Weeks 0 to 4)||0
230084|NCT00883558|560645|P2|COMPLETED|Titration Period (Weeks 0 to 4)||0
230085|NCT00883558|560646|P1|COMPLETED|Titration Period (Weeks 0 to 4)||46
230086|NCT00883558|560644|P3|STARTED|Titration Period (Weeks 0 to 4)||0
230087|NCT00883558|560645|P2|STARTED|Titration Period (Weeks 0 to 4)||0
230088|NCT00883558|560646|P1|STARTED|Titration Period (Weeks 0 to 4)||48
230089|NCT00883675|560656|P1|NOT COMPLETED|Overall Study||0
230090|NCT00883675|560656|P1|COMPLETED|Overall Study||133
230091|NCT00883675|560656|P1|STARTED|Overall Study||133
230092|NCT00883740|560660|P2|NOT COMPLETED|Second Intervention||1
230093|NCT00883740|560661|P1|NOT COMPLETED|Second Intervention||1
230094|NCT00883740|560660|P2|COMPLETED|Second Intervention||50
230095|NCT00883740|560661|P1|COMPLETED|Second Intervention||52
230096|NCT00883740|560660|P2|STARTED|Second Intervention||51
230097|NCT00883740|560661|P1|STARTED|Second Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
230098|NCT00883740|560660|P2|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
230099|NCT00883740|560661|P1|NOT COMPLETED|Taper and Washout Period (2 Weeks)||0
230100|NCT00883740|560660|P2|COMPLETED|Taper and Washout Period (2 Weeks)||51
230101|NCT00883740|560661|P1|COMPLETED|Taper and Washout Period (2 Weeks)||54
230102|NCT00883740|560660|P2|STARTED|Taper and Washout Period (2 Weeks)||51
230103|NCT00883740|560661|P1|STARTED|Taper and Washout Period (2 Weeks)|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|54
230104|NCT00883740|560660|P2|NOT COMPLETED|First Intervention||8
230105|NCT00883740|560661|P1|NOT COMPLETED|First Intervention||7
230106|NCT00883740|560660|P2|COMPLETED|First Intervention||51
230107|NCT00883740|560661|P1|COMPLETED|First Intervention|1 participant not crossed to period 2 but continued on period 1, sponsor terminated as noncompliance|53
230108|NCT00883740|560660|P2|STARTED|First Intervention||59
230109|NCT00883740|560661|P1|STARTED|First Intervention||60
230110|NCT00883753|560701|P1|NOT COMPLETED|Overall Study||107
230111|NCT00883753|560701|P1|COMPLETED|Overall Study||827
230112|NCT00883753|560701|P1|STARTED|Overall Study||934
230113|NCT00883779|560743|P2|NOT COMPLETED|Off-study Phase||202
230114|NCT00883779|560744|P1|NOT COMPLETED|Off-study Phase||209
230115|NCT00883779|560743|P2|COMPLETED|Off-study Phase||0
230116|NCT00883779|560744|P1|COMPLETED|Off-study Phase||0
230117|NCT00883779|560743|P2|STARTED|Off-study Phase||202
230118|NCT00883779|560744|P1|STARTED|Off-study Phase||209
230119|NCT00883779|560743|P2|NOT COMPLETED|Post-Study Treatment Phase||135
230120|NCT00883779|560744|P1|NOT COMPLETED|Post-Study Treatment Phase||112
230121|NCT00883779|560743|P2|COMPLETED|Post-Study Treatment Phase||0
230122|NCT00883779|560744|P1|COMPLETED|Post-Study Treatment Phase||0
230123|NCT00883779|560743|P2|STARTED|Post-Study Treatment Phase||135
230124|NCT00883779|560744|P1|STARTED|Post-Study Treatment Phase||112
230125|NCT00883779|560743|P2|NOT COMPLETED|Primary Study Treatment Phase||86
230126|NCT00883779|560744|P1|NOT COMPLETED|Primary Study Treatment Phase||105
230127|NCT00883779|560743|P2|COMPLETED|Primary Study Treatment Phase||140
230128|NCT00883779|560744|P1|COMPLETED|Primary Study Treatment Phase||120
230129|NCT00883779|560743|P2|STARTED|Primary Study Treatment Phase||226
230130|NCT00883779|560744|P1|STARTED|Primary Study Treatment Phase||225
230131|NCT00884039|560782|P2|NOT COMPLETED|Overall Study||1
230132|NCT00884039|560783|P1|NOT COMPLETED|Overall Study||2
230133|NCT00884039|560782|P2|COMPLETED|Overall Study||1
230134|NCT00884039|560783|P1|COMPLETED|Overall Study||3
230135|NCT00884039|560782|P2|STARTED|Overall Study||2
230136|NCT00884039|560783|P1|STARTED|Overall Study||5
230137|NCT00884065|560791|P2|NOT COMPLETED|Overall Study||0
230138|NCT00884065|560792|P1|NOT COMPLETED|Overall Study||0
230139|NCT00884065|560791|P2|COMPLETED|Overall Study||25
230140|NCT00884065|560792|P1|COMPLETED|Overall Study||25
230141|NCT00884065|560791|P2|STARTED|Overall Study||25
230142|NCT00884065|560792|P1|STARTED|Overall Study||25
230143|NCT00884117|560808|P1|NOT COMPLETED|Overall Study||249
230144|NCT00884117|560808|P1|COMPLETED|Overall Study|Defined as Day 6 visit for those enrolled before Amendment D; thereafter defined as Day 10 visit.|4312
230145|NCT00884117|560808|P1|STARTED|Overall Study||4561
230146|NCT00884221|560852|P2|NOT COMPLETED|Overall Study||32
230147|NCT00884221|560853|P1|NOT COMPLETED|Overall Study||34
230148|NCT00884221|560852|P2|COMPLETED|Overall Study||343
230149|NCT00884221|560853|P1|COMPLETED|Overall Study||340
230150|NCT00884221|560852|P2|STARTED|Overall Study||375
230151|NCT00884221|560853|P1|STARTED|Overall Study||374
230152|NCT00884273|560891|P2|NOT COMPLETED|Overall Study||5
230153|NCT00884273|560892|P1|NOT COMPLETED|Overall Study||2
230154|NCT00884273|560891|P2|COMPLETED|Overall Study||93
230155|NCT00884273|560892|P1|COMPLETED|Overall Study||82
230156|NCT00884273|560891|P2|Safety Analysis Set|Overall Study||98
230157|NCT00884273|560892|P1|Safety Analysis Set|Overall Study||84
230158|NCT00884273|560891|P2|Per Protocol (PP) Analysis Set|Overall Study||92
230159|NCT00884273|560892|P1|Per Protocol (PP) Analysis Set|Overall Study||81
230324|NCT00885170|561292|P2|Treated|Overall Study||121
230160|NCT00884273|560891|P2|Full Analysis Set (FAS)|Overall Study|One participant did not have any post-dose efficacy assessment and was excluded from the FAS.|97
230161|NCT00884273|560892|P1|Full Analysis Set (FAS)|Overall Study|Two participants did not have any post-dose efficacy assessment and were excluded from the FAS.|82
230162|NCT00884273|560891|P2|STARTED|Overall Study|ITT population.|98
230163|NCT00884273|560892|P1|STARTED|Overall Study|Intention-to-treat (ITT) population.|84
230164|NCT00884325|560918|P2|NOT COMPLETED|Overall Study||4
230165|NCT00884325|560919|P1|NOT COMPLETED|Overall Study||3
230166|NCT00884325|560918|P2|COMPLETED|Overall Study||16
230167|NCT00884325|560919|P1|COMPLETED|Overall Study||17
230168|NCT00884325|560918|P2|STARTED|Overall Study||20
230169|NCT00884325|560919|P1|STARTED|Overall Study||20
230170|NCT00884377|560929|P2|NOT COMPLETED|Overall Study||1
230171|NCT00884377|560930|P1|NOT COMPLETED|Overall Study||2
230172|NCT00884377|560929|P2|COMPLETED|Overall Study||27
230173|NCT00884377|560930|P1|COMPLETED|Overall Study|1 received full course of therapy,withdrew consent before completion of the 12 month follow up|26
230174|NCT00884377|560929|P2|STARTED|Overall Study|1 was not treated due to concerns arising from the location of cutaneous leishmaniasis lesion|28
230175|NCT00884377|560930|P1|STARTED|Overall Study|1 not treated because infecting parasite could not be confirmed as L. major on rapid PCR testing,|28
230176|NCT00884390|560952|P2|NOT COMPLETED|Overall Study||8
230177|NCT00884390|560953|P1|NOT COMPLETED|Overall Study||23
230178|NCT00884390|560952|P2|COMPLETED|Overall Study||54
230179|NCT00884390|560953|P1|COMPLETED|Overall Study||123
230180|NCT00884390|560952|P2|STARTED|Overall Study||62
230181|NCT00884390|560953|P1|STARTED|Overall Study||146
230182|NCT00884585|560971|P2|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||0
230183|NCT00884585|560972|P1|NOT COMPLETED|Open-Label Maintenance (Months 9-12)||3
230184|NCT00884585|560971|P2|COMPLETED|Open-Label Maintenance (Months 9-12)||0
230185|NCT00884585|560972|P1|COMPLETED|Open-Label Maintenance (Months 9-12)||144
230186|NCT00884585|560971|P2|STARTED|Open-Label Maintenance (Months 9-12)||0
230187|NCT00884585|560972|P1|STARTED|Open-Label Maintenance (Months 9-12)||147
230188|NCT00884585|560971|P2|NOT COMPLETED|Open-Label Phase (Months 3-9)||0
230189|NCT00884585|560972|P1|NOT COMPLETED|Open-Label Phase (Months 3-9)||15
230190|NCT00884585|560971|P2|COMPLETED|Open-Label Phase (Months 3-9)||0
230191|NCT00884585|560972|P1|COMPLETED|Open-Label Phase (Months 3-9)||147
230192|NCT00884585|560971|P2|STARTED|Open-Label Phase (Months 3-9)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|0
230193|NCT00884585|560972|P1|STARTED|Open-Label Phase (Months 3-9)|All patients who completed the double-masked phase received COS in the open-label phase.|162
230194|NCT00884585|560971|P2|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||4
230195|NCT00884585|560972|P1|NOT COMPLETED|Double-Masked Phase (Day 1-Month 3)||10
230196|NCT00884585|560971|P2|COMPLETED|Double-Masked Phase (Day 1-Month 3)|All placebo patients who completed the double-masked phase received COS in the open-label phase.|83
230197|NCT00884585|560972|P1|COMPLETED|Double-Masked Phase (Day 1-Month 3)||79
230198|NCT00884585|560971|P2|STARTED|Double-Masked Phase (Day 1-Month 3)||87
230199|NCT00884585|560972|P1|STARTED|Double-Masked Phase (Day 1-Month 3)||89
230200|NCT00884741|560987|P4|NOT COMPLETED|Randomization||8
230201|NCT00884741|560988|P3|NOT COMPLETED|Randomization||8
230202|NCT00884741|560989|P2|NOT COMPLETED|Randomization||0
230203|NCT00884741|560990|P1|NOT COMPLETED|Randomization||0
230204|NCT00884741|560987|P4|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|312
230205|NCT00884741|560988|P3|COMPLETED|Randomization|Patients with data available for the primary analysis are considered to have completed the study.|309
230206|NCT00884741|560989|P2|COMPLETED|Randomization||0
230207|NCT00884741|560990|P1|COMPLETED|Randomization||0
230208|NCT00884741|560987|P4|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|320
230209|NCT00884741|560988|P3|STARTED|Randomization|These patients completed the previous period on the Step 2 Registration arm.|317
230210|NCT00884741|560989|P2|STARTED|Randomization|Step 2 Registration Arm goes to a randomized arm.|0
230211|NCT00884741|560990|P1|STARTED|Randomization||0
230212|NCT00884741|560987|P4|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
230213|NCT00884741|560988|P3|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
230214|NCT00884741|560989|P2|NOT COMPLETED|Step 2 Registration: Tissue Analysis||29
230215|NCT00884741|560990|P1|NOT COMPLETED|Step 2 Registration: Tissue Analysis||0
230216|NCT00884741|560987|P4|COMPLETED|Step 2 Registration: Tissue Analysis||0
230217|NCT00884741|560988|P3|COMPLETED|Step 2 Registration: Tissue Analysis||0
230218|NCT00884741|560989|P2|COMPLETED|Step 2 Registration: Tissue Analysis||637
230219|NCT00884741|560990|P1|COMPLETED|Step 2 Registration: Tissue Analysis||0
230220|NCT00884741|560987|P4|STARTED|Step 2 Registration: Tissue Analysis||0
230221|NCT00884741|560988|P3|STARTED|Step 2 Registration: Tissue Analysis||0
230222|NCT00884741|560989|P2|STARTED|Step 2 Registration: Tissue Analysis|These patients completed the previous period on the Step 1 Registration arm.|666
230223|NCT00884741|560990|P1|STARTED|Step 2 Registration: Tissue Analysis|Step 1 Registration Arm goes to Step 2 Registration Arm|0
230224|NCT00884741|560987|P4|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
230225|NCT00884741|560988|P3|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
230226|NCT00884741|560989|P2|NOT COMPLETED|Step 1 Registration: Tissue Screening||0
230227|NCT00884741|560990|P1|NOT COMPLETED|Step 1 Registration: Tissue Screening||312
230228|NCT00884741|560987|P4|COMPLETED|Step 1 Registration: Tissue Screening||0
230229|NCT00884741|560988|P3|COMPLETED|Step 1 Registration: Tissue Screening||0
230230|NCT00884741|560989|P2|COMPLETED|Step 1 Registration: Tissue Screening||0
230231|NCT00884741|560990|P1|COMPLETED|Step 1 Registration: Tissue Screening||666
230232|NCT00884741|560987|P4|STARTED|Step 1 Registration: Tissue Screening||0
230233|NCT00884741|560988|P3|STARTED|Step 1 Registration: Tissue Screening||0
230234|NCT00884741|560989|P2|STARTED|Step 1 Registration: Tissue Screening||0
230235|NCT00884741|560990|P1|STARTED|Step 1 Registration: Tissue Screening||978
230236|NCT00884754|561003|P2|NOT COMPLETED|Overall Study||0
230237|NCT00884754|561004|P1|NOT COMPLETED|Overall Study||0
230238|NCT00884754|561003|P2|COMPLETED|Overall Study||30
230239|NCT00884754|561004|P1|COMPLETED|Overall Study||30
230240|NCT00884754|561003|P2|STARTED|Overall Study||30
230241|NCT00884754|561004|P1|STARTED|Overall Study||30
230242|NCT00884793|561010|P1|NOT COMPLETED|Overall Study||1
230243|NCT00884793|561010|P1|COMPLETED|Overall Study||7
230244|NCT00884793|561010|P1|STARTED|Overall Study||8
230245|NCT00884806|561017|P1|NOT COMPLETED|Overall Study||0
230246|NCT00884806|561017|P1|COMPLETED|Overall Study||110
230247|NCT00884806|561017|P1|STARTED|Overall Study||110
230248|NCT00884832|561024|P2|NOT COMPLETED|Overall Study||1
230249|NCT00884832|561025|P1|NOT COMPLETED|Overall Study||0
230250|NCT00884832|561024|P2|COMPLETED|Overall Study||21
230251|NCT00884832|561025|P1|COMPLETED|Overall Study||22
230252|NCT00884832|561024|P2|STARTED|Overall Study||22
230253|NCT00884832|561025|P1|STARTED|Overall Study||22
230254|NCT00884897|561057|P2|NOT COMPLETED|Overall Study||0
230255|NCT00884897|561058|P1|NOT COMPLETED|Overall Study||0
230256|NCT00884897|561057|P2|COMPLETED|Overall Study||15
230257|NCT00884897|561058|P1|COMPLETED|Overall Study||13
230258|NCT00884897|561057|P2|STARTED|Overall Study||15
230259|NCT00884897|561058|P1|STARTED|Overall Study||13
230260|NCT00884910|561066|P1|NOT COMPLETED|Overall Study||1
230261|NCT00884910|561066|P1|COMPLETED|Overall Study|patient diagnosed with primary pulmonary tumor during study|32
230262|NCT00884910|561066|P1|STARTED|Overall Study||33
230263|NCT00884949|561071|P1|NOT COMPLETED|Continuation Period||0
230264|NCT00884949|561071|P1|COMPLETED|Continuation Period||18
230265|NCT00884949|561071|P1|STARTED|Continuation Period||18
230266|NCT00884949|561071|P1|NOT COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||0
230267|NCT00884949|561071|P1|COMPLETED|Weeks 25-36: 2.0 mg/kg/Week||18
230268|NCT00884949|561071|P1|STARTED|Weeks 25-36: 2.0 mg/kg/Week||18
230269|NCT00884949|561071|P1|NOT COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||0
230270|NCT00884949|561071|P1|COMPLETED|Weeks 13-24: 1.0 mg/kg/Week||18
230271|NCT00884949|561071|P1|STARTED|Weeks 13-24: 1.0 mg/kg/Week||18
230272|NCT00884949|561071|P1|NOT COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||2
230273|NCT00884949|561071|P1|COMPLETED|Weeks 1-12: 0.1 mg/kg/Week||18
230274|NCT00884949|561071|P1|STARTED|Weeks 1-12: 0.1 mg/kg/Week||20
230275|NCT00885079|561090|P2|NOT COMPLETED|Overall Study||4
230276|NCT00885079|561091|P1|NOT COMPLETED|Overall Study||2
230277|NCT00885079|561090|P2|COMPLETED|Overall Study||91
230278|NCT00885079|561091|P1|COMPLETED|Overall Study||91
230279|NCT00885079|561090|P2|STARTED|Overall Study||95
230280|NCT00885079|561091|P1|STARTED|Overall Study||93
230281|NCT00885092|561101|P2|NOT COMPLETED|Period 2, 7 Days||0
230282|NCT00885092|561102|P1|NOT COMPLETED|Period 2, 7 Days||0
230283|NCT00885092|561101|P2|COMPLETED|Period 2, 7 Days||20
230284|NCT00885092|561102|P1|COMPLETED|Period 2, 7 Days||20
230285|NCT00885092|561101|P2|STARTED|Period 2, 7 Days||20
230286|NCT00885092|561102|P1|STARTED|Period 2, 7 Days||20
230287|NCT00885092|561101|P2|NOT COMPLETED|Period 1, 7 Days||0
230288|NCT00885092|561102|P1|NOT COMPLETED|Period 1, 7 Days||0
230289|NCT00885092|561101|P2|COMPLETED|Period 1, 7 Days||20
230290|NCT00885092|561102|P1|COMPLETED|Period 1, 7 Days||20
230291|NCT00885092|561101|P2|STARTED|Period 1, 7 Days||20
230292|NCT00885092|561102|P1|STARTED|Period 1, 7 Days||20
230293|NCT00878228|561114|P2|NOT COMPLETED|Overall Study||12
230294|NCT00878228|561115|P1|NOT COMPLETED|Overall Study||10
230295|NCT00878228|561114|P2|COMPLETED|Overall Study||37
230296|NCT00878228|561115|P1|COMPLETED|Overall Study||39
230297|NCT00878228|561114|P2|STARTED|Overall Study||49
230298|NCT00878228|561115|P1|STARTED|Overall Study||49
230299|NCT00885105|561127|P2|NOT COMPLETED|Overall Study||10
230300|NCT00885105|561128|P1|NOT COMPLETED|Overall Study||1
230301|NCT00885105|561127|P2|COMPLETED|Overall Study||120
230302|NCT00885105|561128|P1|COMPLETED|Overall Study||111
230303|NCT00885105|561127|P2|STARTED|Overall Study||130
230304|NCT00885105|561128|P1|STARTED|Overall Study||112
230305|NCT00885118|561149|P5|NOT COMPLETED|Overall Study||1
230306|NCT00885118|561150|P4|NOT COMPLETED|Overall Study||0
230307|NCT00885118|561151|P3|NOT COMPLETED|Overall Study||1
230308|NCT00885118|561152|P2|NOT COMPLETED|Overall Study||0
230309|NCT00885118|561153|P1|NOT COMPLETED|Overall Study||1
230310|NCT00885118|561149|P5|COMPLETED|Overall Study||18
230311|NCT00885118|561150|P4|COMPLETED|Overall Study||20
230312|NCT00885118|561151|P3|COMPLETED|Overall Study||20
230313|NCT00885118|561152|P2|COMPLETED|Overall Study||19
230314|NCT00885118|561153|P1|COMPLETED|Overall Study||20
230315|NCT00885118|561149|P5|STARTED|Overall Study||19
230316|NCT00885118|561150|P4|STARTED|Overall Study||20
230317|NCT00885118|561151|P3|STARTED|Overall Study||21
230318|NCT00885118|561152|P2|STARTED|Overall Study||19
230319|NCT00885118|561153|P1|STARTED|Overall Study||21
230320|NCT00885170|561292|P2|NOT COMPLETED|Overall Study||23
230321|NCT00885170|561293|P1|NOT COMPLETED|Overall Study||38
230322|NCT00885170|561292|P2|COMPLETED|Overall Study||99
230323|NCT00885170|561293|P1|COMPLETED|Overall Study||86
230325|NCT00885170|561293|P1|Treated|Overall Study||122
230326|NCT00885170|561292|P2|STARTED|Overall Study||122
230327|NCT00885170|561293|P1|STARTED|Overall Study||124
230328|NCT00885352|561349|P2|NOT COMPLETED|Overall Study||20
230329|NCT00885352|561350|P1|NOT COMPLETED|Overall Study||8
230330|NCT00885352|561349|P2|COMPLETED|Overall Study||136
230331|NCT00885352|561350|P1|COMPLETED|Overall Study||149
230332|NCT00885352|561349|P2|STARTED|Overall Study||156
230333|NCT00885352|561350|P1|STARTED|Overall Study||157
230334|NCT00885365|561362|P2|NOT COMPLETED|4 Weeks OFF Treatment||0
230335|NCT00885365|561363|P1|NOT COMPLETED|4 Weeks OFF Treatment||0
230336|NCT00885365|561362|P2|COMPLETED|4 Weeks OFF Treatment||159
230337|NCT00885365|561363|P1|COMPLETED|4 Weeks OFF Treatment||155
230338|NCT00885365|561362|P2|STARTED|4 Weeks OFF Treatment||159
230339|NCT00885365|561363|P1|STARTED|4 Weeks OFF Treatment||155
230340|NCT00885365|561362|P2|NOT COMPLETED|4 Weeks ON Treatment||6
230341|NCT00885365|561363|P1|NOT COMPLETED|4 Weeks ON Treatment||4
230342|NCT00885365|561362|P2|COMPLETED|4 Weeks ON Treatment||159
230343|NCT00885365|561363|P1|COMPLETED|4 Weeks ON Treatment||155
230344|NCT00885365|561362|P2|Safety Population|4 Weeks ON Treatment|Six participants randomized to TOBI were administered Bramitob|168
230345|NCT00885365|561363|P1|Safety Population|4 Weeks ON Treatment|Nine participants randomized to Bramitob were administered TOBI.|156
230346|NCT00885365|561362|P2|Intent-to-Treat Population|4 Weeks ON Treatment||163
230347|NCT00885365|561363|P1|Intent-to-Treat Population|4 Weeks ON Treatment|Participants who took 1 dose of study medication and had baseline and at least 1 post-treatment FEV1|158
230348|NCT00885365|561362|P2|STARTED|4 Weeks ON Treatment||165
230349|NCT00885365|561363|P1|STARTED|4 Weeks ON Treatment||159
230350|NCT00885378|561399|P2|NOT COMPLETED|Overall Study||8
230351|NCT00885378|561400|P1|NOT COMPLETED|Overall Study||8
230352|NCT00885378|561399|P2|COMPLETED|Overall Study||78
230353|NCT00885378|561400|P1|COMPLETED|Overall Study||66
230354|NCT00885378|561399|P2|STARTED|Overall Study|Number randomized.|86
230355|NCT00885378|561400|P1|STARTED|Overall Study|Number randomized.|74
230356|NCT00885638|561428|P2|NOT COMPLETED|Overall Study||0
230357|NCT00885638|561429|P1|NOT COMPLETED|Overall Study||0
230358|NCT00885638|561428|P2|COMPLETED|Overall Study||6
230359|NCT00885638|561429|P1|COMPLETED|Overall Study||6
230360|NCT00885638|561428|P2|STARTED|Overall Study||6
230361|NCT00885638|561429|P1|STARTED|Overall Study||6
230362|NCT00885677|561438|P2|NOT COMPLETED|Overall Study||178
230363|NCT00885677|561439|P1|NOT COMPLETED|Overall Study||183
230364|NCT00885677|561438|P2|COMPLETED|Overall Study||277
230365|NCT00885677|561439|P1|COMPLETED|Overall Study||279
230366|NCT00885677|561438|P2|Intention To Treat|Overall Study||428
230367|NCT00885677|561439|P1|Intention To Treat|Overall Study||437
230368|NCT00885677|561438|P2|STARTED|Overall Study||455
230369|NCT00885677|561439|P1|STARTED|Overall Study||462
230370|NCT00885742|561447|P1|NOT COMPLETED|Overall Study||0
230371|NCT00885742|561447|P1|COMPLETED|Overall Study||41
230372|NCT00885742|561447|P1|STARTED|Overall Study||41
230373|NCT00885755|561461|P3|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
230374|NCT00885755|561462|P2|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||0
230375|NCT00885755|561463|P1|NOT COMPLETED|Part II: Trastuzumab + Capecitabine.||5
230376|NCT00885755|561461|P3|COMPLETED|Part II: Trastuzumab + Capecitabine.||0
230377|NCT00885755|561462|P2|COMPLETED|Part II: Trastuzumab + Capecitabine.||1
230378|NCT00885755|561463|P1|COMPLETED|Part II: Trastuzumab + Capecitabine.||8
230379|NCT00885755|561461|P3|STARTED|Part II: Trastuzumab + Capecitabine.||0
230380|NCT00885755|561462|P2|STARTED|Part II: Trastuzumab + Capecitabine.||1
230381|NCT00885755|561463|P1|STARTED|Part II: Trastuzumab + Capecitabine.||13
230382|NCT00885755|561461|P3|NOT COMPLETED|Part I: Trastuzumab+Taxane||1
230383|NCT00885755|561462|P2|NOT COMPLETED|Part I: Trastuzumab+Taxane||0
230384|NCT00885755|561463|P1|NOT COMPLETED|Part I: Trastuzumab+Taxane||18
230385|NCT00885755|561461|P3|COMPLETED|Part I: Trastuzumab+Taxane||0
230386|NCT00885755|561462|P2|COMPLETED|Part I: Trastuzumab+Taxane||1
230387|NCT00885755|561463|P1|COMPLETED|Part I: Trastuzumab+Taxane||13
230388|NCT00885755|561461|P3|STARTED|Part I: Trastuzumab+Taxane||1
230389|NCT00885755|561462|P2|STARTED|Part I: Trastuzumab+Taxane||1
230390|NCT00885755|561463|P1|STARTED|Part I: Trastuzumab+Taxane||31
230391|NCT00885768|561488|P1|NOT COMPLETED|Overall Study||0
230392|NCT00885768|561488|P1|COMPLETED|Overall Study|all patients with including criteria completed the study|146
230393|NCT00885768|561488|P1|STARTED|Overall Study|all patients with coronary artery stenosis on angiography entered the study|146
230394|NCT00885846|561495|P3|NOT COMPLETED|Overall Study||2
230395|NCT00885846|561496|P2|NOT COMPLETED|Overall Study||5
230396|NCT00885846|561497|P1|NOT COMPLETED|Overall Study||2
230397|NCT00885846|561495|P3|COMPLETED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|8
230398|NCT00885846|561496|P2|COMPLETED|Overall Study|Cohort 1 = 1 Cohort 2 = 5|6
230399|NCT00885846|561497|P1|COMPLETED|Overall Study|Cohort 1 = 3 Cohort 2 = 6|9
230400|NCT00885846|561495|P3|STARTED|Overall Study|Cohort 1 = 4 Cohort 2 = 6|10
230401|NCT00885846|561496|P2|STARTED|Overall Study|Cohort 1 = 6 Cohort 2 = 5|11
230402|NCT00885846|561497|P1|STARTED|Overall Study|Cohort 1 = 5 Cohort 2 = 6|11
230403|NCT00886015|561507|P2|NOT COMPLETED|Overall Study||2
230404|NCT00886015|561508|P1|NOT COMPLETED|Overall Study||0
230405|NCT00886015|561507|P2|COMPLETED|Overall Study|1669 eyes; 956 participants|1669
230406|NCT00886015|561508|P1|COMPLETED|Overall Study|1674 eyes; 960 participants|1674
230407|NCT00886015|561507|P2|STARTED|Overall Study|1671 eyes; 957 participants|1671
230408|NCT00886015|561508|P1|STARTED|Overall Study|1674 eyes; 960 participants|1674
230409|NCT00886119|561524|P2|NOT COMPLETED|Period 2||0
230410|NCT00886119|561525|P1|NOT COMPLETED|Period 2||0
230411|NCT00886119|561524|P2|COMPLETED|Period 2||22
230412|NCT00886119|561525|P1|COMPLETED|Period 2||23
230413|NCT00886119|561524|P2|STARTED|Period 2||22
230414|NCT00886119|561525|P1|STARTED|Period 2||23
230415|NCT00886119|561524|P2|NOT COMPLETED|Period 1||0
230416|NCT00886119|561525|P1|NOT COMPLETED|Period 1||1
230417|NCT00886119|561524|P2|COMPLETED|Period 1||22
230418|NCT00886119|561525|P1|COMPLETED|Period 1||23
230419|NCT00886119|561524|P2|STARTED|Period 1||22
230420|NCT00886119|561525|P1|STARTED|Period 1||24
230421|NCT00886145|561531|P1|NOT COMPLETED|Overall Study||0
230422|NCT00886145|561531|P1|COMPLETED|Overall Study||1
230423|NCT00886145|561531|P1|STARTED|Overall Study||1
230424|NCT00886288|561539|P2|NOT COMPLETED|Overall Study||227
230425|NCT00886288|561540|P1|NOT COMPLETED|Overall Study||743
230426|NCT00886288|561539|P2|COMPLETED|Overall Study||457
230427|NCT00886288|561540|P1|COMPLETED|Overall Study||1284
230428|NCT00886288|561539|P2|STARTED|Overall Study|Baseline Population|684
230429|NCT00886288|561540|P1|STARTED|Overall Study|Baseline Population|2027
230430|NCT00886340|561558|P2|NOT COMPLETED|Overall Study||7
230431|NCT00886340|561559|P1|NOT COMPLETED|Overall Study||0
230432|NCT00886340|561558|P2|COMPLETED|Overall Study||24
230433|NCT00886340|561559|P1|COMPLETED|Overall Study||27
230434|NCT00886340|561558|P2|STARTED|Overall Study||31
230435|NCT00886340|561559|P1|STARTED|Overall Study||27
230436|NCT00886483|561567|P2|NOT COMPLETED|Overall Study||3
230437|NCT00886483|561568|P1|NOT COMPLETED|Overall Study||2
230438|NCT00886483|561567|P2|COMPLETED|Overall Study||10
230439|NCT00886483|561568|P1|COMPLETED|Overall Study||24
230440|NCT00886483|561567|P2|Completed 20 Treatments|Overall Study||11
230441|NCT00886483|561568|P1|Completed 20 Treatments|Overall Study||25
230442|NCT00886483|561567|P2|STARTED|Overall Study||13
230443|NCT00886483|561568|P1|STARTED|Overall Study||26
230444|NCT00886587|561586|P2|NOT COMPLETED|Overall Study||2
230445|NCT00886587|561587|P1|NOT COMPLETED|Overall Study||4
230446|NCT00886587|561586|P2|COMPLETED|Overall Study||39
230447|NCT00886587|561587|P1|COMPLETED|Overall Study||37
230448|NCT00886587|561586|P2|STARTED|Overall Study||41
230449|NCT00886587|561587|P1|STARTED|Overall Study||41
230450|NCT00886600|561603|P4|NOT COMPLETED|Combination Therapy Period||0
230451|NCT00886600|561604|P3|NOT COMPLETED|Combination Therapy Period||2
230452|NCT00886600|561605|P2|NOT COMPLETED|Combination Therapy Period||0
230453|NCT00886600|561606|P1|NOT COMPLETED|Combination Therapy Period||0
230454|NCT00886600|561603|P4|COMPLETED|Combination Therapy Period||23
230455|NCT00886600|561604|P3|COMPLETED|Combination Therapy Period||19
230456|NCT00886600|561605|P2|COMPLETED|Combination Therapy Period||21
230457|NCT00886600|561606|P1|COMPLETED|Combination Therapy Period||28
230458|NCT00886600|561603|P4|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 5-(SiDBP <85); 1-(SiDBP ≥85)|23
230459|NCT00886600|561604|P3|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 7-(SiDBP <85); 1-(SiDBP ≥85)|21
230460|NCT00886600|561605|P2|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 4-(SiDBP <85); 3-(SiDBP ≥85)|21
230461|NCT00886600|561606|P1|STARTED|Combination Therapy Period|Patients did not continue from monotherapy period : 2-(Sitting Diastolic Blood Pressure (SiDBP) <85)|28
230462|NCT00886600|561603|P4|NOT COMPLETED|Double-blind Monotherapy||2
230463|NCT00886600|561604|P3|NOT COMPLETED|Double-blind Monotherapy||1
230464|NCT00886600|561605|P2|NOT COMPLETED|Double-blind Monotherapy||1
230465|NCT00886600|561606|P1|NOT COMPLETED|Double-blind Monotherapy||2
230466|NCT00886600|561603|P4|COMPLETED|Double-blind Monotherapy||29
230467|NCT00886600|561604|P3|COMPLETED|Double-blind Monotherapy||29
230468|NCT00886600|561605|P2|COMPLETED|Double-blind Monotherapy|1 pt discontinued after Wk 4 due to AE starting in placebo baseline and continuing into double-blind|28
230469|NCT00886600|561606|P1|COMPLETED|Double-blind Monotherapy||30
230470|NCT00886600|561603|P4|STARTED|Double-blind Monotherapy||31
230471|NCT00886600|561604|P3|STARTED|Double-blind Monotherapy||30
230472|NCT00886600|561605|P2|STARTED|Double-blind Monotherapy||29
230473|NCT00886600|561606|P1|STARTED|Double-blind Monotherapy||32
230474|NCT00886613|561631|P3|NOT COMPLETED|Overall Study||3
230475|NCT00886613|561632|P2|NOT COMPLETED|Overall Study||0
230476|NCT00886613|561633|P1|NOT COMPLETED|Overall Study||2
230477|NCT00886613|561631|P3|COMPLETED|Overall Study||37
230478|NCT00886613|561632|P2|COMPLETED|Overall Study||39
230479|NCT00886613|561633|P1|COMPLETED|Overall Study||39
230480|NCT00886613|561631|P3|STARTED|Overall Study||40
230481|NCT00886613|561632|P2|STARTED|Overall Study||39
230482|NCT00886613|561633|P1|STARTED|Overall Study||41
230483|NCT00886626|561651|P2|NOT COMPLETED|Period 2 (90 Days)||0
230484|NCT00886626|561652|P1|NOT COMPLETED|Period 2 (90 Days)||0
230485|NCT00886626|561651|P2|COMPLETED|Period 2 (90 Days)||6
230486|NCT00886626|561652|P1|COMPLETED|Period 2 (90 Days)||5
230487|NCT00886626|561651|P2|STARTED|Period 2 (90 Days)||6
230488|NCT00886626|561652|P1|STARTED|Period 2 (90 Days)||5
230489|NCT00886626|561651|P2|NOT COMPLETED|Period 1 (90 Days)||0
230490|NCT00886626|561652|P1|NOT COMPLETED|Period 1 (90 Days)||1
230491|NCT00886626|561651|P2|COMPLETED|Period 1 (90 Days)||6
230492|NCT00886626|561652|P1|COMPLETED|Period 1 (90 Days)||5
230493|NCT00886626|561651|P2|STARTED|Period 1 (90 Days)||6
230494|NCT00886626|561652|P1|STARTED|Period 1 (90 Days)||6
230495|NCT00886639|561658|P1|NOT COMPLETED|Overall Study||16
230496|NCT00886639|561658|P1|COMPLETED|Overall Study||111
230497|NCT00886639|561658|P1|STARTED|Overall Study||127
230498|NCT00886704|561664|P2|NOT COMPLETED|Overall Study||0
230499|NCT00886704|561665|P1|NOT COMPLETED|Overall Study||0
230500|NCT00886704|561664|P2|COMPLETED|Overall Study||10
230501|NCT00886704|561665|P1|COMPLETED|Overall Study||40
230502|NCT00886704|561664|P2|STARTED|Overall Study||10
230503|NCT00886704|561665|P1|STARTED|Overall Study||40
230504|NCT00886743|561673|P1|NOT COMPLETED|Overall Study||4
230505|NCT00886743|561673|P1|COMPLETED|Overall Study||15
230506|NCT00886743|561673|P1|STARTED|Overall Study|Received treatment|19
230507|NCT00886769|561683|P2|NOT COMPLETED|Overall Study||37
230508|NCT00886769|561684|P1|NOT COMPLETED|Overall Study||6
230509|NCT00886769|561683|P2|COMPLETED|Overall Study||4
230510|NCT00886769|561684|P1|COMPLETED|Overall Study||37
230511|NCT00886769|561683|P2|STARTED|Overall Study||41
230512|NCT00886769|561684|P1|STARTED|Overall Study||43
230513|NCT00886795|561708|P1|NOT COMPLETED|Overall Study||1
230514|NCT00886795|561708|P1|COMPLETED|Overall Study||3
230515|NCT00886795|561708|P1|STARTED|Overall Study||4
230516|NCT00886821|561727|P14|NOT COMPLETED|Stage 2||1
230517|NCT00886821|561728|P13|NOT COMPLETED|Stage 2||5
230518|NCT00886821|561729|P12|NOT COMPLETED|Stage 2||1
230519|NCT00886821|561730|P11|NOT COMPLETED|Stage 2||0
230520|NCT00886821|561731|P10|NOT COMPLETED|Stage 2||0
230521|NCT00886821|561732|P9|NOT COMPLETED|Stage 2||0
230522|NCT00886821|561733|P8|NOT COMPLETED|Stage 2||0
230523|NCT00886821|561734|P7|NOT COMPLETED|Stage 2||0
230524|NCT00886821|561735|P6|NOT COMPLETED|Stage 2||0
230525|NCT00886821|561736|P5|NOT COMPLETED|Stage 2||0
230526|NCT00886821|561737|P4|NOT COMPLETED|Stage 2||0
230527|NCT00886821|561738|P3|NOT COMPLETED|Stage 2||0
230528|NCT00886821|561739|P2|NOT COMPLETED|Stage 2||0
230529|NCT00886821|561740|P1|NOT COMPLETED|Stage 2||0
230530|NCT00886821|561727|P14|COMPLETED|Stage 2||8
230531|NCT00886821|561728|P13|COMPLETED|Stage 2||8
230532|NCT00886821|561729|P12|COMPLETED|Stage 2||8
230533|NCT00886821|561730|P11|COMPLETED|Stage 2||9
230534|NCT00886821|561731|P10|COMPLETED|Stage 2||0
230535|NCT00886821|561732|P9|COMPLETED|Stage 2||0
230536|NCT00886821|561733|P8|COMPLETED|Stage 2||0
230537|NCT00886821|561734|P7|COMPLETED|Stage 2||0
230538|NCT00886821|561735|P6|COMPLETED|Stage 2||0
230539|NCT00886821|561736|P5|COMPLETED|Stage 2||0
230540|NCT00886821|561737|P4|COMPLETED|Stage 2||0
230541|NCT00886821|561738|P3|COMPLETED|Stage 2||0
230542|NCT00886821|561739|P2|COMPLETED|Stage 2||0
230543|NCT00886821|561740|P1|COMPLETED|Stage 2||0
230544|NCT00886821|561727|P14|STARTED|Stage 2||9
230545|NCT00886821|561728|P13|STARTED|Stage 2||13
230546|NCT00886821|561729|P12|STARTED|Stage 2||9
230547|NCT00886821|561730|P11|STARTED|Stage 2||9
230548|NCT00886821|561731|P10|STARTED|Stage 2||0
230549|NCT00886821|561732|P9|STARTED|Stage 2||0
230550|NCT00886821|561733|P8|STARTED|Stage 2||0
230551|NCT00886821|561734|P7|STARTED|Stage 2||0
230552|NCT00886821|561735|P6|STARTED|Stage 2||0
230553|NCT00886821|561736|P5|STARTED|Stage 2||0
230554|NCT00886821|561737|P4|STARTED|Stage 2||0
230555|NCT00886821|561738|P3|STARTED|Stage 2||0
230556|NCT00886821|561739|P2|STARTED|Stage 2||0
230557|NCT00886821|561740|P1|STARTED|Stage 2||0
230558|NCT00886821|561727|P14|NOT COMPLETED|Stage 1||0
230559|NCT00886821|561728|P13|NOT COMPLETED|Stage 1||0
230560|NCT00886821|561729|P12|NOT COMPLETED|Stage 1||0
230561|NCT00886821|561730|P11|NOT COMPLETED|Stage 1||0
230562|NCT00886821|561731|P10|NOT COMPLETED|Stage 1||0
230563|NCT00886821|561732|P9|NOT COMPLETED|Stage 1||0
230564|NCT00886821|561733|P8|NOT COMPLETED|Stage 1||0
230565|NCT00886821|561734|P7|NOT COMPLETED|Stage 1||0
230566|NCT00886821|561735|P6|NOT COMPLETED|Stage 1||0
230567|NCT00886821|561736|P5|NOT COMPLETED|Stage 1||0
230568|NCT00886821|561737|P4|NOT COMPLETED|Stage 1||0
230569|NCT00886821|561738|P3|NOT COMPLETED|Stage 1||0
230570|NCT00886821|561739|P2|NOT COMPLETED|Stage 1||0
230571|NCT00886821|561740|P1|NOT COMPLETED|Stage 1||0
230572|NCT00886821|561727|P14|COMPLETED|Stage 1||0
230573|NCT00886821|561728|P13|COMPLETED|Stage 1||0
230574|NCT00886821|561729|P12|COMPLETED|Stage 1||0
230575|NCT00886821|561730|P11|COMPLETED|Stage 1||0
230576|NCT00886821|561731|P10|COMPLETED|Stage 1||18
230577|NCT00886821|561732|P9|COMPLETED|Stage 1||6
230578|NCT00886821|561733|P8|COMPLETED|Stage 1||6
230579|NCT00886821|561734|P7|COMPLETED|Stage 1||6
230580|NCT00886821|561735|P6|COMPLETED|Stage 1||6
230581|NCT00886821|561736|P5|COMPLETED|Stage 1||6
230582|NCT00886821|561737|P4|COMPLETED|Stage 1||7
230583|NCT00886821|561738|P3|COMPLETED|Stage 1||6
230584|NCT00886821|561739|P2|COMPLETED|Stage 1||6
230585|NCT00886821|561740|P1|COMPLETED|Stage 1||7
230586|NCT00886821|561727|P14|STARTED|Stage 1||0
230587|NCT00886821|561728|P13|STARTED|Stage 1||0
230588|NCT00886821|561729|P12|STARTED|Stage 1||0
230589|NCT00886821|561730|P11|STARTED|Stage 1||0
230590|NCT00886821|561731|P10|STARTED|Stage 1||18
230591|NCT00886821|561732|P9|STARTED|Stage 1||6
230592|NCT00886821|561733|P8|STARTED|Stage 1||6
230593|NCT00886821|561734|P7|STARTED|Stage 1||6
230594|NCT00886821|561735|P6|STARTED|Stage 1||6
230595|NCT00886821|561736|P5|STARTED|Stage 1||6
230596|NCT00886821|561737|P4|STARTED|Stage 1||7
230597|NCT00886821|561738|P3|STARTED|Stage 1||6
230598|NCT00886821|561739|P2|STARTED|Stage 1||6
230599|NCT00886821|561740|P1|STARTED|Stage 1||7
230600|NCT00886834|561967|P2|NOT COMPLETED|Overall Study||3
230601|NCT00886834|561968|P1|NOT COMPLETED|Overall Study||0
230602|NCT00886834|561967|P2|COMPLETED|Overall Study||51
230603|NCT00886834|561968|P1|COMPLETED|Overall Study||54
230604|NCT00886834|561967|P2|STARTED|Overall Study||54
230605|NCT00886834|561968|P1|STARTED|Overall Study||54
230606|NCT00886899|561976|P1|NOT COMPLETED|Overall Study||0
230607|NCT00886899|561976|P1|COMPLETED|Overall Study||147
230608|NCT00886899|561976|P1|STARTED|Overall Study||147
230609|NCT00886938|561983|P1|NOT COMPLETED|Overall Study||2
230610|NCT00886938|561983|P1|COMPLETED|Overall Study||10
230611|NCT00886938|561983|P1|STARTED|Overall Study||12
230612|NCT00887159|561990|P3|NOT COMPLETED|Overall Study||56
230613|NCT00887159|561991|P2|NOT COMPLETED|Overall Study||56
230614|NCT00887159|561992|P1|NOT COMPLETED|Overall Study||29
230615|NCT00887159|561990|P3|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
230616|NCT00887159|561991|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicity.|0
230617|NCT00887159|561992|P1|COMPLETED|Overall Study||27
230618|NCT00887159|561990|P3|Eligible/Treated Pts With CTCs Results|Overall Study||38
230619|NCT00887159|561991|P2|Eligible/Treated Pts With CTCs Results|Overall Study||42
230620|NCT00887159|561992|P1|Eligible/Treated Pts With CTCs Results|Overall Study||40
230621|NCT00887159|561990|P3|Eligible and Treated Patients|Overall Study||52
230622|NCT00887159|561991|P2|Eligible and Treated Patients|Overall Study||52
230623|NCT00887159|561992|P1|Eligible and Treated Patients|Overall Study||48
230624|NCT00887159|561990|P3|Patients Who Started Assigned Treatment|Overall Study||52
230625|NCT00887159|561991|P2|Patients Who Started Assigned Treatment|Overall Study||53
230626|NCT00887159|561992|P1|Patients Who Started Assigned Treatment|Overall Study||53
230627|NCT00887159|561990|P3|STARTED|Overall Study||56
230628|NCT00887159|561991|P2|STARTED|Overall Study||56
230629|NCT00887159|561992|P1|STARTED|Overall Study||56
230630|NCT00887198|562010|P2|NOT COMPLETED|Overall Study||431
230631|NCT00887198|562011|P1|NOT COMPLETED|Overall Study||384
230632|NCT00887198|562010|P2|COMPLETED|Overall Study||111
230633|NCT00887198|562011|P1|COMPLETED|Overall Study||162
230634|NCT00887198|562010|P2|STARTED|Overall Study||542
230635|NCT00887198|562011|P1|STARTED|Overall Study||546
230636|NCT00887224|562042|P3|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||30
230637|NCT00887224|562043|P2|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||41
230638|NCT00887224|562044|P1|NOT COMPLETED|DB Taper Phase / Post Study Follow Up||0
230639|NCT00887224|562042|P3|COMPLETED|DB Taper Phase / Post Study Follow Up||235
230640|NCT00887224|562043|P2|COMPLETED|DB Taper Phase / Post Study Follow Up||226
230641|NCT00887224|562044|P1|COMPLETED|DB Taper Phase / Post Study Follow Up||0
230642|NCT00887224|562042|P3|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||30
230643|NCT00887224|562043|P2|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up|DBp could have discontinued at anytime during DB taper period or Follow-up (7 days after last dose).|41
230644|NCT00887224|562044|P1|Discontinued DB Taper|DB Taper Phase / Post Study Follow Up||0
230645|NCT00887224|562042|P3|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||7
230646|NCT00887224|562043|P2|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||9
230647|NCT00887224|562044|P1|Did Not Enter DB Taper|DB Taper Phase / Post Study Follow Up||0
230648|NCT00887224|562042|P3|STARTED|DB Taper Phase / Post Study Follow Up||265
230649|NCT00887224|562043|P2|STARTED|DB Taper Phase / Post Study Follow Up|Double-blind participants (DBp) could have entered 7-day taper period at any time during DB phase.|267
230650|NCT00887224|562044|P1|STARTED|DB Taper Phase / Post Study Follow Up||0
230651|NCT00887224|562042|P3|NOT COMPLETED|Double-blind (DB) Phase||62
230652|NCT00887224|562043|P2|NOT COMPLETED|Double-blind (DB) Phase||100
230653|NCT00887224|562044|P1|NOT COMPLETED|Double-blind (DB) Phase||0
230654|NCT00887224|562042|P3|COMPLETED|Double-blind (DB) Phase||210
230655|NCT00887224|562043|P2|COMPLETED|Double-blind (DB) Phase||176
230656|NCT00887224|562044|P1|COMPLETED|Double-blind (DB) Phase||0
230657|NCT00887224|562042|P3|STARTED|Double-blind (DB) Phase||272
230658|NCT00887224|562043|P2|STARTED|Double-blind (DB) Phase|2 participants randomized in error to DB, then entered OL Taper; counted in OL Taper and DB phases.|276
230659|NCT00887224|562044|P1|STARTED|Double-blind (DB) Phase||0
230660|NCT00887224|562042|P3|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
230661|NCT00887224|562043|P2|NOT COMPLETED|OL Taper Phase / OL Follow Up||0
230662|NCT00887224|562044|P1|NOT COMPLETED|OL Taper Phase / OL Follow Up||144
230663|NCT00887224|562042|P3|COMPLETED|OL Taper Phase / OL Follow Up||0
230664|NCT00887224|562043|P2|COMPLETED|OL Taper Phase / OL Follow Up||0
230665|NCT00887224|562044|P1|COMPLETED|OL Taper Phase / OL Follow Up||163
230666|NCT00887224|562042|P3|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
230667|NCT00887224|562043|P2|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up||0
230668|NCT00887224|562044|P1|Discontinued Open-label Taper|OL Taper Phase / OL Follow Up|Could have discontinued at any time during OL taper phase or OL Follow-up (7 days after last dose).|144
230669|NCT00887224|562042|P3|STARTED|OL Taper Phase / OL Follow Up||0
230670|NCT00887224|562043|P2|STARTED|OL Taper Phase / OL Follow Up||0
230671|NCT00887224|562044|P1|STARTED|OL Taper Phase / OL Follow Up|Could have entered 7-day taper period at any time during either the OLR phase or OLS phase.|307
230672|NCT00887224|562042|P3|NOT COMPLETED|Between OLS and DB Phases||0
230673|NCT00887224|562043|P2|NOT COMPLETED|Between OLS and DB Phases||0
230674|NCT00887224|562044|P1|NOT COMPLETED|Between OLS and DB Phases||28
230675|NCT00887224|562042|P3|COMPLETED|Between OLS and DB Phases||0
230676|NCT00887224|562043|P2|COMPLETED|Between OLS and DB Phases||0
230677|NCT00887224|562044|P1|COMPLETED|Between OLS and DB Phases||548
230678|NCT00887224|562042|P3|STARTED|Between OLS and DB Phases||0
230679|NCT00887224|562043|P2|STARTED|Between OLS and DB Phases||0
230680|NCT00887224|562044|P1|STARTED|Between OLS and DB Phases||576
230681|NCT00887224|562042|P3|NOT COMPLETED|Open-label Stability (OLS) Phase||0
230682|NCT00887224|562043|P2|NOT COMPLETED|Open-label Stability (OLS) Phase||0
230683|NCT00887224|562044|P1|NOT COMPLETED|Open-label Stability (OLS) Phase||83
230684|NCT00887224|562042|P3|COMPLETED|Open-label Stability (OLS) Phase||0
230685|NCT00887224|562043|P2|COMPLETED|Open-label Stability (OLS) Phase||0
230686|NCT00887224|562044|P1|COMPLETED|Open-label Stability (OLS) Phase||576
230687|NCT00887224|562042|P3|STARTED|Open-label Stability (OLS) Phase||0
230688|NCT00887224|562043|P2|STARTED|Open-label Stability (OLS) Phase||0
230689|NCT00887224|562044|P1|STARTED|Open-label Stability (OLS) Phase||659
230690|NCT00887224|562042|P3|NOT COMPLETED|Between OLR and OLS Phases||0
230691|NCT00887224|562043|P2|NOT COMPLETED|Between OLR and OLS Phases||0
230692|NCT00887224|562044|P1|NOT COMPLETED|Between OLR and OLS Phases||93
230693|NCT00887224|562042|P3|COMPLETED|Between OLR and OLS Phases||0
230694|NCT00887224|562043|P2|COMPLETED|Between OLR and OLS Phases||0
230695|NCT00887224|562044|P1|COMPLETED|Between OLR and OLS Phases||659
230696|NCT00887224|562042|P3|STARTED|Between OLR and OLS Phases||0
230697|NCT00887224|562043|P2|STARTED|Between OLR and OLS Phases||0
230698|NCT00887224|562044|P1|STARTED|Between OLR and OLS Phases||752
230699|NCT00887224|562042|P3|NOT COMPLETED|Open-label Response (OLR) Phase||0
230700|NCT00887224|562043|P2|NOT COMPLETED|Open-label Response (OLR) Phase||0
230701|NCT00887224|562044|P1|NOT COMPLETED|Open-label Response (OLR) Phase||122
230702|NCT00887224|562042|P3|COMPLETED|Open-label Response (OLR) Phase||0
230703|NCT00887224|562043|P2|COMPLETED|Open-label Response (OLR) Phase||0
230704|NCT00887224|562044|P1|COMPLETED|Open-label Response (OLR) Phase||752
230705|NCT00887224|562042|P3|STARTED|Open-label Response (OLR) Phase||0
230706|NCT00887224|562043|P2|STARTED|Open-label Response (OLR) Phase||0
230707|NCT00887224|562044|P1|STARTED|Open-label Response (OLR) Phase||874
230708|NCT00887250|562072|P3|NOT COMPLETED|Overall Study||13
230709|NCT00887250|562073|P2|NOT COMPLETED|Overall Study||12
230710|NCT00887250|562074|P1|NOT COMPLETED|Overall Study||18
230711|NCT00887250|562072|P3|COMPLETED|Overall Study||110
230712|NCT00887250|562073|P2|COMPLETED|Overall Study||115
230713|NCT00887250|562074|P1|COMPLETED|Overall Study||98
230714|NCT00887250|562072|P3|STARTED|Overall Study||123
230715|NCT00887250|562073|P2|STARTED|Overall Study||127
230716|NCT00887250|562074|P1|STARTED|Overall Study||116
230717|NCT00887289|562094|P1|NOT COMPLETED|Overall Study||95
230718|NCT00887289|562094|P1|COMPLETED|Overall Study||1409
230719|NCT00887289|562094|P1|STARTED|Overall Study||1504
230720|NCT00887315|562105|P2|NOT COMPLETED|Overall Study||4
230721|NCT00887315|562106|P1|NOT COMPLETED|Overall Study||7
230722|NCT00887315|562105|P2|COMPLETED|Overall Study||0
230723|NCT00887315|562106|P1|COMPLETED|Overall Study||0
230724|NCT00887315|562105|P2|STARTED|Overall Study||4
230725|NCT00887315|562106|P1|STARTED|Overall Study||7
230726|NCT00887341|562116|P2|NOT COMPLETED|Overall Study||3
230727|NCT00887341|562117|P1|NOT COMPLETED|Overall Study||2
230728|NCT00887341|562116|P2|COMPLETED|Overall Study||36
230729|NCT00887341|562117|P1|COMPLETED|Overall Study||35
230730|NCT00887341|562116|P2|STARTED|Overall Study||39
230731|NCT00887341|562117|P1|STARTED|Overall Study||37
230732|NCT00887354|562153|P2|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||6
230733|NCT00887354|562154|P1|NOT COMPLETED|Open Label Phase (Week 26 to Week 78)||3
230734|NCT00887354|562153|P2|COMPLETED|Open Label Phase (Week 26 to Week 78)||59
230735|NCT00887354|562154|P1|COMPLETED|Open Label Phase (Week 26 to Week 78)||57
230736|NCT00887354|562153|P2|STARTED|Open Label Phase (Week 26 to Week 78)||65
230737|NCT00887354|562154|P1|STARTED|Open Label Phase (Week 26 to Week 78)||60
230738|NCT00887354|562153|P2|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||48
230739|NCT00887354|562154|P1|NOT COMPLETED|Treatment Phase (Week 0 to Week 26)||51
230740|NCT00887354|562153|P2|COMPLETED|Treatment Phase (Week 0 to Week 26)||65
230741|NCT00887354|562154|P1|COMPLETED|Treatment Phase (Week 0 to Week 26)||60
230742|NCT00887354|562153|P2|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||85
230743|NCT00887354|562154|P1|Included in Full Analysis Set|Treatment Phase (Week 0 to Week 26)||86
230744|NCT00887354|562153|P2|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||110
230745|NCT00887354|562154|P1|Received at Least 1 Dose of Study Drug|Treatment Phase (Week 0 to Week 26)||106
230746|NCT00887354|562153|P2|STARTED|Treatment Phase (Week 0 to Week 26)||113
230747|NCT00887354|562154|P1|STARTED|Treatment Phase (Week 0 to Week 26)||111
230748|NCT00887458|562174|P2|NOT COMPLETED|Overall Study||4
230749|NCT00887458|562175|P1|NOT COMPLETED|Overall Study||0
230750|NCT00887458|562174|P2|COMPLETED|Overall Study||25
230751|NCT00887458|562175|P1|COMPLETED|Overall Study||17
230752|NCT00887458|562174|P2|STARTED|Overall Study||29
230753|NCT00887458|562175|P1|STARTED|Overall Study||17
230754|NCT00887471|562183|P2|NOT COMPLETED|Overall Study||0
230755|NCT00887471|562184|P1|NOT COMPLETED|Overall Study||0
230756|NCT00887471|562183|P2|COMPLETED|Overall Study||15
230757|NCT00887471|562184|P1|COMPLETED|Overall Study||15
230758|NCT00887471|562183|P2|STARTED|Overall Study||15
230759|NCT00887471|562184|P1|STARTED|Overall Study||15
230760|NCT00887484|562192|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||3
230761|NCT00887484|562192|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||45
230762|NCT00887484|562192|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||48
230763|NCT00887484|562192|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
230764|NCT00887484|562192|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||48
230765|NCT00887484|562192|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||48
230766|NCT00887510|562258|P2|NOT COMPLETED|Overall Study||0
230767|NCT00887510|562259|P1|NOT COMPLETED|Overall Study||0
230768|NCT00887510|562258|P2|COMPLETED|Overall Study||12
230769|NCT00887510|562259|P1|COMPLETED|Overall Study||12
230770|NCT00887510|562258|P2|STARTED|Overall Study||12
230771|NCT00887510|562259|P1|STARTED|Overall Study||12
230772|NCT00887549|562267|P1|NOT COMPLETED|Maintenance Therapy||43
230773|NCT00887549|562267|P1|COMPLETED|Maintenance Therapy||0
230774|NCT00887549|562267|P1|STARTED|Maintenance Therapy||43
230775|NCT00887549|562267|P1|NOT COMPLETED|Induction Therapy||27
230776|NCT00887549|562267|P1|COMPLETED|Induction Therapy||43
230777|NCT00887549|562267|P1|STARTED|Induction Therapy||70
230778|NCT00887562|562277|P3|NOT COMPLETED|Overall Study||1
230779|NCT00887562|562278|P2|NOT COMPLETED|Overall Study||2
230780|NCT00887562|562279|P1|NOT COMPLETED|Overall Study||3
230781|NCT00887562|562277|P3|COMPLETED|Overall Study||7
230782|NCT00887562|562278|P2|COMPLETED|Overall Study||7
230783|NCT00887562|562279|P1|COMPLETED|Overall Study||7
230784|NCT00887562|562277|P3|STARTED|Overall Study||8
230785|NCT00887562|562278|P2|STARTED|Overall Study||9
230786|NCT00887562|562279|P1|STARTED|Overall Study||10
230787|NCT00887575|562293|P3|NOT COMPLETED|Phase II - Maintenance Therapy||0
230788|NCT00887575|562294|P2|NOT COMPLETED|Phase II - Maintenance Therapy||0
230789|NCT00887575|562295|P1|NOT COMPLETED|Phase II - Maintenance Therapy||2
230790|NCT00887575|562293|P3|COMPLETED|Phase II - Maintenance Therapy||0
230791|NCT00887575|562294|P2|COMPLETED|Phase II - Maintenance Therapy||0
230792|NCT00887575|562295|P1|COMPLETED|Phase II - Maintenance Therapy||6
230793|NCT00887575|562293|P3|STARTED|Phase II - Maintenance Therapy||0
230794|NCT00887575|562294|P2|STARTED|Phase II - Maintenance Therapy||0
230795|NCT00887575|562295|P1|STARTED|Phase II - Maintenance Therapy|Pts who completed 6 cycles of Neoadjuvant Therapy & underwent surgery were eligible for maintenance|8
230796|NCT00887575|562293|P3|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
230797|NCT00887575|562294|P2|NOT COMPLETED|Phase II - Neoadjuvant Therapy||0
230798|NCT00887575|562295|P1|NOT COMPLETED|Phase II - Neoadjuvant Therapy||25
230799|NCT00887575|562293|P3|COMPLETED|Phase II - Neoadjuvant Therapy||0
230800|NCT00887575|562294|P2|COMPLETED|Phase II - Neoadjuvant Therapy||0
230801|NCT00887575|562295|P1|COMPLETED|Phase II - Neoadjuvant Therapy||16
230802|NCT00887575|562293|P3|STARTED|Phase II - Neoadjuvant Therapy||0
230803|NCT00887575|562294|P2|STARTED|Phase II - Neoadjuvant Therapy||0
230804|NCT00887575|562295|P1|STARTED|Phase II - Neoadjuvant Therapy|Includes patients treated at MTD during Phase I, 39 additional patients enrolled, 4 were not treated|41
230805|NCT00887575|562293|P3|NOT COMPLETED|Phase I||3
230806|NCT00887575|562294|P2|NOT COMPLETED|Phase I||6
230807|NCT00887575|562295|P1|NOT COMPLETED|Phase I||0
230900|NCT00881530|562558|P5|STARTED|Overall Study||166
230808|NCT00887575|562293|P3|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
230809|NCT00887575|562294|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
230810|NCT00887575|562295|P1|COMPLETED|Phase I||6
230811|NCT00887575|562293|P3|STARTED|Phase I||3
230812|NCT00887575|562294|P2|STARTED|Phase I||6
230813|NCT00887575|562295|P1|STARTED|Phase I||6
230814|NCT00887588|562305|P2|NOT COMPLETED|Extension Period||5
230815|NCT00887588|562306|P1|NOT COMPLETED|Extension Period||6
230816|NCT00887588|562305|P2|COMPLETED|Extension Period||120
230817|NCT00887588|562306|P1|COMPLETED|Extension Period||121
230818|NCT00887588|562305|P2|Arterial Stiffness Set|Extension Period||94
230819|NCT00887588|562306|P1|Arterial Stiffness Set|Extension Period||86
230820|NCT00887588|562305|P2|STARTED|Extension Period||125
230821|NCT00887588|562306|P1|STARTED|Extension Period||127
230822|NCT00887588|562305|P2|NOT COMPLETED|Core Period||21
230823|NCT00887588|562306|P1|NOT COMPLETED|Core Period||19
230824|NCT00887588|562305|P2|COMPLETED|Core Period||131
230825|NCT00887588|562306|P1|COMPLETED|Core Period||130
230826|NCT00887588|562305|P2|Arterial Stiffness Set|Core Period||94
230827|NCT00887588|562306|P1|Arterial Stiffness Set|Core Period||86
230828|NCT00887588|562305|P2|Full Analysis Set|Core Period||146
230829|NCT00887588|562306|P1|Full Analysis Set|Core Period||148
230830|NCT00887588|562305|P2|Extension Efficacy Set|Core Period||125
230831|NCT00887588|562306|P1|Extension Efficacy Set|Core Period||127
230832|NCT00887588|562305|P2|STARTED|Core Period||152
230833|NCT00887588|562306|P1|STARTED|Core Period||149
230834|NCT00887640|562358|P1|NOT COMPLETED|Overall Study||0
230835|NCT00887640|562358|P1|COMPLETED|Overall Study||11
230836|NCT00887640|562358|P1|STARTED|Overall Study||11
230837|NCT00887653|562371|P1|NOT COMPLETED|Overall Study||0
230838|NCT00887653|562371|P1|COMPLETED|Overall Study||20
230839|NCT00887653|562371|P1|STARTED|Overall Study||20
230840|NCT00887679|562377|P1|NOT COMPLETED|Overall Study||10
230841|NCT00887679|562377|P1|COMPLETED|Overall Study|20 subjects completed the study.|20
230842|NCT00887679|562377|P1|STARTED|Overall Study||30
230843|NCT00887744|562386|P1|NOT COMPLETED|Overall Study||34
230844|NCT00887744|562386|P1|COMPLETED|Overall Study||128
230845|NCT00887744|562386|P1|STARTED|Overall Study|162 patients signed an informed consent but only 157 patients were treated with the Aperius.|162
230846|NCT00887809|562397|P2|NOT COMPLETED|Overall Study||0
230847|NCT00887809|562398|P1|NOT COMPLETED|Overall Study||4
230848|NCT00887809|562397|P2|COMPLETED|Overall Study||10
230849|NCT00887809|562398|P1|COMPLETED|Overall Study||33
230850|NCT00887809|562397|P2|STARTED|Overall Study||10
230851|NCT00887809|562398|P1|STARTED|Overall Study||37
230852|NCT00887822|562406|P2|NOT COMPLETED|Overall Study||102
230853|NCT00887822|562407|P1|NOT COMPLETED|Overall Study||97
230854|NCT00887822|562406|P2|COMPLETED|Overall Study||0
230855|NCT00887822|562407|P1|COMPLETED|Overall Study||3
230856|NCT00887822|562406|P2|Treated (Safety Population)|Overall Study||101
230857|NCT00887822|562407|P1|Treated (Safety Population)|Overall Study||100
230858|NCT00887822|562406|P2|STARTED|Overall Study||102
230859|NCT00887822|562407|P1|STARTED|Overall Study||100
230860|NCT00887913|562437|P1|NOT COMPLETED|Overall Study||6
230861|NCT00887913|562437|P1|COMPLETED|Overall Study||63
230862|NCT00887913|562437|P1|STARTED|Overall Study||69
230863|NCT00887965|562443|P1|NOT COMPLETED|Overall Study||0
230864|NCT00887965|562443|P1|COMPLETED|Overall Study||15
230865|NCT00887965|562443|P1|STARTED|Overall Study||15
230866|NCT00887978|562475|P2|NOT COMPLETED|Overall Study||15
230867|NCT00887978|562476|P1|NOT COMPLETED|Overall Study||25
230868|NCT00887978|562475|P2|COMPLETED|Overall Study||138
230869|NCT00887978|562476|P1|COMPLETED|Overall Study||132
230870|NCT00887978|562475|P2|STARTED|Overall Study||153
230871|NCT00887978|562476|P1|STARTED|Overall Study||157
230872|NCT00881335|562514|P2|NOT COMPLETED|Overall Study||2
230873|NCT00881335|562515|P1|NOT COMPLETED|Overall Study||3
230874|NCT00881335|562514|P2|COMPLETED|Overall Study|2 participants did not complete the period|28
230875|NCT00881335|562515|P1|COMPLETED|Overall Study|3 participants did not complete the period|27
230876|NCT00881335|562514|P2|STARTED|Overall Study||30
230877|NCT00881335|562515|P1|STARTED|Overall Study||30
230878|NCT00881465|562535|P2|NOT COMPLETED|Overall Study||0
230879|NCT00881465|562536|P1|NOT COMPLETED|Overall Study||2
230880|NCT00881465|562535|P2|COMPLETED|Overall Study||15
230881|NCT00881465|562536|P1|COMPLETED|Overall Study||14
230882|NCT00881465|562535|P2|STARTED|Overall Study||15
230883|NCT00881465|562536|P1|STARTED|Overall Study||16
230884|NCT00881504|562546|P1|NOT COMPLETED|Overall Study||1
230885|NCT00881504|562546|P1|COMPLETED|Overall Study||8
230886|NCT00881504|562546|P1|STARTED|Overall Study||9
230887|NCT00881530|562557|P6|NOT COMPLETED|Overall Study||5
230888|NCT00881530|562558|P5|NOT COMPLETED|Overall Study||14
230889|NCT00881530|562559|P4|NOT COMPLETED|Overall Study||9
230890|NCT00881530|562560|P3|NOT COMPLETED|Overall Study||5
230891|NCT00881530|562561|P2|NOT COMPLETED|Overall Study||5
230892|NCT00881530|562562|P1|NOT COMPLETED|Overall Study||14
230893|NCT00881530|562557|P6|COMPLETED|Overall Study||51
230894|NCT00881530|562558|P5|COMPLETED|Overall Study||152
230895|NCT00881530|562559|P4|COMPLETED|Overall Study||157
230896|NCT00881530|562560|P3|COMPLETED|Overall Study||51
230897|NCT00881530|562561|P2|COMPLETED|Overall Study||104
230898|NCT00881530|562562|P1|COMPLETED|Overall Study||92
230899|NCT00881530|562557|P6|STARTED|Overall Study||56
230901|NCT00881530|562559|P4|STARTED|Overall Study||166
230902|NCT00881530|562560|P3|STARTED|Overall Study||56
230903|NCT00881530|562561|P2|STARTED|Overall Study||109
230904|NCT00881530|562562|P1|STARTED|Overall Study||106
230905|NCT00881608|562623|P1|NOT COMPLETED|Overall Study||11
230906|NCT00881608|562623|P1|COMPLETED|Overall Study||0
230907|NCT00881608|562623|P1|STARTED|Overall Study||11
230908|NCT00881621|562640|P1|NOT COMPLETED|Overall Study||34
230909|NCT00881621|562640|P1|COMPLETED|Overall Study||17
230910|NCT00881621|562640|P1|STARTED|Overall Study||51
230911|NCT00881647|562649|P2|NOT COMPLETED|Overall Study||1
230912|NCT00881647|562650|P1|NOT COMPLETED|Overall Study||2
230913|NCT00881647|562649|P2|COMPLETED|Overall Study||15
230914|NCT00881647|562650|P1|COMPLETED|Overall Study||27
230915|NCT00881647|562649|P2|STARTED|Overall Study||16
230916|NCT00881647|562650|P1|STARTED|Overall Study||29
230917|NCT00881712|562663|P3|NOT COMPLETED|Overall Study||0
230918|NCT00881712|562664|P2|NOT COMPLETED|Overall Study||0
230919|NCT00881712|562665|P1|NOT COMPLETED|Overall Study||2
230920|NCT00881712|562663|P3|COMPLETED|Overall Study||0
230921|NCT00881712|562664|P2|COMPLETED|Overall Study||0
230922|NCT00881712|562665|P1|COMPLETED|Overall Study||13
230923|NCT00881712|562663|P3|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
230924|NCT00881712|562664|P2|STARTED|Overall Study|This arm was non-randomized and no enrolled patients fit the inclusion criteria for this group.|0
230925|NCT00881712|562665|P1|STARTED|Overall Study||15
230926|NCT00881868|562687|P2|NOT COMPLETED|Overall Study||2
230927|NCT00881868|562688|P1|NOT COMPLETED|Overall Study||8
230928|NCT00881868|562687|P2|COMPLETED|Overall Study||38
230929|NCT00881868|562688|P1|COMPLETED|Overall Study||33
230930|NCT00881868|562687|P2|STARTED|Overall Study||40
230931|NCT00881868|562688|P1|STARTED|Overall Study||41
230932|NCT00881894|562702|P2|NOT COMPLETED|Overall Study||3
230933|NCT00881894|562703|P1|NOT COMPLETED|Overall Study||1
230934|NCT00881894|562702|P2|COMPLETED|Overall Study||23
230935|NCT00881894|562703|P1|COMPLETED|Overall Study||25
231025|NCT00888238|562867|P3|STARTED|Washout Period After Period 2||4
230936|NCT00881894|562702|P2|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|21
230937|NCT00881894|562703|P1|Pharmacokinetic Set (PKS)|Overall Study|Patients with an insufficient patch adhesiveness were excluded from the PKS.|23
230938|NCT00881894|562702|P2|STARTED|Overall Study||26
230939|NCT00881894|562703|P1|STARTED|Overall Study||26
230940|NCT00881959|562735|P2|NOT COMPLETED|Overall Study||4
230941|NCT00881959|562736|P1|NOT COMPLETED|Overall Study||2
230942|NCT00881959|562735|P2|COMPLETED|Overall Study||38
230943|NCT00881959|562736|P1|COMPLETED|Overall Study||36
230944|NCT00881959|562735|P2|STARTED|Overall Study||42
230945|NCT00881959|562736|P1|STARTED|Overall Study||38
230946|NCT00882102|562742|P1|NOT COMPLETED|Overall Study||0
230947|NCT00882102|562742|P1|COMPLETED|Overall Study||40
230948|NCT00882102|562742|P1|STARTED|Overall Study||40
230949|NCT00882206|562746|P1|NOT COMPLETED|Overall Study||0
230950|NCT00882206|562746|P1|COMPLETED|Overall Study||13
230951|NCT00882206|562746|P1|STARTED|Overall Study||13
230952|NCT00882310|562753|P1|NOT COMPLETED|Overall Study||22
230953|NCT00882310|562753|P1|COMPLETED|Overall Study||15
230954|NCT00882310|562753|P1|STARTED|Overall Study||37
230955|NCT00882362|562761|P2|NOT COMPLETED|Overall Study||23
230956|NCT00882362|562762|P1|NOT COMPLETED|Overall Study||49
230957|NCT00882362|562761|P2|COMPLETED|Overall Study||10
230958|NCT00882362|562762|P1|COMPLETED|Overall Study||73
230959|NCT00882362|562761|P2|STARTED|Overall Study||33
230960|NCT00882362|562762|P1|STARTED|Overall Study||122
230961|NCT00882440|562775|P7|NOT COMPLETED|Overall Study||4
230962|NCT00882440|562776|P6|NOT COMPLETED|Overall Study||7
230963|NCT00882440|562777|P5|NOT COMPLETED|Overall Study||10
230964|NCT00882440|562778|P4|NOT COMPLETED|Overall Study||3
230965|NCT00882440|562779|P3|NOT COMPLETED|Overall Study||7
230966|NCT00882440|562780|P2|NOT COMPLETED|Overall Study||8
230967|NCT00882440|562781|P1|NOT COMPLETED|Overall Study||11
230968|NCT00882440|562775|P7|COMPLETED|Overall Study||79
230969|NCT00882440|562776|P6|COMPLETED|Overall Study||77
230970|NCT00882440|562777|P5|COMPLETED|Overall Study||80
230971|NCT00882440|562778|P4|COMPLETED|Overall Study||76
230972|NCT00882440|562779|P3|COMPLETED|Overall Study||75
230973|NCT00882440|562780|P2|COMPLETED|Overall Study||72
230974|NCT00882440|562781|P1|COMPLETED|Overall Study||67
230975|NCT00882440|562775|P7|STARTED|Overall Study||83
230976|NCT00882440|562776|P6|STARTED|Overall Study||84
230977|NCT00882440|562777|P5|STARTED|Overall Study||90
230978|NCT00882440|562778|P4|STARTED|Overall Study||79
230979|NCT00882440|562779|P3|STARTED|Overall Study||82
230980|NCT00882440|562780|P2|STARTED|Overall Study||80
230981|NCT00882440|562781|P1|STARTED|Overall Study||78
230982|NCT00882518|562806|P2|NOT COMPLETED|Overall Study||44
230983|NCT00882518|562807|P1|NOT COMPLETED|Overall Study||38
230984|NCT00882518|562806|P2|COMPLETED|Overall Study||148
230985|NCT00882518|562807|P1|COMPLETED|Overall Study||158
230986|NCT00882518|562806|P2|STARTED|Overall Study||192
230987|NCT00882518|562807|P1|STARTED|Overall Study||196
230988|NCT00882557|562831|P2|NOT COMPLETED|Overall Study||1
230989|NCT00882557|562832|P1|NOT COMPLETED|Overall Study||2
230990|NCT00882557|562831|P2|COMPLETED|Overall Study||7
230991|NCT00882557|562832|P1|COMPLETED|Overall Study||6
230992|NCT00882557|562831|P2|Completed Dose 2|Overall Study||7
230993|NCT00882557|562832|P1|Completed Dose 2|Overall Study||6
230994|NCT00882557|562831|P2|Completed Dose 1|Overall Study||7
230995|NCT00882557|562832|P1|Completed Dose 1|Overall Study||8
230996|NCT00882557|562831|P2|STARTED|Overall Study||8
230997|NCT00882557|562832|P1|STARTED|Overall Study||8
230998|NCT00882583|562852|P2|NOT COMPLETED|Overall Study||1
230999|NCT00882583|562853|P1|NOT COMPLETED|Overall Study||1
231000|NCT00882583|562852|P2|COMPLETED|Overall Study||11
231001|NCT00882583|562853|P1|COMPLETED|Overall Study||6
231002|NCT00882583|562852|P2|STARTED|Overall Study||12
231003|NCT00882583|562853|P1|STARTED|Overall Study||7
231004|NCT00888134|562859|P1|NOT COMPLETED|Follow-up||1
231005|NCT00888134|562859|P1|COMPLETED|Follow-up|23 died; 3 were lost-to-follow-up|26
231006|NCT00888134|562859|P1|STARTED|Follow-up||27
231007|NCT00888134|562859|P1|NOT COMPLETED|Treatment With Study Drug||1
231008|NCT00888134|562859|P1|COMPLETED|Treatment With Study Drug|21 had progressive disease; 5 had unacceptable toxicity; 1 finished treatment|27
231009|NCT00888134|562859|P1|STARTED|Treatment With Study Drug||28
231010|NCT00888238|562867|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
231011|NCT00888238|562868|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
231012|NCT00888238|562869|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
231013|NCT00888238|562867|P3|COMPLETED|Third Period of Treatment Intervention||3
231014|NCT00888238|562868|P2|COMPLETED|Third Period of Treatment Intervention||4
231015|NCT00888238|562869|P1|COMPLETED|Third Period of Treatment Intervention||4
231016|NCT00888238|562867|P3|STARTED|Third Period of Treatment Intervention||3
231017|NCT00888238|562868|P2|STARTED|Third Period of Treatment Intervention||4
231018|NCT00888238|562869|P1|STARTED|Third Period of Treatment Intervention||4
231019|NCT00888238|562867|P3|NOT COMPLETED|Washout Period After Period 2||1
231020|NCT00888238|562868|P2|NOT COMPLETED|Washout Period After Period 2||0
231021|NCT00888238|562869|P1|NOT COMPLETED|Washout Period After Period 2||0
231022|NCT00888238|562867|P3|COMPLETED|Washout Period After Period 2||3
231023|NCT00888238|562868|P2|COMPLETED|Washout Period After Period 2||4
231024|NCT00888238|562869|P1|COMPLETED|Washout Period After Period 2||4
231026|NCT00888238|562868|P2|STARTED|Washout Period After Period 2||4
231027|NCT00888238|562869|P1|STARTED|Washout Period After Period 2||4
231028|NCT00888238|562867|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
231029|NCT00888238|562868|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
231030|NCT00888238|562869|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
231031|NCT00888238|562867|P3|COMPLETED|Second Period of Treatment Intervention||4
231032|NCT00888238|562868|P2|COMPLETED|Second Period of Treatment Intervention||4
231033|NCT00888238|562869|P1|COMPLETED|Second Period of Treatment Intervention||4
231034|NCT00888238|562867|P3|STARTED|Second Period of Treatment Intervention||4
231035|NCT00888238|562868|P2|STARTED|Second Period of Treatment Intervention||4
231036|NCT00888238|562869|P1|STARTED|Second Period of Treatment Intervention||4
231037|NCT00888238|562867|P3|NOT COMPLETED|Washout Period After Period 1||0
231038|NCT00888238|562868|P2|NOT COMPLETED|Washout Period After Period 1||0
231039|NCT00888238|562869|P1|NOT COMPLETED|Washout Period After Period 1||0
231040|NCT00888238|562867|P3|COMPLETED|Washout Period After Period 1||4
231041|NCT00888238|562868|P2|COMPLETED|Washout Period After Period 1||4
231042|NCT00888238|562869|P1|COMPLETED|Washout Period After Period 1||4
231043|NCT00888238|562867|P3|STARTED|Washout Period After Period 1||4
231044|NCT00888238|562868|P2|STARTED|Washout Period After Period 1||4
231045|NCT00888238|562869|P1|STARTED|Washout Period After Period 1||4
231046|NCT00888238|562867|P3|NOT COMPLETED|First Period of Treatment Intervention||0
231047|NCT00888238|562868|P2|NOT COMPLETED|First Period of Treatment Intervention||0
231048|NCT00888238|562869|P1|NOT COMPLETED|First Period of Treatment Intervention||0
231049|NCT00888238|562867|P3|COMPLETED|First Period of Treatment Intervention||4
231050|NCT00888238|562868|P2|COMPLETED|First Period of Treatment Intervention||4
231051|NCT00888238|562869|P1|COMPLETED|First Period of Treatment Intervention||4
231052|NCT00888238|562867|P3|STARTED|First Period of Treatment Intervention||4
231053|NCT00888238|562868|P2|STARTED|First Period of Treatment Intervention||4
231054|NCT00888238|562869|P1|STARTED|First Period of Treatment Intervention||4
231055|NCT00888329|562879|P2|NOT COMPLETED|Overall Study||9
231056|NCT00888329|562880|P1|NOT COMPLETED|Overall Study||6
231057|NCT00888329|562879|P2|COMPLETED|Overall Study||122
231058|NCT00888329|562880|P1|COMPLETED|Overall Study||119
231059|NCT00888329|562879|P2|STARTED|Overall Study||131
231060|NCT00888329|562880|P1|STARTED|Overall Study||125
231061|NCT00888355|562890|P4|NOT COMPLETED|Overall Study||10
231062|NCT00888355|562891|P3|NOT COMPLETED|Overall Study||12
231063|NCT00888355|562892|P2|NOT COMPLETED|Overall Study||9
231064|NCT00888355|562893|P1|NOT COMPLETED|Overall Study||22
231065|NCT00888355|562890|P4|COMPLETED|Overall Study||96
231066|NCT00888355|562891|P3|COMPLETED|Overall Study||94
231067|NCT00888355|562892|P2|COMPLETED|Overall Study||99
231068|NCT00888355|562893|P1|COMPLETED|Overall Study||86
231069|NCT00888355|562890|P4|STARTED|Overall Study||106
231070|NCT00888355|562891|P3|STARTED|Overall Study||106
231071|NCT00888355|562892|P2|STARTED|Overall Study||108
231072|NCT00888355|562893|P1|STARTED|Overall Study||108
231073|NCT00888381|562949|P2|NOT COMPLETED|Overall Study||1
231074|NCT00888381|562950|P1|NOT COMPLETED|Overall Study||0
231075|NCT00888381|562949|P2|COMPLETED|Overall Study||59
231076|NCT00888381|562950|P1|COMPLETED|Overall Study||60
231077|NCT00888381|562949|P2|STARTED|Overall Study||60
231078|NCT00888381|562950|P1|STARTED|Overall Study||60
231079|NCT00888628|562966|P1|NOT COMPLETED|Overall Study||3
231080|NCT00888628|562966|P1|COMPLETED|Overall Study||4
231081|NCT00888628|562966|P1|Transplanted|Overall Study||4
231082|NCT00888628|562966|P1|Withdrawn|Overall Study||1
231083|NCT00888628|562966|P1|Screen Failure|Overall Study||2
231084|NCT00888628|562966|P1|Enrolled|Overall Study||7
231085|NCT00888628|562966|P1|STARTED|Overall Study||7
231086|NCT00888654|562972|P1|NOT COMPLETED|Overall Study||10
231087|NCT00888654|562972|P1|COMPLETED|Overall Study||31
231088|NCT00888654|562972|P1|STARTED|Overall Study||41
231089|NCT00888849|562978|P2|NOT COMPLETED|Overall Study||9
231090|NCT00888849|562979|P1|NOT COMPLETED|Overall Study||5
231091|NCT00888849|562978|P2|COMPLETED|Overall Study||129
231092|NCT00888849|562979|P1|COMPLETED|Overall Study||137
231093|NCT00888849|562978|P2|STARTED|Overall Study||138
231094|NCT00888849|562979|P1|STARTED|Overall Study||142
231095|NCT00888940|562991|P2|NOT COMPLETED|Overall Study||21
231096|NCT00888940|562992|P1|NOT COMPLETED|Overall Study||28
231097|NCT00888940|562991|P2|COMPLETED|Overall Study||101
231098|NCT00888940|562992|P1|COMPLETED|Overall Study||92
231099|NCT00888940|562991|P2|Completed Therapy|Overall Study||106
231100|NCT00888940|562992|P1|Completed Therapy|Overall Study||107
231101|NCT00888940|562991|P2|STARTED|Overall Study||122
231102|NCT00888940|562992|P1|STARTED|Overall Study||120
231103|NCT00888979|563000|P1|NOT COMPLETED|Overall Study||4
231104|NCT00888979|563000|P1|COMPLETED|Overall Study||6
231105|NCT00888979|563000|P1|Received the Inhaler/Counseling|Overall Study||8
231106|NCT00888979|563000|P1|STARTED|Overall Study||10
231107|NCT00889187|563006|P4|NOT COMPLETED|Overall Study||0
231108|NCT00889187|563007|P3|NOT COMPLETED|Overall Study||0
231109|NCT00889187|563008|P2|NOT COMPLETED|Overall Study||0
231110|NCT00889187|563009|P1|NOT COMPLETED|Overall Study||0
231111|NCT00889187|563006|P4|COMPLETED|Overall Study||0
231112|NCT00889187|563007|P3|COMPLETED|Overall Study||4
231113|NCT00889187|563008|P2|COMPLETED|Overall Study||3
231114|NCT00889187|563009|P1|COMPLETED|Overall Study||3
231115|NCT00889187|563006|P4|STARTED|Overall Study||0
231116|NCT00889187|563007|P3|STARTED|Overall Study||4
231117|NCT00889187|563008|P2|STARTED|Overall Study||3
231118|NCT00889187|563009|P1|STARTED|Overall Study||3
231119|NCT00889200|563019|P1|NOT COMPLETED|Overall Study||0
231120|NCT00889200|563019|P1|COMPLETED|Overall Study||12
231121|NCT00889200|563019|P1|STARTED|Overall Study||12
231122|NCT00889252|563025|P2|NOT COMPLETED|Overall Study||4
231123|NCT00889252|563026|P1|NOT COMPLETED|Overall Study||7
231124|NCT00889252|563025|P2|COMPLETED|Overall Study||78
231125|NCT00889252|563026|P1|COMPLETED|Overall Study||161
231126|NCT00889252|563025|P2|STARTED|Overall Study||82
231127|NCT00889252|563026|P1|STARTED|Overall Study||168
231128|NCT00889265|563068|P1|NOT COMPLETED|Overall Study||7
231129|NCT00889265|563068|P1|COMPLETED|Overall Study||44
231130|NCT00889265|563068|P1|STARTED|Overall Study|Date Enrollment Started: 07/21/2009 Date Enrollment Completed: 02/15/2011 Total enrolled: 51|51
231131|NCT00889330|563075|P2|NOT COMPLETED|Overall Study||0
231132|NCT00889330|563076|P1|NOT COMPLETED|Overall Study||0
231133|NCT00889330|563075|P2|COMPLETED|Overall Study||30
231134|NCT00889330|563076|P1|COMPLETED|Overall Study||30
231135|NCT00889330|563075|P2|STARTED|Overall Study||30
231136|NCT00889330|563076|P1|STARTED|Overall Study||30
231137|NCT00889421|563106|P1|NOT COMPLETED|Overall Study||3
231138|NCT00889421|563106|P1|COMPLETED|Overall Study||0
231139|NCT00889421|563106|P1|STARTED|Overall Study||3
231140|NCT00889512|563116|P2|NOT COMPLETED|Overall Study||0
231141|NCT00889512|563117|P1|NOT COMPLETED|Overall Study||0
231142|NCT00889512|563116|P2|COMPLETED|Overall Study||9
231143|NCT00889512|563117|P1|COMPLETED|Overall Study||5
231144|NCT00889512|563116|P2|STARTED|Overall Study||9
231145|NCT00889512|563117|P1|STARTED|Overall Study||5
231146|NCT00889603|563123|P1|NOT COMPLETED|Overall Study||37
231147|NCT00889603|563123|P1|COMPLETED|Overall Study||333
231148|NCT00889603|563123|P1|STARTED|Overall Study||370
231149|NCT00889681|563136|P1|NOT COMPLETED|Overall Study||3
231150|NCT00889681|563136|P1|COMPLETED|Overall Study||78
231151|NCT00889681|563136|P1|Received Treatment|Overall Study||78
231152|NCT00889681|563136|P1|STARTED|Overall Study||81
231153|NCT00889707|563145|P2|NOT COMPLETED|Overall Study||10
231154|NCT00889707|563146|P1|NOT COMPLETED|Overall Study||7
231155|NCT00889707|563145|P2|COMPLETED|Overall Study||21
231156|NCT00889707|563146|P1|COMPLETED|Overall Study||54
231157|NCT00889707|563145|P2|STARTED|Overall Study||31
231158|NCT00889707|563146|P1|STARTED|Overall Study||61
231159|NCT00889720|563154|P1|NOT COMPLETED|Overall Study||8
231160|NCT00889720|563154|P1|COMPLETED|Overall Study||8
231161|NCT00889720|563154|P1|Surgical Population|Overall Study||12
231162|NCT00889720|563154|P1|STARTED|Overall Study||16
231163|NCT00889824|563179|P1|NOT COMPLETED|Overall Study||0
231164|NCT00889824|563179|P1|COMPLETED|Overall Study||5
231165|NCT00889824|563179|P1|STARTED|Overall Study||5
231166|NCT00889863|563183|P2|NOT COMPLETED|Part II: Randomized Double Blind||26
231167|NCT00889863|563184|P1|NOT COMPLETED|Part II: Randomized Double Blind||11
231168|NCT00889863|563183|P2|COMPLETED|Part II: Randomized Double Blind||24
231169|NCT00889863|563184|P1|COMPLETED|Part II: Randomized Double Blind||39
231170|NCT00889863|563183|P2|STARTED|Part II: Randomized Double Blind||50
231171|NCT00889863|563184|P1|STARTED|Part II: Randomized Double Blind||50
231172|NCT00889863|563183|P2|NOT COMPLETED|Part I: Open Label||0
231173|NCT00889863|563184|P1|NOT COMPLETED|Part I: Open Label||77
231174|NCT00889863|563183|P2|COMPLETED|Part I: Open Label||0
231175|NCT00889863|563184|P1|COMPLETED|Part I: Open Label||100
231176|NCT00889863|563183|P2|Entered Part 1d|Part I: Open Label||0
231177|NCT00889863|563184|P1|Entered Part 1d|Part I: Open Label||103
231178|NCT00889863|563183|P2|Entered Part Ic|Part I: Open Label||0
231179|NCT00889863|563184|P1|Entered Part Ic|Part I: Open Label|Patients steroid free at study entry entered Part Id directly and did not participate in Part Ic.|92
231180|NCT00889863|563183|P2|Entered Part Ib|Part I: Open Label||0
231181|NCT00889863|563184|P1|Entered Part Ib|Part I: Open Label||142
231182|NCT00889863|563183|P2|Entered Part Ia|Part I: Open Label||0
231183|NCT00889863|563184|P1|Entered Part Ia|Part I: Open Label||145
231184|NCT00889863|563183|P2|STARTED|Part I: Open Label|No participants received placebo in Part I.|0
231185|NCT00889863|563184|P1|STARTED|Part I: Open Label||177
231186|NCT00889915|563210|P4|NOT COMPLETED|Overall Study||8
231187|NCT00889915|563211|P3|NOT COMPLETED|Overall Study||13
231188|NCT00889915|563212|P2|NOT COMPLETED|Overall Study||5
231189|NCT00889915|563213|P1|NOT COMPLETED|Overall Study||2
231190|NCT00889915|563210|P4|COMPLETED|Overall Study||40
231191|NCT00889915|563211|P3|COMPLETED|Overall Study||54
231192|NCT00889915|563212|P2|COMPLETED|Overall Study||71
231193|NCT00889915|563213|P1|COMPLETED|Overall Study||35
231194|NCT00889915|563210|P4|STARTED|Overall Study||48
231195|NCT00889915|563211|P3|STARTED|Overall Study||67
231196|NCT00889915|563212|P2|STARTED|Overall Study||76
231197|NCT00889915|563213|P1|STARTED|Overall Study||37
231198|NCT00889928|563231|P1|NOT COMPLETED|Overall Study||0
231199|NCT00889928|563231|P1|COMPLETED|Overall Study||7
231200|NCT00889928|563231|P1|STARTED|Overall Study||7
231201|NCT00890084|563235|P1|NOT COMPLETED|Overall Study||142
231202|NCT00890084|563235|P1|COMPLETED|Overall Study||2771
231203|NCT00890084|563235|P1|STARTED|Overall Study||2913
231204|NCT00890097|563249|P3|NOT COMPLETED|Overall Study||77
231205|NCT00890097|563250|P2|NOT COMPLETED|Overall Study||86
231206|NCT00890097|563251|P1|NOT COMPLETED|Overall Study||68
231207|NCT00890097|563249|P3|COMPLETED|Overall Study||184
231208|NCT00890097|563250|P2|COMPLETED|Overall Study||173
231209|NCT00890097|563251|P1|COMPLETED|Overall Study||184
231210|NCT00890097|563249|P3|STARTED|Overall Study||261
231211|NCT00890097|563250|P2|STARTED|Overall Study||259
231212|NCT00890097|563251|P1|STARTED|Overall Study||252
231213|NCT00890201|563261|P2|NOT COMPLETED|Overall Study||56
231214|NCT00890201|563262|P1|NOT COMPLETED|Overall Study||5
231215|NCT00890201|563261|P2|COMPLETED|Overall Study|103 patients without acute cholecystitis or common bile duct stones|103
231216|NCT00890201|563262|P1|COMPLETED|Overall Study|33 patients with gastric cancer and without gallstone disease|33
231217|NCT00890201|563261|P2|STARTED|Overall Study|41 patients with acute cholecystitis and 15 patients with common bile duct stones|159
231218|NCT00890201|563262|P1|STARTED|Overall Study|5 patients with gastric cancer and gallstone disease|38
231219|NCT00890409|563270|P2|NOT COMPLETED|Overall Study||21
231220|NCT00890409|563271|P1|NOT COMPLETED|Overall Study||20
231221|NCT00890409|563270|P2|COMPLETED|Overall Study||119
231222|NCT00890409|563271|P1|COMPLETED|Overall Study||96
231223|NCT00890409|563270|P2|STARTED|Overall Study||140
231224|NCT00890409|563271|P1|STARTED|Overall Study||116
231225|NCT00890552|563279|P1|NOT COMPLETED|On-treatment||10
231226|NCT00890552|563279|P1|COMPLETED|On-treatment||14
231227|NCT00890552|563279|P1|STARTED|On-treatment||24
231228|NCT00890552|563279|P1|NOT COMPLETED|Enrollment and Pre-treatment||1
231229|NCT00890552|563279|P1|COMPLETED|Enrollment and Pre-treatment||24
231230|NCT00890552|563279|P1|STARTED|Enrollment and Pre-treatment||25
231231|NCT00890591|563286|P1|NOT COMPLETED|Overall Study||20
231232|NCT00890591|563286|P1|COMPLETED|Overall Study||124
231233|NCT00890591|563286|P1|STARTED|Overall Study||144
231234|NCT00890656|563292|P1|NOT COMPLETED|Overall Study||0
231235|NCT00890656|563292|P1|COMPLETED|Overall Study||90
231236|NCT00890656|563292|P1|STARTED|Overall Study||90
231237|NCT00890682|563298|P2|NOT COMPLETED|Overall Study||2
231238|NCT00890682|563299|P1|NOT COMPLETED|Overall Study||4
231239|NCT00890682|563298|P2|COMPLETED|Overall Study||94
231240|NCT00890682|563299|P1|COMPLETED|Overall Study||93
231241|NCT00890682|563298|P2|STARTED|Overall Study||96
231242|NCT00890682|563299|P1|STARTED|Overall Study||97
231243|NCT00890695|563307|P2|NOT COMPLETED|Overall Study||0
231244|NCT00890695|563308|P1|NOT COMPLETED|Overall Study||1
231245|NCT00890695|563307|P2|COMPLETED|Overall Study||33
231246|NCT00890695|563308|P1|COMPLETED|Overall Study||31
231247|NCT00890695|563307|P2|STARTED|Overall Study||33
231248|NCT00890695|563308|P1|STARTED|Overall Study||32
231249|NCT00890721|563326|P2|NOT COMPLETED|Overall Study||1
231250|NCT00890721|563327|P1|NOT COMPLETED|Overall Study||1
231251|NCT00890721|563326|P2|COMPLETED|Overall Study||93
231252|NCT00890721|563327|P1|COMPLETED|Overall Study||94
231253|NCT00890721|563326|P2|STARTED|Overall Study||94
231254|NCT00890721|563327|P1|STARTED|Overall Study||95
231255|NCT00890916|563333|P1|NOT COMPLETED|"Rehab - NP OFF"||0
231256|NCT00890916|563333|P1|COMPLETED|"Rehab - NP OFF"||10
231257|NCT00890916|563333|P1|"Grasp Release Pre-Test OFF"|"Rehab - NP OFF"||10
231258|NCT00890916|563333|P1|STARTED|"Rehab - NP OFF"||10
231259|NCT00890916|563333|P1|NOT COMPLETED|"Rehab - NP ON"||0
231260|NCT00890916|563333|P1|COMPLETED|"Rehab - NP ON"||10
231261|NCT00890916|563333|P1|"Grasp Release Pre-Test ON"|"Rehab - NP ON"||10
231262|NCT00890916|563333|P1|STARTED|"Rehab - NP ON"|First IST-12 Implant.|10
231263|NCT00890929|563337|P1|NOT COMPLETED|Overall Study||6
231264|NCT00890929|563337|P1|COMPLETED|Overall Study||39
231265|NCT00890929|563337|P1|Initiated Treatment|Overall Study||43
231266|NCT00890929|563337|P1|Consented & Enrolled|Overall Study||45
231267|NCT00890929|563337|P1|STARTED|Overall Study||45
231268|NCT00890981|563351|P2|NOT COMPLETED|Overall Study||0
231269|NCT00890981|563352|P1|NOT COMPLETED|Overall Study||0
231270|NCT00890981|563351|P2|COMPLETED|Overall Study||40
231271|NCT00890981|563352|P1|COMPLETED|Overall Study||39
231272|NCT00890981|563351|P2|STARTED|Overall Study||40
231273|NCT00890981|563352|P1|STARTED|Overall Study||39
231274|NCT00891020|563385|P3|NOT COMPLETED|Long-term Extension Period||23
231275|NCT00891020|563386|P2|NOT COMPLETED|Long-term Extension Period||24
231276|NCT00891020|563387|P1|NOT COMPLETED|Long-term Extension Period||6
231277|NCT00891020|563385|P3|COMPLETED|Long-term Extension Period||170
231278|NCT00891020|563386|P2|COMPLETED|Long-term Extension Period||172
231279|NCT00891020|563387|P1|COMPLETED|Long-term Extension Period||49
231280|NCT00891020|563385|P3|STARTED|Long-term Extension Period||193
231281|NCT00891020|563386|P2|STARTED|Long-term Extension Period||196
231282|NCT00891020|563387|P1|STARTED|Long-term Extension Period||55
231283|NCT00891020|563385|P3|NOT COMPLETED|24 Week Treatment Period||58
231284|NCT00891020|563386|P2|NOT COMPLETED|24 Week Treatment Period||60
231285|NCT00891020|563387|P1|NOT COMPLETED|24 Week Treatment Period||37
231286|NCT00891020|563385|P3|COMPLETED|24 Week Treatment Period||302
231287|NCT00891020|563386|P2|COMPLETED|24 Week Treatment Period||303
231288|NCT00891020|563387|P1|COMPLETED|24 Week Treatment Period||126
231289|NCT00891020|563385|P3|Safety Set|24 Week Treatment Period|28 patients from Monotherapy arm received DMARD, included in 8 mg/kg +DMARD arm for safety.|381
231290|NCT00891020|563386|P2|Safety Set|24 Week Treatment Period|1 patient from Monotherapy arm and 1 from 8 mg/kg +DMARD, included in 4 mg/kg +DMARD arm for safety.|364
231380|NCT00891293|563668|P1|COMPLETED|Overall Study||9
231291|NCT00891020|563387|P1|Safety Set|24 Week Treatment Period|4 patients from 8 mg/kg +DMARD arm did not receive DMARD, included in Monotherapy arm for safety.|138
231292|NCT00891020|563385|P3|Intent-to-Treat (ITT)|24 Week Treatment Period||358
231293|NCT00891020|563386|P2|Intent-to-Treat (ITT)|24 Week Treatment Period||362
231294|NCT00891020|563387|P1|Intent-to-Treat (ITT)|24 Week Treatment Period||163
231295|NCT00891020|563385|P3|STARTED|24 Week Treatment Period||360
231296|NCT00891020|563386|P2|STARTED|24 Week Treatment Period||363
231297|NCT00891020|563387|P1|STARTED|24 Week Treatment Period||163
231298|NCT00885482|563418|P1|NOT COMPLETED|Overall Study||4
231299|NCT00885482|563418|P1|COMPLETED|Overall Study||36
231300|NCT00885482|563418|P1|STARTED|Overall Study||40
231301|NCT00885534|563422|P1|NOT COMPLETED|Overall Study||1
231302|NCT00885534|563422|P1|COMPLETED|Overall Study||6
231303|NCT00885534|563422|P1|STARTED|Overall Study||7
231304|NCT00891046|563431|P5|NOT COMPLETED|Overall Study||39
231305|NCT00891046|563432|P4|NOT COMPLETED|Overall Study||3
231306|NCT00891046|563433|P3|NOT COMPLETED|Overall Study||23
231307|NCT00891046|563434|P2|NOT COMPLETED|Overall Study||9
231308|NCT00891046|563435|P1|NOT COMPLETED|Overall Study||12
231309|NCT00891046|563431|P5|COMPLETED|Overall Study||84
231310|NCT00891046|563432|P4|COMPLETED|Overall Study||8
231311|NCT00891046|563433|P3|COMPLETED|Overall Study||17
231312|NCT00891046|563434|P2|COMPLETED|Overall Study||54
231313|NCT00891046|563435|P1|COMPLETED|Overall Study||21
231314|NCT00891046|563431|P5|STARTED|Overall Study||123
231315|NCT00891046|563432|P4|STARTED|Overall Study||11
231316|NCT00891046|563433|P3|STARTED|Overall Study||40
231317|NCT00891046|563434|P2|STARTED|Overall Study||63
231318|NCT00891046|563435|P1|STARTED|Overall Study||33
231319|NCT00891176|563512|P4|NOT COMPLETED|At 6 Years of Age||0
231320|NCT00891176|563513|P3|NOT COMPLETED|At 6 Years of Age||0
231321|NCT00891176|563514|P2|NOT COMPLETED|At 6 Years of Age||0
231322|NCT00891176|563515|P1|NOT COMPLETED|At 6 Years of Age||0
231323|NCT00891176|563512|P4|COMPLETED|At 6 Years of Age||135
231324|NCT00891176|563513|P3|COMPLETED|At 6 Years of Age||135
231325|NCT00891176|563514|P2|COMPLETED|At 6 Years of Age||138
231326|NCT00891176|563515|P1|COMPLETED|At 6 Years of Age||131
231327|NCT00891176|563512|P4|STARTED|At 6 Years of Age||135
231328|NCT00891176|563513|P3|STARTED|At 6 Years of Age||135
231329|NCT00891176|563514|P2|STARTED|At 6 Years of Age||138
231330|NCT00891176|563515|P1|STARTED|At 6 Years of Age||131
231331|NCT00891176|563512|P4|NOT COMPLETED|At 4 Years of Age||0
231332|NCT00891176|563513|P3|NOT COMPLETED|At 4 Years of Age||0
231333|NCT00891176|563514|P2|NOT COMPLETED|At 4 Years of Age||0
231334|NCT00891176|563515|P1|NOT COMPLETED|At 4 Years of Age||0
231335|NCT00891176|563512|P4|COMPLETED|At 4 Years of Age||137
231336|NCT00891176|563513|P3|COMPLETED|At 4 Years of Age||142
231337|NCT00891176|563514|P2|COMPLETED|At 4 Years of Age||142
231338|NCT00891176|563515|P1|COMPLETED|At 4 Years of Age||140
231339|NCT00891176|563512|P4|STARTED|At 4 Years of Age||137
231340|NCT00891176|563513|P3|STARTED|At 4 Years of Age||142
231341|NCT00891176|563514|P2|STARTED|At 4 Years of Age||142
231342|NCT00891176|563515|P1|STARTED|At 4 Years of Age||140
231343|NCT00891176|563512|P4|NOT COMPLETED|At 3 Years of Age||0
231344|NCT00891176|563513|P3|NOT COMPLETED|At 3 Years of Age||0
231345|NCT00891176|563514|P2|NOT COMPLETED|At 3 Years of Age||0
231346|NCT00891176|563515|P1|NOT COMPLETED|At 3 Years of Age||0
231347|NCT00891176|563512|P4|COMPLETED|At 3 Years of Age||141
231348|NCT00891176|563513|P3|COMPLETED|At 3 Years of Age||149
231349|NCT00891176|563514|P2|COMPLETED|At 3 Years of Age||147
231350|NCT00891176|563515|P1|COMPLETED|At 3 Years of Age||144
231351|NCT00891176|563512|P4|STARTED|At 3 Years of Age||141
231352|NCT00891176|563513|P3|STARTED|At 3 Years of Age||149
231353|NCT00891176|563514|P2|STARTED|At 3 Years of Age||147
231354|NCT00891176|563515|P1|STARTED|At 3 Years of Age||144
231355|NCT00891202|563643|P4|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||5
231356|NCT00891202|563644|P3|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||7
231357|NCT00891202|563645|P2|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
231358|NCT00891202|563646|P1|NOT COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
231359|NCT00891202|563643|P4|COMPLETED|LTTP (Post-Week 39 up to Week 312)||15
231360|NCT00891202|563644|P3|COMPLETED|LTTP (Post-Week 39 up to Week 312)||12
231361|NCT00891202|563645|P2|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
231362|NCT00891202|563646|P1|COMPLETED|LTTP (Post-Week 39 up to Week 312)||0
231363|NCT00891202|563643|P4|STARTED|LTTP (Post-Week 39 up to Week 312)||20
231364|NCT00891202|563644|P3|STARTED|LTTP (Post-Week 39 up to Week 312)||19
231365|NCT00891202|563645|P2|STARTED|LTTP (Post-Week 39 up to Week 312)||0
231366|NCT00891202|563646|P1|STARTED|LTTP (Post-Week 39 up to Week 312)||0
231367|NCT00891202|563643|P4|NOT COMPLETED|PAP (Up To Week 39)||0
231368|NCT00891202|563644|P3|NOT COMPLETED|PAP (Up To Week 39)||0
231369|NCT00891202|563645|P2|NOT COMPLETED|PAP (Up To Week 39)||0
231370|NCT00891202|563646|P1|NOT COMPLETED|PAP (Up To Week 39)||1
231371|NCT00891202|563643|P4|COMPLETED|PAP (Up To Week 39)||0
231372|NCT00891202|563644|P3|COMPLETED|PAP (Up To Week 39)||0
231373|NCT00891202|563645|P2|COMPLETED|PAP (Up To Week 39)||20
231374|NCT00891202|563646|P1|COMPLETED|PAP (Up To Week 39)||19
231375|NCT00891202|563643|P4|STARTED|PAP (Up To Week 39)||0
231376|NCT00891202|563644|P3|STARTED|PAP (Up To Week 39)||0
231377|NCT00891202|563645|P2|STARTED|PAP (Up To Week 39)||20
231378|NCT00891202|563646|P1|STARTED|PAP (Up To Week 39)||20
231379|NCT00891293|563668|P1|NOT COMPLETED|Overall Study||84
231381|NCT00891293|563668|P1|STARTED|Overall Study|93 participants were enrolled; baseline data are provided for 89 participants (Safety Population).|93
231382|NCT00891371|563680|P1|NOT COMPLETED|Treatment||9
231383|NCT00891371|563680|P1|COMPLETED|Treatment||27
231384|NCT00891371|563680|P1|STARTED|Treatment||36
231385|NCT00891371|563680|P1|NOT COMPLETED|Pre-assignment||6
231386|NCT00891371|563680|P1|COMPLETED|Pre-assignment||36
231387|NCT00891371|563680|P1|STARTED|Pre-assignment||42
231388|NCT00891774|563689|P1|NOT COMPLETED|Overall Study||14
231389|NCT00891774|563689|P1|COMPLETED|Overall Study||158
231390|NCT00891774|563689|P1|STARTED|Overall Study||172
231391|NCT00891813|563693|P1|NOT COMPLETED|Overall Study||12
231392|NCT00891813|563693|P1|COMPLETED|Overall Study||88
231393|NCT00891813|563693|P1|STARTED|Overall Study||100
231394|NCT00891839|563699|P1|NOT COMPLETED|Overall Study||7
231395|NCT00891839|563699|P1|COMPLETED|Overall Study|completed treatment|38
231396|NCT00891839|563699|P1|STARTED|Overall Study||45
231397|NCT00891904|563708|P1|NOT COMPLETED|Overall Study||2
231398|NCT00891904|563708|P1|COMPLETED|Overall Study||0
231399|NCT00891904|563708|P1|STARTED|Overall Study||2
231400|NCT00891930|563715|P1|NOT COMPLETED|Part 2: Panitumumab + Ganitumab||31
231401|NCT00891930|563715|P1|COMPLETED|Part 2: Panitumumab + Ganitumab||5
231402|NCT00891930|563715|P1|STARTED|Part 2: Panitumumab + Ganitumab||36
231403|NCT00891930|563715|P1|NOT COMPLETED|Part 1: Panitumumab +Irinotecan||40
231404|NCT00891930|563715|P1|COMPLETED|Part 1: Panitumumab +Irinotecan||36
231405|NCT00891930|563715|P1|Received Treatment|Part 1: Panitumumab +Irinotecan||74
231406|NCT00891930|563715|P1|STARTED|Part 1: Panitumumab +Irinotecan||76
231407|NCT00891982|563738|P2|NOT COMPLETED|Overall Study||1
231408|NCT00891982|563739|P1|NOT COMPLETED|Overall Study||2
231409|NCT00891982|563738|P2|COMPLETED|Overall Study||30
231410|NCT00891982|563739|P1|COMPLETED|Overall Study||28
231411|NCT00891982|563738|P2|STARTED|Overall Study||31
231412|NCT00891982|563739|P1|STARTED|Overall Study||30
231413|NCT00891995|563785|P2|NOT COMPLETED|Overall Study||0
231414|NCT00891995|563786|P1|NOT COMPLETED|Overall Study||0
231415|NCT00891995|563785|P2|COMPLETED|Overall Study||21
231416|NCT00891995|563786|P1|COMPLETED|Overall Study||50
231417|NCT00891995|563785|P2|STARTED|Overall Study||21
231418|NCT00891995|563786|P1|STARTED|Overall Study||50
231419|NCT00892008|563808|P1|NOT COMPLETED|Overall Study||565
231420|NCT00892008|563808|P1|COMPLETED|Overall Study||1713
231421|NCT00892008|563808|P1|STARTED|Overall Study||2278
231422|NCT00892047|563824|P2|NOT COMPLETED|Overall Study||7
231423|NCT00892047|563825|P1|NOT COMPLETED|Overall Study||4
231424|NCT00892047|563824|P2|COMPLETED|Overall Study||83
231425|NCT00892047|563825|P1|COMPLETED|Overall Study||87
231426|NCT00892047|563824|P2|STARTED|Overall Study||90
231427|NCT00892047|563825|P1|STARTED|Overall Study||91
231428|NCT00892099|563844|P3|NOT COMPLETED|Overall Study||7
231429|NCT00892099|563845|P2|NOT COMPLETED|Overall Study||1
231430|NCT00892099|563846|P1|NOT COMPLETED|Overall Study||5
231431|NCT00892099|563844|P3|COMPLETED|Overall Study||29
231432|NCT00892099|563845|P2|COMPLETED|Overall Study||32
231433|NCT00892099|563846|P1|COMPLETED|Overall Study||31
231434|NCT00892099|563844|P3|STARTED|Overall Study||36
231435|NCT00892099|563845|P2|STARTED|Overall Study||33
231436|NCT00892099|563846|P1|STARTED|Overall Study||36
231437|NCT00892151|563854|P1|NOT COMPLETED|Overall Study||1
231438|NCT00892151|563854|P1|COMPLETED|Overall Study||50
231439|NCT00892151|563854|P1|STARTED|Overall Study||51
231440|NCT00892177|563863|P6|NOT COMPLETED|Phase II||2
231441|NCT00892177|563864|P5|NOT COMPLETED|Phase II||5
231442|NCT00892177|563865|P4|NOT COMPLETED|Phase II||0
231443|NCT00892177|563866|P3|NOT COMPLETED|Phase II||0
231444|NCT00892177|563867|P2|NOT COMPLETED|Phase II||0
231445|NCT00892177|563868|P1|NOT COMPLETED|Phase II||0
231446|NCT00892177|563863|P6|COMPLETED|Phase II||38
231447|NCT00892177|563864|P5|COMPLETED|Phase II||83
231448|NCT00892177|563865|P4|COMPLETED|Phase II||0
231449|NCT00892177|563866|P3|COMPLETED|Phase II||0
231450|NCT00892177|563867|P2|COMPLETED|Phase II||0
231451|NCT00892177|563868|P1|COMPLETED|Phase II||0
231452|NCT00892177|563863|P6|STARTED|Phase II||40
231453|NCT00892177|563864|P5|STARTED|Phase II||88
231454|NCT00892177|563865|P4|STARTED|Phase II||0
231455|NCT00892177|563866|P3|STARTED|Phase II||0
231456|NCT00892177|563867|P2|STARTED|Phase II||0
231457|NCT00892177|563868|P1|STARTED|Phase II||0
231458|NCT00892177|563863|P6|NOT COMPLETED|Phase I: Dose Level 3||0
231459|NCT00892177|563864|P5|NOT COMPLETED|Phase I: Dose Level 3||0
231460|NCT00892177|563865|P4|NOT COMPLETED|Phase I: Dose Level 3||0
231461|NCT00892177|563866|P3|NOT COMPLETED|Phase I: Dose Level 3||0
231462|NCT00892177|563867|P2|NOT COMPLETED|Phase I: Dose Level 3||0
231463|NCT00892177|563868|P1|NOT COMPLETED|Phase I: Dose Level 3||0
231464|NCT00892177|563863|P6|COMPLETED|Phase I: Dose Level 3||0
231465|NCT00892177|563864|P5|COMPLETED|Phase I: Dose Level 3||0
231466|NCT00892177|563865|P4|COMPLETED|Phase I: Dose Level 3||6
231467|NCT00892177|563866|P3|COMPLETED|Phase I: Dose Level 3||0
231468|NCT00892177|563867|P2|COMPLETED|Phase I: Dose Level 3||0
231469|NCT00892177|563868|P1|COMPLETED|Phase I: Dose Level 3||0
231470|NCT00892177|563863|P6|STARTED|Phase I: Dose Level 3||0
231471|NCT00892177|563864|P5|STARTED|Phase I: Dose Level 3||0
231472|NCT00892177|563865|P4|STARTED|Phase I: Dose Level 3||6
231473|NCT00892177|563866|P3|STARTED|Phase I: Dose Level 3||0
231474|NCT00892177|563867|P2|STARTED|Phase I: Dose Level 3||0
231475|NCT00892177|563868|P1|STARTED|Phase I: Dose Level 3||0
231476|NCT00892177|563863|P6|NOT COMPLETED|Phase I: Dose Level 2||0
231477|NCT00892177|563864|P5|NOT COMPLETED|Phase I: Dose Level 2||0
231478|NCT00892177|563865|P4|NOT COMPLETED|Phase I: Dose Level 2||0
231479|NCT00892177|563866|P3|NOT COMPLETED|Phase I: Dose Level 2||0
231480|NCT00892177|563867|P2|NOT COMPLETED|Phase I: Dose Level 2||0
231481|NCT00892177|563868|P1|NOT COMPLETED|Phase I: Dose Level 2||0
231482|NCT00892177|563863|P6|COMPLETED|Phase I: Dose Level 2||0
231483|NCT00892177|563864|P5|COMPLETED|Phase I: Dose Level 2||0
231484|NCT00892177|563865|P4|COMPLETED|Phase I: Dose Level 2||0
231485|NCT00892177|563866|P3|COMPLETED|Phase I: Dose Level 2||3
231486|NCT00892177|563867|P2|COMPLETED|Phase I: Dose Level 2||0
231487|NCT00892177|563868|P1|COMPLETED|Phase I: Dose Level 2||0
231488|NCT00892177|563863|P6|STARTED|Phase I: Dose Level 2||0
231489|NCT00892177|563864|P5|STARTED|Phase I: Dose Level 2||0
231490|NCT00892177|563865|P4|STARTED|Phase I: Dose Level 2||0
231491|NCT00892177|563866|P3|STARTED|Phase I: Dose Level 2||3
231492|NCT00892177|563867|P2|STARTED|Phase I: Dose Level 2||0
231493|NCT00892177|563868|P1|STARTED|Phase I: Dose Level 2||0
231494|NCT00892177|563863|P6|NOT COMPLETED|Phase I: Dose Level 1||0
231495|NCT00892177|563864|P5|NOT COMPLETED|Phase I: Dose Level 1||0
231496|NCT00892177|563865|P4|NOT COMPLETED|Phase I: Dose Level 1||0
231497|NCT00892177|563866|P3|NOT COMPLETED|Phase I: Dose Level 1||0
231498|NCT00892177|563867|P2|NOT COMPLETED|Phase I: Dose Level 1||0
231499|NCT00892177|563868|P1|NOT COMPLETED|Phase I: Dose Level 1||0
231500|NCT00892177|563863|P6|COMPLETED|Phase I: Dose Level 1||0
231501|NCT00892177|563864|P5|COMPLETED|Phase I: Dose Level 1||0
231502|NCT00892177|563865|P4|COMPLETED|Phase I: Dose Level 1||0
231503|NCT00892177|563866|P3|COMPLETED|Phase I: Dose Level 1||0
231504|NCT00892177|563867|P2|COMPLETED|Phase I: Dose Level 1||4
231505|NCT00892177|563868|P1|COMPLETED|Phase I: Dose Level 1||0
231506|NCT00892177|563863|P6|STARTED|Phase I: Dose Level 1||0
231507|NCT00892177|563864|P5|STARTED|Phase I: Dose Level 1||0
231508|NCT00892177|563865|P4|STARTED|Phase I: Dose Level 1||0
231509|NCT00892177|563866|P3|STARTED|Phase I: Dose Level 1||0
231510|NCT00892177|563867|P2|STARTED|Phase I: Dose Level 1||4
231511|NCT00892177|563868|P1|STARTED|Phase I: Dose Level 1||0
231512|NCT00892177|563863|P6|NOT COMPLETED|Phase I: Dose Level 0||0
231513|NCT00892177|563864|P5|NOT COMPLETED|Phase I: Dose Level 0||0
231514|NCT00892177|563865|P4|NOT COMPLETED|Phase I: Dose Level 0||0
231515|NCT00892177|563866|P3|NOT COMPLETED|Phase I: Dose Level 0||0
231516|NCT00892177|563867|P2|NOT COMPLETED|Phase I: Dose Level 0||0
231517|NCT00892177|563868|P1|NOT COMPLETED|Phase I: Dose Level 0||0
231518|NCT00892177|563863|P6|COMPLETED|Phase I: Dose Level 0||0
231519|NCT00892177|563864|P5|COMPLETED|Phase I: Dose Level 0||0
231520|NCT00892177|563865|P4|COMPLETED|Phase I: Dose Level 0||0
231521|NCT00892177|563866|P3|COMPLETED|Phase I: Dose Level 0||0
231522|NCT00892177|563867|P2|COMPLETED|Phase I: Dose Level 0||0
231523|NCT00892177|563868|P1|COMPLETED|Phase I: Dose Level 0||3
231524|NCT00892177|563863|P6|STARTED|Phase I: Dose Level 0||0
231525|NCT00892177|563864|P5|STARTED|Phase I: Dose Level 0||0
231526|NCT00892177|563865|P4|STARTED|Phase I: Dose Level 0||0
231527|NCT00892177|563866|P3|STARTED|Phase I: Dose Level 0||0
231528|NCT00892177|563867|P2|STARTED|Phase I: Dose Level 0||0
231529|NCT00892177|563868|P1|STARTED|Phase I: Dose Level 0||3
231530|NCT00892281|563895|P2|NOT COMPLETED|Overall Study||37
231531|NCT00892281|563896|P1|NOT COMPLETED|Overall Study||267
231532|NCT00892281|563895|P2|COMPLETED|Overall Study||187
231533|NCT00892281|563896|P1|COMPLETED|Overall Study||930
231534|NCT00892281|563895|P2|STARTED|Overall Study||224
231535|NCT00892281|563896|P1|STARTED|Overall Study||1197
231536|NCT00892437|563908|P2|NOT COMPLETED|Open-Label Extension Phase||4
231537|NCT00892437|563909|P1|NOT COMPLETED|Open-Label Extension Phase||12
231538|NCT00892437|563908|P2|COMPLETED|Open-Label Extension Phase||15
231539|NCT00892437|563909|P1|COMPLETED|Open-Label Extension Phase||32
231540|NCT00892437|563908|P2|STARTED|Open-Label Extension Phase|5 participants completed the randomized phase but did not enter the open-label extension phase.|19
231541|NCT00892437|563909|P1|STARTED|Open-Label Extension Phase|1 participant completed the randomized phase but did not enter the open-label extension phase.|44
231542|NCT00892437|563908|P2|NOT COMPLETED|Randomized Phase||5
231543|NCT00892437|563909|P1|NOT COMPLETED|Randomized Phase||11
231544|NCT00892437|563908|P2|COMPLETED|Randomized Phase||24
231545|NCT00892437|563909|P1|COMPLETED|Randomized Phase||45
231546|NCT00892437|563908|P2|Randomized and Treated|Randomized Phase||29
231547|NCT00892437|563909|P1|Randomized and Treated|Randomized Phase||50
231548|NCT00892437|563908|P2|STARTED|Randomized Phase||29
231549|NCT00892437|563909|P1|STARTED|Randomized Phase||56
231550|NCT00892606|563928|P2|NOT COMPLETED|Overall Study||4
231551|NCT00892606|563929|P1|NOT COMPLETED|Overall Study||5
231552|NCT00892606|563928|P2|COMPLETED|Overall Study||33
231553|NCT00892606|563929|P1|COMPLETED|Overall Study||33
231554|NCT00892606|563928|P2|STARTED|Overall Study||37
231555|NCT00892606|563929|P1|STARTED|Overall Study||38
231556|NCT00892697|563939|P1|NOT COMPLETED|Overall Study||0
231557|NCT00892697|563939|P1|COMPLETED|Overall Study||15
231558|NCT00892697|563939|P1|STARTED|Overall Study||15
231559|NCT00892710|563947|P3|NOT COMPLETED|Overall Study||55
231560|NCT00892710|563948|P2|NOT COMPLETED|Overall Study||59
231561|NCT00892710|563949|P1|NOT COMPLETED|Overall Study||48
231562|NCT00892710|563947|P3|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
231563|NCT00892710|563948|P2|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
231564|NCT00892710|563949|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or intolerable toxicity occurred|0
231565|NCT00892710|563947|P3|STARTED|Overall Study||55
231566|NCT00892710|563948|P2|STARTED|Overall Study||59
231567|NCT00892710|563949|P1|STARTED|Overall Study||48
231568|NCT00892723|563975|P3|NOT COMPLETED|Overall Study||2
231569|NCT00892723|563976|P2|NOT COMPLETED|Overall Study||4
231570|NCT00892723|563977|P1|NOT COMPLETED|Overall Study||2
231571|NCT00892723|563975|P3|COMPLETED|Overall Study||17
231572|NCT00892723|563976|P2|COMPLETED|Overall Study||15
231573|NCT00892723|563977|P1|COMPLETED|Overall Study||19
231574|NCT00892723|563975|P3|STARTED|Overall Study||19
231575|NCT00892723|563976|P2|STARTED|Overall Study||19
231576|NCT00892723|563977|P1|STARTED|Overall Study||21
231577|NCT00892957|564020|P2|NOT COMPLETED|Postoperative Day 30 Assessment||0
231578|NCT00892957|564021|P1|NOT COMPLETED|Postoperative Day 30 Assessment||0
231579|NCT00892957|564020|P2|COMPLETED|Postoperative Day 30 Assessment||66
231580|NCT00892957|564021|P1|COMPLETED|Postoperative Day 30 Assessment||70
231581|NCT00892957|564020|P2|STARTED|Postoperative Day 30 Assessment||66
231582|NCT00892957|564021|P1|STARTED|Postoperative Day 30 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|70
231583|NCT00892957|564020|P2|NOT COMPLETED|Postoperative Day 14 Assessment||0
231584|NCT00892957|564021|P1|NOT COMPLETED|Postoperative Day 14 Assessment||0
231585|NCT00892957|564020|P2|COMPLETED|Postoperative Day 14 Assessment||66
231586|NCT00892957|564021|P1|COMPLETED|Postoperative Day 14 Assessment||68
231587|NCT00892957|564020|P2|STARTED|Postoperative Day 14 Assessment||66
231588|NCT00892957|564021|P1|STARTED|Postoperative Day 14 Assessment|Two participants missed postoperative Day 14 assessment, both returned for Day 30 postop assessment|68
231589|NCT00892957|564020|P2|NOT COMPLETED|Between Postoperative Day 1 and Day 14||4
231590|NCT00892957|564021|P1|NOT COMPLETED|Between Postoperative Day 1 and Day 14||0
231591|NCT00892957|564020|P2|COMPLETED|Between Postoperative Day 1 and Day 14||66
231592|NCT00892957|564021|P1|COMPLETED|Between Postoperative Day 1 and Day 14||70
231593|NCT00892957|564020|P2|STARTED|Between Postoperative Day 1 and Day 14||70
231594|NCT00892957|564021|P1|STARTED|Between Postoperative Day 1 and Day 14||70
231595|NCT00892957|564020|P2|NOT COMPLETED|Postoperative Day 1 Assessment||0
231596|NCT00892957|564021|P1|NOT COMPLETED|Postoperative Day 1 Assessment||0
231597|NCT00892957|564020|P2|COMPLETED|Postoperative Day 1 Assessment||70
231598|NCT00892957|564021|P1|COMPLETED|Postoperative Day 1 Assessment||70
231599|NCT00892957|564020|P2|STARTED|Postoperative Day 1 Assessment||70
231600|NCT00892957|564021|P1|STARTED|Postoperative Day 1 Assessment||70
231601|NCT00892957|564020|P2|NOT COMPLETED|Intraoperative Day 0||0
231602|NCT00892957|564021|P1|NOT COMPLETED|Intraoperative Day 0||0
231603|NCT00892957|564020|P2|COMPLETED|Intraoperative Day 0||70
231604|NCT00892957|564021|P1|COMPLETED|Intraoperative Day 0||70
231605|NCT00892957|564020|P2|STARTED|Intraoperative Day 0||70
231606|NCT00892957|564021|P1|STARTED|Intraoperative Day 0||70
231607|NCT00893074|564107|P1|NOT COMPLETED|Overall Study||11
231608|NCT00893074|564107|P1|COMPLETED|Overall Study||13
231609|NCT00893074|564107|P1|STARTED|Overall Study||24
231610|NCT00893113|564127|P2|NOT COMPLETED|Overall Study||16
231611|NCT00893113|564128|P1|NOT COMPLETED|Overall Study||13
231612|NCT00893113|564127|P2|COMPLETED|Overall Study||22
231613|NCT00893113|564128|P1|COMPLETED|Overall Study||23
231614|NCT00893113|564127|P2|STARTED|Overall Study||38
231615|NCT00893113|564128|P1|STARTED|Overall Study||36
231616|NCT00893152|564140|P2|NOT COMPLETED|Overall Study||0
231617|NCT00893152|564141|P1|NOT COMPLETED|Overall Study||0
231618|NCT00893152|564140|P2|COMPLETED|Overall Study||36
231619|NCT00893152|564141|P1|COMPLETED|Overall Study||47
231620|NCT00893152|564140|P2|STARTED|Overall Study||36
231621|NCT00893152|564141|P1|STARTED|Overall Study||47
231622|NCT00893464|564155|P8|NOT COMPLETED|Overall Study||2
231623|NCT00893464|564156|P7|NOT COMPLETED|Overall Study||2
231624|NCT00893464|564157|P6|NOT COMPLETED|Overall Study||0
231625|NCT00893464|564158|P5|NOT COMPLETED|Overall Study||0
231626|NCT00893464|564159|P4|NOT COMPLETED|Overall Study||0
231627|NCT00893464|564160|P3|NOT COMPLETED|Overall Study||0
231628|NCT00893464|564161|P2|NOT COMPLETED|Overall Study||0
231629|NCT00893464|564162|P1|NOT COMPLETED|Overall Study||0
231630|NCT00893464|564155|P8|COMPLETED|Overall Study||3
231631|NCT00893464|564156|P7|COMPLETED|Overall Study||8
231632|NCT00893464|564157|P6|COMPLETED|Overall Study||7
231633|NCT00893464|564158|P5|COMPLETED|Overall Study||4
231634|NCT00893464|564159|P4|COMPLETED|Overall Study||1
231635|NCT00893464|564160|P3|COMPLETED|Overall Study||1
231636|NCT00893464|564161|P2|COMPLETED|Overall Study||1
231637|NCT00893464|564162|P1|COMPLETED|Overall Study||1
231638|NCT00893464|564155|P8|STARTED|Overall Study||5
231639|NCT00893464|564156|P7|STARTED|Overall Study||10
231640|NCT00893464|564157|P6|STARTED|Overall Study||7
231641|NCT00893464|564158|P5|STARTED|Overall Study||4
231642|NCT00893464|564159|P4|STARTED|Overall Study||1
231643|NCT00893464|564160|P3|STARTED|Overall Study||1
231644|NCT00893464|564161|P2|STARTED|Overall Study||1
231645|NCT00893464|564162|P1|STARTED|Overall Study||1
231646|NCT00893737|564278|P1|NOT COMPLETED|Overall Study||12
231647|NCT00893737|564278|P1|COMPLETED|Overall Study||135
231648|NCT00893737|564278|P1|STARTED|Overall Study||147
231649|NCT00893763|564286|P2|NOT COMPLETED|Overall Study||110
231650|NCT00893763|564287|P1|NOT COMPLETED|Overall Study||110
231651|NCT00893763|564286|P2|COMPLETED|Overall Study||47
231652|NCT00893763|564287|P1|COMPLETED|Overall Study||47
231653|NCT00893763|564286|P2|STARTED|Overall Study||157
231654|NCT00893763|564287|P1|STARTED|Overall Study||157
231655|NCT00893789|564299|P4|NOT COMPLETED|Overall Study||13
231656|NCT00893789|564300|P3|NOT COMPLETED|Overall Study||7
231657|NCT00893789|564301|P2|NOT COMPLETED|Overall Study||4
231658|NCT00893789|564302|P1|NOT COMPLETED|Overall Study||6
231659|NCT00893789|564299|P4|COMPLETED|Overall Study||16
231660|NCT00893789|564300|P3|COMPLETED|Overall Study||22
231661|NCT00893789|564301|P2|COMPLETED|Overall Study||26
231662|NCT00893789|564302|P1|COMPLETED|Overall Study||23
231663|NCT00893789|564299|P4|Full Analysis Set (FAS)|Overall Study||27
231664|NCT00893789|564300|P3|Full Analysis Set (FAS)|Overall Study||28
231665|NCT00893789|564301|P2|Full Analysis Set (FAS)|Overall Study||29
231666|NCT00893789|564302|P1|Full Analysis Set (FAS)|Overall Study|FAS = participants in the safety analysis set with ≥1 postbaseline primary efficacy assessment.|29
231667|NCT00893789|564299|P4|Safety Analysis Set (SAS)|Overall Study||29
231668|NCT00893789|564300|P3|Safety Analysis Set (SAS)|Overall Study||29
231669|NCT00893789|564301|P2|Safety Analysis Set (SAS)|Overall Study||30
231670|NCT00893789|564302|P1|Safety Analysis Set (SAS)|Overall Study|SAS = all participants who received 1 or more doses of study drug.|29
231671|NCT00893789|564299|P4|STARTED|Overall Study||29
231672|NCT00893789|564300|P3|STARTED|Overall Study||29
231673|NCT00893789|564301|P2|STARTED|Overall Study||30
231674|NCT00893789|564302|P1|STARTED|Overall Study||29
231675|NCT00893971|564384|P1|NOT COMPLETED|Overall Study||3
231676|NCT00893971|564384|P1|COMPLETED|Overall Study||13
231677|NCT00893971|564384|P1|GP MDI (PT001) + FF MDI (PT005)|Overall Study||16
231678|NCT00893971|564384|P1|Placebo + FF MDI (PT005)|Overall Study||13
231679|NCT00893971|564384|P1|Placebo + GFF MDI (PT003)|Overall Study||15
231680|NCT00893971|564384|P1|Placebo + GP MDI (PT001)|Overall Study||15
231681|NCT00893971|564384|P1|STARTED|Overall Study||16
231682|NCT00893997|564498|P1|NOT COMPLETED|Overall Study||0
231683|NCT00893997|564498|P1|COMPLETED|Overall Study||10
231684|NCT00893997|564498|P1|STARTED|Overall Study||10
231685|NCT00894127|564503|P1|NOT COMPLETED|Overall Study||0
231686|NCT00894127|564503|P1|COMPLETED|Overall Study||128
231687|NCT00894127|564503|P1|STARTED|Overall Study||128
231688|NCT00894166|564515|P8|NOT COMPLETED|Overall Study||34
231689|NCT00894166|564516|P7|NOT COMPLETED|Overall Study||16
231690|NCT00894166|564517|P6|NOT COMPLETED|Overall Study||16
231691|NCT00894166|564518|P5|NOT COMPLETED|Overall Study||24
231692|NCT00894166|564519|P4|NOT COMPLETED|Overall Study||69
231693|NCT00894166|564520|P3|NOT COMPLETED|Overall Study||62
231694|NCT00894166|564521|P2|NOT COMPLETED|Overall Study||63
231695|NCT00894166|564522|P1|NOT COMPLETED|Overall Study||61
231696|NCT00894166|564515|P8|COMPLETED|Overall Study||0
231697|NCT00894166|564516|P7|COMPLETED|Overall Study||19
231698|NCT00894166|564517|P6|COMPLETED|Overall Study||20
231699|NCT00894166|564518|P5|COMPLETED|Overall Study||10
231700|NCT00894166|564519|P4|COMPLETED|Overall Study||45
231701|NCT00894166|564520|P3|COMPLETED|Overall Study||50
231702|NCT00894166|564521|P2|COMPLETED|Overall Study||46
231703|NCT00894166|564522|P1|COMPLETED|Overall Study||71
231704|NCT00894166|564515|P8|STARTED|Overall Study||34
231705|NCT00894166|564516|P7|STARTED|Overall Study||35
231706|NCT00894166|564517|P6|STARTED|Overall Study||36
231707|NCT00894166|564518|P5|STARTED|Overall Study||34
231708|NCT00894166|564519|P4|STARTED|Overall Study||114
231709|NCT00894166|564520|P3|STARTED|Overall Study||112
231710|NCT00894166|564521|P2|STARTED|Overall Study||109
231711|NCT00894166|564522|P1|STARTED|Overall Study||132
231712|NCT00894244|564552|P1|NOT COMPLETED|Overall Study||1
231713|NCT00894244|564552|P1|COMPLETED|Overall Study||24
231714|NCT00894244|564552|P1|STARTED|Overall Study||25
231715|NCT00888433|564558|P2|NOT COMPLETED|Overall Study||3
231716|NCT00888433|564559|P1|NOT COMPLETED|Overall Study||3
231717|NCT00888433|564558|P2|COMPLETED|Overall Study||51
231718|NCT00888433|564559|P1|COMPLETED|Overall Study||49
231719|NCT00888433|564558|P2|STARTED|Overall Study||54
231720|NCT00888433|564559|P1|STARTED|Overall Study||52
231721|NCT00888459|564567|P2|NOT COMPLETED|Overall Study||0
231722|NCT00888459|564568|P1|NOT COMPLETED|Overall Study||0
231723|NCT00888459|564567|P2|COMPLETED|Overall Study||30
231724|NCT00888459|564568|P1|COMPLETED|Overall Study||30
231725|NCT00888459|564567|P2|STARTED|Overall Study||30
231726|NCT00888459|564568|P1|STARTED|Overall Study||30
231727|NCT00894322|564577|P3|NOT COMPLETED|Overall Study||0
231728|NCT00894322|564578|P2|NOT COMPLETED|Overall Study||0
231729|NCT00894322|564579|P1|NOT COMPLETED|Overall Study||1
231730|NCT00894322|564577|P3|COMPLETED|Overall Study||12
231731|NCT00894322|564578|P2|COMPLETED|Overall Study||23
231732|NCT00894322|564579|P1|COMPLETED|Overall Study||29
231733|NCT00894322|564577|P3|STARTED|Overall Study||12
231734|NCT00894322|564578|P2|STARTED|Overall Study||23
231735|NCT00894322|564579|P1|STARTED|Overall Study||30
231736|NCT00894361|564620|P2|NOT COMPLETED|Overall Study||64
231737|NCT00894361|564621|P1|NOT COMPLETED|Overall Study||24
231738|NCT00894361|564620|P2|COMPLETED|Overall Study||136
231739|NCT00894361|564621|P1|COMPLETED|Overall Study||176
231740|NCT00894361|564620|P2|STARTED|Overall Study||200
231741|NCT00894361|564621|P1|STARTED|Overall Study||200
231742|NCT00894387|564629|P2|NOT COMPLETED|Overall Study||175
231743|NCT00894387|564630|P1|NOT COMPLETED|Overall Study||175
231744|NCT00894387|564629|P2|COMPLETED|Overall Study||643
231745|NCT00894387|564630|P1|COMPLETED|Overall Study|"Completed indicates patients whose treatment duration completed as per protocol"|646
231746|NCT00894387|564629|P2|Completed Secondary Efficacy Phase (12m)|Overall Study||640
231747|NCT00894387|564630|P1|Completed Secondary Efficacy Phase (12m)|Overall Study||654
231748|NCT00894387|564629|P2|Completed Primary Efficacy Phase (6 m)|Overall Study||707
231749|NCT00894387|564630|P1|Completed Primary Efficacy Phase (6 m)|Overall Study||717
231750|NCT00894387|564629|P2|Full Analysis Set|Overall Study||807
231751|NCT00894387|564630|P1|Full Analysis Set|Overall Study||808
231752|NCT00894387|564629|P2|Safety Set|Overall Study||810
231753|NCT00894387|564630|P1|Safety Set|Overall Study||808
231754|NCT00894387|564629|P2|STARTED|Overall Study||818
231755|NCT00894387|564630|P1|STARTED|Overall Study|"Started indicates all randomized patients"|821
231756|NCT00894465|564650|P2|NOT COMPLETED|Overall Study||0
231757|NCT00894465|564651|P1|NOT COMPLETED|Overall Study||0
231758|NCT00894465|564650|P2|COMPLETED|Overall Study||22
231759|NCT00894465|564651|P1|COMPLETED|Overall Study||22
231760|NCT00894465|564650|P2|STARTED|Overall Study||22
231761|NCT00894465|564651|P1|STARTED|Overall Study||22
231762|NCT00894504|564659|P1|NOT COMPLETED|Overall Study||71
231763|NCT00894504|564659|P1|COMPLETED|Overall Study||0
231764|NCT00894504|564659|P1|STARTED|Overall Study||71
231765|NCT00894517|564675|P2|NOT COMPLETED|Overall Study||5
231766|NCT00894517|564676|P1|NOT COMPLETED|Overall Study||2
231767|NCT00894517|564675|P2|COMPLETED|Overall Study||26
231768|NCT00894517|564676|P1|COMPLETED|Overall Study||28
231769|NCT00894517|564675|P2|STARTED|Overall Study||31
231770|NCT00894517|564676|P1|STARTED|Overall Study||30
231771|NCT00894543|564692|P2|NOT COMPLETED|Week 4 to Week 8||2
231772|NCT00894543|564693|P1|NOT COMPLETED|Week 4 to Week 8||4
231773|NCT00894543|564692|P2|COMPLETED|Week 4 to Week 8||97
231774|NCT00894543|564693|P1|COMPLETED|Week 4 to Week 8||97
231775|NCT00894543|564692|P2|STARTED|Week 4 to Week 8||99
231776|NCT00894543|564693|P1|STARTED|Week 4 to Week 8||101
231777|NCT00894543|564692|P2|NOT COMPLETED|Baseline to Week 4||2
231778|NCT00894543|564693|P1|NOT COMPLETED|Baseline to Week 4||3
231779|NCT00894543|564692|P2|COMPLETED|Baseline to Week 4||99
231780|NCT00894543|564693|P1|COMPLETED|Baseline to Week 4||101
231781|NCT00894543|564692|P2|STARTED|Baseline to Week 4||101
231782|NCT00894543|564693|P1|STARTED|Baseline to Week 4||104
231783|NCT00894543|564692|P2|NOT COMPLETED|Baseline||0
231784|NCT00894543|564693|P1|NOT COMPLETED|Baseline||0
231785|NCT00894543|564692|P2|COMPLETED|Baseline||101
231786|NCT00894543|564693|P1|COMPLETED|Baseline||104
231787|NCT00894543|564692|P2|STARTED|Baseline||101
231788|NCT00894543|564693|P1|STARTED|Baseline||104
231789|NCT00894556|564718|P4|NOT COMPLETED|Treatment Phase||0
231790|NCT00894556|564719|P3|NOT COMPLETED|Treatment Phase||1
231791|NCT00894556|564720|P2|NOT COMPLETED|Treatment Phase||4
231792|NCT00894556|564721|P1|NOT COMPLETED|Treatment Phase||4
231793|NCT00894556|564718|P4|COMPLETED|Treatment Phase||0
231794|NCT00894556|564719|P3|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|35
231795|NCT00894556|564720|P2|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|32
231796|NCT00894556|564721|P1|COMPLETED|Treatment Phase|Participants who treated 3 acute migraine attacks with study medication during the treatment phase|33
231797|NCT00894556|564718|P4|STARTED|Treatment Phase||0
231798|NCT00894556|564719|P3|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
231799|NCT00894556|564720|P2|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|36
231800|NCT00894556|564721|P1|STARTED|Treatment Phase|Participants who were randomized into the treatment phase|37
231801|NCT00894556|564718|P4|NOT COMPLETED|Baseline Phase||85
231802|NCT00894556|564719|P3|NOT COMPLETED|Baseline Phase||0
231803|NCT00894556|564720|P2|NOT COMPLETED|Baseline Phase||0
231804|NCT00894556|564721|P1|NOT COMPLETED|Baseline Phase||0
231805|NCT00894556|564718|P4|COMPLETED|Baseline Phase||109
231806|NCT00894556|564719|P3|COMPLETED|Baseline Phase||0
231807|NCT00894556|564720|P2|COMPLETED|Baseline Phase||0
231808|NCT00894556|564721|P1|COMPLETED|Baseline Phase||0
231809|NCT00894556|564718|P4|STARTED|Baseline Phase||194
231810|NCT00894556|564719|P3|STARTED|Baseline Phase||0
231811|NCT00894556|564720|P2|STARTED|Baseline Phase||0
231812|NCT00894556|564721|P1|STARTED|Baseline Phase||0
231813|NCT00895453|564733|P3|NOT COMPLETED|Overall Study||23
231814|NCT00895453|564734|P2|NOT COMPLETED|Overall Study||25
231815|NCT00895453|564735|P1|NOT COMPLETED|Overall Study||25
231816|NCT00895453|564733|P3|COMPLETED|Overall Study||23
231817|NCT00895453|564734|P2|COMPLETED|Overall Study||25
231818|NCT00895453|564735|P1|COMPLETED|Overall Study||23
231819|NCT00895453|564733|P3|STARTED|Overall Study||46
231820|NCT00895453|564734|P2|STARTED|Overall Study||50
231821|NCT00895453|564735|P1|STARTED|Overall Study||48
231822|NCT00895531|564745|P2|NOT COMPLETED|Overall Study||0
231823|NCT00895531|564746|P1|NOT COMPLETED|Overall Study||0
231824|NCT00895531|564745|P2|COMPLETED|Overall Study||37
231825|NCT00895531|564746|P1|COMPLETED|Overall Study||38
231826|NCT00895531|564745|P2|STARTED|Overall Study||37
231827|NCT00895531|564746|P1|STARTED|Overall Study||38
231828|NCT00895583|564754|P2|NOT COMPLETED|Overall Study||12
231829|NCT00895583|564755|P1|NOT COMPLETED|Overall Study||44
231830|NCT00895583|564754|P2|COMPLETED|Overall Study||111
231831|NCT00895583|564755|P1|COMPLETED|Overall Study||87
231832|NCT00895583|564754|P2|STARTED|Overall Study||123
231833|NCT00895583|564755|P1|STARTED|Overall Study||131
231834|NCT00895661|564833|P1|NOT COMPLETED|Overall Study||3
231835|NCT00895661|564833|P1|COMPLETED|Overall Study||37
231836|NCT00895661|564833|P1|STARTED|Overall Study||40
231837|NCT00895752|564840|P1|NOT COMPLETED|Overall Study||0
231838|NCT00895752|564840|P1|COMPLETED|Overall Study||6
231839|NCT00895752|564840|P1|STARTED|Overall Study||6
231840|NCT00895817|564853|P2|NOT COMPLETED|Overall Study||0
231841|NCT00895817|564854|P1|NOT COMPLETED|Overall Study||0
231842|NCT00895817|564853|P2|COMPLETED|Overall Study||21
231843|NCT00895817|564854|P1|COMPLETED|Overall Study||21
231844|NCT00895817|564853|P2|STARTED|Overall Study||21
231845|NCT00895817|564854|P1|STARTED|Overall Study||21
231846|NCT00895830|564865|P5|NOT COMPLETED|Overall Study||0
231847|NCT00895830|564866|P4|NOT COMPLETED|Overall Study||0
231848|NCT00895830|564867|P3|NOT COMPLETED|Overall Study||0
231849|NCT00895830|564868|P2|NOT COMPLETED|Overall Study||0
231850|NCT00895830|564869|P1|NOT COMPLETED|Overall Study||0
231851|NCT00895830|564865|P5|COMPLETED|Overall Study||55
231852|NCT00895830|564866|P4|COMPLETED|Overall Study||52
231853|NCT00895830|564867|P3|COMPLETED|Overall Study||49
231854|NCT00895830|564868|P2|COMPLETED|Overall Study||50
231855|NCT00895830|564869|P1|COMPLETED|Overall Study||51
231856|NCT00895830|564865|P5|STARTED|Overall Study||55
231857|NCT00895830|564866|P4|STARTED|Overall Study||52
231858|NCT00895830|564867|P3|STARTED|Overall Study||49
231859|NCT00895830|564868|P2|STARTED|Overall Study||50
231860|NCT00895830|564869|P1|STARTED|Overall Study||51
231861|NCT00895843|564883|P2|NOT COMPLETED|Overall Study||12
231862|NCT00895843|564884|P1|NOT COMPLETED|Overall Study||12
231863|NCT00895843|564883|P2|COMPLETED|Overall Study||50
231864|NCT00895843|564884|P1|COMPLETED|Overall Study||48
231865|NCT00895843|564883|P2|STARTED|Overall Study||62
231866|NCT00895843|564884|P1|STARTED|Overall Study||60
231867|NCT00895895|564895|P5|NOT COMPLETED|Period 2||49
231868|NCT00895895|564896|P4|NOT COMPLETED|Period 2||54
231869|NCT00895895|564897|P3|NOT COMPLETED|Period 2||49
231870|NCT00895895|564898|P2|NOT COMPLETED|Period 2||53
231871|NCT00895895|564899|P1|NOT COMPLETED|Period 2||56
231872|NCT00895895|564895|P5|COMPLETED|Period 2||35
231873|NCT00895895|564896|P4|COMPLETED|Period 2||37
231874|NCT00895895|564897|P3|COMPLETED|Period 2||33
231875|NCT00895895|564898|P2|COMPLETED|Period 2||31
231876|NCT00895895|564899|P1|COMPLETED|Period 2||30
231877|NCT00895895|564895|P5|STARTED|Period 2||84
231878|NCT00895895|564896|P4|STARTED|Period 2||91
231879|NCT00895895|564897|P3|STARTED|Period 2||82
231880|NCT00895895|564898|P2|STARTED|Period 2||84
231881|NCT00895895|564899|P1|STARTED|Period 2||86
231882|NCT00895895|564895|P5|NOT COMPLETED|After Period 1, Prior to Period 2||2
231883|NCT00895895|564896|P4|NOT COMPLETED|After Period 1, Prior to Period 2||0
231884|NCT00895895|564897|P3|NOT COMPLETED|After Period 1, Prior to Period 2||2
231885|NCT00895895|564898|P2|NOT COMPLETED|After Period 1, Prior to Period 2||0
231886|NCT00895895|564899|P1|NOT COMPLETED|After Period 1, Prior to Period 2||0
231887|NCT00895895|564895|P5|COMPLETED|After Period 1, Prior to Period 2||84
231888|NCT00895895|564896|P4|COMPLETED|After Period 1, Prior to Period 2||91
231889|NCT00895895|564897|P3|COMPLETED|After Period 1, Prior to Period 2||82
231890|NCT00895895|564898|P2|COMPLETED|After Period 1, Prior to Period 2||84
231891|NCT00895895|564899|P1|COMPLETED|After Period 1, Prior to Period 2||86
231892|NCT00895895|564895|P5|STARTED|After Period 1, Prior to Period 2||86
231893|NCT00895895|564896|P4|STARTED|After Period 1, Prior to Period 2||91
231894|NCT00895895|564897|P3|STARTED|After Period 1, Prior to Period 2||84
231895|NCT00895895|564898|P2|STARTED|After Period 1, Prior to Period 2||84
231896|NCT00895895|564899|P1|STARTED|After Period 1, Prior to Period 2||86
231897|NCT00895895|564895|P5|NOT COMPLETED|Period 1||20
231898|NCT00895895|564896|P4|NOT COMPLETED|Period 1||13
231899|NCT00895895|564897|P3|NOT COMPLETED|Period 1||20
231900|NCT00895895|564898|P2|NOT COMPLETED|Period 1||21
231901|NCT00895895|564899|P1|NOT COMPLETED|Period 1||21
231902|NCT00895895|564895|P5|COMPLETED|Period 1||86
231903|NCT00895895|564896|P4|COMPLETED|Period 1||91
231904|NCT00895895|564897|P3|COMPLETED|Period 1||84
231905|NCT00895895|564898|P2|COMPLETED|Period 1||84
231906|NCT00895895|564899|P1|COMPLETED|Period 1||86
231907|NCT00895895|564895|P5|Randomized But Not Treated|Period 1||2
231908|NCT00895895|564896|P4|Randomized But Not Treated|Period 1||1
231909|NCT00895895|564897|P3|Randomized But Not Treated|Period 1||1
231910|NCT00895895|564898|P2|Randomized But Not Treated|Period 1||3
231911|NCT00895895|564899|P1|Randomized But Not Treated|Period 1||1
231912|NCT00895895|564895|P5|STARTED|Period 1||106
231913|NCT00895895|564896|P4|STARTED|Period 1||104
231914|NCT00895895|564897|P3|STARTED|Period 1||104
231915|NCT00895895|564898|P2|STARTED|Period 1||105
231916|NCT00895895|564899|P1|STARTED|Period 1||107
231917|NCT00895934|565013|P2|NOT COMPLETED|Overall Study||25
231918|NCT00895934|565014|P1|NOT COMPLETED|Overall Study||6
231919|NCT00895934|565013|P2|COMPLETED|Overall Study||18
231920|NCT00895934|565014|P1|COMPLETED|Overall Study||4
231921|NCT00895934|565013|P2|STARTED|Overall Study||43
231922|NCT00895934|565014|P1|STARTED|Overall Study||10
231923|NCT00895947|565022|P2|NOT COMPLETED|Overall Study||10
231924|NCT00895947|565023|P1|NOT COMPLETED|Overall Study||12
231925|NCT00895947|565022|P2|COMPLETED|Overall Study||90
231926|NCT00895947|565023|P1|COMPLETED|Overall Study||88
231927|NCT00895947|565022|P2|STARTED|Overall Study||100
231928|NCT00895947|565023|P1|STARTED|Overall Study||100
231929|NCT00896025|565039|P1|NOT COMPLETED|Overall Study||0
231930|NCT00896025|565039|P1|COMPLETED|Overall Study||8
231931|NCT00896025|565039|P1|STARTED|Overall Study||8
231932|NCT00896038|565045|P2|NOT COMPLETED|Overall Study||1
231933|NCT00896038|565046|P1|NOT COMPLETED|Overall Study||4
231934|NCT00896038|565045|P2|COMPLETED|Overall Study||27
231935|NCT00896038|565046|P1|COMPLETED|Overall Study||26
231936|NCT00896038|565045|P2|STARTED|Overall Study||28
231937|NCT00896038|565046|P1|STARTED|Overall Study||30
231938|NCT00896051|565086|P2|NOT COMPLETED|Overall Study||9
231939|NCT00896051|565087|P1|NOT COMPLETED|Overall Study||10
231940|NCT00896051|565086|P2|COMPLETED|Overall Study||16
231941|NCT00896051|565087|P1|COMPLETED|Overall Study||15
231942|NCT00896051|565086|P2|STARTED|Overall Study||25
231943|NCT00896051|565087|P1|STARTED|Overall Study||25
231944|NCT00896064|565129|P2|NOT COMPLETED|Overall Study||0
231945|NCT00896064|565130|P1|NOT COMPLETED|Overall Study||0
231946|NCT00896064|565129|P2|COMPLETED|Overall Study||21
231947|NCT00896064|565130|P1|COMPLETED|Overall Study||22
231948|NCT00896064|565129|P2|STARTED|Overall Study||21
231949|NCT00896064|565130|P1|STARTED|Overall Study||22
231950|NCT00896168|565160|P2|NOT COMPLETED|Overall Study||19
231951|NCT00896168|565161|P1|NOT COMPLETED|Overall Study||14
231952|NCT00896168|565160|P2|COMPLETED|Overall Study||111
231953|NCT00896168|565161|P1|COMPLETED|Overall Study||90
231954|NCT00896168|565160|P2|STARTED|Overall Study||130
231955|NCT00896168|565161|P1|STARTED|Overall Study||104
231956|NCT00896233|565189|P1|NOT COMPLETED|Overall Study||1
231957|NCT00896233|565189|P1|COMPLETED|Overall Study||9
231958|NCT00896233|565189|P1|STARTED|Overall Study||10
231959|NCT00896337|565200|P1|NOT COMPLETED|Overall Study||25
231960|NCT00896337|565200|P1|COMPLETED|Overall Study||100
231961|NCT00896337|565200|P1|STARTED|Overall Study||125
231962|NCT00896454|565267|P1|NOT COMPLETED|Overall Study||33
231963|NCT00896454|565267|P1|COMPLETED|Overall Study||0
231964|NCT00896454|565267|P1|STARTED|Overall Study||33
231965|NCT00896649|565279|P1|NOT COMPLETED|Overall Study||5
231966|NCT00896649|565279|P1|COMPLETED|Overall Study||188
231967|NCT00896649|565279|P1|STARTED|Overall Study||193
231968|NCT00896779|565286|P2|NOT COMPLETED|Overall Study||1
231969|NCT00896779|565287|P1|NOT COMPLETED|Overall Study||0
231970|NCT00896779|565286|P2|COMPLETED|Overall Study||11
231971|NCT00896779|565287|P1|COMPLETED|Overall Study||8
231972|NCT00896779|565286|P2|STARTED|Overall Study||12
231973|NCT00896779|565287|P1|STARTED|Overall Study||8
231974|NCT00897104|565296|P3|NOT COMPLETED|Overall Study||8
231975|NCT00897104|565297|P2|NOT COMPLETED|Overall Study||71
231976|NCT00897104|565298|P1|NOT COMPLETED|Overall Study||64
231977|NCT00897104|565296|P3|COMPLETED|Overall Study|Participants who took study drug and completed the study|79
232062|NCT00899379|565587|P4|NOT COMPLETED|Overall Study||37
231978|NCT00897104|565297|P2|COMPLETED|Overall Study|Participants who took study drug and completed the study|357
231979|NCT00897104|565298|P1|COMPLETED|Overall Study|Participants who took study drug and completed the study|354
231980|NCT00897104|565296|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|7
231981|NCT00897104|565297|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|71
231982|NCT00897104|565298|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|63
231983|NCT00897104|565296|P3|Participants Treated|Overall Study|Participants who took study drug|80
231984|NCT00897104|565297|P2|Participants Treated|Overall Study|Participants who took study drug|357
231985|NCT00897104|565298|P1|Participants Treated|Overall Study|Participants who took study drug|355
231986|NCT00897104|565296|P3|STARTED|Overall Study|Participants who were allocated study drug|87
231987|NCT00897104|565297|P2|STARTED|Overall Study|Participants who were allocated study drug|428
231988|NCT00897104|565298|P1|STARTED|Overall Study|Participants who were allocated study drug|418
231989|NCT00897390|565324|P1|NOT COMPLETED|Overall Study||6
231990|NCT00897390|565324|P1|COMPLETED|Overall Study||18
231991|NCT00897390|565324|P1|STARTED|Overall Study||24
231992|NCT00897715|565413|P2|NOT COMPLETED|Overall Study||1
231993|NCT00897715|565414|P1|NOT COMPLETED|Overall Study||2
231994|NCT00897715|565413|P2|COMPLETED|Overall Study||6
231995|NCT00897715|565414|P1|COMPLETED|Overall Study||6
231996|NCT00897715|565413|P2|STARTED|Overall Study||7
231997|NCT00897715|565414|P1|STARTED|Overall Study||8
231998|NCT00897897|565422|P1|NOT COMPLETED|Overall Study||0
231999|NCT00897897|565422|P1|COMPLETED|Overall Study||33
232000|NCT00897897|565422|P1|STARTED|Overall Study||33
232001|NCT00897910|565427|P1|NOT COMPLETED|Overall Study||0
232002|NCT00897910|565427|P1|COMPLETED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected|6
232003|NCT00897910|565427|P1|STARTED|Overall Study|None of the blood samples were analyzed due to lack of funding. No tissue sample was collected.|6
232004|NCT00897949|565434|P3|NOT COMPLETED|Overall Study||69
232005|NCT00897949|565435|P2|NOT COMPLETED|Overall Study||103
232006|NCT00897949|565436|P1|NOT COMPLETED|Overall Study||104
232007|NCT00897949|565434|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|301
232008|NCT00897949|565435|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|446
232009|NCT00897949|565436|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|450
232010|NCT00897949|565434|P3|Patients Treated|Overall Study|Patients who took study drug|304
232011|NCT00897949|565435|P2|Patients Treated|Overall Study|Patients who took study drug|456
232012|NCT00897949|565436|P1|Patients Treated|Overall Study|Patients who took study drug|458
232013|NCT00897949|565434|P3|STARTED|Overall Study|Patients who were allocated study drug|370
232014|NCT00897949|565435|P2|STARTED|Overall Study|Patients who were allocated study drug|549
232015|NCT00897949|565436|P1|STARTED|Overall Study|Patients who were allocated study drug|554
232016|NCT00891436|565461|P2|NOT COMPLETED|Overall Study||0
232017|NCT00891436|565462|P1|NOT COMPLETED|Overall Study||0
232018|NCT00891436|565461|P2|COMPLETED|Overall Study||10
232019|NCT00891436|565462|P1|COMPLETED|Overall Study||10
232020|NCT00891436|565461|P2|STARTED|Overall Study||10
232021|NCT00891436|565462|P1|STARTED|Overall Study||10
232022|NCT00891462|565473|P3|NOT COMPLETED|Overall Study||24
232023|NCT00891462|565474|P2|NOT COMPLETED|Overall Study||33
232024|NCT00891462|565475|P1|NOT COMPLETED|Overall Study||37
232025|NCT00891462|565473|P3|COMPLETED|Overall Study||166
232026|NCT00891462|565474|P2|COMPLETED|Overall Study||152
232027|NCT00891462|565475|P1|COMPLETED|Overall Study||149
232028|NCT00891462|565473|P3|STARTED|Overall Study||190
232029|NCT00891462|565474|P2|STARTED|Overall Study||185
232030|NCT00891462|565475|P1|STARTED|Overall Study||186
232031|NCT00891527|565486|P1|NOT COMPLETED|Overall Study||2
232032|NCT00891527|565486|P1|COMPLETED|Overall Study||48
232033|NCT00891527|565486|P1|STARTED|Overall Study||50
232034|NCT00891618|565492|P1|NOT COMPLETED|Overall Study||1
232035|NCT00891618|565492|P1|COMPLETED|Overall Study||20
232036|NCT00891618|565492|P1|STARTED|Overall Study||21
232037|NCT00891657|565498|P2|NOT COMPLETED|Overall Study||1
232038|NCT00891657|565499|P1|NOT COMPLETED|Overall Study||1
232039|NCT00891657|565498|P2|COMPLETED|Overall Study||5
232040|NCT00891657|565499|P1|COMPLETED|Overall Study||8
232041|NCT00891657|565498|P2|STARTED|Overall Study||6
232042|NCT00891657|565499|P1|STARTED|Overall Study||9
232043|NCT00891735|565515|P4|NOT COMPLETED|Overall Study||15
232044|NCT00891735|565516|P3|NOT COMPLETED|Overall Study||12
232045|NCT00891735|565517|P2|NOT COMPLETED|Overall Study||16
232046|NCT00891735|565518|P1|NOT COMPLETED|Overall Study||17
232047|NCT00891735|565515|P4|COMPLETED|Overall Study||258
232048|NCT00891735|565516|P3|COMPLETED|Overall Study||263
232049|NCT00891735|565517|P2|COMPLETED|Overall Study||258
232050|NCT00891735|565518|P1|COMPLETED|Overall Study||258
232051|NCT00891735|565515|P4|STARTED|Overall Study||273
232052|NCT00891735|565516|P3|STARTED|Overall Study||275
232053|NCT00891735|565517|P2|STARTED|Overall Study||274
232054|NCT00891735|565518|P1|STARTED|Overall Study||275
232055|NCT00898222|565556|P1|NOT COMPLETED|Overall Study||0
232056|NCT00898222|565556|P1|COMPLETED|Overall Study||4
232057|NCT00898222|565556|P1|STARTED|Overall Study||4
232058|NCT00899353|565560|P1|NOT COMPLETED|Overall Study||5
232059|NCT00899353|565560|P1|COMPLETED|Overall Study||11
232060|NCT00899353|565560|P1|STARTED|Overall Study||16
232061|NCT00899379|565586|P5|NOT COMPLETED|Overall Study||31
232063|NCT00899379|565588|P3|NOT COMPLETED|Overall Study||29
232064|NCT00899379|565589|P2|NOT COMPLETED|Overall Study||29
232065|NCT00899379|565590|P1|NOT COMPLETED|Overall Study||34
232066|NCT00899379|565586|P5|COMPLETED|Overall Study|Patients who took study drug and completed the study|63
232067|NCT00899379|565587|P4|COMPLETED|Overall Study|Patients who took study drug and completed the study|57
232068|NCT00899379|565588|P3|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
232069|NCT00899379|565589|P2|COMPLETED|Overall Study|Patients who took study drug and completed the study|66
232070|NCT00899379|565590|P1|COMPLETED|Overall Study|Patients who took study drug and completed the study|61
232071|NCT00899379|565586|P5|Patients Not Treated|Overall Study|Patients who did not take study drug|13
232072|NCT00899379|565587|P4|Patients Not Treated|Overall Study|Patients who did not take study drug|17
232073|NCT00899379|565588|P3|Patients Not Treated|Overall Study|Patients who did not take study drug|11
232074|NCT00899379|565589|P2|Patients Not Treated|Overall Study|Patients who did not take study drug|13
232075|NCT00899379|565590|P1|Patients Not Treated|Overall Study|Patients who did not take study drug|12
232076|NCT00899379|565586|P5|Patients Treated|Overall Study|Patients who took study drug|81
232077|NCT00899379|565587|P4|Patients Treated|Overall Study|Patients who took study drug|77
232078|NCT00899379|565588|P3|Patients Treated|Overall Study|Patients who took study drug|84
232079|NCT00899379|565589|P2|Patients Treated|Overall Study|Patients who took study drug|82
232080|NCT00899379|565590|P1|Patients Treated|Overall Study|Patients who took study drug|83
232081|NCT00899379|565586|P5|STARTED|Overall Study|Patients who were allocated study drug|94
232082|NCT00899379|565587|P4|STARTED|Overall Study|Patients who were allocated study drug|94
232083|NCT00899379|565588|P3|STARTED|Overall Study|Patients who were allocated study drug|95
232084|NCT00899379|565589|P2|STARTED|Overall Study|Patients who were allocated study drug|95
232085|NCT00899379|565590|P1|STARTED|Overall Study|Patients who were allocated study drug|95
232086|NCT00899392|565604|P2|NOT COMPLETED|Overall Study||24
232087|NCT00899392|565605|P1|NOT COMPLETED|Overall Study||21
232088|NCT00899392|565604|P2|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|50
232182|NCT00899600|565704|P1|COMPLETED|Overall Study||50
232089|NCT00899392|565605|P1|COMPLETED|Overall Study|Subjects:PerVariableStudied Consent:47-EAC 50-FBC Anxiety:60-EAC 3-FBC Satisfaction:63-EAC 67-FBC|47
232090|NCT00899392|565604|P2|STARTED|Overall Study||74
232091|NCT00899392|565605|P1|STARTED|Overall Study||68
232092|NCT00899470|565617|P4|NOT COMPLETED|Fourth Therapy||0
232093|NCT00899470|565618|P3|NOT COMPLETED|Fourth Therapy||0
232094|NCT00899470|565619|P2|NOT COMPLETED|Fourth Therapy||0
232095|NCT00899470|565620|P1|NOT COMPLETED|Fourth Therapy||0
232096|NCT00899470|565617|P4|COMPLETED|Fourth Therapy||6
232097|NCT00899470|565618|P3|COMPLETED|Fourth Therapy||6
232098|NCT00899470|565619|P2|COMPLETED|Fourth Therapy||6
232099|NCT00899470|565620|P1|COMPLETED|Fourth Therapy||6
232100|NCT00899470|565617|P4|STARTED|Fourth Therapy||6
232101|NCT00899470|565618|P3|STARTED|Fourth Therapy||6
232102|NCT00899470|565619|P2|STARTED|Fourth Therapy||6
232103|NCT00899470|565620|P1|STARTED|Fourth Therapy||6
232104|NCT00899470|565617|P4|NOT COMPLETED|Third Washout||0
232105|NCT00899470|565618|P3|NOT COMPLETED|Third Washout||0
232106|NCT00899470|565619|P2|NOT COMPLETED|Third Washout||0
232107|NCT00899470|565620|P1|NOT COMPLETED|Third Washout||0
232108|NCT00899470|565617|P4|COMPLETED|Third Washout||6
232109|NCT00899470|565618|P3|COMPLETED|Third Washout||6
232110|NCT00899470|565619|P2|COMPLETED|Third Washout||6
232111|NCT00899470|565620|P1|COMPLETED|Third Washout||6
232112|NCT00899470|565617|P4|STARTED|Third Washout||6
232113|NCT00899470|565618|P3|STARTED|Third Washout||6
232114|NCT00899470|565619|P2|STARTED|Third Washout||6
232115|NCT00899470|565620|P1|STARTED|Third Washout||6
232116|NCT00899470|565617|P4|NOT COMPLETED|Third Therapy||0
232117|NCT00899470|565618|P3|NOT COMPLETED|Third Therapy||0
232118|NCT00899470|565619|P2|NOT COMPLETED|Third Therapy||0
232119|NCT00899470|565620|P1|NOT COMPLETED|Third Therapy||0
232120|NCT00899470|565617|P4|COMPLETED|Third Therapy||6
232121|NCT00899470|565618|P3|COMPLETED|Third Therapy||6
232122|NCT00899470|565619|P2|COMPLETED|Third Therapy||6
232123|NCT00899470|565620|P1|COMPLETED|Third Therapy||6
232124|NCT00899470|565617|P4|STARTED|Third Therapy||6
232125|NCT00899470|565618|P3|STARTED|Third Therapy||6
232126|NCT00899470|565619|P2|STARTED|Third Therapy||6
232127|NCT00899470|565620|P1|STARTED|Third Therapy||6
232128|NCT00899470|565617|P4|NOT COMPLETED|Second Washout||0
232129|NCT00899470|565618|P3|NOT COMPLETED|Second Washout||0
232130|NCT00899470|565619|P2|NOT COMPLETED|Second Washout||0
232131|NCT00899470|565620|P1|NOT COMPLETED|Second Washout||0
232132|NCT00899470|565617|P4|COMPLETED|Second Washout||6
232133|NCT00899470|565618|P3|COMPLETED|Second Washout||6
232134|NCT00899470|565619|P2|COMPLETED|Second Washout||6
232135|NCT00899470|565620|P1|COMPLETED|Second Washout||6
232136|NCT00899470|565617|P4|STARTED|Second Washout||6
232137|NCT00899470|565618|P3|STARTED|Second Washout||6
232138|NCT00899470|565619|P2|STARTED|Second Washout||6
232139|NCT00899470|565620|P1|STARTED|Second Washout||6
232140|NCT00899470|565617|P4|NOT COMPLETED|Second Therapy||0
232141|NCT00899470|565618|P3|NOT COMPLETED|Second Therapy||0
232142|NCT00899470|565619|P2|NOT COMPLETED|Second Therapy||0
232143|NCT00899470|565620|P1|NOT COMPLETED|Second Therapy||0
232144|NCT00899470|565617|P4|COMPLETED|Second Therapy||6
232145|NCT00899470|565618|P3|COMPLETED|Second Therapy||6
232146|NCT00899470|565619|P2|COMPLETED|Second Therapy||6
232147|NCT00899470|565620|P1|COMPLETED|Second Therapy||6
232148|NCT00899470|565617|P4|STARTED|Second Therapy||6
232149|NCT00899470|565618|P3|STARTED|Second Therapy||6
232150|NCT00899470|565619|P2|STARTED|Second Therapy||6
232151|NCT00899470|565620|P1|STARTED|Second Therapy||6
232152|NCT00899470|565617|P4|NOT COMPLETED|First Washout Period||0
232153|NCT00899470|565618|P3|NOT COMPLETED|First Washout Period||0
232154|NCT00899470|565619|P2|NOT COMPLETED|First Washout Period||0
232155|NCT00899470|565620|P1|NOT COMPLETED|First Washout Period||0
232156|NCT00899470|565617|P4|COMPLETED|First Washout Period||6
232157|NCT00899470|565618|P3|COMPLETED|First Washout Period||6
232158|NCT00899470|565619|P2|COMPLETED|First Washout Period||6
232159|NCT00899470|565620|P1|COMPLETED|First Washout Period||6
232160|NCT00899470|565617|P4|STARTED|First Washout Period||6
232161|NCT00899470|565618|P3|STARTED|First Washout Period||6
232162|NCT00899470|565619|P2|STARTED|First Washout Period||6
232163|NCT00899470|565620|P1|STARTED|First Washout Period||6
232164|NCT00899470|565617|P4|NOT COMPLETED|First Therapy||0
232165|NCT00899470|565618|P3|NOT COMPLETED|First Therapy||0
232166|NCT00899470|565619|P2|NOT COMPLETED|First Therapy||0
232167|NCT00899470|565620|P1|NOT COMPLETED|First Therapy||0
232168|NCT00899470|565617|P4|COMPLETED|First Therapy||6
232169|NCT00899470|565618|P3|COMPLETED|First Therapy||6
232170|NCT00899470|565619|P2|COMPLETED|First Therapy||6
232171|NCT00899470|565620|P1|COMPLETED|First Therapy||6
232172|NCT00899470|565617|P4|STARTED|First Therapy||6
232173|NCT00899470|565618|P3|STARTED|First Therapy||6
232174|NCT00899470|565619|P2|STARTED|First Therapy||6
232175|NCT00899470|565620|P1|STARTED|First Therapy||6
232176|NCT00899574|565696|P1|NOT COMPLETED|Overall Study||0
232177|NCT00899574|565696|P1|COMPLETED|Overall Study||10
232178|NCT00899574|565696|P1|STARTED|Overall Study||10
232179|NCT00899600|565703|P2|NOT COMPLETED|Overall Study||0
232180|NCT00899600|565704|P1|NOT COMPLETED|Overall Study||0
232181|NCT00899600|565703|P2|COMPLETED|Overall Study||52
232183|NCT00899600|565703|P2|STARTED|Overall Study||52
232184|NCT00899600|565704|P1|STARTED|Overall Study||50
232185|NCT00899678|565713|P3|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||28
232186|NCT00899678|565714|P2|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||25
232187|NCT00899678|565715|P1|NOT COMPLETED|Maintenance Period (Weeks 8 to 62)||0
232188|NCT00899678|565713|P3|COMPLETED|Maintenance Period (Weeks 8 to 62)||7
232189|NCT00899678|565714|P2|COMPLETED|Maintenance Period (Weeks 8 to 62)||12
232190|NCT00899678|565715|P1|COMPLETED|Maintenance Period (Weeks 8 to 62)||0
232191|NCT00899678|565713|P3|STARTED|Maintenance Period (Weeks 8 to 62)||35
232192|NCT00899678|565714|P2|STARTED|Maintenance Period (Weeks 8 to 62)||37
232193|NCT00899678|565715|P1|STARTED|Maintenance Period (Weeks 8 to 62)|Induction only includes subjects that discontinued before Maintenance Period.|0
232194|NCT00899678|565713|P3|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
232195|NCT00899678|565714|P2|NOT COMPLETED|Induction Period (Weeks 0 to 6)||0
232196|NCT00899678|565715|P1|NOT COMPLETED|Induction Period (Weeks 0 to 6)||25
232197|NCT00899678|565713|P3|COMPLETED|Induction Period (Weeks 0 to 6)||35
232198|NCT00899678|565714|P2|COMPLETED|Induction Period (Weeks 0 to 6)||37
232199|NCT00899678|565715|P1|COMPLETED|Induction Period (Weeks 0 to 6)|2 subjects completed the Induction Phase, but discontinued prior to receiving any Maintenance doses.|2
232200|NCT00899678|565713|P3|STARTED|Induction Period (Weeks 0 to 6)||35
232201|NCT00899678|565714|P2|STARTED|Induction Period (Weeks 0 to 6)||37
232202|NCT00899678|565715|P1|STARTED|Induction Period (Weeks 0 to 6)|Induction only includes subjects that discontinued before Maintenance Period.|27
232203|NCT00899717|565745|P2|NOT COMPLETED|Overall Study||0
232204|NCT00899717|565746|P1|NOT COMPLETED|Overall Study||0
232205|NCT00899717|565745|P2|COMPLETED|Overall Study||11
232206|NCT00899717|565746|P1|COMPLETED|Overall Study||10
232207|NCT00899717|565745|P2|STARTED|Overall Study||11
232208|NCT00899717|565746|P1|STARTED|Overall Study||10
232209|NCT00900029|565765|P5|NOT COMPLETED|Overall Study||6
232210|NCT00900029|565766|P4|NOT COMPLETED|Overall Study||7
232211|NCT00900029|565767|P3|NOT COMPLETED|Overall Study||3
232212|NCT00900029|565768|P2|NOT COMPLETED|Overall Study||4
232213|NCT00900029|565769|P1|NOT COMPLETED|Overall Study||3
232214|NCT00900029|565765|P5|COMPLETED|Overall Study||38
232215|NCT00900029|565766|P4|COMPLETED|Overall Study||35
232216|NCT00900029|565767|P3|COMPLETED|Overall Study||38
232217|NCT00900029|565768|P2|COMPLETED|Overall Study||37
232218|NCT00900029|565769|P1|COMPLETED|Overall Study||35
232219|NCT00900029|565765|P5|STARTED|Overall Study||44
232220|NCT00900029|565766|P4|STARTED|Overall Study||42
232221|NCT00900029|565767|P3|STARTED|Overall Study||41
232222|NCT00900029|565768|P2|STARTED|Overall Study||41
232223|NCT00900029|565769|P1|STARTED|Overall Study||38
232224|NCT00900146|565791|P5|NOT COMPLETED|Intermediate: Period III||167
232225|NCT00900146|565792|P4|NOT COMPLETED|Intermediate: Period III||90
232226|NCT00900146|565793|P3|NOT COMPLETED|Intermediate: Period III||84
232227|NCT00900146|565794|P2|NOT COMPLETED|Intermediate: Period III||93
232228|NCT00900146|565795|P1|NOT COMPLETED|Intermediate: Period III||87
232229|NCT00900146|565791|P5|COMPLETED|Intermediate: Period III||0
232230|NCT00900146|565792|P4|COMPLETED|Intermediate: Period III||0
232231|NCT00900146|565793|P3|COMPLETED|Intermediate: Period III||0
232232|NCT00900146|565794|P2|COMPLETED|Intermediate: Period III||0
232233|NCT00900146|565795|P1|COMPLETED|Intermediate: Period III||0
232234|NCT00900146|565791|P5|Safety Set|Intermediate: Period III||166
232235|NCT00900146|565792|P4|Safety Set|Intermediate: Period III||90
232236|NCT00900146|565793|P3|Safety Set|Intermediate: Period III||84
232237|NCT00900146|565794|P2|Safety Set|Intermediate: Period III||92
232238|NCT00900146|565795|P1|Safety Set|Intermediate: Period III||86
232239|NCT00900146|565791|P5|STARTED|Intermediate: Period III||167
232240|NCT00900146|565792|P4|STARTED|Intermediate: Period III||90
232241|NCT00900146|565793|P3|STARTED|Intermediate: Period III||84
232242|NCT00900146|565794|P2|STARTED|Intermediate: Period III||93
232243|NCT00900146|565795|P1|STARTED|Intermediate: Period III||87
232244|NCT00900146|565791|P5|NOT COMPLETED|Dose Finding: Period II (4 Months)||12
232245|NCT00900146|565792|P4|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
232246|NCT00900146|565793|P3|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
232247|NCT00900146|565794|P2|NOT COMPLETED|Dose Finding: Period II (4 Months)||2
232248|NCT00900146|565795|P1|NOT COMPLETED|Dose Finding: Period II (4 Months)||5
232249|NCT00900146|565791|P5|COMPLETED|Dose Finding: Period II (4 Months)|Placebo also included 1 patient with no study completion page.|167
232250|NCT00900146|565792|P4|COMPLETED|Dose Finding: Period II (4 Months)||90
232251|NCT00900146|565793|P3|COMPLETED|Dose Finding: Period II (4 Months)||87
232252|NCT00900146|565794|P2|COMPLETED|Dose Finding: Period II (4 Months)||93
232253|NCT00900146|565795|P1|COMPLETED|Dose Finding: Period II (4 Months)||88
232254|NCT00900146|565791|P5|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||179
232255|NCT00900146|565792|P4|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
232256|NCT00900146|565793|P3|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||92
232257|NCT00900146|565794|P2|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||95
232258|NCT00900146|565795|P1|Full Analysis Set (FAS)/Safety|Dose Finding: Period II (4 Months)||93
232259|NCT00900146|565791|P5|STARTED|Dose Finding: Period II (4 Months)||179
232260|NCT00900146|565792|P4|STARTED|Dose Finding: Period II (4 Months)||92
232261|NCT00900146|565793|P3|STARTED|Dose Finding: Period II (4 Months)||92
232262|NCT00900146|565794|P2|STARTED|Dose Finding: Period II (4 Months)||95
232263|NCT00900146|565795|P1|STARTED|Dose Finding: Period II (4 Months)||93
232264|NCT00900159|565909|P2|NOT COMPLETED|Second Intervention||0
232265|NCT00900159|565910|P1|NOT COMPLETED|Second Intervention||1
232266|NCT00900159|565909|P2|COMPLETED|Second Intervention||13
232267|NCT00900159|565910|P1|COMPLETED|Second Intervention||10
232268|NCT00900159|565909|P2|STARTED|Second Intervention||13
232269|NCT00900159|565910|P1|STARTED|Second Intervention||11
232270|NCT00900159|565909|P2|NOT COMPLETED|Washout||0
232271|NCT00900159|565910|P1|NOT COMPLETED|Washout||0
232272|NCT00900159|565909|P2|COMPLETED|Washout||13
232273|NCT00900159|565910|P1|COMPLETED|Washout||11
232274|NCT00900159|565909|P2|STARTED|Washout||13
232275|NCT00900159|565910|P1|STARTED|Washout||11
232276|NCT00900159|565909|P2|NOT COMPLETED|First Intervention||0
232277|NCT00900159|565910|P1|NOT COMPLETED|First Intervention||0
232278|NCT00900159|565909|P2|COMPLETED|First Intervention||13
232279|NCT00900159|565910|P1|COMPLETED|First Intervention||11
232280|NCT00900159|565909|P2|STARTED|First Intervention||13
232281|NCT00900159|565910|P1|STARTED|First Intervention||11
232282|NCT00900237|565926|P2|NOT COMPLETED|Overall Study||0
232283|NCT00900237|565927|P1|NOT COMPLETED|Overall Study||0
232284|NCT00900237|565926|P2|COMPLETED|Overall Study||7
232285|NCT00900237|565927|P1|COMPLETED|Overall Study||7
232286|NCT00900237|565926|P2|STARTED|Overall Study||7
232287|NCT00900237|565927|P1|STARTED|Overall Study||7
232288|NCT00900627|565941|P6|NOT COMPLETED|Overall Study||26
232289|NCT00900627|565942|P5|NOT COMPLETED|Overall Study||29
232290|NCT00900627|565943|P4|NOT COMPLETED|Overall Study||6
232291|NCT00900627|565944|P3|NOT COMPLETED|Overall Study||6
232292|NCT00900627|565945|P2|NOT COMPLETED|Overall Study||2
232293|NCT00900627|565946|P1|NOT COMPLETED|Overall Study||6
232294|NCT00900627|565941|P6|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|70
232295|NCT00900627|565942|P5|COMPLETED|Overall Study|No set completion, pts were to remain in study until withdrawn|65
232296|NCT00900627|565943|P4|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
232297|NCT00900627|565944|P3|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
232298|NCT00900627|565945|P2|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
232299|NCT00900627|565946|P1|COMPLETED|Overall Study|No set completion, patients were to remain in study until withdrawn|0
232300|NCT00900627|565941|P6|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|96
232301|NCT00900627|565942|P5|STARTED|Overall Study|The values under 'Not Completed' are based on the time of the primary analysis|94
232302|NCT00900627|565943|P4|STARTED|Overall Study||6
232303|NCT00900627|565944|P3|STARTED|Overall Study||6
232304|NCT00900627|565945|P2|STARTED|Overall Study||2
232305|NCT00900627|565946|P1|STARTED|Overall Study||6
232306|NCT00900666|565966|P2|NOT COMPLETED|Overall Study||0
232307|NCT00900666|565967|P1|NOT COMPLETED|Overall Study||0
232308|NCT00900666|565966|P2|COMPLETED|Overall Study||9
232309|NCT00900666|565967|P1|COMPLETED|Overall Study||10
232310|NCT00900666|565966|P2|STARTED|Overall Study||9
232311|NCT00900666|565967|P1|STARTED|Overall Study||10
232312|NCT00900731|565977|P2|NOT COMPLETED|Overall Study||61
232313|NCT00900731|565978|P1|NOT COMPLETED|Overall Study||60
232314|NCT00900731|565977|P2|COMPLETED|Overall Study||740
232315|NCT00900731|565978|P1|COMPLETED|Overall Study||737
232316|NCT00900731|565977|P2|Safety Set: Received Study Drug|Overall Study||799
232317|NCT00900731|565978|P1|Safety Set: Received Study Drug|Overall Study||794
232318|NCT00900731|565977|P2|STARTED|Overall Study||801
232319|NCT00900731|565978|P1|STARTED|Overall Study|Randomized participants|797
232320|NCT00900757|565998|P1|NOT COMPLETED|Overall Study||19
232321|NCT00900757|565998|P1|COMPLETED|Overall Study||38
232322|NCT00900757|565998|P1|STARTED|Overall Study||57
232323|NCT00900796|566006|P1|NOT COMPLETED|Phase 2||5
232324|NCT00900796|566006|P1|COMPLETED|Phase 2||6
232325|NCT00900796|566006|P1|STARTED|Phase 2||11
232326|NCT00900796|566006|P1|NOT COMPLETED|Between Phase 1 and Phase 2||110
232327|NCT00900796|566006|P1|COMPLETED|Between Phase 1 and Phase 2||11
232328|NCT00900796|566006|P1|STARTED|Between Phase 1 and Phase 2||121
232329|NCT00900796|566006|P1|NOT COMPLETED|Phase 1||11
232330|NCT00900796|566006|P1|COMPLETED|Phase 1||121
232331|NCT00900796|566006|P1|STARTED|Phase 1||132
232332|NCT00900822|566016|P1|NOT COMPLETED|12 Months Clinical Evaluation||0
232333|NCT00900822|566016|P1|COMPLETED|12 Months Clinical Evaluation||11
232334|NCT00900822|566016|P1|STARTED|12 Months Clinical Evaluation||11
232335|NCT00900822|566016|P1|NOT COMPLETED|9 Months Histological Evaluation||0
232336|NCT00900822|566016|P1|COMPLETED|9 Months Histological Evaluation||11
232337|NCT00900822|566016|P1|STARTED|9 Months Histological Evaluation||11
232338|NCT00901017|566026|P1|NOT COMPLETED|Overall Study||0
232339|NCT00901017|566026|P1|COMPLETED|Overall Study||14
232340|NCT00901017|566026|P1|STARTED|Overall Study||14
232341|NCT00901186|566042|P2|NOT COMPLETED|Overall Study||11
232342|NCT00901186|566043|P1|NOT COMPLETED|Overall Study||9
232343|NCT00901186|566042|P2|COMPLETED|Overall Study||32
232344|NCT00901186|566043|P1|COMPLETED|Overall Study||31
232345|NCT00901186|566042|P2|Intent to Treat|Overall Study|Five treated participants did not have at least a baseline and one post-treatment BCVA.|38
232346|NCT00901186|566043|P1|Intent to Treat|Overall Study|Four treated participants did not have at least a baseline and one post-treatment BCVA.|35
232347|NCT00901186|566042|P2|Safety Set|Overall Study||43
232348|NCT00901186|566043|P1|Safety Set|Overall Study|One participant did not receive one intravitreal RFB002 injection.|39
232349|NCT00901186|566042|P2|STARTED|Overall Study||43
232350|NCT00901186|566043|P1|STARTED|Overall Study||40
232351|NCT00901225|566059|P1|NOT COMPLETED|Overall Study||1
232352|NCT00901225|566059|P1|COMPLETED|Overall Study||20
232353|NCT00901225|566059|P1|STARTED|Overall Study||21
232354|NCT00901316|566070|P2|NOT COMPLETED|Overall Study||0
232355|NCT00901316|566071|P1|NOT COMPLETED|Overall Study||0
232356|NCT00901316|566070|P2|COMPLETED|Overall Study||495
232357|NCT00901316|566071|P1|COMPLETED|Overall Study||492
232358|NCT00901316|566070|P2|STARTED|Overall Study||495
232359|NCT00901316|566071|P1|STARTED|Overall Study||492
232360|NCT00901342|566077|P1|NOT COMPLETED|Overall Study||15
232361|NCT00901342|566077|P1|COMPLETED|Overall Study|89 subjects completed the study completion visit|89
232362|NCT00901342|566077|P1|Received at Least 1 Infusion|Overall Study||98
232363|NCT00901342|566077|P1|STARTED|Overall Study||104
232364|NCT00901459|566081|P1|NOT COMPLETED|Overall Study||6
232365|NCT00901459|566081|P1|COMPLETED|Overall Study||15
232366|NCT00901459|566081|P1|STARTED|Overall Study||21
232367|NCT00894647|566094|P2|NOT COMPLETED|Overall Study||14
232368|NCT00894647|566095|P1|NOT COMPLETED|Overall Study||10
232369|NCT00894647|566094|P2|COMPLETED|Overall Study||112
232370|NCT00894647|566095|P1|COMPLETED|Overall Study||111
232371|NCT00894647|566094|P2|STARTED|Overall Study||126
232372|NCT00894647|566095|P1|STARTED|Overall Study||121
232373|NCT00894699|566107|P2|NOT COMPLETED|Overall Study||0
232374|NCT00894699|566108|P1|NOT COMPLETED|Overall Study||0
232375|NCT00894699|566107|P2|COMPLETED|Overall Study||19
232376|NCT00894699|566108|P1|COMPLETED|Overall Study||21
232377|NCT00894699|566107|P2|STARTED|Overall Study||19
232378|NCT00894699|566108|P1|STARTED|Overall Study||21
232379|NCT00894790|566116|P2|NOT COMPLETED|Overall Study||2
232380|NCT00894790|566117|P1|NOT COMPLETED|Overall Study||1
232381|NCT00894790|566116|P2|COMPLETED|Overall Study||2
232382|NCT00894790|566117|P1|COMPLETED|Overall Study||3
232383|NCT00894790|566116|P2|STARTED|Overall Study||4
232384|NCT00894790|566117|P1|STARTED|Overall Study||4
232385|NCT00894803|566141|P2|NOT COMPLETED|Overall Study||5
232386|NCT00894803|566142|P1|NOT COMPLETED|Overall Study||20
232387|NCT00894803|566141|P2|COMPLETED|Overall Study||20
232388|NCT00894803|566142|P1|COMPLETED|Overall Study||81
232389|NCT00894803|566141|P2|STARTED|Overall Study||25
232390|NCT00894803|566142|P1|STARTED|Overall Study||101
232391|NCT00894933|566176|P1|NOT COMPLETED|Overall Study||4
232392|NCT00894933|566176|P1|COMPLETED|Overall Study||29
232393|NCT00894933|566176|P1|STARTED|Overall Study||33
232394|NCT00895011|566195|P3|NOT COMPLETED|Overall Study||8
232395|NCT00895011|566196|P2|NOT COMPLETED|Overall Study||14
232396|NCT00895011|566197|P1|NOT COMPLETED|Overall Study||24
232397|NCT00895011|566195|P3|COMPLETED|Overall Study||91
232398|NCT00895011|566196|P2|COMPLETED|Overall Study||85
232399|NCT00895011|566197|P1|COMPLETED|Overall Study||76
232400|NCT00895011|566195|P3|STARTED|Overall Study||99
232401|NCT00895011|566196|P2|STARTED|Overall Study||99
232402|NCT00895011|566197|P1|STARTED|Overall Study||100
232403|NCT00895180|566213|P2|NOT COMPLETED|Overall Study||0
232404|NCT00895180|566214|P1|NOT COMPLETED|Overall Study||0
232405|NCT00895180|566213|P2|COMPLETED|Overall Study||40
232406|NCT00895180|566214|P1|COMPLETED|Overall Study||40
232407|NCT00895180|566213|P2|Received at Least 1 Dose of Study Drug|Overall Study||40
232408|NCT00895180|566214|P1|Received at Least 1 Dose of Study Drug|Overall Study||40
232409|NCT00895180|566213|P2|STARTED|Overall Study||40
232410|NCT00895180|566214|P1|STARTED|Overall Study||40
232411|NCT00895193|566236|P4|NOT COMPLETED|Overall Study||0
232412|NCT00895193|566237|P3|NOT COMPLETED|Overall Study||0
232413|NCT00895193|566238|P2|NOT COMPLETED|Overall Study||0
232414|NCT00895193|566239|P1|NOT COMPLETED|Overall Study||0
232415|NCT00895193|566236|P4|COMPLETED|Overall Study||25
232416|NCT00895193|566237|P3|COMPLETED|Overall Study||25
232417|NCT00895193|566238|P2|COMPLETED|Overall Study||25
232418|NCT00895193|566239|P1|COMPLETED|Overall Study||25
232419|NCT00895193|566236|P4|STARTED|Overall Study||25
232420|NCT00895193|566237|P3|STARTED|Overall Study||25
232421|NCT00895193|566238|P2|STARTED|Overall Study||25
232422|NCT00895193|566239|P1|STARTED|Overall Study||25
232423|NCT00895232|566264|P3|NOT COMPLETED|Overall Study||5
232424|NCT00895232|566265|P2|NOT COMPLETED|Overall Study||4
232425|NCT00895232|566266|P1|NOT COMPLETED|Overall Study||3
232426|NCT00895232|566264|P3|COMPLETED|Overall Study||3
232427|NCT00895232|566265|P2|COMPLETED|Overall Study||2
232428|NCT00895232|566266|P1|COMPLETED|Overall Study||4
232429|NCT00895232|566264|P3|STARTED|Overall Study||8
232430|NCT00895232|566265|P2|STARTED|Overall Study||6
232431|NCT00895232|566266|P1|STARTED|Overall Study||7
232432|NCT00895245|566280|P1|NOT COMPLETED|Overall Study||6
232433|NCT00895245|566280|P1|COMPLETED|Overall Study||0
232434|NCT00895245|566280|P1|STARTED|Overall Study||6
232435|NCT00895284|566289|P2|NOT COMPLETED|Overall Study||0
232436|NCT00895284|566290|P1|NOT COMPLETED|Overall Study||0
232437|NCT00895284|566289|P2|COMPLETED|Overall Study||0
232438|NCT00895284|566290|P1|COMPLETED|Overall Study||3
232439|NCT00895284|566289|P2|STARTED|Overall Study||0
232440|NCT00895284|566290|P1|STARTED|Overall Study||3
232441|NCT00895310|566296|P1|NOT COMPLETED|Overall Study||1
232442|NCT00895310|566296|P1|COMPLETED|Overall Study||29
232443|NCT00895310|566296|P1|STARTED|Overall Study||30
232444|NCT00901576|566309|P6|NOT COMPLETED|Third Intervention||0
232445|NCT00901576|566310|P5|NOT COMPLETED|Third Intervention||0
232446|NCT00901576|566311|P4|NOT COMPLETED|Third Intervention||0
232447|NCT00901576|566312|P3|NOT COMPLETED|Third Intervention||0
232448|NCT00901576|566313|P2|NOT COMPLETED|Third Intervention||0
232449|NCT00901576|566314|P1|NOT COMPLETED|Third Intervention||0
232450|NCT00901576|566309|P6|COMPLETED|Third Intervention||5
232451|NCT00901576|566310|P5|COMPLETED|Third Intervention||6
232452|NCT00901576|566311|P4|COMPLETED|Third Intervention||5
232453|NCT00901576|566312|P3|COMPLETED|Third Intervention||7
232454|NCT00901576|566313|P2|COMPLETED|Third Intervention||7
232455|NCT00901576|566314|P1|COMPLETED|Third Intervention||5
232456|NCT00901576|566309|P6|STARTED|Third Intervention||5
232457|NCT00901576|566310|P5|STARTED|Third Intervention||6
232458|NCT00901576|566311|P4|STARTED|Third Intervention||5
232459|NCT00901576|566312|P3|STARTED|Third Intervention||7
232460|NCT00901576|566313|P2|STARTED|Third Intervention||7
232461|NCT00901576|566314|P1|STARTED|Third Intervention||5
232462|NCT00901576|566309|P6|NOT COMPLETED|Washout||0
232463|NCT00901576|566310|P5|NOT COMPLETED|Washout||0
232464|NCT00901576|566311|P4|NOT COMPLETED|Washout||0
232465|NCT00901576|566312|P3|NOT COMPLETED|Washout||0
232466|NCT00901576|566313|P2|NOT COMPLETED|Washout||0
232467|NCT00901576|566314|P1|NOT COMPLETED|Washout||0
232468|NCT00901576|566309|P6|COMPLETED|Washout||5
232469|NCT00901576|566310|P5|COMPLETED|Washout||6
232470|NCT00901576|566311|P4|COMPLETED|Washout||5
232471|NCT00901576|566312|P3|COMPLETED|Washout||7
232472|NCT00901576|566313|P2|COMPLETED|Washout||7
232473|NCT00901576|566314|P1|COMPLETED|Washout||5
232474|NCT00901576|566309|P6|STARTED|Washout||5
232475|NCT00901576|566310|P5|STARTED|Washout||6
232476|NCT00901576|566311|P4|STARTED|Washout||5
232477|NCT00901576|566312|P3|STARTED|Washout||7
232478|NCT00901576|566313|P2|STARTED|Washout||7
232479|NCT00901576|566314|P1|STARTED|Washout||5
232480|NCT00901576|566309|P6|NOT COMPLETED|Second Intervention||1
232481|NCT00901576|566310|P5|NOT COMPLETED|Second Intervention||0
232482|NCT00901576|566311|P4|NOT COMPLETED|Second Intervention||1
232483|NCT00901576|566312|P3|NOT COMPLETED|Second Intervention||0
232484|NCT00901576|566313|P2|NOT COMPLETED|Second Intervention||0
232485|NCT00901576|566314|P1|NOT COMPLETED|Second Intervention||1
232486|NCT00901576|566309|P6|COMPLETED|Second Intervention||5
232487|NCT00901576|566310|P5|COMPLETED|Second Intervention||6
232488|NCT00901576|566311|P4|COMPLETED|Second Intervention||5
232489|NCT00901576|566312|P3|COMPLETED|Second Intervention||7
232490|NCT00901576|566313|P2|COMPLETED|Second Intervention||7
232491|NCT00901576|566314|P1|COMPLETED|Second Intervention||5
232492|NCT00901576|566309|P6|STARTED|Second Intervention||6
232493|NCT00901576|566310|P5|STARTED|Second Intervention||6
232494|NCT00901576|566311|P4|STARTED|Second Intervention||6
232495|NCT00901576|566312|P3|STARTED|Second Intervention||7
232496|NCT00901576|566313|P2|STARTED|Second Intervention||7
232497|NCT00901576|566314|P1|STARTED|Second Intervention||6
232498|NCT00901576|566309|P6|NOT COMPLETED|Washout||0
232499|NCT00901576|566310|P5|NOT COMPLETED|Washout||0
232500|NCT00901576|566311|P4|NOT COMPLETED|Washout||0
232501|NCT00901576|566312|P3|NOT COMPLETED|Washout||0
232502|NCT00901576|566313|P2|NOT COMPLETED|Washout||0
232503|NCT00901576|566314|P1|NOT COMPLETED|Washout||0
232504|NCT00901576|566309|P6|COMPLETED|Washout||6
232505|NCT00901576|566310|P5|COMPLETED|Washout||6
232506|NCT00901576|566311|P4|COMPLETED|Washout||6
232507|NCT00901576|566312|P3|COMPLETED|Washout||7
232508|NCT00901576|566313|P2|COMPLETED|Washout||7
232509|NCT00901576|566314|P1|COMPLETED|Washout||6
232510|NCT00901576|566309|P6|STARTED|Washout||6
232511|NCT00901576|566310|P5|STARTED|Washout||6
232512|NCT00901576|566311|P4|STARTED|Washout||6
232513|NCT00901576|566312|P3|STARTED|Washout||7
232514|NCT00901576|566313|P2|STARTED|Washout||7
232515|NCT00901576|566314|P1|STARTED|Washout||6
232516|NCT00901576|566309|P6|NOT COMPLETED|First Intervention||0
232517|NCT00901576|566310|P5|NOT COMPLETED|First Intervention||0
232518|NCT00901576|566311|P4|NOT COMPLETED|First Intervention||0
232519|NCT00901576|566312|P3|NOT COMPLETED|First Intervention||0
232520|NCT00901576|566313|P2|NOT COMPLETED|First Intervention||0
232521|NCT00901576|566314|P1|NOT COMPLETED|First Intervention||0
232522|NCT00901576|566309|P6|COMPLETED|First Intervention||6
232523|NCT00901576|566310|P5|COMPLETED|First Intervention||6
232524|NCT00901576|566311|P4|COMPLETED|First Intervention||6
232525|NCT00901576|566312|P3|COMPLETED|First Intervention||7
232526|NCT00901576|566313|P2|COMPLETED|First Intervention||7
232527|NCT00901576|566314|P1|COMPLETED|First Intervention||6
232528|NCT00901576|566309|P6|STARTED|First Intervention||6
232529|NCT00901576|566310|P5|STARTED|First Intervention||6
232530|NCT00901576|566311|P4|STARTED|First Intervention||6
232531|NCT00901576|566312|P3|STARTED|First Intervention||7
232532|NCT00901576|566313|P2|STARTED|First Intervention||7
232533|NCT00901576|566314|P1|STARTED|First Intervention||6
232534|NCT00901628|566337|P2|NOT COMPLETED|Overall Study||10
232535|NCT00901628|566338|P1|NOT COMPLETED|Overall Study||4
232536|NCT00901628|566337|P2|COMPLETED|Overall Study||42
232537|NCT00901628|566338|P1|COMPLETED|Overall Study||45
232538|NCT00901628|566337|P2|STARTED|Overall Study||52
232539|NCT00901628|566338|P1|STARTED|Overall Study||49
232540|NCT00902668|566354|P1|NOT COMPLETED|Overall Study||3
232541|NCT00902668|566354|P1|COMPLETED|Overall Study||0
232542|NCT00902668|566354|P1|STARTED|Overall Study||3
232543|NCT00902746|566358|P1|NOT COMPLETED|Overall Study||36
232544|NCT00902746|566358|P1|COMPLETED|Overall Study||113
232545|NCT00902746|566358|P1|Transfer to Step 2|Overall Study||133
232546|NCT00902746|566358|P1|Initiation of Study Drug Administration|Overall Study||148
232547|NCT00902746|566358|P1|STARTED|Overall Study||149
232548|NCT00902850|566365|P2|NOT COMPLETED|Overall Study||2
232549|NCT00902850|566366|P1|NOT COMPLETED|Overall Study||2
232550|NCT00902850|566365|P2|COMPLETED|Overall Study||12
232551|NCT00902850|566366|P1|COMPLETED|Overall Study||12
232552|NCT00902850|566365|P2|STARTED|Overall Study||14
232553|NCT00902850|566366|P1|STARTED|Overall Study||14
232554|NCT00903006|566376|P4|NOT COMPLETED|Overall Study||0
232555|NCT00903006|566377|P3|NOT COMPLETED|Overall Study||1
232556|NCT00903006|566378|P2|NOT COMPLETED|Overall Study||3
232557|NCT00903006|566379|P1|NOT COMPLETED|Overall Study||2
232558|NCT00903006|566376|P4|COMPLETED|Overall Study||0
232559|NCT00903006|566377|P3|COMPLETED|Overall Study||0
232560|NCT00903006|566378|P2|COMPLETED|Overall Study||0
232561|NCT00903006|566379|P1|COMPLETED|Overall Study||0
232562|NCT00903006|566376|P4|STARTED|Overall Study|Zero participants started due to smaller sample size.|0
232563|NCT00903006|566377|P3|STARTED|Overall Study||1
232564|NCT00903006|566378|P2|STARTED|Overall Study||3
232565|NCT00903006|566379|P1|STARTED|Overall Study||2
232566|NCT00903032|566391|P2|NOT COMPLETED|Overall Study||5
232567|NCT00903032|566392|P1|NOT COMPLETED|Overall Study||7
232568|NCT00903032|566391|P2|COMPLETED|Overall Study||119
232569|NCT00903032|566392|P1|COMPLETED|Overall Study||122
232570|NCT00903032|566391|P2|STARTED|Overall Study||124
232571|NCT00903032|566392|P1|STARTED|Overall Study||129
232572|NCT00903162|566398|P1|NOT COMPLETED|Overall Study||4
232573|NCT00903162|566398|P1|COMPLETED|Overall Study||12
232574|NCT00903162|566398|P1|STARTED|Overall Study||16
232575|NCT00903175|566406|P2|NOT COMPLETED|Period 2 - Second Line||36
232576|NCT00903175|566407|P1|NOT COMPLETED|Period 2 - Second Line||49
232577|NCT00903175|566406|P2|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|80
232578|NCT00903175|566407|P1|COMPLETED|Period 2 - Second Line|Completed = Disease progression - (completed 2L)|79
232579|NCT00903175|566406|P2|STARTED|Period 2 - Second Line|130 from Sunitinib 1L planned to enter 2L period and cross over to everolimus but only 116 did.|116
232580|NCT00903175|566407|P1|STARTED|Period 2 - Second Line|139 from everolimus 1L planned to enter 2L period and cross over to sunitinib but only 128 did.|128
232581|NCT00903175|566406|P2|NOT COMPLETED|Period 1 - First Line||89
232582|NCT00903175|566407|P1|NOT COMPLETED|Period 1 - First Line||77
232583|NCT00903175|566406|P2|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|142
232584|NCT00903175|566407|P1|COMPLETED|Period 1 - First Line|Completed = Disease progression (completed 1L)|161
232585|NCT00903175|566406|P2|STARTED|Period 1 - First Line||231
232586|NCT00903175|566407|P1|STARTED|Period 1 - First Line||238
232587|NCT00903331|566439|P2|NOT COMPLETED|Overall Study||18
232588|NCT00903331|566440|P1|NOT COMPLETED|Overall Study||5
232589|NCT00903331|566439|P2|COMPLETED|Overall Study||101
232590|NCT00903331|566440|P1|COMPLETED|Overall Study||54
232591|NCT00903331|566439|P2|STARTED|Overall Study||119
232592|NCT00903331|566440|P1|STARTED|Overall Study||59
232593|NCT00903344|566450|P2|NOT COMPLETED|Overall Study||3
232594|NCT00903344|566451|P1|NOT COMPLETED|Overall Study||5
232595|NCT00903344|566450|P2|COMPLETED|Overall Study||7
232596|NCT00903344|566451|P1|COMPLETED|Overall Study||7
232597|NCT00903344|566450|P2|6 Month Visit|Overall Study||10
232598|NCT00903344|566451|P1|6 Month Visit|Overall Study||9
232599|NCT00903344|566450|P2|3 Month Visit|Overall Study||10
232600|NCT00903344|566451|P1|3 Month Visit|Overall Study||10
232601|NCT00903344|566450|P2|STARTED|Overall Study||10
232602|NCT00903344|566451|P1|STARTED|Overall Study||12
232603|NCT00903357|566467|P2|NOT COMPLETED|Second Intervention||0
232604|NCT00903357|566468|P1|NOT COMPLETED|Second Intervention||1
232605|NCT00903357|566467|P2|COMPLETED|Second Intervention||22
232606|NCT00903357|566468|P1|COMPLETED|Second Intervention||21
232607|NCT00903357|566467|P2|STARTED|Second Intervention||22
232608|NCT00903357|566468|P1|STARTED|Second Intervention||22
232609|NCT00903357|566467|P2|NOT COMPLETED|Wash Out Period of 2 Weeks||1
232610|NCT00903357|566468|P1|NOT COMPLETED|Wash Out Period of 2 Weeks||0
232611|NCT00903357|566467|P2|COMPLETED|Wash Out Period of 2 Weeks||22
232612|NCT00903357|566468|P1|COMPLETED|Wash Out Period of 2 Weeks||22
232613|NCT00903357|566467|P2|STARTED|Wash Out Period of 2 Weeks||23
232614|NCT00903357|566468|P1|STARTED|Wash Out Period of 2 Weeks||22
232615|NCT00903357|566467|P2|NOT COMPLETED|First Intervention||4
232616|NCT00903357|566468|P1|NOT COMPLETED|First Intervention||5
232617|NCT00903357|566467|P2|COMPLETED|First Intervention||23
232618|NCT00903357|566468|P1|COMPLETED|First Intervention||22
232619|NCT00903357|566467|P2|STARTED|First Intervention||27
232620|NCT00903357|566468|P1|STARTED|First Intervention||27
232621|NCT00903370|566480|P2|NOT COMPLETED|Overall Study||24
232622|NCT00903370|566481|P1|NOT COMPLETED|Overall Study||28
232623|NCT00903370|566480|P2|COMPLETED|Overall Study||109
232624|NCT00903370|566481|P1|COMPLETED|Overall Study||99
232625|NCT00903370|566480|P2|STARTED|Overall Study||133
232626|NCT00903370|566481|P1|STARTED|Overall Study||127
232627|NCT00903383|566493|P4|NOT COMPLETED|Overall Study||5
232628|NCT00903383|566494|P3|NOT COMPLETED|Overall Study||3
232629|NCT00903383|566495|P2|NOT COMPLETED|Overall Study||6
232630|NCT00903383|566496|P1|NOT COMPLETED|Overall Study||7
232631|NCT00903383|566493|P4|COMPLETED|Overall Study||44
232632|NCT00903383|566494|P3|COMPLETED|Overall Study||47
232633|NCT00903383|566495|P2|COMPLETED|Overall Study||48
232634|NCT00903383|566496|P1|COMPLETED|Overall Study||48
232635|NCT00903383|566493|P4|STARTED|Overall Study||49
232636|NCT00903383|566494|P3|STARTED|Overall Study||50
232637|NCT00903383|566495|P2|STARTED|Overall Study||54
232638|NCT00903383|566496|P1|STARTED|Overall Study||55
232639|NCT00903396|566530|P4|NOT COMPLETED|Overall Study||0
232640|NCT00903396|566531|P3|NOT COMPLETED|Overall Study||0
232641|NCT00903396|566532|P2|NOT COMPLETED|Overall Study||0
232642|NCT00903396|566533|P1|NOT COMPLETED|Overall Study||0
232643|NCT00903396|566530|P4|COMPLETED|Overall Study||1
232644|NCT00903396|566531|P3|COMPLETED|Overall Study||3
232645|NCT00903396|566532|P2|COMPLETED|Overall Study||1
232646|NCT00903396|566533|P1|COMPLETED|Overall Study||2
232647|NCT00903396|566530|P4|STARTED|Overall Study||1
232648|NCT00903396|566531|P3|STARTED|Overall Study||3
232649|NCT00903396|566532|P2|STARTED|Overall Study||1
232650|NCT00903396|566533|P1|STARTED|Overall Study||2
232651|NCT00903409|566561|P2|NOT COMPLETED|Overall Study||27
232652|NCT00903409|566562|P1|NOT COMPLETED|Overall Study||26
232653|NCT00903409|566561|P2|COMPLETED|Overall Study||73
232654|NCT00903409|566562|P1|COMPLETED|Overall Study||62
232655|NCT00903409|566561|P2|STARTED|Overall Study||100
232656|NCT00903409|566562|P1|STARTED|Overall Study||88
232657|NCT00903448|566576|P2|NOT COMPLETED|Period 3: 5 Days||0
232658|NCT00903448|566577|P1|NOT COMPLETED|Period 3: 5 Days||0
232659|NCT00903448|566576|P2|COMPLETED|Period 3: 5 Days||20
232660|NCT00903448|566577|P1|COMPLETED|Period 3: 5 Days||20
232661|NCT00903448|566576|P2|STARTED|Period 3: 5 Days||20
232662|NCT00903448|566577|P1|STARTED|Period 3: 5 Days||20
232663|NCT00903448|566576|P2|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
232664|NCT00903448|566577|P1|NOT COMPLETED|Period 2: 5 Days Then 10 Day Washout||0
232665|NCT00903448|566576|P2|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
232666|NCT00903448|566577|P1|COMPLETED|Period 2: 5 Days Then 10 Day Washout||20
232667|NCT00903448|566576|P2|STARTED|Period 2: 5 Days Then 10 Day Washout||20
232668|NCT00903448|566577|P1|STARTED|Period 2: 5 Days Then 10 Day Washout||20
232669|NCT00903448|566576|P2|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
232670|NCT00903448|566577|P1|NOT COMPLETED|Period 1: 5 Days Then 10 Day Washout||0
232671|NCT00903448|566576|P2|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
232672|NCT00903448|566577|P1|COMPLETED|Period 1: 5 Days Then 10 Day Washout||20
232673|NCT00903448|566576|P2|STARTED|Period 1: 5 Days Then 10 Day Washout||20
232674|NCT00903448|566577|P1|STARTED|Period 1: 5 Days Then 10 Day Washout||20
232675|NCT00903630|566586|P3|NOT COMPLETED|Phase 2||1
232676|NCT00903630|566587|P2|NOT COMPLETED|Phase 2||0
232677|NCT00903630|566588|P1|NOT COMPLETED|Phase 2||0
232678|NCT00903630|566586|P3|COMPLETED|Phase 2|One participant was removed from the study after 2 weeks of treatment due to skin toxicity.|3
232679|NCT00903630|566587|P2|COMPLETED|Phase 2||0
232680|NCT00903630|566588|P1|COMPLETED|Phase 2||6
232681|NCT00903630|566586|P3|STARTED|Phase 2||4
232682|NCT00903630|566587|P2|STARTED|Phase 2||0
232683|NCT00903630|566588|P1|STARTED|Phase 2||6
232684|NCT00903630|566586|P3|NOT COMPLETED|Phase l||0
232685|NCT00903630|566587|P2|NOT COMPLETED|Phase l||0
232686|NCT00903630|566588|P1|NOT COMPLETED|Phase l||0
232687|NCT00903630|566586|P3|COMPLETED|Phase l||0
232688|NCT00903630|566587|P2|COMPLETED|Phase l||5
232689|NCT00903630|566588|P1|COMPLETED|Phase l||6
232690|NCT00903630|566586|P3|STARTED|Phase l||0
232691|NCT00903630|566587|P2|STARTED|Phase l||5
232692|NCT00903630|566588|P1|STARTED|Phase l||6
232693|NCT00903682|566604|P2|NOT COMPLETED|Overall Study||15
232694|NCT00903682|566605|P1|NOT COMPLETED|Overall Study||16
232695|NCT00903682|566604|P2|COMPLETED|Overall Study||63
232696|NCT00903682|566605|P1|COMPLETED|Overall Study||63
232697|NCT00903682|566604|P2|STARTED|Overall Study||78
232698|NCT00903682|566605|P1|STARTED|Overall Study||79
232699|NCT00903695|566625|P2|NOT COMPLETED|Overall Study||0
232700|NCT00903695|566626|P1|NOT COMPLETED|Overall Study||2
232701|NCT00903695|566625|P2|COMPLETED|Overall Study||2
232702|NCT00903695|566626|P1|COMPLETED|Overall Study||6
232703|NCT00903695|566625|P2|STARTED|Overall Study||2
232704|NCT00903695|566626|P1|STARTED|Overall Study||8
232705|NCT00903877|566646|P1|NOT COMPLETED|Overall Study||43
232706|NCT00903877|566646|P1|COMPLETED|Overall Study||8
232707|NCT00903877|566646|P1|STARTED|Overall Study||51
232708|NCT00903929|566650|P4|NOT COMPLETED|Overall Study||3
232709|NCT00903929|566651|P3|NOT COMPLETED|Overall Study||1
232710|NCT00903929|566652|P2|NOT COMPLETED|Overall Study||0
232711|NCT00903929|566653|P1|NOT COMPLETED|Overall Study||0
232712|NCT00903929|566650|P4|COMPLETED|Overall Study||6
232713|NCT00903929|566651|P3|COMPLETED|Overall Study||3
232714|NCT00903929|566652|P2|COMPLETED|Overall Study||3
232715|NCT00903929|566653|P1|COMPLETED|Overall Study||3
232716|NCT00903929|566650|P4|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|9
232806|NCT00904826|566787|P1|STARTED|Overall Study||14
232717|NCT00903929|566651|P3|STARTED|Overall Study|Participants who did not complete the study were replaced with additional participants.|4
232718|NCT00903929|566652|P2|STARTED|Overall Study||3
232719|NCT00903929|566653|P1|STARTED|Overall Study||3
232720|NCT00904007|566661|P2|NOT COMPLETED|Overall Study||0
232721|NCT00904007|566662|P1|NOT COMPLETED|Overall Study||0
232722|NCT00904007|566661|P2|COMPLETED|Overall Study||56
232723|NCT00904007|566662|P1|COMPLETED|Overall Study||55
232724|NCT00904007|566661|P2|STARTED|Overall Study||56
232725|NCT00904007|566662|P1|STARTED|Overall Study||55
232726|NCT00904150|566670|P2|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
232727|NCT00904150|566671|P1|NOT COMPLETED|Blood Samples (RNA): Luteal Phase||0
232728|NCT00904150|566670|P2|COMPLETED|Blood Samples (RNA): Luteal Phase||30
232729|NCT00904150|566671|P1|COMPLETED|Blood Samples (RNA): Luteal Phase||34
232730|NCT00904150|566670|P2|STARTED|Blood Samples (RNA): Luteal Phase||30
232731|NCT00904150|566671|P1|STARTED|Blood Samples (RNA): Luteal Phase||34
232732|NCT00904150|566670|P2|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
232733|NCT00904150|566671|P1|NOT COMPLETED|Blood Samples (RNA): Follicular Phase||0
232734|NCT00904150|566670|P2|COMPLETED|Blood Samples (RNA): Follicular Phase||32
232735|NCT00904150|566671|P1|COMPLETED|Blood Samples (RNA): Follicular Phase||37
232736|NCT00904150|566670|P2|STARTED|Blood Samples (RNA): Follicular Phase||32
232737|NCT00904150|566671|P1|STARTED|Blood Samples (RNA): Follicular Phase||37
232738|NCT00904150|566670|P2|NOT COMPLETED|Saliva Samples (DNA)||145
232739|NCT00904150|566671|P1|NOT COMPLETED|Saliva Samples (DNA)||3
232740|NCT00904150|566670|P2|COMPLETED|Saliva Samples (DNA)||155
232741|NCT00904150|566671|P1|COMPLETED|Saliva Samples (DNA)||282
232742|NCT00904150|566670|P2|STARTED|Saliva Samples (DNA)||300
232743|NCT00904150|566671|P1|STARTED|Saliva Samples (DNA)||285
232744|NCT00904189|566689|P1|NOT COMPLETED|Overall Study||0
232745|NCT00904189|566689|P1|COMPLETED|Overall Study||2
232746|NCT00904189|566689|P1|STARTED|Overall Study||2
232747|NCT00904215|566694|P1|NOT COMPLETED|Overall Study||135
232748|NCT00904215|566694|P1|COMPLETED|Overall Study||960
232749|NCT00904215|566694|P1|STARTED|Overall Study||1095
232750|NCT00904371|566701|P1|NOT COMPLETED|Overall Study||9
232751|NCT00904371|566701|P1|COMPLETED|Overall Study||202
232752|NCT00904371|566701|P1|STARTED|Overall Study||211
232753|NCT00904423|566715|P1|NOT COMPLETED|Overall Study||0
232754|NCT00904423|566715|P1|COMPLETED|Overall Study||8
232755|NCT00904423|566715|P1|STARTED|Overall Study||8
232756|NCT00904618|566723|P1|NOT COMPLETED|Overall Study||0
232757|NCT00904618|566723|P1|COMPLETED|Overall Study||48
232758|NCT00904618|566723|P1|STARTED|Overall Study||48
232759|NCT00904670|566731|P2|NOT COMPLETED|Second Intervention Period||0
232760|NCT00904670|566732|P1|NOT COMPLETED|Second Intervention Period||0
232761|NCT00904670|566731|P2|COMPLETED|Second Intervention Period||22
232762|NCT00904670|566732|P1|COMPLETED|Second Intervention Period||17
232763|NCT00904670|566731|P2|STARTED|Second Intervention Period||22
232764|NCT00904670|566732|P1|STARTED|Second Intervention Period||17
232765|NCT00904670|566731|P2|NOT COMPLETED|First Intervention Period||0
232766|NCT00904670|566732|P1|NOT COMPLETED|First Intervention Period||0
232767|NCT00904670|566731|P2|COMPLETED|First Intervention Period||22
232768|NCT00904670|566732|P1|COMPLETED|First Intervention Period||17
232769|NCT00904670|566731|P2|STARTED|First Intervention Period||22
232770|NCT00904670|566732|P1|STARTED|First Intervention Period||17
232771|NCT00904670|566731|P2|NOT COMPLETED|Open Label Phase||0
232772|NCT00904670|566732|P1|NOT COMPLETED|Open Label Phase||6
232773|NCT00904670|566731|P2|COMPLETED|Open Label Phase||22
232774|NCT00904670|566732|P1|COMPLETED|Open Label Phase||17
232775|NCT00904670|566731|P2|STARTED|Open Label Phase||22
232776|NCT00904670|566732|P1|STARTED|Open Label Phase||23
232777|NCT00904722|566753|P1|NOT COMPLETED|Overall Study||1
232778|NCT00904722|566753|P1|COMPLETED|Overall Study||29
232779|NCT00904722|566753|P1|STARTED|Overall Study||30
232780|NCT00904748|566758|P6|NOT COMPLETED|Overall Study||0
232781|NCT00904748|566759|P5|NOT COMPLETED|Overall Study||1
232782|NCT00904748|566760|P4|NOT COMPLETED|Overall Study||2
232783|NCT00904748|566761|P3|NOT COMPLETED|Overall Study||1
232784|NCT00904748|566762|P2|NOT COMPLETED|Overall Study||1
232785|NCT00904748|566763|P1|NOT COMPLETED|Overall Study||1
232786|NCT00904748|566758|P6|COMPLETED|Overall Study||8
232787|NCT00904748|566759|P5|COMPLETED|Overall Study||7
232788|NCT00904748|566760|P4|COMPLETED|Overall Study||6
232789|NCT00904748|566761|P3|COMPLETED|Overall Study||7
232790|NCT00904748|566762|P2|COMPLETED|Overall Study||7
232791|NCT00904748|566763|P1|COMPLETED|Overall Study||7
232792|NCT00904748|566758|P6|Received Treatment|Overall Study||8
232793|NCT00904748|566759|P5|Received Treatment|Overall Study||7
232794|NCT00904748|566760|P4|Received Treatment|Overall Study||8
232795|NCT00904748|566761|P3|Received Treatment|Overall Study||8
232796|NCT00904748|566762|P2|Received Treatment|Overall Study||8
232797|NCT00904748|566763|P1|Received Treatment|Overall Study||8
232798|NCT00904748|566758|P6|STARTED|Overall Study||8
232799|NCT00904748|566759|P5|STARTED|Overall Study|1 participant randomized to this sequence discontinued prior to receipt of study medication.|8
232800|NCT00904748|566760|P4|STARTED|Overall Study||8
232801|NCT00904748|566761|P3|STARTED|Overall Study||8
232802|NCT00904748|566762|P2|STARTED|Overall Study||8
232803|NCT00904748|566763|P1|STARTED|Overall Study||8
232804|NCT00904826|566787|P1|NOT COMPLETED|Overall Study||0
232805|NCT00904826|566787|P1|COMPLETED|Overall Study||14
232807|NCT00904839|566801|P3|NOT COMPLETED|Overall Study||15
232808|NCT00904839|566802|P2|NOT COMPLETED|Overall Study||18
232809|NCT00904839|566803|P1|NOT COMPLETED|Overall Study||1
232810|NCT00904839|566801|P3|COMPLETED|Overall Study||27
232811|NCT00904839|566802|P2|COMPLETED|Overall Study||64
232812|NCT00904839|566803|P1|COMPLETED|Overall Study||3
232813|NCT00904839|566801|P3|STARTED|Overall Study|Randomised|42
232814|NCT00904839|566802|P2|STARTED|Overall Study|11 patients were randomised to Maximum Tolerable Dose analysis set.|82
232815|NCT00904839|566803|P1|STARTED|Overall Study|All 4 patients were randomised to Maximum Tolerable Dose analysis set.|4
232816|NCT00904917|566841|P4|NOT COMPLETED|Overall Study||2
232817|NCT00904917|566842|P3|NOT COMPLETED|Overall Study||2
232818|NCT00904917|566843|P2|NOT COMPLETED|Overall Study||2
232819|NCT00904917|566844|P1|NOT COMPLETED|Overall Study||2
232820|NCT00904917|566841|P4|COMPLETED|Overall Study||6
232821|NCT00904917|566842|P3|COMPLETED|Overall Study||6
232822|NCT00904917|566843|P2|COMPLETED|Overall Study||9
232823|NCT00904917|566844|P1|COMPLETED|Overall Study||5
232824|NCT00904917|566841|P4|STARTED|Overall Study||8
232825|NCT00904917|566842|P3|STARTED|Overall Study||8
232826|NCT00904917|566843|P2|STARTED|Overall Study||11
232827|NCT00904917|566844|P1|STARTED|Overall Study||7
232828|NCT00904943|566862|P2|NOT COMPLETED|Period 2||0
232829|NCT00904943|566863|P1|NOT COMPLETED|Period 2||0
232830|NCT00904943|566862|P2|COMPLETED|Period 2||8
232831|NCT00904943|566863|P1|COMPLETED|Period 2||9
232832|NCT00904943|566862|P2|STARTED|Period 2|one subject was withdrawn prior to Pd. 2 dosing|8
232833|NCT00904943|566863|P1|STARTED|Period 2||9
232834|NCT00904943|566862|P2|NOT COMPLETED|Period 1||0
232835|NCT00904943|566863|P1|NOT COMPLETED|Period 1||0
232836|NCT00904943|566862|P2|COMPLETED|Period 1||9
232837|NCT00904943|566863|P1|COMPLETED|Period 1||9
232838|NCT00904943|566862|P2|STARTED|Period 1||9
232839|NCT00904943|566863|P1|STARTED|Period 1||9
232840|NCT00904982|566875|P4|NOT COMPLETED|Overall Study||0
232841|NCT00904982|566876|P3|NOT COMPLETED|Overall Study||0
232842|NCT00904982|566877|P2|NOT COMPLETED|Overall Study||0
232843|NCT00904982|566878|P1|NOT COMPLETED|Overall Study||2
232844|NCT00904982|566875|P4|COMPLETED|Overall Study||68
232845|NCT00904982|566876|P3|COMPLETED|Overall Study||67
232846|NCT00904982|566877|P2|COMPLETED|Overall Study||67
232847|NCT00904982|566878|P1|COMPLETED|Overall Study||66
232848|NCT00904982|566875|P4|STARTED|Overall Study||68
232849|NCT00904982|566876|P3|STARTED|Overall Study||67
232850|NCT00904982|566877|P2|STARTED|Overall Study||67
232851|NCT00904982|566878|P1|STARTED|Overall Study||68
232852|NCT00904995|566890|P2|NOT COMPLETED|Overall Study||0
232853|NCT00904995|566891|P1|NOT COMPLETED|Overall Study||0
232854|NCT00904995|566890|P2|COMPLETED|Overall Study||11
232855|NCT00904995|566891|P1|COMPLETED|Overall Study||10
232856|NCT00904995|566890|P2|STARTED|Overall Study||11
232857|NCT00904995|566891|P1|STARTED|Overall Study||10
232858|NCT00905021|566897|P1|NOT COMPLETED|Overall Study||2
232859|NCT00905021|566897|P1|COMPLETED|Overall Study|2 patients were off study due to AE.|2
232860|NCT00905021|566897|P1|STARTED|Overall Study||4
232861|NCT00905034|566902|P1|NOT COMPLETED|Overall Study||1
232862|NCT00905034|566902|P1|COMPLETED|Overall Study||36
232863|NCT00905034|566902|P1|STARTED|Overall Study||37
232864|NCT00905125|566908|P2|NOT COMPLETED|Overall Study||3
232865|NCT00905125|566909|P1|NOT COMPLETED|Overall Study||4
232866|NCT00905125|566908|P2|COMPLETED|Overall Study||53
232867|NCT00905125|566909|P1|COMPLETED|Overall Study||42
232868|NCT00905125|566908|P2|STARTED|Overall Study||56
232869|NCT00905125|566909|P1|STARTED|Overall Study||46
232870|NCT00905151|566941|P1|NOT COMPLETED|Overall Study||6
232871|NCT00905151|566941|P1|COMPLETED|Overall Study||200
232872|NCT00905151|566941|P1|STARTED|Overall Study||206
232873|NCT00898443|566947|P2|NOT COMPLETED|Overall Study||0
232874|NCT00898443|566948|P1|NOT COMPLETED|Overall Study||1
232875|NCT00898443|566947|P2|COMPLETED|Overall Study||8
232876|NCT00898443|566948|P1|COMPLETED|Overall Study||9
232877|NCT00898443|566947|P2|STARTED|Overall Study||8
232878|NCT00898443|566948|P1|STARTED|Overall Study||10
232879|NCT00898560|566956|P1|NOT COMPLETED|Overall Study||1
232880|NCT00898560|566956|P1|COMPLETED|Overall Study||19
232881|NCT00898560|566956|P1|STARTED|Overall Study||20
232882|NCT00898677|566970|P4|NOT COMPLETED|Overall Study||19
232883|NCT00898677|566971|P3|NOT COMPLETED|Overall Study||72
232884|NCT00898677|566972|P2|NOT COMPLETED|Overall Study||69
232885|NCT00898677|566973|P1|NOT COMPLETED|Overall Study||17
232886|NCT00898677|566970|P4|COMPLETED|Overall Study||159
232887|NCT00898677|566971|P3|COMPLETED|Overall Study||383
232888|NCT00898677|566972|P2|COMPLETED|Overall Study||386
232889|NCT00898677|566973|P1|COMPLETED|Overall Study||163
232890|NCT00898677|566970|P4|Patients Treated|Overall Study|Patients Not Treated: 18|160
232891|NCT00898677|566971|P3|Patients Treated|Overall Study|Patients Not Treated: 67|388
232892|NCT00898677|566972|P2|Patients Treated|Overall Study|Patients Not Treated: 68|387
232893|NCT00898677|566973|P1|Patients Treated|Overall Study|Patients Not Treated: 16|164
232894|NCT00898677|566970|P4|STARTED|Overall Study||178
232895|NCT00898677|566971|P3|STARTED|Overall Study||455
232896|NCT00898677|566972|P2|STARTED|Overall Study||455
232897|NCT00898677|566973|P1|STARTED|Overall Study||180
232898|NCT00898807|567001|P2|NOT COMPLETED|Overall Study||9
232899|NCT00898807|567002|P1|NOT COMPLETED|Overall Study||8
232900|NCT00898807|567001|P2|COMPLETED|Overall Study||83
232901|NCT00898807|567002|P1|COMPLETED|Overall Study||86
232902|NCT00898807|567001|P2|STARTED|Overall Study||92
232903|NCT00898807|567002|P1|STARTED|Overall Study||94
232904|NCT00905164|567016|P2|NOT COMPLETED|Period 2||0
232905|NCT00905164|567017|P1|NOT COMPLETED|Period 2||0
232906|NCT00905164|567016|P2|COMPLETED|Period 2||11
232907|NCT00905164|567017|P1|COMPLETED|Period 2||12
232908|NCT00905164|567016|P2|STARTED|Period 2||11
232909|NCT00905164|567017|P1|STARTED|Period 2||12
232910|NCT00905164|567016|P2|NOT COMPLETED|Period 1||1
232911|NCT00905164|567017|P1|NOT COMPLETED|Period 1||0
232912|NCT00905164|567016|P2|COMPLETED|Period 1||11
232913|NCT00905164|567017|P1|COMPLETED|Period 1||12
232914|NCT00905164|567016|P2|STARTED|Period 1||12
232915|NCT00905164|567017|P1|STARTED|Period 1||12
232916|NCT00905255|567027|P2|NOT COMPLETED|Overall Study||9
232917|NCT00905255|567028|P1|NOT COMPLETED|Overall Study||13
232918|NCT00905255|567027|P2|COMPLETED|Overall Study||27
232919|NCT00905255|567028|P1|COMPLETED|Overall Study||20
232920|NCT00905255|567027|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||36
232921|NCT00905255|567028|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|33
232922|NCT00905255|567027|P2|Safety Population|Overall Study||36
232923|NCT00905255|567028|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|33
232924|NCT00905255|567027|P2|STARTED|Overall Study||36
232925|NCT00905255|567028|P1|STARTED|Overall Study|Randomized.|33
232926|NCT00905268|567048|P4|NOT COMPLETED|Overall Study||2
232927|NCT00905268|567049|P3|NOT COMPLETED|Overall Study||0
232928|NCT00905268|567050|P2|NOT COMPLETED|Overall Study||1
232929|NCT00905268|567051|P1|NOT COMPLETED|Overall Study||4
232930|NCT00905268|567048|P4|COMPLETED|Overall Study||57
232931|NCT00905268|567049|P3|COMPLETED|Overall Study||59
232932|NCT00905268|567050|P2|COMPLETED|Overall Study||56
232933|NCT00905268|567051|P1|COMPLETED|Overall Study||53
232934|NCT00905268|567048|P4|STARTED|Overall Study||59
232935|NCT00905268|567049|P3|STARTED|Overall Study||59
232936|NCT00905268|567050|P2|STARTED|Overall Study||57
232937|NCT00905268|567051|P1|STARTED|Overall Study||57
232938|NCT00905307|567087|P6|NOT COMPLETED|Overall Study||42
232939|NCT00905307|567088|P5|NOT COMPLETED|Overall Study||16
232940|NCT00905307|567089|P4|NOT COMPLETED|Overall Study||37
232941|NCT00905307|567090|P3|NOT COMPLETED|Overall Study||37
232942|NCT00905307|567091|P2|NOT COMPLETED|Overall Study||37
232943|NCT00905307|567092|P1|NOT COMPLETED|Overall Study||22
232944|NCT00905307|567087|P6|COMPLETED|Overall Study||53
232945|NCT00905307|567088|P5|COMPLETED|Overall Study||34
232946|NCT00905307|567089|P4|COMPLETED|Overall Study||56
232947|NCT00905307|567090|P3|COMPLETED|Overall Study||53
232948|NCT00905307|567091|P2|COMPLETED|Overall Study||52
232949|NCT00905307|567092|P1|COMPLETED|Overall Study||20
232950|NCT00905307|567087|P6|STARTED|Overall Study||95
232951|NCT00905307|567088|P5|STARTED|Overall Study||50
232952|NCT00905307|567089|P4|STARTED|Overall Study||93
232953|NCT00905307|567090|P3|STARTED|Overall Study||90
232954|NCT00905307|567091|P2|STARTED|Overall Study||89
232955|NCT00905307|567092|P1|STARTED|Overall Study||42
232956|NCT00905346|567150|P2|NOT COMPLETED|Period 2||0
232957|NCT00905346|567151|P1|NOT COMPLETED|Period 2||0
232958|NCT00905346|567150|P2|COMPLETED|Period 2||11
232959|NCT00905346|567151|P1|COMPLETED|Period 2||10
232960|NCT00905346|567150|P2|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|11
232961|NCT00905346|567151|P1|STARTED|Period 2|one subject withdrew prior to Pd. 2 dosing|10
232962|NCT00905346|567150|P2|NOT COMPLETED|Period 1||0
232963|NCT00905346|567151|P1|NOT COMPLETED|Period 1||1
232964|NCT00905346|567150|P2|COMPLETED|Period 1||12
232965|NCT00905346|567151|P1|COMPLETED|Period 1||11
232966|NCT00905346|567150|P2|STARTED|Period 1||12
232967|NCT00905346|567151|P1|STARTED|Period 1||12
232968|NCT00905359|567161|P2|NOT COMPLETED|Overall Study||16
232969|NCT00905359|567162|P1|NOT COMPLETED|Overall Study||24
232970|NCT00905359|567161|P2|COMPLETED|Overall Study||65
232971|NCT00905359|567162|P1|COMPLETED|Overall Study||58
232972|NCT00905359|567161|P2|24 Months Follow up|Overall Study||65
232973|NCT00905359|567162|P1|24 Months Follow up|Overall Study||58
232974|NCT00905359|567161|P2|12 Months Follow up|Overall Study||72
232975|NCT00905359|567162|P1|12 Months Follow up|Overall Study||68
232976|NCT00905359|567161|P2|STARTED|Overall Study||81
232977|NCT00905359|567162|P1|STARTED|Overall Study||82
232978|NCT00905424|567198|P2|NOT COMPLETED|Overall Study||9
232979|NCT00905424|567199|P1|NOT COMPLETED|Overall Study||11
232980|NCT00905424|567198|P2|COMPLETED|Overall Study||79
232981|NCT00905424|567199|P1|COMPLETED|Overall Study||78
232982|NCT00905424|567198|P2|STARTED|Overall Study||88
232983|NCT00905424|567199|P1|STARTED|Overall Study||89
232984|NCT00905437|567241|P2|NOT COMPLETED|Overall Study||10
232985|NCT00905437|567242|P1|NOT COMPLETED|Overall Study||8
232986|NCT00905437|567241|P2|COMPLETED|Overall Study||27
232987|NCT00905437|567242|P1|COMPLETED|Overall Study||27
232988|NCT00905437|567241|P2|STARTED|Overall Study||37
232989|NCT00905437|567242|P1|STARTED|Overall Study||35
232990|NCT00905489|567260|P1|NOT COMPLETED|Optional Extension Phase (OEP)||1
232991|NCT00905489|567260|P1|COMPLETED|Optional Extension Phase (OEP)||39
233085|NCT00908037|567472|P7|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
232992|NCT00905489|567260|P1|STARTED|Optional Extension Phase (OEP)|Includes only subjects who chose to continue trt with nevirapine XR after completing the PK phase.|40
232993|NCT00905489|567260|P1|NOT COMPLETED|Pharmaco-kinetic (PK) Phase||5
232994|NCT00905489|567260|P1|COMPLETED|Pharmaco-kinetic (PK) Phase||80
232995|NCT00905489|567260|P1|STARTED|Pharmaco-kinetic (PK) Phase||85
232996|NCT00907517|567312|P5|NOT COMPLETED|Overall Study||5
232997|NCT00907517|567313|P4|NOT COMPLETED|Overall Study||4
232998|NCT00907517|567314|P3|NOT COMPLETED|Overall Study||4
232999|NCT00907517|567315|P2|NOT COMPLETED|Overall Study||3
233000|NCT00907517|567316|P1|NOT COMPLETED|Overall Study||3
233001|NCT00907517|567312|P5|COMPLETED|Overall Study||1
233002|NCT00907517|567313|P4|COMPLETED|Overall Study||2
233003|NCT00907517|567314|P3|COMPLETED|Overall Study||2
233004|NCT00907517|567315|P2|COMPLETED|Overall Study||0
233005|NCT00907517|567316|P1|COMPLETED|Overall Study||0
233006|NCT00907517|567312|P5|STARTED|Overall Study||6
233007|NCT00907517|567313|P4|STARTED|Overall Study||6
233008|NCT00907517|567314|P3|STARTED|Overall Study||6
233009|NCT00907517|567315|P2|STARTED|Overall Study||3
233010|NCT00907517|567316|P1|STARTED|Overall Study||3
233011|NCT00907621|567340|P2|NOT COMPLETED|Overall Study||4
233012|NCT00907621|567341|P1|NOT COMPLETED|Overall Study||7
233013|NCT00907621|567340|P2|COMPLETED|Overall Study||41
233014|NCT00907621|567341|P1|COMPLETED|Overall Study||38
233015|NCT00907621|567340|P2|STARTED|Overall Study||45
233016|NCT00907621|567341|P1|STARTED|Overall Study||45
233017|NCT00907738|567354|P5|NOT COMPLETED|Overall Study||2
233018|NCT00907738|567355|P4|NOT COMPLETED|Overall Study||4
233019|NCT00907738|567356|P3|NOT COMPLETED|Overall Study||7
233020|NCT00907738|567357|P2|NOT COMPLETED|Overall Study||1
233021|NCT00907738|567358|P1|NOT COMPLETED|Overall Study||13
233022|NCT00907738|567354|P5|COMPLETED|Overall Study||0
233023|NCT00907738|567355|P4|COMPLETED|Overall Study||0
233024|NCT00907738|567356|P3|COMPLETED|Overall Study||0
233025|NCT00907738|567357|P2|COMPLETED|Overall Study||0
233026|NCT00907738|567358|P1|COMPLETED|Overall Study||0
233027|NCT00907738|567354|P5|STARTED|Overall Study||2
233028|NCT00907738|567355|P4|STARTED|Overall Study||4
233029|NCT00907738|567356|P3|STARTED|Overall Study||7
233030|NCT00907738|567357|P2|STARTED|Overall Study||1
233031|NCT00907738|567358|P1|STARTED|Overall Study||13
233032|NCT00907777|567376|P2|NOT COMPLETED|Overall Study||1
233033|NCT00907777|567377|P1|NOT COMPLETED|Overall Study||0
233034|NCT00907777|567376|P2|COMPLETED|Overall Study||26
233035|NCT00907777|567377|P1|COMPLETED|Overall Study||25
233036|NCT00907777|567376|P2|STARTED|Overall Study||27
233037|NCT00907777|567377|P1|STARTED|Overall Study||25
233038|NCT00907803|567402|P3|NOT COMPLETED|Overall Study||0
233039|NCT00907803|567403|P2|NOT COMPLETED|Overall Study||3
233040|NCT00907803|567404|P1|NOT COMPLETED|Overall Study||3
233041|NCT00907803|567402|P3|COMPLETED|Overall Study||16
233042|NCT00907803|567403|P2|COMPLETED|Overall Study||43
233043|NCT00907803|567404|P1|COMPLETED|Overall Study||42
233044|NCT00907803|567402|P3|STARTED|Overall Study||16
233045|NCT00907803|567403|P2|STARTED|Overall Study||46
233046|NCT00907803|567404|P1|STARTED|Overall Study||45
233047|NCT00907881|567433|P1|NOT COMPLETED|Overall Study||85
233048|NCT00907881|567433|P1|COMPLETED|Overall Study||984
233049|NCT00907881|567433|P1|STARTED|Overall Study||1069
233050|NCT00907907|567442|P2|NOT COMPLETED|Period 4||0
233051|NCT00907907|567443|P1|NOT COMPLETED|Period 4||0
233052|NCT00907907|567442|P2|COMPLETED|Period 4||18
233053|NCT00907907|567443|P1|COMPLETED|Period 4||19
233054|NCT00907907|567442|P2|STARTED|Period 4|two subjects were withdrawn prior to Period 4 dosing|18
233055|NCT00907907|567443|P1|STARTED|Period 4|one subject withdrew prior to Period 4 dosing|19
233056|NCT00907907|567442|P2|NOT COMPLETED|Period 3||0
233057|NCT00907907|567443|P1|NOT COMPLETED|Period 3||0
233058|NCT00907907|567442|P2|COMPLETED|Period 3||20
233059|NCT00907907|567443|P1|COMPLETED|Period 3||20
233060|NCT00907907|567442|P2|STARTED|Period 3||20
233061|NCT00907907|567443|P1|STARTED|Period 3||20
233062|NCT00907907|567442|P2|NOT COMPLETED|Period 2||0
233063|NCT00907907|567443|P1|NOT COMPLETED|Period 2||0
233064|NCT00907907|567442|P2|COMPLETED|Period 2||20
233065|NCT00907907|567443|P1|COMPLETED|Period 2||20
233066|NCT00907907|567442|P2|STARTED|Period 2||20
233067|NCT00907907|567443|P1|STARTED|Period 2||20
233068|NCT00907907|567442|P2|NOT COMPLETED|Period 1||0
233069|NCT00907907|567443|P1|NOT COMPLETED|Period 1||0
233070|NCT00907907|567442|P2|COMPLETED|Period 1||20
233071|NCT00907907|567443|P1|COMPLETED|Period 1||20
233072|NCT00907907|567442|P2|STARTED|Period 1||20
233073|NCT00907907|567443|P1|STARTED|Period 1||20
233074|NCT00908011|567453|P2|NOT COMPLETED|Overall Study||2
233075|NCT00908011|567454|P1|NOT COMPLETED|Overall Study||2
233076|NCT00908011|567453|P2|COMPLETED|Overall Study||18
233077|NCT00908011|567454|P1|COMPLETED|Overall Study||21
233078|NCT00908011|567453|P2|STARTED|Overall Study||20
233079|NCT00908011|567454|P1|STARTED|Overall Study||23
233080|NCT00908037|567467|P12|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
233081|NCT00908037|567468|P11|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||4
233082|NCT00908037|567469|P10|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||3
233083|NCT00908037|567470|P9|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233084|NCT00908037|567471|P8|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233086|NCT00908037|567473|P6|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233087|NCT00908037|567474|P5|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233088|NCT00908037|567475|P4|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233089|NCT00908037|567476|P3|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233090|NCT00908037|567477|P2|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233091|NCT00908037|567478|P1|NOT COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233092|NCT00908037|567467|P12|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||12
233093|NCT00908037|567468|P11|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|24
233094|NCT00908037|567469|P10|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||21
233095|NCT00908037|567470|P9|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233096|NCT00908037|567471|P8|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233097|NCT00908037|567472|P7|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233098|NCT00908037|567473|P6|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233099|NCT00908037|567474|P5|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233100|NCT00908037|567475|P4|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233101|NCT00908037|567476|P3|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233102|NCT00908037|567477|P2|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233103|NCT00908037|567478|P1|COMPLETED|Part 2/3(Eltrombopag Open-Label Period)||0
233104|NCT00908037|567467|P12|STARTED|Part 2/3(Eltrombopag Open-Label Period)||15
233105|NCT00908037|567468|P11|STARTED|Part 2/3(Eltrombopag Open-Label Period)|Two participants were randomized but did not receive treatment.|28
233106|NCT00908037|567469|P10|STARTED|Part 2/3(Eltrombopag Open-Label Period)||24
233107|NCT00908037|567470|P9|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233108|NCT00908037|567471|P8|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233109|NCT00908037|567472|P7|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233110|NCT00908037|567473|P6|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233111|NCT00908037|567474|P5|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233112|NCT00908037|567475|P4|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233113|NCT00908037|567476|P3|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233114|NCT00908037|567477|P2|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233115|NCT00908037|567478|P1|STARTED|Part 2/3(Eltrombopag Open-Label Period)||0
233116|NCT00908037|567467|P12|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233117|NCT00908037|567468|P11|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233118|NCT00908037|567469|P10|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233119|NCT00908037|567470|P9|NOT COMPLETED|Part 2 (7 Week Randomized Period)||5
233120|NCT00908037|567471|P8|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233121|NCT00908037|567472|P7|NOT COMPLETED|Part 2 (7 Week Randomized Period)||4
233122|NCT00908037|567473|P6|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233123|NCT00908037|567474|P5|NOT COMPLETED|Part 2 (7 Week Randomized Period)||3
233124|NCT00908037|567475|P4|NOT COMPLETED|Part 2 (7 Week Randomized Period)||1
233125|NCT00908037|567476|P3|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233126|NCT00908037|567477|P2|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233127|NCT00908037|567478|P1|NOT COMPLETED|Part 2 (7 Week Randomized Period)||0
233128|NCT00908037|567467|P12|COMPLETED|Part 2 (7 Week Randomized Period)||0
233129|NCT00908037|567468|P11|COMPLETED|Part 2 (7 Week Randomized Period)||0
233130|NCT00908037|567469|P10|COMPLETED|Part 2 (7 Week Randomized Period)||0
233131|NCT00908037|567470|P9|COMPLETED|Part 2 (7 Week Randomized Period)||5
233132|NCT00908037|567471|P8|COMPLETED|Part 2 (7 Week Randomized Period)||5
233133|NCT00908037|567472|P7|COMPLETED|Part 2 (7 Week Randomized Period)||15
233134|NCT00908037|567473|P6|COMPLETED|Part 2 (7 Week Randomized Period)||9
233135|NCT00908037|567474|P5|COMPLETED|Part 2 (7 Week Randomized Period)||13
233136|NCT00908037|567475|P4|COMPLETED|Part 2 (7 Week Randomized Period)||7
233137|NCT00908037|567476|P3|COMPLETED|Part 2 (7 Week Randomized Period)||0
233138|NCT00908037|567477|P2|COMPLETED|Part 2 (7 Week Randomized Period)||0
233139|NCT00908037|567478|P1|COMPLETED|Part 2 (7 Week Randomized Period)||0
233140|NCT00908037|567467|P12|STARTED|Part 2 (7 Week Randomized Period)||0
233141|NCT00908037|567468|P11|STARTED|Part 2 (7 Week Randomized Period)||0
233142|NCT00908037|567469|P10|STARTED|Part 2 (7 Week Randomized Period)||0
233143|NCT00908037|567470|P9|STARTED|Part 2 (7 Week Randomized Period)||10
233144|NCT00908037|567471|P8|STARTED|Part 2 (7 Week Randomized Period)||5
233145|NCT00908037|567472|P7|STARTED|Part 2 (7 Week Randomized Period)||19
233146|NCT00908037|567473|P6|STARTED|Part 2 (7 Week Randomized Period)||9
233147|NCT00908037|567474|P5|STARTED|Part 2 (7 Week Randomized Period)||16
233148|NCT00908037|567475|P4|STARTED|Part 2 (7 Week Randomized Period)||8
233149|NCT00908037|567476|P3|STARTED|Part 2 (7 Week Randomized Period)||0
233150|NCT00908037|567477|P2|STARTED|Part 2 (7 Week Randomized Period)||0
233151|NCT00908037|567478|P1|STARTED|Part 2 (7 Week Randomized Period)||0
233152|NCT00908037|567467|P12|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233153|NCT00908037|567468|P11|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233154|NCT00908037|567469|P10|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233155|NCT00908037|567470|P9|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233156|NCT00908037|567471|P8|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233157|NCT00908037|567472|P7|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233158|NCT00908037|567473|P6|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233159|NCT00908037|567474|P5|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233160|NCT00908037|567475|P4|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233161|NCT00908037|567476|P3|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233162|NCT00908037|567477|P2|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233163|NCT00908037|567478|P1|NOT COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233164|NCT00908037|567467|P12|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233165|NCT00908037|567468|P11|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233166|NCT00908037|567469|P10|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233167|NCT00908037|567470|P9|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233168|NCT00908037|567471|P8|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233169|NCT00908037|567472|P7|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233170|NCT00908037|567473|P6|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233171|NCT00908037|567474|P5|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233172|NCT00908037|567475|P4|COMPLETED|Part1 (24 Week Dose-Finding Period)||0
233173|NCT00908037|567476|P3|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
233174|NCT00908037|567477|P2|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
233175|NCT00908037|567478|P1|COMPLETED|Part1 (24 Week Dose-Finding Period)|Participants who completed Part 1 did not enroll in Parts 2 or 2/3|5
233176|NCT00908037|567467|P12|STARTED|Part1 (24 Week Dose-Finding Period)||0
233177|NCT00908037|567468|P11|STARTED|Part1 (24 Week Dose-Finding Period)||0
233178|NCT00908037|567469|P10|STARTED|Part1 (24 Week Dose-Finding Period)||0
233179|NCT00908037|567470|P9|STARTED|Part1 (24 Week Dose-Finding Period)||0
233180|NCT00908037|567471|P8|STARTED|Part1 (24 Week Dose-Finding Period)||0
233181|NCT00908037|567472|P7|STARTED|Part1 (24 Week Dose-Finding Period)||0
233182|NCT00908037|567473|P6|STARTED|Part1 (24 Week Dose-Finding Period)||0
233183|NCT00908037|567474|P5|STARTED|Part1 (24 Week Dose-Finding Period)||0
233184|NCT00908037|567475|P4|STARTED|Part1 (24 Week Dose-Finding Period)||0
233185|NCT00908037|567476|P3|STARTED|Part1 (24 Week Dose-Finding Period)||5
233186|NCT00908037|567477|P2|STARTED|Part1 (24 Week Dose-Finding Period)||5
233187|NCT00908037|567478|P1|STARTED|Part1 (24 Week Dose-Finding Period)||5
233188|NCT00908076|567627|P2|NOT COMPLETED|Overall Study||1
233189|NCT00908076|567628|P1|NOT COMPLETED|Overall Study||1
233190|NCT00908076|567627|P2|COMPLETED|Overall Study||26
233191|NCT00908076|567628|P1|COMPLETED|Overall Study||26
233192|NCT00908076|567627|P2|STARTED|Overall Study||27
233193|NCT00908076|567628|P1|STARTED|Overall Study||27
233194|NCT00908115|567634|P1|NOT COMPLETED|Overall Study||14
233195|NCT00908115|567634|P1|COMPLETED|Overall Study||1244
233196|NCT00908115|567634|P1|STARTED|Overall Study||1258
233197|NCT00908128|567642|P2|NOT COMPLETED|Period 4||0
233198|NCT00908128|567643|P1|NOT COMPLETED|Period 4||0
233199|NCT00908128|567642|P2|COMPLETED|Period 4||19
233200|NCT00908128|567643|P1|COMPLETED|Period 4||20
233201|NCT00908128|567642|P2|STARTED|Period 4|One subject withdrew prior to Period 4 dosing due to adverse events|19
233202|NCT00908128|567643|P1|STARTED|Period 4||20
233203|NCT00908128|567642|P2|NOT COMPLETED|Period 3||0
233204|NCT00908128|567643|P1|NOT COMPLETED|Period 3||0
233205|NCT00908128|567642|P2|COMPLETED|Period 3||20
233206|NCT00908128|567643|P1|COMPLETED|Period 3||20
233207|NCT00908128|567642|P2|STARTED|Period 3||20
233208|NCT00908128|567643|P1|STARTED|Period 3||20
233209|NCT00908128|567642|P2|NOT COMPLETED|Period 2||0
233210|NCT00908128|567643|P1|NOT COMPLETED|Period 2||0
233211|NCT00908128|567642|P2|COMPLETED|Period 2||20
233212|NCT00908128|567643|P1|COMPLETED|Period 2||20
233213|NCT00908128|567642|P2|STARTED|Period 2||20
233214|NCT00908128|567643|P1|STARTED|Period 2||20
233215|NCT00908128|567642|P2|NOT COMPLETED|Period 1||0
233216|NCT00908128|567643|P1|NOT COMPLETED|Period 1||0
233217|NCT00908128|567642|P2|COMPLETED|Period 1||20
233218|NCT00908128|567643|P1|COMPLETED|Period 1||20
233219|NCT00908128|567642|P2|STARTED|Period 1||20
233220|NCT00908128|567643|P1|STARTED|Period 1||20
233221|NCT00908141|567653|P2|NOT COMPLETED|Overall Study||1
233222|NCT00908141|567654|P1|NOT COMPLETED|Overall Study||0
233223|NCT00908141|567653|P2|COMPLETED|Overall Study||8
233224|NCT00908141|567654|P1|COMPLETED|Overall Study||8
233225|NCT00908141|567653|P2|STARTED|Overall Study||9
233226|NCT00908141|567654|P1|STARTED|Overall Study||8
233227|NCT00908232|567660|P4|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||0
233228|NCT00908232|567661|P3|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||1
233229|NCT00908232|567662|P2|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||3
233230|NCT00908232|567663|P1|NOT COMPLETED|Randomization (Cycle 5) to Cycle 8||35
233231|NCT00908232|567660|P4|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
233232|NCT00908232|567661|P3|COMPLETED|Randomization (Cycle 5) to Cycle 8||7
233233|NCT00908232|567662|P2|COMPLETED|Randomization (Cycle 5) to Cycle 8||4
233234|NCT00908232|567663|P1|COMPLETED|Randomization (Cycle 5) to Cycle 8||63
233235|NCT00908232|567660|P4|STARTED|Randomization (Cycle 5) to Cycle 8||4
233236|NCT00908232|567661|P3|STARTED|Randomization (Cycle 5) to Cycle 8||8
233237|NCT00908232|567662|P2|STARTED|Randomization (Cycle 5) to Cycle 8||7
233238|NCT00908232|567663|P1|STARTED|Randomization (Cycle 5) to Cycle 8|Responding patients (not randomized) who received 4 more cycles of VD|98
233239|NCT00908232|567660|P4|NOT COMPLETED|Cycle 1 to 4||0
233240|NCT00908232|567661|P3|NOT COMPLETED|Cycle 1 to 4||0
233241|NCT00908232|567662|P2|NOT COMPLETED|Cycle 1 to 4||0
233242|NCT00908232|567663|P1|NOT COMPLETED|Cycle 1 to 4||28
233243|NCT00908232|567660|P4|COMPLETED|Cycle 1 to 4||0
233244|NCT00908232|567661|P3|COMPLETED|Cycle 1 to 4||0
233245|NCT00908232|567662|P2|COMPLETED|Cycle 1 to 4||0
233246|NCT00908232|567663|P1|COMPLETED|Cycle 1 to 4|Of those completed, 120 subjects were assessed for response, 117 w/ Response or SD continued.|135
233247|NCT00908232|567660|P4|STARTED|Cycle 1 to 4||0
233248|NCT00908232|567661|P3|STARTED|Cycle 1 to 4||0
233249|NCT00908232|567662|P2|STARTED|Cycle 1 to 4||0
233250|NCT00908232|567663|P1|STARTED|Cycle 1 to 4|All participants started VD treatment for 4 cycles prior to local site response assessments|163
233251|NCT00908310|567679|P1|NOT COMPLETED|Overall Study||60
233252|NCT00908310|567679|P1|COMPLETED|Overall Study||153
233253|NCT00908310|567679|P1|STARTED|Overall Study||213
233254|NCT00908349|567683|P1|NOT COMPLETED|Overall Study||35
233255|NCT00908349|567683|P1|COMPLETED|Overall Study||179
233256|NCT00908349|567683|P1|STARTED|Overall Study||214
233257|NCT00908375|567689|P2|NOT COMPLETED|Overall Study||10
233258|NCT00908375|567690|P1|NOT COMPLETED|Overall Study||10
233259|NCT00908375|567689|P2|COMPLETED|Overall Study||9
233260|NCT00908375|567690|P1|COMPLETED|Overall Study||10
233261|NCT00908375|567689|P2|STARTED|Overall Study||19
233262|NCT00908375|567690|P1|STARTED|Overall Study||20
233263|NCT00908388|567700|P1|NOT COMPLETED|Overall Study||10
233264|NCT00908388|567700|P1|COMPLETED|Overall Study||40
233265|NCT00908388|567700|P1|STARTED|Overall Study||50
233266|NCT00908583|567708|P1|NOT COMPLETED|Phase 5||3
233267|NCT00908583|567708|P1|COMPLETED|Phase 5||2
233268|NCT00908583|567708|P1|STARTED|Phase 5||5
233269|NCT00908583|567708|P1|NOT COMPLETED|Phase 4||2
233270|NCT00908583|567708|P1|COMPLETED|Phase 4||3
233271|NCT00908583|567708|P1|STARTED|Phase 4||5
233272|NCT00908583|567708|P1|NOT COMPLETED|Phase 3||2
233273|NCT00908583|567708|P1|COMPLETED|Phase 3||8
233274|NCT00908583|567708|P1|STARTED|Phase 3||10
233275|NCT00908583|567708|P1|NOT COMPLETED|Phase 2||2
233276|NCT00908583|567708|P1|COMPLETED|Phase 2||10
233277|NCT00908583|567708|P1|STARTED|Phase 2||12
233278|NCT00908583|567708|P1|NOT COMPLETED|Phase 1||5
233279|NCT00908583|567708|P1|COMPLETED|Phase 1||15
233280|NCT00908583|567708|P1|STARTED|Phase 1||20
233281|NCT00908596|567730|P4|NOT COMPLETED|Overall Study||37
233282|NCT00908596|567731|P3|NOT COMPLETED|Overall Study||74
233283|NCT00908596|567732|P2|NOT COMPLETED|Overall Study||13
233284|NCT00908596|567733|P1|NOT COMPLETED|Overall Study||47
233285|NCT00908596|567730|P4|COMPLETED|Overall Study||48
233286|NCT00908596|567731|P3|COMPLETED|Overall Study||119
233287|NCT00908596|567732|P2|COMPLETED|Overall Study||19
233288|NCT00908596|567733|P1|COMPLETED|Overall Study||0
233289|NCT00908596|567730|P4|STARTED|Overall Study||85
233290|NCT00908596|567731|P3|STARTED|Overall Study||193
233291|NCT00908596|567732|P2|STARTED|Overall Study||32
233292|NCT00908596|567733|P1|STARTED|Overall Study||47
233293|NCT00908648|567765|P2|NOT COMPLETED|Overall Study||0
233294|NCT00908648|567766|P1|NOT COMPLETED|Overall Study||0
233295|NCT00908648|567765|P2|COMPLETED|Overall Study||103
233296|NCT00908648|567766|P1|COMPLETED|Overall Study||108
233297|NCT00908648|567765|P2|STARTED|Overall Study||103
233298|NCT00908648|567766|P1|STARTED|Overall Study||108
233299|NCT00908687|567778|P6|NOT COMPLETED|Overall Study||6
233300|NCT00908687|567779|P5|NOT COMPLETED|Overall Study||4
233301|NCT00908687|567780|P4|NOT COMPLETED|Overall Study||3
233302|NCT00908687|567781|P3|NOT COMPLETED|Overall Study||3
233303|NCT00908687|567782|P2|NOT COMPLETED|Overall Study||1
233304|NCT00908687|567783|P1|NOT COMPLETED|Overall Study||1
233305|NCT00908687|567778|P6|COMPLETED|Overall Study||94
233306|NCT00908687|567779|P5|COMPLETED|Overall Study||94
233307|NCT00908687|567780|P4|COMPLETED|Overall Study||47
233308|NCT00908687|567781|P3|COMPLETED|Overall Study||99
233309|NCT00908687|567782|P2|COMPLETED|Overall Study||99
233310|NCT00908687|567783|P1|COMPLETED|Overall Study||49
233311|NCT00908687|567778|P6|STARTED|Overall Study||100
233312|NCT00908687|567779|P5|STARTED|Overall Study||98
233313|NCT00908687|567780|P4|STARTED|Overall Study||50
233314|NCT00908687|567781|P3|STARTED|Overall Study||102
233315|NCT00908687|567782|P2|STARTED|Overall Study||100
233316|NCT00908687|567783|P1|STARTED|Overall Study||50
233317|NCT00908882|567799|P2|NOT COMPLETED|Overall Study||30
233318|NCT00908882|567800|P1|NOT COMPLETED|Overall Study||28
233319|NCT00908882|567799|P2|COMPLETED|Overall Study||59
233320|NCT00908882|567800|P1|COMPLETED|Overall Study||61
233321|NCT00908882|567799|P2|STARTED|Overall Study||89
233322|NCT00908882|567800|P1|STARTED|Overall Study||89
233323|NCT00908895|567826|P2|NOT COMPLETED|Overall Study||6
233324|NCT00908895|567827|P1|NOT COMPLETED|Overall Study||4
233325|NCT00908895|567826|P2|COMPLETED|Overall Study||57
233326|NCT00908895|567827|P1|COMPLETED|Overall Study||53
233327|NCT00908895|567826|P2|STARTED|Overall Study||63
233328|NCT00908895|567827|P1|STARTED|Overall Study||57
233329|NCT00908908|567835|P1|NOT COMPLETED|Overall Study||0
233330|NCT00908908|567835|P1|COMPLETED|Overall Study||6
233331|NCT00908908|567835|P1|Physician Decision|Overall Study||0
233332|NCT00908908|567835|P1|Administrative/Other|Overall Study||0
233333|NCT00908908|567835|P1|Withdrawl by Subject|Overall Study||0
233334|NCT00908908|567835|P1|Adverse Event|Overall Study||0
233335|NCT00908908|567835|P1|STARTED|Overall Study||6
233336|NCT00908960|567844|P3|NOT COMPLETED|Overall Study||2
233337|NCT00908960|567845|P2|NOT COMPLETED|Overall Study||1
233338|NCT00908960|567846|P1|NOT COMPLETED|Overall Study||1
233339|NCT00908960|567844|P3|COMPLETED|Overall Study||32
233340|NCT00908960|567845|P2|COMPLETED|Overall Study||11
233341|NCT00908960|567846|P1|COMPLETED|Overall Study||23
233342|NCT00908960|567844|P3|STARTED|Overall Study||34
233343|NCT00908960|567845|P2|STARTED|Overall Study||12
233344|NCT00908960|567846|P1|STARTED|Overall Study||24
233345|NCT00909038|567854|P1|NOT COMPLETED|Overall Study||417
233346|NCT00909038|567854|P1|COMPLETED|Overall Study||1994
233347|NCT00909038|567854|P1|STARTED|Overall Study||2411
233348|NCT00909064|567863|P1|NOT COMPLETED|Overall Study||0
233349|NCT00909064|567863|P1|COMPLETED|Overall Study||114
233350|NCT00909064|567863|P1|STARTED|Overall Study||114
233351|NCT00909155|567872|P3|NOT COMPLETED|Overall Study||7
233352|NCT00909155|567873|P2|NOT COMPLETED|Overall Study||5
233353|NCT00909155|567874|P1|NOT COMPLETED|Overall Study||3
233354|NCT00909155|567872|P3|COMPLETED|Overall Study||14
233355|NCT00909155|567873|P2|COMPLETED|Overall Study||9
233356|NCT00909155|567874|P1|COMPLETED|Overall Study||12
233357|NCT00909155|567872|P3|STARTED|Overall Study||21
233358|NCT00909155|567873|P2|STARTED|Overall Study||14
233359|NCT00909155|567874|P1|STARTED|Overall Study||15
233360|NCT00909181|567885|P3|NOT COMPLETED|Overall Study||33
233361|NCT00909181|567886|P2|NOT COMPLETED|Overall Study||18
233362|NCT00909181|567887|P1|NOT COMPLETED|Overall Study||39
233363|NCT00909181|567885|P3|COMPLETED|Overall Study||169
233364|NCT00909181|567886|P2|COMPLETED|Overall Study||196
233365|NCT00909181|567887|P1|COMPLETED|Overall Study||171
233366|NCT00909181|567885|P3|STARTED|Overall Study||202
233367|NCT00909181|567886|P2|STARTED|Overall Study||214
233368|NCT00909181|567887|P1|STARTED|Overall Study||210
233369|NCT00909324|567897|P2|NOT COMPLETED|Overall Study||0
233370|NCT00909324|567898|P1|NOT COMPLETED|Overall Study||0
233371|NCT00909324|567897|P2|COMPLETED|Overall Study||90
233372|NCT00909324|567898|P1|COMPLETED|Overall Study||72
233373|NCT00909324|567897|P2|STARTED|Overall Study||90
233374|NCT00909324|567898|P1|STARTED|Overall Study||72
233375|NCT00909389|567908|P1|NOT COMPLETED|Overall Study||133
233376|NCT00909389|567908|P1|COMPLETED|Overall Study||4615
233377|NCT00909389|567908|P1|STARTED|Overall Study||4748
233378|NCT00909428|567915|P3|NOT COMPLETED|Overall Study||9
233379|NCT00909428|567916|P2|NOT COMPLETED|Overall Study||10
233380|NCT00909428|567917|P1|NOT COMPLETED|Overall Study||13
233381|NCT00909428|567915|P3|COMPLETED|Overall Study||0
233382|NCT00909428|567916|P2|COMPLETED|Overall Study||5
233383|NCT00909428|567917|P1|COMPLETED|Overall Study||5
233384|NCT00909428|567915|P3|STARTED|Overall Study||9
233385|NCT00909428|567916|P2|STARTED|Overall Study||15
233386|NCT00909428|567917|P1|STARTED|Overall Study||18
233387|NCT00909480|567926|P2|NOT COMPLETED|Overall Study||41
233388|NCT00909480|567927|P1|NOT COMPLETED|Overall Study||38
233389|NCT00909480|567926|P2|COMPLETED|Overall Study||188
233390|NCT00909480|567927|P1|COMPLETED|Overall Study||190
233391|NCT00909480|567926|P2|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|227
233392|NCT00909480|567927|P1|Exposed|Overall Study|2 subjects withdrew before exposure to trial insulin|226
233393|NCT00909480|567926|P2|STARTED|Overall Study||229
233394|NCT00909480|567927|P1|STARTED|Overall Study||228
233395|NCT00909532|567961|P2|NOT COMPLETED|Overall Study||6
233396|NCT00909532|567962|P1|NOT COMPLETED|Overall Study||10
233397|NCT00909532|567961|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|77
233398|NCT00909532|567962|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (Through Week 48)|68
233399|NCT00909532|567961|P2|Completed Treatment Period, Week 24|Overall Study||80
233400|NCT00909532|567962|P1|Completed Treatment Period, Week 24|Overall Study||71
233401|NCT00909532|567961|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor).|83
233402|NCT00909532|567962|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo).|78
233403|NCT00909545|567982|P4|NOT COMPLETED|Overall Study||5
233404|NCT00909545|567983|P3|NOT COMPLETED|Overall Study||1
233405|NCT00909545|567984|P2|NOT COMPLETED|Overall Study||1
233406|NCT00909545|567985|P1|NOT COMPLETED|Overall Study||1
233407|NCT00909545|567982|P4|COMPLETED|Overall Study||19
233408|NCT00909545|567983|P3|COMPLETED|Overall Study||25
233409|NCT00909545|567984|P2|COMPLETED|Overall Study||22
233410|NCT00909545|567985|P1|COMPLETED|Overall Study||25
233411|NCT00909545|567982|P4|STARTED|Overall Study||24
233412|NCT00909545|567983|P3|STARTED|Overall Study||26
233413|NCT00909545|567984|P2|STARTED|Overall Study||23
233414|NCT00909545|567985|P1|STARTED|Overall Study||26
233415|NCT00909610|568121|P2|NOT COMPLETED|Period: Second Intervention||0
233416|NCT00909610|568122|P1|NOT COMPLETED|Period: Second Intervention||1
233417|NCT00909610|568121|P2|COMPLETED|Period: Second Intervention||33
233418|NCT00909610|568122|P1|COMPLETED|Period: Second Intervention||36
233419|NCT00909610|568121|P2|STARTED|Period: Second Intervention||33
233420|NCT00909610|568122|P1|STARTED|Period: Second Intervention||37
233421|NCT00909610|568121|P2|NOT COMPLETED|Period: Washout of 28 Days||6
233422|NCT00909610|568122|P1|NOT COMPLETED|Period: Washout of 28 Days||3
233423|NCT00909610|568121|P2|COMPLETED|Period: Washout of 28 Days||33
233424|NCT00909610|568122|P1|COMPLETED|Period: Washout of 28 Days||37
233425|NCT00909610|568121|P2|STARTED|Period: Washout of 28 Days||39
233426|NCT00909610|568122|P1|STARTED|Period: Washout of 28 Days||40
233427|NCT00909610|568121|P2|NOT COMPLETED|Period: First Intervention||1
233428|NCT00909610|568122|P1|NOT COMPLETED|Period: First Intervention||0
233429|NCT00909610|568121|P2|COMPLETED|Period: First Intervention||39
233430|NCT00909610|568122|P1|COMPLETED|Period: First Intervention||40
233431|NCT00909610|568121|P2|STARTED|Period: First Intervention||40
233432|NCT00909610|568122|P1|STARTED|Period: First Intervention||40
233433|NCT00909649|568142|P2|NOT COMPLETED|Overall Study||0
233434|NCT00909649|568143|P1|NOT COMPLETED|Overall Study||0
233435|NCT00909649|568142|P2|COMPLETED|Overall Study||25
233436|NCT00909649|568143|P1|COMPLETED|Overall Study||25
233437|NCT00909649|568142|P2|STARTED|Overall Study||25
233438|NCT00909649|568143|P1|STARTED|Overall Study||25
233439|NCT00909727|568149|P2|NOT COMPLETED|Overall Study||0
233440|NCT00909727|568150|P1|NOT COMPLETED|Overall Study||4
233441|NCT00909727|568149|P2|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|26
233442|NCT00909727|568150|P1|COMPLETED|Overall Study|Completed Treatment and Extension Periods (through Week 48)|22
233443|NCT00909727|568149|P2|Completed Treatment Period, Week 24|Overall Study||26
233444|NCT00909727|568150|P1|Completed Treatment Period, Week 24|Overall Study||23
233445|NCT00909727|568149|P2|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (ivacaftor)|26
233446|NCT00909727|568150|P1|STARTED|Overall Study|All subjects who received at least 1 dose of study drug (placebo)|26
233447|NCT00909753|568166|P2|NOT COMPLETED|Period: Second Intervention||0
233448|NCT00909753|568167|P1|NOT COMPLETED|Period: Second Intervention||1
233449|NCT00909753|568166|P2|COMPLETED|Period: Second Intervention||43
233450|NCT00909753|568167|P1|COMPLETED|Period: Second Intervention||43
233451|NCT00909753|568166|P2|STARTED|Period: Second Intervention||43
233452|NCT00909753|568167|P1|STARTED|Period: Second Intervention||44
233453|NCT00909753|568166|P2|NOT COMPLETED|Period: Washout of 28 Days||3
233454|NCT00909753|568167|P1|NOT COMPLETED|Period: Washout of 28 Days||2
233455|NCT00909753|568166|P2|COMPLETED|Period: Washout of 28 Days||43
233456|NCT00909753|568167|P1|COMPLETED|Period: Washout of 28 Days||44
233457|NCT00909753|568166|P2|STARTED|Period: Washout of 28 Days||46
233458|NCT00909753|568167|P1|STARTED|Period: Washout of 28 Days||46
233459|NCT00909753|568166|P2|NOT COMPLETED|Period: First Intervention||0
233460|NCT00909753|568167|P1|NOT COMPLETED|Period: First Intervention||0
233461|NCT00909753|568166|P2|COMPLETED|Period: First Intervention||46
233462|NCT00909753|568167|P1|COMPLETED|Period: First Intervention||46
233463|NCT00909753|568166|P2|STARTED|Period: First Intervention||46
233464|NCT00909753|568167|P1|STARTED|Period: First Intervention||46
233465|NCT00909779|568187|P2|NOT COMPLETED|Overall Study||165
233466|NCT00909779|568188|P1|NOT COMPLETED|Overall Study||210
233467|NCT00909779|568187|P2|COMPLETED|Overall Study|All subjects but 42 were followed for 12 months/until death (whichever was earlier).|255
233468|NCT00909779|568188|P1|COMPLETED|Overall Study|All subjects but 47 were followed for 12 months/until death (whichever was earlier).|211
233469|NCT00909779|568187|P2|STARTED|Overall Study||420
233470|NCT00909779|568188|P1|STARTED|Overall Study||421
233471|NCT00909792|568210|P2|NOT COMPLETED|Period 2||1
233472|NCT00909792|568211|P1|NOT COMPLETED|Period 2||1
233473|NCT00909792|568210|P2|COMPLETED|Period 2||124
233474|NCT00909792|568211|P1|COMPLETED|Period 2||128
233475|NCT00909792|568210|P2|STARTED|Period 2|Two discontinuations between P1 & P2: 1 for fail inc/exc criteria; 1 for lack of efficacy.|125
233476|NCT00909792|568211|P1|STARTED|Period 2|One participant discontinued between Period 1 and Period 2 due to lack of efficacy.|129
233477|NCT00909792|568210|P2|NOT COMPLETED|Period 1||1
233478|NCT00909792|568211|P1|NOT COMPLETED|Period 1||0
233479|NCT00909792|568210|P2|COMPLETED|Period 1||127
233480|NCT00909792|568211|P1|COMPLETED|Period 1||130
233481|NCT00909792|568210|P2|STARTED|Period 1||128
233482|NCT00909792|568211|P1|STARTED|Period 1||130
233483|NCT00909844|568217|P1|NOT COMPLETED|Overall Study||4
233484|NCT00909844|568217|P1|COMPLETED|Overall Study||31
233485|NCT00909844|568217|P1|STARTED|Overall Study||35
233486|NCT00909857|568237|P2|NOT COMPLETED|Overall Study||45
233487|NCT00909857|568238|P1|NOT COMPLETED|Overall Study||36
233488|NCT00909857|568237|P2|COMPLETED|Overall Study||209
233489|NCT00909857|568238|P1|COMPLETED|Overall Study||217
233490|NCT00909857|568237|P2|Treated|Overall Study||230
233491|NCT00909857|568238|P1|Treated|Overall Study||234
233492|NCT00909857|568237|P2|STARTED|Overall Study||254
233493|NCT00909857|568238|P1|STARTED|Overall Study||253
233494|NCT00909870|568380|P2|NOT COMPLETED|Overall Study||27
233495|NCT00909870|568381|P1|NOT COMPLETED|Overall Study||23
233496|NCT00909870|568380|P2|COMPLETED|Overall Study||236
233497|NCT00909870|568381|P1|COMPLETED|Overall Study||251
233498|NCT00909870|568380|P2|STARTED|Overall Study||263
233499|NCT00909870|568381|P1|STARTED|Overall Study||274
233500|NCT00910000|568397|P6|NOT COMPLETED|Overall Study||1
233501|NCT00910000|568398|P5|NOT COMPLETED|Overall Study||1
233502|NCT00910000|568399|P4|NOT COMPLETED|Overall Study||2
233503|NCT00910000|568400|P3|NOT COMPLETED|Overall Study||3
233504|NCT00910000|568401|P2|NOT COMPLETED|Overall Study||3
233505|NCT00910000|568402|P1|NOT COMPLETED|Overall Study||0
233506|NCT00910000|568397|P6|COMPLETED|Overall Study||0
233507|NCT00910000|568398|P5|COMPLETED|Overall Study||2
233508|NCT00910000|568399|P4|COMPLETED|Overall Study||0
233509|NCT00910000|568400|P3|COMPLETED|Overall Study||0
233510|NCT00910000|568401|P2|COMPLETED|Overall Study||0
233511|NCT00910000|568402|P1|COMPLETED|Overall Study||3
233512|NCT00910000|568397|P6|STARTED|Overall Study||1
233513|NCT00910000|568398|P5|STARTED|Overall Study||3
233514|NCT00910000|568399|P4|STARTED|Overall Study||2
233515|NCT00910000|568400|P3|STARTED|Overall Study||3
233516|NCT00910000|568401|P2|STARTED|Overall Study||3
233517|NCT00910000|568402|P1|STARTED|Overall Study||3
233518|NCT00910039|568418|P1|NOT COMPLETED|Overall Study||1
233519|NCT00910039|568418|P1|COMPLETED|Overall Study||13
233520|NCT00910039|568418|P1|STARTED|Overall Study||14
233521|NCT00901901|568431|P2|NOT COMPLETED|Follow-up Period||259
233522|NCT00901901|568432|P1|NOT COMPLETED|Follow-up Period||246
233523|NCT00901901|568431|P2|COMPLETED|Follow-up Period|These participants are ongoing.|65
233524|NCT00901901|568432|P1|COMPLETED|Follow-up Period|These participants are ongoing.|76
233525|NCT00901901|568431|P2|STARTED|Follow-up Period||324
233526|NCT00901901|568432|P1|STARTED|Follow-up Period||322
233527|NCT00901901|568431|P2|NOT COMPLETED|Treatment Period||168
233528|NCT00901901|568432|P1|NOT COMPLETED|Treatment Period||157
233529|NCT00901901|568431|P2|COMPLETED|Treatment Period|17 of these participants are ongoing|190
233530|NCT00901901|568432|P1|COMPLETED|Treatment Period|19 of these participants are ongoing|205
233531|NCT00901901|568431|P2|Participants Received Treatment|Treatment Period||355
233532|NCT00901901|568432|P1|Participants Received Treatment|Treatment Period||362
233533|NCT00901901|568431|P2|STARTED|Treatment Period||358
233534|NCT00901901|568432|P1|STARTED|Treatment Period||362
233535|NCT00902161|568454|P3|NOT COMPLETED|Period 2||0
233536|NCT00902161|568455|P2|NOT COMPLETED|Period 2||0
233537|NCT00902161|568456|P1|NOT COMPLETED|Period 2||0
233538|NCT00902161|568454|P3|COMPLETED|Period 2||0
233539|NCT00902161|568455|P2|COMPLETED|Period 2||9
233540|NCT00902161|568456|P1|COMPLETED|Period 2|2 participants discontinued and were replaced; 1 due to protocol deviation and 1 withdrew consent|8
233541|NCT00902161|568454|P3|STARTED|Period 2||0
233542|NCT00902161|568455|P2|STARTED|Period 2||9
233543|NCT00902161|568456|P1|STARTED|Period 2||8
233544|NCT00902161|568454|P3|NOT COMPLETED|Post-clamp Washout||0
233545|NCT00902161|568455|P2|NOT COMPLETED|Post-clamp Washout||0
233546|NCT00902161|568456|P1|NOT COMPLETED|Post-clamp Washout||0
233547|NCT00902161|568454|P3|COMPLETED|Post-clamp Washout|2 participants discontinued washout and were replaced; 1 due to an AE and 1 due to lack of efficacy|22
233548|NCT00902161|568455|P2|COMPLETED|Post-clamp Washout||0
233549|NCT00902161|568456|P1|COMPLETED|Post-clamp Washout||0
233550|NCT00902161|568454|P3|STARTED|Post-clamp Washout||22
233551|NCT00902161|568455|P2|STARTED|Post-clamp Washout||0
233552|NCT00902161|568456|P1|STARTED|Post-clamp Washout||0
233553|NCT00902161|568454|P3|NOT COMPLETED|Period 1||0
233554|NCT00902161|568455|P2|NOT COMPLETED|Period 1||0
233555|NCT00902161|568456|P1|NOT COMPLETED|Period 1||0
233556|NCT00902161|568454|P3|COMPLETED|Period 1||0
233557|NCT00902161|568455|P2|COMPLETED|Period 1||10
233558|NCT00902161|568456|P1|COMPLETED|Period 1||12
233559|NCT00902161|568454|P3|STARTED|Period 1||0
233560|NCT00902161|568455|P2|STARTED|Period 1||10
233561|NCT00902161|568456|P1|STARTED|Period 1||12
233562|NCT00902161|568454|P3|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
233563|NCT00902161|568455|P2|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
233564|NCT00902161|568456|P1|NOT COMPLETED|Pre-study Washout/Propanolol Run-in||0
233565|NCT00902161|568454|P3|COMPLETED|Pre-study Washout/Propanolol Run-in||22
233566|NCT00902161|568455|P2|COMPLETED|Pre-study Washout/Propanolol Run-in||0
233567|NCT00902161|568456|P1|COMPLETED|Pre-study Washout/Propanolol Run-in||0
233568|NCT00902161|568454|P3|STARTED|Pre-study Washout/Propanolol Run-in||22
233569|NCT00902161|568455|P2|STARTED|Pre-study Washout/Propanolol Run-in||0
233570|NCT00902161|568456|P1|STARTED|Pre-study Washout/Propanolol Run-in||0
233571|NCT00902174|568473|P2|NOT COMPLETED|Overall Study||18
233572|NCT00902174|568474|P1|NOT COMPLETED|Overall Study||34
233573|NCT00902174|568473|P2|COMPLETED|Overall Study||81
233574|NCT00902174|568474|P1|COMPLETED|Overall Study||69
233575|NCT00902174|568473|P2|STARTED|Overall Study||99
233576|NCT00902174|568474|P1|STARTED|Overall Study||103
233577|NCT00902226|568510|P1|NOT COMPLETED|Overall Study||0
233578|NCT00902226|568510|P1|COMPLETED|Overall Study||30
233579|NCT00902226|568510|P1|STARTED|Overall Study||30
233580|NCT00902265|568520|P1|NOT COMPLETED|Overall Study||6
233581|NCT00902265|568520|P1|COMPLETED|Overall Study||132
233582|NCT00902265|568520|P1|Participants Who Received Treatment|Overall Study||137
233583|NCT00902265|568520|P1|STARTED|Overall Study||138
233584|NCT00902304|568535|P3|NOT COMPLETED|Overall Study||110
233585|NCT00902304|568536|P2|NOT COMPLETED|Overall Study||71
233586|NCT00902304|568537|P1|NOT COMPLETED|Overall Study||58
233587|NCT00902304|568535|P3|COMPLETED|Overall Study||568
233588|NCT00902304|568536|P2|COMPLETED|Overall Study||289
233589|NCT00902304|568537|P1|COMPLETED|Overall Study||466
233590|NCT00902304|568535|P3|STARTED|Overall Study||678
233591|NCT00902304|568536|P2|STARTED|Overall Study||360
233592|NCT00902304|568537|P1|STARTED|Overall Study||524
233593|NCT00902330|568584|P2|NOT COMPLETED|Overall Study||5
233594|NCT00902330|568585|P1|NOT COMPLETED|Overall Study||4
233595|NCT00902330|568584|P2|COMPLETED|Overall Study||75
233596|NCT00902330|568585|P1|COMPLETED|Overall Study||77
233597|NCT00902330|568584|P2|STARTED|Overall Study||80
233598|NCT00902330|568585|P1|STARTED|Overall Study||81
233599|NCT00902538|568622|P6|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||1
233600|NCT00902538|568623|P5|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||2
233601|NCT00902538|568624|P4|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||9
233602|NCT00902538|568625|P3|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
233603|NCT00902538|568626|P2|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
233604|NCT00902538|568627|P1|NOT COMPLETED|4-Randomized Double-blind 2 Treatments||0
233605|NCT00902538|568622|P6|COMPLETED|4-Randomized Double-blind 2 Treatments||196
233606|NCT00902538|568623|P5|COMPLETED|4-Randomized Double-blind 2 Treatments||95
233607|NCT00902538|568624|P4|COMPLETED|4-Randomized Double-blind 2 Treatments||458
233608|NCT00902538|568625|P3|COMPLETED|4-Randomized Double-blind 2 Treatments||0
233609|NCT00902538|568626|P2|COMPLETED|4-Randomized Double-blind 2 Treatments||0
233610|NCT00902538|568627|P1|COMPLETED|4-Randomized Double-blind 2 Treatments||0
233611|NCT00902538|568622|P6|STARTED|4-Randomized Double-blind 2 Treatments||197
233612|NCT00902538|568623|P5|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 non-responders were randomized to OLM 40-AML 10-HCTZ 12.5 or 25 in a 2:1 ratio|97
233613|NCT00902538|568624|P4|STARTED|4-Randomized Double-blind 2 Treatments|Period 3 responders were continued on OLM 40-AML 10-HCTZ 12.5|467
233614|NCT00902538|568625|P3|STARTED|4-Randomized Double-blind 2 Treatments||0
233615|NCT00902538|568626|P2|STARTED|4-Randomized Double-blind 2 Treatments||0
233616|NCT00902538|568627|P1|STARTED|4-Randomized Double-blind 2 Treatments||0
233617|NCT00902538|568622|P6|NOT COMPLETED|3-Single-blind, Single Treatment||0
233618|NCT00902538|568623|P5|NOT COMPLETED|3-Single-blind, Single Treatment||0
233619|NCT00902538|568624|P4|NOT COMPLETED|3-Single-blind, Single Treatment||0
233620|NCT00902538|568625|P3|NOT COMPLETED|3-Single-blind, Single Treatment||0
233621|NCT00902538|568626|P2|NOT COMPLETED|3-Single-blind, Single Treatment||15
233622|NCT00902538|568627|P1|NOT COMPLETED|3-Single-blind, Single Treatment||0
233623|NCT00902538|568622|P6|COMPLETED|3-Single-blind, Single Treatment||0
233624|NCT00902538|568623|P5|COMPLETED|3-Single-blind, Single Treatment||0
233625|NCT00902538|568624|P4|COMPLETED|3-Single-blind, Single Treatment||0
233626|NCT00902538|568625|P3|COMPLETED|3-Single-blind, Single Treatment||0
233627|NCT00902538|568626|P2|COMPLETED|3-Single-blind, Single Treatment||767
233628|NCT00902538|568627|P1|COMPLETED|3-Single-blind, Single Treatment||0
233629|NCT00902538|568622|P6|STARTED|3-Single-blind, Single Treatment||0
233630|NCT00902538|568623|P5|STARTED|3-Single-blind, Single Treatment||0
233631|NCT00902538|568624|P4|STARTED|3-Single-blind, Single Treatment||0
233632|NCT00902538|568625|P3|STARTED|3-Single-blind, Single Treatment||0
233633|NCT00902538|568626|P2|STARTED|3-Single-blind, Single Treatment|Number starting is < total completing previous arm since 3 subjects did not receive at least 1 dose.|782
233634|NCT00902538|568627|P1|STARTED|3-Single-blind, Single Treatment||0
233635|NCT00902538|568622|P6|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
233636|NCT00902538|568623|P5|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
233637|NCT00902538|568624|P4|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||0
233638|NCT00902538|568625|P3|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||8
233639|NCT00902538|568626|P2|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||6
233640|NCT00902538|568627|P1|NOT COMPLETED|2-Randomized Double-blind 3 Treatments||9
233641|NCT00902538|568622|P6|COMPLETED|2-Randomized Double-blind 3 Treatments||0
233642|NCT00902538|568623|P5|COMPLETED|2-Randomized Double-blind 3 Treatments||0
233643|NCT00902538|568624|P4|COMPLETED|2-Randomized Double-blind 3 Treatments||0
233644|NCT00902538|568625|P3|COMPLETED|2-Randomized Double-blind 3 Treatments||262
233645|NCT00902538|568626|P2|COMPLETED|2-Randomized Double-blind 3 Treatments||263
233646|NCT00902538|568627|P1|COMPLETED|2-Randomized Double-blind 3 Treatments||260
233647|NCT00902538|568622|P6|STARTED|2-Randomized Double-blind 3 Treatments||0
233648|NCT00902538|568623|P5|STARTED|2-Randomized Double-blind 3 Treatments||0
233649|NCT00902538|568624|P4|STARTED|2-Randomized Double-blind 3 Treatments||0
233650|NCT00902538|568625|P3|STARTED|2-Randomized Double-blind 3 Treatments||270
233651|NCT00902538|568626|P2|STARTED|2-Randomized Double-blind 3 Treatments||269
233652|NCT00902538|568627|P1|STARTED|2-Randomized Double-blind 3 Treatments|Only 808 began Period 2 because the others finishing Period 1 did not meet the entry criteria.|269
233653|NCT00902538|568622|P6|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233654|NCT00902538|568623|P5|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233655|NCT00902538|568624|P4|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233656|NCT00902538|568625|P3|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233657|NCT00902538|568626|P2|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233658|NCT00902538|568627|P1|NOT COMPLETED|1-Single-blind, Run-in, Single-Treatment||118
233659|NCT00902538|568622|P6|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233660|NCT00902538|568623|P5|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233661|NCT00902538|568624|P4|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233662|NCT00902538|568625|P3|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233663|NCT00902538|568626|P2|COMPLETED|1-Single-blind, Run-in, Single-Treatment||0
233664|NCT00902538|568627|P1|COMPLETED|1-Single-blind, Run-in, Single-Treatment||2086
233665|NCT00902538|568622|P6|STARTED|1-Single-blind, Run-in, Single-Treatment||0
233666|NCT00902538|568623|P5|STARTED|1-Single-blind, Run-in, Single-Treatment||0
233667|NCT00902538|568624|P4|STARTED|1-Single-blind, Run-in, Single-Treatment||0
233668|NCT00902538|568625|P3|STARTED|1-Single-blind, Run-in, Single-Treatment||0
233669|NCT00902538|568626|P2|STARTED|1-Single-blind, Run-in, Single-Treatment||0
233670|NCT00902538|568627|P1|STARTED|1-Single-blind, Run-in, Single-Treatment||2204
233671|NCT00902564|568657|P1|NOT COMPLETED|Overall Study||2
233672|NCT00902564|568657|P1|COMPLETED|Overall Study||28
233673|NCT00902564|568657|P1|STARTED|Overall Study||30
233674|NCT00910091|568671|P2|NOT COMPLETED|Treatment and Survival||4
233675|NCT00910091|568672|P1|NOT COMPLETED|Treatment and Survival||4
233676|NCT00910091|568671|P2|COMPLETED|Treatment and Survival||31
233677|NCT00910091|568672|P1|COMPLETED|Treatment and Survival||32
233678|NCT00910091|568671|P2|STARTED|Treatment and Survival||35
233679|NCT00910091|568672|P1|STARTED|Treatment and Survival||36
233680|NCT00910091|568671|P2|NOT COMPLETED|Pre-assignment||2
233681|NCT00910091|568672|P1|NOT COMPLETED|Pre-assignment||0
233682|NCT00910091|568671|P2|COMPLETED|Pre-assignment||35
233683|NCT00910091|568672|P1|COMPLETED|Pre-assignment||36
233684|NCT00910091|568671|P2|STARTED|Pre-assignment||37
233685|NCT00910091|568672|P1|STARTED|Pre-assignment||36
233686|NCT00910273|568702|P2|NOT COMPLETED|Overall Study||13
233687|NCT00910273|568703|P1|NOT COMPLETED|Overall Study||18
233688|NCT00910273|568702|P2|COMPLETED|Overall Study||3
233689|NCT00910273|568703|P1|COMPLETED|Overall Study||0
233690|NCT00910273|568702|P2|STARTED|Overall Study||16
233691|NCT00910273|568703|P1|STARTED|Overall Study||18
233692|NCT00910299|568755|P2|NOT COMPLETED|Overall Study||74
233693|NCT00910299|568756|P1|NOT COMPLETED|Overall Study||76
233694|NCT00910299|568755|P2|COMPLETED|Overall Study|1 participant died of sepsis while on study drug and was considered a “protocol completer.”|137
233695|NCT00910299|568756|P1|COMPLETED|Overall Study||136
233696|NCT00910299|568755|P2|Received at Least 1 Dose of Study Drug|Overall Study||210
233697|NCT00910299|568756|P1|Received at Least 1 Dose of Study Drug|Overall Study||210
233698|NCT00910299|568755|P2|STARTED|Overall Study||211
233699|NCT00910299|568756|P1|STARTED|Overall Study||212
233700|NCT00913003|568768|P2|NOT COMPLETED|Overall Study||0
233701|NCT00913003|568769|P1|NOT COMPLETED|Overall Study||0
233702|NCT00913003|568768|P2|COMPLETED|Overall Study||11
233703|NCT00913003|568769|P1|COMPLETED|Overall Study||11
233704|NCT00913003|568768|P2|STARTED|Overall Study||11
233705|NCT00913003|568769|P1|STARTED|Overall Study||11
233706|NCT00913081|568779|P1|NOT COMPLETED|Placebo + Niacin 500 mg (1day)||0
233707|NCT00913081|568779|P1|COMPLETED|Placebo + Niacin 500 mg (1day)||17
233708|NCT00913081|568779|P1|STARTED|Placebo + Niacin 500 mg (1day)||17
233709|NCT00913081|568779|P1|NOT COMPLETED|Washout #3 (7days)||0
233710|NCT00913081|568779|P1|COMPLETED|Washout #3 (7days)||17
233711|NCT00913081|568779|P1|STARTED|Washout #3 (7days)||17
233712|NCT00913081|568779|P1|NOT COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||0
233713|NCT00913081|568779|P1|COMPLETED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
233714|NCT00913081|568779|P1|STARTED|Quercetin 2000 mg + Niacin 500 mg (1day)||17
233715|NCT00913081|568779|P1|NOT COMPLETED|Washout #2 (7 Days)||0
233716|NCT00913081|568779|P1|COMPLETED|Washout #2 (7 Days)||17
233717|NCT00913081|568779|P1|STARTED|Washout #2 (7 Days)||17
233718|NCT00913081|568779|P1|NOT COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||0
233719|NCT00913081|568779|P1|COMPLETED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
233720|NCT00913081|568779|P1|STARTED|Quercetin 1000 mg + Niacin 500 mg (1day)||17
233721|NCT00913081|568779|P1|NOT COMPLETED|Washout #1 (7 Days)||0
233722|NCT00913081|568779|P1|COMPLETED|Washout #1 (7 Days)||17
233723|NCT00913081|568779|P1|STARTED|Washout #1 (7 Days)||17
233724|NCT00913081|568779|P1|NOT COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||0
233725|NCT00913081|568779|P1|COMPLETED|Quercetin 500 mg + Niacin 500 mg (1day)||17
233726|NCT00913081|568779|P1|STARTED|Quercetin 500 mg + Niacin 500 mg (1day)||17
233727|NCT00913133|568789|P1|NOT COMPLETED|Overall Study||0
233728|NCT00913133|568789|P1|COMPLETED|Overall Study||516
233729|NCT00913133|568789|P1|STARTED|Overall Study||516
233730|NCT00913263|568794|P1|NOT COMPLETED|Overall Study||0
233731|NCT00913263|568794|P1|COMPLETED|Overall Study||24
233732|NCT00913263|568794|P1|STARTED|Overall Study||24
233733|NCT00913380|568805|P2|NOT COMPLETED|Clinical Outcomes||6
233734|NCT00913380|568806|P1|NOT COMPLETED|Clinical Outcomes||6
233735|NCT00913380|568805|P2|COMPLETED|Clinical Outcomes||441
233736|NCT00913380|568806|P1|COMPLETED|Clinical Outcomes||438
233737|NCT00913380|568805|P2|STARTED|Clinical Outcomes||447
233738|NCT00913380|568806|P1|STARTED|Clinical Outcomes||444
233739|NCT00913380|568805|P2|NOT COMPLETED|CT Examination||0
233740|NCT00913380|568806|P1|NOT COMPLETED|CT Examination||0
233741|NCT00913380|568805|P2|COMPLETED|CT Examination||447
233742|NCT00913380|568806|P1|COMPLETED|CT Examination||444
233743|NCT00913380|568805|P2|STARTED|CT Examination||447
233744|NCT00913380|568806|P1|STARTED|CT Examination||444
233745|NCT00913458|568832|P7|NOT COMPLETED|Phase 3||8
233746|NCT00913458|568833|P6|NOT COMPLETED|Phase 3||18
233747|NCT00913458|568834|P5|NOT COMPLETED|Phase 3||22
233748|NCT00913458|568835|P4|NOT COMPLETED|Phase 3||0
233749|NCT00913458|568836|P3|NOT COMPLETED|Phase 3||0
233750|NCT00913458|568837|P2|NOT COMPLETED|Phase 3||0
233751|NCT00913458|568838|P1|NOT COMPLETED|Phase 3||0
233752|NCT00913458|568832|P7|COMPLETED|Phase 3||24
233753|NCT00913458|568833|P6|COMPLETED|Phase 3||28
233754|NCT00913458|568834|P5|COMPLETED|Phase 3||31
233755|NCT00913458|568835|P4|COMPLETED|Phase 3||0
233756|NCT00913458|568836|P3|COMPLETED|Phase 3||0
233757|NCT00913458|568837|P2|COMPLETED|Phase 3||0
233758|NCT00913458|568838|P1|COMPLETED|Phase 3|This arm is part of Phase 1 of the study.|0
233759|NCT00913458|568832|P7|STARTED|Phase 3|Participants who completed Phase 2 study|32
233760|NCT00913458|568833|P6|STARTED|Phase 3|Participants who completed Phase 2 study|46
233761|NCT00913458|568834|P5|STARTED|Phase 3|Participants who completed Phase 2 study|53
233762|NCT00913458|568835|P4|STARTED|Phase 3||0
233763|NCT00913458|568836|P3|STARTED|Phase 3||0
233764|NCT00913458|568837|P2|STARTED|Phase 3||0
233765|NCT00913458|568838|P1|STARTED|Phase 3|This arm is part of Phase 1 of the study.|0
233766|NCT00913458|568832|P7|NOT COMPLETED|Phase 2||0
233767|NCT00913458|568833|P6|NOT COMPLETED|Phase 2||0
233768|NCT00913458|568834|P5|NOT COMPLETED|Phase 2||0
233769|NCT00913458|568835|P4|NOT COMPLETED|Phase 2||33
233770|NCT00913458|568836|P3|NOT COMPLETED|Phase 2||19
233771|NCT00913458|568837|P2|NOT COMPLETED|Phase 2||10
233772|NCT00913458|568838|P1|NOT COMPLETED|Phase 2||0
233773|NCT00913458|568832|P7|COMPLETED|Phase 2||0
233774|NCT00913458|568833|P6|COMPLETED|Phase 2||0
233775|NCT00913458|568834|P5|COMPLETED|Phase 2||0
233776|NCT00913458|568835|P4|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|32
233777|NCT00913458|568836|P3|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|46
233778|NCT00913458|568837|P2|COMPLETED|Phase 2|Participants randomized into Phase 3 of study.|53
233779|NCT00913458|568838|P1|COMPLETED|Phase 2|This arm is part of Phase 1 of the study.|0
233780|NCT00913458|568832|P7|STARTED|Phase 2||0
233781|NCT00913458|568833|P6|STARTED|Phase 2||0
233782|NCT00913458|568834|P5|STARTED|Phase 2||0
233783|NCT00913458|568835|P4|STARTED|Phase 2||65
233784|NCT00913458|568836|P3|STARTED|Phase 2||65
233785|NCT00913458|568837|P2|STARTED|Phase 2||63
233786|NCT00913458|568838|P1|STARTED|Phase 2|This arm is part of Phase 1 of the study.|0
233787|NCT00913458|568832|P7|NOT COMPLETED|Phase 1||0
233788|NCT00913458|568833|P6|NOT COMPLETED|Phase 1||0
233789|NCT00913458|568834|P5|NOT COMPLETED|Phase 1||0
233790|NCT00913458|568835|P4|NOT COMPLETED|Phase 1||0
233791|NCT00913458|568836|P3|NOT COMPLETED|Phase 1||0
233792|NCT00913458|568837|P2|NOT COMPLETED|Phase 1||0
233793|NCT00913458|568838|P1|NOT COMPLETED|Phase 1||112
233794|NCT00913458|568832|P7|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
233795|NCT00913458|568833|P6|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
233796|NCT00913458|568834|P5|COMPLETED|Phase 1|This arm is part of Phase 3 study|0
233797|NCT00913458|568835|P4|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
233798|NCT00913458|568836|P3|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
233799|NCT00913458|568837|P2|COMPLETED|Phase 1|This arm is part of Phase 2 study|0
233800|NCT00913458|568838|P1|COMPLETED|Phase 1|194 continued to Phase 2 but 1 was randomized in error leaving 193 in the phase 2 analysis.|194
233801|NCT00913458|568832|P7|STARTED|Phase 1|This arm is part of Phase 3 study|0
233802|NCT00913458|568833|P6|STARTED|Phase 1|This arm is part of Phase 3 study|0
233803|NCT00913458|568834|P5|STARTED|Phase 1|This arm is part of Phase 3 study|0
233804|NCT00913458|568835|P4|STARTED|Phase 1|This arm is part of Phase 2 study|0
233805|NCT00913458|568836|P3|STARTED|Phase 1|This arm is part of Phase 2 study|0
233806|NCT00913458|568837|P2|STARTED|Phase 1|This arm is part of Phase 2 study|0
233807|NCT00913458|568838|P1|STARTED|Phase 1||306
233808|NCT00913510|568931|P2|NOT COMPLETED|Overall Study||4
233809|NCT00913510|568932|P1|NOT COMPLETED|Overall Study||8
233810|NCT00913510|568931|P2|COMPLETED|Overall Study||3
233811|NCT00913510|568932|P1|COMPLETED|Overall Study||5
233812|NCT00913510|568931|P2|STARTED|Overall Study||7
233813|NCT00913510|568932|P1|STARTED|Overall Study||13
233814|NCT00913523|568941|P3|NOT COMPLETED|Overall Study||14
233815|NCT00913523|568942|P2|NOT COMPLETED|Overall Study||16
233816|NCT00913523|568943|P1|NOT COMPLETED|Overall Study||18
233817|NCT00913523|568941|P3|COMPLETED|Overall Study||147
233818|NCT00913523|568942|P2|COMPLETED|Overall Study||143
233819|NCT00913523|568943|P1|COMPLETED|Overall Study||144
233820|NCT00913523|568941|P3|STARTED|Overall Study||161
233821|NCT00913523|568942|P2|STARTED|Overall Study||159
233822|NCT00913523|568943|P1|STARTED|Overall Study||162
233823|NCT00913692|568966|P1|NOT COMPLETED|Treatment Phase 2 (5 Months)||0
233824|NCT00913692|568966|P1|COMPLETED|Treatment Phase 2 (5 Months)||1
233825|NCT00913692|568966|P1|STARTED|Treatment Phase 2 (5 Months)||1
233826|NCT00913692|568966|P1|NOT COMPLETED|Washout (2 Weeks)||0
233827|NCT00913692|568966|P1|COMPLETED|Washout (2 Weeks)||1
233828|NCT00913692|568966|P1|STARTED|Washout (2 Weeks)||1
233829|NCT00913692|568966|P1|NOT COMPLETED|Treatment Phase 1 (5 Months)||1
233830|NCT00913692|568966|P1|COMPLETED|Treatment Phase 1 (5 Months)||1
233831|NCT00913692|568966|P1|STARTED|Treatment Phase 1 (5 Months)||2
233832|NCT00913692|568966|P1|NOT COMPLETED|Screening (4 Months)||9
233833|NCT00913692|568966|P1|COMPLETED|Screening (4 Months)||2
233834|NCT00913692|568966|P1|STARTED|Screening (4 Months)||11
233835|NCT00913744|568978|P2|NOT COMPLETED|Overall Study||1
233836|NCT00913744|568979|P1|NOT COMPLETED|Overall Study||5
233837|NCT00913744|568978|P2|COMPLETED|Overall Study||24
233838|NCT00913744|568979|P1|COMPLETED|Overall Study||70
233839|NCT00913744|568978|P2|STARTED|Overall Study||25
233840|NCT00913744|568979|P1|STARTED|Overall Study||75
233841|NCT00913770|568988|P3|NOT COMPLETED|Overall Study||21
233842|NCT00913770|568989|P2|NOT COMPLETED|Overall Study||29
233843|NCT00913770|568990|P1|NOT COMPLETED|Overall Study||35
233844|NCT00913770|568988|P3|COMPLETED|Overall Study||93
233845|NCT00913770|568989|P2|COMPLETED|Overall Study||82
233846|NCT00913770|568990|P1|COMPLETED|Overall Study||69
233847|NCT00913770|568988|P3|STARTED|Overall Study||114
233848|NCT00913770|568989|P2|STARTED|Overall Study||111
233849|NCT00913770|568990|P1|STARTED|Overall Study||104
233850|NCT00913835|569003|P2|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||3
233851|NCT00913835|569004|P1|NOT COMPLETED|Lip Dox: Olaratumab Monotherapy||0
233852|NCT00913835|569003|P2|COMPLETED|Lip Dox: Olaratumab Monotherapy||25
233853|NCT00913835|569004|P1|COMPLETED|Lip Dox: Olaratumab Monotherapy||0
233854|NCT00913835|569003|P2|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||28
233855|NCT00913835|569004|P1|Received at Least 1 Dose of Study Drug|Lip Dox: Olaratumab Monotherapy||0
233856|NCT00913835|569003|P2|STARTED|Lip Dox: Olaratumab Monotherapy||28
233857|NCT00913835|569004|P1|STARTED|Lip Dox: Olaratumab Monotherapy||0
233858|NCT00913835|569003|P2|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||7
233859|NCT00913835|569004|P1|NOT COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||8
233860|NCT00913835|569003|P2|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
233861|NCT00913835|569004|P1|COMPLETED|Olara+Lip Dox and Lip Dox Monotherapy||55
233862|NCT00913835|569003|P2|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||61
233863|NCT00913835|569004|P1|Received Any Study Drug|Olara+Lip Dox and Lip Dox Monotherapy||62
233864|NCT00913835|569003|P2|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||62
233865|NCT00913835|569004|P1|STARTED|Olara+Lip Dox and Lip Dox Monotherapy||63
233866|NCT00913913|569040|P1|NOT COMPLETED|Overall Study||8
233867|NCT00913913|569040|P1|COMPLETED|Overall Study||0
233868|NCT00913913|569040|P1|STARTED|Overall Study||8
233869|NCT00914069|569049|P2|NOT COMPLETED|Overall Study||0
233870|NCT00914069|569050|P1|NOT COMPLETED|Overall Study||0
233871|NCT00914069|569049|P2|COMPLETED|Overall Study||88
233872|NCT00914069|569050|P1|COMPLETED|Overall Study||84
233873|NCT00914069|569049|P2|STARTED|Overall Study||88
233874|NCT00914069|569050|P1|STARTED|Overall Study||84
233875|NCT00914186|569068|P4|NOT COMPLETED|Overall Study||10
233876|NCT00914186|569069|P3|NOT COMPLETED|Overall Study||2
233877|NCT00914186|569070|P2|NOT COMPLETED|Overall Study||2
233878|NCT00914186|569071|P1|NOT COMPLETED|Overall Study||3
233879|NCT00914186|569068|P4|COMPLETED|Overall Study||20
233880|NCT00914186|569069|P3|COMPLETED|Overall Study||29
233881|NCT00914186|569070|P2|COMPLETED|Overall Study||28
233882|NCT00914186|569071|P1|COMPLETED|Overall Study||28
233883|NCT00914186|569068|P4|STARTED|Overall Study||30
233884|NCT00914186|569069|P3|STARTED|Overall Study||31
233885|NCT00914186|569070|P2|STARTED|Overall Study||30
233886|NCT00914186|569071|P1|STARTED|Overall Study||31
233887|NCT00914316|569107|P4|NOT COMPLETED|Phase 2||0
233888|NCT00914316|569108|P3|NOT COMPLETED|Phase 2||1
233889|NCT00914316|569109|P2|NOT COMPLETED|Phase 2||0
233890|NCT00914316|569110|P1|NOT COMPLETED|Phase 2||1
233891|NCT00914316|569107|P4|COMPLETED|Phase 2||6
233892|NCT00914316|569108|P3|COMPLETED|Phase 2||2
233893|NCT00914316|569109|P2|COMPLETED|Phase 2||4
233894|NCT00914316|569110|P1|COMPLETED|Phase 2||1
233895|NCT00914316|569107|P4|STARTED|Phase 2||6
233896|NCT00914316|569108|P3|STARTED|Phase 2||3
233897|NCT00914316|569109|P2|STARTED|Phase 2||4
233898|NCT00914316|569110|P1|STARTED|Phase 2||2
233899|NCT00914316|569107|P4|NOT COMPLETED|Phase 1||2
233900|NCT00914316|569108|P3|NOT COMPLETED|Phase 1||5
233901|NCT00914316|569109|P2|NOT COMPLETED|Phase 1||2
233902|NCT00914316|569110|P1|NOT COMPLETED|Phase 1||5
233903|NCT00914316|569107|P4|COMPLETED|Phase 1||6
233904|NCT00914316|569108|P3|COMPLETED|Phase 1||3
233905|NCT00914316|569109|P2|COMPLETED|Phase 1||4
233906|NCT00914316|569110|P1|COMPLETED|Phase 1||2
233907|NCT00914316|569107|P4|STARTED|Phase 1||8
233908|NCT00914316|569108|P3|STARTED|Phase 1||8
233909|NCT00914316|569109|P2|STARTED|Phase 1||6
233910|NCT00914316|569110|P1|STARTED|Phase 1||7
233911|NCT00914459|569126|P2|NOT COMPLETED|Overall Study||1
233912|NCT00914459|569127|P1|NOT COMPLETED|Overall Study||1
233913|NCT00914459|569126|P2|COMPLETED|Overall Study||18
233914|NCT00914459|569127|P1|COMPLETED|Overall Study||17
233915|NCT00914459|569126|P2|STARTED|Overall Study||19
233916|NCT00914459|569127|P1|STARTED|Overall Study||18
233917|NCT00914485|569153|P1|NOT COMPLETED|Overall Study||0
233918|NCT00914485|569153|P1|COMPLETED|Overall Study||369
233919|NCT00914485|569153|P1|STARTED|Overall Study||369
233920|NCT00914589|569160|P3|NOT COMPLETED|Overall Study||12
233921|NCT00914589|569161|P2|NOT COMPLETED|Overall Study||16
233922|NCT00914589|569162|P1|NOT COMPLETED|Overall Study||25
233923|NCT00914589|569160|P3|COMPLETED|Overall Study||126
233924|NCT00914589|569161|P2|COMPLETED|Overall Study||127
233925|NCT00914589|569162|P1|COMPLETED|Overall Study||103
233926|NCT00914589|569160|P3|STARTED|Overall Study||138
233927|NCT00914589|569161|P2|STARTED|Overall Study||143
233928|NCT00914589|569162|P1|STARTED|Overall Study||128
233929|NCT00914810|569184|P2|NOT COMPLETED|Overall Study||1
233930|NCT00914810|569185|P1|NOT COMPLETED|Overall Study||2
233931|NCT00914810|569184|P2|COMPLETED|Overall Study||18
233932|NCT00914810|569185|P1|COMPLETED|Overall Study||18
233933|NCT00914810|569184|P2|STARTED|Overall Study||19
233934|NCT00914810|569185|P1|STARTED|Overall Study||20
233935|NCT00914849|569195|P2|NOT COMPLETED|Overall Study||1
233936|NCT00914849|569196|P1|NOT COMPLETED|Overall Study||1
233937|NCT00914849|569195|P2|COMPLETED|Overall Study||33
233938|NCT00914849|569196|P1|COMPLETED|Overall Study||33
233939|NCT00914849|569195|P2|STARTED|Overall Study||34
233940|NCT00914849|569196|P1|STARTED|Overall Study||34
233941|NCT00914862|569233|P5|NOT COMPLETED|Overall Study||0
233942|NCT00914862|569234|P4|NOT COMPLETED|Overall Study||0
233943|NCT00914862|569235|P3|NOT COMPLETED|Overall Study||0
233944|NCT00914862|569236|P2|NOT COMPLETED|Overall Study||0
233945|NCT00914862|569237|P1|NOT COMPLETED|Overall Study||0
233946|NCT00914862|569233|P5|COMPLETED|Overall Study||28
233947|NCT00914862|569234|P4|COMPLETED|Overall Study||8
233948|NCT00914862|569235|P3|COMPLETED|Overall Study||8
233949|NCT00914862|569236|P2|COMPLETED|Overall Study||6
233950|NCT00914862|569237|P1|COMPLETED|Overall Study||6
233951|NCT00914862|569233|P5|STARTED|Overall Study||28
233952|NCT00914862|569234|P4|STARTED|Overall Study||8
233953|NCT00914862|569235|P3|STARTED|Overall Study||8
233954|NCT00914862|569236|P2|STARTED|Overall Study||6
233955|NCT00914862|569237|P1|STARTED|Overall Study||6
233956|NCT00914966|569309|P1|NOT COMPLETED|Step 3: 2500 Units||0
233957|NCT00914966|569309|P1|COMPLETED|Step 3: 2500 Units||12
233958|NCT00914966|569309|P1|STARTED|Step 3: 2500 Units||12
233959|NCT00914966|569309|P1|NOT COMPLETED|Step 2: 2000 Units||1
233960|NCT00914966|569309|P1|COMPLETED|Step 2: 2000 Units||12
233961|NCT00914966|569309|P1|STARTED|Step 2: 2000 Units||13
233962|NCT00914966|569309|P1|NOT COMPLETED|Step 1: 1500 Units||2
233963|NCT00914966|569309|P1|COMPLETED|Step 1: 1500 Units|5/18 subjects completing Step 1 (1500 Units) entered the 3 month follow-up and did not dose escalate|18
233964|NCT00914966|569309|P1|STARTED|Step 1: 1500 Units||20
233965|NCT00915148|569321|P1|NOT COMPLETED|Overall Study||0
233966|NCT00915148|569321|P1|COMPLETED|Overall Study|August 2010|110
233967|NCT00915148|569321|P1|STARTED|Overall Study|October 2009|110
233968|NCT00915278|569332|P6|NOT COMPLETED|Overall Study||8
233969|NCT00915278|569333|P5|NOT COMPLETED|Overall Study||2
233970|NCT00915278|569334|P4|NOT COMPLETED|Overall Study||3
233971|NCT00915278|569335|P3|NOT COMPLETED|Overall Study||1
233972|NCT00915278|569336|P2|NOT COMPLETED|Overall Study||3
233973|NCT00915278|569337|P1|NOT COMPLETED|Overall Study||5
233974|NCT00915278|569332|P6|COMPLETED|Overall Study||1
233975|NCT00915278|569333|P5|COMPLETED|Overall Study||1
233976|NCT00915278|569334|P4|COMPLETED|Overall Study||2
233977|NCT00915278|569335|P3|COMPLETED|Overall Study||2
233978|NCT00915278|569336|P2|COMPLETED|Overall Study||2
233979|NCT00915278|569337|P1|COMPLETED|Overall Study||3
233980|NCT00915278|569332|P6|STARTED|Overall Study||9
233981|NCT00915278|569333|P5|STARTED|Overall Study||3
233982|NCT00915278|569334|P4|STARTED|Overall Study||5
233983|NCT00915278|569335|P3|STARTED|Overall Study||3
233984|NCT00915278|569336|P2|STARTED|Overall Study||5
233985|NCT00915278|569337|P1|STARTED|Overall Study||8
233986|NCT00915343|569483|P3|NOT COMPLETED|Part B - Open Label Period||2
233987|NCT00915343|569484|P2|NOT COMPLETED|Part B - Open Label Period||0
233988|NCT00915343|569485|P1|NOT COMPLETED|Part B - Open Label Period||0
233989|NCT00915343|569483|P3|COMPLETED|Part B - Open Label Period||57
233990|NCT00915343|569484|P2|COMPLETED|Part B - Open Label Period||0
233991|NCT00915343|569485|P1|COMPLETED|Part B - Open Label Period||0
233992|NCT00915343|569483|P3|STARTED|Part B - Open Label Period||59
233993|NCT00915343|569484|P2|STARTED|Part B - Open Label Period||0
233994|NCT00915343|569485|P1|STARTED|Part B - Open Label Period||0
233995|NCT00915343|569483|P3|NOT COMPLETED|Part A - Second Intervention Period||0
233996|NCT00915343|569484|P2|NOT COMPLETED|Part A - Second Intervention Period||0
233997|NCT00915343|569485|P1|NOT COMPLETED|Part A - Second Intervention Period||0
233998|NCT00915343|569483|P3|COMPLETED|Part A - Second Intervention Period||0
233999|NCT00915343|569484|P2|COMPLETED|Part A - Second Intervention Period||32
234000|NCT00915343|569485|P1|COMPLETED|Part A - Second Intervention Period||32
234001|NCT00915343|569483|P3|STARTED|Part A - Second Intervention Period||0
234002|NCT00915343|569484|P2|STARTED|Part A - Second Intervention Period||32
234003|NCT00915343|569485|P1|STARTED|Part A - Second Intervention Period||32
234004|NCT00915343|569483|P3|NOT COMPLETED|Part A - First Intervention Period||0
234005|NCT00915343|569484|P2|NOT COMPLETED|Part A - First Intervention Period||0
234006|NCT00915343|569485|P1|NOT COMPLETED|Part A - First Intervention Period||0
234007|NCT00915343|569483|P3|COMPLETED|Part A - First Intervention Period||0
234008|NCT00915343|569484|P2|COMPLETED|Part A - First Intervention Period||32
234009|NCT00915343|569485|P1|COMPLETED|Part A - First Intervention Period||32
234010|NCT00915343|569483|P3|STARTED|Part A - First Intervention Period||0
234011|NCT00915343|569484|P2|STARTED|Part A - First Intervention Period||32
234012|NCT00915343|569485|P1|STARTED|Part A - First Intervention Period||32
234013|NCT00915356|569569|P5|NOT COMPLETED|Overall Study||0
234014|NCT00915356|569570|P4|NOT COMPLETED|Overall Study||0
234015|NCT00915356|569571|P3|NOT COMPLETED|Overall Study||0
234016|NCT00915356|569572|P2|NOT COMPLETED|Overall Study||0
234017|NCT00915356|569573|P1|NOT COMPLETED|Overall Study||1
234018|NCT00915356|569569|P5|COMPLETED|Overall Study||43
234019|NCT00915356|569570|P4|COMPLETED|Overall Study||12
234020|NCT00915356|569571|P3|COMPLETED|Overall Study||45
234021|NCT00915356|569572|P2|COMPLETED|Overall Study||45
234022|NCT00915356|569573|P1|COMPLETED|Overall Study||25
234023|NCT00915356|569569|P5|STARTED|Overall Study||43
234024|NCT00915356|569570|P4|STARTED|Overall Study||12
234025|NCT00915356|569571|P3|STARTED|Overall Study||45
234026|NCT00915356|569572|P2|STARTED|Overall Study||45
234027|NCT00915356|569573|P1|STARTED|Overall Study||26
234028|NCT00905515|569638|P3|NOT COMPLETED|Overall Study||2
234029|NCT00905515|569639|P2|NOT COMPLETED|Overall Study||0
234030|NCT00905515|569640|P1|NOT COMPLETED|Overall Study||2
234031|NCT00905515|569638|P3|COMPLETED|Overall Study||20
234032|NCT00905515|569639|P2|COMPLETED|Overall Study||20
234033|NCT00905515|569640|P1|COMPLETED|Overall Study||19
234034|NCT00905515|569638|P3|STARTED|Overall Study||22
234035|NCT00905515|569639|P2|STARTED|Overall Study||20
234036|NCT00905515|569640|P1|STARTED|Overall Study||21
234037|NCT00905554|569650|P2|NOT COMPLETED|Overall Study||0
234038|NCT00905554|569651|P1|NOT COMPLETED|Overall Study||0
234039|NCT00905554|569650|P2|COMPLETED|Overall Study||114
234040|NCT00905554|569651|P1|COMPLETED|Overall Study||116
234041|NCT00905554|569650|P2|STARTED|Overall Study||114
234042|NCT00905554|569651|P1|STARTED|Overall Study||116
234043|NCT00905567|569661|P2|NOT COMPLETED|Period 2||0
234044|NCT00905567|569662|P1|NOT COMPLETED|Period 2||0
234045|NCT00905567|569661|P2|COMPLETED|Period 2||11
234046|NCT00905567|569662|P1|COMPLETED|Period 2||12
234047|NCT00905567|569661|P2|STARTED|Period 2||11
234048|NCT00905567|569662|P1|STARTED|Period 2||12
234049|NCT00905567|569661|P2|NOT COMPLETED|Washout||1
234050|NCT00905567|569662|P1|NOT COMPLETED|Washout||0
234051|NCT00905567|569661|P2|COMPLETED|Washout||11
234052|NCT00905567|569662|P1|COMPLETED|Washout||12
234053|NCT00905567|569661|P2|STARTED|Washout||12
234054|NCT00905567|569662|P1|STARTED|Washout||12
234055|NCT00905567|569661|P2|NOT COMPLETED|Period 1||0
234056|NCT00905567|569662|P1|NOT COMPLETED|Period 1||0
234057|NCT00905567|569661|P2|COMPLETED|Period 1||12
234058|NCT00905567|569662|P1|COMPLETED|Period 1||12
234059|NCT00905567|569661|P2|STARTED|Period 1||12
234060|NCT00905567|569662|P1|STARTED|Period 1||12
234061|NCT00905580|569672|P2|NOT COMPLETED|Overall Study||3
234062|NCT00905580|569673|P1|NOT COMPLETED|Overall Study||2
234063|NCT00905580|569672|P2|COMPLETED|Overall Study||47
234064|NCT00905580|569673|P1|COMPLETED|Overall Study||47
234065|NCT00905580|569672|P2|STARTED|Overall Study||50
234066|NCT00905580|569673|P1|STARTED|Overall Study||49
234067|NCT00905606|569687|P2|NOT COMPLETED|Period 2||0
234068|NCT00905606|569688|P1|NOT COMPLETED|Period 2||0
234069|NCT00905606|569687|P2|COMPLETED|Period 2||14
234070|NCT00905606|569688|P1|COMPLETED|Period 2||14
234071|NCT00905606|569687|P2|STARTED|Period 2||14
234072|NCT00905606|569688|P1|STARTED|Period 2||14
234073|NCT00905606|569687|P2|NOT COMPLETED|Washout||0
234074|NCT00905606|569688|P1|NOT COMPLETED|Washout||1
234075|NCT00905606|569687|P2|COMPLETED|Washout||14
234076|NCT00905606|569688|P1|COMPLETED|Washout||14
234077|NCT00905606|569687|P2|STARTED|Washout||14
234078|NCT00905606|569688|P1|STARTED|Washout||15
234079|NCT00905606|569687|P2|NOT COMPLETED|Period 1||1
234080|NCT00905606|569688|P1|NOT COMPLETED|Period 1||0
234081|NCT00905606|569687|P2|COMPLETED|Period 1||14
234082|NCT00905606|569688|P1|COMPLETED|Period 1||15
234083|NCT00905606|569687|P2|STARTED|Period 1||15
234084|NCT00905606|569688|P1|STARTED|Period 1||15
234085|NCT00905632|569703|P7|NOT COMPLETED|Overall Study||4
234086|NCT00905632|569704|P6|NOT COMPLETED|Overall Study||1
234087|NCT00905632|569705|P5|NOT COMPLETED|Overall Study||0
234088|NCT00905632|569706|P4|NOT COMPLETED|Overall Study||0
234089|NCT00905632|569707|P3|NOT COMPLETED|Overall Study||0
234090|NCT00905632|569708|P2|NOT COMPLETED|Overall Study||0
234091|NCT00905632|569709|P1|NOT COMPLETED|Overall Study||0
234092|NCT00905632|569703|P7|COMPLETED|Overall Study||7
234093|NCT00905632|569704|P6|COMPLETED|Overall Study||8
234094|NCT00905632|569705|P5|COMPLETED|Overall Study||10
234095|NCT00905632|569706|P4|COMPLETED|Overall Study||6
234096|NCT00905632|569707|P3|COMPLETED|Overall Study||7
234097|NCT00905632|569708|P2|COMPLETED|Overall Study||6
234098|NCT00905632|569709|P1|COMPLETED|Overall Study||8
234099|NCT00905632|569703|P7|STARTED|Overall Study||11
234100|NCT00905632|569704|P6|STARTED|Overall Study||9
234101|NCT00905632|569705|P5|STARTED|Overall Study||10
234102|NCT00905632|569706|P4|STARTED|Overall Study||6
234103|NCT00905632|569707|P3|STARTED|Overall Study||7
234104|NCT00905632|569708|P2|STARTED|Overall Study||6
234105|NCT00905632|569709|P1|STARTED|Overall Study||8
234106|NCT00905827|569848|P3|NOT COMPLETED|Overall Study||0
234107|NCT00905827|569849|P2|NOT COMPLETED|Overall Study||0
234108|NCT00905827|569850|P1|NOT COMPLETED|Overall Study||0
234109|NCT00905827|569848|P3|COMPLETED|Overall Study||73
234110|NCT00905827|569849|P2|COMPLETED|Overall Study||69
234111|NCT00905827|569850|P1|COMPLETED|Overall Study||70
234112|NCT00905827|569848|P3|STARTED|Overall Study||73
234113|NCT00905827|569849|P2|STARTED|Overall Study||69
234114|NCT00905827|569850|P1|STARTED|Overall Study||70
234115|NCT00905840|569860|P1|NOT COMPLETED|Overall Study||16
234116|NCT00905840|569860|P1|COMPLETED|Overall Study||75
234117|NCT00905840|569860|P1|STARTED|Overall Study||91
234118|NCT00906074|569871|P2|NOT COMPLETED|Overall Study||0
234119|NCT00906074|569872|P1|NOT COMPLETED|Overall Study||0
234120|NCT00906074|569871|P2|COMPLETED|Overall Study||90
234121|NCT00906074|569872|P1|COMPLETED|Overall Study||90
234122|NCT00906074|569871|P2|STARTED|Overall Study||90
234123|NCT00906074|569872|P1|STARTED|Overall Study||90
234124|NCT00906087|569896|P1|NOT COMPLETED|Final Washout Period 4 Weeks||0
234125|NCT00906087|569896|P1|COMPLETED|Final Washout Period 4 Weeks||12
234126|NCT00906087|569896|P1|STARTED|Final Washout Period 4 Weeks||12
234127|NCT00906087|569896|P1|NOT COMPLETED|Cosopt Treatment 6 Weeks||0
234128|NCT00906087|569896|P1|COMPLETED|Cosopt Treatment 6 Weeks||12
234129|NCT00906087|569896|P1|STARTED|Cosopt Treatment 6 Weeks||12
234130|NCT00906087|569896|P1|NOT COMPLETED|Initial Washout||2
234131|NCT00906087|569896|P1|COMPLETED|Initial Washout||12
234132|NCT00906087|569896|P1|Completed Washout and Continue Protocol|Initial Washout||12
234133|NCT00906087|569896|P1|Begin Washout|Initial Washout||13
234134|NCT00906087|569896|P1|Completed Screening|Initial Washout||14
234135|NCT00906087|569896|P1|STARTED|Initial Washout||14
234136|NCT00906178|569905|P2|NOT COMPLETED|Overall Study||16
234137|NCT00906178|569906|P1|NOT COMPLETED|Overall Study||15
234138|NCT00906178|569905|P2|COMPLETED|Overall Study||167
234139|NCT00906178|569906|P1|COMPLETED|Overall Study||168
234140|NCT00906178|569905|P2|STARTED|Overall Study||183
234141|NCT00906178|569906|P1|STARTED|Overall Study||183
234142|NCT00906204|569920|P2|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||3
234143|NCT00906204|569921|P1|NOT COMPLETED|Secondary Endpoints (Long-term Safety)||2
234144|NCT00906204|569920|P2|COMPLETED|Secondary Endpoints (Long-term Safety)||48
234145|NCT00906204|569921|P1|COMPLETED|Secondary Endpoints (Long-term Safety)||41
234146|NCT00906204|569920|P2|STARTED|Secondary Endpoints (Long-term Safety)||51
234147|NCT00906204|569921|P1|STARTED|Secondary Endpoints (Long-term Safety)||43
234148|NCT00906204|569920|P2|NOT COMPLETED|Primary Endpoint (Early Safety)||1
234149|NCT00906204|569921|P1|NOT COMPLETED|Primary Endpoint (Early Safety)||2
234150|NCT00906204|569920|P2|COMPLETED|Primary Endpoint (Early Safety)||51
234151|NCT00906204|569921|P1|COMPLETED|Primary Endpoint (Early Safety)||43
234152|NCT00906204|569920|P2|STARTED|Primary Endpoint (Early Safety)||52
234153|NCT00906204|569921|P1|STARTED|Primary Endpoint (Early Safety)||45
234154|NCT00906243|569937|P1|NOT COMPLETED|Overall Study||0
234155|NCT00906243|569937|P1|COMPLETED|Overall Study||6
234156|NCT00906243|569937|P1|STARTED|Overall Study||6
234157|NCT00906282|569941|P1|NOT COMPLETED|Surgical Resection||0
234158|NCT00906282|569941|P1|COMPLETED|Surgical Resection||27
234159|NCT00906282|569941|P1|STARTED|Surgical Resection||27
234160|NCT00906282|569941|P1|NOT COMPLETED|Preoperative Chemotherapy||19
234161|NCT00906282|569941|P1|COMPLETED|Preoperative Chemotherapy|2 of 27 patients completed less than 4 cycles and were deemed surgical candidates.|27
234162|NCT00906282|569941|P1|STARTED|Preoperative Chemotherapy||46
234163|NCT00906347|569951|P2|NOT COMPLETED|Received Study Drug||31
234164|NCT00906347|569952|P1|NOT COMPLETED|Received Study Drug||40
234165|NCT00906347|569951|P2|COMPLETED|Received Study Drug||143
234166|NCT00906347|569952|P1|COMPLETED|Received Study Drug||136
234167|NCT00906347|569951|P2|STARTED|Received Study Drug||174
234168|NCT00906347|569952|P1|STARTED|Received Study Drug||176
234169|NCT00906347|569951|P2|NOT COMPLETED|Randomized||0
234170|NCT00906347|569952|P1|NOT COMPLETED|Randomized||0
234171|NCT00906347|569951|P2|COMPLETED|Randomized||174
234172|NCT00906347|569952|P1|COMPLETED|Randomized||176
234173|NCT00906347|569951|P2|STARTED|Randomized||174
234174|NCT00906347|569952|P1|STARTED|Randomized||176
234175|NCT00906399|569975|P7|NOT COMPLETED|Year 2||29
234176|NCT00906399|569976|P6|NOT COMPLETED|Year 2||47
234177|NCT00906399|569977|P5|NOT COMPLETED|Year 2||35
234178|NCT00906399|569978|P4|NOT COMPLETED|Year 2||30
234179|NCT00906399|569979|P3|NOT COMPLETED|Year 2||0
234180|NCT00906399|569980|P2|NOT COMPLETED|Year 2||0
234181|NCT00906399|569981|P1|NOT COMPLETED|Year 2||0
234182|NCT00906399|569975|P7|COMPLETED|Year 2||409
234183|NCT00906399|569976|P6|COMPLETED|Year 2||391
234184|NCT00906399|569977|P5|COMPLETED|Year 2||193
234185|NCT00906399|569978|P4|COMPLETED|Year 2||198
234186|NCT00906399|569979|P3|COMPLETED|Year 2||0
234187|NCT00906399|569980|P2|COMPLETED|Year 2||0
234188|NCT00906399|569981|P1|COMPLETED|Year 2||0
234189|NCT00906399|569975|P7|Completed Year 2 Study Treatment|Year 2||411
234190|NCT00906399|569976|P6|Completed Year 2 Study Treatment|Year 2||391
234191|NCT00906399|569977|P5|Completed Year 2 Study Treatment|Year 2||196
234192|NCT00906399|569978|P4|Completed Year 2 Study Treatment|Year 2||200
234193|NCT00906399|569979|P3|Completed Year 2 Study Treatment|Year 2||0
234194|NCT00906399|569980|P2|Completed Year 2 Study Treatment|Year 2||0
234195|NCT00906399|569981|P1|Completed Year 2 Study Treatment|Year 2||0
234196|NCT00906399|569975|P7|STARTED|Year 2||438
234197|NCT00906399|569976|P6|STARTED|Year 2||438
234198|NCT00906399|569977|P5|STARTED|Year 2||228
234199|NCT00906399|569978|P4|STARTED|Year 2||228
234200|NCT00906399|569979|P3|STARTED|Year 2||0
234201|NCT00906399|569980|P2|STARTED|Year 2||0
234202|NCT00906399|569981|P1|STARTED|Year 2||0
234203|NCT00906399|569975|P7|NOT COMPLETED|Year 1||0
234204|NCT00906399|569976|P6|NOT COMPLETED|Year 1||0
234205|NCT00906399|569977|P5|NOT COMPLETED|Year 1||0
234206|NCT00906399|569978|P4|NOT COMPLETED|Year 1||0
234207|NCT00906399|569979|P3|NOT COMPLETED|Year 1||76
234208|NCT00906399|569980|P2|NOT COMPLETED|Year 1||63
234209|NCT00906399|569981|P1|NOT COMPLETED|Year 1||44
234210|NCT00906399|569975|P7|COMPLETED|Year 1||0
234211|NCT00906399|569976|P6|COMPLETED|Year 1||0
234212|NCT00906399|569977|P5|COMPLETED|Year 1||0
234213|NCT00906399|569978|P4|COMPLETED|Year 1||0
234214|NCT00906399|569979|P3|COMPLETED|Year 1|1 participant discontinued treatment before end of study period but remained to complete follow-up.|439
234215|NCT00906399|569980|P2|COMPLETED|Year 1||438
234216|NCT00906399|569981|P1|COMPLETED|Year 1||456
234217|NCT00906399|569975|P7|Completed Year 1 Study Treatment|Year 1||0
234218|NCT00906399|569976|P6|Completed Year 1 Study Treatment|Year 1||0
234219|NCT00906399|569977|P5|Completed Year 1 Study Treatment|Year 1||0
234220|NCT00906399|569978|P4|Completed Year 1 Study Treatment|Year 1||0
234221|NCT00906399|569979|P3|Completed Year 1 Study Treatment|Year 1||438
234222|NCT00906399|569980|P2|Completed Year 1 Study Treatment|Year 1||438
234223|NCT00906399|569981|P1|Completed Year 1 Study Treatment|Year 1||456
234224|NCT00906399|569975|P7|STARTED|Year 1||0
234225|NCT00906399|569976|P6|STARTED|Year 1||0
234226|NCT00906399|569977|P5|STARTED|Year 1||0
234227|NCT00906399|569978|P4|STARTED|Year 1||0
234228|NCT00906399|569979|P3|STARTED|Year 1||515
234229|NCT00906399|569980|P2|STARTED|Year 1||501
234230|NCT00906399|569981|P1|STARTED|Year 1||500
234231|NCT00906425|570004|P2|NOT COMPLETED|Overall Study||72
234232|NCT00906425|570005|P1|NOT COMPLETED|Overall Study||73
234233|NCT00906425|570004|P2|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
234234|NCT00906425|570005|P1|COMPLETED|Overall Study|Clinical Trial expected to be completed in 2013|0
234235|NCT00906425|570004|P2|2 Year|Overall Study|ITT population|58
234236|NCT00906425|570005|P1|2 Year|Overall Study|ITT population|62
234237|NCT00906425|570004|P2|1 Year|Overall Study|ITT population|60
234238|NCT00906425|570005|P1|1 Year|Overall Study|ITT population|67
234239|NCT00906425|570004|P2|6 Months|Overall Study|ITT population|64
234240|NCT00906425|570005|P1|6 Months|Overall Study|ITT population|69
234241|NCT00906425|570004|P2|STARTED|Overall Study||72
234242|NCT00906425|570005|P1|STARTED|Overall Study||73
234243|NCT00906503|570015|P1|NOT COMPLETED|Overall Study||0
234244|NCT00906503|570015|P1|COMPLETED|Overall Study||9
234245|NCT00906503|570015|P1|STARTED|Overall Study||9
234246|NCT00906698|570025|P6|NOT COMPLETED|Overall Study||5
234247|NCT00906698|570026|P5|NOT COMPLETED|Overall Study||18
234248|NCT00906698|570027|P4|NOT COMPLETED|Overall Study||4
234249|NCT00906698|570028|P3|NOT COMPLETED|Overall Study||6
234250|NCT00906698|570029|P2|NOT COMPLETED|Overall Study||19
234251|NCT00906698|570030|P1|NOT COMPLETED|Overall Study||3
234252|NCT00906698|570025|P6|COMPLETED|Overall Study||0
234253|NCT00906698|570026|P5|COMPLETED|Overall Study||0
234254|NCT00906698|570027|P4|COMPLETED|Overall Study||0
234255|NCT00906698|570028|P3|COMPLETED|Overall Study||0
234256|NCT00906698|570029|P2|COMPLETED|Overall Study||0
234257|NCT00906698|570030|P1|COMPLETED|Overall Study||0
234258|NCT00906698|570025|P6|STARTED|Overall Study||5
234259|NCT00906698|570026|P5|STARTED|Overall Study||18
234260|NCT00906698|570027|P4|STARTED|Overall Study||4
234261|NCT00906698|570028|P3|STARTED|Overall Study||6
234262|NCT00906698|570029|P2|STARTED|Overall Study||19
234263|NCT00906698|570030|P1|STARTED|Overall Study||3
234264|NCT00906776|570114|P2|NOT COMPLETED|Overall Study||0
234265|NCT00906776|570115|P1|NOT COMPLETED|Overall Study||0
234266|NCT00906776|570114|P2|COMPLETED|Overall Study||8
234267|NCT00906776|570115|P1|COMPLETED|Overall Study||11
234268|NCT00906776|570114|P2|STARTED|Overall Study||8
234269|NCT00906776|570115|P1|STARTED|Overall Study||11
234270|NCT00906789|570131|P1|NOT COMPLETED|Overall Study||0
234271|NCT00906789|570131|P1|COMPLETED|Overall Study||15
234272|NCT00906789|570131|P1|STARTED|Overall Study|Radiologists served as own control. Total enrollment is 15 radiologists.|15
234273|NCT00906945|570144|P6|NOT COMPLETED|Overall Study||2
234274|NCT00906945|570145|P5|NOT COMPLETED|Overall Study||1
234275|NCT00906945|570146|P4|NOT COMPLETED|Overall Study||1
234276|NCT00906945|570147|P3|NOT COMPLETED|Overall Study||0
234277|NCT00906945|570148|P2|NOT COMPLETED|Overall Study||0
234278|NCT00906945|570149|P1|NOT COMPLETED|Overall Study||0
234279|NCT00906945|570144|P6|COMPLETED|Overall Study||14
234280|NCT00906945|570145|P5|COMPLETED|Overall Study||6
234281|NCT00906945|570146|P4|COMPLETED|Overall Study||6
234282|NCT00906945|570147|P3|COMPLETED|Overall Study||3
234283|NCT00906945|570148|P2|COMPLETED|Overall Study||3
234284|NCT00906945|570149|P1|COMPLETED|Overall Study||3
234285|NCT00906945|570144|P6|STARTED|Overall Study||16
234286|NCT00906945|570145|P5|STARTED|Overall Study||7
234287|NCT00906945|570146|P4|STARTED|Overall Study||7
234288|NCT00906945|570147|P3|STARTED|Overall Study||3
234289|NCT00906945|570148|P2|STARTED|Overall Study||3
234290|NCT00906945|570149|P1|STARTED|Overall Study||3
234291|NCT00906971|570178|P2|NOT COMPLETED|Overall Study||3
234292|NCT00906971|570179|P1|NOT COMPLETED|Overall Study||8
234293|NCT00906971|570178|P2|COMPLETED|Overall Study||33
234294|NCT00906971|570179|P1|COMPLETED|Overall Study||28
234295|NCT00906971|570178|P2|STARTED|Overall Study||36
234296|NCT00906971|570179|P1|STARTED|Overall Study||36
234297|NCT00907088|570189|P2|NOT COMPLETED|Overall Study||30
234298|NCT00907088|570190|P1|NOT COMPLETED|Overall Study||20
234299|NCT00907088|570189|P2|COMPLETED|Overall Study||99
234300|NCT00907088|570190|P1|COMPLETED|Overall Study||102
234301|NCT00907088|570189|P2|STARTED|Overall Study||129
234302|NCT00907088|570190|P1|STARTED|Overall Study||122
234303|NCT00907101|570196|P1|NOT COMPLETED|Overall Study||0
234304|NCT00907101|570196|P1|COMPLETED|Overall Study||30
234305|NCT00907101|570196|P1|STARTED|Overall Study||30
234306|NCT00907218|570204|P1|NOT COMPLETED|Overall Study||0
234307|NCT00907218|570204|P1|COMPLETED|Overall Study||2
234308|NCT00907218|570204|P1|STARTED|Overall Study||2
234309|NCT00907257|570210|P2|NOT COMPLETED|Overall Study||12
234310|NCT00907257|570211|P1|NOT COMPLETED|Overall Study||13
234311|NCT00907257|570210|P2|COMPLETED|Overall Study||112
234312|NCT00907257|570211|P1|COMPLETED|Overall Study||110
234313|NCT00907257|570210|P2|STARTED|Overall Study||124
234314|NCT00907257|570211|P1|STARTED|Overall Study||123
234315|NCT00907335|570223|P2|NOT COMPLETED|Overall Study||1
234316|NCT00907335|570224|P1|NOT COMPLETED|Overall Study||8
234317|NCT00907335|570223|P2|COMPLETED|Overall Study||54
234318|NCT00907335|570224|P1|COMPLETED|Overall Study||47
234319|NCT00907335|570223|P2|STARTED|Overall Study||55
234320|NCT00907335|570224|P1|STARTED|Overall Study||55
234321|NCT00907374|570242|P2|NOT COMPLETED|Overall Study||2
234322|NCT00907374|570243|P1|NOT COMPLETED|Overall Study||2
234323|NCT00907374|570242|P2|COMPLETED|Overall Study||11
234324|NCT00907374|570243|P1|COMPLETED|Overall Study||12
234325|NCT00907374|570242|P2|STARTED|Overall Study||13
234326|NCT00907374|570243|P1|STARTED|Overall Study||14
234327|NCT00907426|570258|P3|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||7
234328|NCT00907426|570259|P2|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||3
234329|NCT00907426|570260|P1|NOT COMPLETED|Treatment Period 2 (6 to 12 Months)||11
234330|NCT00907426|570258|P3|COMPLETED|Treatment Period 2 (6 to 12 Months)||77
234331|NCT00907426|570259|P2|COMPLETED|Treatment Period 2 (6 to 12 Months)||52
234332|NCT00907426|570260|P1|COMPLETED|Treatment Period 2 (6 to 12 Months)||184
234333|NCT00907426|570258|P3|STARTED|Treatment Period 2 (6 to 12 Months)||84
234334|NCT00907426|570259|P2|STARTED|Treatment Period 2 (6 to 12 Months)||55
234335|NCT00907426|570260|P1|STARTED|Treatment Period 2 (6 to 12 Months)||195
234336|NCT00907426|570258|P3|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||9
234337|NCT00907426|570259|P2|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||5
234338|NCT00907426|570260|P1|NOT COMPLETED|Treatment Period 1 (0 to 6 Months)||20
234339|NCT00907426|570258|P3|COMPLETED|Treatment Period 1 (0 to 6 Months)||84
234340|NCT00907426|570259|P2|COMPLETED|Treatment Period 1 (0 to 6 Months)||55
234341|NCT00907426|570260|P1|COMPLETED|Treatment Period 1 (0 to 6 Months)||195
234342|NCT00907426|570258|P3|STARTED|Treatment Period 1 (0 to 6 Months)||93
234343|NCT00907426|570259|P2|STARTED|Treatment Period 1 (0 to 6 Months)||60
234344|NCT00907426|570260|P1|STARTED|Treatment Period 1 (0 to 6 Months)||215
234345|NCT00907478|570278|P3|NOT COMPLETED|Overall Study||22
234346|NCT00907478|570279|P2|NOT COMPLETED|Overall Study||17
234347|NCT00907478|570280|P1|NOT COMPLETED|Overall Study||27
234348|NCT00907478|570278|P3|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|47
234349|NCT00907478|570279|P2|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|33
234350|NCT00907478|570280|P1|COMPLETED|Overall Study|Defined as participants who completed the full 3 years and completed the end of study visit.|23
234351|NCT00907478|570278|P3|STARTED|Overall Study||69
234352|NCT00907478|570279|P2|STARTED|Overall Study||50
234353|NCT00907478|570280|P1|STARTED|Overall Study||50
234354|NCT00915473|570310|P2|NOT COMPLETED|4-week Follow Up||5
234355|NCT00915473|570311|P1|NOT COMPLETED|4-week Follow Up||1
234356|NCT00915473|570310|P2|COMPLETED|4-week Follow Up||30
234357|NCT00915473|570311|P1|COMPLETED|4-week Follow Up||33
234358|NCT00915473|570310|P2|STARTED|4-week Follow Up||35
234359|NCT00915473|570311|P1|STARTED|4-week Follow Up||34
234360|NCT00915473|570310|P2|NOT COMPLETED|Injection||0
234361|NCT00915473|570311|P1|NOT COMPLETED|Injection||0
234362|NCT00915473|570310|P2|COMPLETED|Injection||35
234363|NCT00915473|570311|P1|COMPLETED|Injection||34
234364|NCT00915473|570310|P2|STARTED|Injection||35
234365|NCT00915473|570311|P1|STARTED|Injection||34
234366|NCT00915473|570310|P2|NOT COMPLETED|Screening||0
234367|NCT00915473|570311|P1|NOT COMPLETED|Screening||1
234368|NCT00915473|570310|P2|COMPLETED|Screening||35
234369|NCT00915473|570311|P1|COMPLETED|Screening||34
234370|NCT00915473|570310|P2|STARTED|Screening||35
234371|NCT00915473|570311|P1|STARTED|Screening||35
234372|NCT00915499|570325|P2|NOT COMPLETED|Overall Study||2
234373|NCT00915499|570326|P1|NOT COMPLETED|Overall Study||4
234374|NCT00915499|570325|P2|COMPLETED|Overall Study||31
234375|NCT00915499|570326|P1|COMPLETED|Overall Study||29
234376|NCT00915499|570325|P2|STARTED|Overall Study||33
234377|NCT00915499|570326|P1|STARTED|Overall Study||33
234378|NCT00915525|570336|P2|NOT COMPLETED|Overall Study||135
234379|NCT00915525|570337|P1|NOT COMPLETED|Overall Study||265
234380|NCT00915525|570336|P2|COMPLETED|Overall Study||151
234381|NCT00915525|570337|P1|COMPLETED|Overall Study||278
234382|NCT00915525|570336|P2|STARTED|Overall Study||286
234383|NCT00915525|570337|P1|STARTED|Overall Study||543
234384|NCT00915551|570440|P2|NOT COMPLETED|Overall Study||1
234385|NCT00915551|570441|P1|NOT COMPLETED|Overall Study||0
234386|NCT00915551|570440|P2|COMPLETED|Overall Study||135
234387|NCT00915551|570441|P1|COMPLETED|Overall Study||142
234388|NCT00915551|570440|P2|STARTED|Overall Study||136
234389|NCT00915551|570441|P1|STARTED|Overall Study||142
234390|NCT00915590|570451|P2|NOT COMPLETED|Overall Study||1
234391|NCT00915590|570452|P1|NOT COMPLETED|Overall Study||2
234392|NCT00915590|570451|P2|COMPLETED|Overall Study||4
234393|NCT00915590|570452|P1|COMPLETED|Overall Study||3
234394|NCT00915590|570451|P2|STARTED|Overall Study||5
234395|NCT00915590|570452|P1|STARTED|Overall Study||5
234396|NCT00915603|570471|P2|NOT COMPLETED|Overall Study||55
234397|NCT00915603|570472|P1|NOT COMPLETED|Overall Study||56
234398|NCT00915603|570471|P2|COMPLETED|Overall Study||0
234399|NCT00915603|570472|P1|COMPLETED|Overall Study||0
234400|NCT00915603|570471|P2|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|55
234401|NCT00915603|570472|P1|STARTED|Overall Study|One patient enrolled/randomized but did not start treatment|56
234402|NCT00915655|570486|P1|NOT COMPLETED|Overall Study||0
234403|NCT00915655|570486|P1|COMPLETED|Overall Study|'Completed' represents patients who have not discontinued at time of cut-off for Week 24 analysis|12
234404|NCT00915655|570486|P1|STARTED|Overall Study||12
234405|NCT00915759|570491|P1|NOT COMPLETED|Overall Study||0
234406|NCT00915759|570491|P1|COMPLETED|Overall Study|number of participants|40
234407|NCT00915759|570491|P1|STARTED|Overall Study|number of participants|40
234408|NCT00915772|570504|P3|NOT COMPLETED|Overall Study||29
234409|NCT00915772|570505|P2|NOT COMPLETED|Overall Study||46
234410|NCT00915772|570506|P1|NOT COMPLETED|Overall Study||36
234411|NCT00915772|570504|P3|COMPLETED|Overall Study||142
234412|NCT00915772|570505|P2|COMPLETED|Overall Study||179
234413|NCT00915772|570506|P1|COMPLETED|Overall Study||134
234414|NCT00915772|570504|P3|STARTED|Overall Study||171
234415|NCT00915772|570505|P2|STARTED|Overall Study||225
234416|NCT00915772|570506|P1|STARTED|Overall Study||170
234417|NCT00915798|570555|P4|NOT COMPLETED|Overall Study||0
234418|NCT00915798|570556|P3|NOT COMPLETED|Overall Study||0
234419|NCT00915798|570557|P2|NOT COMPLETED|Overall Study||0
234420|NCT00915798|570558|P1|NOT COMPLETED|Overall Study||0
234421|NCT00915798|570555|P4|COMPLETED|Overall Study||26
234422|NCT00915798|570556|P3|COMPLETED|Overall Study||23
234423|NCT00915798|570557|P2|COMPLETED|Overall Study||21
234424|NCT00915798|570558|P1|COMPLETED|Overall Study||19
234425|NCT00915798|570555|P4|STARTED|Overall Study||26
234426|NCT00915798|570556|P3|STARTED|Overall Study||23
234427|NCT00915798|570557|P2|STARTED|Overall Study||21
234428|NCT00915798|570558|P1|STARTED|Overall Study||19
234429|NCT00918346|570578|P2|NOT COMPLETED|Post Study Period||0
234430|NCT00918346|570579|P1|NOT COMPLETED|Post Study Period||0
234431|NCT00918346|570578|P2|COMPLETED|Post Study Period||21
234432|NCT00918346|570579|P1|COMPLETED|Post Study Period||21
234433|NCT00918346|570578|P2|STARTED|Post Study Period||21
234434|NCT00918346|570579|P1|STARTED|Post Study Period||21
234435|NCT00918346|570578|P2|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
234436|NCT00918346|570579|P1|NOT COMPLETED|Second Treatment Period (4 Weeks)||0
234437|NCT00918346|570578|P2|COMPLETED|Second Treatment Period (4 Weeks)||21
234438|NCT00918346|570579|P1|COMPLETED|Second Treatment Period (4 Weeks)||21
234439|NCT00918346|570578|P2|STARTED|Second Treatment Period (4 Weeks)||21
234440|NCT00918346|570579|P1|STARTED|Second Treatment Period (4 Weeks)||21
234441|NCT00918346|570578|P2|NOT COMPLETED|Washout (at Least 4 Weeks)||0
234442|NCT00918346|570579|P1|NOT COMPLETED|Washout (at Least 4 Weeks)||0
234443|NCT00918346|570578|P2|COMPLETED|Washout (at Least 4 Weeks)||21
234444|NCT00918346|570579|P1|COMPLETED|Washout (at Least 4 Weeks)||21
234445|NCT00918346|570578|P2|STARTED|Washout (at Least 4 Weeks)||21
234446|NCT00918346|570579|P1|STARTED|Washout (at Least 4 Weeks)||21
234447|NCT00918346|570578|P2|NOT COMPLETED|First Treatment Period (4 Weeks)||1
234448|NCT00918346|570579|P1|NOT COMPLETED|First Treatment Period (4 Weeks)||0
234449|NCT00918346|570578|P2|COMPLETED|First Treatment Period (4 Weeks)|A patient completed the first treatment period but discontinued thereafter (did not start washout).|21
234450|NCT00918346|570579|P1|COMPLETED|First Treatment Period (4 Weeks)||21
234451|NCT00918346|570578|P2|STARTED|First Treatment Period (4 Weeks)||22
234452|NCT00918346|570579|P1|STARTED|First Treatment Period (4 Weeks)||21
234453|NCT00918385|570595|P2|NOT COMPLETED|Combination Nilutamide and Dasatinib||8
234454|NCT00918385|570596|P1|NOT COMPLETED|Combination Nilutamide and Dasatinib||6
234455|NCT00918385|570595|P2|COMPLETED|Combination Nilutamide and Dasatinib||3
234456|NCT00918385|570596|P1|COMPLETED|Combination Nilutamide and Dasatinib||6
234457|NCT00918385|570595|P2|STARTED|Combination Nilutamide and Dasatinib||11
234458|NCT00918385|570596|P1|STARTED|Combination Nilutamide and Dasatinib||12
234459|NCT00918385|570595|P2|NOT COMPLETED|Monotherapy||6
234460|NCT00918385|570596|P1|NOT COMPLETED|Monotherapy||2
234461|NCT00918385|570595|P2|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|11
234462|NCT00918385|570596|P1|COMPLETED|Monotherapy|Completed = received treatment until first disease progression on single agent.|12
234463|NCT00918385|570595|P2|STARTED|Monotherapy||17
234464|NCT00918385|570596|P1|STARTED|Monotherapy||14
234465|NCT00918580|570605|P1|NOT COMPLETED|After 6-month FU to 1-year FU||60
234466|NCT00918580|570605|P1|COMPLETED|After 6-month FU to 1-year FU||87
234467|NCT00918580|570605|P1|Continued After 6-Month FU|After 6-month FU to 1-year FU||89
234468|NCT00918580|570605|P1|STARTED|After 6-month FU to 1-year FU||147
234469|NCT00918580|570605|P1|NOT COMPLETED|Up to 6-month Follow-up(FU)||11
234470|NCT00918580|570605|P1|COMPLETED|Up to 6-month Follow-up(FU)|Completed include 1 participant:withdrew before Dose 2 (protocol violation) but completed 6-month FU|147
234471|NCT00918580|570605|P1|Vaccinated Dose 2|Up to 6-month Follow-up(FU)||146
234472|NCT00918580|570605|P1|Vaccinated Dose 1|Up to 6-month Follow-up(FU)||158
234473|NCT00918580|570605|P1|STARTED|Up to 6-month Follow-up(FU)||158
234474|NCT00918671|570623|P1|NOT COMPLETED|Overall Study||0
234475|NCT00918671|570623|P1|COMPLETED|Overall Study||60
234476|NCT00918671|570623|P1|STARTED|Overall Study||60
234477|NCT00918684|570628|P1|NOT COMPLETED|Treatment Phase||25
234478|NCT00918684|570628|P1|COMPLETED|Treatment Phase||65
234479|NCT00918684|570628|P1|STARTED|Treatment Phase||90
234480|NCT00918684|570628|P1|NOT COMPLETED|Two Week Drug Washout and Placebo Phase||16
234481|NCT00918684|570628|P1|COMPLETED|Two Week Drug Washout and Placebo Phase||90
234482|NCT00918684|570628|P1|STARTED|Two Week Drug Washout and Placebo Phase||106
234483|NCT00918736|570634|P1|NOT COMPLETED|Overall Study||4
234484|NCT00918736|570634|P1|COMPLETED|Overall Study|October, 2008|46
234485|NCT00918736|570634|P1|STARTED|Overall Study|October, 2007|50
234486|NCT00918749|570641|P3|NOT COMPLETED|Overall Study||7
234487|NCT00918749|570642|P2|NOT COMPLETED|Overall Study||3
234488|NCT00918749|570643|P1|NOT COMPLETED|Overall Study||7
234489|NCT00918749|570641|P3|COMPLETED|Overall Study||62
234490|NCT00918749|570642|P2|COMPLETED|Overall Study||63
234491|NCT00918749|570643|P1|COMPLETED|Overall Study||63
234492|NCT00918749|570641|P3|ITT (Intent to Treat) Population|Overall Study||69
234493|NCT00918749|570642|P2|ITT (Intent to Treat) Population|Overall Study||66
234494|NCT00918749|570643|P1|ITT (Intent to Treat) Population|Overall Study|One subject took no study drug and was not included in ITT Population|69
234495|NCT00918749|570641|P3|STARTED|Overall Study||69
234496|NCT00918749|570642|P2|STARTED|Overall Study||66
234497|NCT00918749|570643|P1|STARTED|Overall Study||70
234498|NCT00918866|570677|P2|NOT COMPLETED|Overall Study||0
234499|NCT00918866|570678|P1|NOT COMPLETED|Overall Study||0
234500|NCT00918866|570677|P2|COMPLETED|Overall Study||16
234501|NCT00918866|570678|P1|COMPLETED|Overall Study||16
234502|NCT00918866|570677|P2|STARTED|Overall Study||16
234503|NCT00918866|570678|P1|STARTED|Overall Study||16
234504|NCT00918879|570694|P2|NOT COMPLETED|Overall Study||6
234505|NCT00918879|570695|P1|NOT COMPLETED|Overall Study||6
234506|NCT00918879|570694|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|100
234507|NCT00918879|570695|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|101
234508|NCT00918879|570694|P2|STARTED|Overall Study|Randomized and treated|106
234509|NCT00918879|570695|P1|STARTED|Overall Study|Randomized and treated|107
234510|NCT00918931|570707|P1|NOT COMPLETED|Overall Study||0
234511|NCT00918931|570707|P1|COMPLETED|Overall Study||3
234512|NCT00918931|570707|P1|STARTED|Overall Study||3
234513|NCT00918957|570713|P2|NOT COMPLETED|Overall Study||0
234514|NCT00918957|570714|P1|NOT COMPLETED|Overall Study||3
234515|NCT00918957|570713|P2|COMPLETED|Overall Study||30
234516|NCT00918957|570714|P1|COMPLETED|Overall Study||29
234517|NCT00918957|570713|P2|STARTED|Overall Study||30
234518|NCT00918957|570714|P1|STARTED|Overall Study||32
234519|NCT00919035|570741|P1|NOT COMPLETED|Overall Study||0
234520|NCT00919035|570741|P1|COMPLETED|Overall Study||21
234521|NCT00919035|570741|P1|STARTED|Overall Study||21
234522|NCT00919061|570747|P1|NOT COMPLETED|Overall Study||2
234523|NCT00919061|570747|P1|COMPLETED|Overall Study||37
234524|NCT00919061|570747|P1|STARTED|Overall Study||39
234525|NCT00919113|570754|P2|NOT COMPLETED|Overall Study||8
234526|NCT00919113|570755|P1|NOT COMPLETED|Overall Study||9
234527|NCT00919113|570754|P2|COMPLETED|Overall Study||40
234528|NCT00919113|570755|P1|COMPLETED|Overall Study||41
234529|NCT00919113|570754|P2|Received Placebo|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
234530|NCT00919113|570755|P1|Received Placebo|Overall Study||0
234531|NCT00919113|570754|P2|Received Uracyst|Overall Study||0
234532|NCT00919113|570755|P1|Received Uracyst|Overall Study|One subject was misrandomized. Actual treatment was used for Demographic and Safety analysis.|49
234533|NCT00919113|570754|P2|STARTED|Overall Study||48
234534|NCT00919113|570755|P1|STARTED|Overall Study||50
234535|NCT00919126|570766|P3|NOT COMPLETED|Overall Study||1
234536|NCT00919126|570767|P2|NOT COMPLETED|Overall Study||5
234537|NCT00919126|570768|P1|NOT COMPLETED|Overall Study||1
234538|NCT00919126|570766|P3|COMPLETED|Overall Study||32
234539|NCT00919126|570767|P2|COMPLETED|Overall Study||32
234540|NCT00919126|570768|P1|COMPLETED|Overall Study||31
234541|NCT00919126|570766|P3|STARTED|Overall Study||33
234542|NCT00919126|570767|P2|STARTED|Overall Study||37
234543|NCT00919126|570768|P1|STARTED|Overall Study||32
234544|NCT00919191|570812|P1|NOT COMPLETED|Overall Study||0
234545|NCT00919191|570812|P1|COMPLETED|Overall Study||26
234546|NCT00919191|570812|P1|STARTED|Overall Study||26
234547|NCT00919633|570823|P4|NOT COMPLETED|Overall Study||21
234548|NCT00919633|570824|P3|NOT COMPLETED|Overall Study||23
234549|NCT00919633|570825|P2|NOT COMPLETED|Overall Study||15
234550|NCT00919633|570826|P1|NOT COMPLETED|Overall Study||22
234551|NCT00919633|570823|P4|COMPLETED|Overall Study||5
234552|NCT00919633|570824|P3|COMPLETED|Overall Study||4
234553|NCT00919633|570825|P2|COMPLETED|Overall Study||10
234554|NCT00919633|570826|P1|COMPLETED|Overall Study||6
234555|NCT00919633|570823|P4|STARTED|Overall Study||26
234556|NCT00919633|570824|P3|STARTED|Overall Study||27
234557|NCT00919633|570825|P2|STARTED|Overall Study||25
234558|NCT00919633|570826|P1|STARTED|Overall Study||28
234559|NCT00919711|570846|P2|NOT COMPLETED|Overall Study||13
234560|NCT00919711|570847|P1|NOT COMPLETED|Overall Study||33
234561|NCT00919711|570846|P2|COMPLETED|Overall Study||422
234562|NCT00919711|570847|P1|COMPLETED|Overall Study||402
234563|NCT00919711|570846|P2|STARTED|Overall Study||435
234564|NCT00919711|570847|P1|STARTED|Overall Study||435
234565|NCT00919724|570861|P2|NOT COMPLETED|Overall Study||0
234566|NCT00919724|570862|P1|NOT COMPLETED|Overall Study||0
234567|NCT00919724|570861|P2|COMPLETED|Overall Study||44
234568|NCT00919724|570862|P1|COMPLETED|Overall Study||45
234569|NCT00919724|570861|P2|STARTED|Overall Study||44
234570|NCT00919724|570862|P1|STARTED|Overall Study||45
234571|NCT00919763|570870|P2|NOT COMPLETED|Overall Study||4
234572|NCT00919763|570871|P1|NOT COMPLETED|Overall Study||12
234573|NCT00919763|570870|P2|COMPLETED|Overall Study||45
234574|NCT00919763|570871|P1|COMPLETED|Overall Study||41
234575|NCT00919763|570870|P2|STARTED|Overall Study||49
234576|NCT00919763|570871|P1|STARTED|Overall Study||53
234577|NCT00919802|570877|P2|NOT COMPLETED|Second Intervention - (24 Hours)||0
234578|NCT00919802|570878|P1|NOT COMPLETED|Second Intervention - (24 Hours)||0
234579|NCT00919802|570877|P2|COMPLETED|Second Intervention - (24 Hours)||13
234580|NCT00919802|570878|P1|COMPLETED|Second Intervention - (24 Hours)||12
234581|NCT00919802|570877|P2|STARTED|Second Intervention - (24 Hours)||13
234582|NCT00919802|570878|P1|STARTED|Second Intervention - (24 Hours)||12
234583|NCT00919802|570877|P2|NOT COMPLETED|First Intervention - (24 Hours)||0
234584|NCT00919802|570878|P1|NOT COMPLETED|First Intervention - (24 Hours)||0
234585|NCT00919802|570877|P2|COMPLETED|First Intervention - (24 Hours)||13
234586|NCT00919802|570878|P1|COMPLETED|First Intervention - (24 Hours)||12
234587|NCT00919802|570877|P2|STARTED|First Intervention - (24 Hours)||13
234588|NCT00919802|570878|P1|STARTED|First Intervention - (24 Hours)||12
234589|NCT00919854|570886|P1|NOT COMPLETED|Overall Study||1
234590|NCT00919854|570886|P1|COMPLETED|Overall Study|'Completed' represents the patients that are ongoing at the time of cut-off for the Week 24 analysis|20
234591|NCT00919854|570886|P1|STARTED|Overall Study||21
234592|NCT00919867|570901|P6|NOT COMPLETED|Third Intervention||0
234593|NCT00919867|570902|P5|NOT COMPLETED|Third Intervention||0
234594|NCT00919867|570903|P4|NOT COMPLETED|Third Intervention||0
234595|NCT00919867|570904|P3|NOT COMPLETED|Third Intervention||0
234596|NCT00919867|570905|P2|NOT COMPLETED|Third Intervention||0
234597|NCT00919867|570906|P1|NOT COMPLETED|Third Intervention||0
234598|NCT00919867|570901|P6|COMPLETED|Third Intervention||6
234599|NCT00919867|570902|P5|COMPLETED|Third Intervention||7
234600|NCT00919867|570903|P4|COMPLETED|Third Intervention||7
234601|NCT00919867|570904|P3|COMPLETED|Third Intervention||6
234602|NCT00919867|570905|P2|COMPLETED|Third Intervention||7
234603|NCT00919867|570906|P1|COMPLETED|Third Intervention||7
234604|NCT00919867|570901|P6|STARTED|Third Intervention||6
234605|NCT00919867|570902|P5|STARTED|Third Intervention||7
234606|NCT00919867|570903|P4|STARTED|Third Intervention||7
234607|NCT00919867|570904|P3|STARTED|Third Intervention||6
234608|NCT00919867|570905|P2|STARTED|Third Intervention||7
234609|NCT00919867|570906|P1|STARTED|Third Intervention||7
234610|NCT00919867|570901|P6|NOT COMPLETED|Washout||0
234611|NCT00919867|570902|P5|NOT COMPLETED|Washout||0
234612|NCT00919867|570903|P4|NOT COMPLETED|Washout||0
234613|NCT00919867|570904|P3|NOT COMPLETED|Washout||0
234614|NCT00919867|570905|P2|NOT COMPLETED|Washout||0
234615|NCT00919867|570906|P1|NOT COMPLETED|Washout||0
234616|NCT00919867|570901|P6|COMPLETED|Washout||6
234617|NCT00919867|570902|P5|COMPLETED|Washout||7
234618|NCT00919867|570903|P4|COMPLETED|Washout||7
234619|NCT00919867|570904|P3|COMPLETED|Washout||6
234620|NCT00919867|570905|P2|COMPLETED|Washout||7
234621|NCT00919867|570906|P1|COMPLETED|Washout||7
234622|NCT00919867|570901|P6|STARTED|Washout||6
234623|NCT00919867|570902|P5|STARTED|Washout||7
234624|NCT00919867|570903|P4|STARTED|Washout||7
234625|NCT00919867|570904|P3|STARTED|Washout||6
234626|NCT00919867|570905|P2|STARTED|Washout||7
234627|NCT00919867|570906|P1|STARTED|Washout||7
234628|NCT00919867|570901|P6|NOT COMPLETED|Second Intervention||0
234629|NCT00919867|570902|P5|NOT COMPLETED|Second Intervention||0
234630|NCT00919867|570903|P4|NOT COMPLETED|Second Intervention||0
234631|NCT00919867|570904|P3|NOT COMPLETED|Second Intervention||0
234632|NCT00919867|570905|P2|NOT COMPLETED|Second Intervention||0
234633|NCT00919867|570906|P1|NOT COMPLETED|Second Intervention||0
234634|NCT00919867|570901|P6|COMPLETED|Second Intervention||6
234635|NCT00919867|570902|P5|COMPLETED|Second Intervention||7
234636|NCT00919867|570903|P4|COMPLETED|Second Intervention||7
234637|NCT00919867|570904|P3|COMPLETED|Second Intervention||6
234638|NCT00919867|570905|P2|COMPLETED|Second Intervention||7
234639|NCT00919867|570906|P1|COMPLETED|Second Intervention||7
234640|NCT00919867|570901|P6|STARTED|Second Intervention||6
234641|NCT00919867|570902|P5|STARTED|Second Intervention||7
234642|NCT00919867|570903|P4|STARTED|Second Intervention||7
234643|NCT00919867|570904|P3|STARTED|Second Intervention||6
234644|NCT00919867|570905|P2|STARTED|Second Intervention||7
234645|NCT00919867|570906|P1|STARTED|Second Intervention||7
234646|NCT00919867|570901|P6|NOT COMPLETED|Washout||0
234647|NCT00919867|570902|P5|NOT COMPLETED|Washout||0
234648|NCT00919867|570903|P4|NOT COMPLETED|Washout||0
234649|NCT00919867|570904|P3|NOT COMPLETED|Washout||0
234650|NCT00919867|570905|P2|NOT COMPLETED|Washout||0
234651|NCT00919867|570906|P1|NOT COMPLETED|Washout||0
234652|NCT00919867|570901|P6|COMPLETED|Washout||6
234653|NCT00919867|570902|P5|COMPLETED|Washout||7
234654|NCT00919867|570903|P4|COMPLETED|Washout||7
234655|NCT00919867|570904|P3|COMPLETED|Washout||6
234656|NCT00919867|570905|P2|COMPLETED|Washout||7
234657|NCT00919867|570906|P1|COMPLETED|Washout||7
234658|NCT00919867|570901|P6|STARTED|Washout||6
234659|NCT00919867|570902|P5|STARTED|Washout||7
234660|NCT00919867|570903|P4|STARTED|Washout||7
234661|NCT00919867|570904|P3|STARTED|Washout||6
234662|NCT00919867|570905|P2|STARTED|Washout||7
234663|NCT00919867|570906|P1|STARTED|Washout||7
234664|NCT00919867|570901|P6|NOT COMPLETED|First Intervention||1
234665|NCT00919867|570902|P5|NOT COMPLETED|First Intervention||0
234666|NCT00919867|570903|P4|NOT COMPLETED|First Intervention||0
234667|NCT00919867|570904|P3|NOT COMPLETED|First Intervention||1
234668|NCT00919867|570905|P2|NOT COMPLETED|First Intervention||0
234669|NCT00919867|570906|P1|NOT COMPLETED|First Intervention||0
234670|NCT00919867|570901|P6|COMPLETED|First Intervention||6
234671|NCT00919867|570902|P5|COMPLETED|First Intervention||7
234672|NCT00919867|570903|P4|COMPLETED|First Intervention||7
234673|NCT00919867|570904|P3|COMPLETED|First Intervention||6
234674|NCT00919867|570905|P2|COMPLETED|First Intervention||7
234675|NCT00919867|570906|P1|COMPLETED|First Intervention||7
234676|NCT00919867|570901|P6|STARTED|First Intervention||7
234677|NCT00919867|570902|P5|STARTED|First Intervention||7
234678|NCT00919867|570903|P4|STARTED|First Intervention||7
234679|NCT00919867|570904|P3|STARTED|First Intervention||7
234680|NCT00919867|570905|P2|STARTED|First Intervention||7
234681|NCT00919867|570906|P1|STARTED|First Intervention||7
234682|NCT00919893|570929|P2|NOT COMPLETED|Overall Study||9
234683|NCT00919893|570930|P1|NOT COMPLETED|Overall Study||19
234684|NCT00919893|570929|P2|COMPLETED|Overall Study||60
234685|NCT00919893|570930|P1|COMPLETED|Overall Study||51
234686|NCT00919893|570929|P2|STARTED|Overall Study||69
234687|NCT00919893|570930|P1|STARTED|Overall Study||70
234688|NCT00919932|570938|P2|NOT COMPLETED|Overall Study||0
234689|NCT00919932|570939|P1|NOT COMPLETED|Overall Study||0
234690|NCT00919932|570938|P2|COMPLETED|Overall Study||5
234691|NCT00919932|570939|P1|COMPLETED|Overall Study||4
234692|NCT00919932|570938|P2|STARTED|Overall Study||5
234693|NCT00919932|570939|P1|STARTED|Overall Study||4
234694|NCT00920023|570947|P1|NOT COMPLETED|Overall Study||0
234695|NCT00920023|570947|P1|COMPLETED|Overall Study||15
234696|NCT00920023|570947|P1|STARTED|Overall Study||15
234697|NCT00920075|570952|P1|NOT COMPLETED|Post Study, 11 Pts Responded||0
234698|NCT00920075|570952|P1|COMPLETED|Post Study, 11 Pts Responded||11
234699|NCT00920075|570952|P1|STARTED|Post Study, 11 Pts Responded||11
234700|NCT00920075|570952|P1|NOT COMPLETED|Last Study,25 Pts Invited,11 Responded||0
234701|NCT00920075|570952|P1|COMPLETED|Last Study,25 Pts Invited,11 Responded||11
234702|NCT00920075|570952|P1|STARTED|Last Study,25 Pts Invited,11 Responded||11
234703|NCT00920140|570963|P5|NOT COMPLETED|Phase 2||11
234704|NCT00920140|570964|P4|NOT COMPLETED|Phase 2||22
234705|NCT00920140|570965|P3|NOT COMPLETED|Phase 2||50
234706|NCT00920140|570966|P2|NOT COMPLETED|Phase 2||0
234707|NCT00920140|570967|P1|NOT COMPLETED|Phase 2||0
234708|NCT00920140|570963|P5|COMPLETED|Phase 2||0
234709|NCT00920140|570964|P4|COMPLETED|Phase 2||0
234710|NCT00920140|570965|P3|COMPLETED|Phase 2||0
234711|NCT00920140|570966|P2|COMPLETED|Phase 2||0
234712|NCT00920140|570967|P1|COMPLETED|Phase 2||0
234713|NCT00920140|570963|P5|STARTED|Phase 2||11
234714|NCT00920140|570964|P4|STARTED|Phase 2||22
234715|NCT00920140|570965|P3|STARTED|Phase 2||50
234716|NCT00920140|570966|P2|STARTED|Phase 2||0
234717|NCT00920140|570967|P1|STARTED|Phase 2||0
234718|NCT00920140|570963|P5|NOT COMPLETED|Phase 1 (Dose Escalation)||0
234719|NCT00920140|570964|P4|NOT COMPLETED|Phase 1 (Dose Escalation)||0
234720|NCT00920140|570965|P3|NOT COMPLETED|Phase 1 (Dose Escalation)||0
234721|NCT00920140|570966|P2|NOT COMPLETED|Phase 1 (Dose Escalation)||9
234722|NCT00920140|570967|P1|NOT COMPLETED|Phase 1 (Dose Escalation)||5
234723|NCT00920140|570963|P5|COMPLETED|Phase 1 (Dose Escalation)||0
234724|NCT00920140|570964|P4|COMPLETED|Phase 1 (Dose Escalation)||0
234725|NCT00920140|570965|P3|COMPLETED|Phase 1 (Dose Escalation)||0
234726|NCT00920140|570966|P2|COMPLETED|Phase 1 (Dose Escalation)||0
234727|NCT00920140|570967|P1|COMPLETED|Phase 1 (Dose Escalation)||0
234728|NCT00920140|570963|P5|STARTED|Phase 1 (Dose Escalation)||0
234729|NCT00920140|570964|P4|STARTED|Phase 1 (Dose Escalation)||0
234730|NCT00920140|570965|P3|STARTED|Phase 1 (Dose Escalation)||0
234731|NCT00920140|570966|P2|STARTED|Phase 1 (Dose Escalation)||9
234732|NCT00920140|570967|P1|STARTED|Phase 1 (Dose Escalation)||5
234733|NCT00920231|571007|P2|NOT COMPLETED|Overall Study||0
234734|NCT00920231|571008|P1|NOT COMPLETED|Overall Study||0
234735|NCT00920231|571007|P2|COMPLETED|Overall Study||8
234736|NCT00920231|571008|P1|COMPLETED|Overall Study||8
234737|NCT00920231|571007|P2|STARTED|Overall Study||8
234738|NCT00920231|571008|P1|STARTED|Overall Study||8
234739|NCT00920309|571018|P2|NOT COMPLETED|Overall Study||0
234740|NCT00920309|571019|P1|NOT COMPLETED|Overall Study||0
234741|NCT00920309|571018|P2|COMPLETED|Overall Study||7
234742|NCT00920309|571019|P1|COMPLETED|Overall Study||14
234743|NCT00920309|571018|P2|STARTED|Overall Study||7
234744|NCT00920309|571019|P1|STARTED|Overall Study||14
234745|NCT00920374|571029|P2|NOT COMPLETED|Overall Study||0
234746|NCT00920374|571030|P1|NOT COMPLETED|Overall Study||0
234747|NCT00920374|571029|P2|COMPLETED|Overall Study||57
234748|NCT00920374|571030|P1|COMPLETED|Overall Study||61
234749|NCT00920374|571029|P2|STARTED|Overall Study||57
234750|NCT00920374|571030|P1|STARTED|Overall Study||61
234751|NCT00920621|571058|P4|NOT COMPLETED|Overall Study||35
234752|NCT00920621|571059|P3|NOT COMPLETED|Overall Study||35
234753|NCT00920621|571060|P2|NOT COMPLETED|Overall Study||45
234754|NCT00920621|571061|P1|NOT COMPLETED|Overall Study||54
234755|NCT00920621|571058|P4|COMPLETED|Overall Study||401
234756|NCT00920621|571059|P3|COMPLETED|Overall Study||405
234757|NCT00920621|571060|P2|COMPLETED|Overall Study||391
234758|NCT00920621|571061|P1|COMPLETED|Overall Study||386
234759|NCT00920621|571058|P4|STARTED|Overall Study||436
234760|NCT00920621|571059|P3|STARTED|Overall Study||440
234761|NCT00920621|571060|P2|STARTED|Overall Study||436
234762|NCT00920621|571061|P1|STARTED|Overall Study||440
234763|NCT00920647|571089|P4|NOT COMPLETED|Overall Study||0
234764|NCT00920647|571090|P3|NOT COMPLETED|Overall Study||0
234765|NCT00920647|571091|P2|NOT COMPLETED|Overall Study||0
234766|NCT00920647|571092|P1|NOT COMPLETED|Overall Study||0
234767|NCT00920647|571089|P4|COMPLETED|Overall Study||4
234768|NCT00920647|571090|P3|COMPLETED|Overall Study||4
234769|NCT00920647|571091|P2|COMPLETED|Overall Study||4
234770|NCT00920647|571092|P1|COMPLETED|Overall Study||4
234771|NCT00920647|571089|P4|STARTED|Overall Study||4
234772|NCT00920647|571090|P3|STARTED|Overall Study||4
234773|NCT00920647|571091|P2|STARTED|Overall Study||4
234774|NCT00920647|571092|P1|STARTED|Overall Study||4
234775|NCT00920686|571143|P3|NOT COMPLETED|Overall Study||13
234776|NCT00920686|571144|P2|NOT COMPLETED|Overall Study||22
234777|NCT00920686|571145|P1|NOT COMPLETED|Overall Study||19
234778|NCT00920686|571143|P3|COMPLETED|Overall Study||62
234779|NCT00920686|571144|P2|COMPLETED|Overall Study||60
234780|NCT00920686|571145|P1|COMPLETED|Overall Study||63
234781|NCT00920686|571143|P3|STARTED|Overall Study||75
234782|NCT00920686|571144|P2|STARTED|Overall Study||82
234783|NCT00920686|571145|P1|STARTED|Overall Study||82
234784|NCT00920790|571165|P1|NOT COMPLETED|Overall Study||14
234785|NCT00920790|571165|P1|COMPLETED|Overall Study||13
234786|NCT00920790|571165|P1|STARTED|Overall Study||27
234787|NCT00910520|571176|P2|NOT COMPLETED|Treatment Cycle 2||8
234788|NCT00910520|571177|P1|NOT COMPLETED|Treatment Cycle 2||7
234789|NCT00910520|571176|P2|COMPLETED|Treatment Cycle 2||215
234790|NCT00910520|571177|P1|COMPLETED|Treatment Cycle 2||156
234791|NCT00910520|571176|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|223
234792|NCT00910520|571177|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|163
234793|NCT00910520|571176|P2|NOT COMPLETED|Treatment Cycle 1||24
234794|NCT00910520|571177|P1|NOT COMPLETED|Treatment Cycle 1||20
234795|NCT00910520|571176|P2|COMPLETED|Treatment Cycle 1||247
234796|NCT00910520|571177|P1|COMPLETED|Treatment Cycle 1||257
234797|NCT00910520|571176|P2|STARTED|Treatment Cycle 1||271
234798|NCT00910520|571177|P1|STARTED|Treatment Cycle 1||277
234799|NCT00910624|571191|P4|NOT COMPLETED|Follow-Up Phase||0
234800|NCT00910624|571192|P3|NOT COMPLETED|Follow-Up Phase||4
234801|NCT00910624|571193|P2|NOT COMPLETED|Follow-Up Phase||4
234802|NCT00910624|571194|P1|NOT COMPLETED|Follow-Up Phase||6
234803|NCT00910624|571191|P4|COMPLETED|Follow-Up Phase||2
234804|NCT00910624|571192|P3|COMPLETED|Follow-Up Phase||25
234805|NCT00910624|571193|P2|COMPLETED|Follow-Up Phase||76
234806|NCT00910624|571194|P1|COMPLETED|Follow-Up Phase||42
234807|NCT00910624|571191|P4|STARTED|Follow-Up Phase||2
234808|NCT00910624|571192|P3|STARTED|Follow-Up Phase||29
234809|NCT00910624|571193|P2|STARTED|Follow-Up Phase||80
234810|NCT00910624|571194|P1|STARTED|Follow-Up Phase||48
234811|NCT00910624|571191|P4|NOT COMPLETED|Treatment Phase||0
234812|NCT00910624|571192|P3|NOT COMPLETED|Treatment Phase||9
234813|NCT00910624|571193|P2|NOT COMPLETED|Treatment Phase||21
234814|NCT00910624|571194|P1|NOT COMPLETED|Treatment Phase||30
234815|NCT00910624|571191|P4|COMPLETED|Treatment Phase||2
234816|NCT00910624|571192|P3|COMPLETED|Treatment Phase||20
234817|NCT00910624|571193|P2|COMPLETED|Treatment Phase||64
234818|NCT00910624|571194|P1|COMPLETED|Treatment Phase||22
234819|NCT00910624|571191|P4|STARTED|Treatment Phase||2
234820|NCT00910624|571192|P3|STARTED|Treatment Phase||29
234821|NCT00910624|571193|P2|STARTED|Treatment Phase||85
234822|NCT00910624|571194|P1|STARTED|Treatment Phase||52
234823|NCT00910663|571208|P2|NOT COMPLETED|Period 2||0
234824|NCT00910663|571209|P1|NOT COMPLETED|Period 2||0
234825|NCT00910663|571208|P2|COMPLETED|Period 2||29
234826|NCT00910663|571209|P1|COMPLETED|Period 2||30
234827|NCT00910663|571208|P2|STARTED|Period 2||29
234828|NCT00910663|571209|P1|STARTED|Period 2||30
234829|NCT00910663|571208|P2|NOT COMPLETED|Period 1||1
234830|NCT00910663|571209|P1|NOT COMPLETED|Period 1||0
234831|NCT00910663|571208|P2|COMPLETED|Period 1||29
234832|NCT00910663|571209|P1|COMPLETED|Period 1||30
234833|NCT00910663|571208|P2|STARTED|Period 1||30
234834|NCT00910663|571209|P1|STARTED|Period 1||30
234835|NCT00910689|571223|P4|NOT COMPLETED|Months 11- 16: Evaluation Period II||6
234836|NCT00910689|571224|P3|NOT COMPLETED|Months 11- 16: Evaluation Period II||7
234837|NCT00910689|571225|P2|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
234838|NCT00910689|571226|P1|NOT COMPLETED|Months 11- 16: Evaluation Period II||10
234839|NCT00910689|571223|P4|COMPLETED|Months 11- 16: Evaluation Period II||35
234840|NCT00910689|571224|P3|COMPLETED|Months 11- 16: Evaluation Period II||28
234841|NCT00910689|571225|P2|COMPLETED|Months 11- 16: Evaluation Period II||25
234842|NCT00910689|571226|P1|COMPLETED|Months 11- 16: Evaluation Period II||30
234843|NCT00910689|571223|P4|STARTED|Months 11- 16: Evaluation Period II||41
234844|NCT00910689|571224|P3|STARTED|Months 11- 16: Evaluation Period II||35
234845|NCT00910689|571225|P2|STARTED|Months 11- 16: Evaluation Period II||35
234846|NCT00910689|571226|P1|STARTED|Months 11- 16: Evaluation Period II||40
234847|NCT00910689|571223|P4|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
234848|NCT00910689|571224|P3|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
234849|NCT00910689|571225|P2|NOT COMPLETED|Months 5 - 10: Evaluation Period I||7
234850|NCT00910689|571226|P1|NOT COMPLETED|Months 5 - 10: Evaluation Period I||4
234851|NCT00910689|571223|P4|COMPLETED|Months 5 - 10: Evaluation Period I||41
234852|NCT00910689|571224|P3|COMPLETED|Months 5 - 10: Evaluation Period I||35
234853|NCT00910689|571225|P2|COMPLETED|Months 5 - 10: Evaluation Period I||35
234854|NCT00910689|571226|P1|COMPLETED|Months 5 - 10: Evaluation Period I||40
234855|NCT00910689|571223|P4|STARTED|Months 5 - 10: Evaluation Period I||48
234856|NCT00910689|571224|P3|STARTED|Months 5 - 10: Evaluation Period I||42
234857|NCT00910689|571225|P2|STARTED|Months 5 - 10: Evaluation Period I||42
234858|NCT00910689|571226|P1|STARTED|Months 5 - 10: Evaluation Period I||44
234859|NCT00910689|571223|P4|NOT COMPLETED|Month 2- 4: Treatment Period||11
234860|NCT00910689|571224|P3|NOT COMPLETED|Month 2- 4: Treatment Period||8
234861|NCT00910689|571225|P2|NOT COMPLETED|Month 2- 4: Treatment Period||10
234862|NCT00910689|571226|P1|NOT COMPLETED|Month 2- 4: Treatment Period||9
234863|NCT00910689|571223|P4|COMPLETED|Month 2- 4: Treatment Period||48
234864|NCT00910689|571224|P3|COMPLETED|Month 2- 4: Treatment Period||42
234865|NCT00910689|571225|P2|COMPLETED|Month 2- 4: Treatment Period||42
234866|NCT00910689|571226|P1|COMPLETED|Month 2- 4: Treatment Period||44
234867|NCT00910689|571223|P4|STARTED|Month 2- 4: Treatment Period||59
234868|NCT00910689|571224|P3|STARTED|Month 2- 4: Treatment Period||50
234869|NCT00910689|571225|P2|STARTED|Month 2- 4: Treatment Period||52
234870|NCT00910689|571226|P1|STARTED|Month 2- 4: Treatment Period||53
234871|NCT00910689|571223|P4|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||10
234872|NCT00910689|571224|P3|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||5
234873|NCT00910689|571225|P2|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||1
234874|NCT00910689|571226|P1|NOT COMPLETED|Month 1: Optimal Acute Therapy Run in||2
234875|NCT00910689|571223|P4|COMPLETED|Month 1: Optimal Acute Therapy Run in||59
234876|NCT00910689|571224|P3|COMPLETED|Month 1: Optimal Acute Therapy Run in||50
234877|NCT00910689|571225|P2|COMPLETED|Month 1: Optimal Acute Therapy Run in||52
234878|NCT00910689|571226|P1|COMPLETED|Month 1: Optimal Acute Therapy Run in||53
234879|NCT00910689|571223|P4|STARTED|Month 1: Optimal Acute Therapy Run in||69
234880|NCT00910689|571224|P3|STARTED|Month 1: Optimal Acute Therapy Run in||55
234881|NCT00910689|571225|P2|STARTED|Month 1: Optimal Acute Therapy Run in||53
234882|NCT00910689|571226|P1|STARTED|Month 1: Optimal Acute Therapy Run in||55
234883|NCT00910715|571259|P3|NOT COMPLETED|Overall Study||0
234884|NCT00910715|571260|P2|NOT COMPLETED|Overall Study||26
234885|NCT00910715|571261|P1|NOT COMPLETED|Overall Study||22
234886|NCT00910715|571259|P3|COMPLETED|Overall Study||81
234887|NCT00910715|571260|P2|COMPLETED|Overall Study||91
234888|NCT00910715|571261|P1|COMPLETED|Overall Study||86
234889|NCT00910715|571259|P3|STARTED|Overall Study||81
234890|NCT00910715|571260|P2|STARTED|Overall Study||117
234891|NCT00910715|571261|P1|STARTED|Overall Study||108
234892|NCT00910728|571280|P9|NOT COMPLETED|Overall Study||3
234893|NCT00910728|571281|P8|NOT COMPLETED|Overall Study||3
234894|NCT00910728|571282|P7|NOT COMPLETED|Overall Study||6
234895|NCT00910728|571283|P6|NOT COMPLETED|Overall Study||1
234896|NCT00910728|571284|P5|NOT COMPLETED|Overall Study||5
234897|NCT00910728|571285|P4|NOT COMPLETED|Overall Study||3
234898|NCT00910728|571286|P3|NOT COMPLETED|Overall Study||3
234899|NCT00910728|571287|P2|NOT COMPLETED|Overall Study||3
234900|NCT00910728|571288|P1|NOT COMPLETED|Overall Study||6
234901|NCT00910728|571280|P9|COMPLETED|Overall Study||0
234902|NCT00910728|571281|P8|COMPLETED|Overall Study||1
234903|NCT00910728|571282|P7|COMPLETED|Overall Study||0
234904|NCT00910728|571283|P6|COMPLETED|Overall Study||0
234905|NCT00910728|571284|P5|COMPLETED|Overall Study||1
234906|NCT00910728|571285|P4|COMPLETED|Overall Study||0
234907|NCT00910728|571286|P3|COMPLETED|Overall Study||0
234908|NCT00910728|571287|P2|COMPLETED|Overall Study||0
234909|NCT00910728|571288|P1|COMPLETED|Overall Study||0
234910|NCT00910728|571280|P9|STARTED|Overall Study||3
234911|NCT00910728|571281|P8|STARTED|Overall Study||4
234912|NCT00910728|571282|P7|STARTED|Overall Study||6
234913|NCT00910728|571283|P6|STARTED|Overall Study||1
234914|NCT00910728|571284|P5|STARTED|Overall Study||6
234915|NCT00910728|571285|P4|STARTED|Overall Study||3
234916|NCT00910728|571286|P3|STARTED|Overall Study||3
234917|NCT00910728|571287|P2|STARTED|Overall Study||3
234918|NCT00910728|571288|P1|STARTED|Overall Study||6
234919|NCT00910845|571409|P2|NOT COMPLETED|Treatment Cycle 2||9
234920|NCT00910845|571410|P1|NOT COMPLETED|Treatment Cycle 2||5
234921|NCT00910845|571409|P2|COMPLETED|Treatment Cycle 2||203
234922|NCT00910845|571410|P1|COMPLETED|Treatment Cycle 2||136
234923|NCT00910845|571409|P2|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|212
234924|NCT00910845|571410|P1|STARTED|Treatment Cycle 2|Not all participants who completed Treatment Cycle 1 went onto Treatment Cycle 2|141
234925|NCT00910845|571409|P2|NOT COMPLETED|Treatment Cycle 1||34
234926|NCT00910845|571410|P1|NOT COMPLETED|Treatment Cycle 1||31
234927|NCT00910845|571409|P2|COMPLETED|Treatment Cycle 1||243
234928|NCT00910845|571410|P1|COMPLETED|Treatment Cycle 1||249
234929|NCT00910845|571409|P2|STARTED|Treatment Cycle 1||277
234930|NCT00910845|571410|P1|STARTED|Treatment Cycle 1||280
234931|NCT00910858|571423|P3|NOT COMPLETED|Combined Treatment Phase||4
234932|NCT00910858|571424|P2|NOT COMPLETED|Combined Treatment Phase||10
234933|NCT00910858|571425|P1|NOT COMPLETED|Combined Treatment Phase||9
234934|NCT00910858|571423|P3|COMPLETED|Combined Treatment Phase||0
234935|NCT00910858|571424|P2|COMPLETED|Combined Treatment Phase||0
234936|NCT00910858|571425|P1|COMPLETED|Combined Treatment Phase||0
234937|NCT00910858|571423|P3|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|4
234938|NCT00910858|571424|P2|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|10
234939|NCT00910858|571425|P1|STARTED|Combined Treatment Phase|Patients who discontinued the Monotherapy Phase due to erythroid non-response or erythroid relapse.|9
234940|NCT00910858|571423|P3|NOT COMPLETED|Monotherapy Phase||7
234941|NCT00910858|571424|P2|NOT COMPLETED|Monotherapy Phase||15
234942|NCT00910858|571425|P1|NOT COMPLETED|Monotherapy Phase||17
234943|NCT00910858|571423|P3|COMPLETED|Monotherapy Phase||0
234944|NCT00910858|571424|P2|COMPLETED|Monotherapy Phase||0
234945|NCT00910858|571425|P1|COMPLETED|Monotherapy Phase||0
234946|NCT00910858|571423|P3|Pharmacokinetic Population|Monotherapy Phase||7
234947|NCT00910858|571424|P2|Pharmacokinetic Population|Monotherapy Phase|Patients in the 15 mg Non-del 5q group were not included in the pharmacokinetic assessment.|0
234948|NCT00910858|571425|P1|Pharmacokinetic Population|Monotherapy Phase||17
234949|NCT00910858|571423|P3|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|7
234950|NCT00910858|571424|P2|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|15
234951|NCT00910858|571425|P1|Safety Population|Monotherapy Phase|All patients who took at least 1 dose of study drug during Monotherapy or Combined Treatment Phase.|17
234952|NCT00910858|571423|P3|STARTED|Monotherapy Phase|Includes 3 participants from the PK Phase and 4 newly enrolled participants.|7
234953|NCT00910858|571424|P2|STARTED|Monotherapy Phase|All 15 participants were newly enrolled into the Monotherapy Phase.|15
234954|NCT00910858|571425|P1|STARTED|Monotherapy Phase|Includes 8 participants from the PK Phase and 9 newly enrolled participants.|17
234955|NCT00910858|571423|P3|NOT COMPLETED|Pharmacokinetic Phase||0
234956|NCT00910858|571424|P2|NOT COMPLETED|Pharmacokinetic Phase||0
234957|NCT00910858|571425|P1|NOT COMPLETED|Pharmacokinetic Phase||1
234958|NCT00910858|571423|P3|COMPLETED|Pharmacokinetic Phase||3
234959|NCT00910858|571424|P2|COMPLETED|Pharmacokinetic Phase||0
234960|NCT00910858|571425|P1|COMPLETED|Pharmacokinetic Phase||8
234961|NCT00910858|571423|P3|STARTED|Pharmacokinetic Phase||3
234962|NCT00910858|571424|P2|STARTED|Pharmacokinetic Phase||0
234963|NCT00910858|571425|P1|STARTED|Pharmacokinetic Phase||9
234964|NCT00910871|571448|P1|NOT COMPLETED|Overall Study||54
234965|NCT00910871|571448|P1|COMPLETED|Overall Study||179
234966|NCT00910871|571448|P1|STARTED|Overall Study||233
234967|NCT00910910|571455|P2|NOT COMPLETED|Overall Study||224
234968|NCT00910910|571456|P1|NOT COMPLETED|Overall Study||225
234969|NCT00910910|571455|P2|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|1
234970|NCT00910910|571456|P1|COMPLETED|Overall Study|Completed includes participants who are continuing with ongoing treatment|0
234971|NCT00910910|571455|P2|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|223
234972|NCT00910910|571456|P1|Safety Population|Overall Study|All randomized participants who received at least 1 dose of the either lenalidomide or chlorambucil|224
234973|NCT00910910|571455|P2|STARTED|Overall Study||225
234974|NCT00910910|571456|P1|STARTED|Overall Study||225
234975|NCT00910988|571494|P4|NOT COMPLETED|Overall Study||0
234976|NCT00910988|571495|P3|NOT COMPLETED|Overall Study||3
234977|NCT00910988|571496|P2|NOT COMPLETED|Overall Study||4
234978|NCT00910988|571497|P1|NOT COMPLETED|Overall Study||2
234979|NCT00910988|571494|P4|COMPLETED|Overall Study||6
234980|NCT00910988|571495|P3|COMPLETED|Overall Study||5
234981|NCT00910988|571496|P2|COMPLETED|Overall Study||12
234982|NCT00910988|571497|P1|COMPLETED|Overall Study||14
234983|NCT00910988|571494|P4|STARTED|Overall Study||6
234984|NCT00910988|571495|P3|STARTED|Overall Study||8
234985|NCT00910988|571496|P2|STARTED|Overall Study||16
234986|NCT00910988|571497|P1|STARTED|Overall Study||16
234987|NCT00911144|571541|P2|NOT COMPLETED|Overall Study||5
234988|NCT00911144|571542|P1|NOT COMPLETED|Overall Study||16
234989|NCT00911144|571541|P2|COMPLETED|Overall Study||108
234990|NCT00911144|571542|P1|COMPLETED|Overall Study||319
234991|NCT00911144|571541|P2|STARTED|Overall Study||113
234992|NCT00911144|571542|P1|STARTED|Overall Study||335
234993|NCT00911157|571568|P2|NOT COMPLETED|Overall Study||2
234994|NCT00911157|571569|P1|NOT COMPLETED|Overall Study||7
234995|NCT00911157|571568|P2|COMPLETED|Overall Study||8
234996|NCT00911157|571569|P1|COMPLETED|Overall Study||22
234997|NCT00911157|571568|P2|STARTED|Overall Study||10
234998|NCT00911157|571569|P1|STARTED|Overall Study||29
234999|NCT00911170|571585|P2|NOT COMPLETED|Long Term Follow-Up||422
235000|NCT00911170|571586|P1|NOT COMPLETED|Long Term Follow-Up||423
235001|NCT00911170|571585|P2|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
235002|NCT00911170|571586|P1|COMPLETED|Long Term Follow-Up|As of the data cut-off date of 8 June 2012|0
235003|NCT00911170|571585|P2|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|422
235004|NCT00911170|571586|P1|STARTED|Long Term Follow-Up|Participants who received treatment in the Treatment Period|423
235005|NCT00911170|571585|P2|NOT COMPLETED|Treatment Period||37
235006|NCT00911170|571586|P1|NOT COMPLETED|Treatment Period||27
235007|NCT00911170|571585|P2|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|386
235008|NCT00911170|571586|P1|COMPLETED|Treatment Period|Completed 4 cycles of treatment including chemotherapy, bevacizumab and investigational product.|397
235009|NCT00911170|571585|P2|Received Investigational Product|Treatment Period||419
235010|NCT00911170|571586|P1|Received Investigational Product|Treatment Period|Includes one participant who received pegfilgrastim in error.|422
235011|NCT00911170|571585|P2|Received Bevacizumab|Treatment Period||420
235012|NCT00911170|571586|P1|Received Bevacizumab|Treatment Period||423
235013|NCT00911170|571585|P2|Received Chemotherapy|Treatment Period|Primary Analysis Set|422
235014|NCT00911170|571586|P1|Received Chemotherapy|Treatment Period|Primary Analysis Set|423
235015|NCT00911170|571585|P2|STARTED|Treatment Period||423
235016|NCT00911170|571586|P1|STARTED|Treatment Period||424
235017|NCT00911274|571610|P2|NOT COMPLETED|Period 2||0
235018|NCT00911274|571611|P1|NOT COMPLETED|Period 2||0
235019|NCT00911274|571610|P2|COMPLETED|Period 2||26
235020|NCT00911274|571611|P1|COMPLETED|Period 2||27
235021|NCT00911274|571610|P2|STARTED|Period 2||26
235022|NCT00911274|571611|P1|STARTED|Period 2||27
235023|NCT00911274|571610|P2|NOT COMPLETED|Period 1||0
235024|NCT00911274|571611|P1|NOT COMPLETED|Period 1||0
235025|NCT00911274|571610|P2|COMPLETED|Period 1||26
235026|NCT00911274|571611|P1|COMPLETED|Period 1||27
235027|NCT00911274|571610|P2|STARTED|Period 1||26
235028|NCT00911274|571611|P1|STARTED|Period 1||27
235029|NCT00911300|571621|P2|NOT COMPLETED|Overall Study||43
235030|NCT00911300|571622|P1|NOT COMPLETED|Overall Study||35
235031|NCT00911300|571621|P2|COMPLETED|Overall Study||131
235032|NCT00911300|571622|P1|COMPLETED|Overall Study||140
235033|NCT00911300|571621|P2|STARTED|Overall Study||174
235034|NCT00911300|571622|P1|STARTED|Overall Study||175
235035|NCT00911326|571646|P1|NOT COMPLETED|Overall Study||16
235036|NCT00911326|571646|P1|COMPLETED|Overall Study||85
235037|NCT00911326|571646|P1|STARTED|Overall Study||101
235038|NCT00911443|571658|P5|NOT COMPLETED|Overall Study||0
235039|NCT00911443|571659|P4|NOT COMPLETED|Overall Study||0
235040|NCT00911443|571660|P3|NOT COMPLETED|Overall Study||0
235041|NCT00911443|571661|P2|NOT COMPLETED|Overall Study||0
235042|NCT00911443|571662|P1|NOT COMPLETED|Overall Study||0
235043|NCT00911443|571658|P5|COMPLETED|Overall Study||97
235044|NCT00911443|571659|P4|COMPLETED|Overall Study||99
235045|NCT00911443|571660|P3|COMPLETED|Overall Study||98
235046|NCT00911443|571661|P2|COMPLETED|Overall Study||97
235047|NCT00911443|571662|P1|COMPLETED|Overall Study||97
235048|NCT00911443|571658|P5|STARTED|Overall Study||97
235049|NCT00911443|571659|P4|STARTED|Overall Study||99
235050|NCT00911443|571660|P3|STARTED|Overall Study||98
235051|NCT00911443|571661|P2|STARTED|Overall Study||97
235052|NCT00911443|571662|P1|STARTED|Overall Study||97
235053|NCT00911495|571679|P1|NOT COMPLETED|Overall Study||1
235054|NCT00911495|571679|P1|COMPLETED|Overall Study||14
235055|NCT00911495|571679|P1|STARTED|Overall Study||15
235056|NCT00911534|571689|P2|NOT COMPLETED|Overall Study||16
235057|NCT00911534|571690|P1|NOT COMPLETED|Overall Study||15
235058|NCT00911534|571689|P2|COMPLETED|Overall Study||137
235059|NCT00911534|571690|P1|COMPLETED|Overall Study||132
235060|NCT00911534|571689|P2|STARTED|Overall Study|Randomized (treated)|153
235061|NCT00911534|571690|P1|STARTED|Overall Study|Randomized (treated)|147
235062|NCT00911547|571706|P4|NOT COMPLETED|Overall Study||16
235063|NCT00911547|571707|P3|NOT COMPLETED|Overall Study||22
235064|NCT00911547|571708|P2|NOT COMPLETED|Overall Study||42
235065|NCT00911547|571709|P1|NOT COMPLETED|Overall Study||11
235066|NCT00911547|571706|P4|COMPLETED|Overall Study||177
235067|NCT00911547|571707|P3|COMPLETED|Overall Study||178
235068|NCT00911547|571708|P2|COMPLETED|Overall Study||159
235069|NCT00911547|571709|P1|COMPLETED|Overall Study||37
235070|NCT00911547|571706|P4|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|193
235071|NCT00911547|571707|P3|STARTED|Overall Study|Efficacy analyses were over the 16 weeks of treatment.|200
235072|NCT00911547|571708|P2|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|201
235073|NCT00911547|571709|P1|STARTED|Overall Study|Efficacy in last 10 wks to minimize confounding effect of beclo in 1st 4 wks & allow beclo washout.|48
235074|NCT00911612|571737|P2|NOT COMPLETED|Overall Study||0
235075|NCT00911612|571738|P1|NOT COMPLETED|Overall Study||0
235076|NCT00911612|571737|P2|COMPLETED|Overall Study||12
235077|NCT00911612|571738|P1|COMPLETED|Overall Study||12
235078|NCT00911612|571737|P2|STARTED|Overall Study||12
235079|NCT00911612|571738|P1|STARTED|Overall Study||12
235080|NCT00911625|571754|P2|NOT COMPLETED|Overall Study||0
235081|NCT00911625|571755|P1|NOT COMPLETED|Overall Study||7
235082|NCT00911625|571754|P2|COMPLETED|Overall Study||57
235083|NCT00911625|571755|P1|COMPLETED|Overall Study||50
235084|NCT00911625|571754|P2|STARTED|Overall Study||57
235085|NCT00911625|571755|P1|STARTED|Overall Study||57
235086|NCT00911742|571765|P2|NOT COMPLETED|Treatment Phase II||0
235087|NCT00911742|571766|P1|NOT COMPLETED|Treatment Phase II||0
235088|NCT00911742|571765|P2|COMPLETED|Treatment Phase II||13
235089|NCT00911742|571766|P1|COMPLETED|Treatment Phase II||13
235090|NCT00911742|571765|P2|STARTED|Treatment Phase II||13
235091|NCT00911742|571766|P1|STARTED|Treatment Phase II||13
235092|NCT00911742|571765|P2|NOT COMPLETED|Treatment Phase I||0
235093|NCT00911742|571766|P1|NOT COMPLETED|Treatment Phase I||0
235094|NCT00911742|571765|P2|COMPLETED|Treatment Phase I||13
235095|NCT00911742|571766|P1|COMPLETED|Treatment Phase I||13
235096|NCT00911742|571765|P2|STARTED|Treatment Phase I||13
235097|NCT00911742|571766|P1|STARTED|Treatment Phase I||13
235098|NCT00911768|571782|P2|NOT COMPLETED|Overall Study||4
235099|NCT00911768|571783|P1|NOT COMPLETED|Overall Study||6
235100|NCT00911768|571782|P2|COMPLETED|Overall Study||46
235101|NCT00911768|571783|P1|COMPLETED|Overall Study||44
235102|NCT00911768|571782|P2|STARTED|Overall Study||50
235103|NCT00911768|571783|P1|STARTED|Overall Study||50
235104|NCT00911807|571796|P3|NOT COMPLETED|Overall Study||23
235105|NCT00911807|571797|P2|NOT COMPLETED|Overall Study||18
235106|NCT00911807|571798|P1|NOT COMPLETED|Overall Study||17
235107|NCT00911807|571796|P3|COMPLETED|Overall Study||52
235108|NCT00911807|571797|P2|COMPLETED|Overall Study||52
235109|NCT00911807|571798|P1|COMPLETED|Overall Study||55
235110|NCT00911807|571796|P3|STARTED|Overall Study||75
235111|NCT00911807|571797|P2|STARTED|Overall Study||70
235112|NCT00911807|571798|P1|STARTED|Overall Study||72
235113|NCT00911859|571809|P3|NOT COMPLETED|Follow-up Period||41
235114|NCT00911859|571810|P2|NOT COMPLETED|Follow-up Period||46
235115|NCT00911859|571811|P1|NOT COMPLETED|Follow-up Period||11
235116|NCT00911859|571809|P3|COMPLETED|Follow-up Period||11
235117|NCT00911859|571810|P2|COMPLETED|Follow-up Period||7
235118|NCT00911859|571811|P1|COMPLETED|Follow-up Period||1
235119|NCT00911859|571809|P3|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|52
235120|NCT00911859|571810|P2|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|53
235121|NCT00911859|571811|P1|STARTED|Follow-up Period|Participants followed until death or 3.5 years after the last participant was assigned to treatment|12
235122|NCT00911859|571809|P3|NOT COMPLETED|Maintainance Period||21
235123|NCT00911859|571810|P2|NOT COMPLETED|Maintainance Period||0
235124|NCT00911859|571811|P1|NOT COMPLETED|Maintainance Period||0
235125|NCT00911859|571809|P3|COMPLETED|Maintainance Period||0
235126|NCT00911859|571810|P2|COMPLETED|Maintainance Period||0
235127|NCT00911859|571811|P1|COMPLETED|Maintainance Period||0
235128|NCT00911859|571809|P3|STARTED|Maintainance Period|Participants who received siltuximab only during the 18-month maintenance period|21
235129|NCT00911859|571810|P2|STARTED|Maintainance Period||0
235130|NCT00911859|571811|P1|STARTED|Maintainance Period||0
235131|NCT00911859|571809|P3|NOT COMPLETED|Treatment Period||25
235132|NCT00911859|571810|P2|NOT COMPLETED|Treatment Period||21
235133|NCT00911859|571811|P1|NOT COMPLETED|Treatment Period||8
235134|NCT00911859|571809|P3|COMPLETED|Treatment Period||27
235135|NCT00911859|571810|P2|COMPLETED|Treatment Period||33
235136|NCT00911859|571811|P1|COMPLETED|Treatment Period||4
235137|NCT00911859|571809|P3|Received Treatment|Treatment Period||52
235138|NCT00911859|571810|P2|Received Treatment|Treatment Period||53
235139|NCT00911859|571811|P1|Received Treatment|Treatment Period||12
235140|NCT00911859|571809|P3|STARTED|Treatment Period||52
235141|NCT00911859|571810|P2|STARTED|Treatment Period||54
235142|NCT00911859|571811|P1|STARTED|Treatment Period||12
235143|NCT00911898|571835|P1|NOT COMPLETED|Overall Study||0
235144|NCT00911898|571835|P1|COMPLETED|Overall Study||20
235145|NCT00911898|571835|P1|STARTED|Overall Study||20
235146|NCT00911937|571841|P2|NOT COMPLETED|Overall Study||95
235147|NCT00911937|571842|P1|NOT COMPLETED|Overall Study||87
235148|NCT00911937|571841|P2|COMPLETED|Overall Study||381
235149|NCT00911937|571842|P1|COMPLETED|Overall Study||400
235150|NCT00911937|571841|P2|Treated|Overall Study||463
235151|NCT00911937|571842|P1|Treated|Overall Study||474
235152|NCT00911937|571841|P2|STARTED|Overall Study||476
235153|NCT00911937|571842|P1|STARTED|Overall Study||487
235154|NCT00911989|571902|P1|NOT COMPLETED|Overall Study||1
235155|NCT00911989|571902|P1|COMPLETED|Overall Study||3
235156|NCT00911989|571902|P1|STARTED|Overall Study||4
235157|NCT00912002|571906|P1|NOT COMPLETED|Overall Study||0
235158|NCT00912002|571906|P1|COMPLETED|Overall Study||6
235159|NCT00912002|571906|P1|STARTED|Overall Study||6
235160|NCT00912015|571916|P4|NOT COMPLETED|Overall Study||2
235161|NCT00912015|571917|P3|NOT COMPLETED|Overall Study||3
235162|NCT00912015|571918|P2|NOT COMPLETED|Overall Study||8
235163|NCT00912015|571919|P1|NOT COMPLETED|Overall Study||16
235164|NCT00912015|571916|P4|COMPLETED|Overall Study||0
235165|NCT00912015|571917|P3|COMPLETED|Overall Study||22
235166|NCT00912015|571918|P2|COMPLETED|Overall Study||62
235167|NCT00912015|571919|P1|COMPLETED|Overall Study||125
235168|NCT00912015|571916|P4|STARTED|Overall Study|Two patients took 100 mg against instructions in protocol that the minimum daily dose was 200 mg.|2
235169|NCT00912015|571917|P3|STARTED|Overall Study|Dose at which a patient spent the longest time.|25
235170|NCT00912015|571918|P2|STARTED|Overall Study|Dose at which a patient spent the longest time.|70
235171|NCT00912015|571919|P1|STARTED|Overall Study|Dose at which a patient spent the longest time.|141
235172|NCT00912028|571932|P5|NOT COMPLETED|Overall Study||3
235173|NCT00912028|571933|P4|NOT COMPLETED|Overall Study||1
235174|NCT00912028|571934|P3|NOT COMPLETED|Overall Study||0
235175|NCT00912028|571935|P2|NOT COMPLETED|Overall Study||3
235176|NCT00912028|571936|P1|NOT COMPLETED|Overall Study||5
235177|NCT00912028|571932|P5|COMPLETED|Overall Study||0
235178|NCT00912028|571933|P4|COMPLETED|Overall Study||16
235179|NCT00912028|571934|P3|COMPLETED|Overall Study||13
235180|NCT00912028|571935|P2|COMPLETED|Overall Study||0
235181|NCT00912028|571936|P1|COMPLETED|Overall Study||30
235182|NCT00912028|571932|P5|STARTED|Overall Study||3
235183|NCT00912028|571933|P4|STARTED|Overall Study||17
235184|NCT00912028|571934|P3|STARTED|Overall Study||13
235185|NCT00912028|571935|P2|STARTED|Overall Study||3
235186|NCT00912028|571936|P1|STARTED|Overall Study||35
235187|NCT00912093|571966|P5|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
235188|NCT00912093|571967|P4|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
235189|NCT00912093|571968|P3|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
235190|NCT00912093|571969|P2|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
235191|NCT00912093|571970|P1|NOT COMPLETED|The Open Label Extension (OLE) Phase||0
235192|NCT00912093|571966|P5|COMPLETED|The Open Label Extension (OLE) Phase||4
235193|NCT00912093|571967|P4|COMPLETED|The Open Label Extension (OLE) Phase||2
235194|NCT00912093|571968|P3|COMPLETED|The Open Label Extension (OLE) Phase||3
235195|NCT00912093|571969|P2|COMPLETED|The Open Label Extension (OLE) Phase||35
235196|NCT00912093|571970|P1|COMPLETED|The Open Label Extension (OLE) Phase||38
235197|NCT00912093|571966|P5|STARTED|The Open Label Extension (OLE) Phase||4
235198|NCT00912093|571967|P4|STARTED|The Open Label Extension (OLE) Phase||2
235199|NCT00912093|571968|P3|STARTED|The Open Label Extension (OLE) Phase||3
235200|NCT00912093|571969|P2|STARTED|The Open Label Extension (OLE) Phase||35
235201|NCT00912093|571970|P1|STARTED|The Open Label Extension (OLE) Phase||38
235202|NCT00912093|571966|P5|NOT COMPLETED|The Controlled Phase||1
235203|NCT00912093|571967|P4|NOT COMPLETED|The Controlled Phase||0
235204|NCT00912093|571968|P3|NOT COMPLETED|The Controlled Phase||0
235205|NCT00912093|571969|P2|NOT COMPLETED|The Controlled Phase||2
235206|NCT00912093|571970|P1|NOT COMPLETED|The Controlled Phase||0
235207|NCT00912093|571966|P5|COMPLETED|The Controlled Phase||4
235208|NCT00912093|571967|P4|COMPLETED|The Controlled Phase||2
235209|NCT00912093|571968|P3|COMPLETED|The Controlled Phase||3
235210|NCT00912093|571969|P2|COMPLETED|The Controlled Phase||43
235211|NCT00912093|571970|P1|COMPLETED|The Controlled Phase||43
235212|NCT00912093|571966|P5|STARTED|The Controlled Phase||5
235213|NCT00912093|571967|P4|STARTED|The Controlled Phase||2
235214|NCT00912093|571968|P3|STARTED|The Controlled Phase||3
235215|NCT00912093|571969|P2|STARTED|The Controlled Phase||45
235216|NCT00912093|571970|P1|STARTED|The Controlled Phase||43
235217|NCT00912158|571989|P3|NOT COMPLETED|Overall Study||0
235218|NCT00912158|571990|P2|NOT COMPLETED|Overall Study||0
235219|NCT00912158|571991|P1|NOT COMPLETED|Overall Study||0
235220|NCT00912158|571989|P3|COMPLETED|Overall Study||41
235221|NCT00912158|571990|P2|COMPLETED|Overall Study||44
235222|NCT00912158|571991|P1|COMPLETED|Overall Study||44
235223|NCT00912158|571989|P3|STARTED|Overall Study||41
235224|NCT00912158|571990|P2|STARTED|Overall Study||44
235225|NCT00912158|571991|P1|STARTED|Overall Study||44
235226|NCT00912223|571996|P1|NOT COMPLETED|Overall Study||3
235227|NCT00912223|571996|P1|COMPLETED|Overall Study||62
235228|NCT00912223|571996|P1|STARTED|Overall Study||65
235229|NCT00912288|572014|P2|NOT COMPLETED|Overall Study||40
235230|NCT00912288|572015|P1|NOT COMPLETED|Overall Study||41
235231|NCT00912288|572014|P2|COMPLETED|Overall Study||2
235232|NCT00912288|572015|P1|COMPLETED|Overall Study||3
235233|NCT00912288|572014|P2|STARTED|Overall Study||42
235234|NCT00912288|572015|P1|STARTED|Overall Study||44
235235|NCT00912301|572040|P3|NOT COMPLETED|Overall Study||0
235236|NCT00912301|572041|P2|NOT COMPLETED|Overall Study||0
235237|NCT00912301|572042|P1|NOT COMPLETED|Overall Study||0
235238|NCT00912301|572040|P3|COMPLETED|Overall Study||13
235239|NCT00912301|572041|P2|COMPLETED|Overall Study||12
235240|NCT00912301|572042|P1|COMPLETED|Overall Study||11
235241|NCT00912301|572040|P3|STARTED|Overall Study||13
235242|NCT00912301|572041|P2|STARTED|Overall Study||12
235243|NCT00912301|572042|P1|STARTED|Overall Study||11
235244|NCT00912405|572062|P1|NOT COMPLETED|Overall Study||5
235245|NCT00912405|572062|P1|COMPLETED|Overall Study||45
235246|NCT00912405|572062|P1|STARTED|Overall Study||50
235247|NCT00912509|572071|P2|NOT COMPLETED|Overall Study||3
235248|NCT00912509|572072|P1|NOT COMPLETED|Overall Study||5
235249|NCT00912509|572071|P2|COMPLETED|Overall Study||7
235250|NCT00912509|572072|P1|COMPLETED|Overall Study||15
235251|NCT00912509|572071|P2|STARTED|Overall Study||10
235252|NCT00912509|572072|P1|STARTED|Overall Study||20
235253|NCT00912743|572080|P2|NOT COMPLETED|Overall Study||20
235254|NCT00912743|572081|P1|NOT COMPLETED|Overall Study||13
235255|NCT00912743|572080|P2|COMPLETED|Overall Study||0
235256|NCT00912743|572081|P1|COMPLETED|Overall Study||0
235257|NCT00912743|572080|P2|STARTED|Overall Study||20
235258|NCT00912743|572081|P1|STARTED|Overall Study||13
235259|NCT00912782|572093|P2|NOT COMPLETED|Overall Study||5
235260|NCT00912782|572094|P1|NOT COMPLETED|Overall Study||3
235261|NCT00912782|572093|P2|COMPLETED|Overall Study||20
235262|NCT00912782|572094|P1|COMPLETED|Overall Study||24
235263|NCT00912782|572093|P2|STARTED|Overall Study||25
235264|NCT00912782|572094|P1|STARTED|Overall Study||27
235265|NCT00912795|572104|P2|NOT COMPLETED|Overall Study||58
235266|NCT00912795|572105|P1|NOT COMPLETED|Overall Study||47
235267|NCT00912795|572104|P2|COMPLETED|Overall Study||17
235268|NCT00912795|572105|P1|COMPLETED|Overall Study||29
235269|NCT00912795|572104|P2|STARTED|Overall Study||75
235270|NCT00912795|572105|P1|STARTED|Overall Study||76
235271|NCT00912808|572119|P2|NOT COMPLETED|Overall Study||1
235272|NCT00912808|572120|P1|NOT COMPLETED|Overall Study||3
235273|NCT00912808|572119|P2|COMPLETED|Overall Study||11
235274|NCT00912808|572120|P1|COMPLETED|Overall Study||8
235275|NCT00912808|572119|P2|STARTED|Overall Study||12
235276|NCT00912808|572120|P1|STARTED|Overall Study||11
235277|NCT00912912|572128|P1|NOT COMPLETED|Overall Study||4
235278|NCT00912912|572128|P1|COMPLETED|Overall Study||1
235279|NCT00912912|572128|P1|STARTED|Overall Study||5
235280|NCT00912925|572134|P2|NOT COMPLETED|Overall Study||0
235281|NCT00912925|572135|P1|NOT COMPLETED|Overall Study||0
235282|NCT00912925|572134|P2|COMPLETED|Overall Study||22
235283|NCT00912925|572135|P1|COMPLETED|Overall Study||23
235284|NCT00912925|572134|P2|STARTED|Overall Study||22
235285|NCT00912925|572135|P1|STARTED|Overall Study||23
235286|NCT00912964|572156|P3|NOT COMPLETED|Overall Study||54
235287|NCT00912964|572157|P2|NOT COMPLETED|Overall Study||46
235288|NCT00912964|572158|P1|NOT COMPLETED|Overall Study||66
235289|NCT00912964|572156|P3|COMPLETED|Overall Study||386
235290|NCT00912964|572157|P2|COMPLETED|Overall Study||387
235291|NCT00912964|572158|P1|COMPLETED|Overall Study||367
235292|NCT00912964|572156|P3|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|257
235293|NCT00912964|572157|P2|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|254
235294|NCT00912964|572158|P1|Full Analysis Set Incontinence (FAS-I)|Overall Study|Full analysis set patients who had at least 1 incontinence episode at Baseline.|262
235295|NCT00912964|572156|P3|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|426
235296|NCT00912964|572157|P2|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|410
235297|NCT00912964|572158|P1|Full Analysis Set (FAS)|Overall Study|Treated patients with a baseline and at least 1 post-baseline micturition measurement.|415
235298|NCT00912964|572156|P3|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|440
235299|NCT00912964|572157|P2|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|432
235300|NCT00912964|572158|P1|Safety Analysis Set (SAF)|Overall Study|All randomized patients who took at least 1 dose of double-blind study drug.|433
235301|NCT00912964|572156|P3|STARTED|Overall Study||440
235302|NCT00912964|572157|P2|STARTED|Overall Study||433
235303|NCT00912964|572158|P1|STARTED|Overall Study||433
235304|NCT00920816|572284|P4|NOT COMPLETED|Overall Study||69
235305|NCT00920816|572285|P3|NOT COMPLETED|Overall Study||135
235306|NCT00920816|572286|P2|NOT COMPLETED|Overall Study||96
235307|NCT00920816|572287|P1|NOT COMPLETED|Overall Study||192
235308|NCT00920816|572284|P4|COMPLETED|Overall Study||0
235309|NCT00920816|572285|P3|COMPLETED|Overall Study||0
235310|NCT00920816|572286|P2|COMPLETED|Overall Study||0
235311|NCT00920816|572287|P1|COMPLETED|Overall Study||0
235312|NCT00920816|572284|P4|Treated|Overall Study||69
235313|NCT00920816|572285|P3|Treated|Overall Study||135
235314|NCT00920816|572286|P2|Treated|Overall Study||96
235315|NCT00920816|572287|P1|Treated|Overall Study||189
235316|NCT00920816|572284|P4|STARTED|Overall Study||69
235317|NCT00920816|572285|P3|STARTED|Overall Study||135
235318|NCT00920816|572286|P2|STARTED|Overall Study||96
235319|NCT00920816|572287|P1|STARTED|Overall Study||192
235320|NCT00920855|572328|P3|NOT COMPLETED|Overall Study||22
235321|NCT00920855|572329|P2|NOT COMPLETED|Overall Study||3
235322|NCT00920855|572330|P1|NOT COMPLETED|Overall Study||5
235323|NCT00920855|572328|P3|COMPLETED|Overall Study|completed eight cycles of treatment|9
235324|NCT00920855|572329|P2|COMPLETED|Overall Study|completed eight cycles of treatment|1
235325|NCT00920855|572330|P1|COMPLETED|Overall Study|completed eight cycles of treatment|0
235326|NCT00920855|572328|P3|Safety and Efficacy Populations|Overall Study||31
235327|NCT00920855|572329|P2|Safety and Efficacy Populations|Overall Study||4
235328|NCT00920855|572330|P1|Safety and Efficacy Populations|Overall Study||5
235329|NCT00920855|572328|P3|STARTED|Overall Study||31
235330|NCT00920855|572329|P2|STARTED|Overall Study||4
235331|NCT00920855|572330|P1|STARTED|Overall Study||5
235332|NCT00920907|572354|P2|NOT COMPLETED|Maintenance Period||13
235333|NCT00920907|572355|P1|NOT COMPLETED|Maintenance Period||12
235334|NCT00920907|572354|P2|COMPLETED|Maintenance Period|2 participants who entered Maintenance Period did not receive study drug during the period.|2
235420|NCT00923091|572418|P11|STARTED|Period V (Double -Blind)||194
235335|NCT00920907|572355|P1|COMPLETED|Maintenance Period|All participants who entered Maintenance were treated with study drug.|3
235336|NCT00920907|572354|P2|STARTED|Maintenance Period|1 patient completed Induction phase but discontinued the study prior to start of maintenance phase.|15
235337|NCT00920907|572355|P1|STARTED|Maintenance Period||15
235338|NCT00920907|572354|P2|NOT COMPLETED|Induction Period||22
235339|NCT00920907|572355|P1|NOT COMPLETED|Induction Period||22
235340|NCT00920907|572354|P2|COMPLETED|Induction Period||16
235341|NCT00920907|572355|P1|COMPLETED|Induction Period||15
235342|NCT00920907|572354|P2|STARTED|Induction Period||38
235343|NCT00920907|572355|P1|STARTED|Induction Period||37
235344|NCT00921024|572395|P2|NOT COMPLETED|Overall Study||3
235345|NCT00921024|572396|P1|NOT COMPLETED|Overall Study||4
235346|NCT00921024|572395|P2|COMPLETED|Overall Study||39
235347|NCT00921024|572396|P1|COMPLETED|Overall Study||81
235348|NCT00921024|572395|P2|STARTED|Overall Study||42
235349|NCT00921024|572396|P1|STARTED|Overall Study||85
235350|NCT00921115|572404|P1|NOT COMPLETED|Overall Study||0
235351|NCT00921115|572404|P1|COMPLETED|Overall Study||42
235352|NCT00921115|572404|P1|STARTED|Overall Study||42
235353|NCT00923091|572416|P13|NOT COMPLETED|Period VI (Open-Label)||0
235354|NCT00923091|572417|P12|NOT COMPLETED|Period VI (Open-Label)||0
235355|NCT00923091|572418|P11|NOT COMPLETED|Period VI (Open-Label)||0
235356|NCT00923091|572419|P10|NOT COMPLETED|Period VI (Open-Label)||0
235357|NCT00923091|572420|P9|NOT COMPLETED|Period VI (Open-Label)||0
235358|NCT00923091|572421|P8|NOT COMPLETED|Period VI (Open-Label)||0
235359|NCT00923091|572422|P7|NOT COMPLETED|Period VI (Open-Label)||0
235360|NCT00923091|572423|P6|NOT COMPLETED|Period VI (Open-Label)||0
235361|NCT00923091|572424|P5|NOT COMPLETED|Period VI (Open-Label)||7
235362|NCT00923091|572425|P4|NOT COMPLETED|Period VI (Open-Label)||3
235363|NCT00923091|572426|P3|NOT COMPLETED|Period VI (Open-Label)||13
235364|NCT00923091|572427|P2|NOT COMPLETED|Period VI (Open-Label)||8
235365|NCT00923091|572428|P1|NOT COMPLETED|Period VI (Open-Label)||39
235366|NCT00923091|572416|P13|COMPLETED|Period VI (Open-Label)||0
235367|NCT00923091|572417|P12|COMPLETED|Period VI (Open-Label)||0
235368|NCT00923091|572418|P11|COMPLETED|Period VI (Open-Label)||0
235369|NCT00923091|572419|P10|COMPLETED|Period VI (Open-Label)||0
235370|NCT00923091|572420|P9|COMPLETED|Period VI (Open-Label)||0
235371|NCT00923091|572421|P8|COMPLETED|Period VI (Open-Label)||0
235372|NCT00923091|572422|P7|COMPLETED|Period VI (Open-Label)||0
235373|NCT00923091|572423|P6|COMPLETED|Period VI (Open-Label)||0
235374|NCT00923091|572424|P5|COMPLETED|Period VI (Open-Label)||157
235375|NCT00923091|572425|P4|COMPLETED|Period VI (Open-Label)||143
235376|NCT00923091|572426|P3|COMPLETED|Period VI (Open-Label)||467
235377|NCT00923091|572427|P2|COMPLETED|Period VI (Open-Label)||264
235378|NCT00923091|572428|P1|COMPLETED|Period VI (Open-Label)||1408
235379|NCT00923091|572416|P13|STARTED|Period VI (Open-Label)||0
235380|NCT00923091|572417|P12|STARTED|Period VI (Open-Label)||0
235381|NCT00923091|572418|P11|STARTED|Period VI (Open-Label)||0
235382|NCT00923091|572419|P10|STARTED|Period VI (Open-Label)||0
235383|NCT00923091|572420|P9|STARTED|Period VI (Open-Label)||0
235384|NCT00923091|572421|P8|STARTED|Period VI (Open-Label)||0
235385|NCT00923091|572422|P7|STARTED|Period VI (Open-Label)||0
235386|NCT00923091|572423|P6|STARTED|Period VI (Open-Label)||0
235387|NCT00923091|572424|P5|STARTED|Period VI (Open-Label)||164
235388|NCT00923091|572425|P4|STARTED|Period VI (Open-Label)||146
235389|NCT00923091|572426|P3|STARTED|Period VI (Open-Label)||480
235390|NCT00923091|572427|P2|STARTED|Period VI (Open-Label)||272
235391|NCT00923091|572428|P1|STARTED|Period VI (Open-Label)|1837 from Period III+2 from Period IV + 670 from Period 5 = 2509|1447
235392|NCT00923091|572416|P13|NOT COMPLETED|Period V (Double -Blind)||2
235393|NCT00923091|572417|P12|NOT COMPLETED|Period V (Double -Blind)||0
235394|NCT00923091|572418|P11|NOT COMPLETED|Period V (Double -Blind)||1
235395|NCT00923091|572419|P10|NOT COMPLETED|Period V (Double -Blind)||0
235396|NCT00923091|572420|P9|NOT COMPLETED|Period V (Double -Blind)||1
235397|NCT00923091|572421|P8|NOT COMPLETED|Period V (Double -Blind)||0
235398|NCT00923091|572422|P7|NOT COMPLETED|Period V (Double -Blind)||0
235399|NCT00923091|572423|P6|NOT COMPLETED|Period V (Double -Blind)||0
235400|NCT00923091|572424|P5|NOT COMPLETED|Period V (Double -Blind)||0
235401|NCT00923091|572425|P4|NOT COMPLETED|Period V (Double -Blind)||0
235402|NCT00923091|572426|P3|NOT COMPLETED|Period V (Double -Blind)||0
235403|NCT00923091|572427|P2|NOT COMPLETED|Period V (Double -Blind)||0
235404|NCT00923091|572428|P1|NOT COMPLETED|Period V (Double -Blind)||0
235405|NCT00923091|572416|P13|COMPLETED|Period V (Double -Blind)||73
235406|NCT00923091|572417|P12|COMPLETED|Period V (Double -Blind)||151
235407|NCT00923091|572418|P11|COMPLETED|Period V (Double -Blind)||193
235408|NCT00923091|572419|P10|COMPLETED|Period V (Double -Blind)||119
235409|NCT00923091|572420|P9|COMPLETED|Period V (Double -Blind)||134
235410|NCT00923091|572421|P8|COMPLETED|Period V (Double -Blind)||0
235411|NCT00923091|572422|P7|COMPLETED|Period V (Double -Blind)||0
235412|NCT00923091|572423|P6|COMPLETED|Period V (Double -Blind)||0
235413|NCT00923091|572424|P5|COMPLETED|Period V (Double -Blind)||0
235414|NCT00923091|572425|P4|COMPLETED|Period V (Double -Blind)||0
235415|NCT00923091|572426|P3|COMPLETED|Period V (Double -Blind)||0
235416|NCT00923091|572427|P2|COMPLETED|Period V (Double -Blind)||0
235417|NCT00923091|572428|P1|COMPLETED|Period V (Double -Blind)||0
235418|NCT00923091|572416|P13|STARTED|Period V (Double -Blind)||75
235419|NCT00923091|572417|P12|STARTED|Period V (Double -Blind)||151
235421|NCT00923091|572419|P10|STARTED|Period V (Double -Blind)||119
235422|NCT00923091|572420|P9|STARTED|Period V (Double -Blind)||135
235423|NCT00923091|572421|P8|STARTED|Period V (Double -Blind)||0
235424|NCT00923091|572422|P7|STARTED|Period V (Double -Blind)||0
235425|NCT00923091|572423|P6|STARTED|Period V (Double -Blind)||0
235426|NCT00923091|572424|P5|STARTED|Period V (Double -Blind)||0
235427|NCT00923091|572425|P4|STARTED|Period V (Double -Blind)||0
235428|NCT00923091|572426|P3|STARTED|Period V (Double -Blind)||0
235429|NCT00923091|572427|P2|STARTED|Period V (Double -Blind)||0
235430|NCT00923091|572428|P1|STARTED|Period V (Double -Blind)|677 completed Period 4. 1 did not continue and 2 erroneously responders were not counted = 674|0
235431|NCT00923091|572416|P13|NOT COMPLETED|Period IV (Double-Blind)||0
235432|NCT00923091|572417|P12|NOT COMPLETED|Period IV (Double-Blind)||0
235433|NCT00923091|572418|P11|NOT COMPLETED|Period IV (Double-Blind)||0
235434|NCT00923091|572419|P10|NOT COMPLETED|Period IV (Double-Blind)||0
235435|NCT00923091|572420|P9|NOT COMPLETED|Period IV (Double-Blind)||0
235436|NCT00923091|572421|P8|NOT COMPLETED|Period IV (Double-Blind)||0
235437|NCT00923091|572422|P7|NOT COMPLETED|Period IV (Double-Blind)||0
235438|NCT00923091|572423|P6|NOT COMPLETED|Period IV (Double-Blind)||0
235439|NCT00923091|572424|P5|NOT COMPLETED|Period IV (Double-Blind)||0
235440|NCT00923091|572425|P4|NOT COMPLETED|Period IV (Double-Blind)||0
235441|NCT00923091|572426|P3|NOT COMPLETED|Period IV (Double-Blind)||0
235442|NCT00923091|572427|P2|NOT COMPLETED|Period IV (Double-Blind)||2
235443|NCT00923091|572428|P1|NOT COMPLETED|Period IV (Double-Blind)||2
235444|NCT00923091|572416|P13|COMPLETED|Period IV (Double-Blind)||0
235445|NCT00923091|572417|P12|COMPLETED|Period IV (Double-Blind)||0
235446|NCT00923091|572418|P11|COMPLETED|Period IV (Double-Blind)||0
235447|NCT00923091|572419|P10|COMPLETED|Period IV (Double-Blind)||0
235448|NCT00923091|572420|P9|COMPLETED|Period IV (Double-Blind)||0
235449|NCT00923091|572421|P8|COMPLETED|Period IV (Double-Blind)||0
235450|NCT00923091|572422|P7|COMPLETED|Period IV (Double-Blind)||0
235451|NCT00923091|572423|P6|COMPLETED|Period IV (Double-Blind)||0
235452|NCT00923091|572424|P5|COMPLETED|Period IV (Double-Blind)||0
235453|NCT00923091|572425|P4|COMPLETED|Period IV (Double-Blind)||0
235454|NCT00923091|572426|P3|COMPLETED|Period IV (Double-Blind)||0
235455|NCT00923091|572427|P2|COMPLETED|Period IV (Double-Blind)||451
235456|NCT00923091|572428|P1|COMPLETED|Period IV (Double-Blind)||226
235457|NCT00923091|572416|P13|STARTED|Period IV (Double-Blind)||0
235458|NCT00923091|572417|P12|STARTED|Period IV (Double-Blind)||0
235459|NCT00923091|572418|P11|STARTED|Period IV (Double-Blind)||0
235460|NCT00923091|572419|P10|STARTED|Period IV (Double-Blind)||0
235461|NCT00923091|572420|P9|STARTED|Period IV (Double-Blind)||0
235462|NCT00923091|572421|P8|STARTED|Period IV (Double-Blind)||0
235463|NCT00923091|572422|P7|STARTED|Period IV (Double-Blind)||0
235464|NCT00923091|572423|P6|STARTED|Period IV (Double-Blind)||0
235465|NCT00923091|572424|P5|STARTED|Period IV (Double-Blind)||0
235466|NCT00923091|572425|P4|STARTED|Period IV (Double-Blind)||0
235467|NCT00923091|572426|P3|STARTED|Period IV (Double-Blind)||0
235468|NCT00923091|572427|P2|STARTED|Period IV (Double-Blind)||453
235469|NCT00923091|572428|P1|STARTED|Period IV (Double-Blind)|2 did not continue in the study and 1837 responders went directly to Period VI. 228+453+2+1837=2520|228
235470|NCT00923091|572416|P13|NOT COMPLETED|Period III (Single-Blind)||0
235471|NCT00923091|572417|P12|NOT COMPLETED|Period III (Single-Blind)||0
235472|NCT00923091|572418|P11|NOT COMPLETED|Period III (Single-Blind)||0
235473|NCT00923091|572419|P10|NOT COMPLETED|Period III (Single-Blind)||0
235474|NCT00923091|572420|P9|NOT COMPLETED|Period III (Single-Blind)||0
235475|NCT00923091|572421|P8|NOT COMPLETED|Period III (Single-Blind)||0
235476|NCT00923091|572422|P7|NOT COMPLETED|Period III (Single-Blind)||0
235477|NCT00923091|572423|P6|NOT COMPLETED|Period III (Single-Blind)||0
235478|NCT00923091|572424|P5|NOT COMPLETED|Period III (Single-Blind)||0
235479|NCT00923091|572425|P4|NOT COMPLETED|Period III (Single-Blind)||0
235480|NCT00923091|572426|P3|NOT COMPLETED|Period III (Single-Blind)||0
235481|NCT00923091|572427|P2|NOT COMPLETED|Period III (Single-Blind)||0
235482|NCT00923091|572428|P1|NOT COMPLETED|Period III (Single-Blind)||20
235483|NCT00923091|572416|P13|COMPLETED|Period III (Single-Blind)||0
235484|NCT00923091|572417|P12|COMPLETED|Period III (Single-Blind)||0
235485|NCT00923091|572418|P11|COMPLETED|Period III (Single-Blind)||0
235486|NCT00923091|572419|P10|COMPLETED|Period III (Single-Blind)||0
235487|NCT00923091|572420|P9|COMPLETED|Period III (Single-Blind)||0
235488|NCT00923091|572421|P8|COMPLETED|Period III (Single-Blind)||0
235489|NCT00923091|572422|P7|COMPLETED|Period III (Single-Blind)||0
235490|NCT00923091|572423|P6|COMPLETED|Period III (Single-Blind)||0
235491|NCT00923091|572424|P5|COMPLETED|Period III (Single-Blind)||0
235492|NCT00923091|572425|P4|COMPLETED|Period III (Single-Blind)||0
235493|NCT00923091|572426|P3|COMPLETED|Period III (Single-Blind)||0
235494|NCT00923091|572427|P2|COMPLETED|Period III (Single-Blind)||0
235495|NCT00923091|572428|P1|COMPLETED|Period III (Single-Blind)||2520
235496|NCT00923091|572416|P13|STARTED|Period III (Single-Blind)||0
235497|NCT00923091|572417|P12|STARTED|Period III (Single-Blind)||0
235498|NCT00923091|572418|P11|STARTED|Period III (Single-Blind)||0
235499|NCT00923091|572419|P10|STARTED|Period III (Single-Blind)||0
235500|NCT00923091|572420|P9|STARTED|Period III (Single-Blind)||0
235501|NCT00923091|572421|P8|STARTED|Period III (Single-Blind)||0
235502|NCT00923091|572422|P7|STARTED|Period III (Single-Blind)||0
235503|NCT00923091|572423|P6|STARTED|Period III (Single-Blind)||0
235504|NCT00923091|572424|P5|STARTED|Period III (Single-Blind)||0
235505|NCT00923091|572425|P4|STARTED|Period III (Single-Blind)||0
235506|NCT00923091|572426|P3|STARTED|Period III (Single-Blind)||0
235507|NCT00923091|572427|P2|STARTED|Period III (Single-Blind)||0
235508|NCT00923091|572428|P1|STARTED|Period III (Single-Blind)|2543 completed Period 2. Three decided not to continue in the study=2540.|2540
235509|NCT00923091|572416|P13|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235510|NCT00923091|572417|P12|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235511|NCT00923091|572418|P11|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235512|NCT00923091|572419|P10|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235513|NCT00923091|572420|P9|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235514|NCT00923091|572421|P8|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||25
235515|NCT00923091|572422|P7|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||18
235516|NCT00923091|572423|P6|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||15
235517|NCT00923091|572424|P5|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||21
235518|NCT00923091|572425|P4|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||27
235519|NCT00923091|572426|P3|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||13
235520|NCT00923091|572427|P2|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||11
235521|NCT00923091|572428|P1|NOT COMPLETED|PeriodI-II (Randomized, Double-Blind)||16
235522|NCT00923091|572416|P13|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235523|NCT00923091|572417|P12|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235524|NCT00923091|572418|P11|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235525|NCT00923091|572419|P10|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235526|NCT00923091|572420|P9|COMPLETED|PeriodI-II (Randomized, Double-Blind)||0
235527|NCT00923091|572421|P8|COMPLETED|PeriodI-II (Randomized, Double-Blind)||311
235528|NCT00923091|572422|P7|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
235529|NCT00923091|572423|P6|COMPLETED|PeriodI-II (Randomized, Double-Blind)||322
235530|NCT00923091|572424|P5|COMPLETED|PeriodI-II (Randomized, Double-Blind)||315
235531|NCT00923091|572425|P4|COMPLETED|PeriodI-II (Randomized, Double-Blind)||309
235532|NCT00923091|572426|P3|COMPLETED|PeriodI-II (Randomized, Double-Blind)||323
235533|NCT00923091|572427|P2|COMPLETED|PeriodI-II (Randomized, Double-Blind)||325
235534|NCT00923091|572428|P1|COMPLETED|PeriodI-II (Randomized, Double-Blind)||319
235535|NCT00923091|572416|P13|STARTED|PeriodI-II (Randomized, Double-Blind)||0
235536|NCT00923091|572417|P12|STARTED|PeriodI-II (Randomized, Double-Blind)||0
235537|NCT00923091|572418|P11|STARTED|PeriodI-II (Randomized, Double-Blind)||0
235538|NCT00923091|572419|P10|STARTED|PeriodI-II (Randomized, Double-Blind)||0
235539|NCT00923091|572420|P9|STARTED|PeriodI-II (Randomized, Double-Blind)||0
235540|NCT00923091|572421|P8|STARTED|PeriodI-II (Randomized, Double-Blind)||336
235541|NCT00923091|572422|P7|STARTED|PeriodI-II (Randomized, Double-Blind)||337
235542|NCT00923091|572423|P6|STARTED|PeriodI-II (Randomized, Double-Blind)||337
235543|NCT00923091|572424|P5|STARTED|PeriodI-II (Randomized, Double-Blind)||336
235544|NCT00923091|572425|P4|STARTED|PeriodI-II (Randomized, Double-Blind)||336
235545|NCT00923091|572426|P3|STARTED|PeriodI-II (Randomized, Double-Blind)||336
235546|NCT00923091|572427|P2|STARTED|PeriodI-II (Randomized, Double-Blind)||336
235547|NCT00923091|572428|P1|STARTED|PeriodI-II (Randomized, Double-Blind)||335
235548|NCT00923117|572477|P2|NOT COMPLETED|Overall Study||0
235549|NCT00923117|572478|P1|NOT COMPLETED|Overall Study||0
235550|NCT00923117|572477|P2|COMPLETED|Overall Study||43
235551|NCT00923117|572478|P1|COMPLETED|Overall Study||44
235552|NCT00923117|572477|P2|STARTED|Overall Study||43
235553|NCT00923117|572478|P1|STARTED|Overall Study||44
235554|NCT00923130|572486|P1|NOT COMPLETED|Overall Study||25
235555|NCT00923130|572486|P1|COMPLETED|Overall Study||5
235556|NCT00923130|572486|P1|STARTED|Overall Study||30
235557|NCT00923156|572505|P3|NOT COMPLETED|Overall Study||3
235558|NCT00923156|572506|P2|NOT COMPLETED|Overall Study||4
235559|NCT00923156|572507|P1|NOT COMPLETED|Overall Study||0
235560|NCT00923156|572505|P3|COMPLETED|Overall Study||38
235561|NCT00923156|572506|P2|COMPLETED|Overall Study||38
235562|NCT00923156|572507|P1|COMPLETED|Overall Study||40
235563|NCT00923156|572505|P3|STARTED|Overall Study||41
235564|NCT00923156|572506|P2|STARTED|Overall Study||42
235565|NCT00923156|572507|P1|STARTED|Overall Study|"Started indicates randomized, safety and pharmacodynamic population"|40
235566|NCT00923195|572535|P2|NOT COMPLETED|Overall Study||1
235567|NCT00923195|572536|P1|NOT COMPLETED|Overall Study||0
235568|NCT00923195|572535|P2|COMPLETED|Overall Study||1
235569|NCT00923195|572536|P1|COMPLETED|Overall Study||2
235570|NCT00923195|572535|P2|STARTED|Overall Study||2
235571|NCT00923195|572536|P1|STARTED|Overall Study||2
235572|NCT00923247|572546|P2|NOT COMPLETED|Overall Study||0
235573|NCT00923247|572547|P1|NOT COMPLETED|Overall Study||0
235574|NCT00923247|572546|P2|COMPLETED|Overall Study||1
235575|NCT00923247|572547|P1|COMPLETED|Overall Study||21
235576|NCT00923247|572546|P2|STARTED|Overall Study||1
235577|NCT00923247|572547|P1|STARTED|Overall Study||21
235578|NCT00923260|572575|P2|NOT COMPLETED|Overall Study||1
235579|NCT00923260|572576|P1|NOT COMPLETED|Overall Study||1
235580|NCT00923260|572575|P2|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
235581|NCT00923260|572576|P1|COMPLETED|Overall Study|Patient didn't complete the follow-up period after surgery|11
235582|NCT00923260|572575|P2|STARTED|Overall Study||12
235583|NCT00923260|572576|P1|STARTED|Overall Study||12
235584|NCT00923273|572713|P5|NOT COMPLETED|Phase II Treatment Period||0
235585|NCT00923273|572714|P4|NOT COMPLETED|Phase II Treatment Period||7
235586|NCT00923273|572715|P3|NOT COMPLETED|Phase II Treatment Period||0
235587|NCT00923273|572716|P2|NOT COMPLETED|Phase II Treatment Period||0
235588|NCT00923273|572717|P1|NOT COMPLETED|Phase II Treatment Period||0
235589|NCT00923273|572713|P5|COMPLETED|Phase II Treatment Period||0
235590|NCT00923273|572714|P4|COMPLETED|Phase II Treatment Period||20
235591|NCT00923273|572715|P3|COMPLETED|Phase II Treatment Period||0
235592|NCT00923273|572716|P2|COMPLETED|Phase II Treatment Period||0
235593|NCT00923273|572717|P1|COMPLETED|Phase II Treatment Period||0
235594|NCT00923273|572713|P5|STARTED|Phase II Treatment Period||0
235595|NCT00923273|572714|P4|STARTED|Phase II Treatment Period|Includes 8 subjects with prior peme;12 subjects who were peme naive; 7 subjects rolled over from phI|27
235596|NCT00923273|572715|P3|STARTED|Phase II Treatment Period||0
235597|NCT00923273|572716|P2|STARTED|Phase II Treatment Period||0
235598|NCT00923273|572717|P1|STARTED|Phase II Treatment Period|The phase II portion will utilize the MTD from the phase I portion.|0
235599|NCT00923273|572713|P5|NOT COMPLETED|Phase I Treatment Period||0
235600|NCT00923273|572714|P4|NOT COMPLETED|Phase I Treatment Period||0
235601|NCT00923273|572715|P3|NOT COMPLETED|Phase I Treatment Period||0
235602|NCT00923273|572716|P2|NOT COMPLETED|Phase I Treatment Period||0
235603|NCT00923273|572717|P1|NOT COMPLETED|Phase I Treatment Period||0
235604|NCT00923273|572713|P5|COMPLETED|Phase I Treatment Period||5
235605|NCT00923273|572714|P4|COMPLETED|Phase I Treatment Period||7
235606|NCT00923273|572715|P3|COMPLETED|Phase I Treatment Period||3
235607|NCT00923273|572716|P2|COMPLETED|Phase I Treatment Period||3
235608|NCT00923273|572717|P1|COMPLETED|Phase I Treatment Period||4
235609|NCT00923273|572713|P5|STARTED|Phase I Treatment Period|5 subjects peme naive.|5
235610|NCT00923273|572714|P4|STARTED|Phase I Treatment Period|3 subjects initially enrolled and 4 subjects added after dose level 5; peme naive.|7
235611|NCT00923273|572715|P3|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
235612|NCT00923273|572716|P2|STARTED|Phase I Treatment Period|3 subjects peme naive.|3
235613|NCT00923273|572717|P1|STARTED|Phase I Treatment Period|The phase I portion will establish the maximum tolerated dose. 4 subjects peme naive.|4
235614|NCT00923351|572742|P3|NOT COMPLETED|Overall Study||12
235615|NCT00923351|572743|P2|NOT COMPLETED|Overall Study||0
235616|NCT00923351|572744|P1|NOT COMPLETED|Overall Study||0
235617|NCT00923351|572742|P3|COMPLETED|Overall Study||0
235618|NCT00923351|572743|P2|COMPLETED|Overall Study||26
235619|NCT00923351|572744|P1|COMPLETED|Overall Study||6
235620|NCT00923351|572742|P3|STARTED|Overall Study||12
235621|NCT00923351|572743|P2|STARTED|Overall Study||26
235622|NCT00923351|572744|P1|STARTED|Overall Study||6
235623|NCT00923481|572752|P1|NOT COMPLETED|Overall Study||0
235624|NCT00923481|572752|P1|COMPLETED|Overall Study||37
235625|NCT00923481|572752|P1|STARTED|Overall Study||37
235626|NCT00923845|572759|P2|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
235627|NCT00923845|572760|P1|NOT COMPLETED|Allogeneic Stem Cell Therapy||0
235628|NCT00923845|572759|P2|COMPLETED|Allogeneic Stem Cell Therapy||10
235629|NCT00923845|572760|P1|COMPLETED|Allogeneic Stem Cell Therapy||0
235630|NCT00923845|572759|P2|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||6
235631|NCT00923845|572760|P1|Received More Unmanipulated DLI for PD|Allogeneic Stem Cell Therapy||0
235632|NCT00923845|572759|P2|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||8
235633|NCT00923845|572760|P1|Received Each of 3 Planned T-Rapa DLI|Allogeneic Stem Cell Therapy||0
235634|NCT00923845|572759|P2|STARTED|Allogeneic Stem Cell Therapy||10
235635|NCT00923845|572760|P1|STARTED|Allogeneic Stem Cell Therapy||0
235636|NCT00923845|572759|P2|NOT COMPLETED|Induction Therapy||2
235637|NCT00923845|572760|P1|NOT COMPLETED|Induction Therapy||0
235638|NCT00923845|572759|P2|COMPLETED|Induction Therapy||10
235639|NCT00923845|572760|P1|COMPLETED|Induction Therapy||0
235640|NCT00923845|572759|P2|STARTED|Induction Therapy||12
235641|NCT00923845|572760|P1|STARTED|Induction Therapy||0
235642|NCT00923845|572759|P2|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
235643|NCT00923845|572760|P1|NOT COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
235644|NCT00923845|572759|P2|COMPLETED|Donor Hematopoietic Stem Cell Harvest||0
235645|NCT00923845|572760|P1|COMPLETED|Donor Hematopoietic Stem Cell Harvest||13
235646|NCT00923845|572759|P2|STARTED|Donor Hematopoietic Stem Cell Harvest||0
235647|NCT00923845|572760|P1|STARTED|Donor Hematopoietic Stem Cell Harvest||13
235648|NCT00923845|572759|P2|NOT COMPLETED|Donor Lymphocyte Harvest||0
235649|NCT00923845|572760|P1|NOT COMPLETED|Donor Lymphocyte Harvest||0
235650|NCT00923845|572759|P2|COMPLETED|Donor Lymphocyte Harvest||0
235651|NCT00923845|572760|P1|COMPLETED|Donor Lymphocyte Harvest||13
235652|NCT00923845|572759|P2|STARTED|Donor Lymphocyte Harvest||0
235653|NCT00923845|572760|P1|STARTED|Donor Lymphocyte Harvest||13
235654|NCT00923910|572783|P2|NOT COMPLETED|Period 2||0
235655|NCT00923910|572784|P1|NOT COMPLETED|Period 2||0
235656|NCT00923910|572783|P2|COMPLETED|Period 2||5
235657|NCT00923910|572784|P1|COMPLETED|Period 2||5
235658|NCT00923910|572783|P2|STARTED|Period 2||5
235659|NCT00923910|572784|P1|STARTED|Period 2||5
235660|NCT00923910|572783|P2|NOT COMPLETED|Period 1||0
235661|NCT00923910|572784|P1|NOT COMPLETED|Period 1||0
235662|NCT00923910|572783|P2|COMPLETED|Period 1||5
235663|NCT00923910|572784|P1|COMPLETED|Period 1||5
235664|NCT00923910|572783|P2|STARTED|Period 1||5
235665|NCT00923910|572784|P1|STARTED|Period 1||5
235666|NCT00923936|572796|P2|NOT COMPLETED|Overall Study||3
235667|NCT00923936|572797|P1|NOT COMPLETED|Overall Study||8
235668|NCT00923936|572796|P2|COMPLETED|Overall Study||3
235669|NCT00923936|572797|P1|COMPLETED|Overall Study||2
235670|NCT00923936|572796|P2|STARTED|Overall Study||6
235671|NCT00923936|572797|P1|STARTED|Overall Study||10
235672|NCT00923949|572811|P1|NOT COMPLETED|Overall Study||0
235673|NCT00923949|572811|P1|COMPLETED|Overall Study||1
235674|NCT00923949|572811|P1|STARTED|Overall Study||1
235675|NCT00923975|572821|P1|NOT COMPLETED|Overall Study||1
235676|NCT00923975|572821|P1|COMPLETED|Overall Study|One subject did not meet inclusion criteria; the data was not used in analysis.|50
235677|NCT00923975|572821|P1|STARTED|Overall Study||51
235678|NCT00924001|572828|P1|NOT COMPLETED|Overall Study||0
235679|NCT00924001|572828|P1|COMPLETED|Overall Study||1
235680|NCT00924001|572828|P1|STARTED|Overall Study||1
235681|NCT00924040|572834|P1|NOT COMPLETED|Overall Study||0
235682|NCT00924040|572834|P1|COMPLETED|Overall Study||1
235683|NCT00924040|572834|P1|STARTED|Overall Study||1
235684|NCT00924053|572850|P4|NOT COMPLETED|Overall Study||0
235685|NCT00924053|572851|P3|NOT COMPLETED|Overall Study||0
235686|NCT00924053|572852|P2|NOT COMPLETED|Overall Study||0
235687|NCT00924053|572853|P1|NOT COMPLETED|Overall Study||0
235688|NCT00924053|572850|P4|COMPLETED|Overall Study||6
235689|NCT00924053|572851|P3|COMPLETED|Overall Study||6
235690|NCT00924053|572852|P2|COMPLETED|Overall Study||6
235691|NCT00924053|572853|P1|COMPLETED|Overall Study||6
235692|NCT00924053|572850|P4|STARTED|Overall Study||6
235693|NCT00924053|572851|P3|STARTED|Overall Study||6
235694|NCT00924053|572852|P2|STARTED|Overall Study||6
235695|NCT00924053|572853|P1|STARTED|Overall Study||6
235696|NCT00924066|572899|P1|NOT COMPLETED|Overall Study||0
235697|NCT00924066|572899|P1|COMPLETED|Overall Study||41
235698|NCT00924066|572899|P1|STARTED|Overall Study||41
235699|NCT00924209|572904|P1|NOT COMPLETED|Overall Study||0
235700|NCT00924209|572904|P1|COMPLETED|Overall Study||7
235701|NCT00924209|572904|P1|STARTED|Overall Study||7
235702|NCT00924287|572909|P1|NOT COMPLETED|Overall Study||1
235703|NCT00924287|572909|P1|COMPLETED|Overall Study||0
235704|NCT00924287|572909|P1|STARTED|Overall Study||1
235705|NCT00924313|572915|P1|NOT COMPLETED|Overall Study||1
235706|NCT00924313|572915|P1|COMPLETED|Overall Study||39
235707|NCT00924313|572915|P1|STARTED|Overall Study||40
235708|NCT00924352|572927|P2|NOT COMPLETED|Overall Study||0
235709|NCT00924352|572928|P1|NOT COMPLETED|Overall Study||0
235710|NCT00924352|572927|P2|COMPLETED|Overall Study||44
235711|NCT00924352|572928|P1|COMPLETED|Overall Study||12
235712|NCT00924352|572927|P2|STARTED|Overall Study||44
235713|NCT00924352|572928|P1|STARTED|Overall Study||12
235714|NCT00924404|572943|P2|NOT COMPLETED|Overall Study||4
235715|NCT00924404|572944|P1|NOT COMPLETED|Overall Study||6
235716|NCT00924404|572943|P2|COMPLETED|Overall Study||22
235717|NCT00924404|572944|P1|COMPLETED|Overall Study||21
235718|NCT00924404|572943|P2|STARTED|Overall Study||26
235719|NCT00924404|572944|P1|STARTED|Overall Study||27
235720|NCT00924443|572950|P1|NOT COMPLETED|Overall Study||3
235721|NCT00924443|572950|P1|COMPLETED|Overall Study||66
235722|NCT00924443|572950|P1|Full Analysis Set (Received Study Drug)|Overall Study||66
235723|NCT00924443|572950|P1|STARTED|Overall Study||69
235724|NCT00924469|572960|P2|NOT COMPLETED|Overall Study||2
235725|NCT00924469|572961|P1|NOT COMPLETED|Overall Study||2
235726|NCT00924469|572960|P2|COMPLETED|Overall Study||26
235727|NCT00924469|572961|P1|COMPLETED|Overall Study||28
235728|NCT00924469|572960|P2|STARTED|Overall Study||28
235729|NCT00924469|572961|P1|STARTED|Overall Study||30
235730|NCT00924482|572983|P1|NOT COMPLETED|Overall Study||0
235731|NCT00924482|572983|P1|COMPLETED|Overall Study||261
235732|NCT00924482|572983|P1|STARTED|Overall Study||261
235733|NCT00924508|572988|P1|NOT COMPLETED|Overall Study||3
235734|NCT00924508|572988|P1|COMPLETED|Overall Study||20
235735|NCT00924508|572988|P1|STARTED|Overall Study||23
235736|NCT00924560|572998|P3|NOT COMPLETED|Overall Study||83
235737|NCT00924560|572999|P2|NOT COMPLETED|Overall Study||208
235738|NCT00924560|573000|P1|NOT COMPLETED|Overall Study||211
235739|NCT00924560|572998|P3|COMPLETED|Overall Study||372
235740|NCT00924560|572999|P2|COMPLETED|Overall Study||240
235741|NCT00924560|573000|P1|COMPLETED|Overall Study||247
235742|NCT00924560|572998|P3|Received Treatment|Overall Study||0
235743|NCT00924560|572999|P2|Received Treatment|Overall Study|Excludes 9 participants from one site that was closed due to audit findings.|411
235744|NCT00924560|573000|P1|Received Treatment|Overall Study|Excludes 7 participants at 1 site that was closed. One participant received 28-day OC in error.|422
235745|NCT00924560|572998|P3|STARTED|Overall Study||455
235746|NCT00924560|572999|P2|STARTED|Overall Study||448
235747|NCT00924560|573000|P1|STARTED|Overall Study||458
235748|NCT00924638|573046|P2|NOT COMPLETED|Overall Study||13
235749|NCT00924638|573047|P1|NOT COMPLETED|Overall Study||12
235750|NCT00924638|573046|P2|COMPLETED|Overall Study|Completed 6 months of follow-up|207
235751|NCT00924638|573047|P1|COMPLETED|Overall Study|Completed 6 months of follow-up|209
235752|NCT00924638|573046|P2|STARTED|Overall Study|Randomized to Control Arm|220
235753|NCT00924638|573047|P1|STARTED|Overall Study|Randomized to Continuous Monitoring Arm|221
235754|NCT00924651|573068|P2|NOT COMPLETED|Overall Study||25
235755|NCT00924651|573069|P1|NOT COMPLETED|Overall Study||25
235756|NCT00924651|573068|P2|COMPLETED|Overall Study||312
235757|NCT00924651|573069|P1|COMPLETED|Overall Study||331
235758|NCT00924651|573068|P2|STARTED|Overall Study||337
235759|NCT00924651|573069|P1|STARTED|Overall Study||356
235760|NCT00924729|573077|P2|NOT COMPLETED|Overall Study||0
235761|NCT00924729|573078|P1|NOT COMPLETED|Overall Study||2
235762|NCT00924729|573077|P2|COMPLETED|Overall Study||25
235763|NCT00924729|573078|P1|COMPLETED|Overall Study||23
235764|NCT00924729|573077|P2|STARTED|Overall Study||25
235765|NCT00924729|573078|P1|STARTED|Overall Study||25
235766|NCT00924781|573088|P2|NOT COMPLETED|Overall Study||10
235767|NCT00924781|573089|P1|NOT COMPLETED|Overall Study||12
235768|NCT00924781|573088|P2|COMPLETED|Overall Study||9
235769|NCT00924781|573089|P1|COMPLETED|Overall Study||8
235770|NCT00924781|573088|P2|STARTED|Overall Study||19
235771|NCT00924781|573089|P1|STARTED|Overall Study||20
235772|NCT00924807|573121|P1|NOT COMPLETED|Overall Study||0
235773|NCT00924807|573121|P1|COMPLETED|Overall Study||4
235774|NCT00924807|573121|P1|STARTED|Overall Study||4
235775|NCT00924833|573128|P3|NOT COMPLETED|Overall Study||0
235776|NCT00924833|573129|P2|NOT COMPLETED|Overall Study||0
235777|NCT00924833|573130|P1|NOT COMPLETED|Overall Study||0
235778|NCT00924833|573128|P3|COMPLETED|Overall Study|1 subject was excluded from the analysis for medical problems unrelated to the study.|9
235779|NCT00924833|573129|P2|COMPLETED|Overall Study|1 subject was excluded from the analysis for incomplete data.|9
235780|NCT00924833|573130|P1|COMPLETED|Overall Study|7 subjects analyzed (2 were excluded for poor cardiopulmonary exercise stress test quality).|9
235781|NCT00924833|573128|P3|STARTED|Overall Study||9
235782|NCT00924833|573129|P2|STARTED|Overall Study||9
235783|NCT00924833|573130|P1|STARTED|Overall Study||9
235784|NCT00924898|573144|P1|NOT COMPLETED|Overall Study||2
235785|NCT00924898|573144|P1|COMPLETED|Overall Study||90
235786|NCT00924898|573144|P1|STARTED|Overall Study||92
235787|NCT00924950|573153|P1|NOT COMPLETED|Overall Study||2
235788|NCT00924950|573153|P1|COMPLETED|Overall Study||28
235789|NCT00924950|573153|P1|STARTED|Overall Study||30
235790|NCT00925015|573161|P3|NOT COMPLETED|Overall Study||6
235791|NCT00925015|573162|P2|NOT COMPLETED|Overall Study||6
235792|NCT00925015|573163|P1|NOT COMPLETED|Overall Study||8
235793|NCT00925015|573161|P3|COMPLETED|Overall Study||0
235794|NCT00925015|573162|P2|COMPLETED|Overall Study||0
235795|NCT00925015|573163|P1|COMPLETED|Overall Study||0
235796|NCT00925015|573161|P3|STARTED|Overall Study||6
235797|NCT00925015|573162|P2|STARTED|Overall Study||6
235798|NCT00925015|573163|P1|STARTED|Overall Study||8
235799|NCT00925132|573219|P5|NOT COMPLETED|Overall Study||5
235800|NCT00925132|573220|P4|NOT COMPLETED|Overall Study||0
235801|NCT00925132|573221|P3|NOT COMPLETED|Overall Study||0
235802|NCT00925132|573222|P2|NOT COMPLETED|Overall Study||0
235803|NCT00925132|573223|P1|NOT COMPLETED|Overall Study||2
235804|NCT00925132|573219|P5|COMPLETED|Overall Study||17
235805|NCT00925132|573220|P4|COMPLETED|Overall Study||4
235806|NCT00925132|573221|P3|COMPLETED|Overall Study||4
235807|NCT00925132|573222|P2|COMPLETED|Overall Study||4
235808|NCT00925132|573223|P1|COMPLETED|Overall Study||3
235809|NCT00925132|573219|P5|STARTED|Overall Study||22
235810|NCT00925132|573220|P4|STARTED|Overall Study||4
235811|NCT00925132|573221|P3|STARTED|Overall Study||4
235812|NCT00925132|573222|P2|STARTED|Overall Study||4
235813|NCT00925132|573223|P1|STARTED|Overall Study||5
235814|NCT00925288|573231|P2|NOT COMPLETED|Overall Study||7
235815|NCT00925288|573232|P1|NOT COMPLETED|Overall Study||9
235816|NCT00925288|573231|P2|COMPLETED|Overall Study||93
235817|NCT00925288|573232|P1|COMPLETED|Overall Study||91
235818|NCT00925288|573231|P2|STARTED|Overall Study||100
235819|NCT00925288|573232|P1|STARTED|Overall Study||100
235820|NCT00925353|573244|P1|NOT COMPLETED|Overall Study||3
235821|NCT00925353|573244|P1|COMPLETED|Overall Study||10
235822|NCT00925353|573244|P1|STARTED|Overall Study||13
235823|NCT00925522|573248|P1|NOT COMPLETED|Overall Study||0
235824|NCT00925522|573248|P1|COMPLETED|Overall Study||20
235825|NCT00925522|573248|P1|STARTED|Overall Study||20
235826|NCT00925548|573254|P2|NOT COMPLETED|Overall Study||5
235827|NCT00925548|573255|P1|NOT COMPLETED|Overall Study||10
235828|NCT00925548|573254|P2|COMPLETED|Overall Study||0
235829|NCT00925548|573255|P1|COMPLETED|Overall Study||1
235830|NCT00925548|573254|P2|STARTED|Overall Study||5
235831|NCT00925548|573255|P1|STARTED|Overall Study||11
235832|NCT00925587|573283|P2|NOT COMPLETED|Overall Study||25
235833|NCT00925587|573284|P1|NOT COMPLETED|Overall Study||36
235834|NCT00925587|573283|P2|COMPLETED|Overall Study||155
235835|NCT00925587|573284|P1|COMPLETED|Overall Study||142
235836|NCT00925587|573283|P2|STARTED|Overall Study||180
235837|NCT00925587|573284|P1|STARTED|Overall Study||178
235838|NCT00925600|573398|P2|NOT COMPLETED|Overall Study||28
235839|NCT00925600|573399|P1|NOT COMPLETED|Overall Study||32
235840|NCT00925600|573398|P2|COMPLETED|Overall Study||355
235841|NCT00925600|573399|P1|COMPLETED|Overall Study||354
235842|NCT00925600|573398|P2|Received Treatment|Overall Study||382
235843|NCT00925600|573399|P1|Received Treatment|Overall Study|Three participants received at least 1 dose of denosumab in error|383
235844|NCT00925600|573398|P2|STARTED|Overall Study||383
235845|NCT00925600|573399|P1|STARTED|Overall Study||386
235846|NCT00915876|573421|P2|NOT COMPLETED|Overall Study||1
235847|NCT00915876|573422|P1|NOT COMPLETED|Overall Study||0
235848|NCT00915876|573421|P2|COMPLETED|Overall Study||20
235849|NCT00915876|573422|P1|COMPLETED|Overall Study||20
235850|NCT00915876|573421|P2|Moving Beyond First Dose|Overall Study||20
235851|NCT00915876|573422|P1|Moving Beyond First Dose|Overall Study||20
235852|NCT00915876|573421|P2|STARTED|Overall Study||21
235853|NCT00915876|573422|P1|STARTED|Overall Study||20
235854|NCT00915902|573430|P2|NOT COMPLETED|2nd Treatment Period||1
235855|NCT00915902|573431|P1|NOT COMPLETED|2nd Treatment Period||0
235856|NCT00915902|573430|P2|COMPLETED|2nd Treatment Period||20
235857|NCT00915902|573431|P1|COMPLETED|2nd Treatment Period||19
235858|NCT00915902|573430|P2|STARTED|2nd Treatment Period||21
235859|NCT00915902|573431|P1|STARTED|2nd Treatment Period||19
235860|NCT00915902|573430|P2|NOT COMPLETED|Washout (4 Weeks)||1
235861|NCT00915902|573431|P1|NOT COMPLETED|Washout (4 Weeks)||0
235862|NCT00915902|573430|P2|COMPLETED|Washout (4 Weeks)||21
235863|NCT00915902|573431|P1|COMPLETED|Washout (4 Weeks)||19
235864|NCT00915902|573430|P2|STARTED|Washout (4 Weeks)||22
235865|NCT00915902|573431|P1|STARTED|Washout (4 Weeks)||19
235866|NCT00915902|573430|P2|NOT COMPLETED|1st Treatment Period||0
235867|NCT00915902|573431|P1|NOT COMPLETED|1st Treatment Period||1
235868|NCT00915902|573430|P2|COMPLETED|1st Treatment Period||22
235869|NCT00915902|573431|P1|COMPLETED|1st Treatment Period||19
235870|NCT00915902|573430|P2|STARTED|1st Treatment Period||22
235871|NCT00915902|573431|P1|STARTED|1st Treatment Period||20
235872|NCT00916006|573441|P2|NOT COMPLETED|Overall Study||7
235873|NCT00916006|573442|P1|NOT COMPLETED|Overall Study||3
235874|NCT00916006|573441|P2|COMPLETED|Overall Study||127
235875|NCT00916006|573442|P1|COMPLETED|Overall Study||132
235876|NCT00916006|573441|P2|STARTED|Overall Study||134
235877|NCT00916006|573442|P1|STARTED|Overall Study||135
235878|NCT00916032|573450|P2|NOT COMPLETED|Overall Study||0
235879|NCT00916032|573451|P1|NOT COMPLETED|Overall Study||0
235880|NCT00916032|573450|P2|COMPLETED|Overall Study||11
235881|NCT00916032|573451|P1|COMPLETED|Overall Study||12
235882|NCT00916032|573450|P2|STARTED|Overall Study||11
235883|NCT00916032|573451|P1|STARTED|Overall Study||12
235884|NCT00916136|573493|P2|NOT COMPLETED|Overall Study||0
235885|NCT00916136|573494|P1|NOT COMPLETED|Overall Study||0
235886|NCT00916136|573493|P2|COMPLETED|Overall Study||29
235887|NCT00916136|573494|P1|COMPLETED|Overall Study||37
235888|NCT00916136|573493|P2|STARTED|Overall Study||29
235889|NCT00916136|573494|P1|STARTED|Overall Study||37
235890|NCT00916279|573502|P1|NOT COMPLETED|Overall Study||4
235891|NCT00916279|573502|P1|COMPLETED|Overall Study||37
235892|NCT00916279|573502|P1|24 Months|Overall Study||37
235893|NCT00916279|573502|P1|6 Months|Overall Study||41
235894|NCT00916279|573502|P1|30 Days|Overall Study||41
235895|NCT00916279|573502|P1|STARTED|Overall Study||41
235896|NCT00916305|573512|P2|NOT COMPLETED|Overall Study||28
235897|NCT00916305|573513|P1|NOT COMPLETED|Overall Study||21
235898|NCT00916305|573512|P2|COMPLETED|Overall Study||9
235899|NCT00916305|573513|P1|COMPLETED|Overall Study||7
235900|NCT00916305|573512|P2|STARTED|Overall Study||37
235901|NCT00916305|573513|P1|STARTED|Overall Study||28
235902|NCT00916344|573521|P1|NOT COMPLETED|Overall Study||8
235903|NCT00916344|573521|P1|COMPLETED|Overall Study||167
235904|NCT00916344|573521|P1|STARTED|Overall Study||175
235905|NCT00916357|573526|P6|NOT COMPLETED|Period 3||0
235906|NCT00916357|573527|P5|NOT COMPLETED|Period 3||0
235907|NCT00916357|573528|P4|NOT COMPLETED|Period 3||0
235908|NCT00916357|573529|P3|NOT COMPLETED|Period 3||0
235909|NCT00916357|573530|P2|NOT COMPLETED|Period 3||0
235910|NCT00916357|573531|P1|NOT COMPLETED|Period 3||0
235911|NCT00916357|573526|P6|COMPLETED|Period 3||4
235912|NCT00916357|573527|P5|COMPLETED|Period 3||3
235913|NCT00916357|573528|P4|COMPLETED|Period 3||3
235914|NCT00916357|573529|P3|COMPLETED|Period 3||4
235915|NCT00916357|573530|P2|COMPLETED|Period 3||4
235916|NCT00916357|573531|P1|COMPLETED|Period 3||3
235917|NCT00916357|573526|P6|STARTED|Period 3||4
235918|NCT00916357|573527|P5|STARTED|Period 3||3
235919|NCT00916357|573528|P4|STARTED|Period 3||3
235920|NCT00916357|573529|P3|STARTED|Period 3||4
235921|NCT00916357|573530|P2|STARTED|Period 3||4
235922|NCT00916357|573531|P1|STARTED|Period 3||3
235923|NCT00916357|573526|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
235924|NCT00916357|573527|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
235925|NCT00916357|573528|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
235926|NCT00916357|573529|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
235927|NCT00916357|573530|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
235928|NCT00916357|573531|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
235929|NCT00916357|573526|P6|COMPLETED|Washout (3 to 14 Days)||4
235930|NCT00916357|573527|P5|COMPLETED|Washout (3 to 14 Days)||3
235931|NCT00916357|573528|P4|COMPLETED|Washout (3 to 14 Days)||3
235932|NCT00916357|573529|P3|COMPLETED|Washout (3 to 14 Days)||4
235933|NCT00916357|573530|P2|COMPLETED|Washout (3 to 14 Days)||4
235934|NCT00916357|573531|P1|COMPLETED|Washout (3 to 14 Days)||3
235935|NCT00916357|573526|P6|STARTED|Washout (3 to 14 Days)||4
235936|NCT00916357|573527|P5|STARTED|Washout (3 to 14 Days)||3
235937|NCT00916357|573528|P4|STARTED|Washout (3 to 14 Days)||3
235938|NCT00916357|573529|P3|STARTED|Washout (3 to 14 Days)||4
235939|NCT00916357|573530|P2|STARTED|Washout (3 to 14 Days)||4
235940|NCT00916357|573531|P1|STARTED|Washout (3 to 14 Days)||3
235941|NCT00916357|573526|P6|NOT COMPLETED|Period 2||0
235942|NCT00916357|573527|P5|NOT COMPLETED|Period 2||0
235943|NCT00916357|573528|P4|NOT COMPLETED|Period 2||1
235944|NCT00916357|573529|P3|NOT COMPLETED|Period 2||0
235945|NCT00916357|573530|P2|NOT COMPLETED|Period 2||0
235946|NCT00916357|573531|P1|NOT COMPLETED|Period 2||0
235947|NCT00916357|573526|P6|COMPLETED|Period 2||4
235948|NCT00916357|573527|P5|COMPLETED|Period 2||3
235949|NCT00916357|573528|P4|COMPLETED|Period 2||3
235950|NCT00916357|573529|P3|COMPLETED|Period 2||4
235951|NCT00916357|573530|P2|COMPLETED|Period 2||4
235952|NCT00916357|573531|P1|COMPLETED|Period 2||3
235953|NCT00916357|573526|P6|STARTED|Period 2||4
235954|NCT00916357|573527|P5|STARTED|Period 2||3
235955|NCT00916357|573528|P4|STARTED|Period 2||4
235956|NCT00916357|573529|P3|STARTED|Period 2||4
235957|NCT00916357|573530|P2|STARTED|Period 2||4
235958|NCT00916357|573531|P1|STARTED|Period 2||3
235959|NCT00916357|573526|P6|NOT COMPLETED|Washout (3 to 14 Days)||0
235960|NCT00916357|573527|P5|NOT COMPLETED|Washout (3 to 14 Days)||0
235961|NCT00916357|573528|P4|NOT COMPLETED|Washout (3 to 14 Days)||0
235962|NCT00916357|573529|P3|NOT COMPLETED|Washout (3 to 14 Days)||0
235963|NCT00916357|573530|P2|NOT COMPLETED|Washout (3 to 14 Days)||0
235964|NCT00916357|573531|P1|NOT COMPLETED|Washout (3 to 14 Days)||0
235965|NCT00916357|573526|P6|COMPLETED|Washout (3 to 14 Days)||4
235966|NCT00916357|573527|P5|COMPLETED|Washout (3 to 14 Days)||3
235967|NCT00916357|573528|P4|COMPLETED|Washout (3 to 14 Days)||4
235968|NCT00916357|573529|P3|COMPLETED|Washout (3 to 14 Days)||4
235969|NCT00916357|573530|P2|COMPLETED|Washout (3 to 14 Days)||4
235970|NCT00916357|573531|P1|COMPLETED|Washout (3 to 14 Days)||3
235971|NCT00916357|573526|P6|STARTED|Washout (3 to 14 Days)||4
235972|NCT00916357|573527|P5|STARTED|Washout (3 to 14 Days)||3
235973|NCT00916357|573528|P4|STARTED|Washout (3 to 14 Days)||4
235974|NCT00916357|573529|P3|STARTED|Washout (3 to 14 Days)||4
235975|NCT00916357|573530|P2|STARTED|Washout (3 to 14 Days)||4
235976|NCT00916357|573531|P1|STARTED|Washout (3 to 14 Days)||3
235977|NCT00916357|573526|P6|NOT COMPLETED|Period 1||0
235978|NCT00916357|573527|P5|NOT COMPLETED|Period 1||0
235979|NCT00916357|573528|P4|NOT COMPLETED|Period 1||0
235980|NCT00916357|573529|P3|NOT COMPLETED|Period 1||0
235981|NCT00916357|573530|P2|NOT COMPLETED|Period 1||0
235982|NCT00916357|573531|P1|NOT COMPLETED|Period 1||1
235983|NCT00916357|573526|P6|COMPLETED|Period 1||4
235984|NCT00916357|573527|P5|COMPLETED|Period 1||3
235985|NCT00916357|573528|P4|COMPLETED|Period 1||4
235986|NCT00916357|573529|P3|COMPLETED|Period 1||4
235987|NCT00916357|573530|P2|COMPLETED|Period 1||4
235988|NCT00916357|573531|P1|COMPLETED|Period 1||3
235989|NCT00916357|573526|P6|Received at Least 1 Dose of Study Drug|Period 1||4
235990|NCT00916357|573527|P5|Received at Least 1 Dose of Study Drug|Period 1||3
235991|NCT00916357|573528|P4|Received at Least 1 Dose of Study Drug|Period 1||4
235992|NCT00916357|573529|P3|Received at Least 1 Dose of Study Drug|Period 1||4
235993|NCT00916357|573530|P2|Received at Least 1 Dose of Study Drug|Period 1||4
235994|NCT00916357|573531|P1|Received at Least 1 Dose of Study Drug|Period 1||4
235995|NCT00916357|573526|P6|STARTED|Period 1||4
235996|NCT00916357|573527|P5|STARTED|Period 1||3
235997|NCT00916357|573528|P4|STARTED|Period 1||4
235998|NCT00916357|573529|P3|STARTED|Period 1||4
235999|NCT00916357|573530|P2|STARTED|Period 1||4
236000|NCT00916357|573531|P1|STARTED|Period 1||4
236001|NCT00916370|573571|P2|NOT COMPLETED|Overall Study||2
236002|NCT00916370|573572|P1|NOT COMPLETED|Overall Study||5
236003|NCT00916370|573571|P2|COMPLETED|Overall Study||102
236004|NCT00916370|573572|P1|COMPLETED|Overall Study||396
236005|NCT00916370|573571|P2|STARTED|Overall Study||104
236006|NCT00916370|573572|P1|STARTED|Overall Study||401
236007|NCT00916383|573746|P1|NOT COMPLETED|Overall Study||3
236008|NCT00916383|573746|P1|COMPLETED|Overall Study||46
236009|NCT00916383|573746|P1|STARTED|Overall Study||49
236010|NCT00916539|573774|P2|NOT COMPLETED|Overall Study||0
236011|NCT00916539|573775|P1|NOT COMPLETED|Overall Study||0
236012|NCT00916539|573774|P2|COMPLETED|Overall Study||31
236013|NCT00916539|573775|P1|COMPLETED|Overall Study||31
236014|NCT00916539|573774|P2|STARTED|Overall Study||31
236015|NCT00916539|573775|P1|STARTED|Overall Study||31
236016|NCT00916617|573801|P4|NOT COMPLETED|Overall Study||7
236017|NCT00916617|573802|P3|NOT COMPLETED|Overall Study||10
236018|NCT00916617|573803|P2|NOT COMPLETED|Overall Study||21
236019|NCT00916617|573804|P1|NOT COMPLETED|Overall Study||23
236020|NCT00916617|573801|P4|COMPLETED|Overall Study||0
236021|NCT00916617|573802|P3|COMPLETED|Overall Study||0
236022|NCT00916617|573803|P2|COMPLETED|Overall Study||0
236023|NCT00916617|573804|P1|COMPLETED|Overall Study||1
236024|NCT00916617|573801|P4|STARTED|Overall Study||7
236025|NCT00916617|573802|P3|STARTED|Overall Study||10
236026|NCT00916617|573803|P2|STARTED|Overall Study||21
236027|NCT00916617|573804|P1|STARTED|Overall Study||24
236028|NCT00916643|573818|P1|NOT COMPLETED|Overall Study||0
236029|NCT00916643|573818|P1|COMPLETED|Overall Study||113
236030|NCT00916643|573818|P1|STARTED|Overall Study||113
236031|NCT00916721|573827|P2|NOT COMPLETED|Overall Study||10
236032|NCT00916721|573828|P1|NOT COMPLETED|Overall Study||10
236033|NCT00916721|573827|P2|COMPLETED|Overall Study||29
236034|NCT00916721|573828|P1|COMPLETED|Overall Study||25
236035|NCT00916721|573827|P2|STARTED|Overall Study||39
236036|NCT00916721|573828|P1|STARTED|Overall Study||35
236037|NCT00916929|573842|P2|NOT COMPLETED|Overall Study||29
236038|NCT00916929|573843|P1|NOT COMPLETED|Overall Study||10
236039|NCT00916929|573842|P2|COMPLETED|Overall Study||53
236040|NCT00916929|573843|P1|COMPLETED|Overall Study||70
236041|NCT00916929|573842|P2|STARTED|Overall Study||82
236042|NCT00916929|573843|P1|STARTED|Overall Study||80
236043|NCT00917124|573853|P2|NOT COMPLETED|Overall Study||6
236044|NCT00917124|573854|P1|NOT COMPLETED|Overall Study||4
236045|NCT00917124|573853|P2|COMPLETED|Overall Study||94
236046|NCT00917124|573854|P1|COMPLETED|Overall Study||96
236047|NCT00917124|573853|P2|STARTED|Overall Study||100
236048|NCT00917124|573854|P1|STARTED|Overall Study||100
236049|NCT00917267|573864|P2|NOT COMPLETED|Overall Study||79
236050|NCT00917267|573865|P1|NOT COMPLETED|Overall Study||39
236051|NCT00917267|573864|P2|COMPLETED|Overall Study||266
236052|NCT00917267|573865|P1|COMPLETED|Overall Study||307
236053|NCT00917267|573864|P2|Intent to Treat (ITT)|Overall Study||338
236054|NCT00917267|573865|P1|Intent to Treat (ITT)|Overall Study||340
236055|NCT00917267|573864|P2|STARTED|Overall Study||345
236056|NCT00917267|573865|P1|STARTED|Overall Study||346
236057|NCT00917384|573893|P2|NOT COMPLETED|Overall Study||4
236058|NCT00917384|573894|P1|NOT COMPLETED|Overall Study||14
236059|NCT00917384|573893|P2|COMPLETED|Overall Study||113
236060|NCT00917384|573894|P1|COMPLETED|Overall Study||224
236061|NCT00917384|573893|P2|Received at Least 1 Dose of Study Drug|Overall Study||115
236062|NCT00917384|573894|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
236063|NCT00917384|573893|P2|STARTED|Overall Study||117
236064|NCT00917384|573894|P1|STARTED|Overall Study||238
236065|NCT00917501|573918|P2|NOT COMPLETED|Overall Study||5
236066|NCT00917501|573919|P1|NOT COMPLETED|Overall Study||8
236067|NCT00917501|573918|P2|COMPLETED|Overall Study||21
236068|NCT00917501|573919|P1|COMPLETED|Overall Study||21
236069|NCT00917501|573918|P2|STARTED|Overall Study||26
236070|NCT00917501|573919|P1|STARTED|Overall Study||29
236071|NCT00917579|573925|P2|NOT COMPLETED|Period 2: 2nd Intervention||0
236072|NCT00917579|573926|P1|NOT COMPLETED|Period 2: 2nd Intervention||0
236073|NCT00917579|573925|P2|COMPLETED|Period 2: 2nd Intervention||37
236074|NCT00917579|573926|P1|COMPLETED|Period 2: 2nd Intervention||37
236075|NCT00917579|573925|P2|STARTED|Period 2: 2nd Intervention||37
236076|NCT00917579|573926|P1|STARTED|Period 2: 2nd Intervention||37
236077|NCT00917579|573925|P2|NOT COMPLETED|Washout >= 2 Weeks||0
236078|NCT00917579|573926|P1|NOT COMPLETED|Washout >= 2 Weeks||2
236079|NCT00917579|573925|P2|COMPLETED|Washout >= 2 Weeks||37
236080|NCT00917579|573926|P1|COMPLETED|Washout >= 2 Weeks||37
236081|NCT00917579|573925|P2|STARTED|Washout >= 2 Weeks||37
236082|NCT00917579|573926|P1|STARTED|Washout >= 2 Weeks||39
236083|NCT00917579|573925|P2|NOT COMPLETED|Period 1: 1st Intervention||0
236084|NCT00917579|573926|P1|NOT COMPLETED|Period 1: 1st Intervention||0
236085|NCT00917579|573925|P2|COMPLETED|Period 1: 1st Intervention||37
236086|NCT00917579|573926|P1|COMPLETED|Period 1: 1st Intervention||39
236087|NCT00917579|573925|P2|STARTED|Period 1: 1st Intervention||37
236088|NCT00917579|573926|P1|STARTED|Period 1: 1st Intervention||39
236089|NCT00917644|573940|P2|NOT COMPLETED|Period 2: Second Intervention||0
236090|NCT00917644|573941|P1|NOT COMPLETED|Period 2: Second Intervention||1
236091|NCT00917644|573940|P2|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Ref drug = 73.|37
236092|NCT00917644|573941|P1|COMPLETED|Period 2: Second Intervention|Total number of subjects completed Test drug = 74.|36
236093|NCT00917644|573940|P2|STARTED|Period 2: Second Intervention|Washout: Reference drug (Ref) 1st, completed = 37; 2nd period: Ref drug 2nd, completed = 36.|37
236094|NCT00917644|573941|P1|STARTED|Period 2: Second Intervention|Washout: Test drug 1st, completed = 37; 2nd period: Test drug 2nd, completed = 37.|37
236095|NCT00917644|573940|P2|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||0
236096|NCT00917644|573941|P1|NOT COMPLETED|Period: Washout Period of > = 2 Weeks||2
236097|NCT00917644|573940|P2|COMPLETED|Period: Washout Period of > = 2 Weeks||37
236098|NCT00917644|573941|P1|COMPLETED|Period: Washout Period of > = 2 Weeks||37
236099|NCT00917644|573940|P2|STARTED|Period: Washout Period of > = 2 Weeks||37
236100|NCT00917644|573941|P1|STARTED|Period: Washout Period of > = 2 Weeks||39
236101|NCT00917644|573940|P2|NOT COMPLETED|Period 1: First Intervention||0
236102|NCT00917644|573941|P1|NOT COMPLETED|Period 1: First Intervention||0
236103|NCT00917644|573940|P2|COMPLETED|Period 1: First Intervention||37
236104|NCT00917644|573941|P1|COMPLETED|Period 1: First Intervention||39
236105|NCT00917644|573940|P2|STARTED|Period 1: First Intervention||37
236106|NCT00917644|573941|P1|STARTED|Period 1: First Intervention||39
236107|NCT00917735|573957|P2|NOT COMPLETED|Overall Study||63
236108|NCT00917735|573958|P1|NOT COMPLETED|Overall Study||75
236109|NCT00917735|573957|P2|COMPLETED|Overall Study||474
236110|NCT00917735|573958|P1|COMPLETED|Overall Study||463
236111|NCT00917735|573957|P2|STARTED|Overall Study||537
236112|NCT00917735|573958|P1|STARTED|Overall Study||538
236113|NCT00917852|573968|P1|NOT COMPLETED|Overall Study||6
236114|NCT00917852|573968|P1|COMPLETED|Overall Study||45
236115|NCT00917852|573968|P1|STARTED|Overall Study||51
236116|NCT00917865|573973|P1|NOT COMPLETED|Overall Study||0
236117|NCT00917865|573973|P1|COMPLETED|Overall Study||11
236118|NCT00917865|573973|P1|STARTED|Overall Study||11
236119|NCT00918125|573986|P2|NOT COMPLETED|Overall Study||0
236120|NCT00918125|573987|P1|NOT COMPLETED|Overall Study||0
236121|NCT00918125|573986|P2|COMPLETED|Overall Study||39
236122|NCT00918125|573987|P1|COMPLETED|Overall Study||20
236123|NCT00918125|573986|P2|STARTED|Overall Study||39
236124|NCT00918125|573987|P1|STARTED|Overall Study||20
236125|NCT00918138|574000|P2|NOT COMPLETED|Overall Study||1
236126|NCT00918138|574001|P1|NOT COMPLETED|Overall Study||2
236127|NCT00918138|574000|P2|COMPLETED|Overall Study||46
236128|NCT00918138|574001|P1|COMPLETED|Overall Study||44
236129|NCT00918138|574000|P2|STARTED|Overall Study||47
236130|NCT00918138|574001|P1|STARTED|Overall Study||46
236131|NCT00918203|574017|P3|NOT COMPLETED|Crossover to Olaratumab Monotherapy||3
236132|NCT00918203|574018|P2|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
236133|NCT00918203|574019|P1|NOT COMPLETED|Crossover to Olaratumab Monotherapy||0
236134|NCT00918203|574017|P3|COMPLETED|Crossover to Olaratumab Monotherapy||14
236135|NCT00918203|574018|P2|COMPLETED|Crossover to Olaratumab Monotherapy||0
236136|NCT00918203|574019|P1|COMPLETED|Crossover to Olaratumab Monotherapy||0
236137|NCT00918203|574017|P3|STARTED|Crossover to Olaratumab Monotherapy|16 participants crossed over to olaratumab after PD and 1 participant of symptomatic deterioration.|17
236138|NCT00918203|574018|P2|STARTED|Crossover to Olaratumab Monotherapy||0
236139|NCT00918203|574019|P1|STARTED|Crossover to Olaratumab Monotherapy||0
236140|NCT00918203|574017|P3|NOT COMPLETED|Treatment With or Without Olaratumab||0
236141|NCT00918203|574018|P2|NOT COMPLETED|Treatment With or Without Olaratumab||14
236142|NCT00918203|574019|P1|NOT COMPLETED|Treatment With or Without Olaratumab||7
236143|NCT00918203|574017|P3|COMPLETED|Treatment With or Without Olaratumab||0
236144|NCT00918203|574018|P2|COMPLETED|Treatment With or Without Olaratumab||53
236145|NCT00918203|574019|P1|COMPLETED|Treatment With or Without Olaratumab||63
236146|NCT00918203|574017|P3|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||0
236147|NCT00918203|574018|P2|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||64
236148|NCT00918203|574019|P1|Received at Least 1 Dose of Study Drug|Treatment With or Without Olaratumab||67
236149|NCT00918203|574017|P3|STARTED|Treatment With or Without Olaratumab||0
236150|NCT00918203|574018|P2|STARTED|Treatment With or Without Olaratumab||67
236151|NCT00918203|574019|P1|STARTED|Treatment With or Without Olaratumab||70
236152|NCT00918255|574051|P3|NOT COMPLETED|Overall Study||5
236153|NCT00918255|574052|P2|NOT COMPLETED|Overall Study||0
236154|NCT00918255|574053|P1|NOT COMPLETED|Overall Study||6
236155|NCT00918255|574051|P3|COMPLETED|Overall Study||46
236156|NCT00918255|574052|P2|COMPLETED|Overall Study||52
236157|NCT00918255|574053|P1|COMPLETED|Overall Study||45
236158|NCT00918255|574051|P3|STARTED|Overall Study||51
236159|NCT00918255|574052|P2|STARTED|Overall Study||52
236160|NCT00918255|574053|P1|STARTED|Overall Study||51
236161|NCT00918281|574079|P1|NOT COMPLETED|Overall Study||29
236162|NCT00918281|574079|P1|COMPLETED|Overall Study||41
236163|NCT00918281|574079|P1|STARTED|Overall Study||70
236164|NCT00925704|574092|P6|NOT COMPLETED|Third Intervention||1
236165|NCT00925704|574093|P5|NOT COMPLETED|Third Intervention||0
236166|NCT00925704|574094|P4|NOT COMPLETED|Third Intervention||0
236167|NCT00925704|574095|P3|NOT COMPLETED|Third Intervention||0
236168|NCT00925704|574096|P2|NOT COMPLETED|Third Intervention||0
236169|NCT00925704|574097|P1|NOT COMPLETED|Third Intervention||0
236170|NCT00925704|574092|P6|COMPLETED|Third Intervention||6
236171|NCT00925704|574093|P5|COMPLETED|Third Intervention||5
236172|NCT00925704|574094|P4|COMPLETED|Third Intervention||6
236173|NCT00925704|574095|P3|COMPLETED|Third Intervention||7
236174|NCT00925704|574096|P2|COMPLETED|Third Intervention||7
236175|NCT00925704|574097|P1|COMPLETED|Third Intervention||5
236176|NCT00925704|574092|P6|STARTED|Third Intervention||7
236177|NCT00925704|574093|P5|STARTED|Third Intervention||5
236178|NCT00925704|574094|P4|STARTED|Third Intervention||6
236179|NCT00925704|574095|P3|STARTED|Third Intervention||7
236180|NCT00925704|574096|P2|STARTED|Third Intervention||7
236181|NCT00925704|574097|P1|STARTED|Third Intervention||5
236182|NCT00925704|574092|P6|NOT COMPLETED|Washout||0
236183|NCT00925704|574093|P5|NOT COMPLETED|Washout||0
236184|NCT00925704|574094|P4|NOT COMPLETED|Washout||0
236185|NCT00925704|574095|P3|NOT COMPLETED|Washout||0
236186|NCT00925704|574096|P2|NOT COMPLETED|Washout||0
236187|NCT00925704|574097|P1|NOT COMPLETED|Washout||0
236188|NCT00925704|574092|P6|COMPLETED|Washout||7
236189|NCT00925704|574093|P5|COMPLETED|Washout||5
236190|NCT00925704|574094|P4|COMPLETED|Washout||6
236191|NCT00925704|574095|P3|COMPLETED|Washout||7
236192|NCT00925704|574096|P2|COMPLETED|Washout||7
236193|NCT00925704|574097|P1|COMPLETED|Washout||5
236194|NCT00925704|574092|P6|STARTED|Washout||7
236195|NCT00925704|574093|P5|STARTED|Washout||5
236196|NCT00925704|574094|P4|STARTED|Washout||6
236197|NCT00925704|574095|P3|STARTED|Washout||7
236198|NCT00925704|574096|P2|STARTED|Washout||7
236199|NCT00925704|574097|P1|STARTED|Washout||5
236200|NCT00925704|574092|P6|NOT COMPLETED|Second Intervention||0
236201|NCT00925704|574093|P5|NOT COMPLETED|Second Intervention||1
236202|NCT00925704|574094|P4|NOT COMPLETED|Second Intervention||0
236203|NCT00925704|574095|P3|NOT COMPLETED|Second Intervention||0
236204|NCT00925704|574096|P2|NOT COMPLETED|Second Intervention||0
236205|NCT00925704|574097|P1|NOT COMPLETED|Second Intervention||1
236206|NCT00925704|574092|P6|COMPLETED|Second Intervention||7
236207|NCT00925704|574093|P5|COMPLETED|Second Intervention||5
236208|NCT00925704|574094|P4|COMPLETED|Second Intervention||6
236209|NCT00925704|574095|P3|COMPLETED|Second Intervention||7
236210|NCT00925704|574096|P2|COMPLETED|Second Intervention||7
236211|NCT00925704|574097|P1|COMPLETED|Second Intervention||5
236212|NCT00925704|574092|P6|STARTED|Second Intervention||7
236213|NCT00925704|574093|P5|STARTED|Second Intervention||6
236214|NCT00925704|574094|P4|STARTED|Second Intervention||6
236215|NCT00925704|574095|P3|STARTED|Second Intervention||7
236216|NCT00925704|574096|P2|STARTED|Second Intervention||7
236217|NCT00925704|574097|P1|STARTED|Second Intervention||6
236218|NCT00925704|574092|P6|NOT COMPLETED|Washout||0
236219|NCT00925704|574093|P5|NOT COMPLETED|Washout||0
236220|NCT00925704|574094|P4|NOT COMPLETED|Washout||0
236221|NCT00925704|574095|P3|NOT COMPLETED|Washout||0
236222|NCT00925704|574096|P2|NOT COMPLETED|Washout||0
236223|NCT00925704|574097|P1|NOT COMPLETED|Washout||0
236224|NCT00925704|574092|P6|COMPLETED|Washout||7
236225|NCT00925704|574093|P5|COMPLETED|Washout||6
236226|NCT00925704|574094|P4|COMPLETED|Washout||6
236227|NCT00925704|574095|P3|COMPLETED|Washout||7
236228|NCT00925704|574096|P2|COMPLETED|Washout||7
236229|NCT00925704|574097|P1|COMPLETED|Washout||6
236230|NCT00925704|574092|P6|STARTED|Washout||7
236231|NCT00925704|574093|P5|STARTED|Washout||6
236232|NCT00925704|574094|P4|STARTED|Washout||6
236233|NCT00925704|574095|P3|STARTED|Washout||7
236234|NCT00925704|574096|P2|STARTED|Washout||7
236235|NCT00925704|574097|P1|STARTED|Washout||6
236236|NCT00925704|574092|P6|NOT COMPLETED|First Intervention||0
236237|NCT00925704|574093|P5|NOT COMPLETED|First Intervention||1
236238|NCT00925704|574094|P4|NOT COMPLETED|First Intervention||1
236239|NCT00925704|574095|P3|NOT COMPLETED|First Intervention||0
236240|NCT00925704|574096|P2|NOT COMPLETED|First Intervention||0
236241|NCT00925704|574097|P1|NOT COMPLETED|First Intervention||0
236242|NCT00925704|574092|P6|COMPLETED|First Intervention||7
236243|NCT00925704|574093|P5|COMPLETED|First Intervention||6
236244|NCT00925704|574094|P4|COMPLETED|First Intervention||6
236245|NCT00925704|574095|P3|COMPLETED|First Intervention||7
236246|NCT00925704|574096|P2|COMPLETED|First Intervention||7
236247|NCT00925704|574097|P1|COMPLETED|First Intervention||6
236248|NCT00925704|574092|P6|STARTED|First Intervention||7
236249|NCT00925704|574093|P5|STARTED|First Intervention||7
236250|NCT00925704|574094|P4|STARTED|First Intervention||7
236251|NCT00925704|574095|P3|STARTED|First Intervention||7
236252|NCT00925704|574096|P2|STARTED|First Intervention||7
236253|NCT00925704|574097|P1|STARTED|First Intervention||6
236254|NCT00925769|574108|P6|NOT COMPLETED|Overall Study||3
236255|NCT00925769|574109|P5|NOT COMPLETED|Overall Study||3
236256|NCT00925769|574110|P4|NOT COMPLETED|Overall Study||6
236257|NCT00925769|574111|P3|NOT COMPLETED|Overall Study||6
236258|NCT00925769|574112|P2|NOT COMPLETED|Overall Study||6
236259|NCT00925769|574113|P1|NOT COMPLETED|Overall Study||6
236260|NCT00925769|574108|P6|COMPLETED|Overall Study||0
236261|NCT00925769|574109|P5|COMPLETED|Overall Study||0
236262|NCT00925769|574110|P4|COMPLETED|Overall Study||0
236263|NCT00925769|574111|P3|COMPLETED|Overall Study||0
236264|NCT00925769|574112|P2|COMPLETED|Overall Study||0
236265|NCT00925769|574113|P1|COMPLETED|Overall Study||0
236266|NCT00925769|574108|P6|STARTED|Overall Study||3
236267|NCT00925769|574109|P5|STARTED|Overall Study||3
236268|NCT00925769|574110|P4|STARTED|Overall Study||6
236269|NCT00925769|574111|P3|STARTED|Overall Study||6
236270|NCT00925769|574112|P2|STARTED|Overall Study||6
236271|NCT00925769|574113|P1|STARTED|Overall Study||6
236272|NCT00925782|574175|P2|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
236273|NCT00925782|574176|P1|NOT COMPLETED|Follow-up(Day +1 to Date of Engraftment)||0
236274|NCT00925782|574175|P2|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
236275|NCT00925782|574176|P1|COMPLETED|Follow-up(Day +1 to Date of Engraftment)||12
236276|NCT00925782|574175|P2|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
236277|NCT00925782|574176|P1|STARTED|Follow-up(Day +1 to Date of Engraftment)||12
236278|NCT00925782|574175|P2|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
236279|NCT00925782|574176|P1|NOT COMPLETED|Study Period (Day -3 to Day 0)||0
236280|NCT00925782|574175|P2|COMPLETED|Study Period (Day -3 to Day 0)||12
236281|NCT00925782|574176|P1|COMPLETED|Study Period (Day -3 to Day 0)||12
236282|NCT00925782|574175|P2|STARTED|Study Period (Day -3 to Day 0)||12
236283|NCT00925782|574176|P1|STARTED|Study Period (Day -3 to Day 0)||12
236284|NCT00925782|574175|P2|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
236285|NCT00925782|574176|P1|NOT COMPLETED|Pretreatment (Day -30 to Day -3)||0
236286|NCT00925782|574175|P2|COMPLETED|Pretreatment (Day -30 to Day -3)||12
236287|NCT00925782|574176|P1|COMPLETED|Pretreatment (Day -30 to Day -3)||12
236288|NCT00925782|574175|P2|STARTED|Pretreatment (Day -30 to Day -3)||12
236289|NCT00925782|574176|P1|STARTED|Pretreatment (Day -30 to Day -3)||12
236290|NCT00925899|574187|P2|NOT COMPLETED|Part 2||12
236291|NCT00925899|574188|P1|NOT COMPLETED|Part 2||6
236292|NCT00925899|574187|P2|COMPLETED|Part 2||9
236293|NCT00925899|574188|P1|COMPLETED|Part 2||9
236294|NCT00925899|574187|P2|STARTED|Part 2|Nine patients withdrew because they did not wish to continue in the study|21
236295|NCT00925899|574188|P1|STARTED|Part 2|All patients received the same intervention in the second part of the study (20 mg melatonin)|15
236296|NCT00925899|574187|P2|NOT COMPLETED|Part 1||11
236297|NCT00925899|574188|P1|NOT COMPLETED|Part 1||11
236298|NCT00925899|574187|P2|COMPLETED|Part 1||27
236299|NCT00925899|574188|P1|COMPLETED|Part 1||23
236300|NCT00925899|574187|P2|STARTED|Part 1||38
236301|NCT00925899|574188|P1|STARTED|Part 1||34
236302|NCT00925938|574209|P3|NOT COMPLETED|Overall Study||0
236303|NCT00925938|574210|P2|NOT COMPLETED|Overall Study||0
236304|NCT00925938|574211|P1|NOT COMPLETED|Overall Study||0
236305|NCT00925938|574209|P3|COMPLETED|Overall Study||17
236306|NCT00925938|574210|P2|COMPLETED|Overall Study||25
236307|NCT00925938|574211|P1|COMPLETED|Overall Study||9
236308|NCT00925938|574209|P3|STARTED|Overall Study||17
236309|NCT00925938|574210|P2|STARTED|Overall Study||25
236310|NCT00925938|574211|P1|STARTED|Overall Study||9
236311|NCT00926185|574235|P4|NOT COMPLETED|Overall Study||10
236312|NCT00926185|574236|P3|NOT COMPLETED|Overall Study||10
236313|NCT00926185|574237|P2|NOT COMPLETED|Overall Study||6
236314|NCT00926185|574238|P1|NOT COMPLETED|Overall Study||3
236315|NCT00926185|574235|P4|COMPLETED|Overall Study||48
236316|NCT00926185|574236|P3|COMPLETED|Overall Study||48
236317|NCT00926185|574237|P2|COMPLETED|Overall Study||51
236318|NCT00926185|574238|P1|COMPLETED|Overall Study||54
236319|NCT00926185|574235|P4|STARTED|Overall Study||58
236320|NCT00926185|574236|P3|STARTED|Overall Study||58
236321|NCT00926185|574237|P2|STARTED|Overall Study||57
236322|NCT00926185|574238|P1|STARTED|Overall Study||57
236323|NCT00926211|574252|P1|NOT COMPLETED|Overall Study||1
236324|NCT00926211|574252|P1|COMPLETED|Overall Study||35
236325|NCT00926211|574252|P1|STARTED|Overall Study|One additional subject was not randomized and did not receive the treatment procedure.|36
236326|NCT00926263|574261|P2|NOT COMPLETED|Overall Study||0
236327|NCT00926263|574262|P1|NOT COMPLETED|Overall Study||0
236328|NCT00926263|574261|P2|COMPLETED|Overall Study||12
236329|NCT00926263|574262|P1|COMPLETED|Overall Study||16
236330|NCT00926263|574261|P2|STARTED|Overall Study||12
236331|NCT00926263|574262|P1|STARTED|Overall Study||16
236332|NCT00926289|574295|P2|NOT COMPLETED|Overall Study||36
236333|NCT00926289|574296|P1|NOT COMPLETED|Overall Study||25
236334|NCT00926289|574295|P2|COMPLETED|Overall Study||558
236335|NCT00926289|574296|P1|COMPLETED|Overall Study||269
236336|NCT00926289|574295|P2|STARTED|Overall Study|Number of treated patients|594
236337|NCT00926289|574296|P1|STARTED|Overall Study|Number of treated patients|294
236338|NCT00926328|574332|P2|NOT COMPLETED|Overall Study||14
236339|NCT00926328|574333|P1|NOT COMPLETED|Overall Study||12
236340|NCT00926328|574332|P2|COMPLETED|Overall Study||46
236341|NCT00926328|574333|P1|COMPLETED|Overall Study||48
236342|NCT00926328|574332|P2|STARTED|Overall Study||60
236343|NCT00926328|574333|P1|STARTED|Overall Study||60
236344|NCT00926367|574343|P2|NOT COMPLETED|Overall Study||3
236345|NCT00926367|574344|P1|NOT COMPLETED|Overall Study||2
236346|NCT00926367|574343|P2|COMPLETED|Overall Study||24
236347|NCT00926367|574344|P1|COMPLETED|Overall Study||23
236348|NCT00926367|574343|P2|STARTED|Overall Study||27
236349|NCT00926367|574344|P1|STARTED|Overall Study||25
236350|NCT00926393|574386|P2|NOT COMPLETED|Overall Study||3
236351|NCT00926393|574387|P1|NOT COMPLETED|Overall Study||2
236352|NCT00926393|574386|P2|COMPLETED|Overall Study||67
236353|NCT00926393|574387|P1|COMPLETED|Overall Study||67
236354|NCT00926393|574386|P2|STARTED|Overall Study||70
236355|NCT00926393|574387|P1|STARTED|Overall Study||69
236356|NCT00926497|574419|P2|NOT COMPLETED|Overall Study||0
236357|NCT00926497|574420|P1|NOT COMPLETED|Overall Study||0
236358|NCT00926497|574419|P2|COMPLETED|Overall Study||61
236359|NCT00926497|574420|P1|COMPLETED|Overall Study||60
236360|NCT00926497|574419|P2|STARTED|Overall Study||61
236361|NCT00926497|574420|P1|STARTED|Overall Study||60
236362|NCT00926536|574430|P2|NOT COMPLETED|Overall Study||2
236363|NCT00926536|574431|P1|NOT COMPLETED|Overall Study||1
236364|NCT00926536|574430|P2|COMPLETED|Overall Study||41
236365|NCT00926536|574431|P1|COMPLETED|Overall Study||43
236366|NCT00926536|574430|P2|STARTED|Overall Study||43
236367|NCT00926536|574431|P1|STARTED|Overall Study||44
236368|NCT00926575|574441|P2|NOT COMPLETED|Overall Study||17
236369|NCT00926575|574442|P1|NOT COMPLETED|Overall Study||16
236370|NCT00926575|574441|P2|COMPLETED|Overall Study||53
236371|NCT00926575|574442|P1|COMPLETED|Overall Study||54
236372|NCT00926575|574441|P2|STARTED|Overall Study||70
236373|NCT00926575|574442|P1|STARTED|Overall Study||70
236374|NCT00926588|574454|P2|NOT COMPLETED|Overall Study||4
236375|NCT00926588|574455|P1|NOT COMPLETED|Overall Study||8
236376|NCT00926588|574454|P2|COMPLETED|Overall Study||122
236377|NCT00926588|574455|P1|COMPLETED|Overall Study||116
236378|NCT00926588|574454|P2|STARTED|Overall Study||126
236379|NCT00926588|574455|P1|STARTED|Overall Study||124
236380|NCT00926783|574463|P2|NOT COMPLETED|Overall Study||3
236381|NCT00926783|574464|P1|NOT COMPLETED|Overall Study||3
236382|NCT00926783|574463|P2|COMPLETED|Overall Study||38
236383|NCT00926783|574464|P1|COMPLETED|Overall Study||39
236384|NCT00926783|574463|P2|STARTED|Overall Study||41
236385|NCT00926783|574464|P1|STARTED|Overall Study||42
236386|NCT00926796|574482|P2|NOT COMPLETED|Overall Study||106
236387|NCT00926796|574483|P1|NOT COMPLETED|Overall Study||107
236388|NCT00926796|574482|P2|COMPLETED|Overall Study|Number eligible and in the full analysis set|199
236389|NCT00926796|574483|P1|COMPLETED|Overall Study|Number eligible and in the full analysis set|202
236390|NCT00926796|574482|P2|STARTED|Overall Study|Number randomized|305
236391|NCT00926796|574483|P1|STARTED|Overall Study|Number randomized|309
236392|NCT00926887|574504|P2|NOT COMPLETED|Overall Study||0
236393|NCT00926887|574505|P1|NOT COMPLETED|Overall Study||0
236394|NCT00926887|574504|P2|COMPLETED|Overall Study||50
236395|NCT00926887|574505|P1|COMPLETED|Overall Study||54
236396|NCT00926887|574504|P2|STARTED|Overall Study||50
236397|NCT00926887|574505|P1|STARTED|Overall Study||54
236398|NCT00926952|574515|P1|NOT COMPLETED|Overall Study||0
236399|NCT00926952|574515|P1|COMPLETED|Overall Study||20
236400|NCT00926952|574515|P1|STARTED|Overall Study||20
236401|NCT00927069|574529|P4|NOT COMPLETED|Week 12 to Week 24||3
236402|NCT00927069|574530|P3|NOT COMPLETED|Week 12 to Week 24||3
236403|NCT00927069|574531|P2|NOT COMPLETED|Week 12 to Week 24||0
236404|NCT00927069|574532|P1|NOT COMPLETED|Week 12 to Week 24||2
236405|NCT00927069|574529|P4|COMPLETED|Week 12 to Week 24||20
236406|NCT00927069|574530|P3|COMPLETED|Week 12 to Week 24||28
236407|NCT00927069|574531|P2|COMPLETED|Week 12 to Week 24||11
236408|NCT00927069|574532|P1|COMPLETED|Week 12 to Week 24||16
236409|NCT00927069|574529|P4|STARTED|Week 12 to Week 24|23 Pts. from Group B had a dose incr. since they did not respond to 40mg adalimumab every other week|23
236410|NCT00927069|574530|P3|STARTED|Week 12 to Week 24|31 Pts. from Group A had a dose incr. since they did not respond to 40mg adalimumab every other week|31
236411|NCT00927069|574531|P2|STARTED|Week 12 to Week 24|11 patients stayed at the same dose of 40 mg Adalimumab every other week|11
236412|NCT00927069|574532|P1|STARTED|Week 12 to Week 24|17 patients stayed at the same dose. One patient withdrew at Week 12 and also had no dose increase|18
236413|NCT00927069|574529|P4|NOT COMPLETED|Week 0 to Week 12||0
236414|NCT00927069|574530|P3|NOT COMPLETED|Week 0 to Week 12||0
236415|NCT00927069|574531|P2|NOT COMPLETED|Week 0 to Week 12||1
236416|NCT00927069|574532|P1|NOT COMPLETED|Week 0 to Week 12||1
236417|NCT00927069|574529|P4|COMPLETED|Week 0 to Week 12||0
236418|NCT00927069|574530|P3|COMPLETED|Week 0 to Week 12||0
236419|NCT00927069|574531|P2|COMPLETED|Week 0 to Week 12||34
236420|NCT00927069|574532|P1|COMPLETED|Week 0 to Week 12||49
236421|NCT00927069|574529|P4|STARTED|Week 0 to Week 12||0
236422|NCT00927069|574530|P3|STARTED|Week 0 to Week 12||0
236423|NCT00927069|574531|P2|STARTED|Week 0 to Week 12||35
236424|NCT00927069|574532|P1|STARTED|Week 0 to Week 12||50
236425|NCT00927082|574546|P4|NOT COMPLETED|Overall Study||19
236426|NCT00927082|574547|P3|NOT COMPLETED|Overall Study||22
236427|NCT00927082|574548|P2|NOT COMPLETED|Overall Study||10
236428|NCT00927082|574549|P1|NOT COMPLETED|Overall Study||12
236429|NCT00927082|574546|P4|COMPLETED|Overall Study||78
236430|NCT00927082|574547|P3|COMPLETED|Overall Study||86
236431|NCT00927082|574548|P2|COMPLETED|Overall Study||77
236432|NCT00927082|574549|P1|COMPLETED|Overall Study||79
236433|NCT00927082|574546|P4|STARTED|Overall Study||97
236434|NCT00927082|574547|P3|STARTED|Overall Study||108
236435|NCT00927082|574548|P2|STARTED|Overall Study||87
236436|NCT00927082|574549|P1|STARTED|Overall Study||91
236437|NCT00927095|574614|P3|NOT COMPLETED|Overall Study||2
236438|NCT00927095|574615|P2|NOT COMPLETED|Overall Study||4
236439|NCT00927095|574616|P1|NOT COMPLETED|Overall Study||6
236440|NCT00927095|574614|P3|COMPLETED|Overall Study||22
236441|NCT00927095|574615|P2|COMPLETED|Overall Study||17
236442|NCT00927095|574616|P1|COMPLETED|Overall Study||16
236443|NCT00927095|574614|P3|STARTED|Overall Study||24
236444|NCT00927095|574615|P2|STARTED|Overall Study||21
236445|NCT00927095|574616|P1|STARTED|Overall Study||22
236446|NCT00927160|574626|P2|NOT COMPLETED|Overall Study||0
236447|NCT00927160|574627|P1|NOT COMPLETED|Overall Study||0
236448|NCT00927160|574626|P2|COMPLETED|Overall Study||173
236449|NCT00927160|574627|P1|COMPLETED|Overall Study||173
236450|NCT00927160|574626|P2|STARTED|Overall Study||173
236451|NCT00927160|574627|P1|STARTED|Overall Study||173
236452|NCT00927186|574637|P2|NOT COMPLETED|12 - 24 Months Extension Treatment||0
236453|NCT00927186|574638|P1|NOT COMPLETED|12 - 24 Months Extension Treatment||0
236454|NCT00927186|574637|P2|COMPLETED|12 - 24 Months Extension Treatment||11
236455|NCT00927186|574638|P1|COMPLETED|12 - 24 Months Extension Treatment||10
236456|NCT00927186|574637|P2|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|11
236457|NCT00927186|574638|P1|STARTED|12 - 24 Months Extension Treatment|Not all participants who completed 12 months of primary study chose to enter 12-month extension.|10
236458|NCT00927186|574637|P2|NOT COMPLETED|12 Months Primary Study||4
236459|NCT00927186|574638|P1|NOT COMPLETED|12 Months Primary Study||7
236460|NCT00927186|574637|P2|COMPLETED|12 Months Primary Study||31
236461|NCT00927186|574638|P1|COMPLETED|12 Months Primary Study||27
236462|NCT00927186|574637|P2|Completed 6 Months Double Blind Phase|12 Months Primary Study||31
236463|NCT00927186|574638|P1|Completed 6 Months Double Blind Phase|12 Months Primary Study||28
236464|NCT00927186|574637|P2|STARTED|12 Months Primary Study||35
236465|NCT00927186|574638|P1|STARTED|12 Months Primary Study||34
236466|NCT00927251|574754|P1|NOT COMPLETED|Overall Study||8
236467|NCT00927251|574754|P1|COMPLETED|Overall Study||82
236468|NCT00927251|574754|P1|STARTED|Overall Study||90
236469|NCT00927264|574760|P2|NOT COMPLETED|Overall Study||25
236470|NCT00927264|574761|P1|NOT COMPLETED|Overall Study||56
236471|NCT00927264|574760|P2|COMPLETED|Overall Study||140
236472|NCT00927264|574761|P1|COMPLETED|Overall Study||109
236473|NCT00927264|574760|P2|STARTED|Overall Study||165
236474|NCT00927264|574761|P1|STARTED|Overall Study||165
236475|NCT00927355|574777|P2|NOT COMPLETED|Overall Study||1
236476|NCT00927355|574778|P1|NOT COMPLETED|Overall Study||1
236477|NCT00927355|574777|P2|COMPLETED|Overall Study||4
236478|NCT00927355|574778|P1|COMPLETED|Overall Study||4
236479|NCT00927355|574777|P2|STARTED|Overall Study||5
236480|NCT00927355|574778|P1|STARTED|Overall Study||5
236481|NCT00927368|574799|P3|NOT COMPLETED|Overall Study||5
236482|NCT00927368|574800|P2|NOT COMPLETED|Overall Study||5
236483|NCT00927368|574801|P1|NOT COMPLETED|Overall Study||6
236484|NCT00927368|574799|P3|COMPLETED|Overall Study||138
236485|NCT00927368|574800|P2|COMPLETED|Overall Study||152
236486|NCT00927368|574801|P1|COMPLETED|Overall Study||147
236487|NCT00927368|574799|P3|STARTED|Overall Study||143
236488|NCT00927368|574800|P2|STARTED|Overall Study||157
236489|NCT00927368|574801|P1|STARTED|Overall Study||153
236490|NCT00927394|574820|P2|NOT COMPLETED|Overall Study||85
236491|NCT00927394|574821|P1|NOT COMPLETED|Overall Study||77
236492|NCT00927394|574820|P2|COMPLETED|Overall Study||483
236493|NCT00927394|574821|P1|COMPLETED|Overall Study||498
236494|NCT00927394|574820|P2|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||562
236495|NCT00927394|574821|P1|Combined Full Analysis Set (FAS 1+FAS 2)|Overall Study||574
236496|NCT00927394|574820|P2|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study||323
236497|NCT00927394|574821|P1|FAS 2 :Ambulatory Blood Pressure Monitor|Overall Study|consists of all patients in FAS 2 who had both valid baseline and post-baseline ABPM assessments.|342
236498|NCT00927394|574820|P2|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study||398
236499|NCT00927394|574821|P1|Cohort 2: Full Analysis Set 2 (FAS 2)|Overall Study|FAS 2= all patients randomized to Cohort 2 and who had a valid baseline assessment of 24 hours ABPM.|417
236500|NCT00927394|574820|P2|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study||164
236501|NCT00927394|574821|P1|Cohort 1: Full Analysis Set 1 (FAS 1)|Overall Study|FAS 1 includes all patients in Cohort 1 to whom study treatments were given through randomization.|157
236502|NCT00927394|574820|P2|Combined Safety Set (Cohort 1 and 2)|Overall Study||565
236503|NCT00927394|574821|P1|Combined Safety Set (Cohort 1 and 2)|Overall Study||574
236504|NCT00927394|574820|P2|Cohort 2 (Randomized)|Overall Study||403
236505|NCT00927394|574821|P1|Cohort 2 (Randomized)|Overall Study|Cohort 2 includes patients with specific eligibility criteria mentioned in protocol section|418
236506|NCT00927394|574820|P2|Cohort 1 (Randomized)|Overall Study||165
236507|NCT00927394|574821|P1|Cohort 1 (Randomized)|Overall Study|Cohort 1 includes patients with specific eligibility criteria mentioned in protocol section|157
236508|NCT00927394|574820|P2|STARTED|Overall Study|One patient was randomized in error and was discontinued by site.|568
236509|NCT00927394|574821|P1|STARTED|Overall Study||575
236510|NCT00927472|574851|P2|NOT COMPLETED|Overall Study||22
236511|NCT00927472|574852|P1|NOT COMPLETED|Overall Study||11
236512|NCT00927472|574851|P2|COMPLETED|Overall Study||106
236513|NCT00927472|574852|P1|COMPLETED|Overall Study||115
236514|NCT00927472|574851|P2|STARTED|Overall Study||128
236515|NCT00927472|574852|P1|STARTED|Overall Study||126
236516|NCT00927563|574876|P1|NOT COMPLETED|Overall Study||2
236517|NCT00927563|574876|P1|COMPLETED|Overall Study||22
236518|NCT00927563|574876|P1|STARTED|Overall Study||24
236519|NCT00927576|574884|P2|NOT COMPLETED|Overall Study||0
236520|NCT00927576|574885|P1|NOT COMPLETED|Overall Study||0
236521|NCT00927576|574884|P2|COMPLETED|Overall Study||28
236522|NCT00927576|574885|P1|COMPLETED|Overall Study||237
236523|NCT00927576|574884|P2|Cognitive Testing|Overall Study||28
236524|NCT00927576|574885|P1|Cognitive Testing|Overall Study||237
236525|NCT00927576|574884|P2|STARTED|Overall Study||28
236526|NCT00927576|574885|P1|STARTED|Overall Study||237
236527|NCT00927589|574890|P1|NOT COMPLETED|Overall Study||16
236528|NCT00927589|574890|P1|COMPLETED|Overall Study|Participants were considered to have completed the study after receiving 3 cycles of treatment.|43
236529|NCT00927589|574890|P1|STARTED|Overall Study||59
236530|NCT00927758|574912|P6|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
236531|NCT00927758|574913|P5|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
236532|NCT00927758|574914|P4|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
236533|NCT00927758|574915|P3|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
236534|NCT00927758|574916|P2|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
236535|NCT00927758|574917|P1|NOT COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||0
236536|NCT00927758|574912|P6|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||2
236537|NCT00927758|574913|P5|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
236538|NCT00927758|574914|P4|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||1
236539|NCT00927758|574915|P3|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||3
236540|NCT00927758|574916|P2|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
236541|NCT00927758|574917|P1|COMPLETED|Treatment Cycle 3 (Day 1 - Day 7)||4
236542|NCT00927758|574912|P6|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||2
236543|NCT00927758|574913|P5|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
236544|NCT00927758|574914|P4|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||1
236545|NCT00927758|574915|P3|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||3
236546|NCT00927758|574916|P2|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
236547|NCT00927758|574917|P1|STARTED|Treatment Cycle 3 (Day 1 - Day 7)||4
236548|NCT00927758|574912|P6|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
236549|NCT00927758|574913|P5|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
236550|NCT00927758|574914|P4|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
236551|NCT00927758|574915|P3|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
236552|NCT00927758|574916|P2|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
236553|NCT00927758|574917|P1|NOT COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||0
236554|NCT00927758|574912|P6|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||2
236555|NCT00927758|574913|P5|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
236556|NCT00927758|574914|P4|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||1
236557|NCT00927758|574915|P3|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||3
236558|NCT00927758|574916|P2|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
236559|NCT00927758|574917|P1|COMPLETED|Treatment Cycle 2 (Day 1 - Day 7)||4
236560|NCT00927758|574912|P6|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||2
236561|NCT00927758|574913|P5|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
236562|NCT00927758|574914|P4|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||1
236563|NCT00927758|574915|P3|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||3
236564|NCT00927758|574916|P2|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
236565|NCT00927758|574917|P1|Per Protocol Population (PP)|Treatment Cycle 2 (Day 1 - Day 7)||4
236566|NCT00927758|574912|P6|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
236567|NCT00927758|574913|P5|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||3
236568|NCT00927758|574914|P4|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||2
236569|NCT00927758|574915|P3|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
236570|NCT00927758|574916|P2|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
236571|NCT00927758|574917|P1|STARTED|Treatment Cycle 2 (Day 1 - Day 7)||4
236572|NCT00927758|574912|P6|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
236573|NCT00927758|574913|P5|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
236574|NCT00927758|574914|P4|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||1
236575|NCT00927758|574915|P3|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
236576|NCT00927758|574916|P2|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
236577|NCT00927758|574917|P1|NOT COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||0
236578|NCT00927758|574912|P6|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
236579|NCT00927758|574913|P5|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||3
236580|NCT00927758|574914|P4|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||2
236581|NCT00927758|574915|P3|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
236582|NCT00927758|574916|P2|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
236583|NCT00927758|574917|P1|COMPLETED|Treatment Cycle 1 (Day 1 - Day 7)||4
236584|NCT00927758|574912|P6|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
236585|NCT00927758|574913|P5|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||3
236586|NCT00927758|574914|P4|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||2
236587|NCT00927758|574915|P3|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
236588|NCT00927758|574916|P2|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
236589|NCT00927758|574917|P1|Intent to Treat (ITT)|Treatment Cycle 1 (Day 1 - Day 7)||4
236590|NCT00927758|574912|P6|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
236591|NCT00927758|574913|P5|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
236592|NCT00927758|574914|P4|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||3
236593|NCT00927758|574915|P3|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
236594|NCT00927758|574916|P2|STARTED|Treatment Cycle 1 (Day 1 - Day 7)||4
236595|NCT00927758|574917|P1|STARTED|Treatment Cycle 1 (Day 1 - Day 7)|"Started  indicates randomized as well as safety set."|4
236596|NCT00927823|574925|P4|NOT COMPLETED|Continuous Dosing Period||5
236597|NCT00927823|574926|P3|NOT COMPLETED|Continuous Dosing Period||26
236598|NCT00927823|574927|P2|NOT COMPLETED|Continuous Dosing Period||3
236599|NCT00927823|574928|P1|NOT COMPLETED|Continuous Dosing Period||3
236600|NCT00927823|574925|P4|COMPLETED|Continuous Dosing Period||0
236601|NCT00927823|574926|P3|COMPLETED|Continuous Dosing Period||0
236602|NCT00927823|574927|P2|COMPLETED|Continuous Dosing Period||0
236603|NCT00927823|574928|P1|COMPLETED|Continuous Dosing Period||0
236604|NCT00927823|574925|P4|Treated|Continuous Dosing Period||5
236605|NCT00927823|574926|P3|Treated|Continuous Dosing Period||23
236606|NCT00927823|574927|P2|Treated|Continuous Dosing Period||3
236607|NCT00927823|574928|P1|Treated|Continuous Dosing Period||3
236608|NCT00927823|574925|P4|STARTED|Continuous Dosing Period||5
236609|NCT00927823|574926|P3|STARTED|Continuous Dosing Period||26
236610|NCT00927823|574927|P2|STARTED|Continuous Dosing Period||3
236611|NCT00927823|574928|P1|STARTED|Continuous Dosing Period||3
236612|NCT00927823|574925|P4|NOT COMPLETED|Lead-In Period||0
236613|NCT00927823|574926|P3|NOT COMPLETED|Lead-In Period||0
236614|NCT00927823|574927|P2|NOT COMPLETED|Lead-In Period||0
236615|NCT00927823|574928|P1|NOT COMPLETED|Lead-In Period||0
236616|NCT00927823|574925|P4|COMPLETED|Lead-In Period||5
236617|NCT00927823|574926|P3|COMPLETED|Lead-In Period||26
236618|NCT00927823|574927|P2|COMPLETED|Lead-In Period||3
236619|NCT00927823|574928|P1|COMPLETED|Lead-In Period||3
236620|NCT00927823|574925|P4|STARTED|Lead-In Period||5
236621|NCT00927823|574926|P3|STARTED|Lead-In Period||26
236622|NCT00927823|574927|P2|STARTED|Lead-In Period||3
236623|NCT00927823|574928|P1|STARTED|Lead-In Period||3
236624|NCT00927849|574995|P3|NOT COMPLETED|Overall Study||0
236625|NCT00927849|574996|P2|NOT COMPLETED|Overall Study||0
236626|NCT00927849|574997|P1|NOT COMPLETED|Overall Study||0
236627|NCT00927849|574995|P3|COMPLETED|Overall Study||21
236628|NCT00927849|574996|P2|COMPLETED|Overall Study||21
236629|NCT00927849|574997|P1|COMPLETED|Overall Study||21
236630|NCT00927849|574995|P3|STARTED|Overall Study||21
236631|NCT00927849|574996|P2|STARTED|Overall Study||21
236632|NCT00927849|574997|P1|STARTED|Overall Study||21
236633|NCT00927862|575007|P2|NOT COMPLETED|Overall Study||45
236634|NCT00927862|575008|P1|NOT COMPLETED|Overall Study||27
236635|NCT00927862|575007|P2|COMPLETED|Overall Study||1866
236636|NCT00927862|575008|P1|COMPLETED|Overall Study|477 patients evaluated in primary analyses and 488 evaluated in secondary analyses.|477
236637|NCT00927862|575007|P2|STARTED|Overall Study||1911
236638|NCT00927862|575008|P1|STARTED|Overall Study||504
236639|NCT00927888|575032|P2|NOT COMPLETED|Overall Study||0
236640|NCT00927888|575033|P1|NOT COMPLETED|Overall Study||0
236641|NCT00927888|575032|P2|COMPLETED|Overall Study||27
236642|NCT00927888|575033|P1|COMPLETED|Overall Study||29
236643|NCT00927888|575032|P2|STARTED|Overall Study||27
236644|NCT00927888|575033|P1|STARTED|Overall Study||29
236645|NCT00927901|575041|P4|NOT COMPLETED|Treatment Period 4||1
236646|NCT00927901|575042|P3|NOT COMPLETED|Treatment Period 4||1
236647|NCT00927901|575043|P2|NOT COMPLETED|Treatment Period 4||0
236648|NCT00927901|575044|P1|NOT COMPLETED|Treatment Period 4||0
236649|NCT00927901|575041|P4|COMPLETED|Treatment Period 4||8
236650|NCT00927901|575042|P3|COMPLETED|Treatment Period 4||5
236651|NCT00927901|575043|P2|COMPLETED|Treatment Period 4||7
236652|NCT00927901|575044|P1|COMPLETED|Treatment Period 4||7
236653|NCT00927901|575041|P4|STARTED|Treatment Period 4||9
236654|NCT00927901|575042|P3|STARTED|Treatment Period 4||6
236655|NCT00927901|575043|P2|STARTED|Treatment Period 4||7
236656|NCT00927901|575044|P1|STARTED|Treatment Period 4||7
236657|NCT00927901|575041|P4|NOT COMPLETED|Treatment Period 3||0
236658|NCT00927901|575042|P3|NOT COMPLETED|Treatment Period 3||0
236659|NCT00927901|575043|P2|NOT COMPLETED|Treatment Period 3||0
236660|NCT00927901|575044|P1|NOT COMPLETED|Treatment Period 3||0
236661|NCT00927901|575041|P4|COMPLETED|Treatment Period 3||9
236662|NCT00927901|575042|P3|COMPLETED|Treatment Period 3||6
236663|NCT00927901|575043|P2|COMPLETED|Treatment Period 3||7
236664|NCT00927901|575044|P1|COMPLETED|Treatment Period 3||7
236665|NCT00927901|575041|P4|STARTED|Treatment Period 3||9
236666|NCT00927901|575042|P3|STARTED|Treatment Period 3||6
236667|NCT00927901|575043|P2|STARTED|Treatment Period 3||7
236668|NCT00927901|575044|P1|STARTED|Treatment Period 3||7
236669|NCT00927901|575041|P4|NOT COMPLETED|Treatment Period 2||0
236670|NCT00927901|575042|P3|NOT COMPLETED|Treatment Period 2||0
236671|NCT00927901|575043|P2|NOT COMPLETED|Treatment Period 2||0
236672|NCT00927901|575044|P1|NOT COMPLETED|Treatment Period 2||0
236673|NCT00927901|575041|P4|COMPLETED|Treatment Period 2||9
236674|NCT00927901|575042|P3|COMPLETED|Treatment Period 2||6
236675|NCT00927901|575043|P2|COMPLETED|Treatment Period 2||7
236676|NCT00927901|575044|P1|COMPLETED|Treatment Period 2||7
236677|NCT00927901|575041|P4|STARTED|Treatment Period 2||9
236678|NCT00927901|575042|P3|STARTED|Treatment Period 2||6
236679|NCT00927901|575043|P2|STARTED|Treatment Period 2||7
236680|NCT00927901|575044|P1|STARTED|Treatment Period 2||7
236681|NCT00927901|575041|P4|NOT COMPLETED|Treatment Period 1||0
236682|NCT00927901|575042|P3|NOT COMPLETED|Treatment Period 1||1
236683|NCT00927901|575043|P2|NOT COMPLETED|Treatment Period 1||0
236684|NCT00927901|575044|P1|NOT COMPLETED|Treatment Period 1||0
236685|NCT00927901|575041|P4|COMPLETED|Treatment Period 1||9
236686|NCT00927901|575042|P3|COMPLETED|Treatment Period 1||6
236687|NCT00927901|575043|P2|COMPLETED|Treatment Period 1||7
236688|NCT00927901|575044|P1|COMPLETED|Treatment Period 1||7
236689|NCT00927901|575041|P4|STARTED|Treatment Period 1||9
236690|NCT00927901|575042|P3|STARTED|Treatment Period 1||7
236691|NCT00927901|575043|P2|STARTED|Treatment Period 1||7
236692|NCT00927901|575044|P1|STARTED|Treatment Period 1||7
236693|NCT00927927|575087|P15|NOT COMPLETED|Overall Study||0
236694|NCT00927927|575088|P14|NOT COMPLETED|Overall Study||0
236695|NCT00927927|575089|P13|NOT COMPLETED|Overall Study||0
236696|NCT00927927|575090|P12|NOT COMPLETED|Overall Study||2
236697|NCT00927927|575091|P11|NOT COMPLETED|Overall Study||0
236698|NCT00927927|575092|P10|NOT COMPLETED|Overall Study||0
236699|NCT00927927|575093|P9|NOT COMPLETED|Overall Study||0
236700|NCT00927927|575094|P8|NOT COMPLETED|Overall Study||2
236701|NCT00927927|575095|P7|NOT COMPLETED|Overall Study||0
236702|NCT00927927|575096|P6|NOT COMPLETED|Overall Study||0
236703|NCT00927927|575097|P5|NOT COMPLETED|Overall Study||0
236704|NCT00927927|575098|P4|NOT COMPLETED|Overall Study||0
236705|NCT00927927|575099|P3|NOT COMPLETED|Overall Study||0
236706|NCT00927927|575100|P2|NOT COMPLETED|Overall Study||0
236707|NCT00927927|575101|P1|NOT COMPLETED|Overall Study||0
236708|NCT00927927|575087|P15|COMPLETED|Overall Study||9
236709|NCT00927927|575088|P14|COMPLETED|Overall Study||5
236710|NCT00927927|575089|P13|COMPLETED|Overall Study||5
236711|NCT00927927|575090|P12|COMPLETED|Overall Study|One subject withdrew consent after being randomised but before receiving any trial product.|4
236712|NCT00927927|575091|P11|COMPLETED|Overall Study||5
236713|NCT00927927|575092|P10|COMPLETED|Overall Study||3
236714|NCT00927927|575093|P9|COMPLETED|Overall Study||8
236715|NCT00927927|575094|P8|COMPLETED|Overall Study||1
236716|NCT00927927|575095|P7|COMPLETED|Overall Study||3
236717|NCT00927927|575096|P6|COMPLETED|Overall Study||3
236718|NCT00927927|575097|P5|COMPLETED|Overall Study||3
236719|NCT00927927|575098|P4|COMPLETED|Overall Study||3
236720|NCT00927927|575099|P3|COMPLETED|Overall Study||3
236721|NCT00927927|575100|P2|COMPLETED|Overall Study||3
236722|NCT00927927|575101|P1|COMPLETED|Overall Study||3
236723|NCT00927927|575087|P15|Exposed|Overall Study||9
236724|NCT00927927|575088|P14|Exposed|Overall Study||5
236725|NCT00927927|575089|P13|Exposed|Overall Study||5
236726|NCT00927927|575090|P12|Exposed|Overall Study||5
236727|NCT00927927|575091|P11|Exposed|Overall Study||5
236728|NCT00927927|575092|P10|Exposed|Overall Study||3
236729|NCT00927927|575093|P9|Exposed|Overall Study||8
236730|NCT00927927|575094|P8|Exposed|Overall Study||3
236731|NCT00927927|575095|P7|Exposed|Overall Study||3
236732|NCT00927927|575096|P6|Exposed|Overall Study||3
236733|NCT00927927|575097|P5|Exposed|Overall Study||3
236734|NCT00927927|575098|P4|Exposed|Overall Study||3
236735|NCT00927927|575099|P3|Exposed|Overall Study||3
236736|NCT00927927|575100|P2|Exposed|Overall Study||3
236737|NCT00927927|575101|P1|Exposed|Overall Study||3
236738|NCT00927927|575087|P15|STARTED|Overall Study||9
236739|NCT00927927|575088|P14|STARTED|Overall Study||5
236740|NCT00927927|575089|P13|STARTED|Overall Study||5
236741|NCT00927927|575090|P12|STARTED|Overall Study||6
236742|NCT00927927|575091|P11|STARTED|Overall Study||5
236743|NCT00927927|575092|P10|STARTED|Overall Study||3
236744|NCT00927927|575093|P9|STARTED|Overall Study||8
236745|NCT00927927|575094|P8|STARTED|Overall Study||3
236746|NCT00927927|575095|P7|STARTED|Overall Study||3
236747|NCT00927927|575096|P6|STARTED|Overall Study||3
236748|NCT00927927|575097|P5|STARTED|Overall Study||3
236749|NCT00927927|575098|P4|STARTED|Overall Study||3
236750|NCT00927927|575099|P3|STARTED|Overall Study||3
236751|NCT00927927|575100|P2|STARTED|Overall Study||3
236752|NCT00927927|575101|P1|STARTED|Overall Study||3
236753|NCT00927940|575148|P1|NOT COMPLETED|Overall Study||1
236754|NCT00927940|575148|P1|COMPLETED|Overall Study|A patient died before 30 days follow up. This pasitent is excluded from primary analysis.|99
236755|NCT00927940|575148|P1|STARTED|Overall Study||100
236756|NCT00927953|575155|P2|NOT COMPLETED|Overall Study||1
236757|NCT00927953|575156|P1|NOT COMPLETED|Overall Study||2
236758|NCT00927953|575155|P2|COMPLETED|Overall Study||6
236759|NCT00927953|575156|P1|COMPLETED|Overall Study||4
236760|NCT00927953|575155|P2|STARTED|Overall Study||7
236761|NCT00927953|575156|P1|STARTED|Overall Study||6
236762|NCT00927992|575170|P1|NOT COMPLETED|Overall Study||0
236763|NCT00927992|575170|P1|COMPLETED|Overall Study||11
236764|NCT00927992|575170|P1|STARTED|Overall Study||11
236765|NCT00928018|575182|P2|NOT COMPLETED|Overall Study||0
236766|NCT00928018|575183|P1|NOT COMPLETED|Overall Study||1
236767|NCT00928018|575182|P2|COMPLETED|Overall Study||73
236768|NCT00928018|575183|P1|COMPLETED|Overall Study||65
236769|NCT00928018|575182|P2|STARTED|Overall Study||73
236770|NCT00928018|575183|P1|STARTED|Overall Study|One Arm A patient withdrew consent, treated as Arm B, but analyzed on Arm A based on intent-to-treat|66
236771|NCT00928057|575203|P2|NOT COMPLETED|Overall Study||4
236772|NCT00928057|575204|P1|NOT COMPLETED|Overall Study||2
236773|NCT00928057|575203|P2|COMPLETED|Overall Study||85
236774|NCT00928057|575204|P1|COMPLETED|Overall Study||82
236775|NCT00928057|575203|P2|STARTED|Overall Study||89
236776|NCT00928057|575204|P1|STARTED|Overall Study||84
236777|NCT00928070|575229|P2|NOT COMPLETED|Overall Study||57
236778|NCT00928070|575230|P1|NOT COMPLETED|Overall Study||63
236779|NCT00928070|575229|P2|COMPLETED|Overall Study||226
236780|NCT00928070|575230|P1|COMPLETED|Overall Study||220
236781|NCT00928070|575229|P2|Treated|Overall Study||281
236782|NCT00928070|575230|P1|Treated|Overall Study||281
236783|NCT00928070|575229|P2|STARTED|Overall Study||283
236784|NCT00928070|575230|P1|STARTED|Overall Study||283
236785|NCT00928083|575289|P9|NOT COMPLETED|Overall Study||0
236786|NCT00928083|575290|P8|NOT COMPLETED|Overall Study||0
236787|NCT00928083|575291|P7|NOT COMPLETED|Overall Study||0
236788|NCT00928083|575292|P6|NOT COMPLETED|Overall Study||0
236789|NCT00928083|575293|P5|NOT COMPLETED|Overall Study||1
236790|NCT00928083|575294|P4|NOT COMPLETED|Overall Study||1
236791|NCT00928083|575295|P3|NOT COMPLETED|Overall Study||0
236792|NCT00928083|575296|P2|NOT COMPLETED|Overall Study||0
236793|NCT00928083|575297|P1|NOT COMPLETED|Overall Study||4
236794|NCT00928083|575289|P9|COMPLETED|Overall Study||6
236795|NCT00928083|575290|P8|COMPLETED|Overall Study||6
236796|NCT00928083|575291|P7|COMPLETED|Overall Study||6
236797|NCT00928083|575292|P6|COMPLETED|Overall Study||6
236798|NCT00928083|575293|P5|COMPLETED|Overall Study||6
236799|NCT00928083|575294|P4|COMPLETED|Overall Study||5
236800|NCT00928083|575295|P3|COMPLETED|Overall Study||8
236801|NCT00928083|575296|P2|COMPLETED|Overall Study||8
236802|NCT00928083|575297|P1|COMPLETED|Overall Study||6
236803|NCT00928083|575289|P9|STARTED|Overall Study||6
236804|NCT00928083|575290|P8|STARTED|Overall Study||6
236805|NCT00928083|575291|P7|STARTED|Overall Study||6
236806|NCT00928083|575292|P6|STARTED|Overall Study||6
236807|NCT00928083|575293|P5|STARTED|Overall Study||7
236808|NCT00928083|575294|P4|STARTED|Overall Study||6
236809|NCT00928083|575295|P3|STARTED|Overall Study||8
236810|NCT00928083|575296|P2|STARTED|Overall Study||8
236811|NCT00928083|575297|P1|STARTED|Overall Study||10
236812|NCT00928174|575406|P1|NOT COMPLETED|Overall Study||5
236813|NCT00928174|575406|P1|COMPLETED|Overall Study|3 withdrawn before start of participation|22
236814|NCT00928174|575406|P1|STARTED|Overall Study||27
236815|NCT00928187|575413|P3|NOT COMPLETED|Overall Study||5
236816|NCT00928187|575414|P2|NOT COMPLETED|Overall Study||6
236817|NCT00928187|575415|P1|NOT COMPLETED|Overall Study||2
236818|NCT00928187|575413|P3|COMPLETED|Overall Study||150
236819|NCT00928187|575414|P2|COMPLETED|Overall Study||141
236820|NCT00928187|575415|P1|COMPLETED|Overall Study||150
236821|NCT00928187|575413|P3|Analysed|Overall Study||154
236822|NCT00928187|575414|P2|Analysed|Overall Study||145
236823|NCT00928187|575415|P1|Analysed|Overall Study||152
236824|NCT00928187|575413|P3|STARTED|Overall Study||155
236825|NCT00928187|575414|P2|STARTED|Overall Study||147
236826|NCT00928187|575415|P1|STARTED|Overall Study||152
236827|NCT00928252|575459|P1|NOT COMPLETED|Overall Study||3
236828|NCT00928252|575459|P1|COMPLETED|Overall Study||42
236829|NCT00928252|575459|P1|STARTED|Overall Study||45
236830|NCT00928304|575465|P2|NOT COMPLETED|Overall Study||0
236831|NCT00928304|575466|P1|NOT COMPLETED|Overall Study||0
236832|NCT00928304|575465|P2|COMPLETED|Overall Study||70
236833|NCT00928304|575466|P1|COMPLETED|Overall Study||39
236834|NCT00928304|575465|P2|STARTED|Overall Study||70
236835|NCT00928304|575466|P1|STARTED|Overall Study||39
236836|NCT00928395|575478|P1|NOT COMPLETED|Overall Study||21
236837|NCT00928395|575478|P1|COMPLETED|Overall Study||29
236838|NCT00928395|575478|P1|STARTED|Overall Study||50
236839|NCT00928408|575482|P1|NOT COMPLETED|Overall Study||23
236840|NCT00928408|575482|P1|COMPLETED|Overall Study||282
236841|NCT00928408|575482|P1|Full Analysis Set|Overall Study|All enrolled participants who fulfilled the study inclusion/exclusion criteria|303
236842|NCT00928408|575482|P1|STARTED|Overall Study|Number Enrolled|305
236843|NCT00928421|575511|P1|NOT COMPLETED|Overall Study||0
236844|NCT00928421|575511|P1|COMPLETED|Overall Study||16
236845|NCT00928421|575511|P1|Treated With Study Drug|Overall Study||16
236846|NCT00928421|575511|P1|STARTED|Overall Study||16
236847|NCT00928434|575518|P3|NOT COMPLETED|Overall Study||44
236848|NCT00928434|575519|P2|NOT COMPLETED|Overall Study||14
236849|NCT00928434|575520|P1|NOT COMPLETED|Overall Study||44
236850|NCT00928434|575518|P3|COMPLETED|Overall Study||134
236851|NCT00928434|575519|P2|COMPLETED|Overall Study||36
236852|NCT00928434|575520|P1|COMPLETED|Overall Study||131
236853|NCT00928434|575518|P3|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|150
236854|NCT00928434|575519|P2|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|41
236855|NCT00928434|575520|P1|Full Phase B Analysis Set|Overall Study|Patients completing 7 months treatment with PSA<2 ng/mL, and having one primary efficacy assessment.|137
236856|NCT00928434|575518|P3|STARTED|Overall Study|Full Analysis Set Patients|178
236857|NCT00928434|575519|P2|STARTED|Overall Study|Full Analysis Set Patients|50
236858|NCT00928434|575520|P1|STARTED|Overall Study|Full Analysis Set Patients|175
236859|NCT00928486|575592|P1|NOT COMPLETED|Overall Study||10
236860|NCT00928486|575592|P1|COMPLETED|Overall Study|Completed = those who continued responding to treatment; upon marketing approval, given lenalidomide|15
237023|NCT00922636|576006|P3|COMPLETED|Overall Study||56
236861|NCT00928486|575592|P1|Efficacy Evaluable (EE)|Overall Study|EE population = given at least 1 dose of study drug, evaluated for efficacy and met eligibility|24
236862|NCT00928486|575592|P1|STARTED|Overall Study||25
236863|NCT00928512|575603|P5|NOT COMPLETED|Overall Study||15
236864|NCT00928512|575604|P4|NOT COMPLETED|Overall Study||21
236865|NCT00928512|575605|P3|NOT COMPLETED|Overall Study||11
236866|NCT00928512|575606|P2|NOT COMPLETED|Overall Study||6
236867|NCT00928512|575607|P1|NOT COMPLETED|Overall Study||10
236868|NCT00928512|575603|P5|COMPLETED|Overall Study||35
236869|NCT00928512|575604|P4|COMPLETED|Overall Study||33
236870|NCT00928512|575605|P3|COMPLETED|Overall Study||38
236871|NCT00928512|575606|P2|COMPLETED|Overall Study||37
236872|NCT00928512|575607|P1|COMPLETED|Overall Study||31
236873|NCT00928512|575603|P5|Entered/Continued to Week 20 (All)|Overall Study||45
236874|NCT00928512|575604|P4|Entered/Continued to Week 20 (All)|Overall Study||45
236875|NCT00928512|575605|P3|Entered/Continued to Week 20 (All)|Overall Study||46
236876|NCT00928512|575606|P2|Entered/Continued to Week 20 (All)|Overall Study||43
236877|NCT00928512|575607|P1|Entered/Continued to Week 20 (All)|Overall Study||37
236878|NCT00928512|575603|P5|Completed Week 16|Overall Study||45
236879|NCT00928512|575604|P4|Completed Week 16|Overall Study||48
236880|NCT00928512|575605|P3|Completed Week 16|Overall Study||47
236881|NCT00928512|575606|P2|Completed Week 16|Overall Study||43
236882|NCT00928512|575607|P1|Completed Week 16|Overall Study||38
236883|NCT00928512|575603|P5|New Groups After Reassignment|Overall Study||0
236884|NCT00928512|575604|P4|New Groups After Reassignment|Overall Study|2 patients in this group continued at Week 16 but did not receive any study drug at Week 20|18
236885|NCT00928512|575605|P3|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|23
236886|NCT00928512|575606|P2|New Groups After Reassignment|Overall Study||115
236887|NCT00928512|575607|P1|New Groups After Reassignment|Overall Study|1 patient in this group continued at Week 16 but did not receive any study drug at Week 20.|60
236888|NCT00928512|575603|P5|Not Reassigned at Week 20 (Responders)|Overall Study||0
236889|NCT00928512|575604|P4|Not Reassigned at Week 20 (Responders)|Overall Study||18
236890|NCT00928512|575605|P3|Not Reassigned at Week 20 (Responders)|Overall Study||23
236891|NCT00928512|575606|P2|Not Reassigned at Week 20 (Responders)|Overall Study||20
236892|NCT00928512|575607|P1|Not Reassigned at Week 20 (Responders)|Overall Study||37
236893|NCT00928512|575603|P5|Reassigned at Week 20 (Non-responders)|Overall Study|All placebo patients (responders & non-responders) were reassigned treatment to the 150 mg group.|45
236894|NCT00928512|575604|P4|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 25 mg group were reassigned treatment to the 150 mg group.|27
236895|NCT00928512|575605|P3|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 75 mg group were reassigned treatment to the 150 mg group.|23
236896|NCT00928512|575606|P2|Reassigned at Week 20 (Non-responders)|Overall Study|Non-responders in the AIN457 150 mg group were reassigned treatment to the 300 mg group.|23
236897|NCT00928512|575607|P1|Reassigned at Week 20 (Non-responders)|Overall Study|All patients in the 300 mg group at Week 20 remained at this dose in this group.|0
236898|NCT00928512|575603|P5|Discontinued Prior to Week 16|Overall Study||5
236899|NCT00928512|575604|P4|Discontinued Prior to Week 16|Overall Study||6
236900|NCT00928512|575605|P3|Discontinued Prior to Week 16|Overall Study||2
236901|NCT00928512|575606|P2|Discontinued Prior to Week 16|Overall Study||0
236902|NCT00928512|575607|P1|Discontinued Prior to Week 16|Overall Study||3
236903|NCT00928512|575603|P5|STARTED|Overall Study||50
236904|NCT00928512|575604|P4|STARTED|Overall Study||54
236905|NCT00928512|575605|P3|STARTED|Overall Study||49
236906|NCT00928512|575606|P2|STARTED|Overall Study||43
236907|NCT00928512|575607|P1|STARTED|Overall Study||41
236908|NCT00928642|575708|P1|NOT COMPLETED|Overall Study||0
236909|NCT00928642|575708|P1|COMPLETED|Overall Study|1 subject withdrew after 1st cycle but before disease assessment. 7 of 8 are evaluable for response|8
236910|NCT00928642|575708|P1|STARTED|Overall Study||8
236911|NCT00921310|575719|P3|NOT COMPLETED|Overall Study||0
236912|NCT00921310|575720|P2|NOT COMPLETED|Overall Study||0
236913|NCT00921310|575721|P1|NOT COMPLETED|Overall Study||0
236914|NCT00921310|575719|P3|COMPLETED|Overall Study||4
236915|NCT00921310|575720|P2|COMPLETED|Overall Study||6
236916|NCT00921310|575721|P1|COMPLETED|Overall Study||2
236917|NCT00921310|575719|P3|STARTED|Overall Study||4
236918|NCT00921310|575720|P2|STARTED|Overall Study||6
236919|NCT00921310|575721|P1|STARTED|Overall Study||2
236920|NCT00921518|575748|P2|NOT COMPLETED|Overall Study||0
236921|NCT00921518|575749|P1|NOT COMPLETED|Overall Study||0
236922|NCT00921518|575748|P2|COMPLETED|Overall Study||44
236923|NCT00921518|575749|P1|COMPLETED|Overall Study||48
236924|NCT00921518|575748|P2|STARTED|Overall Study||44
236925|NCT00921518|575749|P1|STARTED|Overall Study||48
236926|NCT00921557|575758|P3|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
236927|NCT00921557|575759|P2|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||1
236928|NCT00921557|575760|P1|NOT COMPLETED|Weeks 96-144 (Off Study Treatment)||3
236929|NCT00921557|575758|P3|COMPLETED|Weeks 96-144 (Off Study Treatment)||16
236930|NCT00921557|575759|P2|COMPLETED|Weeks 96-144 (Off Study Treatment)||15
236931|NCT00921557|575760|P1|COMPLETED|Weeks 96-144 (Off Study Treatment)||12
236932|NCT00921557|575758|P3|STARTED|Weeks 96-144 (Off Study Treatment)||17
236933|NCT00921557|575759|P2|STARTED|Weeks 96-144 (Off Study Treatment)||16
236934|NCT00921557|575760|P1|STARTED|Weeks 96-144 (Off Study Treatment)||15
236935|NCT00921557|575758|P3|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
236936|NCT00921557|575759|P2|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||1
236937|NCT00921557|575760|P1|NOT COMPLETED|Weeks 48-96 (on Study Treatment)||0
236938|NCT00921557|575758|P3|COMPLETED|Weeks 48-96 (on Study Treatment)||17
236939|NCT00921557|575759|P2|COMPLETED|Weeks 48-96 (on Study Treatment)||16
236940|NCT00921557|575760|P1|COMPLETED|Weeks 48-96 (on Study Treatment)||15
236941|NCT00921557|575758|P3|STARTED|Weeks 48-96 (on Study Treatment)||18
236942|NCT00921557|575759|P2|STARTED|Weeks 48-96 (on Study Treatment)||17
236943|NCT00921557|575760|P1|STARTED|Weeks 48-96 (on Study Treatment)||15
236944|NCT00921557|575758|P3|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
236945|NCT00921557|575759|P2|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||0
236946|NCT00921557|575760|P1|NOT COMPLETED|Weeks 0-48 (on Study Treatment)||2
236947|NCT00921557|575758|P3|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|18
236948|NCT00921557|575759|P2|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|17
236949|NCT00921557|575760|P1|COMPLETED|Weeks 0-48 (on Study Treatment)|Completed 48 weeks|15
236950|NCT00921557|575758|P3|STARTED|Weeks 0-48 (on Study Treatment)||18
236951|NCT00921557|575759|P2|STARTED|Weeks 0-48 (on Study Treatment)||17
236952|NCT00921557|575760|P1|STARTED|Weeks 0-48 (on Study Treatment)||17
236953|NCT00921687|575820|P2|NOT COMPLETED|Overall Study||0
236954|NCT00921687|575821|P1|NOT COMPLETED|Overall Study||0
236955|NCT00921687|575820|P2|COMPLETED|Overall Study||363
236956|NCT00921687|575821|P1|COMPLETED|Overall Study||418
236957|NCT00921687|575820|P2|STARTED|Overall Study||363
236958|NCT00921687|575821|P1|STARTED|Overall Study|eligible patients seen in clinic between 1/1/09 and 1/1/10|418
236959|NCT00921895|575829|P1|NOT COMPLETED|Overall Study||0
236960|NCT00921895|575829|P1|COMPLETED|Overall Study||128
236961|NCT00921895|575829|P1|STARTED|Overall Study||128
236962|NCT00921934|575834|P1|NOT COMPLETED|Overall Study||0
236963|NCT00921934|575834|P1|COMPLETED|Overall Study||68
236964|NCT00921934|575834|P1|STARTED|Overall Study||68
236965|NCT00921947|575840|P2|NOT COMPLETED|Day 28||0
236966|NCT00921947|575841|P1|NOT COMPLETED|Day 28||0
236967|NCT00921947|575840|P2|COMPLETED|Day 28||30
236968|NCT00921947|575841|P1|COMPLETED|Day 28||28
236969|NCT00921947|575840|P2|STARTED|Day 28||30
236970|NCT00921947|575841|P1|STARTED|Day 28|2 subjects were lost to follow-up and did not receive the 2nd vaccination of 1.0 ug i.m.|28
236971|NCT00921947|575840|P2|NOT COMPLETED|Day 0||0
236972|NCT00921947|575841|P1|NOT COMPLETED|Day 0||0
236973|NCT00921947|575840|P2|COMPLETED|Day 0||30
236974|NCT00921947|575841|P1|COMPLETED|Day 0||30
236975|NCT00921947|575840|P2|STARTED|Day 0||30
236976|NCT00921947|575841|P1|STARTED|Day 0||30
236977|NCT00922116|575851|P1|NOT COMPLETED|Overall Study||15
236978|NCT00922116|575851|P1|COMPLETED|Overall Study||176
236979|NCT00922116|575851|P1|STARTED|Overall Study||191
236980|NCT00922194|575860|P1|NOT COMPLETED|Metformin for 12 Months or More||0
236981|NCT00922194|575860|P1|COMPLETED|Metformin for 12 Months or More||102
236982|NCT00922194|575860|P1|STARTED|Metformin for 12 Months or More|Gradually increasing dose of Extended Release Metformin|102
236983|NCT00922194|575860|P1|NOT COMPLETED|Metformin in Maximum Tolerated Dose||0
236984|NCT00922194|575860|P1|COMPLETED|Metformin in Maximum Tolerated Dose|June 2009|102
236985|NCT00922194|575860|P1|STARTED|Metformin in Maximum Tolerated Dose|February 2006|102
236986|NCT00922207|575873|P3|NOT COMPLETED|Overall Study||4
236987|NCT00922207|575874|P2|NOT COMPLETED|Overall Study||7
236988|NCT00922207|575875|P1|NOT COMPLETED|Overall Study||6
236989|NCT00922207|575873|P3|COMPLETED|Overall Study||90
236990|NCT00922207|575874|P2|COMPLETED|Overall Study||88
236991|NCT00922207|575875|P1|COMPLETED|Overall Study||85
236992|NCT00922207|575873|P3|STARTED|Overall Study||94
236993|NCT00922207|575874|P2|STARTED|Overall Study||95
236994|NCT00922207|575875|P1|STARTED|Overall Study||91
236995|NCT00922233|575901|P1|NOT COMPLETED|Overall Study||4
236996|NCT00922233|575901|P1|COMPLETED|Overall Study||68
236997|NCT00922233|575901|P1|STARTED|Overall Study||72
236998|NCT00922272|575907|P2|NOT COMPLETED|Double-blind Phase||6
236999|NCT00922272|575908|P1|NOT COMPLETED|Double-blind Phase||7
237000|NCT00922272|575907|P2|COMPLETED|Double-blind Phase||29
237001|NCT00922272|575908|P1|COMPLETED|Double-blind Phase||27
237002|NCT00922272|575907|P2|STARTED|Double-blind Phase||35
237003|NCT00922272|575908|P1|STARTED|Double-blind Phase||34
237004|NCT00922272|575907|P2|NOT COMPLETED|Open-label Phase||0
237005|NCT00922272|575908|P1|NOT COMPLETED|Open-label Phase||23
237006|NCT00922272|575907|P2|COMPLETED|Open-label Phase||0
237007|NCT00922272|575908|P1|COMPLETED|Open-label Phase||69
237008|NCT00922272|575907|P2|STARTED|Open-label Phase||0
237009|NCT00922272|575908|P1|STARTED|Open-label Phase||92
237010|NCT00922428|575964|P1|NOT COMPLETED|Overall Study||15
237011|NCT00922428|575964|P1|COMPLETED|Overall Study|for 11 participants no gender was given|1374
237012|NCT00922428|575964|P1|STARTED|Overall Study|13 patients were completely not analysed, 2 not for demographic or efficacy but for safety|1389
237013|NCT00922623|575993|P1|NOT COMPLETED|Overall Study||5
237014|NCT00922623|575993|P1|COMPLETED|Overall Study||88
237015|NCT00922623|575993|P1|STARTED|Overall Study||93
237016|NCT00922636|576004|P5|NOT COMPLETED|Overall Study||16
237017|NCT00922636|576005|P4|NOT COMPLETED|Overall Study||17
237018|NCT00922636|576006|P3|NOT COMPLETED|Overall Study||20
237019|NCT00922636|576007|P2|NOT COMPLETED|Overall Study||16
237020|NCT00922636|576008|P1|NOT COMPLETED|Overall Study||7
237021|NCT00922636|576004|P5|COMPLETED|Overall Study||59
237022|NCT00922636|576005|P4|COMPLETED|Overall Study||58
237024|NCT00922636|576007|P2|COMPLETED|Overall Study||62
237025|NCT00922636|576008|P1|COMPLETED|Overall Study||29
237026|NCT00922636|576004|P5|Entered Optional Taper Phase|Overall Study||12
237027|NCT00922636|576005|P4|Entered Optional Taper Phase|Overall Study||7
237028|NCT00922636|576006|P3|Entered Optional Taper Phase|Overall Study||15
237029|NCT00922636|576007|P2|Entered Optional Taper Phase|Overall Study||10
237030|NCT00922636|576008|P1|Entered Optional Taper Phase|Overall Study||4
237031|NCT00922636|576004|P5|STARTED|Overall Study||75
237032|NCT00922636|576005|P4|STARTED|Overall Study||75
237033|NCT00922636|576006|P3|STARTED|Overall Study||76
237034|NCT00922636|576007|P2|STARTED|Overall Study||78
237035|NCT00922636|576008|P1|STARTED|Overall Study||36
237036|NCT00922701|576155|P1|NOT COMPLETED|Overall Study||0
237037|NCT00922701|576155|P1|COMPLETED|Overall Study||4
237038|NCT00922701|576155|P1|STARTED|Overall Study||4
237039|NCT00922766|576159|P1|NOT COMPLETED|Overall Study||7
237040|NCT00922766|576159|P1|COMPLETED|Overall Study||610
237041|NCT00922766|576159|P1|STARTED|Overall Study||617
237042|NCT00922779|576168|P1|NOT COMPLETED|Overall Study||2327
237043|NCT00922779|576168|P1|COMPLETED|Overall Study||4334
237044|NCT00922779|576168|P1|STARTED|Overall Study||6661
237045|NCT00922935|576178|P3|NOT COMPLETED|Overall Study||0
237046|NCT00922935|576179|P2|NOT COMPLETED|Overall Study||5
237047|NCT00922935|576180|P1|NOT COMPLETED|Overall Study||1
237048|NCT00922935|576178|P3|COMPLETED|Overall Study||10
237049|NCT00922935|576179|P2|COMPLETED|Overall Study||11
237050|NCT00922935|576180|P1|COMPLETED|Overall Study||9
237051|NCT00922935|576178|P3|STARTED|Overall Study||10
237052|NCT00922935|576179|P2|STARTED|Overall Study||16
237053|NCT00922935|576180|P1|STARTED|Overall Study||10
237054|NCT00922987|576188|P1|NOT COMPLETED|Overall Study||4
237055|NCT00922987|576188|P1|COMPLETED|Overall Study||277
237056|NCT00922987|576188|P1|STARTED|Overall Study||281
237057|NCT00928668|576200|P5|NOT COMPLETED|Overall Study||1
237058|NCT00928668|576201|P4|NOT COMPLETED|Overall Study||1
237059|NCT00928668|576202|P3|NOT COMPLETED|Overall Study||1
237060|NCT00928668|576203|P2|NOT COMPLETED|Overall Study||1
237061|NCT00928668|576204|P1|NOT COMPLETED|Overall Study||1
237062|NCT00928668|576200|P5|COMPLETED|Overall Study||5
237063|NCT00928668|576201|P4|COMPLETED|Overall Study||3
237064|NCT00928668|576202|P3|COMPLETED|Overall Study||6
237065|NCT00928668|576203|P2|COMPLETED|Overall Study||6
237066|NCT00928668|576204|P1|COMPLETED|Overall Study||6
237067|NCT00928668|576200|P5|STARTED|Overall Study||6
237068|NCT00928668|576201|P4|STARTED|Overall Study||4
237069|NCT00928668|576202|P3|STARTED|Overall Study||7
237070|NCT00928668|576203|P2|STARTED|Overall Study||7
237071|NCT00928668|576204|P1|STARTED|Overall Study||7
237072|NCT00928694|576246|P2|NOT COMPLETED|Second Intervention||0
237073|NCT00928694|576247|P1|NOT COMPLETED|Second Intervention||0
237074|NCT00928694|576246|P2|COMPLETED|Second Intervention||7
237075|NCT00928694|576247|P1|COMPLETED|Second Intervention||7
237076|NCT00928694|576246|P2|STARTED|Second Intervention||7
237077|NCT00928694|576247|P1|STARTED|Second Intervention||7
237078|NCT00928694|576246|P2|NOT COMPLETED|First Intervention||0
237079|NCT00928694|576247|P1|NOT COMPLETED|First Intervention||0
237080|NCT00928694|576246|P2|COMPLETED|First Intervention||7
237081|NCT00928694|576247|P1|COMPLETED|First Intervention||7
237082|NCT00928694|576246|P2|STARTED|First Intervention||7
237083|NCT00928694|576247|P1|STARTED|First Intervention||7
237084|NCT00928720|576258|P3|NOT COMPLETED|Overall Study||3
237085|NCT00928720|576259|P2|NOT COMPLETED|Overall Study||6
237086|NCT00928720|576260|P1|NOT COMPLETED|Overall Study||2
237087|NCT00928720|576258|P3|COMPLETED|Overall Study||15
237088|NCT00928720|576259|P2|COMPLETED|Overall Study||14
237089|NCT00928720|576260|P1|COMPLETED|Overall Study||17
237090|NCT00928720|576258|P3|STARTED|Overall Study||18
237091|NCT00928720|576259|P2|STARTED|Overall Study||20
237092|NCT00928720|576260|P1|STARTED|Overall Study||19
237093|NCT00928746|576268|P1|NOT COMPLETED|Overall Study||6
237094|NCT00928746|576268|P1|COMPLETED|Overall Study||136
237095|NCT00928746|576268|P1|STARTED|Overall Study||142
237096|NCT00928772|576291|P3|NOT COMPLETED|Overall Study||0
237097|NCT00928772|576292|P2|NOT COMPLETED|Overall Study||0
237098|NCT00928772|576293|P1|NOT COMPLETED|Overall Study||0
237099|NCT00928772|576291|P3|COMPLETED|Overall Study||38
237100|NCT00928772|576292|P2|COMPLETED|Overall Study||38
237101|NCT00928772|576293|P1|COMPLETED|Overall Study||39
237102|NCT00928772|576291|P3|STARTED|Overall Study||38
237103|NCT00928772|576292|P2|STARTED|Overall Study||38
237104|NCT00928772|576293|P1|STARTED|Overall Study||39
237105|NCT00928889|576312|P2|NOT COMPLETED|Overall Study||2
237106|NCT00928889|576313|P1|NOT COMPLETED|Overall Study||5
237107|NCT00928889|576312|P2|COMPLETED|Overall Study||78
237108|NCT00928889|576313|P1|COMPLETED|Overall Study||75
237109|NCT00928889|576312|P2|STARTED|Overall Study||80
237110|NCT00928889|576313|P1|STARTED|Overall Study||80
237111|NCT00928954|576337|P2|NOT COMPLETED|Overall Study||0
237112|NCT00928954|576338|P1|NOT COMPLETED|Overall Study||0
237113|NCT00928954|576337|P2|COMPLETED|Overall Study||6
237114|NCT00928954|576338|P1|COMPLETED|Overall Study||4
237115|NCT00928954|576337|P2|STARTED|Overall Study||6
237116|NCT00928954|576338|P1|STARTED|Overall Study||4
237117|NCT00929331|576348|P2|NOT COMPLETED|Overall Study||0
237118|NCT00929331|576349|P1|NOT COMPLETED|Overall Study||0
237119|NCT00929331|576348|P2|COMPLETED|Overall Study||55
237120|NCT00929331|576349|P1|COMPLETED|Overall Study||55
237121|NCT00929331|576348|P2|STARTED|Overall Study||55
237122|NCT00929331|576349|P1|STARTED|Overall Study||55
237123|NCT00929344|576384|P3|NOT COMPLETED|Overall Study||21
237124|NCT00929344|576385|P2|NOT COMPLETED|Overall Study||13
237125|NCT00929344|576386|P1|NOT COMPLETED|Overall Study||22
237126|NCT00929344|576384|P3|COMPLETED|Overall Study||29
237127|NCT00929344|576385|P2|COMPLETED|Overall Study||37
237128|NCT00929344|576386|P1|COMPLETED|Overall Study||28
237129|NCT00929344|576384|P3|STARTED|Overall Study||50
237130|NCT00929344|576385|P2|STARTED|Overall Study||50
237131|NCT00929344|576386|P1|STARTED|Overall Study||50
237132|NCT00929357|576402|P2|NOT COMPLETED|Overall Study||0
237133|NCT00929357|576403|P1|NOT COMPLETED|Overall Study||0
237134|NCT00929357|576402|P2|COMPLETED|Overall Study||64
237135|NCT00929357|576403|P1|COMPLETED|Overall Study||92
237136|NCT00929357|576402|P2|STARTED|Overall Study||64
237137|NCT00929357|576403|P1|STARTED|Overall Study||92
237138|NCT00929383|576423|P1|NOT COMPLETED|Overall Study||15
237139|NCT00929383|576423|P1|COMPLETED|Overall Study||67
237140|NCT00929383|576423|P1|STARTED|Overall Study||82
237141|NCT00929474|576433|P2|NOT COMPLETED|Overall Study||9
237142|NCT00929474|576434|P1|NOT COMPLETED|Overall Study||8
237143|NCT00929474|576433|P2|COMPLETED|Overall Study||0
237144|NCT00929474|576434|P1|COMPLETED|Overall Study||0
237145|NCT00929474|576433|P2|STARTED|Overall Study||9
237146|NCT00929474|576434|P1|STARTED|Overall Study||8
237147|NCT00929526|576442|P2|NOT COMPLETED|Overall Study||29
237148|NCT00929526|576443|P1|NOT COMPLETED|Overall Study||17
237149|NCT00929526|576442|P2|COMPLETED|Overall Study||348
237150|NCT00929526|576443|P1|COMPLETED|Overall Study||358
237151|NCT00929526|576442|P2|STARTED|Overall Study||377
237152|NCT00929526|576443|P1|STARTED|Overall Study||375
237153|NCT00929578|576477|P1|NOT COMPLETED|Overall Study||0
237154|NCT00929578|576477|P1|COMPLETED|Overall Study||15
237155|NCT00929578|576477|P1|STARTED|Overall Study||15
237156|NCT00929643|576488|P1|NOT COMPLETED|Overall Study||2
237157|NCT00929643|576488|P1|COMPLETED|Overall Study||201
237158|NCT00929643|576488|P1|STARTED|Overall Study||203
237159|NCT00929656|576499|P2|NOT COMPLETED|Overall Study||1
237160|NCT00929656|576500|P1|NOT COMPLETED|Overall Study||0
237161|NCT00929656|576499|P2|COMPLETED|Overall Study||8
237162|NCT00929656|576500|P1|COMPLETED|Overall Study||13
237163|NCT00929656|576499|P2|STARTED|Overall Study||9
237164|NCT00929656|576500|P1|STARTED|Overall Study||13
237165|NCT00929695|576516|P2|NOT COMPLETED|Overall Study||6
237166|NCT00929695|576517|P1|NOT COMPLETED|Overall Study||8
237167|NCT00929695|576516|P2|COMPLETED|Overall Study||77
237168|NCT00929695|576517|P1|COMPLETED|Overall Study||73
237169|NCT00929695|576516|P2|STARTED|Overall Study||83
237170|NCT00929695|576517|P1|STARTED|Overall Study||81
237171|NCT00929708|576552|P5|NOT COMPLETED|Overall Study||6
237172|NCT00929708|576553|P4|NOT COMPLETED|Overall Study||6
237173|NCT00929708|576554|P3|NOT COMPLETED|Overall Study||3
237174|NCT00929708|576555|P2|NOT COMPLETED|Overall Study||3
237175|NCT00929708|576556|P1|NOT COMPLETED|Overall Study||4
237176|NCT00929708|576552|P5|COMPLETED|Overall Study||57
237177|NCT00929708|576553|P4|COMPLETED|Overall Study||61
237178|NCT00929708|576554|P3|COMPLETED|Overall Study||62
237179|NCT00929708|576555|P2|COMPLETED|Overall Study||66
237180|NCT00929708|576556|P1|COMPLETED|Overall Study||61
237181|NCT00929708|576552|P5|STARTED|Overall Study||63
237182|NCT00929708|576553|P4|STARTED|Overall Study||67
237183|NCT00929708|576554|P3|STARTED|Overall Study||65
237184|NCT00929708|576555|P2|STARTED|Overall Study||69
237185|NCT00929708|576556|P1|STARTED|Overall Study||65
237186|NCT00929734|576610|P2|NOT COMPLETED|Overall Study||3
237187|NCT00929734|576611|P1|NOT COMPLETED|Overall Study||2
237188|NCT00929734|576610|P2|COMPLETED|Overall Study||47
237189|NCT00929734|576611|P1|COMPLETED|Overall Study||47
237190|NCT00929734|576610|P2|STARTED|Overall Study||50
237191|NCT00929734|576611|P1|STARTED|Overall Study||49
237192|NCT00929773|576625|P2|NOT COMPLETED|Overall Study||0
237193|NCT00929773|576626|P1|NOT COMPLETED|Overall Study||0
237194|NCT00929773|576625|P2|COMPLETED|Overall Study||50
237195|NCT00929773|576626|P1|COMPLETED|Overall Study||50
237196|NCT00929773|576625|P2|STARTED|Overall Study||50
237197|NCT00929773|576626|P1|STARTED|Overall Study||50
237198|NCT00929864|576644|P2|NOT COMPLETED|Overall Study||83
237199|NCT00929864|576645|P1|NOT COMPLETED|Overall Study||66
237200|NCT00929864|576644|P2|COMPLETED|Overall Study||245
237201|NCT00929864|576645|P1|COMPLETED|Overall Study||252
237202|NCT00929864|576644|P2|STARTED|Overall Study||328
237203|NCT00929864|576645|P1|STARTED|Overall Study||318
237204|NCT00929981|576663|P1|NOT COMPLETED|Overall Study||0
237205|NCT00929981|576663|P1|COMPLETED|Overall Study||80
237206|NCT00929981|576663|P1|STARTED|Overall Study||80
237207|NCT00930176|576673|P1|NOT COMPLETED|Overall Study||1
237208|NCT00930176|576673|P1|COMPLETED|Overall Study||15
237209|NCT00930176|576673|P1|STARTED|Overall Study||16
237210|NCT00930293|576680|P2|NOT COMPLETED|Overall Study||7
237211|NCT00930293|576681|P1|NOT COMPLETED|Overall Study||7
237212|NCT00930293|576680|P2|COMPLETED|Overall Study||19
237213|NCT00930293|576681|P1|COMPLETED|Overall Study||17
237214|NCT00930293|576680|P2|STARTED|Overall Study||26
237215|NCT00930293|576681|P1|STARTED|Overall Study||24
237216|NCT00930553|576689|P1|NOT COMPLETED|Overall Study||223
237217|NCT00930553|576689|P1|COMPLETED|Overall Study||1091
237218|NCT00930553|576689|P1|Participants Entered From CAMMS324|Overall Study||685
237219|NCT00930553|576689|P1|Participants Entered From CAMMS323|Overall Study||488
237220|NCT00930553|576689|P1|Participants Entered From CAMMS223|Overall Study||141
237221|NCT00930553|576689|P1|STARTED|Overall Study||1314
237222|NCT00930644|576755|P1|NOT COMPLETED|Overall Study||23
237223|NCT00930644|576755|P1|COMPLETED|Overall Study||65
237224|NCT00930644|576755|P1|STARTED|Overall Study||88
237225|NCT00930722|576768|P1|NOT COMPLETED|Overall Study||27
237226|NCT00930722|576768|P1|COMPLETED|Overall Study||302
237227|NCT00930722|576768|P1|STARTED|Overall Study||329
237228|NCT00930761|576785|P2|NOT COMPLETED|Overall Study||3
237229|NCT00930761|576786|P1|NOT COMPLETED|Overall Study||4
237230|NCT00930761|576785|P2|COMPLETED|Overall Study||48
237231|NCT00930761|576786|P1|COMPLETED|Overall Study||46
237232|NCT00930761|576785|P2|STARTED|Overall Study||51
237233|NCT00930761|576786|P1|STARTED|Overall Study||50
237234|NCT00930774|576802|P4|NOT COMPLETED|Overall Study||0
237235|NCT00930774|576803|P3|NOT COMPLETED|Overall Study||2
237236|NCT00930774|576804|P2|NOT COMPLETED|Overall Study||9
237237|NCT00930774|576805|P1|NOT COMPLETED|Overall Study||1
237238|NCT00930774|576802|P4|COMPLETED|Overall Study||25
237239|NCT00930774|576803|P3|COMPLETED|Overall Study||22
237240|NCT00930774|576804|P2|COMPLETED|Overall Study||16
237241|NCT00930774|576805|P1|COMPLETED|Overall Study||24
237242|NCT00930774|576802|P4|STARTED|Overall Study||25
237243|NCT00930774|576803|P3|STARTED|Overall Study||24
237244|NCT00930774|576804|P2|STARTED|Overall Study||25
237245|NCT00930774|576805|P1|STARTED|Overall Study||25
237246|NCT00930787|576845|P2|NOT COMPLETED|Overall Study||0
237247|NCT00930787|576846|P1|NOT COMPLETED|Overall Study||0
237248|NCT00930787|576845|P2|COMPLETED|Overall Study||9
237249|NCT00930787|576846|P1|COMPLETED|Overall Study||14
237250|NCT00930787|576845|P2|STARTED|Overall Study||9
237251|NCT00930787|576846|P1|STARTED|Overall Study||14
237252|NCT00930813|576854|P2|NOT COMPLETED|Overall Study||14
237253|NCT00930813|576855|P1|NOT COMPLETED|Overall Study||8
237254|NCT00930813|576854|P2|COMPLETED|Overall Study||38
237255|NCT00930813|576855|P1|COMPLETED|Overall Study||41
237256|NCT00930813|576854|P2|STARTED|Overall Study||52
237257|NCT00930813|576855|P1|STARTED|Overall Study||49
237258|NCT00930930|576865|P2|NOT COMPLETED|Overall Study||9
237259|NCT00930930|576866|P1|NOT COMPLETED|Overall Study||21
237260|NCT00930930|576865|P2|COMPLETED|Overall Study||40
237261|NCT00930930|576866|P1|COMPLETED|Overall Study||75
237262|NCT00930930|576865|P2|STARTED|Overall Study||49
237263|NCT00930930|576866|P1|STARTED|Overall Study||96
237264|NCT00930969|576878|P1|NOT COMPLETED|Overall Study||38
237265|NCT00930969|576878|P1|COMPLETED|Overall Study||137
237266|NCT00930969|576878|P1|STARTED|Overall Study||175
237267|NCT00930982|576888|P2|NOT COMPLETED|Overall Study||29
237268|NCT00930982|576889|P1|NOT COMPLETED|Overall Study||21
237269|NCT00930982|576888|P2|COMPLETED|Overall Study||35
237270|NCT00930982|576889|P1|COMPLETED|Overall Study||39
237271|NCT00930982|576888|P2|STARTED|Overall Study||64
237272|NCT00930982|576889|P1|STARTED|Overall Study||60
237273|NCT00931164|576923|P1|NOT COMPLETED|Overall Study||0
237274|NCT00931164|576923|P1|COMPLETED|Overall Study||6
237275|NCT00931164|576923|P1|STARTED|Overall Study||6
237276|NCT00931242|576929|P2|NOT COMPLETED|Overall Study||2
237277|NCT00931242|576930|P1|NOT COMPLETED|Overall Study||5
237278|NCT00931242|576929|P2|COMPLETED|Overall Study||0
237279|NCT00931242|576930|P1|COMPLETED|Overall Study||5
237280|NCT00931242|576929|P2|STARTED|Overall Study||2
237281|NCT00931242|576930|P1|STARTED|Overall Study||10
237282|NCT00931268|576936|P1|NOT COMPLETED|Overall Study||6
237283|NCT00931268|576936|P1|COMPLETED|Overall Study||4
237284|NCT00931268|576936|P1|STARTED|Overall Study||10
237285|NCT00931307|576946|P1|NOT COMPLETED|Overall Study||13
237286|NCT00931307|576946|P1|COMPLETED|Overall Study||9
237287|NCT00931307|576946|P1|STARTED|Overall Study||22
237288|NCT00931359|576952|P2|NOT COMPLETED|Overall Study||13
237289|NCT00931359|576953|P1|NOT COMPLETED|Overall Study||6
237290|NCT00931359|576952|P2|COMPLETED|Overall Study||68
237291|NCT00931359|576953|P1|COMPLETED|Overall Study||33
237292|NCT00931359|576952|P2|STARTED|Overall Study||81
237293|NCT00931359|576953|P1|STARTED|Overall Study||39
237294|NCT00931385|576965|P4|NOT COMPLETED|Overall Study||5
237295|NCT00931385|576966|P3|NOT COMPLETED|Overall Study||1
237296|NCT00931385|576967|P2|NOT COMPLETED|Overall Study||2
237297|NCT00931385|576968|P1|NOT COMPLETED|Overall Study||2
237298|NCT00931385|576965|P4|COMPLETED|Overall Study||21
237299|NCT00931385|576966|P3|COMPLETED|Overall Study||24
237300|NCT00931385|576967|P2|COMPLETED|Overall Study||21
237301|NCT00931385|576968|P1|COMPLETED|Overall Study||23
237302|NCT00931385|576965|P4|STARTED|Overall Study||26
237303|NCT00931385|576966|P3|STARTED|Overall Study||25
237304|NCT00931385|576967|P2|STARTED|Overall Study||23
237305|NCT00931385|576968|P1|STARTED|Overall Study||25
237306|NCT00931411|577024|P2|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||1
237307|NCT00931411|577025|P1|NOT COMPLETED|After Crossover - 14 Days (up to Day 56)||0
237308|NCT00931411|577024|P2|COMPLETED|After Crossover - 14 Days (up to Day 56)||34
237309|NCT00931411|577025|P1|COMPLETED|After Crossover - 14 Days (up to Day 56)||31
237310|NCT00931411|577024|P2|STARTED|After Crossover - 14 Days (up to Day 56)||35
237311|NCT00931411|577025|P1|STARTED|After Crossover - 14 Days (up to Day 56)||31
237312|NCT00931411|577024|P2|NOT COMPLETED|First Intervention - 42 Days||3
237313|NCT00931411|577025|P1|NOT COMPLETED|First Intervention - 42 Days||4
237314|NCT00931411|577024|P2|COMPLETED|First Intervention - 42 Days||35
237315|NCT00931411|577025|P1|COMPLETED|First Intervention - 42 Days||31
237316|NCT00931411|577024|P2|STARTED|First Intervention - 42 Days||38
237317|NCT00931411|577025|P1|STARTED|First Intervention - 42 Days||35
237318|NCT00931463|577048|P2|NOT COMPLETED|Overall Study||5
237319|NCT00931463|577049|P1|NOT COMPLETED|Overall Study||17
237320|NCT00931463|577048|P2|COMPLETED|Overall Study||265
237321|NCT00931463|577049|P1|COMPLETED|Overall Study||254
237322|NCT00931463|577048|P2|STARTED|Overall Study||270
237323|NCT00931463|577049|P1|STARTED|Overall Study||271
237324|NCT00931489|577068|P5|NOT COMPLETED|Overall Study||0
237325|NCT00931489|577069|P4|NOT COMPLETED|Overall Study||0
237326|NCT00931489|577070|P3|NOT COMPLETED|Overall Study||0
237327|NCT00931489|577071|P2|NOT COMPLETED|Overall Study||0
237328|NCT00931489|577072|P1|NOT COMPLETED|Overall Study||0
237329|NCT00931489|577068|P5|COMPLETED|Overall Study||7
237330|NCT00931489|577069|P4|COMPLETED|Overall Study||39
237331|NCT00931489|577070|P3|COMPLETED|Overall Study|3 subjects enrolled in Group 1 (responders) were moved to Group 3 (non-responders)|5
237332|NCT00931489|577071|P2|COMPLETED|Overall Study||40
237333|NCT00931489|577072|P1|COMPLETED|Overall Study||40
237334|NCT00931489|577068|P5|STARTED|Overall Study||7
237335|NCT00931489|577069|P4|STARTED|Overall Study||39
237336|NCT00931489|577070|P3|STARTED|Overall Study||5
237337|NCT00931489|577071|P2|STARTED|Overall Study||40
237338|NCT00931489|577072|P1|STARTED|Overall Study||40
237339|NCT00931515|577087|P2|NOT COMPLETED|Overall Study||5
237340|NCT00931515|577088|P1|NOT COMPLETED|Overall Study||2
237341|NCT00931515|577087|P2|COMPLETED|Overall Study||10
237342|NCT00931515|577088|P1|COMPLETED|Overall Study||13
237343|NCT00931515|577087|P2|STARTED|Overall Study||15
237344|NCT00931515|577088|P1|STARTED|Overall Study||15
237345|NCT00931528|577096|P2|NOT COMPLETED|Overall Study||60
237346|NCT00931528|577097|P1|NOT COMPLETED|Overall Study||41
237347|NCT00931528|577096|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|61
237348|NCT00931528|577097|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|80
237349|NCT00931528|577096|P2|STARTED|Overall Study||121
237350|NCT00931528|577097|P1|STARTED|Overall Study||121
237351|NCT00931632|577105|P2|NOT COMPLETED|Overall Study||18
237352|NCT00931632|577106|P1|NOT COMPLETED|Overall Study||21
237353|NCT00931632|577105|P2|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|204
237354|NCT00931632|577106|P1|COMPLETED|Overall Study|Completed at 36 weeks Postmenstrual Age (PMA)|208
237355|NCT00931632|577105|P2|STARTED|Overall Study|Randomized|222
237356|NCT00931632|577106|P1|STARTED|Overall Study|Randomized|229
237357|NCT00931710|577114|P2|NOT COMPLETED|Overall Study||38
237358|NCT00931710|577115|P1|NOT COMPLETED|Overall Study||34
237359|NCT00931710|577114|P2|COMPLETED|Overall Study||209
237360|NCT00931710|577115|P1|COMPLETED|Overall Study||207
237361|NCT00931710|577114|P2|STARTED|Overall Study||247
237362|NCT00931710|577115|P1|STARTED|Overall Study||241
237363|NCT00931723|577133|P2|NOT COMPLETED|Overall Study||39
237364|NCT00931723|577134|P1|NOT COMPLETED|Overall Study||26
237365|NCT00931723|577133|P2|COMPLETED|Overall Study||144
237366|NCT00931723|577134|P1|COMPLETED|Overall Study||147
237367|NCT00931723|577133|P2|STARTED|Overall Study||183
237368|NCT00931723|577134|P1|STARTED|Overall Study||173
237369|NCT00931801|577183|P3|NOT COMPLETED|Overall Study||4
237370|NCT00931801|577184|P2|NOT COMPLETED|Overall Study||1
237371|NCT00931801|577185|P1|NOT COMPLETED|Overall Study||1
237372|NCT00931801|577183|P3|COMPLETED|Overall Study||10
237373|NCT00931801|577184|P2|COMPLETED|Overall Study||14
237374|NCT00931801|577185|P1|COMPLETED|Overall Study||13
237375|NCT00931801|577183|P3|STARTED|Overall Study||14
237376|NCT00931801|577184|P2|STARTED|Overall Study||15
237377|NCT00931801|577185|P1|STARTED|Overall Study||14
237378|NCT00925990|577208|P2|NOT COMPLETED|Overall Study||11
237379|NCT00925990|577209|P1|NOT COMPLETED|Overall Study||5
237380|NCT00925990|577208|P2|COMPLETED|Overall Study||24
237381|NCT00925990|577209|P1|COMPLETED|Overall Study||30
237382|NCT00925990|577208|P2|STARTED|Overall Study||35
237383|NCT00925990|577209|P1|STARTED|Overall Study||35
237384|NCT00926029|577220|P3|NOT COMPLETED|Overall Study||1
237385|NCT00926029|577221|P2|NOT COMPLETED|Overall Study||1
237386|NCT00926029|577222|P1|NOT COMPLETED|Overall Study||2
237387|NCT00926029|577220|P3|COMPLETED|Overall Study||33
237388|NCT00926029|577221|P2|COMPLETED|Overall Study||33
237389|NCT00926029|577222|P1|COMPLETED|Overall Study||32
237390|NCT00926029|577220|P3|STARTED|Overall Study||34
237391|NCT00926029|577221|P2|STARTED|Overall Study||34
237392|NCT00926029|577222|P1|STARTED|Overall Study||34
237393|NCT00931879|577235|P2|NOT COMPLETED|Overall Study||3
237394|NCT00931879|577236|P1|NOT COMPLETED|Overall Study||3
237395|NCT00931879|577235|P2|COMPLETED|Overall Study||19
237396|NCT00931879|577236|P1|COMPLETED|Overall Study||19
237397|NCT00931879|577235|P2|STARTED|Overall Study||22
237398|NCT00931879|577236|P1|STARTED|Overall Study||22
237399|NCT00931918|577260|P2|NOT COMPLETED|Overall Study||17
237400|NCT00931918|577261|P1|NOT COMPLETED|Overall Study||17
237401|NCT00931918|577260|P2|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
237402|NCT00931918|577261|P1|COMPLETED|Overall Study|Completed the maximum of 6 cycles.|86
237403|NCT00931918|577260|P2|Safety Population: Received Study Drug|Overall Study||101
237404|NCT00931918|577261|P1|Safety Population: Received Study Drug|Overall Study||100
237405|NCT00931918|577260|P2|STARTED|Overall Study||103
237406|NCT00931918|577261|P1|STARTED|Overall Study||103
237407|NCT00931996|577285|P1|NOT COMPLETED|Overall Study||7
237408|NCT00931996|577285|P1|COMPLETED|Overall Study||5
237409|NCT00931996|577285|P1|STARTED|Overall Study||12
237410|NCT00932022|577291|P2|NOT COMPLETED|Overall Study||4
237411|NCT00932022|577292|P1|NOT COMPLETED|Overall Study||5
237412|NCT00932022|577291|P2|COMPLETED|Overall Study||59
237413|NCT00932022|577292|P1|COMPLETED|Overall Study||59
237414|NCT00932022|577291|P2|STARTED|Overall Study||63
237415|NCT00932022|577292|P1|STARTED|Overall Study||64
237416|NCT00932035|577308|P2|NOT COMPLETED|Overall Study||0
237417|NCT00932035|577309|P1|NOT COMPLETED|Overall Study||0
237418|NCT00932035|577308|P2|COMPLETED|Overall Study||21
237419|NCT00932035|577309|P1|COMPLETED|Overall Study||18
237420|NCT00932035|577308|P2|STARTED|Overall Study||21
237421|NCT00932035|577309|P1|STARTED|Overall Study||18
237422|NCT00932113|577321|P2|NOT COMPLETED|Overall Study||0
237423|NCT00932113|577322|P1|NOT COMPLETED|Overall Study||1
237424|NCT00932113|577321|P2|COMPLETED|Overall Study||15
237425|NCT00932113|577322|P1|COMPLETED|Overall Study||14
237426|NCT00932113|577321|P2|STARTED|Overall Study||15
237427|NCT00932113|577322|P1|STARTED|Overall Study||15
237428|NCT00932126|577338|P8|NOT COMPLETED|Overall Study||10
237429|NCT00932126|577339|P7|NOT COMPLETED|Overall Study||5
237430|NCT00932126|577340|P6|NOT COMPLETED|Overall Study||3
237431|NCT00932126|577341|P5|NOT COMPLETED|Overall Study||5
237432|NCT00932126|577342|P4|NOT COMPLETED|Overall Study||3
237433|NCT00932126|577343|P3|NOT COMPLETED|Overall Study||3
237434|NCT00932126|577344|P2|NOT COMPLETED|Overall Study||3
237435|NCT00932126|577345|P1|NOT COMPLETED|Overall Study||3
237436|NCT00932126|577338|P8|COMPLETED|Overall Study||0
237437|NCT00932126|577339|P7|COMPLETED|Overall Study||0
237438|NCT00932126|577340|P6|COMPLETED|Overall Study||0
237439|NCT00932126|577341|P5|COMPLETED|Overall Study||0
237440|NCT00932126|577342|P4|COMPLETED|Overall Study||0
237441|NCT00932126|577343|P3|COMPLETED|Overall Study||0
237442|NCT00932126|577344|P2|COMPLETED|Overall Study||0
237443|NCT00932126|577345|P1|COMPLETED|Overall Study||0
237444|NCT00932126|577338|P8|STARTED|Overall Study||10
237445|NCT00932126|577339|P7|STARTED|Overall Study||5
237446|NCT00932126|577340|P6|STARTED|Overall Study||3
237447|NCT00932126|577341|P5|STARTED|Overall Study||5
237448|NCT00932126|577342|P4|STARTED|Overall Study||3
237449|NCT00932126|577343|P3|STARTED|Overall Study||3
237450|NCT00932126|577344|P2|STARTED|Overall Study||3
237451|NCT00932126|577345|P1|STARTED|Overall Study||3
237452|NCT00932152|577383|P2|NOT COMPLETED|Overall Study||2
237453|NCT00932152|577384|P1|NOT COMPLETED|Overall Study||1
237454|NCT00932152|577383|P2|COMPLETED|Overall Study||0
237455|NCT00932152|577384|P1|COMPLETED|Overall Study||0
237456|NCT00932152|577383|P2|STARTED|Overall Study||2
237457|NCT00932152|577384|P1|STARTED|Overall Study||1
237458|NCT00932165|577388|P1|NOT COMPLETED|Overall Study||1
237459|NCT00932165|577388|P1|COMPLETED|Overall Study||450
237460|NCT00932165|577388|P1|STARTED|Overall Study||451
237461|NCT00935649|577399|P1|NOT COMPLETED|Overall Study||5
237462|NCT00935649|577399|P1|COMPLETED|Overall Study||134
237463|NCT00935649|577399|P1|STARTED|Overall Study||139
237464|NCT00935701|577407|P1|NOT COMPLETED|Overall Study||1
237465|NCT00935701|577407|P1|COMPLETED|Overall Study||9
237466|NCT00935701|577407|P1|Transition Acupressure to Acupuncture|Overall Study||9
237467|NCT00935701|577407|P1|STARTED|Overall Study||10
237468|NCT00935766|577416|P2|NOT COMPLETED|Overall Study||7
237469|NCT00935766|577417|P1|NOT COMPLETED|Overall Study||7
237470|NCT00935766|577416|P2|COMPLETED|Overall Study||27
237471|NCT00935766|577417|P1|COMPLETED|Overall Study||35
237472|NCT00935766|577416|P2|STARTED|Overall Study||34
237473|NCT00935766|577417|P1|STARTED|Overall Study||42
237474|NCT00935792|577430|P3|NOT COMPLETED|Overall Study||0
237475|NCT00935792|577431|P2|NOT COMPLETED|Overall Study||3
237476|NCT00935792|577432|P1|NOT COMPLETED|Overall Study||1
237477|NCT00935792|577430|P3|COMPLETED|Overall Study||12
237478|NCT00935792|577431|P2|COMPLETED|Overall Study||6
237479|NCT00935792|577432|P1|COMPLETED|Overall Study||6
237480|NCT00935792|577430|P3|STARTED|Overall Study||12
237481|NCT00935792|577431|P2|STARTED|Overall Study||9
237482|NCT00935792|577432|P1|STARTED|Overall Study||7
237483|NCT00935818|577449|P2|NOT COMPLETED|Overall Study||100
237484|NCT00935818|577450|P1|NOT COMPLETED|Overall Study||91
237485|NCT00935818|577449|P2|COMPLETED|Overall Study||157
237486|NCT00935818|577450|P1|COMPLETED|Overall Study||158
237487|NCT00935818|577449|P2|End of Medication Phase|Overall Study||184
237488|NCT00935818|577450|P1|End of Medication Phase|Overall Study||182
237489|NCT00935818|577449|P2|STARTED|Overall Study||257
237490|NCT00935818|577450|P1|STARTED|Overall Study||249
237491|NCT00935857|577470|P2|NOT COMPLETED|Overall Study||0
237492|NCT00935857|577471|P1|NOT COMPLETED|Overall Study||0
237493|NCT00935857|577470|P2|COMPLETED|Overall Study||16
237494|NCT00935857|577471|P1|COMPLETED|Overall Study||14
237495|NCT00935857|577470|P2|STARTED|Overall Study||16
237496|NCT00935857|577471|P1|STARTED|Overall Study||14
237497|NCT00935883|577483|P2|NOT COMPLETED|Follow-Up Period||0
237498|NCT00935883|577484|P1|NOT COMPLETED|Follow-Up Period||0
237499|NCT00935883|577483|P2|COMPLETED|Follow-Up Period||38
237500|NCT00935883|577484|P1|COMPLETED|Follow-Up Period||19
237501|NCT00935883|577483|P2|STARTED|Follow-Up Period||38
237502|NCT00935883|577484|P1|STARTED|Follow-Up Period||19
237503|NCT00935883|577483|P2|NOT COMPLETED|Treatment Period||2
237504|NCT00935883|577484|P1|NOT COMPLETED|Treatment Period||1
237505|NCT00935883|577483|P2|COMPLETED|Treatment Period||38
237506|NCT00935883|577484|P1|COMPLETED|Treatment Period||19
237507|NCT00935883|577483|P2|STARTED|Treatment Period||40
237508|NCT00935883|577484|P1|STARTED|Treatment Period||20
237509|NCT00936065|577499|P3|NOT COMPLETED|Overall Study||7
237510|NCT00936065|577500|P2|NOT COMPLETED|Overall Study||4
237511|NCT00936065|577501|P1|NOT COMPLETED|Overall Study||4
237512|NCT00936065|577499|P3|COMPLETED|Overall Study||12
237513|NCT00936065|577500|P2|COMPLETED|Overall Study||16
237514|NCT00936065|577501|P1|COMPLETED|Overall Study||17
237515|NCT00936065|577499|P3|Study Assessments Performed|Overall Study||18
237516|NCT00936065|577500|P2|Study Assessments Performed|Overall Study||19
237517|NCT00936065|577501|P1|Study Assessments Performed|Overall Study||21
237518|NCT00936065|577499|P3|Received Treatment|Overall Study||18
237519|NCT00936065|577500|P2|Received Treatment|Overall Study||20
237520|NCT00936065|577501|P1|Received Treatment|Overall Study||21
237521|NCT00936065|577499|P3|STARTED|Overall Study||19
237522|NCT00936065|577500|P2|STARTED|Overall Study||20
237523|NCT00936065|577501|P1|STARTED|Overall Study||21
237524|NCT00936117|577605|P1|NOT COMPLETED|Overall Study||10
237525|NCT00936117|577605|P1|COMPLETED|Overall Study|Completed 42 days on study drug|10
237526|NCT00936117|577605|P1|STARTED|Overall Study||20
237527|NCT00936208|577612|P2|NOT COMPLETED|Overall Study||22
237528|NCT00936208|577613|P1|NOT COMPLETED|Overall Study||37
237529|NCT00936208|577612|P2|COMPLETED|Overall Study||1574
237530|NCT00936208|577613|P1|COMPLETED|Overall Study||1462
237531|NCT00936208|577612|P2|STARTED|Overall Study||1596
237532|NCT00936208|577613|P1|STARTED|Overall Study||1499
237533|NCT00936221|577633|P2|NOT COMPLETED|Overall Study||1
237534|NCT00936221|577634|P1|NOT COMPLETED|Overall Study||1
237535|NCT00936221|577633|P2|COMPLETED|Overall Study|10 patients ongoing at data cutoff + 35 patients who had died.|45
237536|NCT00936221|577634|P1|COMPLETED|Overall Study|13 patients ongoing cutoff + 31 patients who had died.|44
237537|NCT00936221|577633|P2|Received Treatment|Overall Study||45
237538|NCT00936221|577634|P1|Received Treatment|Overall Study||44
237539|NCT00936221|577633|P2|STARTED|Overall Study||46
237540|NCT00936221|577634|P1|STARTED|Overall Study||45
237541|NCT00936351|577648|P2|NOT COMPLETED|Overall Study||2
237542|NCT00936351|577649|P1|NOT COMPLETED|Overall Study||3
237543|NCT00936351|577648|P2|COMPLETED|Overall Study||14
237544|NCT00936351|577649|P1|COMPLETED|Overall Study||15
237545|NCT00936351|577648|P2|STARTED|Overall Study||16
237546|NCT00936351|577649|P1|STARTED|Overall Study||18
237547|NCT00936377|577662|P3|NOT COMPLETED|Overall Study||0
237548|NCT00936377|577663|P2|NOT COMPLETED|Overall Study||0
237549|NCT00936377|577664|P1|NOT COMPLETED|Overall Study||0
237550|NCT00936377|577662|P3|COMPLETED|Overall Study||8
237551|NCT00936377|577663|P2|COMPLETED|Overall Study||8
237552|NCT00936377|577664|P1|COMPLETED|Overall Study||8
237553|NCT00936377|577662|P3|STARTED|Overall Study||8
237554|NCT00936377|577663|P2|STARTED|Overall Study||8
237555|NCT00936377|577664|P1|STARTED|Overall Study||8
237556|NCT00936455|577695|P2|NOT COMPLETED|Overall Study||0
237557|NCT00936455|577696|P1|NOT COMPLETED|Overall Study||0
237558|NCT00936455|577695|P2|COMPLETED|Overall Study||38
237559|NCT00936455|577696|P1|COMPLETED|Overall Study||37
237560|NCT00936455|577695|P2|STARTED|Overall Study||38
237561|NCT00936455|577696|P1|STARTED|Overall Study||37
237562|NCT00936481|577710|P2|NOT COMPLETED|Overall Study||0
237563|NCT00936481|577711|P1|NOT COMPLETED|Overall Study||0
237564|NCT00936481|577710|P2|COMPLETED|Overall Study||17
237565|NCT00936481|577711|P1|COMPLETED|Overall Study||17
237566|NCT00936481|577710|P2|STARTED|Overall Study||17
237567|NCT00936481|577711|P1|STARTED|Overall Study||17
237568|NCT00936585|577719|P1|NOT COMPLETED|Overall Study||0
237569|NCT00936585|577719|P1|COMPLETED|Overall Study||2
237570|NCT00936585|577719|P1|STARTED|Overall Study||2
237571|NCT00936598|577725|P2|NOT COMPLETED|Overall Study||0
237572|NCT00936598|577726|P1|NOT COMPLETED|Overall Study||2
237573|NCT00936598|577725|P2|COMPLETED|Overall Study||1
237574|NCT00936598|577726|P1|COMPLETED|Overall Study||2
237575|NCT00936598|577725|P2|STARTED|Overall Study||1
237576|NCT00936598|577726|P1|STARTED|Overall Study||4
237577|NCT00936702|577736|P1|NOT COMPLETED|Overall Study||46
237578|NCT00936702|577736|P1|COMPLETED|Overall Study||0
237579|NCT00936702|577736|P1|STARTED|Overall Study||46
237580|NCT00936715|577744|P1|NOT COMPLETED|Overall Study||6
237581|NCT00936715|577744|P1|COMPLETED|Overall Study||18
237582|NCT00936715|577744|P1|STARTED|Overall Study||24
237583|NCT00936741|577748|P1|NOT COMPLETED|Overall Study||9
237584|NCT00936741|577748|P1|COMPLETED|Overall Study||21
237585|NCT00936741|577748|P1|STARTED|Overall Study||30
237586|NCT00936897|577755|P2|NOT COMPLETED|Overall Study||60
237587|NCT00936897|577756|P1|NOT COMPLETED|Overall Study||19
237588|NCT00936897|577755|P2|COMPLETED|Overall Study||356
237589|NCT00936897|577756|P1|COMPLETED|Overall Study||398
237590|NCT00936897|577755|P2|STARTED|Overall Study|Randomized|416
237591|NCT00936897|577756|P1|STARTED|Overall Study|Randomized|417
237592|NCT00936975|577768|P1|NOT COMPLETED|Overall Study||6
237593|NCT00936975|577768|P1|COMPLETED|Overall Study||12
237594|NCT00936975|577768|P1|STARTED|Overall Study||18
237595|NCT00937040|577779|P2|NOT COMPLETED|Overall Study||37
237596|NCT00937040|577780|P1|NOT COMPLETED|Overall Study||41
237597|NCT00937040|577779|P2|COMPLETED|Overall Study||141
237598|NCT00937040|577780|P1|COMPLETED|Overall Study||138
237599|NCT00937040|577779|P2|STARTED|Overall Study||178
237600|NCT00937040|577780|P1|STARTED|Overall Study||179
237601|NCT00937105|577824|P2|NOT COMPLETED|Overall Study||39
237602|NCT00937105|577825|P1|NOT COMPLETED|Overall Study||40
237603|NCT00937105|577824|P2|COMPLETED|Overall Study||70
237604|NCT00937105|577825|P1|COMPLETED|Overall Study||69
237605|NCT00937105|577824|P2|STARTED|Overall Study||109
237606|NCT00937105|577825|P1|STARTED|Overall Study||109
237607|NCT00937118|577840|P1|NOT COMPLETED|Overall Study||0
237608|NCT00937118|577840|P1|COMPLETED|Overall Study||41
237609|NCT00937118|577840|P1|STARTED|Overall Study||41
237610|NCT00937157|577847|P1|NOT COMPLETED|Overall Study||4
237611|NCT00937157|577847|P1|COMPLETED|Overall Study||8
237612|NCT00937157|577847|P1|STARTED|Overall Study||12
237613|NCT00937391|577853|P1|NOT COMPLETED|Stage 2||1
237614|NCT00937391|577853|P1|COMPLETED|Stage 2|The number completed includes participants within the FAS and Per Protocol Set (PPS)|33
237615|NCT00937391|577853|P1|Treated|Stage 2|Valid for Full Analysis Set; participants administered correct Magnevist dose based on body weight|34
237616|NCT00937391|577853|P1|STARTED|Stage 2|Stage 1 and Stage 2 are independent each enrolling a different set of participants|34
237617|NCT00937391|577853|P1|NOT COMPLETED|Stage 1||0
237618|NCT00937391|577853|P1|COMPLETED|Stage 1||20
237619|NCT00937391|577853|P1|Treated|Stage 1|Valid for Full Analysis Set (FAS); includes all participants administered Magnevist Injection|20
237620|NCT00937391|577853|P1|STARTED|Stage 1||20
237621|NCT00937495|577904|P1|NOT COMPLETED|Overall Study||2
237622|NCT00937495|577904|P1|COMPLETED|Overall Study||14
237623|NCT00937495|577904|P1|STARTED|Overall Study||16
237624|NCT00937521|577918|P8|NOT COMPLETED|Booster Phase||2
237625|NCT00937521|577919|P7|NOT COMPLETED|Booster Phase||5
237626|NCT00937521|577920|P6|NOT COMPLETED|Booster Phase||5
237627|NCT00937521|577921|P5|NOT COMPLETED|Booster Phase||5
237628|NCT00937521|577922|P4|NOT COMPLETED|Booster Phase||3
237629|NCT00937521|577923|P3|NOT COMPLETED|Booster Phase||5
237630|NCT00937521|577924|P2|NOT COMPLETED|Booster Phase||2
237631|NCT00937521|577925|P1|NOT COMPLETED|Booster Phase||3
237632|NCT00937521|577918|P8|COMPLETED|Booster Phase||159
237633|NCT00937521|577919|P7|COMPLETED|Booster Phase||160
237634|NCT00937521|577920|P6|COMPLETED|Booster Phase||160
237635|NCT00937521|577921|P5|COMPLETED|Booster Phase||163
237636|NCT00937521|577922|P4|COMPLETED|Booster Phase||167
237637|NCT00937521|577923|P3|COMPLETED|Booster Phase||164
237638|NCT00937521|577924|P2|COMPLETED|Booster Phase||161
237639|NCT00937521|577925|P1|COMPLETED|Booster Phase||152
237640|NCT00937521|577918|P8|Premature Withdrawal|Booster Phase||2
237641|NCT00937521|577919|P7|Premature Withdrawal|Booster Phase||5
237642|NCT00937521|577920|P6|Premature Withdrawal|Booster Phase||5
237643|NCT00937521|577921|P5|Premature Withdrawal|Booster Phase||5
237644|NCT00937521|577922|P4|Premature Withdrawal|Booster Phase||3
237645|NCT00937521|577923|P3|Premature Withdrawal|Booster Phase||5
237646|NCT00937521|577924|P2|Premature Withdrawal|Booster Phase||2
237647|NCT00937521|577925|P1|Premature Withdrawal|Booster Phase||3
237648|NCT00937521|577918|P8|STARTED|Booster Phase||161
237649|NCT00937521|577919|P7|STARTED|Booster Phase||165
237650|NCT00937521|577920|P6|STARTED|Booster Phase||165
237651|NCT00937521|577921|P5|STARTED|Booster Phase||168
237652|NCT00937521|577922|P4|STARTED|Booster Phase||170
237653|NCT00937521|577923|P3|STARTED|Booster Phase||169
237654|NCT00937521|577924|P2|STARTED|Booster Phase||163
237655|NCT00937521|577925|P1|STARTED|Booster Phase||155
237656|NCT00937521|577918|P8|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
237657|NCT00937521|577919|P7|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
237658|NCT00937521|577920|P6|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
237659|NCT00937521|577921|P5|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
237660|NCT00937521|577922|P4|NOT COMPLETED|Overall Study - Prior to Booster Dose||1
237661|NCT00937521|577923|P3|NOT COMPLETED|Overall Study - Prior to Booster Dose||6
237662|NCT00937521|577924|P2|NOT COMPLETED|Overall Study - Prior to Booster Dose||5
237663|NCT00937521|577925|P1|NOT COMPLETED|Overall Study - Prior to Booster Dose||3
237664|NCT00937521|577918|P8|COMPLETED|Overall Study - Prior to Booster Dose||183
237665|NCT00937521|577919|P7|COMPLETED|Overall Study - Prior to Booster Dose||181
237666|NCT00937521|577920|P6|COMPLETED|Overall Study - Prior to Booster Dose||187
237667|NCT00937521|577921|P5|COMPLETED|Overall Study - Prior to Booster Dose||188
237668|NCT00937521|577922|P4|COMPLETED|Overall Study - Prior to Booster Dose||187
237669|NCT00937521|577923|P3|COMPLETED|Overall Study - Prior to Booster Dose||186
237670|NCT00937521|577924|P2|COMPLETED|Overall Study - Prior to Booster Dose||185
237671|NCT00937521|577925|P1|COMPLETED|Overall Study - Prior to Booster Dose||185
237672|NCT00937521|577918|P8|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
237673|NCT00937521|577919|P7|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
237674|NCT00937521|577920|P6|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
237675|NCT00937521|577921|P5|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
237676|NCT00937521|577922|P4|Premature Withdrawal|Overall Study - Prior to Booster Dose||1
237677|NCT00937521|577923|P3|Premature Withdrawal|Overall Study - Prior to Booster Dose||6
237678|NCT00937521|577924|P2|Premature Withdrawal|Overall Study - Prior to Booster Dose||5
237679|NCT00937521|577925|P1|Premature Withdrawal|Overall Study - Prior to Booster Dose||3
237680|NCT00937521|577918|P8|STARTED|Overall Study - Prior to Booster Dose||184
237681|NCT00937521|577919|P7|STARTED|Overall Study - Prior to Booster Dose||186
237682|NCT00937521|577920|P6|STARTED|Overall Study - Prior to Booster Dose||188
237683|NCT00937521|577921|P5|STARTED|Overall Study - Prior to Booster Dose||191
237684|NCT00937521|577922|P4|STARTED|Overall Study - Prior to Booster Dose||188
237685|NCT00937521|577923|P3|STARTED|Overall Study - Prior to Booster Dose||192
237686|NCT00937521|577924|P2|STARTED|Overall Study - Prior to Booster Dose||190
237687|NCT00937521|577925|P1|STARTED|Overall Study - Prior to Booster Dose||188
237688|NCT00937547|578034|P3|NOT COMPLETED|Overall Study||7
237689|NCT00937547|578035|P2|NOT COMPLETED|Overall Study||6
237690|NCT00937547|578036|P1|NOT COMPLETED|Overall Study||1
237691|NCT00937547|578034|P3|COMPLETED|Overall Study||142
237692|NCT00937547|578035|P2|COMPLETED|Overall Study||78
237693|NCT00937547|578036|P1|COMPLETED|Overall Study||95
237694|NCT00937547|578034|P3|Histological Samples|Overall Study||142
237695|NCT00937547|578035|P2|Histological Samples|Overall Study||78
237696|NCT00937547|578036|P1|Histological Samples|Overall Study||95
237697|NCT00937547|578034|P3|STARTED|Overall Study||149
237698|NCT00937547|578035|P2|STARTED|Overall Study||84
237699|NCT00937547|578036|P1|STARTED|Overall Study||96
237700|NCT00937560|578065|P1|NOT COMPLETED|Maintenance Treatment||18
237701|NCT00937560|578065|P1|COMPLETED|Maintenance Treatment||150
237702|NCT00937560|578065|P1|STARTED|Maintenance Treatment||168
237703|NCT00937560|578065|P1|NOT COMPLETED|Initial Treatment||21
237704|NCT00937560|578065|P1|COMPLETED|Initial Treatment||169
237705|NCT00937560|578065|P1|Received Treatment|Initial Treatment||189
237706|NCT00937560|578065|P1|STARTED|Initial Treatment||190
237707|NCT00937768|578075|P2|NOT COMPLETED|Overall Study||8
237708|NCT00937768|578076|P1|NOT COMPLETED|Overall Study||8
237709|NCT00937768|578075|P2|COMPLETED|Overall Study||0
237710|NCT00937768|578076|P1|COMPLETED|Overall Study||0
237711|NCT00937768|578075|P2|STARTED|Overall Study||8
237712|NCT00937768|578076|P1|STARTED|Overall Study||8
237713|NCT00937794|578082|P1|NOT COMPLETED|Overall Study||0
237714|NCT00937794|578082|P1|COMPLETED|Overall Study||33
237715|NCT00937794|578082|P1|STARTED|Overall Study||33
237716|NCT00937833|578089|P2|NOT COMPLETED|Overall Study||17
237717|NCT00937833|578090|P1|NOT COMPLETED|Overall Study||15
237718|NCT00937833|578089|P2|COMPLETED|Overall Study||60
237719|NCT00937833|578090|P1|COMPLETED|Overall Study||58
237720|NCT00937833|578089|P2|STARTED|Overall Study||77
237721|NCT00937833|578090|P1|STARTED|Overall Study||73
237722|NCT00937937|578096|P1|NOT COMPLETED|Overall Study||72
237723|NCT00937937|578096|P1|COMPLETED|Overall Study||0
237724|NCT00937937|578096|P1|STARTED|Overall Study||72
237725|NCT00937950|578103|P1|NOT COMPLETED|Overall Study||216
237726|NCT00937950|578103|P1|COMPLETED|Overall Study||1787
237727|NCT00937950|578103|P1|STARTED|Overall Study||2003
237728|NCT00938015|578119|P1|NOT COMPLETED|Overall Study||147
237729|NCT00938015|578119|P1|COMPLETED|Overall Study||156
237730|NCT00938015|578119|P1|STARTED|Overall Study||303
237731|NCT00938041|578135|P1|NOT COMPLETED|Overall Study||27
237732|NCT00938041|578135|P1|COMPLETED|Overall Study||5
237733|NCT00938041|578135|P1|STARTED|Overall Study||32
237734|NCT00929071|578144|P1|NOT COMPLETED|Overall Study||0
237735|NCT00929071|578144|P1|COMPLETED|Overall Study||10
237736|NCT00929071|578144|P1|STARTED|Overall Study||10
237737|NCT00929110|578154|P3|NOT COMPLETED|Overall Study||62
237738|NCT00929110|578155|P2|NOT COMPLETED|Overall Study||76
237739|NCT00929110|578156|P1|NOT COMPLETED|Overall Study||118
237740|NCT00929110|578154|P3|COMPLETED|Overall Study||206
237741|NCT00929110|578155|P2|COMPLETED|Overall Study||193
237742|NCT00929110|578156|P1|COMPLETED|Overall Study||411
237743|NCT00929110|578154|P3|STARTED|Overall Study||268
237744|NCT00929110|578155|P2|STARTED|Overall Study||269
237745|NCT00929110|578156|P1|STARTED|Overall Study||529
237746|NCT00929162|578223|P2|NOT COMPLETED|Overall Study||42
237747|NCT00929162|578224|P1|NOT COMPLETED|Overall Study||48
237748|NCT00929162|578223|P2|COMPLETED|Overall Study||19
237749|NCT00929162|578224|P1|COMPLETED|Overall Study||11
237750|NCT00929162|578223|P2|Patients Who Received Treatment|Overall Study||58
237751|NCT00929162|578224|P1|Patients Who Received Treatment|Overall Study||58
237752|NCT00929162|578223|P2|STARTED|Overall Study||61
237753|NCT00929162|578224|P1|STARTED|Overall Study||59
237754|NCT00929201|578234|P2|NOT COMPLETED|Period 2||0
237755|NCT00929201|578235|P1|NOT COMPLETED|Period 2||0
237756|NCT00929201|578234|P2|COMPLETED|Period 2||30
237757|NCT00929201|578235|P1|COMPLETED|Period 2||30
237758|NCT00929201|578234|P2|STARTED|Period 2||30
237759|NCT00929201|578235|P1|STARTED|Period 2||30
237760|NCT00929201|578234|P2|NOT COMPLETED|7-day Washout||0
237761|NCT00929201|578235|P1|NOT COMPLETED|7-day Washout||0
237762|NCT00929201|578234|P2|COMPLETED|7-day Washout||30
237763|NCT00929201|578235|P1|COMPLETED|7-day Washout||30
237764|NCT00929201|578234|P2|STARTED|7-day Washout||30
237765|NCT00929201|578235|P1|STARTED|7-day Washout||30
237766|NCT00929201|578234|P2|NOT COMPLETED|Period 1||1
237767|NCT00929201|578235|P1|NOT COMPLETED|Period 1||0
237768|NCT00929201|578234|P2|COMPLETED|Period 1||30
237769|NCT00929201|578235|P1|COMPLETED|Period 1||30
237770|NCT00929201|578234|P2|STARTED|Period 1||31
237771|NCT00929201|578235|P1|STARTED|Period 1||30
237772|NCT00929240|578243|P3|NOT COMPLETED|Maintenance Phase||91
237773|NCT00929240|578244|P2|NOT COMPLETED|Maintenance Phase||94
237774|NCT00929240|578245|P1|NOT COMPLETED|Maintenance Phase||0
237775|NCT00929240|578243|P3|COMPLETED|Maintenance Phase||0
237776|NCT00929240|578244|P2|COMPLETED|Maintenance Phase||0
237777|NCT00929240|578245|P1|COMPLETED|Maintenance Phase||0
237778|NCT00929240|578243|P3|STARTED|Maintenance Phase||91
237779|NCT00929240|578244|P2|STARTED|Maintenance Phase||94
237780|NCT00929240|578245|P1|STARTED|Maintenance Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
237781|NCT00929240|578243|P3|NOT COMPLETED|Initial Treatment Phase||0
237782|NCT00929240|578244|P2|NOT COMPLETED|Initial Treatment Phase||0
237783|NCT00929240|578245|P1|NOT COMPLETED|Initial Treatment Phase||99
237784|NCT00929240|578243|P3|COMPLETED|Initial Treatment Phase||0
237785|NCT00929240|578244|P2|COMPLETED|Initial Treatment Phase||0
237786|NCT00929240|578245|P1|COMPLETED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|185
237787|NCT00929240|578243|P3|STARTED|Initial Treatment Phase||0
237788|NCT00929240|578244|P2|STARTED|Initial Treatment Phase|Participants were randomized to 1 of 2 treatment groups at the end of the initial treatment phase.|0
237789|NCT00929240|578245|P1|STARTED|Initial Treatment Phase|Includes only the participants that received Initial Phase Treatment.|284
237790|NCT00929305|578274|P2|NOT COMPLETED|Overall Study||0
237791|NCT00929305|578275|P1|NOT COMPLETED|Overall Study||0
237792|NCT00929305|578274|P2|COMPLETED|Overall Study||43
237793|NCT00929305|578275|P1|COMPLETED|Overall Study||43
237794|NCT00929305|578274|P2|STARTED|Overall Study||43
237795|NCT00929305|578275|P1|STARTED|Overall Study||43
237796|NCT00938314|578287|P4|NOT COMPLETED|Cohort 3||1
237797|NCT00938314|578288|P3|NOT COMPLETED|Cohort 3||4
237798|NCT00938314|578289|P2|NOT COMPLETED|Cohort 3||0
237799|NCT00938314|578290|P1|NOT COMPLETED|Cohort 3||0
237800|NCT00938314|578287|P4|COMPLETED|Cohort 3||7
237801|NCT00938314|578288|P3|COMPLETED|Cohort 3||20
237802|NCT00938314|578289|P2|COMPLETED|Cohort 3||0
237803|NCT00938314|578290|P1|COMPLETED|Cohort 3||0
237804|NCT00938314|578287|P4|STARTED|Cohort 3||8
237805|NCT00938314|578288|P3|STARTED|Cohort 3||24
237806|NCT00938314|578289|P2|STARTED|Cohort 3||0
237807|NCT00938314|578290|P1|STARTED|Cohort 3||0
237808|NCT00938314|578287|P4|NOT COMPLETED|Cohort 2||2
237809|NCT00938314|578288|P3|NOT COMPLETED|Cohort 2||0
237810|NCT00938314|578289|P2|NOT COMPLETED|Cohort 2||6
237811|NCT00938314|578290|P1|NOT COMPLETED|Cohort 2||0
237812|NCT00938314|578287|P4|COMPLETED|Cohort 2||6
237813|NCT00938314|578288|P3|COMPLETED|Cohort 2||0
237814|NCT00938314|578289|P2|COMPLETED|Cohort 2||18
237815|NCT00938314|578290|P1|COMPLETED|Cohort 2||0
237816|NCT00938314|578287|P4|STARTED|Cohort 2||8
237817|NCT00938314|578288|P3|STARTED|Cohort 2||0
237818|NCT00938314|578289|P2|STARTED|Cohort 2||24
237819|NCT00938314|578290|P1|STARTED|Cohort 2||0
237820|NCT00938314|578287|P4|NOT COMPLETED|Cohort 1||2
237821|NCT00938314|578288|P3|NOT COMPLETED|Cohort 1||0
237822|NCT00938314|578289|P2|NOT COMPLETED|Cohort 1||0
237823|NCT00938314|578290|P1|NOT COMPLETED|Cohort 1||2
237824|NCT00938314|578287|P4|COMPLETED|Cohort 1||6
237825|NCT00938314|578288|P3|COMPLETED|Cohort 1||0
237826|NCT00938314|578289|P2|COMPLETED|Cohort 1||0
237827|NCT00938314|578290|P1|COMPLETED|Cohort 1||22
237828|NCT00938314|578287|P4|STARTED|Cohort 1||8
237829|NCT00938314|578288|P3|STARTED|Cohort 1||0
237830|NCT00938314|578289|P2|STARTED|Cohort 1||0
237831|NCT00938314|578290|P1|STARTED|Cohort 1||24
237832|NCT00938327|578344|P1|NOT COMPLETED|Overall Study||60
237833|NCT00938327|578344|P1|COMPLETED|Overall Study||272
237834|NCT00938327|578344|P1|STARTED|Overall Study||332
237835|NCT00938366|578353|P2|NOT COMPLETED|Overall Study||0
237836|NCT00938366|578354|P1|NOT COMPLETED|Overall Study||1
237837|NCT00938366|578353|P2|COMPLETED|Overall Study||9
237838|NCT00938366|578354|P1|COMPLETED|Overall Study||8
237839|NCT00938366|578353|P2|STARTED|Overall Study||9
237840|NCT00938366|578354|P1|STARTED|Overall Study||9
237841|NCT00938392|578376|P2|NOT COMPLETED|Overall Study||4
237842|NCT00938392|578377|P1|NOT COMPLETED|Overall Study||2
237843|NCT00938392|578376|P2|COMPLETED|Overall Study||358
237844|NCT00938392|578377|P1|COMPLETED|Overall Study||360
237845|NCT00938392|578376|P2|STARTED|Overall Study||362
237846|NCT00938392|578377|P1|STARTED|Overall Study||362
237847|NCT00938431|578404|P3|NOT COMPLETED|Overall Study||8
237848|NCT00938431|578405|P2|NOT COMPLETED|Overall Study||9
237849|NCT00938431|578406|P1|NOT COMPLETED|Overall Study||6
237850|NCT00938431|578404|P3|COMPLETED|Overall Study||1
237851|NCT00938431|578405|P2|COMPLETED|Overall Study||14
237852|NCT00938431|578406|P1|COMPLETED|Overall Study||9
237853|NCT00938431|578404|P3|STARTED|Overall Study||9
237854|NCT00938431|578405|P2|STARTED|Overall Study||23
237855|NCT00938431|578406|P1|STARTED|Overall Study||15
237856|NCT00938860|578433|P2|NOT COMPLETED|Overall Study||17
237857|NCT00938860|578434|P1|NOT COMPLETED|Overall Study||25
237858|NCT00938860|578433|P2|COMPLETED|Overall Study||25
237859|NCT00938860|578434|P1|COMPLETED|Overall Study||25
237860|NCT00938860|578433|P2|Efficacy Population|Overall Study||41
237861|NCT00938860|578434|P1|Efficacy Population|Overall Study||40
237862|NCT00938860|578433|P2|STARTED|Overall Study||42
237863|NCT00938860|578434|P1|STARTED|Overall Study|Intent-to-Treat (ITT) population. ITT population consisted of all randomized patients|50
237864|NCT00938886|578458|P2|NOT COMPLETED|Overall Study||10
237865|NCT00938886|578459|P1|NOT COMPLETED|Overall Study||7
237866|NCT00938886|578458|P2|COMPLETED|Overall Study||65
237867|NCT00938886|578459|P1|COMPLETED|Overall Study||68
237868|NCT00938886|578458|P2|Attended 1 Counseling Session|Overall Study||70
237869|NCT00938886|578459|P1|Attended 1 Counseling Session|Overall Study||70
237870|NCT00938886|578458|P2|STARTED|Overall Study||75
237871|NCT00938886|578459|P1|STARTED|Overall Study||75
237872|NCT00938964|578469|P2|NOT COMPLETED|Overall Study||28
237873|NCT00938964|578470|P1|NOT COMPLETED|Overall Study||30
237874|NCT00938964|578469|P2|COMPLETED|Overall Study||209
237875|NCT00938964|578470|P1|COMPLETED|Overall Study||211
237876|NCT00938964|578469|P2|STARTED|Overall Study||237
237877|NCT00938964|578470|P1|STARTED|Overall Study||241
237878|NCT00939003|578510|P2|NOT COMPLETED|Open-label Treatment Period||29
237879|NCT00939003|578511|P1|NOT COMPLETED|Open-label Treatment Period||29
237880|NCT00939003|578510|P2|COMPLETED|Open-label Treatment Period||62
237881|NCT00939003|578511|P1|COMPLETED|Open-label Treatment Period||66
237882|NCT00939003|578510|P2|STARTED|Open-label Treatment Period||91
237883|NCT00939003|578511|P1|STARTED|Open-label Treatment Period||95
237884|NCT00939003|578510|P2|NOT COMPLETED|Double-blind Treatment Period||4
237885|NCT00939003|578511|P1|NOT COMPLETED|Double-blind Treatment Period||2
237886|NCT00939003|578510|P2|COMPLETED|Double-blind Treatment Period||91
237887|NCT00939003|578511|P1|COMPLETED|Double-blind Treatment Period||95
237888|NCT00939003|578510|P2|STARTED|Double-blind Treatment Period||95
237889|NCT00939003|578511|P1|STARTED|Double-blind Treatment Period||97
237890|NCT00939029|578548|P2|NOT COMPLETED|Overall Study||12
237891|NCT00939029|578549|P1|NOT COMPLETED|Overall Study||6
237892|NCT00939029|578548|P2|COMPLETED|Overall Study||15
237893|NCT00939029|578549|P1|COMPLETED|Overall Study||19
237894|NCT00939029|578548|P2|STARTED|Overall Study||27
237895|NCT00939029|578549|P1|STARTED|Overall Study||25
237896|NCT00939055|578561|P2|NOT COMPLETED|Overall Study||0
237897|NCT00939055|578562|P1|NOT COMPLETED|Overall Study||4
237898|NCT00939055|578561|P2|COMPLETED|Overall Study||39
237899|NCT00939055|578562|P1|COMPLETED|Overall Study||69
237900|NCT00939055|578561|P2|STARTED|Overall Study||39
237901|NCT00939055|578562|P1|STARTED|Overall Study||73
237902|NCT00939094|578572|P2|NOT COMPLETED|Overall Study||10
237903|NCT00939094|578573|P1|NOT COMPLETED|Overall Study||14
237904|NCT00939094|578572|P2|COMPLETED|Overall Study||35
237905|NCT00939094|578573|P1|COMPLETED|Overall Study||28
237906|NCT00939094|578572|P2|STARTED|Overall Study||45
237907|NCT00939094|578573|P1|STARTED|Overall Study||42
237908|NCT00939107|578595|P2|NOT COMPLETED|Overall Study||12
237909|NCT00939107|578596|P1|NOT COMPLETED|Overall Study||14
237910|NCT00939107|578595|P2|COMPLETED|Overall Study||163
237911|NCT00939107|578596|P1|COMPLETED|Overall Study||161
237912|NCT00939107|578595|P2|12 Months Follow-up|Overall Study||163
237913|NCT00939107|578596|P1|12 Months Follow-up|Overall Study||161
237914|NCT00939107|578595|P2|STARTED|Overall Study||175
237915|NCT00939107|578596|P1|STARTED|Overall Study||175
237916|NCT00939120|578610|P2|NOT COMPLETED|Overall Study||5
237917|NCT00939120|578611|P1|NOT COMPLETED|Overall Study||8
237918|NCT00939120|578610|P2|COMPLETED|Overall Study||18
237919|NCT00939120|578611|P1|COMPLETED|Overall Study||15
237920|NCT00939120|578610|P2|STARTED|Overall Study||23
237921|NCT00939120|578611|P1|STARTED|Overall Study||23
237922|NCT00939159|578633|P1|NOT COMPLETED|Overall Study||0
237923|NCT00939159|578633|P1|COMPLETED|Overall Study||13
237924|NCT00939159|578633|P1|STARTED|Overall Study||13
237925|NCT00939185|578637|P1|NOT COMPLETED|Overall Study||25
237926|NCT00939185|578637|P1|COMPLETED|Overall Study||375
237927|NCT00939185|578637|P1|Received Treatment|Overall Study||390
237928|NCT00939185|578637|P1|STARTED|Overall Study||400
237929|NCT00939211|578644|P1|NOT COMPLETED|Placebo||0
237930|NCT00939211|578644|P1|COMPLETED|Placebo||28
237931|NCT00939211|578644|P1|STARTED|Placebo||28
237932|NCT00939211|578644|P1|NOT COMPLETED|Spiriva 18 Mcg First, Then Placebo||0
237933|NCT00939211|578644|P1|COMPLETED|Spiriva 18 Mcg First, Then Placebo||28
237934|NCT00939211|578644|P1|STARTED|Spiriva 18 Mcg First, Then Placebo||28
237935|NCT00939211|578644|P1|NOT COMPLETED|AZD9164 1200 Mcg First, Then Placebo||0
237936|NCT00939211|578644|P1|COMPLETED|AZD9164 1200 Mcg First, Then Placebo||28
237937|NCT00939211|578644|P1|STARTED|AZD9164 1200 Mcg First, Then Placebo||28
237938|NCT00939211|578644|P1|NOT COMPLETED|AZD9164 400 Mcg First, Then Placebo||0
237939|NCT00939211|578644|P1|COMPLETED|AZD9164 400 Mcg First, Then Placebo||28
237940|NCT00939211|578644|P1|STARTED|AZD9164 400 Mcg First, Then Placebo||28
237941|NCT00939211|578644|P1|NOT COMPLETED|AZD9164 100 Mcg First, Then Placebo||0
237942|NCT00939211|578644|P1|COMPLETED|AZD9164 100 Mcg First, Then Placebo||28
237943|NCT00939211|578644|P1|STARTED|AZD9164 100 Mcg First, Then Placebo|Cross-over study|28
237944|NCT00939341|578706|P1|NOT COMPLETED|Overall Study||66
237945|NCT00939341|578706|P1|COMPLETED|Overall Study|862 participants entered into the 12-week treatment,66 discontinued, 796 completed the treatment.|796
237946|NCT00939341|578706|P1|STARTED|Overall Study|1022 participants were enrolled. There were 160 screen failures, 862 proceeded to treatment period.|862
237947|NCT00939367|578726|P2|NOT COMPLETED|Second Intervention||0
237948|NCT00939367|578727|P1|NOT COMPLETED|Second Intervention||0
237949|NCT00939367|578726|P2|COMPLETED|Second Intervention||15
237950|NCT00939367|578727|P1|COMPLETED|Second Intervention||15
237951|NCT00939367|578726|P2|STARTED|Second Intervention||15
237952|NCT00939367|578727|P1|STARTED|Second Intervention||15
237953|NCT00939367|578726|P2|NOT COMPLETED|First Intervention||0
237954|NCT00939367|578727|P1|NOT COMPLETED|First Intervention||0
237955|NCT00939367|578726|P2|COMPLETED|First Intervention||15
237956|NCT00939367|578727|P1|COMPLETED|First Intervention||15
237957|NCT00939367|578726|P2|STARTED|First Intervention||15
237958|NCT00939367|578727|P1|STARTED|First Intervention||15
237959|NCT00939393|578739|P2|NOT COMPLETED|Overall Study||0
237960|NCT00939393|578740|P1|NOT COMPLETED|Overall Study||4
237961|NCT00939393|578739|P2|COMPLETED|Overall Study||35
237962|NCT00939393|578740|P1|COMPLETED|Overall Study||33
237963|NCT00939393|578739|P2|STARTED|Overall Study||35
237964|NCT00939393|578740|P1|STARTED|Overall Study||37
237965|NCT00939471|578760|P1|NOT COMPLETED|Overall Study||11
237966|NCT00939471|578760|P1|COMPLETED|Overall Study||33
237967|NCT00939471|578760|P1|STARTED|Overall Study||44
237968|NCT00939484|578774|P3|NOT COMPLETED|Overall Study||3
237969|NCT00939484|578775|P2|NOT COMPLETED|Overall Study||20
237970|NCT00939484|578776|P1|NOT COMPLETED|Overall Study||8
237971|NCT00939484|578774|P3|COMPLETED|Overall Study||0
237972|NCT00939484|578775|P2|COMPLETED|Overall Study||0
237973|NCT00939484|578776|P1|COMPLETED|Overall Study||0
237974|NCT00939484|578774|P3|STARTED|Overall Study||3
237975|NCT00939484|578775|P2|STARTED|Overall Study||20
237976|NCT00939484|578776|P1|STARTED|Overall Study||8
237977|NCT00939510|578789|P1|NOT COMPLETED|Overall Study||1
237978|NCT00939510|578789|P1|COMPLETED|Overall Study||31
237979|NCT00939510|578789|P1|STARTED|Overall Study||32
237980|NCT00939536|578797|P2|NOT COMPLETED|Second Intervention||0
237981|NCT00939536|578798|P1|NOT COMPLETED|Second Intervention||0
237982|NCT00939536|578797|P2|COMPLETED|Second Intervention||12
237983|NCT00939536|578798|P1|COMPLETED|Second Intervention||12
237984|NCT00939536|578797|P2|STARTED|Second Intervention||12
237985|NCT00939536|578798|P1|STARTED|Second Intervention||12
237986|NCT00939536|578797|P2|NOT COMPLETED|First Intervention||0
237987|NCT00939536|578798|P1|NOT COMPLETED|First Intervention||0
237988|NCT00939536|578797|P2|COMPLETED|First Intervention||12
237989|NCT00939536|578798|P1|COMPLETED|First Intervention||12
237990|NCT00939536|578797|P2|STARTED|First Intervention||12
237991|NCT00939536|578798|P1|STARTED|First Intervention||12
237992|NCT00939562|578808|P2|NOT COMPLETED|Period 2||0
237993|NCT00939562|578809|P1|NOT COMPLETED|Period 2||0
237994|NCT00939562|578808|P2|COMPLETED|Period 2||12
237995|NCT00939562|578809|P1|COMPLETED|Period 2||12
237996|NCT00939562|578808|P2|STARTED|Period 2||12
237997|NCT00939562|578809|P1|STARTED|Period 2||12
237998|NCT00939562|578808|P2|NOT COMPLETED|Period 1||0
237999|NCT00939562|578809|P1|NOT COMPLETED|Period 1||0
238000|NCT00939562|578808|P2|COMPLETED|Period 1||12
238001|NCT00939562|578809|P1|COMPLETED|Period 1||12
238002|NCT00939562|578808|P2|STARTED|Period 1||12
238003|NCT00939562|578809|P1|STARTED|Period 1||12
238004|NCT00939627|578819|P3|NOT COMPLETED|Overall Study||0
238005|NCT00939627|578820|P2|NOT COMPLETED|Overall Study||28
238006|NCT00939627|578821|P1|NOT COMPLETED|Overall Study||27
238007|NCT00939627|578819|P3|COMPLETED|Overall Study||0
238008|NCT00939627|578820|P2|COMPLETED|Overall Study||0
238009|NCT00939627|578821|P1|COMPLETED|Overall Study||0
238010|NCT00939627|578819|P3|STARTED|Overall Study||0
238011|NCT00939627|578820|P2|STARTED|Overall Study||28
238012|NCT00939627|578821|P1|STARTED|Overall Study||27
238013|NCT00939692|578837|P2|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||1
238014|NCT00939692|578838|P1|NOT COMPLETED|Period 2 - Second Intervent - 5 Days||0
238015|NCT00939692|578837|P2|COMPLETED|Period 2 - Second Intervent - 5 Days||12
238016|NCT00939692|578838|P1|COMPLETED|Period 2 - Second Intervent - 5 Days||12
238017|NCT00939692|578837|P2|STARTED|Period 2 - Second Intervent - 5 Days||13
238018|NCT00939692|578838|P1|STARTED|Period 2 - Second Intervent - 5 Days||12
238019|NCT00939692|578837|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
238020|NCT00939692|578838|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||1
238021|NCT00939692|578837|P2|COMPLETED|Period 1 - First Intervention - 5 Days||13
238022|NCT00939692|578838|P1|COMPLETED|Period 1 - First Intervention - 5 Days||12
238023|NCT00939692|578837|P2|STARTED|Period 1 - First Intervention - 5 Days||13
238024|NCT00939692|578838|P1|STARTED|Period 1 - First Intervention - 5 Days||13
238025|NCT00939705|578850|P2|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
238026|NCT00939705|578851|P1|NOT COMPLETED|Period 3 - Second Intervent - 5 Days||0
238027|NCT00939705|578850|P2|COMPLETED|Period 3 - Second Intervent - 5 Days||9
238028|NCT00939705|578851|P1|COMPLETED|Period 3 - Second Intervent - 5 Days||9
238029|NCT00939705|578850|P2|STARTED|Period 3 - Second Intervent - 5 Days||9
238030|NCT00939705|578851|P1|STARTED|Period 3 - Second Intervent - 5 Days||9
238031|NCT00939705|578850|P2|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
238032|NCT00939705|578851|P1|NOT COMPLETED|Period 2 - Washout Period - 21 Days||0
238033|NCT00939705|578850|P2|COMPLETED|Period 2 - Washout Period - 21 Days||9
238034|NCT00939705|578851|P1|COMPLETED|Period 2 - Washout Period - 21 Days||9
238035|NCT00939705|578850|P2|STARTED|Period 2 - Washout Period - 21 Days||9
238036|NCT00939705|578851|P1|STARTED|Period 2 - Washout Period - 21 Days||9
238037|NCT00939705|578850|P2|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
238038|NCT00939705|578851|P1|NOT COMPLETED|Period 1 - First Intervention - 5 Days||0
238039|NCT00939705|578850|P2|COMPLETED|Period 1 - First Intervention - 5 Days||9
238040|NCT00939705|578851|P1|COMPLETED|Period 1 - First Intervention - 5 Days||9
238041|NCT00939705|578850|P2|STARTED|Period 1 - First Intervention - 5 Days||9
238042|NCT00939705|578851|P1|STARTED|Period 1 - First Intervention - 5 Days||9
238043|NCT00939731|578861|P2|NOT COMPLETED|Second Intervention Period||0
238044|NCT00939731|578862|P1|NOT COMPLETED|Second Intervention Period||0
238045|NCT00939731|578861|P2|COMPLETED|Second Intervention Period||12
238046|NCT00939731|578862|P1|COMPLETED|Second Intervention Period||12
238047|NCT00939731|578861|P2|STARTED|Second Intervention Period||12
238048|NCT00939731|578862|P1|STARTED|Second Intervention Period||12
238049|NCT00939731|578861|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
238050|NCT00939731|578862|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
238051|NCT00939731|578861|P2|COMPLETED|Washout Period (at Least 14 Days)||12
238052|NCT00939731|578862|P1|COMPLETED|Washout Period (at Least 14 Days)||12
238053|NCT00939731|578861|P2|STARTED|Washout Period (at Least 14 Days)||12
238054|NCT00939731|578862|P1|STARTED|Washout Period (at Least 14 Days)||12
238055|NCT00939731|578861|P2|NOT COMPLETED|First Intervention Period||0
238056|NCT00939731|578862|P1|NOT COMPLETED|First Intervention Period||0
238057|NCT00939731|578861|P2|COMPLETED|First Intervention Period||12
238058|NCT00939731|578862|P1|COMPLETED|First Intervention Period||12
238059|NCT00939731|578861|P2|STARTED|First Intervention Period||12
238060|NCT00939731|578862|P1|STARTED|First Intervention Period||12
238061|NCT00939783|578880|P1|NOT COMPLETED|Overall Study||649
238062|NCT00939783|578880|P1|COMPLETED|Overall Study||0
238063|NCT00939783|578880|P1|Treated|Overall Study||648
238064|NCT00939783|578880|P1|STARTED|Overall Study||649
238065|NCT00939796|578887|P1|NOT COMPLETED|Overall Study||0
238066|NCT00939796|578887|P1|COMPLETED|Overall Study||16
238067|NCT00939796|578887|P1|STARTED|Overall Study||16
238068|NCT00939809|578893|P1|NOT COMPLETED|Overall Study||3
238069|NCT00939809|578893|P1|COMPLETED|Overall Study|Patients treated until disease progression; completed defined as off treatment due to progression.|28
238070|NCT00939809|578893|P1|STARTED|Overall Study||31
238071|NCT00939874|578901|P1|NOT COMPLETED|Overall Study||20
238072|NCT00939874|578901|P1|COMPLETED|Overall Study||32
238073|NCT00939874|578901|P1|Completed Week 48|Overall Study||37
238074|NCT00939874|578901|P1|STARTED|Overall Study||52
238075|NCT00939900|578908|P2|NOT COMPLETED|Overall Study||7
238076|NCT00939900|578909|P1|NOT COMPLETED|Overall Study||2
238077|NCT00939900|578908|P2|COMPLETED|Overall Study||48
238078|NCT00939900|578909|P1|COMPLETED|Overall Study||53
238079|NCT00939900|578908|P2|STARTED|Overall Study||55
238080|NCT00939900|578909|P1|STARTED|Overall Study||55
238081|NCT00939952|578915|P1|NOT COMPLETED|Overall Study||0
238082|NCT00939952|578915|P1|COMPLETED|Overall Study||7
238083|NCT00939952|578915|P1|STARTED|Overall Study||7
238084|NCT00939991|578927|P2|NOT COMPLETED|Overall Study||0
238085|NCT00939991|578928|P1|NOT COMPLETED|Overall Study||0
238086|NCT00939991|578927|P2|COMPLETED|Overall Study||39
238087|NCT00939991|578928|P1|COMPLETED|Overall Study||9
238088|NCT00939991|578927|P2|STARTED|Overall Study||39
238089|NCT00939991|578928|P1|STARTED|Overall Study||9
238090|NCT00940017|578938|P1|NOT COMPLETED|Overall Study||4
238091|NCT00940017|578938|P1|COMPLETED|Overall Study||20
238092|NCT00940017|578938|P1|Subjects Treated|Overall Study||21
238093|NCT00940017|578938|P1|STARTED|Overall Study||24
238094|NCT00940108|578961|P4|NOT COMPLETED|Overall Study||5
238095|NCT00940108|578962|P3|NOT COMPLETED|Overall Study||3
238096|NCT00940108|578963|P2|NOT COMPLETED|Overall Study||9
238097|NCT00940108|578964|P1|NOT COMPLETED|Overall Study||5
238098|NCT00940108|578961|P4|COMPLETED|Overall Study||99
238099|NCT00940108|578962|P3|COMPLETED|Overall Study||100
238100|NCT00940108|578963|P2|COMPLETED|Overall Study||71
238101|NCT00940108|578964|P1|COMPLETED|Overall Study||77
238102|NCT00940108|578961|P4|STARTED|Overall Study||104
238103|NCT00940108|578962|P3|STARTED|Overall Study||103
238104|NCT00940108|578963|P2|STARTED|Overall Study||80
238105|NCT00940108|578964|P1|STARTED|Overall Study||82
238106|NCT00940290|579018|P4|NOT COMPLETED|Overall Study||0
238107|NCT00940290|579019|P3|NOT COMPLETED|Overall Study||0
238108|NCT00940290|579020|P2|NOT COMPLETED|Overall Study||0
238109|NCT00940290|579021|P1|NOT COMPLETED|Overall Study||0
238110|NCT00940290|579018|P4|COMPLETED|Overall Study||54
238111|NCT00940290|579019|P3|COMPLETED|Overall Study||55
238112|NCT00940290|579020|P2|COMPLETED|Overall Study||53
238113|NCT00940290|579021|P1|COMPLETED|Overall Study||54
238114|NCT00940290|579018|P4|STARTED|Overall Study||54
238115|NCT00940290|579019|P3|STARTED|Overall Study||55
238116|NCT00940290|579020|P2|STARTED|Overall Study||53
238117|NCT00940290|579021|P1|STARTED|Overall Study||54
238118|NCT00940485|579033|P2|NOT COMPLETED|Overall Study||7
238119|NCT00940485|579034|P1|NOT COMPLETED|Overall Study||15
238120|NCT00940485|579033|P2|COMPLETED|Overall Study||93
238121|NCT00940485|579034|P1|COMPLETED|Overall Study||82
238122|NCT00940485|579033|P2|STARTED|Overall Study||100
238123|NCT00940485|579034|P1|STARTED|Overall Study||97
238124|NCT00940537|579060|P2|NOT COMPLETED|Overall Study||0
238125|NCT00940537|579061|P1|NOT COMPLETED|Overall Study||0
238126|NCT00940537|579060|P2|COMPLETED|Overall Study||9
238127|NCT00940537|579061|P1|COMPLETED|Overall Study||5
238128|NCT00940537|579060|P2|STARTED|Overall Study||9
238129|NCT00940537|579061|P1|STARTED|Overall Study||5
238130|NCT00940576|579070|P2|NOT COMPLETED|Overall Study||0
238131|NCT00940576|579071|P1|NOT COMPLETED|Overall Study||0
238132|NCT00940576|579070|P2|COMPLETED|Overall Study||9
238133|NCT00940576|579071|P1|COMPLETED|Overall Study||8
238134|NCT00940576|579070|P2|STARTED|Overall Study||9
238135|NCT00940576|579071|P1|STARTED|Overall Study||8
238136|NCT00940875|579080|P2|NOT COMPLETED|Post-Study Treatment||3
238137|NCT00940875|579081|P1|NOT COMPLETED|Post-Study Treatment||0
238138|NCT00940875|579080|P2|COMPLETED|Post-Study Treatment||1
238139|NCT00940875|579081|P1|COMPLETED|Post-Study Treatment||0
238140|NCT00940875|579080|P2|STARTED|Post-Study Treatment||4
238141|NCT00940875|579081|P1|STARTED|Post-Study Treatment||0
238142|NCT00940875|579080|P2|NOT COMPLETED|Treatment Phase||19
238143|NCT00940875|579081|P1|NOT COMPLETED|Treatment Phase||26
238144|NCT00940875|579080|P2|COMPLETED|Treatment Phase||4
238145|NCT00940875|579081|P1|COMPLETED|Treatment Phase||5
238146|NCT00940875|579080|P2|STARTED|Treatment Phase|3 participants randomized to G+E arm received only gemcitabine and were analyzed in Gemcitabine arm|23
238147|NCT00940875|579081|P1|STARTED|Treatment Phase|Disposition analysis includes 3 participants randomized to G+E but received only gemcitabine|31
238148|NCT00940888|579099|P1|NOT COMPLETED|Overall Study||835
238149|NCT00940888|579099|P1|COMPLETED|Overall Study|Subjects that completed the 60 month follow up visit|866
238150|NCT00940888|579099|P1|STARTED|Overall Study|Total number of subjects consented|1701
238151|NCT00940901|579106|P2|NOT COMPLETED|Week 9-16 (Phase 2)||3
238152|NCT00940901|579107|P1|NOT COMPLETED|Week 9-16 (Phase 2)||2
238153|NCT00940901|579106|P2|COMPLETED|Week 9-16 (Phase 2)||4
238154|NCT00940901|579107|P1|COMPLETED|Week 9-16 (Phase 2)||4
238155|NCT00940901|579106|P2|STARTED|Week 9-16 (Phase 2)||7
238156|NCT00940901|579107|P1|STARTED|Week 9-16 (Phase 2)||6
238157|NCT00940901|579106|P2|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
238158|NCT00940901|579107|P1|NOT COMPLETED|Weeks 1-8 (Phase 1)||0
238159|NCT00940901|579106|P2|COMPLETED|Weeks 1-8 (Phase 1)||7
238160|NCT00940901|579107|P1|COMPLETED|Weeks 1-8 (Phase 1)||6
238161|NCT00940901|579106|P2|STARTED|Weeks 1-8 (Phase 1)||7
238162|NCT00940901|579107|P1|STARTED|Weeks 1-8 (Phase 1)||6
238163|NCT00940927|579117|P1|NOT COMPLETED|Overall Study||0
238164|NCT00940927|579117|P1|COMPLETED|Overall Study||81
238165|NCT00940927|579117|P1|STARTED|Overall Study||81
238166|NCT00940992|579125|P3|NOT COMPLETED|Overall Study||2
238167|NCT00940992|579126|P2|NOT COMPLETED|Overall Study||2
238168|NCT00940992|579127|P1|NOT COMPLETED|Overall Study||4
238169|NCT00940992|579125|P3|COMPLETED|Overall Study||28
238170|NCT00940992|579126|P2|COMPLETED|Overall Study||28
238171|NCT00940992|579127|P1|COMPLETED|Overall Study||28
238172|NCT00940992|579125|P3|STARTED|Overall Study||30
238173|NCT00940992|579126|P2|STARTED|Overall Study||30
238174|NCT00940992|579127|P1|STARTED|Overall Study||32
238175|NCT00941031|579142|P7|NOT COMPLETED|Maintenance Period||43
238176|NCT00941031|579143|P6|NOT COMPLETED|Maintenance Period||6
238177|NCT00941031|579144|P5|NOT COMPLETED|Maintenance Period||9
238178|NCT00941031|579145|P4|NOT COMPLETED|Maintenance Period||0
238179|NCT00941031|579146|P3|NOT COMPLETED|Maintenance Period||0
238180|NCT00941031|579147|P2|NOT COMPLETED|Maintenance Period||0
238181|NCT00941031|579148|P1|NOT COMPLETED|Maintenance Period||0
238182|NCT00941031|579142|P7|COMPLETED|Maintenance Period||204
238183|NCT00941031|579143|P6|COMPLETED|Maintenance Period||61
238184|NCT00941031|579144|P5|COMPLETED|Maintenance Period||56
238185|NCT00941031|579145|P4|COMPLETED|Maintenance Period|Non Responders treated with an open label regimen.|0
238186|NCT00941031|579146|P3|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
238187|NCT00941031|579147|P2|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
238188|NCT00941031|579148|P1|COMPLETED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
238189|NCT00941031|579142|P7|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|247
238190|NCT00941031|579143|P6|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|67
238191|NCT00941031|579144|P5|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|65
238192|NCT00941031|579145|P4|STARTED|Maintenance Period|Non Responders treated with an open label regimen.|0
238193|NCT00941031|579146|P3|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
238194|NCT00941031|579147|P2|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
238195|NCT00941031|579148|P1|STARTED|Maintenance Period|Responders at week 13 were re randomized to one of the maintenance treatment arms in a ratio of 1:1|0
238196|NCT00941031|579142|P7|NOT COMPLETED|Induction Period||0
238197|NCT00941031|579143|P6|NOT COMPLETED|Induction Period||0
238198|NCT00941031|579144|P5|NOT COMPLETED|Induction Period||0
238199|NCT00941031|579145|P4|NOT COMPLETED|Induction Period||9
238200|NCT00941031|579146|P3|NOT COMPLETED|Induction Period||6
238201|NCT00941031|579147|P2|NOT COMPLETED|Induction Period||4
238202|NCT00941031|579148|P1|NOT COMPLETED|Induction Period||5
238203|NCT00941031|579142|P7|COMPLETED|Induction Period||0
238204|NCT00941031|579143|P6|COMPLETED|Induction Period||0
238205|NCT00941031|579144|P5|COMPLETED|Induction Period||0
238206|NCT00941031|579145|P4|COMPLETED|Induction Period||58
238207|NCT00941031|579146|P3|COMPLETED|Induction Period||127
238208|NCT00941031|579147|P2|COMPLETED|Induction Period||134
238209|NCT00941031|579148|P1|COMPLETED|Induction Period||61
238210|NCT00941031|579142|P7|STARTED|Induction Period||0
238211|NCT00941031|579143|P6|STARTED|Induction Period||0
238212|NCT00941031|579144|P5|STARTED|Induction Period||0
238213|NCT00941031|579145|P4|STARTED|Induction Period||67
238214|NCT00941031|579146|P3|STARTED|Induction Period||133
238215|NCT00941031|579147|P2|STARTED|Induction Period||138
238216|NCT00941031|579148|P1|STARTED|Induction Period||66
238217|NCT00941070|579171|P1|NOT COMPLETED|Overall Study||1
238218|NCT00941070|579171|P1|COMPLETED|Overall Study||25
238219|NCT00941070|579171|P1|STARTED|Overall Study||26
238220|NCT00933166|579185|P1|NOT COMPLETED|Overall Study||18
238221|NCT00933166|579185|P1|COMPLETED|Overall Study||151
238222|NCT00933166|579185|P1|STARTED|Overall Study||169
238223|NCT00933244|579192|P3|NOT COMPLETED|Overall Study||3
238224|NCT00933244|579193|P2|NOT COMPLETED|Overall Study||1
238225|NCT00933244|579194|P1|NOT COMPLETED|Overall Study||5
238226|NCT00933244|579192|P3|COMPLETED|Overall Study||73
238227|NCT00933244|579193|P2|COMPLETED|Overall Study||74
238228|NCT00933244|579194|P1|COMPLETED|Overall Study||74
238229|NCT00933244|579192|P3|STARTED|Overall Study||76
238230|NCT00933244|579193|P2|STARTED|Overall Study||75
238231|NCT00933244|579194|P1|STARTED|Overall Study||79
238232|NCT00933270|579211|P1|NOT COMPLETED|Overall Study||87
238233|NCT00933270|579211|P1|COMPLETED|Overall Study||177
238234|NCT00933270|579211|P1|STARTED|Overall Study|ITT population|264
238235|NCT00933335|579304|P2|NOT COMPLETED|Overall Study||16
238236|NCT00933335|579305|P1|NOT COMPLETED|Overall Study||2
238237|NCT00933335|579304|P2|COMPLETED|Overall Study||20
238238|NCT00933335|579305|P1|COMPLETED|Overall Study||0
238239|NCT00933335|579304|P2|STARTED|Overall Study|35/36 participants who received 3 cycles of fludarabine later received a DD and TD of TST/I 131 TST.|36
238240|NCT00933335|579305|P1|STARTED|Overall Study||2
238241|NCT00933491|579377|P2|NOT COMPLETED|Overall Study||0
238242|NCT00933491|579378|P1|NOT COMPLETED|Overall Study||0
238243|NCT00933491|579377|P2|COMPLETED|Overall Study||18
238244|NCT00933491|579378|P1|COMPLETED|Overall Study||14
238245|NCT00933491|579377|P2|STARTED|Overall Study||18
238246|NCT00933491|579378|P1|STARTED|Overall Study||14
238247|NCT00933543|579388|P2|NOT COMPLETED|Overall Study||7
238248|NCT00933543|579389|P1|NOT COMPLETED|Overall Study||3
238249|NCT00933543|579388|P2|COMPLETED|Overall Study||46
238250|NCT00933543|579389|P1|COMPLETED|Overall Study||51
238251|NCT00933543|579388|P2|STARTED|Overall Study||53
238252|NCT00933543|579389|P1|STARTED|Overall Study||54
238253|NCT00933608|579447|P2|NOT COMPLETED|Overall Study||2
238254|NCT00933608|579448|P1|NOT COMPLETED|Overall Study||5
238255|NCT00933608|579447|P2|COMPLETED|Overall Study||8
238256|NCT00933608|579448|P1|COMPLETED|Overall Study||2
238257|NCT00933608|579447|P2|STARTED|Overall Study||10
238258|NCT00933608|579448|P1|STARTED|Overall Study||7
238259|NCT00933686|579456|P2|NOT COMPLETED|Overall Study||11
238260|NCT00933686|579457|P1|NOT COMPLETED|Overall Study||10
238261|NCT00933686|579456|P2|COMPLETED|Overall Study||47
238262|NCT00933686|579457|P1|COMPLETED|Overall Study||45
238263|NCT00933686|579456|P2|STARTED|Overall Study||58
238264|NCT00933686|579457|P1|STARTED|Overall Study||55
238265|NCT00933933|579480|P3|NOT COMPLETED|Pediatric From 2 to 21 Years||0
238266|NCT00933933|579481|P2|NOT COMPLETED|Pediatric From 2 to 21 Years||0
238267|NCT00933933|579482|P1|NOT COMPLETED|Pediatric From 2 to 21 Years||0
238268|NCT00933933|579480|P3|COMPLETED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women|0
238269|NCT00933933|579481|P2|COMPLETED|Pediatric From 2 to 21 Years||64
238270|NCT00933933|579482|P1|COMPLETED|Pediatric From 2 to 21 Years||588
238271|NCT00933933|579480|P3|STARTED|Pediatric From 2 to 21 Years|Specimens from individuals 16-21 years included reactivity for general population or pregnant women.|0
238272|NCT00933933|579481|P2|STARTED|Pediatric From 2 to 21 Years||64
238273|NCT00933933|579482|P1|STARTED|Pediatric From 2 to 21 Years||588
238274|NCT00933933|579480|P3|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
238275|NCT00933933|579481|P2|NOT COMPLETED|Pregnant Females Between 16-44 Years||2
238276|NCT00933933|579482|P1|NOT COMPLETED|Pregnant Females Between 16-44 Years||0
238277|NCT00933933|579480|P3|COMPLETED|Pregnant Females Between 16-44 Years||203
238278|NCT00933933|579481|P2|COMPLETED|Pregnant Females Between 16-44 Years||65
238279|NCT00933933|579482|P1|COMPLETED|Pregnant Females Between 16-44 Years||448
238280|NCT00933933|579480|P3|STARTED|Pregnant Females Between 16-44 Years||203
238281|NCT00933933|579481|P2|STARTED|Pregnant Females Between 16-44 Years||67
238282|NCT00933933|579482|P1|STARTED|Pregnant Females Between 16-44 Years||448
238283|NCT00933933|579480|P3|NOT COMPLETED|General Population From 16 to 89 Years||0
238284|NCT00933933|579481|P2|NOT COMPLETED|General Population From 16 to 89 Years||20
238285|NCT00933933|579482|P1|NOT COMPLETED|General Population From 16 to 89 Years||0
238286|NCT00933933|579480|P3|COMPLETED|General Population From 16 to 89 Years||1206
238287|NCT00933933|579481|P2|COMPLETED|General Population From 16 to 89 Years||1267
238288|NCT00933933|579482|P1|COMPLETED|General Population From 16 to 89 Years||6164
238289|NCT00933933|579480|P3|STARTED|General Population From 16 to 89 Years||1206
238290|NCT00933933|579481|P2|STARTED|General Population From 16 to 89 Years||1287
238291|NCT00933933|579482|P1|STARTED|General Population From 16 to 89 Years||6164
238292|NCT00934050|579504|P6|NOT COMPLETED|Enrolled After 15 Dec 2009||4
238293|NCT00934050|579505|P5|NOT COMPLETED|Enrolled After 15 Dec 2009||7
238294|NCT00934050|579506|P4|NOT COMPLETED|Enrolled After 15 Dec 2009||0
238295|NCT00934050|579507|P3|NOT COMPLETED|Enrolled After 15 Dec 2009||0
238296|NCT00934050|579508|P2|NOT COMPLETED|Enrolled After 15 Dec 2009||0
238297|NCT00934050|579509|P1|NOT COMPLETED|Enrolled After 15 Dec 2009||0
238298|NCT00934050|579504|P6|COMPLETED|Enrolled After 15 Dec 2009||23
238299|NCT00934050|579505|P5|COMPLETED|Enrolled After 15 Dec 2009||19
238300|NCT00934050|579506|P4|COMPLETED|Enrolled After 15 Dec 2009||0
238301|NCT00934050|579507|P3|COMPLETED|Enrolled After 15 Dec 2009||0
238302|NCT00934050|579508|P2|COMPLETED|Enrolled After 15 Dec 2009||0
238303|NCT00934050|579509|P1|COMPLETED|Enrolled After 15 Dec 2009||0
238304|NCT00934050|579504|P6|STARTED|Enrolled After 15 Dec 2009||27
238305|NCT00934050|579505|P5|STARTED|Enrolled After 15 Dec 2009||26
238306|NCT00934050|579506|P4|STARTED|Enrolled After 15 Dec 2009||0
238307|NCT00934050|579507|P3|STARTED|Enrolled After 15 Dec 2009||0
238308|NCT00934050|579508|P2|STARTED|Enrolled After 15 Dec 2009||0
238309|NCT00934050|579509|P1|STARTED|Enrolled After 15 Dec 2009||0
238310|NCT00934050|579504|P6|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
238311|NCT00934050|579505|P5|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||0
238312|NCT00934050|579506|P4|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||14
238313|NCT00934050|579507|P3|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
238314|NCT00934050|579508|P2|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
238315|NCT00934050|579509|P1|NOT COMPLETED|Enrolled Prior to 15 Dec 2009||12
238316|NCT00934050|579504|P6|COMPLETED|Enrolled Prior to 15 Dec 2009||0
238317|NCT00934050|579505|P5|COMPLETED|Enrolled Prior to 15 Dec 2009||0
238318|NCT00934050|579506|P4|COMPLETED|Enrolled Prior to 15 Dec 2009||0
238319|NCT00934050|579507|P3|COMPLETED|Enrolled Prior to 15 Dec 2009||0
238320|NCT00934050|579508|P2|COMPLETED|Enrolled Prior to 15 Dec 2009||0
238321|NCT00934050|579509|P1|COMPLETED|Enrolled Prior to 15 Dec 2009||0
238322|NCT00934050|579504|P6|STARTED|Enrolled Prior to 15 Dec 2009||0
238323|NCT00934050|579505|P5|STARTED|Enrolled Prior to 15 Dec 2009||0
238324|NCT00934050|579506|P4|STARTED|Enrolled Prior to 15 Dec 2009||14
238325|NCT00934050|579507|P3|STARTED|Enrolled Prior to 15 Dec 2009||12
238326|NCT00934050|579508|P2|STARTED|Enrolled Prior to 15 Dec 2009||12
238327|NCT00934050|579509|P1|STARTED|Enrolled Prior to 15 Dec 2009||12
238328|NCT00934102|579519|P3|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
238329|NCT00934102|579520|P2|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
238330|NCT00934102|579521|P1|NOT COMPLETED|Period 2, 7 Days/6 Nights of Wear||0
238331|NCT00934102|579519|P3|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
238332|NCT00934102|579520|P2|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
238333|NCT00934102|579521|P1|COMPLETED|Period 2, 7 Days/6 Nights of Wear||15
238334|NCT00934102|579519|P3|STARTED|Period 2, 7 Days/6 Nights of Wear||15
238335|NCT00934102|579520|P2|STARTED|Period 2, 7 Days/6 Nights of Wear||15
238336|NCT00934102|579521|P1|STARTED|Period 2, 7 Days/6 Nights of Wear||15
238337|NCT00934102|579519|P3|NOT COMPLETED|Period 1, One Night of Wear||0
238338|NCT00934102|579520|P2|NOT COMPLETED|Period 1, One Night of Wear||0
238339|NCT00934102|579521|P1|NOT COMPLETED|Period 1, One Night of Wear||1
238340|NCT00934102|579519|P3|COMPLETED|Period 1, One Night of Wear||15
238341|NCT00934102|579520|P2|COMPLETED|Period 1, One Night of Wear||15
238342|NCT00934102|579521|P1|COMPLETED|Period 1, One Night of Wear||15
238343|NCT00934102|579519|P3|STARTED|Period 1, One Night of Wear||15
238344|NCT00934102|579520|P2|STARTED|Period 1, One Night of Wear||15
238345|NCT00934102|579521|P1|STARTED|Period 1, One Night of Wear||16
238346|NCT00934128|579531|P2|NOT COMPLETED|Second Intervention (2 Hours)||3
238347|NCT00934128|579532|P1|NOT COMPLETED|Second Intervention (2 Hours)||0
238348|NCT00934128|579531|P2|COMPLETED|Second Intervention (2 Hours)||5
238349|NCT00934128|579532|P1|COMPLETED|Second Intervention (2 Hours)||3
238350|NCT00934128|579531|P2|STARTED|Second Intervention (2 Hours)||8
238351|NCT00934128|579532|P1|STARTED|Second Intervention (2 Hours)||3
238352|NCT00934128|579531|P2|NOT COMPLETED|Washout Period (1 Hour)||5
238353|NCT00934128|579532|P1|NOT COMPLETED|Washout Period (1 Hour)||7
238354|NCT00934128|579531|P2|COMPLETED|Washout Period (1 Hour)||8
238355|NCT00934128|579532|P1|COMPLETED|Washout Period (1 Hour)||3
238356|NCT00934128|579531|P2|STARTED|Washout Period (1 Hour)||13
238357|NCT00934128|579532|P1|STARTED|Washout Period (1 Hour)||10
238358|NCT00934128|579531|P2|NOT COMPLETED|First Intervention (2 Hours)||2
238359|NCT00934128|579532|P1|NOT COMPLETED|First Intervention (2 Hours)||5
238360|NCT00934128|579531|P2|COMPLETED|First Intervention (2 Hours)||13
238361|NCT00934128|579532|P1|COMPLETED|First Intervention (2 Hours)||10
238362|NCT00934128|579531|P2|STARTED|First Intervention (2 Hours)||15
238363|NCT00934128|579532|P1|STARTED|First Intervention (2 Hours)||15
238364|NCT00934141|579544|P4|NOT COMPLETED|Overall Study||3
238365|NCT00934141|579545|P3|NOT COMPLETED|Overall Study||0
238366|NCT00934141|579546|P2|NOT COMPLETED|Overall Study||3
238367|NCT00934141|579547|P1|NOT COMPLETED|Overall Study||4
238368|NCT00934141|579544|P4|COMPLETED|Overall Study||51
238369|NCT00934141|579545|P3|COMPLETED|Overall Study||48
238370|NCT00934141|579546|P2|COMPLETED|Overall Study||47
238371|NCT00934141|579547|P1|COMPLETED|Overall Study||45
238372|NCT00934141|579544|P4|STARTED|Overall Study||54
238373|NCT00934141|579545|P3|STARTED|Overall Study||48
238374|NCT00934141|579546|P2|STARTED|Overall Study||50
238375|NCT00934141|579547|P1|STARTED|Overall Study||49
238376|NCT00934180|579571|P2|NOT COMPLETED|Second Intervention||0
238377|NCT00934180|579572|P1|NOT COMPLETED|Second Intervention||0
238378|NCT00934180|579571|P2|COMPLETED|Second Intervention||12
238379|NCT00934180|579572|P1|COMPLETED|Second Intervention||12
238380|NCT00934180|579571|P2|STARTED|Second Intervention||12
238381|NCT00934180|579572|P1|STARTED|Second Intervention||12
238382|NCT00934180|579571|P2|NOT COMPLETED|First Intervention||0
238383|NCT00934180|579572|P1|NOT COMPLETED|First Intervention||0
238384|NCT00934180|579571|P2|COMPLETED|First Intervention||12
238385|NCT00934180|579572|P1|COMPLETED|First Intervention||12
238386|NCT00934180|579571|P2|STARTED|First Intervention||12
238387|NCT00934180|579572|P1|STARTED|First Intervention||12
238388|NCT00934362|579582|P2|NOT COMPLETED|Overall Study||0
238389|NCT00934362|579583|P1|NOT COMPLETED|Overall Study||1
238390|NCT00934362|579582|P2|COMPLETED|Overall Study||8
238391|NCT00934362|579583|P1|COMPLETED|Overall Study||7
238392|NCT00934362|579582|P2|STARTED|Overall Study||8
238393|NCT00934362|579583|P1|STARTED|Overall Study||8
238394|NCT00934375|579593|P2|NOT COMPLETED|Overall Study||22
238395|NCT00934375|579594|P1|NOT COMPLETED|Overall Study||13
238396|NCT00934375|579593|P2|COMPLETED|Overall Study||55
238397|NCT00934375|579594|P1|COMPLETED|Overall Study||55
238398|NCT00934375|579593|P2|STARTED|Overall Study||77
238399|NCT00934375|579594|P1|STARTED|Overall Study||68
238400|NCT00934440|579600|P1|NOT COMPLETED|Overall Study||1
238401|NCT00934440|579600|P1|COMPLETED|Overall Study||10
238402|NCT00934440|579600|P1|STARTED|Overall Study||11
238403|NCT00934544|579607|P2|NOT COMPLETED|Overall Study||42
238404|NCT00934544|579608|P1|NOT COMPLETED|Overall Study||55
238405|NCT00934544|579607|P2|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for the BAT group|31
238406|NCT00934544|579608|P1|COMPLETED|Overall Study|Participants ongoing in the randomized treatment phase for INC424/INCB018424 group|91
238407|NCT00934544|579607|P2|STARTED|Overall Study||73
238408|NCT00934544|579608|P1|STARTED|Overall Study||146
238409|NCT00934596|579624|P2|NOT COMPLETED|Overall Study||0
238410|NCT00934596|579625|P1|NOT COMPLETED|Overall Study||0
238411|NCT00934596|579624|P2|COMPLETED|Overall Study||10
238412|NCT00934596|579625|P1|COMPLETED|Overall Study||10
238413|NCT00934596|579624|P2|STARTED|Overall Study||10
238414|NCT00934596|579625|P1|STARTED|Overall Study|Twenty patients were prospectively randomly assigned to the two arms|10
238415|NCT00934622|579653|P1|NOT COMPLETED|Overall Study||8
238416|NCT00934622|579653|P1|COMPLETED|Overall Study||68
238417|NCT00934622|579653|P1|STARTED|Overall Study||76
238418|NCT00934635|579667|P9|NOT COMPLETED|Overall Study||0
238419|NCT00934635|579668|P8|NOT COMPLETED|Overall Study||0
238420|NCT00934635|579669|P7|NOT COMPLETED|Overall Study||0
238421|NCT00934635|579670|P6|NOT COMPLETED|Overall Study||0
238422|NCT00934635|579671|P5|NOT COMPLETED|Overall Study||0
238423|NCT00934635|579672|P4|NOT COMPLETED|Overall Study||0
238424|NCT00934635|579673|P3|NOT COMPLETED|Overall Study||0
238425|NCT00934635|579674|P2|NOT COMPLETED|Overall Study||0
238426|NCT00934635|579675|P1|NOT COMPLETED|Overall Study||0
238427|NCT00934635|579667|P9|COMPLETED|Overall Study||1
238428|NCT00934635|579668|P8|COMPLETED|Overall Study||0
238429|NCT00934635|579669|P7|COMPLETED|Overall Study||0
238430|NCT00934635|579670|P6|COMPLETED|Overall Study||0
238431|NCT00934635|579671|P5|COMPLETED|Overall Study||0
238432|NCT00934635|579672|P4|COMPLETED|Overall Study||0
238433|NCT00934635|579673|P3|COMPLETED|Overall Study||0
238434|NCT00934635|579674|P2|COMPLETED|Overall Study||1
238435|NCT00934635|579675|P1|COMPLETED|Overall Study||0
238436|NCT00934635|579667|P9|STARTED|Overall Study||1
238437|NCT00934635|579668|P8|STARTED|Overall Study||0
238438|NCT00934635|579669|P7|STARTED|Overall Study||0
238439|NCT00934635|579670|P6|STARTED|Overall Study||0
238440|NCT00934635|579671|P5|STARTED|Overall Study||0
238441|NCT00934635|579672|P4|STARTED|Overall Study||0
238442|NCT00934635|579673|P3|STARTED|Overall Study||0
238443|NCT00934635|579674|P2|STARTED|Overall Study||1
238444|NCT00934635|579675|P1|STARTED|Overall Study||0
238445|NCT00934648|579695|P1|NOT COMPLETED|Overall Study||9
238446|NCT00934648|579695|P1|COMPLETED|Overall Study||6
238447|NCT00934648|579695|P1|STARTED|Overall Study||15
238448|NCT00934791|579704|P2|NOT COMPLETED|Overall Study||0
238449|NCT00934791|579705|P1|NOT COMPLETED|Overall Study||1
238450|NCT00934791|579704|P2|COMPLETED|Overall Study||0
238451|NCT00934791|579705|P1|COMPLETED|Overall Study||0
238452|NCT00934791|579704|P2|STARTED|Overall Study||0
238453|NCT00934791|579705|P1|STARTED|Overall Study||1
238454|NCT00934843|579713|P2|NOT COMPLETED|Overall Study||1
238455|NCT00934843|579714|P1|NOT COMPLETED|Overall Study||0
238456|NCT00934843|579713|P2|COMPLETED|Overall Study|1 subject discontinued intervention, surgery plan changed and did not require CPB|39
238457|NCT00934843|579714|P1|COMPLETED|Overall Study||37
238458|NCT00934843|579713|P2|STARTED|Overall Study||40
238459|NCT00934843|579714|P1|STARTED|Overall Study||37
238460|NCT00934856|579734|P6|NOT COMPLETED|Extension Part||5
238461|NCT00934856|579735|P5|NOT COMPLETED|Extension Part||4
238462|NCT00934856|579736|P4|NOT COMPLETED|Extension Part||2
238463|NCT00934856|579737|P3|NOT COMPLETED|Extension Part||0
238464|NCT00934856|579738|P2|NOT COMPLETED|Extension Part||0
238465|NCT00934856|579739|P1|NOT COMPLETED|Extension Part||0
238466|NCT00934856|579734|P6|COMPLETED|Extension Part||19
238467|NCT00934856|579735|P5|COMPLETED|Extension Part||24
238468|NCT00934856|579736|P4|COMPLETED|Extension Part||2
238469|NCT00934856|579737|P3|COMPLETED|Extension Part||0
238470|NCT00934856|579738|P2|COMPLETED|Extension Part||0
238471|NCT00934856|579739|P1|COMPLETED|Extension Part||0
238472|NCT00934856|579734|P6|STARTED|Extension Part|New participants were enrolled in the extension part.|24
238473|NCT00934856|579735|P5|STARTED|Extension Part|New participants were enrolled in the extension part.|28
238474|NCT00934856|579736|P4|STARTED|Extension Part|New participants were enrolled in the extension part.|4
238475|NCT00934856|579737|P3|STARTED|Extension Part||0
238476|NCT00934856|579738|P2|STARTED|Extension Part||0
238477|NCT00934856|579739|P1|STARTED|Extension Part||0
238478|NCT00934856|579734|P6|NOT COMPLETED|Feasibility Part||3
238479|NCT00934856|579735|P5|NOT COMPLETED|Feasibility Part||0
238480|NCT00934856|579736|P4|NOT COMPLETED|Feasibility Part||5
238481|NCT00934856|579737|P3|NOT COMPLETED|Feasibility Part||3
238482|NCT00934856|579738|P2|NOT COMPLETED|Feasibility Part||5
238483|NCT00934856|579739|P1|NOT COMPLETED|Feasibility Part||5
238484|NCT00934856|579734|P6|COMPLETED|Feasibility Part||6
238485|NCT00934856|579735|P5|COMPLETED|Feasibility Part||12
238486|NCT00934856|579736|P4|COMPLETED|Feasibility Part||1
238487|NCT00934856|579737|P3|COMPLETED|Feasibility Part||0
238488|NCT00934856|579738|P2|COMPLETED|Feasibility Part||1
238489|NCT00934856|579739|P1|COMPLETED|Feasibility Part||1
238490|NCT00934856|579734|P6|STARTED|Feasibility Part||9
238491|NCT00934856|579735|P5|STARTED|Feasibility Part||12
238492|NCT00934856|579736|P4|STARTED|Feasibility Part||6
238493|NCT00934856|579737|P3|STARTED|Feasibility Part||3
238494|NCT00934856|579738|P2|STARTED|Feasibility Part||6
238495|NCT00934856|579739|P1|STARTED|Feasibility Part||6
238496|NCT00934921|579837|P2|NOT COMPLETED|Second Intervention||0
238497|NCT00934921|579838|P1|NOT COMPLETED|Second Intervention||0
238498|NCT00934921|579837|P2|COMPLETED|Second Intervention||12
238499|NCT00934921|579838|P1|COMPLETED|Second Intervention||12
238500|NCT00934921|579837|P2|STARTED|Second Intervention||12
238501|NCT00934921|579838|P1|STARTED|Second Intervention||12
238502|NCT00934921|579837|P2|NOT COMPLETED|First Intervention||0
238503|NCT00934921|579838|P1|NOT COMPLETED|First Intervention||0
238504|NCT00934921|579837|P2|COMPLETED|First Intervention||12
238505|NCT00934921|579838|P1|COMPLETED|First Intervention||12
238506|NCT00934921|579837|P2|STARTED|First Intervention||12
238507|NCT00934921|579838|P1|STARTED|First Intervention||12
238508|NCT00934947|579848|P2|NOT COMPLETED|Overall Study||2
238509|NCT00934947|579849|P1|NOT COMPLETED|Overall Study||0
238510|NCT00934947|579848|P2|COMPLETED|Overall Study||20
238511|NCT00934947|579849|P1|COMPLETED|Overall Study||23
238512|NCT00934947|579848|P2|STARTED|Overall Study||22
238513|NCT00934947|579849|P1|STARTED|Overall Study||23
238514|NCT00935064|579857|P2|NOT COMPLETED|Overall Study||0
238515|NCT00935064|579858|P1|NOT COMPLETED|Overall Study||0
238516|NCT00935064|579857|P2|COMPLETED|Overall Study||30
238517|NCT00935064|579858|P1|COMPLETED|Overall Study||30
238518|NCT00935064|579857|P2|STARTED|Overall Study||30
238519|NCT00935064|579858|P1|STARTED|Overall Study||30
238520|NCT00935220|579872|P1|NOT COMPLETED|Overall Study||2
238521|NCT00935220|579872|P1|COMPLETED|Overall Study||39
238522|NCT00935220|579872|P1|STARTED|Overall Study||41
238523|NCT00935259|579884|P2|NOT COMPLETED|Period 2||0
238524|NCT00935259|579885|P1|NOT COMPLETED|Period 2||0
238525|NCT00935259|579884|P2|COMPLETED|Period 2||14
238526|NCT00935259|579885|P1|COMPLETED|Period 2||15
238527|NCT00935259|579884|P2|STARTED|Period 2||14
238528|NCT00935259|579885|P1|STARTED|Period 2||15
238529|NCT00935259|579884|P2|NOT COMPLETED|Period 1||1
238530|NCT00935259|579885|P1|NOT COMPLETED|Period 1||1
238531|NCT00935259|579884|P2|COMPLETED|Period 1||14
238532|NCT00935259|579885|P1|COMPLETED|Period 1||15
238533|NCT00935259|579884|P2|STARTED|Period 1||15
238534|NCT00935259|579885|P1|STARTED|Period 1||16
238535|NCT00935272|579901|P2|NOT COMPLETED|Overall Study||6
238536|NCT00935272|579902|P1|NOT COMPLETED|Overall Study||19
238537|NCT00935272|579901|P2|COMPLETED|Overall Study||39
238538|NCT00935272|579902|P1|COMPLETED|Overall Study||116
238539|NCT00935272|579901|P2|STARTED|Overall Study||45
238540|NCT00935272|579902|P1|STARTED|Overall Study||135
238541|NCT00935311|579914|P3|NOT COMPLETED|Overall Study||0
238542|NCT00935311|579915|P2|NOT COMPLETED|Overall Study||0
238543|NCT00935311|579916|P1|NOT COMPLETED|Overall Study||0
238544|NCT00935311|579914|P3|COMPLETED|Overall Study||40
238545|NCT00935311|579915|P2|COMPLETED|Overall Study||39
238546|NCT00935311|579916|P1|COMPLETED|Overall Study||43
238547|NCT00935311|579914|P3|STARTED|Overall Study||40
238548|NCT00935311|579915|P2|STARTED|Overall Study||39
238549|NCT00935311|579916|P1|STARTED|Overall Study||43
238550|NCT00935493|579936|P3|NOT COMPLETED|Overall Study||1
238551|NCT00935493|579937|P2|NOT COMPLETED|Overall Study||2
238552|NCT00935493|579938|P1|NOT COMPLETED|Overall Study||1
238553|NCT00935493|579936|P3|COMPLETED|Overall Study||40
238554|NCT00935493|579937|P2|COMPLETED|Overall Study||39
238555|NCT00935493|579938|P1|COMPLETED|Overall Study||40
238556|NCT00935493|579936|P3|STARTED|Overall Study||41
238557|NCT00935493|579937|P2|STARTED|Overall Study||41
238558|NCT00935493|579938|P1|STARTED|Overall Study||41
238559|NCT00935532|579954|P2|NOT COMPLETED|Overall Study||11
238560|NCT00935532|579955|P1|NOT COMPLETED|Overall Study||22
238561|NCT00935532|579954|P2|COMPLETED|Overall Study||201
238562|NCT00935532|579955|P1|COMPLETED|Overall Study||193
238563|NCT00935532|579954|P2|STARTED|Overall Study||212
238564|NCT00935532|579955|P1|STARTED|Overall Study||215
238565|NCT00935584|579983|P2|NOT COMPLETED|Overall Study||4
238566|NCT00935584|579984|P1|NOT COMPLETED|Overall Study||49
238567|NCT00935584|579983|P2|COMPLETED|Overall Study||19
238568|NCT00935584|579984|P1|COMPLETED|Overall Study||77
238569|NCT00935584|579983|P2|STARTED|Overall Study||23
238570|NCT00935584|579984|P1|STARTED|Overall Study|Out of 128 participants consented, 2 patients had no data collected, as the clinic was cancelled.|126
238571|NCT00941304|579999|P5|NOT COMPLETED|Overall Study||0
238572|NCT00941304|580000|P4|NOT COMPLETED|Overall Study||0
238573|NCT00941304|580001|P3|NOT COMPLETED|Overall Study||0
238574|NCT00941304|580002|P2|NOT COMPLETED|Overall Study||0
238575|NCT00941304|580003|P1|NOT COMPLETED|Overall Study||1
238576|NCT00941304|579999|P5|COMPLETED|Overall Study||31
238577|NCT00941304|580000|P4|COMPLETED|Overall Study||30
238578|NCT00941304|580001|P3|COMPLETED|Overall Study||31
238579|NCT00941304|580002|P2|COMPLETED|Overall Study||30
238580|NCT00941304|580003|P1|COMPLETED|Overall Study||30
238581|NCT00941304|579999|P5|STARTED|Overall Study||31
238582|NCT00941304|580000|P4|STARTED|Overall Study||30
238583|NCT00941304|580001|P3|STARTED|Overall Study||31
238584|NCT00941304|580002|P2|STARTED|Overall Study||30
238585|NCT00941304|580003|P1|STARTED|Overall Study||31
238586|NCT00941330|580067|P2|NOT COMPLETED|Overall Study||2
238587|NCT00941330|580068|P1|NOT COMPLETED|Overall Study||1
238588|NCT00941330|580067|P2|COMPLETED|Overall Study||9
238589|NCT00941330|580068|P1|COMPLETED|Overall Study||14
238590|NCT00941330|580067|P2|STARTED|Overall Study||11
238591|NCT00941330|580068|P1|STARTED|Overall Study||15
238592|NCT00941603|580082|P6|NOT COMPLETED|Overall Study||3
238593|NCT00941603|580083|P5|NOT COMPLETED|Overall Study||4
238594|NCT00941603|580084|P4|NOT COMPLETED|Overall Study||4
238595|NCT00941603|580085|P3|NOT COMPLETED|Overall Study||5
238596|NCT00941603|580086|P2|NOT COMPLETED|Overall Study||16
238597|NCT00941603|580087|P1|NOT COMPLETED|Overall Study||11
238598|NCT00941603|580082|P6|COMPLETED|Overall Study||94
238599|NCT00941603|580083|P5|COMPLETED|Overall Study||101
238600|NCT00941603|580084|P4|COMPLETED|Overall Study||100
238601|NCT00941603|580085|P3|COMPLETED|Overall Study||99
238602|NCT00941603|580086|P2|COMPLETED|Overall Study||89
238603|NCT00941603|580087|P1|COMPLETED|Overall Study||93
238604|NCT00941603|580082|P6|STARTED|Overall Study||97
238605|NCT00941603|580083|P5|STARTED|Overall Study||105
238606|NCT00941603|580084|P4|STARTED|Overall Study||104
238607|NCT00941603|580085|P3|STARTED|Overall Study||104
238608|NCT00941603|580086|P2|STARTED|Overall Study||105
238609|NCT00941603|580087|P1|STARTED|Overall Study||104
238610|NCT00941798|580109|P2|NOT COMPLETED|Overall Study||185
238611|NCT00941798|580110|P1|NOT COMPLETED|Overall Study||194
238612|NCT00941798|580109|P2|COMPLETED|Overall Study||578
238613|NCT00941798|580110|P1|COMPLETED|Overall Study||561
238614|NCT00941798|580109|P2|Full Analysis Set|Overall Study||759
238615|NCT00941798|580110|P1|Full Analysis Set|Overall Study||749
238616|NCT00941798|580109|P2|STARTED|Overall Study||763
238617|NCT00941798|580110|P1|STARTED|Overall Study||755
238618|NCT00941863|580143|P5|NOT COMPLETED|Continued After PCD||19
238619|NCT00941863|580144|P4|NOT COMPLETED|Continued After PCD||0
238620|NCT00941863|580145|P3|NOT COMPLETED|Continued After PCD||0
238621|NCT00941863|580146|P2|NOT COMPLETED|Continued After PCD||0
238622|NCT00941863|580147|P1|NOT COMPLETED|Continued After PCD||0
238623|NCT00941863|580143|P5|COMPLETED|Continued After PCD||6
238624|NCT00941863|580144|P4|COMPLETED|Continued After PCD||0
238625|NCT00941863|580145|P3|COMPLETED|Continued After PCD||0
238626|NCT00941863|580146|P2|COMPLETED|Continued After PCD||0
238627|NCT00941863|580147|P1|COMPLETED|Continued After PCD||0
238628|NCT00941863|580143|P5|STARTED|Continued After PCD|25 of 119 participants from the Expansion Phase, were still on the treatment as of 31 May 2005.|25
238629|NCT00941863|580144|P4|STARTED|Continued After PCD||0
238630|NCT00941863|580145|P3|STARTED|Continued After PCD||0
238631|NCT00941863|580146|P2|STARTED|Continued After PCD||0
238632|NCT00941863|580147|P1|STARTED|Continued After PCD||0
238633|NCT00941863|580143|P5|NOT COMPLETED|Until Primary Completion Date (PCD)||94
238634|NCT00941863|580144|P4|NOT COMPLETED|Until Primary Completion Date (PCD)||17
238635|NCT00941863|580145|P3|NOT COMPLETED|Until Primary Completion Date (PCD)||12
238636|NCT00941863|580146|P2|NOT COMPLETED|Until Primary Completion Date (PCD)||3
238637|NCT00941863|580147|P1|NOT COMPLETED|Until Primary Completion Date (PCD)||7
238638|NCT00941863|580143|P5|COMPLETED|Until Primary Completion Date (PCD)||25
238639|NCT00941863|580144|P4|COMPLETED|Until Primary Completion Date (PCD)||0
238640|NCT00941863|580145|P3|COMPLETED|Until Primary Completion Date (PCD)||0
238641|NCT00941863|580146|P2|COMPLETED|Until Primary Completion Date (PCD)||0
238642|NCT00941863|580147|P1|COMPLETED|Until Primary Completion Date (PCD)||0
238643|NCT00941863|580143|P5|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||94
238644|NCT00941863|580144|P4|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||17
238645|NCT00941863|580145|P3|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||12
238646|NCT00941863|580146|P2|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||3
238647|NCT00941863|580147|P1|Maximum Tolerated Dose|Until Primary Completion Date (PCD)||7
238648|NCT00941863|580143|P5|STARTED|Until Primary Completion Date (PCD)||119
238649|NCT00941863|580144|P4|STARTED|Until Primary Completion Date (PCD)||17
238650|NCT00941863|580145|P3|STARTED|Until Primary Completion Date (PCD)||12
238651|NCT00941863|580146|P2|STARTED|Until Primary Completion Date (PCD)||3
238652|NCT00941863|580147|P1|STARTED|Until Primary Completion Date (PCD)||7
238653|NCT00941889|580174|P2|NOT COMPLETED|Overall Study||12
238654|NCT00941889|580175|P1|NOT COMPLETED|Overall Study||12
238655|NCT00941889|580174|P2|COMPLETED|Overall Study||3
238656|NCT00941889|580175|P1|COMPLETED|Overall Study||5
238657|NCT00941889|580174|P2|STARTED|Overall Study||15
238658|NCT00941889|580175|P1|STARTED|Overall Study||17
238659|NCT00941928|580181|P1|NOT COMPLETED|Overall Study||2
238660|NCT00941928|580181|P1|COMPLETED|Overall Study||0
238661|NCT00941928|580181|P1|STARTED|Overall Study||2
238662|NCT00941993|580185|P1|NOT COMPLETED|Overall Study||0
238663|NCT00941993|580185|P1|COMPLETED|Overall Study||109
238664|NCT00941993|580185|P1|STARTED|Overall Study||109
238665|NCT00942084|580193|P1|NOT COMPLETED|Overall Study||2
238666|NCT00942084|580193|P1|COMPLETED|Overall Study|There were 2 infant deaths. None determined to be related to study drug.|30
238667|NCT00942084|580193|P1|STARTED|Overall Study||32
238668|NCT00942149|580202|P1|NOT COMPLETED|Overall Study||0
238669|NCT00942149|580202|P1|COMPLETED|Overall Study||20
238670|NCT00942149|580202|P1|STARTED|Overall Study||20
238671|NCT00942175|580210|P4|NOT COMPLETED|Overall Study||2
238672|NCT00942175|580211|P3|NOT COMPLETED|Overall Study||2
238673|NCT00942175|580212|P2|NOT COMPLETED|Overall Study||4
238674|NCT00942175|580213|P1|NOT COMPLETED|Overall Study||2
238675|NCT00942175|580210|P4|COMPLETED|Overall Study||38
238676|NCT00942175|580211|P3|COMPLETED|Overall Study||38
238677|NCT00942175|580212|P2|COMPLETED|Overall Study||36
238678|NCT00942175|580213|P1|COMPLETED|Overall Study||38
238679|NCT00942175|580210|P4|STARTED|Overall Study||40
238680|NCT00942175|580211|P3|STARTED|Overall Study||40
238681|NCT00942175|580212|P2|STARTED|Overall Study||40
238682|NCT00942175|580213|P1|STARTED|Overall Study||40
238683|NCT00942266|580265|P2|NOT COMPLETED|Overall Study||15
238684|NCT00942266|580266|P1|NOT COMPLETED|Overall Study||43
238685|NCT00942266|580265|P2|COMPLETED|Overall Study||0
238686|NCT00942266|580266|P1|COMPLETED|Overall Study||0
238687|NCT00942266|580265|P2|STARTED|Overall Study||15
238688|NCT00942266|580266|P1|STARTED|Overall Study||43
238689|NCT00942409|580284|P1|NOT COMPLETED|Overall Study||3
238690|NCT00942409|580284|P1|COMPLETED|Overall Study||2
238691|NCT00942409|580284|P1|STARTED|Overall Study||5
238692|NCT00942422|580288|P1|NOT COMPLETED|Overall Study||3
238693|NCT00942422|580288|P1|COMPLETED|Overall Study||5
238694|NCT00942422|580288|P1|STARTED|Overall Study||8
238695|NCT00942448|580296|P4|NOT COMPLETED|Overall Study||0
238696|NCT00942448|580297|P3|NOT COMPLETED|Overall Study||0
238697|NCT00942448|580298|P2|NOT COMPLETED|Overall Study||0
238698|NCT00942448|580299|P1|NOT COMPLETED|Overall Study||0
238699|NCT00942448|580296|P4|COMPLETED|Overall Study||75
238700|NCT00942448|580297|P3|COMPLETED|Overall Study||78
238701|NCT00942448|580298|P2|COMPLETED|Overall Study||76
238702|NCT00942448|580299|P1|COMPLETED|Overall Study||77
238703|NCT00942448|580296|P4|STARTED|Overall Study||75
238704|NCT00942448|580297|P3|STARTED|Overall Study||78
238705|NCT00942448|580298|P2|STARTED|Overall Study||76
238706|NCT00942448|580299|P1|STARTED|Overall Study||77
238707|NCT00942604|580363|P2|NOT COMPLETED|Overall Study||4
238708|NCT00942604|580364|P1|NOT COMPLETED|Overall Study||2
238709|NCT00942604|580363|P2|COMPLETED|Overall Study||99
238710|NCT00942604|580364|P1|COMPLETED|Overall Study||98
238711|NCT00942604|580363|P2|STARTED|Overall Study||103
238712|NCT00942604|580364|P1|STARTED|Overall Study||100
238713|NCT00942734|580372|P1|NOT COMPLETED|Overall Study||8
238714|NCT00942734|580372|P1|COMPLETED|Overall Study||35
238715|NCT00942734|580372|P1|STARTED|Overall Study||43
238716|NCT00942786|580376|P1|NOT COMPLETED|Overall Study||0
238717|NCT00942786|580376|P1|COMPLETED|Overall Study|date of last follow-up|297
238718|NCT00942786|580376|P1|STARTED|Overall Study||297
238719|NCT00942825|580385|P2|NOT COMPLETED|Overall Study||0
238720|NCT00942825|580386|P1|NOT COMPLETED|Overall Study||0
238721|NCT00942825|580385|P2|COMPLETED|Overall Study||98
238722|NCT00942825|580386|P1|COMPLETED|Overall Study||97
238723|NCT00942825|580385|P2|STARTED|Overall Study||98
238724|NCT00942825|580386|P1|STARTED|Overall Study||97
238725|NCT00942851|580394|P2|NOT COMPLETED|Overall Study||1
238726|NCT00942851|580395|P1|NOT COMPLETED|Overall Study||0
238727|NCT00942851|580394|P2|COMPLETED|Overall Study||11
238728|NCT00942851|580395|P1|COMPLETED|Overall Study||12
238729|NCT00942851|580394|P2|STARTED|Overall Study||12
238730|NCT00942851|580395|P1|STARTED|Overall Study||12
238731|NCT00942903|580405|P1|NOT COMPLETED|Overall Study||0
238732|NCT00942903|580405|P1|COMPLETED|Overall Study||20
238733|NCT00942903|580405|P1|STARTED|Overall Study||20
238734|NCT00942968|580410|P1|NOT COMPLETED|Overall Study||229
238735|NCT00942968|580410|P1|COMPLETED|Overall Study||109
238736|NCT00942968|580410|P1|Treated|Overall Study||334
238737|NCT00942968|580410|P1|STARTED|Overall Study||338
238738|NCT00942994|580433|P2|NOT COMPLETED|Overall Study||19
238739|NCT00942994|580434|P1|NOT COMPLETED|Overall Study||16
238740|NCT00942994|580433|P2|COMPLETED|Overall Study||190
238741|NCT00942994|580434|P1|COMPLETED|Overall Study||187
238742|NCT00942994|580433|P2|STARTED|Overall Study||209
238743|NCT00942994|580434|P1|STARTED|Overall Study||203
238744|NCT00943072|580452|P2|NOT COMPLETED|Overall Study||14
238745|NCT00943072|580453|P1|NOT COMPLETED|Overall Study||5
238746|NCT00943072|580452|P2|COMPLETED|Overall Study|60 Participants completed Week 24, From FAS; 50 Participants completed up to Week 100, From SAF|60
238747|NCT00943072|580453|P1|COMPLETED|Overall Study|110 Participants completed Week 24, From FAS; 102 Participants completed up to Week 100, From SAF|110
238748|NCT00943072|580452|P2|Full Analysis Set (FAS) Population|Overall Study||73
238749|NCT00943072|580453|P1|Full Analysis Set (FAS) Population|Overall Study|FAS population used for analysis of Primary and Secondary Outcome Measures|114
238750|NCT00943072|580452|P2|Participants Received Treatment|Overall Study||74
238751|NCT00943072|580453|P1|Participants Received Treatment|Overall Study|Safety population (SAF)|114
238752|NCT00943072|580452|P2|STARTED|Overall Study||74
238753|NCT00943072|580453|P1|STARTED|Overall Study||115
238754|NCT00943098|580471|P2|NOT COMPLETED|Overall Study||0
238755|NCT00943098|580472|P1|NOT COMPLETED|Overall Study||0
238756|NCT00943098|580471|P2|COMPLETED|Overall Study||72
238757|NCT00943098|580472|P1|COMPLETED|Overall Study||70
238758|NCT00943098|580471|P2|STARTED|Overall Study|1 patient was excluded from the ITT and therefore the baseline population is 71|72
238759|NCT00943098|580472|P1|STARTED|Overall Study||70
238760|NCT00943111|580506|P3|NOT COMPLETED|5 Years Long-term Treatment Period||75
238761|NCT00943111|580507|P2|NOT COMPLETED|5 Years Long-term Treatment Period||0
238762|NCT00943111|580508|P1|NOT COMPLETED|5 Years Long-term Treatment Period||0
238763|NCT00943111|580506|P3|COMPLETED|5 Years Long-term Treatment Period||77
238764|NCT00943111|580507|P2|COMPLETED|5 Years Long-term Treatment Period||0
238765|NCT00943111|580508|P1|COMPLETED|5 Years Long-term Treatment Period||0
238766|NCT00943111|580506|P3|STARTED|5 Years Long-term Treatment Period|Participants from both the arms of PAP who completed PAP and remained on-study|152
238767|NCT00943111|580507|P2|STARTED|5 Years Long-term Treatment Period||0
238768|NCT00943111|580508|P1|STARTED|5 Years Long-term Treatment Period||0
238769|NCT00943111|580506|P3|NOT COMPLETED|52-Weeks Primary Analysis Period||0
238770|NCT00943111|580507|P2|NOT COMPLETED|52-Weeks Primary Analysis Period||2
238771|NCT00943111|580508|P1|NOT COMPLETED|52-Weeks Primary Analysis Period||2
238772|NCT00943111|580506|P3|COMPLETED|52-Weeks Primary Analysis Period||0
238773|NCT00943111|580507|P2|COMPLETED|52-Weeks Primary Analysis Period||52
238774|NCT00943111|580508|P1|COMPLETED|52-Weeks Primary Analysis Period||104
238775|NCT00943111|580506|P3|Treated|52-Weeks Primary Analysis Period||0
238776|NCT00943111|580507|P2|Treated|52-Weeks Primary Analysis Period||53
238777|NCT00943111|580508|P1|Treated|52-Weeks Primary Analysis Period||106
238778|NCT00943111|580506|P3|STARTED|52-Weeks Primary Analysis Period||0
238779|NCT00943111|580507|P2|STARTED|52-Weeks Primary Analysis Period||54
238780|NCT00943111|580508|P1|STARTED|52-Weeks Primary Analysis Period||106
238781|NCT00943124|580539|P2|NOT COMPLETED|Period 2||0
238782|NCT00943124|580540|P1|NOT COMPLETED|Period 2||0
238783|NCT00943124|580539|P2|COMPLETED|Period 2||108
238784|NCT00943124|580540|P1|COMPLETED|Period 2||108
238785|NCT00943124|580539|P2|STARTED|Period 2||108
238786|NCT00943124|580540|P1|STARTED|Period 2||108
238787|NCT00943124|580539|P2|NOT COMPLETED|Period 1||2
238788|NCT00943124|580540|P1|NOT COMPLETED|Period 1||2
238789|NCT00943124|580539|P2|COMPLETED|Period 1||108
238790|NCT00943124|580540|P1|COMPLETED|Period 1||108
238791|NCT00943124|580539|P2|STARTED|Period 1||110
238792|NCT00943124|580540|P1|STARTED|Period 1||110
238793|NCT00943150|580562|P2|NOT COMPLETED|Overall Study||0
238794|NCT00943150|580563|P1|NOT COMPLETED|Overall Study||0
238795|NCT00943150|580562|P2|COMPLETED|Overall Study||10
238796|NCT00943150|580563|P1|COMPLETED|Overall Study||10
238797|NCT00943150|580562|P2|STARTED|Overall Study||10
238798|NCT00943150|580563|P1|STARTED|Overall Study||10
238799|NCT00943202|580588|P4|NOT COMPLETED|Overall Study||1
238800|NCT00943202|580589|P3|NOT COMPLETED|Overall Study||0
238801|NCT00943202|580590|P2|NOT COMPLETED|Overall Study||2
238802|NCT00943202|580591|P1|NOT COMPLETED|Overall Study||1
238803|NCT00943202|580588|P4|COMPLETED|Overall Study||131
238804|NCT00943202|580589|P3|COMPLETED|Overall Study||133
238805|NCT00943202|580590|P2|COMPLETED|Overall Study||131
238806|NCT00943202|580591|P1|COMPLETED|Overall Study||132
238807|NCT00943202|580588|P4|STARTED|Overall Study||132
238808|NCT00943202|580589|P3|STARTED|Overall Study||133
238809|NCT00943202|580590|P2|STARTED|Overall Study||133
238810|NCT00943202|580591|P1|STARTED|Overall Study||133
238811|NCT00943384|580805|P1|NOT COMPLETED|Overall Study||49
238812|NCT00943384|580805|P1|COMPLETED|Overall Study|evaluated at the Month 24 visit with complete or partial data|55
238813|NCT00943384|580805|P1|Treated on Protocol|Overall Study|5 subjects were treated off protocol due to intraoperative decisions made by the surgeon|76
238814|NCT00943384|580805|P1|Treated|Overall Study|81 subjects were eligible and willing to participate in the study and were treated|81
238815|NCT00943384|580805|P1|STARTED|Overall Study|104 subjects consented and underwent additional screening to determine eligibility to participate|104
238816|NCT00943397|580821|P2|NOT COMPLETED|Overall Study||72
238817|NCT00943397|580822|P1|NOT COMPLETED|Overall Study||15
238818|NCT00943397|580821|P2|COMPLETED|Overall Study|Site terminated - Merck administrative decision (52); Patient moved (1); Discontinued for other (3)|86
238819|NCT00943397|580822|P1|COMPLETED|Overall Study|Site terminated - Merck administrative decision (11); Discontinued for other (1)|17
238820|NCT00943397|580821|P2|STARTED|Overall Study||158
238821|NCT00943397|580822|P1|STARTED|Overall Study||32
238822|NCT00943436|580830|P2|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
238823|NCT00943436|580831|P1|NOT COMPLETED|Rest Session: 45 Minutes of Reading||0
238824|NCT00943436|580830|P2|COMPLETED|Rest Session: 45 Minutes of Reading||10
238825|NCT00943436|580831|P1|COMPLETED|Rest Session: 45 Minutes of Reading||10
238826|NCT00943436|580830|P2|STARTED|Rest Session: 45 Minutes of Reading||10
238827|NCT00943436|580831|P1|STARTED|Rest Session: 45 Minutes of Reading||10
238828|NCT00943436|580830|P2|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
238829|NCT00943436|580831|P1|NOT COMPLETED|Exercise Session: 45 Minutes of Activity||0
238830|NCT00943436|580830|P2|COMPLETED|Exercise Session: 45 Minutes of Activity||10
238831|NCT00943436|580831|P1|COMPLETED|Exercise Session: 45 Minutes of Activity||10
238832|NCT00943436|580830|P2|STARTED|Exercise Session: 45 Minutes of Activity||10
238833|NCT00943436|580831|P1|STARTED|Exercise Session: 45 Minutes of Activity||10
238834|NCT00943488|580853|P2|NOT COMPLETED|Overall Study||2
238835|NCT00943488|580854|P1|NOT COMPLETED|Overall Study||1
238836|NCT00943488|580853|P2|COMPLETED|Overall Study||202
238837|NCT00943488|580854|P1|COMPLETED|Overall Study||203
238838|NCT00943488|580853|P2|STARTED|Overall Study||204
238839|NCT00943488|580854|P1|STARTED|Overall Study||204
238840|NCT00943579|580910|P2|NOT COMPLETED|Overall Study||5
238841|NCT00943579|580911|P1|NOT COMPLETED|Overall Study||6
238842|NCT00943579|580910|P2|COMPLETED|Overall Study||15
238843|NCT00943579|580911|P1|COMPLETED|Overall Study||15
238844|NCT00943579|580910|P2|STARTED|Overall Study||20
238845|NCT00943579|580911|P1|STARTED|Overall Study||21
238846|NCT00943592|580923|P1|NOT COMPLETED|Overall Study||3
238847|NCT00943592|580923|P1|COMPLETED|Overall Study|None of the three deaths were attributed to the conditioning regimen|79
238848|NCT00943592|580923|P1|Maximum Tolerated Dose|Overall Study|74 patients received the Maximum Tolerated Dose|74
238849|NCT00943592|580923|P1|STARTED|Overall Study||82
238850|NCT00943605|580936|P2|NOT COMPLETED|Overall Study||30
238851|NCT00943605|580937|P1|NOT COMPLETED|Overall Study||30
238852|NCT00943605|580936|P2|COMPLETED|Overall Study||0
238853|NCT00943605|580937|P1|COMPLETED|Overall Study||0
238854|NCT00943605|580936|P2|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
238855|NCT00943605|580937|P1|STARTED|Overall Study|There were 10 total subjects (5/group) who were retrospectively unenrolled for deviations.|30
238856|NCT00943631|580949|P2|NOT COMPLETED|Overall Study||2
238857|NCT00943631|580950|P1|NOT COMPLETED|Overall Study||4
238858|NCT00943631|580949|P2|COMPLETED|Overall Study||202
238859|NCT00943631|580950|P1|COMPLETED|Overall Study||198
238860|NCT00943631|580949|P2|STARTED|Overall Study||204
238861|NCT00943631|580950|P1|STARTED|Overall Study||202
238862|NCT00943670|581000|P1|NOT COMPLETED|Trastuzumab Emtansine + Pertuzumab||18
238863|NCT00943670|581000|P1|COMPLETED|Trastuzumab Emtansine + Pertuzumab|Completed treatment defined as receiving a total of 17 cycles of therapy in both treatment periods.|2
238864|NCT00943670|581000|P1|STARTED|Trastuzumab Emtansine + Pertuzumab|Patients with early progressive disease who elected to receive T-DM1 and pertuzumab.|20
238865|NCT00943670|581000|P1|NOT COMPLETED|Single-agent Trastuzumab Emtansine||42
238866|NCT00943670|581000|P1|COMPLETED|Single-agent Trastuzumab Emtansine|Completed single-agent treatment defined as receiving 17 cycles of trastuzumab emtansine therapy.|9
238867|NCT00943670|581000|P1|Treated|Single-agent Trastuzumab Emtansine||51
238868|NCT00943670|581000|P1|STARTED|Single-agent Trastuzumab Emtansine||51
238869|NCT00943683|581036|P2|NOT COMPLETED|Overall Study||6
238870|NCT00943683|581037|P1|NOT COMPLETED|Overall Study||7
238871|NCT00943683|581036|P2|COMPLETED|Overall Study||169
238872|NCT00943683|581037|P1|COMPLETED|Overall Study||74
238873|NCT00943683|581036|P2|STARTED|Overall Study||175
238874|NCT00943683|581037|P1|STARTED|Overall Study||81
238875|NCT00943722|581048|P5|NOT COMPLETED|Overall Study||22
238876|NCT00943722|581049|P4|NOT COMPLETED|Overall Study||22
238877|NCT00943722|581050|P3|NOT COMPLETED|Overall Study||13
238878|NCT00943722|581051|P2|NOT COMPLETED|Overall Study||22
238879|NCT00943722|581052|P1|NOT COMPLETED|Overall Study||25
238880|NCT00943722|581048|P5|COMPLETED|Overall Study|Includes 4 participants for whom completion status is unknown|448
238881|NCT00943722|581049|P4|COMPLETED|Overall Study||647
238882|NCT00943722|581050|P3|COMPLETED|Overall Study||631
238883|NCT00943722|581051|P2|COMPLETED|Overall Study||621
238884|NCT00943722|581052|P1|COMPLETED|Overall Study||623
238885|NCT00943722|581048|P5|Vaccination 3|Overall Study||455
238886|NCT00943722|581049|P4|Vaccination 3|Overall Study||653
238887|NCT00943722|581050|P3|Vaccination 3|Overall Study||637
238888|NCT00943722|581051|P2|Vaccination 3|Overall Study||627
238889|NCT00943722|581052|P1|Vaccination 3|Overall Study||635
238890|NCT00943722|581048|P5|Vaccination 2|Overall Study||462
238891|NCT00943722|581049|P4|Vaccination 2|Overall Study||658
238892|NCT00943722|581050|P3|Vaccination 2|Overall Study||638
238893|NCT00943722|581051|P2|Vaccination 2|Overall Study||633
238894|NCT00943722|581052|P1|Vaccination 2|Overall Study||637
238895|NCT00943722|581048|P5|Vaccination 1|Overall Study||468
238896|NCT00943722|581049|P4|Vaccination 1|Overall Study||666
238897|NCT00943722|581050|P3|Vaccination 1|Overall Study||644
238898|NCT00943722|581051|P2|Vaccination 1|Overall Study||642
238899|NCT00943722|581052|P1|Vaccination 1|Overall Study||646
238900|NCT00943722|581048|P5|STARTED|Overall Study||470
238901|NCT00943722|581049|P4|STARTED|Overall Study||669
238902|NCT00943722|581050|P3|STARTED|Overall Study||644
238903|NCT00943722|581051|P2|STARTED|Overall Study||643
238904|NCT00943722|581052|P1|STARTED|Overall Study||648
238905|NCT00943735|581080|P1|NOT COMPLETED|Overall Study||32
238906|NCT00943735|581080|P1|COMPLETED|Overall Study||742
238907|NCT00943735|581080|P1|Per Protocol Population|Overall Study||500
238908|NCT00943735|581080|P1|STARTED|Overall Study||774
238909|NCT00943761|581115|P2|NOT COMPLETED|Overall Study||1
238910|NCT00943761|581116|P1|NOT COMPLETED|Overall Study||4
238911|NCT00943761|581115|P2|COMPLETED|Overall Study||23
238912|NCT00943761|581116|P1|COMPLETED|Overall Study||17
238913|NCT00943761|581115|P2|STARTED|Overall Study||24
238914|NCT00943761|581116|P1|STARTED|Overall Study||21
238915|NCT00943787|581128|P1|NOT COMPLETED|Overall Study||7
238916|NCT00943787|581128|P1|COMPLETED|Overall Study||34
238917|NCT00943787|581128|P1|STARTED|Overall Study||41
238918|NCT00943826|581135|P2|NOT COMPLETED|After Primary Overall Survival Analysis||20
238919|NCT00943826|581136|P1|NOT COMPLETED|After Primary Overall Survival Analysis||27
238920|NCT00943826|581135|P2|COMPLETED|After Primary Overall Survival Analysis||0
238921|NCT00943826|581136|P1|COMPLETED|After Primary Overall Survival Analysis||0
238922|NCT00943826|581135|P2|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|20
238923|NCT00943826|581136|P1|STARTED|After Primary Overall Survival Analysis|Some who completed previous period had discontinued, progressed, or died prior to this period.|27
238924|NCT00943826|581135|P2|NOT COMPLETED|Monotherapy Phase||16
238925|NCT00943826|581136|P1|NOT COMPLETED|Monotherapy Phase||65
238926|NCT00943826|581135|P2|COMPLETED|Monotherapy Phase||143
238927|NCT00943826|581136|P1|COMPLETED|Monotherapy Phase||204
238928|NCT00943826|581135|P2|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|159
238929|NCT00943826|581136|P1|STARTED|Monotherapy Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|269
238930|NCT00943826|581135|P2|NOT COMPLETED|Maintenance Phase||39
238931|NCT00943826|581136|P1|NOT COMPLETED|Maintenance Phase||43
238932|NCT00943826|581135|P2|COMPLETED|Maintenance Phase||331
238933|NCT00943826|581136|P1|COMPLETED|Maintenance Phase||353
238934|NCT00943826|581135|P2|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|370
238935|NCT00943826|581136|P1|STARTED|Maintenance Phase|Some who completed previous period had discontinued, progressed, or died prior to this period.|396
238936|NCT00943826|581135|P2|NOT COMPLETED|Concurrent Phase||42
238937|NCT00943826|581136|P1|NOT COMPLETED|Concurrent Phase||61
238938|NCT00943826|581135|P2|COMPLETED|Concurrent Phase||421
238939|NCT00943826|581136|P1|COMPLETED|Concurrent Phase||397
238940|NCT00943826|581135|P2|Treated|Concurrent Phase||459
238941|NCT00943826|581136|P1|Treated|Concurrent Phase||452
238942|NCT00943826|581135|P2|STARTED|Concurrent Phase||463
238943|NCT00943826|581136|P1|STARTED|Concurrent Phase||458
238944|NCT00943852|581154|P10|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238945|NCT00943852|581155|P9|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238946|NCT00943852|581156|P8|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238947|NCT00943852|581157|P7|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238948|NCT00943852|581158|P6|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238949|NCT00943852|581159|P5|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238950|NCT00943852|581160|P4|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238951|NCT00943852|581161|P3|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238952|NCT00943852|581162|P2|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238953|NCT00943852|581163|P1|NOT COMPLETED|Fifth Period of Treatment Intervention||0
238954|NCT00943852|581154|P10|COMPLETED|Fifth Period of Treatment Intervention||1
238955|NCT00943852|581155|P9|COMPLETED|Fifth Period of Treatment Intervention||1
238956|NCT00943852|581156|P8|COMPLETED|Fifth Period of Treatment Intervention||0
238957|NCT00943852|581157|P7|COMPLETED|Fifth Period of Treatment Intervention||0
238958|NCT00943852|581158|P6|COMPLETED|Fifth Period of Treatment Intervention||0
238959|NCT00943852|581159|P5|COMPLETED|Fifth Period of Treatment Intervention||1
238960|NCT00943852|581160|P4|COMPLETED|Fifth Period of Treatment Intervention||0
238961|NCT00943852|581161|P3|COMPLETED|Fifth Period of Treatment Intervention||0
238962|NCT00943852|581162|P2|COMPLETED|Fifth Period of Treatment Intervention||1
238963|NCT00943852|581163|P1|COMPLETED|Fifth Period of Treatment Intervention||1
238964|NCT00943852|581154|P10|STARTED|Fifth Period of Treatment Intervention||1
238965|NCT00943852|581155|P9|STARTED|Fifth Period of Treatment Intervention||1
238966|NCT00943852|581156|P8|STARTED|Fifth Period of Treatment Intervention||0
238967|NCT00943852|581157|P7|STARTED|Fifth Period of Treatment Intervention||0
238968|NCT00943852|581158|P6|STARTED|Fifth Period of Treatment Intervention||0
238969|NCT00943852|581159|P5|STARTED|Fifth Period of Treatment Intervention||1
238970|NCT00943852|581160|P4|STARTED|Fifth Period of Treatment Intervention||0
238971|NCT00943852|581161|P3|STARTED|Fifth Period of Treatment Intervention||0
238972|NCT00943852|581162|P2|STARTED|Fifth Period of Treatment Intervention||1
238973|NCT00943852|581163|P1|STARTED|Fifth Period of Treatment Intervention||1
238974|NCT00943852|581154|P10|NOT COMPLETED|Washout Period After Period 4 Treatment||0
238975|NCT00943852|581155|P9|NOT COMPLETED|Washout Period After Period 4 Treatment||0
238976|NCT00943852|581156|P8|NOT COMPLETED|Washout Period After Period 4 Treatment||1
238977|NCT00943852|581157|P7|NOT COMPLETED|Washout Period After Period 4 Treatment||1
238978|NCT00943852|581158|P6|NOT COMPLETED|Washout Period After Period 4 Treatment||0
238979|NCT00943852|581159|P5|NOT COMPLETED|Washout Period After Period 4 Treatment||0
238980|NCT00943852|581160|P4|NOT COMPLETED|Washout Period After Period 4 Treatment||1
238981|NCT00943852|581161|P3|NOT COMPLETED|Washout Period After Period 4 Treatment||1
239291|NCT00943917|581323|P10|COMPLETED|Stage II||0
238982|NCT00943852|581162|P2|NOT COMPLETED|Washout Period After Period 4 Treatment||0
238983|NCT00943852|581163|P1|NOT COMPLETED|Washout Period After Period 4 Treatment||1
238984|NCT00943852|581154|P10|COMPLETED|Washout Period After Period 4 Treatment||1
238985|NCT00943852|581155|P9|COMPLETED|Washout Period After Period 4 Treatment||1
238986|NCT00943852|581156|P8|COMPLETED|Washout Period After Period 4 Treatment||0
238987|NCT00943852|581157|P7|COMPLETED|Washout Period After Period 4 Treatment||0
238988|NCT00943852|581158|P6|COMPLETED|Washout Period After Period 4 Treatment||0
238989|NCT00943852|581159|P5|COMPLETED|Washout Period After Period 4 Treatment||1
238990|NCT00943852|581160|P4|COMPLETED|Washout Period After Period 4 Treatment||0
238991|NCT00943852|581161|P3|COMPLETED|Washout Period After Period 4 Treatment||0
238992|NCT00943852|581162|P2|COMPLETED|Washout Period After Period 4 Treatment||1
238993|NCT00943852|581163|P1|COMPLETED|Washout Period After Period 4 Treatment||1
238994|NCT00943852|581154|P10|STARTED|Washout Period After Period 4 Treatment||1
238995|NCT00943852|581155|P9|STARTED|Washout Period After Period 4 Treatment||1
238996|NCT00943852|581156|P8|STARTED|Washout Period After Period 4 Treatment||1
238997|NCT00943852|581157|P7|STARTED|Washout Period After Period 4 Treatment||1
238998|NCT00943852|581158|P6|STARTED|Washout Period After Period 4 Treatment||0
238999|NCT00943852|581159|P5|STARTED|Washout Period After Period 4 Treatment||1
239000|NCT00943852|581160|P4|STARTED|Washout Period After Period 4 Treatment||1
239001|NCT00943852|581161|P3|STARTED|Washout Period After Period 4 Treatment||1
239002|NCT00943852|581162|P2|STARTED|Washout Period After Period 4 Treatment||1
239003|NCT00943852|581163|P1|STARTED|Washout Period After Period 4 Treatment||2
239004|NCT00943852|581154|P10|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239005|NCT00943852|581155|P9|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239006|NCT00943852|581156|P8|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239007|NCT00943852|581157|P7|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239008|NCT00943852|581158|P6|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239009|NCT00943852|581159|P5|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239010|NCT00943852|581160|P4|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239011|NCT00943852|581161|P3|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239012|NCT00943852|581162|P2|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239013|NCT00943852|581163|P1|NOT COMPLETED|Fourth Period of Treatment Intervention||0
239014|NCT00943852|581154|P10|COMPLETED|Fourth Period of Treatment Intervention||1
239015|NCT00943852|581155|P9|COMPLETED|Fourth Period of Treatment Intervention||1
239016|NCT00943852|581156|P8|COMPLETED|Fourth Period of Treatment Intervention||1
239017|NCT00943852|581157|P7|COMPLETED|Fourth Period of Treatment Intervention||1
239018|NCT00943852|581158|P6|COMPLETED|Fourth Period of Treatment Intervention||0
239019|NCT00943852|581159|P5|COMPLETED|Fourth Period of Treatment Intervention||1
239020|NCT00943852|581160|P4|COMPLETED|Fourth Period of Treatment Intervention||1
239021|NCT00943852|581161|P3|COMPLETED|Fourth Period of Treatment Intervention||1
239022|NCT00943852|581162|P2|COMPLETED|Fourth Period of Treatment Intervention||1
239023|NCT00943852|581163|P1|COMPLETED|Fourth Period of Treatment Intervention||2
239024|NCT00943852|581154|P10|STARTED|Fourth Period of Treatment Intervention||1
239025|NCT00943852|581155|P9|STARTED|Fourth Period of Treatment Intervention||1
239026|NCT00943852|581156|P8|STARTED|Fourth Period of Treatment Intervention||1
239027|NCT00943852|581157|P7|STARTED|Fourth Period of Treatment Intervention||1
239028|NCT00943852|581158|P6|STARTED|Fourth Period of Treatment Intervention||0
239029|NCT00943852|581159|P5|STARTED|Fourth Period of Treatment Intervention||1
239030|NCT00943852|581160|P4|STARTED|Fourth Period of Treatment Intervention||1
239031|NCT00943852|581161|P3|STARTED|Fourth Period of Treatment Intervention||1
239032|NCT00943852|581162|P2|STARTED|Fourth Period of Treatment Intervention||1
239033|NCT00943852|581163|P1|STARTED|Fourth Period of Treatment Intervention||2
239034|NCT00943852|581154|P10|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239035|NCT00943852|581155|P9|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239036|NCT00943852|581156|P8|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239037|NCT00943852|581157|P7|NOT COMPLETED|Washout Period After Period 3 Treatment||1
239038|NCT00943852|581158|P6|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239039|NCT00943852|581159|P5|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239040|NCT00943852|581160|P4|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239041|NCT00943852|581161|P3|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239042|NCT00943852|581162|P2|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239043|NCT00943852|581163|P1|NOT COMPLETED|Washout Period After Period 3 Treatment||0
239044|NCT00943852|581154|P10|COMPLETED|Washout Period After Period 3 Treatment||1
239045|NCT00943852|581155|P9|COMPLETED|Washout Period After Period 3 Treatment||1
239046|NCT00943852|581156|P8|COMPLETED|Washout Period After Period 3 Treatment||1
239047|NCT00943852|581157|P7|COMPLETED|Washout Period After Period 3 Treatment||1
239048|NCT00943852|581158|P6|COMPLETED|Washout Period After Period 3 Treatment||0
239049|NCT00943852|581159|P5|COMPLETED|Washout Period After Period 3 Treatment||1
239050|NCT00943852|581160|P4|COMPLETED|Washout Period After Period 3 Treatment||1
239051|NCT00943852|581161|P3|COMPLETED|Washout Period After Period 3 Treatment||1
239052|NCT00943852|581162|P2|COMPLETED|Washout Period After Period 3 Treatment||1
239053|NCT00943852|581163|P1|COMPLETED|Washout Period After Period 3 Treatment||2
239054|NCT00943852|581154|P10|STARTED|Washout Period After Period 3 Treatment||1
239055|NCT00943852|581155|P9|STARTED|Washout Period After Period 3 Treatment||1
239056|NCT00943852|581156|P8|STARTED|Washout Period After Period 3 Treatment||1
239057|NCT00943852|581157|P7|STARTED|Washout Period After Period 3 Treatment||2
239058|NCT00943852|581158|P6|STARTED|Washout Period After Period 3 Treatment||0
239059|NCT00943852|581159|P5|STARTED|Washout Period After Period 3 Treatment||1
239060|NCT00943852|581160|P4|STARTED|Washout Period After Period 3 Treatment||1
239061|NCT00943852|581161|P3|STARTED|Washout Period After Period 3 Treatment||1
239062|NCT00943852|581162|P2|STARTED|Washout Period After Period 3 Treatment||1
239063|NCT00943852|581163|P1|STARTED|Washout Period After Period 3 Treatment||2
239064|NCT00943852|581154|P10|NOT COMPLETED|Third Period of Treatment Intervention||0
239065|NCT00943852|581155|P9|NOT COMPLETED|Third Period of Treatment Intervention||0
239066|NCT00943852|581156|P8|NOT COMPLETED|Third Period of Treatment Intervention||0
239067|NCT00943852|581157|P7|NOT COMPLETED|Third Period of Treatment Intervention||0
239068|NCT00943852|581158|P6|NOT COMPLETED|Third Period of Treatment Intervention||0
239069|NCT00943852|581159|P5|NOT COMPLETED|Third Period of Treatment Intervention||0
239070|NCT00943852|581160|P4|NOT COMPLETED|Third Period of Treatment Intervention||0
239071|NCT00943852|581161|P3|NOT COMPLETED|Third Period of Treatment Intervention||0
239072|NCT00943852|581162|P2|NOT COMPLETED|Third Period of Treatment Intervention||0
239073|NCT00943852|581163|P1|NOT COMPLETED|Third Period of Treatment Intervention||0
239074|NCT00943852|581154|P10|COMPLETED|Third Period of Treatment Intervention||1
239075|NCT00943852|581155|P9|COMPLETED|Third Period of Treatment Intervention||1
239076|NCT00943852|581156|P8|COMPLETED|Third Period of Treatment Intervention||1
239077|NCT00943852|581157|P7|COMPLETED|Third Period of Treatment Intervention||2
239078|NCT00943852|581158|P6|COMPLETED|Third Period of Treatment Intervention||0
239079|NCT00943852|581159|P5|COMPLETED|Third Period of Treatment Intervention||1
239080|NCT00943852|581160|P4|COMPLETED|Third Period of Treatment Intervention||1
239081|NCT00943852|581161|P3|COMPLETED|Third Period of Treatment Intervention||1
239082|NCT00943852|581162|P2|COMPLETED|Third Period of Treatment Intervention||1
239083|NCT00943852|581163|P1|COMPLETED|Third Period of Treatment Intervention||2
239084|NCT00943852|581154|P10|STARTED|Third Period of Treatment Intervention||1
239085|NCT00943852|581155|P9|STARTED|Third Period of Treatment Intervention||1
239086|NCT00943852|581156|P8|STARTED|Third Period of Treatment Intervention||1
239087|NCT00943852|581157|P7|STARTED|Third Period of Treatment Intervention||2
239088|NCT00943852|581158|P6|STARTED|Third Period of Treatment Intervention||0
239089|NCT00943852|581159|P5|STARTED|Third Period of Treatment Intervention||1
239090|NCT00943852|581160|P4|STARTED|Third Period of Treatment Intervention||1
239091|NCT00943852|581161|P3|STARTED|Third Period of Treatment Intervention||1
239092|NCT00943852|581162|P2|STARTED|Third Period of Treatment Intervention||1
239093|NCT00943852|581163|P1|STARTED|Third Period of Treatment Intervention||2
239094|NCT00943852|581154|P10|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239095|NCT00943852|581155|P9|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239096|NCT00943852|581156|P8|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239097|NCT00943852|581157|P7|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239098|NCT00943852|581158|P6|NOT COMPLETED|Washout Period After Period 2 Treatment||1
239099|NCT00943852|581159|P5|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239100|NCT00943852|581160|P4|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239101|NCT00943852|581161|P3|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239102|NCT00943852|581162|P2|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239103|NCT00943852|581163|P1|NOT COMPLETED|Washout Period After Period 2 Treatment||0
239104|NCT00943852|581154|P10|COMPLETED|Washout Period After Period 2 Treatment||1
239105|NCT00943852|581155|P9|COMPLETED|Washout Period After Period 2 Treatment||1
239106|NCT00943852|581156|P8|COMPLETED|Washout Period After Period 2 Treatment||1
239107|NCT00943852|581157|P7|COMPLETED|Washout Period After Period 2 Treatment||2
239108|NCT00943852|581158|P6|COMPLETED|Washout Period After Period 2 Treatment||0
239109|NCT00943852|581159|P5|COMPLETED|Washout Period After Period 2 Treatment||1
239110|NCT00943852|581160|P4|COMPLETED|Washout Period After Period 2 Treatment||1
239111|NCT00943852|581161|P3|COMPLETED|Washout Period After Period 2 Treatment||1
239112|NCT00943852|581162|P2|COMPLETED|Washout Period After Period 2 Treatment||1
239113|NCT00943852|581163|P1|COMPLETED|Washout Period After Period 2 Treatment||2
239114|NCT00943852|581154|P10|STARTED|Washout Period After Period 2 Treatment||1
239115|NCT00943852|581155|P9|STARTED|Washout Period After Period 2 Treatment||1
239116|NCT00943852|581156|P8|STARTED|Washout Period After Period 2 Treatment||1
239117|NCT00943852|581157|P7|STARTED|Washout Period After Period 2 Treatment||2
239118|NCT00943852|581158|P6|STARTED|Washout Period After Period 2 Treatment||1
239119|NCT00943852|581159|P5|STARTED|Washout Period After Period 2 Treatment||1
239120|NCT00943852|581160|P4|STARTED|Washout Period After Period 2 Treatment||1
239121|NCT00943852|581161|P3|STARTED|Washout Period After Period 2 Treatment||1
239122|NCT00943852|581162|P2|STARTED|Washout Period After Period 2 Treatment||1
239123|NCT00943852|581163|P1|STARTED|Washout Period After Period 2 Treatment||2
239124|NCT00943852|581154|P10|NOT COMPLETED|Second Period of Treatment Intervention||0
239125|NCT00943852|581155|P9|NOT COMPLETED|Second Period of Treatment Intervention||0
239126|NCT00943852|581156|P8|NOT COMPLETED|Second Period of Treatment Intervention||0
239127|NCT00943852|581157|P7|NOT COMPLETED|Second Period of Treatment Intervention||0
239128|NCT00943852|581158|P6|NOT COMPLETED|Second Period of Treatment Intervention||0
239129|NCT00943852|581159|P5|NOT COMPLETED|Second Period of Treatment Intervention||0
239130|NCT00943852|581160|P4|NOT COMPLETED|Second Period of Treatment Intervention||0
239131|NCT00943852|581161|P3|NOT COMPLETED|Second Period of Treatment Intervention||0
239132|NCT00943852|581162|P2|NOT COMPLETED|Second Period of Treatment Intervention||0
239133|NCT00943852|581163|P1|NOT COMPLETED|Second Period of Treatment Intervention||0
239134|NCT00943852|581154|P10|COMPLETED|Second Period of Treatment Intervention||1
239135|NCT00943852|581155|P9|COMPLETED|Second Period of Treatment Intervention||1
239136|NCT00943852|581156|P8|COMPLETED|Second Period of Treatment Intervention||1
239137|NCT00943852|581157|P7|COMPLETED|Second Period of Treatment Intervention||2
239138|NCT00943852|581158|P6|COMPLETED|Second Period of Treatment Intervention||1
239139|NCT00943852|581159|P5|COMPLETED|Second Period of Treatment Intervention||1
239140|NCT00943852|581160|P4|COMPLETED|Second Period of Treatment Intervention||1
239141|NCT00943852|581161|P3|COMPLETED|Second Period of Treatment Intervention||1
239142|NCT00943852|581162|P2|COMPLETED|Second Period of Treatment Intervention||1
239143|NCT00943852|581163|P1|COMPLETED|Second Period of Treatment Intervention||2
239144|NCT00943852|581154|P10|STARTED|Second Period of Treatment Intervention||1
239145|NCT00943852|581155|P9|STARTED|Second Period of Treatment Intervention||1
239146|NCT00943852|581156|P8|STARTED|Second Period of Treatment Intervention||1
239147|NCT00943852|581157|P7|STARTED|Second Period of Treatment Intervention||2
239148|NCT00943852|581158|P6|STARTED|Second Period of Treatment Intervention||1
239149|NCT00943852|581159|P5|STARTED|Second Period of Treatment Intervention||1
239150|NCT00943852|581160|P4|STARTED|Second Period of Treatment Intervention||1
239151|NCT00943852|581161|P3|STARTED|Second Period of Treatment Intervention||1
239152|NCT00943852|581162|P2|STARTED|Second Period of Treatment Intervention||1
239153|NCT00943852|581163|P1|STARTED|Second Period of Treatment Intervention||2
239154|NCT00943852|581154|P10|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239155|NCT00943852|581155|P9|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239156|NCT00943852|581156|P8|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239157|NCT00943852|581157|P7|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239158|NCT00943852|581158|P6|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239159|NCT00943852|581159|P5|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239160|NCT00943852|581160|P4|NOT COMPLETED|Washout Period After Period 1 Treatment||1
239161|NCT00943852|581161|P3|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239162|NCT00943852|581162|P2|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239163|NCT00943852|581163|P1|NOT COMPLETED|Washout Period After Period 1 Treatment||0
239164|NCT00943852|581154|P10|COMPLETED|Washout Period After Period 1 Treatment||1
239165|NCT00943852|581155|P9|COMPLETED|Washout Period After Period 1 Treatment||1
239166|NCT00943852|581156|P8|COMPLETED|Washout Period After Period 1 Treatment||1
239167|NCT00943852|581157|P7|COMPLETED|Washout Period After Period 1 Treatment||2
239168|NCT00943852|581158|P6|COMPLETED|Washout Period After Period 1 Treatment||1
239169|NCT00943852|581159|P5|COMPLETED|Washout Period After Period 1 Treatment||1
239170|NCT00943852|581160|P4|COMPLETED|Washout Period After Period 1 Treatment||1
239171|NCT00943852|581161|P3|COMPLETED|Washout Period After Period 1 Treatment||1
239172|NCT00943852|581162|P2|COMPLETED|Washout Period After Period 1 Treatment||1
239173|NCT00943852|581163|P1|COMPLETED|Washout Period After Period 1 Treatment||2
239174|NCT00943852|581154|P10|STARTED|Washout Period After Period 1 Treatment||1
239175|NCT00943852|581155|P9|STARTED|Washout Period After Period 1 Treatment||1
239176|NCT00943852|581156|P8|STARTED|Washout Period After Period 1 Treatment||1
239177|NCT00943852|581157|P7|STARTED|Washout Period After Period 1 Treatment||2
239178|NCT00943852|581158|P6|STARTED|Washout Period After Period 1 Treatment||1
239179|NCT00943852|581159|P5|STARTED|Washout Period After Period 1 Treatment||1
239180|NCT00943852|581160|P4|STARTED|Washout Period After Period 1 Treatment||2
239181|NCT00943852|581161|P3|STARTED|Washout Period After Period 1 Treatment||1
239182|NCT00943852|581162|P2|STARTED|Washout Period After Period 1 Treatment||1
239183|NCT00943852|581163|P1|STARTED|Washout Period After Period 1 Treatment||2
239184|NCT00943852|581154|P10|NOT COMPLETED|First Period of Treatment Intervention||0
239185|NCT00943852|581155|P9|NOT COMPLETED|First Period of Treatment Intervention||0
239186|NCT00943852|581156|P8|NOT COMPLETED|First Period of Treatment Intervention||0
239187|NCT00943852|581157|P7|NOT COMPLETED|First Period of Treatment Intervention||0
239188|NCT00943852|581158|P6|NOT COMPLETED|First Period of Treatment Intervention||0
239189|NCT00943852|581159|P5|NOT COMPLETED|First Period of Treatment Intervention||0
239190|NCT00943852|581160|P4|NOT COMPLETED|First Period of Treatment Intervention||0
239191|NCT00943852|581161|P3|NOT COMPLETED|First Period of Treatment Intervention||0
239192|NCT00943852|581162|P2|NOT COMPLETED|First Period of Treatment Intervention||0
239193|NCT00943852|581163|P1|NOT COMPLETED|First Period of Treatment Intervention||0
239194|NCT00943852|581154|P10|COMPLETED|First Period of Treatment Intervention||1
239195|NCT00943852|581155|P9|COMPLETED|First Period of Treatment Intervention||1
239196|NCT00943852|581156|P8|COMPLETED|First Period of Treatment Intervention||1
239197|NCT00943852|581157|P7|COMPLETED|First Period of Treatment Intervention||2
239198|NCT00943852|581158|P6|COMPLETED|First Period of Treatment Intervention||1
239199|NCT00943852|581159|P5|COMPLETED|First Period of Treatment Intervention||1
239200|NCT00943852|581160|P4|COMPLETED|First Period of Treatment Intervention||2
239201|NCT00943852|581161|P3|COMPLETED|First Period of Treatment Intervention||1
239202|NCT00943852|581162|P2|COMPLETED|First Period of Treatment Intervention||1
239203|NCT00943852|581163|P1|COMPLETED|First Period of Treatment Intervention||2
239204|NCT00943852|581154|P10|STARTED|First Period of Treatment Intervention||1
239205|NCT00943852|581155|P9|STARTED|First Period of Treatment Intervention||1
239206|NCT00943852|581156|P8|STARTED|First Period of Treatment Intervention||1
239207|NCT00943852|581157|P7|STARTED|First Period of Treatment Intervention||2
239208|NCT00943852|581158|P6|STARTED|First Period of Treatment Intervention||1
239209|NCT00943852|581159|P5|STARTED|First Period of Treatment Intervention||1
239210|NCT00943852|581160|P4|STARTED|First Period of Treatment Intervention||2
239211|NCT00943852|581161|P3|STARTED|First Period of Treatment Intervention||1
239212|NCT00943852|581162|P2|STARTED|First Period of Treatment Intervention||1
239213|NCT00943852|581163|P1|STARTED|First Period of Treatment Intervention||2
239214|NCT00943878|581178|P4|NOT COMPLETED|Overall Study||2
239215|NCT00943878|581179|P3|NOT COMPLETED|Overall Study||6
239216|NCT00943878|581180|P2|NOT COMPLETED|Overall Study||2
239217|NCT00943878|581181|P1|NOT COMPLETED|Overall Study||2
239218|NCT00943878|581178|P4|COMPLETED|Overall Study||198
239219|NCT00943878|581179|P3|COMPLETED|Overall Study||197
239220|NCT00943878|581180|P2|COMPLETED|Overall Study||198
239221|NCT00943878|581181|P1|COMPLETED|Overall Study||200
239222|NCT00943878|581178|P4|STARTED|Overall Study||200
239223|NCT00943878|581179|P3|STARTED|Overall Study||203
239224|NCT00943878|581180|P2|STARTED|Overall Study||200
239225|NCT00943878|581181|P1|STARTED|Overall Study||202
239226|NCT00943917|581318|P15|NOT COMPLETED|Stage II Continuation||4
239227|NCT00943917|581319|P14|NOT COMPLETED|Stage II Continuation||3
239228|NCT00943917|581320|P13|NOT COMPLETED|Stage II Continuation||3
239229|NCT00943917|581321|P12|NOT COMPLETED|Stage II Continuation||2
239230|NCT00943917|581322|P11|NOT COMPLETED|Stage II Continuation||0
239231|NCT00943917|581323|P10|NOT COMPLETED|Stage II Continuation||1
239232|NCT00943917|581324|P9|NOT COMPLETED|Stage II Continuation||0
239233|NCT00943917|581325|P8|NOT COMPLETED|Stage II Continuation||0
239234|NCT00943917|581326|P7|NOT COMPLETED|Stage II Continuation||0
239235|NCT00943917|581327|P6|NOT COMPLETED|Stage II Continuation||0
239236|NCT00943917|581328|P5|NOT COMPLETED|Stage II Continuation||0
239237|NCT00943917|581329|P4|NOT COMPLETED|Stage II Continuation||0
239238|NCT00943917|581330|P3|NOT COMPLETED|Stage II Continuation||0
239239|NCT00943917|581331|P2|NOT COMPLETED|Stage II Continuation||0
239240|NCT00943917|581332|P1|NOT COMPLETED|Stage II Continuation||0
239241|NCT00943917|581318|P15|COMPLETED|Stage II Continuation||8
239242|NCT00943917|581319|P14|COMPLETED|Stage II Continuation||12
239243|NCT00943917|581320|P13|COMPLETED|Stage II Continuation||13
239244|NCT00943917|581321|P12|COMPLETED|Stage II Continuation||11
239245|NCT00943917|581322|P11|COMPLETED|Stage II Continuation||15
239246|NCT00943917|581323|P10|COMPLETED|Stage II Continuation||14
239247|NCT00943917|581324|P9|COMPLETED|Stage II Continuation||0
239248|NCT00943917|581325|P8|COMPLETED|Stage II Continuation||0
239249|NCT00943917|581326|P7|COMPLETED|Stage II Continuation||0
239250|NCT00943917|581327|P6|COMPLETED|Stage II Continuation||0
239251|NCT00943917|581328|P5|COMPLETED|Stage II Continuation||0
239252|NCT00943917|581329|P4|COMPLETED|Stage II Continuation||0
239253|NCT00943917|581330|P3|COMPLETED|Stage II Continuation||0
239254|NCT00943917|581331|P2|COMPLETED|Stage II Continuation||0
239255|NCT00943917|581332|P1|COMPLETED|Stage II Continuation||0
239256|NCT00943917|581318|P15|STARTED|Stage II Continuation||12
239257|NCT00943917|581319|P14|STARTED|Stage II Continuation||15
239258|NCT00943917|581320|P13|STARTED|Stage II Continuation||16
239259|NCT00943917|581321|P12|STARTED|Stage II Continuation||13
239260|NCT00943917|581322|P11|STARTED|Stage II Continuation||15
239261|NCT00943917|581323|P10|STARTED|Stage II Continuation||15
239262|NCT00943917|581324|P9|STARTED|Stage II Continuation||0
239263|NCT00943917|581325|P8|STARTED|Stage II Continuation||0
239264|NCT00943917|581326|P7|STARTED|Stage II Continuation||0
239265|NCT00943917|581327|P6|STARTED|Stage II Continuation||0
239266|NCT00943917|581328|P5|STARTED|Stage II Continuation||0
239267|NCT00943917|581329|P4|STARTED|Stage II Continuation||0
239268|NCT00943917|581330|P3|STARTED|Stage II Continuation||0
239269|NCT00943917|581331|P2|STARTED|Stage II Continuation||0
239270|NCT00943917|581332|P1|STARTED|Stage II Continuation||0
239271|NCT00943917|581318|P15|NOT COMPLETED|Stage II||0
239272|NCT00943917|581319|P14|NOT COMPLETED|Stage II||0
239273|NCT00943917|581320|P13|NOT COMPLETED|Stage II||0
239274|NCT00943917|581321|P12|NOT COMPLETED|Stage II||0
239275|NCT00943917|581322|P11|NOT COMPLETED|Stage II||0
239276|NCT00943917|581323|P10|NOT COMPLETED|Stage II||0
239277|NCT00943917|581324|P9|NOT COMPLETED|Stage II||1
239278|NCT00943917|581325|P8|NOT COMPLETED|Stage II||0
239279|NCT00943917|581326|P7|NOT COMPLETED|Stage II||3
239280|NCT00943917|581327|P6|NOT COMPLETED|Stage II||3
239281|NCT00943917|581328|P5|NOT COMPLETED|Stage II||0
239282|NCT00943917|581329|P4|NOT COMPLETED|Stage II||0
239283|NCT00943917|581330|P3|NOT COMPLETED|Stage II||0
239284|NCT00943917|581331|P2|NOT COMPLETED|Stage II||0
239285|NCT00943917|581332|P1|NOT COMPLETED|Stage II||0
239286|NCT00943917|581318|P15|COMPLETED|Stage II||0
239287|NCT00943917|581319|P14|COMPLETED|Stage II||0
239288|NCT00943917|581320|P13|COMPLETED|Stage II||0
239289|NCT00943917|581321|P12|COMPLETED|Stage II||0
239290|NCT00943917|581322|P11|COMPLETED|Stage II||0
239292|NCT00943917|581324|P9|COMPLETED|Stage II||20
239293|NCT00943917|581325|P8|COMPLETED|Stage II||23
239294|NCT00943917|581326|P7|COMPLETED|Stage II||20
239295|NCT00943917|581327|P6|COMPLETED|Stage II||20
239296|NCT00943917|581328|P5|COMPLETED|Stage II||21
239297|NCT00943917|581329|P4|COMPLETED|Stage II||20
239298|NCT00943917|581330|P3|COMPLETED|Stage II||0
239299|NCT00943917|581331|P2|COMPLETED|Stage II||0
239300|NCT00943917|581332|P1|COMPLETED|Stage II||0
239301|NCT00943917|581318|P15|STARTED|Stage II||0
239302|NCT00943917|581319|P14|STARTED|Stage II||0
239303|NCT00943917|581320|P13|STARTED|Stage II||0
239304|NCT00943917|581321|P12|STARTED|Stage II||0
239305|NCT00943917|581322|P11|STARTED|Stage II||0
239306|NCT00943917|581323|P10|STARTED|Stage II||0
239307|NCT00943917|581324|P9|STARTED|Stage II||21
239308|NCT00943917|581325|P8|STARTED|Stage II||23
239309|NCT00943917|581326|P7|STARTED|Stage II||23
239310|NCT00943917|581327|P6|STARTED|Stage II||23
239311|NCT00943917|581328|P5|STARTED|Stage II||21
239312|NCT00943917|581329|P4|STARTED|Stage II||20
239313|NCT00943917|581330|P3|STARTED|Stage II||0
239314|NCT00943917|581331|P2|STARTED|Stage II||0
239315|NCT00943917|581332|P1|STARTED|Stage II||0
239316|NCT00943917|581318|P15|NOT COMPLETED|Stage I||0
239317|NCT00943917|581319|P14|NOT COMPLETED|Stage I||0
239318|NCT00943917|581320|P13|NOT COMPLETED|Stage I||0
239319|NCT00943917|581321|P12|NOT COMPLETED|Stage I||0
239320|NCT00943917|581322|P11|NOT COMPLETED|Stage I||0
239321|NCT00943917|581323|P10|NOT COMPLETED|Stage I||0
239322|NCT00943917|581324|P9|NOT COMPLETED|Stage I||0
239323|NCT00943917|581325|P8|NOT COMPLETED|Stage I||0
239324|NCT00943917|581326|P7|NOT COMPLETED|Stage I||0
239325|NCT00943917|581327|P6|NOT COMPLETED|Stage I||0
239326|NCT00943917|581328|P5|NOT COMPLETED|Stage I||0
239327|NCT00943917|581329|P4|NOT COMPLETED|Stage I||0
239328|NCT00943917|581330|P3|NOT COMPLETED|Stage I||6
239329|NCT00943917|581331|P2|NOT COMPLETED|Stage I||3
239330|NCT00943917|581332|P1|NOT COMPLETED|Stage I||4
239331|NCT00943917|581318|P15|COMPLETED|Stage I||0
239332|NCT00943917|581319|P14|COMPLETED|Stage I||0
239333|NCT00943917|581320|P13|COMPLETED|Stage I||0
239334|NCT00943917|581321|P12|COMPLETED|Stage I||0
239335|NCT00943917|581322|P11|COMPLETED|Stage I||0
239336|NCT00943917|581323|P10|COMPLETED|Stage I||0
239337|NCT00943917|581324|P9|COMPLETED|Stage I||0
239338|NCT00943917|581325|P8|COMPLETED|Stage I||0
239339|NCT00943917|581326|P7|COMPLETED|Stage I||0
239340|NCT00943917|581327|P6|COMPLETED|Stage I||0
239341|NCT00943917|581328|P5|COMPLETED|Stage I||0
239342|NCT00943917|581329|P4|COMPLETED|Stage I||0
239343|NCT00943917|581330|P3|COMPLETED|Stage I||47
239344|NCT00943917|581331|P2|COMPLETED|Stage I||48
239345|NCT00943917|581332|P1|COMPLETED|Stage I||47
239346|NCT00943917|581318|P15|STARTED|Stage I||0
239347|NCT00943917|581319|P14|STARTED|Stage I||0
239348|NCT00943917|581320|P13|STARTED|Stage I||0
239349|NCT00943917|581321|P12|STARTED|Stage I||0
239350|NCT00943917|581322|P11|STARTED|Stage I||0
239351|NCT00943917|581323|P10|STARTED|Stage I||0
239352|NCT00943917|581324|P9|STARTED|Stage I||0
239353|NCT00943917|581325|P8|STARTED|Stage I||0
239354|NCT00943917|581326|P7|STARTED|Stage I||0
239355|NCT00943917|581327|P6|STARTED|Stage I||0
239356|NCT00943917|581328|P5|STARTED|Stage I||0
239357|NCT00943917|581329|P4|STARTED|Stage I||0
239358|NCT00943917|581330|P3|STARTED|Stage I||53
239359|NCT00943917|581331|P2|STARTED|Stage I||51
239360|NCT00943917|581332|P1|STARTED|Stage I||51
239361|NCT00944021|581384|P5|NOT COMPLETED|Overall Study||0
239362|NCT00944021|581385|P4|NOT COMPLETED|Overall Study||0
239363|NCT00944021|581386|P3|NOT COMPLETED|Overall Study||0
239364|NCT00944021|581387|P2|NOT COMPLETED|Overall Study||0
239365|NCT00944021|581388|P1|NOT COMPLETED|Overall Study||1
239366|NCT00944021|581384|P5|COMPLETED|Overall Study||8
239367|NCT00944021|581385|P4|COMPLETED|Overall Study||16
239368|NCT00944021|581386|P3|COMPLETED|Overall Study||15
239369|NCT00944021|581387|P2|COMPLETED|Overall Study||15
239370|NCT00944021|581388|P1|COMPLETED|Overall Study||14
239371|NCT00944021|581384|P5|STARTED|Overall Study||8
239372|NCT00944021|581385|P4|STARTED|Overall Study||16
239373|NCT00944021|581386|P3|STARTED|Overall Study||15
239374|NCT00944021|581387|P2|STARTED|Overall Study||15
239375|NCT00944021|581388|P1|STARTED|Overall Study||15
239376|NCT00944034|581457|P12|NOT COMPLETED|Overall Study||4
239377|NCT00944034|581458|P11|NOT COMPLETED|Overall Study||1
239378|NCT00944034|581459|P10|NOT COMPLETED|Overall Study||10
239379|NCT00944034|581460|P9|NOT COMPLETED|Overall Study||10
239380|NCT00944034|581461|P8|NOT COMPLETED|Overall Study||5
239381|NCT00944034|581462|P7|NOT COMPLETED|Overall Study||4
239382|NCT00944034|581463|P6|NOT COMPLETED|Overall Study||20
239383|NCT00944034|581464|P5|NOT COMPLETED|Overall Study||14
239384|NCT00944034|581465|P4|NOT COMPLETED|Overall Study||4
239385|NCT00944034|581466|P3|NOT COMPLETED|Overall Study||9
239386|NCT00944034|581467|P2|NOT COMPLETED|Overall Study||7
239387|NCT00944034|581468|P1|NOT COMPLETED|Overall Study||5
239388|NCT00944034|581457|P12|COMPLETED|Overall Study||52
239389|NCT00944034|581458|P11|COMPLETED|Overall Study||50
239390|NCT00944034|581459|P10|COMPLETED|Overall Study||236
239391|NCT00944034|581460|P9|COMPLETED|Overall Study||63
239392|NCT00944034|581461|P8|COMPLETED|Overall Study||73
239393|NCT00944034|581462|P7|COMPLETED|Overall Study||102
239394|NCT00944034|581463|P6|COMPLETED|Overall Study||123
239395|NCT00944034|581464|P5|COMPLETED|Overall Study||150
239396|NCT00944034|581465|P4|COMPLETED|Overall Study||170
239397|NCT00944034|581466|P3|COMPLETED|Overall Study||143
239398|NCT00944034|581467|P2|COMPLETED|Overall Study||150
239399|NCT00944034|581468|P1|COMPLETED|Overall Study||183
239400|NCT00944034|581457|P12|STARTED|Overall Study||56
239401|NCT00944034|581458|P11|STARTED|Overall Study||51
239402|NCT00944034|581459|P10|STARTED|Overall Study||246
239403|NCT00944034|581460|P9|STARTED|Overall Study||73
239404|NCT00944034|581461|P8|STARTED|Overall Study||78
239405|NCT00944034|581462|P7|STARTED|Overall Study||106
239406|NCT00944034|581463|P6|STARTED|Overall Study||143
239407|NCT00944034|581464|P5|STARTED|Overall Study||164
239408|NCT00944034|581465|P4|STARTED|Overall Study||174
239409|NCT00944034|581466|P3|STARTED|Overall Study||152
239410|NCT00944034|581467|P2|STARTED|Overall Study||157
239411|NCT00944034|581468|P1|STARTED|Overall Study||188
239412|NCT00944073|581535|P2|NOT COMPLETED|Overall Study||4
239413|NCT00944073|581536|P1|NOT COMPLETED|Overall Study||5
239414|NCT00944073|581535|P2|COMPLETED|Overall Study||287
239415|NCT00944073|581536|P1|COMPLETED|Overall Study||287
239416|NCT00944073|581535|P2|STARTED|Overall Study||291
239417|NCT00944073|581536|P1|STARTED|Overall Study||292
239418|NCT00944125|581614|P2|NOT COMPLETED|6 Months to Study Completion||2
239419|NCT00944125|581615|P1|NOT COMPLETED|6 Months to Study Completion||0
239420|NCT00944125|581614|P2|COMPLETED|6 Months to Study Completion||18
239421|NCT00944125|581615|P1|COMPLETED|6 Months to Study Completion||19
239422|NCT00944125|581614|P2|STARTED|6 Months to Study Completion||20
239423|NCT00944125|581615|P1|STARTED|6 Months to Study Completion||19
239424|NCT00944125|581614|P2|NOT COMPLETED|3 to 6 Months||2
239425|NCT00944125|581615|P1|NOT COMPLETED|3 to 6 Months||0
239426|NCT00944125|581614|P2|COMPLETED|3 to 6 Months||20
239427|NCT00944125|581615|P1|COMPLETED|3 to 6 Months||19
239428|NCT00944125|581614|P2|STARTED|3 to 6 Months||22
239429|NCT00944125|581615|P1|STARTED|3 to 6 Months||19
239430|NCT00944125|581614|P2|NOT COMPLETED|Baseline to 3 Months||0
239431|NCT00944125|581615|P1|NOT COMPLETED|Baseline to 3 Months||0
239432|NCT00944125|581614|P2|COMPLETED|Baseline to 3 Months||22
239433|NCT00944125|581615|P1|COMPLETED|Baseline to 3 Months||19
239434|NCT00944125|581614|P2|STARTED|Baseline to 3 Months||22
239435|NCT00944125|581615|P1|STARTED|Baseline to 3 Months||19
239436|NCT00944229|581621|P1|NOT COMPLETED|Overall Study||25
239437|NCT00944229|581621|P1|COMPLETED|Overall Study||33
239438|NCT00944229|581621|P1|STARTED|Overall Study||58
239439|NCT00932321|581629|P2|NOT COMPLETED|Overall Study||46
239440|NCT00932321|581630|P1|NOT COMPLETED|Overall Study||171
239441|NCT00932321|581629|P2|COMPLETED|Overall Study||141
239442|NCT00932321|581630|P1|COMPLETED|Overall Study||580
239443|NCT00932321|581629|P2|MITT Population|Overall Study||181
239444|NCT00932321|581630|P1|MITT Population|Overall Study||705
239445|NCT00932321|581629|P2|STARTED|Overall Study||187
239446|NCT00932321|581630|P1|STARTED|Overall Study||751
239447|NCT00932373|581649|P11|NOT COMPLETED|Overall Study||3
239448|NCT00932373|581650|P10|NOT COMPLETED|Overall Study||13
239449|NCT00932373|581651|P9|NOT COMPLETED|Overall Study||2
239450|NCT00932373|581652|P8|NOT COMPLETED|Overall Study||3
239451|NCT00932373|581653|P7|NOT COMPLETED|Overall Study||1
239452|NCT00932373|581654|P6|NOT COMPLETED|Overall Study||3
239453|NCT00932373|581655|P5|NOT COMPLETED|Overall Study||14
239454|NCT00932373|581656|P4|NOT COMPLETED|Overall Study||0
239455|NCT00932373|581657|P3|NOT COMPLETED|Overall Study||1
239456|NCT00932373|581658|P2|NOT COMPLETED|Overall Study||1
239457|NCT00932373|581659|P1|NOT COMPLETED|Overall Study||3
239458|NCT00932373|581649|P11|COMPLETED|Overall Study||0
239459|NCT00932373|581650|P10|COMPLETED|Overall Study||3
239460|NCT00932373|581651|P9|COMPLETED|Overall Study||1
239461|NCT00932373|581652|P8|COMPLETED|Overall Study||0
239462|NCT00932373|581653|P7|COMPLETED|Overall Study||2
239463|NCT00932373|581654|P6|COMPLETED|Overall Study||0
239464|NCT00932373|581655|P5|COMPLETED|Overall Study||1
239465|NCT00932373|581656|P4|COMPLETED|Overall Study||1
239466|NCT00932373|581657|P3|COMPLETED|Overall Study||0
239467|NCT00932373|581658|P2|COMPLETED|Overall Study||0
239468|NCT00932373|581659|P1|COMPLETED|Overall Study||0
239469|NCT00932373|581649|P11|STARTED|Overall Study||3
239470|NCT00932373|581650|P10|STARTED|Overall Study||16
239471|NCT00932373|581651|P9|STARTED|Overall Study||3
239472|NCT00932373|581652|P8|STARTED|Overall Study||3
239473|NCT00932373|581653|P7|STARTED|Overall Study||3
239474|NCT00932373|581654|P6|STARTED|Overall Study||3
239475|NCT00932373|581655|P5|STARTED|Overall Study||15
239476|NCT00932373|581656|P4|STARTED|Overall Study||1
239477|NCT00932373|581657|P3|STARTED|Overall Study||1
239478|NCT00932373|581658|P2|STARTED|Overall Study||1
239479|NCT00932373|581659|P1|STARTED|Overall Study||3
239480|NCT00932399|581761|P2|NOT COMPLETED|Overall Study||0
239481|NCT00932399|581762|P1|NOT COMPLETED|Overall Study||0
239482|NCT00932399|581761|P2|COMPLETED|Overall Study||3790
239483|NCT00932399|581762|P1|COMPLETED|Overall Study||759
239484|NCT00932399|581761|P2|STARTED|Overall Study||3790
239485|NCT00932399|581762|P1|STARTED|Overall Study||759
239486|NCT00932425|581770|P2|NOT COMPLETED|Overall Study||2
239487|NCT00932425|581771|P1|NOT COMPLETED|Overall Study||0
239488|NCT00932425|581770|P2|COMPLETED|Overall Study||18
239489|NCT00932425|581771|P1|COMPLETED|Overall Study||20
239490|NCT00932425|581770|P2|STARTED|Overall Study||20
239491|NCT00932425|581771|P1|STARTED|Overall Study||20
239492|NCT00932451|581784|P1|NOT COMPLETED|Overall Study||822
239493|NCT00932451|581784|P1|COMPLETED|Overall Study||244
239494|NCT00932451|581784|P1|STARTED|Overall Study||1066
239495|NCT00932477|581806|P6|NOT COMPLETED|Treatment 3||0
239496|NCT00932477|581807|P5|NOT COMPLETED|Treatment 3||0
239497|NCT00932477|581808|P4|NOT COMPLETED|Treatment 3||0
239498|NCT00932477|581809|P3|NOT COMPLETED|Treatment 3||0
239499|NCT00932477|581810|P2|NOT COMPLETED|Treatment 3||0
239500|NCT00932477|581811|P1|NOT COMPLETED|Treatment 3||0
239501|NCT00932477|581806|P6|COMPLETED|Treatment 3||8
239502|NCT00932477|581807|P5|COMPLETED|Treatment 3||8
239503|NCT00932477|581808|P4|COMPLETED|Treatment 3||7
239504|NCT00932477|581809|P3|COMPLETED|Treatment 3||9
239505|NCT00932477|581810|P2|COMPLETED|Treatment 3||8
239506|NCT00932477|581811|P1|COMPLETED|Treatment 3||7
239507|NCT00932477|581806|P6|STARTED|Treatment 3||8
239508|NCT00932477|581807|P5|STARTED|Treatment 3||8
239509|NCT00932477|581808|P4|STARTED|Treatment 3||7
239510|NCT00932477|581809|P3|STARTED|Treatment 3||9
239511|NCT00932477|581810|P2|STARTED|Treatment 3||8
239512|NCT00932477|581811|P1|STARTED|Treatment 3||7
239513|NCT00932477|581806|P6|NOT COMPLETED|Treatment 2||0
239514|NCT00932477|581807|P5|NOT COMPLETED|Treatment 2||0
239515|NCT00932477|581808|P4|NOT COMPLETED|Treatment 2||0
239516|NCT00932477|581809|P3|NOT COMPLETED|Treatment 2||0
239517|NCT00932477|581810|P2|NOT COMPLETED|Treatment 2||0
239518|NCT00932477|581811|P1|NOT COMPLETED|Treatment 2||0
239519|NCT00932477|581806|P6|COMPLETED|Treatment 2||8
239520|NCT00932477|581807|P5|COMPLETED|Treatment 2||8
239521|NCT00932477|581808|P4|COMPLETED|Treatment 2||7
239522|NCT00932477|581809|P3|COMPLETED|Treatment 2||9
239523|NCT00932477|581810|P2|COMPLETED|Treatment 2||8
239524|NCT00932477|581811|P1|COMPLETED|Treatment 2||7
239525|NCT00932477|581806|P6|STARTED|Treatment 2||8
239526|NCT00932477|581807|P5|STARTED|Treatment 2||8
239527|NCT00932477|581808|P4|STARTED|Treatment 2||7
239528|NCT00932477|581809|P3|STARTED|Treatment 2||9
239529|NCT00932477|581810|P2|STARTED|Treatment 2||8
239530|NCT00932477|581811|P1|STARTED|Treatment 2||7
239531|NCT00932477|581806|P6|NOT COMPLETED|Treatment 1||0
239532|NCT00932477|581807|P5|NOT COMPLETED|Treatment 1||0
239533|NCT00932477|581808|P4|NOT COMPLETED|Treatment 1||0
239534|NCT00932477|581809|P3|NOT COMPLETED|Treatment 1||0
239535|NCT00932477|581810|P2|NOT COMPLETED|Treatment 1||0
239536|NCT00932477|581811|P1|NOT COMPLETED|Treatment 1||0
239537|NCT00932477|581806|P6|COMPLETED|Treatment 1||8
239538|NCT00932477|581807|P5|COMPLETED|Treatment 1||8
239539|NCT00932477|581808|P4|COMPLETED|Treatment 1||7
239540|NCT00932477|581809|P3|COMPLETED|Treatment 1||9
239541|NCT00932477|581810|P2|COMPLETED|Treatment 1||8
239542|NCT00932477|581811|P1|COMPLETED|Treatment 1||7
239543|NCT00932477|581806|P6|STARTED|Treatment 1||8
239544|NCT00932477|581807|P5|STARTED|Treatment 1||8
239545|NCT00932477|581808|P4|STARTED|Treatment 1||7
239546|NCT00932477|581809|P3|STARTED|Treatment 1||9
239547|NCT00932477|581810|P2|STARTED|Treatment 1||8
239548|NCT00932477|581811|P1|STARTED|Treatment 1||7
239549|NCT00932620|581830|P2|NOT COMPLETED|Overall Study||0
239550|NCT00932620|581831|P1|NOT COMPLETED|Overall Study||0
239551|NCT00932620|581830|P2|COMPLETED|Overall Study||50
239552|NCT00932620|581831|P1|COMPLETED|Overall Study||50
239553|NCT00932620|581830|P2|STARTED|Overall Study||50
239554|NCT00932620|581831|P1|STARTED|Overall Study||50
239555|NCT00932646|581839|P4|NOT COMPLETED|Overall Study||1
239556|NCT00932646|581840|P3|NOT COMPLETED|Overall Study||4
239557|NCT00932646|581841|P2|NOT COMPLETED|Overall Study||3
239558|NCT00932646|581842|P1|NOT COMPLETED|Overall Study||5
239559|NCT00932646|581839|P4|COMPLETED|Overall Study||24
239560|NCT00932646|581840|P3|COMPLETED|Overall Study||21
239561|NCT00932646|581841|P2|COMPLETED|Overall Study||22
239562|NCT00932646|581842|P1|COMPLETED|Overall Study||20
239563|NCT00932646|581839|P4|STARTED|Overall Study||25
239564|NCT00932646|581840|P3|STARTED|Overall Study||25
239565|NCT00932646|581841|P2|STARTED|Overall Study||25
239566|NCT00932646|581842|P1|STARTED|Overall Study||25
239567|NCT00932659|581896|P1|NOT COMPLETED|Overall Study||0
239568|NCT00932659|581896|P1|COMPLETED|Overall Study||8
239569|NCT00932659|581896|P1|STARTED|Overall Study||8
239570|NCT00932893|581903|P2|NOT COMPLETED|Overall Study||170
239571|NCT00932893|581904|P1|NOT COMPLETED|Overall Study||133
239572|NCT00932893|581903|P2|COMPLETED|Overall Study||4
239573|NCT00932893|581904|P1|COMPLETED|Overall Study||40
239574|NCT00932893|581903|P2|Treated|Overall Study||171
239575|NCT00932893|581904|P1|Treated|Overall Study||172
239576|NCT00932893|581903|P2|STARTED|Overall Study||174
239577|NCT00932893|581904|P1|STARTED|Overall Study||173
239578|NCT00938457|581935|P1|NOT COMPLETED|Overall Study||0
239579|NCT00938457|581935|P1|COMPLETED|Overall Study||3
239580|NCT00938457|581935|P1|STARTED|Overall Study||3
239581|NCT00938470|581950|P2|NOT COMPLETED|Overall Study||3
239582|NCT00938470|581951|P1|NOT COMPLETED|Overall Study||7
239583|NCT00938470|581950|P2|COMPLETED|Overall Study||25
239584|NCT00938470|581951|P1|COMPLETED|Overall Study||27
239585|NCT00938470|581950|P2|STARTED|Overall Study||28
239586|NCT00938470|581951|P1|STARTED|Overall Study||34
239587|NCT00938548|581967|P2|NOT COMPLETED|Overall Study||0
239588|NCT00938548|581968|P1|NOT COMPLETED|Overall Study||0
239589|NCT00938548|581967|P2|COMPLETED|Overall Study||35
239590|NCT00938548|581968|P1|COMPLETED|Overall Study||35
239591|NCT00938548|581967|P2|STARTED|Overall Study||35
239592|NCT00938548|581968|P1|STARTED|Overall Study||35
239593|NCT00938639|581980|P2|NOT COMPLETED|Overall Study||4
239594|NCT00938639|581981|P1|NOT COMPLETED|Overall Study||3
239595|NCT00938639|581980|P2|COMPLETED|Overall Study||116
239596|NCT00938639|581981|P1|COMPLETED|Overall Study||117
239597|NCT00938639|581980|P2|STARTED|Overall Study||120
239598|NCT00938639|581981|P1|STARTED|Overall Study||120
239599|NCT00938704|582051|P2|NOT COMPLETED|Overall Study||0
239600|NCT00938704|582052|P1|NOT COMPLETED|Overall Study||0
239601|NCT00938704|582051|P2|COMPLETED|Overall Study||37
239602|NCT00938704|582052|P1|COMPLETED|Overall Study||33
239603|NCT00938704|582051|P2|STARTED|Overall Study||37
239604|NCT00938704|582052|P1|STARTED|Overall Study||33
239605|NCT00938717|582068|P2|NOT COMPLETED|Overall Study||108
239606|NCT00938717|582069|P1|NOT COMPLETED|Overall Study||98
239607|NCT00938717|582068|P2|COMPLETED|Overall Study||294
239608|NCT00938717|582069|P1|COMPLETED|Overall Study||305
239609|NCT00938717|582068|P2|STARTED|Overall Study||402
239610|NCT00938717|582069|P1|STARTED|Overall Study||403
239611|NCT00938782|582103|P2|NOT COMPLETED|Overall Study||0
239612|NCT00938782|582104|P1|NOT COMPLETED|Overall Study||0
239613|NCT00938782|582103|P2|COMPLETED|Overall Study|Upon discharge from PACU|35
239614|NCT00938782|582104|P1|COMPLETED|Overall Study|Upon discharge from PACU|32
239615|NCT00938782|582103|P2|STARTED|Overall Study|Monitoring started pre-induction of anesthesia|35
239616|NCT00938782|582104|P1|STARTED|Overall Study|Pre-induction of anesthesia|32
239617|NCT00944450|582110|P2|NOT COMPLETED|Period 2||0
239618|NCT00944450|582111|P1|NOT COMPLETED|Period 2||0
239619|NCT00944450|582110|P2|COMPLETED|Period 2||6
239620|NCT00944450|582111|P1|COMPLETED|Period 2||6
239621|NCT00944450|582110|P2|STARTED|Period 2||6
239622|NCT00944450|582111|P1|STARTED|Period 2||6
239623|NCT00944450|582110|P2|NOT COMPLETED|Period 1||0
239624|NCT00944450|582111|P1|NOT COMPLETED|Period 1||0
239625|NCT00944450|582110|P2|COMPLETED|Period 1||6
239626|NCT00944450|582111|P1|COMPLETED|Period 1||6
239627|NCT00944450|582110|P2|STARTED|Period 1||6
239628|NCT00944450|582111|P1|STARTED|Period 1||6
239629|NCT00944554|582121|P2|NOT COMPLETED|Overall Study||29
239630|NCT00944554|582122|P1|NOT COMPLETED|Overall Study||28
239631|NCT00944554|582121|P2|COMPLETED|Overall Study||25
239632|NCT00944554|582122|P1|COMPLETED|Overall Study||22
239633|NCT00944554|582121|P2|STARTED|Overall Study||54
239634|NCT00944554|582122|P1|STARTED|Overall Study||50
239635|NCT00948389|582133|P5|NOT COMPLETED|Overall Study||1
239636|NCT00948389|582134|P4|NOT COMPLETED|Overall Study||9
239637|NCT00948389|582135|P3|NOT COMPLETED|Overall Study||7
239638|NCT00948389|582136|P2|NOT COMPLETED|Overall Study||3
239639|NCT00948389|582137|P1|NOT COMPLETED|Overall Study||6
239640|NCT00948389|582133|P5|COMPLETED|Overall Study||0
239641|NCT00948389|582134|P4|COMPLETED|Overall Study||0
239642|NCT00948389|582135|P3|COMPLETED|Overall Study||0
239643|NCT00948389|582136|P2|COMPLETED|Overall Study||0
239644|NCT00948389|582137|P1|COMPLETED|Overall Study||0
239645|NCT00948389|582133|P5|STARTED|Overall Study||1
239646|NCT00948389|582134|P4|STARTED|Overall Study||9
239647|NCT00948389|582135|P3|STARTED|Overall Study||7
239648|NCT00948389|582136|P2|STARTED|Overall Study||3
239649|NCT00948389|582137|P1|STARTED|Overall Study||6
239650|NCT00948441|582176|P2|NOT COMPLETED|Overall Study||4
239651|NCT00948441|582177|P1|NOT COMPLETED|Overall Study||1
239652|NCT00948441|582176|P2|COMPLETED|Overall Study||4
239653|NCT00948441|582177|P1|COMPLETED|Overall Study||7
239654|NCT00948441|582176|P2|STARTED|Overall Study||8
239655|NCT00948441|582177|P1|STARTED|Overall Study||8
239656|NCT00948506|582187|P2|NOT COMPLETED|Overall Study||1
239657|NCT00948506|582188|P1|NOT COMPLETED|Overall Study||3
239658|NCT00948506|582187|P2|COMPLETED|Overall Study||8
239659|NCT00948506|582188|P1|COMPLETED|Overall Study||8
239660|NCT00948506|582187|P2|STARTED|Overall Study||9
239661|NCT00948506|582188|P1|STARTED|Overall Study||11
239662|NCT00948675|582199|P2|NOT COMPLETED|Overall Study||4
239663|NCT00948675|582200|P1|NOT COMPLETED|Overall Study||7
239664|NCT00948675|582199|P2|COMPLETED|Overall Study||175
239665|NCT00948675|582200|P1|COMPLETED|Overall Study||175
239666|NCT00948675|582199|P2|STARTED|Overall Study||179
239667|NCT00948675|582200|P1|STARTED|Overall Study||182
239668|NCT00948688|582214|P2|NOT COMPLETED|Period 2: 100 mg Vorinostat||1
239669|NCT00948688|582215|P1|NOT COMPLETED|Period 2: 100 mg Vorinostat||0
239670|NCT00948688|582214|P2|COMPLETED|Period 2: 100 mg Vorinostat||5
239671|NCT00948688|582215|P1|COMPLETED|Period 2: 100 mg Vorinostat||0
239672|NCT00948688|582214|P2|STARTED|Period 2: 100 mg Vorinostat||6
239673|NCT00948688|582215|P1|STARTED|Period 2: 100 mg Vorinostat||0
239674|NCT00948688|582214|P2|NOT COMPLETED|Period 1: 200 mg Vorinostat||0
239675|NCT00948688|582215|P1|NOT COMPLETED|Period 1: 200 mg Vorinostat||2
239676|NCT00948688|582214|P2|COMPLETED|Period 1: 200 mg Vorinostat||0
239677|NCT00948688|582215|P1|COMPLETED|Period 1: 200 mg Vorinostat||2
239678|NCT00948688|582214|P2|STARTED|Period 1: 200 mg Vorinostat||0
239679|NCT00948688|582215|P1|STARTED|Period 1: 200 mg Vorinostat||4
239680|NCT00948766|582229|P2|NOT COMPLETED|Extension Study||0
239681|NCT00948766|582230|P1|NOT COMPLETED|Extension Study||91
239682|NCT00948766|582229|P2|COMPLETED|Extension Study||0
239683|NCT00948766|582230|P1|COMPLETED|Extension Study||306
239684|NCT00948766|582229|P2|Exposed to Study Medication|Extension Study||0
239685|NCT00948766|582230|P1|Exposed to Study Medication|Extension Study||396
239686|NCT00948766|582229|P2|STARTED|Extension Study|No patients received this treatment in the extension study.|0
239687|NCT00948766|582230|P1|STARTED|Extension Study|397 of the 463 patients who completed the core study entered the extension study.|397
239688|NCT00948766|582229|P2|NOT COMPLETED|Core Study||126
239689|NCT00948766|582230|P1|NOT COMPLETED|Core Study||127
239690|NCT00948766|582229|P2|COMPLETED|Core Study||234
239691|NCT00948766|582230|P1|COMPLETED|Core Study||229
239692|NCT00948766|582229|P2|Exposed to Study Medication|Core Study||359
239693|NCT00948766|582230|P1|Exposed to Study Medication|Core Study||355
239694|NCT00948766|582229|P2|STARTED|Core Study||360
239695|NCT00948766|582230|P1|STARTED|Core Study||356
239696|NCT00948792|582246|P1|NOT COMPLETED|Overall Study||0
239697|NCT00948792|582246|P1|COMPLETED|Overall Study||21
239698|NCT00948792|582246|P1|STARTED|Overall Study||21
239699|NCT00948818|582258|P2|NOT COMPLETED|Overall Study||94
239700|NCT00948818|582259|P1|NOT COMPLETED|Overall Study||62
239701|NCT00948818|582258|P2|COMPLETED|Overall Study||312
239702|NCT00948818|582259|P1|COMPLETED|Overall Study||335
239703|NCT00948818|582258|P2|STARTED|Overall Study||406
239704|NCT00948818|582259|P1|STARTED|Overall Study||397
239705|NCT00948857|582296|P2|NOT COMPLETED|Overall Study||0
239706|NCT00948857|582297|P1|NOT COMPLETED|Overall Study||1
239707|NCT00948857|582296|P2|COMPLETED|Overall Study||2
239708|NCT00948857|582297|P1|COMPLETED|Overall Study|3 completed and 1 dropped out.|2
239709|NCT00948857|582296|P2|STARTED|Overall Study||2
239710|NCT00948857|582297|P1|STARTED|Overall Study||3
239711|NCT00948896|582311|P8|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
239712|NCT00948896|582312|P7|NOT COMPLETED|24 Months of Age to 36 Months of Age||0
239713|NCT00948896|582313|P6|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
239714|NCT00948896|582314|P5|NOT COMPLETED|24 Months of Age to 36 Months of Age||1
239715|NCT00948896|582315|P4|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
239716|NCT00948896|582316|P3|NOT COMPLETED|24 Months of Age to 36 Months of Age||5
239717|NCT00948896|582317|P2|NOT COMPLETED|24 Months of Age to 36 Months of Age||2
239718|NCT00948896|582318|P1|NOT COMPLETED|24 Months of Age to 36 Months of Age||3
239719|NCT00948896|582311|P8|COMPLETED|24 Months of Age to 36 Months of Age||45
239720|NCT00948896|582312|P7|COMPLETED|24 Months of Age to 36 Months of Age||43
239721|NCT00948896|582313|P6|COMPLETED|24 Months of Age to 36 Months of Age||40
239722|NCT00948896|582314|P5|COMPLETED|24 Months of Age to 36 Months of Age||43
239723|NCT00948896|582315|P4|COMPLETED|24 Months of Age to 36 Months of Age||85
239724|NCT00948896|582316|P3|COMPLETED|24 Months of Age to 36 Months of Age||85
239725|NCT00948896|582317|P2|COMPLETED|24 Months of Age to 36 Months of Age||83
239726|NCT00948896|582318|P1|COMPLETED|24 Months of Age to 36 Months of Age||87
239727|NCT00948896|582311|P8|STARTED|24 Months of Age to 36 Months of Age||45
239728|NCT00948896|582312|P7|STARTED|24 Months of Age to 36 Months of Age||43
239729|NCT00948896|582313|P6|STARTED|24 Months of Age to 36 Months of Age||42
239730|NCT00948896|582314|P5|STARTED|24 Months of Age to 36 Months of Age||44
239731|NCT00948896|582315|P4|STARTED|24 Months of Age to 36 Months of Age||87
239732|NCT00948896|582316|P3|STARTED|24 Months of Age to 36 Months of Age||90
239733|NCT00948896|582317|P2|STARTED|24 Months of Age to 36 Months of Age||85
239734|NCT00948896|582318|P1|STARTED|24 Months of Age to 36 Months of Age||90
239735|NCT00948896|582311|P8|NOT COMPLETED|Randomization to 24 Months of Age||2
239736|NCT00948896|582312|P7|NOT COMPLETED|Randomization to 24 Months of Age||4
239737|NCT00948896|582313|P6|NOT COMPLETED|Randomization to 24 Months of Age||4
239738|NCT00948896|582314|P5|NOT COMPLETED|Randomization to 24 Months of Age||2
239739|NCT00948896|582315|P4|NOT COMPLETED|Randomization to 24 Months of Age||11
239740|NCT00948896|582316|P3|NOT COMPLETED|Randomization to 24 Months of Age||9
239741|NCT00948896|582317|P2|NOT COMPLETED|Randomization to 24 Months of Age||13
239742|NCT00948896|582318|P1|NOT COMPLETED|Randomization to 24 Months of Age||8
239743|NCT00948896|582311|P8|COMPLETED|Randomization to 24 Months of Age||45
239744|NCT00948896|582312|P7|COMPLETED|Randomization to 24 Months of Age||43
239745|NCT00948896|582313|P6|COMPLETED|Randomization to 24 Months of Age||42
239746|NCT00948896|582314|P5|COMPLETED|Randomization to 24 Months of Age||44
239747|NCT00948896|582315|P4|COMPLETED|Randomization to 24 Months of Age||87
239748|NCT00948896|582316|P3|COMPLETED|Randomization to 24 Months of Age||90
239749|NCT00948896|582317|P2|COMPLETED|Randomization to 24 Months of Age||85
239750|NCT00948896|582318|P1|COMPLETED|Randomization to 24 Months of Age||90
239751|NCT00948896|582311|P8|STARTED|Randomization to 24 Months of Age||47
239752|NCT00948896|582312|P7|STARTED|Randomization to 24 Months of Age||47
239753|NCT00948896|582313|P6|STARTED|Randomization to 24 Months of Age||46
239754|NCT00948896|582314|P5|STARTED|Randomization to 24 Months of Age||46
239755|NCT00948896|582315|P4|STARTED|Randomization to 24 Months of Age||98
239756|NCT00948896|582316|P3|STARTED|Randomization to 24 Months of Age||99
239757|NCT00948896|582317|P2|STARTED|Randomization to 24 Months of Age||98
239758|NCT00948896|582318|P1|STARTED|Randomization to 24 Months of Age||98
239759|NCT00949078|582354|P2|NOT COMPLETED|Overall Study||0
239760|NCT00949078|582355|P1|NOT COMPLETED|Overall Study||0
239761|NCT00949078|582354|P2|COMPLETED|Overall Study||9
239762|NCT00949078|582355|P1|COMPLETED|Overall Study||5
239763|NCT00949078|582354|P2|STARTED|Overall Study||9
239764|NCT00949078|582355|P1|STARTED|Overall Study||5
239765|NCT00949117|582379|P2|NOT COMPLETED|Overall Study||5
239766|NCT00949117|582380|P1|NOT COMPLETED|Overall Study||3
239767|NCT00949117|582379|P2|COMPLETED|Overall Study||0
239768|NCT00949117|582380|P1|COMPLETED|Overall Study||1
239769|NCT00949117|582379|P2|STARTED|Overall Study||5
239770|NCT00949117|582380|P1|STARTED|Overall Study||4
239771|NCT00949533|582396|P2|NOT COMPLETED|Overall Study||1
239772|NCT00949533|582397|P1|NOT COMPLETED|Overall Study||0
239773|NCT00949533|582396|P2|COMPLETED|Overall Study||17
239774|NCT00949533|582397|P1|COMPLETED|Overall Study||19
239775|NCT00949533|582396|P2|STARTED|Overall Study||18
239776|NCT00949533|582397|P1|STARTED|Overall Study||19
239777|NCT00949650|582411|P2|NOT COMPLETED|Overall Study||55
239778|NCT00949650|582412|P1|NOT COMPLETED|Overall Study||165
239779|NCT00949650|582411|P2|COMPLETED|Overall Study|6 courses of chemotherapy completed|60
239780|NCT00949650|582412|P1|COMPLETED|Overall Study|On-treatment at primary endpoint analysis cut-off date (09 February 2012).|65
239781|NCT00949650|582411|P2|STARTED|Overall Study|Randomized patients|115
239782|NCT00949650|582412|P1|STARTED|Overall Study|Randomized patients|230
239783|NCT00949702|582448|P1|NOT COMPLETED|Overall Study||48
239784|NCT00949702|582448|P1|COMPLETED|Overall Study||84
239785|NCT00949702|582448|P1|STARTED|Overall Study||132
239786|NCT00949715|582465|P2|NOT COMPLETED|Overall Study||0
239787|NCT00949715|582466|P1|NOT COMPLETED|Overall Study||4
239788|NCT00949715|582465|P2|COMPLETED|Overall Study||33
239789|NCT00949715|582466|P1|COMPLETED|Overall Study||28
239790|NCT00949715|582465|P2|STARTED|Overall Study||33
239791|NCT00949715|582466|P1|STARTED|Overall Study||32
239792|NCT00949884|582480|P3|NOT COMPLETED|Overall Study||58
239793|NCT00949884|582481|P2|NOT COMPLETED|Overall Study||15
239794|NCT00949884|582482|P1|NOT COMPLETED|Overall Study||50
239795|NCT00949884|582480|P3|COMPLETED|Overall Study||411
239796|NCT00949884|582481|P2|COMPLETED|Overall Study||37
239797|NCT00949884|582482|P1|COMPLETED|Overall Study||370
239798|NCT00949884|582480|P3|STARTED|Overall Study||469
239799|NCT00949884|582481|P2|STARTED|Overall Study||52
239800|NCT00949884|582482|P1|STARTED|Overall Study||420
239801|NCT00949910|582535|P1|NOT COMPLETED|Overall Study||6576
239802|NCT00949910|582535|P1|COMPLETED|Overall Study||10
239803|NCT00949910|582535|P1|STARTED|Overall Study||6586
239804|NCT00949975|582549|P4|NOT COMPLETED|Overall Study||28
239805|NCT00949975|582550|P3|NOT COMPLETED|Overall Study||19
239806|NCT00949975|582551|P2|NOT COMPLETED|Overall Study||29
239807|NCT00949975|582552|P1|NOT COMPLETED|Overall Study||27
239808|NCT00949975|582549|P4|COMPLETED|Overall Study||190
239809|NCT00949975|582550|P3|COMPLETED|Overall Study||183
239810|NCT00949975|582551|P2|COMPLETED|Overall Study||177
239811|NCT00949975|582552|P1|COMPLETED|Overall Study||185
239812|NCT00949975|582549|P4|STARTED|Overall Study||218
239813|NCT00949975|582550|P3|STARTED|Overall Study||202
239814|NCT00949975|582551|P2|STARTED|Overall Study||206
239815|NCT00949975|582552|P1|STARTED|Overall Study||212
239816|NCT00950183|582670|P1|NOT COMPLETED|Overall Study||36
239817|NCT00950183|582670|P1|COMPLETED|Overall Study||0
239818|NCT00950183|582670|P1|STARTED|Overall Study||36
239819|NCT00950235|582680|P2|NOT COMPLETED|Overall Study||4
239820|NCT00950235|582681|P1|NOT COMPLETED|Overall Study||2
239821|NCT00950235|582680|P2|COMPLETED|Overall Study||54
239822|NCT00950235|582681|P1|COMPLETED|Overall Study||58
239823|NCT00950235|582680|P2|STARTED|Overall Study||58
239824|NCT00950235|582681|P1|STARTED|Overall Study||60
239825|NCT00950300|582693|P2|NOT COMPLETED|SFU Period||54
239826|NCT00950300|582694|P1|NOT COMPLETED|SFU Period||53
239827|NCT00950300|582693|P2|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
239828|NCT00950300|582694|P1|COMPLETED|SFU Period|Participants who consented to 2 years of follow-up only.|22
239829|NCT00950300|582693|P2|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|76
239830|NCT00950300|582694|P1|STARTED|SFU Period|Participants could withdraw from the study entirely or advance directly to the SFU Period.|75
239831|NCT00950300|582693|P2|NOT COMPLETED|TFFU Period||252
239832|NCT00950300|582694|P1|NOT COMPLETED|TFFU Period||254
239833|NCT00950300|582693|P2|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 7 participants with missing data.|16
239834|NCT00950300|582694|P1|COMPLETED|TFFU Period|Participants who consented to 2 years of follow-up only; includes 3 participants with missing data.|11
239835|NCT00950300|582693|P2|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|268
239836|NCT00950300|582694|P1|STARTED|TFFU Period|Participants could withdraw from the study entirely or advance directly to the TFFU or SFU Period.|265
239837|NCT00950300|582693|P2|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
239838|NCT00950300|582694|P1|NOT COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||42
239839|NCT00950300|582693|P2|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||255
239840|NCT00950300|582694|P1|COMPLETED|Neoadjuvant/Adjuvant Treatment Periods||257
239841|NCT00950300|582693|P2|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||274
239842|NCT00950300|582694|P1|Entered Adjuvant Treatment|Neoadjuvant/Adjuvant Treatment Periods||277
239843|NCT00950300|582693|P2|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||273
239844|NCT00950300|582694|P1|Underwent Surgery|Neoadjuvant/Adjuvant Treatment Periods||278
239845|NCT00950300|582693|P2|STARTED|Neoadjuvant/Adjuvant Treatment Periods||297
239846|NCT00950300|582694|P1|STARTED|Neoadjuvant/Adjuvant Treatment Periods||299
239847|NCT00950352|582749|P2|NOT COMPLETED|Overall Study||11
239848|NCT00950352|582750|P1|NOT COMPLETED|Overall Study||42
239849|NCT00950352|582749|P2|COMPLETED|Overall Study||21
239850|NCT00950352|582750|P1|COMPLETED|Overall Study||30
239851|NCT00950352|582749|P2|STARTED|Overall Study||32
239852|NCT00950352|582750|P1|STARTED|Overall Study||72
239853|NCT00950599|582764|P10|NOT COMPLETED|Follow-Up Period||2
239854|NCT00950599|582765|P9|NOT COMPLETED|Follow-Up Period||13
239855|NCT00950599|582766|P8|NOT COMPLETED|Follow-Up Period||0
239856|NCT00950599|582767|P7|NOT COMPLETED|Follow-Up Period||0
239857|NCT00950599|582768|P6|NOT COMPLETED|Follow-Up Period||0
239858|NCT00950599|582769|P5|NOT COMPLETED|Follow-Up Period||0
239859|NCT00950599|582770|P4|NOT COMPLETED|Follow-Up Period||0
239860|NCT00950599|582771|P3|NOT COMPLETED|Follow-Up Period||0
239861|NCT00950599|582772|P2|NOT COMPLETED|Follow-Up Period||0
239862|NCT00950599|582773|P1|NOT COMPLETED|Follow-Up Period||0
239863|NCT00950599|582764|P10|COMPLETED|Follow-Up Period||78
239864|NCT00950599|582765|P9|COMPLETED|Follow-Up Period||296
239865|NCT00950599|582766|P8|COMPLETED|Follow-Up Period||0
239866|NCT00950599|582767|P7|COMPLETED|Follow-Up Period||0
239867|NCT00950599|582768|P6|COMPLETED|Follow-Up Period||0
239868|NCT00950599|582769|P5|COMPLETED|Follow-Up Period||0
239869|NCT00950599|582770|P4|COMPLETED|Follow-Up Period||0
239870|NCT00950599|582771|P3|COMPLETED|Follow-Up Period||0
239871|NCT00950599|582772|P2|COMPLETED|Follow-Up Period||0
239872|NCT00950599|582773|P1|COMPLETED|Follow-Up Period||0
239873|NCT00950599|582764|P10|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|80
239874|NCT00950599|582765|P9|STARTED|Follow-Up Period|those completing double blind period (DB) + those rescued/discontinued from DB due to hyperglycemia|309
239875|NCT00950599|582766|P8|STARTED|Follow-Up Period||0
239876|NCT00950599|582767|P7|STARTED|Follow-Up Period||0
239877|NCT00950599|582768|P6|STARTED|Follow-Up Period||0
239878|NCT00950599|582769|P5|STARTED|Follow-Up Period||0
239879|NCT00950599|582770|P4|STARTED|Follow-Up Period||0
239880|NCT00950599|582771|P3|STARTED|Follow-Up Period||0
239881|NCT00950599|582772|P2|STARTED|Follow-Up Period||0
239882|NCT00950599|582773|P1|STARTED|Follow-Up Period||0
239883|NCT00950599|582764|P10|NOT COMPLETED|Double-Blind Treatment Period||0
239884|NCT00950599|582765|P9|NOT COMPLETED|Double-Blind Treatment Period||0
239885|NCT00950599|582766|P8|NOT COMPLETED|Double-Blind Treatment Period||6
239886|NCT00950599|582767|P7|NOT COMPLETED|Double-Blind Treatment Period||0
239887|NCT00950599|582768|P6|NOT COMPLETED|Double-Blind Treatment Period||12
239888|NCT00950599|582769|P5|NOT COMPLETED|Double-Blind Treatment Period||7
239889|NCT00950599|582770|P4|NOT COMPLETED|Double-Blind Treatment Period||11
239890|NCT00950599|582771|P3|NOT COMPLETED|Double-Blind Treatment Period||9
239891|NCT00950599|582772|P2|NOT COMPLETED|Double-Blind Treatment Period||10
239892|NCT00950599|582773|P1|NOT COMPLETED|Double-Blind Treatment Period||7
239893|NCT00950599|582764|P10|COMPLETED|Double-Blind Treatment Period||0
239894|NCT00950599|582765|P9|COMPLETED|Double-Blind Treatment Period||0
239895|NCT00950599|582766|P8|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|35
239896|NCT00950599|582767|P7|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|44
239897|NCT00950599|582768|P6|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|55
239898|NCT00950599|582769|P5|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|45
239899|NCT00950599|582770|P4|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|43
239900|NCT00950599|582771|P3|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|54
239989|NCT00941720|583547|P1|COMPLETED|Overall Study||57
239901|NCT00950599|582772|P2|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|37
239902|NCT00950599|582773|P1|COMPLETED|Double-Blind Treatment Period|Completed 12 weeks of treatment|48
239903|NCT00950599|582764|P10|STARTED|Double-Blind Treatment Period||0
239904|NCT00950599|582765|P9|STARTED|Double-Blind Treatment Period||0
239905|NCT00950599|582766|P8|STARTED|Double-Blind Treatment Period||41
239906|NCT00950599|582767|P7|STARTED|Double-Blind Treatment Period||44
239907|NCT00950599|582768|P6|STARTED|Double-Blind Treatment Period||67
239908|NCT00950599|582769|P5|STARTED|Double-Blind Treatment Period||52
239909|NCT00950599|582770|P4|STARTED|Double-Blind Treatment Period||54
239910|NCT00950599|582771|P3|STARTED|Double-Blind Treatment Period||63
239911|NCT00950599|582772|P2|STARTED|Double-Blind Treatment Period||47
239912|NCT00950599|582773|P1|STARTED|Double-Blind Treatment Period||55
239913|NCT00950612|583337|P2|NOT COMPLETED|Overall Study||0
239914|NCT00950612|583338|P1|NOT COMPLETED|Overall Study||0
239915|NCT00950612|583337|P2|COMPLETED|Overall Study||20
239916|NCT00950612|583338|P1|COMPLETED|Overall Study||40
239917|NCT00950612|583337|P2|STARTED|Overall Study||20
239918|NCT00950612|583338|P1|STARTED|Overall Study||40
239919|NCT00950651|583376|P2|NOT COMPLETED|Overall Study||35
239920|NCT00950651|583377|P1|NOT COMPLETED|Overall Study||31
239921|NCT00950651|583376|P2|COMPLETED|Overall Study||181
239922|NCT00950651|583377|P1|COMPLETED|Overall Study||184
239923|NCT00950651|583376|P2|STARTED|Overall Study|216 patients randomized but one never took study medication|216
239924|NCT00950651|583377|P1|STARTED|Overall Study||215
239925|NCT00950664|583425|P2|NOT COMPLETED|Second Intervention||48
239926|NCT00950664|583426|P1|NOT COMPLETED|Second Intervention||46
239927|NCT00950664|583425|P2|COMPLETED|Second Intervention||0
239928|NCT00950664|583426|P1|COMPLETED|Second Intervention||0
239929|NCT00950664|583425|P2|STARTED|Second Intervention||48
239930|NCT00950664|583426|P1|STARTED|Second Intervention||46
239931|NCT00950664|583425|P2|NOT COMPLETED|Washout Period of 4 Weeks||0
239932|NCT00950664|583426|P1|NOT COMPLETED|Washout Period of 4 Weeks||0
239933|NCT00950664|583425|P2|COMPLETED|Washout Period of 4 Weeks||48
239934|NCT00950664|583426|P1|COMPLETED|Washout Period of 4 Weeks||46
239935|NCT00950664|583425|P2|STARTED|Washout Period of 4 Weeks||48
239936|NCT00950664|583426|P1|STARTED|Washout Period of 4 Weeks||46
239937|NCT00950664|583425|P2|NOT COMPLETED|First Intervention||5
239938|NCT00950664|583426|P1|NOT COMPLETED|First Intervention||3
239939|NCT00950664|583425|P2|COMPLETED|First Intervention||48
239940|NCT00950664|583426|P1|COMPLETED|First Intervention||46
239941|NCT00950664|583425|P2|STARTED|First Intervention||53
239942|NCT00950664|583426|P1|STARTED|First Intervention||49
239943|NCT00950690|583444|P1|NOT COMPLETED|Overall Study||244
239944|NCT00950690|583444|P1|COMPLETED|Overall Study||1105
239945|NCT00950690|583444|P1|STARTED|Overall Study||1349
239946|NCT00950729|583449|P1|NOT COMPLETED|Driving With Aircast||0
239947|NCT00950729|583449|P1|COMPLETED|Driving With Aircast||48
239948|NCT00950729|583449|P1|STARTED|Driving With Aircast||48
239949|NCT00950729|583449|P1|NOT COMPLETED|Driving With Plaster Cast||0
239950|NCT00950729|583449|P1|COMPLETED|Driving With Plaster Cast||48
239951|NCT00950729|583449|P1|STARTED|Driving With Plaster Cast||48
239952|NCT00950729|583449|P1|NOT COMPLETED|Driving With Running Shoes||0
239953|NCT00950729|583449|P1|COMPLETED|Driving With Running Shoes|June 2007|48
239954|NCT00950729|583449|P1|STARTED|Driving With Running Shoes|March 2007|48
239955|NCT00950742|583456|P2|NOT COMPLETED|Overall Study||2
239956|NCT00950742|583457|P1|NOT COMPLETED|Overall Study||16
239957|NCT00950742|583456|P2|COMPLETED|Overall Study||0
239958|NCT00950742|583457|P1|COMPLETED|Overall Study||0
239959|NCT00950742|583456|P2|STARTED|Overall Study|entered and treated|2
239960|NCT00950742|583457|P1|STARTED|Overall Study|entered and treated|16
239961|NCT00950755|583473|P1|NOT COMPLETED|Long-Term Follow-Up||9
239962|NCT00950755|583473|P1|COMPLETED|Long-Term Follow-Up||9
239963|NCT00950755|583473|P1|STARTED|Long-Term Follow-Up|18 of the 41 participants withdrawing from Study BEX104505 enrolled in the LTFU study.|18
239964|NCT00950755|583473|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||41
239965|NCT00950755|583473|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
239966|NCT00950755|583473|P1|STARTED|Dosimetric and Therapeutic Treatment||41
239967|NCT00941655|583499|P2|NOT COMPLETED|Overall Study||7
239968|NCT00941655|583500|P1|NOT COMPLETED|Overall Study||6
239969|NCT00941655|583499|P2|COMPLETED|Overall Study||1
239970|NCT00941655|583500|P1|COMPLETED|Overall Study||2
239971|NCT00941655|583499|P2|STARTED|Overall Study||8
239972|NCT00941655|583500|P1|STARTED|Overall Study||8
239973|NCT00941668|583510|P2|NOT COMPLETED|Overall Study||25
239974|NCT00941668|583511|P1|NOT COMPLETED|Overall Study||24
239975|NCT00941668|583510|P2|COMPLETED|Overall Study||0
239976|NCT00941668|583511|P1|COMPLETED|Overall Study||0
239977|NCT00941668|583510|P2|STARTED|Overall Study||25
239978|NCT00941668|583511|P1|STARTED|Overall Study||24
239979|NCT00941681|583522|P3|NOT COMPLETED|Overall Study||0
239980|NCT00941681|583523|P2|NOT COMPLETED|Overall Study||1
239981|NCT00941681|583524|P1|NOT COMPLETED|Overall Study||0
239982|NCT00941681|583522|P3|COMPLETED|Overall Study||12
239983|NCT00941681|583523|P2|COMPLETED|Overall Study||10
239984|NCT00941681|583524|P1|COMPLETED|Overall Study||12
239985|NCT00941681|583522|P3|STARTED|Overall Study||12
239986|NCT00941681|583523|P2|STARTED|Overall Study||11
239987|NCT00941681|583524|P1|STARTED|Overall Study||12
239988|NCT00941720|583547|P1|NOT COMPLETED|Overall Study||14
239990|NCT00941720|583547|P1|STARTED|Overall Study||71
239991|NCT00941733|583555|P2|NOT COMPLETED|Overall Study||28
239992|NCT00941733|583556|P1|NOT COMPLETED|Overall Study||74
239993|NCT00941733|583555|P2|COMPLETED|Overall Study|1 year follow-up|91
239994|NCT00941733|583556|P1|COMPLETED|Overall Study|1 year follow-up|165
239995|NCT00941733|583555|P2|STARTED|Overall Study||119
239996|NCT00941733|583556|P1|STARTED|Overall Study||239
239997|NCT00950807|583596|P10|NOT COMPLETED|Treatment Period 3||1
239998|NCT00950807|583597|P9|NOT COMPLETED|Treatment Period 3||0
239999|NCT00950807|583598|P8|NOT COMPLETED|Treatment Period 3||1
240000|NCT00950807|583599|P7|NOT COMPLETED|Treatment Period 3||1
240001|NCT00950807|583600|P6|NOT COMPLETED|Treatment Period 3||0
240002|NCT00950807|583601|P5|NOT COMPLETED|Treatment Period 3||0
240003|NCT00950807|583602|P4|NOT COMPLETED|Treatment Period 3||0
240004|NCT00950807|583603|P3|NOT COMPLETED|Treatment Period 3||0
240005|NCT00950807|583604|P2|NOT COMPLETED|Treatment Period 3||0
240006|NCT00950807|583605|P1|NOT COMPLETED|Treatment Period 3||1
240007|NCT00950807|583596|P10|COMPLETED|Treatment Period 3||10
240008|NCT00950807|583597|P9|COMPLETED|Treatment Period 3||9
240009|NCT00950807|583598|P8|COMPLETED|Treatment Period 3||9
240010|NCT00950807|583599|P7|COMPLETED|Treatment Period 3||11
240011|NCT00950807|583600|P6|COMPLETED|Treatment Period 3||9
240012|NCT00950807|583601|P5|COMPLETED|Treatment Period 3||12
240013|NCT00950807|583602|P4|COMPLETED|Treatment Period 3||11
240014|NCT00950807|583603|P3|COMPLETED|Treatment Period 3||10
240015|NCT00950807|583604|P2|COMPLETED|Treatment Period 3||9
240016|NCT00950807|583605|P1|COMPLETED|Treatment Period 3||45
240017|NCT00950807|583596|P10|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
240162|NCT00950872|583749|P1|NOT COMPLETED|Overall Study||3
240018|NCT00950807|583597|P9|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
240019|NCT00950807|583598|P8|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
240020|NCT00950807|583599|P7|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
240021|NCT00950807|583600|P6|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
240022|NCT00950807|583601|P5|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|12
240023|NCT00950807|583602|P4|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|11
240024|NCT00950807|583603|P3|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|10
240025|NCT00950807|583604|P2|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|9
240026|NCT00950807|583605|P1|STARTED|Treatment Period 3|By crossover design, participants were assigned to a different treatment arm in each period.|46
240027|NCT00950807|583596|P10|NOT COMPLETED|Washout Period 2||0
240028|NCT00950807|583597|P9|NOT COMPLETED|Washout Period 2||0
240029|NCT00950807|583598|P8|NOT COMPLETED|Washout Period 2||1
240030|NCT00950807|583599|P7|NOT COMPLETED|Washout Period 2||1
240031|NCT00950807|583600|P6|NOT COMPLETED|Washout Period 2||0
240032|NCT00950807|583601|P5|NOT COMPLETED|Washout Period 2||1
240033|NCT00950807|583602|P4|NOT COMPLETED|Washout Period 2||1
240034|NCT00950807|583603|P3|NOT COMPLETED|Washout Period 2||0
240035|NCT00950807|583604|P2|NOT COMPLETED|Washout Period 2||1
240036|NCT00950807|583605|P1|NOT COMPLETED|Washout Period 2||4
240037|NCT00950807|583596|P10|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
240038|NCT00950807|583597|P9|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
240039|NCT00950807|583598|P8|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
240040|NCT00950807|583599|P7|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|8
240041|NCT00950807|583600|P6|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|9
240042|NCT00950807|583601|P5|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|12
240043|NCT00950807|583602|P4|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
240044|NCT00950807|583603|P3|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|10
240045|NCT00950807|583604|P2|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|11
240046|NCT00950807|583605|P1|COMPLETED|Washout Period 2|Participants withdrawing during washout are counted under the last treatment taken.|47
240047|NCT00950807|583596|P10|STARTED|Washout Period 2||11
240048|NCT00950807|583597|P9|STARTED|Washout Period 2||11
240049|NCT00950807|583598|P8|STARTED|Washout Period 2||10
240050|NCT00950807|583599|P7|STARTED|Washout Period 2||9
240051|NCT00950807|583600|P6|STARTED|Washout Period 2||9
240052|NCT00950807|583601|P5|STARTED|Washout Period 2||13
240053|NCT00950807|583602|P4|STARTED|Washout Period 2||12
240054|NCT00950807|583603|P3|STARTED|Washout Period 2||10
240055|NCT00950807|583604|P2|STARTED|Washout Period 2||12
240056|NCT00950807|583605|P1|STARTED|Washout Period 2||51
240057|NCT00950807|583596|P10|NOT COMPLETED|Treatment Period 2||0
240058|NCT00950807|583597|P9|NOT COMPLETED|Treatment Period 2||0
240059|NCT00950807|583598|P8|NOT COMPLETED|Treatment Period 2||3
240060|NCT00950807|583599|P7|NOT COMPLETED|Treatment Period 2||1
240061|NCT00950807|583600|P6|NOT COMPLETED|Treatment Period 2||1
240062|NCT00950807|583601|P5|NOT COMPLETED|Treatment Period 2||0
240063|NCT00950807|583602|P4|NOT COMPLETED|Treatment Period 2||1
240064|NCT00950807|583603|P3|NOT COMPLETED|Treatment Period 2||0
240065|NCT00950807|583604|P2|NOT COMPLETED|Treatment Period 2||1
240066|NCT00950807|583605|P1|NOT COMPLETED|Treatment Period 2||2
240067|NCT00950807|583596|P10|COMPLETED|Treatment Period 2||11
240068|NCT00950807|583597|P9|COMPLETED|Treatment Period 2||11
240069|NCT00950807|583598|P8|COMPLETED|Treatment Period 2||10
240070|NCT00950807|583599|P7|COMPLETED|Treatment Period 2||9
240071|NCT00950807|583600|P6|COMPLETED|Treatment Period 2||9
240072|NCT00950807|583601|P5|COMPLETED|Treatment Period 2||13
240073|NCT00950807|583602|P4|COMPLETED|Treatment Period 2||12
240074|NCT00950807|583603|P3|COMPLETED|Treatment Period 2||10
240075|NCT00950807|583604|P2|COMPLETED|Treatment Period 2||12
240076|NCT00950807|583605|P1|COMPLETED|Treatment Period 2||51
240077|NCT00950807|583596|P10|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
240078|NCT00950807|583597|P9|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|11
240079|NCT00950807|583598|P8|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
240080|NCT00950807|583599|P7|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
240081|NCT00950807|583600|P6|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
240082|NCT00950807|583601|P5|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
240163|NCT00950872|583749|P1|COMPLETED|Overall Study||26
240083|NCT00950807|583602|P4|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
240084|NCT00950807|583603|P3|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|10
240085|NCT00950807|583604|P2|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|13
240086|NCT00950807|583605|P1|STARTED|Treatment Period 2|By crossover design, participants were assigned to a different treatment arm in each period.|53
240087|NCT00950807|583596|P10|NOT COMPLETED|Washout Period 1||0
240088|NCT00950807|583597|P9|NOT COMPLETED|Washout Period 1||1
240089|NCT00950807|583598|P8|NOT COMPLETED|Washout Period 1||1
240090|NCT00950807|583599|P7|NOT COMPLETED|Washout Period 1||2
240091|NCT00950807|583600|P6|NOT COMPLETED|Washout Period 1||0
240092|NCT00950807|583601|P5|NOT COMPLETED|Washout Period 1||1
240093|NCT00950807|583602|P4|NOT COMPLETED|Washout Period 1||1
240094|NCT00950807|583603|P3|NOT COMPLETED|Washout Period 1||0
240095|NCT00950807|583604|P2|NOT COMPLETED|Washout Period 1||0
240096|NCT00950807|583605|P1|NOT COMPLETED|Washout Period 1||5
240097|NCT00950807|583596|P10|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
240098|NCT00950807|583597|P9|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
240099|NCT00950807|583598|P8|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
240100|NCT00950807|583599|P7|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|10
240101|NCT00950807|583600|P6|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
240102|NCT00950807|583601|P5|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
240103|NCT00950807|583602|P4|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|11
240104|NCT00950807|583603|P3|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
240105|NCT00950807|583604|P2|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|13
240106|NCT00950807|583605|P1|COMPLETED|Washout Period 1|Participants withdrawing during washout are counted under the last treatment taken.|51
240107|NCT00950807|583596|P10|STARTED|Washout Period 1||13
240108|NCT00950807|583597|P9|STARTED|Washout Period 1||12
240109|NCT00950807|583598|P8|STARTED|Washout Period 1||14
240110|NCT00950807|583599|P7|STARTED|Washout Period 1||12
240111|NCT00950807|583600|P6|STARTED|Washout Period 1||11
240112|NCT00950807|583601|P5|STARTED|Washout Period 1||12
240113|NCT00950807|583602|P4|STARTED|Washout Period 1||12
240114|NCT00950807|583603|P3|STARTED|Washout Period 1||13
240115|NCT00950807|583604|P2|STARTED|Washout Period 1||13
240116|NCT00950807|583605|P1|STARTED|Washout Period 1||56
240117|NCT00950807|583596|P10|NOT COMPLETED|Treatment Period 1||0
240118|NCT00950807|583597|P9|NOT COMPLETED|Treatment Period 1||1
240119|NCT00950807|583598|P8|NOT COMPLETED|Treatment Period 1||0
240120|NCT00950807|583599|P7|NOT COMPLETED|Treatment Period 1||0
240121|NCT00950807|583600|P6|NOT COMPLETED|Treatment Period 1||2
240122|NCT00950807|583601|P5|NOT COMPLETED|Treatment Period 1||1
240123|NCT00950807|583602|P4|NOT COMPLETED|Treatment Period 1||0
240124|NCT00950807|583603|P3|NOT COMPLETED|Treatment Period 1||1
240125|NCT00950807|583604|P2|NOT COMPLETED|Treatment Period 1||0
240126|NCT00950807|583605|P1|NOT COMPLETED|Treatment Period 1||3
240127|NCT00950807|583596|P10|COMPLETED|Treatment Period 1||13
240128|NCT00950807|583597|P9|COMPLETED|Treatment Period 1||12
240129|NCT00950807|583598|P8|COMPLETED|Treatment Period 1||14
240130|NCT00950807|583599|P7|COMPLETED|Treatment Period 1||12
240131|NCT00950807|583600|P6|COMPLETED|Treatment Period 1||11
240132|NCT00950807|583601|P5|COMPLETED|Treatment Period 1||12
240133|NCT00950807|583602|P4|COMPLETED|Treatment Period 1||12
240134|NCT00950807|583603|P3|COMPLETED|Treatment Period 1||13
240135|NCT00950807|583604|P2|COMPLETED|Treatment Period 1||13
240136|NCT00950807|583605|P1|COMPLETED|Treatment Period 1||56
240137|NCT00950807|583596|P10|STARTED|Treatment Period 1||13
240138|NCT00950807|583597|P9|STARTED|Treatment Period 1||13
240139|NCT00950807|583598|P8|STARTED|Treatment Period 1||14
240140|NCT00950807|583599|P7|STARTED|Treatment Period 1||12
240141|NCT00950807|583600|P6|STARTED|Treatment Period 1||13
240142|NCT00950807|583601|P5|STARTED|Treatment Period 1||13
240143|NCT00950807|583602|P4|STARTED|Treatment Period 1||12
240144|NCT00950807|583603|P3|STARTED|Treatment Period 1||14
240145|NCT00950807|583604|P2|STARTED|Treatment Period 1||13
240146|NCT00950807|583605|P1|STARTED|Treatment Period 1||59
240147|NCT00950833|583650|P3|NOT COMPLETED|Overall Study||0
240148|NCT00950833|583651|P2|NOT COMPLETED|Overall Study||0
240149|NCT00950833|583652|P1|NOT COMPLETED|Overall Study||0
240150|NCT00950833|583650|P3|COMPLETED|Overall Study||223
240151|NCT00950833|583651|P2|COMPLETED|Overall Study||108
240152|NCT00950833|583652|P1|COMPLETED|Overall Study||112
240153|NCT00950833|583650|P3|STARTED|Overall Study||223
240154|NCT00950833|583651|P2|STARTED|Overall Study||108
240155|NCT00950833|583652|P1|STARTED|Overall Study||112
240156|NCT00950859|583708|P2|NOT COMPLETED|Overall Study||10
240157|NCT00950859|583709|P1|NOT COMPLETED|Overall Study||16
240158|NCT00950859|583708|P2|COMPLETED|Overall Study||14
240159|NCT00950859|583709|P1|COMPLETED|Overall Study||11
240160|NCT00950859|583708|P2|STARTED|Overall Study||24
240161|NCT00950859|583709|P1|STARTED|Overall Study||27
240164|NCT00950872|583749|P1|STARTED|Overall Study||29
240165|NCT00950911|583758|P2|NOT COMPLETED|Overall Study||15
240166|NCT00950911|583759|P1|NOT COMPLETED|Overall Study||12
240167|NCT00950911|583758|P2|COMPLETED|Overall Study||3
240168|NCT00950911|583759|P1|COMPLETED|Overall Study||5
240169|NCT00950911|583758|P2|STARTED|Overall Study||18
240170|NCT00950911|583759|P1|STARTED|Overall Study||17
240171|NCT00950937|583767|P2|NOT COMPLETED|Overall Study||0
240172|NCT00950937|583768|P1|NOT COMPLETED|Overall Study||0
240173|NCT00950937|583767|P2|COMPLETED|Overall Study||14
240174|NCT00950937|583768|P1|COMPLETED|Overall Study||14
240175|NCT00950937|583767|P2|STARTED|Overall Study||14
240176|NCT00950937|583768|P1|STARTED|Overall Study||14
240177|NCT00950963|583786|P2|NOT COMPLETED|Overall Study||24
240178|NCT00950963|583787|P1|NOT COMPLETED|Overall Study||29
240179|NCT00950963|583786|P2|COMPLETED|Overall Study||357
240180|NCT00950963|583787|P1|COMPLETED|Overall Study||352
240181|NCT00950963|583786|P2|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
240182|NCT00950963|583787|P1|STARTED|Overall Study|Patients were randomized from a diabetes registry and were followed as intent to treat|381
240183|NCT00951015|583805|P4|NOT COMPLETED|Overall Study||18
240184|NCT00951015|583806|P3|NOT COMPLETED|Overall Study||51
240185|NCT00951015|583807|P2|NOT COMPLETED|Overall Study||51
240186|NCT00951015|583808|P1|NOT COMPLETED|Overall Study||53
240187|NCT00951015|583805|P4|COMPLETED|Overall Study||32
240188|NCT00951015|583806|P3|COMPLETED|Overall Study||0
240189|NCT00951015|583807|P2|COMPLETED|Overall Study||0
240190|NCT00951015|583808|P1|COMPLETED|Overall Study||0
240191|NCT00951015|583805|P4|Ongoing|Overall Study||8
240192|NCT00951015|583806|P3|Ongoing|Overall Study||46
240193|NCT00951015|583807|P2|Ongoing|Overall Study||45
240194|NCT00951015|583808|P1|Ongoing|Overall Study||47
240195|NCT00951015|583805|P4|STARTED|Overall Study||50
240196|NCT00951015|583806|P3|STARTED|Overall Study||51
240197|NCT00951015|583807|P2|STARTED|Overall Study||51
240198|NCT00951015|583808|P1|STARTED|Overall Study||53
240199|NCT00951093|583902|P1|NOT COMPLETED|6 Months After GBP||0
240200|NCT00951093|583902|P1|COMPLETED|6 Months After GBP||53
240201|NCT00951093|583902|P1|STARTED|6 Months After GBP||53
240202|NCT00951093|583902|P1|NOT COMPLETED|Before GBP||0
240203|NCT00951093|583902|P1|COMPLETED|Before GBP||53
240204|NCT00951093|583902|P1|STARTED|Before GBP||53
240205|NCT00952393|583926|P1|NOT COMPLETED|Overall Study||0
240206|NCT00952393|583926|P1|COMPLETED|Overall Study||10
240207|NCT00952393|583926|P1|STARTED|Overall Study|10|10
240208|NCT00952419|583933|P3|NOT COMPLETED|Overall Study||0
240209|NCT00952419|583934|P2|NOT COMPLETED|Overall Study||10
240210|NCT00952419|583935|P1|NOT COMPLETED|Overall Study||6
240211|NCT00952419|583933|P3|COMPLETED|Overall Study||51
240212|NCT00952419|583934|P2|COMPLETED|Overall Study||198
240213|NCT00952419|583935|P1|COMPLETED|Overall Study||209
240214|NCT00952419|583933|P3|STARTED|Overall Study||51
240215|NCT00952419|583934|P2|STARTED|Overall Study||208
240216|NCT00952419|583935|P1|STARTED|Overall Study||215
240217|NCT00952484|583970|P3|NOT COMPLETED|Overall Study||0
240218|NCT00952484|583971|P2|NOT COMPLETED|Overall Study||1
240219|NCT00952484|583972|P1|NOT COMPLETED|Overall Study||0
240220|NCT00952484|583970|P3|COMPLETED|Overall Study||16
240221|NCT00952484|583971|P2|COMPLETED|Overall Study||6
240222|NCT00952484|583972|P1|COMPLETED|Overall Study||6
240223|NCT00952484|583970|P3|STARTED|Overall Study||16
240224|NCT00952484|583971|P2|STARTED|Overall Study||7
240225|NCT00952484|583972|P1|STARTED|Overall Study||6
240226|NCT00952523|583996|P1|NOT COMPLETED|Overall Study||7
240227|NCT00952523|583996|P1|COMPLETED|Overall Study||155
240228|NCT00952523|583996|P1|STARTED|Overall Study||162
240229|NCT00952588|584004|P2|NOT COMPLETED|Overall Study||24
240230|NCT00952588|584005|P1|NOT COMPLETED|Overall Study||36
240231|NCT00952588|584004|P2|COMPLETED|Overall Study||2
240232|NCT00952588|584005|P1|COMPLETED|Overall Study||12
240233|NCT00952588|584004|P2|STARTED|Overall Study||26
240234|NCT00952588|584005|P1|STARTED|Overall Study||48
240235|NCT00952614|584023|P1|NOT COMPLETED|Overall Study||7
240236|NCT00952614|584023|P1|COMPLETED|Overall Study|3 subjects died from unrelated causes, 3 were lost to follow-up & 1 had both eyes included in study.|23
240237|NCT00952614|584023|P1|Participants Started Treatment|Overall Study|29 subjects signed consent; 1 agreed for both eyes to enroll. 30 eyes rec'd drug delivery implant|30
240238|NCT00952614|584023|P1|STARTED|Overall Study||30
240239|NCT00952653|584028|P1|NOT COMPLETED|Period 2: Coadministration DVS SR, MDZ||0
240240|NCT00952653|584028|P1|COMPLETED|Period 2: Coadministration DVS SR, MDZ||28
240241|NCT00952653|584028|P1|STARTED|Period 2: Coadministration DVS SR, MDZ||28
240242|NCT00952653|584028|P1|NOT COMPLETED|Period 1: MDZ Alone||0
240243|NCT00952653|584028|P1|COMPLETED|Period 1: MDZ Alone||28
240244|NCT00952653|584028|P1|STARTED|Period 1: MDZ Alone||28
240245|NCT00952705|584056|P3|NOT COMPLETED|Overall Study||10
240246|NCT00952705|584057|P2|NOT COMPLETED|Overall Study||10
240247|NCT00952705|584058|P1|NOT COMPLETED|Overall Study||33
240248|NCT00952705|584056|P3|COMPLETED|Overall Study||288
240249|NCT00952705|584057|P2|COMPLETED|Overall Study||290
240250|NCT00952705|584058|P1|COMPLETED|Overall Study||1169
240251|NCT00952705|584056|P3|STARTED|Overall Study||298
240252|NCT00952705|584057|P2|STARTED|Overall Study||300
240253|NCT00952705|584058|P1|STARTED|Overall Study|Three not treated with Q/LAIV-BFS (1 treated with FluMist/B/Yamagata; 2 withdrew prior to dosing).|1202
240254|NCT00952731|584122|P2|NOT COMPLETED|Overall Study||0
240255|NCT00952731|584123|P1|NOT COMPLETED|Overall Study||1
240256|NCT00952731|584122|P2|COMPLETED|Overall Study||14
240257|NCT00952731|584123|P1|COMPLETED|Overall Study||12
240258|NCT00952731|584122|P2|Follow-up|Overall Study||14
240259|NCT00952731|584123|P1|Follow-up|Overall Study||12
240260|NCT00952731|584122|P2|Surgery|Overall Study||14
240261|NCT00952731|584123|P1|Surgery|Overall Study||12
240262|NCT00952731|584122|P2|Treatment & Pre-Surgery|Overall Study||14
240263|NCT00952731|584123|P1|Treatment & Pre-Surgery|Overall Study||12
240264|NCT00952731|584122|P2|Randomization|Overall Study||14
240265|NCT00952731|584123|P1|Randomization|Overall Study||13
240266|NCT00952731|584122|P2|STARTED|Overall Study||14
240267|NCT00952731|584123|P1|STARTED|Overall Study||13
240268|NCT00952822|584139|P4|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
240269|NCT00952822|584140|P3|NOT COMPLETED|2nd Pharmacokinetic Evaluation||1
240270|NCT00952822|584141|P2|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
240271|NCT00952822|584142|P1|NOT COMPLETED|2nd Pharmacokinetic Evaluation||0
240272|NCT00952822|584139|P4|COMPLETED|2nd Pharmacokinetic Evaluation||4
240273|NCT00952822|584140|P3|COMPLETED|2nd Pharmacokinetic Evaluation||10
240274|NCT00952822|584141|P2|COMPLETED|2nd Pharmacokinetic Evaluation||17
240275|NCT00952822|584142|P1|COMPLETED|2nd Pharmacokinetic Evaluation||9
240276|NCT00952822|584139|P4|STARTED|2nd Pharmacokinetic Evaluation||4
240277|NCT00952822|584140|P3|STARTED|2nd Pharmacokinetic Evaluation||11
240278|NCT00952822|584141|P2|STARTED|2nd Pharmacokinetic Evaluation||17
240279|NCT00952822|584142|P1|STARTED|2nd Pharmacokinetic Evaluation||9
240280|NCT00952822|584139|P4|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
240281|NCT00952822|584140|P3|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
240282|NCT00952822|584141|P2|NOT COMPLETED|1st Pharmacokinetic Evaluation||1
240283|NCT00952822|584142|P1|NOT COMPLETED|1st Pharmacokinetic Evaluation||0
240284|NCT00952822|584139|P4|COMPLETED|1st Pharmacokinetic Evaluation||4
240285|NCT00952822|584140|P3|COMPLETED|1st Pharmacokinetic Evaluation||11
240286|NCT00952822|584141|P2|COMPLETED|1st Pharmacokinetic Evaluation||17
240287|NCT00952822|584142|P1|COMPLETED|1st Pharmacokinetic Evaluation||9
240288|NCT00952822|584139|P4|STARTED|1st Pharmacokinetic Evaluation||4
240289|NCT00952822|584140|P3|STARTED|1st Pharmacokinetic Evaluation||11
240290|NCT00952822|584141|P2|STARTED|1st Pharmacokinetic Evaluation||18
240291|NCT00952822|584142|P1|STARTED|1st Pharmacokinetic Evaluation||9
240292|NCT00952848|584172|P1|NOT COMPLETED|Overall Study||4
240293|NCT00952848|584172|P1|COMPLETED|Overall Study||14
240294|NCT00952848|584172|P1|STARTED|Overall Study||18
240295|NCT00953017|584183|P4|NOT COMPLETED|Overall Study||5
240296|NCT00953017|584184|P3|NOT COMPLETED|Overall Study||6
240297|NCT00953017|584185|P2|NOT COMPLETED|Overall Study||6
240298|NCT00953017|584186|P1|NOT COMPLETED|Overall Study||5
240299|NCT00953017|584183|P4|COMPLETED|Overall Study||101
240300|NCT00953017|584184|P3|COMPLETED|Overall Study||100
240301|NCT00953017|584185|P2|COMPLETED|Overall Study||101
240302|NCT00953017|584186|P1|COMPLETED|Overall Study||101
240303|NCT00953017|584183|P4|STARTED|Overall Study||106
240304|NCT00953017|584184|P3|STARTED|Overall Study||106
240305|NCT00953017|584185|P2|STARTED|Overall Study||107
240306|NCT00953017|584186|P1|STARTED|Overall Study||106
240307|NCT00953043|584210|P2|NOT COMPLETED|Overall Study||2
240308|NCT00953043|584211|P1|NOT COMPLETED|Overall Study||4
240309|NCT00953043|584210|P2|COMPLETED|Overall Study||28
240310|NCT00953043|584211|P1|COMPLETED|Overall Study||26
240311|NCT00953043|584210|P2|STARTED|Overall Study||30
240312|NCT00953043|584211|P1|STARTED|Overall Study||30
240313|NCT00953056|584237|P6|NOT COMPLETED|Overall Study||4
240314|NCT00953056|584238|P5|NOT COMPLETED|Overall Study||2
240315|NCT00953056|584239|P4|NOT COMPLETED|Overall Study||0
240316|NCT00953056|584240|P3|NOT COMPLETED|Overall Study||0
240317|NCT00953056|584241|P2|NOT COMPLETED|Overall Study||0
240318|NCT00953056|584242|P1|NOT COMPLETED|Overall Study||0
240319|NCT00953056|584237|P6|COMPLETED|Overall Study||20
240320|NCT00953056|584238|P5|COMPLETED|Overall Study|One participant received placebo at the second dose in error, but completed the study.|22
240321|NCT00953056|584239|P4|COMPLETED|Overall Study||24
240322|NCT00953056|584240|P3|COMPLETED|Overall Study||24
240323|NCT00953056|584241|P2|COMPLETED|Overall Study||24
240324|NCT00953056|584242|P1|COMPLETED|Overall Study||24
240325|NCT00953056|584237|P6|STARTED|Overall Study||24
240326|NCT00953056|584238|P5|STARTED|Overall Study||24
240327|NCT00953056|584239|P4|STARTED|Overall Study||24
240328|NCT00953056|584240|P3|STARTED|Overall Study||24
240329|NCT00953056|584241|P2|STARTED|Overall Study||24
240330|NCT00953056|584242|P1|STARTED|Overall Study||24
240331|NCT00953121|584267|P3|NOT COMPLETED|Overall Study||0
240332|NCT00953121|584268|P2|NOT COMPLETED|Overall Study||0
240333|NCT00953121|584269|P1|NOT COMPLETED|Overall Study||0
240334|NCT00953121|584267|P3|COMPLETED|Overall Study||25
240335|NCT00953121|584268|P2|COMPLETED|Overall Study||39
240336|NCT00953121|584269|P1|COMPLETED|Overall Study||40
240337|NCT00953121|584267|P3|STARTED|Overall Study||25
240338|NCT00953121|584268|P2|STARTED|Overall Study||39
240339|NCT00953121|584269|P1|STARTED|Overall Study||40
240340|NCT00953147|584292|P3|NOT COMPLETED|Overall Study||42
240341|NCT00953147|584293|P2|NOT COMPLETED|Overall Study||66
240342|NCT00953147|584294|P1|NOT COMPLETED|Overall Study||37
240343|NCT00953147|584292|P3|COMPLETED|Overall Study||265
240344|NCT00953147|584293|P2|COMPLETED|Overall Study||439
240345|NCT00953147|584294|P1|COMPLETED|Overall Study||261
240346|NCT00953147|584292|P3|STARTED|Overall Study||307
240347|NCT00953147|584293|P2|STARTED|Overall Study||505
240348|NCT00953147|584294|P1|STARTED|Overall Study||298
240349|NCT00953160|584341|P1|NOT COMPLETED|Overall Study||27
240350|NCT00953160|584341|P1|COMPLETED|Overall Study||49
240351|NCT00953160|584341|P1|STARTED|Overall Study||76
240352|NCT00953225|584349|P2|NOT COMPLETED|Overall Study||0
240353|NCT00953225|584350|P1|NOT COMPLETED|Overall Study||2
240354|NCT00953225|584349|P2|COMPLETED|Overall Study||37
240355|NCT00953225|584350|P1|COMPLETED|Overall Study||44
240356|NCT00953225|584349|P2|STARTED|Overall Study||37
240357|NCT00953225|584350|P1|STARTED|Overall Study||46
240358|NCT00953290|584358|P1|NOT COMPLETED|Overall Study||0
240359|NCT00953290|584358|P1|COMPLETED|Overall Study||4
240360|NCT00953290|584358|P1|STARTED|Overall Study||4
240361|NCT00953329|584365|P1|NOT COMPLETED|Overall Study||1
240362|NCT00953329|584365|P1|COMPLETED|Overall Study||0
240363|NCT00953329|584365|P1|STARTED|Overall Study||1
240364|NCT00953407|584374|P5|NOT COMPLETED|Overall Study||1
240365|NCT00953407|584375|P4|NOT COMPLETED|Overall Study||2
240366|NCT00953407|584376|P3|NOT COMPLETED|Overall Study||1
240367|NCT00953407|584377|P2|NOT COMPLETED|Overall Study||1
240368|NCT00953407|584378|P1|NOT COMPLETED|Overall Study||1
240369|NCT00953407|584374|P5|COMPLETED|Overall Study||23
240370|NCT00953407|584375|P4|COMPLETED|Overall Study||23
240371|NCT00953407|584376|P3|COMPLETED|Overall Study||25
240372|NCT00953407|584377|P2|COMPLETED|Overall Study||24
240373|NCT00953407|584378|P1|COMPLETED|Overall Study||25
240374|NCT00953407|584374|P5|STARTED|Overall Study||24
240375|NCT00953407|584375|P4|STARTED|Overall Study||25
240376|NCT00953407|584376|P3|STARTED|Overall Study||26
240377|NCT00953407|584377|P2|STARTED|Overall Study||25
240378|NCT00953407|584378|P1|STARTED|Overall Study||26
240379|NCT00953524|584394|P4|NOT COMPLETED|Overall Study||8
240380|NCT00953524|584395|P3|NOT COMPLETED|Overall Study||14
240381|NCT00953524|584396|P2|NOT COMPLETED|Overall Study||15
240382|NCT00953524|584397|P1|NOT COMPLETED|Overall Study||22
240383|NCT00953524|584394|P4|COMPLETED|Overall Study||91
240384|NCT00953524|584395|P3|COMPLETED|Overall Study||233
240385|NCT00953524|584396|P2|COMPLETED|Overall Study||239
240386|NCT00953524|584397|P1|COMPLETED|Overall Study||227
240387|NCT00953524|584394|P4|STARTED|Overall Study||99
240388|NCT00953524|584395|P3|STARTED|Overall Study||247
240389|NCT00953524|584396|P2|STARTED|Overall Study||254
240390|NCT00953524|584397|P1|STARTED|Overall Study||249
240391|NCT00953615|584435|P1|NOT COMPLETED|Overall Study||1
240392|NCT00953615|584435|P1|COMPLETED|Overall Study||0
240393|NCT00953615|584435|P1|STARTED|Overall Study||1
240394|NCT00953654|584445|P3|NOT COMPLETED|Overall Study||0
240395|NCT00953654|584446|P2|NOT COMPLETED|Overall Study||0
240396|NCT00953654|584447|P1|NOT COMPLETED|Overall Study||0
240397|NCT00953654|584445|P3|COMPLETED|Overall Study||10
240398|NCT00953654|584446|P2|COMPLETED|Overall Study||10
240399|NCT00953654|584447|P1|COMPLETED|Overall Study||10
240400|NCT00953654|584445|P3|STARTED|Overall Study||10
240401|NCT00953654|584446|P2|STARTED|Overall Study||10
240402|NCT00953654|584447|P1|STARTED|Overall Study||10
240403|NCT00953667|584458|P1|NOT COMPLETED|Overall Study||123
240404|NCT00953667|584458|P1|COMPLETED|Overall Study||277
240405|NCT00953667|584458|P1|STARTED|Overall Study||400
240406|NCT00953680|584463|P2|NOT COMPLETED|Period 2||0
240407|NCT00953680|584464|P1|NOT COMPLETED|Period 2||0
240408|NCT00953680|584463|P2|COMPLETED|Period 2||38
240409|NCT00953680|584464|P1|COMPLETED|Period 2||38
240410|NCT00953680|584463|P2|STARTED|Period 2||38
240411|NCT00953680|584464|P1|STARTED|Period 2||38
240412|NCT00953680|584463|P2|NOT COMPLETED|Period 1||1
240413|NCT00953680|584464|P1|NOT COMPLETED|Period 1||0
240414|NCT00953680|584463|P2|COMPLETED|Period 1||38
240415|NCT00953680|584464|P1|COMPLETED|Period 1||38
240416|NCT00953680|584463|P2|STARTED|Period 1||39
240417|NCT00953680|584464|P1|STARTED|Period 1||38
240418|NCT00953706|584478|P4|NOT COMPLETED|Part B (96-Week Open-Label Extension)||33
240419|NCT00953706|584479|P3|NOT COMPLETED|Part B (96-Week Open-Label Extension)||5
240420|NCT00953706|584480|P2|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
240421|NCT00953706|584481|P1|NOT COMPLETED|Part B (96-Week Open-Label Extension)||0
240422|NCT00953706|584478|P4|COMPLETED|Part B (96-Week Open-Label Extension)||0
240423|NCT00953706|584479|P3|COMPLETED|Part B (96-Week Open-Label Extension)||0
240424|NCT00953706|584480|P2|COMPLETED|Part B (96-Week Open-Label Extension)||0
240425|NCT00953706|584481|P1|COMPLETED|Part B (96-Week Open-Label Extension)||0
240426|NCT00953706|584478|P4|STARTED|Part B (96-Week Open-Label Extension)||33
240427|NCT00953706|584479|P3|STARTED|Part B (96-Week Open-Label Extension)||5
240428|NCT00953706|584480|P2|STARTED|Part B (96-Week Open-Label Extension)||0
240429|NCT00953706|584481|P1|STARTED|Part B (96-Week Open-Label Extension)||0
240430|NCT00953706|584478|P4|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
240431|NCT00953706|584479|P3|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||0
240432|NCT00953706|584480|P2|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||8
240433|NCT00953706|584481|P1|NOT COMPLETED|Part A (16-Week Double-Blind Treatment)||2
240434|NCT00953706|584478|P4|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
240435|NCT00953706|584479|P3|COMPLETED|Part A (16-Week Double-Blind Treatment)||0
240436|NCT00953706|584480|P2|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 33 participants continued in Part B.|104
240437|NCT00953706|584481|P1|COMPLETED|Part A (16-Week Double-Blind Treatment)|Only 5 participants continued in Part B.|26
240438|NCT00953706|584478|P4|STARTED|Part A (16-Week Double-Blind Treatment)||0
240439|NCT00953706|584479|P3|STARTED|Part A (16-Week Double-Blind Treatment)||0
240440|NCT00953706|584480|P2|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (ivacaftor)|112
240441|NCT00953706|584481|P1|STARTED|Part A (16-Week Double-Blind Treatment)|All subjects who received at least 1 dose of study drug (placebo)|28
240442|NCT00953719|584515|P2|NOT COMPLETED|Overall Study||5
240443|NCT00953719|584516|P1|NOT COMPLETED|Overall Study||19
240444|NCT00953719|584515|P2|COMPLETED|Overall Study||69
240445|NCT00953719|584516|P1|COMPLETED|Overall Study||150
240446|NCT00953719|584515|P2|STARTED|Overall Study||74
240447|NCT00953719|584516|P1|STARTED|Overall Study||169
240448|NCT00953849|584540|P4|NOT COMPLETED|Overall Study||0
240449|NCT00953849|584541|P3|NOT COMPLETED|Overall Study||0
240450|NCT00953849|584542|P2|NOT COMPLETED|Overall Study||0
240451|NCT00953849|584543|P1|NOT COMPLETED|Overall Study||0
240452|NCT00953849|584540|P4|COMPLETED|Overall Study||5
240453|NCT00953849|584541|P3|COMPLETED|Overall Study||4
240454|NCT00953849|584542|P2|COMPLETED|Overall Study||6
240455|NCT00953849|584543|P1|COMPLETED|Overall Study||6
240456|NCT00953849|584540|P4|STARTED|Overall Study||5
240457|NCT00953849|584541|P3|STARTED|Overall Study||4
240458|NCT00953849|584542|P2|STARTED|Overall Study||6
240459|NCT00953849|584543|P1|STARTED|Overall Study||6
240460|NCT00953862|584565|P1|NOT COMPLETED|Overall Study||6
240461|NCT00953862|584565|P1|COMPLETED|Overall Study||12
240462|NCT00953862|584565|P1|STARTED|Overall Study||18
240463|NCT00953927|584573|P2|NOT COMPLETED|Overall Study||95
240464|NCT00953927|584574|P1|NOT COMPLETED|Overall Study||105
240465|NCT00953927|584573|P2|COMPLETED|Overall Study||1303
240466|NCT00953927|584574|P1|COMPLETED|Overall Study||1294
240467|NCT00953927|584573|P2|STARTED|Overall Study||1398
240468|NCT00953927|584574|P1|STARTED|Overall Study||1399
240469|NCT00954109|584592|P1|NOT COMPLETED|Overall Study||0
240470|NCT00954109|584592|P1|COMPLETED|Overall Study||11
240471|NCT00954109|584592|P1|STARTED|Overall Study||11
240472|NCT00954122|584597|P1|NOT COMPLETED|Overall Study||7
240473|NCT00954122|584597|P1|COMPLETED|Overall Study||28
240474|NCT00954122|584597|P1|STARTED|Overall Study||35
240475|NCT00954187|584609|P2|NOT COMPLETED|Overall Study||0
240476|NCT00954187|584610|P1|NOT COMPLETED|Overall Study||0
240477|NCT00954187|584609|P2|COMPLETED|Overall Study||0
240478|NCT00954187|584610|P1|COMPLETED|Overall Study||0
240479|NCT00954187|584609|P2|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
240480|NCT00954187|584610|P1|STARTED|Overall Study|No subjects were assigned treatment and no study procedures were performed|0
240481|NCT00954356|584618|P2|NOT COMPLETED|Overall Study||0
240482|NCT00954356|584619|P1|NOT COMPLETED|Overall Study||0
240483|NCT00954356|584618|P2|COMPLETED|Overall Study||20
240484|NCT00954356|584619|P1|COMPLETED|Overall Study||41
240485|NCT00954356|584618|P2|STARTED|Overall Study||20
240486|NCT00954356|584619|P1|STARTED|Overall Study||41
240487|NCT00954421|584647|P1|NOT COMPLETED|VIM=ON VO=OFF at 6 Months||1
240488|NCT00954421|584647|P1|COMPLETED|VIM=ON VO=OFF at 6 Months||11
240489|NCT00954421|584647|P1|STARTED|VIM=ON VO=OFF at 6 Months||12
240490|NCT00954421|584647|P1|NOT COMPLETED|VIM=OFF VO=ON at 6 Months||0
240491|NCT00954421|584647|P1|COMPLETED|VIM=OFF VO=ON at 6 Months||12
240492|NCT00954421|584647|P1|STARTED|VIM=OFF VO=ON at 6 Months||12
240493|NCT00954421|584647|P1|NOT COMPLETED|VIM=OFF VO=OFF at 6 Months||0
240494|NCT00954421|584647|P1|COMPLETED|VIM=OFF VO=OFF at 6 Months||12
240495|NCT00954421|584647|P1|STARTED|VIM=OFF VO=OFF at 6 Months||12
240496|NCT00954421|584647|P1|NOT COMPLETED|VIM=ON VO=ON at 6 Months||0
240497|NCT00954421|584647|P1|COMPLETED|VIM=ON VO=ON at 6 Months||12
240498|NCT00954421|584647|P1|STARTED|VIM=ON VO=ON at 6 Months|This is the point of evaluation: Order of assessment was random for periods 4-7|12
240499|NCT00954421|584647|P1|NOT COMPLETED|6 Months of DBS||1
240500|NCT00954421|584647|P1|COMPLETED|6 Months of DBS||12
240501|NCT00954421|584647|P1|STARTED|6 Months of DBS||13
240502|NCT00954421|584647|P1|NOT COMPLETED|Baseline||0
240503|NCT00954421|584647|P1|COMPLETED|Baseline||13
240504|NCT00954421|584647|P1|STARTED|Baseline||13
240505|NCT00954421|584647|P1|NOT COMPLETED|Screening||3
240506|NCT00954421|584647|P1|COMPLETED|Screening||13
240507|NCT00954421|584647|P1|STARTED|Screening||16
240508|NCT00954447|584655|P2|NOT COMPLETED|Overall Study||88
240509|NCT00954447|584656|P1|NOT COMPLETED|Overall Study||110
240510|NCT00954447|584655|P2|COMPLETED|Overall Study||543
240511|NCT00954447|584656|P1|COMPLETED|Overall Study||520
240512|NCT00954447|584655|P2|STARTED|Overall Study||631
240513|NCT00954447|584656|P1|STARTED|Overall Study||630
240514|NCT00954512|584698|P6|NOT COMPLETED|Overall Study||4
240515|NCT00954512|584699|P5|NOT COMPLETED|Overall Study||4
240516|NCT00954512|584700|P4|NOT COMPLETED|Overall Study||2
240517|NCT00954512|584701|P3|NOT COMPLETED|Overall Study||0
240518|NCT00954512|584702|P2|NOT COMPLETED|Overall Study||3
240519|NCT00954512|584703|P1|NOT COMPLETED|Overall Study||2
240520|NCT00954512|584698|P6|COMPLETED|Overall Study||0
240521|NCT00954512|584699|P5|COMPLETED|Overall Study||0
240522|NCT00954512|584700|P4|COMPLETED|Overall Study||0
240523|NCT00954512|584701|P3|COMPLETED|Overall Study||0
240524|NCT00954512|584702|P2|COMPLETED|Overall Study||0
240525|NCT00954512|584703|P1|COMPLETED|Overall Study||0
240526|NCT00954512|584698|P6|STARTED|Overall Study||4
240527|NCT00954512|584699|P5|STARTED|Overall Study||4
240528|NCT00954512|584700|P4|STARTED|Overall Study||2
240529|NCT00954512|584701|P3|STARTED|Overall Study||0
240530|NCT00954512|584702|P2|STARTED|Overall Study||3
240531|NCT00954512|584703|P1|STARTED|Overall Study||2
240532|NCT00954538|584724|P6|NOT COMPLETED|Part III||0
240533|NCT00954538|584725|P5|NOT COMPLETED|Part III||1
240534|NCT00954538|584726|P4|NOT COMPLETED|Part III||0
240535|NCT00954538|584727|P3|NOT COMPLETED|Part III||0
240536|NCT00954538|584728|P2|NOT COMPLETED|Part III||0
240537|NCT00954538|584729|P1|NOT COMPLETED|Part III||0
240538|NCT00954538|584724|P6|COMPLETED|Part III||2
240539|NCT00954538|584725|P5|COMPLETED|Part III|The subject who did not complete received 1 dose of study drug|5
240540|NCT00954538|584726|P4|COMPLETED|Part III||4
240541|NCT00954538|584727|P3|COMPLETED|Part III||0
240542|NCT00954538|584728|P2|COMPLETED|Part III||0
240543|NCT00954538|584729|P1|COMPLETED|Part III||0
240544|NCT00954538|584724|P6|STARTED|Part III|These subjects did not participate in Part I and did participate in Part II and III|2
240545|NCT00954538|584725|P5|STARTED|Part III|These subjects did not participate in Part I or II|6
240546|NCT00954538|584726|P4|STARTED|Part III|These subjects did not participate in Part I or II|4
240547|NCT00954538|584727|P3|STARTED|Part III||0
240548|NCT00954538|584728|P2|STARTED|Part III||0
240549|NCT00954538|584729|P1|STARTED|Part III||0
240550|NCT00954538|584724|P6|NOT COMPLETED|Part II||0
240551|NCT00954538|584725|P5|NOT COMPLETED|Part II||0
240552|NCT00954538|584726|P4|NOT COMPLETED|Part II||0
240553|NCT00954538|584727|P3|NOT COMPLETED|Part II||0
240554|NCT00954538|584728|P2|NOT COMPLETED|Part II||0
240555|NCT00954538|584729|P1|NOT COMPLETED|Part II||0
240556|NCT00954538|584724|P6|COMPLETED|Part II||2
240557|NCT00954538|584725|P5|COMPLETED|Part II||0
240558|NCT00954538|584726|P4|COMPLETED|Part II||0
240559|NCT00954538|584727|P3|COMPLETED|Part II||3
240560|NCT00954538|584728|P2|COMPLETED|Part II||1
240561|NCT00954538|584729|P1|COMPLETED|Part II||0
240562|NCT00954538|584724|P6|STARTED|Part II|These subjects did not participate in Part I and did participate in Part II and III|2
240563|NCT00954538|584725|P5|STARTED|Part II||0
240564|NCT00954538|584726|P4|STARTED|Part II||0
240565|NCT00954538|584727|P3|STARTED|Part II|These subjects did not participate in Part I or III|3
240566|NCT00954538|584728|P2|STARTED|Part II|This subject did not participate in Part I or III|1
240567|NCT00954538|584729|P1|STARTED|Part II||0
240568|NCT00954538|584724|P6|NOT COMPLETED|Part I||0
240569|NCT00954538|584725|P5|NOT COMPLETED|Part I||0
240570|NCT00954538|584726|P4|NOT COMPLETED|Part I||0
240571|NCT00954538|584727|P3|NOT COMPLETED|Part I||0
240572|NCT00954538|584728|P2|NOT COMPLETED|Part I||0
240573|NCT00954538|584729|P1|NOT COMPLETED|Part I||0
240574|NCT00954538|584724|P6|COMPLETED|Part I||0
240575|NCT00954538|584725|P5|COMPLETED|Part I||0
240576|NCT00954538|584726|P4|COMPLETED|Part I||0
240577|NCT00954538|584727|P3|COMPLETED|Part I||0
240578|NCT00954538|584728|P2|COMPLETED|Part I||0
240579|NCT00954538|584729|P1|COMPLETED|Part I||3
240580|NCT00954538|584724|P6|STARTED|Part I||0
240581|NCT00954538|584725|P5|STARTED|Part I||0
240582|NCT00954538|584726|P4|STARTED|Part I||0
240583|NCT00954538|584727|P3|STARTED|Part I||0
240584|NCT00954538|584728|P2|STARTED|Part I||0
240585|NCT00954538|584729|P1|STARTED|Part I|These subjects did not participate in Part II or III|3
240586|NCT00954707|584740|P1|NOT COMPLETED|Overall Study||167
240587|NCT00954707|584740|P1|COMPLETED|Overall Study|2342 Subjects completed 12-month Phase 1 follow-up; 167 subjects didn't complete the Phase 1.|2342
240588|NCT00954707|584740|P1|STARTED|Overall Study||2509
240589|NCT00954733|584756|P1|NOT COMPLETED|Overall Study||1
240590|NCT00954733|584756|P1|COMPLETED|Overall Study||39
240591|NCT00954733|584756|P1|STARTED|Overall Study||40
240592|NCT00954824|584760|P1|NOT COMPLETED|Overall Study||50
240593|NCT00954824|584760|P1|COMPLETED|Overall Study||50
240594|NCT00954824|584760|P1|STARTED|Overall Study||100
240595|NCT00954915|584764|P1|NOT COMPLETED|Overall Study||0
240596|NCT00954915|584764|P1|COMPLETED|Overall Study||1
240597|NCT00954915|584764|P1|STARTED|Overall Study||1
240598|NCT00944645|584768|P2|NOT COMPLETED|Period 2||9
240599|NCT00944645|584769|P1|NOT COMPLETED|Period 2||8
240600|NCT00944645|584768|P2|COMPLETED|Period 2||85
240601|NCT00944645|584769|P1|COMPLETED|Period 2||86
240602|NCT00944645|584768|P2|STARTED|Period 2||94
240603|NCT00944645|584769|P1|STARTED|Period 2||94
240604|NCT00944645|584768|P2|NOT COMPLETED|Period 1||0
240605|NCT00944645|584769|P1|NOT COMPLETED|Period 1||0
240606|NCT00944645|584768|P2|COMPLETED|Period 1||94
240607|NCT00944645|584769|P1|COMPLETED|Period 1||94
240608|NCT00944645|584768|P2|STARTED|Period 1||94
240609|NCT00944645|584769|P1|STARTED|Period 1||94
240610|NCT00944671|584787|P6|NOT COMPLETED|Period III||0
240611|NCT00944671|584788|P5|NOT COMPLETED|Period III||0
240612|NCT00944671|584789|P4|NOT COMPLETED|Period III||0
240613|NCT00944671|584790|P3|NOT COMPLETED|Period III||0
240614|NCT00944671|584791|P2|NOT COMPLETED|Period III||0
240615|NCT00944671|584792|P1|NOT COMPLETED|Period III||0
240616|NCT00944671|584787|P6|COMPLETED|Period III||4
240617|NCT00944671|584788|P5|COMPLETED|Period III||4
240618|NCT00944671|584789|P4|COMPLETED|Period III||4
240619|NCT00944671|584790|P3|COMPLETED|Period III||4
240620|NCT00944671|584791|P2|COMPLETED|Period III||4
240621|NCT00944671|584792|P1|COMPLETED|Period III||4
240622|NCT00944671|584787|P6|STARTED|Period III||4
240623|NCT00944671|584788|P5|STARTED|Period III||4
240624|NCT00944671|584789|P4|STARTED|Period III||4
240625|NCT00944671|584790|P3|STARTED|Period III||4
240626|NCT00944671|584791|P2|STARTED|Period III||4
240627|NCT00944671|584792|P1|STARTED|Period III||4
240628|NCT00944671|584787|P6|NOT COMPLETED|Period II||0
240629|NCT00944671|584788|P5|NOT COMPLETED|Period II||0
240630|NCT00944671|584789|P4|NOT COMPLETED|Period II||0
240631|NCT00944671|584790|P3|NOT COMPLETED|Period II||0
240632|NCT00944671|584791|P2|NOT COMPLETED|Period II||0
240633|NCT00944671|584792|P1|NOT COMPLETED|Period II||0
240634|NCT00944671|584787|P6|COMPLETED|Period II||4
240635|NCT00944671|584788|P5|COMPLETED|Period II||4
240636|NCT00944671|584789|P4|COMPLETED|Period II||4
240637|NCT00944671|584790|P3|COMPLETED|Period II||4
240638|NCT00944671|584791|P2|COMPLETED|Period II||4
240639|NCT00944671|584792|P1|COMPLETED|Period II||4
240640|NCT00944671|584787|P6|STARTED|Period II||4
240641|NCT00944671|584788|P5|STARTED|Period II||4
240642|NCT00944671|584789|P4|STARTED|Period II||4
240643|NCT00944671|584790|P3|STARTED|Period II||4
240644|NCT00944671|584791|P2|STARTED|Period II||4
240645|NCT00944671|584792|P1|STARTED|Period II||4
240646|NCT00944671|584787|P6|NOT COMPLETED|Period I||0
240647|NCT00944671|584788|P5|NOT COMPLETED|Period I||0
240648|NCT00944671|584789|P4|NOT COMPLETED|Period I||0
240649|NCT00944671|584790|P3|NOT COMPLETED|Period I||0
240650|NCT00944671|584791|P2|NOT COMPLETED|Period I||0
240651|NCT00944671|584792|P1|NOT COMPLETED|Period I||0
240652|NCT00944671|584787|P6|COMPLETED|Period I||4
240653|NCT00944671|584788|P5|COMPLETED|Period I||4
240654|NCT00944671|584789|P4|COMPLETED|Period I||4
240655|NCT00944671|584790|P3|COMPLETED|Period I||4
240656|NCT00944671|584791|P2|COMPLETED|Period I||4
240657|NCT00944671|584792|P1|COMPLETED|Period I||4
240658|NCT00944671|584787|P6|STARTED|Period I||4
240659|NCT00944671|584788|P5|STARTED|Period I||4
240660|NCT00944671|584789|P4|STARTED|Period I||4
240661|NCT00944671|584790|P3|STARTED|Period I||4
240662|NCT00944671|584791|P2|STARTED|Period I||4
240663|NCT00944671|584792|P1|STARTED|Period I||4
240664|NCT00944697|584807|P2|NOT COMPLETED|Overall Study||5
240665|NCT00944697|584808|P1|NOT COMPLETED|Overall Study||2
240666|NCT00944697|584807|P2|COMPLETED|Overall Study||43
240667|NCT00944697|584808|P1|COMPLETED|Overall Study||48
240668|NCT00944697|584807|P2|STARTED|Overall Study||48
240669|NCT00944697|584808|P1|STARTED|Overall Study||50
240670|NCT00944710|584816|P2|NOT COMPLETED|Additional Post 10-week Primary Outcome||11
240671|NCT00944710|584817|P1|NOT COMPLETED|Additional Post 10-week Primary Outcome||17
240672|NCT00944710|584816|P2|COMPLETED|Additional Post 10-week Primary Outcome||22
240673|NCT00944710|584817|P1|COMPLETED|Additional Post 10-week Primary Outcome||23
240674|NCT00944710|584816|P2|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||26
240675|NCT00944710|584817|P1|Eligible to Enter Post 10-week Phase|Additional Post 10-week Primary Outcome||24
240676|NCT00944710|584816|P2|STARTED|Additional Post 10-week Primary Outcome||33
240677|NCT00944710|584817|P1|STARTED|Additional Post 10-week Primary Outcome||40
240678|NCT00944710|584816|P2|NOT COMPLETED|12-week Visit (Off-treatment)||0
240679|NCT00944710|584817|P1|NOT COMPLETED|12-week Visit (Off-treatment)||0
240680|NCT00944710|584816|P2|COMPLETED|12-week Visit (Off-treatment)||33
240681|NCT00944710|584817|P1|COMPLETED|12-week Visit (Off-treatment)||40
240682|NCT00944710|584816|P2|STARTED|12-week Visit (Off-treatment)||33
240683|NCT00944710|584817|P1|STARTED|12-week Visit (Off-treatment)||40
240684|NCT00944710|584816|P2|NOT COMPLETED|10-week Primary Outcome||0
240685|NCT00944710|584817|P1|NOT COMPLETED|10-week Primary Outcome||0
240686|NCT00944710|584816|P2|COMPLETED|10-week Primary Outcome||33
240687|NCT00944710|584817|P1|COMPLETED|10-week Primary Outcome||40
240688|NCT00944710|584816|P2|STARTED|10-week Primary Outcome||33
240689|NCT00944710|584817|P1|STARTED|10-week Primary Outcome||40
240690|NCT00944749|584873|P1|NOT COMPLETED|Overall Study||1
240691|NCT00944749|584873|P1|COMPLETED|Overall Study||22
240692|NCT00944749|584873|P1|STARTED|Overall Study||23
240693|NCT00945035|584878|P2|NOT COMPLETED|Period 2||0
240694|NCT00945035|584879|P1|NOT COMPLETED|Period 2||0
240695|NCT00945035|584878|P2|COMPLETED|Period 2||18
240696|NCT00945035|584879|P1|COMPLETED|Period 2||18
240697|NCT00945035|584878|P2|STARTED|Period 2||18
240698|NCT00945035|584879|P1|STARTED|Period 2||18
240699|NCT00945035|584878|P2|NOT COMPLETED|Period 1||0
240700|NCT00945035|584879|P1|NOT COMPLETED|Period 1||0
240701|NCT00945035|584878|P2|COMPLETED|Period 1||18
240702|NCT00945035|584879|P1|COMPLETED|Period 1||18
240703|NCT00945035|584878|P2|STARTED|Period 1||18
240704|NCT00945035|584879|P1|STARTED|Period 1||18
240705|NCT00945100|584889|P2|NOT COMPLETED|Post-10 Week Primary Outcome||7
240706|NCT00945100|584890|P1|NOT COMPLETED|Post-10 Week Primary Outcome||4
240707|NCT00945100|584889|P2|COMPLETED|Post-10 Week Primary Outcome||56
240708|NCT00945100|584890|P1|COMPLETED|Post-10 Week Primary Outcome||51
240709|NCT00945100|584889|P2|STARTED|Post-10 Week Primary Outcome|20 participants were not eligible for Post 10 week Primary Outcome phase|63
240710|NCT00945100|584890|P1|STARTED|Post-10 Week Primary Outcome|27 participants were not eligible for Post 10 week Primary Outcome phase|55
240711|NCT00945100|584889|P2|NOT COMPLETED|10-week Primary Outcome||3
240712|NCT00945100|584890|P1|NOT COMPLETED|10-week Primary Outcome||1
240713|NCT00945100|584889|P2|COMPLETED|10-week Primary Outcome||83
240714|NCT00945100|584890|P1|COMPLETED|10-week Primary Outcome||82
240715|NCT00945100|584889|P2|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|20
240716|NCT00945100|584890|P1|Completed, Not Eligible|10-week Primary Outcome|Not Eligible for Post-10 week phase|27
240717|NCT00945100|584889|P2|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|63
240718|NCT00945100|584890|P1|Completed, Eligible|10-week Primary Outcome|Eligible for Post-10 week phase|55
240719|NCT00945100|584889|P2|STARTED|10-week Primary Outcome||86
240720|NCT00945100|584890|P1|STARTED|10-week Primary Outcome||83
240721|NCT00945139|584954|P1|NOT COMPLETED|Overall Study||0
240722|NCT00945139|584954|P1|COMPLETED|Overall Study||46
240723|NCT00945139|584954|P1|STARTED|Overall Study||46
240724|NCT00945243|584963|P1|NOT COMPLETED|Overall Study||3
240725|NCT00945243|584963|P1|COMPLETED|Overall Study||8
240726|NCT00945243|584963|P1|STARTED|Overall Study|Enrolled and Treated Per Protocol|11
240727|NCT00945256|584974|P5|NOT COMPLETED|Overall Study||1
240728|NCT00945256|584975|P4|NOT COMPLETED|Overall Study||9
240729|NCT00945256|584976|P3|NOT COMPLETED|Overall Study||8
240730|NCT00945256|584977|P2|NOT COMPLETED|Overall Study||2
240731|NCT00945256|584978|P1|NOT COMPLETED|Overall Study||4
240732|NCT00945256|584974|P5|COMPLETED|Overall Study||7
240733|NCT00945256|584975|P4|COMPLETED|Overall Study||7
240734|NCT00945256|584976|P3|COMPLETED|Overall Study||7
240735|NCT00945256|584977|P2|COMPLETED|Overall Study||8
240736|NCT00945256|584978|P1|COMPLETED|Overall Study||9
240737|NCT00945256|584974|P5|STARTED|Overall Study||8
240738|NCT00945256|584975|P4|STARTED|Overall Study||16
240739|NCT00945256|584976|P3|STARTED|Overall Study||15
240740|NCT00945256|584977|P2|STARTED|Overall Study||10
240741|NCT00945256|584978|P1|STARTED|Overall Study||13
240742|NCT00945295|584992|P2|NOT COMPLETED|Overall Study||2
240743|NCT00945295|584993|P1|NOT COMPLETED|Overall Study||0
240744|NCT00945295|584992|P2|COMPLETED|Overall Study||14
240745|NCT00945295|584993|P1|COMPLETED|Overall Study||15
240746|NCT00945295|584992|P2|STARTED|Overall Study||16
240747|NCT00945295|584993|P1|STARTED|Overall Study||15
240748|NCT00945321|585001|P6|NOT COMPLETED|Period 4||1
240749|NCT00945321|585002|P5|NOT COMPLETED|Period 4||0
240750|NCT00945321|585003|P4|NOT COMPLETED|Period 4||0
240751|NCT00945321|585004|P3|NOT COMPLETED|Period 4||0
240752|NCT00945321|585005|P2|NOT COMPLETED|Period 4||0
240753|NCT00945321|585006|P1|NOT COMPLETED|Period 4||0
240754|NCT00945321|585001|P6|COMPLETED|Period 4||6
240755|NCT00945321|585002|P5|COMPLETED|Period 4||6
240756|NCT00945321|585003|P4|COMPLETED|Period 4||7
240757|NCT00945321|585004|P3|COMPLETED|Period 4||7
240758|NCT00945321|585005|P2|COMPLETED|Period 4||7
240759|NCT00945321|585006|P1|COMPLETED|Period 4||7
240760|NCT00945321|585001|P6|STARTED|Period 4||7
240761|NCT00945321|585002|P5|STARTED|Period 4||6
240762|NCT00945321|585003|P4|STARTED|Period 4||7
240763|NCT00945321|585004|P3|STARTED|Period 4||7
240764|NCT00945321|585005|P2|STARTED|Period 4||7
240765|NCT00945321|585006|P1|STARTED|Period 4||7
240766|NCT00945321|585001|P6|NOT COMPLETED|Period 3||0
240767|NCT00945321|585002|P5|NOT COMPLETED|Period 3||0
240768|NCT00945321|585003|P4|NOT COMPLETED|Period 3||0
240769|NCT00945321|585004|P3|NOT COMPLETED|Period 3||0
240770|NCT00945321|585005|P2|NOT COMPLETED|Period 3||0
240771|NCT00945321|585006|P1|NOT COMPLETED|Period 3||0
240772|NCT00945321|585001|P6|COMPLETED|Period 3||7
240773|NCT00945321|585002|P5|COMPLETED|Period 3||6
240774|NCT00945321|585003|P4|COMPLETED|Period 3||7
240775|NCT00945321|585004|P3|COMPLETED|Period 3||7
240776|NCT00945321|585005|P2|COMPLETED|Period 3||7
240777|NCT00945321|585006|P1|COMPLETED|Period 3||7
240778|NCT00945321|585001|P6|STARTED|Period 3||7
240779|NCT00945321|585002|P5|STARTED|Period 3||6
240780|NCT00945321|585003|P4|STARTED|Period 3||7
240781|NCT00945321|585004|P3|STARTED|Period 3||7
240782|NCT00945321|585005|P2|STARTED|Period 3||7
240783|NCT00945321|585006|P1|STARTED|Period 3||7
240784|NCT00945321|585001|P6|NOT COMPLETED|Period 2||0
240785|NCT00945321|585002|P5|NOT COMPLETED|Period 2||0
240786|NCT00945321|585003|P4|NOT COMPLETED|Period 2||0
240787|NCT00945321|585004|P3|NOT COMPLETED|Period 2||0
240788|NCT00945321|585005|P2|NOT COMPLETED|Period 2||0
240789|NCT00945321|585006|P1|NOT COMPLETED|Period 2||0
240790|NCT00945321|585001|P6|COMPLETED|Period 2||7
240791|NCT00945321|585002|P5|COMPLETED|Period 2||6
240792|NCT00945321|585003|P4|COMPLETED|Period 2||7
240793|NCT00945321|585004|P3|COMPLETED|Period 2||7
240794|NCT00945321|585005|P2|COMPLETED|Period 2||7
240795|NCT00945321|585006|P1|COMPLETED|Period 2||7
240796|NCT00945321|585001|P6|STARTED|Period 2||7
240797|NCT00945321|585002|P5|STARTED|Period 2||6
240798|NCT00945321|585003|P4|STARTED|Period 2||7
240799|NCT00945321|585004|P3|STARTED|Period 2||7
240800|NCT00945321|585005|P2|STARTED|Period 2||7
240801|NCT00945321|585006|P1|STARTED|Period 2||7
240802|NCT00945321|585001|P6|NOT COMPLETED|Period 1||0
240803|NCT00945321|585002|P5|NOT COMPLETED|Period 1||1
240804|NCT00945321|585003|P4|NOT COMPLETED|Period 1||0
240805|NCT00945321|585004|P3|NOT COMPLETED|Period 1||0
240806|NCT00945321|585005|P2|NOT COMPLETED|Period 1||0
240807|NCT00945321|585006|P1|NOT COMPLETED|Period 1||0
240808|NCT00945321|585001|P6|COMPLETED|Period 1||7
240809|NCT00945321|585002|P5|COMPLETED|Period 1||6
240810|NCT00945321|585003|P4|COMPLETED|Period 1||7
240811|NCT00945321|585004|P3|COMPLETED|Period 1||7
240812|NCT00945321|585005|P2|COMPLETED|Period 1||7
240813|NCT00945321|585006|P1|COMPLETED|Period 1||7
240814|NCT00945321|585001|P6|STARTED|Period 1||7
240815|NCT00945321|585002|P5|STARTED|Period 1||7
240816|NCT00945321|585003|P4|STARTED|Period 1||7
240817|NCT00945321|585004|P3|STARTED|Period 1||7
240818|NCT00945321|585005|P2|STARTED|Period 1||7
240819|NCT00945321|585006|P1|STARTED|Period 1||7
240820|NCT00945334|585028|P2|NOT COMPLETED|Overall Study||3
240821|NCT00945334|585029|P1|NOT COMPLETED|Overall Study||3
240822|NCT00945334|585028|P2|COMPLETED|Overall Study||15
240823|NCT00945334|585029|P1|COMPLETED|Overall Study||16
240824|NCT00945334|585028|P2|STARTED|Overall Study||18
240825|NCT00945334|585029|P1|STARTED|Overall Study||19
240826|NCT00945477|585037|P1|NOT COMPLETED|Overall Study||6
240827|NCT00945477|585037|P1|COMPLETED|Overall Study||5
240828|NCT00945477|585037|P1|STARTED|Overall Study||11
240829|NCT00945555|585042|P1|NOT COMPLETED|Overall Study||28
240830|NCT00945555|585042|P1|COMPLETED|Overall Study||236
240831|NCT00945555|585042|P1|STARTED|Overall Study||264
240832|NCT00945750|585059|P6|NOT COMPLETED|Period III||0
240833|NCT00945750|585060|P5|NOT COMPLETED|Period III||0
240834|NCT00945750|585061|P4|NOT COMPLETED|Period III||0
240835|NCT00945750|585062|P3|NOT COMPLETED|Period III||0
240836|NCT00945750|585063|P2|NOT COMPLETED|Period III||0
240837|NCT00945750|585064|P1|NOT COMPLETED|Period III||0
240838|NCT00945750|585059|P6|COMPLETED|Period III||5
240839|NCT00945750|585060|P5|COMPLETED|Period III||5
240840|NCT00945750|585061|P4|COMPLETED|Period III||5
240841|NCT00945750|585062|P3|COMPLETED|Period III||5
240842|NCT00945750|585063|P2|COMPLETED|Period III||5
240843|NCT00945750|585064|P1|COMPLETED|Period III||5
240844|NCT00945750|585059|P6|STARTED|Period III||5
240845|NCT00945750|585060|P5|STARTED|Period III||5
240846|NCT00945750|585061|P4|STARTED|Period III||5
240847|NCT00945750|585062|P3|STARTED|Period III||5
240848|NCT00945750|585063|P2|STARTED|Period III||5
240849|NCT00945750|585064|P1|STARTED|Period III||5
240850|NCT00945750|585059|P6|NOT COMPLETED|Period II||0
240851|NCT00945750|585060|P5|NOT COMPLETED|Period II||0
240852|NCT00945750|585061|P4|NOT COMPLETED|Period II||0
240853|NCT00945750|585062|P3|NOT COMPLETED|Period II||0
240854|NCT00945750|585063|P2|NOT COMPLETED|Period II||0
240855|NCT00945750|585064|P1|NOT COMPLETED|Period II||0
240856|NCT00945750|585059|P6|COMPLETED|Period II||5
240857|NCT00945750|585060|P5|COMPLETED|Period II||5
240858|NCT00945750|585061|P4|COMPLETED|Period II||5
240859|NCT00945750|585062|P3|COMPLETED|Period II||5
240860|NCT00945750|585063|P2|COMPLETED|Period II||5
240861|NCT00945750|585064|P1|COMPLETED|Period II||5
240862|NCT00945750|585059|P6|STARTED|Period II||5
240863|NCT00945750|585060|P5|STARTED|Period II||5
240864|NCT00945750|585061|P4|STARTED|Period II||5
240865|NCT00945750|585062|P3|STARTED|Period II||5
240866|NCT00945750|585063|P2|STARTED|Period II||5
240867|NCT00945750|585064|P1|STARTED|Period II||5
240868|NCT00945750|585059|P6|NOT COMPLETED|Period I||0
240869|NCT00945750|585060|P5|NOT COMPLETED|Period I||0
240870|NCT00945750|585061|P4|NOT COMPLETED|Period I||0
240871|NCT00945750|585062|P3|NOT COMPLETED|Period I||0
240872|NCT00945750|585063|P2|NOT COMPLETED|Period I||0
240873|NCT00945750|585064|P1|NOT COMPLETED|Period I||0
240874|NCT00945750|585059|P6|COMPLETED|Period I||5
240875|NCT00945750|585060|P5|COMPLETED|Period I||5
240876|NCT00945750|585061|P4|COMPLETED|Period I||5
240877|NCT00945750|585062|P3|COMPLETED|Period I||5
240878|NCT00945750|585063|P2|COMPLETED|Period I||5
240879|NCT00945750|585064|P1|COMPLETED|Period I||5
240880|NCT00945750|585059|P6|STARTED|Period I||5
240881|NCT00945750|585060|P5|STARTED|Period I||5
240882|NCT00945750|585061|P4|STARTED|Period I||5
240883|NCT00945750|585062|P3|STARTED|Period I||5
240884|NCT00945750|585063|P2|STARTED|Period I||5
240885|NCT00945750|585064|P1|STARTED|Period I||5
240886|NCT00945815|585077|P1|NOT COMPLETED|Overall Study||8
240887|NCT00945815|585077|P1|COMPLETED|Overall Study||27
240888|NCT00945815|585077|P1|Eligible and Began Protocol Therapy|Overall Study||31
240889|NCT00945815|585077|P1|Eligible|Overall Study||32
240890|NCT00945815|585077|P1|STARTED|Overall Study||35
240891|NCT00945854|585084|P2|NOT COMPLETED|Overall Study||4
240892|NCT00945854|585085|P1|NOT COMPLETED|Overall Study||2
240893|NCT00945854|585084|P2|COMPLETED|Overall Study||26
240894|NCT00945854|585085|P1|COMPLETED|Overall Study||28
240895|NCT00945854|585084|P2|STARTED|Overall Study||30
240896|NCT00945854|585085|P1|STARTED|Overall Study||30
240897|NCT00945893|585097|P2|NOT COMPLETED|Overall Study||10
240898|NCT00945893|585098|P1|NOT COMPLETED|Overall Study||3
240899|NCT00945893|585097|P2|COMPLETED|Overall Study||230
240900|NCT00945893|585098|P1|COMPLETED|Overall Study||57
240901|NCT00945893|585097|P2|Day 15 Post Dose 2|Overall Study||226
240902|NCT00945893|585098|P1|Day 15 Post Dose 2|Overall Study||54
240903|NCT00945893|585097|P2|Day 15 Post Dose 1|Overall Study||238
240904|NCT00945893|585098|P1|Day 15 Post Dose 1|Overall Study||60
240905|NCT00945893|585097|P2|STARTED|Overall Study||240
240906|NCT00945893|585098|P1|STARTED|Overall Study||60
240907|NCT00945906|585162|P1|NOT COMPLETED|Overall Study||7
240908|NCT00945906|585162|P1|COMPLETED|Overall Study||54
240909|NCT00945906|585162|P1|STARTED|Overall Study||61
240910|NCT00945945|585173|P2|NOT COMPLETED|Overall Study||55
240911|NCT00945945|585174|P1|NOT COMPLETED|Overall Study||36
240912|NCT00945945|585173|P2|COMPLETED|Overall Study||162
240913|NCT00945945|585174|P1|COMPLETED|Overall Study||171
240914|NCT00945945|585173|P2|STARTED|Overall Study||217
240915|NCT00945945|585174|P1|STARTED|Overall Study||207
240916|NCT00945958|585200|P1|NOT COMPLETED|Overall Study||12
240917|NCT00945958|585200|P1|COMPLETED|Overall Study||149
240918|NCT00945958|585200|P1|STARTED|Overall Study||161
240919|NCT00946088|585207|P2|NOT COMPLETED|Overall Study||1
240920|NCT00946088|585208|P1|NOT COMPLETED|Overall Study||0
240921|NCT00946088|585207|P2|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|2
240922|NCT00946088|585208|P1|COMPLETED|Overall Study|At least one dose administered and pre-term birth status known.|4
240923|NCT00946088|585207|P2|STARTED|Overall Study||3
240924|NCT00946088|585208|P1|STARTED|Overall Study||4
240925|NCT00946101|585232|P2|NOT COMPLETED|Overall Study||2
240926|NCT00946101|585233|P1|NOT COMPLETED|Overall Study||4
240927|NCT00946101|585232|P2|COMPLETED|Overall Study||63
240928|NCT00946101|585233|P1|COMPLETED|Overall Study||257
240929|NCT00946101|585232|P2|Day 15 Post Dose 2|Overall Study||63
240930|NCT00946101|585233|P1|Day 15 Post Dose 2|Overall Study||254
240931|NCT00946101|585232|P2|Day 15 Post Dose 1|Overall Study||64
240932|NCT00946101|585233|P1|Day 15 Post Dose 1|Overall Study||260
240933|NCT00946101|585232|P2|STARTED|Overall Study||65
240934|NCT00946101|585233|P1|STARTED|Overall Study|Intent to Treat population, enrolled and randomized|261
240935|NCT00946114|585299|P2|NOT COMPLETED|Overall Study||2
240936|NCT00946114|585300|P1|NOT COMPLETED|Overall Study||8
240937|NCT00946114|585299|P2|COMPLETED|Overall Study||10
240938|NCT00946114|585300|P1|COMPLETED|Overall Study||12
240939|NCT00946114|585299|P2|STARTED|Overall Study||12
240940|NCT00946114|585300|P1|STARTED|Overall Study||20
240941|NCT00946296|585308|P2|NOT COMPLETED|Overall Study||0
240942|NCT00946296|585309|P1|NOT COMPLETED|Overall Study||3
240943|NCT00946296|585308|P2|COMPLETED|Overall Study||15
240944|NCT00946296|585309|P1|COMPLETED|Overall Study||18
240945|NCT00946296|585308|P2|STARTED|Overall Study||15
240946|NCT00946296|585309|P1|STARTED|Overall Study||21
240947|NCT00946309|585317|P2|NOT COMPLETED|Overall Study||4
240948|NCT00946309|585318|P1|NOT COMPLETED|Overall Study||1
240949|NCT00946309|585317|P2|COMPLETED|Overall Study||19
240950|NCT00946309|585318|P1|COMPLETED|Overall Study||21
240951|NCT00946309|585317|P2|STARTED|Overall Study||23
240952|NCT00946309|585318|P1|STARTED|Overall Study||22
240953|NCT00946322|585334|P1|NOT COMPLETED|Post-treatment||2
240954|NCT00946322|585334|P1|COMPLETED|Post-treatment||9
240955|NCT00946322|585334|P1|STARTED|Post-treatment||11
240956|NCT00946322|585334|P1|NOT COMPLETED|Pre-treatment||1
240957|NCT00946322|585334|P1|COMPLETED|Pre-treatment||11
240958|NCT00946322|585334|P1|STARTED|Pre-treatment||12
240959|NCT00946348|585347|P2|NOT COMPLETED|Overall Study||0
240960|NCT00946348|585348|P1|NOT COMPLETED|Overall Study||0
240961|NCT00946348|585347|P2|COMPLETED|Overall Study||6
240962|NCT00946348|585348|P1|COMPLETED|Overall Study||6
240963|NCT00946348|585347|P2|STARTED|Overall Study||6
240964|NCT00946348|585348|P1|STARTED|Overall Study||6
240965|NCT00946478|585356|P2|NOT COMPLETED|Overall Study||0
240966|NCT00946478|585357|P1|NOT COMPLETED|Overall Study||0
240967|NCT00946478|585356|P2|COMPLETED|Overall Study||20
240968|NCT00946478|585357|P1|COMPLETED|Overall Study||20
240969|NCT00946478|585356|P2|STARTED|Overall Study||20
240970|NCT00946478|585357|P1|STARTED|Overall Study||20
240971|NCT00946530|585367|P4|NOT COMPLETED|Overall Study||4
240972|NCT00946530|585368|P3|NOT COMPLETED|Overall Study||1
240973|NCT00946530|585369|P2|NOT COMPLETED|Overall Study||4
240974|NCT00946530|585370|P1|NOT COMPLETED|Overall Study||1
240975|NCT00946530|585367|P4|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|23
240976|NCT00946530|585368|P3|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
240977|NCT00946530|585369|P2|COMPLETED|Overall Study|23 dyads consisting of 1 AD patient and 1 caregiver completed to the Dim Light (Control) arm|23
240978|NCT00946530|585370|P1|COMPLETED|Overall Study|31 dyads consisting of 1 AD patient and 1 caregiver completed the Bright Light Arm|31
240979|NCT00946530|585367|P4|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
240980|NCT00946530|585368|P3|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
240981|NCT00946530|585369|P2|STARTED|Overall Study|27 dyads consisting of 1 AD patient and 1 caregiver were assigned to the Dim Light (Control) arm|27
240982|NCT00946530|585370|P1|STARTED|Overall Study|32 dyads consisting of 1 AD patient and 1 caregiver were assigned the Bright Light Arm|32
240983|NCT00946920|585386|P2|NOT COMPLETED|Overall Study||44
240984|NCT00946920|585387|P1|NOT COMPLETED|Overall Study||110
240985|NCT00946920|585386|P2|COMPLETED|Overall Study||239
240986|NCT00946920|585387|P1|COMPLETED|Overall Study||455
240987|NCT00946920|585386|P2|Full Analysis Set (FAS)|Overall Study|Received at least one dose of goserelin and had at least one post-dosing efficacy assessment.|282
240988|NCT00946920|585387|P1|Full Analysis Set (FAS)|Overall Study|Received at least one dose of degarelix and had at least one post-dosing efficacy assessment.|565
240989|NCT00946920|585386|P2|STARTED|Overall Study|Received at least one dose of goserelin acetate.|283
241078|NCT00947219|585496|P3|STARTED|Overall Study||26
240990|NCT00946920|585387|P1|STARTED|Overall Study|Received at least one dose of degarelix.|565
240991|NCT00946985|585402|P1|NOT COMPLETED|Relapse Prevention Phase (24 Months)||2
240992|NCT00946985|585402|P1|COMPLETED|Relapse Prevention Phase (24 Months)||0
240993|NCT00946985|585402|P1|STARTED|Relapse Prevention Phase (24 Months)|Both randomized patients were discontinued when the sponsor terminated the trial early.|2
240994|NCT00946985|585402|P1|NOT COMPLETED|Stabilization Phase (25 Weeks)||160
240995|NCT00946985|585402|P1|COMPLETED|Stabilization Phase (25 Weeks)||2
240996|NCT00946985|585402|P1|STARTED|Stabilization Phase (25 Weeks)||162
240997|NCT00947011|585406|P1|NOT COMPLETED|Overall Study||12
240998|NCT00947011|585406|P1|COMPLETED|Overall Study||0
240999|NCT00947011|585406|P1|STARTED|Overall Study||12
241000|NCT00947115|585417|P3|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||15
241001|NCT00947115|585418|P2|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||22
241002|NCT00947115|585419|P1|NOT COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||17
241003|NCT00947115|585417|P3|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||156
241004|NCT00947115|585418|P2|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||172
241005|NCT00947115|585419|P1|COMPLETED|Year 0 (Month 0) - Year 10 (Month 120)||142
241006|NCT00947115|585417|P3|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||171
241007|NCT00947115|585418|P2|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||194
241008|NCT00947115|585419|P1|STARTED|Year 0 (Month 0) - Year 10 (Month 120)||159
241009|NCT00947115|585417|P3|NOT COMPLETED|Year 10 (Month 120)||0
241010|NCT00947115|585418|P2|NOT COMPLETED|Year 10 (Month 120)||0
241011|NCT00947115|585419|P1|NOT COMPLETED|Year 10 (Month 120)||0
241012|NCT00947115|585417|P3|COMPLETED|Year 10 (Month 120)||156
241013|NCT00947115|585418|P2|COMPLETED|Year 10 (Month 120)||172
241014|NCT00947115|585419|P1|COMPLETED|Year 10 (Month 120)||142
241015|NCT00947115|585417|P3|STARTED|Year 10 (Month 120)||156
241016|NCT00947115|585418|P2|STARTED|Year 10 (Month 120)||172
241017|NCT00947115|585419|P1|STARTED|Year 10 (Month 120)||142
241018|NCT00947115|585417|P3|NOT COMPLETED|Year 9 (Month 108)||0
241019|NCT00947115|585418|P2|NOT COMPLETED|Year 9 (Month 108)||0
241020|NCT00947115|585419|P1|NOT COMPLETED|Year 9 (Month 108)||0
241021|NCT00947115|585417|P3|COMPLETED|Year 9 (Month 108)||157
241022|NCT00947115|585418|P2|COMPLETED|Year 9 (Month 108)||180
241023|NCT00947115|585419|P1|COMPLETED|Year 9 (Month 108)||146
241024|NCT00947115|585417|P3|STARTED|Year 9 (Month 108)||157
241025|NCT00947115|585418|P2|STARTED|Year 9 (Month 108)||180
241026|NCT00947115|585419|P1|STARTED|Year 9 (Month 108)||146
241027|NCT00947115|585417|P3|NOT COMPLETED|Year 8 (Month 96)||0
241028|NCT00947115|585418|P2|NOT COMPLETED|Year 8 (Month 96)||0
241029|NCT00947115|585419|P1|NOT COMPLETED|Year 8 (Month 96)||0
241030|NCT00947115|585417|P3|COMPLETED|Year 8 (Month 96)||141
241031|NCT00947115|585418|P2|COMPLETED|Year 8 (Month 96)||152
241032|NCT00947115|585419|P1|COMPLETED|Year 8 (Month 96)||137
241033|NCT00947115|585417|P3|STARTED|Year 8 (Month 96)||141
241034|NCT00947115|585418|P2|STARTED|Year 8 (Month 96)||152
241035|NCT00947115|585419|P1|STARTED|Year 8 (Month 96)||137
241036|NCT00947115|585417|P3|NOT COMPLETED|Year 7 (Month 84)||0
241037|NCT00947115|585418|P2|NOT COMPLETED|Year 7 (Month 84)||0
241038|NCT00947115|585419|P1|NOT COMPLETED|Year 7 (Month 84)||0
241039|NCT00947115|585417|P3|COMPLETED|Year 7 (Month 84)||160
241040|NCT00947115|585418|P2|COMPLETED|Year 7 (Month 84)||165
241041|NCT00947115|585419|P1|COMPLETED|Year 7 (Month 84)||149
241042|NCT00947115|585417|P3|STARTED|Year 7 (Month 84)||160
241043|NCT00947115|585418|P2|STARTED|Year 7 (Month 84)||165
241044|NCT00947115|585419|P1|STARTED|Year 7 (Month 84)||149
241045|NCT00947115|585417|P3|NOT COMPLETED|Year 6 (Month 72)||0
241046|NCT00947115|585418|P2|NOT COMPLETED|Year 6 (Month 72)||0
241047|NCT00947115|585419|P1|NOT COMPLETED|Year 6 (Month 72)||0
241048|NCT00947115|585417|P3|COMPLETED|Year 6 (Month 72)||164
241049|NCT00947115|585418|P2|COMPLETED|Year 6 (Month 72)||177
241050|NCT00947115|585419|P1|COMPLETED|Year 6 (Month 72)||147
241051|NCT00947115|585417|P3|STARTED|Year 6 (Month 72)||164
241052|NCT00947115|585418|P2|STARTED|Year 6 (Month 72)||177
241053|NCT00947115|585419|P1|STARTED|Year 6 (Month 72)||147
241054|NCT00947115|585417|P3|NOT COMPLETED|Year 5 (Month 60)||0
241055|NCT00947115|585418|P2|NOT COMPLETED|Year 5 (Month 60)||0
241056|NCT00947115|585419|P1|NOT COMPLETED|Year 5 (Month 60)||0
241057|NCT00947115|585417|P3|COMPLETED|Year 5 (Month 60)||170
241058|NCT00947115|585418|P2|COMPLETED|Year 5 (Month 60)||184
241059|NCT00947115|585419|P1|COMPLETED|Year 5 (Month 60)||153
241060|NCT00947115|585417|P3|STARTED|Year 5 (Month 60)||170
241061|NCT00947115|585418|P2|STARTED|Year 5 (Month 60)||184
241062|NCT00947115|585419|P1|STARTED|Year 5 (Month 60)||153
241063|NCT00947154|585481|P1|NOT COMPLETED|Overall Study||1
241064|NCT00947154|585481|P1|COMPLETED|Overall Study||11
241065|NCT00947154|585481|P1|STARTED|Overall Study||12
241066|NCT00947167|585488|P1|NOT COMPLETED|Erlotinib Added to Pertuzumab||0
241067|NCT00947167|585488|P1|COMPLETED|Erlotinib Added to Pertuzumab||3
241068|NCT00947167|585488|P1|STARTED|Erlotinib Added to Pertuzumab||3
241069|NCT00947167|585488|P1|NOT COMPLETED|Pertuzumab Alone||0
241070|NCT00947167|585488|P1|COMPLETED|Pertuzumab Alone||4
241071|NCT00947167|585488|P1|STARTED|Pertuzumab Alone||4
241072|NCT00947219|585496|P3|NOT COMPLETED|Overall Study||4
241073|NCT00947219|585497|P2|NOT COMPLETED|Overall Study||4
241074|NCT00947219|585498|P1|NOT COMPLETED|Overall Study||6
241075|NCT00947219|585496|P3|COMPLETED|Overall Study||22
241076|NCT00947219|585497|P2|COMPLETED|Overall Study||21
241077|NCT00947219|585498|P1|COMPLETED|Overall Study||22
241079|NCT00947219|585497|P2|STARTED|Overall Study||25
241080|NCT00947219|585498|P1|STARTED|Overall Study||28
241081|NCT00947271|585510|P4|NOT COMPLETED|12 Months Post Intervention||62
241082|NCT00947271|585511|P3|NOT COMPLETED|12 Months Post Intervention||59
241083|NCT00947271|585512|P2|NOT COMPLETED|12 Months Post Intervention||60
241084|NCT00947271|585513|P1|NOT COMPLETED|12 Months Post Intervention||71
241085|NCT00947271|585510|P4|COMPLETED|12 Months Post Intervention||188
241086|NCT00947271|585511|P3|COMPLETED|12 Months Post Intervention||195
241087|NCT00947271|585512|P2|COMPLETED|12 Months Post Intervention||192
241088|NCT00947271|585513|P1|COMPLETED|12 Months Post Intervention||183
241089|NCT00947271|585510|P4|STARTED|12 Months Post Intervention||250
241090|NCT00947271|585511|P3|STARTED|12 Months Post Intervention||254
241091|NCT00947271|585512|P2|STARTED|12 Months Post Intervention||252
241092|NCT00947271|585513|P1|STARTED|12 Months Post Intervention||254
241093|NCT00947271|585510|P4|NOT COMPLETED|9 Months Post Intervention||59
241094|NCT00947271|585511|P3|NOT COMPLETED|9 Months Post Intervention||61
241095|NCT00947271|585512|P2|NOT COMPLETED|9 Months Post Intervention||60
241096|NCT00947271|585513|P1|NOT COMPLETED|9 Months Post Intervention||70
241097|NCT00947271|585510|P4|COMPLETED|9 Months Post Intervention||191
241098|NCT00947271|585511|P3|COMPLETED|9 Months Post Intervention||193
241099|NCT00947271|585512|P2|COMPLETED|9 Months Post Intervention||192
241100|NCT00947271|585513|P1|COMPLETED|9 Months Post Intervention||184
241101|NCT00947271|585510|P4|STARTED|9 Months Post Intervention||250
241102|NCT00947271|585511|P3|STARTED|9 Months Post Intervention||254
241103|NCT00947271|585512|P2|STARTED|9 Months Post Intervention||252
241104|NCT00947271|585513|P1|STARTED|9 Months Post Intervention||254
241105|NCT00947271|585510|P4|NOT COMPLETED|6 Months Post Intervention||54
241106|NCT00947271|585511|P3|NOT COMPLETED|6 Months Post Intervention||58
241107|NCT00947271|585512|P2|NOT COMPLETED|6 Months Post Intervention||53
241108|NCT00947271|585513|P1|NOT COMPLETED|6 Months Post Intervention||55
241109|NCT00947271|585510|P4|COMPLETED|6 Months Post Intervention||196
241110|NCT00947271|585511|P3|COMPLETED|6 Months Post Intervention||196
241111|NCT00947271|585512|P2|COMPLETED|6 Months Post Intervention||199
241112|NCT00947271|585513|P1|COMPLETED|6 Months Post Intervention||199
241113|NCT00947271|585510|P4|STARTED|6 Months Post Intervention||250
241114|NCT00947271|585511|P3|STARTED|6 Months Post Intervention||254
241115|NCT00947271|585512|P2|STARTED|6 Months Post Intervention||252
241116|NCT00947271|585513|P1|STARTED|6 Months Post Intervention||254
241117|NCT00947271|585510|P4|NOT COMPLETED|3 Months Post Intervention||44
241118|NCT00947271|585511|P3|NOT COMPLETED|3 Months Post Intervention||36
241119|NCT00947271|585512|P2|NOT COMPLETED|3 Months Post Intervention||48
241120|NCT00947271|585513|P1|NOT COMPLETED|3 Months Post Intervention||52
241121|NCT00947271|585510|P4|COMPLETED|3 Months Post Intervention||206
241122|NCT00947271|585511|P3|COMPLETED|3 Months Post Intervention||218
241123|NCT00947271|585512|P2|COMPLETED|3 Months Post Intervention||204
241124|NCT00947271|585513|P1|COMPLETED|3 Months Post Intervention||202
241125|NCT00947271|585510|P4|STARTED|3 Months Post Intervention||250
241126|NCT00947271|585511|P3|STARTED|3 Months Post Intervention||254
241127|NCT00947271|585512|P2|STARTED|3 Months Post Intervention||252
241128|NCT00947271|585513|P1|STARTED|3 Months Post Intervention||254
241129|NCT00947284|585539|P2|NOT COMPLETED|Overall Study||3
241130|NCT00947284|585540|P1|NOT COMPLETED|Overall Study||0
241131|NCT00947284|585539|P2|COMPLETED|Overall Study||0
241132|NCT00947284|585540|P1|COMPLETED|Overall Study||0
241133|NCT00947284|585539|P2|STARTED|Overall Study||3
241134|NCT00947284|585540|P1|STARTED|Overall Study||0
241135|NCT00947297|585544|P1|NOT COMPLETED|Overall Study||7
241136|NCT00947297|585544|P1|COMPLETED|Overall Study||53
241137|NCT00947297|585544|P1|STARTED|Overall Study||60
241138|NCT00947310|585554|P3|NOT COMPLETED|Overall Study||0
241139|NCT00947310|585555|P2|NOT COMPLETED|Overall Study||0
241140|NCT00947310|585556|P1|NOT COMPLETED|Overall Study||0
241141|NCT00947310|585554|P3|COMPLETED|Overall Study||486
241142|NCT00947310|585555|P2|COMPLETED|Overall Study||500
241143|NCT00947310|585556|P1|COMPLETED|Overall Study||514
241144|NCT00947310|585554|P3|STARTED|Overall Study||486
241145|NCT00947310|585555|P2|STARTED|Overall Study||500
241146|NCT00947310|585556|P1|STARTED|Overall Study||514
241147|NCT00947349|585574|P4|NOT COMPLETED|Overall Study Standard of Care||2
241148|NCT00947349|585575|P3|NOT COMPLETED|Overall Study Standard of Care||2
241149|NCT00947349|585576|P2|NOT COMPLETED|Overall Study Standard of Care||0
241150|NCT00947349|585577|P1|NOT COMPLETED|Overall Study Standard of Care||0
241151|NCT00947349|585574|P4|COMPLETED|Overall Study Standard of Care||4
241152|NCT00947349|585575|P3|COMPLETED|Overall Study Standard of Care||4
241153|NCT00947349|585576|P2|COMPLETED|Overall Study Standard of Care||5
241154|NCT00947349|585577|P1|COMPLETED|Overall Study Standard of Care||4
241155|NCT00947349|585574|P4|STARTED|Overall Study Standard of Care||6
241156|NCT00947349|585575|P3|STARTED|Overall Study Standard of Care||6
241157|NCT00947349|585576|P2|STARTED|Overall Study Standard of Care||5
241158|NCT00947349|585577|P1|STARTED|Overall Study Standard of Care||4
241159|NCT00947349|585574|P4|NOT COMPLETED|Triple Treatment Combination Period||0
241160|NCT00947349|585575|P3|NOT COMPLETED|Triple Treatment Combination Period||0
241161|NCT00947349|585576|P2|NOT COMPLETED|Triple Treatment Combination Period||1
241162|NCT00947349|585577|P1|NOT COMPLETED|Triple Treatment Combination Period||0
241163|NCT00947349|585574|P4|COMPLETED|Triple Treatment Combination Period||6
241164|NCT00947349|585575|P3|COMPLETED|Triple Treatment Combination Period||6
241165|NCT00947349|585576|P2|COMPLETED|Triple Treatment Combination Period||5
241166|NCT00947349|585577|P1|COMPLETED|Triple Treatment Combination Period||4
241167|NCT00947349|585574|P4|STARTED|Triple Treatment Combination Period||6
241168|NCT00947349|585575|P3|STARTED|Triple Treatment Combination Period||6
241169|NCT00947349|585576|P2|STARTED|Triple Treatment Combination Period||6
241170|NCT00947349|585577|P1|STARTED|Triple Treatment Combination Period||4
241171|NCT00947427|585711|P2|NOT COMPLETED|Overall Study||4
241172|NCT00947427|585712|P1|NOT COMPLETED|Overall Study||1
241173|NCT00947427|585711|P2|COMPLETED|Overall Study||45
241174|NCT00947427|585712|P1|COMPLETED|Overall Study||21
241175|NCT00947427|585711|P2|STARTED|Overall Study|2 participants discontinued prior to any study drug administration|49
241176|NCT00947427|585712|P1|STARTED|Overall Study||22
241177|NCT00947505|585720|P2|NOT COMPLETED|Overall Study||2
241178|NCT00947505|585721|P1|NOT COMPLETED|Overall Study||9
241179|NCT00947505|585720|P2|COMPLETED|Overall Study||14
241180|NCT00947505|585721|P1|COMPLETED|Overall Study||24
241181|NCT00947505|585720|P2|STARTED|Overall Study||16
241182|NCT00947505|585721|P1|STARTED|Overall Study||33
241183|NCT00947518|585730|P3|NOT COMPLETED|Overall Study||0
241184|NCT00947518|585731|P2|NOT COMPLETED|Overall Study||0
241185|NCT00947518|585732|P1|NOT COMPLETED|Overall Study||0
241186|NCT00947518|585730|P3|COMPLETED|Overall Study||20
241187|NCT00947518|585731|P2|COMPLETED|Overall Study||20
241188|NCT00947518|585732|P1|COMPLETED|Overall Study||20
241189|NCT00947518|585730|P3|STARTED|Overall Study||20
241190|NCT00947518|585731|P2|STARTED|Overall Study||20
241191|NCT00947518|585732|P1|STARTED|Overall Study||20
241192|NCT00947531|585745|P2|NOT COMPLETED|Overall Study||11
241193|NCT00947531|585746|P1|NOT COMPLETED|Overall Study||14
241194|NCT00947531|585745|P2|COMPLETED|Overall Study||110
241195|NCT00947531|585746|P1|COMPLETED|Overall Study||107
241196|NCT00947531|585745|P2|STARTED|Overall Study||121
241197|NCT00947531|585746|P1|STARTED|Overall Study||121
241198|NCT00947544|585752|P2|NOT COMPLETED|Safety-Extension Period (12 Months)||0
241199|NCT00947544|585753|P1|NOT COMPLETED|Safety-Extension Period (12 Months)||1
241200|NCT00947544|585752|P2|COMPLETED|Safety-Extension Period (12 Months)||6
241201|NCT00947544|585753|P1|COMPLETED|Safety-Extension Period (12 Months)||10
241202|NCT00947544|585752|P2|STARTED|Safety-Extension Period (12 Months)|New participants were enrolled due to DSMB approval.|6
241203|NCT00947544|585753|P1|STARTED|Safety-Extension Period (12 Months)||11
241204|NCT00947544|585752|P2|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
241205|NCT00947544|585753|P1|NOT COMPLETED|Switch-Over Period (2 Weeks)||0
241206|NCT00947544|585752|P2|COMPLETED|Switch-Over Period (2 Weeks)||0
241207|NCT00947544|585753|P1|COMPLETED|Switch-Over Period (2 Weeks)||11
241208|NCT00947544|585752|P2|STARTED|Switch-Over Period (2 Weeks)||0
241209|NCT00947544|585753|P1|STARTED|Switch-Over Period (2 Weeks)||11
241210|NCT00947661|585779|P2|NOT COMPLETED|Overall Study||15
241211|NCT00947661|585780|P1|NOT COMPLETED|Overall Study||13
241212|NCT00947661|585779|P2|COMPLETED|Overall Study||274
241213|NCT00947661|585780|P1|COMPLETED|Overall Study||276
241214|NCT00947661|585779|P2|STARTED|Overall Study||289
241215|NCT00947661|585780|P1|STARTED|Overall Study||289
241216|NCT00947752|585788|P2|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
241217|NCT00947752|585789|P1|NOT COMPLETED|Crossover to 2nd 14-day Treatment Period||0
241218|NCT00947752|585788|P2|COMPLETED|Crossover to 2nd 14-day Treatment Period||76
241219|NCT00947752|585789|P1|COMPLETED|Crossover to 2nd 14-day Treatment Period||71
241220|NCT00947752|585788|P2|STARTED|Crossover to 2nd 14-day Treatment Period||76
241221|NCT00947752|585789|P1|STARTED|Crossover to 2nd 14-day Treatment Period||71
241222|NCT00947752|585788|P2|NOT COMPLETED|1st 14-day Treatment Period||0
241223|NCT00947752|585789|P1|NOT COMPLETED|1st 14-day Treatment Period||0
241224|NCT00947752|585788|P2|COMPLETED|1st 14-day Treatment Period||71
241225|NCT00947752|585789|P1|COMPLETED|1st 14-day Treatment Period||76
241226|NCT00947752|585788|P2|STARTED|1st 14-day Treatment Period||71
241227|NCT00947752|585789|P1|STARTED|1st 14-day Treatment Period||76
241228|NCT00947752|585788|P2|NOT COMPLETED|7-Day Run-in Treatment Period||0
241229|NCT00947752|585789|P1|NOT COMPLETED|7-Day Run-in Treatment Period||0
241230|NCT00947752|585788|P2|COMPLETED|7-Day Run-in Treatment Period||0
241231|NCT00947752|585789|P1|COMPLETED|7-Day Run-in Treatment Period||147
241232|NCT00947752|585788|P2|STARTED|7-Day Run-in Treatment Period||0
241233|NCT00947752|585789|P1|STARTED|7-Day Run-in Treatment Period|All subjects started with a daily does of F1 for 7 days|147
241234|NCT00947765|585799|P2|NOT COMPLETED|Overall Study||0
241235|NCT00947765|585800|P1|NOT COMPLETED|Overall Study||0
241236|NCT00947765|585799|P2|COMPLETED|Overall Study||30
241237|NCT00947765|585800|P1|COMPLETED|Overall Study||30
241238|NCT00947765|585799|P2|STARTED|Overall Study||30
241239|NCT00947765|585800|P1|STARTED|Overall Study||30
241240|NCT00947791|585822|P2|NOT COMPLETED|Overall Study||0
241241|NCT00947791|585823|P1|NOT COMPLETED|Overall Study||0
241242|NCT00947791|585822|P2|COMPLETED|Overall Study||1
241243|NCT00947791|585823|P1|COMPLETED|Overall Study||0
241244|NCT00947791|585822|P2|STARTED|Overall Study||1
241245|NCT00947791|585823|P1|STARTED|Overall Study||0
241246|NCT00947856|585841|P2|NOT COMPLETED|Follow-up Period||23
241247|NCT00947856|585842|P1|NOT COMPLETED|Follow-up Period||51
241248|NCT00947856|585841|P2|COMPLETED|Follow-up Period|Completed survival follow-up due to death|9
241249|NCT00947856|585842|P1|COMPLETED|Follow-up Period||27
241250|NCT00947856|585841|P2|STARTED|Follow-up Period|All participants were followed after treatment; thus, number started will not match number completed|32
241251|NCT00947856|585842|P1|STARTED|Follow-up Period||78
241252|NCT00947856|585841|P2|NOT COMPLETED|Treatment Period||32
241253|NCT00947856|585842|P1|NOT COMPLETED|Treatment Period||78
241254|NCT00947856|585841|P2|COMPLETED|Treatment Period|Patients treated until disease progression, unacceptable toxicity or study closure|0
241255|NCT00947856|585842|P1|COMPLETED|Treatment Period||0
241256|NCT00947856|585841|P2|STARTED|Treatment Period|Two patients in extension arm re-enrolled in retreatment arm and are represented in both arms|32
241257|NCT00947856|585842|P1|STARTED|Treatment Period||78
241258|NCT00947882|585873|P4|NOT COMPLETED|Overall Study||82
241259|NCT00947882|585874|P3|NOT COMPLETED|Overall Study||79
241260|NCT00947882|585875|P2|NOT COMPLETED|Overall Study||77
241261|NCT00947882|585876|P1|NOT COMPLETED|Overall Study||74
241262|NCT00947882|585873|P4|COMPLETED|Overall Study||20
241263|NCT00947882|585874|P3|COMPLETED|Overall Study||22
241264|NCT00947882|585875|P2|COMPLETED|Overall Study||24
241265|NCT00947882|585876|P1|COMPLETED|Overall Study|End of Trial, Month 12: Patients who had completed the 12-month period when the trial was stopped.|26
241266|NCT00947882|585873|P4|Visit 12, Month 6|Overall Study||95
241267|NCT00947882|585874|P3|Visit 12, Month 6|Overall Study||90
241268|NCT00947882|585875|P2|Visit 12, Month 6|Overall Study||91
241269|NCT00947882|585876|P1|Visit 12, Month 6|Overall Study|The trial was stopped when all patients had completed Visit 12, scheduled 6 months after the dosing.|93
241270|NCT00947882|585873|P4|Safety Analysis Set|Overall Study||105
241271|NCT00947882|585874|P3|Safety Analysis Set|Overall Study||100
241272|NCT00947882|585875|P2|Safety Analysis Set|Overall Study||101
241273|NCT00947882|585876|P1|Safety Analysis Set|Overall Study|Safety Analysis Set: Received a dose of Investigational Medicinal Product (IMP).|98
241274|NCT00947882|585873|P4|Actual Treatment|Overall Study||105
241275|NCT00947882|585874|P3|Actual Treatment|Overall Study|1 patient randomised to 20 mg degarelix received 30 mg degarelix|100
241276|NCT00947882|585875|P2|Actual Treatment|Overall Study||101
241277|NCT00947882|585876|P1|Actual Treatment|Overall Study|2 placebo patients received 30 mg degarelix|98
241278|NCT00947882|585873|P4|Full Analysis Set (FAS)|Overall Study||102
241279|NCT00947882|585874|P3|Full Analysis Set (FAS)|Overall Study|1 patient received 20 mg degarelix but had no post-baseline IPSS value and was excluded from the FAS|100
241280|NCT00947882|585875|P2|Full Analysis Set (FAS)|Overall Study||101
241281|NCT00947882|585876|P1|Full Analysis Set (FAS)|Overall Study|FAS: Received a dose of IMP and completed at least one post-baseline IPSS questionnaire.|100
241282|NCT00947882|585873|P4|STARTED|Overall Study||102
241283|NCT00947882|585874|P3|STARTED|Overall Study||101
241284|NCT00947882|585875|P2|STARTED|Overall Study||101
241285|NCT00947882|585876|P1|STARTED|Overall Study|Started: Randomised.|100
241286|NCT00948064|585905|P3|NOT COMPLETED|Phase II||1
241287|NCT00948064|585906|P2|NOT COMPLETED|Phase II||1
241288|NCT00948064|585907|P1|NOT COMPLETED|Phase II||0
241289|NCT00948064|585905|P3|COMPLETED|Phase II||26
241290|NCT00948064|585906|P2|COMPLETED|Phase II||51
241291|NCT00948064|585907|P1|COMPLETED|Phase II||0
241292|NCT00948064|585905|P3|STARTED|Phase II||27
241293|NCT00948064|585906|P2|STARTED|Phase II||52
241294|NCT00948064|585907|P1|STARTED|Phase II||0
241295|NCT00948064|585905|P3|NOT COMPLETED|Phase I||0
241296|NCT00948064|585906|P2|NOT COMPLETED|Phase I||0
241297|NCT00948064|585907|P1|NOT COMPLETED|Phase I||1
241298|NCT00948064|585905|P3|COMPLETED|Phase I||0
241299|NCT00948064|585906|P2|COMPLETED|Phase I||0
241300|NCT00948064|585907|P1|COMPLETED|Phase I||30
241301|NCT00948064|585905|P3|STARTED|Phase I||0
241302|NCT00948064|585906|P2|STARTED|Phase I||0
241303|NCT00948064|585907|P1|STARTED|Phase I||31
241304|NCT00948090|585920|P4|NOT COMPLETED|Overall Study||11
241305|NCT00948090|585921|P3|NOT COMPLETED|Overall Study||56
241306|NCT00948090|585922|P2|NOT COMPLETED|Overall Study||1
241307|NCT00948090|585923|P1|NOT COMPLETED|Overall Study||43
241308|NCT00948090|585920|P4|COMPLETED|Overall Study||7
241309|NCT00948090|585921|P3|COMPLETED|Overall Study||67
241310|NCT00948090|585922|P2|COMPLETED|Overall Study||0
241311|NCT00948090|585923|P1|COMPLETED|Overall Study||22
241312|NCT00948090|585920|P4|STARTED|Overall Study||18
241313|NCT00948090|585921|P3|STARTED|Overall Study||123
241314|NCT00948090|585922|P2|STARTED|Overall Study||1
241315|NCT00948090|585923|P1|STARTED|Overall Study||65
241316|NCT00948155|585944|P2|NOT COMPLETED|Second Intervention 21 Days||3
241317|NCT00948155|585945|P1|NOT COMPLETED|Second Intervention 21 Days||2
241318|NCT00948155|585944|P2|COMPLETED|Second Intervention 21 Days||8
241319|NCT00948155|585945|P1|COMPLETED|Second Intervention 21 Days||9
241320|NCT00948155|585944|P2|STARTED|Second Intervention 21 Days||11
241321|NCT00948155|585945|P1|STARTED|Second Intervention 21 Days||11
241322|NCT00948155|585944|P2|NOT COMPLETED|Washout 14 Days||2
241323|NCT00948155|585945|P1|NOT COMPLETED|Washout 14 Days||1
241324|NCT00948155|585944|P2|COMPLETED|Washout 14 Days||11
241325|NCT00948155|585945|P1|COMPLETED|Washout 14 Days||11
241326|NCT00948155|585944|P2|STARTED|Washout 14 Days||13
241327|NCT00948155|585945|P1|STARTED|Washout 14 Days||12
241328|NCT00948155|585944|P2|NOT COMPLETED|First Intervention 21 Days||2
241329|NCT00948155|585945|P1|NOT COMPLETED|First Intervention 21 Days||2
241330|NCT00948155|585944|P2|COMPLETED|First Intervention 21 Days||13
241331|NCT00948155|585945|P1|COMPLETED|First Intervention 21 Days||12
241332|NCT00948155|585944|P2|STARTED|First Intervention 21 Days||15
241333|NCT00948155|585945|P1|STARTED|First Intervention 21 Days||14
241334|NCT00948246|585965|P1|NOT COMPLETED|Overall Study||24
241335|NCT00948246|585965|P1|COMPLETED|Overall Study||86
241336|NCT00948246|585965|P1|STARTED|Overall Study||110
241337|NCT00954941|585974|P2|NOT COMPLETED|Overall Study||7
241338|NCT00954941|585975|P1|NOT COMPLETED|Overall Study||8
241339|NCT00954941|585974|P2|COMPLETED|Overall Study||41
241340|NCT00954941|585975|P1|COMPLETED|Overall Study||42
241341|NCT00954941|585974|P2|STARTED|Overall Study||48
241342|NCT00954941|585975|P1|STARTED|Overall Study||50
241343|NCT00954993|585983|P1|NOT COMPLETED|Period 2||0
241344|NCT00954993|585983|P1|COMPLETED|Period 2||3
241345|NCT00954993|585983|P1|STARTED|Period 2||3
241346|NCT00954993|585983|P1|NOT COMPLETED|Washout||0
241347|NCT00954993|585983|P1|COMPLETED|Washout||3
241348|NCT00954993|585983|P1|STARTED|Washout||3
241349|NCT00954993|585983|P1|NOT COMPLETED|Period 1||0
241350|NCT00954993|585983|P1|COMPLETED|Period 1||3
241351|NCT00954993|585983|P1|STARTED|Period 1||3
241352|NCT00955032|585995|P2|NOT COMPLETED|Overall Study||0
241353|NCT00955032|585996|P1|NOT COMPLETED|Overall Study||0
241354|NCT00955032|585995|P2|COMPLETED|Overall Study||8
241355|NCT00955032|585996|P1|COMPLETED|Overall Study||16
241356|NCT00955032|585995|P2|STARTED|Overall Study||8
241357|NCT00955032|585996|P1|STARTED|Overall Study||16
241358|NCT00955110|586016|P1|NOT COMPLETED|Treatment Phase||6
241359|NCT00955110|586016|P1|COMPLETED|Treatment Phase||35
241360|NCT00955110|586016|P1|Oxycodone CR 60 mg|Treatment Phase||40
241361|NCT00955110|586016|P1|Oxycodone CR 30 mg|Treatment Phase||40
241362|NCT00955110|586016|P1|Oxymorphone ER 30 mg|Treatment Phase||38
241363|NCT00955110|586016|P1|Oxymorphone ER 15 mg|Treatment Phase||37
241364|NCT00955110|586016|P1|Placebo|Treatment Phase||38
241365|NCT00955110|586016|P1|STARTED|Treatment Phase||41
241366|NCT00955110|586016|P1|NOT COMPLETED|Qualification Phase||24
241367|NCT00955110|586016|P1|COMPLETED|Qualification Phase||54
241368|NCT00955110|586016|P1|STARTED|Qualification Phase||78
241369|NCT00956085|586028|P1|NOT COMPLETED|Overall Study||0
241370|NCT00956085|586028|P1|COMPLETED|Overall Study||12
241371|NCT00956085|586028|P1|STARTED|Overall Study||12
241372|NCT00956254|586032|P1|NOT COMPLETED|Overall Study||0
241373|NCT00956254|586032|P1|COMPLETED|Overall Study||18
241374|NCT00956254|586032|P1|STARTED|Overall Study||18
241375|NCT00956293|586044|P3|NOT COMPLETED|Follow-up Period||0
241376|NCT00956293|586045|P2|NOT COMPLETED|Follow-up Period||32
241377|NCT00956293|586046|P1|NOT COMPLETED|Follow-up Period||20
241378|NCT00956293|586044|P3|COMPLETED|Follow-up Period||0
241379|NCT00956293|586045|P2|COMPLETED|Follow-up Period||0
241380|NCT00956293|586046|P1|COMPLETED|Follow-up Period||0
241381|NCT00956293|586044|P3|STARTED|Follow-up Period||0
241382|NCT00956293|586045|P2|STARTED|Follow-up Period||32
241383|NCT00956293|586046|P1|STARTED|Follow-up Period||20
241384|NCT00956293|586044|P3|NOT COMPLETED|Main Period (Randomization)||0
241385|NCT00956293|586045|P2|NOT COMPLETED|Main Period (Randomization)||27
241386|NCT00956293|586046|P1|NOT COMPLETED|Main Period (Randomization)||1
241387|NCT00956293|586044|P3|COMPLETED|Main Period (Randomization)||0
241388|NCT00956293|586045|P2|COMPLETED|Main Period (Randomization)||26
241389|NCT00956293|586046|P1|COMPLETED|Main Period (Randomization)||23
241390|NCT00956293|586044|P3|Randomized Safety Set|Main Period (Randomization)||0
241391|NCT00956293|586045|P2|Randomized Safety Set|Main Period (Randomization)||51
241392|NCT00956293|586046|P1|Randomized Safety Set|Main Period (Randomization)||24
241393|NCT00956293|586044|P3|Full Analysis Set|Main Period (Randomization)||0
241394|NCT00956293|586045|P2|Full Analysis Set|Main Period (Randomization)|Two participants, randomized to this arm, did not receive everolimus.|51
241395|NCT00956293|586046|P1|Full Analysis Set|Main Period (Randomization)||24
241396|NCT00956293|586044|P3|STARTED|Main Period (Randomization)||0
241397|NCT00956293|586045|P2|STARTED|Main Period (Randomization)||53
241398|NCT00956293|586046|P1|STARTED|Main Period (Randomization)||24
241399|NCT00956293|586044|P3|NOT COMPLETED|Main Period (Pre-randomization)||130
241400|NCT00956293|586045|P2|NOT COMPLETED|Main Period (Pre-randomization)||0
241401|NCT00956293|586046|P1|NOT COMPLETED|Main Period (Pre-randomization)||0
241402|NCT00956293|586044|P3|COMPLETED|Main Period (Pre-randomization)||77
241403|NCT00956293|586045|P2|COMPLETED|Main Period (Pre-randomization)||0
241404|NCT00956293|586046|P1|COMPLETED|Main Period (Pre-randomization)||0
241405|NCT00956293|586044|P3|Enrolled Safety Set|Main Period (Pre-randomization)||203
241406|NCT00956293|586045|P2|Enrolled Safety Set|Main Period (Pre-randomization)||0
241407|NCT00956293|586046|P1|Enrolled Safety Set|Main Period (Pre-randomization)||0
241408|NCT00956293|586044|P3|STARTED|Main Period (Pre-randomization)||207
241409|NCT00956293|586045|P2|STARTED|Main Period (Pre-randomization)||0
241410|NCT00956293|586046|P1|STARTED|Main Period (Pre-randomization)||0
241411|NCT00956540|586074|P4|NOT COMPLETED|Overall Study||4
241412|NCT00956540|586075|P3|NOT COMPLETED|Overall Study||3
241413|NCT00956540|586076|P2|NOT COMPLETED|Overall Study||4
241414|NCT00956540|586077|P1|NOT COMPLETED|Overall Study||3
241415|NCT00956540|586074|P4|COMPLETED|Overall Study||41
241416|NCT00956540|586075|P3|COMPLETED|Overall Study||43
241417|NCT00956540|586076|P2|COMPLETED|Overall Study||46
241418|NCT00956540|586077|P1|COMPLETED|Overall Study||51
241419|NCT00956540|586074|P4|STARTED|Overall Study||45
241420|NCT00956540|586075|P3|STARTED|Overall Study||46
241421|NCT00956540|586076|P2|STARTED|Overall Study||50
241422|NCT00956540|586077|P1|STARTED|Overall Study||54
241423|NCT00956592|586089|P2|NOT COMPLETED|Overall Study||3
241424|NCT00956592|586090|P1|NOT COMPLETED|Overall Study||1
241425|NCT00956592|586089|P2|COMPLETED|Overall Study||147
241426|NCT00956592|586090|P1|COMPLETED|Overall Study||149
241427|NCT00956592|586089|P2|STARTED|Overall Study||150
241428|NCT00956592|586090|P1|STARTED|Overall Study||150
241429|NCT00956631|586096|P1|NOT COMPLETED|Overall Study||16
241430|NCT00956631|586096|P1|COMPLETED|Overall Study||62
241431|NCT00956631|586096|P1|STARTED|Overall Study||78
241432|NCT00956657|586104|P2|NOT COMPLETED|Overall Study||0
241433|NCT00956657|586105|P1|NOT COMPLETED|Overall Study||0
241434|NCT00956657|586104|P2|COMPLETED|Overall Study||13
241435|NCT00956657|586105|P1|COMPLETED|Overall Study||18
241436|NCT00956657|586104|P2|STARTED|Overall Study||13
241437|NCT00956657|586105|P1|STARTED|Overall Study||18
241438|NCT00956709|586113|P2|NOT COMPLETED|Overall Study||0
241439|NCT00956709|586114|P1|NOT COMPLETED|Overall Study||0
241440|NCT00956709|586113|P2|COMPLETED|Overall Study||19
241441|NCT00956709|586114|P1|COMPLETED|Overall Study||16
241442|NCT00956709|586113|P2|STARTED|Overall Study||19
241443|NCT00956709|586114|P1|STARTED|Overall Study||16
241444|NCT00956761|586124|P1|NOT COMPLETED|Overall Study||0
241445|NCT00956761|586124|P1|COMPLETED|Overall Study||63
241446|NCT00956761|586124|P1|STARTED|Overall Study||63
241447|NCT00956813|586133|P2|NOT COMPLETED|Continuation Phase||0
241448|NCT00956813|586134|P1|NOT COMPLETED|Continuation Phase||0
241449|NCT00956813|586133|P2|COMPLETED|Continuation Phase||0
241450|NCT00956813|586134|P1|COMPLETED|Continuation Phase||80
241451|NCT00956813|586133|P2|STARTED|Continuation Phase||0
241452|NCT00956813|586134|P1|STARTED|Continuation Phase||80
241453|NCT00956813|586133|P2|NOT COMPLETED|Flaxseed and Placebo||5
241454|NCT00956813|586134|P1|NOT COMPLETED|Flaxseed and Placebo||8
241455|NCT00956813|586133|P2|COMPLETED|Flaxseed and Placebo||100
241456|NCT00956813|586134|P1|COMPLETED|Flaxseed and Placebo||97
241457|NCT00956813|586133|P2|STARTED|Flaxseed and Placebo||105
241458|NCT00956813|586134|P1|STARTED|Flaxseed and Placebo||105
241459|NCT00956839|586152|P3|NOT COMPLETED|Overall Study||3
241460|NCT00956839|586153|P2|NOT COMPLETED|Overall Study||0
241461|NCT00956839|586154|P1|NOT COMPLETED|Overall Study||3
241462|NCT00956839|586152|P3|COMPLETED|Overall Study||10
241463|NCT00956839|586153|P2|COMPLETED|Overall Study||13
241464|NCT00956839|586154|P1|COMPLETED|Overall Study||11
241465|NCT00956839|586152|P3|STARTED|Overall Study||13
241466|NCT00956839|586153|P2|STARTED|Overall Study||13
241467|NCT00956839|586154|P1|STARTED|Overall Study||14
241468|NCT00956943|586167|P2|NOT COMPLETED|Overall Study||10
241469|NCT00956943|586168|P1|NOT COMPLETED|Overall Study||9
241470|NCT00956943|586167|P2|COMPLETED|Overall Study||34
241471|NCT00956943|586168|P1|COMPLETED|Overall Study||34
241472|NCT00956943|586167|P2|Baseline|Overall Study||44
241473|NCT00956943|586168|P1|Baseline|Overall Study||43
241474|NCT00956943|586167|P2|STARTED|Overall Study||44
241475|NCT00956943|586168|P1|STARTED|Overall Study||43
241476|NCT00957008|586180|P4|NOT COMPLETED|Overall Study||24
241477|NCT00957008|586181|P3|NOT COMPLETED|Overall Study||17
241478|NCT00957008|586182|P2|NOT COMPLETED|Overall Study||12
241479|NCT00957008|586183|P1|NOT COMPLETED|Overall Study||21
241480|NCT00957008|586180|P4|COMPLETED|Overall Study||26
241481|NCT00957008|586181|P3|COMPLETED|Overall Study||32
241482|NCT00957008|586182|P2|COMPLETED|Overall Study||37
241483|NCT00957008|586183|P1|COMPLETED|Overall Study||28
241484|NCT00957008|586180|P4|STARTED|Overall Study||50
241485|NCT00957008|586181|P3|STARTED|Overall Study||49
241486|NCT00957008|586182|P2|STARTED|Overall Study||49
241487|NCT00957008|586183|P1|STARTED|Overall Study||49
241488|NCT00957021|586197|P1|NOT COMPLETED|Overall Study||117
241489|NCT00957021|586197|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2 yr primary outcome interval.|237
241490|NCT00957021|586197|P1|STARTED|Overall Study||354
241491|NCT00957034|586209|P3|NOT COMPLETED|Overall Study||6
241492|NCT00957034|586210|P2|NOT COMPLETED|Overall Study||4
241493|NCT00957034|586211|P1|NOT COMPLETED|Overall Study||6
241494|NCT00957034|586209|P3|COMPLETED|Overall Study||1
241495|NCT00957034|586210|P2|COMPLETED|Overall Study||0
241496|NCT00957034|586211|P1|COMPLETED|Overall Study||0
241497|NCT00957034|586209|P3|STARTED|Overall Study||7
241498|NCT00957034|586210|P2|STARTED|Overall Study||4
241499|NCT00957034|586211|P1|STARTED|Overall Study||6
241500|NCT00957047|586238|P5|NOT COMPLETED|PART II||102
241501|NCT00957047|586239|P4|NOT COMPLETED|PART II||0
241502|NCT00957047|586240|P3|NOT COMPLETED|PART II||0
241503|NCT00957047|586241|P2|NOT COMPLETED|PART II||0
241504|NCT00957047|586242|P1|NOT COMPLETED|PART II||0
241505|NCT00957047|586238|P5|COMPLETED|PART II||223
241506|NCT00957047|586239|P4|COMPLETED|PART II||0
241507|NCT00957047|586240|P3|COMPLETED|PART II||0
241508|NCT00957047|586241|P2|COMPLETED|PART II||0
241509|NCT00957047|586242|P1|COMPLETED|PART II||0
241510|NCT00957047|586238|P5|Terminated Prematurely|PART II|Terminated Prematurely during 1-year Open-Label Period|102
241511|NCT00957047|586239|P4|Terminated Prematurely|PART II||0
241512|NCT00957047|586240|P3|Terminated Prematurely|PART II||0
241513|NCT00957047|586241|P2|Terminated Prematurely|PART II||0
241514|NCT00957047|586242|P1|Terminated Prematurely|PART II||0
241610|NCT00957372|586369|P4|Per-Protocol Population|PART I||0
241515|NCT00957047|586238|P5|STARTED|PART II|325 patients who completed Part I were enrolled in Part II.|325
241516|NCT00957047|586239|P4|STARTED|PART II||0
241517|NCT00957047|586240|P3|STARTED|PART II||0
241518|NCT00957047|586241|P2|STARTED|PART II||0
241519|NCT00957047|586242|P1|STARTED|PART II||0
241520|NCT00957047|586238|P5|NOT COMPLETED|PART I||0
241521|NCT00957047|586239|P4|NOT COMPLETED|PART I||30
241522|NCT00957047|586240|P3|NOT COMPLETED|PART I||21
241523|NCT00957047|586241|P2|NOT COMPLETED|PART I||13
241524|NCT00957047|586242|P1|NOT COMPLETED|PART I||6
241525|NCT00957047|586238|P5|COMPLETED|PART I||0
241526|NCT00957047|586239|P4|COMPLETED|PART I||68
241527|NCT00957047|586240|P3|COMPLETED|PART I||80
241528|NCT00957047|586241|P2|COMPLETED|PART I||83
241529|NCT00957047|586242|P1|COMPLETED|PART I||94
241530|NCT00957047|586238|P5|Per-Protocol Population|PART I||0
241531|NCT00957047|586239|P4|Per-Protocol Population|PART I||54
241532|NCT00957047|586240|P3|Per-Protocol Population|PART I||75
241533|NCT00957047|586241|P2|Per-Protocol Population|PART I||70
241534|NCT00957047|586242|P1|Per-Protocol Population|PART I||81
241535|NCT00957047|586238|P5|Intention-to-treat (ITT) Population|PART I||0
241536|NCT00957047|586239|P4|Intention-to-treat (ITT) Population|PART I||97
241537|NCT00957047|586240|P3|Intention-to-treat (ITT) Population|PART I||100
241538|NCT00957047|586241|P2|Intention-to-treat (ITT) Population|PART I||96
241539|NCT00957047|586242|P1|Intention-to-treat (ITT) Population|PART I||100
241540|NCT00957047|586238|P5|Randomized/Safety Population|PART I||0
241541|NCT00957047|586239|P4|Randomized/Safety Population|PART I||98
241542|NCT00957047|586240|P3|Randomized/Safety Population|PART I||101
241543|NCT00957047|586241|P2|Randomized/Safety Population|PART I||96
241544|NCT00957047|586242|P1|Randomized/Safety Population|PART I||100
241545|NCT00957047|586238|P5|STARTED|PART I||0
241546|NCT00957047|586239|P4|STARTED|PART I||98
241547|NCT00957047|586240|P3|STARTED|PART I||101
241548|NCT00957047|586241|P2|STARTED|PART I||96
241549|NCT00957047|586242|P1|STARTED|PART I||100
241550|NCT00957242|586262|P2|NOT COMPLETED|Overall Study||0
241551|NCT00957242|586263|P1|NOT COMPLETED|Overall Study||0
241552|NCT00957242|586262|P2|COMPLETED|Overall Study||72
241553|NCT00957242|586263|P1|COMPLETED|Overall Study||73
241554|NCT00957242|586262|P2|STARTED|Overall Study||72
241555|NCT00957242|586263|P1|STARTED|Overall Study||73
241556|NCT00957268|586296|P5|NOT COMPLETED|Overall Study||0
241557|NCT00957268|586297|P4|NOT COMPLETED|Overall Study||0
241558|NCT00957268|586298|P3|NOT COMPLETED|Overall Study||1
241559|NCT00957268|586299|P2|NOT COMPLETED|Overall Study||0
241560|NCT00957268|586300|P1|NOT COMPLETED|Overall Study||0
241561|NCT00957268|586296|P5|COMPLETED|Overall Study||22
241562|NCT00957268|586297|P4|COMPLETED|Overall Study||7
241563|NCT00957268|586298|P3|COMPLETED|Overall Study||7
241564|NCT00957268|586299|P2|COMPLETED|Overall Study||4
241565|NCT00957268|586300|P1|COMPLETED|Overall Study||5
241566|NCT00957268|586296|P5|STARTED|Overall Study||22
241567|NCT00957268|586297|P4|STARTED|Overall Study||7
241568|NCT00957268|586298|P3|STARTED|Overall Study||8
241569|NCT00957268|586299|P2|STARTED|Overall Study||4
241570|NCT00957268|586300|P1|STARTED|Overall Study||5
241571|NCT00957333|586362|P1|NOT COMPLETED|Overall Study||0
241572|NCT00957333|586362|P1|COMPLETED|Overall Study||44
241573|NCT00957333|586362|P1|STARTED|Overall Study||44
241574|NCT00957372|586369|P4|NOT COMPLETED|PART II||44
241575|NCT00957372|586370|P3|NOT COMPLETED|PART II||0
241576|NCT00957372|586371|P2|NOT COMPLETED|PART II||0
241577|NCT00957372|586372|P1|NOT COMPLETED|PART II||0
241578|NCT00957372|586369|P4|COMPLETED|PART II||150
241579|NCT00957372|586370|P3|COMPLETED|PART II||0
241580|NCT00957372|586371|P2|COMPLETED|PART II||0
241581|NCT00957372|586372|P1|COMPLETED|PART II||0
241582|NCT00957372|586369|P4|Per-Protocol Population|PART II||108
241583|NCT00957372|586370|P3|Per-Protocol Population|PART II||0
241584|NCT00957372|586371|P2|Per-Protocol Population|PART II||0
241585|NCT00957372|586372|P1|Per-Protocol Population|PART II||0
241586|NCT00957372|586369|P4|Intention-to-treat (ITT) Population|PART II||191
241587|NCT00957372|586370|P3|Intention-to-treat (ITT) Population|PART II||0
241588|NCT00957372|586371|P2|Intention-to-treat (ITT) Population|PART II||0
241589|NCT00957372|586372|P1|Intention-to-treat (ITT) Population|PART II||0
241590|NCT00957372|586369|P4|Safety Population|PART II||194
241591|NCT00957372|586370|P3|Safety Population|PART II||0
241592|NCT00957372|586371|P2|Safety Population|PART II||0
241593|NCT00957372|586372|P1|Safety Population|PART II||0
241594|NCT00957372|586369|P4|STARTED|PART II||194
241595|NCT00957372|586370|P3|STARTED|PART II||0
241596|NCT00957372|586371|P2|STARTED|PART II||0
241597|NCT00957372|586372|P1|STARTED|PART II||0
241598|NCT00957372|586369|P4|NOT COMPLETED|PART I||0
241599|NCT00957372|586370|P3|NOT COMPLETED|PART I||1
241600|NCT00957372|586371|P2|NOT COMPLETED|PART I||0
241601|NCT00957372|586372|P1|NOT COMPLETED|PART I||0
241602|NCT00957372|586369|P4|COMPLETED|PART I||0
241603|NCT00957372|586370|P3|COMPLETED|PART I||87
241604|NCT00957372|586371|P2|COMPLETED|PART I||85
241605|NCT00957372|586372|P1|COMPLETED|PART I||80
241606|NCT00957372|586369|P4|Randomized But Not Treated|PART I||0
241607|NCT00957372|586370|P3|Randomized But Not Treated|PART I||1
241608|NCT00957372|586371|P2|Randomized But Not Treated|PART I||0
241609|NCT00957372|586372|P1|Randomized But Not Treated|PART I||0
241611|NCT00957372|586370|P3|Per-Protocol Population|PART I||51
241612|NCT00957372|586371|P2|Per-Protocol Population|PART I||47
241613|NCT00957372|586372|P1|Per-Protocol Population|PART I||35
241614|NCT00957372|586369|P4|Intention-to-Treat Population|PART I||0
241615|NCT00957372|586370|P3|Intention-to-Treat Population|PART I||84
241616|NCT00957372|586371|P2|Intention-to-Treat Population|PART I||84
241617|NCT00957372|586372|P1|Intention-to-Treat Population|PART I||77
241618|NCT00957372|586369|P4|Safety Population|PART I||0
241619|NCT00957372|586370|P3|Safety Population|PART I||87
241620|NCT00957372|586371|P2|Safety Population|PART I||85
241621|NCT00957372|586372|P1|Safety Population|PART I||80
241622|NCT00957372|586369|P4|STARTED|PART I||0
241623|NCT00957372|586370|P3|STARTED|PART I||88
241624|NCT00957372|586371|P2|STARTED|PART I||85
241625|NCT00957372|586372|P1|STARTED|PART I||80
241626|NCT00957424|586388|P1|NOT COMPLETED|Overall Study||23
241627|NCT00957424|586388|P1|COMPLETED|Overall Study||44
241628|NCT00957424|586388|P1|Follow-up #2|Overall Study||50
241629|NCT00957424|586388|P1|Follow-up #1|Overall Study||59
241630|NCT00957424|586388|P1|STARTED|Overall Study||67
241631|NCT00957528|586398|P3|NOT COMPLETED|Overall Study||1
241632|NCT00957528|586399|P2|NOT COMPLETED|Overall Study||1
241633|NCT00957528|586400|P1|NOT COMPLETED|Overall Study||0
241634|NCT00957528|586398|P3|COMPLETED|Overall Study||8
241635|NCT00957528|586399|P2|COMPLETED|Overall Study||8
241636|NCT00957528|586400|P1|COMPLETED|Overall Study||8
241637|NCT00957528|586398|P3|STARTED|Overall Study||9
241638|NCT00957528|586399|P2|STARTED|Overall Study||9
241639|NCT00957528|586400|P1|STARTED|Overall Study||8
241640|NCT00957580|586426|P3|NOT COMPLETED|Overall Study||0
241641|NCT00957580|586427|P2|NOT COMPLETED|Overall Study||2
241642|NCT00957580|586428|P1|NOT COMPLETED|Overall Study||0
241643|NCT00957580|586426|P3|COMPLETED|Overall Study||15
241644|NCT00957580|586427|P2|COMPLETED|Overall Study||31
241645|NCT00957580|586428|P1|COMPLETED|Overall Study||33
241646|NCT00957580|586426|P3|Treated|Overall Study||15
241647|NCT00957580|586427|P2|Treated|Overall Study||32
241648|NCT00957580|586428|P1|Treated|Overall Study||33
241649|NCT00957580|586426|P3|STARTED|Overall Study||15
241650|NCT00957580|586427|P2|STARTED|Overall Study||33
241651|NCT00957580|586428|P1|STARTED|Overall Study||33
241652|NCT00957593|586574|P2|NOT COMPLETED|Overall Study||0
241653|NCT00957593|586575|P1|NOT COMPLETED|Overall Study||0
241654|NCT00957593|586574|P2|COMPLETED|Overall Study||125
241655|NCT00957593|586575|P1|COMPLETED|Overall Study||127
241656|NCT00957593|586574|P2|STARTED|Overall Study||125
241657|NCT00957593|586575|P1|STARTED|Overall Study||127
241658|NCT00957658|586581|P1|NOT COMPLETED|Overall Study||65
241659|NCT00957658|586581|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|169
241660|NCT00957658|586581|P1|STARTED|Overall Study||234
241661|NCT00957684|586598|P5|NOT COMPLETED|PART II||75
241662|NCT00957684|586599|P4|NOT COMPLETED|PART II||0
241663|NCT00957684|586600|P3|NOT COMPLETED|PART II||0
241664|NCT00957684|586601|P2|NOT COMPLETED|PART II||0
241665|NCT00957684|586602|P1|NOT COMPLETED|PART II||0
241666|NCT00957684|586598|P5|COMPLETED|PART II||239
241667|NCT00957684|586599|P4|COMPLETED|PART II||0
241668|NCT00957684|586600|P3|COMPLETED|PART II||0
241669|NCT00957684|586601|P2|COMPLETED|PART II||0
241670|NCT00957684|586602|P1|COMPLETED|PART II||0
241671|NCT00957684|586598|P5|Patients Entered Part II|PART II||314
241672|NCT00957684|586599|P4|Patients Entered Part II|PART II||0
241673|NCT00957684|586600|P3|Patients Entered Part II|PART II||0
241674|NCT00957684|586601|P2|Patients Entered Part II|PART II||0
241675|NCT00957684|586602|P1|Patients Entered Part II|PART II||0
241676|NCT00957684|586598|P5|STARTED|PART II||314
241677|NCT00957684|586599|P4|STARTED|PART II||0
241678|NCT00957684|586600|P3|STARTED|PART II||0
241679|NCT00957684|586601|P2|STARTED|PART II||0
241680|NCT00957684|586602|P1|STARTED|PART II||0
241681|NCT00957684|586598|P5|NOT COMPLETED|PART I||0
241682|NCT00957684|586599|P4|NOT COMPLETED|PART I||18
241683|NCT00957684|586600|P3|NOT COMPLETED|PART I||10
241684|NCT00957684|586601|P2|NOT COMPLETED|PART I||13
241685|NCT00957684|586602|P1|NOT COMPLETED|PART I||31
241686|NCT00957684|586598|P5|COMPLETED|PART I||0
241687|NCT00957684|586599|P4|COMPLETED|PART I||84
241688|NCT00957684|586600|P3|COMPLETED|PART I||90
241689|NCT00957684|586601|P2|COMPLETED|PART I||85
241690|NCT00957684|586602|P1|COMPLETED|PART I||71
241691|NCT00957684|586598|P5|Per-protocol (PP)Population|PART I||0
241692|NCT00957684|586599|P4|Per-protocol (PP)Population|PART I||91
241693|NCT00957684|586600|P3|Per-protocol (PP)Population|PART I||94
241694|NCT00957684|586601|P2|Per-protocol (PP)Population|PART I||86
241695|NCT00957684|586602|P1|Per-protocol (PP)Population|PART I||72
241696|NCT00957684|586598|P5|Intention-to-treat (ITT) Population|PART I||0
241697|NCT00957684|586599|P4|Intention-to-treat (ITT) Population|PART I||102
241698|NCT00957684|586600|P3|Intention-to-treat (ITT) Population|PART I||99
241699|NCT00957684|586601|P2|Intention-to-treat (ITT) Population|PART I||98
241700|NCT00957684|586602|P1|Intention-to-treat (ITT) Population|PART I||98
241701|NCT00957684|586598|P5|Randomised (Safety Population)|PART I||0
241702|NCT00957684|586599|P4|Randomised (Safety Population)|PART I||102
241703|NCT00957684|586600|P3|Randomised (Safety Population)|PART I||100
241704|NCT00957684|586601|P2|Randomised (Safety Population)|PART I||98
241705|NCT00957684|586602|P1|Randomised (Safety Population)|PART I||102
241706|NCT00957684|586598|P5|STARTED|PART I||0
241707|NCT00957684|586599|P4|STARTED|PART I||102
241708|NCT00957684|586600|P3|STARTED|PART I||100
241709|NCT00957684|586601|P2|STARTED|PART I||98
241710|NCT00957684|586602|P1|STARTED|PART I||102
241711|NCT00957723|586612|P1|NOT COMPLETED|Overall Study||121
241712|NCT00957723|586612|P1|COMPLETED|Overall Study|Completed/Not completed counts are based on participant status at the 2yr primary outcome interval.|298
241713|NCT00957723|586612|P1|STARTED|Overall Study||419
241714|NCT00957905|586625|P2|NOT COMPLETED|Part B||4
241715|NCT00957905|586626|P1|NOT COMPLETED|Part B||0
241716|NCT00957905|586625|P2|COMPLETED|Part B||25
241717|NCT00957905|586626|P1|COMPLETED|Part B||0
241718|NCT00957905|586625|P2|STARTED|Part B||29
241719|NCT00957905|586626|P1|STARTED|Part B||0
241720|NCT00957905|586625|P2|NOT COMPLETED|Part A||0
241721|NCT00957905|586626|P1|NOT COMPLETED|Part A||0
241722|NCT00957905|586625|P2|COMPLETED|Part A||0
241723|NCT00957905|586626|P1|COMPLETED|Part A||7
241724|NCT00957905|586625|P2|STARTED|Part A||0
241725|NCT00957905|586626|P1|STARTED|Part A||7
241726|NCT00957944|586634|P2|NOT COMPLETED|Second Intervention- 24 Hours||0
241727|NCT00957944|586635|P1|NOT COMPLETED|Second Intervention- 24 Hours||0
241728|NCT00957944|586634|P2|COMPLETED|Second Intervention- 24 Hours||19
241729|NCT00957944|586635|P1|COMPLETED|Second Intervention- 24 Hours||20
241730|NCT00957944|586634|P2|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours|One subject that fullfilled predefined criteria for patch adhesiveness was excluded from the PKS|18
241731|NCT00957944|586635|P1|Pharmacokinetic Set (PKS)|Second Intervention- 24 Hours||20
241732|NCT00957944|586634|P2|STARTED|Second Intervention- 24 Hours||19
241733|NCT00957944|586635|P1|STARTED|Second Intervention- 24 Hours||20
241734|NCT00957944|586634|P2|NOT COMPLETED|Washout Period of at Least 5 Days||0
241735|NCT00957944|586635|P1|NOT COMPLETED|Washout Period of at Least 5 Days||0
241736|NCT00957944|586634|P2|COMPLETED|Washout Period of at Least 5 Days||19
241737|NCT00957944|586635|P1|COMPLETED|Washout Period of at Least 5 Days||20
241738|NCT00957944|586634|P2|STARTED|Washout Period of at Least 5 Days||19
241739|NCT00957944|586635|P1|STARTED|Washout Period of at Least 5 Days||20
241740|NCT00957944|586634|P2|NOT COMPLETED|First Intervention- 24 Hours||1
241741|NCT00957944|586635|P1|NOT COMPLETED|First Intervention- 24 Hours||0
241742|NCT00957944|586634|P2|COMPLETED|First Intervention- 24 Hours||19
241743|NCT00957944|586635|P1|COMPLETED|First Intervention- 24 Hours||20
241744|NCT00957944|586634|P2|STARTED|First Intervention- 24 Hours||20
241745|NCT00957944|586635|P1|STARTED|First Intervention- 24 Hours||20
241746|NCT00957996|586671|P2|NOT COMPLETED|Overall Study||28
241747|NCT00957996|586672|P1|NOT COMPLETED|Overall Study||26
241748|NCT00957996|586671|P2|COMPLETED|Overall Study||89
241749|NCT00957996|586672|P1|COMPLETED|Overall Study||91
241750|NCT00957996|586671|P2|STARTED|Overall Study||117
241751|NCT00957996|586672|P1|STARTED|Overall Study||117
241752|NCT00958009|586702|P1|NOT COMPLETED|Overall Study||2
241753|NCT00958009|586702|P1|COMPLETED|Overall Study||107
241754|NCT00958009|586702|P1|STARTED|Overall Study||109
241755|NCT00958035|586709|P2|NOT COMPLETED|Overall Study||4
241756|NCT00958035|586710|P1|NOT COMPLETED|Overall Study||3
241757|NCT00958035|586709|P2|COMPLETED|Overall Study||39
241758|NCT00958035|586710|P1|COMPLETED|Overall Study||43
241759|NCT00958035|586709|P2|STARTED|Overall Study||43
241760|NCT00958035|586710|P1|STARTED|Overall Study||46
241761|NCT00958074|586718|P2|NOT COMPLETED|Overall Study||1
241762|NCT00958074|586719|P1|NOT COMPLETED|Overall Study||0
241763|NCT00958074|586718|P2|COMPLETED|Overall Study||6
241764|NCT00958074|586719|P1|COMPLETED|Overall Study||4
241765|NCT00958074|586718|P2|STARTED|Overall Study||7
241766|NCT00958074|586719|P1|STARTED|Overall Study||4
241767|NCT00958126|586733|P8|NOT COMPLETED|Overall Study||0
241768|NCT00958126|586734|P7|NOT COMPLETED|Overall Study||1
241769|NCT00958126|586735|P6|NOT COMPLETED|Overall Study||1
241770|NCT00958126|586736|P5|NOT COMPLETED|Overall Study||0
241771|NCT00958126|586737|P4|NOT COMPLETED|Overall Study||11
241772|NCT00958126|586738|P3|NOT COMPLETED|Overall Study||10
241773|NCT00958126|586739|P2|NOT COMPLETED|Overall Study||9
241774|NCT00958126|586740|P1|NOT COMPLETED|Overall Study||1
241775|NCT00958126|586733|P8|COMPLETED|Overall Study||202
241776|NCT00958126|586734|P7|COMPLETED|Overall Study||199
241777|NCT00958126|586735|P6|COMPLETED|Overall Study||202
241778|NCT00958126|586736|P5|COMPLETED|Overall Study||50
241779|NCT00958126|586737|P4|COMPLETED|Overall Study||192
241780|NCT00958126|586738|P3|COMPLETED|Overall Study||191
241781|NCT00958126|586739|P2|COMPLETED|Overall Study||196
241782|NCT00958126|586740|P1|COMPLETED|Overall Study||48
241783|NCT00958126|586733|P8|STARTED|Overall Study||202
241784|NCT00958126|586734|P7|STARTED|Overall Study||200
241785|NCT00958126|586735|P6|STARTED|Overall Study||203
241786|NCT00958126|586736|P5|STARTED|Overall Study||50
241787|NCT00958126|586737|P4|STARTED|Overall Study||203
241788|NCT00958126|586738|P3|STARTED|Overall Study||201
241789|NCT00958126|586739|P2|STARTED|Overall Study||205
241790|NCT00958126|586740|P1|STARTED|Overall Study||49
241791|NCT00958165|586810|P1|NOT COMPLETED|Overall Study||14
241792|NCT00958165|586810|P1|COMPLETED|Overall Study|Of the 72 treated participants, 67 completed follow-up and were evaluable for effectiveness.|67
241793|NCT00958165|586810|P1|Treated|Overall Study||72
241978|NCT00951821|587395|P1|COMPLETED|Overall Study||16
241794|NCT00958165|586810|P1|STARTED|Overall Study|81 enrolled participants resulted in 72 eligible participants that were treated.|81
241795|NCT00958191|586814|P1|NOT COMPLETED|Overall Study||112
241796|NCT00958191|586814|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|110
241797|NCT00958191|586814|P1|STARTED|Overall Study||222
241798|NCT00958217|586829|P2|NOT COMPLETED|Overall Study||25
241799|NCT00958217|586830|P1|NOT COMPLETED|Overall Study||24
241800|NCT00958217|586829|P2|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
241801|NCT00958217|586830|P1|COMPLETED|Overall Study|Participants were assessed quarterly for one year following end of treatment|37
241802|NCT00958217|586829|P2|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|57
241803|NCT00958217|586830|P1|End of Treatment|Overall Study|Participants had a maximum of 16 weeks to complete 12 individual psychotherapy sessions|56
241804|NCT00958217|586829|P2|STARTED|Overall Study||62
241805|NCT00958217|586830|P1|STARTED|Overall Study||61
241806|NCT00958243|586847|P6|NOT COMPLETED|Overall Study||10
241807|NCT00958243|586848|P5|NOT COMPLETED|Overall Study||9
241808|NCT00958243|586849|P4|NOT COMPLETED|Overall Study||3
241809|NCT00958243|586850|P3|NOT COMPLETED|Overall Study||14
241810|NCT00958243|586851|P2|NOT COMPLETED|Overall Study||6
241811|NCT00958243|586852|P1|NOT COMPLETED|Overall Study||2
241812|NCT00958243|586847|P6|COMPLETED|Overall Study||99
241813|NCT00958243|586848|P5|COMPLETED|Overall Study||100
241814|NCT00958243|586849|P4|COMPLETED|Overall Study||25
241815|NCT00958243|586850|P3|COMPLETED|Overall Study||82
241816|NCT00958243|586851|P2|COMPLETED|Overall Study||99
241817|NCT00958243|586852|P1|COMPLETED|Overall Study||24
241818|NCT00958243|586847|P6|STARTED|Overall Study||109
241819|NCT00958243|586848|P5|STARTED|Overall Study||109
241820|NCT00958243|586849|P4|STARTED|Overall Study||28
241821|NCT00958243|586850|P3|STARTED|Overall Study||96
241822|NCT00958243|586851|P2|STARTED|Overall Study||105
241823|NCT00958243|586852|P1|STARTED|Overall Study||26
241824|NCT00958256|586908|P1|NOT COMPLETED|Overall Study||3
241825|NCT00958256|586908|P1|COMPLETED|Overall Study||18
241826|NCT00958256|586908|P1|STARTED|Overall Study||21
241827|NCT00958282|586914|P2|NOT COMPLETED|Overall Study||6
241828|NCT00958282|586915|P1|NOT COMPLETED|Overall Study||10
241829|NCT00958282|586914|P2|COMPLETED|Overall Study||15
241830|NCT00958282|586915|P1|COMPLETED|Overall Study||12
241831|NCT00958282|586914|P2|STARTED|Overall Study||21
241832|NCT00958282|586915|P1|STARTED|Overall Study||22
241833|NCT00958308|586926|P3|NOT COMPLETED|Overall Study||0
241834|NCT00958308|586927|P2|NOT COMPLETED|Overall Study||0
241835|NCT00958308|586928|P1|NOT COMPLETED|Overall Study||0
241836|NCT00958308|586926|P3|COMPLETED|Overall Study||86
241837|NCT00958308|586927|P2|COMPLETED|Overall Study||85
241838|NCT00958308|586928|P1|COMPLETED|Overall Study||84
241839|NCT00958308|586926|P3|STARTED|Overall Study||86
241840|NCT00958308|586927|P2|STARTED|Overall Study||85
241841|NCT00958308|586928|P1|STARTED|Overall Study||84
241842|NCT00958334|586939|P3|NOT COMPLETED|Overall Study||13
241843|NCT00958334|586940|P2|NOT COMPLETED|Overall Study||17
241844|NCT00958334|586941|P1|NOT COMPLETED|Overall Study||14
241845|NCT00958334|586939|P3|COMPLETED|Overall Study||8
241846|NCT00958334|586940|P2|COMPLETED|Overall Study||5
241847|NCT00958334|586941|P1|COMPLETED|Overall Study||8
241848|NCT00958334|586939|P3|STARTED|Overall Study||21
241849|NCT00958334|586940|P2|STARTED|Overall Study||22
241850|NCT00958334|586941|P1|STARTED|Overall Study||22
241851|NCT00958347|586949|P1|NOT COMPLETED|Overall Study||226
241944|NCT00951665|587280|P4|NOT COMPLETED|Phase 1b||1
241852|NCT00958347|586949|P1|COMPLETED|Overall Study|11 revisions total, one was a bilateral participant with the other hip counted as not completed.|0
241853|NCT00958347|586949|P1|STARTED|Overall Study||226
241854|NCT00958360|586955|P2|NOT COMPLETED|Overall Study||10
241855|NCT00958360|586956|P1|NOT COMPLETED|Overall Study||11
241856|NCT00958360|586955|P2|COMPLETED|Overall Study||150
241857|NCT00958360|586956|P1|COMPLETED|Overall Study||152
241858|NCT00958360|586955|P2|STARTED|Overall Study||160
241859|NCT00958360|586956|P1|STARTED|Overall Study||163
241860|NCT00958438|586973|P3|NOT COMPLETED|Overall Study||6
241861|NCT00958438|586974|P2|NOT COMPLETED|Overall Study||10
241862|NCT00958438|586975|P1|NOT COMPLETED|Overall Study||10
241863|NCT00958438|586973|P3|COMPLETED|Overall Study||78
241864|NCT00958438|586974|P2|COMPLETED|Overall Study||72
241865|NCT00958438|586975|P1|COMPLETED|Overall Study||72
241866|NCT00958438|586973|P3|STARTED|Overall Study||84
241867|NCT00958438|586974|P2|STARTED|Overall Study||82
241868|NCT00958438|586975|P1|STARTED|Overall Study||82
241869|NCT00958477|587002|P4|NOT COMPLETED|Overall Study||0
241870|NCT00958477|587003|P3|NOT COMPLETED|Overall Study||0
241871|NCT00958477|587004|P2|NOT COMPLETED|Overall Study||0
241872|NCT00958477|587005|P1|NOT COMPLETED|Overall Study||0
241873|NCT00958477|587002|P4|COMPLETED|Overall Study||6
241874|NCT00958477|587003|P3|COMPLETED|Overall Study||6
241875|NCT00958477|587004|P2|COMPLETED|Overall Study||6
241876|NCT00958477|587005|P1|COMPLETED|Overall Study||8
241877|NCT00958477|587002|P4|STARTED|Overall Study||6
241878|NCT00958477|587003|P3|STARTED|Overall Study||6
241879|NCT00958477|587004|P2|STARTED|Overall Study||6
241880|NCT00958477|587005|P1|STARTED|Overall Study||8
241881|NCT00951171|587153|P2|NOT COMPLETED|Overall Study||0
241882|NCT00951171|587154|P1|NOT COMPLETED|Overall Study||2
241883|NCT00951171|587153|P2|COMPLETED|Overall Study|2 of the cervical occlusion group transferred to standard group because of pain during attempted IUI|55
241884|NCT00951171|587154|P1|COMPLETED|Overall Study||38
241885|NCT00951171|587153|P2|Pregnancy|Overall Study||7
241886|NCT00951171|587154|P1|Pregnancy|Overall Study||1
241887|NCT00951171|587153|P2|STARTED|Overall Study||55
241888|NCT00951171|587154|P1|STARTED|Overall Study||40
241889|NCT00951275|587160|P1|NOT COMPLETED|Overall Study||13
241890|NCT00951275|587160|P1|COMPLETED|Overall Study||92
241891|NCT00951275|587160|P1|STARTED|Overall Study||105
241892|NCT00951379|587192|P2|NOT COMPLETED|Overall Study||2
241893|NCT00951379|587193|P1|NOT COMPLETED|Overall Study||6
241894|NCT00951379|587192|P2|COMPLETED|Overall Study||23
241895|NCT00951379|587193|P1|COMPLETED|Overall Study||21
241896|NCT00951379|587192|P2|STARTED|Overall Study||25
241897|NCT00951379|587193|P1|STARTED|Overall Study||27
241898|NCT00951483|587237|P2|NOT COMPLETED|Overall Study||0
241899|NCT00951483|587238|P1|NOT COMPLETED|Overall Study||19
241900|NCT00951483|587237|P2|COMPLETED|Overall Study||44
241901|NCT00951483|587238|P1|COMPLETED|Overall Study||28
241902|NCT00951483|587237|P2|STARTED|Overall Study||44
241903|NCT00951483|587238|P1|STARTED|Overall Study||47
241904|NCT00951509|587256|P1|NOT COMPLETED|Overall Study||2
241905|NCT00951509|587256|P1|COMPLETED|Overall Study||29
241906|NCT00951509|587256|P1|Driving Condition 5|Overall Study||30
241907|NCT00951509|587256|P1|Driving Condition 4|Overall Study||28
241908|NCT00951509|587256|P1|Driving Condition 3|Overall Study||25
241909|NCT00951509|587256|P1|Driving Condition 2|Overall Study||29
241910|NCT00951509|587256|P1|Driving Condition 1|Overall Study||29
241911|NCT00951509|587256|P1|STARTED|Overall Study||31
241912|NCT00951561|587264|P4|NOT COMPLETED|Overall Study||1
241913|NCT00951561|587265|P3|NOT COMPLETED|Overall Study||3
241914|NCT00951561|587266|P2|NOT COMPLETED|Overall Study||0
241915|NCT00951561|587267|P1|NOT COMPLETED|Overall Study||0
241916|NCT00951561|587264|P4|COMPLETED|Overall Study|1 subject dropped after period 2|26
241917|NCT00951561|587265|P3|COMPLETED|Overall Study|3 subjects dropped after period 2|18
241918|NCT00951561|587266|P2|COMPLETED|Overall Study||29
241919|NCT00951561|587267|P1|COMPLETED|Overall Study||25
241920|NCT00951561|587264|P4|STARTED|Overall Study||27
241921|NCT00951561|587265|P3|STARTED|Overall Study|1 subject used Vipon periods 1 & 2 instead of Ibuprofen period 2.|21
241922|NCT00951561|587266|P2|STARTED|Overall Study||29
241923|NCT00951561|587267|P1|STARTED|Overall Study|Randomized Vipon or Ibuprofen period 1, crossover period 2, randomized period 3, crossover period 4|25
241924|NCT00951665|587278|P6|NOT COMPLETED|Phase 2a||7
241925|NCT00951665|587279|P5|NOT COMPLETED|Phase 2a||12
241926|NCT00951665|587280|P4|NOT COMPLETED|Phase 2a||0
241927|NCT00951665|587281|P3|NOT COMPLETED|Phase 2a||0
241928|NCT00951665|587282|P2|NOT COMPLETED|Phase 2a||0
241929|NCT00951665|587283|P1|NOT COMPLETED|Phase 2a||0
241930|NCT00951665|587278|P6|COMPLETED|Phase 2a||15
241931|NCT00951665|587279|P5|COMPLETED|Phase 2a||10
241932|NCT00951665|587280|P4|COMPLETED|Phase 2a||0
241933|NCT00951665|587281|P3|COMPLETED|Phase 2a||0
241934|NCT00951665|587282|P2|COMPLETED|Phase 2a||0
241935|NCT00951665|587283|P1|COMPLETED|Phase 2a||0
241936|NCT00951665|587278|P6|STARTED|Phase 2a||22
241937|NCT00951665|587279|P5|STARTED|Phase 2a||22
241938|NCT00951665|587280|P4|STARTED|Phase 2a||0
241939|NCT00951665|587281|P3|STARTED|Phase 2a||0
241940|NCT00951665|587282|P2|STARTED|Phase 2a||0
241941|NCT00951665|587283|P1|STARTED|Phase 2a||0
241942|NCT00951665|587278|P6|NOT COMPLETED|Phase 1b||0
241943|NCT00951665|587279|P5|NOT COMPLETED|Phase 1b||0
241945|NCT00951665|587281|P3|NOT COMPLETED|Phase 1b||17
241946|NCT00951665|587282|P2|NOT COMPLETED|Phase 1b||4
241947|NCT00951665|587283|P1|NOT COMPLETED|Phase 1b||22
241948|NCT00951665|587278|P6|COMPLETED|Phase 1b||0
241949|NCT00951665|587279|P5|COMPLETED|Phase 1b||0
241950|NCT00951665|587280|P4|COMPLETED|Phase 1b||2
241951|NCT00951665|587281|P3|COMPLETED|Phase 1b||4
241952|NCT00951665|587282|P2|COMPLETED|Phase 1b||6
241953|NCT00951665|587283|P1|COMPLETED|Phase 1b||7
241954|NCT00951665|587278|P6|Started Treatment|Phase 1b||0
241955|NCT00951665|587279|P5|Started Treatment|Phase 1b||0
241956|NCT00951665|587280|P4|Started Treatment|Phase 1b||3
241957|NCT00951665|587281|P3|Started Treatment|Phase 1b||21
241958|NCT00951665|587282|P2|Started Treatment|Phase 1b||10
241959|NCT00951665|587283|P1|Started Treatment|Phase 1b||26
241960|NCT00951665|587278|P6|STARTED|Phase 1b||0
241961|NCT00951665|587279|P5|STARTED|Phase 1b||0
241962|NCT00951665|587280|P4|STARTED|Phase 1b||3
241963|NCT00951665|587281|P3|STARTED|Phase 1b||21
241964|NCT00951665|587282|P2|STARTED|Phase 1b||10
241965|NCT00951665|587283|P1|STARTED|Phase 1b||29
241966|NCT00951808|587384|P3|NOT COMPLETED|Overall Study||4
241967|NCT00951808|587385|P2|NOT COMPLETED|Overall Study||0
241968|NCT00951808|587386|P1|NOT COMPLETED|Overall Study||0
241969|NCT00951808|587384|P3|COMPLETED|Overall Study|Four subjects withdrew from the study.|223
241970|NCT00951808|587385|P2|COMPLETED|Overall Study||6
241971|NCT00951808|587386|P1|COMPLETED|Overall Study||4
241972|NCT00951808|587384|P3|STARTED|Overall Study||227
241973|NCT00951808|587385|P2|STARTED|Overall Study||6
241974|NCT00951808|587386|P1|STARTED|Overall Study||4
241975|NCT00951821|587394|P2|NOT COMPLETED|Overall Study||0
241976|NCT00951821|587395|P1|NOT COMPLETED|Overall Study||0
241977|NCT00951821|587394|P2|COMPLETED|Overall Study||8
241979|NCT00951821|587394|P2|STARTED|Overall Study||8
241980|NCT00951821|587395|P1|STARTED|Overall Study||16
241981|NCT00951899|587405|P2|NOT COMPLETED|Overall Study||0
241982|NCT00951899|587406|P1|NOT COMPLETED|Overall Study||0
241983|NCT00951899|587405|P2|COMPLETED|Overall Study||19
241984|NCT00951899|587406|P1|COMPLETED|Overall Study||19
241985|NCT00951899|587405|P2|STARTED|Overall Study||19
241986|NCT00951899|587406|P1|STARTED|Overall Study||19
241987|NCT00951912|587431|P3|NOT COMPLETED|Overall Study||2
241988|NCT00951912|587432|P2|NOT COMPLETED|Overall Study||5
241989|NCT00951912|587433|P1|NOT COMPLETED|Overall Study||7
241990|NCT00951912|587431|P3|COMPLETED|Overall Study||54
241991|NCT00951912|587432|P2|COMPLETED|Overall Study||50
241992|NCT00951912|587433|P1|COMPLETED|Overall Study||47
241993|NCT00951912|587431|P3|STARTED|Overall Study||56
241994|NCT00951912|587432|P2|STARTED|Overall Study||55
241995|NCT00951912|587433|P1|STARTED|Overall Study||54
241996|NCT00952068|587483|P1|NOT COMPLETED|Overall Study||7
241997|NCT00952068|587483|P1|COMPLETED|Overall Study||40
241998|NCT00952068|587483|P1|STARTED|Overall Study||47
241999|NCT00952081|587491|P1|NOT COMPLETED|Overall Study||0
242000|NCT00952081|587491|P1|COMPLETED|Overall Study||22
242001|NCT00952081|587491|P1|STARTED|Overall Study||22
242002|NCT00952120|587498|P3|NOT COMPLETED|Overall Study||0
242003|NCT00952120|587499|P2|NOT COMPLETED|Overall Study||0
242004|NCT00952120|587500|P1|NOT COMPLETED|Overall Study||0
242005|NCT00952120|587498|P3|COMPLETED|Overall Study||5
242006|NCT00952120|587499|P2|COMPLETED|Overall Study||47
242007|NCT00952120|587500|P1|COMPLETED|Overall Study||52
242008|NCT00952120|587498|P3|STARTED|Overall Study||5
242009|NCT00952120|587499|P2|STARTED|Overall Study||47
242010|NCT00952120|587500|P1|STARTED|Overall Study||52
242011|NCT00952133|587510|P2|NOT COMPLETED|Overall Study||0
242012|NCT00952133|587511|P1|NOT COMPLETED|Overall Study||0
242013|NCT00952133|587510|P2|COMPLETED|Overall Study||59
242014|NCT00952133|587511|P1|COMPLETED|Overall Study||59
242015|NCT00952133|587510|P2|STARTED|Overall Study||59
242016|NCT00952133|587511|P1|STARTED|Overall Study||59
242017|NCT00952211|587521|P2|NOT COMPLETED|Overall Study||0
242018|NCT00952211|587522|P1|NOT COMPLETED|Overall Study||0
242019|NCT00952211|587521|P2|COMPLETED|Overall Study||0
242020|NCT00952211|587522|P1|COMPLETED|Overall Study||3
242021|NCT00952211|587521|P2|STARTED|Overall Study||0
242022|NCT00952211|587522|P1|STARTED|Overall Study||3
242023|NCT00952276|587535|P5|NOT COMPLETED|Overall Study||0
242024|NCT00952276|587536|P4|NOT COMPLETED|Overall Study||1
242025|NCT00952276|587537|P3|NOT COMPLETED|Overall Study||0
242026|NCT00952276|587538|P2|NOT COMPLETED|Overall Study||0
242027|NCT00952276|587539|P1|NOT COMPLETED|Overall Study||1
242028|NCT00952276|587535|P5|COMPLETED|Overall Study||63
242029|NCT00952276|587536|P4|COMPLETED|Overall Study||120
242030|NCT00952276|587537|P3|COMPLETED|Overall Study||122
242031|NCT00952276|587538|P2|COMPLETED|Overall Study||115
242032|NCT00952276|587539|P1|COMPLETED|Overall Study||126
242033|NCT00952276|587535|P5|STARTED|Overall Study||63
242034|NCT00952276|587536|P4|STARTED|Overall Study||121
242035|NCT00952276|587537|P3|STARTED|Overall Study||122
242036|NCT00952276|587538|P2|STARTED|Overall Study||115
242037|NCT00952276|587539|P1|STARTED|Overall Study||127
242038|NCT00952289|587588|P2|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||54
242039|NCT00952289|587589|P1|NOT COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
242119|NCT00958828|587771|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
242040|NCT00952289|587588|P2|COMPLETED|Patients Who Crossed Over to Ruxolitinib|Number of cross over subjects who were still in the study as of 25 JAN 2013|57
242041|NCT00952289|587589|P1|COMPLETED|Patients Who Crossed Over to Ruxolitinib||0
242042|NCT00952289|587588|P2|STARTED|Patients Who Crossed Over to Ruxolitinib||111
242043|NCT00952289|587589|P1|STARTED|Patients Who Crossed Over to Ruxolitinib||0
242044|NCT00952289|587588|P2|NOT COMPLETED|All Participants||40
242045|NCT00952289|587589|P1|NOT COMPLETED|All Participants||21
242046|NCT00952289|587588|P2|COMPLETED|All Participants|Includes patients in the study as of 2 November 2010 (78) + those who crossed over to Ruxolitinib.|114
242047|NCT00952289|587589|P1|COMPLETED|All Participants|Represents the number of patients who were still in the study as of 02 November 2010|134
242048|NCT00952289|587588|P2|Safety Population|All Participants|Randomized patients who are documented to have received at least 1 dose of study medication.|151
242049|NCT00952289|587589|P1|Safety Population|All Participants||155
242050|NCT00952289|587588|P2|STARTED|All Participants||154
242051|NCT00952289|587589|P1|STARTED|All Participants||155
242052|NCT00952341|587615|P2|NOT COMPLETED|Cycle 2||12
242053|NCT00952341|587616|P1|NOT COMPLETED|Cycle 2||9
242054|NCT00952341|587615|P2|COMPLETED|Cycle 2||118
242055|NCT00952341|587616|P1|COMPLETED|Cycle 2||101
242056|NCT00952341|587615|P2|STARTED|Cycle 2||130
242057|NCT00952341|587616|P1|STARTED|Cycle 2||110
242058|NCT00952341|587615|P2|NOT COMPLETED|Cycle 1||13
242059|NCT00952341|587616|P1|NOT COMPLETED|Cycle 1||20
242060|NCT00952341|587615|P2|COMPLETED|Cycle 1||199
242061|NCT00952341|587616|P1|COMPLETED|Cycle 1||189
242062|NCT00952341|587615|P2|STARTED|Cycle 1||212
242063|NCT00952341|587616|P1|STARTED|Cycle 1||209
242064|NCT00952367|587636|P1|NOT COMPLETED|Overall Study||6
242065|NCT00952367|587636|P1|COMPLETED|Overall Study||3635
242066|NCT00952367|587636|P1|STARTED|Overall Study||3641
242067|NCT00958568|587649|P4|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||106
242068|NCT00958568|587650|P3|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||82
242069|NCT00958568|587651|P2|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
242070|NCT00958568|587652|P1|NOT COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
242071|NCT00958568|587649|P4|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||117
242072|NCT00958568|587650|P3|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||139
242073|NCT00958568|587651|P2|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
242074|NCT00958568|587652|P1|COMPLETED|SPIV (Wk 21-47, DB Relapse Prevention)||0
242075|NCT00958568|587649|P4|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||223
242076|NCT00958568|587650|P3|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||221
242077|NCT00958568|587651|P2|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
242078|NCT00958568|587652|P1|STARTED|SPIV (Wk 21-47, DB Relapse Prevention)||0
242079|NCT00958568|587649|P4|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
242080|NCT00958568|587650|P3|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
242081|NCT00958568|587651|P2|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||211
242082|NCT00958568|587652|P1|NOT COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
242083|NCT00958568|587649|P4|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
242084|NCT00958568|587650|P3|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
242085|NCT00958568|587651|P2|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||444
242086|NCT00958568|587652|P1|COMPLETED|SPIII (Wk 9-20,Open-label Stabilization)||0
242087|NCT00958568|587649|P4|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
242088|NCT00958568|587650|P3|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
242089|NCT00958568|587651|P2|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||655
242090|NCT00958568|587652|P1|STARTED|SPIII (Wk 9-20,Open-label Stabilization)||0
242091|NCT00958568|587649|P4|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
242092|NCT00958568|587650|P3|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
242093|NCT00958568|587651|P2|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
242094|NCT00958568|587652|P1|NOT COMPLETED|SPII (Wk 0-8, Acute Open-label)||237
242095|NCT00958568|587649|P4|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
242096|NCT00958568|587650|P3|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
242097|NCT00958568|587651|P2|COMPLETED|SPII (Wk 0-8, Acute Open-label)||0
242098|NCT00958568|587652|P1|COMPLETED|SPII (Wk 0-8, Acute Open-label)||655
242099|NCT00958568|587649|P4|STARTED|SPII (Wk 0-8, Acute Open-label)||0
242100|NCT00958568|587650|P3|STARTED|SPII (Wk 0-8, Acute Open-label)||0
242101|NCT00958568|587651|P2|STARTED|SPII (Wk 0-8, Acute Open-label)||0
242102|NCT00958568|587652|P1|STARTED|SPII (Wk 0-8, Acute Open-label)||892
242103|NCT00958776|587735|P2|NOT COMPLETED|Overall Study||29
242104|NCT00958776|587736|P1|NOT COMPLETED|Overall Study||16
242105|NCT00958776|587735|P2|COMPLETED|Overall Study||239
242106|NCT00958776|587736|P1|COMPLETED|Overall Study||121
242107|NCT00958776|587735|P2|STARTED|Overall Study||268
242108|NCT00958776|587736|P1|STARTED|Overall Study||137
242109|NCT00958789|587766|P1|NOT COMPLETED|Overall Study||51
242110|NCT00958789|587766|P1|COMPLETED|Overall Study|Participant status at the 2 year primary outcome interval determined Completed/Not Completed counts.|130
242111|NCT00958789|587766|P1|STARTED|Overall Study||181
242112|NCT00958828|587770|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
242113|NCT00958828|587771|P1|NOT COMPLETED|Period 2, 1 Week of Wear||0
242114|NCT00958828|587770|P2|COMPLETED|Period 2, 1 Week of Wear||87
242115|NCT00958828|587771|P1|COMPLETED|Period 2, 1 Week of Wear||89
242116|NCT00958828|587770|P2|STARTED|Period 2, 1 Week of Wear||88
242117|NCT00958828|587771|P1|STARTED|Period 2, 1 Week of Wear||89
242118|NCT00958828|587770|P2|NOT COMPLETED|Period 1, 1 Week of Wear||1
242120|NCT00958828|587770|P2|COMPLETED|Period 1, 1 Week of Wear||88
242121|NCT00958828|587771|P1|COMPLETED|Period 1, 1 Week of Wear||89
242122|NCT00958828|587770|P2|STARTED|Period 1, 1 Week of Wear||89
242123|NCT00958828|587771|P1|STARTED|Period 1, 1 Week of Wear||89
242124|NCT00958841|587777|P1|NOT COMPLETED|Overall Study||96
242125|NCT00958841|587777|P1|COMPLETED|Overall Study|Completed = Completed extension|22
242126|NCT00958841|587777|P1|Entered in Extension|Overall Study||63
242127|NCT00958841|587777|P1|Completed Month 6 (M6)|Overall Study||90
242128|NCT00958841|587777|P1|STARTED|Overall Study||118
242129|NCT00958880|587797|P2|NOT COMPLETED|Overall Study||2
242130|NCT00958880|587798|P1|NOT COMPLETED|Overall Study||2
242131|NCT00958880|587797|P2|COMPLETED|Overall Study||18
242132|NCT00958880|587798|P1|COMPLETED|Overall Study||18
242133|NCT00958880|587797|P2|STARTED|Overall Study||20
242134|NCT00958880|587798|P1|STARTED|Overall Study||20
242135|NCT00958893|587806|P1|NOT COMPLETED|Overall Study||4
242136|NCT00958893|587806|P1|COMPLETED|Overall Study||0
242137|NCT00958893|587806|P1|STARTED|Overall Study||4
242138|NCT00962741|587810|P1|NOT COMPLETED|Overall Study||8
242139|NCT00962741|587810|P1|COMPLETED|Overall Study||119
242140|NCT00962741|587810|P1|STARTED|Overall Study||127
242141|NCT00962754|587903|P2|NOT COMPLETED|Overall Study||0
242142|NCT00962754|587904|P1|NOT COMPLETED|Overall Study||0
242143|NCT00962754|587903|P2|COMPLETED|Overall Study||84
242144|NCT00962754|587904|P1|COMPLETED|Overall Study||86
242145|NCT00962754|587903|P2|STARTED|Overall Study||84
242146|NCT00962754|587904|P1|STARTED|Overall Study||86
242147|NCT00962780|587916|P2|NOT COMPLETED|Overall Study||14
242148|NCT00962780|587917|P1|NOT COMPLETED|Overall Study||10
242149|NCT00962780|587916|P2|COMPLETED|Overall Study||138
242150|NCT00962780|587917|P1|COMPLETED|Overall Study||141
242151|NCT00962780|587916|P2|Vaccinated 23vPS Dose|Overall Study||139
242152|NCT00962780|587917|P1|Vaccinated 23vPS Dose|Overall Study||143
242153|NCT00962780|587916|P2|Vaccinated 13vPnC Dose 3|Overall Study||142
242154|NCT00962780|587917|P1|Vaccinated 13vPnC Dose 3|Overall Study||144
242155|NCT00962780|587916|P2|Vaccinated 13vPnC Dose 2|Overall Study||145
242156|NCT00962780|587917|P1|Vaccinated 13vPnC Dose 2|Overall Study||145
242157|NCT00962780|587916|P2|Vaccinated 13vPnC Dose 1|Overall Study||151
242158|NCT00962780|587917|P1|Vaccinated 13vPnC Dose 1|Overall Study||150
242159|NCT00962780|587916|P2|STARTED|Overall Study||152
242160|NCT00962780|587917|P1|STARTED|Overall Study||151
242161|NCT00962871|587983|P4|NOT COMPLETED|Overall Study||0
242162|NCT00962871|587984|P3|NOT COMPLETED|Overall Study||0
242163|NCT00962871|587985|P2|NOT COMPLETED|Overall Study||0
242164|NCT00962871|587986|P1|NOT COMPLETED|Overall Study||0
242165|NCT00962871|587983|P4|COMPLETED|Overall Study||6
242166|NCT00962871|587984|P3|COMPLETED|Overall Study||12
242167|NCT00962871|587985|P2|COMPLETED|Overall Study||6
242168|NCT00962871|587986|P1|COMPLETED|Overall Study||6
242169|NCT00962871|587983|P4|STARTED|Overall Study||6
242170|NCT00962871|587984|P3|STARTED|Overall Study||12
242171|NCT00962871|587985|P2|STARTED|Overall Study||6
242172|NCT00962871|587986|P1|STARTED|Overall Study||6
242173|NCT00963157|588005|P5|NOT COMPLETED|Overall Study||2
242174|NCT00963157|588006|P4|NOT COMPLETED|Overall Study||7
242175|NCT00963157|588007|P3|NOT COMPLETED|Overall Study||5
242176|NCT00963157|588008|P2|NOT COMPLETED|Overall Study||4
242177|NCT00963157|588009|P1|NOT COMPLETED|Overall Study||5
242178|NCT00963157|588005|P5|COMPLETED|Overall Study||151
242179|NCT00963157|588006|P4|COMPLETED|Overall Study||150
242180|NCT00963157|588007|P3|COMPLETED|Overall Study||155
242181|NCT00963157|588008|P2|COMPLETED|Overall Study||159
242182|NCT00963157|588009|P1|COMPLETED|Overall Study||151
242183|NCT00963157|588005|P5|STARTED|Overall Study||153
242184|NCT00963157|588006|P4|STARTED|Overall Study||157
242185|NCT00963157|588007|P3|STARTED|Overall Study||160
242186|NCT00963157|588008|P2|STARTED|Overall Study||163
242187|NCT00963157|588009|P1|STARTED|Overall Study||156
242188|NCT00963235|588201|P1|NOT COMPLETED|Overall Study||60
242189|NCT00963235|588201|P1|COMPLETED|Overall Study||271
242190|NCT00963235|588201|P1|Completed Dose 3 1-month Blood Draw|Overall Study||277
242191|NCT00963235|588201|P1|Vaccinated Dose 3|Overall Study||279
242192|NCT00963235|588201|P1|Vaccinated Dose 2|Overall Study||300
242193|NCT00963235|588201|P1|Vaccinated Dose 1|Overall Study||329
242194|NCT00963235|588201|P1|STARTED|Overall Study||331
242195|NCT00963430|588222|P2|NOT COMPLETED|Overall Study||3
242196|NCT00963430|588223|P1|NOT COMPLETED|Overall Study||1
242197|NCT00963430|588222|P2|COMPLETED|Overall Study||57
242198|NCT00963430|588223|P1|COMPLETED|Overall Study||59
242199|NCT00963430|588222|P2|STARTED|Overall Study||60
242200|NCT00963430|588223|P1|STARTED|Overall Study||60
242201|NCT00963469|588264|P3|NOT COMPLETED|Overall Study||10
242202|NCT00963469|588265|P2|NOT COMPLETED|Overall Study||28
242203|NCT00963469|588266|P1|NOT COMPLETED|Overall Study||41
242204|NCT00963469|588264|P3|COMPLETED|Overall Study||170
242205|NCT00963469|588265|P2|COMPLETED|Overall Study||420
242206|NCT00963469|588266|P1|COMPLETED|Overall Study||410
242207|NCT00963469|588264|P3|STARTED|Overall Study||180
242208|NCT00963469|588265|P2|STARTED|Overall Study||448
242209|NCT00963469|588266|P1|STARTED|Overall Study||451
242210|NCT00963482|588294|P2|NOT COMPLETED|Overall Study||17
242211|NCT00963482|588295|P1|NOT COMPLETED|Overall Study||28
242212|NCT00963482|588294|P2|COMPLETED|Overall Study||33
242213|NCT00963482|588295|P1|COMPLETED|Overall Study||25
242214|NCT00963482|588294|P2|STARTED|Overall Study||50
242215|NCT00963482|588295|P1|STARTED|Overall Study||53
242216|NCT00963508|588303|P2|NOT COMPLETED|Overall Study||28
242217|NCT00963508|588304|P1|NOT COMPLETED|Overall Study||10
242218|NCT00963508|588303|P2|COMPLETED|Overall Study||169
242219|NCT00963508|588304|P1|COMPLETED|Overall Study||196
242220|NCT00963508|588303|P2|STARTED|Overall Study||197
242221|NCT00963508|588304|P1|STARTED|Overall Study||206
242222|NCT00963560|588315|P3|NOT COMPLETED|Overall Study||0
242223|NCT00963560|588316|P2|NOT COMPLETED|Overall Study||3
242224|NCT00963560|588317|P1|NOT COMPLETED|Overall Study||3
242225|NCT00963560|588315|P3|COMPLETED|Overall Study||41
242226|NCT00963560|588316|P2|COMPLETED|Overall Study||41
242227|NCT00963560|588317|P1|COMPLETED|Overall Study||44
242228|NCT00963560|588315|P3|STARTED|Overall Study||41
242229|NCT00963560|588316|P2|STARTED|Overall Study||44
242230|NCT00963560|588317|P1|STARTED|Overall Study||47
242231|NCT00963599|588329|P4|NOT COMPLETED|Overall Study||14
242232|NCT00963599|588330|P3|NOT COMPLETED|Overall Study||9
242233|NCT00963599|588331|P2|NOT COMPLETED|Overall Study||6
242234|NCT00963599|588332|P1|NOT COMPLETED|Overall Study||6
242235|NCT00963599|588329|P4|COMPLETED|Overall Study||288
242236|NCT00963599|588330|P3|COMPLETED|Overall Study||292
242237|NCT00963599|588331|P2|COMPLETED|Overall Study||149
242238|NCT00963599|588332|P1|COMPLETED|Overall Study||143
242239|NCT00963599|588329|P4|STARTED|Overall Study||302
242240|NCT00963599|588330|P3|STARTED|Overall Study||301
242241|NCT00963599|588331|P2|STARTED|Overall Study||155
242242|NCT00963599|588332|P1|STARTED|Overall Study||149
242243|NCT00963638|588388|P2|NOT COMPLETED|Overall Study||0
242244|NCT00963638|588389|P1|NOT COMPLETED|Overall Study||0
242245|NCT00963638|588388|P2|COMPLETED|Overall Study||20
242246|NCT00963638|588389|P1|COMPLETED|Overall Study||20
242247|NCT00963638|588388|P2|STARTED|Overall Study||20
242248|NCT00963638|588389|P1|STARTED|Overall Study||20
242249|NCT00963677|588397|P2|NOT COMPLETED|Overall Study||2
242250|NCT00963677|588398|P1|NOT COMPLETED|Overall Study||0
242251|NCT00963677|588397|P2|COMPLETED|Overall Study|Two patients were excluded from the study due to the difficult ventilation with facemask ventilation|18
242252|NCT00963677|588398|P1|COMPLETED|Overall Study||35
242253|NCT00963677|588397|P2|STARTED|Overall Study|Patients with predicted difficult intubation but not ventilation|20
242254|NCT00963677|588398|P1|STARTED|Overall Study|Patients without predicted difficult intubation|35
242255|NCT00963807|588406|P1|NOT COMPLETED|Overall Study||18
242256|NCT00963807|588406|P1|COMPLETED|Overall Study||8
242257|NCT00963807|588406|P1|Completed Post-Cycle 2 FDG Imaging|Overall Study||8
242258|NCT00963807|588406|P1|Completed Post-Cycle 2 FLT Imaging|Overall Study||9
242259|NCT00963807|588406|P1|Completed Post-Cycle 1 Imaging|Overall Study||9
242260|NCT00963807|588406|P1|Completed Baseline Imaging|Overall Study||11
242261|NCT00963807|588406|P1|STARTED|Overall Study||26
242262|NCT00963820|588415|P12|NOT COMPLETED|Expansion Phase||4
242263|NCT00963820|588416|P11|NOT COMPLETED|Expansion Phase||5
242264|NCT00963820|588417|P10|NOT COMPLETED|Expansion Phase||9
242265|NCT00963820|588418|P9|NOT COMPLETED|Expansion Phase||10
242266|NCT00963820|588419|P8|NOT COMPLETED|Expansion Phase||0
242267|NCT00963820|588420|P7|NOT COMPLETED|Expansion Phase||0
242268|NCT00963820|588421|P6|NOT COMPLETED|Expansion Phase||0
242269|NCT00963820|588422|P5|NOT COMPLETED|Expansion Phase||0
242270|NCT00963820|588423|P4|NOT COMPLETED|Expansion Phase||0
242271|NCT00963820|588424|P3|NOT COMPLETED|Expansion Phase||0
242272|NCT00963820|588425|P2|NOT COMPLETED|Expansion Phase||0
242273|NCT00963820|588426|P1|NOT COMPLETED|Expansion Phase||0
242274|NCT00963820|588415|P12|COMPLETED|Expansion Phase||0
242275|NCT00963820|588416|P11|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
242276|NCT00963820|588417|P10|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
242277|NCT00963820|588418|P9|COMPLETED|Expansion Phase|Participant was ongoing at the time of data cut off for analysis|1
242278|NCT00963820|588419|P8|COMPLETED|Expansion Phase||0
242279|NCT00963820|588420|P7|COMPLETED|Expansion Phase||0
242280|NCT00963820|588421|P6|COMPLETED|Expansion Phase||0
242281|NCT00963820|588422|P5|COMPLETED|Expansion Phase||0
242282|NCT00963820|588423|P4|COMPLETED|Expansion Phase||0
242283|NCT00963820|588424|P3|COMPLETED|Expansion Phase||0
242284|NCT00963820|588425|P2|COMPLETED|Expansion Phase||0
242285|NCT00963820|588426|P1|COMPLETED|Expansion Phase||0
242286|NCT00963820|588415|P12|STARTED|Expansion Phase|Includes participants with last dose of carfilzomib 21 to 60 days before 1st ixazomib citrate dose.|4
242287|NCT00963820|588416|P11|STARTED|Expansion Phase|Includes only participants who are proteasome inhibitor (PI)-naïve.|6
242288|NCT00963820|588417|P10|STARTED|Expansion Phase|Includes 1 participant from the dose escalation cohort 2.97 mg/m^2.|10
242289|NCT00963820|588418|P9|STARTED|Expansion Phase|Includes 2 participants from the dose escalation cohort 2.97 mg/m^2.|11
242290|NCT00963820|588419|P8|STARTED|Expansion Phase||0
242291|NCT00963820|588420|P7|STARTED|Expansion Phase||0
242292|NCT00963820|588421|P6|STARTED|Expansion Phase||0
242293|NCT00963820|588422|P5|STARTED|Expansion Phase||0
242294|NCT00963820|588423|P4|STARTED|Expansion Phase||0
242295|NCT00963820|588424|P3|STARTED|Expansion Phase||0
242296|NCT00963820|588425|P2|STARTED|Expansion Phase||0
242297|NCT00963820|588426|P1|STARTED|Expansion Phase|Dose escalation cohorts were not part of the Expansion Phase except as noted in comments.|0
242298|NCT00963820|588415|P12|NOT COMPLETED|Dose Escalation Phase||0
242299|NCT00963820|588416|P11|NOT COMPLETED|Dose Escalation Phase||0
242300|NCT00963820|588417|P10|NOT COMPLETED|Dose Escalation Phase||0
242301|NCT00963820|588418|P9|NOT COMPLETED|Dose Escalation Phase||0
242302|NCT00963820|588419|P8|NOT COMPLETED|Dose Escalation Phase||5
242303|NCT00963820|588420|P7|NOT COMPLETED|Dose Escalation Phase||8
242304|NCT00963820|588421|P6|NOT COMPLETED|Dose Escalation Phase||3
242305|NCT00963820|588422|P5|NOT COMPLETED|Dose Escalation Phase||4
242306|NCT00963820|588423|P4|NOT COMPLETED|Dose Escalation Phase||3
242307|NCT00963820|588424|P3|NOT COMPLETED|Dose Escalation Phase||3
242308|NCT00963820|588425|P2|NOT COMPLETED|Dose Escalation Phase||3
242309|NCT00963820|588426|P1|NOT COMPLETED|Dose Escalation Phase||3
242310|NCT00963820|588415|P12|COMPLETED|Dose Escalation Phase||0
242311|NCT00963820|588416|P11|COMPLETED|Dose Escalation Phase||0
242312|NCT00963820|588417|P10|COMPLETED|Dose Escalation Phase||0
242313|NCT00963820|588418|P9|COMPLETED|Dose Escalation Phase||0
242314|NCT00963820|588419|P8|COMPLETED|Dose Escalation Phase||0
242315|NCT00963820|588420|P7|COMPLETED|Dose Escalation Phase||0
242316|NCT00963820|588421|P6|COMPLETED|Dose Escalation Phase||0
242317|NCT00963820|588422|P5|COMPLETED|Dose Escalation Phase||0
242318|NCT00963820|588423|P4|COMPLETED|Dose Escalation Phase||0
242319|NCT00963820|588424|P3|COMPLETED|Dose Escalation Phase||0
242320|NCT00963820|588425|P2|COMPLETED|Dose Escalation Phase||0
242321|NCT00963820|588426|P1|COMPLETED|Dose Escalation Phase||0
242322|NCT00963820|588415|P12|STARTED|Dose Escalation Phase||0
242323|NCT00963820|588416|P11|STARTED|Dose Escalation Phase||0
242324|NCT00963820|588417|P10|STARTED|Dose Escalation Phase||0
242325|NCT00963820|588418|P9|STARTED|Dose Escalation Phase|Expansion cohorts were not part of Dose Escalation except as noted in comments.|0
242326|NCT00963820|588419|P8|STARTED|Dose Escalation Phase||5
242327|NCT00963820|588420|P7|STARTED|Dose Escalation Phase||8
242328|NCT00963820|588421|P6|STARTED|Dose Escalation Phase||3
242329|NCT00963820|588422|P5|STARTED|Dose Escalation Phase||4
242330|NCT00963820|588423|P4|STARTED|Dose Escalation Phase||3
242331|NCT00963820|588424|P3|STARTED|Dose Escalation Phase||3
242332|NCT00963820|588425|P2|STARTED|Dose Escalation Phase||3
242333|NCT00963820|588426|P1|STARTED|Dose Escalation Phase||3
242334|NCT00963859|588562|P1|NOT COMPLETED|Overall Study||0
242335|NCT00963859|588562|P1|COMPLETED|Overall Study||11
242336|NCT00963859|588562|P1|STARTED|Overall Study||11
242337|NCT00963872|588569|P2|NOT COMPLETED|Overall Study||1
242338|NCT00963872|588570|P1|NOT COMPLETED|Overall Study||1
242339|NCT00963872|588569|P2|COMPLETED|Overall Study||5
242340|NCT00963872|588570|P1|COMPLETED|Overall Study||24
242341|NCT00963872|588569|P2|STARTED|Overall Study||6
242342|NCT00963872|588570|P1|STARTED|Overall Study||25
242343|NCT00963924|588616|P2|NOT COMPLETED|Overall Study||3
242344|NCT00963924|588617|P1|NOT COMPLETED|Overall Study||1
242345|NCT00963924|588616|P2|COMPLETED|Overall Study||15
242346|NCT00963924|588617|P1|COMPLETED|Overall Study||17
242347|NCT00963924|588616|P2|STARTED|Overall Study||18
242348|NCT00963924|588617|P1|STARTED|Overall Study||18
242349|NCT00963937|588636|P3|NOT COMPLETED|Overall Study||4
242350|NCT00963937|588637|P2|NOT COMPLETED|Overall Study||11
242351|NCT00963937|588638|P1|NOT COMPLETED|Overall Study||19
242352|NCT00963937|588636|P3|COMPLETED|Overall Study||41
242353|NCT00963937|588637|P2|COMPLETED|Overall Study||33
242354|NCT00963937|588638|P1|COMPLETED|Overall Study||70
242355|NCT00963937|588636|P3|STARTED|Overall Study||45
242356|NCT00963937|588637|P2|STARTED|Overall Study||44
242357|NCT00963937|588638|P1|STARTED|Overall Study||89
242358|NCT00964028|588676|P2|NOT COMPLETED|Overall Study||1
242359|NCT00964028|588677|P1|NOT COMPLETED|Overall Study||0
242360|NCT00964028|588676|P2|COMPLETED|Overall Study||24
242361|NCT00964028|588677|P1|COMPLETED|Overall Study||25
242362|NCT00964028|588676|P2|STARTED|Overall Study||25
242363|NCT00964028|588677|P1|STARTED|Overall Study||25
242364|NCT00964119|588689|P1|NOT COMPLETED|Overall Study||0
242365|NCT00964119|588689|P1|COMPLETED|Overall Study||15
242366|NCT00964119|588689|P1|STARTED|Overall Study||15
242367|NCT00964223|588693|P1|NOT COMPLETED|Full Face Treatment (Weeks 5 and 8)||1
242368|NCT00964223|588693|P1|COMPLETED|Full Face Treatment (Weeks 5 and 8)||27
242369|NCT00964223|588693|P1|STARTED|Full Face Treatment (Weeks 5 and 8)||28
242370|NCT00964223|588693|P1|NOT COMPLETED|Split Face Treatment (Weeks 1 and 2)||0
242371|NCT00964223|588693|P1|COMPLETED|Split Face Treatment (Weeks 1 and 2)||28
242372|NCT00964223|588693|P1|STARTED|Split Face Treatment (Weeks 1 and 2)||28
242373|NCT00964366|588760|P2|NOT COMPLETED|Overall Study||1
242374|NCT00964366|588761|P1|NOT COMPLETED|Overall Study||1
242375|NCT00964366|588760|P2|COMPLETED|Overall Study||24
242376|NCT00964366|588761|P1|COMPLETED|Overall Study||27
242377|NCT00964366|588760|P2|STARTED|Overall Study||25
242378|NCT00964366|588761|P1|STARTED|Overall Study|27 of the 28 enrolled were eligible after screening.|28
242379|NCT00964392|588777|P2|NOT COMPLETED|Overall Study||190
242380|NCT00964392|588778|P1|NOT COMPLETED|Overall Study||53
242381|NCT00964392|588777|P2|COMPLETED|Overall Study||92
242382|NCT00964392|588778|P1|COMPLETED|Overall Study||72
242383|NCT00964392|588777|P2|STARTED|Overall Study|Both safety and efficacy cohort: Total 292 (10 LEP Excluded)|282
242384|NCT00964392|588778|P1|STARTED|Overall Study|Both safety and efficacy cohort: Total 128 (3 MEP Excluded)|125
242385|NCT00964431|588790|P4|NOT COMPLETED|Overall Study||0
242386|NCT00964431|588791|P3|NOT COMPLETED|Overall Study||0
242387|NCT00964431|588792|P2|NOT COMPLETED|Overall Study||0
242388|NCT00964431|588793|P1|NOT COMPLETED|Overall Study||0
242389|NCT00964431|588790|P4|COMPLETED|Overall Study||51
242390|NCT00964431|588791|P3|COMPLETED|Overall Study||51
242391|NCT00964431|588792|P2|COMPLETED|Overall Study||51
242392|NCT00964431|588793|P1|COMPLETED|Overall Study||50
242393|NCT00964431|588790|P4|STARTED|Overall Study||51
242394|NCT00964431|588791|P3|STARTED|Overall Study||51
242395|NCT00964431|588792|P2|STARTED|Overall Study||51
242396|NCT00964431|588793|P1|STARTED|Overall Study||50
242397|NCT00964444|588803|P1|NOT COMPLETED|Overall Study||0
242398|NCT00964444|588803|P1|COMPLETED|Overall Study||10
242399|NCT00964444|588803|P1|STARTED|Overall Study||10
242400|NCT00964496|588809|P2|NOT COMPLETED|Overall Study||1
242401|NCT00964496|588810|P1|NOT COMPLETED|Overall Study||2
242402|NCT00964496|588809|P2|COMPLETED|Overall Study||26
242403|NCT00964496|588810|P1|COMPLETED|Overall Study||26
242404|NCT00964496|588809|P2|STARTED|Overall Study||27
242405|NCT00964496|588810|P1|STARTED|Overall Study||28
242406|NCT00964548|588830|P2|NOT COMPLETED|Overall Study||0
242407|NCT00964548|588831|P1|NOT COMPLETED|Overall Study||0
242408|NCT00964548|588830|P2|COMPLETED|Overall Study||5
242409|NCT00964548|588831|P1|COMPLETED|Overall Study||5
242410|NCT00964548|588830|P2|STARTED|Overall Study||5
242411|NCT00964548|588831|P1|STARTED|Overall Study||5
242412|NCT00964678|588841|P1|NOT COMPLETED|Overall Study||4
242413|NCT00964678|588841|P1|COMPLETED|Overall Study||6
242414|NCT00964678|588841|P1|STARTED|Overall Study||10
242415|NCT00964743|588848|P1|NOT COMPLETED|Overall Study||2
242416|NCT00964743|588848|P1|COMPLETED|Overall Study||0
242417|NCT00964743|588848|P1|STARTED|Overall Study||2
242418|NCT00964795|588856|P1|NOT COMPLETED|Overall Study||307
242419|NCT00964795|588856|P1|COMPLETED|Overall Study|Prior to amendment 4, 16 participants completed up to Week 120. No participants completed Week 180.|16
242420|NCT00964795|588856|P1|Number of Participants Treated|Overall Study||320
242421|NCT00964795|588856|P1|STARTED|Overall Study|randomized|323
242422|NCT00964860|588865|P2|NOT COMPLETED|Overall Study||1
242423|NCT00964860|588866|P1|NOT COMPLETED|Overall Study||0
242424|NCT00964860|588865|P2|COMPLETED|Overall Study||29
242425|NCT00964860|588866|P1|COMPLETED|Overall Study||30
242426|NCT00964860|588865|P2|STARTED|Overall Study||30
242427|NCT00964860|588866|P1|STARTED|Overall Study||30
242428|NCT00964886|588878|P4|NOT COMPLETED|Overall Study||9
242429|NCT00964886|588879|P3|NOT COMPLETED|Overall Study||16
242430|NCT00964886|588880|P2|NOT COMPLETED|Overall Study||7
242431|NCT00964886|588881|P1|NOT COMPLETED|Overall Study||11
242432|NCT00964886|588878|P4|COMPLETED|Overall Study||24
242433|NCT00964886|588879|P3|COMPLETED|Overall Study||21
242434|NCT00964886|588880|P2|COMPLETED|Overall Study||27
242435|NCT00964886|588881|P1|COMPLETED|Overall Study||27
242436|NCT00964886|588878|P4|STARTED|Overall Study||33
242437|NCT00964886|588879|P3|STARTED|Overall Study||37
242438|NCT00964886|588880|P2|STARTED|Overall Study||34
242439|NCT00964886|588881|P1|STARTED|Overall Study||38
242440|NCT00965081|588897|P2|NOT COMPLETED|Overall Study||43
242441|NCT00965081|588898|P1|NOT COMPLETED|Overall Study||34
242442|NCT00965081|588897|P2|COMPLETED|Overall Study||110
242443|NCT00965081|588898|P1|COMPLETED|Overall Study|In addition, 16/17 rescue participants completed study on protocol-specified study medication.|121
242444|NCT00965081|588897|P2|STARTED|Overall Study||153
242445|NCT00965081|588898|P1|STARTED|Overall Study|2 randomized participants had no post-baseline measures and are not included in outcome measures.|155
242446|NCT00965094|588923|P2|NOT COMPLETED|Overall Study||1
242447|NCT00965094|588924|P1|NOT COMPLETED|Overall Study||5
242448|NCT00965094|588923|P2|COMPLETED|Overall Study||16
242449|NCT00965094|588924|P1|COMPLETED|Overall Study||14
242450|NCT00965094|588923|P2|STARTED|Overall Study||17
242451|NCT00965094|588924|P1|STARTED|Overall Study||19
242452|NCT00965146|588938|P1|NOT COMPLETED|Overall Study||210
242453|NCT00965146|588938|P1|COMPLETED|Overall Study|Study was terminated prior to reaching 15 year endpoint.|0
242454|NCT00965146|588938|P1|STARTED|Overall Study||210
242455|NCT00965185|588944|P2|NOT COMPLETED|Overall Study||1
242456|NCT00965185|588945|P1|NOT COMPLETED|Overall Study||2
242457|NCT00965185|588944|P2|COMPLETED|Overall Study||20
242458|NCT00965185|588945|P1|COMPLETED|Overall Study||17
242459|NCT00965185|588944|P2|9 Month Visit|Overall Study||21
242460|NCT00965185|588945|P1|9 Month Visit|Overall Study||18
242461|NCT00965185|588944|P2|6 Month Visit|Overall Study||21
242462|NCT00965185|588945|P1|6 Month Visit|Overall Study||18
242463|NCT00965185|588944|P2|3 Month Visit|Overall Study||21
242464|NCT00965185|588945|P1|3 Month Visit|Overall Study||18
242465|NCT00965185|588944|P2|1 Month Visit|Overall Study||21
242466|NCT00965185|588945|P1|1 Month Visit|Overall Study||18
242467|NCT00965185|588944|P2|STARTED|Overall Study||21
242468|NCT00965185|588945|P1|STARTED|Overall Study||19
242469|NCT00965237|588961|P2|NOT COMPLETED|Period 2, One Week of Wear||0
242470|NCT00965237|588962|P1|NOT COMPLETED|Period 2, One Week of Wear||0
242471|NCT00965237|588961|P2|COMPLETED|Period 2, One Week of Wear||8
242472|NCT00965237|588962|P1|COMPLETED|Period 2, One Week of Wear||8
242473|NCT00965237|588961|P2|STARTED|Period 2, One Week of Wear||8
242474|NCT00965237|588962|P1|STARTED|Period 2, One Week of Wear||8
242475|NCT00965237|588961|P2|NOT COMPLETED|Period 1, One Week of Wear||0
242476|NCT00965237|588962|P1|NOT COMPLETED|Period 1, One Week of Wear||0
242477|NCT00965237|588961|P2|COMPLETED|Period 1, One Week of Wear||8
242478|NCT00965237|588962|P1|COMPLETED|Period 1, One Week of Wear||8
242479|NCT00965237|588961|P2|STARTED|Period 1, One Week of Wear||8
242480|NCT00965237|588962|P1|STARTED|Period 1, One Week of Wear||8
242481|NCT00965250|588970|P2|NOT COMPLETED|Overall Study||0
242482|NCT00965250|588971|P1|NOT COMPLETED|Overall Study||0
242483|NCT00965250|588970|P2|COMPLETED|Overall Study||12
242484|NCT00965250|588971|P1|COMPLETED|Overall Study||37
242485|NCT00965250|588970|P2|STARTED|Overall Study||12
242486|NCT00965250|588971|P1|STARTED|Overall Study||37
242487|NCT00955266|588991|P2|NOT COMPLETED|Overall Study||0
242488|NCT00955266|588992|P1|NOT COMPLETED|Overall Study||0
242489|NCT00955266|588991|P2|COMPLETED|Overall Study||4
242490|NCT00955266|588992|P1|COMPLETED|Overall Study||4
242491|NCT00955266|588991|P2|STARTED|Overall Study||4
242492|NCT00955266|588992|P1|STARTED|Overall Study||4
242493|NCT00955279|589009|P3|NOT COMPLETED|Overall Study||8
242494|NCT00955279|589010|P2|NOT COMPLETED|Overall Study||4
242495|NCT00955279|589011|P1|NOT COMPLETED|Overall Study||3
242496|NCT00955279|589009|P3|COMPLETED|Overall Study||52
242497|NCT00955279|589010|P2|COMPLETED|Overall Study||51
242498|NCT00955279|589011|P1|COMPLETED|Overall Study||55
242499|NCT00955279|589009|P3|STARTED|Overall Study||60
242500|NCT00955279|589010|P2|STARTED|Overall Study||55
242501|NCT00955279|589011|P1|STARTED|Overall Study||58
242502|NCT00955305|589033|P2|NOT COMPLETED|Overall Study||87
242503|NCT00955305|589034|P1|NOT COMPLETED|Overall Study||88
242504|NCT00955305|589033|P2|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
242505|NCT00955305|589034|P1|COMPLETED|Overall Study|Treatment continued until disease progression or unacceptable toxicities.|0
242506|NCT00955305|589033|P2|Eligible and Treated|Overall Study||75
242507|NCT00955305|589034|P1|Eligible and Treated|Overall Study||78
242508|NCT00955305|589033|P2|Treated|Overall Study||82
242509|NCT00955305|589034|P1|Treated|Overall Study||83
242510|NCT00955305|589033|P2|STARTED|Overall Study||87
242511|NCT00955305|589034|P1|STARTED|Overall Study||88
242512|NCT00955357|589046|P2|NOT COMPLETED|Maintenance Phase||45
242513|NCT00955357|589047|P1|NOT COMPLETED|Maintenance Phase||12
242514|NCT00955357|589046|P2|COMPLETED|Maintenance Phase||249
242515|NCT00955357|589047|P1|COMPLETED|Maintenance Phase||68
242516|NCT00955357|589046|P2|STARTED|Maintenance Phase||294
242517|NCT00955357|589047|P1|STARTED|Maintenance Phase||80
242518|NCT00955357|589046|P2|NOT COMPLETED|Titration Phase||66
242519|NCT00955357|589047|P1|NOT COMPLETED|Titration Phase||16
242520|NCT00955357|589046|P2|COMPLETED|Titration Phase||294
242521|NCT00955357|589047|P1|COMPLETED|Titration Phase||80
242522|NCT00955357|589046|P2|STARTED|Titration Phase||360
242523|NCT00955357|589047|P1|STARTED|Titration Phase||96
242524|NCT00955474|589055|P2|NOT COMPLETED|Overall Study||5
242525|NCT00955474|589056|P1|NOT COMPLETED|Overall Study||7
242526|NCT00955474|589055|P2|COMPLETED|Overall Study||8
242527|NCT00955474|589056|P1|COMPLETED|Overall Study||5
242528|NCT00955474|589055|P2|STARTED|Overall Study||13
242529|NCT00955474|589056|P1|STARTED|Overall Study||12
242530|NCT00955487|589092|P6|NOT COMPLETED|Overall Study||0
242531|NCT00955487|589093|P5|NOT COMPLETED|Overall Study||0
242532|NCT00955487|589094|P4|NOT COMPLETED|Overall Study||0
242533|NCT00955487|589095|P3|NOT COMPLETED|Overall Study||0
242534|NCT00955487|589096|P2|NOT COMPLETED|Overall Study||0
242535|NCT00955487|589097|P1|NOT COMPLETED|Overall Study||0
242536|NCT00955487|589092|P6|COMPLETED|Overall Study||35
242537|NCT00955487|589093|P5|COMPLETED|Overall Study||32
242538|NCT00955487|589094|P4|COMPLETED|Overall Study||21
242539|NCT00955487|589095|P3|COMPLETED|Overall Study||17
242540|NCT00955487|589096|P2|COMPLETED|Overall Study||9
242541|NCT00955487|589097|P1|COMPLETED|Overall Study||10
242542|NCT00955487|589092|P6|STARTED|Overall Study||35
242543|NCT00955487|589093|P5|STARTED|Overall Study||32
242544|NCT00955487|589094|P4|STARTED|Overall Study||21
242545|NCT00955487|589095|P3|STARTED|Overall Study||17
242546|NCT00955487|589096|P2|STARTED|Overall Study||9
242547|NCT00955487|589097|P1|STARTED|Overall Study||10
242548|NCT00955513|589132|P3|NOT COMPLETED|Overall Study||3
242549|NCT00955513|589133|P2|NOT COMPLETED|Overall Study||2
242550|NCT00955513|589134|P1|NOT COMPLETED|Overall Study||1
242551|NCT00955513|589132|P3|COMPLETED|Overall Study||79
242552|NCT00955513|589133|P2|COMPLETED|Overall Study||78
242553|NCT00955513|589134|P1|COMPLETED|Overall Study||79
242554|NCT00955513|589132|P3|STARTED|Overall Study||82
242555|NCT00955513|589133|P2|STARTED|Overall Study||80
242556|NCT00955513|589134|P1|STARTED|Overall Study||80
242557|NCT00955617|589142|P2|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
242558|NCT00955617|589143|P1|NOT COMPLETED|Second MRA (Between Day 1 and Day 51)||3
242559|NCT00955617|589142|P2|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
242560|NCT00955617|589143|P1|COMPLETED|Second MRA (Between Day 1 and Day 51)||7
242561|NCT00955617|589142|P2|STARTED|Second MRA (Between Day 1 and Day 51)||10
242562|NCT00955617|589143|P1|STARTED|Second MRA (Between Day 1 and Day 51)||10
242563|NCT00955617|589142|P2|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
242564|NCT00955617|589143|P1|NOT COMPLETED|First MRA (Between Day0 and Day21)||0
242565|NCT00955617|589142|P2|COMPLETED|First MRA (Between Day0 and Day21)||10
242566|NCT00955617|589143|P1|COMPLETED|First MRA (Between Day0 and Day21)||10
242567|NCT00955617|589142|P2|STARTED|First MRA (Between Day0 and Day21)||10
242568|NCT00955617|589143|P1|STARTED|First MRA (Between Day0 and Day21)||10
242569|NCT00955721|589155|P2|NOT COMPLETED|Overall Study||0
242570|NCT00955721|589156|P1|NOT COMPLETED|Overall Study||3
242571|NCT00955721|589155|P2|COMPLETED|Overall Study||0
242572|NCT00955721|589156|P1|COMPLETED|Overall Study||6
242573|NCT00955721|589155|P2|STARTED|Overall Study||0
242574|NCT00955721|589156|P1|STARTED|Overall Study||9
242575|NCT00955747|589166|P2|NOT COMPLETED|Overall Study||69
242576|NCT00955747|589167|P1|NOT COMPLETED|Overall Study||69
242577|NCT00955747|589166|P2|COMPLETED|Overall Study||172
242578|NCT00955747|589167|P1|COMPLETED|Overall Study||184
242579|NCT00955747|589166|P2|STARTED|Overall Study||241
242580|NCT00955747|589167|P1|STARTED|Overall Study||253
242581|NCT00955825|589175|P2|NOT COMPLETED|Overall Study||17
242582|NCT00955825|589176|P1|NOT COMPLETED|Overall Study||26
242583|NCT00955825|589175|P2|COMPLETED|Overall Study||223
242584|NCT00955825|589176|P1|COMPLETED|Overall Study||207
242585|NCT00955825|589175|P2|STARTED|Overall Study||240
242586|NCT00955825|589176|P1|STARTED|Overall Study||233
242587|NCT00955903|589185|P3|NOT COMPLETED|Overall Study||7
242588|NCT00955903|589186|P2|NOT COMPLETED|Overall Study||3
242589|NCT00955903|589187|P1|NOT COMPLETED|Overall Study||6
242590|NCT00955903|589185|P3|COMPLETED|Overall Study||48
242591|NCT00955903|589186|P2|COMPLETED|Overall Study||51
242592|NCT00955903|589187|P1|COMPLETED|Overall Study||49
242593|NCT00955903|589185|P3|STARTED|Overall Study||55
242594|NCT00955903|589186|P2|STARTED|Overall Study||54
242595|NCT00955903|589187|P1|STARTED|Overall Study||55
242596|NCT00955916|589201|P1|NOT COMPLETED|Overall Study||0
242597|NCT00955916|589201|P1|COMPLETED|Overall Study||38
242598|NCT00955916|589201|P1|STARTED|Overall Study||38
242599|NCT00955955|589210|P3|NOT COMPLETED|Overall Study||0
242600|NCT00955955|589211|P2|NOT COMPLETED|Overall Study||0
242601|NCT00955955|589212|P1|NOT COMPLETED|Overall Study||2
242602|NCT00955955|589210|P3|COMPLETED|Overall Study||28
242603|NCT00955955|589211|P2|COMPLETED|Overall Study||28
242604|NCT00955955|589212|P1|COMPLETED|Overall Study||17
242605|NCT00955955|589210|P3|STARTED|Overall Study||28
242606|NCT00955955|589211|P2|STARTED|Overall Study||28
242607|NCT00955955|589212|P1|STARTED|Overall Study||19
242608|NCT00956020|589226|P1|NOT COMPLETED|Overall Study||0
242609|NCT00956020|589226|P1|COMPLETED|Overall Study||4
242610|NCT00956020|589226|P1|STARTED|Overall Study||4
242611|NCT00965341|589243|P2|NOT COMPLETED|Overall Study||8
242612|NCT00965341|589244|P1|NOT COMPLETED|Overall Study||6
242613|NCT00965341|589243|P2|COMPLETED|Overall Study||16
242614|NCT00965341|589244|P1|COMPLETED|Overall Study||13
242615|NCT00965341|589243|P2|STARTED|Overall Study||24
242616|NCT00965341|589244|P1|STARTED|Overall Study||19
242617|NCT00965458|589254|P2|NOT COMPLETED|Overall Study||4
242618|NCT00965458|589255|P1|NOT COMPLETED|Overall Study||2
242619|NCT00965458|589254|P2|COMPLETED|Overall Study||12
242620|NCT00965458|589255|P1|COMPLETED|Overall Study||31
242621|NCT00965458|589254|P2|STARTED|Overall Study||16
242622|NCT00965458|589255|P1|STARTED|Overall Study||33
242623|NCT00965484|589271|P1|NOT COMPLETED|Overall Study||2
242624|NCT00965484|589271|P1|COMPLETED|Overall Study||134
242625|NCT00965484|589271|P1|STARTED|Overall Study||136
242626|NCT00965497|589278|P1|NOT COMPLETED|Overall Study||1
242627|NCT00965497|589278|P1|COMPLETED|Overall Study||13
242628|NCT00965497|589278|P1|STARTED|Overall Study||14
242629|NCT00965523|589283|P1|NOT COMPLETED|Study 224||6
242630|NCT00965523|589283|P1|COMPLETED|Study 224||0
242631|NCT00965523|589283|P1|STARTED|Study 224|Six subjects continued into Study 224 from Study 221.|6
242632|NCT00965523|589283|P1|NOT COMPLETED|Study 221||7
242633|NCT00965523|589283|P1|COMPLETED|Study 221||74
242634|NCT00965523|589283|P1|STARTED|Study 221|Study 221 (Safety Analysis Set).|81
242635|NCT00965562|589291|P3|NOT COMPLETED|Overall Study||3
242636|NCT00965562|589292|P2|NOT COMPLETED|Overall Study||4
242637|NCT00965562|589293|P1|NOT COMPLETED|Overall Study||3
242638|NCT00965562|589291|P3|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
242639|NCT00965562|589292|P2|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
242640|NCT00965562|589293|P1|COMPLETED|Overall Study|Participants who completed at least 2 visits were analyzed.|13
242641|NCT00965562|589291|P3|Women Who Participated Full Follow up|Overall Study|2 patients discontinued intervention: 2 patient requests|11
242642|NCT00965562|589292|P2|Women Who Participated Full Follow up|Overall Study|3 patients discontinued intervention: 1 out of contact, 2 patient requests|10
242643|NCT00965562|589293|P1|Women Who Participated Full Follow up|Overall Study|7 patients discontinued intervention: 2 out of contact, 4 patient requests, 1 suspended by IRB|6
242644|NCT00965562|589291|P3|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 3 out of contact|13
242645|NCT00965562|589292|P2|Women With at Least 2 Follow up Visits|Overall Study|4 patients with no follow up visits: 2 out of contact, 2 patient requests|13
242646|NCT00965562|589293|P1|Women With at Least 2 Follow up Visits|Overall Study|3 patients with no follow up visits: 1 out of contact, 2 patient requests|13
242647|NCT00965562|589291|P3|STARTED|Overall Study||16
242648|NCT00965562|589292|P2|STARTED|Overall Study||17
242649|NCT00965562|589293|P1|STARTED|Overall Study||16
242650|NCT00966186|589333|P2|NOT COMPLETED|Overall Study||0
242651|NCT00966186|589334|P1|NOT COMPLETED|Overall Study||0
242652|NCT00966186|589333|P2|COMPLETED|Overall Study||60
242653|NCT00966186|589334|P1|COMPLETED|Overall Study||60
242654|NCT00966186|589333|P2|STARTED|Overall Study||60
242655|NCT00966186|589334|P1|STARTED|Overall Study||60
242656|NCT00966238|589346|P6|NOT COMPLETED|Overall Study||0
242657|NCT00966238|589347|P5|NOT COMPLETED|Overall Study||0
242658|NCT00966238|589348|P4|NOT COMPLETED|Overall Study||0
242659|NCT00966238|589349|P3|NOT COMPLETED|Overall Study||0
242660|NCT00966238|589350|P2|NOT COMPLETED|Overall Study||0
242661|NCT00966238|589351|P1|NOT COMPLETED|Overall Study||0
242662|NCT00966238|589346|P6|COMPLETED|Overall Study||20
242663|NCT00966238|589347|P5|COMPLETED|Overall Study||20
242664|NCT00966238|589348|P4|COMPLETED|Overall Study||20
242665|NCT00966238|589349|P3|COMPLETED|Overall Study||20
242666|NCT00966238|589350|P2|COMPLETED|Overall Study||20
242667|NCT00966238|589351|P1|COMPLETED|Overall Study||20
242668|NCT00966238|589346|P6|STARTED|Overall Study||20
242669|NCT00966238|589347|P5|STARTED|Overall Study||20
242670|NCT00966238|589348|P4|STARTED|Overall Study||20
242671|NCT00966238|589349|P3|STARTED|Overall Study||20
242672|NCT00966238|589350|P2|STARTED|Overall Study||20
242673|NCT00966238|589351|P1|STARTED|Overall Study||20
242674|NCT00966264|589373|P2|NOT COMPLETED|Overall Study||3
242675|NCT00966264|589374|P1|NOT COMPLETED|Overall Study||4
242676|NCT00966264|589373|P2|COMPLETED|Overall Study|5 years results|114
242677|NCT00966264|589374|P1|COMPLETED|Overall Study|5 years results|115
242678|NCT00966264|589373|P2|STARTED|Overall Study||117
242679|NCT00966264|589374|P1|STARTED|Overall Study||119
242680|NCT00966277|589382|P2|NOT COMPLETED|Overall Study||4
242681|NCT00966277|589383|P1|NOT COMPLETED|Overall Study||4
242682|NCT00966277|589382|P2|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|33
242683|NCT00966277|589383|P1|COMPLETED|Overall Study|Four participants did not receive study treatment, see 'Reasons Not Completed.'|34
242684|NCT00966277|589382|P2|STARTED|Overall Study||37
242685|NCT00966277|589383|P1|STARTED|Overall Study||38
242686|NCT00966446|589392|P3|NOT COMPLETED|Overall Study||21
242687|NCT00966446|589393|P2|NOT COMPLETED|Overall Study||25
242688|NCT00966446|589394|P1|NOT COMPLETED|Overall Study||28
242689|NCT00966446|589392|P3|COMPLETED|Overall Study||52
242690|NCT00966446|589393|P2|COMPLETED|Overall Study||49
242691|NCT00966446|589394|P1|COMPLETED|Overall Study||48
242692|NCT00966446|589392|P3|STARTED|Overall Study||73
242693|NCT00966446|589393|P2|STARTED|Overall Study||74
242694|NCT00966446|589394|P1|STARTED|Overall Study||76
242695|NCT00966550|589410|P2|NOT COMPLETED|Overall Study||0
242696|NCT00966550|589411|P1|NOT COMPLETED|Overall Study||0
242697|NCT00966550|589410|P2|COMPLETED|Overall Study||12
242698|NCT00966550|589411|P1|COMPLETED|Overall Study||13
242699|NCT00966550|589410|P2|STARTED|Overall Study||12
242700|NCT00966550|589411|P1|STARTED|Overall Study||13
242701|NCT00966641|589417|P2|NOT COMPLETED|Second Intervention||0
242702|NCT00966641|589418|P1|NOT COMPLETED|Second Intervention||0
242703|NCT00966641|589417|P2|COMPLETED|Second Intervention||17
242704|NCT00966641|589418|P1|COMPLETED|Second Intervention||17
242705|NCT00966641|589417|P2|STARTED|Second Intervention||17
242706|NCT00966641|589418|P1|STARTED|Second Intervention||17
242707|NCT00966641|589417|P2|NOT COMPLETED|First Intervention||0
242708|NCT00966641|589418|P1|NOT COMPLETED|First Intervention||0
242709|NCT00966641|589417|P2|COMPLETED|First Intervention||17
242710|NCT00966641|589418|P1|COMPLETED|First Intervention||17
242711|NCT00966641|589417|P2|STARTED|First Intervention||17
242712|NCT00966641|589418|P1|STARTED|First Intervention||17
242713|NCT00966654|589424|P1|NOT COMPLETED|Overall Study||12
242714|NCT00966654|589424|P1|COMPLETED|Overall Study||0
242715|NCT00966654|589424|P1|STARTED|Overall Study||12
242716|NCT00966823|589432|P1|NOT COMPLETED|Overall Study||1
242717|NCT00966823|589432|P1|COMPLETED|Overall Study||2
242718|NCT00966823|589432|P1|STARTED|Overall Study||3
242719|NCT00966875|589449|P9|NOT COMPLETED|Part B||18
242720|NCT00966875|589450|P8|NOT COMPLETED|Part B||19
242721|NCT00966875|589451|P7|NOT COMPLETED|Part B||22
242722|NCT00966875|589452|P6|NOT COMPLETED|Part B||6
242723|NCT00966875|589453|P5|NOT COMPLETED|Part B||7
242724|NCT00966875|589454|P4|NOT COMPLETED|Part B||3
242725|NCT00966875|589455|P3|NOT COMPLETED|Part B||6
242726|NCT00966875|589456|P2|NOT COMPLETED|Part B||3
242727|NCT00966875|589457|P1|NOT COMPLETED|Part B||5
242728|NCT00966875|589449|P9|COMPLETED|Part B||32
242729|NCT00966875|589450|P8|COMPLETED|Part B||38
242730|NCT00966875|589451|P7|COMPLETED|Part B||29
242731|NCT00966875|589452|P6|COMPLETED|Part B||26
242732|NCT00966875|589453|P5|COMPLETED|Part B||44
242733|NCT00966875|589454|P4|COMPLETED|Part B||31
242734|NCT00966875|589455|P3|COMPLETED|Part B||27
242735|NCT00966875|589456|P2|COMPLETED|Part B||33
242736|NCT00966875|589457|P1|COMPLETED|Part B||41
242737|NCT00966875|589449|P9|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|50
242738|NCT00966875|589450|P8|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|57
242739|NCT00966875|589451|P7|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
242740|NCT00966875|589452|P6|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|32
242741|NCT00966875|589453|P5|STARTED|Part B|One (1) participant who completed Part A did not enter Part B.|51
242742|NCT00966875|589454|P4|STARTED|Part B||34
242743|NCT00966875|589455|P3|STARTED|Part B||33
242744|NCT00966875|589456|P2|STARTED|Part B||36
242745|NCT00966875|589457|P1|STARTED|Part B|Two (2) participants who completed Part A did not enter Part B.|46
242746|NCT00966875|589449|P9|NOT COMPLETED|Part A||8
242747|NCT00966875|589450|P8|NOT COMPLETED|Part A||7
242748|NCT00966875|589451|P7|NOT COMPLETED|Part A||12
242749|NCT00966875|589452|P6|NOT COMPLETED|Part A||4
242750|NCT00966875|589453|P5|NOT COMPLETED|Part A||5
242751|NCT00966875|589454|P4|NOT COMPLETED|Part A||3
242752|NCT00966875|589455|P3|NOT COMPLETED|Part A||2
242753|NCT00966875|589456|P2|NOT COMPLETED|Part A||4
242754|NCT00966875|589457|P1|NOT COMPLETED|Part A||6
242755|NCT00966875|589449|P9|COMPLETED|Part A||51
242756|NCT00966875|589450|P8|COMPLETED|Part A||58
242757|NCT00966875|589451|P7|COMPLETED|Part A||52
242758|NCT00966875|589452|P6|COMPLETED|Part A||33
242759|NCT00966875|589453|P5|COMPLETED|Part A||52
242760|NCT00966875|589454|P4|COMPLETED|Part A||34
242761|NCT00966875|589455|P3|COMPLETED|Part A||33
242762|NCT00966875|589456|P2|COMPLETED|Part A||36
242763|NCT00966875|589457|P1|COMPLETED|Part A||48
242764|NCT00966875|589449|P9|Received ≥1 Doses of Study Drug|Part A||59
242765|NCT00966875|589450|P8|Received ≥1 Doses of Study Drug|Part A||65
242766|NCT00966875|589451|P7|Received ≥1 Doses of Study Drug|Part A||64
242767|NCT00966875|589452|P6|Received ≥1 Doses of Study Drug|Part A||37
242768|NCT00966875|589453|P5|Received ≥1 Doses of Study Drug|Part A||57
242769|NCT00966875|589454|P4|Received ≥1 Doses of Study Drug|Part A||37
242770|NCT00966875|589455|P3|Received ≥1 Doses of Study Drug|Part A||35
242771|NCT00966875|589456|P2|Received ≥1 Doses of Study Drug|Part A||40
242772|NCT00966875|589457|P1|Received ≥1 Doses of Study Drug|Part A||54
242773|NCT00966875|589449|P9|STARTED|Part A||59
242774|NCT00966875|589450|P8|STARTED|Part A||65
242775|NCT00966875|589451|P7|STARTED|Part A||64
242776|NCT00966875|589452|P6|STARTED|Part A||37
242777|NCT00966875|589453|P5|STARTED|Part A||57
242778|NCT00966875|589454|P4|STARTED|Part A||37
242779|NCT00966875|589455|P3|STARTED|Part A||35
242780|NCT00966875|589456|P2|STARTED|Part A||40
242781|NCT00966875|589457|P1|STARTED|Part A||54
242782|NCT00966940|589778|P2|NOT COMPLETED|Period 2, Second 6 Weeks||0
242783|NCT00966940|589779|P1|NOT COMPLETED|Period 2, Second 6 Weeks||0
242784|NCT00966940|589778|P2|COMPLETED|Period 2, Second 6 Weeks||23
242785|NCT00966940|589779|P1|COMPLETED|Period 2, Second 6 Weeks||25
242786|NCT00966940|589778|P2|STARTED|Period 2, Second 6 Weeks||23
242787|NCT00966940|589779|P1|STARTED|Period 2, Second 6 Weeks||25
242788|NCT00966940|589778|P2|NOT COMPLETED|Period 1, First 6 Weeks||0
242789|NCT00966940|589779|P1|NOT COMPLETED|Period 1, First 6 Weeks||3
242790|NCT00966940|589778|P2|COMPLETED|Period 1, First 6 Weeks||23
242791|NCT00966940|589779|P1|COMPLETED|Period 1, First 6 Weeks||25
242792|NCT00966940|589778|P2|STARTED|Period 1, First 6 Weeks||23
242793|NCT00966940|589779|P1|STARTED|Period 1, First 6 Weeks||28
242794|NCT00966953|589801|P4|NOT COMPLETED|4th Intervention Order||0
242795|NCT00966953|589802|P3|NOT COMPLETED|4th Intervention Order||0
242796|NCT00966953|589803|P2|NOT COMPLETED|4th Intervention Order||0
242797|NCT00966953|589804|P1|NOT COMPLETED|4th Intervention Order||0
242798|NCT00966953|589801|P4|COMPLETED|4th Intervention Order||7
242799|NCT00966953|589802|P3|COMPLETED|4th Intervention Order||6
242800|NCT00966953|589803|P2|COMPLETED|4th Intervention Order||6
242801|NCT00966953|589804|P1|COMPLETED|4th Intervention Order||6
242802|NCT00966953|589801|P4|STARTED|4th Intervention Order||7
242803|NCT00966953|589802|P3|STARTED|4th Intervention Order||6
242804|NCT00966953|589803|P2|STARTED|4th Intervention Order||6
242805|NCT00966953|589804|P1|STARTED|4th Intervention Order||6
242806|NCT00966953|589801|P4|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
242807|NCT00966953|589802|P3|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
242808|NCT00966953|589803|P2|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
242809|NCT00966953|589804|P1|NOT COMPLETED|1 Week Washout After 3rd Intervention||0
242810|NCT00966953|589801|P4|COMPLETED|1 Week Washout After 3rd Intervention||7
242811|NCT00966953|589802|P3|COMPLETED|1 Week Washout After 3rd Intervention||6
242812|NCT00966953|589803|P2|COMPLETED|1 Week Washout After 3rd Intervention||6
242813|NCT00966953|589804|P1|COMPLETED|1 Week Washout After 3rd Intervention||6
242814|NCT00966953|589801|P4|STARTED|1 Week Washout After 3rd Intervention||7
242815|NCT00966953|589802|P3|STARTED|1 Week Washout After 3rd Intervention||6
242816|NCT00966953|589803|P2|STARTED|1 Week Washout After 3rd Intervention||6
242817|NCT00966953|589804|P1|STARTED|1 Week Washout After 3rd Intervention||6
242818|NCT00966953|589801|P4|NOT COMPLETED|3rd Intervention Order||0
242819|NCT00966953|589802|P3|NOT COMPLETED|3rd Intervention Order||0
242820|NCT00966953|589803|P2|NOT COMPLETED|3rd Intervention Order||0
242821|NCT00966953|589804|P1|NOT COMPLETED|3rd Intervention Order||0
242822|NCT00966953|589801|P4|COMPLETED|3rd Intervention Order||7
242823|NCT00966953|589802|P3|COMPLETED|3rd Intervention Order||6
242824|NCT00966953|589803|P2|COMPLETED|3rd Intervention Order||6
242825|NCT00966953|589804|P1|COMPLETED|3rd Intervention Order||6
242826|NCT00966953|589801|P4|STARTED|3rd Intervention Order||7
242827|NCT00966953|589802|P3|STARTED|3rd Intervention Order||6
242828|NCT00966953|589803|P2|STARTED|3rd Intervention Order||6
242829|NCT00966953|589804|P1|STARTED|3rd Intervention Order||6
242830|NCT00966953|589801|P4|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
242831|NCT00966953|589802|P3|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
242832|NCT00966953|589803|P2|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
242833|NCT00966953|589804|P1|NOT COMPLETED|1 Week Washout After 2nd Intervention||0
242834|NCT00966953|589801|P4|COMPLETED|1 Week Washout After 2nd Intervention||7
242835|NCT00966953|589802|P3|COMPLETED|1 Week Washout After 2nd Intervention||6
242836|NCT00966953|589803|P2|COMPLETED|1 Week Washout After 2nd Intervention||6
242837|NCT00966953|589804|P1|COMPLETED|1 Week Washout After 2nd Intervention||6
242838|NCT00966953|589801|P4|STARTED|1 Week Washout After 2nd Intervention||7
242839|NCT00966953|589802|P3|STARTED|1 Week Washout After 2nd Intervention||6
242840|NCT00966953|589803|P2|STARTED|1 Week Washout After 2nd Intervention||6
242841|NCT00966953|589804|P1|STARTED|1 Week Washout After 2nd Intervention||6
242842|NCT00966953|589801|P4|NOT COMPLETED|2nd Intervention||0
242843|NCT00966953|589802|P3|NOT COMPLETED|2nd Intervention||0
242844|NCT00966953|589803|P2|NOT COMPLETED|2nd Intervention||0
242845|NCT00966953|589804|P1|NOT COMPLETED|2nd Intervention||0
242846|NCT00966953|589801|P4|COMPLETED|2nd Intervention||7
242847|NCT00966953|589802|P3|COMPLETED|2nd Intervention||6
242848|NCT00966953|589803|P2|COMPLETED|2nd Intervention||6
242849|NCT00966953|589804|P1|COMPLETED|2nd Intervention||6
242850|NCT00966953|589801|P4|STARTED|2nd Intervention||7
242851|NCT00966953|589802|P3|STARTED|2nd Intervention||6
242852|NCT00966953|589803|P2|STARTED|2nd Intervention||6
242853|NCT00966953|589804|P1|STARTED|2nd Intervention||6
242854|NCT00966953|589801|P4|NOT COMPLETED|1 Week Washout After 1st Intervention||0
242855|NCT00966953|589802|P3|NOT COMPLETED|1 Week Washout After 1st Intervention||0
242856|NCT00966953|589803|P2|NOT COMPLETED|1 Week Washout After 1st Intervention||0
242857|NCT00966953|589804|P1|NOT COMPLETED|1 Week Washout After 1st Intervention||0
242858|NCT00966953|589801|P4|COMPLETED|1 Week Washout After 1st Intervention||7
242859|NCT00966953|589802|P3|COMPLETED|1 Week Washout After 1st Intervention||6
242860|NCT00966953|589803|P2|COMPLETED|1 Week Washout After 1st Intervention||6
242861|NCT00966953|589804|P1|COMPLETED|1 Week Washout After 1st Intervention||6
242862|NCT00966953|589801|P4|STARTED|1 Week Washout After 1st Intervention||7
242863|NCT00966953|589802|P3|STARTED|1 Week Washout After 1st Intervention||6
242864|NCT00966953|589803|P2|STARTED|1 Week Washout After 1st Intervention||6
242865|NCT00966953|589804|P1|STARTED|1 Week Washout After 1st Intervention||6
242866|NCT00966953|589801|P4|NOT COMPLETED|1st Intervention||0
242867|NCT00966953|589802|P3|NOT COMPLETED|1st Intervention||0
242868|NCT00966953|589803|P2|NOT COMPLETED|1st Intervention||0
242869|NCT00966953|589804|P1|NOT COMPLETED|1st Intervention||0
242870|NCT00966953|589801|P4|COMPLETED|1st Intervention||7
242871|NCT00966953|589802|P3|COMPLETED|1st Intervention||6
242872|NCT00966953|589803|P2|COMPLETED|1st Intervention||6
242873|NCT00966953|589804|P1|COMPLETED|1st Intervention||6
242874|NCT00966953|589801|P4|STARTED|1st Intervention||7
242875|NCT00966953|589802|P3|STARTED|1st Intervention||6
242876|NCT00966953|589803|P2|STARTED|1st Intervention||6
242877|NCT00966953|589804|P1|STARTED|1st Intervention||6
242878|NCT00966992|589812|P2|NOT COMPLETED|Overall Study||0
242879|NCT00966992|589813|P1|NOT COMPLETED|Overall Study||0
242880|NCT00966992|589812|P2|COMPLETED|Overall Study||0
242881|NCT00966992|589813|P1|COMPLETED|Overall Study||3
242882|NCT00966992|589812|P2|STARTED|Overall Study||0
242883|NCT00966992|589813|P1|STARTED|Overall Study||3
242884|NCT00967005|589831|P2|NOT COMPLETED|Overall Study||10
242885|NCT00967005|589832|P1|NOT COMPLETED|Overall Study||7
242886|NCT00967005|589831|P2|COMPLETED|Overall Study||5
242887|NCT00967005|589832|P1|COMPLETED|Overall Study||6
242888|NCT00967005|589831|P2|Treatment Completion|Overall Study||10
242889|NCT00967005|589832|P1|Treatment Completion|Overall Study||10
242890|NCT00967005|589831|P2|STARTED|Overall Study||15
242891|NCT00967005|589832|P1|STARTED|Overall Study||13
242892|NCT00967018|589884|P1|NOT COMPLETED|Overall Study||21
242893|NCT00967018|589884|P1|COMPLETED|Overall Study||56
242894|NCT00967018|589884|P1|STARTED|Overall Study||77
242895|NCT00967044|589891|P1|NOT COMPLETED|Overall Study||0
242896|NCT00967044|589891|P1|COMPLETED|Overall Study||30
242897|NCT00967044|589891|P1|STARTED|Overall Study||30
242898|NCT00967226|589897|P2|NOT COMPLETED|Overall Study||6
242899|NCT00967226|589898|P1|NOT COMPLETED|Overall Study||2
242900|NCT00967226|589897|P2|COMPLETED|Overall Study||2
242901|NCT00967226|589898|P1|COMPLETED|Overall Study||9
242902|NCT00967226|589897|P2|STARTED|Overall Study||8
242903|NCT00967226|589898|P1|STARTED|Overall Study||11
242904|NCT00967330|589930|P2|NOT COMPLETED|Overall Study||60
242905|NCT00967330|589931|P1|NOT COMPLETED|Overall Study||122
242906|NCT00967330|589930|P2|COMPLETED|Overall Study||0
242907|NCT00967330|589931|P1|COMPLETED|Overall Study||0
242908|NCT00967330|589930|P2|STARTED|Overall Study||60
242909|NCT00967330|589931|P1|STARTED|Overall Study||122
242910|NCT00967447|589959|P1|NOT COMPLETED|Overall Study||0
242911|NCT00967447|589959|P1|COMPLETED|Overall Study|there are no collected data in CRF|2
242912|NCT00967447|589959|P1|STARTED|Overall Study|there are no collected data in CRF|2
242913|NCT00967473|589966|P1|NOT COMPLETED|Overall Study||0
242914|NCT00967473|589966|P1|COMPLETED|Overall Study||15
242915|NCT00967473|589966|P1|STARTED|Overall Study||15
242916|NCT00967486|589974|P2|NOT COMPLETED|Overall Study||0
242917|NCT00967486|589975|P1|NOT COMPLETED|Overall Study||0
242918|NCT00967486|589974|P2|COMPLETED|Overall Study||102
242919|NCT00967486|589975|P1|COMPLETED|Overall Study||98
242920|NCT00967486|589974|P2|STARTED|Overall Study||102
242921|NCT00967486|589975|P1|STARTED|Overall Study||98
242922|NCT00967551|589983|P2|NOT COMPLETED|Overall Study||0
242923|NCT00967551|589984|P1|NOT COMPLETED|Overall Study||0
242924|NCT00967551|589983|P2|COMPLETED|Overall Study||75
242925|NCT00967551|589984|P1|COMPLETED|Overall Study||68
242926|NCT00967551|589983|P2|STARTED|Overall Study||75
242927|NCT00967551|589984|P1|STARTED|Overall Study||68
242928|NCT00967668|589995|P3|NOT COMPLETED|Overall Study||69
242929|NCT00967668|589996|P2|NOT COMPLETED|Overall Study||56
242930|NCT00967668|589997|P1|NOT COMPLETED|Overall Study||71
242931|NCT00967668|589995|P3|COMPLETED|Overall Study||90
242932|NCT00967668|589996|P2|COMPLETED|Overall Study||104
242933|NCT00967668|589997|P1|COMPLETED|Overall Study||91
242934|NCT00967668|589995|P3|18-mo Assessment|Overall Study||92
242935|NCT00967668|589996|P2|18-mo Assessment|Overall Study||102
242936|NCT00967668|589997|P1|18-mo Assessment|Overall Study||95
242937|NCT00967668|589995|P3|Completed Year 1 - 12-mo Assessment|Overall Study||119
242938|NCT00967668|589996|P2|Completed Year 1 - 12-mo Assessment|Overall Study||122
242939|NCT00967668|589997|P1|Completed Year 1 - 12-mo Assessment|Overall Study||120
242940|NCT00967668|589995|P3|3-mo Assessment|Overall Study||115
242941|NCT00967668|589996|P2|3-mo Assessment|Overall Study||127
242942|NCT00967668|589997|P1|3-mo Assessment|Overall Study||131
242943|NCT00967668|589995|P3|STARTED|Overall Study||159
242944|NCT00967668|589996|P2|STARTED|Overall Study||160
242945|NCT00967668|589997|P1|STARTED|Overall Study||162
242946|NCT00967694|590008|P1|NOT COMPLETED|Overall Study||6
242947|NCT00967694|590008|P1|COMPLETED|Overall Study|5 discontinued during N2O administration due to agitation ⁄ dysphoria, one due to nausea⁄vomiting.|20
242948|NCT00967694|590008|P1|STARTED|Overall Study||26
242949|NCT00967993|590012|P1|NOT COMPLETED|Overall Study||4
242950|NCT00967993|590012|P1|COMPLETED|Overall Study||18
242951|NCT00967993|590012|P1|STARTED|Overall Study||22
242952|NCT00968019|590016|P1|NOT COMPLETED|Overall Study||15
242953|NCT00968019|590016|P1|COMPLETED|Overall Study||303
242954|NCT00968019|590016|P1|STARTED|Overall Study||318
242955|NCT00968032|590037|P1|NOT COMPLETED|Overall Study||2
242956|NCT00968032|590037|P1|COMPLETED|Overall Study|"1 patient not receiving investigational device due to failure in usage
1 patient denied latest FU"|61
242957|NCT00968032|590037|P1|STARTED|Overall Study||63
242958|NCT00968071|590041|P1|NOT COMPLETED|Overall Study||0
242959|NCT00968071|590041|P1|COMPLETED|Overall Study||71
242960|NCT00968071|590041|P1|STARTED|Overall Study||71
242961|NCT00968149|590047|P2|NOT COMPLETED|Overall Study||6
242962|NCT00968149|590048|P1|NOT COMPLETED|Overall Study||11
242963|NCT00968149|590047|P2|COMPLETED|Overall Study||127
242964|NCT00968149|590048|P1|COMPLETED|Overall Study||269
242965|NCT00968149|590047|P2|STARTED|Overall Study||133
242966|NCT00968149|590048|P1|STARTED|Overall Study||280
242967|NCT00968201|590070|P3|NOT COMPLETED|Extension Study - (Period III)||280
242968|NCT00968201|590071|P2|NOT COMPLETED|Extension Study - (Period III)||124
242969|NCT00968201|590072|P1|NOT COMPLETED|Extension Study - (Period III)||0
242970|NCT00968201|590070|P3|COMPLETED|Extension Study - (Period III)||84
242971|NCT00968201|590071|P2|COMPLETED|Extension Study - (Period III)||33
242972|NCT00968201|590072|P1|COMPLETED|Extension Study - (Period III)||0
242973|NCT00968201|590070|P3|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|364
242974|NCT00968201|590071|P2|STARTED|Extension Study - (Period III)|Eligible Patients who completed Period II and entered the optional Extension Study (Period III)|157
242975|NCT00968201|590072|P1|STARTED|Extension Study - (Period III)||0
242976|NCT00968201|590070|P3|NOT COMPLETED|Base Study - (Period II)||45
242977|NCT00968201|590071|P2|NOT COMPLETED|Base Study - (Period II)||0
242978|NCT00968201|590072|P1|NOT COMPLETED|Base Study - (Period II)||26
242979|NCT00968201|590070|P3|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|416
242980|NCT00968201|590071|P2|COMPLETED|Base Study - (Period II)||0
242981|NCT00968201|590072|P1|COMPLETED|Base Study - (Period II)|Patients completing Period II were eligible to enter the optional Period III|202
242982|NCT00968201|590070|P3|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to montelukast.|461
242983|NCT00968201|590071|P2|STARTED|Base Study - (Period II)||0
242984|NCT00968201|590072|P1|STARTED|Base Study - (Period II)|Includes patients who completed Period I (2-week placebo run-in) and were randomized to placebo.|228
242985|NCT00968227|590131|P1|NOT COMPLETED|Overall Study||0
242986|NCT00968227|590131|P1|COMPLETED|Overall Study||56
242987|NCT00968227|590131|P1|STARTED|Overall Study||56
242988|NCT00960297|590136|P1|NOT COMPLETED|Overall Study||3
242989|NCT00960297|590136|P1|COMPLETED|Overall Study||1
242990|NCT00960297|590136|P1|STARTED|Overall Study||4
242991|NCT00960323|590140|P1|NOT COMPLETED|Colchicine and Atorvastatin||0
242992|NCT00960323|590140|P1|COMPLETED|Colchicine and Atorvastatin||23
242993|NCT00960323|590140|P1|STARTED|Colchicine and Atorvastatin||23
242994|NCT00960323|590140|P1|NOT COMPLETED|Atorvastatin Alone||1
242995|NCT00960323|590140|P1|COMPLETED|Atorvastatin Alone||23
242996|NCT00960323|590140|P1|STARTED|Atorvastatin Alone||24
242997|NCT00960323|590140|P1|NOT COMPLETED|14 Day Washout Period||0
242998|NCT00960323|590140|P1|COMPLETED|14 Day Washout Period||24
242999|NCT00960323|590140|P1|STARTED|14 Day Washout Period||24
243000|NCT00960323|590140|P1|NOT COMPLETED|Colchicine Alone||0
243001|NCT00960323|590140|P1|COMPLETED|Colchicine Alone||24
243002|NCT00960323|590140|P1|STARTED|Colchicine Alone||24
243003|NCT00960375|590153|P2|NOT COMPLETED|Overall Study||22
243004|NCT00960375|590154|P1|NOT COMPLETED|Overall Study||20
243005|NCT00960375|590153|P2|COMPLETED|Overall Study||65
243006|NCT00960375|590154|P1|COMPLETED|Overall Study||72
243007|NCT00960375|590153|P2|STARTED|Overall Study||87
243008|NCT00960375|590154|P1|STARTED|Overall Study||92
243009|NCT00960440|590166|P4|NOT COMPLETED|Overall Study||18
243010|NCT00960440|590167|P3|NOT COMPLETED|Overall Study||13
243011|NCT00960440|590168|P2|NOT COMPLETED|Overall Study||31
243012|NCT00960440|590169|P1|NOT COMPLETED|Overall Study||26
243013|NCT00960440|590166|P4|COMPLETED|Overall Study||48
243014|NCT00960440|590167|P3|COMPLETED|Overall Study||53
243015|NCT00960440|590168|P2|COMPLETED|Overall Study||103
243016|NCT00960440|590169|P1|COMPLETED|Overall Study||107
243017|NCT00960440|590166|P4|STARTED|Overall Study||66
243018|NCT00960440|590167|P3|STARTED|Overall Study||66
243019|NCT00960440|590168|P2|STARTED|Overall Study||134
243020|NCT00960440|590169|P1|STARTED|Overall Study||133
243021|NCT00960531|590349|P10|NOT COMPLETED|Overall Study||1
243022|NCT00960531|590350|P9|NOT COMPLETED|Overall Study||14
243023|NCT00960531|590351|P8|NOT COMPLETED|Overall Study||4
243024|NCT00960531|590352|P7|NOT COMPLETED|Overall Study||24
243025|NCT00960531|590353|P6|NOT COMPLETED|Overall Study||3
243026|NCT00960531|590354|P5|NOT COMPLETED|Overall Study||2
243027|NCT00960531|590355|P4|NOT COMPLETED|Overall Study||8
243028|NCT00960531|590356|P3|NOT COMPLETED|Overall Study||26
243029|NCT00960531|590357|P2|NOT COMPLETED|Overall Study||1
243030|NCT00960531|590358|P1|NOT COMPLETED|Overall Study||10
243031|NCT00960531|590349|P10|COMPLETED|Overall Study|Completed study|3
243032|NCT00960531|590350|P9|COMPLETED|Overall Study|Completed study|2
243033|NCT00960531|590351|P8|COMPLETED|Overall Study|Completed study|2
243034|NCT00960531|590352|P7|COMPLETED|Overall Study|Completed study|3
243035|NCT00960531|590353|P6|COMPLETED|Overall Study|Completed study|6
243036|NCT00960531|590354|P5|COMPLETED|Overall Study|Completed study|3
243037|NCT00960531|590355|P4|COMPLETED|Overall Study|Completed study|17
243038|NCT00960531|590356|P3|COMPLETED|Overall Study|Completed study|15
243039|NCT00960531|590357|P2|COMPLETED|Overall Study|Completed study|5
243040|NCT00960531|590358|P1|COMPLETED|Overall Study|Completed study|11
243041|NCT00960531|590349|P10|Completed Treatment|Overall Study||4
243042|NCT00960531|590350|P9|Completed Treatment|Overall Study||2
243043|NCT00960531|590351|P8|Completed Treatment|Overall Study||3
243044|NCT00960531|590352|P7|Completed Treatment|Overall Study||4
243045|NCT00960531|590353|P6|Completed Treatment|Overall Study||7
243046|NCT00960531|590354|P5|Completed Treatment|Overall Study||3
243047|NCT00960531|590355|P4|Completed Treatment|Overall Study||17
243048|NCT00960531|590356|P3|Completed Treatment|Overall Study||15
243049|NCT00960531|590357|P2|Completed Treatment|Overall Study||5
243050|NCT00960531|590358|P1|Completed Treatment|Overall Study||12
243051|NCT00960531|590349|P10|Treated|Overall Study||4
243052|NCT00960531|590350|P9|Treated|Overall Study||16
243053|NCT00960531|590351|P8|Treated|Overall Study||6
243054|NCT00960531|590352|P7|Treated|Overall Study||27
243055|NCT00960531|590353|P6|Treated|Overall Study||9
243056|NCT00960531|590354|P5|Treated|Overall Study||5
243057|NCT00960531|590355|P4|Treated|Overall Study||24
243058|NCT00960531|590356|P3|Treated|Overall Study||41
243059|NCT00960531|590357|P2|Treated|Overall Study||6
243060|NCT00960531|590358|P1|Treated|Overall Study||21
243061|NCT00960531|590349|P10|STARTED|Overall Study|Started=Randomized|4
243062|NCT00960531|590350|P9|STARTED|Overall Study|Started=Randomized|16
243063|NCT00960531|590351|P8|STARTED|Overall Study|Started=Randomized|6
243064|NCT00960531|590352|P7|STARTED|Overall Study|Started=Randomized|27
243065|NCT00960531|590353|P6|STARTED|Overall Study|Started=Randomized|9
243066|NCT00960531|590354|P5|STARTED|Overall Study|Started=Randomized|5
243067|NCT00960531|590355|P4|STARTED|Overall Study|Started=Randomized.|25
243068|NCT00960531|590356|P3|STARTED|Overall Study|Started=Randomized|41
243069|NCT00960531|590357|P2|STARTED|Overall Study|Started=Randomized|6
243070|NCT00960531|590358|P1|STARTED|Overall Study|Started=Randomized|21
243071|NCT00960570|590402|P1|NOT COMPLETED|Efavirenz and Fenofibric Acid||0
243072|NCT00960570|590402|P1|COMPLETED|Efavirenz and Fenofibric Acid||25
243073|NCT00960570|590402|P1|STARTED|Efavirenz and Fenofibric Acid||25
243074|NCT00960570|590402|P1|NOT COMPLETED|1 Day Period Between Dosing||3
243075|NCT00960570|590402|P1|COMPLETED|1 Day Period Between Dosing||25
243076|NCT00960570|590402|P1|STARTED|1 Day Period Between Dosing||28
243077|NCT00960570|590402|P1|NOT COMPLETED|Fenofibric Acid Alone||0
243078|NCT00960570|590402|P1|COMPLETED|Fenofibric Acid Alone||28
243079|NCT00960570|590402|P1|STARTED|Fenofibric Acid Alone||28
243080|NCT00960570|590402|P1|NOT COMPLETED|21 Day Washout Period||2
243081|NCT00960570|590402|P1|COMPLETED|21 Day Washout Period||28
243082|NCT00960570|590402|P1|STARTED|21 Day Washout Period||30
243083|NCT00960570|590402|P1|NOT COMPLETED|Efavirenz Alone||0
243084|NCT00960570|590402|P1|COMPLETED|Efavirenz Alone||30
243085|NCT00960570|590402|P1|STARTED|Efavirenz Alone||30
243086|NCT00960622|590415|P2|NOT COMPLETED|Overall Study||3
243087|NCT00960622|590416|P1|NOT COMPLETED|Overall Study||0
243088|NCT00960622|590415|P2|COMPLETED|Overall Study||7
243089|NCT00960622|590416|P1|COMPLETED|Overall Study||10
243090|NCT00960622|590415|P2|STARTED|Overall Study||10
243091|NCT00960622|590416|P1|STARTED|Overall Study||10
243092|NCT00960661|590424|P3|NOT COMPLETED|Interventional Phase||46
243093|NCT00960661|590425|P2|NOT COMPLETED|Interventional Phase||52
243094|NCT00960661|590426|P1|NOT COMPLETED|Interventional Phase||0
243095|NCT00960661|590424|P3|COMPLETED|Interventional Phase||275
243096|NCT00960661|590425|P2|COMPLETED|Interventional Phase||264
243097|NCT00960661|590426|P1|COMPLETED|Interventional Phase||0
243098|NCT00960661|590424|P3|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|263
243099|NCT00960661|590425|P2|Per Protocol Population|Interventional Phase|all randomized participants who completed study and had no violations|247
243100|NCT00960661|590426|P1|Per Protocol Population|Interventional Phase||0
243101|NCT00960661|590424|P3|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|312
243102|NCT00960661|590425|P2|Intent to Treat Population|Interventional Phase|all randomized participants who took at least one dose of study drug|315
243103|NCT00960661|590426|P1|Intent to Treat Population|Interventional Phase||0
243104|NCT00960661|590424|P3|STARTED|Interventional Phase||321
243105|NCT00960661|590425|P2|STARTED|Interventional Phase||316
243106|NCT00960661|590426|P1|STARTED|Interventional Phase||0
243107|NCT00960661|590424|P3|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
243108|NCT00960661|590425|P2|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||0
243109|NCT00960661|590426|P1|NOT COMPLETED|Basal Insulin Optimization Phase (BIO)||399
243110|NCT00960661|590424|P3|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
243111|NCT00960661|590425|P2|COMPLETED|Basal Insulin Optimization Phase (BIO)||0
243112|NCT00960661|590426|P1|COMPLETED|Basal Insulin Optimization Phase (BIO)||637
243113|NCT00960661|590424|P3|STARTED|Basal Insulin Optimization Phase (BIO)||0
243114|NCT00960661|590425|P2|STARTED|Basal Insulin Optimization Phase (BIO)||0
243115|NCT00960661|590426|P1|STARTED|Basal Insulin Optimization Phase (BIO)||1036
243116|NCT00960687|590456|P2|NOT COMPLETED|Second Intervention||0
243117|NCT00960687|590457|P1|NOT COMPLETED|Second Intervention||0
243118|NCT00960687|590456|P2|COMPLETED|Second Intervention||24
243119|NCT00960687|590457|P1|COMPLETED|Second Intervention||23
243120|NCT00960687|590456|P2|STARTED|Second Intervention||24
243121|NCT00960687|590457|P1|STARTED|Second Intervention||23
243122|NCT00960687|590456|P2|NOT COMPLETED|Washout Period of 7 Days||3
243123|NCT00960687|590457|P1|NOT COMPLETED|Washout Period of 7 Days||4
243124|NCT00960687|590456|P2|COMPLETED|Washout Period of 7 Days|two subjects withdrew due to adverse events and one subject withdrew for personal reasons.|24
243125|NCT00960687|590457|P1|COMPLETED|Washout Period of 7 Days|three subjects withdrew due to adverse events and one subject withdrew for personal reasons.|23
243126|NCT00960687|590456|P2|STARTED|Washout Period of 7 Days||27
243127|NCT00960687|590457|P1|STARTED|Washout Period of 7 Days||27
243128|NCT00960687|590456|P2|NOT COMPLETED|First Intervention||0
243129|NCT00960687|590457|P1|NOT COMPLETED|First Intervention||0
243130|NCT00960687|590456|P2|COMPLETED|First Intervention||27
243131|NCT00960687|590457|P1|COMPLETED|First Intervention||27
243132|NCT00960687|590456|P2|STARTED|First Intervention||27
243133|NCT00960687|590457|P1|STARTED|First Intervention||27
243134|NCT00960843|590469|P2|NOT COMPLETED|Overall Study||5
243135|NCT00960843|590470|P1|NOT COMPLETED|Overall Study||2
243136|NCT00960843|590469|P2|COMPLETED|Overall Study||21
243137|NCT00960843|590470|P1|COMPLETED|Overall Study||23
243138|NCT00960843|590469|P2|STARTED|Overall Study||26
243139|NCT00960843|590470|P1|STARTED|Overall Study||25
243140|NCT00960856|590480|P4|NOT COMPLETED|Period IV||0
243141|NCT00960856|590481|P3|NOT COMPLETED|Period IV||0
243142|NCT00960856|590482|P2|NOT COMPLETED|Period IV||0
243143|NCT00960856|590483|P1|NOT COMPLETED|Period IV||0
243144|NCT00960856|590480|P4|COMPLETED|Period IV||9
243145|NCT00960856|590481|P3|COMPLETED|Period IV||8
243146|NCT00960856|590482|P2|COMPLETED|Period IV||7
243147|NCT00960856|590483|P1|COMPLETED|Period IV||10
243148|NCT00960856|590480|P4|STARTED|Period IV||9
243149|NCT00960856|590481|P3|STARTED|Period IV||8
243150|NCT00960856|590482|P2|STARTED|Period IV||7
243151|NCT00960856|590483|P1|STARTED|Period IV||10
243152|NCT00960856|590480|P4|NOT COMPLETED|Washout Period of 7 Days||0
243153|NCT00960856|590481|P3|NOT COMPLETED|Washout Period of 7 Days||1
243154|NCT00960856|590482|P2|NOT COMPLETED|Washout Period of 7 Days||0
243155|NCT00960856|590483|P1|NOT COMPLETED|Washout Period of 7 Days||0
243156|NCT00960856|590480|P4|COMPLETED|Washout Period of 7 Days||9
243157|NCT00960856|590481|P3|COMPLETED|Washout Period of 7 Days||8
243158|NCT00960856|590482|P2|COMPLETED|Washout Period of 7 Days||7
243159|NCT00960856|590483|P1|COMPLETED|Washout Period of 7 Days||10
243160|NCT00960856|590480|P4|STARTED|Washout Period of 7 Days||9
243161|NCT00960856|590481|P3|STARTED|Washout Period of 7 Days||9
243162|NCT00960856|590482|P2|STARTED|Washout Period of 7 Days||7
243163|NCT00960856|590483|P1|STARTED|Washout Period of 7 Days||10
243164|NCT00960856|590480|P4|NOT COMPLETED|Period III||0
243165|NCT00960856|590481|P3|NOT COMPLETED|Period III||0
243166|NCT00960856|590482|P2|NOT COMPLETED|Period III||0
243167|NCT00960856|590483|P1|NOT COMPLETED|Period III||0
243168|NCT00960856|590480|P4|COMPLETED|Period III||9
243169|NCT00960856|590481|P3|COMPLETED|Period III||9
243170|NCT00960856|590482|P2|COMPLETED|Period III||7
243171|NCT00960856|590483|P1|COMPLETED|Period III||10
243172|NCT00960856|590480|P4|STARTED|Period III||9
243173|NCT00960856|590481|P3|STARTED|Period III||9
243174|NCT00960856|590482|P2|STARTED|Period III||7
243175|NCT00960856|590483|P1|STARTED|Period III||10
243176|NCT00960856|590480|P4|NOT COMPLETED|Washout Period of 7 Days||0
243177|NCT00960856|590481|P3|NOT COMPLETED|Washout Period of 7 Days||0
243178|NCT00960856|590482|P2|NOT COMPLETED|Washout Period of 7 Days||0
243179|NCT00960856|590483|P1|NOT COMPLETED|Washout Period of 7 Days||0
243180|NCT00960856|590480|P4|COMPLETED|Washout Period of 7 Days||9
243181|NCT00960856|590481|P3|COMPLETED|Washout Period of 7 Days||9
243182|NCT00960856|590482|P2|COMPLETED|Washout Period of 7 Days||7
243183|NCT00960856|590483|P1|COMPLETED|Washout Period of 7 Days||10
243184|NCT00960856|590480|P4|STARTED|Washout Period of 7 Days||9
243185|NCT00960856|590481|P3|STARTED|Washout Period of 7 Days||9
243186|NCT00960856|590482|P2|STARTED|Washout Period of 7 Days||7
243187|NCT00960856|590483|P1|STARTED|Washout Period of 7 Days||10
243188|NCT00960856|590480|P4|NOT COMPLETED|Period II||0
243189|NCT00960856|590481|P3|NOT COMPLETED|Period II||0
243190|NCT00960856|590482|P2|NOT COMPLETED|Period II||0
243191|NCT00960856|590483|P1|NOT COMPLETED|Period II||0
243192|NCT00960856|590480|P4|COMPLETED|Period II||9
243193|NCT00960856|590481|P3|COMPLETED|Period II||9
243194|NCT00960856|590482|P2|COMPLETED|Period II||7
243195|NCT00960856|590483|P1|COMPLETED|Period II||10
243196|NCT00960856|590480|P4|STARTED|Period II||9
243197|NCT00960856|590481|P3|STARTED|Period II||9
243198|NCT00960856|590482|P2|STARTED|Period II||7
243199|NCT00960856|590483|P1|STARTED|Period II||10
243200|NCT00960856|590480|P4|NOT COMPLETED|Washout Period of 7 Days||0
243201|NCT00960856|590481|P3|NOT COMPLETED|Washout Period of 7 Days||0
243202|NCT00960856|590482|P2|NOT COMPLETED|Washout Period of 7 Days||2
243203|NCT00960856|590483|P1|NOT COMPLETED|Washout Period of 7 Days||0
243204|NCT00960856|590480|P4|COMPLETED|Washout Period of 7 Days||9
243205|NCT00960856|590481|P3|COMPLETED|Washout Period of 7 Days||9
243206|NCT00960856|590482|P2|COMPLETED|Washout Period of 7 Days|personal reasons|7
243207|NCT00960856|590483|P1|COMPLETED|Washout Period of 7 Days||10
243208|NCT00960856|590480|P4|STARTED|Washout Period of 7 Days||9
243209|NCT00960856|590481|P3|STARTED|Washout Period of 7 Days||9
243210|NCT00960856|590482|P2|STARTED|Washout Period of 7 Days||9
243211|NCT00960856|590483|P1|STARTED|Washout Period of 7 Days||10
243212|NCT00960856|590480|P4|NOT COMPLETED|Period I||0
243213|NCT00960856|590481|P3|NOT COMPLETED|Period I||0
243214|NCT00960856|590482|P2|NOT COMPLETED|Period I||0
243215|NCT00960856|590483|P1|NOT COMPLETED|Period I||0
243216|NCT00960856|590480|P4|COMPLETED|Period I||9
243217|NCT00960856|590481|P3|COMPLETED|Period I||9
243218|NCT00960856|590482|P2|COMPLETED|Period I||9
243219|NCT00960856|590483|P1|COMPLETED|Period I||10
243220|NCT00960856|590480|P4|STARTED|Period I||9
243221|NCT00960856|590481|P3|STARTED|Period I||9
243222|NCT00960856|590482|P2|STARTED|Period I||9
243223|NCT00960856|590483|P1|STARTED|Period I||10
243224|NCT00960869|590503|P2|NOT COMPLETED|Overall Study||62
243225|NCT00960869|590504|P1|NOT COMPLETED|Overall Study||53
243226|NCT00960869|590503|P2|COMPLETED|Overall Study||198
243227|NCT00960869|590504|P1|COMPLETED|Overall Study||206
243228|NCT00960869|590503|P2|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|259
243229|NCT00960869|590504|P1|Safety Popluation|Overall Study|3 rand to PA32540 took EC-ASA 325mg/3 rand to EC-ASA 325mg took PA32540 counted by actual treatment.|257
243230|NCT00960869|590503|P2|Intent-to-Treat Population (ITT)|Overall Study||260
243231|NCT00960869|590504|P1|Intent-to-Treat Population (ITT)|Overall Study||259
243232|NCT00960869|590503|P2|STARTED|Overall Study||260
243233|NCT00960869|590504|P1|STARTED|Overall Study||259
243234|NCT00960934|590524|P6|NOT COMPLETED|Overall Study||64
243235|NCT00960934|590525|P5|NOT COMPLETED|Overall Study||64
243236|NCT00960934|590526|P4|NOT COMPLETED|Overall Study||64
243237|NCT00960934|590527|P3|NOT COMPLETED|Overall Study||64
243238|NCT00960934|590528|P2|NOT COMPLETED|Overall Study||63
243239|NCT00960934|590529|P1|NOT COMPLETED|Overall Study||64
243240|NCT00960934|590524|P6|COMPLETED|Overall Study||0
243241|NCT00960934|590525|P5|COMPLETED|Overall Study||0
243242|NCT00960934|590526|P4|COMPLETED|Overall Study||0
243243|NCT00960934|590527|P3|COMPLETED|Overall Study||0
243244|NCT00960934|590528|P2|COMPLETED|Overall Study||0
243245|NCT00960934|590529|P1|COMPLETED|Overall Study||0
243246|NCT00960934|590524|P6|Number Treated|Overall Study|1 participant was randomized but not treated|63
243247|NCT00960934|590525|P5|Number Treated|Overall Study|1 participant was randomized but not treated|63
243248|NCT00960934|590526|P4|Number Treated|Overall Study||64
243249|NCT00960934|590527|P3|Number Treated|Overall Study||64
243250|NCT00960934|590528|P2|Number Treated|Overall Study|1 participant was randomized but not treated|62
243251|NCT00960934|590529|P1|Number Treated|Overall Study||64
243252|NCT00960934|590524|P6|STARTED|Overall Study||64
243253|NCT00960934|590525|P5|STARTED|Overall Study||64
243254|NCT00960934|590526|P4|STARTED|Overall Study||64
243255|NCT00960934|590527|P3|STARTED|Overall Study||64
243256|NCT00960934|590528|P2|STARTED|Overall Study||63
243257|NCT00960934|590529|P1|STARTED|Overall Study||64
243258|NCT00960986|590643|P4|NOT COMPLETED|Period 3 (7-week Therapy Period)||25
243259|NCT00960986|590644|P3|NOT COMPLETED|Period 3 (7-week Therapy Period)||20
243260|NCT00960986|590645|P2|NOT COMPLETED|Period 3 (7-week Therapy Period)||23
243261|NCT00960986|590646|P1|NOT COMPLETED|Period 3 (7-week Therapy Period)||30
243262|NCT00960986|590643|P4|COMPLETED|Period 3 (7-week Therapy Period)||36
243263|NCT00960986|590644|P3|COMPLETED|Period 3 (7-week Therapy Period)||39
243264|NCT00960986|590645|P2|COMPLETED|Period 3 (7-week Therapy Period)||36
243265|NCT00960986|590646|P1|COMPLETED|Period 3 (7-week Therapy Period)||26
243266|NCT00960986|590643|P4|STARTED|Period 3 (7-week Therapy Period)||61
243267|NCT00960986|590644|P3|STARTED|Period 3 (7-week Therapy Period)||59
243268|NCT00960986|590645|P2|STARTED|Period 3 (7-week Therapy Period)||59
243269|NCT00960986|590646|P1|STARTED|Period 3 (7-week Therapy Period)||56
243270|NCT00960986|590643|P4|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
243271|NCT00960986|590644|P3|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
243272|NCT00960986|590645|P2|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
243273|NCT00960986|590646|P1|NOT COMPLETED|Period 2 (1-week Initial Dosing Period)||0
243274|NCT00960986|590643|P4|COMPLETED|Period 2 (1-week Initial Dosing Period)||61
243275|NCT00960986|590644|P3|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
243276|NCT00960986|590645|P2|COMPLETED|Period 2 (1-week Initial Dosing Period)||59
243277|NCT00960986|590646|P1|COMPLETED|Period 2 (1-week Initial Dosing Period)||56
243278|NCT00960986|590643|P4|STARTED|Period 2 (1-week Initial Dosing Period)||61
243279|NCT00960986|590644|P3|STARTED|Period 2 (1-week Initial Dosing Period)||59
243280|NCT00960986|590645|P2|STARTED|Period 2 (1-week Initial Dosing Period)||59
243281|NCT00960986|590646|P1|STARTED|Period 2 (1-week Initial Dosing Period)||56
243282|NCT00960986|590643|P4|NOT COMPLETED|Period 1 (Screening and Washout)||3
243283|NCT00960986|590644|P3|NOT COMPLETED|Period 1 (Screening and Washout)||4
243284|NCT00960986|590645|P2|NOT COMPLETED|Period 1 (Screening and Washout)||4
243285|NCT00960986|590646|P1|NOT COMPLETED|Period 1 (Screening and Washout)||3
243286|NCT00960986|590643|P4|COMPLETED|Period 1 (Screening and Washout)||61
243287|NCT00960986|590644|P3|COMPLETED|Period 1 (Screening and Washout)||59
243288|NCT00960986|590645|P2|COMPLETED|Period 1 (Screening and Washout)||59
243289|NCT00960986|590646|P1|COMPLETED|Period 1 (Screening and Washout)||56
243290|NCT00960986|590643|P4|STARTED|Period 1 (Screening and Washout)||64
243291|NCT00960986|590644|P3|STARTED|Period 1 (Screening and Washout)||63
243292|NCT00960986|590645|P2|STARTED|Period 1 (Screening and Washout)||63
243293|NCT00960986|590646|P1|STARTED|Period 1 (Screening and Washout)||59
243294|NCT00960999|590718|P2|NOT COMPLETED|Overall Study||2
243295|NCT00960999|590719|P1|NOT COMPLETED|Overall Study||8
243296|NCT00960999|590718|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|45
243297|NCT00960999|590719|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|39
243298|NCT00960999|590718|P2|STARTED|Overall Study||47
243299|NCT00960999|590719|P1|STARTED|Overall Study||47
243300|NCT00961051|590727|P2|NOT COMPLETED|Overall Study||14
243301|NCT00961051|590728|P1|NOT COMPLETED|Overall Study||12
243302|NCT00961051|590727|P2|COMPLETED|Overall Study||79
243303|NCT00961051|590728|P1|COMPLETED|Overall Study||165
243304|NCT00961051|590727|P2|STARTED|Overall Study||93
243305|NCT00961051|590728|P1|STARTED|Overall Study||177
243306|NCT00961116|590736|P2|NOT COMPLETED|Second Intervention||0
243307|NCT00961116|590737|P1|NOT COMPLETED|Second Intervention||0
243308|NCT00961116|590736|P2|COMPLETED|Second Intervention||24
243309|NCT00961116|590737|P1|COMPLETED|Second Intervention||25
243310|NCT00961116|590736|P2|STARTED|Second Intervention||24
243311|NCT00961116|590737|P1|STARTED|Second Intervention||25
243312|NCT00961116|590736|P2|NOT COMPLETED|Washout Period of 7 Days||3
243313|NCT00961116|590737|P1|NOT COMPLETED|Washout Period of 7 Days||2
243314|NCT00961116|590736|P2|COMPLETED|Washout Period of 7 Days||24
243315|NCT00961116|590737|P1|COMPLETED|Washout Period of 7 Days||25
243316|NCT00961116|590736|P2|STARTED|Washout Period of 7 Days||27
243317|NCT00961116|590737|P1|STARTED|Washout Period of 7 Days||27
243318|NCT00961116|590736|P2|NOT COMPLETED|First Intervention||0
243319|NCT00961116|590737|P1|NOT COMPLETED|First Intervention||0
243320|NCT00961116|590736|P2|COMPLETED|First Intervention||27
243321|NCT00961116|590737|P1|COMPLETED|First Intervention||27
243322|NCT00961116|590736|P2|STARTED|First Intervention||27
243323|NCT00961116|590737|P1|STARTED|First Intervention||27
243324|NCT00961181|590747|P1|NOT COMPLETED|Overall Study||5
243325|NCT00961181|590747|P1|COMPLETED|Overall Study||76
243326|NCT00961181|590747|P1|STARTED|Overall Study||81
243327|NCT00961220|590760|P1|NOT COMPLETED|Overall Study||7
243328|NCT00961220|590760|P1|COMPLETED|Overall Study||10
243329|NCT00961220|590760|P1|STARTED|Overall Study||17
243330|NCT00961233|590778|P2|NOT COMPLETED|Overall Study||1
243331|NCT00961233|590779|P1|NOT COMPLETED|Overall Study||2
243332|NCT00961233|590778|P2|COMPLETED|Overall Study||11
243333|NCT00961233|590779|P1|COMPLETED|Overall Study||11
243334|NCT00961233|590778|P2|STARTED|Overall Study||12
243335|NCT00961233|590779|P1|STARTED|Overall Study||13
243336|NCT00961259|590787|P3|NOT COMPLETED|Third Intervention||0
243337|NCT00961259|590788|P2|NOT COMPLETED|Third Intervention||0
243338|NCT00961259|590789|P1|NOT COMPLETED|Third Intervention||0
243339|NCT00961259|590787|P3|COMPLETED|Third Intervention||18
243340|NCT00961259|590788|P2|COMPLETED|Third Intervention||17
243341|NCT00961259|590789|P1|COMPLETED|Third Intervention||18
243342|NCT00961259|590787|P3|STARTED|Third Intervention||18
243343|NCT00961259|590788|P2|STARTED|Third Intervention||17
243344|NCT00961259|590789|P1|STARTED|Third Intervention||18
243345|NCT00961259|590787|P3|NOT COMPLETED|Washout Period of 7 Days||0
243346|NCT00961259|590788|P2|NOT COMPLETED|Washout Period of 7 Days||0
243347|NCT00961259|590789|P1|NOT COMPLETED|Washout Period of 7 Days||0
243348|NCT00961259|590787|P3|COMPLETED|Washout Period of 7 Days||18
243349|NCT00961259|590788|P2|COMPLETED|Washout Period of 7 Days||17
243350|NCT00961259|590789|P1|COMPLETED|Washout Period of 7 Days||18
243351|NCT00961259|590787|P3|STARTED|Washout Period of 7 Days||18
243352|NCT00961259|590788|P2|STARTED|Washout Period of 7 Days||17
243353|NCT00961259|590789|P1|STARTED|Washout Period of 7 Days||18
243354|NCT00961259|590787|P3|NOT COMPLETED|Second Intervention||0
243355|NCT00961259|590788|P2|NOT COMPLETED|Second Intervention||0
243356|NCT00961259|590789|P1|NOT COMPLETED|Second Intervention||0
243357|NCT00961259|590787|P3|COMPLETED|Second Intervention||18
243358|NCT00961259|590788|P2|COMPLETED|Second Intervention||17
243359|NCT00961259|590789|P1|COMPLETED|Second Intervention||18
243360|NCT00961259|590787|P3|STARTED|Second Intervention||18
243361|NCT00961259|590788|P2|STARTED|Second Intervention||17
243362|NCT00961259|590789|P1|STARTED|Second Intervention||18
243363|NCT00961259|590787|P3|NOT COMPLETED|Washout Period of 7 Days||0
243364|NCT00961259|590788|P2|NOT COMPLETED|Washout Period of 7 Days||1
243365|NCT00961259|590789|P1|NOT COMPLETED|Washout Period of 7 Days||0
243366|NCT00961259|590787|P3|COMPLETED|Washout Period of 7 Days||18
243367|NCT00961259|590788|P2|COMPLETED|Washout Period of 7 Days|dropped due to concomitant medication used prior to admission.|17
243368|NCT00961259|590789|P1|COMPLETED|Washout Period of 7 Days||18
243369|NCT00961259|590787|P3|STARTED|Washout Period of 7 Days||18
243370|NCT00961259|590788|P2|STARTED|Washout Period of 7 Days||18
243371|NCT00961259|590789|P1|STARTED|Washout Period of 7 Days||18
243372|NCT00961259|590787|P3|NOT COMPLETED|First Intervention||0
243373|NCT00961259|590788|P2|NOT COMPLETED|First Intervention||0
243374|NCT00961259|590789|P1|NOT COMPLETED|First Intervention||0
243375|NCT00961259|590787|P3|COMPLETED|First Intervention||18
243376|NCT00961259|590788|P2|COMPLETED|First Intervention||18
243377|NCT00961259|590789|P1|COMPLETED|First Intervention||18
243378|NCT00961259|590787|P3|STARTED|First Intervention||18
243379|NCT00961259|590788|P2|STARTED|First Intervention||18
243380|NCT00961259|590789|P1|STARTED|First Intervention||18
243381|NCT00961298|590806|P1|NOT COMPLETED|12 Weeks Duloxetine Treatment Phase||3
243382|NCT00961298|590806|P1|COMPLETED|12 Weeks Duloxetine Treatment Phase||11
243383|NCT00961298|590806|P1|STARTED|12 Weeks Duloxetine Treatment Phase||14
243384|NCT00961298|590806|P1|NOT COMPLETED|Two Week Placebo Run in||1
243385|NCT00961298|590806|P1|COMPLETED|Two Week Placebo Run in||14
243386|NCT00961298|590806|P1|STARTED|Two Week Placebo Run in||15
243387|NCT00961311|590813|P1|NOT COMPLETED|Overall Study||0
243388|NCT00961311|590813|P1|COMPLETED|Overall Study||51
243389|NCT00961311|590813|P1|STARTED|Overall Study||51
243390|NCT00961350|590822|P2|NOT COMPLETED|Overall Study||67
243391|NCT00961350|590823|P1|NOT COMPLETED|Overall Study||47
243392|NCT00961350|590822|P2|COMPLETED|Overall Study||198
243393|NCT00961350|590823|P1|COMPLETED|Overall Study||218
243394|NCT00961350|590822|P2|Safety Population|Overall Study||265
243395|NCT00961350|590823|P1|Safety Population|Overall Study|1. One sub rand to PA32540 took EC-Aspirin|264
243396|NCT00961350|590822|P2|Intent-to-Treat Population (ITT)|Overall Study||265
243397|NCT00961350|590823|P1|Intent-to-Treat Population (ITT)|Overall Study||265
243398|NCT00961350|590822|P2|STARTED|Overall Study||265
243399|NCT00961350|590823|P1|STARTED|Overall Study||265
243400|NCT00961402|590839|P2|NOT COMPLETED|Overall Study||5
243401|NCT00961402|590840|P1|NOT COMPLETED|Overall Study||1
243402|NCT00961402|590839|P2|COMPLETED|Overall Study||61
243403|NCT00961402|590840|P1|COMPLETED|Overall Study||63
243404|NCT00961402|590839|P2|Randomized|Overall Study||66
243405|NCT00961402|590840|P1|Randomized|Overall Study||64
243406|NCT00961402|590839|P2|STARTED|Overall Study||66
243407|NCT00961402|590840|P1|STARTED|Overall Study||64
243408|NCT00961415|590854|P3|NOT COMPLETED|Maintenance Treatment Phase||45
243409|NCT00961415|590855|P2|NOT COMPLETED|Maintenance Treatment Phase||48
243410|NCT00961415|590856|P1|NOT COMPLETED|Maintenance Treatment Phase||0
243411|NCT00961415|590854|P3|COMPLETED|Maintenance Treatment Phase||83
243412|NCT00961415|590855|P2|COMPLETED|Maintenance Treatment Phase||77
243413|NCT00961415|590856|P1|COMPLETED|Maintenance Treatment Phase||0
243414|NCT00961415|590854|P3|STARTED|Maintenance Treatment Phase||128
243415|NCT00961415|590855|P2|STARTED|Maintenance Treatment Phase||125
243416|NCT00961415|590856|P1|STARTED|Maintenance Treatment Phase||0
243417|NCT00961415|590854|P3|NOT COMPLETED|Induction Treatment Phase||0
243418|NCT00961415|590855|P2|NOT COMPLETED|Induction Treatment Phase||0
243419|NCT00961415|590856|P1|NOT COMPLETED|Induction Treatment Phase||123
243420|NCT00961415|590854|P3|COMPLETED|Induction Treatment Phase||0
243421|NCT00961415|590855|P2|COMPLETED|Induction Treatment Phase||0
243422|NCT00961415|590856|P1|COMPLETED|Induction Treatment Phase||253
243423|NCT00961415|590854|P3|STARTED|Induction Treatment Phase||0
243424|NCT00961415|590855|P2|STARTED|Induction Treatment Phase||0
243425|NCT00961415|590856|P1|STARTED|Induction Treatment Phase||376
243426|NCT00961441|590881|P2|NOT COMPLETED|Overall Study||0
243427|NCT00961441|590882|P1|NOT COMPLETED|Overall Study||0
243428|NCT00961441|590881|P2|COMPLETED|Overall Study||13
243429|NCT00961441|590882|P1|COMPLETED|Overall Study||12
243430|NCT00961441|590881|P2|Pharmacokinetic (PK-PP) Population|Overall Study|Two subjects were excluded due to study medication noncompliance, one due to wrong dosing regimen.|10
243431|NCT00961441|590882|P1|Pharmacokinetic (PK-PP) Population|Overall Study||12
243432|NCT00961441|590881|P2|STARTED|Overall Study||13
243433|NCT00961441|590882|P1|STARTED|Overall Study||12
243434|NCT00961532|590896|P1|NOT COMPLETED|Overall Study||0
243435|NCT00961532|590896|P1|COMPLETED|Overall Study||14
243436|NCT00961532|590896|P1|STARTED|Overall Study||14
243437|NCT00961571|590901|P1|NOT COMPLETED|Overall Study||39
243438|NCT00961571|590901|P1|COMPLETED|Overall Study|high percentage of patient drop-off study prior cancer progression|11
243439|NCT00961571|590901|P1|STARTED|Overall Study||50
243440|NCT00961636|590908|P3|NOT COMPLETED|Overall Study||32
243441|NCT00961636|590909|P2|NOT COMPLETED|Overall Study||131
243442|NCT00961636|590910|P1|NOT COMPLETED|Overall Study||107
243443|NCT00961636|590908|P3|COMPLETED|Overall Study||201
243444|NCT00961636|590909|P2|COMPLETED|Overall Study||325
243445|NCT00961636|590910|P1|COMPLETED|Overall Study||356
243446|NCT00961636|590908|P3|STARTED|Overall Study||233
243447|NCT00961636|590909|P2|STARTED|Overall Study||456
243448|NCT00961636|590910|P1|STARTED|Overall Study||463
243449|NCT00961649|590925|P4|NOT COMPLETED|Overall Study||4
243450|NCT00961649|590926|P3|NOT COMPLETED|Overall Study||5
243451|NCT00961649|590927|P2|NOT COMPLETED|Overall Study||4
243452|NCT00961649|590928|P1|NOT COMPLETED|Overall Study||9
243453|NCT00961649|590925|P4|COMPLETED|Overall Study||37
243454|NCT00961649|590926|P3|COMPLETED|Overall Study||39
243455|NCT00961649|590927|P2|COMPLETED|Overall Study||40
243456|NCT00961649|590928|P1|COMPLETED|Overall Study||32
243457|NCT00961649|590925|P4|STARTED|Overall Study||41
243458|NCT00961649|590926|P3|STARTED|Overall Study||44
243459|NCT00961649|590927|P2|STARTED|Overall Study||44
243460|NCT00961649|590928|P1|STARTED|Overall Study||41
243461|NCT00961662|590942|P3|NOT COMPLETED|Overall Study||19
243462|NCT00961662|590943|P2|NOT COMPLETED|Overall Study||19
243463|NCT00961662|590944|P1|NOT COMPLETED|Overall Study||22
243464|NCT00961662|590942|P3|COMPLETED|Overall Study||34
243465|NCT00961662|590943|P2|COMPLETED|Overall Study||32
243466|NCT00961662|590944|P1|COMPLETED|Overall Study||35
243467|NCT00961662|590942|P3|STARTED|Overall Study||53
243468|NCT00961662|590943|P2|STARTED|Overall Study||51
243469|NCT00961662|590944|P1|STARTED|Overall Study||57
243470|NCT00961805|590954|P2|NOT COMPLETED|Overall Study||0
243471|NCT00961805|590955|P1|NOT COMPLETED|Overall Study||0
243472|NCT00961805|590954|P2|COMPLETED|Overall Study||40
243473|NCT00961805|590955|P1|COMPLETED|Overall Study||40
243474|NCT00961805|590954|P2|STARTED|Overall Study||40
243475|NCT00961805|590955|P1|STARTED|Overall Study||40
243476|NCT00961896|590986|P3|NOT COMPLETED|Overall Study||1
243477|NCT00961896|590987|P2|NOT COMPLETED|Overall Study||0
243478|NCT00961896|590988|P1|NOT COMPLETED|Overall Study||0
243479|NCT00961896|590986|P3|COMPLETED|Overall Study||6
243480|NCT00961896|590987|P2|COMPLETED|Overall Study||3
243481|NCT00961896|590988|P1|COMPLETED|Overall Study||8
243482|NCT00961896|590986|P3|STARTED|Overall Study||7
243483|NCT00961896|590987|P2|STARTED|Overall Study||3
243484|NCT00961896|590988|P1|STARTED|Overall Study||8
243485|NCT00962000|591007|P2|NOT COMPLETED|Period 4 - 1 Week||0
243486|NCT00962000|591008|P1|NOT COMPLETED|Period 4 - 1 Week||0
243487|NCT00962000|591007|P2|COMPLETED|Period 4 - 1 Week||21
243488|NCT00962000|591008|P1|COMPLETED|Period 4 - 1 Week||21
243489|NCT00962000|591007|P2|STARTED|Period 4 - 1 Week||21
243490|NCT00962000|591008|P1|STARTED|Period 4 - 1 Week||21
243491|NCT00962000|591007|P2|NOT COMPLETED|Period 3 - 1 Week||0
243492|NCT00962000|591008|P1|NOT COMPLETED|Period 3 - 1 Week||0
243493|NCT00962000|591007|P2|COMPLETED|Period 3 - 1 Week||21
243494|NCT00962000|591008|P1|COMPLETED|Period 3 - 1 Week||21
243495|NCT00962000|591007|P2|STARTED|Period 3 - 1 Week||21
243496|NCT00962000|591008|P1|STARTED|Period 3 - 1 Week||21
243497|NCT00962000|591007|P2|NOT COMPLETED|Period 2 - 1 Week||0
243498|NCT00962000|591008|P1|NOT COMPLETED|Period 2 - 1 Week||0
243499|NCT00962000|591007|P2|COMPLETED|Period 2 - 1 Week||21
243500|NCT00962000|591008|P1|COMPLETED|Period 2 - 1 Week||21
243501|NCT00962000|591007|P2|STARTED|Period 2 - 1 Week||21
243502|NCT00962000|591008|P1|STARTED|Period 2 - 1 Week||21
243503|NCT00962000|591007|P2|NOT COMPLETED|Period 1 - 1 Week||0
243504|NCT00962000|591008|P1|NOT COMPLETED|Period 1 - 1 Week||0
243505|NCT00962000|591007|P2|COMPLETED|Period 1 - 1 Week||21
243506|NCT00962000|591008|P1|COMPLETED|Period 1 - 1 Week||21
243507|NCT00962000|591007|P2|STARTED|Period 1 - 1 Week||21
243508|NCT00962000|591008|P1|STARTED|Period 1 - 1 Week||21
243509|NCT00962013|591018|P1|NOT COMPLETED|Overall Study||68
243510|NCT00962013|591018|P1|COMPLETED|Overall Study|Number of participants with 5 year primary endpoint data|52
243511|NCT00962013|591018|P1|STARTED|Overall Study||120
243512|NCT00962065|591030|P3|NOT COMPLETED|Overall Study||0
243513|NCT00962065|591031|P2|NOT COMPLETED|Overall Study||0
243514|NCT00962065|591032|P1|NOT COMPLETED|Overall Study||0
243515|NCT00962065|591030|P3|COMPLETED|Overall Study||12
243516|NCT00962065|591031|P2|COMPLETED|Overall Study||12
243517|NCT00962065|591032|P1|COMPLETED|Overall Study||12
243518|NCT00962065|591030|P3|STARTED|Overall Study||12
243519|NCT00962065|591031|P2|STARTED|Overall Study||12
243520|NCT00962065|591032|P1|STARTED|Overall Study||12
243521|NCT00962104|591057|P2|NOT COMPLETED|Overall Study||25
243522|NCT00962104|591058|P1|NOT COMPLETED|Overall Study||40
243523|NCT00962104|591057|P2|COMPLETED|Overall Study||171
243524|NCT00962104|591058|P1|COMPLETED|Overall Study||155
243525|NCT00962104|591057|P2|Full Analysis Set|Overall Study|1 participant was excluded because that participant failed to take the assigned study medication.|195
243526|NCT00962104|591058|P1|Full Analysis Set|Overall Study|2 participants were excluded because they failed to take the assigned study medication.|193
243527|NCT00962104|591057|P2|STARTED|Overall Study||196
243528|NCT00962104|591058|P1|STARTED|Overall Study||195
243529|NCT00962208|591086|P2|NOT COMPLETED|Overall Study||10
243530|NCT00962208|591087|P1|NOT COMPLETED|Overall Study||14
243531|NCT00962208|591086|P2|COMPLETED|Overall Study||41
243532|NCT00962208|591087|P1|COMPLETED|Overall Study||37
243533|NCT00962208|591086|P2|STARTED|Overall Study||51
243534|NCT00962208|591087|P1|STARTED|Overall Study||51
243535|NCT00962247|591093|P1|NOT COMPLETED|50% Reduction of Sedentary Activity||0
243536|NCT00962247|591093|P1|COMPLETED|50% Reduction of Sedentary Activity||56
243537|NCT00962247|591093|P1|STARTED|50% Reduction of Sedentary Activity||56
243538|NCT00962247|591093|P1|NOT COMPLETED|25% Reduction of Sedentary Activity||5
243539|NCT00962247|591093|P1|COMPLETED|25% Reduction of Sedentary Activity||56
243540|NCT00962247|591093|P1|STARTED|25% Reduction of Sedentary Activity||61
243541|NCT00962247|591093|P1|NOT COMPLETED|Usual Sedentary||18
243542|NCT00962247|591093|P1|COMPLETED|Usual Sedentary||61
243543|NCT00962247|591093|P1|STARTED|Usual Sedentary||79
243544|NCT00962390|591106|P4|NOT COMPLETED|Overall Study||1
243545|NCT00962390|591107|P3|NOT COMPLETED|Overall Study||4
243546|NCT00962390|591108|P2|NOT COMPLETED|Overall Study||3
243547|NCT00962390|591109|P1|NOT COMPLETED|Overall Study||4
243548|NCT00962390|591106|P4|COMPLETED|Overall Study||28
243549|NCT00962390|591107|P3|COMPLETED|Overall Study||25
243550|NCT00962390|591108|P2|COMPLETED|Overall Study||26
243551|NCT00962390|591109|P1|COMPLETED|Overall Study||25
243552|NCT00962390|591106|P4|STARTED|Overall Study||29
243553|NCT00962390|591107|P3|STARTED|Overall Study||29
243554|NCT00962390|591108|P2|STARTED|Overall Study||29
243555|NCT00962390|591109|P1|STARTED|Overall Study||29
243556|NCT00962585|591175|P4|NOT COMPLETED|Overall Study||0
243557|NCT00962585|591176|P3|NOT COMPLETED|Overall Study||3
243558|NCT00962585|591177|P2|NOT COMPLETED|Overall Study||2
243559|NCT00962585|591178|P1|NOT COMPLETED|Overall Study||6
243560|NCT00962585|591175|P4|COMPLETED|Overall Study||42
243561|NCT00962585|591176|P3|COMPLETED|Overall Study||39
243562|NCT00962585|591177|P2|COMPLETED|Overall Study||40
243563|NCT00962585|591178|P1|COMPLETED|Overall Study||37
243564|NCT00962585|591175|P4|STARTED|Overall Study||42
243565|NCT00962585|591176|P3|STARTED|Overall Study||42
243566|NCT00962585|591177|P2|STARTED|Overall Study||42
243567|NCT00962585|591178|P1|STARTED|Overall Study||43
243568|NCT00962598|591238|P2|NOT COMPLETED|Overall Study||6
243569|NCT00962598|591239|P1|NOT COMPLETED|Overall Study||6
243570|NCT00962598|591238|P2|COMPLETED|Overall Study||18
243571|NCT00962598|591239|P1|COMPLETED|Overall Study||21
243572|NCT00962598|591238|P2|STARTED|Overall Study||24
243573|NCT00962598|591239|P1|STARTED|Overall Study||27
243574|NCT00962650|591247|P1|NOT COMPLETED|Overall Study||2
243575|NCT00962650|591247|P1|COMPLETED|Overall Study||8
243576|NCT00962650|591247|P1|STARTED|Overall Study||10
243577|NCT00968617|591251|P1|NOT COMPLETED|Overall Study||6
243578|NCT00968617|591251|P1|COMPLETED|Overall Study||1
243579|NCT00968617|591251|P1|STARTED|Overall Study||7
243580|NCT00968669|591267|P4|NOT COMPLETED|Overall Study||9
243581|NCT00968669|591268|P3|NOT COMPLETED|Overall Study||11
243582|NCT00968669|591269|P2|NOT COMPLETED|Overall Study||18
243583|NCT00968669|591270|P1|NOT COMPLETED|Overall Study||18
243584|NCT00968669|591267|P4|COMPLETED|Overall Study||72
243585|NCT00968669|591268|P3|COMPLETED|Overall Study||72
243586|NCT00968669|591269|P2|COMPLETED|Overall Study||63
243587|NCT00968669|591270|P1|COMPLETED|Overall Study||64
243588|NCT00968669|591267|P4|STARTED|Overall Study||81
243589|NCT00968669|591268|P3|STARTED|Overall Study||83
243590|NCT00968669|591269|P2|STARTED|Overall Study||81
243591|NCT00968669|591270|P1|STARTED|Overall Study||82
243592|NCT00971204|591360|P1|NOT COMPLETED|Overall Study||24
243593|NCT00971204|591360|P1|COMPLETED|Overall Study|86 participants were treated and of these 86, 76 completed the study.|76
243594|NCT00971204|591360|P1|Treated|Overall Study||86
243595|NCT00971204|591360|P1|STARTED|Overall Study|100 enrolled participants|100
243596|NCT00971243|591369|P5|NOT COMPLETED|Open-label Period||6
243597|NCT00971243|591370|P4|NOT COMPLETED|Open-label Period||10
243598|NCT00971243|591371|P3|NOT COMPLETED|Open-label Period||5
243599|NCT00971243|591372|P2|NOT COMPLETED|Open-label Period||10
243600|NCT00971243|591373|P1|NOT COMPLETED|Open-label Period||8
243601|NCT00971243|591369|P5|COMPLETED|Open-label Period||64
243602|NCT00971243|591370|P4|COMPLETED|Open-label Period||64
243603|NCT00971243|591371|P3|COMPLETED|Open-label Period||66
243604|NCT00971243|591372|P2|COMPLETED|Open-label Period||71
243605|NCT00971243|591373|P1|COMPLETED|Open-label Period||60
243606|NCT00971243|591369|P5|STARTED|Open-label Period||70
243607|NCT00971243|591370|P4|STARTED|Open-label Period||74
243608|NCT00971243|591371|P3|STARTED|Open-label Period|One Subject did not entered the Open-label Period because of the withdrawal of consent.|71
243609|NCT00971243|591372|P2|STARTED|Open-label Period|One Subject did not entered because of the failure of inclusion/exclusion criteria.|81
243610|NCT00971243|591373|P1|STARTED|Open-label Period||68
243611|NCT00971243|591369|P5|NOT COMPLETED|Double Blind Period||18
243612|NCT00971243|591370|P4|NOT COMPLETED|Double Blind Period||14
243613|NCT00971243|591371|P3|NOT COMPLETED|Double Blind Period||19
243614|NCT00971243|591372|P2|NOT COMPLETED|Double Blind Period||11
243615|NCT00971243|591373|P1|NOT COMPLETED|Double Blind Period||19
243616|NCT00971243|591369|P5|COMPLETED|Double Blind Period||70
243617|NCT00971243|591370|P4|COMPLETED|Double Blind Period||74
243618|NCT00971243|591371|P3|COMPLETED|Double Blind Period||72
243619|NCT00971243|591372|P2|COMPLETED|Double Blind Period||82
243620|NCT00971243|591373|P1|COMPLETED|Double Blind Period||68
243621|NCT00971243|591369|P5|STARTED|Double Blind Period||88
243622|NCT00971243|591370|P4|STARTED|Double Blind Period|One subject who did not receive any study drug was excluded from the ITT|88
243623|NCT00971243|591371|P3|STARTED|Double Blind Period||91
243624|NCT00971243|591372|P2|STARTED|Double Blind Period||93
243625|NCT00971243|591373|P1|STARTED|Double Blind Period||87
243626|NCT00971282|591390|P1|NOT COMPLETED|Overall Study||0
243627|NCT00971282|591390|P1|COMPLETED|Overall Study||30
243628|NCT00971282|591390|P1|STARTED|Overall Study||30
243629|NCT00971295|591404|P2|NOT COMPLETED|Overall Study||1
243630|NCT00971295|591405|P1|NOT COMPLETED|Overall Study||0
243631|NCT00971295|591404|P2|COMPLETED|Overall Study||9
243632|NCT00971295|591405|P1|COMPLETED|Overall Study||10
243633|NCT00971295|591404|P2|STARTED|Overall Study||10
243634|NCT00971295|591405|P1|STARTED|Overall Study||10
243635|NCT00971425|591417|P2|NOT COMPLETED|Overall Study||2
243636|NCT00971425|591418|P1|NOT COMPLETED|Overall Study||1
243637|NCT00971425|591417|P2|COMPLETED|Overall Study||71
243638|NCT00971425|591418|P1|COMPLETED|Overall Study||71
243639|NCT00971425|591417|P2|STARTED|Overall Study||73
243640|NCT00971425|591418|P1|STARTED|Overall Study||72
243641|NCT00971620|591454|P2|NOT COMPLETED|Overall Study||0
243642|NCT00971620|591455|P1|NOT COMPLETED|Overall Study||0
243643|NCT00971620|591454|P2|COMPLETED|Overall Study||9
243644|NCT00971620|591455|P1|COMPLETED|Overall Study||9
243645|NCT00971620|591454|P2|STARTED|Overall Study||9
243646|NCT00971620|591455|P1|STARTED|Overall Study||9
243647|NCT00971633|591485|P6|NOT COMPLETED|Period 3||0
243648|NCT00971633|591486|P5|NOT COMPLETED|Period 3||0
243649|NCT00971633|591487|P4|NOT COMPLETED|Period 3||0
243650|NCT00971633|591488|P3|NOT COMPLETED|Period 3||0
243651|NCT00971633|591489|P2|NOT COMPLETED|Period 3||0
243652|NCT00971633|591490|P1|NOT COMPLETED|Period 3||0
243653|NCT00971633|591485|P6|COMPLETED|Period 3||2
243654|NCT00971633|591486|P5|COMPLETED|Period 3||2
243655|NCT00971633|591487|P4|COMPLETED|Period 3||2
243656|NCT00971633|591488|P3|COMPLETED|Period 3||2
243657|NCT00971633|591489|P2|COMPLETED|Period 3||2
243658|NCT00971633|591490|P1|COMPLETED|Period 3||2
243659|NCT00971633|591485|P6|STARTED|Period 3||2
243660|NCT00971633|591486|P5|STARTED|Period 3||2
243661|NCT00971633|591487|P4|STARTED|Period 3||2
243662|NCT00971633|591488|P3|STARTED|Period 3||2
243663|NCT00971633|591489|P2|STARTED|Period 3||2
243664|NCT00971633|591490|P1|STARTED|Period 3||2
243665|NCT00971633|591485|P6|NOT COMPLETED|Period 2||0
243666|NCT00971633|591486|P5|NOT COMPLETED|Period 2||0
243667|NCT00971633|591487|P4|NOT COMPLETED|Period 2||0
243668|NCT00971633|591488|P3|NOT COMPLETED|Period 2||0
243669|NCT00971633|591489|P2|NOT COMPLETED|Period 2||0
243670|NCT00971633|591490|P1|NOT COMPLETED|Period 2||0
243671|NCT00971633|591485|P6|COMPLETED|Period 2||2
243672|NCT00971633|591486|P5|COMPLETED|Period 2||2
243673|NCT00971633|591487|P4|COMPLETED|Period 2||2
243674|NCT00971633|591488|P3|COMPLETED|Period 2||2
243675|NCT00971633|591489|P2|COMPLETED|Period 2||2
243676|NCT00971633|591490|P1|COMPLETED|Period 2||2
243677|NCT00971633|591485|P6|STARTED|Period 2||2
243678|NCT00971633|591486|P5|STARTED|Period 2||2
243679|NCT00971633|591487|P4|STARTED|Period 2||2
243680|NCT00971633|591488|P3|STARTED|Period 2||2
243681|NCT00971633|591489|P2|STARTED|Period 2||2
243682|NCT00971633|591490|P1|STARTED|Period 2||2
243683|NCT00971633|591485|P6|NOT COMPLETED|Period 1||0
243684|NCT00971633|591486|P5|NOT COMPLETED|Period 1||0
243685|NCT00971633|591487|P4|NOT COMPLETED|Period 1||0
243686|NCT00971633|591488|P3|NOT COMPLETED|Period 1||0
243687|NCT00971633|591489|P2|NOT COMPLETED|Period 1||0
243688|NCT00971633|591490|P1|NOT COMPLETED|Period 1||0
243689|NCT00971633|591485|P6|COMPLETED|Period 1||2
243690|NCT00971633|591486|P5|COMPLETED|Period 1||2
243691|NCT00971633|591487|P4|COMPLETED|Period 1||2
243692|NCT00971633|591488|P3|COMPLETED|Period 1||2
243693|NCT00971633|591489|P2|COMPLETED|Period 1||2
243694|NCT00971633|591490|P1|COMPLETED|Period 1||2
243695|NCT00971633|591485|P6|STARTED|Period 1||2
243696|NCT00971633|591486|P5|STARTED|Period 1||2
243697|NCT00971633|591487|P4|STARTED|Period 1||2
243698|NCT00971633|591488|P3|STARTED|Period 1||2
243699|NCT00971633|591489|P2|STARTED|Period 1||2
243700|NCT00971633|591490|P1|STARTED|Period 1||2
243701|NCT00971750|591501|P1|NOT COMPLETED|Overall Study||0
243702|NCT00971750|591501|P1|COMPLETED|Overall Study||253
243703|NCT00971750|591501|P1|STARTED|Overall Study||253
243704|NCT00971789|591510|P1|NOT COMPLETED|Overall Study||0
243705|NCT00971789|591510|P1|COMPLETED|Overall Study||18
243706|NCT00971789|591510|P1|STARTED|Overall Study||18
243707|NCT00971841|591515|P1|NOT COMPLETED|Overall Study||0
243708|NCT00971841|591515|P1|COMPLETED|Overall Study||1
243709|NCT00971841|591515|P1|STARTED|Overall Study||1
243710|NCT00971932|591520|P1|NOT COMPLETED|Overall Study||7
243711|NCT00971932|591520|P1|COMPLETED|Overall Study||26
243712|NCT00971932|591520|P1|STARTED|Overall Study|Number of participants treated.|33
243713|NCT00971997|591530|P1|NOT COMPLETED|Overall Study||19
243714|NCT00971997|591530|P1|COMPLETED|Overall Study||116
243715|NCT00971997|591530|P1|STARTED|Overall Study||135
243716|NCT00972023|591548|P1|NOT COMPLETED|Overall Study||1
243717|NCT00972023|591548|P1|COMPLETED|Overall Study||0
243718|NCT00972023|591548|P1|STARTED|Overall Study||1
243719|NCT00972088|591555|P1|NOT COMPLETED|Overall Study||0
243720|NCT00972088|591555|P1|COMPLETED|Overall Study||26
243721|NCT00972088|591555|P1|STARTED|Overall Study||26
243722|NCT00972153|591562|P3|NOT COMPLETED|Overall Study||0
243723|NCT00972153|591563|P2|NOT COMPLETED|Overall Study||1
243724|NCT00972153|591564|P1|NOT COMPLETED|Overall Study||0
243725|NCT00972153|591562|P3|COMPLETED|Overall Study||12
243726|NCT00972153|591563|P2|COMPLETED|Overall Study|One case excluded due to technical problem with measuring equipment.|11
243727|NCT00972153|591564|P1|COMPLETED|Overall Study||12
243728|NCT00972153|591562|P3|STARTED|Overall Study||12
243729|NCT00972153|591563|P2|STARTED|Overall Study||12
243730|NCT00972153|591564|P1|STARTED|Overall Study||12
243731|NCT00972205|591575|P1|NOT COMPLETED|Overall Study||0
243732|NCT00972205|591575|P1|COMPLETED|Overall Study||12
243733|NCT00972205|591575|P1|STARTED|Overall Study||12
243734|NCT00972244|591587|P5|NOT COMPLETED|Overall Study||9
243735|NCT00972244|591588|P4|NOT COMPLETED|Overall Study||0
243736|NCT00972244|591589|P3|NOT COMPLETED|Overall Study||2
243737|NCT00972244|591590|P2|NOT COMPLETED|Overall Study||5
243738|NCT00972244|591591|P1|NOT COMPLETED|Overall Study||5
243739|NCT00972244|591587|P5|COMPLETED|Overall Study||45
243740|NCT00972244|591588|P4|COMPLETED|Overall Study||52
243741|NCT00972244|591589|P3|COMPLETED|Overall Study||56
243742|NCT00972244|591590|P2|COMPLETED|Overall Study||51
243743|NCT00972244|591591|P1|COMPLETED|Overall Study||54
243744|NCT00972244|591587|P5|STARTED|Overall Study||54
243745|NCT00972244|591588|P4|STARTED|Overall Study||52
243746|NCT00972244|591589|P3|STARTED|Overall Study||58
243747|NCT00972244|591590|P2|STARTED|Overall Study||56
243748|NCT00972244|591591|P1|STARTED|Overall Study||59
243749|NCT00972283|591615|P2|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||8
243750|NCT00972283|591616|P1|NOT COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||27
243751|NCT00972283|591615|P2|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||183
243752|NCT00972283|591616|P1|COMPLETED|Extension: Week 53 to 78 (NN1250-3667)||539
243753|NCT00972283|591615|P2|STARTED|Extension: Week 53 to 78 (NN1250-3667)|20 subjects did not continue into the extension from main trial|191
243754|NCT00972283|591616|P1|STARTED|Extension: Week 53 to 78 (NN1250-3667)|52 subjects did not continue into the extension from main trial|566
243755|NCT00972283|591615|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||40
243756|NCT00972283|591616|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3582)||137
243757|NCT00972283|591615|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||211
243758|NCT00972283|591616|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3582)||618
243759|NCT00972283|591615|P2|Exposed|Main: Week 0 to 52 (NN1250-3582)||251
243760|NCT00972283|591616|P1|Exposed|Main: Week 0 to 52 (NN1250-3582)|2 subjects were withdrawn prior to exposure to trial products|753
243761|NCT00972283|591615|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|3 subjects were excluded due to closure of a site|248
243762|NCT00972283|591616|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3582)|11 subjects were excluded due to closure of a site|744
243763|NCT00972283|591615|P2|STARTED|Main: Week 0 to 52 (NN1250-3582)||251
243764|NCT00972283|591616|P1|STARTED|Main: Week 0 to 52 (NN1250-3582)||755
243765|NCT00972322|591640|P2|NOT COMPLETED|Overall Study||3
243766|NCT00972322|591641|P1|NOT COMPLETED|Overall Study||3
243767|NCT00972322|591640|P2|COMPLETED|Overall Study||25
243768|NCT00972322|591641|P1|COMPLETED|Overall Study||25
243769|NCT00972322|591640|P2|STARTED|Overall Study||28
243770|NCT00972322|591641|P1|STARTED|Overall Study||28
243771|NCT00972335|591651|P1|NOT COMPLETED|Overall Study||17
243772|NCT00972335|591651|P1|COMPLETED|Overall Study|Patients were on study until an event or condition occured which required them to come off study|0
243773|NCT00972335|591651|P1|STARTED|Overall Study|One patient was enrolled but showed no evidence of disease at study entry and was not treated|17
243774|NCT00972374|591659|P3|NOT COMPLETED|Overall Study||1
243775|NCT00972374|591660|P2|NOT COMPLETED|Overall Study||0
243776|NCT00972374|591661|P1|NOT COMPLETED|Overall Study||2
243777|NCT00972374|591659|P3|COMPLETED|Overall Study||13
243778|NCT00972374|591660|P2|COMPLETED|Overall Study||15
243779|NCT00972374|591661|P1|COMPLETED|Overall Study||13
243780|NCT00972374|591659|P3|STARTED|Overall Study||14
243781|NCT00972374|591660|P2|STARTED|Overall Study||15
243782|NCT00972374|591661|P1|STARTED|Overall Study||15
243783|NCT00972478|591677|P2|NOT COMPLETED|Overall Study||38
243784|NCT00972478|591678|P1|NOT COMPLETED|Overall Study||7
243785|NCT00972478|591677|P2|COMPLETED|Overall Study||34
243786|NCT00972478|591678|P1|COMPLETED|Overall Study||4
243787|NCT00972478|591677|P2|Eligible and Began Protocol Therapy|Overall Study||63
243788|NCT00972478|591678|P1|Eligible and Began Protocol Therapy|Overall Study||9
243789|NCT00972478|591677|P2|STARTED|Overall Study||72
243790|NCT00972478|591678|P1|STARTED|Overall Study||11
243791|NCT00972504|591688|P1|NOT COMPLETED|Overall Study||3
243792|NCT00972504|591688|P1|COMPLETED|Overall Study||51
243793|NCT00972504|591688|P1|STARTED|Overall Study||54
243794|NCT00972530|591720|P2|NOT COMPLETED|Overall Study||0
243795|NCT00972530|591721|P1|NOT COMPLETED|Overall Study||0
243796|NCT00972530|591720|P2|COMPLETED|Overall Study||46
243797|NCT00972530|591721|P1|COMPLETED|Overall Study||44
243798|NCT00972530|591720|P2|STARTED|Overall Study||46
243799|NCT00972530|591721|P1|STARTED|Overall Study||44
243800|NCT00972543|591729|P2|NOT COMPLETED|Overall Study||1
243801|NCT00972543|591730|P1|NOT COMPLETED|Overall Study||5
243802|NCT00972543|591729|P2|COMPLETED|Overall Study||0
243803|NCT00972543|591730|P1|COMPLETED|Overall Study||0
243804|NCT00972543|591729|P2|STARTED|Overall Study||1
243805|NCT00972543|591730|P1|STARTED|Overall Study||5
243806|NCT00972595|591804|P2|NOT COMPLETED|Period 2||0
243807|NCT00972595|591805|P1|NOT COMPLETED|Period 2||0
243808|NCT00972595|591804|P2|COMPLETED|Period 2||22
243809|NCT00972595|591805|P1|COMPLETED|Period 2||22
243810|NCT00972595|591804|P2|STARTED|Period 2||22
243811|NCT00972595|591805|P1|STARTED|Period 2||22
243812|NCT00972595|591804|P2|NOT COMPLETED|Period 1||0
243813|NCT00972595|591805|P1|NOT COMPLETED|Period 1||1
243814|NCT00972595|591804|P2|COMPLETED|Period 1||22
243815|NCT00972595|591805|P1|COMPLETED|Period 1||22
243816|NCT00972595|591804|P2|STARTED|Period 1||22
243817|NCT00972595|591805|P1|STARTED|Period 1||23
243818|NCT00972621|591815|P2|NOT COMPLETED|Overall Study||1
243819|NCT00972621|591816|P1|NOT COMPLETED|Overall Study||0
243820|NCT00972621|591815|P2|COMPLETED|Overall Study|One subject discontinued due to lens exchange.|199
243821|NCT00972621|591816|P1|COMPLETED|Overall Study||200
243822|NCT00972621|591815|P2|STARTED|Overall Study||200
243823|NCT00972621|591816|P1|STARTED|Overall Study||200
243824|NCT00972725|591826|P2|NOT COMPLETED|Overall Study||0
243825|NCT00972725|591827|P1|NOT COMPLETED|Overall Study||0
243826|NCT00972725|591826|P2|COMPLETED|Overall Study||15
243827|NCT00972725|591827|P1|COMPLETED|Overall Study||13
243828|NCT00972725|591826|P2|STARTED|Overall Study||15
243829|NCT00972725|591827|P1|STARTED|Overall Study||13
243830|NCT00972738|591910|P3|NOT COMPLETED|Overall Study||29
243831|NCT00972738|591911|P2|NOT COMPLETED|Overall Study||6
243832|NCT00972738|591912|P1|NOT COMPLETED|Overall Study||21
243833|NCT00972738|591910|P3|COMPLETED|Overall Study||492
243834|NCT00972738|591911|P2|COMPLETED|Overall Study||165
243835|NCT00972738|591912|P1|COMPLETED|Overall Study||501
243836|NCT00972738|591910|P3|STARTED|Overall Study||521
243837|NCT00972738|591911|P2|STARTED|Overall Study||171
243838|NCT00972738|591912|P1|STARTED|Overall Study||522
243839|NCT00972777|591937|P2|NOT COMPLETED|Overall Study||14
243840|NCT00972777|591938|P1|NOT COMPLETED|Overall Study||14
243841|NCT00972777|591937|P2|COMPLETED|Overall Study||229
243842|NCT00972777|591938|P1|COMPLETED|Overall Study||217
243843|NCT00972777|591937|P2|STARTED|Overall Study||243
243844|NCT00972777|591938|P1|STARTED|Overall Study||231
243845|NCT00972816|591958|P8|NOT COMPLETED|Overall Study||9
243846|NCT00972816|591959|P7|NOT COMPLETED|Overall Study||10
243847|NCT00972816|591960|P6|NOT COMPLETED|Overall Study||11
243848|NCT00972816|591961|P5|NOT COMPLETED|Overall Study||12
243849|NCT00972816|591962|P4|NOT COMPLETED|Overall Study||8
243850|NCT00972816|591963|P3|NOT COMPLETED|Overall Study||9
243851|NCT00972816|591964|P2|NOT COMPLETED|Overall Study||11
243852|NCT00972816|591965|P1|NOT COMPLETED|Overall Study||17
243853|NCT00972816|591958|P8|COMPLETED|Overall Study||161
243854|NCT00972816|591959|P7|COMPLETED|Overall Study||159
243855|NCT00972816|591960|P6|COMPLETED|Overall Study||158
243856|NCT00972816|591961|P5|COMPLETED|Overall Study||157
243857|NCT00972816|591962|P4|COMPLETED|Overall Study||161
243858|NCT00972816|591963|P3|COMPLETED|Overall Study||160
243859|NCT00972816|591964|P2|COMPLETED|Overall Study||158
243860|NCT00972816|591965|P1|COMPLETED|Overall Study||156
243861|NCT00972816|591958|P8|STARTED|Overall Study||170
243862|NCT00972816|591959|P7|STARTED|Overall Study||169
243863|NCT00972816|591960|P6|STARTED|Overall Study||169
243864|NCT00972816|591961|P5|STARTED|Overall Study||169
243865|NCT00972816|591962|P4|STARTED|Overall Study||169
243866|NCT00972816|591963|P3|STARTED|Overall Study||169
243867|NCT00972816|591964|P2|STARTED|Overall Study||169
243868|NCT00972816|591965|P1|STARTED|Overall Study||173
243869|NCT00972959|592047|P1|NOT COMPLETED|Overall Study||0
243870|NCT00972959|592047|P1|COMPLETED|Overall Study||17
243871|NCT00972959|592047|P1|STARTED|Overall Study||17
243872|NCT00973349|592078|P16|NOT COMPLETED|Overall Study||2
243873|NCT00973349|592079|P15|NOT COMPLETED|Overall Study||2
243874|NCT00973349|592080|P14|NOT COMPLETED|Overall Study||0
243875|NCT00973349|592081|P13|NOT COMPLETED|Overall Study||1
243876|NCT00973349|592082|P12|NOT COMPLETED|Overall Study||2
243877|NCT00973349|592083|P11|NOT COMPLETED|Overall Study||0
243878|NCT00973349|592084|P10|NOT COMPLETED|Overall Study||6
243879|NCT00973349|592085|P9|NOT COMPLETED|Overall Study||4
243880|NCT00973349|592086|P8|NOT COMPLETED|Overall Study||3
243881|NCT00973349|592087|P7|NOT COMPLETED|Overall Study||2
243882|NCT00973349|592088|P6|NOT COMPLETED|Overall Study||4
243883|NCT00973349|592089|P5|NOT COMPLETED|Overall Study||5
243884|NCT00973349|592090|P4|NOT COMPLETED|Overall Study||5
243885|NCT00973349|592091|P3|NOT COMPLETED|Overall Study||5
243886|NCT00973349|592092|P2|NOT COMPLETED|Overall Study||3
243887|NCT00973349|592093|P1|NOT COMPLETED|Overall Study||4
243888|NCT00973349|592078|P16|COMPLETED|Overall Study||165
243889|NCT00973349|592079|P15|COMPLETED|Overall Study||168
243890|NCT00973349|592080|P14|COMPLETED|Overall Study||171
243891|NCT00973349|592081|P13|COMPLETED|Overall Study||168
243892|NCT00973349|592082|P12|COMPLETED|Overall Study||167
243893|NCT00973349|592083|P11|COMPLETED|Overall Study||174
243894|NCT00973349|592084|P10|COMPLETED|Overall Study||163
243895|NCT00973349|592085|P9|COMPLETED|Overall Study||167
243896|NCT00973349|592086|P8|COMPLETED|Overall Study||166
243897|NCT00973349|592087|P7|COMPLETED|Overall Study||172
243898|NCT00973349|592088|P6|COMPLETED|Overall Study||165
243899|NCT00973349|592089|P5|COMPLETED|Overall Study||165
243900|NCT00973349|592090|P4|COMPLETED|Overall Study||163
243901|NCT00973349|592091|P3|COMPLETED|Overall Study||166
243902|NCT00973349|592092|P2|COMPLETED|Overall Study||165
243903|NCT00973349|592093|P1|COMPLETED|Overall Study||166
243904|NCT00973349|592078|P16|STARTED|Overall Study||167
243905|NCT00973349|592079|P15|STARTED|Overall Study||170
243906|NCT00973349|592080|P14|STARTED|Overall Study||171
243907|NCT00973349|592081|P13|STARTED|Overall Study||169
243908|NCT00973349|592082|P12|STARTED|Overall Study||169
243909|NCT00973349|592083|P11|STARTED|Overall Study||174
243910|NCT00973349|592084|P10|STARTED|Overall Study||169
243911|NCT00973349|592085|P9|STARTED|Overall Study||171
243912|NCT00973349|592086|P8|STARTED|Overall Study||169
243913|NCT00973349|592087|P7|STARTED|Overall Study||174
243914|NCT00973349|592088|P6|STARTED|Overall Study||169
243915|NCT00973349|592089|P5|STARTED|Overall Study||170
243916|NCT00973349|592090|P4|STARTED|Overall Study||168
243917|NCT00973349|592091|P3|STARTED|Overall Study||171
243918|NCT00973349|592092|P2|STARTED|Overall Study||168
243919|NCT00973349|592093|P1|STARTED|Overall Study||170
243920|NCT00973362|592193|P2|NOT COMPLETED|3-Year Follow-up||0
243921|NCT00973362|592194|P1|NOT COMPLETED|3-Year Follow-up||17
243922|NCT00973362|592193|P2|COMPLETED|3-Year Follow-up||0
243923|NCT00973362|592194|P1|COMPLETED|3-Year Follow-up||10854
243924|NCT00973362|592193|P2|STARTED|3-Year Follow-up|ASC-US study arm did not have a follow-up period|0
243925|NCT00973362|592194|P1|STARTED|3-Year Follow-up||10871
243926|NCT00973362|592193|P2|NOT COMPLETED|Baseline Evaluation||223
243927|NCT00973362|592194|P1|NOT COMPLETED|Baseline Evaluation||773
243928|NCT00973362|592193|P2|COMPLETED|Baseline Evaluation||1029
243929|NCT00973362|592194|P1|COMPLETED|Baseline Evaluation||10871
243930|NCT00973362|592193|P2|Conclusive Disease Status|Baseline Evaluation||939
243931|NCT00973362|592194|P1|Conclusive Disease Status|Baseline Evaluation||819
243932|NCT00973362|592193|P2|Evaluable for Analysis|Baseline Evaluation||958
243933|NCT00973362|592194|P1|Evaluable for Analysis|Baseline Evaluation||10871
243934|NCT00973362|592193|P2|STARTED|Baseline Evaluation||1252
243935|NCT00973362|592194|P1|STARTED|Baseline Evaluation||11644
243936|NCT00973479|592205|P2|NOT COMPLETED|Overall Study||69
243937|NCT00973479|592206|P1|NOT COMPLETED|Overall Study||37
243938|NCT00973479|592205|P2|COMPLETED|Overall Study||326
243939|NCT00973479|592206|P1|COMPLETED|Overall Study||160
243940|NCT00973479|592205|P2|STARTED|Overall Study||395
243941|NCT00973479|592206|P1|STARTED|Overall Study||197
243942|NCT00973622|592224|P2|NOT COMPLETED|Overall Study||5
243943|NCT00973622|592225|P1|NOT COMPLETED|Overall Study||31
243944|NCT00973622|592224|P2|COMPLETED|Overall Study|Completed three sessions of rTMS|14
243945|NCT00973622|592225|P1|COMPLETED|Overall Study|Completed three sessions of rTMS|16
243946|NCT00973622|592224|P2|STARTED|Overall Study|21 passed telephone interview; 19 passed the in-person interview, were enrolled, and sent for MRI.|19
243947|NCT00973622|592225|P1|STARTED|Overall Study|75 passed telephone interview; 28 passed in-person interview, were enrolled, and sent for MRI.|47
243948|NCT00958919|592231|P2|NOT COMPLETED|Second Intervention||0
243949|NCT00958919|592232|P1|NOT COMPLETED|Second Intervention||0
243950|NCT00958919|592231|P2|COMPLETED|Second Intervention||7
243951|NCT00958919|592232|P1|COMPLETED|Second Intervention||7
243952|NCT00958919|592231|P2|STARTED|Second Intervention||7
243953|NCT00958919|592232|P1|STARTED|Second Intervention||7
243954|NCT00958919|592231|P2|NOT COMPLETED|First Intervention||0
243955|NCT00958919|592232|P1|NOT COMPLETED|First Intervention||0
243956|NCT00958919|592231|P2|COMPLETED|First Intervention||7
243957|NCT00958919|592232|P1|COMPLETED|First Intervention||7
243958|NCT00958919|592231|P2|STARTED|First Intervention||7
243959|NCT00958919|592232|P1|STARTED|First Intervention||7
243960|NCT00959049|592252|P6|NOT COMPLETED|Overall Study||1
243961|NCT00959049|592253|P5|NOT COMPLETED|Overall Study||9
243962|NCT00959049|592254|P4|NOT COMPLETED|Overall Study||11
243963|NCT00959049|592255|P3|NOT COMPLETED|Overall Study||1
243964|NCT00959049|592256|P2|NOT COMPLETED|Overall Study||7
243965|NCT00959049|592257|P1|NOT COMPLETED|Overall Study||18
243966|NCT00959049|592252|P6|COMPLETED|Overall Study||249
243967|NCT00959049|592253|P5|COMPLETED|Overall Study||248
243968|NCT00959049|592254|P4|COMPLETED|Overall Study||217
243969|NCT00959049|592255|P3|COMPLETED|Overall Study||253
243970|NCT00959049|592256|P2|COMPLETED|Overall Study||247
243971|NCT00959049|592257|P1|COMPLETED|Overall Study||213
243972|NCT00959049|592252|P6|STARTED|Overall Study||250
243973|NCT00959049|592253|P5|STARTED|Overall Study||257
243974|NCT00959049|592254|P4|STARTED|Overall Study||228
243975|NCT00959049|592255|P3|STARTED|Overall Study||254
243976|NCT00959049|592256|P2|STARTED|Overall Study||254
243977|NCT00959049|592257|P1|STARTED|Overall Study||231
243978|NCT00959192|592311|P4|NOT COMPLETED|Overall Study||1
243979|NCT00959192|592312|P3|NOT COMPLETED|Overall Study||3
243980|NCT00959192|592313|P2|NOT COMPLETED|Overall Study||1
243981|NCT00959192|592314|P1|NOT COMPLETED|Overall Study||2
243982|NCT00959192|592311|P4|COMPLETED|Overall Study||7
243983|NCT00959192|592312|P3|COMPLETED|Overall Study||6
243984|NCT00959192|592313|P2|COMPLETED|Overall Study||8
243985|NCT00959192|592314|P1|COMPLETED|Overall Study||4
243986|NCT00959192|592311|P4|STARTED|Overall Study||8
243987|NCT00959192|592312|P3|STARTED|Overall Study||9
243988|NCT00959192|592313|P2|STARTED|Overall Study||9
243989|NCT00959192|592314|P1|STARTED|Overall Study||6
243990|NCT00959374|592356|P1|NOT COMPLETED|Overall Study||23
243991|NCT00959374|592356|P1|COMPLETED|Overall Study||218
243992|NCT00959374|592356|P1|STARTED|Overall Study|Of the 241 enrolled subjects, 229 were randomized and treated|241
243993|NCT00959647|592366|P1|NOT COMPLETED|Overall Study||19
243994|NCT00959647|592366|P1|COMPLETED|Overall Study||0
243995|NCT00959647|592366|P1|STARTED|Overall Study||19
243996|NCT00959699|592373|P2|NOT COMPLETED|Follow-up Period||6
243997|NCT00959699|592374|P1|NOT COMPLETED|Follow-up Period||6
243998|NCT00959699|592373|P2|COMPLETED|Follow-up Period||56
243999|NCT00959699|592374|P1|COMPLETED|Follow-up Period||27
244000|NCT00959699|592373|P2|STARTED|Follow-up Period|2 participants didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|62
244001|NCT00959699|592374|P1|STARTED|Follow-up Period|1 participant didn't enter Follow-up; participants discontinuing treatment could enter Follow-up.|33
244002|NCT00959699|592373|P2|NOT COMPLETED|Treatment Period||25
244003|NCT00959699|592374|P1|NOT COMPLETED|Treatment Period||23
244004|NCT00959699|592373|P2|COMPLETED|Treatment Period||40
244005|NCT00959699|592374|P1|COMPLETED|Treatment Period|At TW24, 4 participants not achieving undetectable HCV-RNA crossed-over and received boceprevir.|11
244006|NCT00959699|592373|P2|Treated|Treatment Period||64
244007|NCT00959699|592374|P1|Treated|Treatment Period||34
244008|NCT00959699|592373|P2|STARTED|Treatment Period||65
244009|NCT00959699|592374|P1|STARTED|Treatment Period||34
244010|NCT00959751|592393|P2|NOT COMPLETED|Overall Study||12
244011|NCT00959751|592394|P1|NOT COMPLETED|Overall Study||9
244012|NCT00959751|592393|P2|COMPLETED|Overall Study||86
244013|NCT00959751|592394|P1|COMPLETED|Overall Study||88
244014|NCT00959751|592393|P2|STARTED|Overall Study||98
244015|NCT00959751|592394|P1|STARTED|Overall Study||97
244016|NCT00959764|592417|P3|NOT COMPLETED|Overall Study||36
244017|NCT00959764|592418|P2|NOT COMPLETED|Overall Study||57
244018|NCT00959764|592419|P1|NOT COMPLETED|Overall Study||95
244019|NCT00959764|592417|P3|COMPLETED|Overall Study||73
244020|NCT00959764|592418|P2|COMPLETED|Overall Study||128
244021|NCT00959764|592419|P1|COMPLETED|Overall Study||176
244022|NCT00959764|592417|P3|STARTED|Overall Study||109
244023|NCT00959764|592418|P2|STARTED|Overall Study||185
244024|NCT00959764|592419|P1|STARTED|Overall Study||271
244025|NCT00959894|592433|P1|NOT COMPLETED|Overall Study||16
244026|NCT00959894|592433|P1|COMPLETED|Overall Study||63
244027|NCT00959894|592433|P1|STARTED|Overall Study|One (1) additional subject became ineligible on the day of entry and never started study medication.|79
244028|NCT00959907|592463|P2|NOT COMPLETED|Overall Study||1
244029|NCT00959907|592464|P1|NOT COMPLETED|Overall Study||3
244030|NCT00959907|592463|P2|COMPLETED|Overall Study||28
244031|NCT00959907|592464|P1|COMPLETED|Overall Study||27
244032|NCT00959907|592463|P2|STARTED|Overall Study||29
244033|NCT00959907|592464|P1|STARTED|Overall Study||30
244034|NCT00959920|592476|P2|NOT COMPLETED|Overall Study||1
244035|NCT00959920|592477|P1|NOT COMPLETED|Overall Study||0
244036|NCT00959920|592476|P2|COMPLETED|Overall Study||66
244037|NCT00959920|592477|P1|COMPLETED|Overall Study||72
244038|NCT00959920|592476|P2|STARTED|Overall Study||67
244039|NCT00959920|592477|P1|STARTED|Overall Study||72
244040|NCT00959946|592493|P8|NOT COMPLETED|Overall Study||2
244041|NCT00959946|592494|P7|NOT COMPLETED|Overall Study||2
244042|NCT00959946|592495|P6|NOT COMPLETED|Overall Study||9
244043|NCT00959946|592496|P5|NOT COMPLETED|Overall Study||4
244044|NCT00959946|592497|P4|NOT COMPLETED|Overall Study||5
244045|NCT00959946|592498|P3|NOT COMPLETED|Overall Study||4
244046|NCT00959946|592499|P2|NOT COMPLETED|Overall Study||4
244047|NCT00959946|592500|P1|NOT COMPLETED|Overall Study||2
244048|NCT00959946|592493|P8|COMPLETED|Overall Study||0
244049|NCT00959946|592494|P7|COMPLETED|Overall Study||0
244050|NCT00959946|592495|P6|COMPLETED|Overall Study||0
244051|NCT00959946|592496|P5|COMPLETED|Overall Study||0
244052|NCT00959946|592497|P4|COMPLETED|Overall Study||0
244053|NCT00959946|592498|P3|COMPLETED|Overall Study||0
244054|NCT00959946|592499|P2|COMPLETED|Overall Study||0
244055|NCT00959946|592500|P1|COMPLETED|Overall Study||0
244056|NCT00959946|592493|P8|STARTED|Overall Study||2
244057|NCT00959946|592494|P7|STARTED|Overall Study||2
244058|NCT00959946|592495|P6|STARTED|Overall Study||9
244059|NCT00959946|592496|P5|STARTED|Overall Study||4
244060|NCT00959946|592497|P4|STARTED|Overall Study||5
244061|NCT00959946|592498|P3|STARTED|Overall Study||4
244062|NCT00959946|592499|P2|STARTED|Overall Study||4
244063|NCT00959946|592500|P1|STARTED|Overall Study||2
244064|NCT00959985|592555|P4|NOT COMPLETED|Overall Study||0
244065|NCT00959985|592556|P3|NOT COMPLETED|Overall Study||0
244066|NCT00959985|592557|P2|NOT COMPLETED|Overall Study||0
244067|NCT00959985|592558|P1|NOT COMPLETED|Overall Study||0
244068|NCT00959985|592555|P4|COMPLETED|Overall Study||4
244069|NCT00959985|592556|P3|COMPLETED|Overall Study||4
244070|NCT00959985|592557|P2|COMPLETED|Overall Study||7
244071|NCT00959985|592558|P1|COMPLETED|Overall Study||8
244072|NCT00959985|592555|P4|STARTED|Overall Study||4
244073|NCT00959985|592556|P3|STARTED|Overall Study||4
244074|NCT00959985|592557|P2|STARTED|Overall Study||7
244075|NCT00959985|592558|P1|STARTED|Overall Study||8
244076|NCT00960063|592599|P3|NOT COMPLETED|Overall Study||3
244077|NCT00960063|592600|P2|NOT COMPLETED|Overall Study||0
244078|NCT00960063|592601|P1|NOT COMPLETED|Overall Study||1
244079|NCT00960063|592599|P3|COMPLETED|Overall Study||0
244080|NCT00960063|592600|P2|COMPLETED|Overall Study||0
244081|NCT00960063|592601|P1|COMPLETED|Overall Study||0
244082|NCT00960063|592599|P3|STARTED|Overall Study||3
244083|NCT00960063|592600|P2|STARTED|Overall Study||0
244084|NCT00960063|592601|P1|STARTED|Overall Study||1
244085|NCT00960076|592641|P2|NOT COMPLETED|Overall Study||25
244086|NCT00960076|592642|P1|NOT COMPLETED|Overall Study||8
244087|NCT00960076|592641|P2|COMPLETED|Overall Study|Completing 18 weeks of treatment|119
244088|NCT00960076|592642|P1|COMPLETED|Overall Study|Completing 18 weeks of treatment|130
244089|NCT00960076|592641|P2|STARTED|Overall Study|Randomized and treated|144
244090|NCT00960076|592642|P1|STARTED|Overall Study|Randomized and treated|138
244091|NCT00960115|592656|P2|NOT COMPLETED|Overall Study||15
244092|NCT00960115|592657|P1|NOT COMPLETED|Overall Study||19
244093|NCT00960115|592656|P2|COMPLETED|Overall Study||43
244094|NCT00960115|592657|P1|COMPLETED|Overall Study||95
244095|NCT00960115|592656|P2|STARTED|Overall Study||58
244096|NCT00960115|592657|P1|STARTED|Overall Study||114
244097|NCT00960141|592672|P3|NOT COMPLETED|Overall Study||7
244098|NCT00960141|592673|P2|NOT COMPLETED|Overall Study||17
244099|NCT00960141|592674|P1|NOT COMPLETED|Overall Study||10
244100|NCT00960141|592672|P3|COMPLETED|Overall Study||163
244101|NCT00960141|592673|P2|COMPLETED|Overall Study||309
244102|NCT00960141|592674|P1|COMPLETED|Overall Study||323
244103|NCT00960141|592672|P3|STARTED|Overall Study||170
244104|NCT00960141|592673|P2|STARTED|Overall Study||326
244105|NCT00960141|592674|P1|STARTED|Overall Study||333
244106|NCT00960154|592699|P2|NOT COMPLETED|Overall Study||25
244107|NCT00960154|592700|P1|NOT COMPLETED|Overall Study||25
244108|NCT00960154|592699|P2|COMPLETED|Overall Study||0
244109|NCT00960154|592700|P1|COMPLETED|Overall Study||0
244110|NCT00960154|592699|P2|STARTED|Overall Study||25
244111|NCT00960154|592700|P1|STARTED|Overall Study||25
244112|NCT00960193|592708|P1|NOT COMPLETED|Colchicine With Seville Orange Juice||0
244113|NCT00960193|592708|P1|COMPLETED|Colchicine With Seville Orange Juice||23
244114|NCT00960193|592708|P1|STARTED|Colchicine With Seville Orange Juice||23
244115|NCT00960193|592708|P1|NOT COMPLETED|Seville Orange Juice Alone||0
244116|NCT00960193|592708|P1|COMPLETED|Seville Orange Juice Alone||23
244117|NCT00960193|592708|P1|STARTED|Seville Orange Juice Alone||23
244118|NCT00960193|592708|P1|NOT COMPLETED|14 Day Washout Period||1
244119|NCT00960193|592708|P1|COMPLETED|14 Day Washout Period||23
244120|NCT00960193|592708|P1|STARTED|14 Day Washout Period||24
244121|NCT00960193|592708|P1|NOT COMPLETED|Colchicine Alone||0
244122|NCT00960193|592708|P1|COMPLETED|Colchicine Alone||24
244123|NCT00960193|592708|P1|STARTED|Colchicine Alone||24
244124|NCT00960206|592722|P3|NOT COMPLETED|Overall Study||12
244125|NCT00960206|592723|P2|NOT COMPLETED|Overall Study||27
244126|NCT00960206|592724|P1|NOT COMPLETED|Overall Study||40
244127|NCT00960206|592722|P3|COMPLETED|Overall Study||77
244128|NCT00960206|592723|P2|COMPLETED|Overall Study||158
244129|NCT00960206|592724|P1|COMPLETED|Overall Study||150
244130|NCT00960206|592722|P3|STARTED|Overall Study||89
244131|NCT00960206|592723|P2|STARTED|Overall Study||185
244132|NCT00960206|592724|P1|STARTED|Overall Study||190
244133|NCT00965718|592742|P1|NOT COMPLETED|Overall Study||4
244134|NCT00965718|592742|P1|COMPLETED|Overall Study||16
244135|NCT00965718|592742|P1|STARTED|Overall Study||20
244136|NCT00965731|592754|P2|NOT COMPLETED|Overall Study||20
244137|NCT00965731|592755|P1|NOT COMPLETED|Overall Study||7
244138|NCT00965731|592754|P2|COMPLETED|Overall Study||0
244139|NCT00965731|592755|P1|COMPLETED|Overall Study||0
244140|NCT00965731|592754|P2|STARTED|Overall Study|Dose level given only after lower dose was successfully administered|20
244141|NCT00965731|592755|P1|STARTED|Overall Study||7
244142|NCT00965757|592821|P4|NOT COMPLETED|Extension Phase||24
244143|NCT00965757|592822|P3|NOT COMPLETED|Extension Phase||33
244144|NCT00965757|592823|P2|NOT COMPLETED|Extension Phase||0
244145|NCT00965757|592824|P1|NOT COMPLETED|Extension Phase||0
244146|NCT00965757|592821|P4|COMPLETED|Extension Phase||64
244147|NCT00965757|592822|P3|COMPLETED|Extension Phase||132
244148|NCT00965757|592823|P2|COMPLETED|Extension Phase||0
244149|NCT00965757|592824|P1|COMPLETED|Extension Phase||0
244150|NCT00965757|592821|P4|STARTED|Extension Phase||88
244151|NCT00965757|592822|P3|STARTED|Extension Phase||165
244152|NCT00965757|592823|P2|STARTED|Extension Phase||0
244153|NCT00965757|592824|P1|STARTED|Extension Phase||0
244154|NCT00965757|592821|P4|NOT COMPLETED|Double-blind Phase||0
244155|NCT00965757|592822|P3|NOT COMPLETED|Double-blind Phase||0
244156|NCT00965757|592823|P2|NOT COMPLETED|Double-blind Phase||18
244157|NCT00965757|592824|P1|NOT COMPLETED|Double-blind Phase||17
244158|NCT00965757|592821|P4|COMPLETED|Double-blind Phase||0
244159|NCT00965757|592822|P3|COMPLETED|Double-blind Phase||0
244160|NCT00965757|592823|P2|COMPLETED|Double-blind Phase||70
244161|NCT00965757|592824|P1|COMPLETED|Double-blind Phase||148
244162|NCT00965757|592821|P4|STARTED|Double-blind Phase||0
244163|NCT00965757|592822|P3|STARTED|Double-blind Phase||0
244164|NCT00965757|592823|P2|STARTED|Double-blind Phase||88
244165|NCT00965757|592824|P1|STARTED|Double-blind Phase||165
244166|NCT00965848|592856|P3|NOT COMPLETED|Overall Study||10
244167|NCT00965848|592857|P2|NOT COMPLETED|Overall Study||2
244168|NCT00965848|592858|P1|NOT COMPLETED|Overall Study||29
244169|NCT00965848|592856|P3|COMPLETED|Overall Study||117
244170|NCT00965848|592857|P2|COMPLETED|Overall Study||32
244171|NCT00965848|592858|P1|COMPLETED|Overall Study||78
244172|NCT00965848|592856|P3|STARTED|Overall Study||127
244173|NCT00965848|592857|P2|STARTED|Overall Study||34
244174|NCT00965848|592858|P1|STARTED|Overall Study||107
244175|NCT00973700|592880|P5|NOT COMPLETED|Overall Study||10
244176|NCT00973700|592881|P4|NOT COMPLETED|Overall Study||18
244177|NCT00973700|592882|P3|NOT COMPLETED|Overall Study||10
244178|NCT00973700|592883|P2|NOT COMPLETED|Overall Study||2
244179|NCT00973700|592884|P1|NOT COMPLETED|Overall Study||7
244180|NCT00973700|592880|P5|COMPLETED|Overall Study||158
244181|NCT00973700|592881|P4|COMPLETED|Overall Study||318
244182|NCT00973700|592882|P3|COMPLETED|Overall Study||158
244183|NCT00973700|592883|P2|COMPLETED|Overall Study||54
244184|NCT00973700|592884|P1|COMPLETED|Overall Study||49
244185|NCT00973700|592880|P5|STARTED|Overall Study||168
244186|NCT00973700|592881|P4|STARTED|Overall Study||336
244187|NCT00973700|592882|P3|STARTED|Overall Study||168
244188|NCT00973700|592883|P2|STARTED|Overall Study||56
244189|NCT00973700|592884|P1|STARTED|Overall Study||56
244190|NCT00973739|592931|P1|NOT COMPLETED|Overall Study||4
244191|NCT00973739|592931|P1|COMPLETED|Overall Study||17
244192|NCT00973739|592931|P1|STARTED|Overall Study||21
244193|NCT00973752|592938|P1|NOT COMPLETED|Overall Study||0
244194|NCT00973752|592938|P1|COMPLETED|Overall Study||30
244195|NCT00973752|592938|P1|STARTED|Overall Study||30
244196|NCT00973765|592944|P2|NOT COMPLETED|Overall Study||14
244197|NCT00973765|592945|P1|NOT COMPLETED|Overall Study||8
244198|NCT00973765|592944|P2|COMPLETED|Overall Study|102|102
244199|NCT00973765|592945|P1|COMPLETED|Overall Study|88|88
244200|NCT00973765|592944|P2|STARTED|Overall Study|116|116
244201|NCT00973765|592945|P1|STARTED|Overall Study|96|96
244202|NCT00973921|592951|P1|NOT COMPLETED|Overall Study||9
244203|NCT00973921|592951|P1|COMPLETED|Overall Study||31
244204|NCT00973921|592951|P1|STARTED|Overall Study||40
244205|NCT00974818|592960|P2|NOT COMPLETED|Overall Study||0
244206|NCT00974818|592961|P1|NOT COMPLETED|Overall Study||0
244207|NCT00974818|592960|P2|COMPLETED|Overall Study||25
244208|NCT00974818|592961|P1|COMPLETED|Overall Study||25
244209|NCT00974818|592960|P2|STARTED|Overall Study||25
244210|NCT00974818|592961|P1|STARTED|Overall Study||25
244211|NCT00974974|592969|P2|NOT COMPLETED|Maintenance - Double Blind Treatment||10
244212|NCT00974974|592970|P1|NOT COMPLETED|Maintenance - Double Blind Treatment||15
244213|NCT00974974|592969|P2|COMPLETED|Maintenance - Double Blind Treatment||182
244214|NCT00974974|592970|P1|COMPLETED|Maintenance - Double Blind Treatment||186
244215|NCT00974974|592969|P2|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|192
244216|NCT00974974|592970|P1|STARTED|Maintenance - Double Blind Treatment|All subjects who completed IPX066 Dose Conversion were randomized to either IPX066 or IR.|201
244217|NCT00974974|592969|P2|NOT COMPLETED|IPX066 Dose Conversion||0
244218|NCT00974974|592970|P1|NOT COMPLETED|IPX066 Dose Conversion||57
244219|NCT00974974|592969|P2|COMPLETED|IPX066 Dose Conversion||0
244220|NCT00974974|592970|P1|COMPLETED|IPX066 Dose Conversion||393
244221|NCT00974974|592969|P2|STARTED|IPX066 Dose Conversion|IR is not applicable in IPX066 dose conversion.|0
244222|NCT00974974|592970|P1|STARTED|IPX066 Dose Conversion|All subjects who completed IR Dose adjustment entered into IPX066 dose conversion.|450
244223|NCT00974974|592969|P2|NOT COMPLETED|IR CD-LD Dose Adjustment||21
244224|NCT00974974|592970|P1|NOT COMPLETED|IR CD-LD Dose Adjustment||0
244225|NCT00974974|592969|P2|COMPLETED|IR CD-LD Dose Adjustment||450
244226|NCT00974974|592970|P1|COMPLETED|IR CD-LD Dose Adjustment||0
244227|NCT00974974|592969|P2|STARTED|IR CD-LD Dose Adjustment||471
244228|NCT00974974|592970|P1|STARTED|IR CD-LD Dose Adjustment||0
244229|NCT00975000|592982|P2|NOT COMPLETED|Overall Study||5
244230|NCT00975000|592983|P1|NOT COMPLETED|Overall Study||5
244231|NCT00975000|592982|P2|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
244232|NCT00975000|592983|P1|COMPLETED|Overall Study|Completed post-treatment follow-up phase|52
244233|NCT00975000|592982|P2|Completed Maintenance Phase|Overall Study||52
244234|NCT00975000|592983|P1|Completed Maintenance Phase|Overall Study||52
244235|NCT00975000|592982|P2|Completed Efficacy Assessment Phase|Overall Study||54
244236|NCT00975000|592983|P1|Completed Efficacy Assessment Phase|Overall Study||54
244237|NCT00975000|592982|P2|Completed Titration Phase|Overall Study||55
244238|NCT00975000|592983|P1|Completed Titration Phase|Overall Study||54
244239|NCT00975000|592982|P2|STARTED|Overall Study||57
244240|NCT00975000|592983|P1|STARTED|Overall Study||57
244241|NCT00975130|593005|P3|NOT COMPLETED|Study Part 2||17
244242|NCT00975130|593006|P2|NOT COMPLETED|Study Part 2||38
244243|NCT00975130|593007|P1|NOT COMPLETED|Study Part 2||0
244244|NCT00975130|593005|P3|COMPLETED|Study Part 2||238
244245|NCT00975130|593006|P2|COMPLETED|Study Part 2||212
244246|NCT00975130|593007|P1|COMPLETED|Study Part 2||0
244247|NCT00975130|593005|P3|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|255
244248|NCT00975130|593006|P2|STARTED|Study Part 2|Good/moderate responders without remission at the end of Part 1 were invited to enroll in Part 2.|250
244249|NCT00975130|593007|P1|STARTED|Study Part 2||0
244250|NCT00975130|593005|P3|NOT COMPLETED|Study Part 1||0
244251|NCT00975130|593006|P2|NOT COMPLETED|Study Part 1||0
244252|NCT00975130|593007|P1|NOT COMPLETED|Study Part 1||280
244253|NCT00975130|593005|P3|COMPLETED|Study Part 1||0
244254|NCT00975130|593006|P2|COMPLETED|Study Part 1||0
244255|NCT00975130|593007|P1|COMPLETED|Study Part 1||3086
244256|NCT00975130|593005|P3|STARTED|Study Part 1||0
244257|NCT00975130|593006|P2|STARTED|Study Part 1||0
244258|NCT00975130|593007|P1|STARTED|Study Part 1||3366
244259|NCT00975143|593191|P2|NOT COMPLETED|Overall Study||60
244260|NCT00975143|593192|P1|NOT COMPLETED|Overall Study||70
244261|NCT00975143|593191|P2|COMPLETED|Overall Study||401
244262|NCT00975143|593192|P1|COMPLETED|Overall Study||394
244263|NCT00975143|593191|P2|Completed Treatment (Week 20)|Overall Study||410
244264|NCT00975143|593192|P1|Completed Treatment (Week 20)|Overall Study||403
244265|NCT00975143|593191|P2|STARTED|Overall Study||461
244266|NCT00975143|593192|P1|STARTED|Overall Study||464
244267|NCT00975156|593204|P2|NOT COMPLETED|Overall Study||1
244268|NCT00975156|593205|P1|NOT COMPLETED|Overall Study||0
244269|NCT00975156|593204|P2|COMPLETED|Overall Study||9
244270|NCT00975156|593205|P1|COMPLETED|Overall Study||11
244271|NCT00975156|593204|P2|STARTED|Overall Study||10
244272|NCT00975156|593205|P1|STARTED|Overall Study||11
244273|NCT00975195|593217|P2|NOT COMPLETED|Overall Study||233
244274|NCT00975195|593218|P1|NOT COMPLETED|Overall Study||228
244275|NCT00975195|593217|P2|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1011
244276|NCT00975195|593218|P1|COMPLETED|Overall Study|Includes open-label treatment if appropriate|1016
244277|NCT00975195|593217|P2|STARTED|Overall Study||1244
244278|NCT00975195|593218|P1|STARTED|Overall Study||1244
244279|NCT00975221|593278|P2|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||1
244280|NCT00975221|593279|P1|NOT COMPLETED|Open-label Extension Phase (Weeks 29-52)||2
244281|NCT00975221|593278|P2|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
244282|NCT00975221|593279|P1|COMPLETED|Open-label Extension Phase (Weeks 29-52)||27
244283|NCT00975221|593278|P2|STARTED|Open-label Extension Phase (Weeks 29-52)||28
244284|NCT00975221|593279|P1|STARTED|Open-label Extension Phase (Weeks 29-52)|1 participant who completed the EAP did not enter the open-label phase|29
244285|NCT00975221|593278|P2|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||1
244286|NCT00975221|593279|P1|NOT COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||0
244287|NCT00975221|593278|P2|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||28
244288|NCT00975221|593279|P1|COMPLETED|Efficacy Assessment Phase (Weeks 13-28)||30
244289|NCT00975221|593278|P2|STARTED|Efficacy Assessment Phase (Weeks 13-28)||29
244290|NCT00975221|593279|P1|STARTED|Efficacy Assessment Phase (Weeks 13-28)|1 participant who completed the Titration Phase did not enter the EAP|30
244291|NCT00975221|593278|P2|NOT COMPLETED|Titration Phase (Weeks 1-12)||4
244292|NCT00975221|593279|P1|NOT COMPLETED|Titration Phase (Weeks 1-12)||3
244293|NCT00975221|593278|P2|COMPLETED|Titration Phase (Weeks 1-12)||29
244294|NCT00975221|593279|P1|COMPLETED|Titration Phase (Weeks 1-12)||31
244295|NCT00975221|593278|P2|Received Study Drug|Titration Phase (Weeks 1-12)||33
244296|NCT00975221|593279|P1|Received Study Drug|Titration Phase (Weeks 1-12)||34
244297|NCT00975221|593278|P2|STARTED|Titration Phase (Weeks 1-12)||33
244298|NCT00975221|593279|P1|STARTED|Titration Phase (Weeks 1-12)||34
244299|NCT00975286|593295|P2|NOT COMPLETED|Overall Study||29
244300|NCT00975286|593296|P1|NOT COMPLETED|Overall Study||12
244301|NCT00975286|593295|P2|COMPLETED|Overall Study||194
244302|NCT00975286|593296|P1|COMPLETED|Overall Study||211
244303|NCT00975286|593295|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||223
244304|NCT00975286|593296|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|223
244305|NCT00975286|593295|P2|Safety Population|Overall Study||223
244306|NCT00975286|593296|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|223
244307|NCT00975286|593295|P2|STARTED|Overall Study||223
244308|NCT00975286|593296|P1|STARTED|Overall Study|Randomized.|223
244309|NCT00975416|593328|P2|NOT COMPLETED|Overall Study||5
244310|NCT00975416|593329|P1|NOT COMPLETED|Overall Study||3
244311|NCT00975416|593328|P2|COMPLETED|Overall Study||11
244312|NCT00975416|593329|P1|COMPLETED|Overall Study||11
244313|NCT00975416|593328|P2|STARTED|Overall Study||16
244314|NCT00975416|593329|P1|STARTED|Overall Study||14
244315|NCT00975481|593336|P6|NOT COMPLETED|Sixth Intervention Period||0
244316|NCT00975481|593337|P5|NOT COMPLETED|Sixth Intervention Period||0
244317|NCT00975481|593338|P4|NOT COMPLETED|Sixth Intervention Period||0
244318|NCT00975481|593339|P3|NOT COMPLETED|Sixth Intervention Period||0
244319|NCT00975481|593340|P2|NOT COMPLETED|Sixth Intervention Period||0
244320|NCT00975481|593341|P1|NOT COMPLETED|Sixth Intervention Period||0
244321|NCT00975481|593336|P6|COMPLETED|Sixth Intervention Period||6
244322|NCT00975481|593337|P5|COMPLETED|Sixth Intervention Period||5
244323|NCT00975481|593338|P4|COMPLETED|Sixth Intervention Period||5
244324|NCT00975481|593339|P3|COMPLETED|Sixth Intervention Period||4
244325|NCT00975481|593340|P2|COMPLETED|Sixth Intervention Period||5
244326|NCT00975481|593341|P1|COMPLETED|Sixth Intervention Period||4
244327|NCT00975481|593336|P6|STARTED|Sixth Intervention Period||6
244328|NCT00975481|593337|P5|STARTED|Sixth Intervention Period||5
244329|NCT00975481|593338|P4|STARTED|Sixth Intervention Period||5
244330|NCT00975481|593339|P3|STARTED|Sixth Intervention Period||4
244331|NCT00975481|593340|P2|STARTED|Sixth Intervention Period||5
244332|NCT00975481|593341|P1|STARTED|Sixth Intervention Period||4
244333|NCT00975481|593336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244334|NCT00975481|593337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244335|NCT00975481|593338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244336|NCT00975481|593339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244337|NCT00975481|593340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244338|NCT00975481|593341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244339|NCT00975481|593336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
244340|NCT00975481|593337|P5|COMPLETED|Washout Period (at Least 7 Days)||5
244341|NCT00975481|593338|P4|COMPLETED|Washout Period (at Least 7 Days)||5
244342|NCT00975481|593339|P3|COMPLETED|Washout Period (at Least 7 Days)||4
244343|NCT00975481|593340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
244344|NCT00975481|593341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
244345|NCT00975481|593336|P6|STARTED|Washout Period (at Least 7 Days)||6
244346|NCT00975481|593337|P5|STARTED|Washout Period (at Least 7 Days)||5
244347|NCT00975481|593338|P4|STARTED|Washout Period (at Least 7 Days)||5
244348|NCT00975481|593339|P3|STARTED|Washout Period (at Least 7 Days)||4
244349|NCT00975481|593340|P2|STARTED|Washout Period (at Least 7 Days)||5
244350|NCT00975481|593341|P1|STARTED|Washout Period (at Least 7 Days)||4
244351|NCT00975481|593336|P6|NOT COMPLETED|Fifth Intervention Period||0
244352|NCT00975481|593337|P5|NOT COMPLETED|Fifth Intervention Period||1
244353|NCT00975481|593338|P4|NOT COMPLETED|Fifth Intervention Period||0
244354|NCT00975481|593339|P3|NOT COMPLETED|Fifth Intervention Period||0
244355|NCT00975481|593340|P2|NOT COMPLETED|Fifth Intervention Period||0
244356|NCT00975481|593341|P1|NOT COMPLETED|Fifth Intervention Period||0
244357|NCT00975481|593336|P6|COMPLETED|Fifth Intervention Period||6
244358|NCT00975481|593337|P5|COMPLETED|Fifth Intervention Period||5
244359|NCT00975481|593338|P4|COMPLETED|Fifth Intervention Period||5
244360|NCT00975481|593339|P3|COMPLETED|Fifth Intervention Period||4
244361|NCT00975481|593340|P2|COMPLETED|Fifth Intervention Period||5
244362|NCT00975481|593341|P1|COMPLETED|Fifth Intervention Period||4
244363|NCT00975481|593336|P6|STARTED|Fifth Intervention Period||6
244364|NCT00975481|593337|P5|STARTED|Fifth Intervention Period||6
244365|NCT00975481|593338|P4|STARTED|Fifth Intervention Period||5
244366|NCT00975481|593339|P3|STARTED|Fifth Intervention Period||4
244367|NCT00975481|593340|P2|STARTED|Fifth Intervention Period||5
244368|NCT00975481|593341|P1|STARTED|Fifth Intervention Period||4
244369|NCT00975481|593336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244370|NCT00975481|593337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244371|NCT00975481|593338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244372|NCT00975481|593339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244373|NCT00975481|593340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244374|NCT00975481|593341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244375|NCT00975481|593336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
244376|NCT00975481|593337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
244377|NCT00975481|593338|P4|COMPLETED|Washout Period (at Least 7 Days)||5
244378|NCT00975481|593339|P3|COMPLETED|Washout Period (at Least 7 Days)||4
244379|NCT00975481|593340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
244380|NCT00975481|593341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
244381|NCT00975481|593336|P6|STARTED|Washout Period (at Least 7 Days)||6
244382|NCT00975481|593337|P5|STARTED|Washout Period (at Least 7 Days)||6
244383|NCT00975481|593338|P4|STARTED|Washout Period (at Least 7 Days)||5
244384|NCT00975481|593339|P3|STARTED|Washout Period (at Least 7 Days)||4
244385|NCT00975481|593340|P2|STARTED|Washout Period (at Least 7 Days)||5
244386|NCT00975481|593341|P1|STARTED|Washout Period (at Least 7 Days)||4
244387|NCT00975481|593336|P6|NOT COMPLETED|Fourth Intervention Period||0
244388|NCT00975481|593337|P5|NOT COMPLETED|Fourth Intervention Period||0
244389|NCT00975481|593338|P4|NOT COMPLETED|Fourth Intervention Period||1
244390|NCT00975481|593339|P3|NOT COMPLETED|Fourth Intervention Period||1
244391|NCT00975481|593340|P2|NOT COMPLETED|Fourth Intervention Period||0
244392|NCT00975481|593341|P1|NOT COMPLETED|Fourth Intervention Period||0
244393|NCT00975481|593336|P6|COMPLETED|Fourth Intervention Period||6
244394|NCT00975481|593337|P5|COMPLETED|Fourth Intervention Period||6
244395|NCT00975481|593338|P4|COMPLETED|Fourth Intervention Period||5
244396|NCT00975481|593339|P3|COMPLETED|Fourth Intervention Period||4
244397|NCT00975481|593340|P2|COMPLETED|Fourth Intervention Period||5
244398|NCT00975481|593341|P1|COMPLETED|Fourth Intervention Period||4
244399|NCT00975481|593336|P6|STARTED|Fourth Intervention Period||6
244400|NCT00975481|593337|P5|STARTED|Fourth Intervention Period||6
244401|NCT00975481|593338|P4|STARTED|Fourth Intervention Period||6
244402|NCT00975481|593339|P3|STARTED|Fourth Intervention Period||5
244403|NCT00975481|593340|P2|STARTED|Fourth Intervention Period||5
244404|NCT00975481|593341|P1|STARTED|Fourth Intervention Period||4
244405|NCT00975481|593336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244406|NCT00975481|593337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244407|NCT00975481|593338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244408|NCT00975481|593339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244409|NCT00975481|593340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244410|NCT00975481|593341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244411|NCT00975481|593336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
244412|NCT00975481|593337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
244413|NCT00975481|593338|P4|COMPLETED|Washout Period (at Least 7 Days)||6
244414|NCT00975481|593339|P3|COMPLETED|Washout Period (at Least 7 Days)||5
244415|NCT00975481|593340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
244416|NCT00975481|593341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
244417|NCT00975481|593336|P6|STARTED|Washout Period (at Least 7 Days)||6
244418|NCT00975481|593337|P5|STARTED|Washout Period (at Least 7 Days)||6
244419|NCT00975481|593338|P4|STARTED|Washout Period (at Least 7 Days)||6
244420|NCT00975481|593339|P3|STARTED|Washout Period (at Least 7 Days)||5
244421|NCT00975481|593340|P2|STARTED|Washout Period (at Least 7 Days)||5
244422|NCT00975481|593341|P1|STARTED|Washout Period (at Least 7 Days)||4
244423|NCT00975481|593336|P6|NOT COMPLETED|Third Intervention Period||0
244424|NCT00975481|593337|P5|NOT COMPLETED|Third Intervention Period||0
244425|NCT00975481|593338|P4|NOT COMPLETED|Third Intervention Period||0
244426|NCT00975481|593339|P3|NOT COMPLETED|Third Intervention Period||0
244427|NCT00975481|593340|P2|NOT COMPLETED|Third Intervention Period||0
244428|NCT00975481|593341|P1|NOT COMPLETED|Third Intervention Period||0
244429|NCT00975481|593336|P6|COMPLETED|Third Intervention Period||6
244430|NCT00975481|593337|P5|COMPLETED|Third Intervention Period||6
244431|NCT00975481|593338|P4|COMPLETED|Third Intervention Period||6
244432|NCT00975481|593339|P3|COMPLETED|Third Intervention Period||5
244433|NCT00975481|593340|P2|COMPLETED|Third Intervention Period||5
244434|NCT00975481|593341|P1|COMPLETED|Third Intervention Period||4
244435|NCT00975481|593336|P6|STARTED|Third Intervention Period||6
244436|NCT00975481|593337|P5|STARTED|Third Intervention Period||6
244437|NCT00975481|593338|P4|STARTED|Third Intervention Period||6
244438|NCT00975481|593339|P3|STARTED|Third Intervention Period||5
244439|NCT00975481|593340|P2|STARTED|Third Intervention Period||5
244440|NCT00975481|593341|P1|STARTED|Third Intervention Period||4
244441|NCT00975481|593336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244442|NCT00975481|593337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244443|NCT00975481|593338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244444|NCT00975481|593339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244445|NCT00975481|593340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244446|NCT00975481|593341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244447|NCT00975481|593336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
244448|NCT00975481|593337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
244449|NCT00975481|593338|P4|COMPLETED|Washout Period (at Least 7 Days)||6
244450|NCT00975481|593339|P3|COMPLETED|Washout Period (at Least 7 Days)||5
244451|NCT00975481|593340|P2|COMPLETED|Washout Period (at Least 7 Days)||5
244452|NCT00975481|593341|P1|COMPLETED|Washout Period (at Least 7 Days)||4
244453|NCT00975481|593336|P6|STARTED|Washout Period (at Least 7 Days)||6
244454|NCT00975481|593337|P5|STARTED|Washout Period (at Least 7 Days)||6
244455|NCT00975481|593338|P4|STARTED|Washout Period (at Least 7 Days)||6
244456|NCT00975481|593339|P3|STARTED|Washout Period (at Least 7 Days)||5
244457|NCT00975481|593340|P2|STARTED|Washout Period (at Least 7 Days)||5
244458|NCT00975481|593341|P1|STARTED|Washout Period (at Least 7 Days)||4
244459|NCT00975481|593336|P6|NOT COMPLETED|Second Intervention Period||0
244460|NCT00975481|593337|P5|NOT COMPLETED|Second Intervention Period||0
244461|NCT00975481|593338|P4|NOT COMPLETED|Second Intervention Period||0
244462|NCT00975481|593339|P3|NOT COMPLETED|Second Intervention Period||1
244463|NCT00975481|593340|P2|NOT COMPLETED|Second Intervention Period||1
244464|NCT00975481|593341|P1|NOT COMPLETED|Second Intervention Period||2
244465|NCT00975481|593336|P6|COMPLETED|Second Intervention Period||6
244466|NCT00975481|593337|P5|COMPLETED|Second Intervention Period||6
244467|NCT00975481|593338|P4|COMPLETED|Second Intervention Period||6
244468|NCT00975481|593339|P3|COMPLETED|Second Intervention Period||5
244469|NCT00975481|593340|P2|COMPLETED|Second Intervention Period||5
244470|NCT00975481|593341|P1|COMPLETED|Second Intervention Period||4
244471|NCT00975481|593336|P6|STARTED|Second Intervention Period||6
244472|NCT00975481|593337|P5|STARTED|Second Intervention Period||6
244473|NCT00975481|593338|P4|STARTED|Second Intervention Period||6
244474|NCT00975481|593339|P3|STARTED|Second Intervention Period||6
244475|NCT00975481|593340|P2|STARTED|Second Intervention Period||6
244476|NCT00975481|593341|P1|STARTED|Second Intervention Period||6
244477|NCT00975481|593336|P6|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244478|NCT00975481|593337|P5|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244479|NCT00975481|593338|P4|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244480|NCT00975481|593339|P3|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244481|NCT00975481|593340|P2|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244482|NCT00975481|593341|P1|NOT COMPLETED|Washout Period (at Least 7 Days)||0
244483|NCT00975481|593336|P6|COMPLETED|Washout Period (at Least 7 Days)||6
244484|NCT00975481|593337|P5|COMPLETED|Washout Period (at Least 7 Days)||6
244485|NCT00975481|593338|P4|COMPLETED|Washout Period (at Least 7 Days)||6
244486|NCT00975481|593339|P3|COMPLETED|Washout Period (at Least 7 Days)||6
244487|NCT00975481|593340|P2|COMPLETED|Washout Period (at Least 7 Days)||6
244488|NCT00975481|593341|P1|COMPLETED|Washout Period (at Least 7 Days)||6
244489|NCT00975481|593336|P6|STARTED|Washout Period (at Least 7 Days)||6
244490|NCT00975481|593337|P5|STARTED|Washout Period (at Least 7 Days)||6
244491|NCT00975481|593338|P4|STARTED|Washout Period (at Least 7 Days)||6
244492|NCT00975481|593339|P3|STARTED|Washout Period (at Least 7 Days)||6
244493|NCT00975481|593340|P2|STARTED|Washout Period (at Least 7 Days)||6
244494|NCT00975481|593341|P1|STARTED|Washout Period (at Least 7 Days)||6
244495|NCT00975481|593336|P6|NOT COMPLETED|First Intervention Period||0
244496|NCT00975481|593337|P5|NOT COMPLETED|First Intervention Period||0
244497|NCT00975481|593338|P4|NOT COMPLETED|First Intervention Period||0
244498|NCT00975481|593339|P3|NOT COMPLETED|First Intervention Period||0
244499|NCT00975481|593340|P2|NOT COMPLETED|First Intervention Period||0
244500|NCT00975481|593341|P1|NOT COMPLETED|First Intervention Period||0
244501|NCT00975481|593336|P6|COMPLETED|First Intervention Period||6
244502|NCT00975481|593337|P5|COMPLETED|First Intervention Period||6
244503|NCT00975481|593338|P4|COMPLETED|First Intervention Period||6
244504|NCT00975481|593339|P3|COMPLETED|First Intervention Period||6
244505|NCT00975481|593340|P2|COMPLETED|First Intervention Period||6
244506|NCT00975481|593341|P1|COMPLETED|First Intervention Period||6
244507|NCT00975481|593336|P6|STARTED|First Intervention Period||6
244508|NCT00975481|593337|P5|STARTED|First Intervention Period||6
244509|NCT00975481|593338|P4|STARTED|First Intervention Period||6
244510|NCT00975481|593339|P3|STARTED|First Intervention Period||6
244511|NCT00975481|593340|P2|STARTED|First Intervention Period||6
244512|NCT00975481|593341|P1|STARTED|First Intervention Period||6
244513|NCT00975507|593441|P2|NOT COMPLETED|Overall Study||4
244514|NCT00975507|593442|P1|NOT COMPLETED|Overall Study||20
244515|NCT00975507|593441|P2|COMPLETED|Overall Study||153
244516|NCT00975507|593442|P1|COMPLETED|Overall Study||303
244517|NCT00975507|593441|P2|Vaccinated at Visit 2|Overall Study|Per-protocol, subjects receiving M-M-R™ II + VARIVAX™ at Visit 1 were not vaccinated at Visit 2|0
244518|NCT00975507|593442|P1|Vaccinated at Visit 2|Overall Study||310
244519|NCT00975507|593441|P2|Vaccinated at Visit 1|Overall Study||157
244520|NCT00975507|593442|P1|Vaccinated at Visit 1|Overall Study||323
244521|NCT00975507|593441|P2|STARTED|Overall Study||157
244522|NCT00975507|593442|P1|STARTED|Overall Study||323
244523|NCT00975585|593464|P2|NOT COMPLETED|Overall Study||12
244524|NCT00975585|593465|P1|NOT COMPLETED|Overall Study||7
244525|NCT00975585|593464|P2|COMPLETED|Overall Study||183
244526|NCT00975585|593465|P1|COMPLETED|Overall Study||177
244527|NCT00975585|593464|P2|STARTED|Overall Study||195
244528|NCT00975585|593465|P1|STARTED|Overall Study||184
244529|NCT00975611|593483|P1|NOT COMPLETED|Overall Study||17
244530|NCT00975611|593483|P1|COMPLETED|Overall Study||5
244531|NCT00975611|593483|P1|STARTED|Overall Study||22
244532|NCT00975637|593492|P5|NOT COMPLETED|Overall Study||2
244533|NCT00975637|593493|P4|NOT COMPLETED|Overall Study||6
244534|NCT00975637|593494|P3|NOT COMPLETED|Overall Study||2
244535|NCT00975637|593495|P2|NOT COMPLETED|Overall Study||1
244536|NCT00975637|593496|P1|NOT COMPLETED|Overall Study||3
244537|NCT00975637|593492|P5|COMPLETED|Overall Study||37
244538|NCT00975637|593493|P4|COMPLETED|Overall Study||32
244539|NCT00975637|593494|P3|COMPLETED|Overall Study||40
244540|NCT00975637|593495|P2|COMPLETED|Overall Study||38
244541|NCT00975637|593496|P1|COMPLETED|Overall Study||37
244542|NCT00975637|593492|P5|STARTED|Overall Study||39
244543|NCT00975637|593493|P4|STARTED|Overall Study||38
244544|NCT00975637|593494|P3|STARTED|Overall Study||42
244545|NCT00975637|593495|P2|STARTED|Overall Study||39
244546|NCT00975637|593496|P1|STARTED|Overall Study||40
244547|NCT00975689|593515|P2|NOT COMPLETED|Overall Study||3
244548|NCT00975689|593516|P1|NOT COMPLETED|Overall Study||2
244549|NCT00975689|593515|P2|COMPLETED|Overall Study||15
244550|NCT00975689|593516|P1|COMPLETED|Overall Study||15
244551|NCT00975689|593515|P2|STARTED|Overall Study||18
244552|NCT00975689|593516|P1|STARTED|Overall Study||17
244553|NCT00975715|593524|P2|NOT COMPLETED|Maintenance Period||1
244554|NCT00975715|593525|P1|NOT COMPLETED|Maintenance Period||2
244555|NCT00975715|593524|P2|COMPLETED|Maintenance Period||50
244556|NCT00975715|593525|P1|COMPLETED|Maintenance Period||39
244557|NCT00975715|593524|P2|STARTED|Maintenance Period||51
244558|NCT00975715|593525|P1|STARTED|Maintenance Period||41
244559|NCT00975715|593524|P2|NOT COMPLETED|Titration Period||0
244560|NCT00975715|593525|P1|NOT COMPLETED|Titration Period||7
244561|NCT00975715|593524|P2|COMPLETED|Titration Period||51
244562|NCT00975715|593525|P1|COMPLETED|Titration Period||41
244563|NCT00975715|593524|P2|STARTED|Titration Period||51
244564|NCT00975715|593525|P1|STARTED|Titration Period||48
244565|NCT00975780|593541|P2|NOT COMPLETED|Follow Up||157
244566|NCT00975780|593542|P1|NOT COMPLETED|Follow Up||102
244567|NCT00975780|593541|P2|COMPLETED|Follow Up||277
244568|NCT00975780|593542|P1|COMPLETED|Follow Up||298
244569|NCT00975780|593541|P2|STARTED|Follow Up||434
244570|NCT00975780|593542|P1|STARTED|Follow Up||400
244571|NCT00975780|593541|P2|NOT COMPLETED|Allocation||0
244572|NCT00975780|593542|P1|NOT COMPLETED|Allocation||0
244573|NCT00975780|593541|P2|COMPLETED|Allocation||434
244574|NCT00975780|593542|P1|COMPLETED|Allocation||400
244575|NCT00975780|593541|P2|STARTED|Allocation||434
244576|NCT00975780|593542|P1|STARTED|Allocation||400
244577|NCT00975806|593553|P3|NOT COMPLETED|Overall Study||4
244578|NCT00975806|593554|P2|NOT COMPLETED|Overall Study||7
244579|NCT00975806|593555|P1|NOT COMPLETED|Overall Study||5
244580|NCT00975806|593553|P3|COMPLETED|Overall Study|Participants were prematurely discontinued|0
244581|NCT00975806|593554|P2|COMPLETED|Overall Study|Participants were prematurely discontinued|0
244582|NCT00975806|593555|P1|COMPLETED|Overall Study|Participants were prematurely discontinued|0
244583|NCT00975806|593553|P3|STARTED|Overall Study||4
244584|NCT00975806|593554|P2|STARTED|Overall Study||7
244585|NCT00975806|593555|P1|STARTED|Overall Study||5
244586|NCT00975923|593579|P2|NOT COMPLETED|Overall Study||1
244587|NCT00975923|593580|P1|NOT COMPLETED|Overall Study||0
244588|NCT00975923|593579|P2|COMPLETED|Overall Study|1 hospital was sold, yielding 29 hospitals in the Tool Kit Group|29
244589|NCT00975923|593580|P1|COMPLETED|Overall Study||30
244590|NCT00975923|593579|P2|STARTED|Overall Study||30
244591|NCT00975923|593580|P1|STARTED|Overall Study||30
244592|NCT00975975|593588|P1|NOT COMPLETED|Overall Study||6
244593|NCT00975975|593588|P1|COMPLETED|Overall Study||11
244594|NCT00975975|593588|P1|STARTED|Overall Study||17
244595|NCT00976027|593596|P2|NOT COMPLETED|Overall Study||215
244596|NCT00976027|593597|P1|NOT COMPLETED|Overall Study||411
244597|NCT00976027|593596|P2|COMPLETED|Overall Study||2835
244598|NCT00976027|593597|P1|COMPLETED|Overall Study||5697
244599|NCT00976027|593596|P2|STARTED|Overall Study||3050
244600|NCT00976027|593597|P1|STARTED|Overall Study||6108
244601|NCT00976183|593609|P1|NOT COMPLETED|Overall Study||0
244602|NCT00976183|593609|P1|COMPLETED|Overall Study|The study was closed on 05/30/12 due to adverse events. We did not complete enrollment|18
244603|NCT00976183|593609|P1|STARTED|Overall Study||18
244604|NCT00976209|593616|P2|NOT COMPLETED|Treatment Period 2||2
244605|NCT00976209|593617|P1|NOT COMPLETED|Treatment Period 2||0
244606|NCT00976209|593616|P2|COMPLETED|Treatment Period 2||161
244607|NCT00976209|593617|P1|COMPLETED|Treatment Period 2||158
244608|NCT00976209|593616|P2|STARTED|Treatment Period 2||163
244609|NCT00976209|593617|P1|STARTED|Treatment Period 2||158
244610|NCT00976209|593616|P2|NOT COMPLETED|Wash-out Period||2
244611|NCT00976209|593617|P1|NOT COMPLETED|Wash-out Period||4
244612|NCT00976209|593616|P2|COMPLETED|Wash-out Period||163
244613|NCT00976209|593617|P1|COMPLETED|Wash-out Period||158
244614|NCT00976209|593616|P2|STARTED|Wash-out Period||165
244615|NCT00976209|593617|P1|STARTED|Wash-out Period||162
244616|NCT00976209|593616|P2|NOT COMPLETED|Treatment Period 1||1
244617|NCT00976209|593617|P1|NOT COMPLETED|Treatment Period 1||3
244618|NCT00976209|593616|P2|COMPLETED|Treatment Period 1||165
244619|NCT00976209|593617|P1|COMPLETED|Treatment Period 1||162
244620|NCT00976209|593616|P2|STARTED|Treatment Period 1||166
244621|NCT00976209|593617|P1|STARTED|Treatment Period 1||165
244622|NCT00976248|593623|P1|NOT COMPLETED|Overall Study||0
244623|NCT00976248|593623|P1|COMPLETED|Overall Study||33
244624|NCT00976248|593623|P1|STARTED|Overall Study||33
244625|NCT00976274|593631|P2|NOT COMPLETED|Overall Study||8
244626|NCT00976274|593632|P1|NOT COMPLETED|Overall Study||7
244627|NCT00976274|593631|P2|COMPLETED|Overall Study||21
244628|NCT00976274|593632|P1|COMPLETED|Overall Study||24
244629|NCT00976274|593631|P2|STARTED|Overall Study||29
244630|NCT00976274|593632|P1|STARTED|Overall Study||31
244631|NCT00976339|593640|P1|NOT COMPLETED|Overall Study||4
244632|NCT00976339|593640|P1|COMPLETED|Overall Study||16
244633|NCT00976339|593640|P1|STARTED|Overall Study||20
244634|NCT00976391|593646|P2|NOT COMPLETED|Follow-up Period (8 Weeks)||34
244635|NCT00976391|593647|P1|NOT COMPLETED|Follow-up Period (8 Weeks)||29
244636|NCT00976391|593646|P2|COMPLETED|Follow-up Period (8 Weeks)||247
244637|NCT00976391|593647|P1|COMPLETED|Follow-up Period (8 Weeks)||256
244638|NCT00976391|593646|P2|STARTED|Follow-up Period (8 Weeks)||281
244639|NCT00976391|593647|P1|STARTED|Follow-up Period (8 Weeks)||285
244640|NCT00976391|593646|P2|NOT COMPLETED|Treatment Period (52 Weeks)||39
244641|NCT00976391|593647|P1|NOT COMPLETED|Treatment Period (52 Weeks)||42
244642|NCT00976391|593646|P2|COMPLETED|Treatment Period (52 Weeks)||242
244643|NCT00976391|593647|P1|COMPLETED|Treatment Period (52 Weeks)||243
244644|NCT00976391|593646|P2|STARTED|Treatment Period (52 Weeks)||281
244645|NCT00976391|593647|P1|STARTED|Treatment Period (52 Weeks)||285
244646|NCT00976404|593669|P2|NOT COMPLETED|Overall Study||0
244647|NCT00976404|593670|P1|NOT COMPLETED|Overall Study||0
244648|NCT00976404|593669|P2|COMPLETED|Overall Study||14
244649|NCT00976404|593670|P1|COMPLETED|Overall Study||14
244650|NCT00976404|593669|P2|STARTED|Overall Study||14
244651|NCT00976404|593670|P1|STARTED|Overall Study||14
244652|NCT00976456|593686|P2|NOT COMPLETED|Overall Study||38
244653|NCT00976456|593687|P1|NOT COMPLETED|Overall Study||43
244654|NCT00976456|593686|P2|COMPLETED|Overall Study||98
244655|NCT00976456|593687|P1|COMPLETED|Overall Study||92
244656|NCT00976456|593686|P2|STARTED|Overall Study||136
244657|NCT00976456|593687|P1|STARTED|Overall Study||135
244658|NCT00976482|593695|P1|NOT COMPLETED|Overall Study||259
244659|NCT00976482|593695|P1|COMPLETED|Overall Study||1486
244660|NCT00976482|593695|P1|Eligible for Last Follow up|Overall Study||1487
244661|NCT00976482|593695|P1|STARTED|Overall Study||1745
244662|NCT00976495|593702|P3|NOT COMPLETED|Overall Study||0
244663|NCT00976495|593703|P2|NOT COMPLETED|Overall Study||1
244664|NCT00976495|593704|P1|NOT COMPLETED|Overall Study||0
244665|NCT00976495|593702|P3|COMPLETED|Overall Study||26
244666|NCT00976495|593703|P2|COMPLETED|Overall Study||23
244667|NCT00976495|593704|P1|COMPLETED|Overall Study||25
244668|NCT00976495|593702|P3|STARTED|Overall Study||26
244669|NCT00976495|593703|P2|STARTED|Overall Study||24
244670|NCT00976495|593704|P1|STARTED|Overall Study||25
244671|NCT00976508|593723|P2|NOT COMPLETED|Overall Study||6
244672|NCT00976508|593724|P1|NOT COMPLETED|Overall Study||14
244673|NCT00976508|593723|P2|COMPLETED|Overall Study||0
244674|NCT00976508|593724|P1|COMPLETED|Overall Study|These subjects withdrew from last study treatment due to progressive disease.|3
244675|NCT00976508|593723|P2|STARTED|Overall Study||6
244676|NCT00976508|593724|P1|STARTED|Overall Study|18 subjects were enrolled; 17 subjects were treated; 1 subject was not eligible.|17
244677|NCT00976521|593758|P4|NOT COMPLETED|Overall Study||19
244678|NCT00976521|593759|P3|NOT COMPLETED|Overall Study||9
244679|NCT00976521|593760|P2|NOT COMPLETED|Overall Study||12
244680|NCT00976521|593761|P1|NOT COMPLETED|Overall Study||9
244681|NCT00976521|593758|P4|COMPLETED|Overall Study||93
244682|NCT00976521|593759|P3|COMPLETED|Overall Study||102
244683|NCT00976521|593760|P2|COMPLETED|Overall Study||99
244684|NCT00976521|593761|P1|COMPLETED|Overall Study||109
244685|NCT00976521|593758|P4|STARTED|Overall Study||112
244686|NCT00976521|593759|P3|STARTED|Overall Study||111
244687|NCT00976521|593760|P2|STARTED|Overall Study||111
244688|NCT00976521|593761|P1|STARTED|Overall Study||118
244689|NCT00976573|593775|P2|NOT COMPLETED|Overall Study||3
244690|NCT00976573|593776|P1|NOT COMPLETED|Overall Study||4
244691|NCT00976573|593775|P2|COMPLETED|Overall Study||71
244692|NCT00976573|593776|P1|COMPLETED|Overall Study||71
244693|NCT00976573|593775|P2|STARTED|Overall Study||74
244694|NCT00976573|593776|P1|STARTED|Overall Study||75
244695|NCT00976599|593790|P2|NOT COMPLETED|Overall Study||0
244696|NCT00976599|593791|P1|NOT COMPLETED|Overall Study||0
244697|NCT00976599|593790|P2|COMPLETED|Overall Study||14
244698|NCT00976599|593791|P1|COMPLETED|Overall Study||15
244699|NCT00976599|593790|P2|STARTED|Overall Study||14
244700|NCT00976599|593791|P1|STARTED|Overall Study||15
244701|NCT00976664|593979|P2|NOT COMPLETED|Overall Study||1
244702|NCT00976664|593980|P1|NOT COMPLETED|Overall Study||3
244703|NCT00976664|593979|P2|COMPLETED|Overall Study||24
244704|NCT00976664|593980|P1|COMPLETED|Overall Study||22
244705|NCT00976664|593979|P2|STARTED|Overall Study||25
244706|NCT00976664|593980|P1|STARTED|Overall Study||25
244707|NCT00976677|593990|P2|NOT COMPLETED|Overall Study||5
244708|NCT00976677|593991|P1|NOT COMPLETED|Overall Study||5
244709|NCT00976677|593990|P2|COMPLETED|Overall Study||0
244710|NCT00976677|593991|P1|COMPLETED|Overall Study||0
244711|NCT00976677|593990|P2|STARTED|Overall Study||5
244712|NCT00976677|593991|P1|STARTED|Overall Study||5
244713|NCT00976703|593999|P2|NOT COMPLETED|Overall Study||3
244714|NCT00976703|594000|P1|NOT COMPLETED|Overall Study||3
244715|NCT00976703|593999|P2|COMPLETED|Overall Study||95
244716|NCT00976703|594000|P1|COMPLETED|Overall Study||96
244717|NCT00976703|593999|P2|STARTED|Overall Study||98
244718|NCT00976703|594000|P1|STARTED|Overall Study||99
244719|NCT00976716|594012|P1|NOT COMPLETED|Overall Study||1
244720|NCT00976716|594012|P1|COMPLETED|Overall Study||79
244721|NCT00976716|594012|P1|STARTED|Overall Study||80
244722|NCT00976911|594030|P2|NOT COMPLETED|Overall Study||179
244723|NCT00976911|594031|P1|NOT COMPLETED|Overall Study||182
244724|NCT00976911|594030|P2|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
244725|NCT00976911|594031|P1|COMPLETED|Overall Study|At time of clinical cutoff for overall survival and safety (25 January 2013)|0
244726|NCT00976911|594030|P2|STARTED|Overall Study||179
244727|NCT00976911|594031|P1|STARTED|Overall Study||182
244728|NCT00976937|594051|P2|NOT COMPLETED|Overall Study||11
244729|NCT00976937|594052|P1|NOT COMPLETED|Overall Study||16
244730|NCT00976937|594051|P2|COMPLETED|Overall Study||150
244731|NCT00976937|594052|P1|COMPLETED|Overall Study||142
244732|NCT00976937|594051|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||161
244733|NCT00976937|594052|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All randomized patients who received at least 1 dose of study drug.|158
244734|NCT00976937|594051|P2|Treated/Safety Population|Overall Study||161
244735|NCT00976937|594052|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|158
244736|NCT00976937|594051|P2|STARTED|Overall Study||161
244737|NCT00976937|594052|P1|STARTED|Overall Study|Randomized|158
244738|NCT00976950|594092|P1|NOT COMPLETED|Overall Study||6
244739|NCT00976950|594092|P1|COMPLETED|Overall Study||36
244740|NCT00976950|594092|P1|STARTED|Overall Study||42
244741|NCT00976989|594101|P3|NOT COMPLETED|Overall Study||17
244742|NCT00976989|594102|P2|NOT COMPLETED|Overall Study||12
244743|NCT00976989|594103|P1|NOT COMPLETED|Overall Study||13
244744|NCT00976989|594101|P3|COMPLETED|Overall Study||60
244745|NCT00976989|594102|P2|COMPLETED|Overall Study||63
244746|NCT00976989|594103|P1|COMPLETED|Overall Study||60
244747|NCT00976989|594101|P3|STARTED|Overall Study||77
244748|NCT00976989|594102|P2|STARTED|Overall Study||75
244749|NCT00976989|594103|P1|STARTED|Overall Study||73
244750|NCT00977080|594148|P4|NOT COMPLETED|Overall Study||17
244751|NCT00977080|594149|P3|NOT COMPLETED|Overall Study||16
244752|NCT00977080|594150|P2|NOT COMPLETED|Overall Study||20
244753|NCT00977080|594151|P1|NOT COMPLETED|Overall Study||12
244754|NCT00977080|594148|P4|COMPLETED|Overall Study||53
244755|NCT00977080|594149|P3|COMPLETED|Overall Study||56
244756|NCT00977080|594150|P2|COMPLETED|Overall Study||44
244757|NCT00977080|594151|P1|COMPLETED|Overall Study||50
244758|NCT00977080|594148|P4|STARTED|Overall Study||70
244759|NCT00977080|594149|P3|STARTED|Overall Study||72
244760|NCT00977080|594150|P2|STARTED|Overall Study||64
244761|NCT00977080|594151|P1|STARTED|Overall Study||62
244762|NCT00977106|594183|P2|NOT COMPLETED|Overall Study||11
244763|NCT00977106|594184|P1|NOT COMPLETED|Overall Study||10
244764|NCT00977106|594183|P2|COMPLETED|Overall Study||45
244765|NCT00977106|594184|P1|COMPLETED|Overall Study||37
244766|NCT00977106|594183|P2|STARTED|Overall Study|Includes 3 participants who were randomized to placebo, but received tocilizumab.|56
244767|NCT00977106|594184|P1|STARTED|Overall Study||47
244768|NCT00977171|594272|P1|NOT COMPLETED|Overall Study||0
244769|NCT00977171|594272|P1|COMPLETED|Overall Study||3
244770|NCT00977171|594272|P1|STARTED|Overall Study||3
244771|NCT00977184|594278|P2|NOT COMPLETED|Overall Study||0
244772|NCT00977184|594279|P1|NOT COMPLETED|Overall Study||0
244773|NCT00977184|594278|P2|COMPLETED|Overall Study||13
244774|NCT00977184|594279|P1|COMPLETED|Overall Study||13
244775|NCT00977184|594278|P2|STARTED|Overall Study||13
244776|NCT00977184|594279|P1|STARTED|Overall Study||13
244777|NCT00977197|594307|P2|NOT COMPLETED|Overall Study||9
244778|NCT00977197|594308|P1|NOT COMPLETED|Overall Study||9
244779|NCT00977197|594307|P2|COMPLETED|Overall Study||35
244780|NCT00977197|594308|P1|COMPLETED|Overall Study||32
244781|NCT00977197|594307|P2|STARTED|Overall Study||44
244782|NCT00977197|594308|P1|STARTED|Overall Study||41
244783|NCT00977314|594338|P2|NOT COMPLETED|Overall Study||0
244784|NCT00977314|594339|P1|NOT COMPLETED|Overall Study||2
244785|NCT00977314|594338|P2|COMPLETED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
244786|NCT00977314|594339|P1|COMPLETED|Overall Study||28
244787|NCT00977314|594338|P2|STARTED|Overall Study|First 5 subjects enrolled were pilot subjects and not included in analysis.|5
244788|NCT00977314|594339|P1|STARTED|Overall Study||30
244789|NCT00968708|594347|P2|NOT COMPLETED|Overall Study||298
244790|NCT00968708|594348|P1|NOT COMPLETED|Overall Study||318
244791|NCT00968708|594347|P2|COMPLETED|Overall Study||2403
244792|NCT00968708|594348|P1|COMPLETED|Overall Study||2361
244793|NCT00968708|594347|P2|Treated|Overall Study||2698
244794|NCT00968708|594348|P1|Treated|Overall Study||2676
244795|NCT00968708|594347|P2|STARTED|Overall Study||2701
244796|NCT00968708|594348|P1|STARTED|Overall Study||2679
244797|NCT00968799|594356|P1|NOT COMPLETED|Overall Study||2
244798|NCT00968799|594356|P1|COMPLETED|Overall Study||4
244799|NCT00968799|594356|P1|STARTED|Overall Study||6
244800|NCT00968812|594367|P3|NOT COMPLETED|Overall Study||168
244801|NCT00968812|594368|P2|NOT COMPLETED|Overall Study||162
244802|NCT00968812|594369|P1|NOT COMPLETED|Overall Study||140
244803|NCT00968812|594367|P3|COMPLETED|Overall Study||314
244804|NCT00968812|594368|P2|COMPLETED|Overall Study||323
244805|NCT00968812|594369|P1|COMPLETED|Overall Study||343
244806|NCT00968812|594367|P3|STARTED|Overall Study||482
244807|NCT00968812|594368|P2|STARTED|Overall Study||485
244808|NCT00968812|594369|P1|STARTED|Overall Study||483
244809|NCT00968838|594391|P2|NOT COMPLETED|Overall Study||0
244810|NCT00968838|594392|P1|NOT COMPLETED|Overall Study||0
244811|NCT00968838|594391|P2|COMPLETED|Overall Study||58
244812|NCT00968838|594392|P1|COMPLETED|Overall Study||50
244813|NCT00968838|594391|P2|STARTED|Overall Study||58
244814|NCT00968838|594392|P1|STARTED|Overall Study||50
244815|NCT00968890|594400|P2|NOT COMPLETED|Overall Study||0
244816|NCT00968890|594401|P1|NOT COMPLETED|Overall Study||0
244817|NCT00968890|594400|P2|COMPLETED|Overall Study||84
244818|NCT00968890|594401|P1|COMPLETED|Overall Study||84
244819|NCT00968890|594400|P2|STARTED|Overall Study||84
244820|NCT00968890|594401|P1|STARTED|Overall Study||84
244821|NCT00968981|594432|P3|NOT COMPLETED|Overall Study||22
244822|NCT00968981|594433|P2|NOT COMPLETED|Overall Study||22
244823|NCT00968981|594434|P1|NOT COMPLETED|Overall Study||22
244824|NCT00968981|594432|P3|COMPLETED|Overall Study||0
244825|NCT00968981|594433|P2|COMPLETED|Overall Study||0
244826|NCT00968981|594434|P1|COMPLETED|Overall Study||1
244827|NCT00968981|594432|P3|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|22
244828|NCT00968981|594433|P2|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|21
244829|NCT00968981|594434|P1|Pharmacokinetic(PK) Evaluable Population|Overall Study|Participants with sufficient data to ensure reliable estimation of PK for at least Day 1 PK profile.|20
244830|NCT00968981|594432|P3|STARTED|Overall Study||22
244831|NCT00968981|594433|P2|STARTED|Overall Study||22
244832|NCT00968981|594434|P1|STARTED|Overall Study||23
244833|NCT00969124|594470|P1|NOT COMPLETED|Overall Study||30
244834|NCT00969124|594470|P1|COMPLETED|Overall Study||298
244835|NCT00969124|594470|P1|STARTED|Overall Study||328
244836|NCT00969150|594478|P2|NOT COMPLETED|Overall Study||40
244837|NCT00969150|594479|P1|NOT COMPLETED|Overall Study||33
244838|NCT00969150|594478|P2|COMPLETED|Overall Study||135
244839|NCT00969150|594479|P1|COMPLETED|Overall Study||149
244840|NCT00969150|594478|P2|STARTED|Overall Study||175
244841|NCT00969150|594479|P1|STARTED|Overall Study||182
244842|NCT00969228|594489|P2|NOT COMPLETED|Overall Study||14
244843|NCT00969228|594490|P1|NOT COMPLETED|Overall Study||43
244844|NCT00969228|594489|P2|COMPLETED|Overall Study||162
244845|NCT00969228|594490|P1|COMPLETED|Overall Study||465
244846|NCT00969228|594489|P2|STARTED|Overall Study||176
244847|NCT00969228|594490|P1|STARTED|Overall Study||508
244848|NCT00969280|594508|P2|NOT COMPLETED|Overall Study||3
244849|NCT00969280|594509|P1|NOT COMPLETED|Overall Study||2
244850|NCT00969280|594508|P2|COMPLETED|Overall Study||18
244851|NCT00969280|594509|P1|COMPLETED|Overall Study||19
244852|NCT00969280|594508|P2|STARTED|Overall Study||21
244853|NCT00969280|594509|P1|STARTED|Overall Study||21
244854|NCT00969501|594515|P1|NOT COMPLETED|Overall Study||5
244855|NCT00969501|594515|P1|COMPLETED|Overall Study||27
244856|NCT00969501|594515|P1|STARTED|Overall Study||32
244857|NCT00969540|594521|P2|NOT COMPLETED|Overall Study||1
244858|NCT00969540|594522|P1|NOT COMPLETED|Overall Study||1
244859|NCT00969540|594521|P2|COMPLETED|Overall Study||3
244860|NCT00969540|594522|P1|COMPLETED|Overall Study||3
244861|NCT00969540|594521|P2|STARTED|Overall Study||4
244862|NCT00969540|594522|P1|STARTED|Overall Study||4
244863|NCT00969618|594540|P1|NOT COMPLETED|Overall Study||78
244864|NCT00969618|594540|P1|COMPLETED|Overall Study||133
244865|NCT00969618|594540|P1|STARTED|Overall Study||211
244866|NCT00969709|594555|P4|NOT COMPLETED|Overall Study||63
244867|NCT00969709|594556|P3|NOT COMPLETED|Overall Study||58
244868|NCT00969709|594557|P2|NOT COMPLETED|Overall Study||48
244869|NCT00969709|594558|P1|NOT COMPLETED|Overall Study||38
244870|NCT00969709|594555|P4|COMPLETED|Overall Study||117
244871|NCT00969709|594556|P3|COMPLETED|Overall Study||121
244872|NCT00969709|594557|P2|COMPLETED|Overall Study||130
244873|NCT00969709|594558|P1|COMPLETED|Overall Study||138
244874|NCT00969709|594555|P4|STARTED|Overall Study||180
244875|NCT00969709|594556|P3|STARTED|Overall Study||179
244876|NCT00969709|594557|P2|STARTED|Overall Study||178
244877|NCT00969709|594558|P1|STARTED|Overall Study||176
244878|NCT00969878|594574|P2|NOT COMPLETED|Overall Study||26
244879|NCT00969878|594575|P1|NOT COMPLETED|Overall Study||30
244880|NCT00969878|594574|P2|COMPLETED|Overall Study||126
244881|NCT00969878|594575|P1|COMPLETED|Overall Study||118
244882|NCT00969878|594574|P2|STARTED|Overall Study||152
244883|NCT00969878|594575|P1|STARTED|Overall Study||148
244884|NCT00970216|594583|P1|NOT COMPLETED|Overall Study||80
244885|NCT00970216|594583|P1|COMPLETED|Overall Study||80
244886|NCT00970216|594583|P1|STARTED|Overall Study||160
244887|NCT00970268|594589|P2|NOT COMPLETED|Overall Study||49
244888|NCT00970268|594590|P1|NOT COMPLETED|Overall Study||43
244889|NCT00970268|594589|P2|COMPLETED|Overall Study||103
244890|NCT00970268|594590|P1|COMPLETED|Overall Study||96
244891|NCT00970268|594589|P2|STARTED|Overall Study||152
244892|NCT00970268|594590|P1|STARTED|Overall Study||139
244893|NCT00970281|594606|P2|NOT COMPLETED|Overall Study||16
244894|NCT00970281|594607|P1|NOT COMPLETED|Overall Study||2
244895|NCT00970281|594606|P2|COMPLETED|Overall Study||29
244896|NCT00970281|594607|P1|COMPLETED|Overall Study||44
244897|NCT00970281|594606|P2|Full Analysis Set|Overall Study||45
244898|NCT00970281|594607|P1|Full Analysis Set|Overall Study|1 participant in the olanzapine arm discontinued before the first intramuscular (IM) injection.|45
244899|NCT00970281|594606|P2|STARTED|Overall Study||45
244900|NCT00970281|594607|P1|STARTED|Overall Study||46
244901|NCT00970294|594623|P1|NOT COMPLETED|Overall Study||5
244902|NCT00970294|594623|P1|COMPLETED|Overall Study||6
244903|NCT00970294|594623|P1|STARTED|Overall Study||11
244904|NCT00970307|594632|P3|NOT COMPLETED|Overall Study||2
244905|NCT00970307|594633|P2|NOT COMPLETED|Overall Study||3
244906|NCT00970307|594634|P1|NOT COMPLETED|Overall Study||3
244907|NCT00970307|594632|P3|COMPLETED|Overall Study||139
244908|NCT00970307|594633|P2|COMPLETED|Overall Study||136
244909|NCT00970307|594634|P1|COMPLETED|Overall Study||138
244910|NCT00970307|594632|P3|STARTED|Overall Study||141
244911|NCT00970307|594633|P2|STARTED|Overall Study||139
244912|NCT00970307|594634|P1|STARTED|Overall Study||141
244913|NCT00970320|594713|P5|NOT COMPLETED|Overall Study||540
244914|NCT00970320|594714|P4|NOT COMPLETED|Overall Study||14
244915|NCT00970320|594715|P3|NOT COMPLETED|Overall Study||13
244916|NCT00970320|594716|P2|NOT COMPLETED|Overall Study||11
244917|NCT00970320|594717|P1|NOT COMPLETED|Overall Study||0
244918|NCT00970320|594713|P5|COMPLETED|Overall Study||1031
244919|NCT00970320|594714|P4|COMPLETED|Overall Study||36
244920|NCT00970320|594715|P3|COMPLETED|Overall Study||35
244921|NCT00970320|594716|P2|COMPLETED|Overall Study||13
244922|NCT00970320|594717|P1|COMPLETED|Overall Study||25
244923|NCT00970320|594713|P5|STARTED|Overall Study||1571
244924|NCT00970320|594714|P4|STARTED|Overall Study||50
244925|NCT00970320|594715|P3|STARTED|Overall Study||48
244926|NCT00970320|594716|P2|STARTED|Overall Study||24
244927|NCT00970320|594717|P1|STARTED|Overall Study||25
244928|NCT00970359|594729|P1|NOT COMPLETED|Overall Study||4
244929|NCT00970359|594729|P1|COMPLETED|Overall Study||20
244930|NCT00970359|594729|P1|STARTED|Overall Study||24
244931|NCT00970489|594737|P2|NOT COMPLETED|Overall Study||41
244932|NCT00970489|594738|P1|NOT COMPLETED|Overall Study||54
244933|NCT00970489|594737|P2|COMPLETED|Overall Study||717
244934|NCT00970489|594738|P1|COMPLETED|Overall Study||704
244935|NCT00970489|594737|P2|STARTED|Overall Study||758
244936|NCT00970489|594738|P1|STARTED|Overall Study||758
244937|NCT00970502|594750|P1|NOT COMPLETED|Overall Study||1
244938|NCT00970502|594750|P1|COMPLETED|Overall Study||14
244939|NCT00970502|594750|P1|STARTED|Overall Study||15
244940|NCT00970606|594761|P2|NOT COMPLETED|Overall Study||0
244941|NCT00970606|594762|P1|NOT COMPLETED|Overall Study||0
244942|NCT00970606|594761|P2|COMPLETED|Overall Study||3
244943|NCT00970606|594762|P1|COMPLETED|Overall Study||4
244944|NCT00970606|594761|P2|STARTED|Overall Study||3
244945|NCT00970606|594762|P1|STARTED|Overall Study||4
244946|NCT00970632|594771|P3|NOT COMPLETED|Overall Study||18
244947|NCT00970632|594772|P2|NOT COMPLETED|Overall Study||15
244948|NCT00970632|594773|P1|NOT COMPLETED|Overall Study||24
244949|NCT00970632|594771|P3|COMPLETED|Overall Study||150
244950|NCT00970632|594772|P2|COMPLETED|Overall Study||156
244951|NCT00970632|594773|P1|COMPLETED|Overall Study||148
244952|NCT00970632|594771|P3|STARTED|Overall Study||168
244953|NCT00970632|594772|P2|STARTED|Overall Study||171
244954|NCT00970632|594773|P1|STARTED|Overall Study||172
244955|NCT00970684|594829|P1|NOT COMPLETED|Overall Study||10
244956|NCT00970684|594829|P1|COMPLETED|Overall Study||3
244957|NCT00970684|594829|P1|STARTED|Overall Study||13
244958|NCT00970736|594835|P1|NOT COMPLETED|Overall Study||2
244959|NCT00970736|594835|P1|COMPLETED|Overall Study||18
244960|NCT00970736|594835|P1|STARTED|Overall Study||20
244961|NCT00970814|594843|P2|NOT COMPLETED|Overall Study||14
244962|NCT00970814|594844|P1|NOT COMPLETED|Overall Study||8
244963|NCT00970814|594843|P2|COMPLETED|Overall Study||50
244964|NCT00970814|594844|P1|COMPLETED|Overall Study||58
244965|NCT00970814|594843|P2|STARTED|Overall Study||64
244966|NCT00970814|594844|P1|STARTED|Overall Study||66
244967|NCT00970853|594856|P2|NOT COMPLETED|Overall Study||0
244968|NCT00970853|594857|P1|NOT COMPLETED|Overall Study||0
244969|NCT00970853|594856|P2|COMPLETED|Overall Study||98
244970|NCT00970853|594857|P1|COMPLETED|Overall Study||89
244971|NCT00970853|594856|P2|STARTED|Overall Study||98
244972|NCT00970853|594857|P1|STARTED|Overall Study||89
244973|NCT00970944|594881|P2|NOT COMPLETED|Overall Study||2
244974|NCT00970944|594882|P1|NOT COMPLETED|Overall Study||1
244975|NCT00970944|594881|P2|COMPLETED|Overall Study||95
244976|NCT00970944|594882|P1|COMPLETED|Overall Study||86
244977|NCT00970944|594881|P2|STARTED|Overall Study||97
244978|NCT00970944|594882|P1|STARTED|Overall Study||87
244979|NCT00971048|594894|P4|NOT COMPLETED|Overall Study||2
244980|NCT00971048|594895|P3|NOT COMPLETED|Overall Study||1
244981|NCT00971048|594896|P2|NOT COMPLETED|Overall Study||2
244982|NCT00971048|594897|P1|NOT COMPLETED|Overall Study||1
244983|NCT00971048|594894|P4|COMPLETED|Overall Study||11
244984|NCT00971048|594895|P3|COMPLETED|Overall Study||11
244985|NCT00971048|594896|P2|COMPLETED|Overall Study||31
244986|NCT00971048|594897|P1|COMPLETED|Overall Study||29
244987|NCT00971048|594894|P4|STARTED|Overall Study||13
244988|NCT00971048|594895|P3|STARTED|Overall Study||12
244989|NCT00971048|594896|P2|STARTED|Overall Study||33
244990|NCT00971048|594897|P1|STARTED|Overall Study||30
244991|NCT00977379|594921|P2|NOT COMPLETED|Overall Study||12
244992|NCT00977379|594922|P1|NOT COMPLETED|Overall Study||12
244993|NCT00977379|594921|P2|COMPLETED|Overall Study||0
244994|NCT00977379|594922|P1|COMPLETED|Overall Study||0
244995|NCT00977379|594921|P2|Treated|Overall Study||11
244996|NCT00977379|594922|P1|Treated|Overall Study||12
244997|NCT00977379|594921|P2|STARTED|Overall Study|Randomized|12
244998|NCT00977379|594922|P1|STARTED|Overall Study|Randomized|12
244999|NCT00977470|594958|P2|NOT COMPLETED|Overall Study||38
245000|NCT00977470|594959|P1|NOT COMPLETED|Overall Study||38
245001|NCT00977470|594958|P2|COMPLETED|Overall Study||0
245002|NCT00977470|594959|P1|COMPLETED|Overall Study||0
245003|NCT00977470|594958|P2|STARTED|Overall Study||38
245004|NCT00977470|594959|P1|STARTED|Overall Study||38
245005|NCT00977548|594977|P1|NOT COMPLETED|Overall Study||13
245006|NCT00977548|594977|P1|COMPLETED|Overall Study||26
245007|NCT00977548|594977|P1|STARTED|Overall Study||39
245008|NCT00977561|594986|P2|NOT COMPLETED|Overall Study||4
245009|NCT00977561|594987|P1|NOT COMPLETED|Overall Study||5
245010|NCT00977561|594986|P2|COMPLETED|Overall Study||0
245011|NCT00977561|594987|P1|COMPLETED|Overall Study||0
245012|NCT00977561|594986|P2|STARTED|Overall Study||4
245013|NCT00977561|594987|P1|STARTED|Overall Study||5
245014|NCT00977613|595014|P1|NOT COMPLETED|Overall Study||16
245015|NCT00977613|595014|P1|COMPLETED|Overall Study||34
245016|NCT00977613|595014|P1|STARTED|Overall Study||50
245017|NCT00977665|595020|P2|NOT COMPLETED|Overall Study||15
245018|NCT00977665|595021|P1|NOT COMPLETED|Overall Study||21
245019|NCT00977665|595020|P2|COMPLETED|Overall Study||75
245020|NCT00977665|595021|P1|COMPLETED|Overall Study||63
245021|NCT00977665|595020|P2|STARTED|Overall Study||90
245022|NCT00977665|595021|P1|STARTED|Overall Study||84
245023|NCT00979420|595057|P4|NOT COMPLETED|Overall Study||2
245024|NCT00979420|595058|P3|NOT COMPLETED|Overall Study||1
245025|NCT00979420|595059|P2|NOT COMPLETED|Overall Study||0
245026|NCT00979420|595060|P1|NOT COMPLETED|Overall Study||7
245027|NCT00979420|595057|P4|COMPLETED|Overall Study||59
245028|NCT00979420|595058|P3|COMPLETED|Overall Study||59
245029|NCT00979420|595059|P2|COMPLETED|Overall Study||57
245030|NCT00979420|595060|P1|COMPLETED|Overall Study||171
245031|NCT00979420|595057|P4|STARTED|Overall Study||61
245032|NCT00979420|595058|P3|STARTED|Overall Study||60
245033|NCT00979420|595059|P2|STARTED|Overall Study||57
245034|NCT00979420|595060|P1|STARTED|Overall Study||178
245035|NCT00979459|595128|P2|NOT COMPLETED|Second Intervention||0
245036|NCT00979459|595129|P1|NOT COMPLETED|Second Intervention||0
245037|NCT00979459|595128|P2|COMPLETED|Second Intervention||6
245038|NCT00979459|595129|P1|COMPLETED|Second Intervention||6
245039|NCT00979459|595128|P2|STARTED|Second Intervention||6
245040|NCT00979459|595129|P1|STARTED|Second Intervention||6
245041|NCT00979459|595128|P2|NOT COMPLETED|7-day Washout Period||0
245042|NCT00979459|595129|P1|NOT COMPLETED|7-day Washout Period||0
245043|NCT00979459|595128|P2|COMPLETED|7-day Washout Period||6
245044|NCT00979459|595129|P1|COMPLETED|7-day Washout Period||6
245045|NCT00979459|595128|P2|STARTED|7-day Washout Period||6
245046|NCT00979459|595129|P1|STARTED|7-day Washout Period||6
245047|NCT00979459|595128|P2|NOT COMPLETED|First Intervention||0
245048|NCT00979459|595129|P1|NOT COMPLETED|First Intervention||0
245049|NCT00979459|595128|P2|COMPLETED|First Intervention||6
245050|NCT00979459|595129|P1|COMPLETED|First Intervention||6
245051|NCT00979459|595128|P2|STARTED|First Intervention||6
245052|NCT00979459|595129|P1|STARTED|First Intervention||6
245053|NCT00979576|595144|P3|NOT COMPLETED|Combination Followed by Monotherapy||1
245054|NCT00979576|595145|P2|NOT COMPLETED|Combination Followed by Monotherapy||2
245055|NCT00979576|595146|P1|NOT COMPLETED|Combination Followed by Monotherapy||0
245056|NCT00979576|595144|P3|COMPLETED|Combination Followed by Monotherapy||0
245057|NCT00979576|595145|P2|COMPLETED|Combination Followed by Monotherapy||0
245058|NCT00979576|595146|P1|COMPLETED|Combination Followed by Monotherapy||0
245059|NCT00979576|595144|P3|STARTED|Combination Followed by Monotherapy||1
245060|NCT00979576|595145|P2|STARTED|Combination Followed by Monotherapy||2
245061|NCT00979576|595146|P1|STARTED|Combination Followed by Monotherapy||0
245062|NCT00979576|595144|P3|NOT COMPLETED|Combination Treatment Phase||9
245063|NCT00979576|595145|P2|NOT COMPLETED|Combination Treatment Phase||6
245064|NCT00979576|595146|P1|NOT COMPLETED|Combination Treatment Phase||3
245065|NCT00979576|595144|P3|COMPLETED|Combination Treatment Phase||0
245066|NCT00979576|595145|P2|COMPLETED|Combination Treatment Phase||0
245067|NCT00979576|595146|P1|COMPLETED|Combination Treatment Phase||0
245068|NCT00979576|595144|P3|STARTED|Combination Treatment Phase||9
245069|NCT00979576|595145|P2|STARTED|Combination Treatment Phase||6
245070|NCT00979576|595146|P1|STARTED|Combination Treatment Phase||3
245071|NCT00979615|595179|P2|NOT COMPLETED|Overall Study||8
245072|NCT00979615|595180|P1|NOT COMPLETED|Overall Study||6
245073|NCT00979615|595179|P2|COMPLETED|Overall Study||58
245074|NCT00979615|595180|P1|COMPLETED|Overall Study||57
245075|NCT00979615|595179|P2|STARTED|Overall Study||66
245076|NCT00979615|595180|P1|STARTED|Overall Study||63
245077|NCT00979628|595197|P3|NOT COMPLETED|Overall Study||6
245078|NCT00979628|595198|P2|NOT COMPLETED|Overall Study||9
245079|NCT00979628|595199|P1|NOT COMPLETED|Overall Study||9
245080|NCT00979628|595197|P3|COMPLETED|Overall Study||74
245081|NCT00979628|595198|P2|COMPLETED|Overall Study||133
245082|NCT00979628|595199|P1|COMPLETED|Overall Study||144
245083|NCT00979628|595197|P3|STARTED|Overall Study||80
245084|NCT00979628|595198|P2|STARTED|Overall Study||142
245085|NCT00979628|595199|P1|STARTED|Overall Study||153
245086|NCT00979654|595207|P1|NOT COMPLETED|Overall Study||36
245087|NCT00979654|595207|P1|COMPLETED|Overall Study||67
245088|NCT00979654|595207|P1|STARTED|Overall Study||103
245089|NCT00979875|595219|P6|NOT COMPLETED|Intervention 3||0
245090|NCT00979875|595220|P5|NOT COMPLETED|Intervention 3||0
245091|NCT00979875|595221|P4|NOT COMPLETED|Intervention 3||0
245092|NCT00979875|595222|P3|NOT COMPLETED|Intervention 3||0
245093|NCT00979875|595223|P2|NOT COMPLETED|Intervention 3||0
245094|NCT00979875|595224|P1|NOT COMPLETED|Intervention 3||0
245095|NCT00979875|595219|P6|COMPLETED|Intervention 3||2
245096|NCT00979875|595220|P5|COMPLETED|Intervention 3||3
245097|NCT00979875|595221|P4|COMPLETED|Intervention 3||2
245098|NCT00979875|595222|P3|COMPLETED|Intervention 3||3
245099|NCT00979875|595223|P2|COMPLETED|Intervention 3||2
245100|NCT00979875|595224|P1|COMPLETED|Intervention 3||2
245101|NCT00979875|595219|P6|STARTED|Intervention 3||2
245102|NCT00979875|595220|P5|STARTED|Intervention 3||3
245103|NCT00979875|595221|P4|STARTED|Intervention 3||2
245104|NCT00979875|595222|P3|STARTED|Intervention 3||3
245105|NCT00979875|595223|P2|STARTED|Intervention 3||2
245106|NCT00979875|595224|P1|STARTED|Intervention 3||2
245107|NCT00979875|595219|P6|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
245108|NCT00979875|595220|P5|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
245109|NCT00979875|595221|P4|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
245110|NCT00979875|595222|P3|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
245111|NCT00979875|595223|P2|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
245112|NCT00979875|595224|P1|NOT COMPLETED|Washout 2 (3 to 14 Days)||0
245113|NCT00979875|595219|P6|COMPLETED|Washout 2 (3 to 14 Days)||2
245114|NCT00979875|595220|P5|COMPLETED|Washout 2 (3 to 14 Days)||3
245115|NCT00979875|595221|P4|COMPLETED|Washout 2 (3 to 14 Days)||2
245116|NCT00979875|595222|P3|COMPLETED|Washout 2 (3 to 14 Days)||3
245117|NCT00979875|595223|P2|COMPLETED|Washout 2 (3 to 14 Days)||2
245118|NCT00979875|595224|P1|COMPLETED|Washout 2 (3 to 14 Days)||2
245119|NCT00979875|595219|P6|STARTED|Washout 2 (3 to 14 Days)||2
245120|NCT00979875|595220|P5|STARTED|Washout 2 (3 to 14 Days)||3
245121|NCT00979875|595221|P4|STARTED|Washout 2 (3 to 14 Days)||2
245122|NCT00979875|595222|P3|STARTED|Washout 2 (3 to 14 Days)||3
245123|NCT00979875|595223|P2|STARTED|Washout 2 (3 to 14 Days)||2
245124|NCT00979875|595224|P1|STARTED|Washout 2 (3 to 14 Days)||2
245125|NCT00979875|595219|P6|NOT COMPLETED|Intervention 2||0
245126|NCT00979875|595220|P5|NOT COMPLETED|Intervention 2||0
245127|NCT00979875|595221|P4|NOT COMPLETED|Intervention 2||0
245128|NCT00979875|595222|P3|NOT COMPLETED|Intervention 2||0
245129|NCT00979875|595223|P2|NOT COMPLETED|Intervention 2||0
245130|NCT00979875|595224|P1|NOT COMPLETED|Intervention 2||0
245131|NCT00979875|595219|P6|COMPLETED|Intervention 2||2
245132|NCT00979875|595220|P5|COMPLETED|Intervention 2||3
245133|NCT00979875|595221|P4|COMPLETED|Intervention 2||2
245134|NCT00979875|595222|P3|COMPLETED|Intervention 2||3
245135|NCT00979875|595223|P2|COMPLETED|Intervention 2||2
245136|NCT00979875|595224|P1|COMPLETED|Intervention 2||2
245137|NCT00979875|595219|P6|STARTED|Intervention 2||2
245138|NCT00979875|595220|P5|STARTED|Intervention 2||3
245139|NCT00979875|595221|P4|STARTED|Intervention 2||2
245140|NCT00979875|595222|P3|STARTED|Intervention 2||3
245141|NCT00979875|595223|P2|STARTED|Intervention 2||2
245142|NCT00979875|595224|P1|STARTED|Intervention 2||2
245143|NCT00979875|595219|P6|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
245144|NCT00979875|595220|P5|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
245145|NCT00979875|595221|P4|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
245146|NCT00979875|595222|P3|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
245147|NCT00979875|595223|P2|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
245148|NCT00979875|595224|P1|NOT COMPLETED|Washout 1 (3 to 14 Days)||0
245149|NCT00979875|595219|P6|COMPLETED|Washout 1 (3 to 14 Days)||2
245150|NCT00979875|595220|P5|COMPLETED|Washout 1 (3 to 14 Days)||3
245151|NCT00979875|595221|P4|COMPLETED|Washout 1 (3 to 14 Days)||2
245152|NCT00979875|595222|P3|COMPLETED|Washout 1 (3 to 14 Days)||3
245153|NCT00979875|595223|P2|COMPLETED|Washout 1 (3 to 14 Days)||2
245154|NCT00979875|595224|P1|COMPLETED|Washout 1 (3 to 14 Days)||2
245155|NCT00979875|595219|P6|STARTED|Washout 1 (3 to 14 Days)||2
245156|NCT00979875|595220|P5|STARTED|Washout 1 (3 to 14 Days)||3
245157|NCT00979875|595221|P4|STARTED|Washout 1 (3 to 14 Days)||2
245158|NCT00979875|595222|P3|STARTED|Washout 1 (3 to 14 Days)||3
245159|NCT00979875|595223|P2|STARTED|Washout 1 (3 to 14 Days)||2
245160|NCT00979875|595224|P1|STARTED|Washout 1 (3 to 14 Days)||2
245161|NCT00979875|595219|P6|NOT COMPLETED|Intervention 1||0
245162|NCT00979875|595220|P5|NOT COMPLETED|Intervention 1||0
245163|NCT00979875|595221|P4|NOT COMPLETED|Intervention 1||0
245164|NCT00979875|595222|P3|NOT COMPLETED|Intervention 1||0
245165|NCT00979875|595223|P2|NOT COMPLETED|Intervention 1||0
245166|NCT00979875|595224|P1|NOT COMPLETED|Intervention 1||0
245167|NCT00979875|595219|P6|COMPLETED|Intervention 1||2
245168|NCT00979875|595220|P5|COMPLETED|Intervention 1||3
245169|NCT00979875|595221|P4|COMPLETED|Intervention 1||2
245170|NCT00979875|595222|P3|COMPLETED|Intervention 1||3
245171|NCT00979875|595223|P2|COMPLETED|Intervention 1||2
245172|NCT00979875|595224|P1|COMPLETED|Intervention 1||2
245173|NCT00979875|595219|P6|Received at Least 1 Dose of Study Drug|Intervention 1||2
245174|NCT00979875|595220|P5|Received at Least 1 Dose of Study Drug|Intervention 1||3
245175|NCT00979875|595221|P4|Received at Least 1 Dose of Study Drug|Intervention 1||2
245176|NCT00979875|595222|P3|Received at Least 1 Dose of Study Drug|Intervention 1||3
245177|NCT00979875|595223|P2|Received at Least 1 Dose of Study Drug|Intervention 1||2
245178|NCT00979875|595224|P1|Received at Least 1 Dose of Study Drug|Intervention 1||2
245179|NCT00979875|595219|P6|STARTED|Intervention 1||2
245180|NCT00979875|595220|P5|STARTED|Intervention 1||3
245181|NCT00979875|595221|P4|STARTED|Intervention 1||2
245182|NCT00979875|595222|P3|STARTED|Intervention 1||3
245183|NCT00979875|595223|P2|STARTED|Intervention 1||2
245184|NCT00979875|595224|P1|STARTED|Intervention 1||2
245185|NCT00979901|595272|P4|NOT COMPLETED|Overall Study||116
245186|NCT00979901|595273|P3|NOT COMPLETED|Overall Study||29
245187|NCT00979901|595274|P2|NOT COMPLETED|Overall Study||12
245188|NCT00979901|595275|P1|NOT COMPLETED|Overall Study||18
245189|NCT00979901|595272|P4|COMPLETED|Overall Study||159
245190|NCT00979901|595273|P3|COMPLETED|Overall Study||573
245191|NCT00979901|595274|P2|COMPLETED|Overall Study||336
245192|NCT00979901|595275|P1|COMPLETED|Overall Study||334
245193|NCT00979901|595272|P4|STARTED|Overall Study||275
245194|NCT00979901|595273|P3|STARTED|Overall Study||602
245195|NCT00979901|595274|P2|STARTED|Overall Study||348
245196|NCT00979901|595275|P1|STARTED|Overall Study||352
245197|NCT00979940|595301|P2|NOT COMPLETED|Overall Study||0
245198|NCT00979940|595302|P1|NOT COMPLETED|Overall Study||0
245199|NCT00979940|595301|P2|COMPLETED|Overall Study||28
245200|NCT00979940|595302|P1|COMPLETED|Overall Study||32
245201|NCT00979940|595301|P2|STARTED|Overall Study||28
245202|NCT00979940|595302|P1|STARTED|Overall Study||32
245203|NCT00979953|595312|P4|NOT COMPLETED|Overall Study||7
245204|NCT00979953|595313|P3|NOT COMPLETED|Overall Study||22
245205|NCT00979953|595314|P2|NOT COMPLETED|Overall Study||5
245206|NCT00979953|595315|P1|NOT COMPLETED|Overall Study||8
245207|NCT00979953|595312|P4|COMPLETED|Overall Study||97
245208|NCT00979953|595313|P3|COMPLETED|Overall Study||82
245209|NCT00979953|595314|P2|COMPLETED|Overall Study||94
245210|NCT00979953|595315|P1|COMPLETED|Overall Study||93
245211|NCT00979953|595312|P4|Received at Least 1 Dose of Study Drug|Overall Study||104
245212|NCT00979953|595313|P3|Received at Least 1 Dose of Study Drug|Overall Study||104
245213|NCT00979953|595314|P2|Received at Least 1 Dose of Study Drug|Overall Study||99
245214|NCT00979953|595315|P1|Received at Least 1 Dose of Study Drug|Overall Study||101
245215|NCT00979953|595312|P4|STARTED|Overall Study||104
245216|NCT00979953|595313|P3|STARTED|Overall Study||104
245217|NCT00979953|595314|P2|STARTED|Overall Study||99
245218|NCT00979953|595315|P1|STARTED|Overall Study||101
245219|NCT00979992|595325|P1|NOT COMPLETED|Overall Study||5
245220|NCT00979992|595325|P1|COMPLETED|Overall Study||30
245221|NCT00979992|595325|P1|STARTED|Overall Study||35
245222|NCT00980005|595335|P2|NOT COMPLETED|Overall Study||63
245223|NCT00980005|595336|P1|NOT COMPLETED|Overall Study||47
245224|NCT00980005|595335|P2|COMPLETED|Overall Study||998
245225|NCT00980005|595336|P1|COMPLETED|Overall Study||1008
245226|NCT00980005|595335|P2|STARTED|Overall Study||1061
245227|NCT00980005|595336|P1|STARTED|Overall Study||1055
245228|NCT00980044|595379|P3|NOT COMPLETED|Overall Study||5
245229|NCT00980044|595380|P2|NOT COMPLETED|Overall Study||7
245230|NCT00980044|595381|P1|NOT COMPLETED|Overall Study||5
245231|NCT00980044|595379|P3|COMPLETED|Overall Study||12
245232|NCT00980044|595380|P2|COMPLETED|Overall Study||12
245233|NCT00980044|595381|P1|COMPLETED|Overall Study||12
245234|NCT00980044|595379|P3|STARTED|Overall Study||17
245235|NCT00980044|595380|P2|STARTED|Overall Study||19
245236|NCT00980044|595381|P1|STARTED|Overall Study||17
245237|NCT00980148|595400|P2|NOT COMPLETED|Overall Study||128
245238|NCT00980148|595401|P1|NOT COMPLETED|Overall Study||129
245239|NCT00980148|595400|P2|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
245240|NCT00980148|595401|P1|COMPLETED|Overall Study|Completed primary evaluation at study visit # 2 (day 28 after therapy started)|155
245241|NCT00980148|595400|P2|STARTED|Overall Study||283
245242|NCT00980148|595401|P1|STARTED|Overall Study||284
245243|NCT00980174|595409|P2|NOT COMPLETED|Overall Study||10
245244|NCT00980174|595410|P1|NOT COMPLETED|Overall Study||4
245245|NCT00980174|595409|P2|COMPLETED|Overall Study||111
245246|NCT00980174|595410|P1|COMPLETED|Overall Study||117
245247|NCT00980174|595409|P2|STARTED|Overall Study||121
245248|NCT00980174|595410|P1|STARTED|Overall Study||121
245249|NCT00980200|595426|P5|NOT COMPLETED|7-day Treatment Period 5||0
245250|NCT00980200|595427|P4|NOT COMPLETED|7-day Treatment Period 5||0
245251|NCT00980200|595428|P3|NOT COMPLETED|7-day Treatment Period 5||0
245252|NCT00980200|595429|P2|NOT COMPLETED|7-day Treatment Period 5||0
245253|NCT00980200|595430|P1|NOT COMPLETED|7-day Treatment Period 5||0
245254|NCT00980200|595426|P5|COMPLETED|7-day Treatment Period 5||14
245255|NCT00980200|595427|P4|COMPLETED|7-day Treatment Period 5||16
245256|NCT00980200|595428|P3|COMPLETED|7-day Treatment Period 5||15
245257|NCT00980200|595429|P2|COMPLETED|7-day Treatment Period 5||12
245258|NCT00980200|595430|P1|COMPLETED|7-day Treatment Period 5||15
245259|NCT00980200|595426|P5|STARTED|7-day Treatment Period 5||14
245260|NCT00980200|595427|P4|STARTED|7-day Treatment Period 5||16
245261|NCT00980200|595428|P3|STARTED|7-day Treatment Period 5||15
245262|NCT00980200|595429|P2|STARTED|7-day Treatment Period 5||12
245263|NCT00980200|595430|P1|STARTED|7-day Treatment Period 5||15
245264|NCT00980200|595426|P5|NOT COMPLETED|7-day Washout Period 4||0
245265|NCT00980200|595427|P4|NOT COMPLETED|7-day Washout Period 4||0
245266|NCT00980200|595428|P3|NOT COMPLETED|7-day Washout Period 4||0
245267|NCT00980200|595429|P2|NOT COMPLETED|7-day Washout Period 4||0
245268|NCT00980200|595430|P1|NOT COMPLETED|7-day Washout Period 4||0
245269|NCT00980200|595426|P5|COMPLETED|7-day Washout Period 4||14
245270|NCT00980200|595427|P4|COMPLETED|7-day Washout Period 4||16
245271|NCT00980200|595428|P3|COMPLETED|7-day Washout Period 4||15
245272|NCT00980200|595429|P2|COMPLETED|7-day Washout Period 4||12
245273|NCT00980200|595430|P1|COMPLETED|7-day Washout Period 4||15
245274|NCT00980200|595426|P5|STARTED|7-day Washout Period 4||14
245275|NCT00980200|595427|P4|STARTED|7-day Washout Period 4||16
245276|NCT00980200|595428|P3|STARTED|7-day Washout Period 4||15
245277|NCT00980200|595429|P2|STARTED|7-day Washout Period 4||12
245278|NCT00980200|595430|P1|STARTED|7-day Washout Period 4||15
245279|NCT00980200|595426|P5|NOT COMPLETED|7-day Treatment Period 4||0
245280|NCT00980200|595427|P4|NOT COMPLETED|7-day Treatment Period 4||0
245281|NCT00980200|595428|P3|NOT COMPLETED|7-day Treatment Period 4||0
245282|NCT00980200|595429|P2|NOT COMPLETED|7-day Treatment Period 4||0
245283|NCT00980200|595430|P1|NOT COMPLETED|7-day Treatment Period 4||0
245284|NCT00980200|595426|P5|COMPLETED|7-day Treatment Period 4||14
245285|NCT00980200|595427|P4|COMPLETED|7-day Treatment Period 4||16
245286|NCT00980200|595428|P3|COMPLETED|7-day Treatment Period 4||15
245287|NCT00980200|595429|P2|COMPLETED|7-day Treatment Period 4||12
245288|NCT00980200|595430|P1|COMPLETED|7-day Treatment Period 4||15
245289|NCT00980200|595426|P5|STARTED|7-day Treatment Period 4||14
245290|NCT00980200|595427|P4|STARTED|7-day Treatment Period 4||16
245291|NCT00980200|595428|P3|STARTED|7-day Treatment Period 4||15
245292|NCT00980200|595429|P2|STARTED|7-day Treatment Period 4||12
245293|NCT00980200|595430|P1|STARTED|7-day Treatment Period 4||15
245294|NCT00980200|595426|P5|NOT COMPLETED|7-day Washout Period 3||0
245295|NCT00980200|595427|P4|NOT COMPLETED|7-day Washout Period 3||0
245296|NCT00980200|595428|P3|NOT COMPLETED|7-day Washout Period 3||0
245297|NCT00980200|595429|P2|NOT COMPLETED|7-day Washout Period 3||0
245298|NCT00980200|595430|P1|NOT COMPLETED|7-day Washout Period 3||0
245299|NCT00980200|595426|P5|COMPLETED|7-day Washout Period 3||14
245300|NCT00980200|595427|P4|COMPLETED|7-day Washout Period 3||16
245301|NCT00980200|595428|P3|COMPLETED|7-day Washout Period 3||15
245302|NCT00980200|595429|P2|COMPLETED|7-day Washout Period 3||12
245303|NCT00980200|595430|P1|COMPLETED|7-day Washout Period 3||15
245304|NCT00980200|595426|P5|STARTED|7-day Washout Period 3||14
245305|NCT00980200|595427|P4|STARTED|7-day Washout Period 3||16
245306|NCT00980200|595428|P3|STARTED|7-day Washout Period 3||15
245307|NCT00980200|595429|P2|STARTED|7-day Washout Period 3||12
245308|NCT00980200|595430|P1|STARTED|7-day Washout Period 3||15
245309|NCT00980200|595426|P5|NOT COMPLETED|7-day Treatment Period 3||1
245310|NCT00980200|595427|P4|NOT COMPLETED|7-day Treatment Period 3||0
245311|NCT00980200|595428|P3|NOT COMPLETED|7-day Treatment Period 3||0
245312|NCT00980200|595429|P2|NOT COMPLETED|7-day Treatment Period 3||1
245313|NCT00980200|595430|P1|NOT COMPLETED|7-day Treatment Period 3||0
245314|NCT00980200|595426|P5|COMPLETED|7-day Treatment Period 3||14
245315|NCT00980200|595427|P4|COMPLETED|7-day Treatment Period 3||16
245316|NCT00980200|595428|P3|COMPLETED|7-day Treatment Period 3||15
245317|NCT00980200|595429|P2|COMPLETED|7-day Treatment Period 3||12
245318|NCT00980200|595430|P1|COMPLETED|7-day Treatment Period 3||15
245319|NCT00980200|595426|P5|STARTED|7-day Treatment Period 3||15
245320|NCT00980200|595427|P4|STARTED|7-day Treatment Period 3||16
245321|NCT00980200|595428|P3|STARTED|7-day Treatment Period 3||15
245322|NCT00980200|595429|P2|STARTED|7-day Treatment Period 3||13
245323|NCT00980200|595430|P1|STARTED|7-day Treatment Period 3||15
245324|NCT00980200|595426|P5|NOT COMPLETED|7-day Washout Period 2||0
245325|NCT00980200|595427|P4|NOT COMPLETED|7-day Washout Period 2||0
245326|NCT00980200|595428|P3|NOT COMPLETED|7-day Washout Period 2||0
245327|NCT00980200|595429|P2|NOT COMPLETED|7-day Washout Period 2||0
245328|NCT00980200|595430|P1|NOT COMPLETED|7-day Washout Period 2||0
245329|NCT00980200|595426|P5|COMPLETED|7-day Washout Period 2||15
245330|NCT00980200|595427|P4|COMPLETED|7-day Washout Period 2||16
245331|NCT00980200|595428|P3|COMPLETED|7-day Washout Period 2||15
245332|NCT00980200|595429|P2|COMPLETED|7-day Washout Period 2||13
245333|NCT00980200|595430|P1|COMPLETED|7-day Washout Period 2||15
245334|NCT00980200|595426|P5|STARTED|7-day Washout Period 2||15
245335|NCT00980200|595427|P4|STARTED|7-day Washout Period 2||16
245336|NCT00980200|595428|P3|STARTED|7-day Washout Period 2||15
245337|NCT00980200|595429|P2|STARTED|7-day Washout Period 2||13
245338|NCT00980200|595430|P1|STARTED|7-day Washout Period 2||15
245339|NCT00980200|595426|P5|NOT COMPLETED|7-day Treatment Period 2||0
245340|NCT00980200|595427|P4|NOT COMPLETED|7-day Treatment Period 2||0
245341|NCT00980200|595428|P3|NOT COMPLETED|7-day Treatment Period 2||0
245342|NCT00980200|595429|P2|NOT COMPLETED|7-day Treatment Period 2||0
245343|NCT00980200|595430|P1|NOT COMPLETED|7-day Treatment Period 2||0
245344|NCT00980200|595426|P5|COMPLETED|7-day Treatment Period 2||15
245345|NCT00980200|595427|P4|COMPLETED|7-day Treatment Period 2||16
245346|NCT00980200|595428|P3|COMPLETED|7-day Treatment Period 2||15
245347|NCT00980200|595429|P2|COMPLETED|7-day Treatment Period 2||13
245348|NCT00980200|595430|P1|COMPLETED|7-day Treatment Period 2||15
245349|NCT00980200|595426|P5|STARTED|7-day Treatment Period 2||15
245350|NCT00980200|595427|P4|STARTED|7-day Treatment Period 2||16
245351|NCT00980200|595428|P3|STARTED|7-day Treatment Period 2||15
245352|NCT00980200|595429|P2|STARTED|7-day Treatment Period 2||13
245353|NCT00980200|595430|P1|STARTED|7-day Treatment Period 2||15
245354|NCT00980200|595426|P5|NOT COMPLETED|7-day Washout Period 1||0
245355|NCT00980200|595427|P4|NOT COMPLETED|7-day Washout Period 1||0
245356|NCT00980200|595428|P3|NOT COMPLETED|7-day Washout Period 1||0
245357|NCT00980200|595429|P2|NOT COMPLETED|7-day Washout Period 1||0
245358|NCT00980200|595430|P1|NOT COMPLETED|7-day Washout Period 1||0
245359|NCT00980200|595426|P5|COMPLETED|7-day Washout Period 1||15
245360|NCT00980200|595427|P4|COMPLETED|7-day Washout Period 1||16
245361|NCT00980200|595428|P3|COMPLETED|7-day Washout Period 1||15
245362|NCT00980200|595429|P2|COMPLETED|7-day Washout Period 1||13
245363|NCT00980200|595430|P1|COMPLETED|7-day Washout Period 1||15
245364|NCT00980200|595426|P5|STARTED|7-day Washout Period 1||15
245365|NCT00980200|595427|P4|STARTED|7-day Washout Period 1||16
245366|NCT00980200|595428|P3|STARTED|7-day Washout Period 1||15
245367|NCT00980200|595429|P2|STARTED|7-day Washout Period 1||13
245368|NCT00980200|595430|P1|STARTED|7-day Washout Period 1||15
245369|NCT00980200|595426|P5|NOT COMPLETED|7-day Treatment Period 1||0
245370|NCT00980200|595427|P4|NOT COMPLETED|7-day Treatment Period 1||0
245371|NCT00980200|595428|P3|NOT COMPLETED|7-day Treatment Period 1||0
245372|NCT00980200|595429|P2|NOT COMPLETED|7-day Treatment Period 1||1
245373|NCT00980200|595430|P1|NOT COMPLETED|7-day Treatment Period 1||0
245374|NCT00980200|595426|P5|COMPLETED|7-day Treatment Period 1||15
245375|NCT00980200|595427|P4|COMPLETED|7-day Treatment Period 1||16
245376|NCT00980200|595428|P3|COMPLETED|7-day Treatment Period 1||15
245377|NCT00980200|595429|P2|COMPLETED|7-day Treatment Period 1||13
245378|NCT00980200|595430|P1|COMPLETED|7-day Treatment Period 1||15
245379|NCT00980200|595426|P5|STARTED|7-day Treatment Period 1||15
245380|NCT00980200|595427|P4|STARTED|7-day Treatment Period 1||16
245381|NCT00980200|595428|P3|STARTED|7-day Treatment Period 1||15
245382|NCT00980200|595429|P2|STARTED|7-day Treatment Period 1||14
245383|NCT00980200|595430|P1|STARTED|7-day Treatment Period 1||15
245384|NCT00980278|595449|P2|NOT COMPLETED|Overall Study||0
245385|NCT00980278|595450|P1|NOT COMPLETED|Overall Study||2
245386|NCT00980278|595449|P2|COMPLETED|Overall Study||13
245387|NCT00980278|595450|P1|COMPLETED|Overall Study||11
245388|NCT00980278|595449|P2|STARTED|Overall Study||13
245389|NCT00980278|595450|P1|STARTED|Overall Study||13
245390|NCT00980330|595471|P7|NOT COMPLETED|Overall Study||7
245391|NCT00980330|595472|P6|NOT COMPLETED|Overall Study||4
245392|NCT00980330|595473|P5|NOT COMPLETED|Overall Study||5
245393|NCT00980330|595474|P4|NOT COMPLETED|Overall Study||5
245394|NCT00980330|595475|P3|NOT COMPLETED|Overall Study||8
245395|NCT00980330|595476|P2|NOT COMPLETED|Overall Study||5
245396|NCT00980330|595477|P1|NOT COMPLETED|Overall Study||5
245397|NCT00980330|595471|P7|COMPLETED|Overall Study||59
245398|NCT00980330|595472|P6|COMPLETED|Overall Study||61
245399|NCT00980330|595473|P5|COMPLETED|Overall Study||63
245400|NCT00980330|595474|P4|COMPLETED|Overall Study||61
245401|NCT00980330|595475|P3|COMPLETED|Overall Study||58
245402|NCT00980330|595476|P2|COMPLETED|Overall Study||60
245403|NCT00980330|595477|P1|COMPLETED|Overall Study||61
245404|NCT00980330|595471|P7|STARTED|Overall Study||66
245405|NCT00980330|595472|P6|STARTED|Overall Study||65
245406|NCT00980330|595473|P5|STARTED|Overall Study||68
245407|NCT00980330|595474|P4|STARTED|Overall Study||66
245408|NCT00980330|595475|P3|STARTED|Overall Study||66
245409|NCT00980330|595476|P2|STARTED|Overall Study||65
245410|NCT00980330|595477|P1|STARTED|Overall Study||66
245411|NCT00980343|595577|P2|NOT COMPLETED|Overall Study||3
245412|NCT00980343|595578|P1|NOT COMPLETED|Overall Study||1
245413|NCT00980343|595577|P2|COMPLETED|Overall Study||20
245414|NCT00980343|595578|P1|COMPLETED|Overall Study||20
245415|NCT00980343|595577|P2|STARTED|Overall Study||23
245416|NCT00980343|595578|P1|STARTED|Overall Study||21
245417|NCT00980590|595597|P2|NOT COMPLETED|Overall Study||0
245418|NCT00980590|595598|P1|NOT COMPLETED|Overall Study||0
245419|NCT00980590|595597|P2|COMPLETED|Overall Study||50
245420|NCT00980590|595598|P1|COMPLETED|Overall Study||50
245421|NCT00980590|595597|P2|STARTED|Overall Study||50
245422|NCT00980590|595598|P1|STARTED|Overall Study||50
245423|NCT00980642|595612|P2|NOT COMPLETED|Overall Study||0
245424|NCT00980642|595613|P1|NOT COMPLETED|Overall Study||0
245425|NCT00980642|595612|P2|COMPLETED|Overall Study||20
245426|NCT00980642|595613|P1|COMPLETED|Overall Study||36
245427|NCT00980642|595612|P2|STARTED|Overall Study||20
245428|NCT00980642|595613|P1|STARTED|Overall Study||36
245429|NCT00980655|595625|P2|NOT COMPLETED|Overall Study||51
245430|NCT00980655|595626|P1|NOT COMPLETED|Overall Study||16
245431|NCT00980655|595625|P2|COMPLETED|Overall Study||139
245432|NCT00980655|595626|P1|COMPLETED|Overall Study||45
245433|NCT00980655|595625|P2|Vaccinated 23vPS Dose|Overall Study||140
245434|NCT00980655|595626|P1|Vaccinated 23vPS Dose|Overall Study||45
245435|NCT00980655|595625|P2|Vaccinated 13vPnC Dose 4|Overall Study||146
245436|NCT00980655|595626|P1|Vaccinated 13vPnC Dose 4|Overall Study||46
245437|NCT00980655|595625|P2|Vaccinated 13vPnC Dose 3|Overall Study||167
245438|NCT00980655|595626|P1|Vaccinated 13vPnC Dose 3|Overall Study||54
245439|NCT00980655|595625|P2|Vaccinated 13vPnC Dose 2|Overall Study||176
245440|NCT00980655|595626|P1|Vaccinated 13vPnC Dose 2|Overall Study||55
245441|NCT00980655|595625|P2|Vaccinated 13vPnC Dose 1|Overall Study||188
245442|NCT00980655|595626|P1|Vaccinated 13vPnC Dose 1|Overall Study||59
245443|NCT00980655|595625|P2|STARTED|Overall Study||190
245444|NCT00980655|595626|P1|STARTED|Overall Study||61
245445|NCT00980681|595672|P1|NOT COMPLETED|Dotarem MRA||0
245446|NCT00980681|595672|P1|COMPLETED|Dotarem MRA||10
245447|NCT00980681|595672|P1|STARTED|Dotarem MRA|Out of the 13 enrolled patients, three did not receive treatment|10
245448|NCT00980681|595672|P1|NOT COMPLETED|TOF MRA||0
245449|NCT00980681|595672|P1|COMPLETED|TOF MRA||10
245450|NCT00980681|595672|P1|STARTED|TOF MRA|Out of the 13 enrolled patients, three did not receive treatment|10
245451|NCT00980746|595684|P6|NOT COMPLETED|Overall Study||18
245452|NCT00980746|595685|P5|NOT COMPLETED|Overall Study||17
245453|NCT00980746|595686|P4|NOT COMPLETED|Overall Study||36
245454|NCT00980746|595687|P3|NOT COMPLETED|Overall Study||20
245455|NCT00980746|595688|P2|NOT COMPLETED|Overall Study||22
245456|NCT00980746|595689|P1|NOT COMPLETED|Overall Study||27
245457|NCT00980746|595684|P6|COMPLETED|Overall Study||78
245458|NCT00980746|595685|P5|COMPLETED|Overall Study||75
245459|NCT00980746|595686|P4|COMPLETED|Overall Study||64
245460|NCT00980746|595687|P3|COMPLETED|Overall Study||75
245461|NCT00980746|595688|P2|COMPLETED|Overall Study||67
245462|NCT00980746|595689|P1|COMPLETED|Overall Study||58
245463|NCT00980746|595684|P6|Per-protocol|Overall Study||74
245464|NCT00980746|595685|P5|Per-protocol|Overall Study||73
245465|NCT00980746|595686|P4|Per-protocol|Overall Study||62
245466|NCT00980746|595687|P3|Per-protocol|Overall Study||73
245467|NCT00980746|595688|P2|Per-protocol|Overall Study||66
245468|NCT00980746|595689|P1|Per-protocol|Overall Study||55
245469|NCT00980746|595684|P6|Safety Population|Overall Study||96
245470|NCT00980746|595685|P5|Safety Population|Overall Study||92
245471|NCT00980746|595686|P4|Safety Population|Overall Study||100
245472|NCT00980746|595687|P3|Safety Population|Overall Study||95
245473|NCT00980746|595688|P2|Safety Population|Overall Study||89
245474|NCT00980746|595689|P1|Safety Population|Overall Study||85
245475|NCT00980746|595684|P6|Randomized|Overall Study||96
245476|NCT00980746|595685|P5|Randomized|Overall Study||92
245477|NCT00980746|595686|P4|Randomized|Overall Study||100
245478|NCT00980746|595687|P3|Randomized|Overall Study||95
245479|NCT00980746|595688|P2|Randomized|Overall Study||89
245480|NCT00980746|595689|P1|Randomized|Overall Study||85
245481|NCT00980746|595684|P6|STARTED|Overall Study||96
245482|NCT00980746|595685|P5|STARTED|Overall Study||92
245483|NCT00980746|595686|P4|STARTED|Overall Study||100
245484|NCT00980746|595687|P3|STARTED|Overall Study||95
245485|NCT00980746|595688|P2|STARTED|Overall Study||89
245486|NCT00980746|595689|P1|STARTED|Overall Study||85
245487|NCT00980798|595705|P2|NOT COMPLETED|Overall Study||55
245488|NCT00980798|595706|P1|NOT COMPLETED|Overall Study||33
245489|NCT00980798|595705|P2|COMPLETED|Overall Study||84
245490|NCT00980798|595706|P1|COMPLETED|Overall Study||116
245491|NCT00980798|595705|P2|STARTED|Overall Study||139
245492|NCT00980798|595706|P1|STARTED|Overall Study||149
245493|NCT00980980|595717|P3|NOT COMPLETED|Overall Study||0
245494|NCT00980980|595718|P2|NOT COMPLETED|Overall Study||1
245495|NCT00980980|595719|P1|NOT COMPLETED|Overall Study||0
245496|NCT00980980|595717|P3|COMPLETED|Overall Study||13
245497|NCT00980980|595718|P2|COMPLETED|Overall Study||13
245498|NCT00980980|595719|P1|COMPLETED|Overall Study||16
245499|NCT00980980|595717|P3|STARTED|Overall Study||13
245500|NCT00980980|595718|P2|STARTED|Overall Study||14
245501|NCT00980980|595719|P1|STARTED|Overall Study||16
245502|NCT00981019|595748|P1|NOT COMPLETED|Overall Study||477
245503|NCT00981019|595748|P1|COMPLETED|Overall Study||301
245504|NCT00981019|595748|P1|STARTED|Overall Study||778
245505|NCT00981045|595754|P2|NOT COMPLETED|Overall Study||9
245506|NCT00981045|595755|P1|NOT COMPLETED|Overall Study||14
245507|NCT00981045|595754|P2|COMPLETED|Overall Study||1285
245508|NCT00981045|595755|P1|COMPLETED|Overall Study||1276
245509|NCT00981045|595754|P2|STARTED|Overall Study||1294
245510|NCT00981045|595755|P1|STARTED|Overall Study||1290
245511|NCT00981058|595765|P2|NOT COMPLETED|Overall Study||97
245512|NCT00981058|595766|P1|NOT COMPLETED|Overall Study||120
245513|NCT00981058|595765|P2|COMPLETED|Overall Study||451
245514|NCT00981058|595766|P1|COMPLETED|Overall Study||425
245515|NCT00981058|595765|P2|Death Due to Any Cause|Overall Study||442
245516|NCT00981058|595766|P1|Death Due to Any Cause|Overall Study||418
245517|NCT00981058|595765|P2|Received at Least 1 Dose of Study Drug|Overall Study||541
245518|NCT00981058|595766|P1|Received at Least 1 Dose of Study Drug|Overall Study||538
245519|NCT00981058|595765|P2|STARTED|Overall Study||548
245520|NCT00981058|595766|P1|STARTED|Overall Study||545
245521|NCT00981084|595788|P2|NOT COMPLETED|Post Intervention (Data Analysis)||1
245522|NCT00981084|595789|P1|NOT COMPLETED|Post Intervention (Data Analysis)||2
245523|NCT00981084|595788|P2|COMPLETED|Post Intervention (Data Analysis)||16
245524|NCT00981084|595789|P1|COMPLETED|Post Intervention (Data Analysis)||14
245525|NCT00981084|595788|P2|STARTED|Post Intervention (Data Analysis)||17
245526|NCT00981084|595789|P1|STARTED|Post Intervention (Data Analysis)||16
245527|NCT00981084|595788|P2|NOT COMPLETED|Second Intervention (One Day)||0
245528|NCT00981084|595789|P1|NOT COMPLETED|Second Intervention (One Day)||0
245529|NCT00981084|595788|P2|COMPLETED|Second Intervention (One Day)||17
245530|NCT00981084|595789|P1|COMPLETED|Second Intervention (One Day)||16
245531|NCT00981084|595788|P2|STARTED|Second Intervention (One Day)||17
245532|NCT00981084|595789|P1|STARTED|Second Intervention (One Day)||16
245533|NCT00981084|595788|P2|NOT COMPLETED|Washout Period (7 Days)||0
245534|NCT00981084|595789|P1|NOT COMPLETED|Washout Period (7 Days)||0
245535|NCT00981084|595788|P2|COMPLETED|Washout Period (7 Days)||17
245536|NCT00981084|595789|P1|COMPLETED|Washout Period (7 Days)||16
245537|NCT00981084|595788|P2|STARTED|Washout Period (7 Days)||17
245538|NCT00981084|595789|P1|STARTED|Washout Period (7 Days)||16
245539|NCT00981084|595788|P2|NOT COMPLETED|First Intervention (One Day)||0
245540|NCT00981084|595789|P1|NOT COMPLETED|First Intervention (One Day)||0
245541|NCT00981084|595788|P2|COMPLETED|First Intervention (One Day)||17
245542|NCT00981084|595789|P1|COMPLETED|First Intervention (One Day)||16
245543|NCT00981084|595788|P2|STARTED|First Intervention (One Day)||17
245544|NCT00981084|595789|P1|STARTED|First Intervention (One Day)||16
245545|NCT00981175|595806|P2|NOT COMPLETED|Booster Dose Vaccination||3
245546|NCT00981175|595807|P1|NOT COMPLETED|Booster Dose Vaccination||2
245547|NCT00981175|595806|P2|COMPLETED|Booster Dose Vaccination||40
245548|NCT00981175|595807|P1|COMPLETED|Booster Dose Vaccination||53
245549|NCT00981175|595806|P2|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|43
245550|NCT00981175|595807|P1|STARTED|Booster Dose Vaccination|A sub-set of participants in the group received the booster ChimeriVax™-JE vaccine.|55
245551|NCT00981175|595806|P2|NOT COMPLETED|Primary Dose Vaccination||2
245552|NCT00981175|595807|P1|NOT COMPLETED|Primary Dose Vaccination||3
245553|NCT00981175|595806|P2|COMPLETED|Primary Dose Vaccination||99
245554|NCT00981175|595807|P1|COMPLETED|Primary Dose Vaccination||98
245555|NCT00981175|595806|P2|STARTED|Primary Dose Vaccination||101
245556|NCT00981175|595807|P1|STARTED|Primary Dose Vaccination||101
245557|NCT00981214|595830|P1|NOT COMPLETED|Overall Study||0
245558|NCT00981214|595830|P1|COMPLETED|Overall Study||19
245559|NCT00981214|595830|P1|STARTED|Overall Study||19
245560|NCT00981227|595850|P6|NOT COMPLETED|Overall Study||18
245561|NCT00981227|595851|P5|NOT COMPLETED|Overall Study||30
245562|NCT00981227|595852|P4|NOT COMPLETED|Overall Study||21
245563|NCT00981227|595853|P3|NOT COMPLETED|Overall Study||21
245564|NCT00981227|595854|P2|NOT COMPLETED|Overall Study||19
245565|NCT00981227|595855|P1|NOT COMPLETED|Overall Study||22
245566|NCT00981227|595850|P6|COMPLETED|Overall Study||75
245567|NCT00981227|595851|P5|COMPLETED|Overall Study||60
245568|NCT00981227|595852|P4|COMPLETED|Overall Study||73
245569|NCT00981227|595853|P3|COMPLETED|Overall Study||73
245570|NCT00981227|595854|P2|COMPLETED|Overall Study||75
245571|NCT00981227|595855|P1|COMPLETED|Overall Study||80
245572|NCT00981227|595850|P6|Per–Protocol|Overall Study||70
245573|NCT00981227|595851|P5|Per–Protocol|Overall Study||50
245574|NCT00981227|595852|P4|Per–Protocol|Overall Study||68
245575|NCT00981227|595853|P3|Per–Protocol|Overall Study||67
245576|NCT00981227|595854|P2|Per–Protocol|Overall Study||72
245577|NCT00981227|595855|P1|Per–Protocol|Overall Study||69
245578|NCT00981227|595850|P6|Safety Population|Overall Study||93
245579|NCT00981227|595851|P5|Safety Population|Overall Study||90
245580|NCT00981227|595852|P4|Safety Population|Overall Study||94
245581|NCT00981227|595853|P3|Safety Population|Overall Study||94
245582|NCT00981227|595854|P2|Safety Population|Overall Study||94
245583|NCT00981227|595855|P1|Safety Population|Overall Study||102
245584|NCT00981227|595850|P6|Randomized|Overall Study||93
245585|NCT00981227|595851|P5|Randomized|Overall Study||90
245586|NCT00981227|595852|P4|Randomized|Overall Study||94
245587|NCT00981227|595853|P3|Randomized|Overall Study||94
245588|NCT00981227|595854|P2|Randomized|Overall Study||94
245589|NCT00981227|595855|P1|Randomized|Overall Study||102
245590|NCT00981227|595850|P6|STARTED|Overall Study||93
245591|NCT00981227|595851|P5|STARTED|Overall Study||90
245592|NCT00981227|595852|P4|STARTED|Overall Study||94
245593|NCT00981227|595853|P3|STARTED|Overall Study||94
245594|NCT00981227|595854|P2|STARTED|Overall Study||94
245595|NCT00981227|595855|P1|STARTED|Overall Study||102
245596|NCT00981292|595879|P6|NOT COMPLETED|Day 3||1
245597|NCT00981292|595880|P5|NOT COMPLETED|Day 3||0
245598|NCT00981292|595881|P4|NOT COMPLETED|Day 3||0
245599|NCT00981292|595882|P3|NOT COMPLETED|Day 3||0
245600|NCT00981292|595883|P2|NOT COMPLETED|Day 3||0
245601|NCT00981292|595884|P1|NOT COMPLETED|Day 3||0
245602|NCT00981292|595879|P6|COMPLETED|Day 3||4
245603|NCT00981292|595880|P5|COMPLETED|Day 3||4
245604|NCT00981292|595881|P4|COMPLETED|Day 3||4
245605|NCT00981292|595882|P3|COMPLETED|Day 3||6
245606|NCT00981292|595883|P2|COMPLETED|Day 3||4
245607|NCT00981292|595884|P1|COMPLETED|Day 3||4
245608|NCT00981292|595879|P6|STARTED|Day 3||5
245609|NCT00981292|595880|P5|STARTED|Day 3||4
245610|NCT00981292|595881|P4|STARTED|Day 3||4
245611|NCT00981292|595882|P3|STARTED|Day 3||6
245612|NCT00981292|595883|P2|STARTED|Day 3||4
245613|NCT00981292|595884|P1|STARTED|Day 3||4
245614|NCT00981292|595879|P6|NOT COMPLETED|Day 2||0
245615|NCT00981292|595880|P5|NOT COMPLETED|Day 2||0
245616|NCT00981292|595881|P4|NOT COMPLETED|Day 2||0
245617|NCT00981292|595882|P3|NOT COMPLETED|Day 2||0
245618|NCT00981292|595883|P2|NOT COMPLETED|Day 2||0
245619|NCT00981292|595884|P1|NOT COMPLETED|Day 2||2
245620|NCT00981292|595879|P6|COMPLETED|Day 2||5
245621|NCT00981292|595880|P5|COMPLETED|Day 2||4
245622|NCT00981292|595881|P4|COMPLETED|Day 2||4
245623|NCT00981292|595882|P3|COMPLETED|Day 2||6
245624|NCT00981292|595883|P2|COMPLETED|Day 2||4
245625|NCT00981292|595884|P1|COMPLETED|Day 2||4
245626|NCT00981292|595879|P6|STARTED|Day 2||5
245627|NCT00981292|595880|P5|STARTED|Day 2||4
245628|NCT00981292|595881|P4|STARTED|Day 2||4
245629|NCT00981292|595882|P3|STARTED|Day 2||6
245630|NCT00981292|595883|P2|STARTED|Day 2||4
245631|NCT00981292|595884|P1|STARTED|Day 2||6
245632|NCT00981292|595879|P6|NOT COMPLETED|Day 1||2
245633|NCT00981292|595880|P5|NOT COMPLETED|Day 1||0
245634|NCT00981292|595881|P4|NOT COMPLETED|Day 1||0
245635|NCT00981292|595882|P3|NOT COMPLETED|Day 1||0
245636|NCT00981292|595883|P2|NOT COMPLETED|Day 1||0
245637|NCT00981292|595884|P1|NOT COMPLETED|Day 1||1
245638|NCT00981292|595879|P6|COMPLETED|Day 1||5
245639|NCT00981292|595880|P5|COMPLETED|Day 1||4
245640|NCT00981292|595881|P4|COMPLETED|Day 1||4
245641|NCT00981292|595882|P3|COMPLETED|Day 1||6
245642|NCT00981292|595883|P2|COMPLETED|Day 1||4
245643|NCT00981292|595884|P1|COMPLETED|Day 1||6
245644|NCT00981292|595879|P6|STARTED|Day 1||7
245645|NCT00981292|595880|P5|STARTED|Day 1||4
245646|NCT00981292|595881|P4|STARTED|Day 1||4
245647|NCT00981292|595882|P3|STARTED|Day 1||6
245648|NCT00981292|595883|P2|STARTED|Day 1||4
245649|NCT00981292|595884|P1|STARTED|Day 1||7
245650|NCT00981305|595903|P2|NOT COMPLETED|Overall Study||10
245651|NCT00981305|595904|P1|NOT COMPLETED|Overall Study||19
245652|NCT00981305|595903|P2|COMPLETED|Overall Study||57
245653|NCT00981305|595904|P1|COMPLETED|Overall Study||50
245654|NCT00981305|595903|P2|STARTED|Overall Study||67
245655|NCT00981305|595904|P1|STARTED|Overall Study||69
245656|NCT00981370|595916|P1|NOT COMPLETED|Overall Study||0
245657|NCT00981370|595916|P1|COMPLETED|Overall Study||0
245658|NCT00981370|595916|P1|STARTED|Overall Study||0
245659|NCT00981409|595922|P2|NOT COMPLETED|Overall Study||1
245660|NCT00981409|595923|P1|NOT COMPLETED|Overall Study||6
245661|NCT00981409|595922|P2|COMPLETED|Overall Study||10
245662|NCT00981409|595923|P1|COMPLETED|Overall Study||24
245663|NCT00981409|595922|P2|STARTED|Overall Study||11
245664|NCT00981409|595923|P1|STARTED|Overall Study||30
245665|NCT00981435|595940|P3|NOT COMPLETED|Overall Study||0
245666|NCT00981435|595941|P2|NOT COMPLETED|Overall Study||0
245667|NCT00981435|595942|P1|NOT COMPLETED|Overall Study||0
245668|NCT00981435|595940|P3|COMPLETED|Overall Study||37
245669|NCT00981435|595941|P2|COMPLETED|Overall Study||29
245670|NCT00981435|595942|P1|COMPLETED|Overall Study||31
245671|NCT00981435|595940|P3|STARTED|Overall Study||37
245672|NCT00981435|595941|P2|STARTED|Overall Study||29
245673|NCT00981435|595942|P1|STARTED|Overall Study||31
245674|NCT00981461|595955|P2|NOT COMPLETED|Overall Study||2
245675|NCT00981461|595956|P1|NOT COMPLETED|Overall Study||5
245676|NCT00981461|595955|P2|COMPLETED|Overall Study||22
245677|NCT00981461|595956|P1|COMPLETED|Overall Study||43
245678|NCT00981461|595955|P2|STARTED|Overall Study||24
245679|NCT00981461|595956|P1|STARTED|Overall Study||48
245680|NCT00981630|595966|P4|NOT COMPLETED|Overall Study||0
245681|NCT00981630|595967|P3|NOT COMPLETED|Overall Study||0
245682|NCT00981630|595968|P2|NOT COMPLETED|Overall Study||0
245683|NCT00981630|595969|P1|NOT COMPLETED|Overall Study||0
245684|NCT00981630|595966|P4|COMPLETED|Overall Study||32
245685|NCT00981630|595967|P3|COMPLETED|Overall Study||32
245686|NCT00981630|595968|P2|COMPLETED|Overall Study||32
245687|NCT00981630|595969|P1|COMPLETED|Overall Study||32
245688|NCT00981630|595966|P4|STARTED|Overall Study||32
245689|NCT00981630|595967|P3|STARTED|Overall Study||32
245690|NCT00981630|595968|P2|STARTED|Overall Study||32
245691|NCT00981630|595969|P1|STARTED|Overall Study||32
245692|NCT00981669|596001|P2|NOT COMPLETED|Overall Study||0
245693|NCT00981669|596002|P1|NOT COMPLETED|Overall Study||1
245694|NCT00981669|596001|P2|COMPLETED|Overall Study||40
245695|NCT00981669|596002|P1|COMPLETED|Overall Study||39
245696|NCT00981669|596001|P2|STARTED|Overall Study||40
245697|NCT00981669|596002|P1|STARTED|Overall Study||40
245698|NCT00981812|596010|P1|NOT COMPLETED|Overall Study||0
245699|NCT00981812|596010|P1|COMPLETED|Overall Study||20
245700|NCT00981812|596010|P1|STARTED|Overall Study||20
245701|NCT00981825|596016|P2|NOT COMPLETED|Second Intervention||0
245702|NCT00981825|596017|P1|NOT COMPLETED|Second Intervention||0
245703|NCT00981825|596016|P2|COMPLETED|Second Intervention||11
245704|NCT00981825|596017|P1|COMPLETED|Second Intervention||11
245705|NCT00981825|596016|P2|STARTED|Second Intervention||11
245706|NCT00981825|596017|P1|STARTED|Second Intervention||11
245707|NCT00981825|596016|P2|NOT COMPLETED|Washout After 1st Intervention||0
245708|NCT00981825|596017|P1|NOT COMPLETED|Washout After 1st Intervention||0
245709|NCT00981825|596016|P2|COMPLETED|Washout After 1st Intervention||11
245710|NCT00981825|596017|P1|COMPLETED|Washout After 1st Intervention||11
245711|NCT00981825|596016|P2|STARTED|Washout After 1st Intervention||11
245712|NCT00981825|596017|P1|STARTED|Washout After 1st Intervention||11
245713|NCT00981825|596016|P2|NOT COMPLETED|First Intervention||0
245714|NCT00981825|596017|P1|NOT COMPLETED|First Intervention||0
245715|NCT00981825|596016|P2|COMPLETED|First Intervention||11
245716|NCT00981825|596017|P1|COMPLETED|First Intervention||11
245717|NCT00981825|596016|P2|STARTED|First Intervention||11
245718|NCT00981825|596017|P1|STARTED|First Intervention||11
245719|NCT00974051|596023|P3|NOT COMPLETED|Overall Study||0
245720|NCT00974051|596024|P2|NOT COMPLETED|Overall Study||0
245721|NCT00974051|596025|P1|NOT COMPLETED|Overall Study||0
245722|NCT00974051|596023|P3|COMPLETED|Overall Study||6
245723|NCT00974051|596024|P2|COMPLETED|Overall Study||4
245724|NCT00974051|596025|P1|COMPLETED|Overall Study||6
245725|NCT00974051|596023|P3|STARTED|Overall Study||6
245726|NCT00974051|596024|P2|STARTED|Overall Study||4
245727|NCT00974051|596025|P1|STARTED|Overall Study||6
245728|NCT00974090|596045|P2|NOT COMPLETED|Period 2: Open-label Period||10
245729|NCT00974090|596046|P1|NOT COMPLETED|Period 2: Open-label Period||8
245730|NCT00974090|596045|P2|COMPLETED|Period 2: Open-label Period||85
245731|NCT00974090|596046|P1|COMPLETED|Period 2: Open-label Period||87
245732|NCT00974090|596045|P2|STARTED|Period 2: Open-label Period||95
245733|NCT00974090|596046|P1|STARTED|Period 2: Open-label Period||95
245734|NCT00974090|596045|P2|NOT COMPLETED|Period 1: Double Blind Period||1
245735|NCT00974090|596046|P1|NOT COMPLETED|Period 1: Double Blind Period||3
245736|NCT00974090|596045|P2|COMPLETED|Period 1: Double Blind Period||95
245737|NCT00974090|596046|P1|COMPLETED|Period 1: Double Blind Period||95
245738|NCT00974090|596045|P2|STARTED|Period 1: Double Blind Period||96
245739|NCT00974090|596046|P1|STARTED|Period 1: Double Blind Period||98
245740|NCT00974220|596062|P2|NOT COMPLETED|Treatment Period 2||0
245741|NCT00974220|596063|P1|NOT COMPLETED|Treatment Period 2||0
245742|NCT00974220|596062|P2|COMPLETED|Treatment Period 2||5
245743|NCT00974220|596063|P1|COMPLETED|Treatment Period 2||7
245744|NCT00974220|596062|P2|STARTED|Treatment Period 2||5
245745|NCT00974220|596063|P1|STARTED|Treatment Period 2||7
245746|NCT00974220|596062|P2|NOT COMPLETED|Treatment Period 1||2
245747|NCT00974220|596063|P1|NOT COMPLETED|Treatment Period 1||2
245748|NCT00974220|596062|P2|COMPLETED|Treatment Period 1||5
245749|NCT00974220|596063|P1|COMPLETED|Treatment Period 1||7
245750|NCT00974220|596062|P2|STARTED|Treatment Period 1||7
245751|NCT00974220|596063|P1|STARTED|Treatment Period 1||9
245752|NCT00974233|596071|P1|NOT COMPLETED|Maintenance Lenalidomide||13
245753|NCT00974233|596071|P1|COMPLETED|Maintenance Lenalidomide||6
245754|NCT00974233|596071|P1|STARTED|Maintenance Lenalidomide||19
245755|NCT00974233|596071|P1|NOT COMPLETED|Induction Chemoimmunotherapy||15
245756|NCT00974233|596071|P1|COMPLETED|Induction Chemoimmunotherapy||19
245757|NCT00974233|596071|P1|STARTED|Induction Chemoimmunotherapy||34
245758|NCT00974246|596084|P1|NOT COMPLETED|Overall Study||0
245759|NCT00974246|596084|P1|COMPLETED|Overall Study||27
245760|NCT00974246|596084|P1|STARTED|Overall Study||27
245761|NCT00974311|596092|P2|NOT COMPLETED|Overall Study||236
245762|NCT00974311|596093|P1|NOT COMPLETED|Overall Study||546
245763|NCT00974311|596092|P2|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|163
245764|NCT00974311|596093|P1|COMPLETED|Overall Study|Indicates participants continuing long-term follow-up as of 25 September 2011.|254
245765|NCT00974311|596092|P2|STARTED|Overall Study||399
245766|NCT00974311|596093|P1|STARTED|Overall Study||800
245767|NCT00974363|596115|P2|NOT COMPLETED|Overall Study||0
245768|NCT00974363|596116|P1|NOT COMPLETED|Overall Study||0
245769|NCT00974363|596115|P2|COMPLETED|Overall Study||168
245770|NCT00974363|596116|P1|COMPLETED|Overall Study||521
245771|NCT00974363|596115|P2|STARTED|Overall Study||168
245772|NCT00974363|596116|P1|STARTED|Overall Study||521
245773|NCT00974376|596138|P2|NOT COMPLETED|Overall Study||33
245774|NCT00974376|596139|P1|NOT COMPLETED|Overall Study||34
245775|NCT00974376|596138|P2|COMPLETED|Overall Study||42
245776|NCT00974376|596139|P1|COMPLETED|Overall Study||41
245777|NCT00974376|596138|P2|STARTED|Overall Study||75
245778|NCT00974376|596139|P1|STARTED|Overall Study||75
245779|NCT00974480|596148|P3|NOT COMPLETED|Overall Study||10
245780|NCT00974480|596149|P2|NOT COMPLETED|Overall Study||7
245781|NCT00974480|596150|P1|NOT COMPLETED|Overall Study||11
245782|NCT00974480|596148|P3|COMPLETED|Overall Study||30
245783|NCT00974480|596149|P2|COMPLETED|Overall Study||33
245784|NCT00974480|596150|P1|COMPLETED|Overall Study||29
245785|NCT00974480|596148|P3|STARTED|Overall Study||40
245786|NCT00974480|596149|P2|STARTED|Overall Study||40
245787|NCT00974480|596150|P1|STARTED|Overall Study||40
245788|NCT00974571|596191|P3|NOT COMPLETED|Overall Study||83
245789|NCT00974571|596192|P2|NOT COMPLETED|Overall Study||16
245790|NCT00974571|596193|P1|NOT COMPLETED|Overall Study||68
245791|NCT00974571|596191|P3|COMPLETED|Overall Study||530
245792|NCT00974571|596192|P2|COMPLETED|Overall Study||106
245793|NCT00974571|596193|P1|COMPLETED|Overall Study||562
245794|NCT00974571|596191|P3|STARTED|Overall Study||613
245795|NCT00974571|596192|P2|STARTED|Overall Study||122
245796|NCT00974571|596193|P1|STARTED|Overall Study||630
245797|NCT00974675|596217|P4|NOT COMPLETED|Overall Study||2
245798|NCT00974675|596218|P3|NOT COMPLETED|Overall Study||2
245799|NCT00974675|596219|P2|NOT COMPLETED|Overall Study||1
245800|NCT00974675|596220|P1|NOT COMPLETED|Overall Study||2
245801|NCT00974675|596217|P4|COMPLETED|Overall Study||2
245802|NCT00974675|596218|P3|COMPLETED|Overall Study||1
245803|NCT00974675|596219|P2|COMPLETED|Overall Study||7
245804|NCT00974675|596220|P1|COMPLETED|Overall Study||6
245805|NCT00974675|596217|P4|STARTED|Overall Study||4
245806|NCT00974675|596218|P3|STARTED|Overall Study||3
245807|NCT00974675|596219|P2|STARTED|Overall Study||8
245808|NCT00974675|596220|P1|STARTED|Overall Study||8
245809|NCT00982007|596270|P4|NOT COMPLETED|Overall Study||6
245810|NCT00982007|596271|P3|NOT COMPLETED|Overall Study||0
245811|NCT00982007|596272|P2|NOT COMPLETED|Overall Study||4
245812|NCT00982007|596273|P1|NOT COMPLETED|Overall Study||4
245813|NCT00982007|596270|P4|COMPLETED|Overall Study||245
245814|NCT00982007|596271|P3|COMPLETED|Overall Study||253
245815|NCT00982007|596272|P2|COMPLETED|Overall Study||253
245816|NCT00982007|596273|P1|COMPLETED|Overall Study||246
245817|NCT00982007|596270|P4|STARTED|Overall Study||251
245818|NCT00982007|596271|P3|STARTED|Overall Study||253
245819|NCT00982007|596272|P2|STARTED|Overall Study||257
245820|NCT00982007|596273|P1|STARTED|Overall Study||250
245821|NCT00982020|596285|P2|NOT COMPLETED|Overall Study||64
245822|NCT00982020|596286|P1|NOT COMPLETED|Overall Study||57
245823|NCT00982020|596285|P2|COMPLETED|Overall Study||37
245824|NCT00982020|596286|P1|COMPLETED|Overall Study||45
245825|NCT00982020|596285|P2|Received at Least 1 Dose of Study Drug|Overall Study||101
245826|NCT00982020|596286|P1|Received at Least 1 Dose of Study Drug|Overall Study||102
245827|NCT00982020|596285|P2|STARTED|Overall Study||101
245828|NCT00982020|596286|P1|STARTED|Overall Study||102
245829|NCT00982033|596308|P2|NOT COMPLETED|Overall Study||0
245830|NCT00982033|596309|P1|NOT COMPLETED|Overall Study||0
245831|NCT00982033|596308|P2|COMPLETED|Overall Study||27
245832|NCT00982033|596309|P1|COMPLETED|Overall Study||25
245833|NCT00982033|596308|P2|STARTED|Overall Study||27
245834|NCT00982033|596309|P1|STARTED|Overall Study||25
245835|NCT00982111|596317|P2|NOT COMPLETED|Overall Study||66
245836|NCT00982111|596318|P1|NOT COMPLETED|Overall Study||75
245837|NCT00982111|596317|P2|COMPLETED|Overall Study||252
245838|NCT00982111|596318|P1|COMPLETED|Overall Study||240
245839|NCT00982111|596317|P2|On Study at Conclusion, Off Treatment|Overall Study||6
245840|NCT00982111|596318|P1|On Study at Conclusion, Off Treatment|Overall Study||4
245841|NCT00982111|596317|P2|Death Due to Any Cause|Overall Study||246
245842|NCT00982111|596318|P1|Death Due to Any Cause|Overall Study||236
245843|NCT00982111|596317|P2|Received at Least 1 Dose of Study Drug|Overall Study||312
245844|NCT00982111|596318|P1|Received at Least 1 Dose of Study Drug|Overall Study||304
245845|NCT00982111|596317|P2|STARTED|Overall Study||318
245846|NCT00982111|596318|P1|STARTED|Overall Study||315
245847|NCT00982137|596344|P4|NOT COMPLETED|Overall Study||1
245848|NCT00982137|596345|P3|NOT COMPLETED|Overall Study||0
245849|NCT00982137|596346|P2|NOT COMPLETED|Overall Study||1
245850|NCT00982137|596347|P1|NOT COMPLETED|Overall Study||0
245851|NCT00982137|596344|P4|COMPLETED|Overall Study||17
245852|NCT00982137|596345|P3|COMPLETED|Overall Study||18
245853|NCT00982137|596346|P2|COMPLETED|Overall Study||35
245854|NCT00982137|596347|P1|COMPLETED|Overall Study||36
245855|NCT00982137|596344|P4|STARTED|Overall Study||18
245856|NCT00982137|596345|P3|STARTED|Overall Study||18
245857|NCT00982137|596346|P2|STARTED|Overall Study||36
245858|NCT00982137|596347|P1|STARTED|Overall Study||36
245859|NCT00982189|596381|P4|NOT COMPLETED|Overall Study||0
245860|NCT00982189|596382|P3|NOT COMPLETED|Overall Study||0
245861|NCT00982189|596383|P2|NOT COMPLETED|Overall Study||0
245862|NCT00982189|596384|P1|NOT COMPLETED|Overall Study||0
245863|NCT00982189|596381|P4|COMPLETED|Overall Study||9
245864|NCT00982189|596382|P3|COMPLETED|Overall Study||9
245865|NCT00982189|596383|P2|COMPLETED|Overall Study||9
245866|NCT00982189|596384|P1|COMPLETED|Overall Study||10
245867|NCT00982189|596381|P4|STARTED|Overall Study||9
245868|NCT00982189|596382|P3|STARTED|Overall Study||9
245869|NCT00982189|596383|P2|STARTED|Overall Study||9
245870|NCT00982189|596384|P1|STARTED|Overall Study||10
245871|NCT00982228|596404|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||5
245872|NCT00982228|596405|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||21
245873|NCT00982228|596404|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||113
245874|NCT00982228|596405|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3644)||330
245875|NCT00982228|596404|P2|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Nineteen subjects from the main trial did not continue into the extension|118
245876|NCT00982228|596405|P1|STARTED|Extension: Week 53 to 104 (NN1250-3644)|Fifty-three subjects from the main trial did not continue into the extension|351
245877|NCT00982228|596404|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||20
245878|NCT00982228|596405|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3583)||68
245879|NCT00982228|596404|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||137
245880|NCT00982228|596405|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3583)||404
245881|NCT00982228|596404|P2|Exposed|Main: Week 0 to 52 (NN1250-3583)|Three subjects withdrew prior to exposure to trial drug|154
245882|NCT00982228|596405|P1|Exposed|Main: Week 0 to 52 (NN1250-3583)||472
245883|NCT00982228|596404|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||157
245884|NCT00982228|596405|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3583)||472
245885|NCT00982228|596404|P2|STARTED|Main: Week 0 to 52 (NN1250-3583)||157
245886|NCT00982228|596405|P1|STARTED|Main: Week 0 to 52 (NN1250-3583)||472
245887|NCT00982995|596429|P1|NOT COMPLETED|Overall Study||0
245888|NCT00982995|596429|P1|COMPLETED|Overall Study||3
245889|NCT00982995|596429|P1|STARTED|Overall Study||3
245890|NCT00983073|596434|P1|NOT COMPLETED|Maintenance Period||16
245891|NCT00983073|596434|P1|COMPLETED|Maintenance Period||144
245892|NCT00983073|596434|P1|STARTED|Maintenance Period||160
245893|NCT00983073|596434|P1|NOT COMPLETED|Titration and Optimal Dose Period||40
245894|NCT00983073|596434|P1|COMPLETED|Titration and Optimal Dose Period||160
245895|NCT00983073|596434|P1|STARTED|Titration and Optimal Dose Period||200
245896|NCT00983073|596434|P1|NOT COMPLETED|Observation Period||24
245897|NCT00983073|596434|P1|COMPLETED|Observation Period|24 participants not eligible to be dosed.|200
245898|NCT00983073|596434|P1|STARTED|Observation Period||224
245899|NCT00983216|596455|P1|NOT COMPLETED|Colchicine With Ketoconazole||0
245900|NCT00983216|596455|P1|COMPLETED|Colchicine With Ketoconazole||24
245901|NCT00983216|596455|P1|STARTED|Colchicine With Ketoconazole||24
245902|NCT00983216|596455|P1|NOT COMPLETED|Ketoconazole Alone||0
245903|NCT00983216|596455|P1|COMPLETED|Ketoconazole Alone||24
245904|NCT00983216|596455|P1|STARTED|Ketoconazole Alone||24
245905|NCT00983216|596455|P1|NOT COMPLETED|14 Day Washout Period||0
245906|NCT00983216|596455|P1|COMPLETED|14 Day Washout Period||24
245907|NCT00983216|596455|P1|STARTED|14 Day Washout Period||24
245908|NCT00983216|596455|P1|NOT COMPLETED|Colchicine Alone||0
245909|NCT00983216|596455|P1|COMPLETED|Colchicine Alone||24
245910|NCT00983216|596455|P1|STARTED|Colchicine Alone||24
245911|NCT00983242|596466|P1|NOT COMPLETED|Colchicine With Verapamil HCl ER||0
245912|NCT00983242|596466|P1|COMPLETED|Colchicine With Verapamil HCl ER||24
245913|NCT00983242|596466|P1|STARTED|Colchicine With Verapamil HCl ER||24
245914|NCT00983242|596466|P1|NOT COMPLETED|Verapamil HCl ER Alone||0
245915|NCT00983242|596466|P1|COMPLETED|Verapamil HCl ER Alone||24
245916|NCT00983242|596466|P1|STARTED|Verapamil HCl ER Alone||24
245917|NCT00983242|596466|P1|NOT COMPLETED|14 Day Washout Period||0
245918|NCT00983242|596466|P1|COMPLETED|14 Day Washout Period||24
245919|NCT00983242|596466|P1|STARTED|14 Day Washout Period||24
245920|NCT00983242|596466|P1|NOT COMPLETED|Colchicine Alone||0
245921|NCT00983242|596466|P1|COMPLETED|Colchicine Alone||24
245922|NCT00983242|596466|P1|STARTED|Colchicine Alone||24
245923|NCT00983281|596479|P2|NOT COMPLETED|Overall Study||0
245924|NCT00983281|596480|P1|NOT COMPLETED|Overall Study||0
245925|NCT00983281|596479|P2|COMPLETED|Overall Study||909
245926|NCT00983281|596480|P1|COMPLETED|Overall Study||805
245927|NCT00983281|596479|P2|STARTED|Overall Study||909
245928|NCT00983281|596480|P1|STARTED|Overall Study||805
245929|NCT00983294|596486|P1|NOT COMPLETED|Colchicine With Azithromycin||1
245930|NCT00983294|596486|P1|COMPLETED|Colchicine With Azithromycin|withdrawn by sponsor on Day 21 due to vomiting on Day 15, prior to azithromycin dosing(1)|21
245931|NCT00983294|596486|P1|STARTED|Colchicine With Azithromycin||22
245932|NCT00983294|596486|P1|NOT COMPLETED|Azithromycin Alone||0
245933|NCT00983294|596486|P1|COMPLETED|Azithromycin Alone||22
245934|NCT00983294|596486|P1|STARTED|Azithromycin Alone||22
245935|NCT00983294|596486|P1|NOT COMPLETED|14 Day Washout Period||2
245936|NCT00983294|596486|P1|COMPLETED|14 Day Washout Period|two subjects withdrew consent due to personal reasons|22
245937|NCT00983294|596486|P1|STARTED|14 Day Washout Period||24
245938|NCT00983294|596486|P1|NOT COMPLETED|Colchicine Alone||0
245939|NCT00983294|596486|P1|COMPLETED|Colchicine Alone||24
245940|NCT00983294|596486|P1|STARTED|Colchicine Alone||24
245941|NCT00983346|596497|P1|NOT COMPLETED|Overall Study||0
245942|NCT00983346|596497|P1|COMPLETED|Overall Study||17
245943|NCT00983346|596497|P1|STARTED|Overall Study||17
245944|NCT00983359|596501|P1|NOT COMPLETED|Overall Study||1
245945|NCT00983359|596501|P1|COMPLETED|Overall Study||39
245946|NCT00983359|596501|P1|Not Eligible for Analysis|Overall Study||1
245947|NCT00983359|596501|P1|STARTED|Overall Study||40
245948|NCT00983372|596509|P1|NOT COMPLETED|Colchicine With Diltiazem ER||0
245949|NCT00983372|596509|P1|COMPLETED|Colchicine With Diltiazem ER||20
245950|NCT00983372|596509|P1|STARTED|Colchicine With Diltiazem ER||20
245951|NCT00983372|596509|P1|NOT COMPLETED|Diltiazem ER Alone||3
245952|NCT00983372|596509|P1|COMPLETED|Diltiazem ER Alone|two subjects dropped due to missed diltiazem ER dose; one subject dropped due to vomitting|20
245953|NCT00983372|596509|P1|STARTED|Diltiazem ER Alone||23
245954|NCT00983372|596509|P1|NOT COMPLETED|14 Day Washout Period||1
245955|NCT00983372|596509|P1|COMPLETED|14 Day Washout Period|subject withdrew consent due to schedule conflict - during washout period or diltiazem alone|23
245956|NCT00983372|596509|P1|STARTED|14 Day Washout Period||24
245957|NCT00983372|596509|P1|NOT COMPLETED|Colchicine Alone||0
245958|NCT00983372|596509|P1|COMPLETED|Colchicine Alone||24
245959|NCT00983372|596509|P1|STARTED|Colchicine Alone||24
245960|NCT00983385|596520|P1|NOT COMPLETED|Maintenance Period||23
245961|NCT00983385|596520|P1|COMPLETED|Maintenance Period||117
245962|NCT00983385|596520|P1|STARTED|Maintenance Period||140
245963|NCT00983385|596520|P1|NOT COMPLETED|Titration and Optimal Dose Period||36
245964|NCT00983385|596520|P1|COMPLETED|Titration and Optimal Dose Period||140
245965|NCT00983385|596520|P1|STARTED|Titration and Optimal Dose Period||176
245966|NCT00983385|596520|P1|NOT COMPLETED|Observation Period||32
245967|NCT00983385|596520|P1|COMPLETED|Observation Period||176
245968|NCT00983385|596520|P1|STARTED|Observation Period||208
245969|NCT00983437|596565|P1|NOT COMPLETED|Overall Study||47
245970|NCT00983437|596565|P1|COMPLETED|Overall Study|Completed 12 months of treatment with armodafinil.|0
245971|NCT00983437|596565|P1|Full Analysis Set (FAS)|Overall Study|Participants had to have at least 1 postbaseline efficacy assessment to be evaluable for efficacy.|45
245972|NCT00983437|596565|P1|Safety Analysis Set (SAS)|Overall Study|Participants who received at least 1 dose of study drug were evaluable for safety.|47
245973|NCT00983437|596565|P1|STARTED|Overall Study||47
245974|NCT00983476|596587|P3|NOT COMPLETED|Overall Study||0
245975|NCT00983476|596588|P2|NOT COMPLETED|Overall Study||22
245976|NCT00983476|596589|P1|NOT COMPLETED|Overall Study||17
245977|NCT00983476|596587|P3|COMPLETED|Overall Study||88
245978|NCT00983476|596588|P2|COMPLETED|Overall Study||71
245979|NCT00983476|596589|P1|COMPLETED|Overall Study||78
245980|NCT00983476|596587|P3|6 Month Follow up Assessment|Overall Study||74
245981|NCT00983476|596588|P2|6 Month Follow up Assessment|Overall Study||62
245982|NCT00983476|596589|P1|6 Month Follow up Assessment|Overall Study||71
245983|NCT00983476|596587|P3|STARTED|Overall Study||88
245984|NCT00983476|596588|P2|STARTED|Overall Study||93
245985|NCT00983476|596589|P1|STARTED|Overall Study||95
245986|NCT00983489|596624|P3|NOT COMPLETED|Overall Study||312
245987|NCT00983489|596625|P2|NOT COMPLETED|Overall Study||285
245988|NCT00983489|596626|P1|NOT COMPLETED|Overall Study||185
245989|NCT00983489|596624|P3|COMPLETED|Overall Study||135
245990|NCT00983489|596625|P2|COMPLETED|Overall Study||168
245991|NCT00983489|596626|P1|COMPLETED|Overall Study||326
245992|NCT00983489|596624|P3|STARTED|Overall Study||447
245993|NCT00983489|596625|P2|STARTED|Overall Study||453
245994|NCT00983489|596626|P1|STARTED|Overall Study||511
245995|NCT00983515|596634|P1|NOT COMPLETED|Colchicine With Ritonavir||1
245996|NCT00983515|596634|P1|COMPLETED|Colchicine With Ritonavir|pharmacokinetic data included since parameters could be estimated for both dosing conditions|17
245997|NCT00983515|596634|P1|STARTED|Colchicine With Ritonavir||18
245998|NCT00983515|596634|P1|NOT COMPLETED|Ritonavir Alone||6
245999|NCT00983515|596634|P1|COMPLETED|Ritonavir Alone||18
246000|NCT00983515|596634|P1|STARTED|Ritonavir Alone||24
246001|NCT00983515|596634|P1|NOT COMPLETED|14 Day Washout Period||0
246002|NCT00983515|596634|P1|COMPLETED|14 Day Washout Period||24
246003|NCT00983515|596634|P1|STARTED|14 Day Washout Period||24
246004|NCT00983515|596634|P1|NOT COMPLETED|Colchicine Alone||0
246005|NCT00983515|596634|P1|COMPLETED|Colchicine Alone||24
246006|NCT00983515|596634|P1|STARTED|Colchicine Alone||24
246007|NCT00983541|596645|P1|NOT COMPLETED|Overall Study||0
246008|NCT00983541|596645|P1|COMPLETED|Overall Study||1
246009|NCT00983541|596645|P1|STARTED|Overall Study||1
246010|NCT00983645|596657|P2|NOT COMPLETED|Overall Study||0
246011|NCT00983645|596658|P1|NOT COMPLETED|Overall Study||0
246012|NCT00983645|596657|P2|COMPLETED|Overall Study||7
246013|NCT00983645|596658|P1|COMPLETED|Overall Study||8
246014|NCT00983645|596657|P2|STARTED|Overall Study||7
246015|NCT00983645|596658|P1|STARTED|Overall Study||8
246016|NCT00983749|596672|P2|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||3
246017|NCT00983749|596673|P1|NOT COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||1
246018|NCT00983749|596672|P2|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||7
246019|NCT00983749|596673|P1|COMPLETED|Follow-up Phase (Hospital DC to 30 Days)||12
246020|NCT00983749|596672|P2|STARTED|Follow-up Phase (Hospital DC to 30 Days)||10
246021|NCT00983749|596673|P1|STARTED|Follow-up Phase (Hospital DC to 30 Days)||13
246022|NCT00983749|596672|P2|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
246023|NCT00983749|596673|P1|NOT COMPLETED|Acute Phase (Enrollment to Hospital DC)||0
246024|NCT00983749|596672|P2|COMPLETED|Acute Phase (Enrollment to Hospital DC)||10
246025|NCT00983749|596673|P1|COMPLETED|Acute Phase (Enrollment to Hospital DC)||13
246026|NCT00983749|596672|P2|STARTED|Acute Phase (Enrollment to Hospital DC)||10
246027|NCT00983749|596673|P1|STARTED|Acute Phase (Enrollment to Hospital DC)||13
246028|NCT00983801|596681|P1|NOT COMPLETED|Overall Study||0
246029|NCT00983801|596681|P1|COMPLETED|Overall Study|Participants who were taken off treatment.|52
246030|NCT00983801|596681|P1|STARTED|Overall Study|Participants who received treatment.|52
246031|NCT00983827|596693|P1|NOT COMPLETED|Overall Study||1
246032|NCT00983827|596693|P1|COMPLETED|Overall Study||7
246033|NCT00983827|596693|P1|STARTED|Overall Study||8
246034|NCT00983853|596703|P6|NOT COMPLETED|Overall Study||1
246035|NCT00983853|596704|P5|NOT COMPLETED|Overall Study||3
246036|NCT00983853|596705|P4|NOT COMPLETED|Overall Study||2
246037|NCT00983853|596706|P3|NOT COMPLETED|Overall Study||3
246038|NCT00983853|596707|P2|NOT COMPLETED|Overall Study||2
246039|NCT00983853|596708|P1|NOT COMPLETED|Overall Study||1
246040|NCT00983853|596703|P6|COMPLETED|Overall Study||7
246041|NCT00983853|596704|P5|COMPLETED|Overall Study||12
246042|NCT00983853|596705|P4|COMPLETED|Overall Study||6
246043|NCT00983853|596706|P3|COMPLETED|Overall Study||14
246044|NCT00983853|596707|P2|COMPLETED|Overall Study||5
246045|NCT00983853|596708|P1|COMPLETED|Overall Study||6
246046|NCT00983853|596703|P6|STARTED|Overall Study||8
246047|NCT00983853|596704|P5|STARTED|Overall Study||15
246048|NCT00983853|596705|P4|STARTED|Overall Study||8
246049|NCT00983853|596706|P3|STARTED|Overall Study|1 subject was randomized but not dosed|17
246050|NCT00983853|596707|P2|STARTED|Overall Study|1 subject was randomized but not dosed|7
246051|NCT00983853|596708|P1|STARTED|Overall Study||7
246052|NCT00983892|596738|P2|NOT COMPLETED|Overall Study||12
246053|NCT00983892|596739|P1|NOT COMPLETED|Overall Study||10
246054|NCT00983892|596738|P2|COMPLETED|Overall Study||56
246055|NCT00983892|596739|P1|COMPLETED|Overall Study||56
246056|NCT00983892|596738|P2|STARTED|Overall Study||68
246057|NCT00983892|596739|P1|STARTED|Overall Study||66
246058|NCT00983905|596745|P1|NOT COMPLETED|Theophylline With Colchicine||0
246059|NCT00983905|596745|P1|COMPLETED|Theophylline With Colchicine||27
246060|NCT00983905|596745|P1|STARTED|Theophylline With Colchicine||27
246061|NCT00983905|596745|P1|NOT COMPLETED|Colchicine Alone||2
246062|NCT00983905|596745|P1|COMPLETED|Colchicine Alone|withdrawn by sponsor due to: diarrhea(1); vomiting and diarrhea(1)|27
246063|NCT00983905|596745|P1|STARTED|Colchicine Alone||29
246064|NCT00983905|596745|P1|NOT COMPLETED|4 Day Washout Period||0
246065|NCT00983905|596745|P1|COMPLETED|4 Day Washout Period||29
246066|NCT00983905|596745|P1|STARTED|4 Day Washout Period||29
246067|NCT00983905|596745|P1|NOT COMPLETED|Theophylline Alone||1
246068|NCT00983905|596745|P1|COMPLETED|Theophylline Alone|withdrawn by sponsor due to vomiting(1)|29
246069|NCT00983905|596745|P1|STARTED|Theophylline Alone||30
246070|NCT00983918|596760|P4|NOT COMPLETED|Overall Study||2
246071|NCT00983918|596761|P3|NOT COMPLETED|Overall Study||2
246072|NCT00983918|596762|P2|NOT COMPLETED|Overall Study||2
246073|NCT00983918|596763|P1|NOT COMPLETED|Overall Study||0
246074|NCT00983918|596760|P4|COMPLETED|Overall Study||18
246075|NCT00983918|596761|P3|COMPLETED|Overall Study||18
246076|NCT00983918|596762|P2|COMPLETED|Overall Study||18
246077|NCT00983918|596763|P1|COMPLETED|Overall Study||20
246078|NCT00983918|596760|P4|STARTED|Overall Study||20
246079|NCT00983918|596761|P3|STARTED|Overall Study||20
246080|NCT00983918|596762|P2|STARTED|Overall Study||20
246081|NCT00983918|596763|P1|STARTED|Overall Study||20
246082|NCT00983931|596773|P1|NOT COMPLETED|Colchicine With Cyclosporine||0
246083|NCT00983931|596773|P1|COMPLETED|Colchicine With Cyclosporine||23
246084|NCT00983931|596773|P1|STARTED|Colchicine With Cyclosporine||23
246085|NCT00983931|596773|P1|NOT COMPLETED|14 Day Washout Period||1
246086|NCT00983931|596773|P1|COMPLETED|14 Day Washout Period|one subject withdrawn due to creatine kinase out of range|23
246087|NCT00983931|596773|P1|STARTED|14 Day Washout Period||24
246088|NCT00983931|596773|P1|NOT COMPLETED|Colchicine Alone||0
246089|NCT00983931|596773|P1|COMPLETED|Colchicine Alone||24
246090|NCT00983931|596773|P1|STARTED|Colchicine Alone||24
246091|NCT00983957|596783|P1|NOT COMPLETED|Overall Study||2
246092|NCT00983957|596783|P1|COMPLETED|Overall Study||18
246093|NCT00983957|596783|P1|Treatment C|Overall Study||18
246094|NCT00983957|596783|P1|Treatment B|Overall Study||20
246095|NCT00983957|596783|P1|Treatment A|Overall Study||20
246096|NCT00983957|596783|P1|STARTED|Overall Study||20
246097|NCT00983983|596820|P3|NOT COMPLETED|Overall Study||1
246098|NCT00983983|596821|P2|NOT COMPLETED|Overall Study||1
246099|NCT00983983|596822|P1|NOT COMPLETED|Overall Study||2
246100|NCT00983983|596820|P3|COMPLETED|Overall Study||6
246101|NCT00983983|596821|P2|COMPLETED|Overall Study||8
246102|NCT00983983|596822|P1|COMPLETED|Overall Study||6
246103|NCT00983983|596820|P3|STARTED|Overall Study||7
246104|NCT00983983|596821|P2|STARTED|Overall Study||9
246105|NCT00983983|596822|P1|STARTED|Overall Study||8
246106|NCT00984009|596839|P1|NOT COMPLETED|Colchicine With Grapefruit Juice||0
246107|NCT00984009|596839|P1|COMPLETED|Colchicine With Grapefruit Juice||21
246108|NCT00984009|596839|P1|STARTED|Colchicine With Grapefruit Juice||21
246109|NCT00984009|596839|P1|NOT COMPLETED|Grapefruit Juice Alone||1
246110|NCT00984009|596839|P1|COMPLETED|Grapefruit Juice Alone|one subject dropped due to missed a.m. serving of grapefruit juice on Day 16|21
246111|NCT00984009|596839|P1|STARTED|Grapefruit Juice Alone||22
246112|NCT00984009|596839|P1|NOT COMPLETED|14 Day Washout Period||0
246113|NCT00984009|596839|P1|COMPLETED|14 Day Washout Period||22
246114|NCT00984009|596839|P1|STARTED|14 Day Washout Period||22
246115|NCT00984009|596839|P1|NOT COMPLETED|Colchicine Alone||0
246116|NCT00984009|596839|P1|COMPLETED|Colchicine Alone||22
246117|NCT00984009|596839|P1|STARTED|Colchicine Alone||22
246118|NCT00984022|596852|P2|NOT COMPLETED|Overall Study||14
246119|NCT00984022|596853|P1|NOT COMPLETED|Overall Study||10
246120|NCT00984022|596852|P2|COMPLETED|Overall Study||35
246121|NCT00984022|596853|P1|COMPLETED|Overall Study||33
246122|NCT00984022|596852|P2|STARTED|Overall Study||49
246123|NCT00984022|596853|P1|STARTED|Overall Study||43
246124|NCT00984061|596863|P1|NOT COMPLETED|Colchicine With Clarithromycin||0
246125|NCT00984061|596863|P1|COMPLETED|Colchicine With Clarithromycin||23
246126|NCT00984061|596863|P1|STARTED|Colchicine With Clarithromycin||23
246127|NCT00984061|596863|P1|NOT COMPLETED|Clarithromycin Alone||1
246128|NCT00984061|596863|P1|COMPLETED|Clarithromycin Alone|One subject was dropped due to noncompliance with outpatient clarithromycin regimen.|23
246129|NCT00984061|596863|P1|STARTED|Clarithromycin Alone||24
246130|NCT00984061|596863|P1|NOT COMPLETED|21 Day Washout Period||0
246131|NCT00984061|596863|P1|COMPLETED|21 Day Washout Period||24
246132|NCT00984061|596863|P1|STARTED|21 Day Washout Period||24
246133|NCT00984061|596863|P1|NOT COMPLETED|Colchicine Alone||0
246134|NCT00984061|596863|P1|COMPLETED|Colchicine Alone||24
246135|NCT00984061|596863|P1|STARTED|Colchicine Alone||24
246136|NCT00984126|596878|P4|NOT COMPLETED|Overall Study||59
246137|NCT00984126|596879|P3|NOT COMPLETED|Overall Study||7
246138|NCT00984126|596880|P2|NOT COMPLETED|Overall Study||8
246139|NCT00984126|596881|P1|NOT COMPLETED|Overall Study||7
246140|NCT00984126|596878|P4|COMPLETED|Overall Study||76
246141|NCT00984126|596879|P3|COMPLETED|Overall Study||16
246142|NCT00984126|596880|P2|COMPLETED|Overall Study||20
246143|NCT00984126|596881|P1|COMPLETED|Overall Study||20
246144|NCT00984126|596878|P4|STARTED|Overall Study||135
246145|NCT00984126|596879|P3|STARTED|Overall Study||23
246146|NCT00984126|596880|P2|STARTED|Overall Study||28
246147|NCT00984126|596881|P1|STARTED|Overall Study||27
246148|NCT00984139|596906|P1|NOT COMPLETED|Overall Study||0
246149|NCT00984139|596906|P1|COMPLETED|Overall Study||306
246150|NCT00984139|596906|P1|STARTED|Overall Study||306
246151|NCT00984165|596922|P4|NOT COMPLETED|Overall Study||4
246152|NCT00984165|596923|P3|NOT COMPLETED|Overall Study||0
246153|NCT00984165|596924|P2|NOT COMPLETED|Overall Study||1
246154|NCT00984165|596925|P1|NOT COMPLETED|Overall Study||7
246155|NCT00984165|596922|P4|COMPLETED|Overall Study||0
246156|NCT00984165|596923|P3|COMPLETED|Overall Study||4
246157|NCT00984165|596924|P2|COMPLETED|Overall Study||0
246158|NCT00984165|596925|P1|COMPLETED|Overall Study||2
246159|NCT00984165|596922|P4|STARTED|Overall Study||4
246160|NCT00984165|596923|P3|STARTED|Overall Study||4
246161|NCT00984165|596924|P2|STARTED|Overall Study||1
246162|NCT00984165|596925|P1|STARTED|Overall Study||9
246163|NCT00984204|596938|P1|NOT COMPLETED|Overall Study||15
246164|NCT00984204|596938|P1|COMPLETED|Overall Study|"Seven subjects of the ten Lack of efficacy were acute failures that had no block after 30 min"|173
246165|NCT00984204|596938|P1|STARTED|Overall Study||188
246166|NCT00984256|596946|P2|NOT COMPLETED|Overall Study||1
246167|NCT00984256|596947|P1|NOT COMPLETED|Overall Study||0
246168|NCT00984256|596946|P2|COMPLETED|Overall Study||29
246169|NCT00984256|596947|P1|COMPLETED|Overall Study||6
246170|NCT00984256|596946|P2|STARTED|Overall Study||30
246171|NCT00984256|596947|P1|STARTED|Overall Study||6
246172|NCT00984282|596969|P2|NOT COMPLETED|Long Term Follow-up||117
246173|NCT00984282|596970|P1|NOT COMPLETED|Long Term Follow-up||114
246174|NCT00984282|596969|P2|COMPLETED|Long Term Follow-up||0
246175|NCT00984282|596970|P1|COMPLETED|Long Term Follow-up||0
246176|NCT00984282|596969|P2|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|117
246177|NCT00984282|596970|P1|STARTED|Long Term Follow-up|Participants entered long-term follow-up if terminated double-blind or open-label periods|114
246178|NCT00984282|596969|P2|NOT COMPLETED|Open-label Treatment||161
246179|NCT00984282|596970|P1|NOT COMPLETED|Open-label Treatment||86
246180|NCT00984282|596969|P2|COMPLETED|Open-label Treatment||0
246181|NCT00984282|596970|P1|COMPLETED|Open-label Treatment||0
246182|NCT00984282|596969|P2|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG4 (RG= Reporting Group for Safety Data)|161
246183|NCT00984282|596970|P1|Received Treatment|Open-label Treatment|Subjects at Risk/Safety Population - in RG3 (RG= Reporting Group for Safety Data)|86
246184|NCT00984282|596969|P2|STARTED|Open-label Treatment||161
246185|NCT00984282|596970|P1|STARTED|Open-label Treatment||86
246186|NCT00984282|596969|P2|NOT COMPLETED|Double Blind Treatment||38
246187|NCT00984282|596970|P1|NOT COMPLETED|Double Blind Treatment||104
246188|NCT00984282|596969|P2|COMPLETED|Double Blind Treatment||172
246189|NCT00984282|596970|P1|COMPLETED|Double Blind Treatment||103
246190|NCT00984282|596969|P2|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG2 (RG= Reporting Group for Safety Data)|209
246191|NCT00984282|596970|P1|Received Treatment|Double Blind Treatment|Subjects at Risk/Safety Population - in RG1 (RG= Reporting Group for Safety Data)|207
246192|NCT00984282|596969|P2|STARTED|Double Blind Treatment||210
246193|NCT00984282|596970|P1|STARTED|Double Blind Treatment||207
246194|NCT00984295|596994|P3|NOT COMPLETED|Overall Study||37
246195|NCT00984295|596995|P2|NOT COMPLETED|Overall Study||32
246196|NCT00984295|596996|P1|NOT COMPLETED|Overall Study||65
246197|NCT00984295|596994|P3|COMPLETED|Overall Study||442
246198|NCT00984295|596995|P2|COMPLETED|Overall Study||453
246199|NCT00984295|596996|P1|COMPLETED|Overall Study||884
246200|NCT00984295|596994|P3|Visit 2|Overall Study||453
246201|NCT00984295|596995|P2|Visit 2|Overall Study||468
246202|NCT00984295|596996|P1|Visit 2|Overall Study||909
246203|NCT00984295|596994|P3|Visit 1|Overall Study||479
246204|NCT00984295|596995|P2|Visit 1|Overall Study||485
246205|NCT00984295|596996|P1|Visit 1|Overall Study||949
246206|NCT00984295|596994|P3|STARTED|Overall Study||479
246207|NCT00984295|596995|P2|STARTED|Overall Study||485
246208|NCT00984295|596996|P1|STARTED|Overall Study|2 patients were incorrectly vaccinated and are excluded from this table.|949
246209|NCT00984308|597063|P2|NOT COMPLETED|Overall Study||6
246210|NCT00984308|597064|P1|NOT COMPLETED|Overall Study||18
246211|NCT00984308|597063|P2|COMPLETED|Overall Study||109
246212|NCT00984308|597064|P1|COMPLETED|Overall Study||92
246213|NCT00984308|597063|P2|STARTED|Overall Study||115
246214|NCT00984308|597064|P1|STARTED|Overall Study||110
246215|NCT00984334|597079|P5|NOT COMPLETED|Overall Study||1
246216|NCT00984334|597080|P4|NOT COMPLETED|Overall Study||1
246217|NCT00984334|597081|P3|NOT COMPLETED|Overall Study||0
246218|NCT00984334|597082|P2|NOT COMPLETED|Overall Study||1
246219|NCT00984334|597083|P1|NOT COMPLETED|Overall Study||1
246220|NCT00984334|597079|P5|COMPLETED|Overall Study||7
246221|NCT00984334|597080|P4|COMPLETED|Overall Study||7
246222|NCT00984334|597081|P3|COMPLETED|Overall Study||8
246223|NCT00984334|597082|P2|COMPLETED|Overall Study||7
246224|NCT00984334|597083|P1|COMPLETED|Overall Study||7
246225|NCT00984334|597079|P5|STARTED|Overall Study||8
246226|NCT00984334|597080|P4|STARTED|Overall Study||8
246227|NCT00984334|597081|P3|STARTED|Overall Study||8
246228|NCT00984334|597082|P2|STARTED|Overall Study||8
246229|NCT00984334|597083|P1|STARTED|Overall Study||8
246230|NCT00984490|597095|P1|NOT COMPLETED|Overall Study||0
246231|NCT00984490|597095|P1|COMPLETED|Overall Study||5
246232|NCT00984490|597095|P1|STARTED|Overall Study||5
246233|NCT00984542|597100|P1|NOT COMPLETED|Overall Study||41
246234|NCT00984542|597100|P1|COMPLETED|Overall Study||9
246235|NCT00984542|597100|P1|STARTED|Overall Study||50
246236|NCT00984568|597110|P2|NOT COMPLETED|Overall Study||6
246237|NCT00984568|597111|P1|NOT COMPLETED|Overall Study||8
246238|NCT00984568|597110|P2|COMPLETED|Overall Study||7
246239|NCT00984568|597111|P1|COMPLETED|Overall Study||7
246240|NCT00984568|597110|P2|STARTED|Overall Study||13
246241|NCT00984568|597111|P1|STARTED|Overall Study||15
246242|NCT00984594|597121|P2|NOT COMPLETED|Overall Study||1
246243|NCT00984594|597122|P1|NOT COMPLETED|Overall Study||1
246244|NCT00984594|597121|P2|COMPLETED|Overall Study||1
246245|NCT00984594|597122|P1|COMPLETED|Overall Study||1
246246|NCT00984594|597121|P2|STARTED|Overall Study|One patient withdrew consent and left the study before treatment.|2
246247|NCT00984594|597122|P1|STARTED|Overall Study||2
246248|NCT00984620|597138|P2|NOT COMPLETED|Overall Study||12
246249|NCT00984620|597139|P1|NOT COMPLETED|Overall Study||6
246250|NCT00984620|597138|P2|COMPLETED|Overall Study||67
246251|NCT00984620|597139|P1|COMPLETED|Overall Study||75
246252|NCT00984620|597138|P2|STARTED|Overall Study||79
246253|NCT00984620|597139|P1|STARTED|Overall Study||81
246254|NCT00984659|597179|P4|NOT COMPLETED|6-week Double-blind Treatment Period||13
246255|NCT00984659|597180|P3|NOT COMPLETED|6-week Double-blind Treatment Period||11
246256|NCT00984659|597181|P2|NOT COMPLETED|6-week Double-blind Treatment Period||6
246257|NCT00984659|597182|P1|NOT COMPLETED|6-week Double-blind Treatment Period||0
246258|NCT00984659|597179|P4|COMPLETED|6-week Double-blind Treatment Period||126
246259|NCT00984659|597180|P3|COMPLETED|6-week Double-blind Treatment Period||141
246260|NCT00984659|597181|P2|COMPLETED|6-week Double-blind Treatment Period||69
246261|NCT00984659|597182|P1|COMPLETED|6-week Double-blind Treatment Period||0
246262|NCT00984659|597179|P4|STARTED|6-week Double-blind Treatment Period||139
246263|NCT00984659|597180|P3|STARTED|6-week Double-blind Treatment Period||152
246264|NCT00984659|597181|P2|STARTED|6-week Double-blind Treatment Period||75
246265|NCT00984659|597182|P1|STARTED|6-week Double-blind Treatment Period||0
246266|NCT00984659|597179|P4|NOT COMPLETED|2-week Run-in Period||0
246267|NCT00984659|597180|P3|NOT COMPLETED|2-week Run-in Period||0
246268|NCT00984659|597181|P2|NOT COMPLETED|2-week Run-in Period||0
246269|NCT00984659|597182|P1|NOT COMPLETED|2-week Run-in Period||52
246270|NCT00984659|597179|P4|COMPLETED|2-week Run-in Period||0
246271|NCT00984659|597180|P3|COMPLETED|2-week Run-in Period||0
246272|NCT00984659|597181|P2|COMPLETED|2-week Run-in Period||0
246273|NCT00984659|597182|P1|COMPLETED|2-week Run-in Period||366
246274|NCT00984659|597179|P4|STARTED|2-week Run-in Period||0
246275|NCT00984659|597180|P3|STARTED|2-week Run-in Period||0
246276|NCT00984659|597181|P2|STARTED|2-week Run-in Period||0
246277|NCT00984659|597182|P1|STARTED|2-week Run-in Period||418
246278|NCT00984698|597209|P2|NOT COMPLETED|Overall Study||8
246279|NCT00984698|597210|P1|NOT COMPLETED|Overall Study||3
246280|NCT00984698|597209|P2|COMPLETED|Overall Study||14
246281|NCT00984698|597210|P1|COMPLETED|Overall Study||18
246282|NCT00984698|597209|P2|STARTED|Overall Study||22
246283|NCT00984698|597210|P1|STARTED|Overall Study||21
246284|NCT00984815|597218|P1|NOT COMPLETED|Overall Study||30
246285|NCT00984815|597218|P1|COMPLETED|Overall Study||56
246286|NCT00984815|597218|P1|STARTED|Overall Study||86
246287|NCT00984867|597227|P2|NOT COMPLETED|Overall Study||17
246288|NCT00984867|597228|P1|NOT COMPLETED|Overall Study||23
246289|NCT00984867|597227|P2|COMPLETED|Overall Study||208
246290|NCT00984867|597228|P1|COMPLETED|Overall Study||203
246291|NCT00984867|597227|P2|STARTED|Overall Study|Of the 225 randomized and treated participants only 223 were included in the full analysis set.|225
246292|NCT00984867|597228|P1|STARTED|Overall Study|Of the 226 randomized and treated participants only 224 were included in the full analysis set.|226
246293|NCT00985010|597248|P2|NOT COMPLETED|Overall Study||0
246294|NCT00985010|597249|P1|NOT COMPLETED|Overall Study||0
246295|NCT00985010|597248|P2|COMPLETED|Overall Study||5
246296|NCT00985010|597249|P1|COMPLETED|Overall Study||4
246297|NCT00985010|597248|P2|STARTED|Overall Study||5
246298|NCT00985010|597249|P1|STARTED|Overall Study||4
246299|NCT00985114|597259|P2|NOT COMPLETED|Overall Study||2
246300|NCT00985114|597260|P1|NOT COMPLETED|Overall Study||1
246301|NCT00985114|597259|P2|COMPLETED|Overall Study||37
246302|NCT00985114|597260|P1|COMPLETED|Overall Study||33
246303|NCT00985114|597259|P2|Diet + Lifestyle Counseling Cross-over|Overall Study|Received device for intended period of 12 months with 6 months follow up|28
246304|NCT00985114|597260|P1|Diet + Lifestyle Counseling Cross-over|Overall Study||0
246305|NCT00985114|597259|P2|STARTED|Overall Study||39
246306|NCT00985114|597260|P1|STARTED|Overall Study|38 randomized, 34 received the device|34
246307|NCT00985140|597266|P1|NOT COMPLETED|Overall Study||0
246308|NCT00985140|597266|P1|COMPLETED|Overall Study||15
246309|NCT00985140|597266|P1|STARTED|Overall Study||15
246310|NCT00985153|597274|P4|NOT COMPLETED|Overall Study||47
246311|NCT00985153|597275|P3|NOT COMPLETED|Overall Study||44
246312|NCT00985153|597276|P2|NOT COMPLETED|Overall Study||44
246313|NCT00985153|597277|P1|NOT COMPLETED|Overall Study||35
246314|NCT00985153|597274|P4|COMPLETED|Overall Study||965
246315|NCT00985153|597275|P3|COMPLETED|Overall Study||918
246316|NCT00985153|597276|P2|COMPLETED|Overall Study||924
246317|NCT00985153|597277|P1|COMPLETED|Overall Study||950
246318|NCT00985153|597274|P4|Vaccinated at Visit 1|Overall Study||1012
246319|NCT00985153|597275|P3|Vaccinated at Visit 1|Overall Study||962
246320|NCT00985153|597276|P2|Vaccinated at Visit 1|Overall Study||968
246321|NCT00985153|597277|P1|Vaccinated at Visit 1|Overall Study||985
246322|NCT00985153|597274|P4|STARTED|Overall Study||1012
246323|NCT00985153|597275|P3|STARTED|Overall Study||962
246324|NCT00985153|597276|P2|STARTED|Overall Study||968
246325|NCT00985153|597277|P1|STARTED|Overall Study||985
246326|NCT00985166|597322|P3|NOT COMPLETED|Overall Study||7
246327|NCT00985166|597323|P2|NOT COMPLETED|Overall Study||4
246328|NCT00985166|597324|P1|NOT COMPLETED|Overall Study||9
246329|NCT00985166|597322|P3|COMPLETED|Overall Study||188
246330|NCT00985166|597323|P2|COMPLETED|Overall Study||201
246331|NCT00985166|597324|P1|COMPLETED|Overall Study||392
246332|NCT00985166|597322|P3|Vaccinated at Visit 1|Overall Study||195
246333|NCT00985166|597323|P2|Vaccinated at Visit 1|Overall Study||205
246334|NCT00985166|597324|P1|Vaccinated at Visit 1|Overall Study||399
246335|NCT00985166|597322|P3|STARTED|Overall Study||195
246336|NCT00985166|597323|P2|STARTED|Overall Study||205
246337|NCT00985166|597324|P1|STARTED|Overall Study|Two randomized subjects withdrew consent before vaccination: no demographic information available.|401
246338|NCT00985192|597340|P1|NOT COMPLETED|Overall Study||4
246339|NCT00985192|597340|P1|COMPLETED|Overall Study||45
246340|NCT00985192|597340|P1|STARTED|Overall Study||49
246341|NCT00985231|597351|P2|NOT COMPLETED|Overall Study||3
246342|NCT00985231|597352|P1|NOT COMPLETED|Overall Study||3
246343|NCT00985231|597351|P2|COMPLETED|Overall Study||129
246344|NCT00985231|597352|P1|COMPLETED|Overall Study||130
246345|NCT00985231|597351|P2|STARTED|Overall Study||132
246346|NCT00985231|597352|P1|STARTED|Overall Study||133
246347|NCT00985257|597360|P1|NOT COMPLETED|Overall Study||0
246348|NCT00985257|597360|P1|COMPLETED|Overall Study||123
246349|NCT00985257|597360|P1|STARTED|Overall Study||123
246350|NCT00977704|597364|P1|NOT COMPLETED|Overall Study||0
246351|NCT00977704|597364|P1|COMPLETED|Overall Study||20
246352|NCT00977704|597364|P1|STARTED|Overall Study||20
246353|NCT00977769|597371|P3|NOT COMPLETED|Overall Study||0
246354|NCT00977769|597372|P2|NOT COMPLETED|Overall Study||0
246355|NCT00977769|597373|P1|NOT COMPLETED|Overall Study||0
246356|NCT00977769|597371|P3|COMPLETED|Overall Study||25
246357|NCT00977769|597372|P2|COMPLETED|Overall Study||26
246358|NCT00977769|597373|P1|COMPLETED|Overall Study||25
246359|NCT00977769|597371|P3|STARTED|Overall Study||25
246360|NCT00977769|597372|P2|STARTED|Overall Study||26
246361|NCT00977769|597373|P1|STARTED|Overall Study||25
246362|NCT00977808|597387|P1|NOT COMPLETED|Overall Study||1
246363|NCT00977808|597387|P1|COMPLETED|Overall Study||11
246364|NCT00977808|597387|P1|Completion of Closed-Loop Admission|Overall Study||11
246365|NCT00977808|597387|P1|Completion of Open-Loop Admission|Overall Study||12
246366|NCT00977808|597387|P1|STARTED|Overall Study||12
246367|NCT00977938|597396|P4|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||3
246368|NCT00977938|597397|P3|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||12
246369|NCT00977938|597398|P2|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||58
246370|NCT00977938|597399|P1|NOT COMPLETED|Observation (30-33 mo. Post Procedure)||51
246371|NCT00977938|597396|P4|COMPLETED|Observation (30-33 mo. Post Procedure)||781
246372|NCT00977938|597397|P3|COMPLETED|Observation (30-33 mo. Post Procedure)||784
246373|NCT00977938|597398|P2|COMPLETED|Observation (30-33 mo. Post Procedure)||4658
246374|NCT00977938|597399|P1|COMPLETED|Observation (30-33 mo. Post Procedure)||4732
246375|NCT00977938|597396|P4|STARTED|Observation (30-33 mo. Post Procedure)||784
246376|NCT00977938|597397|P3|STARTED|Observation (30-33 mo. Post Procedure)||796
246377|NCT00977938|597398|P2|STARTED|Observation (30-33 mo. Post Procedure)||4716
246378|NCT00977938|597399|P1|STARTED|Observation (30-33 mo. Post Procedure)||4783
246379|NCT00977938|597396|P4|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||61
246380|NCT00977938|597397|P3|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||46
246381|NCT00977938|597398|P2|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||225
246382|NCT00977938|597399|P1|NOT COMPLETED|Treatment (12-30 mo. Post Procedure)||237
246383|NCT00977938|597396|P4|COMPLETED|Treatment (12-30 mo. Post Procedure)||784
246384|NCT00977938|597397|P3|COMPLETED|Treatment (12-30 mo. Post Procedure)||796
246385|NCT00977938|597398|P2|COMPLETED|Treatment (12-30 mo. Post Procedure)||4716
246386|NCT00977938|597399|P1|COMPLETED|Treatment (12-30 mo. Post Procedure)||4783
246387|NCT00977938|597396|P4|STARTED|Treatment (12-30 mo. Post Procedure)||845
246388|NCT00977938|597397|P3|STARTED|Treatment (12-30 mo. Post Procedure)||842
246389|NCT00977938|597398|P2|STARTED|Treatment (12-30 mo. Post Procedure)||4941
246390|NCT00977938|597399|P1|STARTED|Treatment (12-30 mo. Post Procedure)||5020
246391|NCT00978029|597436|P3|NOT COMPLETED|Overall Study||6
246392|NCT00978029|597437|P2|NOT COMPLETED|Overall Study||3
246393|NCT00978029|597438|P1|NOT COMPLETED|Overall Study||1
246394|NCT00978029|597436|P3|COMPLETED|Overall Study||59
246395|NCT00978029|597437|P2|COMPLETED|Overall Study||63
246396|NCT00978029|597438|P1|COMPLETED|Overall Study||64
246397|NCT00978029|597436|P3|STARTED|Overall Study||65
246398|NCT00978029|597437|P2|STARTED|Overall Study||66
246399|NCT00978029|597438|P1|STARTED|Overall Study||65
246400|NCT00978042|597463|P2|NOT COMPLETED|Received Repeat Treatment||3
246401|NCT00978042|597464|P1|NOT COMPLETED|Received Repeat Treatment||43
246402|NCT00978042|597463|P2|COMPLETED|Received Repeat Treatment||23
246403|NCT00978042|597464|P1|COMPLETED|Received Repeat Treatment|Completed=Completed Repeat Treatment Follow-up|98
246404|NCT00978042|597463|P2|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|26
246405|NCT00978042|597464|P1|STARTED|Received Repeat Treatment|Participants who were deemed eligible for re-treatment.|141
246406|NCT00978042|597463|P2|NOT COMPLETED|Initial Treatment Period||15
246407|NCT00978042|597464|P1|NOT COMPLETED|Initial Treatment Period||61
246408|NCT00978042|597463|P2|COMPLETED|Initial Treatment Period||32
246409|NCT00978042|597464|P1|COMPLETED|Initial Treatment Period|Completed 24-month Follow-Up|174
246410|NCT00978042|597463|P2|MITT_treated With VOLUMA XC|Initial Treatment Period||35
246411|NCT00978042|597464|P1|MITT_treated With VOLUMA XC|Initial Treatment Period||235
246412|NCT00978042|597463|P2|STARTED|Initial Treatment Period||47
246413|NCT00978042|597464|P1|STARTED|Initial Treatment Period||235
246414|NCT00978120|597478|P4|NOT COMPLETED|Overall Study||2
246415|NCT00978120|597479|P3|NOT COMPLETED|Overall Study||3
246416|NCT00978120|597480|P2|NOT COMPLETED|Overall Study||0
246417|NCT00978120|597481|P1|NOT COMPLETED|Overall Study||2
246418|NCT00978120|597478|P4|COMPLETED|Overall Study||84
246419|NCT00978120|597479|P3|COMPLETED|Overall Study||84
246420|NCT00978120|597480|P2|COMPLETED|Overall Study||107
246421|NCT00978120|597481|P1|COMPLETED|Overall Study||108
246422|NCT00978120|597478|P4|STARTED|Overall Study||86
246423|NCT00978120|597479|P3|STARTED|Overall Study||87
246424|NCT00978120|597480|P2|STARTED|Overall Study||107
246425|NCT00978120|597481|P1|STARTED|Overall Study||110
246426|NCT00978341|597531|P2|NOT COMPLETED|Second Intervention||0
246427|NCT00978341|597532|P1|NOT COMPLETED|Second Intervention||0
246428|NCT00978341|597531|P2|COMPLETED|Second Intervention||7
246429|NCT00978341|597532|P1|COMPLETED|Second Intervention||7
246430|NCT00978341|597531|P2|STARTED|Second Intervention||7
246431|NCT00978341|597532|P1|STARTED|Second Intervention||7
246432|NCT00978341|597531|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
246433|NCT00978341|597532|P1|NOT COMPLETED|Washout Period of 2 Weeks||1
246434|NCT00978341|597531|P2|COMPLETED|Washout Period of 2 Weeks||7
246435|NCT00978341|597532|P1|COMPLETED|Washout Period of 2 Weeks||7
246436|NCT00978341|597531|P2|STARTED|Washout Period of 2 Weeks||7
246437|NCT00978341|597532|P1|STARTED|Washout Period of 2 Weeks||8
246438|NCT00978341|597531|P2|NOT COMPLETED|First Intervention||0
246439|NCT00978341|597532|P1|NOT COMPLETED|First Intervention||0
246440|NCT00978341|597531|P2|COMPLETED|First Intervention||7
246441|NCT00978341|597532|P1|COMPLETED|First Intervention||8
246442|NCT00978341|597531|P2|STARTED|First Intervention||7
246443|NCT00978341|597532|P1|STARTED|First Intervention||8
246444|NCT00978380|597550|P1|NOT COMPLETED|Overall Study||19
246445|NCT00978380|597550|P1|COMPLETED|Overall Study||44
246446|NCT00978380|597550|P1|STARTED|Overall Study||63
246447|NCT00978432|597559|P3|NOT COMPLETED|Overall Study||5
246448|NCT00978432|597560|P2|NOT COMPLETED|Overall Study||1
246449|NCT00978432|597561|P1|NOT COMPLETED|Overall Study||3
246450|NCT00978432|597559|P3|COMPLETED|Overall Study||13
246451|NCT00978432|597560|P2|COMPLETED|Overall Study||4
246452|NCT00978432|597561|P1|COMPLETED|Overall Study||7
246453|NCT00978432|597559|P3|STARTED|Overall Study||18
246454|NCT00978432|597560|P2|STARTED|Overall Study||5
246455|NCT00978432|597561|P1|STARTED|Overall Study||10
246456|NCT00978445|597581|P2|NOT COMPLETED|Overall Study||1
246457|NCT00978445|597582|P1|NOT COMPLETED|Overall Study||2
246458|NCT00978445|597581|P2|COMPLETED|Overall Study||12
246459|NCT00978445|597582|P1|COMPLETED|Overall Study||10
246460|NCT00978445|597581|P2|STARTED|Overall Study||13
246461|NCT00978445|597582|P1|STARTED|Overall Study||12
246462|NCT00978562|597589|P1|NOT COMPLETED|Overall Study||0
246463|NCT00978562|597589|P1|COMPLETED|Overall Study||7
246464|NCT00978562|597589|P1|STARTED|Overall Study||7
246465|NCT00978627|597596|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||9
246466|NCT00978627|597597|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||21
246467|NCT00978627|597596|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||113
246468|NCT00978627|597597|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3645)||233
246469|NCT00978627|597596|P2|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Thirty four subjects from main trial did not continue into extension trial|122
246470|NCT00978627|597597|P1|STARTED|Extension: Week 27 to 52 (NN5401-3645)|Sixty six subjects from main trial did not continue into extension trial|254
246471|NCT00978627|597596|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||26
246472|NCT00978627|597597|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3594)||46
246473|NCT00978627|597596|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||156
246474|NCT00978627|597597|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3594)||320
246475|NCT00978627|597596|P2|Exposed|Main: Week 0 to 26 (NN5401-3594)|Two subjects withdrew prior to exposure to trial products|180
246476|NCT00978627|597597|P1|Exposed|Main: Week 0 to 26 (NN5401-3594)|Four subjects withdrew prior to exposure to trial products|362
246477|NCT00978627|597596|P2|STARTED|Main: Week 0 to 26 (NN5401-3594)||182
246478|NCT00978627|597597|P1|STARTED|Main: Week 0 to 26 (NN5401-3594)||366
246479|NCT00978731|597623|P4|NOT COMPLETED|Overall Study||4
246480|NCT00978731|597624|P3|NOT COMPLETED|Overall Study||5
246481|NCT00978731|597625|P2|NOT COMPLETED|Overall Study||15
246482|NCT00978731|597626|P1|NOT COMPLETED|Overall Study||22
246483|NCT00978731|597623|P4|COMPLETED|Overall Study||0
246484|NCT00978731|597624|P3|COMPLETED|Overall Study||0
246485|NCT00978731|597625|P2|COMPLETED|Overall Study||0
246486|NCT00978731|597626|P1|COMPLETED|Overall Study||0
246487|NCT00978731|597623|P4|STARTED|Overall Study||4
246488|NCT00978731|597624|P3|STARTED|Overall Study||5
246489|NCT00978731|597625|P2|STARTED|Overall Study||15
246490|NCT00978731|597626|P1|STARTED|Overall Study||22
246491|NCT00978757|597666|P2|NOT COMPLETED|Overall Study||3
246492|NCT00978757|597667|P1|NOT COMPLETED|Overall Study||1
246493|NCT00978757|597666|P2|COMPLETED|Overall Study|Junio 2008|17
246494|NCT00978757|597667|P1|COMPLETED|Overall Study|Junio 2008|21
246495|NCT00978757|597666|P2|STARTED|Overall Study|Junio 2001|20
246496|NCT00978757|597667|P1|STARTED|Overall Study|Junio 2001|22
246497|NCT00979017|597673|P1|NOT COMPLETED|Overall Study||0
246498|NCT00979017|597673|P1|COMPLETED|Overall Study||41
246499|NCT00979017|597673|P1|STARTED|Overall Study||41
246500|NCT00979069|597683|P2|NOT COMPLETED|Overall Study||2
246501|NCT00979069|597684|P1|NOT COMPLETED|Overall Study||0
246502|NCT00979069|597683|P2|COMPLETED|Overall Study||8
246503|NCT00979069|597684|P1|COMPLETED|Overall Study||10
246504|NCT00979069|597683|P2|STARTED|Overall Study||10
246505|NCT00979069|597684|P1|STARTED|Overall Study||10
246506|NCT00979121|597692|P2|NOT COMPLETED|Overall Study||0
246507|NCT00979121|597693|P1|NOT COMPLETED|Overall Study||0
246508|NCT00979121|597692|P2|COMPLETED|Overall Study||366
246509|NCT00979121|597693|P1|COMPLETED|Overall Study||379
246510|NCT00979121|597692|P2|STARTED|Overall Study||366
246511|NCT00979121|597693|P1|STARTED|Overall Study||379
246512|NCT00979199|597709|P1|NOT COMPLETED|Overall Study||222
246513|NCT00979199|597709|P1|COMPLETED|Overall Study||475
246514|NCT00979199|597709|P1|STARTED|Overall Study||697
246515|NCT00979212|597715|P2|NOT COMPLETED|Overall Study||8
246516|NCT00979212|597716|P1|NOT COMPLETED|Overall Study||2
246517|NCT00979212|597715|P2|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|39
246518|NCT00979212|597716|P1|COMPLETED|Overall Study|Subjects with data available for primary analysis are considered to have completed the study.|22
246519|NCT00979212|597715|P2|STARTED|Overall Study||47
246520|NCT00979212|597716|P1|STARTED|Overall Study||24
246521|NCT00985439|597738|P4|NOT COMPLETED|Overall Study||0
246522|NCT00985439|597739|P3|NOT COMPLETED|Overall Study||1
246523|NCT00985439|597740|P2|NOT COMPLETED|Overall Study||0
246524|NCT00985439|597741|P1|NOT COMPLETED|Overall Study||0
246525|NCT00985439|597738|P4|COMPLETED|Overall Study||51
246526|NCT00985439|597739|P3|COMPLETED|Overall Study||50
246527|NCT00985439|597740|P2|COMPLETED|Overall Study||51
246528|NCT00985439|597741|P1|COMPLETED|Overall Study||49
246529|NCT00985439|597738|P4|STARTED|Overall Study||51
246530|NCT00985439|597739|P3|STARTED|Overall Study||51
246531|NCT00985439|597740|P2|STARTED|Overall Study||51
246532|NCT00985439|597741|P1|STARTED|Overall Study||49
246533|NCT00985491|597751|P1|NOT COMPLETED|Overall Study||19
246534|NCT00985491|597751|P1|COMPLETED|Overall Study|43 subjects received a device, 27 subjects completed 12 month implant period|27
246535|NCT00985491|597751|P1|Received Device|Overall Study||43
246536|NCT00985491|597751|P1|STARTED|Overall Study|46 subjects underwent an attempted implantation procedure|46
246537|NCT00985504|597758|P2|NOT COMPLETED|Optimization Period||23
246538|NCT00985504|597759|P1|NOT COMPLETED|Optimization Period||26
246539|NCT00985504|597758|P2|COMPLETED|Optimization Period||204
246540|NCT00985504|597759|P1|COMPLETED|Optimization Period||203
246541|NCT00985504|597758|P2|STARTED|Optimization Period||227
246542|NCT00985504|597759|P1|STARTED|Optimization Period||229
246543|NCT00985504|597758|P2|NOT COMPLETED|Acute Treatment Period||12
246544|NCT00985504|597759|P1|NOT COMPLETED|Acute Treatment Period||15
246545|NCT00985504|597758|P2|COMPLETED|Acute Treatment Period||227
246546|NCT00985504|597759|P1|COMPLETED|Acute Treatment Period||229
246547|NCT00985504|597758|P2|STARTED|Acute Treatment Period||239
246548|NCT00985504|597759|P1|STARTED|Acute Treatment Period||244
246549|NCT00985543|597785|P1|NOT COMPLETED|Overall Study||0
246550|NCT00985543|597785|P1|COMPLETED|Overall Study||22
246551|NCT00985543|597785|P1|STARTED|Overall Study||22
246552|NCT00985673|597800|P6|NOT COMPLETED|Overall Study||6
246553|NCT00985673|597801|P5|NOT COMPLETED|Overall Study||8
246554|NCT00985673|597802|P4|NOT COMPLETED|Overall Study||12
246555|NCT00985673|597803|P3|NOT COMPLETED|Overall Study||12
246556|NCT00985673|597804|P2|NOT COMPLETED|Overall Study||11
246557|NCT00985673|597805|P1|NOT COMPLETED|Overall Study||7
246558|NCT00985673|597800|P6|COMPLETED|Overall Study||96
246559|NCT00985673|597801|P5|COMPLETED|Overall Study||93
246560|NCT00985673|597802|P4|COMPLETED|Overall Study||88
246561|NCT00985673|597803|P3|COMPLETED|Overall Study||90
246562|NCT00985673|597804|P2|COMPLETED|Overall Study||93
246563|NCT00985673|597805|P1|COMPLETED|Overall Study||95
246564|NCT00985673|597800|P6|STARTED|Overall Study||102
246565|NCT00985673|597801|P5|STARTED|Overall Study||101
246566|NCT00985673|597802|P4|STARTED|Overall Study||100
246567|NCT00985673|597803|P3|STARTED|Overall Study||102
246568|NCT00985673|597804|P2|STARTED|Overall Study||104
246569|NCT00985673|597805|P1|STARTED|Overall Study||102
246570|NCT00986102|598060|P4|NOT COMPLETED|Overall Study||1
246571|NCT00986102|598061|P3|NOT COMPLETED|Overall Study||0
246572|NCT00986102|598062|P2|NOT COMPLETED|Overall Study||2
246573|NCT00986102|598063|P1|NOT COMPLETED|Overall Study||1
246574|NCT00986102|598060|P4|COMPLETED|Overall Study||66
246575|NCT00986102|598061|P3|COMPLETED|Overall Study||19
246576|NCT00986102|598062|P2|COMPLETED|Overall Study||75
246577|NCT00986102|598063|P1|COMPLETED|Overall Study||52
246578|NCT00986102|598060|P4|STARTED|Overall Study|Number of participants who received study medication|67
246579|NCT00986102|598061|P3|STARTED|Overall Study|Number of participants who received study medication|19
246580|NCT00986102|598062|P2|STARTED|Overall Study|Number of participants who received study medication|77
246581|NCT00986102|598063|P1|STARTED|Overall Study|Number of participants who received study medication|53
246582|NCT00986154|598111|P2|NOT COMPLETED|Overall Study||194
246583|NCT00986154|598112|P1|NOT COMPLETED|Overall Study||206
246584|NCT00986154|598111|P2|COMPLETED|Overall Study||3955
246585|NCT00986154|598112|P1|COMPLETED|Overall Study||3937
246586|NCT00986154|598111|P2|Safety Analysis Set (Received Drug)|Overall Study||4122
246587|NCT00986154|598112|P1|Safety Analysis Set (Received Drug)|Overall Study||4118
246588|NCT00986154|598111|P2|STARTED|Overall Study||4149
246589|NCT00986154|598112|P1|STARTED|Overall Study||4143
246590|NCT00986180|598124|P2|NOT COMPLETED|Overall Study||56
246591|NCT00986180|598125|P1|NOT COMPLETED|Overall Study||44
246592|NCT00986180|598124|P2|COMPLETED|Overall Study||268
246593|NCT00986180|598125|P1|COMPLETED|Overall Study||277
246594|NCT00986180|598124|P2|STARTED|Overall Study||324
246595|NCT00986180|598125|P1|STARTED|Overall Study||321
246596|NCT00986232|598205|P4|NOT COMPLETED|Overall Study||20
246597|NCT00986232|598206|P3|NOT COMPLETED|Overall Study||35
246598|NCT00986232|598207|P2|NOT COMPLETED|Overall Study||50
246599|NCT00986232|598208|P1|NOT COMPLETED|Overall Study||51
246600|NCT00986232|598205|P4|COMPLETED|Overall Study||370
246601|NCT00986232|598206|P3|COMPLETED|Overall Study||346
246602|NCT00986232|598207|P2|COMPLETED|Overall Study||343
246603|NCT00986232|598208|P1|COMPLETED|Overall Study||336
246604|NCT00986232|598205|P4|Vaccination Visit 2|Overall Study||0
246605|NCT00986232|598206|P3|Vaccination Visit 2|Overall Study||360
246606|NCT00986232|598207|P2|Vaccination Visit 2|Overall Study||365
246607|NCT00986232|598208|P1|Vaccination Visit 2|Overall Study||360
246608|NCT00986232|598205|P4|Vaccination Visit 1|Overall Study||390
246609|NCT00986232|598206|P3|Vaccination Visit 1|Overall Study||381
246610|NCT00986232|598207|P2|Vaccination Visit 1|Overall Study||393
246611|NCT00986232|598208|P1|Vaccination Visit 1|Overall Study||387
246612|NCT00986232|598205|P4|STARTED|Overall Study|Excludes 1 patient who was randomized to receive M-M-R™ II + PUVV, but was not vaccinated.|390
246613|NCT00986232|598206|P3|STARTED|Overall Study||381
246614|NCT00986232|598207|P2|STARTED|Overall Study|Excludes 1 patient who was randomized to receive ProQuad (Middle Dose), but was not vaccinated.|393
246615|NCT00986232|598208|P1|STARTED|Overall Study||387
246616|NCT00986245|598280|P2|NOT COMPLETED|Second Intervention||1
246617|NCT00986245|598281|P1|NOT COMPLETED|Second Intervention||2
246618|NCT00986245|598280|P2|COMPLETED|Second Intervention||32
246619|NCT00986245|598281|P1|COMPLETED|Second Intervention||29
246620|NCT00986245|598280|P2|STARTED|Second Intervention||33
246621|NCT00986245|598281|P1|STARTED|Second Intervention||31
246622|NCT00986245|598280|P2|NOT COMPLETED|First Intervention||8
246623|NCT00986245|598281|P1|NOT COMPLETED|First Intervention||10
246624|NCT00986245|598280|P2|COMPLETED|First Intervention||33
246625|NCT00986245|598281|P1|COMPLETED|First Intervention||31
246626|NCT00986245|598280|P2|STARTED|First Intervention||41
246627|NCT00986245|598281|P1|STARTED|First Intervention||41
246628|NCT00986258|598314|P1|NOT COMPLETED|Maintenance Period||9
246629|NCT00986258|598314|P1|COMPLETED|Maintenance Period||93
246630|NCT00986258|598314|P1|STARTED|Maintenance Period||102
246631|NCT00986258|598314|P1|NOT COMPLETED|Titration and Optimal Dose Period||23
246632|NCT00986258|598314|P1|COMPLETED|Titration and Optimal Dose Period||102
246633|NCT00986258|598314|P1|STARTED|Titration and Optimal Dose Period||125
246634|NCT00986258|598314|P1|NOT COMPLETED|Observation Period||11
246635|NCT00986258|598314|P1|COMPLETED|Observation Period||125
246636|NCT00986258|598314|P1|STARTED|Observation Period||136
246637|NCT00986349|598342|P1|NOT COMPLETED|Overall Study||7
246638|NCT00986349|598342|P1|COMPLETED|Overall Study||16
246639|NCT00986349|598342|P1|Early Explant|Overall Study||4
246640|NCT00986349|598342|P1|Successful Implant Procedure|Overall Study|successful device implant procedure|20
246641|NCT00986349|598342|P1|STARTED|Overall Study|attempted implant procedures|23
246642|NCT00986362|598357|P2|NOT COMPLETED|Overall Study||1
246643|NCT00986362|598358|P1|NOT COMPLETED|Overall Study||2
246644|NCT00986362|598357|P2|COMPLETED|Overall Study|7 eyes completed the study (in 7 subjects).|7
246645|NCT00986362|598358|P1|COMPLETED|Overall Study|14 eyes completed the study (in 14 subjects).|14
246646|NCT00986362|598357|P2|STARTED|Overall Study|8 eyes randomized and treated (in 8 subjects).|8
246647|NCT00986362|598358|P1|STARTED|Overall Study|16 eyes randomized and treated (in 15 subjects).|16
246648|NCT00986401|598366|P2|NOT COMPLETED|Period 2||0
246649|NCT00986401|598367|P1|NOT COMPLETED|Period 2||0
246650|NCT00986401|598366|P2|COMPLETED|Period 2||21
246651|NCT00986401|598367|P1|COMPLETED|Period 2||22
246652|NCT00986401|598366|P2|STARTED|Period 2||21
246653|NCT00986401|598367|P1|STARTED|Period 2||22
246654|NCT00986401|598366|P2|NOT COMPLETED|Period 1||1
246655|NCT00986401|598367|P1|NOT COMPLETED|Period 1||0
246656|NCT00986401|598366|P2|COMPLETED|Period 1||21
246657|NCT00986401|598367|P1|COMPLETED|Period 1||22
246658|NCT00986401|598366|P2|STARTED|Period 1||22
246659|NCT00986401|598367|P1|STARTED|Period 1||22
246660|NCT00986427|598378|P2|NOT COMPLETED|Overall Study||0
246661|NCT00986427|598379|P1|NOT COMPLETED|Overall Study||4
246662|NCT00986427|598378|P2|COMPLETED|Overall Study||12
246663|NCT00986427|598379|P1|COMPLETED|Overall Study||8
246664|NCT00986427|598378|P2|STARTED|Overall Study||12
246665|NCT00986427|598379|P1|STARTED|Overall Study||12
246666|NCT00986453|598393|P1|NOT COMPLETED|Overall Study||2
246667|NCT00986453|598393|P1|COMPLETED|Overall Study||43
246668|NCT00986453|598393|P1|STARTED|Overall Study||45
246669|NCT00986479|598409|P2|NOT COMPLETED|Period 2||0
246670|NCT00986479|598410|P1|NOT COMPLETED|Period 2||0
246671|NCT00986479|598409|P2|COMPLETED|Period 2||10
246672|NCT00986479|598410|P1|COMPLETED|Period 2||10
246673|NCT00986479|598409|P2|STARTED|Period 2||10
246674|NCT00986479|598410|P1|STARTED|Period 2||10
246675|NCT00986479|598409|P2|NOT COMPLETED|Period 1||0
246676|NCT00986479|598410|P1|NOT COMPLETED|Period 1||2
246677|NCT00986479|598409|P2|COMPLETED|Period 1||10
246678|NCT00986479|598410|P1|COMPLETED|Period 1||10
246679|NCT00986479|598409|P2|STARTED|Period 1||10
246680|NCT00986479|598410|P1|STARTED|Period 1||12
246681|NCT00986544|598442|P2|NOT COMPLETED|Overall Study||0
246682|NCT00986544|598443|P1|NOT COMPLETED|Overall Study||0
246683|NCT00986544|598442|P2|COMPLETED|Overall Study||53
246684|NCT00986544|598443|P1|COMPLETED|Overall Study||53
246685|NCT00986544|598442|P2|STARTED|Overall Study||53
246686|NCT00986544|598443|P1|STARTED|Overall Study||53
246687|NCT00986570|598451|P1|NOT COMPLETED|Overall Study||7
246688|NCT00986570|598451|P1|COMPLETED|Overall Study||114
246689|NCT00986570|598451|P1|STARTED|Overall Study||121
246690|NCT00986583|598457|P2|NOT COMPLETED|Overall Study||0
246691|NCT00986583|598458|P1|NOT COMPLETED|Overall Study||0
246692|NCT00986583|598457|P2|COMPLETED|Overall Study||32
246693|NCT00986583|598458|P1|COMPLETED|Overall Study||38
246694|NCT00986583|598457|P2|STARTED|Overall Study||32
246695|NCT00986583|598458|P1|STARTED|Overall Study||38
246696|NCT00986674|598477|P3|NOT COMPLETED|Overall Study||48
246697|NCT00986674|598478|P2|NOT COMPLETED|Overall Study||45
246698|NCT00986674|598479|P1|NOT COMPLETED|Overall Study||47
246699|NCT00986674|598477|P3|COMPLETED|Overall Study||0
246700|NCT00986674|598478|P2|COMPLETED|Overall Study||0
246701|NCT00986674|598479|P1|COMPLETED|Overall Study||0
246702|NCT00986674|598477|P3|Eligible and Treated|Overall Study||47
246703|NCT00986674|598478|P2|Eligible and Treated|Overall Study||41
246704|NCT00986674|598479|P1|Eligible and Treated|Overall Study||39
246705|NCT00986674|598477|P3|Treated|Overall Study||47
246706|NCT00986674|598478|P2|Treated|Overall Study||42
246707|NCT00986674|598479|P1|Treated|Overall Study||43
246708|NCT00986674|598477|P3|STARTED|Overall Study||48
246709|NCT00986674|598478|P2|STARTED|Overall Study||45
246710|NCT00986674|598479|P1|STARTED|Overall Study||47
246711|NCT00986856|598495|P2|NOT COMPLETED|Overall Study||0
246712|NCT00986856|598496|P1|NOT COMPLETED|Overall Study||0
246713|NCT00986856|598495|P2|COMPLETED|Overall Study||16
246714|NCT00986856|598496|P1|COMPLETED|Overall Study||42
246715|NCT00986856|598495|P2|STARTED|Overall Study||16
246716|NCT00986856|598496|P1|STARTED|Overall Study||42
246717|NCT00986921|598518|P2|NOT COMPLETED|Overall Study||0
246718|NCT00986921|598519|P1|NOT COMPLETED|Overall Study||1
246719|NCT00986921|598518|P2|COMPLETED|Overall Study||25
246720|NCT00986921|598519|P1|COMPLETED|Overall Study||24
246721|NCT00986921|598518|P2|STARTED|Overall Study||25
246722|NCT00986921|598519|P1|STARTED|Overall Study||25
246723|NCT00986947|598529|P1|NOT COMPLETED|Overall Study||20
246724|NCT00986947|598529|P1|COMPLETED|Overall Study||0
246725|NCT00986947|598529|P1|STARTED|Overall Study||20
246726|NCT00986960|598536|P2|NOT COMPLETED|Overall Study||0
246727|NCT00986960|598537|P1|NOT COMPLETED|Overall Study||0
246728|NCT00986960|598536|P2|COMPLETED|Overall Study||0
246729|NCT00986960|598537|P1|COMPLETED|Overall Study||0
246730|NCT00986960|598536|P2|STARTED|Overall Study||0
246731|NCT00986960|598537|P1|STARTED|Overall Study||0
246732|NCT00986973|598543|P1|NOT COMPLETED|Overall Study||1
246733|NCT00986973|598543|P1|COMPLETED|Overall Study|One subject was withdrawn from the study due to poor compliance with KUVAN therapy.|5
246734|NCT00986973|598543|P1|STARTED|Overall Study||6
246735|NCT00986986|598555|P2|NOT COMPLETED|Overall Study||1
246736|NCT00986986|598556|P1|NOT COMPLETED|Overall Study||0
246737|NCT00986986|598555|P2|COMPLETED|Overall Study||9
246738|NCT00986986|598556|P1|COMPLETED|Overall Study||10
246739|NCT00986986|598555|P2|STARTED|Overall Study||10
246740|NCT00986986|598556|P1|STARTED|Overall Study||10
246741|NCT00986999|598566|P1|NOT COMPLETED|Overall Study||1
246742|NCT00986999|598566|P1|COMPLETED|Overall Study||6
246743|NCT00986999|598566|P1|STARTED|Overall Study||7
246744|NCT00987337|598578|P3|NOT COMPLETED|Overall Study||51
246745|NCT00987337|598579|P2|NOT COMPLETED|Overall Study||55
246746|NCT00987337|598580|P1|NOT COMPLETED|Overall Study||57
246747|NCT00987337|598578|P3|COMPLETED|Overall Study||45
246748|NCT00987337|598579|P2|COMPLETED|Overall Study||41
246749|NCT00987337|598580|P1|COMPLETED|Overall Study||39
246750|NCT00987337|598578|P3|STARTED|Overall Study||96
246751|NCT00987337|598579|P2|STARTED|Overall Study||96
246752|NCT00987337|598580|P1|STARTED|Overall Study||96
246753|NCT00987402|598626|P2|NOT COMPLETED|Overall Study||98
246754|NCT00987402|598627|P1|NOT COMPLETED|Overall Study||86
246755|NCT00987402|598626|P2|COMPLETED|Overall Study|98 patients did not have sufficient data|1537
246756|NCT00987402|598627|P1|COMPLETED|Overall Study|86 patients did not have some data, and could not be evaluated|1596
246757|NCT00987402|598626|P2|STARTED|Overall Study|January 2007 with crossover every 2 months|1635
246758|NCT00987402|598627|P1|STARTED|Overall Study|January 2007, with crossover every 2 months|1682
246759|NCT00987415|598635|P2|NOT COMPLETED|Overall Study||9
246760|NCT00987415|598636|P1|NOT COMPLETED|Overall Study||9
246761|NCT00987415|598635|P2|COMPLETED|Overall Study||116
246762|NCT00987415|598636|P1|COMPLETED|Overall Study||119
246763|NCT00987415|598635|P2|STARTED|Overall Study||125
246764|NCT00987415|598636|P1|STARTED|Overall Study||128
246765|NCT00987467|598650|P1|NOT COMPLETED|Overall Study||2
246766|NCT00987467|598650|P1|COMPLETED|Overall Study||10
246767|NCT00987467|598650|P1|STARTED|Overall Study||12
246768|NCT00987558|598655|P2|NOT COMPLETED|Overall Study||5
246769|NCT00987558|598656|P1|NOT COMPLETED|Overall Study||1
246770|NCT00987558|598655|P2|COMPLETED|Overall Study||12
246771|NCT00987558|598656|P1|COMPLETED|Overall Study||12
246772|NCT00987558|598655|P2|Eslicarbazepine Acetate + Simvastatin|Overall Study||17
246773|NCT00987558|598656|P1|Eslicarbazepine Acetate + Simvastatin|Overall Study||13
246774|NCT00987558|598655|P2|Washout|Overall Study||12
246775|NCT00987558|598656|P1|Washout|Overall Study||13
246776|NCT00987558|598655|P2|Simvastatin|Overall Study||12
246777|NCT00987558|598656|P1|Simvastatin|Overall Study||13
246778|NCT00987558|598655|P2|STARTED|Overall Study||17
246779|NCT00987558|598656|P1|STARTED|Overall Study||13
246780|NCT00987623|598671|P2|NOT COMPLETED|Overall Study||3
246781|NCT00987623|598672|P1|NOT COMPLETED|Overall Study||5
246782|NCT00987623|598671|P2|COMPLETED|Overall Study||151
246783|NCT00987623|598672|P1|COMPLETED|Overall Study||140
246784|NCT00987623|598671|P2|STARTED|Overall Study||154
246785|NCT00987623|598672|P1|STARTED|Overall Study||145
246786|NCT00987727|598680|P2|NOT COMPLETED|Overall Study||7
246787|NCT00987727|598681|P1|NOT COMPLETED|Overall Study||5
246788|NCT00987727|598680|P2|COMPLETED|Overall Study||34
246789|NCT00987727|598681|P1|COMPLETED|Overall Study||36
246790|NCT00987727|598680|P2|STARTED|Overall Study||41
246791|NCT00987727|598681|P1|STARTED|Overall Study||41
246792|NCT00987831|598692|P3|NOT COMPLETED|Overall Study||0
246793|NCT00987831|598693|P2|NOT COMPLETED|Overall Study||3
246794|NCT00987831|598694|P1|NOT COMPLETED|Overall Study||1
246795|NCT00987831|598692|P3|COMPLETED|Overall Study|Anyone who entered this arm completed it the same day|62
246796|NCT00987831|598693|P2|COMPLETED|Overall Study|all controls returned for two visits|52
246797|NCT00987831|598694|P1|COMPLETED|Overall Study|40 patients completed in 6 months. 1 patient did not meet completion definition in 12 months.|40
246798|NCT00987831|598692|P3|STARTED|Overall Study|Anyone who entered this arm completed it the same day|62
246799|NCT00987831|598693|P2|STARTED|Overall Study|52 healthy controls donated biomarkers on two occasions in order to verify biomarkers ranges|55
246800|NCT00987831|598694|P1|STARTED|Overall Study|41 patients improved after depomedrol, if not improved, treated and moved to Group B|41
246801|NCT00987935|598712|P9|NOT COMPLETED|Overall Study||32
246802|NCT00987935|598713|P8|NOT COMPLETED|Overall Study||62
246803|NCT00987935|598714|P7|NOT COMPLETED|Overall Study||15
246804|NCT00987935|598715|P6|NOT COMPLETED|Overall Study||3
246805|NCT00987935|598716|P5|NOT COMPLETED|Overall Study||7
246806|NCT00987935|598717|P4|NOT COMPLETED|Overall Study||3
246807|NCT00987935|598718|P3|NOT COMPLETED|Overall Study||3
246808|NCT00987935|598719|P2|NOT COMPLETED|Overall Study||3
246809|NCT00987935|598720|P1|NOT COMPLETED|Overall Study||4
246810|NCT00987935|598712|P9|COMPLETED|Overall Study||0
246811|NCT00987935|598713|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
246812|NCT00987935|598714|P7|COMPLETED|Overall Study|On-treatment at analysis cut-off date (16 July 2014).|1
246813|NCT00987935|598715|P6|COMPLETED|Overall Study||0
246814|NCT00987935|598716|P5|COMPLETED|Overall Study||0
246815|NCT00987935|598717|P4|COMPLETED|Overall Study||0
246816|NCT00987935|598718|P3|COMPLETED|Overall Study||0
246817|NCT00987935|598719|P2|COMPLETED|Overall Study||0
246818|NCT00987935|598720|P1|COMPLETED|Overall Study||0
246819|NCT00987935|598712|P9|STARTED|Overall Study||32
246820|NCT00987935|598713|P8|STARTED|Overall Study||63
246821|NCT00987935|598714|P7|STARTED|Overall Study||16
246822|NCT00987935|598715|P6|STARTED|Overall Study||3
246823|NCT00987935|598716|P5|STARTED|Overall Study||7
246824|NCT00987935|598717|P4|STARTED|Overall Study||3
246825|NCT00987935|598718|P3|STARTED|Overall Study||3
246826|NCT00987935|598719|P2|STARTED|Overall Study||3
246827|NCT00987935|598720|P1|STARTED|Overall Study||4
246828|NCT00987948|598773|P1|NOT COMPLETED|Overall Study||3
246829|NCT00987948|598773|P1|COMPLETED|Overall Study||12
246830|NCT00987948|598773|P1|STARTED|Overall Study||15
246831|NCT00988065|598781|P3|NOT COMPLETED|Overall Study||15
246832|NCT00988065|598782|P2|NOT COMPLETED|Overall Study||23
246833|NCT00988065|598783|P1|NOT COMPLETED|Overall Study||13
246834|NCT00988065|598781|P3|COMPLETED|Overall Study||135
246835|NCT00988065|598782|P2|COMPLETED|Overall Study||127
246836|NCT00988065|598783|P1|COMPLETED|Overall Study||135
246837|NCT00988065|598781|P3|Received Third Randomized Dose|Overall Study||135
246838|NCT00988065|598782|P2|Received Third Randomized Dose|Overall Study||127
246839|NCT00988065|598783|P1|Received Third Randomized Dose|Overall Study||135
246840|NCT00988065|598781|P3|Received Second Randomized Dose|Overall Study||145
246841|NCT00988065|598782|P2|Received Second Randomized Dose|Overall Study||135
246842|NCT00988065|598783|P1|Received Second Randomized Dose|Overall Study||139
246843|NCT00988065|598781|P3|Received First Randomized Dose|Overall Study||150
246844|NCT00988065|598782|P2|Received First Randomized Dose|Overall Study||150
246845|NCT00988065|598783|P1|Received First Randomized Dose|Overall Study||148
246846|NCT00988065|598781|P3|STARTED|Overall Study|Randomized to double-blind treatment|150
246847|NCT00988065|598782|P2|STARTED|Overall Study|Randomized to double-blind treatment|150
246848|NCT00988065|598783|P1|STARTED|Overall Study|Randomized to double-blind treatment|148
246849|NCT00988091|598805|P2|NOT COMPLETED|Open-label Period||33
246850|NCT00988091|598806|P1|NOT COMPLETED|Open-label Period||21
246851|NCT00988091|598805|P2|COMPLETED|Open-label Period||192
246852|NCT00988091|598806|P1|COMPLETED|Open-label Period||208
246853|NCT00988091|598805|P2|STARTED|Open-label Period|Participation in the Open-label period was optional.|225
246854|NCT00988091|598806|P1|STARTED|Open-label Period|Participation in the Open-label period was optional.|229
246855|NCT00988091|598805|P2|NOT COMPLETED|Double-blind Period||47
246856|NCT00988091|598806|P1|NOT COMPLETED|Double-blind Period||43
246857|NCT00988091|598805|P2|COMPLETED|Double-blind Period||251
246858|NCT00988091|598806|P1|COMPLETED|Double-blind Period||255
246859|NCT00988091|598805|P2|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|295
246860|NCT00988091|598806|P1|Intent to Treat Population|Double-blind Period|ITT population excludes participants from one site which was closed for non-compliance.|294
246861|NCT00988091|598805|P2|STARTED|Double-blind Period||298
246862|NCT00988091|598806|P1|STARTED|Double-blind Period||298
246863|NCT00988117|598825|P1|NOT COMPLETED|9.5 mg/24 Hours From Week 4 to 12||2
246864|NCT00988117|598825|P1|COMPLETED|9.5 mg/24 Hours From Week 4 to 12||12
246865|NCT00988117|598825|P1|STARTED|9.5 mg/24 Hours From Week 4 to 12||14
246866|NCT00988117|598825|P1|NOT COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||1
246867|NCT00988117|598825|P1|COMPLETED|4.6 mg/24 Hours From Baseline to Week 4||14
246868|NCT00988117|598825|P1|STARTED|4.6 mg/24 Hours From Baseline to Week 4||15
246869|NCT00988143|598835|P3|NOT COMPLETED|Overall Study||0
246870|NCT00988143|598836|P2|NOT COMPLETED|Overall Study||0
246871|NCT00988143|598837|P1|NOT COMPLETED|Overall Study||0
246872|NCT00988143|598835|P3|COMPLETED|Overall Study||190
246873|NCT00988143|598836|P2|COMPLETED|Overall Study||190
246874|NCT00988143|598837|P1|COMPLETED|Overall Study||220
246875|NCT00988143|598835|P3|STARTED|Overall Study||190
246876|NCT00988143|598836|P2|STARTED|Overall Study||190
246877|NCT00988143|598837|P1|STARTED|Overall Study||220
246878|NCT00988156|598871|P2|NOT COMPLETED|Overall Study||20
246879|NCT00988156|598872|P1|NOT COMPLETED|Overall Study||17
246880|NCT00988156|598871|P2|COMPLETED|Overall Study||135
246881|NCT00988156|598872|P1|COMPLETED|Overall Study||132
246882|NCT00988156|598871|P2|Safety Set|Overall Study||134
246883|NCT00988156|598872|P1|Safety Set|Overall Study||129
246884|NCT00988156|598871|P2|Per Protocol Set (PP)|Overall Study||97
246885|NCT00988156|598872|P1|Per Protocol Set (PP)|Overall Study||101
246886|NCT00988156|598871|P2|Intention-to-Treat Set (ITT)|Overall Study||134
246887|NCT00988156|598872|P1|Intention-to-Treat Set (ITT)|Overall Study||129
246888|NCT00988156|598871|P2|STARTED|Overall Study||155
246889|NCT00988156|598872|P1|STARTED|Overall Study||149
246890|NCT00988169|598880|P1|NOT COMPLETED|Overall Study||1
246891|NCT00988169|598880|P1|COMPLETED|Overall Study||5
246892|NCT00988169|598880|P1|STARTED|Overall Study||6
246893|NCT00988208|598886|P2|NOT COMPLETED|Overall Study||438
246894|NCT00988208|598887|P1|NOT COMPLETED|Overall Study||431
246895|NCT00988208|598886|P2|COMPLETED|Overall Study|DPL Completed = kept on treatment with docetaxel/prednisone; Lenalidomide discontinued in DPL arm|95
246896|NCT00988208|598887|P1|COMPLETED|Overall Study|DP Completed = kept on treatment with docetaxel/prednisone; Placebo was discontinued in DP arm|95
246897|NCT00988208|598886|P2|Treated|Overall Study||525
246898|NCT00988208|598887|P1|Treated|Overall Study||521
246899|NCT00988208|598886|P2|STARTED|Overall Study||533
246900|NCT00988208|598887|P1|STARTED|Overall Study||526
246901|NCT00988221|598902|P4|NOT COMPLETED|Part III||0
246902|NCT00988221|598903|P3|NOT COMPLETED|Part III||3
246903|NCT00988221|598904|P2|NOT COMPLETED|Part III||1
246904|NCT00988221|598905|P1|NOT COMPLETED|Part III||1
246905|NCT00988221|598902|P4|COMPLETED|Part III||0
246906|NCT00988221|598903|P3|COMPLETED|Part III||103
246907|NCT00988221|598904|P2|COMPLETED|Part III||23
246908|NCT00988221|598905|P1|COMPLETED|Part III||29
246909|NCT00988221|598902|P4|STARTED|Part III|No patients received placebo in Part III of this study.|0
246910|NCT00988221|598903|P3|STARTED|Part III||106
246911|NCT00988221|598904|P2|STARTED|Part III||24
246912|NCT00988221|598905|P1|STARTED|Part III||30
246913|NCT00988221|598902|P4|NOT COMPLETED|Part II||3
246914|NCT00988221|598903|P3|NOT COMPLETED|Part II||3
246915|NCT00988221|598904|P2|NOT COMPLETED|Part II||0
246916|NCT00988221|598905|P1|NOT COMPLETED|Part II||1
246917|NCT00988221|598902|P4|COMPLETED|Part II||81
246918|NCT00988221|598903|P3|COMPLETED|Part II|One participant who did not complete Part II was available to continue in the study and did.|52
246919|NCT00988221|598904|P2|COMPLETED|Part II||11
246920|NCT00988221|598905|P1|COMPLETED|Part II||15
246921|NCT00988221|598902|P4|STARTED|Part II||84
246922|NCT00988221|598903|P3|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|55
246923|NCT00988221|598904|P2|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|11
246924|NCT00988221|598905|P1|STARTED|Part II|Some of the patients in this group in Part I were randomized to receive placebo in Part II.|16
246925|NCT00988221|598902|P4|NOT COMPLETED|Part I||0
246926|NCT00988221|598903|P3|NOT COMPLETED|Part I||8
246927|NCT00988221|598904|P2|NOT COMPLETED|Part I||10
246928|NCT00988221|598905|P1|NOT COMPLETED|Part I||4
246929|NCT00988221|598902|P4|COMPLETED|Part I||0
246930|NCT00988221|598903|P3|COMPLETED|Part I||111
246931|NCT00988221|598904|P2|COMPLETED|Part I||24
246932|NCT00988221|598905|P1|COMPLETED|Part I||31
246933|NCT00988221|598902|P4|STARTED|Part I|No patients received placebo in Part I of this study.|0
246934|NCT00988221|598903|P3|STARTED|Part I||119
246935|NCT00988221|598904|P2|STARTED|Part I||34
246936|NCT00988221|598905|P1|STARTED|Part I||35
246937|NCT00988247|599078|P2|NOT COMPLETED|Overall Study||26
246938|NCT00988247|599079|P1|NOT COMPLETED|Overall Study||83
246939|NCT00988247|599078|P2|COMPLETED|Overall Study||85
246940|NCT00988247|599079|P1|COMPLETED|Overall Study||335
246941|NCT00988247|599078|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|110
246942|NCT00988247|599079|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|414
246943|NCT00988247|599078|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|111
246944|NCT00988247|599079|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|415
246945|NCT00988247|599078|P2|STARTED|Overall Study||111
246946|NCT00988247|599079|P1|STARTED|Overall Study||418
246947|NCT00988325|599098|P3|NOT COMPLETED|Overall Study||0
246948|NCT00988325|599099|P2|NOT COMPLETED|Overall Study||0
246949|NCT00988325|599100|P1|NOT COMPLETED|Overall Study||0
246950|NCT00988325|599098|P3|COMPLETED|Overall Study||5
246951|NCT00988325|599099|P2|COMPLETED|Overall Study||20
246952|NCT00988325|599100|P1|COMPLETED|Overall Study||40
246953|NCT00988325|599098|P3|STARTED|Overall Study||5
246954|NCT00988325|599099|P2|STARTED|Overall Study||20
246955|NCT00988325|599100|P1|STARTED|Overall Study||40
246956|NCT00988351|599158|P2|NOT COMPLETED|Overall Study||12
246957|NCT00988351|599159|P1|NOT COMPLETED|Overall Study||19
246958|NCT00988351|599158|P2|COMPLETED|Overall Study||66
246959|NCT00988351|599159|P1|COMPLETED|Overall Study||59
246960|NCT00988351|599158|P2|Using CPAP or APAP|Overall Study|3 not using APAP (less than 1/2 hour per night)|66
246961|NCT00988351|599159|P1|Using CPAP or APAP|Overall Study|5 not using CPAP (use < 1/2 hour per night)|59
246962|NCT00988351|599158|P2|Clinic Visit|Overall Study|9 lost to follow-up or no show for clinic|69
246963|NCT00988351|599159|P1|Clinic Visit|Overall Study|6 lost to follow-up or no show for clinic|64
246964|NCT00988351|599158|P2|PAP Setup|Overall Study|APAP treatment started|78
246965|NCT00988351|599159|P1|PAP Setup|Overall Study|CPAP treatment started|70
246966|NCT00988351|599158|P2|CPAP Titration|Overall Study|no titration needed|78
246967|NCT00988351|599159|P1|CPAP Titration|Overall Study|8 declined CPAP treatment|78
246968|NCT00988351|599158|P2|STARTED|Overall Study||78
246969|NCT00988351|599159|P1|STARTED|Overall Study||78
246970|NCT00988429|599176|P3|NOT COMPLETED|Overall Study||69
246971|NCT00988429|599177|P2|NOT COMPLETED|Overall Study||43
246972|NCT00988429|599178|P1|NOT COMPLETED|Overall Study||37
246973|NCT00988429|599176|P3|COMPLETED|Overall Study||142
246974|NCT00988429|599177|P2|COMPLETED|Overall Study||173
246975|NCT00988429|599178|P1|COMPLETED|Overall Study||189
246976|NCT00988429|599176|P3|Intention-to-treat (ITT) Population|Overall Study||205
246977|NCT00988429|599177|P2|Intention-to-treat (ITT) Population|Overall Study||215
246978|NCT00988429|599178|P1|Intention-to-treat (ITT) Population|Overall Study||220
246979|NCT00988429|599176|P3|Safety Population|Overall Study||210
246980|NCT00988429|599177|P2|Safety Population|Overall Study||216
246981|NCT00988429|599178|P1|Safety Population|Overall Study||224
246982|NCT00988429|599176|P3|STARTED|Overall Study||211
246983|NCT00988429|599177|P2|STARTED|Overall Study||216
246984|NCT00988429|599178|P1|STARTED|Overall Study||226
246985|NCT00988442|599191|P2|NOT COMPLETED|Overall Study||28
246986|NCT00988442|599192|P1|NOT COMPLETED|Overall Study||30
246987|NCT00988442|599191|P2|COMPLETED|Overall Study||1
246988|NCT00988442|599192|P1|COMPLETED|Overall Study||0
246989|NCT00988442|599191|P2|STARTED|Overall Study||29
246990|NCT00988442|599192|P1|STARTED|Overall Study||30
246991|NCT00988533|599252|P1|NOT COMPLETED|Overall Study||3
246992|NCT00988533|599252|P1|COMPLETED|Overall Study||27
246993|NCT00988533|599252|P1|STARTED|Overall Study||30
246994|NCT00982280|599264|P1|NOT COMPLETED|Maintenance Period||1
246995|NCT00982280|599264|P1|COMPLETED|Maintenance Period||54
246996|NCT00982280|599264|P1|STARTED|Maintenance Period||55
246997|NCT00982280|599264|P1|NOT COMPLETED|Titration and Optimal Dose Period||8
246998|NCT00982280|599264|P1|COMPLETED|Titration and Optimal Dose Period||55
246999|NCT00982280|599264|P1|STARTED|Titration and Optimal Dose Period||63
247000|NCT00982280|599264|P1|NOT COMPLETED|Observation Period||19
247001|NCT00982280|599264|P1|COMPLETED|Observation Period||63
247002|NCT00982280|599264|P1|STARTED|Observation Period||82
247003|NCT00982345|599287|P1|NOT COMPLETED|Overall Study||2
247004|NCT00982345|599287|P1|COMPLETED|Overall Study||18
247005|NCT00982345|599287|P1|STARTED|Overall Study||20
247006|NCT00982410|599293|P2|NOT COMPLETED|12-month Follow-up Assessment||9
247007|NCT00982410|599294|P1|NOT COMPLETED|12-month Follow-up Assessment||9
247008|NCT00982410|599293|P2|COMPLETED|12-month Follow-up Assessment||55
247009|NCT00982410|599294|P1|COMPLETED|12-month Follow-up Assessment||56
247010|NCT00982410|599293|P2|STARTED|12-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
247011|NCT00982410|599294|P1|STARTED|12-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
247012|NCT00982410|599293|P2|NOT COMPLETED|6-month Follow-up Assessment||11
247013|NCT00982410|599294|P1|NOT COMPLETED|6-month Follow-up Assessment||6
247014|NCT00982410|599293|P2|COMPLETED|6-month Follow-up Assessment||53
247015|NCT00982410|599294|P1|COMPLETED|6-month Follow-up Assessment||59
247016|NCT00982410|599293|P2|STARTED|6-month Follow-up Assessment|n=2 persons withdrew before 3-mo. f/u, reducing pool of participants to N=64 with intent to treat.|64
247017|NCT00982410|599294|P1|STARTED|6-month Follow-up Assessment|n=65 : intent to treat. Some persons missed follow-up assessment without withdrawing from study.|65
247018|NCT00982410|599293|P2|NOT COMPLETED|3-month Follow-up Assessment||13
247019|NCT00982410|599294|P1|NOT COMPLETED|3-month Follow-up Assessment||9
247020|NCT00982410|599293|P2|COMPLETED|3-month Follow-up Assessment||53
247021|NCT00982410|599294|P1|COMPLETED|3-month Follow-up Assessment||56
247022|NCT00982410|599293|P2|STARTED|3-month Follow-up Assessment||66
247023|NCT00982410|599294|P1|STARTED|3-month Follow-up Assessment||65
247024|NCT00982423|599318|P2|NOT COMPLETED|Overall Study||0
247025|NCT00982423|599319|P1|NOT COMPLETED|Overall Study||0
247026|NCT00982423|599318|P2|COMPLETED|Overall Study||19
247027|NCT00982423|599319|P1|COMPLETED|Overall Study||13
247028|NCT00982423|599318|P2|STARTED|Overall Study||19
247029|NCT00982423|599319|P1|STARTED|Overall Study||13
247030|NCT00982488|599340|P5|NOT COMPLETED|Overall Study||1
247031|NCT00982488|599341|P4|NOT COMPLETED|Overall Study||3
247032|NCT00982488|599342|P3|NOT COMPLETED|Overall Study||34
247033|NCT00982488|599343|P2|NOT COMPLETED|Overall Study||14
247034|NCT00982488|599344|P1|NOT COMPLETED|Overall Study||185
247035|NCT00982488|599340|P5|COMPLETED|Overall Study|Still receiving treatment|0
247036|NCT00982488|599341|P4|COMPLETED|Overall Study|Still receiving treatment|0
247037|NCT00982488|599342|P3|COMPLETED|Overall Study|Still receiving treatment|0
247038|NCT00982488|599343|P2|COMPLETED|Overall Study|Still receiving treatment|0
247039|NCT00982488|599344|P1|COMPLETED|Overall Study|Still receiving treatment|0
247040|NCT00982488|599340|P5|STARTED|Overall Study|Received treatment|1
247041|NCT00982488|599341|P4|STARTED|Overall Study|Received treatment|3
247042|NCT00982488|599342|P3|STARTED|Overall Study|Received treatment|34
247043|NCT00982488|599343|P2|STARTED|Overall Study|Received treatment|14
247044|NCT00982488|599344|P1|STARTED|Overall Study|Received treatment|185
247045|NCT00982553|599356|P1|NOT COMPLETED|Overall Study||0
247046|NCT00982553|599356|P1|COMPLETED|Overall Study||14
247047|NCT00982553|599356|P1|STARTED|Overall Study||14
247048|NCT00982592|599365|P2|NOT COMPLETED|Overall Study||33
247049|NCT00982592|599366|P1|NOT COMPLETED|Overall Study||31
247050|NCT00982592|599365|P2|COMPLETED|Overall Study|patients who were off treatment due to disease progression|27
247051|NCT00982592|599366|P1|COMPLETED|Overall Study|patients who were off treatment due to disease progression|33
247052|NCT00982592|599365|P2|Treatment Received|Overall Study||52
247053|NCT00982592|599366|P1|Treatment Received|Overall Study||63
247054|NCT00982592|599365|P2|STARTED|Overall Study||60
247055|NCT00982592|599366|P1|STARTED|Overall Study||64
247056|NCT00982644|599382|P2|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||20
247057|NCT00982644|599383|P1|NOT COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||46
247058|NCT00982644|599382|P2|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||154
247059|NCT00982644|599383|P1|COMPLETED|Extension: Week 53 to 104 (NN1250-3643)||505
247060|NCT00982644|599382|P2|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Twenty-three subjects did not continue into extension trial|174
247061|NCT00982644|599383|P1|STARTED|Extension: Week 53 to 104 (NN1250-3643)|Fifty-six subjects did not continue into extension trial|551
247062|NCT00982644|599382|P2|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||60
247063|NCT00982644|599383|P1|NOT COMPLETED|Main: Week 0 to 52 (NN1250-3579)||166
247064|NCT00982644|599382|P2|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||197
247065|NCT00982644|599383|P1|COMPLETED|Main: Week 0 to 52 (NN1250-3579)||607
247066|NCT00982644|599382|P2|Exposed|Main: Week 0 to 52 (NN1250-3579)||257
247067|NCT00982644|599383|P1|Exposed|Main: Week 0 to 52 (NN1250-3579)|7 subjects were withdrawn prior to exposure to trial products|766
247068|NCT00982644|599382|P2|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||257
247069|NCT00982644|599383|P1|Full Analysis Set|Main: Week 0 to 52 (NN1250-3579)||773
247070|NCT00982644|599382|P2|STARTED|Main: Week 0 to 52 (NN1250-3579)||257
247071|NCT00982644|599383|P1|STARTED|Main: Week 0 to 52 (NN1250-3579)||773
247072|NCT00982657|599409|P4|NOT COMPLETED|Overall Study||9
247073|NCT00982657|599410|P3|NOT COMPLETED|Overall Study||2
247074|NCT00982657|599411|P2|NOT COMPLETED|Overall Study||0
247075|NCT00982657|599412|P1|NOT COMPLETED|Overall Study||1
247076|NCT00982657|599409|P4|COMPLETED|Overall Study||7
247077|NCT00982657|599410|P3|COMPLETED|Overall Study||1
247078|NCT00982657|599411|P2|COMPLETED|Overall Study||3
247079|NCT00982657|599412|P1|COMPLETED|Overall Study||11
247080|NCT00982657|599409|P4|STARTED|Overall Study||16
247081|NCT00982657|599410|P3|STARTED|Overall Study||3
247082|NCT00982657|599411|P2|STARTED|Overall Study||3
247083|NCT00982657|599412|P1|STARTED|Overall Study||12
247084|NCT00982735|599451|P1|NOT COMPLETED|Overall Study||230
247085|NCT00982735|599451|P1|COMPLETED|Overall Study||757
247086|NCT00982735|599451|P1|STARTED|Overall Study||987
247087|NCT00988637|599459|P2|NOT COMPLETED|Overall Study||3
247088|NCT00988637|599460|P1|NOT COMPLETED|Overall Study||3
247089|NCT00988637|599459|P2|COMPLETED|Overall Study||65
247090|NCT00988637|599460|P1|COMPLETED|Overall Study||67
247091|NCT00988637|599459|P2|STARTED|Overall Study||68
247092|NCT00988637|599460|P1|STARTED|Overall Study||70
247093|NCT00988832|599490|P1|NOT COMPLETED|Overall Study||0
247094|NCT00988832|599490|P1|COMPLETED|Overall Study||380
247095|NCT00988832|599490|P1|STARTED|Overall Study||380
247096|NCT00988858|599525|P1|NOT COMPLETED|Overall Study||10
247097|NCT00988858|599525|P1|COMPLETED|Overall Study||45
247098|NCT00988858|599525|P1|STARTED|Overall Study||55
247099|NCT00988884|599539|P2|NOT COMPLETED|Overall Study||36
247100|NCT00988884|599540|P1|NOT COMPLETED|Overall Study||35
247101|NCT00988884|599539|P2|COMPLETED|Overall Study||584
247102|NCT00988884|599540|P1|COMPLETED|Overall Study||586
247103|NCT00988884|599539|P2|STARTED|Overall Study||620
247104|NCT00988884|599540|P1|STARTED|Overall Study||621
247105|NCT00994110|599564|P2|NOT COMPLETED|Overall Study||74
247106|NCT00994110|599565|P1|NOT COMPLETED|Overall Study||65
247107|NCT00994110|599564|P2|COMPLETED|Overall Study||148
247108|NCT00994110|599565|P1|COMPLETED|Overall Study||152
247109|NCT00994110|599564|P2|STARTED|Overall Study||222
247110|NCT00994110|599565|P1|STARTED|Overall Study||217
247111|NCT00994123|599574|P3|NOT COMPLETED|Overall Study||0
247112|NCT00994123|599575|P2|NOT COMPLETED|Overall Study||0
247113|NCT00994123|599576|P1|NOT COMPLETED|Overall Study||0
247114|NCT00994123|599574|P3|COMPLETED|Overall Study||44
247115|NCT00994123|599575|P2|COMPLETED|Overall Study||85
247116|NCT00994123|599576|P1|COMPLETED|Overall Study||33
247117|NCT00994123|599574|P3|STARTED|Overall Study||44
247118|NCT00994123|599575|P2|STARTED|Overall Study||85
247119|NCT00994123|599576|P1|STARTED|Overall Study||33
247120|NCT00994214|599599|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
247121|NCT00994214|599600|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||2
247122|NCT00994214|599601|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||3
247123|NCT00994214|599602|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part B||4
247124|NCT00994214|599599|P4|COMPLETED|ITT (Intention-to-Treat) - Part B||0
247125|NCT00994214|599600|P3|COMPLETED|ITT (Intention-to-Treat) - Part B||0
247126|NCT00994214|599601|P2|COMPLETED|ITT (Intention-to-Treat) - Part B||0
247127|NCT00994214|599602|P1|COMPLETED|ITT (Intention-to-Treat) - Part B||0
247128|NCT00994214|599599|P4|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||3
247129|NCT00994214|599600|P3|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||2
247130|NCT00994214|599601|P2|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
247131|NCT00994214|599602|P1|Received Maximum Dose of 6mg|ITT (Intention-to-Treat) - Part B||0
247132|NCT00994214|599599|P4|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
247133|NCT00994214|599600|P3|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||0
247134|NCT00994214|599601|P2|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||3
247135|NCT00994214|599602|P1|Received Maximum Dose of 4mg|ITT (Intention-to-Treat) - Part B||1
247136|NCT00994214|599599|P4|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
247137|NCT00994214|599600|P3|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
247138|NCT00994214|599601|P2|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||0
247139|NCT00994214|599602|P1|Received Maximum Dose of 2mg|ITT (Intention-to-Treat) - Part B||3
247140|NCT00994214|599599|P4|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
247141|NCT00994214|599600|P3|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
247142|NCT00994214|599601|P2|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
247143|NCT00994214|599602|P1|Received Maximum Dose of 1mg|ITT (Intention-to-Treat) - Part B||0
247144|NCT00994214|599599|P4|STARTED|ITT (Intention-to-Treat) - Part B|2 subjects did not enter Part B Arm D|3
247145|NCT00994214|599600|P3|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm C|2
247146|NCT00994214|599601|P2|STARTED|ITT (Intention-to-Treat) - Part B|3 subjects did not enter Part B Arm B|3
247147|NCT00994214|599602|P1|STARTED|ITT (Intention-to-Treat) - Part B|1 subject did not enter Part B Arm A|4
247148|NCT00994214|599599|P4|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||15
247149|NCT00994214|599600|P3|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
247150|NCT00994214|599601|P2|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||13
247151|NCT00994214|599602|P1|NOT COMPLETED|ITT (Intention-to-Treat) - Part A||14
247152|NCT00994214|599599|P4|COMPLETED|ITT (Intention-to-Treat) - Part A||5
247153|NCT00994214|599600|P3|COMPLETED|ITT (Intention-to-Treat) - Part A||5
247154|NCT00994214|599601|P2|COMPLETED|ITT (Intention-to-Treat) - Part A||6
247155|NCT00994214|599602|P1|COMPLETED|ITT (Intention-to-Treat) - Part A||5
247156|NCT00994214|599599|P4|STARTED|ITT (Intention-to-Treat) - Part A||20
247157|NCT00994214|599600|P3|STARTED|ITT (Intention-to-Treat) - Part A||18
247158|NCT00994214|599601|P2|STARTED|ITT (Intention-to-Treat) - Part A||19
247159|NCT00994214|599602|P1|STARTED|ITT (Intention-to-Treat) - Part A||19
247160|NCT00994240|599648|P2|NOT COMPLETED|Overall Study||5
247161|NCT00994240|599649|P1|NOT COMPLETED|Overall Study||6
247162|NCT00994240|599648|P2|COMPLETED|Overall Study||39
247163|NCT00994240|599649|P1|COMPLETED|Overall Study||35
247164|NCT00994240|599648|P2|STARTED|Overall Study||44
247165|NCT00994240|599649|P1|STARTED|Overall Study||41
247166|NCT00994253|599657|P2|NOT COMPLETED|Overall Study||0
247167|NCT00994253|599658|P1|NOT COMPLETED|Overall Study||0
247168|NCT00994253|599657|P2|COMPLETED|Overall Study||0
247169|NCT00994253|599658|P1|COMPLETED|Overall Study||0
247170|NCT00994253|599657|P2|STARTED|Overall Study||0
247171|NCT00994253|599658|P1|STARTED|Overall Study||0
247172|NCT00994279|599666|P2|NOT COMPLETED|Overall Study||5
247173|NCT00994279|599667|P1|NOT COMPLETED|Overall Study||4
247174|NCT00994279|599666|P2|COMPLETED|Overall Study||13
247175|NCT00994279|599667|P1|COMPLETED|Overall Study||18
247176|NCT00994279|599666|P2|STARTED|Overall Study||18
247177|NCT00994279|599667|P1|STARTED|Overall Study||22
247178|NCT00994318|599678|P3|NOT COMPLETED|Overall Study||67
247179|NCT00994318|599679|P2|NOT COMPLETED|Overall Study||18
247180|NCT00994318|599680|P1|NOT COMPLETED|Overall Study||22
247181|NCT00994318|599678|P3|COMPLETED|Overall Study||250
247182|NCT00994318|599679|P2|COMPLETED|Overall Study||136
247183|NCT00994318|599680|P1|COMPLETED|Overall Study||133
247184|NCT00994318|599678|P3|STARTED|Overall Study||317
247185|NCT00994318|599679|P2|STARTED|Overall Study||154
247186|NCT00994318|599680|P1|STARTED|Overall Study||155
247187|NCT00994422|599690|P2|NOT COMPLETED|Overall Study||1
247188|NCT00994422|599691|P1|NOT COMPLETED|Overall Study||7
247189|NCT00994422|599690|P2|COMPLETED|Overall Study||54
247190|NCT00994422|599691|P1|COMPLETED|Overall Study||185
247191|NCT00994422|599690|P2|STARTED|Overall Study||55
247192|NCT00994422|599691|P1|STARTED|Overall Study||192
247193|NCT00994448|599703|P2|NOT COMPLETED|Overall Study||2
247194|NCT00994448|599704|P1|NOT COMPLETED|Overall Study||8
247195|NCT00994448|599703|P2|COMPLETED|Overall Study||5
247196|NCT00994448|599704|P1|COMPLETED|Overall Study||4
247197|NCT00994448|599703|P2|STARTED|Overall Study||7
247198|NCT00994448|599704|P1|STARTED|Overall Study||12
247199|NCT00994461|599713|P3|NOT COMPLETED|Overall Study||0
247200|NCT00994461|599714|P2|NOT COMPLETED|Overall Study||1
247201|NCT00994461|599715|P1|NOT COMPLETED|Overall Study||2
247202|NCT00994461|599713|P3|COMPLETED|Overall Study||37
247203|NCT00994461|599714|P2|COMPLETED|Overall Study||75
247204|NCT00994461|599715|P1|COMPLETED|Overall Study||74
247205|NCT00994461|599713|P3|STARTED|Overall Study|One subject was randomized but did not receive study drug.|37
247206|NCT00994461|599714|P2|STARTED|Overall Study||76
247207|NCT00994461|599715|P1|STARTED|Overall Study||76
247208|NCT00994604|599741|P1|NOT COMPLETED|Overall Study||6
247209|NCT00994604|599741|P1|COMPLETED|Overall Study||45
247210|NCT00994604|599741|P1|STARTED|Overall Study||51
247211|NCT00994682|599750|P2|NOT COMPLETED|Pioglitazone Open Label||7
247212|NCT00994682|599751|P1|NOT COMPLETED|Pioglitazone Open Label||13
247213|NCT00994682|599750|P2|COMPLETED|Pioglitazone Open Label||34
247214|NCT00994682|599751|P1|COMPLETED|Pioglitazone Open Label||29
247215|NCT00994682|599750|P2|STARTED|Pioglitazone Open Label||41
247216|NCT00994682|599751|P1|STARTED|Pioglitazone Open Label||42
247217|NCT00994682|599750|P2|NOT COMPLETED|Double Bilnd||9
247218|NCT00994682|599751|P1|NOT COMPLETED|Double Bilnd||9
247219|NCT00994682|599750|P2|COMPLETED|Double Bilnd||41
247220|NCT00994682|599751|P1|COMPLETED|Double Bilnd||42
247221|NCT00994682|599750|P2|STARTED|Double Bilnd||50
247222|NCT00994682|599751|P1|STARTED|Double Bilnd||51
247223|NCT00994760|599795|P1|NOT COMPLETED|Overall Study||24
247224|NCT00994760|599795|P1|COMPLETED|Overall Study||107
247225|NCT00994760|599795|P1|STARTED|Overall Study||131
247226|NCT00994929|599834|P1|NOT COMPLETED|Overall Study||0
247227|NCT00994929|599834|P1|COMPLETED|Overall Study||9
247228|NCT00994929|599834|P1|STARTED|Overall Study||9
247229|NCT00995007|599842|P2|NOT COMPLETED|Overall Study||2
247230|NCT00995007|599843|P1|NOT COMPLETED|Overall Study||17
247231|NCT00995007|599842|P2|COMPLETED|Overall Study||54
247232|NCT00995007|599843|P1|COMPLETED|Overall Study||39
247233|NCT00995007|599842|P2|Crossover to Vandetanib|Overall Study||0
247234|NCT00995007|599843|P1|Crossover to Vandetanib|Overall Study||42
247235|NCT00995007|599842|P2|STARTED|Overall Study||56
247236|NCT00995007|599843|P1|STARTED|Overall Study||56
247237|NCT00995020|599861|P2|NOT COMPLETED|Overall Study||7
247238|NCT00995020|599862|P1|NOT COMPLETED|Overall Study||3
247239|NCT00995020|599861|P2|COMPLETED|Overall Study|"Reasons for not completed:
margin analysis not performed specimen fragmentation thermal damage"|45
247240|NCT00995020|599862|P1|COMPLETED|Overall Study|"Reasons for not completed:
margin analysis not performed specimen fragmentation thermal damage"|48
247241|NCT00995020|599861|P2|STARTED|Overall Study||52
247242|NCT00995020|599862|P1|STARTED|Overall Study||51
247243|NCT00995085|599870|P1|NOT COMPLETED|Overall Study||5
247244|NCT00995085|599870|P1|COMPLETED|Overall Study||38
247245|NCT00995085|599870|P1|STARTED|Overall Study||43
247246|NCT00995345|599879|P5|NOT COMPLETED|Overall Study||5
247247|NCT00995345|599880|P4|NOT COMPLETED|Overall Study||5
247248|NCT00995345|599881|P3|NOT COMPLETED|Overall Study||7
247249|NCT00995345|599882|P2|NOT COMPLETED|Overall Study||7
247250|NCT00995345|599883|P1|NOT COMPLETED|Overall Study||11
247251|NCT00995345|599879|P5|COMPLETED|Overall Study||75
247252|NCT00995345|599880|P4|COMPLETED|Overall Study||76
247253|NCT00995345|599881|P3|COMPLETED|Overall Study||73
247254|NCT00995345|599882|P2|COMPLETED|Overall Study||74
247255|NCT00995345|599883|P1|COMPLETED|Overall Study||70
247256|NCT00995345|599879|P5|STARTED|Overall Study||80
247257|NCT00995345|599880|P4|STARTED|Overall Study||81
247258|NCT00995345|599881|P3|STARTED|Overall Study||80
247259|NCT00995345|599882|P2|STARTED|Overall Study||81
247260|NCT00995345|599883|P1|STARTED|Overall Study||81
247261|NCT00995371|599912|P2|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
247262|NCT00995371|599913|P1|NOT COMPLETED|After ESI Cross-over to Mild, 26 Weeks||5
247263|NCT00995371|599912|P2|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 17 completed Wk 6 Intent to Treat analysis prior to x-over. After x-over 12 reported Wk 26|12
247264|NCT00995371|599913|P1|COMPLETED|After ESI Cross-over to Mild, 26 Weeks|All 21 completed Wk 6 Intent to Treat analysis. Sixteen reported Week 26 outcomes.|16
247265|NCT00995371|599912|P2|STARTED|After ESI Cross-over to Mild, 26 Weeks||17
247266|NCT00995371|599913|P1|STARTED|After ESI Cross-over to Mild, 26 Weeks||21
247267|NCT00995371|599912|P2|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
247268|NCT00995371|599913|P1|NOT COMPLETED|Prior to ESI Cross-over, 6 Weeks||0
247269|NCT00995371|599912|P2|COMPLETED|Prior to ESI Cross-over, 6 Weeks||17
247270|NCT00995371|599913|P1|COMPLETED|Prior to ESI Cross-over, 6 Weeks||21
247271|NCT00995371|599912|P2|STARTED|Prior to ESI Cross-over, 6 Weeks||17
247272|NCT00995371|599913|P1|STARTED|Prior to ESI Cross-over, 6 Weeks||21
247273|NCT00995410|599926|P1|NOT COMPLETED|Overall Study||88
247274|NCT00995410|599926|P1|COMPLETED|Overall Study||292
247275|NCT00995410|599926|P1|Treated|Overall Study||379
247276|NCT00995410|599926|P1|STARTED|Overall Study||380
247277|NCT00995436|599934|P3|NOT COMPLETED|Overall Study||0
247278|NCT00995436|599935|P2|NOT COMPLETED|Overall Study||5
247279|NCT00995436|599936|P1|NOT COMPLETED|Overall Study||2
247280|NCT00995436|599934|P3|COMPLETED|Overall Study||26
247281|NCT00995436|599935|P2|COMPLETED|Overall Study||22
247282|NCT00995436|599936|P1|COMPLETED|Overall Study||23
247283|NCT00995436|599934|P3|STARTED|Overall Study||26
247284|NCT00995436|599935|P2|STARTED|Overall Study||27
247285|NCT00995436|599936|P1|STARTED|Overall Study|25|25
247286|NCT00995449|599948|P4|NOT COMPLETED|Overall Study||0
247287|NCT00995449|599949|P3|NOT COMPLETED|Overall Study||2
247288|NCT00995449|599950|P2|NOT COMPLETED|Overall Study||0
247289|NCT00995449|599951|P1|NOT COMPLETED|Overall Study||0
247290|NCT00995449|599948|P4|COMPLETED|Overall Study||2
247291|NCT00995449|599949|P3|COMPLETED|Overall Study||5
247292|NCT00995449|599950|P2|COMPLETED|Overall Study||0
247293|NCT00995449|599951|P1|COMPLETED|Overall Study||0
247294|NCT00995449|599948|P4|STARTED|Overall Study||2
247295|NCT00995449|599949|P3|STARTED|Overall Study||7
247296|NCT00995449|599950|P2|STARTED|Overall Study||0
247297|NCT00995449|599951|P1|STARTED|Overall Study||0
247298|NCT00995488|599959|P1|NOT COMPLETED|Overall Study||1
247299|NCT00995488|599959|P1|COMPLETED|Overall Study||15
247300|NCT00995488|599959|P1|STARTED|Overall Study||16
247301|NCT00995501|599972|P8|NOT COMPLETED|Overall Study||0
247302|NCT00995501|599973|P7|NOT COMPLETED|Overall Study||0
247303|NCT00995501|599974|P6|NOT COMPLETED|Overall Study||0
247304|NCT00995501|599975|P5|NOT COMPLETED|Overall Study||0
247305|NCT00995501|599976|P4|NOT COMPLETED|Overall Study||0
247306|NCT00995501|599977|P3|NOT COMPLETED|Overall Study||0
247307|NCT00995501|599978|P2|NOT COMPLETED|Overall Study||0
247308|NCT00995501|599979|P1|NOT COMPLETED|Overall Study||0
247309|NCT00995501|599972|P8|COMPLETED|Overall Study||46
247310|NCT00995501|599973|P7|COMPLETED|Overall Study||49
247311|NCT00995501|599974|P6|COMPLETED|Overall Study||44
247312|NCT00995501|599975|P5|COMPLETED|Overall Study||46
247313|NCT00995501|599976|P4|COMPLETED|Overall Study||46
247314|NCT00995501|599977|P3|COMPLETED|Overall Study||47
247315|NCT00995501|599978|P2|COMPLETED|Overall Study||51
247316|NCT00995501|599979|P1|COMPLETED|Overall Study||52
247317|NCT00995501|599972|P8|STARTED|Overall Study||46
247318|NCT00995501|599973|P7|STARTED|Overall Study||49
247319|NCT00995501|599974|P6|STARTED|Overall Study||44
247320|NCT00995501|599975|P5|STARTED|Overall Study||46
247321|NCT00995501|599976|P4|STARTED|Overall Study||46
247322|NCT00995501|599977|P3|STARTED|Overall Study||47
247323|NCT00995501|599978|P2|STARTED|Overall Study||51
247324|NCT00995501|599979|P1|STARTED|Overall Study||52
247325|NCT00995553|600007|P2|NOT COMPLETED|Overall Study||6
247326|NCT00995553|600008|P1|NOT COMPLETED|Overall Study||2
247327|NCT00995553|600007|P2|COMPLETED|Overall Study||35
247328|NCT00995553|600008|P1|COMPLETED|Overall Study||38
247329|NCT00995553|600007|P2|STARTED|Overall Study||41
247330|NCT00995553|600008|P1|STARTED|Overall Study||40
247331|NCT00995566|600016|P1|NOT COMPLETED|Overall Study||54
247332|NCT00995566|600016|P1|COMPLETED|Overall Study||0
247333|NCT00995566|600016|P1|STARTED|Overall Study||54
247334|NCT00995670|600031|P3|NOT COMPLETED|Overall Study||3
247335|NCT00995670|600032|P2|NOT COMPLETED|Overall Study||0
247336|NCT00995670|600033|P1|NOT COMPLETED|Overall Study||1
247337|NCT00995670|600031|P3|COMPLETED|Overall Study|These 17 volunteers underwent 33 studies on the effect of statins, glucose, and glucose & statins.|14
247338|NCT00995670|600032|P2|COMPLETED|Overall Study|These 16 subjects underwent a total of 25 studies on the effect of Vitamin C.|16
247339|NCT00995670|600033|P1|COMPLETED|Overall Study|These 26 subjects underwent a total of 58 studies to determine the effect of dose of glucose on I/R.|25
247340|NCT00995670|600031|P3|STARTED|Overall Study||17
247341|NCT00995670|600032|P2|STARTED|Overall Study||16
247342|NCT00995670|600033|P1|STARTED|Overall Study||26
247343|NCT00995709|600044|P3|NOT COMPLETED|Overall Study||5
247344|NCT00995709|600045|P2|NOT COMPLETED|Overall Study||9
247345|NCT00995709|600046|P1|NOT COMPLETED|Overall Study||7
247346|NCT00995709|600044|P3|COMPLETED|Overall Study||34
247439|NCT00995904|600129|P3|COMPLETED|Visit 3||4
247347|NCT00995709|600045|P2|COMPLETED|Overall Study|patient in the 300 mg monthly group was randomized,was not eligible,never received study medication|31
247348|NCT00995709|600046|P1|COMPLETED|Overall Study||32
247349|NCT00995709|600044|P3|STARTED|Overall Study||39
247350|NCT00995709|600045|P2|STARTED|Overall Study||40
247351|NCT00995709|600046|P1|STARTED|Overall Study||39
247352|NCT00995722|600071|P2|NOT COMPLETED|Overall Study: 36 Weeks||2
247353|NCT00995722|600072|P1|NOT COMPLETED|Overall Study: 36 Weeks||2
247354|NCT00995722|600071|P2|COMPLETED|Overall Study: 36 Weeks||2
247355|NCT00995722|600072|P1|COMPLETED|Overall Study: 36 Weeks||3
247356|NCT00995722|600071|P2|STARTED|Overall Study: 36 Weeks||4
247357|NCT00995722|600072|P1|STARTED|Overall Study: 36 Weeks||5
247358|NCT00995722|600071|P2|NOT COMPLETED|Double Blinded: 16 Weeks||1
247359|NCT00995722|600072|P1|NOT COMPLETED|Double Blinded: 16 Weeks||1
247360|NCT00995722|600071|P2|COMPLETED|Double Blinded: 16 Weeks||4
247361|NCT00995722|600072|P1|COMPLETED|Double Blinded: 16 Weeks||5
247362|NCT00995722|600071|P2|STARTED|Double Blinded: 16 Weeks||5
247363|NCT00995722|600072|P1|STARTED|Double Blinded: 16 Weeks||6
247364|NCT00995761|600086|P1|NOT COMPLETED|Overall Study||0
247365|NCT00995761|600086|P1|COMPLETED|Overall Study||48
247366|NCT00995761|600086|P1|STARTED|Overall Study||48
247367|NCT00995774|600092|P2|NOT COMPLETED|Training Period 2||0
247368|NCT00995774|600093|P1|NOT COMPLETED|Training Period 2||2
247369|NCT00995774|600092|P2|COMPLETED|Training Period 2||5
247370|NCT00995774|600093|P1|COMPLETED|Training Period 2||5
247371|NCT00995774|600092|P2|STARTED|Training Period 2||5
247372|NCT00995774|600093|P1|STARTED|Training Period 2||7
247373|NCT00995774|600092|P2|NOT COMPLETED|Washout Period||0
247374|NCT00995774|600093|P1|NOT COMPLETED|Washout Period||0
247375|NCT00995774|600092|P2|COMPLETED|Washout Period||5
247376|NCT00995774|600093|P1|COMPLETED|Washout Period||7
247377|NCT00995774|600092|P2|STARTED|Washout Period||5
247378|NCT00995774|600093|P1|STARTED|Washout Period||7
247379|NCT00995774|600092|P2|NOT COMPLETED|Training Period 1||0
247380|NCT00995774|600093|P1|NOT COMPLETED|Training Period 1||0
247381|NCT00995774|600092|P2|COMPLETED|Training Period 1||5
247382|NCT00995774|600093|P1|COMPLETED|Training Period 1||7
247383|NCT00995774|600092|P2|STARTED|Training Period 1||5
247384|NCT00995774|600093|P1|STARTED|Training Period 1||7
247385|NCT00995865|600104|P3|NOT COMPLETED|Overall Study||1
247386|NCT00995865|600105|P2|NOT COMPLETED|Overall Study||0
247387|NCT00995865|600106|P1|NOT COMPLETED|Overall Study||2
247388|NCT00995865|600104|P3|COMPLETED|Overall Study||11
247389|NCT00995865|600105|P2|COMPLETED|Overall Study||24
247390|NCT00995865|600106|P1|COMPLETED|Overall Study||22
247391|NCT00995865|600104|P3|STARTED|Overall Study||12
247392|NCT00995865|600105|P2|STARTED|Overall Study||24
247393|NCT00995865|600106|P1|STARTED|Overall Study||24
247394|NCT00995904|600126|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
247395|NCT00995904|600127|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
247396|NCT00995904|600128|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
247397|NCT00995904|600129|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
247398|NCT00995904|600130|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
247399|NCT00995904|600131|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
247400|NCT00995904|600126|P6|COMPLETED|Follow-up Visit (Final Visit)||3
247401|NCT00995904|600127|P5|COMPLETED|Follow-up Visit (Final Visit)||5
247402|NCT00995904|600128|P4|COMPLETED|Follow-up Visit (Final Visit)||5
247403|NCT00995904|600129|P3|COMPLETED|Follow-up Visit (Final Visit)||4
247404|NCT00995904|600130|P2|COMPLETED|Follow-up Visit (Final Visit)||3
247405|NCT00995904|600131|P1|COMPLETED|Follow-up Visit (Final Visit)||4
247406|NCT00995904|600126|P6|STARTED|Follow-up Visit (Final Visit)||3
247407|NCT00995904|600127|P5|STARTED|Follow-up Visit (Final Visit)||5
247408|NCT00995904|600128|P4|STARTED|Follow-up Visit (Final Visit)||5
247409|NCT00995904|600129|P3|STARTED|Follow-up Visit (Final Visit)||4
247410|NCT00995904|600130|P2|STARTED|Follow-up Visit (Final Visit)||3
247411|NCT00995904|600131|P1|STARTED|Follow-up Visit (Final Visit)||4
247412|NCT00995904|600126|P6|NOT COMPLETED|Visit 4||0
247413|NCT00995904|600127|P5|NOT COMPLETED|Visit 4||0
247414|NCT00995904|600128|P4|NOT COMPLETED|Visit 4||0
247415|NCT00995904|600129|P3|NOT COMPLETED|Visit 4||0
247416|NCT00995904|600130|P2|NOT COMPLETED|Visit 4||0
247417|NCT00995904|600131|P1|NOT COMPLETED|Visit 4||0
247418|NCT00995904|600126|P6|COMPLETED|Visit 4||3
247419|NCT00995904|600127|P5|COMPLETED|Visit 4||5
247420|NCT00995904|600128|P4|COMPLETED|Visit 4||5
247421|NCT00995904|600129|P3|COMPLETED|Visit 4||4
247422|NCT00995904|600130|P2|COMPLETED|Visit 4||3
247423|NCT00995904|600131|P1|COMPLETED|Visit 4||4
247424|NCT00995904|600126|P6|STARTED|Visit 4||3
247425|NCT00995904|600127|P5|STARTED|Visit 4||5
247426|NCT00995904|600128|P4|STARTED|Visit 4||5
247427|NCT00995904|600129|P3|STARTED|Visit 4||4
247428|NCT00995904|600130|P2|STARTED|Visit 4||3
247429|NCT00995904|600131|P1|STARTED|Visit 4||4
247430|NCT00995904|600126|P6|NOT COMPLETED|Visit 3||0
247431|NCT00995904|600127|P5|NOT COMPLETED|Visit 3||0
247432|NCT00995904|600128|P4|NOT COMPLETED|Visit 3||0
247433|NCT00995904|600129|P3|NOT COMPLETED|Visit 3||0
247434|NCT00995904|600130|P2|NOT COMPLETED|Visit 3||0
247435|NCT00995904|600131|P1|NOT COMPLETED|Visit 3||0
247436|NCT00995904|600126|P6|COMPLETED|Visit 3||3
247437|NCT00995904|600127|P5|COMPLETED|Visit 3||5
247438|NCT00995904|600128|P4|COMPLETED|Visit 3||5
247440|NCT00995904|600130|P2|COMPLETED|Visit 3||3
247441|NCT00995904|600131|P1|COMPLETED|Visit 3||4
247442|NCT00995904|600126|P6|STARTED|Visit 3|One subject was withdrawn from the study after completion of Visit 2 but prior to Visit 3.|3
247443|NCT00995904|600127|P5|STARTED|Visit 3||5
247444|NCT00995904|600128|P4|STARTED|Visit 3||5
247445|NCT00995904|600129|P3|STARTED|Visit 3||4
247446|NCT00995904|600130|P2|STARTED|Visit 3||3
247447|NCT00995904|600131|P1|STARTED|Visit 3||4
247448|NCT00995904|600126|P6|NOT COMPLETED|Visit 2 (Randomization)||0
247449|NCT00995904|600127|P5|NOT COMPLETED|Visit 2 (Randomization)||0
247450|NCT00995904|600128|P4|NOT COMPLETED|Visit 2 (Randomization)||0
247451|NCT00995904|600129|P3|NOT COMPLETED|Visit 2 (Randomization)||0
247452|NCT00995904|600130|P2|NOT COMPLETED|Visit 2 (Randomization)||0
247453|NCT00995904|600131|P1|NOT COMPLETED|Visit 2 (Randomization)||0
247454|NCT00995904|600126|P6|COMPLETED|Visit 2 (Randomization)||4
247455|NCT00995904|600127|P5|COMPLETED|Visit 2 (Randomization)||5
247456|NCT00995904|600128|P4|COMPLETED|Visit 2 (Randomization)||5
247457|NCT00995904|600129|P3|COMPLETED|Visit 2 (Randomization)||4
247458|NCT00995904|600130|P2|COMPLETED|Visit 2 (Randomization)||3
247459|NCT00995904|600131|P1|COMPLETED|Visit 2 (Randomization)||4
247460|NCT00995904|600126|P6|STARTED|Visit 2 (Randomization)||4
247461|NCT00995904|600127|P5|STARTED|Visit 2 (Randomization)||5
247462|NCT00995904|600128|P4|STARTED|Visit 2 (Randomization)||5
247463|NCT00995904|600129|P3|STARTED|Visit 2 (Randomization)||4
247464|NCT00995904|600130|P2|STARTED|Visit 2 (Randomization)||3
247465|NCT00995904|600131|P1|STARTED|Visit 2 (Randomization)||4
247466|NCT00995930|600147|P2|NOT COMPLETED|Overall Study||28
247467|NCT00995930|600148|P1|NOT COMPLETED|Overall Study||21
247468|NCT00995930|600147|P2|COMPLETED|Overall Study||67
247469|NCT00995930|600148|P1|COMPLETED|Overall Study||73
247470|NCT00995930|600147|P2|Imaging Analysis Set|Overall Study||92
247471|NCT00995930|600148|P1|Imaging Analysis Set|Overall Study||92
247472|NCT00995930|600147|P2|Pharmacodynamic (PD) Analysis Set|Overall Study||92
247473|NCT00995930|600148|P1|Pharmacodynamic (PD) Analysis Set|Overall Study||92
247474|NCT00995930|600147|P2|Pharmacokinetic (PK) Analysis Set|Overall Study||95
247475|NCT00995930|600148|P1|Pharmacokinetic (PK) Analysis Set|Overall Study||0
247476|NCT00995930|600147|P2|Safety Analysis Set|Overall Study||95
247477|NCT00995930|600148|P1|Safety Analysis Set|Overall Study||94
247478|NCT00995930|600147|P2|STARTED|Overall Study||95
247479|NCT00995930|600148|P1|STARTED|Overall Study||94
247480|NCT00996034|600177|P1|NOT COMPLETED|Overall Study||3
247481|NCT00996034|600177|P1|COMPLETED|Overall Study||11
247482|NCT00996034|600177|P1|STARTED|Overall Study||14
247483|NCT00996125|600183|P2|NOT COMPLETED|Overall Study||11
247484|NCT00996125|600184|P1|NOT COMPLETED|Overall Study||5
247485|NCT00996125|600183|P2|COMPLETED|Overall Study||365
247486|NCT00996125|600184|P1|COMPLETED|Overall Study||369
247487|NCT00996125|600183|P2|STARTED|Overall Study||376
247488|NCT00996125|600184|P1|STARTED|Overall Study||374
247489|NCT00996164|600206|P2|NOT COMPLETED|Overall Study||101
247490|NCT00996164|600207|P1|NOT COMPLETED|Overall Study||135
247491|NCT00996164|600206|P2|COMPLETED|Overall Study||446
247492|NCT00996164|600207|P1|COMPLETED|Overall Study||408
247493|NCT00996164|600206|P2|STARTED|Overall Study||547
247494|NCT00996164|600207|P1|STARTED|Overall Study||543
247495|NCT00996203|600215|P1|NOT COMPLETED|Overall Study||7
247496|NCT00996203|600215|P1|COMPLETED|Overall Study||194
247497|NCT00996203|600215|P1|STARTED|Overall Study||201
247498|NCT00996216|600234|P1|NOT COMPLETED|Part 2 (Antiviral Treatment Phase)||4
247499|NCT00996216|600234|P1|COMPLETED|Part 2 (Antiviral Treatment Phase)||21
247500|NCT00996216|600234|P1|STARTED|Part 2 (Antiviral Treatment Phase)|One participant who completed Part 1 didn’t qualify to begin antiviral treatment in Part 2.|25
247501|NCT00996216|600234|P1|NOT COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||1
247502|NCT00996216|600234|P1|COMPLETED|Part 1 (Pre-Antiviral Treatment Phase)||26
247503|NCT00996216|600234|P1|STARTED|Part 1 (Pre-Antiviral Treatment Phase)||27
247504|NCT00996281|600252|P2|NOT COMPLETED|Overall Study||89
247505|NCT00996281|600253|P1|NOT COMPLETED|Overall Study||131
247506|NCT00996281|600252|P2|COMPLETED|Overall Study||330
247507|NCT00996281|600253|P1|COMPLETED|Overall Study||287
247508|NCT00996281|600252|P2|STARTED|Overall Study||419
247509|NCT00996281|600253|P1|STARTED|Overall Study||418
247510|NCT00996307|600265|P4|NOT COMPLETED|Overall Study||21
247511|NCT00996307|600266|P3|NOT COMPLETED|Overall Study||14
247512|NCT00996307|600267|P2|NOT COMPLETED|Overall Study||17
247513|NCT00996307|600268|P1|NOT COMPLETED|Overall Study||20
247514|NCT00996307|600265|P4|COMPLETED|Overall Study||144
247515|NCT00996307|600266|P3|COMPLETED|Overall Study||146
247516|NCT00996307|600267|P2|COMPLETED|Overall Study||148
247517|NCT00996307|600268|P1|COMPLETED|Overall Study||144
247518|NCT00996307|600265|P4|STARTED|Overall Study||165
247519|NCT00996307|600266|P3|STARTED|Overall Study||160
247520|NCT00996307|600267|P2|STARTED|Overall Study||165
247521|NCT00996307|600268|P1|STARTED|Overall Study||164
247522|NCT00996333|600326|P1|NOT COMPLETED|Overall Study||13
247523|NCT00996333|600326|P1|COMPLETED|Overall Study||33
247524|NCT00996333|600326|P1|STARTED|Overall Study||46
247525|NCT00996346|600335|P3|NOT COMPLETED|Overall Study||0
247526|NCT00996346|600336|P2|NOT COMPLETED|Overall Study||0
247527|NCT00996346|600337|P1|NOT COMPLETED|Overall Study||0
247528|NCT00996346|600335|P3|COMPLETED|Overall Study||3
247529|NCT00996346|600336|P2|COMPLETED|Overall Study||8
247530|NCT00996346|600337|P1|COMPLETED|Overall Study||6
247531|NCT00996346|600335|P3|STARTED|Overall Study||3
247532|NCT00996346|600336|P2|STARTED|Overall Study||8
247533|NCT00996346|600337|P1|STARTED|Overall Study||6
247534|NCT00996372|600346|P2|NOT COMPLETED|Overall Study||84
247535|NCT00996372|600347|P1|NOT COMPLETED|Overall Study||103
247536|NCT00996372|600346|P2|COMPLETED|Overall Study||397
247537|NCT00996372|600347|P1|COMPLETED|Overall Study||365
247538|NCT00996372|600346|P2|STARTED|Overall Study||481
247539|NCT00996372|600347|P1|STARTED|Overall Study||468
247540|NCT00996437|600359|P2|NOT COMPLETED|Overall Study||7
247541|NCT00996437|600360|P1|NOT COMPLETED|Overall Study||5
247542|NCT00996437|600359|P2|COMPLETED|Overall Study||129
247543|NCT00996437|600360|P1|COMPLETED|Overall Study||120
247544|NCT00996437|600359|P2|STARTED|Overall Study||136
247545|NCT00996437|600360|P1|STARTED|Overall Study||125
247546|NCT00996476|600385|P5|NOT COMPLETED|Overall Study||2
247547|NCT00996476|600386|P4|NOT COMPLETED|Overall Study||0
247548|NCT00996476|600387|P3|NOT COMPLETED|Overall Study||1
247549|NCT00996476|600388|P2|NOT COMPLETED|Overall Study||3
247550|NCT00996476|600389|P1|NOT COMPLETED|Overall Study||1
247551|NCT00996476|600385|P5|COMPLETED|Overall Study||11
247552|NCT00996476|600386|P4|COMPLETED|Overall Study||13
247553|NCT00996476|600387|P3|COMPLETED|Overall Study||12
247554|NCT00996476|600388|P2|COMPLETED|Overall Study||23
247555|NCT00996476|600389|P1|COMPLETED|Overall Study||26
247556|NCT00996476|600385|P5|STARTED|Overall Study||13
247557|NCT00996476|600386|P4|STARTED|Overall Study||13
247558|NCT00996476|600387|P3|STARTED|Overall Study||13
247559|NCT00996476|600388|P2|STARTED|Overall Study||26
247560|NCT00996476|600389|P1|STARTED|Overall Study||27
247561|NCT00996502|600455|P1|NOT COMPLETED|Overall Study||0
247562|NCT00996502|600455|P1|COMPLETED|Overall Study||4
247563|NCT00996502|600455|P1|STARTED|Overall Study||4
247564|NCT00985686|600463|P4|NOT COMPLETED|Overall Study||2
247565|NCT00985686|600464|P3|NOT COMPLETED|Overall Study||0
247566|NCT00985686|600465|P2|NOT COMPLETED|Overall Study||1
247567|NCT00985686|600466|P1|NOT COMPLETED|Overall Study||1
247568|NCT00985686|600463|P4|COMPLETED|Overall Study||14
247569|NCT00985686|600464|P3|COMPLETED|Overall Study||13
247570|NCT00985686|600465|P2|COMPLETED|Overall Study||15
247571|NCT00985686|600466|P1|COMPLETED|Overall Study||17
247572|NCT00985686|600463|P4|Visit 4: Data Collection at 24 Weeks|Overall Study||14
247573|NCT00985686|600464|P3|Visit 4: Data Collection at 24 Weeks|Overall Study||13
247574|NCT00985686|600465|P2|Visit 4: Data Collection at 24 Weeks|Overall Study||15
247575|NCT00985686|600466|P1|Visit 4: Data Collection at 24 Weeks|Overall Study||17
247576|NCT00985686|600463|P4|Visit 3: Data Collection at 16 Weeks|Overall Study||16
247577|NCT00985686|600464|P3|Visit 3: Data Collection at 16 Weeks|Overall Study||13
247578|NCT00985686|600465|P2|Visit 3: Data Collection at 16 Weeks|Overall Study||15
247579|NCT00985686|600466|P1|Visit 3: Data Collection at 16 Weeks|Overall Study||17
247580|NCT00985686|600463|P4|Visit 2: Data Collection at 8 Weeks|Overall Study||16
247581|NCT00985686|600464|P3|Visit 2: Data Collection at 8 Weeks|Overall Study||13
247582|NCT00985686|600465|P2|Visit 2: Data Collection at 8 Weeks|Overall Study||15
247583|NCT00985686|600466|P1|Visit 2: Data Collection at 8 Weeks|Overall Study||18
247584|NCT00985686|600463|P4|Visit 1: Baseline Data Collection|Overall Study||16
247585|NCT00985686|600464|P3|Visit 1: Baseline Data Collection|Overall Study||13
247586|NCT00985686|600465|P2|Visit 1: Baseline Data Collection|Overall Study||15
247587|NCT00985686|600466|P1|Visit 1: Baseline Data Collection|Overall Study||18
247588|NCT00985686|600463|P4|STARTED|Overall Study||16
247589|NCT00985686|600464|P3|STARTED|Overall Study||13
247590|NCT00985686|600465|P2|STARTED|Overall Study||16
247591|NCT00985686|600466|P1|STARTED|Overall Study||18
247592|NCT00985712|600476|P2|NOT COMPLETED|Overall Study||7
247593|NCT00985712|600477|P1|NOT COMPLETED|Overall Study||6
247594|NCT00985712|600476|P2|COMPLETED|Overall Study||123
247595|NCT00985712|600477|P1|COMPLETED|Overall Study||127
247596|NCT00985712|600476|P2|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|129
247597|NCT00985712|600477|P1|Full Analysis Set (FAS)|Overall Study|Participants completed baseline and had at least 1 post-baseline measurement for efficacy analysis.|128
247598|NCT00985712|600476|P2|Received at Least One Dose of Study Drug|Overall Study||130
247599|NCT00985712|600477|P1|Received at Least One Dose of Study Drug|Overall Study||131
247600|NCT00985712|600476|P2|STARTED|Overall Study||130
247601|NCT00985712|600477|P1|STARTED|Overall Study||133
247602|NCT00985725|600493|P2|NOT COMPLETED|Overall Study||13
247603|NCT00985725|600494|P1|NOT COMPLETED|Overall Study||11
247604|NCT00985725|600493|P2|COMPLETED|Overall Study||59
247605|NCT00985725|600494|P1|COMPLETED|Overall Study||60
247606|NCT00985725|600493|P2|STARTED|Overall Study||72
247607|NCT00985725|600494|P1|STARTED|Overall Study||71
247608|NCT00985738|600530|P2|NOT COMPLETED|Overall Study||8
247609|NCT00985738|600531|P1|NOT COMPLETED|Overall Study||8
247610|NCT00985738|600530|P2|COMPLETED|Overall Study||0
247611|NCT00985738|600531|P1|COMPLETED|Overall Study||0
247612|NCT00985738|600530|P2|STARTED|Overall Study||8
247613|NCT00985738|600531|P1|STARTED|Overall Study||8
247614|NCT00985790|600539|P2|NOT COMPLETED|Overall Study||8
247615|NCT00985790|600540|P1|NOT COMPLETED|Overall Study||7
247616|NCT00985790|600539|P2|COMPLETED|Overall Study||293
247617|NCT00985790|600540|P1|COMPLETED|Overall Study||291
247704|NCT00996801|600894|P4|COMPLETED|Overall Study||56
247618|NCT00985790|600539|P2|STARTED|Overall Study|97 were primed and 204 were unprimed subjects.|301
247619|NCT00985790|600540|P1|STARTED|Overall Study|95 were primed and 203 were unprimed subjects.|298
247620|NCT00985829|600576|P1|NOT COMPLETED|Overall Study||0
247621|NCT00985829|600576|P1|COMPLETED|Overall Study||28
247622|NCT00985829|600576|P1|STARTED|Overall Study||28
247623|NCT00985946|600585|P1|NOT COMPLETED|Overall Study||7
247624|NCT00985946|600585|P1|COMPLETED|Overall Study||8
247625|NCT00985946|600585|P1|STARTED|Overall Study|Eighty-seven percent (n=13) were evaluable for response.|15
247626|NCT00985959|600596|P3|NOT COMPLETED|Overall Study||59
247627|NCT00985959|600597|P2|NOT COMPLETED|Overall Study||3
247628|NCT00985959|600598|P1|NOT COMPLETED|Overall Study||3
247629|NCT00985959|600596|P3|COMPLETED|Overall Study||28
247630|NCT00985959|600597|P2|COMPLETED|Overall Study|Completed all 9 cycles|3
247631|NCT00985959|600598|P1|COMPLETED|Overall Study|Completed all 9 cycles|3
247632|NCT00985959|600596|P3|STARTED|Overall Study|Number of participants treated|87
247633|NCT00985959|600597|P2|STARTED|Overall Study|Number of participants treated|6
247634|NCT00985959|600598|P1|STARTED|Overall Study|Number of participants treated|6
247635|NCT00985985|600625|P4|NOT COMPLETED|Overall Study||13
247636|NCT00985985|600626|P3|NOT COMPLETED|Overall Study||11
247637|NCT00985985|600627|P2|NOT COMPLETED|Overall Study||24
247638|NCT00985985|600628|P1|NOT COMPLETED|Overall Study||24
247639|NCT00985985|600625|P4|COMPLETED|Overall Study||107
247640|NCT00985985|600626|P3|COMPLETED|Overall Study||109
247641|NCT00985985|600627|P2|COMPLETED|Overall Study||218
247642|NCT00985985|600628|P1|COMPLETED|Overall Study||217
247731|NCT00997516|601086|P1|NOT COMPLETED|Long-term Follow-up (After 6 Months)||6
247643|NCT00985985|600625|P4|Full Analysis Set (FAS) Population|Overall Study|One participant withdrew consent and was not included as the FAS population.|119
247644|NCT00985985|600626|P3|Full Analysis Set (FAS) Population|Overall Study||120
247645|NCT00985985|600627|P2|Full Analysis Set (FAS) Population|Overall Study||242
247646|NCT00985985|600628|P1|Full Analysis Set (FAS) Population|Overall Study||241
247647|NCT00985985|600625|P4|Safety Population|Overall Study||118
247648|NCT00985985|600626|P3|Safety Population|Overall Study||119
247649|NCT00985985|600627|P2|Safety Population|Overall Study||242
247650|NCT00985985|600628|P1|Safety Population|Overall Study||241
247651|NCT00985985|600625|P4|STARTED|Overall Study||120
247652|NCT00985985|600626|P3|STARTED|Overall Study||120
247653|NCT00985985|600627|P2|STARTED|Overall Study||242
247654|NCT00985985|600628|P1|STARTED|Overall Study||241
247655|NCT00996580|600666|P1|NOT COMPLETED|Overall Study||1453
247656|NCT00996580|600666|P1|COMPLETED|Overall Study||2144
247657|NCT00996580|600666|P1|Pregnancy Intent-to-Treat Population|Overall Study||3019
247658|NCT00996580|600666|P1|STARTED|Overall Study||3597
247659|NCT00996593|600694|P1|NOT COMPLETED|Long-Term Follow-Up||3
247660|NCT00996593|600694|P1|COMPLETED|Long-Term Follow-Up||6
247661|NCT00996593|600694|P1|STARTED|Long-Term Follow-Up|9 of the 40 participants withdrawing from Study BEX104507 enrolled in long-term follow-up study.|9
247662|NCT00996593|600694|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||43
247663|NCT00996593|600694|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
247664|NCT00996593|600694|P1|STARTED|Dosimetric and Therapeutic Treatment||43
247665|NCT00996606|600722|P1|NOT COMPLETED|Overall Study||8
247666|NCT00996606|600722|P1|COMPLETED|Overall Study||50
247667|NCT00996606|600722|P1|STARTED|Overall Study||58
247668|NCT00996632|600818|P2|NOT COMPLETED|Overall Study||0
247669|NCT00996632|600819|P1|NOT COMPLETED|Overall Study||0
247670|NCT00996632|600818|P2|COMPLETED|Overall Study||56
247671|NCT00996632|600819|P1|COMPLETED|Overall Study||38
247672|NCT00996632|600818|P2|STARTED|Overall Study||56
247673|NCT00996632|600819|P1|STARTED|Overall Study||38
247674|NCT00996658|600829|P2|NOT COMPLETED|Overall Study||21
247675|NCT00996658|600830|P1|NOT COMPLETED|Overall Study||16
247676|NCT00996658|600829|P2|COMPLETED|Overall Study||165
247677|NCT00996658|600830|P1|COMPLETED|Overall Study||76
247678|NCT00996658|600829|P2|STARTED|Overall Study||186
247679|NCT00996658|600830|P1|STARTED|Overall Study||92
247680|NCT00996736|600858|P2|NOT COMPLETED|Overall Study||18
247681|NCT00996736|600859|P1|NOT COMPLETED|Overall Study||21
247682|NCT00996736|600858|P2|COMPLETED|Overall Study||143
247683|NCT00996736|600859|P1|COMPLETED|Overall Study||141
247684|NCT00996736|600858|P2|3-month Visit|Overall Study||146
247685|NCT00996736|600859|P1|3-month Visit|Overall Study||146
247686|NCT00996736|600858|P2|3-week Visit|Overall Study|144 visited within pre-specified 3-week window (2.5-5 weeks); 7 had a second visit not within window|151
247687|NCT00996736|600859|P1|3-week Visit|Overall Study|149 visited within pre-specified 3-week window (2.5-5 weeks); 6 had a second visit not within window|155
247688|NCT00996736|600858|P2|STARTED|Overall Study||161
247689|NCT00996736|600859|P1|STARTED|Overall Study||162
247690|NCT00996775|600879|P2|NOT COMPLETED|Overall Study||14
247691|NCT00996775|600880|P1|NOT COMPLETED|Overall Study||11
247692|NCT00996775|600879|P2|COMPLETED|Overall Study||75
247693|NCT00996775|600880|P1|COMPLETED|Overall Study||67
247694|NCT00996775|600879|P2|STARTED|Overall Study||89
247695|NCT00996775|600880|P1|STARTED|Overall Study||78
247696|NCT00996801|600892|P6|NOT COMPLETED|Overall Study||19
247697|NCT00996801|600893|P5|NOT COMPLETED|Overall Study||88
247698|NCT00996801|600894|P4|NOT COMPLETED|Overall Study||31
247699|NCT00996801|600895|P3|NOT COMPLETED|Overall Study||23
247700|NCT00996801|600896|P2|NOT COMPLETED|Overall Study||16
247701|NCT00996801|600897|P1|NOT COMPLETED|Overall Study||20
247702|NCT00996801|600892|P6|COMPLETED|Overall Study||68
247703|NCT00996801|600893|P5|COMPLETED|Overall Study||0
247705|NCT00996801|600895|P3|COMPLETED|Overall Study||65
247706|NCT00996801|600896|P2|COMPLETED|Overall Study||72
247707|NCT00996801|600897|P1|COMPLETED|Overall Study||68
247708|NCT00996801|600892|P6|STARTED|Overall Study||87
247709|NCT00996801|600893|P5|STARTED|Overall Study|15-mg arm was discontinued as a result of Protocol Amendment 1.|88
247710|NCT00996801|600894|P4|STARTED|Overall Study||87
247711|NCT00996801|600895|P3|STARTED|Overall Study||88
247712|NCT00996801|600896|P2|STARTED|Overall Study||88
247713|NCT00996801|600897|P1|STARTED|Overall Study||88
247714|NCT00997425|600998|P1|NOT COMPLETED|Overall Study||0
247715|NCT00997425|600998|P1|COMPLETED|Overall Study||19
247716|NCT00997425|600998|P1|STARTED|Overall Study||19
247717|NCT00997438|601006|P3|NOT COMPLETED|Overall Study||4
247718|NCT00997438|601007|P2|NOT COMPLETED|Overall Study||3
247719|NCT00997438|601008|P1|NOT COMPLETED|Overall Study||5
247720|NCT00997438|601006|P3|COMPLETED|Overall Study||20
247721|NCT00997438|601007|P2|COMPLETED|Overall Study||21
247722|NCT00997438|601008|P1|COMPLETED|Overall Study||16
247723|NCT00997438|601006|P3|STARTED|Overall Study||24
247724|NCT00997438|601007|P2|STARTED|Overall Study||24
247725|NCT00997438|601008|P1|STARTED|Overall Study||21
247726|NCT00997503|601043|P1|NOT COMPLETED|Overall Study||273
247727|NCT00997503|601043|P1|COMPLETED|Overall Study||3926
247728|NCT00997503|601043|P1|12 Months|Overall Study|4059 subjects evaluable at 12-months (cardiac death/MI within 365 days or completed follow-up)|4059
247729|NCT00997503|601043|P1|STARTED|Overall Study||4199
247730|NCT00997516|601085|P2|NOT COMPLETED|Long-term Follow-up (After 6 Months)||2
247732|NCT00997516|601085|P2|COMPLETED|Long-term Follow-up (After 6 Months)||36
247733|NCT00997516|601086|P1|COMPLETED|Long-term Follow-up (After 6 Months)||31
247734|NCT00997516|601085|P2|STARTED|Long-term Follow-up (After 6 Months)||38
247735|NCT00997516|601086|P1|STARTED|Long-term Follow-up (After 6 Months)||37
247736|NCT00997516|601085|P2|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
247737|NCT00997516|601086|P1|NOT COMPLETED|Short-term Follow-up (Post Operative)||0
247738|NCT00997516|601085|P2|COMPLETED|Short-term Follow-up (Post Operative)||38
247739|NCT00997516|601086|P1|COMPLETED|Short-term Follow-up (Post Operative)||37
247740|NCT00997516|601085|P2|STARTED|Short-term Follow-up (Post Operative)||38
247741|NCT00997516|601086|P1|STARTED|Short-term Follow-up (Post Operative)||37
247742|NCT00997555|601116|P2|NOT COMPLETED|Overall Study||0
247743|NCT00997555|601117|P1|NOT COMPLETED|Overall Study||0
247744|NCT00997555|601116|P2|COMPLETED|Overall Study||15
247745|NCT00997555|601117|P1|COMPLETED|Overall Study||13
247746|NCT00997555|601116|P2|STARTED|Overall Study||15
247747|NCT00997555|601117|P1|STARTED|Overall Study||13
247748|NCT00997594|601135|P2|NOT COMPLETED|Overall Study||0
247749|NCT00997594|601136|P1|NOT COMPLETED|Overall Study||0
247750|NCT00997594|601135|P2|COMPLETED|Overall Study||9
247751|NCT00997594|601136|P1|COMPLETED|Overall Study||9
247752|NCT00997594|601135|P2|Completion of Ablation Procedure|Overall Study||9
247753|NCT00997594|601136|P1|Completion of Ablation Procedure|Overall Study||9
247754|NCT00997594|601135|P2|STARTED|Overall Study||9
247755|NCT00997594|601136|P1|STARTED|Overall Study||9
247756|NCT00997672|601144|P2|NOT COMPLETED|Overall Study||4
247757|NCT00997672|601145|P1|NOT COMPLETED|Overall Study||4
247758|NCT00997672|601144|P2|COMPLETED|Overall Study||1
247759|NCT00997672|601145|P1|COMPLETED|Overall Study||0
247760|NCT00997672|601144|P2|STARTED|Overall Study||5
247761|NCT00997672|601145|P1|STARTED|Overall Study||4
247762|NCT00997932|601151|P1|NOT COMPLETED|Overall Study||2
247763|NCT00997932|601151|P1|COMPLETED|Overall Study||27
247764|NCT00997932|601151|P1|STARTED|Overall Study||29
247765|NCT00997984|601159|P3|NOT COMPLETED|Overall Study||26
247766|NCT00997984|601160|P2|NOT COMPLETED|Overall Study||34
247767|NCT00997984|601161|P1|NOT COMPLETED|Overall Study||37
247768|NCT00997984|601159|P3|COMPLETED|Overall Study||88
247769|NCT00997984|601160|P2|COMPLETED|Overall Study||79
247770|NCT00997984|601161|P1|COMPLETED|Overall Study||76
247771|NCT00997984|601159|P3|STARTED|Overall Study||114
247772|NCT00997984|601160|P2|STARTED|Overall Study||113
247773|NCT00997984|601161|P1|STARTED|Overall Study||113
247774|NCT00998023|601229|P2|NOT COMPLETED|Overall Study||0
247775|NCT00998023|601230|P1|NOT COMPLETED|Overall Study||0
247776|NCT00998023|601229|P2|COMPLETED|Overall Study||32
247777|NCT00998023|601230|P1|COMPLETED|Overall Study||32
247778|NCT00998023|601229|P2|STARTED|Overall Study||32
247779|NCT00998023|601230|P1|STARTED|Overall Study||32
247780|NCT00998049|601238|P1|NOT COMPLETED|Overall Study||0
247781|NCT00998049|601238|P1|COMPLETED|Overall Study||39
247782|NCT00998049|601238|P1|STARTED|Overall Study||39
247783|NCT00998205|601247|P1|NOT COMPLETED|Overall Study||0
247784|NCT00998205|601247|P1|COMPLETED|Overall Study||16
247785|NCT00998205|601247|P1|STARTED|Overall Study||16
247786|NCT00998296|601263|P11|NOT COMPLETED|Overall Study||7
247787|NCT00998296|601264|P10|NOT COMPLETED|Overall Study||18
247788|NCT00998296|601265|P9|NOT COMPLETED|Overall Study||2
247789|NCT00998296|601266|P8|NOT COMPLETED|Overall Study||2
247790|NCT00998296|601267|P7|NOT COMPLETED|Overall Study||1
247791|NCT00998296|601268|P6|NOT COMPLETED|Overall Study||0
247792|NCT00998296|601269|P5|NOT COMPLETED|Overall Study||2
247793|NCT00998296|601270|P4|NOT COMPLETED|Overall Study||0
247794|NCT00998296|601271|P3|NOT COMPLETED|Overall Study||0
247795|NCT00998296|601272|P2|NOT COMPLETED|Overall Study||1
247796|NCT00998296|601273|P1|NOT COMPLETED|Overall Study||0
247797|NCT00998296|601263|P11|COMPLETED|Overall Study||0
247798|NCT00998296|601264|P10|COMPLETED|Overall Study||0
247799|NCT00998296|601265|P9|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
247800|NCT00998296|601266|P8|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|4
247801|NCT00998296|601267|P7|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
247802|NCT00998296|601268|P6|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
247803|NCT00998296|601269|P5|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
247804|NCT00998296|601270|P4|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
247805|NCT00998296|601271|P3|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|3
247806|NCT00998296|601272|P2|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|2
247807|NCT00998296|601273|P1|COMPLETED|Overall Study|Did not discontinue treatment before or at Day 28|6
247808|NCT00998296|601263|P11|STARTED|Overall Study||7
247809|NCT00998296|601264|P10|STARTED|Overall Study||18
247810|NCT00998296|601265|P9|STARTED|Overall Study||6
247811|NCT00998296|601266|P8|STARTED|Overall Study||6
247812|NCT00998296|601267|P7|STARTED|Overall Study||7
247813|NCT00998296|601268|P6|STARTED|Overall Study||3
247814|NCT00998296|601269|P5|STARTED|Overall Study||8
247815|NCT00998296|601270|P4|STARTED|Overall Study||3
247816|NCT00998296|601271|P3|STARTED|Overall Study||3
247817|NCT00998296|601272|P2|STARTED|Overall Study||3
247818|NCT00998296|601273|P1|STARTED|Overall Study||6
247819|NCT00998309|601340|P1|NOT COMPLETED|Overall Study||4
247820|NCT00998309|601340|P1|COMPLETED|Overall Study||498
247821|NCT00998309|601340|P1|STARTED|Overall Study||502
247822|NCT00998335|601398|P2|NOT COMPLETED|Randomized Period (Months 3 to 6)||2
247823|NCT00998335|601399|P1|NOT COMPLETED|Randomized Period (Months 3 to 6)||0
247824|NCT00998335|601398|P2|COMPLETED|Randomized Period (Months 3 to 6)||20
247825|NCT00998335|601399|P1|COMPLETED|Randomized Period (Months 3 to 6)||8
247826|NCT00998335|601398|P2|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|22
247827|NCT00998335|601399|P1|STARTED|Randomized Period (Months 3 to 6)|"All participants started in the Insulin detemir only arm. At month 3 subjects were randomized 2:1."|8
247828|NCT00998335|601398|P2|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
247829|NCT00998335|601399|P1|NOT COMPLETED|Initial Treatment (Months 0 - 3)||0
247830|NCT00998335|601398|P2|COMPLETED|Initial Treatment (Months 0 - 3)||0
247831|NCT00998335|601399|P1|COMPLETED|Initial Treatment (Months 0 - 3)||30
247832|NCT00998335|601398|P2|STARTED|Initial Treatment (Months 0 - 3)||0
247833|NCT00998335|601399|P1|STARTED|Initial Treatment (Months 0 - 3)||30
247834|NCT00998374|601429|P2|NOT COMPLETED|Overall Study||11
247835|NCT00998374|601430|P1|NOT COMPLETED|Overall Study||12
247836|NCT00998374|601429|P2|COMPLETED|Overall Study||12
247837|NCT00998374|601430|P1|COMPLETED|Overall Study||27
247838|NCT00998374|601429|P2|STARTED|Overall Study||23
247839|NCT00998374|601430|P1|STARTED|Overall Study||39
247840|NCT00998426|601442|P1|NOT COMPLETED|Overall Study||0
247841|NCT00998426|601442|P1|COMPLETED|Overall Study||5
247842|NCT00998426|601442|P1|Blood Glucose Monitoring|Overall Study||5
247843|NCT00998426|601442|P1|STARTED|Overall Study||5
247844|NCT00998517|601450|P3|NOT COMPLETED|Overall Study||0
247845|NCT00998517|601451|P2|NOT COMPLETED|Overall Study||0
247846|NCT00998517|601452|P1|NOT COMPLETED|Overall Study||0
247847|NCT00998517|601450|P3|COMPLETED|Overall Study||918
247848|NCT00998517|601451|P2|COMPLETED|Overall Study||906
247849|NCT00998517|601452|P1|COMPLETED|Overall Study||888
247850|NCT00998517|601450|P3|STARTED|Overall Study||918
247851|NCT00998517|601451|P2|STARTED|Overall Study||906
247852|NCT00998517|601452|P1|STARTED|Overall Study||888
247853|NCT00998582|601480|P2|NOT COMPLETED|Overall Study||0
247854|NCT00998582|601481|P1|NOT COMPLETED|Overall Study||0
247855|NCT00998582|601480|P2|COMPLETED|Overall Study||14
247856|NCT00998582|601481|P1|COMPLETED|Overall Study||13
247857|NCT00998582|601480|P2|STARTED|Overall Study||14
247858|NCT00998582|601481|P1|STARTED|Overall Study||13
247859|NCT00998660|601492|P1|NOT COMPLETED|Overall Study||13
247860|NCT00998660|601492|P1|COMPLETED|Overall Study|87 subjects reached the final study visit at Month 6.|87
247861|NCT00998660|601492|P1|Month 3 Visit|Overall Study||87
247862|NCT00998660|601492|P1|Implanted|Overall Study||93
247863|NCT00998660|601492|P1|STARTED|Overall Study||100
247864|NCT00998738|601496|P1|NOT COMPLETED|Overall Study||1
247865|NCT00998738|601496|P1|COMPLETED|Overall Study||0
247866|NCT00998738|601496|P1|STARTED|Overall Study||1
247867|NCT00998764|601510|P2|NOT COMPLETED|Overall Study||274
247868|NCT00998764|601511|P1|NOT COMPLETED|Overall Study||216
247869|NCT00998764|601510|P2|COMPLETED|Overall Study||2
247870|NCT00998764|601511|P1|COMPLETED|Overall Study||0
247871|NCT00998764|601510|P2|Treated|Overall Study||275
247872|NCT00998764|601511|P1|Treated|Overall Study||215
247873|NCT00998764|601510|P2|STARTED|Overall Study||276
247874|NCT00998764|601511|P1|STARTED|Overall Study||216
247875|NCT00998868|601533|P1|NOT COMPLETED|Overall Study||0
247876|NCT00998868|601533|P1|COMPLETED|Overall Study||51
247877|NCT00998868|601533|P1|STARTED|Overall Study|>=10 for each muscle strength per MRC scale, after excluding the cases following exclusion criteria|51
247878|NCT00998881|601542|P2|NOT COMPLETED|Overall Study||2
247879|NCT00998881|601543|P1|NOT COMPLETED|Overall Study||8
247880|NCT00998881|601542|P2|COMPLETED|Overall Study||97
247881|NCT00998881|601543|P1|COMPLETED|Overall Study||96
247882|NCT00998881|601542|P2|STARTED|Overall Study||99
247883|NCT00998881|601543|P1|STARTED|Overall Study||104
247884|NCT00998985|601569|P14|NOT COMPLETED|Overall Study||0
247885|NCT00998985|601570|P13|NOT COMPLETED|Overall Study||0
247886|NCT00998985|601571|P12|NOT COMPLETED|Overall Study||0
247887|NCT00998985|601572|P11|NOT COMPLETED|Overall Study||0
247888|NCT00998985|601573|P10|NOT COMPLETED|Overall Study||0
247889|NCT00998985|601574|P9|NOT COMPLETED|Overall Study||1
247890|NCT00998985|601575|P8|NOT COMPLETED|Overall Study||0
247891|NCT00998985|601576|P7|NOT COMPLETED|Overall Study||0
247892|NCT00998985|601577|P6|NOT COMPLETED|Overall Study||1
247893|NCT00998985|601578|P5|NOT COMPLETED|Overall Study||0
247894|NCT00998985|601579|P4|NOT COMPLETED|Overall Study||0
247895|NCT00998985|601580|P3|NOT COMPLETED|Overall Study||0
247896|NCT00998985|601581|P2|NOT COMPLETED|Overall Study||0
247897|NCT00998985|601582|P1|NOT COMPLETED|Overall Study||0
247898|NCT00998985|601569|P14|COMPLETED|Overall Study||15
247899|NCT00998985|601570|P13|COMPLETED|Overall Study||5
247900|NCT00998985|601571|P12|COMPLETED|Overall Study||5
247901|NCT00998985|601572|P11|COMPLETED|Overall Study||5
247902|NCT00998985|601573|P10|COMPLETED|Overall Study||5
247903|NCT00998985|601574|P9|COMPLETED|Overall Study||5
247904|NCT00998985|601575|P8|COMPLETED|Overall Study||5
247905|NCT00998985|601576|P7|COMPLETED|Overall Study||5
247906|NCT00998985|601577|P6|COMPLETED|Overall Study||4
247907|NCT00998985|601578|P5|COMPLETED|Overall Study||5
247908|NCT00998985|601579|P4|COMPLETED|Overall Study||5
247909|NCT00998985|601580|P3|COMPLETED|Overall Study||15
247910|NCT00998985|601581|P2|COMPLETED|Overall Study||5
247911|NCT00998985|601582|P1|COMPLETED|Overall Study||5
247912|NCT00998985|601569|P14|STARTED|Overall Study||15
247913|NCT00998985|601570|P13|STARTED|Overall Study||5
247914|NCT00998985|601571|P12|STARTED|Overall Study||5
247915|NCT00998985|601572|P11|STARTED|Overall Study||5
247916|NCT00998985|601573|P10|STARTED|Overall Study||5
247917|NCT00998985|601574|P9|STARTED|Overall Study||6
247918|NCT00998985|601575|P8|STARTED|Overall Study||5
247919|NCT00998985|601576|P7|STARTED|Overall Study||5
247920|NCT00998985|601577|P6|STARTED|Overall Study||5
247921|NCT00998985|601578|P5|STARTED|Overall Study||5
247922|NCT00998985|601579|P4|STARTED|Overall Study||5
247923|NCT00998985|601580|P3|STARTED|Overall Study||15
247924|NCT00998985|601581|P2|STARTED|Overall Study||5
247925|NCT00998985|601582|P1|STARTED|Overall Study||5
247926|NCT00999037|601650|P2|NOT COMPLETED|Overall Study||0
247927|NCT00999037|601651|P1|NOT COMPLETED|Overall Study||0
247928|NCT00999037|601650|P2|COMPLETED|Overall Study||9
247929|NCT00999037|601651|P1|COMPLETED|Overall Study||9
247930|NCT00999037|601650|P2|STARTED|Overall Study|20|9
247931|NCT00999037|601651|P1|STARTED|Overall Study||9
247932|NCT00999141|601661|P1|NOT COMPLETED|Overall Study||0
247933|NCT00999141|601661|P1|COMPLETED|Overall Study||75
247934|NCT00999141|601661|P1|STARTED|Overall Study|Randomized and treated|75
247935|NCT00999167|601745|P3|NOT COMPLETED|Part B: Randomized, Placebo Controlled||21
247936|NCT00999167|601746|P2|NOT COMPLETED|Part B: Randomized, Placebo Controlled||35
247937|NCT00999167|601747|P1|NOT COMPLETED|Part B: Randomized, Placebo Controlled||0
247938|NCT00999167|601745|P3|COMPLETED|Part B: Randomized, Placebo Controlled||67
247939|NCT00999167|601746|P2|COMPLETED|Part B: Randomized, Placebo Controlled||55
247940|NCT00999167|601747|P1|COMPLETED|Part B: Randomized, Placebo Controlled||0
247941|NCT00999167|601745|P3|STARTED|Part B: Randomized, Placebo Controlled||88
247942|NCT00999167|601746|P2|STARTED|Part B: Randomized, Placebo Controlled|4 subjects who participated in Part A enrolled in Part B and remainder were newly enrolled|90
247943|NCT00999167|601747|P1|STARTED|Part B: Randomized, Placebo Controlled||0
247944|NCT00999167|601745|P3|NOT COMPLETED|Part A: Open Label Safety run-in||0
247945|NCT00999167|601746|P2|NOT COMPLETED|Part A: Open Label Safety run-in||0
247946|NCT00999167|601747|P1|NOT COMPLETED|Part A: Open Label Safety run-in||7
247947|NCT00999167|601745|P3|COMPLETED|Part A: Open Label Safety run-in||0
247948|NCT00999167|601746|P2|COMPLETED|Part A: Open Label Safety run-in||0
247949|NCT00999167|601747|P1|COMPLETED|Part A: Open Label Safety run-in||8
247950|NCT00999167|601745|P3|Received 9 mL BID|Part A: Open Label Safety run-in||0
247951|NCT00999167|601746|P2|Received 9 mL BID|Part A: Open Label Safety run-in||0
247952|NCT00999167|601747|P1|Received 9 mL BID|Part A: Open Label Safety run-in||15
247953|NCT00999167|601745|P3|STARTED|Part A: Open Label Safety run-in||0
247954|NCT00999167|601746|P2|STARTED|Part A: Open Label Safety run-in||0
247955|NCT00999167|601747|P1|STARTED|Part A: Open Label Safety run-in||15
247956|NCT00999466|601764|P3|NOT COMPLETED|Main Part||4
247957|NCT00999466|601765|P2|NOT COMPLETED|Main Part||4
247958|NCT00999466|601766|P1|NOT COMPLETED|Main Part||0
247959|NCT00999466|601764|P3|COMPLETED|Main Part||21
247960|NCT00999466|601765|P2|COMPLETED|Main Part||22
247961|NCT00999466|601766|P1|COMPLETED|Main Part||0
247962|NCT00999466|601764|P3|STARTED|Main Part||25
247963|NCT00999466|601765|P2|STARTED|Main Part||26
247964|NCT00999466|601766|P1|STARTED|Main Part|AZD8848 nasal spray 30 μg group was not participated in the Main part|0
247965|NCT00999466|601764|P3|NOT COMPLETED|Pilot Part||0
247966|NCT00999466|601765|P2|NOT COMPLETED|Pilot Part||0
247967|NCT00999466|601766|P1|NOT COMPLETED|Pilot Part||0
247968|NCT00999466|601764|P3|COMPLETED|Pilot Part||3
247969|NCT00999466|601765|P2|COMPLETED|Pilot Part||0
247970|NCT00999466|601766|P1|COMPLETED|Pilot Part||6
247971|NCT00999466|601764|P3|STARTED|Pilot Part||3
247972|NCT00999466|601765|P2|STARTED|Pilot Part|AZD8848 nasal spray 60 μg group was not participated in the Pilot part|0
247973|NCT00999466|601766|P1|STARTED|Pilot Part||6
247974|NCT00999544|602041|P1|NOT COMPLETED|Overall Study||1
247975|NCT00999544|602041|P1|COMPLETED|Overall Study||8
247976|NCT00999544|602041|P1|STARTED|Overall Study||9
247977|NCT00999596|602059|P1|NOT COMPLETED|Overall Study||101
247978|NCT00999596|602059|P1|COMPLETED|Overall Study|Not all patient images were used for the reader evaluation based on new FDA Guidelines|6
247979|NCT00999596|602059|P1|New FDA Guideline Released|Overall Study|FDA Guidance: Class II Special Controls Guidance Document: Full-Field Digital Mammography System|6
247980|NCT00999596|602059|P1|STARTED|Overall Study||107
247981|NCT00999661|602064|P1|NOT COMPLETED|Overall Study||70
247982|NCT00999661|602064|P1|COMPLETED|Overall Study||161
247983|NCT00999661|602064|P1|STARTED|Overall Study||231
247984|NCT00999687|602070|P1|NOT COMPLETED|Second Intervention||3
247985|NCT00999687|602070|P1|COMPLETED|Second Intervention||27
247986|NCT00999687|602070|P1|STARTED|Second Intervention|From week 13 to 24, all participants applied INOE to both hands twice daily.|30
247987|NCT00999687|602070|P1|NOT COMPLETED|First Intervention||1
247988|NCT00999687|602070|P1|COMPLETED|First Intervention||30
247989|NCT00999687|602070|P1|STARTED|First Intervention|16 used the INOE on the right hand,15 used the INOE on the left hand.|31
247990|NCT00999804|602079|P2|NOT COMPLETED|Overall Study||5
247991|NCT00999804|602080|P1|NOT COMPLETED|Overall Study||21
247992|NCT00999804|602079|P2|COMPLETED|Overall Study||38
247993|NCT00999804|602080|P1|COMPLETED|Overall Study||64
247994|NCT00999804|602079|P2|STARTED|Overall Study||43
247995|NCT00999804|602080|P1|STARTED|Overall Study||85
247996|NCT00999830|602094|P2|NOT COMPLETED|Overall Study||0
247997|NCT00999830|602095|P1|NOT COMPLETED|Overall Study||0
247998|NCT00999830|602094|P2|COMPLETED|Overall Study||13
247999|NCT00999830|602095|P1|COMPLETED|Overall Study||14
248000|NCT00999830|602094|P2|STARTED|Overall Study||13
248001|NCT00999830|602095|P1|STARTED|Overall Study||14
248002|NCT00989014|602109|P4|NOT COMPLETED|Overall Study||0
248003|NCT00989014|602110|P3|NOT COMPLETED|Overall Study||0
248004|NCT00989014|602111|P2|NOT COMPLETED|Overall Study||0
248005|NCT00989014|602112|P1|NOT COMPLETED|Overall Study||0
248006|NCT00989014|602109|P4|COMPLETED|Overall Study||32
248007|NCT00989014|602110|P3|COMPLETED|Overall Study||28
248008|NCT00989014|602111|P2|COMPLETED|Overall Study||31
248009|NCT00989014|602112|P1|COMPLETED|Overall Study||31
248010|NCT00989014|602109|P4|STARTED|Overall Study||32
248011|NCT00989014|602110|P3|STARTED|Overall Study||28
248012|NCT00989014|602111|P2|STARTED|Overall Study||31
248013|NCT00989014|602112|P1|STARTED|Overall Study||31
248014|NCT00989092|602124|P2|NOT COMPLETED|Overall Study||28
248015|NCT00989092|602125|P1|NOT COMPLETED|Overall Study||90
248016|NCT00989092|602124|P2|COMPLETED|Overall Study||31
248017|NCT00989092|602125|P1|COMPLETED|Overall Study||138
248018|NCT00989092|602124|P2|Treated With Darbepoetin Alfa|Overall Study||33
248019|NCT00989092|602125|P1|Treated With Darbepoetin Alfa|Overall Study||226
248020|NCT00989092|602124|P2|STARTED|Overall Study||59
248021|NCT00989092|602125|P1|STARTED|Overall Study||228
248022|NCT00989157|602160|P2|NOT COMPLETED|Overall Study||0
248023|NCT00989157|602161|P1|NOT COMPLETED|Overall Study||0
248024|NCT00989157|602160|P2|COMPLETED|Overall Study||10
248025|NCT00989157|602161|P1|COMPLETED|Overall Study||10
248026|NCT00989157|602160|P2|STARTED|Overall Study||10
248027|NCT00989157|602161|P1|STARTED|Overall Study||10
248028|NCT00989196|602175|P2|NOT COMPLETED|Treatment Period||0
248029|NCT00989196|602176|P1|NOT COMPLETED|Treatment Period||1
248030|NCT00989196|602175|P2|COMPLETED|Treatment Period||12
248031|NCT00989196|602176|P1|COMPLETED|Treatment Period||9
248032|NCT00989196|602175|P2|STARTED|Treatment Period||12
248033|NCT00989196|602176|P1|STARTED|Treatment Period||10
248034|NCT00989196|602175|P2|NOT COMPLETED|PK Crossover Period||0
248035|NCT00989196|602176|P1|NOT COMPLETED|PK Crossover Period||0
248036|NCT00989196|602175|P2|COMPLETED|PK Crossover Period||12
248037|NCT00989196|602176|P1|COMPLETED|PK Crossover Period||10
248038|NCT00989196|602175|P2|STARTED|PK Crossover Period||12
248039|NCT00989196|602176|P1|STARTED|PK Crossover Period||10
248040|NCT00989235|602197|P2|NOT COMPLETED|Overall Study||6
248041|NCT00989235|602198|P1|NOT COMPLETED|Overall Study||3
248042|NCT00989235|602197|P2|COMPLETED|Overall Study||44
248043|NCT00989235|602198|P1|COMPLETED|Overall Study||55
248044|NCT00989235|602197|P2|Number Completing Double-Blind Treatment|Overall Study||41
248045|NCT00989235|602198|P1|Number Completing Double-Blind Treatment|Overall Study||51
248046|NCT00989235|602197|P2|Number Rescued to Open-Label Treatment|Overall Study|Of these, 1 was discontinued from open-label treatment (lost to follow-up).|4
248047|NCT00989235|602198|P1|Number Rescued to Open-Label Treatment|Overall Study||4
248048|NCT00989235|602197|P2|STARTED|Overall Study||50
248049|NCT00989235|602198|P1|STARTED|Overall Study||58
248050|NCT00989586|602245|P2|NOT COMPLETED|Overall Study||0
248051|NCT00989586|602246|P1|NOT COMPLETED|Overall Study||0
248052|NCT00989586|602245|P2|COMPLETED|Overall Study||17
248053|NCT00989586|602246|P1|COMPLETED|Overall Study||18
248054|NCT00989586|602245|P2|STARTED|Overall Study||17
248055|NCT00989586|602246|P1|STARTED|Overall Study||18
248056|NCT00989664|602259|P1|NOT COMPLETED|Long-Term Follow-Up||3
248057|NCT00989664|602259|P1|COMPLETED|Long-Term Follow-Up||11
248058|NCT00989664|602259|P1|STARTED|Long-Term Follow-Up|14 of the 61 participants withdrawing from Study BEX104504 enrolled in the LTFU study.|14
248059|NCT00989664|602259|P1|NOT COMPLETED|Dosimetric and Therapeutic Treatment||61
248060|NCT00989664|602259|P1|COMPLETED|Dosimetric and Therapeutic Treatment||0
248061|NCT00989664|602259|P1|STARTED|Dosimetric and Therapeutic Treatment||61
248062|NCT00989768|602287|P1|NOT COMPLETED|Overall Study||1
248063|NCT00989768|602287|P1|COMPLETED|Overall Study||28
248064|NCT00989768|602287|P1|STARTED|Overall Study|All patients received both treatments. They are their own controls|29
248065|NCT00989833|602301|P3|NOT COMPLETED|Overall Study||2
248066|NCT00989833|602302|P2|NOT COMPLETED|Overall Study||3
248067|NCT00989833|602303|P1|NOT COMPLETED|Overall Study||2
248068|NCT00989833|602301|P3|COMPLETED|Overall Study||21
248069|NCT00989833|602302|P2|COMPLETED|Overall Study||19
248070|NCT00989833|602303|P1|COMPLETED|Overall Study||19
248071|NCT00989833|602301|P3|STARTED|Overall Study||23
248072|NCT00989833|602302|P2|STARTED|Overall Study||22
248073|NCT00989833|602303|P1|STARTED|Overall Study||21
248074|NCT00989911|602332|P1|NOT COMPLETED|Overall Study||3
248075|NCT00989911|602332|P1|COMPLETED|Overall Study||7
248076|NCT00989911|602332|P1|STARTED|Overall Study||10
248077|NCT00989950|602340|P4|NOT COMPLETED|Randomized Phase||0
248078|NCT00989950|602341|P3|NOT COMPLETED|Randomized Phase||0
248079|NCT00989950|602342|P2|NOT COMPLETED|Randomized Phase||1
248080|NCT00989950|602343|P1|NOT COMPLETED|Randomized Phase||1
248081|NCT00989950|602340|P4|COMPLETED|Randomized Phase||7
248082|NCT00989950|602341|P3|COMPLETED|Randomized Phase||4
248083|NCT00989950|602342|P2|COMPLETED|Randomized Phase||8
248084|NCT00989950|602343|P1|COMPLETED|Randomized Phase||5
248085|NCT00989950|602340|P4|STARTED|Randomized Phase||7
248086|NCT00989950|602341|P3|STARTED|Randomized Phase||4
248087|NCT00989950|602342|P2|STARTED|Randomized Phase||9
248088|NCT00989950|602343|P1|STARTED|Randomized Phase||6
248089|NCT00989950|602340|P4|NOT COMPLETED|Open Label Dose Optimization||0
248090|NCT00989950|602341|P3|NOT COMPLETED|Open Label Dose Optimization||0
248091|NCT00989950|602342|P2|NOT COMPLETED|Open Label Dose Optimization||0
248092|NCT00989950|602343|P1|NOT COMPLETED|Open Label Dose Optimization||0
248093|NCT00989950|602340|P4|COMPLETED|Open Label Dose Optimization||7
248094|NCT00989950|602341|P3|COMPLETED|Open Label Dose Optimization||4
248095|NCT00989950|602342|P2|COMPLETED|Open Label Dose Optimization||9
248096|NCT00989950|602343|P1|COMPLETED|Open Label Dose Optimization||6
248097|NCT00989950|602340|P4|STARTED|Open Label Dose Optimization||7
248098|NCT00989950|602341|P3|STARTED|Open Label Dose Optimization||4
248099|NCT00989950|602342|P2|STARTED|Open Label Dose Optimization||9
248100|NCT00989950|602343|P1|STARTED|Open Label Dose Optimization||6
248101|NCT00989989|602356|P3|NOT COMPLETED|Overall Study||23
248102|NCT00989989|602357|P2|NOT COMPLETED|Overall Study||10
248103|NCT00989989|602358|P1|NOT COMPLETED|Overall Study||18
248104|NCT00989989|602356|P3|COMPLETED|Overall Study||108
248105|NCT00989989|602357|P2|COMPLETED|Overall Study||123
248106|NCT00989989|602358|P1|COMPLETED|Overall Study||114
248107|NCT00989989|602356|P3|STARTED|Overall Study||131
248108|NCT00989989|602357|P2|STARTED|Overall Study||133
248109|NCT00989989|602358|P1|STARTED|Overall Study||132
248110|NCT00990093|602396|P2|NOT COMPLETED|Test Period 2 (15-28 Days)||1
248111|NCT00990093|602397|P1|NOT COMPLETED|Test Period 2 (15-28 Days)||2
248112|NCT00990093|602396|P2|COMPLETED|Test Period 2 (15-28 Days)||14
248113|NCT00990093|602397|P1|COMPLETED|Test Period 2 (15-28 Days)||13
248114|NCT00990093|602396|P2|STARTED|Test Period 2 (15-28 Days)||15
248115|NCT00990093|602397|P1|STARTED|Test Period 2 (15-28 Days)||15
248116|NCT00990093|602396|P2|NOT COMPLETED|Test Period 1 (1-14 Days)||2
248117|NCT00990093|602397|P1|NOT COMPLETED|Test Period 1 (1-14 Days)||4
248118|NCT00990093|602396|P2|COMPLETED|Test Period 1 (1-14 Days)||15
248119|NCT00990093|602397|P1|COMPLETED|Test Period 1 (1-14 Days)||15
248120|NCT00990093|602396|P2|STARTED|Test Period 1 (1-14 Days)||17
248121|NCT00990093|602397|P1|STARTED|Test Period 1 (1-14 Days)||19
248122|NCT00990106|602405|P2|NOT COMPLETED|Overall Study||12
248123|NCT00990106|602406|P1|NOT COMPLETED|Overall Study||9
248124|NCT00990106|602405|P2|COMPLETED|Overall Study||23
248125|NCT00990106|602406|P1|COMPLETED|Overall Study||23
248126|NCT00990106|602405|P2|STARTED|Overall Study||35
248127|NCT00990106|602406|P1|STARTED|Overall Study||32
248128|NCT00990184|602416|P1|NOT COMPLETED|Overall Study||1
248129|NCT00990184|602416|P1|COMPLETED|Overall Study||20
248130|NCT00990184|602416|P1|STARTED|Overall Study||21
248131|NCT00990340|602424|P2|NOT COMPLETED|Second 14-day Treatment||0
248132|NCT00990340|602425|P1|NOT COMPLETED|Second 14-day Treatment||0
248133|NCT00990340|602424|P2|COMPLETED|Second 14-day Treatment||21
248134|NCT00990340|602425|P1|COMPLETED|Second 14-day Treatment||21
248135|NCT00990340|602424|P2|STARTED|Second 14-day Treatment||21
248136|NCT00990340|602425|P1|STARTED|Second 14-day Treatment||21
248137|NCT00990340|602424|P2|NOT COMPLETED|First 14-day Treatment||4
248138|NCT00990340|602425|P1|NOT COMPLETED|First 14-day Treatment||6
248139|NCT00990340|602424|P2|COMPLETED|First 14-day Treatment||21
248140|NCT00990340|602425|P1|COMPLETED|First 14-day Treatment||21
248141|NCT00990340|602424|P2|STARTED|First 14-day Treatment||25
248142|NCT00990340|602425|P1|STARTED|First 14-day Treatment||27
248143|NCT00990509|602441|P2|NOT COMPLETED|Overall Study||1
248144|NCT00990509|602442|P1|NOT COMPLETED|Overall Study||0
248145|NCT00990509|602441|P2|COMPLETED|Overall Study||8
248146|NCT00990509|602442|P1|COMPLETED|Overall Study||5
248147|NCT00990509|602441|P2|STARTED|Overall Study||9
248148|NCT00990509|602442|P1|STARTED|Overall Study||5
248149|NCT00990561|602454|P4|NOT COMPLETED|Period 2||2
248150|NCT00990561|602455|P3|NOT COMPLETED|Period 2||0
248151|NCT00990561|602456|P2|NOT COMPLETED|Period 2||0
248152|NCT00990561|602457|P1|NOT COMPLETED|Period 2||0
248153|NCT00990561|602454|P4|COMPLETED|Period 2||17
248154|NCT00990561|602455|P3|COMPLETED|Period 2||20
248155|NCT00990561|602456|P2|COMPLETED|Period 2||0
248156|NCT00990561|602457|P1|COMPLETED|Period 2||0
248157|NCT00990561|602454|P4|STARTED|Period 2||19
248158|NCT00990561|602455|P3|STARTED|Period 2||20
248159|NCT00990561|602456|P2|STARTED|Period 2||0
248160|NCT00990561|602457|P1|STARTED|Period 2||0
248161|NCT00990561|602454|P4|NOT COMPLETED|Period 1||0
248162|NCT00990561|602455|P3|NOT COMPLETED|Period 1||0
248163|NCT00990561|602456|P2|NOT COMPLETED|Period 1||1
248164|NCT00990561|602457|P1|NOT COMPLETED|Period 1||0
248165|NCT00990561|602454|P4|COMPLETED|Period 1||0
248166|NCT00990561|602455|P3|COMPLETED|Period 1||0
248167|NCT00990561|602456|P2|COMPLETED|Period 1||19
248168|NCT00990561|602457|P1|COMPLETED|Period 1||20
248169|NCT00990561|602454|P4|STARTED|Period 1||0
248170|NCT00990561|602455|P3|STARTED|Period 1||0
248171|NCT00990561|602456|P2|STARTED|Period 1||20
248172|NCT00990561|602457|P1|STARTED|Period 1||20
248173|NCT00990652|602463|P1|NOT COMPLETED|Post-sugery Bortezomib + Temozolomide||1
248174|NCT00990652|602463|P1|COMPLETED|Post-sugery Bortezomib + Temozolomide||8
248175|NCT00990652|602463|P1|STARTED|Post-sugery Bortezomib + Temozolomide||9
248176|NCT00990652|602463|P1|NOT COMPLETED|Surgical Resection||0
248177|NCT00990652|602463|P1|COMPLETED|Surgical Resection||9
248178|NCT00990652|602463|P1|STARTED|Surgical Resection||9
248179|NCT00990652|602463|P1|NOT COMPLETED|Pre-surgical Bortezomib||1
248180|NCT00990652|602463|P1|COMPLETED|Pre-surgical Bortezomib||9
248181|NCT00990652|602463|P1|STARTED|Pre-surgical Bortezomib||10
248182|NCT00990704|602473|P2|NOT COMPLETED|Overall Study||2
248183|NCT00990704|602474|P1|NOT COMPLETED|Overall Study||1
248184|NCT00990704|602473|P2|COMPLETED|Overall Study||31
248185|NCT00990704|602474|P1|COMPLETED|Overall Study||13
248186|NCT00990704|602473|P2|STARTED|Overall Study||33
248187|NCT00990704|602474|P1|STARTED|Overall Study||14
248188|NCT00990769|602496|P2|NOT COMPLETED|Overall Study||0
248189|NCT00990769|602497|P1|NOT COMPLETED|Overall Study||0
248190|NCT00990769|602496|P2|COMPLETED|Overall Study||18
248191|NCT00990769|602497|P1|COMPLETED|Overall Study||22
248192|NCT00990769|602496|P2|STARTED|Overall Study|Signed consent and assigned to Low-normal BIS|18
248193|NCT00990769|602497|P1|STARTED|Overall Study|Signed consent and assigned to High-normal BIS|22
248194|NCT00990782|602507|P1|NOT COMPLETED|Overall Study||5
248195|NCT00990782|602507|P1|COMPLETED|Overall Study||88
248196|NCT00990782|602507|P1|STARTED|Overall Study||93
248197|NCT00990821|602526|P14|NOT COMPLETED|Overall Study||1
248198|NCT00990821|602527|P13|NOT COMPLETED|Overall Study||2
248199|NCT00990821|602528|P12|NOT COMPLETED|Overall Study||5
248200|NCT00990821|602529|P11|NOT COMPLETED|Overall Study||3
248201|NCT00990821|602530|P10|NOT COMPLETED|Overall Study||1
248202|NCT00990821|602531|P9|NOT COMPLETED|Overall Study||0
248203|NCT00990821|602532|P8|NOT COMPLETED|Overall Study||0
248204|NCT00990821|602533|P7|NOT COMPLETED|Overall Study||1
248205|NCT00990821|602534|P6|NOT COMPLETED|Overall Study||3
248206|NCT00990821|602535|P5|NOT COMPLETED|Overall Study||3
248207|NCT00990821|602536|P4|NOT COMPLETED|Overall Study||0
248208|NCT00990821|602537|P3|NOT COMPLETED|Overall Study||0
248209|NCT00990821|602538|P2|NOT COMPLETED|Overall Study||2
248210|NCT00990821|602539|P1|NOT COMPLETED|Overall Study||0
248211|NCT00990821|602526|P14|COMPLETED|Overall Study||11
248212|NCT00990821|602527|P13|COMPLETED|Overall Study||10
248213|NCT00990821|602528|P12|COMPLETED|Overall Study||9
248214|NCT00990821|602529|P11|COMPLETED|Overall Study||9
248215|NCT00990821|602530|P10|COMPLETED|Overall Study||13
248216|NCT00990821|602531|P9|COMPLETED|Overall Study||12
248217|NCT00990821|602532|P8|COMPLETED|Overall Study||14
248218|NCT00990821|602533|P7|COMPLETED|Overall Study||11
248219|NCT00990821|602534|P6|COMPLETED|Overall Study||14
248220|NCT00990821|602535|P5|COMPLETED|Overall Study||14
248221|NCT00990821|602536|P4|COMPLETED|Overall Study||8
248222|NCT00990821|602537|P3|COMPLETED|Overall Study||14
248223|NCT00990821|602538|P2|COMPLETED|Overall Study||14
248224|NCT00990821|602539|P1|COMPLETED|Overall Study||14
248225|NCT00990821|602526|P14|STARTED|Overall Study||12
248226|NCT00990821|602527|P13|STARTED|Overall Study||12
248227|NCT00990821|602528|P12|STARTED|Overall Study||14
248228|NCT00990821|602529|P11|STARTED|Overall Study||12
248229|NCT00990821|602530|P10|STARTED|Overall Study||14
248230|NCT00990821|602531|P9|STARTED|Overall Study||12
248231|NCT00990821|602532|P8|STARTED|Overall Study||14
248232|NCT00990821|602533|P7|STARTED|Overall Study||12
248233|NCT00990821|602534|P6|STARTED|Overall Study||17
248234|NCT00990821|602535|P5|STARTED|Overall Study||17
248235|NCT00990821|602536|P4|STARTED|Overall Study||8
248236|NCT00990821|602537|P3|STARTED|Overall Study||14
248237|NCT00990821|602538|P2|STARTED|Overall Study||16
248238|NCT00990821|602539|P1|STARTED|Overall Study||14
248239|NCT00991809|602558|P2|NOT COMPLETED|Overall Study||6
248240|NCT00991809|602559|P1|NOT COMPLETED|Overall Study||4
248241|NCT00991809|602558|P2|COMPLETED|Overall Study||4
248242|NCT00991809|602559|P1|COMPLETED|Overall Study||8
248243|NCT00991809|602558|P2|STARTED|Overall Study||10
248244|NCT00991809|602559|P1|STARTED|Overall Study||12
248245|NCT00991939|602567|P2|NOT COMPLETED|Overall Study||2
248246|NCT00991939|602568|P1|NOT COMPLETED|Overall Study||5
248247|NCT00991939|602567|P2|COMPLETED|Overall Study||1
248248|NCT00991939|602568|P1|COMPLETED|Overall Study||0
248249|NCT00991939|602567|P2|STARTED|Overall Study||3
248250|NCT00991939|602568|P1|STARTED|Overall Study||5
248251|NCT00991952|602602|P2|NOT COMPLETED|Overall Study||1
248252|NCT00991952|602603|P1|NOT COMPLETED|Overall Study||0
248253|NCT00991952|602602|P2|COMPLETED|Overall Study||5
248254|NCT00991952|602603|P1|COMPLETED|Overall Study||13
248255|NCT00991952|602602|P2|STARTED|Overall Study||6
248256|NCT00991952|602603|P1|STARTED|Overall Study||13
248257|NCT00992017|602609|P1|NOT COMPLETED|Overall Study||10
248258|NCT00992017|602609|P1|COMPLETED|Overall Study||118
248259|NCT00992017|602609|P1|Received Only One Study Vaccination|Overall Study|Reasons: delivered and LFU; moved; no transportation; ineligible - blood transfusion at delivery|4
248260|NCT00992017|602609|P1|Received Both Study Vaccinations|Overall Study||124
248261|NCT00992017|602609|P1|STARTED|Overall Study|Two additional women were enrolled but left the clinic before vaccine was administered.|128
248262|NCT00992056|602624|P2|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
248263|NCT00992056|602625|P1|NOT COMPLETED|Treatment Period 2 (6 Weeks)||0
248264|NCT00992056|602624|P2|COMPLETED|Treatment Period 2 (6 Weeks)||10
248265|NCT00992056|602625|P1|COMPLETED|Treatment Period 2 (6 Weeks)||10
248266|NCT00992056|602624|P2|STARTED|Treatment Period 2 (6 Weeks)||10
248267|NCT00992056|602625|P1|STARTED|Treatment Period 2 (6 Weeks)||10
248268|NCT00992056|602624|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
248269|NCT00992056|602625|P1|NOT COMPLETED|Washout Period (2 Weeks)||1
248270|NCT00992056|602624|P2|COMPLETED|Washout Period (2 Weeks)||10
248271|NCT00992056|602625|P1|COMPLETED|Washout Period (2 Weeks)||10
248272|NCT00992056|602624|P2|STARTED|Washout Period (2 Weeks)||10
248273|NCT00992056|602625|P1|STARTED|Washout Period (2 Weeks)||11
248274|NCT00992056|602624|P2|NOT COMPLETED|Treatment Period 1 (6 Weeks)||2
248275|NCT00992056|602625|P1|NOT COMPLETED|Treatment Period 1 (6 Weeks)||1
248276|NCT00992056|602624|P2|COMPLETED|Treatment Period 1 (6 Weeks)||10
248277|NCT00992056|602625|P1|COMPLETED|Treatment Period 1 (6 Weeks)|February 2012|11
248278|NCT00992056|602624|P2|STARTED|Treatment Period 1 (6 Weeks)||12
248279|NCT00992056|602625|P1|STARTED|Treatment Period 1 (6 Weeks)||12
248280|NCT00992108|602633|P2|NOT COMPLETED|Overall Study||1
248281|NCT00992108|602634|P1|NOT COMPLETED|Overall Study||0
248282|NCT00992108|602633|P2|COMPLETED|Overall Study||9
248283|NCT00992108|602634|P1|COMPLETED|Overall Study||7
248284|NCT00992108|602633|P2|STARTED|Overall Study||10
248285|NCT00992108|602634|P1|STARTED|Overall Study||7
248286|NCT00992186|602646|P1|NOT COMPLETED|Overall Study||46
248287|NCT00992186|602646|P1|COMPLETED|Overall Study||0
248288|NCT00992186|602646|P1|STARTED|Overall Study||46
248289|NCT00992264|602679|P16|NOT COMPLETED|Overall Study||0
248290|NCT00992264|602680|P15|NOT COMPLETED|Overall Study||0
248291|NCT00992264|602681|P14|NOT COMPLETED|Overall Study||0
248292|NCT00992264|602682|P13|NOT COMPLETED|Overall Study||0
248293|NCT00992264|602683|P12|NOT COMPLETED|Overall Study||0
248294|NCT00992264|602684|P11|NOT COMPLETED|Overall Study||0
248295|NCT00992264|602685|P10|NOT COMPLETED|Overall Study||0
248296|NCT00992264|602686|P9|NOT COMPLETED|Overall Study||0
248297|NCT00992264|602687|P8|NOT COMPLETED|Overall Study||0
248298|NCT00992264|602688|P7|NOT COMPLETED|Overall Study||0
248299|NCT00992264|602689|P6|NOT COMPLETED|Overall Study||0
248300|NCT00992264|602690|P5|NOT COMPLETED|Overall Study||0
248301|NCT00992264|602691|P4|NOT COMPLETED|Overall Study||0
248302|NCT00992264|602692|P3|NOT COMPLETED|Overall Study||0
248303|NCT00992264|602693|P2|NOT COMPLETED|Overall Study||0
248304|NCT00992264|602694|P1|NOT COMPLETED|Overall Study||0
248305|NCT00992264|602679|P16|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
248306|NCT00992264|602680|P15|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248307|NCT00992264|602681|P14|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248308|NCT00992264|602682|P13|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
248309|NCT00992264|602683|P12|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248310|NCT00992264|602684|P11|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248311|NCT00992264|602685|P10|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
248312|NCT00992264|602686|P9|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
248313|NCT00992264|602687|P8|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248314|NCT00992264|602688|P7|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
248315|NCT00992264|602689|P6|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248316|NCT00992264|602690|P5|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248317|NCT00992264|602691|P4|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248318|NCT00992264|602692|P3|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|117
248319|NCT00992264|602693|P2|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
248320|NCT00992264|602694|P1|COMPLETED|Overall Study|All enrolled participants were included in the final intent to treat analytic sample.|116
248321|NCT00992264|602679|P16|STARTED|Overall Study||116
248322|NCT00992264|602680|P15|STARTED|Overall Study||117
248323|NCT00992264|602681|P14|STARTED|Overall Study||117
248324|NCT00992264|602682|P13|STARTED|Overall Study||116
248325|NCT00992264|602683|P12|STARTED|Overall Study||117
248326|NCT00992264|602684|P11|STARTED|Overall Study||117
248327|NCT00992264|602685|P10|STARTED|Overall Study||116
248328|NCT00992264|602686|P9|STARTED|Overall Study||116
248329|NCT00992264|602687|P8|STARTED|Overall Study||117
248330|NCT00992264|602688|P7|STARTED|Overall Study||116
248331|NCT00992264|602689|P6|STARTED|Overall Study||117
248332|NCT00992264|602690|P5|STARTED|Overall Study||117
248333|NCT00992264|602691|P4|STARTED|Overall Study||117
248334|NCT00992264|602692|P3|STARTED|Overall Study||117
248335|NCT00992264|602693|P2|STARTED|Overall Study||116
248336|NCT00992264|602694|P1|STARTED|Overall Study||116
248337|NCT00992394|602710|P2|NOT COMPLETED|Overall Study||14
248338|NCT00992394|602711|P1|NOT COMPLETED|Overall Study||24
248339|NCT00992394|602710|P2|COMPLETED|Overall Study||72
248340|NCT00992394|602711|P1|COMPLETED|Overall Study||64
248341|NCT00992394|602710|P2|mITT Population|Overall Study||84
248342|NCT00992394|602711|P1|mITT Population|Overall Study||86
248343|NCT00992394|602710|P2|Safety Population|Overall Study||84
248344|NCT00992394|602711|P1|Safety Population|Overall Study||87
248345|NCT00992394|602710|P2|STARTED|Overall Study||86
248346|NCT00992394|602711|P1|STARTED|Overall Study||88
248347|NCT00992407|602755|P2|NOT COMPLETED|Overall Study||24
248348|NCT00992407|602756|P1|NOT COMPLETED|Overall Study||31
248349|NCT00992407|602755|P2|COMPLETED|Overall Study||14
248350|NCT00992407|602756|P1|COMPLETED|Overall Study||6
248351|NCT00992407|602755|P2|Treated|Overall Study||25
248352|NCT00992407|602756|P1|Treated|Overall Study||20
248353|NCT00992407|602755|P2|STARTED|Overall Study||38
248354|NCT00992407|602756|P1|STARTED|Overall Study||37
248355|NCT00992433|602806|P2|NOT COMPLETED|Overall Study||7
248356|NCT00992433|602807|P1|NOT COMPLETED|Overall Study||4
248357|NCT00992433|602806|P2|COMPLETED|Overall Study||90
248358|NCT00992433|602807|P1|COMPLETED|Overall Study||91
248359|NCT00992433|602806|P2|STARTED|Overall Study||97
248360|NCT00992433|602807|P1|STARTED|Overall Study||95
248361|NCT00992446|602869|P1|NOT COMPLETED|Overall Study||8
248362|NCT00992446|602869|P1|COMPLETED|Overall Study||19
248363|NCT00992446|602869|P1|STARTED|Overall Study||27
248364|NCT00992459|602876|P2|NOT COMPLETED|Overall Study||1
248365|NCT00992459|602877|P1|NOT COMPLETED|Overall Study||1
248366|NCT00992459|602876|P2|COMPLETED|Overall Study|Totals enrolled and completed in Arm B HPN 100 treatment + NaPBA Placebo are not mutually exclusive.|23
248367|NCT00992459|602877|P1|COMPLETED|Overall Study|Totals enrolled and completed in Arm A NaPBA treatment + HPN 100 Placebo are not mutually exclusive.|21
248368|NCT00992459|602876|P2|STARTED|Overall Study|All patients received NaPBA placebo in Arm B (+ concomitant active HPN 100)|24
248369|NCT00992459|602877|P1|STARTED|Overall Study|All patients received HPN 100 placebo in Arm A (+ concomitant active NaPBA)|22
248370|NCT00992589|602901|P4|NOT COMPLETED|Double-Blind Phase||10
248371|NCT00992589|602902|P3|NOT COMPLETED|Double-Blind Phase||13
248372|NCT00992589|602903|P2|NOT COMPLETED|Double-Blind Phase||13
248373|NCT00992589|602904|P1|NOT COMPLETED|Double-Blind Phase||0
248374|NCT00992589|602901|P4|COMPLETED|Double-Blind Phase||78
248375|NCT00992589|602902|P3|COMPLETED|Double-Blind Phase||77
248376|NCT00992589|602903|P2|COMPLETED|Double-Blind Phase||76
248377|NCT00992589|602904|P1|COMPLETED|Double-Blind Phase||0
248378|NCT00992589|602901|P4|STARTED|Double-Blind Phase||88
248379|NCT00992589|602902|P3|STARTED|Double-Blind Phase||90
248380|NCT00992589|602903|P2|STARTED|Double-Blind Phase||89
248381|NCT00992589|602904|P1|STARTED|Double-Blind Phase||0
248382|NCT00992589|602901|P4|NOT COMPLETED|Open-Label Phase||0
248383|NCT00992589|602902|P3|NOT COMPLETED|Open-Label Phase||0
248384|NCT00992589|602903|P2|NOT COMPLETED|Open-Label Phase||0
248385|NCT00992589|602904|P1|NOT COMPLETED|Open-Label Phase||77
248386|NCT00992589|602901|P4|COMPLETED|Open-Label Phase||0
248387|NCT00992589|602902|P3|COMPLETED|Open-Label Phase||0
248388|NCT00992589|602903|P2|COMPLETED|Open-Label Phase||0
248389|NCT00992589|602904|P1|COMPLETED|Open-Label Phase||267
248390|NCT00992589|602901|P4|STARTED|Open-Label Phase||0
248391|NCT00992589|602902|P3|STARTED|Open-Label Phase||0
248392|NCT00992589|602903|P2|STARTED|Open-Label Phase||0
248393|NCT00992589|602904|P1|STARTED|Open-Label Phase||344
248394|NCT00992602|602946|P1|NOT COMPLETED|Overall Study||3
248395|NCT00992602|602946|P1|COMPLETED|Overall Study||0
248396|NCT00992602|602946|P1|STARTED|Overall Study||3
248397|NCT00992719|602954|P3|NOT COMPLETED|Overall Study||0
248398|NCT00992719|602955|P2|NOT COMPLETED|Overall Study||1
248399|NCT00992719|602956|P1|NOT COMPLETED|Overall Study||1
248400|NCT00992719|602954|P3|COMPLETED|Overall Study||28
248401|NCT00992719|602955|P2|COMPLETED|Overall Study||27
248402|NCT00992719|602956|P1|COMPLETED|Overall Study||27
248403|NCT00992719|602954|P3|STARTED|Overall Study||28
248404|NCT00992719|602955|P2|STARTED|Overall Study||28
248405|NCT00992719|602956|P1|STARTED|Overall Study||28
248406|NCT00992784|602993|P3|NOT COMPLETED|Overall Study||1
248407|NCT00992784|602994|P2|NOT COMPLETED|Overall Study||2
248408|NCT00992784|602995|P1|NOT COMPLETED|Overall Study||3
248409|NCT00992784|602993|P3|COMPLETED|Overall Study||85
248410|NCT00992784|602994|P2|COMPLETED|Overall Study||102
248411|NCT00992784|602995|P1|COMPLETED|Overall Study||177
248412|NCT00992784|602993|P3|STARTED|Overall Study||86
248413|NCT00992784|602994|P2|STARTED|Overall Study||104
248414|NCT00992784|602995|P1|STARTED|Overall Study||180
248415|NCT00992836|603063|P1|NOT COMPLETED|Overall Study||5
248416|NCT00992836|603063|P1|COMPLETED|Overall Study||150
248417|NCT00992836|603063|P1|Received Both Study Vaccinations|Overall Study||150
248418|NCT00992836|603063|P1|STARTED|Overall Study||155
248419|NCT00992927|603077|P2|NOT COMPLETED|Overall Study||0
248420|NCT00992927|603078|P1|NOT COMPLETED|Overall Study||0
248421|NCT00992927|603077|P2|COMPLETED|Overall Study||22
248422|NCT00992927|603078|P1|COMPLETED|Overall Study||32
248423|NCT00992927|603077|P2|STARTED|Overall Study||22
248424|NCT00992927|603078|P1|STARTED|Overall Study||32
248425|NCT00992992|603086|P1|NOT COMPLETED|Overall Study||25
248426|NCT00992992|603086|P1|COMPLETED|Overall Study||0
248427|NCT00992992|603086|P1|STARTED|Overall Study||25
248428|NCT00993044|603106|P1|NOT COMPLETED|Irinotecan 50 mg||1
248429|NCT00993044|603106|P1|COMPLETED|Irinotecan 50 mg||6
248430|NCT00993044|603106|P1|STARTED|Irinotecan 50 mg||7
248431|NCT00993044|603106|P1|NOT COMPLETED|Irinotecan 30 mg||0
248432|NCT00993044|603106|P1|COMPLETED|Irinotecan 30 mg||6
248433|NCT00993044|603106|P1|STARTED|Irinotecan 30 mg||6
248434|NCT00993148|603111|P1|NOT COMPLETED|Overall Study||3
248435|NCT00993148|603111|P1|COMPLETED|Overall Study||22
248436|NCT00993148|603111|P1|STARTED|Overall Study||25
248437|NCT00993187|603125|P2|NOT COMPLETED|Overall Study||37
248438|NCT00993187|603126|P1|NOT COMPLETED|Overall Study||26
248439|NCT00993187|603125|P2|COMPLETED|Overall Study||108
248440|NCT00993187|603126|P1|COMPLETED|Overall Study||121
248441|NCT00993187|603125|P2|Received at Least 1 Dose of Study Drug|Overall Study||144
248442|NCT00993187|603126|P1|Received at Least 1 Dose of Study Drug|Overall Study||146
248443|NCT00993187|603125|P2|STARTED|Overall Study||145
248444|NCT00993187|603126|P1|STARTED|Overall Study||147
248445|NCT00993200|603146|P2|NOT COMPLETED|Overall Study||0
248446|NCT00993200|603147|P1|NOT COMPLETED|Overall Study||0
248447|NCT00993200|603146|P2|COMPLETED|Overall Study||13
248448|NCT00993200|603147|P1|COMPLETED|Overall Study||13
248449|NCT00993200|603146|P2|STARTED|Overall Study||13
248450|NCT00993200|603147|P1|STARTED|Overall Study||13
248451|NCT00993265|603159|P2|NOT COMPLETED|Overall Study||0
248452|NCT00993265|603160|P1|NOT COMPLETED|Overall Study||4
248453|NCT00993265|603159|P2|COMPLETED|Overall Study||19
248454|NCT00993265|603160|P1|COMPLETED|Overall Study||16
248455|NCT00993265|603159|P2|STARTED|Overall Study||19
248456|NCT00993265|603160|P1|STARTED|Overall Study||20
248457|NCT00993291|603178|P1|NOT COMPLETED|Overall Study||1
248458|NCT00993291|603178|P1|COMPLETED|Overall Study||19
248459|NCT00993291|603178|P1|STARTED|Overall Study||20
248460|NCT00993317|603184|P2|NOT COMPLETED|Overall Study||25
248461|NCT00993317|603185|P1|NOT COMPLETED|Overall Study||21
248462|NCT00993317|603184|P2|COMPLETED|Overall Study||60
248463|NCT00993317|603185|P1|COMPLETED|Overall Study||21
248464|NCT00993317|603184|P2|STARTED|Overall Study||85
248465|NCT00993317|603185|P1|STARTED|Overall Study||42
248466|NCT00993421|603210|P7|NOT COMPLETED|Overall Study||42
248467|NCT00993421|603211|P6|NOT COMPLETED|Overall Study||46
248468|NCT00993421|603212|P5|NOT COMPLETED|Overall Study||46
248469|NCT00993421|603213|P4|NOT COMPLETED|Overall Study||45
248470|NCT00993421|603214|P3|NOT COMPLETED|Overall Study||43
248471|NCT00993421|603215|P2|NOT COMPLETED|Overall Study||45
248472|NCT00993421|603216|P1|NOT COMPLETED|Overall Study||44
248473|NCT00993421|603210|P7|COMPLETED|Overall Study||4
248474|NCT00993421|603211|P6|COMPLETED|Overall Study||4
248475|NCT00993421|603212|P5|COMPLETED|Overall Study||6
248476|NCT00993421|603213|P4|COMPLETED|Overall Study||4
248477|NCT00993421|603214|P3|COMPLETED|Overall Study||5
248478|NCT00993421|603215|P2|COMPLETED|Overall Study||4
248479|NCT00993421|603216|P1|COMPLETED|Overall Study||5
248480|NCT00993421|603210|P7|STARTED|Overall Study||46
248481|NCT00993421|603211|P6|STARTED|Overall Study||50
248482|NCT00993421|603212|P5|STARTED|Overall Study||52
248483|NCT00993421|603213|P4|STARTED|Overall Study||49
248484|NCT00993421|603214|P3|STARTED|Overall Study||48
248485|NCT00993421|603215|P2|STARTED|Overall Study||49
248486|NCT00993421|603216|P1|STARTED|Overall Study||49
248487|NCT00993447|603367|P2|NOT COMPLETED|Overall Study||19
248488|NCT00993447|603368|P1|NOT COMPLETED|Overall Study||37
248489|NCT00993447|603367|P2|COMPLETED|Overall Study||180
248490|NCT00993447|603368|P1|COMPLETED|Overall Study||364
248491|NCT00993447|603367|P2|STARTED|Overall Study||199
248492|NCT00993447|603368|P1|STARTED|Overall Study||401
248493|NCT00993473|603400|P2|NOT COMPLETED|Overall Study||10
248494|NCT00993473|603401|P1|NOT COMPLETED|Overall Study||4
248495|NCT00993473|603400|P2|COMPLETED|Overall Study||54
248496|NCT00993473|603401|P1|COMPLETED|Overall Study||57
248497|NCT00993473|603400|P2|STARTED|Overall Study|64 patients randomized to NPH but only 63 patients treated with NPH due to a dispensation's error|64
248498|NCT00993473|603401|P1|STARTED|Overall Study|61 patients randomized to Lantus but 62 patients treated with Lantus due to a dispensation's error|61
248499|NCT00993499|603443|P6|NOT COMPLETED|Discontinued After Starting Course 3||3
248500|NCT00993499|603444|P5|NOT COMPLETED|Discontinued After Starting Course 3||3
248501|NCT00993499|603445|P4|NOT COMPLETED|Discontinued After Starting Course 3||2
248502|NCT00993499|603446|P3|NOT COMPLETED|Discontinued After Starting Course 3||6
248503|NCT00993499|603447|P2|NOT COMPLETED|Discontinued After Starting Course 3||5
248504|NCT00993499|603448|P1|NOT COMPLETED|Discontinued After Starting Course 3||8
248505|NCT00993499|603443|P6|COMPLETED|Discontinued After Starting Course 3||0
248506|NCT00993499|603444|P5|COMPLETED|Discontinued After Starting Course 3||0
248507|NCT00993499|603445|P4|COMPLETED|Discontinued After Starting Course 3||1
248508|NCT00993499|603446|P3|COMPLETED|Discontinued After Starting Course 3||3
248509|NCT00993499|603447|P2|COMPLETED|Discontinued After Starting Course 3||4
248510|NCT00993499|603448|P1|COMPLETED|Discontinued After Starting Course 3||4
248511|NCT00993499|603443|P6|STARTED|Discontinued After Starting Course 3||3
248512|NCT00993499|603444|P5|STARTED|Discontinued After Starting Course 3||3
248513|NCT00993499|603445|P4|STARTED|Discontinued After Starting Course 3||3
248514|NCT00993499|603446|P3|STARTED|Discontinued After Starting Course 3||9
248515|NCT00993499|603447|P2|STARTED|Discontinued After Starting Course 3||9
248516|NCT00993499|603448|P1|STARTED|Discontinued After Starting Course 3||12
248517|NCT00993499|603443|P6|NOT COMPLETED|Discontinued Before Starting Course 3||0
248518|NCT00993499|603444|P5|NOT COMPLETED|Discontinued Before Starting Course 3||0
248519|NCT00993499|603445|P4|NOT COMPLETED|Discontinued Before Starting Course 3||1
248520|NCT00993499|603446|P3|NOT COMPLETED|Discontinued Before Starting Course 3||3
248521|NCT00993499|603447|P2|NOT COMPLETED|Discontinued Before Starting Course 3||4
248522|NCT00993499|603448|P1|NOT COMPLETED|Discontinued Before Starting Course 3||4
248523|NCT00993499|603443|P6|COMPLETED|Discontinued Before Starting Course 3||3
248524|NCT00993499|603444|P5|COMPLETED|Discontinued Before Starting Course 3||3
248525|NCT00993499|603445|P4|COMPLETED|Discontinued Before Starting Course 3||2
248526|NCT00993499|603446|P3|COMPLETED|Discontinued Before Starting Course 3||6
248527|NCT00993499|603447|P2|COMPLETED|Discontinued Before Starting Course 3||5
248528|NCT00993499|603448|P1|COMPLETED|Discontinued Before Starting Course 3||8
248529|NCT00993499|603443|P6|STARTED|Discontinued Before Starting Course 3||3
248530|NCT00993499|603444|P5|STARTED|Discontinued Before Starting Course 3||3
248531|NCT00993499|603445|P4|STARTED|Discontinued Before Starting Course 3||3
248532|NCT00993499|603446|P3|STARTED|Discontinued Before Starting Course 3||9
248533|NCT00993499|603447|P2|STARTED|Discontinued Before Starting Course 3||9
248534|NCT00993499|603448|P1|STARTED|Discontinued Before Starting Course 3||12
248535|NCT00993499|603443|P6|NOT COMPLETED|Run-in Period (8 Days)||0
248536|NCT00993499|603444|P5|NOT COMPLETED|Run-in Period (8 Days)||0
248537|NCT00993499|603445|P4|NOT COMPLETED|Run-in Period (8 Days)||0
248538|NCT00993499|603446|P3|NOT COMPLETED|Run-in Period (8 Days)||1
248539|NCT00993499|603447|P2|NOT COMPLETED|Run-in Period (8 Days)||3
248540|NCT00993499|603448|P1|NOT COMPLETED|Run-in Period (8 Days)||1
248541|NCT00993499|603443|P6|COMPLETED|Run-in Period (8 Days)||3
248542|NCT00993499|603444|P5|COMPLETED|Run-in Period (8 Days)||3
248543|NCT00993499|603445|P4|COMPLETED|Run-in Period (8 Days)||3
248544|NCT00993499|603446|P3|COMPLETED|Run-in Period (8 Days)||9
248545|NCT00993499|603447|P2|COMPLETED|Run-in Period (8 Days)||9
248546|NCT00993499|603448|P1|COMPLETED|Run-in Period (8 Days)||12
248547|NCT00993499|603443|P6|STARTED|Run-in Period (8 Days)||3
248548|NCT00993499|603444|P5|STARTED|Run-in Period (8 Days)||3
248549|NCT00993499|603445|P4|STARTED|Run-in Period (8 Days)||3
248550|NCT00993499|603446|P3|STARTED|Run-in Period (8 Days)||10
248551|NCT00993499|603447|P2|STARTED|Run-in Period (8 Days)||12
248552|NCT00993499|603448|P1|STARTED|Run-in Period (8 Days)||13
248553|NCT00993616|603528|P1|NOT COMPLETED|Overall Study||2
248554|NCT00993616|603528|P1|COMPLETED|Overall Study|Number of eligible and evaluable participants|27
248555|NCT00993616|603528|P1|STARTED|Overall Study||29
248556|NCT00993655|603535|P3|NOT COMPLETED|Overall Study||0
248557|NCT00993655|603536|P2|NOT COMPLETED|Overall Study||0
248558|NCT00993655|603537|P1|NOT COMPLETED|Overall Study||0
248559|NCT00993655|603535|P3|COMPLETED|Overall Study||102
248560|NCT00993655|603536|P2|COMPLETED|Overall Study||72
248561|NCT00993655|603537|P1|COMPLETED|Overall Study||101
248562|NCT00993655|603535|P3|STARTED|Overall Study||102
248563|NCT00993655|603536|P2|STARTED|Overall Study||72
248564|NCT00993655|603537|P1|STARTED|Overall Study||101
248565|NCT00993668|603553|P2|NOT COMPLETED|Open-Label Period||15
248566|NCT00993668|603554|P1|NOT COMPLETED|Open-Label Period||23
248567|NCT00993668|603553|P2|COMPLETED|Open-Label Period||91
248568|NCT00993668|603554|P1|COMPLETED|Open-Label Period||86
248569|NCT00993668|603553|P2|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|106
248570|NCT00993668|603554|P1|STARTED|Open-Label Period|1 subject chose not to enter the optional open-label period|109
248571|NCT00993668|603553|P2|NOT COMPLETED|Single-Blind Period||3
248572|NCT00993668|603554|P1|NOT COMPLETED|Single-Blind Period||4
248573|NCT00993668|603553|P2|COMPLETED|Single-Blind Period||107
248574|NCT00993668|603554|P1|COMPLETED|Single-Blind Period||110
248575|NCT00993668|603553|P2|STARTED|Single-Blind Period||110
248576|NCT00993668|603554|P1|STARTED|Single-Blind Period||114
248577|NCT00993824|603581|P2|NOT COMPLETED|Overall Study||0
248578|NCT00993824|603582|P1|NOT COMPLETED|Overall Study||0
248579|NCT00993824|603581|P2|COMPLETED|Overall Study||10
248580|NCT00993824|603582|P1|COMPLETED|Overall Study||11
248581|NCT00993824|603581|P2|STARTED|Overall Study||10
248582|NCT00993824|603582|P1|STARTED|Overall Study||11
248583|NCT00993915|603594|P1|NOT COMPLETED|Overall Study||9
248584|NCT00993915|603594|P1|COMPLETED|Overall Study||678
248585|NCT00993915|603594|P1|STARTED|Overall Study||687
248586|NCT00993928|603605|P2|NOT COMPLETED|Overall Study||7
248587|NCT00993928|603606|P1|NOT COMPLETED|Overall Study||5
248588|NCT00993928|603605|P2|COMPLETED|Overall Study||38
248589|NCT00993928|603606|P1|COMPLETED|Overall Study||43
248590|NCT00993928|603605|P2|STARTED|Overall Study||45
248591|NCT00993928|603606|P1|STARTED|Overall Study||48
248592|NCT00993954|603622|P2|NOT COMPLETED|Overall Study||2
248593|NCT00993954|603623|P1|NOT COMPLETED|Overall Study||21
248594|NCT00993954|603622|P2|COMPLETED|Overall Study||121
248595|NCT00993954|603623|P1|COMPLETED|Overall Study||124
248596|NCT00993954|603622|P2|STARTED|Overall Study||123
248597|NCT00993954|603623|P1|STARTED|Overall Study||145
248598|NCT00999908|603634|P3|NOT COMPLETED|Treatment Period 3||0
248599|NCT00999908|603635|P2|NOT COMPLETED|Treatment Period 3||0
248600|NCT00999908|603636|P1|NOT COMPLETED|Treatment Period 3||0
248601|NCT00999908|603634|P3|COMPLETED|Treatment Period 3||19
248602|NCT00999908|603635|P2|COMPLETED|Treatment Period 3||16
248603|NCT00999908|603636|P1|COMPLETED|Treatment Period 3||16
248604|NCT00999908|603634|P3|STARTED|Treatment Period 3||19
248605|NCT00999908|603635|P2|STARTED|Treatment Period 3||16
248606|NCT00999908|603636|P1|STARTED|Treatment Period 3||16
248607|NCT00999908|603634|P3|NOT COMPLETED|Treatment Period 2||0
248608|NCT00999908|603635|P2|NOT COMPLETED|Treatment Period 2||0
248609|NCT00999908|603636|P1|NOT COMPLETED|Treatment Period 2||1
248610|NCT00999908|603634|P3|COMPLETED|Treatment Period 2||19
248611|NCT00999908|603635|P2|COMPLETED|Treatment Period 2||16
248612|NCT00999908|603636|P1|COMPLETED|Treatment Period 2||16
248613|NCT00999908|603634|P3|STARTED|Treatment Period 2||19
248614|NCT00999908|603635|P2|STARTED|Treatment Period 2||16
248615|NCT00999908|603636|P1|STARTED|Treatment Period 2||17
248616|NCT00999908|603634|P3|NOT COMPLETED|Treatment Period 1||0
248617|NCT00999908|603635|P2|NOT COMPLETED|Treatment Period 1||0
248618|NCT00999908|603636|P1|NOT COMPLETED|Treatment Period 1||2
248619|NCT00999908|603634|P3|COMPLETED|Treatment Period 1||19
248620|NCT00999908|603635|P2|COMPLETED|Treatment Period 1||16
248621|NCT00999908|603636|P1|COMPLETED|Treatment Period 1||17
248622|NCT00999908|603634|P3|STARTED|Treatment Period 1||19
248623|NCT00999908|603635|P2|STARTED|Treatment Period 1||16
248624|NCT00999908|603636|P1|STARTED|Treatment Period 1||19
248625|NCT00999921|603652|P2|NOT COMPLETED|Overall Study||19
248626|NCT00999921|603653|P1|NOT COMPLETED|Overall Study||10
248627|NCT00999921|603652|P2|COMPLETED|Overall Study||110
248628|NCT00999921|603653|P1|COMPLETED|Overall Study||117
248629|NCT00999921|603652|P2|STARTED|Overall Study||129
248630|NCT00999921|603653|P1|STARTED|Overall Study||127
248631|NCT01000025|603665|P2|NOT COMPLETED|Overall Study||238
248632|NCT01000025|603666|P1|NOT COMPLETED|Overall Study||468
248633|NCT01000025|603665|P2|COMPLETED|Overall Study||2
248634|NCT01000025|603666|P1|COMPLETED|Overall Study||12
248635|NCT01000025|603665|P2|STARTED|Overall Study||240
248636|NCT01000025|603666|P1|STARTED|Overall Study||480
248637|NCT01000064|603682|P2|NOT COMPLETED|Overall Study||1
248638|NCT01000064|603683|P1|NOT COMPLETED|Overall Study||1
248639|NCT01000064|603682|P2|COMPLETED|Overall Study||5
248640|NCT01000064|603683|P1|COMPLETED|Overall Study||6
248641|NCT01000064|603682|P2|STARTED|Overall Study||6
248642|NCT01000064|603683|P1|STARTED|Overall Study||7
248643|NCT01000155|603704|P1|NOT COMPLETED|Overall Study||2
248644|NCT01000155|603704|P1|COMPLETED|Overall Study||3
248645|NCT01000155|603704|P1|STARTED|Overall Study||5
248646|NCT01001806|603713|P3|NOT COMPLETED|Overall Study||4
248647|NCT01001806|603714|P2|NOT COMPLETED|Overall Study||1
248648|NCT01001806|603715|P1|NOT COMPLETED|Overall Study||0
248649|NCT01001806|603713|P3|COMPLETED|Overall Study||38
248650|NCT01001806|603714|P2|COMPLETED|Overall Study||41
248651|NCT01001806|603715|P1|COMPLETED|Overall Study||42
248652|NCT01001806|603713|P3|STARTED|Overall Study||42
248653|NCT01001806|603714|P2|STARTED|Overall Study||42
248654|NCT01001806|603715|P1|STARTED|Overall Study||42
248655|NCT01001832|603725|P2|NOT COMPLETED|Follow-up Period||21
248656|NCT01001832|603726|P1|NOT COMPLETED|Follow-up Period||18
248657|NCT01001832|603725|P2|COMPLETED|Follow-up Period||30
248658|NCT01001832|603726|P1|COMPLETED|Follow-up Period||34
248659|NCT01001832|603725|P2|STARTED|Follow-up Period||51
248660|NCT01001832|603726|P1|STARTED|Follow-up Period||52
248661|NCT01001832|603725|P2|NOT COMPLETED|Long-term Period||5
248662|NCT01001832|603726|P1|NOT COMPLETED|Long-term Period||4
248663|NCT01001832|603725|P2|COMPLETED|Long-term Period||51
248664|NCT01001832|603726|P1|COMPLETED|Long-term Period||52
248665|NCT01001832|603725|P2|STARTED|Long-term Period||56
248666|NCT01001832|603726|P1|STARTED|Long-term Period|1 participant completed the short term period but discontinued before start of the Long-term Period.|56
248667|NCT01001832|603725|P2|NOT COMPLETED|Short-term Period||3
248668|NCT01001832|603726|P1|NOT COMPLETED|Short-term Period||2
248669|NCT01001832|603725|P2|COMPLETED|Short-term Period||56
248670|NCT01001832|603726|P1|COMPLETED|Short-term Period||57
248671|NCT01001832|603725|P2|STARTED|Short-term Period||59
248672|NCT01001832|603726|P1|STARTED|Short-term Period||59
248673|NCT01001975|603771|P2|NOT COMPLETED|Overall Study||0
248674|NCT01001975|603772|P1|NOT COMPLETED|Overall Study||0
248675|NCT01001975|603771|P2|COMPLETED|Overall Study||5
248676|NCT01001975|603772|P1|COMPLETED|Overall Study||5
248677|NCT01001975|603771|P2|STARTED|Overall Study||5
248678|NCT01001975|603772|P1|STARTED|Overall Study||5
248679|NCT01002105|603782|P2|NOT COMPLETED|Overall Study||21
248680|NCT01002105|603783|P1|NOT COMPLETED|Overall Study||19
248681|NCT01002105|603782|P2|COMPLETED|Overall Study||11
248682|NCT01002105|603783|P1|COMPLETED|Overall Study||13
248683|NCT01002105|603782|P2|STARTED|Overall Study||32
248684|NCT01002105|603783|P1|STARTED|Overall Study||32
248685|NCT01002118|603799|P1|NOT COMPLETED|Overall Study||0
248686|NCT01002118|603799|P1|COMPLETED|Overall Study||1
248687|NCT01002118|603799|P1|Randomized Only Patient|Overall Study||1
248688|NCT01002118|603799|P1|STARTED|Overall Study||1
248689|NCT01002287|603807|P2|NOT COMPLETED|Overall Study||0
248690|NCT01002287|603808|P1|NOT COMPLETED|Overall Study||0
248691|NCT01002287|603807|P2|COMPLETED|Overall Study||3
248692|NCT01002287|603808|P1|COMPLETED|Overall Study||8
248693|NCT01002287|603807|P2|STARTED|Overall Study||3
248694|NCT01002287|603808|P1|STARTED|Overall Study||8
248695|NCT01002339|603823|P3|NOT COMPLETED|Overall Study||5
248696|NCT01002339|603824|P2|NOT COMPLETED|Overall Study||1
248697|NCT01002339|603825|P1|NOT COMPLETED|Overall Study||0
248698|NCT01002339|603823|P3|COMPLETED|Overall Study||42
248699|NCT01002339|603824|P2|COMPLETED|Overall Study||42
248700|NCT01002339|603825|P1|COMPLETED|Overall Study||44
248701|NCT01002339|603823|P3|STARTED|Overall Study||47
248702|NCT01002339|603824|P2|STARTED|Overall Study||43
248703|NCT01002339|603825|P1|STARTED|Overall Study||44
248704|NCT01002456|603880|P2|NOT COMPLETED|Overall Study||0
248705|NCT01002456|603881|P1|NOT COMPLETED|Overall Study||0
248706|NCT01002456|603880|P2|COMPLETED|Overall Study||122
248707|NCT01002456|603881|P1|COMPLETED|Overall Study||98
248708|NCT01002456|603880|P2|STARTED|Overall Study||122
248709|NCT01002456|603881|P1|STARTED|Overall Study||98
248710|NCT01002482|603891|P2|NOT COMPLETED|Overall Study||21
248711|NCT01002482|603892|P1|NOT COMPLETED|Overall Study||15
248712|NCT01002482|603891|P2|COMPLETED|Overall Study||1312
248713|NCT01002482|603892|P1|COMPLETED|Overall Study||1336
248714|NCT01002482|603891|P2|STARTED|Overall Study||1333
248715|NCT01002482|603892|P1|STARTED|Overall Study||1351
248716|NCT01002573|603914|P2|NOT COMPLETED|Overall Study||7
248717|NCT01002573|603915|P1|NOT COMPLETED|Overall Study||11
248718|NCT01002573|603914|P2|COMPLETED|Overall Study||53
248719|NCT01002573|603915|P1|COMPLETED|Overall Study||47
248720|NCT01002573|603914|P2|STARTED|Overall Study||60
248721|NCT01002573|603915|P1|STARTED|Overall Study||58
248722|NCT01002742|603935|P2|NOT COMPLETED|Overall Study||1
248723|NCT01002742|603936|P1|NOT COMPLETED|Overall Study||0
248724|NCT01002742|603935|P2|COMPLETED|Overall Study||116
248725|NCT01002742|603936|P1|COMPLETED|Overall Study||119
248726|NCT01002742|603935|P2|STARTED|Overall Study||117
248727|NCT01002742|603936|P1|STARTED|Overall Study||119
248728|NCT01002989|603970|P1|NOT COMPLETED|Overall Study||5
248729|NCT01002989|603970|P1|COMPLETED|Overall Study||93
248730|NCT01002989|603970|P1|STARTED|Overall Study||98
248731|NCT01003067|603979|P2|NOT COMPLETED|Overall Study||24
248732|NCT01003067|603980|P1|NOT COMPLETED|Overall Study||33
248733|NCT01003067|603979|P2|COMPLETED|Overall Study||107
248734|NCT01003067|603980|P1|COMPLETED|Overall Study||103
248735|NCT01003067|603979|P2|STARTED|Overall Study||131
248736|NCT01003067|603980|P1|STARTED|Overall Study||136
248737|NCT01003080|603988|P2|NOT COMPLETED|Overall Study||0
248738|NCT01003080|603989|P1|NOT COMPLETED|Overall Study||0
248739|NCT01003080|603988|P2|COMPLETED|Overall Study||61
248740|NCT01003080|603989|P1|COMPLETED|Overall Study||50
248741|NCT01003080|603988|P2|STARTED|Overall Study||61
248742|NCT01003080|603989|P1|STARTED|Overall Study||50
248743|NCT01003106|603999|P8|NOT COMPLETED|Month 6-Month 36||0
248744|NCT01003106|604000|P7|NOT COMPLETED|Month 6-Month 36||1
248745|NCT01003106|604001|P6|NOT COMPLETED|Month 6-Month 36||0
248746|NCT01003106|604002|P5|NOT COMPLETED|Month 6-Month 36||0
248747|NCT01003106|604003|P4|NOT COMPLETED|Month 6-Month 36||0
248748|NCT01003106|604004|P3|NOT COMPLETED|Month 6-Month 36||1
248749|NCT01003106|604005|P2|NOT COMPLETED|Month 6-Month 36||0
248750|NCT01003106|604006|P1|NOT COMPLETED|Month 6-Month 36||0
248751|NCT01003106|603999|P8|COMPLETED|Month 6-Month 36||18
248752|NCT01003106|604000|P7|COMPLETED|Month 6-Month 36||19
248753|NCT01003106|604001|P6|COMPLETED|Month 6-Month 36||0
248754|NCT01003106|604002|P5|COMPLETED|Month 6-Month 36||0
248755|NCT01003106|604003|P4|COMPLETED|Month 6-Month 36||20
248756|NCT01003106|604004|P3|COMPLETED|Month 6-Month 36||18
248757|NCT01003106|604005|P2|COMPLETED|Month 6-Month 36||0
248758|NCT01003106|604006|P1|COMPLETED|Month 6-Month 36||0
248759|NCT01003106|603999|P8|STARTED|Month 6-Month 36||18
248760|NCT01003106|604000|P7|STARTED|Month 6-Month 36||20
248761|NCT01003106|604001|P6|STARTED|Month 6-Month 36||0
248762|NCT01003106|604002|P5|STARTED|Month 6-Month 36||0
248763|NCT01003106|604003|P4|STARTED|Month 6-Month 36||20
248764|NCT01003106|604004|P3|STARTED|Month 6-Month 36||19
248765|NCT01003106|604005|P2|STARTED|Month 6-Month 36||0
248766|NCT01003106|604006|P1|STARTED|Month 6-Month 36||0
248767|NCT01003106|603999|P8|NOT COMPLETED|Baseline to Month 6||0
248768|NCT01003106|604000|P7|NOT COMPLETED|Baseline to Month 6||0
248769|NCT01003106|604001|P6|NOT COMPLETED|Baseline to Month 6||0
248770|NCT01003106|604002|P5|NOT COMPLETED|Baseline to Month 6||0
248771|NCT01003106|604003|P4|NOT COMPLETED|Baseline to Month 6||0
248772|NCT01003106|604004|P3|NOT COMPLETED|Baseline to Month 6||0
248773|NCT01003106|604005|P2|NOT COMPLETED|Baseline to Month 6||0
248774|NCT01003106|604006|P1|NOT COMPLETED|Baseline to Month 6||0
248775|NCT01003106|603999|P8|COMPLETED|Baseline to Month 6||0
248776|NCT01003106|604000|P7|COMPLETED|Baseline to Month 6||0
248777|NCT01003106|604001|P6|COMPLETED|Baseline to Month 6||20
248778|NCT01003106|604002|P5|COMPLETED|Baseline to Month 6||19
248779|NCT01003106|604003|P4|COMPLETED|Baseline to Month 6||0
248780|NCT01003106|604004|P3|COMPLETED|Baseline to Month 6||0
248781|NCT01003106|604005|P2|COMPLETED|Baseline to Month 6||20
248782|NCT01003106|604006|P1|COMPLETED|Baseline to Month 6||22
248783|NCT01003106|603999|P8|STARTED|Baseline to Month 6||0
248784|NCT01003106|604000|P7|STARTED|Baseline to Month 6||0
248785|NCT01003106|604001|P6|STARTED|Baseline to Month 6||20
248786|NCT01003106|604002|P5|STARTED|Baseline to Month 6||19
248787|NCT01003106|604003|P4|STARTED|Baseline to Month 6||0
248788|NCT01003106|604004|P3|STARTED|Baseline to Month 6||0
248789|NCT01003106|604005|P2|STARTED|Baseline to Month 6||20
248790|NCT01003106|604006|P1|STARTED|Baseline to Month 6||22
248791|NCT01003184|604030|P2|NOT COMPLETED|Overall Study||12
248792|NCT01003184|604031|P1|NOT COMPLETED|Overall Study||19
248793|NCT01003184|604030|P2|COMPLETED|Overall Study||99
248794|NCT01003184|604031|P1|COMPLETED|Overall Study||92
248795|NCT01003184|604030|P2|Full Analysis Set (FAS)|Overall Study||105
248796|NCT01003184|604031|P1|Full Analysis Set (FAS)|Overall Study||111
248797|NCT01003184|604030|P2|STARTED|Overall Study||111
248798|NCT01003184|604031|P1|STARTED|Overall Study||111
248799|NCT01003210|604065|P2|NOT COMPLETED|Overall Study||3
248800|NCT01003210|604066|P1|NOT COMPLETED|Overall Study||1
248801|NCT01003210|604065|P2|COMPLETED|Overall Study||102
248802|NCT01003210|604066|P1|COMPLETED|Overall Study||104
248803|NCT01003210|604065|P2|STARTED|Overall Study||105
248804|NCT01003210|604066|P1|STARTED|Overall Study||105
248805|NCT01003275|604076|P2|NOT COMPLETED|Overall Study||0
248806|NCT01003275|604077|P1|NOT COMPLETED|Overall Study||1
248807|NCT01003275|604076|P2|COMPLETED|Overall Study||11
248808|NCT01003275|604077|P1|COMPLETED|Overall Study||10
248809|NCT01003275|604076|P2|STARTED|Overall Study||11
248810|NCT01003275|604077|P1|STARTED|Overall Study||11
248811|NCT01003288|604085|P1|NOT COMPLETED|Overall Study||0
248812|NCT01003288|604085|P1|COMPLETED|Overall Study||255
248813|NCT01003288|604085|P1|STARTED|Overall Study||255
248814|NCT01003301|604092|P2|NOT COMPLETED|Overall Study||0
248815|NCT01003301|604093|P1|NOT COMPLETED|Overall Study||0
248816|NCT01003301|604092|P2|COMPLETED|Overall Study||9
248817|NCT01003301|604093|P1|COMPLETED|Overall Study||10
248818|NCT01003301|604092|P2|STARTED|Overall Study||9
248819|NCT01003301|604093|P1|STARTED|Overall Study||10
248820|NCT01003886|604099|P1|NOT COMPLETED|Overall Study||230
248821|NCT01003886|604099|P1|COMPLETED|Overall Study||759
248822|NCT01003886|604099|P1|STARTED|Overall Study||989
248823|NCT01003899|604108|P1|NOT COMPLETED|Overall Study||47
248824|NCT01003899|604108|P1|COMPLETED|Overall Study||0
248825|NCT01003899|604108|P1|STARTED|Overall Study|enrolled|47
248826|NCT01003938|604117|P1|NOT COMPLETED|Overall Study||0
248827|NCT01003938|604117|P1|COMPLETED|Overall Study||6
248828|NCT01003938|604117|P1|STARTED|Overall Study||6
248829|NCT01003990|604129|P3|NOT COMPLETED|Overall Study||43
248830|NCT01003990|604130|P2|NOT COMPLETED|Overall Study||51
248831|NCT01003990|604131|P1|NOT COMPLETED|Overall Study||92
248832|NCT01003990|604129|P3|COMPLETED|Overall Study||53
248833|NCT01003990|604130|P2|COMPLETED|Overall Study||103
248834|NCT01003990|604131|P1|COMPLETED|Overall Study||367
248835|NCT01003990|604129|P3|STARTED|Overall Study||96
248836|NCT01003990|604130|P2|STARTED|Overall Study||154
248837|NCT01003990|604131|P1|STARTED|Overall Study||459
248838|NCT01004003|604148|P9|NOT COMPLETED|Overall Study||30
248839|NCT01004003|604149|P8|NOT COMPLETED|Overall Study||60
248840|NCT01004003|604150|P7|NOT COMPLETED|Overall Study||8
248841|NCT01004003|604151|P6|NOT COMPLETED|Overall Study||4
248842|NCT01004003|604152|P5|NOT COMPLETED|Overall Study||4
248843|NCT01004003|604153|P4|NOT COMPLETED|Overall Study||3
248844|NCT01004003|604154|P3|NOT COMPLETED|Overall Study||4
248845|NCT01004003|604155|P2|NOT COMPLETED|Overall Study||3
248846|NCT01004003|604156|P1|NOT COMPLETED|Overall Study||6
248847|NCT01004003|604148|P9|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|1
248848|NCT01004003|604149|P8|COMPLETED|Overall Study|On-treatment at analysis cut-off date (15 July 2014).|2
248849|NCT01004003|604150|P7|COMPLETED|Overall Study||0
248850|NCT01004003|604151|P6|COMPLETED|Overall Study||0
248851|NCT01004003|604152|P5|COMPLETED|Overall Study||0
248852|NCT01004003|604153|P4|COMPLETED|Overall Study||0
248853|NCT01004003|604154|P3|COMPLETED|Overall Study||0
248854|NCT01004003|604155|P2|COMPLETED|Overall Study||0
248855|NCT01004003|604156|P1|COMPLETED|Overall Study||0
248856|NCT01004003|604148|P9|STARTED|Overall Study||31
248857|NCT01004003|604149|P8|STARTED|Overall Study||62
248858|NCT01004003|604150|P7|STARTED|Overall Study||8
248859|NCT01004003|604151|P6|STARTED|Overall Study||4
248860|NCT01004003|604152|P5|STARTED|Overall Study||4
248861|NCT01004003|604153|P4|STARTED|Overall Study||3
248862|NCT01004003|604154|P3|STARTED|Overall Study||4
248863|NCT01004003|604155|P2|STARTED|Overall Study||3
248864|NCT01004003|604156|P1|STARTED|Overall Study||6
248865|NCT01004146|604186|P2|NOT COMPLETED|Overall Study||5
248866|NCT01004146|604187|P1|NOT COMPLETED|Overall Study||4
248867|NCT01004146|604186|P2|COMPLETED|Overall Study||20
248868|NCT01004146|604187|P1|COMPLETED|Overall Study||21
248869|NCT01004146|604186|P2|Have Incentive Spirometry Data|Overall Study||20
248870|NCT01004146|604187|P1|Have Incentive Spirometry Data|Overall Study||21
248871|NCT01004146|604186|P2|STARTED|Overall Study||25
248872|NCT01004146|604187|P1|STARTED|Overall Study||25
248873|NCT01004159|604193|P1|NOT COMPLETED|Overall Study||20
248874|NCT01004159|604193|P1|COMPLETED|Overall Study||0
248875|NCT01004159|604193|P1|STARTED|Overall Study||20
248876|NCT01004172|604198|P1|NOT COMPLETED|Overall Study||38
248877|NCT01004172|604198|P1|COMPLETED|Overall Study||0
248878|NCT01004172|604198|P1|STARTED|Overall Study||38
248879|NCT01004185|604206|P2|NOT COMPLETED|Overall Study||9
248880|NCT01004185|604207|P1|NOT COMPLETED|Overall Study||9
248881|NCT01004185|604206|P2|COMPLETED|Overall Study||11
248882|NCT01004185|604207|P1|COMPLETED|Overall Study||10
248883|NCT01004185|604206|P2|STARTED|Overall Study||20
248884|NCT01004185|604207|P1|STARTED|Overall Study||19
248885|NCT01004250|604215|P1|NOT COMPLETED|Follow-Up (FU) Period||1
248886|NCT01004250|604215|P1|COMPLETED|Follow-Up (FU) Period||100
248887|NCT01004250|604215|P1|STARTED|Follow-Up (FU) Period|Did not enter FU:Death-4pts Ind,1pts Maint; Pt Withdrew-1 pts Ind,1pts Maint; Lost to FU-1 pts Maint|101
248888|NCT01004250|604215|P1|NOT COMPLETED|Maintenance Therapy Period||26
248889|NCT01004250|604215|P1|COMPLETED|Maintenance Therapy Period||46
248890|NCT01004250|604215|P1|Death (Any Cause) or Disease Progression|Maintenance Therapy Period|Pts with death or disease progression considered to have completed phase.|46
248891|NCT01004250|604215|P1|STARTED|Maintenance Therapy Period|Did not enter Maint: 21 pts due to death or disease progression; 1 pts had performance status 2.|72
248892|NCT01004250|604215|P1|NOT COMPLETED|Induction Therapy Period||15
248893|NCT01004250|604215|P1|COMPLETED|Induction Therapy Period||94
248894|NCT01004250|604215|P1|Death (Any Cause) or Disease Progression|Induction Therapy Period|Participants (pts) with death or disease progression considered to have completed phase.|21
248895|NCT01004250|604215|P1|Received at Least One Dose of Study Drug|Induction Therapy Period||109
248896|NCT01004250|604215|P1|STARTED|Induction Therapy Period||109
248897|NCT01004263|604225|P1|NOT COMPLETED|Overall Study||179
248898|NCT01004263|604225|P1|COMPLETED|Overall Study||427
248899|NCT01004263|604225|P1|STARTED|Overall Study|Participants who took study drug|606
248900|NCT00990964|604233|P1|NOT COMPLETED|Overall Study||212
248901|NCT00990964|604233|P1|COMPLETED|Overall Study|Total number of subjects with successful Attain Family lead using Attain Family catheter|1802
248902|NCT00990964|604233|P1|Attain Family Study System Attempt|Overall Study|Total number of subjects with an Attain Family lead attempt after an Attain Family catheter attempt|1917
248903|NCT00990964|604233|P1|STARTED|Overall Study|Total number of subjects enrolled|2014
248904|NCT00991081|604240|P3|NOT COMPLETED|Phase II, Randomized Control Trial||4
248905|NCT00991081|604241|P2|NOT COMPLETED|Phase II, Randomized Control Trial||2
248906|NCT00991081|604242|P1|NOT COMPLETED|Phase II, Randomized Control Trial||0
248907|NCT00991081|604240|P3|COMPLETED|Phase II, Randomized Control Trial||15
248908|NCT00991081|604241|P2|COMPLETED|Phase II, Randomized Control Trial||15
248909|NCT00991081|604242|P1|COMPLETED|Phase II, Randomized Control Trial||0
248910|NCT00991081|604240|P3|Received First Clinical Call|Phase II, Randomized Control Trial||17
248911|NCT00991081|604241|P2|Received First Clinical Call|Phase II, Randomized Control Trial||16
248912|NCT00991081|604242|P1|Received First Clinical Call|Phase II, Randomized Control Trial||0
248913|NCT00991081|604240|P3|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|19
248914|NCT00991081|604241|P2|STARTED|Phase II, Randomized Control Trial|Phase I interview participants were not enrolled in the Phase II RCT.|17
248915|NCT00991081|604242|P1|STARTED|Phase II, Randomized Control Trial||0
248916|NCT00991081|604240|P3|NOT COMPLETED|Phase I, Formative Research||0
248917|NCT00991081|604241|P2|NOT COMPLETED|Phase I, Formative Research||0
248918|NCT00991081|604242|P1|NOT COMPLETED|Phase I, Formative Research||0
248919|NCT00991081|604240|P3|COMPLETED|Phase I, Formative Research||0
248920|NCT00991081|604241|P2|COMPLETED|Phase I, Formative Research||0
248921|NCT00991081|604242|P1|COMPLETED|Phase I, Formative Research|The 10 smokers interviewed were not enrolled in the Phase II RCT.|20
248922|NCT00991081|604240|P3|STARTED|Phase I, Formative Research||0
248923|NCT00991081|604241|P2|STARTED|Phase I, Formative Research||0
248924|NCT00991081|604242|P1|STARTED|Phase I, Formative Research||20
248925|NCT00991185|604274|P1|NOT COMPLETED|Overall Study||0
248926|NCT00991185|604274|P1|COMPLETED|Overall Study||8
248927|NCT00991185|604274|P1|STARTED|Overall Study||8
248928|NCT00991276|604284|P6|NOT COMPLETED|Third Intervention Period||1
248929|NCT00991276|604285|P5|NOT COMPLETED|Third Intervention Period||0
248930|NCT00991276|604286|P4|NOT COMPLETED|Third Intervention Period||1
248931|NCT00991276|604287|P3|NOT COMPLETED|Third Intervention Period||1
248932|NCT00991276|604288|P2|NOT COMPLETED|Third Intervention Period||0
248933|NCT00991276|604289|P1|NOT COMPLETED|Third Intervention Period||1
248934|NCT00991276|604284|P6|COMPLETED|Third Intervention Period||10
248935|NCT00991276|604285|P5|COMPLETED|Third Intervention Period||10
248936|NCT00991276|604286|P4|COMPLETED|Third Intervention Period||8
248937|NCT00991276|604287|P3|COMPLETED|Third Intervention Period||13
248938|NCT00991276|604288|P2|COMPLETED|Third Intervention Period||8
248939|NCT00991276|604289|P1|COMPLETED|Third Intervention Period||13
248940|NCT00991276|604284|P6|STARTED|Third Intervention Period||11
248941|NCT00991276|604285|P5|STARTED|Third Intervention Period||10
248942|NCT00991276|604286|P4|STARTED|Third Intervention Period||9
248943|NCT00991276|604287|P3|STARTED|Third Intervention Period||14
248944|NCT00991276|604288|P2|STARTED|Third Intervention Period||8
248945|NCT00991276|604289|P1|STARTED|Third Intervention Period||14
248946|NCT00991276|604284|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248947|NCT00991276|604285|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248948|NCT00991276|604286|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248949|NCT00991276|604287|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248950|NCT00991276|604288|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248951|NCT00991276|604289|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248952|NCT00991276|604284|P6|COMPLETED|Placebo Wash-out Period (7 Days)||11
248953|NCT00991276|604285|P5|COMPLETED|Placebo Wash-out Period (7 Days)||10
248954|NCT00991276|604286|P4|COMPLETED|Placebo Wash-out Period (7 Days)||9
248955|NCT00991276|604287|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
248956|NCT00991276|604288|P2|COMPLETED|Placebo Wash-out Period (7 Days)||8
248957|NCT00991276|604289|P1|COMPLETED|Placebo Wash-out Period (7 Days)||14
248958|NCT00991276|604284|P6|STARTED|Placebo Wash-out Period (7 Days)||11
248959|NCT00991276|604285|P5|STARTED|Placebo Wash-out Period (7 Days)||10
248960|NCT00991276|604286|P4|STARTED|Placebo Wash-out Period (7 Days)||9
248961|NCT00991276|604287|P3|STARTED|Placebo Wash-out Period (7 Days)||14
248962|NCT00991276|604288|P2|STARTED|Placebo Wash-out Period (7 Days)||8
248963|NCT00991276|604289|P1|STARTED|Placebo Wash-out Period (7 Days)||14
248964|NCT00991276|604284|P6|NOT COMPLETED|Second Intervention Period||1
248965|NCT00991276|604285|P5|NOT COMPLETED|Second Intervention Period||1
248966|NCT00991276|604286|P4|NOT COMPLETED|Second Intervention Period||2
248967|NCT00991276|604287|P3|NOT COMPLETED|Second Intervention Period||0
248968|NCT00991276|604288|P2|NOT COMPLETED|Second Intervention Period||2
248969|NCT00991276|604289|P1|NOT COMPLETED|Second Intervention Period||1
248970|NCT00991276|604284|P6|COMPLETED|Second Intervention Period||11
248971|NCT00991276|604285|P5|COMPLETED|Second Intervention Period||10
248972|NCT00991276|604286|P4|COMPLETED|Second Intervention Period||9
248973|NCT00991276|604287|P3|COMPLETED|Second Intervention Period||14
248974|NCT00991276|604288|P2|COMPLETED|Second Intervention Period||8
248975|NCT00991276|604289|P1|COMPLETED|Second Intervention Period||14
248976|NCT00991276|604284|P6|STARTED|Second Intervention Period||12
248977|NCT00991276|604285|P5|STARTED|Second Intervention Period||11
248978|NCT00991276|604286|P4|STARTED|Second Intervention Period||11
248979|NCT00991276|604287|P3|STARTED|Second Intervention Period||14
248980|NCT00991276|604288|P2|STARTED|Second Intervention Period||10
248981|NCT00991276|604289|P1|STARTED|Second Intervention Period||15
248982|NCT00991276|604284|P6|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248983|NCT00991276|604285|P5|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248984|NCT00991276|604286|P4|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248985|NCT00991276|604287|P3|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248986|NCT00991276|604288|P2|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248987|NCT00991276|604289|P1|NOT COMPLETED|Placebo Wash-out Period (7 Days)||0
248988|NCT00991276|604284|P6|COMPLETED|Placebo Wash-out Period (7 Days)||12
248989|NCT00991276|604285|P5|COMPLETED|Placebo Wash-out Period (7 Days)||11
248990|NCT00991276|604286|P4|COMPLETED|Placebo Wash-out Period (7 Days)||11
248991|NCT00991276|604287|P3|COMPLETED|Placebo Wash-out Period (7 Days)||14
248992|NCT00991276|604288|P2|COMPLETED|Placebo Wash-out Period (7 Days)||10
248993|NCT00991276|604289|P1|COMPLETED|Placebo Wash-out Period (7 Days)||15
248994|NCT00991276|604284|P6|STARTED|Placebo Wash-out Period (7 Days)||12
248995|NCT00991276|604285|P5|STARTED|Placebo Wash-out Period (7 Days)||11
248996|NCT00991276|604286|P4|STARTED|Placebo Wash-out Period (7 Days)||11
248997|NCT00991276|604287|P3|STARTED|Placebo Wash-out Period (7 Days)||14
248998|NCT00991276|604288|P2|STARTED|Placebo Wash-out Period (7 Days)||10
248999|NCT00991276|604289|P1|STARTED|Placebo Wash-out Period (7 Days)||15
249000|NCT00991276|604284|P6|NOT COMPLETED|First Intervention Period||1
249001|NCT00991276|604285|P5|NOT COMPLETED|First Intervention Period||4
249002|NCT00991276|604286|P4|NOT COMPLETED|First Intervention Period||4
249003|NCT00991276|604287|P3|NOT COMPLETED|First Intervention Period||0
249004|NCT00991276|604288|P2|NOT COMPLETED|First Intervention Period||3
249005|NCT00991276|604289|P1|NOT COMPLETED|First Intervention Period||0
249006|NCT00991276|604284|P6|COMPLETED|First Intervention Period||12
249007|NCT00991276|604285|P5|COMPLETED|First Intervention Period||11
249008|NCT00991276|604286|P4|COMPLETED|First Intervention Period||11
249009|NCT00991276|604287|P3|COMPLETED|First Intervention Period||14
249010|NCT00991276|604288|P2|COMPLETED|First Intervention Period||10
249011|NCT00991276|604289|P1|COMPLETED|First Intervention Period||15
249012|NCT00991276|604284|P6|STARTED|First Intervention Period||13
249013|NCT00991276|604285|P5|STARTED|First Intervention Period||15
249014|NCT00991276|604286|P4|STARTED|First Intervention Period||15
249015|NCT00991276|604287|P3|STARTED|First Intervention Period||14
249016|NCT00991276|604288|P2|STARTED|First Intervention Period||13
249017|NCT00991276|604289|P1|STARTED|First Intervention Period||15
249018|NCT00991289|604387|P1|NOT COMPLETED|Overall Study||12
249019|NCT00991289|604387|P1|COMPLETED|Overall Study|Completed study.|55
249020|NCT00991289|604387|P1|COMPLETED Week 16|Overall Study|Completed 16 weeks of the study (the primary endpoint time point). The study continued to Week 76.|61
249021|NCT00991289|604387|P1|STARTED|Overall Study|68 participants enrolled, one was found to have been ineligible and was excluded.|67
249022|NCT00991302|604403|P2|NOT COMPLETED|Overall Study||13
249023|NCT00991302|604404|P1|NOT COMPLETED|Overall Study||14
249024|NCT00991302|604403|P2|COMPLETED|Overall Study||73
249025|NCT00991302|604404|P1|COMPLETED|Overall Study||72
249026|NCT00991302|604403|P2|STARTED|Overall Study||86
249027|NCT00991302|604404|P1|STARTED|Overall Study||86
249028|NCT00991341|604422|P2|NOT COMPLETED|Overall Study||179
249029|NCT00991341|604423|P1|NOT COMPLETED|Overall Study||204
249030|NCT00991341|604422|P2|COMPLETED|Overall Study||560
249031|NCT00991341|604423|P1|COMPLETED|Overall Study||538
249032|NCT00991341|604422|P2|STARTED|Overall Study||739
249033|NCT00991341|604423|P1|STARTED|Overall Study||742
249034|NCT00991458|604462|P3|NOT COMPLETED|Overall Study||25
249035|NCT00991458|604463|P2|NOT COMPLETED|Overall Study||28
249036|NCT00991458|604464|P1|NOT COMPLETED|Overall Study||20
249037|NCT00991458|604462|P3|COMPLETED|Overall Study||180
249038|NCT00991458|604463|P2|COMPLETED|Overall Study||181
249039|NCT00991458|604464|P1|COMPLETED|Overall Study||187
249040|NCT00991458|604462|P3|STARTED|Overall Study||205
249041|NCT00991458|604463|P2|STARTED|Overall Study||209
249042|NCT00991458|604464|P1|STARTED|Overall Study||207
249043|NCT00991510|604483|P2|NOT COMPLETED|Period III (Days 29-112)||1
249044|NCT00991510|604484|P1|NOT COMPLETED|Period III (Days 29-112)||1
249045|NCT00991510|604483|P2|COMPLETED|Period III (Days 29-112)||20
249046|NCT00991510|604484|P1|COMPLETED|Period III (Days 29-112)||20
249047|NCT00991510|604483|P2|STARTED|Period III (Days 29-112)||21
249048|NCT00991510|604484|P1|STARTED|Period III (Days 29-112)||21
249049|NCT00991510|604483|P2|NOT COMPLETED|Period II (Days 15-28)||0
249050|NCT00991510|604484|P1|NOT COMPLETED|Period II (Days 15-28)||0
249051|NCT00991510|604483|P2|COMPLETED|Period II (Days 15-28)||21
249052|NCT00991510|604484|P1|COMPLETED|Period II (Days 15-28)||21
249053|NCT00991510|604483|P2|STARTED|Period II (Days 15-28)||21
249054|NCT00991510|604484|P1|STARTED|Period II (Days 15-28)||21
249055|NCT00991510|604483|P2|NOT COMPLETED|Period I (Days 1-14)||0
249056|NCT00991510|604484|P1|NOT COMPLETED|Period I (Days 1-14)||1
249057|NCT00991510|604483|P2|COMPLETED|Period I (Days 1-14)||21
249058|NCT00991510|604484|P1|COMPLETED|Period I (Days 1-14)||21
249059|NCT00991510|604483|P2|STARTED|Period I (Days 1-14)||21
249060|NCT00991510|604484|P1|STARTED|Period I (Days 1-14)||22
249061|NCT00996892|604506|P20|NOT COMPLETED|Expansion Stage 2A||45
249062|NCT00996892|604507|P19|NOT COMPLETED|Expansion Stage 2A||0
249063|NCT00996892|604508|P18|NOT COMPLETED|Expansion Stage 2A||0
249064|NCT00996892|604509|P17|NOT COMPLETED|Expansion Stage 2A||0
249065|NCT00996892|604510|P16|NOT COMPLETED|Expansion Stage 2A||0
249066|NCT00996892|604511|P15|NOT COMPLETED|Expansion Stage 2A||0
249067|NCT00996892|604512|P14|NOT COMPLETED|Expansion Stage 2A||0
249068|NCT00996892|604513|P13|NOT COMPLETED|Expansion Stage 2A||0
249069|NCT00996892|604514|P12|NOT COMPLETED|Expansion Stage 2A||0
249070|NCT00996892|604515|P11|NOT COMPLETED|Expansion Stage 2A||0
249071|NCT00996892|604516|P10|NOT COMPLETED|Expansion Stage 2A||0
249072|NCT00996892|604517|P9|NOT COMPLETED|Expansion Stage 2A||0
249073|NCT00996892|604518|P8|NOT COMPLETED|Expansion Stage 2A||0
249074|NCT00996892|604519|P7|NOT COMPLETED|Expansion Stage 2A||0
249075|NCT00996892|604520|P6|NOT COMPLETED|Expansion Stage 2A||0
249076|NCT00996892|604521|P5|NOT COMPLETED|Expansion Stage 2A||0
249077|NCT00996892|604522|P4|NOT COMPLETED|Expansion Stage 2A||0
249078|NCT00996892|604523|P3|NOT COMPLETED|Expansion Stage 2A||0
249079|NCT00996892|604524|P2|NOT COMPLETED|Expansion Stage 2A||0
249080|NCT00996892|604525|P1|NOT COMPLETED|Expansion Stage 2A||0
249081|NCT00996892|604506|P20|COMPLETED|Expansion Stage 2A||0
249082|NCT00996892|604507|P19|COMPLETED|Expansion Stage 2A||0
249083|NCT00996892|604508|P18|COMPLETED|Expansion Stage 2A||0
249084|NCT00996892|604509|P17|COMPLETED|Expansion Stage 2A||0
249085|NCT00996892|604510|P16|COMPLETED|Expansion Stage 2A||0
249086|NCT00996892|604511|P15|COMPLETED|Expansion Stage 2A||0
249087|NCT00996892|604512|P14|COMPLETED|Expansion Stage 2A||0
249088|NCT00996892|604513|P13|COMPLETED|Expansion Stage 2A||0
249089|NCT00996892|604514|P12|COMPLETED|Expansion Stage 2A||0
249090|NCT00996892|604515|P11|COMPLETED|Expansion Stage 2A||0
249091|NCT00996892|604516|P10|COMPLETED|Expansion Stage 2A||0
249092|NCT00996892|604517|P9|COMPLETED|Expansion Stage 2A||0
249093|NCT00996892|604518|P8|COMPLETED|Expansion Stage 2A||0
249094|NCT00996892|604519|P7|COMPLETED|Expansion Stage 2A||0
249095|NCT00996892|604520|P6|COMPLETED|Expansion Stage 2A||0
249096|NCT00996892|604521|P5|COMPLETED|Expansion Stage 2A||0
249097|NCT00996892|604522|P4|COMPLETED|Expansion Stage 2A||0
249098|NCT00996892|604523|P3|COMPLETED|Expansion Stage 2A||0
249099|NCT00996892|604524|P2|COMPLETED|Expansion Stage 2A||0
249100|NCT00996892|604525|P1|COMPLETED|Expansion Stage 2A||0
249101|NCT00996892|604506|P20|STARTED|Expansion Stage 2A||45
249102|NCT00996892|604507|P19|STARTED|Expansion Stage 2A||0
249103|NCT00996892|604508|P18|STARTED|Expansion Stage 2A||0
249104|NCT00996892|604509|P17|STARTED|Expansion Stage 2A||0
249105|NCT00996892|604510|P16|STARTED|Expansion Stage 2A||0
249106|NCT00996892|604511|P15|STARTED|Expansion Stage 2A||0
249107|NCT00996892|604512|P14|STARTED|Expansion Stage 2A||0
249108|NCT00996892|604513|P13|STARTED|Expansion Stage 2A||0
249109|NCT00996892|604514|P12|STARTED|Expansion Stage 2A||0
249110|NCT00996892|604515|P11|STARTED|Expansion Stage 2A||0
249111|NCT00996892|604516|P10|STARTED|Expansion Stage 2A||0
249112|NCT00996892|604517|P9|STARTED|Expansion Stage 2A||0
249113|NCT00996892|604518|P8|STARTED|Expansion Stage 2A||0
249114|NCT00996892|604519|P7|STARTED|Expansion Stage 2A||0
249115|NCT00996892|604520|P6|STARTED|Expansion Stage 2A||0
249116|NCT00996892|604521|P5|STARTED|Expansion Stage 2A||0
249117|NCT00996892|604522|P4|STARTED|Expansion Stage 2A||0
249118|NCT00996892|604523|P3|STARTED|Expansion Stage 2A||0
249119|NCT00996892|604524|P2|STARTED|Expansion Stage 2A||0
249120|NCT00996892|604525|P1|STARTED|Expansion Stage 2A||0
249121|NCT00996892|604506|P20|NOT COMPLETED|Expansion Stage 2||0
249122|NCT00996892|604507|P19|NOT COMPLETED|Expansion Stage 2||35
249123|NCT00996892|604508|P18|NOT COMPLETED|Expansion Stage 2||0
249124|NCT00996892|604509|P17|NOT COMPLETED|Expansion Stage 2||0
249125|NCT00996892|604510|P16|NOT COMPLETED|Expansion Stage 2||0
249126|NCT00996892|604511|P15|NOT COMPLETED|Expansion Stage 2||0
249127|NCT00996892|604512|P14|NOT COMPLETED|Expansion Stage 2||0
249128|NCT00996892|604513|P13|NOT COMPLETED|Expansion Stage 2||0
249129|NCT00996892|604514|P12|NOT COMPLETED|Expansion Stage 2||0
249130|NCT00996892|604515|P11|NOT COMPLETED|Expansion Stage 2||0
249131|NCT00996892|604516|P10|NOT COMPLETED|Expansion Stage 2||0
249132|NCT00996892|604517|P9|NOT COMPLETED|Expansion Stage 2||0
249133|NCT00996892|604518|P8|NOT COMPLETED|Expansion Stage 2||0
249134|NCT00996892|604519|P7|NOT COMPLETED|Expansion Stage 2||0
249135|NCT00996892|604520|P6|NOT COMPLETED|Expansion Stage 2||0
249136|NCT00996892|604521|P5|NOT COMPLETED|Expansion Stage 2||0
249137|NCT00996892|604522|P4|NOT COMPLETED|Expansion Stage 2||0
249138|NCT00996892|604523|P3|NOT COMPLETED|Expansion Stage 2||0
249139|NCT00996892|604524|P2|NOT COMPLETED|Expansion Stage 2||0
249140|NCT00996892|604525|P1|NOT COMPLETED|Expansion Stage 2||0
249141|NCT00996892|604506|P20|COMPLETED|Expansion Stage 2||0
249142|NCT00996892|604507|P19|COMPLETED|Expansion Stage 2||0
249143|NCT00996892|604508|P18|COMPLETED|Expansion Stage 2||0
249144|NCT00996892|604509|P17|COMPLETED|Expansion Stage 2||0
249145|NCT00996892|604510|P16|COMPLETED|Expansion Stage 2||0
249146|NCT00996892|604511|P15|COMPLETED|Expansion Stage 2||0
249147|NCT00996892|604512|P14|COMPLETED|Expansion Stage 2||0
249148|NCT00996892|604513|P13|COMPLETED|Expansion Stage 2||0
249149|NCT00996892|604514|P12|COMPLETED|Expansion Stage 2||0
249150|NCT00996892|604515|P11|COMPLETED|Expansion Stage 2||0
249151|NCT00996892|604516|P10|COMPLETED|Expansion Stage 2||0
249152|NCT00996892|604517|P9|COMPLETED|Expansion Stage 2||0
249153|NCT00996892|604518|P8|COMPLETED|Expansion Stage 2||0
249154|NCT00996892|604519|P7|COMPLETED|Expansion Stage 2||0
249155|NCT00996892|604520|P6|COMPLETED|Expansion Stage 2||0
249156|NCT00996892|604521|P5|COMPLETED|Expansion Stage 2||0
249157|NCT00996892|604522|P4|COMPLETED|Expansion Stage 2||0
249158|NCT00996892|604523|P3|COMPLETED|Expansion Stage 2||0
249159|NCT00996892|604524|P2|COMPLETED|Expansion Stage 2||0
249160|NCT00996892|604525|P1|COMPLETED|Expansion Stage 2||0
249161|NCT00996892|604506|P20|STARTED|Expansion Stage 2||0
249162|NCT00996892|604507|P19|STARTED|Expansion Stage 2||35
249163|NCT00996892|604508|P18|STARTED|Expansion Stage 2||0
249164|NCT00996892|604509|P17|STARTED|Expansion Stage 2||0
249165|NCT00996892|604510|P16|STARTED|Expansion Stage 2||0
249166|NCT00996892|604511|P15|STARTED|Expansion Stage 2||0
249167|NCT00996892|604512|P14|STARTED|Expansion Stage 2||0
249168|NCT00996892|604513|P13|STARTED|Expansion Stage 2||0
249169|NCT00996892|604514|P12|STARTED|Expansion Stage 2||0
249170|NCT00996892|604515|P11|STARTED|Expansion Stage 2||0
249171|NCT00996892|604516|P10|STARTED|Expansion Stage 2||0
249172|NCT00996892|604517|P9|STARTED|Expansion Stage 2||0
249173|NCT00996892|604518|P8|STARTED|Expansion Stage 2||0
249174|NCT00996892|604519|P7|STARTED|Expansion Stage 2||0
249175|NCT00996892|604520|P6|STARTED|Expansion Stage 2||0
249176|NCT00996892|604521|P5|STARTED|Expansion Stage 2||0
249177|NCT00996892|604522|P4|STARTED|Expansion Stage 2||0
249178|NCT00996892|604523|P3|STARTED|Expansion Stage 2||0
249179|NCT00996892|604524|P2|STARTED|Expansion Stage 2||0
249180|NCT00996892|604525|P1|STARTED|Expansion Stage 2||0
249181|NCT00996892|604506|P20|NOT COMPLETED|Dose-Escalation Stage 1B||0
249182|NCT00996892|604507|P19|NOT COMPLETED|Dose-Escalation Stage 1B||0
249183|NCT00996892|604508|P18|NOT COMPLETED|Dose-Escalation Stage 1B||5
249184|NCT00996892|604509|P17|NOT COMPLETED|Dose-Escalation Stage 1B||3
249185|NCT00996892|604510|P16|NOT COMPLETED|Dose-Escalation Stage 1B||3
249186|NCT00996892|604511|P15|NOT COMPLETED|Dose-Escalation Stage 1B||4
249187|NCT00996892|604512|P14|NOT COMPLETED|Dose-Escalation Stage 1B||0
249188|NCT00996892|604513|P13|NOT COMPLETED|Dose-Escalation Stage 1B||0
249189|NCT00996892|604514|P12|NOT COMPLETED|Dose-Escalation Stage 1B||0
249190|NCT00996892|604515|P11|NOT COMPLETED|Dose-Escalation Stage 1B||0
249191|NCT00996892|604516|P10|NOT COMPLETED|Dose-Escalation Stage 1B||0
249192|NCT00996892|604517|P9|NOT COMPLETED|Dose-Escalation Stage 1B||0
249193|NCT00996892|604518|P8|NOT COMPLETED|Dose-Escalation Stage 1B||0
249194|NCT00996892|604519|P7|NOT COMPLETED|Dose-Escalation Stage 1B||0
249195|NCT00996892|604520|P6|NOT COMPLETED|Dose-Escalation Stage 1B||0
249196|NCT00996892|604521|P5|NOT COMPLETED|Dose-Escalation Stage 1B||0
249197|NCT00996892|604522|P4|NOT COMPLETED|Dose-Escalation Stage 1B||0
249198|NCT00996892|604523|P3|NOT COMPLETED|Dose-Escalation Stage 1B||0
249199|NCT00996892|604524|P2|NOT COMPLETED|Dose-Escalation Stage 1B||0
249200|NCT00996892|604525|P1|NOT COMPLETED|Dose-Escalation Stage 1B||0
249201|NCT00996892|604506|P20|COMPLETED|Dose-Escalation Stage 1B||0
249202|NCT00996892|604507|P19|COMPLETED|Dose-Escalation Stage 1B||0
249203|NCT00996892|604508|P18|COMPLETED|Dose-Escalation Stage 1B||0
249204|NCT00996892|604509|P17|COMPLETED|Dose-Escalation Stage 1B||0
249205|NCT00996892|604510|P16|COMPLETED|Dose-Escalation Stage 1B||0
249206|NCT00996892|604511|P15|COMPLETED|Dose-Escalation Stage 1B||0
249207|NCT00996892|604512|P14|COMPLETED|Dose-Escalation Stage 1B||0
249208|NCT00996892|604513|P13|COMPLETED|Dose-Escalation Stage 1B||0
249209|NCT00996892|604514|P12|COMPLETED|Dose-Escalation Stage 1B||0
249210|NCT00996892|604515|P11|COMPLETED|Dose-Escalation Stage 1B||0
249211|NCT00996892|604516|P10|COMPLETED|Dose-Escalation Stage 1B||0
249212|NCT00996892|604517|P9|COMPLETED|Dose-Escalation Stage 1B||0
249213|NCT00996892|604518|P8|COMPLETED|Dose-Escalation Stage 1B||0
249214|NCT00996892|604519|P7|COMPLETED|Dose-Escalation Stage 1B||0
249215|NCT00996892|604520|P6|COMPLETED|Dose-Escalation Stage 1B||0
249216|NCT00996892|604521|P5|COMPLETED|Dose-Escalation Stage 1B||0
249217|NCT00996892|604522|P4|COMPLETED|Dose-Escalation Stage 1B||0
249218|NCT00996892|604523|P3|COMPLETED|Dose-Escalation Stage 1B||0
249219|NCT00996892|604524|P2|COMPLETED|Dose-Escalation Stage 1B||0
249220|NCT00996892|604525|P1|COMPLETED|Dose-Escalation Stage 1B||0
249221|NCT00996892|604506|P20|STARTED|Dose-Escalation Stage 1B||0
249222|NCT00996892|604507|P19|STARTED|Dose-Escalation Stage 1B||0
249223|NCT00996892|604508|P18|STARTED|Dose-Escalation Stage 1B||5
249224|NCT00996892|604509|P17|STARTED|Dose-Escalation Stage 1B||3
249225|NCT00996892|604510|P16|STARTED|Dose-Escalation Stage 1B||3
249226|NCT00996892|604511|P15|STARTED|Dose-Escalation Stage 1B||4
249227|NCT00996892|604512|P14|STARTED|Dose-Escalation Stage 1B||0
249228|NCT00996892|604513|P13|STARTED|Dose-Escalation Stage 1B||0
249229|NCT00996892|604514|P12|STARTED|Dose-Escalation Stage 1B||0
249230|NCT00996892|604515|P11|STARTED|Dose-Escalation Stage 1B||0
249231|NCT00996892|604516|P10|STARTED|Dose-Escalation Stage 1B||0
249232|NCT00996892|604517|P9|STARTED|Dose-Escalation Stage 1B||0
249233|NCT00996892|604518|P8|STARTED|Dose-Escalation Stage 1B||0
249234|NCT00996892|604519|P7|STARTED|Dose-Escalation Stage 1B||0
249235|NCT00996892|604520|P6|STARTED|Dose-Escalation Stage 1B||0
249236|NCT00996892|604521|P5|STARTED|Dose-Escalation Stage 1B||0
249237|NCT00996892|604522|P4|STARTED|Dose-Escalation Stage 1B||0
249238|NCT00996892|604523|P3|STARTED|Dose-Escalation Stage 1B||0
249239|NCT00996892|604524|P2|STARTED|Dose-Escalation Stage 1B||0
249240|NCT00996892|604525|P1|STARTED|Dose-Escalation Stage 1B||0
249241|NCT00996892|604506|P20|NOT COMPLETED|Dose-Escalation Stage 1A||0
249242|NCT00996892|604507|P19|NOT COMPLETED|Dose-Escalation Stage 1A||0
249243|NCT00996892|604508|P18|NOT COMPLETED|Dose-Escalation Stage 1A||0
249244|NCT00996892|604509|P17|NOT COMPLETED|Dose-Escalation Stage 1A||0
249245|NCT00996892|604510|P16|NOT COMPLETED|Dose-Escalation Stage 1A||0
249246|NCT00996892|604511|P15|NOT COMPLETED|Dose-Escalation Stage 1A||0
249247|NCT00996892|604512|P14|NOT COMPLETED|Dose-Escalation Stage 1A||5
249248|NCT00996892|604513|P13|NOT COMPLETED|Dose-Escalation Stage 1A||8
249249|NCT00996892|604514|P12|NOT COMPLETED|Dose-Escalation Stage 1A||9
249250|NCT00996892|604515|P11|NOT COMPLETED|Dose-Escalation Stage 1A||7
249251|NCT00996892|604516|P10|NOT COMPLETED|Dose-Escalation Stage 1A||4
249252|NCT00996892|604517|P9|NOT COMPLETED|Dose-Escalation Stage 1A||3
249253|NCT00996892|604518|P8|NOT COMPLETED|Dose-Escalation Stage 1A||3
249254|NCT00996892|604519|P7|NOT COMPLETED|Dose-Escalation Stage 1A||0
249255|NCT00996892|604520|P6|NOT COMPLETED|Dose-Escalation Stage 1A||0
249256|NCT00996892|604521|P5|NOT COMPLETED|Dose-Escalation Stage 1A||0
249257|NCT00996892|604522|P4|NOT COMPLETED|Dose-Escalation Stage 1A||0
249258|NCT00996892|604523|P3|NOT COMPLETED|Dose-Escalation Stage 1A||0
249259|NCT00996892|604524|P2|NOT COMPLETED|Dose-Escalation Stage 1A||0
249260|NCT00996892|604525|P1|NOT COMPLETED|Dose-Escalation Stage 1A||0
249261|NCT00996892|604506|P20|COMPLETED|Dose-Escalation Stage 1A||0
249262|NCT00996892|604507|P19|COMPLETED|Dose-Escalation Stage 1A||0
249263|NCT00996892|604508|P18|COMPLETED|Dose-Escalation Stage 1A||0
249264|NCT00996892|604509|P17|COMPLETED|Dose-Escalation Stage 1A||0
249265|NCT00996892|604510|P16|COMPLETED|Dose-Escalation Stage 1A||0
249266|NCT00996892|604511|P15|COMPLETED|Dose-Escalation Stage 1A||0
249267|NCT00996892|604512|P14|COMPLETED|Dose-Escalation Stage 1A||0
249268|NCT00996892|604513|P13|COMPLETED|Dose-Escalation Stage 1A||0
249269|NCT00996892|604514|P12|COMPLETED|Dose-Escalation Stage 1A||0
249270|NCT00996892|604515|P11|COMPLETED|Dose-Escalation Stage 1A||0
249271|NCT00996892|604516|P10|COMPLETED|Dose-Escalation Stage 1A||0
249272|NCT00996892|604517|P9|COMPLETED|Dose-Escalation Stage 1A||0
249273|NCT00996892|604518|P8|COMPLETED|Dose-Escalation Stage 1A||0
249274|NCT00996892|604519|P7|COMPLETED|Dose-Escalation Stage 1A||0
249275|NCT00996892|604520|P6|COMPLETED|Dose-Escalation Stage 1A||0
249276|NCT00996892|604521|P5|COMPLETED|Dose-Escalation Stage 1A||0
249277|NCT00996892|604522|P4|COMPLETED|Dose-Escalation Stage 1A||0
249278|NCT00996892|604523|P3|COMPLETED|Dose-Escalation Stage 1A||0
249279|NCT00996892|604524|P2|COMPLETED|Dose-Escalation Stage 1A||0
249280|NCT00996892|604525|P1|COMPLETED|Dose-Escalation Stage 1A||0
249281|NCT00996892|604506|P20|STARTED|Dose-Escalation Stage 1A||0
249282|NCT00996892|604507|P19|STARTED|Dose-Escalation Stage 1A||0
249283|NCT00996892|604508|P18|STARTED|Dose-Escalation Stage 1A||0
249284|NCT00996892|604509|P17|STARTED|Dose-Escalation Stage 1A||0
249285|NCT00996892|604510|P16|STARTED|Dose-Escalation Stage 1A||0
249286|NCT00996892|604511|P15|STARTED|Dose-Escalation Stage 1A||0
249287|NCT00996892|604512|P14|STARTED|Dose-Escalation Stage 1A||5
249288|NCT00996892|604513|P13|STARTED|Dose-Escalation Stage 1A||8
249289|NCT00996892|604514|P12|STARTED|Dose-Escalation Stage 1A||9
249290|NCT00996892|604515|P11|STARTED|Dose-Escalation Stage 1A||7
249291|NCT00996892|604516|P10|STARTED|Dose-Escalation Stage 1A||4
249292|NCT00996892|604517|P9|STARTED|Dose-Escalation Stage 1A||3
249293|NCT00996892|604518|P8|STARTED|Dose-Escalation Stage 1A||3
249294|NCT00996892|604519|P7|STARTED|Dose-Escalation Stage 1A||0
249295|NCT00996892|604520|P6|STARTED|Dose-Escalation Stage 1A||0
249296|NCT00996892|604521|P5|STARTED|Dose-Escalation Stage 1A||0
249297|NCT00996892|604522|P4|STARTED|Dose-Escalation Stage 1A||0
249298|NCT00996892|604523|P3|STARTED|Dose-Escalation Stage 1A||0
249299|NCT00996892|604524|P2|STARTED|Dose-Escalation Stage 1A||0
249300|NCT00996892|604525|P1|STARTED|Dose-Escalation Stage 1A||0
249301|NCT00996892|604506|P20|NOT COMPLETED|Dose-Escalation Stage 1||0
249302|NCT00996892|604507|P19|NOT COMPLETED|Dose-Escalation Stage 1||0
249303|NCT00996892|604508|P18|NOT COMPLETED|Dose-Escalation Stage 1||0
249304|NCT00996892|604509|P17|NOT COMPLETED|Dose-Escalation Stage 1||0
249305|NCT00996892|604510|P16|NOT COMPLETED|Dose-Escalation Stage 1||0
249306|NCT00996892|604511|P15|NOT COMPLETED|Dose-Escalation Stage 1||0
249307|NCT00996892|604512|P14|NOT COMPLETED|Dose-Escalation Stage 1||0
249308|NCT00996892|604513|P13|NOT COMPLETED|Dose-Escalation Stage 1||0
249309|NCT00996892|604514|P12|NOT COMPLETED|Dose-Escalation Stage 1||0
249310|NCT00996892|604515|P11|NOT COMPLETED|Dose-Escalation Stage 1||0
249311|NCT00996892|604516|P10|NOT COMPLETED|Dose-Escalation Stage 1||0
249312|NCT00996892|604517|P9|NOT COMPLETED|Dose-Escalation Stage 1||0
249313|NCT00996892|604518|P8|NOT COMPLETED|Dose-Escalation Stage 1||0
249314|NCT00996892|604519|P7|NOT COMPLETED|Dose-Escalation Stage 1||4
249315|NCT00996892|604520|P6|NOT COMPLETED|Dose-Escalation Stage 1||10
249316|NCT00996892|604521|P5|NOT COMPLETED|Dose-Escalation Stage 1||11
249317|NCT00996892|604522|P4|NOT COMPLETED|Dose-Escalation Stage 1||9
249318|NCT00996892|604523|P3|NOT COMPLETED|Dose-Escalation Stage 1||3
249319|NCT00996892|604524|P2|NOT COMPLETED|Dose-Escalation Stage 1||3
249320|NCT00996892|604525|P1|NOT COMPLETED|Dose-Escalation Stage 1||4
249321|NCT00996892|604506|P20|COMPLETED|Dose-Escalation Stage 1||0
249322|NCT00996892|604507|P19|COMPLETED|Dose-Escalation Stage 1||0
249323|NCT00996892|604508|P18|COMPLETED|Dose-Escalation Stage 1||0
249324|NCT00996892|604509|P17|COMPLETED|Dose-Escalation Stage 1||0
249325|NCT00996892|604510|P16|COMPLETED|Dose-Escalation Stage 1||0
249326|NCT00996892|604511|P15|COMPLETED|Dose-Escalation Stage 1||0
249327|NCT00996892|604512|P14|COMPLETED|Dose-Escalation Stage 1||0
249328|NCT00996892|604513|P13|COMPLETED|Dose-Escalation Stage 1||0
249329|NCT00996892|604514|P12|COMPLETED|Dose-Escalation Stage 1||0
249330|NCT00996892|604515|P11|COMPLETED|Dose-Escalation Stage 1||0
249331|NCT00996892|604516|P10|COMPLETED|Dose-Escalation Stage 1||0
249332|NCT00996892|604517|P9|COMPLETED|Dose-Escalation Stage 1||0
249333|NCT00996892|604518|P8|COMPLETED|Dose-Escalation Stage 1||0
249334|NCT00996892|604519|P7|COMPLETED|Dose-Escalation Stage 1||0
249335|NCT00996892|604520|P6|COMPLETED|Dose-Escalation Stage 1||0
249336|NCT00996892|604521|P5|COMPLETED|Dose-Escalation Stage 1||0
249337|NCT00996892|604522|P4|COMPLETED|Dose-Escalation Stage 1||0
249338|NCT00996892|604523|P3|COMPLETED|Dose-Escalation Stage 1||0
249339|NCT00996892|604524|P2|COMPLETED|Dose-Escalation Stage 1||0
249340|NCT00996892|604525|P1|COMPLETED|Dose-Escalation Stage 1||0
249341|NCT00996892|604506|P20|STARTED|Dose-Escalation Stage 1||0
249342|NCT00996892|604507|P19|STARTED|Dose-Escalation Stage 1||0
249343|NCT00996892|604508|P18|STARTED|Dose-Escalation Stage 1||0
249344|NCT00996892|604509|P17|STARTED|Dose-Escalation Stage 1||0
249345|NCT00996892|604510|P16|STARTED|Dose-Escalation Stage 1||0
249346|NCT00996892|604511|P15|STARTED|Dose-Escalation Stage 1||0
249347|NCT00996892|604512|P14|STARTED|Dose-Escalation Stage 1||0
249348|NCT00996892|604513|P13|STARTED|Dose-Escalation Stage 1||0
249349|NCT00996892|604514|P12|STARTED|Dose-Escalation Stage 1||0
249350|NCT00996892|604515|P11|STARTED|Dose-Escalation Stage 1||0
249351|NCT00996892|604516|P10|STARTED|Dose-Escalation Stage 1||0
249352|NCT00996892|604517|P9|STARTED|Dose-Escalation Stage 1||0
249353|NCT00996892|604518|P8|STARTED|Dose-Escalation Stage 1||0
249354|NCT00996892|604519|P7|STARTED|Dose-Escalation Stage 1||4
249355|NCT00996892|604520|P6|STARTED|Dose-Escalation Stage 1||10
249356|NCT00996892|604521|P5|STARTED|Dose-Escalation Stage 1||11
249357|NCT00996892|604522|P4|STARTED|Dose-Escalation Stage 1||9
249358|NCT00996892|604523|P3|STARTED|Dose-Escalation Stage 1||3
249359|NCT00996892|604524|P2|STARTED|Dose-Escalation Stage 1||3
249360|NCT00996892|604525|P1|STARTED|Dose-Escalation Stage 1||4
249361|NCT00996918|605119|P5|NOT COMPLETED|Overall Study||4
249362|NCT00996918|605120|P4|NOT COMPLETED|Overall Study||56
249363|NCT00996918|605121|P3|NOT COMPLETED|Overall Study||37
249364|NCT00996918|605122|P2|NOT COMPLETED|Overall Study||66
249365|NCT00996918|605123|P1|NOT COMPLETED|Overall Study||39
249366|NCT00996918|605119|P5|COMPLETED|Overall Study||0
249367|NCT00996918|605120|P4|COMPLETED|Overall Study||0
249368|NCT00996918|605121|P3|COMPLETED|Overall Study||0
249369|NCT00996918|605122|P2|COMPLETED|Overall Study||0
249370|NCT00996918|605123|P1|COMPLETED|Overall Study||0
249371|NCT00996918|605119|P5|Treated|Overall Study||4
249372|NCT00996918|605120|P4|Treated|Overall Study||56
249373|NCT00996918|605121|P3|Treated|Overall Study||37
249374|NCT00996918|605122|P2|Treated|Overall Study||66
249375|NCT00996918|605123|P1|Treated|Overall Study||39
249376|NCT00996918|605119|P5|STARTED|Overall Study||4
249377|NCT00996918|605120|P4|STARTED|Overall Study||56
249378|NCT00996918|605121|P3|STARTED|Overall Study||37
249379|NCT00996918|605122|P2|STARTED|Overall Study||66
249380|NCT00996918|605123|P1|STARTED|Overall Study||39
249381|NCT00996931|605167|P1|NOT COMPLETED|Overall Study||0
249382|NCT00996931|605167|P1|COMPLETED|Overall Study||6
249383|NCT00996931|605167|P1|STARTED|Overall Study||6
249384|NCT00996944|605174|P2|NOT COMPLETED|Long-term Treatment Period||5
249385|NCT00996944|605175|P1|NOT COMPLETED|Long-term Treatment Period||12
249386|NCT00996944|605174|P2|COMPLETED|Long-term Treatment Period||0
249387|NCT00996944|605175|P1|COMPLETED|Long-term Treatment Period||0
249388|NCT00996944|605174|P2|STARTED|Long-term Treatment Period||5
249389|NCT00996944|605175|P1|STARTED|Long-term Treatment Period||12
249390|NCT00996944|605174|P2|NOT COMPLETED|Double-blind Treatment Period||7
249391|NCT00996944|605175|P1|NOT COMPLETED|Double-blind Treatment Period||10
249392|NCT00996944|605174|P2|COMPLETED|Double-blind Treatment Period||5
249393|NCT00996944|605175|P1|COMPLETED|Double-blind Treatment Period||12
249394|NCT00996944|605174|P2|STARTED|Double-blind Treatment Period||12
249395|NCT00996944|605175|P1|STARTED|Double-blind Treatment Period||22
249396|NCT00996996|605217|P1|NOT COMPLETED|Overall Study||33
249397|NCT00996996|605217|P1|COMPLETED|Overall Study|These participants completed 12 years of follow-up.|44
249398|NCT00996996|605217|P1|STARTED|Overall Study||77
249399|NCT00997035|605251|P2|NOT COMPLETED|3-month Follow-up Visit||6
249400|NCT00997035|605252|P1|NOT COMPLETED|3-month Follow-up Visit||12
249401|NCT00997035|605251|P2|COMPLETED|3-month Follow-up Visit||107
249402|NCT00997035|605252|P1|COMPLETED|3-month Follow-up Visit||100
249403|NCT00997035|605251|P2|STARTED|3-month Follow-up Visit||113
249404|NCT00997035|605252|P1|STARTED|3-month Follow-up Visit||112
249405|NCT00997035|605251|P2|NOT COMPLETED|3-week Followup Visit||6
249406|NCT00997035|605252|P1|NOT COMPLETED|3-week Followup Visit||9
249407|NCT00997035|605251|P2|COMPLETED|3-week Followup Visit||113
249408|NCT00997035|605252|P1|COMPLETED|3-week Followup Visit||112
249409|NCT00997035|605251|P2|STARTED|3-week Followup Visit||119
249410|NCT00997035|605252|P1|STARTED|3-week Followup Visit||121
249411|NCT00997113|605274|P2|NOT COMPLETED|Overall Study||0
249412|NCT00997113|605275|P1|NOT COMPLETED|Overall Study||0
249413|NCT00997113|605274|P2|COMPLETED|Overall Study||10
249414|NCT00997113|605275|P1|COMPLETED|Overall Study||10
249415|NCT00997113|605274|P2|STARTED|Overall Study||10
249416|NCT00997113|605275|P1|STARTED|Overall Study||10
249417|NCT00997126|605287|P2|NOT COMPLETED|Overall Study||11
249418|NCT00997126|605288|P1|NOT COMPLETED|Overall Study||7
249419|NCT00997126|605287|P2|COMPLETED|Overall Study||52
249420|NCT00997126|605288|P1|COMPLETED|Overall Study||56
249421|NCT00997126|605287|P2|STARTED|Overall Study||63
249422|NCT00997126|605288|P1|STARTED|Overall Study||63
249423|NCT00997139|605302|P1|NOT COMPLETED|Overall Study||186
249424|NCT00997139|605302|P1|COMPLETED|Overall Study||30
249425|NCT00997139|605302|P1|Treated for Positive Baseline Culture|Overall Study||30
249426|NCT00997139|605302|P1|STARTED|Overall Study||216
249427|NCT00997204|605310|P2|NOT COMPLETED|Self-administration Phase||1
249428|NCT00997204|605311|P1|NOT COMPLETED|Self-administration Phase||0
249429|NCT00997204|605310|P2|COMPLETED|Self-administration Phase||77
249430|NCT00997204|605311|P1|COMPLETED|Self-administration Phase||19
249431|NCT00997204|605310|P2|STARTED|Self-administration Phase|1 subject did not self-administered icatibant but had a HCP to perform. the data were not included.|78
249432|NCT00997204|605311|P1|STARTED|Self-administration Phase||19
249433|NCT00997204|605310|P2|NOT COMPLETED|Naive Treatment Phase||79
249434|NCT00997204|605311|P1|NOT COMPLETED|Naive Treatment Phase||6
249435|NCT00997204|605310|P2|COMPLETED|Naive Treatment Phase||0
249436|NCT00997204|605311|P1|COMPLETED|Naive Treatment Phase||19
249437|NCT00997204|605310|P2|STARTED|Naive Treatment Phase|Non-naive patients participated in the study but they were not treated in the naive treatment phase|79
249438|NCT00997204|605311|P1|STARTED|Naive Treatment Phase||25
249439|NCT00997243|605322|P1|NOT COMPLETED|Overall Study||7
249440|NCT00997243|605322|P1|COMPLETED|Overall Study||0
249441|NCT00997243|605322|P1|STARTED|Overall Study||7
249442|NCT00997321|605334|P2|NOT COMPLETED|Overall Study||3
249443|NCT00997321|605335|P1|NOT COMPLETED|Overall Study||0
249444|NCT00997321|605334|P2|COMPLETED|Overall Study||47
249445|NCT00997321|605335|P1|COMPLETED|Overall Study||50
249446|NCT00997321|605334|P2|STARTED|Overall Study||50
249447|NCT00997321|605335|P1|STARTED|Overall Study||50
249448|NCT00997334|605347|P1|NOT COMPLETED|Overall Study||25
249449|NCT00997334|605347|P1|COMPLETED|Overall Study||35
249450|NCT00997334|605347|P1|Evaluable|Overall Study|Patients with tissue available for re-biopsy at time of progression|35
249451|NCT00997334|605347|P1|Eligible for Repeat Biopsy|Overall Study|Patients who experience disease progression on treatment were eligible for repeat biopsy|44
249452|NCT00997334|605347|P1|STARTED|Overall Study||60
249453|NCT00997373|605356|P2|NOT COMPLETED|Overall Study||0
249454|NCT00997373|605357|P1|NOT COMPLETED|Overall Study||15
249455|NCT00997373|605356|P2|COMPLETED|Overall Study||15
249456|NCT00997373|605357|P1|COMPLETED|Overall Study||13
249457|NCT00997373|605356|P2|Completed Hysterectomy|Overall Study||15
249458|NCT00997373|605357|P1|Completed Hysterectomy|Overall Study||17
249459|NCT00997373|605356|P2|Received Letrozole|Overall Study||0
249460|NCT00997373|605357|P1|Received Letrozole|Overall Study||23
249461|NCT00997373|605356|P2|STARTED|Overall Study||15
249462|NCT00997373|605357|P1|STARTED|Overall Study||28
249463|NCT01004354|605363|P1|NOT COMPLETED|Overall Study||0
249464|NCT01004354|605363|P1|COMPLETED|Overall Study||12
249465|NCT01004354|605363|P1|STARTED|Overall Study||12
249466|NCT01004393|605367|P1|NOT COMPLETED|Overall Study||0
249467|NCT01004393|605367|P1|COMPLETED|Overall Study||12
249468|NCT01004393|605367|P1|STARTED|Overall Study||12
249469|NCT01004432|605378|P5|NOT COMPLETED|OL Study Extension (Week 52 - 76)||18
249470|NCT01004432|605379|P4|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
249471|NCT01004432|605380|P3|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
249472|NCT01004432|605381|P2|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
249473|NCT01004432|605382|P1|NOT COMPLETED|OL Study Extension (Week 52 - 76)||0
249474|NCT01004432|605378|P5|COMPLETED|OL Study Extension (Week 52 - 76)||194
249475|NCT01004432|605379|P4|COMPLETED|OL Study Extension (Week 52 - 76)||0
249476|NCT01004432|605380|P3|COMPLETED|OL Study Extension (Week 52 - 76)||0
249477|NCT01004432|605381|P2|COMPLETED|OL Study Extension (Week 52 - 76)||0
249478|NCT01004432|605382|P1|COMPLETED|OL Study Extension (Week 52 - 76)||0
249479|NCT01004432|605378|P5|STARTED|OL Study Extension (Week 52 - 76)||212
249480|NCT01004432|605379|P4|STARTED|OL Study Extension (Week 52 - 76)||0
249481|NCT01004432|605380|P3|STARTED|OL Study Extension (Week 52 - 76)||0
249482|NCT01004432|605381|P2|STARTED|OL Study Extension (Week 52 - 76)||0
249483|NCT01004432|605382|P1|STARTED|OL Study Extension (Week 52 - 76)||0
249484|NCT01004432|605378|P5|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
249485|NCT01004432|605379|P4|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||58
249486|NCT01004432|605380|P3|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||37
249487|NCT01004432|605381|P2|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||10
249488|NCT01004432|605382|P1|NOT COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
249489|NCT01004432|605378|P5|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
249490|NCT01004432|605379|P4|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||126
249491|NCT01004432|605380|P3|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||54
249492|NCT01004432|605381|P2|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||65
249493|NCT01004432|605382|P1|COMPLETED|OL/Double-Blind (DB) Period (Week 16-52)||0
249494|NCT01004432|605378|P5|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
249495|NCT01004432|605379|P4|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||184
249496|NCT01004432|605380|P3|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||91
249497|NCT01004432|605381|P2|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||75
249498|NCT01004432|605382|P1|STARTED|OL/Double-Blind (DB) Period (Week 16-52)||0
249499|NCT01004432|605378|P5|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249500|NCT01004432|605379|P4|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249501|NCT01004432|605380|P3|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249502|NCT01004432|605381|P2|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249503|NCT01004432|605382|P1|NOT COMPLETED|Open-label (OL) Period (Week 0 – 16)||83
249504|NCT01004432|605378|P5|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249505|NCT01004432|605379|P4|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249506|NCT01004432|605380|P3|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249507|NCT01004432|605381|P2|COMPLETED|Open-label (OL) Period (Week 0 – 16)||0
249508|NCT01004432|605382|P1|COMPLETED|Open-label (OL) Period (Week 0 – 16)|1 Participant died after completing open-label period. Discontinuation was noted as adverse event.|350
249509|NCT01004432|605378|P5|STARTED|Open-label (OL) Period (Week 0 – 16)||0
249510|NCT01004432|605379|P4|STARTED|Open-label (OL) Period (Week 0 – 16)||0
249511|NCT01004432|605380|P3|STARTED|Open-label (OL) Period (Week 0 – 16)||0
249512|NCT01004432|605381|P2|STARTED|Open-label (OL) Period (Week 0 – 16)||0
249513|NCT01004432|605382|P1|STARTED|Open-label (OL) Period (Week 0 – 16)||433
249514|NCT01004510|605402|P1|NOT COMPLETED|Overall Study||1
249515|NCT01004510|605402|P1|COMPLETED|Overall Study||2
249516|NCT01004510|605402|P1|STARTED|Overall Study||3
249517|NCT01004614|605410|P4|NOT COMPLETED|Second Intervention||0
249518|NCT01004614|605411|P3|NOT COMPLETED|Second Intervention||0
249519|NCT01004614|605412|P2|NOT COMPLETED|Second Intervention||0
249520|NCT01004614|605413|P1|NOT COMPLETED|Second Intervention||0
249521|NCT01004614|605410|P4|COMPLETED|Second Intervention||12
249522|NCT01004614|605411|P3|COMPLETED|Second Intervention||12
249523|NCT01004614|605412|P2|COMPLETED|Second Intervention||11
249524|NCT01004614|605413|P1|COMPLETED|Second Intervention||12
249525|NCT01004614|605410|P4|STARTED|Second Intervention||12
249526|NCT01004614|605411|P3|STARTED|Second Intervention||12
249527|NCT01004614|605412|P2|STARTED|Second Intervention||11
249528|NCT01004614|605413|P1|STARTED|Second Intervention||12
249529|NCT01004614|605410|P4|NOT COMPLETED|Washout||0
249530|NCT01004614|605411|P3|NOT COMPLETED|Washout||0
249531|NCT01004614|605412|P2|NOT COMPLETED|Washout||1
249532|NCT01004614|605413|P1|NOT COMPLETED|Washout||0
249533|NCT01004614|605410|P4|COMPLETED|Washout||12
249534|NCT01004614|605411|P3|COMPLETED|Washout||12
249535|NCT01004614|605412|P2|COMPLETED|Washout||11
249536|NCT01004614|605413|P1|COMPLETED|Washout||12
249537|NCT01004614|605410|P4|STARTED|Washout||12
249538|NCT01004614|605411|P3|STARTED|Washout||12
249539|NCT01004614|605412|P2|STARTED|Washout||12
249540|NCT01004614|605413|P1|STARTED|Washout||12
249541|NCT01004614|605410|P4|NOT COMPLETED|First Intervention||0
249542|NCT01004614|605411|P3|NOT COMPLETED|First Intervention||0
249543|NCT01004614|605412|P2|NOT COMPLETED|First Intervention||0
249544|NCT01004614|605413|P1|NOT COMPLETED|First Intervention||0
249545|NCT01004614|605410|P4|COMPLETED|First Intervention||12
249546|NCT01004614|605411|P3|COMPLETED|First Intervention||12
249547|NCT01004614|605412|P2|COMPLETED|First Intervention||12
249548|NCT01004614|605413|P1|COMPLETED|First Intervention||12
249549|NCT01004614|605410|P4|STARTED|First Intervention||12
249550|NCT01004614|605411|P3|STARTED|First Intervention||12
249551|NCT01004614|605412|P2|STARTED|First Intervention||12
249552|NCT01004614|605413|P1|STARTED|First Intervention||12
249553|NCT01004705|605447|P3|NOT COMPLETED|Period 2 (12 Weeks)||4
249554|NCT01004705|605448|P2|NOT COMPLETED|Period 2 (12 Weeks)||0
249555|NCT01004705|605449|P1|NOT COMPLETED|Period 2 (12 Weeks)||0
249556|NCT01004705|605447|P3|COMPLETED|Period 2 (12 Weeks)||9
249557|NCT01004705|605448|P2|COMPLETED|Period 2 (12 Weeks)||13
249558|NCT01004705|605449|P1|COMPLETED|Period 2 (12 Weeks)||0
249559|NCT01004705|605447|P3|STARTED|Period 2 (12 Weeks)||13
249560|NCT01004705|605448|P2|STARTED|Period 2 (12 Weeks)||13
249561|NCT01004705|605449|P1|STARTED|Period 2 (12 Weeks)||0
249562|NCT01004705|605447|P3|NOT COMPLETED|Washout Period (6 Weeks)||0
249563|NCT01004705|605448|P2|NOT COMPLETED|Washout Period (6 Weeks)||0
249564|NCT01004705|605449|P1|NOT COMPLETED|Washout Period (6 Weeks)||0
249565|NCT01004705|605447|P3|COMPLETED|Washout Period (6 Weeks)||13
249566|NCT01004705|605448|P2|COMPLETED|Washout Period (6 Weeks)||13
249567|NCT01004705|605449|P1|COMPLETED|Washout Period (6 Weeks)||0
249568|NCT01004705|605447|P3|STARTED|Washout Period (6 Weeks)||13
249569|NCT01004705|605448|P2|STARTED|Washout Period (6 Weeks)||13
249570|NCT01004705|605449|P1|STARTED|Washout Period (6 Weeks)||0
249571|NCT01004705|605447|P3|NOT COMPLETED|Period 1 (12 Weeks)||5
249572|NCT01004705|605448|P2|NOT COMPLETED|Period 1 (12 Weeks)||5
249573|NCT01004705|605449|P1|NOT COMPLETED|Period 1 (12 Weeks)||0
249574|NCT01004705|605447|P3|COMPLETED|Period 1 (12 Weeks)||13
249575|NCT01004705|605448|P2|COMPLETED|Period 1 (12 Weeks)||13
249576|NCT01004705|605449|P1|COMPLETED|Period 1 (12 Weeks)||0
249577|NCT01004705|605447|P3|STARTED|Period 1 (12 Weeks)||18
249578|NCT01004705|605448|P2|STARTED|Period 1 (12 Weeks)||18
249579|NCT01004705|605449|P1|STARTED|Period 1 (12 Weeks)||0
249580|NCT01004705|605447|P3|NOT COMPLETED|Run-In||0
249581|NCT01004705|605448|P2|NOT COMPLETED|Run-In||0
249582|NCT01004705|605449|P1|NOT COMPLETED|Run-In||8
249583|NCT01004705|605447|P3|COMPLETED|Run-In||0
249584|NCT01004705|605448|P2|COMPLETED|Run-In||0
249585|NCT01004705|605449|P1|COMPLETED|Run-In||36
249586|NCT01004705|605447|P3|STARTED|Run-In||0
249587|NCT01004705|605448|P2|STARTED|Run-In||0
249588|NCT01004705|605449|P1|STARTED|Run-In||44
249589|NCT01004770|605463|P5|NOT COMPLETED|Overall Study||0
249590|NCT01004770|605464|P4|NOT COMPLETED|Overall Study||0
249591|NCT01004770|605465|P3|NOT COMPLETED|Overall Study||0
249592|NCT01004770|605466|P2|NOT COMPLETED|Overall Study||0
249593|NCT01004770|605467|P1|NOT COMPLETED|Overall Study||0
249594|NCT01004770|605463|P5|COMPLETED|Overall Study||10
249595|NCT01004770|605464|P4|COMPLETED|Overall Study||10
249596|NCT01004770|605465|P3|COMPLETED|Overall Study||10
249597|NCT01004770|605466|P2|COMPLETED|Overall Study||10
249598|NCT01004770|605467|P1|COMPLETED|Overall Study||10
249599|NCT01004770|605463|P5|STARTED|Overall Study||10
249600|NCT01004770|605464|P4|STARTED|Overall Study||10
249601|NCT01004770|605465|P3|STARTED|Overall Study||10
249602|NCT01004770|605466|P2|STARTED|Overall Study||10
249603|NCT01004770|605467|P1|STARTED|Overall Study||10
249604|NCT01004822|605507|P8|NOT COMPLETED|Overall Study||5
249605|NCT01004822|605508|P7|NOT COMPLETED|Overall Study||4
249606|NCT01004822|605509|P6|NOT COMPLETED|Overall Study||4
249607|NCT01004822|605510|P5|NOT COMPLETED|Overall Study||4
249608|NCT01004822|605511|P4|NOT COMPLETED|Overall Study||4
249609|NCT01004822|605512|P3|NOT COMPLETED|Overall Study||4
249610|NCT01004822|605513|P2|NOT COMPLETED|Overall Study||3
249611|NCT01004822|605514|P1|NOT COMPLETED|Overall Study||3
249612|NCT01004822|605507|P8|COMPLETED|Overall Study||0
249613|NCT01004822|605508|P7|COMPLETED|Overall Study||0
249614|NCT01004822|605509|P6|COMPLETED|Overall Study||0
249615|NCT01004822|605510|P5|COMPLETED|Overall Study||0
249616|NCT01004822|605511|P4|COMPLETED|Overall Study||0
249617|NCT01004822|605512|P3|COMPLETED|Overall Study||0
249618|NCT01004822|605513|P2|COMPLETED|Overall Study||0
249619|NCT01004822|605514|P1|COMPLETED|Overall Study||0
249620|NCT01004822|605507|P8|Treated|Overall Study||5
249621|NCT01004822|605508|P7|Treated|Overall Study||4
249622|NCT01004822|605509|P6|Treated|Overall Study||4
249623|NCT01004822|605510|P5|Treated|Overall Study||4
249624|NCT01004822|605511|P4|Treated|Overall Study||4
249625|NCT01004822|605512|P3|Treated|Overall Study||3
249626|NCT01004822|605513|P2|Treated|Overall Study||3
249627|NCT01004822|605514|P1|Treated|Overall Study||3
249628|NCT01004822|605507|P8|STARTED|Overall Study||5
249629|NCT01004822|605508|P7|STARTED|Overall Study||4
249630|NCT01004822|605509|P6|STARTED|Overall Study||4
249631|NCT01004822|605510|P5|STARTED|Overall Study||4
249632|NCT01004822|605511|P4|STARTED|Overall Study||4
249633|NCT01004822|605512|P3|STARTED|Overall Study||4
249634|NCT01004822|605513|P2|STARTED|Overall Study||3
249635|NCT01004822|605514|P1|STARTED|Overall Study||3
249636|NCT01004848|605625|P2|NOT COMPLETED|Overall Study||45
249637|NCT01004848|605626|P1|NOT COMPLETED|Overall Study||55
249638|NCT01004848|605625|P2|COMPLETED|Overall Study||147
249639|NCT01004848|605626|P1|COMPLETED|Overall Study||155
249640|NCT01004848|605625|P2|STARTED|Overall Study||192
249641|NCT01004848|605626|P1|STARTED|Overall Study||210
249642|NCT01004874|605656|P1|NOT COMPLETED|Overall Study||0
249643|NCT01004874|605656|P1|COMPLETED|Overall Study||80
249644|NCT01004874|605656|P1|STARTED|Overall Study||80
249645|NCT01004939|605665|P1|NOT COMPLETED|Overall Study||0
249646|NCT01004939|605665|P1|COMPLETED|Overall Study||120
249647|NCT01004939|605665|P1|STARTED|Overall Study||120
249648|NCT01004991|605706|P1|NOT COMPLETED|Overall Study||0
249649|NCT01004991|605706|P1|COMPLETED|Overall Study||12
249650|NCT01004991|605706|P1|STARTED|Overall Study||12
249651|NCT01005251|605715|P5|NOT COMPLETED|Overall Study||18
249652|NCT01005251|605716|P4|NOT COMPLETED|Overall Study||12
249653|NCT01005251|605717|P3|NOT COMPLETED|Overall Study||22
249654|NCT01005251|605718|P2|NOT COMPLETED|Overall Study||16
249655|NCT01005251|605719|P1|NOT COMPLETED|Overall Study||13
249656|NCT01005251|605715|P5|COMPLETED|Overall Study||122
249657|NCT01005251|605716|P4|COMPLETED|Overall Study||114
249658|NCT01005251|605717|P3|COMPLETED|Overall Study||114
249659|NCT01005251|605718|P2|COMPLETED|Overall Study||109
249660|NCT01005251|605719|P1|COMPLETED|Overall Study||121
249661|NCT01005251|605715|P5|STARTED|Overall Study||140
249662|NCT01005251|605716|P4|STARTED|Overall Study||126
249663|NCT01005251|605717|P3|STARTED|Overall Study||136
249664|NCT01005251|605718|P2|STARTED|Overall Study||125
249665|NCT01005251|605719|P1|STARTED|Overall Study||134
249666|NCT01005290|605736|P3|NOT COMPLETED|Period 2 (5 Weeks)||2
249667|NCT01005290|605737|P2|NOT COMPLETED|Period 2 (5 Weeks)||0
249668|NCT01005290|605738|P1|NOT COMPLETED|Period 2 (5 Weeks)||0
249669|NCT01005290|605736|P3|COMPLETED|Period 2 (5 Weeks)||7
249670|NCT01005290|605737|P2|COMPLETED|Period 2 (5 Weeks)||13
249671|NCT01005290|605738|P1|COMPLETED|Period 2 (5 Weeks)||0
249672|NCT01005290|605736|P3|STARTED|Period 2 (5 Weeks)||9
249673|NCT01005290|605737|P2|STARTED|Period 2 (5 Weeks)||13
249674|NCT01005290|605738|P1|STARTED|Period 2 (5 Weeks)||0
249675|NCT01005290|605736|P3|NOT COMPLETED|Washout Period (2 Weeks)||0
249676|NCT01005290|605737|P2|NOT COMPLETED|Washout Period (2 Weeks)||0
249677|NCT01005290|605738|P1|NOT COMPLETED|Washout Period (2 Weeks)||0
249678|NCT01005290|605736|P3|COMPLETED|Washout Period (2 Weeks)||9
249679|NCT01005290|605737|P2|COMPLETED|Washout Period (2 Weeks)||13
249680|NCT01005290|605738|P1|COMPLETED|Washout Period (2 Weeks)||0
249681|NCT01005290|605736|P3|STARTED|Washout Period (2 Weeks)||9
249682|NCT01005290|605737|P2|STARTED|Washout Period (2 Weeks)||13
249683|NCT01005290|605738|P1|STARTED|Washout Period (2 Weeks)||0
249684|NCT01005290|605736|P3|NOT COMPLETED|Period 1 (5 Weeks)||9
249685|NCT01005290|605737|P2|NOT COMPLETED|Period 1 (5 Weeks)||7
249686|NCT01005290|605738|P1|NOT COMPLETED|Period 1 (5 Weeks)||0
249687|NCT01005290|605736|P3|COMPLETED|Period 1 (5 Weeks)||9
249688|NCT01005290|605737|P2|COMPLETED|Period 1 (5 Weeks)||13
249689|NCT01005290|605738|P1|COMPLETED|Period 1 (5 Weeks)||0
249690|NCT01005290|605736|P3|STARTED|Period 1 (5 Weeks)||18
249691|NCT01005290|605737|P2|STARTED|Period 1 (5 Weeks)||20
249692|NCT01005290|605738|P1|STARTED|Period 1 (5 Weeks)||0
249693|NCT01005290|605736|P3|NOT COMPLETED|Run-In||0
249694|NCT01005290|605737|P2|NOT COMPLETED|Run-In||0
249695|NCT01005290|605738|P1|NOT COMPLETED|Run-In||14
249696|NCT01005290|605736|P3|COMPLETED|Run-In||0
249697|NCT01005290|605737|P2|COMPLETED|Run-In||0
249698|NCT01005290|605738|P1|COMPLETED|Run-In||38
249699|NCT01005290|605736|P3|STARTED|Run-In||0
249700|NCT01005290|605737|P2|STARTED|Run-In||0
249701|NCT01005290|605738|P1|STARTED|Run-In||52
249702|NCT01005316|605749|P4|NOT COMPLETED|Overall Study||108
249703|NCT01005316|605750|P3|NOT COMPLETED|Overall Study||11
249704|NCT01005316|605751|P2|NOT COMPLETED|Overall Study||76
249705|NCT01005316|605752|P1|NOT COMPLETED|Overall Study||50
249706|NCT01005316|605749|P4|COMPLETED|Overall Study||19
249707|NCT01005316|605750|P3|COMPLETED|Overall Study||5
249708|NCT01005316|605751|P2|COMPLETED|Overall Study||21
249709|NCT01005316|605752|P1|COMPLETED|Overall Study||0
249710|NCT01005316|605749|P4|STARTED|Overall Study||127
249711|NCT01005316|605750|P3|STARTED|Overall Study||16
249712|NCT01005316|605751|P2|STARTED|Overall Study||97
249713|NCT01005316|605752|P1|STARTED|Overall Study||50
249714|NCT01005329|605804|P1|NOT COMPLETED|Overall Study||4
249715|NCT01005329|605804|P1|COMPLETED|Overall Study|Subjects contributing data to the primary analysis are considered to have completed the study.|30
249716|NCT01005329|605804|P1|STARTED|Overall Study||34
249717|NCT01005355|605811|P3|NOT COMPLETED|Overall Study||0
249718|NCT01005355|605812|P2|NOT COMPLETED|Overall Study||0
249719|NCT01005355|605813|P1|NOT COMPLETED|Overall Study||0
249720|NCT01005355|605811|P3|COMPLETED|Overall Study||6
249721|NCT01005355|605812|P2|COMPLETED|Overall Study||6
249722|NCT01005355|605813|P1|COMPLETED|Overall Study||3
249723|NCT01005355|605811|P3|Received at Least 1 Dose of Study Drug|Overall Study||6
249724|NCT01005355|605812|P2|Received at Least 1 Dose of Study Drug|Overall Study||6
249725|NCT01005355|605813|P1|Received at Least 1 Dose of Study Drug|Overall Study||3
249726|NCT01005355|605811|P3|STARTED|Overall Study||6
249727|NCT01005355|605812|P2|STARTED|Overall Study||6
249728|NCT01005355|605813|P1|STARTED|Overall Study||3
249729|NCT01005459|605850|P2|NOT COMPLETED|Overall Study||0
249730|NCT01005459|605851|P1|NOT COMPLETED|Overall Study||0
249731|NCT01005459|605850|P2|COMPLETED|Overall Study||23
249732|NCT01005459|605851|P1|COMPLETED|Overall Study||23
249733|NCT01005459|605850|P2|STARTED|Overall Study||23
249734|NCT01005459|605851|P1|STARTED|Overall Study||23
249735|NCT01005602|605859|P2|NOT COMPLETED|Overall Study||0
249736|NCT01005602|605860|P1|NOT COMPLETED|Overall Study||1
249737|NCT01005602|605859|P2|COMPLETED|Overall Study||66
249738|NCT01005602|605860|P1|COMPLETED|Overall Study|One patient completed the trial but was excluded from data analyses due to unreliable clinical data.|65
249739|NCT01005602|605859|P2|STARTED|Overall Study||66
249740|NCT01005602|605860|P1|STARTED|Overall Study||66
249741|NCT01005680|605882|P2|NOT COMPLETED|Overall Study||11
249742|NCT01005680|605883|P1|NOT COMPLETED|Overall Study||6
249743|NCT01005680|605882|P2|COMPLETED|Overall Study||119
249744|NCT01005680|605883|P1|COMPLETED|Overall Study||120
249745|NCT01005680|605882|P2|Received at Least 1 Dose of Study Drug|Overall Study||127
249746|NCT01005680|605883|P1|Received at Least 1 Dose of Study Drug|Overall Study||125
249747|NCT01005680|605882|P2|STARTED|Overall Study||130
249748|NCT01005680|605883|P1|STARTED|Overall Study||126
249749|NCT01005706|605907|P2|NOT COMPLETED|Overall Study||0
249750|NCT01005706|605908|P1|NOT COMPLETED|Overall Study||0
249751|NCT01005706|605907|P2|COMPLETED|Overall Study||17
249752|NCT01005706|605908|P1|COMPLETED|Overall Study||23
249753|NCT01005706|605907|P2|STARTED|Overall Study||17
249754|NCT01005706|605908|P1|STARTED|Overall Study||23
249755|NCT01005719|605914|P6|NOT COMPLETED|Period 3||0
249756|NCT01005719|605915|P5|NOT COMPLETED|Period 3||0
249757|NCT01005719|605916|P4|NOT COMPLETED|Period 3||0
249758|NCT01005719|605917|P3|NOT COMPLETED|Period 3||0
249759|NCT01005719|605918|P2|NOT COMPLETED|Period 3||0
249760|NCT01005719|605919|P1|NOT COMPLETED|Period 3||0
249761|NCT01005719|605914|P6|COMPLETED|Period 3||9
249762|NCT01005719|605915|P5|COMPLETED|Period 3||10
249763|NCT01005719|605916|P4|COMPLETED|Period 3||10
249764|NCT01005719|605917|P3|COMPLETED|Period 3||10
249765|NCT01005719|605918|P2|COMPLETED|Period 3||10
249766|NCT01005719|605919|P1|COMPLETED|Period 3||10
249767|NCT01005719|605914|P6|STARTED|Period 3||9
249768|NCT01005719|605915|P5|STARTED|Period 3||10
249769|NCT01005719|605916|P4|STARTED|Period 3||10
249770|NCT01005719|605917|P3|STARTED|Period 3||10
249771|NCT01005719|605918|P2|STARTED|Period 3||10
249772|NCT01005719|605919|P1|STARTED|Period 3||10
249773|NCT01005719|605914|P6|NOT COMPLETED|Period 2||1
249774|NCT01005719|605915|P5|NOT COMPLETED|Period 2||1
249775|NCT01005719|605916|P4|NOT COMPLETED|Period 2||0
249776|NCT01005719|605917|P3|NOT COMPLETED|Period 2||0
249777|NCT01005719|605918|P2|NOT COMPLETED|Period 2||0
249778|NCT01005719|605919|P1|NOT COMPLETED|Period 2||0
249779|NCT01005719|605914|P6|COMPLETED|Period 2||9
249780|NCT01005719|605915|P5|COMPLETED|Period 2||10
249781|NCT01005719|605916|P4|COMPLETED|Period 2||10
249782|NCT01005719|605917|P3|COMPLETED|Period 2||10
249783|NCT01005719|605918|P2|COMPLETED|Period 2||10
249784|NCT01005719|605919|P1|COMPLETED|Period 2||10
249785|NCT01005719|605914|P6|STARTED|Period 2||10
249786|NCT01005719|605915|P5|STARTED|Period 2||11
249787|NCT01005719|605916|P4|STARTED|Period 2||10
249788|NCT01005719|605917|P3|STARTED|Period 2||10
249789|NCT01005719|605918|P2|STARTED|Period 2||10
249790|NCT01005719|605919|P1|STARTED|Period 2||10
249791|NCT01005719|605914|P6|NOT COMPLETED|Period 1||1
249792|NCT01005719|605915|P5|NOT COMPLETED|Period 1||0
249793|NCT01005719|605916|P4|NOT COMPLETED|Period 1||1
249794|NCT01005719|605917|P3|NOT COMPLETED|Period 1||0
249795|NCT01005719|605918|P2|NOT COMPLETED|Period 1||0
249796|NCT01005719|605919|P1|NOT COMPLETED|Period 1||0
249797|NCT01005719|605914|P6|COMPLETED|Period 1||10
249798|NCT01005719|605915|P5|COMPLETED|Period 1||11
249799|NCT01005719|605916|P4|COMPLETED|Period 1||10
249800|NCT01005719|605917|P3|COMPLETED|Period 1||10
249801|NCT01005719|605918|P2|COMPLETED|Period 1||10
249802|NCT01005719|605919|P1|COMPLETED|Period 1||10
249803|NCT01005719|605914|P6|STARTED|Period 1||11
249804|NCT01005719|605915|P5|STARTED|Period 1||11
249805|NCT01005719|605916|P4|STARTED|Period 1||11
249806|NCT01005719|605917|P3|STARTED|Period 1||10
249807|NCT01005719|605918|P2|STARTED|Period 1||10
249808|NCT01005719|605919|P1|STARTED|Period 1||10
249809|NCT01005732|605975|P1|NOT COMPLETED|Overall Study||11
249810|NCT01005732|605975|P1|COMPLETED|Overall Study||43
249811|NCT01005732|605975|P1|STARTED|Overall Study||54
249812|NCT01005745|605991|P1|NOT COMPLETED|Overall Study||6
249813|NCT01005745|605991|P1|COMPLETED|Overall Study||13
249814|NCT01005745|605991|P1|STARTED|Overall Study||19
249815|NCT01005875|605996|P1|NOT COMPLETED|Overall Study||3
249816|NCT01005875|605996|P1|COMPLETED|Overall Study||2
249817|NCT01005875|605996|P1|STARTED|Overall Study||5
249818|NCT01005888|606008|P2|NOT COMPLETED|Second Intervention||1
249819|NCT01005888|606009|P1|NOT COMPLETED|Second Intervention||1
249820|NCT01005888|606008|P2|COMPLETED|Second Intervention||10
249821|NCT01005888|606009|P1|COMPLETED|Second Intervention||10
249822|NCT01005888|606008|P2|STARTED|Second Intervention||11
249823|NCT01005888|606009|P1|STARTED|Second Intervention||11
249824|NCT01005888|606008|P2|NOT COMPLETED|First Intervention||1
249825|NCT01005888|606009|P1|NOT COMPLETED|First Intervention||1
249826|NCT01005888|606008|P2|COMPLETED|First Intervention||11
249827|NCT01005888|606009|P1|COMPLETED|First Intervention||11
249828|NCT01005888|606008|P2|STARTED|First Intervention||12
249829|NCT01005888|606009|P1|STARTED|First Intervention||12
249830|NCT01005901|606031|P2|NOT COMPLETED|Overall Study||58
249831|NCT01005901|606032|P1|NOT COMPLETED|Overall Study||102
249832|NCT01005901|606031|P2|COMPLETED|Overall Study||212
249833|NCT01005901|606032|P1|COMPLETED|Overall Study||450
249834|NCT01005901|606031|P2|Full Analysis Set|Overall Study||260
249835|NCT01005901|606032|P1|Full Analysis Set|Overall Study||534
249836|NCT01005901|606031|P2|Safety Population|Overall Study||267
249837|NCT01005901|606032|P1|Safety Population|Overall Study||550
249838|NCT01005901|606031|P2|STARTED|Overall Study||270
249839|NCT01005901|606032|P1|STARTED|Overall Study||552
249840|NCT01005914|606070|P1|NOT COMPLETED|Overall Study||10
249841|NCT01005914|606070|P1|COMPLETED|Overall Study||1
249842|NCT01005914|606070|P1|STARTED|Overall Study||11
249843|NCT01005966|606074|P5|NOT COMPLETED|Treatment Period 5 (14 Days)||0
249844|NCT01005966|606075|P4|NOT COMPLETED|Treatment Period 5 (14 Days)||0
249845|NCT01005966|606076|P3|NOT COMPLETED|Treatment Period 5 (14 Days)||0
249846|NCT01005966|606077|P2|NOT COMPLETED|Treatment Period 5 (14 Days)||0
249847|NCT01005966|606078|P1|NOT COMPLETED|Treatment Period 5 (14 Days)||0
249848|NCT01005966|606074|P5|COMPLETED|Treatment Period 5 (14 Days)||10
249849|NCT01005966|606075|P4|COMPLETED|Treatment Period 5 (14 Days)||11
249850|NCT01005966|606076|P3|COMPLETED|Treatment Period 5 (14 Days)||11
249851|NCT01005966|606077|P2|COMPLETED|Treatment Period 5 (14 Days)||12
249852|NCT01005966|606078|P1|COMPLETED|Treatment Period 5 (14 Days)||9
249921|NCT01005966|606077|P2|NOT COMPLETED|Washout Period 2 (4 Days)||0
249853|NCT01005966|606074|P5|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|10
249854|NCT01005966|606075|P4|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
249855|NCT01005966|606076|P3|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|11
249856|NCT01005966|606077|P2|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|12
249857|NCT01005966|606078|P1|STARTED|Treatment Period 5 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 4|9
249858|NCT01005966|606074|P5|NOT COMPLETED|Washout Period 4 (4 Days)||0
249859|NCT01005966|606075|P4|NOT COMPLETED|Washout Period 4 (4 Days)||0
249860|NCT01005966|606076|P3|NOT COMPLETED|Washout Period 4 (4 Days)||0
249861|NCT01005966|606077|P2|NOT COMPLETED|Washout Period 4 (4 Days)||0
249862|NCT01005966|606078|P1|NOT COMPLETED|Washout Period 4 (4 Days)||0
249863|NCT01005966|606074|P5|COMPLETED|Washout Period 4 (4 Days)||12
249864|NCT01005966|606075|P4|COMPLETED|Washout Period 4 (4 Days)||10
249865|NCT01005966|606076|P3|COMPLETED|Washout Period 4 (4 Days)||11
249866|NCT01005966|606077|P2|COMPLETED|Washout Period 4 (4 Days)||10
249867|NCT01005966|606078|P1|COMPLETED|Washout Period 4 (4 Days)||10
249868|NCT01005966|606074|P5|STARTED|Washout Period 4 (4 Days)||12
249869|NCT01005966|606075|P4|STARTED|Washout Period 4 (4 Days)||10
249870|NCT01005966|606076|P3|STARTED|Washout Period 4 (4 Days)||11
249871|NCT01005966|606077|P2|STARTED|Washout Period 4 (4 Days)||10
249872|NCT01005966|606078|P1|STARTED|Washout Period 4 (4 Days)||10
249873|NCT01005966|606074|P5|NOT COMPLETED|Treatment Period 4 (14 Days)||1
249874|NCT01005966|606075|P4|NOT COMPLETED|Treatment Period 4 (14 Days)||0
249875|NCT01005966|606076|P3|NOT COMPLETED|Treatment Period 4 (14 Days)||0
249876|NCT01005966|606077|P2|NOT COMPLETED|Treatment Period 4 (14 Days)||1
249877|NCT01005966|606078|P1|NOT COMPLETED|Treatment Period 4 (14 Days)||0
249878|NCT01005966|606074|P5|COMPLETED|Treatment Period 4 (14 Days)||12
249879|NCT01005966|606075|P4|COMPLETED|Treatment Period 4 (14 Days)||10
249880|NCT01005966|606076|P3|COMPLETED|Treatment Period 4 (14 Days)||11
249881|NCT01005966|606077|P2|COMPLETED|Treatment Period 4 (14 Days)||10
249882|NCT01005966|606078|P1|COMPLETED|Treatment Period 4 (14 Days)||10
249883|NCT01005966|606074|P5|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|13
249884|NCT01005966|606075|P4|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
249885|NCT01005966|606076|P3|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
249886|NCT01005966|606077|P2|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|11
249887|NCT01005966|606078|P1|STARTED|Treatment Period 4 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 3|10
249888|NCT01005966|606074|P5|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
249889|NCT01005966|606075|P4|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
249890|NCT01005966|606076|P3|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
249891|NCT01005966|606077|P2|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
249892|NCT01005966|606078|P1|NOT COMPLETED|Washout Period 3 ( 4 Days)||0
249893|NCT01005966|606074|P5|COMPLETED|Washout Period 3 ( 4 Days)||11
249894|NCT01005966|606075|P4|COMPLETED|Washout Period 3 ( 4 Days)||13
249895|NCT01005966|606076|P3|COMPLETED|Washout Period 3 ( 4 Days)||12
249896|NCT01005966|606077|P2|COMPLETED|Washout Period 3 ( 4 Days)||7
249897|NCT01005966|606078|P1|COMPLETED|Washout Period 3 ( 4 Days)||12
249898|NCT01005966|606074|P5|STARTED|Washout Period 3 ( 4 Days)||11
249899|NCT01005966|606075|P4|STARTED|Washout Period 3 ( 4 Days)||13
249900|NCT01005966|606076|P3|STARTED|Washout Period 3 ( 4 Days)||12
249901|NCT01005966|606077|P2|STARTED|Washout Period 3 ( 4 Days)||7
249902|NCT01005966|606078|P1|STARTED|Washout Period 3 ( 4 Days)||12
249903|NCT01005966|606074|P5|NOT COMPLETED|Treatment Period 3 (14 Days)||1
249904|NCT01005966|606075|P4|NOT COMPLETED|Treatment Period 3 (14 Days)||0
249905|NCT01005966|606076|P3|NOT COMPLETED|Treatment Period 3 (14 Days)||0
249906|NCT01005966|606077|P2|NOT COMPLETED|Treatment Period 3 (14 Days)||1
249907|NCT01005966|606078|P1|NOT COMPLETED|Treatment Period 3 (14 Days)||0
249908|NCT01005966|606074|P5|COMPLETED|Treatment Period 3 (14 Days)||11
249909|NCT01005966|606075|P4|COMPLETED|Treatment Period 3 (14 Days)||13
249910|NCT01005966|606076|P3|COMPLETED|Treatment Period 3 (14 Days)||12
249911|NCT01005966|606077|P2|COMPLETED|Treatment Period 3 (14 Days)||7
249912|NCT01005966|606078|P1|COMPLETED|Treatment Period 3 (14 Days)||12
249913|NCT01005966|606074|P5|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
249914|NCT01005966|606075|P4|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|13
249915|NCT01005966|606076|P3|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
249916|NCT01005966|606077|P2|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|8
249917|NCT01005966|606078|P1|STARTED|Treatment Period 3 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 2|12
249918|NCT01005966|606074|P5|NOT COMPLETED|Washout Period 2 (4 Days)||0
249919|NCT01005966|606075|P4|NOT COMPLETED|Washout Period 2 (4 Days)||0
249920|NCT01005966|606076|P3|NOT COMPLETED|Washout Period 2 (4 Days)||0
249922|NCT01005966|606078|P1|NOT COMPLETED|Washout Period 2 (4 Days)||0
249923|NCT01005966|606074|P5|COMPLETED|Washout Period 2 (4 Days)||11
249924|NCT01005966|606075|P4|COMPLETED|Washout Period 2 (4 Days)||11
249925|NCT01005966|606076|P3|COMPLETED|Washout Period 2 (4 Days)||10
249926|NCT01005966|606077|P2|COMPLETED|Washout Period 2 (4 Days)||12
249927|NCT01005966|606078|P1|COMPLETED|Washout Period 2 (4 Days)||13
249928|NCT01005966|606074|P5|STARTED|Washout Period 2 (4 Days)||11
249929|NCT01005966|606075|P4|STARTED|Washout Period 2 (4 Days)||11
249930|NCT01005966|606076|P3|STARTED|Washout Period 2 (4 Days)||10
249931|NCT01005966|606077|P2|STARTED|Washout Period 2 (4 Days)||12
249932|NCT01005966|606078|P1|STARTED|Washout Period 2 (4 Days)||13
249933|NCT01005966|606074|P5|NOT COMPLETED|Treatment Period 2 (14 Days)||0
249934|NCT01005966|606075|P4|NOT COMPLETED|Treatment Period 2 (14 Days)||1
249935|NCT01005966|606076|P3|NOT COMPLETED|Treatment Period 2 (14 Days)||2
249936|NCT01005966|606077|P2|NOT COMPLETED|Treatment Period 2 (14 Days)||1
249937|NCT01005966|606078|P1|NOT COMPLETED|Treatment Period 2 (14 Days)||0
249938|NCT01005966|606074|P5|COMPLETED|Treatment Period 2 (14 Days)||11
249939|NCT01005966|606075|P4|COMPLETED|Treatment Period 2 (14 Days)||11
249940|NCT01005966|606076|P3|COMPLETED|Treatment Period 2 (14 Days)||10
249941|NCT01005966|606077|P2|COMPLETED|Treatment Period 2 (14 Days)||12
249942|NCT01005966|606078|P1|COMPLETED|Treatment Period 2 (14 Days)||13
249943|NCT01005966|606074|P5|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|11
249944|NCT01005966|606075|P4|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
249945|NCT01005966|606076|P3|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|12
249946|NCT01005966|606077|P2|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
249947|NCT01005966|606078|P1|STARTED|Treatment Period 2 (14 Days)|Due to crossover design, a different set of subjects received this treatment compared to Period 1|13
249948|NCT01005966|606074|P5|NOT COMPLETED|Washout Period 1 (4 Days)||0
249949|NCT01005966|606075|P4|NOT COMPLETED|Washout Period 1 (4 Days)||1
249950|NCT01005966|606076|P3|NOT COMPLETED|Washout Period 1 (4 Days)||0
249951|NCT01005966|606077|P2|NOT COMPLETED|Washout Period 1 (4 Days)||0
249952|NCT01005966|606078|P1|NOT COMPLETED|Washout Period 1 (4 Days)||0
249953|NCT01005966|606074|P5|COMPLETED|Washout Period 1 (4 Days)||13
249954|NCT01005966|606075|P4|COMPLETED|Washout Period 1 (4 Days)||12
249955|NCT01005966|606076|P3|COMPLETED|Washout Period 1 (4 Days)||12
249956|NCT01005966|606077|P2|COMPLETED|Washout Period 1 (4 Days)||13
249957|NCT01005966|606078|P1|COMPLETED|Washout Period 1 (4 Days)||11
249958|NCT01005966|606074|P5|STARTED|Washout Period 1 (4 Days)||13
249959|NCT01005966|606075|P4|STARTED|Washout Period 1 (4 Days)||13
249960|NCT01005966|606076|P3|STARTED|Washout Period 1 (4 Days)||12
249961|NCT01005966|606077|P2|STARTED|Washout Period 1 (4 Days)||13
249962|NCT01005966|606078|P1|STARTED|Washout Period 1 (4 Days)||11
249963|NCT01005966|606074|P5|NOT COMPLETED|Treatment Period 1 (14 Days)||0
249964|NCT01005966|606075|P4|NOT COMPLETED|Treatment Period 1 (14 Days)||0
249965|NCT01005966|606076|P3|NOT COMPLETED|Treatment Period 1 (14 Days)||1
249966|NCT01005966|606077|P2|NOT COMPLETED|Treatment Period 1 (14 Days)||0
249967|NCT01005966|606078|P1|NOT COMPLETED|Treatment Period 1 (14 Days)||2
249968|NCT01005966|606074|P5|COMPLETED|Treatment Period 1 (14 Days)||13
249969|NCT01005966|606075|P4|COMPLETED|Treatment Period 1 (14 Days)||13
249970|NCT01005966|606076|P3|COMPLETED|Treatment Period 1 (14 Days)||12
249971|NCT01005966|606077|P2|COMPLETED|Treatment Period 1 (14 Days)||13
249972|NCT01005966|606078|P1|COMPLETED|Treatment Period 1 (14 Days)||11
249973|NCT01005966|606074|P5|STARTED|Treatment Period 1 (14 Days)||13
249974|NCT01005966|606075|P4|STARTED|Treatment Period 1 (14 Days)||13
249975|NCT01005966|606076|P3|STARTED|Treatment Period 1 (14 Days)||13
249976|NCT01005966|606077|P2|STARTED|Treatment Period 1 (14 Days)||13
249977|NCT01005966|606078|P1|STARTED|Treatment Period 1 (14 Days)||13
249978|NCT01006018|606101|P3|NOT COMPLETED|Overall Study||0
249979|NCT01006018|606102|P2|NOT COMPLETED|Overall Study||0
249980|NCT01006018|606103|P1|NOT COMPLETED|Overall Study||0
249981|NCT01006018|606101|P3|COMPLETED|Overall Study||0
249982|NCT01006018|606102|P2|COMPLETED|Overall Study||0
249983|NCT01006018|606103|P1|COMPLETED|Overall Study||0
249984|NCT01006018|606101|P3|STARTED|Overall Study||0
249985|NCT01006018|606102|P2|STARTED|Overall Study||0
249986|NCT01006018|606103|P1|STARTED|Overall Study||0
249987|NCT01006122|606111|P2|NOT COMPLETED|Second Double-blind Intervention Period||7
249988|NCT01006122|606112|P1|NOT COMPLETED|Second Double-blind Intervention Period||2
249989|NCT01006122|606111|P2|COMPLETED|Second Double-blind Intervention Period||24
249990|NCT01006122|606112|P1|COMPLETED|Second Double-blind Intervention Period||29
249991|NCT01006122|606111|P2|STARTED|Second Double-blind Intervention Period||31
249992|NCT01006122|606112|P1|STARTED|Second Double-blind Intervention Period||31
249993|NCT01006122|606111|P2|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
249994|NCT01006122|606112|P1|NOT COMPLETED|Wash-out Period (at Least 7 Days)||0
249995|NCT01006122|606111|P2|COMPLETED|Wash-out Period (at Least 7 Days)||31
249996|NCT01006122|606112|P1|COMPLETED|Wash-out Period (at Least 7 Days)||31
249997|NCT01006122|606111|P2|STARTED|Wash-out Period (at Least 7 Days)||31
249998|NCT01006122|606112|P1|STARTED|Wash-out Period (at Least 7 Days)||31
249999|NCT01006122|606111|P2|NOT COMPLETED|First Double-blind Intervention Period||17
250000|NCT01006122|606112|P1|NOT COMPLETED|First Double-blind Intervention Period||16
250001|NCT01006122|606111|P2|COMPLETED|First Double-blind Intervention Period||31
250002|NCT01006122|606112|P1|COMPLETED|First Double-blind Intervention Period||31
250003|NCT01006122|606111|P2|STARTED|First Double-blind Intervention Period||48
250004|NCT01006122|606112|P1|STARTED|First Double-blind Intervention Period||47
250005|NCT01006135|606150|P1|NOT COMPLETED|Overall Study||140
250006|NCT01006135|606150|P1|COMPLETED|Overall Study||4712
250007|NCT01006135|606150|P1|STARTED|Overall Study||4852
250008|NCT01006291|606160|P3|NOT COMPLETED|Overall Study||27
250009|NCT01006291|606161|P2|NOT COMPLETED|Overall Study||24
250010|NCT01006291|606162|P1|NOT COMPLETED|Overall Study||26
250011|NCT01006291|606160|P3|COMPLETED|Overall Study||203
250012|NCT01006291|606161|P2|COMPLETED|Overall Study||204
250013|NCT01006291|606162|P1|COMPLETED|Overall Study||203
250014|NCT01006291|606160|P3|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|229
250015|NCT01006291|606161|P2|Exposed|Overall Study|2 subjects received IDeg OD FF|226
250016|NCT01006291|606162|P1|Exposed|Overall Study|1 subject withdrew before exposure to drug. 2 subjects randomised to IDeg OD received IDeg OD FF|230
250017|NCT01006291|606160|P3|STARTED|Overall Study||230
250018|NCT01006291|606161|P2|STARTED|Overall Study||228
250019|NCT01006291|606162|P1|STARTED|Overall Study||229
250020|NCT01006356|606179|P1|NOT COMPLETED|Overall Study||42
250021|NCT01006356|606179|P1|COMPLETED|Overall Study||99
250022|NCT01006356|606179|P1|STARTED|Overall Study||141
250023|NCT01006590|606193|P2|NOT COMPLETED|Overall Study||32
250024|NCT01006590|606194|P1|NOT COMPLETED|Overall Study||28
250025|NCT01006590|606193|P2|COMPLETED|Overall Study|Completed 24 weeks of treatment|107
250026|NCT01006590|606194|P1|COMPLETED|Overall Study|Completed 24 weeks of treatment|119
250027|NCT01006590|606193|P2|STARTED|Overall Study|Randomised and treated|139
250028|NCT01006590|606194|P1|STARTED|Overall Study|Randomised and treated|147
250029|NCT01006603|606212|P2|NOT COMPLETED|Overall Study||75
250030|NCT01006603|606213|P1|NOT COMPLETED|Overall Study||71
250031|NCT01006603|606212|P2|COMPLETED|Overall Study||285
250032|NCT01006603|606213|P1|COMPLETED|Overall Study||289
250033|NCT01006603|606212|P2|STARTED|Overall Study|Completed lead-in period and were randomised|360
250034|NCT01006603|606213|P1|STARTED|Overall Study|Completed lead-in period and were randomised|360
250035|NCT01006616|606235|P4|NOT COMPLETED|Period 2 (18 Months)||82
250036|NCT01006616|606236|P3|NOT COMPLETED|Period 2 (18 Months)||55
250037|NCT01006616|606237|P2|NOT COMPLETED|Period 2 (18 Months)||63
250038|NCT01006616|606238|P1|NOT COMPLETED|Period 2 (18 Months)||75
250039|NCT01006616|606235|P4|COMPLETED|Period 2 (18 Months)||0
250040|NCT01006616|606236|P3|COMPLETED|Period 2 (18 Months)||0
250041|NCT01006616|606237|P2|COMPLETED|Period 2 (18 Months)||0
250042|NCT01006616|606238|P1|COMPLETED|Period 2 (18 Months)||0
250043|NCT01006616|606235|P4|Treated|Period 2 (18 Months)||82
250044|NCT01006616|606236|P3|Treated|Period 2 (18 Months)||55
250045|NCT01006616|606237|P2|Treated|Period 2 (18 Months)||63
250046|NCT01006616|606238|P1|Treated|Period 2 (18 Months)||75
250047|NCT01006616|606235|P4|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|82
250048|NCT01006616|606236|P3|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|55
250049|NCT01006616|606237|P2|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|63
250050|NCT01006616|606238|P1|STARTED|Period 2 (18 Months)|Period 2 was optional. Not all participants completing Period 1 continued into Period 2.|75
250051|NCT01006616|606235|P4|NOT COMPLETED|Period 1 (6 Months)||27
250052|NCT01006616|606236|P3|NOT COMPLETED|Period 1 (6 Months)||51
250053|NCT01006616|606237|P2|NOT COMPLETED|Period 1 (6 Months)||54
250054|NCT01006616|606238|P1|NOT COMPLETED|Period 1 (6 Months)||26
250055|NCT01006616|606235|P4|COMPLETED|Period 1 (6 Months)||128
250056|NCT01006616|606236|P3|COMPLETED|Period 1 (6 Months)||102
250057|NCT01006616|606237|P2|COMPLETED|Period 1 (6 Months)||102
250058|NCT01006616|606238|P1|COMPLETED|Period 1 (6 Months)||126
250059|NCT01006616|606235|P4|Treated|Period 1 (6 Months)||154
250060|NCT01006616|606236|P3|Treated|Period 1 (6 Months)||152
250061|NCT01006616|606237|P2|Treated|Period 1 (6 Months)||156
250062|NCT01006616|606238|P1|Treated|Period 1 (6 Months)||152
250063|NCT01006616|606235|P4|STARTED|Period 1 (6 Months)||155
250064|NCT01006616|606236|P3|STARTED|Period 1 (6 Months)||153
250065|NCT01006616|606237|P2|STARTED|Period 1 (6 Months)||156
250066|NCT01006616|606238|P1|STARTED|Period 1 (6 Months)||152
250067|NCT01006629|606372|P1|NOT COMPLETED|Overall Study||6
250068|NCT01006629|606372|P1|COMPLETED|Overall Study||94
250069|NCT01006629|606372|P1|STARTED|Overall Study||100
250070|NCT01006655|606385|P2|NOT COMPLETED|Second Intervention||0
250071|NCT01006655|606386|P1|NOT COMPLETED|Second Intervention||0
250072|NCT01006655|606385|P2|COMPLETED|Second Intervention||10
250073|NCT01006655|606386|P1|COMPLETED|Second Intervention||11
250074|NCT01006655|606385|P2|STARTED|Second Intervention||10
250075|NCT01006655|606386|P1|STARTED|Second Intervention||11
250076|NCT01006655|606385|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
250077|NCT01006655|606386|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
250078|NCT01006655|606385|P2|COMPLETED|Washout Period of 2 Weeks||10
250079|NCT01006655|606386|P1|COMPLETED|Washout Period of 2 Weeks||11
250080|NCT01006655|606385|P2|STARTED|Washout Period of 2 Weeks||10
250081|NCT01006655|606386|P1|STARTED|Washout Period of 2 Weeks||11
250082|NCT01006655|606385|P2|NOT COMPLETED|First Intervention||0
250083|NCT01006655|606386|P1|NOT COMPLETED|First Intervention||0
250084|NCT01006655|606385|P2|COMPLETED|First Intervention||10
250085|NCT01006655|606386|P1|COMPLETED|First Intervention||11
250086|NCT01006655|606385|P2|STARTED|First Intervention||10
250087|NCT01006655|606386|P1|STARTED|First Intervention||11
250088|NCT01006889|606392|P1|NOT COMPLETED|Overall Study||3
250089|NCT01006889|606392|P1|COMPLETED|Overall Study||17
250090|NCT01006889|606392|P1|STARTED|Overall Study||20
250091|NCT01006980|606405|P2|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||84
250092|NCT01006980|606406|P1|NOT COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
250093|NCT01006980|606405|P2|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
250094|NCT01006980|606406|P1|COMPLETED|Crossover: Dacarbazine to Vemurafenib||0
250095|NCT01006980|606405|P2|STARTED|Crossover: Dacarbazine to Vemurafenib|Participants who crossed over from dacarbazine to vemurafenib treatment.|84
250096|NCT01006980|606406|P1|STARTED|Crossover: Dacarbazine to Vemurafenib||0
250097|NCT01006980|606405|P2|NOT COMPLETED|Vemurafenib and Dacarbazine||338
250098|NCT01006980|606406|P1|NOT COMPLETED|Vemurafenib and Dacarbazine||337
250099|NCT01006980|606405|P2|COMPLETED|Vemurafenib and Dacarbazine||0
250100|NCT01006980|606406|P1|COMPLETED|Vemurafenib and Dacarbazine||0
250101|NCT01006980|606405|P2|Treated|Vemurafenib and Dacarbazine||293
250102|NCT01006980|606406|P1|Treated|Vemurafenib and Dacarbazine||336
250103|NCT01006980|606405|P2|STARTED|Vemurafenib and Dacarbazine||338
250104|NCT01006980|606406|P1|STARTED|Vemurafenib and Dacarbazine||337
250105|NCT01007110|606428|P2|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||5
250106|NCT01007110|606429|P1|NOT COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
250107|NCT01007110|606428|P2|COMPLETED|Neonatal Behavioral Assessment Scale (NB||15
250108|NCT01007110|606429|P1|COMPLETED|Neonatal Behavioral Assessment Scale (NB||12
250109|NCT01007110|606428|P2|STARTED|Neonatal Behavioral Assessment Scale (NB||20
250110|NCT01007110|606429|P1|STARTED|Neonatal Behavioral Assessment Scale (NB||24
250111|NCT01007110|606428|P2|NOT COMPLETED|Follow-Up at 36 Weeks||2
250112|NCT01007110|606429|P1|NOT COMPLETED|Follow-Up at 36 Weeks||0
250113|NCT01007110|606428|P2|COMPLETED|Follow-Up at 36 Weeks||20
250114|NCT01007110|606429|P1|COMPLETED|Follow-Up at 36 Weeks||24
250115|NCT01007110|606428|P2|STARTED|Follow-Up at 36 Weeks||22
250116|NCT01007110|606429|P1|STARTED|Follow-Up at 36 Weeks||24
250117|NCT01007110|606428|P2|NOT COMPLETED|Follow-Up at 32 Weeks||1
250118|NCT01007110|606429|P1|NOT COMPLETED|Follow-Up at 32 Weeks||1
250119|NCT01007110|606428|P2|COMPLETED|Follow-Up at 32 Weeks||22
250120|NCT01007110|606429|P1|COMPLETED|Follow-Up at 32 Weeks||24
250121|NCT01007110|606428|P2|STARTED|Follow-Up at 32 Weeks||23
250122|NCT01007110|606429|P1|STARTED|Follow-Up at 32 Weeks||25
250123|NCT01007110|606428|P2|NOT COMPLETED|Follow-Up at 24 Weeks||4
250124|NCT01007110|606429|P1|NOT COMPLETED|Follow-Up at 24 Weeks||0
250125|NCT01007110|606428|P2|COMPLETED|Follow-Up at 24 Weeks||23
250126|NCT01007110|606429|P1|COMPLETED|Follow-Up at 24 Weeks||25
250127|NCT01007110|606428|P2|STARTED|Follow-Up at 24 Weeks||27
250128|NCT01007110|606429|P1|STARTED|Follow-Up at 24 Weeks||25
250129|NCT01007110|606428|P2|NOT COMPLETED|Allocation||8
250130|NCT01007110|606429|P1|NOT COMPLETED|Allocation||7
250131|NCT01007110|606428|P2|COMPLETED|Allocation||27
250132|NCT01007110|606429|P1|COMPLETED|Allocation||25
250133|NCT01007110|606428|P2|STARTED|Allocation||35
250134|NCT01007110|606429|P1|STARTED|Allocation||32
250135|NCT01007123|606447|P4|NOT COMPLETED|Overall Study||6
250136|NCT01007123|606448|P3|NOT COMPLETED|Overall Study||11
250137|NCT01007123|606449|P2|NOT COMPLETED|Overall Study||6
250138|NCT01007123|606450|P1|NOT COMPLETED|Overall Study||6
250139|NCT01007123|606447|P4|COMPLETED|Overall Study||41
250140|NCT01007123|606448|P3|COMPLETED|Overall Study||37
250141|NCT01007123|606449|P2|COMPLETED|Overall Study||41
250142|NCT01007123|606450|P1|COMPLETED|Overall Study||42
250143|NCT01007123|606447|P4|STARTED|Overall Study||47
250144|NCT01007123|606448|P3|STARTED|Overall Study||48
250145|NCT01007123|606449|P2|STARTED|Overall Study||47
250146|NCT01007123|606450|P1|STARTED|Overall Study||48
250147|NCT01007149|606481|P2|NOT COMPLETED|Overall Study||1
250148|NCT01007149|606482|P1|NOT COMPLETED|Overall Study||0
250149|NCT01007149|606481|P2|COMPLETED|Overall Study||20
250150|NCT01007149|606482|P1|COMPLETED|Overall Study||20
250151|NCT01007149|606481|P2|STARTED|Overall Study||21
250152|NCT01007149|606482|P1|STARTED|Overall Study||20
250153|NCT01000285|606506|P1|NOT COMPLETED|Overall Study||0
250154|NCT01000285|606506|P1|COMPLETED|Overall Study||18
250155|NCT01000285|606506|P1|STARTED|Overall Study||18
250156|NCT01000311|606528|P2|NOT COMPLETED|Overall Study||70
250157|NCT01000311|606529|P1|NOT COMPLETED|Overall Study||45
250158|NCT01000311|606528|P2|COMPLETED|Overall Study||201
250159|NCT01000311|606529|P1|COMPLETED|Overall Study||213
250160|NCT01000311|606528|P2|STARTED|Overall Study||271
250161|NCT01000311|606529|P1|STARTED|Overall Study||258
250162|NCT01000324|606557|P1|NOT COMPLETED|Year 20||0
250163|NCT01000324|606557|P1|COMPLETED|Year 20||28
250164|NCT01000324|606557|P1|STARTED|Year 20||28
250165|NCT01000324|606557|P1|NOT COMPLETED|Year 19||0
250166|NCT01000324|606557|P1|COMPLETED|Year 19||28
250167|NCT01000324|606557|P1|STARTED|Year 19||28
250168|NCT01000324|606557|P1|NOT COMPLETED|Year 18||0
250169|NCT01000324|606557|P1|COMPLETED|Year 18||29
250170|NCT01000324|606557|P1|STARTED|Year 18||29
250171|NCT01000324|606557|P1|NOT COMPLETED|Year 17||0
250172|NCT01000324|606557|P1|COMPLETED|Year 17||32
250173|NCT01000324|606557|P1|STARTED|Year 17||32
250174|NCT01000324|606557|P1|NOT COMPLETED|Year 16||0
250175|NCT01000324|606557|P1|COMPLETED|Year 16||40
250176|NCT01000324|606557|P1|STARTED|Year 16||40
250177|NCT01000337|606569|P2|NOT COMPLETED|Overall Study||3
250178|NCT01000337|606570|P1|NOT COMPLETED|Overall Study||4
250179|NCT01000337|606569|P2|COMPLETED|Overall Study||30
250180|NCT01000337|606570|P1|COMPLETED|Overall Study||30
250181|NCT01000337|606569|P2|STARTED|Overall Study||33
250182|NCT01000337|606570|P1|STARTED|Overall Study||34
250183|NCT01000376|606578|P2|NOT COMPLETED|Cycle 1 Day 15||0
250184|NCT01000376|606579|P1|NOT COMPLETED|Cycle 1 Day 15||0
250185|NCT01000376|606578|P2|COMPLETED|Cycle 1 Day 15||6
250186|NCT01000376|606579|P1|COMPLETED|Cycle 1 Day 15||4
250187|NCT01000376|606578|P2|STARTED|Cycle 1 Day 15||6
250188|NCT01000376|606579|P1|STARTED|Cycle 1 Day 15||4
250189|NCT01000376|606578|P2|NOT COMPLETED|Cycle 1 Day 1||0
250190|NCT01000376|606579|P1|NOT COMPLETED|Cycle 1 Day 1||2
250191|NCT01000376|606578|P2|COMPLETED|Cycle 1 Day 1||6
250192|NCT01000376|606579|P1|COMPLETED|Cycle 1 Day 1||4
250193|NCT01000376|606578|P2|STARTED|Cycle 1 Day 1||6
250194|NCT01000376|606579|P1|STARTED|Cycle 1 Day 1||6
250195|NCT01000480|606587|P1|NOT COMPLETED|Follow-Up Period||0
250196|NCT01000480|606587|P1|COMPLETED|Follow-Up Period||88
250197|NCT01000480|606587|P1|STARTED|Follow-Up Period|One pt lost to follow-up during induction, 1 pt died in concurrent therapy, both not enter follow-up|88
250198|NCT01000480|606587|P1|NOT COMPLETED|Concurrent Therapy Phase||10
250199|NCT01000480|606587|P1|COMPLETED|Concurrent Therapy Phase||65
250200|NCT01000480|606587|P1|Death (Any Cause) or Disease Progression|Concurrent Therapy Phase|Pts who died (any cause) or had disease progression considered to have completed the phase.|1
250201|NCT01000480|606587|P1|STARTED|Concurrent Therapy Phase|Eight participants (pts) who completed Induction Phase, not eligible for Concurrent Therapy Phase.|75
250202|NCT01000480|606587|P1|NOT COMPLETED|Induction Phase||7
250203|NCT01000480|606587|P1|COMPLETED|Induction Phase||83
250204|NCT01000480|606587|P1|Death (Any Cause) or Disease Progression|Induction Phase|Participants who died (any cause) or had disease progression considered to have completed phase.|8
250205|NCT01000480|606587|P1|Received at Least 1 Dose of Either Drug|Induction Phase||90
250206|NCT01000480|606587|P1|STARTED|Induction Phase||90
250207|NCT01000506|606597|P4|NOT COMPLETED|Overall Study||23
250208|NCT01000506|606598|P3|NOT COMPLETED|Overall Study||21
250209|NCT01000506|606599|P2|NOT COMPLETED|Overall Study||24
250210|NCT01000506|606600|P1|NOT COMPLETED|Overall Study||28
250211|NCT01000506|606597|P4|COMPLETED|Overall Study||133
250212|NCT01000506|606598|P3|COMPLETED|Overall Study||131
250213|NCT01000506|606599|P2|COMPLETED|Overall Study||129
250214|NCT01000506|606600|P1|COMPLETED|Overall Study||127
250215|NCT01000506|606597|P4|STARTED|Overall Study||156
250216|NCT01000506|606598|P3|STARTED|Overall Study||152
250217|NCT01000506|606599|P2|STARTED|Overall Study||153
250218|NCT01000506|606600|P1|STARTED|Overall Study||155
250219|NCT01000610|606642|P1|NOT COMPLETED|Overall Study||6
250220|NCT01000610|606642|P1|COMPLETED|Overall Study||12
250221|NCT01000610|606642|P1|STARTED|Overall Study||18
250222|NCT01000649|606653|P4|NOT COMPLETED|Overall Study||6
250223|NCT01000649|606654|P3|NOT COMPLETED|Overall Study||2
250224|NCT01000649|606655|P2|NOT COMPLETED|Overall Study||3
250225|NCT01000649|606656|P1|NOT COMPLETED|Overall Study||5
250226|NCT01000649|606653|P4|COMPLETED|Overall Study||15
250227|NCT01000649|606654|P3|COMPLETED|Overall Study||0
250228|NCT01000649|606655|P2|COMPLETED|Overall Study||16
250229|NCT01000649|606656|P1|COMPLETED|Overall Study||5
250230|NCT01000649|606653|P4|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|21
250231|NCT01000649|606654|P3|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|2
250232|NCT01000649|606655|P2|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|20
250233|NCT01000649|606656|P1|Intention-to-Treat (ITT) Analysis Set|Overall Study|ITT population comprised of all randomized patients.|10
250234|NCT01000649|606653|P4|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|21
250235|NCT01000649|606654|P3|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|2
250236|NCT01000649|606655|P2|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|19
250237|NCT01000649|606656|P1|STARTED|Overall Study|This represents Full Analysis Set population, which comprised of all dosed patients.|10
250238|NCT01000662|606739|P2|NOT COMPLETED|Overall Study||8
250239|NCT01000662|606740|P1|NOT COMPLETED|Overall Study||4
250240|NCT01000662|606739|P2|COMPLETED|Overall Study||198
250241|NCT01000662|606740|P1|COMPLETED|Overall Study||202
250242|NCT01000662|606739|P2|STARTED|Overall Study||206
250243|NCT01000662|606740|P1|STARTED|Overall Study||206
250244|NCT01000727|606748|P2|NOT COMPLETED|Overall Study||176
250245|NCT01000727|606749|P1|NOT COMPLETED|Overall Study||175
250246|NCT01000727|606748|P2|COMPLETED|Overall Study||6328
250247|NCT01000727|606749|P1|COMPLETED|Overall Study||6347
250248|NCT01000727|606748|P2|STARTED|Overall Study||6504
250249|NCT01000727|606749|P1|STARTED|Overall Study||6522
250250|NCT01000805|606779|P2|NOT COMPLETED|Overall Study||62
250251|NCT01000805|606780|P1|NOT COMPLETED|Overall Study||70
250252|NCT01000805|606779|P2|COMPLETED|Overall Study||204
250253|NCT01000805|606780|P1|COMPLETED|Overall Study||192
250254|NCT01000805|606779|P2|STARTED|Overall Study||266
250255|NCT01000805|606780|P1|STARTED|Overall Study||262
250256|NCT01000818|606812|P1|NOT COMPLETED|Omeprazole + Raltegravir||0
250257|NCT01000818|606812|P1|COMPLETED|Omeprazole + Raltegravir||18
250258|NCT01000818|606812|P1|STARTED|Omeprazole + Raltegravir||18
250259|NCT01000818|606812|P1|NOT COMPLETED|Famotidine + Raltegravir||0
250260|NCT01000818|606812|P1|COMPLETED|Famotidine + Raltegravir||18
250261|NCT01000818|606812|P1|STARTED|Famotidine + Raltegravir||18
250262|NCT01000818|606812|P1|NOT COMPLETED|Raltegravir||0
250263|NCT01000818|606812|P1|COMPLETED|Raltegravir||18
250264|NCT01000818|606812|P1|STARTED|Raltegravir||18
250265|NCT01000961|606821|P2|NOT COMPLETED|Second Intervention (3 Weeks)||0
250266|NCT01000961|606822|P1|NOT COMPLETED|Second Intervention (3 Weeks)||0
250267|NCT01000961|606821|P2|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|20
250268|NCT01000961|606822|P1|COMPLETED|Second Intervention (3 Weeks)|Part of Efficacy analysis set|21
250269|NCT01000961|606821|P2|STARTED|Second Intervention (3 Weeks)||20
250270|NCT01000961|606822|P1|STARTED|Second Intervention (3 Weeks)||21
250271|NCT01000961|606821|P2|NOT COMPLETED|First Intervention (3 Weeks)||2
250272|NCT01000961|606822|P1|NOT COMPLETED|First Intervention (3 Weeks)||0
250273|NCT01000961|606821|P2|COMPLETED|First Intervention (3 Weeks)||20
250274|NCT01000961|606822|P1|COMPLETED|First Intervention (3 Weeks)||21
250275|NCT01000961|606821|P2|STARTED|First Intervention (3 Weeks)||22
250276|NCT01000961|606822|P1|STARTED|First Intervention (3 Weeks)||21
250277|NCT01000961|606821|P2|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
250278|NCT01000961|606822|P1|NOT COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||0
250279|NCT01000961|606821|P2|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||22
250280|NCT01000961|606822|P1|COMPLETED|Run-in Period of 2-3 Weeks on Cystagon||21
250281|NCT01000961|606821|P2|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|22
250282|NCT01000961|606822|P1|STARTED|Run-in Period of 2-3 Weeks on Cystagon|Part of the Safety analysis set|21
250283|NCT01000974|606837|P3|NOT COMPLETED|Booster Vaccination Phase||14
250284|NCT01000974|606838|P2|NOT COMPLETED|Booster Vaccination Phase||12
250285|NCT01000974|606839|P1|NOT COMPLETED|Booster Vaccination Phase||67
250286|NCT01000974|606837|P3|COMPLETED|Booster Vaccination Phase||386
250287|NCT01000974|606838|P2|COMPLETED|Booster Vaccination Phase||423
250288|NCT01000974|606839|P1|COMPLETED|Booster Vaccination Phase||2270
250289|NCT01000974|606837|P3|STARTED|Booster Vaccination Phase||400
250290|NCT01000974|606838|P2|STARTED|Booster Vaccination Phase||435
250291|NCT01000974|606839|P1|STARTED|Booster Vaccination Phase||2337
250292|NCT01000974|606837|P3|NOT COMPLETED|Primary Vaccination Phase||63
250293|NCT01000974|606838|P2|NOT COMPLETED|Primary Vaccination Phase||50
250294|NCT01000974|606839|P1|NOT COMPLETED|Primary Vaccination Phase||338
250295|NCT01000974|606837|P3|COMPLETED|Primary Vaccination Phase||457
250296|NCT01000974|606838|P2|COMPLETED|Primary Vaccination Phase||470
250297|NCT01000974|606839|P1|COMPLETED|Primary Vaccination Phase||2625
250298|NCT01000974|606837|P3|STARTED|Primary Vaccination Phase||520
250299|NCT01000974|606838|P2|STARTED|Primary Vaccination Phase||520
250300|NCT01000974|606839|P1|STARTED|Primary Vaccination Phase||2963
250301|NCT01001052|606916|P2|NOT COMPLETED|Overall Study||0
250302|NCT01001052|606917|P1|NOT COMPLETED|Overall Study||0
250303|NCT01001052|606916|P2|COMPLETED|Overall Study||18
250304|NCT01001052|606917|P1|COMPLETED|Overall Study||20
250305|NCT01001052|606916|P2|STARTED|Overall Study||18
250306|NCT01001052|606917|P1|STARTED|Overall Study||20
250307|NCT01001078|606929|P2|NOT COMPLETED|Overall Study||0
250308|NCT01001078|606930|P1|NOT COMPLETED|Overall Study||0
250309|NCT01001078|606929|P2|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 2|50
250310|NCT01001078|606930|P1|COMPLETED|Overall Study|Analyzed: 46, excluded from interview analysis: 5|50
250311|NCT01001078|606929|P2|Lost to Followup Interview|Overall Study|Could not be interviewed.|2
250479|NCT01001559|607525|P2|STARTED|Overall Study||147
250312|NCT01001078|606930|P1|Lost to Followup Interview|Overall Study|Could not be interviewed.|5
250313|NCT01001078|606929|P2|Intubated|Overall Study||1
250314|NCT01001078|606930|P1|Intubated|Overall Study||2
250315|NCT01001078|606929|P2|Received Crossover|Overall Study||3
250316|NCT01001078|606930|P1|Received Crossover|Overall Study||2
250317|NCT01001078|606929|P2|Received Allocated Intervention|Overall Study||46
250318|NCT01001078|606930|P1|Received Allocated Intervention|Overall Study||46
250319|NCT01001078|606929|P2|STARTED|Overall Study||50
250320|NCT01001078|606930|P1|STARTED|Overall Study||50
250321|NCT01001104|606950|P4|NOT COMPLETED|Overall Study||3
250322|NCT01001104|606951|P3|NOT COMPLETED|Overall Study||1
250323|NCT01001104|606952|P2|NOT COMPLETED|Overall Study||1
250324|NCT01001104|606953|P1|NOT COMPLETED|Overall Study||2
250325|NCT01001104|606950|P4|COMPLETED|Overall Study||34
250326|NCT01001104|606951|P3|COMPLETED|Overall Study||35
250327|NCT01001104|606952|P2|COMPLETED|Overall Study||36
250328|NCT01001104|606953|P1|COMPLETED|Overall Study||33
250329|NCT01001104|606950|P4|STARTED|Overall Study||37
250330|NCT01001104|606951|P3|STARTED|Overall Study||36
250331|NCT01001104|606952|P2|STARTED|Overall Study||37
250332|NCT01001104|606953|P1|STARTED|Overall Study||35
250333|NCT01001169|607000|P2|NOT COMPLETED|Overall Study||1
250334|NCT01001169|607001|P1|NOT COMPLETED|Overall Study||2
250335|NCT01001169|607000|P2|COMPLETED|Overall Study||29
250336|NCT01001169|607001|P1|COMPLETED|Overall Study||28
250337|NCT01001169|607000|P2|STARTED|Overall Study||30
250338|NCT01001169|607001|P1|STARTED|Overall Study||30
250339|NCT01001195|607109|P4|NOT COMPLETED|Overall Study||0
250340|NCT01001195|607110|P3|NOT COMPLETED|Overall Study||0
250341|NCT01001195|607111|P2|NOT COMPLETED|Overall Study||2
250342|NCT01001195|607112|P1|NOT COMPLETED|Overall Study||2
250343|NCT01001195|607109|P4|COMPLETED|Overall Study||41
250344|NCT01001195|607110|P3|COMPLETED|Overall Study||44
250345|NCT01001195|607111|P2|COMPLETED|Overall Study||39
250346|NCT01001195|607112|P1|COMPLETED|Overall Study||37
250347|NCT01001195|607109|P4|STARTED|Overall Study||41
250348|NCT01001195|607110|P3|STARTED|Overall Study||44
250349|NCT01001195|607111|P2|STARTED|Overall Study||41
250350|NCT01001195|607112|P1|STARTED|Overall Study||39
250351|NCT01001208|607124|P2|NOT COMPLETED|Overall Study||33
250352|NCT01001208|607125|P1|NOT COMPLETED|Overall Study||28
250353|NCT01001208|607124|P2|COMPLETED|Overall Study||206
250354|NCT01001208|607125|P1|COMPLETED|Overall Study||211
250355|NCT01001208|607124|P2|STARTED|Overall Study||239
250356|NCT01001208|607125|P1|STARTED|Overall Study||239
250357|NCT01001221|607153|P5|NOT COMPLETED|Overall Study||0
250358|NCT01001221|607154|P4|NOT COMPLETED|Overall Study||6
250359|NCT01001221|607155|P3|NOT COMPLETED|Overall Study||3
250360|NCT01001221|607156|P2|NOT COMPLETED|Overall Study||5
250361|NCT01001221|607157|P1|NOT COMPLETED|Overall Study||5
250362|NCT01001221|607153|P5|COMPLETED|Overall Study||0
250363|NCT01001221|607154|P4|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
250364|NCT01001221|607155|P3|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
250365|NCT01001221|607156|P2|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
250366|NCT01001221|607157|P1|COMPLETED|Overall Study|Participants treated until disease progression or unacceptable toxicity.|0
250367|NCT01001221|607153|P5|Completed 1st Treatment Cycle|Overall Study||0
250368|NCT01001221|607154|P4|Completed 1st Treatment Cycle|Overall Study||6
250369|NCT01001221|607155|P3|Completed 1st Treatment Cycle|Overall Study||2
250370|NCT01001221|607156|P2|Completed 1st Treatment Cycle|Overall Study||5
250371|NCT01001221|607157|P1|Completed 1st Treatment Cycle|Overall Study||5
250372|NCT01001221|607153|P5|Treated|Overall Study||0
250373|NCT01001221|607154|P4|Treated|Overall Study||6
250374|NCT01001221|607155|P3|Treated|Overall Study||2
250375|NCT01001221|607156|P2|Treated|Overall Study||5
250376|NCT01001221|607157|P1|Treated|Overall Study||5
250377|NCT01001221|607153|P5|STARTED|Overall Study|Inability to determine the MTD during study part 1|0
250378|NCT01001221|607154|P4|STARTED|Overall Study||6
250379|NCT01001221|607155|P3|STARTED|Overall Study||3
250380|NCT01001221|607156|P2|STARTED|Overall Study||5
250381|NCT01001221|607157|P1|STARTED|Overall Study||5
250382|NCT01001234|607335|P5|NOT COMPLETED|Overall Study||0
250383|NCT01001234|607336|P4|NOT COMPLETED|Overall Study||25
250384|NCT01001234|607337|P3|NOT COMPLETED|Overall Study||32
250385|NCT01001234|607338|P2|NOT COMPLETED|Overall Study||26
250386|NCT01001234|607339|P1|NOT COMPLETED|Overall Study||405
250387|NCT01001234|607335|P5|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|40
250388|NCT01001234|607336|P4|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|385
250389|NCT01001234|607337|P3|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|377
250390|NCT01001234|607338|P2|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|5
250391|NCT01001234|607339|P1|COMPLETED|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2 and completed study|87
250392|NCT01001234|607335|P5|Participants Not Treated|Overall Study|Participants who did not take study drug|0
250393|NCT01001234|607336|P4|Participants Not Treated|Overall Study|Participants who did not take study drug|5
250394|NCT01001234|607337|P3|Participants Not Treated|Overall Study|Participants who did not take study drug|9
250480|NCT01001559|607526|P1|STARTED|Overall Study||95
250395|NCT01001234|607338|P2|Participants Not Treated|Overall Study|Participants who did not take study drug|23
250396|NCT01001234|607339|P1|Participants Not Treated|Overall Study|Participants who did not take study drug|368
250397|NCT01001234|607335|P5|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|40
250398|NCT01001234|607336|P4|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|405
250399|NCT01001234|607337|P3|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|400
250400|NCT01001234|607338|P2|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|8
250401|NCT01001234|607339|P1|Particpants Treated|Overall Study|Participants who took study drug in Stage 1 and/or Stage 2|124
250402|NCT01001234|607335|P5|STARTED|Overall Study|Participants who were randomized to study drug|40
250403|NCT01001234|607336|P4|STARTED|Overall Study|Participants who were randomized to study drug|410
250404|NCT01001234|607337|P3|STARTED|Overall Study|Participants who were randomized to study drug|409
250405|NCT01001234|607338|P2|STARTED|Overall Study|Participants who were randomized to study drug|31
250406|NCT01001234|607339|P1|STARTED|Overall Study|Participants who were randomized to study drug|492
250407|NCT01001299|607351|P1|NOT COMPLETED|Overall Study||25
250408|NCT01001299|607351|P1|COMPLETED|Overall Study||0
250409|NCT01001299|607351|P1|STARTED|Overall Study||25
250410|NCT01001325|607377|P2|NOT COMPLETED|Overall Study||10
250411|NCT01001325|607378|P1|NOT COMPLETED|Overall Study||18
250412|NCT01001325|607377|P2|COMPLETED|Overall Study||224
250413|NCT01001325|607378|P1|COMPLETED|Overall Study||216
250414|NCT01001325|607377|P2|STARTED|Overall Study||234
250415|NCT01001325|607378|P1|STARTED|Overall Study||234
250416|NCT01001377|607386|P2|NOT COMPLETED|Overall Study||421
250417|NCT01001377|607387|P1|NOT COMPLETED|Overall Study||426
250418|NCT01001377|607386|P2|COMPLETED|Overall Study|Indicates participants continuing in study|85
250419|NCT01001377|607387|P1|COMPLETED|Overall Study|Indicates participants continuing in study|78
250420|NCT01001377|607386|P2|Received Treatment|Overall Study||499
250421|NCT01001377|607387|P1|Received Treatment|Overall Study||500
250422|NCT01001377|607386|P2|STARTED|Overall Study||506
250423|NCT01001377|607387|P1|STARTED|Overall Study||504
250424|NCT01001390|607415|P2|NOT COMPLETED|Overall Study||0
250425|NCT01001390|607416|P1|NOT COMPLETED|Overall Study||2
250426|NCT01001390|607415|P2|COMPLETED|Overall Study||0
250427|NCT01001390|607416|P1|COMPLETED|Overall Study||0
250428|NCT01001390|607415|P2|STARTED|Overall Study||0
250429|NCT01001390|607416|P1|STARTED|Overall Study||2
250430|NCT01001403|607424|P2|NOT COMPLETED|Overall Study||0
250431|NCT01001403|607425|P1|NOT COMPLETED|Overall Study||0
250432|NCT01001403|607424|P2|COMPLETED|Overall Study||31
250433|NCT01001403|607425|P1|COMPLETED|Overall Study||31
250434|NCT01001403|607424|P2|STARTED|Overall Study||31
250435|NCT01001403|607425|P1|STARTED|Overall Study||31
250436|NCT01001429|607433|P2|NOT COMPLETED|Overall Study||1
250437|NCT01001429|607434|P1|NOT COMPLETED|Overall Study||0
250438|NCT01001429|607433|P2|COMPLETED|Overall Study||37
250439|NCT01001429|607434|P1|COMPLETED|Overall Study||39
250440|NCT01001429|607433|P2|STARTED|Overall Study||38
250441|NCT01001429|607434|P1|STARTED|Overall Study||39
250442|NCT01001494|607467|P3|NOT COMPLETED|Overall Study||41
250443|NCT01001494|607468|P2|NOT COMPLETED|Overall Study||17
250444|NCT01001494|607469|P1|NOT COMPLETED|Overall Study||24
250445|NCT01001494|607467|P3|COMPLETED|Overall Study||232
250446|NCT01001494|607468|P2|COMPLETED|Overall Study||252
250447|NCT01001494|607469|P1|COMPLETED|Overall Study||253
250448|NCT01001494|607467|P3|STARTED|Overall Study|276 patients were randomized, but baseline data was missing from 3 patients in one center|273
250449|NCT01001494|607468|P2|STARTED|Overall Study|272 patients were randomized, but baseline data was missing from 3 patients in one center|269
250450|NCT01001494|607469|P1|STARTED|Overall Study|280 patients were randomized, but baseline data was missing from 3 patients in one center|277
250451|NCT01001520|607489|P2|NOT COMPLETED|Medication Period 2||3
250452|NCT01001520|607490|P1|NOT COMPLETED|Medication Period 2||0
250453|NCT01001520|607489|P2|COMPLETED|Medication Period 2||13
250454|NCT01001520|607490|P1|COMPLETED|Medication Period 2||16
250455|NCT01001520|607489|P2|STARTED|Medication Period 2||16
250456|NCT01001520|607490|P1|STARTED|Medication Period 2||16
250457|NCT01001520|607489|P2|NOT COMPLETED|Washout Period||1
250458|NCT01001520|607490|P1|NOT COMPLETED|Washout Period||2
250459|NCT01001520|607489|P2|COMPLETED|Washout Period||16
250460|NCT01001520|607490|P1|COMPLETED|Washout Period||16
250461|NCT01001520|607489|P2|STARTED|Washout Period||17
250462|NCT01001520|607490|P1|STARTED|Washout Period||18
250463|NCT01001520|607489|P2|NOT COMPLETED|Medication Period 1||7
250464|NCT01001520|607490|P1|NOT COMPLETED|Medication Period 1||4
250465|NCT01001520|607489|P2|COMPLETED|Medication Period 1||17
250466|NCT01001520|607490|P1|COMPLETED|Medication Period 1||18
250467|NCT01001520|607489|P2|STARTED|Medication Period 1||24
250468|NCT01001520|607490|P1|STARTED|Medication Period 1||22
250469|NCT01001546|607516|P2|NOT COMPLETED|Overall Study||0
250470|NCT01001546|607517|P1|NOT COMPLETED|Overall Study||0
250471|NCT01001546|607516|P2|COMPLETED|Overall Study||207
250472|NCT01001546|607517|P1|COMPLETED|Overall Study||206
250473|NCT01001546|607516|P2|STARTED|Overall Study||207
250474|NCT01001546|607517|P1|STARTED|Overall Study||206
250475|NCT01001559|607525|P2|NOT COMPLETED|Overall Study||0
250476|NCT01001559|607526|P1|NOT COMPLETED|Overall Study||0
250477|NCT01001559|607525|P2|COMPLETED|Overall Study||147
250478|NCT01001559|607526|P1|COMPLETED|Overall Study||95
250481|NCT01001572|607540|P3|NOT COMPLETED|Double-Blind Treatment Phase||19
250482|NCT01001572|607541|P2|NOT COMPLETED|Double-Blind Treatment Phase||10
250483|NCT01001572|607542|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
250484|NCT01001572|607540|P3|COMPLETED|Double-Blind Treatment Phase||306
250485|NCT01001572|607541|P2|COMPLETED|Double-Blind Treatment Phase||319
250486|NCT01001572|607542|P1|COMPLETED|Double-Blind Treatment Phase||0
250487|NCT01001572|607540|P3|Full Analysis Set (FAS)|Double-Blind Treatment Phase|Two patients were excluded from full analysis set for having no post-baseline efficacy assessment.|323
250488|NCT01001572|607541|P2|Full Analysis Set (FAS)|Double-Blind Treatment Phase|One patient was excluded from full analysis set for having no post-baseline efficacy assessment.|328
250489|NCT01001572|607542|P1|Full Analysis Set (FAS)|Double-Blind Treatment Phase||0
250490|NCT01001572|607540|P3|STARTED|Double-Blind Treatment Phase||325
250491|NCT01001572|607541|P2|STARTED|Double-Blind Treatment Phase||329
250492|NCT01001572|607542|P1|STARTED|Double-Blind Treatment Phase|This arm is only used for single blind period. So, no enrollment during double blind period.|0
250493|NCT01001572|607540|P3|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
250494|NCT01001572|607541|P2|NOT COMPLETED|Single-Blind Valsartan 160 mg||0
250495|NCT01001572|607542|P1|NOT COMPLETED|Single-Blind Valsartan 160 mg||278
250496|NCT01001572|607540|P3|COMPLETED|Single-Blind Valsartan 160 mg||0
250497|NCT01001572|607541|P2|COMPLETED|Single-Blind Valsartan 160 mg||0
250498|NCT01001572|607542|P1|COMPLETED|Single-Blind Valsartan 160 mg||654
250499|NCT01001572|607540|P3|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
250500|NCT01001572|607541|P2|STARTED|Single-Blind Valsartan 160 mg|Participants did not enroll into this arm during single blind period.|0
250501|NCT01001572|607542|P1|STARTED|Single-Blind Valsartan 160 mg||932
250502|NCT01001702|607556|P1|NOT COMPLETED|Overall Study||72
250503|NCT01001702|607556|P1|COMPLETED|Overall Study||13
250504|NCT01001702|607556|P1|STARTED|Overall Study||85
250505|NCT01001767|607569|P2|NOT COMPLETED|Overall Study||0
250506|NCT01001767|607570|P1|NOT COMPLETED|Overall Study||4
250507|NCT01001767|607569|P2|COMPLETED|Overall Study||17
250508|NCT01001767|607570|P1|COMPLETED|Overall Study||14
250509|NCT01001767|607569|P2|STARTED|Overall Study||17
250510|NCT01001767|607570|P1|STARTED|Overall Study||18
250511|NCT01007253|607576|P4|NOT COMPLETED|Fourth Intervention||0
250512|NCT01007253|607577|P3|NOT COMPLETED|Fourth Intervention||0
250513|NCT01007253|607578|P2|NOT COMPLETED|Fourth Intervention||0
250514|NCT01007253|607579|P1|NOT COMPLETED|Fourth Intervention||0
250515|NCT01007253|607576|P4|COMPLETED|Fourth Intervention||5
250516|NCT01007253|607577|P3|COMPLETED|Fourth Intervention||5
250517|NCT01007253|607578|P2|COMPLETED|Fourth Intervention||5
250518|NCT01007253|607579|P1|COMPLETED|Fourth Intervention||5
250519|NCT01007253|607576|P4|STARTED|Fourth Intervention||5
250520|NCT01007253|607577|P3|STARTED|Fourth Intervention||5
250521|NCT01007253|607578|P2|STARTED|Fourth Intervention||5
250522|NCT01007253|607579|P1|STARTED|Fourth Intervention||5
250523|NCT01007253|607576|P4|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
250524|NCT01007253|607577|P3|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
250525|NCT01007253|607578|P2|NOT COMPLETED|Washout Period (2 Weeks) # 3||0
250526|NCT01007253|607579|P1|NOT COMPLETED|Washout Period (2 Weeks) # 3||1
250527|NCT01007253|607576|P4|COMPLETED|Washout Period (2 Weeks) # 3||5
250528|NCT01007253|607577|P3|COMPLETED|Washout Period (2 Weeks) # 3||5
250529|NCT01007253|607578|P2|COMPLETED|Washout Period (2 Weeks) # 3||5
250530|NCT01007253|607579|P1|COMPLETED|Washout Period (2 Weeks) # 3||5
250531|NCT01007253|607576|P4|STARTED|Washout Period (2 Weeks) # 3||5
250532|NCT01007253|607577|P3|STARTED|Washout Period (2 Weeks) # 3||5
250533|NCT01007253|607578|P2|STARTED|Washout Period (2 Weeks) # 3||5
250534|NCT01007253|607579|P1|STARTED|Washout Period (2 Weeks) # 3||6
250535|NCT01007253|607576|P4|NOT COMPLETED|Third Intervention||0
250536|NCT01007253|607577|P3|NOT COMPLETED|Third Intervention||0
250537|NCT01007253|607578|P2|NOT COMPLETED|Third Intervention||0
250538|NCT01007253|607579|P1|NOT COMPLETED|Third Intervention||0
250539|NCT01007253|607576|P4|COMPLETED|Third Intervention||5
250540|NCT01007253|607577|P3|COMPLETED|Third Intervention||5
250541|NCT01007253|607578|P2|COMPLETED|Third Intervention||5
250542|NCT01007253|607579|P1|COMPLETED|Third Intervention||6
250543|NCT01007253|607576|P4|STARTED|Third Intervention||5
250544|NCT01007253|607577|P3|STARTED|Third Intervention||5
250545|NCT01007253|607578|P2|STARTED|Third Intervention||5
250546|NCT01007253|607579|P1|STARTED|Third Intervention||6
250547|NCT01007253|607576|P4|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
250548|NCT01007253|607577|P3|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
250549|NCT01007253|607578|P2|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
250550|NCT01007253|607579|P1|NOT COMPLETED|Washout Period (2 Weeks) # 2||0
250551|NCT01007253|607576|P4|COMPLETED|Washout Period (2 Weeks) # 2||5
250552|NCT01007253|607577|P3|COMPLETED|Washout Period (2 Weeks) # 2||5
250553|NCT01007253|607578|P2|COMPLETED|Washout Period (2 Weeks) # 2||5
250554|NCT01007253|607579|P1|COMPLETED|Washout Period (2 Weeks) # 2||6
250555|NCT01007253|607576|P4|STARTED|Washout Period (2 Weeks) # 2||5
250556|NCT01007253|607577|P3|STARTED|Washout Period (2 Weeks) # 2||5
250557|NCT01007253|607578|P2|STARTED|Washout Period (2 Weeks) # 2||5
250558|NCT01007253|607579|P1|STARTED|Washout Period (2 Weeks) # 2||6
250559|NCT01007253|607576|P4|NOT COMPLETED|Second Intervention||0
250560|NCT01007253|607577|P3|NOT COMPLETED|Second Intervention||0
250561|NCT01007253|607578|P2|NOT COMPLETED|Second Intervention||0
250562|NCT01007253|607579|P1|NOT COMPLETED|Second Intervention||0
250563|NCT01007253|607576|P4|COMPLETED|Second Intervention||5
250564|NCT01007253|607577|P3|COMPLETED|Second Intervention||5
250565|NCT01007253|607578|P2|COMPLETED|Second Intervention||5
250566|NCT01007253|607579|P1|COMPLETED|Second Intervention||6
250567|NCT01007253|607576|P4|STARTED|Second Intervention||5
250568|NCT01007253|607577|P3|STARTED|Second Intervention||5
250569|NCT01007253|607578|P2|STARTED|Second Intervention||5
250570|NCT01007253|607579|P1|STARTED|Second Intervention||6
250571|NCT01007253|607576|P4|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
250572|NCT01007253|607577|P3|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
250573|NCT01007253|607578|P2|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
250574|NCT01007253|607579|P1|NOT COMPLETED|Washout Period (2 Weeks) # 1||0
250575|NCT01007253|607576|P4|COMPLETED|Washout Period (2 Weeks) # 1||5
250576|NCT01007253|607577|P3|COMPLETED|Washout Period (2 Weeks) # 1||5
250577|NCT01007253|607578|P2|COMPLETED|Washout Period (2 Weeks) # 1||5
250578|NCT01007253|607579|P1|COMPLETED|Washout Period (2 Weeks) # 1||6
250579|NCT01007253|607576|P4|STARTED|Washout Period (2 Weeks) # 1||5
250580|NCT01007253|607577|P3|STARTED|Washout Period (2 Weeks) # 1||5
250581|NCT01007253|607578|P2|STARTED|Washout Period (2 Weeks) # 1||5
250582|NCT01007253|607579|P1|STARTED|Washout Period (2 Weeks) # 1||6
250583|NCT01007253|607576|P4|NOT COMPLETED|First Intervention||0
250584|NCT01007253|607577|P3|NOT COMPLETED|First Intervention||0
250585|NCT01007253|607578|P2|NOT COMPLETED|First Intervention||0
250586|NCT01007253|607579|P1|NOT COMPLETED|First Intervention||0
250587|NCT01007253|607576|P4|COMPLETED|First Intervention||5
250588|NCT01007253|607577|P3|COMPLETED|First Intervention||5
250589|NCT01007253|607578|P2|COMPLETED|First Intervention||5
250590|NCT01007253|607579|P1|COMPLETED|First Intervention||6
250591|NCT01007253|607576|P4|STARTED|First Intervention||5
250592|NCT01007253|607577|P3|STARTED|First Intervention||5
250593|NCT01007253|607578|P2|STARTED|First Intervention||5
250594|NCT01007253|607579|P1|STARTED|First Intervention||6
250595|NCT01007396|607609|P1|NOT COMPLETED|Overall Study||47
250596|NCT01007396|607609|P1|COMPLETED|Overall Study||275
250597|NCT01007396|607609|P1|STARTED|Overall Study||322
250598|NCT01007435|607618|P4|NOT COMPLETED|Overall Study||56
250599|NCT01007435|607619|P3|NOT COMPLETED|Overall Study||64
250600|NCT01007435|607620|P2|NOT COMPLETED|Overall Study||59
250601|NCT01007435|607621|P1|NOT COMPLETED|Overall Study||63
250602|NCT01007435|607618|P4|COMPLETED|Overall Study||236
250603|NCT01007435|607619|P3|COMPLETED|Overall Study||227
250604|NCT01007435|607620|P2|COMPLETED|Overall Study||231
250605|NCT01007435|607621|P1|COMPLETED|Overall Study||226
250606|NCT01007435|607618|P4|STARTED|Overall Study||292
250607|NCT01007435|607619|P3|STARTED|Overall Study||291
250608|NCT01007435|607620|P2|STARTED|Overall Study||290
250609|NCT01007435|607621|P1|STARTED|Overall Study||289
250610|NCT01013597|607663|P1|NOT COMPLETED|Overall Study||1
250611|NCT01013597|607663|P1|COMPLETED|Overall Study||12
250612|NCT01013597|607663|P1|STARTED|Overall Study||13
250613|NCT01013740|607675|P2|NOT COMPLETED|Overall Study||19
250614|NCT01013740|607676|P1|NOT COMPLETED|Overall Study||11
250615|NCT01013740|607675|P2|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|56
250616|NCT01013740|607676|P1|COMPLETED|Overall Study|Completion also = 18 mos.of a new anti-cancer therapy initiation +/or progression of disease|26
250617|NCT01013740|607675|P2|Ongoing|Overall Study||0
250618|NCT01013740|607676|P1|Ongoing|Overall Study||0
250619|NCT01013740|607675|P2|STARTED|Overall Study|29 participants experiencing PD in the RP elected to enroll in the optional CP.|75
250620|NCT01013740|607676|P1|STARTED|Overall Study|13 participants (par.) experiencing PD in the RP elected to enroll in the optional CP.|37
250621|NCT01013753|607700|P1|NOT COMPLETED|Overall Study||16
250622|NCT01013753|607700|P1|COMPLETED|Overall Study||182
250623|NCT01013753|607700|P1|Received Form 12 mcg Bid|Overall Study||125
250624|NCT01013753|607700|P1|Received Olo 20 mcg qd|Overall Study||124
250625|NCT01013753|607700|P1|Received Olo 10 mcg qd|Overall Study||127
250626|NCT01013753|607700|P1|Received Olo 5 mcg qd|Overall Study||130
250627|NCT01013753|607700|P1|Received Olo 2 mcg qd|Overall Study||121
250628|NCT01013753|607700|P1|Received Placebo|Overall Study||125
250629|NCT01013753|607700|P1|STARTED|Overall Study|Entered and treated|198
250630|NCT01013792|607896|P2|NOT COMPLETED|Overall Study||5
250631|NCT01013792|607897|P1|NOT COMPLETED|Overall Study||2
250632|NCT01013792|607896|P2|COMPLETED|Overall Study||11
250633|NCT01013792|607897|P1|COMPLETED|Overall Study||12
250634|NCT01013792|607896|P2|STARTED|Overall Study||16
250635|NCT01013792|607897|P1|STARTED|Overall Study||14
250636|NCT01013844|607905|P2|NOT COMPLETED|Overall Study||0
250637|NCT01013844|607906|P1|NOT COMPLETED|Overall Study||0
250638|NCT01013844|607905|P2|COMPLETED|Overall Study||65
250639|NCT01013844|607906|P1|COMPLETED|Overall Study||65
250640|NCT01013844|607905|P2|STARTED|Overall Study||65
250641|NCT01013844|607906|P1|STARTED|Overall Study||65
250642|NCT01013870|607930|P2|NOT COMPLETED|Overall Study||3
250643|NCT01013870|607931|P1|NOT COMPLETED|Overall Study||1
250644|NCT01013870|607930|P2|COMPLETED|Overall Study||21
250645|NCT01013870|607931|P1|COMPLETED|Overall Study||27
250646|NCT01013870|607930|P2|STARTED|Overall Study||24
250647|NCT01013870|607931|P1|STARTED|Overall Study||28
250648|NCT01013883|607955|P2|NOT COMPLETED|Overall Study||2
250649|NCT01013883|607956|P1|NOT COMPLETED|Overall Study||2
250650|NCT01013883|607955|P2|COMPLETED|Overall Study||241
250651|NCT01013883|607956|P1|COMPLETED|Overall Study||268
250652|NCT01013883|607955|P2|STARTED|Overall Study||243
250653|NCT01013883|607956|P1|STARTED|Overall Study||270
250654|NCT01013961|607968|P2|NOT COMPLETED|Overall Study||3
250655|NCT01013961|607969|P1|NOT COMPLETED|Overall Study||3
250656|NCT01013961|607968|P2|COMPLETED|Overall Study||12
250657|NCT01013961|607969|P1|COMPLETED|Overall Study||13
250658|NCT01013961|607968|P2|STARTED|Overall Study||15
250659|NCT01013961|607969|P1|STARTED|Overall Study||16
250660|NCT01014013|607987|P2|NOT COMPLETED|Overall Study||56
250661|NCT01014013|607988|P1|NOT COMPLETED|Overall Study||51
250662|NCT01014013|607987|P2|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of Ceftriaxone parentheral therapy|80
250663|NCT01014013|607988|P1|COMPLETED|Overall Study|Patients who completed 7 days therapy including minimum 3 days of MK0826 parentheral therapy|84
250664|NCT01014013|607987|P2|Completed Parenteral Therapy|Overall Study|Patients completing Ceftriaxone as a single daily dose of 2.0g intravenous infusion at least 3 days|88
250665|NCT01014013|607988|P1|Completed Parenteral Therapy|Overall Study|"Patients completing MK0826 as a single daily dose of 1.0g intravenous
infusion at least 3 days"|87
250666|NCT01014013|607987|P2|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of Ceftriaxone parenteral therapy|135
250667|NCT01014013|607988|P1|Adverse Event Reporting|Overall Study|Patients who received at least 1 dose of MK0826 parenteral therapy|132
250668|NCT01014013|607987|P2|STARTED|Overall Study||136
250669|NCT01014013|607988|P1|STARTED|Overall Study||135
250670|NCT01014091|608004|P6|NOT COMPLETED|Overall Study||0
250671|NCT01014091|608005|P5|NOT COMPLETED|Overall Study||0
250672|NCT01014091|608006|P4|NOT COMPLETED|Overall Study||0
250673|NCT01014091|608007|P3|NOT COMPLETED|Overall Study||0
250674|NCT01014091|608008|P2|NOT COMPLETED|Overall Study||0
250675|NCT01014091|608009|P1|NOT COMPLETED|Overall Study||0
250676|NCT01014091|608004|P6|COMPLETED|Overall Study||12
250677|NCT01014091|608005|P5|COMPLETED|Overall Study||6
250678|NCT01014091|608006|P4|COMPLETED|Overall Study||15
250679|NCT01014091|608007|P3|COMPLETED|Overall Study||5
250680|NCT01014091|608008|P2|COMPLETED|Overall Study||13
250681|NCT01014091|608009|P1|COMPLETED|Overall Study||7
250682|NCT01014091|608004|P6|STARTED|Overall Study||12
250683|NCT01014091|608005|P5|STARTED|Overall Study||6
250684|NCT01014091|608006|P4|STARTED|Overall Study||15
250685|NCT01014091|608007|P3|STARTED|Overall Study||5
250686|NCT01014091|608008|P2|STARTED|Overall Study||13
250687|NCT01014091|608009|P1|STARTED|Overall Study||7
250688|NCT01014143|608086|P3|NOT COMPLETED|Third Intervention||0
250689|NCT01014143|608087|P2|NOT COMPLETED|Third Intervention||0
250690|NCT01014143|608088|P1|NOT COMPLETED|Third Intervention||0
250691|NCT01014143|608086|P3|COMPLETED|Third Intervention||9
250692|NCT01014143|608087|P2|COMPLETED|Third Intervention||9
250693|NCT01014143|608088|P1|COMPLETED|Third Intervention||8
250694|NCT01014143|608086|P3|STARTED|Third Intervention||9
250695|NCT01014143|608087|P2|STARTED|Third Intervention||9
250696|NCT01014143|608088|P1|STARTED|Third Intervention||8
250697|NCT01014143|608086|P3|NOT COMPLETED|Washout After 2nd Intervention||0
250698|NCT01014143|608087|P2|NOT COMPLETED|Washout After 2nd Intervention||0
250699|NCT01014143|608088|P1|NOT COMPLETED|Washout After 2nd Intervention||0
250700|NCT01014143|608086|P3|COMPLETED|Washout After 2nd Intervention||9
250701|NCT01014143|608087|P2|COMPLETED|Washout After 2nd Intervention||9
250702|NCT01014143|608088|P1|COMPLETED|Washout After 2nd Intervention||8
250703|NCT01014143|608086|P3|STARTED|Washout After 2nd Intervention||9
250704|NCT01014143|608087|P2|STARTED|Washout After 2nd Intervention||9
250705|NCT01014143|608088|P1|STARTED|Washout After 2nd Intervention||8
250706|NCT01014143|608086|P3|NOT COMPLETED|Second Intervention||0
250707|NCT01014143|608087|P2|NOT COMPLETED|Second Intervention||0
250708|NCT01014143|608088|P1|NOT COMPLETED|Second Intervention||2
250709|NCT01014143|608086|P3|COMPLETED|Second Intervention||9
250710|NCT01014143|608087|P2|COMPLETED|Second Intervention||9
250711|NCT01014143|608088|P1|COMPLETED|Second Intervention||8
250712|NCT01014143|608086|P3|STARTED|Second Intervention||9
250713|NCT01014143|608087|P2|STARTED|Second Intervention||9
250714|NCT01014143|608088|P1|STARTED|Second Intervention||10
250715|NCT01014143|608086|P3|NOT COMPLETED|Washout Period After 1st Intervention||0
250716|NCT01014143|608087|P2|NOT COMPLETED|Washout Period After 1st Intervention||0
250717|NCT01014143|608088|P1|NOT COMPLETED|Washout Period After 1st Intervention||0
250718|NCT01014143|608086|P3|COMPLETED|Washout Period After 1st Intervention||9
250719|NCT01014143|608087|P2|COMPLETED|Washout Period After 1st Intervention||9
250720|NCT01014143|608088|P1|COMPLETED|Washout Period After 1st Intervention||10
250721|NCT01014143|608086|P3|STARTED|Washout Period After 1st Intervention||9
250722|NCT01014143|608087|P2|STARTED|Washout Period After 1st Intervention||9
250723|NCT01014143|608088|P1|STARTED|Washout Period After 1st Intervention||10
250724|NCT01014143|608086|P3|NOT COMPLETED|First Intervention||0
250725|NCT01014143|608087|P2|NOT COMPLETED|First Intervention||0
250726|NCT01014143|608088|P1|NOT COMPLETED|First Intervention||0
250727|NCT01014143|608086|P3|COMPLETED|First Intervention||9
250728|NCT01014143|608087|P2|COMPLETED|First Intervention||9
250729|NCT01014143|608088|P1|COMPLETED|First Intervention||10
250730|NCT01014143|608086|P3|STARTED|First Intervention||9
250731|NCT01014143|608087|P2|STARTED|First Intervention||9
250732|NCT01014143|608088|P1|STARTED|First Intervention||10
250733|NCT01014169|608098|P2|NOT COMPLETED|Overall Study||13
250734|NCT01014169|608099|P1|NOT COMPLETED|Overall Study||7
250735|NCT01014169|608098|P2|COMPLETED|Overall Study||48
250736|NCT01014169|608099|P1|COMPLETED|Overall Study||58
250737|NCT01014169|608098|P2|STARTED|Overall Study||61
250738|NCT01014169|608099|P1|STARTED|Overall Study||65
250739|NCT01014208|608111|P2|NOT COMPLETED|Overall Study||100
250740|NCT01014208|608112|P1|NOT COMPLETED|Overall Study||94
250741|NCT01014208|608111|P2|COMPLETED|Overall Study||122
250742|NCT01014208|608112|P1|COMPLETED|Overall Study||131
250743|NCT01014208|608111|P2|Intent-to-Treat Population|Overall Study||222
250744|NCT01014208|608112|P1|Intent-to-Treat Population|Overall Study||223
250745|NCT01014208|608111|P2|STARTED|Overall Study||222
250746|NCT01014208|608112|P1|STARTED|Overall Study||225
250747|NCT01014351|608138|P1|NOT COMPLETED|Overall Study||37
250748|NCT01014351|608138|P1|COMPLETED|Overall Study||33
250749|NCT01014351|608138|P1|STARTED|Overall Study||70
250750|NCT01014442|608146|P2|NOT COMPLETED|Overall Study||19
250751|NCT01014442|608147|P1|NOT COMPLETED|Overall Study||7
250752|NCT01014442|608146|P2|COMPLETED|Overall Study||16
250753|NCT01014442|608147|P1|COMPLETED|Overall Study||26
250754|NCT01014442|608146|P2|STARTED|Overall Study||35
250755|NCT01014442|608147|P1|STARTED|Overall Study||33
250756|NCT01014455|608261|P2|NOT COMPLETED|Overall Study||0
250757|NCT01014455|608262|P1|NOT COMPLETED|Overall Study||0
250758|NCT01014455|608261|P2|COMPLETED|Overall Study||87
250759|NCT01014455|608262|P1|COMPLETED|Overall Study||82
250760|NCT01014455|608261|P2|STARTED|Overall Study||87
250761|NCT01014455|608262|P1|STARTED|Overall Study||82
250762|NCT01014585|608272|P4|NOT COMPLETED|Overall Study||30
250763|NCT01014585|608273|P3|NOT COMPLETED|Overall Study||23
250764|NCT01014585|608274|P2|NOT COMPLETED|Overall Study||25
250765|NCT01014585|608275|P1|NOT COMPLETED|Overall Study||20
250766|NCT01014585|608272|P4|COMPLETED|Overall Study||99
250767|NCT01014585|608273|P3|COMPLETED|Overall Study||37
250768|NCT01014585|608274|P2|COMPLETED|Overall Study||75
250769|NCT01014585|608275|P1|COMPLETED|Overall Study||31
250770|NCT01014585|608272|P4|STARTED|Overall Study||129
250771|NCT01014585|608273|P3|STARTED|Overall Study||60
250772|NCT01014585|608274|P2|STARTED|Overall Study||100
250773|NCT01014585|608275|P1|STARTED|Overall Study||51
250774|NCT01014624|608295|P2|NOT COMPLETED|Overall Study||1
250775|NCT01014624|608296|P1|NOT COMPLETED|Overall Study||2
250776|NCT01014624|608295|P2|COMPLETED|Overall Study||26
250777|NCT01014624|608296|P1|COMPLETED|Overall Study||27
250778|NCT01014624|608295|P2|STARTED|Overall Study||27
250779|NCT01014624|608296|P1|STARTED|Overall Study||29
250780|NCT01014689|608318|P2|NOT COMPLETED|Overall Study||13
250781|NCT01014689|608319|P1|NOT COMPLETED|Overall Study||13
250782|NCT01014689|608318|P2|COMPLETED|Overall Study||174
250783|NCT01014689|608319|P1|COMPLETED|Overall Study||178
250784|NCT01014689|608318|P2|STARTED|Overall Study||187
250785|NCT01014689|608319|P1|STARTED|Overall Study||191
250786|NCT01014728|608329|P2|NOT COMPLETED|Overall Study||0
250787|NCT01014728|608330|P1|NOT COMPLETED|Overall Study||0
250788|NCT01014728|608329|P2|COMPLETED|Overall Study||15
250789|NCT01014728|608330|P1|COMPLETED|Overall Study||18
250790|NCT01014728|608329|P2|STARTED|Overall Study||15
250791|NCT01014728|608330|P1|STARTED|Overall Study||18
250792|NCT01014741|608342|P2|NOT COMPLETED|Overall Study||5
250793|NCT01014741|608343|P1|NOT COMPLETED|Overall Study||11
250794|NCT01014741|608342|P2|COMPLETED|Overall Study||90
250795|NCT01014741|608343|P1|COMPLETED|Overall Study||94
250796|NCT01014741|608342|P2|STARTED|Overall Study||95
250797|NCT01014741|608343|P1|STARTED|Overall Study||105
250798|NCT01014871|608355|P1|NOT COMPLETED|Overall Study||0
250799|NCT01014871|608355|P1|COMPLETED|Overall Study||30
250800|NCT01014871|608355|P1|STARTED|Overall Study||30
250801|NCT01014910|608363|P2|NOT COMPLETED|Overall Study||2
250802|NCT01014910|608364|P1|NOT COMPLETED|Overall Study||0
250803|NCT01014910|608363|P2|COMPLETED|Overall Study||79
250804|NCT01014910|608364|P1|COMPLETED|Overall Study||80
250805|NCT01014910|608363|P2|STARTED|Overall Study||81
250806|NCT01014910|608364|P1|STARTED|Overall Study||80
250807|NCT01014936|608375|P3|NOT COMPLETED|Overall Study||0
250808|NCT01014936|608376|P2|NOT COMPLETED|Overall Study||0
250809|NCT01014936|608377|P1|NOT COMPLETED|Overall Study||0
250810|NCT01014936|608375|P3|COMPLETED|Overall Study||62
250811|NCT01014936|608376|P2|COMPLETED|Overall Study||45
250812|NCT01014936|608377|P1|COMPLETED|Overall Study||42
250813|NCT01014936|608375|P3|STARTED|Overall Study||62
250814|NCT01014936|608376|P2|STARTED|Overall Study||45
250815|NCT01014936|608377|P1|STARTED|Overall Study||42
250816|NCT01014975|608867|P3|NOT COMPLETED|Overall Study||6
250817|NCT01014975|608868|P2|NOT COMPLETED|Overall Study||3
250818|NCT01014975|608869|P1|NOT COMPLETED|Overall Study||4
250819|NCT01014975|608867|P3|COMPLETED|Overall Study||10
250820|NCT01014975|608868|P2|COMPLETED|Overall Study||13
250821|NCT01014975|608869|P1|COMPLETED|Overall Study||4
250822|NCT01014975|608867|P3|STARTED|Overall Study||16
250823|NCT01014975|608868|P2|STARTED|Overall Study||16
250824|NCT01014975|608869|P1|STARTED|Overall Study||8
250825|NCT01014988|608883|P6|NOT COMPLETED|Overall Study||3
250826|NCT01014988|608884|P5|NOT COMPLETED|Overall Study||1
250827|NCT01014988|608885|P4|NOT COMPLETED|Overall Study||0
250828|NCT01014988|608886|P3|NOT COMPLETED|Overall Study||2
250829|NCT01014988|608887|P2|NOT COMPLETED|Overall Study||0
250830|NCT01014988|608888|P1|NOT COMPLETED|Overall Study||23
250831|NCT01014988|608883|P6|COMPLETED|Overall Study||11
250832|NCT01014988|608884|P5|COMPLETED|Overall Study||26
250833|NCT01014988|608885|P4|COMPLETED|Overall Study||12
250834|NCT01014988|608886|P3|COMPLETED|Overall Study||9
250835|NCT01014988|608887|P2|COMPLETED|Overall Study||7
250836|NCT01014988|608888|P1|COMPLETED|Overall Study||107
250837|NCT01014988|608883|P6|STARTED|Overall Study||14
250838|NCT01014988|608884|P5|STARTED|Overall Study||27
250839|NCT01014988|608885|P4|STARTED|Overall Study||12
250840|NCT01014988|608886|P3|STARTED|Overall Study||11
250841|NCT01014988|608887|P2|STARTED|Overall Study||7
250842|NCT01014988|608888|P1|STARTED|Overall Study||130
250843|NCT01015118|609062|P2|NOT COMPLETED|Overall Study||314
250844|NCT01015118|609063|P1|NOT COMPLETED|Overall Study||641
250845|NCT01015118|609062|P2|COMPLETED|Overall Study|Patients completed according to protocol and Patients on treatment are considered to be completed.|141
250846|NCT01015118|609063|P1|COMPLETED|Overall Study|Patients completed according to protocol and Patients on treatment are considered to be completed.|270
250847|NCT01015118|609062|P2|STARTED|Overall Study||455
250848|NCT01015118|609063|P1|STARTED|Overall Study||911
250849|NCT01015131|609081|P1|NOT COMPLETED|Overall Study||8
250850|NCT01015131|609081|P1|COMPLETED|Overall Study||36
250851|NCT01015131|609081|P1|STARTED|Overall Study||44
250852|NCT01015170|609095|P1|NOT COMPLETED|Overall Study||239
250853|NCT01015170|609095|P1|COMPLETED|Overall Study||215
250854|NCT01015170|609095|P1|STARTED|Overall Study||454
250855|NCT01015287|609103|P2|NOT COMPLETED|Overall Study||79
250856|NCT01015287|609104|P1|NOT COMPLETED|Overall Study||72
250857|NCT01015287|609103|P2|COMPLETED|Overall Study||1958
250858|NCT01015287|609104|P1|COMPLETED|Overall Study||1924
250859|NCT01015287|609103|P2|Received at Least 1 Dose of Study Drug|Overall Study||2037
250860|NCT01015287|609104|P1|Received at Least 1 Dose of Study Drug|Overall Study||1996
250861|NCT01015287|609103|P2|STARTED|Overall Study||2037
250862|NCT01015287|609104|P1|STARTED|Overall Study||1996
250863|NCT01015326|609132|P2|NOT COMPLETED|Overall Study||2
250864|NCT01015326|609133|P1|NOT COMPLETED|Overall Study||1
250865|NCT01015326|609132|P2|COMPLETED|Overall Study||18
250866|NCT01015326|609133|P1|COMPLETED|Overall Study||11
250867|NCT01015326|609132|P2|STARTED|Overall Study||20
250868|NCT01015326|609133|P1|STARTED|Overall Study||12
250869|NCT01015443|609141|P2|NOT COMPLETED|Overall Study||0
250870|NCT01015443|609142|P1|NOT COMPLETED|Overall Study||0
250871|NCT01015443|609141|P2|COMPLETED|Overall Study||94
250872|NCT01015443|609142|P1|COMPLETED|Overall Study||191
250873|NCT01015443|609141|P2|Treated|Overall Study||93
250874|NCT01015443|609142|P1|Treated|Overall Study||191
250875|NCT01015443|609141|P2|STARTED|Overall Study||94
250876|NCT01015443|609142|P1|STARTED|Overall Study||191
250877|NCT01015534|609160|P2|NOT COMPLETED|Overall Study||0
250878|NCT01015534|609161|P1|NOT COMPLETED|Overall Study||1
250879|NCT01015534|609160|P2|COMPLETED|Overall Study||27
250880|NCT01015534|609161|P1|COMPLETED|Overall Study||27
250881|NCT01015534|609160|P2|STARTED|Overall Study||27
250882|NCT01015534|609161|P1|STARTED|Overall Study||28
250883|NCT01015560|609173|P1|NOT COMPLETED|Overall Study||3
250884|NCT01015560|609173|P1|COMPLETED|Overall Study||41
250885|NCT01015560|609173|P1|Eligible and Analyzable|Overall Study||43
250886|NCT01015560|609173|P1|STARTED|Overall Study||44
250887|NCT01015638|609179|P2|NOT COMPLETED|Overall Study||0
250888|NCT01015638|609180|P1|NOT COMPLETED|Overall Study||1
250889|NCT01015638|609179|P2|COMPLETED|Overall Study||19
250890|NCT01015638|609180|P1|COMPLETED|Overall Study||16
250891|NCT01015638|609179|P2|STARTED|Overall Study||19
250892|NCT01015638|609180|P1|STARTED|Overall Study||17
250893|NCT01015677|609211|P3|NOT COMPLETED|Overall Study||0
250894|NCT01015677|609212|P2|NOT COMPLETED|Overall Study||4
250895|NCT01015677|609213|P1|NOT COMPLETED|Overall Study||1
250896|NCT01015677|609211|P3|COMPLETED|Overall Study||33
250897|NCT01015677|609212|P2|COMPLETED|Overall Study||28
250898|NCT01015677|609213|P1|COMPLETED|Overall Study||33
250899|NCT01015677|609211|P3|STARTED|Overall Study||33
250900|NCT01015677|609212|P2|STARTED|Overall Study||32
250901|NCT01015677|609213|P1|STARTED|Overall Study||34
250902|NCT01015703|609238|P5|NOT COMPLETED|Overall Study||0
250903|NCT01015703|609239|P4|NOT COMPLETED|Overall Study||0
250904|NCT01015703|609240|P3|NOT COMPLETED|Overall Study||0
250905|NCT01015703|609241|P2|NOT COMPLETED|Overall Study||1
250906|NCT01015703|609242|P1|NOT COMPLETED|Overall Study||2
250907|NCT01015703|609238|P5|COMPLETED|Overall Study||10
250908|NCT01015703|609239|P4|COMPLETED|Overall Study||10
250909|NCT01015703|609240|P3|COMPLETED|Overall Study||10
250910|NCT01015703|609241|P2|COMPLETED|Overall Study||9
250911|NCT01015703|609242|P1|COMPLETED|Overall Study||8
250912|NCT01015703|609238|P5|STARTED|Overall Study||10
250913|NCT01015703|609239|P4|STARTED|Overall Study||10
250914|NCT01015703|609240|P3|STARTED|Overall Study||10
250915|NCT01015703|609241|P2|STARTED|Overall Study||10
250916|NCT01015703|609242|P1|STARTED|Overall Study||10
250917|NCT01015781|609256|P2|NOT COMPLETED|Overall Study||29
250918|NCT01015781|609257|P1|NOT COMPLETED|Overall Study||37
250919|NCT01015781|609256|P2|COMPLETED|Overall Study||121
250920|NCT01015781|609257|P1|COMPLETED|Overall Study||113
250921|NCT01015781|609256|P2|STARTED|Overall Study||150
250922|NCT01015781|609257|P1|STARTED|Overall Study||150
250923|NCT01015807|609266|P3|NOT COMPLETED|Overall Study||0
250924|NCT01015807|609267|P2|NOT COMPLETED|Overall Study||0
250925|NCT01015807|609268|P1|NOT COMPLETED|Overall Study||0
250926|NCT01015807|609266|P3|COMPLETED|Overall Study||30
250927|NCT01015807|609267|P2|COMPLETED|Overall Study||30
250928|NCT01015807|609268|P1|COMPLETED|Overall Study||30
250929|NCT01015807|609266|P3|STARTED|Overall Study||30
250930|NCT01015807|609267|P2|STARTED|Overall Study||30
250931|NCT01015807|609268|P1|STARTED|Overall Study||30
250932|NCT01015820|609278|P2|NOT COMPLETED|Overall Study||0
250933|NCT01015820|609279|P1|NOT COMPLETED|Overall Study||1
250934|NCT01015820|609278|P2|COMPLETED|Overall Study||15
250935|NCT01015820|609279|P1|COMPLETED|Overall Study||14
250936|NCT01015820|609278|P2|STARTED|Overall Study||15
250937|NCT01015820|609279|P1|STARTED|Overall Study||15
250938|NCT01015976|609287|P2|NOT COMPLETED|Overall Study||0
250939|NCT01015976|609288|P1|NOT COMPLETED|Overall Study||0
250940|NCT01015976|609287|P2|COMPLETED|Overall Study||5
250941|NCT01015976|609288|P1|COMPLETED|Overall Study||5
250942|NCT01015976|609287|P2|STARTED|Overall Study||5
250943|NCT01015976|609288|P1|STARTED|Overall Study||5
250944|NCT01016015|609292|P1|NOT COMPLETED|Overall Study||19
250945|NCT01016015|609292|P1|COMPLETED|Overall Study||159
250946|NCT01016015|609292|P1|STARTED|Overall Study||178
250947|NCT01016067|609298|P2|NOT COMPLETED|Overall Study||4
250948|NCT01016067|609299|P1|NOT COMPLETED|Overall Study||2
250949|NCT01016067|609298|P2|COMPLETED|Overall Study||8
250950|NCT01016067|609299|P1|COMPLETED|Overall Study||9
250951|NCT01016067|609298|P2|STARTED|Overall Study||12
250952|NCT01016067|609299|P1|STARTED|Overall Study||11
250953|NCT01016106|609319|P2|NOT COMPLETED|Overall Study||0
250954|NCT01016106|609320|P1|NOT COMPLETED|Overall Study||0
250955|NCT01016106|609319|P2|COMPLETED|Overall Study||18
250956|NCT01016106|609320|P1|COMPLETED|Overall Study||17
250957|NCT01016106|609319|P2|STARTED|Overall Study||18
250958|NCT01016106|609320|P1|STARTED|Overall Study||17
250959|NCT01016132|609326|P1|NOT COMPLETED|Overall Study||1
250960|NCT01016132|609326|P1|COMPLETED|Overall Study||151
250961|NCT01016132|609326|P1|STARTED|Overall Study||152
250962|NCT01017497|609330|P1|NOT COMPLETED|Overall Study||0
250963|NCT01017497|609330|P1|COMPLETED|Overall Study||49
250964|NCT01017497|609330|P1|STARTED|Overall Study||49
250965|NCT01017536|609345|P2|NOT COMPLETED|Overall Study||0
250966|NCT01017536|609346|P1|NOT COMPLETED|Overall Study||0
250967|NCT01017536|609345|P2|COMPLETED|Overall Study||13
250968|NCT01017536|609346|P1|COMPLETED|Overall Study||13
250969|NCT01017536|609345|P2|STARTED|Overall Study||13
250970|NCT01017536|609346|P1|STARTED|Overall Study||13
250971|NCT01017549|609356|P1|NOT COMPLETED|One-year Follow-up||7
250972|NCT01017549|609356|P1|COMPLETED|One-year Follow-up||36
250973|NCT01017549|609356|P1|STARTED|One-year Follow-up||43
250974|NCT01017549|609356|P1|NOT COMPLETED|Eligibility Through 6 Month Follow-up||1
250975|NCT01017549|609356|P1|COMPLETED|Eligibility Through 6 Month Follow-up|6 month follow-up complete Oct 2008; data through 6 months and 1 year are published.|43
250976|NCT01017549|609356|P1|STARTED|Eligibility Through 6 Month Follow-up||44
250977|NCT01017575|609366|P5|NOT COMPLETED|Overall Study||3
250978|NCT01017575|609367|P4|NOT COMPLETED|Overall Study||1
250979|NCT01017575|609368|P3|NOT COMPLETED|Overall Study||0
250980|NCT01017575|609369|P2|NOT COMPLETED|Overall Study||2
250981|NCT01017575|609370|P1|NOT COMPLETED|Overall Study||1
250982|NCT01017575|609366|P5|COMPLETED|Overall Study||6
250983|NCT01017575|609367|P4|COMPLETED|Overall Study||7
250984|NCT01017575|609368|P3|COMPLETED|Overall Study||8
250985|NCT01017575|609369|P2|COMPLETED|Overall Study||7
250986|NCT01017575|609370|P1|COMPLETED|Overall Study||7
250987|NCT01017575|609366|P5|STARTED|Overall Study||9
250988|NCT01017575|609367|P4|STARTED|Overall Study||8
250989|NCT01017575|609368|P3|STARTED|Overall Study||8
250990|NCT01017575|609369|P2|STARTED|Overall Study||9
250991|NCT01017575|609370|P1|STARTED|Overall Study||8
250992|NCT01017601|609409|P2|NOT COMPLETED|Overall Study||13
250993|NCT01017601|609410|P1|NOT COMPLETED|Overall Study||12
250994|NCT01017601|609409|P2|COMPLETED|Overall Study||11
250995|NCT01017601|609410|P1|COMPLETED|Overall Study||14
250996|NCT01017601|609409|P2|STARTED|Overall Study||24
250997|NCT01017601|609410|P1|STARTED|Overall Study||26
250998|NCT01017653|609432|P1|NOT COMPLETED|Overall Study||0
250999|NCT01017653|609432|P1|COMPLETED|Overall Study||16
251000|NCT01017653|609432|P1|STARTED|Overall Study||16
251001|NCT01017731|609442|P1|NOT COMPLETED|Overall Study||8
251002|NCT01017731|609442|P1|COMPLETED|Overall Study||60
251003|NCT01017731|609442|P1|Received at Least 1 Dose of Study Drug|Overall Study||66
251004|NCT01017731|609442|P1|STARTED|Overall Study||68
251005|NCT01017874|609461|P2|NOT COMPLETED|Overall Study||26
251006|NCT01017874|609462|P1|NOT COMPLETED|Overall Study||30
251007|NCT01017874|609461|P2|COMPLETED|Overall Study||92
251008|NCT01017874|609462|P1|COMPLETED|Overall Study||88
251009|NCT01017874|609461|P2|Received at Least 1 Dose of Study Drug|Overall Study||118
251010|NCT01017874|609462|P1|Received at Least 1 Dose of Study Drug|Overall Study||114
251011|NCT01017874|609461|P2|STARTED|Overall Study||118
251012|NCT01017874|609462|P1|STARTED|Overall Study||118
251013|NCT01017952|609484|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||103
251014|NCT01017952|609485|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||112
251015|NCT01017952|609486|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||109
251016|NCT01017952|609487|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||125
251017|NCT01017952|609488|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
251018|NCT01017952|609484|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|306
251019|NCT01017952|609485|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|291
251020|NCT01017952|609486|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|303
251021|NCT01017952|609487|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|284
251022|NCT01017952|609488|P1|COMPLETED|52-week, Double-blind Treatment Period||0
251023|NCT01017952|609484|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|307
251024|NCT01017952|609485|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|293
251025|NCT01017952|609486|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|305
251026|NCT01017952|609487|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|285
251027|NCT01017952|609488|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
251028|NCT01017952|609484|P5|STARTED|52-week, Double-blind Treatment Period||409
251029|NCT01017952|609485|P4|STARTED|52-week, Double-blind Treatment Period||403
251030|NCT01017952|609486|P3|STARTED|52-week, Double-blind Treatment Period||412
251031|NCT01017952|609487|P2|STARTED|52-week, Double-blind Treatment Period||409
251032|NCT01017952|609488|P1|STARTED|52-week, Double-blind Treatment Period||0
251033|NCT01017952|609484|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
251034|NCT01017952|609485|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
251035|NCT01017952|609486|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
251036|NCT01017952|609487|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
251037|NCT01017952|609488|P1|NOT COMPLETED|4-week, Open-label Run-In Period||459
251038|NCT01017952|609484|P5|COMPLETED|4-week, Open-label Run-In Period||0
251039|NCT01017952|609485|P4|COMPLETED|4-week, Open-label Run-In Period||0
251040|NCT01017952|609486|P3|COMPLETED|4-week, Open-label Run-In Period||0
251041|NCT01017952|609487|P2|COMPLETED|4-week, Open-label Run-In Period||0
251042|NCT01017952|609488|P1|COMPLETED|4-week, Open-label Run-In Period||1633
251043|NCT01017952|609484|P5|STARTED|4-week, Open-label Run-In Period||0
251044|NCT01017952|609485|P4|STARTED|4-week, Open-label Run-In Period||0
251045|NCT01017952|609486|P3|STARTED|4-week, Open-label Run-In Period||0
251046|NCT01017952|609487|P2|STARTED|4-week, Open-label Run-In Period||0
251047|NCT01017952|609488|P1|STARTED|4-week, Open-label Run-In Period||2092
251048|NCT01018030|609513|P3|NOT COMPLETED|Overall Study||13
251049|NCT01018030|609514|P2|NOT COMPLETED|Overall Study||11
251050|NCT01018030|609515|P1|NOT COMPLETED|Overall Study||19
251051|NCT01018030|609513|P3|COMPLETED|Overall Study||239
251052|NCT01018030|609514|P2|COMPLETED|Overall Study||232
251053|NCT01018030|609515|P1|COMPLETED|Overall Study||227
251054|NCT01018030|609513|P3|STARTED|Overall Study||252
251055|NCT01018030|609514|P2|STARTED|Overall Study||243
251056|NCT01018030|609515|P1|STARTED|Overall Study||246
251057|NCT01018056|609565|P3|NOT COMPLETED|Overall Study||1
251058|NCT01018056|609566|P2|NOT COMPLETED|Overall Study||2
251059|NCT01018056|609567|P1|NOT COMPLETED|Overall Study||3
251060|NCT01018056|609565|P3|COMPLETED|Overall Study||5
251061|NCT01018056|609566|P2|COMPLETED|Overall Study||10
251062|NCT01018056|609567|P1|COMPLETED|Overall Study||9
251063|NCT01018056|609565|P3|STARTED|Overall Study||6
251064|NCT01018056|609566|P2|STARTED|Overall Study||12
251065|NCT01018056|609567|P1|STARTED|Overall Study||12
251066|NCT01018095|609601|P2|NOT COMPLETED|Overall Study||62
251067|NCT01018095|609602|P1|NOT COMPLETED|Overall Study||56
251068|NCT01018095|609601|P2|COMPLETED|Overall Study||73
251069|NCT01018095|609602|P1|COMPLETED|Overall Study||79
251070|NCT01018095|609601|P2|STARTED|Overall Study||135
251071|NCT01018095|609602|P1|STARTED|Overall Study||135
251072|NCT01018134|609616|P6|NOT COMPLETED|Overall Study||0
251073|NCT01018134|609617|P5|NOT COMPLETED|Overall Study||0
251074|NCT01018134|609618|P4|NOT COMPLETED|Overall Study||0
251075|NCT01018134|609619|P3|NOT COMPLETED|Overall Study||1
251076|NCT01018134|609620|P2|NOT COMPLETED|Overall Study||1
251077|NCT01018134|609621|P1|NOT COMPLETED|Overall Study||0
251078|NCT01018134|609616|P6|COMPLETED|Overall Study||15
251079|NCT01018134|609617|P5|COMPLETED|Overall Study||15
251080|NCT01018134|609618|P4|COMPLETED|Overall Study||29
251081|NCT01018134|609619|P3|COMPLETED|Overall Study||29
251082|NCT01018134|609620|P2|COMPLETED|Overall Study||30
251083|NCT01018134|609621|P1|COMPLETED|Overall Study||30
251084|NCT01018134|609616|P6|STARTED|Overall Study||15
251085|NCT01018134|609617|P5|STARTED|Overall Study||15
251086|NCT01018134|609618|P4|STARTED|Overall Study|30 enrolled patients, one who did not use the study medication was excluded from all analyses|29
251087|NCT01018134|609619|P3|STARTED|Overall Study||30
251088|NCT01018134|609620|P2|STARTED|Overall Study||31
251089|NCT01018134|609621|P1|STARTED|Overall Study||30
251090|NCT01018186|609662|P4|NOT COMPLETED|52-week Double-blind Treatment Period||29
251091|NCT01018186|609663|P3|NOT COMPLETED|52-week Double-blind Treatment Period||41
251092|NCT01018186|609664|P2|NOT COMPLETED|52-week Double-blind Treatment Period||40
251093|NCT01018186|609665|P1|NOT COMPLETED|52-week Double-blind Treatment Period||0
251094|NCT01018186|609662|P4|COMPLETED|52-week Double-blind Treatment Period||71
251095|NCT01018186|609663|P3|COMPLETED|52-week Double-blind Treatment Period||161
251096|NCT01018186|609664|P2|COMPLETED|52-week Double-blind Treatment Period||161
251097|NCT01018186|609665|P1|COMPLETED|52-week Double-blind Treatment Period||0
251098|NCT01018186|609662|P4|STARTED|52-week Double-blind Treatment Period||100
251099|NCT01018186|609663|P3|STARTED|52-week Double-blind Treatment Period||202
251100|NCT01018186|609664|P2|STARTED|52-week Double-blind Treatment Period||201
251101|NCT01018186|609665|P1|STARTED|52-week Double-blind Treatment Period||0
251102|NCT01018186|609662|P4|NOT COMPLETED|2-week Run-in Period||0
251103|NCT01018186|609663|P3|NOT COMPLETED|2-week Run-in Period||0
251104|NCT01018186|609664|P2|NOT COMPLETED|2-week Run-in Period||0
251105|NCT01018186|609665|P1|NOT COMPLETED|2-week Run-in Period||114
251106|NCT01018186|609662|P4|COMPLETED|2-week Run-in Period||0
251107|NCT01018186|609663|P3|COMPLETED|2-week Run-in Period||0
251108|NCT01018186|609664|P2|COMPLETED|2-week Run-in Period||0
251109|NCT01018186|609665|P1|COMPLETED|2-week Run-in Period||503
251110|NCT01018186|609662|P4|STARTED|2-week Run-in Period||0
251111|NCT01018186|609663|P3|STARTED|2-week Run-in Period||0
251112|NCT01018186|609664|P2|STARTED|2-week Run-in Period||0
251113|NCT01018186|609665|P1|STARTED|2-week Run-in Period||617
251114|NCT01018264|609753|P2|NOT COMPLETED|Overall Study||1
251115|NCT01018264|609754|P1|NOT COMPLETED|Overall Study||1
251116|NCT01018264|609753|P2|COMPLETED|Overall Study||12
251117|NCT01018264|609754|P1|COMPLETED|Overall Study||9
251118|NCT01018264|609753|P2|STARTED|Overall Study||13
251119|NCT01018264|609754|P1|STARTED|Overall Study||10
251120|NCT01018394|609770|P2|NOT COMPLETED|Overall Study||8
251121|NCT01018394|609771|P1|NOT COMPLETED|Overall Study||9
251122|NCT01018394|609770|P2|COMPLETED|Overall Study||33
251123|NCT01018394|609771|P1|COMPLETED|Overall Study||31
251124|NCT01018394|609770|P2|STARTED|Overall Study||41
251125|NCT01018394|609771|P1|STARTED|Overall Study||40
251126|NCT01018420|609781|P2|NOT COMPLETED|Overall Study||0
251127|NCT01018420|609782|P1|NOT COMPLETED|Overall Study||0
251128|NCT01018420|609781|P2|COMPLETED|Overall Study||3
251129|NCT01018420|609782|P1|COMPLETED|Overall Study||15
251130|NCT01018420|609781|P2|STARTED|Overall Study||3
251131|NCT01018420|609782|P1|STARTED|Overall Study||15
251132|NCT01018511|609811|P4|NOT COMPLETED|Overall Study||33
251133|NCT01018511|609812|P3|NOT COMPLETED|Overall Study||40
251134|NCT01018511|609813|P2|NOT COMPLETED|Overall Study||32
251135|NCT01018511|609814|P1|NOT COMPLETED|Overall Study||26
251136|NCT01018511|609811|P4|COMPLETED|Overall Study||294
251137|NCT01018511|609812|P3|COMPLETED|Overall Study||299
251138|NCT01018511|609813|P2|COMPLETED|Overall Study||295
251139|NCT01018511|609814|P1|COMPLETED|Overall Study||315
251140|NCT01018511|609811|P4|Randomized and Treated|Overall Study||324
251141|NCT01018511|609812|P3|Randomized and Treated|Overall Study||338
251142|NCT01018511|609813|P2|Randomized and Treated|Overall Study||326
251143|NCT01018511|609814|P1|Randomized and Treated|Overall Study||341
251144|NCT01018511|609811|P4|STARTED|Overall Study||327
251145|NCT01018511|609812|P3|STARTED|Overall Study||339
251146|NCT01018511|609813|P2|STARTED|Overall Study||327
251147|NCT01018511|609814|P1|STARTED|Overall Study||341
251148|NCT01018680|609983|P2|NOT COMPLETED|Overall Study||75
251149|NCT01018680|609984|P1|NOT COMPLETED|Overall Study||61
251150|NCT01018680|609983|P2|COMPLETED|Overall Study||189
251151|NCT01018680|609984|P1|COMPLETED|Overall Study||199
251152|NCT01018680|609983|P2|STARTED|Overall Study||264
251153|NCT01018680|609984|P1|STARTED|Overall Study||260
251154|NCT01018732|610027|P3|NOT COMPLETED|Overall Study||4
251155|NCT01018732|610028|P2|NOT COMPLETED|Overall Study||2
251156|NCT01018732|610029|P1|NOT COMPLETED|Overall Study||1
251157|NCT01018732|610027|P3|COMPLETED|Overall Study||50
251158|NCT01018732|610028|P2|COMPLETED|Overall Study||49
251159|NCT01018732|610029|P1|COMPLETED|Overall Study||49
251160|NCT01018732|610027|P3|STARTED|Overall Study||54
251161|NCT01018732|610028|P2|STARTED|Overall Study||51
251162|NCT01018732|610029|P1|STARTED|Overall Study||50
251163|NCT01018810|610066|P5|NOT COMPLETED|Overall Study||1
251164|NCT01018810|610067|P4|NOT COMPLETED|Overall Study||1
251165|NCT01018810|610068|P3|NOT COMPLETED|Overall Study||1
251166|NCT01018810|610069|P2|NOT COMPLETED|Overall Study||1
251167|NCT01018810|610070|P1|NOT COMPLETED|Overall Study||2
251168|NCT01018810|610066|P5|COMPLETED|Overall Study||0
251169|NCT01018810|610067|P4|COMPLETED|Overall Study||0
251170|NCT01018810|610068|P3|COMPLETED|Overall Study||0
251171|NCT01018810|610069|P2|COMPLETED|Overall Study||0
251172|NCT01018810|610070|P1|COMPLETED|Overall Study||2
251173|NCT01018810|610066|P5|STARTED|Overall Study||1
251174|NCT01018810|610067|P4|STARTED|Overall Study||1
251175|NCT01018810|610068|P3|STARTED|Overall Study||1
251176|NCT01018810|610069|P2|STARTED|Overall Study||1
251177|NCT01018810|610070|P1|STARTED|Overall Study||4
251178|NCT01018862|610130|P3|NOT COMPLETED|Overall Study||16
251179|NCT01018862|610131|P2|NOT COMPLETED|Overall Study||10
251180|NCT01018862|610132|P1|NOT COMPLETED|Overall Study||13
251181|NCT01018862|610130|P3|COMPLETED|Overall Study||146
251182|NCT01018862|610131|P2|COMPLETED|Overall Study||156
251183|NCT01018862|610132|P1|COMPLETED|Overall Study||148
251184|NCT01018862|610130|P3|STARTED|Overall Study||162
251185|NCT01018862|610131|P2|STARTED|Overall Study||166
251186|NCT01018862|610132|P1|STARTED|Overall Study||161
251187|NCT01018953|610149|P1|NOT COMPLETED|Overall Study||8
251188|NCT01018953|610149|P1|COMPLETED|Overall Study||0
251189|NCT01018953|610149|P1|BIM 23A760 4 mg|Overall Study||3
251190|NCT01018953|610149|P1|BIM 23A760 2 mg|Overall Study||2
251191|NCT01018953|610149|P1|BIM 23A760 1 mg|Overall Study||3
251192|NCT01018953|610149|P1|STARTED|Overall Study||8
251193|NCT01018979|610161|P2|NOT COMPLETED|Overall Study||10
251194|NCT01018979|610162|P1|NOT COMPLETED|Overall Study||3
251195|NCT01018979|610161|P2|COMPLETED|Overall Study||3
251196|NCT01018979|610162|P1|COMPLETED|Overall Study||4
251197|NCT01018979|610161|P2|Received at Least One Dose|Overall Study||12
251198|NCT01018979|610162|P1|Received at Least One Dose|Overall Study||7
251199|NCT01018979|610161|P2|STARTED|Overall Study|A total of 20 subjects were randomized.|13
251200|NCT01018979|610162|P1|STARTED|Overall Study||7
251201|NCT01018992|610194|P2|NOT COMPLETED|Overall Study||16
251202|NCT01018992|610195|P1|NOT COMPLETED|Overall Study||16
251203|NCT01018992|610194|P2|COMPLETED|Overall Study||49
251204|NCT01018992|610195|P1|COMPLETED|Overall Study||47
251205|NCT01018992|610194|P2|STARTED|Overall Study||65
251206|NCT01018992|610195|P1|STARTED|Overall Study||63
251207|NCT01019135|610210|P3|NOT COMPLETED|Overall Study||31
251208|NCT01019135|610211|P2|NOT COMPLETED|Overall Study||19
251209|NCT01019135|610212|P1|NOT COMPLETED|Overall Study||20
251210|NCT01019135|610210|P3|COMPLETED|Overall Study||24
251211|NCT01019135|610211|P2|COMPLETED|Overall Study||40
251212|NCT01019135|610212|P1|COMPLETED|Overall Study||35
251213|NCT01019135|610210|P3|STARTED|Overall Study||55
251214|NCT01019135|610211|P2|STARTED|Overall Study||59
251215|NCT01019135|610212|P1|STARTED|Overall Study||55
251216|NCT01019317|610238|P1|NOT COMPLETED|Overall Study||4
251217|NCT01019317|610238|P1|COMPLETED|Overall Study||147
251218|NCT01019317|610238|P1|STARTED|Overall Study||151
251219|NCT01019369|610244|P2|NOT COMPLETED|Overall Study||7
251220|NCT01019369|610245|P1|NOT COMPLETED|Overall Study||10
251221|NCT01019369|610244|P2|COMPLETED|Overall Study||39
251222|NCT01019369|610245|P1|COMPLETED|Overall Study||76
251223|NCT01019369|610244|P2|STARTED|Overall Study||46
251224|NCT01019369|610245|P1|STARTED|Overall Study||86
251225|NCT01019486|610254|P3|NOT COMPLETED|Overall Study||1
251226|NCT01019486|610255|P2|NOT COMPLETED|Overall Study||1
251227|NCT01019486|610256|P1|NOT COMPLETED|Overall Study||1
251228|NCT01019486|610254|P3|COMPLETED|Overall Study||15
251229|NCT01019486|610255|P2|COMPLETED|Overall Study||4
251230|NCT01019486|610256|P1|COMPLETED|Overall Study||4
251231|NCT01019486|610254|P3|STARTED|Overall Study||16
251232|NCT01019486|610255|P2|STARTED|Overall Study||5
251233|NCT01019486|610256|P1|STARTED|Overall Study||5
251234|NCT01019694|610271|P3|NOT COMPLETED|Overall Study||47
251235|NCT01019694|610272|P2|NOT COMPLETED|Overall Study||38
251236|NCT01019694|610273|P1|NOT COMPLETED|Overall Study||24
251237|NCT01019694|610271|P3|COMPLETED|Overall Study||110
251238|NCT01019694|610272|P2|COMPLETED|Overall Study||118
251239|NCT01019694|610273|P1|COMPLETED|Overall Study||133
251240|NCT01019694|610271|P3|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
251241|NCT01019694|610272|P2|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|156
251242|NCT01019694|610273|P1|STARTED|Overall Study|2 pats. in Comb. Inh. Aero. and 3 pats. in Atro+Alb not treated and excluded from the Treated Set|157
251243|NCT01019707|610395|P2|NOT COMPLETED|Second Phase||0
251244|NCT01019707|610396|P1|NOT COMPLETED|Second Phase||0
251245|NCT01019707|610395|P2|COMPLETED|Second Phase||1
251246|NCT01019707|610396|P1|COMPLETED|Second Phase||3
251247|NCT01019707|610395|P2|STARTED|Second Phase||1
251248|NCT01019707|610396|P1|STARTED|Second Phase||3
251249|NCT01019707|610395|P2|NOT COMPLETED|Washout||2
251250|NCT01019707|610396|P1|NOT COMPLETED|Washout||0
251251|NCT01019707|610395|P2|COMPLETED|Washout||1
251252|NCT01019707|610396|P1|COMPLETED|Washout||3
251253|NCT01019707|610395|P2|STARTED|Washout||3
251254|NCT01019707|610396|P1|STARTED|Washout||3
251255|NCT01019707|610395|P2|NOT COMPLETED|First Phase||0
251256|NCT01019707|610396|P1|NOT COMPLETED|First Phase||0
251257|NCT01019707|610395|P2|COMPLETED|First Phase||3
251258|NCT01019707|610396|P1|COMPLETED|First Phase||3
251259|NCT01019707|610395|P2|STARTED|First Phase||3
251260|NCT01019707|610396|P1|STARTED|First Phase||3
251261|NCT01007552|610406|P1|NOT COMPLETED|Overall Study||1
251262|NCT01007552|610406|P1|COMPLETED|Overall Study||49
251263|NCT01007552|610406|P1|STARTED|Overall Study||50
251264|NCT01007643|610418|P2|NOT COMPLETED|Overall Study||0
251265|NCT01007643|610419|P1|NOT COMPLETED|Overall Study||0
251266|NCT01007643|610418|P2|COMPLETED|Overall Study||14
251267|NCT01007643|610419|P1|COMPLETED|Overall Study||8
251268|NCT01007643|610418|P2|STARTED|Overall Study||14
251269|NCT01007643|610419|P1|STARTED|Overall Study||8
251270|NCT01007656|610425|P1|NOT COMPLETED|Overall Study||0
251271|NCT01007656|610425|P1|COMPLETED|Overall Study||31
251272|NCT01007656|610425|P1|STARTED|Overall Study||31
251273|NCT01007812|610443|P2|NOT COMPLETED|Period 2, One Week||0
251274|NCT01007812|610444|P1|NOT COMPLETED|Period 2, One Week||0
251275|NCT01007812|610443|P2|COMPLETED|Period 2, One Week||24
251276|NCT01007812|610444|P1|COMPLETED|Period 2, One Week||24
251277|NCT01007812|610443|P2|STARTED|Period 2, One Week||24
251278|NCT01007812|610444|P1|STARTED|Period 2, One Week||24
251279|NCT01007812|610443|P2|NOT COMPLETED|Period 1, One Week||1
251280|NCT01007812|610444|P1|NOT COMPLETED|Period 1, One Week||1
251281|NCT01007812|610443|P2|COMPLETED|Period 1, One Week||24
251282|NCT01007812|610444|P1|COMPLETED|Period 1, One Week||24
251283|NCT01007812|610443|P2|STARTED|Period 1, One Week||25
251284|NCT01007812|610444|P1|STARTED|Period 1, One Week||25
251285|NCT01007838|610454|P4|NOT COMPLETED|Overall Study||0
251286|NCT01007838|610455|P3|NOT COMPLETED|Overall Study||0
251287|NCT01007838|610456|P2|NOT COMPLETED|Overall Study||0
251288|NCT01007838|610457|P1|NOT COMPLETED|Overall Study||3
251289|NCT01007838|610454|P4|COMPLETED|Overall Study||4
251290|NCT01007838|610455|P3|COMPLETED|Overall Study||5
251291|NCT01007838|610456|P2|COMPLETED|Overall Study||11
251292|NCT01007838|610457|P1|COMPLETED|Overall Study||9
251293|NCT01007838|610454|P4|STARTED|Overall Study||4
251294|NCT01007838|610455|P3|STARTED|Overall Study||5
251295|NCT01007838|610456|P2|STARTED|Overall Study||11
251296|NCT01007838|610457|P1|STARTED|Overall Study||12
251297|NCT01007916|610467|P2|NOT COMPLETED|Period 2, 4 Weeks of Wear||0
251298|NCT01007916|610468|P1|NOT COMPLETED|Period 2, 4 Weeks of Wear||1
251299|NCT01007916|610467|P2|COMPLETED|Period 2, 4 Weeks of Wear||25
251300|NCT01007916|610468|P1|COMPLETED|Period 2, 4 Weeks of Wear||21
251301|NCT01007916|610467|P2|STARTED|Period 2, 4 Weeks of Wear|One participant completed Period 1 but did not start Period 2 due to failing inclusion criteria.|25
251302|NCT01007916|610468|P1|STARTED|Period 2, 4 Weeks of Wear||22
251303|NCT01007916|610467|P2|NOT COMPLETED|Period 1, 4 Weeks of Wear||0
251304|NCT01007916|610468|P1|NOT COMPLETED|Period 1, 4 Weeks of Wear||1
251305|NCT01007916|610467|P2|COMPLETED|Period 1, 4 Weeks of Wear||26
251306|NCT01007916|610468|P1|COMPLETED|Period 1, 4 Weeks of Wear||22
251307|NCT01007916|610467|P2|STARTED|Period 1, 4 Weeks of Wear||26
251308|NCT01007916|610468|P1|STARTED|Period 1, 4 Weeks of Wear||23
251309|NCT01007942|610476|P2|NOT COMPLETED|Overall Study||278
251310|NCT01007942|610477|P1|NOT COMPLETED|Overall Study||281
251311|NCT01007942|610476|P2|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|7
251312|NCT01007942|610477|P1|COMPLETED|Overall Study|Pts completed= on treatment at time of DCO. Not Completed = ended treatment as per protocol.|3
251313|NCT01007942|610476|P2|STARTED|Overall Study||285
251314|NCT01007942|610477|P1|STARTED|Overall Study||284
251315|NCT01010906|610505|P6|NOT COMPLETED|Overall Study||0
251316|NCT01010906|610506|P5|NOT COMPLETED|Overall Study||0
251317|NCT01010906|610507|P4|NOT COMPLETED|Overall Study||0
251318|NCT01010906|610508|P3|NOT COMPLETED|Overall Study||0
251319|NCT01010906|610509|P2|NOT COMPLETED|Overall Study||0
251320|NCT01010906|610510|P1|NOT COMPLETED|Overall Study||0
251321|NCT01010906|610505|P6|COMPLETED|Overall Study||10
251322|NCT01010906|610506|P5|COMPLETED|Overall Study||10
251323|NCT01010906|610507|P4|COMPLETED|Overall Study||10
251324|NCT01010906|610508|P3|COMPLETED|Overall Study||10
251325|NCT01010906|610509|P2|COMPLETED|Overall Study||10
251326|NCT01010906|610510|P1|COMPLETED|Overall Study||10
251327|NCT01010906|610505|P6|STARTED|Overall Study||10
251328|NCT01010906|610506|P5|STARTED|Overall Study||10
251329|NCT01010906|610507|P4|STARTED|Overall Study||10
251330|NCT01010906|610508|P3|STARTED|Overall Study||10
251331|NCT01010906|610509|P2|STARTED|Overall Study||10
251332|NCT01010906|610510|P1|STARTED|Overall Study||10
251333|NCT01010932|610530|P1|NOT COMPLETED|Overall Study||22
251334|NCT01010932|610530|P1|COMPLETED|Overall Study||200
251335|NCT01010932|610530|P1|STARTED|Overall Study||222
251336|NCT01010971|610545|P3|NOT COMPLETED|Overall Study||13
251337|NCT01010971|610546|P2|NOT COMPLETED|Overall Study||8
251338|NCT01010971|610547|P1|NOT COMPLETED|Overall Study||3
251339|NCT01010971|610545|P3|COMPLETED|Overall Study||207
251340|NCT01010971|610546|P2|COMPLETED|Overall Study||218
251341|NCT01010971|610547|P1|COMPLETED|Overall Study||222
251342|NCT01010971|610545|P3|STARTED|Overall Study||220
251343|NCT01010971|610546|P2|STARTED|Overall Study||226
251344|NCT01010971|610547|P1|STARTED|Overall Study||225
251345|NCT01011049|610636|P4|NOT COMPLETED|Overall Study||0
251346|NCT01011049|610637|P3|NOT COMPLETED|Overall Study||4
251347|NCT01011049|610638|P2|NOT COMPLETED|Overall Study||2
251348|NCT01011049|610639|P1|NOT COMPLETED|Overall Study||1
251349|NCT01011049|610636|P4|COMPLETED|Overall Study||246
251350|NCT01011049|610637|P3|COMPLETED|Overall Study||239
251351|NCT01011049|610638|P2|COMPLETED|Overall Study||250
251352|NCT01011049|610639|P1|COMPLETED|Overall Study||506
251353|NCT01011049|610636|P4|STARTED|Overall Study||246
251354|NCT01011049|610637|P3|STARTED|Overall Study||243
251355|NCT01011049|610638|P2|STARTED|Overall Study||252
251356|NCT01011049|610639|P1|STARTED|Overall Study||507
251357|NCT01011075|610661|P1|NOT COMPLETED|Overall Study||0
251358|NCT01011075|610661|P1|COMPLETED|Overall Study||34
251359|NCT01011075|610661|P1|STARTED|Overall Study||34
251360|NCT01011153|610671|P3|NOT COMPLETED|Overall Study||9
251361|NCT01011153|610672|P2|NOT COMPLETED|Overall Study||11
251362|NCT01011153|610673|P1|NOT COMPLETED|Overall Study||8
251363|NCT01011153|610671|P3|COMPLETED|Overall Study||45
251364|NCT01011153|610672|P2|COMPLETED|Overall Study||64
251365|NCT01011153|610673|P1|COMPLETED|Overall Study||46
251366|NCT01011153|610671|P3|STARTED|Overall Study||54
251367|NCT01011153|610672|P2|STARTED|Overall Study||75
251368|NCT01011153|610673|P1|STARTED|Overall Study||54
251369|NCT01011179|610693|P2|NOT COMPLETED|Overall Study||2
251370|NCT01011179|610694|P1|NOT COMPLETED|Overall Study||4
251371|NCT01011179|610693|P2|COMPLETED|Overall Study||20
251372|NCT01011179|610694|P1|COMPLETED|Overall Study||20
251373|NCT01011179|610693|P2|STARTED|Overall Study||22
251374|NCT01011179|610694|P1|STARTED|Overall Study||24
251375|NCT01011283|610702|P2|NOT COMPLETED|Overall Study||11
251376|NCT01011283|610703|P1|NOT COMPLETED|Overall Study||11
251377|NCT01011283|610702|P2|COMPLETED|Overall Study||2
251378|NCT01011283|610703|P1|COMPLETED|Overall Study||2
251379|NCT01011283|610702|P2|STARTED|Overall Study||13
251380|NCT01011283|610703|P1|STARTED|Overall Study||13
251381|NCT01011309|610714|P3|NOT COMPLETED|Overall Study||5
251382|NCT01011309|610715|P2|NOT COMPLETED|Overall Study||3
251383|NCT01011309|610716|P1|NOT COMPLETED|Overall Study||2
251384|NCT01011309|610714|P3|COMPLETED|Overall Study||16
251385|NCT01011309|610715|P2|COMPLETED|Overall Study||7
251386|NCT01011309|610716|P1|COMPLETED|Overall Study||12
251387|NCT01011309|610714|P3|STARTED|Overall Study||21
251388|NCT01011309|610715|P2|STARTED|Overall Study||10
251389|NCT01011309|610716|P1|STARTED|Overall Study||14
251390|NCT01011387|610730|P1|NOT COMPLETED|Overall Study||6
251391|NCT01011387|610730|P1|COMPLETED|Overall Study||10
251392|NCT01011387|610730|P1|STARTED|Overall Study||16
251393|NCT01011465|610742|P8|NOT COMPLETED|Overall Study||0
251394|NCT01011465|610743|P7|NOT COMPLETED|Overall Study||1
251395|NCT01011465|610744|P6|NOT COMPLETED|Overall Study||0
251396|NCT01011465|610745|P5|NOT COMPLETED|Overall Study||1
251397|NCT01011465|610746|P4|NOT COMPLETED|Overall Study||0
251398|NCT01011465|610747|P3|NOT COMPLETED|Overall Study||0
251399|NCT01011465|610748|P2|NOT COMPLETED|Overall Study||1
251400|NCT01011465|610749|P1|NOT COMPLETED|Overall Study||2
251401|NCT01011465|610742|P8|COMPLETED|Overall Study||32
251402|NCT01011465|610743|P7|COMPLETED|Overall Study||51
251403|NCT01011465|610744|P6|COMPLETED|Overall Study||29
251404|NCT01011465|610745|P5|COMPLETED|Overall Study||46
251405|NCT01011465|610746|P4|COMPLETED|Overall Study||18
251406|NCT01011465|610747|P3|COMPLETED|Overall Study||36
251407|NCT01011465|610748|P2|COMPLETED|Overall Study||19
251408|NCT01011465|610749|P1|COMPLETED|Overall Study||34
251409|NCT01011465|610742|P8|STARTED|Overall Study||32
251410|NCT01011465|610743|P7|STARTED|Overall Study||52
251411|NCT01011465|610744|P6|STARTED|Overall Study||29
251412|NCT01011465|610745|P5|STARTED|Overall Study||47
251413|NCT01011465|610746|P4|STARTED|Overall Study||18
251414|NCT01011465|610747|P3|STARTED|Overall Study||36
251415|NCT01011465|610748|P2|STARTED|Overall Study||20
251416|NCT01011465|610749|P1|STARTED|Overall Study||36
251417|NCT01011556|610781|P4|NOT COMPLETED|Overall Study||13
251418|NCT01011556|610782|P3|NOT COMPLETED|Overall Study||10
251419|NCT01011556|610783|P2|NOT COMPLETED|Overall Study||8
251420|NCT01011556|610784|P1|NOT COMPLETED|Overall Study||6
251421|NCT01011556|610781|P4|COMPLETED|Overall Study||51
251422|NCT01011556|610782|P3|COMPLETED|Overall Study||45
251423|NCT01011556|610783|P2|COMPLETED|Overall Study||48
251424|NCT01011556|610784|P1|COMPLETED|Overall Study||52
251425|NCT01011556|610781|P4|Received at Least 1 Dose of Study Drug|Overall Study||64
251426|NCT01011556|610782|P3|Received at Least 1 Dose of Study Drug|Overall Study||54
251427|NCT01011556|610783|P2|Received at Least 1 Dose of Study Drug|Overall Study||56
251428|NCT01011556|610784|P1|Received at Least 1 Dose of Study Drug|Overall Study||57
251429|NCT01011556|610781|P4|STARTED|Overall Study||64
251430|NCT01011556|610782|P3|STARTED|Overall Study||55
251431|NCT01011556|610783|P2|STARTED|Overall Study||56
251432|NCT01011556|610784|P1|STARTED|Overall Study||58
251433|NCT01011634|610856|P2|NOT COMPLETED|Overall Study||1
251434|NCT01011634|610857|P1|NOT COMPLETED|Overall Study||0
251435|NCT01011634|610856|P2|COMPLETED|Overall Study||8
251436|NCT01011634|610857|P1|COMPLETED|Overall Study||9
251437|NCT01011634|610856|P2|STARTED|Overall Study||9
251438|NCT01011634|610857|P1|STARTED|Overall Study||9
251439|NCT01011673|610867|P2|NOT COMPLETED|24 Hour Follow-up||3
251440|NCT01011673|610868|P1|NOT COMPLETED|24 Hour Follow-up||3
251441|NCT01011673|610867|P2|COMPLETED|24 Hour Follow-up||57
251442|NCT01011673|610868|P1|COMPLETED|24 Hour Follow-up||57
251443|NCT01011673|610867|P2|STARTED|24 Hour Follow-up||60
251444|NCT01011673|610868|P1|STARTED|24 Hour Follow-up||60
251445|NCT01011673|610867|P2|NOT COMPLETED|Emergency Department Portion||0
251446|NCT01011673|610868|P1|NOT COMPLETED|Emergency Department Portion||0
251447|NCT01011673|610867|P2|COMPLETED|Emergency Department Portion||60
251448|NCT01011673|610868|P1|COMPLETED|Emergency Department Portion||60
251449|NCT01011673|610867|P2|STARTED|Emergency Department Portion||60
251450|NCT01011673|610868|P1|STARTED|Emergency Department Portion||60
251451|NCT01011673|610867|P2|NOT COMPLETED|Randomized||1
251452|NCT01011673|610868|P1|NOT COMPLETED|Randomized||2
251453|NCT01011673|610867|P2|COMPLETED|Randomized|1 patient was randomized but not included in analyses bc they did not truly meet study criteria.|60
251454|NCT01011673|610868|P1|COMPLETED|Randomized|2 patients were randomized but not included in analyses bc they did not truly meet study criteria.|60
251455|NCT01011673|610867|P2|STARTED|Randomized||61
251456|NCT01011673|610868|P1|STARTED|Randomized||62
251457|NCT01011738|610879|P3|NOT COMPLETED|Overall Study||17
251458|NCT01011738|610880|P2|NOT COMPLETED|Overall Study||294
251459|NCT01011738|610881|P1|NOT COMPLETED|Overall Study||324
251460|NCT01011738|610879|P3|COMPLETED|Overall Study||36
251461|NCT01011738|610880|P2|COMPLETED|Overall Study||618
251462|NCT01011738|610881|P1|COMPLETED|Overall Study||553
251463|NCT01011738|610879|P3|STARTED|Overall Study||53
251464|NCT01011738|610880|P2|STARTED|Overall Study||912
251465|NCT01011738|610881|P1|STARTED|Overall Study||877
251466|NCT01011816|610921|P2|NOT COMPLETED|78-Week Extended Follow-up||28
251467|NCT01011816|610922|P1|NOT COMPLETED|78-Week Extended Follow-up||72
251468|NCT01011816|610921|P2|COMPLETED|78-Week Extended Follow-up||26
251469|NCT01011816|610922|P1|COMPLETED|78-Week Extended Follow-up||85
251470|NCT01011816|610921|P2|STARTED|78-Week Extended Follow-up||54
251471|NCT01011816|610922|P1|STARTED|78-Week Extended Follow-up||157
251472|NCT01011816|610921|P2|NOT COMPLETED|26-Week Primary Endpoint||2
251473|NCT01011816|610922|P1|NOT COMPLETED|26-Week Primary Endpoint||7
251474|NCT01011816|610921|P2|COMPLETED|26-Week Primary Endpoint||54
251475|NCT01011816|610922|P1|COMPLETED|26-Week Primary Endpoint||157
251476|NCT01011816|610921|P2|STARTED|26-Week Primary Endpoint||56
251477|NCT01011816|610922|P1|STARTED|26-Week Primary Endpoint||164
251478|NCT01011829|610934|P2|NOT COMPLETED|Overall Study||9
251479|NCT01011829|610935|P1|NOT COMPLETED|Overall Study||4
251480|NCT01011829|610934|P2|COMPLETED|Overall Study||1
251481|NCT01011829|610935|P1|COMPLETED|Overall Study||6
251482|NCT01011829|610934|P2|STARTED|Overall Study||10
251483|NCT01011829|610935|P1|STARTED|Overall Study||10
251484|NCT01011868|610946|P3|NOT COMPLETED|After Week 78 Follow-up||44
251485|NCT01011868|610947|P2|NOT COMPLETED|After Week 78 Follow-up||38
251486|NCT01011868|610948|P1|NOT COMPLETED|After Week 78 Follow-up||52
251487|NCT01011868|610946|P3|COMPLETED|After Week 78 Follow-up||111
251488|NCT01011868|610947|P2|COMPLETED|After Week 78 Follow-up||131
251489|NCT01011868|610948|P1|COMPLETED|After Week 78 Follow-up||118
251490|NCT01011868|610946|P3|STARTED|After Week 78 Follow-up||155
251491|NCT01011868|610947|P2|STARTED|After Week 78 Follow-up||169
251492|NCT01011868|610948|P1|STARTED|After Week 78 Follow-up||170
251493|NCT01011868|610946|P3|NOT COMPLETED|After Week 18 Follow-up||26
251494|NCT01011868|610947|P2|NOT COMPLETED|After Week 18 Follow-up||16
251495|NCT01011868|610948|P1|NOT COMPLETED|After Week 18 Follow-up||23
251496|NCT01011868|610946|P3|COMPLETED|After Week 18 Follow-up||129
251497|NCT01011868|610947|P2|COMPLETED|After Week 18 Follow-up||153
251498|NCT01011868|610948|P1|COMPLETED|After Week 18 Follow-up||147
251499|NCT01011868|610946|P3|STARTED|After Week 18 Follow-up||155
251500|NCT01011868|610947|P2|STARTED|After Week 18 Follow-up||169
251501|NCT01011868|610948|P1|STARTED|After Week 18 Follow-up||170
251502|NCT01011894|610983|P1|NOT COMPLETED|Overall Study||0
251503|NCT01011894|610983|P1|COMPLETED|Overall Study||26
251504|NCT01011894|610983|P1|STARTED|Overall Study||26
251505|NCT01011907|610989|P2|NOT COMPLETED|Overall Study||15
251506|NCT01011907|610990|P1|NOT COMPLETED|Overall Study||14
251507|NCT01011907|610989|P2|COMPLETED|Overall Study||18
251508|NCT01011907|610990|P1|COMPLETED|Overall Study||17
251509|NCT01011907|610989|P2|STARTED|Overall Study||33
251510|NCT01011907|610990|P1|STARTED|Overall Study||31
251511|NCT01011933|611000|P1|NOT COMPLETED|Overall Study||4
251512|NCT01011933|611000|P1|COMPLETED|Overall Study|total eligible and evaluable|50
251513|NCT01011933|611000|P1|STARTED|Overall Study|total enrolled|54
251514|NCT01011946|611007|P1|NOT COMPLETED|Overall Study||3
251515|NCT01011946|611007|P1|COMPLETED|Overall Study||33
251516|NCT01011946|611007|P1|STARTED|Overall Study||36
251517|NCT01012037|611014|P3|NOT COMPLETED|Overall Study||10
251518|NCT01012037|611015|P2|NOT COMPLETED|Overall Study||16
251519|NCT01012037|611016|P1|NOT COMPLETED|Overall Study||1
251520|NCT01012037|611014|P3|COMPLETED|Overall Study||214
251521|NCT01012037|611015|P2|COMPLETED|Overall Study||207
251522|NCT01012037|611016|P1|COMPLETED|Overall Study||43
251523|NCT01012037|611014|P3|STARTED|Overall Study||224
251524|NCT01012037|611015|P2|STARTED|Overall Study||223
251525|NCT01012037|611016|P1|STARTED|Overall Study||44
251526|NCT01012167|611054|P3|NOT COMPLETED|Overall Study||4
251527|NCT01012167|611055|P2|NOT COMPLETED|Overall Study||2
251528|NCT01012167|611056|P1|NOT COMPLETED|Overall Study||2
251529|NCT01012167|611054|P3|COMPLETED|Overall Study||17
251530|NCT01012167|611055|P2|COMPLETED|Overall Study||18
251531|NCT01012167|611056|P1|COMPLETED|Overall Study||15
251532|NCT01012167|611054|P3|Exposed to Study Drug|Overall Study||20
251533|NCT01012167|611055|P2|Exposed to Study Drug|Overall Study||20
251534|NCT01012167|611056|P1|Exposed to Study Drug|Overall Study||16
251535|NCT01012167|611054|P3|Withdrawn Prior to Study Drug Exposure|Overall Study||1
251536|NCT01012167|611055|P2|Withdrawn Prior to Study Drug Exposure|Overall Study||0
251537|NCT01012167|611056|P1|Withdrawn Prior to Study Drug Exposure|Overall Study||1
251538|NCT01012167|611054|P3|STARTED|Overall Study||21
251539|NCT01012167|611055|P2|STARTED|Overall Study||20
251540|NCT01012167|611056|P1|STARTED|Overall Study||17
251541|NCT01012219|611310|P1|NOT COMPLETED|Period 3||0
251542|NCT01012219|611310|P1|COMPLETED|Period 3||20
251543|NCT01012219|611310|P1|STARTED|Period 3|of the 36 who started Period 1|20
251544|NCT01012219|611310|P1|NOT COMPLETED|Period 2||1
251545|NCT01012219|611310|P1|COMPLETED|Period 2||34
251546|NCT01012219|611310|P1|STARTED|Period 2|Number who completed Period 1|35
251547|NCT01012219|611310|P1|NOT COMPLETED|Period 1||1
251548|NCT01012219|611310|P1|COMPLETED|Period 1||35
251549|NCT01012219|611310|P1|STARTED|Period 1|Number randomized|36
251550|NCT01012245|611321|P1|NOT COMPLETED|Overall Study||2427
251551|NCT01012245|611321|P1|COMPLETED|Overall Study|More than 1 discontinuation (DC) reason possible per subject. See outcome measure Reasons for DC.|26385
251552|NCT01012245|611321|P1|STARTED|Overall Study||28812
251553|NCT01012258|611358|P1|NOT COMPLETED|Overall Study||66
251554|NCT01012258|611358|P1|COMPLETED|Overall Study||0
251555|NCT01012258|611358|P1|STARTED|Overall Study||66
251556|NCT01012297|611366|P2|NOT COMPLETED|Overall Study||0
251557|NCT01012297|611367|P1|NOT COMPLETED|Overall Study||0
251558|NCT01012297|611366|P2|COMPLETED|Overall Study||53
251559|NCT01012297|611367|P1|COMPLETED|Overall Study||54
251560|NCT01012297|611366|P2|STARTED|Overall Study||53
251561|NCT01012297|611367|P1|STARTED|Overall Study||54
251562|NCT01012323|611379|P1|NOT COMPLETED|Overall Study||1
251563|NCT01012323|611379|P1|COMPLETED|Overall Study||50
251564|NCT01012323|611379|P1|STARTED|Overall Study||51
251565|NCT01012336|611401|P1|NOT COMPLETED|Overall Study||0
251566|NCT01012336|611401|P1|COMPLETED|Overall Study||85
251567|NCT01012336|611401|P1|STARTED|Overall Study||85
251568|NCT01012362|611410|P5|NOT COMPLETED|Overall Study||0
251569|NCT01012362|611411|P4|NOT COMPLETED|Overall Study||0
251570|NCT01012362|611412|P3|NOT COMPLETED|Overall Study||0
251571|NCT01012362|611413|P2|NOT COMPLETED|Overall Study||0
251572|NCT01012362|611414|P1|NOT COMPLETED|Overall Study||0
251573|NCT01012362|611410|P5|COMPLETED|Overall Study||3
251574|NCT01012362|611411|P4|COMPLETED|Overall Study||4
251575|NCT01012362|611412|P3|COMPLETED|Overall Study||9
251576|NCT01012362|611413|P2|COMPLETED|Overall Study||6
251577|NCT01012362|611414|P1|COMPLETED|Overall Study||9
251578|NCT01012362|611410|P5|STARTED|Overall Study||3
251579|NCT01012362|611411|P4|STARTED|Overall Study||4
251580|NCT01012362|611412|P3|STARTED|Overall Study||9
251581|NCT01012362|611413|P2|STARTED|Overall Study||6
251582|NCT01012362|611414|P1|STARTED|Overall Study||9
251583|NCT01012388|611427|P1|NOT COMPLETED|Overall Study||0
251584|NCT01012388|611427|P1|COMPLETED|Overall Study||100
251585|NCT01012388|611427|P1|STARTED|Overall Study||100
251586|NCT01012414|611432|P1|NOT COMPLETED|Overall Study||10
251587|NCT01012414|611432|P1|COMPLETED|Overall Study|No subjects completed the study.|0
251588|NCT01012414|611432|P1|STARTED|Overall Study||10
251589|NCT01012440|611439|P1|NOT COMPLETED|Overall Study||2
251590|NCT01012440|611439|P1|COMPLETED|Overall Study||3
251591|NCT01012440|611439|P1|STARTED|Overall Study||5
251592|NCT01012622|611443|P1|NOT COMPLETED|Overall Study||31
251593|NCT01012622|611443|P1|COMPLETED|Overall Study||111
251594|NCT01012622|611443|P1|STARTED|Overall Study||142
251595|NCT01012661|611462|P1|NOT COMPLETED|Overall Study||0
251596|NCT01012661|611462|P1|COMPLETED|Overall Study||50
251597|NCT01012661|611462|P1|STARTED|Overall Study||50
251598|NCT01012674|611470|P1|NOT COMPLETED|Overall Study||24
251599|NCT01012674|611470|P1|COMPLETED|Overall Study||187
251600|NCT01012674|611470|P1|STARTED|Overall Study||211
251601|NCT01012713|611482|P1|NOT COMPLETED|Overall Study||3
251602|NCT01012713|611482|P1|COMPLETED|Overall Study||27
251603|NCT01012713|611482|P1|STARTED|Overall Study||30
251604|NCT01012739|611488|P4|NOT COMPLETED|Treatment Period 4||0
251605|NCT01012739|611489|P3|NOT COMPLETED|Treatment Period 4||0
251606|NCT01012739|611490|P2|NOT COMPLETED|Treatment Period 4||0
251607|NCT01012739|611491|P1|NOT COMPLETED|Treatment Period 4||0
251608|NCT01012739|611488|P4|COMPLETED|Treatment Period 4||7
251609|NCT01012739|611489|P3|COMPLETED|Treatment Period 4||9
251610|NCT01012739|611490|P2|COMPLETED|Treatment Period 4||8
251611|NCT01012739|611491|P1|COMPLETED|Treatment Period 4||9
251612|NCT01012739|611488|P4|STARTED|Treatment Period 4||7
251613|NCT01012739|611489|P3|STARTED|Treatment Period 4||9
251614|NCT01012739|611490|P2|STARTED|Treatment Period 4||8
251615|NCT01012739|611491|P1|STARTED|Treatment Period 4||9
251616|NCT01012739|611488|P4|NOT COMPLETED|Treatment Period 3||0
251617|NCT01012739|611489|P3|NOT COMPLETED|Treatment Period 3||0
251618|NCT01012739|611490|P2|NOT COMPLETED|Treatment Period 3||0
251619|NCT01012739|611491|P1|NOT COMPLETED|Treatment Period 3||0
251620|NCT01012739|611488|P4|COMPLETED|Treatment Period 3||7
251621|NCT01012739|611489|P3|COMPLETED|Treatment Period 3||9
251622|NCT01012739|611490|P2|COMPLETED|Treatment Period 3||8
251623|NCT01012739|611491|P1|COMPLETED|Treatment Period 3||9
251624|NCT01012739|611488|P4|STARTED|Treatment Period 3||7
251625|NCT01012739|611489|P3|STARTED|Treatment Period 3||9
251626|NCT01012739|611490|P2|STARTED|Treatment Period 3||8
251627|NCT01012739|611491|P1|STARTED|Treatment Period 3||9
251628|NCT01012739|611488|P4|NOT COMPLETED|Treatment Period 2||1
251629|NCT01012739|611489|P3|NOT COMPLETED|Treatment Period 2||0
251630|NCT01012739|611490|P2|NOT COMPLETED|Treatment Period 2||0
251631|NCT01012739|611491|P1|NOT COMPLETED|Treatment Period 2||0
251632|NCT01012739|611488|P4|COMPLETED|Treatment Period 2||7
251633|NCT01012739|611489|P3|COMPLETED|Treatment Period 2||9
251634|NCT01012739|611490|P2|COMPLETED|Treatment Period 2||8
251635|NCT01012739|611491|P1|COMPLETED|Treatment Period 2||9
251636|NCT01012739|611488|P4|STARTED|Treatment Period 2||8
251637|NCT01012739|611489|P3|STARTED|Treatment Period 2||9
251638|NCT01012739|611490|P2|STARTED|Treatment Period 2||8
251639|NCT01012739|611491|P1|STARTED|Treatment Period 2||9
251640|NCT01012739|611488|P4|NOT COMPLETED|Treatment Period 1||1
251641|NCT01012739|611489|P3|NOT COMPLETED|Treatment Period 1||0
251642|NCT01012739|611490|P2|NOT COMPLETED|Treatment Period 1||0
251643|NCT01012739|611491|P1|NOT COMPLETED|Treatment Period 1||0
251644|NCT01012739|611488|P4|COMPLETED|Treatment Period 1||8
251645|NCT01012739|611489|P3|COMPLETED|Treatment Period 1||9
251646|NCT01012739|611490|P2|COMPLETED|Treatment Period 1||8
251647|NCT01012739|611491|P1|COMPLETED|Treatment Period 1||9
251648|NCT01012739|611488|P4|STARTED|Treatment Period 1||9
251649|NCT01012739|611489|P3|STARTED|Treatment Period 1||9
251650|NCT01012739|611490|P2|STARTED|Treatment Period 1||8
251651|NCT01012739|611491|P1|STARTED|Treatment Period 1||9
251652|NCT01012765|611519|P6|NOT COMPLETED|Treatment Period 3||0
251653|NCT01012765|611520|P5|NOT COMPLETED|Treatment Period 3||0
251654|NCT01012765|611521|P4|NOT COMPLETED|Treatment Period 3||0
251655|NCT01012765|611522|P3|NOT COMPLETED|Treatment Period 3||0
251656|NCT01012765|611523|P2|NOT COMPLETED|Treatment Period 3||0
251657|NCT01012765|611524|P1|NOT COMPLETED|Treatment Period 3||0
251658|NCT01012765|611519|P6|COMPLETED|Treatment Period 3||24
251659|NCT01012765|611520|P5|COMPLETED|Treatment Period 3||18
251660|NCT01012765|611521|P4|COMPLETED|Treatment Period 3||15
251661|NCT01012765|611522|P3|COMPLETED|Treatment Period 3||18
251662|NCT01012765|611523|P2|COMPLETED|Treatment Period 3||19
251663|NCT01012765|611524|P1|COMPLETED|Treatment Period 3||16
251664|NCT01012765|611519|P6|STARTED|Treatment Period 3||24
251665|NCT01012765|611520|P5|STARTED|Treatment Period 3||18
251666|NCT01012765|611521|P4|STARTED|Treatment Period 3||15
251667|NCT01012765|611522|P3|STARTED|Treatment Period 3||18
251668|NCT01012765|611523|P2|STARTED|Treatment Period 3||19
251669|NCT01012765|611524|P1|STARTED|Treatment Period 3||16
251670|NCT01012765|611519|P6|NOT COMPLETED|Treatment Period 2||1
251671|NCT01012765|611520|P5|NOT COMPLETED|Treatment Period 2||1
251672|NCT01012765|611521|P4|NOT COMPLETED|Treatment Period 2||0
251673|NCT01012765|611522|P3|NOT COMPLETED|Treatment Period 2||3
251674|NCT01012765|611523|P2|NOT COMPLETED|Treatment Period 2||2
251675|NCT01012765|611524|P1|NOT COMPLETED|Treatment Period 2||1
251676|NCT01012765|611519|P6|COMPLETED|Treatment Period 2||24
251677|NCT01012765|611520|P5|COMPLETED|Treatment Period 2||18
251678|NCT01012765|611521|P4|COMPLETED|Treatment Period 2||15
251679|NCT01012765|611522|P3|COMPLETED|Treatment Period 2||18
251680|NCT01012765|611523|P2|COMPLETED|Treatment Period 2||19
251681|NCT01012765|611524|P1|COMPLETED|Treatment Period 2||16
251682|NCT01012765|611519|P6|STARTED|Treatment Period 2||25
251683|NCT01012765|611520|P5|STARTED|Treatment Period 2||19
251684|NCT01012765|611521|P4|STARTED|Treatment Period 2||15
251685|NCT01012765|611522|P3|STARTED|Treatment Period 2||21
251686|NCT01012765|611523|P2|STARTED|Treatment Period 2||21
251687|NCT01012765|611524|P1|STARTED|Treatment Period 2||17
251688|NCT01012765|611519|P6|NOT COMPLETED|Treatment Period 1||0
251689|NCT01012765|611520|P5|NOT COMPLETED|Treatment Period 1||3
251690|NCT01012765|611521|P4|NOT COMPLETED|Treatment Period 1||3
251691|NCT01012765|611522|P3|NOT COMPLETED|Treatment Period 1||2
251692|NCT01012765|611523|P2|NOT COMPLETED|Treatment Period 1||0
251693|NCT01012765|611524|P1|NOT COMPLETED|Treatment Period 1||3
251694|NCT01012765|611519|P6|COMPLETED|Treatment Period 1||25
251695|NCT01012765|611520|P5|COMPLETED|Treatment Period 1||19
251696|NCT01012765|611521|P4|COMPLETED|Treatment Period 1||15
251697|NCT01012765|611522|P3|COMPLETED|Treatment Period 1||21
251698|NCT01012765|611523|P2|COMPLETED|Treatment Period 1||21
251699|NCT01012765|611524|P1|COMPLETED|Treatment Period 1||17
251700|NCT01012765|611519|P6|STARTED|Treatment Period 1||25
251701|NCT01012765|611520|P5|STARTED|Treatment Period 1||22
251702|NCT01012765|611521|P4|STARTED|Treatment Period 1||18
251703|NCT01012765|611522|P3|STARTED|Treatment Period 1||23
251704|NCT01012765|611523|P2|STARTED|Treatment Period 1||21
251705|NCT01012765|611524|P1|STARTED|Treatment Period 1||20
251706|NCT01012947|611558|P5|NOT COMPLETED|Overall Study||142
251707|NCT01012947|611559|P4|NOT COMPLETED|Overall Study||118
251708|NCT01012947|611560|P3|NOT COMPLETED|Overall Study||130
251709|NCT01012947|611561|P2|NOT COMPLETED|Overall Study||135
251710|NCT01012947|611562|P1|NOT COMPLETED|Overall Study||131
251711|NCT01012947|611558|P5|COMPLETED|Overall Study||94
251712|NCT01012947|611559|P4|COMPLETED|Overall Study||93
251713|NCT01012947|611560|P3|COMPLETED|Overall Study||111
251714|NCT01012947|611561|P2|COMPLETED|Overall Study||80
251715|NCT01012947|611562|P1|COMPLETED|Overall Study||81
251716|NCT01012947|611558|P5|STARTED|Overall Study||236
251717|NCT01012947|611559|P4|STARTED|Overall Study||211
251718|NCT01012947|611560|P3|STARTED|Overall Study||241
251719|NCT01012947|611561|P2|STARTED|Overall Study||215
251720|NCT01012947|611562|P1|STARTED|Overall Study||212
251721|NCT01012973|611576|P2|NOT COMPLETED|Overall Study||19
251722|NCT01012973|611577|P1|NOT COMPLETED|Overall Study||16
251723|NCT01012973|611576|P2|COMPLETED|Overall Study||52
251724|NCT01012973|611577|P1|COMPLETED|Overall Study||90
251725|NCT01012973|611576|P2|Completed Week 52, From FAS|Overall Study||52
251726|NCT01012973|611577|P1|Completed Week 52, From FAS|Overall Study||91
251727|NCT01012973|611576|P2|Completed Week 24, From FAS|Overall Study||57
251728|NCT01012973|611577|P1|Completed Week 24, From FAS|Overall Study||97
251729|NCT01012973|611576|P2|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|68
251730|NCT01012973|611577|P1|Fulfilled Requirements of FAS Population|Overall Study|Full Analysis Set (FAS) Population: Participants received treatment with post baseline measurements|103
251731|NCT01012973|611576|P2|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|68
251732|NCT01012973|611577|P1|Participants Received Treatment|Overall Study|Safety Population: Participants received treatment|104
251733|NCT01012973|611576|P2|STARTED|Overall Study||71
251734|NCT01012973|611577|P1|STARTED|Overall Study||106
251735|NCT01012999|611597|P1|NOT COMPLETED|Overall Study||1
251736|NCT01012999|611597|P1|COMPLETED|Overall Study||15
251737|NCT01012999|611597|P1|STARTED|Overall Study||16
251738|NCT01013194|611603|P2|NOT COMPLETED|Overall Study||0
251739|NCT01013194|611604|P1|NOT COMPLETED|Overall Study||0
251740|NCT01013194|611603|P2|COMPLETED|Overall Study|Retrospectively contemporary matched-pair group|16
251741|NCT01013194|611604|P1|COMPLETED|Overall Study|Consecutive patients|9
251742|NCT01013194|611603|P2|STARTED|Overall Study||16
251743|NCT01013194|611604|P1|STARTED|Overall Study||9
251744|NCT01013207|611614|P1|NOT COMPLETED|CPAP Post Nexus (S9)||6
251745|NCT01013207|611614|P1|COMPLETED|CPAP Post Nexus (S9)||44
251746|NCT01013207|611614|P1|STARTED|CPAP Post Nexus (S9)||50
251747|NCT01013207|611614|P1|NOT COMPLETED|Nexus (S9)||0
251748|NCT01013207|611614|P1|COMPLETED|Nexus (S9)||50
251749|NCT01013207|611614|P1|STARTED|Nexus (S9)||50
251750|NCT01013207|611614|P1|NOT COMPLETED|CPAP Pre Nexus (S9)||0
251751|NCT01013207|611614|P1|COMPLETED|CPAP Pre Nexus (S9)||50
251752|NCT01013207|611614|P1|STARTED|CPAP Pre Nexus (S9)||50
251753|NCT01019928|611621|P2|NOT COMPLETED|Period 3||0
251754|NCT01019928|611622|P1|NOT COMPLETED|Period 3||0
251755|NCT01019928|611621|P2|COMPLETED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
251756|NCT01019928|611622|P1|COMPLETED|Period 3||7
251929|NCT01021852|612009|P6|COMPLETED|Washout Period-No Drug||38
251757|NCT01019928|611621|P2|STARTED|Period 3|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
251758|NCT01019928|611622|P1|STARTED|Period 3||7
251759|NCT01019928|611621|P2|NOT COMPLETED|Period 2||1
251760|NCT01019928|611622|P1|NOT COMPLETED|Period 2||0
251761|NCT01019928|611621|P2|COMPLETED|Period 2|One patient had an SAE, and was withdrawn, prior to receiving AZD1386|6
251762|NCT01019928|611622|P1|COMPLETED|Period 2||7
251763|NCT01019928|611621|P2|STARTED|Period 2||7
251764|NCT01019928|611622|P1|STARTED|Period 2||7
251765|NCT01019928|611621|P2|NOT COMPLETED|Period 1||0
251766|NCT01019928|611622|P1|NOT COMPLETED|Period 1||0
251767|NCT01019928|611621|P2|COMPLETED|Period 1||7
251768|NCT01019928|611622|P1|COMPLETED|Period 1||7
251769|NCT01019928|611621|P2|STARTED|Period 1||7
251770|NCT01019928|611622|P1|STARTED|Period 1||7
251771|NCT01019980|611664|P2|NOT COMPLETED|Overall Study||0
251772|NCT01019980|611665|P1|NOT COMPLETED|Overall Study||2
251773|NCT01019980|611664|P2|COMPLETED|Overall Study||0
251774|NCT01019980|611665|P1|COMPLETED|Overall Study||0
251775|NCT01019980|611664|P2|Discontinued|Overall Study||0
251776|NCT01019980|611665|P1|Discontinued|Overall Study||2
251777|NCT01019980|611664|P2|STARTED|Overall Study||0
251778|NCT01019980|611665|P1|STARTED|Overall Study|2 patients entered study but did not receive any drug since it was not available in the region.|2
251779|NCT01020006|611674|P3|NOT COMPLETED|Overall Study||16
251780|NCT01020006|611675|P2|NOT COMPLETED|Overall Study||18
251781|NCT01020006|611676|P1|NOT COMPLETED|Overall Study||8
251782|NCT01020006|611674|P3|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
251783|NCT01020006|611675|P2|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
251784|NCT01020006|611676|P1|COMPLETED|Overall Study|No subjects reached study completion as defined by protocol.|0
251785|NCT01020006|611674|P3|STARTED|Overall Study||16
251786|NCT01020006|611675|P2|STARTED|Overall Study||18
251787|NCT01020006|611676|P1|STARTED|Overall Study||8
251788|NCT01020019|611686|P2|NOT COMPLETED|Overall Study||29
251789|NCT01020019|611687|P1|NOT COMPLETED|Overall Study||26
251790|NCT01020019|611686|P2|COMPLETED|Overall Study||32
251791|NCT01020019|611687|P1|COMPLETED|Overall Study||35
251792|NCT01020019|611686|P2|STARTED|Overall Study||61
251793|NCT01020019|611687|P1|STARTED|Overall Study||61
251794|NCT01020123|611700|P7|NOT COMPLETED|Extention Period||1
251795|NCT01020123|611701|P6|NOT COMPLETED|Extention Period||2
251796|NCT01020123|611702|P5|NOT COMPLETED|Extention Period||0
251797|NCT01020123|611703|P4|NOT COMPLETED|Extention Period||1
251798|NCT01020123|611704|P3|NOT COMPLETED|Extention Period||2
251799|NCT01020123|611705|P2|NOT COMPLETED|Extention Period||2
251800|NCT01020123|611706|P1|NOT COMPLETED|Extention Period||3
251801|NCT01020123|611700|P7|COMPLETED|Extention Period||18
251802|NCT01020123|611701|P6|COMPLETED|Extention Period||36
251803|NCT01020123|611702|P5|COMPLETED|Extention Period||31
251804|NCT01020123|611703|P4|COMPLETED|Extention Period||12
251805|NCT01020123|611704|P3|COMPLETED|Extention Period||17
251806|NCT01020123|611705|P2|COMPLETED|Extention Period||33
251807|NCT01020123|611706|P1|COMPLETED|Extention Period||37
251808|NCT01020123|611700|P7|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
251809|NCT01020123|611701|P6|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|38
251810|NCT01020123|611702|P5|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|31
251811|NCT01020123|611703|P4|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|13
251812|NCT01020123|611704|P3|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|19
251813|NCT01020123|611705|P2|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|35
251814|NCT01020123|611706|P1|STARTED|Extention Period|Not everyone accepted protocol amendment allowing to enter extension period or was asked to enter.|40
251815|NCT01020123|611700|P7|NOT COMPLETED|Main Period||11
251816|NCT01020123|611701|P6|NOT COMPLETED|Main Period||11
251817|NCT01020123|611702|P5|NOT COMPLETED|Main Period||11
251818|NCT01020123|611703|P4|NOT COMPLETED|Main Period||7
251819|NCT01020123|611704|P3|NOT COMPLETED|Main Period||8
251820|NCT01020123|611705|P2|NOT COMPLETED|Main Period||14
251821|NCT01020123|611706|P1|NOT COMPLETED|Main Period||17
251822|NCT01020123|611700|P7|COMPLETED|Main Period||61
251823|NCT01020123|611701|P6|COMPLETED|Main Period||83
251824|NCT01020123|611702|P5|COMPLETED|Main Period||77
251825|NCT01020123|611703|P4|COMPLETED|Main Period||33
251826|NCT01020123|611704|P3|COMPLETED|Main Period||44
251827|NCT01020123|611705|P2|COMPLETED|Main Period||77
251828|NCT01020123|611706|P1|COMPLETED|Main Period||76
251829|NCT01020123|611700|P7|STARTED|Main Period||72
251830|NCT01020123|611701|P6|STARTED|Main Period||94
251831|NCT01020123|611702|P5|STARTED|Main Period||88
251832|NCT01020123|611703|P4|STARTED|Main Period||40
251833|NCT01020123|611704|P3|STARTED|Main Period||52
251834|NCT01020123|611705|P2|STARTED|Main Period||91
251835|NCT01020123|611706|P1|STARTED|Main Period||93
251836|NCT01021423|611901|P2|NOT COMPLETED|Overall Study||5
251837|NCT01021423|611902|P1|NOT COMPLETED|Overall Study||4
251838|NCT01021423|611901|P2|COMPLETED|Overall Study||0
251839|NCT01021423|611902|P1|COMPLETED|Overall Study||0
251840|NCT01021423|611901|P2|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to disease progression|5
251841|NCT01021423|611902|P1|STARTED|Overall Study|One participant discontinued treatment (continued in the study) due to an AE|4
251842|NCT01021618|611920|P2|NOT COMPLETED|Overall Study||0
251843|NCT01021618|611921|P1|NOT COMPLETED|Overall Study||0
251844|NCT01021618|611920|P2|COMPLETED|Overall Study||96
251845|NCT01021618|611921|P1|COMPLETED|Overall Study||44
251846|NCT01021618|611920|P2|STARTED|Overall Study||96
251847|NCT01021618|611921|P1|STARTED|Overall Study||44
251848|NCT01021683|611929|P1|NOT COMPLETED|Overall Study||71
251849|NCT01021683|611929|P1|COMPLETED|Overall Study||132
251850|NCT01021683|611929|P1|STARTED|Overall Study||203
251851|NCT01021761|611944|P3|NOT COMPLETED|Overall Study||0
251852|NCT01021761|611945|P2|NOT COMPLETED|Overall Study||4
251853|NCT01021761|611946|P1|NOT COMPLETED|Overall Study||1
251854|NCT01021761|611944|P3|COMPLETED|Overall Study||42
251855|NCT01021761|611945|P2|COMPLETED|Overall Study||38
251856|NCT01021761|611946|P1|COMPLETED|Overall Study||41
251857|NCT01021761|611944|P3|STARTED|Overall Study||42
251858|NCT01021761|611945|P2|STARTED|Overall Study||42
251859|NCT01021761|611946|P1|STARTED|Overall Study||42
251860|NCT01021813|611956|P5|NOT COMPLETED|DB Randomized Discontinuation Phase||5
251861|NCT01021813|611957|P4|NOT COMPLETED|DB Randomized Discontinuation Phase||5
251862|NCT01021813|611958|P3|NOT COMPLETED|DB Randomized Discontinuation Phase||4
251863|NCT01021813|611959|P2|NOT COMPLETED|DB Randomized Discontinuation Phase||0
251864|NCT01021813|611960|P1|NOT COMPLETED|DB Randomized Discontinuation Phase||0
251865|NCT01021813|611956|P5|COMPLETED|DB Randomized Discontinuation Phase||157
251866|NCT01021813|611957|P4|COMPLETED|DB Randomized Discontinuation Phase||161
251867|NCT01021813|611958|P3|COMPLETED|DB Randomized Discontinuation Phase||152
251868|NCT01021813|611959|P2|COMPLETED|DB Randomized Discontinuation Phase||0
251869|NCT01021813|611960|P1|COMPLETED|DB Randomized Discontinuation Phase||0
251870|NCT01021813|611956|P5|STARTED|DB Randomized Discontinuation Phase||162
251871|NCT01021813|611957|P4|STARTED|DB Randomized Discontinuation Phase||166
251872|NCT01021813|611958|P3|STARTED|DB Randomized Discontinuation Phase||156
251873|NCT01021813|611959|P2|STARTED|DB Randomized Discontinuation Phase||0
251874|NCT01021813|611960|P1|STARTED|DB Randomized Discontinuation Phase||0
251875|NCT01021813|611956|P5|NOT COMPLETED|DB Treatment Phase||0
251876|NCT01021813|611957|P4|NOT COMPLETED|DB Treatment Phase||0
251877|NCT01021813|611958|P3|NOT COMPLETED|DB Treatment Phase||0
251878|NCT01021813|611959|P2|NOT COMPLETED|DB Treatment Phase||97
251879|NCT01021813|611960|P1|NOT COMPLETED|DB Treatment Phase||200
251880|NCT01021813|611956|P5|COMPLETED|DB Treatment Phase||0
251881|NCT01021813|611957|P4|COMPLETED|DB Treatment Phase||0
251882|NCT01021813|611958|P3|COMPLETED|DB Treatment Phase||0
251883|NCT01021813|611959|P2|COMPLETED|DB Treatment Phase||162
251884|NCT01021813|611960|P1|COMPLETED|DB Treatment Phase||322
251885|NCT01021813|611956|P5|Treated|DB Treatment Phase||0
251886|NCT01021813|611957|P4|Treated|DB Treatment Phase||0
251887|NCT01021813|611958|P3|Treated|DB Treatment Phase||0
251888|NCT01021813|611959|P2|Treated|DB Treatment Phase||258
251889|NCT01021813|611960|P1|Treated|DB Treatment Phase||521
251890|NCT01021813|611956|P5|STARTED|DB Treatment Phase||0
251891|NCT01021813|611957|P4|STARTED|DB Treatment Phase||0
251892|NCT01021813|611958|P3|STARTED|DB Treatment Phase||0
251893|NCT01021813|611959|P2|STARTED|DB Treatment Phase||259
251894|NCT01021813|611960|P1|STARTED|DB Treatment Phase||522
251895|NCT01021852|612007|P8|NOT COMPLETED|Treatment Period 2||2
251896|NCT01021852|612008|P7|NOT COMPLETED|Treatment Period 2||3
251897|NCT01021852|612009|P6|NOT COMPLETED|Treatment Period 2||1
251898|NCT01021852|612010|P5|NOT COMPLETED|Treatment Period 2||2
251899|NCT01021852|612011|P4|NOT COMPLETED|Treatment Period 2||0
251900|NCT01021852|612012|P3|NOT COMPLETED|Treatment Period 2||1
251901|NCT01021852|612013|P2|NOT COMPLETED|Treatment Period 2||1
251902|NCT01021852|612014|P1|NOT COMPLETED|Treatment Period 2||0
251903|NCT01021852|612007|P8|COMPLETED|Treatment Period 2||38
251904|NCT01021852|612008|P7|COMPLETED|Treatment Period 2||37
251905|NCT01021852|612009|P6|COMPLETED|Treatment Period 2||37
251906|NCT01021852|612010|P5|COMPLETED|Treatment Period 2||37
251907|NCT01021852|612011|P4|COMPLETED|Treatment Period 2||37
251908|NCT01021852|612012|P3|COMPLETED|Treatment Period 2||38
251909|NCT01021852|612013|P2|COMPLETED|Treatment Period 2||38
251910|NCT01021852|612014|P1|COMPLETED|Treatment Period 2||37
251911|NCT01021852|612007|P8|STARTED|Treatment Period 2||40
251912|NCT01021852|612008|P7|STARTED|Treatment Period 2||40
251913|NCT01021852|612009|P6|STARTED|Treatment Period 2||38
251914|NCT01021852|612010|P5|STARTED|Treatment Period 2||39
251915|NCT01021852|612011|P4|STARTED|Treatment Period 2||37
251916|NCT01021852|612012|P3|STARTED|Treatment Period 2||39
251917|NCT01021852|612013|P2|STARTED|Treatment Period 2||39
251918|NCT01021852|612014|P1|STARTED|Treatment Period 2||37
251919|NCT01021852|612007|P8|NOT COMPLETED|Washout Period-No Drug||0
251920|NCT01021852|612008|P7|NOT COMPLETED|Washout Period-No Drug||0
251921|NCT01021852|612009|P6|NOT COMPLETED|Washout Period-No Drug||1
251922|NCT01021852|612010|P5|NOT COMPLETED|Washout Period-No Drug||0
251923|NCT01021852|612011|P4|NOT COMPLETED|Washout Period-No Drug||0
251924|NCT01021852|612012|P3|NOT COMPLETED|Washout Period-No Drug||0
251925|NCT01021852|612013|P2|NOT COMPLETED|Washout Period-No Drug||0
251926|NCT01021852|612014|P1|NOT COMPLETED|Washout Period-No Drug||1
251927|NCT01021852|612007|P8|COMPLETED|Washout Period-No Drug||40
251928|NCT01021852|612008|P7|COMPLETED|Washout Period-No Drug||40
251930|NCT01021852|612010|P5|COMPLETED|Washout Period-No Drug||39
251931|NCT01021852|612011|P4|COMPLETED|Washout Period-No Drug||37
251932|NCT01021852|612012|P3|COMPLETED|Washout Period-No Drug||39
251933|NCT01021852|612013|P2|COMPLETED|Washout Period-No Drug||39
251934|NCT01021852|612014|P1|COMPLETED|Washout Period-No Drug||37
251935|NCT01021852|612007|P8|STARTED|Washout Period-No Drug||40
251936|NCT01021852|612008|P7|STARTED|Washout Period-No Drug||40
251937|NCT01021852|612009|P6|STARTED|Washout Period-No Drug|Includes 1 participant who completed Treatment Period 1 but missed Placebo Washout.|39
251938|NCT01021852|612010|P5|STARTED|Washout Period-No Drug||39
251939|NCT01021852|612011|P4|STARTED|Washout Period-No Drug||37
251940|NCT01021852|612012|P3|STARTED|Washout Period-No Drug||39
251941|NCT01021852|612013|P2|STARTED|Washout Period-No Drug||39
251942|NCT01021852|612014|P1|STARTED|Washout Period-No Drug|Includes 1 participant who discontinued Treatment Period 1 (AE) and missed Placebo Washout.|38
251943|NCT01021852|612007|P8|NOT COMPLETED|Washout Period-Placebo||0
251944|NCT01021852|612008|P7|NOT COMPLETED|Washout Period-Placebo||1
251945|NCT01021852|612009|P6|NOT COMPLETED|Washout Period-Placebo||1
251946|NCT01021852|612010|P5|NOT COMPLETED|Washout Period-Placebo||1
251947|NCT01021852|612011|P4|NOT COMPLETED|Washout Period-Placebo||1
251948|NCT01021852|612012|P3|NOT COMPLETED|Washout Period-Placebo||0
251949|NCT01021852|612013|P2|NOT COMPLETED|Washout Period-Placebo||0
251950|NCT01021852|612014|P1|NOT COMPLETED|Washout Period-Placebo||0
251951|NCT01021852|612007|P8|COMPLETED|Washout Period-Placebo||40
251952|NCT01021852|612008|P7|COMPLETED|Washout Period-Placebo||40
251953|NCT01021852|612009|P6|COMPLETED|Washout Period-Placebo||38
251954|NCT01021852|612010|P5|COMPLETED|Washout Period-Placebo||39
251955|NCT01021852|612011|P4|COMPLETED|Washout Period-Placebo||37
251956|NCT01021852|612012|P3|COMPLETED|Washout Period-Placebo||39
251957|NCT01021852|612013|P2|COMPLETED|Washout Period-Placebo||39
251958|NCT01021852|612014|P1|COMPLETED|Washout Period-Placebo||37
251959|NCT01021852|612007|P8|STARTED|Washout Period-Placebo||40
251960|NCT01021852|612008|P7|STARTED|Washout Period-Placebo||41
251961|NCT01021852|612009|P6|STARTED|Washout Period-Placebo|Excludes 1 participant who completed Treatment Period 1 but missed Placebo Washout|39
251962|NCT01021852|612010|P5|STARTED|Washout Period-Placebo|Includes 1 participant that discontinued Treatment Period 1 (AE).|40
251963|NCT01021852|612011|P4|STARTED|Washout Period-Placebo||38
251964|NCT01021852|612012|P3|STARTED|Washout Period-Placebo||39
251965|NCT01021852|612013|P2|STARTED|Washout Period-Placebo||39
251966|NCT01021852|612014|P1|STARTED|Washout Period-Placebo||37
251967|NCT01021852|612007|P8|NOT COMPLETED|Treatment Period 1||1
251968|NCT01021852|612008|P7|NOT COMPLETED|Treatment Period 1||0
251969|NCT01021852|612009|P6|NOT COMPLETED|Treatment Period 1||2
251970|NCT01021852|612010|P5|NOT COMPLETED|Treatment Period 1||3
251971|NCT01021852|612011|P4|NOT COMPLETED|Treatment Period 1||2
251972|NCT01021852|612012|P3|NOT COMPLETED|Treatment Period 1||2
251973|NCT01021852|612013|P2|NOT COMPLETED|Treatment Period 1||1
251974|NCT01021852|612014|P1|NOT COMPLETED|Treatment Period 1||3
251975|NCT01021852|612007|P8|COMPLETED|Treatment Period 1||40
251976|NCT01021852|612008|P7|COMPLETED|Treatment Period 1||41
251977|NCT01021852|612009|P6|COMPLETED|Treatment Period 1||39
251978|NCT01021852|612010|P5|COMPLETED|Treatment Period 1||39
251979|NCT01021852|612011|P4|COMPLETED|Treatment Period 1||38
251980|NCT01021852|612012|P3|COMPLETED|Treatment Period 1||39
251981|NCT01021852|612013|P2|COMPLETED|Treatment Period 1||39
251982|NCT01021852|612014|P1|COMPLETED|Treatment Period 1||37
251983|NCT01021852|612007|P8|Treated|Treatment Period 1||41
251984|NCT01021852|612008|P7|Treated|Treatment Period 1||41
251985|NCT01021852|612009|P6|Treated|Treatment Period 1|1 participant discontinued Treatment Period 1 (AE) but continued in Placebo Washout|41
251986|NCT01021852|612010|P5|Treated|Treatment Period 1||42
251987|NCT01021852|612011|P4|Treated|Treatment Period 1||38
251988|NCT01021852|612012|P3|Treated|Treatment Period 1||41
251989|NCT01021852|612013|P2|Treated|Treatment Period 1||40
251990|NCT01021852|612014|P1|Treated|Treatment Period 1||40
251991|NCT01021852|612007|P8|STARTED|Treatment Period 1||41
251992|NCT01021852|612008|P7|STARTED|Treatment Period 1||41
251993|NCT01021852|612009|P6|STARTED|Treatment Period 1||41
251994|NCT01021852|612010|P5|STARTED|Treatment Period 1||42
251995|NCT01021852|612011|P4|STARTED|Treatment Period 1||40
251996|NCT01021852|612012|P3|STARTED|Treatment Period 1||41
251997|NCT01021852|612013|P2|STARTED|Treatment Period 1||40
251998|NCT01021852|612014|P1|STARTED|Treatment Period 1||40
251999|NCT01021878|612050|P2|NOT COMPLETED|Overall Study||10
252000|NCT01021878|612051|P1|NOT COMPLETED|Overall Study||16
252001|NCT01021878|612050|P2|COMPLETED|Overall Study||17
252002|NCT01021878|612051|P1|COMPLETED|Overall Study||17
252003|NCT01021878|612050|P2|Completed Follow-up|Overall Study||17
252004|NCT01021878|612051|P1|Completed Follow-up|Overall Study||17
252005|NCT01021878|612050|P2|STARTED|Overall Study||27
252006|NCT01021878|612051|P1|STARTED|Overall Study||33
252007|NCT01022073|612067|P2|NOT COMPLETED|Overall Study||18
252008|NCT01022073|612068|P1|NOT COMPLETED|Overall Study||19
252009|NCT01022073|612067|P2|COMPLETED|Overall Study||52
252010|NCT01022073|612068|P1|COMPLETED|Overall Study||67
252011|NCT01022073|612067|P2|STARTED|Overall Study||70
252012|NCT01022073|612068|P1|STARTED|Overall Study||86
252013|NCT01022112|612079|P5|NOT COMPLETED|Overall Study||10
252014|NCT01022112|612080|P4|NOT COMPLETED|Overall Study||3
252015|NCT01022112|612081|P3|NOT COMPLETED|Overall Study||3
252016|NCT01022112|612082|P2|NOT COMPLETED|Overall Study||3
252017|NCT01022112|612083|P1|NOT COMPLETED|Overall Study||3
252018|NCT01022112|612079|P5|COMPLETED|Overall Study||65
252019|NCT01022112|612080|P4|COMPLETED|Overall Study||72
252020|NCT01022112|612081|P3|COMPLETED|Overall Study||74
252021|NCT01022112|612082|P2|COMPLETED|Overall Study||71
252022|NCT01022112|612083|P1|COMPLETED|Overall Study||79
252023|NCT01022112|612079|P5|STARTED|Overall Study||75
252024|NCT01022112|612080|P4|STARTED|Overall Study||75
252025|NCT01022112|612081|P3|STARTED|Overall Study||77
252026|NCT01022112|612082|P2|STARTED|Overall Study||74
252027|NCT01022112|612083|P1|STARTED|Overall Study||82
252028|NCT01022190|612095|P1|NOT COMPLETED|Overall Study||0
252029|NCT01022190|612095|P1|COMPLETED|Overall Study||42
252030|NCT01022190|612095|P1|STARTED|Overall Study||42
252031|NCT01022203|612101|P2|NOT COMPLETED|Follow-Up Assessment||2
252032|NCT01022203|612102|P1|NOT COMPLETED|Follow-Up Assessment||2
252033|NCT01022203|612101|P2|COMPLETED|Follow-Up Assessment||40
252034|NCT01022203|612102|P1|COMPLETED|Follow-Up Assessment||42
252035|NCT01022203|612101|P2|STARTED|Follow-Up Assessment||42
252036|NCT01022203|612102|P1|STARTED|Follow-Up Assessment||44
252037|NCT01022203|612101|P2|NOT COMPLETED|Post Treatment Assessment||14
252038|NCT01022203|612102|P1|NOT COMPLETED|Post Treatment Assessment||14
252039|NCT01022203|612101|P2|COMPLETED|Post Treatment Assessment||42
252040|NCT01022203|612102|P1|COMPLETED|Post Treatment Assessment||44
252041|NCT01022203|612101|P2|STARTED|Post Treatment Assessment||56
252042|NCT01022203|612102|P1|STARTED|Post Treatment Assessment||58
252043|NCT01022203|612101|P2|NOT COMPLETED|PreTreatment Assessment||0
252044|NCT01022203|612102|P1|NOT COMPLETED|PreTreatment Assessment||0
252045|NCT01022203|612101|P2|COMPLETED|PreTreatment Assessment||56
252046|NCT01022203|612102|P1|COMPLETED|PreTreatment Assessment||58
252047|NCT01022203|612101|P2|STARTED|PreTreatment Assessment||56
252048|NCT01022203|612102|P1|STARTED|PreTreatment Assessment||58
252049|NCT01022242|612114|P2|NOT COMPLETED|Overall Study||19
252050|NCT01022242|612115|P1|NOT COMPLETED|Overall Study||21
252051|NCT01022242|612114|P2|COMPLETED|Overall Study||46
252052|NCT01022242|612115|P1|COMPLETED|Overall Study||49
252053|NCT01022242|612114|P2|STARTED|Overall Study|67 pat rand to PXL01. 2 got incorrect mix of PXL01. 65 patients treated with the correct PXL01 mix.|65
252054|NCT01022242|612115|P1|STARTED|Overall Study|71 pat rand to placebo. 1 got incorrect mix of placebo. 70 patients treated with the correct mix.|70
252055|NCT01022307|612123|P2|NOT COMPLETED|Overall Study||4
252056|NCT01022307|612124|P1|NOT COMPLETED|Overall Study||0
252057|NCT01022307|612123|P2|COMPLETED|Overall Study|Some TBI patients could not undergo MR scanning due to contraindications.|24
252058|NCT01022307|612124|P1|COMPLETED|Overall Study||184
252059|NCT01022307|612123|P2|STARTED|Overall Study||28
252060|NCT01022307|612124|P1|STARTED|Overall Study||184
252061|NCT01022398|612132|P2|NOT COMPLETED|Overall Study||2
252062|NCT01022398|612133|P1|NOT COMPLETED|Overall Study||2
252063|NCT01022398|612132|P2|COMPLETED|Overall Study||0
252064|NCT01022398|612133|P1|COMPLETED|Overall Study||0
252065|NCT01022398|612132|P2|STARTED|Overall Study||2
252066|NCT01022398|612133|P1|STARTED|Overall Study||2
252067|NCT01022502|612138|P1|NOT COMPLETED|Overall Study||3
252068|NCT01022502|612138|P1|COMPLETED|Overall Study|3 participants withdrew at week 4,5,6,respectively.|35
252069|NCT01022502|612138|P1|STARTED|Overall Study|19 used the refined ointment on the right site, 19 used the crude ointment on the left site.|38
252070|NCT01022567|612154|P2|NOT COMPLETED|Overall Study||15
252071|NCT01022567|612155|P1|NOT COMPLETED|Overall Study||1
252072|NCT01022567|612154|P2|COMPLETED|Overall Study||242
252073|NCT01022567|612155|P1|COMPLETED|Overall Study||272
252074|NCT01022567|612154|P2|STARTED|Overall Study||257
252075|NCT01022567|612155|P1|STARTED|Overall Study||273
252076|NCT01022762|612163|P2|NOT COMPLETED|Overall Study||28
252077|NCT01022762|612164|P1|NOT COMPLETED|Overall Study||22
252078|NCT01022762|612163|P2|COMPLETED|Overall Study||194
252079|NCT01022762|612164|P1|COMPLETED|Overall Study||196
252080|NCT01022762|612163|P2|Exposed to Trial Drug|Overall Study|Four participants were not exposed to the treatment due to non-compliance or lost to follow-up|218
252081|NCT01022762|612164|P1|Exposed to Trial Drug|Overall Study|One participant was not exposed to the treatment due to fulfillment of exclusion criteria|217
252082|NCT01022762|612163|P2|STARTED|Overall Study||222
252083|NCT01022762|612164|P1|STARTED|Overall Study||218
252084|NCT01022996|612190|P1|NOT COMPLETED|Overall Study||57
252085|NCT01022996|612190|P1|COMPLETED|Overall Study||0
252086|NCT01022996|612190|P1|STARTED|Overall Study||57
252087|NCT01023022|612199|P1|NOT COMPLETED|Overall Study||14
252088|NCT01023022|612199|P1|COMPLETED|Overall Study||162
252089|NCT01023022|612199|P1|STARTED|Overall Study|Previous No.: 178 subjects incl. 2 pts who withdraw their approval for processing personal data|176
252090|NCT01023035|612208|P3|NOT COMPLETED|Follow-up Period (up to Week 72)||39
252091|NCT01023035|612209|P2|NOT COMPLETED|Follow-up Period (up to Week 72)||28
252092|NCT01023035|612210|P1|NOT COMPLETED|Follow-up Period (up to Week 72)||28
252093|NCT01023035|612208|P3|COMPLETED|Follow-up Period (up to Week 72)||108
252094|NCT01023035|612209|P2|COMPLETED|Follow-up Period (up to Week 72)||207
252095|NCT01023035|612210|P1|COMPLETED|Follow-up Period (up to Week 72)||210
252096|NCT01023035|612208|P3|STARTED|Follow-up Period (up to Week 72)||147
252097|NCT01023035|612209|P2|STARTED|Follow-up Period (up to Week 72)||235
252098|NCT01023035|612210|P1|STARTED|Follow-up Period (up to Week 72)||238
252099|NCT01023035|612208|P3|NOT COMPLETED|Treatment Period||118
252100|NCT01023035|612209|P2|NOT COMPLETED|Treatment Period||85
252101|NCT01023035|612210|P1|NOT COMPLETED|Treatment Period||72
252102|NCT01023035|612208|P3|COMPLETED|Treatment Period||69
252103|NCT01023035|612209|P2|COMPLETED|Treatment Period||166
252104|NCT01023035|612210|P1|COMPLETED|Treatment Period||177
252105|NCT01023035|612208|P3|STARTED|Treatment Period||187
252106|NCT01023035|612209|P2|STARTED|Treatment Period||251
252107|NCT01023035|612210|P1|STARTED|Treatment Period||249
252108|NCT01023061|612220|P1|NOT COMPLETED|Overall Study||2
252109|NCT01023061|612220|P1|COMPLETED|Overall Study||22
252110|NCT01023061|612220|P1|STARTED|Overall Study||24
252111|NCT01023074|612229|P3|NOT COMPLETED|Overall Study||0
252112|NCT01023074|612230|P2|NOT COMPLETED|Overall Study||0
252113|NCT01023074|612231|P1|NOT COMPLETED|Overall Study||0
252114|NCT01023074|612229|P3|COMPLETED|Overall Study||13
252115|NCT01023074|612230|P2|COMPLETED|Overall Study||13
252116|NCT01023074|612231|P1|COMPLETED|Overall Study||26
252117|NCT01023074|612229|P3|STARTED|Overall Study||13
252118|NCT01023074|612230|P2|STARTED|Overall Study||13
252119|NCT01023074|612231|P1|STARTED|Overall Study||26
252120|NCT01023178|612248|P3|NOT COMPLETED|Overall Study||3
252121|NCT01023178|612249|P2|NOT COMPLETED|Overall Study||2
252122|NCT01023178|612250|P1|NOT COMPLETED|Overall Study||2
252123|NCT01023178|612248|P3|COMPLETED|Overall Study||4
252124|NCT01023178|612249|P2|COMPLETED|Overall Study||6
252125|NCT01023178|612250|P1|COMPLETED|Overall Study||3
252126|NCT01023178|612248|P3|STARTED|Overall Study||7
252127|NCT01023178|612249|P2|STARTED|Overall Study||8
252128|NCT01023178|612250|P1|STARTED|Overall Study||5
252129|NCT01023217|612260|P2|NOT COMPLETED|Overall Study||0
252130|NCT01023217|612261|P1|NOT COMPLETED|Overall Study||1
252131|NCT01023217|612260|P2|COMPLETED|Overall Study||45
252132|NCT01023217|612261|P1|COMPLETED|Overall Study||44
252133|NCT01023217|612260|P2|STARTED|Overall Study||45
252134|NCT01023217|612261|P1|STARTED|Overall Study||45
252135|NCT01023256|612271|P4|NOT COMPLETED|Overall Study||5
252136|NCT01023256|612272|P3|NOT COMPLETED|Overall Study||1
252137|NCT01023256|612273|P2|NOT COMPLETED|Overall Study||3
252138|NCT01023256|612274|P1|NOT COMPLETED|Overall Study||4
252139|NCT01023256|612271|P4|COMPLETED|Overall Study||22
252140|NCT01023256|612272|P3|COMPLETED|Overall Study||23
252141|NCT01023256|612273|P2|COMPLETED|Overall Study||19
252142|NCT01023256|612274|P1|COMPLETED|Overall Study||21
252143|NCT01023256|612271|P4|STARTED|Overall Study||27
252144|NCT01023256|612272|P3|STARTED|Overall Study||24
252145|NCT01023256|612273|P2|STARTED|Overall Study||22
252146|NCT01023256|612274|P1|STARTED|Overall Study||25
252147|NCT01023308|612316|P2|NOT COMPLETED|Overall Study||279
252148|NCT01023308|612317|P1|NOT COMPLETED|Overall Study||285
252149|NCT01023308|612316|P2|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
252150|NCT01023308|612317|P1|COMPLETED|Overall Study|completed all planned cycles of study treatment as per protocol|102
252151|NCT01023308|612316|P2|STARTED|Overall Study||381
252152|NCT01023308|612317|P1|STARTED|Overall Study||387
252153|NCT01023516|612345|P2|NOT COMPLETED|Overall Study||18
252154|NCT01023516|612346|P1|NOT COMPLETED|Overall Study||24
252155|NCT01023516|612345|P2|COMPLETED|Overall Study||284
252156|NCT01023516|612346|P1|COMPLETED|Overall Study||289
252157|NCT01023516|612345|P2|STARTED|Overall Study||302
252158|NCT01023516|612346|P1|STARTED|Overall Study||313
252159|NCT01023568|612429|P3|NOT COMPLETED|Overall Study||0
252160|NCT01023568|612430|P2|NOT COMPLETED|Overall Study||0
252161|NCT01023568|612431|P1|NOT COMPLETED|Overall Study||0
252162|NCT01023568|612429|P3|COMPLETED|Overall Study||45
252163|NCT01023568|612430|P2|COMPLETED|Overall Study||44
252164|NCT01023568|612431|P1|COMPLETED|Overall Study||45
252165|NCT01023568|612429|P3|STARTED|Overall Study||45
252166|NCT01023568|612430|P2|STARTED|Overall Study||44
252167|NCT01023568|612431|P1|STARTED|Overall Study||45
252168|NCT01023581|612458|P7|NOT COMPLETED|Overall Study||20
252169|NCT01023581|612459|P6|NOT COMPLETED|Overall Study||19
252170|NCT01023581|612460|P5|NOT COMPLETED|Overall Study||16
252171|NCT01023581|612461|P4|NOT COMPLETED|Overall Study||20
252172|NCT01023581|612462|P3|NOT COMPLETED|Overall Study||42
252173|NCT01023581|612463|P2|NOT COMPLETED|Overall Study||23
252174|NCT01023581|612464|P1|NOT COMPLETED|Overall Study||35
252175|NCT01023581|612458|P7|COMPLETED|Overall Study||94
252176|NCT01023581|612459|P6|COMPLETED|Overall Study||92
252177|NCT01023581|612460|P5|COMPLETED|Overall Study||95
252178|NCT01023581|612461|P4|COMPLETED|Overall Study||94
252179|NCT01023581|612462|P3|COMPLETED|Overall Study||71
252180|NCT01023581|612463|P2|COMPLETED|Overall Study||89
252181|NCT01023581|612464|P1|COMPLETED|Overall Study|The number of completed patients represents those who completed study drug.|74
252182|NCT01023581|612458|P7|Received Study Treatment|Overall Study||114
252183|NCT01023581|612459|P6|Received Study Treatment|Overall Study||106
252184|NCT01023581|612460|P5|Received Study Treatment|Overall Study||111
252185|NCT01023581|612461|P4|Received Study Treatment|Overall Study||109
252186|NCT01023581|612462|P3|Received Study Treatment|Overall Study||110
252187|NCT01023581|612463|P2|Received Study Treatment|Overall Study||112
252188|NCT01023581|612464|P1|Received Study Treatment|Overall Study||106
252189|NCT01023581|612458|P7|STARTED|Overall Study||114
252190|NCT01023581|612459|P6|STARTED|Overall Study||111
252191|NCT01023581|612460|P5|STARTED|Overall Study||111
252192|NCT01023581|612461|P4|STARTED|Overall Study||114
252193|NCT01023581|612462|P3|STARTED|Overall Study||113
252194|NCT01023581|612463|P2|STARTED|Overall Study||112
252195|NCT01023581|612464|P1|STARTED|Overall Study||109
252196|NCT01023659|612497|P3|NOT COMPLETED|Overall Study||99
252197|NCT01023659|612498|P2|NOT COMPLETED|Overall Study||228
252198|NCT01023659|612499|P1|NOT COMPLETED|Overall Study||73
252199|NCT01023659|612497|P3|COMPLETED|Overall Study||165
252200|NCT01023659|612498|P2|COMPLETED|Overall Study||137
252201|NCT01023659|612499|P1|COMPLETED|Overall Study||185
252202|NCT01023659|612497|P3|STARTED|Overall Study||264
252203|NCT01023659|612498|P2|STARTED|Overall Study||365
252204|NCT01023659|612499|P1|STARTED|Overall Study||258
252205|NCT01023672|612508|P1|NOT COMPLETED|Overall Study||3
252206|NCT01023672|612508|P1|COMPLETED|Overall Study||17
252207|NCT01023672|612508|P1|STARTED|Overall Study||20
252208|NCT01023711|612512|P1|NOT COMPLETED|Overall Study||0
252209|NCT01023711|612512|P1|COMPLETED|Overall Study||107
252210|NCT01023711|612512|P1|STARTED|Overall Study||107
252211|NCT01023724|612519|P2|NOT COMPLETED|Overall Study||3
252212|NCT01023724|612520|P1|NOT COMPLETED|Overall Study||4
252213|NCT01023724|612519|P2|COMPLETED|Overall Study||22
252214|NCT01023724|612520|P1|COMPLETED|Overall Study||21
252215|NCT01023724|612519|P2|STARTED|Overall Study||25
252216|NCT01023724|612520|P1|STARTED|Overall Study||25
252217|NCT01023776|612526|P1|NOT COMPLETED|Overall Study||0
252218|NCT01023776|612526|P1|COMPLETED|Overall Study||20
252219|NCT01023776|612526|P1|STARTED|Overall Study|Subjects received 2 dose of vaccine 0.1 ml in each nostril intra nasally 28 days apart|20
252220|NCT01023815|612535|P4|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
252221|NCT01023815|612536|P3|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||8
252222|NCT01023815|612537|P2|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||3
252223|NCT01023815|612538|P1|NOT COMPLETED|Randomized Period (Day 90 to Month 12)||0
252224|NCT01023815|612535|P4|COMPLETED|Randomized Period (Day 90 to Month 12)||68
252225|NCT01023815|612536|P3|COMPLETED|Randomized Period (Day 90 to Month 12)||60
252226|NCT01023815|612537|P2|COMPLETED|Randomized Period (Day 90 to Month 12)||42
252227|NCT01023815|612538|P1|COMPLETED|Randomized Period (Day 90 to Month 12)||0
252228|NCT01023815|612535|P4|STARTED|Randomized Period (Day 90 to Month 12)||71
252229|NCT01023815|612536|P3|STARTED|Randomized Period (Day 90 to Month 12)||68
252230|NCT01023815|612537|P2|STARTED|Randomized Period (Day 90 to Month 12)|Randomized patients to Group A, B and C are also intent to treat population.|45
252231|NCT01023815|612538|P1|STARTED|Randomized Period (Day 90 to Month 12)||0
252232|NCT01023815|612535|P4|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252233|NCT01023815|612536|P3|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252234|NCT01023815|612537|P2|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252235|NCT01023815|612538|P1|NOT COMPLETED|Pre-randomization Period (Day 1 to 90)||144
252236|NCT01023815|612535|P4|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252237|NCT01023815|612536|P3|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252238|NCT01023815|612537|P2|COMPLETED|Pre-randomization Period (Day 1 to 90)||0
252239|NCT01023815|612538|P1|COMPLETED|Pre-randomization Period (Day 1 to 90)||184
252240|NCT01023815|612535|P4|STARTED|Pre-randomization Period (Day 1 to 90)||0
252241|NCT01023815|612536|P3|STARTED|Pre-randomization Period (Day 1 to 90)||0
252242|NCT01023815|612537|P2|STARTED|Pre-randomization Period (Day 1 to 90)||0
252243|NCT01023815|612538|P1|STARTED|Pre-randomization Period (Day 1 to 90)|Out of 330 enrolled, 2 patients never received everolimus.|328
252244|NCT01023841|612559|P2|NOT COMPLETED|Overall Study||0
252245|NCT01023841|612560|P1|NOT COMPLETED|Overall Study||1
252246|NCT01023841|612559|P2|COMPLETED|Overall Study||23
252247|NCT01023841|612560|P1|COMPLETED|Overall Study||47
252248|NCT01023841|612559|P2|STARTED|Overall Study||23
252249|NCT01023841|612560|P1|STARTED|Overall Study||48
252250|NCT01008280|612576|P2|NOT COMPLETED|Overall Study||19
252251|NCT01008280|612577|P1|NOT COMPLETED|Overall Study||21
252252|NCT01008280|612576|P2|COMPLETED|Overall Study||73
252253|NCT01008280|612577|P1|COMPLETED|Overall Study||67
252254|NCT01008280|612576|P2|STARTED|Overall Study||92
252255|NCT01008280|612577|P1|STARTED|Overall Study||88
252256|NCT01008449|612589|P2|NOT COMPLETED|Overall Study||19
252257|NCT01008449|612590|P1|NOT COMPLETED|Overall Study||29
252258|NCT01008449|612589|P2|COMPLETED|Overall Study||179
252259|NCT01008449|612590|P1|COMPLETED|Overall Study||171
252260|NCT01008449|612589|P2|STARTED|Overall Study||198
252261|NCT01008449|612590|P1|STARTED|Overall Study||200
252262|NCT01008475|612617|P7|NOT COMPLETED|Overall Study||4
252263|NCT01008475|612618|P6|NOT COMPLETED|Overall Study||6
252264|NCT01008475|612619|P5|NOT COMPLETED|Overall Study||5
252265|NCT01008475|612620|P4|NOT COMPLETED|Overall Study||0
252266|NCT01008475|612621|P3|NOT COMPLETED|Overall Study||0
252267|NCT01008475|612622|P2|NOT COMPLETED|Overall Study||0
252268|NCT01008475|612623|P1|NOT COMPLETED|Overall Study||0
252269|NCT01008475|612617|P7|COMPLETED|Overall Study||67
252270|NCT01008475|612618|P6|COMPLETED|Overall Study||67
252271|NCT01008475|612619|P5|COMPLETED|Overall Study||67
252272|NCT01008475|612620|P4|COMPLETED|Overall Study||3
252273|NCT01008475|612621|P3|COMPLETED|Overall Study||7
252274|NCT01008475|612622|P2|COMPLETED|Overall Study||3
252275|NCT01008475|612623|P1|COMPLETED|Overall Study||3
252276|NCT01008475|612617|P7|Safety Analysis Set|Overall Study||69
252277|NCT01008475|612618|P6|Safety Analysis Set|Overall Study||72
252365|NCT01009762|612931|P1|NOT COMPLETED|Overall Study||0
252278|NCT01008475|612619|P5|Safety Analysis Set|Overall Study|1 subject randomized to EMD525797 1000 mg group received only SoC. Hence, reported under SOC group.|73
252279|NCT01008475|612620|P4|Safety Analysis Set|Overall Study||3
252280|NCT01008475|612621|P3|Safety Analysis Set|Overall Study||7
252281|NCT01008475|612622|P2|Safety Analysis Set|Overall Study||3
252282|NCT01008475|612623|P1|Safety Analysis Set|Overall Study||3
252283|NCT01008475|612617|P7|STARTED|Overall Study||71
252284|NCT01008475|612618|P6|STARTED|Overall Study||73
252285|NCT01008475|612619|P5|STARTED|Overall Study||72
252286|NCT01008475|612620|P4|STARTED|Overall Study||3
252287|NCT01008475|612621|P3|STARTED|Overall Study||7
252288|NCT01008475|612622|P2|STARTED|Overall Study||3
252289|NCT01008475|612623|P1|STARTED|Overall Study||3
252290|NCT01008553|612651|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||51
252291|NCT01008553|612652|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||37
252292|NCT01008553|612653|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
252293|NCT01008553|612651|P3|COMPLETED|Period 2 (Double-Blind Period)||28
252294|NCT01008553|612652|P2|COMPLETED|Period 2 (Double-Blind Period)||47
252295|NCT01008553|612653|P1|COMPLETED|Period 2 (Double-Blind Period)||0
252296|NCT01008553|612651|P3|STARTED|Period 2 (Double-Blind Period)||79
252297|NCT01008553|612652|P2|STARTED|Period 2 (Double-Blind Period)||84
252298|NCT01008553|612653|P1|STARTED|Period 2 (Double-Blind Period)||0
252299|NCT01008553|612651|P3|NOT COMPLETED|Period 1 (Titration Period)||0
252300|NCT01008553|612652|P2|NOT COMPLETED|Period 1 (Titration Period)||0
252301|NCT01008553|612653|P1|NOT COMPLETED|Period 1 (Titration Period)||95
252302|NCT01008553|612651|P3|COMPLETED|Period 1 (Titration Period)||0
252303|NCT01008553|612652|P2|COMPLETED|Period 1 (Titration Period)||0
252304|NCT01008553|612653|P1|COMPLETED|Period 1 (Titration Period)||163
252305|NCT01008553|612651|P3|STARTED|Period 1 (Titration Period)||0
252306|NCT01008553|612652|P2|STARTED|Period 1 (Titration Period)||0
252307|NCT01008553|612653|P1|STARTED|Period 1 (Titration Period)||258
252308|NCT01008605|612678|P1|NOT COMPLETED|Overall Study||0
252309|NCT01008605|612678|P1|COMPLETED|Overall Study||48
252310|NCT01008605|612678|P1|STARTED|Overall Study||48
252311|NCT01008618|612702|P3|NOT COMPLETED|Period 2 (Double-Blind Period)||38
252312|NCT01008618|612703|P2|NOT COMPLETED|Period 2 (Double-Blind Period)||36
252313|NCT01008618|612704|P1|NOT COMPLETED|Period 2 (Double-Blind Period)||0
252314|NCT01008618|612702|P3|COMPLETED|Period 2 (Double-Blind Period)||39
252315|NCT01008618|612703|P2|COMPLETED|Period 2 (Double-Blind Period)||37
252316|NCT01008618|612704|P1|COMPLETED|Period 2 (Double-Blind Period)||0
252317|NCT01008618|612702|P3|STARTED|Period 2 (Double-Blind Period)||77
252318|NCT01008618|612703|P2|STARTED|Period 2 (Double-Blind Period)||73
252319|NCT01008618|612704|P1|STARTED|Period 2 (Double-Blind Period)||0
252320|NCT01008618|612702|P3|NOT COMPLETED|Period 1 (Titration Period)||0
252321|NCT01008618|612703|P2|NOT COMPLETED|Period 1 (Titration Period)||0
252322|NCT01008618|612704|P1|NOT COMPLETED|Period 1 (Titration Period)||68
252323|NCT01008618|612702|P3|COMPLETED|Period 1 (Titration Period)||0
252324|NCT01008618|612703|P2|COMPLETED|Period 1 (Titration Period)||0
252325|NCT01008618|612704|P1|COMPLETED|Period 1 (Titration Period)||150
252326|NCT01008618|612702|P3|STARTED|Period 1 (Titration Period)||0
252327|NCT01008618|612703|P2|STARTED|Period 1 (Titration Period)||0
252328|NCT01008618|612704|P1|STARTED|Period 1 (Titration Period)||218
252329|NCT01009515|612729|P1|NOT COMPLETED|Overall Study||3
252330|NCT01009515|612729|P1|COMPLETED|Overall Study||16
252331|NCT01009515|612729|P1|STARTED|Overall Study||19
252332|NCT01009554|612738|P2|NOT COMPLETED|Overall Study||7
252333|NCT01009554|612739|P1|NOT COMPLETED|Overall Study||2
252334|NCT01009554|612738|P2|COMPLETED|Overall Study||41
252335|NCT01009554|612739|P1|COMPLETED|Overall Study||46
252336|NCT01009554|612738|P2|STARTED|Overall Study||48
252337|NCT01009554|612739|P1|STARTED|Overall Study||48
252338|NCT01009580|612873|P2|NOT COMPLETED|Overall Study||35
252339|NCT01009580|612874|P1|NOT COMPLETED|Overall Study||27
252340|NCT01009580|612873|P2|COMPLETED|Overall Study||188
252341|NCT01009580|612874|P1|COMPLETED|Overall Study||197
252342|NCT01009580|612873|P2|Exposed|Overall Study|One subject was randomised in error and withdrew prior to exposure to drug|222
252343|NCT01009580|612874|P1|Exposed|Overall Study||224
252344|NCT01009580|612873|P2|STARTED|Overall Study||223
252345|NCT01009580|612874|P1|STARTED|Overall Study||224
252346|NCT01009619|612888|P2|NOT COMPLETED|Overall Study||0
252347|NCT01009619|612889|P1|NOT COMPLETED|Overall Study||0
252348|NCT01009619|612888|P2|COMPLETED|Overall Study||43
252349|NCT01009619|612889|P1|COMPLETED|Overall Study||40
252350|NCT01009619|612888|P2|STARTED|Overall Study||43
252351|NCT01009619|612889|P1|STARTED|Overall Study||40
252352|NCT01009645|612911|P4|NOT COMPLETED|Overall Study||5
252353|NCT01009645|612912|P3|NOT COMPLETED|Overall Study||4
252354|NCT01009645|612913|P2|NOT COMPLETED|Overall Study||8
252355|NCT01009645|612914|P1|NOT COMPLETED|Overall Study||2
252356|NCT01009645|612911|P4|COMPLETED|Overall Study||26
252357|NCT01009645|612912|P3|COMPLETED|Overall Study||28
252358|NCT01009645|612913|P2|COMPLETED|Overall Study||23
252359|NCT01009645|612914|P1|COMPLETED|Overall Study||29
252360|NCT01009645|612911|P4|STARTED|Overall Study||31
252361|NCT01009645|612912|P3|STARTED|Overall Study||32
252362|NCT01009645|612913|P2|STARTED|Overall Study||31
252363|NCT01009645|612914|P1|STARTED|Overall Study||31
252364|NCT01009762|612930|P2|NOT COMPLETED|Overall Study||0
252366|NCT01009762|612930|P2|COMPLETED|Overall Study|10 participants received vaccine|10
252367|NCT01009762|612931|P1|COMPLETED|Overall Study|according to randomization this one participant received placebo|1
252368|NCT01009762|612930|P2|Primary Outcome|Overall Study|no SAE, no treatment related side effects DLT grade 3 or more|0
252369|NCT01009762|612931|P1|Primary Outcome|Overall Study|no Serious Adverse Events (SAE), no treatment related side effects DLT grade 3 or more|0
252370|NCT01009762|612930|P2|STARTED|Overall Study||10
252371|NCT01009762|612931|P1|STARTED|Overall Study||1
252372|NCT01009840|612941|P1|NOT COMPLETED|Overall Study||14
252373|NCT01009840|612941|P1|COMPLETED|Overall Study||16
252374|NCT01009840|612941|P1|STARTED|Overall Study||30
252375|NCT01009931|612954|P1|NOT COMPLETED|Overall Study||1
252376|NCT01009931|612954|P1|COMPLETED|Overall Study||0
252377|NCT01009931|612954|P1|STARTED|Overall Study||1
252378|NCT01009983|612960|P1|NOT COMPLETED|Overall Study||1
252379|NCT01009983|612960|P1|COMPLETED|Overall Study||13
252380|NCT01009983|612960|P1|STARTED|Overall Study||14
252381|NCT01010009|612967|P3|NOT COMPLETED|Overall Study||0
252382|NCT01010009|612968|P2|NOT COMPLETED|Overall Study||0
252383|NCT01010009|612969|P1|NOT COMPLETED|Overall Study||0
252384|NCT01010009|612967|P3|COMPLETED|Overall Study||8
252385|NCT01010009|612968|P2|COMPLETED|Overall Study||8
252386|NCT01010009|612969|P1|COMPLETED|Overall Study||8
252387|NCT01010009|612967|P3|STARTED|Overall Study||8
252388|NCT01010009|612968|P2|STARTED|Overall Study||8
252389|NCT01010009|612969|P1|STARTED|Overall Study||8
252390|NCT01010061|612985|P2|NOT COMPLETED|Overall Study||95
252391|NCT01010061|612986|P1|NOT COMPLETED|Overall Study||133
252392|NCT01010061|612985|P2|COMPLETED|Overall Study||23
252393|NCT01010061|612986|P1|COMPLETED|Overall Study|Completed=Completed treatment.|105
252394|NCT01010061|612985|P2|Received Study Drug|Overall Study||116
252395|NCT01010061|612986|P1|Received Study Drug|Overall Study||236
252396|NCT01010061|612985|P2|STARTED|Overall Study||118
252397|NCT01010061|612986|P1|STARTED|Overall Study||238
252398|NCT01010204|613019|P2|NOT COMPLETED|Overall Study||9
252399|NCT01010204|613020|P1|NOT COMPLETED|Overall Study||7
252400|NCT01010204|613019|P2|COMPLETED|Overall Study||20
252401|NCT01010204|613020|P1|COMPLETED|Overall Study||24
252402|NCT01010204|613019|P2|STARTED|Overall Study||29
252403|NCT01010204|613020|P1|STARTED|Overall Study||31
252404|NCT01010230|613030|P2|NOT COMPLETED|Overall Study||7
252405|NCT01010230|613031|P1|NOT COMPLETED|Overall Study||10
252406|NCT01010230|613030|P2|COMPLETED|Overall Study||26
252407|NCT01010230|613031|P1|COMPLETED|Overall Study||22
252408|NCT01010230|613030|P2|STARTED|Overall Study||33
252409|NCT01010230|613031|P1|STARTED|Overall Study||32
252410|NCT01010282|613064|P3|NOT COMPLETED|Overall Study||19
252411|NCT01010282|613065|P2|NOT COMPLETED|Overall Study||7
252412|NCT01010282|613066|P1|NOT COMPLETED|Overall Study||6
252413|NCT01010282|613064|P3|COMPLETED|Overall Study||77
252414|NCT01010282|613065|P2|COMPLETED|Overall Study||88
252415|NCT01010282|613066|P1|COMPLETED|Overall Study||91
252416|NCT01010282|613064|P3|STARTED|Overall Study||96
252417|NCT01010282|613065|P2|STARTED|Overall Study||95
252418|NCT01010282|613066|P1|STARTED|Overall Study||97
252419|NCT01010399|613086|P1|NOT COMPLETED|Overall Study||5
252420|NCT01010399|613086|P1|COMPLETED|Overall Study||31
252421|NCT01010399|613086|P1|STARTED|Overall Study||36
252422|NCT01010477|613093|P2|NOT COMPLETED|Overall Study||3
252423|NCT01010477|613094|P1|NOT COMPLETED|Overall Study||6
252424|NCT01010477|613093|P2|COMPLETED|Overall Study||22
252425|NCT01010477|613094|P1|COMPLETED|Overall Study||21
252426|NCT01010477|613093|P2|STARTED|Overall Study||25
252427|NCT01010477|613094|P1|STARTED|Overall Study||27
252428|NCT01010503|613100|P1|NOT COMPLETED|Overall Study||2
252429|NCT01010503|613100|P1|COMPLETED|Overall Study||30
252430|NCT01010503|613100|P1|STARTED|Overall Study||32
252431|NCT01010555|613118|P2|NOT COMPLETED|Second Four Weeks of Wear||0
252432|NCT01010555|613119|P1|NOT COMPLETED|Second Four Weeks of Wear||0
252433|NCT01010555|613118|P2|COMPLETED|Second Four Weeks of Wear||9
252434|NCT01010555|613119|P1|COMPLETED|Second Four Weeks of Wear||10
252435|NCT01010555|613118|P2|STARTED|Second Four Weeks of Wear||9
252436|NCT01010555|613119|P1|STARTED|Second Four Weeks of Wear||10
252437|NCT01010555|613118|P2|NOT COMPLETED|First Four Weeks of Wear||0
252438|NCT01010555|613119|P1|NOT COMPLETED|First Four Weeks of Wear||0
252439|NCT01010555|613118|P2|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Non-compliance with visit schedule.|10
252440|NCT01010555|613119|P1|COMPLETED|First Four Weeks of Wear|One participant who completed Period 1 did not start Period 2. Relocation.|11
252441|NCT01010555|613118|P2|STARTED|First Four Weeks of Wear||10
252442|NCT01010555|613119|P1|STARTED|First Four Weeks of Wear||11
252443|NCT01010568|613129|P1|NOT COMPLETED|Overall Study||5
252444|NCT01010568|613129|P1|COMPLETED|Overall Study||5
252445|NCT01010568|613129|P1|STARTED|Overall Study||10
252446|NCT01010633|613137|P2|NOT COMPLETED|Overall Study||5
252447|NCT01010633|613138|P1|NOT COMPLETED|Overall Study||4
252448|NCT01010633|613137|P2|COMPLETED|Overall Study||198
252449|NCT01010633|613138|P1|COMPLETED|Overall Study||199
252450|NCT01010633|613137|P2|STARTED|Overall Study||203
252451|NCT01010633|613138|P1|STARTED|Overall Study||203
252452|NCT01010750|613154|P6|NOT COMPLETED|Third Intervention||0
252453|NCT01010750|613155|P5|NOT COMPLETED|Third Intervention||0
252454|NCT01010750|613156|P4|NOT COMPLETED|Third Intervention||0
252455|NCT01010750|613157|P3|NOT COMPLETED|Third Intervention||0
252456|NCT01010750|613158|P2|NOT COMPLETED|Third Intervention||0
252457|NCT01010750|613159|P1|NOT COMPLETED|Third Intervention||0
252458|NCT01010750|613154|P6|COMPLETED|Third Intervention||3
252459|NCT01010750|613155|P5|COMPLETED|Third Intervention||2
252460|NCT01010750|613156|P4|COMPLETED|Third Intervention||3
252461|NCT01010750|613157|P3|COMPLETED|Third Intervention||3
252462|NCT01010750|613158|P2|COMPLETED|Third Intervention||3
252463|NCT01010750|613159|P1|COMPLETED|Third Intervention||3
252464|NCT01010750|613154|P6|STARTED|Third Intervention||3
252465|NCT01010750|613155|P5|STARTED|Third Intervention||2
252466|NCT01010750|613156|P4|STARTED|Third Intervention||3
252467|NCT01010750|613157|P3|STARTED|Third Intervention||3
252468|NCT01010750|613158|P2|STARTED|Third Intervention||3
252469|NCT01010750|613159|P1|STARTED|Third Intervention||3
252470|NCT01010750|613154|P6|NOT COMPLETED|Second Intervention||0
252471|NCT01010750|613155|P5|NOT COMPLETED|Second Intervention||0
252472|NCT01010750|613156|P4|NOT COMPLETED|Second Intervention||0
252473|NCT01010750|613157|P3|NOT COMPLETED|Second Intervention||0
252474|NCT01010750|613158|P2|NOT COMPLETED|Second Intervention||1
252475|NCT01010750|613159|P1|NOT COMPLETED|Second Intervention||0
252476|NCT01010750|613154|P6|COMPLETED|Second Intervention||3
252477|NCT01010750|613155|P5|COMPLETED|Second Intervention||2
252478|NCT01010750|613156|P4|COMPLETED|Second Intervention||3
252479|NCT01010750|613157|P3|COMPLETED|Second Intervention||3
252480|NCT01010750|613158|P2|COMPLETED|Second Intervention||3
252481|NCT01010750|613159|P1|COMPLETED|Second Intervention||3
252482|NCT01010750|613154|P6|STARTED|Second Intervention||3
252483|NCT01010750|613155|P5|STARTED|Second Intervention||2
252484|NCT01010750|613156|P4|STARTED|Second Intervention||3
252485|NCT01010750|613157|P3|STARTED|Second Intervention||3
252486|NCT01010750|613158|P2|STARTED|Second Intervention||4
252487|NCT01010750|613159|P1|STARTED|Second Intervention||3
252488|NCT01010750|613154|P6|NOT COMPLETED|First Intervention||0
252489|NCT01010750|613155|P5|NOT COMPLETED|First Intervention||0
252490|NCT01010750|613156|P4|NOT COMPLETED|First Intervention||0
252491|NCT01010750|613157|P3|NOT COMPLETED|First Intervention||0
252492|NCT01010750|613158|P2|NOT COMPLETED|First Intervention||0
252493|NCT01010750|613159|P1|NOT COMPLETED|First Intervention||0
252494|NCT01010750|613154|P6|COMPLETED|First Intervention||3
252495|NCT01010750|613155|P5|COMPLETED|First Intervention||2
252496|NCT01010750|613156|P4|COMPLETED|First Intervention||3
252497|NCT01010750|613157|P3|COMPLETED|First Intervention||3
252498|NCT01010750|613158|P2|COMPLETED|First Intervention||4
252499|NCT01010750|613159|P1|COMPLETED|First Intervention||3
252500|NCT01010750|613154|P6|STARTED|First Intervention||3
252501|NCT01010750|613155|P5|STARTED|First Intervention||2
252502|NCT01010750|613156|P4|STARTED|First Intervention||3
252503|NCT01010750|613157|P3|STARTED|First Intervention||3
252504|NCT01010750|613158|P2|STARTED|First Intervention||4
252505|NCT01010750|613159|P1|STARTED|First Intervention||3
252506|NCT01010776|613182|P1|NOT COMPLETED|Extension Phase||3
252507|NCT01010776|613182|P1|COMPLETED|Extension Phase||156
252508|NCT01010776|613182|P1|STARTED|Extension Phase||159
252509|NCT01010776|613182|P1|NOT COMPLETED|In-Between Main Phase & Extension Phase||15
252510|NCT01010776|613182|P1|COMPLETED|In-Between Main Phase & Extension Phase||159
252511|NCT01010776|613182|P1|STARTED|In-Between Main Phase & Extension Phase||174
252512|NCT01010776|613182|P1|NOT COMPLETED|Main Phase||49
252513|NCT01010776|613182|P1|COMPLETED|Main Phase||174
252514|NCT01010776|613182|P1|Treated|Main Phase||218
252515|NCT01010776|613182|P1|STARTED|Main Phase||223
252516|NCT01010867|613204|P1|NOT COMPLETED|Overall Study||1
252517|NCT01010867|613204|P1|COMPLETED|Overall Study||30
252518|NCT01010867|613204|P1|STARTED|Overall Study||31
252519|NCT01016483|613215|P4|NOT COMPLETED|Phase II||0
252520|NCT01016483|613216|P3|NOT COMPLETED|Phase II||0
252521|NCT01016483|613217|P2|NOT COMPLETED|Phase II||0
252522|NCT01016483|613218|P1|NOT COMPLETED|Phase II||0
252523|NCT01016483|613215|P4|COMPLETED|Phase II||44
252524|NCT01016483|613216|P3|COMPLETED|Phase II||44
252525|NCT01016483|613217|P2|COMPLETED|Phase II||0
252526|NCT01016483|613218|P1|COMPLETED|Phase II||0
252527|NCT01016483|613215|P4|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|45
252528|NCT01016483|613216|P3|Treated (Safety Analysis Set [SAF])|Phase II|Subjects presented as treated (SAF).|42
252529|NCT01016483|613217|P2|Treated (Safety Analysis Set [SAF])|Phase II||0
252530|NCT01016483|613218|P1|Treated (Safety Analysis Set [SAF])|Phase II||0
252531|NCT01016483|613215|P4|STARTED|Phase II|Subjects presented as randomized (ITT Analysis Set).|44
252532|NCT01016483|613216|P3|STARTED|Phase II|Subjects presented as randomized (Intention-to-Treat [ITT] Analysis Set).|44
252533|NCT01016483|613217|P2|STARTED|Phase II||0
252534|NCT01016483|613218|P1|STARTED|Phase II||0
252535|NCT01016483|613215|P4|NOT COMPLETED|Safety Run-in Part||0
252536|NCT01016483|613216|P3|NOT COMPLETED|Safety Run-in Part||0
252537|NCT01016483|613217|P2|NOT COMPLETED|Safety Run-in Part||0
252538|NCT01016483|613218|P1|NOT COMPLETED|Safety Run-in Part||0
252539|NCT01016483|613215|P4|COMPLETED|Safety Run-in Part||0
252540|NCT01016483|613216|P3|COMPLETED|Safety Run-in Part||0
252541|NCT01016483|613217|P2|COMPLETED|Safety Run-in Part||26
252542|NCT01016483|613218|P1|COMPLETED|Safety Run-in Part||27
252543|NCT01016483|613215|P4|STARTED|Safety Run-in Part||0
252544|NCT01016483|613216|P3|STARTED|Safety Run-in Part||0
252545|NCT01016483|613217|P2|STARTED|Safety Run-in Part||26
252546|NCT01016483|613218|P1|STARTED|Safety Run-in Part||27
252547|NCT01016600|613328|P4|NOT COMPLETED|Overall Study||0
252548|NCT01016600|613329|P3|NOT COMPLETED|Overall Study||0
252549|NCT01016600|613330|P2|NOT COMPLETED|Overall Study||0
252550|NCT01016600|613331|P1|NOT COMPLETED|Overall Study||1
252551|NCT01016600|613328|P4|COMPLETED|Overall Study||12
252552|NCT01016600|613329|P3|COMPLETED|Overall Study||6
252553|NCT01016600|613330|P2|COMPLETED|Overall Study||4
252554|NCT01016600|613331|P1|COMPLETED|Overall Study||8
252555|NCT01016600|613328|P4|STARTED|Overall Study||12
252556|NCT01016600|613329|P3|STARTED|Overall Study||6
252557|NCT01016600|613330|P2|STARTED|Overall Study||4
252558|NCT01016600|613331|P1|STARTED|Overall Study||9
252559|NCT01016652|613396|P2|NOT COMPLETED|Period 2||0
252560|NCT01016652|613397|P1|NOT COMPLETED|Period 2||0
252561|NCT01016652|613396|P2|COMPLETED|Period 2||24
252562|NCT01016652|613397|P1|COMPLETED|Period 2||25
252563|NCT01016652|613396|P2|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|24
252564|NCT01016652|613397|P1|STARTED|Period 2|Crossover study: the completed from period 1 will crossover in period 2 to the opposite arm.|25
252565|NCT01016652|613396|P2|NOT COMPLETED|Period 1||0
252566|NCT01016652|613397|P1|NOT COMPLETED|Period 1||0
252567|NCT01016652|613396|P2|COMPLETED|Period 1||24
252568|NCT01016652|613397|P1|COMPLETED|Period 1||25
252569|NCT01016652|613396|P2|STARTED|Period 1||24
252570|NCT01016652|613397|P1|STARTED|Period 1||25
252571|NCT01016678|613413|P5|NOT COMPLETED|Overall Study||6
252572|NCT01016678|613414|P4|NOT COMPLETED|Overall Study||0
252573|NCT01016678|613415|P3|NOT COMPLETED|Overall Study||4
252574|NCT01016678|613416|P2|NOT COMPLETED|Overall Study||3
252575|NCT01016678|613417|P1|NOT COMPLETED|Overall Study||2
252576|NCT01016678|613413|P5|COMPLETED|Overall Study||13
252577|NCT01016678|613414|P4|COMPLETED|Overall Study||19
252578|NCT01016678|613415|P3|COMPLETED|Overall Study||15
252579|NCT01016678|613416|P2|COMPLETED|Overall Study||14
252580|NCT01016678|613417|P1|COMPLETED|Overall Study||18
252581|NCT01016678|613413|P5|STARTED|Overall Study||19
252582|NCT01016678|613414|P4|STARTED|Overall Study||19
252583|NCT01016678|613415|P3|STARTED|Overall Study||19
252584|NCT01016678|613416|P2|STARTED|Overall Study||17
252585|NCT01016678|613417|P1|STARTED|Overall Study||20
252586|NCT01016691|613440|P3|NOT COMPLETED|Overall Study||0
252587|NCT01016691|613441|P2|NOT COMPLETED|Overall Study||0
252588|NCT01016691|613442|P1|NOT COMPLETED|Overall Study||0
252589|NCT01016691|613440|P3|COMPLETED|Overall Study||18
252590|NCT01016691|613441|P2|COMPLETED|Overall Study||12
252591|NCT01016691|613442|P1|COMPLETED|Overall Study||17
252592|NCT01016691|613440|P3|STARTED|Overall Study||18
252593|NCT01016691|613441|P2|STARTED|Overall Study||12
252594|NCT01016691|613442|P1|STARTED|Overall Study||17
252595|NCT01016834|613450|P1|NOT COMPLETED|Overall Study||22
252596|NCT01016834|613450|P1|COMPLETED|Overall Study||220
252597|NCT01016834|613450|P1|STARTED|Overall Study||242
252598|NCT01016847|613458|P2|NOT COMPLETED|Overall Study||0
252599|NCT01016847|613459|P1|NOT COMPLETED|Overall Study||0
252600|NCT01016847|613458|P2|COMPLETED|Overall Study||2
252601|NCT01016847|613459|P1|COMPLETED|Overall Study||1
252602|NCT01016847|613458|P2|STARTED|Overall Study||2
252603|NCT01016847|613459|P1|STARTED|Overall Study||1
252604|NCT01016873|613478|P3|NOT COMPLETED|36 Months||6
252605|NCT01016873|613479|P2|NOT COMPLETED|36 Months||4
252606|NCT01016873|613480|P1|NOT COMPLETED|36 Months||11
252607|NCT01016873|613478|P3|COMPLETED|36 Months||67
252608|NCT01016873|613479|P2|COMPLETED|36 Months||64
252609|NCT01016873|613480|P1|COMPLETED|36 Months||58
252610|NCT01016873|613478|P3|STARTED|36 Months||73
252611|NCT01016873|613479|P2|STARTED|36 Months||68
252612|NCT01016873|613480|P1|STARTED|36 Months||69
252613|NCT01016873|613478|P3|NOT COMPLETED|24 Months||6
252614|NCT01016873|613479|P2|NOT COMPLETED|24 Months||4
252615|NCT01016873|613480|P1|NOT COMPLETED|24 Months||5
252616|NCT01016873|613478|P3|COMPLETED|24 Months||73
252617|NCT01016873|613479|P2|COMPLETED|24 Months||68
252618|NCT01016873|613480|P1|COMPLETED|24 Months||69
252619|NCT01016873|613478|P3|STARTED|24 Months||79
252620|NCT01016873|613479|P2|STARTED|24 Months||72
252621|NCT01016873|613480|P1|STARTED|24 Months||74
252622|NCT01016873|613478|P3|NOT COMPLETED|12 Months||1
252623|NCT01016873|613479|P2|NOT COMPLETED|12 Months||3
252624|NCT01016873|613480|P1|NOT COMPLETED|12 Months||1
252625|NCT01016873|613478|P3|COMPLETED|12 Months||79
252626|NCT01016873|613479|P2|COMPLETED|12 Months||72
252627|NCT01016873|613480|P1|COMPLETED|12 Months||74
252628|NCT01016873|613478|P3|STARTED|12 Months||80
252629|NCT01016873|613479|P2|STARTED|12 Months||75
252630|NCT01016873|613480|P1|STARTED|12 Months||75
252631|NCT01016912|613514|P5|NOT COMPLETED|Follow-up Period||0
252632|NCT01016912|613515|P4|NOT COMPLETED|Follow-up Period||1
252633|NCT01016912|613516|P3|NOT COMPLETED|Follow-up Period||1
252634|NCT01016912|613517|P2|NOT COMPLETED|Follow-up Period||0
252635|NCT01016912|613518|P1|NOT COMPLETED|Follow-up Period||0
252636|NCT01016912|613514|P5|COMPLETED|Follow-up Period||9
252637|NCT01016912|613515|P4|COMPLETED|Follow-up Period||8
252638|NCT01016912|613516|P3|COMPLETED|Follow-up Period||9
252639|NCT01016912|613517|P2|COMPLETED|Follow-up Period||9
252640|NCT01016912|613518|P1|COMPLETED|Follow-up Period||8
252641|NCT01016912|613514|P5|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
252642|NCT01016912|613515|P4|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
252643|NCT01016912|613516|P3|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|10
252644|NCT01016912|613517|P2|STARTED|Follow-up Period|Those who completed period 1 or with detectable hepatitis C virus RNA, despite length of treatment|9
252645|NCT01016912|613518|P1|STARTED|Follow-up Period||8
252646|NCT01016912|613514|P5|NOT COMPLETED|End of Treatment Period||4
252647|NCT01016912|613515|P4|NOT COMPLETED|End of Treatment Period||4
252648|NCT01016912|613516|P3|NOT COMPLETED|End of Treatment Period||1
252649|NCT01016912|613517|P2|NOT COMPLETED|End of Treatment Period||3
252650|NCT01016912|613518|P1|NOT COMPLETED|End of Treatment Period||0
252651|NCT01016912|613514|P5|COMPLETED|End of Treatment Period||5
252652|NCT01016912|613515|P4|COMPLETED|End of Treatment Period||5
252653|NCT01016912|613516|P3|COMPLETED|End of Treatment Period||9
252654|NCT01016912|613517|P2|COMPLETED|End of Treatment Period||6
252655|NCT01016912|613518|P1|COMPLETED|End of Treatment Period||8
252656|NCT01016912|613514|P5|Received Treatment|End of Treatment Period||9
252657|NCT01016912|613515|P4|Received Treatment|End of Treatment Period||9
252658|NCT01016912|613516|P3|Received Treatment|End of Treatment Period||10
252659|NCT01016912|613517|P2|Received Treatment|End of Treatment Period||9
252660|NCT01016912|613518|P1|Received Treatment|End of Treatment Period||8
252661|NCT01016912|613514|P5|STARTED|End of Treatment Period||9
252662|NCT01016912|613515|P4|STARTED|End of Treatment Period||9
252663|NCT01016912|613516|P3|STARTED|End of Treatment Period||10
252664|NCT01016912|613517|P2|STARTED|End of Treatment Period||9
252665|NCT01016912|613518|P1|STARTED|End of Treatment Period||8
252666|NCT01016938|613560|P1|NOT COMPLETED|Overall Study||9
252667|NCT01016938|613560|P1|COMPLETED|Overall Study||7
252668|NCT01016938|613560|P1|STARTED|Overall Study||16
252669|NCT01016964|613567|P2|NOT COMPLETED|Overall Study||3
252670|NCT01016964|613568|P1|NOT COMPLETED|Overall Study||3
252671|NCT01016964|613567|P2|COMPLETED|Overall Study||39
252672|NCT01016964|613568|P1|COMPLETED|Overall Study||18
252673|NCT01016964|613567|P2|STARTED|Overall Study||42
252674|NCT01016964|613568|P1|STARTED|Overall Study||21
252675|NCT01016977|613576|P2|NOT COMPLETED|Overall Study||2
252676|NCT01016977|613577|P1|NOT COMPLETED|Overall Study||3
252677|NCT01016977|613576|P2|COMPLETED|Overall Study||18
252678|NCT01016977|613577|P1|COMPLETED|Overall Study||17
252679|NCT01016977|613576|P2|STARTED|Overall Study||20
252680|NCT01016977|613577|P1|STARTED|Overall Study||20
252681|NCT01017003|613611|P1|NOT COMPLETED|Colchicine 0.6 mg Final Dose||0
252682|NCT01017003|613611|P1|COMPLETED|Colchicine 0.6 mg Final Dose||13
252683|NCT01017003|613611|P1|STARTED|Colchicine 0.6 mg Final Dose||13
252684|NCT01017003|613611|P1|NOT COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||0
252685|NCT01017003|613611|P1|COMPLETED|Colchicine 0.6 mg Twice Daily x 10 Days||13
252686|NCT01017003|613611|P1|STARTED|Colchicine 0.6 mg Twice Daily x 10 Days||13
252687|NCT01017003|613611|P1|NOT COMPLETED|14 Day Washout Period||0
252688|NCT01017003|613611|P1|COMPLETED|14 Day Washout Period||13
252689|NCT01017003|613611|P1|STARTED|14 Day Washout Period||13
252690|NCT01017003|613611|P1|NOT COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||0
252691|NCT01017003|613611|P1|COMPLETED|Single Dose Colchicine 0.6 mg, Day 1||13
252692|NCT01017003|613611|P1|STARTED|Single Dose Colchicine 0.6 mg, Day 1||13
252693|NCT01017029|613623|P2|NOT COMPLETED|Overall Study||2
252694|NCT01017029|613624|P1|NOT COMPLETED|Overall Study||4
252695|NCT01017029|613623|P2|COMPLETED|Overall Study||90
252696|NCT01017029|613624|P1|COMPLETED|Overall Study||85
252697|NCT01017029|613623|P2|STARTED|Overall Study||92
252698|NCT01017029|613624|P1|STARTED|Overall Study||89
252699|NCT01017042|613640|P1|NOT COMPLETED|Overall Study||0
252700|NCT01017042|613640|P1|COMPLETED|Overall Study||13
252701|NCT01017042|613640|P1|STARTED|Overall Study||13
252702|NCT01017120|613653|P2|NOT COMPLETED|Overall Study||35
252703|NCT01017120|613654|P1|NOT COMPLETED|Overall Study||66
252704|NCT01017120|613653|P2|COMPLETED|Overall Study||334
252705|NCT01017120|613654|P1|COMPLETED|Overall Study||307
252706|NCT01017120|613653|P2|STARTED|Overall Study||369
252707|NCT01017120|613654|P1|STARTED|Overall Study||373
252708|NCT01017146|613704|P2|NOT COMPLETED|Overall Study||39
252709|NCT01017146|613705|P1|NOT COMPLETED|Overall Study||66
252710|NCT01017146|613704|P2|COMPLETED|Overall Study||333
252711|NCT01017146|613705|P1|COMPLETED|Overall Study||306
252712|NCT01017146|613704|P2|STARTED|Overall Study||372
252713|NCT01017146|613705|P1|STARTED|Overall Study||372
252714|NCT01017237|613743|P2|NOT COMPLETED|Overall Study||2
252715|NCT01017237|613744|P1|NOT COMPLETED|Overall Study||5
252716|NCT01017237|613743|P2|COMPLETED|Overall Study||6
252717|NCT01017237|613744|P1|COMPLETED|Overall Study||5
252718|NCT01017237|613743|P2|STARTED|Overall Study||8
252719|NCT01017237|613744|P1|STARTED|Overall Study||10
252720|NCT01017250|613796|P1|NOT COMPLETED|Overall Study||0
252721|NCT01017250|613796|P1|COMPLETED|Overall Study||15
252722|NCT01017250|613796|P1|2-month MRI|Overall Study|1 participant did not return for the 2 month MRI at treating facility. Resides out of state.|14
252723|NCT01017250|613796|P1|STARTED|Overall Study||15
252724|NCT01017263|613816|P1|NOT COMPLETED|Overall Study||12
252725|NCT01017263|613816|P1|COMPLETED|Overall Study|A total of 14 participants screened: 2 qualified and received drug the remaining 12 failed screen|2
252726|NCT01017263|613816|P1|STARTED|Overall Study||14
252727|NCT01024036|613822|P2|NOT COMPLETED|Unblinded Treatment||0
252728|NCT01024036|613823|P1|NOT COMPLETED|Unblinded Treatment||3
252729|NCT01024036|613822|P2|COMPLETED|Unblinded Treatment||0
252730|NCT01024036|613823|P1|COMPLETED|Unblinded Treatment||10
252731|NCT01024036|613822|P2|STARTED|Unblinded Treatment|No participants received Placebo+BSC during unblinded treatment period|0
252732|NCT01024036|613823|P1|STARTED|Unblinded Treatment|Only 13 participants from Placebo+BSC group received siltuximab+BSC in unblinded treatment period|13
252733|NCT01024036|613822|P2|NOT COMPLETED|Blinded Treatment||20
252734|NCT01024036|613823|P1|NOT COMPLETED|Blinded Treatment||22
252735|NCT01024036|613822|P2|COMPLETED|Blinded Treatment||6
252736|NCT01024036|613823|P1|COMPLETED|Blinded Treatment||31
252737|NCT01024036|613822|P2|STARTED|Blinded Treatment||26
252738|NCT01024036|613823|P1|STARTED|Blinded Treatment||53
252739|NCT01024608|613853|P2|NOT COMPLETED|Overall Study||4
252740|NCT01024608|613854|P1|NOT COMPLETED|Overall Study||4
252741|NCT01024608|613853|P2|COMPLETED|Overall Study||167
252742|NCT01024608|613854|P1|COMPLETED|Overall Study||165
252743|NCT01024608|613853|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|171
252744|NCT01024608|613854|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|167
252745|NCT01024608|613853|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|171
252746|NCT01024608|613854|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment|167
252747|NCT01024608|613853|P2|STARTED|Overall Study||171
252748|NCT01024608|613854|P1|STARTED|Overall Study||169
252749|NCT01024738|613869|P3|NOT COMPLETED|Third Intervention:||0
252750|NCT01024738|613870|P2|NOT COMPLETED|Third Intervention:||0
252751|NCT01024738|613871|P1|NOT COMPLETED|Third Intervention:||0
252752|NCT01024738|613869|P3|COMPLETED|Third Intervention:||8
252753|NCT01024738|613870|P2|COMPLETED|Third Intervention:||7
252754|NCT01024738|613871|P1|COMPLETED|Third Intervention:||7
252755|NCT01024738|613869|P3|STARTED|Third Intervention:||8
252756|NCT01024738|613870|P2|STARTED|Third Intervention:||7
252757|NCT01024738|613871|P1|STARTED|Third Intervention:||7
252758|NCT01024738|613869|P3|NOT COMPLETED|Washout After 2nd Intervention||0
252759|NCT01024738|613870|P2|NOT COMPLETED|Washout After 2nd Intervention||0
252760|NCT01024738|613871|P1|NOT COMPLETED|Washout After 2nd Intervention||0
252761|NCT01024738|613869|P3|COMPLETED|Washout After 2nd Intervention||8
252762|NCT01024738|613870|P2|COMPLETED|Washout After 2nd Intervention||7
252763|NCT01024738|613871|P1|COMPLETED|Washout After 2nd Intervention||7
252764|NCT01024738|613869|P3|STARTED|Washout After 2nd Intervention||8
252765|NCT01024738|613870|P2|STARTED|Washout After 2nd Intervention||7
252766|NCT01024738|613871|P1|STARTED|Washout After 2nd Intervention||7
252767|NCT01024738|613869|P3|NOT COMPLETED|Second Intervention:||0
252768|NCT01024738|613870|P2|NOT COMPLETED|Second Intervention:||0
252769|NCT01024738|613871|P1|NOT COMPLETED|Second Intervention:||0
252770|NCT01024738|613869|P3|COMPLETED|Second Intervention:||8
252771|NCT01024738|613870|P2|COMPLETED|Second Intervention:||7
252772|NCT01024738|613871|P1|COMPLETED|Second Intervention:||7
252773|NCT01024738|613869|P3|STARTED|Second Intervention:||8
252774|NCT01024738|613870|P2|STARTED|Second Intervention:||7
252775|NCT01024738|613871|P1|STARTED|Second Intervention:||7
252776|NCT01024738|613869|P3|NOT COMPLETED|Washout After 1st Intervention||0
252777|NCT01024738|613870|P2|NOT COMPLETED|Washout After 1st Intervention||0
252778|NCT01024738|613871|P1|NOT COMPLETED|Washout After 1st Intervention||0
252779|NCT01024738|613869|P3|COMPLETED|Washout After 1st Intervention||8
252780|NCT01024738|613870|P2|COMPLETED|Washout After 1st Intervention||7
252781|NCT01024738|613871|P1|COMPLETED|Washout After 1st Intervention||7
252782|NCT01024738|613869|P3|STARTED|Washout After 1st Intervention||8
252783|NCT01024738|613870|P2|STARTED|Washout After 1st Intervention||7
252784|NCT01024738|613871|P1|STARTED|Washout After 1st Intervention||7
252785|NCT01024738|613869|P3|NOT COMPLETED|First Intervention:||0
252786|NCT01024738|613870|P2|NOT COMPLETED|First Intervention:||0
252787|NCT01024738|613871|P1|NOT COMPLETED|First Intervention:||0
252788|NCT01024738|613869|P3|COMPLETED|First Intervention:||8
252789|NCT01024738|613870|P2|COMPLETED|First Intervention:||7
252790|NCT01024738|613871|P1|COMPLETED|First Intervention:||7
252791|NCT01024738|613869|P3|STARTED|First Intervention:||8
252792|NCT01024738|613870|P2|STARTED|First Intervention:||7
252793|NCT01024738|613871|P1|STARTED|First Intervention:||7
252794|NCT01024751|613881|P2|NOT COMPLETED|Eligible Participants||3
252795|NCT01024751|613882|P1|NOT COMPLETED|Eligible Participants||0
252796|NCT01024751|613881|P2|COMPLETED|Eligible Participants||149
252797|NCT01024751|613882|P1|COMPLETED|Eligible Participants||153
252798|NCT01024751|613881|P2|STARTED|Eligible Participants||152
252799|NCT01024751|613882|P1|STARTED|Eligible Participants||153
252800|NCT01024751|613881|P2|NOT COMPLETED|Enrolled Participants||4
252801|NCT01024751|613882|P1|NOT COMPLETED|Enrolled Participants||3
252802|NCT01024751|613881|P2|COMPLETED|Enrolled Participants||152
252803|NCT01024751|613882|P1|COMPLETED|Enrolled Participants||153
252804|NCT01024751|613881|P2|STARTED|Enrolled Participants||156
252805|NCT01024751|613882|P1|STARTED|Enrolled Participants||156
252806|NCT01024855|613890|P1|NOT COMPLETED|Overall Study||1
252807|NCT01024855|613890|P1|COMPLETED|Overall Study|One subject of the 30 seen for baseline did not meet the inclusion/exclusion criteria|29
252808|NCT01024855|613890|P1|STARTED|Overall Study|30 subjects enrolled in a paired/split-eye evaluation; each subject used both study treatments|30
252809|NCT01024946|613895|P1|NOT COMPLETED|Overall Study||5
252810|NCT01024946|613895|P1|COMPLETED|Overall Study||6
252811|NCT01024946|613895|P1|STARTED|Overall Study||11
252812|NCT01024959|613899|P1|NOT COMPLETED|Overall Study||41
252813|NCT01024959|613899|P1|COMPLETED|Overall Study||466
252814|NCT01024959|613899|P1|STARTED|Overall Study||507
252815|NCT01024972|613910|P2|NOT COMPLETED|Overall Study||0
252816|NCT01024972|613911|P1|NOT COMPLETED|Overall Study||0
252817|NCT01024972|613910|P2|COMPLETED|Overall Study||15
252818|NCT01024972|613911|P1|COMPLETED|Overall Study||16
252819|NCT01024972|613910|P2|STARTED|Overall Study||15
252820|NCT01024972|613911|P1|STARTED|Overall Study||16
252821|NCT01025037|613921|P1|NOT COMPLETED|Overall Study||11
252822|NCT01025037|613921|P1|COMPLETED|Overall Study||50
252823|NCT01025037|613921|P1|STARTED|Overall Study||61
252824|NCT01025076|613930|P1|NOT COMPLETED|Overall Study||0
252825|NCT01025076|613930|P1|COMPLETED|Overall Study||14
252826|NCT01025076|613930|P1|STARTED|Overall Study||14
252827|NCT01025154|613934|P1|NOT COMPLETED|Overall Study||2
252828|NCT01025154|613934|P1|COMPLETED|Overall Study||57
252829|NCT01025154|613934|P1|STARTED|Overall Study||59
252830|NCT01025193|613939|P1|NOT COMPLETED|Overall Study||4
252831|NCT01025193|613939|P1|COMPLETED|Overall Study|one patient was transplanted 2 weeks after 8 month belimumab dose and did not receive further doses.|4
252832|NCT01025193|613939|P1|STARTED|Overall Study||8
252833|NCT01025232|613951|P2|NOT COMPLETED|Overall Study||6
252834|NCT01025232|613952|P1|NOT COMPLETED|Overall Study||3
252835|NCT01025232|613951|P2|COMPLETED|Overall Study||36
252836|NCT01025232|613952|P1|COMPLETED|Overall Study||43
252837|NCT01025232|613951|P2|STARTED|Overall Study||42
252838|NCT01025232|613952|P1|STARTED|Overall Study||46
252839|NCT01025271|613970|P1|NOT COMPLETED|Overall Study||0
252840|NCT01025271|613970|P1|COMPLETED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
252841|NCT01025271|613970|P1|STARTED|Overall Study|unable to meet enrollment no data available. Study terminated early|2
252842|NCT01025336|613980|P5|NOT COMPLETED|Overall Study||0
252843|NCT01025336|613981|P4|NOT COMPLETED|Overall Study||2
252844|NCT01025336|613982|P3|NOT COMPLETED|Overall Study||0
252845|NCT01025336|613983|P2|NOT COMPLETED|Overall Study||0
252846|NCT01025336|613984|P1|NOT COMPLETED|Overall Study||0
252847|NCT01025336|613980|P5|COMPLETED|Overall Study||222
252848|NCT01025336|613981|P4|COMPLETED|Overall Study||219
252849|NCT01025336|613982|P3|COMPLETED|Overall Study||179
252850|NCT01025336|613983|P2|COMPLETED|Overall Study||210
252851|NCT01025336|613984|P1|COMPLETED|Overall Study||130
252852|NCT01025336|613980|P5|STARTED|Overall Study||222
252853|NCT01025336|613981|P4|STARTED|Overall Study||221
252854|NCT01025336|613982|P3|STARTED|Overall Study||179
252855|NCT01025336|613983|P2|STARTED|Overall Study||210
252856|NCT01025336|613984|P1|STARTED|Overall Study||130
252857|NCT01025492|614036|P1|NOT COMPLETED|Overall Study||0
252858|NCT01025492|614036|P1|COMPLETED|Overall Study||24
252859|NCT01025492|614036|P1|STARTED|Overall Study||24
252860|NCT01025635|614042|P2|NOT COMPLETED|Overall Study||25
252861|NCT01025635|614043|P1|NOT COMPLETED|Overall Study||23
252862|NCT01025635|614042|P2|COMPLETED|Overall Study||178
252863|NCT01025635|614043|P1|COMPLETED|Overall Study||175
252864|NCT01025635|614042|P2|STARTED|Overall Study||203
252865|NCT01025635|614043|P1|STARTED|Overall Study||198
252866|NCT01025817|614057|P2|NOT COMPLETED|Completed Study||22
252867|NCT01025817|614058|P1|NOT COMPLETED|Completed Study||16
252868|NCT01025817|614057|P2|COMPLETED|Completed Study|Completed study phase|282
252869|NCT01025817|614058|P1|COMPLETED|Completed Study|Completed study phase|293
252870|NCT01025817|614057|P2|STARTED|Completed Study||304
252871|NCT01025817|614058|P1|STARTED|Completed Study||309
252872|NCT01025817|614057|P2|NOT COMPLETED|Completed Study Medication||72
252873|NCT01025817|614058|P1|NOT COMPLETED|Completed Study Medication||105
252874|NCT01025817|614057|P2|COMPLETED|Completed Study Medication||232
252875|NCT01025817|614058|P1|COMPLETED|Completed Study Medication||204
252876|NCT01025817|614057|P2|STARTED|Completed Study Medication||304
252877|NCT01025817|614058|P1|STARTED|Completed Study Medication||309
252878|NCT01025830|614076|P2|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
252879|NCT01025830|614077|P1|NOT COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||0
252880|NCT01025830|614076|P2|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
252881|NCT01025830|614077|P1|COMPLETED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
252882|NCT01025830|614076|P2|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||12
252883|NCT01025830|614077|P1|STARTED|Brand (Ze/Ep/Vi) First Then Generic (Tr)||8
252884|NCT01025830|614076|P2|NOT COMPLETED|Washout Period of 30 Days||0
252885|NCT01025830|614077|P1|NOT COMPLETED|Washout Period of 30 Days||0
252886|NCT01025830|614076|P2|COMPLETED|Washout Period of 30 Days||12
252887|NCT01025830|614077|P1|COMPLETED|Washout Period of 30 Days||8
252888|NCT01025830|614076|P2|STARTED|Washout Period of 30 Days||12
252889|NCT01025830|614077|P1|STARTED|Washout Period of 30 Days||8
252890|NCT01025830|614076|P2|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
252891|NCT01025830|614077|P1|NOT COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||0
252892|NCT01025830|614076|P2|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
252893|NCT01025830|614077|P1|COMPLETED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
252894|NCT01025830|614076|P2|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||12
252895|NCT01025830|614077|P1|STARTED|Generic (Tr) First Then Brand (Ze/Ep/Vi)||8
252896|NCT01025843|614104|P10|NOT COMPLETED|Period 5||0
252897|NCT01025843|614105|P9|NOT COMPLETED|Period 5||0
252898|NCT01025843|614106|P8|NOT COMPLETED|Period 5||0
252899|NCT01025843|614107|P7|NOT COMPLETED|Period 5||0
252900|NCT01025843|614108|P6|NOT COMPLETED|Period 5||0
252901|NCT01025843|614109|P5|NOT COMPLETED|Period 5||0
252902|NCT01025843|614110|P4|NOT COMPLETED|Period 5||0
252903|NCT01025843|614111|P3|NOT COMPLETED|Period 5||0
252904|NCT01025843|614112|P2|NOT COMPLETED|Period 5||0
252905|NCT01025843|614113|P1|NOT COMPLETED|Period 5||0
252906|NCT01025843|614104|P10|COMPLETED|Period 5||2
252907|NCT01025843|614105|P9|COMPLETED|Period 5||2
252908|NCT01025843|614106|P8|COMPLETED|Period 5||2
252909|NCT01025843|614107|P7|COMPLETED|Period 5||2
252910|NCT01025843|614108|P6|COMPLETED|Period 5||2
252911|NCT01025843|614109|P5|COMPLETED|Period 5||2
252912|NCT01025843|614110|P4|COMPLETED|Period 5||1
252913|NCT01025843|614111|P3|COMPLETED|Period 5||1
252914|NCT01025843|614112|P2|COMPLETED|Period 5||2
252915|NCT01025843|614113|P1|COMPLETED|Period 5||2
252916|NCT01025843|614104|P10|STARTED|Period 5||2
252917|NCT01025843|614105|P9|STARTED|Period 5||2
252918|NCT01025843|614106|P8|STARTED|Period 5||2
252919|NCT01025843|614107|P7|STARTED|Period 5||2
252920|NCT01025843|614108|P6|STARTED|Period 5||2
252921|NCT01025843|614109|P5|STARTED|Period 5||2
252922|NCT01025843|614110|P4|STARTED|Period 5||1
252923|NCT01025843|614111|P3|STARTED|Period 5||1
252924|NCT01025843|614112|P2|STARTED|Period 5||2
252925|NCT01025843|614113|P1|STARTED|Period 5||2
252926|NCT01025843|614104|P10|NOT COMPLETED|Washout 4||0
252927|NCT01025843|614105|P9|NOT COMPLETED|Washout 4||0
252928|NCT01025843|614106|P8|NOT COMPLETED|Washout 4||0
252929|NCT01025843|614107|P7|NOT COMPLETED|Washout 4||0
252930|NCT01025843|614108|P6|NOT COMPLETED|Washout 4||0
252931|NCT01025843|614109|P5|NOT COMPLETED|Washout 4||0
252932|NCT01025843|614110|P4|NOT COMPLETED|Washout 4||1
252933|NCT01025843|614111|P3|NOT COMPLETED|Washout 4||1
252934|NCT01025843|614112|P2|NOT COMPLETED|Washout 4||0
252935|NCT01025843|614113|P1|NOT COMPLETED|Washout 4||0
252936|NCT01025843|614104|P10|COMPLETED|Washout 4||2
252937|NCT01025843|614105|P9|COMPLETED|Washout 4||2
252938|NCT01025843|614106|P8|COMPLETED|Washout 4||2
252939|NCT01025843|614107|P7|COMPLETED|Washout 4||2
252940|NCT01025843|614108|P6|COMPLETED|Washout 4||2
252941|NCT01025843|614109|P5|COMPLETED|Washout 4||2
252942|NCT01025843|614110|P4|COMPLETED|Washout 4||1
252943|NCT01025843|614111|P3|COMPLETED|Washout 4||1
252944|NCT01025843|614112|P2|COMPLETED|Washout 4||2
252945|NCT01025843|614113|P1|COMPLETED|Washout 4||2
252946|NCT01025843|614104|P10|STARTED|Washout 4||2
252947|NCT01025843|614105|P9|STARTED|Washout 4||2
252948|NCT01025843|614106|P8|STARTED|Washout 4||2
252949|NCT01025843|614107|P7|STARTED|Washout 4||2
252950|NCT01025843|614108|P6|STARTED|Washout 4||2
252951|NCT01025843|614109|P5|STARTED|Washout 4||2
252952|NCT01025843|614110|P4|STARTED|Washout 4||2
252953|NCT01025843|614111|P3|STARTED|Washout 4||2
252954|NCT01025843|614112|P2|STARTED|Washout 4||2
252955|NCT01025843|614113|P1|STARTED|Washout 4||2
252956|NCT01025843|614104|P10|NOT COMPLETED|Period 4||0
252957|NCT01025843|614105|P9|NOT COMPLETED|Period 4||0
252958|NCT01025843|614106|P8|NOT COMPLETED|Period 4||0
252959|NCT01025843|614107|P7|NOT COMPLETED|Period 4||0
252960|NCT01025843|614108|P6|NOT COMPLETED|Period 4||0
252961|NCT01025843|614109|P5|NOT COMPLETED|Period 4||0
252962|NCT01025843|614110|P4|NOT COMPLETED|Period 4||0
252963|NCT01025843|614111|P3|NOT COMPLETED|Period 4||0
252964|NCT01025843|614112|P2|NOT COMPLETED|Period 4||0
252965|NCT01025843|614113|P1|NOT COMPLETED|Period 4||0
252966|NCT01025843|614104|P10|COMPLETED|Period 4||2
252967|NCT01025843|614105|P9|COMPLETED|Period 4||2
252968|NCT01025843|614106|P8|COMPLETED|Period 4||2
252969|NCT01025843|614107|P7|COMPLETED|Period 4||2
252970|NCT01025843|614108|P6|COMPLETED|Period 4||2
252971|NCT01025843|614109|P5|COMPLETED|Period 4||2
252972|NCT01025843|614110|P4|COMPLETED|Period 4||2
252973|NCT01025843|614111|P3|COMPLETED|Period 4||2
252974|NCT01025843|614112|P2|COMPLETED|Period 4||2
252975|NCT01025843|614113|P1|COMPLETED|Period 4||2
252976|NCT01025843|614104|P10|STARTED|Period 4||2
252977|NCT01025843|614105|P9|STARTED|Period 4||2
252978|NCT01025843|614106|P8|STARTED|Period 4||2
252979|NCT01025843|614107|P7|STARTED|Period 4||2
252980|NCT01025843|614108|P6|STARTED|Period 4||2
252981|NCT01025843|614109|P5|STARTED|Period 4||2
252982|NCT01025843|614110|P4|STARTED|Period 4||2
252983|NCT01025843|614111|P3|STARTED|Period 4||2
252984|NCT01025843|614112|P2|STARTED|Period 4||2
252985|NCT01025843|614113|P1|STARTED|Period 4||2
252986|NCT01025843|614104|P10|NOT COMPLETED|Washout 3||0
252987|NCT01025843|614105|P9|NOT COMPLETED|Washout 3||0
252988|NCT01025843|614106|P8|NOT COMPLETED|Washout 3||0
252989|NCT01025843|614107|P7|NOT COMPLETED|Washout 3||0
252990|NCT01025843|614108|P6|NOT COMPLETED|Washout 3||0
252991|NCT01025843|614109|P5|NOT COMPLETED|Washout 3||0
252992|NCT01025843|614110|P4|NOT COMPLETED|Washout 3||0
252993|NCT01025843|614111|P3|NOT COMPLETED|Washout 3||0
252994|NCT01025843|614112|P2|NOT COMPLETED|Washout 3||0
252995|NCT01025843|614113|P1|NOT COMPLETED|Washout 3||0
252996|NCT01025843|614104|P10|COMPLETED|Washout 3||2
252997|NCT01025843|614105|P9|COMPLETED|Washout 3||2
252998|NCT01025843|614106|P8|COMPLETED|Washout 3||2
252999|NCT01025843|614107|P7|COMPLETED|Washout 3||2
253000|NCT01025843|614108|P6|COMPLETED|Washout 3||2
253001|NCT01025843|614109|P5|COMPLETED|Washout 3||2
253002|NCT01025843|614110|P4|COMPLETED|Washout 3||2
253003|NCT01025843|614111|P3|COMPLETED|Washout 3||2
253004|NCT01025843|614112|P2|COMPLETED|Washout 3||2
253005|NCT01025843|614113|P1|COMPLETED|Washout 3||2
253006|NCT01025843|614104|P10|STARTED|Washout 3||2
253007|NCT01025843|614105|P9|STARTED|Washout 3||2
253008|NCT01025843|614106|P8|STARTED|Washout 3||2
253009|NCT01025843|614107|P7|STARTED|Washout 3||2
253010|NCT01025843|614108|P6|STARTED|Washout 3||2
253011|NCT01025843|614109|P5|STARTED|Washout 3||2
253012|NCT01025843|614110|P4|STARTED|Washout 3||2
253013|NCT01025843|614111|P3|STARTED|Washout 3||2
253014|NCT01025843|614112|P2|STARTED|Washout 3||2
253015|NCT01025843|614113|P1|STARTED|Washout 3||2
253016|NCT01025843|614104|P10|NOT COMPLETED|Period 3||0
253017|NCT01025843|614105|P9|NOT COMPLETED|Period 3||0
253018|NCT01025843|614106|P8|NOT COMPLETED|Period 3||0
253019|NCT01025843|614107|P7|NOT COMPLETED|Period 3||0
253020|NCT01025843|614108|P6|NOT COMPLETED|Period 3||0
253021|NCT01025843|614109|P5|NOT COMPLETED|Period 3||0
253022|NCT01025843|614110|P4|NOT COMPLETED|Period 3||0
253023|NCT01025843|614111|P3|NOT COMPLETED|Period 3||0
253024|NCT01025843|614112|P2|NOT COMPLETED|Period 3||0
253025|NCT01025843|614113|P1|NOT COMPLETED|Period 3||0
253026|NCT01025843|614104|P10|COMPLETED|Period 3||2
253027|NCT01025843|614105|P9|COMPLETED|Period 3||2
253028|NCT01025843|614106|P8|COMPLETED|Period 3||2
253029|NCT01025843|614107|P7|COMPLETED|Period 3||2
253030|NCT01025843|614108|P6|COMPLETED|Period 3||2
253031|NCT01025843|614109|P5|COMPLETED|Period 3||2
253032|NCT01025843|614110|P4|COMPLETED|Period 3||2
253033|NCT01025843|614111|P3|COMPLETED|Period 3||2
253034|NCT01025843|614112|P2|COMPLETED|Period 3||2
253035|NCT01025843|614113|P1|COMPLETED|Period 3||2
253036|NCT01025843|614104|P10|STARTED|Period 3||2
253037|NCT01025843|614105|P9|STARTED|Period 3||2
253038|NCT01025843|614106|P8|STARTED|Period 3||2
253039|NCT01025843|614107|P7|STARTED|Period 3||2
253040|NCT01025843|614108|P6|STARTED|Period 3||2
253041|NCT01025843|614109|P5|STARTED|Period 3||2
253042|NCT01025843|614110|P4|STARTED|Period 3||2
253043|NCT01025843|614111|P3|STARTED|Period 3||2
253044|NCT01025843|614112|P2|STARTED|Period 3||2
253045|NCT01025843|614113|P1|STARTED|Period 3||2
253046|NCT01025843|614104|P10|NOT COMPLETED|Washout 2||0
253047|NCT01025843|614105|P9|NOT COMPLETED|Washout 2||0
253048|NCT01025843|614106|P8|NOT COMPLETED|Washout 2||0
253049|NCT01025843|614107|P7|NOT COMPLETED|Washout 2||0
253050|NCT01025843|614108|P6|NOT COMPLETED|Washout 2||0
253051|NCT01025843|614109|P5|NOT COMPLETED|Washout 2||0
253052|NCT01025843|614110|P4|NOT COMPLETED|Washout 2||0
253053|NCT01025843|614111|P3|NOT COMPLETED|Washout 2||0
253054|NCT01025843|614112|P2|NOT COMPLETED|Washout 2||0
253055|NCT01025843|614113|P1|NOT COMPLETED|Washout 2||0
253056|NCT01025843|614104|P10|COMPLETED|Washout 2||2
253057|NCT01025843|614105|P9|COMPLETED|Washout 2||2
253058|NCT01025843|614106|P8|COMPLETED|Washout 2||2
253059|NCT01025843|614107|P7|COMPLETED|Washout 2||2
253060|NCT01025843|614108|P6|COMPLETED|Washout 2||2
253061|NCT01025843|614109|P5|COMPLETED|Washout 2||2
253062|NCT01025843|614110|P4|COMPLETED|Washout 2||2
253063|NCT01025843|614111|P3|COMPLETED|Washout 2||2
253064|NCT01025843|614112|P2|COMPLETED|Washout 2||2
253065|NCT01025843|614113|P1|COMPLETED|Washout 2||2
253066|NCT01025843|614104|P10|STARTED|Washout 2||2
253067|NCT01025843|614105|P9|STARTED|Washout 2||2
253068|NCT01025843|614106|P8|STARTED|Washout 2||2
253069|NCT01025843|614107|P7|STARTED|Washout 2||2
253070|NCT01025843|614108|P6|STARTED|Washout 2||2
253071|NCT01025843|614109|P5|STARTED|Washout 2||2
253072|NCT01025843|614110|P4|STARTED|Washout 2||2
253073|NCT01025843|614111|P3|STARTED|Washout 2||2
253074|NCT01025843|614112|P2|STARTED|Washout 2||2
253075|NCT01025843|614113|P1|STARTED|Washout 2||2
253076|NCT01025843|614104|P10|NOT COMPLETED|Period 2||0
253077|NCT01025843|614105|P9|NOT COMPLETED|Period 2||0
253078|NCT01025843|614106|P8|NOT COMPLETED|Period 2||0
253079|NCT01025843|614107|P7|NOT COMPLETED|Period 2||0
253080|NCT01025843|614108|P6|NOT COMPLETED|Period 2||0
253081|NCT01025843|614109|P5|NOT COMPLETED|Period 2||0
253082|NCT01025843|614110|P4|NOT COMPLETED|Period 2||0
253083|NCT01025843|614111|P3|NOT COMPLETED|Period 2||0
253084|NCT01025843|614112|P2|NOT COMPLETED|Period 2||0
253085|NCT01025843|614113|P1|NOT COMPLETED|Period 2||0
253086|NCT01025843|614104|P10|COMPLETED|Period 2||2
253087|NCT01025843|614105|P9|COMPLETED|Period 2||2
253088|NCT01025843|614106|P8|COMPLETED|Period 2||2
253089|NCT01025843|614107|P7|COMPLETED|Period 2||2
253090|NCT01025843|614108|P6|COMPLETED|Period 2||2
253091|NCT01025843|614109|P5|COMPLETED|Period 2||2
253092|NCT01025843|614110|P4|COMPLETED|Period 2||2
253093|NCT01025843|614111|P3|COMPLETED|Period 2||2
253094|NCT01025843|614112|P2|COMPLETED|Period 2||2
253095|NCT01025843|614113|P1|COMPLETED|Period 2||2
253096|NCT01025843|614104|P10|STARTED|Period 2||2
253097|NCT01025843|614105|P9|STARTED|Period 2||2
253098|NCT01025843|614106|P8|STARTED|Period 2||2
253099|NCT01025843|614107|P7|STARTED|Period 2||2
253100|NCT01025843|614108|P6|STARTED|Period 2||2
253101|NCT01025843|614109|P5|STARTED|Period 2||2
253102|NCT01025843|614110|P4|STARTED|Period 2||2
253103|NCT01025843|614111|P3|STARTED|Period 2||2
253104|NCT01025843|614112|P2|STARTED|Period 2||2
253105|NCT01025843|614113|P1|STARTED|Period 2||2
253106|NCT01025843|614104|P10|NOT COMPLETED|Washout 1||0
253107|NCT01025843|614105|P9|NOT COMPLETED|Washout 1||0
253108|NCT01025843|614106|P8|NOT COMPLETED|Washout 1||0
253109|NCT01025843|614107|P7|NOT COMPLETED|Washout 1||0
253110|NCT01025843|614108|P6|NOT COMPLETED|Washout 1||0
253111|NCT01025843|614109|P5|NOT COMPLETED|Washout 1||0
253112|NCT01025843|614110|P4|NOT COMPLETED|Washout 1||0
253113|NCT01025843|614111|P3|NOT COMPLETED|Washout 1||0
253114|NCT01025843|614112|P2|NOT COMPLETED|Washout 1||0
253115|NCT01025843|614113|P1|NOT COMPLETED|Washout 1||0
253116|NCT01025843|614104|P10|COMPLETED|Washout 1||2
253117|NCT01025843|614105|P9|COMPLETED|Washout 1||2
253118|NCT01025843|614106|P8|COMPLETED|Washout 1||2
253119|NCT01025843|614107|P7|COMPLETED|Washout 1||2
253120|NCT01025843|614108|P6|COMPLETED|Washout 1||2
253121|NCT01025843|614109|P5|COMPLETED|Washout 1||2
253122|NCT01025843|614110|P4|COMPLETED|Washout 1||2
253123|NCT01025843|614111|P3|COMPLETED|Washout 1||2
253124|NCT01025843|614112|P2|COMPLETED|Washout 1||2
253125|NCT01025843|614113|P1|COMPLETED|Washout 1||2
253126|NCT01025843|614104|P10|STARTED|Washout 1||2
253127|NCT01025843|614105|P9|STARTED|Washout 1||2
253128|NCT01025843|614106|P8|STARTED|Washout 1||2
253129|NCT01025843|614107|P7|STARTED|Washout 1||2
253130|NCT01025843|614108|P6|STARTED|Washout 1||2
253131|NCT01025843|614109|P5|STARTED|Washout 1||2
253132|NCT01025843|614110|P4|STARTED|Washout 1||2
253133|NCT01025843|614111|P3|STARTED|Washout 1||2
253134|NCT01025843|614112|P2|STARTED|Washout 1||2
253135|NCT01025843|614113|P1|STARTED|Washout 1||2
253136|NCT01025843|614104|P10|NOT COMPLETED|Period 1||0
253137|NCT01025843|614105|P9|NOT COMPLETED|Period 1||0
253138|NCT01025843|614106|P8|NOT COMPLETED|Period 1||0
253139|NCT01025843|614107|P7|NOT COMPLETED|Period 1||0
253140|NCT01025843|614108|P6|NOT COMPLETED|Period 1||0
253141|NCT01025843|614109|P5|NOT COMPLETED|Period 1||0
253142|NCT01025843|614110|P4|NOT COMPLETED|Period 1||0
253143|NCT01025843|614111|P3|NOT COMPLETED|Period 1||0
253144|NCT01025843|614112|P2|NOT COMPLETED|Period 1||0
253145|NCT01025843|614113|P1|NOT COMPLETED|Period 1||0
253146|NCT01025843|614104|P10|COMPLETED|Period 1||2
253147|NCT01025843|614105|P9|COMPLETED|Period 1||2
253148|NCT01025843|614106|P8|COMPLETED|Period 1||2
253149|NCT01025843|614107|P7|COMPLETED|Period 1||2
253150|NCT01025843|614108|P6|COMPLETED|Period 1||2
253151|NCT01025843|614109|P5|COMPLETED|Period 1||2
253152|NCT01025843|614110|P4|COMPLETED|Period 1||2
253153|NCT01025843|614111|P3|COMPLETED|Period 1||2
253154|NCT01025843|614112|P2|COMPLETED|Period 1||2
253155|NCT01025843|614113|P1|COMPLETED|Period 1||2
253156|NCT01025843|614104|P10|STARTED|Period 1||2
253157|NCT01025843|614105|P9|STARTED|Period 1||2
253158|NCT01025843|614106|P8|STARTED|Period 1||2
253159|NCT01025843|614107|P7|STARTED|Period 1||2
253160|NCT01025843|614108|P6|STARTED|Period 1||2
253161|NCT01025843|614109|P5|STARTED|Period 1||2
253162|NCT01025843|614110|P4|STARTED|Period 1||2
253163|NCT01025843|614111|P3|STARTED|Period 1||2
253164|NCT01025843|614112|P2|STARTED|Period 1||2
253165|NCT01025843|614113|P1|STARTED|Period 1||2
253166|NCT01026012|614187|P1|NOT COMPLETED|Overall Study||0
253167|NCT01026012|614187|P1|COMPLETED|Overall Study||40
253168|NCT01026012|614187|P1|STARTED|Overall Study||40
253169|NCT01026038|614194|P3|NOT COMPLETED|Overall Study||0
253170|NCT01026038|614195|P2|NOT COMPLETED|Overall Study||1
253171|NCT01026038|614196|P1|NOT COMPLETED|Overall Study||1
253172|NCT01026038|614194|P3|COMPLETED|Overall Study||67
253173|NCT01026038|614195|P2|COMPLETED|Overall Study||64
253174|NCT01026038|614196|P1|COMPLETED|Overall Study||129
253175|NCT01026038|614194|P3|STARTED|Overall Study||67
253176|NCT01026038|614195|P2|STARTED|Overall Study||65
253177|NCT01026038|614196|P1|STARTED|Overall Study||130
253178|NCT01026103|614231|P1|NOT COMPLETED|Overall Study||2
253179|NCT01026103|614231|P1|COMPLETED|Overall Study||28
253180|NCT01026103|614231|P1|Consented|Overall Study||30
253181|NCT01026103|614231|P1|STARTED|Overall Study||30
253182|NCT01026142|614240|P2|NOT COMPLETED|Overall Study||121
253183|NCT01026142|614241|P1|NOT COMPLETED|Overall Study||139
253184|NCT01026142|614240|P2|COMPLETED|Overall Study||107
253185|NCT01026142|614241|P1|COMPLETED|Overall Study||79
253186|NCT01026142|614240|P2|STARTED|Overall Study||228
253187|NCT01026142|614241|P1|STARTED|Overall Study||218
253188|NCT01026194|614265|P2|NOT COMPLETED|Period 2：Open-label Period||10
253189|NCT01026194|614266|P1|NOT COMPLETED|Period 2：Open-label Period||7
253190|NCT01026194|614265|P2|COMPLETED|Period 2：Open-label Period||88
253191|NCT01026194|614266|P1|COMPLETED|Period 2：Open-label Period||91
253192|NCT01026194|614265|P2|STARTED|Period 2：Open-label Period||98
253193|NCT01026194|614266|P1|STARTED|Period 2：Open-label Period||98
253194|NCT01026194|614265|P2|NOT COMPLETED|Period 1：Double Blind Period||5
253195|NCT01026194|614266|P1|NOT COMPLETED|Period 1：Double Blind Period||3
253196|NCT01026194|614265|P2|COMPLETED|Period 1：Double Blind Period||98
253197|NCT01026194|614266|P1|COMPLETED|Period 1：Double Blind Period||98
253198|NCT01026194|614265|P2|STARTED|Period 1：Double Blind Period||103
253199|NCT01026194|614266|P1|STARTED|Period 1：Double Blind Period||101
253200|NCT01026220|614280|P3|NOT COMPLETED|Consolidation Maintenance||14
253201|NCT01026220|614281|P2|NOT COMPLETED|Consolidation Maintenance||6
253202|NCT01026220|614282|P1|NOT COMPLETED|Consolidation Maintenance||0
253203|NCT01026220|614280|P3|COMPLETED|Consolidation Maintenance||66
253204|NCT01026220|614281|P2|COMPLETED|Consolidation Maintenance||75
253205|NCT01026220|614282|P1|COMPLETED|Consolidation Maintenance||0
253206|NCT01026220|614280|P3|STARTED|Consolidation Maintenance||80
253207|NCT01026220|614281|P2|STARTED|Consolidation Maintenance||81
253208|NCT01026220|614282|P1|STARTED|Consolidation Maintenance||0
253209|NCT01026220|614280|P3|NOT COMPLETED|Induction||0
253210|NCT01026220|614281|P2|NOT COMPLETED|Induction||0
253211|NCT01026220|614282|P1|NOT COMPLETED|Induction||25
253212|NCT01026220|614280|P3|COMPLETED|Induction||0
253213|NCT01026220|614281|P2|COMPLETED|Induction||0
253214|NCT01026220|614282|P1|COMPLETED|Induction||141
253215|NCT01026220|614280|P3|STARTED|Induction||0
253216|NCT01026220|614281|P2|STARTED|Induction||0
253217|NCT01026220|614282|P1|STARTED|Induction||166
253218|NCT01026324|614307|P3|NOT COMPLETED|Follow up/Survival||0
253219|NCT01026324|614308|P2|NOT COMPLETED|Follow up/Survival||0
253220|NCT01026324|614309|P1|NOT COMPLETED|Follow up/Survival||1
253221|NCT01026324|614307|P3|COMPLETED|Follow up/Survival||4
253222|NCT01026324|614308|P2|COMPLETED|Follow up/Survival||3
253223|NCT01026324|614309|P1|COMPLETED|Follow up/Survival||4
253224|NCT01026324|614307|P3|Follow up Discontinuation (Death)|Follow up/Survival||4
253225|NCT01026324|614308|P2|Follow up Discontinuation (Death)|Follow up/Survival||3
253226|NCT01026324|614309|P1|Follow up Discontinuation (Death)|Follow up/Survival||4
253227|NCT01026324|614307|P3|STARTED|Follow up/Survival||4
253228|NCT01026324|614308|P2|STARTED|Follow up/Survival||3
253229|NCT01026324|614309|P1|STARTED|Follow up/Survival||5
253230|NCT01026324|614307|P3|NOT COMPLETED|Treatment Allocation||0
253231|NCT01026324|614308|P2|NOT COMPLETED|Treatment Allocation||0
253232|NCT01026324|614309|P1|NOT COMPLETED|Treatment Allocation||0
253233|NCT01026324|614307|P3|COMPLETED|Treatment Allocation||4
253234|NCT01026324|614308|P2|COMPLETED|Treatment Allocation||3
253235|NCT01026324|614309|P1|COMPLETED|Treatment Allocation||5
253236|NCT01026324|614307|P3|Discontinued Intervention (Withdrew)|Treatment Allocation||0
253237|NCT01026324|614308|P2|Discontinued Intervention (Withdrew)|Treatment Allocation||0
253238|NCT01026324|614309|P1|Discontinued Intervention (Withdrew)|Treatment Allocation||1
253239|NCT01026324|614307|P3|Discontinuted Intervention (Progression)|Treatment Allocation||4
253240|NCT01026324|614308|P2|Discontinuted Intervention (Progression)|Treatment Allocation||3
253241|NCT01026324|614309|P1|Discontinuted Intervention (Progression)|Treatment Allocation||3
253242|NCT01026324|614307|P3|Discontinued Intervention (Toxicity)|Treatment Allocation||0
253243|NCT01026324|614308|P2|Discontinued Intervention (Toxicity)|Treatment Allocation||0
253244|NCT01026324|614309|P1|Discontinued Intervention (Toxicity)|Treatment Allocation||1
253245|NCT01026324|614307|P3|STARTED|Treatment Allocation||4
253246|NCT01026324|614308|P2|STARTED|Treatment Allocation||3
253247|NCT01026324|614309|P1|STARTED|Treatment Allocation||5
253248|NCT01026389|614321|P2|NOT COMPLETED|Overall Study||5
253249|NCT01026389|614322|P1|NOT COMPLETED|Overall Study||5
253250|NCT01026389|614321|P2|COMPLETED|Overall Study||88
253251|NCT01026389|614322|P1|COMPLETED|Overall Study||88
253252|NCT01026389|614321|P2|STARTED|Overall Study||93
253253|NCT01026389|614322|P1|STARTED|Overall Study||93
253254|NCT01026402|614351|P17|NOT COMPLETED|Overall Study||0
253255|NCT01026402|614352|P16|NOT COMPLETED|Overall Study||0
253256|NCT01026402|614353|P15|NOT COMPLETED|Overall Study||0
253257|NCT01026402|614354|P14|NOT COMPLETED|Overall Study||0
253258|NCT01026402|614355|P13|NOT COMPLETED|Overall Study||0
253259|NCT01026402|614356|P12|NOT COMPLETED|Overall Study||0
253260|NCT01026402|614357|P11|NOT COMPLETED|Overall Study||0
253261|NCT01026402|614358|P10|NOT COMPLETED|Overall Study||0
253262|NCT01026402|614359|P9|NOT COMPLETED|Overall Study||0
253263|NCT01026402|614360|P8|NOT COMPLETED|Overall Study||0
253264|NCT01026402|614361|P7|NOT COMPLETED|Overall Study||0
253265|NCT01026402|614362|P6|NOT COMPLETED|Overall Study||0
253266|NCT01026402|614363|P5|NOT COMPLETED|Overall Study||0
253267|NCT01026402|614364|P4|NOT COMPLETED|Overall Study||0
253268|NCT01026402|614365|P3|NOT COMPLETED|Overall Study||0
253269|NCT01026402|614366|P2|NOT COMPLETED|Overall Study||0
253270|NCT01026402|614367|P1|NOT COMPLETED|Overall Study||0
253271|NCT01026402|614351|P17|COMPLETED|Overall Study||4
253272|NCT01026402|614352|P16|COMPLETED|Overall Study||5
253273|NCT01026402|614353|P15|COMPLETED|Overall Study||3
253274|NCT01026402|614354|P14|COMPLETED|Overall Study||6
253275|NCT01026402|614355|P13|COMPLETED|Overall Study||8
253276|NCT01026402|614356|P12|COMPLETED|Overall Study||8
253277|NCT01026402|614357|P11|COMPLETED|Overall Study||7
253278|NCT01026402|614358|P10|COMPLETED|Overall Study||3
253279|NCT01026402|614359|P9|COMPLETED|Overall Study||7
253280|NCT01026402|614360|P8|COMPLETED|Overall Study||3
253281|NCT01026402|614361|P7|COMPLETED|Overall Study||8
253282|NCT01026402|614362|P6|COMPLETED|Overall Study||5
253283|NCT01026402|614363|P5|COMPLETED|Overall Study||3
253284|NCT01026402|614364|P4|COMPLETED|Overall Study||18
253285|NCT01026402|614365|P3|COMPLETED|Overall Study||33
253286|NCT01026402|614366|P2|COMPLETED|Overall Study||8
253287|NCT01026402|614367|P1|COMPLETED|Overall Study||6
253288|NCT01026402|614351|P17|STARTED|Overall Study||4
253289|NCT01026402|614352|P16|STARTED|Overall Study||5
253290|NCT01026402|614353|P15|STARTED|Overall Study||3
253291|NCT01026402|614354|P14|STARTED|Overall Study||6
253292|NCT01026402|614355|P13|STARTED|Overall Study||8
253293|NCT01026402|614356|P12|STARTED|Overall Study||8
253294|NCT01026402|614357|P11|STARTED|Overall Study||7
253295|NCT01026402|614358|P10|STARTED|Overall Study||3
253296|NCT01026402|614359|P9|STARTED|Overall Study||7
253297|NCT01026402|614360|P8|STARTED|Overall Study||3
253298|NCT01026402|614361|P7|STARTED|Overall Study||8
253299|NCT01026402|614362|P6|STARTED|Overall Study||5
253300|NCT01026402|614363|P5|STARTED|Overall Study||3
253301|NCT01026402|614364|P4|STARTED|Overall Study||18
253302|NCT01026402|614365|P3|STARTED|Overall Study||33
253303|NCT01026402|614366|P2|STARTED|Overall Study||8
253304|NCT01026402|614367|P1|STARTED|Overall Study||6
253305|NCT01026454|614677|P2|NOT COMPLETED|Second Intervention||1
253306|NCT01026454|614678|P1|NOT COMPLETED|Second Intervention||1
253307|NCT01026454|614677|P2|COMPLETED|Second Intervention||13
253308|NCT01026454|614678|P1|COMPLETED|Second Intervention||16
253309|NCT01026454|614677|P2|STARTED|Second Intervention||14
253310|NCT01026454|614678|P1|STARTED|Second Intervention||17
253311|NCT01026454|614677|P2|NOT COMPLETED|Washout||0
253312|NCT01026454|614678|P1|NOT COMPLETED|Washout||0
253313|NCT01026454|614677|P2|COMPLETED|Washout||14
253314|NCT01026454|614678|P1|COMPLETED|Washout||18
253315|NCT01026454|614677|P2|STARTED|Washout||14
253316|NCT01026454|614678|P1|STARTED|Washout||18
253317|NCT01026454|614677|P2|NOT COMPLETED|First Intervention||0
253318|NCT01026454|614678|P1|NOT COMPLETED|First Intervention||0
253319|NCT01026454|614677|P2|COMPLETED|First Intervention||14
253320|NCT01026454|614678|P1|COMPLETED|First Intervention||18
253321|NCT01026454|614677|P2|STARTED|First Intervention||14
253322|NCT01026454|614678|P1|STARTED|First Intervention||18
253323|NCT01026493|614692|P8|NOT COMPLETED|Overall Study||1
253324|NCT01026493|614693|P7|NOT COMPLETED|Overall Study||4
253325|NCT01026493|614694|P6|NOT COMPLETED|Overall Study||3
253326|NCT01026493|614695|P5|NOT COMPLETED|Overall Study||2
253327|NCT01026493|614696|P4|NOT COMPLETED|Overall Study||0
253328|NCT01026493|614697|P3|NOT COMPLETED|Overall Study||0
253329|NCT01026493|614698|P2|NOT COMPLETED|Overall Study||1
253330|NCT01026493|614699|P1|NOT COMPLETED|Overall Study||0
253331|NCT01026493|614692|P8|COMPLETED|Overall Study||37
253332|NCT01026493|614693|P7|COMPLETED|Overall Study||32
253333|NCT01026493|614694|P6|COMPLETED|Overall Study||73
253334|NCT01026493|614695|P5|COMPLETED|Overall Study||73
253335|NCT01026493|614696|P4|COMPLETED|Overall Study||8
253336|NCT01026493|614697|P3|COMPLETED|Overall Study||9
253337|NCT01026493|614698|P2|COMPLETED|Overall Study||6
253338|NCT01026493|614699|P1|COMPLETED|Overall Study||8
253339|NCT01026493|614692|P8|STARTED|Overall Study||38
253340|NCT01026493|614693|P7|STARTED|Overall Study||36
253341|NCT01026493|614694|P6|STARTED|Overall Study||76
253342|NCT01026493|614695|P5|STARTED|Overall Study||75
253343|NCT01026493|614696|P4|STARTED|Overall Study||8
253344|NCT01026493|614697|P3|STARTED|Overall Study||9
253345|NCT01026493|614698|P2|STARTED|Overall Study||7
253346|NCT01026493|614699|P1|STARTED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|8
253347|NCT01026792|614725|P1|NOT COMPLETED|Overall Study||1
253348|NCT01026792|614725|P1|COMPLETED|Overall Study||37
253349|NCT01026792|614725|P1|STARTED|Overall Study||38
253350|NCT01026805|614729|P1|NOT COMPLETED|Overall Study||0
253351|NCT01026805|614729|P1|COMPLETED|Overall Study||11
253352|NCT01026805|614729|P1|STARTED|Overall Study||11
253353|NCT01026818|614742|P4|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||3
253354|NCT01026818|614743|P3|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||5
253355|NCT01026818|614744|P2|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||7
253356|NCT01026818|614745|P1|NOT COMPLETED|OL Period (Month 10.5 - 13.5)||0
253357|NCT01026818|614742|P4|COMPLETED|OL Period (Month 10.5 - 13.5)||105
253358|NCT01026818|614743|P3|COMPLETED|OL Period (Month 10.5 - 13.5)||112
253359|NCT01026818|614744|P2|COMPLETED|OL Period (Month 10.5 - 13.5)||98
253360|NCT01026818|614745|P1|COMPLETED|OL Period (Month 10.5 - 13.5)||0
253361|NCT01026818|614742|P4|STARTED|OL Period (Month 10.5 - 13.5)||108
253362|NCT01026818|614743|P3|STARTED|OL Period (Month 10.5 - 13.5)||117
253363|NCT01026818|614744|P2|STARTED|OL Period (Month 10.5 - 13.5)||105
253364|NCT01026818|614745|P1|STARTED|OL Period (Month 10.5 - 13.5)||0
253365|NCT01026818|614742|P4|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||7
253366|NCT01026818|614743|P3|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||5
253367|NCT01026818|614744|P2|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||9
253368|NCT01026818|614745|P1|NOT COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
253369|NCT01026818|614742|P4|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||108
253370|NCT01026818|614743|P3|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||117
253371|NCT01026818|614744|P2|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||105
253372|NCT01026818|614745|P1|COMPLETED|Drug-Free Washout Period (Month 9-10.5)||0
253373|NCT01026818|614742|P4|STARTED|Drug-Free Washout Period (Month 9-10.5)||115
253374|NCT01026818|614743|P3|STARTED|Drug-Free Washout Period (Month 9-10.5)||122
253375|NCT01026818|614744|P2|STARTED|Drug-Free Washout Period (Month 9-10.5)||114
253376|NCT01026818|614745|P1|STARTED|Drug-Free Washout Period (Month 9-10.5)||0
253377|NCT01026818|614742|P4|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||26
253378|NCT01026818|614743|P3|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||21
253379|NCT01026818|614744|P2|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||25
253380|NCT01026818|614745|P1|NOT COMPLETED|DB Treatment Period (Month 0 - 9)||0
253381|NCT01026818|614742|P4|COMPLETED|DB Treatment Period (Month 0 - 9)||115
253382|NCT01026818|614743|P3|COMPLETED|DB Treatment Period (Month 0 - 9)||122
253383|NCT01026818|614744|P2|COMPLETED|DB Treatment Period (Month 0 - 9)||114
253384|NCT01026818|614745|P1|COMPLETED|DB Treatment Period (Month 0 - 9)||0
253385|NCT01026818|614742|P4|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||141
253386|NCT01026818|614743|P3|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||143
253387|NCT01026818|614744|P2|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||139
253388|NCT01026818|614745|P1|Received at Least 1 Dose of Study Drug|DB Treatment Period (Month 0 - 9)||0
253389|NCT01026818|614742|P4|STARTED|DB Treatment Period (Month 0 - 9)||141
253390|NCT01026818|614743|P3|STARTED|DB Treatment Period (Month 0 - 9)||143
253391|NCT01026818|614744|P2|STARTED|DB Treatment Period (Month 0 - 9)||139
253392|NCT01026818|614745|P1|STARTED|DB Treatment Period (Month 0 - 9)||0
253393|NCT01026818|614742|P4|NOT COMPLETED|Screening Period||0
253394|NCT01026818|614743|P3|NOT COMPLETED|Screening Period||0
253395|NCT01026818|614744|P2|NOT COMPLETED|Screening Period||0
253396|NCT01026818|614745|P1|NOT COMPLETED|Screening Period||160
253397|NCT01026818|614742|P4|COMPLETED|Screening Period||0
253398|NCT01026818|614743|P3|COMPLETED|Screening Period||0
253399|NCT01026818|614744|P2|COMPLETED|Screening Period||0
253400|NCT01026818|614745|P1|COMPLETED|Screening Period||423
253401|NCT01026818|614742|P4|STARTED|Screening Period||0
253402|NCT01026818|614743|P3|STARTED|Screening Period||0
253403|NCT01026818|614744|P2|STARTED|Screening Period||0
253404|NCT01026818|614745|P1|STARTED|Screening Period||583
253405|NCT01026831|614825|P2|NOT COMPLETED|Overall Study||11
253406|NCT01026831|614826|P1|NOT COMPLETED|Overall Study||14
253407|NCT01026831|614825|P2|COMPLETED|Overall Study||312
253408|NCT01026831|614826|P1|COMPLETED|Overall Study||306
253409|NCT01026831|614825|P2|STARTED|Overall Study|randomized|323
253410|NCT01026831|614826|P1|STARTED|Overall Study|randomized|320
253411|NCT01026844|614836|P2|NOT COMPLETED|Overall Study||0
253412|NCT01026844|614837|P1|NOT COMPLETED|Overall Study||0
253413|NCT01026844|614836|P2|COMPLETED|Overall Study||8
253414|NCT01026844|614837|P1|COMPLETED|Overall Study||19
253415|NCT01026844|614836|P2|STARTED|Overall Study||8
253416|NCT01026844|614837|P1|STARTED|Overall Study||19
253417|NCT01026909|614851|P2|NOT COMPLETED|Overall Study||0
253418|NCT01026909|614852|P1|NOT COMPLETED|Overall Study||0
253419|NCT01026909|614851|P2|COMPLETED|Overall Study||2
253420|NCT01026909|614852|P1|COMPLETED|Overall Study||1
253421|NCT01026909|614851|P2|STARTED|Overall Study||2
253422|NCT01026909|614852|P1|STARTED|Overall Study||1
253423|NCT01026948|614860|P1|NOT COMPLETED|Overall Study||8
253424|NCT01026948|614860|P1|COMPLETED|Overall Study|8 Women were recalled because of signal loss|62
253425|NCT01026948|614860|P1|STARTED|Overall Study||70
253426|NCT01026974|614869|P4|NOT COMPLETED|Overall Study||3
253427|NCT01026974|614870|P3|NOT COMPLETED|Overall Study||12
253428|NCT01026974|614871|P2|NOT COMPLETED|Overall Study||2
253429|NCT01026974|614872|P1|NOT COMPLETED|Overall Study||1
253430|NCT01026974|614869|P4|COMPLETED|Overall Study||46
253431|NCT01026974|614870|P3|COMPLETED|Overall Study||29
253432|NCT01026974|614871|P2|COMPLETED|Overall Study||12
253433|NCT01026974|614872|P1|COMPLETED|Overall Study||15
253434|NCT01026974|614869|P4|STARTED|Overall Study||49
253435|NCT01026974|614870|P3|STARTED|Overall Study||41
253436|NCT01026974|614871|P2|STARTED|Overall Study||14
253437|NCT01026974|614872|P1|STARTED|Overall Study||16
253438|NCT01027000|614929|P1|NOT COMPLETED|Overall Study||0
253439|NCT01027000|614929|P1|COMPLETED|Overall Study||68
253440|NCT01027000|614929|P1|STARTED|Overall Study||68
253441|NCT01008696|614935|P2|NOT COMPLETED|Overall Study||17
253442|NCT01008696|614936|P1|NOT COMPLETED|Overall Study||17
253443|NCT01008696|614935|P2|COMPLETED|Overall Study||92
253444|NCT01008696|614936|P1|COMPLETED|Overall Study||91
253445|NCT01008696|614935|P2|STARTED|Overall Study||109
253446|NCT01008696|614936|P1|STARTED|Overall Study||108
253447|NCT01008722|614948|P2|NOT COMPLETED|Overall Study||0
253448|NCT01008722|614949|P1|NOT COMPLETED|Overall Study||0
253449|NCT01008722|614948|P2|COMPLETED|Overall Study||71
253450|NCT01008722|614949|P1|COMPLETED|Overall Study||36
253451|NCT01008722|614948|P2|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|71
253452|NCT01008722|614949|P1|STARTED|Overall Study|Based on Power Calculations to see 20% outcome improvement by adding FIRM-guided ablation to PVI|36
253453|NCT01008904|614957|P1|NOT COMPLETED|Overall Study||4
253454|NCT01008904|614957|P1|COMPLETED|Overall Study||25
253455|NCT01008904|614957|P1|STARTED|Overall Study||29
253456|NCT01008943|614962|P1|NOT COMPLETED|Overall Study||1
253457|NCT01008943|614962|P1|COMPLETED|Overall Study||15
253458|NCT01008943|614962|P1|STARTED|Overall Study||16
253459|NCT01008969|614969|P1|NOT COMPLETED|Overall Study||0
253460|NCT01008969|614969|P1|COMPLETED|Overall Study||10
253461|NCT01008969|614969|P1|STARTED|Overall Study||10
253462|NCT01008995|614976|P4|NOT COMPLETED|After Controlled Period||1
253463|NCT01008995|614977|P3|NOT COMPLETED|After Controlled Period||2
253464|NCT01008995|614978|P2|NOT COMPLETED|After Controlled Period||0
253465|NCT01008995|614979|P1|NOT COMPLETED|After Controlled Period||0
253466|NCT01008995|614976|P4|COMPLETED|After Controlled Period||156
253467|NCT01008995|614977|P3|COMPLETED|After Controlled Period||156
253468|NCT01008995|614978|P2|COMPLETED|After Controlled Period||0
253469|NCT01008995|614979|P1|COMPLETED|After Controlled Period||0
253470|NCT01008995|614976|P4|STARTED|After Controlled Period|2 participants discontinued in CP, had follow-up, and are among frequent and serious adverse events.|157
253471|NCT01008995|614977|P3|STARTED|After Controlled Period|1 placebo participant discontinued after completing the CP and did not receive ustekinumab 45 mg.|158
253472|NCT01008995|614978|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
253473|NCT01008995|614979|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
253474|NCT01008995|614976|P4|NOT COMPLETED|Controlled Period||0
253475|NCT01008995|614977|P3|NOT COMPLETED|Controlled Period||0
253476|NCT01008995|614978|P2|NOT COMPLETED|Controlled Period||3
253477|NCT01008995|614979|P1|NOT COMPLETED|Controlled Period||3
253478|NCT01008995|614976|P4|COMPLETED|Controlled Period||0
253479|NCT01008995|614977|P3|COMPLETED|Controlled Period||0
253480|NCT01008995|614978|P2|COMPLETED|Controlled Period||157
253481|NCT01008995|614979|P1|COMPLETED|Controlled Period||159
253482|NCT01008995|614976|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
253483|NCT01008995|614977|P3|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
253484|NCT01008995|614978|P2|STARTED|Controlled Period||160
253485|NCT01008995|614979|P1|STARTED|Controlled Period||162
253486|NCT01009034|614991|P1|NOT COMPLETED|Overall Study||4
253487|NCT01009034|614991|P1|COMPLETED|Overall Study||10
253488|NCT01009034|614991|P1|STARTED|Overall Study||14
253489|NCT01009047|614999|P2|NOT COMPLETED|Overall Study||26
253490|NCT01009047|615000|P1|NOT COMPLETED|Overall Study||28
253491|NCT01009047|614999|P2|COMPLETED|Overall Study||89
253492|NCT01009047|615000|P1|COMPLETED|Overall Study||85
253493|NCT01009047|614999|P2|STARTED|Overall Study||115
253494|NCT01009047|615000|P1|STARTED|Overall Study||113
253495|NCT01009086|615025|P3|NOT COMPLETED|Overall Study||34
253496|NCT01009086|615026|P2|NOT COMPLETED|Overall Study||47
253497|NCT01009086|615027|P1|NOT COMPLETED|Overall Study||44
253498|NCT01009086|615025|P3|COMPLETED|Overall Study||170
253499|NCT01009086|615026|P2|COMPLETED|Overall Study||158
253500|NCT01009086|615027|P1|COMPLETED|Overall Study||162
253501|NCT01009086|615025|P3|STARTED|Overall Study||204
253502|NCT01009086|615026|P2|STARTED|Overall Study||205
253503|NCT01009086|615027|P1|STARTED|Overall Study||206
253504|NCT01009099|615062|P2|NOT COMPLETED|Overall Study||4
253505|NCT01009099|615063|P1|NOT COMPLETED|Overall Study||5
253506|NCT01009099|615062|P2|COMPLETED|Overall Study||57
253507|NCT01009099|615063|P1|COMPLETED|Overall Study||53
253508|NCT01009099|615062|P2|STARTED|Overall Study||61
253509|NCT01009099|615063|P1|STARTED|Overall Study||58
253510|NCT01009138|615071|P2|NOT COMPLETED|Overall Study||20
253511|NCT01009138|615072|P1|NOT COMPLETED|Overall Study||13
253512|NCT01009138|615071|P2|COMPLETED|Overall Study||88
253513|NCT01009138|615072|P1|COMPLETED|Overall Study||93
253514|NCT01009138|615071|P2|STARTED|Overall Study||108
253515|NCT01009138|615072|P1|STARTED|Overall Study||106
253516|NCT01009203|615100|P1|NOT COMPLETED|Overall Study||7
253517|NCT01009203|615100|P1|COMPLETED|Overall Study||6
253518|NCT01009203|615100|P1|Received Treatment|Overall Study|One patient withdrew consent before treatment started.|12
253519|NCT01009203|615100|P1|STARTED|Overall Study||13
253520|NCT01009333|615107|P6|NOT COMPLETED|Week 3||0
253521|NCT01009333|615108|P5|NOT COMPLETED|Week 3||0
253522|NCT01009333|615109|P4|NOT COMPLETED|Week 3||0
253523|NCT01009333|615110|P3|NOT COMPLETED|Week 3||0
253524|NCT01009333|615111|P2|NOT COMPLETED|Week 3||0
253525|NCT01009333|615112|P1|NOT COMPLETED|Week 3||0
253526|NCT01009333|615107|P6|COMPLETED|Week 3||2
253527|NCT01009333|615108|P5|COMPLETED|Week 3||2
253528|NCT01009333|615109|P4|COMPLETED|Week 3||2
253529|NCT01009333|615110|P3|COMPLETED|Week 3||2
253530|NCT01009333|615111|P2|COMPLETED|Week 3||2
253531|NCT01009333|615112|P1|COMPLETED|Week 3||2
253532|NCT01009333|615107|P6|STARTED|Week 3||2
253533|NCT01009333|615108|P5|STARTED|Week 3||2
253534|NCT01009333|615109|P4|STARTED|Week 3||2
253535|NCT01009333|615110|P3|STARTED|Week 3||2
253536|NCT01009333|615111|P2|STARTED|Week 3||2
253537|NCT01009333|615112|P1|STARTED|Week 3||2
253538|NCT01009333|615107|P6|NOT COMPLETED|Week 2||0
253539|NCT01009333|615108|P5|NOT COMPLETED|Week 2||0
253540|NCT01009333|615109|P4|NOT COMPLETED|Week 2||0
253541|NCT01009333|615110|P3|NOT COMPLETED|Week 2||0
253542|NCT01009333|615111|P2|NOT COMPLETED|Week 2||0
253543|NCT01009333|615112|P1|NOT COMPLETED|Week 2||0
253544|NCT01009333|615107|P6|COMPLETED|Week 2||2
253545|NCT01009333|615108|P5|COMPLETED|Week 2||2
253546|NCT01009333|615109|P4|COMPLETED|Week 2||2
253547|NCT01009333|615110|P3|COMPLETED|Week 2||2
253548|NCT01009333|615111|P2|COMPLETED|Week 2||2
253549|NCT01009333|615112|P1|COMPLETED|Week 2||2
253550|NCT01009333|615107|P6|STARTED|Week 2||2
253551|NCT01009333|615108|P5|STARTED|Week 2||2
253552|NCT01009333|615109|P4|STARTED|Week 2||2
253553|NCT01009333|615110|P3|STARTED|Week 2||2
253554|NCT01009333|615111|P2|STARTED|Week 2||2
253555|NCT01009333|615112|P1|STARTED|Week 2||2
253556|NCT01009333|615107|P6|NOT COMPLETED|Week 1||0
253557|NCT01009333|615108|P5|NOT COMPLETED|Week 1||0
253558|NCT01009333|615109|P4|NOT COMPLETED|Week 1||0
253559|NCT01009333|615110|P3|NOT COMPLETED|Week 1||0
253560|NCT01009333|615111|P2|NOT COMPLETED|Week 1||0
253561|NCT01009333|615112|P1|NOT COMPLETED|Week 1||0
253562|NCT01009333|615107|P6|COMPLETED|Week 1||2
253563|NCT01009333|615108|P5|COMPLETED|Week 1||2
253564|NCT01009333|615109|P4|COMPLETED|Week 1||2
253565|NCT01009333|615110|P3|COMPLETED|Week 1||2
253566|NCT01009333|615111|P2|COMPLETED|Week 1|1 participant did not progress to the second period due to a protocol violation.|3
253567|NCT01009333|615112|P1|COMPLETED|Week 1||2
253568|NCT01009333|615107|P6|STARTED|Week 1||2
253569|NCT01009333|615108|P5|STARTED|Week 1||2
253570|NCT01009333|615109|P4|STARTED|Week 1||2
253571|NCT01009333|615110|P3|STARTED|Week 1||2
253572|NCT01009333|615111|P2|STARTED|Week 1||3
253573|NCT01009333|615112|P1|STARTED|Week 1||2
253574|NCT01009346|615126|P1|NOT COMPLETED|Overall Study||4
253575|NCT01009346|615126|P1|COMPLETED|Overall Study||5
253576|NCT01009346|615126|P1|Toxicity|Overall Study||8
253577|NCT01009346|615126|P1|STARTED|Overall Study||9
253578|NCT01009463|615134|P5|NOT COMPLETED|52-week, Double-blind Treatment Period||101
253579|NCT01009463|615135|P4|NOT COMPLETED|52-week, Double-blind Treatment Period||91
253580|NCT01009463|615136|P3|NOT COMPLETED|52-week, Double-blind Treatment Period||93
253581|NCT01009463|615137|P2|NOT COMPLETED|52-week, Double-blind Treatment Period||115
253582|NCT01009463|615138|P1|NOT COMPLETED|52-week, Double-blind Treatment Period||0
253583|NCT01009463|615134|P5|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|301
253584|NCT01009463|615135|P4|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|312
253585|NCT01009463|615136|P3|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|315
253586|NCT01009463|615137|P2|COMPLETED|52-week, Double-blind Treatment Period|Par. completed the study if they completed the treatment period and safety follow-up phone contact.|294
253587|NCT01009463|615138|P1|COMPLETED|52-week, Double-blind Treatment Period||0
253588|NCT01009463|615134|P5|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|303
253589|NCT01009463|615135|P4|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|314
253590|NCT01009463|615136|P3|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|318
253591|NCT01009463|615137|P2|Completed the Treatment Period|52-week, Double-blind Treatment Period|Par. completed the treatment period if they attended the last treatment visit (Visit 11).|295
253592|NCT01009463|615138|P1|Completed the Treatment Period|52-week, Double-blind Treatment Period||0
253593|NCT01009463|615134|P5|STARTED|52-week, Double-blind Treatment Period||402
253594|NCT01009463|615135|P4|STARTED|52-week, Double-blind Treatment Period||403
253595|NCT01009463|615136|P3|STARTED|52-week, Double-blind Treatment Period||408
253596|NCT01009463|615137|P2|STARTED|52-week, Double-blind Treatment Period||409
253597|NCT01009463|615138|P1|STARTED|52-week, Double-blind Treatment Period||0
253598|NCT01009463|615134|P5|NOT COMPLETED|4-week, Open-label Run-In Period||0
253599|NCT01009463|615135|P4|NOT COMPLETED|4-week, Open-label Run-In Period||0
253600|NCT01009463|615136|P3|NOT COMPLETED|4-week, Open-label Run-In Period||0
253601|NCT01009463|615137|P2|NOT COMPLETED|4-week, Open-label Run-In Period||0
253602|NCT01009463|615138|P1|NOT COMPLETED|4-week, Open-label Run-In Period||449
253603|NCT01009463|615134|P5|COMPLETED|4-week, Open-label Run-In Period||0
253604|NCT01009463|615135|P4|COMPLETED|4-week, Open-label Run-In Period||0
253605|NCT01009463|615136|P3|COMPLETED|4-week, Open-label Run-In Period||0
253606|NCT01009463|615137|P2|COMPLETED|4-week, Open-label Run-In Period||0
253607|NCT01009463|615138|P1|COMPLETED|4-week, Open-label Run-In Period||1622
253608|NCT01009463|615134|P5|STARTED|4-week, Open-label Run-In Period||0
253609|NCT01009463|615135|P4|STARTED|4-week, Open-label Run-In Period||0
253610|NCT01009463|615136|P3|STARTED|4-week, Open-label Run-In Period||0
253611|NCT01009463|615137|P2|STARTED|4-week, Open-label Run-In Period||0
253612|NCT01009463|615138|P1|STARTED|4-week, Open-label Run-In Period||2071
253613|NCT01020305|615160|P1|NOT COMPLETED|Overall Study||2
253614|NCT01020305|615160|P1|COMPLETED|Overall Study||3
253615|NCT01020305|615160|P1|STARTED|Overall Study||5
253616|NCT01020448|615164|P1|NOT COMPLETED|Treatment||26
253617|NCT01020448|615164|P1|COMPLETED|Treatment||299
253618|NCT01020448|615164|P1|STARTED|Treatment|One patient was excluded from the safety population as no post-baseline assessment was available|325
253619|NCT01020448|615164|P1|NOT COMPLETED|Pre-assignment||13
253620|NCT01020448|615164|P1|COMPLETED|Pre-assignment||326
253621|NCT01020448|615164|P1|STARTED|Pre-assignment||339
253622|NCT01020474|615175|P2|NOT COMPLETED|Overall Study||17
253623|NCT01020474|615176|P1|NOT COMPLETED|Overall Study||10
253624|NCT01020474|615175|P2|COMPLETED|Overall Study||36
253625|NCT01020474|615176|P1|COMPLETED|Overall Study||44
253626|NCT01020474|615175|P2|STARTED|Overall Study||53
253627|NCT01020474|615176|P1|STARTED|Overall Study||54
253628|NCT01020487|615199|P3|NOT COMPLETED|Part 2 Open-label Period||1
253629|NCT01020487|615200|P2|NOT COMPLETED|Part 2 Open-label Period||4
253630|NCT01020487|615201|P1|NOT COMPLETED|Part 2 Open-label Period||0
253631|NCT01020487|615199|P3|COMPLETED|Part 2 Open-label Period||12
253632|NCT01020487|615200|P2|COMPLETED|Part 2 Open-label Period||12
253633|NCT01020487|615201|P1|COMPLETED|Part 2 Open-label Period||0
253634|NCT01020487|615199|P3|STARTED|Part 2 Open-label Period||13
253635|NCT01020487|615200|P2|STARTED|Part 2 Open-label Period||16
253636|NCT01020487|615201|P1|STARTED|Part 2 Open-label Period||0
253637|NCT01020487|615199|P3|NOT COMPLETED|Part 2 Double-blind Treatment Period||6
253638|NCT01020487|615200|P2|NOT COMPLETED|Part 2 Double-blind Treatment Period||2
253639|NCT01020487|615201|P1|NOT COMPLETED|Part 2 Double-blind Treatment Period||0
253640|NCT01020487|615199|P3|COMPLETED|Part 2 Double-blind Treatment Period||13
253641|NCT01020487|615200|P2|COMPLETED|Part 2 Double-blind Treatment Period||16
253642|NCT01020487|615201|P1|COMPLETED|Part 2 Double-blind Treatment Period||0
253643|NCT01020487|615199|P3|Received Treatment|Part 2 Double-blind Treatment Period||18
253644|NCT01020487|615200|P2|Received Treatment|Part 2 Double-blind Treatment Period||18
253645|NCT01020487|615201|P1|Received Treatment|Part 2 Double-blind Treatment Period||0
253646|NCT01020487|615199|P3|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|19
253647|NCT01020487|615200|P2|STARTED|Part 2 Double-blind Treatment Period|Includes one participant who enrolled in Part 2 after completing Part 1|18
253648|NCT01020487|615201|P1|STARTED|Part 2 Double-blind Treatment Period||0
253649|NCT01020487|615199|P3|NOT COMPLETED|Part 1||0
253650|NCT01020487|615200|P2|NOT COMPLETED|Part 1||0
253651|NCT01020487|615201|P1|NOT COMPLETED|Part 1||0
253652|NCT01020487|615199|P3|COMPLETED|Part 1||0
253653|NCT01020487|615200|P2|COMPLETED|Part 1||0
253654|NCT01020487|615201|P1|COMPLETED|Part 1||12
253655|NCT01020487|615199|P3|STARTED|Part 1||0
253656|NCT01020487|615200|P2|STARTED|Part 1||0
253657|NCT01020487|615201|P1|STARTED|Part 1||12
253658|NCT01020526|615222|P1|NOT COMPLETED|Overall Study||14
253659|NCT01020526|615222|P1|COMPLETED|Overall Study||49
253660|NCT01020526|615222|P1|STARTED|Overall Study||63
253661|NCT01020591|615228|P2|NOT COMPLETED|Overall Study||0
253662|NCT01020591|615229|P1|NOT COMPLETED|Overall Study||0
253663|NCT01020591|615228|P2|COMPLETED|Overall Study||15
253664|NCT01020591|615229|P1|COMPLETED|Overall Study||15
253665|NCT01020591|615228|P2|STARTED|Overall Study||15
253666|NCT01020591|615229|P1|STARTED|Overall Study||15
253667|NCT01020747|615237|P1|NOT COMPLETED|Overall Study||1
253668|NCT01020747|615237|P1|COMPLETED|Overall Study||19
253669|NCT01020747|615237|P1|STARTED|Overall Study||20
253670|NCT01020773|615244|P2|NOT COMPLETED|Overall Study||3
253671|NCT01020773|615245|P1|NOT COMPLETED|Overall Study||4
253672|NCT01020773|615244|P2|COMPLETED|Overall Study||29
253673|NCT01020773|615245|P1|COMPLETED|Overall Study||31
253674|NCT01020773|615244|P2|STARTED|Overall Study||32
253675|NCT01020773|615245|P1|STARTED|Overall Study||35
253676|NCT01020786|615251|P1|NOT COMPLETED|Maintenance Period||60
253677|NCT01020786|615251|P1|COMPLETED|Maintenance Period||0
253678|NCT01020786|615251|P1|STARTED|Maintenance Period||60
253679|NCT01020786|615251|P1|NOT COMPLETED|Induction Period||49
253680|NCT01020786|615251|P1|COMPLETED|Induction Period|Completed induction therapy. Completed=starting the maintenance therapy.|60
253681|NCT01020786|615251|P1|STARTED|Induction Period||109
253682|NCT01020799|615266|P3|NOT COMPLETED|Overall Study||7
253683|NCT01020799|615267|P2|NOT COMPLETED|Overall Study||14
253684|NCT01020799|615268|P1|NOT COMPLETED|Overall Study||19
253685|NCT01020799|615266|P3|COMPLETED|Overall Study||43
253686|NCT01020799|615267|P2|COMPLETED|Overall Study||85
253687|NCT01020799|615268|P1|COMPLETED|Overall Study||79
253688|NCT01020799|615266|P3|Full Analysis Set|Overall Study||49
253689|NCT01020799|615267|P2|Full Analysis Set|Overall Study||94
253690|NCT01020799|615268|P1|Full Analysis Set|Overall Study||91
253691|NCT01020799|615266|P3|Patients Received Treatment|Overall Study||50
253692|NCT01020799|615267|P2|Patients Received Treatment|Overall Study||99
253693|NCT01020799|615268|P1|Patients Received Treatment|Overall Study||96
253694|NCT01020799|615266|P3|STARTED|Overall Study||50
253695|NCT01020799|615267|P2|STARTED|Overall Study||99
253696|NCT01020799|615268|P1|STARTED|Overall Study||98
253697|NCT01020812|615291|P1|NOT COMPLETED|Overall Study||3
253698|NCT01020812|615291|P1|COMPLETED|Overall Study||8
253699|NCT01020812|615291|P1|STARTED|Overall Study||11
253700|NCT01020838|615298|P1|NOT COMPLETED|Overall Study||183
253701|NCT01020838|615298|P1|COMPLETED|Overall Study||35
253702|NCT01020838|615298|P1|Second Annual Repeat Injection|Overall Study|Patients returning for second follow-up administration and PET-scan.|34
253703|NCT01020838|615298|P1|First Annual Repeat Injection|Overall Study|Patients returning for first follow-up administration and PET-scan.|91
253704|NCT01020838|615298|P1|Final Analysis Set (Whole Brain)|Overall Study|Final analysis set comparing PET scans with different histopathological evaluations.|97
253705|NCT01020838|615298|P1|Interim Analysis Set (Primary Efficacy)|Overall Study|Primary efficacy analysis of initial study period (tissue-scan matched regional analysis)|41
253706|NCT01020838|615298|P1|Safety Analysis Set|Overall Study|Two patients were excluded from this population because injection of florbetaben was not done.|216
253707|NCT01020838|615298|P1|STARTED|Overall Study||218
253708|NCT01020877|615315|P2|NOT COMPLETED|Second Intervention||0
253709|NCT01020877|615316|P1|NOT COMPLETED|Second Intervention||1
253710|NCT01020877|615315|P2|COMPLETED|Second Intervention||19
253711|NCT01020877|615316|P1|COMPLETED|Second Intervention||18
253712|NCT01020877|615315|P2|STARTED|Second Intervention||19
253713|NCT01020877|615316|P1|STARTED|Second Intervention||19
253714|NCT01020877|615315|P2|NOT COMPLETED|Washout of 7 Days||0
253715|NCT01020877|615316|P1|NOT COMPLETED|Washout of 7 Days||0
253716|NCT01020877|615315|P2|COMPLETED|Washout of 7 Days||19
253717|NCT01020877|615316|P1|COMPLETED|Washout of 7 Days||19
253718|NCT01020877|615315|P2|STARTED|Washout of 7 Days||19
253719|NCT01020877|615316|P1|STARTED|Washout of 7 Days||19
253720|NCT01020877|615315|P2|NOT COMPLETED|First Intervention||0
253721|NCT01020877|615316|P1|NOT COMPLETED|First Intervention||0
253722|NCT01020877|615315|P2|COMPLETED|First Intervention||19
253723|NCT01020877|615316|P1|COMPLETED|First Intervention||19
253724|NCT01020877|615315|P2|STARTED|First Intervention||19
253725|NCT01020877|615316|P1|STARTED|First Intervention||19
253726|NCT01020903|615328|P2|NOT COMPLETED|Overall Study||0
253727|NCT01020903|615329|P1|NOT COMPLETED|Overall Study||0
253728|NCT01020903|615328|P2|COMPLETED|Overall Study|Please be advised that the investigator of the study entitled left the institution in 2011.|100
253729|NCT01020903|615329|P1|COMPLETED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
253730|NCT01020903|615328|P2|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
253731|NCT01020903|615329|P1|STARTED|Overall Study|Please be advised that the investigator of the study left the institution in 2011.|100
253732|NCT01020981|615337|P2|NOT COMPLETED|Overall Study||90
253733|NCT01020981|615338|P1|NOT COMPLETED|Overall Study||84
253734|NCT01020981|615337|P2|COMPLETED|Overall Study||60
253735|NCT01020981|615338|P1|COMPLETED|Overall Study||66
253736|NCT01020981|615337|P2|STARTED|Overall Study||150
253737|NCT01020981|615338|P1|STARTED|Overall Study||150
253738|NCT01021007|615350|P2|NOT COMPLETED|Overall Study||4
253739|NCT01021007|615351|P1|NOT COMPLETED|Overall Study||2
253740|NCT01021007|615350|P2|COMPLETED|Overall Study||33
253741|NCT01021007|615351|P1|COMPLETED|Overall Study||34
253742|NCT01021007|615350|P2|STARTED|Overall Study||37
253743|NCT01021007|615351|P1|STARTED|Overall Study||36
253744|NCT01021020|615361|P1|NOT COMPLETED|Period III||0
253745|NCT01021020|615361|P1|COMPLETED|Period III||25
253746|NCT01021020|615361|P1|STARTED|Period III||25
253747|NCT01021020|615361|P1|NOT COMPLETED|14 Day Washout Period B||0
253748|NCT01021020|615361|P1|COMPLETED|14 Day Washout Period B||25
253749|NCT01021020|615361|P1|STARTED|14 Day Washout Period B||25
253750|NCT01021020|615361|P1|NOT COMPLETED|Period II||0
253751|NCT01021020|615361|P1|COMPLETED|Period II||25
253752|NCT01021020|615361|P1|STARTED|Period II||25
253753|NCT01021020|615361|P1|NOT COMPLETED|14 Day Washout Period A||1
253754|NCT01021020|615361|P1|COMPLETED|14 Day Washout Period A|Colchicine/Probenecid-medical investigator dropped due to abnormal check-in lab results.|25
253755|NCT01021020|615361|P1|STARTED|14 Day Washout Period A||26
253756|NCT01021020|615361|P1|NOT COMPLETED|Period I||2
253757|NCT01021020|615361|P1|COMPLETED|Period I|Colchicine(fasted)-subject took Claritin-D 12hour.Colchicine(fed)arm-subject had schedule conflict.|26
253758|NCT01021020|615361|P1|STARTED|Period I||28
253759|NCT01021111|615375|P1|NOT COMPLETED|Overall Study||0
253760|NCT01021111|615375|P1|COMPLETED|Overall Study||17
253761|NCT01021111|615375|P1|STARTED|Overall Study||17
253762|NCT01021215|615382|P2|NOT COMPLETED|Overall Study||0
253763|NCT01021215|615383|P1|NOT COMPLETED|Overall Study||3
253764|NCT01021215|615382|P2|COMPLETED|Overall Study||20
253765|NCT01021215|615383|P1|COMPLETED|Overall Study||57
253766|NCT01021215|615382|P2|Received Allocated Intervention|Overall Study||20
253767|NCT01021215|615383|P1|Received Allocated Intervention|Overall Study||60
253768|NCT01021215|615382|P2|STARTED|Overall Study||20
253769|NCT01021215|615383|P1|STARTED|Overall Study||60
253770|NCT01021293|615395|P2|NOT COMPLETED|Overall Study||24
253771|NCT01021293|615396|P1|NOT COMPLETED|Overall Study||12
253772|NCT01021293|615395|P2|COMPLETED|Overall Study||526
253773|NCT01021293|615396|P1|COMPLETED|Overall Study||538
253774|NCT01021293|615395|P2|STARTED|Overall Study||550
253775|NCT01021293|615396|P1|STARTED|Overall Study||550
253776|NCT01021306|615417|P4|NOT COMPLETED|6 Month (Follow-up)||3
253777|NCT01021306|615418|P3|NOT COMPLETED|6 Month (Follow-up)||0
253778|NCT01021306|615419|P2|NOT COMPLETED|6 Month (Follow-up)||1
253779|NCT01021306|615420|P1|NOT COMPLETED|6 Month (Follow-up)||3
253780|NCT01021306|615417|P4|COMPLETED|6 Month (Follow-up)||14
253781|NCT01021306|615418|P3|COMPLETED|6 Month (Follow-up)||14
253782|NCT01021306|615419|P2|COMPLETED|6 Month (Follow-up)||13
253783|NCT01021306|615420|P1|COMPLETED|6 Month (Follow-up)||11
253784|NCT01021306|615417|P4|STARTED|6 Month (Follow-up)||17
253785|NCT01021306|615418|P3|STARTED|6 Month (Follow-up)||14
253786|NCT01021306|615419|P2|STARTED|6 Month (Follow-up)||14
253787|NCT01021306|615420|P1|STARTED|6 Month (Follow-up)||14
253788|NCT01021306|615417|P4|NOT COMPLETED|2 Month (Primary Outcome)||4
253789|NCT01021306|615418|P3|NOT COMPLETED|2 Month (Primary Outcome)||5
253790|NCT01021306|615419|P2|NOT COMPLETED|2 Month (Primary Outcome)||6
253791|NCT01021306|615420|P1|NOT COMPLETED|2 Month (Primary Outcome)||6
253792|NCT01021306|615417|P4|COMPLETED|2 Month (Primary Outcome)||17
253793|NCT01021306|615418|P3|COMPLETED|2 Month (Primary Outcome)||14
253794|NCT01021306|615419|P2|COMPLETED|2 Month (Primary Outcome)||14
253795|NCT01021306|615420|P1|COMPLETED|2 Month (Primary Outcome)||14
253796|NCT01021306|615417|P4|STARTED|2 Month (Primary Outcome)||21
253797|NCT01021306|615418|P3|STARTED|2 Month (Primary Outcome)||19
253798|NCT01021306|615419|P2|STARTED|2 Month (Primary Outcome)||20
253799|NCT01021306|615420|P1|STARTED|2 Month (Primary Outcome)||20
253800|NCT01021332|615438|P1|NOT COMPLETED|Overall Study||106
253801|NCT01021332|615438|P1|COMPLETED|Overall Study||960
253802|NCT01021332|615438|P1|Full Analysis Set (FAS)|Overall Study||1009
253803|NCT01021332|615438|P1|Safety Analysis Set (SAF)|Overall Study||1066
253804|NCT01021332|615438|P1|STARTED|Overall Study|Took ≥ 1 dose of FDC open-label study drug|1066
253805|NCT01027195|615474|P2|NOT COMPLETED|Overall Study||0
253806|NCT01027195|615475|P1|NOT COMPLETED|Overall Study||0
253807|NCT01027195|615474|P2|COMPLETED|Overall Study||69
253808|NCT01027195|615475|P1|COMPLETED|Overall Study||71
253809|NCT01027195|615474|P2|STARTED|Overall Study||69
253810|NCT01027195|615475|P1|STARTED|Overall Study||71
253811|NCT01027273|615497|P2|NOT COMPLETED|Overall Study||33
253812|NCT01027273|615498|P1|NOT COMPLETED|Overall Study||59
253813|NCT01027273|615497|P2|COMPLETED|Overall Study||266
253814|NCT01027273|615498|P1|COMPLETED|Overall Study||242
253815|NCT01027273|615497|P2|STARTED|Overall Study||299
253816|NCT01027273|615498|P1|STARTED|Overall Study||301
253817|NCT01027286|615516|P2|NOT COMPLETED|Overall Study||1
253818|NCT01027286|615517|P1|NOT COMPLETED|Overall Study||1
253819|NCT01027286|615516|P2|COMPLETED|Overall Study||49
253820|NCT01027286|615517|P1|COMPLETED|Overall Study||49
253821|NCT01027286|615516|P2|12 Week Postoperative|Overall Study||49
253822|NCT01027286|615517|P1|12 Week Postoperative|Overall Study||49
253823|NCT01027286|615516|P2|4 Week Postoperative|Overall Study||50
253824|NCT01027286|615517|P1|4 Week Postoperative|Overall Study||49
253825|NCT01027286|615516|P2|Day of Surgery|Overall Study||50
253826|NCT01027286|615517|P1|Day of Surgery|Overall Study||50
253827|NCT01027286|615516|P2|Preoperative|Overall Study||50
253828|NCT01027286|615517|P1|Preoperative|Overall Study||50
253829|NCT01027286|615516|P2|STARTED|Overall Study||50
253830|NCT01027286|615517|P1|STARTED|Overall Study||50
253831|NCT01027351|615541|P6|NOT COMPLETED|Overall Study||5
253832|NCT01027351|615542|P5|NOT COMPLETED|Overall Study||11
253833|NCT01027351|615543|P4|NOT COMPLETED|Overall Study||2
253834|NCT01027351|615544|P3|NOT COMPLETED|Overall Study||1
253835|NCT01027351|615545|P2|NOT COMPLETED|Overall Study||1
253836|NCT01027351|615546|P1|NOT COMPLETED|Overall Study||3
253837|NCT01027351|615541|P6|COMPLETED|Overall Study||45
253838|NCT01027351|615542|P5|COMPLETED|Overall Study||32
253839|NCT01027351|615543|P4|COMPLETED|Overall Study||6
253840|NCT01027351|615544|P3|COMPLETED|Overall Study||13
253841|NCT01027351|615545|P2|COMPLETED|Overall Study||18
253842|NCT01027351|615546|P1|COMPLETED|Overall Study||26
253843|NCT01027351|615541|P6|STARTED|Overall Study||50
253844|NCT01027351|615542|P5|STARTED|Overall Study||43
253845|NCT01027351|615543|P4|STARTED|Overall Study||8
253846|NCT01027351|615544|P3|STARTED|Overall Study||14
253847|NCT01027351|615545|P2|STARTED|Overall Study||19
253848|NCT01027351|615546|P1|STARTED|Overall Study||29
253849|NCT01027884|615630|P2|NOT COMPLETED|Overall Study||7
253850|NCT01027884|615631|P1|NOT COMPLETED|Overall Study||4
253851|NCT01027884|615630|P2|COMPLETED|Overall Study||25
253852|NCT01027884|615631|P1|COMPLETED|Overall Study||30
253853|NCT01027884|615630|P2|STARTED|Overall Study||32
253854|NCT01027884|615631|P1|STARTED|Overall Study||34
253855|NCT01027897|615645|P1|NOT COMPLETED|Overall Study||2
253856|NCT01027897|615645|P1|COMPLETED|Overall Study||28
253857|NCT01027897|615645|P1|STARTED|Overall Study||30
253858|NCT01027910|615653|P2|NOT COMPLETED|Overall Study||0
253859|NCT01027910|615654|P1|NOT COMPLETED|Overall Study||0
253860|NCT01027910|615653|P2|COMPLETED|Overall Study||14
253861|NCT01027910|615654|P1|COMPLETED|Overall Study||6
253862|NCT01027910|615653|P2|STARTED|Overall Study||14
253863|NCT01027910|615654|P1|STARTED|Overall Study||6
253864|NCT01028014|615672|P6|NOT COMPLETED|Overall Study||2
253865|NCT01028014|615673|P5|NOT COMPLETED|Overall Study||1
253866|NCT01028014|615674|P4|NOT COMPLETED|Overall Study||1
253867|NCT01028014|615675|P3|NOT COMPLETED|Overall Study||0
253868|NCT01028014|615676|P2|NOT COMPLETED|Overall Study||2
253869|NCT01028014|615677|P1|NOT COMPLETED|Overall Study||1
253870|NCT01028014|615672|P6|COMPLETED|Overall Study||4
253871|NCT01028014|615673|P5|COMPLETED|Overall Study||9
253872|NCT01028014|615674|P4|COMPLETED|Overall Study||9
253873|NCT01028014|615675|P3|COMPLETED|Overall Study||10
253874|NCT01028014|615676|P2|COMPLETED|Overall Study||8
253875|NCT01028014|615677|P1|COMPLETED|Overall Study||9
253876|NCT01028014|615672|P6|STARTED|Overall Study||6
253877|NCT01028014|615673|P5|STARTED|Overall Study||10
253878|NCT01028014|615674|P4|STARTED|Overall Study||10
253879|NCT01028014|615675|P3|STARTED|Overall Study||10
253880|NCT01028014|615676|P2|STARTED|Overall Study||10
253881|NCT01028014|615677|P1|STARTED|Overall Study||10
253882|NCT01028027|615705|P2|NOT COMPLETED|Overall Study||13
253883|NCT01028027|615706|P1|NOT COMPLETED|Overall Study||16
253884|NCT01028027|615705|P2|COMPLETED|Overall Study||164
253885|NCT01028027|615706|P1|COMPLETED|Overall Study||164
253886|NCT01028027|615705|P2|STARTED|Overall Study||177
253887|NCT01028027|615706|P1|STARTED|Overall Study||180
253888|NCT01028053|615722|P1|NOT COMPLETED|Overall Study||133
253889|NCT01028053|615722|P1|COMPLETED|Overall Study||232
253890|NCT01028053|615722|P1|STARTED|Overall Study||365
253891|NCT01028131|615732|P4|NOT COMPLETED|Overall Study||4
253892|NCT01028131|615733|P3|NOT COMPLETED|Overall Study||6
253893|NCT01028131|615734|P2|NOT COMPLETED|Overall Study||3
253894|NCT01028131|615735|P1|NOT COMPLETED|Overall Study||3
253895|NCT01028131|615732|P4|COMPLETED|Overall Study||26
253896|NCT01028131|615733|P3|COMPLETED|Overall Study||22
253897|NCT01028131|615734|P2|COMPLETED|Overall Study||23
253898|NCT01028131|615735|P1|COMPLETED|Overall Study||23
253899|NCT01028131|615732|P4|Completed Intervention/Control Session|Overall Study||30
253900|NCT01028131|615733|P3|Completed Intervention/Control Session|Overall Study||28
253901|NCT01028131|615734|P2|Completed Intervention/Control Session|Overall Study||26
253902|NCT01028131|615735|P1|Completed Intervention/Control Session|Overall Study||26
253903|NCT01028131|615732|P4|STARTED|Overall Study||30
253904|NCT01028131|615733|P3|STARTED|Overall Study||28
253905|NCT01028131|615734|P2|STARTED|Overall Study||26
253906|NCT01028131|615735|P1|STARTED|Overall Study||26
253907|NCT01028222|615751|P2|NOT COMPLETED|Overall Study||13
253908|NCT01028222|615752|P1|NOT COMPLETED|Overall Study||38
253909|NCT01028222|615751|P2|COMPLETED|Overall Study||0
253910|NCT01028222|615752|P1|COMPLETED|Overall Study||4
253911|NCT01028222|615751|P2|Cross Over From DTIC to Nilotinib|Overall Study||10
253912|NCT01028222|615752|P1|Cross Over From DTIC to Nilotinib|Overall Study||0
253913|NCT01028222|615751|P2|STARTED|Overall Study||13
253914|NCT01028222|615752|P1|STARTED|Overall Study||42
253915|NCT01028300|615773|P1|NOT COMPLETED|Overall Study||4
253916|NCT01028300|615773|P1|COMPLETED|Overall Study||0
253917|NCT01028300|615773|P1|STARTED|Overall Study||4
253918|NCT01028352|615780|P1|NOT COMPLETED|Overall Study||6
253919|NCT01028352|615780|P1|COMPLETED|Overall Study||29
253920|NCT01028352|615780|P1|STARTED|Overall Study||35
253921|NCT01028378|615785|P1|NOT COMPLETED|Overall Study||17
253922|NCT01028378|615785|P1|COMPLETED|Overall Study|195 participants (230 eyes) with myopia|195
253923|NCT01028378|615785|P1|STARTED|Overall Study|212 participants (249 eyes) with myopia|212
253924|NCT01028391|615799|P2|NOT COMPLETED|Overall Study||11
253925|NCT01028391|615800|P1|NOT COMPLETED|Overall Study||14
253926|NCT01028391|615799|P2|COMPLETED|Overall Study||142
253927|NCT01028391|615800|P1|COMPLETED|Overall Study||150
253928|NCT01028391|615799|P2|STARTED|Overall Study||153
253929|NCT01028391|615800|P1|STARTED|Overall Study||164
253930|NCT01028651|615808|P1|NOT COMPLETED|Overall Study||3
253931|NCT01028651|615808|P1|COMPLETED|Overall Study||10
253932|NCT01028651|615808|P1|STARTED|Overall Study||13
253933|NCT01028677|615831|P2|NOT COMPLETED|Overall Study||1
253934|NCT01028677|615832|P1|NOT COMPLETED|Overall Study||2
253935|NCT01028677|615831|P2|COMPLETED|Overall Study||6
253936|NCT01028677|615832|P1|COMPLETED|Overall Study||8
253937|NCT01028677|615831|P2|STARTED|Overall Study||7
253938|NCT01028677|615832|P1|STARTED|Overall Study||10
253939|NCT01028820|615848|P1|NOT COMPLETED|Overall Study||1
253940|NCT01028820|615848|P1|COMPLETED|Overall Study||12
253941|NCT01028820|615848|P1|STARTED|Overall Study||13
253942|NCT01028911|615857|P2|NOT COMPLETED|Overall Study||0
253943|NCT01028911|615858|P1|NOT COMPLETED|Overall Study||0
253944|NCT01028911|615857|P2|COMPLETED|Overall Study||2
253945|NCT01028911|615858|P1|COMPLETED|Overall Study||7
253946|NCT01028911|615857|P2|STARTED|Overall Study||2
253947|NCT01028911|615858|P1|STARTED|Overall Study||7
253948|NCT01029054|615923|P3|NOT COMPLETED|Phase II||0
253949|NCT01029054|615924|P2|NOT COMPLETED|Phase II||0
253950|NCT01029054|615925|P1|NOT COMPLETED|Phase II||0
253951|NCT01029054|615923|P3|COMPLETED|Phase II||18
253952|NCT01029054|615924|P2|COMPLETED|Phase II||0
253953|NCT01029054|615925|P1|COMPLETED|Phase II||0
253954|NCT01029054|615923|P3|STARTED|Phase II|35 participants were enrolled in Ph I. 18 additional participants were enrolled in Ph II at the MTD.|18
253955|NCT01029054|615924|P2|STARTED|Phase II||0
253956|NCT01029054|615925|P1|STARTED|Phase II||0
253957|NCT01029054|615923|P3|NOT COMPLETED|Phase I||0
253958|NCT01029054|615924|P2|NOT COMPLETED|Phase I||0
253959|NCT01029054|615925|P1|NOT COMPLETED|Phase I||0
253960|NCT01029054|615923|P3|COMPLETED|Phase I||18
253961|NCT01029054|615924|P2|COMPLETED|Phase I||13
253962|NCT01029054|615925|P1|COMPLETED|Phase I||4
253963|NCT01029054|615923|P3|STARTED|Phase I||18
253964|NCT01029054|615924|P2|STARTED|Phase I||13
253965|NCT01029054|615925|P1|STARTED|Phase I||4
253966|NCT01029262|615933|P2|NOT COMPLETED|Overall Study||145
253967|NCT01029262|615934|P1|NOT COMPLETED|Overall Study||78
253968|NCT01029262|615933|P2|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|15
253969|NCT01029262|615934|P1|COMPLETED|Overall Study|Completed participants are those who were continuing to receive study drug at time of data cut-off|1
253970|NCT01029262|615933|P2|STARTED|Overall Study||160
253971|NCT01029262|615934|P1|STARTED|Overall Study||79
253972|NCT01029340|615995|P6|NOT COMPLETED|Part C Follow up Period||0
253973|NCT01029340|615996|P5|NOT COMPLETED|Part C Follow up Period||0
253974|NCT01029340|615997|P4|NOT COMPLETED|Part C Follow up Period||0
253975|NCT01029340|615998|P3|NOT COMPLETED|Part C Follow up Period||0
253976|NCT01029340|615999|P2|NOT COMPLETED|Part C Follow up Period||0
253977|NCT01029340|616000|P1|NOT COMPLETED|Part C Follow up Period||0
253978|NCT01029340|615995|P6|COMPLETED|Part C Follow up Period||0
253979|NCT01029340|615996|P5|COMPLETED|Part C Follow up Period||5
253980|NCT01029340|615997|P4|COMPLETED|Part C Follow up Period||0
253981|NCT01029340|615998|P3|COMPLETED|Part C Follow up Period||0
253982|NCT01029340|615999|P2|COMPLETED|Part C Follow up Period||0
253983|NCT01029340|616000|P1|COMPLETED|Part C Follow up Period||0
253984|NCT01029340|615995|P6|STARTED|Part C Follow up Period||0
253985|NCT01029340|615996|P5|STARTED|Part C Follow up Period||5
253986|NCT01029340|615997|P4|STARTED|Part C Follow up Period||0
253987|NCT01029340|615998|P3|STARTED|Part C Follow up Period||0
253988|NCT01029340|615999|P2|STARTED|Part C Follow up Period||0
253989|NCT01029340|616000|P1|STARTED|Part C Follow up Period||0
253990|NCT01029340|615995|P6|NOT COMPLETED|Part C Treatment Period||0
253991|NCT01029340|615996|P5|NOT COMPLETED|Part C Treatment Period||0
253992|NCT01029340|615997|P4|NOT COMPLETED|Part C Treatment Period||0
253993|NCT01029340|615998|P3|NOT COMPLETED|Part C Treatment Period||0
253994|NCT01029340|615999|P2|NOT COMPLETED|Part C Treatment Period||0
253995|NCT01029340|616000|P1|NOT COMPLETED|Part C Treatment Period||0
253996|NCT01029340|615995|P6|COMPLETED|Part C Treatment Period||0
253997|NCT01029340|615996|P5|COMPLETED|Part C Treatment Period||5
253998|NCT01029340|615997|P4|COMPLETED|Part C Treatment Period||0
253999|NCT01029340|615998|P3|COMPLETED|Part C Treatment Period||0
254000|NCT01029340|615999|P2|COMPLETED|Part C Treatment Period||0
254001|NCT01029340|616000|P1|COMPLETED|Part C Treatment Period||0
254002|NCT01029340|615995|P6|Participants Received Treatment|Part C Treatment Period||0
254003|NCT01029340|615996|P5|Participants Received Treatment|Part C Treatment Period||5
254004|NCT01029340|615997|P4|Participants Received Treatment|Part C Treatment Period||0
254005|NCT01029340|615998|P3|Participants Received Treatment|Part C Treatment Period||0
254006|NCT01029340|615999|P2|Participants Received Treatment|Part C Treatment Period||0
254007|NCT01029340|616000|P1|Participants Received Treatment|Part C Treatment Period||0
254008|NCT01029340|615995|P6|STARTED|Part C Treatment Period||0
254009|NCT01029340|615996|P5|STARTED|Part C Treatment Period||5
254010|NCT01029340|615997|P4|STARTED|Part C Treatment Period||0
254011|NCT01029340|615998|P3|STARTED|Part C Treatment Period||0
254012|NCT01029340|615999|P2|STARTED|Part C Treatment Period||0
254013|NCT01029340|616000|P1|STARTED|Part C Treatment Period||0
254014|NCT01029340|615995|P6|NOT COMPLETED|Extension Period||12
254015|NCT01029340|615996|P5|NOT COMPLETED|Extension Period||0
254016|NCT01029340|615997|P4|NOT COMPLETED|Extension Period||0
254017|NCT01029340|615998|P3|NOT COMPLETED|Extension Period||0
254018|NCT01029340|615999|P2|NOT COMPLETED|Extension Period||0
254019|NCT01029340|616000|P1|NOT COMPLETED|Extension Period||0
254020|NCT01029340|615995|P6|COMPLETED|Extension Period||43
254021|NCT01029340|615996|P5|COMPLETED|Extension Period||0
254022|NCT01029340|615997|P4|COMPLETED|Extension Period||0
254023|NCT01029340|615998|P3|COMPLETED|Extension Period||0
254024|NCT01029340|615999|P2|COMPLETED|Extension Period||0
254025|NCT01029340|616000|P1|COMPLETED|Extension Period||0
254026|NCT01029340|615995|P6|STARTED|Extension Period||55
254027|NCT01029340|615996|P5|STARTED|Extension Period||0
254028|NCT01029340|615997|P4|STARTED|Extension Period||0
254029|NCT01029340|615998|P3|STARTED|Extension Period||0
254030|NCT01029340|615999|P2|STARTED|Extension Period||0
254031|NCT01029340|616000|P1|STARTED|Extension Period||0
254032|NCT01029340|615995|P6|NOT COMPLETED|Part B Follow up Period||0
254033|NCT01029340|615996|P5|NOT COMPLETED|Part B Follow up Period||0
254034|NCT01029340|615997|P4|NOT COMPLETED|Part B Follow up Period||0
254035|NCT01029340|615998|P3|NOT COMPLETED|Part B Follow up Period||0
254036|NCT01029340|615999|P2|NOT COMPLETED|Part B Follow up Period||0
254037|NCT01029340|616000|P1|NOT COMPLETED|Part B Follow up Period||0
254038|NCT01029340|615995|P6|COMPLETED|Part B Follow up Period||0
254039|NCT01029340|615996|P5|COMPLETED|Part B Follow up Period||0
254040|NCT01029340|615997|P4|COMPLETED|Part B Follow up Period||32
254041|NCT01029340|615998|P3|COMPLETED|Part B Follow up Period||29
254042|NCT01029340|615999|P2|COMPLETED|Part B Follow up Period||0
254043|NCT01029340|616000|P1|COMPLETED|Part B Follow up Period||0
254044|NCT01029340|615995|P6|STARTED|Part B Follow up Period||0
254045|NCT01029340|615996|P5|STARTED|Part B Follow up Period||0
254046|NCT01029340|615997|P4|STARTED|Part B Follow up Period||32
254047|NCT01029340|615998|P3|STARTED|Part B Follow up Period||29
254048|NCT01029340|615999|P2|STARTED|Part B Follow up Period||0
254049|NCT01029340|616000|P1|STARTED|Part B Follow up Period||0
254050|NCT01029340|615995|P6|NOT COMPLETED|Part B Treatment Period||0
254051|NCT01029340|615996|P5|NOT COMPLETED|Part B Treatment Period||0
254052|NCT01029340|615997|P4|NOT COMPLETED|Part B Treatment Period||0
254053|NCT01029340|615998|P3|NOT COMPLETED|Part B Treatment Period||2
254054|NCT01029340|615999|P2|NOT COMPLETED|Part B Treatment Period||0
254055|NCT01029340|616000|P1|NOT COMPLETED|Part B Treatment Period||0
254056|NCT01029340|615995|P6|COMPLETED|Part B Treatment Period||0
254057|NCT01029340|615996|P5|COMPLETED|Part B Treatment Period||0
254058|NCT01029340|615997|P4|COMPLETED|Part B Treatment Period||32
254059|NCT01029340|615998|P3|COMPLETED|Part B Treatment Period||29
254060|NCT01029340|615999|P2|COMPLETED|Part B Treatment Period||0
254061|NCT01029340|616000|P1|COMPLETED|Part B Treatment Period||0
254062|NCT01029340|615995|P6|Participants Received Treatment|Part B Treatment Period||0
254063|NCT01029340|615996|P5|Participants Received Treatment|Part B Treatment Period||0
254064|NCT01029340|615997|P4|Participants Received Treatment|Part B Treatment Period||32
254065|NCT01029340|615998|P3|Participants Received Treatment|Part B Treatment Period||30
254066|NCT01029340|615999|P2|Participants Received Treatment|Part B Treatment Period||0
254067|NCT01029340|616000|P1|Participants Received Treatment|Part B Treatment Period||0
254068|NCT01029340|615995|P6|STARTED|Part B Treatment Period||0
254069|NCT01029340|615996|P5|STARTED|Part B Treatment Period||0
254070|NCT01029340|615997|P4|STARTED|Part B Treatment Period|Enrolled 7 participants from Arm 1 and 4 participants from Arm 2|32
254071|NCT01029340|615998|P3|STARTED|Part B Treatment Period|Enrolled 4 participants from Arm 1 and 7 participants from Arm 2|31
254072|NCT01029340|615999|P2|STARTED|Part B Treatment Period||0
254073|NCT01029340|616000|P1|STARTED|Part B Treatment Period||0
254074|NCT01029340|615995|P6|NOT COMPLETED|Part A Follow up Period||0
254075|NCT01029340|615996|P5|NOT COMPLETED|Part A Follow up Period||0
254076|NCT01029340|615997|P4|NOT COMPLETED|Part A Follow up Period||0
254077|NCT01029340|615998|P3|NOT COMPLETED|Part A Follow up Period||0
254078|NCT01029340|615999|P2|NOT COMPLETED|Part A Follow up Period||0
254079|NCT01029340|616000|P1|NOT COMPLETED|Part A Follow up Period||0
254080|NCT01029340|615995|P6|COMPLETED|Part A Follow up Period||0
254081|NCT01029340|615996|P5|COMPLETED|Part A Follow up Period||0
254082|NCT01029340|615997|P4|COMPLETED|Part A Follow up Period||0
254083|NCT01029340|615998|P3|COMPLETED|Part A Follow up Period||0
254084|NCT01029340|615999|P2|COMPLETED|Part A Follow up Period||14
254085|NCT01029340|616000|P1|COMPLETED|Part A Follow up Period||14
254086|NCT01029340|615995|P6|STARTED|Part A Follow up Period||0
254087|NCT01029340|615996|P5|STARTED|Part A Follow up Period||0
254088|NCT01029340|615997|P4|STARTED|Part A Follow up Period||0
254089|NCT01029340|615998|P3|STARTED|Part A Follow up Period||0
254090|NCT01029340|615999|P2|STARTED|Part A Follow up Period||14
254091|NCT01029340|616000|P1|STARTED|Part A Follow up Period||14
254092|NCT01029340|615995|P6|NOT COMPLETED|Part A Treatment Period||0
254093|NCT01029340|615996|P5|NOT COMPLETED|Part A Treatment Period||0
254094|NCT01029340|615997|P4|NOT COMPLETED|Part A Treatment Period||0
254095|NCT01029340|615998|P3|NOT COMPLETED|Part A Treatment Period||0
254096|NCT01029340|615999|P2|NOT COMPLETED|Part A Treatment Period||0
254097|NCT01029340|616000|P1|NOT COMPLETED|Part A Treatment Period||0
254098|NCT01029340|615995|P6|COMPLETED|Part A Treatment Period||0
254099|NCT01029340|615996|P5|COMPLETED|Part A Treatment Period||0
254100|NCT01029340|615997|P4|COMPLETED|Part A Treatment Period||0
254101|NCT01029340|615998|P3|COMPLETED|Part A Treatment Period||0
254102|NCT01029340|615999|P2|COMPLETED|Part A Treatment Period||14
254103|NCT01029340|616000|P1|COMPLETED|Part A Treatment Period||14
254104|NCT01029340|615995|P6|Safety Population|Part A Treatment Period||0
254105|NCT01029340|615996|P5|Safety Population|Part A Treatment Period||0
254106|NCT01029340|615997|P4|Safety Population|Part A Treatment Period||0
254107|NCT01029340|615998|P3|Safety Population|Part A Treatment Period||0
254108|NCT01029340|615999|P2|Safety Population|Part A Treatment Period||14
254109|NCT01029340|616000|P1|Safety Population|Part A Treatment Period|One excluded because receiving Kogenate FS twice.|13
254110|NCT01029340|615995|P6|Participants Received Treatment|Part A Treatment Period||0
254111|NCT01029340|615996|P5|Participants Received Treatment|Part A Treatment Period||0
254112|NCT01029340|615997|P4|Participants Received Treatment|Part A Treatment Period||0
254113|NCT01029340|615998|P3|Participants Received Treatment|Part A Treatment Period||0
254114|NCT01029340|615999|P2|Participants Received Treatment|Part A Treatment Period||14
254115|NCT01029340|616000|P1|Participants Received Treatment|Part A Treatment Period||14
254116|NCT01029340|615995|P6|STARTED|Part A Treatment Period||0
254117|NCT01029340|615996|P5|STARTED|Part A Treatment Period||0
254118|NCT01029340|615997|P4|STARTED|Part A Treatment Period||0
254119|NCT01029340|615998|P3|STARTED|Part A Treatment Period||0
254120|NCT01029340|615999|P2|STARTED|Part A Treatment Period||14
254121|NCT01029340|616000|P1|STARTED|Part A Treatment Period||14
254122|NCT01029366|616031|P2|NOT COMPLETED|Overall Study||2
254123|NCT01029366|616032|P1|NOT COMPLETED|Overall Study||4
254124|NCT01029366|616031|P2|COMPLETED|Overall Study||6
254125|NCT01029366|616032|P1|COMPLETED|Overall Study||14
254126|NCT01029366|616031|P2|STARTED|Overall Study||8
254127|NCT01029366|616032|P1|STARTED|Overall Study||18
254128|NCT01029392|616041|P2|NOT COMPLETED|Overall Study||11
254129|NCT01029392|616042|P1|NOT COMPLETED|Overall Study||20
254130|NCT01029392|616041|P2|COMPLETED|Overall Study||27
254131|NCT01029392|616042|P1|COMPLETED|Overall Study||17
254132|NCT01029392|616041|P2|STARTED|Overall Study||38
254133|NCT01029392|616042|P1|STARTED|Overall Study||37
254134|NCT01029405|616054|P4|NOT COMPLETED|Overall Study||5
254135|NCT01029405|616055|P3|NOT COMPLETED|Overall Study||4
254136|NCT01029405|616056|P2|NOT COMPLETED|Overall Study||3
254137|NCT01029405|616057|P1|NOT COMPLETED|Overall Study||2
254138|NCT01029405|616054|P4|COMPLETED|Overall Study||32
254139|NCT01029405|616055|P3|COMPLETED|Overall Study||31
254140|NCT01029405|616056|P2|COMPLETED|Overall Study||34
254141|NCT01029405|616057|P1|COMPLETED|Overall Study||34
254142|NCT01029405|616054|P4|STARTED|Overall Study||37
254143|NCT01029405|616055|P3|STARTED|Overall Study||35
254144|NCT01029405|616056|P2|STARTED|Overall Study||37
254145|NCT01029405|616057|P1|STARTED|Overall Study||36
254146|NCT01029535|616067|P1|NOT COMPLETED|Overall Study||31
254147|NCT01029535|616067|P1|COMPLETED|Overall Study||72
254148|NCT01029535|616067|P1|STARTED|Overall Study||103
254149|NCT01029652|616094|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||3
254150|NCT01029652|616095|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||1
254151|NCT01029652|616094|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||63
254152|NCT01029652|616095|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||68
254153|NCT01029652|616094|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|39
254154|NCT01029652|616095|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab over 72 weeks study duration overall|69
254155|NCT01029652|616094|P2|STARTED|Extension Study 2 (25-72 Weeks)||66
254156|NCT01029652|616095|P1|STARTED|Extension Study 2 (25-72 Weeks)||69
254157|NCT01029652|616094|P2|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||5
254158|NCT01029652|616095|P1|NOT COMPLETED|Extension Study 1 (12-24 Weeks)||3
254159|NCT01029652|616094|P2|COMPLETED|Extension Study 1 (12-24 Weeks)||80
254160|NCT01029652|616095|P1|COMPLETED|Extension Study 1 (12-24 Weeks)||87
254161|NCT01029652|616094|P2|STARTED|Extension Study 1 (12-24 Weeks)||85
254162|NCT01029652|616095|P1|STARTED|Extension Study 1 (12-24 Weeks)||90
254163|NCT01029652|616094|P2|NOT COMPLETED|Core Study (0-12 Weeks)||10
254164|NCT01029652|616095|P1|NOT COMPLETED|Core Study (0-12 Weeks)||6
254165|NCT01029652|616094|P2|COMPLETED|Core Study (0-12 Weeks)||105
254166|NCT01029652|616095|P1|COMPLETED|Core Study (0-12 Weeks)||109
254167|NCT01029652|616094|P2|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||115
254168|NCT01029652|616095|P1|Full Analysis Set (FAS), Safety Set|Core Study (0-12 Weeks)||113
254169|NCT01029652|616094|P2|STARTED|Core Study (0-12 Weeks)||115
254170|NCT01029652|616095|P1|STARTED|Core Study (0-12 Weeks)||115
254171|NCT01029704|616178|P5|NOT COMPLETED|Overall Study||0
254172|NCT01029704|616179|P4|NOT COMPLETED|Overall Study||0
254173|NCT01029704|616180|P3|NOT COMPLETED|Overall Study||0
254174|NCT01029704|616181|P2|NOT COMPLETED|Overall Study||0
254175|NCT01029704|616182|P1|NOT COMPLETED|Overall Study||0
254176|NCT01029704|616178|P5|COMPLETED|Overall Study||26
254177|NCT01029704|616179|P4|COMPLETED|Overall Study||28
254178|NCT01029704|616180|P3|COMPLETED|Overall Study||23
254179|NCT01029704|616181|P2|COMPLETED|Overall Study||24
254180|NCT01029704|616182|P1|COMPLETED|Overall Study||28
254181|NCT01029704|616178|P5|STARTED|Overall Study||26
254182|NCT01029704|616179|P4|STARTED|Overall Study||28
254183|NCT01029704|616180|P3|STARTED|Overall Study||23
254184|NCT01029704|616181|P2|STARTED|Overall Study||24
254185|NCT01029704|616182|P1|STARTED|Overall Study||28
254186|NCT01029730|616209|P1|NOT COMPLETED|Maintenance Therapy||23
254187|NCT01029730|616209|P1|COMPLETED|Maintenance Therapy||14
254188|NCT01029730|616209|P1|STARTED|Maintenance Therapy|Two patients complete study treatment but declined subsequent maintenance therapy|37
254189|NCT01029730|616209|P1|NOT COMPLETED|Combination Therapy||16
254190|NCT01029730|616209|P1|COMPLETED|Combination Therapy|Patients remained on-study until completing 6 cycles or coming off-treatment for any other reason|39
254191|NCT01029730|616209|P1|STARTED|Combination Therapy||55
254192|NCT01029795|616218|P2|NOT COMPLETED|Overall Study||22
254193|NCT01029795|616219|P1|NOT COMPLETED|Overall Study||16
254194|NCT01029795|616218|P2|COMPLETED|Overall Study||0
254195|NCT01029795|616219|P1|COMPLETED|Overall Study||0
254196|NCT01029795|616218|P2|STARTED|Overall Study||22
254197|NCT01029795|616219|P1|STARTED|Overall Study||16
254198|NCT01029886|616273|P2|NOT COMPLETED|Overall Study||60
254199|NCT01029886|616274|P1|NOT COMPLETED|Overall Study||61
254200|NCT01029886|616273|P2|COMPLETED|Overall Study||391
254201|NCT01029886|616274|P1|COMPLETED|Overall Study||400
254202|NCT01029886|616273|P2|Intent to Treat (ITT)|Overall Study||450
254203|NCT01029886|616274|P1|Intent to Treat (ITT)|Overall Study||461
254204|NCT01029886|616273|P2|STARTED|Overall Study||451
254205|NCT01029886|616274|P1|STARTED|Overall Study||461
254206|NCT01029925|616300|P1|NOT COMPLETED|Completion of Cycle 2 (56 Days)||1
254207|NCT01029925|616300|P1|COMPLETED|Completion of Cycle 2 (56 Days)||2
254208|NCT01029925|616300|P1|STARTED|Completion of Cycle 2 (56 Days)||3
254209|NCT01029925|616300|P1|NOT COMPLETED|Completion of Cycle 1 (28 Days)||4
254210|NCT01029925|616300|P1|COMPLETED|Completion of Cycle 1 (28 Days)||3
254211|NCT01029925|616300|P1|STARTED|Completion of Cycle 1 (28 Days)||7
254212|NCT01024244|616309|P5|NOT COMPLETED|Overall Study||14
254213|NCT01024244|616310|P4|NOT COMPLETED|Overall Study||13
254214|NCT01024244|616311|P3|NOT COMPLETED|Overall Study||14
254215|NCT01024244|616312|P2|NOT COMPLETED|Overall Study||11
254216|NCT01024244|616313|P1|NOT COMPLETED|Overall Study||17
254217|NCT01024244|616309|P5|COMPLETED|Overall Study||1
254218|NCT01024244|616310|P4|COMPLETED|Overall Study||1
254219|NCT01024244|616311|P3|COMPLETED|Overall Study||1
254220|NCT01024244|616312|P2|COMPLETED|Overall Study||1
254221|NCT01024244|616313|P1|COMPLETED|Overall Study||5
254222|NCT01024244|616309|P5|STARTED|Overall Study||15
254223|NCT01024244|616310|P4|STARTED|Overall Study||14
254224|NCT01024244|616311|P3|STARTED|Overall Study||15
254225|NCT01024244|616312|P2|STARTED|Overall Study||12
254226|NCT01024244|616313|P1|STARTED|Overall Study||22
254227|NCT01024309|616427|P2|NOT COMPLETED|Overall Study||4
254228|NCT01024309|616428|P1|NOT COMPLETED|Overall Study||8
254229|NCT01024309|616427|P2|COMPLETED|Overall Study||27
254230|NCT01024309|616428|P1|COMPLETED|Overall Study||27
254231|NCT01024309|616427|P2|STARTED|Overall Study||31
254232|NCT01024309|616428|P1|STARTED|Overall Study||35
254233|NCT01024335|616452|P2|NOT COMPLETED|Overall Study||26
254234|NCT01024335|616453|P1|NOT COMPLETED|Overall Study||13
254235|NCT01024335|616452|P2|COMPLETED|Overall Study||14
254236|NCT01024335|616453|P1|COMPLETED|Overall Study||7
254237|NCT01024335|616452|P2|STARTED|Overall Study||40
254238|NCT01024335|616453|P1|STARTED|Overall Study||20
254239|NCT01024465|616461|P1|NOT COMPLETED|Overall Study||3
254240|NCT01024465|616461|P1|COMPLETED|Overall Study||23
254241|NCT01024465|616461|P1|STARTED|Overall Study||26
254242|NCT01030458|616467|P2|NOT COMPLETED|Overall Study||32
254243|NCT01030458|616468|P1|NOT COMPLETED|Overall Study||27
254244|NCT01030458|616467|P2|COMPLETED|Overall Study||57
254245|NCT01030458|616468|P1|COMPLETED|Overall Study||67
254246|NCT01030458|616467|P2|STARTED|Overall Study||89
254247|NCT01030458|616468|P1|STARTED|Overall Study||94
254248|NCT01030653|616482|P2|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
254249|NCT01030653|616483|P1|NOT COMPLETED|Loading Dose & 2nd Maintenance Regimen||0
254250|NCT01030653|616482|P2|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
254251|NCT01030653|616483|P1|COMPLETED|Loading Dose & 2nd Maintenance Regimen||4
254252|NCT01030653|616482|P2|STARTED|Loading Dose & 2nd Maintenance Regimen||4
254253|NCT01030653|616483|P1|STARTED|Loading Dose & 2nd Maintenance Regimen||4
254254|NCT01030653|616482|P2|NOT COMPLETED|7-Day Washout Period||0
254255|NCT01030653|616483|P1|NOT COMPLETED|7-Day Washout Period||0
254256|NCT01030653|616482|P2|COMPLETED|7-Day Washout Period||4
254257|NCT01030653|616483|P1|COMPLETED|7-Day Washout Period||4
254258|NCT01030653|616482|P2|STARTED|7-Day Washout Period||4
254259|NCT01030653|616483|P1|STARTED|7-Day Washout Period||4
254260|NCT01030653|616482|P2|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
254261|NCT01030653|616483|P1|NOT COMPLETED|Loading Dose & First Maintenance Regimen||0
254262|NCT01030653|616482|P2|COMPLETED|Loading Dose & First Maintenance Regimen||4
254263|NCT01030653|616483|P1|COMPLETED|Loading Dose & First Maintenance Regimen||4
254264|NCT01030653|616482|P2|STARTED|Loading Dose & First Maintenance Regimen||4
254265|NCT01030653|616483|P1|STARTED|Loading Dose & First Maintenance Regimen||4
254266|NCT01030666|616494|P2|NOT COMPLETED|Overall Study||2
254267|NCT01030666|616495|P1|NOT COMPLETED|Overall Study||3
254268|NCT01030666|616494|P2|COMPLETED|Overall Study||31
254269|NCT01030666|616495|P1|COMPLETED|Overall Study||25
254270|NCT01030666|616494|P2|STARTED|Overall Study||33
254271|NCT01030666|616495|P1|STARTED|Overall Study||28
254272|NCT01031914|616503|P1|NOT COMPLETED|Overall Study||0
254273|NCT01031914|616503|P1|COMPLETED|Overall Study||36
254274|NCT01031914|616503|P1|STARTED|Overall Study||36
254275|NCT01031953|616507|P1|NOT COMPLETED|Overall Study||0
254276|NCT01031953|616507|P1|COMPLETED|Overall Study||11
254277|NCT01031953|616507|P1|STARTED|Overall Study||11
254278|NCT01031979|616520|P2|NOT COMPLETED|Overall Study||4
254279|NCT01031979|616521|P1|NOT COMPLETED|Overall Study||5
254280|NCT01031979|616520|P2|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|8
254281|NCT01031979|616521|P1|COMPLETED|Overall Study|These are individuals who completed treatment in the study.|9
254282|NCT01031979|616520|P2|Completed Primary Outcome Measure|Overall Study||12
254283|NCT01031979|616521|P1|Completed Primary Outcome Measure|Overall Study||12
254284|NCT01031979|616520|P2|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|12
254285|NCT01031979|616521|P1|STARTED|Overall Study|To meet eligibility requirements for randomization, subjects had to reach session 3 w/o dropping.|14
254286|NCT01032018|616535|P2|NOT COMPLETED|Overall Study||6
254287|NCT01032018|616536|P1|NOT COMPLETED|Overall Study||6
254288|NCT01032018|616535|P2|COMPLETED|Overall Study||67
254289|NCT01032018|616536|P1|COMPLETED|Overall Study||71
254290|NCT01032018|616535|P2|STARTED|Overall Study||73
254291|NCT01032018|616536|P1|STARTED|Overall Study||77
254292|NCT01032044|616546|P2|NOT COMPLETED|Overall Study||20
254293|NCT01032044|616547|P1|NOT COMPLETED|Overall Study||25
254294|NCT01032044|616546|P2|COMPLETED|Overall Study||62
254295|NCT01032044|616547|P1|COMPLETED|Overall Study||57
254296|NCT01032044|616546|P2|Procedure|Overall Study||75
254297|NCT01032044|616547|P1|Procedure|Overall Study||74
254298|NCT01032044|616546|P2|STARTED|Overall Study||82
254299|NCT01032044|616547|P1|STARTED|Overall Study||82
254300|NCT01032070|616555|P2|NOT COMPLETED|Overall Study||12
254301|NCT01032070|616556|P1|NOT COMPLETED|Overall Study||13
254302|NCT01032070|616555|P2|COMPLETED|Overall Study||0
254303|NCT01032070|616556|P1|COMPLETED|Overall Study||0
254304|NCT01032070|616555|P2|STARTED|Overall Study||12
254305|NCT01032070|616556|P1|STARTED|Overall Study||13
254306|NCT01032135|616588|P7|NOT COMPLETED|8 Week Randomization||18
254307|NCT01032135|616589|P6|NOT COMPLETED|8 Week Randomization||17
254308|NCT01032135|616590|P5|NOT COMPLETED|8 Week Randomization||9
254309|NCT01032135|616591|P4|NOT COMPLETED|8 Week Randomization||11
254310|NCT01032135|616592|P3|NOT COMPLETED|8 Week Randomization||0
254311|NCT01032135|616593|P2|NOT COMPLETED|8 Week Randomization||0
254312|NCT01032135|616594|P1|NOT COMPLETED|8 Week Randomization||26
254313|NCT01032135|616588|P7|COMPLETED|8 Week Randomization||36
254314|NCT01032135|616589|P6|COMPLETED|8 Week Randomization||31
254315|NCT01032135|616590|P5|COMPLETED|8 Week Randomization||34
254316|NCT01032135|616591|P4|COMPLETED|8 Week Randomization||30
254317|NCT01032135|616592|P3|COMPLETED|8 Week Randomization||0
254318|NCT01032135|616593|P2|COMPLETED|8 Week Randomization||0
254319|NCT01032135|616594|P1|COMPLETED|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|201
254320|NCT01032135|616588|P7|12 Week Follow up|8 Week Randomization||41
254321|NCT01032135|616589|P6|12 Week Follow up|8 Week Randomization||36
254322|NCT01032135|616590|P5|12 Week Follow up|8 Week Randomization||38
254323|NCT01032135|616591|P4|12 Week Follow up|8 Week Randomization||34
254324|NCT01032135|616592|P3|12 Week Follow up|8 Week Randomization||0
254325|NCT01032135|616593|P2|12 Week Follow up|8 Week Randomization||0
254326|NCT01032135|616594|P1|12 Week Follow up|8 Week Randomization|These participants were'nt included in analyses as they didn't meet criteria for study intervention.|217
254327|NCT01032135|616588|P7|STARTED|8 Week Randomization||54
254328|NCT01032135|616589|P6|STARTED|8 Week Randomization||48
254329|NCT01032135|616590|P5|STARTED|8 Week Randomization||43
254330|NCT01032135|616591|P4|STARTED|8 Week Randomization||41
254331|NCT01032135|616592|P3|STARTED|8 Week Randomization||0
254332|NCT01032135|616593|P2|STARTED|8 Week Randomization||0
254333|NCT01032135|616594|P1|STARTED|8 Week Randomization||227
254334|NCT01032135|616588|P7|NOT COMPLETED|2 Week Randomization||0
254335|NCT01032135|616589|P6|NOT COMPLETED|2 Week Randomization||0
254336|NCT01032135|616590|P5|NOT COMPLETED|2 Week Randomization||0
254337|NCT01032135|616591|P4|NOT COMPLETED|2 Week Randomization||0
254338|NCT01032135|616592|P3|NOT COMPLETED|2 Week Randomization||0
254339|NCT01032135|616593|P2|NOT COMPLETED|2 Week Randomization||0
254340|NCT01032135|616594|P1|NOT COMPLETED|2 Week Randomization||0
254341|NCT01032135|616588|P7|COMPLETED|2 Week Randomization||0
254342|NCT01032135|616589|P6|COMPLETED|2 Week Randomization||0
254343|NCT01032135|616590|P5|COMPLETED|2 Week Randomization||0
254344|NCT01032135|616591|P4|COMPLETED|2 Week Randomization||0
254345|NCT01032135|616592|P3|COMPLETED|2 Week Randomization||96
254346|NCT01032135|616593|P2|COMPLETED|2 Week Randomization||93
254347|NCT01032135|616594|P1|COMPLETED|2 Week Randomization||311
254348|NCT01032135|616588|P7|STARTED|2 Week Randomization||0
254349|NCT01032135|616589|P6|STARTED|2 Week Randomization||0
254350|NCT01032135|616590|P5|STARTED|2 Week Randomization||0
254351|NCT01032135|616591|P4|STARTED|2 Week Randomization||0
254352|NCT01032135|616592|P3|STARTED|2 Week Randomization||96
254353|NCT01032135|616593|P2|STARTED|2 Week Randomization||93
254354|NCT01032135|616594|P1|STARTED|2 Week Randomization||311
254355|NCT01032174|616813|P2|NOT COMPLETED|Overall Study||1
254356|NCT01032174|616814|P1|NOT COMPLETED|Overall Study||0
254357|NCT01032174|616813|P2|COMPLETED|Overall Study||59
254358|NCT01032174|616814|P1|COMPLETED|Overall Study||63
254359|NCT01032174|616813|P2|STARTED|Overall Study||60
254360|NCT01032174|616814|P1|STARTED|Overall Study||63
254361|NCT01032200|616826|P2|NOT COMPLETED|Overall Study||7
254362|NCT01032200|616827|P1|NOT COMPLETED|Overall Study||4
254363|NCT01032200|616826|P2|COMPLETED|Overall Study||21
254364|NCT01032200|616827|P1|COMPLETED|Overall Study||22
254365|NCT01032200|616826|P2|STARTED|Overall Study||28
254366|NCT01032200|616827|P1|STARTED|Overall Study||26
254367|NCT01032265|616843|P2|NOT COMPLETED|Overall Study||17
254368|NCT01032265|616844|P1|NOT COMPLETED|Overall Study||13
254369|NCT01032265|616843|P2|COMPLETED|Overall Study||107
254370|NCT01032265|616844|P1|COMPLETED|Overall Study||113
254371|NCT01032265|616843|P2|STARTED|Overall Study||124
254372|NCT01032265|616844|P1|STARTED|Overall Study||126
254373|NCT01032291|616865|P3|NOT COMPLETED|Proof of Concept||3
254374|NCT01032291|616866|P2|NOT COMPLETED|Proof of Concept||8
254375|NCT01032291|616867|P1|NOT COMPLETED|Proof of Concept||0
254376|NCT01032291|616865|P3|COMPLETED|Proof of Concept|Participants with disease progression|18
254377|NCT01032291|616866|P2|COMPLETED|Proof of Concept|Participants with disease progression|14
254378|NCT01032291|616867|P1|COMPLETED|Proof of Concept||0
254379|NCT01032291|616865|P3|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
254380|NCT01032291|616866|P2|Intent to Treat and Safety Populations|Proof of Concept|Participants who took at least one dose of study drug|21
254381|NCT01032291|616867|P1|Intent to Treat and Safety Populations|Proof of Concept||0
254382|NCT01032291|616865|P3|STARTED|Proof of Concept||21
254383|NCT01032291|616866|P2|STARTED|Proof of Concept||22
254384|NCT01032291|616867|P1|STARTED|Proof of Concept||0
254385|NCT01032291|616865|P3|NOT COMPLETED|Safety Lead-in||0
254386|NCT01032291|616866|P2|NOT COMPLETED|Safety Lead-in||0
254387|NCT01032291|616867|P1|NOT COMPLETED|Safety Lead-in||2
254388|NCT01032291|616865|P3|COMPLETED|Safety Lead-in||0
254389|NCT01032291|616866|P2|COMPLETED|Safety Lead-in||0
254390|NCT01032291|616867|P1|COMPLETED|Safety Lead-in|Participants with disease progression|6
254391|NCT01032291|616865|P3|STARTED|Safety Lead-in||0
254392|NCT01032291|616866|P2|STARTED|Safety Lead-in||0
254393|NCT01032291|616867|P1|STARTED|Safety Lead-in||8
254394|NCT01032382|616893|P2|NOT COMPLETED|Overall Study||5
254395|NCT01032382|616894|P1|NOT COMPLETED|Overall Study||5
254396|NCT01032382|616893|P2|COMPLETED|Overall Study||9
254397|NCT01032382|616894|P1|COMPLETED|Overall Study||11
254398|NCT01032382|616893|P2|STARTED|Overall Study||14
254399|NCT01032382|616894|P1|STARTED|Overall Study||16
254400|NCT01032538|616920|P1|NOT COMPLETED|Overall Study||0
254401|NCT01032538|616920|P1|COMPLETED|Overall Study|Knees|99
254402|NCT01032538|616920|P1|STARTED|Overall Study|Knees|99
254403|NCT01032694|616928|P2|NOT COMPLETED|Overall Study||0
254404|NCT01032694|616929|P1|NOT COMPLETED|Overall Study||0
254405|NCT01032694|616928|P2|COMPLETED|Overall Study||10
254406|NCT01032694|616929|P1|COMPLETED|Overall Study||20
254407|NCT01032694|616928|P2|STARTED|Overall Study||10
254408|NCT01032694|616929|P1|STARTED|Overall Study||20
254409|NCT01032733|616941|P2|NOT COMPLETED|Overall Study||1
254410|NCT01032733|616942|P1|NOT COMPLETED|Overall Study||1
254411|NCT01032733|616941|P2|COMPLETED|Overall Study||16
254412|NCT01032733|616942|P1|COMPLETED|Overall Study||16
254413|NCT01032733|616941|P2|STARTED|Overall Study||17
254414|NCT01032733|616942|P1|STARTED|Overall Study||17
254415|NCT01032759|616958|P2|NOT COMPLETED|Overall Study||3
254416|NCT01032759|616959|P1|NOT COMPLETED|Overall Study||1
254417|NCT01032759|616958|P2|COMPLETED|Overall Study||28
254418|NCT01032759|616959|P1|COMPLETED|Overall Study||31
254419|NCT01032759|616958|P2|Completed 48 Hour Assessment|Overall Study||28
254420|NCT01032759|616959|P1|Completed 48 Hour Assessment|Overall Study||31
254421|NCT01032759|616958|P2|Completed 24 Hour Assessment|Overall Study||30
254422|NCT01032759|616959|P1|Completed 24 Hour Assessment|Overall Study||32
254423|NCT01032759|616958|P2|STARTED|Overall Study||31
254424|NCT01032759|616959|P1|STARTED|Overall Study||32
254425|NCT01032837|616981|P4|NOT COMPLETED|Overall Study||3
254426|NCT01032837|616982|P3|NOT COMPLETED|Overall Study||1
254427|NCT01032837|616983|P2|NOT COMPLETED|Overall Study||3
254428|NCT01032837|616984|P1|NOT COMPLETED|Overall Study||0
254429|NCT01032837|616981|P4|COMPLETED|Overall Study|Represents patients who completed treatment.|22
254430|NCT01032837|616982|P3|COMPLETED|Overall Study|Represents patients who completed treatment.|24
254431|NCT01032837|616983|P2|COMPLETED|Overall Study|Represents patients who completed treatment.|23
254432|NCT01032837|616984|P1|COMPLETED|Overall Study|Represents patients who completed treatment.|26
254433|NCT01032837|616981|P4|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|24
254434|NCT01032837|616982|P3|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|25
254435|NCT01032837|616983|P2|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
254436|NCT01032837|616984|P1|Intent-to-Treat|Overall Study|All patients randomized who received at least one dose of study medication.|26
254437|NCT01032837|616981|P4|STARTED|Overall Study||25
254438|NCT01032837|616982|P3|STARTED|Overall Study||25
254439|NCT01032837|616983|P2|STARTED|Overall Study||26
254440|NCT01032837|616984|P1|STARTED|Overall Study||26
254441|NCT01032850|617030|P1|NOT COMPLETED|Overall Study||2
254442|NCT01032850|617030|P1|COMPLETED|Overall Study||13
254443|NCT01032850|617030|P1|STARTED|Overall Study||15
254444|NCT01032889|617040|P3|NOT COMPLETED|Overall Study||3
254445|NCT01032889|617041|P2|NOT COMPLETED|Overall Study||15
254446|NCT01032889|617042|P1|NOT COMPLETED|Overall Study||8
254447|NCT01032889|617040|P3|COMPLETED|Overall Study||42
254448|NCT01032889|617041|P2|COMPLETED|Overall Study||28
254449|NCT01032889|617042|P1|COMPLETED|Overall Study||33
254450|NCT01032889|617040|P3|Received Treatment|Overall Study||45
254451|NCT01032889|617041|P2|Received Treatment|Overall Study||43
254452|NCT01032889|617042|P1|Received Treatment|Overall Study||41
254453|NCT01032889|617040|P3|STARTED|Overall Study||45
254454|NCT01032889|617041|P2|STARTED|Overall Study||43
254455|NCT01032889|617042|P1|STARTED|Overall Study||41
254456|NCT01032915|617066|P4|NOT COMPLETED|Overall Study||7
254457|NCT01032915|617067|P3|NOT COMPLETED|Overall Study||7
254458|NCT01032915|617068|P2|NOT COMPLETED|Overall Study||11
254459|NCT01032915|617069|P1|NOT COMPLETED|Overall Study||8
254460|NCT01032915|617066|P4|COMPLETED|Overall Study||27
254461|NCT01032915|617067|P3|COMPLETED|Overall Study||24
254462|NCT01032915|617068|P2|COMPLETED|Overall Study||20
254463|NCT01032915|617069|P1|COMPLETED|Overall Study||21
254464|NCT01032915|617066|P4|STARTED|Overall Study||34
254465|NCT01032915|617067|P3|STARTED|Overall Study||31
254466|NCT01032915|617068|P2|STARTED|Overall Study||31
254467|NCT01032915|617069|P1|STARTED|Overall Study||29
254468|NCT01032928|617091|P1|NOT COMPLETED|Overall Study||0
254469|NCT01032928|617091|P1|COMPLETED|Overall Study||30
254470|NCT01032928|617091|P1|STARTED|Overall Study||30
254471|NCT01032993|617105|P2|NOT COMPLETED|Overall Study||0
254472|NCT01032993|617106|P1|NOT COMPLETED|Overall Study||0
254473|NCT01032993|617105|P2|COMPLETED|Overall Study||20
254474|NCT01032993|617106|P1|COMPLETED|Overall Study||19
254475|NCT01032993|617105|P2|STARTED|Overall Study||20
254476|NCT01032993|617106|P1|STARTED|Overall Study||19
254477|NCT01033019|617120|P2|NOT COMPLETED|Overall Study||0
254478|NCT01033019|617121|P1|NOT COMPLETED|Overall Study||1
254479|NCT01033019|617120|P2|COMPLETED|Overall Study||8
254480|NCT01033019|617121|P1|COMPLETED|Overall Study||15
254481|NCT01033019|617120|P2|STARTED|Overall Study||8
254482|NCT01033019|617121|P1|STARTED|Overall Study||16
254483|NCT01033032|617128|P4|NOT COMPLETED|Phase II||0
254484|NCT01033032|617129|P3|NOT COMPLETED|Phase II||66
254485|NCT01033032|617130|P2|NOT COMPLETED|Phase II||0
254486|NCT01033032|617131|P1|NOT COMPLETED|Phase II||0
254487|NCT01033032|617128|P4|COMPLETED|Phase II||0
254488|NCT01033032|617129|P3|COMPLETED|Phase II|Patients continued recieving treatment until disease progression or unacceptable toxicity|0
254489|NCT01033032|617130|P2|COMPLETED|Phase II||0
254490|NCT01033032|617131|P1|COMPLETED|Phase II||0
254491|NCT01033032|617128|P4|STARTED|Phase II||0
254492|NCT01033032|617129|P3|STARTED|Phase II|Includes patients treated at MTD during Phase I (3 patients); 63 additional patients enrolled|66
254493|NCT01033032|617130|P2|STARTED|Phase II||0
254494|NCT01033032|617131|P1|STARTED|Phase II||0
254495|NCT01033032|617128|P4|NOT COMPLETED|Phase I||6
254496|NCT01033032|617129|P3|NOT COMPLETED|Phase I||0
254497|NCT01033032|617130|P2|NOT COMPLETED|Phase I||3
254498|NCT01033032|617131|P1|NOT COMPLETED|Phase I||3
254499|NCT01033032|617128|P4|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
254500|NCT01033032|617129|P3|COMPLETED|Phase I||3
254663|NCT01033487|617245|P1|NOT COMPLETED|Third Intervention Period||0
254501|NCT01033032|617130|P2|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
254502|NCT01033032|617131|P1|COMPLETED|Phase I|Patients were on-study until determination of the Maximum Tolerated Dose (MTD)|0
254503|NCT01033032|617128|P4|STARTED|Phase I||6
254504|NCT01033032|617129|P3|STARTED|Phase I||3
254505|NCT01033032|617130|P2|STARTED|Phase I||3
254506|NCT01033032|617131|P1|STARTED|Phase I||3
254507|NCT01033071|617141|P3|NOT COMPLETED|Overall Study||47
254508|NCT01033071|617142|P2|NOT COMPLETED|Overall Study||77
254509|NCT01033071|617143|P1|NOT COMPLETED|Overall Study||55
254510|NCT01033071|617141|P3|COMPLETED|Overall Study||317
254511|NCT01033071|617142|P2|COMPLETED|Overall Study||275
254512|NCT01033071|617143|P1|COMPLETED|Overall Study||300
254513|NCT01033071|617141|P3|STARTED|Overall Study||364
254514|NCT01033071|617142|P2|STARTED|Overall Study||352
254515|NCT01033071|617143|P1|STARTED|Overall Study||355
254516|NCT01033227|617204|P2|NOT COMPLETED|Overall Study||0
254517|NCT01033227|617205|P1|NOT COMPLETED|Overall Study||0
254518|NCT01033227|617204|P2|COMPLETED|Overall Study||2
254519|NCT01033227|617205|P1|COMPLETED|Overall Study||3
254520|NCT01033227|617204|P2|STARTED|Overall Study||2
254521|NCT01033227|617205|P1|STARTED|Overall Study||3
254522|NCT01033383|617215|P4|NOT COMPLETED|Overall Study||0
254523|NCT01033383|617216|P3|NOT COMPLETED|Overall Study||0
254524|NCT01033383|617217|P2|NOT COMPLETED|Overall Study||0
254525|NCT01033383|617218|P1|NOT COMPLETED|Overall Study||0
254526|NCT01033383|617215|P4|COMPLETED|Overall Study||20
254527|NCT01033383|617216|P3|COMPLETED|Overall Study||20
254528|NCT01033383|617217|P2|COMPLETED|Overall Study||20
254529|NCT01033383|617218|P1|COMPLETED|Overall Study||20
254530|NCT01033383|617215|P4|STARTED|Overall Study||20
254531|NCT01033383|617216|P3|STARTED|Overall Study||20
254532|NCT01033383|617217|P2|STARTED|Overall Study||20
254533|NCT01033383|617218|P1|STARTED|Overall Study||20
254534|NCT01033487|617236|P10|NOT COMPLETED|Fifth Intervention Period||0
254535|NCT01033487|617237|P9|NOT COMPLETED|Fifth Intervention Period||0
254536|NCT01033487|617238|P8|NOT COMPLETED|Fifth Intervention Period||0
254537|NCT01033487|617239|P7|NOT COMPLETED|Fifth Intervention Period||0
254538|NCT01033487|617240|P6|NOT COMPLETED|Fifth Intervention Period||0
254539|NCT01033487|617241|P5|NOT COMPLETED|Fifth Intervention Period||0
254540|NCT01033487|617242|P4|NOT COMPLETED|Fifth Intervention Period||0
254541|NCT01033487|617243|P3|NOT COMPLETED|Fifth Intervention Period||0
254542|NCT01033487|617244|P2|NOT COMPLETED|Fifth Intervention Period||0
254543|NCT01033487|617245|P1|NOT COMPLETED|Fifth Intervention Period||0
254544|NCT01033487|617236|P10|COMPLETED|Fifth Intervention Period||2
254545|NCT01033487|617237|P9|COMPLETED|Fifth Intervention Period||1
254546|NCT01033487|617238|P8|COMPLETED|Fifth Intervention Period||3
254547|NCT01033487|617239|P7|COMPLETED|Fifth Intervention Period||2
254548|NCT01033487|617240|P6|COMPLETED|Fifth Intervention Period||2
254549|NCT01033487|617241|P5|COMPLETED|Fifth Intervention Period||2
254550|NCT01033487|617242|P4|COMPLETED|Fifth Intervention Period||2
254551|NCT01033487|617243|P3|COMPLETED|Fifth Intervention Period||2
254552|NCT01033487|617244|P2|COMPLETED|Fifth Intervention Period||3
254553|NCT01033487|617245|P1|COMPLETED|Fifth Intervention Period||2
254554|NCT01033487|617236|P10|STARTED|Fifth Intervention Period||2
254555|NCT01033487|617237|P9|STARTED|Fifth Intervention Period||1
254556|NCT01033487|617238|P8|STARTED|Fifth Intervention Period||3
254557|NCT01033487|617239|P7|STARTED|Fifth Intervention Period||2
254558|NCT01033487|617240|P6|STARTED|Fifth Intervention Period||2
254559|NCT01033487|617241|P5|STARTED|Fifth Intervention Period||2
254560|NCT01033487|617242|P4|STARTED|Fifth Intervention Period||2
254561|NCT01033487|617243|P3|STARTED|Fifth Intervention Period||2
254562|NCT01033487|617244|P2|STARTED|Fifth Intervention Period||3
254563|NCT01033487|617245|P1|STARTED|Fifth Intervention Period||2
254564|NCT01033487|617236|P10|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254565|NCT01033487|617237|P9|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254566|NCT01033487|617238|P8|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254567|NCT01033487|617239|P7|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254568|NCT01033487|617240|P6|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254569|NCT01033487|617241|P5|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254570|NCT01033487|617242|P4|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254571|NCT01033487|617243|P3|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254572|NCT01033487|617244|P2|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254573|NCT01033487|617245|P1|NOT COMPLETED|Between Period 4 and 5 (At Least 7 Days)||0
254574|NCT01033487|617236|P10|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
254575|NCT01033487|617237|P9|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||1
254576|NCT01033487|617238|P8|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
254577|NCT01033487|617239|P7|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
254578|NCT01033487|617240|P6|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
254579|NCT01033487|617241|P5|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
254580|NCT01033487|617242|P4|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
254581|NCT01033487|617243|P3|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
254582|NCT01033487|617244|P2|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||3
254583|NCT01033487|617245|P1|COMPLETED|Between Period 4 and 5 (At Least 7 Days)||2
254584|NCT01033487|617236|P10|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
254585|NCT01033487|617237|P9|STARTED|Between Period 4 and 5 (At Least 7 Days)||1
254586|NCT01033487|617238|P8|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
254587|NCT01033487|617239|P7|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
254588|NCT01033487|617240|P6|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
254589|NCT01033487|617241|P5|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
254590|NCT01033487|617242|P4|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
254591|NCT01033487|617243|P3|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
254592|NCT01033487|617244|P2|STARTED|Between Period 4 and 5 (At Least 7 Days)||3
254593|NCT01033487|617245|P1|STARTED|Between Period 4 and 5 (At Least 7 Days)||2
254594|NCT01033487|617236|P10|NOT COMPLETED|Fourth Intervention Period||0
254595|NCT01033487|617237|P9|NOT COMPLETED|Fourth Intervention Period||1
254596|NCT01033487|617238|P8|NOT COMPLETED|Fourth Intervention Period||0
254597|NCT01033487|617239|P7|NOT COMPLETED|Fourth Intervention Period||0
254598|NCT01033487|617240|P6|NOT COMPLETED|Fourth Intervention Period||0
254599|NCT01033487|617241|P5|NOT COMPLETED|Fourth Intervention Period||0
254600|NCT01033487|617242|P4|NOT COMPLETED|Fourth Intervention Period||0
254601|NCT01033487|617243|P3|NOT COMPLETED|Fourth Intervention Period||0
254602|NCT01033487|617244|P2|NOT COMPLETED|Fourth Intervention Period||0
254603|NCT01033487|617245|P1|NOT COMPLETED|Fourth Intervention Period||0
254604|NCT01033487|617236|P10|COMPLETED|Fourth Intervention Period||2
254605|NCT01033487|617237|P9|COMPLETED|Fourth Intervention Period||1
254606|NCT01033487|617238|P8|COMPLETED|Fourth Intervention Period||3
254607|NCT01033487|617239|P7|COMPLETED|Fourth Intervention Period||2
254608|NCT01033487|617240|P6|COMPLETED|Fourth Intervention Period||2
254609|NCT01033487|617241|P5|COMPLETED|Fourth Intervention Period||2
254610|NCT01033487|617242|P4|COMPLETED|Fourth Intervention Period||2
254611|NCT01033487|617243|P3|COMPLETED|Fourth Intervention Period||2
254612|NCT01033487|617244|P2|COMPLETED|Fourth Intervention Period||3
254613|NCT01033487|617245|P1|COMPLETED|Fourth Intervention Period||2
254614|NCT01033487|617236|P10|STARTED|Fourth Intervention Period||2
254615|NCT01033487|617237|P9|STARTED|Fourth Intervention Period||2
254616|NCT01033487|617238|P8|STARTED|Fourth Intervention Period||3
254617|NCT01033487|617239|P7|STARTED|Fourth Intervention Period||2
254618|NCT01033487|617240|P6|STARTED|Fourth Intervention Period||2
254619|NCT01033487|617241|P5|STARTED|Fourth Intervention Period||2
254620|NCT01033487|617242|P4|STARTED|Fourth Intervention Period||2
254621|NCT01033487|617243|P3|STARTED|Fourth Intervention Period||2
254622|NCT01033487|617244|P2|STARTED|Fourth Intervention Period||3
254623|NCT01033487|617245|P1|STARTED|Fourth Intervention Period||2
254624|NCT01033487|617236|P10|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254625|NCT01033487|617237|P9|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254626|NCT01033487|617238|P8|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254627|NCT01033487|617239|P7|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254628|NCT01033487|617240|P6|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254629|NCT01033487|617241|P5|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254630|NCT01033487|617242|P4|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254631|NCT01033487|617243|P3|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254632|NCT01033487|617244|P2|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254633|NCT01033487|617245|P1|NOT COMPLETED|Between Period 3 and 4 (At Least 7 Days)||0
254634|NCT01033487|617236|P10|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254635|NCT01033487|617237|P9|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254636|NCT01033487|617238|P8|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
254637|NCT01033487|617239|P7|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254638|NCT01033487|617240|P6|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254639|NCT01033487|617241|P5|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254640|NCT01033487|617242|P4|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254641|NCT01033487|617243|P3|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254642|NCT01033487|617244|P2|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||3
254643|NCT01033487|617245|P1|COMPLETED|Between Period 3 and 4 (At Least 7 Days)||2
254644|NCT01033487|617236|P10|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254645|NCT01033487|617237|P9|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254646|NCT01033487|617238|P8|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
254647|NCT01033487|617239|P7|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254648|NCT01033487|617240|P6|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254649|NCT01033487|617241|P5|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254650|NCT01033487|617242|P4|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254651|NCT01033487|617243|P3|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254652|NCT01033487|617244|P2|STARTED|Between Period 3 and 4 (At Least 7 Days)||3
254653|NCT01033487|617245|P1|STARTED|Between Period 3 and 4 (At Least 7 Days)||2
254654|NCT01033487|617236|P10|NOT COMPLETED|Third Intervention Period||0
254655|NCT01033487|617237|P9|NOT COMPLETED|Third Intervention Period||0
254656|NCT01033487|617238|P8|NOT COMPLETED|Third Intervention Period||0
254657|NCT01033487|617239|P7|NOT COMPLETED|Third Intervention Period||0
254658|NCT01033487|617240|P6|NOT COMPLETED|Third Intervention Period||0
254659|NCT01033487|617241|P5|NOT COMPLETED|Third Intervention Period||0
254660|NCT01033487|617242|P4|NOT COMPLETED|Third Intervention Period||0
254661|NCT01033487|617243|P3|NOT COMPLETED|Third Intervention Period||0
254662|NCT01033487|617244|P2|NOT COMPLETED|Third Intervention Period||0
254664|NCT01033487|617236|P10|COMPLETED|Third Intervention Period||2
254665|NCT01033487|617237|P9|COMPLETED|Third Intervention Period||2
254666|NCT01033487|617238|P8|COMPLETED|Third Intervention Period||3
254667|NCT01033487|617239|P7|COMPLETED|Third Intervention Period||2
254668|NCT01033487|617240|P6|COMPLETED|Third Intervention Period||2
254669|NCT01033487|617241|P5|COMPLETED|Third Intervention Period||2
254670|NCT01033487|617242|P4|COMPLETED|Third Intervention Period||2
254671|NCT01033487|617243|P3|COMPLETED|Third Intervention Period||2
254672|NCT01033487|617244|P2|COMPLETED|Third Intervention Period||3
254673|NCT01033487|617245|P1|COMPLETED|Third Intervention Period||2
254674|NCT01033487|617236|P10|STARTED|Third Intervention Period||2
254675|NCT01033487|617237|P9|STARTED|Third Intervention Period||2
254676|NCT01033487|617238|P8|STARTED|Third Intervention Period||3
254677|NCT01033487|617239|P7|STARTED|Third Intervention Period||2
254678|NCT01033487|617240|P6|STARTED|Third Intervention Period||2
254679|NCT01033487|617241|P5|STARTED|Third Intervention Period||2
254680|NCT01033487|617242|P4|STARTED|Third Intervention Period||2
254681|NCT01033487|617243|P3|STARTED|Third Intervention Period||2
254682|NCT01033487|617244|P2|STARTED|Third Intervention Period||3
254683|NCT01033487|617245|P1|STARTED|Third Intervention Period||2
254684|NCT01033487|617236|P10|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254685|NCT01033487|617237|P9|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254686|NCT01033487|617238|P8|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254687|NCT01033487|617239|P7|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254688|NCT01033487|617240|P6|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254689|NCT01033487|617241|P5|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254690|NCT01033487|617242|P4|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254691|NCT01033487|617243|P3|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254692|NCT01033487|617244|P2|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254693|NCT01033487|617245|P1|NOT COMPLETED|Between Period 2 and 3 (At Least 7 Days)||0
254694|NCT01033487|617236|P10|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254695|NCT01033487|617237|P9|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254696|NCT01033487|617238|P8|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
254697|NCT01033487|617239|P7|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254698|NCT01033487|617240|P6|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254699|NCT01033487|617241|P5|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254700|NCT01033487|617242|P4|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254701|NCT01033487|617243|P3|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254702|NCT01033487|617244|P2|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||3
254703|NCT01033487|617245|P1|COMPLETED|Between Period 2 and 3 (At Least 7 Days)||2
254704|NCT01033487|617236|P10|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254705|NCT01033487|617237|P9|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254706|NCT01033487|617238|P8|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
254707|NCT01033487|617239|P7|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254708|NCT01033487|617240|P6|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254709|NCT01033487|617241|P5|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254710|NCT01033487|617242|P4|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254711|NCT01033487|617243|P3|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254712|NCT01033487|617244|P2|STARTED|Between Period 2 and 3 (At Least 7 Days)||3
254713|NCT01033487|617245|P1|STARTED|Between Period 2 and 3 (At Least 7 Days)||2
254714|NCT01033487|617236|P10|NOT COMPLETED|Second Intervention Period||0
254715|NCT01033487|617237|P9|NOT COMPLETED|Second Intervention Period||0
254716|NCT01033487|617238|P8|NOT COMPLETED|Second Intervention Period||0
254717|NCT01033487|617239|P7|NOT COMPLETED|Second Intervention Period||0
254718|NCT01033487|617240|P6|NOT COMPLETED|Second Intervention Period||0
254719|NCT01033487|617241|P5|NOT COMPLETED|Second Intervention Period||0
254720|NCT01033487|617242|P4|NOT COMPLETED|Second Intervention Period||0
254721|NCT01033487|617243|P3|NOT COMPLETED|Second Intervention Period||0
254722|NCT01033487|617244|P2|NOT COMPLETED|Second Intervention Period||0
254723|NCT01033487|617245|P1|NOT COMPLETED|Second Intervention Period||0
254724|NCT01033487|617236|P10|COMPLETED|Second Intervention Period||2
254725|NCT01033487|617237|P9|COMPLETED|Second Intervention Period||2
254726|NCT01033487|617238|P8|COMPLETED|Second Intervention Period||3
254727|NCT01033487|617239|P7|COMPLETED|Second Intervention Period||2
254728|NCT01033487|617240|P6|COMPLETED|Second Intervention Period||2
254729|NCT01033487|617241|P5|COMPLETED|Second Intervention Period||2
254730|NCT01033487|617242|P4|COMPLETED|Second Intervention Period||2
254731|NCT01033487|617243|P3|COMPLETED|Second Intervention Period||2
254732|NCT01033487|617244|P2|COMPLETED|Second Intervention Period||3
254733|NCT01033487|617245|P1|COMPLETED|Second Intervention Period||2
254734|NCT01033487|617236|P10|STARTED|Second Intervention Period||2
254735|NCT01033487|617237|P9|STARTED|Second Intervention Period||2
254736|NCT01033487|617238|P8|STARTED|Second Intervention Period||3
254737|NCT01033487|617239|P7|STARTED|Second Intervention Period||2
254738|NCT01033487|617240|P6|STARTED|Second Intervention Period||2
254739|NCT01033487|617241|P5|STARTED|Second Intervention Period||2
254740|NCT01033487|617242|P4|STARTED|Second Intervention Period||2
254741|NCT01033487|617243|P3|STARTED|Second Intervention Period||2
254742|NCT01033487|617244|P2|STARTED|Second Intervention Period||3
254743|NCT01033487|617245|P1|STARTED|Second Intervention Period||2
254744|NCT01033487|617236|P10|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254745|NCT01033487|617237|P9|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254746|NCT01033487|617238|P8|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254747|NCT01033487|617239|P7|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254748|NCT01033487|617240|P6|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254749|NCT01033487|617241|P5|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254750|NCT01033487|617242|P4|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254751|NCT01033487|617243|P3|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254752|NCT01033487|617244|P2|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254753|NCT01033487|617245|P1|NOT COMPLETED|Between Period 1 and 2 (At Least 7 Days)||0
254754|NCT01033487|617236|P10|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254755|NCT01033487|617237|P9|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254756|NCT01033487|617238|P8|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
254757|NCT01033487|617239|P7|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254758|NCT01033487|617240|P6|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254759|NCT01033487|617241|P5|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254760|NCT01033487|617242|P4|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254761|NCT01033487|617243|P3|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254762|NCT01033487|617244|P2|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||3
254763|NCT01033487|617245|P1|COMPLETED|Between Period 1 and 2 (At Least 7 Days)||2
254764|NCT01033487|617236|P10|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254765|NCT01033487|617237|P9|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254766|NCT01033487|617238|P8|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
254767|NCT01033487|617239|P7|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254768|NCT01033487|617240|P6|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254769|NCT01033487|617241|P5|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254770|NCT01033487|617242|P4|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254771|NCT01033487|617243|P3|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254772|NCT01033487|617244|P2|STARTED|Between Period 1 and 2 (At Least 7 Days)||3
254773|NCT01033487|617245|P1|STARTED|Between Period 1 and 2 (At Least 7 Days)||2
254774|NCT01033487|617236|P10|NOT COMPLETED|First Intervention Period||0
254775|NCT01033487|617237|P9|NOT COMPLETED|First Intervention Period||0
254776|NCT01033487|617238|P8|NOT COMPLETED|First Intervention Period||0
254777|NCT01033487|617239|P7|NOT COMPLETED|First Intervention Period||0
254778|NCT01033487|617240|P6|NOT COMPLETED|First Intervention Period||0
254779|NCT01033487|617241|P5|NOT COMPLETED|First Intervention Period||0
254780|NCT01033487|617242|P4|NOT COMPLETED|First Intervention Period||0
254781|NCT01033487|617243|P3|NOT COMPLETED|First Intervention Period||0
254782|NCT01033487|617244|P2|NOT COMPLETED|First Intervention Period||0
254783|NCT01033487|617245|P1|NOT COMPLETED|First Intervention Period||0
254784|NCT01033487|617236|P10|COMPLETED|First Intervention Period||2
254785|NCT01033487|617237|P9|COMPLETED|First Intervention Period||2
254786|NCT01033487|617238|P8|COMPLETED|First Intervention Period||3
254787|NCT01033487|617239|P7|COMPLETED|First Intervention Period||2
254788|NCT01033487|617240|P6|COMPLETED|First Intervention Period||2
254789|NCT01033487|617241|P5|COMPLETED|First Intervention Period||2
254790|NCT01033487|617242|P4|COMPLETED|First Intervention Period||2
254791|NCT01033487|617243|P3|COMPLETED|First Intervention Period||2
254792|NCT01033487|617244|P2|COMPLETED|First Intervention Period||3
254793|NCT01033487|617245|P1|COMPLETED|First Intervention Period||2
254794|NCT01033487|617236|P10|STARTED|First Intervention Period||2
254795|NCT01033487|617237|P9|STARTED|First Intervention Period||2
254796|NCT01033487|617238|P8|STARTED|First Intervention Period||3
254797|NCT01033487|617239|P7|STARTED|First Intervention Period||2
254798|NCT01033487|617240|P6|STARTED|First Intervention Period||2
254799|NCT01033487|617241|P5|STARTED|First Intervention Period||2
254800|NCT01033487|617242|P4|STARTED|First Intervention Period||2
254801|NCT01033487|617243|P3|STARTED|First Intervention Period||2
254802|NCT01033487|617244|P2|STARTED|First Intervention Period||3
254803|NCT01033487|617245|P1|STARTED|First Intervention Period||2
254804|NCT01033565|617299|P1|NOT COMPLETED|Overall Study||0
254805|NCT01033565|617299|P1|COMPLETED|Overall Study||1
254806|NCT01033565|617299|P1|STARTED|Overall Study||1
254807|NCT01033734|617303|P1|NOT COMPLETED|Overall Study||1
254808|NCT01033734|617303|P1|COMPLETED|Overall Study||7
254809|NCT01033734|617303|P1|STARTED|Overall Study||8
254810|NCT01033747|617357|P2|NOT COMPLETED|Overall Study||15
254811|NCT01033747|617358|P1|NOT COMPLETED|Overall Study||37
254812|NCT01033747|617357|P2|COMPLETED|Overall Study||4
254813|NCT01033747|617358|P1|COMPLETED|Overall Study||14
254814|NCT01033747|617357|P2|STARTED|Overall Study||19
254815|NCT01033747|617358|P1|STARTED|Overall Study||51
254816|NCT01033825|617373|P7|NOT COMPLETED|Overall Study||0
254817|NCT01033825|617374|P6|NOT COMPLETED|Overall Study||0
254818|NCT01033825|617375|P5|NOT COMPLETED|Overall Study||2
254819|NCT01033825|617376|P4|NOT COMPLETED|Overall Study||2
254820|NCT01033825|617377|P3|NOT COMPLETED|Overall Study||2
254821|NCT01033825|617378|P2|NOT COMPLETED|Overall Study||3
254822|NCT01033825|617379|P1|NOT COMPLETED|Overall Study||3
254823|NCT01033825|617373|P7|COMPLETED|Overall Study||18
254824|NCT01033825|617374|P6|COMPLETED|Overall Study||18
254825|NCT01033825|617375|P5|COMPLETED|Overall Study||56
254826|NCT01033825|617376|P4|COMPLETED|Overall Study||46
254827|NCT01033825|617377|P3|COMPLETED|Overall Study||55
254828|NCT01033825|617378|P2|COMPLETED|Overall Study||57
254829|NCT01033825|617379|P1|COMPLETED|Overall Study||48
254830|NCT01033825|617373|P7|STARTED|Overall Study||18
254831|NCT01033825|617374|P6|STARTED|Overall Study||18
254832|NCT01033825|617375|P5|STARTED|Overall Study||58
254833|NCT01033825|617376|P4|STARTED|Overall Study||48
254834|NCT01033825|617377|P3|STARTED|Overall Study||57
254835|NCT01033825|617378|P2|STARTED|Overall Study||60
254836|NCT01033825|617379|P1|STARTED|Overall Study||51
254837|NCT01033851|617600|P2|NOT COMPLETED|Overall Study||7
254838|NCT01033851|617601|P1|NOT COMPLETED|Overall Study||3
254839|NCT01033851|617600|P2|COMPLETED|Overall Study||34
254840|NCT01033851|617601|P1|COMPLETED|Overall Study||45
254841|NCT01033851|617600|P2|STARTED|Overall Study||41
254842|NCT01033851|617601|P1|STARTED|Overall Study||48
254843|NCT01033864|617611|P2|NOT COMPLETED|Overall Study||0
254844|NCT01033864|617612|P1|NOT COMPLETED|Overall Study||0
254845|NCT01033864|617611|P2|COMPLETED|Overall Study||11
254846|NCT01033864|617612|P1|COMPLETED|Overall Study||12
254847|NCT01033864|617611|P2|STARTED|Overall Study||11
254848|NCT01033864|617612|P1|STARTED|Overall Study||12
254849|NCT01033942|617638|P3|NOT COMPLETED|Overall Study||1
254850|NCT01033942|617639|P2|NOT COMPLETED|Overall Study||4
254851|NCT01033942|617640|P1|NOT COMPLETED|Overall Study||2
254852|NCT01033942|617638|P3|COMPLETED|Overall Study||18
254853|NCT01033942|617639|P2|COMPLETED|Overall Study||15
254854|NCT01033942|617640|P1|COMPLETED|Overall Study||18
254855|NCT01033942|617638|P3|STARTED|Overall Study||19
254856|NCT01033942|617639|P2|STARTED|Overall Study||19
254857|NCT01033942|617640|P1|STARTED|Overall Study||20
254858|NCT01034111|617910|P1|NOT COMPLETED|Overall Study||0
254859|NCT01034111|617910|P1|COMPLETED|Overall Study||30
254860|NCT01034111|617910|P1|STARTED|Overall Study||30
254861|NCT01034137|617918|P3|NOT COMPLETED|Overall Study||30
254862|NCT01034137|617919|P2|NOT COMPLETED|Overall Study||22
254863|NCT01034137|617920|P1|NOT COMPLETED|Overall Study||28
254864|NCT01034137|617918|P3|COMPLETED|Overall Study||78
254865|NCT01034137|617919|P2|COMPLETED|Overall Study||81
254866|NCT01034137|617920|P1|COMPLETED|Overall Study||78
254867|NCT01034137|617918|P3|STARTED|Overall Study||108
254868|NCT01034137|617919|P2|STARTED|Overall Study||103
254869|NCT01034137|617920|P1|STARTED|Overall Study||106
254870|NCT01034163|618053|P2|NOT COMPLETED|Overall Study||14
254871|NCT01034163|618054|P1|NOT COMPLETED|Overall Study||27
254872|NCT01034163|618053|P2|COMPLETED|Overall Study||0
254873|NCT01034163|618054|P1|COMPLETED|Overall Study||0
254874|NCT01034163|618053|P2|In Open Label Phase After Unblinding|Overall Study||0
254875|NCT01034163|618054|P1|In Open Label Phase After Unblinding|Overall Study||5
254876|NCT01034163|618053|P2|Safety Set|Overall Study||12
254877|NCT01034163|618054|P1|Safety Set|Overall Study||26
254878|NCT01034163|618053|P2|Untreated (Not in Safety Set)|Overall Study||2
254879|NCT01034163|618054|P1|Untreated (Not in Safety Set)|Overall Study||1
254880|NCT01034163|618053|P2|STARTED|Overall Study||14
254881|NCT01034163|618054|P1|STARTED|Overall Study||27
254882|NCT01034176|618062|P2|NOT COMPLETED|Overall Study||2
254883|NCT01034176|618063|P1|NOT COMPLETED|Overall Study||2
254884|NCT01034176|618062|P2|COMPLETED|Overall Study||19
254885|NCT01034176|618063|P1|COMPLETED|Overall Study||20
254886|NCT01034176|618062|P2|STARTED|Overall Study||21
254887|NCT01034176|618063|P1|STARTED|Overall Study||22
254888|NCT01034306|618073|P2|NOT COMPLETED|Overall Study||3
254889|NCT01034306|618074|P1|NOT COMPLETED|Overall Study||5
254890|NCT01034306|618073|P2|COMPLETED|Overall Study||34
254891|NCT01034306|618074|P1|COMPLETED|Overall Study||37
254892|NCT01034306|618073|P2|STARTED|Overall Study||37
254893|NCT01034306|618074|P1|STARTED|Overall Study||42
254894|NCT01034358|618080|P1|NOT COMPLETED|Overall Study||2
254895|NCT01034358|618080|P1|COMPLETED|Overall Study|One patient was found after enrollment to have already received one prior dose of the HPV vaccine.|13
254896|NCT01034358|618080|P1|STARTED|Overall Study||15
254897|NCT01027364|618088|P4|NOT COMPLETED|Overall Study||1
254898|NCT01027364|618089|P3|NOT COMPLETED|Overall Study||1
254899|NCT01027364|618090|P2|NOT COMPLETED|Overall Study||2
254900|NCT01027364|618091|P1|NOT COMPLETED|Overall Study||4
254901|NCT01027364|618088|P4|COMPLETED|Overall Study|11 participants total completed Arm 4 (3: compl. Arm 4 only; 7: cont. to Arm 1; 1: cont. to Arm 3)|3
254902|NCT01027364|618089|P3|COMPLETED|Overall Study||26
254903|NCT01027364|618090|P2|COMPLETED|Overall Study||27
254904|NCT01027364|618091|P1|COMPLETED|Overall Study||59
254905|NCT01027364|618088|P4|Started Arm 4 Then Joined Another Arm|Overall Study||0
254906|NCT01027364|618089|P3|Started Arm 4 Then Joined Another Arm|Overall Study||0
254907|NCT01027364|618090|P2|Started Arm 4 Then Joined Another Arm|Overall Study||0
254908|NCT01027364|618091|P1|Started Arm 4 Then Joined Another Arm|Overall Study||2
254909|NCT01027364|618088|P4|Joined Arm 4 for Surgery Then Returned|Overall Study||0
254910|NCT01027364|618089|P3|Joined Arm 4 for Surgery Then Returned|Overall Study||1
254911|NCT01027364|618090|P2|Joined Arm 4 for Surgery Then Returned|Overall Study||0
254912|NCT01027364|618091|P1|Joined Arm 4 for Surgery Then Returned|Overall Study||5
254913|NCT01027364|618088|P4|Enrolled in Sequential PK Subgroup|Overall Study||0
254914|NCT01027364|618089|P3|Enrolled in Sequential PK Subgroup|Overall Study||0
254915|NCT01027364|618090|P2|Enrolled in Sequential PK Subgroup|Overall Study||0
254916|NCT01027364|618091|P1|Enrolled in Sequential PK Subgroup|Overall Study||22
254917|NCT01027364|618088|P4|STARTED|Overall Study|12 total participants in Arm 4 (6 started in Arm 4; 5 joined from Arm 1; 1 joined from Arm 3)|4
254918|NCT01027364|618089|P3|STARTED|Overall Study||27
254919|NCT01027364|618090|P2|STARTED|Overall Study||29
254920|NCT01027364|618091|P1|STARTED|Overall Study||63
254921|NCT01027468|618180|P1|NOT COMPLETED|Overall Study||0
254922|NCT01027468|618180|P1|COMPLETED|Overall Study||160
254923|NCT01027468|618180|P1|STARTED|Overall Study||160
254924|NCT01027598|618186|P2|NOT COMPLETED|Overall Study||67
254925|NCT01027598|618187|P1|NOT COMPLETED|Overall Study||134
254926|NCT01027598|618186|P2|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
254927|NCT01027598|618187|P1|COMPLETED|Overall Study|Patients remained on treatment until coming off for progression, toxicity or any other reason|0
254928|NCT01027598|618186|P2|STARTED|Overall Study||67
254929|NCT01027598|618187|P1|STARTED|Overall Study|One patient was enrolled but not treated|134
254930|NCT01027650|618205|P8|NOT COMPLETED|Overall Study||0
254931|NCT01027650|618206|P7|NOT COMPLETED|Overall Study||1
254932|NCT01027650|618207|P6|NOT COMPLETED|Overall Study||2
254933|NCT01027650|618208|P5|NOT COMPLETED|Overall Study||2
254934|NCT01027650|618209|P4|NOT COMPLETED|Overall Study||0
254935|NCT01027650|618210|P3|NOT COMPLETED|Overall Study||0
254936|NCT01027650|618211|P2|NOT COMPLETED|Overall Study||0
254937|NCT01027650|618212|P1|NOT COMPLETED|Overall Study||0
254938|NCT01027650|618205|P8|COMPLETED|Overall Study||24
254939|NCT01027650|618206|P7|COMPLETED|Overall Study||24
254940|NCT01027650|618207|P6|COMPLETED|Overall Study||24
254941|NCT01027650|618208|P5|COMPLETED|Overall Study||23
254942|NCT01027650|618209|P4|COMPLETED|Overall Study||3
254943|NCT01027650|618210|P3|COMPLETED|Overall Study||6
254944|NCT01027650|618211|P2|COMPLETED|Overall Study||6
254945|NCT01027650|618212|P1|COMPLETED|Overall Study||6
254946|NCT01027650|618205|P8|STARTED|Overall Study||24
254947|NCT01027650|618206|P7|STARTED|Overall Study||25
254948|NCT01027650|618207|P6|STARTED|Overall Study||26
254949|NCT01027650|618208|P5|STARTED|Overall Study||25
254950|NCT01027650|618209|P4|STARTED|Overall Study||3
254951|NCT01027650|618210|P3|STARTED|Overall Study||6
254952|NCT01027650|618211|P2|STARTED|Overall Study||6
254953|NCT01027650|618212|P1|STARTED|Overall Study||6
254954|NCT01027780|618256|P2|NOT COMPLETED|Overall Study||1
254955|NCT01027780|618257|P1|NOT COMPLETED|Overall Study||0
254956|NCT01027780|618256|P2|COMPLETED|Overall Study||102
254957|NCT01027780|618257|P1|COMPLETED|Overall Study||105
254958|NCT01027780|618256|P2|STARTED|Overall Study||103
254959|NCT01027780|618257|P1|STARTED|Overall Study||105
254960|NCT01027819|618269|P2|NOT COMPLETED|Overall Study||0
254961|NCT01027819|618270|P1|NOT COMPLETED|Overall Study||0
254962|NCT01027819|618269|P2|COMPLETED|Overall Study||40
254963|NCT01027819|618270|P1|COMPLETED|Overall Study||40
254964|NCT01027819|618269|P2|STARTED|Overall Study||40
254965|NCT01027819|618270|P1|STARTED|Overall Study||40
254966|NCT01034397|618278|P2|NOT COMPLETED|Overall Study||2
254967|NCT01034397|618279|P1|NOT COMPLETED|Overall Study||7
254968|NCT01034397|618278|P2|COMPLETED|Overall Study||17
254969|NCT01034397|618279|P1|COMPLETED|Overall Study||28
254970|NCT01034397|618278|P2|STARTED|Overall Study||19
254971|NCT01034397|618279|P1|STARTED|Overall Study||35
254972|NCT01034462|618430|P2|NOT COMPLETED|Overall Study||54
254973|NCT01034462|618431|P1|NOT COMPLETED|Overall Study||45
254974|NCT01034462|618430|P2|COMPLETED|Overall Study||163
254975|NCT01034462|618431|P1|COMPLETED|Overall Study||172
254976|NCT01034462|618430|P2|STARTED|Overall Study||217
254977|NCT01034462|618431|P1|STARTED|Overall Study||217
254978|NCT01034540|618441|P2|NOT COMPLETED|Overall Study||1
254979|NCT01034540|618442|P1|NOT COMPLETED|Overall Study||0
254980|NCT01034540|618441|P2|COMPLETED|Overall Study||11
254981|NCT01034540|618442|P1|COMPLETED|Overall Study||11
254982|NCT01034540|618441|P2|Completed 1st Treatment Intervention|Overall Study||11
255076|NCT01035944|618592|P3|STARTED|Overall Study||5
254983|NCT01034540|618442|P1|Completed 1st Treatment Intervention|Overall Study||11
254984|NCT01034540|618441|P2|STARTED|Overall Study||12
254985|NCT01034540|618442|P1|STARTED|Overall Study||11
254986|NCT01034553|618450|P6|NOT COMPLETED|Overall Study||0
254987|NCT01034553|618451|P5|NOT COMPLETED|Overall Study||0
254988|NCT01034553|618452|P4|NOT COMPLETED|Overall Study||0
254989|NCT01034553|618453|P3|NOT COMPLETED|Overall Study||0
254990|NCT01034553|618454|P2|NOT COMPLETED|Overall Study||0
254991|NCT01034553|618455|P1|NOT COMPLETED|Overall Study||0
254992|NCT01034553|618450|P6|COMPLETED|Overall Study||7
254993|NCT01034553|618451|P5|COMPLETED|Overall Study||6
254994|NCT01034553|618452|P4|COMPLETED|Overall Study||3
254995|NCT01034553|618453|P3|COMPLETED|Overall Study||3
254996|NCT01034553|618454|P2|COMPLETED|Overall Study||4
254997|NCT01034553|618455|P1|COMPLETED|Overall Study||3
254998|NCT01034553|618450|P6|STARTED|Overall Study||7
254999|NCT01034553|618451|P5|STARTED|Overall Study||6
255000|NCT01034553|618452|P4|STARTED|Overall Study||3
255001|NCT01034553|618453|P3|STARTED|Overall Study||3
255002|NCT01034553|618454|P2|STARTED|Overall Study||4
255003|NCT01034553|618455|P1|STARTED|Overall Study||3
255004|NCT01034579|618471|P2|NOT COMPLETED|Overall Study||0
255005|NCT01034579|618472|P1|NOT COMPLETED|Overall Study||0
255006|NCT01034579|618471|P2|COMPLETED|Overall Study||166
255007|NCT01034579|618472|P1|COMPLETED|Overall Study||158
255008|NCT01034579|618471|P2|STARTED|Overall Study||166
255009|NCT01034579|618472|P1|STARTED|Overall Study||158
255010|NCT01034592|618486|P1|NOT COMPLETED|Overall Study||0
255011|NCT01034592|618486|P1|COMPLETED|Overall Study||2
255012|NCT01034592|618486|P1|STARTED|Overall Study||2
255013|NCT01034631|618499|P3|NOT COMPLETED|Phase II||2
255014|NCT01034631|618500|P2|NOT COMPLETED|Phase II||1
255015|NCT01034631|618501|P1|NOT COMPLETED|Phase II||0
255016|NCT01034631|618499|P3|COMPLETED|Phase II||67
255017|NCT01034631|618500|P2|COMPLETED|Phase II||69
255018|NCT01034631|618501|P1|COMPLETED|Phase II||0
255019|NCT01034631|618499|P3|STARTED|Phase II||69
255020|NCT01034631|618500|P2|STARTED|Phase II||70
255021|NCT01034631|618501|P1|STARTED|Phase II|No Phase I Participants were enrolled during this time period.|0
255022|NCT01034631|618499|P3|NOT COMPLETED|Phase I||0
255023|NCT01034631|618500|P2|NOT COMPLETED|Phase I||0
255024|NCT01034631|618501|P1|NOT COMPLETED|Phase I||3
255025|NCT01034631|618499|P3|COMPLETED|Phase I||0
255026|NCT01034631|618500|P2|COMPLETED|Phase I||0
255027|NCT01034631|618501|P1|COMPLETED|Phase I||12
255028|NCT01034631|618499|P3|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
255029|NCT01034631|618500|P2|STARTED|Phase I|No Phase II Participants were enrolled during this time period|0
255030|NCT01034631|618501|P1|STARTED|Phase I||15
255031|NCT01034657|618520|P3|NOT COMPLETED|Randomized Phase||1
255032|NCT01034657|618521|P2|NOT COMPLETED|Randomized Phase||6
255033|NCT01034657|618522|P1|NOT COMPLETED|Randomized Phase||5
255034|NCT01034657|618520|P3|COMPLETED|Randomized Phase||0
255035|NCT01034657|618521|P2|COMPLETED|Randomized Phase||0
255036|NCT01034657|618522|P1|COMPLETED|Randomized Phase||1
255037|NCT01034657|618520|P3|STARTED|Randomized Phase||1
255038|NCT01034657|618521|P2|STARTED|Randomized Phase||6
255039|NCT01034657|618522|P1|STARTED|Randomized Phase||6
255040|NCT01034657|618520|P3|NOT COMPLETED|Core Phase||0
255041|NCT01034657|618521|P2|NOT COMPLETED|Core Phase||0
255042|NCT01034657|618522|P1|NOT COMPLETED|Core Phase||14
255043|NCT01034657|618520|P3|COMPLETED|Core Phase||0
255044|NCT01034657|618521|P2|COMPLETED|Core Phase||0
255045|NCT01034657|618522|P1|COMPLETED|Core Phase||20
255046|NCT01034657|618520|P3|STARTED|Core Phase||0
255047|NCT01034657|618521|P2|STARTED|Core Phase||0
255048|NCT01034657|618522|P1|STARTED|Core Phase||34
255049|NCT01034709|618562|P2|NOT COMPLETED|Overall Study||16
255050|NCT01034709|618563|P1|NOT COMPLETED|Overall Study||9
255051|NCT01034709|618562|P2|COMPLETED|Overall Study||42
255052|NCT01034709|618563|P1|COMPLETED|Overall Study||44
255053|NCT01034709|618562|P2|STARTED|Overall Study||58
255054|NCT01034709|618563|P1|STARTED|Overall Study||53
255055|NCT01035788|618571|P2|NOT COMPLETED|Overall Study||14
255056|NCT01035788|618572|P1|NOT COMPLETED|Overall Study||6
255057|NCT01035788|618571|P2|COMPLETED|Overall Study||9
255058|NCT01035788|618572|P1|COMPLETED|Overall Study||17
255059|NCT01035788|618571|P2|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
255060|NCT01035788|618572|P1|STARTED|Overall Study|23 couples = 23 Veterans + 23 partners; only data for Veterans will be included for primary outcome.|23
255061|NCT01035905|618580|P2|NOT COMPLETED|Overall Study||1
255062|NCT01035905|618581|P1|NOT COMPLETED|Overall Study||1
255063|NCT01035905|618580|P2|COMPLETED|Overall Study||30
255064|NCT01035905|618581|P1|COMPLETED|Overall Study||31
255065|NCT01035905|618580|P2|STARTED|Overall Study||31
255066|NCT01035905|618581|P1|STARTED|Overall Study||32
255067|NCT01035944|618591|P4|NOT COMPLETED|Overall Study||0
255068|NCT01035944|618592|P3|NOT COMPLETED|Overall Study||1
255069|NCT01035944|618593|P2|NOT COMPLETED|Overall Study||1
255070|NCT01035944|618594|P1|NOT COMPLETED|Overall Study||3
255071|NCT01035944|618591|P4|COMPLETED|Overall Study||4
255072|NCT01035944|618592|P3|COMPLETED|Overall Study||4
255073|NCT01035944|618593|P2|COMPLETED|Overall Study||13
255074|NCT01035944|618594|P1|COMPLETED|Overall Study||11
255075|NCT01035944|618591|P4|STARTED|Overall Study||4
255077|NCT01035944|618593|P2|STARTED|Overall Study||14
255078|NCT01035944|618594|P1|STARTED|Overall Study||14
255079|NCT01036009|618606|P2|NOT COMPLETED|Overall Study||0
255080|NCT01036009|618607|P1|NOT COMPLETED|Overall Study||0
255081|NCT01036009|618606|P2|COMPLETED|Overall Study||26
255082|NCT01036009|618607|P1|COMPLETED|Overall Study||17
255083|NCT01036009|618606|P2|STARTED|Overall Study||26
255084|NCT01036009|618607|P1|STARTED|Overall Study||17
255085|NCT01036022|618627|P6|NOT COMPLETED|Overall Study||3
255086|NCT01036022|618628|P5|NOT COMPLETED|Overall Study||3
255087|NCT01036022|618629|P4|NOT COMPLETED|Overall Study||2
255088|NCT01036022|618630|P3|NOT COMPLETED|Overall Study||4
255089|NCT01036022|618631|P2|NOT COMPLETED|Overall Study||4
255090|NCT01036022|618632|P1|NOT COMPLETED|Overall Study||2
255091|NCT01036022|618627|P6|COMPLETED|Overall Study||13
255092|NCT01036022|618628|P5|COMPLETED|Overall Study||9
255093|NCT01036022|618629|P4|COMPLETED|Overall Study||10
255094|NCT01036022|618630|P3|COMPLETED|Overall Study||8
255095|NCT01036022|618631|P2|COMPLETED|Overall Study||7
255096|NCT01036022|618632|P1|COMPLETED|Overall Study||13
255097|NCT01036022|618627|P6|STARTED|Overall Study||16
255098|NCT01036022|618628|P5|STARTED|Overall Study||12
255099|NCT01036022|618629|P4|STARTED|Overall Study||12
255100|NCT01036022|618630|P3|STARTED|Overall Study||12
255101|NCT01036022|618631|P2|STARTED|Overall Study||11
255102|NCT01036022|618632|P1|STARTED|Overall Study||15
255103|NCT01036165|618732|P1|NOT COMPLETED|Overall Study||15
255104|NCT01036165|618732|P1|COMPLETED|Overall Study||88
255105|NCT01036165|618732|P1|STARTED|Overall Study||103
255106|NCT01036321|618739|P2|NOT COMPLETED|Overall Study||4
255107|NCT01036321|618740|P1|NOT COMPLETED|Overall Study||5
255108|NCT01036321|618739|P2|COMPLETED|Overall Study||31
255109|NCT01036321|618740|P1|COMPLETED|Overall Study||31
255110|NCT01036321|618739|P2|STARTED|Overall Study||35
255111|NCT01036321|618740|P1|STARTED|Overall Study||36
255112|NCT01036438|618766|P2|NOT COMPLETED|Overall Study||10
255113|NCT01036438|618767|P1|NOT COMPLETED|Overall Study||10
255114|NCT01036438|618766|P2|COMPLETED|Overall Study||90
255115|NCT01036438|618767|P1|COMPLETED|Overall Study||91
255116|NCT01036438|618766|P2|STARTED|Overall Study||100
255117|NCT01036438|618767|P1|STARTED|Overall Study||101
255118|NCT01036490|618775|P2|NOT COMPLETED|Overall Study||0
255119|NCT01036490|618776|P1|NOT COMPLETED|Overall Study||4
255120|NCT01036490|618775|P2|COMPLETED|Overall Study||18
255121|NCT01036490|618776|P1|COMPLETED|Overall Study||14
255122|NCT01036490|618775|P2|STARTED|Overall Study||18
255123|NCT01036490|618776|P1|STARTED|Overall Study||18
255124|NCT01036529|618794|P2|NOT COMPLETED|Overall Study||15
255125|NCT01036529|618795|P1|NOT COMPLETED|Overall Study||13
255126|NCT01036529|618794|P2|COMPLETED|Overall Study||0
255127|NCT01036529|618795|P1|COMPLETED|Overall Study||0
255128|NCT01036529|618794|P2|Crossover to Other Group|Overall Study||1
255129|NCT01036529|618795|P1|Crossover to Other Group|Overall Study||1
255130|NCT01036529|618794|P2|Requested Crossover|Overall Study||2
255131|NCT01036529|618795|P1|Requested Crossover|Overall Study||1
255132|NCT01036529|618794|P2|12 Month Follow-up|Overall Study||3
255133|NCT01036529|618795|P1|12 Month Follow-up|Overall Study||4
255134|NCT01036529|618794|P2|6 Month Follow-up|Overall Study||7
255135|NCT01036529|618795|P1|6 Month Follow-up|Overall Study||6
255136|NCT01036529|618794|P2|3 Month Follow-up|Overall Study||9
255137|NCT01036529|618795|P1|3 Month Follow-up|Overall Study||7
255138|NCT01036529|618794|P2|Index Procedure|Overall Study|Index Procedure: Surgery|11
255139|NCT01036529|618795|P1|Index Procedure|Overall Study|Index Procedure: Trial Stimulation|10
255140|NCT01036529|618794|P2|Baseline Visit|Overall Study||13
255141|NCT01036529|618795|P1|Baseline Visit|Overall Study||10
255142|NCT01036529|618794|P2|STARTED|Overall Study||15
255143|NCT01036529|618795|P1|STARTED|Overall Study||13
255144|NCT01036724|618803|P2|NOT COMPLETED|Overall Study||8
255145|NCT01036724|618804|P1|NOT COMPLETED|Overall Study||6
255146|NCT01036724|618803|P2|COMPLETED|Overall Study||47
255147|NCT01036724|618804|P1|COMPLETED|Overall Study||46
255148|NCT01036724|618803|P2|STARTED|Overall Study||55
255149|NCT01036724|618804|P1|STARTED|Overall Study||52
255150|NCT01036763|618812|P1|NOT COMPLETED|Overall Study||93
255151|NCT01036763|618812|P1|COMPLETED|Overall Study||1171
255152|NCT01036763|618812|P1|STARTED|Overall Study||1264
255153|NCT01036802|618824|P2|NOT COMPLETED|Overall Study||0
255154|NCT01036802|618825|P1|NOT COMPLETED|Overall Study||0
255155|NCT01036802|618824|P2|COMPLETED|Overall Study|Patient was taken off study after 7 months as she required hip replacement surgery.|1
255156|NCT01036802|618825|P1|COMPLETED|Overall Study||2
255157|NCT01036802|618824|P2|STARTED|Overall Study||1
255158|NCT01036802|618825|P1|STARTED|Overall Study||2
255159|NCT01037088|618843|P1|NOT COMPLETED|Overall Study||3
255160|NCT01037088|618843|P1|COMPLETED|Overall Study||36
255161|NCT01037088|618843|P1|Received Placebo|Overall Study||38
255162|NCT01037088|618843|P1|Received 1.29% THC|Overall Study||37
255163|NCT01037088|618843|P1|Received 3.53% THC|Overall Study||36
255164|NCT01037088|618843|P1|STARTED|Overall Study||39
255165|NCT01037114|618851|P1|NOT COMPLETED|Year 20||1
255166|NCT01037114|618851|P1|COMPLETED|Year 20|One subject returned at Y20 but did not do lab test because subject met a study exclusion criteria.|44
255167|NCT01037114|618851|P1|STARTED|Year 20||45
255168|NCT01037114|618851|P1|NOT COMPLETED|Year 19||0
255169|NCT01037114|618851|P1|COMPLETED|Year 19||45
255170|NCT01037114|618851|P1|STARTED|Year 19||45
255171|NCT01037114|618851|P1|NOT COMPLETED|Year 18||0
255172|NCT01037114|618851|P1|COMPLETED|Year 18||44
255173|NCT01037114|618851|P1|STARTED|Year 18||44
255174|NCT01037114|618851|P1|NOT COMPLETED|Year 17||0
255175|NCT01037114|618851|P1|COMPLETED|Year 17||48
255176|NCT01037114|618851|P1|STARTED|Year 17||48
255177|NCT01037114|618851|P1|NOT COMPLETED|Year 16||0
255178|NCT01037114|618851|P1|COMPLETED|Year 16||49
255179|NCT01037114|618851|P1|STARTED|Year 16||49
255180|NCT01037127|618866|P2|NOT COMPLETED|Overall Study||21
255181|NCT01037127|618867|P1|NOT COMPLETED|Overall Study||5
255182|NCT01037127|618866|P2|COMPLETED|Overall Study||36
255183|NCT01037127|618867|P1|COMPLETED|Overall Study||35
255184|NCT01037127|618866|P2|STARTED|Overall Study||57
255185|NCT01037127|618867|P1|STARTED|Overall Study||40
255186|NCT01037192|618901|P2|NOT COMPLETED|Overall Study||0
255187|NCT01037192|618902|P1|NOT COMPLETED|Overall Study||0
255188|NCT01037192|618901|P2|COMPLETED|Overall Study||1
255189|NCT01037192|618902|P1|COMPLETED|Overall Study||3
255190|NCT01037192|618901|P2|STARTED|Overall Study||1
255191|NCT01037192|618902|P1|STARTED|Overall Study||3
255192|NCT01037218|618914|P4|NOT COMPLETED|Overall Study||16
255193|NCT01037218|618915|P3|NOT COMPLETED|Overall Study||21
255194|NCT01037218|618916|P2|NOT COMPLETED|Overall Study||21
255195|NCT01037218|618917|P1|NOT COMPLETED|Overall Study||16
255196|NCT01037218|618914|P4|COMPLETED|Overall Study||134
255197|NCT01037218|618915|P3|COMPLETED|Overall Study||134
255198|NCT01037218|618916|P2|COMPLETED|Overall Study||128
255199|NCT01037218|618917|P1|COMPLETED|Overall Study||131
255200|NCT01037218|618914|P4|mITT Population|Overall Study||141
255201|NCT01037218|618915|P3|mITT Population|Overall Study||147
255202|NCT01037218|618916|P2|mITT Population|Overall Study||140
255203|NCT01037218|618917|P1|mITT Population|Overall Study||141
255204|NCT01037218|618914|P4|Safety Population|Overall Study||150
255205|NCT01037218|618915|P3|Safety Population|Overall Study||154
255206|NCT01037218|618916|P2|Safety Population|Overall Study||148
255207|NCT01037218|618917|P1|Safety Population|Overall Study||147
255208|NCT01037218|618914|P4|STARTED|Overall Study||150
255209|NCT01037218|618915|P3|STARTED|Overall Study||155
255210|NCT01037218|618916|P2|STARTED|Overall Study||149
255211|NCT01037218|618917|P1|STARTED|Overall Study||147
255212|NCT01037244|618979|P4|NOT COMPLETED|Overall Study||14
255213|NCT01037244|618980|P3|NOT COMPLETED|Overall Study||14
255214|NCT01037244|618981|P2|NOT COMPLETED|Overall Study||14
255215|NCT01037244|618982|P1|NOT COMPLETED|Overall Study||13
255216|NCT01037244|618979|P4|COMPLETED|Overall Study||140
255217|NCT01037244|618980|P3|COMPLETED|Overall Study||144
255218|NCT01037244|618981|P2|COMPLETED|Overall Study||138
255219|NCT01037244|618982|P1|COMPLETED|Overall Study||141
255220|NCT01037244|618979|P4|Safety Population|Overall Study||152
255221|NCT01037244|618980|P3|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|159
255222|NCT01037244|618981|P2|Safety Population|Overall Study||150
255223|NCT01037244|618982|P1|Safety Population|Overall Study|Two subjects randomized to receive placebo inadvertently received udenafil (1 - 50 mg and 1- 150 mg)|155
255224|NCT01037244|618979|P4|mITT (Modified Intent-to-Treat)|Overall Study||153
255225|NCT01037244|618980|P3|mITT (Modified Intent-to-Treat)|Overall Study||154
255226|NCT01037244|618981|P2|mITT (Modified Intent-to-Treat)|Overall Study||148
255227|NCT01037244|618982|P1|mITT (Modified Intent-to-Treat)|Overall Study||150
255228|NCT01037244|618979|P4|STARTED|Overall Study||154
255229|NCT01037244|618980|P3|STARTED|Overall Study||158
255230|NCT01037244|618981|P2|STARTED|Overall Study||152
255231|NCT01037244|618982|P1|STARTED|Overall Study||154
255232|NCT01037309|619046|P9|NOT COMPLETED|Intravenous Period 7 - 9||0
255233|NCT01037309|619047|P8|NOT COMPLETED|Intravenous Period 7 - 9||0
255234|NCT01037309|619048|P7|NOT COMPLETED|Intravenous Period 7 - 9||0
255235|NCT01037309|619049|P6|NOT COMPLETED|Intravenous Period 7 - 9||0
255236|NCT01037309|619050|P5|NOT COMPLETED|Intravenous Period 7 - 9||0
255237|NCT01037309|619051|P4|NOT COMPLETED|Intravenous Period 7 - 9||0
255238|NCT01037309|619052|P3|NOT COMPLETED|Intravenous Period 7 - 9||0
255239|NCT01037309|619053|P2|NOT COMPLETED|Intravenous Period 7 - 9||0
255240|NCT01037309|619054|P1|NOT COMPLETED|Intravenous Period 7 - 9||0
255241|NCT01037309|619046|P9|COMPLETED|Intravenous Period 7 - 9||3
255242|NCT01037309|619047|P8|COMPLETED|Intravenous Period 7 - 9||3
255243|NCT01037309|619048|P7|COMPLETED|Intravenous Period 7 - 9||3
255244|NCT01037309|619049|P6|COMPLETED|Intravenous Period 7 - 9||0
255245|NCT01037309|619050|P5|COMPLETED|Intravenous Period 7 - 9||0
255246|NCT01037309|619051|P4|COMPLETED|Intravenous Period 7 - 9||0
255247|NCT01037309|619052|P3|COMPLETED|Intravenous Period 7 - 9||0
255248|NCT01037309|619053|P2|COMPLETED|Intravenous Period 7 - 9||0
255249|NCT01037309|619054|P1|COMPLETED|Intravenous Period 7 - 9||0
255250|NCT01037309|619046|P9|STARTED|Intravenous Period 7 - 9||3
255251|NCT01037309|619047|P8|STARTED|Intravenous Period 7 - 9||3
255252|NCT01037309|619048|P7|STARTED|Intravenous Period 7 - 9||3
255253|NCT01037309|619049|P6|STARTED|Intravenous Period 7 - 9||0
255254|NCT01037309|619050|P5|STARTED|Intravenous Period 7 - 9||0
255255|NCT01037309|619051|P4|STARTED|Intravenous Period 7 - 9||0
255256|NCT01037309|619052|P3|STARTED|Intravenous Period 7 - 9||0
255257|NCT01037309|619053|P2|STARTED|Intravenous Period 7 - 9||0
255258|NCT01037309|619054|P1|STARTED|Intravenous Period 7 - 9||0
255259|NCT01037309|619046|P9|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255260|NCT01037309|619047|P8|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255261|NCT01037309|619048|P7|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255262|NCT01037309|619049|P6|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255263|NCT01037309|619050|P5|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255264|NCT01037309|619051|P4|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255265|NCT01037309|619052|P3|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255266|NCT01037309|619053|P2|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255267|NCT01037309|619054|P1|NOT COMPLETED|Subcutaneous Cohort 1 - 6||0
255268|NCT01037309|619046|P9|COMPLETED|Subcutaneous Cohort 1 - 6||0
255269|NCT01037309|619047|P8|COMPLETED|Subcutaneous Cohort 1 - 6||0
255270|NCT01037309|619048|P7|COMPLETED|Subcutaneous Cohort 1 - 6||0
255271|NCT01037309|619049|P6|COMPLETED|Subcutaneous Cohort 1 - 6||3
255272|NCT01037309|619050|P5|COMPLETED|Subcutaneous Cohort 1 - 6||3
255273|NCT01037309|619051|P4|COMPLETED|Subcutaneous Cohort 1 - 6||3
255274|NCT01037309|619052|P3|COMPLETED|Subcutaneous Cohort 1 - 6||3
255275|NCT01037309|619053|P2|COMPLETED|Subcutaneous Cohort 1 - 6||3
255276|NCT01037309|619054|P1|COMPLETED|Subcutaneous Cohort 1 - 6||3
255277|NCT01037309|619046|P9|STARTED|Subcutaneous Cohort 1 - 6||0
255278|NCT01037309|619047|P8|STARTED|Subcutaneous Cohort 1 - 6||0
255279|NCT01037309|619048|P7|STARTED|Subcutaneous Cohort 1 - 6||0
255280|NCT01037309|619049|P6|STARTED|Subcutaneous Cohort 1 - 6||3
255281|NCT01037309|619050|P5|STARTED|Subcutaneous Cohort 1 - 6||3
255282|NCT01037309|619051|P4|STARTED|Subcutaneous Cohort 1 - 6||3
255283|NCT01037309|619052|P3|STARTED|Subcutaneous Cohort 1 - 6||3
255284|NCT01037309|619053|P2|STARTED|Subcutaneous Cohort 1 - 6||3
255285|NCT01037309|619054|P1|STARTED|Subcutaneous Cohort 1 - 6||3
255286|NCT01037452|619087|P4|NOT COMPLETED|Overall Study||0
255287|NCT01037452|619088|P3|NOT COMPLETED|Overall Study||0
255288|NCT01037452|619089|P2|NOT COMPLETED|Overall Study||0
255289|NCT01037452|619090|P1|NOT COMPLETED|Overall Study||0
255290|NCT01037452|619087|P4|COMPLETED|Overall Study||30
255291|NCT01037452|619088|P3|COMPLETED|Overall Study||30
255292|NCT01037452|619089|P2|COMPLETED|Overall Study||30
255293|NCT01037452|619090|P1|COMPLETED|Overall Study||30
255294|NCT01037452|619087|P4|STARTED|Overall Study||30
255295|NCT01037452|619088|P3|STARTED|Overall Study||30
255296|NCT01037452|619089|P2|STARTED|Overall Study||30
255297|NCT01037452|619090|P1|STARTED|Overall Study||30
255298|NCT01038128|619112|P1|NOT COMPLETED|Overall Study||4
255299|NCT01038128|619112|P1|COMPLETED|Overall Study||1
255300|NCT01038128|619112|P1|Baseline Visit|Overall Study||3
255301|NCT01038128|619112|P1|STARTED|Overall Study||5
255302|NCT01038323|619123|P3|NOT COMPLETED|Overall Study||4
255303|NCT01038323|619124|P2|NOT COMPLETED|Overall Study||2
255304|NCT01038323|619125|P1|NOT COMPLETED|Overall Study||3
255305|NCT01038323|619123|P3|COMPLETED|Overall Study||15
255306|NCT01038323|619124|P2|COMPLETED|Overall Study||17
255307|NCT01038323|619125|P1|COMPLETED|Overall Study||17
255308|NCT01038323|619123|P3|STARTED|Overall Study||19
255309|NCT01038323|619124|P2|STARTED|Overall Study||19
255310|NCT01038323|619125|P1|STARTED|Overall Study||20
255311|NCT01038336|619142|P3|NOT COMPLETED|Overall Study||0
255312|NCT01038336|619143|P2|NOT COMPLETED|Overall Study||0
255313|NCT01038336|619144|P1|NOT COMPLETED|Overall Study||0
255314|NCT01038336|619142|P3|COMPLETED|Overall Study||44
255315|NCT01038336|619143|P2|COMPLETED|Overall Study||42
255316|NCT01038336|619144|P1|COMPLETED|Overall Study||43
255317|NCT01038336|619142|P3|STARTED|Overall Study||44
255318|NCT01038336|619143|P2|STARTED|Overall Study||42
255319|NCT01038336|619144|P1|STARTED|Overall Study||43
255320|NCT01038609|619178|P5|NOT COMPLETED|Overall Study||1
255321|NCT01038609|619179|P4|NOT COMPLETED|Overall Study||1
255322|NCT01038609|619180|P3|NOT COMPLETED|Overall Study||1
255323|NCT01038609|619181|P2|NOT COMPLETED|Overall Study||1
255324|NCT01038609|619182|P1|NOT COMPLETED|Overall Study||1
255325|NCT01038609|619178|P5|COMPLETED|Overall Study||50
255326|NCT01038609|619179|P4|COMPLETED|Overall Study||47
255327|NCT01038609|619180|P3|COMPLETED|Overall Study||48
255328|NCT01038609|619181|P2|COMPLETED|Overall Study||51
255329|NCT01038609|619182|P1|COMPLETED|Overall Study||49
255330|NCT01038609|619178|P5|STARTED|Overall Study||51
255331|NCT01038609|619179|P4|STARTED|Overall Study||48
255332|NCT01038609|619180|P3|STARTED|Overall Study||49
255333|NCT01038609|619181|P2|STARTED|Overall Study||52
255334|NCT01038609|619182|P1|STARTED|Overall Study||50
255335|NCT01038635|619233|P9|NOT COMPLETED|Overall Study||2
255336|NCT01038635|619234|P8|NOT COMPLETED|Overall Study||5
255337|NCT01038635|619235|P7|NOT COMPLETED|Overall Study||2
255338|NCT01038635|619236|P6|NOT COMPLETED|Overall Study||0
255339|NCT01038635|619237|P5|NOT COMPLETED|Overall Study||1
255340|NCT01038635|619238|P4|NOT COMPLETED|Overall Study||0
255341|NCT01038635|619239|P3|NOT COMPLETED|Overall Study||0
255342|NCT01038635|619240|P2|NOT COMPLETED|Overall Study||0
255343|NCT01038635|619241|P1|NOT COMPLETED|Overall Study||2
255344|NCT01038635|619233|P9|COMPLETED|Overall Study||38
255345|NCT01038635|619234|P8|COMPLETED|Overall Study||15
255346|NCT01038635|619235|P7|COMPLETED|Overall Study||5
255347|NCT01038635|619236|P6|COMPLETED|Overall Study||3
255348|NCT01038635|619237|P5|COMPLETED|Overall Study||3
255349|NCT01038635|619238|P4|COMPLETED|Overall Study||3
255350|NCT01038635|619239|P3|COMPLETED|Overall Study||3
255351|NCT01038635|619240|P2|COMPLETED|Overall Study||3
255352|NCT01038635|619241|P1|COMPLETED|Overall Study||3
255353|NCT01038635|619233|P9|STARTED|Overall Study||40
255354|NCT01038635|619234|P8|STARTED|Overall Study||20
255355|NCT01038635|619235|P7|STARTED|Overall Study||7
255356|NCT01038635|619236|P6|STARTED|Overall Study||3
255357|NCT01038635|619237|P5|STARTED|Overall Study||4
255358|NCT01038635|619238|P4|STARTED|Overall Study||3
255359|NCT01038635|619239|P3|STARTED|Overall Study||3
255360|NCT01038635|619240|P2|STARTED|Overall Study||3
255361|NCT01038635|619241|P1|STARTED|Overall Study||5
255362|NCT01038713|619265|P3|NOT COMPLETED|Overall Study||1
255363|NCT01038713|619266|P2|NOT COMPLETED|Overall Study||3
255364|NCT01038713|619267|P1|NOT COMPLETED|Overall Study||5
255365|NCT01038713|619265|P3|COMPLETED|Overall Study||16
255366|NCT01038713|619266|P2|COMPLETED|Overall Study||17
255367|NCT01038713|619267|P1|COMPLETED|Overall Study||21
255368|NCT01038713|619265|P3|STARTED|Overall Study||17
255369|NCT01038713|619266|P2|STARTED|Overall Study||20
255370|NCT01038713|619267|P1|STARTED|Overall Study||26
255371|NCT01038752|619289|P2|NOT COMPLETED|Overall Study||5
255372|NCT01038752|619290|P1|NOT COMPLETED|Overall Study||5
255373|NCT01038752|619289|P2|COMPLETED|Overall Study||1
255374|NCT01038752|619290|P1|COMPLETED|Overall Study||3
255375|NCT01038752|619289|P2|STARTED|Overall Study||6
255376|NCT01038752|619290|P1|STARTED|Overall Study||8
255377|NCT01030718|619313|P3|NOT COMPLETED|Study CA180-036 Only||5
255378|NCT01030718|619314|P2|NOT COMPLETED|Study CA180-036 Only||7
255379|NCT01030718|619315|P1|NOT COMPLETED|Study CA180-036 Only||3
255380|NCT01030718|619313|P3|COMPLETED|Study CA180-036 Only||1
255381|NCT01030718|619314|P2|COMPLETED|Study CA180-036 Only||2
255382|NCT01030718|619315|P1|COMPLETED|Study CA180-036 Only||26
255383|NCT01030718|619313|P3|STARTED|Study CA180-036 Only||6
255384|NCT01030718|619314|P2|STARTED|Study CA180-036 Only||9
255385|NCT01030718|619315|P1|STARTED|Study CA180-036 Only||29
255386|NCT01030718|619313|P3|NOT COMPLETED|Studies CA180-031 and -036 Combined||12
255387|NCT01030718|619314|P2|NOT COMPLETED|Studies CA180-031 and -036 Combined||9
255388|NCT01030718|619315|P1|NOT COMPLETED|Studies CA180-031 and -036 Combined||4
255389|NCT01030718|619313|P3|COMPLETED|Studies CA180-031 and -036 Combined||1
255390|NCT01030718|619314|P2|COMPLETED|Studies CA180-031 and -036 Combined||2
255391|NCT01030718|619315|P1|COMPLETED|Studies CA180-031 and -036 Combined||26
255392|NCT01030718|619313|P3|STARTED|Studies CA180-031 and -036 Combined||13
255393|NCT01030718|619314|P2|STARTED|Studies CA180-031 and -036 Combined||11
255394|NCT01030718|619315|P1|STARTED|Studies CA180-031 and -036 Combined||30
255395|NCT01030757|619374|P1|NOT COMPLETED|Overall Study||0
255396|NCT01030757|619374|P1|COMPLETED|Overall Study||2
255397|NCT01030757|619374|P1|STARTED|Overall Study||2
255398|NCT01030822|619382|P3|NOT COMPLETED|Overall Study||26
255399|NCT01030822|619383|P2|NOT COMPLETED|Overall Study||24
255400|NCT01030822|619384|P1|NOT COMPLETED|Overall Study||31
255401|NCT01030822|619382|P3|COMPLETED|Overall Study||61
255402|NCT01030822|619383|P2|COMPLETED|Overall Study||71
255403|NCT01030822|619384|P1|COMPLETED|Overall Study||69
255404|NCT01030822|619382|P3|STARTED|Overall Study||87
255405|NCT01030822|619383|P2|STARTED|Overall Study||95
255406|NCT01030822|619384|P1|STARTED|Overall Study||100
255407|NCT01030952|619433|P2|NOT COMPLETED|Overall Study||3
255408|NCT01030952|619434|P1|NOT COMPLETED|Overall Study||2
255409|NCT01030952|619433|P2|COMPLETED|Overall Study||49
255410|NCT01030952|619434|P1|COMPLETED|Overall Study||49
255411|NCT01030952|619433|P2|STARTED|Overall Study||52
255412|NCT01030952|619434|P1|STARTED|Overall Study||51
255413|NCT01030965|619472|P4|NOT COMPLETED|Overall Study||7
255414|NCT01030965|619473|P3|NOT COMPLETED|Overall Study||4
255415|NCT01030965|619474|P2|NOT COMPLETED|Overall Study||6
255416|NCT01030965|619475|P1|NOT COMPLETED|Overall Study||4
255417|NCT01030965|619472|P4|COMPLETED|Overall Study||64
255418|NCT01030965|619473|P3|COMPLETED|Overall Study||68
255419|NCT01030965|619474|P2|COMPLETED|Overall Study||65
255420|NCT01030965|619475|P1|COMPLETED|Overall Study||67
255421|NCT01030965|619472|P4|STARTED|Overall Study||71
255422|NCT01030965|619473|P3|STARTED|Overall Study||72
255423|NCT01030965|619474|P2|STARTED|Overall Study||71
255424|NCT01030965|619475|P1|STARTED|Overall Study||71
255425|NCT01031004|619495|P2|NOT COMPLETED|Overall Study||1
255426|NCT01031004|619496|P1|NOT COMPLETED|Overall Study||1
255427|NCT01031004|619495|P2|COMPLETED|Overall Study||24
255428|NCT01031004|619496|P1|COMPLETED|Overall Study||24
255429|NCT01031004|619495|P2|STARTED|Overall Study||25
255430|NCT01031004|619496|P1|STARTED|Overall Study||25
255431|NCT01031043|619536|P1|NOT COMPLETED|Overall Study||1
255432|NCT01031043|619536|P1|COMPLETED|Overall Study||4
255433|NCT01031043|619536|P1|STARTED|Overall Study||5
255434|NCT01031095|619542|P2|NOT COMPLETED|Overall Study||0
255435|NCT01031095|619543|P1|NOT COMPLETED|Overall Study||0
255436|NCT01031095|619542|P2|COMPLETED|Overall Study||100
255437|NCT01031095|619543|P1|COMPLETED|Overall Study||100
255438|NCT01031095|619542|P2|STARTED|Overall Study||100
255439|NCT01031095|619543|P1|STARTED|Overall Study||100
255440|NCT01031134|619551|P2|NOT COMPLETED|Overall Study||10
255441|NCT01031134|619552|P1|NOT COMPLETED|Overall Study||11
255442|NCT01031134|619551|P2|COMPLETED|Overall Study||78
255443|NCT01031134|619552|P1|COMPLETED|Overall Study||103
255444|NCT01031134|619551|P2|STARTED|Overall Study||88
255445|NCT01031134|619552|P1|STARTED|Overall Study||114
255446|NCT01031381|619560|P1|NOT COMPLETED|Overall Study||9
255447|NCT01031381|619560|P1|COMPLETED|Overall Study||50
255448|NCT01031381|619560|P1|STARTED|Overall Study||59
255449|NCT01031446|619565|P1|NOT COMPLETED|Overall Study||55
255450|NCT01031446|619565|P1|COMPLETED|Overall Study||0
255451|NCT01031446|619565|P1|STARTED|Overall Study||55
255452|NCT01031498|619577|P3|NOT COMPLETED|Overall Study||2
255453|NCT01031498|619578|P2|NOT COMPLETED|Overall Study||3
255454|NCT01031498|619579|P1|NOT COMPLETED|Overall Study||2
255455|NCT01031498|619577|P3|COMPLETED|Overall Study||48
255456|NCT01031498|619578|P2|COMPLETED|Overall Study||48
255457|NCT01031498|619579|P1|COMPLETED|Overall Study||47
255458|NCT01031498|619577|P3|STARTED|Overall Study|2 patients were not evaluable in arm 3.|50
255459|NCT01031498|619578|P2|STARTED|Overall Study|3 patients were not evaluable in arm 2|51
255460|NCT01031498|619579|P1|STARTED|Overall Study|2 patients were not evaluable in arm 1.|49
255461|NCT01031550|619589|P2|NOT COMPLETED|Overall Study||0
255462|NCT01031550|619590|P1|NOT COMPLETED|Overall Study||0
255463|NCT01031550|619589|P2|COMPLETED|Overall Study||3
255464|NCT01031550|619590|P1|COMPLETED|Overall Study||5
255465|NCT01031550|619589|P2|STARTED|Overall Study||3
255466|NCT01031550|619590|P1|STARTED|Overall Study||5
255467|NCT01031628|619606|P4|NOT COMPLETED|Overall Study||0
255468|NCT01031628|619607|P3|NOT COMPLETED|Overall Study||3
255469|NCT01031628|619608|P2|NOT COMPLETED|Overall Study||1
255470|NCT01031628|619609|P1|NOT COMPLETED|Overall Study||0
255471|NCT01031628|619606|P4|COMPLETED|Overall Study||0
255472|NCT01031628|619607|P3|COMPLETED|Overall Study||0
255473|NCT01031628|619608|P2|COMPLETED|Overall Study||0
255474|NCT01031628|619609|P1|COMPLETED|Overall Study||0
255475|NCT01031628|619606|P4|STARTED|Overall Study||0
255476|NCT01031628|619607|P3|STARTED|Overall Study||3
255477|NCT01031628|619608|P2|STARTED|Overall Study||1
255478|NCT01031628|619609|P1|STARTED|Overall Study||0
255479|NCT01031680|619621|P2|NOT COMPLETED|Overall Study||58
255480|NCT01031680|619622|P1|NOT COMPLETED|Overall Study||57
255481|NCT01031680|619621|P2|COMPLETED|Overall Study||404
255482|NCT01031680|619622|P1|COMPLETED|Overall Study||403
255483|NCT01031680|619621|P2|STARTED|Overall Study|Of the 462 randomized participants only 459 were included in the full analysis set.|462
255484|NCT01031680|619622|P1|STARTED|Overall Study|Of the 460 randomized participants only 455 were included in the full analysis set.|460
255485|NCT01031706|619640|P2|NOT COMPLETED|Overall Study||1
255486|NCT01031706|619641|P1|NOT COMPLETED|Overall Study||2
255487|NCT01031706|619640|P2|COMPLETED|Overall Study||8
255488|NCT01031706|619641|P1|COMPLETED|Overall Study||12
255489|NCT01031706|619640|P2|STARTED|Overall Study||9
255490|NCT01031706|619641|P1|STARTED|Overall Study||14
255491|NCT01031810|619649|P1|NOT COMPLETED|Overall Study||4
255492|NCT01031810|619649|P1|COMPLETED|Overall Study||9
255493|NCT01031810|619649|P1|STARTED|Overall Study||13
255494|NCT01038869|619658|P1|NOT COMPLETED|Overall Study||7
255495|NCT01038869|619658|P1|COMPLETED|Overall Study||13
255496|NCT01038869|619658|P1|STARTED|Overall Study||20
255497|NCT01038921|619668|P2|NOT COMPLETED|Overall Study||0
255498|NCT01038921|619669|P1|NOT COMPLETED|Overall Study||2
255499|NCT01038921|619668|P2|COMPLETED|Overall Study||20
255500|NCT01038921|619669|P1|COMPLETED|Overall Study|2 subjects withdrew|17
255501|NCT01038921|619668|P2|STARTED|Overall Study|20 subjects received placebo first (10 weeks), washout (6 weeks), melatonin second ( 10 weeks)|20
255502|NCT01038921|619669|P1|STARTED|Overall Study|19 subjects received melatonin first(10 weeks), washout (6 weeks), placebo second (10 weeks)|19
255503|NCT01039376|619677|P2|NOT COMPLETED|Overall Study||202
255504|NCT01039376|619678|P1|NOT COMPLETED|Overall Study||206
255505|NCT01039376|619677|P2|COMPLETED|Overall Study||34
255506|NCT01039376|619678|P1|COMPLETED|Overall Study||32
255507|NCT01039376|619677|P2|Ongoing|Overall Study||182
255508|NCT01039376|619678|P1|Ongoing|Overall Study||189
255509|NCT01039376|619677|P2|STARTED|Overall Study||236
255510|NCT01039376|619678|P1|STARTED|Overall Study||238
255511|NCT01039428|619738|P2|NOT COMPLETED|Overall Study||0
255512|NCT01039428|619739|P1|NOT COMPLETED|Overall Study||2
255513|NCT01039428|619738|P2|COMPLETED|Overall Study||28
255514|NCT01039428|619739|P1|COMPLETED|Overall Study||33
255515|NCT01039428|619738|P2|STARTED|Overall Study||28
255516|NCT01039428|619739|P1|STARTED|Overall Study||35
255517|NCT01039519|619761|P1|NOT COMPLETED|Survival Follow-up||27
255518|NCT01039519|619761|P1|COMPLETED|Survival Follow-up||0
255519|NCT01039519|619761|P1|STARTED|Survival Follow-up||27
255520|NCT01039519|619761|P1|NOT COMPLETED|Treatment||27
255521|NCT01039519|619761|P1|COMPLETED|Treatment|Reason not completed represents reason for terminating treatment.|0
255522|NCT01039519|619761|P1|STARTED|Treatment||27
255523|NCT01039584|619773|P3|NOT COMPLETED|Overall Study||57
255524|NCT01039584|619774|P2|NOT COMPLETED|Overall Study||97
255525|NCT01039584|619775|P1|NOT COMPLETED|Overall Study||103
255526|NCT01039584|619773|P3|COMPLETED|Overall Study||65
255527|NCT01039584|619774|P2|COMPLETED|Overall Study||146
255528|NCT01039584|619775|P1|COMPLETED|Overall Study||143
255529|NCT01039584|619773|P3|STARTED|Overall Study||122
255530|NCT01039584|619774|P2|STARTED|Overall Study||243
255531|NCT01039584|619775|P1|STARTED|Overall Study||246
255532|NCT01039675|619791|P2|NOT COMPLETED|Overall Study||7
255533|NCT01039675|619792|P1|NOT COMPLETED|Overall Study||0
255534|NCT01039675|619791|P2|COMPLETED|Overall Study||35
255535|NCT01039675|619792|P1|COMPLETED|Overall Study||9
255536|NCT01039675|619791|P2|STARTED|Overall Study||42
255537|NCT01039675|619792|P1|STARTED|Overall Study||9
255538|NCT01039792|619804|P2|NOT COMPLETED|Overall Study||1
255539|NCT01039792|619805|P1|NOT COMPLETED|Overall Study||6
255540|NCT01039792|619804|P2|COMPLETED|Overall Study||27
255541|NCT01039792|619805|P1|COMPLETED|Overall Study||23
255542|NCT01039792|619804|P2|STARTED|Overall Study||28
255543|NCT01039792|619805|P1|STARTED|Overall Study||29
255544|NCT01040052|619811|P1|NOT COMPLETED|Overall Study||0
255545|NCT01040052|619811|P1|COMPLETED|Overall Study||30
255546|NCT01040052|619811|P1|STARTED|Overall Study||30
255547|NCT01040130|619815|P6|NOT COMPLETED|Overall Study||4
255548|NCT01040130|619816|P5|NOT COMPLETED|Overall Study||0
255549|NCT01040130|619817|P4|NOT COMPLETED|Overall Study||5
255550|NCT01040130|619818|P3|NOT COMPLETED|Overall Study||2
255551|NCT01040130|619819|P2|NOT COMPLETED|Overall Study||3
255552|NCT01040130|619820|P1|NOT COMPLETED|Overall Study||3
255553|NCT01040130|619815|P6|COMPLETED|Overall Study||22
255554|NCT01040130|619816|P5|COMPLETED|Overall Study||25
255555|NCT01040130|619817|P4|COMPLETED|Overall Study||20
255556|NCT01040130|619818|P3|COMPLETED|Overall Study||23
255557|NCT01040130|619819|P2|COMPLETED|Overall Study||22
255558|NCT01040130|619820|P1|COMPLETED|Overall Study|Number of patients who did not discontinue from the trial.|22
255559|NCT01040130|619815|P6|STARTED|Overall Study||26
255560|NCT01040130|619816|P5|STARTED|Overall Study||25
255561|NCT01040130|619817|P4|STARTED|Overall Study||25
255562|NCT01040130|619818|P3|STARTED|Overall Study||25
255563|NCT01040130|619819|P2|STARTED|Overall Study||25
255564|NCT01040130|619820|P1|STARTED|Overall Study|Number of patients entered and treated|25
255565|NCT01040169|619899|P2|NOT COMPLETED|Overall Study||8
255566|NCT01040169|619900|P1|NOT COMPLETED|Overall Study||3
255567|NCT01040169|619899|P2|COMPLETED|Overall Study||36
255568|NCT01040169|619900|P1|COMPLETED|Overall Study||32
255569|NCT01040169|619899|P2|STARTED|Overall Study||44
255570|NCT01040169|619900|P1|STARTED|Overall Study||35
255571|NCT01040208|619911|P3|NOT COMPLETED|Overall Study||3
255572|NCT01040208|619912|P2|NOT COMPLETED|Overall Study||13
255573|NCT01040208|619913|P1|NOT COMPLETED|Overall Study||6
255574|NCT01040208|619911|P3|COMPLETED|Overall Study||35
255575|NCT01040208|619912|P2|COMPLETED|Overall Study||15
255576|NCT01040208|619913|P1|COMPLETED|Overall Study||39
255577|NCT01040208|619911|P3|STARTED|Overall Study||38
255578|NCT01040208|619912|P2|STARTED|Overall Study||28
255579|NCT01040208|619913|P1|STARTED|Overall Study||45
255580|NCT01040260|619929|P2|NOT COMPLETED|Overall Study||11
255581|NCT01040260|619930|P1|NOT COMPLETED|Overall Study||15
255582|NCT01040260|619929|P2|COMPLETED|Overall Study||39
255583|NCT01040260|619930|P1|COMPLETED|Overall Study||38
255584|NCT01040260|619929|P2|STARTED|Overall Study||50
255585|NCT01040260|619930|P1|STARTED|Overall Study||53
255586|NCT01040351|619938|P2|NOT COMPLETED|Overall Study||2
255587|NCT01040351|619939|P1|NOT COMPLETED|Overall Study||1
255588|NCT01040351|619938|P2|COMPLETED|Overall Study|May 2010|53
255589|NCT01040351|619939|P1|COMPLETED|Overall Study|May 2010|54
255590|NCT01040351|619938|P2|STARTED|Overall Study|October 2006|55
255591|NCT01040351|619939|P1|STARTED|Overall Study|October 2006|55
255592|NCT01040403|619947|P1|NOT COMPLETED|Overall Study||20
255593|NCT01040403|619947|P1|COMPLETED|Overall Study|All treatment periods|213
255594|NCT01040403|619947|P1|Completed T+O 5/10|Overall Study||107
255595|NCT01040403|619947|P1|Completed T+O 2.5/10|Overall Study||110
255596|NCT01040403|619947|P1|Completed T+O 1.25/10|Overall Study||106
255597|NCT01040403|619947|P1|Completed Olo 10|Overall Study||109
255598|NCT01040403|619947|P1|Completed T+O 5/5|Overall Study||106
255599|NCT01040403|619947|P1|Completed T+O 2.5/5|Overall Study||111
255600|NCT01040403|619947|P1|Completed T+O 1.25/5|Overall Study||105
255601|NCT01040403|619947|P1|Completed Olo 5|Overall Study||106
255602|NCT01040403|619947|P1|STARTED|Overall Study||233
255603|NCT01040624|620135|P2|NOT COMPLETED|Overall Study||0
255604|NCT01040624|620136|P1|NOT COMPLETED|Overall Study||0
255605|NCT01040624|620135|P2|COMPLETED|Overall Study||19
255606|NCT01040624|620136|P1|COMPLETED|Overall Study||58
255607|NCT01040624|620135|P2|STARTED|Overall Study||19
255608|NCT01040624|620136|P1|STARTED|Overall Study||58
255609|NCT01040689|620142|P4|NOT COMPLETED|Overall Study||4
255610|NCT01040689|620143|P3|NOT COMPLETED|Overall Study||4
255611|NCT01040689|620144|P2|NOT COMPLETED|Overall Study||2
255612|NCT01040689|620145|P1|NOT COMPLETED|Overall Study||3
255613|NCT01040689|620142|P4|COMPLETED|Overall Study||23
255614|NCT01040689|620143|P3|COMPLETED|Overall Study||23
255615|NCT01040689|620144|P2|COMPLETED|Overall Study||25
255616|NCT01040689|620145|P1|COMPLETED|Overall Study||24
255617|NCT01040689|620142|P4|STARTED|Overall Study||27
255618|NCT01040689|620143|P3|STARTED|Overall Study||27
255619|NCT01040689|620144|P2|STARTED|Overall Study||27
255620|NCT01040689|620145|P1|STARTED|Overall Study||27
255621|NCT01040728|620215|P4|NOT COMPLETED|Overall Study||6
255622|NCT01040728|620216|P3|NOT COMPLETED|Overall Study||1
255623|NCT01040728|620217|P2|NOT COMPLETED|Overall Study||11
255624|NCT01040728|620218|P1|NOT COMPLETED|Overall Study||4
255625|NCT01040728|620215|P4|COMPLETED|Overall Study||24
255626|NCT01040728|620216|P3|COMPLETED|Overall Study||30
255627|NCT01040728|620217|P2|COMPLETED|Overall Study||19
255628|NCT01040728|620218|P1|COMPLETED|Overall Study||27
255629|NCT01040728|620215|P4|STARTED|Overall Study||30
255630|NCT01040728|620216|P3|STARTED|Overall Study||31
255631|NCT01040728|620217|P2|STARTED|Overall Study||30
255632|NCT01040728|620218|P1|STARTED|Overall Study||31
255633|NCT01040780|620290|P2|NOT COMPLETED|Overall Study||3
255634|NCT01040780|620291|P1|NOT COMPLETED|Overall Study||1
255635|NCT01040780|620290|P2|COMPLETED|Overall Study||196
255636|NCT01040780|620291|P1|COMPLETED|Overall Study||199
255637|NCT01040780|620290|P2|STARTED|Overall Study||199
255638|NCT01040780|620291|P1|STARTED|Overall Study||200
255639|NCT01040793|620305|P6|NOT COMPLETED|Overall Study||1
255640|NCT01040793|620306|P5|NOT COMPLETED|Overall Study||4
255641|NCT01040793|620307|P4|NOT COMPLETED|Overall Study||4
255642|NCT01040793|620308|P3|NOT COMPLETED|Overall Study||3
255643|NCT01040793|620309|P2|NOT COMPLETED|Overall Study||5
255644|NCT01040793|620310|P1|NOT COMPLETED|Overall Study||6
255645|NCT01040793|620305|P6|COMPLETED|Overall Study||26
255646|NCT01040793|620306|P5|COMPLETED|Overall Study||22
255647|NCT01040793|620307|P4|COMPLETED|Overall Study||22
255648|NCT01040793|620308|P3|COMPLETED|Overall Study||23
255649|NCT01040793|620309|P2|COMPLETED|Overall Study||21
255650|NCT01040793|620310|P1|COMPLETED|Overall Study||20
255651|NCT01040793|620305|P6|STARTED|Overall Study||27
255652|NCT01040793|620306|P5|STARTED|Overall Study||26
255653|NCT01040793|620307|P4|STARTED|Overall Study||26
255654|NCT01040793|620308|P3|STARTED|Overall Study||26
255655|NCT01040793|620309|P2|STARTED|Overall Study||26
255656|NCT01040793|620310|P1|STARTED|Overall Study|Entered and treated|26
255657|NCT01040819|620389|P2|NOT COMPLETED|Overall Study||0
255658|NCT01040819|620390|P1|NOT COMPLETED|Overall Study||0
255659|NCT01040819|620389|P2|COMPLETED|Overall Study||12
255660|NCT01040819|620390|P1|COMPLETED|Overall Study||13
255661|NCT01040819|620389|P2|STARTED|Overall Study||12
255662|NCT01040819|620390|P1|STARTED|Overall Study||13
255663|NCT01040832|620398|P2|NOT COMPLETED|Overall Study||37
255664|NCT01040832|620399|P1|NOT COMPLETED|Overall Study||46
255665|NCT01040832|620398|P2|COMPLETED|Overall Study||16
255666|NCT01040832|620399|P1|COMPLETED|Overall Study||8
255667|NCT01040832|620398|P2|STARTED|Overall Study||53
255668|NCT01040832|620399|P1|STARTED|Overall Study|One participant was treated with study drug 'Cetuximab Plus EMD 1201081' but was not randomized|54
255669|NCT01040845|620415|P2|NOT COMPLETED|Overall Study||1
255670|NCT01040845|620416|P1|NOT COMPLETED|Overall Study||2
255671|NCT01040845|620415|P2|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1)|14
255672|NCT01040845|620416|P1|COMPLETED|Overall Study|withdrew consent due to schedule conflict (1); dropped by physician due to positive drug screen (1)|13
255673|NCT01040845|620415|P2|STARTED|Overall Study||15
255674|NCT01040845|620416|P1|STARTED|Overall Study||15
255675|NCT01040858|620431|P2|NOT COMPLETED|Overall Study||0
255676|NCT01040858|620432|P1|NOT COMPLETED|Overall Study||9
255677|NCT01040858|620431|P2|COMPLETED|Overall Study||69
255678|NCT01040858|620432|P1|COMPLETED|Overall Study||50
255679|NCT01040858|620431|P2|STARTED|Overall Study||69
255680|NCT01040858|620432|P1|STARTED|Overall Study||59
255681|NCT01040871|620462|P2|NOT COMPLETED|Overall Study||7
255682|NCT01040871|620463|P1|NOT COMPLETED|Overall Study||13
255683|NCT01040871|620462|P2|COMPLETED|Overall Study||73
255684|NCT01040871|620463|P1|COMPLETED|Overall Study||71
255685|NCT01040871|620462|P2|STARTED|Overall Study|Intent to Treat, Randomized|80
255686|NCT01040871|620463|P1|STARTED|Overall Study|Intent to Treat, Randomized|84
255687|NCT01041209|620483|P2|NOT COMPLETED|Overall Study||0
255688|NCT01041209|620484|P1|NOT COMPLETED|Overall Study||0
255689|NCT01041209|620483|P2|COMPLETED|Overall Study||60
255690|NCT01041209|620484|P1|COMPLETED|Overall Study||60
255691|NCT01041209|620483|P2|STARTED|Overall Study||60
255692|NCT01041209|620484|P1|STARTED|Overall Study||60
255693|NCT01041287|620494|P2|NOT COMPLETED|Treatment Period 2 (3 Months)||5
255694|NCT01041287|620495|P1|NOT COMPLETED|Treatment Period 2 (3 Months)||3
255695|NCT01041287|620494|P2|COMPLETED|Treatment Period 2 (3 Months)||14
255696|NCT01041287|620495|P1|COMPLETED|Treatment Period 2 (3 Months)||16
255697|NCT01041287|620494|P2|STARTED|Treatment Period 2 (3 Months)||19
255698|NCT01041287|620495|P1|STARTED|Treatment Period 2 (3 Months)||19
255699|NCT01041287|620494|P2|NOT COMPLETED|Treatment Period 1 (3 Months)||0
255700|NCT01041287|620495|P1|NOT COMPLETED|Treatment Period 1 (3 Months)||0
255701|NCT01041287|620494|P2|COMPLETED|Treatment Period 1 (3 Months)||19
255702|NCT01041287|620495|P1|COMPLETED|Treatment Period 1 (3 Months)||19
255703|NCT01041287|620494|P2|STARTED|Treatment Period 1 (3 Months)||19
255704|NCT01041287|620495|P1|STARTED|Treatment Period 1 (3 Months)||19
255705|NCT01041404|620507|P2|NOT COMPLETED|Overall Study||294
255706|NCT01041404|620508|P1|NOT COMPLETED|Overall Study||290
255707|NCT01041404|620507|P2|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
255708|NCT01041404|620508|P1|COMPLETED|Overall Study|Summary of withdrawals represents withdrawals from treatment, rather than withdrawals from study.|0
255709|NCT01041404|620507|P2|Alive in Follow-up|Overall Study||41
255710|NCT01041404|620508|P1|Alive in Follow-up|Overall Study||40
255711|NCT01041404|620507|P2|Lost to Follow-up|Overall Study||10
255712|NCT01041404|620508|P1|Lost to Follow-up|Overall Study||12
255713|NCT01041404|620507|P2|Died in Follow-up|Overall Study||200
255714|NCT01041404|620508|P1|Died in Follow-up|Overall Study||199
255715|NCT01041404|620507|P2|Entered Follow-Up|Overall Study||251
255716|NCT01041404|620508|P1|Entered Follow-Up|Overall Study||251
255717|NCT01041404|620507|P2|STARTED|Overall Study||294
255718|NCT01041404|620508|P1|STARTED|Overall Study||290
255719|NCT01041417|620549|P2|NOT COMPLETED|Overall Study||3
255720|NCT01041417|620550|P1|NOT COMPLETED|Overall Study||7
255721|NCT01041417|620549|P2|COMPLETED|Overall Study||76
255722|NCT01041417|620550|P1|COMPLETED|Overall Study||73
255723|NCT01041417|620549|P2|STARTED|Overall Study||79
255724|NCT01041417|620550|P1|STARTED|Overall Study||80
255725|NCT01041573|620590|P4|NOT COMPLETED|Overall Study||2
255726|NCT01041573|620591|P3|NOT COMPLETED|Overall Study||7
255727|NCT01041573|620592|P2|NOT COMPLETED|Overall Study||13
255728|NCT01041573|620593|P1|NOT COMPLETED|Overall Study||5
255729|NCT01041573|620590|P4|COMPLETED|Overall Study||62
255730|NCT01041573|620591|P3|COMPLETED|Overall Study||387
255731|NCT01041573|620592|P2|COMPLETED|Overall Study||858
255732|NCT01041573|620593|P1|COMPLETED|Overall Study||535
255733|NCT01041573|620590|P4|STARTED|Overall Study||64
255734|NCT01041573|620591|P3|STARTED|Overall Study||394
255735|NCT01041573|620592|P2|STARTED|Overall Study||871
255736|NCT01041573|620593|P1|STARTED|Overall Study||540
255737|NCT01041638|620603|P1|NOT COMPLETED|Overall Study||27
255738|NCT01041638|620603|P1|COMPLETED|Overall Study||78
255739|NCT01041638|620603|P1|STARTED|Overall Study||105
255740|NCT01035047|620609|P2|NOT COMPLETED|Overall Study||0
255741|NCT01035047|620610|P1|NOT COMPLETED|Overall Study||0
255742|NCT01035047|620609|P2|COMPLETED|Overall Study||53
255743|NCT01035047|620610|P1|COMPLETED|Overall Study||52
255744|NCT01035047|620609|P2|STARTED|Overall Study||53
255745|NCT01035047|620610|P1|STARTED|Overall Study||52
255746|NCT01035060|620626|P2|NOT COMPLETED|Overall Study||14
255747|NCT01035060|620627|P1|NOT COMPLETED|Overall Study||24
255748|NCT01035060|620626|P2|COMPLETED|Overall Study||15
255749|NCT01035060|620627|P1|COMPLETED|Overall Study||15
255750|NCT01035060|620626|P2|STARTED|Overall Study||29
255751|NCT01035060|620627|P1|STARTED|Overall Study||39
255752|NCT01035138|620636|P3|NOT COMPLETED|Overall Study||47
255753|NCT01035138|620637|P2|NOT COMPLETED|Overall Study||60
255754|NCT01035138|620638|P1|NOT COMPLETED|Overall Study||73
255755|NCT01035138|620636|P3|COMPLETED|Overall Study||0
255756|NCT01035138|620637|P2|COMPLETED|Overall Study||0
255757|NCT01035138|620638|P1|COMPLETED|Overall Study||0
255758|NCT01035138|620636|P3|STARTED|Overall Study||47
255759|NCT01035138|620637|P2|STARTED|Overall Study||60
255760|NCT01035138|620638|P1|STARTED|Overall Study||73
255761|NCT01035229|620694|P2|NOT COMPLETED|Overall Study||184
255762|NCT01035229|620695|P1|NOT COMPLETED|Overall Study||362
255763|NCT01035229|620694|P2|COMPLETED|Overall Study||0
255764|NCT01035229|620695|P1|COMPLETED|Overall Study||0
255765|NCT01035229|620694|P2|STARTED|Overall Study||184
255766|NCT01035229|620695|P1|STARTED|Overall Study||362
255767|NCT01035255|620715|P2|NOT COMPLETED|Overall Study||862
255768|NCT01035255|620716|P1|NOT COMPLETED|Overall Study||741
255769|NCT01035255|620715|P2|COMPLETED|Overall Study||3371
255770|NCT01035255|620716|P1|COMPLETED|Overall Study||3468
255771|NCT01035255|620715|P2|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4212
255772|NCT01035255|620716|P1|Full Analysis Set (FAS)|Overall Study|patents with GCP violation and mis-randomized are not included in FAS|4187
255773|NCT01035255|620715|P2|Mis-randomized|Overall Study||2
255774|NCT01035255|620716|P1|Mis-randomized|Overall Study||4
255775|NCT01035255|620715|P2|GCP Violations|Overall Study||19
255776|NCT01035255|620716|P1|GCP Violations|Overall Study||18
255777|NCT01035255|620715|P2|STARTED|Overall Study||4233
255778|NCT01035255|620716|P1|STARTED|Overall Study||4209
255779|NCT01035333|620732|P1|NOT COMPLETED|Overall Study||10
255780|NCT01035333|620732|P1|COMPLETED|Overall Study||9
255781|NCT01035333|620732|P1|STARTED|Overall Study||19
255782|NCT01035346|620739|P2|NOT COMPLETED|Overall Study||0
255783|NCT01035346|620740|P1|NOT COMPLETED|Overall Study||0
255784|NCT01035346|620739|P2|COMPLETED|Overall Study||9
255785|NCT01035346|620740|P1|COMPLETED|Overall Study||7
255786|NCT01035346|620739|P2|STARTED|Overall Study||9
255787|NCT01035346|620740|P1|STARTED|Overall Study||7
255788|NCT01035658|620762|P4|NOT COMPLETED|Overall Study||0
255789|NCT01035658|620763|P3|NOT COMPLETED|Overall Study||0
255790|NCT01035658|620764|P2|NOT COMPLETED|Overall Study||0
255791|NCT01035658|620765|P1|NOT COMPLETED|Overall Study||0
255792|NCT01035658|620762|P4|COMPLETED|Overall Study||6
255793|NCT01035658|620763|P3|COMPLETED|Overall Study||3
255794|NCT01035658|620764|P2|COMPLETED|Overall Study||8
255795|NCT01035658|620765|P1|COMPLETED|Overall Study||5
255796|NCT01035658|620762|P4|STARTED|Overall Study||6
255797|NCT01035658|620763|P3|STARTED|Overall Study||3
255798|NCT01035658|620764|P2|STARTED|Overall Study||8
255799|NCT01035658|620765|P1|STARTED|Overall Study||5
255800|NCT01035749|620792|P4|NOT COMPLETED|Overall Study||0
255801|NCT01035749|620793|P3|NOT COMPLETED|Overall Study||0
255802|NCT01035749|620794|P2|NOT COMPLETED|Overall Study||0
255803|NCT01035749|620795|P1|NOT COMPLETED|Overall Study||0
255804|NCT01035749|620792|P4|COMPLETED|Overall Study||110
255805|NCT01035749|620793|P3|COMPLETED|Overall Study||68
255806|NCT01035749|620794|P2|COMPLETED|Overall Study||66
255807|NCT01035749|620795|P1|COMPLETED|Overall Study||66
255808|NCT01035749|620792|P4|STARTED|Overall Study||110
255809|NCT01035749|620793|P3|STARTED|Overall Study||68
255810|NCT01035749|620794|P2|STARTED|Overall Study||66
255811|NCT01035749|620795|P1|STARTED|Overall Study||66
255812|NCT01041859|620915|P3|NOT COMPLETED|Double-Blind Maintenance||45
255813|NCT01041859|620916|P2|NOT COMPLETED|Double-Blind Maintenance||46
255814|NCT01041859|620917|P1|NOT COMPLETED|Double-Blind Maintenance||0
255815|NCT01041859|620915|P3|COMPLETED|Double-Blind Maintenance||107
255816|NCT01041859|620916|P2|COMPLETED|Double-Blind Maintenance||120
255817|NCT01041859|620917|P1|COMPLETED|Double-Blind Maintenance||0
255818|NCT01041859|620915|P3|STARTED|Double-Blind Maintenance|152 randomized, all were treated.|152
255819|NCT01041859|620916|P2|STARTED|Double-Blind Maintenance|168 were randomized, 2 were not treated (1 randomized in error, 1 withdrew consent).|166
255820|NCT01041859|620917|P1|STARTED|Double-Blind Maintenance||0
255821|NCT01041859|620915|P3|NOT COMPLETED|Open-Label Titration||0
255822|NCT01041859|620916|P2|NOT COMPLETED|Open-Label Titration||0
255823|NCT01041859|620917|P1|NOT COMPLETED|Open-Label Titration||101
255824|NCT01041859|620915|P3|COMPLETED|Open-Label Titration||0
255825|NCT01041859|620916|P2|COMPLETED|Open-Label Titration||0
255826|NCT01041859|620917|P1|COMPLETED|Open-Label Titration|Of 358 completed subjects, 320 were randomized to the Double-Blind Maintenance Period.|358
255827|NCT01041859|620915|P3|STARTED|Open-Label Titration||0
255828|NCT01041859|620916|P2|STARTED|Open-Label Titration||0
255829|NCT01041859|620917|P1|STARTED|Open-Label Titration|Of 460 total enrollment, one subject enrolled twice; this subject's second enrollment is excluded.|459
255830|NCT01041976|620934|P2|NOT COMPLETED|Overall Study||4
255831|NCT01041976|620935|P1|NOT COMPLETED|Overall Study||5
255832|NCT01041976|620934|P2|COMPLETED|Overall Study||38
255833|NCT01041976|620935|P1|COMPLETED|Overall Study||37
255834|NCT01041976|620934|P2|18 Month Follow-up|Overall Study||38
255835|NCT01041976|620935|P1|18 Month Follow-up|Overall Study||37
255836|NCT01041976|620934|P2|12 Month Follow-up|Overall Study||38
255837|NCT01041976|620935|P1|12 Month Follow-up|Overall Study||37
255838|NCT01041976|620934|P2|6 Month Follow-up|Overall Study||41
255839|NCT01041976|620935|P1|6 Month Follow-up|Overall Study||39
255840|NCT01041976|620934|P2|STARTED|Overall Study||42
255841|NCT01041976|620935|P1|STARTED|Overall Study||42
255842|NCT01042093|620947|P4|NOT COMPLETED|Overall Study||4
255843|NCT01042093|620948|P3|NOT COMPLETED|Overall Study||2
255844|NCT01042093|620949|P2|NOT COMPLETED|Overall Study||2
255845|NCT01042093|620950|P1|NOT COMPLETED|Overall Study||2
255846|NCT01042093|620947|P4|COMPLETED|Overall Study||36
255847|NCT01042093|620948|P3|COMPLETED|Overall Study||38
255848|NCT01042093|620949|P2|COMPLETED|Overall Study||38
255849|NCT01042093|620950|P1|COMPLETED|Overall Study||38
255850|NCT01042093|620947|P4|STARTED|Overall Study||40
255851|NCT01042093|620948|P3|STARTED|Overall Study||40
255852|NCT01042093|620949|P2|STARTED|Overall Study||40
255853|NCT01042093|620950|P1|STARTED|Overall Study||40
255854|NCT01043393|620970|P2|NOT COMPLETED|Overall Study||0
255855|NCT01043393|620971|P1|NOT COMPLETED|Overall Study||0
255856|NCT01043393|620970|P2|COMPLETED|Overall Study||12
255857|NCT01043393|620971|P1|COMPLETED|Overall Study||12
255858|NCT01043393|620970|P2|STARTED|Overall Study||12
255859|NCT01043393|620971|P1|STARTED|Overall Study||12
255860|NCT01043432|620985|P4|NOT COMPLETED|Overall Study||0
255861|NCT01043432|620986|P3|NOT COMPLETED|Overall Study||0
255862|NCT01043432|620987|P2|NOT COMPLETED|Overall Study||0
255863|NCT01043432|620988|P1|NOT COMPLETED|Overall Study||0
255864|NCT01043432|620985|P4|COMPLETED|Overall Study||48
255865|NCT01043432|620986|P3|COMPLETED|Overall Study||12
255866|NCT01043432|620987|P2|COMPLETED|Overall Study||51
255867|NCT01043432|620988|P1|COMPLETED|Overall Study||22
255868|NCT01043432|620985|P4|STARTED|Overall Study||48
255869|NCT01043432|620986|P3|STARTED|Overall Study||12
255870|NCT01043432|620987|P2|STARTED|Overall Study||51
255871|NCT01043432|620988|P1|STARTED|Overall Study||22
255872|NCT01043523|620995|P1|NOT COMPLETED|Overall Study||0
255873|NCT01043523|620995|P1|COMPLETED|Overall Study||52
255874|NCT01043523|620995|P1|Participants With Unenhanced Images|Overall Study||51
255875|NCT01043523|620995|P1|STARTED|Overall Study||52
255876|NCT01043640|621020|P1|NOT COMPLETED|Overall Study||0
255877|NCT01043640|621020|P1|COMPLETED|Overall Study||46
255878|NCT01043640|621020|P1|STARTED|Overall Study||46
255879|NCT01043653|621035|P1|NOT COMPLETED|Overall Study||64
255880|NCT01043653|621035|P1|COMPLETED|Overall Study||186
255881|NCT01043653|621035|P1|STARTED|Overall Study||250
255882|NCT01043705|621043|P3|NOT COMPLETED|Overall Study||80
255883|NCT01043705|621044|P2|NOT COMPLETED|Overall Study||131
255884|NCT01043705|621045|P1|NOT COMPLETED|Overall Study||107
255885|NCT01043705|621043|P3|COMPLETED|Overall Study||498
255886|NCT01043705|621044|P2|COMPLETED|Overall Study||447
255887|NCT01043705|621045|P1|COMPLETED|Overall Study||352
255888|NCT01043705|621043|P3|STARTED|Overall Study||578
255889|NCT01043705|621044|P2|STARTED|Overall Study||578
255890|NCT01043705|621045|P1|STARTED|Overall Study||459
255891|NCT01043874|621055|P1|NOT COMPLETED|Overall Study||6
255892|NCT01043874|621055|P1|COMPLETED|Overall Study||39
255893|NCT01043874|621055|P1|STARTED|Overall Study||45
255894|NCT01043926|621064|P4|NOT COMPLETED|Overall Study||0
255895|NCT01043926|621065|P3|NOT COMPLETED|Overall Study||0
255896|NCT01043926|621066|P2|NOT COMPLETED|Overall Study||0
255897|NCT01043926|621067|P1|NOT COMPLETED|Overall Study||0
255898|NCT01043926|621064|P4|COMPLETED|Overall Study||0
255899|NCT01043926|621065|P3|COMPLETED|Overall Study||0
255900|NCT01043926|621066|P2|COMPLETED|Overall Study||8
255901|NCT01043926|621067|P1|COMPLETED|Overall Study||8
255902|NCT01043926|621064|P4|STARTED|Overall Study||0
255903|NCT01043926|621065|P3|STARTED|Overall Study||0
255904|NCT01043926|621066|P2|STARTED|Overall Study||8
255905|NCT01043926|621067|P1|STARTED|Overall Study||8
255906|NCT01043939|621081|P2|NOT COMPLETED|Second Intervention||0
255907|NCT01043939|621082|P1|NOT COMPLETED|Second Intervention||0
255908|NCT01043939|621081|P2|COMPLETED|Second Intervention||12
255909|NCT01043939|621082|P1|COMPLETED|Second Intervention||12
255910|NCT01043939|621081|P2|STARTED|Second Intervention||12
255911|NCT01043939|621082|P1|STARTED|Second Intervention||12
255912|NCT01043939|621081|P2|NOT COMPLETED|Washout Period||0
255913|NCT01043939|621082|P1|NOT COMPLETED|Washout Period||0
255914|NCT01043939|621081|P2|COMPLETED|Washout Period||12
255915|NCT01043939|621082|P1|COMPLETED|Washout Period||12
255916|NCT01043939|621081|P2|STARTED|Washout Period||12
255917|NCT01043939|621082|P1|STARTED|Washout Period||12
255918|NCT01043939|621081|P2|NOT COMPLETED|First Intervention||0
255919|NCT01043939|621082|P1|NOT COMPLETED|First Intervention||0
255920|NCT01043939|621081|P2|COMPLETED|First Intervention||12
255921|NCT01043939|621082|P1|COMPLETED|First Intervention||12
255922|NCT01043939|621081|P2|STARTED|First Intervention||12
255923|NCT01043939|621082|P1|STARTED|First Intervention||12
255924|NCT01044030|621096|P2|NOT COMPLETED|Overall Study||20
255925|NCT01044030|621097|P1|NOT COMPLETED|Overall Study||19
255926|NCT01044030|621096|P2|COMPLETED|Overall Study||146
255927|NCT01044030|621097|P1|COMPLETED|Overall Study||141
255928|NCT01044030|621096|P2|STARTED|Overall Study||166
255929|NCT01044030|621097|P1|STARTED|Overall Study||160
255930|NCT01044056|621110|P3|NOT COMPLETED|Overall Study||0
255931|NCT01044056|621111|P2|NOT COMPLETED|Overall Study||0
255932|NCT01044056|621112|P1|NOT COMPLETED|Overall Study||0
255933|NCT01044056|621110|P3|COMPLETED|Overall Study||8
255934|NCT01044056|621111|P2|COMPLETED|Overall Study||8
255935|NCT01044056|621112|P1|COMPLETED|Overall Study||8
255936|NCT01044056|621110|P3|STARTED|Overall Study||8
255937|NCT01044056|621111|P2|STARTED|Overall Study||8
255938|NCT01044056|621112|P1|STARTED|Overall Study||8
255939|NCT01044212|621131|P2|NOT COMPLETED|Overall Study||7
255940|NCT01044212|621132|P1|NOT COMPLETED|Overall Study||5
255941|NCT01044212|621131|P2|COMPLETED|Overall Study||30
255942|NCT01044212|621132|P1|COMPLETED|Overall Study||30
255943|NCT01044212|621131|P2|STARTED|Overall Study||37
255944|NCT01044212|621132|P1|STARTED|Overall Study||35
255945|NCT01044264|621145|P3|NOT COMPLETED|Overall Study||92
255946|NCT01044264|621146|P2|NOT COMPLETED|Overall Study||94
255947|NCT01044264|621147|P1|NOT COMPLETED|Overall Study||90
255948|NCT01044264|621145|P3|COMPLETED|Overall Study||108
255949|NCT01044264|621146|P2|COMPLETED|Overall Study||108
255950|NCT01044264|621147|P1|COMPLETED|Overall Study||110
255951|NCT01044264|621145|P3|STARTED|Overall Study||200
255952|NCT01044264|621146|P2|STARTED|Overall Study||202
255953|NCT01044264|621147|P1|STARTED|Overall Study||200
255954|NCT01044290|621158|P3|NOT COMPLETED|Follow-Up 2||2
255955|NCT01044290|621159|P2|NOT COMPLETED|Follow-Up 2||2
255956|NCT01044290|621160|P1|NOT COMPLETED|Follow-Up 2||0
255957|NCT01044290|621158|P3|COMPLETED|Follow-Up 2||69
255958|NCT01044290|621159|P2|COMPLETED|Follow-Up 2||67
255959|NCT01044290|621160|P1|COMPLETED|Follow-Up 2||70
255960|NCT01044290|621158|P3|Completed F2 Interview|Follow-Up 2||64
255961|NCT01044290|621159|P2|Completed F2 Interview|Follow-Up 2||57
255962|NCT01044290|621160|P1|Completed F2 Interview|Follow-Up 2||64
255963|NCT01044290|621158|P3|STARTED|Follow-Up 2||71
255964|NCT01044290|621159|P2|STARTED|Follow-Up 2||69
255965|NCT01044290|621160|P1|STARTED|Follow-Up 2||70
255966|NCT01044290|621158|P3|NOT COMPLETED|Follow-up 1||1
255967|NCT01044290|621159|P2|NOT COMPLETED|Follow-up 1||5
255968|NCT01044290|621160|P1|NOT COMPLETED|Follow-up 1||5
255969|NCT01044290|621158|P3|COMPLETED|Follow-up 1||71
255970|NCT01044290|621159|P2|COMPLETED|Follow-up 1||69
255971|NCT01044290|621160|P1|COMPLETED|Follow-up 1||70
255972|NCT01044290|621158|P3|Completed F1 Interview|Follow-up 1||61
255973|NCT01044290|621159|P2|Completed F1 Interview|Follow-up 1||60
255974|NCT01044290|621160|P1|Completed F1 Interview|Follow-up 1||61
255975|NCT01044290|621158|P3|STARTED|Follow-up 1||72
255976|NCT01044290|621159|P2|STARTED|Follow-up 1||74
255977|NCT01044290|621160|P1|STARTED|Follow-up 1||75
255978|NCT01044290|621158|P3|NOT COMPLETED|Randomization||0
255979|NCT01044290|621159|P2|NOT COMPLETED|Randomization||0
255980|NCT01044290|621160|P1|NOT COMPLETED|Randomization||0
255981|NCT01044290|621158|P3|COMPLETED|Randomization||72
255982|NCT01044290|621159|P2|COMPLETED|Randomization||74
255983|NCT01044290|621160|P1|COMPLETED|Randomization||75
255984|NCT01044290|621158|P3|Randomized|Randomization||72
255985|NCT01044290|621159|P2|Randomized|Randomization||74
255986|NCT01044290|621160|P1|Randomized|Randomization||75
255987|NCT01044290|621158|P3|STARTED|Randomization||72
255988|NCT01044290|621159|P2|STARTED|Randomization||74
255989|NCT01044290|621160|P1|STARTED|Randomization||75
255990|NCT01044303|621183|P1|NOT COMPLETED|Overall Study||2
255991|NCT01044303|621183|P1|COMPLETED|Overall Study||30
255992|NCT01044303|621183|P1|STARTED|Overall Study||32
255993|NCT01044459|621192|P2|NOT COMPLETED|Overall Study||131
255994|NCT01044459|621193|P1|NOT COMPLETED|Overall Study||133
255995|NCT01044459|621192|P2|COMPLETED|Overall Study||162
255996|NCT01044459|621193|P1|COMPLETED|Overall Study||179
255997|NCT01044459|621192|P2|STARTED|Overall Study||293
255998|NCT01044459|621193|P1|STARTED|Overall Study||312
255999|NCT01044498|621203|P2|NOT COMPLETED|Overall Study||2
256000|NCT01044498|621204|P1|NOT COMPLETED|Overall Study||3
256001|NCT01044498|621203|P2|COMPLETED|Overall Study||21
256002|NCT01044498|621204|P1|COMPLETED|Overall Study||20
256003|NCT01044498|621203|P2|STARTED|Overall Study||23
256004|NCT01044498|621204|P1|STARTED|Overall Study||23
256005|NCT01044537|621235|P7|NOT COMPLETED|Overall Study||0
256006|NCT01044537|621236|P6|NOT COMPLETED|Overall Study||0
256007|NCT01044537|621237|P5|NOT COMPLETED|Overall Study||0
256008|NCT01044537|621238|P4|NOT COMPLETED|Overall Study||0
256009|NCT01044537|621239|P3|NOT COMPLETED|Overall Study||0
256010|NCT01044537|621240|P2|NOT COMPLETED|Overall Study||0
256011|NCT01044537|621241|P1|NOT COMPLETED|Overall Study||0
256012|NCT01044537|621235|P7|COMPLETED|Overall Study||16
256013|NCT01044537|621236|P6|COMPLETED|Overall Study||5
256014|NCT01044537|621237|P5|COMPLETED|Overall Study||5
256015|NCT01044537|621238|P4|COMPLETED|Overall Study||6
256016|NCT01044537|621239|P3|COMPLETED|Overall Study||6
256017|NCT01044537|621240|P2|COMPLETED|Overall Study||6
256018|NCT01044537|621241|P1|COMPLETED|Overall Study||6
256019|NCT01044537|621235|P7|STARTED|Overall Study||16
256020|NCT01044537|621236|P6|STARTED|Overall Study||5
256021|NCT01044537|621237|P5|STARTED|Overall Study||5
256022|NCT01044537|621238|P4|STARTED|Overall Study||6
256023|NCT01044537|621239|P3|STARTED|Overall Study||6
256024|NCT01044537|621240|P2|STARTED|Overall Study||6
256025|NCT01044537|621241|P1|STARTED|Overall Study||6
256026|NCT01044589|621350|P2|NOT COMPLETED|Overall Study||5
256027|NCT01044589|621351|P1|NOT COMPLETED|Overall Study||3
256028|NCT01044589|621350|P2|COMPLETED|Overall Study||2
256029|NCT01044589|621351|P1|COMPLETED|Overall Study||3
256030|NCT01044589|621350|P2|STARTED|Overall Study||7
256031|NCT01044589|621351|P1|STARTED|Overall Study||6
256032|NCT01044693|621359|P16|NOT COMPLETED|Overall Study||0
256033|NCT01044693|621360|P15|NOT COMPLETED|Overall Study||0
256034|NCT01044693|621361|P14|NOT COMPLETED|Overall Study||0
256035|NCT01044693|621362|P13|NOT COMPLETED|Overall Study||0
256036|NCT01044693|621363|P12|NOT COMPLETED|Overall Study||0
256037|NCT01044693|621364|P11|NOT COMPLETED|Overall Study||0
256038|NCT01044693|621365|P10|NOT COMPLETED|Overall Study||0
256039|NCT01044693|621366|P9|NOT COMPLETED|Overall Study||0
256040|NCT01044693|621367|P8|NOT COMPLETED|Overall Study||0
256041|NCT01044693|621368|P7|NOT COMPLETED|Overall Study||0
256042|NCT01044693|621369|P6|NOT COMPLETED|Overall Study||0
256043|NCT01044693|621370|P5|NOT COMPLETED|Overall Study||0
256044|NCT01044693|621371|P4|NOT COMPLETED|Overall Study||0
256045|NCT01044693|621372|P3|NOT COMPLETED|Overall Study||0
256046|NCT01044693|621373|P2|NOT COMPLETED|Overall Study||0
256047|NCT01044693|621374|P1|NOT COMPLETED|Overall Study||0
256048|NCT01044693|621359|P16|COMPLETED|Overall Study||1
256049|NCT01044693|621360|P15|COMPLETED|Overall Study||1
256050|NCT01044693|621361|P14|COMPLETED|Overall Study||1
256051|NCT01044693|621362|P13|COMPLETED|Overall Study||2
256052|NCT01044693|621363|P12|COMPLETED|Overall Study||1
256053|NCT01044693|621364|P11|COMPLETED|Overall Study||1
256054|NCT01044693|621365|P10|COMPLETED|Overall Study||1
256055|NCT01044693|621366|P9|COMPLETED|Overall Study||1
256056|NCT01044693|621367|P8|COMPLETED|Overall Study||1
256057|NCT01044693|621368|P7|COMPLETED|Overall Study||1
256058|NCT01044693|621369|P6|COMPLETED|Overall Study||2
256059|NCT01044693|621370|P5|COMPLETED|Overall Study||1
256060|NCT01044693|621371|P4|COMPLETED|Overall Study||1
256061|NCT01044693|621372|P3|COMPLETED|Overall Study||1
256062|NCT01044693|621373|P2|COMPLETED|Overall Study||1
256063|NCT01044693|621374|P1|COMPLETED|Overall Study||3
256064|NCT01044693|621359|P16|STARTED|Overall Study||1
256065|NCT01044693|621360|P15|STARTED|Overall Study||1
256066|NCT01044693|621361|P14|STARTED|Overall Study||1
256067|NCT01044693|621362|P13|STARTED|Overall Study||2
256068|NCT01044693|621363|P12|STARTED|Overall Study||1
256069|NCT01044693|621364|P11|STARTED|Overall Study||1
256070|NCT01044693|621365|P10|STARTED|Overall Study||1
256071|NCT01044693|621366|P9|STARTED|Overall Study||1
256072|NCT01044693|621367|P8|STARTED|Overall Study||1
256073|NCT01044693|621368|P7|STARTED|Overall Study||1
256074|NCT01044693|621369|P6|STARTED|Overall Study||2
256075|NCT01044693|621370|P5|STARTED|Overall Study||1
256076|NCT01044693|621371|P4|STARTED|Overall Study||1
256077|NCT01044693|621372|P3|STARTED|Overall Study||1
256078|NCT01044693|621373|P2|STARTED|Overall Study||1
256079|NCT01044693|621374|P1|STARTED|Overall Study||3
256080|NCT01044706|621398|P2|NOT COMPLETED|Overall Study||0
256081|NCT01044706|621399|P1|NOT COMPLETED|Overall Study||0
256082|NCT01044706|621398|P2|COMPLETED|Overall Study||30
256083|NCT01044706|621399|P1|COMPLETED|Overall Study||30
256084|NCT01044706|621398|P2|STARTED|Overall Study||30
256085|NCT01044706|621399|P1|STARTED|Overall Study||30
256086|NCT01044732|621409|P2|NOT COMPLETED|Overall Study||50
256087|NCT01044732|621410|P1|NOT COMPLETED|Overall Study||49
256088|NCT01044732|621409|P2|COMPLETED|Overall Study||176
256089|NCT01044732|621410|P1|COMPLETED|Overall Study||173
256090|NCT01044732|621409|P2|STARTED|Overall Study||226
256091|NCT01044732|621410|P1|STARTED|Overall Study||222
256092|NCT01044758|621425|P7|NOT COMPLETED|Overall Study||10
256093|NCT01044758|621426|P6|NOT COMPLETED|Overall Study||3
256094|NCT01044758|621427|P5|NOT COMPLETED|Overall Study||2
256095|NCT01044758|621428|P4|NOT COMPLETED|Overall Study||2
256096|NCT01044758|621429|P3|NOT COMPLETED|Overall Study||4
256097|NCT01044758|621430|P2|NOT COMPLETED|Overall Study||0
256098|NCT01044758|621431|P1|NOT COMPLETED|Overall Study||4
256099|NCT01044758|621425|P7|COMPLETED|Overall Study||17
256100|NCT01044758|621426|P6|COMPLETED|Overall Study||8
256101|NCT01044758|621427|P5|COMPLETED|Overall Study||9
256102|NCT01044758|621428|P4|COMPLETED|Overall Study||10
256103|NCT01044758|621429|P3|COMPLETED|Overall Study||7
256104|NCT01044758|621430|P2|COMPLETED|Overall Study||12
256105|NCT01044758|621431|P1|COMPLETED|Overall Study||8
256106|NCT01044758|621425|P7|STARTED|Overall Study||27
256107|NCT01044758|621426|P6|STARTED|Overall Study||11
256108|NCT01044758|621427|P5|STARTED|Overall Study||11
256109|NCT01044758|621428|P4|STARTED|Overall Study||12
256110|NCT01044758|621429|P3|STARTED|Overall Study||11
256111|NCT01044758|621430|P2|STARTED|Overall Study||12
256112|NCT01044758|621431|P1|STARTED|Overall Study||12
256113|NCT01044771|621454|P1|NOT COMPLETED|Overall Study||0
256114|NCT01044771|621454|P1|COMPLETED|Overall Study||20
256115|NCT01044771|621454|P1|STARTED|Overall Study||20
256116|NCT01044862|621462|P3|NOT COMPLETED|Overall Study||52
256117|NCT01044862|621463|P2|NOT COMPLETED|Overall Study||49
256118|NCT01044862|621464|P1|NOT COMPLETED|Overall Study||53
256119|NCT01044862|621462|P3|COMPLETED|Overall Study||249
256120|NCT01044862|621463|P2|COMPLETED|Overall Study||251
256121|NCT01044862|621464|P1|COMPLETED|Overall Study||246
256122|NCT01044862|621462|P3|STARTED|Overall Study||301
256123|NCT01044862|621463|P2|STARTED|Overall Study||300
256124|NCT01044862|621464|P1|STARTED|Overall Study||299
256125|NCT01045031|621483|P2|NOT COMPLETED|Overall Study||6
256126|NCT01045031|621484|P1|NOT COMPLETED|Overall Study||9
256127|NCT01045031|621483|P2|COMPLETED|Overall Study||50
256128|NCT01045031|621484|P1|COMPLETED|Overall Study||49
256129|NCT01045031|621483|P2|STARTED|Overall Study||56
256130|NCT01045031|621484|P1|STARTED|Overall Study||58
256131|NCT01045057|621494|P1|NOT COMPLETED|Overall Study||0
256132|NCT01045057|621494|P1|COMPLETED|Overall Study||27
256133|NCT01045057|621494|P1|STARTED|Overall Study||27
256134|NCT01045096|621504|P3|NOT COMPLETED|Overall Study||0
256135|NCT01045096|621505|P2|NOT COMPLETED|Overall Study||0
256136|NCT01045096|621506|P1|NOT COMPLETED|Overall Study||3
256137|NCT01045096|621504|P3|COMPLETED|Overall Study||12
256138|NCT01045096|621505|P2|COMPLETED|Overall Study||12
256139|NCT01045096|621506|P1|COMPLETED|Overall Study||9
256140|NCT01045096|621504|P3|Pharmacokinetic Set|Overall Study||11
256141|NCT01045096|621505|P2|Pharmacokinetic Set|Overall Study||11
256142|NCT01045096|621506|P1|Pharmacokinetic Set|Overall Study|All patients with at least one estimable PK parameter for dexlansoprazole on Day 7.|9
256143|NCT01045096|621504|P3|STARTED|Overall Study||12
256144|NCT01045096|621505|P2|STARTED|Overall Study||12
256145|NCT01045096|621506|P1|STARTED|Overall Study||12
256146|NCT01045122|621532|P2|NOT COMPLETED|Propofol Then Dexmedetomidine||0
256147|NCT01045122|621533|P1|NOT COMPLETED|Propofol Then Dexmedetomidine||0
256148|NCT01045122|621532|P2|COMPLETED|Propofol Then Dexmedetomidine||6
256149|NCT01045122|621533|P1|COMPLETED|Propofol Then Dexmedetomidine||5
256150|NCT01045122|621532|P2|STARTED|Propofol Then Dexmedetomidine||6
256151|NCT01045122|621533|P1|STARTED|Propofol Then Dexmedetomidine||5
256152|NCT01045122|621532|P2|NOT COMPLETED|Dexmedetomidine Then Propofol||0
256153|NCT01045122|621533|P1|NOT COMPLETED|Dexmedetomidine Then Propofol||0
256154|NCT01045122|621532|P2|COMPLETED|Dexmedetomidine Then Propofol||6
256155|NCT01045122|621533|P1|COMPLETED|Dexmedetomidine Then Propofol||5
256156|NCT01045122|621532|P2|STARTED|Dexmedetomidine Then Propofol||6
256157|NCT01045122|621533|P1|STARTED|Dexmedetomidine Then Propofol||5
256158|NCT01045161|621542|P3|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||32
256159|NCT01045161|621543|P2|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
256160|NCT01045161|621544|P1|NOT COMPLETED|Part B - 40 Additional Weeks Open Label||36
256161|NCT01045161|621542|P3|COMPLETED|Part B - 40 Additional Weeks Open Label||115
256162|NCT01045161|621543|P2|COMPLETED|Part B - 40 Additional Weeks Open Label||118
256163|NCT01045161|621544|P1|COMPLETED|Part B - 40 Additional Weeks Open Label||111
256164|NCT01045161|621542|P3|STARTED|Part B - 40 Additional Weeks Open Label||147
256165|NCT01045161|621543|P2|STARTED|Part B - 40 Additional Weeks Open Label||154
256166|NCT01045161|621544|P1|STARTED|Part B - 40 Additional Weeks Open Label||147
256167|NCT01045161|621542|P3|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||30
256168|NCT01045161|621543|P2|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||29
256169|NCT01045161|621544|P1|NOT COMPLETED|Part A - 12 Weeks Double Blind Treatment||31
256170|NCT01045161|621542|P3|COMPLETED|Part A - 12 Weeks Double Blind Treatment||148
256171|NCT01045161|621543|P2|COMPLETED|Part A - 12 Weeks Double Blind Treatment||155
256172|NCT01045161|621544|P1|COMPLETED|Part A - 12 Weeks Double Blind Treatment||151
256173|NCT01045161|621542|P3|STARTED|Part A - 12 Weeks Double Blind Treatment||178
256174|NCT01045161|621543|P2|STARTED|Part A - 12 Weeks Double Blind Treatment||184
256175|NCT01045161|621544|P1|STARTED|Part A - 12 Weeks Double Blind Treatment||182
256176|NCT01045187|621564|P1|NOT COMPLETED|Overall Study||0
256177|NCT01045187|621564|P1|COMPLETED|Overall Study||15
256178|NCT01045187|621564|P1|STARTED|Overall Study||15
256179|NCT01045265|621568|P1|NOT COMPLETED|Overall Study||0
256180|NCT01045265|621568|P1|COMPLETED|Overall Study||16
256181|NCT01045265|621568|P1|STARTED|Overall Study||16
256182|NCT01045421|621581|P11|NOT COMPLETED|Phase 2||2
256183|NCT01045421|621582|P10|NOT COMPLETED|Phase 2||3
256184|NCT01045421|621583|P9|NOT COMPLETED|Phase 2||2
256185|NCT01045421|621584|P8|NOT COMPLETED|Phase 2||5
256186|NCT01045421|621585|P7|NOT COMPLETED|Phase 2||0
256187|NCT01045421|621586|P6|NOT COMPLETED|Phase 2||0
256188|NCT01045421|621587|P5|NOT COMPLETED|Phase 2||0
256189|NCT01045421|621588|P4|NOT COMPLETED|Phase 2||0
256190|NCT01045421|621589|P3|NOT COMPLETED|Phase 2||0
256191|NCT01045421|621590|P2|NOT COMPLETED|Phase 2||0
256192|NCT01045421|621591|P1|NOT COMPLETED|Phase 2||0
256193|NCT01045421|621581|P11|COMPLETED|Phase 2||58
256194|NCT01045421|621582|P10|COMPLETED|Phase 2||23
256195|NCT01045421|621583|P9|COMPLETED|Phase 2||53
256196|NCT01045421|621584|P8|COMPLETED|Phase 2||50
256197|NCT01045421|621585|P7|COMPLETED|Phase 2||53
256198|NCT01045421|621586|P6|COMPLETED|Phase 2||0
256199|NCT01045421|621587|P5|COMPLETED|Phase 2||0
256200|NCT01045421|621588|P4|COMPLETED|Phase 2||0
256201|NCT01045421|621589|P3|COMPLETED|Phase 2||0
256202|NCT01045421|621590|P2|COMPLETED|Phase 2||0
256203|NCT01045421|621591|P1|COMPLETED|Phase 2||0
256204|NCT01045421|621581|P11|STARTED|Phase 2||60
256205|NCT01045421|621582|P10|STARTED|Phase 2||26
256206|NCT01045421|621583|P9|STARTED|Phase 2||55
256207|NCT01045421|621584|P8|STARTED|Phase 2||55
256208|NCT01045421|621585|P7|STARTED|Phase 2||53
256209|NCT01045421|621586|P6|STARTED|Phase 2||0
256210|NCT01045421|621587|P5|STARTED|Phase 2||0
256211|NCT01045421|621588|P4|STARTED|Phase 2||0
256212|NCT01045421|621589|P3|STARTED|Phase 2||0
256213|NCT01045421|621590|P2|STARTED|Phase 2||0
256214|NCT01045421|621591|P1|STARTED|Phase 2||0
256215|NCT01045421|621581|P11|NOT COMPLETED|Phase 1||0
256216|NCT01045421|621582|P10|NOT COMPLETED|Phase 1||0
256217|NCT01045421|621583|P9|NOT COMPLETED|Phase 1||0
256218|NCT01045421|621584|P8|NOT COMPLETED|Phase 1||0
256219|NCT01045421|621585|P7|NOT COMPLETED|Phase 1||0
256220|NCT01045421|621586|P6|NOT COMPLETED|Phase 1||0
256221|NCT01045421|621587|P5|NOT COMPLETED|Phase 1||1
256222|NCT01045421|621588|P4|NOT COMPLETED|Phase 1||1
256223|NCT01045421|621589|P3|NOT COMPLETED|Phase 1||0
256224|NCT01045421|621590|P2|NOT COMPLETED|Phase 1||0
256225|NCT01045421|621591|P1|NOT COMPLETED|Phase 1||0
256226|NCT01045421|621581|P11|COMPLETED|Phase 1||0
256227|NCT01045421|621582|P10|COMPLETED|Phase 1||0
256228|NCT01045421|621583|P9|COMPLETED|Phase 1||0
256229|NCT01045421|621584|P8|COMPLETED|Phase 1||0
256230|NCT01045421|621585|P7|COMPLETED|Phase 1||0
256231|NCT01045421|621586|P6|COMPLETED|Phase 1||1
256232|NCT01045421|621587|P5|COMPLETED|Phase 1||2
256233|NCT01045421|621588|P4|COMPLETED|Phase 1||11
256234|NCT01045421|621589|P3|COMPLETED|Phase 1||4
256235|NCT01045421|621590|P2|COMPLETED|Phase 1||3
256236|NCT01045421|621591|P1|COMPLETED|Phase 1||1
256237|NCT01045421|621581|P11|STARTED|Phase 1||0
256238|NCT01045421|621582|P10|STARTED|Phase 1||0
256239|NCT01045421|621583|P9|STARTED|Phase 1||0
256240|NCT01045421|621584|P8|STARTED|Phase 1||0
256241|NCT01045421|621585|P7|STARTED|Phase 1||0
256242|NCT01045421|621586|P6|STARTED|Phase 1||1
256243|NCT01045421|621587|P5|STARTED|Phase 1||3
256244|NCT01045421|621588|P4|STARTED|Phase 1||12
256245|NCT01045421|621589|P3|STARTED|Phase 1||4
256246|NCT01045421|621590|P2|STARTED|Phase 1||3
256247|NCT01045421|621591|P1|STARTED|Phase 1||1
256248|NCT01045447|621673|P2|NOT COMPLETED|Overall Study||28
256249|NCT01045447|621674|P1|NOT COMPLETED|Overall Study||36
256250|NCT01045447|621673|P2|COMPLETED|Overall Study||205
256251|NCT01045447|621674|P1|COMPLETED|Overall Study||196
256252|NCT01045447|621673|P2|Exposed|Overall Study||233
256253|NCT01045447|621674|P1|Exposed|Overall Study|Two subjects withdrew prior to exposure to trial drug|230
256254|NCT01045447|621673|P2|STARTED|Overall Study||233
256255|NCT01045447|621674|P1|STARTED|Overall Study||232
256256|NCT01045551|621682|P1|NOT COMPLETED|Overall Study||0
256257|NCT01045551|621682|P1|COMPLETED|Overall Study||10
256258|NCT01045551|621682|P1|STARTED|Overall Study||10
256259|NCT01045694|621690|P1|NOT COMPLETED|Overall Study||2
256260|NCT01045694|621690|P1|COMPLETED|Overall Study||6
256261|NCT01045694|621690|P1|STARTED|Overall Study||8
256262|NCT01045707|621696|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||12
256263|NCT01045707|621697|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||13
256264|NCT01045707|621696|P2|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||209
256265|NCT01045707|621697|P1|COMPLETED|Extension: Week 27 to 52 (NN5401-3726)||179
256266|NCT01045707|621696|P2|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Eleven subjects from main trial did not continue into the extension|221
256267|NCT01045707|621697|P1|STARTED|Extension: Week 27 to 52 (NN5401-3726)|Twenty seven subjects from main trial did not continue into the extension|192
256268|NCT01045707|621696|P2|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||32
256269|NCT01045707|621697|P1|NOT COMPLETED|Main: Week 0 to 26 (NN5401-3590)||47
256270|NCT01045707|621696|P2|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||232
256271|NCT01045707|621697|P1|COMPLETED|Main: Week 0 to 26 (NN5401-3590)||219
256272|NCT01045707|621696|P2|Exposed|Main: Week 0 to 26 (NN5401-3590)|Three subjects withdrew prior to exposure to trial drug|261
256273|NCT01045707|621697|P1|Exposed|Main: Week 0 to 26 (NN5401-3590)|One subject withdrew prior to exposure to trial drug|265
256274|NCT01045707|621696|P2|STARTED|Main: Week 0 to 26 (NN5401-3590)||264
256275|NCT01045707|621697|P1|STARTED|Main: Week 0 to 26 (NN5401-3590)||266
256276|NCT01045798|621715|P2|NOT COMPLETED|Overall Study||4
256277|NCT01045798|621716|P1|NOT COMPLETED|Overall Study||2
256278|NCT01045798|621715|P2|COMPLETED|Overall Study||5
256279|NCT01045798|621716|P1|COMPLETED|Overall Study||4
256280|NCT01045798|621715|P2|STARTED|Overall Study||9
256281|NCT01045798|621716|P1|STARTED|Overall Study||6
256282|NCT01045967|621724|P2|NOT COMPLETED|Second Intervention||1
256283|NCT01045967|621725|P1|NOT COMPLETED|Second Intervention||0
256284|NCT01045967|621724|P2|COMPLETED|Second Intervention||27
256285|NCT01045967|621725|P1|COMPLETED|Second Intervention||28
256286|NCT01045967|621724|P2|STARTED|Second Intervention|Subject was dropped prior to dosing in Period II due to positive drug screen.|28
256287|NCT01045967|621725|P1|STARTED|Second Intervention||28
256288|NCT01045967|621724|P2|NOT COMPLETED|Washout of 7 Days||0
256289|NCT01045967|621725|P1|NOT COMPLETED|Washout of 7 Days||0
256290|NCT01045967|621724|P2|COMPLETED|Washout of 7 Days||28
256291|NCT01045967|621725|P1|COMPLETED|Washout of 7 Days||28
256292|NCT01045967|621724|P2|STARTED|Washout of 7 Days||28
256293|NCT01045967|621725|P1|STARTED|Washout of 7 Days||28
256294|NCT01045967|621724|P2|NOT COMPLETED|First Intervention||0
256295|NCT01045967|621725|P1|NOT COMPLETED|First Intervention||0
256296|NCT01045967|621724|P2|COMPLETED|First Intervention||28
256297|NCT01045967|621725|P1|COMPLETED|First Intervention||28
256298|NCT01045967|621724|P2|STARTED|First Intervention||28
256299|NCT01045967|621725|P1|STARTED|First Intervention||28
256300|NCT01045993|621739|P4|NOT COMPLETED|Overall Study||0
256301|NCT01045993|621740|P3|NOT COMPLETED|Overall Study||0
256302|NCT01045993|621741|P2|NOT COMPLETED|Overall Study||1
256303|NCT01045993|621742|P1|NOT COMPLETED|Overall Study||0
256304|NCT01045993|621739|P4|COMPLETED|Overall Study||25
256305|NCT01045993|621740|P3|COMPLETED|Overall Study||5
256306|NCT01045993|621741|P2|COMPLETED|Overall Study||4
256307|NCT01045993|621742|P1|COMPLETED|Overall Study||26
256308|NCT01045993|621739|P4|STARTED|Overall Study||25
256309|NCT01045993|621740|P3|STARTED|Overall Study||5
256310|NCT01045993|621741|P2|STARTED|Overall Study||5
256311|NCT01045993|621742|P1|STARTED|Overall Study||26
256312|NCT01049984|621818|P2|NOT COMPLETED|Overall Study||19
256313|NCT01049984|621819|P1|NOT COMPLETED|Overall Study||19
256314|NCT01049984|621818|P2|COMPLETED|Overall Study||146
256315|NCT01049984|621819|P1|COMPLETED|Overall Study||144
256316|NCT01049984|621818|P2|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|162
256317|NCT01049984|621819|P1|Modified Intent-to-treat Pop|Overall Study|Took >= 1 dose of study drug and had both baseline and at least 1 post-baseline efficacy assessment|159
256318|NCT01049984|621818|P2|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|164
256319|NCT01049984|621819|P1|Safety Population|Overall Study|One patient was randomized but not dosed; omitted from safety population|162
256320|NCT01049984|621818|P2|STARTED|Overall Study||165
256321|NCT01049984|621819|P1|STARTED|Overall Study||163
256322|NCT01050062|621837|P2|NOT COMPLETED|Overall Study||112
256323|NCT01050062|621838|P1|NOT COMPLETED|Overall Study||271
256324|NCT01050062|621837|P2|COMPLETED|Overall Study||243
256325|NCT01050062|621838|P1|COMPLETED|Overall Study||799
256326|NCT01050062|621837|P2|STARTED|Overall Study||355
256327|NCT01050062|621838|P1|STARTED|Overall Study||1070
256328|NCT01050153|621860|P2|NOT COMPLETED|Overall Study||0
256329|NCT01050153|621861|P1|NOT COMPLETED|Overall Study||0
256330|NCT01050153|621860|P2|COMPLETED|Overall Study||25
256331|NCT01050153|621861|P1|COMPLETED|Overall Study||25
256332|NCT01050153|621860|P2|STARTED|Overall Study||25
256333|NCT01050153|621861|P1|STARTED|Overall Study||25
256334|NCT01050205|621887|P2|NOT COMPLETED|Overall Study||4
256335|NCT01050205|621888|P1|NOT COMPLETED|Overall Study||11
256336|NCT01050205|621887|P2|COMPLETED|Overall Study||71
256337|NCT01050205|621888|P1|COMPLETED|Overall Study||137
256338|NCT01050205|621887|P2|STARTED|Overall Study||75
256339|NCT01050205|621888|P1|STARTED|Overall Study||148
256340|NCT01050218|621916|P1|NOT COMPLETED|Overall Study||95
256341|NCT01050218|621916|P1|COMPLETED|Overall Study||142
256342|NCT01050218|621916|P1|STARTED|Overall Study||237
256343|NCT01050257|621923|P3|NOT COMPLETED|Overall Study||7
256344|NCT01050257|621924|P2|NOT COMPLETED|Overall Study||13
256345|NCT01050257|621925|P1|NOT COMPLETED|Overall Study||11
256346|NCT01050257|621923|P3|COMPLETED|Overall Study||8
256347|NCT01050257|621924|P2|COMPLETED|Overall Study||40
256348|NCT01050257|621925|P1|COMPLETED|Overall Study|Completed 5 days of treatment either IV or Oral|39
256349|NCT01050257|621923|P3|Switched to Oral Treatment|Overall Study||3
256350|NCT01050257|621924|P2|Switched to Oral Treatment|Overall Study||31
256351|NCT01050257|621925|P1|Switched to Oral Treatment|Overall Study||28
256352|NCT01050257|621923|P3|Intent-to-treat Infected Confirmed|Overall Study||10
256353|NCT01050257|621924|P2|Intent-to-treat Infected Confirmed|Overall Study||32
256354|NCT01050257|621925|P1|Intent-to-treat Infected Confirmed|Overall Study||30
256355|NCT01050257|621923|P3|Safety Population: Actual Dose Received|Overall Study||14
256356|NCT01050257|621924|P2|Safety Population: Actual Dose Received|Overall Study|One participant randomized to 100 mg actually received the 200 mg doses.|51
256357|NCT01050257|621925|P1|Safety Population: Actual Dose Received|Overall Study||48
256358|NCT01050257|621923|P3|Received Treatment|Overall Study||14
256359|NCT01050257|621924|P2|Received Treatment|Overall Study||50
256360|NCT01050257|621925|P1|Received Treatment|Overall Study||49
256361|NCT01050257|621923|P3|STARTED|Overall Study||15
256362|NCT01050257|621924|P2|STARTED|Overall Study||53
256363|NCT01050257|621925|P1|STARTED|Overall Study||50
256364|NCT01050530|621962|P2|NOT COMPLETED|Overall Study||10
256365|NCT01050530|621963|P1|NOT COMPLETED|Overall Study||8
256366|NCT01050530|621962|P2|COMPLETED|Overall Study||70
256367|NCT01050530|621963|P1|COMPLETED|Overall Study||74
256368|NCT01050530|621962|P2|STARTED|Overall Study||80
256369|NCT01050530|621963|P1|STARTED|Overall Study||82
256370|NCT01050543|621973|P2|NOT COMPLETED|Overall Study||4
256371|NCT01050543|621974|P1|NOT COMPLETED|Overall Study||4
256372|NCT01050543|621973|P2|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
256373|NCT01050543|621974|P1|COMPLETED|Overall Study|Includes 1 participant who started & completed the study but was excluded from Full Analysis Set.|60
256374|NCT01050543|621973|P2|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
256375|NCT01050543|621974|P1|STARTED|Overall Study|Includes 4 participants who were randomized but discontinued before Treatment Phase.|64
256376|NCT01050569|621983|P3|NOT COMPLETED|Overall Study||33
256377|NCT01050569|621984|P2|NOT COMPLETED|Overall Study||24
256378|NCT01050569|621985|P1|NOT COMPLETED|Overall Study||38
256379|NCT01050569|621983|P3|COMPLETED|Overall Study||47
256380|NCT01050569|621984|P2|COMPLETED|Overall Study||52
256381|NCT01050569|621985|P1|COMPLETED|Overall Study||41
256382|NCT01050569|621983|P3|STARTED|Overall Study||80
256383|NCT01050569|621984|P2|STARTED|Overall Study||76
256384|NCT01050569|621985|P1|STARTED|Overall Study||79
256385|NCT01050582|622004|P2|NOT COMPLETED|Overall Study||0
256386|NCT01050582|622005|P1|NOT COMPLETED|Overall Study||0
256387|NCT01050582|622004|P2|COMPLETED|Overall Study||51
256388|NCT01050582|622005|P1|COMPLETED|Overall Study||133
256389|NCT01050582|622004|P2|STARTED|Overall Study||51
256390|NCT01050582|622005|P1|STARTED|Overall Study||133
256391|NCT01050634|622015|P1|NOT COMPLETED|Overall Study||128
256392|NCT01050634|622015|P1|COMPLETED|Overall Study||852
256393|NCT01050634|622015|P1|Received Treatment|Overall Study||924
256394|NCT01050634|622015|P1|STARTED|Overall Study||980
256395|NCT01050660|622025|P2|NOT COMPLETED|Overall Study||0
256396|NCT01050660|622026|P1|NOT COMPLETED|Overall Study||0
256397|NCT01050660|622025|P2|COMPLETED|Overall Study||69
256398|NCT01050660|622026|P1|COMPLETED|Overall Study||67
256399|NCT01050660|622025|P2|STARTED|Overall Study||69
256400|NCT01050660|622026|P1|STARTED|Overall Study||67
256401|NCT01050673|622052|P2|NOT COMPLETED|Overall Study||5
256402|NCT01050673|622053|P1|NOT COMPLETED|Overall Study||4
256403|NCT01050673|622052|P2|COMPLETED|Overall Study||14
256404|NCT01050673|622053|P1|COMPLETED|Overall Study||17
256405|NCT01050673|622052|P2|STARTED|Overall Study||19
256406|NCT01050673|622053|P1|STARTED|Overall Study||21
256407|NCT01050764|622075|P1|NOT COMPLETED|Overall Study||3
256408|NCT01050764|622075|P1|COMPLETED|Overall Study||7
256409|NCT01050764|622075|P1|Received Infusion of T-con Cells|Overall Study||7
256410|NCT01050764|622075|P1|Received Infusion of T-reg Cells|Overall Study||7
256411|NCT01050764|622075|P1|Received HSCT Graft|Overall Study||8
256412|NCT01050764|622075|P1|STARTED|Overall Study||10
256413|NCT01050790|622084|P1|NOT COMPLETED|Overall Study||1
256414|NCT01050790|622084|P1|COMPLETED|Overall Study||16
256415|NCT01050790|622084|P1|STARTED|Overall Study||17
256416|NCT01050816|622094|P1|NOT COMPLETED|Overall Study||4
256417|NCT01050816|622094|P1|COMPLETED|Overall Study||26
256418|NCT01050816|622094|P1|STARTED|Overall Study||30
256419|NCT01050946|622100|P1|NOT COMPLETED|Overall Study||0
256420|NCT01050946|622100|P1|COMPLETED|Overall Study|Patient signed consent 2/3/2011. Patient had their transplant 2/15/2011. Patient died 9/2/2011|1
256421|NCT01050946|622100|P1|STARTED|Overall Study||1
256422|NCT01050998|622115|P5|NOT COMPLETED|Overall Study||14
256423|NCT01050998|622116|P4|NOT COMPLETED|Overall Study||3
256424|NCT01050998|622117|P3|NOT COMPLETED|Overall Study||3
256425|NCT01050998|622118|P2|NOT COMPLETED|Overall Study||2
256426|NCT01050998|622119|P1|NOT COMPLETED|Overall Study||4
256427|NCT01050998|622115|P5|COMPLETED|Overall Study||82
256428|NCT01050998|622116|P4|COMPLETED|Overall Study||45
256429|NCT01050998|622117|P3|COMPLETED|Overall Study||46
256430|NCT01050998|622118|P2|COMPLETED|Overall Study||47
256431|NCT01050998|622119|P1|COMPLETED|Overall Study||44
256432|NCT01050998|622115|P5|STARTED|Overall Study||96
256433|NCT01050998|622116|P4|STARTED|Overall Study||48
256434|NCT01050998|622117|P3|STARTED|Overall Study||49
256435|NCT01050998|622118|P2|STARTED|Overall Study||49
256436|NCT01050998|622119|P1|STARTED|Overall Study||48
256437|NCT01051323|622445|P1|NOT COMPLETED|Overall Study||539
256438|NCT01051323|622445|P1|COMPLETED|Overall Study||1041
256439|NCT01051323|622445|P1|Received at Least One Dose|Overall Study||1547
256440|NCT01051323|622445|P1|STARTED|Overall Study||1580
256441|NCT01051440|622469|P2|NOT COMPLETED|Overall Study||0
256442|NCT01051440|622470|P1|NOT COMPLETED|Overall Study||0
256443|NCT01051440|622469|P2|COMPLETED|Overall Study||1
256444|NCT01051440|622470|P1|COMPLETED|Overall Study||1
256445|NCT01051440|622469|P2|STARTED|Overall Study||1
256446|NCT01051440|622470|P1|STARTED|Overall Study||1
256447|NCT01051466|622482|P2|NOT COMPLETED|Overall Study||5
256448|NCT01051466|622483|P1|NOT COMPLETED|Overall Study||8
256449|NCT01051466|622482|P2|COMPLETED|Overall Study||23
256450|NCT01051466|622483|P1|COMPLETED|Overall Study||24
256451|NCT01051466|622482|P2|STARTED|Overall Study||28
256452|NCT01051466|622483|P1|STARTED|Overall Study||32
256453|NCT01051557|622522|P7|NOT COMPLETED|Overall Study||6
256454|NCT01051557|622523|P6|NOT COMPLETED|Overall Study||6
256455|NCT01051557|622524|P5|NOT COMPLETED|Overall Study||7
256456|NCT01051557|622525|P4|NOT COMPLETED|Overall Study||3
256457|NCT01051557|622526|P3|NOT COMPLETED|Overall Study||6
256458|NCT01051557|622527|P2|NOT COMPLETED|Overall Study||3
256459|NCT01051557|622528|P1|NOT COMPLETED|Overall Study||4
256460|NCT01051557|622522|P7|COMPLETED|Overall Study||0
256461|NCT01051557|622523|P6|COMPLETED|Overall Study||0
256462|NCT01051557|622524|P5|COMPLETED|Overall Study||1
256463|NCT01051557|622525|P4|COMPLETED|Overall Study||0
256464|NCT01051557|622526|P3|COMPLETED|Overall Study||0
256465|NCT01051557|622527|P2|COMPLETED|Overall Study||0
256466|NCT01051557|622528|P1|COMPLETED|Overall Study||0
256467|NCT01051557|622522|P7|STARTED|Overall Study||6
256468|NCT01051557|622523|P6|STARTED|Overall Study||6
256469|NCT01051557|622524|P5|STARTED|Overall Study||8
256470|NCT01051557|622525|P4|STARTED|Overall Study||3
256471|NCT01051557|622526|P3|STARTED|Overall Study||6
256472|NCT01051557|622527|P2|STARTED|Overall Study||3
256473|NCT01051557|622528|P1|STARTED|Overall Study||4
256474|NCT01051570|622538|P1|NOT COMPLETED|Overall Study||0
256475|NCT01051570|622538|P1|COMPLETED|Overall Study||26
256476|NCT01051570|622538|P1|STARTED|Overall Study||26
256477|NCT01051739|622544|P2|NOT COMPLETED|Overall Study||13
256478|NCT01051739|622545|P1|NOT COMPLETED|Overall Study||28
256479|NCT01051739|622544|P2|COMPLETED|Overall Study||47
256480|NCT01051739|622545|P1|COMPLETED|Overall Study||92
256481|NCT01051739|622544|P2|STARTED|Overall Study||60
256482|NCT01051739|622545|P1|STARTED|Overall Study||120
256483|NCT01051778|622553|P2|NOT COMPLETED|Overall Study||0
256484|NCT01051778|622554|P1|NOT COMPLETED|Overall Study||0
256485|NCT01051778|622553|P2|COMPLETED|Overall Study|November 2009|30
256486|NCT01051778|622554|P1|COMPLETED|Overall Study|November 2009|30
256487|NCT01051778|622553|P2|STARTED|Overall Study|June 2006|30
256488|NCT01051778|622554|P1|STARTED|Overall Study|June 2006|30
256489|NCT01051817|622562|P2|NOT COMPLETED|Overall Study||9
256490|NCT01051817|622563|P1|NOT COMPLETED|Overall Study||3
256491|NCT01051817|622562|P2|COMPLETED|Overall Study||26
256492|NCT01051817|622563|P1|COMPLETED|Overall Study||35
256493|NCT01051817|622562|P2|STARTED|Overall Study||35
256494|NCT01051817|622563|P1|STARTED|Overall Study||38
256495|NCT01051856|622575|P2|NOT COMPLETED|Overall Study||0
256496|NCT01051856|622576|P1|NOT COMPLETED|Overall Study||1
256497|NCT01051856|622575|P2|COMPLETED|Overall Study||35
256498|NCT01051856|622576|P1|COMPLETED|Overall Study||32
256499|NCT01051856|622575|P2|STARTED|Overall Study||35
256500|NCT01051856|622576|P1|STARTED|Overall Study||33
256501|NCT01051921|622584|P1|NOT COMPLETED|Overall Study||30
256502|NCT01051921|622584|P1|COMPLETED|Overall Study||37
256503|NCT01051921|622584|P1|STARTED|Overall Study||67
256504|NCT01051986|622591|P2|NOT COMPLETED|Overall Study||4
256505|NCT01051986|622592|P1|NOT COMPLETED|Overall Study||5
256506|NCT01051986|622591|P2|COMPLETED|Overall Study||108
256507|NCT01051986|622592|P1|COMPLETED|Overall Study||107
256508|NCT01051986|622591|P2|STARTED|Overall Study||112
256509|NCT01051986|622592|P1|STARTED|Overall Study||112
256510|NCT01052038|622609|P3|NOT COMPLETED|Overall Study||4
256511|NCT01052038|622610|P2|NOT COMPLETED|Overall Study||6
256512|NCT01052038|622611|P1|NOT COMPLETED|Overall Study||4
256513|NCT01052038|622609|P3|COMPLETED|Overall Study||36
256514|NCT01052038|622610|P2|COMPLETED|Overall Study||34
256515|NCT01052038|622611|P1|COMPLETED|Overall Study||36
256516|NCT01052038|622609|P3|STARTED|Overall Study||40
256517|NCT01052038|622610|P2|STARTED|Overall Study||40
256518|NCT01052038|622611|P1|STARTED|Overall Study||40
256519|NCT01052077|622633|P4|NOT COMPLETED|Phase A+||21
256520|NCT01052077|622634|P3|NOT COMPLETED|Phase A+||0
256521|NCT01052077|622635|P2|NOT COMPLETED|Phase A+||0
256522|NCT01052077|622636|P1|NOT COMPLETED|Phase A+||0
256523|NCT01052077|622633|P4|COMPLETED|Phase A+||230
256524|NCT01052077|622634|P3|COMPLETED|Phase A+||0
256525|NCT01052077|622635|P2|COMPLETED|Phase A+||0
256526|NCT01052077|622636|P1|COMPLETED|Phase A+||0
256527|NCT01052077|622633|P4|STARTED|Phase A+||251
256528|NCT01052077|622634|P3|STARTED|Phase A+||0
256529|NCT01052077|622635|P2|STARTED|Phase A+||0
256530|NCT01052077|622636|P1|STARTED|Phase A+||0
256531|NCT01052077|622633|P4|NOT COMPLETED|Phase B||0
256532|NCT01052077|622634|P3|NOT COMPLETED|Phase B||16
256533|NCT01052077|622635|P2|NOT COMPLETED|Phase B||18
256534|NCT01052077|622636|P1|NOT COMPLETED|Phase B||0
256535|NCT01052077|622633|P4|COMPLETED|Phase B||0
256536|NCT01052077|622634|P3|COMPLETED|Phase B||171
256537|NCT01052077|622635|P2|COMPLETED|Phase B||167
256538|NCT01052077|622636|P1|COMPLETED|Phase B||0
256539|NCT01052077|622633|P4|STARTED|Phase B||0
256540|NCT01052077|622634|P3|STARTED|Phase B||187
256541|NCT01052077|622635|P2|STARTED|Phase B||185
256542|NCT01052077|622636|P1|STARTED|Phase B||0
256543|NCT01052077|622633|P4|NOT COMPLETED|Phase A||0
256544|NCT01052077|622634|P3|NOT COMPLETED|Phase A||0
256545|NCT01052077|622635|P2|NOT COMPLETED|Phase A||0
256546|NCT01052077|622636|P1|NOT COMPLETED|Phase A||146
256547|NCT01052077|622633|P4|COMPLETED|Phase A||0
256548|NCT01052077|622634|P3|COMPLETED|Phase A||0
256549|NCT01052077|622635|P2|COMPLETED|Phase A||0
256550|NCT01052077|622636|P1|COMPLETED|Phase A||623
256551|NCT01052077|622633|P4|STARTED|Phase A||0
256552|NCT01052077|622634|P3|STARTED|Phase A||0
256553|NCT01052077|622635|P2|STARTED|Phase A||0
256554|NCT01052077|622636|P1|STARTED|Phase A||769
256555|NCT01052116|622662|P2|NOT COMPLETED|Overall Study||27
256556|NCT01052116|622663|P1|NOT COMPLETED|Overall Study||14
256557|NCT01052116|622662|P2|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|166
256558|NCT01052116|622663|P1|COMPLETED|Overall Study|Completed: defined as having an FEV1 measurement at 24 weeks|179
256559|NCT01052116|622662|P2|STARTED|Overall Study||193
256560|NCT01052116|622663|P1|STARTED|Overall Study||193
256561|NCT01052207|622671|P2|NOT COMPLETED|Overall Study||0
256562|NCT01052207|622672|P1|NOT COMPLETED|Overall Study||0
256563|NCT01052207|622671|P2|COMPLETED|Overall Study||42
256564|NCT01052207|622672|P1|COMPLETED|Overall Study||60
256565|NCT01052207|622671|P2|STARTED|Overall Study||42
256566|NCT01052207|622672|P1|STARTED|Overall Study||60
256567|NCT01052272|622682|P4|NOT COMPLETED|Overall Study||7
256568|NCT01052272|622683|P3|NOT COMPLETED|Overall Study||8
256569|NCT01052272|622684|P2|NOT COMPLETED|Overall Study||7
256570|NCT01052272|622685|P1|NOT COMPLETED|Overall Study||5
256571|NCT01052272|622682|P4|COMPLETED|Overall Study||11
256572|NCT01052272|622683|P3|COMPLETED|Overall Study||10
256573|NCT01052272|622684|P2|COMPLETED|Overall Study||11
256574|NCT01052272|622685|P1|COMPLETED|Overall Study||13
256575|NCT01052272|622682|P4|STARTED|Overall Study||18
256576|NCT01052272|622683|P3|STARTED|Overall Study||18
256577|NCT01052272|622684|P2|STARTED|Overall Study||18
256578|NCT01052272|622685|P1|STARTED|Overall Study||18
256579|NCT01052428|622721|P2|NOT COMPLETED|Overall Study||1
256580|NCT01052428|622722|P1|NOT COMPLETED|Overall Study||1
256581|NCT01052428|622721|P2|COMPLETED|Overall Study||18
256582|NCT01052428|622722|P1|COMPLETED|Overall Study||18
256583|NCT01052428|622721|P2|STARTED|Overall Study||19
256584|NCT01052428|622722|P1|STARTED|Overall Study||19
256585|NCT01042145|622742|P2|NOT COMPLETED|Overall Study||1
256586|NCT01042145|622743|P1|NOT COMPLETED|Overall Study||1
256587|NCT01042145|622742|P2|COMPLETED|Overall Study||45
256588|NCT01042145|622743|P1|COMPLETED|Overall Study||40
256589|NCT01042145|622742|P2|STARTED|Overall Study||46
256590|NCT01042145|622743|P1|STARTED|Overall Study||41
256591|NCT01042236|622759|P6|NOT COMPLETED|Treatment Period 3||0
256592|NCT01042236|622760|P5|NOT COMPLETED|Treatment Period 3||0
256593|NCT01042236|622761|P4|NOT COMPLETED|Treatment Period 3||2
256594|NCT01042236|622762|P3|NOT COMPLETED|Treatment Period 3||0
256595|NCT01042236|622763|P2|NOT COMPLETED|Treatment Period 3||0
256596|NCT01042236|622764|P1|NOT COMPLETED|Treatment Period 3||0
256597|NCT01042236|622759|P6|COMPLETED|Treatment Period 3||3
256598|NCT01042236|622760|P5|COMPLETED|Treatment Period 3||3
256599|NCT01042236|622761|P4|COMPLETED|Treatment Period 3||3
256600|NCT01042236|622762|P3|COMPLETED|Treatment Period 3||3
256601|NCT01042236|622763|P2|COMPLETED|Treatment Period 3||3
256602|NCT01042236|622764|P1|COMPLETED|Treatment Period 3||3
256603|NCT01042236|622759|P6|STARTED|Treatment Period 3||3
256604|NCT01042236|622760|P5|STARTED|Treatment Period 3||3
256605|NCT01042236|622761|P4|STARTED|Treatment Period 3||5
256606|NCT01042236|622762|P3|STARTED|Treatment Period 3||3
256607|NCT01042236|622763|P2|STARTED|Treatment Period 3||3
256608|NCT01042236|622764|P1|STARTED|Treatment Period 3||3
256609|NCT01042236|622759|P6|NOT COMPLETED|Treatment Period 2||0
256610|NCT01042236|622760|P5|NOT COMPLETED|Treatment Period 2||0
256611|NCT01042236|622761|P4|NOT COMPLETED|Treatment Period 2||0
256612|NCT01042236|622762|P3|NOT COMPLETED|Treatment Period 2||0
256613|NCT01042236|622763|P2|NOT COMPLETED|Treatment Period 2||0
256614|NCT01042236|622764|P1|NOT COMPLETED|Treatment Period 2||0
256615|NCT01042236|622759|P6|COMPLETED|Treatment Period 2||3
256616|NCT01042236|622760|P5|COMPLETED|Treatment Period 2||3
256617|NCT01042236|622761|P4|COMPLETED|Treatment Period 2||5
256618|NCT01042236|622762|P3|COMPLETED|Treatment Period 2||3
256619|NCT01042236|622763|P2|COMPLETED|Treatment Period 2||3
256620|NCT01042236|622764|P1|COMPLETED|Treatment Period 2||3
256621|NCT01042236|622759|P6|STARTED|Treatment Period 2||3
256622|NCT01042236|622760|P5|STARTED|Treatment Period 2||3
256623|NCT01042236|622761|P4|STARTED|Treatment Period 2||5
256624|NCT01042236|622762|P3|STARTED|Treatment Period 2||3
256625|NCT01042236|622763|P2|STARTED|Treatment Period 2||3
256626|NCT01042236|622764|P1|STARTED|Treatment Period 2||3
256627|NCT01042236|622759|P6|NOT COMPLETED|Treatment Period 1||0
256628|NCT01042236|622760|P5|NOT COMPLETED|Treatment Period 1||1
256629|NCT01042236|622761|P4|NOT COMPLETED|Treatment Period 1||0
256630|NCT01042236|622762|P3|NOT COMPLETED|Treatment Period 1||0
256631|NCT01042236|622763|P2|NOT COMPLETED|Treatment Period 1||1
256632|NCT01042236|622764|P1|NOT COMPLETED|Treatment Period 1||0
256633|NCT01042236|622759|P6|COMPLETED|Treatment Period 1||3
256634|NCT01042236|622760|P5|COMPLETED|Treatment Period 1||3
256635|NCT01042236|622761|P4|COMPLETED|Treatment Period 1||5
256636|NCT01042236|622762|P3|COMPLETED|Treatment Period 1||3
256637|NCT01042236|622763|P2|COMPLETED|Treatment Period 1||3
256638|NCT01042236|622764|P1|COMPLETED|Treatment Period 1||3
256639|NCT01042236|622759|P6|STARTED|Treatment Period 1||3
256640|NCT01042236|622760|P5|STARTED|Treatment Period 1||4
256641|NCT01042236|622761|P4|STARTED|Treatment Period 1||5
256642|NCT01042236|622762|P3|STARTED|Treatment Period 1||3
256643|NCT01042236|622763|P2|STARTED|Treatment Period 1||4
256644|NCT01042236|622764|P1|STARTED|Treatment Period 1||3
256645|NCT01042288|622801|P1|NOT COMPLETED|Overall Study||69
256646|NCT01042288|622801|P1|COMPLETED|Overall Study|Patients remained on maintenance until disease progression, toxicity or other reason to come off|0
256647|NCT01042288|622801|P1|Maintenance|Overall Study||27
256648|NCT01042288|622801|P1|STARTED|Overall Study||69
256649|NCT01042366|622812|P3|NOT COMPLETED|Overall Study||0
256650|NCT01042366|622813|P2|NOT COMPLETED|Overall Study||0
256651|NCT01042366|622814|P1|NOT COMPLETED|Overall Study||0
256652|NCT01042366|622812|P3|COMPLETED|Overall Study||4
256653|NCT01042366|622813|P2|COMPLETED|Overall Study||6
256654|NCT01042366|622814|P1|COMPLETED|Overall Study||5
256655|NCT01042366|622812|P3|STARTED|Overall Study||4
256656|NCT01042366|622813|P2|STARTED|Overall Study||6
256657|NCT01042366|622814|P1|STARTED|Overall Study||5
256658|NCT01042392|622825|P4|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
256659|NCT01042392|622826|P3|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||4
256660|NCT01042392|622827|P2|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||1
256661|NCT01042392|622828|P1|NOT COMPLETED|Period III (Unblinded,Controlled, 1 Day)||2
256662|NCT01042392|622825|P4|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||121
256663|NCT01042392|622826|P3|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||115
256664|NCT01042392|622827|P2|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||117
256665|NCT01042392|622828|P1|COMPLETED|Period III (Unblinded,Controlled, 1 Day)||127
256666|NCT01042392|622825|P4|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||82
256667|NCT01042392|622826|P3|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||93
256668|NCT01042392|622827|P2|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)||73
256669|NCT01042392|622828|P1|Per Protocol Missed-dose (PPMD)|Period III (Unblinded,Controlled, 1 Day)|PPMD excluded patients violated protocol instructions for period 3 (duration and treatment intake)|98
256670|NCT01042392|622825|P4|STARTED|Period III (Unblinded,Controlled, 1 Day)||122
256671|NCT01042392|622826|P3|STARTED|Period III (Unblinded,Controlled, 1 Day)||119
256672|NCT01042392|622827|P2|STARTED|Period III (Unblinded,Controlled, 1 Day)||118
256673|NCT01042392|622828|P1|STARTED|Period III (Unblinded,Controlled, 1 Day)||129
256674|NCT01042392|622825|P4|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
256675|NCT01042392|622826|P3|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||8
256676|NCT01042392|622827|P2|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
256677|NCT01042392|622828|P1|NOT COMPLETED|Period II(Randomized,Double Blinded,8wk)||10
256678|NCT01042392|622825|P4|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
256679|NCT01042392|622826|P3|COMPLETED|Period II(Randomized,Double Blinded,8wk)||241
256680|NCT01042392|622827|P2|COMPLETED|Period II(Randomized,Double Blinded,8wk)||0
256681|NCT01042392|622828|P1|COMPLETED|Period II(Randomized,Double Blinded,8wk)||247
256682|NCT01042392|622825|P4|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
256683|NCT01042392|622826|P3|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||222
256684|NCT01042392|622827|P2|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)||0
256685|NCT01042392|622828|P1|Intent to Treat (ITT)|Period II(Randomized,Double Blinded,8wk)|ITT excluded patients from centers where 90% of BP measurements were rounded to 5 or 0|222
256686|NCT01042392|622825|P4|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
256687|NCT01042392|622826|P3|STARTED|Period II(Randomized,Double Blinded,8wk)||249
256688|NCT01042392|622827|P2|STARTED|Period II(Randomized,Double Blinded,8wk)|This arm is used only in Period III.|0
256689|NCT01042392|622828|P1|STARTED|Period II(Randomized,Double Blinded,8wk)||257
256690|NCT01042496|622856|P2|NOT COMPLETED|Overall Study||0
256691|NCT01042496|622857|P1|NOT COMPLETED|Overall Study||0
256692|NCT01042496|622856|P2|COMPLETED|Overall Study||33
256693|NCT01042496|622857|P1|COMPLETED|Overall Study||29
256694|NCT01042496|622856|P2|STARTED|Overall Study||33
256695|NCT01042496|622857|P1|STARTED|Overall Study||29
256696|NCT01042509|622873|P1|NOT COMPLETED|Overall Study||0
256697|NCT01042509|622873|P1|COMPLETED|Overall Study||15
256698|NCT01042509|622873|P1|STARTED|Overall Study||15
256699|NCT01042535|622878|P1|NOT COMPLETED|Overall Study||8
256700|NCT01042535|622878|P1|COMPLETED|Overall Study||36
256701|NCT01042535|622878|P1|STARTED|Overall Study||44
256702|NCT01042600|622888|P2|NOT COMPLETED|Overall Study||0
256703|NCT01042600|622889|P1|NOT COMPLETED|Overall Study||1
256704|NCT01042600|622888|P2|COMPLETED|Overall Study||30
256705|NCT01042600|622889|P1|COMPLETED|Overall Study||30
256706|NCT01042600|622888|P2|STARTED|Overall Study||30
256707|NCT01042600|622889|P1|STARTED|Overall Study||31
256708|NCT01042613|622899|P2|NOT COMPLETED|Overall Study||0
256709|NCT01042613|622900|P1|NOT COMPLETED|Overall Study||0
256710|NCT01042613|622899|P2|COMPLETED|Overall Study||74
256711|NCT01042613|622900|P1|COMPLETED|Overall Study||72
256712|NCT01042613|622899|P2|STARTED|Overall Study||74
256713|NCT01042613|622900|P1|STARTED|Overall Study||72
256714|NCT01042678|622913|P6|NOT COMPLETED|Overall Study||0
256715|NCT01042678|622914|P5|NOT COMPLETED|Overall Study||0
256716|NCT01042678|622915|P4|NOT COMPLETED|Overall Study||0
256717|NCT01042678|622916|P3|NOT COMPLETED|Overall Study||0
256718|NCT01042678|622917|P2|NOT COMPLETED|Overall Study||0
256719|NCT01042678|622918|P1|NOT COMPLETED|Overall Study||1
256720|NCT01042678|622913|P6|COMPLETED|Overall Study||0
256721|NCT01042678|622914|P5|COMPLETED|Overall Study||0
256722|NCT01042678|622915|P4|COMPLETED|Overall Study||0
256723|NCT01042678|622916|P3|COMPLETED|Overall Study||6
256724|NCT01042678|622917|P2|COMPLETED|Overall Study||6
256725|NCT01042678|622918|P1|COMPLETED|Overall Study||5
256726|NCT01042678|622913|P6|STARTED|Overall Study||0
256727|NCT01042678|622914|P5|STARTED|Overall Study||0
256728|NCT01042678|622915|P4|STARTED|Overall Study||0
256729|NCT01042678|622916|P3|STARTED|Overall Study||6
256730|NCT01042678|622917|P2|STARTED|Overall Study||6
256731|NCT01042678|622918|P1|STARTED|Overall Study||6
256732|NCT01042795|622941|P1|NOT COMPLETED|Follow up - 22 Months After Drug Start||2
256733|NCT01042795|622941|P1|COMPLETED|Follow up - 22 Months After Drug Start||0
256734|NCT01042795|622941|P1|STARTED|Follow up - 22 Months After Drug Start||2
256735|NCT01042795|622941|P1|NOT COMPLETED|Dosing Period - 16 Weeks of Daily Doses||5
256736|NCT01042795|622941|P1|COMPLETED|Dosing Period - 16 Weeks of Daily Doses||2
256737|NCT01042795|622941|P1|STARTED|Dosing Period - 16 Weeks of Daily Doses||7
256738|NCT01042938|622947|P2|NOT COMPLETED|Overall Study||2
256739|NCT01042938|622948|P1|NOT COMPLETED|Overall Study||3
256740|NCT01042938|622947|P2|COMPLETED|Overall Study||16
256741|NCT01042938|622948|P1|COMPLETED|Overall Study||14
256742|NCT01042938|622947|P2|STARTED|Overall Study|1 withdrew before radiation; 1 non-compliance.|18
256743|NCT01042938|622948|P1|STARTED|Overall Study|1 withdrew before radiation; 1 ineligible due to other clinical trial; 1 non-compliance.|17
256744|NCT01042977|622962|P2|NOT COMPLETED|Overall Study||55
256745|NCT01042977|622963|P1|NOT COMPLETED|Overall Study||41
256746|NCT01042977|622962|P2|COMPLETED|Overall Study||428
256747|NCT01042977|622963|P1|COMPLETED|Overall Study||441
256748|NCT01042977|622962|P2|STARTED|Overall Study|Of the 483 participants only 482 were included in the full analysis set.|483
256749|NCT01042977|622963|P1|STARTED|Overall Study|Of 482 part. 480 were included in full analysis set. Thereof, 1 part. treated but not randomized.|482
256750|NCT01043094|622983|P2|NOT COMPLETED|Overall Study||0
256751|NCT01043094|622984|P1|NOT COMPLETED|Overall Study||0
256752|NCT01043094|622983|P2|COMPLETED|Overall Study||8
256753|NCT01043094|622984|P1|COMPLETED|Overall Study||8
256754|NCT01043094|622983|P2|STARTED|Overall Study||8
256755|NCT01043094|622984|P1|STARTED|Overall Study||8
256756|NCT01043133|622994|P2|NOT COMPLETED|Overall Study||2
256757|NCT01043133|622995|P1|NOT COMPLETED|Overall Study||1
256758|NCT01043133|622994|P2|COMPLETED|Overall Study||78
256759|NCT01043133|622995|P1|COMPLETED|Overall Study||74
256760|NCT01043133|622994|P2|STARTED|Overall Study||80
256761|NCT01043133|622995|P1|STARTED|Overall Study||75
256762|NCT01043146|623009|P6|NOT COMPLETED|Overall Study||0
256763|NCT01043146|623010|P5|NOT COMPLETED|Overall Study||0
256764|NCT01043146|623011|P4|NOT COMPLETED|Overall Study||0
256765|NCT01043146|623012|P3|NOT COMPLETED|Overall Study||0
256766|NCT01043146|623013|P2|NOT COMPLETED|Overall Study||0
256767|NCT01043146|623014|P1|NOT COMPLETED|Overall Study||0
256768|NCT01043146|623009|P6|COMPLETED|Overall Study||8
256769|NCT01043146|623010|P5|COMPLETED|Overall Study||8
256770|NCT01043146|623011|P4|COMPLETED|Overall Study||8
256771|NCT01043146|623012|P3|COMPLETED|Overall Study||8
256772|NCT01043146|623013|P2|COMPLETED|Overall Study||8
256773|NCT01043146|623014|P1|COMPLETED|Overall Study||10
256774|NCT01043146|623009|P6|STARTED|Overall Study||8
256775|NCT01043146|623010|P5|STARTED|Overall Study||8
256776|NCT01043146|623011|P4|STARTED|Overall Study||8
256777|NCT01043146|623012|P3|STARTED|Overall Study||8
256778|NCT01043146|623013|P2|STARTED|Overall Study||8
256779|NCT01043146|623014|P1|STARTED|Overall Study||10
256780|NCT01043185|623028|P10|NOT COMPLETED|Period 7 - Fourth Intervention||0
256781|NCT01043185|623029|P9|NOT COMPLETED|Period 7 - Fourth Intervention||0
256782|NCT01043185|623030|P8|NOT COMPLETED|Period 7 - Fourth Intervention||0
256783|NCT01043185|623031|P7|NOT COMPLETED|Period 7 - Fourth Intervention||0
256784|NCT01043185|623032|P6|NOT COMPLETED|Period 7 - Fourth Intervention||0
256785|NCT01043185|623033|P5|NOT COMPLETED|Period 7 - Fourth Intervention||0
256786|NCT01043185|623034|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
256787|NCT01043185|623035|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
256788|NCT01043185|623036|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
256789|NCT01043185|623037|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
256790|NCT01043185|623028|P10|COMPLETED|Period 7 - Fourth Intervention||3
256791|NCT01043185|623029|P9|COMPLETED|Period 7 - Fourth Intervention||2
256792|NCT01043185|623030|P8|COMPLETED|Period 7 - Fourth Intervention||3
256793|NCT01043185|623031|P7|COMPLETED|Period 7 - Fourth Intervention||3
256794|NCT01043185|623032|P6|COMPLETED|Period 7 - Fourth Intervention||3
256795|NCT01043185|623033|P5|COMPLETED|Period 7 - Fourth Intervention||2
256796|NCT01043185|623034|P4|COMPLETED|Period 7 - Fourth Intervention||2
256797|NCT01043185|623035|P3|COMPLETED|Period 7 - Fourth Intervention||3
256798|NCT01043185|623036|P2|COMPLETED|Period 7 - Fourth Intervention||2
256799|NCT01043185|623037|P1|COMPLETED|Period 7 - Fourth Intervention||3
256800|NCT01043185|623028|P10|STARTED|Period 7 - Fourth Intervention||3
256801|NCT01043185|623029|P9|STARTED|Period 7 - Fourth Intervention||2
256802|NCT01043185|623030|P8|STARTED|Period 7 - Fourth Intervention||3
256803|NCT01043185|623031|P7|STARTED|Period 7 - Fourth Intervention||3
256804|NCT01043185|623032|P6|STARTED|Period 7 - Fourth Intervention||3
256805|NCT01043185|623033|P5|STARTED|Period 7 - Fourth Intervention||2
256806|NCT01043185|623034|P4|STARTED|Period 7 - Fourth Intervention||2
256807|NCT01043185|623035|P3|STARTED|Period 7 - Fourth Intervention||3
256808|NCT01043185|623036|P2|STARTED|Period 7 - Fourth Intervention||2
256809|NCT01043185|623037|P1|STARTED|Period 7 - Fourth Intervention||3
256810|NCT01043185|623028|P10|NOT COMPLETED|Period 6 - Third Washout Period||0
256811|NCT01043185|623029|P9|NOT COMPLETED|Period 6 - Third Washout Period||1
256812|NCT01043185|623030|P8|NOT COMPLETED|Period 6 - Third Washout Period||0
256813|NCT01043185|623031|P7|NOT COMPLETED|Period 6 - Third Washout Period||0
256814|NCT01043185|623032|P6|NOT COMPLETED|Period 6 - Third Washout Period||0
256815|NCT01043185|623033|P5|NOT COMPLETED|Period 6 - Third Washout Period||0
256816|NCT01043185|623034|P4|NOT COMPLETED|Period 6 - Third Washout Period||0
256817|NCT01043185|623035|P3|NOT COMPLETED|Period 6 - Third Washout Period||0
256818|NCT01043185|623036|P2|NOT COMPLETED|Period 6 - Third Washout Period||0
256819|NCT01043185|623037|P1|NOT COMPLETED|Period 6 - Third Washout Period||0
256820|NCT01043185|623028|P10|COMPLETED|Period 6 - Third Washout Period||3
256821|NCT01043185|623029|P9|COMPLETED|Period 6 - Third Washout Period||2
256822|NCT01043185|623030|P8|COMPLETED|Period 6 - Third Washout Period||3
256823|NCT01043185|623031|P7|COMPLETED|Period 6 - Third Washout Period||3
256824|NCT01043185|623032|P6|COMPLETED|Period 6 - Third Washout Period||3
256825|NCT01043185|623033|P5|COMPLETED|Period 6 - Third Washout Period||2
256826|NCT01043185|623034|P4|COMPLETED|Period 6 - Third Washout Period||2
256827|NCT01043185|623035|P3|COMPLETED|Period 6 - Third Washout Period||3
256828|NCT01043185|623036|P2|COMPLETED|Period 6 - Third Washout Period||2
256829|NCT01043185|623037|P1|COMPLETED|Period 6 - Third Washout Period||3
256830|NCT01043185|623028|P10|STARTED|Period 6 - Third Washout Period||3
256831|NCT01043185|623029|P9|STARTED|Period 6 - Third Washout Period||3
256832|NCT01043185|623030|P8|STARTED|Period 6 - Third Washout Period||3
256833|NCT01043185|623031|P7|STARTED|Period 6 - Third Washout Period||3
256834|NCT01043185|623032|P6|STARTED|Period 6 - Third Washout Period||3
256835|NCT01043185|623033|P5|STARTED|Period 6 - Third Washout Period||2
256836|NCT01043185|623034|P4|STARTED|Period 6 - Third Washout Period||2
256837|NCT01043185|623035|P3|STARTED|Period 6 - Third Washout Period||3
256838|NCT01043185|623036|P2|STARTED|Period 6 - Third Washout Period||2
256839|NCT01043185|623037|P1|STARTED|Period 6 - Third Washout Period||3
256840|NCT01043185|623028|P10|NOT COMPLETED|Period 5 - Third Intervention||0
256841|NCT01043185|623029|P9|NOT COMPLETED|Period 5 - Third Intervention||0
256842|NCT01043185|623030|P8|NOT COMPLETED|Period 5 - Third Intervention||0
256843|NCT01043185|623031|P7|NOT COMPLETED|Period 5 - Third Intervention||0
256844|NCT01043185|623032|P6|NOT COMPLETED|Period 5 - Third Intervention||0
256845|NCT01043185|623033|P5|NOT COMPLETED|Period 5 - Third Intervention||0
256846|NCT01043185|623034|P4|NOT COMPLETED|Period 5 - Third Intervention||0
256847|NCT01043185|623035|P3|NOT COMPLETED|Period 5 - Third Intervention||0
256848|NCT01043185|623036|P2|NOT COMPLETED|Period 5 - Third Intervention||0
256849|NCT01043185|623037|P1|NOT COMPLETED|Period 5 - Third Intervention||0
256850|NCT01043185|623028|P10|COMPLETED|Period 5 - Third Intervention||3
256851|NCT01043185|623029|P9|COMPLETED|Period 5 - Third Intervention||3
256852|NCT01043185|623030|P8|COMPLETED|Period 5 - Third Intervention||3
256853|NCT01043185|623031|P7|COMPLETED|Period 5 - Third Intervention||3
256854|NCT01043185|623032|P6|COMPLETED|Period 5 - Third Intervention||3
256855|NCT01043185|623033|P5|COMPLETED|Period 5 - Third Intervention||2
256856|NCT01043185|623034|P4|COMPLETED|Period 5 - Third Intervention||2
256857|NCT01043185|623035|P3|COMPLETED|Period 5 - Third Intervention||3
256858|NCT01043185|623036|P2|COMPLETED|Period 5 - Third Intervention||2
256859|NCT01043185|623037|P1|COMPLETED|Period 5 - Third Intervention||3
256860|NCT01043185|623028|P10|STARTED|Period 5 - Third Intervention||3
256861|NCT01043185|623029|P9|STARTED|Period 5 - Third Intervention||3
256862|NCT01043185|623030|P8|STARTED|Period 5 - Third Intervention||3
256863|NCT01043185|623031|P7|STARTED|Period 5 - Third Intervention||3
256864|NCT01043185|623032|P6|STARTED|Period 5 - Third Intervention||3
256865|NCT01043185|623033|P5|STARTED|Period 5 - Third Intervention||2
256866|NCT01043185|623034|P4|STARTED|Period 5 - Third Intervention||2
256867|NCT01043185|623035|P3|STARTED|Period 5 - Third Intervention||3
256868|NCT01043185|623036|P2|STARTED|Period 5 - Third Intervention||2
256869|NCT01043185|623037|P1|STARTED|Period 5 - Third Intervention||3
256870|NCT01043185|623028|P10|NOT COMPLETED|Period 4 - Second Washout Period||0
256871|NCT01043185|623029|P9|NOT COMPLETED|Period 4 - Second Washout Period||0
256872|NCT01043185|623030|P8|NOT COMPLETED|Period 4 - Second Washout Period||0
256873|NCT01043185|623031|P7|NOT COMPLETED|Period 4 - Second Washout Period||0
256874|NCT01043185|623032|P6|NOT COMPLETED|Period 4 - Second Washout Period||0
256875|NCT01043185|623033|P5|NOT COMPLETED|Period 4 - Second Washout Period||0
256876|NCT01043185|623034|P4|NOT COMPLETED|Period 4 - Second Washout Period||0
256877|NCT01043185|623035|P3|NOT COMPLETED|Period 4 - Second Washout Period||0
256878|NCT01043185|623036|P2|NOT COMPLETED|Period 4 - Second Washout Period||0
256879|NCT01043185|623037|P1|NOT COMPLETED|Period 4 - Second Washout Period||0
256880|NCT01043185|623028|P10|COMPLETED|Period 4 - Second Washout Period||3
256881|NCT01043185|623029|P9|COMPLETED|Period 4 - Second Washout Period||3
256882|NCT01043185|623030|P8|COMPLETED|Period 4 - Second Washout Period||3
256883|NCT01043185|623031|P7|COMPLETED|Period 4 - Second Washout Period||3
256884|NCT01043185|623032|P6|COMPLETED|Period 4 - Second Washout Period||3
256885|NCT01043185|623033|P5|COMPLETED|Period 4 - Second Washout Period||2
256886|NCT01043185|623034|P4|COMPLETED|Period 4 - Second Washout Period||2
256887|NCT01043185|623035|P3|COMPLETED|Period 4 - Second Washout Period||3
256888|NCT01043185|623036|P2|COMPLETED|Period 4 - Second Washout Period||2
256889|NCT01043185|623037|P1|COMPLETED|Period 4 - Second Washout Period||3
256890|NCT01043185|623028|P10|STARTED|Period 4 - Second Washout Period||3
256891|NCT01043185|623029|P9|STARTED|Period 4 - Second Washout Period||3
256892|NCT01043185|623030|P8|STARTED|Period 4 - Second Washout Period||3
256893|NCT01043185|623031|P7|STARTED|Period 4 - Second Washout Period||3
256894|NCT01043185|623032|P6|STARTED|Period 4 - Second Washout Period||3
256895|NCT01043185|623033|P5|STARTED|Period 4 - Second Washout Period||2
256896|NCT01043185|623034|P4|STARTED|Period 4 - Second Washout Period||2
256897|NCT01043185|623035|P3|STARTED|Period 4 - Second Washout Period||3
256898|NCT01043185|623036|P2|STARTED|Period 4 - Second Washout Period||2
256899|NCT01043185|623037|P1|STARTED|Period 4 - Second Washout Period||3
256900|NCT01043185|623028|P10|NOT COMPLETED|Period 3 - Second Intervention||0
256901|NCT01043185|623029|P9|NOT COMPLETED|Period 3 - Second Intervention||0
256902|NCT01043185|623030|P8|NOT COMPLETED|Period 3 - Second Intervention||0
256903|NCT01043185|623031|P7|NOT COMPLETED|Period 3 - Second Intervention||0
256904|NCT01043185|623032|P6|NOT COMPLETED|Period 3 - Second Intervention||0
256905|NCT01043185|623033|P5|NOT COMPLETED|Period 3 - Second Intervention||0
256906|NCT01043185|623034|P4|NOT COMPLETED|Period 3 - Second Intervention||0
256907|NCT01043185|623035|P3|NOT COMPLETED|Period 3 - Second Intervention||0
256908|NCT01043185|623036|P2|NOT COMPLETED|Period 3 - Second Intervention||0
256909|NCT01043185|623037|P1|NOT COMPLETED|Period 3 - Second Intervention||0
256910|NCT01043185|623028|P10|COMPLETED|Period 3 - Second Intervention||3
256911|NCT01043185|623029|P9|COMPLETED|Period 3 - Second Intervention||3
256912|NCT01043185|623030|P8|COMPLETED|Period 3 - Second Intervention||3
256913|NCT01043185|623031|P7|COMPLETED|Period 3 - Second Intervention||3
256914|NCT01043185|623032|P6|COMPLETED|Period 3 - Second Intervention||3
256915|NCT01043185|623033|P5|COMPLETED|Period 3 - Second Intervention||2
256916|NCT01043185|623034|P4|COMPLETED|Period 3 - Second Intervention||2
256917|NCT01043185|623035|P3|COMPLETED|Period 3 - Second Intervention||3
256918|NCT01043185|623036|P2|COMPLETED|Period 3 - Second Intervention||2
256919|NCT01043185|623037|P1|COMPLETED|Period 3 - Second Intervention||3
256920|NCT01043185|623028|P10|STARTED|Period 3 - Second Intervention||3
256921|NCT01043185|623029|P9|STARTED|Period 3 - Second Intervention||3
256922|NCT01043185|623030|P8|STARTED|Period 3 - Second Intervention||3
256923|NCT01043185|623031|P7|STARTED|Period 3 - Second Intervention||3
256924|NCT01043185|623032|P6|STARTED|Period 3 - Second Intervention||3
256925|NCT01043185|623033|P5|STARTED|Period 3 - Second Intervention||2
256926|NCT01043185|623034|P4|STARTED|Period 3 - Second Intervention||2
256927|NCT01043185|623035|P3|STARTED|Period 3 - Second Intervention||3
256928|NCT01043185|623036|P2|STARTED|Period 3 - Second Intervention||2
256929|NCT01043185|623037|P1|STARTED|Period 3 - Second Intervention||3
256930|NCT01043185|623028|P10|NOT COMPLETED|Period 2 - First Washout Period||0
256931|NCT01043185|623029|P9|NOT COMPLETED|Period 2 - First Washout Period||0
256932|NCT01043185|623030|P8|NOT COMPLETED|Period 2 - First Washout Period||0
256933|NCT01043185|623031|P7|NOT COMPLETED|Period 2 - First Washout Period||0
256934|NCT01043185|623032|P6|NOT COMPLETED|Period 2 - First Washout Period||0
256935|NCT01043185|623033|P5|NOT COMPLETED|Period 2 - First Washout Period||0
256936|NCT01043185|623034|P4|NOT COMPLETED|Period 2 - First Washout Period||0
256937|NCT01043185|623035|P3|NOT COMPLETED|Period 2 - First Washout Period||0
256938|NCT01043185|623036|P2|NOT COMPLETED|Period 2 - First Washout Period||0
256939|NCT01043185|623037|P1|NOT COMPLETED|Period 2 - First Washout Period||0
256940|NCT01043185|623028|P10|COMPLETED|Period 2 - First Washout Period||3
256941|NCT01043185|623029|P9|COMPLETED|Period 2 - First Washout Period||3
256942|NCT01043185|623030|P8|COMPLETED|Period 2 - First Washout Period||3
256943|NCT01043185|623031|P7|COMPLETED|Period 2 - First Washout Period||3
256944|NCT01043185|623032|P6|COMPLETED|Period 2 - First Washout Period||3
256945|NCT01043185|623033|P5|COMPLETED|Period 2 - First Washout Period||2
256946|NCT01043185|623034|P4|COMPLETED|Period 2 - First Washout Period||2
256947|NCT01043185|623035|P3|COMPLETED|Period 2 - First Washout Period||3
256948|NCT01043185|623036|P2|COMPLETED|Period 2 - First Washout Period||2
256949|NCT01043185|623037|P1|COMPLETED|Period 2 - First Washout Period||3
256950|NCT01043185|623028|P10|STARTED|Period 2 - First Washout Period||3
256951|NCT01043185|623029|P9|STARTED|Period 2 - First Washout Period||3
256952|NCT01043185|623030|P8|STARTED|Period 2 - First Washout Period||3
256953|NCT01043185|623031|P7|STARTED|Period 2 - First Washout Period||3
256954|NCT01043185|623032|P6|STARTED|Period 2 - First Washout Period||3
256955|NCT01043185|623033|P5|STARTED|Period 2 - First Washout Period||2
256956|NCT01043185|623034|P4|STARTED|Period 2 - First Washout Period||2
256957|NCT01043185|623035|P3|STARTED|Period 2 - First Washout Period||3
256958|NCT01043185|623036|P2|STARTED|Period 2 - First Washout Period||2
256959|NCT01043185|623037|P1|STARTED|Period 2 - First Washout Period||3
256960|NCT01043185|623028|P10|NOT COMPLETED|Period 1 - First Intervention||0
256961|NCT01043185|623029|P9|NOT COMPLETED|Period 1 - First Intervention||0
256962|NCT01043185|623030|P8|NOT COMPLETED|Period 1 - First Intervention||0
256963|NCT01043185|623031|P7|NOT COMPLETED|Period 1 - First Intervention||0
256964|NCT01043185|623032|P6|NOT COMPLETED|Period 1 - First Intervention||0
256965|NCT01043185|623033|P5|NOT COMPLETED|Period 1 - First Intervention||0
256966|NCT01043185|623034|P4|NOT COMPLETED|Period 1 - First Intervention||0
256967|NCT01043185|623035|P3|NOT COMPLETED|Period 1 - First Intervention||0
256968|NCT01043185|623036|P2|NOT COMPLETED|Period 1 - First Intervention||0
256969|NCT01043185|623037|P1|NOT COMPLETED|Period 1 - First Intervention||0
256970|NCT01043185|623028|P10|COMPLETED|Period 1 - First Intervention||3
256971|NCT01043185|623029|P9|COMPLETED|Period 1 - First Intervention||3
256972|NCT01043185|623030|P8|COMPLETED|Period 1 - First Intervention||3
256973|NCT01043185|623031|P7|COMPLETED|Period 1 - First Intervention||3
256974|NCT01043185|623032|P6|COMPLETED|Period 1 - First Intervention||3
256975|NCT01043185|623033|P5|COMPLETED|Period 1 - First Intervention||2
256976|NCT01043185|623034|P4|COMPLETED|Period 1 - First Intervention||2
256977|NCT01043185|623035|P3|COMPLETED|Period 1 - First Intervention||3
256978|NCT01043185|623036|P2|COMPLETED|Period 1 - First Intervention||2
256979|NCT01043185|623037|P1|COMPLETED|Period 1 - First Intervention||3
256980|NCT01043185|623028|P10|STARTED|Period 1 - First Intervention||3
256981|NCT01043185|623029|P9|STARTED|Period 1 - First Intervention||3
256982|NCT01043185|623030|P8|STARTED|Period 1 - First Intervention||3
256983|NCT01043185|623031|P7|STARTED|Period 1 - First Intervention||3
256984|NCT01043185|623032|P6|STARTED|Period 1 - First Intervention||3
256985|NCT01043185|623033|P5|STARTED|Period 1 - First Intervention||2
256986|NCT01043185|623034|P4|STARTED|Period 1 - First Intervention||2
256987|NCT01043185|623035|P3|STARTED|Period 1 - First Intervention||3
256988|NCT01043185|623036|P2|STARTED|Period 1 - First Intervention||2
256989|NCT01043185|623037|P1|STARTED|Period 1 - First Intervention||3
256990|NCT01052480|623066|P2|NOT COMPLETED|Overall Study||17
256991|NCT01052480|623067|P1|NOT COMPLETED|Overall Study||8
256992|NCT01052480|623066|P2|COMPLETED|Overall Study||32
256993|NCT01052480|623067|P1|COMPLETED|Overall Study||41
256994|NCT01052480|623066|P2|STARTED|Overall Study||49
256995|NCT01052480|623067|P1|STARTED|Overall Study||49
256996|NCT01052545|623117|P2|NOT COMPLETED|Overall Study||0
256997|NCT01052545|623118|P1|NOT COMPLETED|Overall Study||0
256998|NCT01052545|623117|P2|COMPLETED|Overall Study||731
256999|NCT01052545|623118|P1|COMPLETED|Overall Study||867
257000|NCT01052545|623117|P2|STARTED|Overall Study||731
257001|NCT01052545|623118|P1|STARTED|Overall Study||867
257002|NCT01052662|623133|P3|NOT COMPLETED|Overall Study||22
257003|NCT01052662|623134|P2|NOT COMPLETED|Overall Study||22
257004|NCT01052662|623135|P1|NOT COMPLETED|Overall Study||22
257005|NCT01052662|623133|P3|COMPLETED|Overall Study||10
257006|NCT01052662|623134|P2|COMPLETED|Overall Study||5
257007|NCT01052662|623135|P1|COMPLETED|Overall Study||6
257008|NCT01052662|623133|P3|Discontinuation Phase|Overall Study||10
257009|NCT01052662|623134|P2|Discontinuation Phase|Overall Study||5
257010|NCT01052662|623135|P1|Discontinuation Phase|Overall Study||6
257011|NCT01052662|623133|P3|Stabilization Phase|Overall Study||26
257012|NCT01052662|623134|P2|Stabilization Phase|Overall Study||21
257013|NCT01052662|623135|P1|Stabilization Phase|Overall Study||21
257014|NCT01052662|623133|P3|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|32
257015|NCT01052662|623134|P2|STARTED|Overall Study|3 subjects excluded from Intent-to-treat sample for final analysis due to pharmacy issue|27
257016|NCT01052662|623135|P1|STARTED|Overall Study|1 subject excluded from Intent-to-treat sample for final analysis due to pharmacy issue.|28
257017|NCT01052701|623151|P2|NOT COMPLETED|Overall Study||0
257018|NCT01052701|623152|P1|NOT COMPLETED|Overall Study||0
257019|NCT01052701|623151|P2|COMPLETED|Overall Study||12
257020|NCT01052701|623152|P1|COMPLETED|Overall Study||14
257021|NCT01052701|623151|P2|STARTED|Overall Study||12
257022|NCT01052701|623152|P1|STARTED|Overall Study||14
257023|NCT01053156|623162|P2|NOT COMPLETED|Second Intervention (Week 13-24)||5
257024|NCT01053156|623163|P1|NOT COMPLETED|Second Intervention (Week 13-24)||2
257025|NCT01053156|623162|P2|COMPLETED|Second Intervention (Week 13-24)||22
257026|NCT01053156|623163|P1|COMPLETED|Second Intervention (Week 13-24)||26
257027|NCT01053156|623162|P2|STARTED|Second Intervention (Week 13-24)||27
257028|NCT01053156|623163|P1|STARTED|Second Intervention (Week 13-24)||28
257029|NCT01053156|623162|P2|NOT COMPLETED|First Intervention (Week 1-12)||6
257030|NCT01053156|623163|P1|NOT COMPLETED|First Intervention (Week 1-12)||5
257031|NCT01053156|623162|P2|COMPLETED|First Intervention (Week 1-12)||27
257032|NCT01053156|623163|P1|COMPLETED|First Intervention (Week 1-12)||28
257033|NCT01053156|623162|P2|STARTED|First Intervention (Week 1-12)||33
257034|NCT01053156|623163|P1|STARTED|First Intervention (Week 1-12)||33
257035|NCT01053247|623202|P3|NOT COMPLETED|Overall Study||28
257036|NCT01053247|623203|P2|NOT COMPLETED|Overall Study||19
257037|NCT01053247|623204|P1|NOT COMPLETED|Overall Study||20
257038|NCT01053247|623202|P3|COMPLETED|Overall Study||236
257039|NCT01053247|623203|P2|COMPLETED|Overall Study||241
257040|NCT01053247|623204|P1|COMPLETED|Overall Study||249
257041|NCT01053247|623202|P3|STARTED|Overall Study||264
257042|NCT01053247|623203|P2|STARTED|Overall Study||260
257043|NCT01053247|623204|P1|STARTED|Overall Study||269
257044|NCT01053312|623212|P1|NOT COMPLETED|Overall Study||0
257045|NCT01053312|623212|P1|COMPLETED|Overall Study||7
257046|NCT01053312|623212|P1|STARTED|Overall Study||7
257047|NCT01053429|623230|P1|NOT COMPLETED|Overall Study||373
257048|NCT01053429|623230|P1|COMPLETED|Overall Study||3018
257049|NCT01053429|623230|P1|STARTED|Overall Study||3391
257050|NCT01053507|623241|P2|NOT COMPLETED|Overall Study||1
257051|NCT01053507|623242|P1|NOT COMPLETED|Overall Study||3
257052|NCT01053507|623241|P2|COMPLETED|Overall Study||11
257053|NCT01053507|623242|P1|COMPLETED|Overall Study||8
257054|NCT01053507|623241|P2|STARTED|Overall Study||12
257055|NCT01053507|623242|P1|STARTED|Overall Study||11
257056|NCT01053663|623259|P1|NOT COMPLETED|Overall Study||6
257057|NCT01053663|623259|P1|COMPLETED|Overall Study||3
257058|NCT01053663|623259|P1|STARTED|Overall Study||9
257059|NCT01053741|623302|P2|NOT COMPLETED|2nd Study Intervention||1
257060|NCT01053741|623303|P1|NOT COMPLETED|2nd Study Intervention||0
257061|NCT01053741|623302|P2|COMPLETED|2nd Study Intervention||5
257062|NCT01053741|623303|P1|COMPLETED|2nd Study Intervention||5
257063|NCT01053741|623302|P2|STARTED|2nd Study Intervention||6
257064|NCT01053741|623303|P1|STARTED|2nd Study Intervention||5
257065|NCT01053741|623302|P2|NOT COMPLETED|14 Day Washout||0
257066|NCT01053741|623303|P1|NOT COMPLETED|14 Day Washout||0
257067|NCT01053741|623302|P2|COMPLETED|14 Day Washout||6
257068|NCT01053741|623303|P1|COMPLETED|14 Day Washout||5
257069|NCT01053741|623302|P2|STARTED|14 Day Washout||6
257070|NCT01053741|623303|P1|STARTED|14 Day Washout||5
257071|NCT01053741|623302|P2|NOT COMPLETED|1st Intervention||0
257072|NCT01053741|623303|P1|NOT COMPLETED|1st Intervention||0
257073|NCT01053741|623302|P2|COMPLETED|1st Intervention||6
257074|NCT01053741|623303|P1|COMPLETED|1st Intervention||5
257075|NCT01053741|623302|P2|STARTED|1st Intervention||6
257076|NCT01053741|623303|P1|STARTED|1st Intervention||5
257077|NCT01053819|623309|P1|NOT COMPLETED|Overall Study||0
257078|NCT01053819|623309|P1|COMPLETED|Overall Study||6
257079|NCT01053819|623309|P1|STARTED|Overall Study||6
257080|NCT01053897|623313|P1|NOT COMPLETED|Overall Study||0
257081|NCT01053897|623313|P1|COMPLETED|Overall Study||5
257082|NCT01053897|623313|P1|STARTED|Overall Study||5
257083|NCT01053988|623330|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||55
257084|NCT01053988|623331|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||59
257085|NCT01053988|623332|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||63
257086|NCT01053988|623333|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||61
257087|NCT01053988|623334|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||69
257088|NCT01053988|623335|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
257089|NCT01053988|623330|P6|COMPLETED|24-week, Double-blind Treatment Period||151
257090|NCT01053988|623331|P5|COMPLETED|24-week, Double-blind Treatment Period||147
257091|NCT01053988|623332|P4|COMPLETED|24-week, Double-blind Treatment Period||142
257092|NCT01053988|623333|P3|COMPLETED|24-week, Double-blind Treatment Period||145
257093|NCT01053988|623334|P2|COMPLETED|24-week, Double-blind Treatment Period||138
257094|NCT01053988|623335|P1|COMPLETED|24-week, Double-blind Treatment Period||0
257095|NCT01053988|623330|P6|STARTED|24-week, Double-blind Treatment Period||206
257096|NCT01053988|623331|P5|STARTED|24-week, Double-blind Treatment Period||206
257097|NCT01053988|623332|P4|STARTED|24-week, Double-blind Treatment Period||205
257098|NCT01053988|623333|P3|STARTED|24-week, Double-blind Treatment Period||206
257099|NCT01053988|623334|P2|STARTED|24-week, Double-blind Treatment Period||207
257100|NCT01053988|623335|P1|STARTED|24-week, Double-blind Treatment Period||0
257101|NCT01053988|623330|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257102|NCT01053988|623331|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257103|NCT01053988|623332|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257104|NCT01053988|623333|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257105|NCT01053988|623334|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257106|NCT01053988|623335|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||360
257107|NCT01053988|623330|P6|COMPLETED|2-week, Single-blind Run-In Period||0
257108|NCT01053988|623331|P5|COMPLETED|2-week, Single-blind Run-In Period||0
257109|NCT01053988|623332|P4|COMPLETED|2-week, Single-blind Run-In Period||0
257110|NCT01053988|623333|P3|COMPLETED|2-week, Single-blind Run-In Period||0
257111|NCT01053988|623334|P2|COMPLETED|2-week, Single-blind Run-In Period||0
257112|NCT01053988|623335|P1|COMPLETED|2-week, Single-blind Run-In Period||1030
257113|NCT01053988|623330|P6|STARTED|2-week, Single-blind Run-In Period||0
257114|NCT01053988|623331|P5|STARTED|2-week, Single-blind Run-In Period||0
257115|NCT01053988|623332|P4|STARTED|2-week, Single-blind Run-In Period||0
257116|NCT01053988|623333|P3|STARTED|2-week, Single-blind Run-In Period||0
257117|NCT01053988|623334|P2|STARTED|2-week, Single-blind Run-In Period||0
257118|NCT01053988|623335|P1|STARTED|2-week, Single-blind Run-In Period||1390
257119|NCT01054079|623367|P1|NOT COMPLETED|Overall Study||0
257120|NCT01054079|623367|P1|COMPLETED|Overall Study|while all 20 patients received at least some of the intervention, some did not get proper PSA tests.|20
257121|NCT01054079|623367|P1|# Recieved Proper PSA Testing|Overall Study||10
257122|NCT01054079|623367|P1|STARTED|Overall Study||20
257123|NCT01054170|623373|P2|NOT COMPLETED|Overall Study||6
257124|NCT01054170|623374|P1|NOT COMPLETED|Overall Study||4
257125|NCT01054170|623373|P2|COMPLETED|Overall Study||21
257126|NCT01054170|623374|P1|COMPLETED|Overall Study||21
257127|NCT01054170|623373|P2|STARTED|Overall Study||27
257128|NCT01054170|623374|P1|STARTED|Overall Study||25
257129|NCT01054183|623428|P2|NOT COMPLETED|Overall Study||0
257130|NCT01054183|623429|P1|NOT COMPLETED|Overall Study||0
257131|NCT01054183|623428|P2|COMPLETED|Overall Study||12
257132|NCT01054183|623429|P1|COMPLETED|Overall Study||10
257133|NCT01054183|623428|P2|STARTED|Overall Study||12
257134|NCT01054183|623429|P1|STARTED|Overall Study||10
257135|NCT01054222|623437|P1|NOT COMPLETED|Overall Study||11
257136|NCT01054222|623437|P1|COMPLETED|Overall Study||20
257137|NCT01054222|623437|P1|STARTED|Overall Study||31
257138|NCT01054339|623459|P3|NOT COMPLETED|Overall Study||0
257139|NCT01054339|623460|P2|NOT COMPLETED|Overall Study||0
257140|NCT01054339|623461|P1|NOT COMPLETED|Overall Study||0
257141|NCT01054339|623459|P3|COMPLETED|Overall Study||3
257142|NCT01054339|623460|P2|COMPLETED|Overall Study||3
257143|NCT01054339|623461|P1|COMPLETED|Overall Study||3
257144|NCT01054339|623459|P3|STARTED|Overall Study||3
257145|NCT01054339|623460|P2|STARTED|Overall Study||3
257146|NCT01054339|623461|P1|STARTED|Overall Study||3
257147|NCT01054404|623477|P2|NOT COMPLETED|Overall Study||0
257148|NCT01054404|623478|P1|NOT COMPLETED|Overall Study||0
257149|NCT01054404|623477|P2|COMPLETED|Overall Study||13
257150|NCT01054404|623478|P1|COMPLETED|Overall Study||10
257151|NCT01054404|623477|P2|STARTED|Overall Study||13
257152|NCT01054404|623478|P1|STARTED|Overall Study||10
257153|NCT01054560|623486|P2|NOT COMPLETED|Overall Study||28
257154|NCT01054560|623487|P1|NOT COMPLETED|Overall Study||13
257155|NCT01054560|623486|P2|COMPLETED|Overall Study||27
257156|NCT01054560|623487|P1|COMPLETED|Overall Study||45
257157|NCT01054560|623486|P2|STARTED|Overall Study||55
257158|NCT01054560|623487|P1|STARTED|Overall Study||58
257159|NCT01054573|623513|P4|NOT COMPLETED|Overall Study||2
257160|NCT01054573|623514|P3|NOT COMPLETED|Overall Study||3
257161|NCT01054573|623515|P2|NOT COMPLETED|Overall Study||4
257162|NCT01054573|623516|P1|NOT COMPLETED|Overall Study||1
257163|NCT01054573|623513|P4|COMPLETED|Overall Study||25
257164|NCT01054573|623514|P3|COMPLETED|Overall Study||19
257165|NCT01054573|623515|P2|COMPLETED|Overall Study||28
257166|NCT01054573|623516|P1|COMPLETED|Overall Study||8
257167|NCT01054573|623513|P4|STARTED|Overall Study||27
257168|NCT01054573|623514|P3|STARTED|Overall Study||22
257169|NCT01054573|623515|P2|STARTED|Overall Study||32
257170|NCT01054573|623516|P1|STARTED|Overall Study||9
257171|NCT01054586|623564|P4|NOT COMPLETED|Overall Study||0
257172|NCT01054586|623565|P3|NOT COMPLETED|Overall Study||0
257173|NCT01054586|623566|P2|NOT COMPLETED|Overall Study||0
257174|NCT01054586|623567|P1|NOT COMPLETED|Overall Study||0
257175|NCT01054586|623564|P4|COMPLETED|Overall Study||101
257176|NCT01054586|623565|P3|COMPLETED|Overall Study||8
257177|NCT01054586|623566|P2|COMPLETED|Overall Study||15
257178|NCT01054586|623567|P1|COMPLETED|Overall Study||43
257179|NCT01054586|623564|P4|STARTED|Overall Study||101
257180|NCT01054586|623565|P3|STARTED|Overall Study||8
257181|NCT01054586|623566|P2|STARTED|Overall Study||15
257182|NCT01054586|623567|P1|STARTED|Overall Study||43
257183|NCT01054599|623657|P2|NOT COMPLETED|Overall Study||7
257184|NCT01054599|623658|P1|NOT COMPLETED|Overall Study||4
257185|NCT01054599|623657|P2|COMPLETED|Overall Study||9
257186|NCT01054599|623658|P1|COMPLETED|Overall Study||9
257187|NCT01054599|623657|P2|STARTED|Overall Study||16
257188|NCT01054599|623658|P1|STARTED|Overall Study||13
257189|NCT01054625|623669|P3|NOT COMPLETED|Overall Study||1
257190|NCT01054625|623670|P2|NOT COMPLETED|Overall Study||3
257191|NCT01054625|623671|P1|NOT COMPLETED|Overall Study||2
257192|NCT01054625|623669|P3|COMPLETED|Overall Study||9
257193|NCT01054625|623670|P2|COMPLETED|Overall Study||9
257194|NCT01054625|623671|P1|COMPLETED|Overall Study||6
257195|NCT01054625|623669|P3|STARTED|Overall Study||10
257196|NCT01054625|623670|P2|STARTED|Overall Study||12
257197|NCT01054625|623671|P1|STARTED|Overall Study|A total of 31 patients were enrolled, 1 patient died before receiving any zalutumumab|8
257198|NCT01054703|623697|P1|NOT COMPLETED|Overall Study||0
257199|NCT01054703|623697|P1|COMPLETED|Overall Study||14
257200|NCT01054703|623697|P1|STARTED|Overall Study||14
257201|NCT01054729|623705|P4|NOT COMPLETED|Overall Study||3
257202|NCT01054729|623706|P3|NOT COMPLETED|Overall Study||6
257203|NCT01054729|623707|P2|NOT COMPLETED|Overall Study||5
257204|NCT01054729|623708|P1|NOT COMPLETED|Overall Study||4
257205|NCT01054729|623705|P4|COMPLETED|Overall Study||11
257206|NCT01054729|623706|P3|COMPLETED|Overall Study||9
257207|NCT01054729|623707|P2|COMPLETED|Overall Study||14
257208|NCT01054729|623708|P1|COMPLETED|Overall Study||12
257209|NCT01054729|623705|P4|Randomized and Treated|Overall Study||14
257210|NCT01054729|623706|P3|Randomized and Treated|Overall Study||15
257211|NCT01054729|623707|P2|Randomized and Treated|Overall Study||18
257212|NCT01054729|623708|P1|Randomized and Treated|Overall Study||16
257213|NCT01054729|623705|P4|STARTED|Overall Study||14
257214|NCT01054729|623706|P3|STARTED|Overall Study||15
257215|NCT01054729|623707|P2|STARTED|Overall Study||19
257216|NCT01054729|623708|P1|STARTED|Overall Study||16
257217|NCT01054742|623769|P1|NOT COMPLETED|Overall Study||0
257218|NCT01054742|623769|P1|COMPLETED|Overall Study||2
257219|NCT01054742|623769|P1|STARTED|Overall Study||2
257220|NCT01054820|623773|P1|NOT COMPLETED|Overall Study||2
257221|NCT01054820|623773|P1|COMPLETED|Overall Study||121
257222|NCT01054820|623773|P1|STARTED|Overall Study||123
257223|NCT01054846|623789|P2|NOT COMPLETED|Overall Study||17
257224|NCT01054846|623790|P1|NOT COMPLETED|Overall Study||76
257225|NCT01054846|623789|P2|COMPLETED|Overall Study||51
257226|NCT01054846|623790|P1|COMPLETED|Overall Study||246
257227|NCT01054846|623789|P2|STARTED|Overall Study||68
257228|NCT01054846|623790|P1|STARTED|Overall Study||322
257229|NCT01054885|623803|P7|NOT COMPLETED|24-week, Double-blind Treatment Period||47
257230|NCT01054885|623804|P6|NOT COMPLETED|24-week, Double-blind Treatment Period||60
257231|NCT01054885|623805|P5|NOT COMPLETED|24-week, Double-blind Treatment Period||42
257232|NCT01054885|623806|P4|NOT COMPLETED|24-week, Double-blind Treatment Period||43
257233|NCT01054885|623807|P3|NOT COMPLETED|24-week, Double-blind Treatment Period||49
257234|NCT01054885|623808|P2|NOT COMPLETED|24-week, Double-blind Treatment Period||59
257235|NCT01054885|623809|P1|NOT COMPLETED|24-week, Double-blind Treatment Period||0
257236|NCT01054885|623803|P7|COMPLETED|24-week, Double-blind Treatment Period||158
257237|NCT01054885|623804|P6|COMPLETED|24-week, Double-blind Treatment Period||144
257238|NCT01054885|623805|P5|COMPLETED|24-week, Double-blind Treatment Period||161
257239|NCT01054885|623806|P4|COMPLETED|24-week, Double-blind Treatment Period||160
257240|NCT01054885|623807|P3|COMPLETED|24-week, Double-blind Treatment Period||155
257241|NCT01054885|623808|P2|COMPLETED|24-week, Double-blind Treatment Period||146
257242|NCT01054885|623809|P1|COMPLETED|24-week, Double-blind Treatment Period||0
257243|NCT01054885|623803|P7|STARTED|24-week, Double-blind Treatment Period||205
257244|NCT01054885|623804|P6|STARTED|24-week, Double-blind Treatment Period||204
257245|NCT01054885|623805|P5|STARTED|24-week, Double-blind Treatment Period||203
257246|NCT01054885|623806|P4|STARTED|24-week, Double-blind Treatment Period||203
257247|NCT01054885|623807|P3|STARTED|24-week, Double-blind Treatment Period||204
257248|NCT01054885|623808|P2|STARTED|24-week, Double-blind Treatment Period||205
257249|NCT01054885|623809|P1|STARTED|24-week, Double-blind Treatment Period||0
257250|NCT01054885|623803|P7|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257251|NCT01054885|623804|P6|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257252|NCT01054885|623805|P5|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257253|NCT01054885|623806|P4|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257254|NCT01054885|623807|P3|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257255|NCT01054885|623808|P2|NOT COMPLETED|2-week, Single-blind Run-In Period||0
257256|NCT01054885|623809|P1|NOT COMPLETED|2-week, Single-blind Run-In Period||351
257257|NCT01054885|623803|P7|COMPLETED|2-week, Single-blind Run-In Period||0
257258|NCT01054885|623804|P6|COMPLETED|2-week, Single-blind Run-In Period||0
257259|NCT01054885|623805|P5|COMPLETED|2-week, Single-blind Run-In Period||0
257260|NCT01054885|623806|P4|COMPLETED|2-week, Single-blind Run-In Period||0
257261|NCT01054885|623807|P3|COMPLETED|2-week, Single-blind Run-In Period||0
257262|NCT01054885|623808|P2|COMPLETED|2-week, Single-blind Run-In Period||0
257263|NCT01054885|623809|P1|COMPLETED|2-week, Single-blind Run-In Period||1226
257264|NCT01054885|623803|P7|STARTED|2-week, Single-blind Run-In Period||0
257265|NCT01054885|623804|P6|STARTED|2-week, Single-blind Run-In Period||0
257266|NCT01054885|623805|P5|STARTED|2-week, Single-blind Run-In Period||0
257267|NCT01054885|623806|P4|STARTED|2-week, Single-blind Run-In Period||0
257268|NCT01054885|623807|P3|STARTED|2-week, Single-blind Run-In Period||0
257269|NCT01054885|623808|P2|STARTED|2-week, Single-blind Run-In Period||0
257270|NCT01054885|623809|P1|STARTED|2-week, Single-blind Run-In Period||1577
257271|NCT01054911|623847|P1|NOT COMPLETED|Overall Study||0
257272|NCT01054911|623847|P1|COMPLETED|Overall Study||5
257273|NCT01054911|623847|P1|STARTED|Overall Study||5
257274|NCT01054976|623854|P1|NOT COMPLETED|Overall Study||35
257275|NCT01054976|623854|P1|COMPLETED|Overall Study||57
257276|NCT01054976|623854|P1|STARTED|Overall Study||92
257277|NCT01055132|623862|P2|NOT COMPLETED|Period 2 (5-9 Days)||1
257278|NCT01055132|623863|P1|NOT COMPLETED|Period 2 (5-9 Days)||0
257279|NCT01055132|623862|P2|COMPLETED|Period 2 (5-9 Days)||32
257280|NCT01055132|623863|P1|COMPLETED|Period 2 (5-9 Days)||35
257281|NCT01055132|623862|P2|STARTED|Period 2 (5-9 Days)||33
257282|NCT01055132|623863|P1|STARTED|Period 2 (5-9 Days)||35
257283|NCT01055132|623862|P2|NOT COMPLETED|Period 1 (5-9 Days)||0
257284|NCT01055132|623863|P1|NOT COMPLETED|Period 1 (5-9 Days)||1
257285|NCT01055132|623862|P2|COMPLETED|Period 1 (5-9 Days)||33
257286|NCT01055132|623863|P1|COMPLETED|Period 1 (5-9 Days)||35
257287|NCT01055132|623862|P2|STARTED|Period 1 (5-9 Days)||33
257288|NCT01055132|623863|P1|STARTED|Period 1 (5-9 Days)||36
257289|NCT01055171|623876|P2|NOT COMPLETED|Overall Study||7
257290|NCT01055171|623877|P1|NOT COMPLETED|Overall Study||11
257291|NCT01055171|623876|P2|COMPLETED|Overall Study|Received the sugar pill and completed all visits including the one-week follow-up.|21
257292|NCT01055171|623877|P1|COMPLETED|Overall Study|Received the medication and completed all visits including the one-week follow-up.|18
257293|NCT01055171|623876|P2|Test Procedure Completion|Overall Study|Received the placebo and completed the first test session.|23
257294|NCT01055171|623877|P1|Test Procedure Completion|Overall Study|Received the medication and completed the first test session.|21
257295|NCT01055171|623876|P2|Retrieval Completion|Overall Study|Received the sugar pill and completed the retrieval session.|24
257296|NCT01055171|623877|P1|Retrieval Completion|Overall Study|Received the medication and completed the retrieval session.|25
257297|NCT01055171|623876|P2|STARTED|Overall Study|Randomized to receive placebo.|28
257298|NCT01055171|623877|P1|STARTED|Overall Study|Randomized to receive medication.|29
257299|NCT01055184|623891|P1|NOT COMPLETED|Overall Study||0
257300|NCT01055184|623891|P1|COMPLETED|Overall Study||34
257301|NCT01055184|623891|P1|STARTED|Overall Study||34
257302|NCT01055197|623897|P2|NOT COMPLETED|Overall Study||2
257303|NCT01055197|623898|P1|NOT COMPLETED|Overall Study||9
257304|NCT01055197|623897|P2|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|44
257305|NCT01055197|623898|P1|COMPLETED|Overall Study|Subjects with data available for the primary analysis are considered to have completed the study.|42
257306|NCT01055197|623897|P2|STARTED|Overall Study||46
257307|NCT01055197|623898|P1|STARTED|Overall Study||51
257308|NCT01055223|623904|P1|NOT COMPLETED|Overall Study||0
257309|NCT01055223|623904|P1|COMPLETED|Overall Study||98483
257310|NCT01055223|623904|P1|STARTED|Overall Study||98483
257311|NCT01055262|623932|P1|NOT COMPLETED|Overall Study||9
257312|NCT01055262|623932|P1|COMPLETED|Overall Study||160
257313|NCT01055262|623932|P1|STARTED|Overall Study||169
257314|NCT01055314|623945|P2|NOT COMPLETED|Overall Study||38
257315|NCT01055314|623946|P1|NOT COMPLETED|Overall Study||45
257316|NCT01055314|623945|P2|COMPLETED|Overall Study||37
257317|NCT01055314|623946|P1|COMPLETED|Overall Study||55
257318|NCT01055314|623945|P2|STARTED|Overall Study||75
257319|NCT01055314|623946|P1|STARTED|Overall Study||100
257320|NCT01055457|623958|P10|NOT COMPLETED|Overall Study||1
257321|NCT01055457|623959|P9|NOT COMPLETED|Overall Study||0
257322|NCT01055457|623960|P8|NOT COMPLETED|Overall Study||1
257323|NCT01055457|623961|P7|NOT COMPLETED|Overall Study||1
257324|NCT01055457|623962|P6|NOT COMPLETED|Overall Study||3
257325|NCT01055457|623963|P5|NOT COMPLETED|Overall Study||3
257326|NCT01055457|623964|P4|NOT COMPLETED|Overall Study||3
257327|NCT01055457|623965|P3|NOT COMPLETED|Overall Study||2
257328|NCT01055457|623966|P2|NOT COMPLETED|Overall Study||1
257329|NCT01055457|623967|P1|NOT COMPLETED|Overall Study||1
257330|NCT01055457|623958|P10|COMPLETED|Overall Study||19
257331|NCT01055457|623959|P9|COMPLETED|Overall Study||20
257332|NCT01055457|623960|P8|COMPLETED|Overall Study||18
257333|NCT01055457|623961|P7|COMPLETED|Overall Study||18
257334|NCT01055457|623962|P6|COMPLETED|Overall Study||15
257335|NCT01055457|623963|P5|COMPLETED|Overall Study||38
257336|NCT01055457|623964|P4|COMPLETED|Overall Study||37
257337|NCT01055457|623965|P3|COMPLETED|Overall Study||36
257338|NCT01055457|623966|P2|COMPLETED|Overall Study||39
257339|NCT01055457|623967|P1|COMPLETED|Overall Study||39
257340|NCT01055457|623958|P10|STARTED|Overall Study||20
257341|NCT01055457|623959|P9|STARTED|Overall Study||20
257342|NCT01055457|623960|P8|STARTED|Overall Study||19
257343|NCT01055457|623961|P7|STARTED|Overall Study||19
257344|NCT01055457|623962|P6|STARTED|Overall Study||18
257345|NCT01055457|623963|P5|STARTED|Overall Study||41
257346|NCT01055457|623964|P4|STARTED|Overall Study||40
257347|NCT01055457|623965|P3|STARTED|Overall Study||38
257348|NCT01055457|623966|P2|STARTED|Overall Study||40
257349|NCT01055457|623967|P1|STARTED|Overall Study||40
257350|NCT01055613|624001|P2|NOT COMPLETED|Overall Study||4
257351|NCT01055613|624002|P1|NOT COMPLETED|Overall Study||9
257352|NCT01055613|624001|P2|COMPLETED|Overall Study||96
257353|NCT01055613|624002|P1|COMPLETED|Overall Study||191
257354|NCT01055613|624001|P2|STARTED|Overall Study||100
257355|NCT01055613|624002|P1|STARTED|Overall Study||200
257356|NCT01055639|624012|P2|NOT COMPLETED|Overall Study||29
257357|NCT01055639|624013|P1|NOT COMPLETED|Overall Study||21
257358|NCT01055639|624012|P2|COMPLETED|Overall Study||31
257359|NCT01055639|624013|P1|COMPLETED|Overall Study||45
257360|NCT01055639|624012|P2|STARTED|Overall Study||60
257361|NCT01055639|624013|P1|STARTED|Overall Study||66
257362|NCT01046084|624037|P2|NOT COMPLETED|Fourth Intervention||0
257363|NCT01046084|624038|P1|NOT COMPLETED|Fourth Intervention||0
257364|NCT01046084|624037|P2|COMPLETED|Fourth Intervention||25
257365|NCT01046084|624038|P1|COMPLETED|Fourth Intervention||23
257366|NCT01046084|624037|P2|STARTED|Fourth Intervention||25
257367|NCT01046084|624038|P1|STARTED|Fourth Intervention||23
257368|NCT01046084|624037|P2|NOT COMPLETED|Third Washout of 7 Days||0
257369|NCT01046084|624038|P1|NOT COMPLETED|Third Washout of 7 Days||2
257370|NCT01046084|624037|P2|COMPLETED|Third Washout of 7 Days||25
257371|NCT01046084|624038|P1|COMPLETED|Third Washout of 7 Days||23
257372|NCT01046084|624037|P2|STARTED|Third Washout of 7 Days||25
257373|NCT01046084|624038|P1|STARTED|Third Washout of 7 Days||25
257374|NCT01046084|624037|P2|NOT COMPLETED|Third Intervention||0
257375|NCT01046084|624038|P1|NOT COMPLETED|Third Intervention||0
257376|NCT01046084|624037|P2|COMPLETED|Third Intervention||25
257377|NCT01046084|624038|P1|COMPLETED|Third Intervention||25
257378|NCT01046084|624037|P2|STARTED|Third Intervention||25
257379|NCT01046084|624038|P1|STARTED|Third Intervention||25
257380|NCT01046084|624037|P2|NOT COMPLETED|Second Washout of 7 Days||0
257381|NCT01046084|624038|P1|NOT COMPLETED|Second Washout of 7 Days||0
257382|NCT01046084|624037|P2|COMPLETED|Second Washout of 7 Days||25
257383|NCT01046084|624038|P1|COMPLETED|Second Washout of 7 Days||25
257384|NCT01046084|624037|P2|STARTED|Second Washout of 7 Days||25
257385|NCT01046084|624038|P1|STARTED|Second Washout of 7 Days||25
257386|NCT01046084|624037|P2|NOT COMPLETED|Second Intervention||0
257387|NCT01046084|624038|P1|NOT COMPLETED|Second Intervention||0
257388|NCT01046084|624037|P2|COMPLETED|Second Intervention||25
257389|NCT01046084|624038|P1|COMPLETED|Second Intervention||25
257390|NCT01046084|624037|P2|STARTED|Second Intervention||25
257391|NCT01046084|624038|P1|STARTED|Second Intervention||25
257392|NCT01046084|624037|P2|NOT COMPLETED|First Washout of 7 Days||0
257393|NCT01046084|624038|P1|NOT COMPLETED|First Washout of 7 Days||0
257394|NCT01046084|624037|P2|COMPLETED|First Washout of 7 Days||25
257395|NCT01046084|624038|P1|COMPLETED|First Washout of 7 Days||25
257396|NCT01046084|624037|P2|STARTED|First Washout of 7 Days||25
257397|NCT01046084|624038|P1|STARTED|First Washout of 7 Days||25
257398|NCT01046084|624037|P2|NOT COMPLETED|First Intervention||0
257399|NCT01046084|624038|P1|NOT COMPLETED|First Intervention||0
257400|NCT01046084|624037|P2|COMPLETED|First Intervention||25
257401|NCT01046084|624038|P1|COMPLETED|First Intervention||25
257402|NCT01046084|624037|P2|STARTED|First Intervention||25
257403|NCT01046084|624038|P1|STARTED|First Intervention||25
257404|NCT01046110|624050|P2|NOT COMPLETED|Overall Study||55
257405|NCT01046110|624051|P1|NOT COMPLETED|Overall Study||55
257406|NCT01046110|624050|P2|COMPLETED|Overall Study||174
257407|NCT01046110|624051|P1|COMPLETED|Overall Study||174
257408|NCT01046110|624050|P2|Exposed|Overall Study|1 subject was randomised in error|228
257409|NCT01046110|624051|P1|Exposed|Overall Study|2 subjects were randomised in error and 1 subject did not want to take insulin|226
257410|NCT01046110|624050|P2|STARTED|Overall Study||229
257411|NCT01046110|624051|P1|STARTED|Overall Study||229
257412|NCT01046136|624061|P2|NOT COMPLETED|Overall Study||8
257413|NCT01046136|624062|P1|NOT COMPLETED|Overall Study||4
257414|NCT01046136|624061|P2|COMPLETED|Overall Study||182
257415|NCT01046136|624062|P1|COMPLETED|Overall Study||184
257416|NCT01046136|624061|P2|STARTED|Overall Study||190
257417|NCT01046136|624062|P1|STARTED|Overall Study||188
257418|NCT01046253|624074|P2|NOT COMPLETED|Fourth Intervention||0
257419|NCT01046253|624075|P1|NOT COMPLETED|Fourth Intervention||0
257420|NCT01046253|624074|P2|COMPLETED|Fourth Intervention||23
257421|NCT01046253|624075|P1|COMPLETED|Fourth Intervention||25
257422|NCT01046253|624074|P2|STARTED|Fourth Intervention||23
257423|NCT01046253|624075|P1|STARTED|Fourth Intervention||25
257424|NCT01046253|624074|P2|NOT COMPLETED|Third Washout of 7 Days||0
257425|NCT01046253|624075|P1|NOT COMPLETED|Third Washout of 7 Days||0
257426|NCT01046253|624074|P2|COMPLETED|Third Washout of 7 Days||23
257427|NCT01046253|624075|P1|COMPLETED|Third Washout of 7 Days||25
257428|NCT01046253|624074|P2|STARTED|Third Washout of 7 Days||23
257429|NCT01046253|624075|P1|STARTED|Third Washout of 7 Days||25
257430|NCT01046253|624074|P2|NOT COMPLETED|Third Intervention||0
257431|NCT01046253|624075|P1|NOT COMPLETED|Third Intervention||0
257432|NCT01046253|624074|P2|COMPLETED|Third Intervention||23
257433|NCT01046253|624075|P1|COMPLETED|Third Intervention||25
257434|NCT01046253|624074|P2|STARTED|Third Intervention||23
257435|NCT01046253|624075|P1|STARTED|Third Intervention||25
257436|NCT01046253|624074|P2|NOT COMPLETED|Second Washout of 7 Days||0
257437|NCT01046253|624075|P1|NOT COMPLETED|Second Washout of 7 Days||0
257438|NCT01046253|624074|P2|COMPLETED|Second Washout of 7 Days||23
257439|NCT01046253|624075|P1|COMPLETED|Second Washout of 7 Days||25
257440|NCT01046253|624074|P2|STARTED|Second Washout of 7 Days||23
257441|NCT01046253|624075|P1|STARTED|Second Washout of 7 Days||25
257442|NCT01046253|624074|P2|NOT COMPLETED|Second Intervention||2
257443|NCT01046253|624075|P1|NOT COMPLETED|Second Intervention||0
257444|NCT01046253|624074|P2|COMPLETED|Second Intervention||23
257445|NCT01046253|624075|P1|COMPLETED|Second Intervention||25
257446|NCT01046253|624074|P2|STARTED|Second Intervention||25
257447|NCT01046253|624075|P1|STARTED|Second Intervention||25
257448|NCT01046253|624074|P2|NOT COMPLETED|First Washout of 7 Days||0
257449|NCT01046253|624075|P1|NOT COMPLETED|First Washout of 7 Days||0
257450|NCT01046253|624074|P2|COMPLETED|First Washout of 7 Days||25
257451|NCT01046253|624075|P1|COMPLETED|First Washout of 7 Days||25
257452|NCT01046253|624074|P2|STARTED|First Washout of 7 Days||25
257453|NCT01046253|624075|P1|STARTED|First Washout of 7 Days||25
257454|NCT01046253|624074|P2|NOT COMPLETED|First Intervention||0
257455|NCT01046253|624075|P1|NOT COMPLETED|First Intervention||0
257456|NCT01046253|624074|P2|COMPLETED|First Intervention||25
257457|NCT01046253|624075|P1|COMPLETED|First Intervention||25
257458|NCT01046253|624074|P2|STARTED|First Intervention||25
257459|NCT01046253|624075|P1|STARTED|First Intervention||25
257460|NCT01046396|624085|P1|NOT COMPLETED|Overall Study||5
257461|NCT01046396|624085|P1|COMPLETED|Overall Study||64
257462|NCT01046396|624085|P1|STARTED|Overall Study||69
257463|NCT01046565|624094|P1|NOT COMPLETED|Overall Study||9
257464|NCT01046565|624094|P1|COMPLETED|Overall Study||66
257465|NCT01046565|624094|P1|STARTED|Overall Study||75
257466|NCT01046643|624105|P4|NOT COMPLETED|Second Period Treatment or Placebo||0
257467|NCT01046643|624106|P3|NOT COMPLETED|Second Period Treatment or Placebo||0
257468|NCT01046643|624107|P2|NOT COMPLETED|Second Period Treatment or Placebo||0
257469|NCT01046643|624108|P1|NOT COMPLETED|Second Period Treatment or Placebo||0
257470|NCT01046643|624105|P4|COMPLETED|Second Period Treatment or Placebo||7
257471|NCT01046643|624106|P3|COMPLETED|Second Period Treatment or Placebo||7
257472|NCT01046643|624107|P2|COMPLETED|Second Period Treatment or Placebo||6
257473|NCT01046643|624108|P1|COMPLETED|Second Period Treatment or Placebo||9
257474|NCT01046643|624105|P4|STARTED|Second Period Treatment or Placebo||7
257475|NCT01046643|624106|P3|STARTED|Second Period Treatment or Placebo||7
257476|NCT01046643|624107|P2|STARTED|Second Period Treatment or Placebo||6
257477|NCT01046643|624108|P1|STARTED|Second Period Treatment or Placebo||9
257478|NCT01046643|624105|P4|NOT COMPLETED|Washout Period||0
257479|NCT01046643|624106|P3|NOT COMPLETED|Washout Period||0
257480|NCT01046643|624107|P2|NOT COMPLETED|Washout Period||0
257481|NCT01046643|624108|P1|NOT COMPLETED|Washout Period||0
257482|NCT01046643|624105|P4|COMPLETED|Washout Period||7
257483|NCT01046643|624106|P3|COMPLETED|Washout Period||7
257484|NCT01046643|624107|P2|COMPLETED|Washout Period||6
257485|NCT01046643|624108|P1|COMPLETED|Washout Period||9
257486|NCT01046643|624105|P4|STARTED|Washout Period||7
257487|NCT01046643|624106|P3|STARTED|Washout Period||7
257488|NCT01046643|624107|P2|STARTED|Washout Period||6
257489|NCT01046643|624108|P1|STARTED|Washout Period||9
257490|NCT01046643|624105|P4|NOT COMPLETED|First Period Treatment or Placebo||0
257491|NCT01046643|624106|P3|NOT COMPLETED|First Period Treatment or Placebo||0
257492|NCT01046643|624107|P2|NOT COMPLETED|First Period Treatment or Placebo||1
257493|NCT01046643|624108|P1|NOT COMPLETED|First Period Treatment or Placebo||0
257494|NCT01046643|624105|P4|COMPLETED|First Period Treatment or Placebo||7
257495|NCT01046643|624106|P3|COMPLETED|First Period Treatment or Placebo||7
257496|NCT01046643|624107|P2|COMPLETED|First Period Treatment or Placebo||6
257497|NCT01046643|624108|P1|COMPLETED|First Period Treatment or Placebo||9
257498|NCT01046643|624105|P4|STARTED|First Period Treatment or Placebo||7
257499|NCT01046643|624106|P3|STARTED|First Period Treatment or Placebo||7
257500|NCT01046643|624107|P2|STARTED|First Period Treatment or Placebo||7
257501|NCT01046643|624108|P1|STARTED|First Period Treatment or Placebo||9
257502|NCT01046682|624132|P2|NOT COMPLETED|Overall Study||0
257503|NCT01046682|624133|P1|NOT COMPLETED|Overall Study||2
257504|NCT01046682|624132|P2|COMPLETED|Overall Study||20
257505|NCT01046682|624133|P1|COMPLETED|Overall Study||18
257506|NCT01046682|624132|P2|STARTED|Overall Study||20
257507|NCT01046682|624133|P1|STARTED|Overall Study||20
257508|NCT01046695|624141|P2|NOT COMPLETED|Overall Study||2
257509|NCT01046695|624142|P1|NOT COMPLETED|Overall Study||0
257510|NCT01046695|624141|P2|COMPLETED|Overall Study||20
257511|NCT01046695|624142|P1|COMPLETED|Overall Study||20
257512|NCT01046695|624141|P2|STARTED|Overall Study||22
257513|NCT01046695|624142|P1|STARTED|Overall Study||20
257514|NCT01046877|624152|P1|NOT COMPLETED|Overall Study||18
257515|NCT01046877|624152|P1|COMPLETED|Overall Study||7
257516|NCT01046877|624152|P1|Completed Study Late|Overall Study|One completed (evidencing extrusions) at 23.5 mos. Missed 9 mo visit. Exam not possible at 12 mo.|1
257517|NCT01046877|624152|P1|Completed on Schedule|Overall Study|Final visit = the earlier of 24 months post-procedure or 12 months after extrusion.|6
257518|NCT01046877|624152|P1|STARTED|Overall Study||25
257519|NCT01046903|624166|P1|NOT COMPLETED|Overall Study||28
257520|NCT01046903|624166|P1|COMPLETED|Overall Study||475
257521|NCT01046903|624166|P1|STARTED|Overall Study||503
257522|NCT01047189|624181|P2|NOT COMPLETED|Overall Study||0
257523|NCT01047189|624182|P1|NOT COMPLETED|Overall Study||4
257524|NCT01047189|624181|P2|COMPLETED|Overall Study||13
257525|NCT01047189|624182|P1|COMPLETED|Overall Study||9
257526|NCT01047189|624181|P2|STARTED|Overall Study||13
257527|NCT01047189|624182|P1|STARTED|Overall Study||13
257528|NCT01047527|624193|P3|NOT COMPLETED|Overall Study||65
257529|NCT01047527|624194|P2|NOT COMPLETED|Overall Study||61
257530|NCT01047527|624195|P1|NOT COMPLETED|Overall Study||85
257531|NCT01047527|624193|P3|COMPLETED|Overall Study||107
257532|NCT01047527|624194|P2|COMPLETED|Overall Study||112
257533|NCT01047527|624195|P1|COMPLETED|Overall Study||95
257534|NCT01047527|624193|P3|24 Weeks|Overall Study||119
257535|NCT01047527|624194|P2|24 Weeks|Overall Study||123
257536|NCT01047527|624195|P1|24 Weeks|Overall Study||111
257537|NCT01047527|624193|P3|8 Weeks|Overall Study||138
257538|NCT01047527|624194|P2|8 Weeks|Overall Study||142
257539|NCT01047527|624195|P1|8 Weeks|Overall Study||148
257540|NCT01047527|624193|P3|STARTED|Overall Study||172
257541|NCT01047527|624194|P2|STARTED|Overall Study||173
257542|NCT01047527|624195|P1|STARTED|Overall Study||180
257543|NCT01047553|624206|P2|NOT COMPLETED|Overall Study||9
257544|NCT01047553|624207|P1|NOT COMPLETED|Overall Study||17
257545|NCT01047553|624206|P2|COMPLETED|Overall Study||117
257546|NCT01047553|624207|P1|COMPLETED|Overall Study||108
257547|NCT01047553|624206|P2|STARTED|Overall Study||126
257548|NCT01047553|624207|P1|STARTED|Overall Study||125
257549|NCT01047709|624289|P2|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
257550|NCT01047709|624290|P1|NOT COMPLETED|Control/Positioning ad Lib (1 Night)||0
257551|NCT01047709|624289|P2|COMPLETED|Control/Positioning ad Lib (1 Night)||9
257552|NCT01047709|624290|P1|COMPLETED|Control/Positioning ad Lib (1 Night)||9
257553|NCT01047709|624289|P2|STARTED|Control/Positioning ad Lib (1 Night)||9
257554|NCT01047709|624290|P1|STARTED|Control/Positioning ad Lib (1 Night)||9
257555|NCT01047709|624289|P2|NOT COMPLETED|Positional Therapy (1 Night)||0
257556|NCT01047709|624290|P1|NOT COMPLETED|Positional Therapy (1 Night)||0
257557|NCT01047709|624289|P2|COMPLETED|Positional Therapy (1 Night)||9
257558|NCT01047709|624290|P1|COMPLETED|Positional Therapy (1 Night)||9
257559|NCT01047709|624289|P2|STARTED|Positional Therapy (1 Night)||9
257560|NCT01047709|624290|P1|STARTED|Positional Therapy (1 Night)||9
257561|NCT01047839|624299|P3|NOT COMPLETED|Overall Study||6
257562|NCT01047839|624300|P2|NOT COMPLETED|Overall Study||0
257563|NCT01047839|624301|P1|NOT COMPLETED|Overall Study||2
257564|NCT01047839|624299|P3|COMPLETED|Overall Study||53
257565|NCT01047839|624300|P2|COMPLETED|Overall Study||29
257566|NCT01047839|624301|P1|COMPLETED|Overall Study||10
257567|NCT01047839|624299|P3|STARTED|Overall Study||59
257568|NCT01047839|624300|P2|STARTED|Overall Study||29
257569|NCT01047839|624301|P1|STARTED|Overall Study||12
257570|NCT01048099|624309|P1|NOT COMPLETED|Treatment Per Protocol||14
257571|NCT01048099|624309|P1|COMPLETED|Treatment Per Protocol|Patients continued treatment until disease progression or coming off-study for any other reason|0
257572|NCT01048099|624309|P1|STARTED|Treatment Per Protocol||14
257573|NCT01048099|624309|P1|NOT COMPLETED|Pts w/ HER2 Overexpression/Activation||10
257574|NCT01048099|624309|P1|COMPLETED|Pts w/ HER2 Overexpression/Activation|Patients who proceeded to treatment|14
257658|NCT01048333|624339|P2|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||19
257575|NCT01048099|624309|P1|STARTED|Pts w/ HER2 Overexpression/Activation|Patients with detected HER2 activation and/or overexpression|24
257576|NCT01048099|624309|P1|NOT COMPLETED|Patients Evaluated by PRO Onc Assay||202
257577|NCT01048099|624309|P1|COMPLETED|Patients Evaluated by PRO Onc Assay|Patients evaluated by PRO Onc Assay with HER2 overexpression/activation detected|24
257578|NCT01048099|624309|P1|STARTED|Patients Evaluated by PRO Onc Assay|Patients with CTCs who were evaluated by PRO Onc Assay|226
257579|NCT01048099|624309|P1|NOT COMPLETED|Patients Enrolled and Blood Collected||57
257580|NCT01048099|624309|P1|COMPLETED|Patients Enrolled and Blood Collected|Patients with circulating tumor cells (CTCs)|226
257581|NCT01048099|624309|P1|STARTED|Patients Enrolled and Blood Collected|Patients enrolled|283
257582|NCT01048125|624319|P2|NOT COMPLETED|Overall Study||0
257583|NCT01048125|624320|P1|NOT COMPLETED|Overall Study||0
257584|NCT01048125|624319|P2|COMPLETED|Overall Study||0
257585|NCT01048125|624320|P1|COMPLETED|Overall Study||0
257586|NCT01048125|624319|P2|STARTED|Overall Study||0
257587|NCT01048125|624320|P1|STARTED|Overall Study||0
257588|NCT01048242|624328|P2|NOT COMPLETED|Overall Study||2
257589|NCT01048242|624329|P1|NOT COMPLETED|Overall Study||4
257590|NCT01048242|624328|P2|COMPLETED|Overall Study||13
257591|NCT01048242|624329|P1|COMPLETED|Overall Study||8
257592|NCT01048242|624328|P2|STARTED|Overall Study||15
257593|NCT01048242|624329|P1|STARTED|Overall Study||12
257594|NCT01048333|624335|P6|NOT COMPLETED|Treatment Period 3||0
257595|NCT01048333|624336|P5|NOT COMPLETED|Treatment Period 3||0
257596|NCT01048333|624337|P4|NOT COMPLETED|Treatment Period 3||0
257597|NCT01048333|624338|P3|NOT COMPLETED|Treatment Period 3||0
257598|NCT01048333|624339|P2|NOT COMPLETED|Treatment Period 3||0
257599|NCT01048333|624340|P1|NOT COMPLETED|Treatment Period 3||0
257600|NCT01048333|624335|P6|COMPLETED|Treatment Period 3||18
257601|NCT01048333|624336|P5|COMPLETED|Treatment Period 3||17
257602|NCT01048333|624337|P4|COMPLETED|Treatment Period 3||18
257603|NCT01048333|624338|P3|COMPLETED|Treatment Period 3||16
257604|NCT01048333|624339|P2|COMPLETED|Treatment Period 3||18
257605|NCT01048333|624340|P1|COMPLETED|Treatment Period 3||21
257606|NCT01048333|624335|P6|STARTED|Treatment Period 3||18
257607|NCT01048333|624336|P5|STARTED|Treatment Period 3||17
257608|NCT01048333|624337|P4|STARTED|Treatment Period 3||18
257609|NCT01048333|624338|P3|STARTED|Treatment Period 3||16
257610|NCT01048333|624339|P2|STARTED|Treatment Period 3||18
257611|NCT01048333|624340|P1|STARTED|Treatment Period 3||21
257612|NCT01048333|624335|P6|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
257613|NCT01048333|624336|P5|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
257614|NCT01048333|624337|P4|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
257615|NCT01048333|624338|P3|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
257616|NCT01048333|624339|P2|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||1
257617|NCT01048333|624340|P1|NOT COMPLETED|Wash-Out Period 2 of 2 - 7 Days||0
257618|NCT01048333|624335|P6|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
257619|NCT01048333|624336|P5|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||17
257620|NCT01048333|624337|P4|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
257621|NCT01048333|624338|P3|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||16
257622|NCT01048333|624339|P2|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||18
257623|NCT01048333|624340|P1|COMPLETED|Wash-Out Period 2 of 2 - 7 Days||21
257624|NCT01048333|624335|P6|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
257625|NCT01048333|624336|P5|STARTED|Wash-Out Period 2 of 2 - 7 Days||17
257626|NCT01048333|624337|P4|STARTED|Wash-Out Period 2 of 2 - 7 Days||18
257627|NCT01048333|624338|P3|STARTED|Wash-Out Period 2 of 2 - 7 Days||16
257628|NCT01048333|624339|P2|STARTED|Wash-Out Period 2 of 2 - 7 Days||19
257629|NCT01048333|624340|P1|STARTED|Wash-Out Period 2 of 2 - 7 Days||21
257630|NCT01048333|624335|P6|NOT COMPLETED|Treatment Period 2||0
257631|NCT01048333|624336|P5|NOT COMPLETED|Treatment Period 2||0
257632|NCT01048333|624337|P4|NOT COMPLETED|Treatment Period 2||0
257633|NCT01048333|624338|P3|NOT COMPLETED|Treatment Period 2||0
257634|NCT01048333|624339|P2|NOT COMPLETED|Treatment Period 2||0
257635|NCT01048333|624340|P1|NOT COMPLETED|Treatment Period 2||0
257636|NCT01048333|624335|P6|COMPLETED|Treatment Period 2||18
257637|NCT01048333|624336|P5|COMPLETED|Treatment Period 2||17
257638|NCT01048333|624337|P4|COMPLETED|Treatment Period 2||18
257639|NCT01048333|624338|P3|COMPLETED|Treatment Period 2||16
257640|NCT01048333|624339|P2|COMPLETED|Treatment Period 2||19
257641|NCT01048333|624340|P1|COMPLETED|Treatment Period 2||21
257642|NCT01048333|624335|P6|STARTED|Treatment Period 2||18
257643|NCT01048333|624336|P5|STARTED|Treatment Period 2||17
257644|NCT01048333|624337|P4|STARTED|Treatment Period 2||18
257645|NCT01048333|624338|P3|STARTED|Treatment Period 2||16
257646|NCT01048333|624339|P2|STARTED|Treatment Period 2||19
257647|NCT01048333|624340|P1|STARTED|Treatment Period 2||21
257648|NCT01048333|624335|P6|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
257649|NCT01048333|624336|P5|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
257650|NCT01048333|624337|P4|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
257651|NCT01048333|624338|P3|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
257652|NCT01048333|624339|P2|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
257653|NCT01048333|624340|P1|NOT COMPLETED|Wash-Out Period 1 of 2 - 7 Days||0
257654|NCT01048333|624335|P6|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
257655|NCT01048333|624336|P5|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||17
257656|NCT01048333|624337|P4|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||18
257657|NCT01048333|624338|P3|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||16
257659|NCT01048333|624340|P1|COMPLETED|Wash-Out Period 1 of 2 - 7 Days||21
257660|NCT01048333|624335|P6|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
257661|NCT01048333|624336|P5|STARTED|Wash-Out Period 1 of 2 - 7 Days||17
257662|NCT01048333|624337|P4|STARTED|Wash-Out Period 1 of 2 - 7 Days||18
257663|NCT01048333|624338|P3|STARTED|Wash-Out Period 1 of 2 - 7 Days||16
257664|NCT01048333|624339|P2|STARTED|Wash-Out Period 1 of 2 - 7 Days||19
257665|NCT01048333|624340|P1|STARTED|Wash-Out Period 1 of 2 - 7 Days||21
257666|NCT01048333|624335|P6|NOT COMPLETED|Treatment Period 1||0
257667|NCT01048333|624336|P5|NOT COMPLETED|Treatment Period 1||0
257668|NCT01048333|624337|P4|NOT COMPLETED|Treatment Period 1||0
257669|NCT01048333|624338|P3|NOT COMPLETED|Treatment Period 1||0
257670|NCT01048333|624339|P2|NOT COMPLETED|Treatment Period 1||0
257671|NCT01048333|624340|P1|NOT COMPLETED|Treatment Period 1||0
257672|NCT01048333|624335|P6|COMPLETED|Treatment Period 1||18
257673|NCT01048333|624336|P5|COMPLETED|Treatment Period 1||17
257674|NCT01048333|624337|P4|COMPLETED|Treatment Period 1||18
257675|NCT01048333|624338|P3|COMPLETED|Treatment Period 1||16
257676|NCT01048333|624339|P2|COMPLETED|Treatment Period 1||19
257677|NCT01048333|624340|P1|COMPLETED|Treatment Period 1||21
257678|NCT01048333|624335|P6|STARTED|Treatment Period 1||18
257679|NCT01048333|624336|P5|STARTED|Treatment Period 1||17
257680|NCT01048333|624337|P4|STARTED|Treatment Period 1||18
257681|NCT01048333|624338|P3|STARTED|Treatment Period 1||16
257682|NCT01048333|624339|P2|STARTED|Treatment Period 1||19
257683|NCT01048333|624340|P1|STARTED|Treatment Period 1||21
257684|NCT01048424|624362|P2|NOT COMPLETED|Overall Study||0
257685|NCT01048424|624363|P1|NOT COMPLETED|Overall Study||2
257686|NCT01048424|624362|P2|COMPLETED|Overall Study||10
257687|NCT01048424|624363|P1|COMPLETED|Overall Study||8
257688|NCT01048424|624362|P2|STARTED|Overall Study||10
257689|NCT01048424|624363|P1|STARTED|Overall Study||10
257690|NCT01048502|624389|P4|NOT COMPLETED|Overall Study||4
257691|NCT01048502|624390|P3|NOT COMPLETED|Overall Study||5
257692|NCT01048502|624391|P2|NOT COMPLETED|Overall Study||7
257693|NCT01048502|624392|P1|NOT COMPLETED|Overall Study||4
257694|NCT01048502|624389|P4|COMPLETED|Overall Study||21
257695|NCT01048502|624390|P3|COMPLETED|Overall Study||23
257696|NCT01048502|624391|P2|COMPLETED|Overall Study||16
257697|NCT01048502|624392|P1|COMPLETED|Overall Study||20
257698|NCT01048502|624389|P4|STARTED|Overall Study||25
257699|NCT01048502|624390|P3|STARTED|Overall Study||28
257700|NCT01048502|624391|P2|STARTED|Overall Study||23
257701|NCT01048502|624392|P1|STARTED|Overall Study||24
257702|NCT01048541|624403|P2|NOT COMPLETED|Overall Study||0
257703|NCT01048541|624404|P1|NOT COMPLETED|Overall Study||1
257704|NCT01048541|624403|P2|COMPLETED|Overall Study||19
257705|NCT01048541|624404|P1|COMPLETED|Overall Study||17
257706|NCT01048541|624403|P2|STARTED|Overall Study||19
257707|NCT01048541|624404|P1|STARTED|Overall Study||18
257708|NCT01048593|624413|P3|NOT COMPLETED|Overall Study||0
257709|NCT01048593|624414|P2|NOT COMPLETED|Overall Study||0
257710|NCT01048593|624415|P1|NOT COMPLETED|Overall Study||0
257711|NCT01048593|624413|P3|COMPLETED|Overall Study||1
257712|NCT01048593|624414|P2|COMPLETED|Overall Study||2
257713|NCT01048593|624415|P1|COMPLETED|Overall Study||3
257714|NCT01048593|624413|P3|STARTED|Overall Study||1
257715|NCT01048593|624414|P2|STARTED|Overall Study||2
257716|NCT01048593|624415|P1|STARTED|Overall Study||3
257717|NCT01048606|624427|P4|NOT COMPLETED|Overall Study||5
257718|NCT01048606|624428|P3|NOT COMPLETED|Overall Study||10
257719|NCT01048606|624429|P2|NOT COMPLETED|Overall Study||7
257720|NCT01048606|624430|P1|NOT COMPLETED|Overall Study||12
257721|NCT01048606|624427|P4|COMPLETED|Overall Study||5
257722|NCT01048606|624428|P3|COMPLETED|Overall Study||16
257723|NCT01048606|624429|P2|COMPLETED|Overall Study||8
257724|NCT01048606|624430|P1|COMPLETED|Overall Study||16
257725|NCT01048606|624427|P4|STARTED|Overall Study||10
257726|NCT01048606|624428|P3|STARTED|Overall Study||26
257727|NCT01048606|624429|P2|STARTED|Overall Study||15
257728|NCT01048606|624430|P1|STARTED|Overall Study||28
257729|NCT01048658|624442|P2|NOT COMPLETED|Overall Study||0
257730|NCT01048658|624443|P1|NOT COMPLETED|Overall Study||0
257731|NCT01048658|624442|P2|COMPLETED|Overall Study||80
257732|NCT01048658|624443|P1|COMPLETED|Overall Study||80
257733|NCT01048658|624442|P2|STARTED|Overall Study||80
257734|NCT01048658|624443|P1|STARTED|Overall Study||80
257735|NCT01048671|624460|P3|NOT COMPLETED|Overall Study||1
257736|NCT01048671|624461|P2|NOT COMPLETED|Overall Study||1
257737|NCT01048671|624462|P1|NOT COMPLETED|Overall Study||0
257738|NCT01048671|624460|P3|COMPLETED|Overall Study||151
257739|NCT01048671|624461|P2|COMPLETED|Overall Study||263
257740|NCT01048671|624462|P1|COMPLETED|Overall Study||66
257741|NCT01048671|624460|P3|STARTED|Overall Study||152
257742|NCT01048671|624461|P2|STARTED|Overall Study||264
257743|NCT01048671|624462|P1|STARTED|Overall Study||66
257744|NCT01048697|624483|P1|NOT COMPLETED|Overall Study||0
257745|NCT01048697|624483|P1|COMPLETED|Overall Study||18
257746|NCT01048697|624483|P1|STARTED|Overall Study||18
257747|NCT01048723|624487|P1|NOT COMPLETED|Overall Study||0
257748|NCT01048723|624487|P1|COMPLETED|Overall Study||2
257749|NCT01048723|624487|P1|STARTED|Overall Study||2
257750|NCT01048788|624497|P3|NOT COMPLETED|Overall Study||2
257751|NCT01048788|624498|P2|NOT COMPLETED|Overall Study||2
257752|NCT01048788|624499|P1|NOT COMPLETED|Overall Study||5
257753|NCT01048788|624497|P3|COMPLETED|Overall Study||11
257754|NCT01048788|624498|P2|COMPLETED|Overall Study||28
257755|NCT01048788|624499|P1|COMPLETED|Overall Study||3
257756|NCT01048788|624497|P3|STARTED|Overall Study||13
257757|NCT01048788|624498|P2|STARTED|Overall Study||30
257758|NCT01048788|624499|P1|STARTED|Overall Study||8
257759|NCT01048879|624510|P3|NOT COMPLETED|Overall Study||0
257760|NCT01048879|624511|P2|NOT COMPLETED|Overall Study||0
257761|NCT01048879|624512|P1|NOT COMPLETED|Overall Study||0
257762|NCT01048879|624510|P3|COMPLETED|Overall Study||5
257763|NCT01048879|624511|P2|COMPLETED|Overall Study||9
257764|NCT01048879|624512|P1|COMPLETED|Overall Study||1
257765|NCT01048879|624510|P3|STARTED|Overall Study||5
257766|NCT01048879|624511|P2|STARTED|Overall Study||9
257767|NCT01048879|624512|P1|STARTED|Overall Study||1
257768|NCT01048944|624527|P4|NOT COMPLETED|Overall Study||2
257769|NCT01048944|624528|P3|NOT COMPLETED|Overall Study||10
257770|NCT01048944|624529|P2|NOT COMPLETED|Overall Study||10
257771|NCT01048944|624530|P1|NOT COMPLETED|Overall Study||8
257772|NCT01048944|624527|P4|COMPLETED|Overall Study||19
257773|NCT01048944|624528|P3|COMPLETED|Overall Study||25
257774|NCT01048944|624529|P2|COMPLETED|Overall Study||28
257775|NCT01048944|624530|P1|COMPLETED|Overall Study||24
257776|NCT01048944|624527|P4|STARTED|Overall Study||21
257777|NCT01048944|624528|P3|STARTED|Overall Study||35
257778|NCT01048944|624529|P2|STARTED|Overall Study||38
257779|NCT01048944|624530|P1|STARTED|Overall Study||32
257780|NCT01049009|624546|P2|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
257781|NCT01049009|624547|P1|NOT COMPLETED|Treatment Period 2 (12 Weeks)||10
257782|NCT01049009|624546|P2|COMPLETED|Treatment Period 2 (12 Weeks)||8
257783|NCT01049009|624547|P1|COMPLETED|Treatment Period 2 (12 Weeks)||11
257784|NCT01049009|624546|P2|STARTED|Treatment Period 2 (12 Weeks)||18
257785|NCT01049009|624547|P1|STARTED|Treatment Period 2 (12 Weeks)||21
257786|NCT01049009|624546|P2|NOT COMPLETED|Treatment Period 1 (12 Weeks)||3
257787|NCT01049009|624547|P1|NOT COMPLETED|Treatment Period 1 (12 Weeks)||2
257788|NCT01049009|624546|P2|COMPLETED|Treatment Period 1 (12 Weeks)||18
257789|NCT01049009|624547|P1|COMPLETED|Treatment Period 1 (12 Weeks)||21
257790|NCT01049009|624546|P2|STARTED|Treatment Period 1 (12 Weeks)||21
257791|NCT01049009|624547|P1|STARTED|Treatment Period 1 (12 Weeks)||23
257792|NCT01049217|624557|P2|NOT COMPLETED|Overall Study||63
257793|NCT01049217|624558|P1|NOT COMPLETED|Overall Study||56
257794|NCT01049217|624557|P2|COMPLETED|Overall Study||131
257795|NCT01049217|624558|P1|COMPLETED|Overall Study||127
257796|NCT01049217|624557|P2|Treated|Overall Study||192
257797|NCT01049217|624558|P1|Treated|Overall Study||183
257798|NCT01049217|624557|P2|STARTED|Overall Study||194
257799|NCT01049217|624558|P1|STARTED|Overall Study||183
257800|NCT01049243|624628|P1|NOT COMPLETED|Overall Study||2
257801|NCT01049243|624628|P1|COMPLETED|Overall Study||18
257802|NCT01049243|624628|P1|STARTED|Overall Study||20
257803|NCT01049308|624632|P1|NOT COMPLETED|Pill Counts||83
257804|NCT01049308|624632|P1|COMPLETED|Pill Counts||168
257805|NCT01049308|624632|P1|STARTED|Pill Counts||251
257806|NCT01049308|624632|P1|NOT COMPLETED|Evaluation of Cognitive Impairment||0
257807|NCT01049308|624632|P1|COMPLETED|Evaluation of Cognitive Impairment||251
257808|NCT01049308|624632|P1|STARTED|Evaluation of Cognitive Impairment||251
257809|NCT01049360|624639|P20|NOT COMPLETED|Period 4||0
257810|NCT01049360|624640|P19|NOT COMPLETED|Period 4||0
257811|NCT01049360|624641|P18|NOT COMPLETED|Period 4||1
257812|NCT01049360|624642|P17|NOT COMPLETED|Period 4||0
257813|NCT01049360|624643|P16|NOT COMPLETED|Period 4||0
257814|NCT01049360|624644|P15|NOT COMPLETED|Period 4||0
257815|NCT01049360|624645|P14|NOT COMPLETED|Period 4||0
257816|NCT01049360|624646|P13|NOT COMPLETED|Period 4||0
257817|NCT01049360|624647|P12|NOT COMPLETED|Period 4||0
257818|NCT01049360|624648|P11|NOT COMPLETED|Period 4||0
257819|NCT01049360|624649|P10|NOT COMPLETED|Period 4||0
257820|NCT01049360|624650|P9|NOT COMPLETED|Period 4||0
257821|NCT01049360|624651|P8|NOT COMPLETED|Period 4||0
257822|NCT01049360|624652|P7|NOT COMPLETED|Period 4||0
257823|NCT01049360|624653|P6|NOT COMPLETED|Period 4||0
257824|NCT01049360|624654|P5|NOT COMPLETED|Period 4||0
257825|NCT01049360|624655|P4|NOT COMPLETED|Period 4||1
257826|NCT01049360|624656|P3|NOT COMPLETED|Period 4||0
257827|NCT01049360|624657|P2|NOT COMPLETED|Period 4||0
257828|NCT01049360|624658|P1|NOT COMPLETED|Period 4||0
257829|NCT01049360|624639|P20|COMPLETED|Period 4||5
257830|NCT01049360|624640|P19|COMPLETED|Period 4||5
257831|NCT01049360|624641|P18|COMPLETED|Period 4||5
257832|NCT01049360|624642|P17|COMPLETED|Period 4||5
257833|NCT01049360|624643|P16|COMPLETED|Period 4||6
257834|NCT01049360|624644|P15|COMPLETED|Period 4||5
257835|NCT01049360|624645|P14|COMPLETED|Period 4||6
257836|NCT01049360|624646|P13|COMPLETED|Period 4||4
257837|NCT01049360|624647|P12|COMPLETED|Period 4||6
257838|NCT01049360|624648|P11|COMPLETED|Period 4||5
257839|NCT01049360|624649|P10|COMPLETED|Period 4||6
257840|NCT01049360|624650|P9|COMPLETED|Period 4||4
257841|NCT01049360|624651|P8|COMPLETED|Period 4||4
257842|NCT01049360|624652|P7|COMPLETED|Period 4||6
257843|NCT01049360|624653|P6|COMPLETED|Period 4||5
257844|NCT01049360|624654|P5|COMPLETED|Period 4||7
257845|NCT01049360|624655|P4|COMPLETED|Period 4||3
257846|NCT01049360|624656|P3|COMPLETED|Period 4||7
257847|NCT01049360|624657|P2|COMPLETED|Period 4||4
257848|NCT01049360|624658|P1|COMPLETED|Period 4||6
257849|NCT01049360|624639|P20|STARTED|Period 4||5
257850|NCT01049360|624640|P19|STARTED|Period 4||5
257851|NCT01049360|624641|P18|STARTED|Period 4||6
257852|NCT01049360|624642|P17|STARTED|Period 4||5
257853|NCT01049360|624643|P16|STARTED|Period 4||6
257854|NCT01049360|624644|P15|STARTED|Period 4||5
257855|NCT01049360|624645|P14|STARTED|Period 4||6
257856|NCT01049360|624646|P13|STARTED|Period 4||4
257857|NCT01049360|624647|P12|STARTED|Period 4||6
257858|NCT01049360|624648|P11|STARTED|Period 4||5
257859|NCT01049360|624649|P10|STARTED|Period 4||6
257860|NCT01049360|624650|P9|STARTED|Period 4||4
257861|NCT01049360|624651|P8|STARTED|Period 4||4
257862|NCT01049360|624652|P7|STARTED|Period 4||6
257863|NCT01049360|624653|P6|STARTED|Period 4||5
257864|NCT01049360|624654|P5|STARTED|Period 4||7
257865|NCT01049360|624655|P4|STARTED|Period 4||4
257866|NCT01049360|624656|P3|STARTED|Period 4||7
257867|NCT01049360|624657|P2|STARTED|Period 4||4
257868|NCT01049360|624658|P1|STARTED|Period 4||6
257869|NCT01049360|624639|P20|NOT COMPLETED|Period 3||0
257870|NCT01049360|624640|P19|NOT COMPLETED|Period 3||0
257871|NCT01049360|624641|P18|NOT COMPLETED|Period 3||0
257872|NCT01049360|624642|P17|NOT COMPLETED|Period 3||0
257873|NCT01049360|624643|P16|NOT COMPLETED|Period 3||0
257874|NCT01049360|624644|P15|NOT COMPLETED|Period 3||0
257875|NCT01049360|624645|P14|NOT COMPLETED|Period 3||0
257876|NCT01049360|624646|P13|NOT COMPLETED|Period 3||0
257877|NCT01049360|624647|P12|NOT COMPLETED|Period 3||0
257878|NCT01049360|624648|P11|NOT COMPLETED|Period 3||0
257879|NCT01049360|624649|P10|NOT COMPLETED|Period 3||0
257880|NCT01049360|624650|P9|NOT COMPLETED|Period 3||0
257881|NCT01049360|624651|P8|NOT COMPLETED|Period 3||0
257882|NCT01049360|624652|P7|NOT COMPLETED|Period 3||0
257883|NCT01049360|624653|P6|NOT COMPLETED|Period 3||0
257884|NCT01049360|624654|P5|NOT COMPLETED|Period 3||0
257885|NCT01049360|624655|P4|NOT COMPLETED|Period 3||0
257886|NCT01049360|624656|P3|NOT COMPLETED|Period 3||0
257887|NCT01049360|624657|P2|NOT COMPLETED|Period 3||0
257888|NCT01049360|624658|P1|NOT COMPLETED|Period 3||0
257889|NCT01049360|624639|P20|COMPLETED|Period 3||5
257890|NCT01049360|624640|P19|COMPLETED|Period 3||5
257891|NCT01049360|624641|P18|COMPLETED|Period 3||6
257892|NCT01049360|624642|P17|COMPLETED|Period 3||5
257893|NCT01049360|624643|P16|COMPLETED|Period 3||6
257894|NCT01049360|624644|P15|COMPLETED|Period 3||5
257895|NCT01049360|624645|P14|COMPLETED|Period 3||6
257896|NCT01049360|624646|P13|COMPLETED|Period 3||4
257897|NCT01049360|624647|P12|COMPLETED|Period 3||6
257898|NCT01049360|624648|P11|COMPLETED|Period 3||5
257899|NCT01049360|624649|P10|COMPLETED|Period 3||6
257900|NCT01049360|624650|P9|COMPLETED|Period 3||4
257901|NCT01049360|624651|P8|COMPLETED|Period 3||4
257902|NCT01049360|624652|P7|COMPLETED|Period 3||6
257903|NCT01049360|624653|P6|COMPLETED|Period 3||5
257904|NCT01049360|624654|P5|COMPLETED|Period 3||7
257905|NCT01049360|624655|P4|COMPLETED|Period 3||4
257906|NCT01049360|624656|P3|COMPLETED|Period 3||7
257907|NCT01049360|624657|P2|COMPLETED|Period 3||4
257908|NCT01049360|624658|P1|COMPLETED|Period 3||6
257909|NCT01049360|624639|P20|STARTED|Period 3||5
257910|NCT01049360|624640|P19|STARTED|Period 3||5
257911|NCT01049360|624641|P18|STARTED|Period 3||6
257912|NCT01049360|624642|P17|STARTED|Period 3||5
257913|NCT01049360|624643|P16|STARTED|Period 3||6
257914|NCT01049360|624644|P15|STARTED|Period 3||5
257915|NCT01049360|624645|P14|STARTED|Period 3||6
257916|NCT01049360|624646|P13|STARTED|Period 3||4
257917|NCT01049360|624647|P12|STARTED|Period 3||6
257918|NCT01049360|624648|P11|STARTED|Period 3||5
257919|NCT01049360|624649|P10|STARTED|Period 3||6
257920|NCT01049360|624650|P9|STARTED|Period 3||4
257921|NCT01049360|624651|P8|STARTED|Period 3||4
257922|NCT01049360|624652|P7|STARTED|Period 3||6
257923|NCT01049360|624653|P6|STARTED|Period 3||5
257924|NCT01049360|624654|P5|STARTED|Period 3||7
257925|NCT01049360|624655|P4|STARTED|Period 3||4
257926|NCT01049360|624656|P3|STARTED|Period 3||7
257927|NCT01049360|624657|P2|STARTED|Period 3||4
257928|NCT01049360|624658|P1|STARTED|Period 3||6
257929|NCT01049360|624639|P20|NOT COMPLETED|Period 2||2
257930|NCT01049360|624640|P19|NOT COMPLETED|Period 2||0
257931|NCT01049360|624641|P18|NOT COMPLETED|Period 2||0
257932|NCT01049360|624642|P17|NOT COMPLETED|Period 2||0
257933|NCT01049360|624643|P16|NOT COMPLETED|Period 2||1
257934|NCT01049360|624644|P15|NOT COMPLETED|Period 2||2
257935|NCT01049360|624645|P14|NOT COMPLETED|Period 2||0
257936|NCT01049360|624646|P13|NOT COMPLETED|Period 2||0
257937|NCT01049360|624647|P12|NOT COMPLETED|Period 2||0
257938|NCT01049360|624648|P11|NOT COMPLETED|Period 2||0
257939|NCT01049360|624649|P10|NOT COMPLETED|Period 2||0
257940|NCT01049360|624650|P9|NOT COMPLETED|Period 2||1
257941|NCT01049360|624651|P8|NOT COMPLETED|Period 2||0
257942|NCT01049360|624652|P7|NOT COMPLETED|Period 2||0
257943|NCT01049360|624653|P6|NOT COMPLETED|Period 2||1
257944|NCT01049360|624654|P5|NOT COMPLETED|Period 2||0
257945|NCT01049360|624655|P4|NOT COMPLETED|Period 2||2
257946|NCT01049360|624656|P3|NOT COMPLETED|Period 2||0
257947|NCT01049360|624657|P2|NOT COMPLETED|Period 2||1
257948|NCT01049360|624658|P1|NOT COMPLETED|Period 2||0
257949|NCT01049360|624639|P20|COMPLETED|Period 2||5
257950|NCT01049360|624640|P19|COMPLETED|Period 2||5
257951|NCT01049360|624641|P18|COMPLETED|Period 2||6
257952|NCT01049360|624642|P17|COMPLETED|Period 2||5
257953|NCT01049360|624643|P16|COMPLETED|Period 2||6
257954|NCT01049360|624644|P15|COMPLETED|Period 2||5
257955|NCT01049360|624645|P14|COMPLETED|Period 2||6
257956|NCT01049360|624646|P13|COMPLETED|Period 2||4
257957|NCT01049360|624647|P12|COMPLETED|Period 2||6
257958|NCT01049360|624648|P11|COMPLETED|Period 2||5
257959|NCT01049360|624649|P10|COMPLETED|Period 2||6
257960|NCT01049360|624650|P9|COMPLETED|Period 2||4
257961|NCT01049360|624651|P8|COMPLETED|Period 2||4
257962|NCT01049360|624652|P7|COMPLETED|Period 2||6
257963|NCT01049360|624653|P6|COMPLETED|Period 2||5
257964|NCT01049360|624654|P5|COMPLETED|Period 2||7
257965|NCT01049360|624655|P4|COMPLETED|Period 2||4
257966|NCT01049360|624656|P3|COMPLETED|Period 2||7
257967|NCT01049360|624657|P2|COMPLETED|Period 2||4
257968|NCT01049360|624658|P1|COMPLETED|Period 2||6
257969|NCT01049360|624639|P20|STARTED|Period 2||7
257970|NCT01049360|624640|P19|STARTED|Period 2||5
257971|NCT01049360|624641|P18|STARTED|Period 2||6
257972|NCT01049360|624642|P17|STARTED|Period 2||5
257973|NCT01049360|624643|P16|STARTED|Period 2||7
257974|NCT01049360|624644|P15|STARTED|Period 2||7
257975|NCT01049360|624645|P14|STARTED|Period 2||6
257976|NCT01049360|624646|P13|STARTED|Period 2||4
257977|NCT01049360|624647|P12|STARTED|Period 2||6
257978|NCT01049360|624648|P11|STARTED|Period 2||5
257979|NCT01049360|624649|P10|STARTED|Period 2||6
257980|NCT01049360|624650|P9|STARTED|Period 2||5
257981|NCT01049360|624651|P8|STARTED|Period 2||4
257982|NCT01049360|624652|P7|STARTED|Period 2||6
257983|NCT01049360|624653|P6|STARTED|Period 2||6
257984|NCT01049360|624654|P5|STARTED|Period 2||7
257985|NCT01049360|624655|P4|STARTED|Period 2||6
257986|NCT01049360|624656|P3|STARTED|Period 2||7
257987|NCT01049360|624657|P2|STARTED|Period 2||5
257988|NCT01049360|624658|P1|STARTED|Period 2||6
257989|NCT01049360|624639|P20|NOT COMPLETED|Period 1||0
257990|NCT01049360|624640|P19|NOT COMPLETED|Period 1||1
257991|NCT01049360|624641|P18|NOT COMPLETED|Period 1||0
257992|NCT01049360|624642|P17|NOT COMPLETED|Period 1||1
257993|NCT01049360|624643|P16|NOT COMPLETED|Period 1||0
257994|NCT01049360|624644|P15|NOT COMPLETED|Period 1||0
257995|NCT01049360|624645|P14|NOT COMPLETED|Period 1||1
257996|NCT01049360|624646|P13|NOT COMPLETED|Period 1||2
257997|NCT01049360|624647|P12|NOT COMPLETED|Period 1||0
257998|NCT01049360|624648|P11|NOT COMPLETED|Period 1||1
257999|NCT01049360|624649|P10|NOT COMPLETED|Period 1||0
258000|NCT01049360|624650|P9|NOT COMPLETED|Period 1||2
258001|NCT01049360|624651|P8|NOT COMPLETED|Period 1||2
258002|NCT01049360|624652|P7|NOT COMPLETED|Period 1||0
258003|NCT01049360|624653|P6|NOT COMPLETED|Period 1||0
258004|NCT01049360|624654|P5|NOT COMPLETED|Period 1||0
258005|NCT01049360|624655|P4|NOT COMPLETED|Period 1||1
258006|NCT01049360|624656|P3|NOT COMPLETED|Period 1||0
258007|NCT01049360|624657|P2|NOT COMPLETED|Period 1||1
258008|NCT01049360|624658|P1|NOT COMPLETED|Period 1||0
258009|NCT01049360|624639|P20|COMPLETED|Period 1||7
258010|NCT01049360|624640|P19|COMPLETED|Period 1||5
258011|NCT01049360|624641|P18|COMPLETED|Period 1||6
258012|NCT01049360|624642|P17|COMPLETED|Period 1||5
258013|NCT01049360|624643|P16|COMPLETED|Period 1||7
258014|NCT01049360|624644|P15|COMPLETED|Period 1||7
258015|NCT01049360|624645|P14|COMPLETED|Period 1||6
258016|NCT01049360|624646|P13|COMPLETED|Period 1||4
258017|NCT01049360|624647|P12|COMPLETED|Period 1||6
258018|NCT01049360|624648|P11|COMPLETED|Period 1||5
258019|NCT01049360|624649|P10|COMPLETED|Period 1||6
258020|NCT01049360|624650|P9|COMPLETED|Period 1||5
258021|NCT01049360|624651|P8|COMPLETED|Period 1||4
258022|NCT01049360|624652|P7|COMPLETED|Period 1||6
258023|NCT01049360|624653|P6|COMPLETED|Period 1||6
258024|NCT01049360|624654|P5|COMPLETED|Period 1||7
258025|NCT01049360|624655|P4|COMPLETED|Period 1||6
258026|NCT01049360|624656|P3|COMPLETED|Period 1||7
258027|NCT01049360|624657|P2|COMPLETED|Period 1||5
258028|NCT01049360|624658|P1|COMPLETED|Period 1||6
258029|NCT01049360|624639|P20|STARTED|Period 1||7
258030|NCT01049360|624640|P19|STARTED|Period 1||6
258031|NCT01049360|624641|P18|STARTED|Period 1||6
258032|NCT01049360|624642|P17|STARTED|Period 1||6
258033|NCT01049360|624643|P16|STARTED|Period 1||7
258034|NCT01049360|624644|P15|STARTED|Period 1||7
258035|NCT01049360|624645|P14|STARTED|Period 1||7
258036|NCT01049360|624646|P13|STARTED|Period 1||6
258037|NCT01049360|624647|P12|STARTED|Period 1||6
258038|NCT01049360|624648|P11|STARTED|Period 1||6
258039|NCT01049360|624649|P10|STARTED|Period 1||6
258040|NCT01049360|624650|P9|STARTED|Period 1||7
258041|NCT01049360|624651|P8|STARTED|Period 1||6
258042|NCT01049360|624652|P7|STARTED|Period 1||6
258043|NCT01049360|624653|P6|STARTED|Period 1||6
258044|NCT01049360|624654|P5|STARTED|Period 1||7
258045|NCT01049360|624655|P4|STARTED|Period 1||7
258046|NCT01049360|624656|P3|STARTED|Period 1||7
258047|NCT01049360|624657|P2|STARTED|Period 1||6
258048|NCT01049360|624658|P1|STARTED|Period 1||6
258049|NCT01049373|624682|P2|NOT COMPLETED|Overall Study||44
258050|NCT01049373|624683|P1|NOT COMPLETED|Overall Study||39
258051|NCT01049373|624682|P2|COMPLETED|Overall Study||65
258052|NCT01049373|624683|P1|COMPLETED|Overall Study||73
258053|NCT01049373|624682|P2|STARTED|Overall Study||109
258054|NCT01049373|624683|P1|STARTED|Overall Study||112
258055|NCT01049503|624703|P6|NOT COMPLETED|Overall Study||8
258056|NCT01049503|624704|P5|NOT COMPLETED|Overall Study||27
258057|NCT01049503|624705|P4|NOT COMPLETED|Overall Study||26
258058|NCT01049503|624706|P3|NOT COMPLETED|Overall Study||24
258059|NCT01049503|624707|P2|NOT COMPLETED|Overall Study||12
258060|NCT01049503|624708|P1|NOT COMPLETED|Overall Study||11
258061|NCT01049503|624703|P6|COMPLETED|Overall Study||40
258062|NCT01049503|624704|P5|COMPLETED|Overall Study||29
258063|NCT01049503|624705|P4|COMPLETED|Overall Study||29
258064|NCT01049503|624706|P3|COMPLETED|Overall Study||32
258065|NCT01049503|624707|P2|COMPLETED|Overall Study||36
258066|NCT01049503|624708|P1|COMPLETED|Overall Study||41
258067|NCT01049503|624703|P6|STARTED|Overall Study||48
258068|NCT01049503|624704|P5|STARTED|Overall Study||56
258069|NCT01049503|624705|P4|STARTED|Overall Study||55
258070|NCT01049503|624706|P3|STARTED|Overall Study||56
258071|NCT01049503|624707|P2|STARTED|Overall Study||48
258072|NCT01049503|624708|P1|STARTED|Overall Study||52
258073|NCT01049581|624739|P2|NOT COMPLETED|Overall Study||1
258074|NCT01049581|624740|P1|NOT COMPLETED|Overall Study||2
258075|NCT01049581|624739|P2|COMPLETED|Overall Study||13
258076|NCT01049581|624740|P1|COMPLETED|Overall Study||11
258077|NCT01049581|624739|P2|STARTED|Overall Study||14
258078|NCT01049581|624740|P1|STARTED|Overall Study||13
258079|NCT01049776|624749|P1|NOT COMPLETED|Overall Study||20
258080|NCT01049776|624749|P1|COMPLETED|Overall Study||12
258081|NCT01049776|624749|P1|STARTED|Overall Study||32
258082|NCT01049802|624755|P2|NOT COMPLETED|Overall Study||0
258083|NCT01049802|624756|P1|NOT COMPLETED|Overall Study||0
258084|NCT01049802|624755|P2|COMPLETED|Overall Study||10
258085|NCT01049802|624756|P1|COMPLETED|Overall Study||20
258086|NCT01049802|624755|P2|STARTED|Overall Study||10
258087|NCT01049802|624756|P1|STARTED|Overall Study||20
258088|NCT01049945|624772|P6|NOT COMPLETED|Overall Study||0
258089|NCT01049945|624773|P5|NOT COMPLETED|Overall Study||0
258090|NCT01049945|624774|P4|NOT COMPLETED|Overall Study||0
258091|NCT01049945|624775|P3|NOT COMPLETED|Overall Study||0
258092|NCT01049945|624776|P2|NOT COMPLETED|Overall Study||0
258093|NCT01049945|624777|P1|NOT COMPLETED|Overall Study||0
258094|NCT01049945|624772|P6|COMPLETED|Overall Study||49
258095|NCT01049945|624773|P5|COMPLETED|Overall Study||3
258096|NCT01049945|624774|P4|COMPLETED|Overall Study||6
258097|NCT01049945|624775|P3|COMPLETED|Overall Study||3
258098|NCT01049945|624776|P2|COMPLETED|Overall Study||6
258099|NCT01049945|624777|P1|COMPLETED|Overall Study||3
258100|NCT01049945|624772|P6|STARTED|Overall Study||49
258101|NCT01049945|624773|P5|STARTED|Overall Study||3
258102|NCT01049945|624774|P4|STARTED|Overall Study||6
258103|NCT01049945|624775|P3|STARTED|Overall Study||3
258104|NCT01049945|624776|P2|STARTED|Overall Study||6
258105|NCT01049945|624777|P1|STARTED|Overall Study||3
258106|NCT01055704|624795|P4|NOT COMPLETED|Overall Study||0
258107|NCT01055704|624796|P3|NOT COMPLETED|Overall Study||0
258108|NCT01055704|624797|P2|NOT COMPLETED|Overall Study||0
258109|NCT01055704|624798|P1|NOT COMPLETED|Overall Study||0
258110|NCT01055704|624795|P4|COMPLETED|Overall Study||8
258111|NCT01055704|624796|P3|COMPLETED|Overall Study||16
258112|NCT01055704|624797|P2|COMPLETED|Overall Study||8
258113|NCT01055704|624798|P1|COMPLETED|Overall Study||16
258114|NCT01055704|624795|P4|STARTED|Overall Study||8
258115|NCT01055704|624796|P3|STARTED|Overall Study||16
258116|NCT01055704|624797|P2|STARTED|Overall Study||8
258117|NCT01055704|624798|P1|STARTED|Overall Study||16
258118|NCT01055769|624836|P2|NOT COMPLETED|Second Intervention||0
258119|NCT01055769|624837|P1|NOT COMPLETED|Second Intervention||0
258120|NCT01055769|624836|P2|COMPLETED|Second Intervention||10
258121|NCT01055769|624837|P1|COMPLETED|Second Intervention||10
258122|NCT01055769|624836|P2|STARTED|Second Intervention||10
258123|NCT01055769|624837|P1|STARTED|Second Intervention||10
258124|NCT01055769|624836|P2|NOT COMPLETED|Washout Period of Atleast 4 Days||0
258125|NCT01055769|624837|P1|NOT COMPLETED|Washout Period of Atleast 4 Days||0
258126|NCT01055769|624836|P2|COMPLETED|Washout Period of Atleast 4 Days||10
258127|NCT01055769|624837|P1|COMPLETED|Washout Period of Atleast 4 Days||10
258128|NCT01055769|624836|P2|STARTED|Washout Period of Atleast 4 Days||10
258129|NCT01055769|624837|P1|STARTED|Washout Period of Atleast 4 Days||10
258130|NCT01055769|624836|P2|NOT COMPLETED|First Intervention||0
258131|NCT01055769|624837|P1|NOT COMPLETED|First Intervention||0
258132|NCT01055769|624836|P2|COMPLETED|First Intervention||10
258133|NCT01055769|624837|P1|COMPLETED|First Intervention||10
258134|NCT01055769|624836|P2|STARTED|First Intervention||10
258135|NCT01055769|624837|P1|STARTED|First Intervention||10
258136|NCT01055782|624853|P2|NOT COMPLETED|Overall Study||0
258137|NCT01055782|624854|P1|NOT COMPLETED|Overall Study||0
258138|NCT01055782|624853|P2|COMPLETED|Overall Study||449
258139|NCT01055782|624854|P1|COMPLETED|Overall Study||555
258140|NCT01055782|624853|P2|STARTED|Overall Study||449
258141|NCT01055782|624854|P1|STARTED|Overall Study||555
258142|NCT01055834|624864|P2|NOT COMPLETED|Treatment Period III||0
258143|NCT01055834|624865|P1|NOT COMPLETED|Treatment Period III||0
258144|NCT01055834|624864|P2|COMPLETED|Treatment Period III||14
258145|NCT01055834|624865|P1|COMPLETED|Treatment Period III||0
258146|NCT01055834|624864|P2|STARTED|Treatment Period III|14 of 21 participants in Group B who were treated in Period II participated in Period III.|14
258147|NCT01055834|624865|P1|STARTED|Treatment Period III|Participants from Group A did not continue into Period III.|0
258148|NCT01055834|624864|P2|NOT COMPLETED|Treatment Period II||0
258149|NCT01055834|624865|P1|NOT COMPLETED|Treatment Period II||0
258150|NCT01055834|624864|P2|COMPLETED|Treatment Period II||21
258151|NCT01055834|624865|P1|COMPLETED|Treatment Period II||20
258152|NCT01055834|624864|P2|STARTED|Treatment Period II||21
258153|NCT01055834|624865|P1|STARTED|Treatment Period II||20
258154|NCT01055834|624864|P2|NOT COMPLETED|Treatment Period I||0
258155|NCT01055834|624865|P1|NOT COMPLETED|Treatment Period I||1
258156|NCT01055834|624864|P2|COMPLETED|Treatment Period I||21
258157|NCT01055834|624865|P1|COMPLETED|Treatment Period I||20
258158|NCT01055834|624864|P2|STARTED|Treatment Period I||21
258159|NCT01055834|624865|P1|STARTED|Treatment Period I||21
258160|NCT01055886|624879|P2|NOT COMPLETED|Overall Study||11
258161|NCT01055886|624880|P1|NOT COMPLETED|Overall Study||5
258162|NCT01055886|624879|P2|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|21
258163|NCT01055886|624880|P1|COMPLETED|Overall Study|This includes those who completed all sessions and those with w/d post quit (missing = smoking).|28
258164|NCT01055886|624879|P2|Reached Pre-quit Period|Overall Study|1 lost to contact|31
258165|NCT01055886|624880|P1|Reached Pre-quit Period|Overall Study|2 withdrawals, 1 lost to contact|30
258166|NCT01055886|624879|P2|STARTED|Overall Study||32
258167|NCT01055886|624880|P1|STARTED|Overall Study||33
258168|NCT01056107|624894|P4|NOT COMPLETED|Overall Study||0
258169|NCT01056107|624895|P3|NOT COMPLETED|Overall Study||3
258170|NCT01056107|624896|P2|NOT COMPLETED|Overall Study||1
258171|NCT01056107|624897|P1|NOT COMPLETED|Overall Study||0
258172|NCT01056107|624894|P4|COMPLETED|Overall Study||12
258173|NCT01056107|624895|P3|COMPLETED|Overall Study||9
258174|NCT01056107|624896|P2|COMPLETED|Overall Study||10
258175|NCT01056107|624897|P1|COMPLETED|Overall Study||11
258176|NCT01056107|624894|P4|STARTED|Overall Study||12
258177|NCT01056107|624895|P3|STARTED|Overall Study||12
258178|NCT01056107|624896|P2|STARTED|Overall Study||11
258179|NCT01056107|624897|P1|STARTED|Overall Study||11
258180|NCT01056198|624945|P2|NOT COMPLETED|Overall Study||0
258181|NCT01056198|624946|P1|NOT COMPLETED|Overall Study||0
258182|NCT01056198|624945|P2|COMPLETED|Overall Study||24
258183|NCT01056198|624946|P1|COMPLETED|Overall Study||24
258184|NCT01056198|624945|P2|STARTED|Overall Study||24
258185|NCT01056198|624946|P1|STARTED|Overall Study||24
258186|NCT01056263|624958|P1|NOT COMPLETED|Overall Study||52
258187|NCT01056263|624958|P1|COMPLETED|Overall Study||0
258188|NCT01056263|624958|P1|STARTED|Overall Study||52
258189|NCT01056276|624964|P2|NOT COMPLETED|Maintenance Therapy||28
258190|NCT01056276|624965|P1|NOT COMPLETED|Maintenance Therapy||0
258191|NCT01056276|624964|P2|COMPLETED|Maintenance Therapy|14 patients are continuing maintenance therapy.|0
258192|NCT01056276|624965|P1|COMPLETED|Maintenance Therapy||0
258193|NCT01056276|624964|P2|STARTED|Maintenance Therapy|5 patients completed 8 cycles but did not have maintenance therapy.|28
258194|NCT01056276|624965|P1|STARTED|Maintenance Therapy|Original regimen did not include maintenance therapy.|0
258195|NCT01056276|624964|P2|NOT COMPLETED|Treatment Period-Cycles 1-8||8
258196|NCT01056276|624965|P1|NOT COMPLETED|Treatment Period-Cycles 1-8||13
258197|NCT01056276|624964|P2|COMPLETED|Treatment Period-Cycles 1-8||33
258198|NCT01056276|624965|P1|COMPLETED|Treatment Period-Cycles 1-8||5
258199|NCT01056276|624964|P2|STARTED|Treatment Period-Cycles 1-8||41
258200|NCT01056276|624965|P1|STARTED|Treatment Period-Cycles 1-8||18
258201|NCT01056289|624979|P4|NOT COMPLETED|Double-blind Phase||10
258202|NCT01056289|624980|P3|NOT COMPLETED|Double-blind Phase||13
258203|NCT01056289|624981|P2|NOT COMPLETED|Double-blind Phase||4
258204|NCT01056289|624982|P1|NOT COMPLETED|Double-blind Phase||0
258205|NCT01056289|624979|P4|COMPLETED|Double-blind Phase||138
258206|NCT01056289|624980|P3|COMPLETED|Double-blind Phase||127
258207|NCT01056289|624981|P2|COMPLETED|Double-blind Phase||69
258208|NCT01056289|624982|P1|COMPLETED|Double-blind Phase||0
258209|NCT01056289|624979|P4|STARTED|Double-blind Phase||148
258210|NCT01056289|624980|P3|STARTED|Double-blind Phase||140
258211|NCT01056289|624981|P2|STARTED|Double-blind Phase||73
258212|NCT01056289|624982|P1|STARTED|Double-blind Phase||0
258213|NCT01056289|624979|P4|NOT COMPLETED|Open-label Phase||0
258214|NCT01056289|624980|P3|NOT COMPLETED|Open-label Phase||0
258215|NCT01056289|624981|P2|NOT COMPLETED|Open-label Phase||0
258216|NCT01056289|624982|P1|NOT COMPLETED|Open-label Phase||119
258217|NCT01056289|624979|P4|COMPLETED|Open-label Phase||0
258218|NCT01056289|624980|P3|COMPLETED|Open-label Phase||0
258219|NCT01056289|624981|P2|COMPLETED|Open-label Phase||0
258220|NCT01056289|624982|P1|COMPLETED|Open-label Phase|Participants transitioned to Double-blind phase|361
258221|NCT01056289|624979|P4|STARTED|Open-label Phase||0
258222|NCT01056289|624980|P3|STARTED|Open-label Phase||0
258223|NCT01056289|624981|P2|STARTED|Open-label Phase||0
258224|NCT01056289|624982|P1|STARTED|Open-label Phase||480
258225|NCT01056315|624999|P2|NOT COMPLETED|Overall Study||11
258226|NCT01056315|625000|P1|NOT COMPLETED|Overall Study||14
258227|NCT01056315|624999|P2|COMPLETED|Overall Study||12
258228|NCT01056315|625000|P1|COMPLETED|Overall Study||13
258229|NCT01056315|624999|P2|STARTED|Overall Study||23
258230|NCT01056315|625000|P1|STARTED|Overall Study||27
258231|NCT01056328|625036|P2|NOT COMPLETED|Overall Study||16
258232|NCT01056328|625037|P1|NOT COMPLETED|Overall Study||17
258233|NCT01056328|625036|P2|COMPLETED|Overall Study||144
258234|NCT01056328|625037|P1|COMPLETED|Overall Study||147
258235|NCT01056328|625036|P2|STARTED|Overall Study||160
258236|NCT01056328|625037|P1|STARTED|Overall Study||164
258237|NCT01056341|625056|P5|NOT COMPLETED|Overall Study||14
258238|NCT01056341|625057|P4|NOT COMPLETED|Overall Study||36
258239|NCT01056341|625058|P3|NOT COMPLETED|Overall Study||15
258240|NCT01056341|625059|P2|NOT COMPLETED|Overall Study||36
258241|NCT01056341|625060|P1|NOT COMPLETED|Overall Study||36
258242|NCT01056341|625056|P5|COMPLETED|Overall Study||88
258243|NCT01056341|625057|P4|COMPLETED|Overall Study||65
258244|NCT01056341|625058|P3|COMPLETED|Overall Study||88
258245|NCT01056341|625059|P2|COMPLETED|Overall Study||63
258246|NCT01056341|625060|P1|COMPLETED|Overall Study||19
258247|NCT01056341|625056|P5|Interim Analysis|Overall Study||43
258248|NCT01056341|625057|P4|Interim Analysis|Overall Study||40
258249|NCT01056341|625058|P3|Interim Analysis|Overall Study||41
258250|NCT01056341|625059|P2|Interim Analysis|Overall Study||41
258251|NCT01056341|625060|P1|Interim Analysis|Overall Study||25
258252|NCT01056341|625056|P5|STARTED|Overall Study||102
258253|NCT01056341|625057|P4|STARTED|Overall Study||101
258254|NCT01056341|625058|P3|STARTED|Overall Study||103
258255|NCT01056341|625059|P2|STARTED|Overall Study||99
258256|NCT01056341|625060|P1|STARTED|Overall Study||55
258257|NCT01056380|625081|P2|NOT COMPLETED|Overall Study||3
258258|NCT01056380|625082|P1|NOT COMPLETED|Overall Study||2
258259|NCT01056380|625081|P2|COMPLETED|Overall Study||39
258260|NCT01056380|625082|P1|COMPLETED|Overall Study||35
258261|NCT01056380|625081|P2|STARTED|Overall Study||42
258262|NCT01056380|625082|P1|STARTED|Overall Study||37
258263|NCT01056484|625106|P2|NOT COMPLETED|Follow up - Non-randomized||2
258264|NCT01056484|625107|P1|NOT COMPLETED|Follow up - Non-randomized||0
258265|NCT01056484|625106|P2|COMPLETED|Follow up - Non-randomized||56
258266|NCT01056484|625107|P1|COMPLETED|Follow up - Non-randomized||57
258267|NCT01056484|625106|P2|STARTED|Follow up - Non-randomized|Out of the enrolled control subjects (N=59), 58 completed Period 1 and entered into Period 2.|58
258268|NCT01056484|625107|P1|STARTED|Follow up - Non-randomized|Out of the enrolled experimental subjects (N=64), 57 completed Period 1 and entered into Period 2.|57
258269|NCT01056484|625106|P2|NOT COMPLETED|Randomized Controlled Trial||1
258270|NCT01056484|625107|P1|NOT COMPLETED|Randomized Controlled Trial||7
258271|NCT01056484|625106|P2|COMPLETED|Randomized Controlled Trial||58
258272|NCT01056484|625107|P1|COMPLETED|Randomized Controlled Trial||57
258273|NCT01056484|625106|P2|STARTED|Randomized Controlled Trial||59
258274|NCT01056484|625107|P1|STARTED|Randomized Controlled Trial||64
258275|NCT01056510|625123|P2|NOT COMPLETED|Overall Study||64
258276|NCT01056510|625124|P1|NOT COMPLETED|Overall Study||54
258277|NCT01056510|625123|P2|COMPLETED|Overall Study||115
258278|NCT01056510|625124|P1|COMPLETED|Overall Study||124
258279|NCT01056510|625123|P2|STARTED|Overall Study||179
258280|NCT01056510|625124|P1|STARTED|Overall Study||178
258281|NCT01056523|625168|P7|NOT COMPLETED|Overall Study||1
258282|NCT01056523|625169|P6|NOT COMPLETED|Overall Study||0
258283|NCT01056523|625170|P5|NOT COMPLETED|Overall Study||0
258284|NCT01056523|625171|P4|NOT COMPLETED|Overall Study||3
258285|NCT01056523|625172|P3|NOT COMPLETED|Overall Study||2
258286|NCT01056523|625173|P2|NOT COMPLETED|Overall Study||0
258287|NCT01056523|625174|P1|NOT COMPLETED|Overall Study||1
258288|NCT01056523|625168|P7|COMPLETED|Overall Study||4
258289|NCT01056523|625169|P6|COMPLETED|Overall Study||3
258290|NCT01056523|625170|P5|COMPLETED|Overall Study||3
258291|NCT01056523|625171|P4|COMPLETED|Overall Study||3
258292|NCT01056523|625172|P3|COMPLETED|Overall Study||3
258293|NCT01056523|625173|P2|COMPLETED|Overall Study||3
258294|NCT01056523|625174|P1|COMPLETED|Overall Study||3
258295|NCT01056523|625168|P7|STARTED|Overall Study||5
258296|NCT01056523|625169|P6|STARTED|Overall Study||3
258297|NCT01056523|625170|P5|STARTED|Overall Study||3
258298|NCT01056523|625171|P4|STARTED|Overall Study||6
258299|NCT01056523|625172|P3|STARTED|Overall Study||5
258300|NCT01056523|625173|P2|STARTED|Overall Study||3
258301|NCT01056523|625174|P1|STARTED|Overall Study||4
258302|NCT01056601|625182|P1|NOT COMPLETED|Overall Study||0
258303|NCT01056601|625182|P1|COMPLETED|Overall Study||7
258304|NCT01056601|625182|P1|STARTED|Overall Study||7
258305|NCT01056640|625190|P2|NOT COMPLETED|Overall Study||12
258306|NCT01056640|625191|P1|NOT COMPLETED|Overall Study||26
258307|NCT01056640|625190|P2|COMPLETED|Overall Study||91
258308|NCT01056640|625191|P1|COMPLETED|Overall Study||76
258309|NCT01056640|625190|P2|STARTED|Overall Study||103
258310|NCT01056640|625191|P1|STARTED|Overall Study||102
258311|NCT01056653|625200|P3|NOT COMPLETED|Overall Study||2
258312|NCT01056653|625201|P2|NOT COMPLETED|Overall Study||0
258313|NCT01056653|625202|P1|NOT COMPLETED|Overall Study||0
258314|NCT01056653|625200|P3|COMPLETED|Overall Study|2 were lost to follow-up because one mother left the country and one father was too busy.|42
258315|NCT01056653|625201|P2|COMPLETED|Overall Study||23
258316|NCT01056653|625202|P1|COMPLETED|Overall Study||46
258317|NCT01056653|625200|P3|STARTED|Overall Study||44
258318|NCT01056653|625201|P2|STARTED|Overall Study||23
258319|NCT01056653|625202|P1|STARTED|Overall Study||46
258320|NCT01056718|625216|P1|NOT COMPLETED|Overall Study||3
258321|NCT01056718|625216|P1|COMPLETED|Overall Study||50
258322|NCT01056718|625216|P1|STARTED|Overall Study||53
258323|NCT01056822|625248|P2|NOT COMPLETED|Overall Study||7
258324|NCT01056822|625249|P1|NOT COMPLETED|Overall Study||8
258325|NCT01056822|625248|P2|COMPLETED|Overall Study||35
258326|NCT01056822|625249|P1|COMPLETED|Overall Study||39
258327|NCT01056822|625248|P2|Safety (SAF) Population: NO|Overall Study||2
258328|NCT01056822|625249|P1|Safety (SAF) Population: NO|Overall Study||1
258329|NCT01056822|625248|P2|Safety (SAF) Population: YES|Overall Study||40
258330|NCT01056822|625249|P1|Safety (SAF) Population: YES|Overall Study||46
258331|NCT01056822|625248|P2|Per-protocol (PP) Population: NO|Overall Study||17
258332|NCT01056822|625249|P1|Per-protocol (PP) Population: NO|Overall Study||18
258333|NCT01056822|625248|P2|Per-protocol (PP) Population: YES|Overall Study||25
258334|NCT01056822|625249|P1|Per-protocol (PP) Population: YES|Overall Study||29
258335|NCT01056822|625248|P2|Intention-to-treat (ITT) Population: NO|Overall Study||4
258336|NCT01056822|625249|P1|Intention-to-treat (ITT) Population: NO|Overall Study||4
258337|NCT01056822|625248|P2|Intention-to-treat (ITT) Population: YES|Overall Study||38
258338|NCT01056822|625249|P1|Intention-to-treat (ITT) Population: YES|Overall Study||43
258339|NCT01056822|625248|P2|STARTED|Overall Study||42
258340|NCT01056822|625249|P1|STARTED|Overall Study||47
258341|NCT01056913|625298|P1|NOT COMPLETED|Overall Study||0
258342|NCT01056913|625298|P1|COMPLETED|Overall Study||62
258343|NCT01056913|625298|P1|STARTED|Overall Study||62
258344|NCT01057017|625302|P1|NOT COMPLETED|Overall Study||0
258345|NCT01057017|625302|P1|COMPLETED|Overall Study||5
258346|NCT01057017|625302|P1|STARTED|Overall Study||5
258347|NCT01057121|625308|P5|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258348|NCT01057121|625309|P4|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258349|NCT01057121|625310|P3|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258350|NCT01057121|625311|P2|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258351|NCT01057121|625312|P1|NOT COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258352|NCT01057121|625308|P5|COMPLETED|Phase II: 25 mg/Day Lenalidomide||23
258353|NCT01057121|625309|P4|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258354|NCT01057121|625310|P3|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258355|NCT01057121|625311|P2|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258356|NCT01057121|625312|P1|COMPLETED|Phase II: 25 mg/Day Lenalidomide||0
258357|NCT01057121|625308|P5|STARTED|Phase II: 25 mg/Day Lenalidomide||23
258358|NCT01057121|625309|P4|STARTED|Phase II: 25 mg/Day Lenalidomide||0
258359|NCT01057121|625310|P3|STARTED|Phase II: 25 mg/Day Lenalidomide||0
258360|NCT01057121|625311|P2|STARTED|Phase II: 25 mg/Day Lenalidomide||0
258361|NCT01057121|625312|P1|STARTED|Phase II: 25 mg/Day Lenalidomide||0
258362|NCT01057121|625308|P5|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258363|NCT01057121|625309|P4|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258364|NCT01057121|625310|P3|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258365|NCT01057121|625311|P2|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258366|NCT01057121|625312|P1|NOT COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258367|NCT01057121|625308|P5|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258368|NCT01057121|625309|P4|COMPLETED|Phase I: 25 mg/Day Lenalidomide||6
258369|NCT01057121|625310|P3|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258370|NCT01057121|625311|P2|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258371|NCT01057121|625312|P1|COMPLETED|Phase I: 25 mg/Day Lenalidomide||0
258372|NCT01057121|625308|P5|STARTED|Phase I: 25 mg/Day Lenalidomide||0
258373|NCT01057121|625309|P4|STARTED|Phase I: 25 mg/Day Lenalidomide||6
258374|NCT01057121|625310|P3|STARTED|Phase I: 25 mg/Day Lenalidomide||0
258375|NCT01057121|625311|P2|STARTED|Phase I: 25 mg/Day Lenalidomide||0
258376|NCT01057121|625312|P1|STARTED|Phase I: 25 mg/Day Lenalidomide||0
258377|NCT01057121|625308|P5|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258378|NCT01057121|625309|P4|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258379|NCT01057121|625310|P3|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258380|NCT01057121|625311|P2|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258381|NCT01057121|625312|P1|NOT COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258382|NCT01057121|625308|P5|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258383|NCT01057121|625309|P4|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258384|NCT01057121|625310|P3|COMPLETED|Phase I: 20 mg/Day Lenalidomide||3
258385|NCT01057121|625311|P2|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258386|NCT01057121|625312|P1|COMPLETED|Phase I: 20 mg/Day Lenalidomide||0
258387|NCT01057121|625308|P5|STARTED|Phase I: 20 mg/Day Lenalidomide||0
258388|NCT01057121|625309|P4|STARTED|Phase I: 20 mg/Day Lenalidomide||0
258389|NCT01057121|625310|P3|STARTED|Phase I: 20 mg/Day Lenalidomide||3
258390|NCT01057121|625311|P2|STARTED|Phase I: 20 mg/Day Lenalidomide||0
258391|NCT01057121|625312|P1|STARTED|Phase I: 20 mg/Day Lenalidomide||0
258392|NCT01057121|625308|P5|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258393|NCT01057121|625309|P4|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258394|NCT01057121|625310|P3|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258395|NCT01057121|625311|P2|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258396|NCT01057121|625312|P1|NOT COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258397|NCT01057121|625308|P5|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258398|NCT01057121|625309|P4|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258399|NCT01057121|625310|P3|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258400|NCT01057121|625311|P2|COMPLETED|Phase I: 15 mg/Day Lenolidomide||3
258401|NCT01057121|625312|P1|COMPLETED|Phase I: 15 mg/Day Lenolidomide||0
258402|NCT01057121|625308|P5|STARTED|Phase I: 15 mg/Day Lenolidomide||0
258403|NCT01057121|625309|P4|STARTED|Phase I: 15 mg/Day Lenolidomide||0
258404|NCT01057121|625310|P3|STARTED|Phase I: 15 mg/Day Lenolidomide||0
258405|NCT01057121|625311|P2|STARTED|Phase I: 15 mg/Day Lenolidomide||3
258406|NCT01057121|625312|P1|STARTED|Phase I: 15 mg/Day Lenolidomide||0
258407|NCT01057121|625308|P5|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258408|NCT01057121|625309|P4|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258409|NCT01057121|625310|P3|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258410|NCT01057121|625311|P2|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258411|NCT01057121|625312|P1|NOT COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258412|NCT01057121|625308|P5|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258413|NCT01057121|625309|P4|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258414|NCT01057121|625310|P3|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258415|NCT01057121|625311|P2|COMPLETED|Phase I: 10 mg/Day Lenalidomide||0
258416|NCT01057121|625312|P1|COMPLETED|Phase I: 10 mg/Day Lenalidomide||3
258417|NCT01057121|625308|P5|STARTED|Phase I: 10 mg/Day Lenalidomide||0
258418|NCT01057121|625309|P4|STARTED|Phase I: 10 mg/Day Lenalidomide||0
258419|NCT01057121|625310|P3|STARTED|Phase I: 10 mg/Day Lenalidomide||0
258420|NCT01057121|625311|P2|STARTED|Phase I: 10 mg/Day Lenalidomide||0
258421|NCT01057121|625312|P1|STARTED|Phase I: 10 mg/Day Lenalidomide||3
258422|NCT01057225|625341|P6|NOT COMPLETED|Overall Study||0
258423|NCT01057225|625342|P5|NOT COMPLETED|Overall Study||0
258424|NCT01057225|625343|P4|NOT COMPLETED|Overall Study||0
258425|NCT01057225|625344|P3|NOT COMPLETED|Overall Study||0
258426|NCT01057225|625345|P2|NOT COMPLETED|Overall Study||0
258427|NCT01057225|625346|P1|NOT COMPLETED|Overall Study||0
258428|NCT01057225|625341|P6|COMPLETED|Overall Study||23
258429|NCT01057225|625342|P5|COMPLETED|Overall Study||22
258430|NCT01057225|625343|P4|COMPLETED|Overall Study||7
258431|NCT01057225|625344|P3|COMPLETED|Overall Study||6
258432|NCT01057225|625345|P2|COMPLETED|Overall Study||3
258433|NCT01057225|625346|P1|COMPLETED|Overall Study||3
258434|NCT01057225|625341|P6|STARTED|Overall Study||23
258435|NCT01057225|625342|P5|STARTED|Overall Study||22
258436|NCT01057225|625343|P4|STARTED|Overall Study||7
258437|NCT01057225|625344|P3|STARTED|Overall Study||6
258438|NCT01057225|625345|P2|STARTED|Overall Study||3
258439|NCT01057225|625346|P1|STARTED|Overall Study||3
258440|NCT01057251|625368|P2|NOT COMPLETED|Overall Study||29
258441|NCT01057251|625369|P1|NOT COMPLETED|Overall Study||28
258442|NCT01057251|625368|P2|COMPLETED|Overall Study||114
258443|NCT01057251|625369|P1|COMPLETED|Overall Study||262
258444|NCT01057251|625368|P2|STARTED|Overall Study|The safety population is 142, as one patient was randomized, but never received study drug.|143
258445|NCT01057251|625369|P1|STARTED|Overall Study||290
258446|NCT01057277|625377|P1|NOT COMPLETED|Overall Study||0
258447|NCT01057277|625377|P1|COMPLETED|Overall Study||3
258448|NCT01057277|625377|P1|STARTED|Overall Study||3
258449|NCT01057394|625381|P2|NOT COMPLETED|Overall Study||2
258450|NCT01057394|625382|P1|NOT COMPLETED|Overall Study||0
258451|NCT01057394|625381|P2|COMPLETED|Overall Study|19 treated participants|19
258452|NCT01057394|625382|P1|COMPLETED|Overall Study||0
258453|NCT01057394|625381|P2|STARTED|Overall Study|21 enrolled participants|21
258454|NCT01057394|625382|P1|STARTED|Overall Study||0
258455|NCT01057433|625386|P1|NOT COMPLETED|Overall Study||1
258456|NCT01057433|625386|P1|COMPLETED|Overall Study||23
258457|NCT01057433|625386|P1|STARTED|Overall Study||24
258458|NCT01057589|625390|P1|NOT COMPLETED|Overall Study||66
258459|NCT01057589|625390|P1|COMPLETED|Overall Study||0
258460|NCT01057589|625390|P1|STARTED|Overall Study||66
258461|NCT01057693|625399|P3|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||36
258462|NCT01057693|625400|P2|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||22
258463|NCT01057693|625401|P1|NOT COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
258464|NCT01057693|625399|P3|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||113
258465|NCT01057693|625400|P2|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||125
258466|NCT01057693|625401|P1|COMPLETED|Double-Blind Phase (Week 7 to Week 19)||0
258467|NCT01057693|625399|P3|Treated|Double-Blind Phase (Week 7 to Week 19)||147
258468|NCT01057693|625400|P2|Treated|Double-Blind Phase (Week 7 to Week 19)||147
258469|NCT01057693|625401|P1|Treated|Double-Blind Phase (Week 7 to Week 19)||0
258470|NCT01057693|625399|P3|STARTED|Double-Blind Phase (Week 7 to Week 19)||149
258471|NCT01057693|625400|P2|STARTED|Double-Blind Phase (Week 7 to Week 19)||147
258472|NCT01057693|625401|P1|STARTED|Double-Blind Phase (Week 7 to Week 19)||0
258473|NCT01057693|625399|P3|NOT COMPLETED|Between Single-Blind and Double-Blind||0
258474|NCT01057693|625400|P2|NOT COMPLETED|Between Single-Blind and Double-Blind||0
258475|NCT01057693|625401|P1|NOT COMPLETED|Between Single-Blind and Double-Blind||270
258476|NCT01057693|625399|P3|COMPLETED|Between Single-Blind and Double-Blind||0
258477|NCT01057693|625400|P2|COMPLETED|Between Single-Blind and Double-Blind||0
258478|NCT01057693|625401|P1|COMPLETED|Between Single-Blind and Double-Blind||296
258479|NCT01057693|625399|P3|STARTED|Between Single-Blind and Double-Blind||0
258480|NCT01057693|625400|P2|STARTED|Between Single-Blind and Double-Blind||0
258481|NCT01057693|625401|P1|STARTED|Between Single-Blind and Double-Blind||566
258482|NCT01057693|625399|P3|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
258483|NCT01057693|625400|P2|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||0
258484|NCT01057693|625401|P1|NOT COMPLETED|Single-Blind Phase (Up to Week 6)||99
258485|NCT01057693|625399|P3|COMPLETED|Single-Blind Phase (Up to Week 6)||0
258486|NCT01057693|625400|P2|COMPLETED|Single-Blind Phase (Up to Week 6)||0
258487|NCT01057693|625401|P1|COMPLETED|Single-Blind Phase (Up to Week 6)||566
258488|NCT01057693|625399|P3|STARTED|Single-Blind Phase (Up to Week 6)||0
258489|NCT01057693|625400|P2|STARTED|Single-Blind Phase (Up to Week 6)||0
258490|NCT01057693|625401|P1|STARTED|Single-Blind Phase (Up to Week 6)||665
258491|NCT01057810|625449|P2|NOT COMPLETED|Overall Study||398
258492|NCT01057810|625450|P1|NOT COMPLETED|Overall Study||198
258493|NCT01057810|625449|P2|COMPLETED|Overall Study||1
258494|NCT01057810|625450|P1|COMPLETED|Overall Study||1
258495|NCT01057810|625449|P2|STARTED|Overall Study||399
258496|NCT01057810|625450|P1|STARTED|Overall Study||199
258497|NCT01057888|625469|P3|NOT COMPLETED|Overall Study||0
258498|NCT01057888|625470|P2|NOT COMPLETED|Overall Study||0
258499|NCT01057888|625471|P1|NOT COMPLETED|Overall Study||0
258500|NCT01057888|625469|P3|COMPLETED|Overall Study||2494
258501|NCT01057888|625470|P2|COMPLETED|Overall Study||2406
258502|NCT01057888|625471|P1|COMPLETED|Overall Study||2504
258503|NCT01057888|625469|P3|STARTED|Overall Study||2494
258504|NCT01057888|625470|P2|STARTED|Overall Study||2406
258505|NCT01057888|625471|P1|STARTED|Overall Study||2504
258506|NCT01057901|625482|P2|NOT COMPLETED|Overall Study||246
258507|NCT01057901|625483|P1|NOT COMPLETED|Overall Study||260
258508|NCT01057901|625482|P2|COMPLETED|Overall Study||126
258509|NCT01057901|625483|P1|COMPLETED|Overall Study||116
258510|NCT01057901|625482|P2|STARTED|Overall Study||372
258511|NCT01057901|625483|P1|STARTED|Overall Study||376
258512|NCT01058005|625494|P3|NOT COMPLETED|Overall Study||20
258513|NCT01058005|625495|P2|NOT COMPLETED|Overall Study||25
258514|NCT01058005|625496|P1|NOT COMPLETED|Overall Study||38
258515|NCT01058005|625494|P3|COMPLETED|Overall Study||1
258516|NCT01058005|625495|P2|COMPLETED|Overall Study||0
258517|NCT01058005|625496|P1|COMPLETED|Overall Study||0
258518|NCT01058005|625494|P3|Dosed With Study Treatment|Overall Study||17
258519|NCT01058005|625495|P2|Dosed With Study Treatment|Overall Study||22
258520|NCT01058005|625496|P1|Dosed With Study Treatment|Overall Study||36
258521|NCT01058005|625494|P3|STARTED|Overall Study||21
258522|NCT01058005|625495|P2|STARTED|Overall Study||25
258523|NCT01058005|625496|P1|STARTED|Overall Study||38
258524|NCT01058070|625504|P1|NOT COMPLETED|Overall Study||11
258525|NCT01058070|625504|P1|COMPLETED|Overall Study||33
258526|NCT01058070|625504|P1|STARTED|Overall Study||44
258527|NCT01058096|625511|P2|NOT COMPLETED|Safety Follow-up||4
258528|NCT01058096|625512|P1|NOT COMPLETED|Safety Follow-up||4
258529|NCT01058096|625511|P2|COMPLETED|Safety Follow-up||130
258530|NCT01058096|625512|P1|COMPLETED|Safety Follow-up||129
258531|NCT01058096|625511|P2|STARTED|Safety Follow-up||134
258532|NCT01058096|625512|P1|STARTED|Safety Follow-up|Not all participants continued to Safety Follow-up.|133
258533|NCT01058096|625511|P2|NOT COMPLETED|Double-blind Treatment Phase||50
258534|NCT01058096|625512|P1|NOT COMPLETED|Double-blind Treatment Phase||48
258535|NCT01058096|625511|P2|COMPLETED|Double-blind Treatment Phase||108
258536|NCT01058096|625512|P1|COMPLETED|Double-blind Treatment Phase||106
258537|NCT01058096|625511|P2|STARTED|Double-blind Treatment Phase||158
258538|NCT01058096|625512|P1|STARTED|Double-blind Treatment Phase||154
258539|NCT01058265|625522|P2|NOT COMPLETED|Overall Study||12
258540|NCT01058265|625523|P1|NOT COMPLETED|Overall Study||11
258541|NCT01058265|625522|P2|COMPLETED|Overall Study||13
258542|NCT01058265|625523|P1|COMPLETED|Overall Study||11
258543|NCT01058265|625522|P2|STARTED|Overall Study||25
258544|NCT01058265|625523|P1|STARTED|Overall Study||22
258545|NCT01058304|625533|P2|NOT COMPLETED|Overall Study||33
258546|NCT01058304|625534|P1|NOT COMPLETED|Overall Study||27
258547|NCT01058304|625533|P2|COMPLETED|Overall Study||128
258548|NCT01058304|625534|P1|COMPLETED|Overall Study||132
258549|NCT01058304|625533|P2|STARTED|Overall Study||161
258550|NCT01058304|625534|P1|STARTED|Overall Study||159
258551|NCT01058356|625542|P1|NOT COMPLETED|Overall Study||42
258552|NCT01058356|625542|P1|COMPLETED|Overall Study||172
258553|NCT01058356|625542|P1|STARTED|Overall Study||214
258554|NCT01058421|625549|P2|NOT COMPLETED|6 Month Outcomes||26
258555|NCT01058421|625550|P1|NOT COMPLETED|6 Month Outcomes||19
258556|NCT01058421|625549|P2|COMPLETED|6 Month Outcomes||24
258557|NCT01058421|625550|P1|COMPLETED|6 Month Outcomes||27
258558|NCT01058421|625549|P2|STARTED|6 Month Outcomes|61 (subjects started Period 1) minus 11 (deceased subjects in Periods 1 & 2) = 50 started Period 3.|50
258559|NCT01058421|625550|P1|STARTED|6 Month Outcomes|55 (subjects started Period 1) minus 13 (deceased subjects in Periods 1 & 2) = 46 started Period 3.|46
258560|NCT01058421|625549|P2|NOT COMPLETED|3 Month Outcomes||26
258561|NCT01058421|625550|P1|NOT COMPLETED|3 Month Outcomes||20
258562|NCT01058421|625549|P2|COMPLETED|3 Month Outcomes||29
258563|NCT01058421|625550|P1|COMPLETED|3 Month Outcomes||29
258564|NCT01058421|625549|P2|STARTED|3 Month Outcomes|61 (Subjects started Period 1) minus 6 (deceased subjects during Period 1) = 55 started Period 2.|55
258565|NCT01058421|625550|P1|STARTED|3 Month Outcomes|59 (Subjects started Period 1) minus 10 (deceased subjects during Period 1) = 49 started Period 2.|49
258566|NCT01058421|625549|P2|NOT COMPLETED|1 Month Outcomes||42
258567|NCT01058421|625550|P1|NOT COMPLETED|1 Month Outcomes||39
258568|NCT01058421|625549|P2|COMPLETED|1 Month Outcomes||19
258569|NCT01058421|625550|P1|COMPLETED|1 Month Outcomes||20
258570|NCT01058421|625549|P2|STARTED|1 Month Outcomes||61
258571|NCT01058421|625550|P1|STARTED|1 Month Outcomes||59
258572|NCT01047241|625572|P1|NOT COMPLETED|Overall Study||0
258573|NCT01047241|625572|P1|COMPLETED|Overall Study||50
258574|NCT01047241|625572|P1|STARTED|Overall Study||50
258575|NCT01047293|625581|P4|NOT COMPLETED|Overall Study||0
258576|NCT01047293|625582|P3|NOT COMPLETED|Overall Study||0
258577|NCT01047293|625583|P2|NOT COMPLETED|Overall Study||1
258578|NCT01047293|625584|P1|NOT COMPLETED|Overall Study||1
258579|NCT01047293|625581|P4|COMPLETED|Overall Study||26
258580|NCT01047293|625582|P3|COMPLETED|Overall Study||9
258581|NCT01047293|625583|P2|COMPLETED|Overall Study||7
258582|NCT01047293|625584|P1|COMPLETED|Overall Study||3
258583|NCT01047293|625581|P4|STARTED|Overall Study||26
258584|NCT01047293|625582|P3|STARTED|Overall Study||9
258585|NCT01047293|625583|P2|STARTED|Overall Study||8
258586|NCT01047293|625584|P1|STARTED|Overall Study||4
258587|NCT01047306|625593|P2|NOT COMPLETED|Overall Study||0
258588|NCT01047306|625594|P1|NOT COMPLETED|Overall Study||3
258589|NCT01047306|625593|P2|COMPLETED|Overall Study||6
258590|NCT01047306|625594|P1|COMPLETED|Overall Study||16
258591|NCT01047306|625593|P2|Discontinued From the Study|Overall Study||0
258592|NCT01047306|625594|P1|Discontinued From the Study|Overall Study||3
258593|NCT01047306|625593|P2|STARTED|Overall Study||6
258594|NCT01047306|625594|P1|STARTED|Overall Study||19
258595|NCT01047332|625670|P2|NOT COMPLETED|Overall Study||64
258596|NCT01047332|625671|P1|NOT COMPLETED|Overall Study||57
258597|NCT01047332|625670|P2|COMPLETED|Overall Study|Alive at final follow-up|4
258598|NCT01047332|625671|P1|COMPLETED|Overall Study|Alive at final follow-up|4
258599|NCT01047332|625670|P2|STARTED|Overall Study||68
258600|NCT01047332|625671|P1|STARTED|Overall Study||61
258601|NCT01047345|625685|P3|NOT COMPLETED|Extension||6
258602|NCT01047345|625686|P2|NOT COMPLETED|Extension||0
258603|NCT01047345|625687|P1|NOT COMPLETED|Extension||0
258604|NCT01047345|625685|P3|COMPLETED|Extension||96
258605|NCT01047345|625686|P2|COMPLETED|Extension||0
258606|NCT01047345|625687|P1|COMPLETED|Extension||0
258607|NCT01047345|625685|P3|Vaccination 6|Extension|1 participant received 6th vaccination outside the context of study but completed the study.|95
258608|NCT01047345|625686|P2|Vaccination 6|Extension||0
258609|NCT01047345|625687|P1|Vaccination 6|Extension||0
258610|NCT01047345|625685|P3|Vaccination 5|Extension||99
258611|NCT01047345|625686|P2|Vaccination 5|Extension||0
258612|NCT01047345|625687|P1|Vaccination 5|Extension||0
258613|NCT01047345|625685|P3|Vaccination 4|Extension||102
258614|NCT01047345|625686|P2|Vaccination 4|Extension||0
258615|NCT01047345|625687|P1|Vaccination 4|Extension||0
258616|NCT01047345|625685|P3|STARTED|Extension|Not all eligible participants elected to participate in extension|102
258617|NCT01047345|625686|P2|STARTED|Extension||0
258618|NCT01047345|625687|P1|STARTED|Extension||0
258619|NCT01047345|625685|P3|NOT COMPLETED|Base Study||0
258620|NCT01047345|625686|P2|NOT COMPLETED|Base Study||6
258621|NCT01047345|625687|P1|NOT COMPLETED|Base Study||22
258622|NCT01047345|625685|P3|COMPLETED|Base Study||0
258623|NCT01047345|625686|P2|COMPLETED|Base Study||300
258624|NCT01047345|625687|P1|COMPLETED|Base Study|Includes 1 participant for whom completion status is unknown|596
258625|NCT01047345|625685|P3|Vaccination 3|Base Study||0
258626|NCT01047345|625686|P2|Vaccination 3|Base Study||300
258627|NCT01047345|625687|P1|Vaccination 3|Base Study||597
258628|NCT01047345|625685|P3|Vaccination 2|Base Study||0
258629|NCT01047345|625686|P2|Vaccination 2|Base Study||304
258630|NCT01047345|625687|P1|Vaccination 2|Base Study||604
258631|NCT01047345|625685|P3|Vaccination 1|Base Study||0
258632|NCT01047345|625686|P2|Vaccination 1|Base Study||306
258633|NCT01047345|625687|P1|Vaccination 1|Base Study||615
258634|NCT01047345|625685|P3|STARTED|Base Study||0
258635|NCT01047345|625686|P2|STARTED|Base Study||306
258636|NCT01047345|625687|P1|STARTED|Base Study||618
258637|NCT01047358|625707|P1|NOT COMPLETED|Overall Study||0
258638|NCT01047358|625707|P1|COMPLETED|Overall Study|At least one safety assessment (Safety Population)|206
258639|NCT01047358|625707|P1|STARTED|Overall Study||206
258640|NCT01047436|625716|P2|NOT COMPLETED|Overall Study||0
258641|NCT01047436|625717|P1|NOT COMPLETED|Overall Study||1
258642|NCT01047436|625716|P2|COMPLETED|Overall Study||15
258643|NCT01047436|625717|P1|COMPLETED|Overall Study||15
258644|NCT01047436|625716|P2|STARTED|Overall Study||15
258645|NCT01047436|625717|P1|STARTED|Overall Study||16
258646|NCT01047475|625735|P2|NOT COMPLETED|Overall Study||7
258647|NCT01047475|625736|P1|NOT COMPLETED|Overall Study||5
258648|NCT01047475|625735|P2|COMPLETED|Overall Study||31
258649|NCT01047475|625736|P1|COMPLETED|Overall Study||29
258650|NCT01047475|625735|P2|STARTED|Overall Study||38
258651|NCT01047475|625736|P1|STARTED|Overall Study||34
258652|NCT01052831|625744|P2|NOT COMPLETED|Overall Study||1
258653|NCT01052831|625745|P1|NOT COMPLETED|Overall Study||4
258654|NCT01052831|625744|P2|COMPLETED|Overall Study||23
258655|NCT01052831|625745|P1|COMPLETED|Overall Study||22
258656|NCT01052831|625744|P2|STARTED|Overall Study||24
258657|NCT01052831|625745|P1|STARTED|Overall Study||26
258658|NCT01052844|625755|P2|NOT COMPLETED|Overall Study||1
258659|NCT01052844|625756|P1|NOT COMPLETED|Overall Study||0
258660|NCT01052844|625755|P2|COMPLETED|Overall Study||39
258661|NCT01052844|625756|P1|COMPLETED|Overall Study||40
258662|NCT01052844|625755|P2|STARTED|Overall Study||40
258663|NCT01052844|625756|P1|STARTED|Overall Study||40
258664|NCT01052948|625768|P4|NOT COMPLETED|Overall Study||0
258665|NCT01052948|625769|P3|NOT COMPLETED|Overall Study||0
258666|NCT01052948|625770|P2|NOT COMPLETED|Overall Study||0
258667|NCT01052948|625771|P1|NOT COMPLETED|Overall Study||0
258668|NCT01052948|625768|P4|COMPLETED|Overall Study||29311
258669|NCT01052948|625769|P3|COMPLETED|Overall Study||15147
258670|NCT01052948|625770|P2|COMPLETED|Overall Study||14669
258671|NCT01052948|625771|P1|COMPLETED|Overall Study||27812
258672|NCT01052948|625768|P4|STARTED|Overall Study||29311
258673|NCT01052948|625769|P3|STARTED|Overall Study||15147
258674|NCT01052948|625770|P2|STARTED|Overall Study||14669
258675|NCT01052948|625771|P1|STARTED|Overall Study||27812
258676|NCT01053000|625793|P2|NOT COMPLETED|Overall Study||0
258677|NCT01053000|625794|P1|NOT COMPLETED|Overall Study||0
258678|NCT01053000|625793|P2|COMPLETED|Overall Study||5
258679|NCT01053000|625794|P1|COMPLETED|Overall Study||5
258680|NCT01053000|625793|P2|STARTED|Overall Study||5
258681|NCT01053000|625794|P1|STARTED|Overall Study||5
258682|NCT01053078|625802|P2|NOT COMPLETED|Overall Study||3
258683|NCT01053078|625803|P1|NOT COMPLETED|Overall Study||4
258684|NCT01053078|625802|P2|COMPLETED|Overall Study||12
258685|NCT01053078|625803|P1|COMPLETED|Overall Study||10
258686|NCT01053078|625802|P2|STARTED|Overall Study||15
258687|NCT01053078|625803|P1|STARTED|Overall Study||14
258688|NCT01058642|625813|P4|NOT COMPLETED|Treatment Period 2||0
258689|NCT01058642|625814|P3|NOT COMPLETED|Treatment Period 2||0
258690|NCT01058642|625815|P2|NOT COMPLETED|Treatment Period 2||0
258691|NCT01058642|625816|P1|NOT COMPLETED|Treatment Period 2||0
258692|NCT01058642|625813|P4|COMPLETED|Treatment Period 2||7
258693|NCT01058642|625814|P3|COMPLETED|Treatment Period 2||9
258694|NCT01058642|625815|P2|COMPLETED|Treatment Period 2||11
258695|NCT01058642|625816|P1|COMPLETED|Treatment Period 2||7
258783|NCT01060072|625934|P2|COMPLETED|Overall Study||196
258696|NCT01058642|625813|P4|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
258697|NCT01058642|625814|P3|Received at Least 1 Dose of Study Drug|Treatment Period 2||9
258698|NCT01058642|625815|P2|Received at Least 1 Dose of Study Drug|Treatment Period 2||11
258699|NCT01058642|625816|P1|Received at Least 1 Dose of Study Drug|Treatment Period 2||7
258700|NCT01058642|625813|P4|STARTED|Treatment Period 2||7
258701|NCT01058642|625814|P3|STARTED|Treatment Period 2||9
258702|NCT01058642|625815|P2|STARTED|Treatment Period 2||11
258703|NCT01058642|625816|P1|STARTED|Treatment Period 2||7
258704|NCT01058642|625813|P4|NOT COMPLETED|Washout Period||0
258705|NCT01058642|625814|P3|NOT COMPLETED|Washout Period||0
258706|NCT01058642|625815|P2|NOT COMPLETED|Washout Period||0
258707|NCT01058642|625816|P1|NOT COMPLETED|Washout Period||0
258708|NCT01058642|625813|P4|COMPLETED|Washout Period||7
258709|NCT01058642|625814|P3|COMPLETED|Washout Period||9
258710|NCT01058642|625815|P2|COMPLETED|Washout Period||11
258711|NCT01058642|625816|P1|COMPLETED|Washout Period||7
258712|NCT01058642|625813|P4|STARTED|Washout Period||7
258713|NCT01058642|625814|P3|STARTED|Washout Period||9
258714|NCT01058642|625815|P2|STARTED|Washout Period||11
258715|NCT01058642|625816|P1|STARTED|Washout Period||7
258716|NCT01058642|625813|P4|NOT COMPLETED|Treatment Period 1||2
258717|NCT01058642|625814|P3|NOT COMPLETED|Treatment Period 1||2
258718|NCT01058642|625815|P2|NOT COMPLETED|Treatment Period 1||1
258719|NCT01058642|625816|P1|NOT COMPLETED|Treatment Period 1||2
258720|NCT01058642|625813|P4|COMPLETED|Treatment Period 1||7
258721|NCT01058642|625814|P3|COMPLETED|Treatment Period 1||9
258722|NCT01058642|625815|P2|COMPLETED|Treatment Period 1||11
258723|NCT01058642|625816|P1|COMPLETED|Treatment Period 1||7
258724|NCT01058642|625813|P4|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
258725|NCT01058642|625814|P3|Received at Least 1 Dose of Study Drug|Treatment Period 1||11
258726|NCT01058642|625815|P2|Received at Least 1 Dose of Study Drug|Treatment Period 1||12
258727|NCT01058642|625816|P1|Received at Least 1 Dose of Study Drug|Treatment Period 1||9
258728|NCT01058642|625813|P4|STARTED|Treatment Period 1||9
258729|NCT01058642|625814|P3|STARTED|Treatment Period 1||11
258730|NCT01058642|625815|P2|STARTED|Treatment Period 1||12
258731|NCT01058642|625816|P1|STARTED|Treatment Period 1||9
258732|NCT01058655|625828|P4|NOT COMPLETED|Overall Study||42
258733|NCT01058655|625829|P3|NOT COMPLETED|Overall Study||8
258734|NCT01058655|625830|P2|NOT COMPLETED|Overall Study||3
258735|NCT01058655|625831|P1|NOT COMPLETED|Overall Study||3
258736|NCT01058655|625828|P4|COMPLETED|Overall Study||0
258737|NCT01058655|625829|P3|COMPLETED|Overall Study||0
258738|NCT01058655|625830|P2|COMPLETED|Overall Study||0
258739|NCT01058655|625831|P1|COMPLETED|Overall Study||0
258740|NCT01058655|625828|P4|Evaluable|Overall Study||40
258741|NCT01058655|625829|P3|Evaluable|Overall Study||6
258742|NCT01058655|625830|P2|Evaluable|Overall Study||3
258743|NCT01058655|625831|P1|Evaluable|Overall Study||3
258744|NCT01058655|625828|P4|STARTED|Overall Study||42
258745|NCT01058655|625829|P3|STARTED|Overall Study||8
258746|NCT01058655|625830|P2|STARTED|Overall Study||3
258747|NCT01058655|625831|P1|STARTED|Overall Study||3
258748|NCT01058668|625848|P3|NOT COMPLETED|Safety Follow-up||7
258749|NCT01058668|625849|P2|NOT COMPLETED|Safety Follow-up||0
258750|NCT01058668|625850|P1|NOT COMPLETED|Safety Follow-up||5
258751|NCT01058668|625848|P3|COMPLETED|Safety Follow-up||141
258752|NCT01058668|625849|P2|COMPLETED|Safety Follow-up||146
258753|NCT01058668|625850|P1|COMPLETED|Safety Follow-up||139
258754|NCT01058668|625848|P3|STARTED|Safety Follow-up||148
258755|NCT01058668|625849|P2|STARTED|Safety Follow-up||146
258756|NCT01058668|625850|P1|STARTED|Safety Follow-up|Not all participants entered the Safety-Follow-up|144
258757|NCT01058668|625848|P3|NOT COMPLETED|Double-blind Treatment Phase||50
258758|NCT01058668|625849|P2|NOT COMPLETED|Double-blind Treatment Phase||38
258759|NCT01058668|625850|P1|NOT COMPLETED|Double-blind Treatment Phase||39
258760|NCT01058668|625848|P3|COMPLETED|Double-blind Treatment Phase||119
258761|NCT01058668|625849|P2|COMPLETED|Double-blind Treatment Phase||129
258762|NCT01058668|625850|P1|COMPLETED|Double-blind Treatment Phase||122
258763|NCT01058668|625848|P3|STARTED|Double-blind Treatment Phase||169
258764|NCT01058668|625849|P2|STARTED|Double-blind Treatment Phase||167
258765|NCT01058668|625850|P1|STARTED|Double-blind Treatment Phase||161
258766|NCT01058863|625861|P1|NOT COMPLETED|Overall Study||4
258767|NCT01058863|625861|P1|COMPLETED|Overall Study||68
258768|NCT01058863|625861|P1|Treated With Placebo Inhaler|Overall Study||69
258769|NCT01058863|625861|P1|Treated With ProAir® HFA 180 mcg|Overall Study||68
258770|NCT01058863|625861|P1|Treated With ProAir® HFA 90 mcg|Overall Study||70
258771|NCT01058863|625861|P1|Treated With Albuterol Spiromax® 180 mcg|Overall Study||68
258772|NCT01058863|625861|P1|Treated With Albuterol Spiromax® 90 mcg|Overall Study||68
258773|NCT01058863|625861|P1|Safety and ITT Populations|Overall Study|One patient was randomized in error and never received the study drug.|71
258774|NCT01058863|625861|P1|STARTED|Overall Study||72
258775|NCT01060059|625881|P2|NOT COMPLETED|Overall Study||67
258776|NCT01060059|625882|P1|NOT COMPLETED|Overall Study||67
258777|NCT01060059|625881|P2|COMPLETED|Overall Study||371
258778|NCT01060059|625882|P1|COMPLETED|Overall Study||377
258779|NCT01060059|625881|P2|STARTED|Overall Study||438
258780|NCT01060059|625882|P1|STARTED|Overall Study||444
258781|NCT01060072|625934|P2|NOT COMPLETED|Overall Study||5
258782|NCT01060072|625935|P1|NOT COMPLETED|Overall Study||2
258784|NCT01060072|625935|P1|COMPLETED|Overall Study||204
258785|NCT01060072|625934|P2|STARTED|Overall Study||201
258786|NCT01060072|625935|P1|STARTED|Overall Study||206
258787|NCT01060111|625952|P3|NOT COMPLETED|Overall Study||35
258788|NCT01060111|625953|P2|NOT COMPLETED|Overall Study||23
258789|NCT01060111|625954|P1|NOT COMPLETED|Overall Study||27
258790|NCT01060111|625952|P3|COMPLETED|Overall Study||45
258791|NCT01060111|625953|P2|COMPLETED|Overall Study||61
258792|NCT01060111|625954|P1|COMPLETED|Overall Study||54
258793|NCT01060111|625952|P3|Treated|Overall Study||79
258794|NCT01060111|625953|P2|Treated|Overall Study||83
258795|NCT01060111|625954|P1|Treated|Overall Study||81
258796|NCT01060111|625952|P3|STARTED|Overall Study||80
258797|NCT01060111|625953|P2|STARTED|Overall Study||84
258798|NCT01060111|625954|P1|STARTED|Overall Study||81
258799|NCT01060124|625971|P1|NOT COMPLETED|Overall Study||37
258800|NCT01060124|625971|P1|COMPLETED|Overall Study||66
258801|NCT01060124|625971|P1|STARTED|Overall Study||103
258802|NCT01060150|625979|P1|NOT COMPLETED|Overall Study||23
258803|NCT01060150|625979|P1|COMPLETED|Overall Study||92
258804|NCT01060150|625979|P1|Treated|Overall Study||113
258805|NCT01060150|625979|P1|STARTED|Overall Study||115
258806|NCT01060540|625996|P2|NOT COMPLETED|Overall Study||65
258807|NCT01060540|625997|P1|NOT COMPLETED|Overall Study||64
258808|NCT01060540|625996|P2|COMPLETED|Overall Study||233
258809|NCT01060540|625997|P1|COMPLETED|Overall Study||239
258810|NCT01060540|625996|P2|STARTED|Overall Study||298
258811|NCT01060540|625997|P1|STARTED|Overall Study||303
258812|NCT01060553|626011|P2|NOT COMPLETED|Overall Study||10
258813|NCT01060553|626012|P1|NOT COMPLETED|Overall Study||9
258814|NCT01060553|626011|P2|COMPLETED|Overall Study||5
258815|NCT01060553|626012|P1|COMPLETED|Overall Study|5 subjects completed more than half the sessions and midpoint outcome measures were obtained|6
258816|NCT01060553|626011|P2|STARTED|Overall Study||15
258817|NCT01060553|626012|P1|STARTED|Overall Study||15
258818|NCT01060592|626019|P2|NOT COMPLETED|12m||18
258819|NCT01060592|626020|P1|NOT COMPLETED|12m||0
258820|NCT01060592|626019|P2|COMPLETED|12m|Historic data was not available at 12m for 18 of the historic controls|31
258821|NCT01060592|626020|P1|COMPLETED|12m||35
258822|NCT01060592|626019|P2|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|49
258823|NCT01060592|626020|P1|STARTED|12m|For some pts, %EWL were not taken/available in the 4-6w period but were available for the 12m period|35
258824|NCT01060592|626019|P2|NOT COMPLETED|4-6w||10
258825|NCT01060592|626020|P1|NOT COMPLETED|4-6w||12
258826|NCT01060592|626019|P2|COMPLETED|4-6w||39
258827|NCT01060592|626020|P1|COMPLETED|4-6w||23
258828|NCT01060592|626019|P2|STARTED|4-6w||49
258829|NCT01060592|626020|P1|STARTED|4-6w||35
258830|NCT01060670|626036|P2|NOT COMPLETED|Follow up Phase||35
258831|NCT01060670|626037|P1|NOT COMPLETED|Follow up Phase||22
258832|NCT01060670|626036|P2|COMPLETED|Follow up Phase||82
258833|NCT01060670|626037|P1|COMPLETED|Follow up Phase||106
258834|NCT01060670|626036|P2|Withdrew From Follow up Phase|Follow up Phase||35
258835|NCT01060670|626037|P1|Withdrew From Follow up Phase|Follow up Phase||22
258836|NCT01060670|626036|P2|Recurrence|Follow up Phase||9
258837|NCT01060670|626037|P1|Recurrence|Follow up Phase||14
258838|NCT01060670|626036|P2|STARTED|Follow up Phase||117
258839|NCT01060670|626037|P1|STARTED|Follow up Phase||128
258840|NCT01060670|626036|P2|NOT COMPLETED|Treatment Phase||36
258841|NCT01060670|626037|P1|NOT COMPLETED|Treatment Phase||26
258842|NCT01060670|626036|P2|COMPLETED|Treatment Phase||117
258843|NCT01060670|626037|P1|COMPLETED|Treatment Phase||128
258844|NCT01060670|626036|P2|Withdrew From Treatment|Treatment Phase||36
258845|NCT01060670|626037|P1|Withdrew From Treatment|Treatment Phase||26
258846|NCT01060670|626036|P2|Did Not Heal by Treatment Visit 17|Treatment Phase||68
258847|NCT01060670|626037|P1|Did Not Heal by Treatment Visit 17|Treatment Phase||49
258848|NCT01060670|626036|P2|Healed at End of Treatment Phase|Treatment Phase||49
258849|NCT01060670|626037|P1|Healed at End of Treatment Phase|Treatment Phase||79
258850|NCT01060670|626036|P2|STARTED|Treatment Phase||153
258851|NCT01060670|626037|P1|STARTED|Treatment Phase||154
258852|NCT01060670|626036|P2|NOT COMPLETED|Run In||238
258853|NCT01060670|626037|P1|NOT COMPLETED|Run In||0
258854|NCT01060670|626036|P2|COMPLETED|Run In||307
258855|NCT01060670|626037|P1|COMPLETED|Run In||0
258856|NCT01060670|626036|P2|STARTED|Run In||545
258857|NCT01060670|626037|P1|STARTED|Run In||0
258858|NCT01061008|626057|P2|NOT COMPLETED|Overall Study||6
258859|NCT01061008|626058|P1|NOT COMPLETED|Overall Study||6
258860|NCT01061008|626057|P2|COMPLETED|Overall Study||9
258861|NCT01061008|626058|P1|COMPLETED|Overall Study||10
258862|NCT01061008|626057|P2|STARTED|Overall Study||15
258863|NCT01061008|626058|P1|STARTED|Overall Study||16
258864|NCT01061034|626064|P1|NOT COMPLETED|Aspirin Plus Omeprazole||0
258865|NCT01061034|626064|P1|COMPLETED|Aspirin Plus Omeprazole||9
258866|NCT01061034|626064|P1|STARTED|Aspirin Plus Omeprazole||9
258867|NCT01061034|626064|P1|NOT COMPLETED|Aspirin||0
258868|NCT01061034|626064|P1|COMPLETED|Aspirin||9
258869|NCT01061034|626064|P1|STARTED|Aspirin||9
258870|NCT01061177|626069|P1|NOT COMPLETED|Overall Study||208
258871|NCT01061177|626069|P1|COMPLETED|Overall Study||881
258872|NCT01061177|626069|P1|ITT_CyR (Ph+ Patients Only)|Overall Study||983
258873|NCT01061177|626069|P1|ITT_MR (b2a2 &/or b3a2 +ve Pts Only)|Overall Study||1056
258874|NCT01061177|626069|P1|STARTED|Overall Study||1089
258875|NCT01061333|626088|P2|NOT COMPLETED|Period 7: Mometasone||0
258876|NCT01061333|626089|P1|NOT COMPLETED|Period 7: Mometasone||0
258877|NCT01061333|626088|P2|COMPLETED|Period 7: Mometasone||7
258878|NCT01061333|626089|P1|COMPLETED|Period 7: Mometasone||8
258879|NCT01061333|626088|P2|STARTED|Period 7: Mometasone||7
258880|NCT01061333|626089|P1|STARTED|Period 7: Mometasone||8
258881|NCT01061333|626088|P2|NOT COMPLETED|Period 6: 20-day Washout||0
258882|NCT01061333|626089|P1|NOT COMPLETED|Period 6: 20-day Washout||0
258883|NCT01061333|626088|P2|COMPLETED|Period 6: 20-day Washout||7
258884|NCT01061333|626089|P1|COMPLETED|Period 6: 20-day Washout||8
258885|NCT01061333|626088|P2|STARTED|Period 6: 20-day Washout||7
258886|NCT01061333|626089|P1|STARTED|Period 6: 20-day Washout||8
258887|NCT01061333|626088|P2|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
258888|NCT01061333|626089|P1|NOT COMPLETED|Period 5: Nedocromil-Montelukast X-over||0
258889|NCT01061333|626088|P2|COMPLETED|Period 5: Nedocromil-Montelukast X-over||7
258890|NCT01061333|626089|P1|COMPLETED|Period 5: Nedocromil-Montelukast X-over||8
258891|NCT01061333|626088|P2|STARTED|Period 5: Nedocromil-Montelukast X-over||7
258892|NCT01061333|626089|P1|STARTED|Period 5: Nedocromil-Montelukast X-over||8
258893|NCT01061333|626088|P2|NOT COMPLETED|Period 4: 20-day Washout||1
258894|NCT01061333|626089|P1|NOT COMPLETED|Period 4: 20-day Washout||0
258895|NCT01061333|626088|P2|COMPLETED|Period 4: 20-day Washout||7
258896|NCT01061333|626089|P1|COMPLETED|Period 4: 20-day Washout||8
258897|NCT01061333|626088|P2|STARTED|Period 4: 20-day Washout||8
258898|NCT01061333|626089|P1|STARTED|Period 4: 20-day Washout||8
258899|NCT01061333|626088|P2|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
258900|NCT01061333|626089|P1|NOT COMPLETED|Period 3: Nedocromil-Montelukast X-over||0
258901|NCT01061333|626088|P2|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
258902|NCT01061333|626089|P1|COMPLETED|Period 3: Nedocromil-Montelukast X-over||8
258903|NCT01061333|626088|P2|STARTED|Period 3: Nedocromil-Montelukast X-over||8
258904|NCT01061333|626089|P1|STARTED|Period 3: Nedocromil-Montelukast X-over||8
258905|NCT01061333|626088|P2|NOT COMPLETED|Period 2: 20-day Washout||0
258906|NCT01061333|626089|P1|NOT COMPLETED|Period 2: 20-day Washout||0
258907|NCT01061333|626088|P2|COMPLETED|Period 2: 20-day Washout||8
258908|NCT01061333|626089|P1|COMPLETED|Period 2: 20-day Washout||8
258909|NCT01061333|626088|P2|STARTED|Period 2: 20-day Washout||8
258910|NCT01061333|626089|P1|STARTED|Period 2: 20-day Washout||8
258911|NCT01061333|626088|P2|NOT COMPLETED|Period 1: Placebo Run-in||0
258912|NCT01061333|626089|P1|NOT COMPLETED|Period 1: Placebo Run-in||0
258913|NCT01061333|626088|P2|COMPLETED|Period 1: Placebo Run-in||8
258914|NCT01061333|626089|P1|COMPLETED|Period 1: Placebo Run-in||8
258915|NCT01061333|626088|P2|STARTED|Period 1: Placebo Run-in||8
258916|NCT01061333|626089|P1|STARTED|Period 1: Placebo Run-in||8
258917|NCT01061359|626127|P1|NOT COMPLETED|Overall Study||1302
258918|NCT01061359|626127|P1|COMPLETED|Overall Study|Completed 5 years of follow-up: 668 Disease free and 2 Relapsed|670
258919|NCT01061359|626127|P1|STARTED|Overall Study||1972
258920|NCT01061385|626135|P2|NOT COMPLETED|Overall Study||1
258921|NCT01061385|626136|P1|NOT COMPLETED|Overall Study||1
258922|NCT01061385|626135|P2|COMPLETED|Overall Study||8
258923|NCT01061385|626136|P1|COMPLETED|Overall Study||20
258924|NCT01061385|626135|P2|STARTED|Overall Study||9
258925|NCT01061385|626136|P1|STARTED|Overall Study||21
258926|NCT01061476|626144|P1|NOT COMPLETED|Overall Study||0
258927|NCT01061476|626144|P1|COMPLETED|Overall Study||12
258928|NCT01061476|626144|P1|STARTED|Overall Study||12
258929|NCT01061567|626148|P1|NOT COMPLETED|Overall Study||76
258930|NCT01061567|626148|P1|COMPLETED|Overall Study||1738
258931|NCT01061567|626148|P1|STARTED|Overall Study||1814
258932|NCT01061606|626157|P1|NOT COMPLETED|Overall Study||8
258933|NCT01061606|626157|P1|COMPLETED|Overall Study||0
258934|NCT01061606|626157|P1|STARTED|Overall Study||8
258935|NCT01061671|626168|P2|NOT COMPLETED|Overall Study||55
258936|NCT01061671|626169|P1|NOT COMPLETED|Overall Study||47
258937|NCT01061671|626168|P2|COMPLETED|Overall Study||397
258938|NCT01061671|626169|P1|COMPLETED|Overall Study||386
258939|NCT01061671|626168|P2|STARTED|Overall Study||452
258940|NCT01061671|626169|P1|STARTED|Overall Study||433
258941|NCT01061710|626181|P1|NOT COMPLETED|Overall Study||14
258942|NCT01061710|626181|P1|COMPLETED|Overall Study||6
258943|NCT01061710|626181|P1|STARTED|Overall Study||20
258944|NCT01061723|626195|P6|NOT COMPLETED|Overall Study||9
258945|NCT01061723|626196|P5|NOT COMPLETED|Overall Study||3
258946|NCT01061723|626197|P4|NOT COMPLETED|Overall Study||8
258947|NCT01061723|626198|P3|NOT COMPLETED|Overall Study||10
258948|NCT01061723|626199|P2|NOT COMPLETED|Overall Study||6
258949|NCT01061723|626200|P1|NOT COMPLETED|Overall Study||4
258950|NCT01061723|626195|P6|COMPLETED|Overall Study||41
258951|NCT01061723|626196|P5|COMPLETED|Overall Study||47
258952|NCT01061723|626197|P4|COMPLETED|Overall Study||44
258953|NCT01061723|626198|P3|COMPLETED|Overall Study||40
258954|NCT01061723|626199|P2|COMPLETED|Overall Study||43
258955|NCT01061723|626200|P1|COMPLETED|Overall Study||46
258956|NCT01061723|626195|P6|Treated|Overall Study||49
258957|NCT01061723|626196|P5|Treated|Overall Study||50
258958|NCT01061723|626197|P4|Treated|Overall Study||52
258959|NCT01061723|626198|P3|Treated|Overall Study||50
258960|NCT01061723|626199|P2|Treated|Overall Study||49
258961|NCT01061723|626200|P1|Treated|Overall Study||50
258962|NCT01061723|626195|P6|STARTED|Overall Study||50
258963|NCT01061723|626196|P5|STARTED|Overall Study||50
258964|NCT01061723|626197|P4|STARTED|Overall Study||52
258965|NCT01061723|626198|P3|STARTED|Overall Study||50
258966|NCT01061723|626199|P2|STARTED|Overall Study||49
258967|NCT01061723|626200|P1|STARTED|Overall Study||50
258968|NCT01061736|626290|P10|NOT COMPLETED|Overall Study||74
258969|NCT01061736|626291|P9|NOT COMPLETED|Overall Study||97
258970|NCT01061736|626292|P8|NOT COMPLETED|Overall Study||94
258971|NCT01061736|626293|P7|NOT COMPLETED|Overall Study||84
258972|NCT01061736|626294|P6|NOT COMPLETED|Overall Study||3
258973|NCT01061736|626295|P5|NOT COMPLETED|Overall Study||7
258974|NCT01061736|626296|P4|NOT COMPLETED|Overall Study||3
258975|NCT01061736|626297|P3|NOT COMPLETED|Overall Study||6
258976|NCT01061736|626298|P2|NOT COMPLETED|Overall Study||4
258977|NCT01061736|626299|P1|NOT COMPLETED|Overall Study||13
258978|NCT01061736|626290|P10|COMPLETED|Overall Study||354
258979|NCT01061736|626291|P9|COMPLETED|Overall Study||330
258980|NCT01061736|626292|P8|COMPLETED|Overall Study||336
258981|NCT01061736|626293|P7|COMPLETED|Overall Study||0
258982|NCT01061736|626294|P6|COMPLETED|Overall Study||49
258983|NCT01061736|626295|P5|COMPLETED|Overall Study||45
258984|NCT01061736|626296|P4|COMPLETED|Overall Study||48
258985|NCT01061736|626297|P3|COMPLETED|Overall Study||45
258986|NCT01061736|626298|P2|COMPLETED|Overall Study||46
258987|NCT01061736|626299|P1|COMPLETED|Overall Study||37
258988|NCT01061736|626290|P10|Rescued|Overall Study|Included both participants who completed and did not complete the study.|168
258989|NCT01061736|626291|P9|Rescued|Overall Study|Included both participants who completed and did not complete the study.|55
258990|NCT01061736|626292|P8|Rescued|Overall Study|Included both participants who completed and did not complete the study.|61
258991|NCT01061736|626293|P7|Rescued|Overall Study||0
258992|NCT01061736|626294|P6|Rescued|Overall Study||0
258993|NCT01061736|626295|P5|Rescued|Overall Study||0
258994|NCT01061736|626296|P4|Rescued|Overall Study||0
258995|NCT01061736|626297|P3|Rescued|Overall Study||0
258996|NCT01061736|626298|P2|Rescued|Overall Study||0
258997|NCT01061736|626299|P1|Rescued|Overall Study||0
258998|NCT01061736|626290|P10|Treated|Overall Study||428
258999|NCT01061736|626291|P9|Treated|Overall Study||426
259000|NCT01061736|626292|P8|Treated|Overall Study||428
259001|NCT01061736|626293|P7|Treated|Overall Study||84
259002|NCT01061736|626294|P6|Treated|Overall Study||52
259003|NCT01061736|626295|P5|Treated|Overall Study||51
259004|NCT01061736|626296|P4|Treated|Overall Study||51
259005|NCT01061736|626297|P3|Treated|Overall Study||51
259006|NCT01061736|626298|P2|Treated|Overall Study||50
259007|NCT01061736|626299|P1|Treated|Overall Study||50
259008|NCT01061736|626290|P10|STARTED|Overall Study||428
259009|NCT01061736|626291|P9|STARTED|Overall Study||427
259010|NCT01061736|626292|P8|STARTED|Overall Study||430
259011|NCT01061736|626293|P7|STARTED|Overall Study||84
259012|NCT01061736|626294|P6|STARTED|Overall Study||52
259013|NCT01061736|626295|P5|STARTED|Overall Study||52
259014|NCT01061736|626296|P4|STARTED|Overall Study||51
259015|NCT01061736|626297|P3|STARTED|Overall Study||51
259016|NCT01061736|626298|P2|STARTED|Overall Study||50
259017|NCT01061736|626299|P1|STARTED|Overall Study||50
259018|NCT01061775|626332|P1|NOT COMPLETED|Overall Study||3
259019|NCT01061775|626332|P1|COMPLETED|Overall Study||16
259020|NCT01061775|626332|P1|STARTED|Overall Study||19
259021|NCT01061866|626339|P1|NOT COMPLETED|Overall Study||2
259022|NCT01061866|626339|P1|COMPLETED|Overall Study||5
259023|NCT01061866|626339|P1|STARTED|Overall Study||7
259024|NCT01062061|626343|P1|NOT COMPLETED|Overall Study||27
259025|NCT01062061|626343|P1|COMPLETED|Overall Study||727
259026|NCT01062061|626343|P1|STARTED|Overall Study||754
259027|NCT01062074|626357|P1|NOT COMPLETED|Overall Study||0
259028|NCT01062074|626357|P1|COMPLETED|Overall Study||3605
259029|NCT01062074|626357|P1|STARTED|Overall Study||3605
259030|NCT01062113|626365|P3|NOT COMPLETED|Overall Study||31
259031|NCT01062113|626366|P2|NOT COMPLETED|Overall Study||22
259032|NCT01062113|626367|P1|NOT COMPLETED|Overall Study||40
259033|NCT01062113|626365|P3|COMPLETED|Overall Study||27
259034|NCT01062113|626366|P2|COMPLETED|Overall Study||42
259035|NCT01062113|626367|P1|COMPLETED|Overall Study||93
259036|NCT01062113|626365|P3|STARTED|Overall Study||58
259037|NCT01062113|626366|P2|STARTED|Overall Study||64
259038|NCT01062113|626367|P1|STARTED|Overall Study||133
259039|NCT01062165|626380|P1|NOT COMPLETED|Overall Study||0
259040|NCT01062165|626380|P1|COMPLETED|Overall Study||18
259041|NCT01062165|626380|P1|STARTED|Overall Study||18
259042|NCT01062230|626384|P1|NOT COMPLETED|Overall Study||0
259043|NCT01062230|626384|P1|COMPLETED|Overall Study||6
259044|NCT01062230|626384|P1|STARTED|Overall Study||6
259045|NCT01062256|626391|P3|NOT COMPLETED|Overall Study||4
259046|NCT01062256|626392|P2|NOT COMPLETED|Overall Study||7
259047|NCT01062256|626393|P1|NOT COMPLETED|Overall Study||3
259048|NCT01062256|626391|P3|COMPLETED|Overall Study||103
259049|NCT01062256|626392|P2|COMPLETED|Overall Study||96
259050|NCT01062256|626393|P1|COMPLETED|Overall Study||52
259051|NCT01062256|626391|P3|STARTED|Overall Study||107
259052|NCT01062256|626392|P2|STARTED|Overall Study||103
259053|NCT01062256|626393|P1|STARTED|Overall Study||55
259054|NCT01062269|626416|P1|NOT COMPLETED|Overall Study||0
259055|NCT01062269|626416|P1|COMPLETED|Overall Study||42
259056|NCT01062269|626416|P1|STARTED|Overall Study||42
259057|NCT01062308|626429|P2|NOT COMPLETED|Overall Study||10
259058|NCT01062308|626430|P1|NOT COMPLETED|Overall Study||16
259059|NCT01062308|626429|P2|COMPLETED|Overall Study||72
259060|NCT01062308|626430|P1|COMPLETED|Overall Study||64
259061|NCT01062308|626429|P2|STARTED|Overall Study||82
259062|NCT01062308|626430|P1|STARTED|Overall Study||80
259063|NCT01062425|626440|P2|NOT COMPLETED|Overall Study||6
259064|NCT01062425|626441|P1|NOT COMPLETED|Overall Study||3
259065|NCT01062425|626440|P2|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|97
259066|NCT01062425|626441|P1|COMPLETED|Overall Study|Randomized eligible subjects are considered to have completed the study.|52
259067|NCT01062425|626440|P2|STARTED|Overall Study||103
259068|NCT01062425|626441|P1|STARTED|Overall Study||55
259069|NCT01056016|626455|P2|NOT COMPLETED|Overall Study||1
259070|NCT01056016|626456|P1|NOT COMPLETED|Overall Study||2
259071|NCT01056016|626455|P2|COMPLETED|Overall Study||26
259072|NCT01056016|626456|P1|COMPLETED|Overall Study||20
259073|NCT01056016|626455|P2|STARTED|Overall Study|27 pediatricians were at 4 practices; practices were unit of randomization|27
259074|NCT01056016|626456|P1|STARTED|Overall Study|22 pediatricians were at 4 practices; practices were unit of randomization|22
259075|NCT01062763|626464|P2|NOT COMPLETED|Overall Study||4
259076|NCT01062763|626465|P1|NOT COMPLETED|Overall Study||3
259077|NCT01062763|626464|P2|COMPLETED|Overall Study||57
259078|NCT01062763|626465|P1|COMPLETED|Overall Study||55
259079|NCT01062763|626464|P2|STARTED|Overall Study||61
259080|NCT01062763|626465|P1|STARTED|Overall Study|119 randomized.|58
259081|NCT01067846|626477|P2|NOT COMPLETED|Overall Study||19
259082|NCT01067846|626478|P1|NOT COMPLETED|Overall Study||19
259083|NCT01067846|626477|P2|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|11
259084|NCT01067846|626478|P1|COMPLETED|Overall Study|Participants that completed all 4 weeks of treatment.|10
259085|NCT01067846|626477|P2|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
259086|NCT01067846|626478|P1|Completed 3 Tx Sessions|Overall Study|Our final analysis includes these participants.|15
259087|NCT01067846|626477|P2|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|30
259088|NCT01067846|626478|P1|STARTED|Overall Study|Due to exclusion prior to group assignment, Study Enrollment will not equal Total # of Participants.|29
259089|NCT01067976|626486|P1|NOT COMPLETED|Overall Study||22
259090|NCT01067976|626486|P1|COMPLETED|Overall Study|study course completed|424
259091|NCT01067976|626486|P1|Fulfilled Requirements of FAS Population|Overall Study||390
259092|NCT01067976|626486|P1|Received Treatment|Overall Study|treatment started|426
259093|NCT01067976|626486|P1|STARTED|Overall Study|screened and enrolled|446
259094|NCT01068158|626547|P2|NOT COMPLETED|Overall Study||4
259095|NCT01068158|626548|P1|NOT COMPLETED|Overall Study||8
259096|NCT01068158|626547|P2|COMPLETED|Overall Study||198
259097|NCT01068158|626548|P1|COMPLETED|Overall Study||161
259098|NCT01068158|626547|P2|STARTED|Overall Study||202
259099|NCT01068158|626548|P1|STARTED|Overall Study||169
259100|NCT01068262|626564|P4|NOT COMPLETED|Overall Study||0
259101|NCT01068262|626565|P3|NOT COMPLETED|Overall Study||1
259102|NCT01068262|626566|P2|NOT COMPLETED|Overall Study||1
259103|NCT01068262|626567|P1|NOT COMPLETED|Overall Study||3
259104|NCT01068262|626564|P4|COMPLETED|Overall Study||2
259105|NCT01068262|626565|P3|COMPLETED|Overall Study||9
259106|NCT01068262|626566|P2|COMPLETED|Overall Study||8
259107|NCT01068262|626567|P1|COMPLETED|Overall Study||20
259108|NCT01068262|626564|P4|STARTED|Overall Study||2
259109|NCT01068262|626565|P3|STARTED|Overall Study||10
259110|NCT01068262|626566|P2|STARTED|Overall Study||9
259111|NCT01068262|626567|P1|STARTED|Overall Study||23
259112|NCT01068418|626595|P1|NOT COMPLETED|Overall Study||12
259113|NCT01068418|626595|P1|COMPLETED|Overall Study|14 participants completed all study procedures.|14
259114|NCT01068418|626595|P1|Medication Washout|Overall Study|9 participants were disempaneled during the medication washout phase due to noncompliance or high BP|17
259115|NCT01068418|626595|P1|STARTED|Overall Study|26 participants found to be eligible|26
259116|NCT01068509|626603|P3|NOT COMPLETED|Overall Study||21
259117|NCT01068509|626604|P2|NOT COMPLETED|Overall Study||22
259118|NCT01068509|626605|P1|NOT COMPLETED|Overall Study||6
259119|NCT01068509|626603|P3|COMPLETED|Overall Study||6
259120|NCT01068509|626604|P2|COMPLETED|Overall Study||7
259121|NCT01068509|626605|P1|COMPLETED|Overall Study||1
259122|NCT01068509|626603|P3|STARTED|Overall Study||27
259123|NCT01068509|626604|P2|STARTED|Overall Study||29
259124|NCT01068509|626605|P1|STARTED|Overall Study||7
259125|NCT01068548|626620|P2|NOT COMPLETED|Overall Study||0
259126|NCT01068548|626621|P1|NOT COMPLETED|Overall Study||0
259127|NCT01068548|626620|P2|COMPLETED|Overall Study||63
259128|NCT01068548|626621|P1|COMPLETED|Overall Study||66
259129|NCT01068548|626620|P2|STARTED|Overall Study||63
259130|NCT01068548|626621|P1|STARTED|Overall Study||66
259131|NCT01068600|626629|P2|NOT COMPLETED|Overall Study||17
259132|NCT01068600|626630|P1|NOT COMPLETED|Overall Study||11
259133|NCT01068600|626629|P2|COMPLETED|Overall Study||142
259134|NCT01068600|626630|P1|COMPLETED|Overall Study||148
259135|NCT01068600|626629|P2|STARTED|Overall Study||159
259136|NCT01068600|626630|P1|STARTED|Overall Study||159
259137|NCT01068626|626640|P2|NOT COMPLETED|Overall Study||2
259138|NCT01068626|626641|P1|NOT COMPLETED|Overall Study||3
259139|NCT01068626|626640|P2|COMPLETED|Overall Study||27
259140|NCT01068626|626641|P1|COMPLETED|Overall Study||27
259141|NCT01068626|626640|P2|STARTED|Overall Study||29
259142|NCT01068626|626641|P1|STARTED|Overall Study||30
259143|NCT01068652|626659|P2|NOT COMPLETED|Overall Study||15
259144|NCT01068652|626660|P1|NOT COMPLETED|Overall Study||18
259145|NCT01068652|626659|P2|COMPLETED|Overall Study||188
259146|NCT01068652|626660|P1|COMPLETED|Overall Study||182
259147|NCT01068652|626659|P2|STARTED|Overall Study||203
259148|NCT01068652|626660|P1|STARTED|Overall Study||200
259149|NCT01068665|626700|P2|NOT COMPLETED|Overall Study||29
259150|NCT01068665|626701|P1|NOT COMPLETED|Overall Study||30
259151|NCT01068665|626700|P2|COMPLETED|Overall Study||201
259152|NCT01068665|626701|P1|COMPLETED|Overall Study||200
259153|NCT01068665|626700|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug.|228
259154|NCT01068665|626701|P1|Exposed|Overall Study||228
259155|NCT01068665|626700|P2|Full Analysis Set|Overall Study|One subject was withdrawn because the subject was randomised in error.|229
259156|NCT01068665|626701|P1|Full Analysis Set|Overall Study|Two subjects were withdrawn because the subjects were randomised in error.|228
259157|NCT01068665|626700|P2|STARTED|Overall Study||230
259158|NCT01068665|626701|P1|STARTED|Overall Study||230
259159|NCT01068678|626711|P2|NOT COMPLETED|Overall Study||24
259160|NCT01068678|626712|P1|NOT COMPLETED|Overall Study||38
259161|NCT01068678|626711|P2|COMPLETED|Overall Study||206
259162|NCT01068678|626712|P1|COMPLETED|Overall Study||192
259163|NCT01068678|626711|P2|Exposed|Overall Study|one subject withdrew prior to exposure to trial product|229
259164|NCT01068678|626712|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial product.|227
259165|NCT01068678|626711|P2|STARTED|Overall Study||230
259166|NCT01068678|626712|P1|STARTED|Overall Study||230
259167|NCT01068717|626720|P4|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
259168|NCT01068717|626721|P3|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
259169|NCT01068717|626722|P2|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
259170|NCT01068717|626723|P1|NOT COMPLETED|Period 4: Treatment Schedule Phase 4||0
259171|NCT01068717|626720|P4|COMPLETED|Period 4: Treatment Schedule Phase 4||7
259172|NCT01068717|626721|P3|COMPLETED|Period 4: Treatment Schedule Phase 4||7
259173|NCT01068717|626722|P2|COMPLETED|Period 4: Treatment Schedule Phase 4||6
259174|NCT01068717|626723|P1|COMPLETED|Period 4: Treatment Schedule Phase 4||7
259175|NCT01068717|626720|P4|STARTED|Period 4: Treatment Schedule Phase 4||7
259176|NCT01068717|626721|P3|STARTED|Period 4: Treatment Schedule Phase 4||7
259177|NCT01068717|626722|P2|STARTED|Period 4: Treatment Schedule Phase 4||6
259178|NCT01068717|626723|P1|STARTED|Period 4: Treatment Schedule Phase 4|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
259179|NCT01068717|626720|P4|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
259180|NCT01068717|626721|P3|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
259181|NCT01068717|626722|P2|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
259182|NCT01068717|626723|P1|NOT COMPLETED|Period 3: Treatment Schedule Phase 3||0
259183|NCT01068717|626720|P4|COMPLETED|Period 3: Treatment Schedule Phase 3||7
259184|NCT01068717|626721|P3|COMPLETED|Period 3: Treatment Schedule Phase 3||7
259185|NCT01068717|626722|P2|COMPLETED|Period 3: Treatment Schedule Phase 3||6
259186|NCT01068717|626723|P1|COMPLETED|Period 3: Treatment Schedule Phase 3||7
259187|NCT01068717|626720|P4|STARTED|Period 3: Treatment Schedule Phase 3||7
259188|NCT01068717|626721|P3|STARTED|Period 3: Treatment Schedule Phase 3||7
259189|NCT01068717|626722|P2|STARTED|Period 3: Treatment Schedule Phase 3||6
259190|NCT01068717|626723|P1|STARTED|Period 3: Treatment Schedule Phase 3|Patient who withdrew during Treatment Period 1 returned for Treatment Periods 3 and 4.|7
259191|NCT01068717|626720|P4|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
259192|NCT01068717|626721|P3|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
259193|NCT01068717|626722|P2|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
259194|NCT01068717|626723|P1|NOT COMPLETED|Period 2: Treatment Schedule Phase 2||0
259195|NCT01068717|626720|P4|COMPLETED|Period 2: Treatment Schedule Phase 2||7
259196|NCT01068717|626721|P3|COMPLETED|Period 2: Treatment Schedule Phase 2||7
259197|NCT01068717|626722|P2|COMPLETED|Period 2: Treatment Schedule Phase 2||6
259198|NCT01068717|626723|P1|COMPLETED|Period 2: Treatment Schedule Phase 2||6
259199|NCT01068717|626720|P4|STARTED|Period 2: Treatment Schedule Phase 2||7
259200|NCT01068717|626721|P3|STARTED|Period 2: Treatment Schedule Phase 2||7
259201|NCT01068717|626722|P2|STARTED|Period 2: Treatment Schedule Phase 2||6
259202|NCT01068717|626723|P1|STARTED|Period 2: Treatment Schedule Phase 2||6
259203|NCT01068717|626720|P4|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
259204|NCT01068717|626721|P3|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
259205|NCT01068717|626722|P2|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||0
259206|NCT01068717|626723|P1|NOT COMPLETED|Period 1: Treatment Schedule Phase 1||1
259207|NCT01068717|626720|P4|COMPLETED|Period 1: Treatment Schedule Phase 1||7
259208|NCT01068717|626721|P3|COMPLETED|Period 1: Treatment Schedule Phase 1||7
259209|NCT01068717|626722|P2|COMPLETED|Period 1: Treatment Schedule Phase 1||6
259210|NCT01068717|626723|P1|COMPLETED|Period 1: Treatment Schedule Phase 1|Patient who withdrew returned for Treatment Periods 3 and 4.|6
259211|NCT01068717|626720|P4|STARTED|Period 1: Treatment Schedule Phase 1||7
259212|NCT01068717|626721|P3|STARTED|Period 1: Treatment Schedule Phase 1||7
259213|NCT01068717|626722|P2|STARTED|Period 1: Treatment Schedule Phase 1||6
259214|NCT01068717|626723|P1|STARTED|Period 1: Treatment Schedule Phase 1||7
259215|NCT01068730|626777|P4|NOT COMPLETED|Period 4||0
259216|NCT01068730|626778|P3|NOT COMPLETED|Period 4||0
259217|NCT01068730|626779|P2|NOT COMPLETED|Period 4||1
259218|NCT01068730|626780|P1|NOT COMPLETED|Period 4||0
259219|NCT01068730|626777|P4|COMPLETED|Period 4||7
259220|NCT01068730|626778|P3|COMPLETED|Period 4||7
259221|NCT01068730|626779|P2|COMPLETED|Period 4||6
259222|NCT01068730|626780|P1|COMPLETED|Period 4||6
259223|NCT01068730|626777|P4|STARTED|Period 4||7
259224|NCT01068730|626778|P3|STARTED|Period 4||7
259225|NCT01068730|626779|P2|STARTED|Period 4||7
259226|NCT01068730|626780|P1|STARTED|Period 4||6
259227|NCT01068730|626777|P4|NOT COMPLETED|Period 3||0
259228|NCT01068730|626778|P3|NOT COMPLETED|Period 3||0
259229|NCT01068730|626779|P2|NOT COMPLETED|Period 3||0
259230|NCT01068730|626780|P1|NOT COMPLETED|Period 3||1
259231|NCT01068730|626777|P4|COMPLETED|Period 3||7
259232|NCT01068730|626778|P3|COMPLETED|Period 3||7
259233|NCT01068730|626779|P2|COMPLETED|Period 3||7
259234|NCT01068730|626780|P1|COMPLETED|Period 3||6
259235|NCT01068730|626777|P4|STARTED|Period 3||7
259236|NCT01068730|626778|P3|STARTED|Period 3||7
259237|NCT01068730|626779|P2|STARTED|Period 3||7
259238|NCT01068730|626780|P1|STARTED|Period 3||7
259239|NCT01068730|626777|P4|NOT COMPLETED|Period 2||0
259240|NCT01068730|626778|P3|NOT COMPLETED|Period 2||0
259241|NCT01068730|626779|P2|NOT COMPLETED|Period 2||0
259242|NCT01068730|626780|P1|NOT COMPLETED|Period 2||0
259243|NCT01068730|626777|P4|COMPLETED|Period 2||7
259244|NCT01068730|626778|P3|COMPLETED|Period 2||7
259245|NCT01068730|626779|P2|COMPLETED|Period 2||7
259246|NCT01068730|626780|P1|COMPLETED|Period 2||7
259247|NCT01068730|626777|P4|STARTED|Period 2||7
259248|NCT01068730|626778|P3|STARTED|Period 2||7
259249|NCT01068730|626779|P2|STARTED|Period 2||7
259250|NCT01068730|626780|P1|STARTED|Period 2||7
259251|NCT01068730|626777|P4|NOT COMPLETED|Period 1||0
259252|NCT01068730|626778|P3|NOT COMPLETED|Period 1||0
259253|NCT01068730|626779|P2|NOT COMPLETED|Period 1||0
259254|NCT01068730|626780|P1|NOT COMPLETED|Period 1||0
259255|NCT01068730|626777|P4|COMPLETED|Period 1||7
259256|NCT01068730|626778|P3|COMPLETED|Period 1||7
259257|NCT01068730|626779|P2|COMPLETED|Period 1||7
259258|NCT01068730|626780|P1|COMPLETED|Period 1||7
259259|NCT01068730|626777|P4|STARTED|Period 1||7
259260|NCT01068730|626778|P3|STARTED|Period 1||7
259261|NCT01068730|626779|P2|STARTED|Period 1||7
259262|NCT01068730|626780|P1|STARTED|Period 1||7
259263|NCT01068743|626834|P4|NOT COMPLETED|Period 4||0
259264|NCT01068743|626835|P3|NOT COMPLETED|Period 4||0
259265|NCT01068743|626836|P2|NOT COMPLETED|Period 4||0
259266|NCT01068743|626837|P1|NOT COMPLETED|Period 4||0
259267|NCT01068743|626834|P4|COMPLETED|Period 4||6
259268|NCT01068743|626835|P3|COMPLETED|Period 4||6
259269|NCT01068743|626836|P2|COMPLETED|Period 4||5
259270|NCT01068743|626837|P1|COMPLETED|Period 4||6
259271|NCT01068743|626834|P4|STARTED|Period 4||6
259272|NCT01068743|626835|P3|STARTED|Period 4||6
259273|NCT01068743|626836|P2|STARTED|Period 4||5
259274|NCT01068743|626837|P1|STARTED|Period 4||6
259275|NCT01068743|626834|P4|NOT COMPLETED|Period 3||0
259276|NCT01068743|626835|P3|NOT COMPLETED|Period 3||0
259277|NCT01068743|626836|P2|NOT COMPLETED|Period 3||1
259278|NCT01068743|626837|P1|NOT COMPLETED|Period 3||0
259279|NCT01068743|626834|P4|COMPLETED|Period 3||6
259280|NCT01068743|626835|P3|COMPLETED|Period 3||6
259281|NCT01068743|626836|P2|COMPLETED|Period 3||5
259282|NCT01068743|626837|P1|COMPLETED|Period 3||6
259283|NCT01068743|626834|P4|STARTED|Period 3||6
259284|NCT01068743|626835|P3|STARTED|Period 3||6
259285|NCT01068743|626836|P2|STARTED|Period 3||6
259286|NCT01068743|626837|P1|STARTED|Period 3||6
259287|NCT01068743|626834|P4|NOT COMPLETED|Period 2||0
259288|NCT01068743|626835|P3|NOT COMPLETED|Period 2||0
259289|NCT01068743|626836|P2|NOT COMPLETED|Period 2||0
259290|NCT01068743|626837|P1|NOT COMPLETED|Period 2||0
259291|NCT01068743|626834|P4|COMPLETED|Period 2||6
259292|NCT01068743|626835|P3|COMPLETED|Period 2||6
259293|NCT01068743|626836|P2|COMPLETED|Period 2||6
259294|NCT01068743|626837|P1|COMPLETED|Period 2||6
259295|NCT01068743|626834|P4|STARTED|Period 2||6
259296|NCT01068743|626835|P3|STARTED|Period 2||6
259297|NCT01068743|626836|P2|STARTED|Period 2||6
259298|NCT01068743|626837|P1|STARTED|Period 2||6
259299|NCT01068743|626834|P4|NOT COMPLETED|Period 1||0
259300|NCT01068743|626835|P3|NOT COMPLETED|Period 1||0
259301|NCT01068743|626836|P2|NOT COMPLETED|Period 1||0
259302|NCT01068743|626837|P1|NOT COMPLETED|Period 1||0
259303|NCT01068743|626834|P4|COMPLETED|Period 1||6
259304|NCT01068743|626835|P3|COMPLETED|Period 1||6
259305|NCT01068743|626836|P2|COMPLETED|Period 1||6
259306|NCT01068743|626837|P1|COMPLETED|Period 1||6
259307|NCT01068743|626834|P4|STARTED|Period 1||6
259308|NCT01068743|626835|P3|STARTED|Period 1||6
259309|NCT01068743|626836|P2|STARTED|Period 1||6
259310|NCT01068743|626837|P1|STARTED|Period 1||6
259311|NCT01068769|626911|P1|NOT COMPLETED|Overall Study||1
259312|NCT01068769|626911|P1|COMPLETED|Overall Study||33
259313|NCT01068769|626911|P1|STARTED|Overall Study||34
259314|NCT01068821|626918|P2|NOT COMPLETED|Overall Study||0
259315|NCT01068821|626919|P1|NOT COMPLETED|Overall Study||1
259316|NCT01068821|626918|P2|COMPLETED|Overall Study||29
259317|NCT01068821|626919|P1|COMPLETED|Overall Study|1 patient had slide measured, but her patient ID not listed; couldn't do postoperative followup.|30
259318|NCT01068821|626918|P2|STARTED|Overall Study||29
259319|NCT01068821|626919|P1|STARTED|Overall Study||31
259320|NCT01068860|626937|P10|NOT COMPLETED|Overall Study||4
259321|NCT01068860|626938|P9|NOT COMPLETED|Overall Study||0
259322|NCT01068860|626939|P8|NOT COMPLETED|Overall Study||0
259323|NCT01068860|626940|P7|NOT COMPLETED|Overall Study||0
259324|NCT01068860|626941|P6|NOT COMPLETED|Overall Study||2
259325|NCT01068860|626942|P5|NOT COMPLETED|Overall Study||0
259326|NCT01068860|626943|P4|NOT COMPLETED|Overall Study||1
259327|NCT01068860|626944|P3|NOT COMPLETED|Overall Study||0
259328|NCT01068860|626945|P2|NOT COMPLETED|Overall Study||1
259329|NCT01068860|626946|P1|NOT COMPLETED|Overall Study||0
259330|NCT01068860|626937|P10|COMPLETED|Overall Study||23
259331|NCT01068860|626938|P9|COMPLETED|Overall Study||28
259332|NCT01068860|626939|P8|COMPLETED|Overall Study||15
259333|NCT01068860|626940|P7|COMPLETED|Overall Study||28
259334|NCT01068860|626941|P6|COMPLETED|Overall Study||14
259335|NCT01068860|626942|P5|COMPLETED|Overall Study||32
259336|NCT01068860|626943|P4|COMPLETED|Overall Study||16
259337|NCT01068860|626944|P3|COMPLETED|Overall Study||33
259338|NCT01068860|626945|P2|COMPLETED|Overall Study||16
259339|NCT01068860|626946|P1|COMPLETED|Overall Study||33
259340|NCT01068860|626937|P10|STARTED|Overall Study||27
259341|NCT01068860|626938|P9|STARTED|Overall Study||28
259342|NCT01068860|626939|P8|STARTED|Overall Study||15
259343|NCT01068860|626940|P7|STARTED|Overall Study||28
259344|NCT01068860|626941|P6|STARTED|Overall Study||16
259345|NCT01068860|626942|P5|STARTED|Overall Study||32
259346|NCT01068860|626943|P4|STARTED|Overall Study||17
259347|NCT01068860|626944|P3|STARTED|Overall Study||33
259348|NCT01068860|626945|P2|STARTED|Overall Study||17
259349|NCT01068860|626946|P1|STARTED|Overall Study||33
259350|NCT01068912|627121|P3|NOT COMPLETED|Overall Study||15
259351|NCT01068912|627122|P2|NOT COMPLETED|Overall Study||22
259352|NCT01068912|627123|P1|NOT COMPLETED|Overall Study||11
259353|NCT01068912|627121|P3|COMPLETED|Overall Study||186
259354|NCT01068912|627122|P2|COMPLETED|Overall Study||173
259355|NCT01068912|627123|P1|COMPLETED|Overall Study||123
259356|NCT01068912|627121|P3|STARTED|Overall Study||201
259357|NCT01068912|627122|P2|STARTED|Overall Study||195
259358|NCT01068912|627123|P1|STARTED|Overall Study||134
259359|NCT01068964|627133|P2|NOT COMPLETED|Overall Study||10
259360|NCT01068964|627134|P1|NOT COMPLETED|Overall Study||8
259361|NCT01068964|627133|P2|COMPLETED|Overall Study||104
259362|NCT01068964|627134|P1|COMPLETED|Overall Study||113
259363|NCT01068964|627133|P2|STARTED|Overall Study||114
259364|NCT01068964|627134|P1|STARTED|Overall Study||121
259365|NCT01069003|627143|P3|NOT COMPLETED|Overall Study||475
259366|NCT01069003|627144|P2|NOT COMPLETED|Overall Study||54
259367|NCT01069003|627145|P1|NOT COMPLETED|Overall Study||46
259368|NCT01069003|627143|P3|COMPLETED|Overall Study||976
259369|NCT01069003|627144|P2|COMPLETED|Overall Study||358
259370|NCT01069003|627145|P1|COMPLETED|Overall Study||353
259371|NCT01069003|627143|P3|STARTED|Overall Study||1451
259372|NCT01069003|627144|P2|STARTED|Overall Study||412
259373|NCT01069003|627145|P1|STARTED|Overall Study||399
259374|NCT01069120|627161|P1|NOT COMPLETED|Overall Study||27
259375|NCT01069120|627161|P1|COMPLETED|Overall Study||0
259376|NCT01069120|627161|P1|STARTED|Overall Study||27
259377|NCT01069172|627167|P2|NOT COMPLETED|Overall Study||0
259378|NCT01069172|627168|P1|NOT COMPLETED|Overall Study||1
259379|NCT01069172|627167|P2|COMPLETED|Overall Study|30 eyes|30
259380|NCT01069172|627168|P1|COMPLETED|Overall Study|29 eyes|29
259381|NCT01069172|627167|P2|STARTED|Overall Study|30 eyes|30
259382|NCT01069172|627168|P1|STARTED|Overall Study|30 eyes|30
259383|NCT01069289|627178|P2|NOT COMPLETED|Overall Study||56
259384|NCT01069289|627179|P1|NOT COMPLETED|Overall Study||42
259385|NCT01069289|627178|P2|COMPLETED|Overall Study||601
259386|NCT01069289|627179|P1|COMPLETED|Overall Study||594
259387|NCT01069289|627178|P2|STARTED|Overall Study||657
259388|NCT01069289|627179|P1|STARTED|Overall Study||636
259389|NCT01069341|627217|P1|NOT COMPLETED|Overall Study||1
259390|NCT01069341|627217|P1|COMPLETED|Overall Study||3
259391|NCT01069341|627217|P1|STARTED|Overall Study||4
259392|NCT01069419|627228|P1|NOT COMPLETED|Overall Study||715
259393|NCT01069419|627228|P1|COMPLETED|Overall Study||402
259394|NCT01069419|627228|P1|Full Analysis Set|Overall Study||851
259395|NCT01069419|627228|P1|Safety Set|Overall Study||1111
259396|NCT01069419|627228|P1|STARTED|Overall Study||1117
259397|NCT01069484|627237|P2|NOT COMPLETED|Overall Study||3
259398|NCT01069484|627238|P1|NOT COMPLETED|Overall Study||12
259399|NCT01069484|627237|P2|COMPLETED|Overall Study|27 in the stratum with major levator ani muscle defects and 58 in the stratum without such defects.|85
259400|NCT01069484|627238|P1|COMPLETED|Overall Study|24 in the stratum with major levator ani muscle defects and 51 in the stratum without such defects.|75
259401|NCT01069484|627237|P2|STARTED|Overall Study|28 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|88
259402|NCT01069484|627238|P1|STARTED|Overall Study|27 in the stratum with major levator ani muscle defects and 60 in the stratum without such defects.|87
259403|NCT01069523|627248|P2|NOT COMPLETED|Overall Study||7
259404|NCT01069523|627249|P1|NOT COMPLETED|Overall Study||4
259405|NCT01069523|627248|P2|COMPLETED|Overall Study||9
259406|NCT01069523|627249|P1|COMPLETED|Overall Study||9
259407|NCT01069523|627248|P2|STARTED|Overall Study||16
259408|NCT01069523|627249|P1|STARTED|Overall Study||13
259409|NCT01069562|627259|P2|NOT COMPLETED|Overall Study||0
259410|NCT01069562|627260|P1|NOT COMPLETED|Overall Study||0
259411|NCT01069562|627259|P2|COMPLETED|Overall Study||20
259412|NCT01069562|627260|P1|COMPLETED|Overall Study||20
259413|NCT01069562|627259|P2|STARTED|Overall Study||20
259414|NCT01069562|627260|P1|STARTED|Overall Study||20
259415|NCT01069627|627284|P1|NOT COMPLETED|Overall Study||20
259416|NCT01069627|627284|P1|COMPLETED|Overall Study||0
259417|NCT01069627|627284|P1|STARTED|Overall Study||20
259418|NCT01069861|627305|P1|NOT COMPLETED|Overall Study||3
259419|NCT01069861|627305|P1|COMPLETED|Overall Study||1
259420|NCT01069861|627305|P1|STARTED|Overall Study||4
259421|NCT01069900|627320|P2|NOT COMPLETED|Overall Study||4
259422|NCT01069900|627321|P1|NOT COMPLETED|Overall Study||18
259423|NCT01069900|627320|P2|COMPLETED|Overall Study||149
259424|NCT01069900|627321|P1|COMPLETED|Overall Study||287
259425|NCT01069900|627320|P2|Treated|Overall Study||150
259426|NCT01069900|627321|P1|Treated|Overall Study||301
259427|NCT01069900|627320|P2|STARTED|Overall Study||153
259428|NCT01069900|627321|P1|STARTED|Overall Study||305
259429|NCT01069939|627367|P2|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||32
259430|NCT01069939|627368|P1|NOT COMPLETED|At Data Cut Off Date (26 Feb 2011)||31
259431|NCT01069939|627367|P2|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
259432|NCT01069939|627368|P1|COMPLETED|At Data Cut Off Date (26 Feb 2011)||182
259433|NCT01069939|627367|P2|STARTED|At Data Cut Off Date (26 Feb 2011)||214
259434|NCT01069939|627368|P1|STARTED|At Data Cut Off Date (26 Feb 2011)||213
259435|NCT01069939|627367|P2|NOT COMPLETED|Randomised and Included in the Analyses||77
259436|NCT01069939|627368|P1|NOT COMPLETED|Randomised and Included in the Analyses||49
259437|NCT01069939|627367|P2|COMPLETED|Randomised and Included in the Analyses||137
259438|NCT01069939|627368|P1|COMPLETED|Randomised and Included in the Analyses||164
259439|NCT01069939|627367|P2|STARTED|Randomised and Included in the Analyses||214
259440|NCT01069939|627368|P1|STARTED|Randomised and Included in the Analyses||213
259441|NCT01070043|627394|P3|NOT COMPLETED|Double-Blind Treatment||2
259442|NCT01070043|627395|P2|NOT COMPLETED|Double-Blind Treatment||0
259443|NCT01070043|627396|P1|NOT COMPLETED|Double-Blind Treatment||0
259444|NCT01070043|627394|P3|COMPLETED|Double-Blind Treatment||19
259445|NCT01070043|627395|P2|COMPLETED|Double-Blind Treatment||21
259446|NCT01070043|627396|P1|COMPLETED|Double-Blind Treatment||0
259447|NCT01070043|627394|P3|STARTED|Double-Blind Treatment||21
259448|NCT01070043|627395|P2|STARTED|Double-Blind Treatment||21
259449|NCT01070043|627396|P1|STARTED|Double-Blind Treatment||0
259450|NCT01070043|627394|P3|NOT COMPLETED|Run-In Phase||0
259451|NCT01070043|627395|P2|NOT COMPLETED|Run-In Phase||0
259452|NCT01070043|627396|P1|NOT COMPLETED|Run-In Phase||18
259453|NCT01070043|627394|P3|COMPLETED|Run-In Phase||0
259454|NCT01070043|627395|P2|COMPLETED|Run-In Phase||0
259455|NCT01070043|627396|P1|COMPLETED|Run-In Phase||42
259456|NCT01070043|627394|P3|STARTED|Run-In Phase|This monotherapy (Valsartan 160 mg) treatment arm is used only for double-blind phase.|0
259457|NCT01070043|627395|P2|STARTED|Run-In Phase|This combination therapy arm is used only for double-blind phase.|0
259458|NCT01070043|627396|P1|STARTED|Run-In Phase||60
259459|NCT01070173|627413|P3|NOT COMPLETED|Overall Study||0
259460|NCT01070173|627414|P2|NOT COMPLETED|Overall Study||0
259461|NCT01070173|627415|P1|NOT COMPLETED|Overall Study||0
259462|NCT01070173|627413|P3|COMPLETED|Overall Study||11
259463|NCT01070173|627414|P2|COMPLETED|Overall Study||8
259464|NCT01070173|627415|P1|COMPLETED|Overall Study||33
259465|NCT01070173|627413|P3|STARTED|Overall Study||11
259466|NCT01070173|627414|P2|STARTED|Overall Study||8
259467|NCT01070173|627415|P1|STARTED|Overall Study||33
259468|NCT01070303|627428|P1|NOT COMPLETED|Overall Study||89
259469|NCT01070303|627428|P1|COMPLETED|Overall Study||88
259470|NCT01070303|627428|P1|STARTED|Overall Study||177
259471|NCT01070316|627484|P1|NOT COMPLETED|Extension Phase||4
259472|NCT01070316|627484|P1|COMPLETED|Extension Phase||14
259473|NCT01070316|627484|P1|STARTED|Extension Phase|Two participants did not qualify for Extension Phase as defined by protocol|18
259474|NCT01070316|627484|P1|NOT COMPLETED|Main Phase||0
259475|NCT01070316|627484|P1|COMPLETED|Main Phase||20
259476|NCT01070316|627484|P1|STARTED|Main Phase||20
259477|NCT01070329|627491|P2|NOT COMPLETED|Overall Study||49
259478|NCT01070329|627492|P1|NOT COMPLETED|Overall Study||52
259479|NCT01070329|627491|P2|COMPLETED|Overall Study||217
259480|NCT01070329|627492|P1|COMPLETED|Overall Study||209
259481|NCT01070329|627491|P2|STARTED|Overall Study||266
259482|NCT01070329|627492|P1|STARTED|Overall Study||261
259483|NCT01058941|627526|P2|NOT COMPLETED|Overall Study||11
259484|NCT01058941|627527|P1|NOT COMPLETED|Overall Study||9
259485|NCT01058941|627526|P2|COMPLETED|Overall Study||22
259486|NCT01058941|627527|P1|COMPLETED|Overall Study||25
259487|NCT01058941|627526|P2|STARTED|Overall Study||33
259488|NCT01058941|627527|P1|STARTED|Overall Study||34
259489|NCT01058993|627535|P1|NOT COMPLETED|Overall Study||0
259490|NCT01058993|627535|P1|COMPLETED|Overall Study||6
259491|NCT01058993|627535|P1|STARTED|Overall Study||6
259492|NCT01059071|627539|P4|NOT COMPLETED|Overall Study||6
259493|NCT01059071|627540|P3|NOT COMPLETED|Overall Study||2
259494|NCT01059071|627541|P2|NOT COMPLETED|Overall Study||4
259495|NCT01059071|627542|P1|NOT COMPLETED|Overall Study||2
259496|NCT01059071|627539|P4|COMPLETED|Overall Study||3
259497|NCT01059071|627540|P3|COMPLETED|Overall Study||1
259498|NCT01059071|627541|P2|COMPLETED|Overall Study||1
259499|NCT01059071|627542|P1|COMPLETED|Overall Study||2
259500|NCT01059071|627539|P4|STARTED|Overall Study||9
259501|NCT01059071|627540|P3|STARTED|Overall Study||3
259502|NCT01059071|627541|P2|STARTED|Overall Study||5
259503|NCT01059071|627542|P1|STARTED|Overall Study||4
259504|NCT01059175|627556|P2|NOT COMPLETED|Overall Study||20
259505|NCT01059175|627557|P1|NOT COMPLETED|Overall Study||21
259506|NCT01059175|627556|P2|COMPLETED|Overall Study|17 patients deceased 3 patients were prematurely exited|21
259507|NCT01059175|627557|P1|COMPLETED|Overall Study|17 patients deceased 4 additional patients were prematurely exited|22
259508|NCT01059175|627556|P2|STARTED|Overall Study||41
259509|NCT01059175|627557|P1|STARTED|Overall Study||43
259510|NCT01059305|627579|P1|NOT COMPLETED|Overall Study||0
259511|NCT01059305|627579|P1|COMPLETED|Overall Study||10
259512|NCT01059305|627579|P1|STARTED|Overall Study||10
259513|NCT01059344|627585|P2|NOT COMPLETED|Overall Study||46
259514|NCT01059344|627586|P1|NOT COMPLETED|Overall Study||22
259515|NCT01059344|627585|P2|COMPLETED|Overall Study||95
259516|NCT01059344|627586|P1|COMPLETED|Overall Study||118
259517|NCT01059344|627585|P2|STARTED|Overall Study||141
259518|NCT01059344|627586|P1|STARTED|Overall Study||140
259519|NCT01059526|627606|P2|NOT COMPLETED|Overall Study||22
259520|NCT01059526|627607|P1|NOT COMPLETED|Overall Study||30
259521|NCT01059526|627606|P2|COMPLETED|Overall Study||18
259522|NCT01059526|627607|P1|COMPLETED|Overall Study||11
259523|NCT01059526|627606|P2|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|23
259524|NCT01059526|627607|P1|Treated|Overall Study|Safety population; defined as all patients who received at least 1 treatment dose of KALBITOR|21
259525|NCT01059526|627606|P2|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|40
259526|NCT01059526|627607|P1|STARTED|Overall Study|ITT population; defined as signing informed consent and meeting all inclusion/ exclusion criteria|41
259527|NCT01059565|627617|P2|NOT COMPLETED|24-Week Open-Label Phase||3
259528|NCT01059565|627618|P1|NOT COMPLETED|24-Week Open-Label Phase||5
259529|NCT01059565|627617|P2|COMPLETED|24-Week Open-Label Phase||42
259530|NCT01059565|627618|P1|COMPLETED|24-Week Open-Label Phase||34
259531|NCT01059565|627617|P2|STARTED|24-Week Open-Label Phase||45
259532|NCT01059565|627618|P1|STARTED|24-Week Open-Label Phase||39
259533|NCT01059565|627617|P2|NOT COMPLETED|24-Week Randomized Phase||7
259534|NCT01059565|627618|P1|NOT COMPLETED|24-Week Randomized Phase||10
259535|NCT01059565|627617|P2|COMPLETED|24-Week Randomized Phase||45
259536|NCT01059565|627618|P1|COMPLETED|24-Week Randomized Phase||39
259537|NCT01059565|627617|P2|Randomized and Treated|24-Week Randomized Phase||52
259538|NCT01059565|627618|P1|Randomized and Treated|24-Week Randomized Phase||48
259539|NCT01059565|627617|P2|STARTED|24-Week Randomized Phase||52
259540|NCT01059565|627618|P1|STARTED|24-Week Randomized Phase||49
259541|NCT01059617|627656|P4|NOT COMPLETED|Overall Study||6
259542|NCT01059617|627657|P3|NOT COMPLETED|Overall Study||8
259543|NCT01059617|627658|P2|NOT COMPLETED|Overall Study||1
259544|NCT01059617|627659|P1|NOT COMPLETED|Overall Study||7
259545|NCT01059617|627656|P4|COMPLETED|Overall Study||27
259546|NCT01059617|627657|P3|COMPLETED|Overall Study||25
259547|NCT01059617|627658|P2|COMPLETED|Overall Study||33
259548|NCT01059617|627659|P1|COMPLETED|Overall Study||26
259549|NCT01059617|627656|P4|STARTED|Overall Study||33
259550|NCT01059617|627657|P3|STARTED|Overall Study||33
259551|NCT01059617|627658|P2|STARTED|Overall Study||34
259552|NCT01059617|627659|P1|STARTED|Overall Study||33
259553|NCT01059630|627829|P2|NOT COMPLETED|Maintenance Period (up to 2 Years)||108
259554|NCT01059630|627830|P1|NOT COMPLETED|Maintenance Period (up to 2 Years)||0
259555|NCT01059630|627829|P2|COMPLETED|Maintenance Period (up to 2 Years)||35
259556|NCT01059630|627830|P1|COMPLETED|Maintenance Period (up to 2 Years)||0
259557|NCT01059630|627829|P2|STARTED|Maintenance Period (up to 2 Years)|Of all participants who completed induction, 13 participants did not start maintenance.|143
259558|NCT01059630|627830|P1|STARTED|Maintenance Period (up to 2 Years)|Maintenance was not planned for this arm.|0
259559|NCT01059630|627829|P2|NOT COMPLETED|Induction Period (6 Months)||38
259560|NCT01059630|627830|P1|NOT COMPLETED|Induction Period (6 Months)||73
259561|NCT01059630|627829|P2|COMPLETED|Induction Period (6 Months)||156
259562|NCT01059630|627830|P1|COMPLETED|Induction Period (6 Months)||129
259563|NCT01059630|627829|P2|Treated|Induction Period (6 Months)||194
259564|NCT01059630|627830|P1|Treated|Induction Period (6 Months)||198
259565|NCT01059630|627829|P2|STARTED|Induction Period (6 Months)||194
259566|NCT01059630|627830|P1|STARTED|Induction Period (6 Months)||202
259567|NCT01059760|627888|P2|NOT COMPLETED|Overall Study||0
259568|NCT01059760|627889|P1|NOT COMPLETED|Overall Study||0
259569|NCT01059760|627888|P2|COMPLETED|Overall Study||14
259570|NCT01059760|627889|P1|COMPLETED|Overall Study||16
259571|NCT01059760|627888|P2|STARTED|Overall Study||14
259572|NCT01059760|627889|P1|STARTED|Overall Study||16
259573|NCT01059773|627997|P2|NOT COMPLETED|Overall Study||24
259574|NCT01059773|627998|P1|NOT COMPLETED|Overall Study||20
259575|NCT01059773|627997|P2|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|221
259576|NCT01059773|627998|P1|COMPLETED|Overall Study|Completed is refering to no Discontinuation of Study Agent Through Week 52|224
259577|NCT01059773|627997|P2|STARTED|Overall Study||245
259578|NCT01059773|627998|P1|STARTED|Overall Study||244
259579|NCT01059799|628030|P2|NOT COMPLETED|Overall Study||10
259580|NCT01059799|628031|P1|NOT COMPLETED|Overall Study||31
259581|NCT01059799|628030|P2|COMPLETED|Overall Study||136
259582|NCT01059799|628031|P1|COMPLETED|Overall Study||258
259583|NCT01059799|628030|P2|Exposed|Overall Study||146
259584|NCT01059799|628031|P1|Exposed|Overall Study|Five subjects withdrew before exposure to trial drug|284
259585|NCT01059799|628030|P2|STARTED|Overall Study||146
259586|NCT01059799|628031|P1|STARTED|Overall Study||289
259587|NCT01059812|628045|P2|NOT COMPLETED|Overall Study||16
259588|NCT01059812|628046|P1|NOT COMPLETED|Overall Study||37
259589|NCT01059812|628045|P2|COMPLETED|Overall Study||126
259590|NCT01059812|628046|P1|COMPLETED|Overall Study||245
259591|NCT01059812|628045|P2|Exposed|Overall Study|One subject withdrew prior to exposure to trial drug|141
259592|NCT01059812|628046|P1|Exposed|Overall Study|Three subjects withdrew prior to exposure to trial drug|279
259593|NCT01059812|628045|P2|STARTED|Overall Study||142
259594|NCT01059812|628046|P1|STARTED|Overall Study||282
259595|NCT01059851|628062|P6|NOT COMPLETED|Overall Study||0
259596|NCT01059851|628063|P5|NOT COMPLETED|Overall Study||0
259597|NCT01059851|628064|P4|NOT COMPLETED|Overall Study||0
259598|NCT01059851|628065|P3|NOT COMPLETED|Overall Study||0
259599|NCT01059851|628066|P2|NOT COMPLETED|Overall Study||0
259600|NCT01059851|628067|P1|NOT COMPLETED|Overall Study||0
259601|NCT01059851|628062|P6|COMPLETED|Overall Study||0
259602|NCT01059851|628063|P5|COMPLETED|Overall Study||0
259603|NCT01059851|628064|P4|COMPLETED|Overall Study||0
259604|NCT01059851|628065|P3|COMPLETED|Overall Study||0
259605|NCT01059851|628066|P2|COMPLETED|Overall Study||8
259606|NCT01059851|628067|P1|COMPLETED|Overall Study||8
259607|NCT01059851|628062|P6|STARTED|Overall Study||0
259608|NCT01059851|628063|P5|STARTED|Overall Study||0
259609|NCT01059851|628064|P4|STARTED|Overall Study||0
259610|NCT01059851|628065|P3|STARTED|Overall Study||0
259611|NCT01059851|628066|P2|STARTED|Overall Study||8
259612|NCT01059851|628067|P1|STARTED|Overall Study||8
259613|NCT01059864|628081|P3|NOT COMPLETED|Double-Blind Treatment Phase||3
259614|NCT01059864|628082|P2|NOT COMPLETED|Double-Blind Treatment Phase||3
259615|NCT01059864|628083|P1|NOT COMPLETED|Double-Blind Treatment Phase||0
259616|NCT01059864|628081|P3|COMPLETED|Double-Blind Treatment Phase||45
259617|NCT01059864|628082|P2|COMPLETED|Double-Blind Treatment Phase||47
259618|NCT01059864|628083|P1|COMPLETED|Double-Blind Treatment Phase||0
259619|NCT01059864|628081|P3|Treated|Double-Blind Treatment Phase||47
259620|NCT01059864|628082|P2|Treated|Double-Blind Treatment Phase||50
259621|NCT01059864|628083|P1|Treated|Double-Blind Treatment Phase||0
259622|NCT01059864|628081|P3|STARTED|Double-Blind Treatment Phase||48
259623|NCT01059864|628082|P2|STARTED|Double-Blind Treatment Phase||50
259624|NCT01059864|628083|P1|STARTED|Double-Blind Treatment Phase||0
259625|NCT01059864|628081|P3|NOT COMPLETED|Open-Label Run-In Phase||0
259626|NCT01059864|628082|P2|NOT COMPLETED|Open-Label Run-In Phase||0
259627|NCT01059864|628083|P1|NOT COMPLETED|Open-Label Run-In Phase||13
259628|NCT01059864|628081|P3|COMPLETED|Open-Label Run-In Phase||0
259629|NCT01059864|628082|P2|COMPLETED|Open-Label Run-In Phase||0
259630|NCT01059864|628083|P1|COMPLETED|Open-Label Run-In Phase||98
259631|NCT01059864|628081|P3|STARTED|Open-Label Run-In Phase||0
259632|NCT01059864|628082|P2|STARTED|Open-Label Run-In Phase||0
259633|NCT01059864|628083|P1|STARTED|Open-Label Run-In Phase||111
259634|NCT01059903|628132|P2|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
259635|NCT01059903|628133|P1|NOT COMPLETED|Period 3: Second Intervention- 24 Hours||0
259636|NCT01059903|628132|P2|COMPLETED|Period 3: Second Intervention- 24 Hours||24
259637|NCT01059903|628133|P1|COMPLETED|Period 3: Second Intervention- 24 Hours||24
259638|NCT01059903|628132|P2|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Two subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|22
259639|NCT01059903|628133|P1|Pharmacokinetic Set (PKS)|Period 3: Second Intervention- 24 Hours|Six subjects who fullfilled predefined criteria for patch adhesiveness were excluded from the PKS|18
259640|NCT01059903|628132|P2|STARTED|Period 3: Second Intervention- 24 Hours||24
259641|NCT01059903|628133|P1|STARTED|Period 3: Second Intervention- 24 Hours||24
259642|NCT01059903|628132|P2|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
259643|NCT01059903|628133|P1|NOT COMPLETED|Period 2: Washout Period (>= 5 Days)||0
259644|NCT01059903|628132|P2|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
259645|NCT01059903|628133|P1|COMPLETED|Period 2: Washout Period (>= 5 Days)||24
259646|NCT01059903|628132|P2|STARTED|Period 2: Washout Period (>= 5 Days)||24
259647|NCT01059903|628133|P1|STARTED|Period 2: Washout Period (>= 5 Days)||24
259648|NCT01059903|628132|P2|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
259649|NCT01059903|628133|P1|NOT COMPLETED|Period 1: First Intervention- 24 Hours||1
259650|NCT01059903|628132|P2|COMPLETED|Period 1: First Intervention- 24 Hours||24
259651|NCT01059903|628133|P1|COMPLETED|Period 1: First Intervention- 24 Hours||24
259652|NCT01059903|628132|P2|STARTED|Period 1: First Intervention- 24 Hours||25
259653|NCT01059903|628133|P1|STARTED|Period 1: First Intervention- 24 Hours||25
259654|NCT01059994|628171|P4|NOT COMPLETED|Overall Study||1
259655|NCT01059994|628172|P3|NOT COMPLETED|Overall Study||0
259656|NCT01059994|628173|P2|NOT COMPLETED|Overall Study||0
259657|NCT01059994|628174|P1|NOT COMPLETED|Overall Study||0
259658|NCT01059994|628171|P4|COMPLETED|Overall Study||3
259659|NCT01059994|628172|P3|COMPLETED|Overall Study||3
259660|NCT01059994|628173|P2|COMPLETED|Overall Study||2
259661|NCT01059994|628174|P1|COMPLETED|Overall Study||3
259662|NCT01059994|628171|P4|STARTED|Overall Study||4
259663|NCT01059994|628172|P3|STARTED|Overall Study||3
259664|NCT01059994|628173|P2|STARTED|Overall Study||2
259665|NCT01059994|628174|P1|STARTED|Overall Study||3
259666|NCT01060007|628188|P1|NOT COMPLETED|Overall Study||4
259667|NCT01060007|628188|P1|COMPLETED|Overall Study||76
259668|NCT01060007|628188|P1|STARTED|Overall Study||80
259669|NCT01070381|628202|P2|NOT COMPLETED|Period 2, 1 Week of Wear||1
259670|NCT01070381|628203|P1|NOT COMPLETED|Period 2, 1 Week of Wear||1
259671|NCT01070381|628202|P2|COMPLETED|Period 2, 1 Week of Wear||106
259672|NCT01070381|628203|P1|COMPLETED|Period 2, 1 Week of Wear||108
259673|NCT01070381|628202|P2|STARTED|Period 2, 1 Week of Wear||107
259674|NCT01070381|628203|P1|STARTED|Period 2, 1 Week of Wear||109
259675|NCT01070381|628202|P2|NOT COMPLETED|Period 1, 1 Week of Wear||0
259676|NCT01070381|628203|P1|NOT COMPLETED|Period 1, 1 Week of Wear||0
259677|NCT01070381|628202|P2|COMPLETED|Period 1, 1 Week of Wear||107
259678|NCT01070381|628203|P1|COMPLETED|Period 1, 1 Week of Wear|One subject could not continue into Period 2 due to product unavailability.|109
259679|NCT01070381|628202|P2|STARTED|Period 1, 1 Week of Wear||107
259680|NCT01070381|628203|P1|STARTED|Period 1, 1 Week of Wear|One subject could not be dispensed into Period 1 product. Subject started Period 2 wear.|109
259681|NCT01070394|628209|P1|NOT COMPLETED|Overall Study||7
259682|NCT01070394|628209|P1|COMPLETED|Overall Study||33
259683|NCT01070394|628209|P1|STARTED|Overall Study||40
259684|NCT01070550|628226|P6|NOT COMPLETED|Overall Study||7
259685|NCT01070550|628227|P5|NOT COMPLETED|Overall Study||1
259686|NCT01070550|628228|P4|NOT COMPLETED|Overall Study||77
259687|NCT01070550|628229|P3|NOT COMPLETED|Overall Study||216
259688|NCT01070550|628230|P2|NOT COMPLETED|Overall Study||62
259689|NCT01070550|628231|P1|NOT COMPLETED|Overall Study||1285
259690|NCT01070550|628226|P6|COMPLETED|Overall Study||35
259691|NCT01070550|628227|P5|COMPLETED|Overall Study||20
259692|NCT01070550|628228|P4|COMPLETED|Overall Study||124
259693|NCT01070550|628229|P3|COMPLETED|Overall Study||528
259694|NCT01070550|628230|P2|COMPLETED|Overall Study||254
259695|NCT01070550|628231|P1|COMPLETED|Overall Study||2071
259696|NCT01070550|628226|P6|STARTED|Overall Study||42
259697|NCT01070550|628227|P5|STARTED|Overall Study||21
259698|NCT01070550|628228|P4|STARTED|Overall Study||201
259699|NCT01070550|628229|P3|STARTED|Overall Study||744
259700|NCT01070550|628230|P2|STARTED|Overall Study||316
259701|NCT01070550|628231|P1|STARTED|Overall Study||3356
259702|NCT01070771|628371|P1|NOT COMPLETED|Overall Study||3
259703|NCT01070771|628371|P1|COMPLETED|Overall Study|August 2012|200
259704|NCT01070771|628371|P1|STARTED|Overall Study|September 2008|203
259705|NCT01070784|628378|P2|NOT COMPLETED|Overall Study||18
259706|NCT01070784|628379|P1|NOT COMPLETED|Overall Study||20
259707|NCT01070784|628378|P2|COMPLETED|Overall Study||112
259708|NCT01070784|628379|P1|COMPLETED|Overall Study||110
259709|NCT01070784|628378|P2|STARTED|Overall Study||130
259710|NCT01070784|628379|P1|STARTED|Overall Study||130
259711|NCT01070810|628469|P2|NOT COMPLETED|Overall Study||0
259712|NCT01070810|628470|P1|NOT COMPLETED|Overall Study||0
259713|NCT01070810|628469|P2|COMPLETED|Overall Study||43
259714|NCT01070810|628470|P1|COMPLETED|Overall Study||45
259715|NCT01070810|628469|P2|STARTED|Overall Study||43
259716|NCT01070810|628470|P1|STARTED|Overall Study||45
259717|NCT01070888|628486|P2|NOT COMPLETED|Second Intervention (14 Days)||0
259718|NCT01070888|628487|P1|NOT COMPLETED|Second Intervention (14 Days)||0
259719|NCT01070888|628486|P2|COMPLETED|Second Intervention (14 Days)||2
259720|NCT01070888|628487|P1|COMPLETED|Second Intervention (14 Days)||1
259721|NCT01070888|628486|P2|STARTED|Second Intervention (14 Days)||2
259722|NCT01070888|628487|P1|STARTED|Second Intervention (14 Days)||1
259723|NCT01070888|628486|P2|NOT COMPLETED|Washout (14 Days)||0
259724|NCT01070888|628487|P1|NOT COMPLETED|Washout (14 Days)||1
259725|NCT01070888|628486|P2|COMPLETED|Washout (14 Days)||2
259726|NCT01070888|628487|P1|COMPLETED|Washout (14 Days)||1
259727|NCT01070888|628486|P2|STARTED|Washout (14 Days)||2
259728|NCT01070888|628487|P1|STARTED|Washout (14 Days)||2
259729|NCT01070888|628486|P2|NOT COMPLETED|First Intervention (14 Days)||2
259730|NCT01070888|628487|P1|NOT COMPLETED|First Intervention (14 Days)||0
259731|NCT01070888|628486|P2|COMPLETED|First Intervention (14 Days)||2
259732|NCT01070888|628487|P1|COMPLETED|First Intervention (14 Days)||2
259733|NCT01070888|628486|P2|STARTED|First Intervention (14 Days)||4
259734|NCT01070888|628487|P1|STARTED|First Intervention (14 Days)||2
259735|NCT01070953|628493|P1|NOT COMPLETED|Participants for Efficacy Evaluation||227
259736|NCT01070953|628493|P1|COMPLETED|Participants for Efficacy Evaluation||3309
259737|NCT01070953|628493|P1|STARTED|Participants for Efficacy Evaluation||3536
259738|NCT01070953|628493|P1|NOT COMPLETED|Participants for Safety Evaluation||931
259739|NCT01070953|628493|P1|COMPLETED|Participants for Safety Evaluation||3536
259740|NCT01070953|628493|P1|STARTED|Participants for Safety Evaluation||4467
259741|NCT01070966|628504|P1|NOT COMPLETED|Participants for Efficacy Evaluation||82
259742|NCT01070966|628504|P1|COMPLETED|Participants for Efficacy Evaluation||1929
259743|NCT01070966|628504|P1|STARTED|Participants for Efficacy Evaluation||2011
259744|NCT01070966|628504|P1|NOT COMPLETED|Participants for Safety Evaluation||78
259745|NCT01070966|628504|P1|COMPLETED|Participants for Safety Evaluation||2011
259746|NCT01070966|628504|P1|STARTED|Participants for Safety Evaluation||2089
259747|NCT01070979|628518|P3|NOT COMPLETED|Overall Study||13
259748|NCT01070979|628519|P2|NOT COMPLETED|Overall Study||12
259749|NCT01070979|628520|P1|NOT COMPLETED|Overall Study||11
259750|NCT01070979|628518|P3|COMPLETED|Overall Study||72
259751|NCT01070979|628519|P2|COMPLETED|Overall Study||73
259752|NCT01070979|628520|P1|COMPLETED|Overall Study||68
259753|NCT01070979|628518|P3|STARTED|Overall Study||85
259754|NCT01070979|628519|P2|STARTED|Overall Study||85
259755|NCT01070979|628520|P1|STARTED|Overall Study||79
259756|NCT01071044|628548|P2|NOT COMPLETED|Overall Study||0
259757|NCT01071044|628549|P1|NOT COMPLETED|Overall Study||2
259758|NCT01071044|628548|P2|COMPLETED|Overall Study||11
259759|NCT01071044|628549|P1|COMPLETED|Overall Study||13
259760|NCT01071044|628548|P2|STARTED|Overall Study||11
259761|NCT01071044|628549|P1|STARTED|Overall Study||15
259762|NCT01071070|628569|P2|NOT COMPLETED|Overall Study||3
259763|NCT01071070|628570|P1|NOT COMPLETED|Overall Study||4
259764|NCT01071070|628569|P2|COMPLETED|Overall Study||105
259765|NCT01071070|628570|P1|COMPLETED|Overall Study||104
259766|NCT01071070|628569|P2|STARTED|Overall Study||108
259767|NCT01071070|628570|P1|STARTED|Overall Study||108
259768|NCT01071083|628597|P5|NOT COMPLETED|Overall Study||8
259769|NCT01071083|628598|P4|NOT COMPLETED|Overall Study||2
259770|NCT01071083|628599|P3|NOT COMPLETED|Overall Study||5
259771|NCT01071083|628600|P2|NOT COMPLETED|Overall Study||2
259772|NCT01071083|628601|P1|NOT COMPLETED|Overall Study||7
259773|NCT01071083|628597|P5|COMPLETED|Overall Study||46
259774|NCT01071083|628598|P4|COMPLETED|Overall Study||15
259775|NCT01071083|628599|P3|COMPLETED|Overall Study||12
259776|NCT01071083|628600|P2|COMPLETED|Overall Study||43
259777|NCT01071083|628601|P1|COMPLETED|Overall Study||35
259778|NCT01071083|628597|P5|STARTED|Overall Study||54
259779|NCT01071083|628598|P4|STARTED|Overall Study||17
259780|NCT01071083|628599|P3|STARTED|Overall Study||17
259781|NCT01071083|628600|P2|STARTED|Overall Study||45
259782|NCT01071083|628601|P1|STARTED|Overall Study||42
259783|NCT01071096|628618|P2|NOT COMPLETED|Second Intervention (90 Days)||0
259784|NCT01071096|628619|P1|NOT COMPLETED|Second Intervention (90 Days)||0
259785|NCT01071096|628618|P2|COMPLETED|Second Intervention (90 Days)||10
259786|NCT01071096|628619|P1|COMPLETED|Second Intervention (90 Days)||9
259787|NCT01071096|628618|P2|STARTED|Second Intervention (90 Days)||10
259788|NCT01071096|628619|P1|STARTED|Second Intervention (90 Days)||9
259789|NCT01071096|628618|P2|NOT COMPLETED|Washout Period (30 Days)||0
259790|NCT01071096|628619|P1|NOT COMPLETED|Washout Period (30 Days)||0
259791|NCT01071096|628618|P2|COMPLETED|Washout Period (30 Days)||10
259792|NCT01071096|628619|P1|COMPLETED|Washout Period (30 Days)||9
259793|NCT01071096|628618|P2|STARTED|Washout Period (30 Days)||10
259794|NCT01071096|628619|P1|STARTED|Washout Period (30 Days)||9
259795|NCT01071096|628618|P2|NOT COMPLETED|First Intervention (90 Days)||0
259796|NCT01071096|628619|P1|NOT COMPLETED|First Intervention (90 Days)||1
259797|NCT01071096|628618|P2|COMPLETED|First Intervention (90 Days)||10
259798|NCT01071096|628619|P1|COMPLETED|First Intervention (90 Days)||9
259799|NCT01071096|628618|P2|STARTED|First Intervention (90 Days)||10
259800|NCT01071096|628619|P1|STARTED|First Intervention (90 Days)||10
259801|NCT01071200|628640|P2|NOT COMPLETED|Overall Study||3
259802|NCT01071200|628641|P1|NOT COMPLETED|Overall Study||7
259803|NCT01071200|628640|P2|COMPLETED|Overall Study||63
259804|NCT01071200|628641|P1|COMPLETED|Overall Study||60
259805|NCT01071200|628640|P2|STARTED|Overall Study||66
259806|NCT01071200|628641|P1|STARTED|Overall Study||67
259807|NCT01071252|628678|P5|NOT COMPLETED|Overall Study||11
259808|NCT01071252|628679|P4|NOT COMPLETED|Overall Study||7
259809|NCT01071252|628680|P3|NOT COMPLETED|Overall Study||4
259810|NCT01071252|628681|P2|NOT COMPLETED|Overall Study||10
259811|NCT01071252|628682|P1|NOT COMPLETED|Overall Study||15
259812|NCT01071252|628678|P5|COMPLETED|Overall Study||11
259813|NCT01071252|628679|P4|COMPLETED|Overall Study||20
259814|NCT01071252|628680|P3|COMPLETED|Overall Study||17
259815|NCT01071252|628681|P2|COMPLETED|Overall Study||16
259816|NCT01071252|628682|P1|COMPLETED|Overall Study||14
259817|NCT01071252|628678|P5|STARTED|Overall Study||22
259818|NCT01071252|628679|P4|STARTED|Overall Study||27
259819|NCT01071252|628680|P3|STARTED|Overall Study||21
259820|NCT01071252|628681|P2|STARTED|Overall Study||26
259821|NCT01071252|628682|P1|STARTED|Overall Study||29
259822|NCT01071278|628708|P1|NOT COMPLETED|Overall Study||713
259823|NCT01071278|628708|P1|COMPLETED|Overall Study||1677
259824|NCT01071278|628708|P1|STARTED|Overall Study||2390
259825|NCT01071395|628716|P2|NOT COMPLETED|Overall Study||2
259826|NCT01071395|628717|P1|NOT COMPLETED|Overall Study||5
259827|NCT01071395|628716|P2|COMPLETED|Overall Study||30
259828|NCT01071395|628717|P1|COMPLETED|Overall Study||31
259829|NCT01071395|628716|P2|STARTED|Overall Study||32
259830|NCT01071395|628717|P1|STARTED|Overall Study||36
259831|NCT01071538|628723|P1|NOT COMPLETED|Overall Study||2
259832|NCT01071538|628723|P1|COMPLETED|Overall Study||13
259833|NCT01071538|628723|P1|STARTED|Overall Study||15
259834|NCT01071798|628733|P1|NOT COMPLETED|Subpopulation Who Received Two Cycles||15
259835|NCT01071798|628733|P1|COMPLETED|Subpopulation Who Received Two Cycles||805
259836|NCT01071798|628733|P1|Baseline and Safety Analysis Set|Subpopulation Who Received Two Cycles||820
259837|NCT01071798|628733|P1|STARTED|Subpopulation Who Received Two Cycles||820
259838|NCT01071798|628733|P1|NOT COMPLETED|Participants Who Received One Cycle||65
259839|NCT01071798|628733|P1|COMPLETED|Participants Who Received One Cycle||1588
259840|NCT01071798|628733|P1|Baseline and Safety Analysis Set|Participants Who Received One Cycle||1653
259841|NCT01071798|628733|P1|STARTED|Participants Who Received One Cycle||1653
259842|NCT01071915|628753|P1|NOT COMPLETED|Overall Study||9
259843|NCT01071915|628753|P1|COMPLETED|Overall Study||148
259844|NCT01071915|628753|P1|Safety Analysis Set|Overall Study||156
259845|NCT01071915|628753|P1|Full Analysis Set (FAS)|Overall Study||155
259846|NCT01071915|628753|P1|STARTED|Overall Study|Intention to Treat Analysis Set|157
259847|NCT01072006|628767|P4|NOT COMPLETED|Overall Study||0
259848|NCT01072006|628768|P3|NOT COMPLETED|Overall Study||0
259849|NCT01072006|628769|P2|NOT COMPLETED|Overall Study||0
259850|NCT01072006|628770|P1|NOT COMPLETED|Overall Study||0
259851|NCT01072006|628767|P4|COMPLETED|Overall Study||11
259852|NCT01072006|628768|P3|COMPLETED|Overall Study||0
259853|NCT01072006|628769|P2|COMPLETED|Overall Study||5
259854|NCT01072006|628770|P1|COMPLETED|Overall Study||14
259855|NCT01072006|628767|P4|STARTED|Overall Study||11
259856|NCT01072006|628768|P3|STARTED|Overall Study||0
259857|NCT01072006|628769|P2|STARTED|Overall Study||5
259858|NCT01072006|628770|P1|STARTED|Overall Study||14
259859|NCT01072032|628789|P2|NOT COMPLETED|Overall Study||9
259860|NCT01072032|628790|P1|NOT COMPLETED|Overall Study||8
259861|NCT01072032|628789|P2|COMPLETED|Overall Study||5
259862|NCT01072032|628790|P1|COMPLETED|Overall Study||5
259863|NCT01072032|628789|P2|STARTED|Overall Study||14
259864|NCT01072032|628790|P1|STARTED|Overall Study||13
259865|NCT01072136|628802|P2|NOT COMPLETED|Overall Study||31
259866|NCT01072136|628803|P1|NOT COMPLETED|Overall Study||23
259867|NCT01072136|628802|P2|COMPLETED|Overall Study||12
259868|NCT01072136|628803|P1|COMPLETED|Overall Study||21
259869|NCT01072136|628802|P2|Met All Enrollment Criteria|Overall Study||25
259870|NCT01072136|628803|P1|Met All Enrollment Criteria|Overall Study|Some eligibility test results were not available until after randomization.|30
259871|NCT01072136|628802|P2|STARTED|Overall Study||43
259872|NCT01072136|628803|P1|STARTED|Overall Study||44
259873|NCT01072149|628825|P18|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259874|NCT01072149|628826|P17|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259875|NCT01072149|628827|P16|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259876|NCT01072149|628828|P15|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259877|NCT01072149|628829|P14|NOT COMPLETED|Treatment Period 3 (28 Days)||1
259878|NCT01072149|628830|P13|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259879|NCT01072149|628831|P12|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259880|NCT01072149|628832|P11|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259881|NCT01072149|628833|P10|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259882|NCT01072149|628834|P9|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259883|NCT01072149|628835|P8|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259884|NCT01072149|628836|P7|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259885|NCT01072149|628837|P6|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259886|NCT01072149|628838|P5|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259887|NCT01072149|628839|P4|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259888|NCT01072149|628840|P3|NOT COMPLETED|Treatment Period 3 (28 Days)||1
259889|NCT01072149|628841|P2|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259890|NCT01072149|628842|P1|NOT COMPLETED|Treatment Period 3 (28 Days)||0
259891|NCT01072149|628825|P18|COMPLETED|Treatment Period 3 (28 Days)||2
259892|NCT01072149|628826|P17|COMPLETED|Treatment Period 3 (28 Days)||3
259893|NCT01072149|628827|P16|COMPLETED|Treatment Period 3 (28 Days)||1
259894|NCT01072149|628828|P15|COMPLETED|Treatment Period 3 (28 Days)||3
259895|NCT01072149|628829|P14|COMPLETED|Treatment Period 3 (28 Days)||2
259896|NCT01072149|628830|P13|COMPLETED|Treatment Period 3 (28 Days)||2
259897|NCT01072149|628831|P12|COMPLETED|Treatment Period 3 (28 Days)||3
259898|NCT01072149|628832|P11|COMPLETED|Treatment Period 3 (28 Days)||2
259899|NCT01072149|628833|P10|COMPLETED|Treatment Period 3 (28 Days)||3
259900|NCT01072149|628834|P9|COMPLETED|Treatment Period 3 (28 Days)||3
259901|NCT01072149|628835|P8|COMPLETED|Treatment Period 3 (28 Days)||2
259902|NCT01072149|628836|P7|COMPLETED|Treatment Period 3 (28 Days)||3
259903|NCT01072149|628837|P6|COMPLETED|Treatment Period 3 (28 Days)||3
259904|NCT01072149|628838|P5|COMPLETED|Treatment Period 3 (28 Days)||3
259905|NCT01072149|628839|P4|COMPLETED|Treatment Period 3 (28 Days)||3
259906|NCT01072149|628840|P3|COMPLETED|Treatment Period 3 (28 Days)||0
259907|NCT01072149|628841|P2|COMPLETED|Treatment Period 3 (28 Days)||2
259908|NCT01072149|628842|P1|COMPLETED|Treatment Period 3 (28 Days)||2
259909|NCT01072149|628825|P18|STARTED|Treatment Period 3 (28 Days)||2
259910|NCT01072149|628826|P17|STARTED|Treatment Period 3 (28 Days)||3
259911|NCT01072149|628827|P16|STARTED|Treatment Period 3 (28 Days)||1
259912|NCT01072149|628828|P15|STARTED|Treatment Period 3 (28 Days)||3
259913|NCT01072149|628829|P14|STARTED|Treatment Period 3 (28 Days)||3
259914|NCT01072149|628830|P13|STARTED|Treatment Period 3 (28 Days)||2
259915|NCT01072149|628831|P12|STARTED|Treatment Period 3 (28 Days)||3
259916|NCT01072149|628832|P11|STARTED|Treatment Period 3 (28 Days)||2
259917|NCT01072149|628833|P10|STARTED|Treatment Period 3 (28 Days)||3
259918|NCT01072149|628834|P9|STARTED|Treatment Period 3 (28 Days)||3
259919|NCT01072149|628835|P8|STARTED|Treatment Period 3 (28 Days)||2
259920|NCT01072149|628836|P7|STARTED|Treatment Period 3 (28 Days)||3
259921|NCT01072149|628837|P6|STARTED|Treatment Period 3 (28 Days)||3
259922|NCT01072149|628838|P5|STARTED|Treatment Period 3 (28 Days)||3
259923|NCT01072149|628839|P4|STARTED|Treatment Period 3 (28 Days)||3
259924|NCT01072149|628840|P3|STARTED|Treatment Period 3 (28 Days)||1
259925|NCT01072149|628841|P2|STARTED|Treatment Period 3 (28 Days)||2
259926|NCT01072149|628842|P1|STARTED|Treatment Period 3 (28 Days)||2
259927|NCT01072149|628825|P18|NOT COMPLETED|Washout Period 2 (14 Days)||0
259928|NCT01072149|628826|P17|NOT COMPLETED|Washout Period 2 (14 Days)||0
259929|NCT01072149|628827|P16|NOT COMPLETED|Washout Period 2 (14 Days)||2
259930|NCT01072149|628828|P15|NOT COMPLETED|Washout Period 2 (14 Days)||0
259931|NCT01072149|628829|P14|NOT COMPLETED|Washout Period 2 (14 Days)||0
259932|NCT01072149|628830|P13|NOT COMPLETED|Washout Period 2 (14 Days)||1
259933|NCT01072149|628831|P12|NOT COMPLETED|Washout Period 2 (14 Days)||0
259934|NCT01072149|628832|P11|NOT COMPLETED|Washout Period 2 (14 Days)||0
259935|NCT01072149|628833|P10|NOT COMPLETED|Washout Period 2 (14 Days)||0
259936|NCT01072149|628834|P9|NOT COMPLETED|Washout Period 2 (14 Days)||0
259937|NCT01072149|628835|P8|NOT COMPLETED|Washout Period 2 (14 Days)||0
259938|NCT01072149|628836|P7|NOT COMPLETED|Washout Period 2 (14 Days)||0
259939|NCT01072149|628837|P6|NOT COMPLETED|Washout Period 2 (14 Days)||0
259940|NCT01072149|628838|P5|NOT COMPLETED|Washout Period 2 (14 Days)||0
259941|NCT01072149|628839|P4|NOT COMPLETED|Washout Period 2 (14 Days)||0
259942|NCT01072149|628840|P3|NOT COMPLETED|Washout Period 2 (14 Days)||0
259943|NCT01072149|628841|P2|NOT COMPLETED|Washout Period 2 (14 Days)||0
259944|NCT01072149|628842|P1|NOT COMPLETED|Washout Period 2 (14 Days)||1
259945|NCT01072149|628825|P18|COMPLETED|Washout Period 2 (14 Days)||2
259946|NCT01072149|628826|P17|COMPLETED|Washout Period 2 (14 Days)||3
259947|NCT01072149|628827|P16|COMPLETED|Washout Period 2 (14 Days)||1
259948|NCT01072149|628828|P15|COMPLETED|Washout Period 2 (14 Days)||3
259949|NCT01072149|628829|P14|COMPLETED|Washout Period 2 (14 Days)||3
259950|NCT01072149|628830|P13|COMPLETED|Washout Period 2 (14 Days)||2
259951|NCT01072149|628831|P12|COMPLETED|Washout Period 2 (14 Days)||3
259952|NCT01072149|628832|P11|COMPLETED|Washout Period 2 (14 Days)||2
259953|NCT01072149|628833|P10|COMPLETED|Washout Period 2 (14 Days)||3
259954|NCT01072149|628834|P9|COMPLETED|Washout Period 2 (14 Days)||3
259955|NCT01072149|628835|P8|COMPLETED|Washout Period 2 (14 Days)||2
259956|NCT01072149|628836|P7|COMPLETED|Washout Period 2 (14 Days)||3
259957|NCT01072149|628837|P6|COMPLETED|Washout Period 2 (14 Days)||3
259958|NCT01072149|628838|P5|COMPLETED|Washout Period 2 (14 Days)||3
259959|NCT01072149|628839|P4|COMPLETED|Washout Period 2 (14 Days)||3
259960|NCT01072149|628840|P3|COMPLETED|Washout Period 2 (14 Days)||1
259961|NCT01072149|628841|P2|COMPLETED|Washout Period 2 (14 Days)||2
259962|NCT01072149|628842|P1|COMPLETED|Washout Period 2 (14 Days)||2
259963|NCT01072149|628825|P18|STARTED|Washout Period 2 (14 Days)||2
259964|NCT01072149|628826|P17|STARTED|Washout Period 2 (14 Days)||3
259965|NCT01072149|628827|P16|STARTED|Washout Period 2 (14 Days)||3
259966|NCT01072149|628828|P15|STARTED|Washout Period 2 (14 Days)||3
259967|NCT01072149|628829|P14|STARTED|Washout Period 2 (14 Days)||3
259968|NCT01072149|628830|P13|STARTED|Washout Period 2 (14 Days)||3
259969|NCT01072149|628831|P12|STARTED|Washout Period 2 (14 Days)||3
259970|NCT01072149|628832|P11|STARTED|Washout Period 2 (14 Days)||2
259971|NCT01072149|628833|P10|STARTED|Washout Period 2 (14 Days)||3
259972|NCT01072149|628834|P9|STARTED|Washout Period 2 (14 Days)||3
259973|NCT01072149|628835|P8|STARTED|Washout Period 2 (14 Days)||2
259974|NCT01072149|628836|P7|STARTED|Washout Period 2 (14 Days)||3
259975|NCT01072149|628837|P6|STARTED|Washout Period 2 (14 Days)||3
259976|NCT01072149|628838|P5|STARTED|Washout Period 2 (14 Days)||3
259977|NCT01072149|628839|P4|STARTED|Washout Period 2 (14 Days)||3
259978|NCT01072149|628840|P3|STARTED|Washout Period 2 (14 Days)||1
259979|NCT01072149|628841|P2|STARTED|Washout Period 2 (14 Days)||2
259980|NCT01072149|628842|P1|STARTED|Washout Period 2 (14 Days)||3
259981|NCT01072149|628825|P18|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259982|NCT01072149|628826|P17|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259983|NCT01072149|628827|P16|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259984|NCT01072149|628828|P15|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259985|NCT01072149|628829|P14|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259986|NCT01072149|628830|P13|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259987|NCT01072149|628831|P12|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259988|NCT01072149|628832|P11|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259989|NCT01072149|628833|P10|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259990|NCT01072149|628834|P9|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259991|NCT01072149|628835|P8|NOT COMPLETED|Treatment Period 2 (28 Days)||1
259992|NCT01072149|628836|P7|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259993|NCT01072149|628837|P6|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259994|NCT01072149|628838|P5|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259995|NCT01072149|628839|P4|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259996|NCT01072149|628840|P3|NOT COMPLETED|Treatment Period 2 (28 Days)||1
259997|NCT01072149|628841|P2|NOT COMPLETED|Treatment Period 2 (28 Days)||1
259998|NCT01072149|628842|P1|NOT COMPLETED|Treatment Period 2 (28 Days)||0
259999|NCT01072149|628825|P18|COMPLETED|Treatment Period 2 (28 Days)||2
260000|NCT01072149|628826|P17|COMPLETED|Treatment Period 2 (28 Days)||3
260001|NCT01072149|628827|P16|COMPLETED|Treatment Period 2 (28 Days)||3
260002|NCT01072149|628828|P15|COMPLETED|Treatment Period 2 (28 Days)||3
260003|NCT01072149|628829|P14|COMPLETED|Treatment Period 2 (28 Days)||3
260004|NCT01072149|628830|P13|COMPLETED|Treatment Period 2 (28 Days)||3
260005|NCT01072149|628831|P12|COMPLETED|Treatment Period 2 (28 Days)||3
260006|NCT01072149|628832|P11|COMPLETED|Treatment Period 2 (28 Days)||2
260007|NCT01072149|628833|P10|COMPLETED|Treatment Period 2 (28 Days)||3
260008|NCT01072149|628834|P9|COMPLETED|Treatment Period 2 (28 Days)||3
260009|NCT01072149|628835|P8|COMPLETED|Treatment Period 2 (28 Days)||2
260010|NCT01072149|628836|P7|COMPLETED|Treatment Period 2 (28 Days)||3
260011|NCT01072149|628837|P6|COMPLETED|Treatment Period 2 (28 Days)||3
260012|NCT01072149|628838|P5|COMPLETED|Treatment Period 2 (28 Days)||3
260013|NCT01072149|628839|P4|COMPLETED|Treatment Period 2 (28 Days)||3
260014|NCT01072149|628840|P3|COMPLETED|Treatment Period 2 (28 Days)||1
260015|NCT01072149|628841|P2|COMPLETED|Treatment Period 2 (28 Days)||2
260016|NCT01072149|628842|P1|COMPLETED|Treatment Period 2 (28 Days)||3
260017|NCT01072149|628825|P18|STARTED|Treatment Period 2 (28 Days)||2
260018|NCT01072149|628826|P17|STARTED|Treatment Period 2 (28 Days)||3
260019|NCT01072149|628827|P16|STARTED|Treatment Period 2 (28 Days)||3
260020|NCT01072149|628828|P15|STARTED|Treatment Period 2 (28 Days)||3
260021|NCT01072149|628829|P14|STARTED|Treatment Period 2 (28 Days)||3
260022|NCT01072149|628830|P13|STARTED|Treatment Period 2 (28 Days)||3
260023|NCT01072149|628831|P12|STARTED|Treatment Period 2 (28 Days)||3
260024|NCT01072149|628832|P11|STARTED|Treatment Period 2 (28 Days)||2
260025|NCT01072149|628833|P10|STARTED|Treatment Period 2 (28 Days)||3
260026|NCT01072149|628834|P9|STARTED|Treatment Period 2 (28 Days)||3
260027|NCT01072149|628835|P8|STARTED|Treatment Period 2 (28 Days)||3
260028|NCT01072149|628836|P7|STARTED|Treatment Period 2 (28 Days)||3
260029|NCT01072149|628837|P6|STARTED|Treatment Period 2 (28 Days)||3
260030|NCT01072149|628838|P5|STARTED|Treatment Period 2 (28 Days)||3
260031|NCT01072149|628839|P4|STARTED|Treatment Period 2 (28 Days)||3
260032|NCT01072149|628840|P3|STARTED|Treatment Period 2 (28 Days)||2
260033|NCT01072149|628841|P2|STARTED|Treatment Period 2 (28 Days)||3
260034|NCT01072149|628842|P1|STARTED|Treatment Period 2 (28 Days)||3
260035|NCT01072149|628825|P18|NOT COMPLETED|Washout Period 1 (14 Days)||0
260036|NCT01072149|628826|P17|NOT COMPLETED|Washout Period 1 (14 Days)||0
260037|NCT01072149|628827|P16|NOT COMPLETED|Washout Period 1 (14 Days)||0
260038|NCT01072149|628828|P15|NOT COMPLETED|Washout Period 1 (14 Days)||0
260039|NCT01072149|628829|P14|NOT COMPLETED|Washout Period 1 (14 Days)||0
260040|NCT01072149|628830|P13|NOT COMPLETED|Washout Period 1 (14 Days)||0
260041|NCT01072149|628831|P12|NOT COMPLETED|Washout Period 1 (14 Days)||0
260042|NCT01072149|628832|P11|NOT COMPLETED|Washout Period 1 (14 Days)||0
260043|NCT01072149|628833|P10|NOT COMPLETED|Washout Period 1 (14 Days)||0
260044|NCT01072149|628834|P9|NOT COMPLETED|Washout Period 1 (14 Days)||0
260045|NCT01072149|628835|P8|NOT COMPLETED|Washout Period 1 (14 Days)||0
260046|NCT01072149|628836|P7|NOT COMPLETED|Washout Period 1 (14 Days)||0
260047|NCT01072149|628837|P6|NOT COMPLETED|Washout Period 1 (14 Days)||0
260048|NCT01072149|628838|P5|NOT COMPLETED|Washout Period 1 (14 Days)||0
260049|NCT01072149|628839|P4|NOT COMPLETED|Washout Period 1 (14 Days)||0
260050|NCT01072149|628840|P3|NOT COMPLETED|Washout Period 1 (14 Days)||0
260051|NCT01072149|628841|P2|NOT COMPLETED|Washout Period 1 (14 Days)||0
260052|NCT01072149|628842|P1|NOT COMPLETED|Washout Period 1 (14 Days)||0
260053|NCT01072149|628825|P18|COMPLETED|Washout Period 1 (14 Days)||2
260054|NCT01072149|628826|P17|COMPLETED|Washout Period 1 (14 Days)||3
260055|NCT01072149|628827|P16|COMPLETED|Washout Period 1 (14 Days)||3
260056|NCT01072149|628828|P15|COMPLETED|Washout Period 1 (14 Days)||3
260057|NCT01072149|628829|P14|COMPLETED|Washout Period 1 (14 Days)||3
260058|NCT01072149|628830|P13|COMPLETED|Washout Period 1 (14 Days)||3
260059|NCT01072149|628831|P12|COMPLETED|Washout Period 1 (14 Days)||3
260060|NCT01072149|628832|P11|COMPLETED|Washout Period 1 (14 Days)||2
260061|NCT01072149|628833|P10|COMPLETED|Washout Period 1 (14 Days)||3
260062|NCT01072149|628834|P9|COMPLETED|Washout Period 1 (14 Days)||3
260063|NCT01072149|628835|P8|COMPLETED|Washout Period 1 (14 Days)||3
260064|NCT01072149|628836|P7|COMPLETED|Washout Period 1 (14 Days)||3
260065|NCT01072149|628837|P6|COMPLETED|Washout Period 1 (14 Days)||3
260066|NCT01072149|628838|P5|COMPLETED|Washout Period 1 (14 Days)||3
260067|NCT01072149|628839|P4|COMPLETED|Washout Period 1 (14 Days)||3
260068|NCT01072149|628840|P3|COMPLETED|Washout Period 1 (14 Days)||2
260069|NCT01072149|628841|P2|COMPLETED|Washout Period 1 (14 Days)||3
260070|NCT01072149|628842|P1|COMPLETED|Washout Period 1 (14 Days)||3
260071|NCT01072149|628825|P18|STARTED|Washout Period 1 (14 Days)||2
260072|NCT01072149|628826|P17|STARTED|Washout Period 1 (14 Days)||3
260073|NCT01072149|628827|P16|STARTED|Washout Period 1 (14 Days)||3
260074|NCT01072149|628828|P15|STARTED|Washout Period 1 (14 Days)||3
260075|NCT01072149|628829|P14|STARTED|Washout Period 1 (14 Days)||3
260076|NCT01072149|628830|P13|STARTED|Washout Period 1 (14 Days)||3
260077|NCT01072149|628831|P12|STARTED|Washout Period 1 (14 Days)||3
260078|NCT01072149|628832|P11|STARTED|Washout Period 1 (14 Days)||2
260079|NCT01072149|628833|P10|STARTED|Washout Period 1 (14 Days)||3
260080|NCT01072149|628834|P9|STARTED|Washout Period 1 (14 Days)||3
260081|NCT01072149|628835|P8|STARTED|Washout Period 1 (14 Days)||3
260082|NCT01072149|628836|P7|STARTED|Washout Period 1 (14 Days)||3
260083|NCT01072149|628837|P6|STARTED|Washout Period 1 (14 Days)||3
260084|NCT01072149|628838|P5|STARTED|Washout Period 1 (14 Days)||3
260085|NCT01072149|628839|P4|STARTED|Washout Period 1 (14 Days)||3
260086|NCT01072149|628840|P3|STARTED|Washout Period 1 (14 Days)||2
260087|NCT01072149|628841|P2|STARTED|Washout Period 1 (14 Days)||3
260088|NCT01072149|628842|P1|STARTED|Washout Period 1 (14 Days)||3
260089|NCT01072149|628825|P18|NOT COMPLETED|Treatment Period 1 (28 Days)||1
260090|NCT01072149|628826|P17|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260091|NCT01072149|628827|P16|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260092|NCT01072149|628828|P15|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260093|NCT01072149|628829|P14|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260094|NCT01072149|628830|P13|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260095|NCT01072149|628831|P12|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260096|NCT01072149|628832|P11|NOT COMPLETED|Treatment Period 1 (28 Days)||1
260097|NCT01072149|628833|P10|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260098|NCT01072149|628834|P9|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260099|NCT01072149|628835|P8|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260100|NCT01072149|628836|P7|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260101|NCT01072149|628837|P6|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260102|NCT01072149|628838|P5|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260103|NCT01072149|628839|P4|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260104|NCT01072149|628840|P3|NOT COMPLETED|Treatment Period 1 (28 Days)||1
260105|NCT01072149|628841|P2|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260106|NCT01072149|628842|P1|NOT COMPLETED|Treatment Period 1 (28 Days)||0
260107|NCT01072149|628825|P18|COMPLETED|Treatment Period 1 (28 Days)||2
260108|NCT01072149|628826|P17|COMPLETED|Treatment Period 1 (28 Days)||3
260109|NCT01072149|628827|P16|COMPLETED|Treatment Period 1 (28 Days)||3
260110|NCT01072149|628828|P15|COMPLETED|Treatment Period 1 (28 Days)||3
260111|NCT01072149|628829|P14|COMPLETED|Treatment Period 1 (28 Days)||3
260112|NCT01072149|628830|P13|COMPLETED|Treatment Period 1 (28 Days)||3
260113|NCT01072149|628831|P12|COMPLETED|Treatment Period 1 (28 Days)||3
260114|NCT01072149|628832|P11|COMPLETED|Treatment Period 1 (28 Days)||2
260115|NCT01072149|628833|P10|COMPLETED|Treatment Period 1 (28 Days)||3
260116|NCT01072149|628834|P9|COMPLETED|Treatment Period 1 (28 Days)||3
260117|NCT01072149|628835|P8|COMPLETED|Treatment Period 1 (28 Days)||3
260118|NCT01072149|628836|P7|COMPLETED|Treatment Period 1 (28 Days)||3
260119|NCT01072149|628837|P6|COMPLETED|Treatment Period 1 (28 Days)||3
260120|NCT01072149|628838|P5|COMPLETED|Treatment Period 1 (28 Days)||3
260121|NCT01072149|628839|P4|COMPLETED|Treatment Period 1 (28 Days)||3
260122|NCT01072149|628840|P3|COMPLETED|Treatment Period 1 (28 Days)||2
260123|NCT01072149|628841|P2|COMPLETED|Treatment Period 1 (28 Days)||3
260124|NCT01072149|628842|P1|COMPLETED|Treatment Period 1 (28 Days)||3
260125|NCT01072149|628825|P18|STARTED|Treatment Period 1 (28 Days)||3
260126|NCT01072149|628826|P17|STARTED|Treatment Period 1 (28 Days)||3
260127|NCT01072149|628827|P16|STARTED|Treatment Period 1 (28 Days)||3
260128|NCT01072149|628828|P15|STARTED|Treatment Period 1 (28 Days)||3
260129|NCT01072149|628829|P14|STARTED|Treatment Period 1 (28 Days)||3
260130|NCT01072149|628830|P13|STARTED|Treatment Period 1 (28 Days)||3
260131|NCT01072149|628831|P12|STARTED|Treatment Period 1 (28 Days)||3
260132|NCT01072149|628832|P11|STARTED|Treatment Period 1 (28 Days)||3
260133|NCT01072149|628833|P10|STARTED|Treatment Period 1 (28 Days)||3
260134|NCT01072149|628834|P9|STARTED|Treatment Period 1 (28 Days)||3
260135|NCT01072149|628835|P8|STARTED|Treatment Period 1 (28 Days)||3
260136|NCT01072149|628836|P7|STARTED|Treatment Period 1 (28 Days)||3
260137|NCT01072149|628837|P6|STARTED|Treatment Period 1 (28 Days)||3
260138|NCT01072149|628838|P5|STARTED|Treatment Period 1 (28 Days)||3
260139|NCT01072149|628839|P4|STARTED|Treatment Period 1 (28 Days)||3
260140|NCT01072149|628840|P3|STARTED|Treatment Period 1 (28 Days)||3
260141|NCT01072149|628841|P2|STARTED|Treatment Period 1 (28 Days)||3
260142|NCT01072149|628842|P1|STARTED|Treatment Period 1 (28 Days)||3
260143|NCT01072175|628872|P13|NOT COMPLETED|Part D (HPMC Capsules)||39
260144|NCT01072175|628873|P12|NOT COMPLETED|Part D (HPMC Capsules)||43
260145|NCT01072175|628874|P11|NOT COMPLETED|Part D (HPMC Capsules)||16
260146|NCT01072175|628875|P10|NOT COMPLETED|Part D (HPMC Capsules)||12
260147|NCT01072175|628876|P9|NOT COMPLETED|Part D (HPMC Capsules)||0
260148|NCT01072175|628877|P8|NOT COMPLETED|Part D (HPMC Capsules)||0
260149|NCT01072175|628878|P7|NOT COMPLETED|Part D (HPMC Capsules)||0
260150|NCT01072175|628879|P6|NOT COMPLETED|Part D (HPMC Capsules)||0
260151|NCT01072175|628880|P5|NOT COMPLETED|Part D (HPMC Capsules)||0
260152|NCT01072175|628881|P4|NOT COMPLETED|Part D (HPMC Capsules)||0
260153|NCT01072175|628882|P3|NOT COMPLETED|Part D (HPMC Capsules)||0
260154|NCT01072175|628883|P2|NOT COMPLETED|Part D (HPMC Capsules)||0
260155|NCT01072175|628884|P1|NOT COMPLETED|Part D (HPMC Capsules)||0
260156|NCT01072175|628872|P13|COMPLETED|Part D (HPMC Capsules)||0
260157|NCT01072175|628873|P12|COMPLETED|Part D (HPMC Capsules)||0
260158|NCT01072175|628874|P11|COMPLETED|Part D (HPMC Capsules)||0
260159|NCT01072175|628875|P10|COMPLETED|Part D (HPMC Capsules)||0
260160|NCT01072175|628876|P9|COMPLETED|Part D (HPMC Capsules)||0
260161|NCT01072175|628877|P8|COMPLETED|Part D (HPMC Capsules)||0
260162|NCT01072175|628878|P7|COMPLETED|Part D (HPMC Capsules)||0
260163|NCT01072175|628879|P6|COMPLETED|Part D (HPMC Capsules)||0
260164|NCT01072175|628880|P5|COMPLETED|Part D (HPMC Capsules)||0
260165|NCT01072175|628881|P4|COMPLETED|Part D (HPMC Capsules)||0
260166|NCT01072175|628882|P3|COMPLETED|Part D (HPMC Capsules)||0
260167|NCT01072175|628883|P2|COMPLETED|Part D (HPMC Capsules)||0
260168|NCT01072175|628884|P1|COMPLETED|Part D (HPMC Capsules)||0
260169|NCT01072175|628872|P13|Ongoing|Part D (HPMC Capsules)||34
260170|NCT01072175|628873|P12|Ongoing|Part D (HPMC Capsules)||34
260171|NCT01072175|628874|P11|Ongoing|Part D (HPMC Capsules)||12
260172|NCT01072175|628875|P10|Ongoing|Part D (HPMC Capsules)||10
260173|NCT01072175|628876|P9|Ongoing|Part D (HPMC Capsules)||0
260174|NCT01072175|628877|P8|Ongoing|Part D (HPMC Capsules)||0
260175|NCT01072175|628878|P7|Ongoing|Part D (HPMC Capsules)||0
260176|NCT01072175|628879|P6|Ongoing|Part D (HPMC Capsules)||0
260177|NCT01072175|628880|P5|Ongoing|Part D (HPMC Capsules)||0
260178|NCT01072175|628881|P4|Ongoing|Part D (HPMC Capsules)||0
260179|NCT01072175|628882|P3|Ongoing|Part D (HPMC Capsules)||0
260180|NCT01072175|628883|P2|Ongoing|Part D (HPMC Capsules)||0
260181|NCT01072175|628884|P1|Ongoing|Part D (HPMC Capsules)||0
260182|NCT01072175|628872|P13|STARTED|Part D (HPMC Capsules)||39
260183|NCT01072175|628873|P12|STARTED|Part D (HPMC Capsules)||43
260184|NCT01072175|628874|P11|STARTED|Part D (HPMC Capsules)||16
260185|NCT01072175|628875|P10|STARTED|Part D (HPMC Capsules)||12
260186|NCT01072175|628876|P9|STARTED|Part D (HPMC Capsules)||0
260187|NCT01072175|628877|P8|STARTED|Part D (HPMC Capsules)||0
260188|NCT01072175|628878|P7|STARTED|Part D (HPMC Capsules)||0
260189|NCT01072175|628879|P6|STARTED|Part D (HPMC Capsules)||0
260190|NCT01072175|628880|P5|STARTED|Part D (HPMC Capsules)||0
260191|NCT01072175|628881|P4|STARTED|Part D (HPMC Capsules)||0
260192|NCT01072175|628882|P3|STARTED|Part D (HPMC Capsules)||0
260193|NCT01072175|628883|P2|STARTED|Part D (HPMC Capsules)||0
260194|NCT01072175|628884|P1|STARTED|Part D (HPMC Capsules)||0
260195|NCT01072175|628872|P13|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260196|NCT01072175|628873|P12|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260197|NCT01072175|628874|P11|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260198|NCT01072175|628875|P10|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260199|NCT01072175|628876|P9|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||43
260200|NCT01072175|628877|P8|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260201|NCT01072175|628878|P7|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260202|NCT01072175|628879|P6|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260203|NCT01072175|628880|P5|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260204|NCT01072175|628881|P4|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260205|NCT01072175|628882|P3|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260206|NCT01072175|628883|P2|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260207|NCT01072175|628884|P1|NOT COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260208|NCT01072175|628872|P13|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260209|NCT01072175|628873|P12|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260210|NCT01072175|628874|P11|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260211|NCT01072175|628875|P10|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260212|NCT01072175|628876|P9|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260213|NCT01072175|628877|P8|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260214|NCT01072175|628878|P7|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260215|NCT01072175|628879|P6|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260216|NCT01072175|628880|P5|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260217|NCT01072175|628881|P4|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260218|NCT01072175|628882|P3|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260219|NCT01072175|628883|P2|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260220|NCT01072175|628884|P1|COMPLETED|Part C (Phase II: Crossover Phase [CP])||0
260221|NCT01072175|628872|P13|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260222|NCT01072175|628873|P12|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260223|NCT01072175|628874|P11|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260224|NCT01072175|628875|P10|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260225|NCT01072175|628876|P9|Ongoing|Part C (Phase II: Crossover Phase [CP])||28
260226|NCT01072175|628877|P8|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260227|NCT01072175|628878|P7|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260228|NCT01072175|628879|P6|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260229|NCT01072175|628880|P5|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260230|NCT01072175|628881|P4|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260231|NCT01072175|628882|P3|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260232|NCT01072175|628883|P2|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260233|NCT01072175|628884|P1|Ongoing|Part C (Phase II: Crossover Phase [CP])||0
260234|NCT01072175|628872|P13|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260235|NCT01072175|628873|P12|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260236|NCT01072175|628874|P11|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260237|NCT01072175|628875|P10|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260238|NCT01072175|628876|P9|STARTED|Part C (Phase II: Crossover Phase [CP])||43
260239|NCT01072175|628877|P8|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260240|NCT01072175|628878|P7|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260241|NCT01072175|628879|P6|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260242|NCT01072175|628880|P5|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260243|NCT01072175|628881|P4|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260244|NCT01072175|628882|P3|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260245|NCT01072175|628883|P2|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260246|NCT01072175|628884|P1|STARTED|Part C (Phase II: Crossover Phase [CP])||0
260247|NCT01072175|628872|P13|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260248|NCT01072175|628873|P12|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260249|NCT01072175|628874|P11|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260250|NCT01072175|628875|P10|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260251|NCT01072175|628876|P9|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260252|NCT01072175|628877|P8|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
260253|NCT01072175|628878|P7|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
260254|NCT01072175|628879|P6|NOT COMPLETED|Part C (Phase II: Randomized Phase)||54
260255|NCT01072175|628880|P5|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260256|NCT01072175|628881|P4|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260257|NCT01072175|628882|P3|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260258|NCT01072175|628883|P2|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260259|NCT01072175|628884|P1|NOT COMPLETED|Part C (Phase II: Randomized Phase)||0
260260|NCT01072175|628872|P13|COMPLETED|Part C (Phase II: Randomized Phase)||0
260261|NCT01072175|628873|P12|COMPLETED|Part C (Phase II: Randomized Phase)||0
260262|NCT01072175|628874|P11|COMPLETED|Part C (Phase II: Randomized Phase)||0
260263|NCT01072175|628875|P10|COMPLETED|Part C (Phase II: Randomized Phase)||0
260264|NCT01072175|628876|P9|COMPLETED|Part C (Phase II: Randomized Phase)||0
260265|NCT01072175|628877|P8|COMPLETED|Part C (Phase II: Randomized Phase)||0
260266|NCT01072175|628878|P7|COMPLETED|Part C (Phase II: Randomized Phase)||0
260267|NCT01072175|628879|P6|COMPLETED|Part C (Phase II: Randomized Phase)||0
260268|NCT01072175|628880|P5|COMPLETED|Part C (Phase II: Randomized Phase)||0
260269|NCT01072175|628881|P4|COMPLETED|Part C (Phase II: Randomized Phase)||0
260270|NCT01072175|628882|P3|COMPLETED|Part C (Phase II: Randomized Phase)||0
260271|NCT01072175|628883|P2|COMPLETED|Part C (Phase II: Randomized Phase)||0
260272|NCT01072175|628884|P1|COMPLETED|Part C (Phase II: Randomized Phase)||0
260273|NCT01072175|628872|P13|Ongoing|Part C (Phase II: Randomized Phase)||0
260274|NCT01072175|628873|P12|Ongoing|Part C (Phase II: Randomized Phase)||0
260275|NCT01072175|628874|P11|Ongoing|Part C (Phase II: Randomized Phase)||0
260276|NCT01072175|628875|P10|Ongoing|Part C (Phase II: Randomized Phase)||0
260277|NCT01072175|628876|P9|Ongoing|Part C (Phase II: Randomized Phase)||0
260278|NCT01072175|628877|P8|Ongoing|Part C (Phase II: Randomized Phase)||40
260279|NCT01072175|628878|P7|Ongoing|Part C (Phase II: Randomized Phase)||32
260280|NCT01072175|628879|P6|Ongoing|Part C (Phase II: Randomized Phase)||35
260281|NCT01072175|628880|P5|Ongoing|Part C (Phase II: Randomized Phase)||0
260282|NCT01072175|628881|P4|Ongoing|Part C (Phase II: Randomized Phase)||0
260283|NCT01072175|628882|P3|Ongoing|Part C (Phase II: Randomized Phase)||0
260284|NCT01072175|628883|P2|Ongoing|Part C (Phase II: Randomized Phase)||0
260285|NCT01072175|628884|P1|Ongoing|Part C (Phase II: Randomized Phase)||0
260286|NCT01072175|628872|P13|STARTED|Part C (Phase II: Randomized Phase)||0
260287|NCT01072175|628873|P12|STARTED|Part C (Phase II: Randomized Phase)||0
260288|NCT01072175|628874|P11|STARTED|Part C (Phase II: Randomized Phase)||0
260289|NCT01072175|628875|P10|STARTED|Part C (Phase II: Randomized Phase)||0
260290|NCT01072175|628876|P9|STARTED|Part C (Phase II: Randomized Phase)||0
260291|NCT01072175|628877|P8|STARTED|Part C (Phase II: Randomized Phase)||54
260292|NCT01072175|628878|P7|STARTED|Part C (Phase II: Randomized Phase)||54
260293|NCT01072175|628879|P6|STARTED|Part C (Phase II: Randomized Phase)||54
260294|NCT01072175|628880|P5|STARTED|Part C (Phase II: Randomized Phase)||0
260295|NCT01072175|628881|P4|STARTED|Part C (Phase II: Randomized Phase)||0
260296|NCT01072175|628882|P3|STARTED|Part C (Phase II: Randomized Phase)||0
260297|NCT01072175|628883|P2|STARTED|Part C (Phase II: Randomized Phase)||0
260298|NCT01072175|628884|P1|STARTED|Part C (Phase II: Randomized Phase)||0
260299|NCT01072175|628872|P13|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260300|NCT01072175|628873|P12|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260301|NCT01072175|628874|P11|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260302|NCT01072175|628875|P10|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260303|NCT01072175|628876|P9|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260304|NCT01072175|628877|P8|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260305|NCT01072175|628878|P7|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260306|NCT01072175|628879|P6|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260307|NCT01072175|628880|P5|NOT COMPLETED|Part B (Dose Escalation and Expansion)||79
260308|NCT01072175|628881|P4|NOT COMPLETED|Part B (Dose Escalation and Expansion)||27
260309|NCT01072175|628882|P3|NOT COMPLETED|Part B (Dose Escalation and Expansion)||23
260310|NCT01072175|628883|P2|NOT COMPLETED|Part B (Dose Escalation and Expansion)||6
260311|NCT01072175|628884|P1|NOT COMPLETED|Part B (Dose Escalation and Expansion)||0
260312|NCT01072175|628872|P13|COMPLETED|Part B (Dose Escalation and Expansion)||0
260313|NCT01072175|628873|P12|COMPLETED|Part B (Dose Escalation and Expansion)||0
260314|NCT01072175|628874|P11|COMPLETED|Part B (Dose Escalation and Expansion)||0
260315|NCT01072175|628875|P10|COMPLETED|Part B (Dose Escalation and Expansion)||0
260316|NCT01072175|628876|P9|COMPLETED|Part B (Dose Escalation and Expansion)||0
260317|NCT01072175|628877|P8|COMPLETED|Part B (Dose Escalation and Expansion)||0
260318|NCT01072175|628878|P7|COMPLETED|Part B (Dose Escalation and Expansion)||0
260319|NCT01072175|628879|P6|COMPLETED|Part B (Dose Escalation and Expansion)||0
260320|NCT01072175|628880|P5|COMPLETED|Part B (Dose Escalation and Expansion)||0
260321|NCT01072175|628881|P4|COMPLETED|Part B (Dose Escalation and Expansion)||0
260322|NCT01072175|628882|P3|COMPLETED|Part B (Dose Escalation and Expansion)||0
260323|NCT01072175|628883|P2|COMPLETED|Part B (Dose Escalation and Expansion)||0
260324|NCT01072175|628884|P1|COMPLETED|Part B (Dose Escalation and Expansion)||0
260325|NCT01072175|628872|P13|Ongoing|Part B (Dose Escalation and Expansion)||0
260326|NCT01072175|628873|P12|Ongoing|Part B (Dose Escalation and Expansion)||0
260327|NCT01072175|628874|P11|Ongoing|Part B (Dose Escalation and Expansion)||0
260328|NCT01072175|628875|P10|Ongoing|Part B (Dose Escalation and Expansion)||0
260329|NCT01072175|628876|P9|Ongoing|Part B (Dose Escalation and Expansion)||0
260330|NCT01072175|628877|P8|Ongoing|Part B (Dose Escalation and Expansion)||0
260331|NCT01072175|628878|P7|Ongoing|Part B (Dose Escalation and Expansion)||0
260332|NCT01072175|628879|P6|Ongoing|Part B (Dose Escalation and Expansion)||0
260333|NCT01072175|628880|P5|Ongoing|Part B (Dose Escalation and Expansion)||28
260334|NCT01072175|628881|P4|Ongoing|Part B (Dose Escalation and Expansion)||9
260335|NCT01072175|628882|P3|Ongoing|Part B (Dose Escalation and Expansion)||10
260336|NCT01072175|628883|P2|Ongoing|Part B (Dose Escalation and Expansion)||2
260337|NCT01072175|628884|P1|Ongoing|Part B (Dose Escalation and Expansion)||0
260338|NCT01072175|628872|P13|STARTED|Part B (Dose Escalation and Expansion)||0
260339|NCT01072175|628873|P12|STARTED|Part B (Dose Escalation and Expansion)||0
260340|NCT01072175|628874|P11|STARTED|Part B (Dose Escalation and Expansion)||0
260341|NCT01072175|628875|P10|STARTED|Part B (Dose Escalation and Expansion)||0
260342|NCT01072175|628876|P9|STARTED|Part B (Dose Escalation and Expansion)||0
260343|NCT01072175|628877|P8|STARTED|Part B (Dose Escalation and Expansion)||0
260344|NCT01072175|628878|P7|STARTED|Part B (Dose Escalation and Expansion)||0
260345|NCT01072175|628879|P6|STARTED|Part B (Dose Escalation and Expansion)||0
260346|NCT01072175|628880|P5|STARTED|Part B (Dose Escalation and Expansion)||79
260347|NCT01072175|628881|P4|STARTED|Part B (Dose Escalation and Expansion)||27
260348|NCT01072175|628882|P3|STARTED|Part B (Dose Escalation and Expansion)||23
260349|NCT01072175|628883|P2|STARTED|Part B (Dose Escalation and Expansion)||6
260350|NCT01072175|628884|P1|STARTED|Part B (Dose Escalation and Expansion)||0
260351|NCT01072175|628872|P13|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260352|NCT01072175|628873|P12|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260353|NCT01072175|628874|P11|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260354|NCT01072175|628875|P10|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260355|NCT01072175|628876|P9|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260356|NCT01072175|628877|P8|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260357|NCT01072175|628878|P7|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260358|NCT01072175|628879|P6|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260359|NCT01072175|628880|P5|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260360|NCT01072175|628881|P4|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260361|NCT01072175|628882|P3|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260362|NCT01072175|628883|P2|NOT COMPLETED|Part A (Drug-Drug Interaction)||0
260363|NCT01072175|628884|P1|NOT COMPLETED|Part A (Drug-Drug Interaction)||8
260364|NCT01072175|628872|P13|COMPLETED|Part A (Drug-Drug Interaction)||0
260365|NCT01072175|628873|P12|COMPLETED|Part A (Drug-Drug Interaction)||0
260366|NCT01072175|628874|P11|COMPLETED|Part A (Drug-Drug Interaction)||0
260367|NCT01072175|628875|P10|COMPLETED|Part A (Drug-Drug Interaction)||0
260368|NCT01072175|628876|P9|COMPLETED|Part A (Drug-Drug Interaction)||0
260369|NCT01072175|628877|P8|COMPLETED|Part A (Drug-Drug Interaction)||0
260370|NCT01072175|628878|P7|COMPLETED|Part A (Drug-Drug Interaction)||0
260371|NCT01072175|628879|P6|COMPLETED|Part A (Drug-Drug Interaction)||0
260372|NCT01072175|628880|P5|COMPLETED|Part A (Drug-Drug Interaction)||0
260373|NCT01072175|628881|P4|COMPLETED|Part A (Drug-Drug Interaction)||0
260374|NCT01072175|628882|P3|COMPLETED|Part A (Drug-Drug Interaction)||0
260375|NCT01072175|628883|P2|COMPLETED|Part A (Drug-Drug Interaction)||0
260376|NCT01072175|628884|P1|COMPLETED|Part A (Drug-Drug Interaction)||0
260377|NCT01072175|628872|P13|STARTED|Part A (Drug-Drug Interaction)||0
260378|NCT01072175|628873|P12|STARTED|Part A (Drug-Drug Interaction)||0
260379|NCT01072175|628874|P11|STARTED|Part A (Drug-Drug Interaction)||0
260380|NCT01072175|628875|P10|STARTED|Part A (Drug-Drug Interaction)||0
260381|NCT01072175|628876|P9|STARTED|Part A (Drug-Drug Interaction)||0
260382|NCT01072175|628877|P8|STARTED|Part A (Drug-Drug Interaction)||0
260383|NCT01072175|628878|P7|STARTED|Part A (Drug-Drug Interaction)||0
260384|NCT01072175|628879|P6|STARTED|Part A (Drug-Drug Interaction)||0
260385|NCT01072175|628880|P5|STARTED|Part A (Drug-Drug Interaction)||0
260386|NCT01072175|628881|P4|STARTED|Part A (Drug-Drug Interaction)||0
260387|NCT01072175|628882|P3|STARTED|Part A (Drug-Drug Interaction)||0
260388|NCT01072175|628883|P2|STARTED|Part A (Drug-Drug Interaction)||0
260389|NCT01072175|628884|P1|STARTED|Part A (Drug-Drug Interaction)||8
260390|NCT01072188|629069|P2|NOT COMPLETED|Overall Study||0
260391|NCT01072188|629070|P1|NOT COMPLETED|Overall Study||0
260392|NCT01072188|629069|P2|COMPLETED|Overall Study||23
260393|NCT01072188|629070|P1|COMPLETED|Overall Study||22
260394|NCT01072188|629069|P2|STARTED|Overall Study||23
260395|NCT01072188|629070|P1|STARTED|Overall Study||22
260396|NCT01072201|629080|P2|NOT COMPLETED|Overall Study||1
260397|NCT01072201|629081|P1|NOT COMPLETED|Overall Study||0
260398|NCT01072201|629080|P2|COMPLETED|Overall Study||29
260399|NCT01072201|629081|P1|COMPLETED|Overall Study||30
260400|NCT01072201|629080|P2|STARTED|Overall Study||30
260401|NCT01072201|629081|P1|STARTED|Overall Study||30
260402|NCT01072331|629094|P3|NOT COMPLETED|Overall Study||0
260403|NCT01072331|629095|P2|NOT COMPLETED|Overall Study||0
260404|NCT01072331|629096|P1|NOT COMPLETED|Overall Study||0
260405|NCT01072331|629094|P3|COMPLETED|Overall Study||32
260406|NCT01072331|629095|P2|COMPLETED|Overall Study||33
260407|NCT01072331|629096|P1|COMPLETED|Overall Study||34
260408|NCT01072331|629094|P3|STARTED|Overall Study||32
260409|NCT01072331|629095|P2|STARTED|Overall Study||33
260410|NCT01072331|629096|P1|STARTED|Overall Study||34
260411|NCT01072344|629115|P2|NOT COMPLETED|Overall Study||18
260412|NCT01072344|629116|P1|NOT COMPLETED|Overall Study||11
260413|NCT01072344|629115|P2|COMPLETED|Overall Study||29
260414|NCT01072344|629116|P1|COMPLETED|Overall Study||35
260415|NCT01072344|629115|P2|STARTED|Overall Study||47
260416|NCT01072344|629116|P1|STARTED|Overall Study||46
260417|NCT01072357|629132|P2|NOT COMPLETED|Overall Study||1
260418|NCT01072357|629133|P1|NOT COMPLETED|Overall Study||0
260419|NCT01072357|629132|P2|COMPLETED|Overall Study||14
260420|NCT01072357|629133|P1|COMPLETED|Overall Study||15
260421|NCT01072357|629132|P2|STARTED|Overall Study||15
260422|NCT01072357|629133|P1|STARTED|Overall Study||15
260423|NCT01072396|629143|P2|NOT COMPLETED|Period Two||3
260424|NCT01072396|629144|P1|NOT COMPLETED|Period Two||1
260425|NCT01072396|629143|P2|COMPLETED|Period Two||57
260426|NCT01072396|629144|P1|COMPLETED|Period Two||57
260427|NCT01072396|629143|P2|STARTED|Period Two||60
260428|NCT01072396|629144|P1|STARTED|Period Two||58
260429|NCT01072396|629143|P2|NOT COMPLETED|Washout Period||1
260430|NCT01072396|629144|P1|NOT COMPLETED|Washout Period||0
260431|NCT01072396|629143|P2|COMPLETED|Washout Period||60
260432|NCT01072396|629144|P1|COMPLETED|Washout Period||58
260433|NCT01072396|629143|P2|STARTED|Washout Period||61
260434|NCT01072396|629144|P1|STARTED|Washout Period||58
260435|NCT01072396|629143|P2|NOT COMPLETED|Period One||2
260436|NCT01072396|629144|P1|NOT COMPLETED|Period One||5
260437|NCT01072396|629143|P2|COMPLETED|Period One||61
260438|NCT01072396|629144|P1|COMPLETED|Period One||58
260439|NCT01072396|629143|P2|STARTED|Period One||63
260440|NCT01072396|629144|P1|STARTED|Period One||63
260441|NCT01072409|629154|P1|NOT COMPLETED|Overall Study||7
260442|NCT01072409|629154|P1|COMPLETED|Overall Study||38
260443|NCT01072409|629154|P1|STARTED|Overall Study||45
260444|NCT01072448|629160|P2|NOT COMPLETED|Overall Study||30
260445|NCT01072448|629161|P1|NOT COMPLETED|Overall Study||19
260446|NCT01072448|629160|P2|COMPLETED|Overall Study||130
260447|NCT01072448|629161|P1|COMPLETED|Overall Study||144
260448|NCT01072448|629160|P2|STARTED|Overall Study||160
260449|NCT01072448|629161|P1|STARTED|Overall Study||163
260450|NCT01072500|629171|P2|NOT COMPLETED|Overall Study||14
260451|NCT01072500|629172|P1|NOT COMPLETED|Overall Study||24
260452|NCT01072500|629171|P2|COMPLETED|Overall Study||803
260453|NCT01072500|629172|P1|COMPLETED|Overall Study||794
260454|NCT01072500|629171|P2|STARTED|Overall Study||817
260455|NCT01072500|629172|P1|STARTED|Overall Study||818
260456|NCT01072526|629180|P2|NOT COMPLETED|Overall Study||0
260457|NCT01072526|629181|P1|NOT COMPLETED|Overall Study||0
260458|NCT01072526|629180|P2|COMPLETED|Overall Study||0
260459|NCT01072526|629181|P1|COMPLETED|Overall Study|Study completed in September 2008(recruited 6 patients total of 20 anticipated)|6
260460|NCT01072526|629180|P2|STARTED|Overall Study||0
260461|NCT01072526|629181|P1|STARTED|Overall Study|Study started in December 2007 (recruited 6 patients total of 20 anticipated)|6
260462|NCT01072539|629194|P1|NOT COMPLETED|Overall Study||3
260463|NCT01072539|629194|P1|COMPLETED|Overall Study|Refer to the Safety Analysis Set. Data for completion were not collected.|3169
260464|NCT01072539|629194|P1|STARTED|Overall Study||3172
260465|NCT01072617|629202|P1|NOT COMPLETED|Overall Study||0
260466|NCT01072617|629202|P1|COMPLETED|Overall Study||8
260467|NCT01072617|629202|P1|STARTED|Overall Study||8
260468|NCT01072630|629212|P3|NOT COMPLETED|Overall Study||13
260469|NCT01072630|629213|P2|NOT COMPLETED|Overall Study||60
260470|NCT01072630|629214|P1|NOT COMPLETED|Overall Study||55
260471|NCT01072630|629212|P3|COMPLETED|Overall Study||17
260472|NCT01072630|629213|P2|COMPLETED|Overall Study||172
260473|NCT01072630|629214|P1|COMPLETED|Overall Study||175
260474|NCT01072630|629212|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|28
260475|NCT01072630|629213|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|230
260476|NCT01072630|629214|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|224
260477|NCT01072630|629212|P3|Safety Population|Overall Study|Treated participants.|30
260478|NCT01072630|629213|P2|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|231
260479|NCT01072630|629214|P1|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|229
260480|NCT01072630|629212|P3|STARTED|Overall Study||30
260481|NCT01072630|629213|P2|STARTED|Overall Study||232
260482|NCT01072630|629214|P1|STARTED|Overall Study||230
260483|NCT01072643|629288|P1|NOT COMPLETED|Overall Study||0
260484|NCT01072643|629288|P1|COMPLETED|Overall Study||4
260485|NCT01072643|629288|P1|STARTED|Overall Study||4
260486|NCT01072656|629297|P2|NOT COMPLETED|Second Intervention||0
260487|NCT01072656|629298|P1|NOT COMPLETED|Second Intervention||0
260488|NCT01072656|629297|P2|COMPLETED|Second Intervention||4
260489|NCT01072656|629298|P1|COMPLETED|Second Intervention||5
260490|NCT01072656|629297|P2|STARTED|Second Intervention||4
260491|NCT01072656|629298|P1|STARTED|Second Intervention||5
260492|NCT01072656|629297|P2|NOT COMPLETED|First Intervention||0
260493|NCT01072656|629298|P1|NOT COMPLETED|First Intervention||0
260494|NCT01072656|629297|P2|COMPLETED|First Intervention||4
260495|NCT01072656|629298|P1|COMPLETED|First Intervention||5
260496|NCT01072656|629297|P2|STARTED|First Intervention||4
260497|NCT01072656|629298|P1|STARTED|First Intervention||5
260498|NCT01072669|629310|P2|NOT COMPLETED|Overall Study||0
260499|NCT01072669|629311|P1|NOT COMPLETED|Overall Study||0
260500|NCT01072669|629310|P2|COMPLETED|Overall Study||5
260501|NCT01072669|629311|P1|COMPLETED|Overall Study||15
260502|NCT01072669|629310|P2|STARTED|Overall Study||5
260503|NCT01072669|629311|P1|STARTED|Overall Study||15
260504|NCT01072773|629317|P1|NOT COMPLETED|Overall Study||0
260505|NCT01072773|629317|P1|COMPLETED|Overall Study||2
260506|NCT01072773|629317|P1|STARTED|Overall Study||2
260507|NCT01072877|629331|P5|NOT COMPLETED|Overall Study||0
260508|NCT01072877|629332|P4|NOT COMPLETED|Overall Study||2
260509|NCT01072877|629333|P3|NOT COMPLETED|Overall Study||0
260510|NCT01072877|629334|P2|NOT COMPLETED|Overall Study||1
260511|NCT01072877|629335|P1|NOT COMPLETED|Overall Study||1
260512|NCT01072877|629331|P5|COMPLETED|Overall Study||63
260513|NCT01072877|629332|P4|COMPLETED|Overall Study||50
260514|NCT01072877|629333|P3|COMPLETED|Overall Study||51
260515|NCT01072877|629334|P2|COMPLETED|Overall Study||56
260516|NCT01072877|629335|P1|COMPLETED|Overall Study||55
260517|NCT01072877|629331|P5|STARTED|Overall Study||63
260518|NCT01072877|629332|P4|STARTED|Overall Study||52
260519|NCT01072877|629333|P3|STARTED|Overall Study||51
260520|NCT01072877|629334|P2|STARTED|Overall Study||57
260521|NCT01072877|629335|P1|STARTED|Overall Study||56
260522|NCT01072929|629360|P3|NOT COMPLETED|Overall Study||9
260523|NCT01072929|629361|P2|NOT COMPLETED|Overall Study||51
260524|NCT01072929|629362|P1|NOT COMPLETED|Overall Study||44
260525|NCT01072929|629360|P3|COMPLETED|Overall Study||24
260526|NCT01072929|629361|P2|COMPLETED|Overall Study||150
260527|NCT01072929|629362|P1|COMPLETED|Overall Study||155
260528|NCT01072929|629360|P3|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|31
260529|NCT01072929|629361|P2|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|197
260530|NCT01072929|629362|P1|Full Analysis Population|Overall Study|Treated participants who have at least 1 postbaseline IDS-C30 efficacy assessment|196
260531|NCT01072929|629360|P3|Safety Population|Overall Study|Treated participants. One participant was randomized but not treated.|32
260532|NCT01072929|629361|P2|Safety Population|Overall Study|Treated participants. Three participants were randomized but not treated.|198
260533|NCT01072929|629362|P1|Safety Population|Overall Study|Treated participants|199
260534|NCT01072929|629360|P3|STARTED|Overall Study||33
260535|NCT01072929|629361|P2|STARTED|Overall Study||201
260536|NCT01072929|629362|P1|STARTED|Overall Study||199
260537|NCT01073163|629436|P1|NOT COMPLETED|Overall Study||3
260538|NCT01073163|629436|P1|COMPLETED|Overall Study|Patients completed study|51
260539|NCT01073163|629436|P1|Treated With >=6 Cycles|Overall Study||49
260540|NCT01073163|629436|P1|Treated With <6 Cycles|Overall Study||4
260541|NCT01073163|629436|P1|Enrolled But Not Treated|Overall Study||1
260542|NCT01073163|629436|P1|STARTED|Overall Study||54
260543|NCT01062841|629458|P2|NOT COMPLETED|Overall Study||53
260544|NCT01062841|629459|P1|NOT COMPLETED|Overall Study||49
260545|NCT01062841|629458|P2|COMPLETED|Overall Study||162
260546|NCT01062841|629459|P1|COMPLETED|Overall Study||154
260547|NCT01062841|629458|P2|STARTED|Overall Study||215
260548|NCT01062841|629459|P1|STARTED|Overall Study||203
260549|NCT01063036|629487|P1|NOT COMPLETED|Post Dosing Follow-up Through 24 Weeks||39
260550|NCT01063036|629487|P1|COMPLETED|Post Dosing Follow-up Through 24 Weeks||46
260551|NCT01063036|629487|P1|STARTED|Post Dosing Follow-up Through 24 Weeks|2 included did not complete treatment; 3 completed treatment but not included (lost to follow-up).|85
260552|NCT01063036|629487|P1|NOT COMPLETED|Participants Treated With Study Drug||6
260553|NCT01063036|629487|P1|COMPLETED|Participants Treated With Study Drug||86
260554|NCT01063036|629487|P1|STARTED|Participants Treated With Study Drug||92
260555|NCT01063049|629504|P3|NOT COMPLETED|Overall Study||0
260556|NCT01063049|629505|P2|NOT COMPLETED|Overall Study||0
260557|NCT01063049|629506|P1|NOT COMPLETED|Overall Study||0
260558|NCT01063049|629504|P3|COMPLETED|Overall Study||200
260559|NCT01063049|629505|P2|COMPLETED|Overall Study||200
260560|NCT01063049|629506|P1|COMPLETED|Overall Study||200
260561|NCT01063049|629504|P3|STARTED|Overall Study||200
260562|NCT01063049|629505|P2|STARTED|Overall Study||200
260563|NCT01063049|629506|P1|STARTED|Overall Study||200
260564|NCT01063062|629519|P2|NOT COMPLETED|Overall Study||12
260565|NCT01063062|629520|P1|NOT COMPLETED|Overall Study||8
260566|NCT01063062|629519|P2|COMPLETED|Overall Study||65
260567|NCT01063062|629520|P1|COMPLETED|Overall Study||22
260568|NCT01063062|629519|P2|Received Study Drug|Overall Study||76
260569|NCT01063062|629520|P1|Received Study Drug|Overall Study||29
260570|NCT01063062|629519|P2|STARTED|Overall Study||77
260571|NCT01063062|629520|P1|STARTED|Overall Study||30
260572|NCT01063075|629558|P4|NOT COMPLETED|Overall Study||1
260573|NCT01063075|629559|P3|NOT COMPLETED|Overall Study||5
260574|NCT01063075|629560|P2|NOT COMPLETED|Overall Study||2
260575|NCT01063075|629561|P1|NOT COMPLETED|Overall Study||1
260576|NCT01063075|629558|P4|COMPLETED|Overall Study||14
260577|NCT01063075|629559|P3|COMPLETED|Overall Study||9
260578|NCT01063075|629560|P2|COMPLETED|Overall Study||1
260579|NCT01063075|629561|P1|COMPLETED|Overall Study||1
260580|NCT01063075|629558|P4|STARTED|Overall Study||15
260581|NCT01063075|629559|P3|STARTED|Overall Study||14
260582|NCT01063075|629560|P2|STARTED|Overall Study||3
260583|NCT01063075|629561|P1|STARTED|Overall Study||2
260584|NCT01063153|629579|P2|NOT COMPLETED|Overall Study||12
260585|NCT01063153|629580|P1|NOT COMPLETED|Overall Study||2
260586|NCT01063153|629579|P2|COMPLETED|Overall Study||26
260587|NCT01063153|629580|P1|COMPLETED|Overall Study||31
260588|NCT01063153|629579|P2|STARTED|Overall Study||38
260589|NCT01063153|629580|P1|STARTED|Overall Study||33
260590|NCT01063348|629592|P2|NOT COMPLETED|Overall Study||10
260591|NCT01063348|629593|P1|NOT COMPLETED|Overall Study||3
260592|NCT01063348|629592|P2|COMPLETED|Overall Study||21
260593|NCT01063348|629593|P1|COMPLETED|Overall Study||32
260594|NCT01063348|629592|P2|STARTED|Overall Study||31
260595|NCT01063348|629593|P1|STARTED|Overall Study||35
260596|NCT01063517|629603|P2|NOT COMPLETED|Overall Study||60
260597|NCT01063517|629604|P1|NOT COMPLETED|Overall Study||58
260598|NCT01063517|629603|P2|COMPLETED|Overall Study||2
260599|NCT01063517|629604|P1|COMPLETED|Overall Study||4
260600|NCT01063517|629603|P2|Received Randomised Treatment|Overall Study||62
260601|NCT01063517|629604|P1|Received Randomised Treatment|Overall Study||61
260602|NCT01063517|629603|P2|STARTED|Overall Study||62
260603|NCT01063517|629604|P1|STARTED|Overall Study||62
260604|NCT01063595|629642|P2|NOT COMPLETED|Second Intervention||0
260605|NCT01063595|629643|P1|NOT COMPLETED|Second Intervention||0
260606|NCT01063595|629642|P2|COMPLETED|Second Intervention||24
260607|NCT01063595|629643|P1|COMPLETED|Second Intervention||29
260608|NCT01063595|629642|P2|STARTED|Second Intervention||24
260609|NCT01063595|629643|P1|STARTED|Second Intervention||29
260610|NCT01063595|629642|P2|NOT COMPLETED|First Intervention||5
260611|NCT01063595|629643|P1|NOT COMPLETED|First Intervention||2
260612|NCT01063595|629642|P2|COMPLETED|First Intervention||24
260613|NCT01063595|629643|P1|COMPLETED|First Intervention||29
260614|NCT01063595|629642|P2|STARTED|First Intervention||29
260615|NCT01063595|629643|P1|STARTED|First Intervention||31
260616|NCT01063595|629642|P2|NOT COMPLETED|Enrolled in Study and Randomized||2
260617|NCT01063595|629643|P1|NOT COMPLETED|Enrolled in Study and Randomized||1
260618|NCT01063595|629642|P2|COMPLETED|Enrolled in Study and Randomized||29
260619|NCT01063595|629643|P1|COMPLETED|Enrolled in Study and Randomized||31
260620|NCT01063595|629642|P2|Received Treatment|Enrolled in Study and Randomized||29
260621|NCT01063595|629643|P1|Received Treatment|Enrolled in Study and Randomized||31
260622|NCT01063595|629642|P2|STARTED|Enrolled in Study and Randomized||31
260623|NCT01063595|629643|P1|STARTED|Enrolled in Study and Randomized||32
260624|NCT01063712|629653|P1|NOT COMPLETED|Overall Study||0
260625|NCT01063712|629653|P1|COMPLETED|Overall Study||29
260626|NCT01063712|629653|P1|STARTED|Overall Study||29
260627|NCT01063764|629658|P1|NOT COMPLETED|2nd Period (Week 22 to the End of Study)||20
260628|NCT01063764|629658|P1|COMPLETED|2nd Period (Week 22 to the End of Study)||35
260629|NCT01063764|629658|P1|STARTED|2nd Period (Week 22 to the End of Study)|7 subjects who completed Period 1 did not enter the Second Period.|55
260630|NCT01063764|629658|P1|NOT COMPLETED|1st Period (From Week 8 to Week 22)||11
260631|NCT01063764|629658|P1|COMPLETED|1st Period (From Week 8 to Week 22)|62 subjects completed the First Period, but 7 of these subjects did not enter the Second Period.|62
260632|NCT01063764|629658|P1|STARTED|1st Period (From Week 8 to Week 22)||73
260633|NCT01063855|629674|P2|NOT COMPLETED|Overall Study||29
260634|NCT01063855|629675|P1|NOT COMPLETED|Overall Study||37
260635|NCT01063855|629674|P2|COMPLETED|Overall Study||221
260636|NCT01063855|629675|P1|COMPLETED|Overall Study||208
260637|NCT01063855|629674|P2|STARTED|Overall Study||250
260638|NCT01063855|629675|P1|STARTED|Overall Study||245
260639|NCT01063868|629699|P2|NOT COMPLETED|Overall Study||12
260640|NCT01063868|629700|P1|NOT COMPLETED|Overall Study||35
260641|NCT01063868|629699|P2|COMPLETED|Overall Study||0
260642|NCT01063868|629700|P1|COMPLETED|Overall Study||0
260643|NCT01063868|629699|P2|STARTED|Overall Study||12
260644|NCT01063868|629700|P1|STARTED|Overall Study||35
260645|NCT01063881|629709|P3|NOT COMPLETED|Overall Study||1
260646|NCT01063881|629710|P2|NOT COMPLETED|Overall Study||11
260647|NCT01063881|629711|P1|NOT COMPLETED|Overall Study||55
260648|NCT01063881|629709|P3|COMPLETED|Overall Study||12
260649|NCT01063881|629710|P2|COMPLETED|Overall Study||114
260650|NCT01063881|629711|P1|COMPLETED|Overall Study||92
260651|NCT01063881|629709|P3|STARTED|Overall Study||13
260652|NCT01063881|629710|P2|STARTED|Overall Study||125
260653|NCT01063881|629711|P1|STARTED|Overall Study||147
260654|NCT01063907|629733|P2|NOT COMPLETED|Overall Study||0
260655|NCT01063907|629734|P1|NOT COMPLETED|Overall Study||0
260656|NCT01063907|629733|P2|COMPLETED|Overall Study||80
260657|NCT01063907|629734|P1|COMPLETED|Overall Study||15
260658|NCT01063907|629733|P2|STARTED|Overall Study||80
260659|NCT01063907|629734|P1|STARTED|Overall Study||15
260660|NCT01064076|629764|P1|NOT COMPLETED|Overall Study||18
260661|NCT01064076|629764|P1|COMPLETED|Overall Study|303 subjects completed a minimum of 180 days of follow up|303
260662|NCT01064076|629764|P1|STARTED|Overall Study|321 subjects underwent an implant procedure for the S-ICD System|321
260663|NCT01064167|629771|P2|NOT COMPLETED|Overall Study||15
260664|NCT01064167|629772|P1|NOT COMPLETED|Overall Study||14
260665|NCT01064167|629771|P2|COMPLETED|Overall Study||115
260666|NCT01064167|629772|P1|COMPLETED|Overall Study||116
260667|NCT01064167|629771|P2|STARTED|Overall Study||130
260668|NCT01064167|629772|P1|STARTED|Overall Study||130
260669|NCT01064284|629782|P2|NOT COMPLETED|Overall Study||17
260670|NCT01064284|629783|P1|NOT COMPLETED|Overall Study||18
260671|NCT01064284|629782|P2|COMPLETED|Overall Study||109
260672|NCT01064284|629783|P1|COMPLETED|Overall Study||107
260673|NCT01064284|629782|P2|STARTED|Overall Study|Taking into account the analyzed patients only|126
260674|NCT01064284|629783|P1|STARTED|Overall Study|Taking into account the analyzed patients only|125
260675|NCT01064297|629806|P3|NOT COMPLETED|Overall Study||133
260676|NCT01064297|629807|P2|NOT COMPLETED|Overall Study||48
260677|NCT01064297|629808|P1|NOT COMPLETED|Overall Study||791
260678|NCT01064297|629806|P3|COMPLETED|Overall Study||497
260679|NCT01064297|629807|P2|COMPLETED|Overall Study||171
260680|NCT01064297|629808|P1|COMPLETED|Overall Study||1776
260681|NCT01064297|629806|P3|STARTED|Overall Study||630
260682|NCT01064297|629807|P2|STARTED|Overall Study||219
260683|NCT01064297|629808|P1|STARTED|Overall Study||2567
260684|NCT01064310|629854|P3|NOT COMPLETED|Open Label Pazopinib||84
260685|NCT01064310|629855|P2|NOT COMPLETED|Open Label Pazopinib||0
260686|NCT01064310|629856|P1|NOT COMPLETED|Open Label Pazopinib||0
260687|NCT01064310|629854|P3|COMPLETED|Open Label Pazopinib||0
260688|NCT01064310|629855|P2|COMPLETED|Open Label Pazopinib||0
260689|NCT01064310|629856|P1|COMPLETED|Open Label Pazopinib||0
260690|NCT01064310|629854|P3|STARTED|Open Label Pazopinib||84
260691|NCT01064310|629855|P2|STARTED|Open Label Pazopinib||0
260692|NCT01064310|629856|P1|STARTED|Open Label Pazopinib||0
260693|NCT01064310|629854|P3|NOT COMPLETED|Period 2||0
260694|NCT01064310|629855|P2|NOT COMPLETED|Period 2||6
260695|NCT01064310|629856|P1|NOT COMPLETED|Period 2||4
260696|NCT01064310|629854|P3|COMPLETED|Period 2||0
260697|NCT01064310|629855|P2|COMPLETED|Period 2||62
260698|NCT01064310|629856|P1|COMPLETED|Period 2||64
260699|NCT01064310|629854|P3|STARTED|Period 2||0
260700|NCT01064310|629855|P2|STARTED|Period 2||68
260701|NCT01064310|629856|P1|STARTED|Period 2||68
260702|NCT01064310|629854|P3|NOT COMPLETED|Period 1||0
260703|NCT01064310|629855|P2|NOT COMPLETED|Period 1||18
260704|NCT01064310|629856|P1|NOT COMPLETED|Period 1||14
260705|NCT01064310|629854|P3|COMPLETED|Period 1||0
260706|NCT01064310|629855|P2|COMPLETED|Period 1||68
260707|NCT01064310|629856|P1|COMPLETED|Period 1||68
260708|NCT01064310|629854|P3|STARTED|Period 1||0
260709|NCT01064310|629855|P2|STARTED|Period 1||86
260710|NCT01064310|629856|P1|STARTED|Period 1||82
260711|NCT01064323|629883|P1|NOT COMPLETED|Overall Study||0
260712|NCT01064323|629883|P1|COMPLETED|Overall Study||10
260713|NCT01064323|629883|P1|STARTED|Overall Study||10
260714|NCT01064362|629907|P2|NOT COMPLETED|Overall Study||0
260715|NCT01064362|629908|P1|NOT COMPLETED|Overall Study||0
260716|NCT01064362|629907|P2|COMPLETED|Overall Study||11883
260717|NCT01064362|629908|P1|COMPLETED|Overall Study||1559
260718|NCT01064362|629907|P2|STARTED|Overall Study||11883
260719|NCT01064362|629908|P1|STARTED|Overall Study||1559
260720|NCT01064401|629918|P2|NOT COMPLETED|Overall Study||195
260721|NCT01064401|629919|P1|NOT COMPLETED|Overall Study||228
260722|NCT01064401|629918|P2|COMPLETED|Overall Study||724
260723|NCT01064401|629919|P1|COMPLETED|Overall Study||694
260724|NCT01064401|629918|P2|STARTED|Overall Study||919
260725|NCT01064401|629919|P1|STARTED|Overall Study||922
260726|NCT01064414|629936|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
260727|NCT01064414|629937|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
260728|NCT01064414|629938|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
260729|NCT01064414|629936|P3|COMPLETED|Extension Period: Week 26 to Week 52||76
260730|NCT01064414|629937|P2|COMPLETED|Extension Period: Week 26 to Week 52||67
260731|NCT01064414|629938|P1|COMPLETED|Extension Period: Week 26 to Week 52||64
260732|NCT01064414|629936|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|81
260733|NCT01064414|629937|P2|STARTED|Extension Period: Week 26 to Week 52|3 pts completed core but did not enter ext. Reason: other (not specified) (3).|72
260734|NCT01064414|629938|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext. Reason: other (not specified).|76
260735|NCT01064414|629936|P3|NOT COMPLETED|Core Period: Baseline to Week 26||7
260736|NCT01064414|629937|P2|NOT COMPLETED|Core Period: Baseline to Week 26||15
260737|NCT01064414|629938|P1|NOT COMPLETED|Core Period: Baseline to Week 26||13
260738|NCT01064414|629936|P3|COMPLETED|Core Period: Baseline to Week 26||82
260739|NCT01064414|629937|P2|COMPLETED|Core Period: Baseline to Week 26||75
260740|NCT01064414|629938|P1|COMPLETED|Core Period: Baseline to Week 26||77
260741|NCT01064414|629936|P3|STARTED|Core Period: Baseline to Week 26||89
260742|NCT01064414|629937|P2|STARTED|Core Period: Baseline to Week 26||90
260743|NCT01064414|629938|P1|STARTED|Core Period: Baseline to Week 26||90
260744|NCT01064622|629958|P2|NOT COMPLETED|Crossover of Arm I||0
260745|NCT01064622|629959|P1|NOT COMPLETED|Crossover of Arm I||0
260746|NCT01064622|629958|P2|COMPLETED|Crossover of Arm I||0
260747|NCT01064622|629959|P1|COMPLETED|Crossover of Arm I||22
260748|NCT01064622|629958|P2|STARTED|Crossover of Arm I||0
260749|NCT01064622|629959|P1|STARTED|Crossover of Arm I|Among 53 patients, 45 had disease progression; however 23 elected not to crossover to vismodegib.|22
260750|NCT01064622|629958|P2|NOT COMPLETED|Randomized Phase II||3
260751|NCT01064622|629959|P1|NOT COMPLETED|Randomized Phase II||2
260752|NCT01064622|629958|P2|COMPLETED|Randomized Phase II||53
260753|NCT01064622|629959|P1|COMPLETED|Randomized Phase II||53
260754|NCT01064622|629958|P2|STARTED|Randomized Phase II||56
260755|NCT01064622|629959|P1|STARTED|Randomized Phase II||55
260756|NCT01064622|629958|P2|NOT COMPLETED|Lead-in Phase I||0
260757|NCT01064622|629959|P1|NOT COMPLETED|Lead-in Phase I||0
260758|NCT01064622|629958|P2|COMPLETED|Lead-in Phase I||7
260759|NCT01064622|629959|P1|COMPLETED|Lead-in Phase I||0
260760|NCT01064622|629958|P2|STARTED|Lead-in Phase I||7
260761|NCT01064622|629959|P1|STARTED|Lead-in Phase I||0
260762|NCT01064687|629984|P4|NOT COMPLETED|Overall Study||17
260763|NCT01064687|629985|P3|NOT COMPLETED|Overall Study||41
260764|NCT01064687|629986|P2|NOT COMPLETED|Overall Study||26
260765|NCT01064687|629987|P1|NOT COMPLETED|Overall Study||34
260766|NCT01064687|629984|P4|COMPLETED|Overall Study||124
260767|NCT01064687|629985|P3|COMPLETED|Overall Study||237
260768|NCT01064687|629986|P2|COMPLETED|Overall Study||254
260769|NCT01064687|629987|P1|COMPLETED|Overall Study||245
260770|NCT01064687|629984|P4|Completed 26 Weeks|Overall Study||124
260771|NCT01064687|629985|P3|Completed 26 Weeks|Overall Study||252
260772|NCT01064687|629986|P2|Completed 26 Weeks|Overall Study||263
260773|NCT01064687|629987|P1|Completed 26 Weeks|Overall Study||260
260774|NCT01064687|629984|P4|Received at Least 1 Dose of Study Drug|Overall Study||141
260775|NCT01064687|629985|P3|Received at Least 1 Dose of Study Drug|Overall Study||276
260776|NCT01064687|629986|P2|Received at Least 1 Dose of Study Drug|Overall Study||280
260777|NCT01064687|629987|P1|Received at Least 1 Dose of Study Drug|Overall Study||279
260778|NCT01064687|629984|P4|STARTED|Overall Study||141
260779|NCT01064687|629985|P3|STARTED|Overall Study|Of 278 participants randomized to Exenatide, 2 chose not to take study drug.|278
260780|NCT01064687|629986|P2|STARTED|Overall Study||280
260781|NCT01064687|629987|P1|STARTED|Overall Study||279
260782|NCT01064739|630164|P1|NOT COMPLETED|Fixed Sodium Diet + Fava Beans||1
260783|NCT01064739|630164|P1|COMPLETED|Fixed Sodium Diet + Fava Beans|1 participant withdrew with blood in his urine on the fava bean study day.|13
260784|NCT01064739|630164|P1|STARTED|Fixed Sodium Diet + Fava Beans||14
260785|NCT01064739|630164|P1|NOT COMPLETED|Fixed Sodium Study Diet||0
260786|NCT01064739|630164|P1|COMPLETED|Fixed Sodium Study Diet||14
260787|NCT01064739|630164|P1|STARTED|Fixed Sodium Study Diet|14 participants consumed the fixed-sodium study diet prior to the fava bean supplement study day.|14
260788|NCT01064817|630222|P2|NOT COMPLETED|Study Completion||0
260789|NCT01064817|630223|P1|NOT COMPLETED|Study Completion||2
260790|NCT01064817|630222|P2|COMPLETED|Study Completion||62
260791|NCT01064817|630223|P1|COMPLETED|Study Completion||60
260792|NCT01064817|630222|P2|STARTED|Study Completion||62
260793|NCT01064817|630223|P1|STARTED|Study Completion||62
260794|NCT01064817|630222|P2|NOT COMPLETED|All Study Treatment Days 1-9||0
260795|NCT01064817|630223|P1|NOT COMPLETED|All Study Treatment Days 1-9||0
260796|NCT01064817|630222|P2|COMPLETED|All Study Treatment Days 1-9||62
260797|NCT01064817|630223|P1|COMPLETED|All Study Treatment Days 1-9||62
260798|NCT01064817|630222|P2|STARTED|All Study Treatment Days 1-9||62
260799|NCT01064817|630223|P1|STARTED|All Study Treatment Days 1-9||62
260800|NCT01064830|630237|P2|NOT COMPLETED|Overall Study||4
260801|NCT01064830|630238|P1|NOT COMPLETED|Overall Study||2
260802|NCT01064830|630237|P2|COMPLETED|Overall Study||7
260803|NCT01064830|630238|P1|COMPLETED|Overall Study||8
260804|NCT01064830|630237|P2|STARTED|Overall Study||11
260805|NCT01064830|630238|P1|STARTED|Overall Study||10
260806|NCT01064856|630248|P4|NOT COMPLETED|Open-label (OL) Period||20
260807|NCT01064856|630249|P3|NOT COMPLETED|Open-label (OL) Period||26
260808|NCT01064856|630250|P2|NOT COMPLETED|Open-label (OL) Period||0
260809|NCT01064856|630251|P1|NOT COMPLETED|Open-label (OL) Period||0
260810|NCT01064856|630248|P4|COMPLETED|Open-label (OL) Period||61
260811|NCT01064856|630249|P3|COMPLETED|Open-label (OL) Period||56
260812|NCT01064856|630250|P2|COMPLETED|Open-label (OL) Period||0
260813|NCT01064856|630251|P1|COMPLETED|Open-label (OL) Period||0
260814|NCT01064856|630248|P4|STARTED|Open-label (OL) Period||81
260815|NCT01064856|630249|P3|STARTED|Open-label (OL) Period||82
260816|NCT01064856|630250|P2|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
260817|NCT01064856|630251|P1|STARTED|Open-label (OL) Period|This treatment group is not applicable for this period.|0
260818|NCT01064856|630248|P4|NOT COMPLETED|Double-blind (DB) Period||0
260819|NCT01064856|630249|P3|NOT COMPLETED|Double-blind (DB) Period||0
260820|NCT01064856|630250|P2|NOT COMPLETED|Double-blind (DB) Period||0
260821|NCT01064856|630251|P1|NOT COMPLETED|Double-blind (DB) Period||2
260822|NCT01064856|630248|P4|COMPLETED|Double-blind (DB) Period||0
260823|NCT01064856|630249|P3|COMPLETED|Double-blind (DB) Period||0
260824|NCT01064856|630250|P2|COMPLETED|Double-blind (DB) Period||81
260825|NCT01064856|630251|P1|COMPLETED|Double-blind (DB) Period||82
260826|NCT01064856|630248|P4|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
260827|NCT01064856|630249|P3|STARTED|Double-blind (DB) Period|This treatment group is not applicable for this period.|0
260828|NCT01064856|630250|P2|STARTED|Double-blind (DB) Period||81
260829|NCT01064856|630251|P1|STARTED|Double-blind (DB) Period||84
260830|NCT01064882|630285|P3|NOT COMPLETED|Overall Study||2
260831|NCT01064882|630286|P2|NOT COMPLETED|Overall Study||2
260832|NCT01064882|630287|P1|NOT COMPLETED|Overall Study||2
260833|NCT01064882|630285|P3|COMPLETED|Overall Study||32
260834|NCT01064882|630286|P2|COMPLETED|Overall Study||32
260835|NCT01064882|630287|P1|COMPLETED|Overall Study||34
260836|NCT01064882|630285|P3|STARTED|Overall Study||34
260837|NCT01064882|630286|P2|STARTED|Overall Study||34
260838|NCT01064882|630287|P1|STARTED|Overall Study||36
260839|NCT01064947|630313|P1|NOT COMPLETED|Overall Study||41
260840|NCT01064947|630313|P1|COMPLETED|Overall Study||29
260841|NCT01064947|630313|P1|STARTED|Overall Study||70
260842|NCT01065051|630323|P2|NOT COMPLETED|Overall Study||0
260843|NCT01065051|630324|P1|NOT COMPLETED|Overall Study||0
260844|NCT01065051|630323|P2|COMPLETED|Overall Study||0
260845|NCT01065051|630324|P1|COMPLETED|Overall Study||1
260846|NCT01065051|630323|P2|STARTED|Overall Study||0
260847|NCT01065051|630324|P1|STARTED|Overall Study||1
260848|NCT01065350|630352|P2|NOT COMPLETED|Overall Study||1
260849|NCT01065350|630353|P1|NOT COMPLETED|Overall Study||0
260850|NCT01065350|630352|P2|COMPLETED|Overall Study||41
260851|NCT01065350|630353|P1|COMPLETED|Overall Study||43
260852|NCT01065350|630352|P2|STARTED|Overall Study||42
260853|NCT01065350|630353|P1|STARTED|Overall Study||43
260854|NCT01065428|630387|P2|NOT COMPLETED|Overall Study||0
260855|NCT01065428|630388|P1|NOT COMPLETED|Overall Study||0
260856|NCT01065428|630387|P2|COMPLETED|Overall Study||35
260857|NCT01065428|630388|P1|COMPLETED|Overall Study||17
260858|NCT01065428|630387|P2|STARTED|Overall Study||35
260859|NCT01065428|630388|P1|STARTED|Overall Study||17
260860|NCT01065454|630400|P4|NOT COMPLETED|Follow up||44
260861|NCT01065454|630401|P3|NOT COMPLETED|Follow up||17
260862|NCT01065454|630402|P2|NOT COMPLETED|Follow up||24
260863|NCT01065454|630403|P1|NOT COMPLETED|Follow up||39
260864|NCT01065454|630400|P4|COMPLETED|Follow up||13
260865|NCT01065454|630401|P3|COMPLETED|Follow up||6
260866|NCT01065454|630402|P2|COMPLETED|Follow up||4
260867|NCT01065454|630403|P1|COMPLETED|Follow up||15
260868|NCT01065454|630400|P4|Entering Follow-up|Follow up||51
260869|NCT01065454|630401|P3|Entering Follow-up|Follow up||23
260870|NCT01065454|630402|P2|Entering Follow-up|Follow up||27
260871|NCT01065454|630403|P1|Entering Follow-up|Follow up||49
260872|NCT01065454|630400|P4|STARTED|Follow up||57
260873|NCT01065454|630401|P3|STARTED|Follow up||23
260874|NCT01065454|630402|P2|STARTED|Follow up||28
260875|NCT01065454|630403|P1|STARTED|Follow up||54
260876|NCT01065454|630400|P4|NOT COMPLETED|Treatment||12
260877|NCT01065454|630401|P3|NOT COMPLETED|Treatment||9
260878|NCT01065454|630402|P2|NOT COMPLETED|Treatment||5
260879|NCT01065454|630403|P1|NOT COMPLETED|Treatment||13
260880|NCT01065454|630400|P4|COMPLETED|Treatment||57
260881|NCT01065454|630401|P3|COMPLETED|Treatment||23
260882|NCT01065454|630402|P2|COMPLETED|Treatment||28
260883|NCT01065454|630403|P1|COMPLETED|Treatment||54
260884|NCT01065454|630400|P4|STARTED|Treatment||69
260885|NCT01065454|630401|P3|STARTED|Treatment||32
260886|NCT01065454|630402|P2|STARTED|Treatment||33
260887|NCT01065454|630403|P1|STARTED|Treatment||67
260888|NCT01065506|630515|P2|NOT COMPLETED|Overall Study||38
260889|NCT01065506|630516|P1|NOT COMPLETED|Overall Study||32
260890|NCT01065506|630515|P2|COMPLETED|Overall Study||34
260891|NCT01065506|630516|P1|COMPLETED|Overall Study||32
260892|NCT01065506|630515|P2|4-Month Follow-Up|Overall Study||34
260893|NCT01065506|630516|P1|4-Month Follow-Up|Overall Study||35
260894|NCT01065506|630515|P2|End of Treatment|Overall Study||37
260895|NCT01065506|630516|P1|End of Treatment|Overall Study||44
260896|NCT01065506|630515|P2|STARTED|Overall Study||72
260897|NCT01065506|630516|P1|STARTED|Overall Study||64
260898|NCT01065558|630522|P1|NOT COMPLETED|Overall Study||0
260899|NCT01065558|630522|P1|COMPLETED|Overall Study||5
260900|NCT01065558|630522|P1|STARTED|Overall Study||5
260901|NCT01065597|630527|P1|NOT COMPLETED|Overall Study||1
260902|NCT01065597|630527|P1|COMPLETED|Overall Study||12
260903|NCT01065597|630527|P1|STARTED|Overall Study||13
260904|NCT01065714|630534|P1|NOT COMPLETED|Overall Study||0
260905|NCT01065714|630534|P1|COMPLETED|Overall Study||20
260906|NCT01065714|630534|P1|STARTED|Overall Study|"This was a split body Study. All participants used both Hydrogel and Eucerin"|20
260907|NCT01065766|630541|P1|NOT COMPLETED|Overall Study||32
260908|NCT01065766|630541|P1|COMPLETED|Overall Study||4033
260909|NCT01065766|630541|P1|STARTED|Overall Study||4065
260910|NCT01065779|630553|P1|NOT COMPLETED|Overall Study||82
260911|NCT01065779|630553|P1|COMPLETED|Overall Study||798
260912|NCT01065779|630553|P1|STARTED|Overall Study||880
260913|NCT01065844|630564|P1|NOT COMPLETED|Overall Study||5
260914|NCT01065844|630564|P1|COMPLETED|Overall Study||10
260915|NCT01065844|630564|P1|STARTED|Overall Study||15
260916|NCT01066000|630568|P1|NOT COMPLETED|Overall Study||9
260917|NCT01066000|630568|P1|COMPLETED|Overall Study||24
260918|NCT01066000|630568|P1|STARTED|Overall Study||33
260919|NCT01066039|630579|P1|NOT COMPLETED|Overall Study||44
260920|NCT01066039|630579|P1|COMPLETED|Overall Study||158
260921|NCT01066039|630579|P1|Treated|Overall Study||200
260922|NCT01066039|630579|P1|STARTED|Overall Study||202
260923|NCT01066104|630594|P2|NOT COMPLETED|Overall Study||1
260924|NCT01066104|630595|P1|NOT COMPLETED|Overall Study||2
260925|NCT01066104|630594|P2|COMPLETED|Overall Study||12
260926|NCT01066104|630595|P1|COMPLETED|Overall Study||12
260927|NCT01066104|630594|P2|STARTED|Overall Study||13
260928|NCT01066104|630595|P1|STARTED|Overall Study||14
260929|NCT01066143|630603|P1|NOT COMPLETED|Overall Study||8
260930|NCT01066143|630603|P1|COMPLETED|Overall Study||0
260931|NCT01066143|630603|P1|STARTED|Overall Study||8
260932|NCT01066156|630607|P1|NOT COMPLETED|Overall Study||10
260933|NCT01066156|630607|P1|COMPLETED|Overall Study||24
260934|NCT01066156|630607|P1|STARTED|Overall Study||34
260935|NCT01066520|630614|P3|NOT COMPLETED|Overall Study||0
260936|NCT01066520|630615|P2|NOT COMPLETED|Overall Study||0
260937|NCT01066520|630616|P1|NOT COMPLETED|Overall Study||0
260938|NCT01066520|630614|P3|COMPLETED|Overall Study||137
260939|NCT01066520|630615|P2|COMPLETED|Overall Study||140
260940|NCT01066520|630616|P1|COMPLETED|Overall Study||143
260941|NCT01066520|630614|P3|STARTED|Overall Study||137
260942|NCT01066520|630615|P2|STARTED|Overall Study||140
260943|NCT01066520|630616|P1|STARTED|Overall Study||143
260944|NCT01066546|630630|P1|NOT COMPLETED|Overall Study||5
260945|NCT01066546|630630|P1|COMPLETED|Overall Study||0
260946|NCT01066546|630630|P1|STARTED|Overall Study||5
260947|NCT01066585|630643|P2|NOT COMPLETED|Overall Study||3
260948|NCT01066585|630644|P1|NOT COMPLETED|Overall Study||1
260949|NCT01066585|630643|P2|COMPLETED|Overall Study||196
260950|NCT01066585|630644|P1|COMPLETED|Overall Study||210
260951|NCT01066585|630643|P2|STARTED|Overall Study||199
260952|NCT01066585|630644|P1|STARTED|Overall Study||211
260953|NCT01066624|630659|P3|NOT COMPLETED|Overall Study||0
260954|NCT01066624|630660|P2|NOT COMPLETED|Overall Study||0
260955|NCT01066624|630661|P1|NOT COMPLETED|Overall Study||0
260956|NCT01066624|630659|P3|COMPLETED|Overall Study||39
260957|NCT01066624|630660|P2|COMPLETED|Overall Study||40
260958|NCT01066624|630661|P1|COMPLETED|Overall Study||38
260959|NCT01066624|630659|P3|STARTED|Overall Study||39
260960|NCT01066624|630660|P2|STARTED|Overall Study||40
260961|NCT01066624|630661|P1|STARTED|Overall Study||38
260962|NCT01066780|630669|P2|NOT COMPLETED|Overall Study||1
260963|NCT01066780|630670|P1|NOT COMPLETED|Overall Study||1
260964|NCT01066780|630669|P2|COMPLETED|Overall Study||23
260965|NCT01066780|630670|P1|COMPLETED|Overall Study||23
260966|NCT01066780|630669|P2|STARTED|Overall Study||24
260967|NCT01066780|630670|P1|STARTED|Overall Study||24
260968|NCT01066793|630680|P6|NOT COMPLETED|Overall Study||1
260969|NCT01066793|630681|P5|NOT COMPLETED|Overall Study||0
260970|NCT01066793|630682|P4|NOT COMPLETED|Overall Study||49
260971|NCT01066793|630683|P3|NOT COMPLETED|Overall Study||115
260972|NCT01066793|630684|P2|NOT COMPLETED|Overall Study||77
260973|NCT01066793|630685|P1|NOT COMPLETED|Overall Study||374
260974|NCT01066793|630680|P6|COMPLETED|Overall Study||4
260975|NCT01066793|630681|P5|COMPLETED|Overall Study||11
260976|NCT01066793|630682|P4|COMPLETED|Overall Study||94
260977|NCT01066793|630683|P3|COMPLETED|Overall Study||369
260978|NCT01066793|630684|P2|COMPLETED|Overall Study||495
260979|NCT01066793|630685|P1|COMPLETED|Overall Study||754
260980|NCT01066793|630680|P6|STARTED|Overall Study||5
260981|NCT01066793|630681|P5|STARTED|Overall Study||11
260982|NCT01066793|630682|P4|STARTED|Overall Study||143
260983|NCT01066793|630683|P3|STARTED|Overall Study||484
260984|NCT01066793|630684|P2|STARTED|Overall Study||572
260985|NCT01066793|630685|P1|STARTED|Overall Study||1128
260986|NCT01066819|630831|P6|NOT COMPLETED|Overall Study||6
260987|NCT01066819|630832|P5|NOT COMPLETED|Overall Study||4
260988|NCT01066819|630833|P4|NOT COMPLETED|Overall Study||17
260989|NCT01066819|630834|P3|NOT COMPLETED|Overall Study||146
260990|NCT01066819|630835|P2|NOT COMPLETED|Overall Study||171
260991|NCT01066819|630836|P1|NOT COMPLETED|Overall Study||689
260992|NCT01066819|630831|P6|COMPLETED|Overall Study||7
260993|NCT01066819|630832|P5|COMPLETED|Overall Study||3
260994|NCT01066819|630833|P4|COMPLETED|Overall Study||8
260995|NCT01066819|630834|P3|COMPLETED|Overall Study||111
260996|NCT01066819|630835|P2|COMPLETED|Overall Study||177
260997|NCT01066819|630836|P1|COMPLETED|Overall Study||317
260998|NCT01066819|630831|P6|STARTED|Overall Study||13
260999|NCT01066819|630832|P5|STARTED|Overall Study||7
261000|NCT01066819|630833|P4|STARTED|Overall Study||25
261001|NCT01066819|630834|P3|STARTED|Overall Study||257
261002|NCT01066819|630835|P2|STARTED|Overall Study||348
261003|NCT01066819|630836|P1|STARTED|Overall Study||1006
261004|NCT01066871|630975|P4|NOT COMPLETED|Overall Study||5
261005|NCT01066871|630976|P3|NOT COMPLETED|Overall Study||6
261006|NCT01066871|630977|P2|NOT COMPLETED|Overall Study||5
261007|NCT01066871|630978|P1|NOT COMPLETED|Overall Study||4
261008|NCT01066871|630975|P4|COMPLETED|Overall Study||13
261009|NCT01066871|630976|P3|COMPLETED|Overall Study||12
261010|NCT01066871|630977|P2|COMPLETED|Overall Study||13
261011|NCT01066871|630978|P1|COMPLETED|Overall Study||16
261012|NCT01066871|630975|P4|STARTED|Overall Study||18
261013|NCT01066871|630976|P3|STARTED|Overall Study||18
261014|NCT01066871|630977|P2|STARTED|Overall Study||18
261015|NCT01066871|630978|P1|STARTED|Overall Study||20
261016|NCT01066897|631038|P2|NOT COMPLETED|Overall Study||0
261017|NCT01066897|631039|P1|NOT COMPLETED|Overall Study||2
261018|NCT01066897|631038|P2|COMPLETED|Overall Study||9
261019|NCT01066897|631039|P1|COMPLETED|Overall Study||5
261020|NCT01066897|631038|P2|STARTED|Overall Study||9
261021|NCT01066897|631039|P1|STARTED|Overall Study||7
261022|NCT01066923|631053|P4|NOT COMPLETED|Overall Study||8
261023|NCT01066923|631054|P3|NOT COMPLETED|Overall Study||8
261024|NCT01066923|631055|P2|NOT COMPLETED|Overall Study||3
261025|NCT01066923|631056|P1|NOT COMPLETED|Overall Study||3
261026|NCT01066923|631053|P4|COMPLETED|Overall Study||23
261027|NCT01066923|631054|P3|COMPLETED|Overall Study||25
261028|NCT01066923|631055|P2|COMPLETED|Overall Study||29
261029|NCT01066923|631056|P1|COMPLETED|Overall Study||25
261030|NCT01066923|631053|P4|Retinal Imaging|Overall Study||0
261031|NCT01066923|631054|P3|Retinal Imaging|Overall Study||0
261032|NCT01066923|631055|P2|Retinal Imaging|Overall Study||0
261033|NCT01066923|631056|P1|Retinal Imaging|Overall Study||0
261034|NCT01066923|631053|P4|Activation of Coagulation|Overall Study||0
261035|NCT01066923|631054|P3|Activation of Coagulation|Overall Study||0
261036|NCT01066923|631055|P2|Activation of Coagulation|Overall Study||0
261037|NCT01066923|631056|P1|Activation of Coagulation|Overall Study||0
261038|NCT01066923|631053|P4|Vascular Function|Overall Study||13
261039|NCT01066923|631054|P3|Vascular Function|Overall Study||12
261040|NCT01066923|631055|P2|Vascular Function|Overall Study||14
261041|NCT01066923|631056|P1|Vascular Function|Overall Study||13
261042|NCT01066923|631053|P4|Platelet Closure Time|Overall Study||23
261043|NCT01066923|631054|P3|Platelet Closure Time|Overall Study||25
261044|NCT01066923|631055|P2|Platelet Closure Time|Overall Study||29
261045|NCT01066923|631056|P1|Platelet Closure Time|Overall Study||25
261046|NCT01066923|631053|P4|STARTED|Overall Study||31
261047|NCT01066923|631054|P3|STARTED|Overall Study||33
261048|NCT01066923|631055|P2|STARTED|Overall Study||32
261049|NCT01066923|631056|P1|STARTED|Overall Study||28
261050|NCT01067105|631070|P1|NOT COMPLETED|Overall Study||141
261051|NCT01067105|631070|P1|COMPLETED|Overall Study||683
261052|NCT01067105|631070|P1|STARTED|Overall Study||824
261053|NCT01067326|631089|P2|NOT COMPLETED|Overall Study||3
261054|NCT01067326|631090|P1|NOT COMPLETED|Overall Study||2
261055|NCT01067326|631089|P2|COMPLETED|Overall Study||5
261056|NCT01067326|631090|P1|COMPLETED|Overall Study||12
261057|NCT01067326|631089|P2|STARTED|Overall Study||8
261058|NCT01067326|631090|P1|STARTED|Overall Study||14
261059|NCT01067339|631104|P2|NOT COMPLETED|Overall Study||5
261060|NCT01067339|631105|P1|NOT COMPLETED|Overall Study||6
261061|NCT01067339|631104|P2|COMPLETED|Overall Study||29
261062|NCT01067339|631105|P1|COMPLETED|Overall Study||25
261063|NCT01067339|631104|P2|STARTED|Overall Study||34
261064|NCT01067339|631105|P1|STARTED|Overall Study||31
261065|NCT01067352|631116|P3|NOT COMPLETED|Overall Study||1
261066|NCT01067352|631117|P2|NOT COMPLETED|Overall Study||3
261067|NCT01067352|631118|P1|NOT COMPLETED|Overall Study||1
261068|NCT01067352|631116|P3|COMPLETED|Overall Study||9
261069|NCT01067352|631117|P2|COMPLETED|Overall Study||3
261070|NCT01067352|631118|P1|COMPLETED|Overall Study||8
261071|NCT01067352|631116|P3|STARTED|Overall Study||10
261072|NCT01067352|631117|P2|STARTED|Overall Study||6
261073|NCT01067352|631118|P1|STARTED|Overall Study||9
261074|NCT01067456|631134|P2|NOT COMPLETED|Overall Study||0
261075|NCT01067456|631135|P1|NOT COMPLETED|Overall Study||0
261076|NCT01067456|631134|P2|COMPLETED|Overall Study||29
261077|NCT01067456|631135|P1|COMPLETED|Overall Study||30
261078|NCT01067456|631134|P2|STARTED|Overall Study||29
261079|NCT01067456|631135|P1|STARTED|Overall Study||30
261080|NCT01067716|631144|P3|NOT COMPLETED|Overall Study||0
261081|NCT01067716|631145|P2|NOT COMPLETED|Overall Study||0
261082|NCT01067716|631146|P1|NOT COMPLETED|Overall Study||0
261083|NCT01067716|631144|P3|COMPLETED|Overall Study|15 eyes|9
261084|NCT01067716|631145|P2|COMPLETED|Overall Study|25 eyes|13
261085|NCT01067716|631146|P1|COMPLETED|Overall Study|110 eyes|57
261086|NCT01067716|631144|P3|STARTED|Overall Study|15 eyes|9
261087|NCT01067716|631145|P2|STARTED|Overall Study|25 eyes|13
261088|NCT01067716|631146|P1|STARTED|Overall Study|110 eyes|57
261089|NCT01067768|631165|P2|NOT COMPLETED|Overall Study||0
261090|NCT01067768|631166|P1|NOT COMPLETED|Overall Study||0
261091|NCT01067768|631165|P2|COMPLETED|Overall Study||605
261092|NCT01067768|631166|P1|COMPLETED|Overall Study||604
261093|NCT01067768|631165|P2|STARTED|Overall Study||605
261094|NCT01067768|631166|P1|STARTED|Overall Study||604
261095|NCT01067781|631178|P4|NOT COMPLETED|Up to Day 720||101
261096|NCT01067781|631179|P3|NOT COMPLETED|Up to Day 720||97
261097|NCT01067781|631180|P2|NOT COMPLETED|Up to Day 720||195
261098|NCT01067781|631181|P1|NOT COMPLETED|Up to Day 720||200
261099|NCT01067781|631178|P4|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
261100|NCT01067781|631179|P3|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|0
261101|NCT01067781|631180|P2|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|4
261102|NCT01067781|631181|P1|COMPLETED|Up to Day 720|all subects followed till Day180; if ongoing local AE, FU every 6 mths till AE resolved (max.Day720)|3
261103|NCT01067781|631178|P4|STARTED|Up to Day 720||101
261104|NCT01067781|631179|P3|STARTED|Up to Day 720||97
261105|NCT01067781|631180|P2|STARTED|Up to Day 720||199
261106|NCT01067781|631181|P1|STARTED|Up to Day 720||203
261107|NCT01067781|631178|P4|NOT COMPLETED|Up to Day 180||12
261108|NCT01067781|631179|P3|NOT COMPLETED|Up to Day 180||8
261109|NCT01067781|631180|P2|NOT COMPLETED|Up to Day 180||31
261110|NCT01067781|631181|P1|NOT COMPLETED|Up to Day 180||30
261111|NCT01067781|631178|P4|COMPLETED|Up to Day 180||89
261112|NCT01067781|631179|P3|COMPLETED|Up to Day 180||89
261113|NCT01067781|631180|P2|COMPLETED|Up to Day 180||168
261114|NCT01067781|631181|P1|COMPLETED|Up to Day 180||173
261115|NCT01067781|631178|P4|STARTED|Up to Day 180||101
261116|NCT01067781|631179|P3|STARTED|Up to Day 180||97
261117|NCT01067781|631180|P2|STARTED|Up to Day 180||199
261118|NCT01067781|631181|P1|STARTED|Up to Day 180||203
261119|NCT01073267|631189|P1|NOT COMPLETED|Overall Study||3
261120|NCT01073267|631189|P1|COMPLETED|Overall Study||1
261121|NCT01073267|631189|P1|STARTED|Overall Study||4
261122|NCT01073293|631195|P2|NOT COMPLETED|Overall Study||11
261123|NCT01073293|631196|P1|NOT COMPLETED|Overall Study||5
261124|NCT01073293|631195|P2|COMPLETED|Overall Study||517
261125|NCT01073293|631196|P1|COMPLETED|Overall Study||521
261126|NCT01073293|631195|P2|STARTED|Overall Study||528
261127|NCT01073293|631196|P1|STARTED|Overall Study||526
261128|NCT01073449|631218|P1|NOT COMPLETED|Overall Study||0
261129|NCT01073449|631218|P1|COMPLETED|Overall Study||3362
261130|NCT01073449|631218|P1|STARTED|Overall Study||3362
261131|NCT01073462|631224|P1|NOT COMPLETED|Overall Study||41
261132|NCT01073462|631224|P1|COMPLETED|Overall Study||26
261133|NCT01073462|631224|P1|STARTED|Overall Study||67
261134|NCT01073930|631237|P2|NOT COMPLETED|Overall Study||6
261135|NCT01073930|631238|P1|NOT COMPLETED|Overall Study||3
261136|NCT01073930|631237|P2|COMPLETED|Overall Study||295
261137|NCT01073930|631238|P1|COMPLETED|Overall Study||304
261138|NCT01073930|631237|P2|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|297
261139|NCT01073930|631238|P1|Intent to Treat Population|Overall Study|One treated participant did not have an efficacy assessment performed.|304
261140|NCT01073930|631237|P2|Safety Population (Treated)|Overall Study||298
261141|NCT01073930|631238|P1|Safety Population (Treated)|Overall Study||305
261142|NCT01073930|631237|P2|STARTED|Overall Study||301
261143|NCT01073930|631238|P1|STARTED|Overall Study||307
261144|NCT01073943|631262|P2|NOT COMPLETED|Overall Study||8
261145|NCT01073943|631263|P1|NOT COMPLETED|Overall Study||13
261146|NCT01073943|631262|P2|COMPLETED|Overall Study||295
261147|NCT01073943|631263|P1|COMPLETED|Overall Study||287
261148|NCT01073943|631262|P2|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|300
261149|NCT01073943|631263|P1|Intent to Treat Population|Overall Study|Two treated participants did not have an efficacy assessment performed.|294
261150|NCT01073943|631262|P2|Safety Population (Treated)|Overall Study||302
261151|NCT01073943|631263|P1|Safety Population (Treated)|Overall Study||296
261152|NCT01073943|631262|P2|STARTED|Overall Study||303
261153|NCT01073943|631263|P1|STARTED|Overall Study||300
261154|NCT01074008|631296|P9|NOT COMPLETED|Overall Study||4
261155|NCT01074008|631297|P8|NOT COMPLETED|Overall Study||0
261156|NCT01074008|631298|P7|NOT COMPLETED|Overall Study||1
261157|NCT01074008|631299|P6|NOT COMPLETED|Overall Study||0
261158|NCT01074008|631300|P5|NOT COMPLETED|Overall Study||2
261159|NCT01074008|631301|P4|NOT COMPLETED|Overall Study||1
261160|NCT01074008|631302|P3|NOT COMPLETED|Overall Study||2
261161|NCT01074008|631303|P2|NOT COMPLETED|Overall Study||3
261162|NCT01074008|631304|P1|NOT COMPLETED|Overall Study||1
261163|NCT01074008|631296|P9|COMPLETED|Overall Study||7
261164|NCT01074008|631297|P8|COMPLETED|Overall Study||8
261165|NCT01074008|631298|P7|COMPLETED|Overall Study||7
261166|NCT01074008|631299|P6|COMPLETED|Overall Study||7
261167|NCT01074008|631300|P5|COMPLETED|Overall Study||6
261168|NCT01074008|631301|P4|COMPLETED|Overall Study||7
261169|NCT01074008|631302|P3|COMPLETED|Overall Study||6
261170|NCT01074008|631303|P2|COMPLETED|Overall Study||5
261171|NCT01074008|631304|P1|COMPLETED|Overall Study||7
261172|NCT01074008|631296|P9|Completed Direct-acting Antiviral Agent|Overall Study||5
261173|NCT01074008|631297|P8|Completed Direct-acting Antiviral Agent|Overall Study||7
261174|NCT01074008|631298|P7|Completed Direct-acting Antiviral Agent|Overall Study||8
261175|NCT01074008|631299|P6|Completed Direct-acting Antiviral Agent|Overall Study||5
261176|NCT01074008|631300|P5|Completed Direct-acting Antiviral Agent|Overall Study||8
261177|NCT01074008|631301|P4|Completed Direct-acting Antiviral Agent|Overall Study||8
261178|NCT01074008|631302|P3|Completed Direct-acting Antiviral Agent|Overall Study||7
261179|NCT01074008|631303|P2|Completed Direct-acting Antiviral Agent|Overall Study||7
261180|NCT01074008|631304|P1|Completed Direct-acting Antiviral Agent|Overall Study||8
261181|NCT01074008|631296|P9|STARTED|Overall Study||11
261182|NCT01074008|631297|P8|STARTED|Overall Study||8
261183|NCT01074008|631298|P7|STARTED|Overall Study||8
261184|NCT01074008|631299|P6|STARTED|Overall Study||7
261185|NCT01074008|631300|P5|STARTED|Overall Study||8
261186|NCT01074008|631301|P4|STARTED|Overall Study||8
261187|NCT01074008|631302|P3|STARTED|Overall Study||8
261188|NCT01074008|631303|P2|STARTED|Overall Study||8
261189|NCT01074008|631304|P1|STARTED|Overall Study||8
261190|NCT01074034|631412|P1|NOT COMPLETED|Overall Study||6
261191|NCT01074034|631412|P1|COMPLETED|Overall Study||205
261192|NCT01074034|631412|P1|STARTED|Overall Study||211
261193|NCT01074047|631419|P2|NOT COMPLETED|Extension Phase||0
261194|NCT01074047|631420|P1|NOT COMPLETED|Extension Phase||22
261195|NCT01074047|631419|P2|COMPLETED|Extension Phase||0
261196|NCT01074047|631420|P1|COMPLETED|Extension Phase||0
261197|NCT01074047|631419|P2|Safety Population|Extension Phase||0
261198|NCT01074047|631420|P1|Safety Population|Extension Phase|Participants who enrolled in the extension phase|22
261199|NCT01074047|631419|P2|STARTED|Extension Phase||0
261200|NCT01074047|631420|P1|STARTED|Extension Phase|2 participants did not enroll in the extension period.|22
261201|NCT01074047|631419|P2|NOT COMPLETED|Survival Follow-Up Phase||136
261202|NCT01074047|631420|P1|NOT COMPLETED|Survival Follow-Up Phase||124
261203|NCT01074047|631419|P2|COMPLETED|Survival Follow-Up Phase||27
261204|NCT01074047|631420|P1|COMPLETED|Survival Follow-Up Phase||16
261205|NCT01074047|631419|P2|STARTED|Survival Follow-Up Phase||163
261206|NCT01074047|631420|P1|STARTED|Survival Follow-Up Phase||140
261207|NCT01074047|631419|P2|NOT COMPLETED|Treatment Phase||234
261208|NCT01074047|631420|P1|NOT COMPLETED|Treatment Phase||217
261209|NCT01074047|631419|P2|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|13
261210|NCT01074047|631420|P1|COMPLETED|Treatment Phase|Participants who were continuing study treatment at the time of study closure|24
261211|NCT01074047|631419|P2|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|191
261212|NCT01074047|631420|P1|Evaluable Population|Treatment Phase|Did not meet criteria for exclusion, received ≥1 cycle of treatment and had ≥ 1 efficacy assessment|179
261296|NCT01074450|631637|P2|COMPLETED|Washout of 7 Days||10
261213|NCT01074047|631419|P2|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|235
261214|NCT01074047|631420|P1|Safety Population|Treatment Phase|Received at least one dose of study medication and had at least 1 post dose safety assessment|236
261215|NCT01074047|631419|P2|Treated Population|Treatment Phase|7 patients not treated with any drug regimen|240
261216|NCT01074047|631420|P1|Treated Population|Treatment Phase|5 patients not treated with any drug regimen|236
261217|NCT01074047|631419|P2|STARTED|Treatment Phase||247
261218|NCT01074047|631420|P1|STARTED|Treatment Phase||241
261219|NCT01074099|631496|P2|NOT COMPLETED|Overall Study||0
261220|NCT01074099|631497|P1|NOT COMPLETED|Overall Study||0
261221|NCT01074099|631496|P2|COMPLETED|Overall Study||3
261222|NCT01074099|631497|P1|COMPLETED|Overall Study||2
261223|NCT01074099|631496|P2|STARTED|Overall Study||3
261224|NCT01074099|631497|P1|STARTED|Overall Study||2
261225|NCT01074125|631508|P3|NOT COMPLETED|Overall Study||12
261226|NCT01074125|631509|P2|NOT COMPLETED|Overall Study||5
261227|NCT01074125|631510|P1|NOT COMPLETED|Overall Study||12
261228|NCT01074125|631508|P3|COMPLETED|Overall Study||36
261229|NCT01074125|631509|P2|COMPLETED|Overall Study||47
261230|NCT01074125|631510|P1|COMPLETED|Overall Study||39
261231|NCT01074125|631508|P3|STARTED|Overall Study||48
261232|NCT01074125|631509|P2|STARTED|Overall Study||52
261233|NCT01074125|631510|P1|STARTED|Overall Study||51
261234|NCT01074164|631526|P2|NOT COMPLETED|Overall Study||1
261235|NCT01074164|631527|P1|NOT COMPLETED|Overall Study||3
261236|NCT01074164|631526|P2|COMPLETED|Overall Study||7
261237|NCT01074164|631527|P1|COMPLETED|Overall Study||4
261238|NCT01074164|631526|P2|STARTED|Overall Study||8
261239|NCT01074164|631527|P1|STARTED|Overall Study||7
261240|NCT01074216|631545|P1|NOT COMPLETED|Overall Study||13
261241|NCT01074216|631545|P1|COMPLETED|Overall Study||41
261242|NCT01074216|631545|P1|STARTED|Overall Study||54
261243|NCT01074229|631552|P3|NOT COMPLETED|Overall Study||4
261244|NCT01074229|631553|P2|NOT COMPLETED|Overall Study||3
261245|NCT01074229|631554|P1|NOT COMPLETED|Overall Study||2
261246|NCT01074229|631552|P3|COMPLETED|Overall Study||21
261247|NCT01074229|631553|P2|COMPLETED|Overall Study||22
261248|NCT01074229|631554|P1|COMPLETED|Overall Study||23
261249|NCT01074229|631552|P3|STARTED|Overall Study||25
261250|NCT01074229|631553|P2|STARTED|Overall Study||25
261251|NCT01074229|631554|P1|STARTED|Overall Study||25
261252|NCT01074242|631565|P1|NOT COMPLETED|Overall Study||403
261253|NCT01074242|631565|P1|COMPLETED|Overall Study||3395
261254|NCT01074242|631565|P1|Received at Least 1 Dose of Vaccine|Overall Study||3395
261255|NCT01074242|631565|P1|STARTED|Overall Study||3798
261256|NCT01074255|631570|P1|NOT COMPLETED|Overall Study||2
261257|NCT01074255|631570|P1|COMPLETED|Overall Study||3139
261258|NCT01074255|631570|P1|Treated|Overall Study||3139
261259|NCT01074255|631570|P1|STARTED|Overall Study||3141
261260|NCT01074268|631576|P2|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||7
261261|NCT01074268|631577|P1|NOT COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||6
261262|NCT01074268|631576|P2|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||115
261263|NCT01074268|631577|P1|COMPLETED|Extension: Week 27 to 52 (NN1250-3725)||242
261264|NCT01074268|631576|P2|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Sixteen subjects from main trial did not continue into the extension|122
261265|NCT01074268|631577|P1|STARTED|Extension: Week 27 to 52 (NN1250-3725)|Thirty five subjects from main trial did not continue into the extension|248
261266|NCT01074268|631576|P2|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||15
261267|NCT01074268|631577|P1|NOT COMPLETED|Main: Week 0 to 26 (NN1250-3585)||20
261268|NCT01074268|631576|P2|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||138
261269|NCT01074268|631577|P1|COMPLETED|Main: Week 0 to 26 (NN1250-3585)||283
261270|NCT01074268|631576|P2|Exposed|Main: Week 0 to 26 (NN1250-3585)|One subject withdrew prior to exposure to trial drugs|152
261271|NCT01074268|631577|P1|Exposed|Main: Week 0 to 26 (NN1250-3585)|Two subjects withdrew prior to exposure to trial drugs|301
261272|NCT01074268|631576|P2|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)||153
261273|NCT01074268|631577|P1|Full Analysis Set|Main: Week 0 to 26 (NN1250-3585)|One subject was withdrawn because the subject was randomised in error (screening failure)|302
261274|NCT01074268|631576|P2|STARTED|Main: Week 0 to 26 (NN1250-3585)||153
261275|NCT01074268|631577|P1|STARTED|Main: Week 0 to 26 (NN1250-3585)||303
261276|NCT01074307|631605|P2|NOT COMPLETED|Overall Study||12
261277|NCT01074307|631606|P1|NOT COMPLETED|Overall Study||22
261278|NCT01074307|631605|P2|COMPLETED|Overall Study||102
261279|NCT01074307|631606|P1|COMPLETED|Overall Study||44
261280|NCT01074307|631605|P2|STARTED|Overall Study||114
261281|NCT01074307|631606|P1|STARTED|Overall Study||66
261282|NCT01074437|631628|P2|NOT COMPLETED|Overall Study||0
261283|NCT01074437|631629|P1|NOT COMPLETED|Overall Study||0
261284|NCT01074437|631628|P2|COMPLETED|Overall Study||5
261285|NCT01074437|631629|P1|COMPLETED|Overall Study||4
261286|NCT01074437|631628|P2|STARTED|Overall Study||5
261287|NCT01074437|631629|P1|STARTED|Overall Study||4
261288|NCT01074450|631637|P2|NOT COMPLETED|Second Intervention||1
261289|NCT01074450|631638|P1|NOT COMPLETED|Second Intervention||1
261290|NCT01074450|631637|P2|COMPLETED|Second Intervention|Influenze Symptoms Present at Check in.|9
261291|NCT01074450|631638|P1|COMPLETED|Second Intervention|Positive Drug Screen at Check in.|11
261292|NCT01074450|631637|P2|STARTED|Second Intervention||10
261293|NCT01074450|631638|P1|STARTED|Second Intervention||12
261294|NCT01074450|631637|P2|NOT COMPLETED|Washout of 7 Days||0
261295|NCT01074450|631638|P1|NOT COMPLETED|Washout of 7 Days||0
261297|NCT01074450|631638|P1|COMPLETED|Washout of 7 Days||12
261298|NCT01074450|631637|P2|STARTED|Washout of 7 Days||10
261299|NCT01074450|631638|P1|STARTED|Washout of 7 Days||12
261300|NCT01074450|631637|P2|NOT COMPLETED|First Intervention||2
261301|NCT01074450|631638|P1|NOT COMPLETED|First Intervention||0
261302|NCT01074450|631637|P2|COMPLETED|First Intervention||10
261303|NCT01074450|631638|P1|COMPLETED|First Intervention||12
261304|NCT01074450|631637|P2|STARTED|First Intervention||12
261305|NCT01074450|631638|P1|STARTED|First Intervention||12
261306|NCT01074463|631650|P2|NOT COMPLETED|Second Intervention||0
261307|NCT01074463|631651|P1|NOT COMPLETED|Second Intervention||0
261308|NCT01074463|631650|P2|COMPLETED|Second Intervention||12
261309|NCT01074463|631651|P1|COMPLETED|Second Intervention||12
261310|NCT01074463|631650|P2|STARTED|Second Intervention||12
261311|NCT01074463|631651|P1|STARTED|Second Intervention||12
261312|NCT01074463|631650|P2|NOT COMPLETED|Washout of 7 Days||0
261313|NCT01074463|631651|P1|NOT COMPLETED|Washout of 7 Days||0
261314|NCT01074463|631650|P2|COMPLETED|Washout of 7 Days||12
261315|NCT01074463|631651|P1|COMPLETED|Washout of 7 Days||12
261316|NCT01074463|631650|P2|STARTED|Washout of 7 Days||12
261317|NCT01074463|631651|P1|STARTED|Washout of 7 Days||12
261318|NCT01074463|631650|P2|NOT COMPLETED|First Intervention||0
261319|NCT01074463|631651|P1|NOT COMPLETED|First Intervention||0
261320|NCT01074463|631650|P2|COMPLETED|First Intervention||12
261321|NCT01074463|631651|P1|COMPLETED|First Intervention||12
261322|NCT01074463|631650|P2|STARTED|First Intervention||12
261323|NCT01074463|631651|P1|STARTED|First Intervention||12
261324|NCT01074502|631661|P1|NOT COMPLETED|Overall Study||1
261325|NCT01074502|631661|P1|COMPLETED|Overall Study||2
261326|NCT01074502|631661|P1|STARTED|Overall Study||3
261327|NCT01074554|631672|P2|NOT COMPLETED|Overall Study||4
261328|NCT01074554|631673|P1|NOT COMPLETED|Overall Study||3
261329|NCT01074554|631672|P2|COMPLETED|Overall Study||11
261330|NCT01074554|631673|P1|COMPLETED|Overall Study||11
261331|NCT01074554|631672|P2|STARTED|Overall Study||15
261332|NCT01074554|631673|P1|STARTED|Overall Study||14
261333|NCT01074658|631683|P1|NOT COMPLETED|Overall Study||19
261334|NCT01074658|631683|P1|COMPLETED|Overall Study||996
261335|NCT01074658|631683|P1|Attempted Implant|Overall Study||996
261336|NCT01074658|631683|P1|STARTED|Overall Study||1015
261337|NCT01074931|631689|P1|NOT COMPLETED|Overall Study||6
261338|NCT01074931|631689|P1|COMPLETED|Overall Study||92
261339|NCT01074931|631689|P1|STARTED|Overall Study||98
261340|NCT01074944|631701|P5|NOT COMPLETED|Extended Treatment (up to 42 Months)||5
261341|NCT01074944|631702|P4|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
261342|NCT01074944|631703|P3|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
261343|NCT01074944|631704|P2|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
261344|NCT01074944|631705|P1|NOT COMPLETED|Extended Treatment (up to 42 Months)||0
261345|NCT01074944|631701|P5|COMPLETED|Extended Treatment (up to 42 Months)||20
261346|NCT01074944|631702|P4|COMPLETED|Extended Treatment (up to 42 Months)||0
261347|NCT01074944|631703|P3|COMPLETED|Extended Treatment (up to 42 Months)||0
261348|NCT01074944|631704|P2|COMPLETED|Extended Treatment (up to 42 Months)||0
261349|NCT01074944|631705|P1|COMPLETED|Extended Treatment (up to 42 Months)||0
261350|NCT01074944|631701|P5|STARTED|Extended Treatment (up to 42 Months)|Participants who were failed to meet the randomization criteria during the lead-in period.|25
261351|NCT01074944|631702|P4|STARTED|Extended Treatment (up to 42 Months)||0
261352|NCT01074944|631703|P3|STARTED|Extended Treatment (up to 42 Months)||0
261353|NCT01074944|631704|P2|STARTED|Extended Treatment (up to 42 Months)||0
261354|NCT01074944|631705|P1|STARTED|Extended Treatment (up to 42 Months)||0
261355|NCT01074944|631701|P5|NOT COMPLETED|Long Term Treatment||0
261356|NCT01074944|631702|P4|NOT COMPLETED|Long Term Treatment||26
261357|NCT01074944|631703|P3|NOT COMPLETED|Long Term Treatment||0
261358|NCT01074944|631704|P2|NOT COMPLETED|Long Term Treatment||0
261359|NCT01074944|631705|P1|NOT COMPLETED|Long Term Treatment||0
261360|NCT01074944|631701|P5|COMPLETED|Long Term Treatment||0
261361|NCT01074944|631702|P4|COMPLETED|Long Term Treatment||95
261362|NCT01074944|631703|P3|COMPLETED|Long Term Treatment||0
261363|NCT01074944|631704|P2|COMPLETED|Long Term Treatment||0
261364|NCT01074944|631705|P1|COMPLETED|Long Term Treatment||0
261365|NCT01074944|631701|P5|STARTED|Long Term Treatment||0
261366|NCT01074944|631702|P4|STARTED|Long Term Treatment|Participants who completed PAP (114) including those who considered as treatment failure in PAP (7).|121
261367|NCT01074944|631703|P3|STARTED|Long Term Treatment||0
261368|NCT01074944|631704|P2|STARTED|Long Term Treatment||0
261369|NCT01074944|631705|P1|STARTED|Long Term Treatment||0
261370|NCT01074944|631701|P5|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
261371|NCT01074944|631702|P4|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
261372|NCT01074944|631703|P3|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||6
261373|NCT01074944|631704|P2|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||11
261374|NCT01074944|631705|P1|NOT COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
261375|NCT01074944|631701|P5|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
261376|NCT01074944|631702|P4|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
261377|NCT01074944|631703|P3|COMPLETED|Primary Analysis Period (up to 52 Weeks)||60
261378|NCT01074944|631704|P2|COMPLETED|Primary Analysis Period (up to 52 Weeks)||54
261379|NCT01074944|631705|P1|COMPLETED|Primary Analysis Period (up to 52 Weeks)||0
261380|NCT01074944|631701|P5|STARTED|Primary Analysis Period (up to 52 Weeks)||0
261381|NCT01074944|631702|P4|STARTED|Primary Analysis Period (up to 52 Weeks)||0
261382|NCT01074944|631703|P3|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|66
261383|NCT01074944|631704|P2|STARTED|Primary Analysis Period (up to 52 Weeks)|Participants who were randomized after LIP received treatment in PAP.|65
261384|NCT01074944|631705|P1|STARTED|Primary Analysis Period (up to 52 Weeks)||0
261385|NCT01074944|631701|P5|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
261386|NCT01074944|631702|P4|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
261387|NCT01074944|631703|P3|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
261388|NCT01074944|631704|P2|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||0
261389|NCT01074944|631705|P1|NOT COMPLETED|Lead-in Period (up to 78 Weeks)||13
261390|NCT01074944|631701|P5|COMPLETED|Lead-in Period (up to 78 Weeks)||0
261391|NCT01074944|631702|P4|COMPLETED|Lead-in Period (up to 78 Weeks)||0
261392|NCT01074944|631703|P3|COMPLETED|Lead-in Period (up to 78 Weeks)||0
261393|NCT01074944|631704|P2|COMPLETED|Lead-in Period (up to 78 Weeks)||0
261394|NCT01074944|631705|P1|COMPLETED|Lead-in Period (up to 78 Weeks)||157
261395|NCT01074944|631701|P5|STARTED|Lead-in Period (up to 78 Weeks)||0
261396|NCT01074944|631702|P4|STARTED|Lead-in Period (up to 78 Weeks)||0
261397|NCT01074944|631703|P3|STARTED|Lead-in Period (up to 78 Weeks)||0
261398|NCT01074944|631704|P2|STARTED|Lead-in Period (up to 78 Weeks)||0
261399|NCT01074944|631705|P1|STARTED|Lead-in Period (up to 78 Weeks)|LIP conducted to assess randomization criteria of all participants in single reporting arm.|170
261400|NCT01075074|631762|P3|NOT COMPLETED|Overall Study||2
261401|NCT01075074|631763|P2|NOT COMPLETED|Overall Study||2
261402|NCT01075074|631764|P1|NOT COMPLETED|Overall Study||1
261403|NCT01075074|631762|P3|COMPLETED|Overall Study||23
261404|NCT01075074|631763|P2|COMPLETED|Overall Study||23
261405|NCT01075074|631764|P1|COMPLETED|Overall Study||24
261406|NCT01075074|631762|P3|STARTED|Overall Study||25
261407|NCT01075074|631763|P2|STARTED|Overall Study||25
261408|NCT01075074|631764|P1|STARTED|Overall Study||25
261409|NCT01075087|631783|P2|NOT COMPLETED|Overall Study||0
261410|NCT01075087|631784|P1|NOT COMPLETED|Overall Study||0
261411|NCT01075087|631783|P2|COMPLETED|Overall Study||10
261412|NCT01075087|631784|P1|COMPLETED|Overall Study||9
261413|NCT01075087|631783|P2|STARTED|Overall Study||10
261414|NCT01075087|631784|P1|STARTED|Overall Study||9
261415|NCT01075100|631794|P2|NOT COMPLETED|Overall Study||53
261416|NCT01075100|631795|P1|NOT COMPLETED|Overall Study||49
261417|NCT01075100|631794|P2|COMPLETED|Overall Study||1
261418|NCT01075100|631795|P1|COMPLETED|Overall Study||0
261419|NCT01075100|631794|P2|STARTED|Overall Study||54
261420|NCT01075100|631795|P1|STARTED|Overall Study||49
261421|NCT01075152|631813|P2|NOT COMPLETED|Overall Study||0
261422|NCT01075152|631814|P1|NOT COMPLETED|Overall Study||1
261423|NCT01075152|631813|P2|COMPLETED|Overall Study||89
261424|NCT01075152|631814|P1|COMPLETED|Overall Study||87
261425|NCT01075152|631813|P2|STARTED|Overall Study|randomized|89
261426|NCT01075152|631814|P1|STARTED|Overall Study|randomized|88
261427|NCT01075178|631840|P2|NOT COMPLETED|Subject Chart Review||9
261428|NCT01075178|631841|P1|NOT COMPLETED|Subject Chart Review||9
261429|NCT01075178|631840|P2|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
261430|NCT01075178|631841|P1|COMPLETED|Subject Chart Review|subjects in full analysis set|1009
261431|NCT01075178|631840|P2|STARTED|Subject Chart Review|subjects matched|1018
261432|NCT01075178|631841|P1|STARTED|Subject Chart Review|subjects matched|1018
261433|NCT01075178|631840|P2|NOT COMPLETED|Subject Matching||403
261434|NCT01075178|631841|P1|NOT COMPLETED|Subject Matching||130
261435|NCT01075178|631840|P2|COMPLETED|Subject Matching|subjects matched|1018
261436|NCT01075178|631841|P1|COMPLETED|Subject Matching|subjects matched|1018
261437|NCT01075178|631840|P2|STARTED|Subject Matching|eligible for matching|1421
261438|NCT01075178|631841|P1|STARTED|Subject Matching|eligible for matching|1148
261439|NCT01075191|631853|P1|NOT COMPLETED|Overall Study||18
261440|NCT01075191|631853|P1|COMPLETED|Overall Study||42
261441|NCT01075191|631853|P1|Discontinued Year 3|Overall Study||5
261442|NCT01075191|631853|P1|Discontinued Year 2|Overall Study||6
261443|NCT01075191|631853|P1|Discontinued Year 1|Overall Study||7
261444|NCT01075191|631853|P1|STARTED|Overall Study|65 participants were enrolled; 5 protocol violations were excluded from all analyses except safety.|60
261445|NCT01075204|631862|P1|NOT COMPLETED|Overall Study||0
261446|NCT01075204|631862|P1|COMPLETED|Overall Study||335
261447|NCT01075204|631862|P1|STARTED|Overall Study||335
261448|NCT01075217|631881|P2|NOT COMPLETED|Overall Study||1
261449|NCT01075217|631882|P1|NOT COMPLETED|Overall Study||2
261450|NCT01075217|631881|P2|COMPLETED|Overall Study||84
261451|NCT01075217|631882|P1|COMPLETED|Overall Study||82
261452|NCT01075217|631881|P2|STARTED|Overall Study|86 patients randomized to receive Visipaque; 1 of the patients did not meet entry requirements|85
261453|NCT01075217|631882|P1|STARTED|Overall Study|88 patients randomized to receive Isovue; 4 of the patients did not meet entry requirements|84
261454|NCT01075243|631901|P3|NOT COMPLETED|Overall Study||0
261455|NCT01075243|631902|P2|NOT COMPLETED|Overall Study||3
261456|NCT01075243|631903|P1|NOT COMPLETED|Overall Study||6
261457|NCT01075243|631901|P3|COMPLETED|Overall Study||80
261458|NCT01075243|631902|P2|COMPLETED|Overall Study||155
261459|NCT01075243|631903|P1|COMPLETED|Overall Study||157
261460|NCT01075243|631901|P3|STARTED|Overall Study||80
261461|NCT01075243|631902|P2|STARTED|Overall Study||158
261462|NCT01075243|631903|P1|STARTED|Overall Study||163
261463|NCT01075256|631956|P3|NOT COMPLETED|Overall Study||0
261464|NCT01075256|631957|P2|NOT COMPLETED|Overall Study||0
261465|NCT01075256|631958|P1|NOT COMPLETED|Overall Study||1
261466|NCT01075256|631956|P3|COMPLETED|Overall Study||65
261467|NCT01075256|631957|P2|COMPLETED|Overall Study||66
261468|NCT01075256|631958|P1|COMPLETED|Overall Study||63
261469|NCT01075256|631956|P3|STARTED|Overall Study||65
261470|NCT01075256|631957|P2|STARTED|Overall Study||66
261471|NCT01075256|631958|P1|STARTED|Overall Study||64
261472|NCT01075282|631990|P3|NOT COMPLETED|Overall Study||27
261473|NCT01075282|631991|P2|NOT COMPLETED|Overall Study||29
261474|NCT01075282|631992|P1|NOT COMPLETED|Overall Study||31
261475|NCT01075282|631990|P3|COMPLETED|Overall Study||238
261476|NCT01075282|631991|P2|COMPLETED|Overall Study||243
261477|NCT01075282|631992|P1|COMPLETED|Overall Study||242
261478|NCT01075282|631990|P3|Received at Least One Dose of Study Drug|Overall Study||262
261479|NCT01075282|631991|P2|Received at Least One Dose of Study Drug|Overall Study||272
261480|NCT01075282|631992|P1|Received at Least One Dose of Study Drug|Overall Study||273
261481|NCT01075282|631990|P3|STARTED|Overall Study|Of 265 participants randomized to Insulin Glargine, 3 chose not to take study drug.|265
261482|NCT01075282|631991|P2|STARTED|Overall Study||272
261483|NCT01075282|631992|P1|STARTED|Overall Study||273
261484|NCT01075347|632074|P2|NOT COMPLETED|Overall Study||0
261485|NCT01075347|632075|P1|NOT COMPLETED|Overall Study||0
261486|NCT01075347|632074|P2|COMPLETED|Overall Study||83
261487|NCT01075347|632075|P1|COMPLETED|Overall Study||82
261488|NCT01075347|632074|P2|STARTED|Overall Study||83
261489|NCT01075347|632075|P1|STARTED|Overall Study||82
261490|NCT01075399|632083|P1|NOT COMPLETED|Overall Study||8
261491|NCT01075399|632083|P1|COMPLETED|Overall Study|42 of 50 patients received at least one dose and 39 of 50 patients completed two pre-treatment scan|42
261492|NCT01075399|632083|P1|STARTED|Overall Study|A total of 50 patients were enrolled into the study.|50
261493|NCT01075646|632091|P4|NOT COMPLETED|Overall Study||2
261494|NCT01075646|632092|P3|NOT COMPLETED|Overall Study||1
261495|NCT01075646|632093|P2|NOT COMPLETED|Overall Study||3
261496|NCT01075646|632094|P1|NOT COMPLETED|Overall Study||4
261497|NCT01075646|632091|P4|COMPLETED|Overall Study||44
261498|NCT01075646|632092|P3|COMPLETED|Overall Study||52
261499|NCT01075646|632093|P2|COMPLETED|Overall Study||31
261500|NCT01075646|632094|P1|COMPLETED|Overall Study||29
261501|NCT01075646|632091|P4|STARTED|Overall Study||46
261502|NCT01075646|632092|P3|STARTED|Overall Study||53
261503|NCT01075646|632093|P2|STARTED|Overall Study||34
261504|NCT01075646|632094|P1|STARTED|Overall Study||33
261505|NCT01075685|632126|P2|NOT COMPLETED|Overall Study||226
261506|NCT01075685|632127|P1|NOT COMPLETED|Overall Study||592
261507|NCT01075685|632126|P2|COMPLETED|Overall Study||188
261508|NCT01075685|632127|P1|COMPLETED|Overall Study||151
261509|NCT01075685|632126|P2|Completed Baseline Measures|Overall Study||263
261510|NCT01075685|632127|P1|Completed Baseline Measures|Overall Study||225
261511|NCT01075685|632126|P2|Met Inclusion Criteria|Overall Study||413
261512|NCT01075685|632127|P1|Met Inclusion Criteria|Overall Study||734
261513|NCT01075685|632126|P2|STARTED|Overall Study||414
261514|NCT01075685|632127|P1|STARTED|Overall Study||743
261515|NCT01075763|632141|P2|NOT COMPLETED|Overall Study||4
261516|NCT01075763|632142|P1|NOT COMPLETED|Overall Study||4
261517|NCT01075763|632141|P2|COMPLETED|Overall Study||15
261518|NCT01075763|632142|P1|COMPLETED|Overall Study||19
261519|NCT01075763|632141|P2|STARTED|Overall Study||19
261520|NCT01075763|632142|P1|STARTED|Overall Study||23
261521|NCT01075815|632166|P2|NOT COMPLETED|Overall Study||4
261522|NCT01075815|632167|P1|NOT COMPLETED|Overall Study||10
261523|NCT01075815|632166|P2|COMPLETED|Overall Study||31
261524|NCT01075815|632167|P1|COMPLETED|Overall Study||30
261525|NCT01075815|632166|P2|STARTED|Overall Study|Number of participants treated.|35
261526|NCT01075815|632167|P1|STARTED|Overall Study|Number of participants treated.|40
261527|NCT01075958|632203|P1|NOT COMPLETED|Overall Study||44
261528|NCT01075958|632203|P1|COMPLETED|Overall Study||239
261529|NCT01075958|632203|P1|STARTED|Overall Study||283
261530|NCT01075971|632217|P1|NOT COMPLETED|Overall Study||0
261531|NCT01075971|632217|P1|COMPLETED|Overall Study||52
261532|NCT01075971|632217|P1|STARTED|Overall Study||52
261533|NCT01075984|632226|P5|NOT COMPLETED|Follow-up Phase||47
261534|NCT01075984|632227|P4|NOT COMPLETED|Follow-up Phase||2
261535|NCT01075984|632228|P3|NOT COMPLETED|Follow-up Phase||1
261536|NCT01075984|632229|P2|NOT COMPLETED|Follow-up Phase||0
261537|NCT01075984|632230|P1|NOT COMPLETED|Follow-up Phase||0
261538|NCT01075984|632226|P5|COMPLETED|Follow-up Phase||165
261539|NCT01075984|632227|P4|COMPLETED|Follow-up Phase||19
261540|NCT01075984|632228|P3|COMPLETED|Follow-up Phase||19
261541|NCT01075984|632229|P2|COMPLETED|Follow-up Phase||10
261542|NCT01075984|632230|P1|COMPLETED|Follow-up Phase||10
261543|NCT01075984|632226|P5|STARTED|Follow-up Phase|One participant withdrew consent before the start of the follow-up phase.|212
261544|NCT01075984|632227|P4|STARTED|Follow-up Phase|Three participants did not start the follow-up phase: one died and two were lost to follow-up.|21
261545|NCT01075984|632228|P3|STARTED|Follow-up Phase|One participant did not start the follow-up phase for reasons unrelated to study procedures.|20
261546|NCT01075984|632229|P2|STARTED|Follow-up Phase||10
261547|NCT01075984|632230|P1|STARTED|Follow-up Phase||10
261548|NCT01075984|632226|P5|NOT COMPLETED|Treatment Phase||60
261549|NCT01075984|632227|P4|NOT COMPLETED|Treatment Phase||7
261550|NCT01075984|632228|P3|NOT COMPLETED|Treatment Phase||7
261551|NCT01075984|632229|P2|NOT COMPLETED|Treatment Phase||1
261552|NCT01075984|632230|P1|NOT COMPLETED|Treatment Phase||0
261553|NCT01075984|632226|P5|COMPLETED|Treatment Phase||153
261554|NCT01075984|632227|P4|COMPLETED|Treatment Phase||17
261555|NCT01075984|632228|P3|COMPLETED|Treatment Phase||14
261556|NCT01075984|632229|P2|COMPLETED|Treatment Phase||10
261557|NCT01075984|632230|P1|COMPLETED|Treatment Phase||10
261558|NCT01075984|632226|P5|STARTED|Treatment Phase||213
261559|NCT01075984|632227|P4|STARTED|Treatment Phase||24
261560|NCT01075984|632228|P3|STARTED|Treatment Phase||21
261561|NCT01075984|632229|P2|STARTED|Treatment Phase||11
261562|NCT01075984|632230|P1|STARTED|Treatment Phase||10
261563|NCT01076036|632284|P1|NOT COMPLETED|Overall Study||2
261564|NCT01076036|632284|P1|COMPLETED|Overall Study||8
261565|NCT01076036|632284|P1|Complete CorPath Procedures|Overall Study||8
261566|NCT01076036|632284|P1|# of Procedures|Overall Study||8
261567|NCT01076036|632284|P1|STARTED|Overall Study||10
261568|NCT01076075|632291|P2|NOT COMPLETED|Overall Study||47
261569|NCT01076075|632292|P1|NOT COMPLETED|Overall Study||41
261570|NCT01076075|632291|P2|COMPLETED|Overall Study||167
261571|NCT01076075|632292|P1|COMPLETED|Overall Study||172
261572|NCT01076075|632291|P2|Completed Phase A|Overall Study||189
261573|NCT01076075|632292|P1|Completed Phase A|Overall Study||199
261574|NCT01076075|632291|P2|STARTED|Overall Study|2 participants were excluded from safety and efficacy analyses due to one site's non-compliance|214
261575|NCT01076075|632292|P1|STARTED|Overall Study|3 participants were excluded from safety and efficacy analyses due to one site's non-compliance|213
261576|NCT01076088|632312|P6|NOT COMPLETED|Overall Study||23
261577|NCT01076088|632313|P5|NOT COMPLETED|Overall Study||16
261578|NCT01076088|632314|P4|NOT COMPLETED|Overall Study||15
261579|NCT01076088|632315|P3|NOT COMPLETED|Overall Study||17
261580|NCT01076088|632316|P2|NOT COMPLETED|Overall Study||18
261581|NCT01076088|632317|P1|NOT COMPLETED|Overall Study||11
261582|NCT01076088|632312|P6|COMPLETED|Overall Study||104
261583|NCT01076088|632313|P5|COMPLETED|Overall Study||104
261584|NCT01076088|632314|P4|COMPLETED|Overall Study||109
261585|NCT01076088|632315|P3|COMPLETED|Overall Study||109
261586|NCT01076088|632316|P2|COMPLETED|Overall Study||107
261587|NCT01076088|632317|P1|COMPLETED|Overall Study||111
261588|NCT01076088|632312|P6|STARTED|Overall Study||127
261589|NCT01076088|632313|P5|STARTED|Overall Study||120
261590|NCT01076088|632314|P4|STARTED|Overall Study||124
261591|NCT01076088|632315|P3|STARTED|Overall Study||126
261592|NCT01076088|632316|P2|STARTED|Overall Study||125
261593|NCT01076088|632317|P1|STARTED|Overall Study||122
261594|NCT01076153|632343|P1|NOT COMPLETED|Overall Study||11
261595|NCT01076153|632343|P1|COMPLETED|Overall Study||749
261596|NCT01076153|632343|P1|STARTED|Overall Study||760
261597|NCT01076166|632351|P1|NOT COMPLETED|Overall Study||9
261598|NCT01076166|632351|P1|COMPLETED|Overall Study||328
261599|NCT01076166|632351|P1|STARTED|Overall Study||337
261600|NCT01076179|632358|P1|NOT COMPLETED|Overall Study||1
261601|NCT01076179|632358|P1|COMPLETED|Overall Study||501
261602|NCT01076179|632358|P1|STARTED|Overall Study||502
261603|NCT01076192|632381|P1|NOT COMPLETED|Overall Study||197
261604|NCT01076192|632381|P1|COMPLETED|Overall Study||350
261605|NCT01076192|632381|P1|STARTED|Overall Study||547
261606|NCT01076244|632396|P1|NOT COMPLETED|Overall Study||4
261607|NCT01076244|632396|P1|COMPLETED|Overall Study||42
261608|NCT01076244|632396|P1|STARTED|Overall Study||46
261609|NCT01076270|632403|P1|NOT COMPLETED|Overall Study||0
261610|NCT01076270|632403|P1|COMPLETED|Overall Study||1
261611|NCT01076270|632403|P1|STARTED|Overall Study||1
261612|NCT01076283|632410|P2|NOT COMPLETED|Overall Study||0
261613|NCT01076283|632411|P1|NOT COMPLETED|Overall Study||1
261614|NCT01076283|632410|P2|COMPLETED|Overall Study||7
261615|NCT01076283|632411|P1|COMPLETED|Overall Study||6
261616|NCT01076283|632410|P2|STARTED|Overall Study||7
261617|NCT01076283|632411|P1|STARTED|Overall Study||7
261618|NCT01076296|632419|P8|NOT COMPLETED|Overall Study||0
261619|NCT01076296|632420|P7|NOT COMPLETED|Overall Study||0
261620|NCT01076296|632421|P6|NOT COMPLETED|Overall Study||0
261621|NCT01076296|632422|P5|NOT COMPLETED|Overall Study||0
261622|NCT01076296|632423|P4|NOT COMPLETED|Overall Study||0
261623|NCT01076296|632424|P3|NOT COMPLETED|Overall Study||0
261624|NCT01076296|632425|P2|NOT COMPLETED|Overall Study||0
261625|NCT01076296|632426|P1|NOT COMPLETED|Overall Study||0
261626|NCT01076296|632419|P8|COMPLETED|Overall Study||199
261627|NCT01076296|632420|P7|COMPLETED|Overall Study||51
261628|NCT01076296|632421|P6|COMPLETED|Overall Study||191
261629|NCT01076296|632422|P5|COMPLETED|Overall Study||59
261630|NCT01076296|632423|P4|COMPLETED|Overall Study||199
261631|NCT01076296|632424|P3|COMPLETED|Overall Study||51
261632|NCT01076296|632425|P2|COMPLETED|Overall Study||196
261633|NCT01076296|632426|P1|COMPLETED|Overall Study||54
261634|NCT01076296|632419|P8|STARTED|Overall Study||199
261635|NCT01076296|632420|P7|STARTED|Overall Study||51
261636|NCT01076296|632421|P6|STARTED|Overall Study||191
261637|NCT01076296|632422|P5|STARTED|Overall Study||59
261638|NCT01076296|632423|P4|STARTED|Overall Study||199
261639|NCT01076296|632424|P3|STARTED|Overall Study||51
261640|NCT01076296|632425|P2|STARTED|Overall Study||196
261641|NCT01076296|632426|P1|STARTED|Overall Study||54
261642|NCT01076335|632444|P1|NOT COMPLETED|Overall Study||4
261643|NCT01076335|632444|P1|COMPLETED|Overall Study||36
261644|NCT01076335|632444|P1|STARTED|Overall Study||40
261645|NCT01076348|632448|P1|NOT COMPLETED|Overall Study||22
261646|NCT01076348|632448|P1|COMPLETED|Overall Study||51
261647|NCT01076348|632448|P1|STARTED|Overall Study||73
261648|NCT01076361|632452|P1|NOT COMPLETED|Overall Study||21
261649|NCT01076361|632452|P1|COMPLETED|Overall Study|Follow-up data was not available for 21 participants (22 leads)|349
261650|NCT01076361|632452|P1|STARTED|Overall Study|631 leads were implanted in 370 patients. 22 leads in 21 patients were excluded from analysis.|370
261651|NCT01070693|632458|P2|NOT COMPLETED|Overall Study||39
261652|NCT01070693|632459|P1|NOT COMPLETED|Overall Study||28
261653|NCT01070693|632458|P2|COMPLETED|Overall Study||110
261654|NCT01070693|632459|P1|COMPLETED|Overall Study||122
261655|NCT01070693|632458|P2|STARTED|Overall Study||149
261656|NCT01070693|632459|P1|STARTED|Overall Study||150
261657|NCT01076452|632467|P2|NOT COMPLETED|Overall Study||14
261658|NCT01076452|632468|P1|NOT COMPLETED|Overall Study||24
261659|NCT01076452|632467|P2|COMPLETED|Overall Study||138
261660|NCT01076452|632468|P1|COMPLETED|Overall Study||123
261661|NCT01076452|632467|P2|STARTED|Overall Study||152
261662|NCT01076452|632468|P1|STARTED|Overall Study||147
261663|NCT01076504|632480|P1|NOT COMPLETED|Overall Study||80
261664|NCT01076504|632480|P1|COMPLETED|Overall Study|Patients remained on study until disease progression or withdrawal for any other reason|0
261665|NCT01076504|632480|P1|STARTED|Overall Study||80
261666|NCT01076647|632490|P2|NOT COMPLETED|Overall Study||25
261667|NCT01076647|632491|P1|NOT COMPLETED|Overall Study||25
261668|NCT01076647|632490|P2|COMPLETED|Overall Study||209
261669|NCT01076647|632491|P1|COMPLETED|Overall Study||208
261670|NCT01076647|632490|P2|STARTED|Overall Study||234
261671|NCT01076647|632491|P1|STARTED|Overall Study||233
261672|NCT01076686|632503|P4|NOT COMPLETED|Overall Study||0
261673|NCT01076686|632504|P3|NOT COMPLETED|Overall Study||0
261674|NCT01076686|632505|P2|NOT COMPLETED|Overall Study||0
261675|NCT01076686|632506|P1|NOT COMPLETED|Overall Study||0
261676|NCT01076686|632503|P4|COMPLETED|Overall Study||31
261677|NCT01076686|632504|P3|COMPLETED|Overall Study||32
261678|NCT01076686|632505|P2|COMPLETED|Overall Study||14
261679|NCT01076686|632506|P1|COMPLETED|Overall Study||17
261680|NCT01076686|632503|P4|STARTED|Overall Study||31
261681|NCT01076686|632504|P3|STARTED|Overall Study||32
261682|NCT01076686|632505|P2|STARTED|Overall Study||14
261683|NCT01076686|632506|P1|STARTED|Overall Study||17
261684|NCT01085045|632516|P1|NOT COMPLETED|Part B||15
261685|NCT01085045|632516|P1|COMPLETED|Part B||89
261686|NCT01085045|632516|P1|GP MDI 36 µg (PT001)|Part B||0
261687|NCT01085045|632516|P1|Foradil 12 µg|Part B||41
261688|NCT01085045|632516|P1|Placebo MDI|Part B||47
261689|NCT01085045|632516|P1|FF MDI 7.2 µg (PT005)|Part B||43
261690|NCT01085045|632516|P1|FF MDI 9.6 µg (PT005)|Part B||43
261691|NCT01085045|632516|P1|Spiriva 18 µg|Part B||0
261692|NCT01085045|632516|P1|GFF MDI 36/9.6 µg|Part B||0
261693|NCT01085045|632516|P1|GFF MDI 72/9.6mcg (PT003)|Part B||0
261694|NCT01085045|632516|P1|STARTED|Part B||104
261695|NCT01085045|632516|P1|NOT COMPLETED|Part A||18
261696|NCT01085045|632516|P1|COMPLETED|Part A||104
261697|NCT01085045|632516|P1|Foradil 12 µg|Part A||14
261698|NCT01085045|632516|P1|Placebo MDI|Part A||5
261699|NCT01085045|632516|P1|FF MDI 7.2 µg (PT005)|Part A||21
261700|NCT01085045|632516|P1|FF MDI 9.6 µg (PT005)|Part A||20
261701|NCT01085045|632516|P1|Spiriva 18 µg|Part A||58
261702|NCT01085045|632516|P1|GP MDI 36 µg (PT001)|Part A||40
261703|NCT01085045|632516|P1|GFF MDI 36/9.6 µg (PT003)|Part A||42
261704|NCT01085045|632516|P1|GFF MDI 72/9.6mcg|Part A||40
261705|NCT01085045|632516|P1|STARTED|Part A||122
261706|NCT01085136|632616|P3|NOT COMPLETED|Part B||26
261707|NCT01085136|632617|P2|NOT COMPLETED|Part B||51
261708|NCT01085136|632618|P1|NOT COMPLETED|Part B||0
261709|NCT01085136|632616|P3|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|42
261710|NCT01085136|632617|P2|COMPLETED|Part B|Completed trial as per protocol, had progressive disease, clinical signs or symptoms of progression|87
261711|NCT01085136|632618|P1|COMPLETED|Part B|Afatinib monotherapy not administered in Part B|0
261712|NCT01085136|632616|P3|STARTED|Part B||68
261713|NCT01085136|632617|P2|STARTED|Part B||138
261714|NCT01085136|632618|P1|STARTED|Part B|Afatinib monotherapy not administered in Part B|0
261715|NCT01085136|632616|P3|NOT COMPLETED|Part A||0
261716|NCT01085136|632617|P2|NOT COMPLETED|Part A||0
261717|NCT01085136|632618|P1|NOT COMPLETED|Part A||323
261718|NCT01085136|632616|P3|COMPLETED|Part A||0
261719|NCT01085136|632617|P2|COMPLETED|Part A||0
261720|NCT01085136|632618|P1|COMPLETED|Part A|Randomized to Part B & completed trial as per protocol, had PD, clinical progression.|831
261721|NCT01085136|632616|P3|Randomized to Part B|Part A||0
261722|NCT01085136|632617|P2|Randomized to Part B|Part A||0
261723|NCT01085136|632618|P1|Randomized to Part B|Part A|Discontinued Part A -Randomized to Part B|206
261724|NCT01085136|632616|P3|STARTED|Part A||0
261725|NCT01085136|632617|P2|STARTED|Part A|Only Afatinib monotherapy administered in Part A|0
261726|NCT01085136|632618|P1|STARTED|Part A||1154
261727|NCT01085201|632639|P5|NOT COMPLETED|Overall Study||0
261728|NCT01085201|632640|P4|NOT COMPLETED|Overall Study||0
261729|NCT01085201|632641|P3|NOT COMPLETED|Overall Study||2
261730|NCT01085201|632642|P2|NOT COMPLETED|Overall Study||1
261731|NCT01085201|632643|P1|NOT COMPLETED|Overall Study||3
261732|NCT01085201|632639|P5|COMPLETED|Overall Study||3
261733|NCT01085201|632640|P4|COMPLETED|Overall Study||6
261734|NCT01085201|632641|P3|COMPLETED|Overall Study||3
261735|NCT01085201|632642|P2|COMPLETED|Overall Study||6
261736|NCT01085201|632643|P1|COMPLETED|Overall Study||15
261737|NCT01085201|632639|P5|STARTED|Overall Study||3
261738|NCT01085201|632640|P4|STARTED|Overall Study||6
261739|NCT01085201|632641|P3|STARTED|Overall Study||5
261740|NCT01085201|632642|P2|STARTED|Overall Study||7
261741|NCT01085201|632643|P1|STARTED|Overall Study||18
261742|NCT01085214|632665|P1|NOT COMPLETED|Overall Study||1
261743|NCT01085214|632665|P1|COMPLETED|Overall Study||36
261744|NCT01085214|632665|P1|STARTED|Overall Study||37
261745|NCT01085318|632674|P2|NOT COMPLETED|Overall Study||0
261746|NCT01085318|632675|P1|NOT COMPLETED|Overall Study||2
261747|NCT01085318|632674|P2|COMPLETED|Overall Study||15
261748|NCT01085318|632675|P1|COMPLETED|Overall Study||21
261749|NCT01085318|632674|P2|STARTED|Overall Study||15
261750|NCT01085318|632675|P1|STARTED|Overall Study||23
261751|NCT01085331|632687|P2|NOT COMPLETED|Overall Study||0
261752|NCT01085331|632688|P1|NOT COMPLETED|Overall Study||0
261753|NCT01085331|632687|P2|COMPLETED|Overall Study||6
261754|NCT01085331|632688|P1|COMPLETED|Overall Study||10
261755|NCT01085331|632687|P2|STARTED|Overall Study||6
261756|NCT01085331|632688|P1|STARTED|Overall Study||10
261757|NCT01085357|632727|P2|NOT COMPLETED|Overall Study||6
261758|NCT01085357|632728|P1|NOT COMPLETED|Overall Study||19
261759|NCT01085357|632727|P2|COMPLETED|Overall Study||125
261760|NCT01085357|632728|P1|COMPLETED|Overall Study||355
261761|NCT01085357|632727|P2|STARTED|Overall Study||131
261762|NCT01085357|632728|P1|STARTED|Overall Study||374
261763|NCT01085500|632740|P2|NOT COMPLETED|Overall Study||0
261764|NCT01085500|632741|P1|NOT COMPLETED|Overall Study||0
261765|NCT01085500|632740|P2|COMPLETED|Overall Study||24
261766|NCT01085500|632741|P1|COMPLETED|Overall Study||26
261767|NCT01085500|632740|P2|STARTED|Overall Study||24
261768|NCT01085500|632741|P1|STARTED|Overall Study||26
261769|NCT01085513|632753|P2|NOT COMPLETED|Overall Study||0
261770|NCT01085513|632754|P1|NOT COMPLETED|Overall Study||0
261771|NCT01085513|632753|P2|COMPLETED|Overall Study||68
261772|NCT01085513|632754|P1|COMPLETED|Overall Study|recruitment was premature terminated|75
261773|NCT01085513|632753|P2|STARTED|Overall Study||68
261774|NCT01085513|632754|P1|STARTED|Overall Study||75
261775|NCT01085539|632760|P1|NOT COMPLETED|100Sat Secs-100 Second Alarm Evaluation||0
261776|NCT01085539|632760|P1|COMPLETED|100Sat Secs-100 Second Alarm Evaluation||50
261777|NCT01085539|632760|P1|STARTED|100Sat Secs-100 Second Alarm Evaluation||50
261778|NCT01085539|632760|P1|NOT COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||0
261779|NCT01085539|632760|P1|COMPLETED|50 Sat Secs--50 Second Alarm Evaluation||50
261780|NCT01085539|632760|P1|STARTED|50 Sat Secs--50 Second Alarm Evaluation||50
261781|NCT01085539|632760|P1|NOT COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||0
261782|NCT01085539|632760|P1|COMPLETED|25 Sat Secs--25 Second Alarm Evaluation||50
261783|NCT01085539|632760|P1|STARTED|25 Sat Secs--25 Second Alarm Evaluation||50
261784|NCT01085539|632760|P1|NOT COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||0
261785|NCT01085539|632760|P1|COMPLETED|10 Sat Secs--10 Second Alarm Evaluation||50
261786|NCT01085539|632760|P1|STARTED|10 Sat Secs--10 Second Alarm Evaluation||50
261787|NCT01085539|632760|P1|NOT COMPLETED|Sat Secs Off--No Alarm Evaluation||0
261788|NCT01085539|632760|P1|COMPLETED|Sat Secs Off--No Alarm Evaluation||50
261789|NCT01085539|632760|P1|STARTED|Sat Secs Off--No Alarm Evaluation||50
261790|NCT01085591|632767|P3|NOT COMPLETED|Overall Study||7
261791|NCT01085591|632768|P2|NOT COMPLETED|Overall Study||6
261792|NCT01085591|632769|P1|NOT COMPLETED|Overall Study||3
261793|NCT01085591|632767|P3|COMPLETED|Overall Study||63
261794|NCT01085591|632768|P2|COMPLETED|Overall Study||65
261795|NCT01085591|632769|P1|COMPLETED|Overall Study||66
261796|NCT01085591|632767|P3|Received at Least 1 Dose of Study Drug|Overall Study||70
261797|NCT01085591|632768|P2|Received at Least 1 Dose of Study Drug|Overall Study||69
261798|NCT01085591|632769|P1|Received at Least 1 Dose of Study Drug|Overall Study||68
261799|NCT01085591|632767|P3|STARTED|Overall Study||70
261800|NCT01085591|632768|P2|STARTED|Overall Study||71
261801|NCT01085591|632769|P1|STARTED|Overall Study||69
261802|NCT01085643|632792|P1|NOT COMPLETED|Overall Study||0
261803|NCT01085643|632792|P1|COMPLETED|Overall Study||4
261804|NCT01085643|632792|P1|STARTED|Overall Study||4
261805|NCT01085682|632803|P2|NOT COMPLETED|Overall Study||25
261806|NCT01085682|632804|P1|NOT COMPLETED|Overall Study||25
261807|NCT01085682|632803|P2|COMPLETED|Overall Study||3
261808|NCT01085682|632804|P1|COMPLETED|Overall Study||6
261809|NCT01085682|632803|P2|STARTED|Overall Study||28
261810|NCT01085682|632804|P1|STARTED|Overall Study||31
261811|NCT01085734|632812|P2|NOT COMPLETED|Overall Study||4
261812|NCT01085734|632813|P1|NOT COMPLETED|Overall Study||1
261813|NCT01085734|632812|P2|COMPLETED|Overall Study||11
261814|NCT01085734|632813|P1|COMPLETED|Overall Study||14
261815|NCT01085734|632812|P2|STARTED|Overall Study||15
261816|NCT01085734|632813|P1|STARTED|Overall Study||15
261817|NCT01085760|632827|P4|NOT COMPLETED|Overall Study||3
261818|NCT01085760|632828|P3|NOT COMPLETED|Overall Study||2
261819|NCT01085760|632829|P2|NOT COMPLETED|Overall Study||1
261820|NCT01085760|632830|P1|NOT COMPLETED|Overall Study||1
261821|NCT01085760|632827|P4|COMPLETED|Overall Study||6
261822|NCT01085760|632828|P3|COMPLETED|Overall Study||7
261823|NCT01085760|632829|P2|COMPLETED|Overall Study||8
261824|NCT01085760|632830|P1|COMPLETED|Overall Study||7
261825|NCT01085760|632827|P4|STARTED|Overall Study||9
261826|NCT01085760|632828|P3|STARTED|Overall Study||9
261827|NCT01085760|632829|P2|STARTED|Overall Study||9
261828|NCT01085760|632830|P1|STARTED|Overall Study||8
261829|NCT01085786|632854|P2|NOT COMPLETED|Overall Study||0
261830|NCT01085786|632855|P1|NOT COMPLETED|Overall Study||0
261831|NCT01085786|632854|P2|COMPLETED|Overall Study||117
261832|NCT01085786|632855|P1|COMPLETED|Overall Study||123
261833|NCT01085786|632854|P2|STARTED|Overall Study||117
261834|NCT01085786|632855|P1|STARTED|Overall Study||123
261835|NCT01085825|632863|P2|NOT COMPLETED|Overall Study||1
261836|NCT01085825|632864|P1|NOT COMPLETED|Overall Study||1
261837|NCT01085825|632863|P2|COMPLETED|Overall Study||247
261838|NCT01085825|632864|P1|COMPLETED|Overall Study||251
261839|NCT01085825|632863|P2|STARTED|Overall Study||248
261840|NCT01085825|632864|P1|STARTED|Overall Study|1st participant enrolled|252
261841|NCT01085903|632872|P3|NOT COMPLETED|Overall Study||0
261842|NCT01085903|632873|P2|NOT COMPLETED|Overall Study||0
261843|NCT01085903|632874|P1|NOT COMPLETED|Overall Study||0
261844|NCT01085903|632872|P3|COMPLETED|Overall Study||3
261845|NCT01085903|632873|P2|COMPLETED|Overall Study||4
261846|NCT01085903|632874|P1|COMPLETED|Overall Study||21
261847|NCT01085903|632872|P3|STARTED|Overall Study||3
261848|NCT01085903|632873|P2|STARTED|Overall Study||4
261849|NCT01085903|632874|P1|STARTED|Overall Study||21
261850|NCT01085968|632900|P2|NOT COMPLETED|Overall Study||4
261851|NCT01085968|632901|P1|NOT COMPLETED|Overall Study||10
261852|NCT01085968|632900|P2|COMPLETED|Overall Study||21
261853|NCT01085968|632901|P1|COMPLETED|Overall Study||19
261854|NCT01085968|632900|P2|STARTED|Overall Study||25
261855|NCT01085968|632901|P1|STARTED|Overall Study||29
261856|NCT01086033|632915|P1|NOT COMPLETED|Overall Study||304
261857|NCT01086033|632915|P1|COMPLETED|Overall Study||262
261858|NCT01086033|632915|P1|STARTED|Overall Study||566
261859|NCT01086215|632931|P4|NOT COMPLETED|Overall Study||3
261860|NCT01086215|632932|P3|NOT COMPLETED|Overall Study||26
261861|NCT01086215|632933|P2|NOT COMPLETED|Overall Study||47
261862|NCT01086215|632934|P1|NOT COMPLETED|Overall Study||36
261863|NCT01086215|632931|P4|COMPLETED|Overall Study||11
261864|NCT01086215|632932|P3|COMPLETED|Overall Study||47
261865|NCT01086215|632933|P2|COMPLETED|Overall Study||154
261866|NCT01086215|632934|P1|COMPLETED|Overall Study||176
261867|NCT01086215|632931|P4|12 Month Follow Up|Overall Study|0 LTF; 1 Death|11
261868|NCT01086215|632932|P3|12 Month Follow Up|Overall Study|9 LTF; 4 Deaths|47
261869|NCT01086215|632933|P2|12 Month Follow Up|Overall Study|16 LTF; 2 Deaths|154
261870|NCT01086215|632934|P1|12 Month Follow Up|Overall Study|10 LTF; 6 Deaths|176
261871|NCT01086215|632931|P4|6 Month Follow Up|Overall Study|1 LTF; 0 Deaths|12
261872|NCT01086215|632932|P3|6 Month Follow Up|Overall Study|4 LTF; 0 Deaths|60
261873|NCT01086215|632933|P2|6 Month Follow Up|Overall Study|13 LTF; 2 Deaths|172
261874|NCT01086215|632934|P1|6 Month Follow Up|Overall Study|5 LTF; 4 Deaths|192
261875|NCT01086215|632931|P4|3 Month Follow Up|Overall Study|1 LTF; 0 Deaths|13
261876|NCT01086215|632932|P3|3 Month Follow Up|Overall Study|5 LTF; 4 Deaths|64
261877|NCT01086215|632933|P2|3 Month Follow Up|Overall Study|10 LTF; 4 Deaths|187
261878|NCT01086215|632934|P1|3 Month Follow Up|Overall Study|7 LTF; 4 Deaths|201
261879|NCT01086215|632931|P4|STARTED|Overall Study||14
261880|NCT01086215|632932|P3|STARTED|Overall Study||73
261881|NCT01086215|632933|P2|STARTED|Overall Study||201
261882|NCT01086215|632934|P1|STARTED|Overall Study||212
261883|NCT01086384|632954|P3|NOT COMPLETED|Treatment Period||124
261884|NCT01086384|632955|P2|NOT COMPLETED|Treatment Period||148
261885|NCT01086384|632956|P1|NOT COMPLETED|Treatment Period||0
261886|NCT01086384|632954|P3|COMPLETED|Treatment Period||885
261887|NCT01086384|632955|P2|COMPLETED|Treatment Period||863
261888|NCT01086384|632956|P1|COMPLETED|Treatment Period||0
261889|NCT01086384|632954|P3|STARTED|Treatment Period||1009
261890|NCT01086384|632955|P2|STARTED|Treatment Period||1011
261891|NCT01086384|632956|P1|STARTED|Treatment Period||0
261892|NCT01086384|632954|P3|NOT COMPLETED|2-week Run-in Period||0
261893|NCT01086384|632955|P2|NOT COMPLETED|2-week Run-in Period||0
261894|NCT01086384|632956|P1|NOT COMPLETED|2-week Run-in Period||163
261895|NCT01086384|632954|P3|COMPLETED|2-week Run-in Period||0
261896|NCT01086384|632955|P2|COMPLETED|2-week Run-in Period||0
261897|NCT01086384|632956|P1|COMPLETED|2-week Run-in Period||2020
261898|NCT01086384|632954|P3|STARTED|2-week Run-in Period||0
261899|NCT01086384|632955|P2|STARTED|2-week Run-in Period||0
261900|NCT01086384|632956|P1|STARTED|2-week Run-in Period||2183
261901|NCT01086410|632970|P4|NOT COMPLETED|Overall Study||2
261902|NCT01086410|632971|P3|NOT COMPLETED|Overall Study||1
261903|NCT01086410|632972|P2|NOT COMPLETED|Overall Study||2
261904|NCT01086410|632973|P1|NOT COMPLETED|Overall Study||3
261905|NCT01086410|632970|P4|COMPLETED|Overall Study||13
261906|NCT01086410|632971|P3|COMPLETED|Overall Study||55
261907|NCT01086410|632972|P2|COMPLETED|Overall Study||54
261908|NCT01086410|632973|P1|COMPLETED|Overall Study||55
261909|NCT01086410|632970|P4|STARTED|Overall Study||15
261910|NCT01086410|632971|P3|STARTED|Overall Study||56
261911|NCT01086410|632972|P2|STARTED|Overall Study||56
261912|NCT01086410|632973|P1|STARTED|Overall Study||58
261913|NCT01086423|633070|P3|NOT COMPLETED|Overall Study||9
261914|NCT01086423|633071|P2|NOT COMPLETED|Overall Study||3
261915|NCT01086423|633072|P1|NOT COMPLETED|Overall Study||10
261916|NCT01086423|633070|P3|COMPLETED|Overall Study||321
261917|NCT01086423|633071|P2|COMPLETED|Overall Study||321
261918|NCT01086423|633072|P1|COMPLETED|Overall Study||320
261919|NCT01086423|633070|P3|STARTED|Overall Study||330
261920|NCT01086423|633071|P2|STARTED|Overall Study||324
261921|NCT01086423|633072|P1|STARTED|Overall Study||330
261922|NCT01086475|633115|P2|NOT COMPLETED|Overall Study||0
261923|NCT01086475|633116|P1|NOT COMPLETED|Overall Study||0
261924|NCT01086475|633115|P2|COMPLETED|Overall Study||33
261925|NCT01086475|633116|P1|COMPLETED|Overall Study||34
261926|NCT01086475|633115|P2|STARTED|Overall Study||33
261927|NCT01086475|633116|P1|STARTED|Overall Study||34
261928|NCT01086605|633128|P2|NOT COMPLETED|Overall Study||0
261929|NCT01086605|633129|P1|NOT COMPLETED|Overall Study||0
261930|NCT01086605|633128|P2|COMPLETED|Overall Study||22
261931|NCT01086605|633129|P1|COMPLETED|Overall Study||24
261932|NCT01086605|633128|P2|STARTED|Overall Study||22
261933|NCT01086605|633129|P1|STARTED|Overall Study||24
261934|NCT01086761|633149|P6|NOT COMPLETED|Overall Study||0
261935|NCT01086761|633150|P5|NOT COMPLETED|Overall Study||0
261936|NCT01086761|633151|P4|NOT COMPLETED|Overall Study||0
261937|NCT01086761|633152|P3|NOT COMPLETED|Overall Study||0
261938|NCT01086761|633153|P2|NOT COMPLETED|Overall Study||0
261939|NCT01086761|633154|P1|NOT COMPLETED|Overall Study||0
261940|NCT01086761|633149|P6|COMPLETED|Overall Study||0
261941|NCT01086761|633150|P5|COMPLETED|Overall Study||4
261942|NCT01086761|633151|P4|COMPLETED|Overall Study||6
261943|NCT01086761|633152|P3|COMPLETED|Overall Study||6
261944|NCT01086761|633153|P2|COMPLETED|Overall Study||7
261945|NCT01086761|633154|P1|COMPLETED|Overall Study||9
261946|NCT01086761|633149|P6|STARTED|Overall Study||0
261947|NCT01086761|633150|P5|STARTED|Overall Study||4
261948|NCT01086761|633151|P4|STARTED|Overall Study||6
261949|NCT01086761|633152|P3|STARTED|Overall Study||6
261950|NCT01086761|633153|P2|STARTED|Overall Study||7
261951|NCT01086761|633154|P1|STARTED|Overall Study||9
261952|NCT01086852|633192|P1|NOT COMPLETED|Overall Study||0
261953|NCT01086852|633192|P1|COMPLETED|Overall Study||4
261954|NCT01086852|633192|P1|STARTED|Overall Study||4
261955|NCT01086969|633206|P3|NOT COMPLETED|Overall Study||0
261956|NCT01086969|633207|P2|NOT COMPLETED|Overall Study||2
261957|NCT01086969|633208|P1|NOT COMPLETED|Overall Study||1
261958|NCT01086969|633206|P3|COMPLETED|Overall Study||100
261959|NCT01086969|633207|P2|COMPLETED|Overall Study||98
261960|NCT01086969|633208|P1|COMPLETED|Overall Study||99
261961|NCT01086969|633206|P3|STARTED|Overall Study||100
261962|NCT01086969|633207|P2|STARTED|Overall Study||100
261963|NCT01086969|633208|P1|STARTED|Overall Study||100
261964|NCT01087489|633225|P2|NOT COMPLETED|Overall Study||3
261965|NCT01087489|633226|P1|NOT COMPLETED|Overall Study||0
261966|NCT01087489|633225|P2|COMPLETED|Overall Study||31
261967|NCT01087489|633226|P1|COMPLETED|Overall Study||19
261968|NCT01087489|633225|P2|STARTED|Overall Study||34
261969|NCT01087489|633226|P1|STARTED|Overall Study||19
261970|NCT01087502|633238|P2|NOT COMPLETED|Up to Final Analysis (Week 52)||23
261971|NCT01087502|633239|P1|NOT COMPLETED|Up to Final Analysis (Week 52)||33
261972|NCT01087502|633238|P2|COMPLETED|Up to Final Analysis (Week 52)||95
261973|NCT01087502|633239|P1|COMPLETED|Up to Final Analysis (Week 52)||90
261974|NCT01087502|633238|P2|STARTED|Up to Final Analysis (Week 52)||118
261975|NCT01087502|633239|P1|STARTED|Up to Final Analysis (Week 52)||123
261976|NCT01087502|633238|P2|NOT COMPLETED|Up to Interim Analysis (Week 12)||8
261977|NCT01087502|633239|P1|NOT COMPLETED|Up to Interim Analysis (Week 12)||9
261978|NCT01087502|633238|P2|COMPLETED|Up to Interim Analysis (Week 12)||110
261979|NCT01087502|633239|P1|COMPLETED|Up to Interim Analysis (Week 12)||114
261980|NCT01087502|633238|P2|STARTED|Up to Interim Analysis (Week 12)||118
261981|NCT01087502|633239|P1|STARTED|Up to Interim Analysis (Week 12)||123
261982|NCT01073566|633260|P2|NOT COMPLETED|Period 2 (6 Weeks)||0
261983|NCT01073566|633261|P1|NOT COMPLETED|Period 2 (6 Weeks)||1
261984|NCT01073566|633260|P2|COMPLETED|Period 2 (6 Weeks)||19
261985|NCT01073566|633261|P1|COMPLETED|Period 2 (6 Weeks)||18
261986|NCT01073566|633260|P2|STARTED|Period 2 (6 Weeks)||19
261987|NCT01073566|633261|P1|STARTED|Period 2 (6 Weeks)||19
261988|NCT01073566|633260|P2|NOT COMPLETED|Period 1 (6 Weeks)||0
261989|NCT01073566|633261|P1|NOT COMPLETED|Period 1 (6 Weeks)||0
261990|NCT01073566|633260|P2|COMPLETED|Period 1 (6 Weeks)||19
261991|NCT01073566|633261|P1|COMPLETED|Period 1 (6 Weeks)||19
261992|NCT01073566|633260|P2|STARTED|Period 1 (6 Weeks)||19
261993|NCT01073566|633261|P1|STARTED|Period 1 (6 Weeks)||19
261994|NCT01073605|633276|P3|NOT COMPLETED|Overall Study||61
261995|NCT01073605|633277|P2|NOT COMPLETED|Overall Study||67
261996|NCT01073605|633278|P1|NOT COMPLETED|Overall Study||62
261997|NCT01073605|633276|P3|COMPLETED|Overall Study|Corresponds to follow-up until final height|8
261998|NCT01073605|633277|P2|COMPLETED|Overall Study|Corresponds to follow-up until final height|4
261999|NCT01073605|633278|P1|COMPLETED|Overall Study|Corresponds to follow-up until final height|6
262000|NCT01073605|633276|P3|Received Treatment|Overall Study||68
262001|NCT01073605|633277|P2|Received Treatment|Overall Study||70
262002|NCT01073605|633278|P1|Received Treatment|Overall Study||68
262003|NCT01073605|633276|P3|STARTED|Overall Study||69
262004|NCT01073605|633277|P2|STARTED|Overall Study||71
262005|NCT01073605|633278|P1|STARTED|Overall Study||68
262006|NCT01073618|633322|P1|NOT COMPLETED|Overall Study||307
262007|NCT01073618|633322|P1|COMPLETED|Overall Study||385
262008|NCT01073618|633322|P1|STARTED|Overall Study||692
262009|NCT01073631|633327|P1|NOT COMPLETED|Overall Study||169
262010|NCT01073631|633327|P1|COMPLETED|Overall Study||374
262011|NCT01073631|633327|P1|STARTED|Overall Study||543
262012|NCT01073657|633334|P2|NOT COMPLETED|Overall Study||0
262013|NCT01073657|633335|P1|NOT COMPLETED|Overall Study||0
262014|NCT01073657|633334|P2|COMPLETED|Overall Study||16
262015|NCT01073657|633335|P1|COMPLETED|Overall Study||17
262016|NCT01073657|633334|P2|STARTED|Overall Study||16
262017|NCT01073657|633335|P1|STARTED|Overall Study||17
262018|NCT01073865|633343|P2|NOT COMPLETED|Overall Study||39
262019|NCT01073865|633344|P1|NOT COMPLETED|Overall Study||28
262020|NCT01073865|633343|P2|COMPLETED|Overall Study|Number of patients completed the study|74
262021|NCT01073865|633344|P1|COMPLETED|Overall Study|Number of patients completed the study|81
262022|NCT01073865|633343|P2|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|113
262023|NCT01073865|633344|P1|Received Randomised Treatment|Overall Study|Number of patients received randomised treatment|108
262024|NCT01073865|633343|P2|STARTED|Overall Study|Number of patients randomised|113
262025|NCT01073865|633344|P1|STARTED|Overall Study|Number of patients randomised|109
262026|NCT01087528|633354|P1|NOT COMPLETED|Overall Study||7
262027|NCT01087528|633354|P1|COMPLETED|Overall Study|withdrawn from the study prior to any procedure|44
262028|NCT01087528|633354|P1|STARTED|Overall Study||51
262029|NCT01087541|633360|P2|NOT COMPLETED|Overall Study||0
262030|NCT01087541|633361|P1|NOT COMPLETED|Overall Study||0
262031|NCT01087541|633360|P2|COMPLETED|Overall Study||3523
262032|NCT01087541|633361|P1|COMPLETED|Overall Study||3307
262033|NCT01087541|633360|P2|STARTED|Overall Study||3523
262034|NCT01087541|633361|P1|STARTED|Overall Study||3307
262035|NCT01087723|633379|P2|NOT COMPLETED|Overall Study||20
262036|NCT01087723|633380|P1|NOT COMPLETED|Overall Study||14
262037|NCT01087723|633379|P2|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1089
262038|NCT01087723|633380|P1|COMPLETED|Overall Study|Completed 1-year follow-up in the study|1075
262039|NCT01087723|633379|P2|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1094
262040|NCT01087723|633380|P1|Received at Least 1 Dose of Study Drug|Overall Study|Participants who were randomized with signed ICF by treatment actually received; Safety population|1099
262041|NCT01087723|633379|P2|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1109
262042|NCT01087723|633380|P1|STARTED|Overall Study|Randomized participants who signed an informed consent form (ICF); Intent-to-treat (ITT) population|1089
262043|NCT01087736|633404|P2|NOT COMPLETED|Overall Study||2
262044|NCT01087736|633405|P1|NOT COMPLETED|Overall Study||1
262045|NCT01087736|633404|P2|COMPLETED|Overall Study||14
262046|NCT01087736|633405|P1|COMPLETED|Overall Study||13
262047|NCT01087736|633404|P2|STARTED|Overall Study||16
262048|NCT01087736|633405|P1|STARTED|Overall Study||14
262049|NCT01087762|633416|P5|NOT COMPLETED|Open-Label Period (Weeks 48-204)||57
262050|NCT01087762|633417|P4|NOT COMPLETED|Open-Label Period (Weeks 48-204)||59
262051|NCT01087762|633418|P3|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
262052|NCT01087762|633419|P2|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
262053|NCT01087762|633420|P1|NOT COMPLETED|Open-Label Period (Weeks 48-204)||0
262054|NCT01087762|633416|P5|COMPLETED|Open-Label Period (Weeks 48-204)||100
262055|NCT01087762|633417|P4|COMPLETED|Open-Label Period (Weeks 48-204)||99
262056|NCT01087762|633418|P3|COMPLETED|Open-Label Period (Weeks 48-204)||0
262057|NCT01087762|633419|P2|COMPLETED|Open-Label Period (Weeks 48-204)||0
262058|NCT01087762|633420|P1|COMPLETED|Open-Label Period (Weeks 48-204)||0
262059|NCT01087762|633416|P5|STARTED|Open-Label Period (Weeks 48-204)||157
262060|NCT01087762|633417|P4|STARTED|Open-Label Period (Weeks 48-204)||158
262061|NCT01087762|633418|P3|STARTED|Open-Label Period (Weeks 48-204)||0
262062|NCT01087762|633419|P2|STARTED|Open-Label Period (Weeks 48-204)||0
262063|NCT01087762|633420|P1|STARTED|Open-Label Period (Weeks 48-204)||0
262064|NCT01087762|633416|P5|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
262065|NCT01087762|633417|P4|NOT COMPLETED|Double Blind Period (Weeks 0-24)||0
262066|NCT01087762|633418|P3|NOT COMPLETED|Double Blind Period (Weeks 0-24)||9
262067|NCT01087762|633419|P2|NOT COMPLETED|Double Blind Period (Weeks 0-24)||6
262068|NCT01087762|633420|P1|NOT COMPLETED|Double Blind Period (Weeks 0-24)||12
262069|NCT01087762|633416|P5|COMPLETED|Double Blind Period (Weeks 0-24)||0
262070|NCT01087762|633417|P4|COMPLETED|Double Blind Period (Weeks 0-24)||0
262071|NCT01087762|633418|P3|COMPLETED|Double Blind Period (Weeks 0-24)||98
262072|NCT01087762|633419|P2|COMPLETED|Double Blind Period (Weeks 0-24)||105
262073|NCT01087762|633420|P1|COMPLETED|Double Blind Period (Weeks 0-24)||95
262074|NCT01087762|633416|P5|STARTED|Double Blind Period (Weeks 0-24)||0
262075|NCT01087762|633417|P4|STARTED|Double Blind Period (Weeks 0-24)||0
262076|NCT01087762|633418|P3|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
262077|NCT01087762|633419|P2|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|111
262078|NCT01087762|633420|P1|STARTED|Double Blind Period (Weeks 0-24)|Completed 24-weeks Double-blind Period|107
262079|NCT01087788|633469|P3|NOT COMPLETED|Open-Label Period (OL-P)||28
262080|NCT01087788|633470|P2|NOT COMPLETED|Open-Label Period (OL-P)||24
262081|NCT01087788|633471|P1|NOT COMPLETED|Open-Label Period (OL-P)||30
262082|NCT01087788|633469|P3|COMPLETED|Open-Label Period (OL-P)||86
262083|NCT01087788|633470|P2|COMPLETED|Open-Label Period (OL-P)||97
262084|NCT01087788|633471|P1|COMPLETED|Open-Label Period (OL-P)||81
262085|NCT01087788|633469|P3|STARTED|Open-Label Period (OL-P)||114
262161|NCT01088984|633560|P1|NOT COMPLETED|Phase 1||5
262254|NCT01089127|633643|P5|COMPLETED|Overall Study||90
262086|NCT01087788|633470|P2|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|121
262087|NCT01087788|633471|P1|STARTED|Open-Label Period (OL-P)|2 subj. completed the Dose-Blind Period, then withdrew from the study rather than entering the OL-P.|111
262088|NCT01087788|633469|P3|NOT COMPLETED|24-weeks Dose-blind Period||6
262089|NCT01087788|633470|P2|NOT COMPLETED|24-weeks Dose-blind Period||5
262090|NCT01087788|633471|P1|NOT COMPLETED|24-weeks Dose-blind Period||7
262091|NCT01087788|633469|P3|COMPLETED|24-weeks Dose-blind Period||114
262092|NCT01087788|633470|P2|COMPLETED|24-weeks Dose-blind Period||123
262093|NCT01087788|633471|P1|COMPLETED|24-weeks Dose-blind Period||113
262094|NCT01087788|633469|P3|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
262095|NCT01087788|633470|P2|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
262096|NCT01087788|633471|P1|Received CZP 400 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 400mg Q2W at week 16 (29 subjects) and at week 24 (31 subjects)|60
262097|NCT01087788|633469|P3|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
262098|NCT01087788|633470|P2|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|not applicable for this arm|0
262099|NCT01087788|633471|P1|Received CZP 200 mg Q2W at 24 Weeks|24-weeks Dose-blind Period|Sum of subjects re-randomized to CZP 200mg Q2W at week 16 (30 subjects) and at week 24 (30 subjects)|60
262100|NCT01087788|633469|P3|STARTED|24-weeks Dose-blind Period||120
262101|NCT01087788|633470|P2|STARTED|24-weeks Dose-blind Period||128
262102|NCT01087788|633471|P1|STARTED|24-weeks Dose-blind Period||120
262103|NCT01087788|633469|P3|NOT COMPLETED|24-weeks Double-blind Period||15
262104|NCT01087788|633470|P2|NOT COMPLETED|24-weeks Double-blind Period||10
262105|NCT01087788|633471|P1|NOT COMPLETED|24-weeks Double-blind Period||16
262106|NCT01087788|633469|P3|COMPLETED|24-weeks Double-blind Period||120
262107|NCT01087788|633470|P2|COMPLETED|24-weeks Double-blind Period||128
262108|NCT01087788|633471|P1|COMPLETED|24-weeks Double-blind Period||120
262109|NCT01087788|633469|P3|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
262110|NCT01087788|633470|P2|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
262111|NCT01087788|633471|P1|Received CZP 400 mg Q4W at 16 Weeks|24-weeks Double-blind Period|29 subjects left the Placebo group and were re-randomized to CZP 400 mg Q4W on Week 16.|29
262112|NCT01087788|633469|P3|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
262113|NCT01087788|633470|P2|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|not applicable for this arm|0
262114|NCT01087788|633471|P1|Received CZP 200 mg Q2W at 16 Weeks|24-weeks Double-blind Period|30 subjects left the Placebo group and were re-randomized to CZP 200 mg Q2W on Week 16.|30
262115|NCT01087788|633469|P3|STARTED|24-weeks Double-blind Period||135
262116|NCT01087788|633470|P2|STARTED|24-weeks Double-blind Period||138
262117|NCT01087788|633471|P1|STARTED|24-weeks Double-blind Period||136
262118|NCT01087801|633500|P2|NOT COMPLETED|Overall Study||5
262119|NCT01087801|633501|P1|NOT COMPLETED|Overall Study||4
262120|NCT01087801|633500|P2|COMPLETED|Overall Study||29
262121|NCT01087801|633501|P1|COMPLETED|Overall Study||26
262122|NCT01087801|633500|P2|STARTED|Overall Study||34
262123|NCT01087801|633501|P1|STARTED|Overall Study||30
262124|NCT01087814|633509|P2|NOT COMPLETED|Second Intervention (5 Days)||0
262125|NCT01087814|633510|P1|NOT COMPLETED|Second Intervention (5 Days)||1
262126|NCT01087814|633509|P2|COMPLETED|Second Intervention (5 Days)||6
262127|NCT01087814|633510|P1|COMPLETED|Second Intervention (5 Days)||4
262128|NCT01087814|633509|P2|STARTED|Second Intervention (5 Days)||6
262129|NCT01087814|633510|P1|STARTED|Second Intervention (5 Days)||5
262130|NCT01087814|633509|P2|NOT COMPLETED|First Intervention (5 Days)||1
262131|NCT01087814|633510|P1|NOT COMPLETED|First Intervention (5 Days)||3
262132|NCT01087814|633509|P2|COMPLETED|First Intervention (5 Days)||6
262133|NCT01087814|633510|P1|COMPLETED|First Intervention (5 Days)||5
262134|NCT01087814|633509|P2|STARTED|First Intervention (5 Days)||7
262135|NCT01087814|633510|P1|STARTED|First Intervention (5 Days)||8
262136|NCT01088646|633516|P1|NOT COMPLETED|Overall Study||0
262137|NCT01088646|633516|P1|COMPLETED|Overall Study||25
262138|NCT01088646|633516|P1|STARTED|Overall Study||25
262139|NCT01088672|633520|P1|NOT COMPLETED|Overall Study||0
262140|NCT01088672|633520|P1|COMPLETED|Overall Study||60
262141|NCT01088672|633520|P1|STARTED|Overall Study||60
262142|NCT01088711|633530|P4|NOT COMPLETED|Overall Study||0
262143|NCT01088711|633531|P3|NOT COMPLETED|Overall Study||0
262144|NCT01088711|633532|P2|NOT COMPLETED|Overall Study||0
262145|NCT01088711|633533|P1|NOT COMPLETED|Overall Study||0
262146|NCT01088711|633530|P4|COMPLETED|Overall Study||2
262147|NCT01088711|633531|P3|COMPLETED|Overall Study||6
262148|NCT01088711|633532|P2|COMPLETED|Overall Study||6
262149|NCT01088711|633533|P1|COMPLETED|Overall Study||18
262150|NCT01088711|633530|P4|STARTED|Overall Study||2
262151|NCT01088711|633531|P3|STARTED|Overall Study||6
262152|NCT01088711|633532|P2|STARTED|Overall Study||6
262153|NCT01088711|633533|P1|STARTED|Overall Study||18
262154|NCT01088984|633559|P2|NOT COMPLETED|Phase 2||32
262155|NCT01088984|633560|P1|NOT COMPLETED|Phase 2||0
262156|NCT01088984|633559|P2|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
262157|NCT01088984|633560|P1|COMPLETED|Phase 2|completed follow-up up to 12 month from last dose of study drug|0
262158|NCT01088984|633559|P2|STARTED|Phase 2||32
262159|NCT01088984|633560|P1|STARTED|Phase 2||0
262160|NCT01088984|633559|P2|NOT COMPLETED|Phase 1||6
262162|NCT01088984|633559|P2|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
262163|NCT01088984|633560|P1|COMPLETED|Phase 1|completed follow-up up to 12 month from last dose of study drug|0
262164|NCT01088984|633559|P2|STARTED|Phase 1||6
262165|NCT01088984|633560|P1|STARTED|Phase 1||5
262166|NCT01088997|633580|P2|NOT COMPLETED|Overall Study||3
262167|NCT01088997|633581|P1|NOT COMPLETED|Overall Study||3
262168|NCT01088997|633580|P2|COMPLETED|Overall Study||2
262169|NCT01088997|633581|P1|COMPLETED|Overall Study||4
262170|NCT01088997|633580|P2|STARTED|Overall Study||5
262171|NCT01088997|633581|P1|STARTED|Overall Study||7
262172|NCT01089023|633590|P1|NOT COMPLETED|Overall Study||7
262173|NCT01089023|633590|P1|COMPLETED|Overall Study||88
262174|NCT01089023|633590|P1|STARTED|Overall Study||95
262175|NCT01089062|633608|P6|NOT COMPLETED|Follow-up Visit (Final Visit)||0
262176|NCT01089062|633609|P5|NOT COMPLETED|Follow-up Visit (Final Visit)||0
262177|NCT01089062|633610|P4|NOT COMPLETED|Follow-up Visit (Final Visit)||0
262178|NCT01089062|633611|P3|NOT COMPLETED|Follow-up Visit (Final Visit)||0
262179|NCT01089062|633612|P2|NOT COMPLETED|Follow-up Visit (Final Visit)||0
262180|NCT01089062|633613|P1|NOT COMPLETED|Follow-up Visit (Final Visit)||0
262181|NCT01089062|633608|P6|COMPLETED|Follow-up Visit (Final Visit)||3
262182|NCT01089062|633609|P5|COMPLETED|Follow-up Visit (Final Visit)||3
262183|NCT01089062|633610|P4|COMPLETED|Follow-up Visit (Final Visit)||3
262184|NCT01089062|633611|P3|COMPLETED|Follow-up Visit (Final Visit)||3
262185|NCT01089062|633612|P2|COMPLETED|Follow-up Visit (Final Visit)||3
262186|NCT01089062|633613|P1|COMPLETED|Follow-up Visit (Final Visit)||3
262187|NCT01089062|633608|P6|STARTED|Follow-up Visit (Final Visit)||3
262188|NCT01089062|633609|P5|STARTED|Follow-up Visit (Final Visit)||3
262189|NCT01089062|633610|P4|STARTED|Follow-up Visit (Final Visit)||3
262190|NCT01089062|633611|P3|STARTED|Follow-up Visit (Final Visit)||3
262191|NCT01089062|633612|P2|STARTED|Follow-up Visit (Final Visit)||3
262192|NCT01089062|633613|P1|STARTED|Follow-up Visit (Final Visit)||3
262193|NCT01089062|633608|P6|NOT COMPLETED|Visit 4||0
262194|NCT01089062|633609|P5|NOT COMPLETED|Visit 4||0
262195|NCT01089062|633610|P4|NOT COMPLETED|Visit 4||0
262196|NCT01089062|633611|P3|NOT COMPLETED|Visit 4||0
262197|NCT01089062|633612|P2|NOT COMPLETED|Visit 4||0
262198|NCT01089062|633613|P1|NOT COMPLETED|Visit 4||0
262199|NCT01089062|633608|P6|COMPLETED|Visit 4||3
262200|NCT01089062|633609|P5|COMPLETED|Visit 4||3
262201|NCT01089062|633610|P4|COMPLETED|Visit 4||3
262202|NCT01089062|633611|P3|COMPLETED|Visit 4||3
262203|NCT01089062|633612|P2|COMPLETED|Visit 4||3
262204|NCT01089062|633613|P1|COMPLETED|Visit 4||3
262205|NCT01089062|633608|P6|STARTED|Visit 4||3
262206|NCT01089062|633609|P5|STARTED|Visit 4||3
262207|NCT01089062|633610|P4|STARTED|Visit 4||3
262208|NCT01089062|633611|P3|STARTED|Visit 4||3
262209|NCT01089062|633612|P2|STARTED|Visit 4||3
262210|NCT01089062|633613|P1|STARTED|Visit 4||3
262211|NCT01089062|633608|P6|NOT COMPLETED|Visit 3||0
262212|NCT01089062|633609|P5|NOT COMPLETED|Visit 3||0
262213|NCT01089062|633610|P4|NOT COMPLETED|Visit 3||1
262214|NCT01089062|633611|P3|NOT COMPLETED|Visit 3||0
262215|NCT01089062|633612|P2|NOT COMPLETED|Visit 3||0
262216|NCT01089062|633613|P1|NOT COMPLETED|Visit 3||0
262217|NCT01089062|633608|P6|COMPLETED|Visit 3||3
262218|NCT01089062|633609|P5|COMPLETED|Visit 3||3
262219|NCT01089062|633610|P4|COMPLETED|Visit 3||3
262220|NCT01089062|633611|P3|COMPLETED|Visit 3||3
262221|NCT01089062|633612|P2|COMPLETED|Visit 3||3
262222|NCT01089062|633613|P1|COMPLETED|Visit 3||3
262223|NCT01089062|633608|P6|STARTED|Visit 3||3
262224|NCT01089062|633609|P5|STARTED|Visit 3||3
262225|NCT01089062|633610|P4|STARTED|Visit 3||4
262226|NCT01089062|633611|P3|STARTED|Visit 3||3
262227|NCT01089062|633612|P2|STARTED|Visit 3||3
262228|NCT01089062|633613|P1|STARTED|Visit 3||3
262229|NCT01089062|633608|P6|NOT COMPLETED|Visit 2 (Randomization)||1
262230|NCT01089062|633609|P5|NOT COMPLETED|Visit 2 (Randomization)||1
262231|NCT01089062|633610|P4|NOT COMPLETED|Visit 2 (Randomization)||0
262232|NCT01089062|633611|P3|NOT COMPLETED|Visit 2 (Randomization)||1
262233|NCT01089062|633612|P2|NOT COMPLETED|Visit 2 (Randomization)||1
262234|NCT01089062|633613|P1|NOT COMPLETED|Visit 2 (Randomization)||1
262235|NCT01089062|633608|P6|COMPLETED|Visit 2 (Randomization)||3
262236|NCT01089062|633609|P5|COMPLETED|Visit 2 (Randomization)||3
262237|NCT01089062|633610|P4|COMPLETED|Visit 2 (Randomization)||4
262238|NCT01089062|633611|P3|COMPLETED|Visit 2 (Randomization)||3
262239|NCT01089062|633612|P2|COMPLETED|Visit 2 (Randomization)||3
262240|NCT01089062|633613|P1|COMPLETED|Visit 2 (Randomization)||3
262241|NCT01089062|633608|P6|STARTED|Visit 2 (Randomization)||4
262242|NCT01089062|633609|P5|STARTED|Visit 2 (Randomization)||4
262243|NCT01089062|633610|P4|STARTED|Visit 2 (Randomization)||4
262244|NCT01089062|633611|P3|STARTED|Visit 2 (Randomization)||4
262245|NCT01089062|633612|P2|STARTED|Visit 2 (Randomization)||4
262246|NCT01089062|633613|P1|STARTED|Visit 2 (Randomization)||4
262247|NCT01089127|633642|P6|NOT COMPLETED|Overall Study||3
262248|NCT01089127|633643|P5|NOT COMPLETED|Overall Study||2
262249|NCT01089127|633644|P4|NOT COMPLETED|Overall Study||1
262250|NCT01089127|633645|P3|NOT COMPLETED|Overall Study||2
262251|NCT01089127|633646|P2|NOT COMPLETED|Overall Study||5
262252|NCT01089127|633647|P1|NOT COMPLETED|Overall Study||8
262253|NCT01089127|633642|P6|COMPLETED|Overall Study||88
262255|NCT01089127|633644|P4|COMPLETED|Overall Study||91
262256|NCT01089127|633645|P3|COMPLETED|Overall Study||92
262257|NCT01089127|633646|P2|COMPLETED|Overall Study||86
262258|NCT01089127|633647|P1|COMPLETED|Overall Study||84
262259|NCT01089127|633642|P6|Exposed to Study Drug|Overall Study||91
262260|NCT01089127|633643|P5|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|91
262261|NCT01089127|633644|P4|Exposed to Study Drug|Overall Study||92
262262|NCT01089127|633645|P3|Exposed to Study Drug|Overall Study||94
262263|NCT01089127|633646|P2|Exposed to Study Drug|Overall Study|1 randomized patient in this group was not exposed to study treatment.|90
262264|NCT01089127|633647|P1|Exposed to Study Drug|Overall Study|3 randomized patients in this group were not exposed to study treatment.|89
262265|NCT01089127|633642|P6|STARTED|Overall Study||91
262266|NCT01089127|633643|P5|STARTED|Overall Study||92
262267|NCT01089127|633644|P4|STARTED|Overall Study||92
262268|NCT01089127|633645|P3|STARTED|Overall Study||94
262269|NCT01089127|633646|P2|STARTED|Overall Study||91
262270|NCT01089127|633647|P1|STARTED|Overall Study||92
262271|NCT01089231|633671|P4|NOT COMPLETED|Overall Study||1
262272|NCT01089231|633672|P3|NOT COMPLETED|Overall Study||2
262273|NCT01089231|633673|P2|NOT COMPLETED|Overall Study||2
262274|NCT01089231|633674|P1|NOT COMPLETED|Overall Study||4
262275|NCT01089231|633671|P4|COMPLETED|Overall Study|1 subject excluded (low RNA yield)|9
262276|NCT01089231|633672|P3|COMPLETED|Overall Study|2 subject excluded (1 use of not allowed drugs; 1 low RNA yield)|8
262277|NCT01089231|633673|P2|COMPLETED|Overall Study|2 subjects excluded (1 highly elevated TG and TC data; 1 elevated inflammation (CRP level))|8
262278|NCT01089231|633674|P1|COMPLETED|Overall Study|4 subjects excluded (2 alcohol use / TG level changes; 1 use of not allowed drugs; 1 low RNA yield)|6
262279|NCT01089231|633671|P4|STARTED|Overall Study||10
262280|NCT01089231|633672|P3|STARTED|Overall Study||10
262281|NCT01089231|633673|P2|STARTED|Overall Study||10
262282|NCT01089231|633674|P1|STARTED|Overall Study||10
262283|NCT01089361|633694|P2|NOT COMPLETED|Overall Study||0
262284|NCT01089361|633695|P1|NOT COMPLETED|Overall Study||1
262285|NCT01089361|633694|P2|COMPLETED|Overall Study||10
262286|NCT01089361|633695|P1|COMPLETED|Overall Study||8
262287|NCT01089361|633694|P2|STARTED|Overall Study||10
262288|NCT01089361|633695|P1|STARTED|Overall Study||9
262289|NCT01089413|633716|P1|NOT COMPLETED|Overall Study||201
262290|NCT01089413|633716|P1|COMPLETED|Overall Study||0
262291|NCT01089413|633716|P1|Received Bevacizumab in First Line|Overall Study||199
262292|NCT01089413|633716|P1|STARTED|Overall Study||201
262293|NCT01089504|633735|P2|NOT COMPLETED|Overall Study||1
262294|NCT01089504|633736|P1|NOT COMPLETED|Overall Study||3
262295|NCT01089504|633735|P2|COMPLETED|Overall Study||4
262296|NCT01089504|633736|P1|COMPLETED|Overall Study||5
262297|NCT01089504|633735|P2|STARTED|Overall Study||5
262298|NCT01089504|633736|P1|STARTED|Overall Study||8
262299|NCT01089517|633749|P3|NOT COMPLETED|Overall Study||5
262300|NCT01089517|633750|P2|NOT COMPLETED|Overall Study||5
262301|NCT01089517|633751|P1|NOT COMPLETED|Overall Study||4
262302|NCT01089517|633749|P3|COMPLETED|Overall Study||147
262303|NCT01089517|633750|P2|COMPLETED|Overall Study||144
262304|NCT01089517|633751|P1|COMPLETED|Overall Study||144
262305|NCT01089517|633749|P3|STARTED|Overall Study||152
262306|NCT01089517|633750|P2|STARTED|Overall Study||149
262307|NCT01089517|633751|P1|STARTED|Overall Study||148
262308|NCT01089543|633769|P4|NOT COMPLETED|Overall Study||2
262309|NCT01089543|633770|P3|NOT COMPLETED|Overall Study||3
262310|NCT01089543|633771|P2|NOT COMPLETED|Overall Study||4
262311|NCT01089543|633772|P1|NOT COMPLETED|Overall Study||3
262312|NCT01089543|633769|P4|COMPLETED|Overall Study||83
262313|NCT01089543|633770|P3|COMPLETED|Overall Study||81
262314|NCT01089543|633771|P2|COMPLETED|Overall Study||81
262315|NCT01089543|633772|P1|COMPLETED|Overall Study||81
262316|NCT01089543|633769|P4|STARTED|Overall Study||85
262317|NCT01089543|633770|P3|STARTED|Overall Study||84
262318|NCT01089543|633771|P2|STARTED|Overall Study||85
262319|NCT01089543|633772|P1|STARTED|Overall Study||84
262320|NCT01089556|633788|P6|NOT COMPLETED|Study Period III (Weeks 9-16)||7
262321|NCT01089556|633789|P5|NOT COMPLETED|Study Period III (Weeks 9-16)||12
262322|NCT01089556|633790|P4|NOT COMPLETED|Study Period III (Weeks 9-16)||9
262323|NCT01089556|633791|P3|NOT COMPLETED|Study Period III (Weeks 9-16)||14
262324|NCT01089556|633792|P2|NOT COMPLETED|Study Period III (Weeks 9-16)||0
262325|NCT01089556|633793|P1|NOT COMPLETED|Study Period III (Weeks 9-16)||0
262326|NCT01089556|633788|P6|COMPLETED|Study Period III (Weeks 9-16)||92
262327|NCT01089556|633789|P5|COMPLETED|Study Period III (Weeks 9-16)||83
262328|NCT01089556|633790|P4|COMPLETED|Study Period III (Weeks 9-16)||66
262329|NCT01089556|633791|P3|COMPLETED|Study Period III (Weeks 9-16)||60
262330|NCT01089556|633792|P2|COMPLETED|Study Period III (Weeks 9-16)||0
262331|NCT01089556|633793|P1|COMPLETED|Study Period III (Weeks 9-16)||0
262332|NCT01089556|633788|P6|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|97
262333|NCT01089556|633789|P5|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|94
262334|NCT01089556|633790|P4|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|75
262335|NCT01089556|633791|P3|Efficacy and Safety Population|Study Period III (Weeks 9-16)|Received ≥1 dose study drug, had Week 8 and at least 1 assessment during Weeks 9-16 (SPIII)|73
262336|NCT01089556|633792|P2|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
262337|NCT01089556|633793|P1|Efficacy and Safety Population|Study Period III (Weeks 9-16)||0
262338|NCT01089556|633788|P6|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 1 responders entered SPIII|99
262339|NCT01089556|633789|P5|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|95
262340|NCT01089556|633790|P4|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 6 non-responders did not enter SPIII, while 3 responders entered SPIII|75
262341|NCT01089556|633791|P3|STARTED|Study Period III (Weeks 9-16)|Of those who completed SPII, 10 non-responders did not enter SPIII, while 4 responders entered SPIII|74
262342|NCT01089556|633792|P2|STARTED|Study Period III (Weeks 9-16)||0
262343|NCT01089556|633793|P1|STARTED|Study Period III (Weeks 9-16)||0
262344|NCT01089556|633788|P6|NOT COMPLETED|Study Period II (Weeks 1-8)||0
262345|NCT01089556|633789|P5|NOT COMPLETED|Study Period II (Weeks 1-8)||0
262346|NCT01089556|633790|P4|NOT COMPLETED|Study Period II (Weeks 1-8)||0
262347|NCT01089556|633791|P3|NOT COMPLETED|Study Period II (Weeks 1-8)||0
262348|NCT01089556|633792|P2|NOT COMPLETED|Study Period II (Weeks 1-8)||74
262349|NCT01089556|633793|P1|NOT COMPLETED|Study Period II (Weeks 1-8)||71
262350|NCT01089556|633788|P6|COMPLETED|Study Period II (Weeks 1-8)||0
262351|NCT01089556|633789|P5|COMPLETED|Study Period II (Weeks 1-8)||0
262352|NCT01089556|633790|P4|COMPLETED|Study Period II (Weeks 1-8)||0
262353|NCT01089556|633791|P3|COMPLETED|Study Period II (Weeks 1-8)||0
262354|NCT01089556|633792|P2|COMPLETED|Study Period II (Weeks 1-8)||333
262355|NCT01089556|633793|P1|COMPLETED|Study Period II (Weeks 1-8)||333
262356|NCT01089556|633788|P6|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
262357|NCT01089556|633789|P5|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
262358|NCT01089556|633790|P4|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
262359|NCT01089556|633791|P3|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||0
262360|NCT01089556|633792|P2|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||205
262361|NCT01089556|633793|P1|Non-responders Who Completed SPII|Study Period II (Weeks 1-8)||158
262362|NCT01089556|633788|P6|Safety Population|Study Period II (Weeks 1-8)||0
262363|NCT01089556|633789|P5|Safety Population|Study Period II (Weeks 1-8)||0
262364|NCT01089556|633790|P4|Safety Population|Study Period II (Weeks 1-8)||0
262365|NCT01089556|633791|P3|Safety Population|Study Period II (Weeks 1-8)||0
262366|NCT01089556|633792|P2|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|403
262367|NCT01089556|633793|P1|Safety Population|Study Period II (Weeks 1-8)|Received at least 1 dose of study drug.|401
262368|NCT01089556|633788|P6|STARTED|Study Period II (Weeks 1-8)||0
262369|NCT01089556|633789|P5|STARTED|Study Period II (Weeks 1-8)||0
262370|NCT01089556|633790|P4|STARTED|Study Period II (Weeks 1-8)||0
262371|NCT01089556|633791|P3|STARTED|Study Period II (Weeks 1-8)||0
262372|NCT01089556|633792|P2|STARTED|Study Period II (Weeks 1-8)||407
262373|NCT01089556|633793|P1|STARTED|Study Period II (Weeks 1-8)||404
262374|NCT01089569|633866|P3|NOT COMPLETED|Overall Study||4
262375|NCT01089569|633867|P2|NOT COMPLETED|Overall Study||3
262376|NCT01089569|633868|P1|NOT COMPLETED|Overall Study||4
262377|NCT01089569|633866|P3|COMPLETED|Overall Study||16
262378|NCT01089569|633867|P2|COMPLETED|Overall Study||17
262379|NCT01089569|633868|P1|COMPLETED|Overall Study||16
262380|NCT01089569|633866|P3|STARTED|Overall Study||20
262381|NCT01089569|633867|P2|STARTED|Overall Study||20
262382|NCT01089569|633868|P1|STARTED|Overall Study||20
262383|NCT01089582|633894|P1|NOT COMPLETED|Overall Study||30
262384|NCT01089582|633894|P1|COMPLETED|Overall Study|1 subject died during the study; 1 subject died following permanent discontinuation from the study.|573
262385|NCT01089582|633894|P1|STARTED|Overall Study||603
262386|NCT01089595|633906|P2|NOT COMPLETED|Overall Study||0
262387|NCT01089595|633907|P1|NOT COMPLETED|Overall Study||0
262388|NCT01089595|633906|P2|COMPLETED|Overall Study||3
262389|NCT01089595|633907|P1|COMPLETED|Overall Study||2
262390|NCT01089595|633906|P2|STARTED|Overall Study||3
262391|NCT01089595|633907|P1|STARTED|Overall Study||2
262392|NCT01089608|633917|P2|NOT COMPLETED|Overall Study||6
262393|NCT01089608|633918|P1|NOT COMPLETED|Overall Study||0
262394|NCT01089608|633917|P2|COMPLETED|Overall Study||44
262395|NCT01089608|633918|P1|COMPLETED|Overall Study||43
262396|NCT01089608|633917|P2|STARTED|Overall Study||50
262397|NCT01089608|633918|P1|STARTED|Overall Study||43
262398|NCT01089751|633926|P2|NOT COMPLETED|Overall Study||27
262399|NCT01089751|633927|P1|NOT COMPLETED|Overall Study||34
262400|NCT01089751|633926|P2|COMPLETED|Overall Study||132
262401|NCT01089751|633927|P1|COMPLETED|Overall Study||129
262402|NCT01089751|633926|P2|STARTED|Overall Study||159
262403|NCT01089751|633927|P1|STARTED|Overall Study||163
262404|NCT01090011|633947|P1|NOT COMPLETED|Overall Study||171
262405|NCT01090011|633947|P1|COMPLETED|Overall Study||0
262406|NCT01090011|633947|P1|STARTED|Overall Study||171
262407|NCT01090050|634017|P2|NOT COMPLETED|Overall Study||7
262408|NCT01090050|634018|P1|NOT COMPLETED|Overall Study||1
262409|NCT01090050|634017|P2|COMPLETED|Overall Study||5
262410|NCT01090050|634018|P1|COMPLETED|Overall Study||15
262411|NCT01090050|634017|P2|STARTED|Overall Study||12
262412|NCT01090050|634018|P1|STARTED|Overall Study||16
262413|NCT01090063|634038|P1|NOT COMPLETED|Treatment||4
262414|NCT01090063|634038|P1|COMPLETED|Treatment||20
262415|NCT01090063|634038|P1|STARTED|Treatment||24
262416|NCT01090063|634038|P1|NOT COMPLETED|Screen||4
262417|NCT01090063|634038|P1|COMPLETED|Screen||24
262418|NCT01090063|634038|P1|STARTED|Screen||28
262419|NCT01090076|634054|P2|NOT COMPLETED|Overall Study||2
262420|NCT01090076|634055|P1|NOT COMPLETED|Overall Study||1
262421|NCT01090076|634054|P2|COMPLETED|Overall Study||12
262422|NCT01090076|634055|P1|COMPLETED|Overall Study||11
262423|NCT01090076|634054|P2|STARTED|Overall Study||14
262424|NCT01090076|634055|P1|STARTED|Overall Study||12
262425|NCT01090102|634067|P2|NOT COMPLETED|Second 12 Weeks||1
262426|NCT01090102|634068|P1|NOT COMPLETED|Second 12 Weeks||0
262427|NCT01090102|634067|P2|COMPLETED|Second 12 Weeks||15
262428|NCT01090102|634068|P1|COMPLETED|Second 12 Weeks||11
262429|NCT01090102|634067|P2|STARTED|Second 12 Weeks||16
262430|NCT01090102|634068|P1|STARTED|Second 12 Weeks||11
262431|NCT01090102|634067|P2|NOT COMPLETED|First 12 Weeks||2
262432|NCT01090102|634068|P1|NOT COMPLETED|First 12 Weeks||4
262433|NCT01090102|634067|P2|COMPLETED|First 12 Weeks||16
262434|NCT01090102|634068|P1|COMPLETED|First 12 Weeks||11
262435|NCT01090102|634067|P2|STARTED|First 12 Weeks||18
262436|NCT01090102|634068|P1|STARTED|First 12 Weeks||15
262437|NCT01090180|634078|P2|NOT COMPLETED|Overall Study||8
262438|NCT01090180|634079|P1|NOT COMPLETED|Overall Study||11
262439|NCT01090180|634078|P2|COMPLETED|Overall Study||21
262440|NCT01090180|634079|P1|COMPLETED|Overall Study||22
262441|NCT01090180|634078|P2|STARTED|Overall Study||29
262442|NCT01090180|634079|P1|STARTED|Overall Study||33
262443|NCT01090310|634091|P4|NOT COMPLETED|Extension Study||20
262444|NCT01090310|634092|P3|NOT COMPLETED|Extension Study||15
262445|NCT01090310|634093|P2|NOT COMPLETED|Extension Study||16
262446|NCT01090310|634094|P1|NOT COMPLETED|Extension Study||14
262447|NCT01090310|634091|P4|COMPLETED|Extension Study||1
262448|NCT01090310|634092|P3|COMPLETED|Extension Study||1
262449|NCT01090310|634093|P2|COMPLETED|Extension Study||0
262450|NCT01090310|634094|P1|COMPLETED|Extension Study||3
262451|NCT01090310|634091|P4|STARTED|Extension Study||21
262452|NCT01090310|634092|P3|STARTED|Extension Study||16
262453|NCT01090310|634093|P2|STARTED|Extension Study||16
262454|NCT01090310|634094|P1|STARTED|Extension Study||17
262455|NCT01090310|634091|P4|NOT COMPLETED|Core Study||7
262456|NCT01090310|634092|P3|NOT COMPLETED|Core Study||7
262457|NCT01090310|634093|P2|NOT COMPLETED|Core Study||11
262458|NCT01090310|634094|P1|NOT COMPLETED|Core Study||8
262459|NCT01090310|634091|P4|COMPLETED|Core Study||27
262460|NCT01090310|634092|P3|COMPLETED|Core Study||24
262461|NCT01090310|634093|P2|COMPLETED|Core Study||20
262462|NCT01090310|634094|P1|COMPLETED|Core Study||21
262463|NCT01090310|634091|P4|STARTED|Core Study||34
262464|NCT01090310|634092|P3|STARTED|Core Study||31
262465|NCT01090310|634093|P2|STARTED|Core Study||31
262466|NCT01090310|634094|P1|STARTED|Core Study||29
262467|NCT01090323|634122|P2|NOT COMPLETED|Overall Study||34
262468|NCT01090323|634123|P1|NOT COMPLETED|Overall Study||89
262469|NCT01090323|634122|P2|COMPLETED|Overall Study||19
262470|NCT01090323|634123|P1|COMPLETED|Overall Study||43
262471|NCT01090323|634122|P2|STARTED|Overall Study||53
262472|NCT01090323|634123|P1|STARTED|Overall Study||132
262473|NCT01090427|634134|P7|NOT COMPLETED|After Controlled Period||2
262474|NCT01090427|634135|P6|NOT COMPLETED|After Controlled Period||5
262475|NCT01090427|634136|P5|NOT COMPLETED|After Controlled Period||0
262476|NCT01090427|634137|P4|NOT COMPLETED|After Controlled Period||2
262477|NCT01090427|634138|P3|NOT COMPLETED|After Controlled Period||0
262478|NCT01090427|634139|P2|NOT COMPLETED|After Controlled Period||0
262479|NCT01090427|634140|P1|NOT COMPLETED|After Controlled Period||0
262480|NCT01090427|634134|P7|COMPLETED|After Controlled Period||34
262481|NCT01090427|634135|P6|COMPLETED|After Controlled Period||32
262482|NCT01090427|634136|P5|COMPLETED|After Controlled Period||18
262483|NCT01090427|634137|P4|COMPLETED|After Controlled Period||17
262484|NCT01090427|634138|P3|COMPLETED|After Controlled Period||0
262485|NCT01090427|634139|P2|COMPLETED|After Controlled Period||0
262486|NCT01090427|634140|P1|COMPLETED|After Controlled Period||0
262487|NCT01090427|634134|P7|STARTED|After Controlled Period||36
262488|NCT01090427|634135|P6|STARTED|After Controlled Period||37
262489|NCT01090427|634136|P5|STARTED|After Controlled Period||18
262490|NCT01090427|634137|P4|STARTED|After Controlled Period||19
262491|NCT01090427|634138|P3|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
262492|NCT01090427|634139|P2|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
262493|NCT01090427|634140|P1|STARTED|After Controlled Period|"0 in column indicates this reporting group is not relevant to after Control Period."|0
262494|NCT01090427|634134|P7|NOT COMPLETED|Controlled Period||0
262495|NCT01090427|634135|P6|NOT COMPLETED|Controlled Period||0
262496|NCT01090427|634136|P5|NOT COMPLETED|Controlled Period||0
262497|NCT01090427|634137|P4|NOT COMPLETED|Controlled Period||0
262498|NCT01090427|634138|P3|NOT COMPLETED|Controlled Period||0
262499|NCT01090427|634139|P2|NOT COMPLETED|Controlled Period||0
262500|NCT01090427|634140|P1|NOT COMPLETED|Controlled Period||0
262501|NCT01090427|634134|P7|COMPLETED|Controlled Period||0
262502|NCT01090427|634135|P6|COMPLETED|Controlled Period||0
262503|NCT01090427|634136|P5|COMPLETED|Controlled Period||0
262504|NCT01090427|634137|P4|COMPLETED|Controlled Period||0
262505|NCT01090427|634138|P3|COMPLETED|Controlled Period||36
262506|NCT01090427|634139|P2|COMPLETED|Controlled Period||37
262507|NCT01090427|634140|P1|COMPLETED|Controlled Period||37
262508|NCT01090427|634134|P7|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
262509|NCT01090427|634135|P6|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
262510|NCT01090427|634136|P5|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
262511|NCT01090427|634137|P4|STARTED|Controlled Period|"0 in column indicates this reporting group is not relevant to Control Period."|0
262512|NCT01090427|634138|P3|STARTED|Controlled Period||36
262513|NCT01090427|634139|P2|STARTED|Controlled Period||37
262514|NCT01090427|634140|P1|STARTED|Controlled Period||37
262515|NCT01090453|634175|P2|NOT COMPLETED|Overall Study||14
262516|NCT01090453|634176|P1|NOT COMPLETED|Overall Study||13
262517|NCT01090453|634175|P2|COMPLETED|Overall Study||228
262518|NCT01090453|634176|P1|COMPLETED|Overall Study||225
262519|NCT01090453|634175|P2|STARTED|Overall Study||242
262520|NCT01090453|634176|P1|STARTED|Overall Study||238
262521|NCT01090479|634222|P2|NOT COMPLETED|Overall Study||0
262522|NCT01090479|634223|P1|NOT COMPLETED|Overall Study||0
262523|NCT01090479|634222|P2|COMPLETED|Overall Study||50
262524|NCT01090479|634223|P1|COMPLETED|Overall Study||50
262525|NCT01090479|634222|P2|STARTED|Overall Study||50
262526|NCT01090479|634223|P1|STARTED|Overall Study||50
262527|NCT01090739|634229|P1|NOT COMPLETED|36 Month Follow-up||23
262528|NCT01090739|634229|P1|COMPLETED|36 Month Follow-up||115
262529|NCT01090739|634229|P1|STARTED|36 Month Follow-up||138
262530|NCT01090739|634229|P1|NOT COMPLETED|24 Month Follow-up||9
262531|NCT01090739|634229|P1|COMPLETED|24 Month Follow-up||138
262532|NCT01090739|634229|P1|STARTED|24 Month Follow-up||147
262533|NCT01090739|634229|P1|NOT COMPLETED|12 Month Follow-up||5
262534|NCT01090739|634229|P1|COMPLETED|12 Month Follow-up||147
262535|NCT01090739|634229|P1|STARTED|12 Month Follow-up||152
262536|NCT01090739|634229|P1|NOT COMPLETED|Enrollment||55
262537|NCT01090739|634229|P1|COMPLETED|Enrollment||152
262538|NCT01090739|634229|P1|STARTED|Enrollment|Subject enrollment = signed informed consent form|207
262539|NCT01090752|634248|P2|NOT COMPLETED|Overall Study||0
262540|NCT01090752|634249|P1|NOT COMPLETED|Overall Study||0
262541|NCT01090752|634248|P2|COMPLETED|Overall Study||8
262542|NCT01090752|634249|P1|COMPLETED|Overall Study||8
262543|NCT01090752|634248|P2|STARTED|Overall Study||8
262544|NCT01090752|634249|P1|STARTED|Overall Study||8
262545|NCT01090765|634265|P6|NOT COMPLETED|Overall Study||1
262546|NCT01090765|634266|P5|NOT COMPLETED|Overall Study||2
262547|NCT01090765|634267|P4|NOT COMPLETED|Overall Study||1
262548|NCT01090765|634268|P3|NOT COMPLETED|Overall Study||0
262549|NCT01090765|634269|P2|NOT COMPLETED|Overall Study||0
262550|NCT01090765|634270|P1|NOT COMPLETED|Overall Study||0
262551|NCT01090765|634265|P6|COMPLETED|Overall Study||3
262552|NCT01090765|634266|P5|COMPLETED|Overall Study||4
262553|NCT01090765|634267|P4|COMPLETED|Overall Study||1
262554|NCT01090765|634268|P3|COMPLETED|Overall Study||3
262555|NCT01090765|634269|P2|COMPLETED|Overall Study||3
262556|NCT01090765|634270|P1|COMPLETED|Overall Study||3
262557|NCT01090765|634265|P6|STARTED|Overall Study||4
262558|NCT01090765|634266|P5|STARTED|Overall Study||6
262559|NCT01090765|634267|P4|STARTED|Overall Study||2
262560|NCT01090765|634268|P3|STARTED|Overall Study||3
262561|NCT01090765|634269|P2|STARTED|Overall Study||3
262562|NCT01090765|634270|P1|STARTED|Overall Study||3
262563|NCT01090973|634285|P1|NOT COMPLETED|Overall Study||1
262564|NCT01090973|634285|P1|COMPLETED|Overall Study||0
262565|NCT01090973|634285|P1|STARTED|Overall Study||1
262566|NCT01079130|634301|P6|NOT COMPLETED|Overall Study||5
262567|NCT01079130|634302|P5|NOT COMPLETED|Overall Study||8
262568|NCT01079130|634303|P4|NOT COMPLETED|Overall Study||5
262569|NCT01079130|634304|P3|NOT COMPLETED|Overall Study||1
262570|NCT01079130|634305|P2|NOT COMPLETED|Overall Study||7
262571|NCT01079130|634306|P1|NOT COMPLETED|Overall Study||2
262572|NCT01079130|634301|P6|COMPLETED|Overall Study||80
262573|NCT01079130|634302|P5|COMPLETED|Overall Study||78
262574|NCT01079130|634303|P4|COMPLETED|Overall Study||81
262575|NCT01079130|634304|P3|COMPLETED|Overall Study||83
262576|NCT01079130|634305|P2|COMPLETED|Overall Study||78
262577|NCT01079130|634306|P1|COMPLETED|Overall Study||83
262578|NCT01079130|634301|P6|Full Analysis Set (FAS)|Overall Study||84
262579|NCT01079130|634302|P5|Full Analysis Set (FAS)|Overall Study||84
262580|NCT01079130|634303|P4|Full Analysis Set (FAS)|Overall Study||85
262581|NCT01079130|634304|P3|Full Analysis Set (FAS)|Overall Study||83
262582|NCT01079130|634305|P2|Full Analysis Set (FAS)|Overall Study|2 patients (1 in 37.5 µg;1 in 75 µg group) randomized more than once and were excluded from the FAS.|80
262583|NCT01079130|634306|P1|Full Analysis Set (FAS)|Overall Study||84
262584|NCT01079130|634301|P6|Safety Set: Received Study Drug|Overall Study||84
262585|NCT01079130|634302|P5|Safety Set: Received Study Drug|Overall Study||84
262586|NCT01079130|634303|P4|Safety Set: Received Study Drug|Overall Study||85
262587|NCT01079130|634304|P3|Safety Set: Received Study Drug|Overall Study||84
262588|NCT01079130|634305|P2|Safety Set: Received Study Drug|Overall Study||81
262589|NCT01079130|634306|P1|Safety Set: Received Study Drug|Overall Study||84
262590|NCT01079130|634301|P6|STARTED|Overall Study||85
262591|NCT01079130|634302|P5|STARTED|Overall Study||86
262592|NCT01079130|634303|P4|STARTED|Overall Study||86
262593|NCT01079130|634304|P3|STARTED|Overall Study||84
262594|NCT01079130|634305|P2|STARTED|Overall Study||85
262595|NCT01079130|634306|P1|STARTED|Overall Study||85
262596|NCT01079143|634330|P4|NOT COMPLETED|Overall Study||5
262597|NCT01079143|634331|P3|NOT COMPLETED|Overall Study||5
262598|NCT01079143|634332|P2|NOT COMPLETED|Overall Study||17
262599|NCT01079143|634333|P1|NOT COMPLETED|Overall Study||9
262600|NCT01079143|634330|P4|COMPLETED|Overall Study||54
262601|NCT01079143|634331|P3|COMPLETED|Overall Study||34
262602|NCT01079143|634332|P2|COMPLETED|Overall Study||43
262603|NCT01079143|634333|P1|COMPLETED|Overall Study||27
262604|NCT01079143|634330|P4|M3 and M12 Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
262605|NCT01079143|634331|P3|M3 and M12 Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
262606|NCT01079143|634332|P2|M3 and M12 Biopsies|Overall Study||43
262607|NCT01079143|634333|P1|M3 and M12 Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
262608|NCT01079143|634330|P4|Month 12 (M12) Biopsies|Overall Study|Only 53 out of 59 participants in this group had graft biopsy that was eligible for analysis.|53
262609|NCT01079143|634331|P3|Month 12 (M12) Biopsies|Overall Study|Only 32 out of 39 participants in this group had graft biopsy that was eligible for analysis.|32
262610|NCT01079143|634332|P2|Month 12 (M12) Biopsies|Overall Study||43
262611|NCT01079143|634333|P1|Month 12 (M12) Biopsies|Overall Study|Only 26 out of 36 participants in this group had graft biopsy that was eligible for analysis.|26
262612|NCT01079143|634330|P4|Month 3 (M3) Biopsies|Overall Study||59
262613|NCT01079143|634331|P3|Month 3 (M3) Biopsies|Overall Study||39
262614|NCT01079143|634332|P2|Month 3 (M3) Biopsies|Overall Study|1 patient was excluded due to an IF/TA Grade of III at the M3 Biopsy|59
262615|NCT01079143|634333|P1|Month 3 (M3) Biopsies|Overall Study||36
262616|NCT01079143|634330|P4|Exposed|Overall Study||59
262617|NCT01079143|634331|P3|Exposed|Overall Study||39
262618|NCT01079143|634332|P2|Exposed|Overall Study||60
262619|NCT01079143|634333|P1|Exposed|Overall Study||36
262620|NCT01079143|634330|P4|STARTED|Overall Study||59
262621|NCT01079143|634331|P3|STARTED|Overall Study||39
262622|NCT01079143|634332|P2|STARTED|Overall Study||60
262623|NCT01079143|634333|P1|STARTED|Overall Study||36
262624|NCT01079182|634401|P1|NOT COMPLETED|Overall Study||2719
262625|NCT01079182|634401|P1|COMPLETED|Overall Study||1962
262626|NCT01079182|634401|P1|STARTED|Overall Study||4681
262627|NCT01079195|634428|P1|NOT COMPLETED|Overall Study||1431
262628|NCT01079195|634428|P1|COMPLETED|Overall Study||14442
262629|NCT01079195|634428|P1|STARTED|Overall Study||15873
262630|NCT01079234|634437|P4|NOT COMPLETED|Extension: Week 27 to 52||16
262631|NCT01079234|634438|P3|NOT COMPLETED|Extension: Week 27 to 52||11
262632|NCT01079234|634439|P2|NOT COMPLETED|Extension: Week 27 to 52||0
262633|NCT01079234|634440|P1|NOT COMPLETED|Extension: Week 27 to 52||0
262634|NCT01079234|634437|P4|COMPLETED|Extension: Week 27 to 52||223
262635|NCT01079234|634438|P3|COMPLETED|Extension: Week 27 to 52||122
262636|NCT01079234|634439|P2|COMPLETED|Extension: Week 27 to 52||0
262637|NCT01079234|634440|P1|COMPLETED|Extension: Week 27 to 52||0
262638|NCT01079234|634437|P4|STARTED|Extension: Week 27 to 52|Thirty eight subjects did not continue into extension trial.|239
262639|NCT01079234|634438|P3|STARTED|Extension: Week 27 to 52|Nineteen subjects from main trial did not continue into extension trial|133
262640|NCT01079234|634439|P2|STARTED|Extension: Week 27 to 52||0
262641|NCT01079234|634440|P1|STARTED|Extension: Week 27 to 52||0
262642|NCT01079234|634437|P4|NOT COMPLETED|Main: Week 0 to 26||0
262643|NCT01079234|634438|P3|NOT COMPLETED|Main: Week 0 to 26||12
262644|NCT01079234|634439|P2|NOT COMPLETED|Main: Week 0 to 26||26
262645|NCT01079234|634440|P1|NOT COMPLETED|Main: Week 0 to 26||26
262646|NCT01079234|634437|P4|COMPLETED|Main: Week 0 to 26||0
262647|NCT01079234|634438|P3|COMPLETED|Main: Week 0 to 26||152
262648|NCT01079234|634439|P2|COMPLETED|Main: Week 0 to 26||139
262649|NCT01079234|634440|P1|COMPLETED|Main: Week 0 to 26||138
262650|NCT01079234|634437|P4|Exposed|Main: Week 0 to 26||0
262651|NCT01079234|634438|P3|Exposed|Main: Week 0 to 26|Three subjects withdrew prior to exposure to trial drug.|161
262652|NCT01079234|634439|P2|Exposed|Main: Week 0 to 26||165
262653|NCT01079234|634440|P1|Exposed|Main: Week 0 to 26||164
262654|NCT01079234|634437|P4|STARTED|Main: Week 0 to 26||0
262655|NCT01079234|634438|P3|STARTED|Main: Week 0 to 26||164
262656|NCT01079234|634439|P2|STARTED|Main: Week 0 to 26||165
262657|NCT01079234|634440|P1|STARTED|Main: Week 0 to 26||164
262658|NCT01079299|634460|P2|NOT COMPLETED|Overall Study||0
262659|NCT01079299|634461|P1|NOT COMPLETED|Overall Study||0
262660|NCT01079299|634460|P2|COMPLETED|Overall Study||25
262661|NCT01079299|634461|P1|COMPLETED|Overall Study||27
262662|NCT01079299|634460|P2|STARTED|Overall Study||25
262663|NCT01079299|634461|P1|STARTED|Overall Study||27
262664|NCT01079390|634470|P3|NOT COMPLETED|Overall Study||4
262665|NCT01079390|634471|P2|NOT COMPLETED|Overall Study||5
262666|NCT01079390|634472|P1|NOT COMPLETED|Overall Study||5
262667|NCT01079390|634470|P3|COMPLETED|Overall Study||10
262668|NCT01079390|634471|P2|COMPLETED|Overall Study||10
262669|NCT01079390|634472|P1|COMPLETED|Overall Study||10
262670|NCT01079390|634470|P3|STARTED|Overall Study||14
262671|NCT01079390|634471|P2|STARTED|Overall Study||15
262672|NCT01079390|634472|P1|STARTED|Overall Study||15
262673|NCT01079598|634482|P1|NOT COMPLETED|Overall Study||0
262674|NCT01079598|634482|P1|COMPLETED|Overall Study||8
262675|NCT01079598|634482|P1|STARTED|Overall Study||8
262676|NCT01079806|634491|P2|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||2
262856|NCT01080794|634882|P4|COMPLETED|Overall Study||13
262677|NCT01079806|634492|P1|NOT COMPLETED|Long-term Follow-up: Day 1-End of Study||0
262678|NCT01079806|634491|P2|COMPLETED|Long-term Follow-up: Day 1-End of Study||4
262679|NCT01079806|634492|P1|COMPLETED|Long-term Follow-up: Day 1-End of Study||14
262680|NCT01079806|634491|P2|STARTED|Long-term Follow-up: Day 1-End of Study||6
262681|NCT01079806|634492|P1|STARTED|Long-term Follow-up: Day 1-End of Study||14
262682|NCT01079806|634491|P2|NOT COMPLETED|Day 1 to Week 96||4
262683|NCT01079806|634492|P1|NOT COMPLETED|Day 1 to Week 96||4
262684|NCT01079806|634491|P2|COMPLETED|Day 1 to Week 96|Includes 53 continuing treatment|56
262685|NCT01079806|634492|P1|COMPLETED|Day 1 to Week 96|Includes 91 continuing treatment|116
262686|NCT01079806|634491|P2|Primary Endpoint Cohort|Day 1 to Week 96||41
262687|NCT01079806|634492|P1|Primary Endpoint Cohort|Day 1 to Week 96||82
262688|NCT01079806|634491|P2|Received Treatment|Day 1 to Week 96||60
262689|NCT01079806|634492|P1|Received Treatment|Day 1 to Week 96||120
262690|NCT01079806|634491|P2|STARTED|Day 1 to Week 96|Randomized|60
262691|NCT01079806|634492|P1|STARTED|Day 1 to Week 96|Randomized|120
262692|NCT01079832|634512|P1|NOT COMPLETED|Overall Study||1
262693|NCT01079832|634512|P1|COMPLETED|Overall Study||49
262694|NCT01079832|634512|P1|STARTED|Overall Study||50
262695|NCT01079936|634524|P5|NOT COMPLETED|Phase II||1
262696|NCT01079936|634525|P4|NOT COMPLETED|Phase II||0
262697|NCT01079936|634526|P3|NOT COMPLETED|Phase II||1
262698|NCT01079936|634527|P2|NOT COMPLETED|Phase II||0
262699|NCT01079936|634528|P1|NOT COMPLETED|Phase II||0
262700|NCT01079936|634524|P5|COMPLETED|Phase II||25
262701|NCT01079936|634525|P4|COMPLETED|Phase II||24
262702|NCT01079936|634526|P3|COMPLETED|Phase II||5
262703|NCT01079936|634527|P2|COMPLETED|Phase II||3
262704|NCT01079936|634528|P1|COMPLETED|Phase II||0
262705|NCT01079936|634524|P5|STARTED|Phase II||26
262706|NCT01079936|634525|P4|STARTED|Phase II||24
262707|NCT01079936|634526|P3|STARTED|Phase II||6
262708|NCT01079936|634527|P2|STARTED|Phase II||3
262709|NCT01079936|634528|P1|STARTED|Phase II||0
262710|NCT01079936|634524|P5|NOT COMPLETED|Phase I: MTD||0
262711|NCT01079936|634525|P4|NOT COMPLETED|Phase I: MTD||0
262712|NCT01079936|634526|P3|NOT COMPLETED|Phase I: MTD||0
262713|NCT01079936|634527|P2|NOT COMPLETED|Phase I: MTD||0
262714|NCT01079936|634528|P1|NOT COMPLETED|Phase I: MTD||4
262715|NCT01079936|634524|P5|COMPLETED|Phase I: MTD||0
262716|NCT01079936|634525|P4|COMPLETED|Phase I: MTD||0
262717|NCT01079936|634526|P3|COMPLETED|Phase I: MTD||0
262718|NCT01079936|634527|P2|COMPLETED|Phase I: MTD||0
262719|NCT01079936|634528|P1|COMPLETED|Phase I: MTD|The 12 Phase I participants were randomized across 4 dose arms for Phase II.|12
262720|NCT01079936|634524|P5|STARTED|Phase I: MTD||0
262721|NCT01079936|634525|P4|STARTED|Phase I: MTD||0
262722|NCT01079936|634526|P3|STARTED|Phase I: MTD||0
262723|NCT01079936|634527|P2|STARTED|Phase I: MTD||0
262724|NCT01079936|634528|P1|STARTED|Phase I: MTD||16
262725|NCT01079949|634549|P2|NOT COMPLETED|Overall Study||13
262726|NCT01079949|634550|P1|NOT COMPLETED|Overall Study||15
262727|NCT01079949|634549|P2|COMPLETED|Overall Study||34
262728|NCT01079949|634550|P1|COMPLETED|Overall Study||31
262729|NCT01079949|634549|P2|STARTED|Overall Study||47
262730|NCT01079949|634550|P1|STARTED|Overall Study||46
262731|NCT01079962|634594|P2|NOT COMPLETED|Overall Study||15
262732|NCT01079962|634595|P1|NOT COMPLETED|Overall Study||15
262733|NCT01079962|634594|P2|COMPLETED|Overall Study||89
262734|NCT01079962|634595|P1|COMPLETED|Overall Study||90
262735|NCT01079962|634594|P2|STARTED|Overall Study||104
262736|NCT01079962|634595|P1|STARTED|Overall Study||105
262737|NCT01079988|634626|P5|NOT COMPLETED|Overall Study||1
262738|NCT01079988|634627|P4|NOT COMPLETED|Overall Study||3
262739|NCT01079988|634628|P3|NOT COMPLETED|Overall Study||0
262740|NCT01079988|634629|P2|NOT COMPLETED|Overall Study||0
262741|NCT01079988|634630|P1|NOT COMPLETED|Overall Study||1
262742|NCT01079988|634626|P5|COMPLETED|Overall Study||1
262743|NCT01079988|634627|P4|COMPLETED|Overall Study||17
262744|NCT01079988|634628|P3|COMPLETED|Overall Study||8
262745|NCT01079988|634629|P2|COMPLETED|Overall Study||1
262746|NCT01079988|634630|P1|COMPLETED|Overall Study||9
262747|NCT01079988|634626|P5|STARTED|Overall Study||2
262748|NCT01079988|634627|P4|STARTED|Overall Study||20
262749|NCT01079988|634628|P3|STARTED|Overall Study||8
262750|NCT01079988|634629|P2|STARTED|Overall Study||1
262751|NCT01079988|634630|P1|STARTED|Overall Study||10
262752|NCT01080118|634649|P4|NOT COMPLETED|Overall Study||0
262753|NCT01080118|634650|P3|NOT COMPLETED|Overall Study||0
262754|NCT01080118|634651|P2|NOT COMPLETED|Overall Study||0
262755|NCT01080118|634652|P1|NOT COMPLETED|Overall Study||0
262756|NCT01080118|634649|P4|COMPLETED|Overall Study||30
262757|NCT01080118|634650|P3|COMPLETED|Overall Study||30
262758|NCT01080118|634651|P2|COMPLETED|Overall Study||15
262759|NCT01080118|634652|P1|COMPLETED|Overall Study||15
262760|NCT01080118|634649|P4|STARTED|Overall Study||30
262761|NCT01080118|634650|P3|STARTED|Overall Study||30
262762|NCT01080118|634651|P2|STARTED|Overall Study||15
262763|NCT01080118|634652|P1|STARTED|Overall Study||15
262764|NCT01080131|634662|P2|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||11
262765|NCT01080131|634663|P1|NOT COMPLETED|Extension Study 2 (25-72 Weeks)||8
262766|NCT01080131|634662|P2|COMPLETED|Extension Study 2 (25-72 Weeks)||54
262767|NCT01080131|634663|P1|COMPLETED|Extension Study 2 (25-72 Weeks)||64
262857|NCT01080794|634883|P3|COMPLETED|Overall Study||10
262858|NCT01080794|634884|P2|COMPLETED|Overall Study||12
262768|NCT01080131|634662|P2|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients switched to canakinumab from Week 25 - Week 72|41
262769|NCT01080131|634663|P1|Re-treated With or Switch to Canakinumab|Extension Study 2 (25-72 Weeks)|Includes patients re-treated with canakinumab at any time during the 72 weeks|62
262770|NCT01080131|634662|P2|STARTED|Extension Study 2 (25-72 Weeks)||65
262771|NCT01080131|634663|P1|STARTED|Extension Study 2 (25-72 Weeks)||72
262772|NCT01080131|634662|P2|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||4
262773|NCT01080131|634663|P1|NOT COMPLETED|Extension Study 1 (12 -24 Weeks)||6
262774|NCT01080131|634662|P2|COMPLETED|Extension Study 1 (12 -24 Weeks)||72
262775|NCT01080131|634663|P1|COMPLETED|Extension Study 1 (12 -24 Weeks)||78
262776|NCT01080131|634662|P2|STARTED|Extension Study 1 (12 -24 Weeks)||76
262777|NCT01080131|634663|P1|STARTED|Extension Study 1 (12 -24 Weeks)||84
262778|NCT01080131|634662|P2|NOT COMPLETED|Core Study (0- 12 Weeks)||11
262779|NCT01080131|634663|P1|NOT COMPLETED|Core Study (0- 12 Weeks)||13
262780|NCT01080131|634662|P2|COMPLETED|Core Study (0- 12 Weeks)||103
262781|NCT01080131|634663|P1|COMPLETED|Core Study (0- 12 Weeks)||99
262782|NCT01080131|634662|P2|STARTED|Core Study (0- 12 Weeks)||114
262783|NCT01080131|634663|P1|STARTED|Core Study (0- 12 Weeks)||112
262784|NCT01080209|634747|P7|NOT COMPLETED|Overall Study||7
262785|NCT01080209|634748|P6|NOT COMPLETED|Overall Study||0
262786|NCT01080209|634749|P5|NOT COMPLETED|Overall Study||0
262787|NCT01080209|634750|P4|NOT COMPLETED|Overall Study||5
262788|NCT01080209|634751|P3|NOT COMPLETED|Overall Study||5
262789|NCT01080209|634752|P2|NOT COMPLETED|Overall Study||11
262790|NCT01080209|634753|P1|NOT COMPLETED|Overall Study||6
262791|NCT01080209|634747|P7|COMPLETED|Overall Study||44
262792|NCT01080209|634748|P6|COMPLETED|Overall Study||2
262793|NCT01080209|634749|P5|COMPLETED|Overall Study||6
262794|NCT01080209|634750|P4|COMPLETED|Overall Study||37
262795|NCT01080209|634751|P3|COMPLETED|Overall Study||28
262796|NCT01080209|634752|P2|COMPLETED|Overall Study||42
262797|NCT01080209|634753|P1|COMPLETED|Overall Study||22
262798|NCT01080209|634747|P7|STARTED|Overall Study||51
262799|NCT01080209|634748|P6|STARTED|Overall Study||2
262800|NCT01080209|634749|P5|STARTED|Overall Study||6
262801|NCT01080209|634750|P4|STARTED|Overall Study||42
262802|NCT01080209|634751|P3|STARTED|Overall Study||33
262803|NCT01080209|634752|P2|STARTED|Overall Study||53
262804|NCT01080209|634753|P1|STARTED|Overall Study||28
262805|NCT01080248|634776|P1|NOT COMPLETED|Overall Study||0
262806|NCT01080248|634776|P1|COMPLETED|Overall Study||2
262807|NCT01080248|634776|P1|STARTED|Overall Study||2
262808|NCT01080261|634783|P1|NOT COMPLETED|Overall Study||0
262809|NCT01080261|634783|P1|COMPLETED|Overall Study||60
262810|NCT01080261|634783|P1|STARTED|Overall Study||60
262811|NCT01080300|634800|P2|NOT COMPLETED|Overall Study||104
262812|NCT01080300|634801|P1|NOT COMPLETED|Overall Study||94
262813|NCT01080300|634800|P2|COMPLETED|Overall Study||191
262814|NCT01080300|634801|P1|COMPLETED|Overall Study||206
262815|NCT01080300|634800|P2|STARTED|Overall Study|298 subjects were randomized, but only 295 received study treatment.|295
262816|NCT01080300|634801|P1|STARTED|Overall Study|302 subjects were randomized, but only 300 received study treatment.|300
262817|NCT01080326|634809|P1|NOT COMPLETED|Overall Study||4
262818|NCT01080326|634809|P1|COMPLETED|Overall Study||3
262819|NCT01080326|634809|P1|STARTED|Overall Study||7
262820|NCT01080391|634815|P2|NOT COMPLETED|Overall Study||13
262821|NCT01080391|634816|P1|NOT COMPLETED|Overall Study||23
262822|NCT01080391|634815|P2|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|383
262823|NCT01080391|634816|P1|COMPLETED|Overall Study|Participants are ongoing as of 16 June 2014 or who have died on study.|373
262824|NCT01080391|634815|P2|Treated|Overall Study||392
262825|NCT01080391|634816|P1|Treated|Overall Study||389
262826|NCT01080391|634815|P2|STARTED|Overall Study||396
262827|NCT01080391|634816|P1|STARTED|Overall Study||396
262828|NCT01080625|634837|P3|NOT COMPLETED|Overall Study||1
262829|NCT01080625|634838|P2|NOT COMPLETED|Overall Study||2
262830|NCT01080625|634839|P1|NOT COMPLETED|Overall Study||0
262831|NCT01080625|634837|P3|COMPLETED|Overall Study||31
262832|NCT01080625|634838|P2|COMPLETED|Overall Study||31
262833|NCT01080625|634839|P1|COMPLETED|Overall Study||31
262834|NCT01080625|634837|P3|STARTED|Overall Study||32
262835|NCT01080625|634838|P2|STARTED|Overall Study||33
262836|NCT01080625|634839|P1|STARTED|Overall Study||31
262837|NCT01080677|634850|P3|NOT COMPLETED|Overall Study||0
262838|NCT01080677|634851|P2|NOT COMPLETED|Overall Study||0
262839|NCT01080677|634852|P1|NOT COMPLETED|Overall Study||0
262840|NCT01080677|634850|P3|COMPLETED|Overall Study||20
262841|NCT01080677|634851|P2|COMPLETED|Overall Study||20
262842|NCT01080677|634852|P1|COMPLETED|Overall Study||20
262843|NCT01080677|634850|P3|STARTED|Overall Study||20
262844|NCT01080677|634851|P2|STARTED|Overall Study||20
262845|NCT01080677|634852|P1|STARTED|Overall Study||20
262846|NCT01080768|634871|P2|NOT COMPLETED|Overall Study||1
262847|NCT01080768|634872|P1|NOT COMPLETED|Overall Study||2
262848|NCT01080768|634871|P2|COMPLETED|Overall Study||16
262849|NCT01080768|634872|P1|COMPLETED|Overall Study||12
262850|NCT01080768|634871|P2|STARTED|Overall Study||17
262851|NCT01080768|634872|P1|STARTED|Overall Study||14
262852|NCT01080794|634882|P4|NOT COMPLETED|Overall Study||2
262853|NCT01080794|634883|P3|NOT COMPLETED|Overall Study||2
262854|NCT01080794|634884|P2|NOT COMPLETED|Overall Study||2
262855|NCT01080794|634885|P1|NOT COMPLETED|Overall Study||5
262859|NCT01080794|634885|P1|COMPLETED|Overall Study||15
262860|NCT01080794|634882|P4|STARTED|Overall Study||15
262861|NCT01080794|634883|P3|STARTED|Overall Study||12
262862|NCT01080794|634884|P2|STARTED|Overall Study||14
262863|NCT01080794|634885|P1|STARTED|Overall Study||20
262864|NCT01080807|634933|P2|NOT COMPLETED|Overall Study||23
262865|NCT01080807|634934|P1|NOT COMPLETED|Overall Study||35
262866|NCT01080807|634933|P2|COMPLETED|Overall Study||167
262867|NCT01080807|634934|P1|COMPLETED|Overall Study||158
262868|NCT01080807|634933|P2|STARTED|Overall Study|Three patients randomly assigned to the placebo treatment group did not receive study drug.|190
262869|NCT01080807|634934|P1|STARTED|Overall Study|Nine patients randomly assigned to the armodafinil treatment group did not receive study drug.|193
262870|NCT01081041|634991|P3|NOT COMPLETED|Overall Study||2
262871|NCT01081041|634992|P2|NOT COMPLETED|Overall Study||4
262872|NCT01081041|634993|P1|NOT COMPLETED|Overall Study||0
262873|NCT01081041|634991|P3|COMPLETED|Overall Study||71
262874|NCT01081041|634992|P2|COMPLETED|Overall Study||77
262875|NCT01081041|634993|P1|COMPLETED|Overall Study||33
262876|NCT01081041|634991|P3|Received at Least 1 Dose of Study Drug|Overall Study||71
262877|NCT01081041|634992|P2|Received at Least 1 Dose of Study Drug|Overall Study||77
262878|NCT01081041|634993|P1|Received at Least 1 Dose of Study Drug|Overall Study||33
262879|NCT01081041|634991|P3|STARTED|Overall Study||73
262880|NCT01081041|634992|P2|STARTED|Overall Study||81
262881|NCT01081041|634993|P1|STARTED|Overall Study||33
262882|NCT01081132|635023|P2|NOT COMPLETED|Overall Study||52
262883|NCT01081132|635024|P1|NOT COMPLETED|Overall Study||55
262884|NCT01081132|635023|P2|COMPLETED|Overall Study||105
262885|NCT01081132|635024|P1|COMPLETED|Overall Study||102
262886|NCT01081132|635023|P2|STARTED|Overall Study||157
262887|NCT01081132|635024|P1|STARTED|Overall Study||157
262888|NCT01081145|635062|P2|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||106
262889|NCT01081145|635063|P1|NOT COMPLETED|Double-Blind Randomized-Withdrawal Phase||81
262890|NCT01081145|635062|P2|COMPLETED|Double-Blind Randomized-Withdrawal Phase||53
262891|NCT01081145|635063|P1|COMPLETED|Double-Blind Randomized-Withdrawal Phase||76
262892|NCT01081145|635062|P2|STARTED|Double-Blind Randomized-Withdrawal Phase||159
262893|NCT01081145|635063|P1|STARTED|Double-Blind Randomized-Withdrawal Phase||157
262894|NCT01081145|635062|P2|NOT COMPLETED|Open-Label Phase||0
262895|NCT01081145|635063|P1|NOT COMPLETED|Open-Label Phase||212
262896|NCT01081145|635062|P2|COMPLETED|Open-Label Phase||0
262897|NCT01081145|635063|P1|COMPLETED|Open-Label Phase||316
262898|NCT01081145|635062|P2|STARTED|Open-Label Phase||0
262899|NCT01081145|635063|P1|STARTED|Open-Label Phase||528
262900|NCT01081249|635089|P2|NOT COMPLETED|Overall Study||1
262901|NCT01081249|635090|P1|NOT COMPLETED|Overall Study||0
262902|NCT01081249|635089|P2|COMPLETED|Overall Study||6
262903|NCT01081249|635090|P1|COMPLETED|Overall Study||11
262904|NCT01081249|635089|P2|Second Psychotherapy Appointment (1 Day)|Overall Study||6
262905|NCT01081249|635090|P1|Second Psychotherapy Appointment (1 Day)|Overall Study||11
262906|NCT01081249|635089|P2|Washout (5-10 Days)|Overall Study||6
262907|NCT01081249|635090|P1|Washout (5-10 Days)|Overall Study||11
262908|NCT01081249|635089|P2|First Psychotherapy Appointment (1 Day)|Overall Study||6
262909|NCT01081249|635090|P1|First Psychotherapy Appointment (1 Day)|Overall Study||11
262910|NCT01081249|635089|P2|STARTED|Overall Study||7
262911|NCT01081249|635090|P1|STARTED|Overall Study||11
262912|NCT01081301|635096|P1|NOT COMPLETED|Overall Study||14
262913|NCT01081301|635096|P1|COMPLETED|Overall Study||22
262914|NCT01081301|635096|P1|STARTED|Overall Study||36
262915|NCT01081626|635136|P2|NOT COMPLETED|Overall Study||61
262916|NCT01081626|635137|P1|NOT COMPLETED|Overall Study||60
262917|NCT01081626|635136|P2|COMPLETED|Overall Study||94
262918|NCT01081626|635137|P1|COMPLETED|Overall Study||95
262919|NCT01081626|635136|P2|Assessed for Efficacy|Overall Study||125
262920|NCT01081626|635137|P1|Assessed for Efficacy|Overall Study||122
262921|NCT01081626|635136|P2|STARTED|Overall Study||155
262922|NCT01081626|635137|P1|STARTED|Overall Study||155
262923|NCT01081665|635163|P1|NOT COMPLETED|Overall Study||95
262924|NCT01081665|635163|P1|COMPLETED|Overall Study||142
262925|NCT01081665|635163|P1|Evaluable Population|Overall Study|Participants with baseline and at least 2 post-baseline parathormone measurements at 24 months.|212
262926|NCT01081665|635163|P1|Full Analysis Set|Overall Study||237
262927|NCT01081665|635163|P1|STARTED|Overall Study||237
262928|NCT01081769|635175|P2|NOT COMPLETED|CORE Intent-To-Treat||97
262929|NCT01081769|635176|P1|NOT COMPLETED|CORE Intent-To-Treat||80
262930|NCT01081769|635175|P2|COMPLETED|CORE Intent-To-Treat||266
262931|NCT01081769|635176|P1|COMPLETED|CORE Intent-To-Treat||272
262932|NCT01081769|635175|P2|STARTED|CORE Intent-To-Treat||363
262933|NCT01081769|635176|P1|STARTED|CORE Intent-To-Treat||352
262934|NCT01081769|635175|P2|NOT COMPLETED|Whole Intent-to-Treat||25
262935|NCT01081769|635176|P1|NOT COMPLETED|Whole Intent-to-Treat||24
262936|NCT01081769|635175|P2|COMPLETED|Whole Intent-to-Treat||363
262937|NCT01081769|635176|P1|COMPLETED|Whole Intent-to-Treat||352
262938|NCT01081769|635175|P2|STARTED|Whole Intent-to-Treat||388
262939|NCT01081769|635176|P1|STARTED|Whole Intent-to-Treat||376
262940|NCT01081795|635213|P3|NOT COMPLETED|Overall Study||30
262941|NCT01081795|635214|P2|NOT COMPLETED|Overall Study||35
262942|NCT01081795|635215|P1|NOT COMPLETED|Overall Study||33
262943|NCT01081795|635213|P3|COMPLETED|Overall Study||97
262944|NCT01081795|635214|P2|COMPLETED|Overall Study||95
262945|NCT01081795|635215|P1|COMPLETED|Overall Study||97
262946|NCT01081795|635213|P3|STARTED|Overall Study||127
262947|NCT01081795|635214|P2|STARTED|Overall Study||130
262948|NCT01081795|635215|P1|STARTED|Overall Study||130
262949|NCT01081834|635255|P5|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
262950|NCT01081834|635256|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||0
262951|NCT01081834|635257|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||5
262952|NCT01081834|635258|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
262953|NCT01081834|635259|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||20
262954|NCT01081834|635255|P5|COMPLETED|Extension Period: Week 26 to Week 52||0
262955|NCT01081834|635256|P4|COMPLETED|Extension Period: Week 26 to Week 52||0
262956|NCT01081834|635257|P3|COMPLETED|Extension Period: Week 26 to Week 52||165
262957|NCT01081834|635258|P2|COMPLETED|Extension Period: Week 26 to Week 52||152
262958|NCT01081834|635259|P1|COMPLETED|Extension Period: Week 26 to Week 52||135
262959|NCT01081834|635255|P5|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
262960|NCT01081834|635256|P4|STARTED|Extension Period: Week 26 to Week 52|The treatment duration for the High Glycemic Substudy was 26 weeks only.|0
262961|NCT01081834|635257|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued last day of core: AE (1), lost f/u (1), PV (1), NS (1), physician decision (1).|170
262962|NCT01081834|635258|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued on last day of core: adverse event (AE) (1), protocol violation (PV) (1).|170
262963|NCT01081834|635259|P1|STARTED|Extension Period: Week 26 to Week 52|5 pts discontinued on last day of core: lack of efficacy on rescue (2), not specified (NS) (3).|155
262964|NCT01081834|635255|P5|NOT COMPLETED|Core Period: Baseline to Week 26||4
262965|NCT01081834|635256|P4|NOT COMPLETED|Core Period: Baseline to Week 26||7
262966|NCT01081834|635257|P3|NOT COMPLETED|Core Period: Baseline to Week 26||22
262967|NCT01081834|635258|P2|NOT COMPLETED|Core Period: Baseline to Week 26||23
262968|NCT01081834|635259|P1|NOT COMPLETED|Core Period: Baseline to Week 26||32
262969|NCT01081834|635255|P5|COMPLETED|Core Period: Baseline to Week 26||40
262970|NCT01081834|635256|P4|COMPLETED|Core Period: Baseline to Week 26||40
262971|NCT01081834|635257|P3|COMPLETED|Core Period: Baseline to Week 26||175
262972|NCT01081834|635258|P2|COMPLETED|Core Period: Baseline to Week 26||172
262973|NCT01081834|635259|P1|COMPLETED|Core Period: Baseline to Week 26||160
262974|NCT01081834|635255|P5|STARTED|Core Period: Baseline to Week 26||44
262975|NCT01081834|635256|P4|STARTED|Core Period: Baseline to Week 26||47
262976|NCT01081834|635257|P3|STARTED|Core Period: Baseline to Week 26||197
262977|NCT01081834|635258|P2|STARTED|Core Period: Baseline to Week 26||195
262978|NCT01081834|635259|P1|STARTED|Core Period: Baseline to Week 26||192
262979|NCT01082575|635317|P1|NOT COMPLETED|Overall Study||0
262980|NCT01082575|635317|P1|COMPLETED|Overall Study||100
262981|NCT01082575|635317|P1|STARTED|Overall Study||100
262982|NCT01082588|635324|P2|NOT COMPLETED|Overall Study||5
262983|NCT01082588|635325|P1|NOT COMPLETED|Overall Study||6
262984|NCT01082588|635324|P2|COMPLETED|Overall Study||25
262985|NCT01082588|635325|P1|COMPLETED|Overall Study||24
262986|NCT01082588|635324|P2|STARTED|Overall Study||30
262987|NCT01082588|635325|P1|STARTED|Overall Study||30
262988|NCT01082614|635345|P2|NOT COMPLETED|Overall Study||5
262989|NCT01082614|635346|P1|NOT COMPLETED|Overall Study||3
262990|NCT01082614|635345|P2|COMPLETED|Overall Study||18
262991|NCT01082614|635346|P1|COMPLETED|Overall Study||20
262992|NCT01082614|635345|P2|STARTED|Overall Study||23
262993|NCT01082614|635346|P1|STARTED|Overall Study||23
262994|NCT01082640|635355|P3|NOT COMPLETED|Overall Study||8
262995|NCT01082640|635356|P2|NOT COMPLETED|Overall Study||15
262996|NCT01082640|635357|P1|NOT COMPLETED|Overall Study||17
262997|NCT01082640|635355|P3|COMPLETED|Overall Study||24
262998|NCT01082640|635356|P2|COMPLETED|Overall Study||17
262999|NCT01082640|635357|P1|COMPLETED|Overall Study||15
263000|NCT01082640|635355|P3|STARTED|Overall Study||32
263001|NCT01082640|635356|P2|STARTED|Overall Study||32
263002|NCT01082640|635357|P1|STARTED|Overall Study||32
263003|NCT01082874|635381|P4|NOT COMPLETED|Overall Study||13
263004|NCT01082874|635382|P3|NOT COMPLETED|Overall Study||11
263005|NCT01082874|635383|P2|NOT COMPLETED|Overall Study||12
263006|NCT01082874|635384|P1|NOT COMPLETED|Overall Study||11
263007|NCT01082874|635381|P4|COMPLETED|Overall Study||2489
263008|NCT01082874|635382|P3|COMPLETED|Overall Study||2488
263009|NCT01082874|635383|P2|COMPLETED|Overall Study||2498
263010|NCT01082874|635384|P1|COMPLETED|Overall Study||2488
263011|NCT01082874|635381|P4|STARTED|Overall Study||2502
263012|NCT01082874|635382|P3|STARTED|Overall Study||2499
263013|NCT01082874|635383|P2|STARTED|Overall Study||2510
263014|NCT01082874|635384|P1|STARTED|Overall Study||2499
263015|NCT01082939|635394|P1|NOT COMPLETED|Overall Study||0
263016|NCT01082939|635394|P1|COMPLETED|Overall Study||80
263017|NCT01082939|635394|P1|STARTED|Overall Study||80
263018|NCT01082952|635400|P2|NOT COMPLETED|Overall Study||0
263019|NCT01082952|635401|P1|NOT COMPLETED|Overall Study||0
263020|NCT01082952|635400|P2|COMPLETED|Overall Study||6
263021|NCT01082952|635401|P1|COMPLETED|Overall Study||6
263022|NCT01082952|635400|P2|STARTED|Overall Study||6
263023|NCT01082952|635401|P1|STARTED|Overall Study||6
263024|NCT01082965|635411|P2|NOT COMPLETED|Overall Study||2
263025|NCT01082965|635412|P1|NOT COMPLETED|Overall Study||1
263026|NCT01082965|635411|P2|COMPLETED|Overall Study||6
263027|NCT01082965|635412|P1|COMPLETED|Overall Study||9
263028|NCT01082965|635411|P2|STARTED|Overall Study||8
263029|NCT01082965|635412|P1|STARTED|Overall Study||10
263030|NCT01083121|635430|P1|NOT COMPLETED|Overall Study||81
263031|NCT01083121|635430|P1|COMPLETED|Overall Study|Participants included in the analysis|1698
263032|NCT01083121|635430|P1|STARTED|Overall Study|Participants who were enrolled in the study|1779
263033|NCT01083160|635438|P1|NOT COMPLETED|Overall Study||1
263034|NCT01083160|635438|P1|COMPLETED|Overall Study||81
263035|NCT01083160|635438|P1|Evaluable Population|Overall Study||71
263036|NCT01083160|635438|P1|STARTED|Overall Study||82
263037|NCT01083173|635445|P2|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||377
263038|NCT01083173|635446|P1|NOT COMPLETED|Long-term Surveillance: Effectiveness Gr||0
263039|NCT01083173|635445|P2|COMPLETED|Long-term Surveillance: Effectiveness Gr||102
263040|NCT01083173|635446|P1|COMPLETED|Long-term Surveillance: Effectiveness Gr||0
263041|NCT01083173|635445|P2|STARTED|Long-term Surveillance: Effectiveness Gr||479
263042|NCT01083173|635446|P1|STARTED|Long-term Surveillance: Effectiveness Gr||0
263043|NCT01083173|635445|P2|NOT COMPLETED|Long-term Surveillance: Safety Group||116
263044|NCT01083173|635446|P1|NOT COMPLETED|Long-term Surveillance: Safety Group||0
263045|NCT01083173|635445|P2|COMPLETED|Long-term Surveillance: Safety Group||479
263046|NCT01083173|635446|P1|COMPLETED|Long-term Surveillance: Safety Group||0
263047|NCT01083173|635445|P2|STARTED|Long-term Surveillance: Safety Group||595
263048|NCT01083173|635446|P1|STARTED|Long-term Surveillance: Safety Group||0
263049|NCT01083173|635445|P2|NOT COMPLETED|Main Surveillance: Effectiveness Group||0
263050|NCT01083173|635446|P1|NOT COMPLETED|Main Surveillance: Effectiveness Group||382
263051|NCT01083173|635445|P2|COMPLETED|Main Surveillance: Effectiveness Group||0
263052|NCT01083173|635446|P1|COMPLETED|Main Surveillance: Effectiveness Group||198
263053|NCT01083173|635445|P2|STARTED|Main Surveillance: Effectiveness Group||0
263054|NCT01083173|635446|P1|STARTED|Main Surveillance: Effectiveness Group||580
263055|NCT01083173|635445|P2|NOT COMPLETED|Main Surveillance: Safety Group||0
263056|NCT01083173|635446|P1|NOT COMPLETED|Main Surveillance: Safety Group||15
263057|NCT01083173|635445|P2|COMPLETED|Main Surveillance: Safety Group||0
263058|NCT01083173|635446|P1|COMPLETED|Main Surveillance: Safety Group||580
263059|NCT01083173|635445|P2|STARTED|Main Surveillance: Safety Group||0
263060|NCT01083173|635446|P1|STARTED|Main Surveillance: Safety Group||595
263061|NCT01083186|635464|P1|NOT COMPLETED|Overall Study||94
263062|NCT01083186|635464|P1|COMPLETED|Overall Study||406
263063|NCT01083186|635464|P1|STARTED|Overall Study||500
263064|NCT01083199|635505|P1|NOT COMPLETED|Overall Study||0
263065|NCT01083199|635505|P1|COMPLETED|Overall Study||10
263066|NCT01083199|635505|P1|STARTED|Overall Study||10
263067|NCT01083316|635510|P1|NOT COMPLETED|Overall Study||3
263068|NCT01083316|635510|P1|COMPLETED|Overall Study||32
263069|NCT01083316|635510|P1|STARTED|Overall Study||35
263070|NCT01083472|635518|P2|NOT COMPLETED|Overall Study||0
263071|NCT01083472|635519|P1|NOT COMPLETED|Overall Study||0
263072|NCT01083472|635518|P2|COMPLETED|Overall Study||19
263073|NCT01083472|635519|P1|COMPLETED|Overall Study||18
263074|NCT01083472|635518|P2|STARTED|Overall Study||19
263075|NCT01083472|635519|P1|STARTED|Overall Study||18
263076|NCT01083485|635527|P2|NOT COMPLETED|Overall Study||3
263077|NCT01083485|635528|P1|NOT COMPLETED|Overall Study||7
263078|NCT01083485|635527|P2|COMPLETED|Overall Study||64
263079|NCT01083485|635528|P1|COMPLETED|Overall Study||63
263080|NCT01083485|635527|P2|STARTED|Overall Study||67
263081|NCT01083485|635528|P1|STARTED|Overall Study||70
263082|NCT01083576|635538|P2|NOT COMPLETED|Overall Study||1
263083|NCT01083576|635539|P1|NOT COMPLETED|Overall Study||6
263084|NCT01083576|635538|P2|COMPLETED|Overall Study||14
263085|NCT01083576|635539|P1|COMPLETED|Overall Study||9
263086|NCT01083576|635538|P2|STARTED|Overall Study||15
263087|NCT01083576|635539|P1|STARTED|Overall Study||15
263088|NCT01083602|635567|P1|NOT COMPLETED|Overall Study||55
263089|NCT01083602|635567|P1|COMPLETED|Overall Study||0
263090|NCT01083602|635567|P1|STARTED|Overall Study||55
263091|NCT01083641|635576|P1|NOT COMPLETED|Overall Study||2
263092|NCT01083641|635576|P1|COMPLETED|Overall Study||15
263093|NCT01083641|635576|P1|STARTED|Overall Study||17
263094|NCT01083654|635585|P2|NOT COMPLETED|Overall Study||0
263095|NCT01083654|635586|P1|NOT COMPLETED|Overall Study||0
263096|NCT01083654|635585|P2|COMPLETED|Overall Study||50
263097|NCT01083654|635586|P1|COMPLETED|Overall Study||53
263098|NCT01083654|635585|P2|STARTED|Overall Study||50
263099|NCT01083654|635586|P1|STARTED|Overall Study||53
263100|NCT01083667|635592|P1|NOT COMPLETED|Overall Study||10
263101|NCT01083667|635592|P1|COMPLETED|Overall Study|22 completed to visit 9, the last visit on study.|22
263102|NCT01083667|635592|P1|STARTED|Overall Study|enrolled|32
263103|NCT01083680|635597|P1|NOT COMPLETED|Overall Study||3844
263104|NCT01083680|635597|P1|COMPLETED|Overall Study||263
263105|NCT01083680|635597|P1|Full Analysis Set (FAS), Efficacy|Overall Study||1621
263106|NCT01083680|635597|P1|STARTED|Overall Study||4107
263107|NCT01083693|635609|P3|NOT COMPLETED|Overall Study||7
263108|NCT01083693|635610|P2|NOT COMPLETED|Overall Study||6
263109|NCT01083693|635611|P1|NOT COMPLETED|Overall Study||20
263110|NCT01083693|635609|P3|COMPLETED|Overall Study||33
263111|NCT01083693|635610|P2|COMPLETED|Overall Study||22
263112|NCT01083693|635611|P1|COMPLETED|Overall Study||73
263113|NCT01083693|635609|P3|STARTED|Overall Study||40
263114|NCT01083693|635610|P2|STARTED|Overall Study||28
263115|NCT01083693|635611|P1|STARTED|Overall Study||93
263116|NCT01083706|635646|P1|NOT COMPLETED|Overall Study||0
263117|NCT01083706|635646|P1|COMPLETED|Overall Study||39
263118|NCT01083706|635646|P1|STARTED|Overall Study||39
263119|NCT01083732|635655|P3|NOT COMPLETED|Overall Study||0
263120|NCT01083732|635656|P2|NOT COMPLETED|Overall Study||0
263121|NCT01083732|635657|P1|NOT COMPLETED|Overall Study||0
263122|NCT01083732|635655|P3|COMPLETED|Overall Study||3
263123|NCT01083732|635656|P2|COMPLETED|Overall Study||9
263124|NCT01083732|635657|P1|COMPLETED|Overall Study||6
263125|NCT01083732|635655|P3|STARTED|Overall Study||3
263126|NCT01083732|635656|P2|STARTED|Overall Study||9
263127|NCT01083732|635657|P1|STARTED|Overall Study||6
263128|NCT01083758|635708|P1|NOT COMPLETED|Overall Study||2
263129|NCT01083758|635708|P1|COMPLETED|Overall Study||29
263130|NCT01083758|635708|P1|STARTED|Overall Study||31
263131|NCT01083771|635739|P1|NOT COMPLETED|Overall Study||5
263132|NCT01083771|635739|P1|COMPLETED|Overall Study||16
263133|NCT01083771|635739|P1|STARTED|Overall Study||21
263134|NCT01083810|635747|P3|NOT COMPLETED|Overall Study||20
263135|NCT01083810|635748|P2|NOT COMPLETED|Overall Study||45
263136|NCT01083810|635749|P1|NOT COMPLETED|Overall Study||65
263137|NCT01083810|635747|P3|COMPLETED|Overall Study||35
263138|NCT01083810|635748|P2|COMPLETED|Overall Study||47
263139|NCT01083810|635749|P1|COMPLETED|Overall Study||72
263140|NCT01083810|635747|P3|STARTED|Overall Study||55
263141|NCT01083810|635748|P2|STARTED|Overall Study||92
263142|NCT01083810|635749|P1|STARTED|Overall Study||137
263143|NCT01083849|635772|P2|NOT COMPLETED|Overall Study||111
263144|NCT01083849|635773|P1|NOT COMPLETED|Overall Study||60
263145|NCT01083849|635772|P2|COMPLETED|Overall Study||527
263146|NCT01083849|635773|P1|COMPLETED|Overall Study||61
263147|NCT01083849|635772|P2|STARTED|Overall Study||638
263148|NCT01083849|635773|P1|STARTED|Overall Study||121
263149|NCT01083901|635796|P3|NOT COMPLETED|Overall Study||2
263150|NCT01083901|635797|P2|NOT COMPLETED|Overall Study||2
263151|NCT01083901|635798|P1|NOT COMPLETED|Overall Study||1
263152|NCT01083901|635796|P3|COMPLETED|Overall Study||11
263153|NCT01083901|635797|P2|COMPLETED|Overall Study||6
263154|NCT01083901|635798|P1|COMPLETED|Overall Study||12
263155|NCT01083901|635796|P3|STARTED|Overall Study||13
263156|NCT01083901|635797|P2|STARTED|Overall Study||8
263157|NCT01083901|635798|P1|STARTED|Overall Study||13
263158|NCT01083979|635815|P1|NOT COMPLETED|Overall Study||0
263159|NCT01083979|635815|P1|COMPLETED|Overall Study||1
263160|NCT01083979|635815|P1|STARTED|Overall Study||1
263161|NCT01084005|635822|P2|NOT COMPLETED|Overall Study||16
263162|NCT01084005|635823|P1|NOT COMPLETED|Overall Study||5
263163|NCT01084005|635822|P2|COMPLETED|Overall Study||146
263164|NCT01084005|635823|P1|COMPLETED|Overall Study||74
263165|NCT01084005|635822|P2|STARTED|Overall Study||162
263166|NCT01084005|635823|P1|STARTED|Overall Study||79
263167|NCT01084083|635851|P1|NOT COMPLETED|Overall Study||12
263168|NCT01084083|635851|P1|COMPLETED|Overall Study||78
263169|NCT01084083|635851|P1|CR and Treated With 5400 cGy IMRT|Overall Study|This is the primary study population for the primary endpoint (24-month PFS).|44
263170|NCT01084083|635851|P1|CR to Induction Therapy|Overall Study||56
263171|NCT01084083|635851|P1|Eligible and Treated|Overall Study|This is the eligible and treated patients for secondary efficacy endpoints|80
263172|NCT01084083|635851|P1|Eligible|Overall Study||81
263173|NCT01084083|635851|P1|Treated|Overall Study|This is the all treated patients for toxicity analysis|89
263174|NCT01084083|635851|P1|STARTED|Overall Study||90
263175|NCT01084135|635861|P2|NOT COMPLETED|20 Week||1
263176|NCT01084135|635862|P1|NOT COMPLETED|20 Week||0
263177|NCT01084135|635861|P2|COMPLETED|20 Week||10
263178|NCT01084135|635862|P1|COMPLETED|20 Week||12
263179|NCT01084135|635861|P2|STARTED|20 Week||11
263180|NCT01084135|635862|P1|STARTED|20 Week||12
263181|NCT01084135|635861|P2|NOT COMPLETED|12 Week||0
263182|NCT01084135|635862|P1|NOT COMPLETED|12 Week||0
263183|NCT01084135|635861|P2|COMPLETED|12 Week||4
263184|NCT01084135|635862|P1|COMPLETED|12 Week||4
263185|NCT01084135|635861|P2|STARTED|12 Week||4
263186|NCT01084135|635862|P1|STARTED|12 Week||4
263187|NCT01084148|635874|P2|NOT COMPLETED|Overall Study||16
263188|NCT01084148|635875|P1|NOT COMPLETED|Overall Study||30
263189|NCT01084148|635874|P2|COMPLETED|Overall Study||102
263190|NCT01084148|635875|P1|COMPLETED|Overall Study||88
263191|NCT01084148|635874|P2|STARTED|Overall Study|Among those 118 patients randomized into V0034 CR 01B vehicle arm, one patient not treated.|118
263192|NCT01084148|635875|P1|STARTED|Overall Study||118
263193|NCT01084174|635883|P2|NOT COMPLETED|Overall Study||4
263194|NCT01084174|635884|P1|NOT COMPLETED|Overall Study||1
263195|NCT01084174|635883|P2|COMPLETED|Overall Study||7
263196|NCT01084174|635884|P1|COMPLETED|Overall Study||9
263197|NCT01084174|635883|P2|STARTED|Overall Study||11
263198|NCT01084174|635884|P1|STARTED|Overall Study||10
263199|NCT01084239|635904|P2|NOT COMPLETED|28-Day Follow-up||9
263200|NCT01084239|635905|P1|NOT COMPLETED|28-Day Follow-up||4
263201|NCT01084239|635904|P2|COMPLETED|28-Day Follow-up||490
263202|NCT01084239|635905|P1|COMPLETED|28-Day Follow-up||497
263203|NCT01084239|635904|P2|STARTED|28-Day Follow-up||499
263204|NCT01084239|635905|P1|STARTED|28-Day Follow-up|All 501 patients enrolled were evaluated for follow-up at 28 days.|501
263205|NCT01084239|635904|P2|NOT COMPLETED|Randomization - Index Hospitalization||0
263206|NCT01084239|635905|P1|NOT COMPLETED|Randomization - Index Hospitalization||0
263207|NCT01084239|635904|P2|COMPLETED|Randomization - Index Hospitalization||499
263208|NCT01084239|635905|P1|COMPLETED|Randomization - Index Hospitalization||501
263209|NCT01084239|635904|P2|STARTED|Randomization - Index Hospitalization||499
263210|NCT01084239|635905|P1|STARTED|Randomization - Index Hospitalization||501
263211|NCT01084265|635921|P1|NOT COMPLETED|Overall Study||0
263212|NCT01084265|635921|P1|COMPLETED|Overall Study||31
263213|NCT01084265|635921|P1|STARTED|Overall Study||31
263214|NCT01084278|635938|P5|NOT COMPLETED|Overall Study||0
263215|NCT01084278|635939|P4|NOT COMPLETED|Overall Study||0
263216|NCT01084278|635940|P3|NOT COMPLETED|Overall Study||0
263217|NCT01084278|635941|P2|NOT COMPLETED|Overall Study||0
263218|NCT01084278|635942|P1|NOT COMPLETED|Overall Study||0
263219|NCT01084278|635938|P5|COMPLETED|Overall Study||8
263220|NCT01084278|635939|P4|COMPLETED|Overall Study||8
263221|NCT01084278|635940|P3|COMPLETED|Overall Study||8
263222|NCT01084278|635941|P2|COMPLETED|Overall Study||8
263223|NCT01084278|635942|P1|COMPLETED|Overall Study||8
263224|NCT01084278|635938|P5|STARTED|Overall Study||8
263225|NCT01084278|635939|P4|STARTED|Overall Study||8
263226|NCT01084278|635940|P3|STARTED|Overall Study||8
263227|NCT01084278|635941|P2|STARTED|Overall Study||8
263228|NCT01084278|635942|P1|STARTED|Overall Study||8
263229|NCT01084538|636023|P1|NOT COMPLETED|Overall Study||68
263230|NCT01084538|636023|P1|COMPLETED|Overall Study||113
263231|NCT01084538|636023|P1|STARTED|Overall Study||181
263232|NCT01084551|636033|P3|NOT COMPLETED|Overall Study||8
263233|NCT01084551|636034|P2|NOT COMPLETED|Overall Study||14
263234|NCT01084551|636035|P1|NOT COMPLETED|Overall Study||9
263235|NCT01084551|636033|P3|COMPLETED|Overall Study||86
263236|NCT01084551|636034|P2|COMPLETED|Overall Study||81
263237|NCT01084551|636035|P1|COMPLETED|Overall Study||86
263238|NCT01084551|636033|P3|STARTED|Overall Study||94
263239|NCT01084551|636034|P2|STARTED|Overall Study||95
263240|NCT01084551|636035|P1|STARTED|Overall Study||95
263241|NCT01084603|636073|P1|NOT COMPLETED|Oral Nicotine 4||0
263242|NCT01084603|636073|P1|COMPLETED|Oral Nicotine 4||39
263243|NCT01084603|636073|P1|STARTED|Oral Nicotine 4||39
263244|NCT01084603|636073|P1|NOT COMPLETED|Washout Period 4||1
263245|NCT01084603|636073|P1|COMPLETED|Washout Period 4||39
263246|NCT01084603|636073|P1|STARTED|Washout Period 4||40
263247|NCT01084603|636073|P1|NOT COMPLETED|Oral Nicotine 2||0
263248|NCT01084603|636073|P1|COMPLETED|Oral Nicotine 2||40
263249|NCT01084603|636073|P1|STARTED|Oral Nicotine 2||40
263250|NCT01084603|636073|P1|NOT COMPLETED|Washout Period 3||0
263251|NCT01084603|636073|P1|COMPLETED|Washout Period 3||40
263252|NCT01084603|636073|P1|STARTED|Washout Period 3||40
263253|NCT01084603|636073|P1|NOT COMPLETED|Oral Nicotine 1||1
263254|NCT01084603|636073|P1|COMPLETED|Oral Nicotine 1||40
263255|NCT01084603|636073|P1|STARTED|Oral Nicotine 1||41
263256|NCT01084603|636073|P1|NOT COMPLETED|Washout Period 2||0
263257|NCT01084603|636073|P1|COMPLETED|Washout Period 2||41
263258|NCT01084603|636073|P1|STARTED|Washout Period 2||41
263259|NCT01084603|636073|P1|NOT COMPLETED|Nicorette® Gum||1
263260|NCT01084603|636073|P1|COMPLETED|Nicorette® Gum||41
263261|NCT01084603|636073|P1|STARTED|Nicorette® Gum||42
263262|NCT01084603|636073|P1|NOT COMPLETED|Washout Period 1||0
263263|NCT01084603|636073|P1|COMPLETED|Washout Period 1||42
263264|NCT01084603|636073|P1|STARTED|Washout Period 1||42
263265|NCT01084603|636073|P1|NOT COMPLETED|NiQuitinTM Lozenge||1
263266|NCT01084603|636073|P1|COMPLETED|NiQuitinTM Lozenge||42
263267|NCT01084603|636073|P1|STARTED|NiQuitinTM Lozenge||43
263268|NCT01084603|636073|P1|NOT COMPLETED|Baseline||2
263269|NCT01084603|636073|P1|COMPLETED|Baseline||43
263270|NCT01084603|636073|P1|STARTED|Baseline||45
263271|NCT01084668|636106|P1|NOT COMPLETED|Overall Study||9
263272|NCT01084668|636106|P1|COMPLETED|Overall Study||33
263273|NCT01084668|636106|P1|STARTED|Overall Study|Three participants who took Humira prior to study entry have been excluded from the database.|42
263274|NCT01084707|636115|P1|NOT COMPLETED|Overall Study||6
263275|NCT01084707|636115|P1|COMPLETED|Overall Study||34
263276|NCT01084707|636115|P1|STARTED|Overall Study||40
263277|NCT01084759|636149|P1|NOT COMPLETED|Overall Study||2
263278|NCT01084759|636149|P1|COMPLETED|Overall Study||14
263279|NCT01084759|636149|P1|STARTED|Overall Study||16
263280|NCT01085006|636157|P2|NOT COMPLETED|Overall Study||0
263281|NCT01085006|636158|P1|NOT COMPLETED|Overall Study||0
263282|NCT01085006|636157|P2|COMPLETED|Overall Study||50
263283|NCT01085006|636158|P1|COMPLETED|Overall Study||50
263284|NCT01085006|636157|P2|STARTED|Overall Study||50
263285|NCT01085006|636158|P1|STARTED|Overall Study||50
263286|NCT01076959|636164|P1|NOT COMPLETED|Overall Study||2250
263287|NCT01076959|636164|P1|COMPLETED|Overall Study||5490
263288|NCT01076959|636164|P1|STARTED|Overall Study||7740
263289|NCT01076972|636181|P1|NOT COMPLETED|Overall Study||0
263290|NCT01076972|636181|P1|COMPLETED|Overall Study||1184
263291|NCT01076972|636181|P1|STARTED|Overall Study||1184
263292|NCT01076985|636196|P1|NOT COMPLETED|Overall Study||0
263293|NCT01076985|636196|P1|COMPLETED|Overall Study||24
263294|NCT01076985|636196|P1|STARTED|Overall Study||24
263295|NCT01077024|636204|P2|NOT COMPLETED|Overall Study||28
263296|NCT01077024|636205|P1|NOT COMPLETED|Overall Study||31
263297|NCT01077024|636204|P2|COMPLETED|Overall Study||243
263298|NCT01077024|636205|P1|COMPLETED|Overall Study||236
263299|NCT01077024|636204|P2|STARTED|Overall Study||271
263300|NCT01077024|636205|P1|STARTED|Overall Study||267
263301|NCT01077050|636223|P1|NOT COMPLETED|Overall Study||9
263302|NCT01077050|636223|P1|COMPLETED|Overall Study||1942
263303|NCT01077050|636223|P1|STARTED|Overall Study||1951
263304|NCT01077063|636229|P2|NOT COMPLETED|Overall Study||3
263305|NCT01077063|636230|P1|NOT COMPLETED|Overall Study||4
263306|NCT01077063|636229|P2|COMPLETED|Overall Study||0
263307|NCT01077063|636230|P1|COMPLETED|Overall Study||0
263308|NCT01077063|636229|P2|STARTED|Overall Study||3
263309|NCT01077063|636230|P1|STARTED|Overall Study||4
263310|NCT01077076|636236|P6|NOT COMPLETED|Third Intervention||1
263311|NCT01077076|636237|P5|NOT COMPLETED|Third Intervention||0
263312|NCT01077076|636238|P4|NOT COMPLETED|Third Intervention||0
263313|NCT01077076|636239|P3|NOT COMPLETED|Third Intervention||0
263314|NCT01077076|636240|P2|NOT COMPLETED|Third Intervention||0
263315|NCT01077076|636241|P1|NOT COMPLETED|Third Intervention||0
263316|NCT01077076|636236|P6|COMPLETED|Third Intervention||4
263317|NCT01077076|636237|P5|COMPLETED|Third Intervention||5
263318|NCT01077076|636238|P4|COMPLETED|Third Intervention||5
263319|NCT01077076|636239|P3|COMPLETED|Third Intervention||5
263320|NCT01077076|636240|P2|COMPLETED|Third Intervention||5
263321|NCT01077076|636241|P1|COMPLETED|Third Intervention||4
263322|NCT01077076|636236|P6|STARTED|Third Intervention||5
263323|NCT01077076|636237|P5|STARTED|Third Intervention||5
263324|NCT01077076|636238|P4|STARTED|Third Intervention||5
263325|NCT01077076|636239|P3|STARTED|Third Intervention||5
263326|NCT01077076|636240|P2|STARTED|Third Intervention||5
263327|NCT01077076|636241|P1|STARTED|Third Intervention||4
263328|NCT01077076|636236|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
263329|NCT01077076|636237|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
263330|NCT01077076|636238|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
263331|NCT01077076|636239|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
263332|NCT01077076|636240|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
263333|NCT01077076|636241|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
263334|NCT01077076|636236|P6|COMPLETED|Washout Period of 2 Weeks||5
263335|NCT01077076|636237|P5|COMPLETED|Washout Period of 2 Weeks||5
263336|NCT01077076|636238|P4|COMPLETED|Washout Period of 2 Weeks||5
263337|NCT01077076|636239|P3|COMPLETED|Washout Period of 2 Weeks||5
263338|NCT01077076|636240|P2|COMPLETED|Washout Period of 2 Weeks||5
263339|NCT01077076|636241|P1|COMPLETED|Washout Period of 2 Weeks||4
263340|NCT01077076|636236|P6|STARTED|Washout Period of 2 Weeks||5
263341|NCT01077076|636237|P5|STARTED|Washout Period of 2 Weeks||5
263342|NCT01077076|636238|P4|STARTED|Washout Period of 2 Weeks||5
263343|NCT01077076|636239|P3|STARTED|Washout Period of 2 Weeks||5
263344|NCT01077076|636240|P2|STARTED|Washout Period of 2 Weeks||5
263345|NCT01077076|636241|P1|STARTED|Washout Period of 2 Weeks||4
263346|NCT01077076|636236|P6|NOT COMPLETED|Second Intervention||0
263347|NCT01077076|636237|P5|NOT COMPLETED|Second Intervention||0
263348|NCT01077076|636238|P4|NOT COMPLETED|Second Intervention||0
263349|NCT01077076|636239|P3|NOT COMPLETED|Second Intervention||0
263350|NCT01077076|636240|P2|NOT COMPLETED|Second Intervention||0
263351|NCT01077076|636241|P1|NOT COMPLETED|Second Intervention||0
263352|NCT01077076|636236|P6|COMPLETED|Second Intervention||5
263353|NCT01077076|636237|P5|COMPLETED|Second Intervention||5
263354|NCT01077076|636238|P4|COMPLETED|Second Intervention||5
263355|NCT01077076|636239|P3|COMPLETED|Second Intervention||5
263356|NCT01077076|636240|P2|COMPLETED|Second Intervention||5
263357|NCT01077076|636241|P1|COMPLETED|Second Intervention||4
263358|NCT01077076|636236|P6|STARTED|Second Intervention||5
263359|NCT01077076|636237|P5|STARTED|Second Intervention||5
263360|NCT01077076|636238|P4|STARTED|Second Intervention||5
263361|NCT01077076|636239|P3|STARTED|Second Intervention||5
263362|NCT01077076|636240|P2|STARTED|Second Intervention||5
263363|NCT01077076|636241|P1|STARTED|Second Intervention||4
263364|NCT01077076|636236|P6|NOT COMPLETED|Washout Period of 2 Weeks||0
263365|NCT01077076|636237|P5|NOT COMPLETED|Washout Period of 2 Weeks||0
263366|NCT01077076|636238|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
263367|NCT01077076|636239|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
263368|NCT01077076|636240|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
263369|NCT01077076|636241|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
263370|NCT01077076|636236|P6|COMPLETED|Washout Period of 2 Weeks||5
263371|NCT01077076|636237|P5|COMPLETED|Washout Period of 2 Weeks||5
263372|NCT01077076|636238|P4|COMPLETED|Washout Period of 2 Weeks||5
263373|NCT01077076|636239|P3|COMPLETED|Washout Period of 2 Weeks||5
263374|NCT01077076|636240|P2|COMPLETED|Washout Period of 2 Weeks||5
263375|NCT01077076|636241|P1|COMPLETED|Washout Period of 2 Weeks||4
263376|NCT01077076|636236|P6|STARTED|Washout Period of 2 Weeks||5
263377|NCT01077076|636237|P5|STARTED|Washout Period of 2 Weeks||5
263378|NCT01077076|636238|P4|STARTED|Washout Period of 2 Weeks||5
263379|NCT01077076|636239|P3|STARTED|Washout Period of 2 Weeks||5
263380|NCT01077076|636240|P2|STARTED|Washout Period of 2 Weeks||5
263381|NCT01077076|636241|P1|STARTED|Washout Period of 2 Weeks||4
263382|NCT01077076|636236|P6|NOT COMPLETED|First Intervention||0
263383|NCT01077076|636237|P5|NOT COMPLETED|First Intervention||0
263384|NCT01077076|636238|P4|NOT COMPLETED|First Intervention||0
263385|NCT01077076|636239|P3|NOT COMPLETED|First Intervention||0
263386|NCT01077076|636240|P2|NOT COMPLETED|First Intervention||0
263387|NCT01077076|636241|P1|NOT COMPLETED|First Intervention||1
263388|NCT01077076|636236|P6|COMPLETED|First Intervention||5
263389|NCT01077076|636237|P5|COMPLETED|First Intervention||5
263390|NCT01077076|636238|P4|COMPLETED|First Intervention||5
263391|NCT01077076|636239|P3|COMPLETED|First Intervention||5
263392|NCT01077076|636240|P2|COMPLETED|First Intervention||5
263393|NCT01077076|636241|P1|COMPLETED|First Intervention||4
263394|NCT01077076|636236|P6|STARTED|First Intervention||5
263395|NCT01077076|636237|P5|STARTED|First Intervention||5
263396|NCT01077076|636238|P4|STARTED|First Intervention||5
263397|NCT01077076|636239|P3|STARTED|First Intervention||5
263398|NCT01077076|636240|P2|STARTED|First Intervention||5
263399|NCT01077076|636241|P1|STARTED|First Intervention||5
263400|NCT01077128|636249|P1|NOT COMPLETED|Overall Study||67
263401|NCT01077128|636249|P1|COMPLETED|Overall Study||433
263402|NCT01077128|636249|P1|STARTED|Overall Study||500
263403|NCT01077193|636307|P1|NOT COMPLETED|Overall Study||44
263404|NCT01077193|636307|P1|COMPLETED|Overall Study||0
263405|NCT01077193|636307|P1|STARTED|Overall Study||44
263406|NCT01077258|636311|P1|NOT COMPLETED|Overall Study||2568
263407|NCT01077258|636311|P1|COMPLETED|Overall Study||1640
263408|NCT01077258|636311|P1|STARTED|Overall Study||4208
263409|NCT01077271|636351|P1|NOT COMPLETED|Overall Study||22
263410|NCT01077271|636351|P1|COMPLETED|Overall Study||102
263411|NCT01077271|636351|P1|Number of Participants Analyzed|Overall Study||120
263412|NCT01077271|636351|P1|Participants Treated With Palivizumab|Overall Study||120
263413|NCT01077271|636351|P1|STARTED|Overall Study||124
263414|NCT01077284|636392|P3|NOT COMPLETED|Overall Study||3
263415|NCT01077284|636393|P2|NOT COMPLETED|Overall Study||5
263416|NCT01077284|636394|P1|NOT COMPLETED|Overall Study||5
263417|NCT01077284|636392|P3|COMPLETED|Overall Study||30
263418|NCT01077284|636393|P2|COMPLETED|Overall Study||28
263419|NCT01077284|636394|P1|COMPLETED|Overall Study||28
263420|NCT01077284|636392|P3|STARTED|Overall Study||33
263421|NCT01077284|636393|P2|STARTED|Overall Study||33
263422|NCT01077284|636394|P1|STARTED|Overall Study||33
263423|NCT01077310|636413|P2|NOT COMPLETED|Overall Study||0
263424|NCT01077310|636414|P1|NOT COMPLETED|Overall Study||0
263425|NCT01077310|636413|P2|COMPLETED|Overall Study||33
263426|NCT01077310|636414|P1|COMPLETED|Overall Study||67
263427|NCT01077310|636413|P2|STARTED|Overall Study||33
263428|NCT01077310|636414|P1|STARTED|Overall Study||67
263429|NCT01077323|636437|P3|NOT COMPLETED|Overall Study||11912089
263430|NCT01077323|636438|P2|NOT COMPLETED|Overall Study||386263
263431|NCT01077323|636439|P1|NOT COMPLETED|Overall Study||11378
263432|NCT01077323|636437|P3|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|103511
263433|NCT01077323|636438|P2|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|234536
263434|NCT01077323|636439|P1|COMPLETED|Overall Study|COMPLETED = Group of subjects for whom data in outcome measures is presented.|25719
263435|NCT01077323|636437|P3|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|12015600
263436|NCT01077323|636438|P2|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|620799
263437|NCT01077323|636439|P1|STARTED|Overall Study|STARTED = Number of subjects considered for inclusion in this cohort.|37097
263438|NCT01077362|636459|P3|NOT COMPLETED|Overall Study||24
263439|NCT01077362|636460|P2|NOT COMPLETED|Overall Study||19
263440|NCT01077362|636461|P1|NOT COMPLETED|Overall Study||31
263441|NCT01077362|636459|P3|COMPLETED|Overall Study||81
263442|NCT01077362|636460|P2|COMPLETED|Overall Study||84
263443|NCT01077362|636461|P1|COMPLETED|Overall Study||73
263444|NCT01077362|636459|P3|STARTED|Overall Study||105
263445|NCT01077362|636460|P2|STARTED|Overall Study||103
263446|NCT01077362|636461|P1|STARTED|Overall Study||104
263447|NCT01077375|636496|P2|NOT COMPLETED|Overall Study||35
263448|NCT01077375|636497|P1|NOT COMPLETED|Overall Study||10
263449|NCT01077375|636496|P2|COMPLETED|Overall Study||51
263450|NCT01077375|636497|P1|COMPLETED|Overall Study||11
263451|NCT01077375|636496|P2|STARTED|Overall Study|One randomized patient not taking study drug was excluded from the Double-blind Safety Population.|86
263452|NCT01077375|636497|P1|STARTED|Overall Study||21
263453|NCT01077401|636507|P2|NOT COMPLETED|Overall Study||21
263454|NCT01077401|636508|P1|NOT COMPLETED|Overall Study||18
263455|NCT01077401|636507|P2|COMPLETED|Overall Study||54
263456|NCT01077401|636508|P1|COMPLETED|Overall Study||59
263457|NCT01077401|636507|P2|STARTED|Overall Study||75
263458|NCT01077401|636508|P1|STARTED|Overall Study||77
263459|NCT01077544|636520|P2|NOT COMPLETED|Overall Study||5
263460|NCT01077544|636521|P1|NOT COMPLETED|Overall Study||3
263461|NCT01077544|636520|P2|COMPLETED|Overall Study||2
263462|NCT01077544|636521|P1|COMPLETED|Overall Study||5
263463|NCT01077544|636520|P2|STARTED|Overall Study||7
263464|NCT01077544|636521|P1|STARTED|Overall Study||8
263465|NCT01077596|636559|P12|NOT COMPLETED|Overall Study||0
263466|NCT01077596|636560|P11|NOT COMPLETED|Overall Study||0
263467|NCT01077596|636561|P10|NOT COMPLETED|Overall Study||0
263468|NCT01077596|636562|P9|NOT COMPLETED|Overall Study||0
263469|NCT01077596|636563|P8|NOT COMPLETED|Overall Study||0
263470|NCT01077596|636564|P7|NOT COMPLETED|Overall Study||0
263471|NCT01077596|636565|P6|NOT COMPLETED|Overall Study||0
263472|NCT01077596|636566|P5|NOT COMPLETED|Overall Study||0
263473|NCT01077596|636567|P4|NOT COMPLETED|Overall Study||0
263474|NCT01077596|636568|P3|NOT COMPLETED|Overall Study||0
263475|NCT01077596|636569|P2|NOT COMPLETED|Overall Study||0
263476|NCT01077596|636570|P1|NOT COMPLETED|Overall Study||0
263477|NCT01077596|636559|P12|COMPLETED|Overall Study||22150
263478|NCT01077596|636560|P11|COMPLETED|Overall Study||2215
263479|NCT01077596|636561|P10|COMPLETED|Overall Study||28420
263480|NCT01077596|636562|P9|COMPLETED|Overall Study||2842
263481|NCT01077596|636563|P8|COMPLETED|Overall Study||837
263482|NCT01077596|636564|P7|COMPLETED|Overall Study||308
263483|NCT01077596|636565|P6|COMPLETED|Overall Study||882
263484|NCT01077596|636566|P5|COMPLETED|Overall Study||294
263485|NCT01077596|636567|P4|COMPLETED|Overall Study||1370
263486|NCT01077596|636568|P3|COMPLETED|Overall Study||457
263487|NCT01077596|636569|P2|COMPLETED|Overall Study||1050
263488|NCT01077596|636570|P1|COMPLETED|Overall Study||350
263489|NCT01077596|636559|P12|STARTED|Overall Study||22150
263490|NCT01077596|636560|P11|STARTED|Overall Study||2215
263491|NCT01077596|636561|P10|STARTED|Overall Study||28420
263492|NCT01077596|636562|P9|STARTED|Overall Study||2842
263493|NCT01077596|636563|P8|STARTED|Overall Study||837
263494|NCT01077596|636564|P7|STARTED|Overall Study||308
263495|NCT01077596|636565|P6|STARTED|Overall Study||882
263496|NCT01077596|636566|P5|STARTED|Overall Study||294
263497|NCT01077596|636567|P4|STARTED|Overall Study||1370
263498|NCT01077596|636568|P3|STARTED|Overall Study||457
263499|NCT01077596|636569|P2|STARTED|Overall Study||1050
263500|NCT01077596|636570|P1|STARTED|Overall Study||350
263501|NCT01077622|636619|P1|NOT COMPLETED|Overall Study||3
263502|NCT01077622|636619|P1|COMPLETED|Overall Study||7
263503|NCT01077622|636619|P1|STARTED|Overall Study||10
263504|NCT01077713|636667|P2|NOT COMPLETED|Overall Study||36
263505|NCT01077713|636668|P1|NOT COMPLETED|Overall Study||36
263506|NCT01077713|636667|P2|COMPLETED|Overall Study||6
263507|NCT01077713|636668|P1|COMPLETED|Overall Study||8
263508|NCT01077713|636667|P2|STARTED|Overall Study||42
263509|NCT01077713|636668|P1|STARTED|Overall Study||44
263510|NCT01077739|636694|P2|NOT COMPLETED|Overall Study||10
263511|NCT01077739|636695|P1|NOT COMPLETED|Overall Study||5
263512|NCT01077739|636694|P2|COMPLETED|Overall Study||40
263513|NCT01077739|636695|P1|COMPLETED|Overall Study||20
263514|NCT01077739|636694|P2|STARTED|Overall Study||50
263515|NCT01077739|636695|P1|STARTED|Overall Study||25
263516|NCT01077804|636707|P1|NOT COMPLETED|Overall Study||199
263517|NCT01077804|636707|P1|COMPLETED|Overall Study||7386
263518|NCT01077804|636707|P1|STARTED|Overall Study||7585
263519|NCT01077817|636714|P1|NOT COMPLETED|Overall Study||0
263520|NCT01077817|636714|P1|COMPLETED|Overall Study||684815
263521|NCT01077817|636714|P1|STARTED|Overall Study|STARTED and COMPLETED is the number of participants meeting incl./excl. criteria in the GPRD.|684815
263522|NCT01077830|636727|P2|NOT COMPLETED|Overall Study||0
263523|NCT01077830|636728|P1|NOT COMPLETED|Overall Study||0
263524|NCT01077830|636727|P2|COMPLETED|Overall Study||682
263525|NCT01077830|636728|P1|COMPLETED|Overall Study||677
263526|NCT01077830|636727|P2|STARTED|Overall Study||682
263527|NCT01077830|636728|P1|STARTED|Overall Study||677
263528|NCT01077856|636741|P3|NOT COMPLETED|Overall Study||0
263529|NCT01077856|636742|P2|NOT COMPLETED|Overall Study||0
263530|NCT01077856|636743|P1|NOT COMPLETED|Overall Study||0
263531|NCT01077856|636741|P3|COMPLETED|Overall Study||15713
263532|NCT01077856|636742|P2|COMPLETED|Overall Study||16604
263533|NCT01077856|636743|P1|COMPLETED|Overall Study||22199
263534|NCT01077856|636741|P3|STARTED|Overall Study||15713
263535|NCT01077856|636742|P2|STARTED|Overall Study||16604
263536|NCT01077856|636743|P1|STARTED|Overall Study||22199
263537|NCT01077921|636924|P2|NOT COMPLETED|Second Intervention||1
263538|NCT01077921|636925|P1|NOT COMPLETED|Second Intervention||0
263539|NCT01077921|636924|P2|COMPLETED|Second Intervention||9
263540|NCT01077921|636925|P1|COMPLETED|Second Intervention||13
263541|NCT01077921|636924|P2|STARTED|Second Intervention||10
263542|NCT01077921|636925|P1|STARTED|Second Intervention||13
263543|NCT01077921|636924|P2|NOT COMPLETED|Washout||2
263544|NCT01077921|636925|P1|NOT COMPLETED|Washout||0
263545|NCT01077921|636924|P2|COMPLETED|Washout||10
263546|NCT01077921|636925|P1|COMPLETED|Washout||13
263547|NCT01077921|636924|P2|STARTED|Washout||12
263548|NCT01077921|636925|P1|STARTED|Washout||13
263549|NCT01077921|636924|P2|NOT COMPLETED|First Intervention||1
263550|NCT01077921|636925|P1|NOT COMPLETED|First Intervention||1
263551|NCT01077921|636924|P2|COMPLETED|First Intervention||12
263552|NCT01077921|636925|P1|COMPLETED|First Intervention||13
263553|NCT01077921|636924|P2|STARTED|First Intervention||13
263554|NCT01077921|636925|P1|STARTED|First Intervention||14
263555|NCT01077960|636955|P1|NOT COMPLETED|Overall Study||16
263556|NCT01077960|636955|P1|COMPLETED|Overall Study|Modified Intent To Treat (ITT) Population|110
263557|NCT01077960|636955|P1|STARTED|Overall Study|130 subjects consented to participate, 129 enrolled in the study, and 126 received study drug|126
263558|NCT01077973|636967|P3|NOT COMPLETED|Overall Study||0
263559|NCT01077973|636968|P2|NOT COMPLETED|Overall Study||0
263560|NCT01077973|636969|P1|NOT COMPLETED|Overall Study||0
263561|NCT01077973|636967|P3|COMPLETED|Overall Study||80
263562|NCT01077973|636968|P2|COMPLETED|Overall Study||79
263563|NCT01077973|636969|P1|COMPLETED|Overall Study||41
263564|NCT01077973|636967|P3|STARTED|Overall Study||80
263565|NCT01077973|636968|P2|STARTED|Overall Study||79
263566|NCT01077973|636969|P1|STARTED|Overall Study||41
263567|NCT01078090|637017|P1|NOT COMPLETED|Overall Study||4593
263568|NCT01078090|637017|P1|COMPLETED|Overall Study||1152
263569|NCT01078090|637017|P1|STARTED|Overall Study||5745
263570|NCT01078116|637058|P1|NOT COMPLETED|Overall Study||48
263571|NCT01078116|637058|P1|COMPLETED|Overall Study||76
263572|NCT01078116|637058|P1|STARTED|Overall Study|121 participants were included in analysis (3 were excluded due to missing case report form data).|124
263573|NCT01078155|637066|P1|NOT COMPLETED|Overall Study||44
263574|NCT01078155|637066|P1|COMPLETED|Overall Study||87
263575|NCT01078155|637066|P1|STARTED|Overall Study||131
263576|NCT01078207|637082|P1|NOT COMPLETED|Overall Study||0
263577|NCT01078207|637082|P1|COMPLETED|Overall Study||100
263578|NCT01078207|637082|P1|STARTED|Overall Study||100
263579|NCT01078220|637087|P1|NOT COMPLETED|Overall Study||0
263580|NCT01078220|637087|P1|COMPLETED|Overall Study||189629
263581|NCT01078220|637087|P1|STARTED|Overall Study||189629
263582|NCT01078233|637103|P6|NOT COMPLETED|Overall Study||0
263583|NCT01078233|637104|P5|NOT COMPLETED|Overall Study||0
263584|NCT01078233|637105|P4|NOT COMPLETED|Overall Study||0
263585|NCT01078233|637106|P3|NOT COMPLETED|Overall Study||0
263586|NCT01078233|637107|P2|NOT COMPLETED|Overall Study||0
263587|NCT01078233|637108|P1|NOT COMPLETED|Overall Study||0
263588|NCT01078233|637103|P6|COMPLETED|Overall Study||154
263589|NCT01078233|637104|P5|COMPLETED|Overall Study||3199
263590|NCT01078233|637105|P4|COMPLETED|Overall Study||631
263591|NCT01078233|637106|P3|COMPLETED|Overall Study||1681
263592|NCT01078233|637107|P2|COMPLETED|Overall Study||296
263593|NCT01078233|637108|P1|COMPLETED|Overall Study||656
263594|NCT01078233|637103|P6|STARTED|Overall Study||154
263595|NCT01078233|637104|P5|STARTED|Overall Study||3199
263596|NCT01078233|637105|P4|STARTED|Overall Study||631
263597|NCT01078233|637106|P3|STARTED|Overall Study||1681
263598|NCT01078233|637107|P2|STARTED|Overall Study||296
263599|NCT01078233|637108|P1|STARTED|Overall Study||656
263600|NCT01078246|637132|P7|NOT COMPLETED|Overall Study||0
263601|NCT01078246|637133|P6|NOT COMPLETED|Overall Study||0
263602|NCT01078246|637134|P5|NOT COMPLETED|Overall Study||0
263603|NCT01078246|637135|P4|NOT COMPLETED|Overall Study||0
263604|NCT01078246|637136|P3|NOT COMPLETED|Overall Study||0
263605|NCT01078246|637137|P2|NOT COMPLETED|Overall Study||0
263606|NCT01078246|637138|P1|NOT COMPLETED|Overall Study||0
263607|NCT01078246|637132|P7|COMPLETED|Overall Study||22
263608|NCT01078246|637133|P6|COMPLETED|Overall Study||231
263609|NCT01078246|637134|P5|COMPLETED|Overall Study||3310
263610|NCT01078246|637135|P4|COMPLETED|Overall Study||152
263611|NCT01078246|637136|P3|COMPLETED|Overall Study||1963
263612|NCT01078246|637137|P2|COMPLETED|Overall Study||405
263613|NCT01078246|637138|P1|COMPLETED|Overall Study||1041
263614|NCT01078246|637132|P7|STARTED|Overall Study||22
263615|NCT01078246|637133|P6|STARTED|Overall Study||231
263616|NCT01078246|637134|P5|STARTED|Overall Study||3310
263617|NCT01078246|637135|P4|STARTED|Overall Study||152
263618|NCT01078246|637136|P3|STARTED|Overall Study||1963
263619|NCT01078246|637137|P2|STARTED|Overall Study||405
263620|NCT01078246|637138|P1|STARTED|Overall Study||1041
263621|NCT01078298|637166|P2|NOT COMPLETED|Overall Study||90
263622|NCT01078298|637167|P1|NOT COMPLETED|Overall Study||81
263623|NCT01078298|637166|P2|COMPLETED|Overall Study||179
263624|NCT01078298|637167|P1|COMPLETED|Overall Study||175
263625|NCT01078298|637166|P2|STARTED|Overall Study||269
263626|NCT01078298|637167|P1|STARTED|Overall Study||256
263627|NCT01078363|637195|P2|NOT COMPLETED|Overall Study||0
263628|NCT01078363|637196|P1|NOT COMPLETED|Overall Study||0
263629|NCT01078363|637195|P2|COMPLETED|Overall Study||49
263630|NCT01078363|637196|P1|COMPLETED|Overall Study||47
263631|NCT01078363|637195|P2|STARTED|Overall Study||49
263632|NCT01078363|637196|P1|STARTED|Overall Study||47
263633|NCT01078376|637216|P4|NOT COMPLETED|Overall Study||0
263634|NCT01078376|637217|P3|NOT COMPLETED|Overall Study||0
263635|NCT01078376|637218|P2|NOT COMPLETED|Overall Study||0
263636|NCT01078376|637219|P1|NOT COMPLETED|Overall Study||0
263637|NCT01078376|637216|P4|COMPLETED|Overall Study||3
263638|NCT01078376|637217|P3|COMPLETED|Overall Study||8
263639|NCT01078376|637218|P2|COMPLETED|Overall Study||9
263640|NCT01078376|637219|P1|COMPLETED|Overall Study||9
263641|NCT01078376|637216|P4|STARTED|Overall Study||3
263642|NCT01078376|637217|P3|STARTED|Overall Study||8
263643|NCT01078376|637218|P2|STARTED|Overall Study||9
263644|NCT01078376|637219|P1|STARTED|Overall Study||9
263645|NCT01078389|637340|P2|NOT COMPLETED|Overall Study||67
263646|NCT01078389|637341|P1|NOT COMPLETED|Overall Study||64
263647|NCT01078389|637340|P2|COMPLETED|Overall Study||90
263648|NCT01078389|637341|P1|COMPLETED|Overall Study||93
263649|NCT01078389|637340|P2|STARTED|Overall Study||157
263650|NCT01078389|637341|P1|STARTED|Overall Study||157
263651|NCT01078402|637358|P3|NOT COMPLETED|Overall Study||68
263652|NCT01078402|637359|P2|NOT COMPLETED|Overall Study||29
263653|NCT01078402|637360|P1|NOT COMPLETED|Overall Study||107
263654|NCT01078402|637358|P3|COMPLETED|Overall Study||166
263655|NCT01078402|637359|P2|COMPLETED|Overall Study||95
263656|NCT01078402|637360|P1|COMPLETED|Overall Study||324
263657|NCT01078402|637358|P3|STARTED|Overall Study||234
263658|NCT01078402|637359|P2|STARTED|Overall Study||124
263659|NCT01078402|637360|P1|STARTED|Overall Study||431
263660|NCT01078441|637389|P1|NOT COMPLETED|Overall Study||1
263661|NCT01078441|637389|P1|COMPLETED|Overall Study||1
263662|NCT01078441|637389|P1|STARTED|Overall Study||2
263663|NCT01078454|637395|P2|NOT COMPLETED|Overall Study||2
263664|NCT01078454|637396|P1|NOT COMPLETED|Overall Study||1
263665|NCT01078454|637395|P2|COMPLETED|Overall Study||3
263666|NCT01078454|637396|P1|COMPLETED|Overall Study||5
263667|NCT01078454|637395|P2|STARTED|Overall Study||5
263668|NCT01078454|637396|P1|STARTED|Overall Study||6
263669|NCT01078545|637402|P1|NOT COMPLETED|Overall Study||26
263670|NCT01078545|637402|P1|COMPLETED|Overall Study||703
263671|NCT01078545|637402|P1|Per Protocol Population|Overall Study||661
263672|NCT01078545|637402|P1|Intent-to-treat Population|Overall Study||729
263673|NCT01078545|637402|P1|STARTED|Overall Study||729
263674|NCT01078571|637410|P1|NOT COMPLETED|Overall Study||115
263675|NCT01078571|637410|P1|COMPLETED|Overall Study||590
263676|NCT01078571|637410|P1|Intent-to-treat (ITT) Population|Overall Study||591
263677|NCT01078571|637410|P1|Safety Population|Overall Study||675
263678|NCT01078571|637410|P1|STARTED|Overall Study||705
263679|NCT01078584|637426|P1|NOT COMPLETED|Overall Study||3010
263680|NCT01078584|637426|P1|COMPLETED|Overall Study||4983
263681|NCT01078584|637426|P1|Participants Conducted Visit 4(12-month)|Overall Study||4983
263682|NCT01078584|637426|P1|Participants Conducted Visit 3 (6-month)|Overall Study||5833
263683|NCT01078584|637426|P1|Participants Conducted Visit 2 (3-month)|Overall Study||7125
263684|NCT01078584|637426|P1|STARTED|Overall Study||7993
263685|NCT01078623|637507|P20|NOT COMPLETED|Treatment Period 4||0
263686|NCT01078623|637508|P19|NOT COMPLETED|Treatment Period 4||0
263687|NCT01078623|637509|P18|NOT COMPLETED|Treatment Period 4||0
263688|NCT01078623|637510|P17|NOT COMPLETED|Treatment Period 4||0
263689|NCT01078623|637511|P16|NOT COMPLETED|Treatment Period 4||1
263690|NCT01078623|637512|P15|NOT COMPLETED|Treatment Period 4||0
263691|NCT01078623|637513|P14|NOT COMPLETED|Treatment Period 4||0
263692|NCT01078623|637514|P13|NOT COMPLETED|Treatment Period 4||0
263693|NCT01078623|637515|P12|NOT COMPLETED|Treatment Period 4||0
263694|NCT01078623|637516|P11|NOT COMPLETED|Treatment Period 4||0
263695|NCT01078623|637517|P10|NOT COMPLETED|Treatment Period 4||0
263696|NCT01078623|637518|P9|NOT COMPLETED|Treatment Period 4||0
263697|NCT01078623|637519|P8|NOT COMPLETED|Treatment Period 4||0
263698|NCT01078623|637520|P7|NOT COMPLETED|Treatment Period 4||0
263699|NCT01078623|637521|P6|NOT COMPLETED|Treatment Period 4||0
263700|NCT01078623|637522|P5|NOT COMPLETED|Treatment Period 4||0
263701|NCT01078623|637523|P4|NOT COMPLETED|Treatment Period 4||0
263702|NCT01078623|637524|P3|NOT COMPLETED|Treatment Period 4||1
263703|NCT01078623|637525|P2|NOT COMPLETED|Treatment Period 4||0
263704|NCT01078623|637526|P1|NOT COMPLETED|Treatment Period 4||0
263705|NCT01078623|637507|P20|COMPLETED|Treatment Period 4||7
263706|NCT01078623|637508|P19|COMPLETED|Treatment Period 4||6
263707|NCT01078623|637509|P18|COMPLETED|Treatment Period 4||7
263708|NCT01078623|637510|P17|COMPLETED|Treatment Period 4||7
263709|NCT01078623|637511|P16|COMPLETED|Treatment Period 4||6
263710|NCT01078623|637512|P15|COMPLETED|Treatment Period 4||7
263711|NCT01078623|637513|P14|COMPLETED|Treatment Period 4||6
263712|NCT01078623|637514|P13|COMPLETED|Treatment Period 4||7
263713|NCT01078623|637515|P12|COMPLETED|Treatment Period 4||7
263714|NCT01078623|637516|P11|COMPLETED|Treatment Period 4||6
263715|NCT01078623|637517|P10|COMPLETED|Treatment Period 4||6
263716|NCT01078623|637518|P9|COMPLETED|Treatment Period 4||5
263717|NCT01078623|637519|P8|COMPLETED|Treatment Period 4||6
263718|NCT01078623|637520|P7|COMPLETED|Treatment Period 4||5
263719|NCT01078623|637521|P6|COMPLETED|Treatment Period 4||4
263720|NCT01078623|637522|P5|COMPLETED|Treatment Period 4||6
263721|NCT01078623|637523|P4|COMPLETED|Treatment Period 4||6
263722|NCT01078623|637524|P3|COMPLETED|Treatment Period 4||5
263723|NCT01078623|637525|P2|COMPLETED|Treatment Period 4||5
263724|NCT01078623|637526|P1|COMPLETED|Treatment Period 4||5
263725|NCT01078623|637507|P20|STARTED|Treatment Period 4||7
263726|NCT01078623|637508|P19|STARTED|Treatment Period 4||6
263727|NCT01078623|637509|P18|STARTED|Treatment Period 4||7
263728|NCT01078623|637510|P17|STARTED|Treatment Period 4||7
263729|NCT01078623|637511|P16|STARTED|Treatment Period 4||7
263730|NCT01078623|637512|P15|STARTED|Treatment Period 4||7
263731|NCT01078623|637513|P14|STARTED|Treatment Period 4||6
263732|NCT01078623|637514|P13|STARTED|Treatment Period 4||7
263733|NCT01078623|637515|P12|STARTED|Treatment Period 4||7
263734|NCT01078623|637516|P11|STARTED|Treatment Period 4||6
263735|NCT01078623|637517|P10|STARTED|Treatment Period 4||6
263736|NCT01078623|637518|P9|STARTED|Treatment Period 4||5
263737|NCT01078623|637519|P8|STARTED|Treatment Period 4||6
263738|NCT01078623|637520|P7|STARTED|Treatment Period 4||5
263739|NCT01078623|637521|P6|STARTED|Treatment Period 4||4
263740|NCT01078623|637522|P5|STARTED|Treatment Period 4||6
263741|NCT01078623|637523|P4|STARTED|Treatment Period 4||6
263742|NCT01078623|637524|P3|STARTED|Treatment Period 4||6
263743|NCT01078623|637525|P2|STARTED|Treatment Period 4||5
263744|NCT01078623|637526|P1|STARTED|Treatment Period 4||5
263745|NCT01078623|637507|P20|NOT COMPLETED|Treatment Period 3||0
263746|NCT01078623|637508|P19|NOT COMPLETED|Treatment Period 3||0
263747|NCT01078623|637509|P18|NOT COMPLETED|Treatment Period 3||0
263748|NCT01078623|637510|P17|NOT COMPLETED|Treatment Period 3||0
263749|NCT01078623|637511|P16|NOT COMPLETED|Treatment Period 3||0
263750|NCT01078623|637512|P15|NOT COMPLETED|Treatment Period 3||0
263751|NCT01078623|637513|P14|NOT COMPLETED|Treatment Period 3||1
263752|NCT01078623|637514|P13|NOT COMPLETED|Treatment Period 3||0
263753|NCT01078623|637515|P12|NOT COMPLETED|Treatment Period 3||0
263754|NCT01078623|637516|P11|NOT COMPLETED|Treatment Period 3||0
263755|NCT01078623|637517|P10|NOT COMPLETED|Treatment Period 3||0
263756|NCT01078623|637518|P9|NOT COMPLETED|Treatment Period 3||0
263757|NCT01078623|637519|P8|NOT COMPLETED|Treatment Period 3||0
263758|NCT01078623|637520|P7|NOT COMPLETED|Treatment Period 3||0
263759|NCT01078623|637521|P6|NOT COMPLETED|Treatment Period 3||0
263760|NCT01078623|637522|P5|NOT COMPLETED|Treatment Period 3||1
263761|NCT01078623|637523|P4|NOT COMPLETED|Treatment Period 3||0
263762|NCT01078623|637524|P3|NOT COMPLETED|Treatment Period 3||0
263763|NCT01078623|637525|P2|NOT COMPLETED|Treatment Period 3||0
263764|NCT01078623|637526|P1|NOT COMPLETED|Treatment Period 3||0
263765|NCT01078623|637507|P20|COMPLETED|Treatment Period 3||7
263766|NCT01078623|637508|P19|COMPLETED|Treatment Period 3||6
263767|NCT01078623|637509|P18|COMPLETED|Treatment Period 3||7
263768|NCT01078623|637510|P17|COMPLETED|Treatment Period 3||7
263769|NCT01078623|637511|P16|COMPLETED|Treatment Period 3||7
263770|NCT01078623|637512|P15|COMPLETED|Treatment Period 3||7
263771|NCT01078623|637513|P14|COMPLETED|Treatment Period 3||6
263772|NCT01078623|637514|P13|COMPLETED|Treatment Period 3||7
263773|NCT01078623|637515|P12|COMPLETED|Treatment Period 3||7
263774|NCT01078623|637516|P11|COMPLETED|Treatment Period 3||6
263775|NCT01078623|637517|P10|COMPLETED|Treatment Period 3||6
263776|NCT01078623|637518|P9|COMPLETED|Treatment Period 3||5
263777|NCT01078623|637519|P8|COMPLETED|Treatment Period 3||6
263778|NCT01078623|637520|P7|COMPLETED|Treatment Period 3||5
263779|NCT01078623|637521|P6|COMPLETED|Treatment Period 3||4
263780|NCT01078623|637522|P5|COMPLETED|Treatment Period 3||6
263781|NCT01078623|637523|P4|COMPLETED|Treatment Period 3||6
263782|NCT01078623|637524|P3|COMPLETED|Treatment Period 3||6
263783|NCT01078623|637525|P2|COMPLETED|Treatment Period 3||5
263784|NCT01078623|637526|P1|COMPLETED|Treatment Period 3||5
263785|NCT01078623|637507|P20|STARTED|Treatment Period 3||7
263786|NCT01078623|637508|P19|STARTED|Treatment Period 3||6
263787|NCT01078623|637509|P18|STARTED|Treatment Period 3||7
263788|NCT01078623|637510|P17|STARTED|Treatment Period 3||7
263789|NCT01078623|637511|P16|STARTED|Treatment Period 3||7
263790|NCT01078623|637512|P15|STARTED|Treatment Period 3||7
263791|NCT01078623|637513|P14|STARTED|Treatment Period 3||7
263792|NCT01078623|637514|P13|STARTED|Treatment Period 3||7
263793|NCT01078623|637515|P12|STARTED|Treatment Period 3||7
263794|NCT01078623|637516|P11|STARTED|Treatment Period 3||6
263795|NCT01078623|637517|P10|STARTED|Treatment Period 3||6
263796|NCT01078623|637518|P9|STARTED|Treatment Period 3||5
263797|NCT01078623|637519|P8|STARTED|Treatment Period 3||6
263798|NCT01078623|637520|P7|STARTED|Treatment Period 3||5
263799|NCT01078623|637521|P6|STARTED|Treatment Period 3||4
263800|NCT01078623|637522|P5|STARTED|Treatment Period 3||7
263801|NCT01078623|637523|P4|STARTED|Treatment Period 3||6
263802|NCT01078623|637524|P3|STARTED|Treatment Period 3||6
263803|NCT01078623|637525|P2|STARTED|Treatment Period 3||5
263804|NCT01078623|637526|P1|STARTED|Treatment Period 3||5
263805|NCT01078623|637507|P20|NOT COMPLETED|Treatment Period 2||0
263806|NCT01078623|637508|P19|NOT COMPLETED|Treatment Period 2||1
263807|NCT01078623|637509|P18|NOT COMPLETED|Treatment Period 2||0
263808|NCT01078623|637510|P17|NOT COMPLETED|Treatment Period 2||0
263809|NCT01078623|637511|P16|NOT COMPLETED|Treatment Period 2||0
263810|NCT01078623|637512|P15|NOT COMPLETED|Treatment Period 2||0
263811|NCT01078623|637513|P14|NOT COMPLETED|Treatment Period 2||0
263812|NCT01078623|637514|P13|NOT COMPLETED|Treatment Period 2||0
263813|NCT01078623|637515|P12|NOT COMPLETED|Treatment Period 2||0
263814|NCT01078623|637516|P11|NOT COMPLETED|Treatment Period 2||0
263815|NCT01078623|637517|P10|NOT COMPLETED|Treatment Period 2||0
263816|NCT01078623|637518|P9|NOT COMPLETED|Treatment Period 2||0
263817|NCT01078623|637519|P8|NOT COMPLETED|Treatment Period 2||0
263818|NCT01078623|637520|P7|NOT COMPLETED|Treatment Period 2||1
263819|NCT01078623|637521|P6|NOT COMPLETED|Treatment Period 2||1
263820|NCT01078623|637522|P5|NOT COMPLETED|Treatment Period 2||0
263821|NCT01078623|637523|P4|NOT COMPLETED|Treatment Period 2||0
263822|NCT01078623|637524|P3|NOT COMPLETED|Treatment Period 2||0
263823|NCT01078623|637525|P2|NOT COMPLETED|Treatment Period 2||0
263824|NCT01078623|637526|P1|NOT COMPLETED|Treatment Period 2||0
263825|NCT01078623|637507|P20|COMPLETED|Treatment Period 2||7
263826|NCT01078623|637508|P19|COMPLETED|Treatment Period 2||6
263827|NCT01078623|637509|P18|COMPLETED|Treatment Period 2||7
263828|NCT01078623|637510|P17|COMPLETED|Treatment Period 2||7
263829|NCT01078623|637511|P16|COMPLETED|Treatment Period 2||7
263830|NCT01078623|637512|P15|COMPLETED|Treatment Period 2||7
263831|NCT01078623|637513|P14|COMPLETED|Treatment Period 2||7
263832|NCT01078623|637514|P13|COMPLETED|Treatment Period 2||7
263833|NCT01078623|637515|P12|COMPLETED|Treatment Period 2||7
263834|NCT01078623|637516|P11|COMPLETED|Treatment Period 2||6
263835|NCT01078623|637517|P10|COMPLETED|Treatment Period 2||6
263836|NCT01078623|637518|P9|COMPLETED|Treatment Period 2||5
263837|NCT01078623|637519|P8|COMPLETED|Treatment Period 2||6
263838|NCT01078623|637520|P7|COMPLETED|Treatment Period 2||5
263839|NCT01078623|637521|P6|COMPLETED|Treatment Period 2||4
263840|NCT01078623|637522|P5|COMPLETED|Treatment Period 2||7
263841|NCT01078623|637523|P4|COMPLETED|Treatment Period 2||6
263842|NCT01078623|637524|P3|COMPLETED|Treatment Period 2||6
263843|NCT01078623|637525|P2|COMPLETED|Treatment Period 2||5
263844|NCT01078623|637526|P1|COMPLETED|Treatment Period 2||5
263845|NCT01078623|637507|P20|STARTED|Treatment Period 2||7
263846|NCT01078623|637508|P19|STARTED|Treatment Period 2||7
263847|NCT01078623|637509|P18|STARTED|Treatment Period 2||7
263848|NCT01078623|637510|P17|STARTED|Treatment Period 2||7
263849|NCT01078623|637511|P16|STARTED|Treatment Period 2||7
263850|NCT01078623|637512|P15|STARTED|Treatment Period 2||7
263851|NCT01078623|637513|P14|STARTED|Treatment Period 2||7
263852|NCT01078623|637514|P13|STARTED|Treatment Period 2||7
263853|NCT01078623|637515|P12|STARTED|Treatment Period 2||7
263854|NCT01078623|637516|P11|STARTED|Treatment Period 2||6
263855|NCT01078623|637517|P10|STARTED|Treatment Period 2||6
263856|NCT01078623|637518|P9|STARTED|Treatment Period 2||5
263857|NCT01078623|637519|P8|STARTED|Treatment Period 2||6
263858|NCT01078623|637520|P7|STARTED|Treatment Period 2||6
263859|NCT01078623|637521|P6|STARTED|Treatment Period 2||5
263860|NCT01078623|637522|P5|STARTED|Treatment Period 2||7
263861|NCT01078623|637523|P4|STARTED|Treatment Period 2||6
263862|NCT01078623|637524|P3|STARTED|Treatment Period 2||6
263863|NCT01078623|637525|P2|STARTED|Treatment Period 2||5
263864|NCT01078623|637526|P1|STARTED|Treatment Period 2||5
263865|NCT01078623|637507|P20|NOT COMPLETED|Treatment Period 1||0
263866|NCT01078623|637508|P19|NOT COMPLETED|Treatment Period 1||0
263867|NCT01078623|637509|P18|NOT COMPLETED|Treatment Period 1||0
263868|NCT01078623|637510|P17|NOT COMPLETED|Treatment Period 1||0
263869|NCT01078623|637511|P16|NOT COMPLETED|Treatment Period 1||0
263870|NCT01078623|637512|P15|NOT COMPLETED|Treatment Period 1||0
263871|NCT01078623|637513|P14|NOT COMPLETED|Treatment Period 1||0
263872|NCT01078623|637514|P13|NOT COMPLETED|Treatment Period 1||0
263873|NCT01078623|637515|P12|NOT COMPLETED|Treatment Period 1||0
263874|NCT01078623|637516|P11|NOT COMPLETED|Treatment Period 1||1
263875|NCT01078623|637517|P10|NOT COMPLETED|Treatment Period 1||1
263876|NCT01078623|637518|P9|NOT COMPLETED|Treatment Period 1||1
263877|NCT01078623|637519|P8|NOT COMPLETED|Treatment Period 1||1
263878|NCT01078623|637520|P7|NOT COMPLETED|Treatment Period 1||1
263879|NCT01078623|637521|P6|NOT COMPLETED|Treatment Period 1||1
263880|NCT01078623|637522|P5|NOT COMPLETED|Treatment Period 1||0
263881|NCT01078623|637523|P4|NOT COMPLETED|Treatment Period 1||0
263882|NCT01078623|637524|P3|NOT COMPLETED|Treatment Period 1||1
263883|NCT01078623|637525|P2|NOT COMPLETED|Treatment Period 1||1
263884|NCT01078623|637526|P1|NOT COMPLETED|Treatment Period 1||1
263885|NCT01078623|637507|P20|COMPLETED|Treatment Period 1||7
263886|NCT01078623|637508|P19|COMPLETED|Treatment Period 1||7
263887|NCT01078623|637509|P18|COMPLETED|Treatment Period 1||7
263888|NCT01078623|637510|P17|COMPLETED|Treatment Period 1||7
263889|NCT01078623|637511|P16|COMPLETED|Treatment Period 1||7
263890|NCT01078623|637512|P15|COMPLETED|Treatment Period 1||7
263891|NCT01078623|637513|P14|COMPLETED|Treatment Period 1||7
263892|NCT01078623|637514|P13|COMPLETED|Treatment Period 1||7
263893|NCT01078623|637515|P12|COMPLETED|Treatment Period 1||7
263894|NCT01078623|637516|P11|COMPLETED|Treatment Period 1||6
263895|NCT01078623|637517|P10|COMPLETED|Treatment Period 1||6
263896|NCT01078623|637518|P9|COMPLETED|Treatment Period 1||5
263897|NCT01078623|637519|P8|COMPLETED|Treatment Period 1||6
263898|NCT01078623|637520|P7|COMPLETED|Treatment Period 1||6
263899|NCT01078623|637521|P6|COMPLETED|Treatment Period 1||5
263900|NCT01078623|637522|P5|COMPLETED|Treatment Period 1||7
263901|NCT01078623|637523|P4|COMPLETED|Treatment Period 1||6
263902|NCT01078623|637524|P3|COMPLETED|Treatment Period 1||6
263903|NCT01078623|637525|P2|COMPLETED|Treatment Period 1||5
263904|NCT01078623|637526|P1|COMPLETED|Treatment Period 1||5
263905|NCT01078623|637507|P20|STARTED|Treatment Period 1||7
263906|NCT01078623|637508|P19|STARTED|Treatment Period 1||7
263907|NCT01078623|637509|P18|STARTED|Treatment Period 1||7
263908|NCT01078623|637510|P17|STARTED|Treatment Period 1||7
263909|NCT01078623|637511|P16|STARTED|Treatment Period 1||7
263910|NCT01078623|637512|P15|STARTED|Treatment Period 1||7
263911|NCT01078623|637513|P14|STARTED|Treatment Period 1||7
263912|NCT01078623|637514|P13|STARTED|Treatment Period 1||7
263913|NCT01078623|637515|P12|STARTED|Treatment Period 1||7
263914|NCT01078623|637516|P11|STARTED|Treatment Period 1||7
263915|NCT01078623|637517|P10|STARTED|Treatment Period 1||7
263916|NCT01078623|637518|P9|STARTED|Treatment Period 1||6
263917|NCT01078623|637519|P8|STARTED|Treatment Period 1||7
263918|NCT01078623|637520|P7|STARTED|Treatment Period 1||7
263919|NCT01078623|637521|P6|STARTED|Treatment Period 1||6
263920|NCT01078623|637522|P5|STARTED|Treatment Period 1||7
263921|NCT01078623|637523|P4|STARTED|Treatment Period 1||6
263922|NCT01078623|637524|P3|STARTED|Treatment Period 1||7
263923|NCT01078623|637525|P2|STARTED|Treatment Period 1||6
263924|NCT01078623|637526|P1|STARTED|Treatment Period 1||6
263925|NCT01078662|637553|P5|NOT COMPLETED|Overall Study||11
263926|NCT01078662|637554|P4|NOT COMPLETED|Overall Study||7
263927|NCT01078662|637555|P3|NOT COMPLETED|Overall Study||21
263928|NCT01078662|637556|P2|NOT COMPLETED|Overall Study||168
263929|NCT01078662|637557|P1|NOT COMPLETED|Overall Study||58
263930|NCT01078662|637553|P5|COMPLETED|Overall Study||1
263931|NCT01078662|637554|P4|COMPLETED|Overall Study||1
263932|NCT01078662|637555|P3|COMPLETED|Overall Study||2
263933|NCT01078662|637556|P2|COMPLETED|Overall Study||25
263934|NCT01078662|637557|P1|COMPLETED|Overall Study||4
263935|NCT01078662|637553|P5|STARTED|Overall Study||12
263936|NCT01078662|637554|P4|STARTED|Overall Study||8
263937|NCT01078662|637555|P3|STARTED|Overall Study||23
263938|NCT01078662|637556|P2|STARTED|Overall Study||193
263939|NCT01078662|637557|P1|STARTED|Overall Study||62
263940|NCT01078675|637598|P2|NOT COMPLETED|Overall Study||6
263941|NCT01078675|637599|P1|NOT COMPLETED|Overall Study||68
263942|NCT01078675|637598|P2|COMPLETED|Overall Study|Healthy siblings did not participate in investigational product administration.|59
263943|NCT01078675|637599|P1|COMPLETED|Overall Study||182
263944|NCT01078675|637598|P2|Patients Treated|Overall Study||0
263945|NCT01078675|637599|P1|Patients Treated|Overall Study||198
263946|NCT01078675|637598|P2|STARTED|Overall Study||65
263947|NCT01078675|637599|P1|STARTED|Overall Study||250
263948|NCT01078753|637618|P2|NOT COMPLETED|Treatment Period II||0
263949|NCT01078753|637619|P1|NOT COMPLETED|Treatment Period II||0
263950|NCT01078753|637618|P2|COMPLETED|Treatment Period II||44
263951|NCT01078753|637619|P1|COMPLETED|Treatment Period II||45
263952|NCT01078753|637618|P2|Full Analysis Set|Treatment Period II||44
263953|NCT01078753|637619|P1|Full Analysis Set|Treatment Period II|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
263954|NCT01078753|637618|P2|STARTED|Treatment Period II||44
263955|NCT01078753|637619|P1|STARTED|Treatment Period II|Desmopressin 120 µg - 4 participants Desmopressin 240 µg - 41 participants|45
263956|NCT01078753|637618|P2|NOT COMPLETED|Treatment Period I||0
263957|NCT01078753|637619|P1|NOT COMPLETED|Treatment Period I||0
263958|NCT01078753|637618|P2|COMPLETED|Treatment Period I||44
263959|NCT01078753|637619|P1|COMPLETED|Treatment Period I||45
263960|NCT01078753|637618|P2|Full Analysis Set|Treatment Period I||44
263961|NCT01078753|637619|P1|Full Analysis Set|Treatment Period I|One patient was excluded from the full analysis set due to failure to satisfy the entry criteria.|44
263962|NCT01078753|637618|P2|STARTED|Treatment Period I||44
263963|NCT01078753|637619|P1|STARTED|Treatment Period I||45
263964|NCT01078805|637629|P1|NOT COMPLETED|Overall Study||2050
263965|NCT01078805|637629|P1|COMPLETED|Overall Study||2117
263966|NCT01078805|637629|P1|Modified Intent-To-Treat|Overall Study|≥1 dose of study drug (SD) and didn't discontinue SD more than 3 consecutive months during treatment|3720
263967|NCT01078805|637629|P1|Took at Least 1 Dose of Study Drug|Overall Study||4085
263968|NCT01078805|637629|P1|STARTED|Overall Study||4167
263969|NCT01078844|637641|P1|NOT COMPLETED|Overall Study||4
263970|NCT01078844|637641|P1|COMPLETED|Overall Study||0
263971|NCT01078844|637641|P1|STARTED|Overall Study||4
263972|NCT01078909|637651|P5|NOT COMPLETED|Overall Study||2
263973|NCT01078909|637652|P4|NOT COMPLETED|Overall Study||1
263974|NCT01078909|637653|P3|NOT COMPLETED|Overall Study||1
263975|NCT01078909|637654|P2|NOT COMPLETED|Overall Study||4
263976|NCT01078909|637655|P1|NOT COMPLETED|Overall Study||2
263977|NCT01078909|637651|P5|COMPLETED|Overall Study||23
263978|NCT01078909|637652|P4|COMPLETED|Overall Study||24
263979|NCT01078909|637653|P3|COMPLETED|Overall Study||24
263980|NCT01078909|637654|P2|COMPLETED|Overall Study||21
263981|NCT01078909|637655|P1|COMPLETED|Overall Study||23
263982|NCT01078909|637651|P5|STARTED|Overall Study||25
263983|NCT01078909|637652|P4|STARTED|Overall Study||25
263984|NCT01078909|637653|P3|STARTED|Overall Study||25
263985|NCT01078909|637654|P2|STARTED|Overall Study||25
263986|NCT01078909|637655|P1|STARTED|Overall Study||25
263987|NCT01078922|637672|P1|NOT COMPLETED|Overall Study||1
263988|NCT01078922|637672|P1|COMPLETED|Overall Study||10
263989|NCT01078922|637672|P1|STARTED|Overall Study||11
263990|NCT01078974|637677|P1|NOT COMPLETED|Overall Study||3
263991|NCT01078974|637677|P1|COMPLETED|Overall Study||4
263992|NCT01078974|637677|P1|STARTED|Overall Study||7
263993|NCT01091103|637682|P1|NOT COMPLETED|Overall Study||4
263994|NCT01091103|637682|P1|COMPLETED|Overall Study|Patients on study drug and completed Week 9 visit assessments.|56
263995|NCT01091103|637682|P1|STARTED|Overall Study||60
263996|NCT01091116|637707|P5|NOT COMPLETED|Overall Study||11
263997|NCT01091116|637708|P4|NOT COMPLETED|Overall Study||4
263998|NCT01091116|637709|P3|NOT COMPLETED|Overall Study||11
263999|NCT01091116|637710|P2|NOT COMPLETED|Overall Study||8
264000|NCT01091116|637711|P1|NOT COMPLETED|Overall Study||6
264001|NCT01091116|637707|P5|COMPLETED|Overall Study||73
264002|NCT01091116|637708|P4|COMPLETED|Overall Study||80
264003|NCT01091116|637709|P3|COMPLETED|Overall Study||73
264004|NCT01091116|637710|P2|COMPLETED|Overall Study||80
264005|NCT01091116|637711|P1|COMPLETED|Overall Study||77
264006|NCT01091116|637707|P5|STARTED|Overall Study||84
264007|NCT01091116|637708|P4|STARTED|Overall Study||84
264008|NCT01091116|637709|P3|STARTED|Overall Study||84
264009|NCT01091116|637710|P2|STARTED|Overall Study||88
264010|NCT01091116|637711|P1|STARTED|Overall Study||83
264011|NCT01091155|637763|P1|NOT COMPLETED|Overall Study||9
264012|NCT01091155|637763|P1|COMPLETED|Overall Study||279
264013|NCT01091155|637763|P1|STARTED|Overall Study||288
264014|NCT01091246|637770|P3|NOT COMPLETED|Overall Study||13
264015|NCT01091246|637771|P2|NOT COMPLETED|Overall Study||16
264016|NCT01091246|637772|P1|NOT COMPLETED|Overall Study||35
264017|NCT01091246|637770|P3|COMPLETED|Overall Study||450
264018|NCT01091246|637771|P2|COMPLETED|Overall Study||448
264019|NCT01091246|637772|P1|COMPLETED|Overall Study||1350
264020|NCT01091246|637770|P3|STARTED|Overall Study||463
264021|NCT01091246|637771|P2|STARTED|Overall Study||464
264022|NCT01091246|637772|P1|STARTED|Overall Study||1385
264023|NCT01091259|637846|P1|NOT COMPLETED|Overall Study||5
264024|NCT01091259|637846|P1|COMPLETED|Overall Study|Number of patients who had at least 2 cycles of treatments|24
264025|NCT01091259|637846|P1|STARTED|Overall Study||29
264026|NCT01093599|637856|P2|NOT COMPLETED|Overall Study||46
264027|NCT01093599|637857|P1|NOT COMPLETED|Overall Study||32
264028|NCT01093599|637856|P2|COMPLETED|Overall Study||59
264029|NCT01093599|637857|P1|COMPLETED|Overall Study||59
264030|NCT01093599|637856|P2|STARTED|Overall Study||105
264031|NCT01093599|637857|P1|STARTED|Overall Study||91
264032|NCT01093625|637865|P2|NOT COMPLETED|1-Year Visit||3
264033|NCT01093625|637866|P1|NOT COMPLETED|1-Year Visit||5
264034|NCT01093625|637865|P2|COMPLETED|1-Year Visit||37
264035|NCT01093625|637866|P1|COMPLETED|1-Year Visit||29
264036|NCT01093625|637865|P2|STARTED|1-Year Visit||40
264037|NCT01093625|637866|P1|STARTED|1-Year Visit||34
264038|NCT01093625|637865|P2|NOT COMPLETED|6-Month Visit||9
264039|NCT01093625|637866|P1|NOT COMPLETED|6-Month Visit||8
264040|NCT01093625|637865|P2|COMPLETED|6-Month Visit||40
264041|NCT01093625|637866|P1|COMPLETED|6-Month Visit||34
264042|NCT01093625|637865|P2|STARTED|6-Month Visit||49
264043|NCT01093625|637866|P1|STARTED|6-Month Visit||42
264044|NCT01093625|637865|P2|NOT COMPLETED|3-Month Visit||0
264045|NCT01093625|637866|P1|NOT COMPLETED|3-Month Visit||2
264046|NCT01093625|637865|P2|COMPLETED|3-Month Visit||49
264047|NCT01093625|637866|P1|COMPLETED|3-Month Visit||42
264048|NCT01093625|637865|P2|STARTED|3-Month Visit||49
264049|NCT01093625|637866|P1|STARTED|3-Month Visit||44
264050|NCT01093625|637865|P2|NOT COMPLETED|1-Month Visit||0
264051|NCT01093625|637866|P1|NOT COMPLETED|1-Month Visit||2
264052|NCT01093625|637865|P2|COMPLETED|1-Month Visit||49
264053|NCT01093625|637866|P1|COMPLETED|1-Month Visit||44
264054|NCT01093625|637865|P2|STARTED|1-Month Visit||49
264055|NCT01093625|637866|P1|STARTED|1-Month Visit||46
264056|NCT01093625|637865|P2|NOT COMPLETED|2-Week Visit||0
264057|NCT01093625|637866|P1|NOT COMPLETED|2-Week Visit||1
264058|NCT01093625|637865|P2|COMPLETED|2-Week Visit||49
264059|NCT01093625|637866|P1|COMPLETED|2-Week Visit||46
264060|NCT01093625|637865|P2|STARTED|2-Week Visit||49
264061|NCT01093625|637866|P1|STARTED|2-Week Visit||47
264062|NCT01093625|637865|P2|NOT COMPLETED|Baseline and Dispensed||0
264063|NCT01093625|637866|P1|NOT COMPLETED|Baseline and Dispensed||2
264064|NCT01093625|637865|P2|COMPLETED|Baseline and Dispensed||49
264065|NCT01093625|637866|P1|COMPLETED|Baseline and Dispensed||47
264066|NCT01093625|637865|P2|STARTED|Baseline and Dispensed||49
264067|NCT01093625|637866|P1|STARTED|Baseline and Dispensed||49
264068|NCT01093651|637886|P2|NOT COMPLETED|Overall Study||0
264069|NCT01093651|637887|P1|NOT COMPLETED|Overall Study||0
264070|NCT01093651|637886|P2|COMPLETED|Overall Study||10
264071|NCT01093651|637887|P1|COMPLETED|Overall Study||10
264072|NCT01093651|637886|P2|STARTED|Overall Study||10
264073|NCT01093651|637887|P1|STARTED|Overall Study||10
264074|NCT01093690|637907|P2|NOT COMPLETED|Overall Study||0
264075|NCT01093690|637908|P1|NOT COMPLETED|Overall Study||0
264076|NCT01093690|637907|P2|COMPLETED|Overall Study||79
264077|NCT01093690|637908|P1|COMPLETED|Overall Study||83
264078|NCT01093690|637907|P2|STARTED|Overall Study||79
264079|NCT01093690|637908|P1|STARTED|Overall Study||83
264080|NCT01093755|637916|P2|NOT COMPLETED|Overall Study||4
264081|NCT01093755|637917|P1|NOT COMPLETED|Overall Study||3
264082|NCT01093755|637916|P2|COMPLETED|Overall Study||10
264083|NCT01093755|637917|P1|COMPLETED|Overall Study||13
264084|NCT01093755|637916|P2|STARTED|Overall Study||14
264085|NCT01093755|637917|P1|STARTED|Overall Study||16
264086|NCT01093794|637925|P4|NOT COMPLETED|Treatment Period 4||0
264087|NCT01093794|637926|P3|NOT COMPLETED|Treatment Period 4||0
264088|NCT01093794|637927|P2|NOT COMPLETED|Treatment Period 4||0
264089|NCT01093794|637928|P1|NOT COMPLETED|Treatment Period 4||0
264090|NCT01093794|637925|P4|COMPLETED|Treatment Period 4||7
264091|NCT01093794|637926|P3|COMPLETED|Treatment Period 4||6
264092|NCT01093794|637927|P2|COMPLETED|Treatment Period 4||7
264093|NCT01093794|637928|P1|COMPLETED|Treatment Period 4||7
264094|NCT01093794|637925|P4|STARTED|Treatment Period 4||7
264095|NCT01093794|637926|P3|STARTED|Treatment Period 4||6
264096|NCT01093794|637927|P2|STARTED|Treatment Period 4||7
264097|NCT01093794|637928|P1|STARTED|Treatment Period 4||7
264098|NCT01093794|637925|P4|NOT COMPLETED|Treatment Period 3||0
264099|NCT01093794|637926|P3|NOT COMPLETED|Treatment Period 3||0
264100|NCT01093794|637927|P2|NOT COMPLETED|Treatment Period 3||0
264101|NCT01093794|637928|P1|NOT COMPLETED|Treatment Period 3||0
264102|NCT01093794|637925|P4|COMPLETED|Treatment Period 3||7
264103|NCT01093794|637926|P3|COMPLETED|Treatment Period 3||6
264104|NCT01093794|637927|P2|COMPLETED|Treatment Period 3||7
264105|NCT01093794|637928|P1|COMPLETED|Treatment Period 3||7
264106|NCT01093794|637925|P4|STARTED|Treatment Period 3||7
264107|NCT01093794|637926|P3|STARTED|Treatment Period 3||6
264108|NCT01093794|637927|P2|STARTED|Treatment Period 3||7
264109|NCT01093794|637928|P1|STARTED|Treatment Period 3||7
264110|NCT01093794|637925|P4|NOT COMPLETED|Treatment Period 2||0
264111|NCT01093794|637926|P3|NOT COMPLETED|Treatment Period 2||0
264112|NCT01093794|637927|P2|NOT COMPLETED|Treatment Period 2||0
264113|NCT01093794|637928|P1|NOT COMPLETED|Treatment Period 2||0
264114|NCT01093794|637925|P4|COMPLETED|Treatment Period 2||7
264115|NCT01093794|637926|P3|COMPLETED|Treatment Period 2||6
264116|NCT01093794|637927|P2|COMPLETED|Treatment Period 2||7
264117|NCT01093794|637928|P1|COMPLETED|Treatment Period 2||7
264118|NCT01093794|637925|P4|STARTED|Treatment Period 2||7
264119|NCT01093794|637926|P3|STARTED|Treatment Period 2|After period 1, one participant was discontinued by the investigator due to a protocol deviation.|6
264120|NCT01093794|637927|P2|STARTED|Treatment Period 2||7
264121|NCT01093794|637928|P1|STARTED|Treatment Period 2||7
264122|NCT01093794|637925|P4|NOT COMPLETED|Treatment Period 1||0
264123|NCT01093794|637926|P3|NOT COMPLETED|Treatment Period 1||0
264124|NCT01093794|637927|P2|NOT COMPLETED|Treatment Period 1||0
264125|NCT01093794|637928|P1|NOT COMPLETED|Treatment Period 1||0
264126|NCT01093794|637925|P4|COMPLETED|Treatment Period 1||7
264127|NCT01093794|637926|P3|COMPLETED|Treatment Period 1||7
264128|NCT01093794|637927|P2|COMPLETED|Treatment Period 1||7
264129|NCT01093794|637928|P1|COMPLETED|Treatment Period 1||7
264130|NCT01093794|637925|P4|STARTED|Treatment Period 1||7
264131|NCT01093794|637926|P3|STARTED|Treatment Period 1||7
264132|NCT01093794|637927|P2|STARTED|Treatment Period 1||7
264133|NCT01093794|637928|P1|STARTED|Treatment Period 1||7
264134|NCT01093846|637945|P3|NOT COMPLETED|Overall Study||21
264135|NCT01093846|637946|P2|NOT COMPLETED|Overall Study||18
264136|NCT01093846|637947|P1|NOT COMPLETED|Overall Study||19
264137|NCT01093846|637945|P3|COMPLETED|Overall Study||1
264138|NCT01093846|637946|P2|COMPLETED|Overall Study||0
264139|NCT01093846|637947|P1|COMPLETED|Overall Study||0
264140|NCT01093846|637945|P3|STARTED|Overall Study||22
264141|NCT01093846|637946|P2|STARTED|Overall Study||18
264142|NCT01093846|637947|P1|STARTED|Overall Study||19
264143|NCT01093976|637953|P1|NOT COMPLETED|Overall Study||0
264144|NCT01093976|637953|P1|COMPLETED|Overall Study||14
264145|NCT01093976|637953|P1|STARTED|Overall Study||14
264146|NCT01094119|637959|P2|NOT COMPLETED|Overall Study||4
264147|NCT01094119|637960|P1|NOT COMPLETED|Overall Study||2
264148|NCT01094119|637959|P2|COMPLETED|Overall Study||32
264149|NCT01094119|637960|P1|COMPLETED|Overall Study||32
264150|NCT01094119|637959|P2|STARTED|Overall Study||36
264151|NCT01094119|637960|P1|STARTED|Overall Study||34
264152|NCT01094171|637968|P1|NOT COMPLETED|Overall Study||10
264153|NCT01094171|637968|P1|COMPLETED|Overall Study||390
264154|NCT01094171|637968|P1|STARTED|Overall Study||400
264155|NCT01094522|637977|P2|NOT COMPLETED|Overall Study||0
264156|NCT01094522|637978|P1|NOT COMPLETED|Overall Study||0
264157|NCT01094522|637977|P2|COMPLETED|Overall Study||20
264158|NCT01094522|637978|P1|COMPLETED|Overall Study||20
264159|NCT01094522|637977|P2|STARTED|Overall Study||20
264160|NCT01094522|637978|P1|STARTED|Overall Study||20
264161|NCT01094548|637990|P2|NOT COMPLETED|Overall Study||0
264162|NCT01094548|637991|P1|NOT COMPLETED|Overall Study||0
264163|NCT01094548|637990|P2|COMPLETED|Overall Study||17
264164|NCT01094548|637991|P1|COMPLETED|Overall Study||17
264165|NCT01094548|637990|P2|STARTED|Overall Study||17
264166|NCT01094548|637991|P1|STARTED|Overall Study||17
264167|NCT01094561|638009|P1|NOT COMPLETED|Overall Study||6
264168|NCT01094561|638009|P1|COMPLETED|Overall Study||17
264169|NCT01094561|638009|P1|STARTED|Overall Study||23
264170|NCT01094574|638020|P6|NOT COMPLETED|Overall Study||0
264171|NCT01094574|638021|P5|NOT COMPLETED|Overall Study||0
264172|NCT01094574|638022|P4|NOT COMPLETED|Overall Study||0
264173|NCT01094574|638023|P3|NOT COMPLETED|Overall Study||0
264174|NCT01094574|638024|P2|NOT COMPLETED|Overall Study||0
264175|NCT01094574|638025|P1|NOT COMPLETED|Overall Study||0
264176|NCT01094574|638020|P6|COMPLETED|Overall Study||2
264177|NCT01094574|638021|P5|COMPLETED|Overall Study||2
264178|NCT01094574|638022|P4|COMPLETED|Overall Study||2
264179|NCT01094574|638023|P3|COMPLETED|Overall Study||2
264180|NCT01094574|638024|P2|COMPLETED|Overall Study||1
264181|NCT01094574|638025|P1|COMPLETED|Overall Study||1
264182|NCT01094574|638020|P6|STARTED|Overall Study||2
264183|NCT01094574|638021|P5|STARTED|Overall Study||2
264184|NCT01094574|638022|P4|STARTED|Overall Study||2
264185|NCT01094574|638023|P3|STARTED|Overall Study||2
264186|NCT01094574|638024|P2|STARTED|Overall Study||1
264187|NCT01094574|638025|P1|STARTED|Overall Study||1
264188|NCT01094704|638074|P2|NOT COMPLETED|Overall Study||0
264189|NCT01094704|638075|P1|NOT COMPLETED|Overall Study||0
264190|NCT01094704|638074|P2|COMPLETED|Overall Study||8
264191|NCT01094704|638075|P1|COMPLETED|Overall Study||8
264192|NCT01094704|638074|P2|STARTED|Overall Study||8
264193|NCT01094704|638075|P1|STARTED|Overall Study||8
264194|NCT01094730|638081|P2|NOT COMPLETED|Period 2 (14 Days)||2
264195|NCT01094730|638082|P1|NOT COMPLETED|Period 2 (14 Days)||3
264196|NCT01094730|638081|P2|COMPLETED|Period 2 (14 Days)||84
264197|NCT01094730|638082|P1|COMPLETED|Period 2 (14 Days)||87
264198|NCT01094730|638081|P2|STARTED|Period 2 (14 Days)||86
264199|NCT01094730|638082|P1|STARTED|Period 2 (14 Days)||90
264200|NCT01094730|638081|P2|NOT COMPLETED|Period 1 (14 Days)||2
264201|NCT01094730|638082|P1|NOT COMPLETED|Period 1 (14 Days)||2
264202|NCT01094730|638081|P2|COMPLETED|Period 1 (14 Days)||86
264203|NCT01094730|638082|P1|COMPLETED|Period 1 (14 Days)||90
264204|NCT01094730|638081|P2|STARTED|Period 1 (14 Days)||88
264205|NCT01094730|638082|P1|STARTED|Period 1 (14 Days)||92
264206|NCT01094743|638093|P1|NOT COMPLETED|Period 2||0
264207|NCT01094743|638093|P1|COMPLETED|Period 2||50
264208|NCT01094743|638093|P1|STARTED|Period 2||50
264209|NCT01094743|638093|P1|NOT COMPLETED|Period 1||2
264210|NCT01094743|638093|P1|COMPLETED|Period 1||50
264211|NCT01094743|638093|P1|STARTED|Period 1||52
264212|NCT01094808|638113|P3|NOT COMPLETED|Overall Study||0
264213|NCT01094808|638114|P2|NOT COMPLETED|Overall Study||1
264214|NCT01094808|638115|P1|NOT COMPLETED|Overall Study||1
264215|NCT01094808|638113|P3|COMPLETED|Overall Study||21
264216|NCT01094808|638114|P2|COMPLETED|Overall Study||19
264217|NCT01094808|638115|P1|COMPLETED|Overall Study||20
264218|NCT01094808|638113|P3|STARTED|Overall Study||21
264219|NCT01094808|638114|P2|STARTED|Overall Study||20
264220|NCT01094808|638115|P1|STARTED|Overall Study||21
264221|NCT01094886|638150|P1|NOT COMPLETED|Overall Study||7
264222|NCT01094886|638150|P1|COMPLETED|Overall Study||46
264223|NCT01094886|638150|P1|STARTED|Overall Study||53
264224|NCT01095094|638157|P1|NOT COMPLETED|Overall Study||3
264225|NCT01095094|638157|P1|COMPLETED|Overall Study||16
264226|NCT01095094|638157|P1|STARTED|Overall Study||19
264227|NCT01095250|638166|P4|NOT COMPLETED|Overall Study||5
264228|NCT01095250|638167|P3|NOT COMPLETED|Overall Study||8
264229|NCT01095250|638168|P2|NOT COMPLETED|Overall Study||10
264230|NCT01095250|638169|P1|NOT COMPLETED|Overall Study||8
264231|NCT01095250|638166|P4|COMPLETED|Overall Study||0
264232|NCT01095250|638167|P3|COMPLETED|Overall Study||0
264233|NCT01095250|638168|P2|COMPLETED|Overall Study||0
264234|NCT01095250|638169|P1|COMPLETED|Overall Study||0
264235|NCT01095250|638166|P4|STARTED|Overall Study||5
264236|NCT01095250|638167|P3|STARTED|Overall Study||8
264237|NCT01095250|638168|P2|STARTED|Overall Study||10
264238|NCT01095250|638169|P1|STARTED|Overall Study||8
264239|NCT01095497|638201|P2|NOT COMPLETED|Subcutaneous CINRYZE||0
264240|NCT01095497|638202|P1|NOT COMPLETED|Subcutaneous CINRYZE||1
264241|NCT01095497|638201|P2|COMPLETED|Subcutaneous CINRYZE||12
264242|NCT01095497|638202|P1|COMPLETED|Subcutaneous CINRYZE||12
264243|NCT01095497|638201|P2|STARTED|Subcutaneous CINRYZE||12
264244|NCT01095497|638202|P1|STARTED|Subcutaneous CINRYZE||13
264245|NCT01095497|638201|P2|NOT COMPLETED|Intravenous CINRYZE||0
264246|NCT01095497|638202|P1|NOT COMPLETED|Intravenous CINRYZE||1
264247|NCT01095497|638201|P2|COMPLETED|Intravenous CINRYZE||12
264248|NCT01095497|638202|P1|COMPLETED|Intravenous CINRYZE||13
264249|NCT01095497|638201|P2|STARTED|Intravenous CINRYZE||12
264250|NCT01095497|638202|P1|STARTED|Intravenous CINRYZE||14
264251|NCT01095510|638213|P4|NOT COMPLETED|Overall Study||0
264252|NCT01095510|638214|P3|NOT COMPLETED|Overall Study||0
264253|NCT01095510|638215|P2|NOT COMPLETED|Overall Study||0
264254|NCT01095510|638216|P1|NOT COMPLETED|Overall Study||0
264255|NCT01095510|638213|P4|COMPLETED|Overall Study||3
264256|NCT01095510|638214|P3|COMPLETED|Overall Study||3
264257|NCT01095510|638215|P2|COMPLETED|Overall Study||0
264258|NCT01095510|638216|P1|COMPLETED|Overall Study||3
264259|NCT01095510|638213|P4|STARTED|Overall Study||3
264260|NCT01095510|638214|P3|STARTED|Overall Study||3
264261|NCT01095510|638215|P2|STARTED|Overall Study||0
264262|NCT01095510|638216|P1|STARTED|Overall Study||3
264263|NCT01095653|638236|P3|NOT COMPLETED|Overall Study||16
264264|NCT01095653|638237|P2|NOT COMPLETED|Overall Study||15
264265|NCT01095653|638238|P1|NOT COMPLETED|Overall Study||19
264266|NCT01095653|638236|P3|COMPLETED|Overall Study||117
264267|NCT01095653|638237|P2|COMPLETED|Overall Study||113
264268|NCT01095653|638238|P1|COMPLETED|Overall Study||113
264269|NCT01095653|638236|P3|STARTED|Overall Study||133
264270|NCT01095653|638237|P2|STARTED|Overall Study||128
264271|NCT01095653|638238|P1|STARTED|Overall Study||132
264272|NCT01095757|638258|P1|NOT COMPLETED|Overall Study||0
264273|NCT01095757|638258|P1|COMPLETED|Overall Study||45
264274|NCT01095757|638258|P1|STARTED|Overall Study||45
264275|NCT01095796|638269|P2|NOT COMPLETED|Overall Study||289
264276|NCT01095796|638270|P1|NOT COMPLETED|Overall Study||295
264277|NCT01095796|638269|P2|COMPLETED|Overall Study||65
264278|NCT01095796|638270|P1|COMPLETED|Overall Study||58
264279|NCT01095796|638269|P2|STARTED|Overall Study||354
264280|NCT01095796|638270|P1|STARTED|Overall Study||353
264281|NCT01095835|638291|P3|NOT COMPLETED|Overall Study||8
264282|NCT01095835|638292|P2|NOT COMPLETED|Overall Study||12
264283|NCT01095835|638293|P1|NOT COMPLETED|Overall Study||10
264284|NCT01095835|638291|P3|COMPLETED|Overall Study||17
264285|NCT01095835|638292|P2|COMPLETED|Overall Study||40
264286|NCT01095835|638293|P1|COMPLETED|Overall Study||41
264287|NCT01095835|638291|P3|STARTED|Overall Study||25
264288|NCT01095835|638292|P2|STARTED|Overall Study||52
264289|NCT01095835|638293|P1|STARTED|Overall Study||51
264290|NCT01095887|638329|P1|NOT COMPLETED|Overall Study||0
264291|NCT01095887|638329|P1|COMPLETED|Overall Study||6
264292|NCT01095887|638329|P1|STARTED|Overall Study||6
264293|NCT01095978|638333|P1|NOT COMPLETED|Overall Study||3
264294|NCT01095978|638333|P1|COMPLETED|Overall Study||2819
264295|NCT01095978|638333|P1|STARTED|Overall Study||2822
264296|NCT01096017|638360|P2|NOT COMPLETED|Treatment Period 2||1
264297|NCT01096017|638361|P1|NOT COMPLETED|Treatment Period 2||1
264298|NCT01096017|638360|P2|COMPLETED|Treatment Period 2||11
264299|NCT01096017|638361|P1|COMPLETED|Treatment Period 2||11
264300|NCT01096017|638360|P2|STARTED|Treatment Period 2||12
264301|NCT01096017|638361|P1|STARTED|Treatment Period 2||12
264302|NCT01096017|638360|P2|NOT COMPLETED|Washout 1 - 14 Days||0
264303|NCT01096017|638361|P1|NOT COMPLETED|Washout 1 - 14 Days||0
264304|NCT01096017|638360|P2|COMPLETED|Washout 1 - 14 Days||12
264305|NCT01096017|638361|P1|COMPLETED|Washout 1 - 14 Days||12
264306|NCT01096017|638360|P2|STARTED|Washout 1 - 14 Days||12
264307|NCT01096017|638361|P1|STARTED|Washout 1 - 14 Days||12
264308|NCT01096017|638360|P2|NOT COMPLETED|Treatment Period 1||0
264309|NCT01096017|638361|P1|NOT COMPLETED|Treatment Period 1||0
264310|NCT01096017|638360|P2|COMPLETED|Treatment Period 1||12
264311|NCT01096017|638361|P1|COMPLETED|Treatment Period 1||12
264312|NCT01096017|638360|P2|STARTED|Treatment Period 1||12
264313|NCT01096017|638361|P1|STARTED|Treatment Period 1||12
264314|NCT01096056|638391|P2|NOT COMPLETED|Overall Study||1
264315|NCT01096056|638392|P1|NOT COMPLETED|Overall Study||0
264316|NCT01096056|638391|P2|COMPLETED|Overall Study||19
264317|NCT01096056|638392|P1|COMPLETED|Overall Study||20
264318|NCT01096056|638391|P2|Completed at Day 42|Overall Study||20
264319|NCT01096056|638392|P1|Completed at Day 42|Overall Study||20
264320|NCT01096056|638391|P2|STARTED|Overall Study||20
264321|NCT01096056|638392|P1|STARTED|Overall Study||20
264322|NCT01081873|638424|P1|NOT COMPLETED|Overall Study||298
264323|NCT01081873|638424|P1|COMPLETED|Overall Study||2416
264324|NCT01081873|638424|P1|STARTED|Overall Study|3 patients were excluded from this and all analyses due to no available data from Baseline.|2714
264325|NCT01081886|638493|P2|NOT COMPLETED|Overall Study||13
264326|NCT01081886|638494|P1|NOT COMPLETED|Overall Study||11
264327|NCT01081886|638493|P2|COMPLETED|Overall Study||0
264328|NCT01081886|638494|P1|COMPLETED|Overall Study||0
264329|NCT01081886|638493|P2|STARTED|Overall Study||13
264330|NCT01081886|638494|P1|STARTED|Overall Study||11
264331|NCT01081912|638502|P3|NOT COMPLETED|Maintenance Treatment||92
264332|NCT01081912|638503|P2|NOT COMPLETED|Maintenance Treatment||27
264333|NCT01081912|638504|P1|NOT COMPLETED|Maintenance Treatment||0
264334|NCT01081912|638502|P3|COMPLETED|Maintenance Treatment||59
264335|NCT01081912|638503|P2|COMPLETED|Maintenance Treatment||124
264336|NCT01081912|638504|P1|COMPLETED|Maintenance Treatment||0
264337|NCT01081912|638502|P3|STARTED|Maintenance Treatment||151
264338|NCT01081912|638503|P2|STARTED|Maintenance Treatment||151
264339|NCT01081912|638504|P1|STARTED|Maintenance Treatment||0
264340|NCT01081912|638502|P3|NOT COMPLETED|Conversion/Titration||0
264341|NCT01081912|638503|P2|NOT COMPLETED|Conversion/Titration||0
264342|NCT01081912|638504|P1|NOT COMPLETED|Conversion/Titration||208
264343|NCT01081912|638502|P3|COMPLETED|Conversion/Titration||0
264344|NCT01081912|638503|P2|COMPLETED|Conversion/Titration||0
264345|NCT01081912|638504|P1|COMPLETED|Conversion/Titration||302
264346|NCT01081912|638502|P3|STARTED|Conversion/Titration||0
264347|NCT01081912|638503|P2|STARTED|Conversion/Titration||0
264348|NCT01081912|638504|P1|STARTED|Conversion/Titration||510
264349|NCT01081951|638513|P2|NOT COMPLETED|Overall Study||55
264350|NCT01081951|638514|P1|NOT COMPLETED|Overall Study||56
264351|NCT01081951|638513|P2|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off), either on-treatment or in survival follow-up|26
264352|NCT01081951|638514|P1|COMPLETED|Overall Study|Completed is ongoing study at DCO (Data cut-off),either on-treatment or in survival follow-up|25
264353|NCT01081951|638513|P2|Ongoing Study Treatment at Data Cut-off|Overall Study||0
264354|NCT01081951|638514|P1|Ongoing Study Treatment at Data Cut-off|Overall Study||11
264355|NCT01081951|638513|P2|Entered Maintenance Phase|Overall Study||55
264356|NCT01081951|638514|P1|Entered Maintenance Phase|Overall Study||66
264357|NCT01081951|638513|P2|Received Study Treatment|Overall Study||75
264358|NCT01081951|638514|P1|Received Study Treatment|Overall Study||81
264359|NCT01081951|638513|P2|STARTED|Overall Study||81
264360|NCT01081951|638514|P1|STARTED|Overall Study||81
264361|NCT01082081|638527|P3|NOT COMPLETED|Overall Study||2
264362|NCT01082081|638528|P2|NOT COMPLETED|Overall Study||1
264363|NCT01082081|638529|P1|NOT COMPLETED|Overall Study||0
264364|NCT01082081|638527|P3|COMPLETED|Overall Study||58
264365|NCT01082081|638528|P2|COMPLETED|Overall Study||118
264366|NCT01082081|638529|P1|COMPLETED|Overall Study||121
264367|NCT01082081|638527|P3|STARTED|Overall Study||60
264368|NCT01082081|638528|P2|STARTED|Overall Study||119
264369|NCT01082081|638529|P1|STARTED|Overall Study||121
264370|NCT01082159|638579|P1|NOT COMPLETED|Overall Study||9
264371|NCT01082159|638579|P1|COMPLETED|Overall Study||46
264372|NCT01082159|638579|P1|STARTED|Overall Study||55
264373|NCT01082211|638585|P1|NOT COMPLETED|Overall Study||7
264462|NCT01087970|638777|P1|STARTED|Overall Study||69
264374|NCT01082211|638585|P1|COMPLETED|Overall Study|Subjects with data available for analysis are considered to have completed the study.|58
264375|NCT01082211|638585|P1|STARTED|Overall Study||65
264376|NCT01082328|638596|P1|NOT COMPLETED|Overall Study||1
264377|NCT01082328|638596|P1|COMPLETED|Overall Study||58
264378|NCT01082328|638596|P1|STARTED|Overall Study||59
264379|NCT01082367|638607|P2|NOT COMPLETED|Follow-up (F-U) Period||1
264380|NCT01082367|638608|P1|NOT COMPLETED|Follow-up (F-U) Period||2
264381|NCT01082367|638607|P2|COMPLETED|Follow-up (F-U) Period||9
264382|NCT01082367|638608|P1|COMPLETED|Follow-up (F-U) Period||17
264383|NCT01082367|638607|P2|Treated in F-U|Follow-up (F-U) Period||5
264384|NCT01082367|638608|P1|Treated in F-U|Follow-up (F-U) Period||5
264385|NCT01082367|638607|P2|STARTED|Follow-up (F-U) Period||10
264386|NCT01082367|638608|P1|STARTED|Follow-up (F-U) Period||19
264387|NCT01082367|638607|P2|NOT COMPLETED|Double-blind Period||13
264388|NCT01082367|638608|P1|NOT COMPLETED|Double-blind Period||5
264389|NCT01082367|638607|P2|COMPLETED|Double-blind Period||12
264390|NCT01082367|638608|P1|COMPLETED|Double-blind Period||21
264391|NCT01082367|638607|P2|Stage 4:no tx for Patients Not in co|Double-blind Period||0
264392|NCT01082367|638608|P1|Stage 4:no tx for Patients Not in co|Double-blind Period||0
264393|NCT01082367|638607|P2|Stage 3: Cross-over (co) tx|Double-blind Period||6
264394|NCT01082367|638608|P1|Stage 3: Cross-over (co) tx|Double-blind Period||13
264395|NCT01082367|638607|P2|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||0
264396|NCT01082367|638608|P1|P.A-free,Day 29 w/ no Cross-over|Double-blind Period||9
264397|NCT01082367|638607|P2|Entered OL TOBI|Double-blind Period||18
264398|NCT01082367|638608|P1|Entered OL TOBI|Double-blind Period||4
264399|NCT01082367|638607|P2|Stage 2:no tx|Double-blind Period||0
264400|NCT01082367|638608|P1|Stage 2:no tx|Double-blind Period||0
264401|NCT01082367|638607|P2|Stage 1:1st Treatment (tx) Cycle|Double-blind Period|1 participant discontinued after cycle 1 due to an SAE|25
264402|NCT01082367|638608|P1|Stage 1:1st Treatment (tx) Cycle|Double-blind Period||26
264403|NCT01082367|638607|P2|STARTED|Double-blind Period||25
264404|NCT01082367|638608|P1|STARTED|Double-blind Period||26
264405|NCT01082380|638622|P1|NOT COMPLETED|Overall Study||0
264406|NCT01082380|638622|P1|COMPLETED|Overall Study||6
264407|NCT01082380|638622|P1|STARTED|Overall Study||6
264408|NCT01087905|638663|P8|NOT COMPLETED|Overall Study||29
264409|NCT01087905|638664|P7|NOT COMPLETED|Overall Study||23
264410|NCT01087905|638665|P6|NOT COMPLETED|Overall Study||28
264411|NCT01087905|638666|P5|NOT COMPLETED|Overall Study||31
264412|NCT01087905|638667|P4|NOT COMPLETED|Overall Study||36
264413|NCT01087905|638668|P3|NOT COMPLETED|Overall Study||22
264414|NCT01087905|638669|P2|NOT COMPLETED|Overall Study||32
264415|NCT01087905|638670|P1|NOT COMPLETED|Overall Study||29
264416|NCT01087905|638663|P8|COMPLETED|Overall Study||98
264417|NCT01087905|638664|P7|COMPLETED|Overall Study||98
264418|NCT01087905|638665|P6|COMPLETED|Overall Study||99
264419|NCT01087905|638666|P5|COMPLETED|Overall Study||91
264420|NCT01087905|638667|P4|COMPLETED|Overall Study||86
264421|NCT01087905|638668|P3|COMPLETED|Overall Study||101
264422|NCT01087905|638669|P2|COMPLETED|Overall Study||94
264423|NCT01087905|638670|P1|COMPLETED|Overall Study||90
264424|NCT01087905|638663|P8|STARTED|Overall Study||127
264425|NCT01087905|638664|P7|STARTED|Overall Study||121
264426|NCT01087905|638665|P6|STARTED|Overall Study||127
264427|NCT01087905|638666|P5|STARTED|Overall Study||122
264428|NCT01087905|638667|P4|STARTED|Overall Study||122
264429|NCT01087905|638668|P3|STARTED|Overall Study||123
264430|NCT01087905|638669|P2|STARTED|Overall Study||126
264431|NCT01087905|638670|P1|STARTED|Overall Study||119
264432|NCT01087918|638692|P2|NOT COMPLETED|Overall Study||0
264433|NCT01087918|638693|P1|NOT COMPLETED|Overall Study||0
264434|NCT01087918|638692|P2|COMPLETED|Overall Study||4
264435|NCT01087918|638693|P1|COMPLETED|Overall Study||5
264436|NCT01087918|638692|P2|STARTED|Overall Study||4
264437|NCT01087918|638693|P1|STARTED|Overall Study||5
264438|NCT01087944|638719|P2|NOT COMPLETED|Period 2 (Week 4-6)||2
264439|NCT01087944|638720|P1|NOT COMPLETED|Period 2 (Week 4-6)||0
264440|NCT01087944|638719|P2|COMPLETED|Period 2 (Week 4-6)||28
264441|NCT01087944|638720|P1|COMPLETED|Period 2 (Week 4-6)||29
264442|NCT01087944|638719|P2|STARTED|Period 2 (Week 4-6)||30
264443|NCT01087944|638720|P1|STARTED|Period 2 (Week 4-6)||29
264444|NCT01087944|638719|P2|NOT COMPLETED|Period 1 (Week 1-3)||0
264445|NCT01087944|638720|P1|NOT COMPLETED|Period 1 (Week 1-3)||1
264446|NCT01087944|638719|P2|COMPLETED|Period 1 (Week 1-3)||30
264447|NCT01087944|638720|P1|COMPLETED|Period 1 (Week 1-3)||29
264448|NCT01087944|638719|P2|STARTED|Period 1 (Week 1-3)||30
264449|NCT01087944|638720|P1|STARTED|Period 1 (Week 1-3)||30
264450|NCT01087957|638750|P2|NOT COMPLETED|Overall Study||55
264451|NCT01087957|638751|P1|NOT COMPLETED|Overall Study||41
264452|NCT01087957|638750|P2|COMPLETED|Overall Study||187
264453|NCT01087957|638751|P1|COMPLETED|Overall Study||212
264454|NCT01087957|638750|P2|STARTED|Overall Study||242
264455|NCT01087957|638751|P1|STARTED|Overall Study||253
264456|NCT01087970|638777|P1|NOT COMPLETED|Overall Study||2
264457|NCT01087970|638777|P1|COMPLETED|Overall Study||67
264458|NCT01087970|638777|P1|Received Carboplatin|Overall Study||63
264459|NCT01087970|638777|P1|Efficacy Population|Overall Study|All treated participants excluding those from a noncompliant study site.|58
264460|NCT01087970|638777|P1|Completed 6 Cycles|Overall Study||69
264461|NCT01087970|638777|P1|Received ≥1 Dose of Any Study Drug|Overall Study||69
264463|NCT01087996|638789|P2|NOT COMPLETED|Overall Study||0
264464|NCT01087996|638790|P1|NOT COMPLETED|Overall Study||0
264465|NCT01087996|638789|P2|COMPLETED|Overall Study||15
264466|NCT01087996|638790|P1|COMPLETED|Overall Study||15
264467|NCT01087996|638789|P2|STARTED|Overall Study||15
264468|NCT01087996|638790|P1|STARTED|Overall Study||15
264469|NCT01088295|638812|P1|NOT COMPLETED|Overall Study||1
264470|NCT01088295|638812|P1|COMPLETED|Overall Study||35
264471|NCT01088295|638812|P1|STARTED|Overall Study||36
264472|NCT01088399|638819|P3|NOT COMPLETED|Overall Study||281
264473|NCT01088399|638820|P2|NOT COMPLETED|Overall Study||1347
264474|NCT01088399|638821|P1|NOT COMPLETED|Overall Study||7121
264475|NCT01088399|638819|P3|COMPLETED|Overall Study||21
264476|NCT01088399|638820|P2|COMPLETED|Overall Study||308
264477|NCT01088399|638821|P1|COMPLETED|Overall Study||1595
264478|NCT01088399|638819|P3|STARTED|Overall Study||302
264479|NCT01088399|638820|P2|STARTED|Overall Study||1655
264480|NCT01088399|638821|P1|STARTED|Overall Study||8716
264481|NCT01088438|638846|P2|NOT COMPLETED|Overall Study||36
264482|NCT01088438|638847|P1|NOT COMPLETED|Overall Study||29
264483|NCT01088438|638846|P2|COMPLETED|Overall Study||59
264484|NCT01088438|638847|P1|COMPLETED|Overall Study||65
264485|NCT01088438|638846|P2|STARTED|Overall Study||95
264486|NCT01088438|638847|P1|STARTED|Overall Study||94
264487|NCT01088464|638860|P3|NOT COMPLETED|Overall Study||0
264488|NCT01088464|638861|P2|NOT COMPLETED|Overall Study||0
264489|NCT01088464|638862|P1|NOT COMPLETED|Overall Study||0
264490|NCT01088464|638860|P3|COMPLETED|Overall Study||6
264491|NCT01088464|638861|P2|COMPLETED|Overall Study||6
264492|NCT01088464|638862|P1|COMPLETED|Overall Study||3
264493|NCT01088464|638860|P3|Received Any Quantity of Study Drug|Overall Study||6
264494|NCT01088464|638861|P2|Received Any Quantity of Study Drug|Overall Study||6
264495|NCT01088464|638862|P1|Received Any Quantity of Study Drug|Overall Study||3
264496|NCT01088464|638860|P3|STARTED|Overall Study||6
264497|NCT01088464|638861|P2|STARTED|Overall Study||6
264498|NCT01088464|638862|P1|STARTED|Overall Study||3
264499|NCT01088503|638915|P3|NOT COMPLETED|Overall Study||17
264500|NCT01088503|638916|P2|NOT COMPLETED|Overall Study||685
264501|NCT01088503|638917|P1|NOT COMPLETED|Overall Study||182
264502|NCT01088503|638915|P3|COMPLETED|Overall Study||241
264503|NCT01088503|638916|P2|COMPLETED|Overall Study||8161
264504|NCT01088503|638917|P1|COMPLETED|Overall Study||2941
264505|NCT01088503|638915|P3|STARTED|Overall Study||258
264506|NCT01088503|638916|P2|STARTED|Overall Study||8846
264507|NCT01088503|638917|P1|STARTED|Overall Study||3123
264508|NCT01088529|638940|P2|NOT COMPLETED|Overall Study||1
264509|NCT01088529|638941|P1|NOT COMPLETED|Overall Study||0
264510|NCT01088529|638940|P2|COMPLETED|Overall Study||21
264511|NCT01088529|638941|P1|COMPLETED|Overall Study||44
264512|NCT01088529|638940|P2|Received Treatment|Overall Study||21
264513|NCT01088529|638941|P1|Received Treatment|Overall Study||44
264514|NCT01088529|638940|P2|STARTED|Overall Study||22
264515|NCT01088529|638941|P1|STARTED|Overall Study||44
264516|NCT01096186|638951|P1|NOT COMPLETED|Overall Study||50
264517|NCT01096186|638951|P1|COMPLETED|Overall Study||567
264518|NCT01096186|638951|P1|STARTED|Overall Study||617
264519|NCT01096316|638959|P2|NOT COMPLETED|Overall Study||9
264520|NCT01096316|638960|P1|NOT COMPLETED|Overall Study||15
264521|NCT01096316|638959|P2|COMPLETED|Overall Study||94
264522|NCT01096316|638960|P1|COMPLETED|Overall Study||87
264523|NCT01096316|638959|P2|STARTED|Overall Study||103
264524|NCT01096316|638960|P1|STARTED|Overall Study||102
264525|NCT01096342|638970|P1|NOT COMPLETED|Overall Study||1
264526|NCT01096342|638970|P1|COMPLETED|Overall Study||15
264527|NCT01096342|638970|P1|STARTED|Overall Study||16
264528|NCT01098461|638980|P4|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
264529|NCT01098461|638981|P3|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||1
264530|NCT01098461|638982|P2|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||3
264531|NCT01098461|638983|P1|NOT COMPLETED|Follow-up (FU) Period (8 Weeks)||0
264532|NCT01098461|638980|P4|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
264533|NCT01098461|638981|P3|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
264534|NCT01098461|638982|P2|COMPLETED|Follow-up (FU) Period (8 Weeks)||49
264535|NCT01098461|638983|P1|COMPLETED|Follow-up (FU) Period (8 Weeks)||52
264536|NCT01098461|638980|P4|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
264537|NCT01098461|638981|P3|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|53
264538|NCT01098461|638982|P2|STARTED|Follow-up (FU) Period (8 Weeks)||52
264539|NCT01098461|638983|P1|STARTED|Follow-up (FU) Period (8 Weeks)|Par. withdrawing from the TP could enter the FU Period. One par. did not participate in the FU.|52
264540|NCT01098461|638980|P4|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||3
264541|NCT01098461|638981|P3|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||1
264542|NCT01098461|638982|P2|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||7
264543|NCT01098461|638983|P1|NOT COMPLETED|Treatment Period (TP) (16 Weeks)||12
264544|NCT01098461|638980|P4|COMPLETED|Treatment Period (TP) (16 Weeks)||50
264545|NCT01098461|638981|P3|COMPLETED|Treatment Period (TP) (16 Weeks)||53
264546|NCT01098461|638982|P2|COMPLETED|Treatment Period (TP) (16 Weeks)||45
264547|NCT01098461|638983|P1|COMPLETED|Treatment Period (TP) (16 Weeks)||41
264548|NCT01098461|638980|P4|STARTED|Treatment Period (TP) (16 Weeks)||53
264549|NCT01098461|638981|P3|STARTED|Treatment Period (TP) (16 Weeks)||54
264550|NCT01098461|638982|P2|STARTED|Treatment Period (TP) (16 Weeks)||52
264551|NCT01098461|638983|P1|STARTED|Treatment Period (TP) (16 Weeks)||53
264552|NCT01098487|639013|P1|NOT COMPLETED|Overall Study||44
264553|NCT01098487|639013|P1|COMPLETED|Overall Study||118
264554|NCT01098487|639013|P1|STARTED|Overall Study||162
264555|NCT01098500|639025|P1|NOT COMPLETED|Overall Study||0
264556|NCT01098500|639025|P1|COMPLETED|Overall Study||3800
264557|NCT01098500|639025|P1|STARTED|Overall Study||3800
264558|NCT01098539|639042|P2|NOT COMPLETED|Overall Study||68
264559|NCT01098539|639043|P1|NOT COMPLETED|Overall Study||51
264560|NCT01098539|639042|P2|COMPLETED|Overall Study||178
264561|NCT01098539|639043|P1|COMPLETED|Overall Study||198
264562|NCT01098539|639042|P2|STARTED|Overall Study||246
264563|NCT01098539|639043|P1|STARTED|Overall Study||249
264564|NCT01098578|639079|P1|NOT COMPLETED|Overall Study||0
264565|NCT01098578|639079|P1|COMPLETED|Overall Study||20
264566|NCT01098578|639079|P1|STARTED|Overall Study||20
264567|NCT01098747|639090|P4|NOT COMPLETED|Overall Study||0
264568|NCT01098747|639091|P3|NOT COMPLETED|Overall Study||0
264569|NCT01098747|639092|P2|NOT COMPLETED|Overall Study||0
264570|NCT01098747|639093|P1|NOT COMPLETED|Overall Study||0
264571|NCT01098747|639090|P4|COMPLETED|Overall Study||87
264572|NCT01098747|639091|P3|COMPLETED|Overall Study||86
264573|NCT01098747|639092|P2|COMPLETED|Overall Study||95
264574|NCT01098747|639093|P1|COMPLETED|Overall Study||48
264575|NCT01098747|639090|P4|STARTED|Overall Study||87
264576|NCT01098747|639091|P3|STARTED|Overall Study||86
264577|NCT01098747|639092|P2|STARTED|Overall Study||95
264578|NCT01098747|639093|P1|STARTED|Overall Study||48
264579|NCT01098812|639146|P3|NOT COMPLETED|Overall Study||1
264580|NCT01098812|639147|P2|NOT COMPLETED|Overall Study||1
264581|NCT01098812|639148|P1|NOT COMPLETED|Overall Study||2
264582|NCT01098812|639146|P3|COMPLETED|Overall Study||71
264583|NCT01098812|639147|P2|COMPLETED|Overall Study||101
264584|NCT01098812|639148|P1|COMPLETED|Overall Study||93
264585|NCT01098812|639146|P3|STARTED|Overall Study||72
264586|NCT01098812|639147|P2|STARTED|Overall Study||102
264587|NCT01098812|639148|P1|STARTED|Overall Study||95
264588|NCT01098851|639160|P2|NOT COMPLETED|Overall Study||0
264589|NCT01098851|639161|P1|NOT COMPLETED|Overall Study||1
264590|NCT01098851|639160|P2|COMPLETED|Overall Study||10
264591|NCT01098851|639161|P1|COMPLETED|Overall Study||10
264592|NCT01098851|639160|P2|STARTED|Overall Study||10
264593|NCT01098851|639161|P1|STARTED|Overall Study||11
264594|NCT01099111|639174|P5|NOT COMPLETED|Overall Study||0
264595|NCT01099111|639175|P4|NOT COMPLETED|Overall Study||0
264596|NCT01099111|639176|P3|NOT COMPLETED|Overall Study||0
264597|NCT01099111|639177|P2|NOT COMPLETED|Overall Study||0
264598|NCT01099111|639178|P1|NOT COMPLETED|Overall Study||0
264599|NCT01099111|639174|P5|COMPLETED|Overall Study|6 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
264600|NCT01099111|639175|P4|COMPLETED|Overall Study||29
264601|NCT01099111|639176|P3|COMPLETED|Overall Study|2 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|46
264602|NCT01099111|639177|P2|COMPLETED|Overall Study|3 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
264603|NCT01099111|639178|P1|COMPLETED|Overall Study|5 subjects were dropped out because of insufficient DNA extraction and accordingly replaced randomly|50
264604|NCT01099111|639174|P5|STARTED|Overall Study||50
264605|NCT01099111|639175|P4|STARTED|Overall Study||29
264606|NCT01099111|639176|P3|STARTED|Overall Study||46
264607|NCT01099111|639177|P2|STARTED|Overall Study||50
264608|NCT01099111|639178|P1|STARTED|Overall Study||50
264609|NCT01099202|639192|P2|NOT COMPLETED|Overall Study||0
264610|NCT01099202|639193|P1|NOT COMPLETED|Overall Study||0
264611|NCT01099202|639192|P2|COMPLETED|Overall Study||54
264612|NCT01099202|639193|P1|COMPLETED|Overall Study||55
264613|NCT01099202|639192|P2|STARTED|Overall Study||54
264614|NCT01099202|639193|P1|STARTED|Overall Study||55
264615|NCT01099215|639203|P2|NOT COMPLETED|Overall Study||1
264616|NCT01099215|639204|P1|NOT COMPLETED|Overall Study||1
264617|NCT01099215|639203|P2|COMPLETED|Overall Study||9
264618|NCT01099215|639204|P1|COMPLETED|Overall Study||10
264619|NCT01099215|639203|P2|STARTED|Overall Study||10
264620|NCT01099215|639204|P1|STARTED|Overall Study||11
264621|NCT01099267|639240|P1|NOT COMPLETED|MDS-009 Extension Follow-up||0
264622|NCT01099267|639240|P1|COMPLETED|MDS-009 Extension Follow-up||54
264623|NCT01099267|639240|P1|Other Source of Follow-up Info Used|MDS-009 Extension Follow-up|Social Security Death Index, public records, verbal reports from health providers and next of kin.|21
264624|NCT01099267|639240|P1|Informed Consent Given|MDS-009 Extension Follow-up||33
264625|NCT01099267|639240|P1|STARTED|MDS-009 Extension Follow-up|Participants from MDS-003 (including some who did not complete) at sites participating in MDS-009.|54
264626|NCT01099267|639240|P1|NOT COMPLETED|MDS-003 Study||124
264627|NCT01099267|639240|P1|COMPLETED|MDS-003 Study||24
264628|NCT01099267|639240|P1|STARTED|MDS-003 Study|This information duplicates results in NCT00065156.|148
264629|NCT01099358|639248|P4|NOT COMPLETED|Overall Study||4
264630|NCT01099358|639249|P3|NOT COMPLETED|Overall Study||8
264631|NCT01099358|639250|P2|NOT COMPLETED|Overall Study||1
264632|NCT01099358|639251|P1|NOT COMPLETED|Overall Study||3
264633|NCT01099358|639248|P4|COMPLETED|Overall Study||12
264634|NCT01099358|639249|P3|COMPLETED|Overall Study||13
264635|NCT01099358|639250|P2|COMPLETED|Overall Study||5
264636|NCT01099358|639251|P1|COMPLETED|Overall Study||1
264637|NCT01099358|639248|P4|Received at Least One Dose of Study Drug|Overall Study||15
264638|NCT01099358|639249|P3|Received at Least One Dose of Study Drug|Overall Study||20
264639|NCT01099358|639250|P2|Received at Least One Dose of Study Drug|Overall Study||6
264640|NCT01099358|639251|P1|Received at Least One Dose of Study Drug|Overall Study||3
264641|NCT01099358|639248|P4|STARTED|Overall Study||16
264642|NCT01099358|639249|P3|STARTED|Overall Study||21
264643|NCT01099358|639250|P2|STARTED|Overall Study||6
264644|NCT01099358|639251|P1|STARTED|Overall Study||4
264645|NCT01099397|639270|P1|NOT COMPLETED|Overall Study||13
264646|NCT01099397|639270|P1|COMPLETED|Overall Study||26
264647|NCT01099397|639270|P1|STARTED|Overall Study||39
264648|NCT01099475|639277|P2|NOT COMPLETED|Overall Study||0
264649|NCT01099475|639278|P1|NOT COMPLETED|Overall Study||0
264650|NCT01099475|639277|P2|COMPLETED|Overall Study||10
264651|NCT01099475|639278|P1|COMPLETED|Overall Study||10
264652|NCT01099475|639277|P2|STARTED|Overall Study||10
264653|NCT01099475|639278|P1|STARTED|Overall Study||10
264654|NCT01099579|639293|P3|NOT COMPLETED|Stage 2 (ATV Capsules )||15
264655|NCT01099579|639294|P2|NOT COMPLETED|Stage 2 (ATV Capsules )||14
264656|NCT01099579|639295|P1|NOT COMPLETED|Stage 2 (ATV Capsules )||16
264657|NCT01099579|639293|P3|COMPLETED|Stage 2 (ATV Capsules )||0
264658|NCT01099579|639294|P2|COMPLETED|Stage 2 (ATV Capsules )||0
264659|NCT01099579|639295|P1|COMPLETED|Stage 2 (ATV Capsules )||0
264660|NCT01099579|639293|P3|STARTED|Stage 2 (ATV Capsules )||15
264661|NCT01099579|639294|P2|STARTED|Stage 2 (ATV Capsules )||14
264662|NCT01099579|639295|P1|STARTED|Stage 2 (ATV Capsules )||16
264663|NCT01099579|639293|P3|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||1
264664|NCT01099579|639294|P2|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||5
264755|NCT01100307|639491|P1|STARTED|Double Masked Phase (Up to Week 24)||123
264665|NCT01099579|639295|P1|NOT COMPLETED|Stage 1 (ATV Powder Formulation)||4
264666|NCT01099579|639293|P3|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|15
264667|NCT01099579|639294|P2|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|14
264668|NCT01099579|639295|P1|COMPLETED|Stage 1 (ATV Powder Formulation)|Completed Stage 1|17
264669|NCT01099579|639293|P3|STARTED|Stage 1 (ATV Powder Formulation)||16
264670|NCT01099579|639294|P2|STARTED|Stage 1 (ATV Powder Formulation)||19
264671|NCT01099579|639295|P1|STARTED|Stage 1 (ATV Powder Formulation)||21
264672|NCT01099618|639352|P3|NOT COMPLETED|Overall Study||0
264673|NCT01099618|639353|P2|NOT COMPLETED|Overall Study||0
264674|NCT01099618|639354|P1|NOT COMPLETED|Overall Study||0
264675|NCT01099618|639352|P3|COMPLETED|Overall Study||15
264676|NCT01099618|639353|P2|COMPLETED|Overall Study||16
264677|NCT01099618|639354|P1|COMPLETED|Overall Study||17
264678|NCT01099618|639352|P3|STARTED|Overall Study||15
264679|NCT01099618|639353|P2|STARTED|Overall Study||16
264680|NCT01099618|639354|P1|STARTED|Overall Study||17
264681|NCT01099709|639362|P2|NOT COMPLETED|Period 2||0
264682|NCT01099709|639363|P1|NOT COMPLETED|Period 2||0
264683|NCT01099709|639362|P2|COMPLETED|Period 2||41
264684|NCT01099709|639363|P1|COMPLETED|Period 2||41
264685|NCT01099709|639362|P2|STARTED|Period 2||41
264686|NCT01099709|639363|P1|STARTED|Period 2||41
264687|NCT01099709|639362|P2|NOT COMPLETED|Period 1||2
264688|NCT01099709|639363|P1|NOT COMPLETED|Period 1||1
264689|NCT01099709|639362|P2|COMPLETED|Period 1||41
264690|NCT01099709|639363|P1|COMPLETED|Period 1||41
264691|NCT01099709|639362|P2|STARTED|Period 1||43
264692|NCT01099709|639363|P1|STARTED|Period 1||42
264693|NCT01099761|639377|P4|NOT COMPLETED|Overall Study||0
264694|NCT01099761|639378|P3|NOT COMPLETED|Overall Study||0
264695|NCT01099761|639379|P2|NOT COMPLETED|Overall Study||0
264696|NCT01099761|639380|P1|NOT COMPLETED|Overall Study||0
264697|NCT01099761|639377|P4|COMPLETED|Overall Study||6
264698|NCT01099761|639378|P3|COMPLETED|Overall Study||0
264699|NCT01099761|639379|P2|COMPLETED|Overall Study||9
264700|NCT01099761|639380|P1|COMPLETED|Overall Study||9
264701|NCT01099761|639377|P4|STARTED|Overall Study||6
264702|NCT01099761|639378|P3|STARTED|Overall Study|Study terminated prior to enrolling cohort 3|0
264703|NCT01099761|639379|P2|STARTED|Overall Study||9
264704|NCT01099761|639380|P1|STARTED|Overall Study||9
264705|NCT01099774|639418|P2|NOT COMPLETED|Overall Study||6
264706|NCT01099774|639419|P1|NOT COMPLETED|Overall Study||6
264707|NCT01099774|639418|P2|COMPLETED|Overall Study||289
264708|NCT01099774|639419|P1|COMPLETED|Overall Study||296
264709|NCT01099774|639418|P2|STARTED|Overall Study||295
264710|NCT01099774|639419|P1|STARTED|Overall Study||302
264711|NCT01099917|639431|P1|NOT COMPLETED|Overall Study||27
264712|NCT01099917|639431|P1|COMPLETED|Overall Study||18
264713|NCT01099917|639431|P1|STARTED|Overall Study||45
264714|NCT01100073|639435|P1|NOT COMPLETED|Overall Study||100
264715|NCT01100073|639435|P1|COMPLETED|Overall Study|End of study (Visit 3)|1599
264716|NCT01100073|639435|P1|STARTED|Overall Study|Baseline (Visit 1)|1699
264717|NCT01100086|639450|P2|NOT COMPLETED|Period 2||0
264718|NCT01100086|639451|P1|NOT COMPLETED|Period 2||0
264719|NCT01100086|639450|P2|COMPLETED|Period 2||41
264720|NCT01100086|639451|P1|COMPLETED|Period 2||42
264721|NCT01100086|639450|P2|STARTED|Period 2||41
264722|NCT01100086|639451|P1|STARTED|Period 2||42
264723|NCT01100086|639450|P2|NOT COMPLETED|Period 1||0
264724|NCT01100086|639451|P1|NOT COMPLETED|Period 1||1
264725|NCT01100086|639450|P2|COMPLETED|Period 1||41
264726|NCT01100086|639451|P1|COMPLETED|Period 1||42
264727|NCT01100086|639450|P2|STARTED|Period 1||41
264728|NCT01100086|639451|P1|STARTED|Period 1||43
264729|NCT01100112|639461|P1|NOT COMPLETED|Overall Study||8
264730|NCT01100112|639461|P1|COMPLETED|Overall Study||52
264731|NCT01100112|639461|P1|STARTED|Overall Study||60
264732|NCT01100242|639468|P1|NOT COMPLETED|Overall Study||0
264733|NCT01100242|639468|P1|COMPLETED|Overall Study||17
264734|NCT01100242|639468|P1|STARTED|Overall Study||17
264735|NCT01100255|639476|P2|NOT COMPLETED|Overall Study||0
264736|NCT01100255|639477|P1|NOT COMPLETED|Overall Study||0
264737|NCT01100255|639476|P2|COMPLETED|Overall Study||7
264738|NCT01100255|639477|P1|COMPLETED|Overall Study||8
264739|NCT01100255|639476|P2|STARTED|Overall Study||7
264740|NCT01100255|639477|P1|STARTED|Overall Study||8
264741|NCT01100268|639483|P1|NOT COMPLETED|Overall Study||0
264742|NCT01100268|639483|P1|COMPLETED|Overall Study||4
264743|NCT01100268|639483|P1|STARTED|Overall Study||4
264744|NCT01100307|639490|P2|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||13
264745|NCT01100307|639491|P1|NOT COMPLETED|Open Phase (Week 24 up to Week 54)||6
264746|NCT01100307|639490|P2|COMPLETED|Open Phase (Week 24 up to Week 54)||99
264747|NCT01100307|639491|P1|COMPLETED|Open Phase (Week 24 up to Week 54)||110
264748|NCT01100307|639490|P2|STARTED|Open Phase (Week 24 up to Week 54)|Four participants did not enter to the open phase after completing the double masked phase.|112
264749|NCT01100307|639491|P1|STARTED|Open Phase (Week 24 up to Week 54)|One participant discontinued from the study due to adverse event before study drug administration.|116
264750|NCT01100307|639490|P2|NOT COMPLETED|Double Masked Phase (Up to Week 24)||4
264751|NCT01100307|639491|P1|NOT COMPLETED|Double Masked Phase (Up to Week 24)||6
264752|NCT01100307|639490|P2|COMPLETED|Double Masked Phase (Up to Week 24)||116
264753|NCT01100307|639491|P1|COMPLETED|Double Masked Phase (Up to Week 24)||117
264754|NCT01100307|639490|P2|STARTED|Double Masked Phase (Up to Week 24)||120
264756|NCT01100320|639533|P2|NOT COMPLETED|Period 2||1
264757|NCT01100320|639534|P1|NOT COMPLETED|Period 2||1
264758|NCT01100320|639533|P2|COMPLETED|Period 2||37
264759|NCT01100320|639534|P1|COMPLETED|Period 2||37
264760|NCT01100320|639533|P2|STARTED|Period 2||38
264761|NCT01100320|639534|P1|STARTED|Period 2||38
264762|NCT01100320|639533|P2|NOT COMPLETED|Period 1||7
264763|NCT01100320|639534|P1|NOT COMPLETED|Period 1||5
264764|NCT01100320|639533|P2|COMPLETED|Period 1||38
264765|NCT01100320|639534|P1|COMPLETED|Period 1||38
264766|NCT01100320|639533|P2|STARTED|Period 1||45
264767|NCT01100320|639534|P1|STARTED|Period 1||43
264768|NCT01100437|639544|P3|NOT COMPLETED|Treatment 2||0
264769|NCT01100437|639545|P2|NOT COMPLETED|Treatment 2||0
264770|NCT01100437|639546|P1|NOT COMPLETED|Treatment 2||0
264771|NCT01100437|639544|P3|COMPLETED|Treatment 2||0
264772|NCT01100437|639545|P2|COMPLETED|Treatment 2||2
264773|NCT01100437|639546|P1|COMPLETED|Treatment 2||4
264774|NCT01100437|639544|P3|STARTED|Treatment 2||0
264775|NCT01100437|639545|P2|STARTED|Treatment 2||2
264776|NCT01100437|639546|P1|STARTED|Treatment 2||4
264777|NCT01100437|639544|P3|NOT COMPLETED|Washout (4 Days)||0
264778|NCT01100437|639545|P2|NOT COMPLETED|Washout (4 Days)||0
264779|NCT01100437|639546|P1|NOT COMPLETED|Washout (4 Days)||0
264780|NCT01100437|639544|P3|COMPLETED|Washout (4 Days)||0
264781|NCT01100437|639545|P2|COMPLETED|Washout (4 Days)||2
264782|NCT01100437|639546|P1|COMPLETED|Washout (4 Days)||4
264783|NCT01100437|639544|P3|STARTED|Washout (4 Days)||0
264784|NCT01100437|639545|P2|STARTED|Washout (4 Days)||2
264785|NCT01100437|639546|P1|STARTED|Washout (4 Days)||4
264786|NCT01100437|639544|P3|NOT COMPLETED|Treatment 1||0
264787|NCT01100437|639545|P2|NOT COMPLETED|Treatment 1||0
264788|NCT01100437|639546|P1|NOT COMPLETED|Treatment 1||0
264789|NCT01100437|639544|P3|COMPLETED|Treatment 1||0
264790|NCT01100437|639545|P2|COMPLETED|Treatment 1||2
264791|NCT01100437|639546|P1|COMPLETED|Treatment 1||4
264792|NCT01100437|639544|P3|STARTED|Treatment 1||0
264793|NCT01100437|639545|P2|STARTED|Treatment 1||2
264794|NCT01100437|639546|P1|STARTED|Treatment 1||4
264795|NCT01100437|639544|P3|NOT COMPLETED|Maintenance||2
264796|NCT01100437|639545|P2|NOT COMPLETED|Maintenance||0
264797|NCT01100437|639546|P1|NOT COMPLETED|Maintenance||0
264798|NCT01100437|639544|P3|COMPLETED|Maintenance||0
264799|NCT01100437|639545|P2|COMPLETED|Maintenance||2
264800|NCT01100437|639546|P1|COMPLETED|Maintenance||4
264801|NCT01100437|639544|P3|STARTED|Maintenance||2
264802|NCT01100437|639545|P2|STARTED|Maintenance||2
264803|NCT01100437|639546|P1|STARTED|Maintenance||4
264804|NCT01100437|639544|P3|NOT COMPLETED|Titration/Stabilization||6
264805|NCT01100437|639545|P2|NOT COMPLETED|Titration/Stabilization||0
264806|NCT01100437|639546|P1|NOT COMPLETED|Titration/Stabilization||0
264807|NCT01100437|639544|P3|COMPLETED|Titration/Stabilization||2
264808|NCT01100437|639545|P2|COMPLETED|Titration/Stabilization||2
264809|NCT01100437|639546|P1|COMPLETED|Titration/Stabilization||4
264810|NCT01100437|639544|P3|STARTED|Titration/Stabilization||8
264811|NCT01100437|639545|P2|STARTED|Titration/Stabilization||2
264812|NCT01100437|639546|P1|STARTED|Titration/Stabilization||4
264813|NCT01100437|639544|P3|NOT COMPLETED|Screening||0
264814|NCT01100437|639545|P2|NOT COMPLETED|Screening||0
264815|NCT01100437|639546|P1|NOT COMPLETED|Screening||0
264816|NCT01100437|639544|P3|COMPLETED|Screening||8
264817|NCT01100437|639545|P2|COMPLETED|Screening||2
264818|NCT01100437|639546|P1|COMPLETED|Screening||4
264819|NCT01100437|639544|P3|STARTED|Screening||8
264820|NCT01100437|639545|P2|STARTED|Screening||2
264821|NCT01100437|639546|P1|STARTED|Screening||4
264822|NCT01100502|639585|P2|NOT COMPLETED|Long-Term Follow-up||139
264823|NCT01100502|639586|P1|NOT COMPLETED|Long-Term Follow-up||137
264824|NCT01100502|639585|P2|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|25
264825|NCT01100502|639586|P1|COMPLETED|Long-Term Follow-up|Completed follow-up due to death|28
264826|NCT01100502|639585|P2|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|164
264827|NCT01100502|639586|P1|STARTED|Long-Term Follow-up|All participants were to be followed after treatment|165
264828|NCT01100502|639585|P2|NOT COMPLETED|Treatment Period||83
264829|NCT01100502|639586|P1|NOT COMPLETED|Treatment Period||87
264830|NCT01100502|639585|P2|COMPLETED|Treatment Period||81
264831|NCT01100502|639586|P1|COMPLETED|Treatment Period||78
264832|NCT01100502|639585|P2|STARTED|Treatment Period||164
264833|NCT01100502|639586|P1|STARTED|Treatment Period||165
264834|NCT01100567|639598|P2|NOT COMPLETED|Overall Study||16
264835|NCT01100567|639599|P1|NOT COMPLETED|Overall Study||12
264836|NCT01100567|639598|P2|COMPLETED|Overall Study||35
264837|NCT01100567|639599|P1|COMPLETED|Overall Study||38
264838|NCT01100567|639598|P2|STARTED|Overall Study||51
264839|NCT01100567|639599|P1|STARTED|Overall Study||50
264840|NCT01100606|639607|P2|NOT COMPLETED|Second Treatment Period||0
264841|NCT01100606|639608|P1|NOT COMPLETED|Second Treatment Period||0
264842|NCT01100606|639607|P2|COMPLETED|Second Treatment Period|Due to difficulty with syringe nurser, 1 participant completed study using apple sauce|7
264843|NCT01100606|639608|P1|COMPLETED|Second Treatment Period|Due to intolerance to apple sauce & apple juice,1 participant completed study with banana-based food|8
264844|NCT01100606|639607|P2|STARTED|Second Treatment Period||7
264845|NCT01100606|639608|P1|STARTED|Second Treatment Period||8
264846|NCT01100606|639607|P2|NOT COMPLETED|First Treatment Period||0
264847|NCT01100606|639608|P1|NOT COMPLETED|First Treatment Period||0
264848|NCT01100606|639607|P2|COMPLETED|First Treatment Period||7
264849|NCT01100606|639608|P1|COMPLETED|First Treatment Period|Due to difficulty with syringe nurser,1 participant completed study with apple sauce,not apple juice|8
264850|NCT01100606|639607|P2|STARTED|First Treatment Period||7
264851|NCT01100606|639608|P1|STARTED|First Treatment Period||8
264852|NCT01100658|639632|P1|NOT COMPLETED|Overall Study||1
264853|NCT01100658|639632|P1|COMPLETED|Overall Study||0
264854|NCT01100658|639632|P1|STARTED|Overall Study||1
264855|NCT01100723|639637|P1|NOT COMPLETED|Overall Study||14
264856|NCT01100723|639637|P1|COMPLETED|Overall Study|78 subjects had laboratory data at the 12 month analysis and were compared to their baseline data.|78
264857|NCT01100723|639637|P1|6 Month Analysis|Overall Study|85 subjects had laboratory data at the 6 month analysis and were compared to their baseline data.|85
264858|NCT01100723|639637|P1|STARTED|Overall Study||92
264859|NCT01100762|639646|P1|NOT COMPLETED|Overall Study||0
264860|NCT01100762|639646|P1|COMPLETED|Overall Study||10
264861|NCT01100762|639646|P1|STARTED|Overall Study||10
264862|NCT01100853|639669|P2|NOT COMPLETED|Overall Study||23
264863|NCT01100853|639670|P1|NOT COMPLETED|Overall Study||27
264864|NCT01100853|639669|P2|COMPLETED|Overall Study||26
264865|NCT01100853|639670|P1|COMPLETED|Overall Study||24
264866|NCT01100853|639669|P2|STARTED|Overall Study||49
264867|NCT01100853|639670|P1|STARTED|Overall Study||51
264868|NCT01091454|639686|P1|NOT COMPLETED|Overall Study||1
264869|NCT01091454|639686|P1|COMPLETED|Overall Study||47
264870|NCT01091454|639686|P1|STARTED|Overall Study||48
264871|NCT01091519|639697|P2|NOT COMPLETED|Overall Study||73
264872|NCT01091519|639698|P1|NOT COMPLETED|Overall Study||55
264873|NCT01091519|639697|P2|COMPLETED|Overall Study||362
264874|NCT01091519|639698|P1|COMPLETED|Overall Study||291
264875|NCT01091519|639697|P2|Treated|Overall Study||431
264876|NCT01091519|639698|P1|Treated|Overall Study||342
264877|NCT01091519|639697|P2|STARTED|Overall Study||435
264878|NCT01091519|639698|P1|STARTED|Overall Study||346
264879|NCT01091662|639712|P2|NOT COMPLETED|Overall Study||34
264880|NCT01091662|639713|P1|NOT COMPLETED|Overall Study||17
264881|NCT01091662|639712|P2|COMPLETED|Overall Study||80
264882|NCT01091662|639713|P1|COMPLETED|Overall Study||41
264883|NCT01091662|639712|P2|STARTED|Overall Study||114
264884|NCT01091662|639713|P1|STARTED|Overall Study||58
264885|NCT01091675|639749|P1|NOT COMPLETED|Overall Study||34
264886|NCT01091675|639749|P1|COMPLETED|Overall Study||23
264887|NCT01091675|639749|P1|STARTED|Overall Study|7 patients leave the study due to hypertension, 27 patients withdrew due to lack of efficacy|57
264888|NCT01091948|639755|P2|NOT COMPLETED|Overall Study||0
264889|NCT01091948|639756|P1|NOT COMPLETED|Overall Study||0
264890|NCT01091948|639755|P2|COMPLETED|Overall Study||38
264891|NCT01091948|639756|P1|COMPLETED|Overall Study||37
264892|NCT01091948|639755|P2|STARTED|Overall Study||38
264893|NCT01091948|639756|P1|STARTED|Overall Study||37
264894|NCT01091974|639778|P4|NOT COMPLETED|Overall Study||7
264895|NCT01091974|639779|P3|NOT COMPLETED|Overall Study||6
264896|NCT01091974|639780|P2|NOT COMPLETED|Overall Study||5
264897|NCT01091974|639781|P1|NOT COMPLETED|Overall Study||5
264898|NCT01091974|639778|P4|COMPLETED|Overall Study||17
264899|NCT01091974|639779|P3|COMPLETED|Overall Study||19
264900|NCT01091974|639780|P2|COMPLETED|Overall Study||18
264901|NCT01091974|639781|P1|COMPLETED|Overall Study||19
264902|NCT01091974|639778|P4|STARTED|Overall Study||24
264903|NCT01091974|639779|P3|STARTED|Overall Study||25
264904|NCT01091974|639780|P2|STARTED|Overall Study||23
264905|NCT01091974|639781|P1|STARTED|Overall Study||24
264906|NCT01092338|639797|P2|NOT COMPLETED|Overall Study||1
264907|NCT01092338|639798|P1|NOT COMPLETED|Overall Study||1
264908|NCT01092338|639797|P2|COMPLETED|Overall Study||21
264909|NCT01092338|639798|P1|COMPLETED|Overall Study||21
264910|NCT01092338|639797|P2|STARTED|Overall Study||22
264911|NCT01092338|639798|P1|STARTED|Overall Study||22
264912|NCT01092416|639806|P1|NOT COMPLETED|12-Month Follow-up||25
264913|NCT01092416|639806|P1|COMPLETED|12-Month Follow-up||413
264914|NCT01092416|639806|P1|STARTED|12-Month Follow-up||438
264915|NCT01092416|639806|P1|NOT COMPLETED|30-Day Follow-up||10
264916|NCT01092416|639806|P1|COMPLETED|30-Day Follow-up||430
264917|NCT01092416|639806|P1|STARTED|30-Day Follow-up||440
264918|NCT01092416|639806|P1|NOT COMPLETED|Enrollment||3
264919|NCT01092416|639806|P1|COMPLETED|Enrollment||440
264920|NCT01092416|639806|P1|STARTED|Enrollment||443
264921|NCT01092442|639817|P2|NOT COMPLETED|Overall Study||0
264922|NCT01092442|639818|P1|NOT COMPLETED|Overall Study||0
264923|NCT01092442|639817|P2|COMPLETED|Overall Study||60
264924|NCT01092442|639818|P1|COMPLETED|Overall Study||80
264925|NCT01092442|639817|P2|STARTED|Overall Study||60
264926|NCT01092442|639818|P1|STARTED|Overall Study||80
264927|NCT01092507|639834|P2|NOT COMPLETED|Overall Study||0
264928|NCT01092507|639835|P1|NOT COMPLETED|Overall Study||2
264929|NCT01092507|639834|P2|COMPLETED|Overall Study||150
264930|NCT01092507|639835|P1|COMPLETED|Overall Study||147
264931|NCT01092507|639834|P2|STARTED|Overall Study||150
264932|NCT01092507|639835|P1|STARTED|Overall Study||149
264933|NCT01092546|639853|P1|NOT COMPLETED|Overall Study||4
264934|NCT01092546|639853|P1|COMPLETED|Overall Study||12
264935|NCT01092546|639853|P1|STARTED|Overall Study||16
264936|NCT01092559|639858|P1|NOT COMPLETED|Overall Study||0
264937|NCT01092559|639858|P1|COMPLETED|Overall Study||10
264938|NCT01092559|639858|P1|STARTED|Overall Study||10
264939|NCT01092637|639865|P2|NOT COMPLETED|Overall Study||49
264940|NCT01092637|639866|P1|NOT COMPLETED|Overall Study||47
264941|NCT01092637|639865|P2|COMPLETED|Overall Study||86
264942|NCT01092637|639866|P1|COMPLETED|Overall Study||98
264943|NCT01092637|639865|P2|STARTED|Overall Study||135
264944|NCT01092637|639866|P1|STARTED|Overall Study||145
264945|NCT01092663|639878|P2|NOT COMPLETED|Overall Study||4
264946|NCT01092663|639879|P1|NOT COMPLETED|Overall Study||7
264947|NCT01092663|639878|P2|COMPLETED|Overall Study||26
264948|NCT01092663|639879|P1|COMPLETED|Overall Study||24
264949|NCT01092663|639878|P2|STARTED|Overall Study||30
264950|NCT01092663|639879|P1|STARTED|Overall Study||31
264951|NCT01092702|639925|P1|NOT COMPLETED|Overall Study||9
264952|NCT01092702|639925|P1|COMPLETED|Overall Study||23
264953|NCT01092702|639925|P1|STARTED|Overall Study||32
264954|NCT01092728|639931|P2|NOT COMPLETED|Overall Study||14
264955|NCT01092728|639932|P1|NOT COMPLETED|Overall Study||4
264956|NCT01092728|639931|P2|COMPLETED|Overall Study||0
264957|NCT01092728|639932|P1|COMPLETED|Overall Study||0
264958|NCT01092728|639931|P2|STARTED|Overall Study||14
264959|NCT01092728|639932|P1|STARTED|Overall Study||4
264960|NCT01092767|639940|P1|NOT COMPLETED|Overall Study||5
264961|NCT01092767|639940|P1|COMPLETED|Overall Study||45
264962|NCT01092767|639940|P1|STARTED|Overall Study||50
264963|NCT01092780|639944|P4|NOT COMPLETED|Treatment Period 4||0
264964|NCT01092780|639945|P3|NOT COMPLETED|Treatment Period 4||0
264965|NCT01092780|639946|P2|NOT COMPLETED|Treatment Period 4||0
264966|NCT01092780|639947|P1|NOT COMPLETED|Treatment Period 4||0
264967|NCT01092780|639944|P4|COMPLETED|Treatment Period 4||13
264968|NCT01092780|639945|P3|COMPLETED|Treatment Period 4||13
264969|NCT01092780|639946|P2|COMPLETED|Treatment Period 4||13
264970|NCT01092780|639947|P1|COMPLETED|Treatment Period 4||13
264971|NCT01092780|639944|P4|STARTED|Treatment Period 4||13
264972|NCT01092780|639945|P3|STARTED|Treatment Period 4||13
264973|NCT01092780|639946|P2|STARTED|Treatment Period 4||13
264974|NCT01092780|639947|P1|STARTED|Treatment Period 4||13
264975|NCT01092780|639944|P4|NOT COMPLETED|Washout Period 3||0
264976|NCT01092780|639945|P3|NOT COMPLETED|Washout Period 3||0
264977|NCT01092780|639946|P2|NOT COMPLETED|Washout Period 3||0
264978|NCT01092780|639947|P1|NOT COMPLETED|Washout Period 3||0
264979|NCT01092780|639944|P4|COMPLETED|Washout Period 3||13
264980|NCT01092780|639945|P3|COMPLETED|Washout Period 3||13
264981|NCT01092780|639946|P2|COMPLETED|Washout Period 3||13
264982|NCT01092780|639947|P1|COMPLETED|Washout Period 3||13
264983|NCT01092780|639944|P4|STARTED|Washout Period 3||13
264984|NCT01092780|639945|P3|STARTED|Washout Period 3||13
264985|NCT01092780|639946|P2|STARTED|Washout Period 3||13
264986|NCT01092780|639947|P1|STARTED|Washout Period 3||13
264987|NCT01092780|639944|P4|NOT COMPLETED|Treatment Period 3||0
264988|NCT01092780|639945|P3|NOT COMPLETED|Treatment Period 3||0
264989|NCT01092780|639946|P2|NOT COMPLETED|Treatment Period 3||0
264990|NCT01092780|639947|P1|NOT COMPLETED|Treatment Period 3||0
264991|NCT01092780|639944|P4|COMPLETED|Treatment Period 3||13
264992|NCT01092780|639945|P3|COMPLETED|Treatment Period 3||13
264993|NCT01092780|639946|P2|COMPLETED|Treatment Period 3||13
264994|NCT01092780|639947|P1|COMPLETED|Treatment Period 3||13
264995|NCT01092780|639944|P4|STARTED|Treatment Period 3||13
264996|NCT01092780|639945|P3|STARTED|Treatment Period 3||13
264997|NCT01092780|639946|P2|STARTED|Treatment Period 3||13
264998|NCT01092780|639947|P1|STARTED|Treatment Period 3||13
264999|NCT01092780|639944|P4|NOT COMPLETED|Washout Period 2||0
265000|NCT01092780|639945|P3|NOT COMPLETED|Washout Period 2||1
265001|NCT01092780|639946|P2|NOT COMPLETED|Washout Period 2||1
265002|NCT01092780|639947|P1|NOT COMPLETED|Washout Period 2||0
265003|NCT01092780|639944|P4|COMPLETED|Washout Period 2||13
265004|NCT01092780|639945|P3|COMPLETED|Washout Period 2||13
265005|NCT01092780|639946|P2|COMPLETED|Washout Period 2||13
265006|NCT01092780|639947|P1|COMPLETED|Washout Period 2||13
265007|NCT01092780|639944|P4|STARTED|Washout Period 2||13
265008|NCT01092780|639945|P3|STARTED|Washout Period 2||14
265009|NCT01092780|639946|P2|STARTED|Washout Period 2||14
265010|NCT01092780|639947|P1|STARTED|Washout Period 2||13
265011|NCT01092780|639944|P4|NOT COMPLETED|Treatment Period 2||0
265012|NCT01092780|639945|P3|NOT COMPLETED|Treatment Period 2||0
265013|NCT01092780|639946|P2|NOT COMPLETED|Treatment Period 2||0
265014|NCT01092780|639947|P1|NOT COMPLETED|Treatment Period 2||0
265015|NCT01092780|639944|P4|COMPLETED|Treatment Period 2||13
265016|NCT01092780|639945|P3|COMPLETED|Treatment Period 2||14
265017|NCT01092780|639946|P2|COMPLETED|Treatment Period 2||14
265018|NCT01092780|639947|P1|COMPLETED|Treatment Period 2||13
265019|NCT01092780|639944|P4|STARTED|Treatment Period 2||13
265020|NCT01092780|639945|P3|STARTED|Treatment Period 2||14
265021|NCT01092780|639946|P2|STARTED|Treatment Period 2||14
265022|NCT01092780|639947|P1|STARTED|Treatment Period 2||13
265023|NCT01092780|639944|P4|NOT COMPLETED|Washout Period 1||0
265024|NCT01092780|639945|P3|NOT COMPLETED|Washout Period 1||0
265025|NCT01092780|639946|P2|NOT COMPLETED|Washout Period 1||1
265026|NCT01092780|639947|P1|NOT COMPLETED|Washout Period 1||1
265027|NCT01092780|639944|P4|COMPLETED|Washout Period 1||13
265028|NCT01092780|639945|P3|COMPLETED|Washout Period 1||14
265029|NCT01092780|639946|P2|COMPLETED|Washout Period 1||14
265030|NCT01092780|639947|P1|COMPLETED|Washout Period 1||13
265031|NCT01092780|639944|P4|STARTED|Washout Period 1||13
265032|NCT01092780|639945|P3|STARTED|Washout Period 1||14
265033|NCT01092780|639946|P2|STARTED|Washout Period 1||15
265034|NCT01092780|639947|P1|STARTED|Washout Period 1||14
265035|NCT01092780|639944|P4|NOT COMPLETED|Treatment Period 1||0
265036|NCT01092780|639945|P3|NOT COMPLETED|Treatment Period 1||0
265037|NCT01092780|639946|P2|NOT COMPLETED|Treatment Period 1||0
265038|NCT01092780|639947|P1|NOT COMPLETED|Treatment Period 1||0
265039|NCT01092780|639944|P4|COMPLETED|Treatment Period 1||13
265040|NCT01092780|639945|P3|COMPLETED|Treatment Period 1||14
265041|NCT01092780|639946|P2|COMPLETED|Treatment Period 1||15
265042|NCT01092780|639947|P1|COMPLETED|Treatment Period 1||14
265043|NCT01092780|639944|P4|STARTED|Treatment Period 1||13
265044|NCT01092780|639945|P3|STARTED|Treatment Period 1||14
265045|NCT01092780|639946|P2|STARTED|Treatment Period 1||15
265046|NCT01092780|639947|P1|STARTED|Treatment Period 1||14
265047|NCT01092832|639979|P2|NOT COMPLETED|Overall Study||0
265048|NCT01092832|639980|P1|NOT COMPLETED|Overall Study||1
265049|NCT01092832|639979|P2|COMPLETED|Overall Study||8
265050|NCT01092832|639980|P1|COMPLETED|Overall Study||13
265051|NCT01092832|639979|P2|STARTED|Overall Study||8
265052|NCT01092832|639980|P1|STARTED|Overall Study||14
265053|NCT01092910|639992|P1|NOT COMPLETED|Overall Study||5
265054|NCT01092910|639992|P1|COMPLETED|Overall Study||52
265055|NCT01092910|639992|P1|10 Month Follow-up|Overall Study||52
265056|NCT01092910|639992|P1|4 Month Follow-up|Overall Study||54
265057|NCT01092910|639992|P1|STARTED|Overall Study||57
265058|NCT01092923|640004|P2|NOT COMPLETED|Overall Study||0
265059|NCT01092923|640005|P1|NOT COMPLETED|Overall Study||0
265060|NCT01092923|640004|P2|COMPLETED|Overall Study||10
265061|NCT01092923|640005|P1|COMPLETED|Overall Study||10
265062|NCT01092923|640004|P2|STARTED|Overall Study||10
265063|NCT01092923|640005|P1|STARTED|Overall Study||10
265064|NCT01093014|640017|P3|NOT COMPLETED|Overall Study||0
265065|NCT01093014|640018|P2|NOT COMPLETED|Overall Study||0
265066|NCT01093014|640019|P1|NOT COMPLETED|Overall Study||0
265067|NCT01093014|640017|P3|COMPLETED|Overall Study||12
265068|NCT01093014|640018|P2|COMPLETED|Overall Study||9
265069|NCT01093014|640019|P1|COMPLETED|Overall Study||12
265070|NCT01093014|640017|P3|STARTED|Overall Study||12
265071|NCT01093014|640018|P2|STARTED|Overall Study||9
265072|NCT01093014|640019|P1|STARTED|Overall Study||12
265073|NCT01093027|640038|P2|NOT COMPLETED|Visit 2||0
265074|NCT01093027|640039|P1|NOT COMPLETED|Visit 2||0
265075|NCT01093027|640038|P2|COMPLETED|Visit 2||10
265076|NCT01093027|640039|P1|COMPLETED|Visit 2||10
265077|NCT01093027|640038|P2|STARTED|Visit 2||10
265078|NCT01093027|640039|P1|STARTED|Visit 2||10
265079|NCT01093027|640038|P2|NOT COMPLETED|Visit 1||0
265080|NCT01093027|640039|P1|NOT COMPLETED|Visit 1||0
265081|NCT01093027|640038|P2|COMPLETED|Visit 1||10
265082|NCT01093027|640039|P1|COMPLETED|Visit 1||10
265083|NCT01093027|640038|P2|STARTED|Visit 1||10
265084|NCT01093027|640039|P1|STARTED|Visit 1||10
265085|NCT01093222|640047|P1|NOT COMPLETED|Overall Study||40
265086|NCT01093222|640047|P1|COMPLETED|Overall Study||0
265087|NCT01093222|640047|P1|Eligible and Began Protocol Therapy|Overall Study||34
265088|NCT01093222|640047|P1|STARTED|Overall Study||40
265089|NCT01093417|640056|P2|NOT COMPLETED|Overall Study||1
265090|NCT01093417|640057|P1|NOT COMPLETED|Overall Study||0
265091|NCT01093417|640056|P2|COMPLETED|Overall Study||29
265092|NCT01093417|640057|P1|COMPLETED|Overall Study||15
265093|NCT01093417|640056|P2|STARTED|Overall Study||30
265094|NCT01093417|640057|P1|STARTED|Overall Study||15
265095|NCT01093469|640068|P3|NOT COMPLETED|Overall Study||1
265096|NCT01093469|640069|P2|NOT COMPLETED|Overall Study||0
265097|NCT01093469|640070|P1|NOT COMPLETED|Overall Study||0
265098|NCT01093469|640068|P3|COMPLETED|Overall Study||12
265099|NCT01093469|640069|P2|COMPLETED|Overall Study||13
265100|NCT01093469|640070|P1|COMPLETED|Overall Study||13
265101|NCT01093469|640068|P3|STARTED|Overall Study||13
265102|NCT01093469|640069|P2|STARTED|Overall Study||13
265103|NCT01093469|640070|P1|STARTED|Overall Study||13
265104|NCT01093521|640078|P1|NOT COMPLETED|Overall Study||0
265105|NCT01093521|640078|P1|COMPLETED|Overall Study||20
265106|NCT01093521|640078|P1|STARTED|Overall Study||20
265107|NCT01093534|640096|P3|NOT COMPLETED|Overall Study||9
265108|NCT01093534|640097|P2|NOT COMPLETED|Overall Study||16
265109|NCT01093534|640098|P1|NOT COMPLETED|Overall Study||10
265110|NCT01093534|640096|P3|COMPLETED|Overall Study||169
265111|NCT01093534|640097|P2|COMPLETED|Overall Study||167
265112|NCT01093534|640098|P1|COMPLETED|Overall Study||176
265113|NCT01093534|640096|P3|Received Study Treatment|Overall Study||175
265114|NCT01093534|640097|P2|Received Study Treatment|Overall Study||182
265115|NCT01093534|640098|P1|Received Study Treatment|Overall Study||186
265116|NCT01093534|640096|P3|STARTED|Overall Study||178
265117|NCT01093534|640097|P2|STARTED|Overall Study||183
265118|NCT01093534|640098|P1|STARTED|Overall Study||186
265119|NCT01100931|640205|P2|NOT COMPLETED|Phase II||0
265120|NCT01100931|640206|P1|NOT COMPLETED|Phase II||0
265121|NCT01100931|640205|P2|COMPLETED|Phase II||19
265122|NCT01100931|640206|P1|COMPLETED|Phase II||0
265123|NCT01100931|640205|P2|STARTED|Phase II||19
265124|NCT01100931|640206|P1|STARTED|Phase II||0
265125|NCT01100931|640205|P2|NOT COMPLETED|Phase I||0
265126|NCT01100931|640206|P1|NOT COMPLETED|Phase I||0
265127|NCT01100931|640205|P2|COMPLETED|Phase I||0
265128|NCT01100931|640206|P1|COMPLETED|Phase I||22
265129|NCT01100931|640205|P2|STARTED|Phase I||0
265130|NCT01100931|640206|P1|STARTED|Phase I||22
265131|NCT01100944|640214|P3|NOT COMPLETED|Expansion Phase - Phase 2||0
265132|NCT01100944|640215|P2|NOT COMPLETED|Expansion Phase - Phase 2||0
265133|NCT01100944|640216|P1|NOT COMPLETED|Expansion Phase - Phase 2||0
265134|NCT01100944|640214|P3|COMPLETED|Expansion Phase - Phase 2||18
265135|NCT01100944|640215|P2|COMPLETED|Expansion Phase - Phase 2||0
265136|NCT01100944|640216|P1|COMPLETED|Expansion Phase - Phase 2||0
265137|NCT01100944|640214|P3|STARTED|Expansion Phase - Phase 2||18
265138|NCT01100944|640215|P2|STARTED|Expansion Phase - Phase 2||0
265139|NCT01100944|640216|P1|STARTED|Expansion Phase - Phase 2||0
265140|NCT01100944|640214|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
265141|NCT01100944|640215|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||2
265142|NCT01100944|640216|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
265143|NCT01100944|640214|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
265144|NCT01100944|640215|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
265145|NCT01100944|640216|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 2||0
265146|NCT01100944|640214|P3|STARTED|Dose Escalation Phase 1 Dose Level 2||0
265147|NCT01100944|640215|P2|STARTED|Dose Escalation Phase 1 Dose Level 2||2
265148|NCT01100944|640216|P1|STARTED|Dose Escalation Phase 1 Dose Level 2||0
265149|NCT01100944|640214|P3|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
265150|NCT01100944|640215|P2|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
265151|NCT01100944|640216|P1|NOT COMPLETED|Dose Escalation Phase 1 Dose Level 1||4
265152|NCT01100944|640214|P3|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
265153|NCT01100944|640215|P2|COMPLETED|Dose Escalation Phase 1 Dose Level 1||0
265154|NCT01100944|640216|P1|COMPLETED|Dose Escalation Phase 1 Dose Level 1||2
265155|NCT01100944|640214|P3|STARTED|Dose Escalation Phase 1 Dose Level 1||0
265156|NCT01100944|640215|P2|STARTED|Dose Escalation Phase 1 Dose Level 1||0
265157|NCT01100944|640216|P1|STARTED|Dose Escalation Phase 1 Dose Level 1||6
265158|NCT01101022|640263|P2|NOT COMPLETED|Overall Study||27
265159|NCT01101022|640264|P1|NOT COMPLETED|Overall Study||17
265160|NCT01101022|640263|P2|COMPLETED|Overall Study||53
265161|NCT01101022|640264|P1|COMPLETED|Overall Study||62
265162|NCT01101022|640263|P2|STARTED|Overall Study||80
265163|NCT01101022|640264|P1|STARTED|Overall Study||79
265164|NCT01101165|640298|P2|NOT COMPLETED|Period 2||1
265165|NCT01101165|640299|P1|NOT COMPLETED|Period 2||4
265166|NCT01101165|640298|P2|COMPLETED|Period 2||39
265167|NCT01101165|640299|P1|COMPLETED|Period 2||41
265168|NCT01101165|640298|P2|STARTED|Period 2||40
265169|NCT01101165|640299|P1|STARTED|Period 2||45
265170|NCT01101165|640298|P2|NOT COMPLETED|Period 1||5
265171|NCT01101165|640299|P1|NOT COMPLETED|Period 1||2
265172|NCT01101165|640298|P2|COMPLETED|Period 1||40
265173|NCT01101165|640299|P1|COMPLETED|Period 1||45
265174|NCT01101165|640298|P2|STARTED|Period 1||45
265175|NCT01101165|640299|P1|STARTED|Period 1||47
265176|NCT01101178|640309|P2|NOT COMPLETED|Period 2||1
265177|NCT01101178|640310|P1|NOT COMPLETED|Period 2||0
265178|NCT01101178|640309|P2|COMPLETED|Period 2||34
265179|NCT01101178|640310|P1|COMPLETED|Period 2||36
265180|NCT01101178|640309|P2|STARTED|Period 2||35
265181|NCT01101178|640310|P1|STARTED|Period 2||36
265182|NCT01101178|640309|P2|NOT COMPLETED|Period 1||4
265183|NCT01101178|640310|P1|NOT COMPLETED|Period 1||4
265184|NCT01101178|640309|P2|COMPLETED|Period 1||35
265185|NCT01101178|640310|P1|COMPLETED|Period 1||36
265186|NCT01101178|640309|P2|STARTED|Period 1||39
265187|NCT01101178|640310|P1|STARTED|Period 1||40
265188|NCT01101191|640321|P2|NOT COMPLETED|Period 2||0
265189|NCT01101191|640322|P1|NOT COMPLETED|Period 2||0
265190|NCT01101191|640321|P2|COMPLETED|Period 2||40
265191|NCT01101191|640322|P1|COMPLETED|Period 2||40
265192|NCT01101191|640321|P2|STARTED|Period 2||40
265193|NCT01101191|640322|P1|STARTED|Period 2||40
265194|NCT01101191|640321|P2|NOT COMPLETED|Period 1||2
265195|NCT01101191|640322|P1|NOT COMPLETED|Period 1||2
265196|NCT01101191|640321|P2|COMPLETED|Period 1||40
265197|NCT01101191|640322|P1|COMPLETED|Period 1||40
265198|NCT01101191|640321|P2|STARTED|Period 1||42
265199|NCT01101191|640322|P1|STARTED|Period 1||42
265200|NCT01101841|640335|P2|NOT COMPLETED|Overall Study||67
265201|NCT01101841|640336|P1|NOT COMPLETED|Overall Study||50
265202|NCT01101841|640335|P2|COMPLETED|Overall Study||218
265203|NCT01101841|640336|P1|COMPLETED|Overall Study||235
265204|NCT01101841|640335|P2|STARTED|Overall Study||285
265205|NCT01101841|640336|P1|STARTED|Overall Study||285
265206|NCT01101867|640376|P2|NOT COMPLETED|Overall Study||4
265207|NCT01101867|640377|P1|NOT COMPLETED|Overall Study||1
265208|NCT01101867|640376|P2|COMPLETED|Overall Study||59
265209|NCT01101867|640377|P1|COMPLETED|Overall Study||62
265210|NCT01101867|640376|P2|STARTED|Overall Study||63
265211|NCT01101867|640377|P1|STARTED|Overall Study||63
265212|NCT01101958|640389|P2|NOT COMPLETED|Overall Study||5
265213|NCT01101958|640390|P1|NOT COMPLETED|Overall Study||11
265214|NCT01101958|640389|P2|COMPLETED|Overall Study||29
265215|NCT01101958|640390|P1|COMPLETED|Overall Study||51
265216|NCT01101958|640389|P2|STARTED|Overall Study||34
265217|NCT01101958|640390|P1|STARTED|Overall Study||62
265218|NCT01101971|640396|P1|NOT COMPLETED|Overall Study||0
265219|NCT01101971|640396|P1|COMPLETED|Overall Study||45
265220|NCT01101971|640396|P1|STARTED|Overall Study||45
265221|NCT01102140|640402|P2|NOT COMPLETED|Overall Study||2
265222|NCT01102140|640403|P1|NOT COMPLETED|Overall Study||3
265223|NCT01102140|640402|P2|COMPLETED|Overall Study||5
265224|NCT01102140|640403|P1|COMPLETED|Overall Study||10
265225|NCT01102140|640402|P2|STARTED|Overall Study||7
265226|NCT01102140|640403|P1|STARTED|Overall Study||13
265227|NCT01102218|640417|P2|NOT COMPLETED|Overall Study||10
265228|NCT01102218|640418|P1|NOT COMPLETED|Overall Study||11
265229|NCT01102218|640417|P2|COMPLETED|Overall Study||14
265230|NCT01102218|640418|P1|COMPLETED|Overall Study||13
265231|NCT01102218|640417|P2|STARTED|Overall Study||24
265232|NCT01102218|640418|P1|STARTED|Overall Study||24
265233|NCT01102257|640426|P2|NOT COMPLETED|Overall Study||0
265234|NCT01102257|640427|P1|NOT COMPLETED|Overall Study||2
265235|NCT01102257|640426|P2|COMPLETED|Overall Study||9
265236|NCT01102257|640427|P1|COMPLETED|Overall Study|2 withdrew from the study d/t adverse events. 1 had shortness of breath and the other had chest pain|7
265237|NCT01102257|640426|P2|STARTED|Overall Study||9
265238|NCT01102257|640427|P1|STARTED|Overall Study||9
265239|NCT01102270|640433|P2|NOT COMPLETED|Overall Study||0
265240|NCT01102270|640434|P1|NOT COMPLETED|Overall Study||0
265241|NCT01102270|640433|P2|COMPLETED|Overall Study||9
265242|NCT01102270|640434|P1|COMPLETED|Overall Study||8
265243|NCT01102270|640433|P2|STARTED|Overall Study||9
265244|NCT01102270|640434|P1|STARTED|Overall Study||8
265245|NCT01102374|640448|P2|NOT COMPLETED|Overall Study||19
265246|NCT01102374|640449|P1|NOT COMPLETED|Overall Study||16
265247|NCT01102374|640448|P2|COMPLETED|Overall Study||33
265248|NCT01102374|640449|P1|COMPLETED|Overall Study||39
265249|NCT01102374|640448|P2|STARTED|Overall Study||52
265250|NCT01102374|640449|P1|STARTED|Overall Study||55
265251|NCT01102413|640485|P2|NOT COMPLETED|Overall Study||12
265252|NCT01102413|640486|P1|NOT COMPLETED|Overall Study||25
265253|NCT01102413|640485|P2|COMPLETED|Overall Study||106
265254|NCT01102413|640486|P1|COMPLETED|Overall Study||208
265255|NCT01102413|640485|P2|STARTED|Overall Study||118
265256|NCT01102413|640486|P1|STARTED|Overall Study||233
265257|NCT01102491|640496|P2|NOT COMPLETED|Overall Study||12
265258|NCT01102491|640497|P1|NOT COMPLETED|Overall Study||11
265259|NCT01102491|640496|P2|COMPLETED|Overall Study|12 patients were excluded|59
265260|NCT01102491|640497|P1|COMPLETED|Overall Study|11 patient excluded|60
265261|NCT01102491|640496|P2|STARTED|Overall Study||71
265262|NCT01102491|640497|P1|STARTED|Overall Study||71
265263|NCT01102764|640505|P2|NOT COMPLETED|Overall Study||13
265264|NCT01102764|640506|P1|NOT COMPLETED|Overall Study||21
265265|NCT01102764|640505|P2|COMPLETED|Overall Study||55
265266|NCT01102764|640506|P1|COMPLETED|Overall Study||43
265267|NCT01102764|640505|P2|STARTED|Overall Study||68
265268|NCT01102764|640506|P1|STARTED|Overall Study||64
265269|NCT01102777|640518|P2|NOT COMPLETED|Overall Study||16
265270|NCT01102777|640519|P1|NOT COMPLETED|Overall Study||9
265271|NCT01102777|640518|P2|COMPLETED|Overall Study||139
265272|NCT01102777|640519|P1|COMPLETED|Overall Study||75
265273|NCT01102777|640518|P2|STARTED|Overall Study||155
265274|NCT01102777|640519|P1|STARTED|Overall Study||84
265275|NCT01102803|640545|P2|NOT COMPLETED|Post to Follow-Up||3
265276|NCT01102803|640546|P1|NOT COMPLETED|Post to Follow-Up||1
265277|NCT01102803|640545|P2|COMPLETED|Post to Follow-Up||12
265278|NCT01102803|640546|P1|COMPLETED|Post to Follow-Up||10
265279|NCT01102803|640545|P2|STARTED|Post to Follow-Up||15
265280|NCT01102803|640546|P1|STARTED|Post to Follow-Up||11
265281|NCT01102803|640545|P2|NOT COMPLETED|Baseline to Post-Treatment||0
265282|NCT01102803|640546|P1|NOT COMPLETED|Baseline to Post-Treatment||3
265283|NCT01102803|640545|P2|COMPLETED|Baseline to Post-Treatment||15
265284|NCT01102803|640546|P1|COMPLETED|Baseline to Post-Treatment||11
265285|NCT01102803|640545|P2|STARTED|Baseline to Post-Treatment||15
265286|NCT01102803|640546|P1|STARTED|Baseline to Post-Treatment||14
265287|NCT01102894|640558|P1|NOT COMPLETED|Overall Study||0
265288|NCT01102894|640558|P1|COMPLETED|Overall Study||10
265289|NCT01102894|640558|P1|STARTED|Overall Study||10
265290|NCT01102972|640570|P2|NOT COMPLETED|Overall Study||14
265291|NCT01102972|640571|P1|NOT COMPLETED|Overall Study||29
265292|NCT01102972|640570|P2|COMPLETED|Overall Study|These participants completed Study Week 48.|83
265293|NCT01102972|640571|P1|COMPLETED|Overall Study|These participants completed Study Week 48.|170
265294|NCT01102972|640570|P2|Completed Week 24|Overall Study||88
265295|NCT01102972|640571|P1|Completed Week 24|Overall Study||180
265296|NCT01102972|640570|P2|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|97
265297|NCT01102972|640571|P1|STARTED|Overall Study|297 PAR enrolled. 1 PAR withdrew before taking investigational product and didn’t “start” the study.|199
265298|NCT01103063|640625|P2|NOT COMPLETED|Overall Study||421
265299|NCT01103063|640626|P1|NOT COMPLETED|Overall Study||477
265300|NCT01103063|640625|P2|COMPLETED|Overall Study||1024
265301|NCT01103063|640626|P1|COMPLETED|Overall Study||969
265302|NCT01103063|640625|P2|STARTED|Overall Study||1445
265303|NCT01103063|640626|P1|STARTED|Overall Study||1446
265304|NCT01103141|640694|P2|NOT COMPLETED|Overall Study||2
265305|NCT01103141|640695|P1|NOT COMPLETED|Overall Study||2
265306|NCT01103141|640694|P2|COMPLETED|Overall Study||74
265307|NCT01103141|640695|P1|COMPLETED|Overall Study||65
265308|NCT01103141|640694|P2|STARTED|Overall Study||76
265309|NCT01103141|640695|P1|STARTED|Overall Study||67
265310|NCT01103232|640703|P2|NOT COMPLETED|Overall Study||2
265311|NCT01103232|640704|P1|NOT COMPLETED|Overall Study||1
265312|NCT01103232|640703|P2|COMPLETED|Overall Study||11
265313|NCT01103232|640704|P1|COMPLETED|Overall Study||12
265314|NCT01103232|640703|P2|STARTED|Overall Study||13
265315|NCT01103232|640704|P1|STARTED|Overall Study||13
265316|NCT01103271|640712|P2|NOT COMPLETED|Overall Study||4
265317|NCT01103271|640713|P1|NOT COMPLETED|Overall Study||1
265318|NCT01103271|640712|P2|COMPLETED|Overall Study||5
265319|NCT01103271|640713|P1|COMPLETED|Overall Study||10
265320|NCT01103271|640712|P2|STARTED|Overall Study||9
265321|NCT01103271|640713|P1|STARTED|Overall Study||11
265322|NCT01103284|640722|P2|NOT COMPLETED|Overall Study||44
265323|NCT01103284|640723|P1|NOT COMPLETED|Overall Study||42
265324|NCT01103284|640722|P2|COMPLETED|Overall Study||195
265325|NCT01103284|640723|P1|COMPLETED|Overall Study||194
265326|NCT01103284|640722|P2|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS)|235
265327|NCT01103284|640723|P1|At Least One Post-baseline Visit (FAS)|Overall Study|Patients reaching this milestone were included in the Full Analysis Set (FAS) population|233
265328|NCT01103284|640722|P2|Treated|Overall Study||238
265329|NCT01103284|640723|P1|Treated|Overall Study||236
265330|NCT01103284|640722|P2|STARTED|Overall Study||239
265331|NCT01103284|640723|P1|STARTED|Overall Study||236
265332|NCT01103323|640739|P2|NOT COMPLETED|Switched From Placebo to Regorafenib||1
265333|NCT01103323|640740|P1|NOT COMPLETED|Switched From Placebo to Regorafenib||0
265334|NCT01103323|640739|P2|COMPLETED|Switched From Placebo to Regorafenib||3
265335|NCT01103323|640740|P1|COMPLETED|Switched From Placebo to Regorafenib||0
265336|NCT01103323|640739|P2|STARTED|Switched From Placebo to Regorafenib|Participants in the placebo+BSC group switched to Regorafenib treatment after unblinding.|4
265337|NCT01103323|640740|P1|STARTED|Switched From Placebo to Regorafenib||0
265338|NCT01103323|640739|P2|NOT COMPLETED|Without/Before Drug Switch||18
265339|NCT01103323|640740|P1|NOT COMPLETED|Without/Before Drug Switch||76
265340|NCT01103323|640739|P2|COMPLETED|Without/Before Drug Switch||237
265341|NCT01103323|640740|P1|COMPLETED|Without/Before Drug Switch||429
265342|NCT01103323|640739|P2|Participants Received Treatment|Without/Before Drug Switch||253
265343|NCT01103323|640740|P1|Participants Received Treatment|Without/Before Drug Switch||500
265344|NCT01103323|640739|P2|STARTED|Without/Before Drug Switch||255
265345|NCT01103323|640740|P1|STARTED|Without/Before Drug Switch||505
265346|NCT01103362|640755|P1|NOT COMPLETED|Overall Study||596
265347|NCT01103362|640755|P1|COMPLETED|Overall Study||0
265348|NCT01103362|640755|P1|STARTED|Overall Study||596
265349|NCT01103414|640764|P5|NOT COMPLETED|Overall Study||15
265350|NCT01103414|640765|P4|NOT COMPLETED|Overall Study||7
265351|NCT01103414|640766|P3|NOT COMPLETED|Overall Study||15
265352|NCT01103414|640767|P2|NOT COMPLETED|Overall Study||9
265353|NCT01103414|640768|P1|NOT COMPLETED|Overall Study||13
265354|NCT01103414|640764|P5|COMPLETED|Overall Study||56
265355|NCT01103414|640765|P4|COMPLETED|Overall Study||64
265356|NCT01103414|640766|P3|COMPLETED|Overall Study||56
265357|NCT01103414|640767|P2|COMPLETED|Overall Study||62
265358|NCT01103414|640768|P1|COMPLETED|Overall Study||59
265359|NCT01103414|640764|P5|STARTED|Overall Study||71
265360|NCT01103414|640765|P4|STARTED|Overall Study||71
265361|NCT01103414|640766|P3|STARTED|Overall Study||71
265362|NCT01103414|640767|P2|STARTED|Overall Study||71
265363|NCT01103414|640768|P1|STARTED|Overall Study||72
265364|NCT01103466|640830|P3|NOT COMPLETED|Third Period (14 +/- 3 Days)||1
265365|NCT01103466|640831|P2|NOT COMPLETED|Third Period (14 +/- 3 Days)||0
265366|NCT01103466|640832|P1|NOT COMPLETED|Third Period (14 +/- 3 Days)||2
265367|NCT01103466|640830|P3|COMPLETED|Third Period (14 +/- 3 Days)||13
265368|NCT01103466|640831|P2|COMPLETED|Third Period (14 +/- 3 Days)||8
265369|NCT01103466|640832|P1|COMPLETED|Third Period (14 +/- 3 Days)||6
265370|NCT01103466|640830|P3|STARTED|Third Period (14 +/- 3 Days)||14
265371|NCT01103466|640831|P2|STARTED|Third Period (14 +/- 3 Days)||8
265372|NCT01103466|640832|P1|STARTED|Third Period (14 +/- 3 Days)||8
265373|NCT01103466|640830|P3|NOT COMPLETED|Second Period (14 +/- 3 Days)||1
265374|NCT01103466|640831|P2|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
265375|NCT01103466|640832|P1|NOT COMPLETED|Second Period (14 +/- 3 Days)||2
265376|NCT01103466|640830|P3|COMPLETED|Second Period (14 +/- 3 Days)||6
265377|NCT01103466|640831|P2|COMPLETED|Second Period (14 +/- 3 Days)||11
265378|NCT01103466|640832|P1|COMPLETED|Second Period (14 +/- 3 Days)||13
265379|NCT01103466|640830|P3|STARTED|Second Period (14 +/- 3 Days)||7
265380|NCT01103466|640831|P2|STARTED|Second Period (14 +/- 3 Days)||13
265381|NCT01103466|640832|P1|STARTED|Second Period (14 +/- 3 Days)||15
265382|NCT01103466|640830|P3|NOT COMPLETED|First Period (14 +/- 3 Days)||0
265383|NCT01103466|640831|P2|NOT COMPLETED|First Period (14 +/- 3 Days)||0
265384|NCT01103466|640832|P1|NOT COMPLETED|First Period (14 +/- 3 Days)||2
265385|NCT01103466|640830|P3|COMPLETED|First Period (14 +/- 3 Days)||13
265386|NCT01103466|640831|P2|COMPLETED|First Period (14 +/- 3 Days)||12
265387|NCT01103466|640832|P1|COMPLETED|First Period (14 +/- 3 Days)||10
265388|NCT01103466|640830|P3|STARTED|First Period (14 +/- 3 Days)||13
265389|NCT01103466|640831|P2|STARTED|First Period (14 +/- 3 Days)||12
265390|NCT01103466|640832|P1|STARTED|First Period (14 +/- 3 Days)||12
265391|NCT01103479|640843|P3|NOT COMPLETED|Overall Study||14
265392|NCT01103479|640844|P2|NOT COMPLETED|Overall Study||9
265393|NCT01103479|640845|P1|NOT COMPLETED|Overall Study||5
265394|NCT01103479|640843|P3|COMPLETED|Overall Study||174
265395|NCT01103479|640844|P2|COMPLETED|Overall Study||201
265396|NCT01103479|640845|P1|COMPLETED|Overall Study||163
265397|NCT01103479|640843|P3|STARTED|Overall Study||188
265398|NCT01103479|640844|P2|STARTED|Overall Study||210
265399|NCT01103479|640845|P1|STARTED|Overall Study||168
265400|NCT01103492|640858|P1|NOT COMPLETED|Overall Study||0
265401|NCT01103492|640858|P1|COMPLETED|Overall Study||1
265402|NCT01103492|640858|P1|STARTED|Overall Study||1
265403|NCT01103713|640862|P1|NOT COMPLETED|Overall Study||13
265404|NCT01103713|640862|P1|COMPLETED|Overall Study||155
265405|NCT01103713|640862|P1|STARTED|Overall Study||168
265406|NCT01103934|640890|P2|NOT COMPLETED|Overall Study||0
265407|NCT01103934|640891|P1|NOT COMPLETED|Overall Study||0
265408|NCT01103934|640890|P2|COMPLETED|Overall Study||18
265409|NCT01103934|640891|P1|COMPLETED|Overall Study||17
265410|NCT01103934|640890|P2|STARTED|Overall Study||18
265411|NCT01103934|640891|P1|STARTED|Overall Study||17
265412|NCT01103960|640901|P2|NOT COMPLETED|Overall Study||2
265413|NCT01103960|640902|P1|NOT COMPLETED|Overall Study||5
265414|NCT01103960|640901|P2|COMPLETED|Overall Study|Completed study medication.|158
265415|NCT01103960|640902|P1|COMPLETED|Overall Study|Completed study medication.|159
265416|NCT01103960|640901|P2|STARTED|Overall Study|Randomised and treated.|160
265417|NCT01103960|640902|P1|STARTED|Overall Study|Randomised and treated.|164
265418|NCT01103973|640928|P2|NOT COMPLETED|Overall Study||0
265419|NCT01103973|640929|P1|NOT COMPLETED|Overall Study||0
265420|NCT01103973|640928|P2|COMPLETED|Overall Study||46
265421|NCT01103973|640929|P1|COMPLETED|Overall Study||51
265422|NCT01103973|640928|P2|STARTED|Overall Study||46
265423|NCT01103973|640929|P1|STARTED|Overall Study||51
265424|NCT01096446|640937|P2|NOT COMPLETED|Overall Study||0
265425|NCT01096446|640938|P1|NOT COMPLETED|Overall Study||3
265426|NCT01096446|640937|P2|COMPLETED|Overall Study||10
265427|NCT01096446|640938|P1|COMPLETED|Overall Study|One infant was SGA; one infant had a congenital anomaly; and one discontinued medical management|9
265428|NCT01096446|640937|P2|STARTED|Overall Study||10
265429|NCT01096446|640938|P1|STARTED|Overall Study||12
265430|NCT01096550|640945|P2|NOT COMPLETED|Overall Study||29
265431|NCT01096550|640946|P1|NOT COMPLETED|Overall Study||37
265432|NCT01096550|640945|P2|COMPLETED|Overall Study||146
265433|NCT01096550|640946|P1|COMPLETED|Overall Study||133
265434|NCT01096550|640945|P2|STARTED|Overall Study||175
265435|NCT01096550|640946|P1|STARTED|Overall Study||170
265436|NCT01096589|640956|P4|NOT COMPLETED|Overall Study||3
265437|NCT01096589|640957|P3|NOT COMPLETED|Overall Study||4
265438|NCT01096589|640958|P2|NOT COMPLETED|Overall Study||2
265439|NCT01096589|640959|P1|NOT COMPLETED|Overall Study||4
265440|NCT01096589|640956|P4|COMPLETED|Overall Study||15
265441|NCT01096589|640957|P3|COMPLETED|Overall Study||18
265442|NCT01096589|640958|P2|COMPLETED|Overall Study||18
265443|NCT01096589|640959|P1|COMPLETED|Overall Study||18
265444|NCT01096589|640956|P4|STARTED|Overall Study||18
265445|NCT01096589|640957|P3|STARTED|Overall Study||22
265446|NCT01096589|640958|P2|STARTED|Overall Study||20
265447|NCT01096589|640959|P1|STARTED|Overall Study||22
265448|NCT01096680|640974|P5|NOT COMPLETED|Overall Study||0
265449|NCT01096680|640975|P4|NOT COMPLETED|Overall Study||0
265450|NCT01096680|640976|P3|NOT COMPLETED|Overall Study||0
265451|NCT01096680|640977|P2|NOT COMPLETED|Overall Study||0
265452|NCT01096680|640978|P1|NOT COMPLETED|Overall Study||0
265453|NCT01096680|640974|P5|COMPLETED|Overall Study||27
265454|NCT01096680|640975|P4|COMPLETED|Overall Study||27
265455|NCT01096680|640976|P3|COMPLETED|Overall Study||27
265456|NCT01096680|640977|P2|COMPLETED|Overall Study||27
265457|NCT01096680|640978|P1|COMPLETED|Overall Study||27
265458|NCT01096680|640974|P5|STARTED|Overall Study||27
265459|NCT01096680|640975|P4|STARTED|Overall Study||27
265460|NCT01096680|640976|P3|STARTED|Overall Study||27
265461|NCT01096680|640977|P2|STARTED|Overall Study||27
265462|NCT01096680|640978|P1|STARTED|Overall Study||27
265463|NCT01096771|641012|P2|NOT COMPLETED|Overall Study||0
265464|NCT01096771|641013|P1|NOT COMPLETED|Overall Study||0
265465|NCT01096771|641012|P2|COMPLETED|Overall Study||7
265466|NCT01096771|641013|P1|COMPLETED|Overall Study||7
265467|NCT01096771|641012|P2|STARTED|Overall Study||7
265468|NCT01096771|641013|P1|STARTED|Overall Study||7
265469|NCT01096784|641039|P2|NOT COMPLETED|Overall Study||14
265470|NCT01096784|641040|P1|NOT COMPLETED|Overall Study||15
265471|NCT01096784|641039|P2|COMPLETED|Overall Study||46
265472|NCT01096784|641040|P1|COMPLETED|Overall Study||46
265473|NCT01096784|641039|P2|STARTED|Overall Study||60
265474|NCT01096784|641040|P1|STARTED|Overall Study||61
265475|NCT01096810|641072|P1|NOT COMPLETED|Overall Study||0
265476|NCT01096810|641072|P1|COMPLETED|Overall Study||20
265477|NCT01096810|641072|P1|STARTED|Overall Study||20
265478|NCT01096823|641080|P2|NOT COMPLETED|Overall Study||1
265479|NCT01096823|641081|P1|NOT COMPLETED|Overall Study||3
265480|NCT01096823|641080|P2|COMPLETED|Overall Study||15
265481|NCT01096823|641081|P1|COMPLETED|Overall Study||11
265482|NCT01096823|641080|P2|STARTED|Overall Study||16
265483|NCT01096823|641081|P1|STARTED|Overall Study||14
265484|NCT01096875|641095|P2|NOT COMPLETED|Overall Study||1
265485|NCT01096875|641096|P1|NOT COMPLETED|Overall Study||0
265486|NCT01096875|641095|P2|COMPLETED|Overall Study||29
265487|NCT01096875|641096|P1|COMPLETED|Overall Study||30
265488|NCT01096875|641095|P2|STARTED|Overall Study||30
265489|NCT01096875|641096|P1|STARTED|Overall Study||30
265490|NCT01097005|641108|P1|NOT COMPLETED|Overall Study||365
265491|NCT01097005|641108|P1|COMPLETED|Overall Study||101
265492|NCT01097005|641108|P1|Analysis of CGI|Overall Study|number of participants who were measured for Clinical Global Improvement (CGI)|249
265493|NCT01097005|641108|P1|Analysis of Bacilli Negative Conversion|Overall Study|number of participants who were analysed for bacilli negative conversion|285
265494|NCT01097005|641108|P1|Analysis of NTM Lung Disease|Overall Study|number of participants who contributed to the Baseline data|340
265495|NCT01097005|641108|P1|Analysis of Safety|Overall Study|number of participants who could be measured for Adverse Events|441
265496|NCT01097005|641108|P1|STARTED|Overall Study|number of participants who were enrolled for this study.|466
265497|NCT01097057|641114|P1|NOT COMPLETED|Overall Study||3
265498|NCT01097057|641114|P1|COMPLETED|Overall Study||17
265499|NCT01097057|641114|P1|STARTED|Overall Study||20
265500|NCT01097304|641121|P1|NOT COMPLETED|Overall Study||7
265501|NCT01097304|641121|P1|COMPLETED|Overall Study||29
265502|NCT01097304|641121|P1|STARTED|Overall Study||36
265503|NCT01097343|641125|P2|NOT COMPLETED|Second Intervention- 30 Days||0
265504|NCT01097343|641126|P1|NOT COMPLETED|Second Intervention- 30 Days||0
265505|NCT01097343|641125|P2|COMPLETED|Second Intervention- 30 Days||25
265506|NCT01097343|641126|P1|COMPLETED|Second Intervention- 30 Days||25
265507|NCT01097343|641125|P2|STARTED|Second Intervention- 30 Days||25
265508|NCT01097343|641126|P1|STARTED|Second Intervention- 30 Days||25
265509|NCT01097343|641125|P2|NOT COMPLETED|First Intervention- 30 Days||0
265510|NCT01097343|641126|P1|NOT COMPLETED|First Intervention- 30 Days||0
265511|NCT01097343|641125|P2|COMPLETED|First Intervention- 30 Days||25
265512|NCT01097343|641126|P1|COMPLETED|First Intervention- 30 Days||25
265513|NCT01097343|641125|P2|STARTED|First Intervention- 30 Days||25
265514|NCT01097343|641126|P1|STARTED|First Intervention- 30 Days||25
265515|NCT01097421|641132|P1|NOT COMPLETED|Overall Study||14
265516|NCT01097421|641132|P1|COMPLETED|Overall Study||314
265517|NCT01097421|641132|P1|STARTED|Overall Study||328
265518|NCT01097460|641142|P1|NOT COMPLETED|Overall Study||0
265519|NCT01097460|641142|P1|COMPLETED|Overall Study||16
265520|NCT01097460|641142|P1|STARTED|Overall Study||16
265521|NCT01097616|641149|P8|NOT COMPLETED|DB RO Phase||1
265522|NCT01097616|641150|P7|NOT COMPLETED|DB RO Phase||1
265523|NCT01097616|641151|P6|NOT COMPLETED|DB RO Phase||2
265524|NCT01097616|641152|P5|NOT COMPLETED|DB RO Phase||1
265525|NCT01097616|641153|P4|NOT COMPLETED|DB RO Phase||1
265526|NCT01097616|641154|P3|NOT COMPLETED|DB RO Phase||0
265527|NCT01097616|641155|P2|NOT COMPLETED|DB RO Phase||0
265528|NCT01097616|641156|P1|NOT COMPLETED|DB RO Phase||0
265529|NCT01097616|641149|P8|COMPLETED|DB RO Phase||326
265530|NCT01097616|641150|P7|COMPLETED|DB RO Phase||161
265531|NCT01097616|641151|P6|COMPLETED|DB RO Phase||159
265532|NCT01097616|641152|P5|COMPLETED|DB RO Phase||111
265533|NCT01097616|641153|P4|COMPLETED|DB RO Phase||100
265534|NCT01097616|641154|P3|COMPLETED|DB RO Phase||0
265535|NCT01097616|641155|P2|COMPLETED|DB RO Phase||0
265536|NCT01097616|641156|P1|COMPLETED|DB RO Phase||0
265537|NCT01097616|641149|P8|STARTED|DB RO Phase||327
265538|NCT01097616|641150|P7|STARTED|DB RO Phase||162
265539|NCT01097616|641151|P6|STARTED|DB RO Phase|1 entered RO but was not treated during RO|161
265540|NCT01097616|641152|P5|STARTED|DB RO Phase|1 was randomized to this group but actually received suvorexant LD during RO|112
265541|NCT01097616|641153|P4|STARTED|DB RO Phase||101
265542|NCT01097616|641154|P3|STARTED|DB RO Phase||0
265543|NCT01097616|641155|P2|STARTED|DB RO Phase||0
265544|NCT01097616|641156|P1|STARTED|DB RO Phase||0
265545|NCT01097616|641149|P8|NOT COMPLETED|Optional DB EXT Phase||0
265546|NCT01097616|641150|P7|NOT COMPLETED|Optional DB EXT Phase||0
265547|NCT01097616|641151|P6|NOT COMPLETED|Optional DB EXT Phase||0
265548|NCT01097616|641152|P5|NOT COMPLETED|Optional DB EXT Phase||0
265549|NCT01097616|641153|P4|NOT COMPLETED|Optional DB EXT Phase||0
265550|NCT01097616|641154|P3|NOT COMPLETED|Optional DB EXT Phase||10
265551|NCT01097616|641155|P2|NOT COMPLETED|Optional DB EXT Phase||21
265552|NCT01097616|641156|P1|NOT COMPLETED|Optional DB EXT Phase||15
265553|NCT01097616|641149|P8|COMPLETED|Optional DB EXT Phase||0
265554|NCT01097616|641150|P7|COMPLETED|Optional DB EXT Phase||0
265555|NCT01097616|641151|P6|COMPLETED|Optional DB EXT Phase||0
265556|NCT01097616|641152|P5|COMPLETED|Optional DB EXT Phase||0
265557|NCT01097616|641153|P4|COMPLETED|Optional DB EXT Phase||0
265558|NCT01097616|641154|P3|COMPLETED|Optional DB EXT Phase|All 141 continued into RO|141
265559|NCT01097616|641155|P2|COMPLETED|Optional DB EXT Phase|All 151 continued into RO|151
265560|NCT01097616|641156|P1|COMPLETED|Optional DB EXT Phase|All 85 continued into RO|85
265561|NCT01097616|641149|P8|STARTED|Optional DB EXT Phase||0
265562|NCT01097616|641150|P7|STARTED|Optional DB EXT Phase||0
265563|NCT01097616|641151|P6|STARTED|Optional DB EXT Phase||0
265564|NCT01097616|641152|P5|STARTED|Optional DB EXT Phase||0
265565|NCT01097616|641153|P4|STARTED|Optional DB EXT Phase||0
265566|NCT01097616|641154|P3|STARTED|Optional DB EXT Phase||151
265567|NCT01097616|641155|P2|STARTED|Optional DB EXT Phase||172
265568|NCT01097616|641156|P1|STARTED|Optional DB EXT Phase||100
265569|NCT01097616|641149|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265570|NCT01097616|641150|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265571|NCT01097616|641151|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265572|NCT01097616|641152|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265573|NCT01097616|641153|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265574|NCT01097616|641154|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||44
265575|NCT01097616|641155|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||38
265576|NCT01097616|641156|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||24
265577|NCT01097616|641149|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265578|NCT01097616|641150|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265579|NCT01097616|641151|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265580|NCT01097616|641152|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265581|NCT01097616|641153|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265582|NCT01097616|641154|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|151 continued into EXT, 186 continued directly into RO, 4 did not continue into either Phase|341
265583|NCT01097616|641155|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|172 continued into EXT, 172 continued directly into RO, 1 did not continue into either Phase|345
265584|NCT01097616|641156|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|100 continued into EXT, 128 continued directly into RO, 2 did not continue into either Phase|230
265585|NCT01097616|641149|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265586|NCT01097616|641150|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265587|NCT01097616|641151|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265588|NCT01097616|641152|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265589|NCT01097616|641153|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265590|NCT01097616|641154|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||384
265591|NCT01097616|641155|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
265592|NCT01097616|641156|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||254
265593|NCT01097616|641149|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265594|NCT01097616|641150|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265595|NCT01097616|641151|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265596|NCT01097616|641152|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265597|NCT01097616|641153|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265598|NCT01097616|641154|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||385
265599|NCT01097616|641155|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||383
265600|NCT01097616|641156|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||254
265601|NCT01097629|641230|P8|NOT COMPLETED|DB RO Phase||1
265602|NCT01097629|641231|P7|NOT COMPLETED|DB RO Phase||3
265603|NCT01097629|641232|P6|NOT COMPLETED|DB RO Phase||1
265604|NCT01097629|641233|P5|NOT COMPLETED|DB RO Phase||0
265605|NCT01097629|641234|P4|NOT COMPLETED|DB RO Phase||1
265606|NCT01097629|641235|P3|NOT COMPLETED|DB RO Phase||0
265607|NCT01097629|641236|P2|NOT COMPLETED|DB RO Phase||0
265608|NCT01097629|641237|P1|NOT COMPLETED|DB RO Phase||0
265609|NCT01097629|641230|P8|COMPLETED|DB RO Phase||326
265610|NCT01097629|641231|P7|COMPLETED|DB RO Phase||168
265611|NCT01097629|641232|P6|COMPLETED|DB RO Phase||172
265612|NCT01097629|641233|P5|COMPLETED|DB RO Phase||108
265613|NCT01097629|641234|P4|COMPLETED|DB RO Phase||96
265614|NCT01097629|641235|P3|COMPLETED|DB RO Phase||0
265615|NCT01097629|641236|P2|COMPLETED|DB RO Phase||0
265616|NCT01097629|641237|P1|COMPLETED|DB RO Phase||0
265617|NCT01097629|641230|P8|STARTED|DB RO Phase||327
265618|NCT01097629|641231|P7|STARTED|DB RO Phase||171
265619|NCT01097629|641232|P6|STARTED|DB RO Phase||173
265620|NCT01097629|641233|P5|STARTED|DB RO Phase||108
265621|NCT01097629|641234|P4|STARTED|DB RO Phase||97
265622|NCT01097629|641235|P3|STARTED|DB RO Phase||0
265623|NCT01097629|641236|P2|STARTED|DB RO Phase||0
265624|NCT01097629|641237|P1|STARTED|DB RO Phase||0
265625|NCT01097629|641230|P8|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265626|NCT01097629|641231|P7|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265627|NCT01097629|641232|P6|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265628|NCT01097629|641233|P5|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265629|NCT01097629|641234|P4|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265630|NCT01097629|641235|P3|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||57
265631|NCT01097629|641236|P2|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||46
265632|NCT01097629|641237|P1|NOT COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||35
265633|NCT01097629|641230|P8|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265634|NCT01097629|641231|P7|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265635|NCT01097629|641232|P6|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265636|NCT01097629|641233|P5|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265637|NCT01097629|641234|P4|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||0
265638|NCT01097629|641235|P3|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|3 did not continue into RO|330
265639|NCT01097629|641236|P2|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase|2 did not continue into RO|346
265640|NCT01097629|641237|P1|COMPLETED|Double-Blind (DB) Treatment (TRT) Phase||205
265641|NCT01097629|641230|P8|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265642|NCT01097629|641231|P7|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265643|NCT01097629|641232|P6|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265644|NCT01097629|641233|P5|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265645|NCT01097629|641234|P4|Treated|Double-Blind (DB) Treatment (TRT) Phase||0
265646|NCT01097629|641235|P3|Treated|Double-Blind (DB) Treatment (TRT) Phase||383
265647|NCT01097629|641236|P2|Treated|Double-Blind (DB) Treatment (TRT) Phase||387
265648|NCT01097629|641237|P1|Treated|Double-Blind (DB) Treatment (TRT) Phase||239
265649|NCT01097629|641230|P8|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265650|NCT01097629|641231|P7|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265651|NCT01097629|641232|P6|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265652|NCT01097629|641233|P5|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265653|NCT01097629|641234|P4|STARTED|Double-Blind (DB) Treatment (TRT) Phase||0
265654|NCT01097629|641235|P3|STARTED|Double-Blind (DB) Treatment (TRT) Phase||387
265655|NCT01097629|641236|P2|STARTED|Double-Blind (DB) Treatment (TRT) Phase||392
265656|NCT01097629|641237|P1|STARTED|Double-Blind (DB) Treatment (TRT) Phase||240
265657|NCT01097655|641285|P1|NOT COMPLETED|Overall Study||10
265658|NCT01097655|641285|P1|COMPLETED|Overall Study|participants included for analysis|3039
265659|NCT01097655|641285|P1|STARTED|Overall Study||3049
265660|NCT01097668|641294|P2|NOT COMPLETED|Overall Study||2
265661|NCT01097668|641295|P1|NOT COMPLETED|Overall Study||2
265662|NCT01097668|641294|P2|COMPLETED|Overall Study||20
265663|NCT01097668|641295|P1|COMPLETED|Overall Study||19
265664|NCT01097668|641294|P2|Week 48|Overall Study||20
265665|NCT01097668|641295|P1|Week 48|Overall Study||19
265666|NCT01097668|641294|P2|Week 20|Overall Study|Patient evaluability time point = week 20|22
265667|NCT01097668|641295|P1|Week 20|Overall Study|Patient evaluability time point = week 20|21
265668|NCT01097668|641294|P2|STARTED|Overall Study||22
265669|NCT01097668|641295|P1|STARTED|Overall Study||21
265670|NCT01097694|641307|P2|NOT COMPLETED|Overall Study||4
265671|NCT01097694|641308|P1|NOT COMPLETED|Overall Study||8
265672|NCT01097694|641307|P2|COMPLETED|Overall Study||26
265673|NCT01097694|641308|P1|COMPLETED|Overall Study||24
265674|NCT01097694|641307|P2|STARTED|Overall Study||30
265675|NCT01097694|641308|P1|STARTED|Overall Study||32
265676|NCT01097785|641370|P2|NOT COMPLETED|Cycle 3 (30 Days)||0
265677|NCT01097785|641371|P1|NOT COMPLETED|Cycle 3 (30 Days)||0
265678|NCT01097785|641370|P2|COMPLETED|Cycle 3 (30 Days)||6
265679|NCT01097785|641371|P1|COMPLETED|Cycle 3 (30 Days)||6
265680|NCT01097785|641370|P2|STARTED|Cycle 3 (30 Days)||6
265681|NCT01097785|641371|P1|STARTED|Cycle 3 (30 Days)||6
265682|NCT01097785|641370|P2|NOT COMPLETED|Washout (2 Weeks)||0
265683|NCT01097785|641371|P1|NOT COMPLETED|Washout (2 Weeks)||0
265684|NCT01097785|641370|P2|COMPLETED|Washout (2 Weeks)||6
265685|NCT01097785|641371|P1|COMPLETED|Washout (2 Weeks)||6
265686|NCT01097785|641370|P2|STARTED|Washout (2 Weeks)||6
265687|NCT01097785|641371|P1|STARTED|Washout (2 Weeks)||6
265688|NCT01097785|641370|P2|NOT COMPLETED|Cycle 1 (30 Days)||0
265689|NCT01097785|641371|P1|NOT COMPLETED|Cycle 1 (30 Days)||0
265690|NCT01097785|641370|P2|COMPLETED|Cycle 1 (30 Days)||6
265691|NCT01097785|641371|P1|COMPLETED|Cycle 1 (30 Days)||6
265692|NCT01097785|641370|P2|STARTED|Cycle 1 (30 Days)||6
265693|NCT01097785|641371|P1|STARTED|Cycle 1 (30 Days)||6
265694|NCT01097863|641382|P3|NOT COMPLETED|Overall Study||2
265695|NCT01097863|641383|P2|NOT COMPLETED|Overall Study||0
265696|NCT01097863|641384|P1|NOT COMPLETED|Overall Study||1
265697|NCT01097863|641382|P3|COMPLETED|Overall Study||89
265698|NCT01097863|641383|P2|COMPLETED|Overall Study||98
265699|NCT01097863|641384|P1|COMPLETED|Overall Study||89
265700|NCT01097863|641382|P3|STARTED|Overall Study||91
265701|NCT01097863|641383|P2|STARTED|Overall Study||98
265702|NCT01097863|641384|P1|STARTED|Overall Study||90
265703|NCT01097915|641395|P3|NOT COMPLETED|Overall Study||30
265704|NCT01097915|641396|P2|NOT COMPLETED|Overall Study||42
265705|NCT01097915|641397|P1|NOT COMPLETED|Overall Study||23
265706|NCT01097915|641395|P3|COMPLETED|Overall Study||20
265707|NCT01097915|641396|P2|COMPLETED|Overall Study||28
265708|NCT01097915|641397|P1|COMPLETED|Overall Study||27
265709|NCT01097915|641395|P3|STARTED|Overall Study||50
265710|NCT01097915|641396|P2|STARTED|Overall Study||70
265711|NCT01097915|641397|P1|STARTED|Overall Study||50
265712|NCT01098032|641413|P2|NOT COMPLETED|Overall Study||1
265713|NCT01098032|641414|P1|NOT COMPLETED|Overall Study||1
265714|NCT01098032|641413|P2|COMPLETED|Overall Study||146
265715|NCT01098032|641414|P1|COMPLETED|Overall Study||146
265716|NCT01098032|641413|P2|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
265717|NCT01098032|641414|P1|STARTED|Overall Study|1 patient di not receive the treatment. Therefore this patient was excluded from the analysis.|147
265718|NCT01098071|641420|P1|NOT COMPLETED|Overall Study||15
265719|NCT01098071|641420|P1|COMPLETED|Overall Study||19
265720|NCT01098071|641420|P1|STARTED|Overall Study||34
265721|NCT01098097|641431|P1|NOT COMPLETED|Overall Study||82
265722|NCT01098097|641431|P1|COMPLETED|Overall Study|Participants completing the study received at least 12 weeks of treatment|881
265723|NCT01098097|641431|P1|STARTED|Overall Study||963
265724|NCT01098110|641443|P3|NOT COMPLETED|Overall Study||94
265725|NCT01098110|641444|P2|NOT COMPLETED|Overall Study||73
265726|NCT01098110|641445|P1|NOT COMPLETED|Overall Study||62
265727|NCT01098110|641443|P3|COMPLETED|Overall Study||80
265728|NCT01098110|641444|P2|COMPLETED|Overall Study||109
265729|NCT01098110|641445|P1|COMPLETED|Overall Study||114
265730|NCT01098110|641443|P3|Treated|Overall Study|Received at least one dose of trial medication|174
265731|NCT01098110|641444|P2|Treated|Overall Study|Received at least one dose of trial medication|181
265732|NCT01098110|641445|P1|Treated|Overall Study|Received at least one dose of trial medication|175
265733|NCT01098110|641443|P3|STARTED|Overall Study|Randomized participants|174
265734|NCT01098110|641444|P2|STARTED|Overall Study|Randomized participants|182
265735|NCT01098110|641445|P1|STARTED|Overall Study|Randomized participants|176
265736|NCT01098162|641486|P1|NOT COMPLETED|Overall Study||112
265737|NCT01098162|641486|P1|COMPLETED|Overall Study||461
265738|NCT01098162|641486|P1|STARTED|Overall Study||573
265739|NCT01098240|641495|P3|NOT COMPLETED|Double-Blind Phase||22
265740|NCT01098240|641496|P2|NOT COMPLETED|Double-Blind Phase||17
265741|NCT01098240|641497|P1|NOT COMPLETED|Double-Blind Phase||0
265742|NCT01098240|641495|P3|COMPLETED|Double-Blind Phase||63
265743|NCT01098240|641496|P2|COMPLETED|Double-Blind Phase||60
265744|NCT01098240|641497|P1|COMPLETED|Double-Blind Phase||0
265745|NCT01098240|641495|P3|STARTED|Double-Blind Phase||85
265746|NCT01098240|641496|P2|STARTED|Double-Blind Phase||77
265747|NCT01098240|641497|P1|STARTED|Double-Blind Phase||0
265748|NCT01098240|641495|P3|NOT COMPLETED|Open-Label Phase||0
265749|NCT01098240|641496|P2|NOT COMPLETED|Open-Label Phase||0
265750|NCT01098240|641497|P1|NOT COMPLETED|Open-Label Phase||135
265751|NCT01098240|641495|P3|COMPLETED|Open-Label Phase||0
265752|NCT01098240|641496|P2|COMPLETED|Open-Label Phase||0
265753|NCT01098240|641497|P1|COMPLETED|Open-Label Phase||162
265754|NCT01098240|641495|P3|STARTED|Open-Label Phase||0
265755|NCT01098240|641496|P2|STARTED|Open-Label Phase||0
265756|NCT01098240|641497|P1|STARTED|Open-Label Phase||297
265757|NCT01098253|641529|P2|NOT COMPLETED|Overall Study||0
265758|NCT01098253|641530|P1|NOT COMPLETED|Overall Study||2
265759|NCT01098253|641529|P2|COMPLETED|Overall Study||88
265760|NCT01098253|641530|P1|COMPLETED|Overall Study||92
265761|NCT01098253|641529|P2|STARTED|Overall Study||88
265762|NCT01098253|641530|P1|STARTED|Overall Study||94
265763|NCT01098305|641540|P2|NOT COMPLETED|Overall Study||33
265764|NCT01098305|641541|P1|NOT COMPLETED|Overall Study||31
265765|NCT01098305|641540|P2|COMPLETED|Overall Study||85
265766|NCT01098305|641541|P1|COMPLETED|Overall Study||88
265767|NCT01098305|641540|P2|STARTED|Overall Study||118
265768|NCT01098305|641541|P1|STARTED|Overall Study||119
265769|NCT01098318|641552|P3|NOT COMPLETED|Overall Study||3
265770|NCT01098318|641553|P2|NOT COMPLETED|Overall Study||7
265771|NCT01098318|641554|P1|NOT COMPLETED|Overall Study||3
265772|NCT01098318|641552|P3|COMPLETED|Overall Study||15
265773|NCT01098318|641553|P2|COMPLETED|Overall Study||12
265774|NCT01098318|641554|P1|COMPLETED|Overall Study||17
265775|NCT01098318|641552|P3|STARTED|Overall Study||18
265776|NCT01098318|641553|P2|STARTED|Overall Study||19
265777|NCT01098318|641554|P1|STARTED|Overall Study||20
265778|NCT01104103|641564|P2|NOT COMPLETED|Overall Study||0
265779|NCT01104103|641565|P1|NOT COMPLETED|Overall Study||0
265780|NCT01104103|641564|P2|COMPLETED|Overall Study||224
265781|NCT01104103|641565|P1|COMPLETED|Overall Study||243
265782|NCT01104103|641564|P2|STARTED|Overall Study||224
265783|NCT01104103|641565|P1|STARTED|Overall Study||243
265784|NCT01104116|641573|P1|NOT COMPLETED|Overall Study||0
265785|NCT01104116|641573|P1|COMPLETED|Overall Study||1
265786|NCT01104116|641573|P1|STARTED|Overall Study||1
265787|NCT01104155|641580|P2|NOT COMPLETED|Overall Study||18
265788|NCT01104155|641581|P1|NOT COMPLETED|Overall Study||25
265789|NCT01104155|641580|P2|COMPLETED|Overall Study||42
265790|NCT01104155|641581|P1|COMPLETED|Overall Study||38
265791|NCT01104155|641580|P2|STARTED|Overall Study||60
265792|NCT01104155|641581|P1|STARTED|Overall Study||63
265793|NCT01104207|641597|P2|NOT COMPLETED|Overall Study||3
265794|NCT01104207|641598|P1|NOT COMPLETED|Overall Study||3
265795|NCT01104207|641597|P2|COMPLETED|Overall Study||32
265796|NCT01104207|641598|P1|COMPLETED|Overall Study||32
265797|NCT01104207|641597|P2|STARTED|Overall Study||35
265798|NCT01104207|641598|P1|STARTED|Overall Study||35
265799|NCT01104246|641604|P1|NOT COMPLETED|Overall Study||5
265800|NCT01104246|641604|P1|COMPLETED|Overall Study||35
265801|NCT01104246|641604|P1|Baseline Characteristics Measured|Overall Study||35
265802|NCT01104246|641604|P1|STARTED|Overall Study||40
265803|NCT01104285|641610|P2|NOT COMPLETED|Overall Study||0
265804|NCT01104285|641611|P1|NOT COMPLETED|Overall Study||0
265805|NCT01104285|641610|P2|COMPLETED|Overall Study||86
265806|NCT01104285|641611|P1|COMPLETED|Overall Study||112
265807|NCT01104285|641610|P2|STARTED|Overall Study||86
265808|NCT01104285|641611|P1|STARTED|Overall Study||112
265809|NCT01104311|641619|P2|NOT COMPLETED|Overall Study||12
265810|NCT01104311|641620|P1|NOT COMPLETED|Overall Study||10
265811|NCT01104311|641619|P2|COMPLETED|Overall Study||54
265812|NCT01104311|641620|P1|COMPLETED|Overall Study||56
265813|NCT01104311|641619|P2|STARTED|Overall Study||66
265814|NCT01104311|641620|P1|STARTED|Overall Study||66
265815|NCT01104636|641638|P1|NOT COMPLETED|Overall Study||178
265816|NCT01104636|641638|P1|COMPLETED|Overall Study||999
265817|NCT01104636|641638|P1|STARTED|Overall Study||1177
265818|NCT01104662|641651|P8|NOT COMPLETED|Overall Study||0
265819|NCT01104662|641652|P7|NOT COMPLETED|Overall Study||0
265820|NCT01104662|641653|P6|NOT COMPLETED|Overall Study||4
265821|NCT01104662|641654|P5|NOT COMPLETED|Overall Study||1
265822|NCT01104662|641655|P4|NOT COMPLETED|Overall Study||1
265823|NCT01104662|641656|P3|NOT COMPLETED|Overall Study||1
265824|NCT01104662|641657|P2|NOT COMPLETED|Overall Study||10
265825|NCT01104662|641658|P1|NOT COMPLETED|Overall Study||10
265826|NCT01104662|641651|P8|COMPLETED|Overall Study||6
265827|NCT01104662|641652|P7|COMPLETED|Overall Study||5
265828|NCT01104662|641653|P6|COMPLETED|Overall Study||12
265829|NCT01104662|641654|P5|COMPLETED|Overall Study||14
265830|NCT01104662|641655|P4|COMPLETED|Overall Study||3
265831|NCT01104662|641656|P3|COMPLETED|Overall Study||4
265832|NCT01104662|641657|P2|COMPLETED|Overall Study||11
265833|NCT01104662|641658|P1|COMPLETED|Overall Study||10
265834|NCT01104662|641651|P8|Received at Least 1 Dose of Study Drug|Overall Study||6
265835|NCT01104662|641652|P7|Received at Least 1 Dose of Study Drug|Overall Study||5
265836|NCT01104662|641653|P6|Received at Least 1 Dose of Study Drug|Overall Study||15
265837|NCT01104662|641654|P5|Received at Least 1 Dose of Study Drug|Overall Study||15
265838|NCT01104662|641655|P4|Received at Least 1 Dose of Study Drug|Overall Study||4
265839|NCT01104662|641656|P3|Received at Least 1 Dose of Study Drug|Overall Study||4
265840|NCT01104662|641657|P2|Received at Least 1 Dose of Study Drug|Overall Study||17
265841|NCT01104662|641658|P1|Received at Least 1 Dose of Study Drug|Overall Study||17
265842|NCT01104662|641651|P8|STARTED|Overall Study||6
265843|NCT01104662|641652|P7|STARTED|Overall Study||5
265844|NCT01104662|641653|P6|STARTED|Overall Study||16
265845|NCT01104662|641654|P5|STARTED|Overall Study||15
265846|NCT01104662|641655|P4|STARTED|Overall Study||4
265847|NCT01104662|641656|P3|STARTED|Overall Study||5
265848|NCT01104662|641657|P2|STARTED|Overall Study||21
265849|NCT01104662|641658|P1|STARTED|Overall Study||20
265850|NCT01104701|641688|P4|NOT COMPLETED|Overall Study||2
265851|NCT01104701|641689|P3|NOT COMPLETED|Overall Study||2
265852|NCT01104701|641690|P2|NOT COMPLETED|Overall Study||3
265853|NCT01104701|641691|P1|NOT COMPLETED|Overall Study||0
265854|NCT01104701|641688|P4|COMPLETED|Overall Study||28
265855|NCT01104701|641689|P3|COMPLETED|Overall Study||29
265856|NCT01104701|641690|P2|COMPLETED|Overall Study||27
265857|NCT01104701|641691|P1|COMPLETED|Overall Study||30
265858|NCT01104701|641688|P4|STARTED|Overall Study||30
265859|NCT01104701|641689|P3|STARTED|Overall Study||31
265860|NCT01104701|641690|P2|STARTED|Overall Study||30
265861|NCT01104701|641691|P1|STARTED|Overall Study||30
265862|NCT01104870|641748|P3|NOT COMPLETED|Overall Study||2
265863|NCT01104870|641749|P2|NOT COMPLETED|Overall Study||1
265864|NCT01104870|641750|P1|NOT COMPLETED|Overall Study||1
265865|NCT01104870|641748|P3|COMPLETED|Overall Study||18
265866|NCT01104870|641749|P2|COMPLETED|Overall Study||18
265867|NCT01104870|641750|P1|COMPLETED|Overall Study||10
265868|NCT01104870|641748|P3|STARTED|Overall Study||20
265869|NCT01104870|641749|P2|STARTED|Overall Study||19
265870|NCT01104870|641750|P1|STARTED|Overall Study||11
265871|NCT01105065|641779|P1|NOT COMPLETED|Overall Study||6
265872|NCT01105065|641779|P1|COMPLETED|Overall Study||17
265873|NCT01105065|641779|P1|STARTED|Overall Study||23
265874|NCT01105091|641787|P2|NOT COMPLETED|Overall Study||0
265875|NCT01105091|641788|P1|NOT COMPLETED|Overall Study||2
265876|NCT01105091|641787|P2|COMPLETED|Overall Study||10
265877|NCT01105091|641788|P1|COMPLETED|Overall Study||18
265878|NCT01105091|641787|P2|STARTED|Overall Study||10
265879|NCT01105091|641788|P1|STARTED|Overall Study||20
265880|NCT01105117|641814|P2|NOT COMPLETED|Overall Study||0
265881|NCT01105117|641815|P1|NOT COMPLETED|Overall Study||0
265882|NCT01105117|641814|P2|COMPLETED|Overall Study||1
265883|NCT01105117|641815|P1|COMPLETED|Overall Study||1
265884|NCT01105117|641814|P2|STARTED|Overall Study||1
265885|NCT01105117|641815|P1|STARTED|Overall Study||1
265886|NCT01105130|641826|P3|NOT COMPLETED|Overall Study||10
265887|NCT01105130|641827|P2|NOT COMPLETED|Overall Study||11
265888|NCT01105130|641828|P1|NOT COMPLETED|Overall Study||10
265889|NCT01105130|641826|P3|COMPLETED|Overall Study||37
265890|NCT01105130|641827|P2|COMPLETED|Overall Study||34
265891|NCT01105130|641828|P1|COMPLETED|Overall Study||38
265892|NCT01105130|641826|P3|STARTED|Overall Study||47
265893|NCT01105130|641827|P2|STARTED|Overall Study||45
265894|NCT01105130|641828|P1|STARTED|Overall Study||48
265895|NCT01105247|641847|P2|NOT COMPLETED|Overall Study||0
265896|NCT01105247|641848|P1|NOT COMPLETED|Overall Study||37
265897|NCT01105247|641847|P2|COMPLETED|Overall Study||16
265898|NCT01105247|641848|P1|COMPLETED|Overall Study||79
265899|NCT01105247|641847|P2|STARTED|Overall Study||16
265900|NCT01105247|641848|P1|STARTED|Overall Study||116
265901|NCT01105312|641864|P3|NOT COMPLETED|Overall Study||0
265902|NCT01105312|641865|P2|NOT COMPLETED|Overall Study||0
265903|NCT01105312|641866|P1|NOT COMPLETED|Overall Study||3
265904|NCT01105312|641864|P3|COMPLETED|Overall Study||6
265905|NCT01105312|641865|P2|COMPLETED|Overall Study||6
265906|NCT01105312|641866|P1|COMPLETED|Overall Study||13
265907|NCT01105312|641864|P3|STARTED|Overall Study||6
265908|NCT01105312|641865|P2|STARTED|Overall Study||6
265909|NCT01105312|641866|P1|STARTED|Overall Study||16
265910|NCT01105377|641884|P2|NOT COMPLETED|Overall Study||1
265911|NCT01105377|641885|P1|NOT COMPLETED|Overall Study||0
265912|NCT01105377|641884|P2|COMPLETED|Overall Study||22
265913|NCT01105377|641885|P1|COMPLETED|Overall Study||24
265914|NCT01105377|641884|P2|STARTED|Overall Study||23
265915|NCT01105377|641885|P1|STARTED|Overall Study||24
265916|NCT01105533|641893|P9|NOT COMPLETED|Overall Study||12
265917|NCT01105533|641894|P8|NOT COMPLETED|Overall Study||4
265918|NCT01105533|641895|P7|NOT COMPLETED|Overall Study||8
265919|NCT01105533|641896|P6|NOT COMPLETED|Overall Study||7
265920|NCT01105533|641897|P5|NOT COMPLETED|Overall Study||7
265921|NCT01105533|641898|P4|NOT COMPLETED|Overall Study||3
265922|NCT01105533|641899|P3|NOT COMPLETED|Overall Study||3
265923|NCT01105533|641900|P2|NOT COMPLETED|Overall Study||1
265924|NCT01105533|641901|P1|NOT COMPLETED|Overall Study||1
265925|NCT01105533|641893|P9|COMPLETED|Overall Study||0
265926|NCT01105533|641894|P8|COMPLETED|Overall Study||0
265927|NCT01105533|641895|P7|COMPLETED|Overall Study||0
265928|NCT01105533|641896|P6|COMPLETED|Overall Study||0
265929|NCT01105533|641897|P5|COMPLETED|Overall Study||0
265930|NCT01105533|641898|P4|COMPLETED|Overall Study||0
265931|NCT01105533|641899|P3|COMPLETED|Overall Study||0
265932|NCT01105533|641900|P2|COMPLETED|Overall Study||0
265933|NCT01105533|641901|P1|COMPLETED|Overall Study||0
265934|NCT01105533|641893|P9|STARTED|Overall Study||12
265935|NCT01105533|641894|P8|STARTED|Overall Study||4
265936|NCT01105533|641895|P7|STARTED|Overall Study||8
265937|NCT01105533|641896|P6|STARTED|Overall Study||7
265938|NCT01105533|641897|P5|STARTED|Overall Study||7
265939|NCT01105533|641898|P4|STARTED|Overall Study||3
265940|NCT01105533|641899|P3|STARTED|Overall Study||3
265941|NCT01105533|641900|P2|STARTED|Overall Study||1
265942|NCT01105533|641901|P1|STARTED|Overall Study||1
265943|NCT01105650|641992|P4|NOT COMPLETED|Overall Study||0
265944|NCT01105650|641993|P3|NOT COMPLETED|Overall Study||0
265945|NCT01105650|641994|P2|NOT COMPLETED|Overall Study||0
265946|NCT01105650|641995|P1|NOT COMPLETED|Overall Study||0
265947|NCT01105650|641992|P4|COMPLETED|Overall Study||0
265948|NCT01105650|641993|P3|COMPLETED|Overall Study||7
265949|NCT01105650|641994|P2|COMPLETED|Overall Study||3
265950|NCT01105650|641995|P1|COMPLETED|Overall Study||3
265951|NCT01105650|641992|P4|STARTED|Overall Study|Arm 3 was determined to be successful, thus eliminating the need to test Arm 4.|0
265952|NCT01105650|641993|P3|STARTED|Overall Study||7
265953|NCT01105650|641994|P2|STARTED|Overall Study||3
265954|NCT01105650|641995|P1|STARTED|Overall Study||3
265955|NCT01105702|642012|P1|NOT COMPLETED|Overall Study||18
265956|NCT01105702|642012|P1|COMPLETED|Overall Study||10
265957|NCT01105702|642012|P1|STARTED|Overall Study||28
265958|NCT01105754|642021|P2|NOT COMPLETED|Overall Study||12
265959|NCT01105754|642022|P1|NOT COMPLETED|Overall Study||15
265960|NCT01105754|642021|P2|COMPLETED|Overall Study||307
265961|NCT01105754|642022|P1|COMPLETED|Overall Study||304
265962|NCT01105754|642021|P2|STARTED|Overall Study||319
265963|NCT01105754|642022|P1|STARTED|Overall Study||319
265964|NCT01105767|642033|P3|NOT COMPLETED|Overall Study||1184
265965|NCT01105767|642034|P2|NOT COMPLETED|Overall Study||1614
265966|NCT01105767|642035|P1|NOT COMPLETED|Overall Study||1160
265967|NCT01105767|642033|P3|COMPLETED|Overall Study||8846
265968|NCT01105767|642034|P2|COMPLETED|Overall Study||9250
265969|NCT01105767|642035|P1|COMPLETED|Overall Study||8155
265970|NCT01105767|642033|P3|STARTED|Overall Study||10030
265971|NCT01105767|642034|P2|STARTED|Overall Study||10864
265972|NCT01105767|642035|P1|STARTED|Overall Study||9315
265973|NCT01105936|642046|P4|NOT COMPLETED|Period 3||0
265974|NCT01105936|642047|P3|NOT COMPLETED|Period 3||0
265975|NCT01105936|642048|P2|NOT COMPLETED|Period 3||2
265976|NCT01105936|642049|P1|NOT COMPLETED|Period 3||0
265977|NCT01105936|642046|P4|COMPLETED|Period 3||7
265978|NCT01105936|642047|P3|COMPLETED|Period 3||7
265979|NCT01105936|642048|P2|COMPLETED|Period 3||6
265980|NCT01105936|642049|P1|COMPLETED|Period 3||7
265981|NCT01105936|642046|P4|STARTED|Period 3||7
265982|NCT01105936|642047|P3|STARTED|Period 3||7
265983|NCT01105936|642048|P2|STARTED|Period 3||8
265984|NCT01105936|642049|P1|STARTED|Period 3||7
265985|NCT01105936|642046|P4|NOT COMPLETED|Wash-out Period 2||0
265986|NCT01105936|642047|P3|NOT COMPLETED|Wash-out Period 2||0
265987|NCT01105936|642048|P2|NOT COMPLETED|Wash-out Period 2||0
265988|NCT01105936|642049|P1|NOT COMPLETED|Wash-out Period 2||0
265989|NCT01105936|642046|P4|COMPLETED|Wash-out Period 2||7
265990|NCT01105936|642047|P3|COMPLETED|Wash-out Period 2||7
265991|NCT01105936|642048|P2|COMPLETED|Wash-out Period 2||8
265992|NCT01105936|642049|P1|COMPLETED|Wash-out Period 2||7
265993|NCT01105936|642046|P4|STARTED|Wash-out Period 2||7
265994|NCT01105936|642047|P3|STARTED|Wash-out Period 2||7
265995|NCT01105936|642048|P2|STARTED|Wash-out Period 2||8
265996|NCT01105936|642049|P1|STARTED|Wash-out Period 2||7
265997|NCT01105936|642046|P4|NOT COMPLETED|Period 2||0
265998|NCT01105936|642047|P3|NOT COMPLETED|Period 2||0
265999|NCT01105936|642048|P2|NOT COMPLETED|Period 2||0
266000|NCT01105936|642049|P1|NOT COMPLETED|Period 2||1
266001|NCT01105936|642046|P4|COMPLETED|Period 2||7
266002|NCT01105936|642047|P3|COMPLETED|Period 2||7
266003|NCT01105936|642048|P2|COMPLETED|Period 2||8
266004|NCT01105936|642049|P1|COMPLETED|Period 2||7
266005|NCT01105936|642046|P4|STARTED|Period 2||7
266006|NCT01105936|642047|P3|STARTED|Period 2||7
266007|NCT01105936|642048|P2|STARTED|Period 2||8
266008|NCT01105936|642049|P1|STARTED|Period 2||8
266009|NCT01105936|642046|P4|NOT COMPLETED|Wash-out Period 1||0
266010|NCT01105936|642047|P3|NOT COMPLETED|Wash-out Period 1||0
266011|NCT01105936|642048|P2|NOT COMPLETED|Wash-out Period 1||0
266012|NCT01105936|642049|P1|NOT COMPLETED|Wash-out Period 1||0
266013|NCT01105936|642046|P4|COMPLETED|Wash-out Period 1||7
266014|NCT01105936|642047|P3|COMPLETED|Wash-out Period 1||7
266015|NCT01105936|642048|P2|COMPLETED|Wash-out Period 1||8
266016|NCT01105936|642049|P1|COMPLETED|Wash-out Period 1||8
266017|NCT01105936|642046|P4|STARTED|Wash-out Period 1||7
266018|NCT01105936|642047|P3|STARTED|Wash-out Period 1||7
266019|NCT01105936|642048|P2|STARTED|Wash-out Period 1||8
266020|NCT01105936|642049|P1|STARTED|Wash-out Period 1||8
266021|NCT01105936|642046|P4|NOT COMPLETED|Period 1||1
266022|NCT01105936|642047|P3|NOT COMPLETED|Period 1||0
266023|NCT01105936|642048|P2|NOT COMPLETED|Period 1||0
266024|NCT01105936|642049|P1|NOT COMPLETED|Period 1||0
266025|NCT01105936|642046|P4|COMPLETED|Period 1||7
266026|NCT01105936|642047|P3|COMPLETED|Period 1||7
266027|NCT01105936|642048|P2|COMPLETED|Period 1||8
266028|NCT01105936|642049|P1|COMPLETED|Period 1||8
266029|NCT01105936|642046|P4|STARTED|Period 1||8
266030|NCT01105936|642047|P3|STARTED|Period 1||7
266031|NCT01105936|642048|P2|STARTED|Period 1||8
266032|NCT01105936|642049|P1|STARTED|Period 1||8
266033|NCT01106014|642077|P2|NOT COMPLETED|Overall Study||330
266034|NCT01106014|642078|P1|NOT COMPLETED|Overall Study||285
266035|NCT01106014|642077|P2|COMPLETED|Overall Study||252
266036|NCT01106014|642078|P1|COMPLETED|Overall Study||289
266037|NCT01106014|642077|P2|STARTED|Overall Study||582
266038|NCT01106014|642078|P1|STARTED|Overall Study||574
266039|NCT01106040|642088|P1|NOT COMPLETED|Overall Study||11
266040|NCT01106040|642088|P1|COMPLETED|Overall Study||152
266041|NCT01106040|642088|P1|STARTED|Overall Study||163
266042|NCT01106092|642097|P4|NOT COMPLETED|Overall Study||1
266043|NCT01106092|642098|P3|NOT COMPLETED|Overall Study||0
266044|NCT01106092|642099|P2|NOT COMPLETED|Overall Study||0
266045|NCT01106092|642100|P1|NOT COMPLETED|Overall Study||0
266046|NCT01106092|642097|P4|COMPLETED|Overall Study||77
266047|NCT01106092|642098|P3|COMPLETED|Overall Study||78
266048|NCT01106092|642099|P2|COMPLETED|Overall Study||78
266049|NCT01106092|642100|P1|COMPLETED|Overall Study||78
266050|NCT01106092|642097|P4|STARTED|Overall Study||78
266051|NCT01106092|642098|P3|STARTED|Overall Study||78
266052|NCT01106092|642099|P2|STARTED|Overall Study||78
266053|NCT01106092|642100|P1|STARTED|Overall Study||78
266054|NCT01106157|642180|P2|NOT COMPLETED|Overall Study||0
266055|NCT01106157|642181|P1|NOT COMPLETED|Overall Study||1
266056|NCT01106157|642180|P2|COMPLETED|Overall Study||8
266057|NCT01106157|642181|P1|COMPLETED|Overall Study||16
266058|NCT01106157|642180|P2|STARTED|Overall Study||8
266059|NCT01106157|642181|P1|STARTED|Overall Study||17
266060|NCT01106248|642205|P1|NOT COMPLETED|Overall Study||3
266061|NCT01106248|642205|P1|COMPLETED|Overall Study||23
266062|NCT01106248|642205|P1|STARTED|Overall Study||26
266063|NCT01106287|642215|P4|NOT COMPLETED|Overall Study||0
266064|NCT01106287|642216|P3|NOT COMPLETED|Overall Study||0
266065|NCT01106287|642217|P2|NOT COMPLETED|Overall Study||0
266066|NCT01106287|642218|P1|NOT COMPLETED|Overall Study||1
266067|NCT01106287|642215|P4|COMPLETED|Overall Study||3
266068|NCT01106287|642216|P3|COMPLETED|Overall Study||3
266069|NCT01106287|642217|P2|COMPLETED|Overall Study||3
266070|NCT01106287|642218|P1|COMPLETED|Overall Study||3
266071|NCT01106287|642215|P4|STARTED|Overall Study||3
266072|NCT01106287|642216|P3|STARTED|Overall Study||3
266073|NCT01106287|642217|P2|STARTED|Overall Study||3
266074|NCT01106287|642218|P1|STARTED|Overall Study|One participant that discontinued the study due to a pre-treatment adverse event was replaced.|4
266075|NCT01106326|642238|P1|NOT COMPLETED|Overall Study||2
266076|NCT01106326|642238|P1|COMPLETED|Overall Study||28
266077|NCT01106326|642238|P1|STARTED|Overall Study||30
266078|NCT01106352|642249|P5|NOT COMPLETED|Overall Study||8
266079|NCT01106352|642250|P4|NOT COMPLETED|Overall Study||13
266080|NCT01106352|642251|P3|NOT COMPLETED|Overall Study||2
266081|NCT01106352|642252|P2|NOT COMPLETED|Overall Study||0
266082|NCT01106352|642253|P1|NOT COMPLETED|Overall Study||1
266083|NCT01106352|642249|P5|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|9
266084|NCT01106352|642250|P4|COMPLETED|Overall Study|This group is only applicable for Safety cohort period.|23
266085|NCT01106352|642251|P3|COMPLETED|Overall Study||5
266086|NCT01106352|642252|P2|COMPLETED|Overall Study||3
266087|NCT01106352|642253|P1|COMPLETED|Overall Study||6
266088|NCT01106352|642249|P5|Completed Safety Cohort|Overall Study||9
266089|NCT01106352|642250|P4|Completed Safety Cohort|Overall Study||23
266090|NCT01106352|642251|P3|Completed Safety Cohort|Overall Study||0
266091|NCT01106352|642252|P2|Completed Safety Cohort|Overall Study||0
266092|NCT01106352|642253|P1|Completed Safety Cohort|Overall Study||0
266093|NCT01106352|642249|P5|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|13
266094|NCT01106352|642250|P4|Treated Safety Cohort|Overall Study|Number of subjects for safety analysis set.|33
266095|NCT01106352|642251|P3|Treated Safety Cohort|Overall Study||0
266096|NCT01106352|642252|P2|Treated Safety Cohort|Overall Study||0
266097|NCT01106352|642253|P1|Treated Safety Cohort|Overall Study||0
266098|NCT01106352|642249|P5|Started Safety Cohort|Overall Study||17
266099|NCT01106352|642250|P4|Started Safety Cohort|Overall Study||36
266100|NCT01106352|642251|P3|Started Safety Cohort|Overall Study||0
266101|NCT01106352|642252|P2|Started Safety Cohort|Overall Study||0
266102|NCT01106352|642253|P1|Started Safety Cohort|Overall Study||0
266103|NCT01106352|642249|P5|Completed Dose Escalation|Overall Study||0
266104|NCT01106352|642250|P4|Completed Dose Escalation|Overall Study||0
266105|NCT01106352|642251|P3|Completed Dose Escalation|Overall Study||5
266106|NCT01106352|642252|P2|Completed Dose Escalation|Overall Study||3
266107|NCT01106352|642253|P1|Completed Dose Escalation|Overall Study||6
266108|NCT01106352|642249|P5|Started Dose Escalation|Overall Study||0
266109|NCT01106352|642250|P4|Started Dose Escalation|Overall Study||0
266110|NCT01106352|642251|P3|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
266111|NCT01106352|642252|P2|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|3
266112|NCT01106352|642253|P1|Started Dose Escalation|Overall Study|Number of subjects for safety analysis set.|7
266113|NCT01106352|642249|P5|STARTED|Overall Study||17
266114|NCT01106352|642250|P4|STARTED|Overall Study||36
266115|NCT01106352|642251|P3|STARTED|Overall Study||7
266116|NCT01106352|642252|P2|STARTED|Overall Study||3
266117|NCT01106352|642253|P1|STARTED|Overall Study||7
266118|NCT01106391|642339|P1|NOT COMPLETED|Overall Study||0
266119|NCT01106391|642339|P1|COMPLETED|Overall Study||60
266120|NCT01106391|642339|P1|STARTED|Overall Study||60
266121|NCT01106404|642346|P2|NOT COMPLETED|Period II (Second 6 Weeks)||0
266122|NCT01106404|642347|P1|NOT COMPLETED|Period II (Second 6 Weeks)||0
266123|NCT01106404|642346|P2|COMPLETED|Period II (Second 6 Weeks)||38
266124|NCT01106404|642347|P1|COMPLETED|Period II (Second 6 Weeks)||33
266125|NCT01106404|642346|P2|STARTED|Period II (Second 6 Weeks)||38
266126|NCT01106404|642347|P1|STARTED|Period II (Second 6 Weeks)||33
266127|NCT01106404|642346|P2|NOT COMPLETED|Period I (First 6 Weeks)||2
266128|NCT01106404|642347|P1|NOT COMPLETED|Period I (First 6 Weeks)||3
266129|NCT01106404|642346|P2|COMPLETED|Period I (First 6 Weeks)||38
266130|NCT01106404|642347|P1|COMPLETED|Period I (First 6 Weeks)||33
266131|NCT01106404|642346|P2|STARTED|Period I (First 6 Weeks)||40
266132|NCT01106404|642347|P1|STARTED|Period I (First 6 Weeks)||36
266133|NCT01106430|642362|P2|NOT COMPLETED|Overall Study||33
266134|NCT01106430|642363|P1|NOT COMPLETED|Overall Study||33
266135|NCT01106430|642362|P2|COMPLETED|Overall Study||101
266136|NCT01106430|642363|P1|COMPLETED|Overall Study||100
266137|NCT01106430|642362|P2|STARTED|Overall Study||134
266138|NCT01106430|642363|P1|STARTED|Overall Study||133
266139|NCT01106456|642385|P2|NOT COMPLETED|Overall Study||124
266140|NCT01106456|642386|P1|NOT COMPLETED|Overall Study||103
266141|NCT01106456|642385|P2|COMPLETED|Overall Study||96
266142|NCT01106456|642386|P1|COMPLETED|Overall Study||140
266143|NCT01106456|642385|P2|STARTED|Overall Study||220
266144|NCT01106456|642386|P1|STARTED|Overall Study||243
266145|NCT01106534|642392|P1|NOT COMPLETED|Overall Study||37
266146|NCT01106534|642392|P1|COMPLETED|Overall Study||2960
266147|NCT01106534|642392|P1|STARTED|Overall Study||2997
266148|NCT01106586|642415|P2|NOT COMPLETED|Overall Study||285
266149|NCT01106586|642416|P1|NOT COMPLETED|Overall Study||285
266150|NCT01106586|642415|P2|COMPLETED|Overall Study||70
266151|NCT01106586|642416|P1|COMPLETED|Overall Study||68
266152|NCT01106586|642415|P2|STARTED|Overall Study||355
266153|NCT01106586|642416|P1|STARTED|Overall Study||353
266154|NCT01106625|642437|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||17
266155|NCT01106625|642438|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
266156|NCT01106625|642439|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||29
266157|NCT01106625|642437|P3|COMPLETED|Extension Period: Week 26 to Week 52||111
266158|NCT01106625|642438|P2|COMPLETED|Extension Period: Week 26 to Week 52||109
266159|NCT01106625|642439|P1|COMPLETED|Extension Period: Week 26 to Week 52||90
266160|NCT01106625|642437|P3|STARTED|Extension Period: Week 26 to Week 52|1 pt discontinued last day of core: withdrawal by subject (1).|128
266161|NCT01106625|642438|P2|STARTED|Extension Period: Week 26 to Week 52|2 pts discontinued last day of core: adverse event (1), not specified (1).|127
266162|NCT01106625|642439|P1|STARTED|Extension Period: Week 26 to Week 52|4 pts discontinued last day of core: physician decision (1), noncompliance (1), not specified (2).|119
266163|NCT01106625|642437|P3|NOT COMPLETED|Core Period: Baseline to Week 26||27
266164|NCT01106625|642438|P2|NOT COMPLETED|Core Period: Baseline to Week 26||28
266165|NCT01106625|642439|P1|NOT COMPLETED|Core Period: Baseline to Week 26||33
266166|NCT01106625|642437|P3|COMPLETED|Core Period: Baseline to Week 26||129
266167|NCT01106625|642438|P2|COMPLETED|Core Period: Baseline to Week 26||129
266168|NCT01106625|642439|P1|COMPLETED|Core Period: Baseline to Week 26||123
266169|NCT01106625|642437|P3|STARTED|Core Period: Baseline to Week 26||156
266170|NCT01106625|642438|P2|STARTED|Core Period: Baseline to Week 26||157
266171|NCT01106625|642439|P1|STARTED|Core Period: Baseline to Week 26||156
266172|NCT01106651|642471|P3|NOT COMPLETED|Overall Study||58
266173|NCT01106651|642472|P2|NOT COMPLETED|Overall Study||57
266174|NCT01106651|642473|P1|NOT COMPLETED|Overall Study||79
266175|NCT01106651|642471|P3|COMPLETED|Overall Study||178
266176|NCT01106651|642472|P2|COMPLETED|Overall Study||184
266177|NCT01106651|642473|P1|COMPLETED|Overall Study||158
266178|NCT01106651|642471|P3|STARTED|Overall Study||236
266179|NCT01106651|642472|P2|STARTED|Overall Study||241
266180|NCT01106651|642473|P1|STARTED|Overall Study||237
266181|NCT01106677|642527|P4|NOT COMPLETED|Extension Period: Week 26 to Week 52||28
266182|NCT01106677|642528|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||22
266183|NCT01106677|642529|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||18
266184|NCT01106677|642530|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||15
266185|NCT01106677|642527|P4|COMPLETED|Extension Period: Week 26 to Week 52||285
266186|NCT01106677|642528|P3|COMPLETED|Extension Period: Week 26 to Week 52||299
266187|NCT01106677|642529|P2|COMPLETED|Extension Period: Week 26 to Week 52||298
266188|NCT01106677|642530|P1|COMPLETED|Extension Period: Week 26 to Week 52||138
266189|NCT01106677|642527|P4|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(3), physician decision(2), lost to f/u(1).|313
266190|NCT01106677|642528|P3|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: not specified(1), withdrawal by subject(1).|321
266191|NCT01106677|642529|P2|STARTED|Extension Period: Week 26 to Week 52|6 pts completed core but did not enter ext: not specified(5), withdrawal by subject(1).|316
266192|NCT01106677|642530|P1|STARTED|Extension Period: Week 26 to Week 52|2 pts completed core but did not enter ext: protcol violation(1), lost to f/u(1).|153
266193|NCT01106677|642527|P4|NOT COMPLETED|Core Period: Baseline to Week 26||47
266194|NCT01106677|642528|P3|NOT COMPLETED|Core Period: Baseline to Week 26||44
266195|NCT01106677|642529|P2|NOT COMPLETED|Core Period: Baseline to Week 26||46
266196|NCT01106677|642530|P1|NOT COMPLETED|Core Period: Baseline to Week 26||28
266197|NCT01106677|642527|P4|COMPLETED|Core Period: Baseline to Week 26||319
266198|NCT01106677|642528|P3|COMPLETED|Core Period: Baseline to Week 26||323
266199|NCT01106677|642529|P2|COMPLETED|Core Period: Baseline to Week 26||322
266200|NCT01106677|642530|P1|COMPLETED|Core Period: Baseline to Week 26||155
266201|NCT01106677|642527|P4|STARTED|Core Period: Baseline to Week 26||366
266202|NCT01106677|642528|P3|STARTED|Core Period: Baseline to Week 26||367
266203|NCT01106677|642529|P2|STARTED|Core Period: Baseline to Week 26||368
266204|NCT01106677|642530|P1|STARTED|Core Period: Baseline to Week 26||183
266205|NCT01106690|642593|P3|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
266206|NCT01106690|642594|P2|NOT COMPLETED|Extension Period: Week 26 to Week 52||7
266207|NCT01106690|642595|P1|NOT COMPLETED|Extension Period: Week 26 to Week 52||12
266208|NCT01106690|642593|P3|COMPLETED|Extension Period: Week 26 to Week 52||89
266209|NCT01106690|642594|P2|COMPLETED|Extension Period: Week 26 to Week 52||96
266210|NCT01106690|642595|P1|COMPLETED|Extension Period: Week 26 to Week 52||78
266211|NCT01106690|642593|P3|STARTED|Extension Period: Week 26 to Week 52|5 pts completed core but did not exter ext: lost to f/u(1), not spec(2), AE(1), eGFR criteria(1).|96
266212|NCT01106690|642594|P2|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|103
266213|NCT01106690|642595|P1|STARTED|Extension Period: Week 26 to Week 52|1 pt completed core but did not enter ext: physician decision(1).|90
266214|NCT01106690|642593|P3|NOT COMPLETED|Core Period: Baseline to Week 26||13
266215|NCT01106690|642594|P2|NOT COMPLETED|Core Period: Baseline to Week 26||9
266216|NCT01106690|642595|P1|NOT COMPLETED|Core Period: Baseline to Week 26||24
266217|NCT01106690|642593|P3|COMPLETED|Core Period: Baseline to Week 26||101
266218|NCT01106690|642594|P2|COMPLETED|Core Period: Baseline to Week 26||104
266219|NCT01106690|642595|P1|COMPLETED|Core Period: Baseline to Week 26||91
266220|NCT01106690|642593|P3|STARTED|Core Period: Baseline to Week 26||114
266221|NCT01106690|642594|P2|STARTED|Core Period: Baseline to Week 26||113
266222|NCT01106690|642595|P1|STARTED|Core Period: Baseline to Week 26||115
266223|NCT01106846|642629|P2|NOT COMPLETED|Overall Study||1
266224|NCT01106846|642630|P1|NOT COMPLETED|Overall Study||0
266225|NCT01106846|642629|P2|COMPLETED|Overall Study||9
266226|NCT01106846|642630|P1|COMPLETED|Overall Study||12
266227|NCT01106846|642629|P2|STARTED|Overall Study||10
266228|NCT01106846|642630|P1|STARTED|Overall Study||12
266229|NCT01106859|642636|P1|NOT COMPLETED|Overall Study||0
266230|NCT01106859|642636|P1|COMPLETED|Overall Study||40
266231|NCT01106859|642636|P1|STARTED|Overall Study|Intent to treat population and safety population are the same (40 participants)|40
266232|NCT01106911|642675|P1|NOT COMPLETED|Overall Study||5
266233|NCT01106911|642675|P1|COMPLETED|Overall Study||1080
266234|NCT01106911|642675|P1|STARTED|Overall Study||1085
266235|NCT01106950|642679|P1|NOT COMPLETED|Overall Study||0
266236|NCT01106950|642679|P1|COMPLETED|Overall Study||15
266237|NCT01106950|642679|P1|STARTED|Overall Study||15
266238|NCT01106976|642689|P1|NOT COMPLETED|Overall Study||8
266239|NCT01106976|642689|P1|COMPLETED|Overall Study||59
266240|NCT01106976|642689|P1|STARTED|Overall Study||67
266241|NCT01101308|642693|P2|NOT COMPLETED|Period 2||0
266242|NCT01101308|642694|P1|NOT COMPLETED|Period 2||0
266243|NCT01101308|642693|P2|COMPLETED|Period 2||27
266244|NCT01101308|642694|P1|COMPLETED|Period 2||24
266245|NCT01101308|642693|P2|STARTED|Period 2||27
266246|NCT01101308|642694|P1|STARTED|Period 2||24
266247|NCT01101308|642693|P2|NOT COMPLETED|Period 1||1
266248|NCT01101308|642694|P1|NOT COMPLETED|Period 1||3
266249|NCT01101308|642693|P2|COMPLETED|Period 1||27
266250|NCT01101308|642694|P1|COMPLETED|Period 1||24
266251|NCT01101308|642693|P2|STARTED|Period 1||28
266252|NCT01101308|642694|P1|STARTED|Period 1||27
266253|NCT01101321|642705|P2|NOT COMPLETED|Period 2||0
266254|NCT01101321|642706|P1|NOT COMPLETED|Period 2||0
266255|NCT01101321|642705|P2|COMPLETED|Period 2||24
266256|NCT01101321|642706|P1|COMPLETED|Period 2||26
266257|NCT01101321|642705|P2|STARTED|Period 2||24
266258|NCT01101321|642706|P1|STARTED|Period 2||26
266259|NCT01101321|642705|P2|NOT COMPLETED|Period 1||4
266260|NCT01101321|642706|P1|NOT COMPLETED|Period 1||4
266261|NCT01101321|642705|P2|COMPLETED|Period 1||24
266262|NCT01101321|642706|P1|COMPLETED|Period 1||26
266263|NCT01101321|642705|P2|STARTED|Period 1||28
266264|NCT01101321|642706|P1|STARTED|Period 1||30
266265|NCT01101464|642718|P2|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
266266|NCT01101464|642719|P1|NOT COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||0
266267|NCT01101464|642718|P2|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
266268|NCT01101464|642719|P1|COMPLETED|PM Dose of Day 5 Through AM Dose of Day7||4
266269|NCT01101464|642718|P2|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
266270|NCT01101464|642719|P1|STARTED|PM Dose of Day 5 Through AM Dose of Day7||4
266271|NCT01101464|642718|P2|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
266272|NCT01101464|642719|P1|NOT COMPLETED|Day 1 Through AM Dose of Day 5||0
266273|NCT01101464|642718|P2|COMPLETED|Day 1 Through AM Dose of Day 5||4
266274|NCT01101464|642719|P1|COMPLETED|Day 1 Through AM Dose of Day 5||4
266275|NCT01101464|642718|P2|STARTED|Day 1 Through AM Dose of Day 5||4
266276|NCT01101464|642719|P1|STARTED|Day 1 Through AM Dose of Day 5||4
266277|NCT01101477|642732|P3|NOT COMPLETED|Overall Study||1
266278|NCT01101477|642733|P2|NOT COMPLETED|Overall Study||3
266279|NCT01101477|642734|P1|NOT COMPLETED|Overall Study||5
266280|NCT01101477|642732|P3|COMPLETED|Overall Study||45
266281|NCT01101477|642733|P2|COMPLETED|Overall Study||46
266282|NCT01101477|642734|P1|COMPLETED|Overall Study||44
266283|NCT01101477|642732|P3|STARTED|Overall Study||46
266284|NCT01101477|642733|P2|STARTED|Overall Study||49
266285|NCT01101477|642734|P1|STARTED|Overall Study||49
266286|NCT01101542|642742|P1|NOT COMPLETED|Year 6 Surveillance Period||991
266287|NCT01101542|642742|P1|COMPLETED|Year 6 Surveillance Period||2100
266288|NCT01101542|642742|P1|STARTED|Year 6 Surveillance Period||3091
266289|NCT01101542|642742|P1|NOT COMPLETED|Year 5 Surveillance Period||141
266290|NCT01101542|642742|P1|COMPLETED|Year 5 Surveillance Period||668
266291|NCT01101542|642742|P1|STARTED|Year 5 Surveillance Period||809
266292|NCT01101542|642742|P1|NOT COMPLETED|Year 4 Surveillance Period||287
266293|NCT01101542|642742|P1|COMPLETED|Year 4 Surveillance Period||282
266294|NCT01101542|642742|P1|STARTED|Year 4 Surveillance Period||569
266295|NCT01101542|642742|P1|NOT COMPLETED|Year 3 Surveillance Period||11
266296|NCT01101542|642742|P1|COMPLETED|Year 3 Surveillance Period||94
266297|NCT01101542|642742|P1|STARTED|Year 3 Surveillance Period||105
266298|NCT01107197|642760|P2|NOT COMPLETED|Overall Study||23
266299|NCT01107197|642761|P1|NOT COMPLETED|Overall Study||20
266300|NCT01107197|642760|P2|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 64 patients )|78
266301|NCT01107197|642761|P1|COMPLETED|Overall Study|Included in intention-to-treat efficacy analyses (per-protocol analyses were based on 67 patients )|79
266302|NCT01107197|642760|P2|STARTED|Overall Study||101
266303|NCT01107197|642761|P1|STARTED|Overall Study||99
266304|NCT01107353|642781|P2|NOT COMPLETED|Overall Study||0
266305|NCT01107353|642782|P1|NOT COMPLETED|Overall Study||1
266306|NCT01107353|642781|P2|COMPLETED|Overall Study||20
266307|NCT01107353|642782|P1|COMPLETED|Overall Study||19
266308|NCT01107353|642781|P2|STARTED|Overall Study||20
266309|NCT01107353|642782|P1|STARTED|Overall Study||20
266310|NCT01107379|642788|P1|NOT COMPLETED|Overall Study||21
266311|NCT01107379|642788|P1|COMPLETED|Overall Study||182
266312|NCT01107379|642788|P1|STARTED|Overall Study||203
266313|NCT01107392|642799|P2|NOT COMPLETED|Overall Study||3
266314|NCT01107392|642800|P1|NOT COMPLETED|Overall Study||5
266315|NCT01107392|642799|P2|COMPLETED|Overall Study||154
266316|NCT01107392|642800|P1|COMPLETED|Overall Study||153
266317|NCT01107392|642799|P2|STARTED|Overall Study||157
266318|NCT01107392|642800|P1|STARTED|Overall Study||158
266319|NCT01107405|642817|P5|NOT COMPLETED|Overall Study||3
266320|NCT01107405|642818|P4|NOT COMPLETED|Overall Study||3
266321|NCT01107405|642819|P3|NOT COMPLETED|Overall Study||2
266322|NCT01107405|642820|P2|NOT COMPLETED|Overall Study||1
266323|NCT01107405|642821|P1|NOT COMPLETED|Overall Study||2
266324|NCT01107405|642817|P5|COMPLETED|Overall Study||17
266325|NCT01107405|642818|P4|COMPLETED|Overall Study||17
266326|NCT01107405|642819|P3|COMPLETED|Overall Study||18
266327|NCT01107405|642820|P2|COMPLETED|Overall Study||19
266328|NCT01107405|642821|P1|COMPLETED|Overall Study||19
266329|NCT01107405|642817|P5|STARTED|Overall Study||20
266330|NCT01107405|642818|P4|STARTED|Overall Study||20
266331|NCT01107405|642819|P3|STARTED|Overall Study||20
266332|NCT01107405|642820|P2|STARTED|Overall Study||20
266333|NCT01107405|642821|P1|STARTED|Overall Study||21
266334|NCT01107418|642862|P1|NOT COMPLETED|Overall Study||52
266335|NCT01107418|642862|P1|COMPLETED|Overall Study||0
266336|NCT01107418|642862|P1|STARTED|Overall Study||52
266337|NCT01107730|642933|P3|NOT COMPLETED|Overall Study||0
266338|NCT01107730|642934|P2|NOT COMPLETED|Overall Study||0
266339|NCT01107730|642935|P1|NOT COMPLETED|Overall Study||0
266340|NCT01107730|642933|P3|COMPLETED|Overall Study||11
266341|NCT01107730|642934|P2|COMPLETED|Overall Study||11
266342|NCT01107730|642935|P1|COMPLETED|Overall Study||11
266343|NCT01107730|642933|P3|STARTED|Overall Study||11
266344|NCT01107730|642934|P2|STARTED|Overall Study||11
266345|NCT01107730|642935|P1|STARTED|Overall Study||11
266346|NCT01107743|642943|P1|NOT COMPLETED|Overall Study||46
266347|NCT01107743|642943|P1|COMPLETED|Overall Study||1245
266348|NCT01107743|642943|P1|STARTED|Overall Study||1291
266349|NCT01107834|643031|P2|NOT COMPLETED|Overall Study||0
266350|NCT01107834|643032|P1|NOT COMPLETED|Overall Study||0
266351|NCT01107834|643031|P2|COMPLETED|Overall Study||30
266352|NCT01107834|643032|P1|COMPLETED|Overall Study||30
266353|NCT01107834|643031|P2|STARTED|Overall Study||30
266354|NCT01107834|643032|P1|STARTED|Overall Study||30
266355|NCT01107886|643050|P2|NOT COMPLETED|Overall Study||214
266356|NCT01107886|643051|P1|NOT COMPLETED|Overall Study||202
266357|NCT01107886|643050|P2|COMPLETED|Overall Study|Completed subjects|7998
266358|NCT01107886|643051|P1|COMPLETED|Overall Study|Completed subjects|8078
266359|NCT01107886|643050|P2|STARTED|Overall Study|Randomized subjects|8212
266360|NCT01107886|643051|P1|STARTED|Overall Study|Randomized subjects|8280
266361|NCT01107899|643064|P3|NOT COMPLETED|Overall Study||4
266362|NCT01107899|643065|P2|NOT COMPLETED|Overall Study||0
266363|NCT01107899|643066|P1|NOT COMPLETED|Overall Study||5
266364|NCT01107899|643064|P3|COMPLETED|Overall Study||5
266365|NCT01107899|643065|P2|COMPLETED|Overall Study||10
266366|NCT01107899|643066|P1|COMPLETED|Overall Study||5
266367|NCT01107899|643064|P3|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|4
266368|NCT01107899|643065|P2|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|10
266369|NCT01107899|643066|P1|Primary Washout Population|Overall Study|Primary WP: Completed study with no missed visits, had evaluable PD data through Day 11.|5
266370|NCT01107899|643064|P3|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|6
266371|NCT01107899|643065|P2|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|10
266372|NCT01107899|643066|P1|ITT Washout Population|Overall Study|ITT Washout Population (WP): Received LD, had evaluable baseline PD data (pre-LD) and post-LD.|5
266373|NCT01107899|643064|P3|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|6
266374|NCT01107899|643065|P2|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|10
266375|NCT01107899|643066|P1|Loading Dose (LD) Intent to Treat (ITT)|Overall Study|Received LD and had evaluable pharmacodynamic (PD) measurements 24-hours post-LD.|5
266376|NCT01107899|643064|P3|Received at Least One Dose of Study Drug|Overall Study||8
266377|NCT01107899|643065|P2|Received at Least One Dose of Study Drug|Overall Study||10
266378|NCT01107899|643066|P1|Received at Least One Dose of Study Drug|Overall Study||10
266379|NCT01107899|643064|P3|STARTED|Overall Study||9
266380|NCT01107899|643065|P2|STARTED|Overall Study||10
266381|NCT01107899|643066|P1|STARTED|Overall Study||10
266382|NCT01107912|643114|P6|NOT COMPLETED|Period 3||0
266383|NCT01107912|643115|P5|NOT COMPLETED|Period 3||0
266384|NCT01107912|643116|P4|NOT COMPLETED|Period 3||1
266385|NCT01107912|643117|P3|NOT COMPLETED|Period 3||1
266386|NCT01107912|643118|P2|NOT COMPLETED|Period 3||1
266387|NCT01107912|643119|P1|NOT COMPLETED|Period 3||0
266388|NCT01107912|643114|P6|COMPLETED|Period 3||41
266389|NCT01107912|643115|P5|COMPLETED|Period 3||0
266390|NCT01107912|643116|P4|COMPLETED|Period 3||37
266391|NCT01107912|643117|P3|COMPLETED|Period 3||35
266392|NCT01107912|643118|P2|COMPLETED|Period 3||34
266393|NCT01107912|643119|P1|COMPLETED|Period 3||0
266394|NCT01107912|643114|P6|STARTED|Period 3|Participants who received 5 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|41
266395|NCT01107912|643115|P5|STARTED|Period 3||0
266396|NCT01107912|643116|P4|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 5 mg prasugrel in Period 3|38
266397|NCT01107912|643117|P3|STARTED|Period 3|Participants who received 10 mg prasugrel in Period 2 received 75 mg clopidogrel in Period 3|36
266398|NCT01107912|643118|P2|STARTED|Period 3|Participants who received 75 mg clopidogrel in Period 2 received 10 mg prasugrel in Period 3|35
266399|NCT01107912|643119|P1|STARTED|Period 3||0
266400|NCT01107912|643114|P6|NOT COMPLETED|Period 2||0
266401|NCT01107912|643115|P5|NOT COMPLETED|Period 2||0
266402|NCT01107912|643116|P4|NOT COMPLETED|Period 2||0
266403|NCT01107912|643117|P3|NOT COMPLETED|Period 2||1
266404|NCT01107912|643118|P2|NOT COMPLETED|Period 2||0
266405|NCT01107912|643119|P1|NOT COMPLETED|Period 2||0
266406|NCT01107912|643114|P6|COMPLETED|Period 2||38
266407|NCT01107912|643115|P5|COMPLETED|Period 2||0
266408|NCT01107912|643116|P4|COMPLETED|Period 2||41
266409|NCT01107912|643117|P3|COMPLETED|Period 2||35
266410|NCT01107912|643118|P2|COMPLETED|Period 2||36
266411|NCT01107912|643119|P1|COMPLETED|Period 2||0
266412|NCT01107912|643114|P6|STARTED|Period 2||38
266413|NCT01107912|643115|P5|STARTED|Period 2|Participants switched to either 5 mg prasugrel or 75 mg clopidogrel in Period 2.|0
266414|NCT01107912|643116|P4|STARTED|Period 2||41
266415|NCT01107912|643117|P3|STARTED|Period 2||36
266416|NCT01107912|643118|P2|STARTED|Period 2||36
266501|NCT01107925|643162|P1|COMPLETED|Period 1-Randomization up Through Day 12||33
266417|NCT01107912|643119|P1|STARTED|Period 2|Participants switched to either 10 mg prasugrel or 75 mg clopidogrel in Period 2.|0
266418|NCT01107912|643114|P6|NOT COMPLETED|Period 1||0
266419|NCT01107912|643115|P5|NOT COMPLETED|Period 1||3
266420|NCT01107912|643116|P4|NOT COMPLETED|Period 1||0
266421|NCT01107912|643117|P3|NOT COMPLETED|Period 1||0
266422|NCT01107912|643118|P2|NOT COMPLETED|Period 1||0
266423|NCT01107912|643119|P1|NOT COMPLETED|Period 1||1
266424|NCT01107912|643114|P6|COMPLETED|Period 1||0
266425|NCT01107912|643115|P5|COMPLETED|Period 1||79
266426|NCT01107912|643116|P4|COMPLETED|Period 1||0
266427|NCT01107912|643117|P3|COMPLETED|Period 1||0
266428|NCT01107912|643118|P2|COMPLETED|Period 1||0
266429|NCT01107912|643119|P1|COMPLETED|Period 1||72
266430|NCT01107912|643114|P6|Received at Least 1 Dose of Study Drug|Period 1||0
266431|NCT01107912|643115|P5|Received at Least 1 Dose of Study Drug|Period 1||82
266432|NCT01107912|643116|P4|Received at Least 1 Dose of Study Drug|Period 1||0
266433|NCT01107912|643117|P3|Received at Least 1 Dose of Study Drug|Period 1||0
266434|NCT01107912|643118|P2|Received at Least 1 Dose of Study Drug|Period 1||0
266435|NCT01107912|643119|P1|Received at Least 1 Dose of Study Drug|Period 1||73
266436|NCT01107912|643114|P6|STARTED|Period 1||0
266437|NCT01107912|643115|P5|STARTED|Period 1||82
266438|NCT01107912|643116|P4|STARTED|Period 1||0
266439|NCT01107912|643117|P3|STARTED|Period 1||0
266440|NCT01107912|643118|P2|STARTED|Period 1||0
266441|NCT01107912|643119|P1|STARTED|Period 1||73
266442|NCT01107925|643157|P6|NOT COMPLETED|Period 3||0
266443|NCT01107925|643158|P5|NOT COMPLETED|Period 3||0
266444|NCT01107925|643159|P4|NOT COMPLETED|Period 3||0
266445|NCT01107925|643160|P3|NOT COMPLETED|Period 3||0
266446|NCT01107925|643161|P2|NOT COMPLETED|Period 3||0
266447|NCT01107925|643162|P1|NOT COMPLETED|Period 3||0
266448|NCT01107925|643157|P6|COMPLETED|Period 3||20
266449|NCT01107925|643158|P5|COMPLETED|Period 3||0
266450|NCT01107925|643159|P4|COMPLETED|Period 3||16
266451|NCT01107925|643160|P3|COMPLETED|Period 3||15
266452|NCT01107925|643161|P2|COMPLETED|Period 3||17
266453|NCT01107925|643162|P1|COMPLETED|Period 3||0
266454|NCT01107925|643157|P6|Took at Least 1 Dose of Study Drug|Period 3||20
266455|NCT01107925|643158|P5|Took at Least 1 Dose of Study Drug|Period 3||0
266456|NCT01107925|643159|P4|Took at Least 1 Dose of Study Drug|Period 3||16
266457|NCT01107925|643160|P3|Took at Least 1 Dose of Study Drug|Period 3||15
266458|NCT01107925|643161|P2|Took at Least 1 Dose of Study Drug|Period 3||17
266459|NCT01107925|643162|P1|Took at Least 1 Dose of Study Drug|Period 3||0
266460|NCT01107925|643157|P6|STARTED|Period 3|5 mg prasugrel (Period 2, HBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|20
266461|NCT01107925|643158|P5|STARTED|Period 3||0
266462|NCT01107925|643159|P4|STARTED|Period 3|75 mg clopidogrel (Period 2, HBW treatment sequence) crossed over to 5 mg prasugrel (Period 3).|16
266463|NCT01107925|643160|P3|STARTED|Period 3|10 mg prasugrel (Period 2, LBW treatment sequence) crossed over to 75 mg clopidogrel (Period 3).|15
266464|NCT01107925|643161|P2|STARTED|Period 3|75 mg clopidogrel (Period 2, LBW treatment sequence) crossed over to 10 mg prasugrel (Period 3).|17
266465|NCT01107925|643162|P1|STARTED|Period 3||0
266466|NCT01107925|643157|P6|NOT COMPLETED|Period 2||1
266467|NCT01107925|643158|P5|NOT COMPLETED|Period 2||0
266468|NCT01107925|643159|P4|NOT COMPLETED|Period 2||0
266469|NCT01107925|643160|P3|NOT COMPLETED|Period 2||0
266470|NCT01107925|643161|P2|NOT COMPLETED|Period 2||1
266471|NCT01107925|643162|P1|NOT COMPLETED|Period 2||0
266472|NCT01107925|643157|P6|COMPLETED|Period 2||16
266473|NCT01107925|643158|P5|COMPLETED|Period 2||0
266474|NCT01107925|643159|P4|COMPLETED|Period 2||20
266475|NCT01107925|643160|P3|COMPLETED|Period 2||17
266476|NCT01107925|643161|P2|COMPLETED|Period 2||15
266477|NCT01107925|643162|P1|COMPLETED|Period 2||0
266478|NCT01107925|643157|P6|Took at Least 1 Dose of Study Drug|Period 2||17
266479|NCT01107925|643158|P5|Took at Least 1 Dose of Study Drug|Period 2||0
266480|NCT01107925|643159|P4|Took at Least 1 Dose of Study Drug|Period 2||20
266481|NCT01107925|643160|P3|Took at Least 1 Dose of Study Drug|Period 2||17
266482|NCT01107925|643161|P2|Took at Least 1 Dose of Study Drug|Period 2||16
266483|NCT01107925|643162|P1|Took at Least 1 Dose of Study Drug|Period 2||0
266484|NCT01107925|643157|P6|STARTED|Period 2||17
266485|NCT01107925|643158|P5|STARTED|Period 2|10 mg prasugrel (Period 1, HBW treatment) switched to 5 mg prasugrel or 75 mg clopidogrel (Period 2)|0
266486|NCT01107925|643159|P4|STARTED|Period 2||20
266487|NCT01107925|643160|P3|STARTED|Period 2||17
266488|NCT01107925|643161|P2|STARTED|Period 2||16
266489|NCT01107925|643162|P1|STARTED|Period 2|5 mg prasugrel (Period 1, LBW treatment) switched to 10 mg prasugrel or 75 mg clopidogrel (Period 2)|0
266490|NCT01107925|643157|P6|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
266491|NCT01107925|643158|P5|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
266492|NCT01107925|643159|P4|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
266493|NCT01107925|643160|P3|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
266494|NCT01107925|643161|P2|NOT COMPLETED|Period 1-Randomization up Through Day 12||0
266495|NCT01107925|643162|P1|NOT COMPLETED|Period 1-Randomization up Through Day 12||1
266496|NCT01107925|643157|P6|COMPLETED|Period 1-Randomization up Through Day 12||0
266497|NCT01107925|643158|P5|COMPLETED|Period 1-Randomization up Through Day 12||37
266498|NCT01107925|643159|P4|COMPLETED|Period 1-Randomization up Through Day 12||0
266499|NCT01107925|643160|P3|COMPLETED|Period 1-Randomization up Through Day 12||0
266500|NCT01107925|643161|P2|COMPLETED|Period 1-Randomization up Through Day 12||0
266502|NCT01107925|643157|P6|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
266503|NCT01107925|643158|P5|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||38
266504|NCT01107925|643159|P4|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
266505|NCT01107925|643160|P3|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
266506|NCT01107925|643161|P2|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||0
266507|NCT01107925|643162|P1|Took at Least 1 Dose of Study Drug|Period 1-Randomization up Through Day 12||34
266508|NCT01107925|643157|P6|STARTED|Period 1-Randomization up Through Day 12||0
266509|NCT01107925|643158|P5|STARTED|Period 1-Randomization up Through Day 12||38
266510|NCT01107925|643159|P4|STARTED|Period 1-Randomization up Through Day 12||0
266511|NCT01107925|643160|P3|STARTED|Period 1-Randomization up Through Day 12||0
266512|NCT01107925|643161|P2|STARTED|Period 1-Randomization up Through Day 12||0
266513|NCT01107925|643162|P1|STARTED|Period 1-Randomization up Through Day 12||34
266514|NCT01108003|643198|P2|NOT COMPLETED|Overall Study||0
266515|NCT01108003|643199|P1|NOT COMPLETED|Overall Study||0
266516|NCT01108003|643198|P2|COMPLETED|Overall Study||3
266517|NCT01108003|643199|P1|COMPLETED|Overall Study||4
266518|NCT01108003|643198|P2|STARTED|Overall Study||3
266519|NCT01108003|643199|P1|STARTED|Overall Study||4
266520|NCT01108055|643207|P1|NOT COMPLETED|Overall Study||15
266521|NCT01108055|643207|P1|COMPLETED|Overall Study||28
266522|NCT01108055|643207|P1|Eligible and Started Treatment|Overall Study||32
266523|NCT01108055|643207|P1|STARTED|Overall Study||43
266524|NCT01108081|643219|P4|NOT COMPLETED|Overall Study||4
266525|NCT01108081|643220|P3|NOT COMPLETED|Overall Study||0
266526|NCT01108081|643221|P2|NOT COMPLETED|Overall Study||2
266527|NCT01108081|643222|P1|NOT COMPLETED|Overall Study||2
266528|NCT01108081|643219|P4|COMPLETED|Overall Study||39
266529|NCT01108081|643220|P3|COMPLETED|Overall Study||38
266530|NCT01108081|643221|P2|COMPLETED|Overall Study||40
266531|NCT01108081|643222|P1|COMPLETED|Overall Study||44
266532|NCT01108081|643219|P4|STARTED|Overall Study||43
266533|NCT01108081|643220|P3|STARTED|Overall Study||38
266534|NCT01108081|643221|P2|STARTED|Overall Study||42
266535|NCT01108081|643222|P1|STARTED|Overall Study||46
266536|NCT01108185|643236|P1|NOT COMPLETED|Overall Study||27
266537|NCT01108185|643236|P1|COMPLETED|Overall Study||3154
266538|NCT01108185|643236|P1|Per Protocol Population|Overall Study||3181
266539|NCT01108185|643236|P1|STARTED|Overall Study||3181
266540|NCT01108237|643251|P2|NOT COMPLETED|Overall Study||17
266541|NCT01108237|643252|P1|NOT COMPLETED|Overall Study||9
266542|NCT01108237|643251|P2|COMPLETED|Overall Study||84
266543|NCT01108237|643252|P1|COMPLETED|Overall Study|66 subjects underwent surgery per the protocol, however, only 64 met the primary end point.|64
266544|NCT01108237|643251|P2|STARTED|Overall Study||101
266545|NCT01108237|643252|P1|STARTED|Overall Study|78 subjects were consented with intent to treat, however, 73 had surgery.|73
266546|NCT01108263|643260|P2|NOT COMPLETED|Overall Study||1
266547|NCT01108263|643261|P1|NOT COMPLETED|Overall Study||0
266548|NCT01108263|643260|P2|COMPLETED|Overall Study||2
266549|NCT01108263|643261|P1|COMPLETED|Overall Study||2
266550|NCT01108263|643260|P2|STARTED|Overall Study||3
266551|NCT01108263|643261|P1|STARTED|Overall Study||2
266552|NCT01108341|643269|P1|NOT COMPLETED|Overall Study||5
266553|NCT01108341|643269|P1|COMPLETED|Overall Study||45
266554|NCT01108341|643269|P1|Safety Set (Enrolled and Treated)|Overall Study||49
266555|NCT01108341|643269|P1|STARTED|Overall Study||50
266556|NCT01108406|643274|P1|NOT COMPLETED|Overall Study||0
266557|NCT01108406|643274|P1|COMPLETED|Overall Study||22
266558|NCT01108406|643274|P1|STARTED|Overall Study||22
266559|NCT01108445|643282|P2|NOT COMPLETED|Overall Study||49
266560|NCT01108445|643283|P1|NOT COMPLETED|Overall Study||56
266561|NCT01108445|643282|P2|COMPLETED|Overall Study||2
266562|NCT01108445|643283|P1|COMPLETED|Overall Study||1
266563|NCT01108445|643282|P2|STARTED|Overall Study||51
266564|NCT01108445|643283|P1|STARTED|Overall Study||57
266565|NCT01108458|643317|P1|NOT COMPLETED|Overall Study||1
266566|NCT01108458|643317|P1|COMPLETED|Overall Study||0
266567|NCT01108458|643317|P1|STARTED|Overall Study||1
266568|NCT01108510|643328|P2|NOT COMPLETED|Overall Study||268
266569|NCT01108510|643329|P1|NOT COMPLETED|Overall Study||279
266570|NCT01108510|643328|P2|COMPLETED|Overall Study||81
266571|NCT01108510|643329|P1|COMPLETED|Overall Study||70
266572|NCT01108510|643328|P2|STARTED|Overall Study||349
266573|NCT01108510|643329|P1|STARTED|Overall Study||349
266574|NCT01108523|643349|P1|NOT COMPLETED|Overall Study||4
266575|NCT01108523|643349|P1|COMPLETED|Overall Study||3
266576|NCT01108523|643349|P1|STARTED|Overall Study||7
266577|NCT01108718|643356|P2|NOT COMPLETED|Received Second Intervention (2 Months)||0
266578|NCT01108718|643357|P1|NOT COMPLETED|Received Second Intervention (2 Months)||1
266579|NCT01108718|643356|P2|COMPLETED|Received Second Intervention (2 Months)||7
266580|NCT01108718|643357|P1|COMPLETED|Received Second Intervention (2 Months)||4
266581|NCT01108718|643356|P2|STARTED|Received Second Intervention (2 Months)||7
266582|NCT01108718|643357|P1|STARTED|Received Second Intervention (2 Months)|Used control mattress was delivered to participant at crossover causing her to withdraw.|5
266583|NCT01108718|643356|P2|NOT COMPLETED|Received First Intervention (2 Months)||0
266584|NCT01108718|643357|P1|NOT COMPLETED|Received First Intervention (2 Months)||0
266585|NCT01108718|643356|P2|COMPLETED|Received First Intervention (2 Months)||7
266586|NCT01108718|643357|P1|COMPLETED|Received First Intervention (2 Months)||5
266587|NCT01108718|643356|P2|STARTED|Received First Intervention (2 Months)||7
266588|NCT01108718|643357|P1|STARTED|Received First Intervention (2 Months)||5
266589|NCT01108731|643364|P2|NOT COMPLETED|Overall Study||4
266590|NCT01108731|643365|P1|NOT COMPLETED|Overall Study||4
266591|NCT01108731|643364|P2|COMPLETED|Overall Study||13
266592|NCT01108731|643365|P1|COMPLETED|Overall Study||13
266593|NCT01108731|643364|P2|STARTED|Overall Study||17
266594|NCT01108731|643365|P1|STARTED|Overall Study||17
266595|NCT01108796|643379|P2|NOT COMPLETED|Overall Study||7
266596|NCT01108796|643380|P1|NOT COMPLETED|Overall Study||7
266597|NCT01108796|643379|P2|COMPLETED|Overall Study||1060
266598|NCT01108796|643380|P1|COMPLETED|Overall Study||767
266599|NCT01108796|643379|P2|STARTED|Overall Study||1067
266600|NCT01108796|643380|P1|STARTED|Overall Study||774
266601|NCT01108809|643412|P1|NOT COMPLETED|Overall Study||4
266602|NCT01108809|643412|P1|COMPLETED|Overall Study||291
266603|NCT01108809|643412|P1|STARTED|Overall Study||295
266604|NCT01108835|643427|P2|NOT COMPLETED|Overall Study||21
266605|NCT01108835|643428|P1|NOT COMPLETED|Overall Study||17
266606|NCT01108835|643427|P2|COMPLETED|Overall Study||69
266607|NCT01108835|643428|P1|COMPLETED|Overall Study||73
266608|NCT01108835|643427|P2|STARTED|Overall Study||90
266609|NCT01108835|643428|P1|STARTED|Overall Study||90
266610|NCT01109056|643444|P2|NOT COMPLETED|Overall Study||5
266611|NCT01109056|643445|P1|NOT COMPLETED|Overall Study||7
266612|NCT01109056|643444|P2|COMPLETED|Overall Study||53
266613|NCT01109056|643445|P1|COMPLETED|Overall Study||50
266614|NCT01109056|643444|P2|STARTED|Overall Study||58
266615|NCT01109056|643445|P1|STARTED|Overall Study||57
266616|NCT01109108|643457|P2|NOT COMPLETED|Overall Study||0
266617|NCT01109108|643458|P1|NOT COMPLETED|Overall Study||0
266618|NCT01109108|643457|P2|COMPLETED|Overall Study||4755
266619|NCT01109108|643458|P1|COMPLETED|Overall Study||4035
266620|NCT01109108|643457|P2|STARTED|Overall Study||4755
266621|NCT01109108|643458|P1|STARTED|Overall Study||4035
266622|NCT01109147|643467|P3|NOT COMPLETED|Overall Study||10
266623|NCT01109147|643468|P2|NOT COMPLETED|Overall Study||3
266624|NCT01109147|643469|P1|NOT COMPLETED|Overall Study||2
266625|NCT01109147|643467|P3|COMPLETED|Overall Study|10 have been excluded of the results|26
266626|NCT01109147|643468|P2|COMPLETED|Overall Study|3 have been excluded of the results|11
266627|NCT01109147|643469|P1|COMPLETED|Overall Study|2 have been excluded of the results|15
266628|NCT01109147|643467|P3|STARTED|Overall Study||36
266629|NCT01109147|643468|P2|STARTED|Overall Study||14
266630|NCT01109147|643469|P1|STARTED|Overall Study||17
266631|NCT01109173|643481|P4|NOT COMPLETED|Overall Study||93
266632|NCT01109173|643482|P3|NOT COMPLETED|Overall Study||101
266633|NCT01109173|643483|P2|NOT COMPLETED|Overall Study||86
266634|NCT01109173|643484|P1|NOT COMPLETED|Overall Study||88
266635|NCT01109173|643481|P4|COMPLETED|Overall Study||120
266636|NCT01109173|643482|P3|COMPLETED|Overall Study||110
266637|NCT01109173|643483|P2|COMPLETED|Overall Study||759
266638|NCT01109173|643484|P1|COMPLETED|Overall Study||763
266639|NCT01109173|643481|P4|STARTED|Overall Study||213
266640|NCT01109173|643482|P3|STARTED|Overall Study||211
266641|NCT01109173|643483|P2|STARTED|Overall Study||845
266642|NCT01109173|643484|P1|STARTED|Overall Study||851
266643|NCT01109316|643504|P3|NOT COMPLETED|Study Period 3||1
266644|NCT01109316|643505|P2|NOT COMPLETED|Study Period 3||2
266645|NCT01109316|643506|P1|NOT COMPLETED|Study Period 3||0
266646|NCT01109316|643504|P3|COMPLETED|Study Period 3||38
266647|NCT01109316|643505|P2|COMPLETED|Study Period 3||39
266648|NCT01109316|643506|P1|COMPLETED|Study Period 3||39
266649|NCT01109316|643504|P3|STARTED|Study Period 3||39
266650|NCT01109316|643505|P2|STARTED|Study Period 3||41
266651|NCT01109316|643506|P1|STARTED|Study Period 3||39
266652|NCT01109316|643504|P3|NOT COMPLETED|Study Period 2||2
266653|NCT01109316|643505|P2|NOT COMPLETED|Study Period 2||2
266654|NCT01109316|643506|P1|NOT COMPLETED|Study Period 2||1
266655|NCT01109316|643504|P3|COMPLETED|Study Period 2||41
266656|NCT01109316|643505|P2|COMPLETED|Study Period 2||40
266657|NCT01109316|643506|P1|COMPLETED|Study Period 2||38
266658|NCT01109316|643504|P3|STARTED|Study Period 2||43
266659|NCT01109316|643505|P2|STARTED|Study Period 2||42
266660|NCT01109316|643506|P1|STARTED|Study Period 2||39
266661|NCT01109316|643504|P3|NOT COMPLETED|Study Period 1||4
266662|NCT01109316|643505|P2|NOT COMPLETED|Study Period 1||4
266663|NCT01109316|643506|P1|NOT COMPLETED|Study Period 1||0
266664|NCT01109316|643504|P3|COMPLETED|Study Period 1||40
266665|NCT01109316|643505|P2|COMPLETED|Study Period 1||40
266666|NCT01109316|643506|P1|COMPLETED|Study Period 1||44
266667|NCT01109316|643504|P3|Received at Least One Dose of Study Drug|Study Period 1||42
266668|NCT01109316|643505|P2|Received at Least One Dose of Study Drug|Study Period 1||44
266669|NCT01109316|643506|P1|Received at Least One Dose of Study Drug|Study Period 1||44
266670|NCT01109316|643504|P3|STARTED|Study Period 1||44
266671|NCT01109316|643505|P2|STARTED|Study Period 1||44
266672|NCT01109316|643506|P1|STARTED|Study Period 1||44
266673|NCT01109381|643550|P1|NOT COMPLETED|Overall Study||2
266674|NCT01109381|643550|P1|COMPLETED|Overall Study||31
266675|NCT01109381|643550|P1|STARTED|Overall Study||33
266676|NCT01109524|643556|P1|NOT COMPLETED|Overall Study||57
266677|NCT01109524|643556|P1|COMPLETED|Overall Study||3
266678|NCT01109524|643556|P1|STARTED|Overall Study||60
266679|NCT01109576|643566|P1|NOT COMPLETED|Overall Study||1
266680|NCT01109576|643566|P1|COMPLETED|Overall Study||12
266681|NCT01109576|643566|P1|STARTED|Overall Study||13
266682|NCT01109602|643573|P3|NOT COMPLETED|Overall Study||1
266683|NCT01109602|643574|P2|NOT COMPLETED|Overall Study||2
266684|NCT01109602|643575|P1|NOT COMPLETED|Overall Study||1
266685|NCT01109602|643573|P3|COMPLETED|Overall Study||9
266686|NCT01109602|643574|P2|COMPLETED|Overall Study||21
266687|NCT01109602|643575|P1|COMPLETED|Overall Study||13
266688|NCT01109602|643573|P3|STARTED|Overall Study||10
266689|NCT01109602|643574|P2|STARTED|Overall Study||23
266690|NCT01109602|643575|P1|STARTED|Overall Study||14
266691|NCT01109849|643588|P5|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
266692|NCT01109849|643589|P4|NOT COMPLETED|Adaptive Randomization: Weight Recovery||3
266693|NCT01109849|643590|P3|NOT COMPLETED|Adaptive Randomization: Weight Recovery||1
266694|NCT01109849|643591|P2|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
266695|NCT01109849|643592|P1|NOT COMPLETED|Adaptive Randomization: Weight Recovery||0
266696|NCT01109849|643588|P5|COMPLETED|Adaptive Randomization: Weight Recovery||24
266697|NCT01109849|643589|P4|COMPLETED|Adaptive Randomization: Weight Recovery||20
266698|NCT01109849|643590|P3|COMPLETED|Adaptive Randomization: Weight Recovery||23
266699|NCT01109849|643591|P2|COMPLETED|Adaptive Randomization: Weight Recovery||0
266700|NCT01109849|643592|P1|COMPLETED|Adaptive Randomization: Weight Recovery||0
266701|NCT01109849|643588|P5|STARTED|Adaptive Randomization: Weight Recovery||25
266702|NCT01109849|643589|P4|STARTED|Adaptive Randomization: Weight Recovery||23
266703|NCT01109849|643590|P3|STARTED|Adaptive Randomization: Weight Recovery||24
266704|NCT01109849|643591|P2|STARTED|Adaptive Randomization: Weight Recovery||0
266705|NCT01109849|643592|P1|STARTED|Adaptive Randomization: Weight Recovery||0
266706|NCT01109849|643588|P5|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
266707|NCT01109849|643589|P4|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
266708|NCT01109849|643590|P3|NOT COMPLETED|Initial Randomization: ADHD Treatment||0
266709|NCT01109849|643591|P2|NOT COMPLETED|Initial Randomization: ADHD Treatment||49
266710|NCT01109849|643592|P1|NOT COMPLETED|Initial Randomization: ADHD Treatment||18
266711|NCT01109849|643588|P5|COMPLETED|Initial Randomization: ADHD Treatment||0
266712|NCT01109849|643589|P4|COMPLETED|Initial Randomization: ADHD Treatment||0
266713|NCT01109849|643590|P3|COMPLETED|Initial Randomization: ADHD Treatment||0
266714|NCT01109849|643591|P2|COMPLETED|Initial Randomization: ADHD Treatment||131
266715|NCT01109849|643592|P1|COMPLETED|Initial Randomization: ADHD Treatment||32
266716|NCT01109849|643588|P5|STARTED|Initial Randomization: ADHD Treatment||0
266717|NCT01109849|643589|P4|STARTED|Initial Randomization: ADHD Treatment||0
266718|NCT01109849|643590|P3|STARTED|Initial Randomization: ADHD Treatment||0
266719|NCT01109849|643591|P2|STARTED|Initial Randomization: ADHD Treatment||180
266720|NCT01109849|643592|P1|STARTED|Initial Randomization: ADHD Treatment||50
266721|NCT01109979|643643|P2|NOT COMPLETED|Overall Study||1
266722|NCT01109979|643644|P1|NOT COMPLETED|Overall Study||2
266723|NCT01109979|643643|P2|COMPLETED|Overall Study||11
266724|NCT01109979|643644|P1|COMPLETED|Overall Study||10
266725|NCT01109979|643643|P2|STARTED|Overall Study||12
266726|NCT01109979|643644|P1|STARTED|Overall Study||12
266727|NCT01110005|643652|P2|NOT COMPLETED|Overall Study||5
266728|NCT01110005|643653|P1|NOT COMPLETED|Overall Study||4
266729|NCT01110005|643652|P2|COMPLETED|Overall Study||156
266730|NCT01110005|643653|P1|COMPLETED|Overall Study||153
266731|NCT01110005|643652|P2|STARTED|Overall Study||161
266732|NCT01110005|643653|P1|STARTED|Overall Study||157
266733|NCT01104376|643663|P1|NOT COMPLETED|Overall Study||28
266734|NCT01104376|643663|P1|COMPLETED|Overall Study||61
266735|NCT01104376|643663|P1|STARTED|Overall Study||89
266736|NCT01104493|643669|P2|NOT COMPLETED|Overall Study||2
266737|NCT01104493|643670|P1|NOT COMPLETED|Overall Study||0
266738|NCT01104493|643669|P2|COMPLETED|Overall Study||58
266739|NCT01104493|643670|P1|COMPLETED|Overall Study||240
266740|NCT01104493|643669|P2|STARTED|Overall Study||60
266741|NCT01104493|643670|P1|STARTED|Overall Study||240
266742|NCT01104558|643688|P1|NOT COMPLETED|Overall Study||17
266743|NCT01104558|643688|P1|COMPLETED|Overall Study||83
266744|NCT01104558|643688|P1|STARTED|Overall Study||100
266745|NCT01104584|643729|P1|NOT COMPLETED|Overall Study||23
266746|NCT01104584|643729|P1|COMPLETED|Overall Study|study course completed|437
266747|NCT01104584|643729|P1|Fulfilled Requirements of FAS Population|Overall Study||397
266748|NCT01104584|643729|P1|Received Treatment|Overall Study|treatment started|439
266749|NCT01104584|643729|P1|STARTED|Overall Study|screened and enrolled|460
266750|NCT01110135|643799|P1|NOT COMPLETED|Overall Study||9
266751|NCT01110135|643799|P1|COMPLETED|Overall Study||34
266752|NCT01110135|643799|P1|STARTED|Overall Study||43
266753|NCT01110187|643805|P2|NOT COMPLETED|Overall Study||0
266754|NCT01110187|643806|P1|NOT COMPLETED|Overall Study||0
266755|NCT01110187|643805|P2|COMPLETED|Overall Study|completed 7 day treatment|4
266756|NCT01110187|643806|P1|COMPLETED|Overall Study|completed 7 day treatment|7
266757|NCT01110187|643805|P2|STARTED|Overall Study||4
266758|NCT01110187|643806|P1|STARTED|Overall Study||7
266759|NCT01110200|643816|P2|NOT COMPLETED|Overall Study||121
266760|NCT01110200|643817|P1|NOT COMPLETED|Overall Study||106
266761|NCT01110200|643816|P2|COMPLETED|Overall Study||204
266762|NCT01110200|643817|P1|COMPLETED|Overall Study||208
266763|NCT01110200|643816|P2|STARTED|Overall Study||325
266764|NCT01110200|643817|P1|STARTED|Overall Study||314
266765|NCT01110239|643835|P4|NOT COMPLETED|10 Min Ischemia||0
266766|NCT01110239|643836|P3|NOT COMPLETED|10 Min Ischemia||0
266767|NCT01110239|643837|P2|NOT COMPLETED|10 Min Ischemia||0
266768|NCT01110239|643838|P1|NOT COMPLETED|10 Min Ischemia||0
266769|NCT01110239|643835|P4|COMPLETED|10 Min Ischemia||6
266770|NCT01110239|643836|P3|COMPLETED|10 Min Ischemia||0
266771|NCT01110239|643837|P2|COMPLETED|10 Min Ischemia||0
266772|NCT01110239|643838|P1|COMPLETED|10 Min Ischemia||0
266773|NCT01110239|643835|P4|STARTED|10 Min Ischemia||6
266774|NCT01110239|643836|P3|STARTED|10 Min Ischemia||0
266775|NCT01110239|643837|P2|STARTED|10 Min Ischemia||0
266776|NCT01110239|643838|P1|STARTED|10 Min Ischemia||0
266777|NCT01110239|643835|P4|NOT COMPLETED|7.5 Min Ischemia||0
266778|NCT01110239|643836|P3|NOT COMPLETED|7.5 Min Ischemia||1
266779|NCT01110239|643837|P2|NOT COMPLETED|7.5 Min Ischemia||0
266780|NCT01110239|643838|P1|NOT COMPLETED|7.5 Min Ischemia||0
266781|NCT01110239|643835|P4|COMPLETED|7.5 Min Ischemia||0
266782|NCT01110239|643836|P3|COMPLETED|7.5 Min Ischemia||6
266783|NCT01110239|643837|P2|COMPLETED|7.5 Min Ischemia||0
266784|NCT01110239|643838|P1|COMPLETED|7.5 Min Ischemia||0
266785|NCT01110239|643835|P4|STARTED|7.5 Min Ischemia||0
266786|NCT01110239|643836|P3|STARTED|7.5 Min Ischemia||7
266787|NCT01110239|643837|P2|STARTED|7.5 Min Ischemia||0
266788|NCT01110239|643838|P1|STARTED|7.5 Min Ischemia||0
266789|NCT01110239|643835|P4|NOT COMPLETED|5 Min Ischemia||0
266790|NCT01110239|643836|P3|NOT COMPLETED|5 Min Ischemia||0
266791|NCT01110239|643837|P2|NOT COMPLETED|5 Min Ischemia||14
266792|NCT01110239|643838|P1|NOT COMPLETED|5 Min Ischemia||0
266793|NCT01110239|643835|P4|COMPLETED|5 Min Ischemia||0
266794|NCT01110239|643836|P3|COMPLETED|5 Min Ischemia||0
266795|NCT01110239|643837|P2|COMPLETED|5 Min Ischemia||0
266796|NCT01110239|643838|P1|COMPLETED|5 Min Ischemia||0
266797|NCT01110239|643835|P4|STARTED|5 Min Ischemia||0
266798|NCT01110239|643836|P3|STARTED|5 Min Ischemia||0
266799|NCT01110239|643837|P2|STARTED|5 Min Ischemia||14
266800|NCT01110239|643838|P1|STARTED|5 Min Ischemia||0
266801|NCT01110239|643835|P4|NOT COMPLETED|Sham Preconditioning||0
266802|NCT01110239|643836|P3|NOT COMPLETED|Sham Preconditioning||1
266803|NCT01110239|643837|P2|NOT COMPLETED|Sham Preconditioning||0
266804|NCT01110239|643838|P1|NOT COMPLETED|Sham Preconditioning||0
266805|NCT01110239|643835|P4|COMPLETED|Sham Preconditioning||6
266806|NCT01110239|643836|P3|COMPLETED|Sham Preconditioning||6
266807|NCT01110239|643837|P2|COMPLETED|Sham Preconditioning||14
266808|NCT01110239|643838|P1|COMPLETED|Sham Preconditioning||7
266809|NCT01110239|643835|P4|STARTED|Sham Preconditioning||6
266810|NCT01110239|643836|P3|STARTED|Sham Preconditioning||7
266811|NCT01110239|643837|P2|STARTED|Sham Preconditioning||14
266812|NCT01110239|643838|P1|STARTED|Sham Preconditioning||7
266813|NCT01110252|643852|P1|NOT COMPLETED|Post-procedure (Stem Cells Infusion)||0
266814|NCT01110252|643852|P1|COMPLETED|Post-procedure (Stem Cells Infusion)||4
266815|NCT01110252|643852|P1|STARTED|Post-procedure (Stem Cells Infusion)||4
266816|NCT01110252|643852|P1|NOT COMPLETED|Pre-procedure (Stem Cells Infusion)||0
266817|NCT01110252|643852|P1|COMPLETED|Pre-procedure (Stem Cells Infusion)||4
266818|NCT01110252|643852|P1|STARTED|Pre-procedure (Stem Cells Infusion)||4
266819|NCT01110330|643868|P3|NOT COMPLETED|Overall Study||26
266820|NCT01110330|643869|P2|NOT COMPLETED|Overall Study||23
266821|NCT01110330|643870|P1|NOT COMPLETED|Overall Study||15
266822|NCT01110330|643868|P3|COMPLETED|Overall Study||208
266823|NCT01110330|643869|P2|COMPLETED|Overall Study||207
266824|NCT01110330|643870|P1|COMPLETED|Overall Study||104
266825|NCT01110330|643868|P3|Positive Baseline Culture Set|Overall Study||114
266826|NCT01110330|643869|P2|Positive Baseline Culture Set|Overall Study||111
266827|NCT01110330|643870|P1|Positive Baseline Culture Set|Overall Study||56
266828|NCT01110330|643868|P3|STARTED|Overall Study||234
266829|NCT01110330|643869|P2|STARTED|Overall Study||230
266830|NCT01110330|643870|P1|STARTED|Overall Study||119
266831|NCT01110382|643883|P2|NOT COMPLETED|Overall Study||2
266832|NCT01110382|643884|P1|NOT COMPLETED|Overall Study||0
266833|NCT01110382|643883|P2|COMPLETED|Overall Study||8
266834|NCT01110382|643884|P1|COMPLETED|Overall Study||31
266835|NCT01110382|643883|P2|STARTED|Overall Study||10
266836|NCT01110382|643884|P1|STARTED|Overall Study||31
266837|NCT01110408|643904|P2|NOT COMPLETED|Overall Study||0
266838|NCT01110408|643905|P1|NOT COMPLETED|Overall Study||1
266839|NCT01110408|643904|P2|COMPLETED|Overall Study||10
266840|NCT01110408|643905|P1|COMPLETED|Overall Study||30
266841|NCT01110408|643904|P2|STARTED|Overall Study||10
266842|NCT01110408|643905|P1|STARTED|Overall Study||31
266843|NCT01110421|643925|P2|NOT COMPLETED|Overall Study||0
266844|NCT01110421|643926|P1|NOT COMPLETED|Overall Study||0
266845|NCT01110421|643925|P2|COMPLETED|Overall Study||2
266846|NCT01110421|643926|P1|COMPLETED|Overall Study|Includes 1 participant who discontinued study drug due to an adverse event of empyema on Days 9-13.|5
266847|NCT01110421|643925|P2|STARTED|Overall Study||2
266848|NCT01110421|643926|P1|STARTED|Overall Study||5
266849|NCT01111838|643944|P1|NOT COMPLETED|Overall Study||7
266850|NCT01111838|643944|P1|COMPLETED|Overall Study||15
266851|NCT01111838|643944|P1|STARTED|Overall Study||22
266852|NCT01111851|643950|P2|NOT COMPLETED|Overall Study||0
266853|NCT01111851|643951|P1|NOT COMPLETED|Overall Study||2
266854|NCT01111851|643950|P2|COMPLETED|Overall Study||8
266855|NCT01111851|643951|P1|COMPLETED|Overall Study||6
266856|NCT01111851|643950|P2|STARTED|Overall Study||8
266857|NCT01111851|643951|P1|STARTED|Overall Study||8
266858|NCT01112059|643965|P2|NOT COMPLETED|Overall Study||0
266859|NCT01112059|643966|P1|NOT COMPLETED|Overall Study||1
266860|NCT01112059|643965|P2|COMPLETED|Overall Study||20
266861|NCT01112059|643966|P1|COMPLETED|Overall Study||19
266862|NCT01112059|643965|P2|STARTED|Overall Study||20
266863|NCT01112059|643966|P1|STARTED|Overall Study||20
266864|NCT01112241|643978|P1|NOT COMPLETED|Overall Study||0
266865|NCT01112241|643978|P1|COMPLETED|Overall Study||17
266866|NCT01112241|643978|P1|STARTED|Overall Study||17
266867|NCT01112267|643993|P2|NOT COMPLETED|Overall Study||18
266868|NCT01112267|643994|P1|NOT COMPLETED|Overall Study||34
266869|NCT01112267|643993|P2|COMPLETED|Overall Study||104
266870|NCT01112267|643994|P1|COMPLETED|Overall Study||92
266871|NCT01112267|643993|P2|Treated|Overall Study||120
266872|NCT01112267|643994|P1|Treated|Overall Study||125
266873|NCT01112267|643993|P2|STARTED|Overall Study||122
266874|NCT01112267|643994|P1|STARTED|Overall Study||126
266875|NCT01112514|644012|P1|NOT COMPLETED|Overall Study||1
266876|NCT01112514|644012|P1|COMPLETED|Overall Study||3
266877|NCT01112514|644012|P1|STARTED|Overall Study||4
266878|NCT01112579|644018|P2|NOT COMPLETED|Overall Study||3
266879|NCT01112579|644019|P1|NOT COMPLETED|Overall Study||1
266880|NCT01112579|644018|P2|COMPLETED|Overall Study||21
266881|NCT01112579|644019|P1|COMPLETED|Overall Study||41
266882|NCT01112579|644018|P2|STARTED|Overall Study||24
266883|NCT01112579|644019|P1|STARTED|Overall Study||42
266884|NCT01112670|644029|P6|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266885|NCT01112670|644030|P5|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266886|NCT01112670|644031|P4|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266887|NCT01112670|644032|P3|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266973|NCT01113632|644186|P2|COMPLETED|Overall Study||19
266888|NCT01112670|644033|P2|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266889|NCT01112670|644034|P1|NOT COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266890|NCT01112670|644029|P6|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||5
266891|NCT01112670|644030|P5|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266892|NCT01112670|644031|P4|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||4
266893|NCT01112670|644032|P3|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266894|NCT01112670|644033|P2|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||3
266895|NCT01112670|644034|P1|COMPLETED|Sitagliptin+Atorvastatin to Sitagliptin||0
266896|NCT01112670|644029|P6|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||5
266897|NCT01112670|644030|P5|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
266898|NCT01112670|644031|P4|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||4
266899|NCT01112670|644032|P3|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
266900|NCT01112670|644033|P2|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||3
266901|NCT01112670|644034|P1|STARTED|Sitagliptin+Atorvastatin to Sitagliptin||0
266902|NCT01112670|644029|P6|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
266903|NCT01112670|644030|P5|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
266904|NCT01112670|644031|P4|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
266905|NCT01112670|644032|P3|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
266906|NCT01112670|644033|P2|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
266907|NCT01112670|644034|P1|NOT COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||1
266908|NCT01112670|644029|P6|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
266909|NCT01112670|644030|P5|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||5
266910|NCT01112670|644031|P4|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
266911|NCT01112670|644032|P3|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||6
266912|NCT01112670|644033|P2|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||0
266913|NCT01112670|644034|P1|COMPLETED|Sitagliptin to Sitagliptin+Atorvastatin||7
266914|NCT01112670|644029|P6|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
266915|NCT01112670|644030|P5|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||6
266916|NCT01112670|644031|P4|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
266917|NCT01112670|644032|P3|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||7
266918|NCT01112670|644033|P2|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||0
266919|NCT01112670|644034|P1|STARTED|Sitagliptin to Sitagliptin+Atorvastatin||8
266920|NCT01112683|644072|P2|NOT COMPLETED|Overall Study||1
266921|NCT01112683|644073|P1|NOT COMPLETED|Overall Study||1
266922|NCT01112683|644072|P2|COMPLETED|Overall Study||19
266923|NCT01112683|644073|P1|COMPLETED|Overall Study||18
266924|NCT01112683|644072|P2|STARTED|Overall Study||20
266925|NCT01112683|644073|P1|STARTED|Overall Study||19
266926|NCT01112696|644083|P1|NOT COMPLETED|Overall Study||2
266927|NCT01112696|644083|P1|COMPLETED|Overall Study||98
266928|NCT01112696|644083|P1|STARTED|Overall Study||100
266929|NCT01112865|644087|P2|NOT COMPLETED|Second Intervention||0
266930|NCT01112865|644088|P1|NOT COMPLETED|Second Intervention||0
266931|NCT01112865|644087|P2|COMPLETED|Second Intervention||61
266932|NCT01112865|644088|P1|COMPLETED|Second Intervention||59
266933|NCT01112865|644087|P2|STARTED|Second Intervention||61
266934|NCT01112865|644088|P1|STARTED|Second Intervention||59
266935|NCT01112865|644087|P2|NOT COMPLETED|First Intervention||0
266936|NCT01112865|644088|P1|NOT COMPLETED|First Intervention||0
266937|NCT01112865|644087|P2|COMPLETED|First Intervention||61
266938|NCT01112865|644088|P1|COMPLETED|First Intervention||59
266939|NCT01112865|644087|P2|STARTED|First Intervention||61
266940|NCT01112865|644088|P1|STARTED|First Intervention||59
266941|NCT01112917|644098|P2|NOT COMPLETED|Overall Study||15
266942|NCT01112917|644099|P1|NOT COMPLETED|Overall Study||7
266943|NCT01112917|644098|P2|COMPLETED|Overall Study||38
266944|NCT01112917|644099|P1|COMPLETED|Overall Study||89
266945|NCT01112917|644098|P2|STARTED|Overall Study||53
266946|NCT01112917|644099|P1|STARTED|Overall Study||96
266947|NCT01113008|644106|P2|NOT COMPLETED|Overall Study||0
266948|NCT01113008|644107|P1|NOT COMPLETED|Overall Study||0
266949|NCT01113008|644106|P2|COMPLETED|Overall Study||133
266950|NCT01113008|644107|P1|COMPLETED|Overall Study||133
266951|NCT01113008|644106|P2|STARTED|Overall Study||133
266952|NCT01113008|644107|P1|STARTED|Overall Study||133
266953|NCT01113385|644117|P1|NOT COMPLETED|Overall Study||0
266954|NCT01113385|644117|P1|COMPLETED|Overall Study||7
266955|NCT01113385|644117|P1|STARTED|Overall Study||7
266956|NCT01113398|644122|P1|NOT COMPLETED|Overall Study||0
266957|NCT01113398|644122|P1|COMPLETED|Overall Study|Completed= Discontinued study drug due to disease progression, death, toxicity or any other reason|36
266958|NCT01113398|644122|P1|STARTED|Overall Study||36
266959|NCT01113463|644129|P1|NOT COMPLETED|Overall Study||5
266960|NCT01113463|644129|P1|COMPLETED|Overall Study||12
266961|NCT01113463|644129|P1|STARTED|Overall Study||17
266962|NCT01113541|644134|P1|NOT COMPLETED|Overall Study||13
266963|NCT01113541|644134|P1|COMPLETED|Overall Study||0
266964|NCT01113541|644134|P1|STARTED|Overall Study||13
266965|NCT01113580|644169|P2|NOT COMPLETED|Overall Study||0
266966|NCT01113580|644170|P1|NOT COMPLETED|Overall Study||1
266967|NCT01113580|644169|P2|COMPLETED|Overall Study||60
266968|NCT01113580|644170|P1|COMPLETED|Overall Study||59
266969|NCT01113580|644169|P2|STARTED|Overall Study||60
266970|NCT01113580|644170|P1|STARTED|Overall Study||60
266971|NCT01113632|644186|P2|NOT COMPLETED|Overall Study||25
266972|NCT01113632|644187|P1|NOT COMPLETED|Overall Study||31
266974|NCT01113632|644187|P1|COMPLETED|Overall Study||2
266975|NCT01113632|644186|P2|STARTED|Overall Study||44
266976|NCT01113632|644187|P1|STARTED|Overall Study||33
266977|NCT01113710|644201|P1|NOT COMPLETED|Overall Study||269
266978|NCT01113710|644201|P1|COMPLETED|Overall Study|"Discontinued reasons for Other are listed in the Participant Flow."|418
266979|NCT01113710|644201|P1|STARTED|Overall Study|See Additional Study Description for further information regarding withdrawal due to Adverse Event.|687
266980|NCT01113723|644212|P2|NOT COMPLETED|Overall Study||0
266981|NCT01113723|644213|P1|NOT COMPLETED|Overall Study||0
266982|NCT01113723|644212|P2|COMPLETED|Overall Study||70
266983|NCT01113723|644213|P1|COMPLETED|Overall Study||70
266984|NCT01113723|644212|P2|STARTED|Overall Study||70
266985|NCT01113723|644213|P1|STARTED|Overall Study||70
266986|NCT01113749|644225|P2|NOT COMPLETED|Overall Study||2
266987|NCT01113749|644226|P1|NOT COMPLETED|Overall Study||1
266988|NCT01113749|644225|P2|COMPLETED|Overall Study||127
266989|NCT01113749|644226|P1|COMPLETED|Overall Study||126
266990|NCT01113749|644225|P2|STARTED|Overall Study||129
266991|NCT01113749|644226|P1|STARTED|Overall Study||127
266992|NCT01113931|644238|P2|NOT COMPLETED|Overall Study||17
266993|NCT01113931|644239|P1|NOT COMPLETED|Overall Study||19
266994|NCT01113931|644238|P2|COMPLETED|Overall Study||231
266995|NCT01113931|644239|P1|COMPLETED|Overall Study||228
266996|NCT01113931|644238|P2|mITT Population|Overall Study||190
266997|NCT01113931|644239|P1|mITT Population|Overall Study||188
266998|NCT01113931|644238|P2|Safety Population|Overall Study||248
266999|NCT01113931|644239|P1|Safety Population|Overall Study|1 subject did not take any study medication|246
267000|NCT01113931|644238|P2|STARTED|Overall Study||248
267001|NCT01113931|644239|P1|STARTED|Overall Study||247
267002|NCT01107457|644256|P6|NOT COMPLETED|Part B and C||120
267003|NCT01107457|644257|P5|NOT COMPLETED|Part B and C||0
267004|NCT01107457|644258|P4|NOT COMPLETED|Part B and C||0
267005|NCT01107457|644259|P3|NOT COMPLETED|Part B and C||0
267006|NCT01107457|644260|P2|NOT COMPLETED|Part B and C||0
267007|NCT01107457|644261|P1|NOT COMPLETED|Part B and C||0
267008|NCT01107457|644256|P6|COMPLETED|Part B and C|No participants completed the study as Part C was stopped.|0
267009|NCT01107457|644257|P5|COMPLETED|Part B and C||0
267010|NCT01107457|644258|P4|COMPLETED|Part B and C||0
267011|NCT01107457|644259|P3|COMPLETED|Part B and C||0
267012|NCT01107457|644260|P2|COMPLETED|Part B and C||0
267013|NCT01107457|644261|P1|COMPLETED|Part B and C||0
267014|NCT01107457|644256|P6|Post Treatment Safety Visits|Part B and C|Only participants with neutropenia entered the post treatment safety visits.|6
267015|NCT01107457|644257|P5|Post Treatment Safety Visits|Part B and C||0
267016|NCT01107457|644258|P4|Post Treatment Safety Visits|Part B and C||0
267017|NCT01107457|644259|P3|Post Treatment Safety Visits|Part B and C||0
267018|NCT01107457|644260|P2|Post Treatment Safety Visits|Part B and C||0
267019|NCT01107457|644261|P1|Post Treatment Safety Visits|Part B and C||0
267020|NCT01107457|644256|P6|Completed Part C|Part B and C|Part C was stopped once ixekizumab became available through marketing authorization.|0
267021|NCT01107457|644257|P5|Completed Part C|Part B and C||0
267022|NCT01107457|644258|P4|Completed Part C|Part B and C||0
267023|NCT01107457|644259|P3|Completed Part C|Part B and C||0
267024|NCT01107457|644260|P2|Completed Part C|Part B and C||0
267025|NCT01107457|644261|P1|Completed Part C|Part B and C||0
267026|NCT01107457|644256|P6|Completed Part B (Week 240)|Part B and C||74
267027|NCT01107457|644257|P5|Completed Part B (Week 240)|Part B and C||0
267028|NCT01107457|644258|P4|Completed Part B (Week 240)|Part B and C||0
267029|NCT01107457|644259|P3|Completed Part B (Week 240)|Part B and C||0
267030|NCT01107457|644260|P2|Completed Part B (Week 240)|Part B and C||0
267031|NCT01107457|644261|P1|Completed Part B (Week 240)|Part B and C||0
267032|NCT01107457|644256|P6|STARTED|Part B and C|80 and 120 mg ixekizumab were administered during Part B and C.|120
267033|NCT01107457|644257|P5|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
267034|NCT01107457|644258|P4|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
267035|NCT01107457|644259|P3|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
267036|NCT01107457|644260|P2|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
267037|NCT01107457|644261|P1|STARTED|Part B and C|Placebo,10mg, 25mg,75mg and 150mg ixekizumab were administered during in Part A.|0
267038|NCT01107457|644256|P6|NOT COMPLETED|Part A||0
267039|NCT01107457|644257|P5|NOT COMPLETED|Part A||1
267040|NCT01107457|644258|P4|NOT COMPLETED|Part A||3
267041|NCT01107457|644259|P3|NOT COMPLETED|Part A||1
267042|NCT01107457|644260|P2|NOT COMPLETED|Part A||7
267043|NCT01107457|644261|P1|NOT COMPLETED|Part A||5
267044|NCT01107457|644256|P6|COMPLETED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
267045|NCT01107457|644257|P5|COMPLETED|Part A||27
267046|NCT01107457|644258|P4|COMPLETED|Part A||26
267047|NCT01107457|644259|P3|COMPLETED|Part A||29
267048|NCT01107457|644260|P2|COMPLETED|Part A||21
267049|NCT01107457|644261|P1|COMPLETED|Part A||22
267050|NCT01107457|644256|P6|Received at Least 1 Dose of Study Drug|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
267051|NCT01107457|644257|P5|Received at Least 1 Dose of Study Drug|Part A||28
267052|NCT01107457|644258|P4|Received at Least 1 Dose of Study Drug|Part A||29
267053|NCT01107457|644259|P3|Received at Least 1 Dose of Study Drug|Part A||30
267054|NCT01107457|644260|P2|Received at Least 1 Dose of Study Drug|Part A||28
267055|NCT01107457|644261|P1|Received at Least 1 Dose of Study Drug|Part A||27
267056|NCT01107457|644256|P6|STARTED|Part A|120 mg and 80 mg ixekizumab were administered during Part B and C.|0
267057|NCT01107457|644257|P5|STARTED|Part A||28
267058|NCT01107457|644258|P4|STARTED|Part A||29
267059|NCT01107457|644259|P3|STARTED|Part A||30
267060|NCT01107457|644260|P2|STARTED|Part A||28
267061|NCT01107457|644261|P1|STARTED|Part A||27
267062|NCT01107535|644387|P1|NOT COMPLETED|Overall Study||5
267063|NCT01107535|644387|P1|COMPLETED|Overall Study||77
267064|NCT01107535|644387|P1|Number of Participants Analyzed|Overall Study||82
267065|NCT01107535|644387|P1|STARTED|Overall Study||82
267066|NCT01114334|644397|P2|NOT COMPLETED|Overall Study||22
267067|NCT01114334|644398|P1|NOT COMPLETED|Overall Study||21
267068|NCT01114334|644397|P2|COMPLETED|Overall Study||58
267069|NCT01114334|644398|P1|COMPLETED|Overall Study||67
267070|NCT01114334|644397|P2|STARTED|Overall Study||80
267071|NCT01114334|644398|P1|STARTED|Overall Study||88
267072|NCT01114360|644408|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||0
267073|NCT01114360|644409|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
267074|NCT01114360|644408|P2|COMPLETED|Intervention 2 (4 Weeks)||18
267075|NCT01114360|644409|P1|COMPLETED|Intervention 2 (4 Weeks)||18
267076|NCT01114360|644408|P2|STARTED|Intervention 2 (4 Weeks)||18
267077|NCT01114360|644409|P1|STARTED|Intervention 2 (4 Weeks)||18
267078|NCT01114360|644408|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||1
267079|NCT01114360|644409|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||0
267080|NCT01114360|644408|P2|COMPLETED|Intervention 1 (4 Weeks)||18
267081|NCT01114360|644409|P1|COMPLETED|Intervention 1 (4 Weeks)||18
267082|NCT01114360|644408|P2|STARTED|Intervention 1 (4 Weeks)||19
267083|NCT01114360|644409|P1|STARTED|Intervention 1 (4 Weeks)||18
267084|NCT01114373|644445|P2|NOT COMPLETED|Intervention 2 (4 Weeks)||1
267085|NCT01114373|644446|P1|NOT COMPLETED|Intervention 2 (4 Weeks)||0
267086|NCT01114373|644445|P2|COMPLETED|Intervention 2 (4 Weeks)||18
267087|NCT01114373|644446|P1|COMPLETED|Intervention 2 (4 Weeks)||18
267088|NCT01114373|644445|P2|STARTED|Intervention 2 (4 Weeks)||19
267089|NCT01114373|644446|P1|STARTED|Intervention 2 (4 Weeks)||18
267090|NCT01114373|644445|P2|NOT COMPLETED|Intervention 1 (4 Weeks)||0
267091|NCT01114373|644446|P1|NOT COMPLETED|Intervention 1 (4 Weeks)||3
267092|NCT01114373|644445|P2|COMPLETED|Intervention 1 (4 Weeks)||19
267093|NCT01114373|644446|P1|COMPLETED|Intervention 1 (4 Weeks)||18
267094|NCT01114373|644445|P2|STARTED|Intervention 1 (4 Weeks)||19
267095|NCT01114373|644446|P1|STARTED|Intervention 1 (4 Weeks)||21
267096|NCT01114581|644480|P2|NOT COMPLETED|Overall Study||0
267097|NCT01114581|644481|P1|NOT COMPLETED|Overall Study||0
267098|NCT01114581|644480|P2|COMPLETED|Overall Study||19
267099|NCT01114581|644481|P1|COMPLETED|Overall Study||19
267100|NCT01114581|644480|P2|STARTED|Overall Study||19
267101|NCT01114581|644481|P1|STARTED|Overall Study||19
267102|NCT01114672|644491|P2|NOT COMPLETED|Overall Study||2
267103|NCT01114672|644492|P1|NOT COMPLETED|Overall Study||4
267104|NCT01114672|644491|P2|COMPLETED|Overall Study||23
267105|NCT01114672|644492|P1|COMPLETED|Overall Study||21
267106|NCT01114672|644491|P2|STARTED|Overall Study||25
267107|NCT01114672|644492|P1|STARTED|Overall Study||25
267108|NCT01114724|644498|P1|NOT COMPLETED|Overall Study||10
267109|NCT01114724|644498|P1|COMPLETED|Overall Study||40
267110|NCT01114724|644498|P1|STARTED|Overall Study||50
267111|NCT01114737|644518|P2|NOT COMPLETED|Open-Label Treatment Period||2
267112|NCT01114737|644519|P1|NOT COMPLETED|Open-Label Treatment Period||5
267113|NCT01114737|644518|P2|COMPLETED|Open-Label Treatment Period||95
267114|NCT01114737|644519|P1|COMPLETED|Open-Label Treatment Period||100
267115|NCT01114737|644518|P2|STARTED|Open-Label Treatment Period|Two subjects did not receive a single dose of the study drug|97
267116|NCT01114737|644519|P1|STARTED|Open-Label Treatment Period|One subject did not receive a single dose of the study drug|105
267117|NCT01114737|644518|P2|NOT COMPLETED|Randomized Treatment Period||1
267118|NCT01114737|644519|P1|NOT COMPLETED|Randomized Treatment Period||3
267119|NCT01114737|644518|P2|COMPLETED|Randomized Treatment Period||97
267120|NCT01114737|644519|P1|COMPLETED|Randomized Treatment Period||105
267121|NCT01114737|644518|P2|STARTED|Randomized Treatment Period||98
267122|NCT01114737|644519|P1|STARTED|Randomized Treatment Period||108
267123|NCT01114828|644569|P2|NOT COMPLETED|Overall Study||4
267124|NCT01114828|644570|P1|NOT COMPLETED|Overall Study||3
267125|NCT01114828|644569|P2|COMPLETED|Overall Study||17
267126|NCT01114828|644570|P1|COMPLETED|Overall Study||16
267127|NCT01114828|644569|P2|STARTED|Overall Study||21
267128|NCT01114828|644570|P1|STARTED|Overall Study||19
267129|NCT01114880|644580|P2|NOT COMPLETED|Period 2 (Week 12 to Week 24)||2
267130|NCT01114880|644581|P1|NOT COMPLETED|Period 2 (Week 12 to Week 24)||3
267131|NCT01114880|644580|P2|COMPLETED|Period 2 (Week 12 to Week 24)||111
267132|NCT01114880|644581|P1|COMPLETED|Period 2 (Week 12 to Week 24)||221
267133|NCT01114880|644580|P2|STARTED|Period 2 (Week 12 to Week 24)||113
267134|NCT01114880|644581|P1|STARTED|Period 2 (Week 12 to Week 24)||224
267135|NCT01114880|644580|P2|NOT COMPLETED|Period 1 (Week 0 to Week 12)||2
267136|NCT01114880|644581|P1|NOT COMPLETED|Period 1 (Week 0 to Week 12)||5
267137|NCT01114880|644580|P2|COMPLETED|Period 1 (Week 0 to Week 12)||113
267138|NCT01114880|644581|P1|COMPLETED|Period 1 (Week 0 to Week 12)||224
267139|NCT01114880|644580|P2|STARTED|Period 1 (Week 0 to Week 12)||115
267140|NCT01114880|644581|P1|STARTED|Period 1 (Week 0 to Week 12)||229
267141|NCT01114893|644636|P5|NOT COMPLETED|Overall Study||0
267142|NCT01114893|644637|P4|NOT COMPLETED|Overall Study||0
267143|NCT01114893|644638|P3|NOT COMPLETED|Overall Study||0
267144|NCT01114893|644639|P2|NOT COMPLETED|Overall Study||0
267145|NCT01114893|644640|P1|NOT COMPLETED|Overall Study||0
267146|NCT01114893|644636|P5|COMPLETED|Overall Study||12
267147|NCT01114893|644637|P4|COMPLETED|Overall Study||13
267148|NCT01114893|644638|P3|COMPLETED|Overall Study||14
267149|NCT01114893|644639|P2|COMPLETED|Overall Study||14
267150|NCT01114893|644640|P1|COMPLETED|Overall Study||14
267151|NCT01114893|644636|P5|STARTED|Overall Study||12
267152|NCT01114893|644637|P4|STARTED|Overall Study||13
267153|NCT01114893|644638|P3|STARTED|Overall Study||14
267154|NCT01114893|644639|P2|STARTED|Overall Study||14
267155|NCT01114893|644640|P1|STARTED|Overall Study||14
267156|NCT01114945|644661|P4|NOT COMPLETED|Overall Study||0
267157|NCT01114945|644662|P3|NOT COMPLETED|Overall Study||0
267158|NCT01114945|644663|P2|NOT COMPLETED|Overall Study||0
267159|NCT01114945|644664|P1|NOT COMPLETED|Overall Study||0
267160|NCT01114945|644661|P4|COMPLETED|Overall Study||31
267161|NCT01114945|644662|P3|COMPLETED|Overall Study||30
267162|NCT01114945|644663|P2|COMPLETED|Overall Study||30
267163|NCT01114945|644664|P1|COMPLETED|Overall Study||30
267164|NCT01114945|644661|P4|STARTED|Overall Study||31
267165|NCT01114945|644662|P3|STARTED|Overall Study||30
267166|NCT01114945|644663|P2|STARTED|Overall Study||30
267167|NCT01114945|644664|P1|STARTED|Overall Study||30
267168|NCT01114997|644689|P3|NOT COMPLETED|Overall Study||0
267169|NCT01114997|644690|P2|NOT COMPLETED|Overall Study||0
267170|NCT01114997|644691|P1|NOT COMPLETED|Overall Study||0
267171|NCT01114997|644689|P3|COMPLETED|Overall Study||11
267172|NCT01114997|644690|P2|COMPLETED|Overall Study||10
267173|NCT01114997|644691|P1|COMPLETED|Overall Study||11
267174|NCT01114997|644689|P3|STARTED|Overall Study||11
267175|NCT01114997|644690|P2|STARTED|Overall Study||10
267176|NCT01114997|644691|P1|STARTED|Overall Study||11
267177|NCT01115101|644719|P2|NOT COMPLETED|Overall Study||0
267178|NCT01115101|644720|P1|NOT COMPLETED|Overall Study||0
267179|NCT01115101|644719|P2|COMPLETED|Overall Study||126
267180|NCT01115101|644720|P1|COMPLETED|Overall Study||113
267181|NCT01115101|644719|P2|STARTED|Overall Study||126
267182|NCT01115101|644720|P1|STARTED|Overall Study||113
267183|NCT01115166|644726|P1|NOT COMPLETED|Overall Study||0
267184|NCT01115166|644726|P1|COMPLETED|Overall Study||10
267185|NCT01115166|644726|P1|STARTED|Overall Study||10
267186|NCT01115452|644732|P1|NOT COMPLETED|Overall Study||0
267187|NCT01115452|644732|P1|COMPLETED|Overall Study||32
267188|NCT01115452|644732|P1|STARTED|Overall Study||32
267189|NCT01115491|644782|P1|NOT COMPLETED|Overall Study||30
267190|NCT01115491|644782|P1|COMPLETED|Overall Study||2
267191|NCT01115491|644782|P1|STARTED|Overall Study||32
267192|NCT01115517|644793|P2|NOT COMPLETED|Overall Study||5
267193|NCT01115517|644794|P1|NOT COMPLETED|Overall Study||4
267194|NCT01115517|644793|P2|COMPLETED|Overall Study||16
267195|NCT01115517|644794|P1|COMPLETED|Overall Study||14
267196|NCT01115517|644793|P2|STARTED|Overall Study||21
267197|NCT01115517|644794|P1|STARTED|Overall Study||18
267198|NCT01115569|644804|P2|NOT COMPLETED|Maintenance Phase||139
267199|NCT01115569|644805|P1|NOT COMPLETED|Maintenance Phase||0
267200|NCT01115569|644804|P2|COMPLETED|Maintenance Phase||285
267201|NCT01115569|644805|P1|COMPLETED|Maintenance Phase||0
267202|NCT01115569|644804|P2|STARTED|Maintenance Phase||424
267203|NCT01115569|644805|P1|STARTED|Maintenance Phase||0
267204|NCT01115569|644804|P2|NOT COMPLETED|Conversion/Titration Phase||0
267205|NCT01115569|644805|P1|NOT COMPLETED|Conversion/Titration Phase||214
267206|NCT01115569|644804|P2|COMPLETED|Conversion/Titration Phase||0
267207|NCT01115569|644805|P1|COMPLETED|Conversion/Titration Phase||424
267208|NCT01115569|644804|P2|STARTED|Conversion/Titration Phase||0
267209|NCT01115569|644805|P1|STARTED|Conversion/Titration Phase||638
267210|NCT01115582|644810|P1|NOT COMPLETED|Overall Study||0
267211|NCT01115582|644810|P1|COMPLETED|Overall Study||16
267212|NCT01115582|644810|P1|STARTED|Overall Study||16
267213|NCT01115660|644821|P2|NOT COMPLETED|Overall Study||0
267214|NCT01115660|644822|P1|NOT COMPLETED|Overall Study||1
267215|NCT01115660|644821|P2|COMPLETED|Overall Study||10
267216|NCT01115660|644822|P1|COMPLETED|Overall Study||19
267217|NCT01115660|644821|P2|STARTED|Overall Study||10
267218|NCT01115660|644822|P1|STARTED|Overall Study||20
267219|NCT01115673|644833|P3|NOT COMPLETED|Overall Study||0
267220|NCT01115673|644834|P2|NOT COMPLETED|Overall Study||0
267221|NCT01115673|644835|P1|NOT COMPLETED|Overall Study||0
267222|NCT01115673|644833|P3|COMPLETED|Overall Study||60
267223|NCT01115673|644834|P2|COMPLETED|Overall Study||241
267224|NCT01115673|644835|P1|COMPLETED|Overall Study||239
267225|NCT01115673|644833|P3|STARTED|Overall Study||60
267226|NCT01115673|644834|P2|STARTED|Overall Study||241
267227|NCT01115673|644835|P1|STARTED|Overall Study||239
267228|NCT01115699|644969|P1|NOT COMPLETED|Overall Study||0
267229|NCT01115699|644969|P1|COMPLETED|Overall Study||2
267230|NCT01115699|644969|P1|STARTED|Overall Study||2
267231|NCT01115738|644977|P3|NOT COMPLETED|Overall Study||27
267232|NCT01115738|644978|P2|NOT COMPLETED|Overall Study||21
267233|NCT01115738|644979|P1|NOT COMPLETED|Overall Study||25
267234|NCT01115738|644977|P3|COMPLETED|Overall Study||62
267235|NCT01115738|644978|P2|COMPLETED|Overall Study||62
267236|NCT01115738|644979|P1|COMPLETED|Overall Study||85
267237|NCT01115738|644977|P3|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|50
267238|NCT01115738|644978|P2|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|47
267239|NCT01115738|644979|P1|Pharmacodynamic (PD) Population|Overall Study|Received prasugrel LD and had at least one evaluable PD measurement after prasugrel LD.|52
267240|NCT01115738|644977|P3|Received Any Treatment|Overall Study||88
267241|NCT01115738|644978|P2|Received Any Treatment|Overall Study||79
267242|NCT01115738|644979|P1|Received Any Treatment|Overall Study||109
267243|NCT01115738|644977|P3|STARTED|Overall Study||89
267244|NCT01115738|644978|P2|STARTED|Overall Study||83
267245|NCT01115738|644979|P1|STARTED|Overall Study||110
267246|NCT01115855|645015|P2|NOT COMPLETED|Overall Study||36
267247|NCT01115855|645016|P1|NOT COMPLETED|Overall Study||36
267248|NCT01115855|645015|P2|COMPLETED|Overall Study||74
267249|NCT01115855|645016|P1|COMPLETED|Overall Study||75
267250|NCT01115855|645015|P2|STARTED|Overall Study||110
267251|NCT01115855|645016|P1|STARTED|Overall Study||111
267252|NCT01115933|645064|P1|NOT COMPLETED|Overall Study||1
267253|NCT01115933|645064|P1|COMPLETED|Overall Study||64
267254|NCT01115933|645064|P1|STARTED|Overall Study||65
267255|NCT01115998|645161|P2|NOT COMPLETED|Overall Study||6
267256|NCT01115998|645162|P1|NOT COMPLETED|Overall Study||6
267257|NCT01115998|645161|P2|COMPLETED|Overall Study||11
267258|NCT01115998|645162|P1|COMPLETED|Overall Study||11
267259|NCT01115998|645161|P2|STARTED|Overall Study||17
267260|NCT01115998|645162|P1|STARTED|Overall Study||17
267261|NCT01116024|645172|P1|NOT COMPLETED|Overall Study||52
267262|NCT01116024|645172|P1|COMPLETED|Overall Study|Patient Enrollment stop date|96
267263|NCT01116024|645172|P1|STARTED|Overall Study|Patient Enrollment start date|148
267264|NCT01116037|645211|P1|NOT COMPLETED|Overall Study||25
267265|NCT01116037|645211|P1|COMPLETED|Overall Study||1
267266|NCT01116037|645211|P1|STARTED|Overall Study||26
267267|NCT01116102|645224|P8|NOT COMPLETED|Overall Study||0
267268|NCT01116102|645225|P7|NOT COMPLETED|Overall Study||0
267269|NCT01116102|645226|P6|NOT COMPLETED|Overall Study||0
267270|NCT01116102|645227|P5|NOT COMPLETED|Overall Study||0
267271|NCT01116102|645228|P4|NOT COMPLETED|Overall Study||0
267272|NCT01116102|645229|P3|NOT COMPLETED|Overall Study||0
267273|NCT01116102|645230|P2|NOT COMPLETED|Overall Study||0
267274|NCT01116102|645231|P1|NOT COMPLETED|Overall Study||0
267275|NCT01116102|645224|P8|COMPLETED|Overall Study||3
267276|NCT01116102|645225|P7|COMPLETED|Overall Study||2
267277|NCT01116102|645226|P6|COMPLETED|Overall Study||2
267278|NCT01116102|645227|P5|COMPLETED|Overall Study||2
267279|NCT01116102|645228|P4|COMPLETED|Overall Study||3
267280|NCT01116102|645229|P3|COMPLETED|Overall Study||3
267281|NCT01116102|645230|P2|COMPLETED|Overall Study||3
267282|NCT01116102|645231|P1|COMPLETED|Overall Study||2
267283|NCT01116102|645224|P8|STARTED|Overall Study||3
267284|NCT01116102|645225|P7|STARTED|Overall Study||2
267285|NCT01116102|645226|P6|STARTED|Overall Study||2
267286|NCT01116102|645227|P5|STARTED|Overall Study||2
267287|NCT01116102|645228|P4|STARTED|Overall Study||3
267288|NCT01116102|645229|P3|STARTED|Overall Study||3
267289|NCT01116102|645230|P2|STARTED|Overall Study||3
267290|NCT01116102|645231|P1|STARTED|Overall Study||2
267291|NCT01116232|645273|P1|NOT COMPLETED|Overall Study||4
267292|NCT01116232|645273|P1|COMPLETED|Overall Study||0
267293|NCT01116232|645273|P1|STARTED|Overall Study||4
267294|NCT01116427|645280|P2|NOT COMPLETED|Extension Phase||2
267295|NCT01116427|645281|P1|NOT COMPLETED|Extension Phase||9
267296|NCT01116427|645280|P2|COMPLETED|Extension Phase||18
267297|NCT01116427|645281|P1|COMPLETED|Extension Phase||29
267298|NCT01116427|645280|P2|STARTED|Extension Phase||20
267299|NCT01116427|645281|P1|STARTED|Extension Phase|One participant that completed core phase did not meet eligibility for Extension Phase|38
267300|NCT01116427|645280|P2|NOT COMPLETED|Core Phase||1
267301|NCT01116427|645281|P1|NOT COMPLETED|Core Phase||5
267302|NCT01116427|645280|P2|COMPLETED|Core Phase||20
267303|NCT01116427|645281|P1|COMPLETED|Core Phase||39
267304|NCT01116427|645280|P2|STARTED|Core Phase||21
267305|NCT01116427|645281|P1|STARTED|Core Phase||44
267306|NCT01116466|645317|P1|NOT COMPLETED|Overall Study||0
267307|NCT01116466|645317|P1|COMPLETED|Overall Study||5
267308|NCT01116466|645317|P1|STARTED|Overall Study||5
267309|NCT01116687|645325|P1|NOT COMPLETED|Overall Study||4
267310|NCT01116687|645325|P1|COMPLETED|Overall Study||33
267311|NCT01116687|645325|P1|STARTED|Overall Study||37
267312|NCT01116882|645334|P2|NOT COMPLETED|12-month||99
267313|NCT01116882|645335|P1|NOT COMPLETED|12-month||267
267314|NCT01116882|645334|P2|COMPLETED|12-month||787
267315|NCT01116882|645335|P1|COMPLETED|12-month||2439
267316|NCT01116882|645334|P2|STARTED|12-month||886
267317|NCT01116882|645335|P1|STARTED|12-month||2706
267318|NCT01116882|645334|P2|NOT COMPLETED|30-day||31
267319|NCT01116882|645335|P1|NOT COMPLETED|30-day||68
267320|NCT01116882|645334|P2|COMPLETED|30-day||886
267321|NCT01116882|645335|P1|COMPLETED|30-day||2706
267322|NCT01116882|645334|P2|STARTED|30-day||917
267323|NCT01116882|645335|P1|STARTED|30-day||2774
267324|NCT01116921|645375|P2|NOT COMPLETED|Overall Study||0
267325|NCT01116921|645376|P1|NOT COMPLETED|Overall Study||0
267326|NCT01116921|645375|P2|COMPLETED|Overall Study||50
267327|NCT01116921|645376|P1|COMPLETED|Overall Study||53
267328|NCT01116921|645375|P2|STARTED|Overall Study||50
267329|NCT01116921|645376|P1|STARTED|Overall Study||53
267330|NCT01116934|645394|P2|NOT COMPLETED|Overall Study||0
267331|NCT01116934|645395|P1|NOT COMPLETED|Overall Study||0
267332|NCT01116934|645394|P2|COMPLETED|Overall Study||9
267333|NCT01116934|645395|P1|COMPLETED|Overall Study||8
267334|NCT01116934|645394|P2|STARTED|Overall Study||9
267335|NCT01116934|645395|P1|STARTED|Overall Study||8
267336|NCT01116986|645433|P32|NOT COMPLETED|Overall Study||3
267337|NCT01116986|645434|P31|NOT COMPLETED|Overall Study||1
267338|NCT01116986|645435|P30|NOT COMPLETED|Overall Study||0
267339|NCT01116986|645436|P29|NOT COMPLETED|Overall Study||0
267340|NCT01116986|645437|P28|NOT COMPLETED|Overall Study||1
267341|NCT01116986|645438|P27|NOT COMPLETED|Overall Study||4
267342|NCT01116986|645439|P26|NOT COMPLETED|Overall Study||0
267343|NCT01116986|645440|P25|NOT COMPLETED|Overall Study||3
267344|NCT01116986|645441|P24|NOT COMPLETED|Overall Study||2
267345|NCT01116986|645442|P23|NOT COMPLETED|Overall Study||4
267346|NCT01116986|645443|P22|NOT COMPLETED|Overall Study||2
267347|NCT01116986|645444|P21|NOT COMPLETED|Overall Study||2
267348|NCT01116986|645445|P20|NOT COMPLETED|Overall Study||2
267349|NCT01116986|645446|P19|NOT COMPLETED|Overall Study||3
267350|NCT01116986|645447|P18|NOT COMPLETED|Overall Study||5
267351|NCT01116986|645448|P17|NOT COMPLETED|Overall Study||3
267352|NCT01116986|645449|P16|NOT COMPLETED|Overall Study||6
267353|NCT01116986|645450|P15|NOT COMPLETED|Overall Study||0
267354|NCT01116986|645451|P14|NOT COMPLETED|Overall Study||3
267355|NCT01116986|645452|P13|NOT COMPLETED|Overall Study||1
267356|NCT01116986|645453|P12|NOT COMPLETED|Overall Study||0
267357|NCT01116986|645454|P11|NOT COMPLETED|Overall Study||1
267358|NCT01116986|645455|P10|NOT COMPLETED|Overall Study||4
267359|NCT01116986|645456|P9|NOT COMPLETED|Overall Study||1
267360|NCT01116986|645457|P8|NOT COMPLETED|Overall Study||2
267361|NCT01116986|645458|P7|NOT COMPLETED|Overall Study||2
267362|NCT01116986|645459|P6|NOT COMPLETED|Overall Study||2
267363|NCT01116986|645460|P5|NOT COMPLETED|Overall Study||4
267364|NCT01116986|645461|P4|NOT COMPLETED|Overall Study||2
267365|NCT01116986|645462|P3|NOT COMPLETED|Overall Study||2
267366|NCT01116986|645463|P2|NOT COMPLETED|Overall Study||3
267367|NCT01116986|645464|P1|NOT COMPLETED|Overall Study||2
267368|NCT01116986|645433|P32|COMPLETED|Overall Study||14
267369|NCT01116986|645434|P31|COMPLETED|Overall Study||16
267370|NCT01116986|645435|P30|COMPLETED|Overall Study||17
267371|NCT01116986|645436|P29|COMPLETED|Overall Study||17
267372|NCT01116986|645437|P28|COMPLETED|Overall Study||18
267373|NCT01116986|645438|P27|COMPLETED|Overall Study||14
267374|NCT01116986|645439|P26|COMPLETED|Overall Study||19
267375|NCT01116986|645440|P25|COMPLETED|Overall Study||15
267376|NCT01116986|645441|P24|COMPLETED|Overall Study||19
267377|NCT01116986|645442|P23|COMPLETED|Overall Study||19
267378|NCT01116986|645443|P22|COMPLETED|Overall Study||18
267379|NCT01116986|645444|P21|COMPLETED|Overall Study||22
267380|NCT01116986|645445|P20|COMPLETED|Overall Study||13
267381|NCT01116986|645446|P19|COMPLETED|Overall Study||20
267382|NCT01116986|645447|P18|COMPLETED|Overall Study||19
267383|NCT01116986|645448|P17|COMPLETED|Overall Study||13
267384|NCT01116986|645449|P16|COMPLETED|Overall Study||15
267385|NCT01116986|645450|P15|COMPLETED|Overall Study||17
267386|NCT01116986|645451|P14|COMPLETED|Overall Study||16
267387|NCT01116986|645452|P13|COMPLETED|Overall Study||16
267388|NCT01116986|645453|P12|COMPLETED|Overall Study||20
267389|NCT01116986|645454|P11|COMPLETED|Overall Study||18
267390|NCT01116986|645455|P10|COMPLETED|Overall Study||19
267391|NCT01116986|645456|P9|COMPLETED|Overall Study||19
267392|NCT01116986|645457|P8|COMPLETED|Overall Study||20
267393|NCT01116986|645458|P7|COMPLETED|Overall Study||20
267394|NCT01116986|645459|P6|COMPLETED|Overall Study||20
267395|NCT01116986|645460|P5|COMPLETED|Overall Study||20
267396|NCT01116986|645461|P4|COMPLETED|Overall Study||20
267397|NCT01116986|645462|P3|COMPLETED|Overall Study||16
267398|NCT01116986|645463|P2|COMPLETED|Overall Study||16
267399|NCT01116986|645464|P1|COMPLETED|Overall Study||22
267400|NCT01116986|645433|P32|STARTED|Overall Study||17
267401|NCT01116986|645434|P31|STARTED|Overall Study||17
267402|NCT01116986|645435|P30|STARTED|Overall Study||17
267403|NCT01116986|645436|P29|STARTED|Overall Study||17
267404|NCT01116986|645437|P28|STARTED|Overall Study||19
267405|NCT01116986|645438|P27|STARTED|Overall Study||18
267406|NCT01116986|645439|P26|STARTED|Overall Study||19
267407|NCT01116986|645440|P25|STARTED|Overall Study||18
267408|NCT01116986|645441|P24|STARTED|Overall Study||21
267409|NCT01116986|645442|P23|STARTED|Overall Study||23
267410|NCT01116986|645443|P22|STARTED|Overall Study||20
267411|NCT01116986|645444|P21|STARTED|Overall Study||24
267412|NCT01116986|645445|P20|STARTED|Overall Study||15
267413|NCT01116986|645446|P19|STARTED|Overall Study||23
267414|NCT01116986|645447|P18|STARTED|Overall Study||24
267415|NCT01116986|645448|P17|STARTED|Overall Study||16
267416|NCT01116986|645449|P16|STARTED|Overall Study||21
267417|NCT01116986|645450|P15|STARTED|Overall Study||17
267418|NCT01116986|645451|P14|STARTED|Overall Study||19
267419|NCT01116986|645452|P13|STARTED|Overall Study||17
267420|NCT01116986|645453|P12|STARTED|Overall Study||20
267421|NCT01116986|645454|P11|STARTED|Overall Study||19
267422|NCT01116986|645455|P10|STARTED|Overall Study||23
267423|NCT01116986|645456|P9|STARTED|Overall Study||20
267424|NCT01116986|645457|P8|STARTED|Overall Study||22
267425|NCT01116986|645458|P7|STARTED|Overall Study||22
267426|NCT01116986|645459|P6|STARTED|Overall Study||22
267427|NCT01116986|645460|P5|STARTED|Overall Study||24
267428|NCT01116986|645461|P4|STARTED|Overall Study||22
267429|NCT01116986|645462|P3|STARTED|Overall Study||18
267430|NCT01116986|645463|P2|STARTED|Overall Study||19
267431|NCT01116986|645464|P1|STARTED|Overall Study||24
267432|NCT01117012|645498|P2|NOT COMPLETED|Overall Study||5
267433|NCT01117012|645499|P1|NOT COMPLETED|Overall Study||8
267434|NCT01117012|645498|P2|COMPLETED|Overall Study||98
267435|NCT01117012|645499|P1|COMPLETED|Overall Study||81
267436|NCT01117012|645498|P2|STARTED|Overall Study||103
267437|NCT01117012|645499|P1|STARTED|Overall Study||89
267438|NCT01117051|645517|P2|NOT COMPLETED|Overall Study||11
267439|NCT01117051|645518|P1|NOT COMPLETED|Overall Study||13
267440|NCT01117051|645517|P2|COMPLETED|Overall Study||77
267441|NCT01117051|645518|P1|COMPLETED|Overall Study||73
267442|NCT01117051|645517|P2|STARTED|Overall Study||88
267443|NCT01117051|645518|P1|STARTED|Overall Study||86
267444|NCT01110499|645534|P8|NOT COMPLETED|Overall Study||0
267445|NCT01110499|645535|P7|NOT COMPLETED|Overall Study||0
267446|NCT01110499|645536|P6|NOT COMPLETED|Overall Study||0
267447|NCT01110499|645537|P5|NOT COMPLETED|Overall Study||0
267448|NCT01110499|645538|P4|NOT COMPLETED|Overall Study||0
267449|NCT01110499|645539|P3|NOT COMPLETED|Overall Study||0
267450|NCT01110499|645540|P2|NOT COMPLETED|Overall Study||0
267451|NCT01110499|645541|P1|NOT COMPLETED|Overall Study||0
267452|NCT01110499|645534|P8|COMPLETED|Overall Study||40
267453|NCT01110499|645535|P7|COMPLETED|Overall Study||39
267454|NCT01110499|645536|P6|COMPLETED|Overall Study||14
267455|NCT01110499|645537|P5|COMPLETED|Overall Study||14
267456|NCT01110499|645538|P4|COMPLETED|Overall Study||14
267457|NCT01110499|645539|P3|COMPLETED|Overall Study||14
267458|NCT01110499|645540|P2|COMPLETED|Overall Study||14
267459|NCT01110499|645541|P1|COMPLETED|Overall Study||14
267460|NCT01110499|645534|P8|STARTED|Overall Study||40
267461|NCT01110499|645535|P7|STARTED|Overall Study||39
267462|NCT01110499|645536|P6|STARTED|Overall Study||14
267463|NCT01110499|645537|P5|STARTED|Overall Study||14
267464|NCT01110499|645538|P4|STARTED|Overall Study||14
267465|NCT01110499|645539|P3|STARTED|Overall Study||14
267466|NCT01110499|645540|P2|STARTED|Overall Study||14
267467|NCT01110499|645541|P1|STARTED|Overall Study||14
267468|NCT01110915|645563|P2|NOT COMPLETED|Overall Study||2
267469|NCT01110915|645564|P1|NOT COMPLETED|Overall Study||10
267470|NCT01110915|645563|P2|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|84
267471|NCT01110915|645564|P1|COMPLETED|Overall Study|Subjects completing at least 4 months of follow-up.|167
267472|NCT01110915|645563|P2|STARTED|Overall Study|Subjects being randomized to the Control group.|86
267473|NCT01110915|645564|P1|STARTED|Overall Study|Subjects being randomized to the MRI group.|177
267474|NCT01110967|645579|P1|NOT COMPLETED|Overall Study||9
267475|NCT01110967|645579|P1|COMPLETED|Overall Study||31
267476|NCT01110967|645579|P1|12 Months Follow up|Overall Study||31
267477|NCT01110967|645579|P1|6 Months Follow up|Overall Study||24
267478|NCT01110967|645579|P1|3 Months Follow up|Overall Study||28
267479|NCT01110967|645579|P1|1 Month Follow up|Overall Study||26
267480|NCT01110967|645579|P1|Surgery|Overall Study||40
267481|NCT01110967|645579|P1|STARTED|Overall Study||40
267482|NCT01111110|645592|P2|NOT COMPLETED|Overall Study||0
267483|NCT01111110|645593|P1|NOT COMPLETED|Overall Study||0
267484|NCT01111110|645592|P2|COMPLETED|Overall Study||4
267485|NCT01111110|645593|P1|COMPLETED|Overall Study||3
267486|NCT01111110|645592|P2|STARTED|Overall Study||4
267487|NCT01111110|645593|P1|STARTED|Overall Study||3
267488|NCT01111123|645605|P2|NOT COMPLETED|Maintenance Phase||2
267489|NCT01111123|645606|P1|NOT COMPLETED|Maintenance Phase||0
267490|NCT01111123|645605|P2|COMPLETED|Maintenance Phase||18
267491|NCT01111123|645606|P1|COMPLETED|Maintenance Phase||21
267492|NCT01111123|645605|P2|STARTED|Maintenance Phase||20
267493|NCT01111123|645606|P1|STARTED|Maintenance Phase||21
267494|NCT01111123|645605|P2|NOT COMPLETED|Open- Label Phase||0
267495|NCT01111123|645606|P1|NOT COMPLETED|Open- Label Phase||14
267496|NCT01111123|645605|P2|COMPLETED|Open- Label Phase||0
267497|NCT01111123|645606|P1|COMPLETED|Open- Label Phase||41
267498|NCT01111123|645605|P2|STARTED|Open- Label Phase||0
267499|NCT01111123|645606|P1|STARTED|Open- Label Phase||55
267500|NCT01111149|645617|P3|NOT COMPLETED|Overall Study||4
267501|NCT01111149|645618|P2|NOT COMPLETED|Overall Study||1
267502|NCT01111149|645619|P1|NOT COMPLETED|Overall Study||2
267503|NCT01111149|645617|P3|COMPLETED|Overall Study||5
267504|NCT01111149|645618|P2|COMPLETED|Overall Study||5
267505|NCT01111149|645619|P1|COMPLETED|Overall Study||7
267506|NCT01111149|645617|P3|STARTED|Overall Study||9
267507|NCT01111149|645618|P2|STARTED|Overall Study||6
267508|NCT01111149|645619|P1|STARTED|Overall Study||9
267509|NCT01111162|645693|P1|NOT COMPLETED|Overall Study||0
267510|NCT01111162|645693|P1|COMPLETED|Overall Study||120
267511|NCT01111162|645693|P1|STARTED|Overall Study||120
267512|NCT01111240|645698|P1|NOT COMPLETED|Overall Study||1066
267513|NCT01111240|645698|P1|COMPLETED|Overall Study||3569
267514|NCT01111240|645698|P1|STARTED|Overall Study||4635
267515|NCT01111292|645722|P2|NOT COMPLETED|Follow-Up||0
267516|NCT01111292|645723|P1|NOT COMPLETED|Follow-Up||0
267517|NCT01111292|645722|P2|COMPLETED|Follow-Up||1
267518|NCT01111292|645723|P1|COMPLETED|Follow-Up||2
267519|NCT01111292|645722|P2|STARTED|Follow-Up||1
267520|NCT01111292|645723|P1|STARTED|Follow-Up||2
267521|NCT01111292|645722|P2|NOT COMPLETED|Post Treatment Biopsy||0
267522|NCT01111292|645723|P1|NOT COMPLETED|Post Treatment Biopsy||0
267523|NCT01111292|645722|P2|COMPLETED|Post Treatment Biopsy||1
267524|NCT01111292|645723|P1|COMPLETED|Post Treatment Biopsy||2
267525|NCT01111292|645722|P2|STARTED|Post Treatment Biopsy||1
267526|NCT01111292|645723|P1|STARTED|Post Treatment Biopsy||2
267527|NCT01111292|645722|P2|NOT COMPLETED|Treatment||1
267528|NCT01111292|645723|P1|NOT COMPLETED|Treatment||1
267529|NCT01111292|645722|P2|COMPLETED|Treatment||1
267530|NCT01111292|645723|P1|COMPLETED|Treatment||2
267531|NCT01111292|645722|P2|STARTED|Treatment||2
267532|NCT01111292|645723|P1|STARTED|Treatment||3
267533|NCT01111292|645722|P2|NOT COMPLETED|Randomization||0
267534|NCT01111292|645723|P1|NOT COMPLETED|Randomization||0
267535|NCT01111292|645722|P2|COMPLETED|Randomization||2
267536|NCT01111292|645723|P1|COMPLETED|Randomization||3
267537|NCT01111292|645722|P2|STARTED|Randomization||2
267538|NCT01111292|645723|P1|STARTED|Randomization||3
267539|NCT01111305|645731|P2|NOT COMPLETED|Overall Study||0
267540|NCT01111305|645732|P1|NOT COMPLETED|Overall Study||0
267541|NCT01111305|645731|P2|COMPLETED|Overall Study||4
267542|NCT01111305|645732|P1|COMPLETED|Overall Study||4
267543|NCT01111305|645731|P2|STARTED|Overall Study||4
267544|NCT01111305|645732|P1|STARTED|Overall Study||4
267545|NCT01111318|645746|P4|NOT COMPLETED|Overall Study||0
267546|NCT01111318|645747|P3|NOT COMPLETED|Overall Study||0
267547|NCT01111318|645748|P2|NOT COMPLETED|Overall Study||0
267548|NCT01111318|645749|P1|NOT COMPLETED|Overall Study||0
267549|NCT01111318|645746|P4|COMPLETED|Overall Study||8
267550|NCT01111318|645747|P3|COMPLETED|Overall Study||8
267551|NCT01111318|645748|P2|COMPLETED|Overall Study||8
267552|NCT01111318|645749|P1|COMPLETED|Overall Study||12
267553|NCT01111318|645746|P4|STARTED|Overall Study||8
267554|NCT01111318|645747|P3|STARTED|Overall Study||8
267555|NCT01111318|645748|P2|STARTED|Overall Study||8
267556|NCT01111318|645749|P1|STARTED|Overall Study||12
267557|NCT01111331|645811|P2|NOT COMPLETED|Overall Study||0
267558|NCT01111331|645812|P1|NOT COMPLETED|Overall Study||0
267559|NCT01111331|645811|P2|COMPLETED|Overall Study||9
267560|NCT01111331|645812|P1|COMPLETED|Overall Study||9
267561|NCT01111331|645811|P2|STARTED|Overall Study||9
267562|NCT01111331|645812|P1|STARTED|Overall Study||9
267563|NCT01111370|645890|P1|NOT COMPLETED|Overall Study||2
267564|NCT01111370|645890|P1|COMPLETED|Overall Study||58
267565|NCT01111370|645890|P1|STARTED|Overall Study||60
267566|NCT01111461|645894|P1|NOT COMPLETED|Overall Study||51
267567|NCT01111461|645894|P1|COMPLETED|Overall Study|On treatment at data cut-off or on treatment until disease progression|82
267568|NCT01111461|645894|P1|STARTED|Overall Study||133
267569|NCT01111526|645907|P3|NOT COMPLETED|Overall Study||2
267570|NCT01111526|645908|P2|NOT COMPLETED|Overall Study||1
267571|NCT01111526|645909|P1|NOT COMPLETED|Overall Study||0
267572|NCT01111526|645907|P3|COMPLETED|Overall Study||8
267573|NCT01111526|645908|P2|COMPLETED|Overall Study||7
267574|NCT01111526|645909|P1|COMPLETED|Overall Study||4
267575|NCT01111526|645907|P3|STARTED|Overall Study||10
267576|NCT01111526|645908|P2|STARTED|Overall Study||8
267577|NCT01111526|645909|P1|STARTED|Overall Study||4
267578|NCT01117090|645921|P1|NOT COMPLETED|Overall Study||0
267579|NCT01117090|645921|P1|COMPLETED|Overall Study||47
267580|NCT01117090|645921|P1|STARTED|Overall Study||47
267581|NCT01117181|645934|P2|NOT COMPLETED|Overall Study||2
267582|NCT01117181|645935|P1|NOT COMPLETED|Overall Study||1
267583|NCT01117181|645934|P2|COMPLETED|Overall Study||29
267584|NCT01117181|645935|P1|COMPLETED|Overall Study||28
267585|NCT01117181|645934|P2|STARTED|Overall Study||31
267586|NCT01117181|645935|P1|STARTED|Overall Study||29
267587|NCT01117311|645953|P2|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
267588|NCT01117311|645954|P1|NOT COMPLETED|Second Intervention - Mixed Meal 3||0
267589|NCT01117311|645953|P2|COMPLETED|Second Intervention - Mixed Meal 3||4
267590|NCT01117311|645954|P1|COMPLETED|Second Intervention - Mixed Meal 3||3
267591|NCT01117311|645953|P2|STARTED|Second Intervention - Mixed Meal 3||4
267592|NCT01117311|645954|P1|STARTED|Second Intervention - Mixed Meal 3||3
267593|NCT01117311|645953|P2|NOT COMPLETED|First Intervention - Mixed Meal 2||0
267594|NCT01117311|645954|P1|NOT COMPLETED|First Intervention - Mixed Meal 2||0
267595|NCT01117311|645953|P2|COMPLETED|First Intervention - Mixed Meal 2||4
267596|NCT01117311|645954|P1|COMPLETED|First Intervention - Mixed Meal 2||3
267597|NCT01117311|645953|P2|STARTED|First Intervention - Mixed Meal 2||4
267598|NCT01117311|645954|P1|STARTED|First Intervention - Mixed Meal 2||3
267599|NCT01117311|645953|P2|NOT COMPLETED|Lead-in Mixed Meal 1||0
267600|NCT01117311|645954|P1|NOT COMPLETED|Lead-in Mixed Meal 1||0
267601|NCT01117311|645953|P2|COMPLETED|Lead-in Mixed Meal 1||4
267602|NCT01117311|645954|P1|COMPLETED|Lead-in Mixed Meal 1||3
267603|NCT01117311|645953|P2|STARTED|Lead-in Mixed Meal 1||4
267604|NCT01117311|645954|P1|STARTED|Lead-in Mixed Meal 1||3
267605|NCT01117337|645964|P2|NOT COMPLETED|Overall Study||0
267606|NCT01117337|645965|P1|NOT COMPLETED|Overall Study||4
267607|NCT01117337|645964|P2|COMPLETED|Overall Study||52
267608|NCT01117337|645965|P1|COMPLETED|Overall Study|48 completed one year follow-up. 4 lost to follow-up.|48
267609|NCT01117337|645964|P2|Underwent Surgery|Overall Study||52
267610|NCT01117337|645965|P1|Underwent Surgery|Overall Study|52 patients underwent surgery|52
267611|NCT01117337|645964|P2|STARTED|Overall Study||52
267612|NCT01117337|645965|P1|STARTED|Overall Study|52 pateints on inguinal hernia were randomized to mesh fixation group|52
267613|NCT01117350|645977|P2|NOT COMPLETED|Extension Period||63
267614|NCT01117350|645978|P1|NOT COMPLETED|Extension Period||0
267615|NCT01117350|645977|P2|COMPLETED|Extension Period||147
267616|NCT01117350|645978|P1|COMPLETED|Extension Period||0
267617|NCT01117350|645977|P2|mITT Population (Extension)|Extension Period|mITT (extension): treated patients with at least 1 efficacy value both at entry and during extension|154
267618|NCT01117350|645978|P1|mITT Population (Extension)|Extension Period||0
267619|NCT01117350|645977|P2|TREATED = Safety Population (Extension)|Extension Period|Safety population (extension): treated with insulin glargine during the extension period|160
267620|NCT01117350|645978|P1|TREATED = Safety Population (Extension)|Extension Period||0
267621|NCT01117350|645977|P2|STARTED|Extension Period|STARTED: patients having completed the comparative period and eligible for the extension period|210
267622|NCT01117350|645978|P1|STARTED|Extension Period||0
267623|NCT01117350|645977|P2|NOT COMPLETED|Comparative Period||75
267624|NCT01117350|645978|P1|NOT COMPLETED|Comparative Period||42
267625|NCT01117350|645977|P2|COMPLETED|Comparative Period||414
267626|NCT01117350|645978|P1|COMPLETED|Comparative Period||447
267627|NCT01117350|645977|P2|mITT Population|Comparative Period||470
267628|NCT01117350|645978|P1|mITT Population|Comparative Period|modified Intent-To-Treat population: treated patients with at least one efficacy post-baseline value|474
267629|NCT01117350|645977|P2|TREATED = Safety Population|Comparative Period||481
267630|NCT01117350|645978|P1|TREATED = Safety Population|Comparative Period|Safety population: all randomized and treated patients (received at least one dose)|484
267631|NCT01117350|645977|P2|STARTED|Comparative Period||489
267632|NCT01117350|645978|P1|STARTED|Comparative Period|STARTED: randomized|489
267633|NCT01118325|646011|P3|NOT COMPLETED|Overall Study||1
267634|NCT01118325|646012|P2|NOT COMPLETED|Overall Study||0
267635|NCT01118325|646013|P1|NOT COMPLETED|Overall Study||1
267636|NCT01118325|646011|P3|COMPLETED|Overall Study||45
267637|NCT01118325|646012|P2|COMPLETED|Overall Study||43
267638|NCT01118325|646013|P1|COMPLETED|Overall Study||49
267639|NCT01118325|646011|P3|STARTED|Overall Study||46
267640|NCT01118325|646012|P2|STARTED|Overall Study||43
267641|NCT01118325|646013|P1|STARTED|Overall Study||50
267642|NCT01118377|646057|P1|NOT COMPLETED|Overall Study||42
267643|NCT01118377|646057|P1|COMPLETED|Overall Study||3
267644|NCT01118377|646057|P1|STARTED|Overall Study||45
267645|NCT01118455|646065|P2|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
267646|NCT01118455|646066|P1|NOT COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||0
267647|NCT01118455|646065|P2|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||69
267648|NCT01118455|646066|P1|COMPLETED|Treatment Phase (VNS/AED) [Visits 3-10]||65
267649|NCT01118455|646065|P2|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||69
267650|NCT01118455|646066|P1|STARTED|Treatment Phase (VNS/AED) [Visits 3-10]||65
267651|NCT01118455|646065|P2|NOT COMPLETED|Baseline [Visits 1 & 2]||0
267652|NCT01118455|646066|P1|NOT COMPLETED|Baseline [Visits 1 & 2]||1
267653|NCT01118455|646065|P2|COMPLETED|Baseline [Visits 1 & 2]||69
267654|NCT01118455|646066|P1|COMPLETED|Baseline [Visits 1 & 2]||65
267655|NCT01118455|646065|P2|Actual Patients Treated|Baseline [Visits 1 & 2]||69
267656|NCT01118455|646066|P1|Actual Patients Treated|Baseline [Visits 1 & 2]||65
267657|NCT01118455|646065|P2|STARTED|Baseline [Visits 1 & 2]||69
267658|NCT01118455|646066|P1|STARTED|Baseline [Visits 1 & 2]||66
267659|NCT01118624|646094|P1|NOT COMPLETED|Overall Study||22
267660|NCT01118624|646094|P1|COMPLETED|Overall Study||0
267661|NCT01118624|646094|P1|STARTED|Overall Study||22
267662|NCT01118663|646103|P2|NOT COMPLETED|Overall Study||2
267663|NCT01118663|646104|P1|NOT COMPLETED|Overall Study||2
267664|NCT01118663|646103|P2|COMPLETED|Overall Study||8
267665|NCT01118663|646104|P1|COMPLETED|Overall Study||5
267666|NCT01118663|646103|P2|STARTED|Overall Study||10
267667|NCT01118663|646104|P1|STARTED|Overall Study||7
267668|NCT01118728|646118|P1|NOT COMPLETED|Overall Study||223
267669|NCT01118728|646118|P1|COMPLETED|Overall Study||0
267670|NCT01118728|646118|P1|STARTED|Overall Study||223
267671|NCT01118741|646125|P2|NOT COMPLETED|Overall Study||0
267672|NCT01118741|646126|P1|NOT COMPLETED|Overall Study||0
267673|NCT01118741|646125|P2|COMPLETED|Overall Study||10
267674|NCT01118741|646126|P1|COMPLETED|Overall Study||9
267675|NCT01118741|646125|P2|STARTED|Overall Study||10
267676|NCT01118741|646126|P1|STARTED|Overall Study||9
267677|NCT01118780|646134|P2|NOT COMPLETED|Overall Study||35
267678|NCT01118780|646135|P1|NOT COMPLETED|Overall Study||36
267679|NCT01118780|646134|P2|COMPLETED|Overall Study||105
267680|NCT01118780|646135|P1|COMPLETED|Overall Study||115
267681|NCT01118780|646134|P2|STARTED|Overall Study||140
267682|NCT01118780|646135|P1|STARTED|Overall Study||151
267683|NCT01118845|646182|P1|NOT COMPLETED|Overall Study||42
267684|NCT01118845|646182|P1|COMPLETED|Overall Study||17
267685|NCT01118845|646182|P1|STARTED|Overall Study||59
267686|NCT01118949|646201|P1|NOT COMPLETED|Overall Study||9
267687|NCT01118949|646201|P1|COMPLETED|Overall Study||40
267688|NCT01118949|646201|P1|STARTED|Overall Study||49
267689|NCT01118962|646210|P1|NOT COMPLETED|Overall Study||10
267690|NCT01118962|646210|P1|COMPLETED|Overall Study||29
267691|NCT01118962|646210|P1|STARTED|Overall Study||39
267692|NCT01118975|646217|P2|NOT COMPLETED|Overall Study||1
267693|NCT01118975|646218|P1|NOT COMPLETED|Overall Study||0
267694|NCT01118975|646217|P2|COMPLETED|Overall Study||2
267695|NCT01118975|646218|P1|COMPLETED|Overall Study||9
267696|NCT01118975|646217|P2|STARTED|Overall Study||3
267697|NCT01118975|646218|P1|STARTED|Overall Study||9
267698|NCT01118988|646227|P3|NOT COMPLETED|Overall Study||4
267699|NCT01118988|646228|P2|NOT COMPLETED|Overall Study||1
267700|NCT01118988|646229|P1|NOT COMPLETED|Overall Study||5
267701|NCT01118988|646227|P3|COMPLETED|Overall Study||3
267702|NCT01118988|646228|P2|COMPLETED|Overall Study||3
267703|NCT01118988|646229|P1|COMPLETED|Overall Study||11
267704|NCT01118988|646227|P3|STARTED|Overall Study||7
267705|NCT01118988|646228|P2|STARTED|Overall Study||4
267706|NCT01118988|646229|P1|STARTED|Overall Study||16
267707|NCT01119001|646260|P1|NOT COMPLETED|Overall Study||2
267708|NCT01119001|646260|P1|COMPLETED|Overall Study||11
267709|NCT01119001|646260|P1|STARTED|Overall Study||13
267710|NCT01119040|646266|P1|NOT COMPLETED|Overall Study||1
267711|NCT01119040|646266|P1|COMPLETED|Overall Study||0
267712|NCT01119040|646266|P1|STARTED|Overall Study||1
267713|NCT01119118|646270|P1|NOT COMPLETED|Overall Study||1
267714|NCT01119118|646270|P1|COMPLETED|Overall Study||5
267715|NCT01119118|646270|P1|STARTED|Overall Study||6
267716|NCT01119131|646281|P3|NOT COMPLETED|Overall Study||6
267717|NCT01119131|646282|P2|NOT COMPLETED|Overall Study||1
267718|NCT01119131|646283|P1|NOT COMPLETED|Overall Study||2
267719|NCT01119131|646281|P3|COMPLETED|Overall Study||24
267720|NCT01119131|646282|P2|COMPLETED|Overall Study||27
267721|NCT01119131|646283|P1|COMPLETED|Overall Study||8
267722|NCT01119131|646281|P3|STARTED|Overall Study||30
267723|NCT01119131|646282|P2|STARTED|Overall Study||28
267724|NCT01119131|646283|P1|STARTED|Overall Study||10
267725|NCT01119222|646312|P4|NOT COMPLETED|Overall Study||0
267726|NCT01119222|646313|P3|NOT COMPLETED|Overall Study||0
267727|NCT01119222|646314|P2|NOT COMPLETED|Overall Study||0
267728|NCT01119222|646315|P1|NOT COMPLETED|Overall Study||0
267729|NCT01119222|646312|P4|COMPLETED|Overall Study||4
267730|NCT01119222|646313|P3|COMPLETED|Overall Study||5
267731|NCT01119222|646314|P2|COMPLETED|Overall Study||5
267732|NCT01119222|646315|P1|COMPLETED|Overall Study||5
267733|NCT01119222|646312|P4|STARTED|Overall Study||4
267734|NCT01119222|646313|P3|STARTED|Overall Study||5
267735|NCT01119222|646314|P2|STARTED|Overall Study||5
267736|NCT01119222|646315|P1|STARTED|Overall Study||5
267737|NCT01119287|646359|P6|NOT COMPLETED|Overall Study||0
267738|NCT01119287|646360|P5|NOT COMPLETED|Overall Study||1
267739|NCT01119287|646361|P4|NOT COMPLETED|Overall Study||2
267740|NCT01119287|646362|P3|NOT COMPLETED|Overall Study||2
267741|NCT01119287|646363|P2|NOT COMPLETED|Overall Study||0
267742|NCT01119287|646364|P1|NOT COMPLETED|Overall Study||0
267743|NCT01119287|646359|P6|COMPLETED|Overall Study||32
267744|NCT01119287|646360|P5|COMPLETED|Overall Study||30
267745|NCT01119287|646361|P4|COMPLETED|Overall Study||29
267746|NCT01119287|646362|P3|COMPLETED|Overall Study||24
267747|NCT01119287|646363|P2|COMPLETED|Overall Study||24
267748|NCT01119287|646364|P1|COMPLETED|Overall Study||26
267749|NCT01119287|646359|P6|STARTED|Overall Study||32
267750|NCT01119287|646360|P5|STARTED|Overall Study||31
267751|NCT01119287|646361|P4|STARTED|Overall Study||31
267752|NCT01119287|646362|P3|STARTED|Overall Study||26
267753|NCT01119287|646363|P2|STARTED|Overall Study||24
267754|NCT01119287|646364|P1|STARTED|Overall Study||26
267755|NCT01119443|646379|P2|NOT COMPLETED|End of Study (All Patients)||0
267756|NCT01119443|646380|P1|NOT COMPLETED|End of Study (All Patients)||0
267757|NCT01119443|646379|P2|COMPLETED|End of Study (All Patients)||14
267758|NCT01119443|646380|P1|COMPLETED|End of Study (All Patients)||14
267759|NCT01119443|646379|P2|STARTED|End of Study (All Patients)||14
267760|NCT01119443|646380|P1|STARTED|End of Study (All Patients)||14
267761|NCT01119443|646379|P2|NOT COMPLETED|Down-titration Period (1 Day)||0
267762|NCT01119443|646380|P1|NOT COMPLETED|Down-titration Period (1 Day)||0
267763|NCT01119443|646379|P2|COMPLETED|Down-titration Period (1 Day)||13
267764|NCT01119443|646380|P1|COMPLETED|Down-titration Period (1 Day)||14
267765|NCT01119443|646379|P2|STARTED|Down-titration Period (1 Day)||13
267766|NCT01119443|646380|P1|STARTED|Down-titration Period (1 Day)||14
267767|NCT01119443|646379|P2|NOT COMPLETED|Crossover Period 4 (5 Days)||0
267768|NCT01119443|646380|P1|NOT COMPLETED|Crossover Period 4 (5 Days)||0
267769|NCT01119443|646379|P2|COMPLETED|Crossover Period 4 (5 Days)||13
267770|NCT01119443|646380|P1|COMPLETED|Crossover Period 4 (5 Days)||14
267771|NCT01119443|646379|P2|STARTED|Crossover Period 4 (5 Days)||13
267772|NCT01119443|646380|P1|STARTED|Crossover Period 4 (5 Days)||14
267773|NCT01119443|646379|P2|NOT COMPLETED|Crossover Period 3 (5 Days)||0
267774|NCT01119443|646380|P1|NOT COMPLETED|Crossover Period 3 (5 Days)||0
267775|NCT01119443|646379|P2|COMPLETED|Crossover Period 3 (5 Days)||13
267776|NCT01119443|646380|P1|COMPLETED|Crossover Period 3 (5 Days)||14
267777|NCT01119443|646379|P2|STARTED|Crossover Period 3 (5 Days)||13
267778|NCT01119443|646380|P1|STARTED|Crossover Period 3 (5 Days)||14
267779|NCT01119443|646379|P2|NOT COMPLETED|Crossover Period 2 (5 Days)||0
267780|NCT01119443|646380|P1|NOT COMPLETED|Crossover Period 2 (5 Days)||0
267781|NCT01119443|646379|P2|COMPLETED|Crossover Period 2 (5 Days)||13
267782|NCT01119443|646380|P1|COMPLETED|Crossover Period 2 (5 Days)||14
267783|NCT01119443|646379|P2|STARTED|Crossover Period 2 (5 Days)||13
267784|NCT01119443|646380|P1|STARTED|Crossover Period 2 (5 Days)||14
267785|NCT01119443|646379|P2|NOT COMPLETED|Crossover Period 1 (5 Days)||1
267786|NCT01119443|646380|P1|NOT COMPLETED|Crossover Period 1 (5 Days)||0
267787|NCT01119443|646379|P2|COMPLETED|Crossover Period 1 (5 Days)||13
267788|NCT01119443|646380|P1|COMPLETED|Crossover Period 1 (5 Days)||14
267789|NCT01119443|646379|P2|STARTED|Crossover Period 1 (5 Days)||14
267790|NCT01119443|646380|P1|STARTED|Crossover Period 1 (5 Days)||14
267791|NCT01119443|646379|P2|NOT COMPLETED|Up-titration Period (10 Days)||0
267792|NCT01119443|646380|P1|NOT COMPLETED|Up-titration Period (10 Days)||0
267793|NCT01119443|646379|P2|COMPLETED|Up-titration Period (10 Days)||14
267794|NCT01119443|646380|P1|COMPLETED|Up-titration Period (10 Days)||14
267795|NCT01119443|646379|P2|STARTED|Up-titration Period (10 Days)||14
267796|NCT01119443|646380|P1|STARTED|Up-titration Period (10 Days)||14
267797|NCT01119625|646419|P2|NOT COMPLETED|Overall Study||4
267798|NCT01119625|646420|P1|NOT COMPLETED|Overall Study||3
267799|NCT01119625|646419|P2|COMPLETED|Overall Study||116
267800|NCT01119625|646420|P1|COMPLETED|Overall Study||115
267801|NCT01119625|646419|P2|STARTED|Overall Study||120
267802|NCT01119625|646420|P1|STARTED|Overall Study||118
267803|NCT01119703|646462|P2|NOT COMPLETED|Overall Study||1
267804|NCT01119703|646463|P1|NOT COMPLETED|Overall Study||0
267805|NCT01119703|646462|P2|COMPLETED|Overall Study||143
267806|NCT01119703|646463|P1|COMPLETED|Overall Study||30
267807|NCT01119703|646462|P2|STARTED|Overall Study||144
267808|NCT01119703|646463|P1|STARTED|Overall Study||30
267809|NCT01119716|646475|P1|NOT COMPLETED|Overall Study||0
267810|NCT01119716|646475|P1|COMPLETED|Overall Study||4658
267811|NCT01119716|646475|P1|STARTED|Overall Study||4658
267812|NCT01119755|646496|P1|NOT COMPLETED|Overall Study||0
267813|NCT01119755|646496|P1|COMPLETED|Overall Study||80
267814|NCT01119755|646496|P1|STARTED|Overall Study||80
267815|NCT01119768|646509|P2|NOT COMPLETED|Follow-up||2
267816|NCT01119768|646510|P1|NOT COMPLETED|Follow-up||1
267817|NCT01119768|646509|P2|COMPLETED|Follow-up||122
267818|NCT01119768|646510|P1|COMPLETED|Follow-up||135
267819|NCT01119768|646509|P2|STARTED|Follow-up||124
267820|NCT01119768|646510|P1|STARTED|Follow-up||136
267821|NCT01119768|646509|P2|NOT COMPLETED|Treatment Period||25
267822|NCT01119768|646510|P1|NOT COMPLETED|Treatment Period||18
267823|NCT01119768|646509|P2|COMPLETED|Treatment Period||126
267824|NCT01119768|646510|P1|COMPLETED|Treatment Period||136
267825|NCT01119768|646509|P2|STARTED|Treatment Period||151
267826|NCT01119768|646510|P1|STARTED|Treatment Period||154
267827|NCT01119794|646532|P1|NOT COMPLETED|Overall Study||0
267828|NCT01119794|646532|P1|COMPLETED|Overall Study||10
267829|NCT01119794|646532|P1|STARTED|Overall Study||10
267830|NCT01119859|646538|P2|NOT COMPLETED|Overall Study||30
267831|NCT01119859|646539|P1|NOT COMPLETED|Overall Study||24
267832|NCT01119859|646538|P2|COMPLETED|Overall Study||133
267833|NCT01119859|646539|P1|COMPLETED|Overall Study||139
267834|NCT01119859|646538|P2|STARTED|Overall Study||163
267835|NCT01119859|646539|P1|STARTED|Overall Study||163
267836|NCT01119937|646557|P2|NOT COMPLETED|Overall Study||7
267837|NCT01119937|646558|P1|NOT COMPLETED|Overall Study||19
267838|NCT01119937|646557|P2|COMPLETED|Overall Study||33
267839|NCT01119937|646558|P1|COMPLETED|Overall Study||104
267840|NCT01119937|646557|P2|STARTED|Overall Study||40
267841|NCT01119937|646558|P1|STARTED|Overall Study||123
267842|NCT01119950|646584|P1|NOT COMPLETED|Overall Study||47
267843|NCT01119950|646584|P1|COMPLETED|Overall Study|These participants completed both periods 1 and 2|341
267925|NCT01120093|646839|P4|COMPLETED|Treatment Period 1||14
267844|NCT01119950|646584|P1|Placebo|Overall Study|3 randomized participants did not receive study drug, 82 completed treatment, 5 discontinued.|94
267845|NCT01119950|646584|P1|NVA237 50 ug b.i.d.|Overall Study|6 randomized and 1 misrandomized patients did not receive study drug, 82 completed, 5 discontinued.|94
267846|NCT01119950|646584|P1|NVA237 100 ug q.d.|Overall Study|2 randomized participants did not receive study drug, 92 completed treatment, 4 discontinued.|98
267847|NCT01119950|646584|P1|NVA237 25 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 7 discontinued.|100
267848|NCT01119950|646584|P1|NVA237 50 ug q.d.|Overall Study|4 randomized participants did not receive study drug, 89 completed treatment, 3 discontinued.|96
267849|NCT01119950|646584|P1|NVA237 12.5 ug b.i.d.|Overall Study|4 randomized participants did not receive study drug, 93 completed treatment, 2 discontinued.|99
267850|NCT01119950|646584|P1|NVA237 25 ug q.d.|Overall Study|3 randomized participants did not receive study drug, 91 completed treatment, 5 discontinued.|99
267851|NCT01119950|646584|P1|NVA237 12.5 ug q.d.|Overall Study|5 randomized and 2 misrandomized patients did not receive study drug, 80 completed, 9 discontinued.|96
267852|NCT01119950|646584|P1|STARTED|Overall Study|These participants were randomized to 2 different treatment sequences during period 1 and 2.|388
267853|NCT01120067|646831|P2|NOT COMPLETED|Overall Study||1
267854|NCT01120067|646832|P1|NOT COMPLETED|Overall Study||5
267855|NCT01120067|646831|P2|COMPLETED|Overall Study||10
267856|NCT01120067|646832|P1|COMPLETED|Overall Study||7
267857|NCT01120067|646831|P2|STARTED|Overall Study||11
267858|NCT01120067|646832|P1|STARTED|Overall Study||12
267859|NCT01120093|646838|P5|NOT COMPLETED|Treatment Period 5||0
267860|NCT01120093|646839|P4|NOT COMPLETED|Treatment Period 5||1
267861|NCT01120093|646840|P3|NOT COMPLETED|Treatment Period 5||0
267862|NCT01120093|646841|P2|NOT COMPLETED|Treatment Period 5||1
267863|NCT01120093|646842|P1|NOT COMPLETED|Treatment Period 5||0
267864|NCT01120093|646838|P5|COMPLETED|Treatment Period 5||13
267865|NCT01120093|646839|P4|COMPLETED|Treatment Period 5||11
267866|NCT01120093|646840|P3|COMPLETED|Treatment Period 5||15
267867|NCT01120093|646841|P2|COMPLETED|Treatment Period 5||12
267868|NCT01120093|646842|P1|COMPLETED|Treatment Period 5||17
267869|NCT01120093|646838|P5|STARTED|Treatment Period 5||13
267870|NCT01120093|646839|P4|STARTED|Treatment Period 5||12
267871|NCT01120093|646840|P3|STARTED|Treatment Period 5||15
267872|NCT01120093|646841|P2|STARTED|Treatment Period 5||13
267873|NCT01120093|646842|P1|STARTED|Treatment Period 5||17
267874|NCT01120093|646838|P5|NOT COMPLETED|Treatment Period 4||0
267875|NCT01120093|646839|P4|NOT COMPLETED|Treatment Period 4||0
267876|NCT01120093|646840|P3|NOT COMPLETED|Treatment Period 4||0
267877|NCT01120093|646841|P2|NOT COMPLETED|Treatment Period 4||0
267878|NCT01120093|646842|P1|NOT COMPLETED|Treatment Period 4||1
267879|NCT01120093|646838|P5|COMPLETED|Treatment Period 4||13
267880|NCT01120093|646839|P4|COMPLETED|Treatment Period 4||12
267881|NCT01120093|646840|P3|COMPLETED|Treatment Period 4||15
267882|NCT01120093|646841|P2|COMPLETED|Treatment Period 4||13
267883|NCT01120093|646842|P1|COMPLETED|Treatment Period 4||17
267884|NCT01120093|646838|P5|STARTED|Treatment Period 4||13
267885|NCT01120093|646839|P4|STARTED|Treatment Period 4||12
267886|NCT01120093|646840|P3|STARTED|Treatment Period 4||15
267887|NCT01120093|646841|P2|STARTED|Treatment Period 4||13
267888|NCT01120093|646842|P1|STARTED|Treatment Period 4||18
267889|NCT01120093|646838|P5|NOT COMPLETED|Treatment Period 3||1
267890|NCT01120093|646839|P4|NOT COMPLETED|Treatment Period 3||1
267891|NCT01120093|646840|P3|NOT COMPLETED|Treatment Period 3||1
267892|NCT01120093|646841|P2|NOT COMPLETED|Treatment Period 3||0
267893|NCT01120093|646842|P1|NOT COMPLETED|Treatment Period 3||0
267894|NCT01120093|646838|P5|COMPLETED|Treatment Period 3||13
267895|NCT01120093|646839|P4|COMPLETED|Treatment Period 3||12
267896|NCT01120093|646840|P3|COMPLETED|Treatment Period 3||15
267897|NCT01120093|646841|P2|COMPLETED|Treatment Period 3||13
267898|NCT01120093|646842|P1|COMPLETED|Treatment Period 3||18
267899|NCT01120093|646838|P5|STARTED|Treatment Period 3||14
267900|NCT01120093|646839|P4|STARTED|Treatment Period 3||13
267901|NCT01120093|646840|P3|STARTED|Treatment Period 3||16
267902|NCT01120093|646841|P2|STARTED|Treatment Period 3||13
267903|NCT01120093|646842|P1|STARTED|Treatment Period 3||18
267904|NCT01120093|646838|P5|NOT COMPLETED|Treatment Period 2||1
267905|NCT01120093|646839|P4|NOT COMPLETED|Treatment Period 2||1
267906|NCT01120093|646840|P3|NOT COMPLETED|Treatment Period 2||0
267907|NCT01120093|646841|P2|NOT COMPLETED|Treatment Period 2||0
267908|NCT01120093|646842|P1|NOT COMPLETED|Treatment Period 2||0
267909|NCT01120093|646838|P5|COMPLETED|Treatment Period 2||14
267910|NCT01120093|646839|P4|COMPLETED|Treatment Period 2||13
267911|NCT01120093|646840|P3|COMPLETED|Treatment Period 2||16
267912|NCT01120093|646841|P2|COMPLETED|Treatment Period 2||13
267913|NCT01120093|646842|P1|COMPLETED|Treatment Period 2||18
267914|NCT01120093|646838|P5|STARTED|Treatment Period 2||15
267915|NCT01120093|646839|P4|STARTED|Treatment Period 2||14
267916|NCT01120093|646840|P3|STARTED|Treatment Period 2||16
267917|NCT01120093|646841|P2|STARTED|Treatment Period 2||13
267918|NCT01120093|646842|P1|STARTED|Treatment Period 2||18
267919|NCT01120093|646838|P5|NOT COMPLETED|Treatment Period 1||1
267920|NCT01120093|646839|P4|NOT COMPLETED|Treatment Period 1||0
267921|NCT01120093|646840|P3|NOT COMPLETED|Treatment Period 1||1
267922|NCT01120093|646841|P2|NOT COMPLETED|Treatment Period 1||1
267923|NCT01120093|646842|P1|NOT COMPLETED|Treatment Period 1||0
267924|NCT01120093|646838|P5|COMPLETED|Treatment Period 1||15
267926|NCT01120093|646840|P3|COMPLETED|Treatment Period 1||16
267927|NCT01120093|646841|P2|COMPLETED|Treatment Period 1||13
267928|NCT01120093|646842|P1|COMPLETED|Treatment Period 1||18
267929|NCT01120093|646838|P5|STARTED|Treatment Period 1||16
267930|NCT01120093|646839|P4|STARTED|Treatment Period 1||14
267931|NCT01120093|646840|P3|STARTED|Treatment Period 1||17
267932|NCT01120093|646841|P2|STARTED|Treatment Period 1||14
267933|NCT01120093|646842|P1|STARTED|Treatment Period 1||18
267934|NCT01120184|646872|P3|NOT COMPLETED|Overall Study||154
267935|NCT01120184|646873|P2|NOT COMPLETED|Overall Study||154
267936|NCT01120184|646874|P1|NOT COMPLETED|Overall Study||169
267937|NCT01120184|646872|P3|COMPLETED|Overall Study|Includes 72 ongoing treatment at clinical cutoff and 137 in survival follow-up at clinical cutoff.|209
267938|NCT01120184|646873|P2|COMPLETED|Overall Study|Includes 64 ongoing treatment at clinical cutoff and 149 in survival follow-up at clinical cutoff.|213
267939|NCT01120184|646874|P1|COMPLETED|Overall Study|Includes 52 ongoing treatment at clinical cutoff and 144 in survival follow-up at clinical cutoff.|196
267940|NCT01120184|646872|P3|Treated|Overall Study||360
267941|NCT01120184|646873|P2|Treated|Overall Study||365
267942|NCT01120184|646874|P1|Treated|Overall Study||355
267943|NCT01120184|646872|P3|STARTED|Overall Study||363
267944|NCT01120184|646873|P2|STARTED|Overall Study||367
267945|NCT01120184|646874|P1|STARTED|Overall Study||365
267946|NCT01120197|646998|P2|NOT COMPLETED|Overall Study||10
267947|NCT01120197|646999|P1|NOT COMPLETED|Overall Study||9
267948|NCT01120197|646998|P2|COMPLETED|Overall Study||32
267949|NCT01120197|646999|P1|COMPLETED|Overall Study||38
267950|NCT01120197|646998|P2|STARTED|Overall Study||42
267951|NCT01120197|646999|P1|STARTED|Overall Study||47
267952|NCT01120210|647015|P2|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
267953|NCT01120210|647016|P1|NOT COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||0
267954|NCT01120210|647015|P2|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
267955|NCT01120210|647016|P1|COMPLETED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
267956|NCT01120210|647015|P2|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||7
267957|NCT01120210|647016|P1|STARTED|18-HOUR EXTENDED INFUSION SUBSTUDY||3
267958|NCT01120210|647015|P2|NOT COMPLETED|MAIN INFUSION||1
267959|NCT01120210|647016|P1|NOT COMPLETED|MAIN INFUSION||1
267960|NCT01120210|647015|P2|COMPLETED|MAIN INFUSION||45
267961|NCT01120210|647016|P1|COMPLETED|MAIN INFUSION||15
267962|NCT01120210|647015|P2|STARTED|MAIN INFUSION||46
267963|NCT01120210|647016|P1|STARTED|MAIN INFUSION||16
267964|NCT01120223|647046|P1|NOT COMPLETED|Overall Study||4
267965|NCT01120223|647046|P1|COMPLETED|Overall Study||74
267966|NCT01120223|647046|P1|STARTED|Overall Study||78
267967|NCT01120236|647076|P2|NOT COMPLETED|Overall Study||0
267968|NCT01120236|647077|P1|NOT COMPLETED|Overall Study||0
267969|NCT01120236|647076|P2|COMPLETED|Overall Study||106
267970|NCT01120236|647077|P1|COMPLETED|Overall Study||105
267971|NCT01120236|647076|P2|STARTED|Overall Study||106
267972|NCT01120236|647077|P1|STARTED|Overall Study||105
267973|NCT01120275|647087|P1|NOT COMPLETED|Overall Study||36
267974|NCT01120275|647087|P1|COMPLETED|Overall Study||0
267975|NCT01120275|647087|P1|Eligible and Treated|Overall Study||32
267976|NCT01120275|647087|P1|STARTED|Overall Study||36
267977|NCT01120379|647094|P1|NOT COMPLETED|Four Year Timepoint||368
267978|NCT01120379|647094|P1|COMPLETED|Four Year Timepoint||3923
267979|NCT01120379|647094|P1|STARTED|Four Year Timepoint||4291
267980|NCT01120379|647094|P1|NOT COMPLETED|Three Year Timepoint||214
267981|NCT01120379|647094|P1|COMPLETED|Three Year Timepoint||4291
267982|NCT01120379|647094|P1|STARTED|Three Year Timepoint||4505
267983|NCT01120379|647094|P1|NOT COMPLETED|Two Year Timepoint||237
267984|NCT01120379|647094|P1|COMPLETED|Two Year Timepoint||4505
267985|NCT01120379|647094|P1|STARTED|Two Year Timepoint||4742
267986|NCT01120379|647094|P1|NOT COMPLETED|One Year Timepoint||278
267987|NCT01120379|647094|P1|COMPLETED|One Year Timepoint||4742
267988|NCT01120379|647094|P1|STARTED|One Year Timepoint||5020
267989|NCT01120405|647132|P2|NOT COMPLETED|Overall Study||33
267990|NCT01120405|647133|P1|NOT COMPLETED|Overall Study||27
267991|NCT01120405|647132|P2|COMPLETED|Overall Study||269
267992|NCT01120405|647133|P1|COMPLETED|Overall Study||271
267993|NCT01120405|647132|P2|STARTED|Overall Study||302
267994|NCT01120405|647133|P1|STARTED|Overall Study||298
267995|NCT01120626|647163|P2|NOT COMPLETED|Overall Study||0
267996|NCT01120626|647164|P1|NOT COMPLETED|Overall Study||1
267997|NCT01120626|647163|P2|COMPLETED|Overall Study||22
267998|NCT01120626|647164|P1|COMPLETED|Overall Study||19
267999|NCT01120626|647163|P2|STARTED|Overall Study||22
268000|NCT01120626|647164|P1|STARTED|Overall Study||20
268001|NCT01120691|647175|P3|NOT COMPLETED|Overall Study||183
268002|NCT01120691|647176|P2|NOT COMPLETED|Overall Study||203
268003|NCT01120691|647177|P1|NOT COMPLETED|Overall Study||171
268004|NCT01120691|647175|P3|COMPLETED|Overall Study||559
268005|NCT01120691|647176|P2|COMPLETED|Overall Study||538
268006|NCT01120691|647177|P1|COMPLETED|Overall Study||570
268007|NCT01120691|647175|P3|Modified Full Analysis Set (mFAS)|Overall Study||737
268008|NCT01120691|647176|P2|Modified Full Analysis Set (mFAS)|Overall Study||739
268009|NCT01120691|647177|P1|Modified Full Analysis Set (mFAS)|Overall Study||729
268010|NCT01120691|647175|P3|Modified Safety Set (mSAF)|Overall Study||737
268011|NCT01120691|647176|P2|Modified Safety Set (mSAF)|Overall Study||740
268012|NCT01120691|647177|P1|Modified Safety Set (mSAF)|Overall Study||729
268013|NCT01120691|647175|P3|Safety Set (SAF)|Overall Study||739
268014|NCT01120691|647176|P2|Safety Set (SAF)|Overall Study||740
268015|NCT01120691|647177|P1|Safety Set (SAF)|Overall Study||736
268016|NCT01120691|647175|P3|Full Analysis Set (FAS)|Overall Study||739
268017|NCT01120691|647176|P2|Full Analysis Set (FAS)|Overall Study||739
268018|NCT01120691|647177|P1|Full Analysis Set (FAS)|Overall Study||736
268019|NCT01120691|647175|P3|STARTED|Overall Study||742
268020|NCT01120691|647176|P2|STARTED|Overall Study||741
268021|NCT01120691|647177|P1|STARTED|Overall Study||741
268022|NCT01120704|647251|P32|NOT COMPLETED|Overall Study||1
268023|NCT01120704|647252|P31|NOT COMPLETED|Overall Study||2
268024|NCT01120704|647253|P30|NOT COMPLETED|Overall Study||3
268025|NCT01120704|647254|P29|NOT COMPLETED|Overall Study||5
268026|NCT01120704|647255|P28|NOT COMPLETED|Overall Study||2
268027|NCT01120704|647256|P27|NOT COMPLETED|Overall Study||3
268028|NCT01120704|647257|P26|NOT COMPLETED|Overall Study||0
268029|NCT01120704|647258|P25|NOT COMPLETED|Overall Study||2
268030|NCT01120704|647259|P24|NOT COMPLETED|Overall Study||3
268031|NCT01120704|647260|P23|NOT COMPLETED|Overall Study||4
268032|NCT01120704|647261|P22|NOT COMPLETED|Overall Study||0
268033|NCT01120704|647262|P21|NOT COMPLETED|Overall Study||3
268034|NCT01120704|647263|P20|NOT COMPLETED|Overall Study||3
268035|NCT01120704|647264|P19|NOT COMPLETED|Overall Study||2
268036|NCT01120704|647265|P18|NOT COMPLETED|Overall Study||0
268037|NCT01120704|647266|P17|NOT COMPLETED|Overall Study||1
268038|NCT01120704|647267|P16|NOT COMPLETED|Overall Study||2
268039|NCT01120704|647268|P15|NOT COMPLETED|Overall Study||1
268040|NCT01120704|647269|P14|NOT COMPLETED|Overall Study||4
268041|NCT01120704|647270|P13|NOT COMPLETED|Overall Study||3
268042|NCT01120704|647271|P12|NOT COMPLETED|Overall Study||2
268043|NCT01120704|647272|P11|NOT COMPLETED|Overall Study||1
268044|NCT01120704|647273|P10|NOT COMPLETED|Overall Study||1
268045|NCT01120704|647274|P9|NOT COMPLETED|Overall Study||3
268046|NCT01120704|647275|P8|NOT COMPLETED|Overall Study||2
268047|NCT01120704|647276|P7|NOT COMPLETED|Overall Study||3
268048|NCT01120704|647277|P6|NOT COMPLETED|Overall Study||1
268049|NCT01120704|647278|P5|NOT COMPLETED|Overall Study||2
268050|NCT01120704|647279|P4|NOT COMPLETED|Overall Study||4
268051|NCT01120704|647280|P3|NOT COMPLETED|Overall Study||1
268052|NCT01120704|647281|P2|NOT COMPLETED|Overall Study||4
268053|NCT01120704|647282|P1|NOT COMPLETED|Overall Study||3
268054|NCT01120704|647251|P32|COMPLETED|Overall Study||17
268055|NCT01120704|647252|P31|COMPLETED|Overall Study||12
268056|NCT01120704|647253|P30|COMPLETED|Overall Study||12
268057|NCT01120704|647254|P29|COMPLETED|Overall Study||14
268058|NCT01120704|647255|P28|COMPLETED|Overall Study||16
268059|NCT01120704|647256|P27|COMPLETED|Overall Study||15
268060|NCT01120704|647257|P26|COMPLETED|Overall Study||14
268061|NCT01120704|647258|P25|COMPLETED|Overall Study||16
268062|NCT01120704|647259|P24|COMPLETED|Overall Study||13
268063|NCT01120704|647260|P23|COMPLETED|Overall Study||17
268064|NCT01120704|647261|P22|COMPLETED|Overall Study||16
268065|NCT01120704|647262|P21|COMPLETED|Overall Study||14
268066|NCT01120704|647263|P20|COMPLETED|Overall Study||15
268067|NCT01120704|647264|P19|COMPLETED|Overall Study||15
268068|NCT01120704|647265|P18|COMPLETED|Overall Study||16
268069|NCT01120704|647266|P17|COMPLETED|Overall Study||13
268070|NCT01120704|647267|P16|COMPLETED|Overall Study||16
268071|NCT01120704|647268|P15|COMPLETED|Overall Study||17
268072|NCT01120704|647269|P14|COMPLETED|Overall Study||15
268073|NCT01120704|647270|P13|COMPLETED|Overall Study||14
268074|NCT01120704|647271|P12|COMPLETED|Overall Study||14
268075|NCT01120704|647272|P11|COMPLETED|Overall Study||16
268076|NCT01120704|647273|P10|COMPLETED|Overall Study||19
268077|NCT01120704|647274|P9|COMPLETED|Overall Study||19
268078|NCT01120704|647275|P8|COMPLETED|Overall Study||13
268079|NCT01120704|647276|P7|COMPLETED|Overall Study||12
268080|NCT01120704|647277|P6|COMPLETED|Overall Study||18
268081|NCT01120704|647278|P5|COMPLETED|Overall Study||14
268082|NCT01120704|647279|P4|COMPLETED|Overall Study||15
268083|NCT01120704|647280|P3|COMPLETED|Overall Study||13
268084|NCT01120704|647281|P2|COMPLETED|Overall Study||13
268085|NCT01120704|647282|P1|COMPLETED|Overall Study||10
268086|NCT01120704|647251|P32|STARTED|Overall Study||18
268087|NCT01120704|647252|P31|STARTED|Overall Study||14
268088|NCT01120704|647253|P30|STARTED|Overall Study||15
268089|NCT01120704|647254|P29|STARTED|Overall Study||19
268090|NCT01120704|647255|P28|STARTED|Overall Study||18
268091|NCT01120704|647256|P27|STARTED|Overall Study||18
268092|NCT01120704|647257|P26|STARTED|Overall Study||14
268093|NCT01120704|647258|P25|STARTED|Overall Study||18
268094|NCT01120704|647259|P24|STARTED|Overall Study||16
268095|NCT01120704|647260|P23|STARTED|Overall Study||21
268096|NCT01120704|647261|P22|STARTED|Overall Study||16
268097|NCT01120704|647262|P21|STARTED|Overall Study||17
268098|NCT01120704|647263|P20|STARTED|Overall Study||18
268099|NCT01120704|647264|P19|STARTED|Overall Study||17
268100|NCT01120704|647265|P18|STARTED|Overall Study||16
268101|NCT01120704|647266|P17|STARTED|Overall Study||14
268102|NCT01120704|647267|P16|STARTED|Overall Study||18
268103|NCT01120704|647268|P15|STARTED|Overall Study||18
268104|NCT01120704|647269|P14|STARTED|Overall Study||19
268105|NCT01120704|647270|P13|STARTED|Overall Study||17
268106|NCT01120704|647271|P12|STARTED|Overall Study||16
268107|NCT01120704|647272|P11|STARTED|Overall Study||17
268108|NCT01120704|647273|P10|STARTED|Overall Study||20
268109|NCT01120704|647274|P9|STARTED|Overall Study||22
268110|NCT01120704|647275|P8|STARTED|Overall Study||15
268111|NCT01120704|647276|P7|STARTED|Overall Study||15
268112|NCT01120704|647277|P6|STARTED|Overall Study||19
268113|NCT01120704|647278|P5|STARTED|Overall Study||16
268114|NCT01120704|647279|P4|STARTED|Overall Study||19
268115|NCT01120704|647280|P3|STARTED|Overall Study||14
268116|NCT01120704|647281|P2|STARTED|Overall Study||17
268117|NCT01120704|647282|P1|STARTED|Overall Study||13
268118|NCT01120717|647308|P2|NOT COMPLETED|Overall Study||24
268119|NCT01120717|647309|P1|NOT COMPLETED|Overall Study||32
268120|NCT01120717|647308|P2|COMPLETED|Overall Study||89
268121|NCT01120717|647309|P1|COMPLETED|Overall Study||194
268122|NCT01120717|647308|P2|Safety Population: Received Study Drug|Overall Study||113
268123|NCT01120717|647309|P1|Safety Population: Received Study Drug|Overall Study||225
268124|NCT01120717|647308|P2|STARTED|Overall Study||113
268125|NCT01120717|647309|P1|STARTED|Overall Study||226
268126|NCT01120782|647325|P1|NOT COMPLETED|Overall Study||11
268127|NCT01120782|647325|P1|COMPLETED|Overall Study||34
268128|NCT01120782|647325|P1|STARTED|Overall Study||45
268129|NCT01114438|647329|P1|NOT COMPLETED|Overall Study||14
268130|NCT01114438|647329|P1|COMPLETED|Overall Study||31
268131|NCT01114438|647329|P1|STARTED|Overall Study||45
268132|NCT01114503|647339|P1|NOT COMPLETED|Overall Study||0
268133|NCT01114503|647339|P1|COMPLETED|Overall Study||2
268134|NCT01114503|647339|P1|STARTED|Overall Study||2
268135|NCT01114516|647362|P2|NOT COMPLETED|Overall Study||1
268136|NCT01114516|647363|P1|NOT COMPLETED|Overall Study||2
268137|NCT01114516|647362|P2|COMPLETED|Overall Study||26
268138|NCT01114516|647363|P1|COMPLETED|Overall Study||24
268139|NCT01114516|647362|P2|STARTED|Overall Study||27
268140|NCT01114516|647363|P1|STARTED|Overall Study||26
268141|NCT01114529|647380|P3|NOT COMPLETED|Completed Study Phase at Month 24||14
268142|NCT01114529|647381|P2|NOT COMPLETED|Completed Study Phase at Month 24||16
268143|NCT01114529|647382|P1|NOT COMPLETED|Completed Study Phase at Month 24||40
268144|NCT01114529|647380|P3|COMPLETED|Completed Study Phase at Month 24|at month 24|111
268145|NCT01114529|647381|P2|COMPLETED|Completed Study Phase at Month 24|at month 24|215
268146|NCT01114529|647382|P1|COMPLETED|Completed Study Phase at Month 24|at month 24|313
268147|NCT01114529|647380|P3|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|125
268148|NCT01114529|647381|P2|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|231
268149|NCT01114529|647382|P1|STARTED|Completed Study Phase at Month 24|It includes those discontinued treatment|353
268150|NCT01114529|647380|P3|NOT COMPLETED|Completed Study Medication at Month 24||32
268151|NCT01114529|647381|P2|NOT COMPLETED|Completed Study Medication at Month 24||41
268152|NCT01114529|647382|P1|NOT COMPLETED|Completed Study Medication at Month 24||124
268153|NCT01114529|647380|P3|COMPLETED|Completed Study Medication at Month 24|completed at month 24|93
268154|NCT01114529|647381|P2|COMPLETED|Completed Study Medication at Month 24|completed at month 24|190
268155|NCT01114529|647382|P1|COMPLETED|Completed Study Medication at Month 24|completed at month 24|229
268156|NCT01114529|647380|P3|STARTED|Completed Study Medication at Month 24|Randomized set-125 Full analysis set -125 Safety analysis set -121***|125
268157|NCT01114529|647381|P2|STARTED|Completed Study Medication at Month 24|Randomized set -231 Full analysis set -231 Safety analysis set -238**|231
268158|NCT01114529|647382|P1|STARTED|Completed Study Medication at Month 24|Randomized set - 360 Full analysis set - 353 Safety analysis set -346*|353
268159|NCT01120808|647399|P1|NOT COMPLETED|Overall Study||46
268160|NCT01120808|647399|P1|COMPLETED|Overall Study||90
268161|NCT01120808|647399|P1|STARTED|Overall Study||136
268162|NCT01120834|647403|P1|NOT COMPLETED|Overall Study||0
268163|NCT01120834|647403|P1|COMPLETED|Overall Study||18
268164|NCT01120834|647403|P1|STARTED|Overall Study||18
268165|NCT01120899|647407|P1|NOT COMPLETED|Overall Study||3
268166|NCT01120899|647407|P1|COMPLETED|Overall Study||3
268167|NCT01120899|647407|P1|Month 18|Overall Study||3
268168|NCT01120899|647407|P1|Month 12|Overall Study||3
268169|NCT01120899|647407|P1|Month 6|Overall Study||5
268170|NCT01120899|647407|P1|STARTED|Overall Study||6
268171|NCT01120990|647427|P1|NOT COMPLETED|Overall Study||0
268172|NCT01120990|647427|P1|COMPLETED|Overall Study||51
268173|NCT01120990|647427|P1|STARTED|Overall Study||51
268174|NCT01121484|647436|P2|NOT COMPLETED|Overall Study||43
268175|NCT01121484|647437|P1|NOT COMPLETED|Overall Study||33
268176|NCT01121484|647436|P2|COMPLETED|Overall Study||178
268177|NCT01121484|647437|P1|COMPLETED|Overall Study||185
268178|NCT01121484|647436|P2|Treated|Overall Study||217
268179|NCT01121484|647437|P1|Treated|Overall Study||217
268180|NCT01121484|647436|P2|STARTED|Overall Study||221
268181|NCT01121484|647437|P1|STARTED|Overall Study||218
268182|NCT01121536|647453|P1|NOT COMPLETED|Overall Study||361
268183|NCT01121536|647453|P1|COMPLETED|Overall Study|One participant 'completed' early due to study closeout.|506
268184|NCT01121536|647453|P1|Full Analysis Population|Overall Study|Treated participants who had at least 1 post-baseline efficacy assessment.|859
268185|NCT01121536|647453|P1|Safety Population|Overall Study|Participants treated|863
268186|NCT01121536|647453|P1|STARTED|Overall Study||867
268187|NCT01121549|647472|P1|NOT COMPLETED|Overall Study||347
268188|NCT01121549|647472|P1|COMPLETED|Overall Study||31
268189|NCT01121549|647472|P1|STARTED|Overall Study||378
268190|NCT01121562|647483|P1|NOT COMPLETED|Overall Study||12
268191|NCT01121562|647483|P1|COMPLETED|Overall Study||0
268192|NCT01121562|647483|P1|STARTED|Overall Study||12
268193|NCT01121575|647498|P6|NOT COMPLETED|Overall Study||12
268194|NCT01121575|647499|P5|NOT COMPLETED|Overall Study||25
268195|NCT01121575|647500|P4|NOT COMPLETED|Overall Study||6
268196|NCT01121575|647501|P3|NOT COMPLETED|Overall Study||7
268197|NCT01121575|647502|P2|NOT COMPLETED|Overall Study||6
268198|NCT01121575|647503|P1|NOT COMPLETED|Overall Study||14
268199|NCT01121575|647498|P6|COMPLETED|Overall Study||0
268200|NCT01121575|647499|P5|COMPLETED|Overall Study||0
268201|NCT01121575|647500|P4|COMPLETED|Overall Study||0
268202|NCT01121575|647501|P3|COMPLETED|Overall Study||0
268203|NCT01121575|647502|P2|COMPLETED|Overall Study||0
268204|NCT01121575|647503|P1|COMPLETED|Overall Study||0
268205|NCT01121575|647498|P6|Treated|Overall Study||12
268206|NCT01121575|647499|P5|Treated|Overall Study||25
268207|NCT01121575|647500|P4|Treated|Overall Study||6
268208|NCT01121575|647501|P3|Treated|Overall Study||7
268209|NCT01121575|647502|P2|Treated|Overall Study||6
268210|NCT01121575|647503|P1|Treated|Overall Study||14
268211|NCT01121575|647498|P6|STARTED|Overall Study||12
268212|NCT01121575|647499|P5|STARTED|Overall Study||25
268213|NCT01121575|647500|P4|STARTED|Overall Study||6
268214|NCT01121575|647501|P3|STARTED|Overall Study||7
268215|NCT01121575|647502|P2|STARTED|Overall Study||6
268216|NCT01121575|647503|P1|STARTED|Overall Study||14
268217|NCT01121666|647629|P2|NOT COMPLETED|Overall Study||10
268218|NCT01121666|647630|P1|NOT COMPLETED|Overall Study||29
268219|NCT01121666|647629|P2|COMPLETED|Overall Study||113
268220|NCT01121666|647630|P1|COMPLETED|Overall Study||220
268221|NCT01121666|647629|P2|STARTED|Overall Study||123
268222|NCT01121666|647630|P1|STARTED|Overall Study||249
268223|NCT01121757|647682|P2|NOT COMPLETED|Combination||1
268224|NCT01121757|647683|P1|NOT COMPLETED|Combination||2
268225|NCT01121757|647682|P2|COMPLETED|Combination||0
268226|NCT01121757|647683|P1|COMPLETED|Combination||0
268227|NCT01121757|647682|P2|STARTED|Combination||1
268228|NCT01121757|647683|P1|STARTED|Combination|2 subjects did not start combination drug. 1 elected surgery 1 had a complete response after drug 2.|2
268229|NCT01121757|647682|P2|NOT COMPLETED|Second Drug||0
268230|NCT01121757|647683|P1|NOT COMPLETED|Second Drug||0
268231|NCT01121757|647682|P2|COMPLETED|Second Drug||1
268232|NCT01121757|647683|P1|COMPLETED|Second Drug||4
268233|NCT01121757|647682|P2|STARTED|Second Drug||1
268234|NCT01121757|647683|P1|STARTED|Second Drug|1 subject did not start drug 2 due to disease progression|4
268235|NCT01121757|647682|P2|NOT COMPLETED|First Drug||2
268236|NCT01121757|647683|P1|NOT COMPLETED|First Drug||1
268237|NCT01121757|647682|P2|COMPLETED|First Drug|Completed a minimum of 4 cycles of Lenalidomide|1
268238|NCT01121757|647683|P1|COMPLETED|First Drug|Completed a minimum of 4 cycles of Azacitidine.|5
268239|NCT01121757|647682|P2|STARTED|First Drug||3
268240|NCT01121757|647683|P1|STARTED|First Drug||6
268241|NCT01121900|647697|P2|NOT COMPLETED|Second Intervention Period||0
268242|NCT01121900|647698|P1|NOT COMPLETED|Second Intervention Period||0
268243|NCT01121900|647697|P2|COMPLETED|Second Intervention Period||11
268244|NCT01121900|647698|P1|COMPLETED|Second Intervention Period||12
268245|NCT01121900|647697|P2|STARTED|Second Intervention Period||11
268246|NCT01121900|647698|P1|STARTED|Second Intervention Period||12
268247|NCT01121900|647697|P2|NOT COMPLETED|Washout Period of 7 Days||1
268248|NCT01121900|647698|P1|NOT COMPLETED|Washout Period of 7 Days||0
268249|NCT01121900|647697|P2|COMPLETED|Washout Period of 7 Days||11
268250|NCT01121900|647698|P1|COMPLETED|Washout Period of 7 Days||12
268251|NCT01121900|647697|P2|STARTED|Washout Period of 7 Days||12
268252|NCT01121900|647698|P1|STARTED|Washout Period of 7 Days||12
268253|NCT01121900|647697|P2|NOT COMPLETED|First Intervention Period||1
268254|NCT01121900|647698|P1|NOT COMPLETED|First Intervention Period||1
268255|NCT01121900|647697|P2|COMPLETED|First Intervention Period||12
268256|NCT01121900|647698|P1|COMPLETED|First Intervention Period||12
268257|NCT01121900|647697|P2|STARTED|First Intervention Period||13
268258|NCT01121900|647698|P1|STARTED|First Intervention Period||13
268259|NCT01121913|647716|P4|NOT COMPLETED|Fourth Intervention Period||0
268260|NCT01121913|647717|P3|NOT COMPLETED|Fourth Intervention Period||0
268261|NCT01121913|647718|P2|NOT COMPLETED|Fourth Intervention Period||0
268262|NCT01121913|647719|P1|NOT COMPLETED|Fourth Intervention Period||0
268263|NCT01121913|647716|P4|COMPLETED|Fourth Intervention Period||6
268264|NCT01121913|647717|P3|COMPLETED|Fourth Intervention Period||3
268265|NCT01121913|647718|P2|COMPLETED|Fourth Intervention Period||6
268266|NCT01121913|647719|P1|COMPLETED|Fourth Intervention Period||4
268267|NCT01121913|647716|P4|STARTED|Fourth Intervention Period||6
268268|NCT01121913|647717|P3|STARTED|Fourth Intervention Period||3
268269|NCT01121913|647718|P2|STARTED|Fourth Intervention Period||6
268270|NCT01121913|647719|P1|STARTED|Fourth Intervention Period||4
268271|NCT01121913|647716|P4|NOT COMPLETED|Third Washout Period||0
268272|NCT01121913|647717|P3|NOT COMPLETED|Third Washout Period||0
268273|NCT01121913|647718|P2|NOT COMPLETED|Third Washout Period||0
268274|NCT01121913|647719|P1|NOT COMPLETED|Third Washout Period||1
268275|NCT01121913|647716|P4|COMPLETED|Third Washout Period||6
268276|NCT01121913|647717|P3|COMPLETED|Third Washout Period||3
268277|NCT01121913|647718|P2|COMPLETED|Third Washout Period||6
268278|NCT01121913|647719|P1|COMPLETED|Third Washout Period||4
268279|NCT01121913|647716|P4|STARTED|Third Washout Period||6
268280|NCT01121913|647717|P3|STARTED|Third Washout Period||3
268281|NCT01121913|647718|P2|STARTED|Third Washout Period||6
268282|NCT01121913|647719|P1|STARTED|Third Washout Period||5
268283|NCT01121913|647716|P4|NOT COMPLETED|Third Intervention Period||0
268284|NCT01121913|647717|P3|NOT COMPLETED|Third Intervention Period||0
268285|NCT01121913|647718|P2|NOT COMPLETED|Third Intervention Period||0
268286|NCT01121913|647719|P1|NOT COMPLETED|Third Intervention Period||0
268287|NCT01121913|647716|P4|COMPLETED|Third Intervention Period||6
268288|NCT01121913|647717|P3|COMPLETED|Third Intervention Period||3
268289|NCT01121913|647718|P2|COMPLETED|Third Intervention Period||6
268290|NCT01121913|647719|P1|COMPLETED|Third Intervention Period||5
268291|NCT01121913|647716|P4|STARTED|Third Intervention Period||6
268292|NCT01121913|647717|P3|STARTED|Third Intervention Period||3
268293|NCT01121913|647718|P2|STARTED|Third Intervention Period||6
268294|NCT01121913|647719|P1|STARTED|Third Intervention Period||5
268295|NCT01121913|647716|P4|NOT COMPLETED|Second Washout Period||0
268296|NCT01121913|647717|P3|NOT COMPLETED|Second Washout Period||1
268297|NCT01121913|647718|P2|NOT COMPLETED|Second Washout Period||0
268298|NCT01121913|647719|P1|NOT COMPLETED|Second Washout Period||0
268299|NCT01121913|647716|P4|COMPLETED|Second Washout Period||6
268300|NCT01121913|647717|P3|COMPLETED|Second Washout Period||3
268301|NCT01121913|647718|P2|COMPLETED|Second Washout Period||6
268302|NCT01121913|647719|P1|COMPLETED|Second Washout Period||5
268303|NCT01121913|647716|P4|STARTED|Second Washout Period||6
268304|NCT01121913|647717|P3|STARTED|Second Washout Period||4
268305|NCT01121913|647718|P2|STARTED|Second Washout Period||6
268306|NCT01121913|647719|P1|STARTED|Second Washout Period||5
268307|NCT01121913|647716|P4|NOT COMPLETED|Second Intervention Period||0
268308|NCT01121913|647717|P3|NOT COMPLETED|Second Intervention Period||1
268309|NCT01121913|647718|P2|NOT COMPLETED|Second Intervention Period||0
268310|NCT01121913|647719|P1|NOT COMPLETED|Second Intervention Period||0
268311|NCT01121913|647716|P4|COMPLETED|Second Intervention Period||6
268312|NCT01121913|647717|P3|COMPLETED|Second Intervention Period||4
268313|NCT01121913|647718|P2|COMPLETED|Second Intervention Period||6
268314|NCT01121913|647719|P1|COMPLETED|Second Intervention Period||5
268315|NCT01121913|647716|P4|STARTED|Second Intervention Period||6
268316|NCT01121913|647717|P3|STARTED|Second Intervention Period||5
268317|NCT01121913|647718|P2|STARTED|Second Intervention Period||6
268318|NCT01121913|647719|P1|STARTED|Second Intervention Period||5
268319|NCT01121913|647716|P4|NOT COMPLETED|First Washout Period||0
268320|NCT01121913|647717|P3|NOT COMPLETED|First Washout Period||0
268321|NCT01121913|647718|P2|NOT COMPLETED|First Washout Period||0
268322|NCT01121913|647719|P1|NOT COMPLETED|First Washout Period||1
268323|NCT01121913|647716|P4|COMPLETED|First Washout Period||6
268324|NCT01121913|647717|P3|COMPLETED|First Washout Period||5
268325|NCT01121913|647718|P2|COMPLETED|First Washout Period||6
268326|NCT01121913|647719|P1|COMPLETED|First Washout Period||5
268327|NCT01121913|647716|P4|STARTED|First Washout Period||6
268328|NCT01121913|647717|P3|STARTED|First Washout Period||5
268329|NCT01121913|647718|P2|STARTED|First Washout Period||6
268330|NCT01121913|647719|P1|STARTED|First Washout Period||6
268331|NCT01121913|647716|P4|NOT COMPLETED|First Intervention Period||0
268332|NCT01121913|647717|P3|NOT COMPLETED|First Intervention Period||1
268333|NCT01121913|647718|P2|NOT COMPLETED|First Intervention Period||0
268334|NCT01121913|647719|P1|NOT COMPLETED|First Intervention Period||0
268335|NCT01121913|647716|P4|COMPLETED|First Intervention Period||6
268336|NCT01121913|647717|P3|COMPLETED|First Intervention Period||5
268337|NCT01121913|647718|P2|COMPLETED|First Intervention Period||6
268338|NCT01121913|647719|P1|COMPLETED|First Intervention Period||6
268339|NCT01121913|647716|P4|STARTED|First Intervention Period||6
268340|NCT01121913|647717|P3|STARTED|First Intervention Period||6
268341|NCT01121913|647718|P2|STARTED|First Intervention Period||6
268342|NCT01121913|647719|P1|STARTED|First Intervention Period||6
268343|NCT01121926|647749|P2|NOT COMPLETED|Second Intervention Period||0
268344|NCT01121926|647750|P1|NOT COMPLETED|Second Intervention Period||0
268345|NCT01121926|647749|P2|COMPLETED|Second Intervention Period||13
268346|NCT01121926|647750|P1|COMPLETED|Second Intervention Period||14
268347|NCT01121926|647749|P2|STARTED|Second Intervention Period||13
268348|NCT01121926|647750|P1|STARTED|Second Intervention Period||14
268349|NCT01121926|647749|P2|NOT COMPLETED|Washout Period||2
268350|NCT01121926|647750|P1|NOT COMPLETED|Washout Period||0
268351|NCT01121926|647749|P2|COMPLETED|Washout Period||13
268352|NCT01121926|647750|P1|COMPLETED|Washout Period||14
268353|NCT01121926|647749|P2|STARTED|Washout Period||15
268354|NCT01121926|647750|P1|STARTED|Washout Period||14
268355|NCT01121926|647749|P2|NOT COMPLETED|First Intervention Period||0
268356|NCT01121926|647750|P1|NOT COMPLETED|First Intervention Period||1
268357|NCT01121926|647749|P2|COMPLETED|First Intervention Period||15
268358|NCT01121926|647750|P1|COMPLETED|First Intervention Period||14
268359|NCT01121926|647749|P2|STARTED|First Intervention Period||15
268360|NCT01121926|647750|P1|STARTED|First Intervention Period||15
268361|NCT01121939|647768|P1|NOT COMPLETED|Overall Study||43
268362|NCT01121939|647768|P1|COMPLETED|Overall Study|Patients remained on-study until disease progression or unacceptable toxicity occurred.|0
268363|NCT01121939|647768|P1|STARTED|Overall Study||43
268364|NCT01121991|647782|P1|NOT COMPLETED|Overall Study||6
268365|NCT01121991|647782|P1|COMPLETED|Overall Study||46
268366|NCT01121991|647782|P1|STARTED|Overall Study|Number of participants treated|52
268367|NCT01122030|647800|P7|NOT COMPLETED|Overall Study||0
268368|NCT01122030|647801|P6|NOT COMPLETED|Overall Study||0
268369|NCT01122030|647802|P5|NOT COMPLETED|Overall Study||0
268370|NCT01122030|647803|P4|NOT COMPLETED|Overall Study||0
268371|NCT01122030|647804|P3|NOT COMPLETED|Overall Study||0
268372|NCT01122030|647805|P2|NOT COMPLETED|Overall Study||0
268373|NCT01122030|647806|P1|NOT COMPLETED|Overall Study||0
268374|NCT01122030|647800|P7|COMPLETED|Overall Study||9
268375|NCT01122030|647801|P6|COMPLETED|Overall Study||9
268376|NCT01122030|647802|P5|COMPLETED|Overall Study||9
268377|NCT01122030|647803|P4|COMPLETED|Overall Study||9
268378|NCT01122030|647804|P3|COMPLETED|Overall Study||9
268379|NCT01122030|647805|P2|COMPLETED|Overall Study||9
268380|NCT01122030|647806|P1|COMPLETED|Overall Study||18
268381|NCT01122030|647800|P7|Received Treatment|Overall Study||9
268382|NCT01122030|647801|P6|Received Treatment|Overall Study||9
268383|NCT01122030|647802|P5|Received Treatment|Overall Study||9
268384|NCT01122030|647803|P4|Received Treatment|Overall Study||9
268385|NCT01122030|647804|P3|Received Treatment|Overall Study||9
268386|NCT01122030|647805|P2|Received Treatment|Overall Study||9
268387|NCT01122030|647806|P1|Received Treatment|Overall Study||18
268388|NCT01122030|647800|P7|STARTED|Overall Study||9
268389|NCT01122030|647801|P6|STARTED|Overall Study||9
268390|NCT01122030|647802|P5|STARTED|Overall Study||9
268391|NCT01122030|647803|P4|STARTED|Overall Study||9
268392|NCT01122030|647804|P3|STARTED|Overall Study||9
268393|NCT01122030|647805|P2|STARTED|Overall Study||9
268394|NCT01122030|647806|P1|STARTED|Overall Study||18
268395|NCT01122108|647992|P2|NOT COMPLETED|Overall Study||0
268396|NCT01122108|647993|P1|NOT COMPLETED|Overall Study||0
268397|NCT01122108|647992|P2|COMPLETED|Overall Study||21
268398|NCT01122108|647993|P1|COMPLETED|Overall Study||21
268399|NCT01122108|647992|P2|STARTED|Overall Study||21
268400|NCT01122108|647993|P1|STARTED|Overall Study||21
268401|NCT01122160|648002|P2|NOT COMPLETED|Second Intervention (7 Days)||0
268402|NCT01122160|648003|P1|NOT COMPLETED|Second Intervention (7 Days)||0
268403|NCT01122160|648002|P2|COMPLETED|Second Intervention (7 Days)||5
268404|NCT01122160|648003|P1|COMPLETED|Second Intervention (7 Days)||6
268405|NCT01122160|648002|P2|STARTED|Second Intervention (7 Days)||5
268406|NCT01122160|648003|P1|STARTED|Second Intervention (7 Days)||6
268407|NCT01122160|648002|P2|NOT COMPLETED|Washout (7-14 Days)||0
268408|NCT01122160|648003|P1|NOT COMPLETED|Washout (7-14 Days)||0
268409|NCT01122160|648002|P2|COMPLETED|Washout (7-14 Days)||5
268410|NCT01122160|648003|P1|COMPLETED|Washout (7-14 Days)||6
268411|NCT01122160|648002|P2|STARTED|Washout (7-14 Days)||5
268412|NCT01122160|648003|P1|STARTED|Washout (7-14 Days)||6
268413|NCT01122160|648002|P2|NOT COMPLETED|First Intervention (7 Days)||0
268414|NCT01122160|648003|P1|NOT COMPLETED|First Intervention (7 Days)||0
268415|NCT01122160|648002|P2|COMPLETED|First Intervention (7 Days)||5
268416|NCT01122160|648003|P1|COMPLETED|First Intervention (7 Days)||6
268417|NCT01122160|648002|P2|STARTED|First Intervention (7 Days)||5
268418|NCT01122160|648003|P1|STARTED|First Intervention (7 Days)||6
268419|NCT01122238|648025|P16|NOT COMPLETED|Overall Study||0
268420|NCT01122238|648026|P15|NOT COMPLETED|Overall Study||0
268421|NCT01122238|648027|P14|NOT COMPLETED|Overall Study||1
268422|NCT01122238|648028|P13|NOT COMPLETED|Overall Study||2
268423|NCT01122238|648029|P12|NOT COMPLETED|Overall Study||2
268424|NCT01122238|648030|P11|NOT COMPLETED|Overall Study||0
268425|NCT01122238|648031|P10|NOT COMPLETED|Overall Study||1
268426|NCT01122238|648032|P9|NOT COMPLETED|Overall Study||1
268427|NCT01122238|648033|P8|NOT COMPLETED|Overall Study||0
268428|NCT01122238|648034|P7|NOT COMPLETED|Overall Study||1
268429|NCT01122238|648035|P6|NOT COMPLETED|Overall Study||1
268430|NCT01122238|648036|P5|NOT COMPLETED|Overall Study||0
268431|NCT01122238|648037|P4|NOT COMPLETED|Overall Study||0
268432|NCT01122238|648038|P3|NOT COMPLETED|Overall Study||5
268433|NCT01122238|648039|P2|NOT COMPLETED|Overall Study||1
268434|NCT01122238|648040|P1|NOT COMPLETED|Overall Study||2
268435|NCT01122238|648025|P16|COMPLETED|Overall Study||31
268436|NCT01122238|648026|P15|COMPLETED|Overall Study||28
268437|NCT01122238|648027|P14|COMPLETED|Overall Study||31
268438|NCT01122238|648028|P13|COMPLETED|Overall Study||28
268439|NCT01122238|648029|P12|COMPLETED|Overall Study||31
268440|NCT01122238|648030|P11|COMPLETED|Overall Study||32
268441|NCT01122238|648031|P10|COMPLETED|Overall Study||33
268442|NCT01122238|648032|P9|COMPLETED|Overall Study||31
268443|NCT01122238|648033|P8|COMPLETED|Overall Study||32
268444|NCT01122238|648034|P7|COMPLETED|Overall Study||34
268445|NCT01122238|648035|P6|COMPLETED|Overall Study||31
268446|NCT01122238|648036|P5|COMPLETED|Overall Study||33
268447|NCT01122238|648037|P4|COMPLETED|Overall Study||33
268448|NCT01122238|648038|P3|COMPLETED|Overall Study||28
268449|NCT01122238|648039|P2|COMPLETED|Overall Study||36
268450|NCT01122238|648040|P1|COMPLETED|Overall Study||28
268451|NCT01122238|648025|P16|STARTED|Overall Study||31
268452|NCT01122238|648026|P15|STARTED|Overall Study||28
268453|NCT01122238|648027|P14|STARTED|Overall Study||32
268454|NCT01122238|648028|P13|STARTED|Overall Study||30
268455|NCT01122238|648029|P12|STARTED|Overall Study||33
268456|NCT01122238|648030|P11|STARTED|Overall Study||32
268457|NCT01122238|648031|P10|STARTED|Overall Study||34
268458|NCT01122238|648032|P9|STARTED|Overall Study||32
268459|NCT01122238|648033|P8|STARTED|Overall Study||32
268460|NCT01122238|648034|P7|STARTED|Overall Study||35
268461|NCT01122238|648035|P6|STARTED|Overall Study||32
268462|NCT01122238|648036|P5|STARTED|Overall Study||33
268463|NCT01122238|648037|P4|STARTED|Overall Study||33
268464|NCT01122238|648038|P3|STARTED|Overall Study||33
268465|NCT01122238|648039|P2|STARTED|Overall Study||37
268466|NCT01122238|648040|P1|STARTED|Overall Study||30
268467|NCT01122264|648065|P3|NOT COMPLETED|Overall Study||47
268468|NCT01122264|648066|P2|NOT COMPLETED|Overall Study||29
268469|NCT01122264|648067|P1|NOT COMPLETED|Overall Study||32
268470|NCT01122264|648065|P3|COMPLETED|Overall Study||214
268471|NCT01122264|648066|P2|COMPLETED|Overall Study||228
268472|NCT01122264|648067|P1|COMPLETED|Overall Study||220
268473|NCT01122264|648065|P3|Received at Least 1 Dose of Study Drug|Overall Study||260
268474|NCT01122264|648066|P2|Received at Least 1 Dose of Study Drug|Overall Study||257
268475|NCT01122264|648067|P1|Received at Least 1 Dose of Study Drug|Overall Study||250
268476|NCT01122264|648065|P3|STARTED|Overall Study||261
268477|NCT01122264|648066|P2|STARTED|Overall Study||257
268478|NCT01122264|648067|P1|STARTED|Overall Study||252
268479|NCT01122381|648126|P2|NOT COMPLETED|Overall Study||1
268480|NCT01122381|648127|P1|NOT COMPLETED|Overall Study||0
268481|NCT01122381|648126|P2|COMPLETED|Overall Study||0
268482|NCT01122381|648127|P1|COMPLETED|Overall Study|Subject never took the drug per review of ESX levels after unblinding|1
268483|NCT01122381|648126|P2|STARTED|Overall Study||1
268484|NCT01122381|648127|P1|STARTED|Overall Study||1
268485|NCT01122394|648135|P2|NOT COMPLETED|Overall Study||4
268486|NCT01122394|648136|P1|NOT COMPLETED|Overall Study||3
268487|NCT01122394|648135|P2|COMPLETED|Overall Study||70
268488|NCT01122394|648136|P1|COMPLETED|Overall Study||63
268489|NCT01122394|648135|P2|STARTED|Overall Study||74
268490|NCT01122394|648136|P1|STARTED|Overall Study||66
268491|NCT01122511|648152|P2|NOT COMPLETED|Overall Study||2
268492|NCT01122511|648153|P1|NOT COMPLETED|Overall Study||2
268493|NCT01122511|648152|P2|COMPLETED|Overall Study||0
268494|NCT01122511|648153|P1|COMPLETED|Overall Study||0
268495|NCT01122511|648152|P2|STARTED|Overall Study||2
268496|NCT01122511|648153|P1|STARTED|Overall Study||2
268497|NCT01122576|648168|P3|NOT COMPLETED|Post-Cataract Surgery||2
268498|NCT01122576|648169|P2|NOT COMPLETED|Post-Cataract Surgery||0
268499|NCT01122576|648170|P1|NOT COMPLETED|Post-Cataract Surgery||0
268500|NCT01122576|648168|P3|COMPLETED|Post-Cataract Surgery||22
268501|NCT01122576|648169|P2|COMPLETED|Post-Cataract Surgery||25
268502|NCT01122576|648170|P1|COMPLETED|Post-Cataract Surgery||26
268503|NCT01122576|648168|P3|STARTED|Post-Cataract Surgery||24
268504|NCT01122576|648169|P2|STARTED|Post-Cataract Surgery||25
268505|NCT01122576|648170|P1|STARTED|Post-Cataract Surgery||26
268506|NCT01122576|648168|P3|NOT COMPLETED|Pre-Cataract Surgery||2
268507|NCT01122576|648169|P2|NOT COMPLETED|Pre-Cataract Surgery||1
268508|NCT01122576|648170|P1|NOT COMPLETED|Pre-Cataract Surgery||0
268509|NCT01122576|648168|P3|COMPLETED|Pre-Cataract Surgery||24
268510|NCT01122576|648169|P2|COMPLETED|Pre-Cataract Surgery||25
268511|NCT01122576|648170|P1|COMPLETED|Pre-Cataract Surgery||26
268512|NCT01122576|648168|P3|STARTED|Pre-Cataract Surgery||26
268513|NCT01122576|648169|P2|STARTED|Pre-Cataract Surgery||26
268514|NCT01122576|648170|P1|STARTED|Pre-Cataract Surgery||26
268515|NCT01122680|648307|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
268516|NCT01122680|648308|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
268517|NCT01122680|648309|P2|NOT COMPLETED|Period 3 (4 Weeks)||1
268518|NCT01122680|648310|P1|NOT COMPLETED|Period 3 (4 Weeks)||1
268519|NCT01122680|648307|P4|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|23
268520|NCT01122680|648308|P3|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|26
268521|NCT01122680|648309|P2|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
268522|NCT01122680|648310|P1|COMPLETED|Period 3 (4 Weeks)|Completed treatment in this crossover period.|24
268523|NCT01122680|648307|P4|STARTED|Period 3 (4 Weeks)|Entered this study period.|23
268524|NCT01122680|648308|P3|STARTED|Period 3 (4 Weeks)|Entered this study period.|26
268525|NCT01122680|648309|P2|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
268526|NCT01122680|648310|P1|STARTED|Period 3 (4 Weeks)|Entered this study period.|25
268527|NCT01122680|648307|P4|NOT COMPLETED|Period 2 (4 Weeks)||1
268528|NCT01122680|648308|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
268529|NCT01122680|648309|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
268530|NCT01122680|648310|P1|NOT COMPLETED|Period 2 (4 Weeks)||1
268531|NCT01122680|648307|P4|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|23
268532|NCT01122680|648308|P3|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|26
268533|NCT01122680|648309|P2|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
268534|NCT01122680|648310|P1|COMPLETED|Period 2 (4 Weeks)|Completed treatment in this crossover period.|25
268535|NCT01122680|648307|P4|STARTED|Period 2 (4 Weeks)|Entered this study period.|24
268536|NCT01122680|648308|P3|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
268537|NCT01122680|648309|P2|STARTED|Period 2 (4 Weeks)|Entered this study period.|25
268538|NCT01122680|648310|P1|STARTED|Period 2 (4 Weeks)|Entered this study period.|26
268539|NCT01122680|648307|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
268540|NCT01122680|648308|P3|NOT COMPLETED|Period 1 (4 Weeks)||0
268541|NCT01122680|648309|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
268542|NCT01122680|648310|P1|NOT COMPLETED|Period 1 (4 Weeks)||3
268543|NCT01122680|648307|P4|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|24
268627|NCT01123395|648484|P1|COMPLETED|Period 1||8
268544|NCT01122680|648308|P3|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
268545|NCT01122680|648309|P2|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|25
268546|NCT01122680|648310|P1|COMPLETED|Period 1 (4 Weeks)|Completed treatment in this crossover period.|26
268547|NCT01122680|648307|P4|STARTED|Period 1 (4 Weeks)|Entered this study period.|24
268548|NCT01122680|648308|P3|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
268549|NCT01122680|648309|P2|STARTED|Period 1 (4 Weeks)|Entered this study period.|26
268550|NCT01122680|648310|P1|STARTED|Period 1 (4 Weeks)|Entered this study period.|29
268551|NCT01122862|648372|P3|NOT COMPLETED|Period 3||0
268552|NCT01122862|648373|P2|NOT COMPLETED|Period 3||0
268553|NCT01122862|648374|P1|NOT COMPLETED|Period 3||0
268554|NCT01122862|648372|P3|COMPLETED|Period 3||8
268555|NCT01122862|648373|P2|COMPLETED|Period 3||7
268556|NCT01122862|648374|P1|COMPLETED|Period 3||6
268557|NCT01122862|648372|P3|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|8
268558|NCT01122862|648373|P2|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|7
268559|NCT01122862|648374|P1|STARTED|Period 3|Due to crossover design,a different set of participants received this treatment compared to Period 2|6
268560|NCT01122862|648372|P3|NOT COMPLETED|Period 2||1
268561|NCT01122862|648373|P2|NOT COMPLETED|Period 2||0
268562|NCT01122862|648374|P1|NOT COMPLETED|Period 2||0
268563|NCT01122862|648372|P3|COMPLETED|Period 2||6
268564|NCT01122862|648373|P2|COMPLETED|Period 2||7
268565|NCT01122862|648374|P1|COMPLETED|Period 2||8
268566|NCT01122862|648372|P3|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
268567|NCT01122862|648373|P2|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|7
268660|NCT01117428|648531|P6|STARTED|Overall Study||20
268568|NCT01122862|648374|P1|STARTED|Period 2|Due to crossover design,a different set of participants received this treatment compared to Period 1|8
268569|NCT01122862|648372|P3|NOT COMPLETED|Period 1||0
268570|NCT01122862|648373|P2|NOT COMPLETED|Period 1||1
268571|NCT01122862|648374|P1|NOT COMPLETED|Period 1||0
268572|NCT01122862|648372|P3|COMPLETED|Period 1||7
268573|NCT01122862|648373|P2|COMPLETED|Period 1||7
268574|NCT01122862|648374|P1|COMPLETED|Period 1||8
268575|NCT01122862|648372|P3|STARTED|Period 1||7
268576|NCT01122862|648373|P2|STARTED|Period 1||8
268577|NCT01122862|648374|P1|STARTED|Period 1||8
268578|NCT01122901|648394|P2|NOT COMPLETED|Overall Study||0
268579|NCT01122901|648395|P1|NOT COMPLETED|Overall Study||0
268580|NCT01122901|648394|P2|COMPLETED|Overall Study||7
268581|NCT01122901|648395|P1|COMPLETED|Overall Study||40
268582|NCT01122901|648394|P2|STARTED|Overall Study||7
268583|NCT01122901|648395|P1|STARTED|Overall Study||40
268584|NCT01122927|648413|P2|NOT COMPLETED|Period 2- Open-label Treatment Phase||312
268585|NCT01122927|648414|P1|NOT COMPLETED|Period 2- Open-label Treatment Phase||0
268586|NCT01122927|648413|P2|COMPLETED|Period 2- Open-label Treatment Phase|De novo participants who completed Month 24 visit or rolled over from study NCT01149655.|198
268587|NCT01122927|648414|P1|COMPLETED|Period 2- Open-label Treatment Phase||0
268588|NCT01122927|648413|P2|STARTED|Period 2- Open-label Treatment Phase|362 were de novo participants and 148 had rolled over from study NCT01149655.|510
268589|NCT01122927|648414|P1|STARTED|Period 2- Open-label Treatment Phase||0
268590|NCT01122927|648413|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
268591|NCT01122927|648414|P1|NOT COMPLETED|Period 1 - Conversion Phase||14
268592|NCT01122927|648413|P2|COMPLETED|Period 1 - Conversion Phase||0
268593|NCT01122927|648414|P1|COMPLETED|Period 1 - Conversion Phase||283
268594|NCT01122927|648413|P2|STARTED|Period 1 - Conversion Phase||0
268595|NCT01122927|648414|P1|STARTED|Period 1 - Conversion Phase||297
268596|NCT01123148|648445|P1|NOT COMPLETED|Overall Study||2
268597|NCT01123148|648445|P1|COMPLETED|Overall Study||12
268598|NCT01123148|648445|P1|BCI Calibration >50% Accuracy|Overall Study||13
268599|NCT01123148|648445|P1|STARTED|Overall Study||14
268600|NCT01123161|648451|P2|NOT COMPLETED|Overall Study||0
268601|NCT01123161|648452|P1|NOT COMPLETED|Overall Study||2
268602|NCT01123161|648451|P2|COMPLETED|Overall Study||63
268603|NCT01123161|648452|P1|COMPLETED|Overall Study||55
268604|NCT01123161|648451|P2|STARTED|Overall Study||63
268605|NCT01123161|648452|P1|STARTED|Overall Study||57
268606|NCT01123200|648470|P1|NOT COMPLETED|Overall Study||1
268607|NCT01123200|648470|P1|COMPLETED|Overall Study||0
268608|NCT01123200|648470|P1|STARTED|Overall Study||1
268609|NCT01123356|648475|P1|NOT COMPLETED|Overall Study||7
268610|NCT01123356|648475|P1|COMPLETED|Overall Study||14
268611|NCT01123356|648475|P1|STARTED|Overall Study||21
268612|NCT01123395|648483|P2|NOT COMPLETED|Period 2||0
268613|NCT01123395|648484|P1|NOT COMPLETED|Period 2||0
268614|NCT01123395|648483|P2|COMPLETED|Period 2||7
268615|NCT01123395|648484|P1|COMPLETED|Period 2||8
268616|NCT01123395|648483|P2|STARTED|Period 2||7
268617|NCT01123395|648484|P1|STARTED|Period 2||8
268618|NCT01123395|648483|P2|NOT COMPLETED|Washout Period of 14 Days||1
268619|NCT01123395|648484|P1|NOT COMPLETED|Washout Period of 14 Days||0
268620|NCT01123395|648483|P2|COMPLETED|Washout Period of 14 Days||7
268621|NCT01123395|648484|P1|COMPLETED|Washout Period of 14 Days||8
268622|NCT01123395|648483|P2|STARTED|Washout Period of 14 Days||8
268623|NCT01123395|648484|P1|STARTED|Washout Period of 14 Days||8
268624|NCT01123395|648483|P2|NOT COMPLETED|Period 1||0
268625|NCT01123395|648484|P1|NOT COMPLETED|Period 1||0
268626|NCT01123395|648483|P2|COMPLETED|Period 1||8
268628|NCT01123395|648483|P2|STARTED|Period 1||8
268629|NCT01123395|648484|P1|STARTED|Period 1||8
268630|NCT01123512|648496|P2|NOT COMPLETED|Overall Study||21
268631|NCT01123512|648497|P1|NOT COMPLETED|Overall Study||26
268632|NCT01123512|648496|P2|COMPLETED|Overall Study||126
268633|NCT01123512|648497|P1|COMPLETED|Overall Study||127
268634|NCT01123512|648496|P2|STARTED|Overall Study||147
268635|NCT01123512|648497|P1|STARTED|Overall Study||153
268636|NCT01123642|648503|P1|NOT COMPLETED|Overall Study||68
268637|NCT01123642|648503|P1|COMPLETED|Overall Study||277
268638|NCT01123642|648503|P1|STARTED|Overall Study||345
268639|NCT01123850|648507|P1|NOT COMPLETED|Overall Study||45
268640|NCT01123850|648507|P1|COMPLETED|Overall Study||0
268641|NCT01123850|648507|P1|STARTED|Overall Study||45
268642|NCT01123889|648514|P2|NOT COMPLETED|Overall Study||1
268643|NCT01123889|648515|P1|NOT COMPLETED|Overall Study||3
268644|NCT01123889|648514|P2|COMPLETED|Overall Study||6
268645|NCT01123889|648515|P1|COMPLETED|Overall Study||2
268646|NCT01123889|648514|P2|STARTED|Overall Study||7
268647|NCT01123889|648515|P1|STARTED|Overall Study||5
268648|NCT01117428|648531|P6|NOT COMPLETED|Overall Study||20
268649|NCT01117428|648532|P5|NOT COMPLETED|Overall Study||17
268650|NCT01117428|648533|P4|NOT COMPLETED|Overall Study||12
268651|NCT01117428|648534|P3|NOT COMPLETED|Overall Study||13
268652|NCT01117428|648535|P2|NOT COMPLETED|Overall Study||29
268653|NCT01117428|648536|P1|NOT COMPLETED|Overall Study||20
268654|NCT01117428|648531|P6|COMPLETED|Overall Study||0
268655|NCT01117428|648532|P5|COMPLETED|Overall Study||0
268656|NCT01117428|648533|P4|COMPLETED|Overall Study||0
268657|NCT01117428|648534|P3|COMPLETED|Overall Study||0
268658|NCT01117428|648535|P2|COMPLETED|Overall Study||0
268659|NCT01117428|648536|P1|COMPLETED|Overall Study||0
268661|NCT01117428|648532|P5|STARTED|Overall Study||17
268662|NCT01117428|648533|P4|STARTED|Overall Study||12
268663|NCT01117428|648534|P3|STARTED|Overall Study||13
268664|NCT01117428|648535|P2|STARTED|Overall Study||29
268665|NCT01117428|648536|P1|STARTED|Overall Study|"0.4 mg/kg=1
0.75 mg/kg=1
1.5 mg/kg=3
3 mg/kg=3
6 mg/kg=3
9 mg/kg=6
12 mg/kg=3"|20
268666|NCT01117454|648570|P2|NOT COMPLETED|Overall Study||1
268667|NCT01117454|648571|P1|NOT COMPLETED|Overall Study||0
268668|NCT01117454|648570|P2|COMPLETED|Overall Study||7
268669|NCT01117454|648571|P1|COMPLETED|Overall Study||6
268670|NCT01117454|648570|P2|STARTED|Overall Study||8
268671|NCT01117454|648571|P1|STARTED|Overall Study||6
268672|NCT01117480|648577|P1|NOT COMPLETED|Overall Study||28
268673|NCT01117480|648577|P1|COMPLETED|Overall Study||985
268674|NCT01117480|648577|P1|STARTED|Overall Study||1013
268675|NCT01117623|648591|P8|NOT COMPLETED|Overall Study||26
268676|NCT01117623|648592|P7|NOT COMPLETED|Overall Study||6
268677|NCT01117623|648593|P6|NOT COMPLETED|Overall Study||16
268678|NCT01117623|648594|P5|NOT COMPLETED|Overall Study||10
268679|NCT01117623|648595|P4|NOT COMPLETED|Overall Study||6
268680|NCT01117623|648596|P3|NOT COMPLETED|Overall Study||11
268681|NCT01117623|648597|P2|NOT COMPLETED|Overall Study||8
268682|NCT01117623|648598|P1|NOT COMPLETED|Overall Study||3
268683|NCT01117623|648591|P8|COMPLETED|Overall Study||0
268684|NCT01117623|648592|P7|COMPLETED|Overall Study||0
268685|NCT01117623|648593|P6|COMPLETED|Overall Study||0
268686|NCT01117623|648594|P5|COMPLETED|Overall Study||0
268687|NCT01117623|648595|P4|COMPLETED|Overall Study||0
268688|NCT01117623|648596|P3|COMPLETED|Overall Study||0
268689|NCT01117623|648597|P2|COMPLETED|Overall Study||0
268690|NCT01117623|648598|P1|COMPLETED|Overall Study||0
268691|NCT01117623|648591|P8|PK Population|Overall Study||24
268692|NCT01117623|648592|P7|PK Population|Overall Study||6
268693|NCT01117623|648593|P6|PK Population|Overall Study||14
268694|NCT01117623|648594|P5|PK Population|Overall Study||10
268695|NCT01117623|648595|P4|PK Population|Overall Study||6
268696|NCT01117623|648596|P3|PK Population|Overall Study||10
268697|NCT01117623|648597|P2|PK Population|Overall Study||8
268698|NCT01117623|648598|P1|PK Population|Overall Study||3
268699|NCT01117623|648591|P8|ITT Efficacy Analysis Population|Overall Study||22
268700|NCT01117623|648592|P7|ITT Efficacy Analysis Population|Overall Study||6
268701|NCT01117623|648593|P6|ITT Efficacy Analysis Population|Overall Study||16
268702|NCT01117623|648594|P5|ITT Efficacy Analysis Population|Overall Study||10
268703|NCT01117623|648595|P4|ITT Efficacy Analysis Population|Overall Study||5
268704|NCT01117623|648596|P3|ITT Efficacy Analysis Population|Overall Study||11
268705|NCT01117623|648597|P2|ITT Efficacy Analysis Population|Overall Study||8
268706|NCT01117623|648598|P1|ITT Efficacy Analysis Population|Overall Study||3
268707|NCT01117623|648591|P8|STARTED|Overall Study||26
268708|NCT01117623|648592|P7|STARTED|Overall Study||6
268709|NCT01117623|648593|P6|STARTED|Overall Study||16
268710|NCT01117623|648594|P5|STARTED|Overall Study||10
268711|NCT01117623|648595|P4|STARTED|Overall Study||6
268712|NCT01117623|648596|P3|STARTED|Overall Study||11
268713|NCT01117623|648597|P2|STARTED|Overall Study||8
268714|NCT01117623|648598|P1|STARTED|Overall Study||3
268715|NCT01117727|648750|P1|NOT COMPLETED|Overall Study||0
268716|NCT01117727|648750|P1|COMPLETED|Overall Study||1
268717|NCT01117727|648750|P1|STARTED|Overall Study||1
268718|NCT01117766|648755|P2|NOT COMPLETED|Second Intervention||5
268719|NCT01117766|648756|P1|NOT COMPLETED|Second Intervention||2
268720|NCT01117766|648755|P2|COMPLETED|Second Intervention||9
268721|NCT01117766|648756|P1|COMPLETED|Second Intervention||11
268722|NCT01117766|648755|P2|STARTED|Second Intervention||14
268723|NCT01117766|648756|P1|STARTED|Second Intervention||13
268724|NCT01117766|648755|P2|NOT COMPLETED|Washout Period||2
268725|NCT01117766|648756|P1|NOT COMPLETED|Washout Period||0
268726|NCT01117766|648755|P2|COMPLETED|Washout Period||14
268727|NCT01117766|648756|P1|COMPLETED|Washout Period||13
268728|NCT01117766|648755|P2|STARTED|Washout Period||16
268729|NCT01117766|648756|P1|STARTED|Washout Period||13
268730|NCT01117766|648755|P2|NOT COMPLETED|First Intervention||1
268731|NCT01117766|648756|P1|NOT COMPLETED|First Intervention||1
268732|NCT01117766|648755|P2|COMPLETED|First Intervention||16
268733|NCT01117766|648756|P1|COMPLETED|First Intervention||13
268734|NCT01117766|648755|P2|Received Treatment|First Intervention||17
268735|NCT01117766|648756|P1|Received Treatment|First Intervention||14
268736|NCT01117766|648755|P2|STARTED|First Intervention||17
268737|NCT01117766|648756|P1|STARTED|First Intervention||14
268738|NCT01117857|648780|P1|NOT COMPLETED|Overall Study||9
268739|NCT01117857|648780|P1|COMPLETED|Overall Study||13
268740|NCT01117857|648780|P1|STARTED|Overall Study||22
268741|NCT01117870|648790|P2|NOT COMPLETED|Overall Study||0
268742|NCT01117870|648791|P1|NOT COMPLETED|Overall Study||1
268743|NCT01117870|648790|P2|COMPLETED|Overall Study||16
268744|NCT01117870|648791|P1|COMPLETED|Overall Study|One did not receive the allocated intervention; (degenerate spine/inability to place needle).|14
268745|NCT01117870|648790|P2|STARTED|Overall Study||16
268746|NCT01117870|648791|P1|STARTED|Overall Study||15
268747|NCT01117948|648807|P2|NOT COMPLETED|Open Label||47
268748|NCT01117948|648808|P1|NOT COMPLETED|Open Label||52
268749|NCT01117948|648807|P2|COMPLETED|Open Label||51
268750|NCT01117948|648808|P1|COMPLETED|Open Label||41
268751|NCT01117948|648807|P2|STARTED|Open Label||98
268752|NCT01117948|648808|P1|STARTED|Open Label||93
268753|NCT01117948|648807|P2|NOT COMPLETED|Double Blind||10
268754|NCT01117948|648808|P1|NOT COMPLETED|Double Blind||18
268755|NCT01117948|648807|P2|COMPLETED|Double Blind||98
268756|NCT01117948|648808|P1|COMPLETED|Double Blind||93
268757|NCT01117948|648807|P2|STARTED|Double Blind||108
268758|NCT01117948|648808|P1|STARTED|Double Blind||111
268759|NCT01117987|648816|P2|NOT COMPLETED|Overall Study||74
268760|NCT01117987|648817|P1|NOT COMPLETED|Overall Study||61
268761|NCT01117987|648816|P2|COMPLETED|Overall Study||4
268762|NCT01117987|648817|P1|COMPLETED|Overall Study||5
268763|NCT01117987|648816|P2|STARTED|Overall Study||78
268764|NCT01117987|648817|P1|STARTED|Overall Study||66
268765|NCT01118013|648827|P1|NOT COMPLETED|Overall Study||0
268766|NCT01118013|648827|P1|COMPLETED|Overall Study||6
268767|NCT01118013|648827|P1|STARTED|Overall Study||6
268768|NCT01118091|648837|P2|NOT COMPLETED|Overall Study||0
268769|NCT01118091|648838|P1|NOT COMPLETED|Overall Study||0
268770|NCT01118091|648837|P2|COMPLETED|Overall Study||5
268771|NCT01118091|648838|P1|COMPLETED|Overall Study|Continued from above: These 2 pts are only represented in Arm 1 (and not Arm 2).|7
268772|NCT01118091|648837|P2|STARTED|Overall Study||5
268773|NCT01118091|648838|P1|STARTED|Overall Study|2pts were randomized to Arm 2, were not able to grow cell product, were treated with Arm 1 regimen.|7
268774|NCT01118117|648850|P2|NOT COMPLETED|Overall Study||0
268775|NCT01118117|648851|P1|NOT COMPLETED|Overall Study||21
268776|NCT01118117|648850|P2|COMPLETED|Overall Study||15
268777|NCT01118117|648851|P1|COMPLETED|Overall Study||240
268778|NCT01118117|648850|P2|STARTED|Overall Study||15
268779|NCT01118117|648851|P1|STARTED|Overall Study||261
268780|NCT01118143|648872|P2|NOT COMPLETED|Overall Study||5
268781|NCT01118143|648873|P1|NOT COMPLETED|Overall Study||2
268782|NCT01118143|648872|P2|COMPLETED|Overall Study||64
268783|NCT01118143|648873|P1|COMPLETED|Overall Study||62
268784|NCT01118143|648872|P2|STARTED|Overall Study||69
268785|NCT01118143|648873|P1|STARTED|Overall Study||64
268786|NCT01118221|648883|P2|NOT COMPLETED|Overall Study||1
268787|NCT01118221|648884|P1|NOT COMPLETED|Overall Study||3
268788|NCT01118221|648883|P2|COMPLETED|Overall Study||10
268789|NCT01118221|648884|P1|COMPLETED|Overall Study||11
268790|NCT01118221|648883|P2|STARTED|Overall Study||11
268791|NCT01118221|648884|P1|STARTED|Overall Study||14
268792|NCT01118273|648900|P6|NOT COMPLETED|Overall Study||0
268793|NCT01118273|648901|P5|NOT COMPLETED|Overall Study||0
268794|NCT01118273|648902|P4|NOT COMPLETED|Overall Study||0
268795|NCT01118273|648903|P3|NOT COMPLETED|Overall Study||0
268796|NCT01118273|648904|P2|NOT COMPLETED|Overall Study||0
268797|NCT01118273|648905|P1|NOT COMPLETED|Overall Study||0
268798|NCT01118273|648900|P6|COMPLETED|Overall Study||27
268799|NCT01118273|648901|P5|COMPLETED|Overall Study||27
268800|NCT01118273|648902|P4|COMPLETED|Overall Study||27
268801|NCT01118273|648903|P3|COMPLETED|Overall Study||27
268802|NCT01118273|648904|P2|COMPLETED|Overall Study||27
268803|NCT01118273|648905|P1|COMPLETED|Overall Study||27
268804|NCT01118273|648900|P6|STARTED|Overall Study||27
268805|NCT01118273|648901|P5|STARTED|Overall Study||27
268806|NCT01118273|648902|P4|STARTED|Overall Study||27
268807|NCT01118273|648903|P3|STARTED|Overall Study||27
268808|NCT01118273|648904|P2|STARTED|Overall Study||27
268809|NCT01118273|648905|P1|STARTED|Overall Study||27
268810|NCT01118312|649071|P2|NOT COMPLETED|Overall Study||35
268811|NCT01118312|649072|P1|NOT COMPLETED|Overall Study||34
268812|NCT01118312|649071|P2|COMPLETED|Overall Study||164
268813|NCT01118312|649072|P1|COMPLETED|Overall Study||155
268814|NCT01118312|649071|P2|STARTED|Overall Study||199
268815|NCT01118312|649072|P1|STARTED|Overall Study||189
268816|NCT01123928|649082|P2|NOT COMPLETED|Overall Study||0
268817|NCT01123928|649083|P1|NOT COMPLETED|Overall Study||0
268818|NCT01123928|649082|P2|COMPLETED|Overall Study||222
268819|NCT01123928|649083|P1|COMPLETED|Overall Study||212
268820|NCT01123928|649082|P2|STARTED|Overall Study||222
268821|NCT01123928|649083|P1|STARTED|Overall Study||212
268822|NCT01123941|649103|P2|NOT COMPLETED|Overall Study||1
268823|NCT01123941|649104|P1|NOT COMPLETED|Overall Study||2
268824|NCT01123941|649103|P2|COMPLETED|Overall Study||24
268825|NCT01123941|649104|P1|COMPLETED|Overall Study||23
268826|NCT01123941|649103|P2|STARTED|Overall Study||25
268827|NCT01123941|649104|P1|STARTED|Overall Study||25
268828|NCT01123980|649118|P2|NOT COMPLETED|Overall Study||24
268829|NCT01123980|649119|P1|NOT COMPLETED|Overall Study||19
268830|NCT01123980|649118|P2|COMPLETED|Overall Study||236
268831|NCT01123980|649119|P1|COMPLETED|Overall Study||242
268832|NCT01123980|649118|P2|STARTED|Overall Study||260
268833|NCT01123980|649119|P1|STARTED|Overall Study||261
268834|NCT01124006|649140|P3|NOT COMPLETED|Overall Study||2
268835|NCT01124006|649141|P2|NOT COMPLETED|Overall Study||2
268836|NCT01124006|649142|P1|NOT COMPLETED|Overall Study||3
268837|NCT01124006|649140|P3|COMPLETED|Overall Study||2
268838|NCT01124006|649141|P2|COMPLETED|Overall Study||8
268839|NCT01124006|649142|P1|COMPLETED|Overall Study||7
268840|NCT01124006|649140|P3|STARTED|Overall Study||4
268841|NCT01124006|649141|P2|STARTED|Overall Study||10
268842|NCT01124006|649142|P1|STARTED|Overall Study||10
268843|NCT01124045|649170|P2|NOT COMPLETED|Overall Study||3
268844|NCT01124045|649171|P1|NOT COMPLETED|Overall Study||0
268845|NCT01124045|649170|P2|COMPLETED|Overall Study||37
268846|NCT01124045|649171|P1|COMPLETED|Overall Study||39
268847|NCT01124045|649170|P2|STARTED|Overall Study||40
268848|NCT01124045|649171|P1|STARTED|Overall Study||39
268849|NCT01124097|649205|P4|NOT COMPLETED|Overall Study||14
268850|NCT01124097|649206|P3|NOT COMPLETED|Overall Study||20
268851|NCT01124097|649207|P2|NOT COMPLETED|Overall Study||22
268852|NCT01124097|649208|P1|NOT COMPLETED|Overall Study||34
268853|NCT01124097|649205|P4|COMPLETED|Overall Study||46
268854|NCT01124097|649206|P3|COMPLETED|Overall Study||40
268855|NCT01124097|649207|P2|COMPLETED|Overall Study||38
268856|NCT01124097|649208|P1|COMPLETED|Overall Study||26
268857|NCT01124097|649205|P4|Efficacy Population|Overall Study||51
268858|NCT01124097|649206|P3|Efficacy Population|Overall Study||53
268859|NCT01124097|649207|P2|Efficacy Population|Overall Study||53
268860|NCT01124097|649208|P1|Efficacy Population|Overall Study||52
268861|NCT01124097|649205|P4|Safety Population|Overall Study||60
268862|NCT01124097|649206|P3|Safety Population|Overall Study||60
268863|NCT01124097|649207|P2|Safety Population|Overall Study||60
268864|NCT01124097|649208|P1|Safety Population|Overall Study||60
268865|NCT01124097|649205|P4|STARTED|Overall Study||60
268866|NCT01124097|649206|P3|STARTED|Overall Study||60
268867|NCT01124097|649207|P2|STARTED|Overall Study||60
268868|NCT01124097|649208|P1|STARTED|Overall Study||60
268869|NCT01124149|649218|P1|NOT COMPLETED|Maintenance Phase||96
268870|NCT01124149|649218|P1|COMPLETED|Maintenance Phase||373
268871|NCT01124149|649218|P1|STARTED|Maintenance Phase||469
268872|NCT01124149|649218|P1|NOT COMPLETED|Acute Phase||83
268873|NCT01124149|649218|P1|COMPLETED|Acute Phase||639
268874|NCT01124149|649218|P1|STARTED|Acute Phase||722
268875|NCT01124162|649236|P2|NOT COMPLETED|Second Intervention||0
268876|NCT01124162|649237|P1|NOT COMPLETED|Second Intervention||0
268877|NCT01124162|649236|P2|COMPLETED|Second Intervention||40
268878|NCT01124162|649237|P1|COMPLETED|Second Intervention||37
268879|NCT01124162|649236|P2|STARTED|Second Intervention||40
268880|NCT01124162|649237|P1|STARTED|Second Intervention||37
268881|NCT01124162|649236|P2|NOT COMPLETED|Washout of 7 Days||0
268882|NCT01124162|649237|P1|NOT COMPLETED|Washout of 7 Days||1
268883|NCT01124162|649236|P2|COMPLETED|Washout of 7 Days||40
268884|NCT01124162|649237|P1|COMPLETED|Washout of 7 Days||37
268885|NCT01124162|649236|P2|STARTED|Washout of 7 Days||40
268886|NCT01124162|649237|P1|STARTED|Washout of 7 Days||38
268887|NCT01124162|649236|P2|NOT COMPLETED|First Intervention||0
268888|NCT01124162|649237|P1|NOT COMPLETED|First Intervention||2
268889|NCT01124162|649236|P2|COMPLETED|First Intervention||40
268890|NCT01124162|649237|P1|COMPLETED|First Intervention||38
268891|NCT01124162|649236|P2|STARTED|First Intervention||40
268892|NCT01124162|649237|P1|STARTED|First Intervention||40
268893|NCT01124175|649255|P2|NOT COMPLETED|Second Intervention||0
268894|NCT01124175|649256|P1|NOT COMPLETED|Second Intervention||0
268895|NCT01124175|649255|P2|COMPLETED|Second Intervention||38
268896|NCT01124175|649256|P1|COMPLETED|Second Intervention||40
268897|NCT01124175|649255|P2|STARTED|Second Intervention||38
268898|NCT01124175|649256|P1|STARTED|Second Intervention||40
268899|NCT01124175|649255|P2|NOT COMPLETED|Washout of 7 Days||2
268900|NCT01124175|649256|P1|NOT COMPLETED|Washout of 7 Days||0
268901|NCT01124175|649255|P2|COMPLETED|Washout of 7 Days||38
268902|NCT01124175|649256|P1|COMPLETED|Washout of 7 Days||40
268903|NCT01124175|649255|P2|STARTED|Washout of 7 Days||40
268904|NCT01124175|649256|P1|STARTED|Washout of 7 Days||40
268905|NCT01124175|649255|P2|NOT COMPLETED|First Intervention||0
268906|NCT01124175|649256|P1|NOT COMPLETED|First Intervention||0
268907|NCT01124175|649255|P2|COMPLETED|First Intervention||40
268908|NCT01124175|649256|P1|COMPLETED|First Intervention||40
268909|NCT01124175|649255|P2|STARTED|First Intervention||40
268910|NCT01124175|649256|P1|STARTED|First Intervention||40
268911|NCT01124188|649274|P2|NOT COMPLETED|Overall Study||6
268912|NCT01124188|649275|P1|NOT COMPLETED|Overall Study||8
268913|NCT01124188|649274|P2|COMPLETED|Overall Study||65
268914|NCT01124188|649275|P1|COMPLETED|Overall Study||60
268915|NCT01124188|649274|P2|STARTED|Overall Study||71
268916|NCT01124188|649275|P1|STARTED|Overall Study||68
268917|NCT01127087|649287|P2|NOT COMPLETED|Overall Study||0
268918|NCT01127087|649288|P1|NOT COMPLETED|Overall Study||0
268919|NCT01127087|649287|P2|COMPLETED|Overall Study||2
268920|NCT01127087|649288|P1|COMPLETED|Overall Study||8
268921|NCT01127087|649287|P2|STARTED|Overall Study||2
268922|NCT01127087|649288|P1|STARTED|Overall Study||8
268923|NCT01127139|649296|P1|NOT COMPLETED|Overall Study||57
268924|NCT01127139|649296|P1|COMPLETED|Overall Study||3771
268925|NCT01127139|649296|P1|Number of Participants Analyzed|Overall Study||3828
268926|NCT01127139|649296|P1|STARTED|Overall Study||3828
268927|NCT01127165|649313|P2|NOT COMPLETED|Overall Study||19
268928|NCT01127165|649314|P1|NOT COMPLETED|Overall Study||16
268929|NCT01127165|649313|P2|COMPLETED|Overall Study||41
268930|NCT01127165|649314|P1|COMPLETED|Overall Study||49
268931|NCT01127165|649313|P2|STARTED|Overall Study||60
268932|NCT01127165|649314|P1|STARTED|Overall Study||65
268933|NCT01127256|649328|P2|NOT COMPLETED|Overall Study||39
268934|NCT01127256|649329|P1|NOT COMPLETED|Overall Study||39
268935|NCT01127256|649328|P2|COMPLETED|Overall Study||65
268936|NCT01127256|649329|P1|COMPLETED|Overall Study||57
268937|NCT01127256|649328|P2|STARTED|Overall Study||104
268938|NCT01127256|649329|P1|STARTED|Overall Study||96
268939|NCT01127321|649344|P5|NOT COMPLETED|Overall Study||0
268940|NCT01127321|649345|P4|NOT COMPLETED|Overall Study||0
268941|NCT01127321|649346|P3|NOT COMPLETED|Overall Study||0
268942|NCT01127321|649347|P2|NOT COMPLETED|Overall Study||0
268943|NCT01127321|649348|P1|NOT COMPLETED|Overall Study||0
268944|NCT01127321|649344|P5|COMPLETED|Overall Study||5
268945|NCT01127321|649345|P4|COMPLETED|Overall Study||7
268946|NCT01127321|649346|P3|COMPLETED|Overall Study||1
268947|NCT01127321|649347|P2|COMPLETED|Overall Study||1
268948|NCT01127321|649348|P1|COMPLETED|Overall Study||3
268949|NCT01127321|649344|P5|STARTED|Overall Study||5
268950|NCT01127321|649345|P4|STARTED|Overall Study||7
268951|NCT01127321|649346|P3|STARTED|Overall Study||1
268952|NCT01127321|649347|P2|STARTED|Overall Study||1
268953|NCT01127321|649348|P1|STARTED|Overall Study||3
268954|NCT01127438|649376|P6|NOT COMPLETED|Overall Study||0
268955|NCT01127438|649377|P5|NOT COMPLETED|Overall Study||0
268956|NCT01127438|649378|P4|NOT COMPLETED|Overall Study||0
268957|NCT01127438|649379|P3|NOT COMPLETED|Overall Study||0
268958|NCT01127438|649380|P2|NOT COMPLETED|Overall Study||0
268959|NCT01127438|649381|P1|NOT COMPLETED|Overall Study||0
268960|NCT01127438|649376|P6|COMPLETED|Overall Study||25
268961|NCT01127438|649377|P5|COMPLETED|Overall Study||28
268962|NCT01127438|649378|P4|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|24
268963|NCT01127438|649379|P3|COMPLETED|Overall Study|(n=25) One subject randomized to the approved dose group received a lower dose in error.|26
268964|NCT01127438|649380|P2|COMPLETED|Overall Study||25
268965|NCT01127438|649381|P1|COMPLETED|Overall Study||25
268966|NCT01127438|649376|P6|STARTED|Overall Study||25
268967|NCT01127438|649377|P5|STARTED|Overall Study||28
268968|NCT01127438|649378|P4|STARTED|Overall Study||24
268969|NCT01127438|649379|P3|STARTED|Overall Study||26
268970|NCT01127438|649380|P2|STARTED|Overall Study||25
268971|NCT01127438|649381|P1|STARTED|Overall Study||25
268972|NCT01127581|649405|P2|NOT COMPLETED|Overall Study||0
268973|NCT01127581|649406|P1|NOT COMPLETED|Overall Study||0
268974|NCT01127581|649405|P2|COMPLETED|Overall Study||680
268975|NCT01127581|649406|P1|COMPLETED|Overall Study||678
268976|NCT01127581|649405|P2|STARTED|Overall Study||680
268977|NCT01127581|649406|P1|STARTED|Overall Study||678
268978|NCT01127607|649434|P2|NOT COMPLETED|Phase II (Between Subjects)||2
268979|NCT01127607|649435|P1|NOT COMPLETED|Phase II (Between Subjects)||1
268980|NCT01127607|649434|P2|COMPLETED|Phase II (Between Subjects)||11
268981|NCT01127607|649435|P1|COMPLETED|Phase II (Between Subjects)||13
268982|NCT01127607|649434|P2|STARTED|Phase II (Between Subjects)||13
268983|NCT01127607|649435|P1|STARTED|Phase II (Between Subjects)||14
268984|NCT01127607|649434|P2|NOT COMPLETED|Phase I (Within Subjects)||0
268985|NCT01127607|649435|P1|NOT COMPLETED|Phase I (Within Subjects)||0
268986|NCT01127607|649434|P2|COMPLETED|Phase I (Within Subjects)||13
268987|NCT01127607|649435|P1|COMPLETED|Phase I (Within Subjects)||14
268988|NCT01127607|649434|P2|STARTED|Phase I (Within Subjects)||13
268989|NCT01127607|649435|P1|STARTED|Phase I (Within Subjects)||14
268990|NCT01127646|649508|P2|NOT COMPLETED|Overall Study||1
268991|NCT01127646|649509|P1|NOT COMPLETED|Overall Study||1
268992|NCT01127646|649508|P2|COMPLETED|Overall Study||7
268993|NCT01127646|649509|P1|COMPLETED|Overall Study||14
268994|NCT01127646|649508|P2|STARTED|Overall Study||8
268995|NCT01127646|649509|P1|STARTED|Overall Study||15
268996|NCT01127659|649547|P6|NOT COMPLETED|Overall Study||0
268997|NCT01127659|649548|P5|NOT COMPLETED|Overall Study||0
268998|NCT01127659|649549|P4|NOT COMPLETED|Overall Study||4
268999|NCT01127659|649550|P3|NOT COMPLETED|Overall Study||2
269000|NCT01127659|649551|P2|NOT COMPLETED|Overall Study||8
269001|NCT01127659|649552|P1|NOT COMPLETED|Overall Study||2
269002|NCT01127659|649547|P6|COMPLETED|Overall Study||21
269003|NCT01127659|649548|P5|COMPLETED|Overall Study||50
269004|NCT01127659|649549|P4|COMPLETED|Overall Study||6
269005|NCT01127659|649550|P3|COMPLETED|Overall Study||10
269006|NCT01127659|649551|P2|COMPLETED|Overall Study||14
269007|NCT01127659|649552|P1|COMPLETED|Overall Study||20
269008|NCT01127659|649547|P6|STARTED|Overall Study||21
269009|NCT01127659|649548|P5|STARTED|Overall Study||50
269010|NCT01127659|649549|P4|STARTED|Overall Study||10
269011|NCT01127659|649550|P3|STARTED|Overall Study||12
269012|NCT01127659|649551|P2|STARTED|Overall Study||22
269013|NCT01127659|649552|P1|STARTED|Overall Study||22
269014|NCT01127737|649568|P2|NOT COMPLETED|Overall Study||0
269015|NCT01127737|649569|P1|NOT COMPLETED|Overall Study||0
269016|NCT01127737|649568|P2|COMPLETED|Overall Study||38
269017|NCT01127737|649569|P1|COMPLETED|Overall Study||37
269018|NCT01127737|649568|P2|STARTED|Overall Study||38
269019|NCT01127737|649569|P1|STARTED|Overall Study||37
269020|NCT01127763|649575|P1|NOT COMPLETED|Overall Study||5
269021|NCT01127763|649575|P1|COMPLETED|Overall Study|Patients off study due to disease progression were considered to have completed the study.|20
269022|NCT01127763|649575|P1|STARTED|Overall Study||25
269023|NCT01128049|649587|P3|NOT COMPLETED|Overall Study||0
269024|NCT01128049|649588|P2|NOT COMPLETED|Overall Study||0
269025|NCT01128049|649589|P1|NOT COMPLETED|Overall Study||0
269026|NCT01128049|649587|P3|COMPLETED|Overall Study||5
269027|NCT01128049|649588|P2|COMPLETED|Overall Study||5
269028|NCT01128049|649589|P1|COMPLETED|Overall Study||5
269029|NCT01128049|649587|P3|STARTED|Overall Study||5
269030|NCT01128049|649588|P2|STARTED|Overall Study||5
269031|NCT01128049|649589|P1|STARTED|Overall Study||5
269032|NCT01128114|649597|P1|NOT COMPLETED|Overall Study||8
269033|NCT01128114|649597|P1|COMPLETED|Overall Study||24
269034|NCT01128114|649597|P1|STARTED|Overall Study||32
269035|NCT01128153|649603|P2|NOT COMPLETED|Overall Study||15
269036|NCT01128153|649604|P1|NOT COMPLETED|Overall Study||16
269037|NCT01128153|649603|P2|COMPLETED|Overall Study|Completed 24 weeks|113
269038|NCT01128153|649604|P1|COMPLETED|Overall Study|Completed 24 weeks|113
269039|NCT01128153|649603|P2|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|128
269040|NCT01128153|649604|P1|Full Analysis Set|Overall Study|Received at least 1 dose of investigational product during 24 week blinded period|127
269041|NCT01128153|649603|P2|STARTED|Overall Study|Randomised|128
269042|NCT01128153|649604|P1|STARTED|Overall Study|Randomised|129
269043|NCT01128179|649622|P2|NOT COMPLETED|Overall Study||0
269044|NCT01128179|649623|P1|NOT COMPLETED|Overall Study||2
269045|NCT01128179|649622|P2|COMPLETED|Overall Study||12
269046|NCT01128179|649623|P1|COMPLETED|Overall Study||21
269047|NCT01128179|649622|P2|STARTED|Overall Study||12
269048|NCT01128179|649623|P1|STARTED|Overall Study||23
269049|NCT01128192|649643|P3|NOT COMPLETED|Overall Study||0
269050|NCT01128192|649644|P2|NOT COMPLETED|Overall Study||0
269051|NCT01128192|649645|P1|NOT COMPLETED|Overall Study||0
269052|NCT01128192|649643|P3|COMPLETED|Overall Study||7
269053|NCT01128192|649644|P2|COMPLETED|Overall Study||19
269054|NCT01128192|649645|P1|COMPLETED|Overall Study||19
269055|NCT01128192|649643|P3|STARTED|Overall Study||7
269056|NCT01128192|649644|P2|STARTED|Overall Study||19
269057|NCT01128192|649645|P1|STARTED|Overall Study||19
269058|NCT01128244|649672|P1|NOT COMPLETED|Overall Study||3
269059|NCT01128244|649672|P1|COMPLETED|Overall Study||10
269060|NCT01128244|649672|P1|STARTED|Overall Study||13
269061|NCT01128270|649680|P1|NOT COMPLETED|Therapeutic Chloral Hydrate (2B)||0
269062|NCT01128270|649680|P1|COMPLETED|Therapeutic Chloral Hydrate (2B)||8
269063|NCT01128270|649680|P1|STARTED|Therapeutic Chloral Hydrate (2B)||8
269064|NCT01128270|649680|P1|NOT COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||0
269065|NCT01128270|649680|P1|COMPLETED|Therapeutic Chloral Hydrate and DCA (2A)||8
269066|NCT01128270|649680|P1|STARTED|Therapeutic Chloral Hydrate and DCA (2A)||8
269067|NCT01128270|649680|P1|NOT COMPLETED|Environmental Chloral Hydrate (1B)||0
269068|NCT01128270|649680|P1|COMPLETED|Environmental Chloral Hydrate (1B)||8
269069|NCT01128270|649680|P1|STARTED|Environmental Chloral Hydrate (1B)|Per the suggestion from Heather, periods are not in chronological order, but defined by treatment.|8
269070|NCT01128270|649680|P1|NOT COMPLETED|Environment Chloral Hydrate and DCA (1A)||0
269071|NCT01128270|649680|P1|COMPLETED|Environment Chloral Hydrate and DCA (1A)||7
269072|NCT01128270|649680|P1|STARTED|Environment Chloral Hydrate and DCA (1A)||7
269073|NCT01128296|649693|P6|NOT COMPLETED|Overall Study||5
269074|NCT01128296|649694|P5|NOT COMPLETED|Overall Study||0
269075|NCT01128296|649695|P4|NOT COMPLETED|Overall Study||0
269076|NCT01128296|649696|P3|NOT COMPLETED|Overall Study||0
269077|NCT01128296|649697|P2|NOT COMPLETED|Overall Study||0
269078|NCT01128296|649698|P1|NOT COMPLETED|Overall Study||0
269079|NCT01128296|649693|P6|COMPLETED|Overall Study||21
269080|NCT01128296|649694|P5|COMPLETED|Overall Study||1
269081|NCT01128296|649695|P4|COMPLETED|Overall Study||1
269082|NCT01128296|649696|P3|COMPLETED|Overall Study||1
269083|NCT01128296|649697|P2|COMPLETED|Overall Study||1
269084|NCT01128296|649698|P1|COMPLETED|Overall Study||1
269085|NCT01128296|649693|P6|STARTED|Overall Study||26
269086|NCT01128296|649694|P5|STARTED|Overall Study||1
269087|NCT01128296|649695|P4|STARTED|Overall Study||1
269088|NCT01128296|649696|P3|STARTED|Overall Study||1
269089|NCT01128296|649697|P2|STARTED|Overall Study||1
269090|NCT01128296|649698|P1|STARTED|Overall Study||1
269091|NCT01128361|649718|P2|NOT COMPLETED|Overall Study||3
269092|NCT01128361|649719|P1|NOT COMPLETED|Overall Study||5
269093|NCT01128361|649718|P2|COMPLETED|Overall Study||34
269094|NCT01128361|649719|P1|COMPLETED|Overall Study||34
269095|NCT01128361|649718|P2|STARTED|Overall Study||37
269096|NCT01128361|649719|P1|STARTED|Overall Study||39
269097|NCT01128400|649734|P3|NOT COMPLETED|Overall Study||16
269098|NCT01128400|649735|P2|NOT COMPLETED|Overall Study||0
269099|NCT01128400|649736|P1|NOT COMPLETED|Overall Study||2
269100|NCT01128400|649734|P3|COMPLETED|Overall Study||7
269101|NCT01128400|649735|P2|COMPLETED|Overall Study||9
269102|NCT01128400|649736|P1|COMPLETED|Overall Study||6
269103|NCT01128400|649734|P3|STARTED|Overall Study||23
269104|NCT01128400|649735|P2|STARTED|Overall Study||9
269105|NCT01128400|649736|P1|STARTED|Overall Study||8
269106|NCT01128413|649749|P2|NOT COMPLETED|Overall Study||1
269107|NCT01128413|649750|P1|NOT COMPLETED|Overall Study||4
269108|NCT01128413|649749|P2|COMPLETED|Overall Study||10
269109|NCT01128413|649750|P1|COMPLETED|Overall Study||7
269110|NCT01128413|649749|P2|STARTED|Overall Study||11
269111|NCT01128413|649750|P1|STARTED|Overall Study||11
269112|NCT01128426|649756|P1|NOT COMPLETED|Overall Study||0
269113|NCT01128426|649756|P1|COMPLETED|Overall Study||53902
269114|NCT01128426|649756|P1|STARTED|Overall Study||53902
269115|NCT01128543|649774|P1|NOT COMPLETED|Overall Study||4
269116|NCT01128543|649774|P1|COMPLETED|Overall Study||25
269117|NCT01128543|649774|P1|STARTED|Overall Study||29
269118|NCT01128569|649780|P6|NOT COMPLETED|Treatment Period 3||0
269119|NCT01128569|649781|P5|NOT COMPLETED|Treatment Period 3||0
269120|NCT01128569|649782|P4|NOT COMPLETED|Treatment Period 3||0
269121|NCT01128569|649783|P3|NOT COMPLETED|Treatment Period 3||0
269122|NCT01128569|649784|P2|NOT COMPLETED|Treatment Period 3||0
269123|NCT01128569|649785|P1|NOT COMPLETED|Treatment Period 3||0
269124|NCT01128569|649780|P6|COMPLETED|Treatment Period 3||9
269125|NCT01128569|649781|P5|COMPLETED|Treatment Period 3||9
269126|NCT01128569|649782|P4|COMPLETED|Treatment Period 3||8
269127|NCT01128569|649783|P3|COMPLETED|Treatment Period 3||8
269128|NCT01128569|649784|P2|COMPLETED|Treatment Period 3||7
269129|NCT01128569|649785|P1|COMPLETED|Treatment Period 3||9
269130|NCT01128569|649780|P6|STARTED|Treatment Period 3||9
269131|NCT01128569|649781|P5|STARTED|Treatment Period 3||9
269132|NCT01128569|649782|P4|STARTED|Treatment Period 3||8
269133|NCT01128569|649783|P3|STARTED|Treatment Period 3||8
269134|NCT01128569|649784|P2|STARTED|Treatment Period 3||7
269135|NCT01128569|649785|P1|STARTED|Treatment Period 3||9
269136|NCT01128569|649780|P6|NOT COMPLETED|Washout Period 2||0
269137|NCT01128569|649781|P5|NOT COMPLETED|Washout Period 2||0
269138|NCT01128569|649782|P4|NOT COMPLETED|Washout Period 2||0
269139|NCT01128569|649783|P3|NOT COMPLETED|Washout Period 2||0
269140|NCT01128569|649784|P2|NOT COMPLETED|Washout Period 2||0
269141|NCT01128569|649785|P1|NOT COMPLETED|Washout Period 2||0
269142|NCT01128569|649780|P6|COMPLETED|Washout Period 2||9
269143|NCT01128569|649781|P5|COMPLETED|Washout Period 2||9
269144|NCT01128569|649782|P4|COMPLETED|Washout Period 2||8
269145|NCT01128569|649783|P3|COMPLETED|Washout Period 2||8
269146|NCT01128569|649784|P2|COMPLETED|Washout Period 2||7
269147|NCT01128569|649785|P1|COMPLETED|Washout Period 2||9
269148|NCT01128569|649780|P6|STARTED|Washout Period 2||9
269149|NCT01128569|649781|P5|STARTED|Washout Period 2||9
269150|NCT01128569|649782|P4|STARTED|Washout Period 2||8
269151|NCT01128569|649783|P3|STARTED|Washout Period 2||8
269152|NCT01128569|649784|P2|STARTED|Washout Period 2||7
269153|NCT01128569|649785|P1|STARTED|Washout Period 2||9
269154|NCT01128569|649780|P6|NOT COMPLETED|Treatment Period 2||0
269155|NCT01128569|649781|P5|NOT COMPLETED|Treatment Period 2||0
269156|NCT01128569|649782|P4|NOT COMPLETED|Treatment Period 2||0
269157|NCT01128569|649783|P3|NOT COMPLETED|Treatment Period 2||0
269158|NCT01128569|649784|P2|NOT COMPLETED|Treatment Period 2||1
269159|NCT01128569|649785|P1|NOT COMPLETED|Treatment Period 2||0
269160|NCT01128569|649780|P6|COMPLETED|Treatment Period 2||9
269161|NCT01128569|649781|P5|COMPLETED|Treatment Period 2||9
269162|NCT01128569|649782|P4|COMPLETED|Treatment Period 2||8
269163|NCT01128569|649783|P3|COMPLETED|Treatment Period 2||8
269164|NCT01128569|649784|P2|COMPLETED|Treatment Period 2||7
269165|NCT01128569|649785|P1|COMPLETED|Treatment Period 2||9
269166|NCT01128569|649780|P6|STARTED|Treatment Period 2||9
269167|NCT01128569|649781|P5|STARTED|Treatment Period 2||9
269168|NCT01128569|649782|P4|STARTED|Treatment Period 2||8
269169|NCT01128569|649783|P3|STARTED|Treatment Period 2||8
269170|NCT01128569|649784|P2|STARTED|Treatment Period 2||8
269171|NCT01128569|649785|P1|STARTED|Treatment Period 2||9
269172|NCT01128569|649780|P6|NOT COMPLETED|Washout Period 1||0
269173|NCT01128569|649781|P5|NOT COMPLETED|Washout Period 1||0
269174|NCT01128569|649782|P4|NOT COMPLETED|Washout Period 1||0
269175|NCT01128569|649783|P3|NOT COMPLETED|Washout Period 1||1
269176|NCT01128569|649784|P2|NOT COMPLETED|Washout Period 1||0
269177|NCT01128569|649785|P1|NOT COMPLETED|Washout Period 1||0
269178|NCT01128569|649780|P6|COMPLETED|Washout Period 1||9
269179|NCT01128569|649781|P5|COMPLETED|Washout Period 1||9
269180|NCT01128569|649782|P4|COMPLETED|Washout Period 1||8
269181|NCT01128569|649783|P3|COMPLETED|Washout Period 1||8
269182|NCT01128569|649784|P2|COMPLETED|Washout Period 1||8
269183|NCT01128569|649785|P1|COMPLETED|Washout Period 1||9
269184|NCT01128569|649780|P6|STARTED|Washout Period 1||9
269185|NCT01128569|649781|P5|STARTED|Washout Period 1||9
269186|NCT01128569|649782|P4|STARTED|Washout Period 1||8
269187|NCT01128569|649783|P3|STARTED|Washout Period 1||9
269188|NCT01128569|649784|P2|STARTED|Washout Period 1||8
269189|NCT01128569|649785|P1|STARTED|Washout Period 1||9
269190|NCT01128569|649780|P6|NOT COMPLETED|Treatment Period 1||0
269191|NCT01128569|649781|P5|NOT COMPLETED|Treatment Period 1||0
269192|NCT01128569|649782|P4|NOT COMPLETED|Treatment Period 1||0
269193|NCT01128569|649783|P3|NOT COMPLETED|Treatment Period 1||0
269194|NCT01128569|649784|P2|NOT COMPLETED|Treatment Period 1||0
269195|NCT01128569|649785|P1|NOT COMPLETED|Treatment Period 1||0
269196|NCT01128569|649780|P6|COMPLETED|Treatment Period 1||9
269197|NCT01128569|649781|P5|COMPLETED|Treatment Period 1||9
269198|NCT01128569|649782|P4|COMPLETED|Treatment Period 1||8
269199|NCT01128569|649783|P3|COMPLETED|Treatment Period 1||9
269200|NCT01128569|649784|P2|COMPLETED|Treatment Period 1||8
269201|NCT01128569|649785|P1|COMPLETED|Treatment Period 1||9
269202|NCT01128569|649780|P6|STARTED|Treatment Period 1||9
269203|NCT01128569|649781|P5|STARTED|Treatment Period 1||9
269204|NCT01128569|649782|P4|STARTED|Treatment Period 1||8
269205|NCT01128569|649783|P3|STARTED|Treatment Period 1||9
269206|NCT01128569|649784|P2|STARTED|Treatment Period 1||8
269207|NCT01128569|649785|P1|STARTED|Treatment Period 1||9
269208|NCT01128595|649802|P4|NOT COMPLETED|Treatment Period 4||0
269209|NCT01128595|649803|P3|NOT COMPLETED|Treatment Period 4||0
269210|NCT01128595|649804|P2|NOT COMPLETED|Treatment Period 4||0
269211|NCT01128595|649805|P1|NOT COMPLETED|Treatment Period 4||0
269212|NCT01128595|649802|P4|COMPLETED|Treatment Period 4||7
269213|NCT01128595|649803|P3|COMPLETED|Treatment Period 4||7
269214|NCT01128595|649804|P2|COMPLETED|Treatment Period 4||5
269215|NCT01128595|649805|P1|COMPLETED|Treatment Period 4||7
269216|NCT01128595|649802|P4|STARTED|Treatment Period 4||7
269217|NCT01128595|649803|P3|STARTED|Treatment Period 4||7
269218|NCT01128595|649804|P2|STARTED|Treatment Period 4||5
269219|NCT01128595|649805|P1|STARTED|Treatment Period 4||7
269220|NCT01128595|649802|P4|NOT COMPLETED|Washout Period 3||0
269221|NCT01128595|649803|P3|NOT COMPLETED|Washout Period 3||0
269222|NCT01128595|649804|P2|NOT COMPLETED|Washout Period 3||0
269223|NCT01128595|649805|P1|NOT COMPLETED|Washout Period 3||0
269224|NCT01128595|649802|P4|COMPLETED|Washout Period 3||7
269225|NCT01128595|649803|P3|COMPLETED|Washout Period 3||7
269226|NCT01128595|649804|P2|COMPLETED|Washout Period 3||5
269227|NCT01128595|649805|P1|COMPLETED|Washout Period 3||7
269228|NCT01128595|649802|P4|STARTED|Washout Period 3||7
269229|NCT01128595|649803|P3|STARTED|Washout Period 3||7
269230|NCT01128595|649804|P2|STARTED|Washout Period 3||5
269231|NCT01128595|649805|P1|STARTED|Washout Period 3||7
269232|NCT01128595|649802|P4|NOT COMPLETED|Treatment Period 3||0
269233|NCT01128595|649803|P3|NOT COMPLETED|Treatment Period 3||0
269234|NCT01128595|649804|P2|NOT COMPLETED|Treatment Period 3||1
269235|NCT01128595|649805|P1|NOT COMPLETED|Treatment Period 3||0
269236|NCT01128595|649802|P4|COMPLETED|Treatment Period 3||7
269237|NCT01128595|649803|P3|COMPLETED|Treatment Period 3||7
269238|NCT01128595|649804|P2|COMPLETED|Treatment Period 3||5
269239|NCT01128595|649805|P1|COMPLETED|Treatment Period 3||7
269240|NCT01128595|649802|P4|STARTED|Treatment Period 3||7
269241|NCT01128595|649803|P3|STARTED|Treatment Period 3||7
269242|NCT01128595|649804|P2|STARTED|Treatment Period 3||6
269243|NCT01128595|649805|P1|STARTED|Treatment Period 3||7
269244|NCT01128595|649802|P4|NOT COMPLETED|Washout Period 2||0
269245|NCT01128595|649803|P3|NOT COMPLETED|Washout Period 2||0
269246|NCT01128595|649804|P2|NOT COMPLETED|Washout Period 2||0
269247|NCT01128595|649805|P1|NOT COMPLETED|Washout Period 2||0
269248|NCT01128595|649802|P4|COMPLETED|Washout Period 2||7
269249|NCT01128595|649803|P3|COMPLETED|Washout Period 2||7
269250|NCT01128595|649804|P2|COMPLETED|Washout Period 2||6
269251|NCT01128595|649805|P1|COMPLETED|Washout Period 2||7
269252|NCT01128595|649802|P4|STARTED|Washout Period 2||7
269253|NCT01128595|649803|P3|STARTED|Washout Period 2||7
269254|NCT01128595|649804|P2|STARTED|Washout Period 2||6
269255|NCT01128595|649805|P1|STARTED|Washout Period 2||7
269256|NCT01128595|649802|P4|NOT COMPLETED|Treatment Period 2||0
269257|NCT01128595|649803|P3|NOT COMPLETED|Treatment Period 2||0
269258|NCT01128595|649804|P2|NOT COMPLETED|Treatment Period 2||0
269259|NCT01128595|649805|P1|NOT COMPLETED|Treatment Period 2||0
269260|NCT01128595|649802|P4|COMPLETED|Treatment Period 2||7
269261|NCT01128595|649803|P3|COMPLETED|Treatment Period 2||7
269262|NCT01128595|649804|P2|COMPLETED|Treatment Period 2||6
269263|NCT01128595|649805|P1|COMPLETED|Treatment Period 2||7
269264|NCT01128595|649802|P4|STARTED|Treatment Period 2||7
269265|NCT01128595|649803|P3|STARTED|Treatment Period 2||7
269266|NCT01128595|649804|P2|STARTED|Treatment Period 2||6
269267|NCT01128595|649805|P1|STARTED|Treatment Period 2||7
269268|NCT01128595|649802|P4|NOT COMPLETED|Washout Period 1||0
269269|NCT01128595|649803|P3|NOT COMPLETED|Washout Period 1||0
269270|NCT01128595|649804|P2|NOT COMPLETED|Washout Period 1||0
269271|NCT01128595|649805|P1|NOT COMPLETED|Washout Period 1||0
269272|NCT01128595|649802|P4|COMPLETED|Washout Period 1||7
269273|NCT01128595|649803|P3|COMPLETED|Washout Period 1||7
269274|NCT01128595|649804|P2|COMPLETED|Washout Period 1||6
269275|NCT01128595|649805|P1|COMPLETED|Washout Period 1||7
269276|NCT01128595|649802|P4|STARTED|Washout Period 1||7
269277|NCT01128595|649803|P3|STARTED|Washout Period 1||7
269278|NCT01128595|649804|P2|STARTED|Washout Period 1||6
269279|NCT01128595|649805|P1|STARTED|Washout Period 1||7
269280|NCT01128595|649802|P4|NOT COMPLETED|Treatment Period 1||0
269281|NCT01128595|649803|P3|NOT COMPLETED|Treatment Period 1||0
269282|NCT01128595|649804|P2|NOT COMPLETED|Treatment Period 1||0
269283|NCT01128595|649805|P1|NOT COMPLETED|Treatment Period 1||0
269284|NCT01128595|649802|P4|COMPLETED|Treatment Period 1||7
269285|NCT01128595|649803|P3|COMPLETED|Treatment Period 1||7
269286|NCT01128595|649804|P2|COMPLETED|Treatment Period 1||6
269287|NCT01128595|649805|P1|COMPLETED|Treatment Period 1||7
269288|NCT01128595|649802|P4|STARTED|Treatment Period 1||7
269289|NCT01128595|649803|P3|STARTED|Treatment Period 1||7
269290|NCT01128595|649804|P2|STARTED|Treatment Period 1||6
269291|NCT01128595|649805|P1|STARTED|Treatment Period 1||7
269292|NCT01128738|649837|P2|NOT COMPLETED|Second TP||3
269293|NCT01128738|649838|P1|NOT COMPLETED|Second TP||0
269294|NCT01128738|649837|P2|COMPLETED|Second TP||63
269295|NCT01128738|649838|P1|COMPLETED|Second TP||34
269296|NCT01128738|649837|P2|STARTED|Second TP|Only participants who received a second treatment entered this phase.|66
269297|NCT01128738|649838|P1|STARTED|Second TP|Only participants who received a second treatment entered this phase.|34
269298|NCT01128738|649837|P2|NOT COMPLETED|First Treatment Phase (TP)||1
269299|NCT01128738|649838|P1|NOT COMPLETED|First Treatment Phase (TP)||4
269300|NCT01128738|649837|P2|COMPLETED|First Treatment Phase (TP)||73
269301|NCT01128738|649838|P1|COMPLETED|First Treatment Phase (TP)||74
269302|NCT01128738|649837|P2|STARTED|First Treatment Phase (TP)||74
269303|NCT01128738|649838|P1|STARTED|First Treatment Phase (TP)||78
269304|NCT01128829|649961|P2|NOT COMPLETED|Overall Study||0
269305|NCT01128829|649962|P1|NOT COMPLETED|Overall Study||0
269306|NCT01128829|649961|P2|COMPLETED|Overall Study||11
269307|NCT01128829|649962|P1|COMPLETED|Overall Study||6
269308|NCT01128829|649961|P2|STARTED|Overall Study||11
269309|NCT01128829|649962|P1|STARTED|Overall Study||6
269310|NCT01128894|649968|P2|NOT COMPLETED|Overall Study||68
269311|NCT01128894|649969|P1|NOT COMPLETED|Overall Study||58
269312|NCT01128894|649968|P2|COMPLETED|Overall Study||340
269313|NCT01128894|649969|P1|COMPLETED|Overall Study||346
269314|NCT01128894|649968|P2|STARTED|Overall Study||408
269315|NCT01128894|649969|P1|STARTED|Overall Study||404
269316|NCT01128946|649987|P4|NOT COMPLETED|Period IV||0
269317|NCT01128946|649988|P3|NOT COMPLETED|Period IV||0
269318|NCT01128946|649989|P2|NOT COMPLETED|Period IV||0
269319|NCT01128946|649990|P1|NOT COMPLETED|Period IV||0
269320|NCT01128946|649987|P4|COMPLETED|Period IV||19
269321|NCT01128946|649988|P3|COMPLETED|Period IV||19
269322|NCT01128946|649989|P2|COMPLETED|Period IV||20
269323|NCT01128946|649990|P1|COMPLETED|Period IV||19
269324|NCT01128946|649987|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
269325|NCT01128946|649988|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
269326|NCT01128946|649989|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|20
269327|NCT01128946|649990|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|19
269328|NCT01128946|649987|P4|NOT COMPLETED|Period III||0
269329|NCT01128946|649988|P3|NOT COMPLETED|Period III||0
269330|NCT01128946|649989|P2|NOT COMPLETED|Period III||0
269331|NCT01128946|649990|P1|NOT COMPLETED|Period III||1
269332|NCT01128946|649987|P4|COMPLETED|Period III||19
269333|NCT01128946|649988|P3|COMPLETED|Period III||20
269334|NCT01128946|649989|P2|COMPLETED|Period III||19
269335|NCT01128946|649990|P1|COMPLETED|Period III||19
269336|NCT01128946|649987|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
269337|NCT01128946|649988|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
269338|NCT01128946|649989|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|19
269339|NCT01128946|649990|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|20
269340|NCT01128946|649987|P4|NOT COMPLETED|Period II||1
269341|NCT01128946|649988|P3|NOT COMPLETED|Period II||0
269342|NCT01128946|649989|P2|NOT COMPLETED|Period II||1
269343|NCT01128946|649990|P1|NOT COMPLETED|Period II||0
269344|NCT01128946|649987|P4|COMPLETED|Period II||19
269345|NCT01128946|649988|P3|COMPLETED|Period II||20
269346|NCT01128946|649989|P2|COMPLETED|Period II||19
269347|NCT01128946|649990|P1|COMPLETED|Period II||20
269348|NCT01128946|649987|P4|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
269349|NCT01128946|649988|P3|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
269350|NCT01128946|649989|P2|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
269351|NCT01128946|649990|P1|STARTED|Period II|Due to crossover design, different set of participants received this treatment compared to Period I|20
269352|NCT01128946|649987|P4|NOT COMPLETED|Period I||1
269353|NCT01128946|649988|P3|NOT COMPLETED|Period I||1
269354|NCT01128946|649989|P2|NOT COMPLETED|Period I||1
269355|NCT01128946|649990|P1|NOT COMPLETED|Period I||0
269356|NCT01128946|649987|P4|COMPLETED|Period I||20
269357|NCT01128946|649988|P3|COMPLETED|Period I||20
269358|NCT01128946|649989|P2|COMPLETED|Period I||20
269359|NCT01128946|649990|P1|COMPLETED|Period I||20
269360|NCT01128946|649987|P4|STARTED|Period I||21
269361|NCT01128946|649988|P3|STARTED|Period I||21
269362|NCT01128946|649989|P2|STARTED|Period I||21
269363|NCT01128946|649990|P1|STARTED|Period I||20
269364|NCT01128959|650006|P1|NOT COMPLETED|Treatment Period||4
269365|NCT01128959|650006|P1|COMPLETED|Treatment Period||101
269366|NCT01128959|650006|P1|STARTED|Treatment Period||105
269367|NCT01128959|650006|P1|NOT COMPLETED|Lead in Period||3
269368|NCT01128959|650006|P1|COMPLETED|Lead in Period||105
269369|NCT01128959|650006|P1|STARTED|Lead in Period||108
269370|NCT01128972|650012|P5|NOT COMPLETED|Period V||0
269371|NCT01128972|650013|P4|NOT COMPLETED|Period V||0
269372|NCT01128972|650014|P3|NOT COMPLETED|Period V||0
269373|NCT01128972|650015|P2|NOT COMPLETED|Period V||0
269374|NCT01128972|650016|P1|NOT COMPLETED|Period V||0
269375|NCT01128972|650012|P5|COMPLETED|Period V||7
269376|NCT01128972|650013|P4|COMPLETED|Period V||7
269377|NCT01128972|650014|P3|COMPLETED|Period V||7
269378|NCT01128972|650015|P2|COMPLETED|Period V||7
269379|NCT01128972|650016|P1|COMPLETED|Period V||8
269380|NCT01128972|650012|P5|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
269381|NCT01128972|650013|P4|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
269382|NCT01128972|650014|P3|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
269383|NCT01128972|650015|P2|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|7
269464|NCT01129115|650088|P4|COMPLETED|Overall Study||15
269384|NCT01128972|650016|P1|STARTED|Period V|Due to crossover design, different set of participants received this treatment compared to Period IV|8
269385|NCT01128972|650012|P5|NOT COMPLETED|Period IV||0
269386|NCT01128972|650013|P4|NOT COMPLETED|Period IV||0
269387|NCT01128972|650014|P3|NOT COMPLETED|Period IV||0
269388|NCT01128972|650015|P2|NOT COMPLETED|Period IV||0
269389|NCT01128972|650016|P1|NOT COMPLETED|Period IV||0
269390|NCT01128972|650012|P5|COMPLETED|Period IV||7
269391|NCT01128972|650013|P4|COMPLETED|Period IV||7
269392|NCT01128972|650014|P3|COMPLETED|Period IV||7
269393|NCT01128972|650015|P2|COMPLETED|Period IV||8
269394|NCT01128972|650016|P1|COMPLETED|Period IV||7
269395|NCT01128972|650012|P5|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
269396|NCT01128972|650013|P4|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
269397|NCT01128972|650014|P3|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
269398|NCT01128972|650015|P2|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|8
269399|NCT01128972|650016|P1|STARTED|Period IV|Due to crossover design,different set of participants received this treatment compared to Period III|7
269400|NCT01128972|650012|P5|NOT COMPLETED|Period III||0
269401|NCT01128972|650013|P4|NOT COMPLETED|Period III||0
269402|NCT01128972|650014|P3|NOT COMPLETED|Period III||0
269403|NCT01128972|650015|P2|NOT COMPLETED|Period III||0
269404|NCT01128972|650016|P1|NOT COMPLETED|Period III||0
269405|NCT01128972|650012|P5|COMPLETED|Period III||7
269406|NCT01128972|650013|P4|COMPLETED|Period III||7
269407|NCT01128972|650014|P3|COMPLETED|Period III||8
269408|NCT01128972|650015|P2|COMPLETED|Period III||7
269409|NCT01128972|650016|P1|COMPLETED|Period III||7
269410|NCT01128972|650012|P5|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
269411|NCT01128972|650013|P4|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
269412|NCT01128972|650014|P3|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|8
269413|NCT01128972|650015|P2|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
269414|NCT01128972|650016|P1|STARTED|Period III|Due to crossover design, different set of participants received this treatment compared to Period II|7
269415|NCT01128972|650012|P5|NOT COMPLETED|Period II||0
269416|NCT01128972|650013|P4|NOT COMPLETED|Period II||0
269417|NCT01128972|650014|P3|NOT COMPLETED|Period II||0
269418|NCT01128972|650015|P2|NOT COMPLETED|Period II||0
269419|NCT01128972|650016|P1|NOT COMPLETED|Period II||0
269420|NCT01128972|650012|P5|COMPLETED|Period II||7
269421|NCT01128972|650013|P4|COMPLETED|Period II||8
269422|NCT01128972|650014|P3|COMPLETED|Period II||7
269423|NCT01128972|650015|P2|COMPLETED|Period II||7
269424|NCT01128972|650016|P1|COMPLETED|Period II||7
269425|NCT01128972|650012|P5|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
269426|NCT01128972|650013|P4|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|8
269427|NCT01128972|650014|P3|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
269428|NCT01128972|650015|P2|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
269429|NCT01128972|650016|P1|STARTED|Period II|Due to cross over design, different set of participants received this treatment compared to Period I|7
269430|NCT01128972|650012|P5|NOT COMPLETED|Period I||0
269431|NCT01128972|650013|P4|NOT COMPLETED|Period I||0
269432|NCT01128972|650014|P3|NOT COMPLETED|Period I||0
269433|NCT01128972|650015|P2|NOT COMPLETED|Period I||0
269434|NCT01128972|650016|P1|NOT COMPLETED|Period I||0
269435|NCT01128972|650012|P5|COMPLETED|Period I||8
269436|NCT01128972|650013|P4|COMPLETED|Period I||7
269437|NCT01128972|650014|P3|COMPLETED|Period I||7
269438|NCT01128972|650015|P2|COMPLETED|Period I||7
269439|NCT01128972|650016|P1|COMPLETED|Period I||7
269440|NCT01128972|650012|P5|STARTED|Period I||8
269441|NCT01128972|650013|P4|STARTED|Period I||7
269442|NCT01128972|650014|P3|STARTED|Period I||7
269443|NCT01128972|650015|P2|STARTED|Period I||7
269444|NCT01128972|650016|P1|STARTED|Period I||7
269445|NCT01129011|650047|P2|NOT COMPLETED|Overall Study||57
269446|NCT01129011|650048|P1|NOT COMPLETED|Overall Study||59
269447|NCT01129011|650047|P2|COMPLETED|Overall Study||153
269448|NCT01129011|650048|P1|COMPLETED|Overall Study||151
269449|NCT01129011|650047|P2|STARTED|Overall Study|Safety, Intent-to-Treat population|210
269450|NCT01129011|650048|P1|STARTED|Overall Study|Safety, Intent-to-Treat population|210
269451|NCT01129102|650073|P3|NOT COMPLETED|Overall Study||7
269452|NCT01129102|650074|P2|NOT COMPLETED|Overall Study||6
269453|NCT01129102|650075|P1|NOT COMPLETED|Overall Study||8
269454|NCT01129102|650073|P3|COMPLETED|Overall Study||48
269455|NCT01129102|650074|P2|COMPLETED|Overall Study||44
269456|NCT01129102|650075|P1|COMPLETED|Overall Study||102
269457|NCT01129102|650073|P3|STARTED|Overall Study||55
269458|NCT01129102|650074|P2|STARTED|Overall Study||50
269459|NCT01129102|650075|P1|STARTED|Overall Study||110
269460|NCT01129115|650088|P4|NOT COMPLETED|Overall Study||9
269461|NCT01129115|650089|P3|NOT COMPLETED|Overall Study||6
269462|NCT01129115|650090|P2|NOT COMPLETED|Overall Study||7
269463|NCT01129115|650091|P1|NOT COMPLETED|Overall Study||2
269465|NCT01129115|650089|P3|COMPLETED|Overall Study||21
269466|NCT01129115|650090|P2|COMPLETED|Overall Study||18
269467|NCT01129115|650091|P1|COMPLETED|Overall Study||23
269468|NCT01129115|650088|P4|STARTED|Overall Study||24
269469|NCT01129115|650089|P3|STARTED|Overall Study||27
269470|NCT01129115|650090|P2|STARTED|Overall Study||25
269471|NCT01129115|650091|P1|STARTED|Overall Study||25
269472|NCT01129128|650128|P3|NOT COMPLETED|Overall Study||4
269473|NCT01129128|650129|P2|NOT COMPLETED|Overall Study||4
269474|NCT01129128|650130|P1|NOT COMPLETED|Overall Study||3
269475|NCT01129128|650128|P3|COMPLETED|Overall Study||19
269476|NCT01129128|650129|P2|COMPLETED|Overall Study||18
269477|NCT01129128|650130|P1|COMPLETED|Overall Study||19
269478|NCT01129128|650128|P3|STARTED|Overall Study||23
269479|NCT01129128|650129|P2|STARTED|Overall Study||22
269480|NCT01129128|650130|P1|STARTED|Overall Study||22
269481|NCT01129141|650152|P2|NOT COMPLETED|Overall Study||13
269482|NCT01129141|650153|P1|NOT COMPLETED|Overall Study||15
269483|NCT01129141|650152|P2|COMPLETED|Overall Study||91
269484|NCT01129141|650153|P1|COMPLETED|Overall Study||86
269485|NCT01129141|650152|P2|STARTED|Overall Study||104
269486|NCT01129141|650153|P1|STARTED|Overall Study||101
269487|NCT01129206|650159|P1|NOT COMPLETED|Overall Study||0
269488|NCT01129206|650159|P1|COMPLETED|Overall Study||6
269489|NCT01129206|650159|P1|STARTED|Overall Study||6
269490|NCT01129245|650169|P2|NOT COMPLETED|Overall Study||0
269491|NCT01129245|650170|P1|NOT COMPLETED|Overall Study||0
269492|NCT01129245|650169|P2|COMPLETED|Overall Study||4
269493|NCT01129245|650170|P1|COMPLETED|Overall Study||7
269494|NCT01129245|650169|P2|STARTED|Overall Study||4
269495|NCT01129245|650170|P1|STARTED|Overall Study||7
269496|NCT01129284|650179|P3|NOT COMPLETED|Overall Study||1
269497|NCT01129284|650180|P2|NOT COMPLETED|Overall Study||0
269498|NCT01129284|650181|P1|NOT COMPLETED|Overall Study||2
269499|NCT01129284|650179|P3|COMPLETED|Overall Study||4
269500|NCT01129284|650180|P2|COMPLETED|Overall Study||5
269501|NCT01129284|650181|P1|COMPLETED|Overall Study||3
269502|NCT01129284|650179|P3|STARTED|Overall Study||5
269503|NCT01129284|650180|P2|STARTED|Overall Study||5
269504|NCT01129284|650181|P1|STARTED|Overall Study||5
269505|NCT01129336|650194|P2|NOT COMPLETED|Overall Study||16
269506|NCT01129336|650195|P1|NOT COMPLETED|Overall Study||12
269507|NCT01129336|650194|P2|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|13
269508|NCT01129336|650195|P1|COMPLETED|Overall Study|Completed indicates Completed Study as per protocol.|3
269509|NCT01129336|650194|P2|Completed Treatment|Overall Study||3
269510|NCT01129336|650195|P1|Completed Treatment|Overall Study||1
269511|NCT01129336|650194|P2|STARTED|Overall Study||29
269512|NCT01129336|650195|P1|STARTED|Overall Study||15
269513|NCT01121146|650209|P2|NOT COMPLETED|Overall Study||42
269514|NCT01121146|650210|P1|NOT COMPLETED|Overall Study||26
269515|NCT01121146|650209|P2|COMPLETED|Overall Study|The 72 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|72
269516|NCT01121146|650210|P1|COMPLETED|Overall Study|The 90 hips include those that were not revised and had a minimum 9-year questionnaire or radiograph|90
269517|NCT01121146|650209|P2|STARTED|Overall Study||114
269518|NCT01121146|650210|P1|STARTED|Overall Study||116
269519|NCT01121172|650226|P2|NOT COMPLETED|Overall Study||0
269520|NCT01121172|650227|P1|NOT COMPLETED|Overall Study||0
269521|NCT01121172|650226|P2|COMPLETED|Overall Study||90
269522|NCT01121172|650227|P1|COMPLETED|Overall Study||90
269523|NCT01121172|650226|P2|STARTED|Overall Study||90
269524|NCT01121172|650227|P1|STARTED|Overall Study||90
269525|NCT01121185|650236|P2|NOT COMPLETED|Overall Study||1
269526|NCT01121185|650237|P1|NOT COMPLETED|Overall Study||1
269527|NCT01121185|650236|P2|COMPLETED|Overall Study||5
269528|NCT01121185|650237|P1|COMPLETED|Overall Study||6
269529|NCT01121185|650236|P2|Transplanted|Overall Study||5
269530|NCT01121185|650237|P1|Transplanted|Overall Study|One subject initiated the first study infusion, but transplant surgery was subsequently cancelled.|6
269531|NCT01121185|650236|P2|Infused|Overall Study|Excluded medical condition identified in one subject after randomization but before study infusion.|5
269532|NCT01121185|650237|P1|Infused|Overall Study||7
269533|NCT01121185|650236|P2|STARTED|Overall Study||6
269534|NCT01121185|650237|P1|STARTED|Overall Study||7
269535|NCT01121211|650261|P2|NOT COMPLETED|Overall Study||12
269536|NCT01121211|650262|P1|NOT COMPLETED|Overall Study||11
269537|NCT01121211|650261|P2|COMPLETED|Overall Study||35
269538|NCT01121211|650262|P1|COMPLETED|Overall Study||32
269539|NCT01121211|650261|P2|STARTED|Overall Study||47
269540|NCT01121211|650262|P1|STARTED|Overall Study||43
269541|NCT01121263|650272|P2|NOT COMPLETED|Overall Study||15
269542|NCT01121263|650273|P1|NOT COMPLETED|Overall Study||25
269543|NCT01121263|650272|P2|COMPLETED|Overall Study||83
269544|NCT01121263|650273|P1|COMPLETED|Overall Study||175
269545|NCT01121263|650272|P2|STARTED|Overall Study||98
269546|NCT01121263|650273|P1|STARTED|Overall Study||200
269547|NCT01121393|650283|P2|NOT COMPLETED|Overall Study||84
269548|NCT01121393|650284|P1|NOT COMPLETED|Overall Study||219
269549|NCT01121393|650283|P2|COMPLETED|Overall Study|Completed 6 courses of chemotherapy|38
269550|NCT01121393|650284|P1|COMPLETED|Overall Study|On-treatment at analysis cut-off date (27 December 2013)|23
269551|NCT01121393|650283|P2|STARTED|Overall Study|randomised|122
269552|NCT01121393|650284|P1|STARTED|Overall Study|randomised|242
269553|NCT01121406|650329|P2|NOT COMPLETED|Overall Study||55
269554|NCT01121406|650330|P1|NOT COMPLETED|Overall Study||55
269555|NCT01121406|650329|P2|COMPLETED|Overall Study||0
269556|NCT01121406|650330|P1|COMPLETED|Overall Study||0
269557|NCT01121406|650329|P2|STARTED|Overall Study|24 patients switched to Volasertib (BI 6727) due to disease progression or occurrence of toxicity|55
269558|NCT01121406|650330|P1|STARTED|Overall Study||55
269559|NCT01129531|650381|P3|NOT COMPLETED|Treatment Cycle 2||5
269560|NCT01129531|650382|P2|NOT COMPLETED|Treatment Cycle 2||3
269561|NCT01129531|650383|P1|NOT COMPLETED|Treatment Cycle 2||6
269562|NCT01129531|650381|P3|COMPLETED|Treatment Cycle 2||74
269563|NCT01129531|650382|P2|COMPLETED|Treatment Cycle 2||92
269564|NCT01129531|650383|P1|COMPLETED|Treatment Cycle 2||88
269565|NCT01129531|650381|P3|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|79
269566|NCT01129531|650382|P2|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|95
269567|NCT01129531|650383|P1|STARTED|Treatment Cycle 2|Participants who completed Treatment Cycle 1 were re-randomized.|94
269568|NCT01129531|650381|P3|NOT COMPLETED|Treatment Cycle 1||16
269569|NCT01129531|650382|P2|NOT COMPLETED|Treatment Cycle 1||6
269570|NCT01129531|650383|P1|NOT COMPLETED|Treatment Cycle 1||4
269571|NCT01129531|650381|P3|COMPLETED|Treatment Cycle 1||110
269572|NCT01129531|650382|P2|COMPLETED|Treatment Cycle 1||78
269573|NCT01129531|650383|P1|COMPLETED|Treatment Cycle 1||80
269574|NCT01129531|650381|P3|STARTED|Treatment Cycle 1||126
269575|NCT01129531|650382|P2|STARTED|Treatment Cycle 1||84
269576|NCT01129531|650383|P1|STARTED|Treatment Cycle 1||84
269577|NCT01129557|650406|P3|NOT COMPLETED|Overall Study||4
269578|NCT01129557|650407|P2|NOT COMPLETED|Overall Study||5
269579|NCT01129557|650408|P1|NOT COMPLETED|Overall Study||4
269580|NCT01129557|650406|P3|COMPLETED|Overall Study||10
269581|NCT01129557|650407|P2|COMPLETED|Overall Study||12
269582|NCT01129557|650408|P1|COMPLETED|Overall Study||11
269583|NCT01129557|650406|P3|STARTED|Overall Study||14
269584|NCT01129557|650407|P2|STARTED|Overall Study||17
269585|NCT01129557|650408|P1|STARTED|Overall Study||15
269586|NCT01129583|650478|P2|NOT COMPLETED|Overall Study||2
269587|NCT01129583|650479|P1|NOT COMPLETED|Overall Study||3
269588|NCT01129583|650478|P2|COMPLETED|Overall Study||7
269589|NCT01129583|650479|P1|COMPLETED|Overall Study||6
269590|NCT01129583|650478|P2|STARTED|Overall Study||9
269591|NCT01129583|650479|P1|STARTED|Overall Study||9
269592|NCT01129622|650489|P1|NOT COMPLETED|Overall Study||2
269593|NCT01129622|650489|P1|COMPLETED|Overall Study||14
269594|NCT01129622|650489|P1|STARTED|Overall Study||16
269595|NCT01129765|650494|P1|NOT COMPLETED|Overall Study||0
269596|NCT01129765|650494|P1|COMPLETED|Overall Study||30
269597|NCT01129765|650494|P1|STARTED|Overall Study||30
269598|NCT01129778|650503|P1|NOT COMPLETED|Overall Study||7
269599|NCT01129778|650503|P1|COMPLETED|Overall Study||15
269600|NCT01129778|650503|P1|STARTED|Overall Study||22
269601|NCT01130740|650510|P2|NOT COMPLETED|Overall Study||15
269602|NCT01130740|650511|P1|NOT COMPLETED|Overall Study||12
269603|NCT01130740|650510|P2|COMPLETED|Overall Study||136
269604|NCT01130740|650511|P1|COMPLETED|Overall Study||137
269605|NCT01130740|650510|P2|STARTED|Overall Study||151
269606|NCT01130740|650511|P1|STARTED|Overall Study||149
269607|NCT01130831|650521|P1|NOT COMPLETED|Overall Study||14
269608|NCT01130831|650521|P1|COMPLETED|Overall Study||52
269609|NCT01130831|650521|P1|STARTED|Overall Study||66
269610|NCT01130844|650550|P3|NOT COMPLETED|Overall Study||0
269611|NCT01130844|650551|P2|NOT COMPLETED|Overall Study||0
269612|NCT01130844|650552|P1|NOT COMPLETED|Overall Study||0
269613|NCT01130844|650550|P3|COMPLETED|Overall Study||9
269614|NCT01130844|650551|P2|COMPLETED|Overall Study||22
269615|NCT01130844|650552|P1|COMPLETED|Overall Study||21
269616|NCT01130844|650550|P3|STARTED|Overall Study||9
269617|NCT01130844|650551|P2|STARTED|Overall Study||22
269618|NCT01130844|650552|P1|STARTED|Overall Study||21
269619|NCT01130883|650590|P1|NOT COMPLETED|Overall Study||10
269620|NCT01130883|650590|P1|COMPLETED|Overall Study||3120
269621|NCT01130883|650590|P1|Participants Analyzed|Overall Study||3128
269622|NCT01130883|650590|P1|STARTED|Overall Study||3130
269623|NCT01130974|650606|P2|NOT COMPLETED|Overall Study||13
269624|NCT01130974|650607|P1|NOT COMPLETED|Overall Study||15
269625|NCT01130974|650606|P2|COMPLETED|Overall Study||87
269626|NCT01130974|650607|P1|COMPLETED|Overall Study||85
269627|NCT01130974|650606|P2|STARTED|Overall Study||100
269628|NCT01130974|650607|P1|STARTED|Overall Study||100
269629|NCT01131052|650629|P2|NOT COMPLETED|Overall Study||0
269630|NCT01131052|650630|P1|NOT COMPLETED|Overall Study||0
269631|NCT01131052|650629|P2|COMPLETED|Overall Study||75
269632|NCT01131052|650630|P1|COMPLETED|Overall Study||75
269633|NCT01131052|650629|P2|STARTED|Overall Study||75
269634|NCT01131052|650630|P1|STARTED|Overall Study||75
269635|NCT01131065|650650|P1|NOT COMPLETED|Overall Study||0
269636|NCT01131065|650650|P1|COMPLETED|Overall Study||15
269637|NCT01131065|650650|P1|STARTED|Overall Study||15
269638|NCT01131078|650659|P3|NOT COMPLETED|Overall Study||102
269639|NCT01131078|650660|P2|NOT COMPLETED|Overall Study||101
269640|NCT01131078|650661|P1|NOT COMPLETED|Overall Study||101
269641|NCT01131078|650659|P3|COMPLETED|Overall Study||1
269642|NCT01131078|650660|P2|COMPLETED|Overall Study||1
269643|NCT01131078|650661|P1|COMPLETED|Overall Study||0
269644|NCT01131078|650659|P3|STARTED|Overall Study||103
269645|NCT01131078|650660|P2|STARTED|Overall Study||102
269646|NCT01131078|650661|P1|STARTED|Overall Study||101
269647|NCT01131130|650717|P1|NOT COMPLETED|Period 3- Crossover||1
269648|NCT01131130|650717|P1|COMPLETED|Period 3- Crossover||116
269649|NCT01131130|650717|P1|STARTED|Period 3- Crossover||117
269650|NCT01131130|650717|P1|NOT COMPLETED|Period 2 - Crossover||0
269651|NCT01131130|650717|P1|COMPLETED|Period 2 - Crossover||117
269652|NCT01131130|650717|P1|STARTED|Period 2 - Crossover||117
269653|NCT01131130|650717|P1|NOT COMPLETED|Period 1 - Baseline||1
269654|NCT01131130|650717|P1|COMPLETED|Period 1 - Baseline|Participant was discontinued 1 day following dispensing and not reported in result tables|117
269655|NCT01131130|650717|P1|STARTED|Period 1 - Baseline||118
269656|NCT01131182|650732|P2|NOT COMPLETED|Overall Study||16
269657|NCT01131182|650733|P1|NOT COMPLETED|Overall Study||16
269658|NCT01131182|650732|P2|COMPLETED|Overall Study||521
269659|NCT01131182|650733|P1|COMPLETED|Overall Study||513
269660|NCT01131182|650732|P2|STARTED|Overall Study||537
269661|NCT01131182|650733|P1|STARTED|Overall Study||529
269662|NCT01131299|650741|P2|NOT COMPLETED|Overall Study||7
269663|NCT01131299|650742|P1|NOT COMPLETED|Overall Study||4
269664|NCT01131299|650741|P2|COMPLETED|Overall Study||37
269665|NCT01131299|650742|P1|COMPLETED|Overall Study||38
269666|NCT01131299|650741|P2|STARTED|Overall Study||44
269667|NCT01131299|650742|P1|STARTED|Overall Study||42
269668|NCT01131455|650756|P3|NOT COMPLETED|Overall Study||0
269669|NCT01131455|650757|P2|NOT COMPLETED|Overall Study||4
269670|NCT01131455|650758|P1|NOT COMPLETED|Overall Study||6
269671|NCT01131455|650756|P3|COMPLETED|Overall Study||0
269672|NCT01131455|650757|P2|COMPLETED|Overall Study||0
269673|NCT01131455|650758|P1|COMPLETED|Overall Study||0
269674|NCT01131455|650756|P3|STARTED|Overall Study||0
269675|NCT01131455|650757|P2|STARTED|Overall Study||4
269676|NCT01131455|650758|P1|STARTED|Overall Study||6
269677|NCT01131494|650766|P1|NOT COMPLETED|Overall Study||2
269678|NCT01131494|650766|P1|COMPLETED|Overall Study||15
269679|NCT01131494|650766|P1|STARTED|Overall Study||17
269680|NCT01131507|650773|P1|NOT COMPLETED|Overall Study||3
269681|NCT01131507|650773|P1|COMPLETED|Overall Study||12
269682|NCT01131507|650773|P1|STARTED|Overall Study||15
269683|NCT01131520|650780|P2|NOT COMPLETED|Overall Study||4
269684|NCT01131520|650781|P1|NOT COMPLETED|Overall Study||1
269685|NCT01131520|650780|P2|COMPLETED|Overall Study||176
269686|NCT01131520|650781|P1|COMPLETED|Overall Study||179
269687|NCT01131520|650780|P2|STARTED|Overall Study||180
269688|NCT01131520|650781|P1|STARTED|Overall Study||180
269689|NCT01131585|650805|P2|NOT COMPLETED|Overall Study||43
269690|NCT01131585|650806|P1|NOT COMPLETED|Overall Study||85
269691|NCT01131585|650805|P2|COMPLETED|Overall Study||0
269692|NCT01131585|650806|P1|COMPLETED|Overall Study||0
269693|NCT01131585|650805|P2|STARTED|Overall Study||43
269694|NCT01131585|650806|P1|STARTED|Overall Study||85
269695|NCT01131676|650815|P3|NOT COMPLETED|Discontinuation From Study (Treated Set)||63
269696|NCT01131676|650816|P2|NOT COMPLETED|Discontinuation From Study (Treated Set)||81
269697|NCT01131676|650817|P1|NOT COMPLETED|Discontinuation From Study (Treated Set)||67
269698|NCT01131676|650815|P3|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2279
269699|NCT01131676|650816|P2|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2264
269700|NCT01131676|650817|P1|COMPLETED|Discontinuation From Study (Treated Set)|Completed the trial or died|2266
269701|NCT01131676|650815|P3|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2327
269702|NCT01131676|650816|P2|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2324
269703|NCT01131676|650817|P1|Final Vital Status (VS) Available|Discontinuation From Study (Treated Set)||2316
269704|NCT01131676|650815|P3|STARTED|Discontinuation From Study (Treated Set)||2342
269705|NCT01131676|650816|P2|STARTED|Discontinuation From Study (Treated Set)||2345
269706|NCT01131676|650817|P1|STARTED|Discontinuation From Study (Treated Set)||2333
269707|NCT01131676|650815|P3|NOT COMPLETED|Discontinuation From Treatment||544
269708|NCT01131676|650816|P2|NOT COMPLETED|Discontinuation From Treatment||557
269709|NCT01131676|650817|P1|NOT COMPLETED|Discontinuation From Treatment||687
269710|NCT01131676|650815|P3|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1800
269711|NCT01131676|650816|P2|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1790
269712|NCT01131676|650817|P1|COMPLETED|Discontinuation From Treatment|Not prematurely discontinued from trial medication|1650
269713|NCT01131676|650815|P3|STARTED|Discontinuation From Treatment|Randomised|2344
269714|NCT01131676|650816|P2|STARTED|Discontinuation From Treatment|Randomised|2347
269715|NCT01131676|650817|P1|STARTED|Discontinuation From Treatment|Randomised|2337
269716|NCT01131884|650852|P2|NOT COMPLETED|Overall Study||0
269717|NCT01131884|650853|P1|NOT COMPLETED|Overall Study||0
269718|NCT01131884|650852|P2|COMPLETED|Overall Study||0
269719|NCT01131884|650853|P1|COMPLETED|Overall Study||1
269720|NCT01131884|650852|P2|STARTED|Overall Study||0
269721|NCT01131884|650853|P1|STARTED|Overall Study||1
269722|NCT01132118|650861|P2|NOT COMPLETED|Second Intervention (8 Weeks)||1
269723|NCT01132118|650862|P1|NOT COMPLETED|Second Intervention (8 Weeks)||0
269724|NCT01132118|650861|P2|COMPLETED|Second Intervention (8 Weeks)||11
269725|NCT01132118|650862|P1|COMPLETED|Second Intervention (8 Weeks)||12
269726|NCT01132118|650861|P2|STARTED|Second Intervention (8 Weeks)||12
269727|NCT01132118|650862|P1|STARTED|Second Intervention (8 Weeks)||12
269728|NCT01132118|650861|P2|NOT COMPLETED|First Intervention (8 Weeks)||3
269729|NCT01132118|650862|P1|NOT COMPLETED|First Intervention (8 Weeks)||3
269730|NCT01132118|650861|P2|COMPLETED|First Intervention (8 Weeks)||12
269731|NCT01132118|650862|P1|COMPLETED|First Intervention (8 Weeks)||12
269732|NCT01132118|650861|P2|STARTED|First Intervention (8 Weeks)||15
269733|NCT01132118|650862|P1|STARTED|First Intervention (8 Weeks)||15
269734|NCT01132144|650882|P2|NOT COMPLETED|Overall Study||0
269735|NCT01132144|650883|P1|NOT COMPLETED|Overall Study||0
269736|NCT01132144|650882|P2|COMPLETED|Overall Study||79
269737|NCT01132144|650883|P1|COMPLETED|Overall Study||79
269738|NCT01132144|650882|P2|STARTED|Overall Study||79
269739|NCT01132144|650883|P1|STARTED|Overall Study||79
269740|NCT01132313|650915|P12|NOT COMPLETED|Overall Study||0
269741|NCT01132313|650916|P11|NOT COMPLETED|Overall Study||1
269742|NCT01132313|650917|P10|NOT COMPLETED|Overall Study||20
269743|NCT01132313|650918|P9|NOT COMPLETED|Overall Study||21
269744|NCT01132313|650919|P8|NOT COMPLETED|Overall Study||8
269745|NCT01132313|650920|P7|NOT COMPLETED|Overall Study||30
269746|NCT01132313|650921|P6|NOT COMPLETED|Overall Study||25
269747|NCT01132313|650922|P5|NOT COMPLETED|Overall Study||45
269748|NCT01132313|650923|P4|NOT COMPLETED|Overall Study||32
269749|NCT01132313|650924|P3|NOT COMPLETED|Overall Study||20
269750|NCT01132313|650925|P2|NOT COMPLETED|Overall Study||0
269751|NCT01132313|650926|P1|NOT COMPLETED|Overall Study||3
269752|NCT01132313|650915|P12|COMPLETED|Overall Study||2
269753|NCT01132313|650916|P11|COMPLETED|Overall Study||0
269754|NCT01132313|650917|P10|COMPLETED|Overall Study||5
269755|NCT01132313|650918|P9|COMPLETED|Overall Study||5
269756|NCT01132313|650919|P8|COMPLETED|Overall Study||24
269757|NCT01132313|650920|P7|COMPLETED|Overall Study||19
269758|NCT01132313|650921|P6|COMPLETED|Overall Study||54
269759|NCT01132313|650922|P5|COMPLETED|Overall Study||34
269760|NCT01132313|650923|P4|COMPLETED|Overall Study||48
269761|NCT01132313|650924|P3|COMPLETED|Overall Study||61
269762|NCT01132313|650925|P2|COMPLETED|Overall Study||17
269763|NCT01132313|650926|P1|COMPLETED|Overall Study||14
269764|NCT01132313|650915|P12|STARTED|Overall Study||2
269765|NCT01132313|650916|P11|STARTED|Overall Study||1
269766|NCT01132313|650917|P10|STARTED|Overall Study||25
269767|NCT01132313|650918|P9|STARTED|Overall Study||26
269768|NCT01132313|650919|P8|STARTED|Overall Study||32
269769|NCT01132313|650920|P7|STARTED|Overall Study||49
269770|NCT01132313|650921|P6|STARTED|Overall Study||79
269771|NCT01132313|650922|P5|STARTED|Overall Study||79
269772|NCT01132313|650923|P4|STARTED|Overall Study||80
269773|NCT01132313|650924|P3|STARTED|Overall Study||81
269774|NCT01132313|650925|P2|STARTED|Overall Study||17
269775|NCT01132313|650926|P1|STARTED|Overall Study||17
269776|NCT01132326|650981|P1|NOT COMPLETED|Overall Study||218
269777|NCT01132326|650981|P1|COMPLETED|Overall Study||132
269778|NCT01132326|650981|P1|STARTED|Overall Study||350
269779|NCT01132378|650985|P1|NOT COMPLETED|Overall Study||0
269780|NCT01132378|650985|P1|COMPLETED|Overall Study||40
269781|NCT01132378|650985|P1|STARTED|Overall Study||40
269782|NCT01132495|650994|P4|NOT COMPLETED|Overall Study||12
269783|NCT01132495|650995|P3|NOT COMPLETED|Overall Study||20
269784|NCT01132495|650996|P2|NOT COMPLETED|Overall Study||38
269785|NCT01132495|650997|P1|NOT COMPLETED|Overall Study||40
269786|NCT01132495|650994|P4|COMPLETED|Overall Study||104
269787|NCT01132495|650995|P3|COMPLETED|Overall Study||146
269788|NCT01132495|650996|P2|COMPLETED|Overall Study||403
269789|NCT01132495|650997|P1|COMPLETED|Overall Study||407
269790|NCT01132495|650994|P4|STARTED|Overall Study||116
269791|NCT01132495|650995|P3|STARTED|Overall Study||166
269792|NCT01132495|650996|P2|STARTED|Overall Study||441
269793|NCT01132495|650997|P1|STARTED|Overall Study||447
269794|NCT01132508|651005|P1|NOT COMPLETED|Overall Study||9
269795|NCT01132508|651005|P1|COMPLETED|Overall Study||24
269796|NCT01132508|651005|P1|104 Weeks|Overall Study||27
269797|NCT01132508|651005|P1|78 Weeks|Overall Study||28
269798|NCT01132508|651005|P1|52 Weeks|Overall Study||30
269799|NCT01132508|651005|P1|26 Weeks|Overall Study||33
269800|NCT01132508|651005|P1|12 Weeks|Overall Study||33
269801|NCT01132508|651005|P1|6 Weeks|Overall Study||33
269802|NCT01132508|651005|P1|Treated at Baseline|Overall Study||33
269803|NCT01132508|651005|P1|STARTED|Overall Study||33
269804|NCT01132547|651063|P2|NOT COMPLETED|Overall Study||1
269805|NCT01132547|651064|P1|NOT COMPLETED|Overall Study||4
269806|NCT01132547|651063|P2|COMPLETED|Overall Study||12
269807|NCT01132547|651064|P1|COMPLETED|Overall Study||5
269808|NCT01132547|651063|P2|STARTED|Overall Study||13
269809|NCT01132547|651064|P1|STARTED|Overall Study||9
269810|NCT01132651|651076|P2|NOT COMPLETED|Overall Study||1
269811|NCT01132651|651077|P1|NOT COMPLETED|Overall Study||1
269812|NCT01132651|651076|P2|COMPLETED|Overall Study||4
269813|NCT01132651|651077|P1|COMPLETED|Overall Study||3
269814|NCT01132651|651076|P2|STARTED|Overall Study||5
269815|NCT01132651|651077|P1|STARTED|Overall Study||4
269816|NCT01132664|651090|P5|NOT COMPLETED|BM Cohort||6
269817|NCT01132664|651091|P4|NOT COMPLETED|BM Cohort||3
269818|NCT01132664|651092|P3|NOT COMPLETED|BM Cohort||0
269819|NCT01132664|651093|P2|NOT COMPLETED|BM Cohort||0
269820|NCT01132664|651094|P1|NOT COMPLETED|BM Cohort||0
269821|NCT01132664|651090|P5|COMPLETED|BM Cohort||0
269822|NCT01132664|651091|P4|COMPLETED|BM Cohort||0
269823|NCT01132664|651092|P3|COMPLETED|BM Cohort||0
269824|NCT01132664|651093|P2|COMPLETED|BM Cohort||0
269825|NCT01132664|651094|P1|COMPLETED|BM Cohort||0
269826|NCT01132664|651090|P5|STARTED|BM Cohort||6
269827|NCT01132664|651091|P4|STARTED|BM Cohort||3
269828|NCT01132664|651092|P3|STARTED|BM Cohort||0
269829|NCT01132664|651093|P2|STARTED|BM Cohort||0
269830|NCT01132664|651094|P1|STARTED|BM Cohort||0
269831|NCT01132664|651090|P5|NOT COMPLETED|Phase ll||0
269832|NCT01132664|651091|P4|NOT COMPLETED|Phase ll||0
269833|NCT01132664|651092|P3|NOT COMPLETED|Phase ll||50
269834|NCT01132664|651093|P2|NOT COMPLETED|Phase ll||0
269835|NCT01132664|651094|P1|NOT COMPLETED|Phase ll||0
269836|NCT01132664|651090|P5|COMPLETED|Phase ll||0
269837|NCT01132664|651091|P4|COMPLETED|Phase ll||0
269838|NCT01132664|651092|P3|COMPLETED|Phase ll||0
269839|NCT01132664|651093|P2|COMPLETED|Phase ll||0
269840|NCT01132664|651094|P1|COMPLETED|Phase ll||0
269841|NCT01132664|651090|P5|STARTED|Phase ll||0
269842|NCT01132664|651091|P4|STARTED|Phase ll||0
269843|NCT01132664|651092|P3|STARTED|Phase ll|Of the 50 patients, 8 were from phase lb & were eligible for inclusion in Phase II|50
269844|NCT01132664|651093|P2|STARTED|Phase ll||0
269845|NCT01132664|651094|P1|STARTED|Phase ll||0
269846|NCT01132664|651090|P5|NOT COMPLETED|Phase lb||0
269847|NCT01132664|651091|P4|NOT COMPLETED|Phase lb||0
269848|NCT01132664|651092|P3|NOT COMPLETED|Phase lb||0
269849|NCT01132664|651093|P2|NOT COMPLETED|Phase lb||12
269850|NCT01132664|651094|P1|NOT COMPLETED|Phase lb||5
269851|NCT01132664|651090|P5|COMPLETED|Phase lb||0
269852|NCT01132664|651091|P4|COMPLETED|Phase lb||0
269853|NCT01132664|651092|P3|COMPLETED|Phase lb||0
269854|NCT01132664|651093|P2|COMPLETED|Phase lb||0
269855|NCT01132664|651094|P1|COMPLETED|Phase lb||0
269856|NCT01132664|651090|P5|STARTED|Phase lb||0
269857|NCT01132664|651091|P4|STARTED|Phase lb||0
269858|NCT01132664|651092|P3|STARTED|Phase lb||0
269859|NCT01132664|651093|P2|STARTED|Phase lb||12
269860|NCT01132664|651094|P1|STARTED|Phase lb||5
269861|NCT01132690|651128|P2|NOT COMPLETED|Overall Study||0
269862|NCT01132690|651129|P1|NOT COMPLETED|Overall Study||0
269863|NCT01132690|651128|P2|COMPLETED|Overall Study||5
269864|NCT01132690|651129|P1|COMPLETED|Overall Study||6
269865|NCT01132690|651128|P2|STARTED|Overall Study||5
269866|NCT01132690|651129|P1|STARTED|Overall Study||6
269867|NCT01132820|651145|P1|NOT COMPLETED|Overall Study||5
269868|NCT01132820|651145|P1|COMPLETED|Overall Study||48
269869|NCT01132820|651145|P1|STARTED|Overall Study||53
269870|NCT01132846|651157|P3|NOT COMPLETED|Overall Study||11
269871|NCT01132846|651158|P2|NOT COMPLETED|Overall Study||18
269872|NCT01132846|651159|P1|NOT COMPLETED|Overall Study||16
269873|NCT01132846|651157|P3|COMPLETED|Overall Study||108
269874|NCT01132846|651158|P2|COMPLETED|Overall Study||101
269875|NCT01132846|651159|P1|COMPLETED|Overall Study||106
269876|NCT01132846|651157|P3|STARTED|Overall Study||119
269877|NCT01132846|651158|P2|STARTED|Overall Study||119
269878|NCT01132846|651159|P1|STARTED|Overall Study||122
269879|NCT01133171|651212|P3|NOT COMPLETED|Overall Study||0
269880|NCT01133171|651213|P2|NOT COMPLETED|Overall Study||2
269881|NCT01133171|651214|P1|NOT COMPLETED|Overall Study||1
269882|NCT01133171|651212|P3|COMPLETED|Overall Study||25
269883|NCT01133171|651213|P2|COMPLETED|Overall Study||25
269884|NCT01133171|651214|P1|COMPLETED|Overall Study||24
269885|NCT01133171|651212|P3|STARTED|Overall Study||25
269886|NCT01133171|651213|P2|STARTED|Overall Study||27
269887|NCT01133171|651214|P1|STARTED|Overall Study||25
269888|NCT01124604|651226|P2|NOT COMPLETED|Overall Study||2
269889|NCT01124604|651227|P1|NOT COMPLETED|Overall Study||15
269890|NCT01124604|651226|P2|COMPLETED|Overall Study||29
269891|NCT01124604|651227|P1|COMPLETED|Overall Study||45
269892|NCT01124604|651226|P2|STARTED|Overall Study||31
269893|NCT01124604|651227|P1|STARTED|Overall Study||60
269894|NCT01124617|651266|P2|NOT COMPLETED|Overall Study||6
269895|NCT01124617|651267|P1|NOT COMPLETED|Overall Study||19
269896|NCT01124617|651266|P2|COMPLETED|Overall Study||25
269897|NCT01124617|651267|P1|COMPLETED|Overall Study||41
269898|NCT01124617|651266|P2|STARTED|Overall Study||31
269899|NCT01124617|651267|P1|STARTED|Overall Study||60
269900|NCT01124643|651297|P1|NOT COMPLETED|Overall Study||1
269901|NCT01124643|651297|P1|COMPLETED|Overall Study||34
269902|NCT01124643|651297|P1|STARTED|Overall Study||35
269903|NCT01124786|651311|P2|NOT COMPLETED|Overall Study||5
269904|NCT01124786|651312|P1|NOT COMPLETED|Overall Study||4
269905|NCT01124786|651311|P2|COMPLETED|Overall Study||180
269906|NCT01124786|651312|P1|COMPLETED|Overall Study||178
269907|NCT01124786|651311|P2|Tumor Evaluable Population|Overall Study||180
269908|NCT01124786|651312|P1|Tumor Evaluable Population|Overall Study|All pts with measurable/evaluable tumor at baseline per RECIST and have received ≥ one dose of drug|178
269909|NCT01124786|651311|P2|Safety Population|Overall Study||181
269910|NCT01124786|651312|P1|Safety Population|Overall Study|All pts who received at least one dose of study drug|179
269911|NCT01124786|651311|P2|Intent-to-Treat (ITT) Population|Overall Study||185
269912|NCT01124786|651312|P1|Intent-to-Treat (ITT) Population|Overall Study|All randomized patients (pts)|182
269913|NCT01124786|651311|P2|STARTED|Overall Study||185
269914|NCT01124786|651312|P1|STARTED|Overall Study||182
269915|NCT01124838|651334|P2|NOT COMPLETED|Overall Study||15
269916|NCT01124838|651335|P1|NOT COMPLETED|Overall Study||18
269917|NCT01124838|651334|P2|COMPLETED|Overall Study||116
269918|NCT01124838|651335|P1|COMPLETED|Overall Study||112
269919|NCT01124838|651334|P2|Enrolled in Japan Sub-study|Overall Study||16
269920|NCT01124838|651335|P1|Enrolled in Japan Sub-study|Overall Study||16
269921|NCT01124838|651334|P2|Enrolled in Main Study|Overall Study||115
269922|NCT01124838|651335|P1|Enrolled in Main Study|Overall Study||114
269923|NCT01124838|651334|P2|STARTED|Overall Study||131
269924|NCT01124838|651335|P1|STARTED|Overall Study||130
269925|NCT01124864|651385|P6|NOT COMPLETED|Overall Study||3
269926|NCT01124864|651386|P5|NOT COMPLETED|Overall Study||30
269927|NCT01124864|651387|P4|NOT COMPLETED|Overall Study||21
269928|NCT01124864|651388|P3|NOT COMPLETED|Overall Study||34
269929|NCT01124864|651389|P2|NOT COMPLETED|Overall Study||35
269930|NCT01124864|651390|P1|NOT COMPLETED|Overall Study||28
269931|NCT01124864|651385|P6|COMPLETED|Overall Study||0
269932|NCT01124864|651386|P5|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
269933|NCT01124864|651387|P4|COMPLETED|Overall Study|1 patient ongoing at time of data cut-off 30-Jul-2013|1
269934|NCT01124864|651388|P3|COMPLETED|Overall Study||0
269935|NCT01124864|651389|P2|COMPLETED|Overall Study||0
269936|NCT01124864|651390|P1|COMPLETED|Overall Study||0
269937|NCT01124864|651385|P6|STARTED|Overall Study||3
269938|NCT01124864|651386|P5|STARTED|Overall Study||31
269939|NCT01124864|651387|P4|STARTED|Overall Study||22
269940|NCT01124864|651388|P3|STARTED|Overall Study||34
269941|NCT01124864|651389|P2|STARTED|Overall Study||35
269942|NCT01124864|651390|P1|STARTED|Overall Study||28
269943|NCT01124916|651424|P2|NOT COMPLETED|Overall Study||2
269944|NCT01124916|651425|P1|NOT COMPLETED|Overall Study||3
269945|NCT01124916|651424|P2|COMPLETED|Overall Study||38
269946|NCT01124916|651425|P1|COMPLETED|Overall Study||35
269947|NCT01124916|651424|P2|STARTED|Overall Study||40
269948|NCT01124916|651425|P1|STARTED|Overall Study||38
269949|NCT01124955|651435|P2|NOT COMPLETED|Overall Study||0
269950|NCT01124955|651436|P1|NOT COMPLETED|Overall Study||0
269951|NCT01124955|651435|P2|COMPLETED|Overall Study||40
269952|NCT01124955|651436|P1|COMPLETED|Overall Study||40
269953|NCT01124955|651435|P2|STARTED|Overall Study||40
269954|NCT01124955|651436|P1|STARTED|Overall Study||40
269955|NCT01125098|651452|P2|NOT COMPLETED|Overall Study||0
269956|NCT01125098|651453|P1|NOT COMPLETED|Overall Study||3
269957|NCT01125098|651452|P2|COMPLETED|Overall Study||90
269958|NCT01125098|651453|P1|COMPLETED|Overall Study||88
269959|NCT01125098|651452|P2|STARTED|Overall Study||90
269960|NCT01125098|651453|P1|STARTED|Overall Study||91
269961|NCT01125189|651462|P3|NOT COMPLETED|Follow up Period||16
269962|NCT01125189|651463|P2|NOT COMPLETED|Follow up Period||15
269963|NCT01125189|651464|P1|NOT COMPLETED|Follow up Period||20
269964|NCT01125189|651462|P3|COMPLETED|Follow up Period||58
269965|NCT01125189|651463|P2|COMPLETED|Follow up Period||138
269966|NCT01125189|651464|P1|COMPLETED|Follow up Period||132
269967|NCT01125189|651462|P3|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|74
269968|NCT01125189|651463|P2|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|153
269969|NCT01125189|651464|P1|STARTED|Follow up Period|All participants who received treatment continued in the follow-up phase.|152
269970|NCT01125189|651462|P3|NOT COMPLETED|Treatment Period||41
269971|NCT01125189|651463|P2|NOT COMPLETED|Treatment Period||35
269972|NCT01125189|651464|P1|NOT COMPLETED|Treatment Period||31
269973|NCT01125189|651462|P3|COMPLETED|Treatment Period||37
269974|NCT01125189|651463|P2|COMPLETED|Treatment Period||123
269975|NCT01125189|651464|P1|COMPLETED|Treatment Period||128
269976|NCT01125189|651462|P3|STARTED|Treatment Period||78
269977|NCT01125189|651463|P2|STARTED|Treatment Period||158
269978|NCT01125189|651464|P1|STARTED|Treatment Period||159
269979|NCT01125202|651492|P2|NOT COMPLETED|Overall Study||7
269980|NCT01125202|651493|P1|NOT COMPLETED|Overall Study||12
269981|NCT01125202|651492|P2|COMPLETED|Overall Study||79
269982|NCT01125202|651493|P1|COMPLETED|Overall Study||81
269983|NCT01125202|651492|P2|STARTED|Overall Study||86
269984|NCT01125202|651493|P1|STARTED|Overall Study||93
269985|NCT01125514|651515|P1|NOT COMPLETED|Treatment Period2(Day9-Day27) and Day 28||4
269986|NCT01125514|651515|P1|COMPLETED|Treatment Period2(Day9-Day27) and Day 28||28
269987|NCT01125514|651515|P1|STARTED|Treatment Period2(Day9-Day27) and Day 28||32
269988|NCT01125514|651515|P1|NOT COMPLETED|Treatment Period 2 (Day 8 - Day 17)||3
269989|NCT01125514|651515|P1|COMPLETED|Treatment Period 2 (Day 8 - Day 17)||32
269990|NCT01125514|651515|P1|Pharmacodynamics (PD) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
269991|NCT01125514|651515|P1|Pharmacokinetic (PK) Analysis Set|Treatment Period 2 (Day 8 - Day 17)||33
269992|NCT01125514|651515|P1|STARTED|Treatment Period 2 (Day 8 - Day 17)||35
269993|NCT01125514|651515|P1|NOT COMPLETED|Treatment Period 1 (Day 1 - Day 7)||2
269994|NCT01125514|651515|P1|COMPLETED|Treatment Period 1 (Day 1 - Day 7)||35
269995|NCT01125514|651515|P1|STARTED|Treatment Period 1 (Day 1 - Day 7)|Randomized and safety population|37
269996|NCT01125566|651589|P3|NOT COMPLETED|Patients Who Switched From AV to TV||24
269997|NCT01125566|651590|P2|NOT COMPLETED|Patients Who Switched From AV to TV||0
269998|NCT01125566|651591|P1|NOT COMPLETED|Patients Who Switched From AV to TV||0
269999|NCT01125566|651589|P3|COMPLETED|Patients Who Switched From AV to TV|On TV treatment at analysis cut-off date (03Sep2013)|49
270000|NCT01125566|651590|P2|COMPLETED|Patients Who Switched From AV to TV||0
270001|NCT01125566|651591|P1|COMPLETED|Patients Who Switched From AV to TV||0
270002|NCT01125566|651589|P3|STARTED|Patients Who Switched From AV to TV|All patients without disease progression who chose to switch from AV to TV by 08Jun2013|73
270003|NCT01125566|651590|P2|STARTED|Patients Who Switched From AV to TV||0
270004|NCT01125566|651591|P1|STARTED|Patients Who Switched From AV to TV||0
270005|NCT01125566|651589|P3|NOT COMPLETED|Patients Before the Switch (26Apr2013)||0
270006|NCT01125566|651590|P2|NOT COMPLETED|Patients Before the Switch (26Apr2013)||136
270007|NCT01125566|651591|P1|NOT COMPLETED|Patients Before the Switch (26Apr2013)||260
270008|NCT01125566|651589|P3|COMPLETED|Patients Before the Switch (26Apr2013)||0
270009|NCT01125566|651590|P2|COMPLETED|Patients Before the Switch (26Apr2013)|On treatment at analysis cut-off date (03Sep2013)|33
270010|NCT01125566|651591|P1|COMPLETED|Patients Before the Switch (26Apr2013)|All patients without disease progression who were on treatment on 08Jun2013|79
270011|NCT01125566|651589|P3|STARTED|Patients Before the Switch (26Apr2013)||0
270012|NCT01125566|651590|P2|STARTED|Patients Before the Switch (26Apr2013)|Randomised|169
270013|NCT01125566|651591|P1|STARTED|Patients Before the Switch (26Apr2013)|Randomised|339
270014|NCT01125605|651604|P1|NOT COMPLETED|Overall Study||0
270015|NCT01125605|651604|P1|COMPLETED|Overall Study||325
270016|NCT01125605|651604|P1|Safety|Overall Study|1 patient was only analysed for safety|326
270017|NCT01125605|651604|P1|STARTED|Overall Study|started = had baseline values|325
270018|NCT01125722|651637|P2|NOT COMPLETED|Overall Study||1
270019|NCT01125722|651638|P1|NOT COMPLETED|Overall Study||3
270020|NCT01125722|651637|P2|COMPLETED|Overall Study||36
270021|NCT01125722|651638|P1|COMPLETED|Overall Study||34
270022|NCT01125722|651637|P2|STARTED|Overall Study||37
270023|NCT01125722|651638|P1|STARTED|Overall Study||37
270024|NCT01125748|651654|P2|NOT COMPLETED|Overall Study||14
270025|NCT01125748|651655|P1|NOT COMPLETED|Overall Study||10
270026|NCT01125748|651654|P2|COMPLETED|Overall Study||74
270027|NCT01125748|651655|P1|COMPLETED|Overall Study||78
270028|NCT01125748|651654|P2|STARTED|Overall Study||88
270029|NCT01125748|651655|P1|STARTED|Overall Study||88
270030|NCT01125774|651665|P4|NOT COMPLETED|Overall Study||3
270031|NCT01125774|651666|P3|NOT COMPLETED|Overall Study||9
270032|NCT01125774|651667|P2|NOT COMPLETED|Overall Study||554
270033|NCT01125774|651668|P1|NOT COMPLETED|Overall Study||1125
270034|NCT01125774|651665|P4|COMPLETED|Overall Study|Completed study at least once|3
270035|NCT01125774|651666|P3|COMPLETED|Overall Study|"Completed study at least once while treated with telcagepant (otherwise counted Not Completed)"|13
270036|NCT01125774|651667|P2|COMPLETED|Overall Study||948
270037|NCT01125774|651668|P1|COMPLETED|Overall Study||1893
270038|NCT01125774|651665|P4|Treated|Overall Study||5
270039|NCT01125774|651666|P3|Treated|Overall Study|Received telcagepant|21
270040|NCT01125774|651667|P2|Treated|Overall Study|1 mistakenly took telcagepant and is included with telcagepant group for adverse event analysis|1322
270041|NCT01125774|651668|P1|Treated|Overall Study||2638
270042|NCT01125774|651665|P4|STARTED|Overall Study|Unique participants randomized|6
270043|NCT01125774|651666|P3|STARTED|Overall Study|Unique participants randomized|22
270044|NCT01125774|651667|P2|STARTED|Overall Study|Randomized|1502
270045|NCT01125774|651668|P1|STARTED|Overall Study|Randomized|3018
270046|NCT01125800|651695|P5|NOT COMPLETED|Phase II||11
270047|NCT01125800|651696|P4|NOT COMPLETED|Phase II||1
270048|NCT01125800|651697|P3|NOT COMPLETED|Phase II||0
270049|NCT01125800|651698|P2|NOT COMPLETED|Phase II||0
270050|NCT01125800|651699|P1|NOT COMPLETED|Phase II||0
270051|NCT01125800|651695|P5|COMPLETED|Phase II||5
270052|NCT01125800|651696|P4|COMPLETED|Phase II||0
270053|NCT01125800|651697|P3|COMPLETED|Phase II||0
270054|NCT01125800|651698|P2|COMPLETED|Phase II||0
270055|NCT01125800|651699|P1|COMPLETED|Phase II||0
270056|NCT01125800|651695|P5|STARTED|Phase II|Additional participants were enrolled to this treatment in this period.|16
270057|NCT01125800|651696|P4|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|1
270058|NCT01125800|651697|P3|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
270059|NCT01125800|651698|P2|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
270060|NCT01125800|651699|P1|STARTED|Phase II|None of participants were enrolled to this treatment in this period.|0
270061|NCT01125800|651695|P5|NOT COMPLETED|Phase I||0
270062|NCT01125800|651696|P4|NOT COMPLETED|Phase I||11
270063|NCT01125800|651697|P3|NOT COMPLETED|Phase I||4
270064|NCT01125800|651698|P2|NOT COMPLETED|Phase I||9
270065|NCT01125800|651699|P1|NOT COMPLETED|Phase I||8
270066|NCT01125800|651695|P5|COMPLETED|Phase I||0
270067|NCT01125800|651696|P4|COMPLETED|Phase I||10
270068|NCT01125800|651697|P3|COMPLETED|Phase I||7
270069|NCT01125800|651698|P2|COMPLETED|Phase I||7
270070|NCT01125800|651699|P1|COMPLETED|Phase I||3
270071|NCT01125800|651695|P5|STARTED|Phase I|None of participants were enrolled to this treatment in this period.|0
270072|NCT01125800|651696|P4|STARTED|Phase I||21
270073|NCT01125800|651697|P3|STARTED|Phase I||11
270074|NCT01125800|651698|P2|STARTED|Phase I||16
270075|NCT01125800|651699|P1|STARTED|Phase I||11
270076|NCT01125813|651736|P1|NOT COMPLETED|Overall Study||6
270077|NCT01125813|651736|P1|COMPLETED|Overall Study||30
270078|NCT01125813|651736|P1|STARTED|Overall Study||36
270079|NCT01125917|651741|P1|NOT COMPLETED|Overall Study||339
270080|NCT01125917|651741|P1|COMPLETED|Overall Study||15
270081|NCT01125917|651741|P1|STARTED|Overall Study||354
270082|NCT01125930|651747|P2|NOT COMPLETED|Overall Study||10
270083|NCT01125930|651748|P1|NOT COMPLETED|Overall Study||1
270084|NCT01125930|651747|P2|COMPLETED|Overall Study||36
270085|NCT01125930|651748|P1|COMPLETED|Overall Study||21
270086|NCT01125930|651747|P2|STARTED|Overall Study||46
270087|NCT01125930|651748|P1|STARTED|Overall Study||22
270088|NCT01126060|651904|P2|NOT COMPLETED|Overall Study||2
270089|NCT01126060|651905|P1|NOT COMPLETED|Overall Study||0
270090|NCT01126060|651904|P2|COMPLETED|Overall Study||38
270091|NCT01126060|651905|P1|COMPLETED|Overall Study||40
270092|NCT01126060|651904|P2|STARTED|Overall Study||40
270093|NCT01126060|651905|P1|STARTED|Overall Study||40
270094|NCT01126099|651913|P2|NOT COMPLETED|Open-label Extension||1
270095|NCT01126099|651914|P1|NOT COMPLETED|Open-label Extension||1
270096|NCT01126099|651913|P2|COMPLETED|Open-label Extension||6
270097|NCT01126099|651914|P1|COMPLETED|Open-label Extension||4
270098|NCT01126099|651913|P2|STARTED|Open-label Extension||7
270099|NCT01126099|651914|P1|STARTED|Open-label Extension|2 in the Prazosin arm of the Double Blind Phase elected not to enter the Open-Label extension|5
270100|NCT01126099|651913|P2|NOT COMPLETED|Double Blind Phase||2
270101|NCT01126099|651914|P1|NOT COMPLETED|Double Blind Phase||4
270102|NCT01126099|651913|P2|COMPLETED|Double Blind Phase||7
270103|NCT01126099|651914|P1|COMPLETED|Double Blind Phase||7
270104|NCT01126099|651913|P2|STARTED|Double Blind Phase||9
270105|NCT01126099|651914|P1|STARTED|Double Blind Phase||11
270106|NCT01126268|651926|P1|NOT COMPLETED|Overall Study||1
270107|NCT01126268|651926|P1|COMPLETED|Overall Study||37
270108|NCT01126268|651926|P1|STARTED|Overall Study||38
270109|NCT01126359|651948|P2|NOT COMPLETED|Second Intervention (20-minutes)||0
270110|NCT01126359|651949|P1|NOT COMPLETED|Second Intervention (20-minutes)||0
270111|NCT01126359|651948|P2|COMPLETED|Second Intervention (20-minutes)||5
270112|NCT01126359|651949|P1|COMPLETED|Second Intervention (20-minutes)||5
270113|NCT01126359|651948|P2|STARTED|Second Intervention (20-minutes)||5
270114|NCT01126359|651949|P1|STARTED|Second Intervention (20-minutes)||5
270115|NCT01126359|651948|P2|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
270116|NCT01126359|651949|P1|NOT COMPLETED|Dressing Replacement/Healing (48-hours)||0
270117|NCT01126359|651948|P2|COMPLETED|Dressing Replacement/Healing (48-hours)||5
270118|NCT01126359|651949|P1|COMPLETED|Dressing Replacement/Healing (48-hours)||5
270119|NCT01126359|651948|P2|STARTED|Dressing Replacement/Healing (48-hours)||5
270120|NCT01126359|651949|P1|STARTED|Dressing Replacement/Healing (48-hours)||5
270121|NCT01126359|651948|P2|NOT COMPLETED|First Intervention (20-minutes)||1
270122|NCT01126359|651949|P1|NOT COMPLETED|First Intervention (20-minutes)||0
270123|NCT01126359|651948|P2|COMPLETED|First Intervention (20-minutes)||5
270124|NCT01126359|651949|P1|COMPLETED|First Intervention (20-minutes)||5
270125|NCT01126359|651948|P2|STARTED|First Intervention (20-minutes)||6
270126|NCT01126359|651949|P1|STARTED|First Intervention (20-minutes)||5
270127|NCT01126424|651967|P6|NOT COMPLETED|Overall Study||0
270128|NCT01126424|651968|P5|NOT COMPLETED|Overall Study||2
270129|NCT01126424|651969|P4|NOT COMPLETED|Overall Study||3
270130|NCT01126424|651970|P3|NOT COMPLETED|Overall Study||1
270131|NCT01126424|651971|P2|NOT COMPLETED|Overall Study||0
270132|NCT01126424|651972|P1|NOT COMPLETED|Overall Study||0
270133|NCT01126424|651967|P6|COMPLETED|Overall Study||4
270134|NCT01126424|651968|P5|COMPLETED|Overall Study||2
270135|NCT01126424|651969|P4|COMPLETED|Overall Study||3
270136|NCT01126424|651970|P3|COMPLETED|Overall Study||4
270137|NCT01126424|651971|P2|COMPLETED|Overall Study||4
270138|NCT01126424|651972|P1|COMPLETED|Overall Study||3
270139|NCT01126424|651967|P6|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
270140|NCT01126424|651968|P5|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
270141|NCT01126424|651969|P4|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
270142|NCT01126424|651970|P3|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
270143|NCT01126424|651971|P2|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|4
270144|NCT01126424|651972|P1|Safety Analysis Subset 1 (SAF 1)|Overall Study|Took at least 1 dose of study drug and completed cognitive function tests for at least 2 treatments.|3
270145|NCT01126424|651967|P6|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
270146|NCT01126424|651968|P5|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
270147|NCT01126424|651969|P4|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|6
270148|NCT01126424|651970|P3|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|5
270149|NCT01126424|651971|P2|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|4
270150|NCT01126424|651972|P1|STARTED|Overall Study|All randomized patients who took at least 1 dose of study drug|3
270151|NCT01126437|651998|P3|NOT COMPLETED|Overall Study||1313
270152|NCT01126437|651999|P2|NOT COMPLETED|Overall Study||1330
270153|NCT01126437|652000|P1|NOT COMPLETED|Overall Study||1341
270154|NCT01126437|651998|P3|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
270155|NCT01126437|651999|P2|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4399
270156|NCT01126437|652000|P1|COMPLETED|Overall Study|See Pre-Assignment Details above for comments.|4400
270157|NCT01126437|651998|P3|STARTED|Overall Study||5713
270158|NCT01126437|651999|P2|STARTED|Overall Study||5729
270159|NCT01126437|652000|P1|STARTED|Overall Study||5741
270160|NCT01126541|652035|P3|NOT COMPLETED|Overall Study||26
270161|NCT01126541|652036|P2|NOT COMPLETED|Overall Study||12
270162|NCT01126541|652037|P1|NOT COMPLETED|Overall Study||10
270163|NCT01126541|652035|P3|COMPLETED|Overall Study||55
270164|NCT01126541|652036|P2|COMPLETED|Overall Study||61
270165|NCT01126541|652037|P1|COMPLETED|Overall Study||60
270166|NCT01126541|652035|P3|STARTED|Overall Study||81
270167|NCT01126541|652036|P2|STARTED|Overall Study||73
270168|NCT01126541|652037|P1|STARTED|Overall Study||70
270169|NCT01126580|652121|P3|NOT COMPLETED|Overall Study||55
270170|NCT01126580|652122|P2|NOT COMPLETED|Overall Study||52
270171|NCT01126580|652123|P1|NOT COMPLETED|Overall Study||49
270172|NCT01126580|652121|P3|COMPLETED|Overall Study||213
270173|NCT01126580|652122|P2|COMPLETED|Overall Study||218
270174|NCT01126580|652123|P1|COMPLETED|Overall Study||220
270175|NCT01126580|652121|P3|Completed 26 Weeks|Overall Study||226
270176|NCT01126580|652122|P2|Completed 26 Weeks|Overall Study||242
270177|NCT01126580|652123|P1|Completed 26 Weeks|Overall Study||233
270178|NCT01126580|652121|P3|Received at Least 1 Dose of Study Drug|Overall Study||268
270179|NCT01126580|652122|P2|Received at Least 1 Dose of Study Drug|Overall Study||270
270180|NCT01126580|652123|P1|Received at Least 1 Dose of Study Drug|Overall Study||269
270181|NCT01126580|652121|P3|STARTED|Overall Study||268
270182|NCT01126580|652122|P2|STARTED|Overall Study||270
270183|NCT01126580|652123|P1|STARTED|Overall Study||269
270184|NCT01126593|652218|P3|NOT COMPLETED|Overall Study||2
270185|NCT01126593|652219|P2|NOT COMPLETED|Overall Study||2
270186|NCT01126593|652220|P1|NOT COMPLETED|Overall Study||4
270187|NCT01126593|652218|P3|COMPLETED|Overall Study||32
270188|NCT01126593|652219|P2|COMPLETED|Overall Study||27
270189|NCT01126593|652220|P1|COMPLETED|Overall Study||29
270190|NCT01126593|652218|P3|STARTED|Overall Study||34
270191|NCT01126593|652219|P2|STARTED|Overall Study||29
270192|NCT01126593|652220|P1|STARTED|Overall Study||33
270193|NCT01126619|652228|P1|NOT COMPLETED|Overall Study||17
270194|NCT01126619|652228|P1|COMPLETED|Overall Study|The completed population was used for all effectiveness analyses.|86
270195|NCT01126619|652228|P1|STARTED|Overall Study||103
270196|NCT01126671|652242|P2|NOT COMPLETED|Overall Study||0
270197|NCT01126671|652243|P1|NOT COMPLETED|Overall Study||0
270198|NCT01126671|652242|P2|COMPLETED|Overall Study||29
270199|NCT01126671|652243|P1|COMPLETED|Overall Study||25
270200|NCT01126671|652242|P2|STARTED|Overall Study||29
270201|NCT01126671|652243|P1|STARTED|Overall Study||25
270202|NCT01126723|652253|P2|NOT COMPLETED|Overall Study||3
270203|NCT01126723|652254|P1|NOT COMPLETED|Overall Study||6
270204|NCT01126723|652253|P2|COMPLETED|Overall Study||28
270205|NCT01126723|652254|P1|COMPLETED|Overall Study||29
270206|NCT01126723|652253|P2|STARTED|Overall Study||31
270207|NCT01126723|652254|P1|STARTED|Overall Study||35
270208|NCT01126801|652262|P2|NOT COMPLETED|Overall Study||0
270209|NCT01126801|652263|P1|NOT COMPLETED|Overall Study||0
270210|NCT01126801|652262|P2|COMPLETED|Overall Study||1
270211|NCT01126801|652263|P1|COMPLETED|Overall Study||1
270212|NCT01126801|652262|P2|STARTED|Overall Study||1
270213|NCT01126801|652263|P1|STARTED|Overall Study||1
270214|NCT01126957|652269|P1|NOT COMPLETED|Overall Study||0
270215|NCT01126957|652269|P1|COMPLETED|Overall Study||103
270216|NCT01126957|652269|P1|STARTED|Overall Study||103
270217|NCT01133275|652274|P1|NOT COMPLETED|Overall Study||2
270218|NCT01133275|652274|P1|COMPLETED|Overall Study||26
270219|NCT01133275|652274|P1|STARTED|Overall Study||28
270220|NCT01133288|652279|P1|NOT COMPLETED|Intervention Allocation||2
270221|NCT01133288|652279|P1|COMPLETED|Intervention Allocation||0
270222|NCT01133288|652279|P1|STARTED|Intervention Allocation||2
270223|NCT01133288|652279|P1|NOT COMPLETED|Eligibility Assessment||5
270224|NCT01133288|652279|P1|COMPLETED|Eligibility Assessment||2
270225|NCT01133288|652279|P1|STARTED|Eligibility Assessment||7
270226|NCT01133379|652287|P3|NOT COMPLETED|Overall Study||2
270227|NCT01133379|652288|P2|NOT COMPLETED|Overall Study||2
270228|NCT01133379|652289|P1|NOT COMPLETED|Overall Study||1
270229|NCT01133379|652287|P3|COMPLETED|Overall Study||56
270230|NCT01133379|652288|P2|COMPLETED|Overall Study||56
270231|NCT01133379|652289|P1|COMPLETED|Overall Study||57
270232|NCT01133379|652287|P3|STARTED|Overall Study||58
270233|NCT01133379|652288|P2|STARTED|Overall Study||58
270234|NCT01133379|652289|P1|STARTED|Overall Study||58
270235|NCT01133392|652344|P2|NOT COMPLETED|Fourth Intervention (1 Day)||0
270236|NCT01133392|652345|P1|NOT COMPLETED|Fourth Intervention (1 Day)||0
270237|NCT01133392|652344|P2|COMPLETED|Fourth Intervention (1 Day)||16
270238|NCT01133392|652345|P1|COMPLETED|Fourth Intervention (1 Day)||20
270239|NCT01133392|652344|P2|STARTED|Fourth Intervention (1 Day)||16
270240|NCT01133392|652345|P1|STARTED|Fourth Intervention (1 Day)||20
270241|NCT01133392|652344|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
270242|NCT01133392|652345|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
270243|NCT01133392|652344|P2|COMPLETED|Interval Between Dosing (4-7 Days)||16
270244|NCT01133392|652345|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
270245|NCT01133392|652344|P2|STARTED|Interval Between Dosing (4-7 Days)||17
270246|NCT01133392|652345|P1|STARTED|Interval Between Dosing (4-7 Days)||20
270247|NCT01133392|652344|P2|NOT COMPLETED|Third Intervention (1 Day)||0
270248|NCT01133392|652345|P1|NOT COMPLETED|Third Intervention (1 Day)||0
270249|NCT01133392|652344|P2|COMPLETED|Third Intervention (1 Day)||17
270250|NCT01133392|652345|P1|COMPLETED|Third Intervention (1 Day)||20
270251|NCT01133392|652344|P2|STARTED|Third Intervention (1 Day)||17
270252|NCT01133392|652345|P1|STARTED|Third Intervention (1 Day)||20
270253|NCT01133392|652344|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
270254|NCT01133392|652345|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
270255|NCT01133392|652344|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
270256|NCT01133392|652345|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
270257|NCT01133392|652344|P2|STARTED|Interval Between Dosing (4-7 Days)||17
270258|NCT01133392|652345|P1|STARTED|Interval Between Dosing (4-7 Days)||20
270259|NCT01133392|652344|P2|NOT COMPLETED|Second Intervention (1 Day)||0
270260|NCT01133392|652345|P1|NOT COMPLETED|Second Intervention (1 Day)||0
270261|NCT01133392|652344|P2|COMPLETED|Second Intervention (1 Day)||17
270262|NCT01133392|652345|P1|COMPLETED|Second Intervention (1 Day)||20
270263|NCT01133392|652344|P2|STARTED|Second Intervention (1 Day)||17
270264|NCT01133392|652345|P1|STARTED|Second Intervention (1 Day)||20
270265|NCT01133392|652344|P2|NOT COMPLETED|Interval Between Dosing (4-7 Days)||1
270266|NCT01133392|652345|P1|NOT COMPLETED|Interval Between Dosing (4-7 Days)||0
270267|NCT01133392|652344|P2|COMPLETED|Interval Between Dosing (4-7 Days)||17
270268|NCT01133392|652345|P1|COMPLETED|Interval Between Dosing (4-7 Days)||20
270269|NCT01133392|652344|P2|STARTED|Interval Between Dosing (4-7 Days)||18
270270|NCT01133392|652345|P1|STARTED|Interval Between Dosing (4-7 Days)||20
270271|NCT01133392|652344|P2|NOT COMPLETED|First Intervention (1 Day )||0
270272|NCT01133392|652345|P1|NOT COMPLETED|First Intervention (1 Day )||0
270273|NCT01133392|652344|P2|COMPLETED|First Intervention (1 Day )||18
270274|NCT01133392|652345|P1|COMPLETED|First Intervention (1 Day )||20
270275|NCT01133392|652344|P2|STARTED|First Intervention (1 Day )||18
270276|NCT01133392|652345|P1|STARTED|First Intervention (1 Day )||20
270277|NCT01133418|652361|P2|NOT COMPLETED|Overall Study||6
270278|NCT01133418|652362|P1|NOT COMPLETED|Overall Study||5
270279|NCT01133418|652361|P2|COMPLETED|Overall Study||32
270280|NCT01133418|652362|P1|COMPLETED|Overall Study||29
270281|NCT01133418|652361|P2|STARTED|Overall Study||38
270282|NCT01133418|652362|P1|STARTED|Overall Study||34
270283|NCT01133522|652384|P10|NOT COMPLETED|Overall Study||0
270284|NCT01133522|652385|P9|NOT COMPLETED|Overall Study||0
270285|NCT01133522|652386|P8|NOT COMPLETED|Overall Study||0
270286|NCT01133522|652387|P7|NOT COMPLETED|Overall Study||0
270287|NCT01133522|652388|P6|NOT COMPLETED|Overall Study||0
270288|NCT01133522|652389|P5|NOT COMPLETED|Overall Study||1
270289|NCT01133522|652390|P4|NOT COMPLETED|Overall Study||1
270290|NCT01133522|652391|P3|NOT COMPLETED|Overall Study||0
270291|NCT01133522|652392|P2|NOT COMPLETED|Overall Study||1
270292|NCT01133522|652393|P1|NOT COMPLETED|Overall Study||0
270293|NCT01133522|652384|P10|COMPLETED|Overall Study||4
270294|NCT01133522|652385|P9|COMPLETED|Overall Study||2
270295|NCT01133522|652386|P8|COMPLETED|Overall Study||9
270296|NCT01133522|652387|P7|COMPLETED|Overall Study||2
270297|NCT01133522|652388|P6|COMPLETED|Overall Study||6
270298|NCT01133522|652389|P5|COMPLETED|Overall Study||6
270299|NCT01133522|652390|P4|COMPLETED|Overall Study||6
270300|NCT01133522|652391|P3|COMPLETED|Overall Study||6
270301|NCT01133522|652392|P2|COMPLETED|Overall Study||6
270302|NCT01133522|652393|P1|COMPLETED|Overall Study||10
270303|NCT01133522|652384|P10|Received Treatment|Overall Study||4
270304|NCT01133522|652385|P9|Received Treatment|Overall Study||2
270305|NCT01133522|652386|P8|Received Treatment|Overall Study||9
270306|NCT01133522|652387|P7|Received Treatment|Overall Study||2
270307|NCT01133522|652388|P6|Received Treatment|Overall Study||6
270308|NCT01133522|652389|P5|Received Treatment|Overall Study||6
270309|NCT01133522|652390|P4|Received Treatment|Overall Study||6
270310|NCT01133522|652391|P3|Received Treatment|Overall Study||6
270311|NCT01133522|652392|P2|Received Treatment|Overall Study||6
270312|NCT01133522|652393|P1|Received Treatment|Overall Study||10
270313|NCT01133522|652384|P10|STARTED|Overall Study||4
270314|NCT01133522|652385|P9|STARTED|Overall Study||2
270315|NCT01133522|652386|P8|STARTED|Overall Study||9
270316|NCT01133522|652387|P7|STARTED|Overall Study||2
270317|NCT01133522|652388|P6|STARTED|Overall Study||6
270318|NCT01133522|652389|P5|STARTED|Overall Study||7
270319|NCT01133522|652390|P4|STARTED|Overall Study||7
270320|NCT01133522|652391|P3|STARTED|Overall Study||6
270321|NCT01133522|652392|P2|STARTED|Overall Study||7
270322|NCT01133522|652393|P1|STARTED|Overall Study||10
270323|NCT01134042|652462|P3|NOT COMPLETED|Overall Study||34
270324|NCT01134042|652463|P2|NOT COMPLETED|Overall Study||28
270325|NCT01134042|652464|P1|NOT COMPLETED|Overall Study||48
270326|NCT01134042|652462|P3|COMPLETED|Overall Study||161
270327|NCT01134042|652463|P2|COMPLETED|Overall Study||169
270328|NCT01134042|652464|P1|COMPLETED|Overall Study||146
270329|NCT01134042|652462|P3|STARTED|Overall Study||195
270330|NCT01134042|652463|P2|STARTED|Overall Study||197
270331|NCT01134042|652464|P1|STARTED|Overall Study||194
270332|NCT01134081|652502|P1|NOT COMPLETED|Overall Study||0
270333|NCT01134081|652502|P1|COMPLETED|Overall Study||44
270334|NCT01134081|652502|P1|STARTED|Overall Study||44
270335|NCT01134107|652512|P2|NOT COMPLETED|Period 2-Second Treatment Intervention||0
270336|NCT01134107|652513|P1|NOT COMPLETED|Period 2-Second Treatment Intervention||4
270337|NCT01134107|652512|P2|COMPLETED|Period 2-Second Treatment Intervention||61
270338|NCT01134107|652513|P1|COMPLETED|Period 2-Second Treatment Intervention||57
270339|NCT01134107|652512|P2|STARTED|Period 2-Second Treatment Intervention||61
270340|NCT01134107|652513|P1|STARTED|Period 2-Second Treatment Intervention||61
270341|NCT01134107|652512|P2|NOT COMPLETED|Period 1-First Treatment Intervention||5
270342|NCT01134107|652513|P1|NOT COMPLETED|Period 1-First Treatment Intervention||6
270343|NCT01134107|652512|P2|COMPLETED|Period 1-First Treatment Intervention||61
270344|NCT01134107|652513|P1|COMPLETED|Period 1-First Treatment Intervention||61
270345|NCT01134107|652512|P2|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
270346|NCT01134107|652513|P1|Received at Least One Dose of Study Drug|Period 1-First Treatment Intervention||66
270347|NCT01134107|652512|P2|STARTED|Period 1-First Treatment Intervention||66
270348|NCT01134107|652513|P1|STARTED|Period 1-First Treatment Intervention||67
270349|NCT01134276|652547|P2|NOT COMPLETED|Overall Study||0
270350|NCT01134276|652548|P1|NOT COMPLETED|Overall Study||0
270351|NCT01134276|652547|P2|COMPLETED|Overall Study||107
270352|NCT01134276|652548|P1|COMPLETED|Overall Study||104
270353|NCT01134276|652547|P2|STARTED|Overall Study||107
270354|NCT01134276|652548|P1|STARTED|Overall Study||104
270355|NCT01134315|652560|P2|NOT COMPLETED|Overall Study||19
270356|NCT01134315|652561|P1|NOT COMPLETED|Overall Study||9
270357|NCT01134315|652560|P2|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|21
270358|NCT01134315|652561|P1|COMPLETED|Overall Study|Completed study drug treatment during the observational study (ie, prior to study termination).|12
270359|NCT01134315|652560|P2|STARTED|Overall Study||40
270360|NCT01134315|652561|P1|STARTED|Overall Study||21
270361|NCT01134393|652581|P1|NOT COMPLETED|Overall Study||52
270362|NCT01134393|652581|P1|COMPLETED|Overall Study|Completed trial medication.|449
270363|NCT01134393|652581|P1|STARTED|Overall Study|Entered and treated.|501
270364|NCT01134510|652597|P2|NOT COMPLETED|Overall Study||1
270365|NCT01134510|652598|P1|NOT COMPLETED|Overall Study||0
270366|NCT01134510|652597|P2|COMPLETED|Overall Study||9
270367|NCT01134510|652598|P1|COMPLETED|Overall Study||10
270368|NCT01134510|652597|P2|Month 3|Overall Study||9
270369|NCT01134510|652598|P1|Month 3|Overall Study||10
270370|NCT01134510|652597|P2|Month 1|Overall Study||10
270371|NCT01134510|652598|P1|Month 1|Overall Study||10
270372|NCT01134510|652597|P2|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
270373|NCT01134510|652598|P1|Week 4|Overall Study|Infusion #8 C1 esterase inhibitor vs Placebo|10
270374|NCT01134510|652597|P2|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
270375|NCT01134510|652598|P1|Week 4|Overall Study|Infusion #7 C1 esterase inhibitor vs Placebo|10
270376|NCT01134510|652597|P2|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
270377|NCT01134510|652598|P1|Week 3|Overall Study|Infusion #6 C1 esterase inhibitor vs Placebo|10
270378|NCT01134510|652597|P2|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
270379|NCT01134510|652598|P1|Week 3|Overall Study|Infusion #5 C1 esterase inhibitor vs Placebo|10
270380|NCT01134510|652597|P2|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
270381|NCT01134510|652598|P1|Week 2|Overall Study|Infusion #4 C1 esterase inhibitor vs Placebo|10
270382|NCT01134510|652597|P2|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
270383|NCT01134510|652598|P1|Week 2|Overall Study|Infusion #3 C1 esterase inhibitor vs Placebo|10
270384|NCT01134510|652597|P2|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
270385|NCT01134510|652598|P1|Day 2|Overall Study|Infusion #2 C1 esterase inhibitor vs Placebo|10
270386|NCT01134510|652597|P2|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
270387|NCT01134510|652598|P1|STARTED|Overall Study|Transplant Day; Infusion #1 C1 esterase inhibitor vs Placebo|10
270388|NCT01134549|652615|P5|NOT COMPLETED|Overall Study||0
270389|NCT01134549|652616|P4|NOT COMPLETED|Overall Study||0
270390|NCT01134549|652617|P3|NOT COMPLETED|Overall Study||0
270391|NCT01134549|652618|P2|NOT COMPLETED|Overall Study||0
270392|NCT01134549|652619|P1|NOT COMPLETED|Overall Study||0
270393|NCT01134549|652615|P5|COMPLETED|Overall Study||6
270394|NCT01134549|652616|P4|COMPLETED|Overall Study||6
270395|NCT01134549|652617|P3|COMPLETED|Overall Study||6
270396|NCT01134549|652618|P2|COMPLETED|Overall Study||6
270397|NCT01134549|652619|P1|COMPLETED|Overall Study||8
270398|NCT01134549|652615|P5|STARTED|Overall Study||6
270399|NCT01134549|652616|P4|STARTED|Overall Study||6
270400|NCT01134549|652617|P3|STARTED|Overall Study||6
270401|NCT01134549|652618|P2|STARTED|Overall Study||6
270402|NCT01134549|652619|P1|STARTED|Overall Study||8
270403|NCT01134614|652705|P2|NOT COMPLETED|Overall Study||122
270404|NCT01134614|652706|P1|NOT COMPLETED|Overall Study||123
270405|NCT01134614|652705|P2|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicities|0
270406|NCT01134614|652706|P1|COMPLETED|Overall Study|Treatment continues until disease progression or unacceptable toxicity.|0
270407|NCT01134614|652705|P2|Treated and Toxicity Assessed|Overall Study||120
270408|NCT01134614|652706|P1|Treated and Toxicity Assessed|Overall Study||118
270409|NCT01134614|652705|P2|Treated|Overall Study||121
270410|NCT01134614|652706|P1|Treated|Overall Study||119
270411|NCT01134614|652705|P2|STARTED|Overall Study||122
270412|NCT01134614|652706|P1|STARTED|Overall Study||123
270413|NCT01134627|652718|P2|NOT COMPLETED|Overall Study||67
270414|NCT01134627|652719|P1|NOT COMPLETED|Overall Study||69
270415|NCT01134627|652718|P2|COMPLETED|Overall Study||88
270416|NCT01134627|652719|P1|COMPLETED|Overall Study||80
270417|NCT01134627|652718|P2|STARTED|Overall Study|Number of participants treated.|155
270418|NCT01134627|652719|P1|STARTED|Overall Study|Number of participants treated.|149
270419|NCT01134705|652749|P2|NOT COMPLETED|Overall Study||22
270420|NCT01134705|652750|P1|NOT COMPLETED|Overall Study||15
270421|NCT01134705|652749|P2|COMPLETED|Overall Study||216
270422|NCT01134705|652750|P1|COMPLETED|Overall Study||221
270423|NCT01134705|652749|P2|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|234
270424|NCT01134705|652750|P1|Intent to Treat Population|Overall Study|Participants who received at least 1 dose of study drug and had at least 1 post-baseline assessment.|232
270425|NCT01134705|652749|P2|STARTED|Overall Study||238
270426|NCT01134705|652750|P1|STARTED|Overall Study||236
270427|NCT01134731|652763|P3|NOT COMPLETED|Overall Study||8
270428|NCT01134731|652764|P2|NOT COMPLETED|Overall Study||11
270429|NCT01134731|652765|P1|NOT COMPLETED|Overall Study||13
270430|NCT01134731|652763|P3|COMPLETED|Overall Study||2
270431|NCT01134731|652764|P2|COMPLETED|Overall Study||10
270432|NCT01134731|652765|P1|COMPLETED|Overall Study||10
270433|NCT01134731|652763|P3|STARTED|Overall Study||10
270434|NCT01134731|652764|P2|STARTED|Overall Study||21
270435|NCT01134731|652765|P1|STARTED|Overall Study||23
270436|NCT01134783|652778|P2|NOT COMPLETED|Overall Study||37
270437|NCT01134783|652779|P1|NOT COMPLETED|Overall Study||36
270438|NCT01134783|652778|P2|COMPLETED|Overall Study||180
270439|NCT01134783|652779|P1|COMPLETED|Overall Study||188
270440|NCT01134783|652778|P2|STARTED|Overall Study||217
270441|NCT01134783|652779|P1|STARTED|Overall Study||224
270442|NCT01134887|652799|P4|NOT COMPLETED|Overall Study||0
270443|NCT01134887|652800|P3|NOT COMPLETED|Overall Study||0
270444|NCT01134887|652801|P2|NOT COMPLETED|Overall Study||4
270445|NCT01134887|652802|P1|NOT COMPLETED|Overall Study||0
270446|NCT01134887|652799|P4|COMPLETED|Overall Study||5
270447|NCT01134887|652800|P3|COMPLETED|Overall Study||5
270448|NCT01134887|652801|P2|COMPLETED|Overall Study|Four patients in the Veteran-Control arm did not have two clinic visits videotaped and left study.|7
270449|NCT01134887|652802|P1|COMPLETED|Overall Study||9
270450|NCT01134887|652799|P4|STARTED|Overall Study||5
270451|NCT01134887|652800|P3|STARTED|Overall Study||5
270452|NCT01134887|652801|P2|STARTED|Overall Study||11
270453|NCT01134887|652802|P1|STARTED|Overall Study||9
270454|NCT01134900|652812|P2|NOT COMPLETED|Overall Study||0
270455|NCT01134900|652813|P1|NOT COMPLETED|Overall Study||0
270456|NCT01134900|652812|P2|COMPLETED|Overall Study||196
270457|NCT01134900|652813|P1|COMPLETED|Overall Study||200
270458|NCT01134900|652812|P2|STARTED|Overall Study||196
270459|NCT01134900|652813|P1|STARTED|Overall Study||200
270460|NCT01134939|652829|P8|NOT COMPLETED|Overall Study||0
270461|NCT01134939|652830|P7|NOT COMPLETED|Overall Study||9
270462|NCT01134939|652831|P6|NOT COMPLETED|Overall Study||9
270463|NCT01134939|652832|P5|NOT COMPLETED|Overall Study||10
270464|NCT01134939|652833|P4|NOT COMPLETED|Overall Study||14
270465|NCT01134939|652834|P3|NOT COMPLETED|Overall Study||10
270466|NCT01134939|652835|P2|NOT COMPLETED|Overall Study||18
270467|NCT01134939|652836|P1|NOT COMPLETED|Overall Study||17
270468|NCT01134939|652829|P8|COMPLETED|Overall Study||1
270469|NCT01134939|652830|P7|COMPLETED|Overall Study||10
270470|NCT01134939|652831|P6|COMPLETED|Overall Study||5
270471|NCT01134939|652832|P5|COMPLETED|Overall Study||23
270472|NCT01134939|652833|P4|COMPLETED|Overall Study||32
270473|NCT01134939|652834|P3|COMPLETED|Overall Study||41
270474|NCT01134939|652835|P2|COMPLETED|Overall Study||24
270475|NCT01134939|652836|P1|COMPLETED|Overall Study||42
270476|NCT01134939|652829|P8|STARTED|Overall Study||1
270477|NCT01134939|652830|P7|STARTED|Overall Study||19
270478|NCT01134939|652831|P6|STARTED|Overall Study||14
270479|NCT01134939|652832|P5|STARTED|Overall Study||33
270480|NCT01134939|652833|P4|STARTED|Overall Study||46
270481|NCT01134939|652834|P3|STARTED|Overall Study||51
270482|NCT01134939|652835|P2|STARTED|Overall Study||42
270483|NCT01134939|652836|P1|STARTED|Overall Study||59
270484|NCT01134952|652946|P1|NOT COMPLETED|Overall Study||0
270485|NCT01134952|652946|P1|COMPLETED|Overall Study||11
270486|NCT01134952|652946|P1|STARTED|Overall Study||11
270487|NCT01135017|652962|P2|NOT COMPLETED|Overall Study||12
270488|NCT01135017|652963|P1|NOT COMPLETED|Overall Study||6
270489|NCT01135017|652962|P2|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|45
270490|NCT01135017|652963|P1|COMPLETED|Overall Study|The study was terminated after enrolled participants completed the study period as per protocol|49
270491|NCT01135017|652962|P2|Evaluable for Efficacy|Overall Study|Two participants did not have interrogation of the pacemaker after randomization|55
270492|NCT01135017|652963|P1|Evaluable for Efficacy|Overall Study||55
270493|NCT01135017|652962|P2|Treated|Overall Study||57
270494|NCT01135017|652963|P1|Treated|Overall Study||55
270495|NCT01135017|652962|P2|STARTED|Overall Study||57
270496|NCT01135017|652963|P1|STARTED|Overall Study||55
270497|NCT01135069|652982|P3|NOT COMPLETED|Overall Study||10
270498|NCT01135069|652983|P2|NOT COMPLETED|Overall Study||32
270499|NCT01135069|652984|P1|NOT COMPLETED|Overall Study||36
270500|NCT01135069|652982|P3|COMPLETED|Overall Study||56
270501|NCT01135069|652983|P2|COMPLETED|Overall Study||177
270502|NCT01135069|652984|P1|COMPLETED|Overall Study||169
270503|NCT01135069|652982|P3|STARTED|Overall Study||66
270504|NCT01135069|652983|P2|STARTED|Overall Study||209
270505|NCT01135069|652984|P1|STARTED|Overall Study||205
270506|NCT01135134|652994|P2|NOT COMPLETED|Overall Study||1
270507|NCT01135134|652995|P1|NOT COMPLETED|Overall Study||2
270508|NCT01135134|652994|P2|COMPLETED|Overall Study||112
270509|NCT01135134|652995|P1|COMPLETED|Overall Study||218
270510|NCT01135134|652994|P2|STARTED|Overall Study||113
270511|NCT01135134|652995|P1|STARTED|Overall Study||220
270512|NCT01135186|653003|P1|NOT COMPLETED|Overall Study||0
270513|NCT01135186|653003|P1|COMPLETED|Overall Study||9
270514|NCT01135186|653003|P1|STARTED|Overall Study||9
270515|NCT01135368|653010|P1|NOT COMPLETED|Overall Study||251
270516|NCT01135368|653010|P1|COMPLETED|Overall Study||255
270517|NCT01135368|653010|P1|STARTED|Overall Study||506
270518|NCT01135381|653130|P4|NOT COMPLETED|Overall Study||1
270519|NCT01135381|653131|P3|NOT COMPLETED|Overall Study||4
270520|NCT01135381|653132|P2|NOT COMPLETED|Overall Study||7
270521|NCT01135381|653133|P1|NOT COMPLETED|Overall Study||21
270522|NCT01135381|653130|P4|COMPLETED|Overall Study||67
270523|NCT01135381|653131|P3|COMPLETED|Overall Study||65
270524|NCT01135381|653132|P2|COMPLETED|Overall Study||178
270525|NCT01135381|653133|P1|COMPLETED|Overall Study||168
270526|NCT01135381|653130|P4|STARTED|Overall Study||68
270527|NCT01135381|653131|P3|STARTED|Overall Study||69
270528|NCT01135381|653132|P2|STARTED|Overall Study||185
270529|NCT01135381|653133|P1|STARTED|Overall Study||189
270530|NCT01135420|653153|P2|NOT COMPLETED|Overall Study||32
270531|NCT01135420|653154|P1|NOT COMPLETED|Overall Study||44
270532|NCT01135420|653153|P2|COMPLETED|Overall Study||175
270533|NCT01135420|653154|P1|COMPLETED|Overall Study||155
270534|NCT01135420|653153|P2|STARTED|Overall Study||207
270535|NCT01135420|653154|P1|STARTED|Overall Study||199
270536|NCT01135498|653160|P1|NOT COMPLETED|Overall Study||90
270537|NCT01135498|653160|P1|COMPLETED|Overall Study||0
270538|NCT01135498|653160|P1|STARTED|Overall Study||90
270539|NCT01135511|653178|P9|NOT COMPLETED|Overall Study||1
270540|NCT01135511|653179|P8|NOT COMPLETED|Overall Study||1
270541|NCT01135511|653180|P7|NOT COMPLETED|Overall Study||1
270542|NCT01135511|653181|P6|NOT COMPLETED|Overall Study||1
270543|NCT01135511|653182|P5|NOT COMPLETED|Overall Study||1
270544|NCT01135511|653183|P4|NOT COMPLETED|Overall Study||3
270545|NCT01135511|653184|P3|NOT COMPLETED|Overall Study||8
270546|NCT01135511|653185|P2|NOT COMPLETED|Overall Study||3
270547|NCT01135511|653186|P1|NOT COMPLETED|Overall Study||0
270548|NCT01135511|653178|P9|COMPLETED|Overall Study||20
270549|NCT01135511|653179|P8|COMPLETED|Overall Study||20
270550|NCT01135511|653180|P7|COMPLETED|Overall Study||18
270551|NCT01135511|653181|P6|COMPLETED|Overall Study||20
270552|NCT01135511|653182|P5|COMPLETED|Overall Study||38
270553|NCT01135511|653183|P4|COMPLETED|Overall Study||37
270554|NCT01135511|653184|P3|COMPLETED|Overall Study||33
270555|NCT01135511|653185|P2|COMPLETED|Overall Study||39
270556|NCT01135511|653186|P1|COMPLETED|Overall Study||41
270557|NCT01135511|653178|P9|STARTED|Overall Study||21
270558|NCT01135511|653179|P8|STARTED|Overall Study||21
270559|NCT01135511|653180|P7|STARTED|Overall Study||19
270560|NCT01135511|653181|P6|STARTED|Overall Study||21
270561|NCT01135511|653182|P5|STARTED|Overall Study||39
270562|NCT01135511|653183|P4|STARTED|Overall Study||40
270563|NCT01135511|653184|P3|STARTED|Overall Study||41
270564|NCT01135511|653185|P2|STARTED|Overall Study||42
270565|NCT01135511|653186|P1|STARTED|Overall Study||41
270566|NCT01135524|653468|P1|NOT COMPLETED|Overall Study||196
270567|NCT01135524|653468|P1|COMPLETED|Overall Study||0
270568|NCT01135524|653468|P1|STARTED|Overall Study||196
270569|NCT01135914|653475|P3|NOT COMPLETED|Overall Study||22
270570|NCT01135914|653476|P2|NOT COMPLETED|Overall Study||5
270571|NCT01135914|653477|P1|NOT COMPLETED|Overall Study||4
270572|NCT01135914|653475|P3|COMPLETED|Overall Study||59
270573|NCT01135914|653476|P2|COMPLETED|Overall Study||75
270574|NCT01135914|653477|P1|COMPLETED|Overall Study||74
270575|NCT01135914|653475|P3|Safety Population|Overall Study||74
270576|NCT01135914|653476|P2|Safety Population|Overall Study||75
270577|NCT01135914|653477|P1|Safety Population|Overall Study||73
270578|NCT01135914|653475|P3|Intent to Treat (ITT) Population|Overall Study||72
270579|NCT01135914|653476|P2|Intent to Treat (ITT) Population|Overall Study||75
270580|NCT01135914|653477|P1|Intent to Treat (ITT) Population|Overall Study||73
270581|NCT01135914|653475|P3|STARTED|Overall Study||81
270582|NCT01135914|653476|P2|STARTED|Overall Study||80
270583|NCT01135914|653477|P1|STARTED|Overall Study||78
270584|NCT01135992|653506|P1|NOT COMPLETED|Overall Study||21
270585|NCT01135992|653506|P1|COMPLETED|Overall Study||122
270586|NCT01135992|653506|P1|Full Analysis Set|Overall Study||129
270587|NCT01135992|653506|P1|Exposed|Overall Study|One subject was withdrawn before being exposed.|142
270588|NCT01135992|653506|P1|STARTED|Overall Study||143
270589|NCT01136174|653519|P4|NOT COMPLETED|Overall Study||4
270590|NCT01136174|653520|P3|NOT COMPLETED|Overall Study||0
270591|NCT01136174|653521|P2|NOT COMPLETED|Overall Study||0
270592|NCT01136174|653522|P1|NOT COMPLETED|Overall Study||0
270593|NCT01136174|653519|P4|COMPLETED|Overall Study||20
270594|NCT01136174|653520|P3|COMPLETED|Overall Study||8
270595|NCT01136174|653521|P2|COMPLETED|Overall Study||6
270596|NCT01136174|653522|P1|COMPLETED|Overall Study||12
270597|NCT01136174|653519|P4|STARTED|Overall Study||24
270598|NCT01136174|653520|P3|STARTED|Overall Study||8
270599|NCT01136174|653521|P2|STARTED|Overall Study||6
270600|NCT01136174|653522|P1|STARTED|Overall Study||12
270601|NCT01136226|653602|P1|NOT COMPLETED|Overall Study||13
270602|NCT01136226|653602|P1|COMPLETED|Overall Study||29
270603|NCT01136226|653602|P1|STARTED|Overall Study||42
270604|NCT01136291|653608|P2|NOT COMPLETED|Overall Study||1
270605|NCT01136291|653609|P1|NOT COMPLETED|Overall Study||1
270606|NCT01136291|653608|P2|COMPLETED|Overall Study||41
270607|NCT01136291|653609|P1|COMPLETED|Overall Study||39
270608|NCT01136291|653608|P2|Follow|Overall Study||42
270609|NCT01136291|653609|P1|Follow|Overall Study||40
270610|NCT01136291|653608|P2|STARTED|Overall Study||42
270611|NCT01136291|653609|P1|STARTED|Overall Study||40
270612|NCT01136356|653619|P2|NOT COMPLETED|Second 18-day Withdrawal||1
270613|NCT01136356|653620|P1|NOT COMPLETED|Second 18-day Withdrawal||0
270614|NCT01136356|653619|P2|COMPLETED|Second 18-day Withdrawal||5
270615|NCT01136356|653620|P1|COMPLETED|Second 18-day Withdrawal||2
270616|NCT01136356|653619|P2|STARTED|Second 18-day Withdrawal||6
270617|NCT01136356|653620|P1|STARTED|Second 18-day Withdrawal||2
270618|NCT01136356|653619|P2|NOT COMPLETED|Second Intervention||0
270619|NCT01136356|653620|P1|NOT COMPLETED|Second Intervention||0
270620|NCT01136356|653619|P2|COMPLETED|Second Intervention||6
270621|NCT01136356|653620|P1|COMPLETED|Second Intervention||2
270622|NCT01136356|653619|P2|STARTED|Second Intervention||6
270623|NCT01136356|653620|P1|STARTED|Second Intervention||2
270624|NCT01136356|653619|P2|NOT COMPLETED|First 18-day Withdrawal||0
270625|NCT01136356|653620|P1|NOT COMPLETED|First 18-day Withdrawal||4
270626|NCT01136356|653619|P2|COMPLETED|First 18-day Withdrawal||6
270627|NCT01136356|653620|P1|COMPLETED|First 18-day Withdrawal||2
270628|NCT01136356|653619|P2|STARTED|First 18-day Withdrawal||6
270629|NCT01136356|653620|P1|STARTED|First 18-day Withdrawal||6
270630|NCT01136356|653619|P2|NOT COMPLETED|First Intervention||0
270631|NCT01136356|653620|P1|NOT COMPLETED|First Intervention||0
270632|NCT01136356|653619|P2|COMPLETED|First Intervention||6
270633|NCT01136356|653620|P1|COMPLETED|First Intervention||6
270634|NCT01136356|653619|P2|STARTED|First Intervention||6
270635|NCT01136356|653620|P1|STARTED|First Intervention||6
270636|NCT01136382|653631|P2|NOT COMPLETED|Overall Study||31
270637|NCT01136382|653632|P1|NOT COMPLETED|Overall Study||60
270638|NCT01136382|653631|P2|COMPLETED|Overall Study||121
270639|NCT01136382|653632|P1|COMPLETED|Overall Study||92
270640|NCT01136382|653631|P2|STARTED|Overall Study||152
270641|NCT01136382|653632|P1|STARTED|Overall Study||152
270642|NCT01136408|653661|P3|NOT COMPLETED|Overall Study||5
270643|NCT01136408|653662|P2|NOT COMPLETED|Overall Study||9
270644|NCT01136408|653663|P1|NOT COMPLETED|Overall Study||5
270645|NCT01136408|653661|P3|COMPLETED|Overall Study||57
270646|NCT01136408|653662|P2|COMPLETED|Overall Study||49
270647|NCT01136408|653663|P1|COMPLETED|Overall Study||41
270648|NCT01136408|653661|P3|STARTED|Overall Study||62
270649|NCT01136408|653662|P2|STARTED|Overall Study||58
270650|NCT01136408|653663|P1|STARTED|Overall Study||46
270651|NCT01136486|653718|P1|NOT COMPLETED|Overall Study||0
270652|NCT01136486|653718|P1|COMPLETED|Overall Study||56
270653|NCT01136486|653718|P1|STARTED|Overall Study||56
270654|NCT01124292|653725|P3|NOT COMPLETED|Overall Study||10
270655|NCT01124292|653726|P2|NOT COMPLETED|Overall Study||15
270656|NCT01124292|653727|P1|NOT COMPLETED|Overall Study||2
270657|NCT01124292|653725|P3|COMPLETED|Overall Study||11
270658|NCT01124292|653726|P2|COMPLETED|Overall Study||9
270659|NCT01124292|653727|P1|COMPLETED|Overall Study||14
270660|NCT01124292|653725|P3|STARTED|Overall Study||21
270661|NCT01124292|653726|P2|STARTED|Overall Study||24
270662|NCT01124292|653727|P1|STARTED|Overall Study||16
270663|NCT01124305|653785|P2|NOT COMPLETED|Overall Study||10
270664|NCT01124305|653786|P1|NOT COMPLETED|Overall Study||8
270665|NCT01124305|653785|P2|COMPLETED|Overall Study||26
270666|NCT01124305|653786|P1|COMPLETED|Overall Study||26
270667|NCT01124305|653785|P2|STARTED|Overall Study||36
270668|NCT01124305|653786|P1|STARTED|Overall Study||34
270669|NCT01124370|653798|P1|NOT COMPLETED|Overall Study||20
270670|NCT01124370|653798|P1|COMPLETED|Overall Study|Completed 2 year post-implant follow-up|37
270671|NCT01124370|653798|P1|3 Month Visit|Overall Study|Defines evaluable population|47
270672|NCT01124370|653798|P1|Therapy Initiated|Overall Study||48
270673|NCT01124370|653798|P1|Successfully Implanted|Overall Study||50
270674|NCT01124370|653798|P1|STARTED|Overall Study|Underwent implant attempt|57
270675|NCT01124422|653810|P3|NOT COMPLETED|4-Week Double-blind Treatment Phase||9
270676|NCT01124422|653811|P2|NOT COMPLETED|4-Week Double-blind Treatment Phase||11
270677|NCT01124422|653812|P1|NOT COMPLETED|4-Week Double-blind Treatment Phase||0
270678|NCT01124422|653810|P3|COMPLETED|4-Week Double-blind Treatment Phase||115
270679|NCT01124422|653811|P2|COMPLETED|4-Week Double-blind Treatment Phase||120
270680|NCT01124422|653812|P1|COMPLETED|4-Week Double-blind Treatment Phase||0
270681|NCT01124422|653810|P3|STARTED|4-Week Double-blind Treatment Phase||124
270682|NCT01124422|653811|P2|STARTED|4-Week Double-blind Treatment Phase||131
270683|NCT01124422|653812|P1|STARTED|4-Week Double-blind Treatment Phase||0
270684|NCT01124422|653810|P3|NOT COMPLETED|4-Week Open-label Run-in Phase||0
270685|NCT01124422|653811|P2|NOT COMPLETED|4-Week Open-label Run-in Phase||0
270686|NCT01124422|653812|P1|NOT COMPLETED|4-Week Open-label Run-in Phase||83
270687|NCT01124422|653810|P3|COMPLETED|4-Week Open-label Run-in Phase||0
270688|NCT01124422|653811|P2|COMPLETED|4-Week Open-label Run-in Phase||0
270689|NCT01124422|653812|P1|COMPLETED|4-Week Open-label Run-in Phase||255
270690|NCT01124422|653810|P3|STARTED|4-Week Open-label Run-in Phase||0
270691|NCT01124422|653811|P2|STARTED|4-Week Open-label Run-in Phase||0
270692|NCT01124422|653812|P1|STARTED|4-Week Open-label Run-in Phase||338
270693|NCT01124448|653856|P2|NOT COMPLETED|Overall Study||3
270694|NCT01124448|653857|P1|NOT COMPLETED|Overall Study||2
270695|NCT01124448|653856|P2|COMPLETED|Overall Study||12
270696|NCT01124448|653857|P1|COMPLETED|Overall Study||23
270697|NCT01124448|653856|P2|STARTED|Overall Study||15
270698|NCT01124448|653857|P1|STARTED|Overall Study||25
270699|NCT01129921|653865|P2|NOT COMPLETED|After Sham Cross-over to Mild, One Year||7
270700|NCT01129921|653866|P1|NOT COMPLETED|After Sham Cross-over to Mild, One Year||2
270701|NCT01129921|653865|P2|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis prior to x-over. After x-over 13 reported Year 1.|13
270702|NCT01129921|653866|P1|COMPLETED|After Sham Cross-over to Mild, One Year|All 20 completed Wk 6-12 Intent to Treat analysis. Eighteen reported Year 1 outcomes.|18
270703|NCT01129921|653865|P2|STARTED|After Sham Cross-over to Mild, One Year||20
270704|NCT01129921|653866|P1|STARTED|After Sham Cross-over to Mild, One Year||20
270705|NCT01129921|653865|P2|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
270706|NCT01129921|653866|P1|NOT COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||0
270707|NCT01129921|653865|P2|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
270708|NCT01129921|653866|P1|COMPLETED|Prior to Sham Cross-over, 6-12 Weeks||20
270709|NCT01129921|653865|P2|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
270710|NCT01129921|653866|P1|STARTED|Prior to Sham Cross-over, 6-12 Weeks||20
270711|NCT01129960|653880|P4|NOT COMPLETED|Overall Study||13
270712|NCT01129960|653881|P3|NOT COMPLETED|Overall Study||26
270713|NCT01129960|653882|P2|NOT COMPLETED|Overall Study||22
270714|NCT01129960|653883|P1|NOT COMPLETED|Overall Study||30
270715|NCT01129960|653880|P4|COMPLETED|Overall Study||70
270716|NCT01129960|653881|P3|COMPLETED|Overall Study||56
270717|NCT01129960|653882|P2|COMPLETED|Overall Study||61
270718|NCT01129960|653883|P1|COMPLETED|Overall Study||54
270719|NCT01129960|653880|P4|Full Analysis Set (FAS|Overall Study||71
270720|NCT01129960|653881|P3|Full Analysis Set (FAS|Overall Study||68
270721|NCT01129960|653882|P2|Full Analysis Set (FAS|Overall Study||67
270722|NCT01129960|653883|P1|Full Analysis Set (FAS|Overall Study||71
270723|NCT01129960|653880|P4|Per-Protocol|Overall Study||55
270724|NCT01129960|653881|P3|Per-Protocol|Overall Study||49
270725|NCT01129960|653882|P2|Per-Protocol|Overall Study||52
270726|NCT01129960|653883|P1|Per-Protocol|Overall Study||34
270727|NCT01129960|653880|P4|Intent-to-Treat|Overall Study||83
270728|NCT01129960|653881|P3|Intent-to-Treat|Overall Study||82
270729|NCT01129960|653882|P2|Intent-to-Treat|Overall Study||83
270730|NCT01129960|653883|P1|Intent-to-Treat|Overall Study||84
270731|NCT01129960|653880|P4|Safety|Overall Study||82
270732|NCT01129960|653881|P3|Safety|Overall Study|One subject was randomized to placebo, but was dispensed in error with an ESL 800 mg kit at DB Visit|83
270733|NCT01129960|653882|P2|Safety|Overall Study||83
270734|NCT01129960|653883|P1|Safety|Overall Study||84
270735|NCT01129960|653880|P4|STARTED|Overall Study||83
270736|NCT01129960|653881|P3|STARTED|Overall Study||82
270737|NCT01129960|653882|P2|STARTED|Overall Study||83
270738|NCT01129960|653883|P1|STARTED|Overall Study||84
270739|NCT01130051|653893|P2|NOT COMPLETED|Period 2||0
270740|NCT01130051|653894|P1|NOT COMPLETED|Period 2||0
270741|NCT01130051|653893|P2|COMPLETED|Period 2||6
270742|NCT01130051|653894|P1|COMPLETED|Period 2||7
270743|NCT01130051|653893|P2|STARTED|Period 2||6
270744|NCT01130051|653894|P1|STARTED|Period 2||7
270745|NCT01130051|653893|P2|NOT COMPLETED|Washout Period of 14 Days||2
270746|NCT01130051|653894|P1|NOT COMPLETED|Washout Period of 14 Days||1
270747|NCT01130051|653893|P2|COMPLETED|Washout Period of 14 Days||6
270748|NCT01130051|653894|P1|COMPLETED|Washout Period of 14 Days||7
270749|NCT01130051|653893|P2|STARTED|Washout Period of 14 Days||8
270750|NCT01130051|653894|P1|STARTED|Washout Period of 14 Days||8
270751|NCT01130051|653893|P2|NOT COMPLETED|Period 1||0
270752|NCT01130051|653894|P1|NOT COMPLETED|Period 1||0
270753|NCT01130051|653893|P2|COMPLETED|Period 1||8
270754|NCT01130051|653894|P1|COMPLETED|Period 1||8
270755|NCT01130051|653893|P2|STARTED|Period 1||8
270756|NCT01130051|653894|P1|STARTED|Period 1||8
270757|NCT01130103|653906|P2|NOT COMPLETED|Maintenance Treatment||2
270758|NCT01130103|653907|P1|NOT COMPLETED|Maintenance Treatment||2
270759|NCT01130103|653906|P2|COMPLETED|Maintenance Treatment||11
270760|NCT01130103|653907|P1|COMPLETED|Maintenance Treatment||11
270761|NCT01130103|653906|P2|STARTED|Maintenance Treatment||13
270762|NCT01130103|653907|P1|STARTED|Maintenance Treatment||13
270763|NCT01130103|653906|P2|NOT COMPLETED|Randomized Treatment||5
270764|NCT01130103|653907|P1|NOT COMPLETED|Randomized Treatment||6
270765|NCT01130103|653906|P2|COMPLETED|Randomized Treatment||13
270766|NCT01130103|653907|P1|COMPLETED|Randomized Treatment||13
270767|NCT01130103|653906|P2|STARTED|Randomized Treatment||18
270768|NCT01130103|653907|P1|STARTED|Randomized Treatment||19
270769|NCT01130168|653921|P6|NOT COMPLETED|Period 3||0
270770|NCT01130168|653922|P5|NOT COMPLETED|Period 3||0
270771|NCT01130168|653923|P4|NOT COMPLETED|Period 3||0
270772|NCT01130168|653924|P3|NOT COMPLETED|Period 3||0
270773|NCT01130168|653925|P2|NOT COMPLETED|Period 3||0
270774|NCT01130168|653926|P1|NOT COMPLETED|Period 3||0
270775|NCT01130168|653921|P6|COMPLETED|Period 3||6
270776|NCT01130168|653922|P5|COMPLETED|Period 3||5
270777|NCT01130168|653923|P4|COMPLETED|Period 3||5
270778|NCT01130168|653924|P3|COMPLETED|Period 3||5
270779|NCT01130168|653925|P2|COMPLETED|Period 3||6
270780|NCT01130168|653926|P1|COMPLETED|Period 3||6
270781|NCT01130168|653921|P6|STARTED|Period 3||6
270782|NCT01130168|653922|P5|STARTED|Period 3||5
270783|NCT01130168|653923|P4|STARTED|Period 3||5
270784|NCT01130168|653924|P3|STARTED|Period 3||5
270785|NCT01130168|653925|P2|STARTED|Period 3||6
270786|NCT01130168|653926|P1|STARTED|Period 3||6
270787|NCT01130168|653921|P6|NOT COMPLETED|Period 2||0
270788|NCT01130168|653922|P5|NOT COMPLETED|Period 2||0
270789|NCT01130168|653923|P4|NOT COMPLETED|Period 2||0
270790|NCT01130168|653924|P3|NOT COMPLETED|Period 2||0
270791|NCT01130168|653925|P2|NOT COMPLETED|Period 2||0
270792|NCT01130168|653926|P1|NOT COMPLETED|Period 2||0
270793|NCT01130168|653921|P6|COMPLETED|Period 2||6
270794|NCT01130168|653922|P5|COMPLETED|Period 2||5
270795|NCT01130168|653923|P4|COMPLETED|Period 2||5
270796|NCT01130168|653924|P3|COMPLETED|Period 2||5
270797|NCT01130168|653925|P2|COMPLETED|Period 2||6
270798|NCT01130168|653926|P1|COMPLETED|Period 2||6
270799|NCT01130168|653921|P6|STARTED|Period 2||6
270800|NCT01130168|653922|P5|STARTED|Period 2||5
270801|NCT01130168|653923|P4|STARTED|Period 2||5
270802|NCT01130168|653924|P3|STARTED|Period 2||5
270803|NCT01130168|653925|P2|STARTED|Period 2||6
270804|NCT01130168|653926|P1|STARTED|Period 2||6
270805|NCT01130168|653921|P6|NOT COMPLETED|Period 1||0
270806|NCT01130168|653922|P5|NOT COMPLETED|Period 1||0
270807|NCT01130168|653923|P4|NOT COMPLETED|Period 1||3
270808|NCT01130168|653924|P3|NOT COMPLETED|Period 1||1
270809|NCT01130168|653925|P2|NOT COMPLETED|Period 1||1
270810|NCT01130168|653926|P1|NOT COMPLETED|Period 1||0
270811|NCT01130168|653921|P6|COMPLETED|Period 1||6
270812|NCT01130168|653922|P5|COMPLETED|Period 1||5
270813|NCT01130168|653923|P4|COMPLETED|Period 1||5
270814|NCT01130168|653924|P3|COMPLETED|Period 1||5
270815|NCT01130168|653925|P2|COMPLETED|Period 1||6
270816|NCT01130168|653926|P1|COMPLETED|Period 1||6
270817|NCT01130168|653921|P6|STARTED|Period 1||6
270818|NCT01130168|653922|P5|STARTED|Period 1||5
270819|NCT01130168|653923|P4|STARTED|Period 1||8
270820|NCT01130168|653924|P3|STARTED|Period 1||6
270821|NCT01130168|653925|P2|STARTED|Period 1||7
270822|NCT01130168|653926|P1|STARTED|Period 1||6
270823|NCT01130337|653961|P1|NOT COMPLETED|Overall Study||14
270824|NCT01130337|653961|P1|COMPLETED|Overall Study||22
270825|NCT01130337|653961|P1|STARTED|Overall Study||36
270826|NCT01130532|653971|P4|NOT COMPLETED|Period IV (Weeks 13-16)||10
270827|NCT01130532|653972|P3|NOT COMPLETED|Period IV (Weeks 13-16)||0
270828|NCT01130532|653973|P2|NOT COMPLETED|Period IV (Weeks 13-16)||0
270829|NCT01130532|653974|P1|NOT COMPLETED|Period IV (Weeks 13-16)||0
270830|NCT01130532|653971|P4|COMPLETED|Period IV (Weeks 13-16)||552
270831|NCT01130532|653972|P3|COMPLETED|Period IV (Weeks 13-16)||0
270832|NCT01130532|653973|P2|COMPLETED|Period IV (Weeks 13-16)||0
270833|NCT01130532|653974|P1|COMPLETED|Period IV (Weeks 13-16)||0
270834|NCT01130532|653971|P4|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||546
270835|NCT01130532|653972|P3|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
270836|NCT01130532|653973|P2|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
270837|NCT01130532|653974|P1|Received at Least 1 Dose of Study Drug|Period IV (Weeks 13-16)||0
270838|NCT01130532|653971|P4|STARTED|Period IV (Weeks 13-16)|Three participants who completed Period III chose not to continue into Period IV.|562
270839|NCT01130532|653972|P3|STARTED|Period IV (Weeks 13-16)||0
270840|NCT01130532|653973|P2|STARTED|Period IV (Weeks 13-16)||0
270841|NCT01130532|653974|P1|STARTED|Period IV (Weeks 13-16)||0
270842|NCT01130532|653971|P4|NOT COMPLETED|Period III (Weeks 0-12)||0
270843|NCT01130532|653972|P3|NOT COMPLETED|Period III (Weeks 0-12)||19
270844|NCT01130532|653973|P2|NOT COMPLETED|Period III (Weeks 0-12)||18
270845|NCT01130532|653974|P1|NOT COMPLETED|Period III (Weeks 0-12)||21
270846|NCT01130532|653971|P4|COMPLETED|Period III (Weeks 0-12)||0
270847|NCT01130532|653972|P3|COMPLETED|Period III (Weeks 0-12)||190
270848|NCT01130532|653973|P2|COMPLETED|Period III (Weeks 0-12)||189
270849|NCT01130532|653974|P1|COMPLETED|Period III (Weeks 0-12)||186
270850|NCT01130532|653971|P4|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||0
270851|NCT01130532|653972|P3|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||207
270852|NCT01130532|653973|P2|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
270853|NCT01130532|653974|P1|Received at Least 1 Dose of Study Drug|Period III (Weeks 0-12)||205
270854|NCT01130532|653971|P4|STARTED|Period III (Weeks 0-12)||0
270855|NCT01130532|653972|P3|STARTED|Period III (Weeks 0-12)||209
270856|NCT01130532|653973|P2|STARTED|Period III (Weeks 0-12)||207
270857|NCT01130532|653974|P1|STARTED|Period III (Weeks 0-12)||207
270858|NCT01130597|654019|P1|NOT COMPLETED|Overall Study||7
270859|NCT01130597|654019|P1|COMPLETED|Overall Study||56
270860|NCT01130597|654019|P1|STARTED|Overall Study||63
270861|NCT01136655|654041|P1|NOT COMPLETED|Washout After BUD 160/ Foradil (7 Days)||0
270862|NCT01136655|654041|P1|COMPLETED|Washout After BUD 160/ Foradil (7 Days)||50
270863|NCT01136655|654041|P1|STARTED|Washout After BUD 160/ Foradil (7 Days)||50
270864|NCT01136655|654041|P1|NOT COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||0
270865|NCT01136655|654041|P1|COMPLETED|BUD 160/ Foradil 12.0 (1 Dose)||50
270866|NCT01136655|654041|P1|STARTED|BUD 160/ Foradil 12.0 (1 Dose)||50
270867|NCT01136655|654041|P1|NOT COMPLETED|Washout After BUD 160 (7 Days)||0
270868|NCT01136655|654041|P1|COMPLETED|Washout After BUD 160 (7 Days)||51
270869|NCT01136655|654041|P1|STARTED|Washout After BUD 160 (7 Days)||51
270870|NCT01136655|654041|P1|NOT COMPLETED|BUD 160 (1 Dose)||0
270871|NCT01136655|654041|P1|COMPLETED|BUD 160 (1 Dose)||51
270872|NCT01136655|654041|P1|STARTED|BUD 160 (1 Dose)||51
270873|NCT01136655|654041|P1|NOT COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||2
270874|NCT01136655|654041|P1|COMPLETED|Washout After BUD 160/FM 9.0 (7 Days)||51
270875|NCT01136655|654041|P1|STARTED|Washout After BUD 160/FM 9.0 (7 Days)||53
270876|NCT01136655|654041|P1|NOT COMPLETED|BUD 160/FM 9.0 (1 Dose)||0
270877|NCT01136655|654041|P1|COMPLETED|BUD 160/FM 9.0 (1 Dose)||53
270878|NCT01136655|654041|P1|STARTED|BUD 160/FM 9.0 (1 Dose)||53
270879|NCT01136655|654041|P1|NOT COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||1
270880|NCT01136655|654041|P1|COMPLETED|Washout After BUD 160/FM 4.5 (7 Days)||52
270881|NCT01136655|654041|P1|STARTED|Washout After BUD 160/FM 4.5 (7 Days)||53
270882|NCT01136655|654041|P1|NOT COMPLETED|BUD 160/FM 4.5 (1 Dose)||0
270883|NCT01136655|654041|P1|COMPLETED|BUD 160/FM 4.5 (1 Dose)||53
270884|NCT01136655|654041|P1|STARTED|BUD 160/FM 4.5 (1 Dose)||53
270885|NCT01136655|654041|P1|NOT COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||1
270886|NCT01136655|654041|P1|COMPLETED|Washout After BUD 160/FM 2.25 (7 Days)||53
270887|NCT01136655|654041|P1|STARTED|Washout After BUD 160/FM 2.25 (7 Days)||54
270888|NCT01136655|654041|P1|NOT COMPLETED|BUD 160/FM 2.25 (1 Dose)||0
270889|NCT01136655|654041|P1|COMPLETED|BUD 160/FM 2.25 (1 Dose)||54
270890|NCT01136655|654041|P1|STARTED|BUD 160/FM 2.25 (1 Dose)||54
270891|NCT01136746|654069|P2|NOT COMPLETED|Overall Study||3
270892|NCT01136746|654070|P1|NOT COMPLETED|Overall Study||3
270893|NCT01136746|654069|P2|COMPLETED|Overall Study||4
270894|NCT01136746|654070|P1|COMPLETED|Overall Study||6
270895|NCT01136746|654069|P2|STARTED|Overall Study||7
270896|NCT01136746|654070|P1|STARTED|Overall Study||9
270897|NCT01136772|654132|P2|NOT COMPLETED|Overall Study||110
270898|NCT01136772|654133|P1|NOT COMPLETED|Overall Study||116
270899|NCT01136772|654132|P2|COMPLETED|Overall Study||44
270900|NCT01136772|654133|P1|COMPLETED|Overall Study||41
270901|NCT01136772|654132|P2|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
270902|NCT01136772|654133|P1|Safety Population|Overall Study|Includes all randomized participants who received at least one dose of the injectable medication|147
270903|NCT01136772|654132|P2|STARTED|Overall Study||154
270904|NCT01136772|654133|P1|STARTED|Overall Study||157
270905|NCT01136785|654143|P2|NOT COMPLETED|Overall Study||1
270906|NCT01136785|654144|P1|NOT COMPLETED|Overall Study||2
270907|NCT01136785|654143|P2|COMPLETED|Overall Study||6
270908|NCT01136785|654144|P1|COMPLETED|Overall Study||13
270909|NCT01136785|654143|P2|STARTED|Overall Study||7
270910|NCT01136785|654144|P1|STARTED|Overall Study||15
270911|NCT01137539|654157|P1|NOT COMPLETED|Overall Study||0
270912|NCT01137539|654157|P1|COMPLETED|Overall Study||50
270913|NCT01137539|654157|P1|STARTED|Overall Study||50
270914|NCT01137578|654162|P3|NOT COMPLETED|Overall Study||6
270915|NCT01137578|654163|P2|NOT COMPLETED|Overall Study||2
270916|NCT01137578|654164|P1|NOT COMPLETED|Overall Study||16
270917|NCT01137578|654162|P3|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|37
270918|NCT01137578|654163|P2|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|12
270919|NCT01137578|654164|P1|COMPLETED|Overall Study|Completed defined as having completed all 3 study-related imaging procedures.|61
270920|NCT01137578|654162|P3|STARTED|Overall Study||43
270921|NCT01137578|654163|P2|STARTED|Overall Study||14
270922|NCT01137578|654164|P1|STARTED|Overall Study||77
270923|NCT01137604|654208|P4|NOT COMPLETED|Overall Study||11
270924|NCT01137604|654209|P3|NOT COMPLETED|Overall Study||13
270925|NCT01137604|654210|P2|NOT COMPLETED|Overall Study||10
270926|NCT01137604|654211|P1|NOT COMPLETED|Overall Study||2
270927|NCT01137604|654208|P4|COMPLETED|Overall Study||21
270928|NCT01137604|654209|P3|COMPLETED|Overall Study||26
270929|NCT01137604|654210|P2|COMPLETED|Overall Study||32
270930|NCT01137604|654211|P1|COMPLETED|Overall Study|Participants with disease progression and treatment ongoing at data cutoff (19 Mar 2013)|36
270931|NCT01137604|654208|P4|Treatment Ongoing at Data Cutoff|Overall Study||0
270932|NCT01137604|654209|P3|Treatment Ongoing at Data Cutoff|Overall Study||1
270933|NCT01137604|654210|P2|Treatment Ongoing at Data Cutoff|Overall Study||3
270934|NCT01137604|654211|P1|Treatment Ongoing at Data Cutoff|Overall Study||2
270935|NCT01137604|654208|P4|Disease Progression|Overall Study||21
270936|NCT01137604|654209|P3|Disease Progression|Overall Study||25
270937|NCT01137604|654210|P2|Disease Progression|Overall Study||29
270938|NCT01137604|654211|P1|Disease Progression|Overall Study||34
270939|NCT01137604|654208|P4|STARTED|Overall Study||32
270940|NCT01137604|654209|P3|STARTED|Overall Study||39
270941|NCT01137604|654210|P2|STARTED|Overall Study||42
270942|NCT01137604|654211|P1|STARTED|Overall Study|39 participants were randomized but 1 participant died prior to receiving treatment.|38
270943|NCT01137682|654248|P3|NOT COMPLETED|Overall Study||3
270944|NCT01137682|654249|P2|NOT COMPLETED|Overall Study||8
270945|NCT01137682|654250|P1|NOT COMPLETED|Overall Study||6
270946|NCT01137682|654248|P3|COMPLETED|Overall Study||65
270947|NCT01137682|654249|P2|COMPLETED|Overall Study||57
270948|NCT01137682|654250|P1|COMPLETED|Overall Study||59
270949|NCT01137682|654248|P3|Safety Set|Overall Study|2 patients never received drug.|66
270950|NCT01137682|654249|P2|Safety Set|Overall Study|2 patients never received drug. 1 patient had no post baseline safety assement.|62
270951|NCT01137682|654250|P1|Safety Set|Overall Study|2 patients never received drug.|63
270952|NCT01137682|654248|P3|Continuing Into Extension|Overall Study||62
270953|NCT01137682|654249|P2|Continuing Into Extension|Overall Study||53
270954|NCT01137682|654250|P1|Continuing Into Extension|Overall Study||56
270955|NCT01137682|654248|P3|Not Continuing Into Extension|Overall Study||3
270956|NCT01137682|654249|P2|Not Continuing Into Extension|Overall Study||4
270957|NCT01137682|654250|P1|Not Continuing Into Extension|Overall Study||3
270958|NCT01137682|654248|P3|Completed 24-Week Core Phase|Overall Study||65
270959|NCT01137682|654249|P2|Completed 24-Week Core Phase|Overall Study||57
270960|NCT01137682|654250|P1|Completed 24-Week Core Phase|Overall Study||59
270961|NCT01137682|654248|P3|Treated|Overall Study||67
270962|NCT01137682|654249|P2|Treated|Overall Study||64
270963|NCT01137682|654250|P1|Treated|Overall Study||63
270964|NCT01137682|654248|P3|Not Treated|Overall Study||1
270965|NCT01137682|654249|P2|Not Treated|Overall Study||1
270966|NCT01137682|654250|P1|Not Treated|Overall Study||2
270967|NCT01137682|654248|P3|STARTED|Overall Study||68
270968|NCT01137682|654249|P2|STARTED|Overall Study||65
270969|NCT01137682|654250|P1|STARTED|Overall Study||65
270970|NCT01137773|654263|P2|NOT COMPLETED|Overall Study||3
270971|NCT01137773|654264|P1|NOT COMPLETED|Overall Study||9
270972|NCT01137773|654263|P2|COMPLETED|Overall Study||20
270973|NCT01137773|654264|P1|COMPLETED|Overall Study||24
270974|NCT01137773|654263|P2|STARTED|Overall Study||23
270975|NCT01137773|654264|P1|STARTED|Overall Study||33
270976|NCT01137786|654274|P2|NOT COMPLETED|Overall Study||3
270977|NCT01137786|654275|P1|NOT COMPLETED|Overall Study||1
270978|NCT01137786|654274|P2|COMPLETED|Overall Study||21
270979|NCT01137786|654275|P1|COMPLETED|Overall Study||24
270980|NCT01137786|654274|P2|STARTED|Overall Study||24
270981|NCT01137786|654275|P1|STARTED|Overall Study||25
270982|NCT01137812|654285|P2|NOT COMPLETED|Overall Study||168
270983|NCT01137812|654286|P1|NOT COMPLETED|Overall Study||123
270984|NCT01137812|654285|P2|COMPLETED|Overall Study||210
270985|NCT01137812|654286|P1|COMPLETED|Overall Study||254
270986|NCT01137812|654285|P2|STARTED|Overall Study||378
270987|NCT01137812|654286|P1|STARTED|Overall Study||377
270988|NCT01138007|654307|P3|NOT COMPLETED|Overall Study||48
270989|NCT01138007|654308|P2|NOT COMPLETED|Overall Study||30
270990|NCT01138007|654309|P1|NOT COMPLETED|Overall Study||22
270991|NCT01138007|654307|P3|COMPLETED|Overall Study||144
270992|NCT01138007|654308|P2|COMPLETED|Overall Study||160
270993|NCT01138007|654309|P1|COMPLETED|Overall Study||165
270994|NCT01138007|654307|P3|STARTED|Overall Study||192
270995|NCT01138007|654308|P2|STARTED|Overall Study||190
270996|NCT01138007|654309|P1|STARTED|Overall Study||187
270997|NCT01138046|654341|P1|NOT COMPLETED|Overall Study||6
270998|NCT01138046|654341|P1|COMPLETED|Overall Study||6
270999|NCT01138046|654341|P1|STARTED|Overall Study||12
271000|NCT01138098|654360|P2|NOT COMPLETED|Overall Study||0
271001|NCT01138098|654361|P1|NOT COMPLETED|Overall Study||0
271002|NCT01138098|654360|P2|COMPLETED|Overall Study||90
271003|NCT01138098|654361|P1|COMPLETED|Overall Study||95
271004|NCT01138098|654360|P2|STARTED|Overall Study||90
271005|NCT01138098|654361|P1|STARTED|Overall Study||95
271006|NCT01138111|654383|P1|NOT COMPLETED|Overall Study||9
271007|NCT01138111|654383|P1|COMPLETED|Overall Study||36
271008|NCT01138111|654383|P1|STARTED|Overall Study||45
271009|NCT01138124|654416|P4|NOT COMPLETED|Overall Study||0
271010|NCT01138124|654417|P3|NOT COMPLETED|Overall Study||0
271011|NCT01138124|654418|P2|NOT COMPLETED|Overall Study||0
271012|NCT01138124|654419|P1|NOT COMPLETED|Overall Study||0
271013|NCT01138124|654416|P4|COMPLETED|Overall Study||19046
271014|NCT01138124|654417|P3|COMPLETED|Overall Study||1981
271015|NCT01138124|654418|P2|COMPLETED|Overall Study||30026
271016|NCT01138124|654419|P1|COMPLETED|Overall Study||3149
271017|NCT01138124|654416|P4|STARTED|Overall Study||19046
271018|NCT01138124|654417|P3|STARTED|Overall Study||1981
271019|NCT01138124|654418|P2|STARTED|Overall Study||30026
271020|NCT01138124|654419|P1|STARTED|Overall Study||3149
271021|NCT01138150|654443|P2|NOT COMPLETED|Overall Study||1
271022|NCT01138150|654444|P1|NOT COMPLETED|Overall Study||1
271023|NCT01138150|654443|P2|COMPLETED|Overall Study||17
271024|NCT01138150|654444|P1|COMPLETED|Overall Study||17
271025|NCT01138150|654443|P2|STARTED|Overall Study||18
271026|NCT01138150|654444|P1|STARTED|Overall Study||18
271027|NCT01138475|654499|P3|NOT COMPLETED|Overall Study||0
271028|NCT01138475|654500|P2|NOT COMPLETED|Overall Study||0
271029|NCT01138475|654501|P1|NOT COMPLETED|Overall Study||0
271030|NCT01138475|654499|P3|COMPLETED|Overall Study||17
271031|NCT01138475|654500|P2|COMPLETED|Overall Study||16
271032|NCT01138475|654501|P1|COMPLETED|Overall Study||16
271033|NCT01138475|654499|P3|STARTED|Overall Study||17
271034|NCT01138475|654500|P2|STARTED|Overall Study||16
271035|NCT01138475|654501|P1|STARTED|Overall Study||16
271036|NCT01138501|654533|P1|NOT COMPLETED|Overall Study||5
271037|NCT01138501|654533|P1|COMPLETED|Overall Study||60
271038|NCT01138501|654533|P1|Exposed|Overall Study||63
271039|NCT01138501|654533|P1|STARTED|Overall Study|Two subjects withdrew consent after being enrolled but before receiving any trial product.|65
271040|NCT01138514|654541|P3|NOT COMPLETED|Overall Study||93
271041|NCT01138514|654542|P2|NOT COMPLETED|Overall Study||53
271042|NCT01138514|654543|P1|NOT COMPLETED|Overall Study||48
271043|NCT01138514|654541|P3|COMPLETED|Overall Study||424
271044|NCT01138514|654542|P2|COMPLETED|Overall Study||463
271045|NCT01138514|654543|P1|COMPLETED|Overall Study||474
271046|NCT01138514|654541|P3|STARTED|Overall Study||517
271047|NCT01138514|654542|P2|STARTED|Overall Study||516
271048|NCT01138514|654543|P1|STARTED|Overall Study||522
271049|NCT01138657|654559|P2|NOT COMPLETED|Overall Study||18
271050|NCT01138657|654560|P1|NOT COMPLETED|Overall Study||8
271051|NCT01138657|654559|P2|COMPLETED|Overall Study||101
271052|NCT01138657|654560|P1|COMPLETED|Overall Study||112
271053|NCT01138657|654559|P2|Enrolled in Japan Sub-study|Overall Study||8
271054|NCT01138657|654560|P1|Enrolled in Japan Sub-study|Overall Study||8
271055|NCT01138657|654559|P2|Enrolled in Main Study|Overall Study||111
271056|NCT01138657|654560|P1|Enrolled in Main Study|Overall Study||112
271057|NCT01138657|654559|P2|STARTED|Overall Study||119
271058|NCT01138657|654560|P1|STARTED|Overall Study||120
271059|NCT01138735|654606|P2|NOT COMPLETED|Overall Study||17
271060|NCT01138735|654607|P1|NOT COMPLETED|Overall Study||8
271061|NCT01138735|654606|P2|COMPLETED|Overall Study||126
271062|NCT01138735|654607|P1|COMPLETED|Overall Study||134
271063|NCT01138735|654606|P2|STARTED|Overall Study||143
271064|NCT01138735|654607|P1|STARTED|Overall Study||142
271065|NCT01138826|654619|P6|NOT COMPLETED|Third Intervention Period||0
271066|NCT01138826|654620|P5|NOT COMPLETED|Third Intervention Period||0
271067|NCT01138826|654621|P4|NOT COMPLETED|Third Intervention Period||0
271068|NCT01138826|654622|P3|NOT COMPLETED|Third Intervention Period||0
271069|NCT01138826|654623|P2|NOT COMPLETED|Third Intervention Period||0
271070|NCT01138826|654624|P1|NOT COMPLETED|Third Intervention Period||0
271071|NCT01138826|654619|P6|COMPLETED|Third Intervention Period||3
271072|NCT01138826|654620|P5|COMPLETED|Third Intervention Period||2
271073|NCT01138826|654621|P4|COMPLETED|Third Intervention Period||3
271074|NCT01138826|654622|P3|COMPLETED|Third Intervention Period||3
271075|NCT01138826|654623|P2|COMPLETED|Third Intervention Period||2
271076|NCT01138826|654624|P1|COMPLETED|Third Intervention Period||2
271077|NCT01138826|654619|P6|STARTED|Third Intervention Period||3
271078|NCT01138826|654620|P5|STARTED|Third Intervention Period||2
271079|NCT01138826|654621|P4|STARTED|Third Intervention Period||3
271080|NCT01138826|654622|P3|STARTED|Third Intervention Period||3
271081|NCT01138826|654623|P2|STARTED|Third Intervention Period||2
271082|NCT01138826|654624|P1|STARTED|Third Intervention Period||2
271083|NCT01138826|654619|P6|NOT COMPLETED|Washout Period II (of 16 Days)||0
271084|NCT01138826|654620|P5|NOT COMPLETED|Washout Period II (of 16 Days)||0
271085|NCT01138826|654621|P4|NOT COMPLETED|Washout Period II (of 16 Days)||0
271086|NCT01138826|654622|P3|NOT COMPLETED|Washout Period II (of 16 Days)||0
271087|NCT01138826|654623|P2|NOT COMPLETED|Washout Period II (of 16 Days)||0
271088|NCT01138826|654624|P1|NOT COMPLETED|Washout Period II (of 16 Days)||0
271089|NCT01138826|654619|P6|COMPLETED|Washout Period II (of 16 Days)||3
271090|NCT01138826|654620|P5|COMPLETED|Washout Period II (of 16 Days)||2
271091|NCT01138826|654621|P4|COMPLETED|Washout Period II (of 16 Days)||3
271092|NCT01138826|654622|P3|COMPLETED|Washout Period II (of 16 Days)||3
271093|NCT01138826|654623|P2|COMPLETED|Washout Period II (of 16 Days)||2
271094|NCT01138826|654624|P1|COMPLETED|Washout Period II (of 16 Days)||2
271095|NCT01138826|654619|P6|STARTED|Washout Period II (of 16 Days)||3
271096|NCT01138826|654620|P5|STARTED|Washout Period II (of 16 Days)||2
271097|NCT01138826|654621|P4|STARTED|Washout Period II (of 16 Days)||3
271098|NCT01138826|654622|P3|STARTED|Washout Period II (of 16 Days)||3
271099|NCT01138826|654623|P2|STARTED|Washout Period II (of 16 Days)||2
271100|NCT01138826|654624|P1|STARTED|Washout Period II (of 16 Days)||2
271101|NCT01138826|654619|P6|NOT COMPLETED|Second Intervention Period||0
271102|NCT01138826|654620|P5|NOT COMPLETED|Second Intervention Period||0
271103|NCT01138826|654621|P4|NOT COMPLETED|Second Intervention Period||0
271104|NCT01138826|654622|P3|NOT COMPLETED|Second Intervention Period||0
271105|NCT01138826|654623|P2|NOT COMPLETED|Second Intervention Period||0
271106|NCT01138826|654624|P1|NOT COMPLETED|Second Intervention Period||0
271107|NCT01138826|654619|P6|COMPLETED|Second Intervention Period||3
271108|NCT01138826|654620|P5|COMPLETED|Second Intervention Period||2
271109|NCT01138826|654621|P4|COMPLETED|Second Intervention Period||3
271110|NCT01138826|654622|P3|COMPLETED|Second Intervention Period||3
271111|NCT01138826|654623|P2|COMPLETED|Second Intervention Period||2
271112|NCT01138826|654624|P1|COMPLETED|Second Intervention Period||2
271113|NCT01138826|654619|P6|STARTED|Second Intervention Period||3
271114|NCT01138826|654620|P5|STARTED|Second Intervention Period||2
271115|NCT01138826|654621|P4|STARTED|Second Intervention Period||3
271116|NCT01138826|654622|P3|STARTED|Second Intervention Period||3
271117|NCT01138826|654623|P2|STARTED|Second Intervention Period||2
271118|NCT01138826|654624|P1|STARTED|Second Intervention Period||2
271119|NCT01138826|654619|P6|NOT COMPLETED|Washout Period I (of 16 Days)||0
271120|NCT01138826|654620|P5|NOT COMPLETED|Washout Period I (of 16 Days)||1
271121|NCT01138826|654621|P4|NOT COMPLETED|Washout Period I (of 16 Days)||0
271122|NCT01138826|654622|P3|NOT COMPLETED|Washout Period I (of 16 Days)||0
271123|NCT01138826|654623|P2|NOT COMPLETED|Washout Period I (of 16 Days)||1
271124|NCT01138826|654624|P1|NOT COMPLETED|Washout Period I (of 16 Days)||1
271125|NCT01138826|654619|P6|COMPLETED|Washout Period I (of 16 Days)||3
271126|NCT01138826|654620|P5|COMPLETED|Washout Period I (of 16 Days)||2
271127|NCT01138826|654621|P4|COMPLETED|Washout Period I (of 16 Days)||3
271128|NCT01138826|654622|P3|COMPLETED|Washout Period I (of 16 Days)||3
271129|NCT01138826|654623|P2|COMPLETED|Washout Period I (of 16 Days)||2
271130|NCT01138826|654624|P1|COMPLETED|Washout Period I (of 16 Days)||2
271131|NCT01138826|654619|P6|STARTED|Washout Period I (of 16 Days)||3
271132|NCT01138826|654620|P5|STARTED|Washout Period I (of 16 Days)||3
271133|NCT01138826|654621|P4|STARTED|Washout Period I (of 16 Days)||3
271134|NCT01138826|654622|P3|STARTED|Washout Period I (of 16 Days)||3
271135|NCT01138826|654623|P2|STARTED|Washout Period I (of 16 Days)||3
271136|NCT01138826|654624|P1|STARTED|Washout Period I (of 16 Days)||3
271137|NCT01138826|654619|P6|NOT COMPLETED|First Intervention Period||0
271138|NCT01138826|654620|P5|NOT COMPLETED|First Intervention Period||0
271139|NCT01138826|654621|P4|NOT COMPLETED|First Intervention Period||0
271140|NCT01138826|654622|P3|NOT COMPLETED|First Intervention Period||0
271141|NCT01138826|654623|P2|NOT COMPLETED|First Intervention Period||0
271142|NCT01138826|654624|P1|NOT COMPLETED|First Intervention Period||0
271143|NCT01138826|654619|P6|COMPLETED|First Intervention Period||3
271144|NCT01138826|654620|P5|COMPLETED|First Intervention Period||3
271145|NCT01138826|654621|P4|COMPLETED|First Intervention Period||3
271146|NCT01138826|654622|P3|COMPLETED|First Intervention Period||3
271147|NCT01138826|654623|P2|COMPLETED|First Intervention Period||3
271148|NCT01138826|654624|P1|COMPLETED|First Intervention Period||3
271149|NCT01138826|654619|P6|STARTED|First Intervention Period||3
271150|NCT01138826|654620|P5|STARTED|First Intervention Period||3
271151|NCT01138826|654621|P4|STARTED|First Intervention Period||3
271152|NCT01138826|654622|P3|STARTED|First Intervention Period||3
271153|NCT01138826|654623|P2|STARTED|First Intervention Period||3
271154|NCT01138826|654624|P1|STARTED|First Intervention Period||3
271155|NCT01138969|654646|P2|NOT COMPLETED|Overall Study||0
271156|NCT01138969|654647|P1|NOT COMPLETED|Overall Study||0
271157|NCT01138969|654646|P2|COMPLETED|Overall Study||82
271158|NCT01138969|654647|P1|COMPLETED|Overall Study||83
271159|NCT01138969|654646|P2|STARTED|Overall Study||82
271160|NCT01138969|654647|P1|STARTED|Overall Study||83
271161|NCT01138995|654657|P2|NOT COMPLETED|Overall Study||25
271162|NCT01138995|654658|P1|NOT COMPLETED|Overall Study||10
271163|NCT01138995|654657|P2|COMPLETED|Overall Study||74
271164|NCT01138995|654658|P1|COMPLETED|Overall Study||88
271165|NCT01138995|654657|P2|STARTED|Overall Study||99
271166|NCT01138995|654658|P1|STARTED|Overall Study||98
271167|NCT01139008|654668|P1|NOT COMPLETED|Overall Study||6
271168|NCT01139008|654668|P1|COMPLETED|Overall Study||74
271169|NCT01139008|654668|P1|STARTED|Overall Study||80
271170|NCT01139021|654683|P6|NOT COMPLETED|Overall Study||0
271171|NCT01139021|654684|P5|NOT COMPLETED|Overall Study||9
271172|NCT01139021|654685|P4|NOT COMPLETED|Overall Study||1
271173|NCT01139021|654686|P3|NOT COMPLETED|Overall Study||0
271174|NCT01139021|654687|P2|NOT COMPLETED|Overall Study||0
271175|NCT01139021|654688|P1|NOT COMPLETED|Overall Study||1
271176|NCT01139021|654683|P6|COMPLETED|Overall Study||1
271177|NCT01139021|654684|P5|COMPLETED|Overall Study||107
271178|NCT01139021|654685|P4|COMPLETED|Overall Study||18
271179|NCT01139021|654686|P3|COMPLETED|Overall Study||67
271180|NCT01139021|654687|P2|COMPLETED|Overall Study||153
271181|NCT01139021|654688|P1|COMPLETED|Overall Study||151
271182|NCT01139021|654683|P6|STARTED|Overall Study||1
271183|NCT01139021|654684|P5|STARTED|Overall Study||116
271184|NCT01139021|654685|P4|STARTED|Overall Study||19
271185|NCT01139021|654686|P3|STARTED|Overall Study||67
271186|NCT01139021|654687|P2|STARTED|Overall Study||153
271187|NCT01139021|654688|P1|STARTED|Overall Study||152
271188|NCT01139047|654724|P1|NOT COMPLETED|Overall Study||1
271189|NCT01139047|654724|P1|COMPLETED|Overall Study||76
271190|NCT01139047|654724|P1|STARTED|Overall Study||77
271191|NCT01139125|654733|P1|NOT COMPLETED|Overall Study||1
271192|NCT01139125|654733|P1|COMPLETED|Overall Study||2
271193|NCT01139125|654733|P1|STARTED|Overall Study||3
271194|NCT01139164|654740|P3|NOT COMPLETED|Overall Study||0
271195|NCT01139164|654741|P2|NOT COMPLETED|Overall Study||2
271196|NCT01139164|654742|P1|NOT COMPLETED|Overall Study||0
271197|NCT01139164|654740|P3|COMPLETED|Overall Study||7
271198|NCT01139164|654741|P2|COMPLETED|Overall Study||65
271199|NCT01139164|654742|P1|COMPLETED|Overall Study||4
271200|NCT01139164|654740|P3|STARTED|Overall Study||7
271201|NCT01139164|654741|P2|STARTED|Overall Study||67
271202|NCT01139164|654742|P1|STARTED|Overall Study||4
271203|NCT01139190|654758|P2|NOT COMPLETED|Overall Study||1
271204|NCT01139190|654759|P1|NOT COMPLETED|Overall Study||0
271205|NCT01139190|654758|P2|COMPLETED|Overall Study||38
271206|NCT01139190|654759|P1|COMPLETED|Overall Study||38
271207|NCT01139190|654758|P2|STARTED|Overall Study||39
271208|NCT01139190|654759|P1|STARTED|Overall Study||38
271209|NCT01139294|654767|P2|NOT COMPLETED|Overall Study||0
271210|NCT01139294|654768|P1|NOT COMPLETED|Overall Study||0
271211|NCT01139294|654767|P2|COMPLETED|Overall Study||0
271212|NCT01139294|654768|P1|COMPLETED|Overall Study||0
271213|NCT01139294|654767|P2|STARTED|Overall Study||0
271214|NCT01139294|654768|P1|STARTED|Overall Study||0
271215|NCT01139411|654778|P2|NOT COMPLETED|Overall Study||4
271216|NCT01139411|654779|P1|NOT COMPLETED|Overall Study||2
271217|NCT01139411|654778|P2|COMPLETED|Overall Study||19
271218|NCT01139411|654779|P1|COMPLETED|Overall Study||24
271219|NCT01139411|654778|P2|STARTED|Overall Study||23
271220|NCT01139411|654779|P1|STARTED|Overall Study||26
271221|NCT01139450|654800|P3|NOT COMPLETED|Overall Study||38
271222|NCT01139450|654801|P2|NOT COMPLETED|Overall Study||25
271223|NCT01139450|654802|P1|NOT COMPLETED|Overall Study||27
271224|NCT01139450|654800|P3|COMPLETED|Overall Study||262
271225|NCT01139450|654801|P2|COMPLETED|Overall Study||272
271226|NCT01139450|654802|P1|COMPLETED|Overall Study||275
271227|NCT01139450|654800|P3|STARTED|Overall Study||300
271228|NCT01139450|654801|P2|STARTED|Overall Study||297
271229|NCT01139450|654802|P1|STARTED|Overall Study||302
271230|NCT01139515|654810|P4|NOT COMPLETED|Fourth Intervention Period||0
271231|NCT01139515|654811|P3|NOT COMPLETED|Fourth Intervention Period||0
271232|NCT01139515|654812|P2|NOT COMPLETED|Fourth Intervention Period||0
271233|NCT01139515|654813|P1|NOT COMPLETED|Fourth Intervention Period||0
271234|NCT01139515|654810|P4|COMPLETED|Fourth Intervention Period||4
271235|NCT01139515|654811|P3|COMPLETED|Fourth Intervention Period||4
271236|NCT01139515|654812|P2|COMPLETED|Fourth Intervention Period||4
271237|NCT01139515|654813|P1|COMPLETED|Fourth Intervention Period||4
271238|NCT01139515|654810|P4|STARTED|Fourth Intervention Period||4
271239|NCT01139515|654811|P3|STARTED|Fourth Intervention Period||4
271240|NCT01139515|654812|P2|STARTED|Fourth Intervention Period||4
271241|NCT01139515|654813|P1|STARTED|Fourth Intervention Period||4
271242|NCT01139515|654810|P4|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
271243|NCT01139515|654811|P3|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
271244|NCT01139515|654812|P2|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
271245|NCT01139515|654813|P1|NOT COMPLETED|Washout Period 3 (46 Hrs)||0
271246|NCT01139515|654810|P4|COMPLETED|Washout Period 3 (46 Hrs)||4
271247|NCT01139515|654811|P3|COMPLETED|Washout Period 3 (46 Hrs)||4
271248|NCT01139515|654812|P2|COMPLETED|Washout Period 3 (46 Hrs)||4
271249|NCT01139515|654813|P1|COMPLETED|Washout Period 3 (46 Hrs)||4
271250|NCT01139515|654810|P4|STARTED|Washout Period 3 (46 Hrs)||4
271251|NCT01139515|654811|P3|STARTED|Washout Period 3 (46 Hrs)||4
271252|NCT01139515|654812|P2|STARTED|Washout Period 3 (46 Hrs)||4
271253|NCT01139515|654813|P1|STARTED|Washout Period 3 (46 Hrs)||4
271254|NCT01139515|654810|P4|NOT COMPLETED|Third Intervention Period||0
271255|NCT01139515|654811|P3|NOT COMPLETED|Third Intervention Period||0
271256|NCT01139515|654812|P2|NOT COMPLETED|Third Intervention Period||0
271257|NCT01139515|654813|P1|NOT COMPLETED|Third Intervention Period||0
271258|NCT01139515|654810|P4|COMPLETED|Third Intervention Period||4
271259|NCT01139515|654811|P3|COMPLETED|Third Intervention Period||4
271260|NCT01139515|654812|P2|COMPLETED|Third Intervention Period||4
271261|NCT01139515|654813|P1|COMPLETED|Third Intervention Period||4
271262|NCT01139515|654810|P4|STARTED|Third Intervention Period||4
271263|NCT01139515|654811|P3|STARTED|Third Intervention Period||4
271264|NCT01139515|654812|P2|STARTED|Third Intervention Period||4
271265|NCT01139515|654813|P1|STARTED|Third Intervention Period||4
271266|NCT01139515|654810|P4|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
271267|NCT01139515|654811|P3|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
271268|NCT01139515|654812|P2|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
271269|NCT01139515|654813|P1|NOT COMPLETED|Washout Period 2 (46 Hrs)||0
271270|NCT01139515|654810|P4|COMPLETED|Washout Period 2 (46 Hrs)||4
271271|NCT01139515|654811|P3|COMPLETED|Washout Period 2 (46 Hrs)||4
271272|NCT01139515|654812|P2|COMPLETED|Washout Period 2 (46 Hrs)||4
271273|NCT01139515|654813|P1|COMPLETED|Washout Period 2 (46 Hrs)||4
271274|NCT01139515|654810|P4|STARTED|Washout Period 2 (46 Hrs)||4
271275|NCT01139515|654811|P3|STARTED|Washout Period 2 (46 Hrs)||4
271276|NCT01139515|654812|P2|STARTED|Washout Period 2 (46 Hrs)||4
271277|NCT01139515|654813|P1|STARTED|Washout Period 2 (46 Hrs)||4
271278|NCT01139515|654810|P4|NOT COMPLETED|Second Intervention Period||0
271279|NCT01139515|654811|P3|NOT COMPLETED|Second Intervention Period||0
271280|NCT01139515|654812|P2|NOT COMPLETED|Second Intervention Period||0
271281|NCT01139515|654813|P1|NOT COMPLETED|Second Intervention Period||0
271282|NCT01139515|654810|P4|COMPLETED|Second Intervention Period||4
271283|NCT01139515|654811|P3|COMPLETED|Second Intervention Period||4
271284|NCT01139515|654812|P2|COMPLETED|Second Intervention Period||4
271285|NCT01139515|654813|P1|COMPLETED|Second Intervention Period||4
271286|NCT01139515|654810|P4|STARTED|Second Intervention Period||4
271287|NCT01139515|654811|P3|STARTED|Second Intervention Period||4
271288|NCT01139515|654812|P2|STARTED|Second Intervention Period||4
271289|NCT01139515|654813|P1|STARTED|Second Intervention Period||4
271290|NCT01139515|654810|P4|NOT COMPLETED|Washout Period I (46hrs)||0
271291|NCT01139515|654811|P3|NOT COMPLETED|Washout Period I (46hrs)||0
271292|NCT01139515|654812|P2|NOT COMPLETED|Washout Period I (46hrs)||0
271293|NCT01139515|654813|P1|NOT COMPLETED|Washout Period I (46hrs)||0
271294|NCT01139515|654810|P4|COMPLETED|Washout Period I (46hrs)||4
271295|NCT01139515|654811|P3|COMPLETED|Washout Period I (46hrs)||4
271296|NCT01139515|654812|P2|COMPLETED|Washout Period I (46hrs)||4
271297|NCT01139515|654813|P1|COMPLETED|Washout Period I (46hrs)||4
271298|NCT01139515|654810|P4|STARTED|Washout Period I (46hrs)||4
271299|NCT01139515|654811|P3|STARTED|Washout Period I (46hrs)||4
271300|NCT01139515|654812|P2|STARTED|Washout Period I (46hrs)||4
271301|NCT01139515|654813|P1|STARTED|Washout Period I (46hrs)||4
271302|NCT01139515|654810|P4|NOT COMPLETED|First Intervention Period||0
271303|NCT01139515|654811|P3|NOT COMPLETED|First Intervention Period||0
271304|NCT01139515|654812|P2|NOT COMPLETED|First Intervention Period||0
271305|NCT01139515|654813|P1|NOT COMPLETED|First Intervention Period||0
271306|NCT01139515|654810|P4|COMPLETED|First Intervention Period||4
271307|NCT01139515|654811|P3|COMPLETED|First Intervention Period||4
271308|NCT01139515|654812|P2|COMPLETED|First Intervention Period||4
271309|NCT01139515|654813|P1|COMPLETED|First Intervention Period||4
271310|NCT01139515|654810|P4|STARTED|First Intervention Period||4
271311|NCT01139515|654811|P3|STARTED|First Intervention Period||4
271312|NCT01139515|654812|P2|STARTED|First Intervention Period||4
271313|NCT01139515|654813|P1|STARTED|First Intervention Period||4
271314|NCT01139580|654841|P2|NOT COMPLETED|Overall Study||18
271315|NCT01139580|654842|P1|NOT COMPLETED|Overall Study||23
271316|NCT01139580|654841|P2|COMPLETED|Overall Study||164
271317|NCT01139580|654842|P1|COMPLETED|Overall Study||158
271318|NCT01139580|654841|P2|STARTED|Overall Study||182
271319|NCT01139580|654842|P1|STARTED|Overall Study||181
271320|NCT01139658|654860|P2|NOT COMPLETED|Overall Study||113
271321|NCT01139658|654861|P1|NOT COMPLETED|Overall Study||56
271322|NCT01139658|654860|P2|COMPLETED|Overall Study||816
271323|NCT01139658|654861|P1|COMPLETED|Overall Study||691
271324|NCT01139658|654860|P2|STARTED|Overall Study||929
271325|NCT01139658|654861|P1|STARTED|Overall Study||747
271326|NCT01139762|654899|P3|NOT COMPLETED|Double-Blind Randomized Active Treatment||64
271327|NCT01139762|654900|P2|NOT COMPLETED|Double-Blind Randomized Active Treatment||40
271328|NCT01139762|654901|P1|NOT COMPLETED|Double-Blind Randomized Active Treatment||0
271329|NCT01139762|654899|P3|COMPLETED|Double-Blind Randomized Active Treatment||286
271330|NCT01139762|654900|P2|COMPLETED|Double-Blind Randomized Active Treatment||306
271331|NCT01139762|654901|P1|COMPLETED|Double-Blind Randomized Active Treatment||0
271332|NCT01139762|654899|P3|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||350
271333|NCT01139762|654900|P2|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||345
271334|NCT01139762|654901|P1|Received at Least 1 Dose of Study Drug|Double-Blind Randomized Active Treatment||0
271335|NCT01139762|654899|P3|STARTED|Double-Blind Randomized Active Treatment||350
271336|NCT01139762|654900|P2|STARTED|Double-Blind Randomized Active Treatment||346
271337|NCT01139762|654901|P1|STARTED|Double-Blind Randomized Active Treatment||0
271338|NCT01139762|654899|P3|NOT COMPLETED|Washout and Placebo Lead-In Period||0
271339|NCT01139762|654900|P2|NOT COMPLETED|Washout and Placebo Lead-In Period||0
271340|NCT01139762|654901|P1|NOT COMPLETED|Washout and Placebo Lead-In Period||374
271341|NCT01139762|654899|P3|COMPLETED|Washout and Placebo Lead-In Period||0
271342|NCT01139762|654900|P2|COMPLETED|Washout and Placebo Lead-In Period||0
271343|NCT01139762|654901|P1|COMPLETED|Washout and Placebo Lead-In Period||696
271344|NCT01139762|654899|P3|STARTED|Washout and Placebo Lead-In Period||0
271345|NCT01139762|654900|P2|STARTED|Washout and Placebo Lead-In Period||0
271346|NCT01139762|654901|P1|STARTED|Washout and Placebo Lead-In Period||1070
271347|NCT01139814|654934|P1|NOT COMPLETED|Overall Study||0
271348|NCT01139814|654934|P1|COMPLETED|Overall Study||181
271349|NCT01139814|654934|P1|STARTED|Overall Study||181
271350|NCT01139879|654939|P1|NOT COMPLETED|Overall Study||0
271351|NCT01139879|654939|P1|COMPLETED|Overall Study||10
271352|NCT01139879|654939|P1|STARTED|Overall Study||10
271353|NCT01133626|654948|P3|NOT COMPLETED|Overall Study||2
271354|NCT01133626|654949|P2|NOT COMPLETED|Overall Study||5
271355|NCT01133626|654950|P1|NOT COMPLETED|Overall Study||1
271356|NCT01133626|654948|P3|COMPLETED|Overall Study||9
271357|NCT01133626|654949|P2|COMPLETED|Overall Study||41
271358|NCT01133626|654950|P1|COMPLETED|Overall Study||49
271359|NCT01133626|654948|P3|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|9
271360|NCT01133626|654949|P2|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|41
271361|NCT01133626|654950|P1|Per Protocol Population|Overall Study|Received >=1 dose of study drug and >=1 post-baseline assessment prior to major protocol deviation.|48
271362|NCT01133626|654948|P3|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|11
271363|NCT01133626|654949|P2|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|46
271364|NCT01133626|654950|P1|Safety Population|Overall Study|Participants who received at least 1 dose of study drug|50
271365|NCT01133626|654948|P3|STARTED|Overall Study||11
271366|NCT01133626|654949|P2|STARTED|Overall Study||46
271367|NCT01133626|654950|P1|STARTED|Overall Study||50
271368|NCT01133665|654958|P1|NOT COMPLETED|Overall Study||2
271369|NCT01133665|654958|P1|COMPLETED|Overall Study||40
271370|NCT01133665|654958|P1|STARTED|Overall Study||42
271371|NCT01133704|655001|P2|NOT COMPLETED|Overall Study||26
271372|NCT01133704|655002|P1|NOT COMPLETED|Overall Study||49
271373|NCT01133704|655001|P2|COMPLETED|Overall Study|(including 3 year follow-up)|7
271374|NCT01133704|655002|P1|COMPLETED|Overall Study|(including 3 year follow-up)|16
271375|NCT01133704|655001|P2|STARTED|Overall Study||33
271376|NCT01133704|655002|P1|STARTED|Overall Study||65
271377|NCT01133756|655013|P3|NOT COMPLETED|Overall Study||2
271378|NCT01133756|655014|P2|NOT COMPLETED|Overall Study||3
271379|NCT01133756|655015|P1|NOT COMPLETED|Overall Study||2
271380|NCT01133756|655013|P3|COMPLETED|Overall Study||0
271381|NCT01133756|655014|P2|COMPLETED|Overall Study||0
271382|NCT01133756|655015|P1|COMPLETED|Overall Study||0
271383|NCT01133756|655013|P3|Completed 6 Cycles|Overall Study||0
271384|NCT01133756|655014|P2|Completed 6 Cycles|Overall Study||0
271385|NCT01133756|655015|P1|Completed 6 Cycles|Overall Study|One participant completed 6 cycles and remained in the study until 18 Sep 2012.|1
271386|NCT01133756|655013|P3|STARTED|Overall Study||2
271387|NCT01133756|655014|P2|STARTED|Overall Study||3
271388|NCT01133756|655015|P1|STARTED|Overall Study||2
271389|NCT01133821|655031|P2|NOT COMPLETED|Overall Study||19
271390|NCT01133821|655032|P1|NOT COMPLETED|Overall Study||18
271391|NCT01133821|655031|P2|COMPLETED|Overall Study||28
271392|NCT01133821|655032|P1|COMPLETED|Overall Study||27
271393|NCT01133821|655031|P2|STARTED|Overall Study||47
271394|NCT01133821|655032|P1|STARTED|Overall Study||45
271395|NCT01133847|655041|P3|NOT COMPLETED|Follow-Up Phase||7
271396|NCT01133847|655042|P2|NOT COMPLETED|Follow-Up Phase||3
271397|NCT01133847|655043|P1|NOT COMPLETED|Follow-Up Phase||1
271398|NCT01133847|655041|P3|COMPLETED|Follow-Up Phase||60
271399|NCT01133847|655042|P2|COMPLETED|Follow-Up Phase||70
271400|NCT01133847|655043|P1|COMPLETED|Follow-Up Phase||72
271401|NCT01133847|655041|P3|STARTED|Follow-Up Phase||67
271402|NCT01133847|655042|P2|STARTED|Follow-Up Phase||73
271403|NCT01133847|655043|P1|STARTED|Follow-Up Phase||73
271404|NCT01133847|655041|P3|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||3
271405|NCT01133847|655042|P2|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||1
271406|NCT01133847|655043|P1|NOT COMPLETED|Active Treatment Phase (Weeks 1-16)||5
271407|NCT01133847|655041|P3|COMPLETED|Active Treatment Phase (Weeks 1-16)||67
271408|NCT01133847|655042|P2|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
271409|NCT01133847|655043|P1|COMPLETED|Active Treatment Phase (Weeks 1-16)||73
271410|NCT01133847|655041|P3|STARTED|Active Treatment Phase (Weeks 1-16)||70
271411|NCT01133847|655042|P2|STARTED|Active Treatment Phase (Weeks 1-16)||74
271412|NCT01133847|655043|P1|STARTED|Active Treatment Phase (Weeks 1-16)||78
271413|NCT01133860|655081|P1|NOT COMPLETED|Overall Study||0
271414|NCT01133860|655081|P1|COMPLETED|Overall Study||12
271415|NCT01133860|655081|P1|STARTED|Overall Study||12
271416|NCT01133977|655093|P5|NOT COMPLETED|Overall Study||38
271417|NCT01133977|655094|P4|NOT COMPLETED|Overall Study||39
271418|NCT01133977|655095|P3|NOT COMPLETED|Overall Study||6
271419|NCT01133977|655096|P2|NOT COMPLETED|Overall Study||7
271420|NCT01133977|655097|P1|NOT COMPLETED|Overall Study||3
271421|NCT01133977|655093|P5|COMPLETED|Overall Study||1
271422|NCT01133977|655094|P4|COMPLETED|Overall Study||3
271423|NCT01133977|655095|P3|COMPLETED|Overall Study||0
271424|NCT01133977|655096|P2|COMPLETED|Overall Study||0
271425|NCT01133977|655097|P1|COMPLETED|Overall Study||0
271426|NCT01133977|655093|P5|STARTED|Overall Study|Treated|39
271427|NCT01133977|655094|P4|STARTED|Overall Study|Treated|42
271428|NCT01133977|655095|P3|STARTED|Overall Study|Treated|6
271429|NCT01133977|655096|P2|STARTED|Overall Study|Treated|7
271430|NCT01133977|655097|P1|STARTED|Overall Study|Treated|3
271431|NCT01134016|655114|P1|NOT COMPLETED|Overall Study||3
271432|NCT01134016|655114|P1|COMPLETED|Overall Study||10
271433|NCT01134016|655114|P1|STARTED|Overall Study||13
271434|NCT01139996|655149|P2|NOT COMPLETED|Overall Study||0
271435|NCT01139996|655150|P1|NOT COMPLETED|Overall Study||0
271436|NCT01139996|655149|P2|COMPLETED|Overall Study||11
271437|NCT01139996|655150|P1|COMPLETED|Overall Study||11
271438|NCT01139996|655149|P2|STARTED|Overall Study||11
271439|NCT01139996|655150|P1|STARTED|Overall Study||11
271440|NCT01140048|655156|P1|NOT COMPLETED|Overall Study||45
271441|NCT01140048|655156|P1|COMPLETED|Overall Study||298
271442|NCT01140048|655156|P1|STARTED|Overall Study||343
271443|NCT01140061|655172|P10|NOT COMPLETED|Extension||1
271444|NCT01140061|655173|P9|NOT COMPLETED|Extension||0
271445|NCT01140061|655174|P8|NOT COMPLETED|Extension||0
271446|NCT01140061|655175|P7|NOT COMPLETED|Extension||0
271447|NCT01140061|655176|P6|NOT COMPLETED|Extension||0
271448|NCT01140061|655177|P5|NOT COMPLETED|Extension||0
271449|NCT01140061|655178|P4|NOT COMPLETED|Extension||0
271450|NCT01140061|655179|P3|NOT COMPLETED|Extension||0
271451|NCT01140061|655180|P2|NOT COMPLETED|Extension||0
271452|NCT01140061|655181|P1|NOT COMPLETED|Extension||0
271453|NCT01140061|655172|P10|COMPLETED|Extension||1
271454|NCT01140061|655173|P9|COMPLETED|Extension||7
271455|NCT01140061|655174|P8|COMPLETED|Extension||0
271456|NCT01140061|655175|P7|COMPLETED|Extension||0
271457|NCT01140061|655176|P6|COMPLETED|Extension||0
271458|NCT01140061|655177|P5|COMPLETED|Extension||0
271459|NCT01140061|655178|P4|COMPLETED|Extension||0
271460|NCT01140061|655179|P3|COMPLETED|Extension||0
271461|NCT01140061|655180|P2|COMPLETED|Extension||0
271462|NCT01140061|655181|P1|COMPLETED|Extension||0
271463|NCT01140061|655172|P10|STARTED|Extension||2
271464|NCT01140061|655173|P9|STARTED|Extension||7
271465|NCT01140061|655174|P8|STARTED|Extension||0
271466|NCT01140061|655175|P7|STARTED|Extension||0
271467|NCT01140061|655176|P6|STARTED|Extension||0
271468|NCT01140061|655177|P5|STARTED|Extension||0
271469|NCT01140061|655178|P4|STARTED|Extension||0
271470|NCT01140061|655179|P3|STARTED|Extension||0
271471|NCT01140061|655180|P2|STARTED|Extension||0
271472|NCT01140061|655181|P1|STARTED|Extension||0
271473|NCT01140061|655172|P10|NOT COMPLETED|Part III||0
271474|NCT01140061|655173|P9|NOT COMPLETED|Part III||0
271475|NCT01140061|655174|P8|NOT COMPLETED|Part III||0
271476|NCT01140061|655175|P7|NOT COMPLETED|Part III||0
271477|NCT01140061|655176|P6|NOT COMPLETED|Part III||0
271478|NCT01140061|655177|P5|NOT COMPLETED|Part III||0
271479|NCT01140061|655178|P4|NOT COMPLETED|Part III||0
271480|NCT01140061|655179|P3|NOT COMPLETED|Part III||0
271481|NCT01140061|655180|P2|NOT COMPLETED|Part III||0
271482|NCT01140061|655181|P1|NOT COMPLETED|Part III||0
271483|NCT01140061|655172|P10|COMPLETED|Part III||2
271484|NCT01140061|655173|P9|COMPLETED|Part III||7
271485|NCT01140061|655174|P8|COMPLETED|Part III||0
271486|NCT01140061|655175|P7|COMPLETED|Part III||0
271487|NCT01140061|655176|P6|COMPLETED|Part III||0
271488|NCT01140061|655177|P5|COMPLETED|Part III||0
271489|NCT01140061|655178|P4|COMPLETED|Part III||0
271490|NCT01140061|655179|P3|COMPLETED|Part III||0
271491|NCT01140061|655180|P2|COMPLETED|Part III||0
271492|NCT01140061|655181|P1|COMPLETED|Part III||0
271493|NCT01140061|655172|P10|STARTED|Part III|Includes 1 replacement participant|2
271494|NCT01140061|655173|P9|STARTED|Part III||7
271495|NCT01140061|655174|P8|STARTED|Part III||0
271496|NCT01140061|655175|P7|STARTED|Part III||0
271497|NCT01140061|655176|P6|STARTED|Part III||0
271498|NCT01140061|655177|P5|STARTED|Part III||0
271499|NCT01140061|655178|P4|STARTED|Part III||0
271500|NCT01140061|655179|P3|STARTED|Part III||0
271501|NCT01140061|655180|P2|STARTED|Part III||0
271502|NCT01140061|655181|P1|STARTED|Part III||0
271503|NCT01140061|655172|P10|NOT COMPLETED|Part II||0
271504|NCT01140061|655173|P9|NOT COMPLETED|Part II||0
271505|NCT01140061|655174|P8|NOT COMPLETED|Part II||0
271506|NCT01140061|655175|P7|NOT COMPLETED|Part II||0
271507|NCT01140061|655176|P6|NOT COMPLETED|Part II||0
271508|NCT01140061|655177|P5|NOT COMPLETED|Part II||0
271509|NCT01140061|655178|P4|NOT COMPLETED|Part II||0
271510|NCT01140061|655179|P3|NOT COMPLETED|Part II||0
271511|NCT01140061|655180|P2|NOT COMPLETED|Part II||0
271512|NCT01140061|655181|P1|NOT COMPLETED|Part II||0
271513|NCT01140061|655172|P10|COMPLETED|Part II||0
271514|NCT01140061|655173|P9|COMPLETED|Part II||0
271515|NCT01140061|655174|P8|COMPLETED|Part II||2
271516|NCT01140061|655175|P7|COMPLETED|Part II||6
271517|NCT01140061|655176|P6|COMPLETED|Part II||2
271518|NCT01140061|655177|P5|COMPLETED|Part II||6
271519|NCT01140061|655178|P4|COMPLETED|Part II||2
271520|NCT01140061|655179|P3|COMPLETED|Part II||6
271521|NCT01140061|655180|P2|COMPLETED|Part II||0
271522|NCT01140061|655181|P1|COMPLETED|Part II||0
271523|NCT01140061|655172|P10|STARTED|Part II||0
271524|NCT01140061|655173|P9|STARTED|Part II||0
271525|NCT01140061|655174|P8|STARTED|Part II||2
271526|NCT01140061|655175|P7|STARTED|Part II||6
271527|NCT01140061|655176|P6|STARTED|Part II||2
271528|NCT01140061|655177|P5|STARTED|Part II||6
271529|NCT01140061|655178|P4|STARTED|Part II||2
271530|NCT01140061|655179|P3|STARTED|Part II||6
271531|NCT01140061|655180|P2|STARTED|Part II||0
271532|NCT01140061|655181|P1|STARTED|Part II||0
271533|NCT01140061|655172|P10|NOT COMPLETED|Part I||0
271534|NCT01140061|655173|P9|NOT COMPLETED|Part I||0
271535|NCT01140061|655174|P8|NOT COMPLETED|Part I||0
271536|NCT01140061|655175|P7|NOT COMPLETED|Part I||0
271537|NCT01140061|655176|P6|NOT COMPLETED|Part I||0
271538|NCT01140061|655177|P5|NOT COMPLETED|Part I||0
271539|NCT01140061|655178|P4|NOT COMPLETED|Part I||0
271540|NCT01140061|655179|P3|NOT COMPLETED|Part I||0
271541|NCT01140061|655180|P2|NOT COMPLETED|Part I||0
271542|NCT01140061|655181|P1|NOT COMPLETED|Part I||1
271543|NCT01140061|655172|P10|COMPLETED|Part I||0
271544|NCT01140061|655173|P9|COMPLETED|Part I||0
271545|NCT01140061|655174|P8|COMPLETED|Part I||0
271546|NCT01140061|655175|P7|COMPLETED|Part I||0
271547|NCT01140061|655176|P6|COMPLETED|Part I||0
271548|NCT01140061|655177|P5|COMPLETED|Part I||0
271549|NCT01140061|655178|P4|COMPLETED|Part I||0
271550|NCT01140061|655179|P3|COMPLETED|Part I||0
271551|NCT01140061|655180|P2|COMPLETED|Part I||2
271552|NCT01140061|655181|P1|COMPLETED|Part I||6
271553|NCT01140061|655172|P10|STARTED|Part I||0
271554|NCT01140061|655173|P9|STARTED|Part I||0
271555|NCT01140061|655174|P8|STARTED|Part I||0
271556|NCT01140061|655175|P7|STARTED|Part I||0
271557|NCT01140061|655176|P6|STARTED|Part I||0
271558|NCT01140061|655177|P5|STARTED|Part I||0
271559|NCT01140061|655178|P4|STARTED|Part I||0
271560|NCT01140061|655179|P3|STARTED|Part I||0
271561|NCT01140061|655180|P2|STARTED|Part I||2
271562|NCT01140061|655181|P1|STARTED|Part I|Includes 1 replacement participant|7
271563|NCT01140191|655208|P1|NOT COMPLETED|Overall Study||0
271564|NCT01140191|655208|P1|COMPLETED|Overall Study||1
271565|NCT01140191|655208|P1|STARTED|Overall Study||1
271566|NCT01140295|655219|P2|NOT COMPLETED|Overall Study||2
271567|NCT01140295|655220|P1|NOT COMPLETED|Overall Study||1
271568|NCT01140295|655219|P2|COMPLETED|Overall Study||14
271569|NCT01140295|655220|P1|COMPLETED|Overall Study||16
271570|NCT01140295|655219|P2|STARTED|Overall Study||16
271571|NCT01140295|655220|P1|STARTED|Overall Study||17
271572|NCT01140477|655230|P2|NOT COMPLETED|Overall Study||6
271573|NCT01140477|655231|P1|NOT COMPLETED|Overall Study||8
271574|NCT01140477|655230|P2|COMPLETED|Overall Study||70
271575|NCT01140477|655231|P1|COMPLETED|Overall Study||145
271576|NCT01140477|655230|P2|STARTED|Overall Study||76
271577|NCT01140477|655231|P1|STARTED|Overall Study||153
271578|NCT01140503|655240|P1|NOT COMPLETED|Overall Study||1
271579|NCT01140503|655240|P1|COMPLETED|Overall Study||4
271580|NCT01140503|655240|P1|STARTED|Overall Study||5
271581|NCT01140646|655246|P1|NOT COMPLETED|Overall Study||9
271582|NCT01140646|655246|P1|COMPLETED|Overall Study||34
271583|NCT01140646|655246|P1|STARTED|Overall Study||43
271584|NCT01140815|655252|P2|NOT COMPLETED|Overall Study||0
271585|NCT01140815|655253|P1|NOT COMPLETED|Overall Study||0
271586|NCT01140815|655252|P2|COMPLETED|Overall Study||25
271587|NCT01140815|655253|P1|COMPLETED|Overall Study||25
271588|NCT01140815|655252|P2|STARTED|Overall Study||25
271589|NCT01140815|655253|P1|STARTED|Overall Study||25
271590|NCT01140867|655283|P1|NOT COMPLETED|Overall Study||33
271591|NCT01140867|655283|P1|COMPLETED|Overall Study||88
271592|NCT01140867|655283|P1|STARTED|Overall Study||121
271593|NCT01140880|655292|P2|NOT COMPLETED|Overall Study||44
271594|NCT01140880|655293|P1|NOT COMPLETED|Overall Study||14
271595|NCT01140880|655292|P2|COMPLETED|Overall Study||56
271596|NCT01140880|655293|P1|COMPLETED|Overall Study||56
271597|NCT01140880|655292|P2|STARTED|Overall Study||100
271598|NCT01140880|655293|P1|STARTED|Overall Study||70
271599|NCT01140906|655309|P4|NOT COMPLETED|Overall Study||16
271600|NCT01140906|655310|P3|NOT COMPLETED|Overall Study||26
271601|NCT01140906|655311|P2|NOT COMPLETED|Overall Study||34
271602|NCT01140906|655312|P1|NOT COMPLETED|Overall Study||25
271603|NCT01140906|655309|P4|COMPLETED|Overall Study||131
271604|NCT01140906|655310|P3|COMPLETED|Overall Study||125
271605|NCT01140906|655311|P2|COMPLETED|Overall Study||117
271606|NCT01140906|655312|P1|COMPLETED|Overall Study||133
271607|NCT01140906|655309|P4|STARTED|Overall Study||147
271608|NCT01140906|655310|P3|STARTED|Overall Study||151
271609|NCT01140906|655311|P2|STARTED|Overall Study||151
271610|NCT01140906|655312|P1|STARTED|Overall Study||158
271611|NCT01141205|655352|P2|NOT COMPLETED|Overall Study||2
271612|NCT01141205|655353|P1|NOT COMPLETED|Overall Study||3
271613|NCT01141205|655352|P2|COMPLETED|Overall Study||3
271614|NCT01141205|655353|P1|COMPLETED|Overall Study||15
271615|NCT01141205|655352|P2|STARTED|Overall Study||5
271616|NCT01141205|655353|P1|STARTED|Overall Study||18
271617|NCT01141283|655365|P1|NOT COMPLETED|Overall Study||88
271618|NCT01141283|655365|P1|COMPLETED|Overall Study||202
271619|NCT01141283|655365|P1|STARTED|Overall Study||290
271620|NCT01141374|655372|P3|NOT COMPLETED|Overall Study||0
271621|NCT01141374|655373|P2|NOT COMPLETED|Overall Study||0
271622|NCT01141374|655374|P1|NOT COMPLETED|Overall Study||0
271623|NCT01141374|655372|P3|COMPLETED|Overall Study||22
271624|NCT01141374|655373|P2|COMPLETED|Overall Study||27
271625|NCT01141374|655374|P1|COMPLETED|Overall Study||26
271626|NCT01141374|655372|P3|STARTED|Overall Study||22
271627|NCT01141374|655373|P2|STARTED|Overall Study||27
271628|NCT01141374|655374|P1|STARTED|Overall Study||26
271629|NCT01141491|655387|P2|NOT COMPLETED|Overall Study||47
271630|NCT01141491|655388|P1|NOT COMPLETED|Overall Study||48
271631|NCT01141491|655387|P2|COMPLETED|Overall Study||21
271632|NCT01141491|655388|P1|COMPLETED|Overall Study||20
271633|NCT01141491|655387|P2|STARTED|Overall Study||68
271634|NCT01141491|655388|P1|STARTED|Overall Study||68
271635|NCT01141569|655394|P1|NOT COMPLETED|Overall Study||0
271636|NCT01141569|655394|P1|COMPLETED|Overall Study||12
271637|NCT01141569|655394|P1|STARTED|Overall Study||12
271638|NCT01141595|655403|P1|NOT COMPLETED|Overall Study||2
271639|NCT01141595|655403|P1|COMPLETED|Overall Study||8
271640|NCT01141595|655403|P1|STARTED|Overall Study||10
271641|NCT01141647|655407|P1|NOT COMPLETED|Overall Study||46
271642|NCT01141647|655407|P1|COMPLETED|Overall Study||167
271643|NCT01141647|655407|P1|STARTED|Overall Study||213
271644|NCT01141660|655422|P2|NOT COMPLETED|Overall Study||12
271645|NCT01141660|655423|P1|NOT COMPLETED|Overall Study||0
271646|NCT01141660|655422|P2|COMPLETED|Overall Study||48
271647|NCT01141660|655423|P1|COMPLETED|Overall Study||71
271648|NCT01141660|655422|P2|STARTED|Overall Study||60
271649|NCT01141660|655423|P1|STARTED|Overall Study||71
271650|NCT01141712|655429|P1|NOT COMPLETED|Overall Study||3
271651|NCT01141712|655429|P1|COMPLETED|Overall Study||40
271652|NCT01141712|655429|P1|STARTED|Overall Study||43
271653|NCT01141725|655448|P3|NOT COMPLETED|Overall Study||0
271654|NCT01141725|655449|P2|NOT COMPLETED|Overall Study||0
271655|NCT01141725|655450|P1|NOT COMPLETED|Overall Study||0
271656|NCT01141725|655448|P3|COMPLETED|Overall Study||3
271657|NCT01141725|655449|P2|COMPLETED|Overall Study||33
271658|NCT01141725|655450|P1|COMPLETED|Overall Study||3
271659|NCT01141725|655448|P3|STARTED|Overall Study||3
271660|NCT01141725|655449|P2|STARTED|Overall Study||33
271661|NCT01141725|655450|P1|STARTED|Overall Study||3
271662|NCT01142115|655462|P2|NOT COMPLETED|Second Intervention||0
271663|NCT01142115|655463|P1|NOT COMPLETED|Second Intervention||0
271664|NCT01142115|655462|P2|COMPLETED|Second Intervention||19
271665|NCT01142115|655463|P1|COMPLETED|Second Intervention||19
271666|NCT01142115|655462|P2|STARTED|Second Intervention||19
271667|NCT01142115|655463|P1|STARTED|Second Intervention||19
271668|NCT01142115|655462|P2|NOT COMPLETED|First Intervention||1
271669|NCT01142115|655463|P1|NOT COMPLETED|First Intervention||2
271670|NCT01142115|655462|P2|COMPLETED|First Intervention||19
271671|NCT01142115|655463|P1|COMPLETED|First Intervention||19
271672|NCT01142115|655462|P2|STARTED|First Intervention||20
271673|NCT01142115|655463|P1|STARTED|First Intervention||21
271674|NCT01142128|655482|P1|NOT COMPLETED|Overall Study||4
271675|NCT01142128|655482|P1|COMPLETED|Overall Study||4
271676|NCT01142128|655482|P1|Viokase 16 Plus Placebo to Nexium|Overall Study||0
271677|NCT01142128|655482|P1|Viokase 16 Plus Nexium|Overall Study||2
271678|NCT01142128|655482|P1|Placebo to Nexium, Alone|Overall Study||3
271679|NCT01142128|655482|P1|Nexium Alone|Overall Study||3
271680|NCT01142128|655482|P1|STARTED|Overall Study||8
271681|NCT01142193|655494|P2|NOT COMPLETED|Overall Study||11
271682|NCT01142193|655495|P1|NOT COMPLETED|Overall Study||21
271683|NCT01142193|655494|P2|COMPLETED|Overall Study||114
271684|NCT01142193|655495|P1|COMPLETED|Overall Study||103
271685|NCT01142193|655494|P2|STARTED|Overall Study||125
271686|NCT01142193|655495|P1|STARTED|Overall Study||124
271687|NCT01142297|655519|P1|NOT COMPLETED|Overall Study||6
271688|NCT01142297|655519|P1|COMPLETED|Overall Study||18
271689|NCT01142297|655519|P1|STARTED|Overall Study||24
271690|NCT01142323|655525|P1|NOT COMPLETED|Overall Study||0
271691|NCT01142323|655525|P1|COMPLETED|Overall Study||8
271692|NCT01142323|655525|P1|STARTED|Overall Study||8
271693|NCT01142336|655532|P2|NOT COMPLETED|Overall Study||2
271694|NCT01142336|655533|P1|NOT COMPLETED|Overall Study||1
271695|NCT01142336|655532|P2|COMPLETED|Overall Study||21
271696|NCT01142336|655533|P1|COMPLETED|Overall Study||25
271697|NCT01142336|655532|P2|STARTED|Overall Study||23
271698|NCT01142336|655533|P1|STARTED|Overall Study||26
271699|NCT01142388|655545|P2|NOT COMPLETED|Overall Study||47
271700|NCT01142388|655546|P1|NOT COMPLETED|Overall Study||47
271701|NCT01142388|655545|P2|COMPLETED|Overall Study||0
271702|NCT01142388|655546|P1|COMPLETED|Overall Study|Treatment continued until disease progression or intolerable toxicity.|0
271703|NCT01142388|655545|P2|Treated|Overall Study||44
271704|NCT01142388|655546|P1|Treated|Overall Study||40
271705|NCT01142388|655545|P2|Eligible|Overall Study||44
271706|NCT01142388|655546|P1|Eligible|Overall Study||43
271707|NCT01142388|655545|P2|STARTED|Overall Study||47
271708|NCT01142388|655546|P1|STARTED|Overall Study||47
271709|NCT01142466|655558|P2|NOT COMPLETED|Overall Study||2
271710|NCT01142466|655559|P1|NOT COMPLETED|Overall Study||3
271711|NCT01142466|655558|P2|COMPLETED|Overall Study||13
271712|NCT01142466|655559|P1|COMPLETED|Overall Study||12
271713|NCT01142466|655558|P2|STARTED|Overall Study||15
271714|NCT01142466|655559|P1|STARTED|Overall Study||15
271715|NCT01142596|655579|P2|NOT COMPLETED|Overall Study||86
271716|NCT01142596|655580|P1|NOT COMPLETED|Overall Study||29
271717|NCT01142596|655579|P2|COMPLETED|Overall Study||71
271718|NCT01142596|655580|P1|COMPLETED|Overall Study||15
271719|NCT01142596|655579|P2|STARTED|Overall Study||157
271720|NCT01142596|655580|P1|STARTED|Overall Study||44
271721|NCT01142661|655630|P1|NOT COMPLETED|Overall Study||4
271722|NCT01142661|655630|P1|COMPLETED|Overall Study||5
271723|NCT01142661|655630|P1|STARTED|Overall Study||9
271724|NCT01142726|655638|P3|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||3
271725|NCT01142726|655639|P2|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||2
271726|NCT01142726|655640|P1|NOT COMPLETED|Re-Exposure Phase: Months 24 up to 30||1
271727|NCT01142726|655638|P3|COMPLETED|Re-Exposure Phase: Months 24 up to 30||40
271728|NCT01142726|655639|P2|COMPLETED|Re-Exposure Phase: Months 24 up to 30||46
271729|NCT01142726|655640|P1|COMPLETED|Re-Exposure Phase: Months 24 up to 30||54
271730|NCT01142726|655638|P3|STARTED|Re-Exposure Phase: Months 24 up to 30||43
271731|NCT01142726|655639|P2|STARTED|Re-Exposure Phase: Months 24 up to 30||48
271732|NCT01142726|655640|P1|STARTED|Re-Exposure Phase: Months 24 up to 30||55
271733|NCT01142726|655638|P3|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||58
271734|NCT01142726|655639|P2|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||56
271735|NCT01142726|655640|P1|NOT COMPLETED|Withdrawal Phase: Months 12 up to 24||70
271736|NCT01142726|655638|P3|COMPLETED|Withdrawal Phase: Months 12 up to 24||17
271737|NCT01142726|655639|P2|COMPLETED|Withdrawal Phase: Months 12 up to 24||10
271738|NCT01142726|655640|P1|COMPLETED|Withdrawal Phase: Months 12 up to 24||14
271739|NCT01142726|655638|P3|STARTED|Withdrawal Phase: Months 12 up to 24||75
271740|NCT01142726|655639|P2|STARTED|Withdrawal Phase: Months 12 up to 24||66
271741|NCT01142726|655640|P1|STARTED|Withdrawal Phase: Months 12 up to 24||84
271742|NCT01142726|655638|P3|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||20
271743|NCT01142726|655639|P2|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||25
271744|NCT01142726|655640|P1|NOT COMPLETED|Treatment Phase: Day 1 Through Month 12||16
271745|NCT01142726|655638|P3|COMPLETED|Treatment Phase: Day 1 Through Month 12||96
271746|NCT01142726|655639|P2|COMPLETED|Treatment Phase: Day 1 Through Month 12||91
271747|NCT01142726|655640|P1|COMPLETED|Treatment Phase: Day 1 Through Month 12||103
271748|NCT01142726|655638|P3|STARTED|Treatment Phase: Day 1 Through Month 12||116
271749|NCT01142726|655639|P2|STARTED|Treatment Phase: Day 1 Through Month 12||116
271750|NCT01142726|655640|P1|STARTED|Treatment Phase: Day 1 Through Month 12||119
271751|NCT01142908|655705|P2|NOT COMPLETED|Overall Study||22
271752|NCT01142908|655706|P1|NOT COMPLETED|Overall Study||32
271753|NCT01142908|655705|P2|COMPLETED|Overall Study||191
271754|NCT01142908|655706|P1|COMPLETED|Overall Study||183
271755|NCT01142908|655705|P2|6 Month f/u|Overall Study||196
271756|NCT01142908|655706|P1|6 Month f/u|Overall Study||188
271757|NCT01142908|655705|P2|STARTED|Overall Study||213
271758|NCT01142908|655706|P1|STARTED|Overall Study||215
271759|NCT01136876|655754|P2|NOT COMPLETED|Overall Study||6
271760|NCT01136876|655755|P1|NOT COMPLETED|Overall Study||3
271761|NCT01136876|655754|P2|COMPLETED|Overall Study||23
271762|NCT01136876|655755|P1|COMPLETED|Overall Study||25
271763|NCT01136876|655754|P2|STARTED|Overall Study||29
271764|NCT01136876|655755|P1|STARTED|Overall Study||28
271765|NCT01136915|655765|P2|NOT COMPLETED|Overall Study||1
271766|NCT01136915|655766|P1|NOT COMPLETED|Overall Study||2
271767|NCT01136915|655765|P2|COMPLETED|Overall Study||6
271768|NCT01136915|655766|P1|COMPLETED|Overall Study||6
271769|NCT01136915|655765|P2|STARTED|Overall Study||7
271770|NCT01136915|655766|P1|STARTED|Overall Study||8
271771|NCT01136954|655776|P2|NOT COMPLETED|Overall Study||21
271772|NCT01136954|655777|P1|NOT COMPLETED|Overall Study||24
271773|NCT01136954|655776|P2|COMPLETED|Overall Study||51
271774|NCT01136954|655777|P1|COMPLETED|Overall Study||48
271775|NCT01136954|655776|P2|STARTED|Overall Study||72
271776|NCT01136954|655777|P1|STARTED|Overall Study||72
271777|NCT01136967|655791|P2|NOT COMPLETED|Overall Study||27
271778|NCT01136967|655792|P1|NOT COMPLETED|Overall Study||24
271779|NCT01136967|655791|P2|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (15 April 2013)|62
271780|NCT01136967|655792|P1|COMPLETED|Overall Study|Disease Progression and treatment ongoing at data cutoff (18 January 2012)|69
271781|NCT01136967|655791|P2|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (15 April 2013)|6
271782|NCT01136967|655792|P1|Treatment Ongoing at Data Cutoff|Overall Study|Entered Extension Phase on treatment at data cut-off (18 January 2012)|14
271783|NCT01136967|655791|P2|Disease Progression|Overall Study||56
271784|NCT01136967|655792|P1|Disease Progression|Overall Study||55
271785|NCT01136967|655791|P2|STARTED|Overall Study||89
271786|NCT01136967|655792|P1|STARTED|Overall Study||93
271787|NCT01137032|655808|P1|NOT COMPLETED|Overall Study||0
271788|NCT01137032|655808|P1|COMPLETED|Overall Study||19
271789|NCT01137032|655808|P1|STARTED|Overall Study||19
271790|NCT01137071|655814|P1|NOT COMPLETED|Overall Study||14
271791|NCT01137071|655814|P1|COMPLETED|Overall Study|Of the eligible patients|15
271792|NCT01137071|655814|P1|STARTED|Overall Study|all patients considered eligible were included on the study|29
271793|NCT01137292|655875|P1|NOT COMPLETED|Overall Study||54
271794|NCT01137292|655875|P1|COMPLETED|Overall Study||123
271795|NCT01137292|655875|P1|STARTED|Overall Study||177
271796|NCT01137370|655884|P2|NOT COMPLETED|Overall Study||0
271797|NCT01137370|655885|P1|NOT COMPLETED|Overall Study||0
271798|NCT01137370|655884|P2|COMPLETED|Overall Study||87
271799|NCT01137370|655885|P1|COMPLETED|Overall Study||116
271800|NCT01137370|655884|P2|STARTED|Overall Study||87
271801|NCT01137370|655885|P1|STARTED|Overall Study||116
271802|NCT01137396|655893|P2|NOT COMPLETED|Overall Study||2
271803|NCT01137396|655894|P1|NOT COMPLETED|Overall Study||8
271804|NCT01137396|655893|P2|COMPLETED|Overall Study||25
271805|NCT01137396|655894|P1|COMPLETED|Overall Study||22
271806|NCT01137396|655893|P2|STARTED|Overall Study||27
271807|NCT01137396|655894|P1|STARTED|Overall Study||30
271808|NCT01137435|655902|P1|NOT COMPLETED|Overall Study||28
271809|NCT01137435|655902|P1|COMPLETED|Overall Study||659
271810|NCT01137435|655902|P1|STARTED|Overall Study||687
271811|NCT01137474|655913|P4|NOT COMPLETED|Overall Study||21
271812|NCT01137474|655914|P3|NOT COMPLETED|Overall Study||7
271813|NCT01137474|655915|P2|NOT COMPLETED|Overall Study||12
271814|NCT01137474|655916|P1|NOT COMPLETED|Overall Study||24
271815|NCT01137474|655913|P4|COMPLETED|Overall Study||281
271816|NCT01137474|655914|P3|COMPLETED|Overall Study||158
271817|NCT01137474|655915|P2|COMPLETED|Overall Study||154
271818|NCT01137474|655916|P1|COMPLETED|Overall Study||287
271819|NCT01137474|655913|P4|Received Treatment|Overall Study||302
271820|NCT01137474|655914|P3|Received Treatment|Overall Study||165
271821|NCT01137474|655915|P2|Received Treatment|Overall Study||166
271822|NCT01137474|655916|P1|Received Treatment|Overall Study||311
271823|NCT01137474|655913|P4|STARTED|Overall Study||302
271824|NCT01137474|655914|P3|STARTED|Overall Study||165
271825|NCT01137474|655915|P2|STARTED|Overall Study||166
271826|NCT01137474|655916|P1|STARTED|Overall Study||311
271827|NCT01143038|655934|P1|NOT COMPLETED|Overall Study||16
271828|NCT01143038|655934|P1|COMPLETED|Overall Study|Defined as completion of romiplostim treatment|59
271829|NCT01143038|655934|P1|STARTED|Overall Study||75
271830|NCT01143051|655948|P6|NOT COMPLETED|Visit 3||0
271831|NCT01143051|655949|P5|NOT COMPLETED|Visit 3||0
271832|NCT01143051|655950|P4|NOT COMPLETED|Visit 3||0
271833|NCT01143051|655951|P3|NOT COMPLETED|Visit 3||0
271834|NCT01143051|655952|P2|NOT COMPLETED|Visit 3||0
271835|NCT01143051|655953|P1|NOT COMPLETED|Visit 3||0
271836|NCT01143051|655948|P6|COMPLETED|Visit 3||3
271837|NCT01143051|655949|P5|COMPLETED|Visit 3||4
271838|NCT01143051|655950|P4|COMPLETED|Visit 3||4
271839|NCT01143051|655951|P3|COMPLETED|Visit 3||3
271840|NCT01143051|655952|P2|COMPLETED|Visit 3||4
271841|NCT01143051|655953|P1|COMPLETED|Visit 3||4
271842|NCT01143051|655948|P6|STARTED|Visit 3||3
271843|NCT01143051|655949|P5|STARTED|Visit 3||4
271844|NCT01143051|655950|P4|STARTED|Visit 3||4
271845|NCT01143051|655951|P3|STARTED|Visit 3||3
271846|NCT01143051|655952|P2|STARTED|Visit 3||4
271847|NCT01143051|655953|P1|STARTED|Visit 3||4
271848|NCT01143051|655948|P6|NOT COMPLETED|3-14 Day Washout||1
271849|NCT01143051|655949|P5|NOT COMPLETED|3-14 Day Washout||0
271850|NCT01143051|655950|P4|NOT COMPLETED|3-14 Day Washout||0
271851|NCT01143051|655951|P3|NOT COMPLETED|3-14 Day Washout||0
271852|NCT01143051|655952|P2|NOT COMPLETED|3-14 Day Washout||0
271853|NCT01143051|655953|P1|NOT COMPLETED|3-14 Day Washout||0
271854|NCT01143051|655948|P6|COMPLETED|3-14 Day Washout||3
271855|NCT01143051|655949|P5|COMPLETED|3-14 Day Washout||4
271856|NCT01143051|655950|P4|COMPLETED|3-14 Day Washout||4
271857|NCT01143051|655951|P3|COMPLETED|3-14 Day Washout||3
271858|NCT01143051|655952|P2|COMPLETED|3-14 Day Washout||4
271859|NCT01143051|655953|P1|COMPLETED|3-14 Day Washout||4
271860|NCT01143051|655948|P6|STARTED|3-14 Day Washout||4
271861|NCT01143051|655949|P5|STARTED|3-14 Day Washout||4
271862|NCT01143051|655950|P4|STARTED|3-14 Day Washout||4
271863|NCT01143051|655951|P3|STARTED|3-14 Day Washout||3
271864|NCT01143051|655952|P2|STARTED|3-14 Day Washout||4
271865|NCT01143051|655953|P1|STARTED|3-14 Day Washout||4
271866|NCT01143051|655948|P6|NOT COMPLETED|Visit 2||0
271867|NCT01143051|655949|P5|NOT COMPLETED|Visit 2||0
271868|NCT01143051|655950|P4|NOT COMPLETED|Visit 2||0
271869|NCT01143051|655951|P3|NOT COMPLETED|Visit 2||0
271870|NCT01143051|655952|P2|NOT COMPLETED|Visit 2||0
271871|NCT01143051|655953|P1|NOT COMPLETED|Visit 2||0
271872|NCT01143051|655948|P6|COMPLETED|Visit 2||4
271873|NCT01143051|655949|P5|COMPLETED|Visit 2||4
271874|NCT01143051|655950|P4|COMPLETED|Visit 2||4
271875|NCT01143051|655951|P3|COMPLETED|Visit 2||3
271876|NCT01143051|655952|P2|COMPLETED|Visit 2||4
271877|NCT01143051|655953|P1|COMPLETED|Visit 2||4
271878|NCT01143051|655948|P6|STARTED|Visit 2||4
271879|NCT01143051|655949|P5|STARTED|Visit 2||4
271880|NCT01143051|655950|P4|STARTED|Visit 2||4
271881|NCT01143051|655951|P3|STARTED|Visit 2||3
271882|NCT01143051|655952|P2|STARTED|Visit 2||4
271883|NCT01143051|655953|P1|STARTED|Visit 2||4
271884|NCT01143051|655948|P6|NOT COMPLETED|3-14 Day Washout||0
271885|NCT01143051|655949|P5|NOT COMPLETED|3-14 Day Washout||0
271886|NCT01143051|655950|P4|NOT COMPLETED|3-14 Day Washout||0
271887|NCT01143051|655951|P3|NOT COMPLETED|3-14 Day Washout||1
271888|NCT01143051|655952|P2|NOT COMPLETED|3-14 Day Washout||0
271889|NCT01143051|655953|P1|NOT COMPLETED|3-14 Day Washout||0
271890|NCT01143051|655948|P6|COMPLETED|3-14 Day Washout||4
271891|NCT01143051|655949|P5|COMPLETED|3-14 Day Washout||4
271892|NCT01143051|655950|P4|COMPLETED|3-14 Day Washout||4
271893|NCT01143051|655951|P3|COMPLETED|3-14 Day Washout||3
271894|NCT01143051|655952|P2|COMPLETED|3-14 Day Washout||4
271895|NCT01143051|655953|P1|COMPLETED|3-14 Day Washout||4
271896|NCT01143051|655948|P6|STARTED|3-14 Day Washout||4
271897|NCT01143051|655949|P5|STARTED|3-14 Day Washout||4
271898|NCT01143051|655950|P4|STARTED|3-14 Day Washout||4
271899|NCT01143051|655951|P3|STARTED|3-14 Day Washout||4
271900|NCT01143051|655952|P2|STARTED|3-14 Day Washout||4
271901|NCT01143051|655953|P1|STARTED|3-14 Day Washout||4
271902|NCT01143051|655948|P6|NOT COMPLETED|Visit 1||0
271903|NCT01143051|655949|P5|NOT COMPLETED|Visit 1||0
271904|NCT01143051|655950|P4|NOT COMPLETED|Visit 1||0
271905|NCT01143051|655951|P3|NOT COMPLETED|Visit 1||0
271906|NCT01143051|655952|P2|NOT COMPLETED|Visit 1||0
271907|NCT01143051|655953|P1|NOT COMPLETED|Visit 1||0
271908|NCT01143051|655948|P6|COMPLETED|Visit 1||4
271909|NCT01143051|655949|P5|COMPLETED|Visit 1||4
271910|NCT01143051|655950|P4|COMPLETED|Visit 1||4
271911|NCT01143051|655951|P3|COMPLETED|Visit 1||4
271912|NCT01143051|655952|P2|COMPLETED|Visit 1||4
271913|NCT01143051|655953|P1|COMPLETED|Visit 1||4
271914|NCT01143051|655948|P6|STARTED|Visit 1||4
271915|NCT01143051|655949|P5|STARTED|Visit 1||4
271916|NCT01143051|655950|P4|STARTED|Visit 1||4
271917|NCT01143051|655951|P3|STARTED|Visit 1||4
271918|NCT01143051|655952|P2|STARTED|Visit 1||4
271919|NCT01143051|655953|P1|STARTED|Visit 1||4
271920|NCT01143077|655979|P3|NOT COMPLETED|Overall Study||15
271921|NCT01143077|655980|P2|NOT COMPLETED|Overall Study||15
271922|NCT01143077|655981|P1|NOT COMPLETED|Overall Study||16
271923|NCT01143077|655979|P3|COMPLETED|Overall Study||67
271924|NCT01143077|655980|P2|COMPLETED|Overall Study||73
271925|NCT01143077|655981|P1|COMPLETED|Overall Study||58
271926|NCT01143077|655979|P3|STARTED|Overall Study||82
271927|NCT01143077|655980|P2|STARTED|Overall Study||88
271928|NCT01143077|655981|P1|STARTED|Overall Study||74
271929|NCT01143090|655992|P1|NOT COMPLETED|Overall Study||51
271930|NCT01143090|655992|P1|COMPLETED|Overall Study||98
271931|NCT01143090|655992|P1|STARTED|Overall Study||149
271932|NCT01143142|655998|P2|NOT COMPLETED|Overall Study||0
271933|NCT01143142|655999|P1|NOT COMPLETED|Overall Study||0
271934|NCT01143142|655998|P2|COMPLETED|Overall Study||34
271935|NCT01143142|655999|P1|COMPLETED|Overall Study||36
271936|NCT01143142|655998|P2|STARTED|Overall Study||34
271937|NCT01143142|655999|P1|STARTED|Overall Study||36
271938|NCT01143207|656007|P1|NOT COMPLETED|Overall Study||2
271939|NCT01143207|656007|P1|COMPLETED|Overall Study||24
271940|NCT01143207|656007|P1|STARTED|Overall Study||26
271941|NCT01144182|656018|P2|NOT COMPLETED|Overall Study||21
271942|NCT01144182|656019|P1|NOT COMPLETED|Overall Study||17
271943|NCT01144182|656018|P2|COMPLETED|Overall Study||47
271944|NCT01144182|656019|P1|COMPLETED|Overall Study||51
271945|NCT01144182|656018|P2|STARTED|Overall Study||68
271946|NCT01144182|656019|P1|STARTED|Overall Study||68
271947|NCT01144286|656053|P4|NOT COMPLETED|Overall Study||0
271948|NCT01144286|656054|P3|NOT COMPLETED|Overall Study||0
271949|NCT01144286|656055|P2|NOT COMPLETED|Overall Study||0
271950|NCT01144286|656056|P1|NOT COMPLETED|Overall Study||0
271951|NCT01144286|656053|P4|COMPLETED|Overall Study||56
271952|NCT01144286|656054|P3|COMPLETED|Overall Study||58
271953|NCT01144286|656055|P2|COMPLETED|Overall Study||58
271954|NCT01144286|656056|P1|COMPLETED|Overall Study||57
271955|NCT01144286|656053|P4|STARTED|Overall Study||56
271956|NCT01144286|656054|P3|STARTED|Overall Study||58
271957|NCT01144286|656055|P2|STARTED|Overall Study||58
271958|NCT01144286|656056|P1|STARTED|Overall Study||57
271959|NCT01144299|656072|P2|NOT COMPLETED|Overall Study||0
271960|NCT01144299|656073|P1|NOT COMPLETED|Overall Study||2
271961|NCT01144299|656072|P2|COMPLETED|Overall Study||54
271962|NCT01144299|656073|P1|COMPLETED|Overall Study||58
271963|NCT01144299|656072|P2|STARTED|Overall Study||54
271964|NCT01144299|656073|P1|STARTED|Overall Study||60
271965|NCT01144364|656097|P3|NOT COMPLETED|Follow-Up/Maintenance Phase||41
271966|NCT01144364|656098|P2|NOT COMPLETED|Follow-Up/Maintenance Phase||35
271967|NCT01144364|656099|P1|NOT COMPLETED|Follow-Up/Maintenance Phase||0
271968|NCT01144364|656097|P3|COMPLETED|Follow-Up/Maintenance Phase||60
271969|NCT01144364|656098|P2|COMPLETED|Follow-Up/Maintenance Phase||66
271970|NCT01144364|656099|P1|COMPLETED|Follow-Up/Maintenance Phase||0
271971|NCT01144364|656097|P3|STARTED|Follow-Up/Maintenance Phase||101
271972|NCT01144364|656098|P2|STARTED|Follow-Up/Maintenance Phase||101
271973|NCT01144364|656099|P1|STARTED|Follow-Up/Maintenance Phase||0
271974|NCT01144364|656097|P3|NOT COMPLETED|Induction Phase||0
271975|NCT01144364|656098|P2|NOT COMPLETED|Induction Phase||0
271976|NCT01144364|656099|P1|NOT COMPLETED|Induction Phase||32
271977|NCT01144364|656097|P3|COMPLETED|Induction Phase||0
271978|NCT01144364|656098|P2|COMPLETED|Induction Phase||0
271979|NCT01144364|656099|P1|COMPLETED|Induction Phase||202
271980|NCT01144364|656097|P3|STARTED|Induction Phase||0
271981|NCT01144364|656098|P2|STARTED|Induction Phase||0
271982|NCT01144364|656099|P1|STARTED|Induction Phase||234
271983|NCT01144403|656123|P1|NOT COMPLETED|Overall Study||5
271984|NCT01144403|656123|P1|COMPLETED|Overall Study||3
271985|NCT01144403|656123|P1|STARTED|Overall Study||8
271986|NCT01144416|656132|P2|NOT COMPLETED|Pregnancy Follow-up Period||10
271987|NCT01144416|656133|P1|NOT COMPLETED|Pregnancy Follow-up Period||8
271988|NCT01144416|656132|P2|COMPLETED|Pregnancy Follow-up Period||157
271989|NCT01144416|656133|P1|COMPLETED|Pregnancy Follow-up Period||146
271990|NCT01144416|656132|P2|STARTED|Pregnancy Follow-up Period|Participants received daily injections of 300 IU recFSH in Intervention Period and became pregnant.|167
271991|NCT01144416|656133|P1|STARTED|Pregnancy Follow-up Period|Participants received 150 ug SCH 900962 in Intervention Period and became pregnant.|154
271992|NCT01144416|656132|P2|NOT COMPLETED|Intervention Period||49
271993|NCT01144416|656133|P1|NOT COMPLETED|Intervention Period||62
271994|NCT01144416|656132|P2|COMPLETED|Intervention Period||647
271995|NCT01144416|656133|P1|COMPLETED|Intervention Period||632
271996|NCT01144416|656132|P2|STARTED|Intervention Period||696
271997|NCT01144416|656133|P1|STARTED|Intervention Period||694
271998|NCT01144442|656149|P1|NOT COMPLETED|Overall Study||0
271999|NCT01144442|656149|P1|COMPLETED|Overall Study||10
272000|NCT01144442|656149|P1|STARTED|Overall Study||10
272001|NCT01144598|656154|P1|NOT COMPLETED|Overall Study||0
272002|NCT01144598|656154|P1|COMPLETED|Overall Study||356
272003|NCT01144598|656154|P1|Analysis Population|Overall Study||356
272004|NCT01144598|656154|P1|STARTED|Overall Study||356
272005|NCT01144624|656175|P3|NOT COMPLETED|Overall Study||0
272006|NCT01144624|656176|P2|NOT COMPLETED|Overall Study||0
272007|NCT01144624|656177|P1|NOT COMPLETED|Overall Study||0
272008|NCT01144624|656175|P3|COMPLETED|Overall Study|Two patients died during the study. Death was not a reason for treatment or study discontinuation.|6
272009|NCT01144624|656176|P2|COMPLETED|Overall Study||7
272010|NCT01144624|656177|P1|COMPLETED|Overall Study|One patient died during the study. Death was not a reason for treatment or study discontinuation.|7
272011|NCT01144624|656175|P3|Completed Treatment|Overall Study|Two patients died during the dosing period. Death was not a reason for treatment discontinuation.|6
272012|NCT01144624|656176|P2|Completed Treatment|Overall Study||7
272013|NCT01144624|656177|P1|Completed Treatment|Overall Study|One patient died after completing the full course of study treatment.|7
272014|NCT01144624|656175|P3|Received Treatment|Overall Study||6
272015|NCT01144624|656176|P2|Received Treatment|Overall Study||7
272016|NCT01144624|656177|P1|Received Treatment|Overall Study||7
272017|NCT01144624|656175|P3|STARTED|Overall Study||6
272018|NCT01144624|656176|P2|STARTED|Overall Study||7
272019|NCT01144624|656177|P1|STARTED|Overall Study||7
272020|NCT01144715|656193|P2|NOT COMPLETED|Overall Study||3
272021|NCT01144715|656194|P1|NOT COMPLETED|Overall Study||4
272022|NCT01144715|656193|P2|COMPLETED|Overall Study||45
272023|NCT01144715|656194|P1|COMPLETED|Overall Study||47
272024|NCT01144715|656193|P2|STARTED|Overall Study||48
272025|NCT01144715|656194|P1|STARTED|Overall Study||51
272026|NCT01144949|656208|P2|NOT COMPLETED|Overall Study||14
272027|NCT01144949|656209|P1|NOT COMPLETED|Overall Study||11
272028|NCT01144949|656208|P2|COMPLETED|Overall Study||106
272029|NCT01144949|656209|P1|COMPLETED|Overall Study||108
272030|NCT01144949|656208|P2|STARTED|Overall Study||120
272031|NCT01144949|656209|P1|STARTED|Overall Study||119
272032|NCT01145001|656229|P4|NOT COMPLETED|Overall Study||6
272033|NCT01145001|656230|P3|NOT COMPLETED|Overall Study||5
272034|NCT01145001|656231|P2|NOT COMPLETED|Overall Study||6
272035|NCT01145001|656232|P1|NOT COMPLETED|Overall Study||8
272036|NCT01145001|656229|P4|COMPLETED|Overall Study||31
272037|NCT01145001|656230|P3|COMPLETED|Overall Study||39
272038|NCT01145001|656231|P2|COMPLETED|Overall Study||31
272039|NCT01145001|656232|P1|COMPLETED|Overall Study||28
272040|NCT01145001|656229|P4|STARTED|Overall Study||37
272041|NCT01145001|656230|P3|STARTED|Overall Study||44
272042|NCT01145001|656231|P2|STARTED|Overall Study||37
272043|NCT01145001|656232|P1|STARTED|Overall Study||36
272044|NCT01145053|656246|P1|NOT COMPLETED|Overall Study||93
272045|NCT01145053|656246|P1|COMPLETED|Overall Study||248
272046|NCT01145053|656246|P1|STARTED|Overall Study||341
272047|NCT01145352|656256|P1|NOT COMPLETED|Overall Study||11
272048|NCT01145352|656256|P1|COMPLETED|Overall Study||102
272049|NCT01145352|656256|P1|STARTED|Overall Study||113
272050|NCT01145391|656266|P2|NOT COMPLETED|Overall Study||0
272051|NCT01145391|656267|P1|NOT COMPLETED|Overall Study||0
272052|NCT01145391|656266|P2|COMPLETED|Overall Study||298
272053|NCT01145391|656267|P1|COMPLETED|Overall Study||293
272054|NCT01145391|656266|P2|9 Months Post-randomization|Overall Study||298
272055|NCT01145391|656267|P1|9 Months Post-randomization|Overall Study||293
272056|NCT01145391|656266|P2|STARTED|Overall Study||298
272057|NCT01145391|656267|P1|STARTED|Overall Study||293
272058|NCT01145417|656277|P2|NOT COMPLETED|Overall Study||47
272059|NCT01145417|656278|P1|NOT COMPLETED|Overall Study||41
272060|NCT01145417|656277|P2|COMPLETED|Overall Study||62
272061|NCT01145417|656278|P1|COMPLETED|Overall Study||67
272062|NCT01145417|656277|P2|STARTED|Overall Study||109
272063|NCT01145417|656278|P1|STARTED|Overall Study||108
272064|NCT01145482|656302|P2|NOT COMPLETED|Second Intervention (1 Day)||0
272065|NCT01145482|656303|P1|NOT COMPLETED|Second Intervention (1 Day)||0
272066|NCT01145482|656302|P2|COMPLETED|Second Intervention (1 Day)||6
272067|NCT01145482|656303|P1|COMPLETED|Second Intervention (1 Day)||5
272068|NCT01145482|656302|P2|STARTED|Second Intervention (1 Day)||6
272069|NCT01145482|656303|P1|STARTED|Second Intervention (1 Day)||5
272070|NCT01145482|656302|P2|NOT COMPLETED|First Intervention (1 Day)||1
272071|NCT01145482|656303|P1|NOT COMPLETED|First Intervention (1 Day)||0
272072|NCT01145482|656302|P2|COMPLETED|First Intervention (1 Day)||5
272073|NCT01145482|656303|P1|COMPLETED|First Intervention (1 Day)||6
272074|NCT01145482|656302|P2|STARTED|First Intervention (1 Day)||6
272075|NCT01145482|656303|P1|STARTED|First Intervention (1 Day)||6
272076|NCT01145495|656311|P1|NOT COMPLETED|Overall Study||12
272077|NCT01145495|656311|P1|COMPLETED|Overall Study||51
272078|NCT01145495|656311|P1|STARTED|Overall Study||63
272079|NCT01145508|656317|P2|NOT COMPLETED|Overall Study||2
272080|NCT01145508|656318|P1|NOT COMPLETED|Overall Study||5
272081|NCT01145508|656317|P2|COMPLETED|Overall Study||1
272082|NCT01145508|656318|P1|COMPLETED|Overall Study||2
272083|NCT01145508|656317|P2|Treated|Overall Study||2
272084|NCT01145508|656318|P1|Treated|Overall Study||6
272085|NCT01145508|656317|P2|STARTED|Overall Study||3
272086|NCT01145508|656318|P1|STARTED|Overall Study||7
272087|NCT01145547|656324|P2|NOT COMPLETED|Overall Study||0
272088|NCT01145547|656325|P1|NOT COMPLETED|Overall Study||0
272089|NCT01145547|656324|P2|COMPLETED|Overall Study||3
272090|NCT01145547|656325|P1|COMPLETED|Overall Study||4
272091|NCT01145547|656324|P2|STARTED|Overall Study||3
272092|NCT01145547|656325|P1|STARTED|Overall Study||4
272093|NCT01145560|656334|P3|NOT COMPLETED|Overall Study||2
272094|NCT01145560|656335|P2|NOT COMPLETED|Overall Study||4
272095|NCT01145560|656336|P1|NOT COMPLETED|Overall Study||4
272096|NCT01145560|656334|P3|COMPLETED|Overall Study|27 patients died during the study. Death was not a reason for treatment or study discontinuation.|98
272097|NCT01145560|656335|P2|COMPLETED|Overall Study|33 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
272098|NCT01145560|656336|P1|COMPLETED|Overall Study|20 patients died during the study. Death was not a reason for treatment or study discontinuation.|96
272099|NCT01145560|656334|P3|Completed Treatment|Overall Study|7 patients died during the treatment period without completing the full course of treatment.|78
272100|NCT01145560|656335|P2|Completed Treatment|Overall Study|8 patients died during the treatment period without completing the full course of treatment.|85
272101|NCT01145560|656336|P1|Completed Treatment|Overall Study|9 patients died during the treatment period without completing the full course of treatment.|69
272102|NCT01145560|656334|P3|Received Treatment|Overall Study||99
272103|NCT01145560|656335|P2|Received Treatment|Overall Study||98
272104|NCT01145560|656336|P1|Received Treatment|Overall Study||99
272105|NCT01145560|656334|P3|STARTED|Overall Study||100
272106|NCT01145560|656335|P2|STARTED|Overall Study||100
272107|NCT01145560|656336|P1|STARTED|Overall Study||100
272108|NCT01145625|656355|P2|NOT COMPLETED|Overall Study||31
272109|NCT01145625|656356|P1|NOT COMPLETED|Overall Study||24
272110|NCT01145625|656355|P2|COMPLETED|Overall Study||130
272111|NCT01145625|656356|P1|COMPLETED|Overall Study||137
272112|NCT01145625|656355|P2|STARTED|Overall Study||161
272113|NCT01145625|656356|P1|STARTED|Overall Study||161
272114|NCT01145638|656368|P2|NOT COMPLETED|Overall Study||57
272115|NCT01145638|656369|P1|NOT COMPLETED|Overall Study||90
272116|NCT01145638|656368|P2|COMPLETED|Overall Study||62
272117|NCT01145638|656369|P1|COMPLETED|Overall Study||141
272118|NCT01145638|656368|P2|STARTED|Overall Study||119
272119|NCT01145638|656369|P1|STARTED|Overall Study||231
272120|NCT01145755|656380|P3|NOT COMPLETED|Overall Study||25
272121|NCT01145755|656381|P2|NOT COMPLETED|Overall Study||28
272122|NCT01145755|656382|P1|NOT COMPLETED|Overall Study||20
272123|NCT01145755|656380|P3|COMPLETED|Overall Study||19
272124|NCT01145755|656381|P2|COMPLETED|Overall Study||19
272125|NCT01145755|656382|P1|COMPLETED|Overall Study||20
272126|NCT01145755|656380|P3|STARTED|Overall Study||44
272127|NCT01145755|656381|P2|STARTED|Overall Study||47
272128|NCT01145755|656382|P1|STARTED|Overall Study||40
272129|NCT01145898|656398|P2|NOT COMPLETED|3-year Treatment||16
272130|NCT01145898|656399|P1|NOT COMPLETED|3-year Treatment||3
272131|NCT01145898|656398|P2|COMPLETED|3-year Treatment||28
272132|NCT01145898|656399|P1|COMPLETED|3-year Treatment||9
272133|NCT01145898|656398|P2|STARTED|3-year Treatment||44
272134|NCT01145898|656399|P1|STARTED|3-year Treatment||12
272135|NCT01145898|656398|P2|NOT COMPLETED|6-month Treatment||0
272136|NCT01145898|656399|P1|NOT COMPLETED|6-month Treatment||0
272137|NCT01145898|656398|P2|COMPLETED|6-month Treatment||44
272138|NCT01145898|656399|P1|COMPLETED|6-month Treatment||12
272139|NCT01145898|656398|P2|STARTED|6-month Treatment||44
272140|NCT01145898|656399|P1|STARTED|6-month Treatment||12
272141|NCT01146054|656430|P1|NOT COMPLETED|Overall Study||10
272142|NCT01146054|656430|P1|COMPLETED|Overall Study||49
272143|NCT01146054|656430|P1|STARTED|Overall Study||59
272144|NCT01146275|656438|P1|NOT COMPLETED|Overall Study||0
272145|NCT01146275|656438|P1|COMPLETED|Overall Study||6
272146|NCT01146275|656438|P1|STARTED|Overall Study||6
272147|NCT01146288|656445|P2|NOT COMPLETED|Second Intervention (1 Day)||0
272148|NCT01146288|656446|P1|NOT COMPLETED|Second Intervention (1 Day)||0
272149|NCT01146288|656445|P2|COMPLETED|Second Intervention (1 Day)||5
272150|NCT01146288|656446|P1|COMPLETED|Second Intervention (1 Day)||7
272151|NCT01146288|656445|P2|STARTED|Second Intervention (1 Day)||5
272152|NCT01146288|656446|P1|STARTED|Second Intervention (1 Day)||7
272153|NCT01146288|656445|P2|NOT COMPLETED|First Intervention(1 Day)||1
272154|NCT01146288|656446|P1|NOT COMPLETED|First Intervention(1 Day)||0
272155|NCT01146288|656445|P2|COMPLETED|First Intervention(1 Day)||5
272156|NCT01146288|656446|P1|COMPLETED|First Intervention(1 Day)||7
272157|NCT01146288|656445|P2|STARTED|First Intervention(1 Day)||6
272158|NCT01146288|656446|P1|STARTED|First Intervention(1 Day)||7
272159|NCT01146379|656459|P4|NOT COMPLETED|Overall Study||1
272160|NCT01146379|656460|P3|NOT COMPLETED|Overall Study||0
272161|NCT01146379|656461|P2|NOT COMPLETED|Overall Study||1
272162|NCT01146379|656462|P1|NOT COMPLETED|Overall Study||1
272163|NCT01146379|656459|P4|COMPLETED|Overall Study||20
272164|NCT01146379|656460|P3|COMPLETED|Overall Study||21
272165|NCT01146379|656461|P2|COMPLETED|Overall Study||21
272166|NCT01146379|656462|P1|COMPLETED|Overall Study||20
272167|NCT01146379|656459|P4|STARTED|Overall Study||21
272168|NCT01146379|656460|P3|STARTED|Overall Study||21
272169|NCT01146379|656461|P2|STARTED|Overall Study||22
272170|NCT01146379|656462|P1|STARTED|Overall Study||21
272171|NCT01146418|656474|P4|NOT COMPLETED|Live-Born Infant Follow Up||5
272172|NCT01146418|656475|P3|NOT COMPLETED|Live-Born Infant Follow Up||6
272173|NCT01146418|656476|P2|NOT COMPLETED|Live-Born Infant Follow Up||0
272174|NCT01146418|656477|P1|NOT COMPLETED|Live-Born Infant Follow Up||0
272175|NCT01146418|656474|P4|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|51
272176|NCT01146418|656475|P3|COMPLETED|Live-Born Infant Follow Up|Infants who completed follow up|55
272177|NCT01146418|656476|P2|COMPLETED|Live-Born Infant Follow Up||0
272178|NCT01146418|656477|P1|COMPLETED|Live-Born Infant Follow Up||0
272179|NCT01146418|656474|P4|STARTED|Live-Born Infant Follow Up||56
272180|NCT01146418|656475|P3|STARTED|Live-Born Infant Follow Up||61
272181|NCT01146418|656476|P2|STARTED|Live-Born Infant Follow Up||0
272182|NCT01146418|656477|P1|STARTED|Live-Born Infant Follow Up||0
272183|NCT01146418|656474|P4|NOT COMPLETED|Women/Expectant Mother Follow Up||0
272184|NCT01146418|656475|P3|NOT COMPLETED|Women/Expectant Mother Follow Up||0
272185|NCT01146418|656476|P2|NOT COMPLETED|Women/Expectant Mother Follow Up||40
272186|NCT01146418|656477|P1|NOT COMPLETED|Women/Expectant Mother Follow Up||44
272187|NCT01146418|656474|P4|COMPLETED|Women/Expectant Mother Follow Up||0
272188|NCT01146418|656475|P3|COMPLETED|Women/Expectant Mother Follow Up||0
272189|NCT01146418|656476|P2|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|110
272190|NCT01146418|656477|P1|COMPLETED|Women/Expectant Mother Follow Up|Participants with ET transfer who completed follow-up study|113
272191|NCT01146418|656474|P4|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
272192|NCT01146418|656475|P3|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up||0
272193|NCT01146418|656476|P2|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|50
272194|NCT01146418|656477|P1|Participants With an Ongoing Pregnancy|Women/Expectant Mother Follow Up|Ongoing pregnancy defined as intra-uterine pregnancy with fetal heart beat on USS 10 weeks after ET|52
272195|NCT01146418|656474|P4|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
272196|NCT01146418|656475|P3|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||0
272197|NCT01146418|656476|P2|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||147
272198|NCT01146418|656477|P1|Participants With Embryo Transfer (ET)|Women/Expectant Mother Follow Up||151
272199|NCT01146418|656474|P4|STARTED|Women/Expectant Mother Follow Up||0
272200|NCT01146418|656475|P3|STARTED|Women/Expectant Mother Follow Up||0
272201|NCT01146418|656476|P2|STARTED|Women/Expectant Mother Follow Up|Participants from base study P06029 with at least one embryo thawed for use in FTET cycle.|150
272202|NCT01146418|656477|P1|STARTED|Women/Expectant Mother Follow Up|Participants from Base Study P06029 with at least one embryo thawed for use in FTET cycle.|157
272203|NCT01146418|656474|P4|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
272204|NCT01146418|656475|P3|NOT COMPLETED|Base Study P06029 (NCT01144416)||0
272205|NCT01146418|656476|P2|NOT COMPLETED|Base Study P06029 (NCT01144416)||49
272206|NCT01146418|656477|P1|NOT COMPLETED|Base Study P06029 (NCT01144416)||62
272207|NCT01146418|656474|P4|COMPLETED|Base Study P06029 (NCT01144416)||0
272208|NCT01146418|656475|P3|COMPLETED|Base Study P06029 (NCT01144416)||0
272209|NCT01146418|656476|P2|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|647
272210|NCT01146418|656477|P1|COMPLETED|Base Study P06029 (NCT01144416)|Participants who underwent ET in base study|632
272211|NCT01146418|656474|P4|STARTED|Base Study P06029 (NCT01144416)||0
272212|NCT01146418|656475|P3|STARTED|Base Study P06029 (NCT01144416)||0
272213|NCT01146418|656476|P2|STARTED|Base Study P06029 (NCT01144416)||696
272214|NCT01146418|656477|P1|STARTED|Base Study P06029 (NCT01144416)||694
272215|NCT01146457|656494|P5|NOT COMPLETED|Overall Study||0
272216|NCT01146457|656495|P4|NOT COMPLETED|Overall Study||0
272217|NCT01146457|656496|P3|NOT COMPLETED|Overall Study||1
272218|NCT01146457|656497|P2|NOT COMPLETED|Overall Study||0
272219|NCT01146457|656498|P1|NOT COMPLETED|Overall Study||0
272220|NCT01146457|656494|P5|COMPLETED|Overall Study||13
272221|NCT01146457|656495|P4|COMPLETED|Overall Study||13
272222|NCT01146457|656496|P3|COMPLETED|Overall Study||20
272223|NCT01146457|656497|P2|COMPLETED|Overall Study||17
272224|NCT01146457|656498|P1|COMPLETED|Overall Study||19
272225|NCT01146457|656494|P5|STARTED|Overall Study||13
272226|NCT01146457|656495|P4|STARTED|Overall Study||13
272227|NCT01146457|656496|P3|STARTED|Overall Study||21
272228|NCT01146457|656497|P2|STARTED|Overall Study||17
272229|NCT01146457|656498|P1|STARTED|Overall Study||19
272230|NCT01146600|656512|P2|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
272231|NCT01146600|656513|P1|NOT COMPLETED|Period 2 (Weeks 4 & 5)||0
272232|NCT01146600|656512|P2|COMPLETED|Period 2 (Weeks 4 & 5)||10
272233|NCT01146600|656513|P1|COMPLETED|Period 2 (Weeks 4 & 5)||10
272234|NCT01146600|656512|P2|STARTED|Period 2 (Weeks 4 & 5)||10
272235|NCT01146600|656513|P1|STARTED|Period 2 (Weeks 4 & 5)||10
272236|NCT01146600|656512|P2|NOT COMPLETED|Washout (Week 3)||0
272237|NCT01146600|656513|P1|NOT COMPLETED|Washout (Week 3)||0
272238|NCT01146600|656512|P2|COMPLETED|Washout (Week 3)||10
272239|NCT01146600|656513|P1|COMPLETED|Washout (Week 3)||10
272240|NCT01146600|656512|P2|STARTED|Washout (Week 3)||10
272241|NCT01146600|656513|P1|STARTED|Washout (Week 3)||10
272242|NCT01146600|656512|P2|NOT COMPLETED|Period 1 (Weeks 1 & 2)||0
272243|NCT01146600|656513|P1|NOT COMPLETED|Period 1 (Weeks 1 & 2)||3
272244|NCT01146600|656512|P2|COMPLETED|Period 1 (Weeks 1 & 2)||10
272245|NCT01146600|656513|P1|COMPLETED|Period 1 (Weeks 1 & 2)||10
272246|NCT01146600|656512|P2|STARTED|Period 1 (Weeks 1 & 2)||10
272247|NCT01146600|656513|P1|STARTED|Period 1 (Weeks 1 & 2)||13
272248|NCT01146613|656540|P2|NOT COMPLETED|Overall Study||12
272249|NCT01146613|656541|P1|NOT COMPLETED|Overall Study||7
272250|NCT01146613|656540|P2|COMPLETED|Overall Study||89
272251|NCT01146613|656541|P1|COMPLETED|Overall Study||92
272252|NCT01146613|656540|P2|STARTED|Overall Study||101
272253|NCT01146613|656541|P1|STARTED|Overall Study||99
272254|NCT01140347|656549|P2|NOT COMPLETED|Overall Study||14
272255|NCT01140347|656550|P1|NOT COMPLETED|Overall Study||18
272256|NCT01140347|656549|P2|COMPLETED|Overall Study||268
272257|NCT01140347|656550|P1|COMPLETED|Overall Study||265
272258|NCT01140347|656549|P2|Received at Least 1 Dose of Study Drug|Overall Study||276
272259|NCT01140347|656550|P1|Received at Least 1 Dose of Study Drug|Overall Study||277
272260|NCT01140347|656549|P2|STARTED|Overall Study||282
272261|NCT01140347|656550|P1|STARTED|Overall Study||283
272262|NCT01140360|656573|P1|NOT COMPLETED|Overall Study||6
272263|NCT01140360|656573|P1|COMPLETED|Overall Study||15
272264|NCT01140360|656573|P1|STARTED|Overall Study||21
272265|NCT01146782|656577|P1|NOT COMPLETED|Primary Endpoint Cohort||6
272266|NCT01146782|656577|P1|COMPLETED|Primary Endpoint Cohort|57 Subjects in the Primary Endpoint Cohort completed the 28 day study|57
272267|NCT01146782|656577|P1|STARTED|Primary Endpoint Cohort|63 Subjects in the Primary Endpoint Cohort|63
272268|NCT01146782|656577|P1|NOT COMPLETED|Safety Cohort||83
272269|NCT01146782|656577|P1|COMPLETED|Safety Cohort||63
272270|NCT01146782|656577|P1|STARTED|Safety Cohort||146
272271|NCT01146782|656577|P1|NOT COMPLETED|Screening Cohort||221
272272|NCT01146782|656577|P1|COMPLETED|Screening Cohort||146
272273|NCT01146782|656577|P1|STARTED|Screening Cohort||367
272274|NCT01146808|656584|P1|NOT COMPLETED|Overall Study||0
272275|NCT01146808|656584|P1|COMPLETED|Overall Study||16
272276|NCT01146808|656584|P1|STARTED|Overall Study||16
272277|NCT01146860|656592|P2|NOT COMPLETED|Overall Study||1
272278|NCT01146860|656593|P1|NOT COMPLETED|Overall Study||0
272279|NCT01146860|656592|P2|COMPLETED|Overall Study||191
272280|NCT01146860|656593|P1|COMPLETED|Overall Study||194
272281|NCT01146860|656592|P2|STARTED|Overall Study||192
272282|NCT01146860|656593|P1|STARTED|Overall Study||194
272283|NCT01146873|656609|P2|NOT COMPLETED|Overall Study||6
272284|NCT01146873|656610|P1|NOT COMPLETED|Overall Study||0
272285|NCT01146873|656609|P2|COMPLETED|Overall Study||144
272286|NCT01146873|656610|P1|COMPLETED|Overall Study||148
272287|NCT01146873|656609|P2|STARTED|Overall Study||150
272288|NCT01146873|656610|P1|STARTED|Overall Study||148
272289|NCT01146912|656631|P8|NOT COMPLETED|Overall Study||0
272290|NCT01146912|656632|P7|NOT COMPLETED|Overall Study||56
272291|NCT01146912|656633|P6|NOT COMPLETED|Overall Study||61
272292|NCT01146912|656634|P5|NOT COMPLETED|Overall Study||41
272293|NCT01146912|656635|P4|NOT COMPLETED|Overall Study||17
272294|NCT01146912|656636|P3|NOT COMPLETED|Overall Study||17
272295|NCT01146912|656637|P2|NOT COMPLETED|Overall Study||822
272296|NCT01146912|656638|P1|NOT COMPLETED|Overall Study||817
272297|NCT01146912|656631|P8|COMPLETED|Overall Study|Parents are considered subjects but outcomes are on child level|14675
272298|NCT01146912|656632|P7|COMPLETED|Overall Study||1764
272299|NCT01146912|656633|P6|COMPLETED|Overall Study||1760
272300|NCT01146912|656634|P5|COMPLETED|Overall Study||1780
272301|NCT01146912|656635|P4|COMPLETED|Overall Study||577
272302|NCT01146912|656636|P3|COMPLETED|Overall Study||576
272303|NCT01146912|656637|P2|COMPLETED|Overall Study||3784
272304|NCT01146912|656638|P1|COMPLETED|Overall Study||3790
272305|NCT01146912|656631|P8|STARTED|Overall Study||14675
272306|NCT01146912|656632|P7|STARTED|Overall Study||1820
272307|NCT01146912|656633|P6|STARTED|Overall Study||1821
272308|NCT01146912|656634|P5|STARTED|Overall Study||1821
272309|NCT01146912|656635|P4|STARTED|Overall Study||594
272310|NCT01146912|656636|P3|STARTED|Overall Study||593
272311|NCT01146912|656637|P2|STARTED|Overall Study||4606
272312|NCT01146912|656638|P1|STARTED|Overall Study||4607
272313|NCT01146951|656660|P2|NOT COMPLETED|Overall Study||1
272314|NCT01146951|656661|P1|NOT COMPLETED|Overall Study||4
272315|NCT01146951|656660|P2|COMPLETED|Overall Study||29
272316|NCT01146951|656661|P1|COMPLETED|Overall Study||25
272317|NCT01146951|656660|P2|STARTED|Overall Study||30
272318|NCT01146951|656661|P1|STARTED|Overall Study||29
272319|NCT01147172|656675|P1|NOT COMPLETED|Overall Study||4
272320|NCT01147172|656675|P1|COMPLETED|Overall Study||96
272321|NCT01147172|656675|P1|STARTED|Overall Study||100
272322|NCT01147250|656688|P2|NOT COMPLETED|Overall Study||105
272323|NCT01147250|656689|P1|NOT COMPLETED|Overall Study||110
272324|NCT01147250|656688|P2|COMPLETED|Overall Study||2929
272325|NCT01147250|656689|P1|COMPLETED|Overall Study||2924
272326|NCT01147250|656688|P2|Treated|Overall Study||3031
272327|NCT01147250|656689|P1|Treated|Overall Study||3032
272328|NCT01147250|656688|P2|STARTED|Overall Study||3034
272329|NCT01147250|656689|P1|STARTED|Overall Study||3034
272330|NCT01147302|656703|P2|NOT COMPLETED|Overall Study||0
272331|NCT01147302|656704|P1|NOT COMPLETED|Overall Study||0
272332|NCT01147302|656703|P2|COMPLETED|Overall Study||9
272333|NCT01147302|656704|P1|COMPLETED|Overall Study||9
272334|NCT01147302|656703|P2|STARTED|Overall Study||9
272335|NCT01147302|656704|P1|STARTED|Overall Study||9
272336|NCT01147341|656736|P2|NOT COMPLETED|Open Label Period||0
272337|NCT01147341|656737|P1|NOT COMPLETED|Open Label Period||4
272338|NCT01147341|656736|P2|COMPLETED|Open Label Period||8
272339|NCT01147341|656737|P1|COMPLETED|Open Label Period||22
272340|NCT01147341|656736|P2|STARTED|Open Label Period||8
272341|NCT01147341|656737|P1|STARTED|Open Label Period||26
272342|NCT01147341|656736|P2|NOT COMPLETED|Double Blind Period||2
272343|NCT01147341|656737|P1|NOT COMPLETED|Double Blind Period||1
272344|NCT01147341|656736|P2|COMPLETED|Double Blind Period||8
272345|NCT01147341|656737|P1|COMPLETED|Double Blind Period||26
272346|NCT01147341|656736|P2|STARTED|Double Blind Period||10
272347|NCT01147341|656737|P1|STARTED|Double Blind Period||27
272348|NCT01147380|656767|P2|NOT COMPLETED|Overall Study||0
272349|NCT01147380|656768|P1|NOT COMPLETED|Overall Study||0
272350|NCT01147380|656767|P2|COMPLETED|Overall Study||12
272351|NCT01147380|656768|P1|COMPLETED|Overall Study||6
272352|NCT01147380|656767|P2|STARTED|Overall Study||12
272353|NCT01147380|656768|P1|STARTED|Overall Study||6
272354|NCT01147393|656776|P1|NOT COMPLETED|Dose Level -1||1
272355|NCT01147393|656776|P1|COMPLETED|Dose Level -1||0
272356|NCT01147393|656776|P1|STARTED|Dose Level -1||1
272357|NCT01147393|656776|P1|NOT COMPLETED|Dose Level 1||2
272358|NCT01147393|656776|P1|COMPLETED|Dose Level 1||1
272359|NCT01147393|656776|P1|STARTED|Dose Level 1||3
272360|NCT01147406|656790|P6|NOT COMPLETED|Overall Study||0
272361|NCT01147406|656791|P5|NOT COMPLETED|Overall Study||0
272362|NCT01147406|656792|P4|NOT COMPLETED|Overall Study||0
272363|NCT01147406|656793|P3|NOT COMPLETED|Overall Study||0
272364|NCT01147406|656794|P2|NOT COMPLETED|Overall Study||0
272365|NCT01147406|656795|P1|NOT COMPLETED|Overall Study||0
272366|NCT01147406|656790|P6|COMPLETED|Overall Study||10
272367|NCT01147406|656791|P5|COMPLETED|Overall Study||6
272368|NCT01147406|656792|P4|COMPLETED|Overall Study||6
272369|NCT01147406|656793|P3|COMPLETED|Overall Study||1
272370|NCT01147406|656794|P2|COMPLETED|Overall Study||12
272371|NCT01147406|656795|P1|COMPLETED|Overall Study||6
272372|NCT01147406|656790|P6|STARTED|Overall Study||10
272373|NCT01147406|656791|P5|STARTED|Overall Study||6
272374|NCT01147406|656792|P4|STARTED|Overall Study||6
272375|NCT01147406|656793|P3|STARTED|Overall Study||1
272376|NCT01147406|656794|P2|STARTED|Overall Study||12
272377|NCT01147406|656795|P1|STARTED|Overall Study||6
272378|NCT01147458|656815|P4|NOT COMPLETED|Second Intervention||4
272379|NCT01147458|656816|P3|NOT COMPLETED|Second Intervention||8
272380|NCT01147458|656817|P2|NOT COMPLETED|Second Intervention||7
272381|NCT01147458|656818|P1|NOT COMPLETED|Second Intervention||9
272382|NCT01147458|656815|P4|COMPLETED|Second Intervention||30
272383|NCT01147458|656816|P3|COMPLETED|Second Intervention||27
272384|NCT01147458|656817|P2|COMPLETED|Second Intervention||24
272385|NCT01147458|656818|P1|COMPLETED|Second Intervention||25
272386|NCT01147458|656815|P4|STARTED|Second Intervention||34
272387|NCT01147458|656816|P3|STARTED|Second Intervention||35
272388|NCT01147458|656817|P2|STARTED|Second Intervention||31
272389|NCT01147458|656818|P1|STARTED|Second Intervention||34
272390|NCT01147458|656815|P4|NOT COMPLETED|Washout Period of 2 Weeks||0
272391|NCT01147458|656816|P3|NOT COMPLETED|Washout Period of 2 Weeks||0
272392|NCT01147458|656817|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
272393|NCT01147458|656818|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
272394|NCT01147458|656815|P4|COMPLETED|Washout Period of 2 Weeks||34
272395|NCT01147458|656816|P3|COMPLETED|Washout Period of 2 Weeks||35
272396|NCT01147458|656817|P2|COMPLETED|Washout Period of 2 Weeks||31
272397|NCT01147458|656818|P1|COMPLETED|Washout Period of 2 Weeks||34
272398|NCT01147458|656815|P4|STARTED|Washout Period of 2 Weeks||34
272399|NCT01147458|656816|P3|STARTED|Washout Period of 2 Weeks||35
272400|NCT01147458|656817|P2|STARTED|Washout Period of 2 Weeks||31
272401|NCT01147458|656818|P1|STARTED|Washout Period of 2 Weeks||34
272402|NCT01147458|656815|P4|NOT COMPLETED|First Intervention||14
272403|NCT01147458|656816|P3|NOT COMPLETED|First Intervention||12
272404|NCT01147458|656817|P2|NOT COMPLETED|First Intervention||16
272405|NCT01147458|656818|P1|NOT COMPLETED|First Intervention||14
272406|NCT01147458|656815|P4|COMPLETED|First Intervention||34
272407|NCT01147458|656816|P3|COMPLETED|First Intervention||35
272408|NCT01147458|656817|P2|COMPLETED|First Intervention||31
272409|NCT01147458|656818|P1|COMPLETED|First Intervention||34
272410|NCT01147458|656815|P4|STARTED|First Intervention||48
272411|NCT01147458|656816|P3|STARTED|First Intervention||47
272412|NCT01147458|656817|P2|STARTED|First Intervention||47
272413|NCT01147458|656818|P1|STARTED|First Intervention||48
272414|NCT01147471|656868|P2|NOT COMPLETED|6 Month Follow Up||2
272415|NCT01147471|656869|P1|NOT COMPLETED|6 Month Follow Up||4
272416|NCT01147471|656868|P2|COMPLETED|6 Month Follow Up||4
272417|NCT01147471|656869|P1|COMPLETED|6 Month Follow Up||8
272418|NCT01147471|656868|P2|STARTED|6 Month Follow Up||6
272419|NCT01147471|656869|P1|STARTED|6 Month Follow Up||12
272420|NCT01147471|656868|P2|NOT COMPLETED|3 Month Follow Up||2
272421|NCT01147471|656869|P1|NOT COMPLETED|3 Month Follow Up||1
272422|NCT01147471|656868|P2|COMPLETED|3 Month Follow Up||6
272423|NCT01147471|656869|P1|COMPLETED|3 Month Follow Up||12
272424|NCT01147471|656868|P2|STARTED|3 Month Follow Up||8
272425|NCT01147471|656869|P1|STARTED|3 Month Follow Up||13
272426|NCT01147471|656868|P2|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||3
272427|NCT01147471|656869|P1|NOT COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||0
272428|NCT01147471|656868|P2|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||8
272429|NCT01147471|656869|P1|COMPLETED|Post-discharge Follow Up (Approx 2 Wks)||13
272430|NCT01147471|656868|P2|STARTED|Post-discharge Follow Up (Approx 2 Wks)||11
272431|NCT01147471|656869|P1|STARTED|Post-discharge Follow Up (Approx 2 Wks)||13
272432|NCT01147471|656868|P2|NOT COMPLETED|Through Initial Hospital Discharge||0
272433|NCT01147471|656869|P1|NOT COMPLETED|Through Initial Hospital Discharge||0
272434|NCT01147471|656868|P2|COMPLETED|Through Initial Hospital Discharge||11
272435|NCT01147471|656869|P1|COMPLETED|Through Initial Hospital Discharge||13
272436|NCT01147471|656868|P2|STARTED|Through Initial Hospital Discharge||11
272437|NCT01147471|656869|P1|STARTED|Through Initial Hospital Discharge||13
272438|NCT01147497|656885|P2|NOT COMPLETED|Overall Study||0
272439|NCT01147497|656886|P1|NOT COMPLETED|Overall Study||2
272440|NCT01147497|656885|P2|COMPLETED|Overall Study||36
272441|NCT01147497|656886|P1|COMPLETED|Overall Study||35
272442|NCT01147497|656885|P2|STARTED|Overall Study||36
272443|NCT01147497|656886|P1|STARTED|Overall Study||37
272444|NCT01147601|656898|P2|NOT COMPLETED|Overall Study||0
272445|NCT01147601|656899|P1|NOT COMPLETED|Overall Study||3
272446|NCT01147601|656898|P2|COMPLETED|Overall Study||1
272447|NCT01147601|656899|P1|COMPLETED|Overall Study||2
272448|NCT01147601|656898|P2|STARTED|Overall Study||1
272449|NCT01147601|656899|P1|STARTED|Overall Study||5
272450|NCT01147627|656908|P3|NOT COMPLETED|Overall Study||18
272451|NCT01147627|656909|P2|NOT COMPLETED|Overall Study||24
272452|NCT01147627|656910|P1|NOT COMPLETED|Overall Study||32
272453|NCT01147627|656908|P3|COMPLETED|Overall Study||118
272454|NCT01147627|656909|P2|COMPLETED|Overall Study||114
272455|NCT01147627|656910|P1|COMPLETED|Overall Study||110
272456|NCT01147627|656908|P3|STARTED|Overall Study||136
272457|NCT01147627|656909|P2|STARTED|Overall Study||138
272458|NCT01147627|656910|P1|STARTED|Overall Study||142
272459|NCT01147640|656920|P2|NOT COMPLETED|Overall Study||1
272460|NCT01147640|656921|P1|NOT COMPLETED|Overall Study||5
272461|NCT01147640|656920|P2|COMPLETED|Overall Study||38
272462|NCT01147640|656921|P1|COMPLETED|Overall Study||78
272463|NCT01147640|656920|P2|STARTED|Overall Study||39
272464|NCT01147640|656921|P1|STARTED|Overall Study||83
272465|NCT01147653|656931|P2|NOT COMPLETED|Year 2||3
272466|NCT01147653|656932|P1|NOT COMPLETED|Year 2||2
272467|NCT01147653|656931|P2|COMPLETED|Year 2||28
272468|NCT01147653|656932|P1|COMPLETED|Year 2||30
272469|NCT01147653|656931|P2|STARTED|Year 2||31
272470|NCT01147653|656932|P1|STARTED|Year 2||32
272471|NCT01147653|656931|P2|NOT COMPLETED|Year 1||0
272472|NCT01147653|656932|P1|NOT COMPLETED|Year 1||0
272473|NCT01147653|656931|P2|COMPLETED|Year 1||31
272474|NCT01147653|656932|P1|COMPLETED|Year 1||32
272475|NCT01147653|656931|P2|STARTED|Year 1||31
272476|NCT01147653|656932|P1|STARTED|Year 1||32
272477|NCT01147809|656993|P6|NOT COMPLETED|Phase II (168 Days)||33
272478|NCT01147809|656994|P5|NOT COMPLETED|Phase II (168 Days)||16
272479|NCT01147809|656995|P4|NOT COMPLETED|Phase II (168 Days)||0
272480|NCT01147809|656996|P3|NOT COMPLETED|Phase II (168 Days)||0
272481|NCT01147809|656997|P2|NOT COMPLETED|Phase II (168 Days)||0
272482|NCT01147809|656998|P1|NOT COMPLETED|Phase II (168 Days)||0
272483|NCT01147809|656993|P6|COMPLETED|Phase II (168 Days)||19
272484|NCT01147809|656994|P5|COMPLETED|Phase II (168 Days)||7
272485|NCT01147809|656995|P4|COMPLETED|Phase II (168 Days)||0
272486|NCT01147809|656996|P3|COMPLETED|Phase II (168 Days)||0
272487|NCT01147809|656997|P2|COMPLETED|Phase II (168 Days)||0
272488|NCT01147809|656998|P1|COMPLETED|Phase II (168 Days)||0
272489|NCT01147809|656993|P6|Ongoing|Phase II (168 Days)||0
272490|NCT01147809|656994|P5|Ongoing|Phase II (168 Days)||1
272491|NCT01147809|656995|P4|Ongoing|Phase II (168 Days)||0
272492|NCT01147809|656996|P3|Ongoing|Phase II (168 Days)||0
272493|NCT01147809|656997|P2|Ongoing|Phase II (168 Days)||0
272494|NCT01147809|656998|P1|Ongoing|Phase II (168 Days)||0
272495|NCT01147809|656993|P6|STARTED|Phase II (168 Days)||52
272496|NCT01147809|656994|P5|STARTED|Phase II (168 Days)||23
272497|NCT01147809|656995|P4|STARTED|Phase II (168 Days)||0
272498|NCT01147809|656996|P3|STARTED|Phase II (168 Days)||0
272499|NCT01147809|656997|P2|STARTED|Phase II (168 Days)||0
272500|NCT01147809|656998|P1|STARTED|Phase II (168 Days)||0
272501|NCT01147809|656993|P6|NOT COMPLETED|Phase I (168 Days)||0
272502|NCT01147809|656994|P5|NOT COMPLETED|Phase I (168 Days)||0
272503|NCT01147809|656995|P4|NOT COMPLETED|Phase I (168 Days)||5
272504|NCT01147809|656996|P3|NOT COMPLETED|Phase I (168 Days)||2
272505|NCT01147809|656997|P2|NOT COMPLETED|Phase I (168 Days)||1
272506|NCT01147809|656998|P1|NOT COMPLETED|Phase I (168 Days)||1
272507|NCT01147809|656993|P6|COMPLETED|Phase I (168 Days)||0
272508|NCT01147809|656994|P5|COMPLETED|Phase I (168 Days)||0
272509|NCT01147809|656995|P4|COMPLETED|Phase I (168 Days)||5
272510|NCT01147809|656996|P3|COMPLETED|Phase I (168 Days)||2
272511|NCT01147809|656997|P2|COMPLETED|Phase I (168 Days)||8
272512|NCT01147809|656998|P1|COMPLETED|Phase I (168 Days)||2
272513|NCT01147809|656993|P6|STARTED|Phase I (168 Days)||0
272514|NCT01147809|656994|P5|STARTED|Phase I (168 Days)||0
272515|NCT01147809|656995|P4|STARTED|Phase I (168 Days)||10
272516|NCT01147809|656996|P3|STARTED|Phase I (168 Days)||4
272517|NCT01147809|656997|P2|STARTED|Phase I (168 Days)||9
272518|NCT01147809|656998|P1|STARTED|Phase I (168 Days)||3
272519|NCT01147822|657114|P2|NOT COMPLETED|Overall Study||179
272520|NCT01147822|657115|P1|NOT COMPLETED|Overall Study||188
272521|NCT01147822|657114|P2|COMPLETED|Overall Study||0
272522|NCT01147822|657115|P1|COMPLETED|Overall Study||0
272523|NCT01147822|657114|P2|Not Completed/Ongoing|Overall Study||102
272524|NCT01147822|657115|P1|Not Completed/Ongoing|Overall Study||111
272525|NCT01147822|657114|P2|STARTED|Overall Study||179
272526|NCT01147822|657115|P1|STARTED|Overall Study||188
272527|NCT01147848|657131|P3|NOT COMPLETED|Randomized Phase||46
272528|NCT01147848|657132|P2|NOT COMPLETED|Randomized Phase||45
272529|NCT01147848|657133|P1|NOT COMPLETED|Randomized Phase||0
272530|NCT01147848|657131|P3|COMPLETED|Randomized Phase||357
272531|NCT01147848|657132|P2|COMPLETED|Randomized Phase||358
272532|NCT01147848|657133|P1|COMPLETED|Randomized Phase||0
272533|NCT01147848|657131|P3|STARTED|Randomized Phase||403
272534|NCT01147848|657132|P2|STARTED|Randomized Phase||403
272535|NCT01147848|657133|P1|STARTED|Randomized Phase||0
272536|NCT01147848|657131|P3|NOT COMPLETED|Run-in Period||0
272537|NCT01147848|657132|P2|NOT COMPLETED|Run-in Period||0
272538|NCT01147848|657133|P1|NOT COMPLETED|Run-in Period||758
272539|NCT01147848|657131|P3|COMPLETED|Run-in Period||0
272540|NCT01147848|657132|P2|COMPLETED|Run-in Period||0
272541|NCT01147848|657133|P1|COMPLETED|Run-in Period||806
272542|NCT01147848|657131|P3|STARTED|Run-in Period||0
272543|NCT01147848|657132|P2|STARTED|Run-in Period||0
272544|NCT01147848|657133|P1|STARTED|Run-in Period||1564
272545|NCT01147874|657163|P1|NOT COMPLETED|Overall Study||67
272546|NCT01147874|657163|P1|COMPLETED|Overall Study||946
272547|NCT01147874|657163|P1|STARTED|Overall Study||1013
272548|NCT01147900|657172|P3|NOT COMPLETED|At Year 10||0
272549|NCT01147900|657173|P2|NOT COMPLETED|At Year 10||1
272550|NCT01147900|657174|P1|NOT COMPLETED|At Year 10||0
272551|NCT01147900|657172|P3|COMPLETED|At Year 10||62
272552|NCT01147900|657173|P2|COMPLETED|At Year 10||59
272553|NCT01147900|657174|P1|COMPLETED|At Year 10||55
272554|NCT01147900|657172|P3|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled.|62
272555|NCT01147900|657173|P2|STARTED|At Year 10||60
272556|NCT01147900|657174|P1|STARTED|At Year 10|At Year 10, a total of 177 subjects (out of the 180 planned) were enrolled|55
272557|NCT01147900|657172|P3|NOT COMPLETED|At Year 8.5||0
272558|NCT01147900|657173|P2|NOT COMPLETED|At Year 8.5||0
272559|NCT01147900|657174|P1|NOT COMPLETED|At Year 8.5||0
272560|NCT01147900|657172|P3|COMPLETED|At Year 8.5||66
272561|NCT01147900|657173|P2|COMPLETED|At Year 8.5||60
272562|NCT01147900|657174|P1|COMPLETED|At Year 8.5||54
272563|NCT01147900|657172|P3|STARTED|At Year 8.5||66
272564|NCT01147900|657173|P2|STARTED|At Year 8.5||60
272565|NCT01147900|657174|P1|STARTED|At Year 8.5||54
272566|NCT01147926|657235|P2|NOT COMPLETED|Overall Study||29
272567|NCT01147926|657236|P1|NOT COMPLETED|Overall Study||27
272568|NCT01147926|657235|P2|COMPLETED|Overall Study||158
272569|NCT01147926|657236|P1|COMPLETED|Overall Study||160
272570|NCT01147926|657235|P2|STARTED|Overall Study||187
272571|NCT01147926|657236|P1|STARTED|Overall Study||187
272572|NCT01148017|657272|P4|NOT COMPLETED|Overall Study||0
272573|NCT01148017|657273|P3|NOT COMPLETED|Overall Study||0
272574|NCT01148017|657274|P2|NOT COMPLETED|Overall Study||34
272575|NCT01148017|657275|P1|NOT COMPLETED|Overall Study||80
272576|NCT01148017|657272|P4|COMPLETED|Overall Study||45
272577|NCT01148017|657273|P3|COMPLETED|Overall Study||53
272578|NCT01148017|657274|P2|COMPLETED|Overall Study||87
272579|NCT01148017|657275|P1|COMPLETED|Overall Study||134
272580|NCT01148017|657272|P4|STARTED|Overall Study||45
272581|NCT01148017|657273|P3|STARTED|Overall Study||53
272582|NCT01148017|657274|P2|STARTED|Overall Study||121
272583|NCT01148017|657275|P1|STARTED|Overall Study||214
272584|NCT01148056|657312|P1|NOT COMPLETED|Overall Study||0
272585|NCT01148056|657312|P1|COMPLETED|Overall Study||2
272586|NCT01148056|657312|P1|STARTED|Overall Study||2
272587|NCT01148420|657321|P1|NOT COMPLETED|Overall Study||0
272588|NCT01148420|657321|P1|COMPLETED|Overall Study||48
272589|NCT01148420|657321|P1|STARTED|Overall Study||48
272590|NCT01148511|657329|P3|NOT COMPLETED|Randomized||6
272591|NCT01148511|657330|P2|NOT COMPLETED|Randomized||10
272592|NCT01148511|657331|P1|NOT COMPLETED|Randomized||0
272593|NCT01148511|657329|P3|COMPLETED|Randomized||39
272594|NCT01148511|657330|P2|COMPLETED|Randomized||38
272595|NCT01148511|657331|P1|COMPLETED|Randomized||0
272596|NCT01148511|657329|P3|STARTED|Randomized||45
272597|NCT01148511|657330|P2|STARTED|Randomized||48
272598|NCT01148511|657331|P1|STARTED|Randomized|All patients were randomized into the Treat and Extend and the Treat and Observe treatment groups.|0
272599|NCT01148511|657329|P3|NOT COMPLETED|Exposed to Study Drug||0
272600|NCT01148511|657330|P2|NOT COMPLETED|Exposed to Study Drug||0
272601|NCT01148511|657331|P1|NOT COMPLETED|Exposed to Study Drug||6
272602|NCT01148511|657329|P3|COMPLETED|Exposed to Study Drug||0
272603|NCT01148511|657330|P2|COMPLETED|Exposed to Study Drug||0
272604|NCT01148511|657331|P1|COMPLETED|Exposed to Study Drug||93
272605|NCT01148511|657329|P3|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
272606|NCT01148511|657330|P2|STARTED|Exposed to Study Drug|Patients were not randomized to this group until the Randomized Period.|0
272607|NCT01148511|657331|P1|STARTED|Exposed to Study Drug||99
272608|NCT01148524|657359|P9|NOT COMPLETED|Overall Study||0
272609|NCT01148524|657360|P8|NOT COMPLETED|Overall Study||0
272610|NCT01148524|657361|P7|NOT COMPLETED|Overall Study||0
272611|NCT01148524|657362|P6|NOT COMPLETED|Overall Study||0
272612|NCT01148524|657363|P5|NOT COMPLETED|Overall Study||0
272613|NCT01148524|657364|P4|NOT COMPLETED|Overall Study||0
272614|NCT01148524|657365|P3|NOT COMPLETED|Overall Study||0
272615|NCT01148524|657366|P2|NOT COMPLETED|Overall Study||0
272616|NCT01148524|657367|P1|NOT COMPLETED|Overall Study||0
272617|NCT01148524|657359|P9|COMPLETED|Overall Study||151
272618|NCT01148524|657360|P8|COMPLETED|Overall Study||51
272619|NCT01148524|657361|P7|COMPLETED|Overall Study||153
272620|NCT01148524|657362|P6|COMPLETED|Overall Study||106
272621|NCT01148524|657363|P5|COMPLETED|Overall Study||57
272622|NCT01148524|657364|P4|COMPLETED|Overall Study||102
272623|NCT01148524|657365|P3|COMPLETED|Overall Study||53
272624|NCT01148524|657366|P2|COMPLETED|Overall Study||95
272625|NCT01148524|657367|P1|COMPLETED|Overall Study||49
272626|NCT01148524|657359|P9|STARTED|Overall Study||151
272627|NCT01148524|657360|P8|STARTED|Overall Study||51
272628|NCT01148524|657361|P7|STARTED|Overall Study||153
272629|NCT01148524|657362|P6|STARTED|Overall Study||106
272630|NCT01148524|657363|P5|STARTED|Overall Study||57
272631|NCT01148524|657364|P4|STARTED|Overall Study||102
272632|NCT01148524|657365|P3|STARTED|Overall Study||53
272633|NCT01148524|657366|P2|STARTED|Overall Study||95
272634|NCT01148524|657367|P1|STARTED|Overall Study||49
272635|NCT01148537|657416|P3|NOT COMPLETED|Overall Study||3
272636|NCT01148537|657417|P2|NOT COMPLETED|Overall Study||0
272637|NCT01148537|657418|P1|NOT COMPLETED|Overall Study||3
272638|NCT01148537|657416|P3|COMPLETED|Overall Study||41
272639|NCT01148537|657417|P2|COMPLETED|Overall Study||44
272640|NCT01148537|657418|P1|COMPLETED|Overall Study||41
272641|NCT01148537|657416|P3|STARTED|Overall Study||44
272642|NCT01148537|657417|P2|STARTED|Overall Study||44
272643|NCT01148537|657418|P1|STARTED|Overall Study||44
272644|NCT01148693|657441|P2|NOT COMPLETED|Overall Study||10
272645|NCT01148693|657442|P1|NOT COMPLETED|Overall Study||13
272646|NCT01148693|657441|P2|COMPLETED|Overall Study||57
272647|NCT01148693|657442|P1|COMPLETED|Overall Study||57
272648|NCT01148693|657441|P2|STARTED|Overall Study||67
272649|NCT01148693|657442|P1|STARTED|Overall Study||70
272650|NCT01148745|657448|P1|NOT COMPLETED|Overall Study||0
272651|NCT01148745|657448|P1|COMPLETED|Overall Study||15
272652|NCT01148745|657448|P1|STARTED|Overall Study||15
272653|NCT01148771|657456|P2|NOT COMPLETED|Second Intervention||0
272654|NCT01148771|657457|P1|NOT COMPLETED|Second Intervention||0
272655|NCT01148771|657456|P2|COMPLETED|Second Intervention||5
272656|NCT01148771|657457|P1|COMPLETED|Second Intervention||6
272657|NCT01148771|657456|P2|STARTED|Second Intervention||5
272658|NCT01148771|657457|P1|STARTED|Second Intervention||6
272659|NCT01148771|657456|P2|NOT COMPLETED|Washout Period||1
272660|NCT01148771|657457|P1|NOT COMPLETED|Washout Period||0
272661|NCT01148771|657456|P2|COMPLETED|Washout Period||5
272662|NCT01148771|657457|P1|COMPLETED|Washout Period||6
272663|NCT01148771|657456|P2|STARTED|Washout Period||6
272664|NCT01148771|657457|P1|STARTED|Washout Period||6
272665|NCT01148771|657456|P2|NOT COMPLETED|First Intervention||0
272666|NCT01148771|657457|P1|NOT COMPLETED|First Intervention||0
272667|NCT01148771|657456|P2|COMPLETED|First Intervention||6
272668|NCT01148771|657457|P1|COMPLETED|First Intervention||6
272669|NCT01148771|657456|P2|STARTED|First Intervention||6
272670|NCT01148771|657457|P1|STARTED|First Intervention||6
272671|NCT01148836|657471|P2|NOT COMPLETED|Overall Study||2
272672|NCT01148836|657472|P1|NOT COMPLETED|Overall Study||1
272673|NCT01148836|657471|P2|COMPLETED|Overall Study||8
272674|NCT01148836|657472|P1|COMPLETED|Overall Study|Enrollment completed|7
272675|NCT01148836|657471|P2|STARTED|Overall Study||10
272676|NCT01148836|657472|P1|STARTED|Overall Study|Enrollment completed|8
272677|NCT01148862|657491|P2|NOT COMPLETED|Second Intervention||2
272678|NCT01148862|657492|P1|NOT COMPLETED|Second Intervention||0
272679|NCT01148862|657491|P2|COMPLETED|Second Intervention||23
272680|NCT01148862|657492|P1|COMPLETED|Second Intervention||25
272681|NCT01148862|657491|P2|STARTED|Second Intervention||25
272682|NCT01148862|657492|P1|STARTED|Second Intervention||25
272683|NCT01148862|657491|P2|NOT COMPLETED|Washout Period of 2 Weeks||0
272684|NCT01148862|657492|P1|NOT COMPLETED|Washout Period of 2 Weeks||0
272685|NCT01148862|657491|P2|COMPLETED|Washout Period of 2 Weeks||25
272686|NCT01148862|657492|P1|COMPLETED|Washout Period of 2 Weeks||25
272687|NCT01148862|657491|P2|STARTED|Washout Period of 2 Weeks||25
272688|NCT01148862|657492|P1|STARTED|Washout Period of 2 Weeks||25
272689|NCT01148862|657491|P2|NOT COMPLETED|First Intervention||0
272690|NCT01148862|657492|P1|NOT COMPLETED|First Intervention||0
272691|NCT01148862|657491|P2|COMPLETED|First Intervention||25
272692|NCT01148862|657492|P1|COMPLETED|First Intervention||25
272693|NCT01148862|657491|P2|STARTED|First Intervention||25
272694|NCT01148862|657492|P1|STARTED|First Intervention||25
272695|NCT01148979|657502|P2|NOT COMPLETED|Overall Study||1
272696|NCT01148979|657503|P1|NOT COMPLETED|Overall Study||0
272697|NCT01148979|657502|P2|COMPLETED|Overall Study||15
272698|NCT01148979|657503|P1|COMPLETED|Overall Study||13
272699|NCT01148979|657502|P2|STARTED|Overall Study||16
272700|NCT01148979|657503|P1|STARTED|Overall Study||13
272701|NCT01149057|657509|P1|NOT COMPLETED|Overall Study||57
272702|NCT01149057|657509|P1|COMPLETED|Overall Study||88
272703|NCT01149057|657509|P1|STARTED|Overall Study||145
272704|NCT01149148|657536|P2|NOT COMPLETED|Overall Study||2
272705|NCT01149148|657537|P1|NOT COMPLETED|Overall Study||2
272706|NCT01149148|657536|P2|COMPLETED|Overall Study||11
272707|NCT01149148|657537|P1|COMPLETED|Overall Study||10
272708|NCT01149148|657536|P2|STARTED|Overall Study||13
272709|NCT01149148|657537|P1|STARTED|Overall Study||12
272710|NCT01149421|657548|P3|NOT COMPLETED|Overall Study||44
272711|NCT01149421|657549|P2|NOT COMPLETED|Overall Study||29
272712|NCT01149421|657550|P1|NOT COMPLETED|Overall Study||52
272713|NCT01149421|657548|P3|COMPLETED|Overall Study||206
272714|NCT01149421|657549|P2|COMPLETED|Overall Study||225
272715|NCT01149421|657550|P1|COMPLETED|Overall Study||199
272716|NCT01149421|657548|P3|Received at Least One Dose of Study Drug|Overall Study||250
272717|NCT01149421|657549|P2|Received at Least One Dose of Study Drug|Overall Study||254
272718|NCT01149421|657550|P1|Received at Least One Dose of Study Drug|Overall Study||251
272719|NCT01149421|657548|P3|STARTED|Overall Study||250
272720|NCT01149421|657549|P2|STARTED|Overall Study||254
272721|NCT01149421|657550|P1|STARTED|Overall Study||251
272722|NCT01149434|657631|P2|NOT COMPLETED|Overall Study||5
272723|NCT01149434|657632|P1|NOT COMPLETED|Overall Study||0
272724|NCT01149434|657631|P2|COMPLETED|Overall Study||10
272725|NCT01149434|657632|P1|COMPLETED|Overall Study||4
272726|NCT01149434|657631|P2|STARTED|Overall Study||15
272727|NCT01149434|657632|P1|STARTED|Overall Study||4
272728|NCT01149460|657645|P2|NOT COMPLETED|Overall Study||2
272729|NCT01149460|657646|P1|NOT COMPLETED|Overall Study||0
272730|NCT01149460|657645|P2|COMPLETED|Overall Study||16
272731|NCT01149460|657646|P1|COMPLETED|Overall Study||18
272732|NCT01149460|657645|P2|STARTED|Overall Study||18
272733|NCT01149460|657646|P1|STARTED|Overall Study||18
272734|NCT01149473|657664|P2|NOT COMPLETED|Second Intervention||0
272735|NCT01149473|657665|P1|NOT COMPLETED|Second Intervention||0
272736|NCT01149473|657664|P2|COMPLETED|Second Intervention||38
272737|NCT01149473|657665|P1|COMPLETED|Second Intervention||38
272738|NCT01149473|657664|P2|STARTED|Second Intervention||38
272739|NCT01149473|657665|P1|STARTED|Second Intervention||38
272740|NCT01149473|657664|P2|NOT COMPLETED|Washout of 7 Days||1
272741|NCT01149473|657665|P1|NOT COMPLETED|Washout of 7 Days||1
272742|NCT01149473|657664|P2|COMPLETED|Washout of 7 Days||38
272743|NCT01149473|657665|P1|COMPLETED|Washout of 7 Days||38
272744|NCT01149473|657664|P2|STARTED|Washout of 7 Days||39
272745|NCT01149473|657665|P1|STARTED|Washout of 7 Days||39
272746|NCT01149473|657664|P2|NOT COMPLETED|First Intervention||1
272747|NCT01149473|657665|P1|NOT COMPLETED|First Intervention||1
272748|NCT01149473|657664|P2|COMPLETED|First Intervention||39
272749|NCT01149473|657665|P1|COMPLETED|First Intervention||39
272750|NCT01149473|657664|P2|STARTED|First Intervention||40
272751|NCT01149473|657665|P1|STARTED|First Intervention||40
272752|NCT01149486|657683|P2|NOT COMPLETED|Second Intervention||0
272753|NCT01149486|657684|P1|NOT COMPLETED|Second Intervention||0
272754|NCT01149486|657683|P2|COMPLETED|Second Intervention||9
272755|NCT01149486|657684|P1|COMPLETED|Second Intervention||10
272756|NCT01149486|657683|P2|STARTED|Second Intervention||9
272757|NCT01149486|657684|P1|STARTED|Second Intervention||10
272758|NCT01149486|657683|P2|NOT COMPLETED|Washout of 7 Days||0
272759|NCT01149486|657684|P1|NOT COMPLETED|Washout of 7 Days||0
272760|NCT01149486|657683|P2|COMPLETED|Washout of 7 Days||9
272761|NCT01149486|657684|P1|COMPLETED|Washout of 7 Days||10
272762|NCT01149486|657683|P2|STARTED|Washout of 7 Days||9
272763|NCT01149486|657684|P1|STARTED|Washout of 7 Days||10
272764|NCT01149486|657683|P2|NOT COMPLETED|First Intervention||1
272765|NCT01149486|657684|P1|NOT COMPLETED|First Intervention||0
272766|NCT01149486|657683|P2|COMPLETED|First Intervention||9
272767|NCT01149486|657684|P1|COMPLETED|First Intervention||10
272768|NCT01149486|657683|P2|STARTED|First Intervention||10
272769|NCT01149486|657684|P1|STARTED|First Intervention||10
272770|NCT01149512|657706|P1|NOT COMPLETED|Overall Study||0
272771|NCT01149512|657706|P1|COMPLETED|Overall Study||178
272772|NCT01149512|657706|P1|STARTED|Overall Study||178
272773|NCT01149538|657713|P2|NOT COMPLETED|Overall Study||4
272774|NCT01149538|657714|P1|NOT COMPLETED|Overall Study||5
272775|NCT01149538|657713|P2|COMPLETED|Overall Study||25
272776|NCT01149538|657714|P1|COMPLETED|Overall Study||26
272777|NCT01149538|657713|P2|STARTED|Overall Study||29
272778|NCT01149538|657714|P1|STARTED|Overall Study||31
272779|NCT01143259|657730|P2|NOT COMPLETED|Overall Study||20
272780|NCT01143259|657731|P1|NOT COMPLETED|Overall Study||23
272781|NCT01143259|657730|P2|COMPLETED|Overall Study||118
272782|NCT01143259|657731|P1|COMPLETED|Overall Study||113
272783|NCT01143259|657730|P2|STARTED|Overall Study||138
272784|NCT01143259|657731|P1|STARTED|Overall Study||136
272785|NCT01143272|657741|P2|NOT COMPLETED|Overall Study||0
272786|NCT01143272|657742|P1|NOT COMPLETED|Overall Study||0
272787|NCT01143272|657741|P2|COMPLETED|Overall Study||231
272788|NCT01143272|657742|P1|COMPLETED|Overall Study||246
272789|NCT01143272|657741|P2|STARTED|Overall Study||231
272790|NCT01143272|657742|P1|STARTED|Overall Study||246
272791|NCT01143324|657760|P1|NOT COMPLETED|Overall Study||19
272792|NCT01143324|657760|P1|COMPLETED|Overall Study||233
272793|NCT01143324|657760|P1|STARTED|Overall Study||252
272794|NCT01143337|657778|P3|NOT COMPLETED|Overall Study||12
272795|NCT01143337|657779|P2|NOT COMPLETED|Overall Study||11
272796|NCT01143337|657780|P1|NOT COMPLETED|Overall Study||10
272797|NCT01143337|657778|P3|COMPLETED|Overall Study|Frequency of this arm AE was higher than assumption before study initiation.|1
272798|NCT01143337|657779|P2|COMPLETED|Overall Study||39
272799|NCT01143337|657780|P1|COMPLETED|Overall Study||39
272800|NCT01143337|657778|P3|STARTED|Overall Study||13
272801|NCT01143337|657779|P2|STARTED|Overall Study||50
272802|NCT01143337|657780|P1|STARTED|Overall Study||49
272803|NCT01143402|657797|P3|NOT COMPLETED|Overall Study||1
272804|NCT01143402|657798|P2|NOT COMPLETED|Overall Study||1
272805|NCT01143402|657799|P1|NOT COMPLETED|Overall Study||1
272806|NCT01143402|657797|P3|COMPLETED|Overall Study||18
272807|NCT01143402|657798|P2|COMPLETED|Overall Study||49
272808|NCT01143402|657799|P1|COMPLETED|Overall Study||50
272809|NCT01143402|657797|P3|STARTED|Overall Study||19
272810|NCT01143402|657798|P2|STARTED|Overall Study||50
272811|NCT01143402|657799|P1|STARTED|Overall Study||51
272812|NCT01143610|657810|P2|NOT COMPLETED|Overall Study||0
272813|NCT01143610|657811|P1|NOT COMPLETED|Overall Study||0
272814|NCT01143610|657810|P2|COMPLETED|Overall Study||8
272815|NCT01143610|657811|P1|COMPLETED|Overall Study||7
272816|NCT01143610|657810|P2|STARTED|Overall Study||8
272817|NCT01143610|657811|P1|STARTED|Overall Study||7
272818|NCT01143636|657822|P4|NOT COMPLETED|Overall Study||0
272819|NCT01143636|657823|P3|NOT COMPLETED|Overall Study||0
272820|NCT01143636|657824|P2|NOT COMPLETED|Overall Study||1
272821|NCT01143636|657825|P1|NOT COMPLETED|Overall Study||1
272822|NCT01143636|657822|P4|COMPLETED|Overall Study||7
272823|NCT01143636|657823|P3|COMPLETED|Overall Study||8
272824|NCT01143636|657824|P2|COMPLETED|Overall Study||4
272825|NCT01143636|657825|P1|COMPLETED|Overall Study||5
272826|NCT01143636|657822|P4|STARTED|Overall Study||7
272827|NCT01143636|657823|P3|STARTED|Overall Study||8
272828|NCT01143636|657824|P2|STARTED|Overall Study||5
272829|NCT01143636|657825|P1|STARTED|Overall Study||6
272830|NCT01143649|657858|P6|NOT COMPLETED|Overall Study||2
272831|NCT01143649|657859|P5|NOT COMPLETED|Overall Study||1
272832|NCT01143649|657860|P4|NOT COMPLETED|Overall Study||0
272833|NCT01143649|657861|P3|NOT COMPLETED|Overall Study||0
272834|NCT01143649|657862|P2|NOT COMPLETED|Overall Study||0
272835|NCT01143649|657863|P1|NOT COMPLETED|Overall Study||0
272836|NCT01143649|657858|P6|COMPLETED|Overall Study||3
272837|NCT01143649|657859|P5|COMPLETED|Overall Study||4
272838|NCT01143649|657860|P4|COMPLETED|Overall Study||10
272839|NCT01143649|657861|P3|COMPLETED|Overall Study||10
272840|NCT01143649|657862|P2|COMPLETED|Overall Study||7
272841|NCT01143649|657863|P1|COMPLETED|Overall Study||7
272842|NCT01143649|657858|P6|STARTED|Overall Study||5
272843|NCT01143649|657859|P5|STARTED|Overall Study||5
272844|NCT01143649|657860|P4|STARTED|Overall Study||10
272845|NCT01143649|657861|P3|STARTED|Overall Study||10
272846|NCT01143649|657862|P2|STARTED|Overall Study||7
272847|NCT01143649|657863|P1|STARTED|Overall Study||7
272848|NCT01143688|657877|P1|NOT COMPLETED|Overall Study||0
272849|NCT01143688|657877|P1|COMPLETED|Overall Study||39
272850|NCT01143688|657877|P1|STARTED|Overall Study||39
272851|NCT01143701|657893|P2|NOT COMPLETED|Overall Study||32
272852|NCT01143701|657894|P1|NOT COMPLETED|Overall Study||23
272853|NCT01143701|657893|P2|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|287
272854|NCT01143701|657894|P1|COMPLETED|Overall Study|Number of patients for whom at least one set of post-baseline parent-ratings were collected|235
272855|NCT01143701|657893|P2|STARTED|Overall Study||319
272856|NCT01143701|657894|P1|STARTED|Overall Study||258
272857|NCT01143714|657904|P2|NOT COMPLETED|Overall Study||3
272858|NCT01143714|657905|P1|NOT COMPLETED|Overall Study||7
272859|NCT01143714|657904|P2|COMPLETED|Overall Study||25
272860|NCT01143714|657905|P1|COMPLETED|Overall Study||22
272861|NCT01143714|657904|P2|STARTED|Overall Study||28
272862|NCT01143714|657905|P1|STARTED|Overall Study||29
272863|NCT01143727|657915|P2|NOT COMPLETED|Overall Study||0
272864|NCT01143727|657916|P1|NOT COMPLETED|Overall Study||0
272865|NCT01143727|657915|P2|COMPLETED|Overall Study||8
272866|NCT01143727|657916|P1|COMPLETED|Overall Study||9
272867|NCT01143727|657915|P2|STARTED|Overall Study||8
272868|NCT01143727|657916|P1|STARTED|Overall Study||9
272869|NCT01143766|657926|P2|NOT COMPLETED|Overall Study||0
272870|NCT01143766|657927|P1|NOT COMPLETED|Overall Study||0
272871|NCT01143766|657926|P2|COMPLETED|Overall Study||31
272872|NCT01143766|657927|P1|COMPLETED|Overall Study||25
272873|NCT01143766|657926|P2|STARTED|Overall Study||31
272874|NCT01143766|657927|P1|STARTED|Overall Study||25
272875|NCT01143792|657936|P3|NOT COMPLETED|Overall Study||0
272876|NCT01143792|657937|P2|NOT COMPLETED|Overall Study||0
272877|NCT01143792|657938|P1|NOT COMPLETED|Overall Study||0
272878|NCT01143792|657936|P3|COMPLETED|Overall Study||91
272879|NCT01143792|657937|P2|COMPLETED|Overall Study||86
272880|NCT01143792|657938|P1|COMPLETED|Overall Study||93
272881|NCT01143792|657936|P3|STARTED|Overall Study||91
272882|NCT01143792|657937|P2|STARTED|Overall Study||86
272883|NCT01143792|657938|P1|STARTED|Overall Study||93
272884|NCT01143818|657970|P1|NOT COMPLETED|Overall Study||250
272885|NCT01143818|657970|P1|COMPLETED|Overall Study||799
272886|NCT01143818|657970|P1|STARTED|Overall Study|A total of 1053 participants were enrolled but only 1049 received study drug.|1049
272887|NCT01143883|657979|P2|NOT COMPLETED|Overall Study||0
272888|NCT01143883|657980|P1|NOT COMPLETED|Overall Study||0
272889|NCT01143883|657979|P2|COMPLETED|Overall Study||55
272890|NCT01143883|657980|P1|COMPLETED|Overall Study||55
272891|NCT01143883|657979|P2|STARTED|Overall Study||55
272892|NCT01143883|657980|P1|STARTED|Overall Study||55
272893|NCT01143896|657988|P2|NOT COMPLETED|Overall Study||25
272894|NCT01143896|657989|P1|NOT COMPLETED|Overall Study||42
272895|NCT01143896|657988|P2|COMPLETED|Overall Study||128
272896|NCT01143896|657989|P1|COMPLETED|Overall Study||114
272897|NCT01143896|657988|P2|STARTED|Overall Study||153
272898|NCT01143896|657989|P1|STARTED|Overall Study||156
272899|NCT01144026|658007|P2|NOT COMPLETED|Overall Study||0
272900|NCT01144026|658008|P1|NOT COMPLETED|Overall Study||0
272901|NCT01144026|658007|P2|COMPLETED|Overall Study||5
272902|NCT01144026|658008|P1|COMPLETED|Overall Study||10
272903|NCT01144026|658007|P2|STARTED|Overall Study||5
272904|NCT01144026|658008|P1|STARTED|Overall Study||10
272905|NCT01144052|658016|P2|NOT COMPLETED|Overall Study||1
272906|NCT01144052|658017|P1|NOT COMPLETED|Overall Study||1
272907|NCT01144052|658016|P2|COMPLETED|Overall Study||8
272908|NCT01144052|658017|P1|COMPLETED|Overall Study||9
272909|NCT01144052|658016|P2|STARTED|Overall Study||9
272910|NCT01144052|658017|P1|STARTED|Overall Study||10
272911|NCT01149616|658039|P2|NOT COMPLETED|Overall Study||0
272912|NCT01149616|658040|P1|NOT COMPLETED|Overall Study||0
272913|NCT01149616|658039|P2|COMPLETED|Overall Study||41
272914|NCT01149616|658040|P1|COMPLETED|Overall Study||41
272915|NCT01149616|658039|P2|STARTED|Overall Study||41
272916|NCT01149616|658040|P1|STARTED|Overall Study||41
272917|NCT01149655|658052|P4|NOT COMPLETED|Period 3-DB Maintenance Phase||42
272918|NCT01149655|658053|P3|NOT COMPLETED|Period 3-DB Maintenance Phase||83
272919|NCT01149655|658054|P2|NOT COMPLETED|Period 3-DB Maintenance Phase||0
272920|NCT01149655|658055|P1|NOT COMPLETED|Period 3-DB Maintenance Phase||0
272921|NCT01149655|658052|P4|COMPLETED|Period 3-DB Maintenance Phase||6
272922|NCT01149655|658053|P3|COMPLETED|Period 3-DB Maintenance Phase||15
272923|NCT01149655|658054|P2|COMPLETED|Period 3-DB Maintenance Phase||0
272924|NCT01149655|658055|P1|COMPLETED|Period 3-DB Maintenance Phase||0
272925|NCT01149655|658052|P4|STARTED|Period 3-DB Maintenance Phase||48
272926|NCT01149655|658053|P3|STARTED|Period 3-DB Maintenance Phase||98
272927|NCT01149655|658054|P2|STARTED|Period 3-DB Maintenance Phase||0
272928|NCT01149655|658055|P1|STARTED|Period 3-DB Maintenance Phase||0
272929|NCT01149655|658052|P4|NOT COMPLETED|Period 2-Stabilization Phase||0
272930|NCT01149655|658053|P3|NOT COMPLETED|Period 2-Stabilization Phase||0
272931|NCT01149655|658054|P2|NOT COMPLETED|Period 2-Stabilization Phase||37
272932|NCT01149655|658055|P1|NOT COMPLETED|Period 2-Stabilization Phase||0
272933|NCT01149655|658052|P4|COMPLETED|Period 2-Stabilization Phase||0
272934|NCT01149655|658053|P3|COMPLETED|Period 2-Stabilization Phase||0
272935|NCT01149655|658054|P2|COMPLETED|Period 2-Stabilization Phase||146
272936|NCT01149655|658055|P1|COMPLETED|Period 2-Stabilization Phase||0
272937|NCT01149655|658052|P4|STARTED|Period 2-Stabilization Phase||0
272938|NCT01149655|658053|P3|STARTED|Period 2-Stabilization Phase||0
272939|NCT01149655|658054|P2|STARTED|Period 2-Stabilization Phase||183
272940|NCT01149655|658055|P1|STARTED|Period 2-Stabilization Phase||0
272941|NCT01149655|658052|P4|NOT COMPLETED|Period 1 - Conversion Phase||0
272942|NCT01149655|658053|P3|NOT COMPLETED|Period 1 - Conversion Phase||0
272943|NCT01149655|658054|P2|NOT COMPLETED|Period 1 - Conversion Phase||0
272944|NCT01149655|658055|P1|NOT COMPLETED|Period 1 - Conversion Phase||18
272945|NCT01149655|658052|P4|COMPLETED|Period 1 - Conversion Phase||0
272946|NCT01149655|658053|P3|COMPLETED|Period 1 - Conversion Phase||0
272947|NCT01149655|658054|P2|COMPLETED|Period 1 - Conversion Phase||0
272948|NCT01149655|658055|P1|COMPLETED|Period 1 - Conversion Phase||168
272949|NCT01149655|658052|P4|STARTED|Period 1 - Conversion Phase||0
272950|NCT01149655|658053|P3|STARTED|Period 1 - Conversion Phase||0
272951|NCT01149655|658054|P2|STARTED|Period 1 - Conversion Phase||0
272952|NCT01149655|658055|P1|STARTED|Period 1 - Conversion Phase||186
272953|NCT01149733|658085|P2|NOT COMPLETED|Overall Study||0
272954|NCT01149733|658086|P1|NOT COMPLETED|Overall Study||0
272955|NCT01149733|658085|P2|COMPLETED|Overall Study||16
272956|NCT01149733|658086|P1|COMPLETED|Overall Study||16
272957|NCT01149733|658085|P2|STARTED|Overall Study||16
272958|NCT01149733|658086|P1|STARTED|Overall Study||16
272959|NCT01149759|658096|P1|NOT COMPLETED|Overall Study||0
272960|NCT01149759|658096|P1|COMPLETED|Overall Study||9
272961|NCT01149759|658096|P1|STARTED|Overall Study||9
272962|NCT01149772|658103|P2|NOT COMPLETED|Overall Study||21
272963|NCT01149772|658104|P1|NOT COMPLETED|Overall Study||48
272964|NCT01149772|658103|P2|COMPLETED|Overall Study||101
272965|NCT01149772|658104|P1|COMPLETED|Overall Study||132
272966|NCT01149772|658103|P2|STARTED|Overall Study||122
272967|NCT01149772|658104|P1|STARTED|Overall Study||180
272968|NCT01149785|658120|P2|NOT COMPLETED|Second Intervention||0
272969|NCT01149785|658121|P1|NOT COMPLETED|Second Intervention||0
272970|NCT01149785|658120|P2|COMPLETED|Second Intervention||15
272971|NCT01149785|658121|P1|COMPLETED|Second Intervention||0
272972|NCT01149785|658120|P2|STARTED|Second Intervention||15
272973|NCT01149785|658121|P1|STARTED|Second Intervention||0
272974|NCT01149785|658120|P2|NOT COMPLETED|Washout Period of at Least 14 Days||0
272975|NCT01149785|658121|P1|NOT COMPLETED|Washout Period of at Least 14 Days||0
272976|NCT01149785|658120|P2|COMPLETED|Washout Period of at Least 14 Days||0
272977|NCT01149785|658121|P1|COMPLETED|Washout Period of at Least 14 Days||15
272978|NCT01149785|658120|P2|STARTED|Washout Period of at Least 14 Days||0
272979|NCT01149785|658121|P1|STARTED|Washout Period of at Least 14 Days||15
272980|NCT01149785|658120|P2|NOT COMPLETED|First Intervention||0
272981|NCT01149785|658121|P1|NOT COMPLETED|First Intervention||0
272982|NCT01149785|658120|P2|COMPLETED|First Intervention||0
272983|NCT01149785|658121|P1|COMPLETED|First Intervention||15
272984|NCT01149785|658120|P2|STARTED|First Intervention||0
272985|NCT01149785|658121|P1|STARTED|First Intervention||15
272986|NCT01149863|658153|P1|NOT COMPLETED|Overall Study||3
272987|NCT01149863|658153|P1|COMPLETED|Overall Study||31
272988|NCT01149863|658153|P1|STARTED|Overall Study||34
272989|NCT01149876|658162|P4|NOT COMPLETED|Overall Study||0
272990|NCT01149876|658163|P3|NOT COMPLETED|Overall Study||1
272991|NCT01149876|658164|P2|NOT COMPLETED|Overall Study||0
272992|NCT01149876|658165|P1|NOT COMPLETED|Overall Study||1
272993|NCT01149876|658162|P4|COMPLETED|Overall Study||18
272994|NCT01149876|658163|P3|COMPLETED|Overall Study||20
272995|NCT01149876|658164|P2|COMPLETED|Overall Study||20
272996|NCT01149876|658165|P1|COMPLETED|Overall Study||20
272997|NCT01149876|658162|P4|STARTED|Overall Study||18
272998|NCT01149876|658163|P3|STARTED|Overall Study||21
272999|NCT01149876|658164|P2|STARTED|Overall Study||20
273000|NCT01149876|658165|P1|STARTED|Overall Study||21
273001|NCT01151761|658179|P1|NOT COMPLETED|Overall Study||0
273002|NCT01151761|658179|P1|COMPLETED|Overall Study||2
273003|NCT01151761|658179|P1|STARTED|Overall Study||2
273004|NCT01151852|658192|P2|NOT COMPLETED|Overall Study||0
273005|NCT01151852|658193|P1|NOT COMPLETED|Overall Study||0
273006|NCT01151852|658192|P2|COMPLETED|Overall Study||40
273007|NCT01151852|658193|P1|COMPLETED|Overall Study||41
273008|NCT01151852|658192|P2|STARTED|Overall Study||40
273009|NCT01151852|658193|P1|STARTED|Overall Study||41
273010|NCT01151904|658209|P1|NOT COMPLETED|Overall Study||0
273011|NCT01151904|658209|P1|COMPLETED|Overall Study||17
273012|NCT01151904|658209|P1|STARTED|Overall Study||17
273013|NCT01152190|658217|P2|NOT COMPLETED|Overall Study||8
273014|NCT01152190|658218|P1|NOT COMPLETED|Overall Study||5
273015|NCT01152190|658217|P2|COMPLETED|Overall Study||39
273016|NCT01152190|658218|P1|COMPLETED|Overall Study||45
273017|NCT01152190|658217|P2|Received at Least 1 Dose of Study Drug|Overall Study||47
273018|NCT01152190|658218|P1|Received at Least 1 Dose of Study Drug|Overall Study||50
273019|NCT01152190|658217|P2|STARTED|Overall Study||47
273020|NCT01152190|658218|P1|STARTED|Overall Study||50
273021|NCT01152294|658232|P2|NOT COMPLETED|Overall Study||0
273022|NCT01152294|658233|P1|NOT COMPLETED|Overall Study||0
273023|NCT01152294|658232|P2|COMPLETED|Overall Study||188
273024|NCT01152294|658233|P1|COMPLETED|Overall Study||213
273025|NCT01152294|658232|P2|STARTED|Overall Study||188
273026|NCT01152294|658233|P1|STARTED|Overall Study||213
273027|NCT01152307|658241|P2|NOT COMPLETED|Overall Study||0
273028|NCT01152307|658242|P1|NOT COMPLETED|Overall Study||0
273029|NCT01152307|658241|P2|COMPLETED|Overall Study||214
273030|NCT01152307|658242|P1|COMPLETED|Overall Study||191
273031|NCT01152307|658241|P2|STARTED|Overall Study||214
273032|NCT01152307|658242|P1|STARTED|Overall Study||191
273033|NCT01152359|658250|P2|NOT COMPLETED|Overall Study||22
273034|NCT01152359|658251|P1|NOT COMPLETED|Overall Study||24
273035|NCT01152359|658250|P2|COMPLETED|Overall Study||80
273036|NCT01152359|658251|P1|COMPLETED|Overall Study||81
273037|NCT01152359|658250|P2|STARTED|Overall Study||102
273038|NCT01152359|658251|P1|STARTED|Overall Study||105
273039|NCT01152385|658261|P4|NOT COMPLETED|Overall Study||5
273040|NCT01152385|658262|P3|NOT COMPLETED|Overall Study||5
273041|NCT01152385|658263|P2|NOT COMPLETED|Overall Study||6
273042|NCT01152385|658264|P1|NOT COMPLETED|Overall Study||9
273043|NCT01152385|658261|P4|COMPLETED|Overall Study||50
273044|NCT01152385|658262|P3|COMPLETED|Overall Study||51
273045|NCT01152385|658263|P2|COMPLETED|Overall Study||52
273046|NCT01152385|658264|P1|COMPLETED|Overall Study||46
273047|NCT01152385|658261|P4|STARTED|Overall Study||55
273048|NCT01152385|658262|P3|STARTED|Overall Study||56
273049|NCT01152385|658263|P2|STARTED|Overall Study||58
273050|NCT01152385|658264|P1|STARTED|Overall Study||55
273051|NCT01152437|658305|P3|NOT COMPLETED|Overall Study||43
273052|NCT01152437|658306|P2|NOT COMPLETED|Overall Study||15
273053|NCT01152437|658307|P1|NOT COMPLETED|Overall Study||36
273054|NCT01152437|658305|P3|COMPLETED|Overall Study||0
273055|NCT01152437|658306|P2|COMPLETED|Overall Study||0
273056|NCT01152437|658307|P1|COMPLETED|Overall Study||0
273057|NCT01152437|658305|P3|STARTED|Overall Study|entered|43
273058|NCT01152437|658306|P2|STARTED|Overall Study|randomised|15
273059|NCT01152437|658307|P1|STARTED|Overall Study|randomised|36
273060|NCT01152450|658323|P6|NOT COMPLETED|Period 3 (4 Weeks)||0
273061|NCT01152450|658324|P5|NOT COMPLETED|Period 3 (4 Weeks)||0
273062|NCT01152450|658325|P4|NOT COMPLETED|Period 3 (4 Weeks)||0
273063|NCT01152450|658326|P3|NOT COMPLETED|Period 3 (4 Weeks)||0
273064|NCT01152450|658327|P2|NOT COMPLETED|Period 3 (4 Weeks)||0
273065|NCT01152450|658328|P1|NOT COMPLETED|Period 3 (4 Weeks)||0
273066|NCT01152450|658323|P6|COMPLETED|Period 3 (4 Weeks)||12
273067|NCT01152450|658324|P5|COMPLETED|Period 3 (4 Weeks)||16
273068|NCT01152450|658325|P4|COMPLETED|Period 3 (4 Weeks)||15
273069|NCT01152450|658326|P3|COMPLETED|Period 3 (4 Weeks)||16
273070|NCT01152450|658327|P2|COMPLETED|Period 3 (4 Weeks)||15
273071|NCT01152450|658328|P1|COMPLETED|Period 3 (4 Weeks)||15
273072|NCT01152450|658323|P6|STARTED|Period 3 (4 Weeks)||12
273073|NCT01152450|658324|P5|STARTED|Period 3 (4 Weeks)||16
273074|NCT01152450|658325|P4|STARTED|Period 3 (4 Weeks)||15
273075|NCT01152450|658326|P3|STARTED|Period 3 (4 Weeks)||16
273076|NCT01152450|658327|P2|STARTED|Period 3 (4 Weeks)||15
273077|NCT01152450|658328|P1|STARTED|Period 3 (4 Weeks)||15
273078|NCT01152450|658323|P6|NOT COMPLETED|Period 2 (4 Weeks)||0
273079|NCT01152450|658324|P5|NOT COMPLETED|Period 2 (4 Weeks)||0
273080|NCT01152450|658325|P4|NOT COMPLETED|Period 2 (4 Weeks)||0
273081|NCT01152450|658326|P3|NOT COMPLETED|Period 2 (4 Weeks)||0
273082|NCT01152450|658327|P2|NOT COMPLETED|Period 2 (4 Weeks)||0
273083|NCT01152450|658328|P1|NOT COMPLETED|Period 2 (4 Weeks)||0
273084|NCT01152450|658323|P6|COMPLETED|Period 2 (4 Weeks)||12
273085|NCT01152450|658324|P5|COMPLETED|Period 2 (4 Weeks)||16
273086|NCT01152450|658325|P4|COMPLETED|Period 2 (4 Weeks)||15
273087|NCT01152450|658326|P3|COMPLETED|Period 2 (4 Weeks)||16
273088|NCT01152450|658327|P2|COMPLETED|Period 2 (4 Weeks)||15
273089|NCT01152450|658328|P1|COMPLETED|Period 2 (4 Weeks)||15
273090|NCT01152450|658323|P6|STARTED|Period 2 (4 Weeks)||12
273091|NCT01152450|658324|P5|STARTED|Period 2 (4 Weeks)||16
273092|NCT01152450|658325|P4|STARTED|Period 2 (4 Weeks)||15
273093|NCT01152450|658326|P3|STARTED|Period 2 (4 Weeks)||16
273094|NCT01152450|658327|P2|STARTED|Period 2 (4 Weeks)||15
273095|NCT01152450|658328|P1|STARTED|Period 2 (4 Weeks)||15
273096|NCT01152450|658323|P6|NOT COMPLETED|Period 1 (4 Weeks)||1
273097|NCT01152450|658324|P5|NOT COMPLETED|Period 1 (4 Weeks)||2
273098|NCT01152450|658325|P4|NOT COMPLETED|Period 1 (4 Weeks)||0
273099|NCT01152450|658326|P3|NOT COMPLETED|Period 1 (4 Weeks)||1
273100|NCT01152450|658327|P2|NOT COMPLETED|Period 1 (4 Weeks)||1
273101|NCT01152450|658328|P1|NOT COMPLETED|Period 1 (4 Weeks)||0
273102|NCT01152450|658323|P6|COMPLETED|Period 1 (4 Weeks)||12
273103|NCT01152450|658324|P5|COMPLETED|Period 1 (4 Weeks)||16
273104|NCT01152450|658325|P4|COMPLETED|Period 1 (4 Weeks)||15
273105|NCT01152450|658326|P3|COMPLETED|Period 1 (4 Weeks)||16
273106|NCT01152450|658327|P2|COMPLETED|Period 1 (4 Weeks)||15
273107|NCT01152450|658328|P1|COMPLETED|Period 1 (4 Weeks)||15
273108|NCT01152450|658323|P6|STARTED|Period 1 (4 Weeks)||13
273109|NCT01152450|658324|P5|STARTED|Period 1 (4 Weeks)||18
273110|NCT01152450|658325|P4|STARTED|Period 1 (4 Weeks)||15
273111|NCT01152450|658326|P3|STARTED|Period 1 (4 Weeks)||17
273112|NCT01152450|658327|P2|STARTED|Period 1 (4 Weeks)||16
273113|NCT01152450|658328|P1|STARTED|Period 1 (4 Weeks)||15
273114|NCT01152554|658398|P2|NOT COMPLETED|Overall Study||111
273115|NCT01152554|658399|P1|NOT COMPLETED|Overall Study||334
273116|NCT01152554|658398|P2|COMPLETED|Overall Study||92
273117|NCT01152554|658399|P1|COMPLETED|Overall Study||276
273118|NCT01152554|658398|P2|Received Treatment|Overall Study||201
273119|NCT01152554|658399|P1|Received Treatment|Overall Study||607
273120|NCT01152554|658398|P2|STARTED|Overall Study||203
273121|NCT01152554|658399|P1|STARTED|Overall Study||610
273122|NCT01152580|658423|P2|NOT COMPLETED|Overall Study||1
273123|NCT01152580|658424|P1|NOT COMPLETED|Overall Study||0
273124|NCT01152580|658423|P2|COMPLETED|Overall Study||13
273125|NCT01152580|658424|P1|COMPLETED|Overall Study||5
273126|NCT01152580|658423|P2|STARTED|Overall Study||14
273127|NCT01152580|658424|P1|STARTED|Overall Study||5
273128|NCT01152697|658444|P1|NOT COMPLETED|Overall Study||19
273129|NCT01152697|658444|P1|COMPLETED|Overall Study||11
273130|NCT01152697|658444|P1|STARTED|Overall Study||30
273131|NCT01152788|658469|P2|NOT COMPLETED|Overall Study||4
273132|NCT01152788|658470|P1|NOT COMPLETED|Overall Study||0
273133|NCT01152788|658469|P2|COMPLETED|Overall Study||28
273134|NCT01152788|658470|P1|COMPLETED|Overall Study||32
273135|NCT01152788|658469|P2|STARTED|Overall Study||32
273136|NCT01152788|658470|P1|STARTED|Overall Study||32
273137|NCT01152814|658482|P1|NOT COMPLETED|Overall Study||2
273138|NCT01152814|658482|P1|COMPLETED|Overall Study||62
273139|NCT01152814|658482|P1|STARTED|Overall Study||64
273140|NCT01152996|658489|P1|NOT COMPLETED|Overall Study||537
273141|NCT01152996|658489|P1|COMPLETED|Overall Study||538
273142|NCT01152996|658489|P1|Treated|Overall Study||1073
273143|NCT01152996|658489|P1|STARTED|Overall Study||1075
273144|NCT01153009|658506|P4|NOT COMPLETED|Overall Study||37
273145|NCT01153009|658507|P3|NOT COMPLETED|Overall Study||41
273146|NCT01153009|658508|P2|NOT COMPLETED|Overall Study||34
273147|NCT01153009|658509|P1|NOT COMPLETED|Overall Study||32
273148|NCT01153009|658506|P4|COMPLETED|Overall Study||115
273149|NCT01153009|658507|P3|COMPLETED|Overall Study||113
273150|NCT01153009|658508|P2|COMPLETED|Overall Study||113
273151|NCT01153009|658509|P1|COMPLETED|Overall Study||129
273152|NCT01153009|658506|P4|Treated|Overall Study||150
273153|NCT01153009|658507|P3|Treated|Overall Study||154
273154|NCT01153009|658508|P2|Treated|Overall Study||147
273155|NCT01153009|658509|P1|Treated|Overall Study||159
273156|NCT01153009|658506|P4|STARTED|Overall Study||152
273157|NCT01153009|658507|P3|STARTED|Overall Study||154
273158|NCT01153009|658508|P2|STARTED|Overall Study||147
273159|NCT01153009|658509|P1|STARTED|Overall Study||161
273160|NCT01153269|658539|P1|NOT COMPLETED|Overall Study||2
273161|NCT01153269|658539|P1|COMPLETED|Overall Study||31
273162|NCT01153269|658539|P1|Participants Analyzed|Overall Study||33
273163|NCT01153269|658539|P1|STARTED|Overall Study||33
273164|NCT01153321|658600|P2|NOT COMPLETED|Overall Study||3
273165|NCT01153321|658601|P1|NOT COMPLETED|Overall Study||1
273166|NCT01153321|658600|P2|COMPLETED|Overall Study||19
273167|NCT01153321|658601|P1|COMPLETED|Overall Study||21
273168|NCT01153321|658600|P2|STARTED|Overall Study||22
273169|NCT01153321|658601|P1|STARTED|Overall Study||22
273170|NCT01153347|658717|P4|NOT COMPLETED|Overall Study||32
273171|NCT01153347|658718|P3|NOT COMPLETED|Overall Study||50
273172|NCT01153347|658719|P2|NOT COMPLETED|Overall Study||44
273173|NCT01153347|658720|P1|NOT COMPLETED|Overall Study||33
273174|NCT01153347|658717|P4|COMPLETED|Overall Study||129
273175|NCT01153347|658718|P3|COMPLETED|Overall Study||110
273176|NCT01153347|658719|P2|COMPLETED|Overall Study||116
273177|NCT01153347|658720|P1|COMPLETED|Overall Study||127
273178|NCT01153347|658717|P4|Received Treatment|Overall Study||160
273179|NCT01153347|658718|P3|Received Treatment|Overall Study||158
273180|NCT01153347|658719|P2|Received Treatment|Overall Study||158
273181|NCT01153347|658720|P1|Received Treatment|Overall Study||160
273182|NCT01153347|658717|P4|STARTED|Overall Study||161
273183|NCT01153347|658718|P3|STARTED|Overall Study||160
273184|NCT01153347|658719|P2|STARTED|Overall Study||160
273185|NCT01153347|658720|P1|STARTED|Overall Study||160
273186|NCT01153425|658820|P2|NOT COMPLETED|Overall Study||3
273187|NCT01153425|658821|P1|NOT COMPLETED|Overall Study||3
273188|NCT01153425|658820|P2|COMPLETED|Overall Study||14
273189|NCT01153425|658821|P1|COMPLETED|Overall Study||13
273190|NCT01153425|658820|P2|STARTED|Overall Study||17
273191|NCT01153425|658821|P1|STARTED|Overall Study||16
273192|NCT01153503|658832|P3|NOT COMPLETED|Overall Study||0
273193|NCT01153503|658833|P2|NOT COMPLETED|Overall Study||1
273194|NCT01153503|658834|P1|NOT COMPLETED|Overall Study||0
273195|NCT01153503|658832|P3|COMPLETED|Overall Study||25
273196|NCT01153503|658833|P2|COMPLETED|Overall Study||24
273197|NCT01153503|658834|P1|COMPLETED|Overall Study||25
273198|NCT01153503|658832|P3|STARTED|Overall Study||25
273199|NCT01153503|658833|P2|STARTED|Overall Study||25
273200|NCT01153503|658834|P1|STARTED|Overall Study||25
273201|NCT01153581|658842|P1|NOT COMPLETED|Overall Study||0
273202|NCT01153581|658842|P1|COMPLETED|Overall Study||109
273203|NCT01153581|658842|P1|STARTED|Overall Study||109
273204|NCT01153620|658854|P2|NOT COMPLETED|Overall Study||0
273205|NCT01153620|658855|P1|NOT COMPLETED|Overall Study||0
273206|NCT01153620|658854|P2|COMPLETED|Overall Study|30 patients (31 wounds)|30
273207|NCT01153620|658855|P1|COMPLETED|Overall Study||30
273208|NCT01153620|658854|P2|STARTED|Overall Study|30 patients (31 wounds)|30
273209|NCT01153620|658855|P1|STARTED|Overall Study||30
273210|NCT01153633|658863|P2|NOT COMPLETED|Overall Study||4
273211|NCT01153633|658864|P1|NOT COMPLETED|Overall Study||4
273212|NCT01153633|658863|P2|COMPLETED|Overall Study||13
273213|NCT01153633|658864|P1|COMPLETED|Overall Study||13
273214|NCT01153633|658863|P2|STARTED|Overall Study||17
273215|NCT01153633|658864|P1|STARTED|Overall Study||17
273216|NCT01153672|658880|P1|NOT COMPLETED|Overall Study||2
273217|NCT01153672|658880|P1|COMPLETED|Overall Study||6
273218|NCT01153672|658880|P1|STARTED|Overall Study||8
273219|NCT01153685|658888|P2|NOT COMPLETED|Overall Study||0
273220|NCT01153685|658889|P1|NOT COMPLETED|Overall Study||0
273221|NCT01153685|658888|P2|COMPLETED|Overall Study||70
273222|NCT01153685|658889|P1|COMPLETED|Overall Study||50
273223|NCT01153685|658888|P2|STARTED|Overall Study||70
273224|NCT01153685|658889|P1|STARTED|Overall Study||50
273225|NCT01153698|658913|P1|NOT COMPLETED|Overall Study||29
273226|NCT01153698|658913|P1|COMPLETED|Overall Study|Completed Pradaxa treatment.|139
273227|NCT01153698|658913|P1|STARTED|Overall Study|Entered and treated.|168
273228|NCT01153711|658927|P1|NOT COMPLETED|Overall Study||0
273229|NCT01153711|658927|P1|COMPLETED|Overall Study||32
273230|NCT01153711|658927|P1|STARTED|Overall Study||32
273231|NCT01153724|658947|P1|NOT COMPLETED|Treatment Period 2||2
273232|NCT01153724|658947|P1|COMPLETED|Treatment Period 2||32
273233|NCT01153724|658947|P1|STARTED|Treatment Period 2||34
273234|NCT01153724|658947|P1|NOT COMPLETED|Treatment Period 1||1
273235|NCT01153724|658947|P1|COMPLETED|Treatment Period 1||34
273236|NCT01153724|658947|P1|STARTED|Treatment Period 1||35
273237|NCT01153763|658967|P1|NOT COMPLETED|Overall Study||21
273238|NCT01153763|658967|P1|COMPLETED|Overall Study||71
273239|NCT01153763|658967|P1|STARTED|Overall Study||92
273240|NCT01153815|658985|P2|NOT COMPLETED|Overall Study||5
273241|NCT01153815|658986|P1|NOT COMPLETED|Overall Study||9
273242|NCT01153815|658985|P2|COMPLETED|Overall Study||82
273243|NCT01153815|658986|P1|COMPLETED|Overall Study||74
273244|NCT01153815|658985|P2|STARTED|Overall Study||87
273245|NCT01153815|658986|P1|STARTED|Overall Study||83
273246|NCT01153841|659010|P2|NOT COMPLETED|Overall Study||0
273247|NCT01153841|659011|P1|NOT COMPLETED|Overall Study||6
273248|NCT01153841|659010|P2|COMPLETED|Overall Study||99
273249|NCT01153841|659011|P1|COMPLETED|Overall Study||193
273250|NCT01153841|659010|P2|STARTED|Overall Study||99
273251|NCT01153841|659011|P1|STARTED|Overall Study||199
273252|NCT01153893|659027|P2|NOT COMPLETED|Overall Study||0
273253|NCT01153893|659028|P1|NOT COMPLETED|Overall Study||1
273254|NCT01153893|659027|P2|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 3.|36
273255|NCT01153893|659028|P1|COMPLETED|Overall Study|Number of subjects who completed the follow-up visit at Month 1.|67
273256|NCT01153893|659027|P2|STARTED|Overall Study||36
273257|NCT01153893|659028|P1|STARTED|Overall Study|Issues with the informed consent obtained from one child led to related data not used in this report|68
273258|NCT01153958|659054|P2|NOT COMPLETED|Overall Study||32
273259|NCT01153958|659055|P1|NOT COMPLETED|Overall Study||36
273260|NCT01153958|659054|P2|COMPLETED|Overall Study||35
273261|NCT01153958|659055|P1|COMPLETED|Overall Study||30
273262|NCT01153958|659054|P2|STARTED|Overall Study||67
273263|NCT01153958|659055|P1|STARTED|Overall Study||66
273264|NCT01153971|659071|P1|NOT COMPLETED|Follow-up (Months 17-40 of Study)||4
273265|NCT01153971|659071|P1|COMPLETED|Follow-up (Months 17-40 of Study)||37
273266|NCT01153971|659071|P1|STARTED|Follow-up (Months 17-40 of Study)||41
273267|NCT01153971|659071|P1|NOT COMPLETED|Maintenance Phase (Months 8-16 of Study)||3
273268|NCT01153971|659071|P1|COMPLETED|Maintenance Phase (Months 8-16 of Study)||41
273269|NCT01153971|659071|P1|STARTED|Maintenance Phase (Months 8-16 of Study)||44
273270|NCT01153971|659071|P1|NOT COMPLETED|Induction Phase (Months 1 to 7 of Study)||3
273271|NCT01153971|659071|P1|COMPLETED|Induction Phase (Months 1 to 7 of Study)||44
273272|NCT01153971|659071|P1|STARTED|Induction Phase (Months 1 to 7 of Study)||47
273273|NCT01153984|659092|P1|NOT COMPLETED|Overall Study||2
273274|NCT01153984|659092|P1|COMPLETED|Overall Study||21
273275|NCT01153984|659092|P1|STARTED|Overall Study||23
273276|NCT01154010|659105|P2|NOT COMPLETED|Overall Study||1
273277|NCT01154010|659106|P1|NOT COMPLETED|Overall Study||0
273278|NCT01154010|659105|P2|COMPLETED|Overall Study||8
273279|NCT01154010|659106|P1|COMPLETED|Overall Study||9
273280|NCT01154010|659105|P2|STARTED|Overall Study||9
273281|NCT01154010|659106|P1|STARTED|Overall Study||9
273282|NCT01154036|659115|P8|NOT COMPLETED|Phase II||6
273283|NCT01154036|659116|P7|NOT COMPLETED|Phase II||9
273284|NCT01154036|659117|P6|NOT COMPLETED|Phase II||5
273285|NCT01154036|659118|P5|NOT COMPLETED|Phase II||8
273286|NCT01154036|659119|P4|NOT COMPLETED|Phase II||1
273287|NCT01154036|659120|P3|NOT COMPLETED|Phase II||0
273288|NCT01154036|659121|P2|NOT COMPLETED|Phase II||0
273289|NCT01154036|659122|P1|NOT COMPLETED|Phase II||0
273290|NCT01154036|659115|P8|COMPLETED|Phase II||200
273291|NCT01154036|659116|P7|COMPLETED|Phase II||225
273292|NCT01154036|659117|P6|COMPLETED|Phase II||121
273293|NCT01154036|659118|P5|COMPLETED|Phase II||116
273294|NCT01154036|659119|P4|COMPLETED|Phase II||27
273295|NCT01154036|659120|P3|COMPLETED|Phase II||0
273296|NCT01154036|659121|P2|COMPLETED|Phase II||0
273297|NCT01154036|659122|P1|COMPLETED|Phase II||0
273298|NCT01154036|659115|P8|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|206
273299|NCT01154036|659116|P7|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|234
273300|NCT01154036|659117|P6|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|126
273301|NCT01154036|659118|P5|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|124
273302|NCT01154036|659119|P4|STARTED|Phase II|Only participants who did not meet LDL-C goals at the end of Phase I, were eligible for Phase II|28
273303|NCT01154036|659120|P3|STARTED|Phase II||0
273304|NCT01154036|659121|P2|STARTED|Phase II||0
273305|NCT01154036|659122|P1|STARTED|Phase II||0
273306|NCT01154036|659115|P8|NOT COMPLETED|Phase I||0
273307|NCT01154036|659116|P7|NOT COMPLETED|Phase I||0
273308|NCT01154036|659117|P6|NOT COMPLETED|Phase I||0
273309|NCT01154036|659118|P5|NOT COMPLETED|Phase I||0
273310|NCT01154036|659119|P4|NOT COMPLETED|Phase I||0
273311|NCT01154036|659120|P3|NOT COMPLETED|Phase I||56
273312|NCT01154036|659121|P2|NOT COMPLETED|Phase I||28
273313|NCT01154036|659122|P1|NOT COMPLETED|Phase I||3
273314|NCT01154036|659115|P8|COMPLETED|Phase I||0
273315|NCT01154036|659116|P7|COMPLETED|Phase I||0
273316|NCT01154036|659117|P6|COMPLETED|Phase I||0
273317|NCT01154036|659118|P5|COMPLETED|Phase I||0
273318|NCT01154036|659119|P4|COMPLETED|Phase I||0
273319|NCT01154036|659120|P3|COMPLETED|Phase I|Not all completers were eligible for Phase II|888
273320|NCT01154036|659121|P2|COMPLETED|Phase I|Not all completers were eligible for Phase II|455
273321|NCT01154036|659122|P1|COMPLETED|Phase I|Not all completers were eligible for Phase II|117
273322|NCT01154036|659115|P8|STARTED|Phase I||0
273323|NCT01154036|659116|P7|STARTED|Phase I||0
273324|NCT01154036|659117|P6|STARTED|Phase I||0
273325|NCT01154036|659118|P5|STARTED|Phase I||0
273326|NCT01154036|659119|P4|STARTED|Phase I||0
273327|NCT01154036|659120|P3|STARTED|Phase I||944
273328|NCT01154036|659121|P2|STARTED|Phase I||483
273329|NCT01154036|659122|P1|STARTED|Phase I||120
273330|NCT01147055|659244|P2|NOT COMPLETED|Second Intervention Period||0
273331|NCT01147055|659245|P1|NOT COMPLETED|Second Intervention Period||0
273332|NCT01147055|659244|P2|COMPLETED|Second Intervention Period||14
273333|NCT01147055|659245|P1|COMPLETED|Second Intervention Period||0
273334|NCT01147055|659244|P2|STARTED|Second Intervention Period||14
273335|NCT01147055|659245|P1|STARTED|Second Intervention Period||0
273336|NCT01147055|659244|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273337|NCT01147055|659245|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273338|NCT01147055|659244|P2|COMPLETED|Washout Period (at Least 14 Days)||0
273339|NCT01147055|659245|P1|COMPLETED|Washout Period (at Least 14 Days)||14
273340|NCT01147055|659244|P2|STARTED|Washout Period (at Least 14 Days)||0
273341|NCT01147055|659245|P1|STARTED|Washout Period (at Least 14 Days)||14
273342|NCT01147055|659244|P2|NOT COMPLETED|First Intervention Period||0
273343|NCT01147055|659245|P1|NOT COMPLETED|First Intervention Period||1
273344|NCT01147055|659244|P2|COMPLETED|First Intervention Period||0
273345|NCT01147055|659245|P1|COMPLETED|First Intervention Period||14
273346|NCT01147055|659244|P2|STARTED|First Intervention Period||0
273347|NCT01147055|659245|P1|STARTED|First Intervention Period||15
273348|NCT01147068|659284|P7|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
273349|NCT01147068|659285|P6|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
273350|NCT01147068|659286|P5|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
273351|NCT01147068|659287|P4|NOT COMPLETED|Subjects That Completed Safety Follow-up||2
273352|NCT01147068|659288|P3|NOT COMPLETED|Subjects That Completed Safety Follow-up||0
273353|NCT01147068|659289|P2|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
273354|NCT01147068|659290|P1|NOT COMPLETED|Subjects That Completed Safety Follow-up||1
273355|NCT01147068|659284|P7|COMPLETED|Subjects That Completed Safety Follow-up||54
273356|NCT01147068|659285|P6|COMPLETED|Subjects That Completed Safety Follow-up||52
273357|NCT01147068|659286|P5|COMPLETED|Subjects That Completed Safety Follow-up||56
273358|NCT01147068|659287|P4|COMPLETED|Subjects That Completed Safety Follow-up||54
273359|NCT01147068|659288|P3|COMPLETED|Subjects That Completed Safety Follow-up||55
273360|NCT01147068|659289|P2|COMPLETED|Subjects That Completed Safety Follow-up||56
273361|NCT01147068|659290|P1|COMPLETED|Subjects That Completed Safety Follow-up||59
273362|NCT01147068|659284|P7|STARTED|Subjects That Completed Safety Follow-up||55
273363|NCT01147068|659285|P6|STARTED|Subjects That Completed Safety Follow-up|One subject was lost to follow up and one subject did not complete the study.|53
273364|NCT01147068|659286|P5|STARTED|Subjects That Completed Safety Follow-up|Data for one subject is unknown.|56
273365|NCT01147068|659287|P4|STARTED|Subjects That Completed Safety Follow-up||56
273366|NCT01147068|659288|P3|STARTED|Subjects That Completed Safety Follow-up|Data on three subjects is unknown.|55
273367|NCT01147068|659289|P2|STARTED|Subjects That Completed Safety Follow-up|One subject was ineligible, one subject did not complete the study, and the other data is unknown.|57
273368|NCT01147068|659290|P1|STARTED|Subjects That Completed Safety Follow-up|Participants were eligible for follow-up regardless of number of doses received.|60
273454|NCT01154218|659448|P3|COMPLETED|Fourth Intervention Period||9
273369|NCT01147068|659284|P7|NOT COMPLETED|Subjects That Received 2nd Dose||0
273370|NCT01147068|659285|P6|NOT COMPLETED|Subjects That Received 2nd Dose||2
273371|NCT01147068|659286|P5|NOT COMPLETED|Subjects That Received 2nd Dose||1
273372|NCT01147068|659287|P4|NOT COMPLETED|Subjects That Received 2nd Dose||0
273373|NCT01147068|659288|P3|NOT COMPLETED|Subjects That Received 2nd Dose||3
273374|NCT01147068|659289|P2|NOT COMPLETED|Subjects That Received 2nd Dose||5
273375|NCT01147068|659290|P1|NOT COMPLETED|Subjects That Received 2nd Dose||1
273376|NCT01147068|659284|P7|COMPLETED|Subjects That Received 2nd Dose||55
273377|NCT01147068|659285|P6|COMPLETED|Subjects That Received 2nd Dose||51
273378|NCT01147068|659286|P5|COMPLETED|Subjects That Received 2nd Dose||55
273379|NCT01147068|659287|P4|COMPLETED|Subjects That Received 2nd Dose||56
273380|NCT01147068|659288|P3|COMPLETED|Subjects That Received 2nd Dose||52
273381|NCT01147068|659289|P2|COMPLETED|Subjects That Received 2nd Dose||52
273382|NCT01147068|659290|P1|COMPLETED|Subjects That Received 2nd Dose||59
273383|NCT01147068|659284|P7|STARTED|Subjects That Received 2nd Dose||55
273384|NCT01147068|659285|P6|STARTED|Subjects That Received 2nd Dose||53
273385|NCT01147068|659286|P5|STARTED|Subjects That Received 2nd Dose||56
273386|NCT01147068|659287|P4|STARTED|Subjects That Received 2nd Dose||56
273387|NCT01147068|659288|P3|STARTED|Subjects That Received 2nd Dose||55
273388|NCT01147068|659289|P2|STARTED|Subjects That Received 2nd Dose||57
273389|NCT01147068|659290|P1|STARTED|Subjects That Received 2nd Dose||60
273390|NCT01147068|659284|P7|NOT COMPLETED|Subjects That Received 1st Dose||0
273391|NCT01147068|659285|P6|NOT COMPLETED|Subjects That Received 1st Dose||0
273392|NCT01147068|659286|P5|NOT COMPLETED|Subjects That Received 1st Dose||0
273393|NCT01147068|659287|P4|NOT COMPLETED|Subjects That Received 1st Dose||0
273394|NCT01147068|659288|P3|NOT COMPLETED|Subjects That Received 1st Dose||0
273395|NCT01147068|659289|P2|NOT COMPLETED|Subjects That Received 1st Dose||0
273396|NCT01147068|659290|P1|NOT COMPLETED|Subjects That Received 1st Dose||0
273397|NCT01147068|659284|P7|COMPLETED|Subjects That Received 1st Dose||55
273398|NCT01147068|659285|P6|COMPLETED|Subjects That Received 1st Dose||53
273399|NCT01147068|659286|P5|COMPLETED|Subjects That Received 1st Dose||56
273400|NCT01147068|659287|P4|COMPLETED|Subjects That Received 1st Dose||56
273401|NCT01147068|659288|P3|COMPLETED|Subjects That Received 1st Dose||55
273402|NCT01147068|659289|P2|COMPLETED|Subjects That Received 1st Dose||57
273403|NCT01147068|659290|P1|COMPLETED|Subjects That Received 1st Dose||60
273404|NCT01147068|659284|P7|STARTED|Subjects That Received 1st Dose||55
273405|NCT01147068|659285|P6|STARTED|Subjects That Received 1st Dose||53
273406|NCT01147068|659286|P5|STARTED|Subjects That Received 1st Dose||56
273407|NCT01147068|659287|P4|STARTED|Subjects That Received 1st Dose||56
273408|NCT01147068|659288|P3|STARTED|Subjects That Received 1st Dose||55
273409|NCT01147068|659289|P2|STARTED|Subjects That Received 1st Dose||57
273410|NCT01147068|659290|P1|STARTED|Subjects That Received 1st Dose||60
273411|NCT01154127|659322|P2|NOT COMPLETED|Period 2 (21 Days)||1
273412|NCT01154127|659323|P1|NOT COMPLETED|Period 2 (21 Days)||0
273413|NCT01154127|659322|P2|COMPLETED|Period 2 (21 Days)||46
273414|NCT01154127|659323|P1|COMPLETED|Period 2 (21 Days)||49
273415|NCT01154127|659322|P2|STARTED|Period 2 (21 Days)||47
273416|NCT01154127|659323|P1|STARTED|Period 2 (21 Days)||49
273417|NCT01154127|659322|P2|NOT COMPLETED|Washout (14 - 28 Days)||0
273418|NCT01154127|659323|P1|NOT COMPLETED|Washout (14 - 28 Days)||3
273419|NCT01154127|659322|P2|COMPLETED|Washout (14 - 28 Days)||47
273420|NCT01154127|659323|P1|COMPLETED|Washout (14 - 28 Days)||49
273421|NCT01154127|659322|P2|STARTED|Washout (14 - 28 Days)||47
273422|NCT01154127|659323|P1|STARTED|Washout (14 - 28 Days)||52
273423|NCT01154127|659322|P2|NOT COMPLETED|Period 1 (21 Days)||6
273424|NCT01154127|659323|P1|NOT COMPLETED|Period 1 (21 Days)||3
273425|NCT01154127|659322|P2|COMPLETED|Period 1 (21 Days)||47
273426|NCT01154127|659323|P1|COMPLETED|Period 1 (21 Days)||52
273427|NCT01154127|659322|P2|STARTED|Period 1 (21 Days)||53
273428|NCT01154127|659323|P1|STARTED|Period 1 (21 Days)||55
273429|NCT01154140|659347|P2|NOT COMPLETED|Overall Study||171
273430|NCT01154140|659348|P1|NOT COMPLETED|Overall Study||172
273431|NCT01154140|659347|P2|COMPLETED|Overall Study||0
273432|NCT01154140|659348|P1|COMPLETED|Overall Study||0
273433|NCT01154140|659347|P2|Treated|Overall Study||169
273434|NCT01154140|659348|P1|Treated|Overall Study||171
273435|NCT01154140|659347|P2|STARTED|Overall Study||171
273436|NCT01154140|659348|P1|STARTED|Overall Study||172
273437|NCT01154153|659397|P2|NOT COMPLETED|Overall Study||3
273438|NCT01154153|659398|P1|NOT COMPLETED|Overall Study||5
273439|NCT01154153|659397|P2|COMPLETED|Overall Study||66
273440|NCT01154153|659398|P1|COMPLETED|Overall Study||66
273441|NCT01154153|659397|P2|STARTED|Overall Study||69
273442|NCT01154153|659398|P1|STARTED|Overall Study||71
273443|NCT01154166|659416|P2|NOT COMPLETED|Overall Study||12
273444|NCT01154166|659417|P1|NOT COMPLETED|Overall Study||34
273445|NCT01154166|659416|P2|COMPLETED|Overall Study||163
273446|NCT01154166|659417|P1|COMPLETED|Overall Study||135
273447|NCT01154166|659416|P2|STARTED|Overall Study||175
273448|NCT01154166|659417|P1|STARTED|Overall Study||169
273449|NCT01154218|659447|P4|NOT COMPLETED|Fourth Intervention Period||0
273450|NCT01154218|659448|P3|NOT COMPLETED|Fourth Intervention Period||0
273451|NCT01154218|659449|P2|NOT COMPLETED|Fourth Intervention Period||0
273452|NCT01154218|659450|P1|NOT COMPLETED|Fourth Intervention Period||1
273453|NCT01154218|659447|P4|COMPLETED|Fourth Intervention Period||8
273455|NCT01154218|659449|P2|COMPLETED|Fourth Intervention Period||8
273456|NCT01154218|659450|P1|COMPLETED|Fourth Intervention Period||8
273457|NCT01154218|659447|P4|STARTED|Fourth Intervention Period||8
273458|NCT01154218|659448|P3|STARTED|Fourth Intervention Period||9
273459|NCT01154218|659449|P2|STARTED|Fourth Intervention Period||8
273460|NCT01154218|659450|P1|STARTED|Fourth Intervention Period||9
273461|NCT01154218|659447|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||1
273462|NCT01154218|659448|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273463|NCT01154218|659449|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273464|NCT01154218|659450|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273465|NCT01154218|659447|P4|COMPLETED|Washout Period (at Least 14 Days)||8
273466|NCT01154218|659448|P3|COMPLETED|Washout Period (at Least 14 Days)||9
273467|NCT01154218|659449|P2|COMPLETED|Washout Period (at Least 14 Days)||8
273468|NCT01154218|659450|P1|COMPLETED|Washout Period (at Least 14 Days)||9
273469|NCT01154218|659447|P4|STARTED|Washout Period (at Least 14 Days)||9
273470|NCT01154218|659448|P3|STARTED|Washout Period (at Least 14 Days)||9
273471|NCT01154218|659449|P2|STARTED|Washout Period (at Least 14 Days)||8
273472|NCT01154218|659450|P1|STARTED|Washout Period (at Least 14 Days)||9
273473|NCT01154218|659447|P4|NOT COMPLETED|Third Intervention Period||0
273474|NCT01154218|659448|P3|NOT COMPLETED|Third Intervention Period||0
273475|NCT01154218|659449|P2|NOT COMPLETED|Third Intervention Period||1
273476|NCT01154218|659450|P1|NOT COMPLETED|Third Intervention Period||0
273477|NCT01154218|659447|P4|COMPLETED|Third Intervention Period||9
273478|NCT01154218|659448|P3|COMPLETED|Third Intervention Period||9
273479|NCT01154218|659449|P2|COMPLETED|Third Intervention Period||8
273480|NCT01154218|659450|P1|COMPLETED|Third Intervention Period||9
273481|NCT01154218|659447|P4|STARTED|Third Intervention Period||9
273482|NCT01154218|659448|P3|STARTED|Third Intervention Period||9
273483|NCT01154218|659449|P2|STARTED|Third Intervention Period||9
273484|NCT01154218|659450|P1|STARTED|Third Intervention Period||9
273485|NCT01154218|659447|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273486|NCT01154218|659448|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273487|NCT01154218|659449|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273488|NCT01154218|659450|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273489|NCT01154218|659447|P4|COMPLETED|Washout Period (at Least 14 Days)||9
273490|NCT01154218|659448|P3|COMPLETED|Washout Period (at Least 14 Days)||9
273491|NCT01154218|659449|P2|COMPLETED|Washout Period (at Least 14 Days)||9
273492|NCT01154218|659450|P1|COMPLETED|Washout Period (at Least 14 Days)||9
273493|NCT01154218|659447|P4|STARTED|Washout Period (at Least 14 Days)||9
273494|NCT01154218|659448|P3|STARTED|Washout Period (at Least 14 Days)||9
273495|NCT01154218|659449|P2|STARTED|Washout Period (at Least 14 Days)||9
273496|NCT01154218|659450|P1|STARTED|Washout Period (at Least 14 Days)||9
273497|NCT01154218|659447|P4|NOT COMPLETED|Second Intervention Period||0
273498|NCT01154218|659448|P3|NOT COMPLETED|Second Intervention Period||0
273499|NCT01154218|659449|P2|NOT COMPLETED|Second Intervention Period||0
273500|NCT01154218|659450|P1|NOT COMPLETED|Second Intervention Period||0
273501|NCT01154218|659447|P4|COMPLETED|Second Intervention Period||9
273502|NCT01154218|659448|P3|COMPLETED|Second Intervention Period||9
273503|NCT01154218|659449|P2|COMPLETED|Second Intervention Period||9
273504|NCT01154218|659450|P1|COMPLETED|Second Intervention Period||9
273505|NCT01154218|659447|P4|STARTED|Second Intervention Period||9
273506|NCT01154218|659448|P3|STARTED|Second Intervention Period||9
273507|NCT01154218|659449|P2|STARTED|Second Intervention Period||9
273508|NCT01154218|659450|P1|STARTED|Second Intervention Period||9
273509|NCT01154218|659447|P4|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273510|NCT01154218|659448|P3|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273511|NCT01154218|659449|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273512|NCT01154218|659450|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
273513|NCT01154218|659447|P4|COMPLETED|Washout Period (at Least 14 Days)||9
273514|NCT01154218|659448|P3|COMPLETED|Washout Period (at Least 14 Days)||9
273515|NCT01154218|659449|P2|COMPLETED|Washout Period (at Least 14 Days)||9
273516|NCT01154218|659450|P1|COMPLETED|Washout Period (at Least 14 Days)||9
273517|NCT01154218|659447|P4|STARTED|Washout Period (at Least 14 Days)||9
273518|NCT01154218|659448|P3|STARTED|Washout Period (at Least 14 Days)||9
273519|NCT01154218|659449|P2|STARTED|Washout Period (at Least 14 Days)||9
273520|NCT01154218|659450|P1|STARTED|Washout Period (at Least 14 Days)||9
273521|NCT01154218|659447|P4|NOT COMPLETED|First Intervention Period||0
273522|NCT01154218|659448|P3|NOT COMPLETED|First Intervention Period||0
273523|NCT01154218|659449|P2|NOT COMPLETED|First Intervention Period||0
273524|NCT01154218|659450|P1|NOT COMPLETED|First Intervention Period||0
273525|NCT01154218|659447|P4|COMPLETED|First Intervention Period||9
273526|NCT01154218|659448|P3|COMPLETED|First Intervention Period||9
273527|NCT01154218|659449|P2|COMPLETED|First Intervention Period||9
273528|NCT01154218|659450|P1|COMPLETED|First Intervention Period||9
273529|NCT01154218|659447|P4|STARTED|First Intervention Period||9
273530|NCT01154218|659448|P3|STARTED|First Intervention Period||9
273531|NCT01154218|659449|P2|STARTED|First Intervention Period||9
273532|NCT01154218|659450|P1|STARTED|First Intervention Period||9
273533|NCT01154231|659500|P1|NOT COMPLETED|Overall Study||2
273534|NCT01154231|659500|P1|COMPLETED|Overall Study||312
273535|NCT01154231|659500|P1|STARTED|Overall Study||314
273536|NCT01154283|659508|P2|NOT COMPLETED|7-12 Weeks||1
273537|NCT01154283|659509|P1|NOT COMPLETED|7-12 Weeks||1
273538|NCT01154283|659508|P2|COMPLETED|7-12 Weeks||10
273539|NCT01154283|659509|P1|COMPLETED|7-12 Weeks||6
273540|NCT01154283|659508|P2|STARTED|7-12 Weeks||11
273541|NCT01154283|659509|P1|STARTED|7-12 Weeks||7
273542|NCT01154283|659508|P2|NOT COMPLETED|0-6 Weeks||3
273543|NCT01154283|659509|P1|NOT COMPLETED|0-6 Weeks||7
273544|NCT01154283|659508|P2|COMPLETED|0-6 Weeks||11
273545|NCT01154283|659509|P1|COMPLETED|0-6 Weeks||7
273546|NCT01154283|659508|P2|STARTED|0-6 Weeks||14
273547|NCT01154283|659509|P1|STARTED|0-6 Weeks||14
273548|NCT01154296|659523|P2|NOT COMPLETED|6-month Follow-up||328
273549|NCT01154296|659524|P1|NOT COMPLETED|6-month Follow-up||328
273550|NCT01154296|659523|P2|COMPLETED|6-month Follow-up||2179
273551|NCT01154296|659524|P1|COMPLETED|6-month Follow-up||2177
273552|NCT01154296|659523|P2|STARTED|6-month Follow-up||2507
273553|NCT01154296|659524|P1|STARTED|6-month Follow-up||2505
273554|NCT01154296|659523|P2|NOT COMPLETED|Randomization and Intervention||2
273555|NCT01154296|659524|P1|NOT COMPLETED|Randomization and Intervention||5
273556|NCT01154296|659523|P2|COMPLETED|Randomization and Intervention||2505
273557|NCT01154296|659524|P1|COMPLETED|Randomization and Intervention||2500
273558|NCT01154296|659523|P2|STARTED|Randomization and Intervention||2507
273559|NCT01154296|659524|P1|STARTED|Randomization and Intervention||2505
273560|NCT01154322|659540|P1|NOT COMPLETED|Overall Study||2
273561|NCT01154322|659540|P1|COMPLETED|Overall Study||14
273562|NCT01154322|659540|P1|STARTED|Overall Study||16
273563|NCT01154335|659548|P3|NOT COMPLETED|Overall Study||5
273564|NCT01154335|659549|P2|NOT COMPLETED|Overall Study||6
273565|NCT01154335|659550|P1|NOT COMPLETED|Overall Study||7
273566|NCT01154335|659548|P3|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
273567|NCT01154335|659549|P2|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
273568|NCT01154335|659550|P1|COMPLETED|Overall Study|Patients continued treatment until disease progression or unacceptable toxicity occurred.|0
273569|NCT01154335|659548|P3|STARTED|Overall Study||5
273570|NCT01154335|659549|P2|STARTED|Overall Study||6
273571|NCT01154335|659550|P1|STARTED|Overall Study||7
273572|NCT01154816|659569|P12|NOT COMPLETED|Overall Study||4
273573|NCT01154816|659570|P11|NOT COMPLETED|Overall Study||11
273574|NCT01154816|659571|P10|NOT COMPLETED|Overall Study||10
273575|NCT01154816|659572|P9|NOT COMPLETED|Overall Study||9
273576|NCT01154816|659573|P8|NOT COMPLETED|Overall Study||7
273577|NCT01154816|659574|P7|NOT COMPLETED|Overall Study||6
273578|NCT01154816|659575|P6|NOT COMPLETED|Overall Study||8
273579|NCT01154816|659576|P5|NOT COMPLETED|Overall Study||10
273580|NCT01154816|659577|P4|NOT COMPLETED|Overall Study||10
273581|NCT01154816|659578|P3|NOT COMPLETED|Overall Study||10
273582|NCT01154816|659579|P2|NOT COMPLETED|Overall Study||10
273583|NCT01154816|659580|P1|NOT COMPLETED|Overall Study||20
273584|NCT01154816|659569|P12|COMPLETED|Overall Study||0
273585|NCT01154816|659570|P11|COMPLETED|Overall Study||0
273586|NCT01154816|659571|P10|COMPLETED|Overall Study||0
273587|NCT01154816|659572|P9|COMPLETED|Overall Study||1
273588|NCT01154816|659573|P8|COMPLETED|Overall Study||0
273589|NCT01154816|659574|P7|COMPLETED|Overall Study||0
273590|NCT01154816|659575|P6|COMPLETED|Overall Study||0
273591|NCT01154816|659576|P5|COMPLETED|Overall Study||0
273592|NCT01154816|659577|P4|COMPLETED|Overall Study||0
273593|NCT01154816|659578|P3|COMPLETED|Overall Study||0
273594|NCT01154816|659579|P2|COMPLETED|Overall Study||2
273595|NCT01154816|659580|P1|COMPLETED|Overall Study||0
273596|NCT01154816|659569|P12|STARTED|Overall Study||4
273597|NCT01154816|659570|P11|STARTED|Overall Study||11
273598|NCT01154816|659571|P10|STARTED|Overall Study||10
273599|NCT01154816|659572|P9|STARTED|Overall Study||10
273600|NCT01154816|659573|P8|STARTED|Overall Study||7
273601|NCT01154816|659574|P7|STARTED|Overall Study||6
273602|NCT01154816|659575|P6|STARTED|Overall Study||8
273603|NCT01154816|659576|P5|STARTED|Overall Study||10
273604|NCT01154816|659577|P4|STARTED|Overall Study||10
273605|NCT01154816|659578|P3|STARTED|Overall Study||10
273606|NCT01154816|659579|P2|STARTED|Overall Study||12
273607|NCT01154816|659580|P1|STARTED|Overall Study||20
273608|NCT01154985|659616|P3|NOT COMPLETED|Overall Study||18
273609|NCT01154985|659617|P2|NOT COMPLETED|Overall Study||27
273610|NCT01154985|659618|P1|NOT COMPLETED|Overall Study||17
273611|NCT01154985|659616|P3|COMPLETED|Overall Study||68
273612|NCT01154985|659617|P2|COMPLETED|Overall Study||55
273613|NCT01154985|659618|P1|COMPLETED|Overall Study||58
273614|NCT01154985|659616|P3|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|64
273615|NCT01154985|659617|P2|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
273616|NCT01154985|659618|P1|Efficacy Evaluable Analysis Set|Overall Study|12-months histological data, no major protocol violations; after minimum 6 months treatment|55
273617|NCT01154985|659616|P3|Valid Biopsy -Baseline and Month 12.5|Overall Study||68
273618|NCT01154985|659617|P2|Valid Biopsy -Baseline and Month 12.5|Overall Study||62
273619|NCT01154985|659618|P1|Valid Biopsy -Baseline and Month 12.5|Overall Study||60
273620|NCT01154985|659616|P3|Full Analysis Set|Overall Study|Received at least one dose of study medication|86
273621|NCT01154985|659617|P2|Full Analysis Set|Overall Study|Received at least one dose of study medication|82
273622|NCT01154985|659618|P1|Full Analysis Set|Overall Study|Received at least one dose of study medication|75
273623|NCT01154985|659616|P3|STARTED|Overall Study|Randomized|86
273624|NCT01154985|659617|P2|STARTED|Overall Study|Randomized|82
273625|NCT01154985|659618|P1|STARTED|Overall Study|Randomized|75
273626|NCT01155011|659634|P2|NOT COMPLETED|6 to 12 Months||10
273627|NCT01155011|659635|P1|NOT COMPLETED|6 to 12 Months||9
273628|NCT01155011|659634|P2|COMPLETED|6 to 12 Months||121
273629|NCT01155011|659635|P1|COMPLETED|6 to 12 Months||120
273630|NCT01155011|659634|P2|STARTED|6 to 12 Months||131
273631|NCT01155011|659635|P1|STARTED|6 to 12 Months||129
273632|NCT01155011|659634|P2|NOT COMPLETED|Baseline to 6 Months||25
273633|NCT01155011|659635|P1|NOT COMPLETED|Baseline to 6 Months||22
273634|NCT01155011|659634|P2|COMPLETED|Baseline to 6 Months||131
273635|NCT01155011|659635|P1|COMPLETED|Baseline to 6 Months||129
273636|NCT01155011|659634|P2|STARTED|Baseline to 6 Months||156
273637|NCT01155011|659635|P1|STARTED|Baseline to 6 Months||151
273638|NCT01155024|659645|P2|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||6
273639|NCT01155024|659646|P1|NOT COMPLETED|Direct Manufactured Socket 3 Month Trial||0
273640|NCT01155024|659645|P2|COMPLETED|Direct Manufactured Socket 3 Month Trial||4
273641|NCT01155024|659646|P1|COMPLETED|Direct Manufactured Socket 3 Month Trial||0
273642|NCT01155024|659645|P2|STARTED|Direct Manufactured Socket 3 Month Trial||10
273643|NCT01155024|659646|P1|STARTED|Direct Manufactured Socket 3 Month Trial||0
273644|NCT01155024|659645|P2|NOT COMPLETED|Second Socket Intervention Fitting||0
273645|NCT01155024|659646|P1|NOT COMPLETED|Second Socket Intervention Fitting||0
273646|NCT01155024|659645|P2|COMPLETED|Second Socket Intervention Fitting||5
273647|NCT01155024|659646|P1|COMPLETED|Second Socket Intervention Fitting||5
273648|NCT01155024|659645|P2|STARTED|Second Socket Intervention Fitting||5
273649|NCT01155024|659646|P1|STARTED|Second Socket Intervention Fitting||5
273650|NCT01155024|659645|P2|NOT COMPLETED|First Socket Intervention Fitting||0
273651|NCT01155024|659646|P1|NOT COMPLETED|First Socket Intervention Fitting||0
273652|NCT01155024|659645|P2|COMPLETED|First Socket Intervention Fitting||5
273653|NCT01155024|659646|P1|COMPLETED|First Socket Intervention Fitting||5
273654|NCT01155024|659645|P2|STARTED|First Socket Intervention Fitting||5
273655|NCT01155024|659646|P1|STARTED|First Socket Intervention Fitting||5
273656|NCT01155063|659654|P1|NOT COMPLETED|Overall Study||89
273657|NCT01155063|659654|P1|COMPLETED|Overall Study||0
273658|NCT01155063|659654|P1|STARTED|Overall Study||89
273659|NCT01155141|659664|P1|NOT COMPLETED|Overall Study||2
273660|NCT01155141|659664|P1|COMPLETED|Overall Study||14
273661|NCT01155141|659664|P1|STARTED|Overall Study||16
273662|NCT01155154|659679|P3|NOT COMPLETED|Overall Study||0
273663|NCT01155154|659680|P2|NOT COMPLETED|Overall Study||0
273664|NCT01155154|659681|P1|NOT COMPLETED|Overall Study||0
273665|NCT01155154|659679|P3|COMPLETED|Overall Study||24
273666|NCT01155154|659680|P2|COMPLETED|Overall Study||24
273667|NCT01155154|659681|P1|COMPLETED|Overall Study||25
273668|NCT01155154|659679|P3|STARTED|Overall Study||24
273669|NCT01155154|659680|P2|STARTED|Overall Study||24
273670|NCT01155154|659681|P1|STARTED|Overall Study||25
273671|NCT01155167|659691|P2|NOT COMPLETED|Overall Study||0
273672|NCT01155167|659692|P1|NOT COMPLETED|Overall Study||3
273673|NCT01155167|659691|P2|COMPLETED|Overall Study||43
273674|NCT01155167|659692|P1|COMPLETED|Overall Study||40
273675|NCT01155167|659691|P2|STARTED|Overall Study||43
273676|NCT01155167|659692|P1|STARTED|Overall Study||43
273677|NCT01155180|659704|P2|NOT COMPLETED|Overall Study||0
273678|NCT01155180|659705|P1|NOT COMPLETED|Overall Study||0
273679|NCT01155180|659704|P2|COMPLETED|Overall Study||6
273680|NCT01155180|659705|P1|COMPLETED|Overall Study||18
273681|NCT01155180|659704|P2|STARTED|Overall Study||6
273682|NCT01155180|659705|P1|STARTED|Overall Study||18
273683|NCT01155219|659713|P2|NOT COMPLETED|Overall Study||3
273684|NCT01155219|659714|P1|NOT COMPLETED|Overall Study||4
273685|NCT01155219|659713|P2|COMPLETED|Overall Study||70
273686|NCT01155219|659714|P1|COMPLETED|Overall Study||73
273687|NCT01155219|659713|P2|STARTED|Overall Study||73
273688|NCT01155219|659714|P1|STARTED|Overall Study||77
273689|NCT01155323|659720|P2|NOT COMPLETED|Second Intervention||1
273690|NCT01155323|659721|P1|NOT COMPLETED|Second Intervention||1
273691|NCT01155323|659720|P2|COMPLETED|Second Intervention||56
273692|NCT01155323|659721|P1|COMPLETED|Second Intervention||58
273693|NCT01155323|659720|P2|STARTED|Second Intervention||57
273694|NCT01155323|659721|P1|STARTED|Second Intervention||59
273695|NCT01155323|659720|P2|NOT COMPLETED|First Intervention||1
273696|NCT01155323|659721|P1|NOT COMPLETED|First Intervention||1
273697|NCT01155323|659720|P2|COMPLETED|First Intervention||57
273698|NCT01155323|659721|P1|COMPLETED|First Intervention||59
273699|NCT01155323|659720|P2|STARTED|First Intervention||58
273700|NCT01155323|659721|P1|STARTED|First Intervention||60
273701|NCT01155336|659739|P2|NOT COMPLETED|Overall Study||0
273702|NCT01155336|659740|P1|NOT COMPLETED|Overall Study||0
273703|NCT01155336|659739|P2|COMPLETED|Overall Study|We did not complete the study.|4
273704|NCT01155336|659740|P1|COMPLETED|Overall Study|We did not complete the study.|0
273705|NCT01155336|659739|P2|STARTED|Overall Study|We did not complete the study.|4
273706|NCT01155336|659740|P1|STARTED|Overall Study|We did not complete the study.|0
273707|NCT01155466|659751|P5|NOT COMPLETED|Overall Study||27
273708|NCT01155466|659752|P4|NOT COMPLETED|Overall Study||21
273709|NCT01155466|659753|P3|NOT COMPLETED|Overall Study||20
273710|NCT01155466|659754|P2|NOT COMPLETED|Overall Study||25
273711|NCT01155466|659755|P1|NOT COMPLETED|Overall Study||22
273712|NCT01155466|659751|P5|COMPLETED|Overall Study|Completed treatment phase|129
273713|NCT01155466|659752|P4|COMPLETED|Overall Study|Completed treatment phase|134
273714|NCT01155466|659753|P3|COMPLETED|Overall Study|Completed treatment phase|136
273715|NCT01155466|659754|P2|COMPLETED|Overall Study|Completed treatment phase|130
273716|NCT01155466|659755|P1|COMPLETED|Overall Study|Completed treatment phase|134
273717|NCT01155466|659751|P5|Treated|Overall Study||154
273718|NCT01155466|659752|P4|Treated|Overall Study||155
273719|NCT01155466|659753|P3|Treated|Overall Study||153
273720|NCT01155466|659754|P2|Treated|Overall Study||153
273721|NCT01155466|659755|P1|Treated|Overall Study||154
273722|NCT01155466|659751|P5|STARTED|Overall Study||156
273723|NCT01155466|659752|P4|STARTED|Overall Study||155
273724|NCT01155466|659753|P3|STARTED|Overall Study||156
273725|NCT01155466|659754|P2|STARTED|Overall Study||155
273726|NCT01155466|659755|P1|STARTED|Overall Study||156
273727|NCT01155479|659812|P5|NOT COMPLETED|Part II||55
273728|NCT01155479|659813|P4|NOT COMPLETED|Part II||50
273729|NCT01155479|659814|P3|NOT COMPLETED|Part II||58
273730|NCT01155479|659815|P2|NOT COMPLETED|Part II||61
273731|NCT01155479|659816|P1|NOT COMPLETED|Part II||59
273732|NCT01155479|659812|P5|COMPLETED|Part II||126
273733|NCT01155479|659813|P4|COMPLETED|Part II||127
273734|NCT01155479|659814|P3|COMPLETED|Part II||109
273735|NCT01155479|659815|P2|COMPLETED|Part II||116
273736|NCT01155479|659816|P1|COMPLETED|Part II||107
273737|NCT01155479|659812|P5|STARTED|Part II||181
273738|NCT01155479|659813|P4|STARTED|Part II||177
273739|NCT01155479|659814|P3|STARTED|Part II||167
273740|NCT01155479|659815|P2|STARTED|Part II||177
273741|NCT01155479|659816|P1|STARTED|Part II||166
273742|NCT01155479|659812|P5|NOT COMPLETED|Part I||23
273743|NCT01155479|659813|P4|NOT COMPLETED|Part I||27
273744|NCT01155479|659814|P3|NOT COMPLETED|Part I||39
273745|NCT01155479|659815|P2|NOT COMPLETED|Part I||27
273746|NCT01155479|659816|P1|NOT COMPLETED|Part I||38
273747|NCT01155479|659812|P5|COMPLETED|Part I||181
273748|NCT01155479|659813|P4|COMPLETED|Part I||177
273749|NCT01155479|659814|P3|COMPLETED|Part I||167
273750|NCT01155479|659815|P2|COMPLETED|Part I||177
273751|NCT01155479|659816|P1|COMPLETED|Part I||166
273752|NCT01155479|659812|P5|Treated|Part I||203
273753|NCT01155479|659813|P4|Treated|Part I||198
273754|NCT01155479|659814|P3|Treated|Part I||204
273755|NCT01155479|659815|P2|Treated|Part I||202
273756|NCT01155479|659816|P1|Treated|Part I||200
273757|NCT01155479|659812|P5|STARTED|Part I||204
273758|NCT01155479|659813|P4|STARTED|Part I||204
273759|NCT01155479|659814|P3|STARTED|Part I||206
273760|NCT01155479|659815|P2|STARTED|Part I||204
273761|NCT01155479|659816|P1|STARTED|Part I||204
273762|NCT01155531|659867|P4|NOT COMPLETED|Overall Study||1
273763|NCT01155531|659868|P3|NOT COMPLETED|Overall Study||2
273764|NCT01155531|659869|P2|NOT COMPLETED|Overall Study||0
273765|NCT01155531|659870|P1|NOT COMPLETED|Overall Study||1
273766|NCT01155531|659867|P4|COMPLETED|Overall Study||9
273767|NCT01155531|659868|P3|COMPLETED|Overall Study||8
273768|NCT01155531|659869|P2|COMPLETED|Overall Study||10
273769|NCT01155531|659870|P1|COMPLETED|Overall Study||9
273770|NCT01155531|659867|P4|STARTED|Overall Study||10
273771|NCT01155531|659868|P3|STARTED|Overall Study||10
273772|NCT01155531|659869|P2|STARTED|Overall Study||10
273773|NCT01155531|659870|P1|STARTED|Overall Study||10
273774|NCT01155570|659888|P1|NOT COMPLETED|Overall Study||142
273775|NCT01155570|659888|P1|COMPLETED|Overall Study||592
273776|NCT01155570|659888|P1|Efficacy Analysis Population|Overall Study|5 received Humira off-label, 21 did not receive Humira after the first administration|708
273777|NCT01155570|659888|P1|STARTED|Overall Study|Safety Analysis Population|734
273778|NCT01155726|659918|P4|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
273779|NCT01155726|659919|P3|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
273780|NCT01155726|659920|P2|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
273781|NCT01155726|659921|P1|NOT COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||0
273782|NCT01155726|659918|P4|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||25
273783|NCT01155726|659919|P3|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||28
273784|NCT01155726|659920|P2|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||20
273785|NCT01155726|659921|P1|COMPLETED|Period 2, 3 Days (Unmask) or (Partial)||23
273786|NCT01155726|659918|P4|STARTED|Period 2, 3 Days (Unmask) or (Partial)||25
273787|NCT01155726|659919|P3|STARTED|Period 2, 3 Days (Unmask) or (Partial)||28
273788|NCT01155726|659920|P2|STARTED|Period 2, 3 Days (Unmask) or (Partial)||20
273789|NCT01155726|659921|P1|STARTED|Period 2, 3 Days (Unmask) or (Partial)||23
273790|NCT01155726|659918|P4|NOT COMPLETED|Period 1, 3 Days (Masked)||0
273791|NCT01155726|659919|P3|NOT COMPLETED|Period 1, 3 Days (Masked)||2
273792|NCT01155726|659920|P2|NOT COMPLETED|Period 1, 3 Days (Masked)||0
273793|NCT01155726|659921|P1|NOT COMPLETED|Period 1, 3 Days (Masked)||1
273794|NCT01155726|659918|P4|COMPLETED|Period 1, 3 Days (Masked)||25
273795|NCT01155726|659919|P3|COMPLETED|Period 1, 3 Days (Masked)||28
273796|NCT01155726|659920|P2|COMPLETED|Period 1, 3 Days (Masked)||20
273797|NCT01155726|659921|P1|COMPLETED|Period 1, 3 Days (Masked)||23
273798|NCT01155726|659918|P4|STARTED|Period 1, 3 Days (Masked)||25
273799|NCT01155726|659919|P3|STARTED|Period 1, 3 Days (Masked)||30
273800|NCT01155726|659920|P2|STARTED|Period 1, 3 Days (Masked)||20
273801|NCT01155726|659921|P1|STARTED|Period 1, 3 Days (Masked)||24
273802|NCT01155830|659946|P3|NOT COMPLETED|Overall Study||0
273803|NCT01155830|659947|P2|NOT COMPLETED|Overall Study||0
273804|NCT01155830|659948|P1|NOT COMPLETED|Overall Study||0
273805|NCT01155830|659946|P3|COMPLETED|Overall Study||21
273806|NCT01155830|659947|P2|COMPLETED|Overall Study||0
273807|NCT01155830|659948|P1|COMPLETED|Overall Study||0
273808|NCT01155830|659946|P3|STARTED|Overall Study||21
273809|NCT01155830|659947|P2|STARTED|Overall Study||0
273810|NCT01155830|659948|P1|STARTED|Overall Study||0
273811|NCT01155869|659961|P2|NOT COMPLETED|Overall Study||1
273812|NCT01155869|659962|P1|NOT COMPLETED|Overall Study||3
273813|NCT01155869|659961|P2|COMPLETED|Overall Study||3
273814|NCT01155869|659962|P1|COMPLETED|Overall Study||0
273815|NCT01155869|659961|P2|STARTED|Overall Study||4
273816|NCT01155869|659962|P1|STARTED|Overall Study||3
273817|NCT01155999|659972|P2|NOT COMPLETED|Overall Study||4
273818|NCT01155999|659973|P1|NOT COMPLETED|Overall Study||7
273819|NCT01155999|659972|P2|COMPLETED|Overall Study||136
273820|NCT01155999|659973|P1|COMPLETED|Overall Study||139
273821|NCT01155999|659972|P2|STARTED|Overall Study||140
273822|NCT01155999|659973|P1|STARTED|Overall Study||146
273823|NCT01156012|659981|P2|NOT COMPLETED|Overall Study||3
273824|NCT01156012|659982|P1|NOT COMPLETED|Overall Study||7
273825|NCT01156012|659981|P2|COMPLETED|Overall Study||186
273826|NCT01156012|659982|P1|COMPLETED|Overall Study||206
273827|NCT01156012|659981|P2|STARTED|Overall Study||189
273828|NCT01156012|659982|P1|STARTED|Overall Study||213
273829|NCT01156051|659990|P2|NOT COMPLETED|Overall Study||1
273830|NCT01156051|659991|P1|NOT COMPLETED|Overall Study||1
273831|NCT01156051|659990|P2|COMPLETED|Overall Study||16
273832|NCT01156051|659991|P1|COMPLETED|Overall Study||11
273833|NCT01156051|659990|P2|STARTED|Overall Study||17
273834|NCT01156051|659991|P1|STARTED|Overall Study||12
273835|NCT01156116|660005|P2|NOT COMPLETED|Overall Study||1
273836|NCT01156116|660006|P1|NOT COMPLETED|Overall Study||5
273837|NCT01156116|660005|P2|COMPLETED|Overall Study||12
273838|NCT01156116|660006|P1|COMPLETED|Overall Study||21
273839|NCT01156116|660005|P2|STARTED|Overall Study||13
273840|NCT01156116|660006|P1|STARTED|Overall Study||26
273841|NCT01156142|660020|P2|NOT COMPLETED|Overall Study||7
273842|NCT01156142|660021|P1|NOT COMPLETED|Overall Study||8
273843|NCT01156142|660020|P2|COMPLETED|Overall Study||71
273844|NCT01156142|660021|P1|COMPLETED|Overall Study||69
273845|NCT01156142|660020|P2|STARTED|Overall Study||78
273846|NCT01156142|660021|P1|STARTED|Overall Study||77
273847|NCT01156311|660039|P4|NOT COMPLETED|6-month Add-on Therapy Period||10
273848|NCT01156311|660040|P3|NOT COMPLETED|6-month Add-on Therapy Period||12
273849|NCT01156311|660041|P2|NOT COMPLETED|6-month Add-on Therapy Period||0
273850|NCT01156311|660042|P1|NOT COMPLETED|6-month Add-on Therapy Period||0
273851|NCT01156311|660039|P4|COMPLETED|6-month Add-on Therapy Period||37
273852|NCT01156311|660040|P3|COMPLETED|6-month Add-on Therapy Period||45
273853|NCT01156311|660041|P2|COMPLETED|6-month Add-on Therapy Period||0
273854|NCT01156311|660042|P1|COMPLETED|6-month Add-on Therapy Period||0
273855|NCT01156311|660039|P4|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||38
273856|NCT01156311|660040|P3|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||45
273857|NCT01156311|660041|P2|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
273858|NCT01156311|660042|P1|Completed BG00012 Combination Therapy|6-month Add-on Therapy Period||0
273859|NCT01156311|660039|P4|STARTED|6-month Add-on Therapy Period||47
273860|NCT01156311|660040|P3|STARTED|6-month Add-on Therapy Period||57
273861|NCT01156311|660041|P2|STARTED|6-month Add-on Therapy Period||0
273862|NCT01156311|660042|P1|STARTED|6-month Add-on Therapy Period||0
273863|NCT01156311|660039|P4|NOT COMPLETED|2-Month Monotherapy Period||0
273864|NCT01156311|660040|P3|NOT COMPLETED|2-Month Monotherapy Period||0
273865|NCT01156311|660041|P2|NOT COMPLETED|2-Month Monotherapy Period||2
273866|NCT01156311|660042|P1|NOT COMPLETED|2-Month Monotherapy Period||2
273867|NCT01156311|660039|P4|COMPLETED|2-Month Monotherapy Period||0
273868|NCT01156311|660040|P3|COMPLETED|2-Month Monotherapy Period||0
273869|NCT01156311|660041|P2|COMPLETED|2-Month Monotherapy Period||47
273870|NCT01156311|660042|P1|COMPLETED|2-Month Monotherapy Period||57
273871|NCT01156311|660039|P4|STARTED|2-Month Monotherapy Period||0
273872|NCT01156311|660040|P3|STARTED|2-Month Monotherapy Period||0
273873|NCT01156311|660041|P2|STARTED|2-Month Monotherapy Period||49
273874|NCT01156311|660042|P1|STARTED|2-Month Monotherapy Period||59
273875|NCT01156363|660064|P1|NOT COMPLETED|Overall Study||22
273876|NCT01156363|660064|P1|COMPLETED|Overall Study||64
273877|NCT01156363|660064|P1|STARTED|Overall Study||86
273878|NCT01156376|660087|P3|NOT COMPLETED|Overall Study||4
273879|NCT01156376|660088|P2|NOT COMPLETED|Overall Study||0
273880|NCT01156376|660089|P1|NOT COMPLETED|Overall Study||1
273881|NCT01156376|660087|P3|COMPLETED|Overall Study||23
273882|NCT01156376|660088|P2|COMPLETED|Overall Study||26
273883|NCT01156376|660089|P1|COMPLETED|Overall Study||26
273884|NCT01156376|660087|P3|STARTED|Overall Study||27
273885|NCT01156376|660088|P2|STARTED|Overall Study||26
273886|NCT01156376|660089|P1|STARTED|Overall Study||27
273887|NCT01156480|660312|P2|NOT COMPLETED|Overall Study||1
273888|NCT01156480|660313|P1|NOT COMPLETED|Overall Study||0
273889|NCT01156480|660312|P2|COMPLETED|Overall Study||1
273890|NCT01156480|660313|P1|COMPLETED|Overall Study||0
273891|NCT01156480|660312|P2|STARTED|Overall Study||2
273892|NCT01156480|660313|P1|STARTED|Overall Study||0
273893|NCT01156532|660321|P1|NOT COMPLETED|Overall Study||2
273894|NCT01156532|660321|P1|COMPLETED|Overall Study||28
273895|NCT01156532|660321|P1|STARTED|Overall Study||30
273896|NCT01156571|660333|P2|NOT COMPLETED|Overall Study||19
273897|NCT01156571|660334|P1|NOT COMPLETED|Overall Study||17
273898|NCT01156571|660333|P2|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5545
273899|NCT01156571|660334|P1|COMPLETED|Overall Study|Completed = ITT patients who completed scheduled visits or developed a primary endpoint event|5564
273900|NCT01156571|660333|P2|STARTED|Overall Study|ITT: defined as all patients randomized.|5564
273901|NCT01156571|660334|P1|STARTED|Overall Study|ITT: defined as all patients randomized.|5581
273902|NCT01156597|660346|P2|NOT COMPLETED|Overall Study||1
273903|NCT01156597|660347|P1|NOT COMPLETED|Overall Study||3
273904|NCT01156597|660346|P2|COMPLETED|Overall Study||13
273905|NCT01156597|660347|P1|COMPLETED|Overall Study||13
273906|NCT01156597|660346|P2|STARTED|Overall Study||14
273907|NCT01156597|660347|P1|STARTED|Overall Study||16
273908|NCT01156701|660357|P4|NOT COMPLETED|Overall Study||0
273909|NCT01156701|660358|P3|NOT COMPLETED|Overall Study||0
273910|NCT01156701|660359|P2|NOT COMPLETED|Overall Study||0
273911|NCT01156701|660360|P1|NOT COMPLETED|Overall Study||0
273912|NCT01156701|660357|P4|COMPLETED|Overall Study||6725
273913|NCT01156701|660358|P3|COMPLETED|Overall Study||163716
273914|NCT01156701|660359|P2|COMPLETED|Overall Study||1007
273915|NCT01156701|660360|P1|COMPLETED|Overall Study||257
273916|NCT01156701|660357|P4|STARTED|Overall Study||6725
273917|NCT01156701|660358|P3|STARTED|Overall Study||163716
273918|NCT01156701|660359|P2|STARTED|Overall Study||1007
273919|NCT01156701|660360|P1|STARTED|Overall Study||257
273920|NCT01156792|660394|P1|NOT COMPLETED|Overall Study||69
273921|NCT01156792|660394|P1|COMPLETED|Overall Study||93
273922|NCT01156792|660394|P1|STARTED|Overall Study||162
273923|NCT01156844|660463|P4|NOT COMPLETED|Overall Study||6
273924|NCT01156844|660464|P3|NOT COMPLETED|Overall Study||6
273925|NCT01156844|660465|P2|NOT COMPLETED|Overall Study||2
273926|NCT01156844|660466|P1|NOT COMPLETED|Overall Study||2
273927|NCT01156844|660463|P4|COMPLETED|Overall Study||41
273928|NCT01156844|660464|P3|COMPLETED|Overall Study||42
273929|NCT01156844|660465|P2|COMPLETED|Overall Study||46
273930|NCT01156844|660466|P1|COMPLETED|Overall Study||46
273931|NCT01156844|660463|P4|PD & Safety Sets: Received Study Drug|Overall Study||46
273932|NCT01156844|660464|P3|PD & Safety Sets: Received Study Drug|Overall Study||48
273933|NCT01156844|660465|P2|PD & Safety Sets: Received Study Drug|Overall Study||47
273934|NCT01156844|660466|P1|PD & Safety Sets: Received Study Drug|Overall Study|PD=Pharmacodynamic|48
273935|NCT01156844|660463|P4|STARTED|Overall Study||47
273936|NCT01156844|660464|P3|STARTED|Overall Study||48
273937|NCT01156844|660465|P2|STARTED|Overall Study||48
273938|NCT01156844|660466|P1|STARTED|Overall Study|Randomized participants.|48
273939|NCT01156987|660487|P2|NOT COMPLETED|Overall Study||11
273940|NCT01156987|660488|P1|NOT COMPLETED|Overall Study||0
273941|NCT01156987|660487|P2|COMPLETED|Overall Study||12
273942|NCT01156987|660488|P1|COMPLETED|Overall Study||8
273943|NCT01156987|660487|P2|STARTED|Overall Study||23
273944|NCT01156987|660488|P1|STARTED|Overall Study||8
273945|NCT01157065|660496|P2|NOT COMPLETED|Overall Study||1
273946|NCT01157065|660497|P1|NOT COMPLETED|Overall Study||0
273947|NCT01157065|660496|P2|COMPLETED|Overall Study||10
273948|NCT01157065|660497|P1|COMPLETED|Overall Study||38
273949|NCT01157065|660496|P2|STARTED|Overall Study||11
273950|NCT01157065|660497|P1|STARTED|Overall Study||38
273951|NCT01157078|660507|P2|NOT COMPLETED|Overall Study||36
273952|NCT01157078|660508|P1|NOT COMPLETED|Overall Study||35
273953|NCT01157078|660507|P2|COMPLETED|Overall Study||124
273954|NCT01157078|660508|P1|COMPLETED|Overall Study||124
273955|NCT01157078|660507|P2|Received Treatment|Overall Study||159
273956|NCT01157078|660508|P1|Received Treatment|Overall Study||157
273957|NCT01157078|660507|P2|STARTED|Overall Study||160
273958|NCT01157078|660508|P1|STARTED|Overall Study||159
273959|NCT01157117|660559|P3|NOT COMPLETED|Overall Study||15
273960|NCT01157117|660560|P2|NOT COMPLETED|Overall Study||11
273961|NCT01157117|660561|P1|NOT COMPLETED|Overall Study||9
273962|NCT01157117|660559|P3|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|5
273963|NCT01157117|660560|P2|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|18
273964|NCT01157117|660561|P1|COMPLETED|Overall Study|Completed final study visit at Month 38, 6 months after final Month 32 OFC.|19
273965|NCT01157117|660559|P3|Completed Final Month 38 Study Visit|Overall Study||3
273966|NCT01157117|660560|P2|Completed Final Month 38 Study Visit|Overall Study||18
273967|NCT01157117|660561|P1|Completed Final Month 38 Study Visit|Overall Study||19
273968|NCT01157117|660559|P3|Completed Month 32 Tolerance OFC|Overall Study||0
273969|NCT01157117|660560|P2|Completed Month 32 Tolerance OFC|Overall Study||20
273970|NCT01157117|660561|P1|Completed Month 32 Tolerance OFC|Overall Study||24
273971|NCT01157117|660559|P3|Discontinued Milk OIT at Month 30|Overall Study||0
273972|NCT01157117|660560|P2|Discontinued Milk OIT at Month 30|Overall Study||20
273973|NCT01157117|660561|P1|Discontinued Milk OIT at Month 30|Overall Study||24
273974|NCT01157117|660559|P3|Completed Month 28 Desensitization OFC|Overall Study||0
273975|NCT01157117|660560|P2|Completed Month 28 Desensitization OFC|Overall Study||24
273976|NCT01157117|660561|P1|Completed Month 28 Desensitization OFC|Overall Study||26
273977|NCT01157117|660559|P3|Unblinded at Month 16|Overall Study||0
273978|NCT01157117|660560|P2|Unblinded at Month 16|Overall Study||26
273979|NCT01157117|660561|P1|Unblinded at Month 16|Overall Study||26
273980|NCT01157117|660559|P3|Reached Milk OIT Maintenance Dosing|Overall Study||0
273981|NCT01157117|660560|P2|Reached Milk OIT Maintenance Dosing|Overall Study||26
273982|NCT01157117|660561|P1|Reached Milk OIT Maintenance Dosing|Overall Study||26
273983|NCT01157117|660559|P3|Began Milk OIT Dosing at Month 4|Overall Study||0
273984|NCT01157117|660560|P2|Began Milk OIT Dosing at Month 4|Overall Study||28
273985|NCT01157117|660561|P1|Began Milk OIT Dosing at Month 4|Overall Study||27
273986|NCT01157117|660559|P3|Began Omalizumab or Placebo Dosing|Overall Study||0
273987|NCT01157117|660560|P2|Began Omalizumab or Placebo Dosing|Overall Study||28
273988|NCT01157117|660561|P1|Began Omalizumab or Placebo Dosing|Overall Study||27
273989|NCT01157117|660559|P3|STARTED|Overall Study||20
273990|NCT01157117|660560|P2|STARTED|Overall Study||29
273991|NCT01157117|660561|P1|STARTED|Overall Study||28
273992|NCT01157169|660602|P2|NOT COMPLETED|Second Intervention||1
273993|NCT01157169|660603|P1|NOT COMPLETED|Second Intervention||0
273994|NCT01157169|660602|P2|COMPLETED|Second Intervention||17
273995|NCT01157169|660603|P1|COMPLETED|Second Intervention||16
273996|NCT01157169|660602|P2|STARTED|Second Intervention||18
273997|NCT01157169|660603|P1|STARTED|Second Intervention||16
273998|NCT01157169|660602|P2|NOT COMPLETED|Washout of 10 Days||0
273999|NCT01157169|660603|P1|NOT COMPLETED|Washout of 10 Days||0
274000|NCT01157169|660602|P2|COMPLETED|Washout of 10 Days||18
274001|NCT01157169|660603|P1|COMPLETED|Washout of 10 Days||16
274002|NCT01157169|660602|P2|STARTED|Washout of 10 Days||18
274003|NCT01157169|660603|P1|STARTED|Washout of 10 Days||16
274004|NCT01157169|660602|P2|NOT COMPLETED|First Intervention||2
274005|NCT01157169|660603|P1|NOT COMPLETED|First Intervention||4
274006|NCT01157169|660602|P2|COMPLETED|First Intervention||18
274007|NCT01157169|660603|P1|COMPLETED|First Intervention||16
274008|NCT01157169|660602|P2|STARTED|First Intervention||20
274009|NCT01157169|660603|P1|STARTED|First Intervention||20
274010|NCT01157182|660621|P2|NOT COMPLETED|Second Intervention||0
274011|NCT01157182|660622|P1|NOT COMPLETED|Second Intervention||0
274012|NCT01157182|660621|P2|COMPLETED|Second Intervention||18
274013|NCT01157182|660622|P1|COMPLETED|Second Intervention||16
274014|NCT01157182|660621|P2|STARTED|Second Intervention||18
274015|NCT01157182|660622|P1|STARTED|Second Intervention||16
274016|NCT01157182|660621|P2|NOT COMPLETED|Washout of 28 Days||0
274017|NCT01157182|660622|P1|NOT COMPLETED|Washout of 28 Days||2
274018|NCT01157182|660621|P2|COMPLETED|Washout of 28 Days||18
274019|NCT01157182|660622|P1|COMPLETED|Washout of 28 Days||16
274020|NCT01157182|660621|P2|STARTED|Washout of 28 Days||18
274021|NCT01157182|660622|P1|STARTED|Washout of 28 Days||18
274022|NCT01157182|660621|P2|NOT COMPLETED|First Intervention||0
274023|NCT01157182|660622|P1|NOT COMPLETED|First Intervention||0
274024|NCT01157182|660621|P2|COMPLETED|First Intervention||18
274025|NCT01157182|660622|P1|COMPLETED|First Intervention||18
274026|NCT01157182|660621|P2|STARTED|First Intervention||18
274027|NCT01157182|660622|P1|STARTED|First Intervention||18
274028|NCT01150097|660671|P3|NOT COMPLETED|Months 24 to 48 Post-transplantation||0
274029|NCT01150097|660672|P2|NOT COMPLETED|Months 24 to 48 Post-transplantation||4
274030|NCT01150097|660673|P1|NOT COMPLETED|Months 24 to 48 Post-transplantation||11
274031|NCT01150097|660671|P3|COMPLETED|Months 24 to 48 Post-transplantation||0
274032|NCT01150097|660672|P2|COMPLETED|Months 24 to 48 Post-transplantation||47
274033|NCT01150097|660673|P1|COMPLETED|Months 24 to 48 Post-transplantation||95
274034|NCT01150097|660671|P3|STARTED|Months 24 to 48 Post-transplantation||0
274035|NCT01150097|660672|P2|STARTED|Months 24 to 48 Post-transplantation||51
274036|NCT01150097|660673|P1|STARTED|Months 24 to 48 Post-transplantation||106
274037|NCT01150097|660671|P3|NOT COMPLETED|Months 24 to 36 Post-transplantation||8
274038|NCT01150097|660672|P2|NOT COMPLETED|Months 24 to 36 Post-transplantation||2
274039|NCT01150097|660673|P1|NOT COMPLETED|Months 24 to 36 Post-transplantation||10
274040|NCT01150097|660671|P3|COMPLETED|Months 24 to 36 Post-transplantation||117
274041|NCT01150097|660672|P2|COMPLETED|Months 24 to 36 Post-transplantation||49
274042|NCT01150097|660673|P1|COMPLETED|Months 24 to 36 Post-transplantation||96
274043|NCT01150097|660671|P3|STARTED|Months 24 to 36 Post-transplantation||125
274044|NCT01150097|660672|P2|STARTED|Months 24 to 36 Post-transplantation||51
274045|NCT01150097|660673|P1|STARTED|Months 24 to 36 Post-transplantation||106
274046|NCT01150123|660714|P18|NOT COMPLETED|Overall Study||1
274047|NCT01150123|660715|P17|NOT COMPLETED|Overall Study||0
274048|NCT01150123|660716|P16|NOT COMPLETED|Overall Study||1
274049|NCT01150123|660717|P15|NOT COMPLETED|Overall Study||0
274050|NCT01150123|660718|P14|NOT COMPLETED|Overall Study||0
274051|NCT01150123|660719|P13|NOT COMPLETED|Overall Study||3
274052|NCT01150123|660720|P12|NOT COMPLETED|Overall Study||1
274053|NCT01150123|660721|P11|NOT COMPLETED|Overall Study||2
274054|NCT01150123|660722|P10|NOT COMPLETED|Overall Study||1
274055|NCT01150123|660723|P9|NOT COMPLETED|Overall Study||5
274056|NCT01150123|660724|P8|NOT COMPLETED|Overall Study||3
274057|NCT01150123|660725|P7|NOT COMPLETED|Overall Study||0
274058|NCT01150123|660726|P6|NOT COMPLETED|Overall Study||6
274059|NCT01150123|660727|P5|NOT COMPLETED|Overall Study||3
274060|NCT01150123|660728|P4|NOT COMPLETED|Overall Study||3
274061|NCT01150123|660729|P3|NOT COMPLETED|Overall Study||4
274062|NCT01150123|660730|P2|NOT COMPLETED|Overall Study||2
274063|NCT01150123|660731|P1|NOT COMPLETED|Overall Study||3
274064|NCT01150123|660714|P18|COMPLETED|Overall Study||19
274065|NCT01150123|660715|P17|COMPLETED|Overall Study||40
274066|NCT01150123|660716|P16|COMPLETED|Overall Study||39
274067|NCT01150123|660717|P15|COMPLETED|Overall Study||40
274068|NCT01150123|660718|P14|COMPLETED|Overall Study||40
274069|NCT01150123|660719|P13|COMPLETED|Overall Study||37
274070|NCT01150123|660720|P12|COMPLETED|Overall Study||39
274071|NCT01150123|660721|P11|COMPLETED|Overall Study||38
274072|NCT01150123|660722|P10|COMPLETED|Overall Study||39
274073|NCT01150123|660723|P9|COMPLETED|Overall Study||15
274074|NCT01150123|660724|P8|COMPLETED|Overall Study||37
274075|NCT01150123|660725|P7|COMPLETED|Overall Study||39
274076|NCT01150123|660726|P6|COMPLETED|Overall Study||34
274077|NCT01150123|660727|P5|COMPLETED|Overall Study||37
274078|NCT01150123|660728|P4|COMPLETED|Overall Study||37
274079|NCT01150123|660729|P3|COMPLETED|Overall Study||35
274080|NCT01150123|660730|P2|COMPLETED|Overall Study||38
274081|NCT01150123|660731|P1|COMPLETED|Overall Study||37
274082|NCT01150123|660714|P18|STARTED|Overall Study||20
274083|NCT01150123|660715|P17|STARTED|Overall Study||40
274084|NCT01150123|660716|P16|STARTED|Overall Study||40
274085|NCT01150123|660717|P15|STARTED|Overall Study||40
274086|NCT01150123|660718|P14|STARTED|Overall Study||40
274087|NCT01150123|660719|P13|STARTED|Overall Study||40
274088|NCT01150123|660720|P12|STARTED|Overall Study||40
274089|NCT01150123|660721|P11|STARTED|Overall Study||40
274090|NCT01150123|660722|P10|STARTED|Overall Study||40
274091|NCT01150123|660723|P9|STARTED|Overall Study||20
274092|NCT01150123|660724|P8|STARTED|Overall Study||40
274093|NCT01150123|660725|P7|STARTED|Overall Study||39
274094|NCT01150123|660726|P6|STARTED|Overall Study||40
274095|NCT01150123|660727|P5|STARTED|Overall Study||40
274096|NCT01150123|660728|P4|STARTED|Overall Study||40
274097|NCT01150123|660729|P3|STARTED|Overall Study||39
274098|NCT01150123|660730|P2|STARTED|Overall Study||40
274099|NCT01150123|660731|P1|STARTED|Overall Study||40
274100|NCT01150357|660907|P3|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||2
274101|NCT01150357|660908|P2|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||0
274102|NCT01150357|660909|P1|NOT COMPLETED|Placebo-controlled Withdrawal (Phase 2)||3
274103|NCT01150357|660907|P3|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||100
274104|NCT01150357|660908|P2|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||51
274105|NCT01150357|660909|P1|COMPLETED|Placebo-controlled Withdrawal (Phase 2)||104
274106|NCT01150357|660907|P3|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||51
274107|NCT01150357|660908|P2|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||21
274108|NCT01150357|660909|P1|Completed Placebo Treament|Placebo-controlled Withdrawal (Phase 2)||54
274109|NCT01150357|660907|P3|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||52
274110|NCT01150357|660908|P2|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||21
274111|NCT01150357|660909|P1|Started Placebo Treatment|Placebo-controlled Withdrawal (Phase 2)||57
274112|NCT01150357|660907|P3|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||49
274113|NCT01150357|660908|P2|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
274114|NCT01150357|660909|P1|Completed Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
274115|NCT01150357|660907|P3|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
274116|NCT01150357|660908|P2|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||30
274117|NCT01150357|660909|P1|Started Aliskiren Treament|Placebo-controlled Withdrawal (Phase 2)||50
274118|NCT01150357|660907|P3|STARTED|Placebo-controlled Withdrawal (Phase 2)||102
274119|NCT01150357|660908|P2|STARTED|Placebo-controlled Withdrawal (Phase 2)||51
274120|NCT01150357|660909|P1|STARTED|Placebo-controlled Withdrawal (Phase 2)||107
274121|NCT01150357|660907|P3|NOT COMPLETED|Dose Response Phase (Phase 1)||3
274122|NCT01150357|660908|P2|NOT COMPLETED|Dose Response Phase (Phase 1)||3
274123|NCT01150357|660909|P1|NOT COMPLETED|Dose Response Phase (Phase 1)||1
274124|NCT01150357|660907|P3|COMPLETED|Dose Response Phase (Phase 1)||102
274125|NCT01150357|660908|P2|COMPLETED|Dose Response Phase (Phase 1)||51
274126|NCT01150357|660909|P1|COMPLETED|Dose Response Phase (Phase 1)||107
274127|NCT01150357|660907|P3|STARTED|Dose Response Phase (Phase 1)||105
274128|NCT01150357|660908|P2|STARTED|Dose Response Phase (Phase 1)||54
274129|NCT01150357|660909|P1|STARTED|Dose Response Phase (Phase 1)||108
274130|NCT01150409|660973|P2|NOT COMPLETED|Overall Study||0
274131|NCT01150409|660974|P1|NOT COMPLETED|Overall Study||0
274132|NCT01150409|660973|P2|COMPLETED|Overall Study||0
274133|NCT01150409|660974|P1|COMPLETED|Overall Study||11
274134|NCT01150409|660973|P2|STARTED|Overall Study||0
274135|NCT01150409|660974|P1|STARTED|Overall Study||11
274136|NCT01150461|660982|P2|NOT COMPLETED|Overall Study||0
274137|NCT01150461|660983|P1|NOT COMPLETED|Overall Study||0
274138|NCT01150461|660982|P2|COMPLETED|Overall Study||9
274139|NCT01150461|660983|P1|COMPLETED|Overall Study||11
274140|NCT01150461|660982|P2|STARTED|Overall Study||9
274141|NCT01150461|660983|P1|STARTED|Overall Study||11
274142|NCT01150474|660993|P2|NOT COMPLETED|Overall Study||3
274143|NCT01150474|660994|P1|NOT COMPLETED|Overall Study||10
274144|NCT01150474|660993|P2|COMPLETED|Overall Study||49
274145|NCT01150474|660994|P1|COMPLETED|Overall Study||41
274146|NCT01150474|660993|P2|STARTED|Overall Study||52
274147|NCT01150474|660994|P1|STARTED|Overall Study||51
274148|NCT01150500|661016|P1|NOT COMPLETED|Overall Study||65
274149|NCT01150500|661016|P1|COMPLETED|Overall Study||0
274150|NCT01150500|661016|P1|STARTED|Overall Study||65
274151|NCT01150760|661027|P2|NOT COMPLETED|Overall Study||0
274152|NCT01150760|661028|P1|NOT COMPLETED|Overall Study||0
274153|NCT01150760|661027|P2|COMPLETED|Overall Study||3525
274154|NCT01150760|661028|P1|COMPLETED|Overall Study||3525
274155|NCT01150760|661027|P2|STARTED|Overall Study||3525
274156|NCT01150760|661028|P1|STARTED|Overall Study||3525
274157|NCT01150903|661062|P2|NOT COMPLETED|Overall Study||0
274158|NCT01150903|661063|P1|NOT COMPLETED|Overall Study||0
274159|NCT01150903|661062|P2|COMPLETED|Overall Study||74124
274160|NCT01150903|661063|P1|COMPLETED|Overall Study||24708
274161|NCT01150903|661062|P2|STARTED|Overall Study||74124
274162|NCT01150903|661063|P1|STARTED|Overall Study||24708
274163|NCT01150981|661079|P2|NOT COMPLETED|Overall Study||2
274164|NCT01150981|661080|P1|NOT COMPLETED|Overall Study||4
274165|NCT01150981|661079|P2|COMPLETED|Overall Study||13
274166|NCT01150981|661080|P1|COMPLETED|Overall Study||16
274167|NCT01150981|661079|P2|STARTED|Overall Study||15
274168|NCT01150981|661080|P1|STARTED|Overall Study||20
274169|NCT01151020|661088|P1|NOT COMPLETED|Overall Study||110
274170|NCT01151020|661088|P1|COMPLETED|Overall Study||0
274171|NCT01151020|661088|P1|12-month|Overall Study||99
274172|NCT01151020|661088|P1|30-day|Overall Study||110
274173|NCT01151020|661088|P1|STARTED|Overall Study||110
274174|NCT01151046|661095|P2|NOT COMPLETED|Overall Study||0
274175|NCT01151046|661096|P1|NOT COMPLETED|Overall Study||3
274176|NCT01151046|661095|P2|COMPLETED|Overall Study||59
274177|NCT01151046|661096|P1|COMPLETED|Overall Study||56
274178|NCT01151046|661095|P2|STARTED|Overall Study||59
274179|NCT01151046|661096|P1|STARTED|Overall Study||59
274180|NCT01151085|661108|P1|NOT COMPLETED|Overall Study||56
274181|NCT01151085|661108|P1|COMPLETED|Overall Study||946
274182|NCT01151085|661108|P1|STARTED|Overall Study||1002
274183|NCT01151098|661124|P1|NOT COMPLETED|Overall Study||117
274184|NCT01151098|661124|P1|COMPLETED|Overall Study||72
274185|NCT01151098|661124|P1|STARTED|Overall Study|Extension Safety Population|189
274186|NCT01151137|661130|P2|NOT COMPLETED|Overall Study||28
274187|NCT01151137|661131|P1|NOT COMPLETED|Overall Study||16
274188|NCT01151137|661130|P2|COMPLETED|Overall Study||1591
274189|NCT01151137|661131|P1|COMPLETED|Overall Study||1601
274190|NCT01151137|661130|P2|Discontinued Treatment|Overall Study||342
274191|NCT01151137|661131|P1|Discontinued Treatment|Overall Study||171
274192|NCT01151137|661130|P2|Treated|Overall Study||1613
274193|NCT01151137|661131|P1|Treated|Overall Study|One participant randomized to the placebo group received Dronedarone for 7 days by mistake|1610
274194|NCT01151137|661130|P2|STARTED|Overall Study||1619
274195|NCT01151137|661131|P1|STARTED|Overall Study||1617
274196|NCT01151189|661151|P2|NOT COMPLETED|Overall Study||10
274197|NCT01151189|661152|P1|NOT COMPLETED|Overall Study||15
274198|NCT01151189|661151|P2|COMPLETED|Overall Study||314
274199|NCT01151189|661152|P1|COMPLETED|Overall Study||311
274200|NCT01151189|661151|P2|Received Vaccine|Overall Study||324
274201|NCT01151189|661152|P1|Received Vaccine|Overall Study||325
274202|NCT01151189|661151|P2|STARTED|Overall Study||324
274203|NCT01151189|661152|P1|STARTED|Overall Study||326
274204|NCT01151215|661177|P3|NOT COMPLETED|Overall Study||19
274205|NCT01151215|661178|P2|NOT COMPLETED|Overall Study||23
274206|NCT01151215|661179|P1|NOT COMPLETED|Overall Study||20
274207|NCT01151215|661177|P3|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|102
274208|NCT01151215|661178|P2|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|95
274209|NCT01151215|661179|P1|COMPLETED|Overall Study|This is number of patients who were continuing at cut off (ie not withdrawn)|100
274210|NCT01151215|661177|P3|STARTED|Overall Study||121
274211|NCT01151215|661178|P2|STARTED|Overall Study||118
274212|NCT01151215|661179|P1|STARTED|Overall Study||120
274213|NCT01151280|661190|P1|NOT COMPLETED|Overall Study||4
274214|NCT01151280|661190|P1|COMPLETED|Overall Study||6
274215|NCT01151280|661190|P1|STARTED|Overall Study||10
274216|NCT01151345|661200|P2|NOT COMPLETED|Second Intervention Period||0
274217|NCT01151345|661201|P1|NOT COMPLETED|Second Intervention Period||0
274218|NCT01151345|661200|P2|COMPLETED|Second Intervention Period||12
274219|NCT01151345|661201|P1|COMPLETED|Second Intervention Period||13
274220|NCT01151345|661200|P2|STARTED|Second Intervention Period||12
274221|NCT01151345|661201|P1|STARTED|Second Intervention Period||13
274222|NCT01151345|661200|P2|NOT COMPLETED|Wash-out Period (7 Days)||0
274223|NCT01151345|661201|P1|NOT COMPLETED|Wash-out Period (7 Days)||0
274224|NCT01151345|661200|P2|COMPLETED|Wash-out Period (7 Days)||12
274225|NCT01151345|661201|P1|COMPLETED|Wash-out Period (7 Days)||13
274226|NCT01151345|661200|P2|STARTED|Wash-out Period (7 Days)||12
274227|NCT01151345|661201|P1|STARTED|Wash-out Period (7 Days)||13
274228|NCT01151345|661200|P2|NOT COMPLETED|First Intervention Period||1
274229|NCT01151345|661201|P1|NOT COMPLETED|First Intervention Period||0
274230|NCT01151345|661200|P2|COMPLETED|First Intervention Period||12
274231|NCT01151345|661201|P1|COMPLETED|First Intervention Period||13
274232|NCT01151345|661200|P2|Treated|First Intervention Period||12
274233|NCT01151345|661201|P1|Treated|First Intervention Period||13
274234|NCT01151345|661200|P2|STARTED|First Intervention Period||13
274235|NCT01151345|661201|P1|STARTED|First Intervention Period||13
274236|NCT01151371|661218|P3|NOT COMPLETED|Overall Study||7
274237|NCT01151371|661219|P2|NOT COMPLETED|Overall Study||1
274238|NCT01151371|661220|P1|NOT COMPLETED|Overall Study||5
274239|NCT01151371|661218|P3|COMPLETED|Overall Study||146
274240|NCT01151371|661219|P2|COMPLETED|Overall Study||149
274241|NCT01151371|661220|P1|COMPLETED|Overall Study||144
274242|NCT01151371|661218|P3|STARTED|Overall Study||153
274243|NCT01151371|661219|P2|STARTED|Overall Study||150
274244|NCT01151371|661220|P1|STARTED|Overall Study||149
274245|NCT01151410|661251|P2|NOT COMPLETED|Overall Study||15
274246|NCT01151410|661252|P1|NOT COMPLETED|Overall Study||11
274247|NCT01151410|661251|P2|COMPLETED|Overall Study||89
274248|NCT01151410|661252|P1|COMPLETED|Overall Study||93
274249|NCT01151410|661251|P2|Safety Set (SAF)|Overall Study|Number of patients in SAF differed due to kit dispensing error in 1 patient at Visit 12|103
274250|NCT01151410|661252|P1|Safety Set (SAF)|Overall Study||105
274251|NCT01151410|661251|P2|STARTED|Overall Study||104
274252|NCT01151410|661252|P1|STARTED|Overall Study||104
274253|NCT01151436|661262|P1|NOT COMPLETED|Overall Study||1
274254|NCT01151436|661262|P1|COMPLETED|Overall Study||76
274255|NCT01151436|661262|P1|STARTED|Overall Study||77
274256|NCT01151449|661292|P1|NOT COMPLETED|Overall Study||0
274257|NCT01151449|661292|P1|COMPLETED|Overall Study||6
274258|NCT01151449|661292|P1|STARTED|Overall Study||6
274259|NCT01151553|661300|P1|NOT COMPLETED|Overall Study||0
274260|NCT01151553|661300|P1|COMPLETED|Overall Study||5
274261|NCT01151553|661300|P1|STARTED|Overall Study||5
274262|NCT01151579|661306|P2|NOT COMPLETED|Overall Study||7
274263|NCT01151579|661307|P1|NOT COMPLETED|Overall Study||12
274264|NCT01151579|661306|P2|COMPLETED|Overall Study||24
274265|NCT01151579|661307|P1|COMPLETED|Overall Study||46
274266|NCT01151579|661306|P2|STARTED|Overall Study||31
274267|NCT01151579|661307|P1|STARTED|Overall Study||58
274268|NCT01157234|661319|P2|NOT COMPLETED|Overall Study||0
274269|NCT01157234|661320|P1|NOT COMPLETED|Overall Study||1
274270|NCT01157234|661319|P2|COMPLETED|Overall Study||15
274271|NCT01157234|661320|P1|COMPLETED|Overall Study||14
274272|NCT01157234|661319|P2|STARTED|Overall Study||15
274273|NCT01157234|661320|P1|STARTED|Overall Study||15
274274|NCT01157351|661352|P2|NOT COMPLETED|Overall Study||132
274275|NCT01157351|661353|P1|NOT COMPLETED|Overall Study||137
274276|NCT01157351|661352|P2|COMPLETED|Overall Study||88
274277|NCT01157351|661353|P1|COMPLETED|Overall Study||93
274278|NCT01157351|661352|P2|Treated|Overall Study||218
274279|NCT01157351|661353|P1|Treated|Overall Study||226
274280|NCT01157351|661352|P2|STARTED|Overall Study||220
274281|NCT01157351|661353|P1|STARTED|Overall Study||230
274282|NCT01157377|661376|P7|NOT COMPLETED|Overall Study||2
274283|NCT01157377|661377|P6|NOT COMPLETED|Overall Study||3
274284|NCT01157377|661378|P5|NOT COMPLETED|Overall Study||2
274285|NCT01157377|661379|P4|NOT COMPLETED|Overall Study||1
274286|NCT01157377|661380|P3|NOT COMPLETED|Overall Study||1
274287|NCT01157377|661381|P2|NOT COMPLETED|Overall Study||3
274288|NCT01157377|661382|P1|NOT COMPLETED|Overall Study||2
274289|NCT01157377|661376|P7|COMPLETED|Overall Study||27
274290|NCT01157377|661377|P6|COMPLETED|Overall Study||16
274291|NCT01157377|661378|P5|COMPLETED|Overall Study||18
274292|NCT01157377|661379|P4|COMPLETED|Overall Study||14
274293|NCT01157377|661380|P3|COMPLETED|Overall Study||26
274294|NCT01157377|661381|P2|COMPLETED|Overall Study||20
274295|NCT01157377|661382|P1|COMPLETED|Overall Study||21
274296|NCT01157377|661376|P7|STARTED|Overall Study||29
274297|NCT01157377|661377|P6|STARTED|Overall Study||19
274298|NCT01157377|661378|P5|STARTED|Overall Study||20
274299|NCT01157377|661379|P4|STARTED|Overall Study||15
274300|NCT01157377|661380|P3|STARTED|Overall Study||27
274301|NCT01157377|661381|P2|STARTED|Overall Study||23
274302|NCT01157377|661382|P1|STARTED|Overall Study||23
274303|NCT01157416|661400|P2|NOT COMPLETED|Overall Study||0
274304|NCT01157416|661401|P1|NOT COMPLETED|Overall Study||2
274305|NCT01157416|661400|P2|COMPLETED|Overall Study||16
274306|NCT01157416|661401|P1|COMPLETED|Overall Study||15
274307|NCT01157416|661400|P2|STARTED|Overall Study||16
274308|NCT01157416|661401|P1|STARTED|Overall Study||17
274309|NCT01157429|661409|P2|NOT COMPLETED|Overall Study||4
274310|NCT01157429|661410|P1|NOT COMPLETED|Overall Study||4
274311|NCT01157429|661409|P2|COMPLETED|Overall Study||8
274312|NCT01157429|661410|P1|COMPLETED|Overall Study||8
274313|NCT01157429|661409|P2|STARTED|Overall Study||12
274314|NCT01157429|661410|P1|STARTED|Overall Study||12
274315|NCT01157533|661416|P1|NOT COMPLETED|Overall Study||0
274316|NCT01157533|661416|P1|COMPLETED|Overall Study||1
274317|NCT01157533|661416|P1|STARTED|Overall Study||1
274318|NCT01157845|661420|P1|NOT COMPLETED|Overall Study||35
274319|NCT01157845|661420|P1|COMPLETED|Overall Study||130
274320|NCT01157845|661420|P1|STARTED|Overall Study||165
274321|NCT01158118|661427|P2|NOT COMPLETED|Overall Study||3
274322|NCT01158118|661428|P1|NOT COMPLETED|Overall Study||1
274323|NCT01158118|661427|P2|COMPLETED|Overall Study||21
274324|NCT01158118|661428|P1|COMPLETED|Overall Study||23
274325|NCT01158118|661427|P2|STARTED|Overall Study||24
274326|NCT01158118|661428|P1|STARTED|Overall Study||24
274327|NCT01158261|661444|P1|NOT COMPLETED|Overall Study||17
274328|NCT01158261|661444|P1|COMPLETED|Overall Study||283
274329|NCT01158261|661444|P1|STARTED|Overall Study||300
274330|NCT01158378|661450|P2|NOT COMPLETED|Overall Study||9
274331|NCT01158378|661451|P1|NOT COMPLETED|Overall Study||10
274332|NCT01158378|661450|P2|COMPLETED|Overall Study||117
274333|NCT01158378|661451|P1|COMPLETED|Overall Study||114
274334|NCT01158378|661450|P2|STARTED|Overall Study||126
274335|NCT01158378|661451|P1|STARTED|Overall Study||124
274336|NCT01158534|661463|P1|NOT COMPLETED|Overall Study||3
274337|NCT01158534|661463|P1|COMPLETED|Overall Study|All three pts that did not complete study had some treatment|14
274338|NCT01158534|661463|P1|STARTED|Overall Study||17
274339|NCT01158703|661473|P2|NOT COMPLETED|Overall Study||0
274340|NCT01158703|661474|P1|NOT COMPLETED|Overall Study||0
274341|NCT01158703|661473|P2|COMPLETED|Overall Study||8
274342|NCT01158703|661474|P1|COMPLETED|Overall Study||12
274343|NCT01158703|661473|P2|STARTED|Overall Study||8
274344|NCT01158703|661474|P1|STARTED|Overall Study||12
274345|NCT01158716|661492|P2|NOT COMPLETED|Overall Study||1
274346|NCT01158716|661493|P1|NOT COMPLETED|Overall Study||1
274347|NCT01158716|661492|P2|COMPLETED|Overall Study||47
274348|NCT01158716|661493|P1|COMPLETED|Overall Study||47
274349|NCT01158716|661492|P2|STARTED|Overall Study||48
274350|NCT01158716|661493|P1|STARTED|Overall Study||48
274351|NCT01158924|661501|P2|NOT COMPLETED|Overall Study||3
274352|NCT01158924|661502|P1|NOT COMPLETED|Overall Study||1
274353|NCT01158924|661501|P2|COMPLETED|Overall Study||23
274354|NCT01158924|661502|P1|COMPLETED|Overall Study||13
274355|NCT01158924|661501|P2|STARTED|Overall Study||26
274356|NCT01158924|661502|P1|STARTED|Overall Study||14
274357|NCT01159054|661516|P1|NOT COMPLETED|Overall Study||20
274358|NCT01159054|661516|P1|COMPLETED|Overall Study||2
274359|NCT01159054|661516|P1|STARTED|Overall Study||22
274360|NCT01159171|661528|P1|NOT COMPLETED|Overall Study||50
274361|NCT01159171|661528|P1|COMPLETED|Overall Study||0
274362|NCT01159171|661528|P1|STARTED|Overall Study||50
274363|NCT01159262|661546|P3|NOT COMPLETED|Overall Study||0
274364|NCT01159262|661547|P2|NOT COMPLETED|Overall Study||0
274365|NCT01159262|661548|P1|NOT COMPLETED|Overall Study||0
274366|NCT01159262|661546|P3|COMPLETED|Overall Study||8
274367|NCT01159262|661547|P2|COMPLETED|Overall Study||14
274368|NCT01159262|661548|P1|COMPLETED|Overall Study||14
274369|NCT01159262|661546|P3|STARTED|Overall Study||8
274370|NCT01159262|661547|P2|STARTED|Overall Study||14
274371|NCT01159262|661548|P1|STARTED|Overall Study||14
274372|NCT01159431|661582|P2|NOT COMPLETED|Overall Study||6
274373|NCT01159431|661583|P1|NOT COMPLETED|Overall Study||2
274374|NCT01159431|661582|P2|COMPLETED|Overall Study||19
274375|NCT01159431|661583|P1|COMPLETED|Overall Study||23
274376|NCT01159431|661582|P2|STARTED|Overall Study||25
274377|NCT01159431|661583|P1|STARTED|Overall Study||25
274378|NCT01159535|661602|P3|NOT COMPLETED|Overall Study||31
274379|NCT01159535|661603|P2|NOT COMPLETED|Overall Study||24
274380|NCT01159535|661604|P1|NOT COMPLETED|Overall Study||24
274381|NCT01159535|661602|P3|COMPLETED|Overall Study||64
274382|NCT01159535|661603|P2|COMPLETED|Overall Study||64
274383|NCT01159535|661604|P1|COMPLETED|Overall Study||79
274384|NCT01159535|661602|P3|STARTED|Overall Study||95
274385|NCT01159535|661603|P2|STARTED|Overall Study||88
274386|NCT01159535|661604|P1|STARTED|Overall Study||103
274387|NCT01159574|661612|P1|NOT COMPLETED|Follow Up Phase||20
274388|NCT01159574|661612|P1|COMPLETED|Follow Up Phase|Completion defined as those that are no longer in long term follow up due to death.|92
274389|NCT01159574|661612|P1|STARTED|Follow Up Phase||112
274390|NCT01159574|661612|P1|NOT COMPLETED|Treatment Phase||21
274391|NCT01159574|661612|P1|COMPLETED|Treatment Phase||100
274392|NCT01159574|661612|P1|STARTED|Treatment Phase||121
274393|NCT01159600|661626|P8|NOT COMPLETED|Overall Study||18
274394|NCT01159600|661627|P7|NOT COMPLETED|Overall Study||19
274395|NCT01159600|661628|P6|NOT COMPLETED|Overall Study||18
274396|NCT01159600|661629|P5|NOT COMPLETED|Overall Study||24
274397|NCT01159600|661630|P4|NOT COMPLETED|Overall Study||11
274398|NCT01159600|661631|P3|NOT COMPLETED|Overall Study||18
274399|NCT01159600|661632|P2|NOT COMPLETED|Overall Study||8
274400|NCT01159600|661633|P1|NOT COMPLETED|Overall Study||21
274401|NCT01159600|661626|P8|COMPLETED|Overall Study||85
274402|NCT01159600|661627|P7|COMPLETED|Overall Study||199
274403|NCT01159600|661628|P6|COMPLETED|Overall Study||208
274404|NCT01159600|661629|P5|COMPLETED|Overall Study||201
274405|NCT01159600|661630|P4|COMPLETED|Overall Study||58
274406|NCT01159600|661631|P3|COMPLETED|Overall Study||196
274407|NCT01159600|661632|P2|COMPLETED|Overall Study||209
274408|NCT01159600|661633|P1|COMPLETED|Overall Study||186
274409|NCT01159600|661626|P8|STARTED|Overall Study||103
274410|NCT01159600|661627|P7|STARTED|Overall Study||218
274411|NCT01159600|661628|P6|STARTED|Overall Study||226
274412|NCT01159600|661629|P5|STARTED|Overall Study||225
274413|NCT01159600|661630|P4|STARTED|Overall Study||69
274414|NCT01159600|661631|P3|STARTED|Overall Study||214
274415|NCT01159600|661632|P2|STARTED|Overall Study||217
274416|NCT01159600|661633|P1|STARTED|Overall Study||207
274417|NCT01159665|661681|P6|NOT COMPLETED|Overall Study||0
274418|NCT01159665|661682|P5|NOT COMPLETED|Overall Study||0
274419|NCT01159665|661683|P4|NOT COMPLETED|Overall Study||0
274420|NCT01159665|661684|P3|NOT COMPLETED|Overall Study||0
274421|NCT01159665|661685|P2|NOT COMPLETED|Overall Study||1
274422|NCT01159665|661686|P1|NOT COMPLETED|Overall Study||0
274423|NCT01159665|661681|P6|COMPLETED|Overall Study||4
274424|NCT01159665|661682|P5|COMPLETED|Overall Study||4
274425|NCT01159665|661683|P4|COMPLETED|Overall Study||4
274426|NCT01159665|661684|P3|COMPLETED|Overall Study||8
274427|NCT01159665|661685|P2|COMPLETED|Overall Study||8
274428|NCT01159665|661686|P1|COMPLETED|Overall Study||9
274429|NCT01159665|661681|P6|STARTED|Overall Study||4
274430|NCT01159665|661682|P5|STARTED|Overall Study||4
274431|NCT01159665|661683|P4|STARTED|Overall Study||4
274432|NCT01159665|661684|P3|STARTED|Overall Study||8
274433|NCT01159665|661685|P2|STARTED|Overall Study||9
274434|NCT01159665|661686|P1|STARTED|Overall Study||9
274435|NCT01159691|661706|P1|NOT COMPLETED|Overall Study||22
274436|NCT01159691|661706|P1|COMPLETED|Overall Study|Multiple discontinuation reasons were possible.|54
274437|NCT01159691|661706|P1|STARTED|Overall Study||76
274438|NCT01159743|661715|P2|NOT COMPLETED|Overall Study||0
274439|NCT01159743|661716|P1|NOT COMPLETED|Overall Study||0
274440|NCT01159743|661715|P2|COMPLETED|Overall Study||109
274441|NCT01159743|661716|P1|COMPLETED|Overall Study||237
274442|NCT01159743|661715|P2|STARTED|Overall Study||109
274443|NCT01159743|661716|P1|STARTED|Overall Study||237
274444|NCT01159769|661728|P1|NOT COMPLETED|Overall Study||1
274445|NCT01159769|661728|P1|COMPLETED|Overall Study||214
274446|NCT01159769|661728|P1|STARTED|Overall Study||215
274447|NCT01159912|661736|P3|NOT COMPLETED|Overall Study||26
274448|NCT01159912|661737|P2|NOT COMPLETED|Overall Study||22
274449|NCT01159912|661738|P1|NOT COMPLETED|Overall Study||40
274450|NCT01159912|661736|P3|COMPLETED|Overall Study||88
274451|NCT01159912|661737|P2|COMPLETED|Overall Study||92
274452|NCT01159912|661738|P1|COMPLETED|Overall Study||75
274453|NCT01159912|661736|P3|STARTED|Overall Study||114
274454|NCT01159912|661737|P2|STARTED|Overall Study||114
274455|NCT01159912|661738|P1|STARTED|Overall Study||115
274456|NCT01159938|661764|P5|NOT COMPLETED|Second Study Period||0
274457|NCT01159938|661765|P4|NOT COMPLETED|Second Study Period||0
274458|NCT01159938|661766|P3|NOT COMPLETED|Second Study Period||0
274459|NCT01159938|661767|P2|NOT COMPLETED|Second Study Period||0
274460|NCT01159938|661768|P1|NOT COMPLETED|Second Study Period||0
274461|NCT01159938|661764|P5|COMPLETED|Second Study Period||12
274462|NCT01159938|661765|P4|COMPLETED|Second Study Period||12
274463|NCT01159938|661766|P3|COMPLETED|Second Study Period||10
274464|NCT01159938|661767|P2|COMPLETED|Second Study Period||11
274465|NCT01159938|661768|P1|COMPLETED|Second Study Period||0
274466|NCT01159938|661764|P5|STARTED|Second Study Period||12
274467|NCT01159938|661765|P4|STARTED|Second Study Period||12
274468|NCT01159938|661766|P3|STARTED|Second Study Period||10
274469|NCT01159938|661767|P2|STARTED|Second Study Period||11
274470|NCT01159938|661768|P1|STARTED|Second Study Period||0
274471|NCT01159938|661764|P5|NOT COMPLETED|First Study Period||0
274472|NCT01159938|661765|P4|NOT COMPLETED|First Study Period||0
274473|NCT01159938|661766|P3|NOT COMPLETED|First Study Period||1
274474|NCT01159938|661767|P2|NOT COMPLETED|First Study Period||0
274475|NCT01159938|661768|P1|NOT COMPLETED|First Study Period||0
274476|NCT01159938|661764|P5|COMPLETED|First Study Period||12
274477|NCT01159938|661765|P4|COMPLETED|First Study Period||12
274478|NCT01159938|661766|P3|COMPLETED|First Study Period||10
274479|NCT01159938|661767|P2|COMPLETED|First Study Period||11
274480|NCT01159938|661768|P1|COMPLETED|First Study Period||26
274481|NCT01159938|661764|P5|Safety and Efficacy Analysis Population|First Study Period||12
274482|NCT01159938|661765|P4|Safety and Efficacy Analysis Population|First Study Period||12
274483|NCT01159938|661766|P3|Safety and Efficacy Analysis Population|First Study Period|Microalbuminuria relaxed with protocol amendment. T2DM albuminuria participant included in analyses.|11
274484|NCT01159938|661767|P2|Safety and Efficacy Analysis Population|First Study Period||11
274485|NCT01159938|661768|P1|Safety and Efficacy Analysis Population|First Study Period|One healthy participant completed study but was excluded from analyses (major protocol violation).|25
274486|NCT01159938|661764|P5|Received at Least 1 Dose of Study Drug|First Study Period||12
274487|NCT01159938|661765|P4|Received at Least 1 Dose of Study Drug|First Study Period||12
274488|NCT01159938|661766|P3|Received at Least 1 Dose of Study Drug|First Study Period||11
274489|NCT01159938|661767|P2|Received at Least 1 Dose of Study Drug|First Study Period||11
274490|NCT01159938|661768|P1|Received at Least 1 Dose of Study Drug|First Study Period||0
274491|NCT01159938|661764|P5|STARTED|First Study Period||12
274492|NCT01159938|661765|P4|STARTED|First Study Period||12
274493|NCT01159938|661766|P3|STARTED|First Study Period||11
274494|NCT01159938|661767|P2|STARTED|First Study Period||11
274495|NCT01159938|661768|P1|STARTED|First Study Period||26
274496|NCT01160237|661831|P3|NOT COMPLETED|Overall Study||0
274497|NCT01160237|661832|P2|NOT COMPLETED|Overall Study||0
274498|NCT01160237|661833|P1|NOT COMPLETED|Overall Study||0
274499|NCT01160237|661831|P3|COMPLETED|Overall Study||0
274500|NCT01160237|661832|P2|COMPLETED|Overall Study||3
274501|NCT01160237|661833|P1|COMPLETED|Overall Study||4
274502|NCT01160237|661831|P3|STARTED|Overall Study||0
274503|NCT01160237|661832|P2|STARTED|Overall Study||3
274504|NCT01160237|661833|P1|STARTED|Overall Study||4
274505|NCT01154452|661860|P4|NOT COMPLETED|Phase II||6
274506|NCT01154452|661861|P3|NOT COMPLETED|Phase II||5
274507|NCT01154452|661862|P2|NOT COMPLETED|Phase II||0
274508|NCT01154452|661863|P1|NOT COMPLETED|Phase II||0
274509|NCT01154452|661860|P4|COMPLETED|Phase II||27
274510|NCT01154452|661861|P3|COMPLETED|Phase II||30
274511|NCT01154452|661862|P2|COMPLETED|Phase II||0
274512|NCT01154452|661863|P1|COMPLETED|Phase II||0
274513|NCT01154452|661860|P4|STARTED|Phase II||33
274514|NCT01154452|661861|P3|STARTED|Phase II||35
274515|NCT01154452|661862|P2|STARTED|Phase II||0
274516|NCT01154452|661863|P1|STARTED|Phase II||0
274517|NCT01154452|661860|P4|NOT COMPLETED|Phase Ib||0
274518|NCT01154452|661861|P3|NOT COMPLETED|Phase Ib||0
274519|NCT01154452|661862|P2|NOT COMPLETED|Phase Ib||1
274520|NCT01154452|661863|P1|NOT COMPLETED|Phase Ib||3
274521|NCT01154452|661860|P4|COMPLETED|Phase Ib||0
274522|NCT01154452|661861|P3|COMPLETED|Phase Ib||0
274523|NCT01154452|661862|P2|COMPLETED|Phase Ib||3
274524|NCT01154452|661863|P1|COMPLETED|Phase Ib||3
274525|NCT01154452|661860|P4|STARTED|Phase Ib||0
274526|NCT01154452|661861|P3|STARTED|Phase Ib||0
274527|NCT01154452|661862|P2|STARTED|Phase Ib||4
274528|NCT01154452|661863|P1|STARTED|Phase Ib||6
274529|NCT01154634|661878|P4|NOT COMPLETED|Period 7 - Fourth Intervention||0
274530|NCT01154634|661879|P3|NOT COMPLETED|Period 7 - Fourth Intervention||0
274531|NCT01154634|661880|P2|NOT COMPLETED|Period 7 - Fourth Intervention||0
274532|NCT01154634|661881|P1|NOT COMPLETED|Period 7 - Fourth Intervention||0
274533|NCT01154634|661878|P4|COMPLETED|Period 7 - Fourth Intervention||5
274534|NCT01154634|661879|P3|COMPLETED|Period 7 - Fourth Intervention||4
274535|NCT01154634|661880|P2|COMPLETED|Period 7 - Fourth Intervention||7
274536|NCT01154634|661881|P1|COMPLETED|Period 7 - Fourth Intervention||4
274537|NCT01154634|661878|P4|STARTED|Period 7 - Fourth Intervention||5
274538|NCT01154634|661879|P3|STARTED|Period 7 - Fourth Intervention||4
274539|NCT01154634|661880|P2|STARTED|Period 7 - Fourth Intervention||7
274540|NCT01154634|661881|P1|STARTED|Period 7 - Fourth Intervention||4
274541|NCT01154634|661878|P4|NOT COMPLETED|Period 6 - Washout||0
274542|NCT01154634|661879|P3|NOT COMPLETED|Period 6 - Washout||0
274543|NCT01154634|661880|P2|NOT COMPLETED|Period 6 - Washout||0
274544|NCT01154634|661881|P1|NOT COMPLETED|Period 6 - Washout||0
274545|NCT01154634|661878|P4|COMPLETED|Period 6 - Washout||5
274546|NCT01154634|661879|P3|COMPLETED|Period 6 - Washout||4
274547|NCT01154634|661880|P2|COMPLETED|Period 6 - Washout||7
274548|NCT01154634|661881|P1|COMPLETED|Period 6 - Washout||4
274549|NCT01154634|661878|P4|STARTED|Period 6 - Washout||5
274550|NCT01154634|661879|P3|STARTED|Period 6 - Washout||4
274551|NCT01154634|661880|P2|STARTED|Period 6 - Washout||7
274552|NCT01154634|661881|P1|STARTED|Period 6 - Washout||4
274553|NCT01154634|661878|P4|NOT COMPLETED|Period 5 - Third Intervention||0
274554|NCT01154634|661879|P3|NOT COMPLETED|Period 5 - Third Intervention||0
274555|NCT01154634|661880|P2|NOT COMPLETED|Period 5 - Third Intervention||0
274556|NCT01154634|661881|P1|NOT COMPLETED|Period 5 - Third Intervention||0
274557|NCT01154634|661878|P4|COMPLETED|Period 5 - Third Intervention||5
274558|NCT01154634|661879|P3|COMPLETED|Period 5 - Third Intervention||4
274559|NCT01154634|661880|P2|COMPLETED|Period 5 - Third Intervention||7
274560|NCT01154634|661881|P1|COMPLETED|Period 5 - Third Intervention||4
274561|NCT01154634|661878|P4|STARTED|Period 5 - Third Intervention||5
274562|NCT01154634|661879|P3|STARTED|Period 5 - Third Intervention||4
274563|NCT01154634|661880|P2|STARTED|Period 5 - Third Intervention||7
274564|NCT01154634|661881|P1|STARTED|Period 5 - Third Intervention||4
274565|NCT01154634|661878|P4|NOT COMPLETED|Period 4 - Washout||0
274566|NCT01154634|661879|P3|NOT COMPLETED|Period 4 - Washout||0
274567|NCT01154634|661880|P2|NOT COMPLETED|Period 4 - Washout||0
274568|NCT01154634|661881|P1|NOT COMPLETED|Period 4 - Washout||0
274569|NCT01154634|661878|P4|COMPLETED|Period 4 - Washout||5
274570|NCT01154634|661879|P3|COMPLETED|Period 4 - Washout||4
274571|NCT01154634|661880|P2|COMPLETED|Period 4 - Washout||7
274572|NCT01154634|661881|P1|COMPLETED|Period 4 - Washout||4
274573|NCT01154634|661878|P4|STARTED|Period 4 - Washout||5
274574|NCT01154634|661879|P3|STARTED|Period 4 - Washout||4
274575|NCT01154634|661880|P2|STARTED|Period 4 - Washout||7
274576|NCT01154634|661881|P1|STARTED|Period 4 - Washout||4
274577|NCT01154634|661878|P4|NOT COMPLETED|Period 3- Second Intervention||0
274578|NCT01154634|661879|P3|NOT COMPLETED|Period 3- Second Intervention||0
274579|NCT01154634|661880|P2|NOT COMPLETED|Period 3- Second Intervention||0
274580|NCT01154634|661881|P1|NOT COMPLETED|Period 3- Second Intervention||0
274581|NCT01154634|661878|P4|COMPLETED|Period 3- Second Intervention||5
274582|NCT01154634|661879|P3|COMPLETED|Period 3- Second Intervention||4
274583|NCT01154634|661880|P2|COMPLETED|Period 3- Second Intervention||7
274584|NCT01154634|661881|P1|COMPLETED|Period 3- Second Intervention||4
274585|NCT01154634|661878|P4|STARTED|Period 3- Second Intervention||5
274586|NCT01154634|661879|P3|STARTED|Period 3- Second Intervention||4
274587|NCT01154634|661880|P2|STARTED|Period 3- Second Intervention||7
274588|NCT01154634|661881|P1|STARTED|Period 3- Second Intervention||4
274589|NCT01154634|661878|P4|NOT COMPLETED|Period 2 - Washout||0
274590|NCT01154634|661879|P3|NOT COMPLETED|Period 2 - Washout||0
274591|NCT01154634|661880|P2|NOT COMPLETED|Period 2 - Washout||0
274592|NCT01154634|661881|P1|NOT COMPLETED|Period 2 - Washout||0
274593|NCT01154634|661878|P4|COMPLETED|Period 2 - Washout||5
274594|NCT01154634|661879|P3|COMPLETED|Period 2 - Washout||4
274595|NCT01154634|661880|P2|COMPLETED|Period 2 - Washout||7
274596|NCT01154634|661881|P1|COMPLETED|Period 2 - Washout||4
274597|NCT01154634|661878|P4|STARTED|Period 2 - Washout||5
274598|NCT01154634|661879|P3|STARTED|Period 2 - Washout||4
274599|NCT01154634|661880|P2|STARTED|Period 2 - Washout||7
274600|NCT01154634|661881|P1|STARTED|Period 2 - Washout||4
274601|NCT01154634|661878|P4|NOT COMPLETED|Period 1 - First Intervention||0
274602|NCT01154634|661879|P3|NOT COMPLETED|Period 1 - First Intervention||0
274603|NCT01154634|661880|P2|NOT COMPLETED|Period 1 - First Intervention||0
274604|NCT01154634|661881|P1|NOT COMPLETED|Period 1 - First Intervention||0
274605|NCT01154634|661878|P4|COMPLETED|Period 1 - First Intervention||5
274606|NCT01154634|661879|P3|COMPLETED|Period 1 - First Intervention||4
274607|NCT01154634|661880|P2|COMPLETED|Period 1 - First Intervention||7
274608|NCT01154634|661881|P1|COMPLETED|Period 1 - First Intervention||4
274609|NCT01154634|661878|P4|STARTED|Period 1 - First Intervention||5
274610|NCT01154634|661879|P3|STARTED|Period 1 - First Intervention||4
274611|NCT01154634|661880|P2|STARTED|Period 1 - First Intervention||7
274612|NCT01154634|661881|P1|STARTED|Period 1 - First Intervention||4
274613|NCT01154673|661921|P2|NOT COMPLETED|Overall Study||0
274614|NCT01154673|661922|P1|NOT COMPLETED|Overall Study||2
274615|NCT01154673|661921|P2|COMPLETED|Overall Study||16
274616|NCT01154673|661922|P1|COMPLETED|Overall Study||14
274617|NCT01154673|661921|P2|STARTED|Overall Study||16
274618|NCT01154673|661922|P1|STARTED|Overall Study||16
274619|NCT01154699|661930|P2|NOT COMPLETED|Second Intervention||0
274620|NCT01154699|661931|P1|NOT COMPLETED|Second Intervention||0
274621|NCT01154699|661930|P2|COMPLETED|Second Intervention||8
274622|NCT01154699|661931|P1|COMPLETED|Second Intervention||13
274623|NCT01154699|661930|P2|Subjects With Asthma + OSA|Second Intervention||2
274624|NCT01154699|661931|P1|Subjects With Asthma + OSA|Second Intervention||6
274625|NCT01154699|661930|P2|Subjects With Asthma Only|Second Intervention||6
274626|NCT01154699|661931|P1|Subjects With Asthma Only|Second Intervention||7
274627|NCT01154699|661930|P2|STARTED|Second Intervention||8
274628|NCT01154699|661931|P1|STARTED|Second Intervention||13
274629|NCT01154699|661930|P2|NOT COMPLETED|Washout Period (4 Weeks)||0
274630|NCT01154699|661931|P1|NOT COMPLETED|Washout Period (4 Weeks)||0
274631|NCT01154699|661930|P2|COMPLETED|Washout Period (4 Weeks)||8
274632|NCT01154699|661931|P1|COMPLETED|Washout Period (4 Weeks)||13
274633|NCT01154699|661930|P2|Subjects With Asthma + OSA|Washout Period (4 Weeks)||2
274634|NCT01154699|661931|P1|Subjects With Asthma + OSA|Washout Period (4 Weeks)||6
274635|NCT01154699|661930|P2|Subjects With Asthma Only|Washout Period (4 Weeks)||6
274636|NCT01154699|661931|P1|Subjects With Asthma Only|Washout Period (4 Weeks)||7
274637|NCT01154699|661930|P2|STARTED|Washout Period (4 Weeks)||8
274638|NCT01154699|661931|P1|STARTED|Washout Period (4 Weeks)||13
274639|NCT01154699|661930|P2|NOT COMPLETED|First Intervention (4 Weeks)||0
274640|NCT01154699|661931|P1|NOT COMPLETED|First Intervention (4 Weeks)||0
274641|NCT01154699|661930|P2|COMPLETED|First Intervention (4 Weeks)||8
274642|NCT01154699|661931|P1|COMPLETED|First Intervention (4 Weeks)||13
274643|NCT01154699|661930|P2|Subjects With Asthma + OSA|First Intervention (4 Weeks)||2
274644|NCT01154699|661931|P1|Subjects With Asthma + OSA|First Intervention (4 Weeks)||6
274645|NCT01154699|661930|P2|Subjects With Asthma Only|First Intervention (4 Weeks)||6
274646|NCT01154699|661931|P1|Subjects With Asthma Only|First Intervention (4 Weeks)||7
274647|NCT01154699|661930|P2|STARTED|First Intervention (4 Weeks)||8
274648|NCT01154699|661931|P1|STARTED|First Intervention (4 Weeks)||13
274649|NCT01154751|661947|P1|NOT COMPLETED|3-year Follow-up||49
274650|NCT01154751|661947|P1|COMPLETED|3-year Follow-up||34
274651|NCT01154751|661947|P1|STARTED|3-year Follow-up||83
274652|NCT01154751|661947|P1|NOT COMPLETED|2-year Follow-up||10
274653|NCT01154751|661947|P1|COMPLETED|2-year Follow-up||83
274654|NCT01154751|661947|P1|STARTED|2-year Follow-up||93
274655|NCT01154751|661947|P1|NOT COMPLETED|1-year Follow-up||5
274656|NCT01154751|661947|P1|COMPLETED|1-year Follow-up||93
274657|NCT01154751|661947|P1|STARTED|1-year Follow-up||98
274658|NCT01154751|661947|P1|NOT COMPLETED|6-month Follow-up||11
274659|NCT01154751|661947|P1|COMPLETED|6-month Follow-up||98
274660|NCT01154751|661947|P1|STARTED|6-month Follow-up||109
274661|NCT01160380|661972|P2|NOT COMPLETED|Overall Study||5
274662|NCT01160380|661973|P1|NOT COMPLETED|Overall Study||8
274663|NCT01160380|661972|P2|COMPLETED|Overall Study||20
274664|NCT01160380|661973|P1|COMPLETED|Overall Study||17
274665|NCT01160380|661972|P2|STARTED|Overall Study||25
274666|NCT01160380|661973|P1|STARTED|Overall Study||25
274667|NCT01160445|661993|P2|NOT COMPLETED|Overall Study||0
274668|NCT01160445|661994|P1|NOT COMPLETED|Overall Study||0
274669|NCT01160445|661993|P2|COMPLETED|Overall Study||2
274670|NCT01160445|661994|P1|COMPLETED|Overall Study||7
274671|NCT01160445|661993|P2|STARTED|Overall Study||2
274672|NCT01160445|661994|P1|STARTED|Overall Study||7
274673|NCT01160458|662002|P1|NOT COMPLETED|Overall Study||0
274674|NCT01160458|662002|P1|COMPLETED|Overall Study||20
274675|NCT01160458|662002|P1|STARTED|Overall Study||20
274676|NCT01160484|662010|P1|NOT COMPLETED|Overall Study||18
274677|NCT01160484|662010|P1|COMPLETED|Overall Study||22
274678|NCT01160484|662010|P1|STARTED|Overall Study||40
274679|NCT01160614|662022|P2|NOT COMPLETED|Overall Study||2
274680|NCT01160614|662023|P1|NOT COMPLETED|Overall Study||0
274681|NCT01160614|662022|P2|COMPLETED|Overall Study||23
274682|NCT01160614|662023|P1|COMPLETED|Overall Study||5
274683|NCT01160614|662022|P2|STARTED|Overall Study||25
274684|NCT01160614|662023|P1|STARTED|Overall Study||5
274685|NCT01160640|662073|P2|NOT COMPLETED|Overall Study||6
274686|NCT01160640|662074|P1|NOT COMPLETED|Overall Study||4
274687|NCT01160640|662073|P2|COMPLETED|Overall Study||110
274688|NCT01160640|662074|P1|COMPLETED|Overall Study||113
274689|NCT01160640|662073|P2|STARTED|Overall Study||116
274690|NCT01160640|662074|P1|STARTED|Overall Study||117
274691|NCT01161329|662090|P2|NOT COMPLETED|Overall Study||10
274692|NCT01161329|662091|P1|NOT COMPLETED|Overall Study||4
274693|NCT01161329|662090|P2|COMPLETED|Overall Study||24
274694|NCT01161329|662091|P1|COMPLETED|Overall Study||29
274695|NCT01161329|662090|P2|STARTED|Overall Study||34
274696|NCT01161329|662091|P1|STARTED|Overall Study||33
274697|NCT01161407|662101|P2|NOT COMPLETED|Overall Study||1
274698|NCT01161407|662102|P1|NOT COMPLETED|Overall Study||3
274699|NCT01161407|662101|P2|COMPLETED|Overall Study||5
274700|NCT01161407|662102|P1|COMPLETED|Overall Study||3
274701|NCT01161407|662101|P2|STARTED|Overall Study||6
274702|NCT01161407|662102|P1|STARTED|Overall Study||6
274703|NCT01161420|662112|P1|NOT COMPLETED|Withdrawal Study - Withdrawal||0
274704|NCT01161420|662112|P1|COMPLETED|Withdrawal Study - Withdrawal||23
274705|NCT01161420|662112|P1|STARTED|Withdrawal Study - Withdrawal||23
274706|NCT01161420|662112|P1|NOT COMPLETED|Withdrawal Study - Maintenance||0
274707|NCT01161420|662112|P1|COMPLETED|Withdrawal Study - Maintenance||23
274708|NCT01161420|662112|P1|STARTED|Withdrawal Study - Maintenance||23
274709|NCT01161420|662112|P1|NOT COMPLETED|Inspire Therapy||2
274710|NCT01161420|662112|P1|COMPLETED|Inspire Therapy||124
274711|NCT01161420|662112|P1|STARTED|Inspire Therapy||126
274712|NCT01161446|662126|P2|NOT COMPLETED|Overall Study||15
274713|NCT01161446|662127|P1|NOT COMPLETED|Overall Study||18
274714|NCT01161446|662126|P2|COMPLETED|Overall Study||99
274715|NCT01161446|662127|P1|COMPLETED|Overall Study||98
274716|NCT01161446|662126|P2|STARTED|Overall Study||114
274717|NCT01161446|662127|P1|STARTED|Overall Study||116
274718|NCT01161472|662139|P4|NOT COMPLETED|Fourth Intervention Period||0
274719|NCT01161472|662140|P3|NOT COMPLETED|Fourth Intervention Period||0
274720|NCT01161472|662141|P2|NOT COMPLETED|Fourth Intervention Period||0
274721|NCT01161472|662142|P1|NOT COMPLETED|Fourth Intervention Period||0
274722|NCT01161472|662139|P4|COMPLETED|Fourth Intervention Period||5
274723|NCT01161472|662140|P3|COMPLETED|Fourth Intervention Period||5
274724|NCT01161472|662141|P2|COMPLETED|Fourth Intervention Period||5
274725|NCT01161472|662142|P1|COMPLETED|Fourth Intervention Period||4
274726|NCT01161472|662139|P4|STARTED|Fourth Intervention Period||5
274727|NCT01161472|662140|P3|STARTED|Fourth Intervention Period||5
274728|NCT01161472|662141|P2|STARTED|Fourth Intervention Period||5
274729|NCT01161472|662142|P1|STARTED|Fourth Intervention Period||4
274730|NCT01161472|662139|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274731|NCT01161472|662140|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274732|NCT01161472|662141|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274733|NCT01161472|662142|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274734|NCT01161472|662139|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274735|NCT01161472|662140|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274736|NCT01161472|662141|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274737|NCT01161472|662142|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
274738|NCT01161472|662139|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
274739|NCT01161472|662140|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
274740|NCT01161472|662141|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
274741|NCT01161472|662142|P1|STARTED|Washout Period (At Least 3 to 6 Days)||4
274742|NCT01161472|662139|P4|NOT COMPLETED|Third Intervention Period||0
274743|NCT01161472|662140|P3|NOT COMPLETED|Third Intervention Period||0
274744|NCT01161472|662141|P2|NOT COMPLETED|Third Intervention Period||0
274745|NCT01161472|662142|P1|NOT COMPLETED|Third Intervention Period||0
274746|NCT01161472|662139|P4|COMPLETED|Third Intervention Period||5
274747|NCT01161472|662140|P3|COMPLETED|Third Intervention Period||5
274748|NCT01161472|662141|P2|COMPLETED|Third Intervention Period||5
274749|NCT01161472|662142|P1|COMPLETED|Third Intervention Period||4
274750|NCT01161472|662139|P4|STARTED|Third Intervention Period||5
274751|NCT01161472|662140|P3|STARTED|Third Intervention Period||5
274752|NCT01161472|662141|P2|STARTED|Third Intervention Period||5
274753|NCT01161472|662142|P1|STARTED|Third Intervention Period||4
274754|NCT01161472|662139|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274755|NCT01161472|662140|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274756|NCT01161472|662141|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274757|NCT01161472|662142|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||1
274758|NCT01161472|662139|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274759|NCT01161472|662140|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274760|NCT01161472|662141|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274761|NCT01161472|662142|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||4
274762|NCT01161472|662139|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
274763|NCT01161472|662140|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
274764|NCT01161472|662141|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
274765|NCT01161472|662142|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
274766|NCT01161472|662139|P4|NOT COMPLETED|Second Intervention Period||0
274767|NCT01161472|662140|P3|NOT COMPLETED|Second Intervention Period||0
274768|NCT01161472|662141|P2|NOT COMPLETED|Second Intervention Period||0
274769|NCT01161472|662142|P1|NOT COMPLETED|Second Intervention Period||0
274770|NCT01161472|662139|P4|COMPLETED|Second Intervention Period||5
274771|NCT01161472|662140|P3|COMPLETED|Second Intervention Period||5
274772|NCT01161472|662141|P2|COMPLETED|Second Intervention Period||5
274773|NCT01161472|662142|P1|COMPLETED|Second Intervention Period||5
274774|NCT01161472|662139|P4|STARTED|Second Intervention Period||5
274775|NCT01161472|662140|P3|STARTED|Second Intervention Period||5
274776|NCT01161472|662141|P2|STARTED|Second Intervention Period||5
274777|NCT01161472|662142|P1|STARTED|Second Intervention Period||5
274778|NCT01161472|662139|P4|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274779|NCT01161472|662140|P3|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274780|NCT01161472|662141|P2|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274781|NCT01161472|662142|P1|NOT COMPLETED|Washout Period (At Least 3 to 6 Days)||0
274782|NCT01161472|662139|P4|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274783|NCT01161472|662140|P3|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274784|NCT01161472|662141|P2|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274785|NCT01161472|662142|P1|COMPLETED|Washout Period (At Least 3 to 6 Days)||5
274786|NCT01161472|662139|P4|STARTED|Washout Period (At Least 3 to 6 Days)||5
274787|NCT01161472|662140|P3|STARTED|Washout Period (At Least 3 to 6 Days)||5
274788|NCT01161472|662141|P2|STARTED|Washout Period (At Least 3 to 6 Days)||5
274789|NCT01161472|662142|P1|STARTED|Washout Period (At Least 3 to 6 Days)||5
274790|NCT01161472|662139|P4|NOT COMPLETED|First Intervention Period||0
274791|NCT01161472|662140|P3|NOT COMPLETED|First Intervention Period||0
274792|NCT01161472|662141|P2|NOT COMPLETED|First Intervention Period||0
274793|NCT01161472|662142|P1|NOT COMPLETED|First Intervention Period||0
274794|NCT01161472|662139|P4|COMPLETED|First Intervention Period||5
274795|NCT01161472|662140|P3|COMPLETED|First Intervention Period||5
274796|NCT01161472|662141|P2|COMPLETED|First Intervention Period||5
274797|NCT01161472|662142|P1|COMPLETED|First Intervention Period||5
274798|NCT01161472|662139|P4|Treated|First Intervention Period||5
274799|NCT01161472|662140|P3|Treated|First Intervention Period||5
274800|NCT01161472|662141|P2|Treated|First Intervention Period||5
274801|NCT01161472|662142|P1|Treated|First Intervention Period||5
274802|NCT01161472|662139|P4|STARTED|First Intervention Period||5
274803|NCT01161472|662140|P3|STARTED|First Intervention Period||5
274804|NCT01161472|662141|P2|STARTED|First Intervention Period||5
274805|NCT01161472|662142|P1|STARTED|First Intervention Period||5
274806|NCT01161498|662198|P2|NOT COMPLETED|Overall Study||1
274807|NCT01161498|662199|P1|NOT COMPLETED|Overall Study||0
274808|NCT01161498|662198|P2|COMPLETED|Overall Study||1
274809|NCT01161498|662199|P1|COMPLETED|Overall Study||3
274810|NCT01161498|662198|P2|STARTED|Overall Study||2
274811|NCT01161498|662199|P1|STARTED|Overall Study||3
274812|NCT01161537|662223|P1|NOT COMPLETED|Part B||2
274813|NCT01161537|662223|P1|COMPLETED|Part B||7
274814|NCT01161537|662223|P1|STARTED|Part B|4 subjects from Part A continued in Part B of the study.|9
274815|NCT01161537|662223|P1|NOT COMPLETED|Part A||0
274816|NCT01161537|662223|P1|COMPLETED|Part A||8
274817|NCT01161537|662223|P1|STARTED|Part A||8
274818|NCT01161563|662241|P2|NOT COMPLETED|Overall Study||6
274819|NCT01161563|662242|P1|NOT COMPLETED|Overall Study||5
274820|NCT01161563|662241|P2|COMPLETED|Overall Study||49
274821|NCT01161563|662242|P1|COMPLETED|Overall Study||58
274822|NCT01161563|662241|P2|STARTED|Overall Study||55
274823|NCT01161563|662242|P1|STARTED|Overall Study||63
274824|NCT01161628|662250|P1|NOT COMPLETED|Overall Study||8
274825|NCT01161628|662250|P1|COMPLETED|Overall Study||17
274826|NCT01161628|662250|P1|STARTED|Overall Study||25
274827|NCT01161771|662262|P1|NOT COMPLETED|Overall Study||0
274828|NCT01161771|662262|P1|COMPLETED|Overall Study||32
274829|NCT01161771|662262|P1|STARTED|Overall Study||32
274830|NCT01162096|662271|P1|NOT COMPLETED|Overall Study||0
274831|NCT01162096|662271|P1|COMPLETED|Overall Study||34
274832|NCT01162096|662271|P1|STARTED|Overall Study||34
274833|NCT01162122|662277|P2|NOT COMPLETED|Overall Study||196
274834|NCT01162122|662278|P1|NOT COMPLETED|Overall Study||191
274835|NCT01162122|662277|P2|COMPLETED|Overall Study||3356
274836|NCT01162122|662278|P1|COMPLETED|Overall Study||3361
274837|NCT01162122|662277|P2|Vaccinated|Overall Study||3541
274838|NCT01162122|662278|P1|Vaccinated|Overall Study||3541
274839|NCT01162122|662277|P2|STARTED|Overall Study||3552
274840|NCT01162122|662278|P1|STARTED|Overall Study||3552
274841|NCT01162135|662335|P1|NOT COMPLETED|Overall Study||3
274842|NCT01162135|662335|P1|COMPLETED|Overall Study||13
274843|NCT01162135|662335|P1|STARTED|Overall Study||16
274844|NCT01162304|662339|P1|NOT COMPLETED|Overall Study||11
274845|NCT01162304|662339|P1|COMPLETED|Overall Study||7
274846|NCT01162304|662339|P1|STARTED|Overall Study||18
274847|NCT01162317|662355|P2|NOT COMPLETED|Overall Study||2
274848|NCT01162317|662356|P1|NOT COMPLETED|Overall Study||3
274849|NCT01162317|662355|P2|COMPLETED|Overall Study||28
274850|NCT01162317|662356|P1|COMPLETED|Overall Study||27
274851|NCT01162317|662355|P2|STARTED|Overall Study||30
274852|NCT01162317|662356|P1|STARTED|Overall Study||30
274853|NCT01162421|662366|P2|NOT COMPLETED|Overall Study||13
274854|NCT01162421|662367|P1|NOT COMPLETED|Overall Study||8
274855|NCT01162421|662366|P2|COMPLETED|Overall Study||27
274856|NCT01162421|662367|P1|COMPLETED|Overall Study||29
274857|NCT01162421|662366|P2|STARTED|Overall Study||40
274858|NCT01162421|662367|P1|STARTED|Overall Study||37
274859|NCT01162473|662447|P2|NOT COMPLETED|Overall Study||5
274860|NCT01162473|662448|P1|NOT COMPLETED|Overall Study||2
274861|NCT01162473|662447|P2|COMPLETED|Overall Study||12
274862|NCT01162473|662448|P1|COMPLETED|Overall Study||6
274863|NCT01162473|662447|P2|STARTED|Overall Study||17
274864|NCT01162473|662448|P1|STARTED|Overall Study||8
274865|NCT01162499|662454|P2|NOT COMPLETED|Intervention 2 (4 Hours)||0
274866|NCT01162499|662455|P1|NOT COMPLETED|Intervention 2 (4 Hours)||0
274867|NCT01162499|662454|P2|COMPLETED|Intervention 2 (4 Hours)||3
274868|NCT01162499|662455|P1|COMPLETED|Intervention 2 (4 Hours)||3
274869|NCT01162499|662454|P2|STARTED|Intervention 2 (4 Hours)||3
274870|NCT01162499|662455|P1|STARTED|Intervention 2 (4 Hours)||3
274871|NCT01162499|662454|P2|NOT COMPLETED|Intervention 1 (4 Hours)||1
274872|NCT01162499|662455|P1|NOT COMPLETED|Intervention 1 (4 Hours)||0
274873|NCT01162499|662454|P2|COMPLETED|Intervention 1 (4 Hours)||3
274874|NCT01162499|662455|P1|COMPLETED|Intervention 1 (4 Hours)||3
274875|NCT01162499|662454|P2|Received Intervention|Intervention 1 (4 Hours)||3
274876|NCT01162499|662455|P1|Received Intervention|Intervention 1 (4 Hours)||3
274877|NCT01162499|662454|P2|STARTED|Intervention 1 (4 Hours)||4
274878|NCT01162499|662455|P1|STARTED|Intervention 1 (4 Hours)||3
274879|NCT01162733|662477|P2|NOT COMPLETED|Overall Study||25
274880|NCT01162733|662478|P1|NOT COMPLETED|Overall Study||27
274881|NCT01162733|662477|P2|COMPLETED|Overall Study||25
274882|NCT01162733|662478|P1|COMPLETED|Overall Study||22
274883|NCT01162733|662477|P2|STARTED|Overall Study||50
274884|NCT01162733|662478|P1|STARTED|Overall Study||49
274885|NCT01162863|662489|P3|NOT COMPLETED|Overall Study||0
274886|NCT01162863|662490|P2|NOT COMPLETED|Overall Study||1
274887|NCT01162863|662491|P1|NOT COMPLETED|Overall Study||1
274888|NCT01162863|662489|P3|COMPLETED|Overall Study||17
274889|NCT01162863|662490|P2|COMPLETED|Overall Study||16
274890|NCT01162863|662491|P1|COMPLETED|Overall Study||17
274891|NCT01162863|662489|P3|STARTED|Overall Study||17
274892|NCT01162863|662490|P2|STARTED|Overall Study||17
274893|NCT01162863|662491|P1|STARTED|Overall Study||18
274894|NCT01163032|662508|P3|NOT COMPLETED|Open Label Extension Phase||16
274895|NCT01163032|662509|P2|NOT COMPLETED|Open Label Extension Phase||0
274896|NCT01163032|662510|P1|NOT COMPLETED|Open Label Extension Phase||0
274897|NCT01163032|662508|P3|COMPLETED|Open Label Extension Phase||39
274898|NCT01163032|662509|P2|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
274899|NCT01163032|662510|P1|COMPLETED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
274900|NCT01163032|662508|P3|STARTED|Open Label Extension Phase|3 randomized patients rolled into extension (2 randomized to tasimelteon and one to placebo)|55
274901|NCT01163032|662509|P2|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
274902|NCT01163032|662510|P1|STARTED|Open Label Extension Phase|Not applicable for Open Label Extension Phase|0
274903|NCT01163032|662508|P3|NOT COMPLETED|Randomization Phase||0
274904|NCT01163032|662509|P2|NOT COMPLETED|Randomization Phase||12
274905|NCT01163032|662510|P1|NOT COMPLETED|Randomization Phase||10
274906|NCT01163032|662508|P3|COMPLETED|Randomization Phase|Not applicable for Randomized Phase|0
274907|NCT01163032|662509|P2|COMPLETED|Randomization Phase||30
274908|NCT01163032|662510|P1|COMPLETED|Randomization Phase||32
274909|NCT01163032|662508|P3|STARTED|Randomization Phase|Not applicable for Randomized Phase|0
274910|NCT01163032|662509|P2|STARTED|Randomization Phase||42
274911|NCT01163032|662510|P1|STARTED|Randomization Phase||42
274912|NCT01163097|662543|P3|NOT COMPLETED|Overall Study||0
274913|NCT01163097|662544|P2|NOT COMPLETED|Overall Study||0
274914|NCT01163097|662545|P1|NOT COMPLETED|Overall Study||6
274915|NCT01163097|662543|P3|COMPLETED|Overall Study||8
274916|NCT01163097|662544|P2|COMPLETED|Overall Study||16
274917|NCT01163097|662545|P1|COMPLETED|Overall Study||14
274918|NCT01163097|662543|P3|STARTED|Overall Study||8
274919|NCT01163097|662544|P2|STARTED|Overall Study||16
274920|NCT01163097|662545|P1|STARTED|Overall Study|15 subjects were successfully titrated and entered the palifermin treatment|20
274921|NCT01163162|662595|P1|NOT COMPLETED|Overall Study||0
274922|NCT01163162|662595|P1|COMPLETED|Overall Study||16
274923|NCT01163162|662595|P1|STARTED|Overall Study||16
274924|NCT01163214|662603|P2|NOT COMPLETED|Overall Study||0
274925|NCT01163214|662604|P1|NOT COMPLETED|Overall Study||0
274926|NCT01163214|662603|P2|COMPLETED|Overall Study||81
274927|NCT01163214|662604|P1|COMPLETED|Overall Study||79
274928|NCT01163214|662603|P2|STARTED|Overall Study||81
274929|NCT01163214|662604|P1|STARTED|Overall Study||79
274930|NCT01163253|662622|P2|NOT COMPLETED|Overall Study||586
274931|NCT01163253|662623|P1|NOT COMPLETED|Overall Study||2281
274932|NCT01163253|662622|P2|COMPLETED|Overall Study||0
274933|NCT01163253|662623|P1|COMPLETED|Overall Study||0
274934|NCT01163253|662622|P2|STARTED|Overall Study||586
274935|NCT01163253|662623|P1|STARTED|Overall Study||2281
274936|NCT01163266|662786|P3|NOT COMPLETED|Overall Study||28
274937|NCT01163266|662787|P2|NOT COMPLETED|Overall Study||31
274938|NCT01163266|662788|P1|NOT COMPLETED|Overall Study||18
274939|NCT01163266|662786|P3|COMPLETED|Overall Study||122
274940|NCT01163266|662787|P2|COMPLETED|Overall Study||124
274941|NCT01163266|662788|P1|COMPLETED|Overall Study||139
274942|NCT01163266|662786|P3|Treated|Overall Study||150
274943|NCT01163266|662787|P2|Treated|Overall Study||155
274944|NCT01163266|662788|P1|Treated|Overall Study||157
274945|NCT01163266|662786|P3|STARTED|Overall Study||150
274946|NCT01163266|662787|P2|STARTED|Overall Study||155
274947|NCT01163266|662788|P1|STARTED|Overall Study||157
274948|NCT01163279|662813|P2|NOT COMPLETED|Overall Study||0
274949|NCT01163279|662814|P1|NOT COMPLETED|Overall Study||2
274950|NCT01163279|662813|P2|COMPLETED|Overall Study||9
274951|NCT01163279|662814|P1|COMPLETED|Overall Study||8
274952|NCT01163279|662813|P2|STARTED|Overall Study||9
274953|NCT01163279|662814|P1|STARTED|Overall Study||10
274954|NCT01163292|662842|P2|NOT COMPLETED|Overall Study||22
274955|NCT01163292|662843|P1|NOT COMPLETED|Overall Study||41
274956|NCT01163292|662842|P2|COMPLETED|Overall Study||92
274957|NCT01163292|662843|P1|COMPLETED|Overall Study||65
274958|NCT01163292|662842|P2|STARTED|Overall Study||114
274959|NCT01163292|662843|P1|STARTED|Overall Study||106
274960|NCT01163318|662857|P1|NOT COMPLETED|Overall Study||268
274961|NCT01163318|662857|P1|COMPLETED|Overall Study||284
274962|NCT01163318|662857|P1|STARTED|Overall Study||552
274969|NCT01163474|662869|P1|NOT COMPLETED|Overall Study||16
274970|NCT01163474|662869|P1|COMPLETED|Overall Study||24
274971|NCT01163474|662869|P1|STARTED|Overall Study||40
274972|NCT01163604|662877|P2|NOT COMPLETED|Overall Study||0
274973|NCT01163604|662878|P1|NOT COMPLETED|Overall Study||0
274974|NCT01163604|662877|P2|COMPLETED|Overall Study|August 2011|56
274975|NCT01163604|662878|P1|COMPLETED|Overall Study|August 2011|58
274976|NCT01163604|662877|P2|STARTED|Overall Study|August 2010|56
274977|NCT01163604|662878|P1|STARTED|Overall Study|August 2010|58
274978|NCT01163617|662884|P8|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274979|NCT01163617|662885|P7|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274980|NCT01163617|662886|P6|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274981|NCT01163617|662887|P5|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274982|NCT01163617|662888|P4|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274983|NCT01163617|662889|P3|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274984|NCT01163617|662890|P2|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274985|NCT01163617|662891|P1|NOT COMPLETED|Phase B (Injection Time), Week 4||0
274986|NCT01163617|662884|P8|COMPLETED|Phase B (Injection Time), Week 4||20
274987|NCT01163617|662885|P7|COMPLETED|Phase B (Injection Time), Week 4||16
274988|NCT01163617|662886|P6|COMPLETED|Phase B (Injection Time), Week 4||27
274989|NCT01163617|662887|P5|COMPLETED|Phase B (Injection Time), Week 4||18
274990|NCT01163617|662888|P4|COMPLETED|Phase B (Injection Time), Week 4||0
274991|NCT01163617|662889|P3|COMPLETED|Phase B (Injection Time), Week 4||0
274992|NCT01163617|662890|P2|COMPLETED|Phase B (Injection Time), Week 4||0
274993|NCT01163617|662891|P1|COMPLETED|Phase B (Injection Time), Week 4||0
274994|NCT01163617|662884|P8|STARTED|Phase B (Injection Time), Week 4||20
274995|NCT01163617|662885|P7|STARTED|Phase B (Injection Time), Week 4||16
274996|NCT01163617|662886|P6|STARTED|Phase B (Injection Time), Week 4||27
274997|NCT01163617|662887|P5|STARTED|Phase B (Injection Time), Week 4||18
274998|NCT01163617|662888|P4|STARTED|Phase B (Injection Time), Week 4||0
274999|NCT01163617|662889|P3|STARTED|Phase B (Injection Time), Week 4||0
275000|NCT01163617|662890|P2|STARTED|Phase B (Injection Time), Week 4||0
275001|NCT01163617|662891|P1|STARTED|Phase B (Injection Time), Week 4||0
275002|NCT01163617|662884|P8|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275003|NCT01163617|662885|P7|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275004|NCT01163617|662886|P6|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275005|NCT01163617|662887|P5|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275006|NCT01163617|662888|P4|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275007|NCT01163617|662889|P3|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||1
275008|NCT01163617|662890|P2|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||2
275009|NCT01163617|662891|P1|NOT COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275010|NCT01163617|662884|P8|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275011|NCT01163617|662885|P7|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275012|NCT01163617|662886|P6|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275013|NCT01163617|662887|P5|COMPLETED|Phase A (User Experience), Weeks 0 and 2||0
275014|NCT01163617|662888|P4|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
275015|NCT01163617|662889|P3|COMPLETED|Phase A (User Experience), Weeks 0 and 2||20
275016|NCT01163617|662890|P2|COMPLETED|Phase A (User Experience), Weeks 0 and 2||21
275017|NCT01163617|662891|P1|COMPLETED|Phase A (User Experience), Weeks 0 and 2||19
275018|NCT01163617|662884|P8|STARTED|Phase A (User Experience), Weeks 0 and 2||0
275019|NCT01163617|662885|P7|STARTED|Phase A (User Experience), Weeks 0 and 2||0
275020|NCT01163617|662886|P6|STARTED|Phase A (User Experience), Weeks 0 and 2||0
275021|NCT01163617|662887|P5|STARTED|Phase A (User Experience), Weeks 0 and 2||0
275022|NCT01163617|662888|P4|STARTED|Phase A (User Experience), Weeks 0 and 2||21
275023|NCT01163617|662889|P3|STARTED|Phase A (User Experience), Weeks 0 and 2||21
275024|NCT01163617|662890|P2|STARTED|Phase A (User Experience), Weeks 0 and 2||23
275025|NCT01163617|662891|P1|STARTED|Phase A (User Experience), Weeks 0 and 2||19
275026|NCT01163656|662913|P2|NOT COMPLETED|Overall Study||3
275027|NCT01163656|662914|P1|NOT COMPLETED|Overall Study||3
275028|NCT01163656|662913|P2|COMPLETED|Overall Study||30
275029|NCT01163656|662914|P1|COMPLETED|Overall Study||30
275030|NCT01163656|662913|P2|STARTED|Overall Study||33
275031|NCT01163656|662914|P1|STARTED|Overall Study||33
275032|NCT01163721|662922|P2|NOT COMPLETED|Overall Study||12
275033|NCT01163721|662923|P1|NOT COMPLETED|Overall Study||8
275034|NCT01163721|662922|P2|COMPLETED|Overall Study||29
275035|NCT01163721|662923|P1|COMPLETED|Overall Study||31
275036|NCT01163721|662922|P2|STARTED|Overall Study||41
275037|NCT01163721|662923|P1|STARTED|Overall Study||39
275038|NCT01163747|662935|P2|NOT COMPLETED|Overall Study||11
275039|NCT01163747|662936|P1|NOT COMPLETED|Overall Study||6
275040|NCT01163747|662935|P2|COMPLETED|Overall Study||49
275041|NCT01163747|662936|P1|COMPLETED|Overall Study||25
275042|NCT01163747|662935|P2|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|54
275043|NCT01163747|662936|P1|Per Protocol Population|Overall Study|Participants who received at least 1 dose of study treatment excluding major protocol violators.|27
275044|NCT01163747|662935|P2|STARTED|Overall Study||60
275045|NCT01163747|662936|P1|STARTED|Overall Study||31
275046|NCT01163760|662954|P4|NOT COMPLETED|Period 4 (Follow-up)||0
275047|NCT01163760|662955|P3|NOT COMPLETED|Period 4 (Follow-up)||0
275048|NCT01163760|662956|P2|NOT COMPLETED|Period 4 (Follow-up)||0
275049|NCT01163760|662957|P1|NOT COMPLETED|Period 4 (Follow-up)||0
275050|NCT01163760|662954|P4|COMPLETED|Period 4 (Follow-up)||12
275051|NCT01163760|662955|P3|COMPLETED|Period 4 (Follow-up)||13
275052|NCT01163760|662956|P2|COMPLETED|Period 4 (Follow-up)||13
275053|NCT01163760|662957|P1|COMPLETED|Period 4 (Follow-up)||12
275054|NCT01163760|662954|P4|STARTED|Period 4 (Follow-up)||12
275055|NCT01163760|662955|P3|STARTED|Period 4 (Follow-up)||13
275056|NCT01163760|662956|P2|STARTED|Period 4 (Follow-up)||13
275057|NCT01163760|662957|P1|STARTED|Period 4 (Follow-up)||12
275058|NCT01163760|662954|P4|NOT COMPLETED|Period 3 (Fit)||0
275059|NCT01163760|662955|P3|NOT COMPLETED|Period 3 (Fit)||0
275060|NCT01163760|662956|P2|NOT COMPLETED|Period 3 (Fit)||0
275061|NCT01163760|662957|P1|NOT COMPLETED|Period 3 (Fit)||0
275062|NCT01163760|662954|P4|COMPLETED|Period 3 (Fit)||12
275063|NCT01163760|662955|P3|COMPLETED|Period 3 (Fit)||13
275064|NCT01163760|662956|P2|COMPLETED|Period 3 (Fit)||13
275065|NCT01163760|662957|P1|COMPLETED|Period 3 (Fit)||12
275066|NCT01163760|662954|P4|STARTED|Period 3 (Fit)||12
275067|NCT01163760|662955|P3|STARTED|Period 3 (Fit)||13
275068|NCT01163760|662956|P2|STARTED|Period 3 (Fit)||13
275069|NCT01163760|662957|P1|STARTED|Period 3 (Fit)||12
275070|NCT01163760|662954|P4|NOT COMPLETED|Period 2 (Follow-up)||0
275071|NCT01163760|662955|P3|NOT COMPLETED|Period 2 (Follow-up)||0
275072|NCT01163760|662956|P2|NOT COMPLETED|Period 2 (Follow-up)||0
275073|NCT01163760|662957|P1|NOT COMPLETED|Period 2 (Follow-up)||0
275074|NCT01163760|662954|P4|COMPLETED|Period 2 (Follow-up)||12
275075|NCT01163760|662955|P3|COMPLETED|Period 2 (Follow-up)||13
275076|NCT01163760|662956|P2|COMPLETED|Period 2 (Follow-up)||13
275077|NCT01163760|662957|P1|COMPLETED|Period 2 (Follow-up)||12
275078|NCT01163760|662954|P4|STARTED|Period 2 (Follow-up)||12
275079|NCT01163760|662955|P3|STARTED|Period 2 (Follow-up)||13
275080|NCT01163760|662956|P2|STARTED|Period 2 (Follow-up)||13
275081|NCT01163760|662957|P1|STARTED|Period 2 (Follow-up)||12
275082|NCT01163760|662954|P4|NOT COMPLETED|Period 1 (Fit)||0
275083|NCT01163760|662955|P3|NOT COMPLETED|Period 1 (Fit)||0
275084|NCT01163760|662956|P2|NOT COMPLETED|Period 1 (Fit)||0
275085|NCT01163760|662957|P1|NOT COMPLETED|Period 1 (Fit)||0
275086|NCT01163760|662954|P4|COMPLETED|Period 1 (Fit)||12
275087|NCT01163760|662955|P3|COMPLETED|Period 1 (Fit)||13
275088|NCT01163760|662956|P2|COMPLETED|Period 1 (Fit)||13
275089|NCT01163760|662957|P1|COMPLETED|Period 1 (Fit)||12
275090|NCT01163760|662954|P4|STARTED|Period 1 (Fit)||12
275091|NCT01163760|662955|P3|STARTED|Period 1 (Fit)||13
275092|NCT01163760|662956|P2|STARTED|Period 1 (Fit)||13
275093|NCT01163760|662957|P1|STARTED|Period 1 (Fit)||12
275094|NCT01163851|662971|P2|NOT COMPLETED|Overall Study||1
275095|NCT01163851|662972|P1|NOT COMPLETED|Overall Study||1
275096|NCT01163851|662971|P2|COMPLETED|Overall Study||11
275097|NCT01163851|662972|P1|COMPLETED|Overall Study||12
275098|NCT01163851|662971|P2|TREATED|Overall Study||12
275099|NCT01163851|662972|P1|TREATED|Overall Study||12
275100|NCT01163851|662971|P2|STARTED|Overall Study||12
275101|NCT01163851|662972|P1|STARTED|Overall Study||13
275102|NCT01163916|663049|P3|NOT COMPLETED|Overall Study||20
275103|NCT01163916|663050|P2|NOT COMPLETED|Overall Study||4
275104|NCT01163916|663051|P1|NOT COMPLETED|Overall Study||30
275105|NCT01163916|663049|P3|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|71
275106|NCT01163916|663050|P2|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|31
275107|NCT01163916|663051|P1|COMPLETED|Overall Study|Completed 12-months treatment with adalimumab|96
275108|NCT01163916|663049|P3|Safety Population|Overall Study||91
275109|NCT01163916|663050|P2|Safety Population|Overall Study||35
275110|NCT01163916|663051|P1|Safety Population|Overall Study|One patient discontinued prior to receiving treatment with adalimumab due to absence of medication.|125
275111|NCT01163916|663049|P3|STARTED|Overall Study||91
275112|NCT01163916|663050|P2|STARTED|Overall Study||35
275113|NCT01163916|663051|P1|STARTED|Overall Study||126
275114|NCT01163955|663089|P2|NOT COMPLETED|Overall Study||4
275115|NCT01163955|663090|P1|NOT COMPLETED|Overall Study||0
275116|NCT01163955|663089|P2|COMPLETED|Overall Study||26
275117|NCT01163955|663090|P1|COMPLETED|Overall Study||26
275118|NCT01163955|663089|P2|STARTED|Overall Study||30
275119|NCT01163955|663090|P1|STARTED|Overall Study||26
275120|NCT01164007|663096|P1|NOT COMPLETED|Overall Study||40
275121|NCT01164007|663096|P1|COMPLETED|Overall Study||0
275122|NCT01164007|663096|P1|Treated|Overall Study||37
275123|NCT01164007|663096|P1|STARTED|Overall Study||40
275124|NCT01164644|663112|P2|NOT COMPLETED|Overall Study||1
275125|NCT01164644|663113|P1|NOT COMPLETED|Overall Study||3
275126|NCT01164644|663112|P2|COMPLETED|Overall Study||13
275127|NCT01164644|663113|P1|COMPLETED|Overall Study||9
275128|NCT01164644|663112|P2|STARTED|Overall Study||14
275129|NCT01164644|663113|P1|STARTED|Overall Study||12
275130|NCT01164722|663125|P2|NOT COMPLETED|Overall Study||15
275131|NCT01164722|663126|P1|NOT COMPLETED|Overall Study||18
275132|NCT01164722|663125|P2|COMPLETED|Overall Study||45
275133|NCT01164722|663126|P1|COMPLETED|Overall Study||42
275134|NCT01164722|663125|P2|STARTED|Overall Study||60
275135|NCT01164722|663126|P1|STARTED|Overall Study||60
275136|NCT01164865|663142|P2|NOT COMPLETED|Overall Study||1
275137|NCT01164865|663143|P1|NOT COMPLETED|Overall Study||2
275138|NCT01164865|663142|P2|COMPLETED|Overall Study||38
275139|NCT01164865|663143|P1|COMPLETED|Overall Study||37
275140|NCT01164865|663142|P2|STARTED|Overall Study||39
275141|NCT01164865|663143|P1|STARTED|Overall Study||39
275142|NCT01164891|663151|P1|NOT COMPLETED|Overall Study||6
275143|NCT01164891|663151|P1|COMPLETED|Overall Study||1
275144|NCT01164891|663151|P1|STARTED|Overall Study||7
275145|NCT01165021|663169|P1|NOT COMPLETED|Overall Study||1
275146|NCT01165021|663169|P1|COMPLETED|Overall Study||18
275147|NCT01165021|663169|P1|3 Cycles of Chemo, Then Surgery|Overall Study||15
275148|NCT01165021|663169|P1|≥1 Dose Chemo, Baseline, Cy 3 Assessment|Overall Study||17
275149|NCT01165021|663169|P1|≥1 Dose Chemo|Overall Study||19
275150|NCT01165021|663169|P1|STARTED|Overall Study||19
275151|NCT01165047|663177|P1|NOT COMPLETED|Overall Study||0
275152|NCT01165047|663177|P1|COMPLETED|Overall Study||10
275153|NCT01165047|663177|P1|STARTED|Overall Study||10
275154|NCT01165112|663181|P1|NOT COMPLETED|Overall Study||0
275155|NCT01165112|663181|P1|COMPLETED|Overall Study||48
275156|NCT01165112|663181|P1|STARTED|Overall Study||48
275157|NCT01165138|663191|P4|NOT COMPLETED|Overall Study||22
275158|NCT01165138|663192|P3|NOT COMPLETED|Overall Study||20
275159|NCT01165138|663193|P2|NOT COMPLETED|Overall Study||52
275160|NCT01165138|663194|P1|NOT COMPLETED|Overall Study||0
275161|NCT01165138|663191|P4|COMPLETED|Overall Study||179
275162|NCT01165138|663192|P3|COMPLETED|Overall Study||185
275163|NCT01165138|663193|P2|COMPLETED|Overall Study||151
275164|NCT01165138|663194|P1|COMPLETED|Overall Study||0
275165|NCT01165138|663191|P4|STARTED|Overall Study||201
275166|NCT01165138|663192|P3|STARTED|Overall Study||205
275167|NCT01165138|663193|P2|STARTED|Overall Study||203
275168|NCT01165138|663194|P1|STARTED|Overall Study||0
275169|NCT01165177|663255|P2|NOT COMPLETED|Overall Study||902
275170|NCT01165177|663256|P1|NOT COMPLETED|Overall Study||922
275171|NCT01165177|663255|P2|COMPLETED|Overall Study||6808
275172|NCT01165177|663256|P1|COMPLETED|Overall Study||6773
275173|NCT01165177|663255|P2|STARTED|Overall Study||7710
275174|NCT01165177|663256|P1|STARTED|Overall Study||7695
275175|NCT01165203|663380|P2|NOT COMPLETED|Extended Safety Follow-up Phase||4
275176|NCT01165203|663381|P1|NOT COMPLETED|Extended Safety Follow-up Phase||7
275177|NCT01165203|663380|P2|COMPLETED|Extended Safety Follow-up Phase||45
275178|NCT01165203|663381|P1|COMPLETED|Extended Safety Follow-up Phase||67
275179|NCT01165203|663380|P2|STARTED|Extended Safety Follow-up Phase||49
275180|NCT01165203|663381|P1|STARTED|Extended Safety Follow-up Phase||74
275181|NCT01165203|663380|P2|NOT COMPLETED|Active Phase||2
275182|NCT01165203|663381|P1|NOT COMPLETED|Active Phase||5
275183|NCT01165203|663380|P2|COMPLETED|Active Phase||47
275184|NCT01165203|663381|P1|COMPLETED|Active Phase||69
275185|NCT01165203|663380|P2|STARTED|Active Phase||49
275186|NCT01165203|663381|P1|STARTED|Active Phase||74
275187|NCT01165216|663471|P2|NOT COMPLETED|Overall Study||7
275188|NCT01165216|663472|P1|NOT COMPLETED|Overall Study||8
275189|NCT01165216|663471|P2|COMPLETED|Overall Study|Completed=still on study drug|0
275190|NCT01165216|663472|P1|COMPLETED|Overall Study|Completed=still on study drug|0
275191|NCT01165216|663471|P2|Received at Least 1 Dose of Ipilimumab|Overall Study||6
275192|NCT01165216|663472|P1|Received at Least 1 Dose of Ipilimumab|Overall Study||6
275193|NCT01165216|663471|P2|STARTED|Overall Study|Participants who received any study drug|7
275194|NCT01165216|663472|P1|STARTED|Overall Study|Participants who received any study drug|8
275195|NCT01165242|663495|P3|NOT COMPLETED|Overall Study||14
275196|NCT01165242|663496|P2|NOT COMPLETED|Overall Study||10
275197|NCT01165242|663497|P1|NOT COMPLETED|Overall Study||10
275198|NCT01165242|663495|P3|COMPLETED|Overall Study||324
275199|NCT01165242|663496|P2|COMPLETED|Overall Study||326
275200|NCT01165242|663497|P1|COMPLETED|Overall Study||327
275201|NCT01165242|663495|P3|STARTED|Overall Study||338
275202|NCT01165242|663496|P2|STARTED|Overall Study||336
275203|NCT01165242|663497|P1|STARTED|Overall Study||337
275204|NCT01165281|663531|P2|NOT COMPLETED|Overall Study||51
275205|NCT01165281|663532|P1|NOT COMPLETED|Overall Study||58
275206|NCT01165281|663531|P2|COMPLETED|Overall Study||121
275207|NCT01165281|663532|P1|COMPLETED|Overall Study||110
275208|NCT01165281|663531|P2|STARTED|Overall Study||172
275209|NCT01165281|663532|P1|STARTED|Overall Study||168
275210|NCT01165307|663552|P2|NOT COMPLETED|Overall Study||3
275211|NCT01165307|663553|P1|NOT COMPLETED|Overall Study||14
275212|NCT01165307|663552|P2|COMPLETED|Overall Study||31
275213|NCT01165307|663553|P1|COMPLETED|Overall Study||19
275214|NCT01165307|663552|P2|STARTED|Overall Study||34
275215|NCT01165307|663553|P1|STARTED|Overall Study||33
275216|NCT01165320|663583|P3|NOT COMPLETED|Overall Study||0
275217|NCT01165320|663584|P2|NOT COMPLETED|Overall Study||4
275218|NCT01165320|663585|P1|NOT COMPLETED|Overall Study||3
275219|NCT01165320|663583|P3|COMPLETED|Overall Study||0
275220|NCT01165320|663584|P2|COMPLETED|Overall Study||4
275221|NCT01165320|663585|P1|COMPLETED|Overall Study||9
275222|NCT01165320|663583|P3|STARTED|Overall Study|No participants with esophageal candidiasis were identified for inclusion in the study|0
275223|NCT01165320|663584|P2|STARTED|Overall Study||8
275224|NCT01165320|663585|P1|STARTED|Overall Study||12
275225|NCT01165424|663593|P1|NOT COMPLETED|Overall Study||4
275226|NCT01165424|663593|P1|COMPLETED|Overall Study||76
275227|NCT01165424|663593|P1|STARTED|Overall Study||80
275228|NCT01165450|663598|P1|NOT COMPLETED|Overall Study||0
275229|NCT01165450|663598|P1|COMPLETED|Overall Study||2
275230|NCT01165450|663598|P1|STARTED|Overall Study||2
275231|NCT01165541|663608|P1|NOT COMPLETED|Quetiapine XR and Mirtazepine||5
275232|NCT01165541|663608|P1|COMPLETED|Quetiapine XR and Mirtazepine||11
275233|NCT01165541|663608|P1|STARTED|Quetiapine XR and Mirtazepine||16
275234|NCT01165541|663608|P1|NOT COMPLETED|Quetiapine XR Monotherapy||4
275235|NCT01165541|663608|P1|COMPLETED|Quetiapine XR Monotherapy||16
275236|NCT01165541|663608|P1|STARTED|Quetiapine XR Monotherapy||20
275237|NCT01165554|663614|P1|NOT COMPLETED|Overall Study||23
275238|NCT01165554|663614|P1|COMPLETED|Overall Study||180
275239|NCT01165554|663614|P1|STARTED|Overall Study|This was the number of subjects that started the study.|203
275240|NCT01165684|663623|P2|NOT COMPLETED|Overall Study||52
275241|NCT01165684|663624|P1|NOT COMPLETED|Overall Study||28
275242|NCT01165684|663623|P2|COMPLETED|Overall Study||148
275243|NCT01165684|663624|P1|COMPLETED|Overall Study||173
275244|NCT01165684|663623|P2|Exposed|Overall Study|1 subject withdrew prior to exposure to trial drug|199
275245|NCT01165684|663624|P1|Exposed|Overall Study|3 subjects withdrew prior to exposure to trial drug|198
275246|NCT01165684|663623|P2|STARTED|Overall Study||200
275247|NCT01165684|663624|P1|STARTED|Overall Study||201
275248|NCT01165775|663658|P1|NOT COMPLETED|Overall Study||2
275249|NCT01165775|663658|P1|COMPLETED|Overall Study||15
275250|NCT01165775|663658|P1|STARTED|Overall Study||17
275251|NCT01165840|663666|P1|NOT COMPLETED|Overall Study||0
275252|NCT01165840|663666|P1|COMPLETED|Overall Study||36
275253|NCT01165840|663666|P1|STARTED|Overall Study||36
275254|NCT01165983|663672|P2|NOT COMPLETED|Overall Study||7
275255|NCT01165983|663673|P1|NOT COMPLETED|Overall Study||5
275256|NCT01165983|663672|P2|COMPLETED|Overall Study||42
275257|NCT01165983|663673|P1|COMPLETED|Overall Study||46
275258|NCT01165983|663672|P2|STARTED|Overall Study||49
275259|NCT01165983|663673|P1|STARTED|Overall Study||51
275260|NCT01165996|663717|P1|NOT COMPLETED|Overall Study||2
275261|NCT01165996|663717|P1|COMPLETED|Overall Study||23
275262|NCT01165996|663717|P1|Maintenance Phase|Overall Study||23
275263|NCT01165996|663717|P1|Induction Phase|Overall Study||25
275264|NCT01165996|663717|P1|STARTED|Overall Study||25
275265|NCT01166126|663723|P1|NOT COMPLETED|Overall Study||0
275266|NCT01166126|663723|P1|COMPLETED|Overall Study||4
275267|NCT01166126|663723|P1|STARTED|Overall Study||4
275268|NCT01166178|663732|P2|NOT COMPLETED|Overall Study||8
275269|NCT01166178|663733|P1|NOT COMPLETED|Overall Study||21
275270|NCT01166178|663732|P2|COMPLETED|Overall Study||0
275271|NCT01166178|663733|P1|COMPLETED|Overall Study||0
275272|NCT01166178|663732|P2|STARTED|Overall Study||8
275273|NCT01166178|663733|P1|STARTED|Overall Study||21
275274|NCT01166230|663761|P2|NOT COMPLETED|Overall Study||16
275275|NCT01166230|663762|P1|NOT COMPLETED|Overall Study||19
275276|NCT01166230|663761|P2|COMPLETED|Overall Study||255
275277|NCT01166230|663762|P1|COMPLETED|Overall Study||261
275278|NCT01166230|663761|P2|STARTED|Overall Study||271
275279|NCT01166230|663762|P1|STARTED|Overall Study||280
275280|NCT01166282|663776|P3|NOT COMPLETED|Open-label Period||17
275281|NCT01166282|663777|P2|NOT COMPLETED|Open-label Period||0
275282|NCT01166282|663778|P1|NOT COMPLETED|Open-label Period||0
275283|NCT01166282|663776|P3|COMPLETED|Open-label Period||29
275284|NCT01166282|663777|P2|COMPLETED|Open-label Period||0
275285|NCT01166282|663778|P1|COMPLETED|Open-label Period||0
275286|NCT01166282|663776|P3|STARTED|Open-label Period||46
275287|NCT01166282|663777|P2|STARTED|Open-label Period||0
275288|NCT01166282|663778|P1|STARTED|Open-label Period||0
275289|NCT01166282|663776|P3|NOT COMPLETED|Double-blind Period||0
275290|NCT01166282|663777|P2|NOT COMPLETED|Double-blind Period||0
275291|NCT01166282|663778|P1|NOT COMPLETED|Double-blind Period||0
275292|NCT01166282|663776|P3|COMPLETED|Double-blind Period||0
275293|NCT01166282|663777|P2|COMPLETED|Double-blind Period||31
275294|NCT01166282|663778|P1|COMPLETED|Double-blind Period||15
275295|NCT01166282|663776|P3|STARTED|Double-blind Period||0
275296|NCT01166282|663777|P2|STARTED|Double-blind Period||31
275297|NCT01166282|663778|P1|STARTED|Double-blind Period||15
275298|NCT01166646|663802|P2|NOT COMPLETED|Overall Study||1
275299|NCT01166646|663803|P1|NOT COMPLETED|Overall Study||1
275300|NCT01166646|663802|P2|COMPLETED|Overall Study||21
275301|NCT01166646|663803|P1|COMPLETED|Overall Study||20
275302|NCT01166646|663802|P2|STARTED|Overall Study||22
275303|NCT01166646|663803|P1|STARTED|Overall Study||21
275304|NCT01166659|663819|P1|NOT COMPLETED|Overall Study||13
275305|NCT01166659|663819|P1|COMPLETED|Overall Study||35
275306|NCT01166659|663819|P1|STARTED|Overall Study||48
275307|NCT01166724|663828|P2|NOT COMPLETED|Overall Study||5
275308|NCT01166724|663829|P1|NOT COMPLETED|Overall Study||7
275309|NCT01166724|663828|P2|COMPLETED|Overall Study||0
275310|NCT01166724|663829|P1|COMPLETED|Overall Study||0
275311|NCT01166724|663828|P2|STARTED|Overall Study||5
275312|NCT01166724|663829|P1|STARTED|Overall Study||7
275313|NCT01166750|663839|P2|NOT COMPLETED|Overall Study||0
275314|NCT01166750|663840|P1|NOT COMPLETED|Overall Study||1
275315|NCT01166750|663839|P2|COMPLETED|Overall Study||13
275316|NCT01166750|663840|P1|COMPLETED|Overall Study||9
275317|NCT01166750|663839|P2|STARTED|Overall Study||13
275318|NCT01166750|663840|P1|STARTED|Overall Study||10
275319|NCT01166763|663846|P1|NOT COMPLETED|Overall Study||3
275320|NCT01166763|663846|P1|COMPLETED|Overall Study||27
275321|NCT01166763|663846|P1|STARTED|Overall Study||30
275322|NCT01166958|663854|P2|NOT COMPLETED|Overall Study||0
275323|NCT01166958|663855|P1|NOT COMPLETED|Overall Study||1
275324|NCT01166958|663854|P2|COMPLETED|Overall Study||13
275325|NCT01166958|663855|P1|COMPLETED|Overall Study||12
275326|NCT01166958|663854|P2|STARTED|Overall Study||13
275327|NCT01166958|663855|P1|STARTED|Overall Study||13
275328|NCT01166971|663871|P2|NOT COMPLETED|Overall Study||1
275329|NCT01166971|663872|P1|NOT COMPLETED|Overall Study||1
275330|NCT01166971|663871|P2|COMPLETED|Overall Study||30
275331|NCT01166971|663872|P1|COMPLETED|Overall Study||32
275332|NCT01166971|663871|P2|STARTED|Overall Study||31
275333|NCT01166971|663872|P1|STARTED|Overall Study||33
275334|NCT01166997|663880|P2|NOT COMPLETED|Overall Study||0
275335|NCT01166997|663881|P1|NOT COMPLETED|Overall Study||2
275336|NCT01166997|663880|P2|COMPLETED|Overall Study||30
275337|NCT01166997|663881|P1|COMPLETED|Overall Study||27
275338|NCT01166997|663880|P2|STARTED|Overall Study||30
275339|NCT01166997|663881|P1|STARTED|Overall Study||29
275340|NCT01167023|663891|P3|NOT COMPLETED|Overall Study||2
275341|NCT01167023|663892|P2|NOT COMPLETED|Overall Study||3
275342|NCT01167023|663893|P1|NOT COMPLETED|Overall Study||0
275343|NCT01167023|663891|P3|COMPLETED|Overall Study||39
275344|NCT01167023|663892|P2|COMPLETED|Overall Study||18
275345|NCT01167023|663893|P1|COMPLETED|Overall Study||0
275346|NCT01167023|663891|P3|Received at Least 1 Dose of Study Drug|Overall Study||41
275347|NCT01167023|663892|P2|Received at Least 1 Dose of Study Drug|Overall Study||19
275348|NCT01167023|663893|P1|Received at Least 1 Dose of Study Drug|Overall Study||0
275349|NCT01167023|663891|P3|STARTED|Overall Study||41
275350|NCT01167023|663892|P2|STARTED|Overall Study||21
275351|NCT01167023|663893|P1|STARTED|Overall Study||0
275352|NCT01160744|663915|P4|NOT COMPLETED|Overall Study||22
275353|NCT01160744|663916|P3|NOT COMPLETED|Overall Study||20
275354|NCT01160744|663917|P2|NOT COMPLETED|Overall Study||25
275355|NCT01160744|663918|P1|NOT COMPLETED|Overall Study||20
275356|NCT01160744|663915|P4|COMPLETED|Overall Study||49
275357|NCT01160744|663916|P3|COMPLETED|Overall Study||49
275358|NCT01160744|663917|P2|COMPLETED|Overall Study||44
275359|NCT01160744|663918|P1|COMPLETED|Overall Study||51
275360|NCT01160744|663915|P4|Received Study Drug|Overall Study||71
275361|NCT01160744|663916|P3|Received Study Drug|Overall Study||63
275362|NCT01160744|663917|P2|Received Study Drug|Overall Study||67
275363|NCT01160744|663918|P1|Received Study Drug|Overall Study||69
275364|NCT01160744|663915|P4|STARTED|Overall Study||71
275365|NCT01160744|663916|P3|STARTED|Overall Study||69
275366|NCT01160744|663917|P2|STARTED|Overall Study||69
275367|NCT01160744|663918|P1|STARTED|Overall Study||71
275368|NCT01160770|663952|P1|NOT COMPLETED|Overall Study||79
275369|NCT01160770|663952|P1|COMPLETED|Overall Study||188
275370|NCT01160770|663952|P1|STARTED|Overall Study||267
275371|NCT01160822|663968|P7|NOT COMPLETED|Overall Study||9
275372|NCT01160822|663969|P6|NOT COMPLETED|Overall Study||7
275373|NCT01160822|663970|P5|NOT COMPLETED|Overall Study||9
275374|NCT01160822|663971|P4|NOT COMPLETED|Overall Study||0
275375|NCT01160822|663972|P3|NOT COMPLETED|Overall Study||0
275376|NCT01160822|663973|P2|NOT COMPLETED|Overall Study||0
275377|NCT01160822|663974|P1|NOT COMPLETED|Overall Study||0
275378|NCT01160822|663968|P7|COMPLETED|Overall Study||44
275379|NCT01160822|663969|P6|COMPLETED|Overall Study||40
275380|NCT01160822|663970|P5|COMPLETED|Overall Study||36
275381|NCT01160822|663971|P4|COMPLETED|Overall Study||5
275382|NCT01160822|663972|P3|COMPLETED|Overall Study||6
275383|NCT01160822|663973|P2|COMPLETED|Overall Study||7
275384|NCT01160822|663974|P1|COMPLETED|Overall Study||6
275385|NCT01160822|663968|P7|STARTED|Overall Study||53
275386|NCT01160822|663969|P6|STARTED|Overall Study||47
275387|NCT01160822|663970|P5|STARTED|Overall Study||45
275388|NCT01160822|663971|P4|STARTED|Overall Study||5
275389|NCT01160822|663972|P3|STARTED|Overall Study||6
275390|NCT01160822|663973|P2|STARTED|Overall Study||7
275391|NCT01160822|663974|P1|STARTED|Overall Study||6
275392|NCT01160848|664065|P2|NOT COMPLETED|Overall Study||0
275393|NCT01160848|664066|P1|NOT COMPLETED|Overall Study||0
275394|NCT01160848|664065|P2|COMPLETED|Overall Study||8
275395|NCT01160848|664066|P1|COMPLETED|Overall Study||12
275396|NCT01160848|664065|P2|STARTED|Overall Study||8
275397|NCT01160848|664066|P1|STARTED|Overall Study||12
275398|NCT01161121|664088|P1|NOT COMPLETED|Overall Study||0
275399|NCT01161121|664088|P1|COMPLETED|Overall Study||46
275400|NCT01161121|664088|P1|STARTED|Overall Study||46
275401|NCT01161160|664101|P3|NOT COMPLETED|Overall Study||0
275402|NCT01161160|664102|P2|NOT COMPLETED|Overall Study||0
275403|NCT01161160|664103|P1|NOT COMPLETED|Overall Study||0
275404|NCT01161160|664101|P3|COMPLETED|Overall Study||58
275405|NCT01161160|664102|P2|COMPLETED|Overall Study||75
275406|NCT01161160|664103|P1|COMPLETED|Overall Study||76
275407|NCT01161160|664101|P3|STARTED|Overall Study||58
275408|NCT01161160|664102|P2|STARTED|Overall Study||75
275409|NCT01161160|664103|P1|STARTED|Overall Study||76
275410|NCT01161173|664174|P1|NOT COMPLETED|Overall Study||347
275411|NCT01161173|664174|P1|COMPLETED|Overall Study||0
275412|NCT01161173|664174|P1|STARTED|Overall Study||347
275413|NCT01161225|664186|P3|NOT COMPLETED|Overall Study||2
275414|NCT01161225|664187|P2|NOT COMPLETED|Overall Study||9
275415|NCT01161225|664188|P1|NOT COMPLETED|Overall Study||14
275416|NCT01161225|664186|P3|COMPLETED|Overall Study||12
275417|NCT01161225|664187|P2|COMPLETED|Overall Study||44
275418|NCT01161225|664188|P1|COMPLETED|Overall Study||45
275419|NCT01161225|664186|P3|STARTED|Overall Study||14
275420|NCT01161225|664187|P2|STARTED|Overall Study||53
275421|NCT01161225|664188|P1|STARTED|Overall Study||59
275422|NCT01167140|664217|P1|NOT COMPLETED|Overall Study||1
275423|NCT01167140|664217|P1|COMPLETED|Overall Study||41
275424|NCT01167140|664217|P1|STARTED|Overall Study||42
275425|NCT01167153|664225|P2|NOT COMPLETED|Overall Study||33
275426|NCT01167153|664226|P1|NOT COMPLETED|Overall Study||18
275427|NCT01167153|664225|P2|COMPLETED|Overall Study||249
275428|NCT01167153|664226|P1|COMPLETED|Overall Study||264
275429|NCT01167153|664225|P2|Intention to Treat (ITT)|Overall Study||268
275430|NCT01167153|664226|P1|Intention to Treat (ITT)|Overall Study||272
275431|NCT01167153|664225|P2|STARTED|Overall Study||282
275432|NCT01167153|664226|P1|STARTED|Overall Study||282
275433|NCT01167192|664244|P1|NOT COMPLETED|Overall Study||4
275434|NCT01167192|664244|P1|COMPLETED|Overall Study||6
275435|NCT01167192|664244|P1|STARTED|Overall Study||10
275436|NCT01167257|664261|P2|NOT COMPLETED|Overall Study||3
275437|NCT01167257|664262|P1|NOT COMPLETED|Overall Study||3
275438|NCT01167257|664261|P2|COMPLETED|Overall Study||28
275439|NCT01167257|664262|P1|COMPLETED|Overall Study||28
275440|NCT01167257|664261|P2|STARTED|Overall Study||31
275441|NCT01167257|664262|P1|STARTED|Overall Study||31
275442|NCT01167881|664286|P2|NOT COMPLETED|Overall Study||191
275443|NCT01167881|664287|P1|NOT COMPLETED|Overall Study||159
275444|NCT01167881|664286|P2|COMPLETED|Overall Study||589
275445|NCT01167881|664287|P1|COMPLETED|Overall Study||610
275446|NCT01167881|664286|P2|Completed After 4 Years Treatment|Overall Study||462
275447|NCT01167881|664287|P1|Completed After 4 Years Treatment|Overall Study||515
275448|NCT01167881|664286|P2|Completed After 2 Years Treatment|Overall Study||127
275449|NCT01167881|664287|P1|Completed After 2 Years Treatment|Overall Study||95
275450|NCT01167881|664286|P2|STARTED|Overall Study||780
275451|NCT01167881|664287|P1|STARTED|Overall Study||769
275452|NCT01168024|664313|P2|NOT COMPLETED|Overall Study||0
275453|NCT01168024|664314|P1|NOT COMPLETED|Overall Study||0
275454|NCT01168024|664313|P2|COMPLETED|Overall Study||3
275455|NCT01168024|664314|P1|COMPLETED|Overall Study||13
275456|NCT01168024|664313|P2|STARTED|Overall Study||3
275457|NCT01168024|664314|P1|STARTED|Overall Study|13 tx/3 controls. Roll-ins occurred for product training, several more treatment cases than control.|13
275458|NCT01168232|664326|P1|NOT COMPLETED|Overall Study||8
275459|NCT01168232|664326|P1|COMPLETED|Overall Study|Eligible and treated patients|34
275460|NCT01168232|664326|P1|STARTED|Overall Study||42
275461|NCT01168349|664333|P1|NOT COMPLETED|Overall Study||301
275462|NCT01168349|664333|P1|COMPLETED|Overall Study||754
275463|NCT01168349|664333|P1|STARTED|Overall Study||1055
275464|NCT01168427|664439|P1|NOT COMPLETED|Overall Study||1
275465|NCT01168427|664439|P1|COMPLETED|Overall Study||65
275466|NCT01168427|664439|P1|STARTED|Overall Study||66
275467|NCT01168596|664446|P2|NOT COMPLETED|Overall Study||1
275468|NCT01168596|664447|P1|NOT COMPLETED|Overall Study||3
275469|NCT01168596|664446|P2|COMPLETED|Overall Study||13
275470|NCT01168596|664447|P1|COMPLETED|Overall Study||13
275471|NCT01168596|664446|P2|STARTED|Overall Study||14
275472|NCT01168596|664447|P1|STARTED|Overall Study||16
275473|NCT01168674|664491|P2|NOT COMPLETED|Overall Study||0
275474|NCT01168674|664492|P1|NOT COMPLETED|Overall Study||0
275475|NCT01168674|664491|P2|COMPLETED|Overall Study||24
275476|NCT01168674|664492|P1|COMPLETED|Overall Study||25
275477|NCT01168674|664491|P2|STARTED|Overall Study||24
275478|NCT01168674|664492|P1|STARTED|Overall Study||25
275479|NCT01168687|664501|P2|NOT COMPLETED|Overall Study||0
275480|NCT01168687|664502|P1|NOT COMPLETED|Overall Study||0
275481|NCT01168687|664501|P2|COMPLETED|Overall Study||23
275482|NCT01168687|664502|P1|COMPLETED|Overall Study||23
275483|NCT01168687|664501|P2|STARTED|Overall Study||23
275484|NCT01168687|664502|P1|STARTED|Overall Study||23
275485|NCT01168726|664511|P3|NOT COMPLETED|Overall Study||5
275486|NCT01168726|664512|P2|NOT COMPLETED|Overall Study||9
275487|NCT01168726|664513|P1|NOT COMPLETED|Overall Study||8
275488|NCT01168726|664511|P3|COMPLETED|Overall Study||128
275489|NCT01168726|664512|P2|COMPLETED|Overall Study||112
275490|NCT01168726|664513|P1|COMPLETED|Overall Study||103
275491|NCT01168726|664511|P3|STARTED|Overall Study||133
275492|NCT01168726|664512|P2|STARTED|Overall Study||121
275493|NCT01168726|664513|P1|STARTED|Overall Study||111
275494|NCT01168856|664532|P2|NOT COMPLETED|Overall Study||343
275495|NCT01168856|664533|P1|NOT COMPLETED|Overall Study||18
275496|NCT01168856|664532|P2|COMPLETED|Overall Study||215
275497|NCT01168856|664533|P1|COMPLETED|Overall Study||158
275498|NCT01168856|664532|P2|STARTED|Overall Study||558
275499|NCT01168856|664533|P1|STARTED|Overall Study||176
275500|NCT01168934|664590|P2|NOT COMPLETED|Second Intervention Period||0
275501|NCT01168934|664591|P1|NOT COMPLETED|Second Intervention Period||0
275502|NCT01168934|664590|P2|COMPLETED|Second Intervention Period||7
275503|NCT01168934|664591|P1|COMPLETED|Second Intervention Period||7
275504|NCT01168934|664590|P2|STARTED|Second Intervention Period||7
275505|NCT01168934|664591|P1|STARTED|Second Intervention Period||7
275506|NCT01168934|664590|P2|NOT COMPLETED|Washout Period (at Least 14 Days)||0
275507|NCT01168934|664591|P1|NOT COMPLETED|Washout Period (at Least 14 Days)||0
275508|NCT01168934|664590|P2|COMPLETED|Washout Period (at Least 14 Days)||7
275509|NCT01168934|664591|P1|COMPLETED|Washout Period (at Least 14 Days)||7
275510|NCT01168934|664590|P2|STARTED|Washout Period (at Least 14 Days)||7
275511|NCT01168934|664591|P1|STARTED|Washout Period (at Least 14 Days)||7
275512|NCT01168934|664590|P2|NOT COMPLETED|First Intervention Period||0
275513|NCT01168934|664591|P1|NOT COMPLETED|First Intervention Period||0
275514|NCT01168934|664590|P2|COMPLETED|First Intervention Period||7
275515|NCT01168934|664591|P1|COMPLETED|First Intervention Period||7
275516|NCT01168934|664590|P2|STARTED|First Intervention Period||7
275517|NCT01168934|664591|P1|STARTED|First Intervention Period||7
275518|NCT01168973|664625|P2|NOT COMPLETED|Overall Study||611
275519|NCT01168973|664626|P1|NOT COMPLETED|Overall Study||613
275520|NCT01168973|664625|P2|COMPLETED|Overall Study||14
275521|NCT01168973|664626|P1|COMPLETED|Overall Study||15
275522|NCT01168973|664625|P2|Received Any Quantity of Any Study Drug|Overall Study|Three participants randomized to placebo and docetaxel received 1 dose of ramucirumab in error.|621
275523|NCT01168973|664626|P1|Received Any Quantity of Any Study Drug|Overall Study||624
275524|NCT01168973|664625|P2|STARTED|Overall Study||625
275525|NCT01168973|664626|P1|STARTED|Overall Study||628
275526|NCT01168986|664650|P3|NOT COMPLETED|Overall Study||0
275527|NCT01168986|664651|P2|NOT COMPLETED|Overall Study||1
275528|NCT01168986|664652|P1|NOT COMPLETED|Overall Study||2
275529|NCT01168986|664650|P3|COMPLETED|Overall Study||21
275530|NCT01168986|664651|P2|COMPLETED|Overall Study||20
275531|NCT01168986|664652|P1|COMPLETED|Overall Study||18
275532|NCT01168986|664650|P3|STARTED|Overall Study||21
275533|NCT01168986|664651|P2|STARTED|Overall Study||21
275534|NCT01168986|664652|P1|STARTED|Overall Study||20
275535|NCT01168999|664673|P4|NOT COMPLETED|Overall Study||0
275536|NCT01168999|664674|P3|NOT COMPLETED|Overall Study||0
275537|NCT01168999|664675|P2|NOT COMPLETED|Overall Study||1
275538|NCT01168999|664676|P1|NOT COMPLETED|Overall Study||2
275539|NCT01168999|664673|P4|COMPLETED|Overall Study||28
275540|NCT01168999|664674|P3|COMPLETED|Overall Study||27
275541|NCT01168999|664675|P2|COMPLETED|Overall Study||26
275542|NCT01168999|664676|P1|COMPLETED|Overall Study||26
275543|NCT01168999|664673|P4|STARTED|Overall Study||28
275544|NCT01168999|664674|P3|STARTED|Overall Study||27
275545|NCT01168999|664675|P2|STARTED|Overall Study||27
275546|NCT01168999|664676|P1|STARTED|Overall Study||28
275547|NCT01169038|664718|P1|NOT COMPLETED|Overall Study||7
275548|NCT01169038|664718|P1|COMPLETED|Overall Study||8
275549|NCT01169038|664718|P1|STARTED|Overall Study||15
275550|NCT01169064|664724|P2|NOT COMPLETED|Overall Study||0
275551|NCT01169064|664725|P1|NOT COMPLETED|Overall Study||0
275552|NCT01169064|664724|P2|COMPLETED|Overall Study||236
275553|NCT01169064|664725|P1|COMPLETED|Overall Study||239
275554|NCT01169064|664724|P2|STARTED|Overall Study||236
275555|NCT01169064|664725|P1|STARTED|Overall Study||239
275556|NCT01169103|664737|P2|NOT COMPLETED|Overall Study||4
275557|NCT01169103|664738|P1|NOT COMPLETED|Overall Study||6
275558|NCT01169103|664737|P2|COMPLETED|Overall Study||7
275559|NCT01169103|664738|P1|COMPLETED|Overall Study||5
275560|NCT01169103|664737|P2|STARTED|Overall Study||11
275561|NCT01169103|664738|P1|STARTED|Overall Study||11
275562|NCT01169311|664752|P1|NOT COMPLETED|Overall Study||0
275563|NCT01169311|664752|P1|COMPLETED|Overall Study||27
275564|NCT01169311|664752|P1|STARTED|Overall Study||27
275565|NCT01169467|664766|P2|NOT COMPLETED|Overall Study||4
275566|NCT01169467|664767|P1|NOT COMPLETED|Overall Study||7
275567|NCT01169467|664766|P2|COMPLETED|Overall Study||36
275568|NCT01169467|664767|P1|COMPLETED|Overall Study||37
275569|NCT01169467|664766|P2|STARTED|Overall Study||40
275570|NCT01169467|664767|P1|STARTED|Overall Study||44
275571|NCT01169493|664787|P6|NOT COMPLETED|Period 3 (6 Months)||0
275572|NCT01169493|664788|P5|NOT COMPLETED|Period 3 (6 Months)||0
275573|NCT01169493|664789|P4|NOT COMPLETED|Period 3 (6 Months)||0
275574|NCT01169493|664790|P3|NOT COMPLETED|Period 3 (6 Months)||1
275575|NCT01169493|664791|P2|NOT COMPLETED|Period 3 (6 Months)||2
275576|NCT01169493|664792|P1|NOT COMPLETED|Period 3 (6 Months)||0
275577|NCT01169493|664787|P6|COMPLETED|Period 3 (6 Months)||2
275578|NCT01169493|664788|P5|COMPLETED|Period 3 (6 Months)||0
275579|NCT01169493|664789|P4|COMPLETED|Period 3 (6 Months)||0
275580|NCT01169493|664790|P3|COMPLETED|Period 3 (6 Months)||2
275581|NCT01169493|664791|P2|COMPLETED|Period 3 (6 Months)||1
275582|NCT01169493|664792|P1|COMPLETED|Period 3 (6 Months)||2
275583|NCT01169493|664787|P6|STARTED|Period 3 (6 Months)||2
275584|NCT01169493|664788|P5|STARTED|Period 3 (6 Months)||0
275585|NCT01169493|664789|P4|STARTED|Period 3 (6 Months)||0
275586|NCT01169493|664790|P3|STARTED|Period 3 (6 Months)||3
275587|NCT01169493|664791|P2|STARTED|Period 3 (6 Months)||3
275588|NCT01169493|664792|P1|STARTED|Period 3 (6 Months)||2
275589|NCT01169493|664787|P6|NOT COMPLETED|Period 2 (6 Months)||0
275590|NCT01169493|664788|P5|NOT COMPLETED|Period 2 (6 Months)||0
275591|NCT01169493|664789|P4|NOT COMPLETED|Period 2 (6 Months)||0
275592|NCT01169493|664790|P3|NOT COMPLETED|Period 2 (6 Months)||0
275593|NCT01169493|664791|P2|NOT COMPLETED|Period 2 (6 Months)||0
275594|NCT01169493|664792|P1|NOT COMPLETED|Period 2 (6 Months)||0
275595|NCT01169493|664787|P6|COMPLETED|Period 2 (6 Months)||2
275596|NCT01169493|664788|P5|COMPLETED|Period 2 (6 Months)||0
275597|NCT01169493|664789|P4|COMPLETED|Period 2 (6 Months)||0
275598|NCT01169493|664790|P3|COMPLETED|Period 2 (6 Months)||3
275599|NCT01169493|664791|P2|COMPLETED|Period 2 (6 Months)||3
275600|NCT01169493|664792|P1|COMPLETED|Period 2 (6 Months)||2
275601|NCT01169493|664787|P6|STARTED|Period 2 (6 Months)||2
275602|NCT01169493|664788|P5|STARTED|Period 2 (6 Months)||0
275603|NCT01169493|664789|P4|STARTED|Period 2 (6 Months)||0
275604|NCT01169493|664790|P3|STARTED|Period 2 (6 Months)||3
275605|NCT01169493|664791|P2|STARTED|Period 2 (6 Months)||3
275606|NCT01169493|664792|P1|STARTED|Period 2 (6 Months)||2
275607|NCT01169493|664787|P6|NOT COMPLETED|Period 1 (6 Months)||3
275608|NCT01169493|664788|P5|NOT COMPLETED|Period 1 (6 Months)||0
275609|NCT01169493|664789|P4|NOT COMPLETED|Period 1 (6 Months)||0
275610|NCT01169493|664790|P3|NOT COMPLETED|Period 1 (6 Months)||2
275611|NCT01169493|664791|P2|NOT COMPLETED|Period 1 (6 Months)||1
275612|NCT01169493|664792|P1|NOT COMPLETED|Period 1 (6 Months)||0
275613|NCT01169493|664787|P6|COMPLETED|Period 1 (6 Months)||2
275614|NCT01169493|664788|P5|COMPLETED|Period 1 (6 Months)||0
275615|NCT01169493|664789|P4|COMPLETED|Period 1 (6 Months)||0
275616|NCT01169493|664790|P3|COMPLETED|Period 1 (6 Months)||3
275617|NCT01169493|664791|P2|COMPLETED|Period 1 (6 Months)||3
275618|NCT01169493|664792|P1|COMPLETED|Period 1 (6 Months)||2
275619|NCT01169493|664787|P6|STARTED|Period 1 (6 Months)||5
275620|NCT01169493|664788|P5|STARTED|Period 1 (6 Months)||0
275621|NCT01169493|664789|P4|STARTED|Period 1 (6 Months)||0
275622|NCT01169493|664790|P3|STARTED|Period 1 (6 Months)||5
275623|NCT01169493|664791|P2|STARTED|Period 1 (6 Months)||4
275624|NCT01169493|664792|P1|STARTED|Period 1 (6 Months)||2
275625|NCT01169519|664821|P1|NOT COMPLETED|Overall Study||0
275626|NCT01169519|664821|P1|COMPLETED|Overall Study||21
275627|NCT01169519|664821|P1|STARTED|Overall Study|This was a pre-post study, All patients receiving a baseline assessment, also received sildenafil.|21
275628|NCT01169558|664833|P1|NOT COMPLETED|Overall Study||156
275629|NCT01169558|664833|P1|COMPLETED|Overall Study||6
275630|NCT01169558|664833|P1|STARTED|Overall Study||162
275631|NCT01169610|664840|P1|NOT COMPLETED|Overall Study||0
275632|NCT01169610|664840|P1|COMPLETED|Overall Study||1
275633|NCT01169610|664840|P1|STARTED|Overall Study||1
275634|NCT01169649|664848|P1|NOT COMPLETED|Overall Study||3
275635|NCT01169649|664848|P1|COMPLETED|Overall Study||8
275636|NCT01169649|664848|P1|STARTED|Overall Study||11
275637|NCT01169675|664857|P5|NOT COMPLETED|Overall Study||6
275638|NCT01169675|664858|P4|NOT COMPLETED|Overall Study||17
275639|NCT01169675|664859|P3|NOT COMPLETED|Overall Study||7
275640|NCT01169675|664860|P2|NOT COMPLETED|Overall Study||3
275641|NCT01169675|664861|P1|NOT COMPLETED|Overall Study||20
275642|NCT01169675|664857|P5|COMPLETED|Overall Study||0
275643|NCT01169675|664858|P4|COMPLETED|Overall Study||0
275644|NCT01169675|664859|P3|COMPLETED|Overall Study||0
275645|NCT01169675|664860|P2|COMPLETED|Overall Study||0
275646|NCT01169675|664861|P1|COMPLETED|Overall Study||0
275647|NCT01169675|664857|P5|STARTED|Overall Study||6
275648|NCT01169675|664858|P4|STARTED|Overall Study||17
275649|NCT01169675|664859|P3|STARTED|Overall Study||7
275650|NCT01169675|664860|P2|STARTED|Overall Study||3
275651|NCT01169675|664861|P1|STARTED|Overall Study||20
275652|NCT01169701|664900|P2|NOT COMPLETED|Overall Study||10
275653|NCT01169701|664901|P1|NOT COMPLETED|Overall Study||5
275654|NCT01169701|664900|P2|COMPLETED|Overall Study||25
275655|NCT01169701|664901|P1|COMPLETED|Overall Study||31
275656|NCT01169701|664900|P2|Intent to Treat (ITT) Set|Overall Study||28
275657|NCT01169701|664901|P1|Intent to Treat (ITT) Set|Overall Study||32
275658|NCT01169701|664900|P2|Safety Set|Overall Study||35
275659|NCT01169701|664901|P1|Safety Set|Overall Study||36
275660|NCT01169701|664900|P2|STARTED|Overall Study||35
275661|NCT01169701|664901|P1|STARTED|Overall Study||36
275662|NCT01169753|664935|P2|NOT COMPLETED|Overall Study||1
275663|NCT01169753|664936|P1|NOT COMPLETED|Overall Study||0
275664|NCT01169753|664935|P2|COMPLETED|Overall Study||0
275665|NCT01169753|664936|P1|COMPLETED|Overall Study||0
275666|NCT01169753|664935|P2|STARTED|Overall Study||1
275667|NCT01169753|664936|P1|STARTED|Overall Study||0
275668|NCT01169779|664944|P2|NOT COMPLETED|Overall Study||17
275669|NCT01169779|664945|P1|NOT COMPLETED|Overall Study||11
275670|NCT01169779|664944|P2|COMPLETED|Overall Study||179
275671|NCT01169779|664945|P1|COMPLETED|Overall Study||184
275672|NCT01169779|664944|P2|Subgroup for Standardized Meal Test|Overall Study||121
275673|NCT01169779|664945|P1|Subgroup for Standardized Meal Test|Overall Study|Patients at selected sites where standardized meal test was performed.|130
275674|NCT01169779|664944|P2|Modified Intent-to-Treat(mITT)Population|Overall Study||195
275675|NCT01169779|664945|P1|Modified Intent-to-Treat(mITT)Population|Overall Study|All patients who received at least 1 dose;had baseline,at least 1 post-baseline efficacy assessment.|193
275676|NCT01169779|664944|P2|Treated/Safety Population|Overall Study||196
275677|NCT01169779|664945|P1|Treated/Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|194
275678|NCT01169779|664944|P2|STARTED|Overall Study||196
275679|NCT01169779|664945|P1|STARTED|Overall Study|Randomized.|195
275680|NCT01169987|664969|P1|NOT COMPLETED|Overall Study||31
275681|NCT01169987|664969|P1|COMPLETED|Overall Study||160
275682|NCT01169987|664969|P1|STARTED|Overall Study||191
275683|NCT01170039|665035|P2|NOT COMPLETED|Overall Study||6
275684|NCT01170039|665036|P1|NOT COMPLETED|Overall Study||8
275685|NCT01170039|665035|P2|COMPLETED|Overall Study||33
275686|NCT01170039|665036|P1|COMPLETED|Overall Study||29
275687|NCT01170039|665035|P2|STARTED|Overall Study||39
275688|NCT01170039|665036|P1|STARTED|Overall Study||37
275689|NCT01170091|665048|P1|NOT COMPLETED|Overall Study||24
275690|NCT01170091|665048|P1|COMPLETED|Overall Study||627
275691|NCT01170091|665048|P1|STARTED|Overall Study||651
275692|NCT01170117|665057|P2|NOT COMPLETED|Overall Study||20
275693|NCT01170117|665058|P1|NOT COMPLETED|Overall Study||30
275694|NCT01170117|665057|P2|COMPLETED|Overall Study||55
275695|NCT01170117|665058|P1|COMPLETED|Overall Study||47
275696|NCT01170117|665057|P2|STARTED|Overall Study||75
275697|NCT01170117|665058|P1|STARTED|Overall Study||77
275698|NCT01170208|665069|P3|NOT COMPLETED|Overall Study||2
275699|NCT01170208|665070|P2|NOT COMPLETED|Overall Study||0
275700|NCT01170208|665071|P1|NOT COMPLETED|Overall Study||6
275701|NCT01170208|665069|P3|COMPLETED|Overall Study||4
275702|NCT01170208|665070|P2|COMPLETED|Overall Study||20
275703|NCT01170208|665071|P1|COMPLETED|Overall Study||14
275704|NCT01170208|665069|P3|STARTED|Overall Study||6
275705|NCT01170208|665070|P2|STARTED|Overall Study||20
275706|NCT01170208|665071|P1|STARTED|Overall Study||20
275707|NCT01170221|665081|P2|NOT COMPLETED|Overall Study||28
275708|NCT01170221|665082|P1|NOT COMPLETED|Overall Study||33
275709|NCT01170221|665081|P2|COMPLETED|Overall Study||307
275710|NCT01170221|665082|P1|COMPLETED|Overall Study||299
275711|NCT01170221|665081|P2|STARTED|Overall Study||335
275712|NCT01170221|665082|P1|STARTED|Overall Study||332
275713|NCT01170247|665104|P2|NOT COMPLETED|Overall Study||0
275714|NCT01170247|665105|P1|NOT COMPLETED|Overall Study||0
275715|NCT01170247|665104|P2|COMPLETED|Overall Study||1
275716|NCT01170247|665105|P1|COMPLETED|Overall Study||2
275717|NCT01170247|665104|P2|STARTED|Overall Study||1
275718|NCT01170247|665105|P1|STARTED|Overall Study||2
275719|NCT01170273|665113|P2|NOT COMPLETED|Overall Study||9
275720|NCT01170273|665114|P1|NOT COMPLETED|Overall Study||8
275721|NCT01170273|665113|P2|COMPLETED|Overall Study||57
275722|NCT01170273|665114|P1|COMPLETED|Overall Study||56
275723|NCT01170273|665113|P2|STARTED|Overall Study||66
275724|NCT01170273|665114|P1|STARTED|Overall Study||64
275725|NCT01164137|665122|P2|NOT COMPLETED|Overall Study||0
275726|NCT01164137|665123|P1|NOT COMPLETED|Overall Study||3
275727|NCT01164137|665122|P2|COMPLETED|Overall Study||76
275728|NCT01164137|665123|P1|COMPLETED|Overall Study||77
275729|NCT01164137|665122|P2|STARTED|Overall Study||76
275730|NCT01164137|665123|P1|STARTED|Overall Study||80
275731|NCT01164475|665139|P2|NOT COMPLETED|Overall Study||2
275732|NCT01164475|665140|P1|NOT COMPLETED|Overall Study||2
275733|NCT01164475|665139|P2|COMPLETED|Overall Study||29
275734|NCT01164475|665140|P1|COMPLETED|Overall Study||28
275735|NCT01164475|665139|P2|STARTED|Overall Study||31
275736|NCT01164475|665140|P1|STARTED|Overall Study||30
275737|NCT01164501|665167|P3|NOT COMPLETED|Overall Study||42
275738|NCT01164501|665168|P2|NOT COMPLETED|Overall Study||10
275739|NCT01164501|665169|P1|NOT COMPLETED|Overall Study||43
275740|NCT01164501|665167|P3|COMPLETED|Overall Study||280
275741|NCT01164501|665168|P2|COMPLETED|Overall Study||88
275742|NCT01164501|665169|P1|COMPLETED|Overall Study||278
275743|NCT01164501|665167|P3|STARTED|Overall Study||322
275744|NCT01164501|665168|P2|STARTED|Overall Study||98
275745|NCT01164501|665169|P1|STARTED|Overall Study||321
275746|NCT01164579|665187|P3|NOT COMPLETED|Overall Study||16
275747|NCT01164579|665188|P2|NOT COMPLETED|Overall Study||9
275748|NCT01164579|665189|P1|NOT COMPLETED|Overall Study||8
275749|NCT01164579|665187|P3|COMPLETED|Overall Study||21
275750|NCT01164579|665188|P2|COMPLETED|Overall Study||27
275751|NCT01164579|665189|P1|COMPLETED|Overall Study||28
275752|NCT01164579|665187|P3|STARTED|Overall Study||37
275753|NCT01164579|665188|P2|STARTED|Overall Study||36
275754|NCT01164579|665189|P1|STARTED|Overall Study||36
275755|NCT01170364|665268|P2|NOT COMPLETED|Overall Study||1
275756|NCT01170364|665269|P1|NOT COMPLETED|Overall Study||4
275757|NCT01170364|665268|P2|COMPLETED|Overall Study|One participant was unable to begin the second testing period due to scheduling conflicts.|5
275758|NCT01170364|665269|P1|COMPLETED|Overall Study||4
275759|NCT01170364|665268|P2|STARTED|Overall Study||6
275760|NCT01170364|665269|P1|STARTED|Overall Study||8
275761|NCT01170390|665277|P3|NOT COMPLETED|Randomized Treatment||0
275762|NCT01170390|665278|P2|NOT COMPLETED|Randomized Treatment||1
275763|NCT01170390|665279|P1|NOT COMPLETED|Randomized Treatment||0
275764|NCT01170390|665277|P3|COMPLETED|Randomized Treatment||15
275765|NCT01170390|665278|P2|COMPLETED|Randomized Treatment||16
275766|NCT01170390|665279|P1|COMPLETED|Randomized Treatment||0
275767|NCT01170390|665277|P3|STARTED|Randomized Treatment||15
275768|NCT01170390|665278|P2|STARTED|Randomized Treatment||17
275769|NCT01170390|665279|P1|STARTED|Randomized Treatment||0
275770|NCT01170390|665277|P3|NOT COMPLETED|Oral Contraceptives||0
275771|NCT01170390|665278|P2|NOT COMPLETED|Oral Contraceptives||0
275772|NCT01170390|665279|P1|NOT COMPLETED|Oral Contraceptives||1
275773|NCT01170390|665277|P3|COMPLETED|Oral Contraceptives||0
275774|NCT01170390|665278|P2|COMPLETED|Oral Contraceptives||0
275775|NCT01170390|665279|P1|COMPLETED|Oral Contraceptives||31
275776|NCT01170390|665277|P3|STARTED|Oral Contraceptives||0
275777|NCT01170390|665278|P2|STARTED|Oral Contraceptives||0
275778|NCT01170390|665279|P1|STARTED|Oral Contraceptives||32
275779|NCT01170533|665293|P2|NOT COMPLETED|Pantoprazole Cross-over||0
275780|NCT01170533|665294|P1|NOT COMPLETED|Pantoprazole Cross-over||0
275781|NCT01170533|665293|P2|COMPLETED|Pantoprazole Cross-over||20
275782|NCT01170533|665294|P1|COMPLETED|Pantoprazole Cross-over||0
275783|NCT01170533|665293|P2|STARTED|Pantoprazole Cross-over|15 participants continued from omeprazole cross-over; the remaining 5 were new participants|20
275784|NCT01170533|665294|P1|STARTED|Pantoprazole Cross-over||0
275785|NCT01170533|665293|P2|NOT COMPLETED|Omeprazole Cross-over||0
275786|NCT01170533|665294|P1|NOT COMPLETED|Omeprazole Cross-over||0
275787|NCT01170533|665293|P2|COMPLETED|Omeprazole Cross-over||0
275788|NCT01170533|665294|P1|COMPLETED|Omeprazole Cross-over||20
275789|NCT01170533|665293|P2|STARTED|Omeprazole Cross-over||0
275790|NCT01170533|665294|P1|STARTED|Omeprazole Cross-over||20
275791|NCT01170546|665308|P4|NOT COMPLETED|Overall Study||0
275792|NCT01170546|665309|P3|NOT COMPLETED|Overall Study||0
275793|NCT01170546|665310|P2|NOT COMPLETED|Overall Study||0
275794|NCT01170546|665311|P1|NOT COMPLETED|Overall Study||0
275795|NCT01170546|665308|P4|COMPLETED|Overall Study||8
275796|NCT01170546|665309|P3|COMPLETED|Overall Study||6
275797|NCT01170546|665310|P2|COMPLETED|Overall Study||7
275798|NCT01170546|665311|P1|COMPLETED|Overall Study||7
275799|NCT01170546|665308|P4|STARTED|Overall Study||8
275800|NCT01170546|665309|P3|STARTED|Overall Study||6
275801|NCT01170546|665310|P2|STARTED|Overall Study||7
275802|NCT01170546|665311|P1|STARTED|Overall Study||7
275803|NCT01170598|665321|P1|NOT COMPLETED|Overall Study||6
275804|NCT01170598|665321|P1|COMPLETED|Overall Study||29
275805|NCT01170598|665321|P1|STARTED|Overall Study||35
275806|NCT01170663|665338|P2|NOT COMPLETED|Overall Study||27
275807|NCT01170663|665339|P1|NOT COMPLETED|Overall Study||24
275808|NCT01170663|665338|P2|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|308
275809|NCT01170663|665339|P1|COMPLETED|Overall Study|Participants who died due to any cause or alive at study end but off study drug considered complete.|306
275810|NCT01170663|665338|P2|Received Any Treatment (Safety Pop)|Overall Study||329
275811|NCT01170663|665339|P1|Received Any Treatment (Safety Pop)|Overall Study||327
275812|NCT01170663|665338|P2|STARTED|Overall Study||335
275813|NCT01170663|665339|P1|STARTED|Overall Study||330
275814|NCT01170754|665369|P2|NOT COMPLETED|Overall Study||0
275815|NCT01170754|665370|P1|NOT COMPLETED|Overall Study||0
275816|NCT01170754|665369|P2|COMPLETED|Overall Study||70
275817|NCT01170754|665370|P1|COMPLETED|Overall Study||66
275818|NCT01170754|665369|P2|STARTED|Overall Study||70
275819|NCT01170754|665370|P1|STARTED|Overall Study||66
275820|NCT01170884|665378|P2|NOT COMPLETED|Overall Study||2
275821|NCT01170884|665379|P1|NOT COMPLETED|Overall Study||5
275822|NCT01170884|665378|P2|COMPLETED|Overall Study||60
275823|NCT01170884|665379|P1|COMPLETED|Overall Study||54
275824|NCT01170884|665378|P2|STARTED|Overall Study||62
275825|NCT01170884|665379|P1|STARTED|Overall Study||59
275826|NCT01170949|665387|P2|NOT COMPLETED|Overall Study||4
275827|NCT01170949|665388|P1|NOT COMPLETED|Overall Study||7
275828|NCT01170949|665387|P2|COMPLETED|Overall Study||22
275829|NCT01170949|665388|P1|COMPLETED|Overall Study||43
275830|NCT01170949|665387|P2|STARTED|Overall Study||26
275831|NCT01170949|665388|P1|STARTED|Overall Study||50
275832|NCT01170962|665397|P3|NOT COMPLETED|Follow up Period||6
275833|NCT01170962|665398|P2|NOT COMPLETED|Follow up Period||27
275834|NCT01170962|665399|P1|NOT COMPLETED|Follow up Period||39
275835|NCT01170962|665397|P3|COMPLETED|Follow up Period||9
275836|NCT01170962|665398|P2|COMPLETED|Follow up Period||165
275837|NCT01170962|665399|P1|COMPLETED|Follow up Period||159
275838|NCT01170962|665397|P3|STARTED|Follow up Period|Out of 17 participants who entered the treatment period, 15 continued in the follow-up period.|15
275839|NCT01170962|665398|P2|STARTED|Follow up Period|Out of 199 participants who entered the treatment period, 192 continued in the follow-up period.|192
275840|NCT01170962|665399|P1|STARTED|Follow up Period|Out of 203 participants who entered the treatment period, 198 continued in the follow-up period.|198
275841|NCT01170962|665397|P3|NOT COMPLETED|Treatment Period||12
275842|NCT01170962|665398|P2|NOT COMPLETED|Treatment Period||111
275843|NCT01170962|665399|P1|NOT COMPLETED|Treatment Period||127
275844|NCT01170962|665397|P3|COMPLETED|Treatment Period||5
275845|NCT01170962|665398|P2|COMPLETED|Treatment Period||88
275846|NCT01170962|665399|P1|COMPLETED|Treatment Period||76
275847|NCT01170962|665397|P3|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||0
275848|NCT01170962|665398|P2|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||36
275849|NCT01170962|665399|P1|PDR ­Randomized to 48 Weeks Follow­-up|Treatment Period||28
275850|NCT01170962|665397|P3|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||0
275851|NCT01170962|665398|P2|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||36
275852|NCT01170962|665399|P1|PDR ­Randomized to 24 Weeks pegIFNα­-2a|Treatment Period||30
275853|NCT01170962|665397|P3|No PDR|Treatment Period||17
275854|NCT01170962|665398|P2|No PDR|Treatment Period||127
275855|NCT01170962|665399|P1|No PDR|Treatment Period||145
275856|NCT01170962|665397|P3|STARTED|Treatment Period||17
275857|NCT01170962|665398|P2|STARTED|Treatment Period||199
275858|NCT01170962|665399|P1|STARTED|Treatment Period||203
275859|NCT01171118|665443|P1|NOT COMPLETED|Overall Study||0
275860|NCT01171118|665443|P1|COMPLETED|Overall Study||10
275861|NCT01171118|665443|P1|STARTED|Overall Study||10
275862|NCT01171183|665455|P2|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||5
275863|NCT01171183|665456|P1|NOT COMPLETED|Outpatient Participation (Weeks 3-10)||10
275864|NCT01171183|665455|P2|COMPLETED|Outpatient Participation (Weeks 3-10)||4
275865|NCT01171183|665456|P1|COMPLETED|Outpatient Participation (Weeks 3-10)||2
275866|NCT01171183|665455|P2|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but was discharged due to protocol noncompliance.|9
275867|NCT01171183|665456|P1|STARTED|Outpatient Participation (Weeks 3-10)|One subject completed the residential stay but withdrew prior to starting the outpatient phase.|12
275868|NCT01171183|665455|P2|NOT COMPLETED|Residential Facility (Weeks 1-2)||6
275869|NCT01171183|665456|P1|NOT COMPLETED|Residential Facility (Weeks 1-2)||2
275870|NCT01171183|665455|P2|COMPLETED|Residential Facility (Weeks 1-2)||10
275871|NCT01171183|665456|P1|COMPLETED|Residential Facility (Weeks 1-2)||13
275872|NCT01171183|665455|P2|STARTED|Residential Facility (Weeks 1-2)|Subjects receiving at least one dose of study med. One did not due to BP outside study parameters.|16
275873|NCT01171183|665456|P1|STARTED|Residential Facility (Weeks 1-2)|Those who were admitted to the residential facility and received at least one dose of study med.|15
275874|NCT01171521|665464|P1|NOT COMPLETED|Overall Study||6
275875|NCT01171521|665464|P1|COMPLETED|Overall Study||0
275876|NCT01171521|665464|P1|STARTED|Overall Study||6
275877|NCT01171534|665471|P2|NOT COMPLETED|Overall Study||3
275878|NCT01171534|665472|P1|NOT COMPLETED|Overall Study||0
275879|NCT01171534|665471|P2|COMPLETED|Overall Study||4
275880|NCT01171534|665472|P1|COMPLETED|Overall Study||0
275881|NCT01171534|665471|P2|STARTED|Overall Study||7
275882|NCT01171534|665472|P1|STARTED|Overall Study|retrospective arm never performed on study|0
275883|NCT01171612|665480|P1|NOT COMPLETED|Overall Study||51
275884|NCT01171612|665480|P1|COMPLETED|Overall Study||432
275885|NCT01171612|665480|P1|STARTED|Overall Study||483
275886|NCT01171677|665490|P2|NOT COMPLETED|Overall Study||3
275887|NCT01171677|665491|P1|NOT COMPLETED|Overall Study||6
275888|NCT01171677|665490|P2|COMPLETED|Overall Study||12
275889|NCT01171677|665491|P1|COMPLETED|Overall Study||11
275890|NCT01171677|665490|P2|STARTED|Overall Study||15
275891|NCT01171677|665491|P1|STARTED|Overall Study||17
275892|NCT01171690|665525|P2|NOT COMPLETED|Overall Study||0
275893|NCT01171690|665526|P1|NOT COMPLETED|Overall Study||0
275894|NCT01171690|665525|P2|COMPLETED|Overall Study||5
275895|NCT01171690|665526|P1|COMPLETED|Overall Study||5
275896|NCT01171690|665525|P2|STARTED|Overall Study||5
275897|NCT01171690|665526|P1|STARTED|Overall Study||5
275898|NCT01171794|665536|P2|NOT COMPLETED|Overall Study||0
275899|NCT01171794|665537|P1|NOT COMPLETED|Overall Study||3
275900|NCT01171794|665536|P2|COMPLETED|Overall Study||42
275901|NCT01171794|665537|P1|COMPLETED|Overall Study||44
275902|NCT01171794|665536|P2|STARTED|Overall Study||42
275903|NCT01171794|665537|P1|STARTED|Overall Study||47
275904|NCT01171820|665547|P2|NOT COMPLETED|Overall Study||6
275905|NCT01171820|665548|P1|NOT COMPLETED|Overall Study||6
275906|NCT01171820|665547|P2|COMPLETED|Overall Study||212
275907|NCT01171820|665548|P1|COMPLETED|Overall Study||100
275908|NCT01171820|665547|P2|STARTED|Overall Study||218
275909|NCT01171820|665548|P1|STARTED|Overall Study||106
275910|NCT01171924|665604|P2|NOT COMPLETED|Overall Study||23
275911|NCT01171924|665605|P1|NOT COMPLETED|Overall Study||23
275912|NCT01171924|665604|P2|COMPLETED|Overall Study||0
275913|NCT01171924|665605|P1|COMPLETED|Overall Study||0
275914|NCT01171924|665604|P2|STARTED|Overall Study||23
275915|NCT01171924|665605|P1|STARTED|Overall Study||23
275916|NCT01171963|665613|P2|NOT COMPLETED|Overall Study||168
275917|NCT01171963|665614|P1|NOT COMPLETED|Overall Study||148
275918|NCT01171963|665613|P2|COMPLETED|Overall Study||1499
275919|NCT01171963|665614|P1|COMPLETED|Overall Study||1518
275920|NCT01171963|665613|P2|STARTED|Overall Study||1667
275921|NCT01171963|665614|P1|STARTED|Overall Study||1666
275922|NCT01171976|665673|P3|NOT COMPLETED|Overall Study||15
275923|NCT01171976|665674|P2|NOT COMPLETED|Overall Study||11
275924|NCT01171976|665675|P1|NOT COMPLETED|Overall Study||14
275925|NCT01171976|665673|P3|COMPLETED|Overall Study||108
275926|NCT01171976|665674|P2|COMPLETED|Overall Study||117
275927|NCT01171976|665675|P1|COMPLETED|Overall Study||107
275928|NCT01171976|665673|P3|Safety Set|Overall Study|Exclude 1 who did not get drug and 4 got laser treatment|118
275929|NCT01171976|665674|P2|Safety Set|Overall Study|Exclude 1 who did not get drug and 3 got laser treatment, include 2 from 1st arm with no laser|126
275930|NCT01171976|665675|P1|Safety Set|Overall Study|Include 4 from PRN and 3 from TE alone who got laser treatment, exclude 2 with no laser treatment.|126
275931|NCT01171976|665673|P3|STARTED|Overall Study||123
275932|NCT01171976|665674|P2|STARTED|Overall Study||128
275933|NCT01171976|665675|P1|STARTED|Overall Study||121
275934|NCT01171989|665713|P3|NOT COMPLETED|Overall Study||1
275935|NCT01171989|665714|P2|NOT COMPLETED|Overall Study||0
275936|NCT01171989|665715|P1|NOT COMPLETED|Overall Study||0
275937|NCT01171989|665713|P3|COMPLETED|Overall Study||120
275938|NCT01171989|665714|P2|COMPLETED|Overall Study||133
275939|NCT01171989|665715|P1|COMPLETED|Overall Study||137
275940|NCT01171989|665713|P3|STARTED|Overall Study||121
275941|NCT01171989|665714|P2|STARTED|Overall Study||133
275942|NCT01171989|665715|P1|STARTED|Overall Study||137
275943|NCT01172145|665788|P2|NOT COMPLETED|Overall Study||0
275944|NCT01172145|665789|P1|NOT COMPLETED|Overall Study||0
275945|NCT01172145|665788|P2|COMPLETED|Overall Study||11
275946|NCT01172145|665789|P1|COMPLETED|Overall Study||11
275947|NCT01172145|665788|P2|STARTED|Overall Study||11
275948|NCT01172145|665789|P1|STARTED|Overall Study||11
275949|NCT01172184|665809|P1|NOT COMPLETED|Overall Study||0
275950|NCT01172184|665809|P1|COMPLETED|Overall Study||111
275951|NCT01172184|665809|P1|STARTED|Overall Study||111
275952|NCT01172288|665817|P2|NOT COMPLETED|Overall Study||1
275953|NCT01172288|665818|P1|NOT COMPLETED|Overall Study||1
275954|NCT01172288|665817|P2|COMPLETED|Overall Study||13
275955|NCT01172288|665818|P1|COMPLETED|Overall Study||16
275956|NCT01172288|665817|P2|STARTED|Overall Study||14
275957|NCT01172288|665818|P1|STARTED|Overall Study||17
275958|NCT01172353|665834|P2|NOT COMPLETED|Overall Study||0
275959|NCT01172353|665835|P1|NOT COMPLETED|Overall Study||0
275960|NCT01172353|665834|P2|COMPLETED|Overall Study||151
275961|NCT01172353|665835|P1|COMPLETED|Overall Study||150
275962|NCT01172353|665834|P2|STARTED|Overall Study||151
275963|NCT01172353|665835|P1|STARTED|Overall Study||150
275964|NCT01172418|665845|P2|NOT COMPLETED|Overall Study||0
275965|NCT01172418|665846|P1|NOT COMPLETED|Overall Study||0
275966|NCT01172418|665845|P2|COMPLETED|Overall Study||100
275967|NCT01172418|665846|P1|COMPLETED|Overall Study||100
275968|NCT01172418|665845|P2|STARTED|Overall Study||100
275969|NCT01172418|665846|P1|STARTED|Overall Study||100
275970|NCT01172522|665854|P2|NOT COMPLETED|Overall Study||0
275971|NCT01172522|665855|P1|NOT COMPLETED|Overall Study||0
275972|NCT01172522|665854|P2|COMPLETED|Overall Study||15
275973|NCT01172522|665855|P1|COMPLETED|Overall Study||15
275974|NCT01172522|665854|P2|STARTED|Overall Study||15
275975|NCT01172522|665855|P1|STARTED|Overall Study||15
275976|NCT01172535|665860|P1|NOT COMPLETED|Overall Study||8
275977|NCT01172535|665860|P1|COMPLETED|Overall Study||89
275978|NCT01172535|665860|P1|STARTED|Overall Study||97
275979|NCT01172600|665877|P2|NOT COMPLETED|Overall Study||0
275980|NCT01172600|665878|P1|NOT COMPLETED|Overall Study||0
275981|NCT01172600|665877|P2|COMPLETED|Overall Study||39
275982|NCT01172600|665878|P1|COMPLETED|Overall Study||39
275983|NCT01172600|665877|P2|STARTED|Overall Study||39
275984|NCT01172600|665878|P1|STARTED|Overall Study||39
275985|NCT01172808|665912|P4|NOT COMPLETED|Overall Study||15
275986|NCT01172808|665913|P3|NOT COMPLETED|Overall Study||23
275987|NCT01172808|665914|P2|NOT COMPLETED|Overall Study||13
275988|NCT01172808|665915|P1|NOT COMPLETED|Overall Study||21
275989|NCT01172808|665912|P4|COMPLETED|Overall Study||260
275990|NCT01172808|665913|P3|COMPLETED|Overall Study||241
275991|NCT01172808|665914|P2|COMPLETED|Overall Study||249
275992|NCT01172808|665915|P1|COMPLETED|Overall Study||248
275993|NCT01172808|665912|P4|STARTED|Overall Study|Entered and Treated|275
275994|NCT01172808|665913|P3|STARTED|Overall Study|Entered and Treated|264
275995|NCT01172808|665914|P2|STARTED|Overall Study|Entered and Treated|262
275996|NCT01172808|665915|P1|STARTED|Overall Study|Entered and Treated|269
275997|NCT01172821|666005|P4|NOT COMPLETED|Overall Study||17
275998|NCT01172821|666006|P3|NOT COMPLETED|Overall Study||13
275999|NCT01172821|666007|P2|NOT COMPLETED|Overall Study||12
276000|NCT01172821|666008|P1|NOT COMPLETED|Overall Study||14
276001|NCT01172821|666005|P4|COMPLETED|Overall Study||249
276002|NCT01172821|666006|P3|COMPLETED|Overall Study||240
276003|NCT01172821|666007|P2|COMPLETED|Overall Study||245
276004|NCT01172821|666008|P1|COMPLETED|Overall Study||240
276005|NCT01172821|666005|P4|STARTED|Overall Study|Entered and Treated|266
276006|NCT01172821|666006|P3|STARTED|Overall Study|Entered and Treated|253
276007|NCT01172821|666007|P2|STARTED|Overall Study|Entered and Treated|257
276008|NCT01172821|666008|P1|STARTED|Overall Study|Entered and Treated|254
276009|NCT01172847|666094|P1|NOT COMPLETED|Overall Study||3
276010|NCT01172847|666094|P1|COMPLETED|Overall Study||21
276011|NCT01172847|666094|P1|Oseltamivir + Rimantadine|Overall Study||21
276012|NCT01172847|666094|P1|Rimantadine|Overall Study||22
276013|NCT01172847|666094|P1|Oseltamivir|Overall Study||24
276014|NCT01172847|666094|P1|STARTED|Overall Study||24
276015|NCT01172873|666121|P2|NOT COMPLETED|Overall Study||2
276016|NCT01172873|666122|P1|NOT COMPLETED|Overall Study||3
276017|NCT01172873|666121|P2|COMPLETED|Overall Study||3
276018|NCT01172873|666122|P1|COMPLETED|Overall Study||8
276019|NCT01172873|666121|P2|STARTED|Overall Study||5
276020|NCT01172873|666122|P1|STARTED|Overall Study||11
276021|NCT01172938|666135|P7|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||2
276022|NCT01172938|666136|P6|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
276023|NCT01172938|666137|P5|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||4
276024|NCT01172938|666138|P4|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||7
276025|NCT01172938|666139|P3|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||15
276026|NCT01172938|666140|P2|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||12
276027|NCT01172938|666141|P1|NOT COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
276028|NCT01172938|666135|P7|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||22
276029|NCT01172938|666136|P6|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||34
276030|NCT01172938|666137|P5|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||19
276031|NCT01172938|666138|P4|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||44
276032|NCT01172938|666139|P3|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||130
276033|NCT01172938|666140|P2|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||124
276034|NCT01172938|666141|P1|COMPLETED|Active Treatment Phase (Weeks 25 - 52)||0
276035|NCT01172938|666135|P7|STARTED|Active Treatment Phase (Weeks 25 - 52)||24
276036|NCT01172938|666136|P6|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|49
276037|NCT01172938|666137|P5|STARTED|Active Treatment Phase (Weeks 25 - 52)||23
276038|NCT01172938|666138|P4|STARTED|Active Treatment Phase (Weeks 25 - 52)|One participant who escaped early and completed Week 24 did not enter the active treatment phase|51
276039|NCT01172938|666139|P3|STARTED|Active Treatment Phase (Weeks 25 - 52)|Three participants who completed Week 24 did not enter the active treatment phase|145
276040|NCT01172938|666140|P2|STARTED|Active Treatment Phase (Weeks 25 - 52)|Ten participants who completed Week 24 did not enter the active treatment phase|136
276041|NCT01172938|666141|P1|STARTED|Active Treatment Phase (Weeks 25 - 52)||0
276042|NCT01172938|666135|P7|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276043|NCT01172938|666136|P6|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276044|NCT01172938|666137|P5|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276045|NCT01172938|666138|P4|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276046|NCT01172938|666139|P3|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||20
276047|NCT01172938|666140|P2|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||22
276048|NCT01172938|666141|P1|NOT COMPLETED|Placebo-controlled Phase (Week 0 - 24)||18
276049|NCT01172938|666135|P7|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276050|NCT01172938|666136|P6|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276051|NCT01172938|666137|P5|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276052|NCT01172938|666138|P4|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||0
276053|NCT01172938|666139|P3|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||148
276054|NCT01172938|666140|P2|COMPLETED|Placebo-controlled Phase (Week 0 - 24)||146
276055|NCT01172938|666141|P1|COMPLETED|Placebo-controlled Phase (Week 0 - 24)|One participant who completed Week 24 did not enter the active treatment phase|150
276056|NCT01172938|666135|P7|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276057|NCT01172938|666136|P6|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276058|NCT01172938|666137|P5|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276059|NCT01172938|666138|P4|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276060|NCT01172938|666139|P3|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)||58
276061|NCT01172938|666140|P2|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Six participants who escaped early did not complete Week 24|78
276062|NCT01172938|666141|P1|Early Escape at Week 16|Placebo-controlled Phase (Week 0 - 24)|Five participants who escaped early did not complete Week 24|107
276063|NCT01172938|666135|P7|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276064|NCT01172938|666136|P6|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276065|NCT01172938|666137|P5|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276066|NCT01172938|666138|P4|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||0
276067|NCT01172938|666139|P3|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||154
276068|NCT01172938|666140|P2|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
276069|NCT01172938|666141|P1|Completed Week 16|Placebo-controlled Phase (Week 0 - 24)||158
276070|NCT01172938|666135|P7|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
276071|NCT01172938|666136|P6|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
276072|NCT01172938|666137|P5|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
276073|NCT01172938|666138|P4|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||0
276074|NCT01172938|666139|P3|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
276075|NCT01172938|666140|P2|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
276076|NCT01172938|666141|P1|Received Treatment|Placebo-controlled Phase (Week 0 - 24)||168
276077|NCT01172938|666135|P7|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
276078|NCT01172938|666136|P6|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
276079|NCT01172938|666137|P5|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
276080|NCT01172938|666138|P4|STARTED|Placebo-controlled Phase (Week 0 - 24)||0
276081|NCT01172938|666139|P3|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
276082|NCT01172938|666140|P2|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
276083|NCT01172938|666141|P1|STARTED|Placebo-controlled Phase (Week 0 - 24)||168
276084|NCT01173029|666320|P2|NOT COMPLETED|Overall Study||0
276085|NCT01173029|666321|P1|NOT COMPLETED|Overall Study||0
276086|NCT01173029|666320|P2|COMPLETED|Overall Study||31
276087|NCT01173029|666321|P1|COMPLETED|Overall Study||61
276088|NCT01173029|666320|P2|STARTED|Overall Study||31
276089|NCT01173029|666321|P1|STARTED|Overall Study||61
276090|NCT01173055|666340|P2|NOT COMPLETED|Period 2 - Day 64 to 112||1
276091|NCT01173055|666341|P1|NOT COMPLETED|Period 2 - Day 64 to 112||0
276092|NCT01173055|666340|P2|COMPLETED|Period 2 - Day 64 to 112||9
276093|NCT01173055|666341|P1|COMPLETED|Period 2 - Day 64 to 112||8
276094|NCT01173055|666340|P2|STARTED|Period 2 - Day 64 to 112||10
276095|NCT01173055|666341|P1|STARTED|Period 2 - Day 64 to 112||8
276096|NCT01173055|666340|P2|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
276097|NCT01173055|666341|P1|NOT COMPLETED|Placebo Washout Period - Day 50 to 63||0
276098|NCT01173055|666340|P2|COMPLETED|Placebo Washout Period - Day 50 to 63||10
276099|NCT01173055|666341|P1|COMPLETED|Placebo Washout Period - Day 50 to 63||8
276100|NCT01173055|666340|P2|STARTED|Placebo Washout Period - Day 50 to 63||10
276101|NCT01173055|666341|P1|STARTED|Placebo Washout Period - Day 50 to 63||8
276102|NCT01173055|666340|P2|NOT COMPLETED|Period 1 - Day 1 to 49||2
276103|NCT01173055|666341|P1|NOT COMPLETED|Period 1 - Day 1 to 49||2
276104|NCT01173055|666340|P2|COMPLETED|Period 1 - Day 1 to 49||10
276105|NCT01173055|666341|P1|COMPLETED|Period 1 - Day 1 to 49||8
276106|NCT01173055|666340|P2|STARTED|Period 1 - Day 1 to 49||12
276107|NCT01173055|666341|P1|STARTED|Period 1 - Day 1 to 49||10
276108|NCT01173120|666357|P1|NOT COMPLETED|Overall Study||62
276109|NCT01173120|666357|P1|COMPLETED|Overall Study||0
276110|NCT01173120|666357|P1|Discontinued ACP Substudy and Main Study|Overall Study||5
276111|NCT01173120|666357|P1|Switched Back to Main Study|Overall Study||57
276112|NCT01173120|666357|P1|STARTED|Overall Study||62
276113|NCT01173211|666379|P6|NOT COMPLETED|Overall Study||0
276114|NCT01173211|666380|P5|NOT COMPLETED|Overall Study||0
276115|NCT01173211|666381|P4|NOT COMPLETED|Overall Study||0
276116|NCT01173211|666382|P3|NOT COMPLETED|Overall Study||2
276117|NCT01173211|666383|P2|NOT COMPLETED|Overall Study||1
276118|NCT01173211|666384|P1|NOT COMPLETED|Overall Study||2
276119|NCT01173211|666379|P6|COMPLETED|Overall Study||13
276120|NCT01173211|666380|P5|COMPLETED|Overall Study||16
276121|NCT01173211|666381|P4|COMPLETED|Overall Study||15
276122|NCT01173211|666382|P3|COMPLETED|Overall Study||44
276123|NCT01173211|666383|P2|COMPLETED|Overall Study||44
276124|NCT01173211|666384|P1|COMPLETED|Overall Study||46
276125|NCT01173211|666379|P6|STARTED|Overall Study||13
276126|NCT01173211|666380|P5|STARTED|Overall Study||16
276127|NCT01173211|666381|P4|STARTED|Overall Study||15
276128|NCT01173211|666382|P3|STARTED|Overall Study||46
276129|NCT01173211|666383|P2|STARTED|Overall Study||45
276130|NCT01173211|666384|P1|STARTED|Overall Study||48
276131|NCT01167426|666485|P1|NOT COMPLETED|Overall Study||10
276132|NCT01167426|666485|P1|COMPLETED|Overall Study||138
276133|NCT01167426|666485|P1|STARTED|Overall Study||148
276134|NCT01167452|666491|P1|NOT COMPLETED|Overall Study||0
276135|NCT01167452|666491|P1|COMPLETED|Overall Study||36
276136|NCT01167452|666491|P1|STARTED|Overall Study||36
276137|NCT01167504|666496|P1|NOT COMPLETED|Overall Study||3
276138|NCT01167504|666496|P1|COMPLETED|Overall Study||12
276139|NCT01167504|666496|P1|STARTED|Overall Study||15
276140|NCT01167582|666503|P2|NOT COMPLETED|Overall Study||1
276141|NCT01167582|666504|P1|NOT COMPLETED|Overall Study||0
276142|NCT01167582|666503|P2|COMPLETED|Overall Study||54
276143|NCT01167582|666504|P1|COMPLETED|Overall Study||55
276144|NCT01167582|666503|P2|STARTED|Overall Study||55
276145|NCT01167582|666504|P1|STARTED|Overall Study||55
276146|NCT01167608|666516|P1|NOT COMPLETED|Overall Study||114
276147|NCT01167608|666516|P1|COMPLETED|Overall Study||769
276148|NCT01167608|666516|P1|STARTED|Overall Study||883
276149|NCT01167634|666529|P4|NOT COMPLETED|Overall Study||4
276150|NCT01167634|666530|P3|NOT COMPLETED|Overall Study||3
276151|NCT01167634|666531|P2|NOT COMPLETED|Overall Study||4
276152|NCT01167634|666532|P1|NOT COMPLETED|Overall Study||2
276153|NCT01167634|666529|P4|COMPLETED|Overall Study||29
276154|NCT01167634|666530|P3|COMPLETED|Overall Study||30
276155|NCT01167634|666531|P2|COMPLETED|Overall Study||29
276156|NCT01167634|666532|P1|COMPLETED|Overall Study||31
276157|NCT01167634|666529|P4|STARTED|Overall Study||33
276158|NCT01167634|666530|P3|STARTED|Overall Study||33
276159|NCT01167634|666531|P2|STARTED|Overall Study||33
276160|NCT01167634|666532|P1|STARTED|Overall Study||33
276161|NCT01167829|666542|P1|NOT COMPLETED|Overall Study||0
276162|NCT01167829|666542|P1|COMPLETED|Overall Study||12
276163|NCT01167829|666542|P1|STARTED|Overall Study||12
276164|NCT01173471|666559|P4|NOT COMPLETED|Overall Study||1
276165|NCT01173471|666560|P3|NOT COMPLETED|Overall Study||3
276166|NCT01173471|666561|P2|NOT COMPLETED|Overall Study||0
276167|NCT01173471|666562|P1|NOT COMPLETED|Overall Study||2
276168|NCT01173471|666559|P4|COMPLETED|Overall Study|Completed study|18
276169|NCT01173471|666560|P3|COMPLETED|Overall Study|Completed study|15
276170|NCT01173471|666561|P2|COMPLETED|Overall Study|Completed study|7
276171|NCT01173471|666562|P1|COMPLETED|Overall Study|Completed study|4
276172|NCT01173471|666559|P4|Completed Treatment|Overall Study||18
276173|NCT01173471|666560|P3|Completed Treatment|Overall Study||15
276174|NCT01173471|666561|P2|Completed Treatment|Overall Study||7
276175|NCT01173471|666562|P1|Completed Treatment|Overall Study||4
276176|NCT01173471|666559|P4|Received Treatment|Overall Study||19
276177|NCT01173471|666560|P3|Received Treatment|Overall Study||18
276178|NCT01173471|666561|P2|Received Treatment|Overall Study||7
276179|NCT01173471|666562|P1|Received Treatment|Overall Study||6
276180|NCT01173471|666559|P4|STARTED|Overall Study|Randomized|19
276181|NCT01173471|666560|P3|STARTED|Overall Study|Randomized|18
276182|NCT01173471|666561|P2|STARTED|Overall Study|Randomized|7
276183|NCT01173471|666562|P1|STARTED|Overall Study|Randomized|6
276184|NCT01173523|666582|P2|NOT COMPLETED|Overall Study||12
276185|NCT01173523|666583|P1|NOT COMPLETED|Overall Study||13
276186|NCT01173523|666582|P2|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
276187|NCT01173523|666583|P1|COMPLETED|Overall Study|Since treatment was not of fixed duration, all participants were considered as 'Not Completed'.|0
276188|NCT01173523|666582|P2|STARTED|Overall Study||12
276189|NCT01173523|666583|P1|STARTED|Overall Study||13
276190|NCT01173718|666595|P1|NOT COMPLETED|Overall Study||44
276191|NCT01173718|666595|P1|COMPLETED|Overall Study||94
276192|NCT01173718|666595|P1|STARTED|Overall Study||138
276193|NCT01173848|666606|P2|NOT COMPLETED|Overall Study||8
276194|NCT01173848|666607|P1|NOT COMPLETED|Overall Study||4
276195|NCT01173848|666606|P2|COMPLETED|Overall Study||3
276196|NCT01173848|666607|P1|COMPLETED|Overall Study||4
276197|NCT01173848|666606|P2|STARTED|Overall Study||11
276198|NCT01173848|666607|P1|STARTED|Overall Study||8
276199|NCT01173874|666614|P2|NOT COMPLETED|Overall Study||23
276200|NCT01173874|666615|P1|NOT COMPLETED|Overall Study||23
276201|NCT01173874|666614|P2|COMPLETED|Overall Study||41
276202|NCT01173874|666615|P1|COMPLETED|Overall Study||33
276203|NCT01173874|666614|P2|STARTED|Overall Study||64
276204|NCT01173874|666615|P1|STARTED|Overall Study||56
276205|NCT01174004|666629|P2|NOT COMPLETED|Overall Study||16
276206|NCT01174004|666630|P1|NOT COMPLETED|Overall Study||7
276207|NCT01174004|666629|P2|COMPLETED|Overall Study||89
276208|NCT01174004|666630|P1|COMPLETED|Overall Study||87
276209|NCT01174004|666629|P2|STARTED|Overall Study||105
276210|NCT01174004|666630|P1|STARTED|Overall Study||94
276211|NCT01174030|666643|P5|NOT COMPLETED|Overall Study||1
276212|NCT01174030|666644|P4|NOT COMPLETED|Overall Study||2
276213|NCT01174030|666645|P3|NOT COMPLETED|Overall Study||2
276214|NCT01174030|666646|P2|NOT COMPLETED|Overall Study||2
276215|NCT01174030|666647|P1|NOT COMPLETED|Overall Study||2
276216|NCT01174030|666643|P5|COMPLETED|Overall Study||52
276217|NCT01174030|666644|P4|COMPLETED|Overall Study||53
276218|NCT01174030|666645|P3|COMPLETED|Overall Study||52
276219|NCT01174030|666646|P2|COMPLETED|Overall Study||52
276220|NCT01174030|666647|P1|COMPLETED|Overall Study||51
276221|NCT01174030|666643|P5|STARTED|Overall Study||53
276222|NCT01174030|666644|P4|STARTED|Overall Study||55
276223|NCT01174030|666645|P3|STARTED|Overall Study||54
276224|NCT01174030|666646|P2|STARTED|Overall Study||54
276225|NCT01174030|666647|P1|STARTED|Overall Study||53
276226|NCT01174043|666669|P1|NOT COMPLETED|Overall Study||11
276227|NCT01174043|666669|P1|COMPLETED|Overall Study||0
276228|NCT01174043|666669|P1|STARTED|Overall Study||11
276229|NCT01174160|666677|P2|NOT COMPLETED|Overall Study||6
276230|NCT01174160|666678|P1|NOT COMPLETED|Overall Study||8
276231|NCT01174160|666677|P2|COMPLETED|Overall Study||56
276232|NCT01174160|666678|P1|COMPLETED|Overall Study||53
276233|NCT01174160|666677|P2|Discontinued Post Dose|Overall Study||0
276234|NCT01174160|666678|P1|Discontinued Post Dose|Overall Study||2
276235|NCT01174160|666677|P2|Dosed|Overall Study||56
276236|NCT01174160|666678|P1|Dosed|Overall Study||55
276237|NCT01174160|666677|P2|Discontinued Pre Dose|Overall Study||6
276238|NCT01174160|666678|P1|Discontinued Pre Dose|Overall Study||6
276239|NCT01174160|666677|P2|STARTED|Overall Study||62
276240|NCT01174160|666678|P1|STARTED|Overall Study||61
276241|NCT01174173|666684|P1|NOT COMPLETED|Overall Study||1
276242|NCT01174173|666684|P1|COMPLETED|Overall Study||10
276243|NCT01174173|666684|P1|STARTED|Overall Study||11
276244|NCT01174186|666694|P2|NOT COMPLETED|Overall Study||3
276245|NCT01174186|666695|P1|NOT COMPLETED|Overall Study||0
276246|NCT01174186|666694|P2|COMPLETED|Overall Study||12
276247|NCT01174186|666695|P1|COMPLETED|Overall Study||15
276248|NCT01174186|666694|P2|STARTED|Overall Study||15
276249|NCT01174186|666695|P1|STARTED|Overall Study|Patients were included over three years|15
276250|NCT01174264|666705|P3|NOT COMPLETED|Steady-state Pharmacokinetics||2
276251|NCT01174264|666706|P2|NOT COMPLETED|Steady-state Pharmacokinetics||0
276252|NCT01174264|666707|P1|NOT COMPLETED|Steady-state Pharmacokinetics||6
276253|NCT01174264|666705|P3|COMPLETED|Steady-state Pharmacokinetics||27
276254|NCT01174264|666706|P2|COMPLETED|Steady-state Pharmacokinetics||0
276255|NCT01174264|666707|P1|COMPLETED|Steady-state Pharmacokinetics||25
276256|NCT01174264|666705|P3|STARTED|Steady-state Pharmacokinetics|Includes 11 patients from period 1 high-fat arm and 18 patients from period 1 low-fat arm|29
276257|NCT01174264|666706|P2|STARTED|Steady-state Pharmacokinetics|Patients in period 2 were randomized to fasting vs. fed state only.|0
276258|NCT01174264|666707|P1|STARTED|Steady-state Pharmacokinetics|Includes 22 patients from period 1 fasting arm and 9 patients from period 1 high-fat arm|31
276259|NCT01174264|666705|P3|NOT COMPLETED|Single Dose Pharmacokinetics||2
276260|NCT01174264|666706|P2|NOT COMPLETED|Single Dose Pharmacokinetics||0
276261|NCT01174264|666707|P1|NOT COMPLETED|Single Dose Pharmacokinetics||1
276262|NCT01174264|666705|P3|COMPLETED|Single Dose Pharmacokinetics||18
276263|NCT01174264|666706|P2|COMPLETED|Single Dose Pharmacokinetics||20
276264|NCT01174264|666707|P1|COMPLETED|Single Dose Pharmacokinetics||22
276265|NCT01174264|666705|P3|STARTED|Single Dose Pharmacokinetics||20
276266|NCT01174264|666706|P2|STARTED|Single Dose Pharmacokinetics||20
276267|NCT01174264|666707|P1|STARTED|Single Dose Pharmacokinetics||23
276268|NCT01174342|666739|P1|NOT COMPLETED|Overall Study||4
276269|NCT01174342|666739|P1|COMPLETED|Overall Study||26
276270|NCT01174342|666739|P1|STARTED|Overall Study||30
276271|NCT01174446|666743|P4|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
276272|NCT01174446|666744|P3|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
276273|NCT01174446|666745|P2|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
276274|NCT01174446|666746|P1|NOT COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||1
276275|NCT01174446|666743|P4|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
276276|NCT01174446|666744|P3|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||0
276277|NCT01174446|666745|P2|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
276278|NCT01174446|666746|P1|COMPLETED|Part 3 -Pharmacokinetic BAX326 Only||13
276279|NCT01174446|666743|P4|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
276280|NCT01174446|666744|P3|STARTED|Part 3 -Pharmacokinetic BAX326 Only||0
276281|NCT01174446|666745|P2|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
276282|NCT01174446|666746|P1|STARTED|Part 3 -Pharmacokinetic BAX326 Only|Includes all participants who completed Part 1|14
276283|NCT01174446|666743|P4|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
276284|NCT01174446|666744|P3|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||2
276285|NCT01174446|666745|P2|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
276286|NCT01174446|666746|P1|NOT COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||0
276287|NCT01174446|666743|P4|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
276288|NCT01174446|666744|P3|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||29
276289|NCT01174446|666745|P2|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
276290|NCT01174446|666746|P1|COMPLETED|Part 2 -BAX326 Prophylaxis and On-demand||14
276291|NCT01174446|666743|P4|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|14
276292|NCT01174446|666744|P3|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|This group only participated in Study Part 2|31
276293|NCT01174446|666745|P2|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
276294|NCT01174446|666746|P1|STARTED|Part 2 -BAX326 Prophylaxis and On-demand|In Study Part 2 all 14 participants received Prophylaxis|14
276295|NCT01174446|666743|P4|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
276296|NCT01174446|666744|P3|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
276297|NCT01174446|666745|P2|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
276298|NCT01174446|666746|P1|NOT COMPLETED|Part 1 -Pharmacokinetic Crossover||0
276299|NCT01174446|666743|P4|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
276300|NCT01174446|666744|P3|COMPLETED|Part 1 -Pharmacokinetic Crossover||0
276301|NCT01174446|666745|P2|COMPLETED|Part 1 -Pharmacokinetic Crossover||14
276302|NCT01174446|666746|P1|COMPLETED|Part 1 -Pharmacokinetic Crossover|BAX326 was mistakenly infused for second PK infusion (ie should have been BeneFIX) for 1 participant|14
276303|NCT01174446|666743|P4|STARTED|Part 1 -Pharmacokinetic Crossover||0
276304|NCT01174446|666744|P3|STARTED|Part 1 -Pharmacokinetic Crossover||0
276305|NCT01174446|666745|P2|STARTED|Part 1 -Pharmacokinetic Crossover||14
276306|NCT01174446|666746|P1|STARTED|Part 1 -Pharmacokinetic Crossover||14
276307|NCT01174459|666933|P1|NOT COMPLETED|Overall Study||5
276308|NCT01174459|666933|P1|COMPLETED|Overall Study|Case report form (CRF) collected|566
276309|NCT01174459|666933|P1|STARTED|Overall Study|Registered patients|571
276310|NCT01174550|666940|P2|NOT COMPLETED|Overall Study||873
276311|NCT01174550|666941|P1|NOT COMPLETED|Overall Study||1270
276312|NCT01174550|666940|P2|COMPLETED|Overall Study||4123
276313|NCT01174550|666941|P1|COMPLETED|Overall Study||3737
276314|NCT01174550|666940|P2|STARTED|Overall Study||4996
276315|NCT01174550|666941|P1|STARTED|Overall Study||5007
276316|NCT01174576|666969|P1|NOT COMPLETED|Overall Study||0
276317|NCT01174576|666969|P1|COMPLETED|Overall Study||16
276318|NCT01174576|666969|P1|STARTED|Overall Study|All participants received all interventions without exception.|16
276319|NCT01174784|667010|P1|NOT COMPLETED|Overall Study||0
276320|NCT01174784|667010|P1|COMPLETED|Overall Study||88
276321|NCT01174784|667010|P1|STARTED|Overall Study||88
276322|NCT01175005|667015|P1|NOT COMPLETED|Overall Study||0
276323|NCT01175005|667015|P1|COMPLETED|Overall Study||62
276324|NCT01175005|667015|P1|STARTED|Overall Study||62
276325|NCT01175018|667022|P2|NOT COMPLETED|Overall Study||1
276326|NCT01175018|667023|P1|NOT COMPLETED|Overall Study||3
276327|NCT01175018|667022|P2|COMPLETED|Overall Study||14
276328|NCT01175018|667023|P1|COMPLETED|Overall Study||12
276329|NCT01175018|667022|P2|STARTED|Overall Study||15
276330|NCT01175018|667023|P1|STARTED|Overall Study||15
276331|NCT01175031|667059|P1|NOT COMPLETED|Overall Study||0
276332|NCT01175031|667059|P1|COMPLETED|Overall Study||45
276333|NCT01175031|667059|P1|STARTED|Overall Study||45
276334|NCT01175148|667069|P2|NOT COMPLETED|Overall Study||0
276335|NCT01175148|667070|P1|NOT COMPLETED|Overall Study||0
276336|NCT01175148|667069|P2|COMPLETED|Overall Study||30
276337|NCT01175148|667070|P1|COMPLETED|Overall Study||30
276338|NCT01175148|667069|P2|STARTED|Overall Study||30
276339|NCT01175148|667070|P1|STARTED|Overall Study||30
276340|NCT01175213|667079|P2|NOT COMPLETED|Safety Follow-up||0
276341|NCT01175213|667080|P1|NOT COMPLETED|Safety Follow-up||1
276342|NCT01175213|667079|P2|COMPLETED|Safety Follow-up||3
276343|NCT01175213|667080|P1|COMPLETED|Safety Follow-up||47
276344|NCT01175213|667079|P2|STARTED|Safety Follow-up||3
276345|NCT01175213|667080|P1|STARTED|Safety Follow-up||48
276346|NCT01175213|667079|P2|NOT COMPLETED|IGSC, 10%/rHuPH20||0
276347|NCT01175213|667080|P1|NOT COMPLETED|IGSC, 10%/rHuPH20||15
276348|NCT01175213|667079|P2|COMPLETED|IGSC, 10%/rHuPH20||3
276349|NCT01175213|667080|P1|COMPLETED|IGSC, 10%/rHuPH20||48
276350|NCT01175213|667079|P2|STARTED|IGSC, 10%/rHuPH20|3 participants treated IV with IGIV,10% without rHuPH20 throughout the study.|3
276351|NCT01175213|667080|P1|STARTED|IGSC, 10%/rHuPH20||63
276352|NCT01175226|667127|P2|NOT COMPLETED|Overall Study||5
276353|NCT01175226|667128|P1|NOT COMPLETED|Overall Study||11
276354|NCT01175226|667127|P2|COMPLETED|Overall Study||140
276355|NCT01175226|667128|P1|COMPLETED|Overall Study||144
276356|NCT01175226|667127|P2|STARTED|Overall Study||145
276357|NCT01175226|667128|P1|STARTED|Overall Study||155
276358|NCT01175317|667136|P2|NOT COMPLETED|Overall Study||0
276359|NCT01175317|667137|P1|NOT COMPLETED|Overall Study||0
276360|NCT01175317|667136|P2|COMPLETED|Overall Study||31
276361|NCT01175317|667137|P1|COMPLETED|Overall Study||27
276362|NCT01175317|667136|P2|STARTED|Overall Study||31
276363|NCT01175317|667137|P1|STARTED|Overall Study||27
276364|NCT01175343|667145|P1|NOT COMPLETED|Overall Study||0
276365|NCT01175343|667145|P1|COMPLETED|Overall Study||44
276366|NCT01175343|667145|P1|STARTED|Overall Study||44
276367|NCT01175369|667157|P2|NOT COMPLETED|Overall Study||5
276368|NCT01175369|667158|P1|NOT COMPLETED|Overall Study||2
276369|NCT01175369|667157|P2|COMPLETED|Overall Study||260
276370|NCT01175369|667158|P1|COMPLETED|Overall Study||263
276371|NCT01175369|667157|P2|STARTED|Overall Study||265
276372|NCT01175369|667158|P1|STARTED|Overall Study||265
276373|NCT01175382|667167|P3|NOT COMPLETED|Overall Study||6
276374|NCT01175382|667168|P2|NOT COMPLETED|Overall Study||7
276375|NCT01175382|667169|P1|NOT COMPLETED|Overall Study||8
276376|NCT01175382|667167|P3|COMPLETED|Overall Study||59
276377|NCT01175382|667168|P2|COMPLETED|Overall Study||61
276378|NCT01175382|667169|P1|COMPLETED|Overall Study||63
276379|NCT01175382|667167|P3|STARTED|Overall Study||65
276380|NCT01175382|667168|P2|STARTED|Overall Study||68
276381|NCT01175382|667169|P1|STARTED|Overall Study||71
276382|NCT01175395|667246|P1|NOT COMPLETED|Overall Study||0
276383|NCT01175395|667246|P1|COMPLETED|Overall Study||10
276384|NCT01175395|667246|P1|STARTED|Overall Study||10
276385|NCT01175434|667253|P2|NOT COMPLETED|Overall Study||0
276386|NCT01175434|667254|P1|NOT COMPLETED|Overall Study||0
276387|NCT01175434|667253|P2|COMPLETED|Overall Study||51
276388|NCT01175434|667254|P1|COMPLETED|Overall Study||48
276389|NCT01175434|667253|P2|STARTED|Overall Study||51
276390|NCT01175434|667254|P1|STARTED|Overall Study||48
276391|NCT01175473|667262|P2|NOT COMPLETED|Overall Study||2
276392|NCT01175473|667263|P1|NOT COMPLETED|Overall Study||2
276393|NCT01175473|667262|P2|COMPLETED|Overall Study||69
276394|NCT01175473|667263|P1|COMPLETED|Overall Study||75
276395|NCT01175473|667262|P2|Pharmacodynamic (PD) Population|Overall Study||68
276396|NCT01175473|667263|P1|Pharmacodynamic (PD) Population|Overall Study|All patients who received at least 1 dose; had baseline and at least 1 post-baseline PD assessment.|75
276397|NCT01175473|667262|P2|Safety Population|Overall Study||71
276398|NCT01175473|667263|P1|Safety Population|Overall Study|All patients who were exposed to at least 1 dose, regardless of amount of treatment administered.|77
276399|NCT01175473|667262|P2|STARTED|Overall Study||71
276400|NCT01175473|667263|P1|STARTED|Overall Study|Randomized and treated.|77
276401|NCT01175590|667289|P2|NOT COMPLETED|Overall Study||10
276402|NCT01175590|667290|P1|NOT COMPLETED|Overall Study||12
276403|NCT01175590|667289|P2|COMPLETED|Overall Study||161
276404|NCT01175590|667290|P1|COMPLETED|Overall Study||335
276405|NCT01175590|667289|P2|Safety Population|Overall Study||170
276406|NCT01175590|667290|P1|Safety Population|Overall Study||344
276407|NCT01175590|667289|P2|Modified Intent to Treat Population|Overall Study||87
276408|NCT01175590|667290|P1|Modified Intent to Treat Population|Overall Study||212
276409|NCT01175590|667289|P2|STARTED|Overall Study||171
276410|NCT01175590|667290|P1|STARTED|Overall Study||347
276411|NCT01175668|667324|P2|NOT COMPLETED|Overall Study||0
276412|NCT01175668|667325|P1|NOT COMPLETED|Overall Study||2
276413|NCT01175668|667324|P2|COMPLETED|Overall Study||34
276414|NCT01175668|667325|P1|COMPLETED|Overall Study||32
276415|NCT01175668|667324|P2|STARTED|Overall Study||34
276416|NCT01175668|667325|P1|STARTED|Overall Study||34
276417|NCT01175707|667335|P2|NOT COMPLETED|Overall Study||6
276418|NCT01175707|667336|P1|NOT COMPLETED|Overall Study||4
276419|NCT01175707|667335|P2|COMPLETED|Overall Study||34
276420|NCT01175707|667336|P1|COMPLETED|Overall Study||36
276421|NCT01175707|667335|P2|STARTED|Overall Study||40
276422|NCT01175707|667336|P1|STARTED|Overall Study||40
276423|NCT01175798|667372|P2|NOT COMPLETED|Overall Study||21
276424|NCT01175798|667373|P1|NOT COMPLETED|Overall Study||7
276425|NCT01175798|667372|P2|COMPLETED|Overall Study||41
276426|NCT01175798|667373|P1|COMPLETED|Overall Study||27
276427|NCT01175798|667372|P2|STARTED|Overall Study||62
276428|NCT01175798|667373|P1|STARTED|Overall Study||34
276429|NCT01175811|667381|P2|NOT COMPLETED|Overall Study||14
276430|NCT01175811|667382|P1|NOT COMPLETED|Overall Study||16
276431|NCT01175811|667381|P2|COMPLETED|Overall Study||189
276432|NCT01175811|667382|P1|COMPLETED|Overall Study||183
276433|NCT01175811|667381|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
276434|NCT01175811|667382|P1|Received at Least 1 Dose of Study Drug|Overall Study||197
276435|NCT01175811|667381|P2|STARTED|Overall Study||203
276436|NCT01175811|667382|P1|STARTED|Overall Study||199
276437|NCT01175824|667408|P2|NOT COMPLETED|Overall Study||22
276438|NCT01175824|667409|P1|NOT COMPLETED|Overall Study||16
276439|NCT01175824|667408|P2|COMPLETED|Overall Study||220
276440|NCT01175824|667409|P1|COMPLETED|Overall Study||220
276441|NCT01175824|667408|P2|Received at Least 1 Dose of Study Drug|Overall Study||240
276442|NCT01175824|667409|P1|Received at Least 1 Dose of Study Drug|Overall Study||236
276443|NCT01175824|667408|P2|STARTED|Overall Study||242
276444|NCT01175824|667409|P1|STARTED|Overall Study||236
276445|NCT01175850|667443|P2|NOT COMPLETED|IN.PACT SFA II Phase||5
276446|NCT01175850|667444|P1|NOT COMPLETED|IN.PACT SFA II Phase||12
276447|NCT01175850|667443|P2|COMPLETED|IN.PACT SFA II Phase||55
276448|NCT01175850|667444|P1|COMPLETED|IN.PACT SFA II Phase||109
276449|NCT01175850|667443|P2|STARTED|IN.PACT SFA II Phase||60
276450|NCT01175850|667444|P1|STARTED|IN.PACT SFA II Phase||121
276451|NCT01175850|667443|P2|NOT COMPLETED|IN.PACT SFA I Phase||2
276452|NCT01175850|667444|P1|NOT COMPLETED|IN.PACT SFA I Phase||11
276453|NCT01175850|667443|P2|COMPLETED|IN.PACT SFA I Phase||49
276454|NCT01175850|667444|P1|COMPLETED|IN.PACT SFA I Phase||88
276455|NCT01175850|667443|P2|STARTED|IN.PACT SFA I Phase||51
276456|NCT01175850|667444|P1|STARTED|IN.PACT SFA I Phase||99
276457|NCT01175902|667488|P2|NOT COMPLETED|Overall Study||0
276458|NCT01175902|667489|P1|NOT COMPLETED|Overall Study||0
276459|NCT01175902|667488|P2|COMPLETED|Overall Study||22
276460|NCT01175902|667489|P1|COMPLETED|Overall Study||22
276461|NCT01175902|667488|P2|STARTED|Overall Study||22
276462|NCT01175902|667489|P1|STARTED|Overall Study||22
276463|NCT01176032|667507|P2|NOT COMPLETED|Overall Study||1
276464|NCT01176032|667508|P1|NOT COMPLETED|Overall Study||6
276465|NCT01176032|667507|P2|COMPLETED|Overall Study||36
276466|NCT01176032|667508|P1|COMPLETED|Overall Study||31
276467|NCT01176032|667507|P2|Intention-to-treat (ITT) Population|Overall Study||37
276468|NCT01176032|667508|P1|Intention-to-treat (ITT) Population|Overall Study||32
276469|NCT01176032|667507|P2|STARTED|Overall Study||37
276470|NCT01176032|667508|P1|STARTED|Overall Study|"Started indicates randomized and safety population"|37
276471|NCT01176058|667568|P2|NOT COMPLETED|Overall Study||3
276472|NCT01176058|667569|P1|NOT COMPLETED|Overall Study||4
276473|NCT01176058|667568|P2|COMPLETED|Overall Study||5
276474|NCT01176058|667569|P1|COMPLETED|Overall Study||5
276475|NCT01176058|667568|P2|STARTED|Overall Study||8
276476|NCT01176058|667569|P1|STARTED|Overall Study||9
276477|NCT01176240|667595|P2|NOT COMPLETED|Study 306B||17
276478|NCT01176240|667596|P1|NOT COMPLETED|Study 306B||26
276479|NCT01176240|667595|P2|COMPLETED|Study 306B||68
276480|NCT01176240|667596|P1|COMPLETED|Study 306B||63
276481|NCT01176240|667595|P2|4 wk of Stable Dosing and Visit 6|Study 306B||73
276482|NCT01176240|667596|P1|4 wk of Stable Dosing and Visit 6|Study 306B||67
276483|NCT01176240|667595|P2|2 wk of Stable Dosing and Visit 5|Study 306B||75
276484|NCT01176240|667596|P1|2 wk of Stable Dosing and Visit 5|Study 306B||68
276485|NCT01176240|667595|P2|1 wk of Stable Dosing and Visit 4|Study 306B||78
276486|NCT01176240|667596|P1|1 wk of Stable Dosing and Visit 4|Study 306B||69
276487|NCT01176240|667595|P2|Took at Least 1 Dose of Study Drug|Study 306B|One randomized patient discontinued before receiving study drug.|84
276488|NCT01176240|667596|P1|Took at Least 1 Dose of Study Drug|Study 306B|Two randomized patients discontinued before receiving study drug.|87
276489|NCT01176240|667595|P2|STARTED|Study 306B||85
276490|NCT01176240|667596|P1|STARTED|Study 306B||89
276491|NCT01176240|667595|P2|NOT COMPLETED|Study 306A||3
276492|NCT01176240|667596|P1|NOT COMPLETED|Study 306A||3
276493|NCT01176240|667595|P2|COMPLETED|Study 306A||24
276494|NCT01176240|667596|P1|COMPLETED|Study 306A||21
276495|NCT01176240|667595|P2|STARTED|Study 306A||27
276496|NCT01176240|667596|P1|STARTED|Study 306A||24
276497|NCT01176292|667622|P2|NOT COMPLETED|Overall Study||9
276498|NCT01176292|667623|P1|NOT COMPLETED|Overall Study||5
276499|NCT01176292|667622|P2|COMPLETED|Overall Study||62
276500|NCT01176292|667623|P1|COMPLETED|Overall Study||66
276501|NCT01176292|667622|P2|STARTED|Overall Study||71
276502|NCT01176292|667623|P1|STARTED|Overall Study||71
276503|NCT01176448|667641|P1|NOT COMPLETED|Overall Study||0
276504|NCT01176448|667641|P1|COMPLETED|Overall Study||6
276505|NCT01176448|667641|P1|STARTED|Overall Study||6
276506|NCT01176513|667649|P1|NOT COMPLETED|Overall Study||3
276507|NCT01176513|667649|P1|COMPLETED|Overall Study||22
276508|NCT01176513|667649|P1|STARTED|Overall Study||25
276509|NCT01179191|667654|P1|NOT COMPLETED|Maintenance Phase (8 Weeks)||117
276510|NCT01179191|667654|P1|COMPLETED|Maintenance Phase (8 Weeks)||234
276511|NCT01179191|667654|P1|STARTED|Maintenance Phase (8 Weeks)||351
276512|NCT01179191|667654|P1|NOT COMPLETED|Titration Phase (up to 6 Weeks)||333
276513|NCT01179191|667654|P1|COMPLETED|Titration Phase (up to 6 Weeks)||351
276514|NCT01179191|667654|P1|STARTED|Titration Phase (up to 6 Weeks)||684
276515|NCT01179217|667673|P2|NOT COMPLETED|Overall Study||19
276516|NCT01179217|667674|P1|NOT COMPLETED|Overall Study||55
276517|NCT01179217|667673|P2|COMPLETED|Overall Study||59
276518|NCT01179217|667674|P1|COMPLETED|Overall Study||97
276519|NCT01179217|667673|P2|STARTED|Overall Study||78
276520|NCT01179217|667674|P1|STARTED|Overall Study||152
276521|NCT01179334|667700|P2|NOT COMPLETED|Long-term Extension (LTE) Period||6
276522|NCT01179334|667701|P1|NOT COMPLETED|Long-term Extension (LTE) Period||11
276523|NCT01179334|667700|P2|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
276524|NCT01179334|667701|P1|COMPLETED|Long-term Extension (LTE) Period|LTE phase was terminated by sponsor|0
276525|NCT01179334|667700|P2|STARTED|Long-term Extension (LTE) Period||6
276526|NCT01179334|667701|P1|STARTED|Long-term Extension (LTE) Period||11
276527|NCT01179334|667700|P2|NOT COMPLETED|Treatment Period||0
276528|NCT01179334|667701|P1|NOT COMPLETED|Treatment Period||1
276529|NCT01179334|667700|P2|COMPLETED|Treatment Period||6
276530|NCT01179334|667701|P1|COMPLETED|Treatment Period||11
276531|NCT01179334|667700|P2|Participants Received Treatment|Treatment Period||6
276532|NCT01179334|667701|P1|Participants Received Treatment|Treatment Period||12
276533|NCT01179334|667700|P2|STARTED|Treatment Period||6
276534|NCT01179334|667701|P1|STARTED|Treatment Period||12
276535|NCT01179347|667731|P2|NOT COMPLETED|Open-label Period (12 Weeks)||16
276536|NCT01179347|667732|P1|NOT COMPLETED|Open-label Period (12 Weeks)||15
276537|NCT01179347|667731|P2|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|278
276538|NCT01179347|667732|P1|COMPLETED|Open-label Period (12 Weeks)|Completed open-label period.|132
276539|NCT01179347|667731|P2|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|294
276540|NCT01179347|667732|P1|STARTED|Open-label Period (12 Weeks)|Treated in open-label period.|147
276541|NCT01179347|667731|P2|NOT COMPLETED|Double-blind Period (12 Weeks)||14
276542|NCT01179347|667732|P1|NOT COMPLETED|Double-blind Period (12 Weeks)||8
276543|NCT01179347|667731|P2|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|294
276544|NCT01179347|667732|P1|COMPLETED|Double-blind Period (12 Weeks)|Completed double-blind period.|147
276545|NCT01179347|667731|P2|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|308
276546|NCT01179347|667732|P1|STARTED|Double-blind Period (12 Weeks)|Entered and treated in double-blind period.|155
276547|NCT01179399|667752|P1|NOT COMPLETED|Overall Study||32
276548|NCT01179399|667752|P1|COMPLETED|Overall Study||0
276549|NCT01179399|667752|P1|STARTED|Overall Study||32
276550|NCT01179490|667756|P1|NOT COMPLETED|Overall Study||0
276551|NCT01179490|667756|P1|COMPLETED|Overall Study||5
276552|NCT01179490|667756|P1|STARTED|Overall Study||5
276553|NCT01179516|667780|P3|NOT COMPLETED|Overall Study||31
276554|NCT01179516|667781|P2|NOT COMPLETED|Overall Study||26
276555|NCT01179516|667782|P1|NOT COMPLETED|Overall Study||27
276556|NCT01179516|667780|P3|COMPLETED|Overall Study||121
276557|NCT01179516|667781|P2|COMPLETED|Overall Study||131
276558|NCT01179516|667782|P1|COMPLETED|Overall Study||133
276559|NCT01179516|667780|P3|Treated|Overall Study||151
276560|NCT01179516|667781|P2|Treated|Overall Study||154
276561|NCT01179516|667782|P1|Treated|Overall Study||160
276562|NCT01179516|667780|P3|STARTED|Overall Study||152
276563|NCT01179516|667781|P2|STARTED|Overall Study||157
276564|NCT01179516|667782|P1|STARTED|Overall Study||160
276565|NCT01179568|667809|P4|NOT COMPLETED|Overall Study||20
276566|NCT01179568|667810|P3|NOT COMPLETED|Overall Study||23
276567|NCT01179568|667811|P2|NOT COMPLETED|Overall Study||38
276568|NCT01179568|667812|P1|NOT COMPLETED|Overall Study||28
276569|NCT01179568|667809|P4|COMPLETED|Overall Study||76
276570|NCT01179568|667810|P3|COMPLETED|Overall Study||76
276571|NCT01179568|667811|P2|COMPLETED|Overall Study||61
276572|NCT01179568|667812|P1|COMPLETED|Overall Study||73
276573|NCT01179568|667809|P4|Completed Week 12 Assessment|Overall Study||75
276574|NCT01179568|667810|P3|Completed Week 12 Assessment|Overall Study||76
276575|NCT01179568|667811|P2|Completed Week 12 Assessment|Overall Study||69
276576|NCT01179568|667812|P1|Completed Week 12 Assessment|Overall Study||69
276577|NCT01179568|667809|P4|STARTED|Overall Study||96
276578|NCT01179568|667810|P3|STARTED|Overall Study||99
276579|NCT01179568|667811|P2|STARTED|Overall Study||99
276580|NCT01179568|667812|P1|STARTED|Overall Study||101
276581|NCT01179672|667834|P2|NOT COMPLETED|Overall Study||26
276582|NCT01179672|667835|P1|NOT COMPLETED|Overall Study||30
276583|NCT01179672|667834|P2|COMPLETED|Overall Study||176
276584|NCT01179672|667835|P1|COMPLETED|Overall Study||173
276585|NCT01179672|667834|P2|Entered Taper|Overall Study||177
276586|NCT01179672|667835|P1|Entered Taper|Overall Study||181
276587|NCT01179672|667834|P2|Received at Least 1 Dose of Study Drug|Overall Study||202
276588|NCT01179672|667835|P1|Received at Least 1 Dose of Study Drug|Overall Study||202
276589|NCT01179672|667834|P2|STARTED|Overall Study||202
276590|NCT01179672|667835|P1|STARTED|Overall Study||203
276591|NCT01173653|667863|P2|NOT COMPLETED|Overall Study||41
276592|NCT01173653|667864|P1|NOT COMPLETED|Overall Study||53
276593|NCT01173653|667863|P2|COMPLETED|Overall Study||49
276594|NCT01173653|667864|P1|COMPLETED|Overall Study||56
276595|NCT01173653|667863|P2|STARTED|Overall Study||90
276596|NCT01173653|667864|P1|STARTED|Overall Study||109
276597|NCT01173679|667870|P1|NOT COMPLETED|Overall Study||1
276598|NCT01173679|667870|P1|COMPLETED|Overall Study||9
276599|NCT01173679|667870|P1|STARTED|Overall Study||10
276600|NCT01176773|667876|P1|NOT COMPLETED|Overall Study||3
276601|NCT01176773|667876|P1|COMPLETED|Overall Study||59
276602|NCT01176773|667876|P1|STARTED|Overall Study||62
276603|NCT01176877|667885|P1|NOT COMPLETED|Overall Study||9
276604|NCT01176877|667885|P1|COMPLETED|Overall Study||31
276605|NCT01176877|667885|P1|STARTED|Overall Study||40
276606|NCT01176955|667892|P2|NOT COMPLETED|Overall Study||2
276607|NCT01176955|667893|P1|NOT COMPLETED|Overall Study||3
276608|NCT01176955|667892|P2|COMPLETED|Overall Study||8
276609|NCT01176955|667893|P1|COMPLETED|Overall Study||7
276610|NCT01176955|667892|P2|STARTED|Overall Study||10
276611|NCT01176955|667893|P1|STARTED|Overall Study||10
276612|NCT01176968|667905|P2|NOT COMPLETED|Overall Study||82
276613|NCT01176968|667906|P1|NOT COMPLETED|Overall Study||84
276614|NCT01176968|667905|P2|COMPLETED|Overall Study||424
276615|NCT01176968|667906|P1|COMPLETED|Overall Study||422
276616|NCT01176968|667905|P2|Treated|Overall Study||505
276617|NCT01176968|667906|P1|Treated|Overall Study||505
276618|NCT01176968|667905|P2|STARTED|Overall Study||506
276619|NCT01176968|667906|P1|STARTED|Overall Study||506
276620|NCT01177007|667938|P1|NOT COMPLETED|Overall Study||38
276621|NCT01177007|667938|P1|COMPLETED|Overall Study||12
276622|NCT01177007|667938|P1|Completed First Clinical and Imaging|Overall Study||43
276623|NCT01177007|667938|P1|Completed First Y90 Treatment|Overall Study||50
276624|NCT01177007|667938|P1|STARTED|Overall Study||50
276625|NCT01177098|667952|P2|NOT COMPLETED|Overall Study||12
276626|NCT01177098|667953|P1|NOT COMPLETED|Overall Study||9
276627|NCT01177098|667952|P2|COMPLETED|Overall Study||271
276628|NCT01177098|667953|P1|COMPLETED|Overall Study||269
276629|NCT01177098|667952|P2|STARTED|Overall Study||283
276630|NCT01177098|667953|P1|STARTED|Overall Study||278
276631|NCT01177228|667973|P4|NOT COMPLETED|Overall Study||0
276632|NCT01177228|667974|P3|NOT COMPLETED|Overall Study||0
276633|NCT01177228|667975|P2|NOT COMPLETED|Overall Study||2
276634|NCT01177228|667976|P1|NOT COMPLETED|Overall Study||1
276635|NCT01177228|667973|P4|COMPLETED|Overall Study||11
276636|NCT01177228|667974|P3|COMPLETED|Overall Study||14
276637|NCT01177228|667975|P2|COMPLETED|Overall Study||11
276638|NCT01177228|667976|P1|COMPLETED|Overall Study||8
276639|NCT01177228|667973|P4|Received Treatment|Overall Study||11
276640|NCT01177228|667974|P3|Received Treatment|Overall Study||14
276641|NCT01177228|667975|P2|Received Treatment|Overall Study||12
276642|NCT01177228|667976|P1|Received Treatment|Overall Study||9
276643|NCT01177228|667973|P4|STARTED|Overall Study||11
276644|NCT01177228|667974|P3|STARTED|Overall Study||14
276645|NCT01177228|667975|P2|STARTED|Overall Study||13
276646|NCT01177228|667976|P1|STARTED|Overall Study||9
276647|NCT01177293|668014|P2|NOT COMPLETED|Second Intervention Period||0
276648|NCT01177293|668015|P1|NOT COMPLETED|Second Intervention Period||0
276649|NCT01177293|668014|P2|COMPLETED|Second Intervention Period||6
276650|NCT01177293|668015|P1|COMPLETED|Second Intervention Period||7
276651|NCT01177293|668014|P2|STARTED|Second Intervention Period||6
276652|NCT01177293|668015|P1|STARTED|Second Intervention Period||7
276653|NCT01177293|668014|P2|NOT COMPLETED|Washout Period (of 14 Days)||1
276654|NCT01177293|668015|P1|NOT COMPLETED|Washout Period (of 14 Days)||0
276655|NCT01177293|668014|P2|COMPLETED|Washout Period (of 14 Days)||6
276656|NCT01177293|668015|P1|COMPLETED|Washout Period (of 14 Days)||7
276657|NCT01177293|668014|P2|STARTED|Washout Period (of 14 Days)||7
276658|NCT01177293|668015|P1|STARTED|Washout Period (of 14 Days)||7
276659|NCT01177293|668014|P2|NOT COMPLETED|First Intervention Period||0
276660|NCT01177293|668015|P1|NOT COMPLETED|First Intervention Period||0
276661|NCT01177293|668014|P2|COMPLETED|First Intervention Period||7
276662|NCT01177293|668015|P1|COMPLETED|First Intervention Period||7
276663|NCT01177293|668014|P2|STARTED|First Intervention Period||7
276664|NCT01177293|668015|P1|STARTED|First Intervention Period||7
276665|NCT01177384|668031|P2|NOT COMPLETED|Overall Study||26
276666|NCT01177384|668032|P1|NOT COMPLETED|Overall Study||14
276667|NCT01177384|668031|P2|COMPLETED|Overall Study||164
276668|NCT01177384|668032|P1|COMPLETED|Overall Study||177
276669|NCT01177384|668031|P2|STARTED|Overall Study|Includes the second randomization of a participant|190
276670|NCT01177384|668032|P1|STARTED|Overall Study||191
276671|NCT01177410|668047|P3|NOT COMPLETED|Overall Study||5
276672|NCT01177410|668048|P2|NOT COMPLETED|Overall Study||7
276673|NCT01177410|668049|P1|NOT COMPLETED|Overall Study||1
276674|NCT01177410|668047|P3|COMPLETED|Overall Study||45
276675|NCT01177410|668048|P2|COMPLETED|Overall Study||40
276676|NCT01177410|668049|P1|COMPLETED|Overall Study||50
276677|NCT01177410|668047|P3|STARTED|Overall Study||50
276678|NCT01177410|668048|P2|STARTED|Overall Study||47
276679|NCT01177410|668049|P1|STARTED|Overall Study||51
276680|NCT01177553|668062|P2|NOT COMPLETED|Overall Study||0
276681|NCT01177553|668063|P1|NOT COMPLETED|Overall Study||1
276682|NCT01177553|668062|P2|COMPLETED|Overall Study|data as of March 2009|2
276683|NCT01177553|668063|P1|COMPLETED|Overall Study|data as of March 2009|2
276684|NCT01177553|668062|P2|STARTED|Overall Study||2
276685|NCT01177553|668063|P1|STARTED|Overall Study||3
276686|NCT01177670|668069|P1|NOT COMPLETED|Overall Study||169
276687|NCT01177670|668069|P1|COMPLETED|Overall Study||0
276688|NCT01177670|668069|P1|STARTED|Overall Study||169
276689|NCT01177709|668074|P1|NOT COMPLETED|Overall Study||0
276690|NCT01177709|668074|P1|COMPLETED|Overall Study||12
276691|NCT01177709|668074|P1|STARTED|Overall Study||12
276692|NCT01177722|668084|P4|NOT COMPLETED|Overall Study||7
276693|NCT01177722|668085|P3|NOT COMPLETED|Overall Study||9
276694|NCT01177722|668086|P2|NOT COMPLETED|Overall Study||10
276695|NCT01177722|668087|P1|NOT COMPLETED|Overall Study||13
276696|NCT01177722|668084|P4|COMPLETED|Overall Study||338
276697|NCT01177722|668085|P3|COMPLETED|Overall Study||333
276698|NCT01177722|668086|P2|COMPLETED|Overall Study||334
276699|NCT01177722|668087|P1|COMPLETED|Overall Study||331
276700|NCT01177722|668084|P4|STARTED|Overall Study||345
276701|NCT01177722|668085|P3|STARTED|Overall Study||342
276702|NCT01177722|668086|P2|STARTED|Overall Study|A randomized participant got Batch A vaccine, analyses was according to actual vaccine administered.|344
276703|NCT01177722|668087|P1|STARTED|Overall Study|A Batch B participant got Batch A vaccine data analyses was according to actual vaccine administered|344
276704|NCT01177735|668113|P1|NOT COMPLETED|Overall Study||71
276705|NCT01177735|668113|P1|COMPLETED|Overall Study||0
276706|NCT01177735|668113|P1|STARTED|Overall Study||71
276707|NCT01177800|668119|P2|NOT COMPLETED|Overall Study||5
276708|NCT01177800|668120|P1|NOT COMPLETED|Overall Study||10
276709|NCT01177800|668119|P2|COMPLETED|Overall Study||40
276710|NCT01177800|668120|P1|COMPLETED|Overall Study||74
276711|NCT01177800|668119|P2|STARTED|Overall Study||45
276712|NCT01177800|668120|P1|STARTED|Overall Study||84
276713|NCT01177813|668139|P5|NOT COMPLETED|Overall Study||9
276714|NCT01177813|668140|P4|NOT COMPLETED|Overall Study||17
276715|NCT01177813|668141|P3|NOT COMPLETED|Overall Study||20
276716|NCT01177813|668142|P2|NOT COMPLETED|Overall Study||18
276717|NCT01177813|668143|P1|NOT COMPLETED|Overall Study||41
276718|NCT01177813|668139|P5|COMPLETED|Overall Study||78
276719|NCT01177813|668140|P4|COMPLETED|Overall Study||206
276720|NCT01177813|668141|P3|COMPLETED|Overall Study||204
276721|NCT01177813|668142|P2|COMPLETED|Overall Study||206
276722|NCT01177813|668143|P1|COMPLETED|Overall Study||187
276723|NCT01177813|668139|P5|STARTED|Overall Study||87
276724|NCT01177813|668140|P4|STARTED|Overall Study||223
276725|NCT01177813|668141|P3|STARTED|Overall Study||224
276726|NCT01177813|668142|P2|STARTED|Overall Study||224
276727|NCT01177813|668143|P1|STARTED|Overall Study||228
276728|NCT01177943|668172|P2|NOT COMPLETED|Second Intervention||0
276729|NCT01177943|668173|P1|NOT COMPLETED|Second Intervention||0
276730|NCT01177943|668172|P2|COMPLETED|Second Intervention||21
276731|NCT01177943|668173|P1|COMPLETED|Second Intervention||19
276732|NCT01177943|668172|P2|STARTED|Second Intervention||21
276733|NCT01177943|668173|P1|STARTED|Second Intervention||19
276734|NCT01177943|668172|P2|NOT COMPLETED|First Intervention||0
276735|NCT01177943|668173|P1|NOT COMPLETED|First Intervention||2
276736|NCT01177943|668172|P2|COMPLETED|First Intervention||21
276737|NCT01177943|668173|P1|COMPLETED|First Intervention||19
276738|NCT01177943|668172|P2|STARTED|First Intervention||21
276739|NCT01177943|668173|P1|STARTED|First Intervention||21
276740|NCT01177956|668181|P1|NOT COMPLETED|Overall Study||0
276741|NCT01177956|668181|P1|COMPLETED|Overall Study||68
276742|NCT01177956|668181|P1|STARTED|Overall Study||68
276743|NCT01177969|668196|P2|NOT COMPLETED|Overall Study||3
276744|NCT01177969|668197|P1|NOT COMPLETED|Overall Study||3
276745|NCT01177969|668196|P2|COMPLETED|Overall Study||11
276746|NCT01177969|668197|P1|COMPLETED|Overall Study||16
276747|NCT01177969|668196|P2|STARTED|Overall Study||14
276748|NCT01177969|668197|P1|STARTED|Overall Study||19
276749|NCT01178073|668208|P3|NOT COMPLETED|Overall Study||46
276750|NCT01178073|668209|P2|NOT COMPLETED|Overall Study||44
276751|NCT01178073|668210|P1|NOT COMPLETED|Overall Study||62
276752|NCT01178073|668208|P3|COMPLETED|Overall Study||105
276753|NCT01178073|668209|P2|COMPLETED|Overall Study||108
276754|NCT01178073|668210|P1|COMPLETED|Overall Study||240
276755|NCT01178073|668208|P3|STARTED|Overall Study||151
276756|NCT01178073|668209|P2|STARTED|Overall Study||152
276757|NCT01178073|668210|P1|STARTED|Overall Study||302
276758|NCT01178099|668243|P2|NOT COMPLETED|Overall Study||1
276759|NCT01178099|668244|P1|NOT COMPLETED|Overall Study||0
276760|NCT01178099|668243|P2|COMPLETED|Overall Study||12
276761|NCT01178099|668244|P1|COMPLETED|Overall Study||13
276762|NCT01178099|668243|P2|STARTED|Overall Study||13
276763|NCT01178099|668244|P1|STARTED|Overall Study||13
276764|NCT01178125|668282|P1|NOT COMPLETED|Overall Study||1178
276765|NCT01178125|668282|P1|COMPLETED|Overall Study||1680
276766|NCT01178125|668282|P1|Pregnancy ITT (PITT) Population|Overall Study|Participants in the ITT population between the ages of 18 and 35, inclusive.|2401
276767|NCT01178125|668282|P1|Intent to Treat (ITT) Population|Overall Study|Completed at least one 28-day cycle of investigational product.|2607
276768|NCT01178125|668282|P1|Safety Population|Overall Study|Received at least 1 dose of DR-102.|2765
276769|NCT01178125|668282|P1|STARTED|Overall Study|Number enrolled.|2858
276770|NCT01178138|668309|P1|NOT COMPLETED|Overall Study||23
276771|NCT01178138|668309|P1|COMPLETED|Overall Study||1
276772|NCT01178138|668309|P1|Completed 3 Sessions|Overall Study||1
276773|NCT01178138|668309|P1|Completed 5 Sessions|Overall Study||1
276774|NCT01178138|668309|P1|Completed 6 Sessions|Overall Study||1
276775|NCT01178138|668309|P1|STARTED|Overall Study||24
276776|NCT01178268|668332|P2|NOT COMPLETED|Overall Study||1
276777|NCT01178268|668333|P1|NOT COMPLETED|Overall Study||7
276778|NCT01178268|668332|P2|COMPLETED|Overall Study||120
276779|NCT01178268|668333|P1|COMPLETED|Overall Study||360
276780|NCT01178268|668332|P2|STARTED|Overall Study||121
276781|NCT01178268|668333|P1|STARTED|Overall Study||367
276782|NCT01178281|668552|P2|NOT COMPLETED|Overall Study||77
276783|NCT01178281|668553|P1|NOT COMPLETED|Overall Study||149
276784|NCT01178281|668552|P2|COMPLETED|Overall Study|Participants remain on treatment|7
276785|NCT01178281|668553|P1|COMPLETED|Overall Study|Participants remain on treatment|19
276786|NCT01178281|668552|P2|STARTED|Overall Study|Intent to Treat Population (ITT)|84
276787|NCT01178281|668553|P1|STARTED|Overall Study|Intent to Treat Population (ITT)|168
276788|NCT01178294|668559|P1|NOT COMPLETED|Overall Study||11
276789|NCT01178294|668559|P1|COMPLETED|Overall Study||18
276790|NCT01178294|668559|P1|STARTED|Overall Study|25 subjects enrolled under OBI-1-301 + 4 subjects enrolled under expanded access OBI-1-301a.|29
276791|NCT01178333|668583|P3|NOT COMPLETED|Overall Study||0
276792|NCT01178333|668584|P2|NOT COMPLETED|Overall Study||0
276793|NCT01178333|668585|P1|NOT COMPLETED|Overall Study||0
276794|NCT01178333|668583|P3|COMPLETED|Overall Study||87
276795|NCT01178333|668584|P2|COMPLETED|Overall Study||284
276796|NCT01178333|668585|P1|COMPLETED|Overall Study||71
276797|NCT01178333|668583|P3|STARTED|Overall Study||87
276798|NCT01178333|668584|P2|STARTED|Overall Study||284
276799|NCT01178333|668585|P1|STARTED|Overall Study||71
276800|NCT01178385|668641|P2|NOT COMPLETED|Overall Study||0
276801|NCT01178385|668642|P1|NOT COMPLETED|Overall Study||2
276802|NCT01178385|668641|P2|COMPLETED|Overall Study||21
276803|NCT01178385|668642|P1|COMPLETED|Overall Study||22
276804|NCT01178385|668641|P2|STARTED|Overall Study||21
276805|NCT01178385|668642|P1|STARTED|Overall Study||24
276806|NCT01178528|668655|P3|NOT COMPLETED|Overall Study||0
276807|NCT01178528|668656|P2|NOT COMPLETED|Overall Study||0
276808|NCT01178528|668657|P1|NOT COMPLETED|Overall Study||0
276809|NCT01178528|668655|P3|COMPLETED|Overall Study||42
276810|NCT01178528|668656|P2|COMPLETED|Overall Study||38
276811|NCT01178528|668657|P1|COMPLETED|Overall Study||41
276812|NCT01178528|668655|P3|STARTED|Overall Study||42
276813|NCT01178528|668656|P2|STARTED|Overall Study||38
276814|NCT01178528|668657|P1|STARTED|Overall Study||41
276815|NCT01178671|668676|P2|NOT COMPLETED|Overall Study||15
276816|NCT01178671|668677|P1|NOT COMPLETED|Overall Study||12
276817|NCT01178671|668676|P2|COMPLETED|Overall Study||3
276818|NCT01178671|668677|P1|COMPLETED|Overall Study||6
276819|NCT01178671|668676|P2|STARTED|Overall Study||18
276820|NCT01178671|668677|P1|STARTED|Overall Study||18
276821|NCT01178762|668701|P1|NOT COMPLETED|Overall Study||15
276822|NCT01178762|668701|P1|COMPLETED|Overall Study||27
276823|NCT01178762|668701|P1|STARTED|Overall Study||42
276824|NCT01178827|668708|P3|NOT COMPLETED|Overall Study||0
276825|NCT01178827|668709|P2|NOT COMPLETED|Overall Study||0
276826|NCT01178827|668710|P1|NOT COMPLETED|Overall Study||0
276827|NCT01178827|668708|P3|COMPLETED|Overall Study||4
276828|NCT01178827|668709|P2|COMPLETED|Overall Study||10
276829|NCT01178827|668710|P1|COMPLETED|Overall Study||6
276830|NCT01178827|668708|P3|STARTED|Overall Study||4
276831|NCT01178827|668709|P2|STARTED|Overall Study||10
276832|NCT01178827|668710|P1|STARTED|Overall Study||6
276833|NCT01178853|668741|P2|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||3
276834|NCT01178853|668742|P1|NOT COMPLETED|Period 4 (Warfarin + Study Drug)||0
276835|NCT01178853|668741|P2|COMPLETED|Period 4 (Warfarin + Study Drug)||19
276836|NCT01178853|668742|P1|COMPLETED|Period 4 (Warfarin + Study Drug)||21
276837|NCT01178853|668741|P2|STARTED|Period 4 (Warfarin + Study Drug)||22
276838|NCT01178853|668742|P1|STARTED|Period 4 (Warfarin + Study Drug)||21
276839|NCT01178853|668741|P2|NOT COMPLETED|Period 3 (Warfarin Titration)||0
276840|NCT01178853|668742|P1|NOT COMPLETED|Period 3 (Warfarin Titration)||1
276841|NCT01178853|668741|P2|COMPLETED|Period 3 (Warfarin Titration)||22
276842|NCT01178853|668742|P1|COMPLETED|Period 3 (Warfarin Titration)||21
276843|NCT01178853|668741|P2|STARTED|Period 3 (Warfarin Titration)||22
276844|NCT01178853|668742|P1|STARTED|Period 3 (Warfarin Titration)||22
276845|NCT01178853|668741|P2|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||0
276846|NCT01178853|668742|P1|NOT COMPLETED|Period 2 (Warfarin + Study Drug)||1
276847|NCT01178853|668741|P2|COMPLETED|Period 2 (Warfarin + Study Drug)||22
276848|NCT01178853|668742|P1|COMPLETED|Period 2 (Warfarin + Study Drug)||22
276849|NCT01178853|668741|P2|STARTED|Period 2 (Warfarin + Study Drug)||22
276850|NCT01178853|668742|P1|STARTED|Period 2 (Warfarin + Study Drug)||23
276851|NCT01178853|668741|P2|NOT COMPLETED|Period 1 (Warfarin Titration)||2
276852|NCT01178853|668742|P1|NOT COMPLETED|Period 1 (Warfarin Titration)||1
276853|NCT01178853|668741|P2|COMPLETED|Period 1 (Warfarin Titration)||22
276854|NCT01178853|668742|P1|COMPLETED|Period 1 (Warfarin Titration)||23
276855|NCT01178853|668741|P2|STARTED|Period 1 (Warfarin Titration)||24
276856|NCT01178853|668742|P1|STARTED|Period 1 (Warfarin Titration)||24
276857|NCT01179048|668750|P2|NOT COMPLETED|Overall Study||159
276858|NCT01179048|668751|P1|NOT COMPLETED|Overall Study||139
276859|NCT01179048|668750|P2|COMPLETED|Overall Study||4513
276860|NCT01179048|668751|P1|COMPLETED|Overall Study||4529
276861|NCT01179048|668750|P2|STARTED|Overall Study||4672
276862|NCT01179048|668751|P1|STARTED|Overall Study||4668
276863|NCT01179113|668769|P2|NOT COMPLETED|Overall Study||0
276864|NCT01179113|668770|P1|NOT COMPLETED|Overall Study||0
276865|NCT01179113|668769|P2|COMPLETED|Overall Study||16
276866|NCT01179113|668770|P1|COMPLETED|Overall Study||17
276867|NCT01179113|668769|P2|STARTED|Overall Study||16
276868|NCT01179113|668770|P1|STARTED|Overall Study||17
276869|NCT01176565|668782|P2|NOT COMPLETED|Overall Study||19
276870|NCT01176565|668783|P1|NOT COMPLETED|Overall Study||20
276871|NCT01176565|668782|P2|COMPLETED|Overall Study||481
276872|NCT01176565|668783|P1|COMPLETED|Overall Study||480
276873|NCT01176565|668782|P2|STARTED|Overall Study||500
276874|NCT01176565|668783|P1|STARTED|Overall Study||500
276875|NCT02773758|668803|P2|NOT COMPLETED|Overall Study||0
276876|NCT02773758|668804|P1|NOT COMPLETED|Overall Study||0
276877|NCT02773758|668803|P2|COMPLETED|Overall Study||70
276878|NCT02773758|668804|P1|COMPLETED|Overall Study||71
276879|NCT02773758|668803|P2|STARTED|Overall Study||70
276880|NCT02773758|668804|P1|STARTED|Overall Study||71
276884|NCT02223364|668878|P3|NOT COMPLETED|Overall Study||3
276885|NCT02223364|668879|P2|NOT COMPLETED|Overall Study||0
276886|NCT02223364|668880|P1|NOT COMPLETED|Overall Study||5
276887|NCT02223364|668878|P3|COMPLETED|Overall Study||52
276888|NCT02223364|668879|P2|COMPLETED|Overall Study||55
276889|NCT02223364|668880|P1|COMPLETED|Overall Study||50
276890|NCT02223364|668878|P3|STARTED|Overall Study||55
276891|NCT02223364|668879|P2|STARTED|Overall Study||55
276892|NCT02223364|668880|P1|STARTED|Overall Study||55
276899|NCT02116582|668960|P1|NOT COMPLETED|Overall Study||185
276900|NCT02116582|668960|P1|COMPLETED|Overall Study|Completed indicates participants were still on study drug at the time of the data cut-off.|30
276901|NCT02116582|668960|P1|Treated|Overall Study||214
276902|NCT02116582|668960|P1|STARTED|Overall Study||215
276903|NCT01262560|668971|P3|NOT COMPLETED|Overall Study||2
276904|NCT01262560|668972|P2|NOT COMPLETED|Overall Study||1
276905|NCT01262560|668973|P1|NOT COMPLETED|Overall Study||0
276906|NCT01262560|668971|P3|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|54
276907|NCT01262560|668972|P2|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
276908|NCT01262560|668973|P1|COMPLETED|Overall Study|Randomized eligible patients who received protocol treatment.|53
276909|NCT01262560|668971|P3|STARTED|Overall Study||56
276910|NCT01262560|668972|P2|STARTED|Overall Study||54
276911|NCT01262560|668973|P1|STARTED|Overall Study||53
276918|NCT00670631|669013|P1|NOT COMPLETED|Overall Study||0
276919|NCT00670631|669013|P1|COMPLETED|Overall Study||0
276920|NCT00670631|669013|P1|STARTED|Overall Study||0
276927|NCT02283268|669031|P1|NOT COMPLETED|Overall Study||1
276928|NCT02283268|669031|P1|COMPLETED|Overall Study||14
276929|NCT02283268|669031|P1|STARTED|Overall Study||15
276930|NCT02154425|669092|P1|NOT COMPLETED|Sampling Period||0
276931|NCT02154425|669092|P1|COMPLETED|Sampling Period||17
276932|NCT02154425|669092|P1|STARTED|Sampling Period||17
276933|NCT02154425|669092|P1|NOT COMPLETED|Screening Period||1
276934|NCT02154425|669092|P1|COMPLETED|Screening Period||17
276935|NCT02154425|669092|P1|STARTED|Screening Period||18
276966|NCT01163461|669157|P2|NOT COMPLETED|Overall Study||0
276967|NCT01163461|669158|P1|NOT COMPLETED|Overall Study||0
276968|NCT01163461|669157|P2|COMPLETED|Overall Study||14
276969|NCT01163461|669158|P1|COMPLETED|Overall Study||14
276970|NCT01163461|669157|P2|STARTED|Overall Study||14
276971|NCT01163461|669158|P1|STARTED|Overall Study||14
276978|NCT00641641|669215|P1|NOT COMPLETED|Overall Study||0
276979|NCT00641641|669215|P1|COMPLETED|Overall Study||16
276980|NCT00641641|669215|P1|STARTED|Overall Study||16
276981|NCT00407888|669219|P1|NOT COMPLETED|Overall Study||0
276982|NCT00407888|669219|P1|COMPLETED|Overall Study||60
276983|NCT00407888|669219|P1|STARTED|Overall Study||60
276984|NCT00127660|669231|P4|NOT COMPLETED|Overall Study||0
276985|NCT00127660|669232|P3|NOT COMPLETED|Overall Study||5
276986|NCT00127660|669233|P2|NOT COMPLETED|Overall Study||3
276987|NCT00127660|669234|P1|NOT COMPLETED|Overall Study||3
276988|NCT00127660|669231|P4|COMPLETED|Overall Study||150
276989|NCT00127660|669232|P3|COMPLETED|Overall Study||143
276990|NCT00127660|669233|P2|COMPLETED|Overall Study||151
276991|NCT00127660|669234|P1|COMPLETED|Overall Study||150
276992|NCT00127660|669231|P4|STARTED|Overall Study||150
276993|NCT00127660|669232|P3|STARTED|Overall Study||148
276994|NCT00127660|669233|P2|STARTED|Overall Study||154
276995|NCT00127660|669234|P1|STARTED|Overall Study||153
276996|NCT01793883|669247|P3|NOT COMPLETED|Overall Study||8
276997|NCT01793883|669248|P2|NOT COMPLETED|Overall Study||10
276998|NCT01793883|669249|P1|NOT COMPLETED|Overall Study||12
276999|NCT01793883|669247|P3|COMPLETED|Overall Study||204
277000|NCT01793883|669248|P2|COMPLETED|Overall Study||204
277001|NCT01793883|669249|P1|COMPLETED|Overall Study||201
277002|NCT01793883|669247|P3|STARTED|Overall Study||212
277003|NCT01793883|669248|P2|STARTED|Overall Study||214
277004|NCT01793883|669249|P1|STARTED|Overall Study||213
277005|NCT01268553|669257|P1|NOT COMPLETED|Overall Study||0
277006|NCT01268553|669257|P1|COMPLETED|Overall Study||6
277007|NCT01268553|669257|P1|STARTED|Overall Study||6
277008|NCT01244893|669266|P2|NOT COMPLETED|Final Visit||0
277009|NCT01244893|669267|P1|NOT COMPLETED|Final Visit||0
277010|NCT01244893|669266|P2|COMPLETED|Final Visit||21
277011|NCT01244893|669267|P1|COMPLETED|Final Visit||21
277012|NCT01244893|669266|P2|STARTED|Final Visit||21
277013|NCT01244893|669267|P1|STARTED|Final Visit||21
277014|NCT01244893|669266|P2|NOT COMPLETED|1-Week Follow Up||0
277015|NCT01244893|669267|P1|NOT COMPLETED|1-Week Follow Up||1
277016|NCT01244893|669266|P2|COMPLETED|1-Week Follow Up||21
277017|NCT01244893|669267|P1|COMPLETED|1-Week Follow Up||21
277018|NCT01244893|669266|P2|STARTED|1-Week Follow Up||21
277019|NCT01244893|669267|P1|STARTED|1-Week Follow Up||22
277020|NCT01244893|669266|P2|NOT COMPLETED|Baseline||1
277021|NCT01244893|669267|P1|NOT COMPLETED|Baseline||0
277022|NCT01244893|669266|P2|COMPLETED|Baseline||21
277023|NCT01244893|669267|P1|COMPLETED|Baseline||22
277024|NCT01244893|669266|P2|STARTED|Baseline||22
277025|NCT01244893|669267|P1|STARTED|Baseline||22
277026|NCT01000493|669281|P2|NOT COMPLETED|Overall Study||55
277027|NCT01000493|669282|P1|NOT COMPLETED|Overall Study||39
277028|NCT01000493|669281|P2|COMPLETED|Overall Study||14
277029|NCT01000493|669282|P1|COMPLETED|Overall Study||21
277030|NCT01000493|669281|P2|STARTED|Overall Study||69
277031|NCT01000493|669282|P1|STARTED|Overall Study||60
